<SEC-DOCUMENT>0000051253-24-000006.txt : 20240228
<SEC-HEADER>0000051253-24-000006.hdr.sgml : 20240228
<ACCEPTANCE-DATETIME>20240228083545
ACCESSION NUMBER:		0000051253-24-000006
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		160
CONFORMED PERIOD OF REPORT:	20231231
FILED AS OF DATE:		20240228
DATE AS OF CHANGE:		20240228

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			INTERNATIONAL FLAVORS & FRAGRANCES INC
		CENTRAL INDEX KEY:			0000051253
		STANDARD INDUSTRIAL CLASSIFICATION:	INDUSTRIAL ORGANIC CHEMICALS [2860]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				131432060
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-04858
		FILM NUMBER:		24690429

	BUSINESS ADDRESS:	
		STREET 1:		521 W 57TH ST
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019
		BUSINESS PHONE:		2127655500

	MAIL ADDRESS:	
		STREET 1:		521 W 57TH ST
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	VANAMERIGEN HAEBLER INC
		DATE OF NAME CHANGE:	19680426
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>iff-20231231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns="http://www.w3.org/1999/xhtml" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:srt="http://fasb.org/srt/2023" xmlns:ecd="http://xbrl.sec.gov/ecd/2023" xmlns:iff="http://www.iff.com/20231231" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>iff-20231231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-43">false</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-44">2023</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-45">FY</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-46">0000051253</ix:nonNumeric><ix:nonNumeric contextRef="c-11" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="f-1085">http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-12" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="f-1086">http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-11" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="f-1141">http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-12" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="f-1142">http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-11" name="us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="f-1145">http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-12" name="us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="f-1146">http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-11" name="us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="f-1149">http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-12" name="us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="f-1150">http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-11" name="us-gaap:DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration" id="f-2472">http://fasb.org/us-gaap/2023#OtherAssetsCurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-11" name="us-gaap:DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration" id="f-2477">http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-786" name="us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="f-2581">http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpense</ix:nonNumeric><ix:nonNumeric contextRef="c-787" name="us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="f-2582">http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpense</ix:nonNumeric><ix:nonNumeric contextRef="c-790" name="us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="f-2585">http://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSold</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="iff-20231231.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:OtherAddressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">iff:A1.750SeniorNotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">iff:A1.800SeniorNotesDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-02-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">iff:TradeAccountsReceivableWithTheCompanysOwnFactoringAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">iff:TradeAccountsReceivableWithTheCompanysOwnFactoringAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">iff:TradeAccountsReceivableWithTheCompanysOwnFactoringAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">iff:TradeAccountsReceivableWithTheCompanysOwnFactoringAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">iff:TradeAccountsReceivableWithTheCompanysOwnFactoringAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">iff:RussiaUkraineWarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:EG</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">iff:RussiaUkraineWarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iff:BuildingsAndImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iff:BuildingsAndImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iff:InformationTechnologyHardwareAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iff:InformationTechnologyHardwareAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">iff:RussiaUkraineWarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">iff:RussiaUkraineWarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:FiniteLivedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">iff:RussiaUkraineWarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="reporting_unit"><xbrli:measure>iff:reporting_unit</xbrli:measure></xbrli:unit><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">iff:NourishMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">iff:HealthBiosciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:FrutaromIntegrationInitiativeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="facility"><xbrli:measure>iff:Facility</xbrli:measure></xbrli:unit><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:FrutaromIntegrationInitiativeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:A2019SeveranceInitiativesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="position"><xbrli:measure>iff:Position</xbrli:measure></xbrli:unit><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:A2019SeveranceInitiativesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:A2023RestructuringProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="position2"><xbrli:measure>iff:position</xbrli:measure></xbrli:unit><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:FrutaromIntegrationInitiativeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:FrutaromIntegrationInitiativeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:FrutaromIntegrationInitiativeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">iff:FixedAssetWriteDownMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:FrutaromIntegrationInitiativeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">iff:FixedAssetWriteDownMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:FrutaromIntegrationInitiativeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">iff:FixedAssetWriteDownMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:FrutaromIntegrationInitiativeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:FrutaromIntegrationInitiativeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:FrutaromIntegrationInitiativeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:FrutaromIntegrationInitiativeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:A2019SeveranceInitiativesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:A2019SeveranceInitiativesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:A2019SeveranceInitiativesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:FrutaromIntegrationInitiativeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:FrutaromIntegrationInitiativeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">iff:FixedAssetWriteDownMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:FrutaromIntegrationInitiativeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">iff:FixedAssetWriteDownMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:FrutaromIntegrationInitiativeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:FrutaromIntegrationInitiativeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:FrutaromIntegrationInitiativeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:A2019SeveranceInitiativesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:A2019SeveranceInitiativesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:FrutaromIntegrationInitiativeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:FrutaromIntegrationInitiativeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:A2023RestructuringProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:A2023RestructuringProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:A2023RestructuringProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:NourishMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:NourishMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:NourishMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:HealthBiosciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:HealthBiosciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:HealthBiosciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:ScentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:ScentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:ScentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:PharmaSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:PharmaSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:PharmaSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:HealthWrightProductsIncHealthWrightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:HealthWrightProductsIncHealthWrightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:HealthWrightProductsIncHealthWrightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:HealthWrightProductsIncHealthWrightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:HealthWrightProductsIncHealthWrightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:HealthWrightProductsIncHealthWrightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:HealthWrightProductsIncHealthWrightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-02-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">iff:DuPontdeNemoursIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">iff:InternationalFlavorsFragrancesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">iff:InternationalFlavorsFragrancesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-02-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-02-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-170"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iff:FlavorSpecialtyIngredientsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-01</xbrli:startDate><xbrli:endDate>2023-08-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-171"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iff:FlavorSpecialtyIngredientsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iff:FlavorSpecialtyIngredientsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iff:FlavorSpecialtyIngredientsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-174"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iff:FlavorSpecialtyIngredientsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iff:SavorySolutionsBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-31</xbrli:startDate><xbrli:endDate>2023-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-176"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iff:SavorySolutionsBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-177"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iff:SavorySolutionsBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iff:SavorySolutionsBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-179"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iff:SavorySolutionsBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-180"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iff:MicrobialControlMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-181"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iff:MicrobialControlMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-182"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iff:MicrobialControlMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-183"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iff:MicrobialControlMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-184"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iff:MicrobialControlMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-185"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-186"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-187"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-188"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-189"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-190"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-191"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:TechnologyEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-192"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:TechnologyEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-193"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-194"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-195"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:NourishMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-196"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:HealthBiosciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-197"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:ScentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-198"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:PharmaSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-199"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:NourishMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-200"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:HealthBiosciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:ScentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:PharmaSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:NourishMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">iff:HealthBiosciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:ScentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:PharmaSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:HealthBiosciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">iff:HealthBiosciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">iff:FragranceIngredientsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">iff:PharmaSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandTwentyThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandTwentyThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesEuroNotesDueTwoThousandTwentyFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesEuroNotesDueTwoThousandTwentyFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-224"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandTwentyFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandTwentyFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesEuroNotesDueTwoThousandTwentySixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesEuroNotesDueTwoThousandTwentySixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandTwentySevenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandTwentySevenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandTwentyEightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandTwentyEightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-232"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandThirtyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-233"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandThirtyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-234"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandFortyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-235"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandFortyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-236"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandFortySevenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-237"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandFortySevenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-238"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandFortyEightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-239"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandFortyEightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-240"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandFiftyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-241"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandFiftyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-242"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:A2024TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-243"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:A2024TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-244"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:A2026TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-245"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:A2026TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-246"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-247"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-248"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:BankBorrowingsAndOverdraftsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-249"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:BankBorrowingsAndOverdraftsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-250"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iff:EurocurrencyRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">iff:CitibankN.AMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-28</xbrli:startDate><xbrli:endDate>2021-07-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-251"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iff:EurocurrencyRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">iff:CitibankN.AMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-28</xbrli:startDate><xbrli:endDate>2021-07-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-252"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">iff:CitibankN.AMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-28</xbrli:startDate><xbrli:endDate>2021-07-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-253"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">iff:CitibankN.AMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-28</xbrli:startDate><xbrli:endDate>2021-07-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-254"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorUnsecuredTermLoanFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-255"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorUnsecuredNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-256"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorUnsecuredNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-02-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-257"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorUnsecuredNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-02-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-258"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:A2024TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-259"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:A2026TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-260"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iff:LondonInterbankOfferedRateLIBOR1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:A2024TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-261"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iff:LondonInterbankOfferedRateLIBOR1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:A2024TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-262"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iff:LondonInterbankOfferedRateLIBOR1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:A2026TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-263"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iff:LondonInterbankOfferedRateLIBOR1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:A2026TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-264"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:A2024TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-265"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:A2024TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-266"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:A2026TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-267"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:A2026TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-268"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:TermLoanCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iff:SecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-23</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-269"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="iff:DebtCovenantPeriodAxis">iff:FiscalQuarterEndingOnOrBeforeMarch312024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:TermLoanCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-270"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="iff:DebtCovenantPeriodAxis">iff:FiscalQuarterEndingJune302024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:TermLoanCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-271"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:TermLoanCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="iff:DebtCovenantPeriodAxis">iff:FiscalQuarterEndingSeptember302024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-272"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="iff:DebtCovenantPeriodAxis">iff:SubsequentFiscalQuarterEndingOnOrBeforeMarch312025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:TermLoanCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-273"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="iff:DebtCovenantPeriodAxis">iff:SubsequentFiscalQuarterEndingOnOrBeforeSeptember302025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:TermLoanCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-274"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="iff:DebtCovenantPeriodAxis">iff:FiscalQuarterEndingDecember312025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:TermLoanCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-275"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:TermLoanCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-09-19</xbrli:startDate><xbrli:endDate>2023-09-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-276"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:TermLoanCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-277"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:A2024TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-278"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorUnsecuredNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-279"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandTwentyTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-280"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandTwentyFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-281"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandTwentySevenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-282"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandThirtyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-283"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandFortyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-284"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandFiftyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-285"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandTwentyTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-15</xbrli:startDate><xbrli:endDate>2022-09-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-286"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">iff:CitibankN.AMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-06-06</xbrli:startDate><xbrli:endDate>2018-06-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-287"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iff:EuroInterbankOfferedRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-23</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-288"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iff:SecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-23</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-289"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="iff:DebtCovenantPeriodAxis">iff:FiscalQuarterEndingOnOrBeforeMarch312024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-290"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="iff:DebtCovenantPeriodAxis">iff:FiscalQuarterEndingJune302024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-291"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="iff:DebtCovenantPeriodAxis">iff:FiscalQuarterEndingSeptember302024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-292"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="iff:DebtCovenantPeriodAxis">iff:SubsequentFiscalQuarterEndingOnOrBeforeMarch312025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-293"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="iff:DebtCovenantPeriodAxis">iff:SubsequentFiscalQuarterEndingOnOrBeforeSeptember302025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-294"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="iff:DebtCovenantPeriodAxis">iff:FiscalQuarterEndingDecember312025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-295"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-09-19</xbrli:startDate><xbrli:endDate>2023-09-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-296"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-297"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">iff:CitibankN.AMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-298"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-299"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">iff:CitibankN.AMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-300"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">iff:CitibankN.AMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-28</xbrli:startDate><xbrli:endDate>2021-07-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">iff:CitibankN.AMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-302"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">iff:CitibankN.AMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-303"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesEuroNotesDueTwoThousandTwentySixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="c-304"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">iff:SeniorNotesEuroNotesDueTwoThousandTwentySixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-305"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandTwentyEightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-306"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">iff:SeniorNotesDueTwoThousandTwentyEightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-307"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandFortyEightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">iff:SeniorNotesDueTwoThousandFortyEightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandTwentyThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2013-04-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-310"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandTwentyThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-04-04</xbrli:startDate><xbrli:endDate>2013-04-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-311"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandTwentyThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2023-05-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-312"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesEuroNotesDueTwoThousandTwentyFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-03-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-313"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesEuroNotesDueTwoThousandTwentyFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-03-14</xbrli:startDate><xbrli:endDate>2016-03-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-314"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandFortySevenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-05-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-315"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandFortySevenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-05-18</xbrli:startDate><xbrli:endDate>2017-05-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-316"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:InternationalFlavorsFragrancesIncSeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">iff:InternationalFlavorsFragrancesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-317"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesEuroNotesDueTwoThousandTwentyFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">iff:InternationalFlavorsFragrancesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-318"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesEuroNotesDueTwoThousandTwentySixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">iff:InternationalFlavorsFragrancesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-319"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandTwentyEightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">iff:InternationalFlavorsFragrancesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-320"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandFortySevenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">iff:InternationalFlavorsFragrancesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-321"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandFortyEightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">iff:InternationalFlavorsFragrancesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-322"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:NutritionBiosciencesIncSeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-323"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandTwentyFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-324"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandTwentySevenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-325"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandThirtyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandFortyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandFiftyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:A2024TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-02-01</xbrli:startDate><xbrli:endDate>2024-02-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">iff:TwoThousandTwentyThreeToTwoThousandFortyTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">iff:TwoThousandTwentyTwoToTwoThousandFortyOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">iff:IndefiniteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-332"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis">iff:UnrecognizedTaxBenefitsOtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-333"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis">iff:UnrecognizedTaxBenefitsOtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-334"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis">iff:UnrecognizedTaxBenefitsOtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-335"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis">iff:UnrecognizedTaxBenefitsOtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-336"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis">iff:UnrecognizedTaxBenefitsOtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-337"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis">iff:UnrecognizedTaxBenefitsOtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-338"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-339"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-340"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-341"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-342"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-343"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-344"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-345"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-346"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-17</xbrli:startDate><xbrli:endDate>2018-09-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-347"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-348"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-15</xbrli:startDate><xbrli:endDate>2021-09-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-349"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iff:ShareEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-350"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iff:ShareEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-351"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iff:ShareEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-352"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iff:EquityBasedAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-353"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iff:EquityBasedAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-354"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iff:EquityBasedAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-355"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iff:LiabilityBasedAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-356"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iff:LiabilityBasedAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-357"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iff:LiabilityBasedAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-358"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iff:TwoThousandTwentyOnePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-359"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iff:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-360"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iff:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-361"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iff:TwoThousandNineteenToTwoThousandTwentyOneCycleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-362"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iff:TwoThousandTwentyToTwoThousandTwentyTwoCycleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-363"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iff:TwoThousandTwentyOneToTwoThousandTwentyThreeCycleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-364"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-02-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-365"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-02-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-366"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-02-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-367"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-368"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iff:StockOptionsAndStockSettledAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-369"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iff:StockOptionsAndStockSettledAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-370"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iff:StockOptionsAndStockSettledAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-371"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iff:StockOptionsAndStockSettledAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-372"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iff:StockOptionsAndStockSettledAppreciationRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iff:Over65Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-373"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iff:StockOptionsAndStockSettledAppreciationRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iff:Over65Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-374"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iff:StockOptionsAndStockSettledAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-375"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iff:StockOptionsAndStockSettledAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-376"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-377"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-378"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-379"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-380"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iff:PurchasedRestrictedStockUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-381"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iff:PurchasedRestrictedStockUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-382"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iff:PurchasedRestrictedStockUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-383"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iff:PurchasedRestrictedStockUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-384"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iff:PurchasedRestrictedStockUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-385"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iff:CashRestrictedStockUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-386"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iff:CashRestrictedStockUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-387"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iff:CashRestrictedStockUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>iff:segment</xbrli:measure></xbrli:unit><xbrli:unit id="category"><xbrli:measure>iff:category</xbrli:measure></xbrli:unit><xbrli:context id="c-388"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:NourishMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-389"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:NourishMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-390"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:NourishMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-391"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:HealthBiosciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-392"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:HealthBiosciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-393"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:HealthBiosciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-394"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:ScentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-395"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:ScentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-396"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:ScentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-397"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:PharmaSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-398"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:PharmaSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-399"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:PharmaSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-400"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:NourishMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:NourishMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:HealthBiosciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:HealthBiosciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-404"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:ScentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-405"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:ScentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-406"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:PharmaSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-407"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:PharmaSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-408"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-409"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="customer"><xbrli:measure>iff:customer</xbrli:measure></xbrli:unit><xbrli:context id="c-410"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-411"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-412"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iff:TopOneCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-413"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iff:TopOneCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-414"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iff:TopOneCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-415"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-416"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-417"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-418"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-419"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DK</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-420"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DK</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-421"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FI</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-422"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FI</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-423"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-425"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-426"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-427"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iff:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-428"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iff:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-431"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-432"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-433"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-434"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-435"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-436"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-437"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-438"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-439"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-440"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-441"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-442"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-443"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-444"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-445"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-446"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-447"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-448"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-449"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="benefit_plan"><xbrli:measure>iff:benefit_plan</xbrli:measure></xbrli:unit><xbrli:context id="c-450"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis">us-gaap:DeferredCompensationArrangementWithIndividualByTypeOfCompensationPensionAndOtherPostretirementBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-451"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis">us-gaap:DeferredCompensationArrangementWithIndividualByTypeOfCompensationPensionAndOtherPostretirementBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-452"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-453"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-454"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-455"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-456"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-457"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-458"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-459"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-460"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-461"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-462"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-463"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-464"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-465"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-466"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-467"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-468"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-469"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-470"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-471"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-472"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-473"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-474"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-475"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-476"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-477"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-478"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-479"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-480"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-481"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-482"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-483"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-484"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-485"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-486"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-487"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-488"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-489"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-490"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentCompaniesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-491"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentCompaniesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-492"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentCompaniesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-493"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentCompaniesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-494"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-495"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-496"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-497"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-498"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-499"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:GovernmentAndGovernmentAgencyBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-500"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:GovernmentAndGovernmentAgencyBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-501"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:GovernmentAndGovernmentAgencyBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-502"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:GovernmentAndGovernmentAgencyBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-503"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-504"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-505"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-506"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-507"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-508"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-509"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-510"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-511"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:PooledFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-512"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:FairValueOfPlanAssetsBeforeReceivablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-513"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:FairValueOfPlanAssetsBeforeReceivablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-514"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:FairValueOfPlanAssetsBeforeReceivablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-515"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:FairValueOfPlanAssetsBeforeReceivablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-516"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:ReceivablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-517"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-518"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-519"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-520"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:GovernmentAndGovernmentAgencyBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-521"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:GovernmentAndGovernmentAgencyBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-522"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:GovernmentAndGovernmentAgencyBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-523"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:GovernmentAndGovernmentAgencyBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-524"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-525"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-526"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-527"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-528"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-529"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-530"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-532"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:PooledFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-533"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:FairValueOfPlanAssetsBeforeReceivablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-534"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:FairValueOfPlanAssetsBeforeReceivablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-535"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:FairValueOfPlanAssetsBeforeReceivablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-536"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:FairValueOfPlanAssetsBeforeReceivablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-537"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:ReceivablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-538"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:PooledFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-539"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:PooledFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-540"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-541"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-542"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-543"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-544"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-545"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-546"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-547"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-548"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-549"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-550"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMidCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-551"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMidCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-552"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMidCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-553"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMidCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-554"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsSmallCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-555"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsSmallCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-556"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsSmallCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-557"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsSmallCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-558"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesLargeCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-559"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesLargeCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-560"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesLargeCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-561"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesLargeCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-562"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMidCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-563"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMidCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-564"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMidCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-565"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMidCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-566"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesSmallCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-567"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesSmallCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-568"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesSmallCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-569"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesSmallCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-570"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:EmergingMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-571"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:EmergingMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-572"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:EmergingMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-573"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:EmergingMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-574"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:USCorporateBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-575"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:USCorporateBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-576"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:USCorporateBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-577"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:USCorporateBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-578"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSTreasuriesOrGovernmentBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-579"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSTreasuriesOrGovernmentBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-580"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSTreasuriesOrGovernmentBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-581"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSTreasuriesOrGovernmentBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-582"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSCorporateBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-583"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSCorporateBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-584"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSCorporateBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-585"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSCorporateBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-586"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-587"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-588"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-589"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-590"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSOtherFixedIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-591"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSOtherFixedIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-592"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSOtherFixedIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-593"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSOtherFixedIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-594"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:InsuranceContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-595"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:InsuranceContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-596"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:InsuranceContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-597"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:InsuranceContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-598"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DerivativeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-599"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DerivativeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-600"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DerivativeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DerivativeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-602"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:AbsoluteReturnHedgeFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-603"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:AbsoluteReturnHedgeFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-604"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:AbsoluteReturnHedgeFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-605"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:AbsoluteReturnHedgeFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-606"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-607"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-608"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-609"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-610"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-611"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-612"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-613"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-614"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-615"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-616"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-617"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-618"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-619"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-620"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-621"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-622"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-623"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-624"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-625"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMidCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMidCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMidCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMidCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-629"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesLargeCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesLargeCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-631"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesLargeCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-632"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesLargeCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-633"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMidCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-634"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMidCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-635"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMidCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-636"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMidCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-637"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesSmallCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-638"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesSmallCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-639"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesSmallCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-640"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesSmallCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-641"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:EmergingMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-642"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:EmergingMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-643"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:EmergingMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-644"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:EmergingMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-645"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:USCorporateBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-646"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:USCorporateBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-647"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:USCorporateBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-648"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:USCorporateBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-649"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSTreasuriesOrGovernmentBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-650"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSTreasuriesOrGovernmentBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-651"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSTreasuriesOrGovernmentBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-652"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSTreasuriesOrGovernmentBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-653"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSCorporateBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-654"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSCorporateBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-655"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSCorporateBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-656"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSCorporateBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-657"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-658"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-659"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-660"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-661"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSOtherFixedIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-662"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSOtherFixedIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-663"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSOtherFixedIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-664"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSOtherFixedIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-665"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:InsuranceContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-666"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:InsuranceContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-667"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:InsuranceContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-668"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:InsuranceContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-669"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DerivativeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-670"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DerivativeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-671"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DerivativeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-672"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DerivativeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-673"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:AbsoluteReturnHedgeFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-674"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:AbsoluteReturnHedgeFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-675"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:AbsoluteReturnHedgeFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-676"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:AbsoluteReturnHedgeFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-677"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-678"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-679"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-680"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-681"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-682"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-683"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-684"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-685"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-686"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-687"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-688"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-689"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-690"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-691"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-692"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iff:ExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-693"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iff:ExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-694"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-695"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-696"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iff:ExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-697"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iff:ExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-698"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-699"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-700"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTaxStatusAxis">us-gaap:QualifiedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTaxStatusAxis">us-gaap:NonqualifiedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-702"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-703"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-704"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-705"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-706"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandTwentyThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-707"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandTwentyThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-708"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandTwentyThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-709"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandTwentyThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-710"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesEuroNotesDueTwoThousandTwentyFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-711"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesEuroNotesDueTwoThousandTwentyFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-712"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesEuroNotesDueTwoThousandTwentyFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-713"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesEuroNotesDueTwoThousandTwentyFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-714"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandTwentyFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-715"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandTwentyFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-716"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandTwentyFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-717"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandTwentyFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-718"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesEuroNotesDueTwoThousandTwentySixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-719"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesEuroNotesDueTwoThousandTwentySixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-720"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesEuroNotesDueTwoThousandTwentySixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-721"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesEuroNotesDueTwoThousandTwentySixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-722"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandTwentySevenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandTwentySevenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-724"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandTwentySevenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandTwentySevenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-726"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandTwentyEightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-727"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandTwentyEightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-728"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandTwentyEightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandTwentyEightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-730"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandThirtyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandThirtyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-732"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandThirtyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-733"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandThirtyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-734"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandFortyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-735"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandFortyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-736"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandFortyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-737"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandFortyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-738"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandFortySevenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-739"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandFortySevenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-740"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandFortySevenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-741"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandFortySevenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-742"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandFortyEightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-743"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandFortyEightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-744"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandFortyEightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-745"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandFortyEightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-746"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandFiftyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-747"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandFiftyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-748"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandFiftyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-749"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandFiftyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-750"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:A2024TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-751"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:A2024TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-752"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:A2024TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-753"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:A2024TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-754"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:A2026TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-755"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:A2026TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-756"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:A2026TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-757"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:A2026TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-758"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="agreement"><xbrli:measure>iff:Agreement</xbrli:measure></xbrli:unit><xbrli:context id="c-759"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-01-01</xbrli:startDate><xbrli:endDate>2016-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-760"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-05-18</xbrli:startDate><xbrli:endDate>2017-05-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-761"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iff:A2019And2022CrossCurrencySwapsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="swap"><xbrli:measure>iff:swap</xbrli:measure></xbrli:unit><xbrli:context id="c-762"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iff:A2019And2022CrossCurrencySwapsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-763"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iff:A2022CrossCurrencySwapsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-764"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iff:A2022CrossCurrencySwapsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-765"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iff:A2022CrossCurrencySwapsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-766"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-767"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-768"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-769"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-770"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-771"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-772"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-773"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-774"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-775"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-776"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-777"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-778"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-779"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-780"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-781"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-782"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-783"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-784"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-785"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-786"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-787"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-788"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-789"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-790"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-791"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-792"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-793"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iff:CrossCurrencySwapsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-794"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iff:CrossCurrencySwapsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-795"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iff:SeniorNotesEuroNotesDueTwoThousandTwentyFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-796"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iff:SeniorNotesEuroNotesDueTwoThousandTwentyFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-797"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iff:SeniorNotesEuroNotesMaturing2021And2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-798"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iff:SeniorNotesEuroNotesMaturing2021And2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-799"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-800"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-801"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-802"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-803"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-804"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-805"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-806"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-807"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-808"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-809"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-810"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-811"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-812"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-813"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-814"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-815"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-816"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-817"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-818"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-819"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-820"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-821"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-822"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-824"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-825"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-826"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-827"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-828"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-829"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-830"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-832"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-833"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-834"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-835"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iff:AccumulatedDefinedBenefitPlansAdjustmentOtherItemsAttributableToParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-836"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iff:AccumulatedDefinedBenefitPlansAdjustmentOtherItemsAttributableToParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-837"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iff:AccumulatedDefinedBenefitPlansAdjustmentOtherItemsAttributableToParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-838"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-839"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-840"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-841"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-842"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-843"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-844"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iff:AllForeignCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-845"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iff:AllForeignCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-846"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iff:AllForeignCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-847"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">iff:PledgedAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-848"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-29</xbrli:startDate><xbrli:endDate>2019-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-849"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-11</xbrli:startDate><xbrli:endDate>2020-03-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-850"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iff:ZhejiangChinaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iff:ZhejiangIngredientsPlantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-851"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iff:ZhejiangChinaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iff:ZhejiangIngredientsPlantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-852"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iff:ZhejiangChinaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iff:ZhejiangIngredientsPlantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-853"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iff:ZhejiangChinaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iff:ZhejiangIngredientsPlantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-05</xbrli:startDate><xbrli:endDate>2023-06-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-854"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iff:ZhejiangChinaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iff:ZhejiangIngredientsPlantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-855"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ManufacturingFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-856"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">country:BR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-857"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">country:BR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-858"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:BR</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">country:BR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-859"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">iff:BrazilTaxCreditsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-860"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-861"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-862"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iff:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-863"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iff:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-864"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iff:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-865"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iff:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-866"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iff:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-867"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iff:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-868"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iff:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-869"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iff:SonaromeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iff:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-870"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iff:CosmeticIngredientsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-871"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iff:SavorySolutionsAndFlavorSpecialtyIngredientsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-872"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-873"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-874"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-875"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-876"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-877"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-878"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-879"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-880"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-881"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-882"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-883"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-884"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-885"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_1"></div><div style="min-height:31.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:3pt;text-align:center;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">10-K</ix:nonNumeric></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:549.00pt"><tr><td style="width:1.0pt"/><td style="width:28.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:517.00pt"/><td style="width:1.0pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentAnnualReport" format="ixt-sec:boolballotbox" id="f-2">&#9745;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-3"><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="f-4">December&#160;31</ix:nonNumeric>, 2023</ix:nonNumeric></span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:549.00pt"><tr><td style="width:1.0pt"/><td style="width:28.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:517.00pt"/><td style="width:1.0pt"/></tr><tr style="height:17pt"><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="f-5">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr><tr style="height:14pt"><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the transition period from _______ to _______</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Commission File Number <ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-6">1-4858</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:22pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-7">INTERNATIONAL FLAVORS&#160;&amp; FRAGRANCES INC</ix:nonNumeric>.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-8">New York</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-9">13-1432060</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(State or other jurisdiction<br/>of incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-10">521 West 57th Street</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-11">New York</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" id="f-12">NY</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-13">10019-2960</ix:nonNumeric></span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-2" name="dei:EntityAddressAddressLine1" id="f-14">200 Powder Mill Road</ix:nonNumeric>, <ix:nonNumeric contextRef="c-2" name="dei:EntityAddressCityOrTown" id="f-15">Wilmington</ix:nonNumeric>, <ix:nonNumeric contextRef="c-2" name="dei:EntityAddressStateOrProvince" id="f-16">DE</ix:nonNumeric> <ix:nonNumeric contextRef="c-2" name="dei:EntityAddressPostalZipCode" id="f-17">19803-2907</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(Address of principal executive offices) (Zip Code</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">)</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Registrant&#8217;s telephone number, including area code (<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-18">212</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-19">765-5500</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.907%"><tr><td style="width:1.0%"/><td style="width:41.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.490%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.490%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:41.305%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of Each Class</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading Symbol</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of Each Exchange on Which Registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-3" name="dei:Security12bTitle" id="f-20">Common Stock, par value 12&#160;1/2&#162; per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-3" name="dei:TradingSymbol" id="f-21">IFF</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-3" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-22">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-4" name="dei:Security12bTitle" id="f-23">1.750% Senior Notes due 2024</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-4" name="dei:TradingSymbol" id="f-24">IFF 24</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-4" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-25">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-5" name="dei:Security12bTitle" id="f-26">1.800% Senior Notes due 2026</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-5" name="dei:TradingSymbol" id="f-27">IFF 26</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-5" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-28">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES REGISTERED PURSUANT TO SECTION 12(g) OF THE ACT: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. &#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityWellKnownSeasonedIssuer" id="f-29">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;No&#160;&#160;&#9744;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or Section&#160;15(d) of the Act.  Yes&#160;&#160;&#9744;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityVoluntaryFilers" id="f-30">No</ix:nonNumeric>&#160;&#160; &#9745;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.  <ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-31">Yes</ix:nonNumeric>&#160;&#160;&#9745;&#160;&#160;No&#160;&#160;&#9744;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  <ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-32">Yes</ix:nonNumeric>&#160;&#160;&#9745;  No&#160;&#160;&#9744;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.038%"><tr><td style="width:1.0%"/><td style="width:43.281%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.447%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.281%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.591%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-33">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9745;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="f-34">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="f-35">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160; &#9744;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.  <ix:nonNumeric contextRef="c-1" name="dei:IcfrAuditorAttestationFlag" format="ixt-sec:boolballotbox" id="f-36">&#9745;</ix:nonNumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.&#160; <ix:nonNumeric contextRef="c-1" name="dei:DocumentFinStmtErrorCorrectionFlag" format="ixt-sec:boolballotbox" id="f-37">&#9745;</ix:nonNumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167; 240.10D-1(b).&#160; <ix:nonNumeric contextRef="c-1" name="dei:DocumentFinStmtRestatementRecoveryAnalysisFlag" format="ixt-sec:boolballotbox" id="f-38">&#9745;</ix:nonNumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="f-39">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;No&#160;&#160;&#9745;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate market value of the voting stock held by non-affiliates of the Registrant was $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="0" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="0" id="f-40">20,313,097,570</ix:nonFraction> as of June 30, 2023.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of February&#160;21, 2024, there were <ix:nonFraction unitRef="shares" contextRef="c-7" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-41">255,314,909</ix:nonFraction> shares of the registrant&#8217;s common stock, par value 12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#160;1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#162; per share, outstanding.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><ix:nonNumeric contextRef="c-1" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="f-42" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Portions of the registrant&#8217;s proxy statement for the 2024 Annual Meeting of Shareholders (the &#8220;IFF 2024 Proxy Statement&#8221;) are incorporated by reference in Part III of this Form 10-K.</span></div></ix:nonNumeric><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTERNATIONAL FLAVORS&#160;&amp; FRAGRANCES INC.</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:8.284%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:81.744%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.672%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">PAGE</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART I</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_13">Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_13">3</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM&#160;1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_16">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_16">12</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM 1B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_19">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_19">30</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM 1C.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_1718">Cybersecurity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_1718">30</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_22">Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_22">32</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_25">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_25">32</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_28">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_28">32</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART II</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM 5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_34">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_34">32</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM 6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_37">[Reserved]</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_37">33</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM 7.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_40">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_40">33</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM 7A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_58">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_58">48</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM 8.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_61">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_61">48</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM 9.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_64">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_64">48</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM 9A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_67">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_67">49</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM 9B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_70">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_70">49</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM 9C.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_73">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_73">49</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART III</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM 10.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_79">Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_79">49</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM 11.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_82">Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_82">50</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM 12.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_85">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_85">50</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM 13.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_88">Certain Relationships and Related Transactions and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_88">50</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM 14.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_91">Principal Accountant Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_91">50</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART IV</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM 15.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_97">Exhibits and Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_97">50</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM 16.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_202">Form 10-K Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_202">116</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_205">SIGNATURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_205">117</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 2</span></div></div></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In this report, we use the terms &#8220;IFF,&#8221; &#8220;the Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; and &#8220;our&#8221; to refer to International Flavors&#160;&amp; Fragrances Inc. and its subsidiaries.</span></div><div><span><br/></span></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_13"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;1.&#160;&#160;&#160;&#160;BUSINESS.</span></div><div style="margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a leading creator and manufacturer of food, beverage, health &amp; biosciences, scent and pharma solutions and complementary adjacent products, including cosmetic active and natural health ingredients, which are used in a wide variety of consumer products. Our products are sold principally to manufacturers of dairy, meat, beverages, snacks, savory, sweet, baked goods and other foods, personal care products, soaps and detergents, cleaning products, perfumes and cosmetics, dietary supplements, food protection, infant and elderly nutrition, functional food, pharmaceutical and oral care products. As a result, we hold global leadership positions in the Food &amp; Beverage, Home &amp; Personal Care and Health &amp; Wellness markets, and across key Tastes, Textures, Scents, Nutrition, Enzymes, Cultures, Soy Proteins, Pharmaceutical Excipients and Probiotics categories.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales in 2023 were approximately $11.479 billion. Based on 2023 sales, approximately </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46%</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of sales were to global consumer products companies and approximately </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54%</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of sales were to small and mid-sized companies. During 2023, our 25 largest customers accounted for approximately 32% of sales. In 2023, no customer accounted for more than 10% of sales.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is geographically diverse, with sales in the U.S. representing approximately </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28%</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of sales in 2023. No other country represented more than 7% of sales.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Product Offerings</span></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business currently consists of four segments: Nourish, Health &amp; Biosciences, Scent and Pharma Solutions.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nourish</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a leading creator of ingredients and solutions, we help our customers deliver on the promise of healthy and delicious foods and drinks that appeal to consumers. We create products in our regional creative centers which allows us to satisfy local customer preferences, while also helping to ensure regulatory compliance and production standards. We develop thousands of different Nourish offerings, most of which are tailor-made, and we continually develop new ingredients and solutions to meet changing consumer preferences and customer needs.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Nourish segment consists of an innovative and broad portfolio of natural-based ingredients to enhance nutritional value, texture and functionality in a wide range of beverage, dairy, bakery, confectionery and culinary applications and consists of Ingredients, Flavors and Food Designs.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ingredients</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> include a diversified portfolio across natural and plant-based specialty food ingredients derived from herbs and plants that provide texturizing solutions used in the food industry, food protection solutions used in food and beverage products, as well as specialty soy and pea protein with value-added formulations, emulsifiers and sweeteners. Natural food protection ingredients consist of natural antioxidants and anti-microbials used for natural food preservation and shelf-life extension for beverages, cosmetic and healthcare products, pet food and feed additives.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Flavors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> include a range of flavor compounds and natural taste solutions that are ultimately used by our customers in savory products (soups, sauces, meat, fish, poultry, snacks, etc.), beverages (juice drinks, carbonated or flavored beverages, spirits, etc.), sweets (bakery products, candy, cereal, chewing gum, etc.), and dairy products (yogurt, ice cream, cheese, etc.). Flavors also include value-added spices and seasoning ingredients for meat, food service, convenience, alternative protein and culinary products.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Food Designs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> include savory solution products such as spices, sauces, marinades and mixtures. During the fourth quarter of 2022, we announced our entry into an agreement to sell a portion of the Savory Solutions business and completed the divestiture on May 31, 2023. Additionally, Food Designs provide inclusion products that help with taste and texture by, among other things, combining flavorings with fruit, vegetables and other natural ingredients for a wide range of food products, such as health snacks, baked goods, cereals, pastries, ice cream and other dairy products.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health &amp; Biosciences </span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Health &amp; Biosciences segment consists of the development and production of an advanced biotechnology-derived portfolio of enzymes, food cultures, probiotics and specialty ingredients for food and non-food applications. Among many other applications, this biotechnology-driven portfolio includes cultures for use in fermented foods such as yogurt, cheese and fermented beverages, probiotic strains, many with documented clinical health claims for use as dietary supplements and through industrial fermentation the production of enzymes and microorganisms that provide product and process performance benefits to household detergents, animal feed, ethanol production and brewing. Health &amp; Biosciences is comprised of Health, Cultures &amp; Food Enzymes, Home &amp; Personal Care, Animal Nutrition and Grain Processing.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> provides ingredients for dietary supplements, functional food and beverage, specialized nutrition and pharma.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cultures &amp; Food Enzymes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> provides products that aim to serve the global demand for healthy, natural, clean label and fermented food for fresh dairy, cheese, bakery and brewing products. Such products contribute to extended shelf life, stability, taste and texture, helping our customers to improve their product offerings. The business&#8217;s enzyme solutions also allow our customers to provide low sugar, high fiber and lactose-free dairy products.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Home &amp; Personal Ca</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">re produces enzymes for laundry and dishwashing detergents, cleaning and textiles to help enhance the product and process performance of products in the fabric and home care, textiles and industrials and personal care markets. In 2023, we introduced patented enzymatic polymers that are renewable, biodegradable alternatives to functional ingredients used in home cleaning and beauty care products.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Animal Nutrition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> produces feed enzymes and animal health solutions that help to improve nutrition, welfare, performance and sustainability of livestock animal farming.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Grain Processing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> produces yeasts and enzymes for biofuel production and carbohydrate processing.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Scent</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Scent segment creates fragrance compounds, fragrance ingredients and cosmetic ingredients that are integral elements in the world&#8217;s finest perfumes and best-known household and personal care products. Consumer insights science and creativity are at the heart of our Scent business, and, along with our unique portfolio of natural and synthetic ingredients, global footprint, innovative technologies and know-how, and customer intimacy, we believe make us a market leader in scent products. The Scent segment is comprised of Fragrance Compounds, Fragrance Ingredients and Cosmetic Ingredients.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fragrance Compounds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are unique and proprietary combinations of multiple fragrance ingredients that are ultimately used by our customers in their consumer goods. Our creative and commercial teams within fragrance compounds are organized into two broad categories: fine fragrances and consumer fragrances.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our perfumers harness creativity and leverage our innovative captive molecules, sustainable natural ingredients obtained with innovative processes, biotech ingredients, data science, and consumer insights to create unique and inspiring fragrances driving consumer preferences.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fine fragrances focus on perfumes and colognes, creating global and local namesake brands, from high luxury to mass market, from market leading to ultra-niche products.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consumer fragrances include three end-use categories of products: </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Fabric Care, including laundry detergents, fabric softeners and specialty laundry products;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Home Care, including household cleaners, dishwashing detergents and air fresheners; and</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Body Care, including personal wash, hair care and toiletries products.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fragrance Ingredients</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are natural and synthetic, and active and functional ingredients that are used internally and sold to third parties, including competitors, for use in the preparation of compounds. While the principal role of our fragrance ingredients facilities is to support our fragrance compounds business, we utilize excess manufacturing capacity to manufacture and sell certain fragrance ingredients to third parties, enabling us to leverage our fixed costs while maintaining the security of our supply for our perfumers and ultimately our customers. Flavor ingredients include natural flavor extracts, specialty botanical extracts, distillates, essential oils, citrus products, aroma chemicals and natural gums and resins. Such ingredients are used for food, beverage and flavors, and are often sold directly to food and beverage manufacturers who use them in producing consumer products. During the fourth quarter of 2022, we announced our entry into an agreement to sell our Flavor Specialty Ingredients business and completed the divestiture on August 1, 2023.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cosmetic Ingredients </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">designs, develops, manufactures and markets innovative ingredients for the cosmetics and personal care industry, while offering active ingredients, functional ingredients, and delivery systems. During the fourth quarter of 2023, we entered into an agreement to sell our Cosmetic Ingredients business and expect the divestiture to be completed in the first quarter of 2024.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pharma Solutions </span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Pharma Solutions segment produces, among other things, a vast portfolio of cellulosics and seaweed-based pharmaceutical excipients, used to improve the functionality and delivery of active pharmaceutical ingredients, including controlled or modified drug release formulations, and enabling the development of more effective pharmaceutical finished dosage formulations. Our excipients are used in prescription and over-the-counter pharmaceuticals and dietary supplements. Our Pharma Solutions products also serve a variety of other specialty and industrial end-uses including coatings, inks, electronics, agriculture and consumer products.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consumer Insights, Research and Product Development Process</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The markets in which we compete require constant innovation to remain competitive. Consumer preferences tend to drive change in our markets, and as science evolves and sustainability continues to be a key factor to customers and consumers, we must continue to strengthen our research and development platforms and adapt our capabilities to provide differentiated products.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consumer Insights</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the first step to creating an innovative and unique product experience begins with gaining insight into the consumer and emerging industry trends. By developing a deep understanding of what consumers value and prefer through our consumer insight programs, we are better able to focus our research and development and creative efforts.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consumer science, insight and marketing teams interpret trends, monitor product launches, analyze quantitative market data and conduct numerous consumer interviews annually.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on this information, we develop innovative and proprietary programs to evaluate potential products that enable us to understand the emotional connections between a prospective product and the consumer. We believe this ability to pinpoint the likelihood of a product&#8217;s success translates into stronger brand equity, resulting in increased returns and greater market share gains for our customers as well as for IFF.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider our research and development infrastructure to be one of our key competencies and critical to our ability to provide differentiated products to our customers. We have strong product and application development pipelines built upon a global network that includes research and development, as well as regulatory and product stewardship capabilities.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We focus and invest substantial resources in the research and development of new and innovative molecules, compounds, formulations and technologies and the application of these to our customers&#8217; products. Using the knowledge gained from our consumer insights programs and business unit needs, we strategically focus our resources around key research and development platforms that address or anticipate consumer needs or preferences. Our innovation-based platforms are aligned with key consumer insight-led growth themes: improving home and personal care, empowering wellbeing and healthy lives, transforming food systems and accelerating climate solutions. By aligning our capabilities and resources to these platforms, we ensure the proper support and focus for each program so that our products can be further developed and eventually accepted for commercial application.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, we have 880 granted U.S. patents and 431 pending U.S. patent applications, as well as numerous other granted patents and pending patent applications around the world. We have developed many unique molecules and delivery systems for our customers that are used as the foundations of successful products around the world.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal basic research and development activities are located in Union Beach, New Jersey; Wilmington, Delaware; Palo Alto, California; Brabrand, Denmark; and Leiden, The Netherlands. At those locations, our scientists and application engineers, while collaborating with our other research and development centers around the world, support the:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">discovery of new materials;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">development of new technologies, such as delivery systems;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">creation of new compounds; and</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">enhancement of existing ingredients and compounds.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, we employed approximately 3,700 people globally in research and development activities.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Creative Application</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through our global network of creative centers and application laboratories, we create or adapt the basic Nourish, Health &amp; Biosciences, Scent and Pharma Solutions products that we have developed in the research and development process to commercialize for use in our customers&#8217; consumer products. Our global creative teams consist of marketing, consumer science, consumer insights and technical application experts, from a wide range of cultures and nationalities. In close partnership with our customers&#8217; product development groups, our creative teams create the experiences that our customers are seeking in order to satisfy consumer demands in each of their respective markets.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New product development is driven by a variety of sources including requests from our customers, who are in need of specific products for use in a new or modified consumer product, or as a result of internal initiatives stemming from our consumer insights program. Our product development team works in partnership with our scientists and researchers to optimize the consumer appeal and relevance of our offerings. We use a collaborative process between our researchers, our product development team and our customers to perfect our offerings so they are ready to be included in the final consumer product.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to creating new products, our researchers and product development teams advise customers on ways to improve their existing products by moderating or substituting current ingredients with more readily accessible or less expensive materials enhancing their yield, or helping to increase or improve functionality of their formulations. This often results in creating a better value proposition for our customers.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most of our formulas are treated as trade secrets and remain our proprietary assets. Our business is not materially dependent upon any individual patent, trademark or license.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Center for Commercial Excellence</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Center for Commercial Excellence utilizes a holistic and centralized approach towards commercial execution by, among other things:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Unlocking value through improved customer experience based on market, customer and pricing insights, digital and advanced analytics, sales enablement, and marketing excellence;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Building further sales force capability to deliver growth targets, own the end-to-end process, and deliver sales synergies using CRM systems, pricing tools, segmentation models, commercial opportunity management, account plan development, training, and incentive plans;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Evaluating and driving new business development opportunities, including analyzing potential markets, assessing client needs, and identifying competitor response strategies; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Strengthening collaboration across divisions by collecting and disseminating best practices and anchoring business decisions in data-driven insights.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supply Chain</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We strive to provide our customers with consistent and quality products on a timely and cost-effective basis by managing all aspects of the supply chain, from raw material sourcing through manufacturing, quality assurance, regulatory compliance and distribution.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Procurement</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the manufacture of our products, we use natural and synthetic ingredients. As of December&#160;31, 2023, we purchased approximately 24,000 different raw materials sourced from an extensive network of domestic and international suppliers and distributors.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Natural ingredients are derived from flowers, fruits and other botanical products, as well as from plant, animal and marine products, and commodity crops like wheat, corn and soy. They contain varying numbers of organic chemicals that are responsible for the fragrance, flavor, antioxidant properties and nutrition of the natural products. Natural products are purchased directly from farms or in processed and semi-processed forms. Some natural products are used in compounds in the state in which they are obtained and others are used after further processing. Natural products, together with various chemicals, are also used as raw materials for the manufacture of synthetic ingredients by chemical processes.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to ensure our supply of raw materials, achieve favorable pricing and provide timely transparency regarding inflationary trends to our customers, we continue to focus on:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">purchasing under contract with fixed or formula-based pricing for set time periods;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">entering into hedging for raw materials we purchase that can be hedged against liquid commodity assets;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">entering into supplier relationships to gain access to supplies we would not otherwise have;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">implementing indexed pricing;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">reducing the complexity of our formulations;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">evaluating the profitability of whether to buy or make an ingredient;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">sourcing from local countries with our own procurement professionals; and</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">periodically assessing our supply base with a view towards greater cost efficiencies and improvements.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Manufacturing and Distribution</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, we had approximately 190 manufacturing facilities, creative centers and application laboratories located in approximately 40 different countries. Our major manufacturing facilities are located in the United States, The Netherlands, Spain, Germany, Indonesia, Turkey, Brazil, Mexico, Slovenia, China, India, Ireland, Norway, Finland, Denmark, Belgium and Singapore.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the last few years in connection with the acquisition of Frutarom, we undertook an initiative to optimize our global operations footprint to efficiently and cost-effectively deliver value to our global customers (the &#8220;Frutarom Integration Initiative&#8221;). From the inception of the Frutarom Integration Initiative through its completion as of March 31, 2023, we completed the closure of 22 sites.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our supply chain initiatives are focused on increasing capacity and investing in key technologies. Within our more mature markets, we tend to focus on consolidation and cost optimization as well as the implementation of new technologies. In addition to our own manufacturing facilities, we develop relationships with third parties, including contract manufacturing organizations, that expand our access to the technologies, capabilities and capacity that we need to better serve our customers.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more detailed information about risks related to our supply chain, please refer to Item 1A, &#8220;Risk Factors&#8221; &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Supply chain disruptions, geopolitical developments, including the Russia-Ukraine war, the Israel-Hamas war and wider Middle East developments (including disruptions to the Red Sea passage or such conflicts spreading further in the relevant regions), or climate-change events (including severe weather events) may adversely affect our suppliers or our procurement of raw materials, and thus may impact our business and financial results.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Environmental, Social, and Governance</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the integration with Nutrition and Biosciences, Inc. (</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">N&amp;B</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we launched a refreshed and comprehensive Environmental, Social, and Governance (</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;ESG&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) roadmap, the &#8216;Do More Good Plan&#8217; (</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Plan</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), which aligns with IFF&#8217;s purpose of applying science and creativity for a better world and our strategy for long term growth and value creation. The Plan includes ambitious 2030 goals across four key areas: Environmental, Social, Governance and Sustainable Solutions.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Environmental: Climate &amp; Planetary Health</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supporting environmental stewardship across our operations, including commitments to climate action, zero waste to landfill, water stewardship solutions and an acceleration of our responsible sourcing practices by promoting regenerative ecosystems and achieving zero deforestation for strategic raw material supply chains.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Social: Equity &amp; Wellbeing</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advancing our commitment to people and communities by strengthening diversity, equity &amp; inclusion within our workforce, while continuously improving our safety program by striving for an injury-free workplace, and achieving world-class safety performance. Within our responsible sourcing program, the Company will continue to promote human rights and animal welfare, while supporting farmers&#8217; livelihoods and ensuring prosperous and equitable value chains.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Governance: Transparency &amp; Accountability</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Continuing our commitment to good governance which starts with our Board and Executive Leadership Team and is supported by a strong governance framework, including having a robust program to ensure compliance with our Codes of Conduct and adherence to the highest standards of ethics, integrity, honesty and respect in our dealings internally and with our business partners. To enhance accountability in line with evolving stakeholder expectations, the Company has launched ESG metrics tied to executive compensation, while expanding oversight for ESG at the Board of Directors level.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sustainable Solutions</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Focusing on the sustainability value proposition and growth for all new innovations as we assist customers in achieving their own ESG goals by delivering an expanded suite of sustainable solutions for the market.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2023, our Company continued to achieve notable recognitions in these areas. We qualified as a constituent of the Dow Jones Sustainability Index, North America for the fourth consecutive year, a family of best-in-class benchmarks for investors who recognize that sustainable business practices are critical to generating long-term shareholder value. This distinction validates IFF&#8217;s leadership position in sustainability performance and underscores our commitment to executing on key ESG priorities. We were also awarded the 2023 EcoVadis Platinum sustainability rating for the third time, placing IFF among the top 1% of companies assessed. In addition, following our submission to CDP Climate Change, Water Security and Forests, we maintained our leadership position in CDP Climate Change and achieved management level for CDP Water Security and Forests for 2023. IFF continues to be listed in the FTSE4Good Index series as well as in the Euronext Vigeo World 120 Index for ESG performance.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in 2023 IFF further aligned with the recommendations of the Task Force on Climate-Related Financial Disclosures (TCFD) by completing the first phase of a climate scenario analysis to understand and quantify the potential risks and opportunities related to climate change. For more detailed information about our ESG programs and performance, please refer to our annual ESG report.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Governmental Regulation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We develop, produce and market our products in a number of jurisdictions around the world and are subject to federal, regional and local legislation and regulations in various countries. Our products, which among other industries, are intended for use in food, beverage, pharmaceutical and dietary supplements, home and personal care, feed, cosmetics industries, are subject to strict quality and regulatory standards and environmental laws and regulations. We in turn are required to meet strict standards which, in recent years, have become increasingly stringent and affect both existing as well as new products. While the cost of compliance with such laws and regulations leads to higher overall capital expenditure, which can be significant in certain periods, we do not currently anticipate any material capital expenditures necessary to comply with such laws and regulations. We continue to monitor existing and pending laws and regulations and while the impact of regulatory changes cannot be predicted with certainty, compliance has not had, and is not expected to have a material adverse effect on capital expenditure, earnings or competitive position.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products and operations are subject to regulation by governmental agencies in each of the markets in which we operate. These agencies include (1) the Food and Drug Administration and equivalent international agencies that regulate flavors, pharmaceutical excipients and other ingredients in consumer products, (2) the Environmental Protection Agency and equivalent international agencies that regulate our manufacturing facilities, as well as fragrance products (including encapsulation systems), (3) the Occupational Safety and Health Administration and equivalent international agencies that regulate the working conditions in our manufacturing, research laboratories and creative centers, (4) local and international agencies that regulate trade and customs, (5) the Drug Enforcement Administration and other local or international agencies that regulate controlled chemicals that we use in our operations, (6) the Chemical Registration/Notification authorities that regulate chemicals that we use in, or transport to, the various countries in which we manufacture and/or market our products, and (7) the U.S. Department of Agriculture and equivalent international authorities with respect to, among other things, labeling of consumer products. We have seen an increase in registration and reporting requirements concerning the use of certain chemicals in a number of countries, such as Registration, Evaluation, Authorization and Restriction of Chemicals (&#8220;REACH&#8221;) regulations in the European Union, as well as similar regulations in other countries.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we are subject to various rules relating to health, work safety and the environment at the local and international levels in the various countries in which we operate. Our manufacturing facilities throughout the world are subject to environmental standards relating to air emissions, sewage discharges, the use of hazardous materials, waste disposal practices and clean-up of existing environmental contamination. In recent years, there has been an increase in the stringency of environmental regulation and enforcement of environmental standards, and the costs of compliance have risen significantly, a trend we expect will continue in the future.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more detailed information about risks related to governmental regulation applicable to the Company, please refer to Item 1A, &#8220;Risk Factors&#8221; &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">If we are unable to comply with regulatory requirements and industry standards, including those regarding product safety, quality, efficacy and environmental impact, we could incur significant costs and suffer reputational harm which could adversely affect results of operations.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Competition</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The markets for our products are part of a larger market that supplies a wide variety of ingredients and compounds used in consumer products. The broader market includes functional foods and food additives, including seasonings, texturizers, spices, cultures, enzymes, probiotics, certain food-related commodities, and fortified products, as well as natural ingredients, nutritional ingredients, supplements and active cosmetic ingredients. Our acquisitions have also expanded our reach in products within the functional food ingredient market, including ingredients focused on improving the health and wellness characteristics of a consumer good, the dietary supplement, pharmaceutical ingredient, infant nutrition markets and the cosmetic actives market.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The global market for our products has expanded, primarily as a result of an increase in demand for, and an increase in the variety of, consumer products.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market for our products is highly competitive. Our main competitors consist of (1) other large global companies, such as Givaudan, DSM-Firmenich Symrise, Kerry, ADM, Novonesis, (2) mid-sized companies, (3) numerous regional and local manufacturers and (4) consumer product companies who may develop their own competing products.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our ability to create products with the sustainability related attributes customers expect and compete successfully in the various sub-market is based on:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">our in-depth understanding of consumers,</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">vertical integration,</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">innovation and technological advances from our research and development activities and, as applicable, our scientists,</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">our ability to tailor products to customers&#8217; needs,</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">our ability to manufacture products on a global scale, and</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">broad-based regulatory capabilities.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In certain industries, large multi-national customers and, increasingly, mid-sized customers, may limit the number of their suppliers by placing some on &#8220;core lists,&#8221; giving them priority for development and production of their new or modified products. To compete more successfully, we must make continued investments in customer relationships and tailor our research and development efforts to anticipate customers&#8217; needs, provide effective service and secure and maintain inclusion on these &#8220;core lists.&#8221;</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Private label manufacturers, mostly medium-sized, local or small food manufacturers, constitute a growing segment in certain markets where we are active. Over the last decade, with the strengthening of supermarket chains, online platforms and growing consumer price consciousness, consumption of private label products has grown at a faster rate than the brand food industry rate. We believe that new business opportunities will continue to arise from these clients as they are increasing their demand for products that are similar to existing products in the market, distinctive premium products, as well as more innovative products.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our People</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of our business is built on our talented employees. At December&#160;31, 2023, we had approximately 21,500 employees worldwide, of whom approximately 5,200 are employed in the United States. Our workforce plans and talent management programs support our employees to best deliver the business strategy and ensure their development and engagement.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Culture and Values</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our culture is based on our five corporate values of empowerment, expertise, innovation, integrity and responsibility, and the expression of these values can be seen and felt throughout our history. Our employees appreciate that they contribute to products that touch and enhance the lives of millions of people around the world. Our robust culture ambassador programs continue to engage a broad portion of the IFF community in building common identity and shared purpose and strengthen engagement and motivation by providing programming on IFF values and providing recognition of individuals who exemplify them.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leadership and Development</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our leadership development efforts empower employees to become forward-looking, inspiring and capable decision-makers, agents of change and great leaders. A full portfolio of proprietary leadership development programs and an overarching talent management system is in place to support growth of leaders and at all levels. To cultivate our employees&#8217; talent and build sustainable long-lasting careers at IFF, we provide tools that enable our employees to envision their career journeys in the form of articulated career &#8220;ladders&#8221; and &#8220;frameworks&#8221;. We offer corresponding development opportunities to include specialized courses for employees globally by partnering with leading institutions and universities to help provide the latest training and development offerings at all levels. We also offer to our employees an extensive library of on-demand courses and materials on leadership, management and professional skills development. Those learning resources are integrated into our human capital platform, allowing managers and employees to establish digitalized learning plans that are ultimately captured as a part of their employee profile. Further, those offerings complement our talent acquisition strategy and organized and personalized feedback process, supported by industry-leading assessment tools.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Diversity, Equity, &amp; Inclusion (&#8220;DE&amp;I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">)</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Your Uniqueness Unleashes Our Potential</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is the unifying vision for DE&amp;I at IFF around the world because we know that the diverse backgrounds, experiences and knowledge of our global workforce is what unleashes the potential that exists at the intersection of science and creativity. This is what enables us to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Be the Premier</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Partner</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our customers.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2023, we refreshed our strategic framework to continue accelerating our journey. This new strategic framework builds on what has come before and increases focus on integrating DE&amp;I into how we operate on a daily basis - fostering inclusive talent processes, inclusive employee experiences and external engagement. Through this new strategic framework, among other things:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">We made progress against our ESG goals, increasing representation for women in senior leadership roles to approximately 38%;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">We expanded accountability beyond the executive team by tying senior leader bonus awards to progress towards our 2030 gender diversity goals;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Our colleague communities or employee resource groups (open to all IFF employees, with a focus on Women, Black, LGBTQIA+, Latino/a/e, Asian, People with Disabilities, Early in Career, Veterans &amp; First Responders) increased visibility and impact with well-attended events around the world; and</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">We committed to the Living Wage Pledge.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IFF is proud to continue to be globally EDGE certified for gender equality at the &#8220;Move&#8221; level by the Edge Certified Foundation and we continue to leverage and be recognized by other external benchmarking organizations including Bloomberg Gender Equality Index; DisabilityIN&#8217;s Disability Equality Index, Workplace Pride, as well as others.  In 2023, we participated in the Black Equality Index for the first time. These indices allow us to understand what it takes to raise the bar and refine or adjust our DE&amp;I initiatives accordingly. IFF was also listed as a &#8220;Best Place to Work for Disability Inclusion&#8221; for the fourth consecutive year.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Occupational Health &amp; Safety</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employee safety is one of the cornerstones of our business. Our occupational health and safety management system requires and encourages employees and supervised contractors at sites globally to uphold IFF&#8217;s protocols, report any incidents and suggest improvements that improve the safety of work sites. Our safety management system is based on U.S. Occupational Safety and Health Administration (&#8220;OSHA&#8221;) standards which apply to all of our sites in conjunction with any local regulations. To work toward a safer workplace, we have put in place a set of protocols and programs related to three areas of focus: (a) safety governance (setting and updating comprehensive safety policies and procedures), (b) safety training of employees based on IFF policies and local requirements, and (c) safety culture characterized by awareness and communication.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Availability of Reports</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We make available free of charge on or through the &#8220;Investors&#8221; link on our website, www.iff.com, all materials that we file electronically with the Securities and Exchange Commission (&#8220;SEC&#8221;), including our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to those reports, filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, as soon as reasonably practicable after electronically filing such materials with, or furnishing them to, the SEC. During the period covered by this Form 10-K, we made all such materials available through our website as soon as reasonably practicable after filing such materials with the SEC.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The SEC maintains an Internet website, www.sec.gov, that contains reports, proxy and information statements and other information that we file electronically with the SEC.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A copy of our By-Laws, Corporate Governance Guidelines, Codes of Conduct, and the charters of the Audit Committee, Human Capital &amp; Compensation Committee, Governance &amp; Corporate Responsibility Committee and Innovation Committee of the Board of Directors are posted on the &#8220;Investors&#8221; section of our website, www.iff.com.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal executive offices are located at 521 West 57th Street, New York, New York 10019 and 200 Powder Mill Road, Wilmington, Delaware 19803.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Executive Officers of Registrant</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a list of the executive officers of the Company and other significant employees who are members of our Executive Leadership Team as of February&#160;28, 2024.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.847%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:73.026%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Age</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Position</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">J. Erik Fyrwald</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Executive Officer and member of our Board of Directors</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Yuvraj Arora</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">President, Nourish</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deborah Borg</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Executive Vice President, Chief Human Resources, Diversity &amp; Inclusion and Communications Officer</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Michael DeVeau</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Vice President, Corporate Finance and Investor Relations</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ralf Finzel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Executive Vice President, Global Operations Officer</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Simon Herriott</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">President, Health &amp; Biosciences and Scent</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Jennifer Johnson</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Executive Vice President, General Counsel and Corporate Secretary</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Glenn Richter</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Executive Vice President, Chief Financial &amp; Business Transformation Officer</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Angela Strzelecki</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">President, Pharma Solutions</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vic Verma</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Executive Vice President, Chief Information Officer</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Casper Vroemen</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Executive Vice President, Chief Research &amp; Development Officer</span></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________________</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">These individuals are executive officers and file reports under Section 16 of the Securities Exchange Act of 1934.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">J. Erik</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fyrwald </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has served as our Chief Executive Officer and a member of our Board of Directors since February 6, 2024. Mr. Fyrwald joined us from Syngenta, where he served as Chief Executive Officer since 2016. Prior to his role at Syngenta, Mr. Fyrwald served as Chief Executive Officer of Univar Solutions from May 2012 until May 2016, as Chairman and Chief Executive Officer of Nalco from 2008 until 2011, when Nalco merged with Ecolab Inc., and following the merger, he served as President of Ecolab. Mr. Fyrwald began his career at DuPont starting in 1981. During his 27 years at DuPont, Mr. Fyrwald held a number of positions, including Group Vice President of the Agriculture and Nutrition Division at DuPont and Vice President and General Manager of DuPont&#8217;s Nutrition and Health Business.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yuvraj Arora </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has served as our Executive Vice President and President, Nourish since June 19, 2023. Mr. Arora joined IFF from Kellogg North America, where he served as the President of the company&#8217;s six U.S. categories since April 2021. He was with Kellogg for more than 20 years, beginning in India in 2002 where he held roles in marketing and category management. He later assumed roles of increasing responsibility in marketing, brand management and general management upon his relocation to the United States in 2005 and in Singapore from 2012-2015.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deborah Borg </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has served as our Executive Vice President, Chief Human Resources, Diversity &amp; Inclusion and Communications Officer since August 29, 2022. Ms. Borg joined IFF from Bunge Limited, where she served as Chief Human Resources and Communications Officer since 2016. Prior to joining Bunge, she served in a variety of business leadership and Human Resources roles in Australia, Switzerland and the U.S. for Dow Chemical between 2000 and 2015. She began her career at General Motors Australia.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Michael DeVeau</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as our Senior Vice President, Corporate Finance and Investor Relations since December 2022 and had previously served as Senior Vice President, Chief Investor Relations &amp; Communications Officer from February 2021 to December 2022, Vice President, Investor Relations, Communications, and Chief of Staff from September 2014 to February 2021, as well as divisional Chief Financial Officer, Scent from 2018 to 2020 and head of Corporate Strategy from 2016 to 2018. Since joining the Company in 2009 as head of investor relations, Mr. DeVeau has held various roles of increasing scope and responsibility in communications, finance and strategy. Prior to joining the Company, he served in leadership positions in investor relations, finance and corporate development at PepsiCo. Mr. DeVeau began his career as an Equity Research Analyst at Citigroup Investment Research.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ralf Finzel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as our Executive Vice President, Global Operations Officer since November 1, 2022. Previously, Mr. Finzel served as Vice President of Integrated Supply Chain for Honeywell International Performance Materials and Technologies Business Group in Houston since 2020. Prior to that, he served as Vice President of Integrated Supply Chain for Honeywell International Building Technologies Business Group from July 2017 to March 2020. He first joined Honeywell in Germany as an operations manager in 1999, and held various roles of increasing responsibility and scope in Europe and the U.S. Prior to joining Honeywell, he worked in research and plant management roles for Hoechst AG.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simon Herriott </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has served as our President, Health &amp; Biosciences since February 2021 and President, Scent since June 2023. From 2019 to February 2021, Mr. Herriott was Vice President and Global Business Director, Health &amp; Biosciences for the N&amp;B Business and from 2016 to 2019, he served as Global Business Director, Bioactives, Industrial Biosciences and Vice President, Danisco Inc. Mr. Herriott was employed by DuPont&#8217;s predecessor or formerly affiliated companies for 15 years and held a variety of roles, including Global Business Director, Biomaterials, Industrial Biosciences.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Jennifer Johnson </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has served as our Executive Vice President, General Counsel and Corporate Secretary since February 2021. From 2019 to February 2021, Dr. Johnson served as Associate General Counsel for the N&amp;B Business. Dr. Johnson </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">joined DuPont in 2013, where she led the legal team for DuPont&#8217;s former Industrial Biosciences business as Associate General Counsel and previously served as Assistant Chief Intellectual Property Counsel for Industrial Biosciences. Prior to joining DuPont, Dr. Johnson was a Partner at the law firm of Finnegan, Henderson, Farabow, Garrett &amp; Dunner, L.L.P.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Glenn Richter</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as our Executive Vice President, Chief Financial &amp; Business Transformation Officer since February 2023. Mr. Richter served as our Executive Vice President, Chief Financial Officer from September 2021 to February 2023. Prior to joining IFF, Mr. Richter was Chief Financial Officer of TIAA, having worked at the company in various leadership roles from April 2015 to July 2021. Previously, Mr. Richter worked for Nuveen Investments as Chief Operating Officer and Chief Administrative Officer and before joining Nuveen Investments in 2006, he served as Executive Vice President, Chief Financial Officer for RR Donnelley &amp; Sons, and prior to that he was Executive Vice President &amp; CFO of Sears, Roebuck and Co. and Chairman of Sears Canada, a publicly-traded affiliate.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Angela Strzelecki</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as our President, Pharma Solutions since February 2021. From 2019 to February 2021, Dr. Strzelecki was Global Business Director, Pharma Solutions for the N&amp;B Business. During her 29 year career with DuPont or its formerly affiliated companies, Dr. Strzelecki held a variety of leadership positions, including Planning Director - Corporate Planning and M&amp;A, Global Business Director - Electronics &amp; Communications, North America Business Director - Building Innovations, Global Business Director - Industrial Coatings and Global Technology Director for Coatings.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Vic Verma </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has served as our Executive Vice President, Chief Information Officer since February 2021 and had previously served as our Senior Vice President, Chief Information Officer from 2016 to February 2021. Before joining the Company, Mr. Verma served as Vice President of Global Infrastructure Operations at American Express, a multinational financial services company. Prior to that, Mr. Verma held several other leadership positions at American Express as well as Vice President, Division CIO and management consulting roles with GlaxoSmithKline, Bristol Myers Squibb and PricewaterhouseCoopers.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Casper Vroemen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as our Executive Vice President, Chief Research &amp; Development Officer since September 2023. Dr. Vroemen has been with the N&amp;B Business since 2004. Over the past two decades, he has assumed roles of increasing responsibility in research and development in Europe and the U.S.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Developments</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 11, 2024, we announced the departure of Frank K. Clyburn Jr. as our Chief Executive Officer, effective February 6, 2024. The Board of Directors appointed J. Erik Fyrwald as our Chief Executive Officer, effective February 6, 2024.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_16"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;1A.&#160;&#160;&#160;&#160;RISK FACTORS.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risk Factor Summary</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following summary highlights some of the principal risks that could adversely affect our business, financial condition or results of operations. This summary is not complete and the risks summarized below are not the only risks we face. These risks are discussed more fully further below in this section entitled &#8220;Risk Factors&#8221; in Item 1A. of this report. These risks include, but are not limited to, the following:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">We have a substantial amount of indebtedness that could materially adversely affect, among other things, our financial condition, our ability to return capital to our shareholders, needed investments into our business, and our credit ratings.</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">If we are unable to successfully execute the next phase of our strategic transformation, including our portfolio optimization, it may have a material adverse effect on our business, results of operations and financial condition.</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Our ability to declare and pay dividends is subject to certain considerations.</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Our results of operations may be negatively impacted by the outcome of uncertainties related to legal claims, disputes, investigations and litigation, including the ongoing antitrust and competition investigations and related class actions lawsuits.</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Inflationary trends and pricing uncertainty, including in the price of our input costs, such as raw materials, transportation and energy, could adversely affect our business and financial results in the short term and result in uncertainties in the long term.</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Supply chain disruptions, geopolitical developments, including the Russia-Ukraine war, the Israel-Hamas war and wider Middle East developments (including disruptions to the Red Sea passage or such conflicts spreading further in the relevant regions), or climate-change events (including severe weather events) may adversely affect our suppliers or our procurement of raw materials, and thus may impact our business and financial results.</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Our success depends on attracting and retaining talented people within our business and our management team. Changes to management, including turnover of our top executives, and significant shortfalls in recruitment, retention or transition of employees or our management team could adversely affect our ability to compete and achieve our strategic goals.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">If we are unable to successfully market to our expanded and diverse customer base, our operating results and future growth may be adversely affected.</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Our business is highly competitive, and if we are unable to compete effectively our sales and results of operations will suffer.</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">A significant portion of our sales is generated from a limited number of large multi-national customers, which are currently under competitive pressures that may affect the demand for our products and profitability.</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">We may not successfully develop and introduce new products that meet our customers&#8217; needs, which may adversely affect our results of operations.</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">International conflicts (such as the Russia-Ukraine war and the Israel-Hamas war), geopolitical events, natural disasters, public health crises (such as the COVID-19 pandemic), trade wars, terrorist acts, labor strikes, political or economic crises (such as uncertainty related to protracted U.S. federal government funding negotiations), accidents and other events could adversely affect our business and financial results, including by disrupting development, manufacturing, distribution or sale of our products.</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">A significant data breach or other disruption to our information technology systems could disrupt our operations, result in the loss of confidential information or personal data, and adversely impact our reputation, business or results of operations.</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">We are subject to risks associated with the potential use of artificial intelligence (&#8220;AI&#8221;) in our own operations and by third-party partners that we may engage with.</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">We have made investments in and continue to expand our business into emerging markets, which exposes us to certain risks.</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">The impact of currency fluctuation or devaluation in the international markets in which we operate may negatively affect our results of operations.</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">International economic, political, legal, compliance and business factors could negatively affect our financial statements, operations and growth.</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Economic uncertainty, including increased inflation, may adversely affect demand for our products which may have a negative impact on our operating results and future growth.</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">The integration of the N&amp;B Business may continue to present significant challenges, and we may not realize anticipated synergies and other benefits of the N&amp;B Transaction.</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">If we are unable to react in a timely and cost-effective manner to changes in consumer trends, such as increasing awareness of health and wellness, our results of operations and future growth may be adversely affected.</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">We are subject to increasing customer, consumer, shareholder and regulatory focus on sustainability, which may result in additional costs in order to meet new requirements.</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Our performance may be adversely impacted if we are not successful in managing our inventory and/or working capital balances.</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Any impairment of our tangible or intangible long-lived assets, including goodwill, may adversely impact our profitability.</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">If we fail to successfully enter into or close collaborations, joint ventures, partnerships or acquisitions, or successfully manage such transactions, it could adversely affect our business and growth opportunities.</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Our funding obligations for our pension and postretirement plans could adversely affect our earnings and cash flows.</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">The phase out of the London Interbank Offered Rate (&#8220;LIBOR&#8221;) may impact the interest rates paid on our variable rate indebtedness and could cause our interest expense to increase.</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">If we are unable to comply with regulatory requirements and industry standards, including those regarding product safety, quality, efficacy and environmental impact, we could incur significant costs and suffer reputational harm which could adversely affect results of operations.</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Defects, quality issues (including product recalls), inadequate disclosure or misuse with respect to the products and capabilities could adversely affect our business, reputation and results of operations.</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Failure to comply with environmental protection laws may cause us to close, relocate or operate one or more of our plants at reduced production levels, and expose us to civil or criminal liability, which could adversely affect our operating results and future growth.</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">We could be adversely affected by violations, by us or our counterparties, of the U.S. Foreign Corrupt Practices Act, similar U.S. or foreign anti-bribery and anti-corruption laws and regulations, applicable sanctions laws and regulations in the jurisdictions in which we operate or ethical business practices and related laws and regulations.</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Our ability to compete effectively depends on our ability to protect our intellectual property rights.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Changes in our tax rates, the adoption of new U.S. or international tax legislation, or changes in existing tax laws could expose us to additional tax liabilities that may affect our future results.</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">The N&amp;B Transaction could result in significant tax liability, and we may be obligated to indemnify DuPont for any such tax liability imposed on DuPont.</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">If we fail to comply with data protection laws in the U.S. and abroad, we may be subject to fines, penalties and other costs.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risk Factors</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We routinely encounter and address risks in conducting our business. Some of these risks may cause our future results to be different - sometimes materially different - than we presently anticipate. Below are material risks we have identified that could adversely affect our business. How we react to material future developments, as well as how our competitors and customers react to those developments, could also affect our future results.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Risks Related to Our Business and Industry</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We have a substantial amount of indebtedness that could materially adversely affect, among other things, our financial condition, our ability to return capital to our shareholders, needed investments into our business and our credit ratings.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, our total debt was $10.071 billion. Despite our level of indebtedness, we expect to continue to have the ability to borrow additional debt. There may be circumstances in which required payments of principal and/or interest on our debt could adversely affect our cash flows, our operating results or our ability to return capital to our shareholders. In addition, our existing Revolving Credit Facility and Term Loans are also at variable interest rates, exposing us to potentially material interest rate risk at our current level of indebtedness.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, our degree of leverage could adversely affect our future credit ratings. If we are unable to maintain or improve our current investment grade rating or improve our leverage, it could adversely affect our future cost of funding, liquidity and access to capital markets. The Company does not have any rating downgrade triggers that would accelerate the maturity dates of its senior unsecured debt. However, any downgrade in our credit rating may, depending on the extent of such downgrade, negatively impact our ability to raise additional debt capital, our liquidity and capital position, and may increase our cost of borrowing for new capital raises. In addition, our existing Revolving Credit Facility and Term Loans have pricing grids that are based on credit rating, such that our cost of borrowing may increase as our public debt rating decreases. The pricing grid rates have increased by 0.125% for the duration that financial covenant relief (as described below) is provided.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Revolving Credit Facility and Term Loans contain various covenants, limitations and events of default customary for similar facilities for similarly rated borrowers, including the requirement for us to maintain, at the end of each fiscal quarter, a maximum ratio of net debt for borrowed money to credit adjusted EBITDA in respect of the previous four fiscal quarters. On September 19, 2023, we entered into further amendments to our Revolving Credit Facility and Term Loans that extend certain relief with respect to this financial covenant by providing that during the relief period our leverage ratio shall not exceed as of the end of the fiscal quarter (for the period of the four fiscal quarters then ended): (i) 5.25x for any fiscal quarter ending on or before March 31, 2024, (ii) 4.75x for the fiscal quarter ending June 30, 2024, (iii) 4.50x for the fiscal quarter ending September 30, 2024, (iv) 4.25x for any subsequent fiscal quarter ending on or before March 31, 2025, (v) 4.00x for any subsequent fiscal quarter ending on or before September 30, 2025 and (vi) 3.75x for the fiscal quarter ending December 31, 2025. The financial covenant relief provided in these most recent amendments superseded the ratios and step downs set forth in prior amendments to these credit facilities entered into on August 4, 2022 and March 23, 2023.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the financial covenant relief period, the amendments prohibit us from (i) effecting share repurchases, (ii) declaring and paying dividends in cash on common stock in excess of $0.81 per share per fiscal quarter (for an aggregate amount of $3.24 per fiscal year) and (iii) creating liens to secure debt in excess of the greater of $300&#160;million and 3.65% of Consolidated Net Tangible Assets, in each case subject to certain exceptions set forth in the amendments. During the financial covenant relief period, the Term Loans are subject to a mandatory prepayment provision whereby certain asset sale proceeds must be used to pay down amounts outstanding thereunder. See Note 9 for additional information on the amendments to the debt agreements.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our current level of leverage could increase our vulnerability to sustained, adverse macroeconomic weakness, limit our ability to obtain further financing, lead to a reduction or suspension of our dividend payments, decrease our flexibility in responding to or preparing for changes in the industry in which we operate and our ability to pursue certain operational and strategic projects or opportunities, including necessary investments into our business or large acquisitions. Our level of indebtedness, as well as a failure to comply with covenants under our debt instruments, could adversely affect our business, results of operation and financial condition or our ability to return capital to our shareholders and any additional debt modifications, instruments or covenant reliefs may subject us to additional covenants and restrictions.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If we are unable to successfully execute the next phase of our strategic transformation, including our portfolio optimization, it may have a material adverse effect on our business, results of operations and financial condition.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, we announced our new strategic and financial vision previewing a refreshed strategic plan and new operating model, which among other things, consists of a renewed growth-focus strategy, enhanced cost &amp; productivity initiatives, a redesigned operating model, a reaffirmation of our commitment to our portfolio optimization initiatives and a plan to evolve our Board in line with best-in-class governance standards, as well as certain changes to our Executive Leadership Team. Implementing such changes can be complex, costly and time-consuming and may also result in unanticipated issues, such as additional expenses, competitive responses, employee turnover or impact on our commercial relationships. Even if such initiatives are implemented successfully, the full benefits may not be realized or may not be realized within the desired timeframe. The failure to meet the challenges involved in implementing our strategic transformation could result in a material adverse impact on our business, results of operations and financial condition.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a part of our ongoing strategic transformation and our portfolio optimization strategy as discussed above, we continue to evaluate and work towards divestitures or strategic transactions. For instance, during the third quarter of 2022, the second quarter of 2023 and the third quarter of 2023, we completed divestitures of our Microbial Control business, a portion of the Savory Solutions business and our Flavor Specialty Ingredients business, respectively. During the third quarter of 2023, we announced that we entered into an agreement for the sale of our Cosmetics Ingredients business, which is expected to close in the first quarter of 2024, subject to customary closing conditions. The successful entry into and closing of such transactions is contingent on many factors, including, among other things, the performance of the underlying assets or business as well as the relevant industry dynamics overall, the interest of potential buyers and their ability to finance such transactions (which is also impacted by general economic and financial conditions and market dynamics), requisite regulatory approvals, and related separation activities. Divestitures involve separation costs and efforts that may divert management&#8217;s and employees&#8217; attention and also result in stranded costs and dis-synergies for the Company. Moreover, divestitures often entail post-closing third party agreements, such as supply arrangements (including with &#8220;take or pay&#8221; provisions), product manufacturing, cross-licensing, transitional, or site services agreements (&#8220;ancillary agreements&#8221;), that may bind the Company for certain periods after closing, during which market or Company conditions may change. Any failure to enter into, complete or potential delays in closing any such transaction, any failure to mitigate or manage the associated costs of such transactions, or obtain appropriate terms for ancillary agreements, could adversely affect the implementation of our portfolio optimization strategy as well as our financial condition, including our leverage ratio.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our ability to declare and pay dividends is subject to certain considerations.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends are authorized and determined by our Board of Directors in its sole discretion and depend upon a number of factors, including:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">cash available for dividends;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">our results of operations and anticipated future results of operations;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">our financial condition, including our current or forecasted future cash flows provided by our operating activities (after deducting anticipated future capital expenditures and other commitments required to carry out our operations and business strategy);</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">our operating expenses;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">restrictions in our credit agreement related to the issuance of dividends, including minimum capital requirements; and</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">other general and economic conditions or other factors our Board of Directors deems to be relevant.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to continue to pay dividends to our shareholders; however, our Board may reduce, suspend or discontinue the payment of dividends at any time. Any reduction in the amount of dividends we pay to shareholders could have an adverse effect on the trading price of our common stock.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our results of operations may be negatively impacted by the outcome of uncertainties related to legal claims, disputes, investigations and litigation, including the ongoing antitrust and competition investigations and related class actions lawsuits.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time we are involved in a number of legal claims, regulatory investigations and litigation, including claims related to intellectual property, product liability, competition and antitrust, environmental matters and indirect taxes. For instance, product liability claims may arise due to the fact that we supply products to the food and beverage, functional food, pharma/nutraceutical and personal care industries. Our manufacturing and other facilities may expose us to environmental claims and regulatory investigations and potential fines. In addition, and as further described in our consolidated financial statements, we are subject to antitrust and competition investigations in the United States and Europe, as well as class action lawsuits against us and certain of our competitors in the United States and Canada, alleging violations of antitrust laws and related claims. We may face additional civil suits in the United States or elsewhere, relating to such alleged conduct. At this </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">time, we are unable to predict or determine the scope, duration, or outcome of these investigations. Our results of operations, liquidity or financial condition could be adversely impacted by unfavorable outcomes in these or other pending or future claims, disputes, investigations or litigation. Poor results of operations, liquidity or financial condition&#8212;particularly as we work towards implementation of our ongoing strategic transformation and our portfolio optimization strategy&#8212;may increase the likelihood of shareholder litigation.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in light of our product offerings into functional food, nutraceuticals, natural antioxidants or pharmaceutical products, we may also be subject to claims of false or deceptive advertising claims relating to the efficacy, health benefits or other performance attributes of such offerings in the U.S., Europe and other foreign jurisdictions in which we offer these types of products. These claims can arise as a result of function claims, health claims, nutrient content claims and other claims that impermissibly suggest such benefits or attributes for certain foods or food components. The cost of defending these claims or our obligations for direct damages and indemnification if we were found liable could adversely affect our results of operations.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our insurance may not be adequate to protect us from potential material expenses related to pending and future claims and our current levels of insurance may not be available in the future at commercially reasonable prices. Any of these factors could adversely affect our profitability and results of operations.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inflationary trends and pricing uncertainty, including in the price of our input costs, such as raw materials, transportation and energy, could adversely affect our business and financial results in the short term and result in uncertainties in the long term.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The global economy continues to experience high rates of inflation. Though inflation appears to be gradually declining in certain parts of the world, inflationary pressure and price uncertainty is expected to continue in 2024. As a result of the broader inflationary environment and supply chain disruptions we have experienced, and may continue to experience, volatility and increases in the price of input costs, such as certain raw materials, transportation and energy costs. We might also suffer from supply disruptions from supplier exits as higher costs may become unaffordable for certain suppliers. In addition, though many central banks have paused monetary policies such as increasing interest rates to counter inflation, rates remain at historical highs and may continue to remain at such levels. These and other monetary policies to counter inflation could negatively affect our borrowing costs and those of our customers and suppliers, as well as exchange rates and other macroeconomic factors.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are unable to increase the prices of our products to our customers to offset inflationary cost trends, or if we are unable to achieve cost savings to offset such cost increases, we could fail to meet our cost expectations, and our profits and operating results could be adversely affected. Our ability to price our products competitively to timely reflect higher input costs is critical to maintain and grow our sales. Increases in prices of our products to customers or the impact of the broader inflationary environment on our customers may continue to lead to declines in demand and sales volumes. Further, we may not be able to accurately predict or hedge for price fluctuations of input costs, or predict the volume impact of the price increases in our products, while our competitors may be able to more successfully adjust to such input cost volatility. Increasing our prices to our customers could result in long-term sales declines or loss of market share if our customers find alternative suppliers or choose to reformulate their consumer products to rely less on our products, which could have an adverse long-term impact on our results of operations. Increased cost volatility trends may also impact the business and financial situation of our customers or suppliers, which could in turn affect the demand or supply, respectively, by such parties. Future inflationary and deflationary trends are beyond our control, and we may not be able to sufficiently mitigate any impact on our business and financial situation.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supply chain disruptions, geopolitical developments, including the Russia-Ukraine war, the Israel-Hamas war and wider Middle East developments (including disruptions to the Red Sea passage or such conflicts spreading further in the relevant regions), or climate-change events (including severe weather events) may adversely affect our suppliers or our procurement of raw materials, and thus may impact our business and financial results.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with our manufacturing of our products, we often rely on third party suppliers for raw materials. We use many different raw materials for our business, such as essential oils, extracts and concentrates derived from fruits, vegetables, flowers, woods and other botanicals, animal products, raw fruits, organic chemicals and petroleum-based chemicals, as well as, gelatin, glycols, cellulose processed grains, guar, locust bean gum, organic vegetable oils, peels, saccharides, seaweed, soybeans, and sugars and yeasts.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supply chain disruptions, such as the ones related to the COVID-19 pandemic, may impair or delay our ability to obtain sufficient quantities of certain raw materials through our ordinary supply channels and cause us to incur higher costs by procuring raw materials from other sources in order to compensate for such delays or lack of availability.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our suppliers, similar to us, are subject to risks, inherent in agriculture, manufacturing and distribution on a global scale, including industrial accidents, environmental events, climate change, strikes and other labor disputes, disruptions in supply chain or information systems, disruption or loss of key research or manufacturing sites, product quality control, safety and environmental compliance issues, licensing requirements and other regulatory issues, as well as natural disasters, global or </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">local health crises, international conflicts, terrorist acts, geopolitical developments, trade wars, and other external factors over which neither they nor we have control. These suppliers could also become insolvent or experience other financial distress.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our suppliers are unable to supply us with sufficient quantities of ingredients and raw materials to meet our needs, we would need to seek alternative sources of such materials (which may result in higher transportation or procurement costs) or pursue our own production of such ingredients or direct acquisition of such raw materials. However, for certain of our ingredients and raw materials, we rely on a limited number of suppliers where there are not readily available alternatives. If we are unable to obtain or manufacture alternative sources of such ingredients or raw materials at a similar cost, we may seek to (i) reformulate our products and/or (ii) increase pricing to reflect the higher supply cost. To mitigate our sourcing risk, we maintain strategic stock levels for critical items. However, if we do not accurately estimate the amount of raw materials that will be used for the geographic region in which we will need these materials or competitively price our products, our margins could be adversely affected.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Geopolitical developments, such as trade wars, the Russia-Ukraine war, the Israel-Hamas war and wider Middle East developments (including disruptions to the Red Sea passage or such conflicts spreading further in the relevant regions), could adversely impact, among other things, our raw material, energy and transportation costs, certain of our suppliers, distributors, customers and local markets, global and local macroeconomic conditions, and cause further supply chain disruptions (including by delaying the delivery times of raw materials needed for our business or our products to customers). As the Russia-Ukraine war has prolonged, it continues to impact our sourcing of certain raw materials for future years, and we continue to look for alternative suppliers or adjust the types of raw materials used in our products. In addition, as the Israel-Hamas war develops with potential implications for the wider Middle East (including the Red Sea passage), it may have similar impacts on suppliers, customers or local markets.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the same time, climate-change related disruptions, may affect the availability, quality and pricing of raw materials. There is growing evidence that carbon dioxide and other greenhouse gases in the atmosphere may have an adverse impact on global temperatures, weather and precipitation patterns, growing and harvesting conditions (both on land and in the sea), and the frequency and severity of extreme weather and natural disasters, such as floods, wildfires, droughts and water scarcity. To the extent such climate change effects have a negative impact on crop size and quality, supply chain, energy or transportation costs, it could impact the availability, quality and pricing of affected raw materials. Climate related policies and energy production restrictions and pricing may exacerbate such negative impacts.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">More generally, as we source many of our raw materials globally to help ensure quality control or to mitigate supply chain disruptions, we are subject to additional risks related to the increases in energy or transportation costs. Energy prices are in turn subject to significant volatility caused by, among other things, market fluctuations, supply and demand changes, currency fluctuations, production and transportation disruptions, and other world events, as well as geopolitical developments and climate change related conditions discussed above.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are not able to successfully mitigate such supply chain and climate-change related risks, we could experience disruptions in production or increased costs, which may result in decrease in our gross margin or reduced sales, and have a material adverse effect on our business, results of operations and financial condition.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our success depends on attracting and retaining talented people within our business and our management team. Changes to management, including turnover of our top executives, and significant shortfalls in recruitment, retention or transition of employees or our management team could adversely affect our ability to compete and achieve our strategic goals.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attracting, developing, and retaining talented employees is essential to the successful delivery of our products and has become more difficult and costly in the current labor market. Furthermore, as we continue to focus on innovation, our need for scientists and other professionals will increase and may result in increased labor costs. The ability to attract and retain talented employees is critical in the development of new products and technologies which is an integral component of our growth strategy.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Competition for employees can be intense and if we are unable to successfully integrate, motivate and reward our employees, we may not be able to retain them. If we are unable to retain our employees or attract new employees in the future, our ability to effectively compete with our competitors and to grow our business could be adversely affected. In addition, we have announced, as part of our strategic transformation initiatives, certain headcount reductions to re-align our workforce to match strategic and financial objectives and optimize resources for long-term growth. Such reductions could lead to increased uncertainty, attrition or lower morale amongst those employees who are not directly affected by the headcount reductions as those reductions are being implemented, which may result in decreased productivity or could otherwise impact our results of operation.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the loss of any member of our senior management could materially adversely affect our ability to execute our business plan and strategy. We may not find an adequate replacement in a timely fashion, or at all and any replacement may </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">view the business differently than current members of management. Future executives may make changes to our strategic focus, operations, business plans or financial guidance and outlook, with corresponding changes in how we report our results of operations. We can make no assurances that we would be able to properly manage any shift in focus or that any changes to our business would ultimately prove successful.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lastly, our success may depend on the ability of our new Chief Executive Officer to integrate and quickly adapt to and understand our business, operations, and strategic plans. This will be critical to the Company and our management&#8217;s ability to make informed decisions about our near-term strategic direction and operations. While our Board of Directors strives to mitigate the risk through a robust management succession process, which includes the outgoing Chief Executive Officer serving in an advisory role until December 2024, leadership transitions can be inherently difficult to manage. An inadequate transition may cause disruption to our business due to, among other things, diverting management&#8217;s attention away from the Company&#8217;s financial and operational goals or causing a deterioration in morale.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If we are unable to successfully market to our expanded and diverse customer base, our operating results and future growth may be adversely affected.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of our acquisition of Frutarom and the N&amp;B Transaction, the number of our customers significantly increased and became more diverse. Our historical customer base was primarily comprised of large and medium-sized food, beverage and consumer products companies. With the completion of the N&amp;B Transaction, our customer base has further increased significantly and, based on 2023 sales, we had approximately 27,000 customers, approximately 54% of which are small and mid-sized companies. This substantial increase in and diversity of our customer base has required us and may continue to require us to adjust, among other things, our product development, manufacturing, distribution, marketing, customer relationship and sales strategy as well as adapt corporate, information technology, finance and administrative infrastructures to support different go-to-market models. We may experience difficulty managing the growth of a portfolio of customers that is more diverse in terms of its geographical presence as well as with respect to the types of services they require and the infrastructure required to deliver our products. If we are unable to successfully gain market share or maintain our relationships with these customers, our future growth could be adversely affected.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our business is highly competitive, and if we are unable to compete effectively our sales and results of operations will suffer.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The markets in which we compete are highly competitive. We face vigorous competition from companies throughout the world, including multi-national and specialized companies active in flavors, fragrances, enzymes, pharmaceutical excipients, nutrition and specialty ingredients, as well as consumer product companies which may develop their own competing products. For instance, in the flavors industry, we face increasing competition from ingredient suppliers that have expanded their portfolios to include flavor offerings. Some of our competitors specialize in one or more of our product sub-segments, while others participate in many of our product sub-segments. In addition, some of our global competitors may have more resources than we do or may have proprietary products that could permit them to respond to changing business and economic conditions more effectively than we can. Moreover, there has been increased consolidation among our competitors, and such consolidation or partnerships among our competitors may exacerbate these risks.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we continue to enter into adjacent markets, such as functional foods, specialty fine ingredients and nutrition products, we may face greater competition-related risks in these markets than with our other businesses. For example, the specialty fine ingredients market is more price sensitive than the flavors market and is characterized by relatively lower profit margins. Some fine ingredients products are less unique and more replaceable than competitors&#8217; products. There is no assurance that operating margins will remain at current levels, which could substantially impact our business, operating results and financial condition.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Competition in our business is based, among other things, on innovation, product quality, regulatory compliance, pricing, quality of customer service, the support provided by marketing and application groups, and understanding of consumers. It is difficult for us to predict the timing, scale and success of our competitors&#8217; actions in these areas. In particular, the discovery and development of new products, protection of our intellectual property and development and retention of key employees are critical to our ability to effectively compete in our business. Advancement in technologies have also enhanced the ability of our competitors to develop substitutable products. Increased competition by existing or future competitors, including aggressive price competition, could result in the loss of sales, reduced pricing and margin pressure and could adversely impact our sales and profitability.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Failing to identify and make capital expenditures to achieve growth opportunities, being unable to make new concepts scalable, or failing to effectively and timely reinvest in our business operations, could result in the loss of competitive position and adversely affect our financial condition or results of operations.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A significant portion of our sales is generated from a limited number of large multi-national customers, which are currently under competitive pressures that may affect the demand for our products and profitability.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2023, our 25 largest customers, a majority of which were multi-national consumer products companies, collectively accounted for approximately 32% of our sales in the aggregate. Large multi-national customers&#8217; market share, especially in the consumer product industry, continues to be pressured by new smaller companies and specialty players that cater to or are more adept at adjusting to the latest consumer trends, including towards natural products and clean labels, changes in the retail landscape (including e-commerce and consolidation), and increased competition from private labels, which have resulted and may continue to result in decreased demand for our products by such multi-national customers and volume erosion, especially in our Nourish business. Furthermore, consolidations amongst our customers have resulted in larger and more sophisticated customers with greater buying power and additional negotiating strength. If such trends continue, our sales could be adversely impacted if we are not able to replace these sales.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, large multi-national customers and increasingly middle market customers continue to utilize &#8220;core lists&#8221; of suppliers to improve margins and profitability in the flavors and fragrance segments. Typically, these &#8220;core list&#8221; suppliers are then given priority for new or modified products. Recently, these customers are making inclusion on their &#8220;core lists&#8221; contingent upon a supplier providing more favorable terms, including rebates, which could adversely affect our margins. We must either offer competitive cost-in-use solutions to secure and maintain inclusion on these &#8220;core lists&#8221; or seek to manage the relationship without being on the &#8220;core-list.&#8221; If we choose not to pursue &#8220;core-list&#8221; status due to profitability concerns or if we are unable to obtain &#8220;core-list&#8221; status, our ability to maintain our share of these customers&#8217; future purchases could be adversely affected and therefore our future results of operations.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We may not successfully develop and introduce new products that meet our customers&#8217; needs, which may adversely affect our results of operations.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to differentiate ourselves and deliver growth largely depends on our ability to successfully develop and introduce new products and product improvements that meet our customers&#8217; needs, and ultimately appeal to consumers. Innovation is a key element of our ability to develop and introduce new products. We cannot be certain that we will be successful in achieving our innovation goals, such as the development of new molecules, new and expanded delivery systems and other technologies. In 2023, we spent approximately 5.5% of our sales on research and development, and as part of our new strategic vision announced in December 2022, we expect to continue investment in research and development and innovation initiatives. This investment level may vary in the future if available resources to invest in research and development are limited due to our ongoing integration and restructuring efforts or from adverse macroeconomic or supply chain factors. We also may need to devote more resources to enhancing our existing product portfolios. Our research and development investments may only generate future revenues to the extent that we are able to develop products that meet our customers&#8217; specifications, are at an acceptable cost and achieve acceptance by the targeted consumer market. Furthermore, there may be significant lag times from the time we incur research and development costs to the time that these research and development costs may result in increased revenue.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consequently, even when we &#8220;win&#8221; a project, our ability to generate revenues as a result of these investments is subject to numerous customer, economic and other risks that are outside of our control, including delays by our customers in the launch of a new product, the level of promotional support for the launch, poor performance of our third-party vendors, anticipated sales by our customers not being realized or changes in market preferences or demands, or disruptive innovations by competitors.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">International conflicts (such as the Russia-Ukraine war and Israel-Hamas war), geopolitical events, natural disasters, public health crises (such as the COVID-19 pandemic), trade wars, terrorist acts, labor strikes, political or economic crises (such as uncertainty related to protracted U.S. federal government funding negotiations), accidents and other events could adversely affect our business and financial results, including by disrupting development, manufacturing, distribution or sale of our products.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a company engaged in the global development, manufacture and distribution of products, we are subject to the risks inherent in such activities, including industrial accidents, environmental events, strikes and other labor disputes, product quality control issues, safety, licensing requirements and other regulatory issues, as well as natural disasters, public health crises, such as pandemics or epidemics, international conflicts, geopolitical events, trade wars, terrorist acts, political or economic crises (such as the uncertainty related to protracted U.S. federal government funding negotiations) and other external factors over which we have no control. See, also </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;&#8212;Supply chain disruptions, geopolitical developments, including the Russia-Ukraine war, the Israel-Hamas war and wider Middle East developments (including disruptions to the Red Sea passage), or climate-change events (including severe weather events) may adversely affect our suppliers or our procurement of raw materials, and thus may impact our business and financial results.&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For instance, the Russia-Ukraine war has adversely impacted and may continue to impact, among other things, certain of our local markets and suppliers, global and local macroeconomic conditions, foreign exchange rates and financial markets, raw material, energy and transportation costs, and cause further supply chain disruptions. We maintain operations in both Russia and Ukraine and export products to customers in Russia and Ukraine from operations outside the region. In response to the events in Ukraine, the Company has limited the production and supply of ingredients in and to Russia to only those that meet the essential needs of people, including food, hygiene and medicine. As a result of changes and uncertainties arising out of the Russia-Ukraine war, our operating performance in Russia remains lower compared </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to previous years and may not reverse in the near future. The Israel-Hamas war may also have impacts on our operations in Israel and certain of our customers, local markets and suppliers.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we operate research and development, manufacturing and distribution facilities throughout the world, many of these facilities are extremely specialized and certain of our research and development or creative laboratories facilities are uniquely situated to support our research and development efforts while certain of our manufacturing facilities are the sole location where a specific ingredient or product is produced. If our research and development activities or the manufacturing of ingredients or products were disrupted, the cost of relocating or replacing these activities or reformulating these ingredients or products may be substantial, which could result in production or development delays or otherwise have an adverse effect on our margins, operating results and future growth.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, as a result of the COVID-19 pandemic&#8217;s impact on the global supply chain, we have experienced, and may continue to experience, increased costs, delays or limited availability related to raw materials, strain on shipping and transportation resources, and higher energy prices, which have negatively impacted and may continue to negatively impact, our margins and operating results. Although we do not currently anticipate any impairment charges related to COVID-19, the continuing effects of the pandemic could result in increased risks to us of asset write-downs and impairments, including, but not limited to, property, plant and equipment, goodwill and other intangibles, and equity investments. Any of these events or factors could potentially result in a material adverse impact on our business and results of operations.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A significant data breach or other disruption to our information technology systems could disrupt our operations, result in the loss of confidential information or personal data, and adversely impact our reputation, business or results of operations.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on information technology systems, including some managed by third-party providers, to conduct business and to support our business processes, including those relating to product formulas, product development, manufacturing, sales, order and invoice processing, production, distribution, internal communications and communications with third parties throughout the world, processing transactions, summarizing and reporting results of operations, complying with regulatory (including SEC), tax or legal requirements, and collecting and storing customer, supplier, employee and other stakeholder information.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To address the risks to our information technology systems and the associated costs, we maintain an information security program that includes updating technology and information security policies and controls, cybersecurity insurance, cybersecurity governance and compliance, employee/consultant awareness training, table-top exercises, logging and monitoring and routine testing of our information technology systems. We believe that these preventative actions provide adequate measures of protection against information security breaches/incidents and generally reduce our cybersecurity risks, however, cybersecurity incidents, data breaches and operational disruptions are constantly evolving, becoming more sophisticated, including through the increasing use of AI, and conducted by groups and individuals with a wide range of expertise and motives, including foreign governments, cyber terrorists, cyber criminals, malicious employees and other insiders and outsiders. Additionally, continued geopolitical turmoil, including the ongoing conflicts in the Middle East and between Russia and Ukraine, heightened the risk of cyber incidents. We and our third-party providers are subject to the risks posed by such incidents, which can take many forms, including code anomalies, &#8220;Acts of God,&#8221; data leakage, hardware or software failures, human errors, cyber extortion, password theft or introduction of viruses, malware and ransomware, including through phishing emails.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A disruption to our information technology systems could result in the loss of confidential business, customer, supplier or employee information, litigation or fines, and may require substantial investigations, repairs or replacements or impact our ability to summarize and report financial results in a timely manner, resulting in significant financial, legal and relational costs and potentially harming our reputation and adversely impacting our operations, customer service and results of operations. Additionally, the increasing use and evolution of technology, including cloud-based computing and AI, may lead to potential loss or unauthorized disclosure or use of personal data and proprietary information that was collected, used, stored, or transferred with respect to our business, and to dissemination or destruction of confidential information, unintentionally or otherwise, stored in our or in our third party providers&#8217; systems or through use of AI, which may significantly increase our business and information security costs, and expose us to reputational harm, penalties, or legal liability. As we complete integration of systems of prior acquired companies with IFF&#8217;s systems and prepare for the announced divestitures, we reduce our risk profile. Additionally, an information security or data breach could require us to devote significant management and financial resources to address the problems created, and, as a result of the private rights of action provided for under the European Union&#8217;s General Data Protection Regulation (the &#8220;GDPR&#8221;), the California Consumer Privacy Act (the &#8220;CCPA&#8221;) and other laws relating to data protection and privacy in other jurisdictions, in the event of such breaches, additional private litigation against us may result. These types of adverse impacts could also occur in the event the confidentiality, integrity or availability of company, customer, supplier or employee information are compromised due to a data loss by us or a trusted third party. We or the third parties with which we share information may not discover any such incidents and/or loss of information for a significant period of time after the incident occurs. In addition, our hybrid and remote work arrangements could introduce operational risk, including cybersecurity and IT systems management risks.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have experienced threats to our data and our systems and although we have not experienced a material incident to date, there can be no assurance that these measures will prevent or limit the impact of a future incident. Additionally, while we have insurance coverage designed to address certain aspects of cyber risks in place, such insurance coverage may be insufficient to cover all losses or all types of claims that may arise.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are subject to risks associated with the potential use of AI in our own operations and by third-party partners that we may engage with.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recent technological advances in AI come with significant risks related to its use across many industries, including our own. IFF may be exposed to such risks in cases where IFF utilizes AI in connection with certain business activities now or in the future, in cases where, whether known or unknown to IFF, IFF personnel, use AI for our business or at IFF locations, or in cases where our third-party partners, whether or not known to IFF, use AI in their business activities (which we may not be in a position to control).</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The use of AI by us, our employees or any of our third-party partners may result in unauthorized disclosure of personal data, proprietary information and trade secrets, commercially sensitive or confidential information of IFF, our employees or our partners. Similarly, we may become, through the use of AI and unbeknownst to us, recipients or users of such information provided by other parties, which may enable, among other things, third parties to claim that we infringed on their intellectual property rights. Such unauthorized disclosures or uses of information can result, among other things, in reputational harm, loss of confidence by our customers or employees, penalties, litigation costs, or legal liability.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Analyses, results or business processes relying on AI may also be deficient, inaccurate, or biased and we may fail to identify in a timely fashion or at all, if or to the extent that is the case. Furthermore, AI can exacerbate our cybersecurity or IT risks. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;--A significant data breach or other disruption to our information technology systems could disrupt our operations, result in the loss of confidential information or personal data, and adversely impact our reputation, business or results of operations.&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> With new and evolving AI comes a continually changing AI regulatory environment, which may create additional compliance costs and risks. At the same time, AI has the potential to significantly change the way we do our business by, among other things, creating efficiencies, improving our processes, customer experience, talent management and our decision-making. Any failure to capitalize on the AI benefits to the same degree or with the same speed as our competitors may put us in a disadvantageous position.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are unable to successfully manage these risks, it may have a material adverse effect on our business, results of operations and financial condition.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We have made investments in and continue to expand our business into emerging markets, which exposes us to certain risks.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our growth strategy, we have increased our presence in emerging markets by expanding our manufacturing presence, sales organization and product offerings in these markets, and we expect to continue to expand our business in these markets as part of our new strategic vision announced in December 2022. With our acquisition of Frutarom in 2018 and the N&amp;B Transaction, each of which also had a significant presence in emerging markets, our business in these markets has meaningfully grown. In addition to the currency and international risks described below, our operations in these markets may be subject to a variety of other risks. Emerging markets typically have a consumer base with limited or fluctuating disposable income and customer demand in these markets may fluctuate accordingly. As a result, a decrease in customer demand in emerging markets may have an adverse effect on our ability to execute our growth strategy.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, there is no assurance that our existing products, variants of our existing products or new products that we make, manufacture, distribute or sell will be accepted or be successful in any particular developing or emerging market, due to local or global competition, product price, cultural differences, consumer preferences or otherwise. In addition, emerging markets may have weak legal systems which may affect our ability to enforce our intellectual property and contractual rights, exchange controls, unstable governments and privatization or other government actions that may affect taxes, subsidies and incentive programs and the flow of goods and currency. In conducting our business, we move products from one country to another and may provide services in one country from a subsidiary located in another country. Accordingly, we are vulnerable to abrupt changes in trade, customs and tax regimes in these markets. If we are unable to expand our business in developing and emerging markets, effectively operate, or manage the risks associated with operating in these markets, or achieve the return on capital we expect from our investments in these markets, our operating results and future growth could be adversely affected.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The impact of currency fluctuation or devaluation in the international markets in which we operate may negatively affect our results of operations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have significant operations outside the U.S., the results of which are reported in the local currency and then translated into U.S. dollars at applicable exchange rates for inclusion in our consolidated financial statements. The exchange rates between these currencies and the U.S. dollar have fluctuated and will continue to do so in the future, with the fluctuations being particularly pronounced in certain emerging markets. Changes in exchange rates between these local currencies and the U.S. dollar will affect the recorded levels of sales, profitability, assets and/or liabilities. Along with other macroeconomic uncertainty we are experiencing such as a highly inflationary global environment and supply chain disruptions discussed elsewhere in these risk factors, we have experienced and continue to expect volatility in global foreign currency exchange rates. Changes to interest rate policy as managed by the Federal Reserve Bank to counter inflationary trends may further impact such exchange rates. Further volatility or unfavorable movements in currency exchange rates may adversely impact our financial condition, cash flows or liquidity. Although we employ a variety of techniques to mitigate the impact of exchange rate fluctuations, including sourcing strategies and a limited number of foreign currency hedging activities, we cannot guarantee that such hedging and risk management strategies will be effective, and our results of operations could be adversely affected.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">International economic, political, legal, compliance and business factors could negatively affect our financial statements, operations and growth.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate on a global basis, with manufacturing and sales facilities in or supply arrangements with companies based in the U.S., Europe, Africa, the Middle East, Latin America, and Greater Asia. During 2023, approximately 72% of our combined net sales were to customers outside the U.S. and we intend to continue expansion of our international operations. As a result, our business is increasingly exposed to risks inherent in international operations. These risks, which can vary substantially by location, include the following:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">governmental laws, regulations and policies adopted to manage national economic and macroeconomic conditions, such as increases in taxes, austerity measures that may impact consumer spending, monetary policies that may impact inflation rates, employment regulations, currency fluctuations or controls and sustainability of resources;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">changes in environmental, health and safety permits or regulations, such as regulations related to biodiversity or the continued implementation and evolution of the European Union&#8217;s REACH regulations and similar regulations that are being evaluated and adopted in other markets, or the ban on microplastics recently adopted by the European Commission (&#8220;EC&#8221;) and the burdens and costs of our compliance with such regulations which may differ significantly across jurisdictions;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">increased product labeling and ingredient prohibitions in specific markets that may impact consumer preferences, products costs and/or customer acceptance;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">the imposition of or changes in customs, tariffs, quotas, trade barriers, other trade protection measures, import or export licensing requirements, and sanctions on trade with certain countries, imposed by the U.S. or other countries, which could adversely affect our cost or ability to import raw materials or export our products to surrounding markets;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">risks and costs arising from our ability to cater to local demand and customer preferences, language and cultural differences;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">the movement for increased unionization in the U.S. and internationally may lead to labor instability, employee turnover, increased labor costs or production and operation disruptions;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">changes in the laws and policies that govern foreign investment in the countries in which we operate, including the risk of expropriation or nationalization, the costs and ability to repatriate the profit that we generate in these countries;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">risks and costs associated with complying with anti-money laundering and counter-terrorism financing laws;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">risks and costs associated with complying with the U.S. Foreign Corrupt Practices Act, similar U.S. or foreign anti-bribery and anti-corruption laws and regulations, applicable sanctions laws and regulations in the jurisdictions in which we operate or ethical business practices and related laws and regulations;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">risks and costs associated with political and economic instability, bribery and corruption, anti-American sentiment, and social and ethnic unrest in the countries in which we operate;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">difficulty in recruiting and retaining trained local personnel;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">natural disasters, global or local health crisis, pandemics (such as the COVID-19 pandemic), epidemics or international conflicts (such as the Russia-Ukraine war and Israel-Hamas war) or geopolitical tension (such as deteriorating U.S.-China relations), including terrorist acts, political crisis, national and regional labor strikes in the countries in which we operate, which could endanger our personnel, interrupt our operations or adversely affect the demand for our products, the results of certain regions or our global supply chain; or</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">the risks of operating in developing or emerging markets in which there are significant uncertainties regarding the interpretation, application and enforceability of laws and regulations and the enforceability of contract rights and intellectual property rights.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The occurrence of any one or more of these factors could increase our costs and adversely affect our results of operations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Economic uncertainty, including increased inflation, may adversely affect demand for our products which may have a negative impact on our operating results and future growth.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of our products are ingredients in a wide assortment of global consumer products throughout the world. Historically, demand for consumer products using our products, was stimulated and broadened by changing social habits and consumer needs, population growth, an expanding global middle-class and general economic growth, especially in emerging markets.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the global, regional or local economic conditions have, and may in the near future, adversely impact demand for consumer products at a regional or global level. Such parameters include, but are not limited to, increased inflation, unemployment and underemployment, salaries and wage rates stagnation, low growth rates, and ongoing impacts of the COVID-19 pandemic. Reduced consumer spending may cause changes in our customer orders including reduced demand for our products or order cancellations. The timing of placing of orders and the amounts of these orders are generally at our customers&#8217; discretion. Customers may cancel, reduce or postpone orders with us on relatively short notice. Significant cancellations, reductions or delays in orders by customers could affect our results of operation.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The integration of the N&amp;B Business may continue to present significant challenges, and we may not realize anticipated synergies and other benefits of the N&amp;B Transaction.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The combination of large, diverse and independent businesses is complex, costly and time-consuming. The combination with the N&amp;B Business may result in material unanticipated problems, expenses, liabilities, competitive responses, employee turnover and loss of customer and other business relationships. In addition, even though the operations of the N&amp;B Business are being integrated, the full benefits of the transaction may not be realized, including, among others, the synergies, cost savings or revenue growth that are expected. These benefits may not be achieved within the anticipated time frame or at all, which could result in a material adverse impact on our business and results of operations.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If we are unable to react in a timely and cost-effective manner to changes in consumer trends, such as increasing awareness of health and wellness our results of operations and future growth may be adversely affected.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We must continually anticipate and react, in a timely and cost-effective manner, to changes in consumer preferences and demands, including changes in demand driven by increasing awareness of health and wellness, demands for transparency or cleaner labels with respect to product ingredients by consumers and regulators, and attitudes towards the impact of biotechnology advances such as gene editing and mapping. Consumers, especially in developed economies such as the U.S. and Western Europe, are rapidly shifting away from products containing artificial ingredients to all-natural, healthier alternatives, and the development of certain new weight management pharmaceutical products such as glucagon-like peptide-1 (GLP-1) receptor agonists may affect consumer behavior and trends, and ultimately decrease demand for our product offerings. In addition, there has been a growing demand by consumers, non-governmental organizations and, to a lesser extent, governmental agencies to provide more transparency in product labeling and our customers have been taking steps to address this demand, including by voluntarily providing product-specific ingredients disclosure. These trends could affect the types and volumes of our ingredients and compounds that our customers include in their consumer product offerings and, therefore, affect the demand for our products. If we are unable to react to or anticipate these trends in a timely and cost-effective manner, our results of operations and future growth may be adversely affected.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are subject to increasing customer, consumer, shareholder and regulatory focus on sustainability, which may result in additional costs in order to meet new requirements.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal, state, local and foreign governments, our customers, consumers and shareholders are becoming increasingly sensitive to environmental and other sustainability issues. In response, we have committed to a sustainability strategy to better understand the opportunities and risks in our sustainable efforts.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increased focus on sustainability may result in new regulations and customer requirements that could affect us. These could cause us to incur additional direct costs or to make changes to our operations in order to comply with any new regulations and customer requirements. We could also lose revenue if our customers divert business from us because we have not complied with their sustainability requirements. Increased shareholder activism with respect to sustainability or other governance issues or management concerns could also lead to increased costs and disruption to operations. These potential costs, changes and loss of revenue could have a material adverse effect on our business, results of operations and financial condition.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our performance may be adversely impacted if we are not successful in managing our inventory and/or working capital balances.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate our inventory balances of materials based on shelf life, expected sourcing levels, known uses and anticipated demand based on forecasted customer order activity and changes in our product/sales mix. Efficient inventory management is a key component of our business success, financial returns and profitability. To be successful, we must maintain sufficient inventory levels and an appropriate product/sales mix to meet our customers&#8217; demands, without allowing those levels to increase to such an extent that the costs associated with storing and holding other inventory adversely impact our financial results. If our buying decisions do not accurately predict sourcing levels, customer trends or our expectations about customer needs are inaccurate, we may have to take unanticipated markdowns or charges to dispose of the excess or obsolete inventory, which can adversely impact our financial results. Current supply-chain related issues could also lead to raw material shortages and inventory depletion, which may adversely affect our operations. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;&#8212;Supply chain disruptions, geopolitical developments, including the Russia-Ukraine war, the Israel-Hamas war and wider Middle East developments (including disruptions to the Red Sea passage), or climate-change events (including severe weather events) may adversely affect our suppliers or our procurement of raw materials, and thus may impact our business and financial results.&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Additionally, we believe excess inventory levels of raw materials with a short shelf life in our manufacturing facilities subjects us to the risk of increased inventory shrinkage. If we are not successful in managing our inventory balances and shrinkage, our results of and cash flows from operations may be negatively affected.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sell certain accounts receivable on a non-recourse basis to unrelated financial institutions under &#8220;factoring&#8221; agreements, some of which are sponsored by certain customers. The cost of participating in these programs was immaterial to our results in all periods. Should we choose not to participate, or if these programs were no longer available, it could reduce our cash flows from operations in the period in which the arrangement ends.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Any impairment of our tangible or intangible long-lived assets, including goodwill, may adversely impact our profitability.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A significant portion of our assets consists of long-lived assets, including tangible assets such as our manufacturing facilities, and intangible assets, including goodwill and customer relationships.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of our recent acquisitions, including the acquisition of Frutarom and the N&amp;B Transaction, as of December&#160;31, 2023, we recorded approximately $18.992&#160;billion of intangible assets and goodwill, including $4.289&#160;billion of goodwill associated with the acquisition of Frutarom and $11.817&#160;billion of goodwill associated with the merger with the N&amp;B Business, prior to the impact of impairment charges and business divestitures. Our results of operations and financial position in future periods could be negatively impacted should future impairments of our long-lived assets, including intangible assets or goodwill occur.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At least annually, we assess both goodwill and indefinite-lived intangible assets for impairment. We test for impairment by comparing the estimated fair value of a reporting unit with its carrying amount. If the carrying amount of a reporting unit exceeds its estimated fair value, we record an impairment charge based on the difference of the two. Intangible assets with finite lives are also tested for impairment when events or changes in circumstances indicate the carrying value may not be recoverable. Such events and changes in circumstances could include a sustained decrease in our market capitalization, increased competition or unexpected loss of market share, increased input costs beyond projections (for example due to regulatory or industry changes), our inability to recognize the anticipated benefits of acquisitions, unexpected business disruptions (for example due to a natural disaster, public health crises, such as pandemics or epidemics or loss of a customer, supplier, or other significant business relationship), acts by governments and courts, operating results falling short of projections, or significant adverse changes in the markets in which we operate. During the year ended December 31, 2023, we recorded a goodwill impairment charge of $2.623 billion in the Consolidated Statements of (Loss) Income and Comprehensive Loss. Refer to Part II, Item 7 and Note 1 and Note 6 to the Consolidated Financial Statements for additional information.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value determinations require considerable judgment and are sensitive to changes in underlying assumptions, estimates and market factors. Estimating the fair value of reporting units requires us to make assumptions and estimates regarding our business performance, future plans, future annual net cash flows, income tax considerations, discount rates and growth rates based on industry, economic, regulatory conditions and other market factors. Moreover, management will make significant accounting judgments and estimates for the application of acquisition accounting under GAAP, and the underlying valuation models. IFF&#8217;s business, operating results and financial condition could be materially and adversely impacted in future periods if IFF&#8217;s accounting judgments and estimates related to these models prove to be inaccurate.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent any of our acquisitions, including the acquisitions of Frutarom and the N&amp;B Business, do not perform as anticipated and our underlying assumptions and estimates related to their fair value determination are not met, whether due to internal or external factors, the value of goodwill and other long-lived assets may be negatively affected and we may be required to record impairment charges.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If we fail to successfully enter into or close collaborations, joint ventures, partnerships or acquisitions, or successfully manage such transactions, it could adversely affect our business and growth opportunities.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we evaluate and enter into collaborations, joint ventures or partnerships to enhance our research and development efforts, expand our product portfolios and technology, or modify or enter into new distribution arrangements. The process of establishing and maintaining such relationships is difficult and time-consuming to negotiate, document and implement. We may not be able to successfully negotiate such arrangements or the terms of the arrangements may not be as favorable as anticipated. Furthermore, our ability to generate revenues from such collaborations will depend on our partners&#8217; abilities and efforts to successfully perform the functions assigned to them in these arrangements and these collaborations may not lead to development or commercialization of products in the most efficient manner, or at all. In addition, from time to time, we have acquired, and we may acquire, only a majority interest in companies and provided or may provide earnouts for the former owners along with the ability, at our option, or obligation, at the former owners&#8217; option, to purchase the minority interests at a future date at an established price. These investments may have additional risks and may not be as efficient as other operations as we may have fiduciary or contractual obligations to the minority investors and may rely on former owners for the continuing operation of the acquired business. If we are unable to successfully establish and manage these collaborative relationships and majority investments, it could adversely affect our future growth.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, from time to time, we evaluate acquisition candidates that may strategically fit our business and/or growth objectives. If we are unable to successfully integrate and develop acquired businesses, we could fail to achieve anticipated synergies and cost savings, including any expected increase in revenues and operating results, which could have a material adverse effect on our financial results. Furthermore, even if successfully integrated, the acquisition target may fail to further the Company&#8217;s business strategy as anticipated, expose the Company to increased competition or other challenges with respect to the Company&#8217;s products or geographic markets, and expose the Company to additional liabilities associated with the acquired business, technology or other asset or arrangement. We may also incur asset impairment charges related to acquisitions if we fail to maintain and integrate the acquired businesses and such impairments charges would reduce our earnings.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our funding obligations for our pension and postretirement plans could adversely affect our earnings and cash flows.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The funding obligations for our pension plans are impacted by the performance of the financial markets, particularly the equity markets and interest rates. Funding obligations are determined under government regulations and are measured each year based on the value of assets and liabilities on a specific date. If the financial markets do not provide the long-term returns that are expected under the governmental funding calculations, we could be required to make larger contributions. The equity markets can be very volatile, and therefore our estimate of future contribution requirements can change dramatically in relatively short periods of time. Similarly, changes in interest rates and legislation enacted by governmental authorities can impact the timing and amounts of contribution requirements. An adverse change in the funded status of the plans could significantly increase our required contributions in the future and adversely impact our liquidity.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assumptions used in determining projected benefit obligations and the fair value of plan assets for our pension and other postretirement benefit plans are determined by us in consultation with outside consultants and advisors. In the event that we determine that changes are warranted in the assumptions used, such as the discount rate, expected long-term rate of return on assets, or expected health care costs, our future pension and postretirement benefit expenses could increase or decrease. Due to changing market conditions or changes in the participant population, the assumptions that we use may differ from actual results, which could have a significant impact on our pension and postretirement liabilities and related costs and funding requirements.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The phase out of the London Interbank Offered Rate (&#8220;LIBOR&#8221;) may impact the interest rates paid on our variable rate indebtedness and could cause our interest expense to increase.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After consultations among financial regulators in the United States and Europe, the Secured Overnight Financing Rate (&#8220;SOFR&#8221;) was identified as the replacement rate for LIBOR, which ceased publication in June 2023. SOFR is observed and backward-looking, which stands in contrast with LIBOR&#8217;s methodology, which was an estimated forward-looking rate and relied, to some degree, on the expert judgment of submitting panel members. Given that SOFR is a secured rate backed by government securities, it is a rate that does not take into account bank credit risk (as was the case with LIBOR). SOFR is a relatively new reference rate with a limited history and so it is difficult to predict its future performance. As such, the transition from LIBOR to SOFR may pose future uncertainties and challenges.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings under our Revolving Credit Facility and Term Loans are at variable interest rates and have been amended to be based on SOFR. No assurance can be made that such alternative rate will perform in a manner similar to LIBOR and may result in interest rates that are higher or lower than those that would have resulted had LIBOR remained in effect. Any of these occurrences could materially and adversely affect our borrowing costs, financial condition and results of operations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Risks Related to Legal and Regulatory Considerations</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If we are unable to comply with regulatory requirements and industry standards, including those regarding product safety, quality, efficacy and environmental impact, we could incur significant costs and suffer reputational harm which could adversely affect results of operations.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The development, manufacture and sale of our products are subject to various regulatory requirements in each of the countries in which our products are developed, manufactured and sold. In addition, we are subject to product safety and compliance requirements established by governments, non-governmental organizations, including industry or similar oversight bodies, or contractually by our customers, including requirements concerning product safety, quality and efficacy, environmental impacts (including packaging, energy and water use and waste management) and other sustainability or similar issues. Changes to regulations or the implementation of additional regulations, especially in certain highly regulated markets we are active in, such as regulatory modernization of food safety laws and evolving standards and regulations affecting pharmaceutical excipients or in reaction to new or next-generation technologies, including advances in protein engineering, biotechnology (e.g., gene editing and gene mapping), novel uses of existing technologies or stricter rules on ingredients produced by biotechnology techniques have required and may in the future require us to reduce or remove certain ingredients, substances or processing aids from the product portfolio and may result in significant costs or capital expenditures or require changes in business practice that could result in reduced margins or profitability.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As concerns regarding safety, quality and environmental impact become more pressing, we may see new, more restrictive regulations adopted that impact our products. For example, the EC recently adopted a ban on microplastics, including those found in personal care items, detergents and cosmetics, to reduce plastics pollution. We are now required to modify our products and/or innovate new solutions to replace microplastics in our products. The EU Green Deal includes a Chemicals Strategy for Sustainability (CSS), which will trigger updates of the main regulations governing chemical substances used in household and cosmetic products or in industrial applications (REACH, CLP, Cosmetic Regulation and Detergent Regulation). This strategy aims for an expansion of the generic risk management approach based on hazard rather than risk and will introduce other concepts like grouping of similar substances to accelerate regulatory decision making. The practical implementation of this strategy may negatively impact some of the products we place on the market, including some enzymes or fragrance ingredients. If we are unable to adapt to these new regulations or standards in a cost effective and timely manner, we may lose business to competitors who are able to provide compliant products, expose ourselves to customer claims, regulatory fines, litigation or reputational damage.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gaps in our operational processes or those of our suppliers or distributors can result in products that do not meet our quality control or industry standards or fail to comply with the relevant regulatory requirements, which in turn can result in finished consumer goods that do not comply with applicable standards and requirements. Products that are mislabeled, contaminated or damaged could result in a regulatory non-compliance event or even a product recall by the FDA or a similar foreign agency. For instance, the Company had determined in the past that certain grades of microcrystalline cellulose (Avicel&#174; PH 101, 102, and 200 NF and Avicel&#174; RC-591 NF) were found to be out-of-specification. Although the Company does not expect the OOS conductivity issue to affect the functionality of Avicel&#174; NF grades or to pose a human health hazard, corrective actions have been implemented to improve operational and laboratory conditions.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may also be exposed to serious adverse health claims related to undetected poor quality of raw materials, internal system failures to adequately reduce or eliminate certain hazards (such as pathogens, allergens, contaminants, pesticides, physical hazards, etc.) or products that are not in line with required or agreed specifications. Supply chain complexities, aging equipment and infrastructure, human errors, or other failures may exacerbate such risks.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contracts often require us to indemnify our customers for the costs associated with a product non-compliance event, including penalties, costs and settlements arising from litigation, remediation costs or loss of sales. As our offerings are used in many products intended for human use or consumption, these consequences would be exacerbated if we or our customer did not identify the defect before the product reaches the consumer and there was a resulting impact at the consumer level. Such a result could lead to potentially large-scale adverse publicity, negative effects on consumer&#8217;s health, recalls and potential litigation, fines, penalties, sanctions or other regulatory actions. In addition, if we do not have adequate insurance or contractual indemnification from suppliers or other third parties, or if insurance or indemnification is not available, the liability relating to product or possible third-party claims arising from mislabeled, contaminated or damaged products could adversely affect our business, financial condition or results of operations. Furthermore, adverse publicity about our products, or our customers&#8217; products that contain our ingredients, including concerns about product safety or similar issues, whether real or perceived, could harm our reputation and result in an immediate adverse effect on our sales and customer relationships, as well as require us to utilize significant resources to rebuild our reputation.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Defects, quality issues (including product recalls), inadequate disclosure or misuse with respect to the products and capabilities could adversely affect our business, reputation and results of operations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Defects in, misuse of, quality issues with respect to (including products recalls) or inadequate disclosure of risks relating to our products, could lead to lost profits and other economic damage, property damage, personal injury or other liability resulting in third-party claims, criminal liability, significant costs, damage to our reputation and loss of business. Any of these factors could adversely affect our business, financial condition and our results of operations.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Failure to comply with environmental protection laws may cause us to close, relocate or operate one or more of our plants at reduced production levels, and expose us to civil or criminal liability, which could adversely affect our operating results and future growth.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business operations and properties procure, make use of, manufacture, sell, and distribute substances that are sometimes considered hazardous and are therefore subject to extensive and increasingly stringent federal, state, local and foreign laws and regulations pertaining to protection of the environment, including air emissions, sewage discharges, the use of hazardous materials, waste disposal practices and clean-up of existing environmental contamination.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Failure to comply with these laws and regulations or any future changes to them may result in significant consequences to us, including the need to close or relocate one or more of our production facilities, administrative, civil and criminal penalties, fines, sanctions, litigation, costly remediation measures, liability for damages and negative publicity. If we are unable to meet production requirements, we can lose customer orders, which can adversely affect our future growth or we may be required to make incremental capital investments to ensure supply. Idling of facilities or production modifications has caused or may cause customers to seek alternate suppliers due to concerns regarding supply interruptions and these customers may not return or may order at reduced levels even once issues are remediated. If these non-compliance issues reoccur in China or occur or in any other jurisdiction, we may lose business and may be required to incur capital spending above previous expectations, close a plant, or operate a plant at significantly reduced production levels on a permanent basis, and our operating results and cash flows from operations may be adversely affected.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We could be adversely affected by violations, by us or our counterparties, of the U.S. Foreign Corrupt Practices Act, similar U.S. or foreign anti-bribery and anti-corruption laws and regulations, applicable sanctions laws and regulations in the jurisdictions in which we operate or ethical business practices and related laws and regulations.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The global nature of our business, our increased size and employee count, the significance of our international revenue, our focus on emerging markets and presence in regulated industries create various domestic and local regulatory challenges and subject us to risks associated with our international operations. The U.S. Foreign Corrupt Practices Act (the &#8220;FCPA&#8221;) and similar anti-bribery and anti-corruption laws and regulations in other countries generally prohibit companies and their intermediaries from making improper payments to foreign officials for the purpose of obtaining or keeping business or for other commercial advantage. In addition, U.S. public companies are required to maintain records that accurately and fairly represent their transactions and have an adequate system of internal accounting controls. Under the FCPA, U.S. companies may be held liable for the corrupt actions taken by directors, officers, employees, agents, or other strategic or local partners or representatives. As such, if we or our intermediaries fail to comply with the requirements of the FCPA or similar legislation, governmental authorities in the U.S. and elsewhere could seek to impose substantial civil and/or criminal fines and penalties which could have a material adverse effect on our business, reputation, operating results and financial condition.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate or may pursue opportunities in some jurisdictions, such as China, India, Brazil, Russia and Africa, that pose potentially elevated risks of fraud or corruption or increased risk of internal control issues. In certain jurisdictions, compliance with anti-bribery laws may conflict with local customs and practices. From time to time, we have conducted and will conduct internal investigations of the relevant facts and circumstances, control testing and compliance reviews, and take remedial actions, when appropriate, to help ensure that we are in compliance with applicable corruption and similar laws and regulations. For example, in August 2019, during the integration of Frutarom, we were made aware of allegations that two Frutarom businesses operating principally in Russia and Ukraine made certain improper payments, including to representatives of a number of customers. Our investigation substantiated the allegations that improper payments to representatives of customers were made and that key members of Frutarom&#8217;s senior management at the time were aware of such payments. We did not uncover any evidence suggesting that such payments had any connection to the U.S. In addition, Frutarom grew through rapid acquisition and, as part of our integration efforts, we have implemented our anti-corruption and similar policies throughout a number of those acquired companies, many of which were not previously subject to these U.S. laws.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Detecting, investigating and resolving actual or alleged violations of the FCPA or other anti-bribery and anti-corruption laws and regulations is expensive, could consume significant time and attention of our senior management and could subject us to investigations and inquiries by governmental and other regulatory bodies. Any allegations of non-compliance with such laws and regulations could have a disruptive effect on our operations in such jurisdiction, including interruptions of business or loss of third-party relationships, which may negatively impact our results of operations or financial condition. Any determination that our operations or activities are not in compliance with such laws and regulations could expose us to severe criminal or civil penalties or other sanctions, significant fines, termination of necessary licenses and permits and penalties or other sanctions that may harm our business and reputation.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given the international scope of our business, we also sell certain of our products to countries that are subject to U.S. and other sanctions under general licenses and authorizations related to such products, technologies and transactions. For example, the U.S., the European Union and other countries have imposed sanctions and export controls on Russia, Belarus and occupied regions of Ukraine. As a result, we have limited our export of ingredients to customers in Russia, Belarus and occupied regions of Ukraine to only those that are permitted and meet the essential needs of people. Compliance with sanctions laws is highly technical and requires careful oversight, and it is possible that actions taken by us, our subsidiaries or our suppliers may cause us to be in breach with these laws, which could have a material adverse effect to our business.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our reputation and our customers&#8217; willingness to purchase our products depend in part on our compliance by our suppliers, distributors, customers or other counterparties with ethical employment practices, such as with respect to child labor, wages and benefits, forced labor, discrimination, safe and healthy working conditions, as well as with all legal and regulatory requirements relating to the conduct of their businesses (including the ones mentioned in the preceding paragraphs). While we generally require that third-parties we work with agree to our code of conduct, we do not exercise control over our suppliers, distributors, vendors and customers and due to the global nature of our business cannot guarantee their compliance with such ethical and lawful business practices or such legal requirements. If our counterparties fail to comply with applicable laws, regulations, safety codes, employment practices, human rights standards, quality standards, environmental standards, production practices, or other obligations, norms, or ethical standards, our reputation and brand image could be harmed, and we could be exposed to litigation, investigations, enforcement actions, monetary liability, and additional costs that would harm our reputation, business, financial condition, results of operations and prospects.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our ability to compete effectively depends on our ability to protect our intellectual property rights.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on patents, trademarks, copyrights and trade secrets to protect our intellectual property rights. We often rely on trade secrets to protect our products, manufacturing processes, extract methodologies and other processes, as this does not require us to publicly file information regarding our intellectual property. From time to time, a third party may claim that we have infringed upon or misappropriated their intellectual property rights, or a third party may infringe upon or misappropriate our intellectual property rights. We could incur significant costs in connection with legal actions to assert our intellectual property rights against third parties or to defend ourselves from third-party assertions of invalidity, infringement, misappropriation or other claims. Any settlement or adverse judgment resulting from such litigation could require us to obtain a license to continue to use the intellectual property rights that are the subject of the claim, or otherwise restrict or prohibit our use of such intellectual property rights. Any required licensing fees may not be available to us on acceptable terms, if at all. For those intellectual property rights that are protected as trade secrets, this litigation could result in even higher costs, and potentially the loss of certain rights, since we would not have a perfected intellectual property right that precludes others from making, using or selling our products or processes. The ongoing trend among our customers towards more transparent labeling could further diminish our ability to effectively protect our products.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We vigilantly protect our intellectual property rights, including trade secrets. We have designed and implemented internal controls intended to restrict access to and distribution of our respective intellectual property. Despite these precautions, our intellectual property is vulnerable to unauthorized access through employee error or actions, theft and cybersecurity incidents, and other security breaches, including due to increasing use of AI tools. See, also - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;We are subject to risks associated with the potential use of AI in our own operations and by third-party partners that we may engage with.&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Protecting intellectual property related to biotechnology is particularly challenging because theft can be difficult to detect and biotechnology can be self-replicating. Accordingly, the impact of such theft can be significant.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For intellectual property rights that we seek to protect through patents, we cannot be certain that these rights, if obtained, will not later be opposed, invalidated or circumvented. In addition, even if such rights are obtained in the U.S., the laws of some other countries in which our products are or may be sold may not protect intellectual property rights to the same extent as the laws of the U.S. For instance, we may be unable to obtain or defend intellectual property rights in new and inventive technology developed in whole or in part by relying on AI tools. If other parties were to infringe on our intellectual property rights, or if our intellectual property rights were the subject of unauthorized access leading to competitive pressure or if a third party successfully asserted that we had infringed on their intellectual property rights, it could materially and adversely affect our future results of operations by, among other things, (i) being required to cease production and marketing or reducing the price that we could obtain in the marketplace for products which are based on such rights, (ii) increasing the royalty or other fees that we may be required to pay in connection with such rights, (iii) limiting the volume, if any, of such products that we can sell or (iv) resulting in significant litigation costs and potential liability.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in our tax rates, the adoption of new U.S. or international tax legislation, or changes in existing tax laws could expose us to additional tax liabilities that may affect our future results.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to taxes in the U.S. and numerous foreign jurisdictions. Our future effective tax rates could be affected by changes in the mix of earnings in countries with differing statutory tax rates, changes in the valuation of deferred tax assets and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">liabilities, changes in liabilities for uncertain tax positions, cost of repatriations or changes in tax laws or their interpretation. Any of these changes could have a material adverse effect on our profitability.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have and will continue to implement transfer pricing policies among our various operations located in different countries. These transfer pricing policies are a significant component of the management and compliance of our operations across international boundaries and overall financial results. Many countries routinely examine transfer pricing policies of taxpayers subject to their jurisdiction, challenge transfer pricing policies aggressively where there is potential non-compliance and impose significant interest charges and penalties where non-compliance is determined. However, governmental authorities could challenge these policies more aggressively in the future and, if challenged, we may not prevail. We could suffer significant costs related to one or more challenges to our transfer pricing policies.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the continual examination of our income tax returns by the Internal Revenue Service, state tax authorities and foreign tax authorities in those countries in which we operate, and may be subject to assessments or audits in the future in any of the countries in which we operate. The final determination of tax audits and any related litigation could be materially different from our historical income tax provisions and accruals, and while we do not believe the results that follow would have a material adverse effect on our financial condition, such results could have a material effect on our income tax provision, net income or cash flows in the period or periods in which that determination is made.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, a number of international legislative and regulatory bodies have proposed legislation and begun investigations of the tax practices of multi-national companies and, in the European Union, the tax policies of certain European Union member states. In December 2021, the Organisation for Economic Co-operation and Development (&#8220;OECD&#8221;) released the Pillar Two model rules to reform international corporate taxation that aim to ensure that applicable multinationals (global revenue exceeding &#8364;750 million) pay a minimum effective corporate tax rate of 15%. The rules are due to be passed into national legislation based on each country&#8217;s approach, and some countries have already enacted or substantively enacted the rules. The OECD continues to release additional guidance on the Two-Pillar framework, with widespread implementation anticipated by 2024. We are continuing to evaluate the potential impact on future periods of the Pillar Two Framework, pending legislative adoption by individual countries. This new legislation may have a material effect on our effective tax rate, income tax expense, net income or cash flows.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since 2013, the European Commission (&#8220;EC&#8221;) has been investigating tax rulings granted by tax authorities in a number of European Union member states with respect to specific multi-national corporations to determine whether such rulings comply with European Union rules on state aid, as well as more recent investigations of the tax regimes of certain European Union member states. Under European Union law, selective tax advantages for particular taxpayers that are not sufficiently grounded in economic realities may constitute impermissible state aid. If the EC determines that a tax ruling or tax regime violates the state aid restrictions, the tax authorities of the affected European Union member state may be required to collect back taxes for the period of time covered by the ruling. If the EC or tax authorities in other jurisdictions were to successfully challenge tax rulings applicable to us in any of the member states in which we are subject to taxation or our internal intercompany arrangements, we could be exposed to increased tax liabilities.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022, the U.S. government enacted legislation commonly referred to as the &#8220;Inflation Reduction Act&#8221;, which, among other things, imposes a minimum &#8220;book&#8221; tax on certain corporations effective for taxable years beginning after December 31, 2022 and creates a new excise tax on stock repurchases made by certain publicly traded corporations after December 31, 2022. We will continue to evaluate its impact as further guidance becomes available.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The N&amp;B Transaction could result in significant tax liability, and we may be obligated to indemnify DuPont for any such tax liability imposed on DuPont.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The completion of the N&amp;B Transaction in 2021 was conditioned upon the receipt by DuPont of an opinion that the transaction generally will qualify as a tax-free reorganization. The tax opinion was based upon various factual representations and assumptions, as well as certain undertakings made by DuPont, IFF and N&amp;B. If any of those factual representations or assumptions were untrue or incomplete in any material respect, any undertaking was or is not complied with, or the facts upon which the opinion was based are materially different from the facts at the closing of the N&amp;B Transaction, the transaction may not qualify (in whole or part) for tax-free treatment.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The N&amp;B spin-off and certain aspects of the pre-spin-off internal reorganizations to form N&amp;B could be taxable to DuPont if N&amp;B or we were to engage in a &#8220;Spinco Tainting Act&#8221; (as defined in the Tax Matters Agreement, by and among DuPont, N&amp;B and IFF, a form of which is attached to IFF&#8217;s registration statement on Form S-4 (Registration Number 333-238072)). A Spinco Tainting Act is generally any action (or inaction) within our control or under the control of N&amp;B or their affiliates, any event involving our common stock or the common stock of N&amp;B or any assets of N&amp;B or its subsidiaries, or any breach by N&amp;B or any of its subsidiaries of any factual representations, assumptions, or undertakings made by it, in each case, that would affect the non-recognition treatment of the spin-off and internal reorganizations for U.S. federal income tax purposes, as described above. Under the Tax Matters Agreement, we and N&amp;B will be required to indemnify DuPont for any taxes resulting from a Spinco Tainting Act. If we were required to indemnify DuPont pursuant to the Tax Matters Agreement as described </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">above, this indemnification obligation may be substantial and could have a material adverse effect on us, including with respect to our financial condition and results of operations.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, we are not indemnified for tax liabilities related to pre-spin-off periods. Tax liabilities could increase as an outcome of final determination of tax examinations and could adversely impact our financial results.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If we fail to comply with data protection laws in the U.S. and abroad, we may be subject to fines, penalties and other costs.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legal requirements relating to the collection, storage, handling, use, disclosure, transfer, and security of personal data continue to evolve, and regulatory scrutiny in this area is increasing around the world. This regulatory environment is increasingly challenging and may present material obligations and risks to our business, including significantly expanded compliance burdens, restrictions on transfer of personal data, costs and enforcement risks. Many governments have enacted or are enacting new or updated data protection laws, including data localization laws that require data to stay within their borders. All of these evolving compliance and operational requirements, restrictions on use of personal data, as well as the uncertain interpretation and enforcement of laws, impose significant costs and regulatory risks that are likely to increase over time. Our failure to comply with these evolving regulations could expose us to fines, sanctions, penalties and other costs that could harm our reputation and adversely impact our financial results.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_19"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;1B.&#160;&#160;&#160;&#160;UNRESOLVED STAFF COMMENTS.</span></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_1718"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;1C.&#160;&#160;&#160;&#160;CYBERSECURITY.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risk Management and Strategy</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our comprehensive Incident Response Plan outlines processes to identify, detect, assess, respond to and recover from threats, including cybersecurity threats. We follow those processes to manage material risks from cybersecurity threats, including risks relating to disruption of business operations or financial reporting systems, intellectual property theft; fraud; extortion; harm to employees or customers; violation of privacy laws and other litigation/legal risk; and reputational risk, as part of our overall risk management system and processes.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our Enterprise Risk Management (&#8220;ERM&#8221;) program considers cybersecurity risks alongside other company risks. Our enterprise risk professionals consult with cross-organizational leaders to gather information necessary to identify cybersecurity risks, evaluate their likelihood and severity, identify necessary mitigations and assess the potential impact of those mitigations on residual risk. Our ERM Committee, chaired by the Chief Financial Officer (&#8220;CFO&#8221;) and General Counsel (&#8220;GC&#8221;), and comprised of senior leaders representing each risk domain, integrates global risks, including cybersecurity and compliance, to ensure appropriate prioritization of resources and alignment across the Company. The ERM Committee meets with our Executive Leadership Team and presents at least annually to our Board of Directors on the ERM process and on our risk mitigation actions, including providing reporting focused on compliance and cybersecurity risks.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Chief Information Officer (&#8220;CIO&#8221;) is responsible for delivering on the Company&#8217;s global Information Technology (&#8220;IT&#8221;) strategy, including infrastructure, data and analytics, application delivery, end user services, cybersecurity risk management and the digital technology transformation program. The IT leadership team leads the implementation of the IT strategy and the day-to-day operations. Under the guidance of the CIO, our Chief Information Security Officer (&#8220;CISO&#8221;) leads Information Security (&#8220;InfoSec&#8221;), which includes the Cyber Fusion Center, Infrastructure Security, including network segmentation, firewalls and intrusion detection and prevention systems, Identity and Access Management, Application Security, Data Security and InfoSec Governance, Risk and Compliance. InfoSec is overseen by the InfoSec Steering Committee, comprised of senior leaders representing all corporate functions and business units, and the InfoSec Governance Review Board, comprised of the IT leadership team and the InfoSec leadership team. InfoSec is governed in coordination with IFF&#8217;s ERM Committee and is aligned to the U.S. National Institute of Standards and Technology (&#8220;NIST&#8221;) Cybersecurity Framework.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to our dedicated leadership team overseeing InfoSec, we view InfoSec as a shared responsibility, and to best protect our network, computers and data from threats, we empower our employees to be our first line of defense. To that end, all employees globally complete annual mandatory InfoSec training on email security, password security and our Acceptable Use Policy. We use email security, endpoint security, logging and monitoring, remote access, application security and other tools to deter threat actors, block malicious/phishing emails and avoid IT system interruptions.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our comprehensive InfoSec Incident Response Plan is updated at least annually, and provides guidance for detecting, containing, eradicating and recovering from potential incidents. It outlines escalation procedures, reporting requirements, incident severity levels, a materiality assessment and roles and responsibilities for key partners, including IT, Legal/Employee Relations, Corporate Communications, Human Resources and other senior leaders. Our escalation procedures include escalation to our Executive Leadership Team, Audit Committee, Disclosure Committee, and Board of Directors, and reporting to </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">regulators, customers, investors, and others. We also maintain cybersecurity insurance, regularly evaluate the effectiveness of our systems, and test our contingency plans by conducting vulnerability analysis and tabletop exercises with both technical incident responders and senior leaders.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on industry baselines and discussions throughout our membership in various global InfoSec communities, we believe that these preventative actions provide adequate measures of protection against information security breaches/incidents and reduce our cybersecurity risks. Given the evolving nature of InfoSec incidents, we regularly engage with our peers on threat intelligence and collaborate with organizations both in our industry and across industries to share best practices.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with our InfoSec risk management processes, we engage third-party assessors and outside counsel. Our program includes review and assessment by external, independent third parties, who assess and report on our overall InfoSec program and identify areas for continued focus and improvement. Our CIO, CISO and GC oversee our technology risk management and privacy teams, which work in partnership with our Internal Audit team to review IT-related controls as part of the overall internal controls process and regulatory requirements. We consult with outside counsel to advise our team and our Board of Directors on best practices for InfoSec oversight, and the evolution of that oversight over time. InfoSec employees regularly speak at and attend industry events to ensure awareness of evolving threats and innovative prevention and remediation techniques. Further, our InfoSec risk management processes extend to the oversight and identification of threats associated with our use of third-party service providers through relationship due diligence, InfoSec assessments and contractual provisions.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business strategy, results of operations and financial condition have not been materially affected by risks from cybersecurity threats, including as a result of previous cybersecurity incidents, but we cannot provide assurance that they will not be materially affected in the future by such risks and any future material incidents. For more detailed information about risks related to our cybersecurity, refer to Item 1A, &#8220;Risk Factors&#8221; &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;A significant data breach or other disruption to our information technology systems could disrupt our operations, result in the loss of confidential information or personal data, and adversely impact our reputation, business or results of operations.&#8221;</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Governance</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board of Directors is responsible for overseeing and reviewing with management the Company&#8217;s InfoSec risks and the policies and practices established to manage such risks. In that effort, the Board of Directors delegates certain responsibilities to our Audit Committee. This committee-level focus on InfoSec allows the Board to further enhance its understanding of these issues as it continues to have overall oversight responsibility for risk.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee assists the Board of Directors in its oversight by staying apprised of our InfoSec programs, strategy, policies, standards, architecture, processes and material risks, and by overseeing response to InfoSec incidents. Our Audit Committee receives from management updates, at least quarterly, on material security risks, including any material incidents, relevant industry developments, threat vectors and material risks identified in periodic penetration tests or vulnerability scans. These updates also include material legal and legislative developments concerning InfoSec, our approach to complying with applicable law and material engagement with regulators concerning IT and InfoSec.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board of Directors receives regular reports from the Audit Committee which detail (a) InfoSec initiatives, (b) reviews of the policies and practices established to manage these processes, and (c) reviews of the Company&#8217;s procedures for monitoring compliance with applicable laws. Additionally, the Board of Directors also receives updates on the Company&#8217;s risks through ERM program reports, which include management&#8217;s approach to mitigating and managing InfoSec risks.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Members of the Board of Directors stay apprised of the rapidly evolving cyber threat landscape and provide guidance to management, as appropriate, to address the effectiveness of our overall data privacy and cybersecurity program. Recently, members of the Board of Directors and Executive Leadership Team participated in a Cybersecurity Exercise led by our CIO and CISO as training, and, to prepare for incident response. The Board of Directors and Audit Committee also receive regular cybersecurity posture reports from an external third-party, and outside counsel advises the Board of Directors on best practices for the Board&#8217;s oversight of InfoSec and the evolution of that oversight over time. Additionally, two members of our Board of Directors and Audit Committee have experience in InfoSec matters.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board of Directors and Audit Committee&#8217;s principal role is one of oversight, recognizing that management, led by our CIO and CISO, is responsible for the design, implementation and maintenance of an effective program for identifying, detecting, protecting against, responding to, recovering from and mitigating data privacy and InfoSec risks. Our CIO has more than 30 years of technology experience, including leadership across a variety of enterprise technologies, including InfoSec, and across multiple industries. Our CISO has more than 20 years of experience in InfoSec, across multiple industries, and is a Certified Information Systems Security Professional (CISSP). The CIO and CISO provide, at least, annual updates on IT and InfoSec initiatives to the Board of Directors and quarterly updates to the Audit Committee.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 31</span></div></div></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;2.&#160;&#160;&#160;&#160;PROPERTIES.</span></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal owned and leased properties, as of December&#160;31, 2023, are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:31.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:66.250%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.705%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Europe, Africa &amp; the Middle East</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North America</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Greater Asia</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Latin America</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Owned</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Leased</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Owned</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Leased</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Owned</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Leased</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Owned</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plant</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warehouse</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal executive offices are located at 521 West 57th Street, New York, New York and 200 Powder Mill Road, Wilmington, Delaware. Our principal sites include facilities which, in the opinion of its management, are suitable and adequate for their use and have sufficient capacity for its current business needs and expected near-term growth.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_25"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;3.&#160;&#160;&#160;&#160;LEGAL PROCEEDINGS.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to various claims and legal actions in the ordinary course of our business. The Company&#8217;s material legal proceedings are described in Part II, Item 8 of this Form 10-K in the Notes to Consolidated Financial Statements in Note 19, &#8220;Commitments and Contingencies&#8221; under the heading &#8220;Litigation.&#8221; For more detailed information about risks related to legal proceedings, refer to Item 1A, &#8220;Risk Factors&#8221; &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Our results of operations may be negatively impacted by the outcome of uncertainties related to legal claims, disputes, investigations and litigation, including the ongoing antitrust and competition investigations and related class actions lawsuits.&#8221;</span></div><div style="text-align:justify"><span><br/></span></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_28"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;4.&#160;&#160;&#160;&#160;MINE SAFETY DISCLOSURES.</span></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div><span><br/></span></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_31"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_34"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 5. MARKET FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market Information.</span></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock is principally traded on the New York Stock Exchange under the ticker symbol &#8220;IFF.&#8221;</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we have historically paid dividends on a quarterly basis to shareholders of our common stock, the declaration and payment of future dividends will depend on many factors, including, but not limited to, our earnings, financial condition, business development needs and regulatory considerations. Our Board of Directors may reduce, suspend or discontinue the payment of dividends at any time. See Part II, Item 8 of this Form 10-K in the &#8220;Consolidated Statements of Shareholders&#8217; Equity&#8221; and in the Notes to Consolidated Financial Statements in Note 12 for additional information.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Approximate Number of Equity Security Holders.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.607%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.463%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of Class</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of shareholders of record as of February 21, 2024</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, par value 12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#160;1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/2&#162; per share</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,249</span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Issuer Purchases of Equity Securities.</span></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Performance Graph.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following graph compares a shareholder&#8217;s cumulative total return for the last five fiscal years as if such amounts had been invested in: (i) our common stock; (ii) the stocks included in the S&amp;P 500 Index; (iii) the stocks included in the S&amp;P 500 Consumer Staples Index; and (iv) the stocks included in the S&amp;P 500 Specialty Chemicals Index. The graph is based on historical stock prices and measures total shareholder return, which takes into account both changes in stock price and dividends. The total return assumes that dividends were reinvested daily and is based on a $100 investment on December 31, 2018.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="text-align:center"><img src="iff-20231231_g1.jpg" alt="971" style="height:415px;margin-bottom:5pt;vertical-align:text-bottom;width:625px"/></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SOURCE: S&amp;P Capital IQ</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:31.257%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.173%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.173%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.173%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.173%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.173%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.178%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year-end Data</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Flavors &amp; Fragrances</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120.59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.40&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.58&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S&amp;P 500 Index</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200.37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164.08&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207.21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S&amp;P 500 Consumer Staples Index</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141.32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167.65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166.61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167.47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S&amp;P 500 Specialty Chemicals Index</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138.57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129.71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150.65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_37"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;6.&#160;&#160;&#160;&#160;[RESERVED]</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:40.076%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.076%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.076%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.076%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.076%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.080%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:39.989%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.092%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.092%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.092%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.092%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.099%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_40"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;7.&#160;&#160;&#160;&#160;MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNLESS INDICATED OTHERWISE, DOLLARS IN MILLIONS EXCEPT PER SHARE AMOUNTS)</span></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_43"></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OVERVIEW</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Company Background</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 1, 2021, one of our wholly owned subsidiaries merged with and into the N&amp;B Business (the &#8220;Merger&#8221;), pursuant to a Merger Agreement with DuPont. The shares issued in the Merger represented approximately 55.4% of the common stock of IFF on a fully diluted basis, after giving effect to the Merger, as of February 1, 2021. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The N&amp;B Business is an innovation-driven and customer-focused business that provides solutions for the global food and beverage, dietary supplements, home and personal care, energy, animal nutrition and pharma markets. The transaction was made in order to strengthen IFF</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s customer base and market presence, with an enhanced position in the food &amp; beverage, home &amp; personal care and health &amp; wellness markets. See Note 3 to the Consolidated Financial Statements for additional information related to the N&amp;B Transaction.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the N&amp;B Transaction, and following our prior 2018 acquisition of Frutarom Industries Ltd., we have expanded our global leadership positions, which now include high-value ingredients and solutions in the Food &amp; Beverage, Home &amp; Personal Care and Health &amp; Wellness markets, and across key Taste, Texture, Scent, Nutrition, Enzymes, Cultures, Soy Proteins, Pharmaceutical Excipients and Probiotics categories.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are organized into four segments: Nourish, Health &amp; Biosciences, Scent and Pharma Solutions. Our consolidated financial information for the years ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2023</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022 </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reflects the results of N&amp;B for the full twelve months of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023 and 2022</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, whereas the year ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2021</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> only reflects the results of N&amp;B for eleven months of 2021.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Nourish segment consists of an innovative and broad portfolio of natural-based ingredients to enhance nutritional value, texture and functionality in a wide range of beverage, dairy, bakery, confectionery and culinary applications and consists of Ingredients, Flavors and Food Designs.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Health &amp; Biosciences segment consists of the development and production of an advanced biotechnology-derived portfolio of enzymes, food cultures, probiotics and specialty ingredients for food and non-food applications. Among many other applications, this biotechnology-driven portfolio includes cultures for use in fermented foods such as yogurt, cheese and fermented beverages, probiotic strains, many with documented clinical health claims for use as dietary supplements and through industrial fermentation the production of enzymes and microorganisms that provide product and process performance benefits to household detergents, animal feed, ethanol production and brewing. Health &amp; Biosciences is comprised of Health, Cultures &amp; Food Enzymes, Home &amp; Personal Care, Animal Nutrition and Grain Processing.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Scent segment creates fragrance compounds, fragrance ingredients and cosmetic ingredients that are integral elements in the world&#8217;s finest perfumes and best-known household and personal care products. Consumer insights science and creativity are at the heart of our Scent business, and, along with our unique portfolio of natural and synthetic ingredients, global footprint, innovative technologies and know-how, and customer intimacy, we believe make us a market leader in scent products. The Scent segment is comprised of Fragrance Compounds, Fragrance Ingredients and Cosmetic Ingredients.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Pharma Solutions segment produces, among other things, a vast portfolio of cellulosics and seaweed-based pharmaceutical excipients, used to improve the functionality and delivery of active pharmaceutical ingredients, including controlled or modified drug release formulations, and enabling the development of more effective pharmaceutical finished dosage formulations. Our excipients are used in prescription and over-the-counter pharmaceuticals and dietary supplements. Our Pharma Solutions products also serve a variety of other specialty and industrial end-uses including coatings, inks, electronics, agriculture and consumer products.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Measures &#8212; Currency Neutral</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial results include the impact of foreign currency exchange rates. We provide currency neutral calculations in this report to remove the impact of foreign currency exchange rates fluctuations. We calculate currency neutral numbers by translating current year invoiced sale amounts at the exchange rates used for the corresponding prior year period. We use currency neutral results in our analysis of subsidiary and/or segment performance. We also use currency neutral numbers when analyzing our performance against our competitors.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairment of Goodwill</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2023, we determined that the carrying value of the Nourish reporting unit exceeded its fair value and recorded an impairment charge of $2.623&#160;billion in the Consolidated Statements of (Loss) Income and Comprehensive Loss for the year ended December 31, 2023.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, we determined that the carrying value of the Health &amp; Biosciences reporting unit exceeded its fair value and recorded a goodwill impairment charge of $2.250 billion in the Consolidated Statements of (Loss) Income and Comprehensive Loss for the year ended December 31, 2022.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Critical Accounting Policies and Use of Estimates&#8221; and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 6 to the Consolidated Financial Statements for additional information. For more detailed information about risks related to impairment of goodwill, refer to Item 1A, &#8220;Risk Factors&#8221; &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Any impairment of our tangible or intangible long-lived assets, including goodwill, may adversely impact our profitability.&#8221;</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impact related to the Israel-Hamas War</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain operations in Israel and, additionally, export products to customers in Israel from operations outside the region. We will continue to evaluate the current events and any potential impacts related to this matter, but we do not expect there to be a material impact to our Consolidated Financial Statements.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2023, total sales to Israeli customers were approximately 1% of total sales.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impact related to the Russia-Ukraine War</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain operations in both Russia and Ukraine and, additionally, export products to customers in Russia and Ukraine from operations outside the region. In response to the events in Ukraine, we have limited the production and supply of ingredients in and to Russia to only those that meet the essential needs of people, including food, hygiene and medicine.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2023, total sales to Russian customers were approximately 1% of total sales. In 2022, total sales to Russian customers were approximately 2% of total sales.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2023 and 2022, total sales to Ukrainian customers were both less than 1% of total sales.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a reserve of approximately $3&#160;million related to expected credit losses on receivables from customers located in Russia and Ukraine. During the second quarter of 2022, we also recorded a charge of $120 million related to the impairment of certain long-lived assets in Russia. See Note 1, Note 5 and Note 6 to the Consolidated Financial Statements for additional information.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more detailed information about risks related to the Russia-Ukraine war and the Israel-Hamas war, refer to Item 1A, &#8220;Risk Factors&#8221; - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">International conflicts (such as the Russia-Ukraine war and Israel-Hamas war), geopolitical events, natural disasters, public health crises (such as the COVID-19 pandemic), trade wars, terrorist acts, labor strikes, political or economic crises (such as uncertainty related to protracted U.S. federal government funding negotiations), accidents and other events could adversely affect our business and financial results, including by disrupting development, manufacturing, distribution or sale of our products.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impact of COVID-19 Pandemic</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 11, 2020, the World Health Organization designated COVID-19 as a global pandemic. As a result of disruptions or uncertainty relating to the COVID-19 pandemic, we have experienced, and may continue to experience, increased costs, delays or limited availability related to raw materials, strain on shipping and transportation resources, and higher energy prices, which have negatively impacted, and may continue to negatively impact, our margins and operating results. We will continue to evaluate the nature and extent of these potential impacts to our business, consolidated results of operations, segment results, liquidity and capital resources.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more detailed information about risks related to COVID-19 pandemic, refer to Item 1A, &#8220;Risk Factors&#8221; - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">International conflicts (such as the Russia-Ukraine war and Israel-Hamas war), geopolitical events, natural disasters, public health crises (such as the COVID-19 pandemic), trade wars, terrorist acts, labor strikes, political or economic crises (such as uncertainty related to protracted U.S. federal government funding negotiations), accidents and other events could adversely affect our business and financial results, including by disrupting development, manufacturing, distribution or sale of our products.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023 Financial Performance Overview</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a reconciliation between reported and adjusted figures, please refer to the &#8220;Non-GAAP Financial Measures&#8221; section.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sales</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales in 2023 decreased $961 million, or 8% on a reported basis, to $11.479 billion compared to $12.440 billion in the 2022 period. On a currency neutral basis, sales in 2023 decreased 6% compared to the 2022 period. Exchange rate variations had an unfavorable impact on net sales in 2023 of 2%. The effect of exchange rates can vary by business and region, depending upon the mix of sales priced in U.S. dollars as compared to other currencies. In addition, the decrease in sales was primarily driven by volume decreases across various businesses and the net impact of the divestitures of the Microbial Control business unit, the portion of the Savory Solutions business, and Flavor Specialty Ingredients (&#8220;FSI&#8221;) business and the acquisition of Health Wright Products, Inc. (collectively, the &#8220;net impact of the change in business portfolio mix&#8221;), which was approximately $572 million, offset in part by price increases across all businesses.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our 25 largest customers accounted for approximately 32% of total sales in 2023. In 2023, no customer accounted for more than 10% of sales. A key factor for commercial success is our inclusion on strategic customers&#8217; core supplier lists, which provides opportunities to expand and win new business. We are on the core supplier lists of a large majority of our global and strategic customers.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gross Profit</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit in 2023 decreased $470 million, or 11% on a reported basis, to $3.681 billion (32.1% of sales) compared to $4.151 billion (33.4% of sales) in the 2022 period. The decrease in gross profit was primarily driven by volume decreases, the net impact of the change in business portfolio mix and unfavorable manufacturing absorption primarily related to our inventory reduction program, offset in part by favorable net pricing and productivity gains.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 35</span></div></div></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_46"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESULTS OF OPERATIONS</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.580%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS EXCEPT PER SHARE AMOUNTS)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023 vs. 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022 vs. 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,479&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,440&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,656&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,798&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,289&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,921&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,681&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,151&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,735&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development (R&amp;D) expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">636&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">603&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and administrative (S&amp;A) expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,787&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,768&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,749&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and other charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NMF</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquisition-related intangibles</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">727&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">732&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NMF</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of long-lived assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NMF</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains on sale of assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating (loss) profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,110)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,326)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">585&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NMF</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(176)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) income before taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,518)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,625)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NMF</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,563)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,864)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NMF</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to non-controlling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income attributable to IFF shareholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,567)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,871)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NMF</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income per share &#8212; diluted</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.05)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.32)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.10&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NMF</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">bps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">bps</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">R&amp;D as a percentage of sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">bps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">bps</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S&amp;A as a percentage of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">bps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">bps</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating margin</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NMF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NMF</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NMF</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NMF</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Segment net sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nourish</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,060&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,829&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,264&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health &amp; Biosciences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,081&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,339&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,329&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Scent</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,393&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,301&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharma Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">971&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">809&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,479&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,440&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,656&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">NMF: Not meaningful</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of goods sold includes the cost of materials and manufacturing expenses. R&amp;D expenses include expenses related to the development of new and improved products and technical product support. S&amp;A expenses include expenses necessary to support our commercial activities and administrative expenses supporting our overall operating activities including compliance with governmental regulations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">2023 IN COMPARISON TO 2022</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales performance by segment was as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.736%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.615%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.617%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change in Sales - 2023 vs. 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reported</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency Neutral</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nourish</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">-11</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">-9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Health &amp; Biosciences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">-11</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">-10</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Scent</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pharma Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">-3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">-3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">-8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">-6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-top:3pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt">Currency neutral sales is calculated by translating current year invoiced sale amounts at the exchange rates for the corresponding prior year period.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nourish</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nourish sales in 2023 decreased $769 million, or 11% on a reported basis, to $6.060 billion compared to $6.829 billion in the 2022 period. On a currency neutral basis, Nourish sales decreased 9% in 2023 compared to the 2022 period as exchange rate variations had an unfavorable impact. In addition, performance in the Nourish operating segment was driven by volume decreases across various business units and the divestiture of the portion of the Savory Solutions business, with an impact of approximately $310 million, offset in part by price increases across all business units.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health &amp; Biosciences</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health &amp; Biosciences sales in 2023 decreased $258 million, or 11% on a reported basis, to $2.081 billion compared to $2.339 billion in the 2022 period. On a currency neutral basis, Health &amp; Biosciences sales decreased 10% in 2023 compared to the 2022 period as exchange rate variations had an unfavorable impact. In addition, performance in the Health &amp; Biosciences operating segment was driven by the net impact of the divestiture of the Microbial Control business unit and acquisition of Health Wright Products, Inc., which was approximately $228 million, and volume decreases across various business units, offset in part by price increases across all business units.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Scent</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Scent sales in 2023 increased $92 million, or 4% on a reported basis, to $2.393 billion compared to $2.301 billion in the 2022 period. On a currency neutral basis, Scent sales increased 6% in 2023 compared to the 2022 period as exchange rate variations had an unfavorable impact. In addition, performance in the Scent operating segment was driven by price increases, primarily in Fragrance Compounds and Fragrance Ingredients, and volume increases, offset in part by the divestiture of the FSI business, with an impact of approximately $34 million.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharma Solutions</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pharma Solutions sales in 2023 decreased $26 million, or 3% on a reported basis, to $945 million compared to $971 million in the 2022 period. On a currency neutral basis, Pharma Solutions sales also decreased 3% in 2023 compared to the 2022 period as the impact of exchange rate variations was flat. In addition, performance in the Pharma Solutions operating segment was driven by volume decreases, offset in part by price increases.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cost of Goods Sold</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of goods sold decreased $491 million to $7.798 billion (67.9% of sales) in 2023 compared to $8.289 billion (66.6% of sales) in 2022. The decrease in cost of goods sold was primarily driven by volume decreases in sales and the net impact of the change in business portfolio mix, which was approximately $405&#160;million, offset in part by unfavorable manufacturing absorption primarily related to our inventory reduction program and a write-down of inventory related to Locust Bean Kernel (&#8220;LBK&#8221;) in Nourish, which was approximately $72 million.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development (R&amp;D) Expenses</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D expenses increased $33 million to $636 million (5.5% of sales) in 2023 compared to $603 million (4.8% of sales) in 2022. The increase in R&amp;D expenses was primarily driven by higher operating expenses for R&amp;D related activities, offset in part by the net impact of the change in business portfolio mix.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Selling and Administrative (S&amp;A) Expenses</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S&amp;A expenses increased $19 million to $1.787 billion (15.6% of sales) in 2023 compared to $1.768 billion (14.2% of sales) in 2022. The increase in S&amp;A expenses was primarily driven by higher operating expenses for S&amp;A related activities and legal fees incurred for the ongoing investigations of the fragrance businesses, offset in part by lower professional fees, including consulting costs, and the net impact of the change in business portfolio mix.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restructuring and Other Charges</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring and other charges increased to $68 million in 2023 compared to $12 million in 2022. The increase was driven by higher severance costs incurred as part of the 2023 Restructuring Program, net of reversals of prior severance cost accruals. See Note 2 for additional information.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amortization of Acquisition-Related Intangibles</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expenses decreased to $680 million in 2023 compared to $727 million in 2022. The decrease in amortization expense was primarily driven by the reduction in intangible assets as a result of the divestitures of the Microbial Control business unit in 2022, the portion of the Savory Solutions business and FSI business in 2023, an impairment of intangible assets of an asset group that operates primarily in Russia during 2022 and intangible assets of the portion of the Savory Solutions business, FSI business and Cosmetic Ingredients business being classified as &#8220;held for sale,&#8221; and therefore no longer recognizing amortization expense on those intangible assets. The portion of the Savory Solutions business and FSI business were classified as held for sale up until May 31, 2023 and August 1, 2023, respectively, when we completed the divestiture of the businesses (see Note 4, Note 6 and Note 21 for additional information). The decrease in amortization expense was offset in part by the impact of acquisitions of intangible assets from Health Wright Products, Inc.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairment of Goodwill</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impairment of goodwill was $2.623 billion in 2023 compared to $2.250 billion in 2022, which was related to the Nourish and Health &amp; Biosciences reporting units, respectively. See Note 1 and Note 6 for additional information.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairment of Long-Lived Assets</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was no impairment of long-lived assets in 2023. Impairment of long-lived assets was $120 million in 2022. The impairment charge was due to the uncertainties related to our operations in Russia and Ukraine and was allocated on a pro rata basis to intangible assets and property, plant and equipment. See Note 1, Note 5 and Note 6 for additional information.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Expense</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense increased $44 million to $380 million in 2023 compared to $336 million in 2022. The increase in interest expense was due to higher interest rates on our cash pooling arrangements, commercial paper borrowings, outstanding Term Loan Facilities (see Note 9 for additional information) and factoring programs (see Note 1 for additional information).</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Expense (Income), Net</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense (income), net, decreased $65 million to an expense of $28 million in 2023 compared to income of $37 million in 2022. The change was primarily due to higher foreign exchange losses and losses incurred from business divestitures, such as the liquidation of a business in Russia for the sale of the portion of the Savory Solutions business and divestitures of the portion of the Savory Solutions business and FSI business (see Note 4 for additional information), compared to gains incurred from the divestiture of the Microbial Control business unit in 2022, offset in part by the gain resulting from the completion of the China facility relocation (see Note 19 for additional information) and higher pension-related benefits.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rate in 2023 was (1.8)% compared to (14.7)% in 2022. The year-over-year change was primarily driven by book to tax differences related to impairment of goodwill, lower tax charges on business divestitures and the recognition of a deferred tax benefit related to an internal restructuring.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Adjusted Operating EBITDA Results by Business Unit</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use Segment Adjusted Operating EBITDA for internal reporting and performance measurement purposes. Segment Adjusted Operating EBITDA is defined as (Loss) Income Before Taxes before depreciation and amortization expense, interest expense, restructuring and other charges and certain items that are not related to recurring operations. Our determination of reportable segments was made on the basis of our strategic priorities within each segment and corresponds to the manner in which our Chief Operating Decision Maker reviews and evaluates operating performance to make decisions about resources to be allocated to the segment. In addition to our strategic priorities, segment reporting is also based on differences in the products and services we provide.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.352%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended<br/>December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Adjusted Operating EBITDA</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nourish</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health &amp; Biosciences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">588&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">634&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Scent</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharma Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,980&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,455&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation &amp; Amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,142)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,179)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(380)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(336)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (Expense) Income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and Other Charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,623)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,250)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of Long-Lived Assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(120)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition, Divestiture and Integration Related Costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(174)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(201)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Strategic Initiatives Costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Regulatory Costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss Before Taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,518)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,625)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Adjusted Operating EBITDA margin:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nourish</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health &amp; Biosciences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Scent</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharma Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nourish Segment Adjusted Operating EBITDA</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nourish Segment Adjusted Operating EBITDA decreased $444 million, or 38% on a reported basis, to $732 million (12.1% of segment sales) in 2023 from $1.176 billion (17.2% of segment sales) in the comparable 2022 period. On a currency neutral basis, Nourish Segment Adjusted Operating EBITDA decreased 30% in 2023 compared to the 2022 period as exchange rate variations had an unfavorable impact. In addition, the performance was primarily driven by volume decreases, unfavorable manufacturing absorption primarily related to our inventory reduction program, a write-down of inventory related to LBK and the impact of the divestiture of the portion of the Savory Solutions business, offset in part by favorable net pricing and productivity gains.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health &amp; Biosciences Segment Adjusted Operating EBITDA</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health &amp; Biosciences Segment Adjusted Operating EBITDA decreased $46 million, or 7% on a reported basis, to $588 million (28.3% of segment sales) in 2023 from $634 million (27.1% of segment sales) in the comparable 2022 period. On a currency neutral basis, Health &amp; Biosciences Segment Adjusted Operating EBITDA decreased 4% in 2023 compared to the 2022 period as exchange rate variations had an unfavorable impact. In addition, the performance was primarily driven by volume decreases, the net impact of the divestiture of the Microbial Control business unit and acquisition of Health Wright Products, Inc. and unfavorable manufacturing absorption primarily related to our inventory reduction program, offset in part by favorable net pricing and productivity gains.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Scent Segment Adjusted Operating EBITDA</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Scent Segment Adjusted Operating EBITDA increased $38 million, or 9% on a reported basis, to $461 million (19.3% of segment sales) in 2023 from $423 million (18.4% of segment sales) in the comparable 2022 period. On a currency neutral basis, Scent Segment Adjusted Operating EBITDA increased 19% in 2023 compared to the 2022 period as exchange rate variations had an unfavorable impact. In addition, the performance was primarily driven by favorable net pricing, productivity gains and volume increases, offset in part by the impact of the divestiture of the FSI business.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharma Solutions Segment Adjusted Operating EBITDA</span></div><div style="margin-top:4pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pharma Solutions Segment Adjusted Operating EBITDA decreased $23 million, or 10% on a reported basis, to $199 million (21.1% of segment sales) in 2023 from $222 million (22.9% of segment sales) in the comparable 2022 period. On a currency neutral basis, Pharma Solutions Segment Adjusted Operating EBITDA also decreased 10% in 2023 compared to the 2022 period as the impact of exchange rate variations was flat. In addition, the performance was primarily driven by volume decreases and unfavorable manufacturing absorption primarily related to our inventory reduction program, offset in part by favorable net pricing and productivity gains.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">2022 IN COMPARISON TO 2021</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a comparison of our results of operations for the fiscal years ended December&#160;31, 2022&#160;and&#160;December&#160;31, 2021, see &#8220;Part II, Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; of our Form 10-K for the fiscal year ended&#160;December&#160;31, 2022, filed with the SEC on February 27, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_49"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had cash and cash equivalents of approximately $729 million, inclusive of $26 million currently in Assets held for sale on the Consolidated Balance Sheets, at December&#160;31, 2023 compared to $535 million, inclusive of $52 million in Assets held for sale on the Consolidated Balance Sheets, at December&#160;31, 2022 and of this balance, a portion was held outside the United States. Cash balances held in foreign jurisdictions are, in most circumstances, available to be repatriated to the United States.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective utilization of the cash generated by our international operations is a critical component of our strategy. We regularly repatriate cash from our non-U.S. subsidiaries to fund financial obligations in the U.S. As we repatriate these funds to the U.S. we will be required to pay income taxes in certain U.S. states and applicable foreign withholding taxes during the period when such repatriation occurs. Accordingly, as of December&#160;31, 2023, we had a deferred tax liability of approximately $155 million for the effect of repatriating the funds to the U.S., attributable to various non-U.S. subsidiaries. There is no deferred tax liability associated with non-U.S. subsidiaries where we intend to indefinitely reinvest the earnings to fund local operations and/or capital projects.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flows Provided By Operating Activities</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flows provided by operating activities in 2023 were $1.439 billion, or 12.5% of sales, compared to $397 million, or 3.2% of sales, in 2022 and $1.437 billion, or 12.3% of sales, in 2021. The increase in cash flows from operating activities from 2022 to 2023 was primarily driven by the decrease in working capital, largely related to inventories and accounts receivable, offset in part by lower cash earnings, excluding the impact of non-cash adjustments. The decrease in cash flows from operating activities from 2021 to 2022 was primarily driven by the increase in working capital, largely related to inventories and accounts payable.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flows Provided By (Used In) Investing Activities</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flows provided by investing activities in 2023 were $574 million compared to $745 million in 2022 and cash flows used in investing activities of $18 million in 2021. The decrease in cash flows from investing activities from 2022 to 2023 was primarily driven by the net impact of the change in net proceeds received from business divestitures and unwinding of derivative instruments, offset by the change in cash paid for acquisitions, net of cash received and higher proceeds from disposal of assets. The increase in cash flows from investing activities from 2021 to 2022 was primarily driven by the change in net proceeds received from business divestiture and unwinding of derivative instruments, offset in part by the change in cash provided by the Merger with N&amp;B, higher spending on property, plant and equipment and cash paid for acquisitions, net of cash received in 2022.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have evaluated and re-prioritized our capital projects and expect that capital spending in 2024 will be approximately 4.9% of sales (net of potential grants and other reimbursements from government authorities).</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flows Used In Financing Activities</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flows used in financing activities in 2023 were $1.851 billion compared to $1.229 billion and $1.304 billion in 2022 and 2021, respectively. The increase in cash flows used in financing activities from 2022 to 2023 was primarily driven by higher repayments of long-term and short-term debts, compared to lower net repayments of long-term and short-term debts in 2022, and higher net repayments of commercial paper. The decrease in cash flows used in financing activities from 2021 to 2022 was primarily driven by lower repayments of long-term debt and an increase in revolving credit facility and short-term borrowings, offset in part by net repayments of commercial paper, compared to proceeds from issuance of commercial paper in 2021, higher cash dividend payments and higher purchases of redeemable non-controlling interests.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We paid dividends totaling $826 million, $810 million and $667 million in 2023, 2022 and 2021, respectively. The cash dividend declared per share in 2023, 2022 and 2021 was $3.24, $3.20 and $3.12, respectively.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our capital allocation strategy is primarily focused on debt repayment to maintain our investment grade rating. We will also prioritize capital investment in our businesses to support the strategic long-term plans.&#160;We are also committed to maintaining our history of paying a dividend to investors determined by our Board of Directors at its discretion based on various factors.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Capital Resources </span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flow provides the primary source of funds for capital investment needs, dividends paid to shareholders and debt service repayments. We anticipate that cash flows from operations, cash proceeds generated from planned business divestitures and availability under our existing credit facilities will be sufficient to meet our investing and financing needs, including our debt service requirements. We regularly assess our capital structure, including both current and long-term debt instruments, as compared to our cash generation and investment needs in order to provide ample flexibility and to optimize our leverage ratios. See Note 9 for additional information.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transaction with Nutrition &amp; Biosciences, Inc.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 1, 2021, the N&amp;B Term Loan Facility was funded, which provided for a senior unsecured term loan credit facility in an aggregate principal amount of $1.250&#160;billion, comprised of a $625&#160;million three-year tranche (&#8220;2024 Term Loan Facility&#8221;) and a $625&#160;million five-year tranche (&#8220;2026 Term Loan Facility&#8221;). Following the Merger, we assumed the indebtedness incurred by N&amp;B in the debt financings, which included (i) the 2024 Term Loan Facility and 2026 Term Loan Facility and (ii) a series of Senior Notes in the aggregate amount of $6.250&#160;billion with maturities ranging from 2 to 30 years. N&amp;B&#8217;s indebtedness raised prior to the Merger was used to finance the Special Cash Payment (as defined below) to DuPont, which has been paid, and for the satisfaction of the related transaction fees and expenses. See Note 3 and Note 9 for additional information.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the N&amp;B Transaction, a wholly owned subsidiary of IFF merged with and into N&amp;B in exchange for 141,740,461 shares of IFF common stock, par value $0.125 per share (&#8220;IFF Common Stock&#8221;), which had been approved in the special shareholder meeting that occurred on August 27, 2020 where IFF shareholders voted to approve the issuance of shares of IFF common stock in connection with the N&amp;B Transaction pursuant to the Merger Agreement. In connection with the N&amp;B Transaction, DuPont received a one-time $7.359 billion special cash payment (the &#8220;Special Cash Payment&#8221;). The shares issued in the Merger represented approximately 55.4% of the common stock of IFF on a fully diluted basis, after giving effect to the Merger, as of February 1, 2021. See Note 3 for additional information.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Term Loans and Revolving Credit Facility</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our credit agreements contain various covenants, limitations and events of default customary for similar facilities for similarly rated borrowers, including the requirement for us to maintain, at the end of each fiscal quarter, a ratio of net debt for borrowed money to credit adjusted EBITDA in respect of the previous 12-month period. On March 23, 2023, we entered into Term Loan Amendment No. 3, Term Loan Amendment No. 4, Revolver Amendment No. 2 and Revolver Amendment No. 3. On September 19, 2023, we entered into Term Loan Amendment No. 5 and Revolver Amendment No. 4.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Term Loan Amendment No. 3 and Revolver Amendment No. 2, among other things, extended the period during which certain relief was provided with respect to the financial covenant contained in the Existing Term Loan Credit Agreement and the Existing Revolving Credit Agreement, respectively, which have been superseded by Term Loan Amendment No. 5 and Revolver Amendment No. 4, respectively.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the reference rate for U.S. dollar-denominated loans was updated from LIBOR to Term SOFR. From March 23, 2023, the Term Loans and Revolving Credit Facility now bear interest at a base rate or a rate equal to Term SOFR plus an adjustment of 0.10% per annum or, in the case of euro-denominated loans, the Euro interbank offered rate, plus, in each case, an applicable margin based on our public debt rating. Loans may be prepaid without premium or penalty, subject to customary breakage costs.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Term Loan Amendment No. 5 and Revolver Amendment No. 4, among other things, extend the period during which a Term Loan Covenant Relief Period and Revolver Covenant Relief Period are provided with respect to the financial covenant contained in the Existing Term Loan Credit Agreement and the Existing Revolving Credit Agreement, respectively, through December 31, 2025, or such earlier date on which the Company elects to terminate such period, by providing that during the Term Loan Covenant Relief Period and Revolver Covenant Relief Period, our consolidated leverage ratio shall not exceed as of the end of the fiscal quarter for the period of the four fiscal quarters then ended: (i) 5.25x for any fiscal quarter ending on or before March 31, 2024, (ii) 4.75x for the fiscal quarter ending June 30, 2024, (iii) 4.50x for the fiscal quarter ending September 30, 2024, (iv) 4.25x for any subsequent fiscal quarter ending on or before March 31, 2025, (v) 4.00x for any subsequent fiscal quarter ending on or before September 30, 2025 and (vi) 3.75x for the fiscal quarter ending December 31, 2025. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the Term Loan Covenant Relief Period and the Revolver Covenant Relief Period, the amendments prohibit us from (i) effecting share repurchases, (ii) declaring and paying dividends in cash on common stock in excess of $0.81 per share per fiscal quarter (for an aggregate amount of $3.24 per fiscal year) and (iii) creating liens to secure debt in excess of the greater of $300&#160;million and 3.65% of Consolidated Net Tangible Assets (as defined in the Term Loan Credit Agreement and Revolving Credit Agreement), in each case subject to certain exceptions set forth therein. See Note 9 for additional information on the amendments to the credit agreements.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, we had no outstanding borrowings under our $2.000 billion Revolving Credit Facility. The amount that we are able to draw down under the Revolving Credit Facility is limited by financial covenants as described in more detail below. As of December&#160;31, 2023, our borrowing capacity was approximately $1.548 billion under the Revolving Credit Facility.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 9 to the Consolidated Financial Statements for additional information on our credit agreements.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt Covenants</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2023, we were in compliance with all financial and other covenants under our credit agreements, including the net debt to credit adjusted EBITDA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ratio. At December&#160;31, 2023 our net debt to credit adjusted EBITDA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;ratio was 4.51 to 1.0 as defined by the credit facility agreements, which is below the relevant level provided by our financial covenants of existing outstanding debt. The most comparable GAAP measure is the total debt to net loss ratio, which was (3.93) to 1.0 at December&#160;31, 2023.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________&#160;</span></div><div style="margin-top:3pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt">Credit adjusted EBITDA and net debt, which are non-GAAP measures used for these covenants, are calculated in accordance with the definition in the debt agreements. In this context, these measures are used solely to provide information on the extent to which we are in compliance with debt covenants and may not be comparable to credit adjusted EBITDA and net debt used by other companies. Reconciliations of credit adjusted EBITDA to net loss and net debt to total debt are as follows:</span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:64.346%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.454%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,567)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specified items</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,944&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash items</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Credit Adjusted EBITDA</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,079&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________&#160;</span></div><div style="margin-top:3pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt">Beginning in the fourth quarter of 2023, certain adjustments were made to interest expense associated with our cash pooling arrangements.</span></div><div style="margin-top:3pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt">Specified items consisted of restructuring and other charges, impairment of goodwill, acquisition, divestiture and integration related costs, strategic initiatives costs, regulatory costs and other costs that are not related to recurring operations.</span></div><div style="margin-top:3pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt">Non-cash items consisted of gains on sale of assets, losses on business disposals, gain on China facility relocation, write-down of inventory related to LBK and stock-based compensation.</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:78.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.398%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,096&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">729&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,367&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-top:3pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt">Total debt used for the calculation of net debt consisted of short-term debt, long-term debt, short-term finance lease obligations and long-term finance lease obligations.</span></div><div style="margin-top:3pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt">Cash and cash equivalents included approximately $26 million currently in Assets held for sale on the Consolidated Balance Sheets.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Notes</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, we had $9.085 billion aggregate principal amount outstanding in senior unsecured notes, with $1.435 billion principal amount denominated in EUR and $7.650 billion principal amount denominated in USD, which includes the N&amp;B Senior Notes assumed as a result of the Merger. The notes bear effective interest rates ranging from 1.22% per year to </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.12% per year, with maturities from March 14, 2024 to December 1, 2050. See Note 9 to the Consolidated Financial Statements for additional information.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tangible Equity Units - Senior Unsecured Amortizing Notes</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 14, 2021, the Company notified holders of the tangible equity units (&#8220;TEUs&#8221;) that the final settlement rate in respect of each of the prepaid stock purchase contracts (&#8220;SPCs&#8221;) was 0.330911 shares of IFF&#8217;s common stock. On September 15, 2021, 5,460,031 shares of IFF&#8217;s common stock were issued in settlement of the SPCs. See&#160;Note 11 to the Consolidated Financial Statements for additional information.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Contingencies</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 19 to the Consolidated Financial Statements for information related to Other Contingencies</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Commitments</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compliance with existing governmental requirements regulating the discharge of materials into the environment has not materially affected our operations, earnings or competitive position. In 2023 and 2022, we spent approximately $23&#160;million and $30&#160;million on capital projects and $139&#160;million and $135&#160;million in operating expenses and governmental charges, respectively, for the purpose of complying with such regulations. Expenditures for these purposes will continue for the foreseeable future. In addition, we are party to a number of proceedings brought under the Comprehensive Environmental Response, Compensation and Liability Act or similar state statutes. It is expected that the impact of any judgments in or voluntary settlements of such proceedings will not be material to our financial condition, results of operations or liquidity.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contractual Obligations</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes its balances of cash and cash equivalents, which totaled approximately $729 million as of December&#160;31, 2023, inclusive of approximately $26 million currently in Assets held for sale on the Consolidated Balance Sheets, along with cash generated by ongoing operations and continued access to debt markets, will be sufficient to satisfy its cash requirements and capital return program over the next 12 months and beyond. The Company&#8217;s material cash requirements include the following contractual and other obligations.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Borrowings and Interest on Borrowings</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, the Company had outstanding floating and fixed rate notes with varying maturities for an aggregate principal amount of approximately $9.980 billion (collectively the &#8220;Notes&#8221;), with approximately $885 million payable within 12 months. Future interest payments associated with the Notes total approximately $3.965 billion, with approximately $292 million payable within 12 months.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also issues unsecured short-term promissory notes (&#8220;Commercial Paper&#8221;) pursuant to a commercial paper program. As of December&#160;31, 2023, the Company had no Commercial Paper outstanding.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, the Company had no borrowings outstanding under the Revolving Credit Facility.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 9 to the Consolidated Financial Statements for a further discussion of our various borrowing facilities.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has lease arrangements for certain corporate offices, manufacturing facilities, research and development facilities, and certain transportation and office equipment. As of December&#160;31, 2023, the Company had fixed lease payment obligations of approximately $926 million, with approximately $122 million payable within 12 months. See Note 8 to the Consolidated Financial Statements for a further discussion of our various lease arrangements.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pension and Other Postretirement Obligations</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, the Company had pension funding obligations of approximately $854 million, with approximately $138 million payable within 12 months. See Note 15 to the Consolidated Financial Statements for a further discussion of our retirement plans.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, the Company had postretirement obligations of approximately $38 million, with approximately $4 million payable within 12 months.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase Commitments</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has various purchase commitments that include agreements for raw material procurement and contractual capital expenditures. As of December&#160;31, 2023, the Company had purchase commitment obligations of approximately $391 million, with approximately $229 million payable within 12 months.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. Tax Reform Toll-Charge</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has obligations related to a 2017 U.S. tax reform &#8220;toll-charge&#8221; that is payable in installments over 8 years beginning in 2018. As a result of the Merger with N&amp;B, the remaining toll-charge obligations were accelerated and paid in full in the amount of approximately $39 million in 2022. As of December&#160;31, 2023, there were no toll-charge obligations remaining.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_52"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Use of Estimates</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our significant accounting policies are more fully described in Note 1 to the Consolidated Financial Statements. As disclosed in Note 1, the preparation of financial statements in conformity with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) requires management to make estimates and assumptions that affect reported amounts and accompanying disclosures. These estimates are based on management&#8217;s best judgment of current events and actions that we may undertake in the future. Actual results may ultimately differ from these estimates.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Those areas requiring the greatest degree of management judgment or deemed most critical to our financial reporting involve:</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time we enter into strategic acquisitions in an effort to better service existing customers and to attain new customers. When we acquire a controlling financial interest in an entity or group of assets that are determined to meet the definition of a business, we apply the acquisition method described in ASC Topic 805, Business Combinations. In accordance with GAAP, the results of the acquisitions we have completed are reflected in our financial statements from the date of acquisition forward.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocate the purchase consideration paid to acquire the business to the assets acquired and liabilities assumed based on estimated fair values at the acquisition date, with the excess of purchase price over the estimated fair value of the net assets acquired recorded as goodwill. If during the measurement period (a period not to exceed twelve months from the acquisition date) we receive additional information that existed as of the acquisition date but at the time of the original allocation described above was unknown to us, we make the appropriate adjustments to the purchase price allocation in the reporting period in which the amounts are determined.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant judgment is required to estimate the intangibles and fair value of fixed assets and in assigning their respective useful lives. Accordingly, we typically engage third-party valuation specialists, who work under the direction of management, to assist in valuing significant tangible and intangible assets acquired.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value estimates are based on available historical information, future expectations and assumptions deemed reasonable by management, but are inherently uncertain.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We typically use an income method to estimate the fair value of intangible assets, which is based on forecasts of the expected future cash flows attributable to the respective assets. Significant estimates and assumptions inherent in the valuations reflect a consideration of other marketplace participants, and include the amount and timing of future cash flows (including expected growth rates, discount rates and profitability), royalty rates used in the relief of royalty method, customer attrition rates, product obsolescence factors, a brand&#8217;s relative market position and the discount rate applied to the cash flows. Unanticipated market or macroeconomic events and circumstances may occur, which could affect the accuracy or validity of the estimates and assumptions.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Determining the useful life of an intangible asset also requires significant judgment. All of our acquired intangible assets (e.g., trademarks, product formulas, non-compete agreements and customer relationships) are expected to have finite useful lives. Our estimates of the useful lives of finite-lived intangible assets are based on a number of factors including competitive environment, market share, brand history, operating plans and the macroeconomic environment of the regions in which the brands are sold.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The costs of finite-lived intangible assets are amortized through expense over their estimated lives. The value of residual goodwill is not amortized, but is tested at least annually for impairment as described in the following note. For acquired intangible assets, the remaining useful life of the trade names and trademarks, product formulas, and customer relationships was estimated at the point at which substantially all of the present value of cumulative cash flows have been earned.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Periodic Assessment of Potential Impairment of Goodwill</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, we have goodwill of approximately $10.635 billion. We test goodwill for impairment at the reporting unit level as of November 30 every year or more frequently if events or changes in circumstances indicate the asset might be impaired. A reporting unit is an operating segment or one level below an operating segment (referred to as a component) to which goodwill is assigned when initially recorded.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We identify our reporting units by assessing whether the components of our operating segments constitute businesses for which discrete financial information is available and management of each operating segment regularly reviews the operating results of those components. Components within a segment that have similar economic characteristics have been aggregated as a single reporting unit. We determined that we have six reporting units under the Nourish, Health &amp; Biosciences, Scent and Pharma Solutions segments: (1) Nourish, (2) Fragrance Compounds, (3) Fragrance Ingredients, (4) Cosmetic Ingredients, (5) Health &amp; Biosciences and (6) Pharma Solutions.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the annual impairment test as of November 30, 2023, we first utilized Step 0 of the guidance in ASC Topic 350, Intangibles &#8211; Goodwill and Other, which allows for the assessment of qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. If, based on a review of qualitative factors, it is more likely than not that the fair value of a reporting unit is less than its carrying value, a quantitative impairment test is performed by comparing the fair value of a reporting unit with its carrying amount. Based on a review of qualitative factors, we determined that for one of the reporting units, Cosmetic Ingredients, a quantitative (Step 1) impairment analysis was not necessary to determine if the carrying values of the reporting unit exceeded its fair values. For the other five reporting units, we determined that a Step 1 test was necessary.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assessed the fair value of the reporting units using an income approach. Under the income approach, we determined the fair value by using a discounted cash flow method at a rate of return that reflects the relative risk of the projected future cash flows of each reporting unit, as well as a terminal value. We used the most current actual and forecasted operating data available. Key estimates and assumptions used in these valuations include revenue growth rates, gross margins, adjusted operating EBITDA margins, terminal growth rates and discount rates.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the quantitative impairment test, we determined that the fair value of four of the five reporting units exceeded their carrying values and determined that there was no further impairment of goodwill in these reporting units as of November 30, 2023.&#160;We determined that the carrying value of the Nourish reporting unit exceeded its fair value and recorded an impairment charge of $2.623&#160;billion in the Consolidated Statements of (Loss) Income and Comprehensive Loss for the year ended December 31, 2023. The primary drivers of the impairment charge was a decrease in fair value due to declines in projections of the reporting unit, impacts of continued inflation and increases in interest rates. Based on the quantitative impairment test performed, we determined that the Health &amp; Biosciences, Fragrance Ingredients and Pharma Solutions reporting units had excess fair value over carrying value of less than 25%. The Health &amp; Biosciences, Fragrance Ingredients and Pharma Solutions reporting units had excess fair value over carrying value of approximately 8%, 18% and 8%, respectively. While we believe that the assumptions used in the impairment test were reasonable, changes in key assumptions, including lower revenue growth, operating margin, terminal growth rates or increase in discount rates could result in a future impairment. Such charge could have a material effect on our Consolidated Statements of Operations and Balance Sheets.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, based on the quantitative impairment test using the income approach, we determined that the carrying value of the Health &amp; Biosciences reporting unit exceeded its fair value and recorded a goodwill impairment charge of $2.250 billion in the Consolidated Statements of (Loss) Income and Comprehensive Loss for the year ended December 31, 2022.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 6 </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the Consolidated Financial Statements </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for additional information.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Periodic Assessment of Potential Impairment of Long-lived Assets</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We review long-lived assets for impairment when events or changes in business conditions indicate that their full carrying value may not be recovered. An estimate of undiscounted future cash flows produced by an asset or group of assets is compared to the carrying value to determine whether impairment exists. If assets are determined to be impaired, the loss is measured based on an estimate of fair value using various valuation techniques, including a discounted estimate of future cash flows.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the uncertainties related to our operations in Russia and Ukraine, we recorded a charge of approximately $120 million related to the impairment of certain long-lived assets in Russia </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the Consolidated Statements of (Loss) Income and Comprehensive Loss for the year ended December 31, 2022. See Note 1 to the Consolidated Financial Statements for additional information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_55"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Standards</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;See Note 1 to the Consolidated Financial Statements for a discussion of recent accounting pronouncements.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP Financial Measures</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use non-GAAP financial measures in this Form 10-K, including: (i) currency neutral metrics and (ii) adjusted operating EBITDA and adjusted operating EBITDA margin. We also provide the non-GAAP measure net debt solely for the purpose of providing information on the extent to which the Company is in compliance with debt covenants contained in its debt agreements. Our non-GAAP financial measures are defined below.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These non-GAAP financial measures are intended to provide additional information regarding our underlying operating results and comparable year-over-year performance. Such information is supplemental to information presented in accordance with GAAP and is not intended to represent a presentation in accordance with GAAP. In discussing our historical and expected future results and financial condition, we believe it is meaningful for investors to be made aware of and to be assisted in a better understanding of, on a period-to-period comparable basis, financial amounts both including and excluding these identified items, as well as the impact of exchange rate fluctuations. These non-GAAP measures should not be considered in isolation or as substitutes for analysis of the Company&#8217;s results under GAAP and may not be comparable to other companies&#8217; calculation of such metrics.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted operating EBITDA and adjusted operating EBITDA margin exclude depreciation and amortization expense, interest expense, other income (expense), net, restructuring and other charges and certain items unrelated to recurring operations such as impairment of goodwill, impairment of long-lived assets, acquisition, divestiture and integration related costs, strategic initiatives costs, regulatory costs, N&amp;B inventory step-up costs and other costs that are not related to recurring operations.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net debt to credit adjusted EBITDA is the leverage ratio used in our credit agreement and defined as net debt divided by credit adjusted EBITDA. However, as credit adjusted EBITDA for these purposes was calculated in accordance with the provisions of the credit agreement, it may differ from the calculation used for adjusted operating EBITDA.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cautionary Statement Under the Private Securities Litigation Reform Act of 1995</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Statements in this Form 10-K, which are not historical facts or information, are &#8220;forward-looking statements&#8221; within the meaning of The Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based on management&#8217;s current assumptions, estimates and expectations and include statements concerning (i) expected cash flow and availability of capital resources to fund our operations and meet our debt service requirements; (ii) our ability to execute on our strategic and financial transformation, including the progress and success of our portfolio optimization strategy, through non-core business divestitures and acquisitions, and expectations regarding the implementation of our refreshed growth-focused strategy; (iii) our ability to continue to generate value for, and return cash to, our shareholders; (iv) expectations of the impact of inflationary pressures and the pricing actions to offset exposure to such impacts; (v) the impact of high input costs, including commodities, raw materials, transportation and energy; (vi) the expected impact of global supply chain challenges; (vii) our ability to enhance our innovation efforts, drive cost efficiencies and execute on specific consumer trends and demands; (viii) the growth potential of the markets in which we operate, including the emerging markets; (ix) expectations regarding sales and profit for the fiscal year 2024, including the impact of foreign exchange, pricing actions, raw materials, energy, and sourcing, logistics and manufacturing costs; (x) the impact of global economic uncertainty and recessionary pressures on demand for consumer products; (xi) the success of our integration efforts, following the N&amp;B Transaction, and ability to deliver on our synergy commitments as well as future opportunities for the combined company; (xii) our strategic investments in capacity and increasing inventory to drive improved profitability; (xiii) our ability to drive cost discipline measures and the ability to recover margin to pre-inflation levels; (xiv) expected capital expenditures in 2024; and (xv) the expected costs and benefits of our ongoing optimization of our manufacturing operations, including the expected number of closings. These forward-looking statements should be evaluated with consideration given to the many risks and uncertainties inherent in our business that could cause actual results and events to differ materially from those in the forward-looking statements. Certain of such forward-looking information may be identified by such terms as &#8220;expect&#8221;, &#8220;anticipate&#8221;, &#8220;believe&#8221;, &#8220;intend&#8221;, &#8220;outlook&#8221;, &#8220;may&#8221;, &#8220;estimate&#8221;, &#8220;should&#8221;, &#8220;predict&#8221; and similar terms or variations thereof. Such forward-looking statements are based on a series of expectations, assumptions, estimates and projections about the Company, are not guarantees of future results or performance, and involve significant risks, uncertainties and other factors, including assumptions and projections, for all forward periods. Our actual results may differ materially from any future results expressed or implied by such forward-looking statements. Such risks, uncertainties and other factors include, among others, the following:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our substantial amount of indebtedness and its impact on our liquidity, credit ratings and ability to return capital to its shareholders;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to successfully execute the next phase of our strategic transformation;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to declare and pay dividends which is subject to certain considerations;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of the outcomes of legal claims, disputes, regulatory investigations and litigation;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">inflationary trends, including in the price of our input costs, such as raw materials, transportation and energy;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">supply chain disruptions, geopolitical developments, including the Russia-Ukraine war, the Israel-Hamas war and wider Middle East developments (including disruptions to the Red Sea passage) or climate-change related events (including severe weather events) that may affect our suppliers or procurement of raw materials;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to attract and retain key employees, and manage turnover of top executives;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to successfully market to our expanded and diverse customer base;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to effectively compete in our market and develop and introduce new products that meet customers&#8217; needs;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in demand from large multi-national customers due to increased competition and our ability to maintain &#8220;core list&#8221; status with customers;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to successfully develop innovative and cost-effective products that allow customers to achieve their own profitability expectations;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">disruption in the development, manufacture, distribution or sale of our products from international conflicts (such as the Russia-Ukraine war and the Israel-Hamas war), geopolitical events, trade wars, natural disasters (such as the COVID-19 pandemic), public health crises, terrorist acts, labor strikes, political or economic crises (such as the uncertainty related to U.S. government funding negotiations), accidents and similar events;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of a significant data breach or other disruption in our information technology systems, and our ability to comply with data protection laws in the U.S. and abroad;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to benefit from our investments and expansion in emerging markets;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of currency fluctuations or devaluations in the principal foreign markets in which we operate;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">economic, regulatory and political risks associated with our international operations;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of global economic uncertainty (including increased inflation) on demand for consumer products;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to integrate the N&amp;B Business and realize anticipated synergies, among other benefits;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to react in a timely and cost-effective manner to changes in consumer preferences and demands, including increased awareness of health and wellness;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to meet increasing customer, consumer, shareholder and regulatory focus on sustainability;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to successfully manage our working capital and inventory balances;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any impairment on our tangible or intangible long-lived assets;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to enter into or close strategic transactions or divestments, or successfully establish and manage acquisitions, collaborations, joint ventures or partnerships;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in market conditions or governmental regulations relating to our pension and postretirement obligations;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of the phase out of the London Interbank Offered Rate (&#8220;LIBOR&#8221;) on our variable rate interest expense;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to comply with, and the costs associated with compliance with, regulatory requirements and industry standards, including regarding product safety, quality, efficacy and environment impact;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">defects, quality issues (including product recalls), inadequate disclosure or misuse with respect to the products and capabilities;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to comply with, and the costs associated with compliance with, U.S. and foreign environmental protection laws;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of our or our counterparties&#8217; failure to comply with the U.S. Foreign Corrupt Practices Act, similar U.S. or foreign anti-bribery and anti-corruption laws and regulations, applicable sanctions laws and regulations in the jurisdictions in which we operate or ethical business practices and related laws and regulations;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to protect our intellectual property rights;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of changes in federal, state, local and international tax legislation or policies and adverse results of tax audits, assessments, or disputes;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of any tax liability resulting from the N&amp;B Transaction; and </span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to comply with data protection laws in the U.S. and abroad.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing list of important factors does not include all such factors, nor necessarily present them in order of importance. In addition, you should consult other disclosures made by the Company (such as in our other filings with the SEC or in company press releases) for other factors that may cause actual results to differ materially from those projected by the Company. Please refer to Part I. Item&#160;1A., Risk Factors, of this Form 10-K for additional information regarding factors that could affect our results of operations, financial condition and liquidity.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend our forward-looking statements to speak only as of the time of such statements and do not undertake or plan to update or revise them as more information becomes available or to reflect changes in expectations, assumptions or results. We can give no assurance that such expectations or forward-looking statements will prove to be correct. An occurrence of, or any material adverse change in, one or more of the risk factors or risks and uncertainties referred to in this report or included in our other periodic reports filed with the SEC could materially and adversely impact our operations and our future financial results.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any public statements or disclosures made by us following this report that modify or impact any of the forward-looking statements contained in or accompanying this report will be deemed to modify or supersede such outlook or other forward-looking statements in or accompanying this report.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span><br/></span></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_58"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate on a global basis and are exposed to currency fluctuation related to the manufacture and sale of our products in currencies other than the U.S. dollar. The major foreign currencies involve the markets in the European Union, Great Britain, Mexico, Brazil, China, India, Indonesia, Australia, Russia and Japan, although all regions are subject to foreign currency fluctuations versus the U.S. dollar. We actively monitor our foreign currency exposures in all major markets in which we operate, and employ a variety of techniques to mitigate the impact of exchange rate fluctuations, including foreign currency hedging activities.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have established a centralized reporting system to evaluate the effects of changes in interest rates, currency exchange rates and other relevant market risks. Our risk management procedures include the monitoring of interest rate and foreign exchange exposures and hedge positions utilizing statistical analyses of cash flows, market value and sensitivity analysis. However, the use of these techniques to quantify the market risk of such instruments should not be construed as an endorsement of their accuracy or the accuracy of the related assumptions. For the year ended December&#160;31, 2023, our exposure to market risk was estimated using sensitivity analyses, which illustrate the change in the fair value of a derivative financial instrument assuming hypothetical changes in foreign exchange rates and interest rates.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into foreign currency forward contracts with the objective of managing our exchange rate risk related to foreign currency denominated monetary assets and liabilities of our operations. These contracts, and the counterparties to which are major international financial institutions, generally involve the exchange of one currency for a second currency at a future date, have maturities not exceeding twelve months, and are marked-to-market with changes in fair value that are recorded to Other expense (income), net within our Consolidated Statements of (Loss) Income and Comprehensive Loss. Based on a hypothetical decrease or increase of 10% in the applicable balance sheet exchange rates (primarily against the U.S. dollar), the estimated fair value of our foreign currency forward contracts would change by approximately $153&#160;million as of December&#160;31, 2023. However, any change in the value of the contracts, real or hypothetical, would be significantly offset by a corresponding change in the value of the underlying hedged items.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use derivative instruments as part of our interest rate risk management strategy. We have entered into certain cross currency swap agreements in order to mitigate a portion of our net European investments from foreign currency risk. As of December&#160;31, 2023, these swaps were in a liability position with an aggregate fair value of $161&#160;million. Based on a hypothetical decrease or increase of 10% in the value of the U.S. dollar against the Euro, the estimated fair value of our cross currency swaps would change by approximately $152&#160;million.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2023, the fair value of our EUR fixed rate debt was $1.384 billion. Based on a hypothetical decrease or increase of 10% in foreign exchange rates, the estimated fair value of our EUR fixed rate debt would change by approximately $143&#160;million.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2023, the fair value of our USD fixed rate debt was $6.227 billion. Based on a hypothetical decrease or increase of 10% in interest rates, the estimated fair value of our US fixed rate debt would change by approximately $623&#160;million.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2023, the total amount of our outstanding debt subject to interest rate fluctuations was $895 million. Based on a hypothetical decrease or increase of 1% in interest rates, our annual interest expense would change by approximately $6 million.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We purchase certain commodities, such as natural gas, electricity, petroleum-based products and certain crop related items. We generally purchase these commodities based upon market prices that are established with the vendor as part of the purchase process. In general, with the exception of soy and natural gas, we do not use commodity financial instruments to hedge commodity prices.</span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_61"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;8.&#160;&#160;&#160;&#160;FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See index to Consolidated Financial Statements on page <a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i2f76b3bf6f194379a886ecfc128c8f1b_94">50</a>.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_64"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;9.&#160;&#160;&#160;&#160;CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="margin-top:1pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 48</span></div></div></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_67"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;9A.&#160;&#160;&#160;&#160;CONTROLS AND PROCEDURES.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures and Changes in Internal Control over Financial Reporting.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Chief Executive Officer and Chief Financial Officer, with the assistance of other members of our management, have evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this Form 10-K. Based on such evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures are effective as of the end of the period covered by this Form 10-K.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have established controls and procedures designed to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission&#8217;s rules and forms and is accumulated and communicated to management, including the principal executive officer and the principal financial officer, to allow timely decisions regarding required disclosure.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Chief Executive Officer and Chief Financial Officer have concluded that there have not been any changes in our internal control over financial reporting during the fourth quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Management&#8217;s Report on Internal Control Over Financial Reporting.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934. Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management assessed the effectiveness of our internal control over financial reporting as of December&#160;31, 2023. In making this assessment, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (&#8220;COSO&#8221;) in its 2013 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control &#8212; Integrated Framework</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on this assessment, management determined that, as of December&#160;31, 2023, our internal control over financial reporting was effective.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PricewaterhouseCoopers LLP, our independent registered public accounting firm, has audited the effectiveness of our internal control over financial reporting as of December&#160;31, 2023 as stated in their report which is included herein.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_70"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;9B.&#160;&#160;&#160;&#160;OTHER INFORMATION.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Rule 10b5-1 Trading Plans</span></div><ix:nonNumeric contextRef="c-1" name="ecd:MtrlTermsOfTrdArrTextBlock" id="f-47" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the quarter ended December&#160;31, 2023, none of our directors or executive officers <ix:nonNumeric contextRef="c-8" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-48"><ix:nonNumeric contextRef="c-8" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-49">adopted</ix:nonNumeric></ix:nonNumeric> or <ix:nonNumeric contextRef="c-8" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-50"><ix:nonNumeric contextRef="c-8" name="ecd:Rule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-51">terminated</ix:nonNumeric></ix:nonNumeric> any contract, instruction or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) (a &#8220;10b5-1 trading arrangement&#8221;) or any &#8220;non-Rule 10b5-1 trading arrangement&#8221; as defined in Item 408(c) of Regulation S-K.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_73"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;9C.&#160;&#160;&#160;&#160;DISCLOSURES REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_76"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div><span><br/></span></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_79"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;10.&#160;&#160;&#160;&#160;DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information relating to directors and nominees of the Company is set forth in the IFF 2024 Proxy Statement and is incorporated by reference herein. The information relating to Section&#160;16(a) beneficial ownership reporting compliance that appears in the IFF 2024 Proxy Statement is also incorporated by reference herein. See Part I, Item&#160;1 of this Form 10-K for information relating to the Company&#8217;s Executive Officers.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have adopted a Code of Conduct (the &#8220;Code of Conduct&#8221;) that applies to all of our employees, including our chief executive officer and our chief financial officer. We have also adopted a Code of Conduct for Directors and a Code of Conduct for Executive Officers (together with the Code of Conduct, the &#8220;Codes&#8221;). The Codes are available through the Investors &#8212; Governance link on our website at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">https://ir.iff.com/governance.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Only the Board of Directors or the Audit Committee of the Board may grant a waiver from any provision of our Codes in favor of a director or executive officer, and any such waiver will be publicly disclosed. We will disclose substantive amendments to and any waivers from the Codes provided to our chief executive officer, principal financial officer or principal accounting officer, as well as any other executive officer or director, on the Company&#8217;s website: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">www.iff.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information regarding the Company&#8217;s Audit Committee and its designated audit committee financial experts is set forth in the IFF 2024 Proxy Statement and such information is incorporated by reference herein.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information concerning procedures by which shareholders may recommend director nominees is set forth in the IFF 2024 Proxy Statement and such information is incorporated by reference herein.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_82"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;11.&#160;&#160;&#160;&#160;EXECUTIVE COMPENSATION.</span></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The items required by Part III, Item&#160;11 are incorporated herein by reference from the IFF 2024 Proxy Statement to be filed on or before April&#160;29, 2024, except as to information required pursuant to Item 402(v) of Regulation S-K relating to pay versus performance.</span></div><div><span><br/></span></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_85"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;12.&#160;&#160;&#160;&#160;SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The items required by Part III, Item&#160;12 are incorporated herein by reference from the IFF 2024 Proxy Statement to be filed on or before April&#160;29, 2024.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_88"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;13.&#160;&#160;&#160;&#160;CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The items required by Part III, Item&#160;13 are incorporated herein by reference from the IFF 2024 Proxy Statement to be filed on or before April&#160;29, 2024.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_91"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;14.&#160;&#160;&#160;&#160;PRINCIPAL ACCOUNTANT FEES AND SERVICES.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The items required by Part III, Item&#160;14 are incorporated herein by reference from the IFF 2024 Proxy Statement to be filed on or before April&#160;29, 2024.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_94"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_97"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;15.&#160;&#160;&#160;&#160;EXHIBITS AND FINANCIAL STATEMENT SCHEDULES.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:91.128%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.672%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)(1) FINANCIAL STATEMENTS: The following consolidated financial statements, related notes, and independent registered public accounting firm&#8217;s report are included in this Form 10-K:</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_100">Report of Independent Registered Public Accounting Firm</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> (PCAOB ID: <ix:nonNumeric contextRef="c-1" name="dei:AuditorFirmId" id="f-52">238</ix:nonNumeric>)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_100">51</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_103">Consolidated Statements of (Loss) Income and Comprehensive </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_103">Loss</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_103"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_103">for the years ended December&#160;31, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_103">3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_103">, 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_103">22</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_103"> and 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_103">1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_103">53</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_106">Consolidated Balance Sheets as of December&#160;31, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_106">3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_106"> and 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_106">2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_106">54</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_109">Consolidated Statements of Cash Flows for the years ended December&#160;31, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_109">3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_109">, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_109">2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_109"> and 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_109">1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_109">55</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_112">Consolidated Statements of Shareholders&#8217; Equity for the years ended December 31, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_112">3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_112">, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_112">2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_112"> and 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_112">1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_112">56</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_118">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_118">57</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_199">(a)(3) EXHIBITS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_199">112</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)(2) FINANCIAL STATEMENT SCHEDULES</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_208">Schedule II &#8212; Valuation and Qualifying Accounts and Reserves for the years ended December&#160;31, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_208">3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_208">, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_208">2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_208"> and 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_208">1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_208">S-1</a></span></div></td></tr></table></div><div style="margin-top:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All other schedules are omitted because they are not applicable or the required information is shown in the financial statements or notes thereto.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 50</span></div></div></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_100"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Board of Directors and Shareholders of International Flavors &amp; Fragrances Inc.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Opinions on the Financial Statements and Internal Control over Financial Reporting</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of International Flavors &amp; Fragrances Inc. and its subsidiaries (the &#8220;Company&#8221;) as of December&#160;31, 2023 and 2022, and the related consolidated statements of (loss) income and comprehensive loss, of shareholders&#8217; equity and of cash flows for each of the three years in the period ended December&#160;31, 2023, including the related notes and financial statement schedule listed in the index appearing under Item 15(a)(2) (collectively referred to as the &#8220;consolidated financial statements&#8221;). We also have audited the Company&#8217;s internal control over financial reporting as of December&#160;31, 2023, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control - Integrated Framework </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December&#160;31, 2023 and 2022, and the results of its operations and its cash flows for each of the three years in the period ended December&#160;31, 2023 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December&#160;31, 2023, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control - Integrated Framework</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (2013) issued by the COSO.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis for Opinions</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in Management&#8217;s Report on Internal Control Over Financial Reporting appearing under Item 9A. Our responsibility is to express opinions on the Company&#8217;s consolidated financial statements and on the Company&#8217;s internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Definition and Limitations of Internal Control over Financial Reporting</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Critical Audit Matters</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that (i) relates to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill Impairment Assessments - Nourish, Health &amp; Biosciences and Pharma Solutions Reporting Units</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in Notes 1 and 6 to the consolidated financial statements, the Company&#8217;s goodwill balance was $10.635 billion as of December&#160;31, 2023, and the goodwill related to the Nourish, Health &amp; Biosciences, and Pharma Solutions reportable segments was $3.489 billion, $4.391 billion, and $1.265 billion, respectively. Management has determined that the Nourish, Health &amp; Biosciences, and Pharma Solutions reportable segments are each also a reporting unit. Management tests goodwill for impairment at the reporting unit level as of November 30 every year or more frequently if events or changes in circumstances indicate the asset might be impaired. If a reporting unit&#8217;s carrying amount exceeds its fair value, the Company will record an impairment charge based on that difference. Management assessed the fair value of the reporting units using an income approach. Under the income approach, management determined the fair value by using a discounted cash flow method at a rate of return that reflects the relative risk of the projected future cash flows of each reporting unit, as well as a terminal value. Key estimates and assumptions include revenue growth rates, gross margins, EBITDA margins, terminal growth rates, and discount rates. Management determined that the carrying value of the Nourish reporting unit exceeded its fair value and recorded an impairment charge of $2.623 billion for the year ended December 31, 2023.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal considerations for our determination that performing procedures relating to the goodwill impairment assessments of the Nourish, Health &amp; Biosciences, and Pharma Solutions reporting units is a critical audit matter are (i) the significant judgment by management when developing the fair value estimate of the Nourish, Health &amp; Biosciences, and Pharma Solutions reporting units; (ii) a high degree of auditor judgment, subjectivity, and effort in performing procedures and evaluating management&#8217;s significant assumptions related to revenue growth rates, gross margins, EBITDA margins, terminal growth rates, and discount rates; and (iii) the audit effort involved the use of professionals with specialized skill and knowledge.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to management&#8217;s goodwill impairment assessments, including controls over the valuation of the Nourish, Health &amp; Biosciences, and Pharma Solutions reporting units. These procedures also included, among others (i) testing management&#8217;s process for developing the fair value estimate of the Nourish, Health &amp; Biosciences, and Pharma Solutions reporting units; (ii) evaluating the appropriateness of the discounted cash flow method used by management; (iii) testing the completeness and accuracy of underlying data used in the discounted cash flow method; and (iv) evaluating the reasonableness of the significant assumptions used by management related to revenue growth rates, gross margins, EBITDA margins, terminal growth rates, and discount rates. Evaluating management&#8217;s assumptions related to revenue growth rates, gross margins, and EBITDA margins involved evaluating whether the assumptions used by management were reasonable considering (i) the current and past performance of the Nourish, Health &amp; Biosciences, and Pharma Solutions reporting units; (ii) the consistency with external market and industry data; and (iii) whether the assumptions were consistent with evidence obtained in other areas of the audit. Professionals with specialized skill and knowledge were used to assist in evaluating (i) the appropriateness of the discounted cash flow method and (ii) the reasonableness of the terminal growth rate and discount rate assumptions.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ <ix:nonNumeric contextRef="c-1" name="dei:AuditorName" id="f-53">PricewaterhouseCoopers LLP</ix:nonNumeric></span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:AuditorLocation" id="f-54">New York, New York</ix:nonNumeric></span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;28, 2024</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company&#8217;s auditor since 1957.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 52</span></div></div></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_103"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTERNATIONAL FLAVORS&#160;&amp; FRAGRANCES INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF (LOSS) INCOME AND COMPREHENSIVE LOSS</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS EXCEPT PER SHARE AMOUNTS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-55">11,479</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-56">12,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-57">11,656</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="f-58">7,798</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="f-59">8,289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="f-60">7,921</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="f-61">3,681</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="f-62">4,151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="f-63">3,735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-64">636</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-65">603</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-66">629</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="f-67">1,787</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="f-68">1,768</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="f-69">1,749</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and other charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="iff:RestructuringandOtherCharges" scale="6" id="f-70">68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="iff:RestructuringandOtherCharges" scale="6" id="f-71">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="iff:RestructuringandOtherCharges" scale="6" id="f-72">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquisition-related intangibles</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-73">680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-74">727</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-75">732</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="f-76">2,623</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="f-77">2,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="f-78">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of long-lived assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:fixed-zero" scale="6" id="f-79">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" scale="6" id="f-80">120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:fixed-zero" scale="6" id="f-81">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains on sale of assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="6" id="f-82">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="6" id="f-83">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="6" id="f-84">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating (loss) profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-85">2,110</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-86">1,326</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-87">585</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="f-88">380</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="f-89">336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="f-90">289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-91">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-92">37</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-93">58</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) income before taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-94">2,518</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-95">1,625</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-96">354</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-97">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-98">239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-99">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="f-100">2,563</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="f-101">1,864</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="f-102">279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to non-controlling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="f-103">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="f-104">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="f-105">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income attributable to IFF shareholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="6" id="f-106">2,567</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="6" id="f-107">1,871</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="f-108">270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income per share &#8212; basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-109">10.05</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-9" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-110">7.32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-10" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-111">1.11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income per share &#8212; diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-112">10.05</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-9" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-113">7.32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-10" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-114">1.10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average number of shares outstanding - basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-115">255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-9" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-116">255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-117">243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average number of shares outstanding - diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-118">255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-9" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-119">255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-120">243</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statements of Comprehensive Loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="f-121">2,563</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="f-122">1,864</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="f-123">279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), after tax:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="f-124">414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="f-125">933</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="f-126">848</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains on derivatives qualifying as hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="f-127">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="f-128">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="f-129">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement liability adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="f-130">112</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="f-131">158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="f-132">115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-133">302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-134">775</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-135">725</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-136">2,261</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-137">2,639</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-138">446</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to non-controlling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="f-139">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="f-140">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="f-141">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss attributable to IFF shareholders</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="f-142">2,265</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="f-143">2,646</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="f-144">455</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Notes to Consolidated Financial Statements</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_106"></div><hr style="page-break-after:always"/><div style="min-height:22.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTERNATIONAL FLAVORS&#160;&amp; FRAGRANCES INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-145">703</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-146">483</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:RestrictedCashCurrent" scale="6" id="f-147">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:RestrictedCashCurrent" scale="6" id="f-148">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables (net of allowances of $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="f-149">52</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="f-150">53</ix:nonFraction>, respectively)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="f-151">1,726</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="f-152">1,818</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="f-153">2,477</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="f-154">3,151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held for sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="f-155">506</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="6" id="f-156">1,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="f-157">875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="f-158">770</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Current Assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-159">6,293</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-160">7,432</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="f-161">4,240</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="f-162">4,203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-163">10,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-164">13,373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="f-165">8,357</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="f-166">9,082</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="f-167">689</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="f-168">743</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="f-169">764</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="f-170">689</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-171">30,978</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-172">35,522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank borrowings, overdrafts and current portion of long-term debt</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:DebtCurrent" scale="6" id="f-173">885</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:DebtCurrent" scale="6" id="f-174">410</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="iff:CommercialPaperCurrent" format="ixt:fixed-zero" scale="6" id="f-175">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="iff:CommercialPaperCurrent" scale="6" id="f-176">187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="f-177">1,378</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="f-178">1,418</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued payroll and bonus</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="f-179">265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="f-180">267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:DividendsPayableCurrent" scale="6" id="f-181">207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:DividendsPayableCurrent" scale="6" id="f-182">206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities held for sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="f-183">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="f-184">212</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="f-185">977</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-186">1,028</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Current Liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-187">3,758</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-188">3,728</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-189">9,186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-190">10,373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retirement liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="f-191">253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="f-192">231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="f-193">1,937</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="f-194">2,283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="f-195">642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="f-196">672</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="f-197">560</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="f-198">491</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Other Liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:LiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-199">12,578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:LiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-200">14,050</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commitments and Contingencies (Note 19)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-11" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-201"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-12" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-202"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable non-controlling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" format="ixt:fixed-zero" scale="6" id="f-203">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="f-204">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shareholders&#8217; Equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Common stock $<ix:nonFraction unitRef="usdPerShare" contextRef="c-11" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-205"><ix:nonFraction unitRef="usdPerShare" contextRef="c-12" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-206">0.125</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="c-12" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-207"><ix:nonFraction unitRef="shares" contextRef="c-11" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-208">500,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="c-11" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-209">275,726,629</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-12" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-210">275,726,629</ix:nonFraction> shares issued as of December&#160;31, 2023 and December&#160;31, 2022, respectively; and <ix:nonFraction unitRef="shares" contextRef="c-11" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-211">255,288,535</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-12" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-212">254,968,463</ix:nonFraction> shares outstanding as of December&#160;31, 2023 and December&#160;31, 2022, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="f-213">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="f-214">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital in excess of par value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="f-215">19,874</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="f-216">19,841</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Accumulated deficit) retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="f-217">2,439</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="f-218">955</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="f-219">1,896</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="f-220">2,198</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Treasury stock, at cost (<ix:nonFraction unitRef="shares" contextRef="c-11" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-221">20,438,094</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-12" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-222">20,758,166</ix:nonFraction> shares as of December&#160;31, 2023 and December&#160;31, 2022, respectively)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:TreasuryStockValue" scale="6" id="f-223">963</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:TreasuryStockValue" scale="6" id="f-224">978</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Shareholders&#8217; Equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-225">14,611</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-226">17,655</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-controlling interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="f-227">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="f-228">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Shareholders&#8217; Equity including non-controlling interest</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-229">14,642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-230">17,685</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Liabilities and Shareholders&#8217; Equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-231">30,978</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-232">35,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Notes to Consolidated Financial Statements</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_109"></div><hr style="page-break-after:always"/><div style="min-height:18pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTERNATIONAL FLAVORS&#160;&amp; FRAGRANCES INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.613%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.228%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.451%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.228%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.451%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.229%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="f-233">2,563</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="f-234">1,864</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="f-235">279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-236">1,142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-237">1,179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-238">1,156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="f-239">369</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="f-240">237</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="f-241">236</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gains on sale of assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:GainLossOnDispositionOfAssets" scale="6" id="f-242">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:GainLossOnDispositionOfAssets" scale="6" id="f-243">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:GainLossOnDispositionOfAssets" scale="6" id="f-244">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Losses (gains) on business divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="f-245">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="f-246">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="f-247">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="f-248">65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="f-249">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="f-250">54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pension contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:PensionContributions" scale="6" id="f-251">36</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:PensionContributions" scale="6" id="f-252">36</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:PensionContributions" scale="6" id="f-253">37</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of inventory step-up</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="iff:AmortizationOfInventoryStepUp" format="ixt:fixed-zero" scale="6" id="f-254">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="iff:AmortizationOfInventoryStepUp" format="ixt:fixed-zero" scale="6" id="f-255">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="iff:AmortizationOfInventoryStepUp" scale="6" id="f-256">368</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment of goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="f-257">2,623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="f-258">2,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="f-259">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment of long-lived assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:fixed-zero" scale="6" id="f-260">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" scale="6" id="f-261">120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:fixed-zero" scale="6" id="f-262">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventory write-down</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:InventoryWriteDown" scale="6" id="f-263">72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:InventoryWriteDown" format="ixt:fixed-zero" scale="6" id="f-264">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:InventoryWriteDown" format="ixt:fixed-zero" scale="6" id="f-265">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in assets and liabilities, net of acquisitions:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="f-266">51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="f-267">117</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="f-268">169</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="f-269">605</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="f-270">893</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="f-271">363</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="f-272">39</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="f-273">57</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="f-274">419</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accruals for incentive compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="6" id="f-275">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="6" id="f-276">34</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="6" id="f-277">96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current payables and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" scale="6" id="f-278">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" scale="6" id="f-279">92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" scale="6" id="f-280">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets/liabilities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="f-281">149</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="f-282">41</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="f-283">120</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="f-284">1,439</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="f-285">397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="f-286">1,437</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for acquisitions, net of cash received</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:fixed-zero" scale="6" id="f-287">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="f-288">110</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:fixed-zero" scale="6" id="f-289">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additions to property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="f-290">503</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="f-291">504</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="f-292">393</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additions to intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:PaymentsToAcquireIntangibleAssets" format="ixt:fixed-zero" scale="6" id="f-293">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="6" id="f-294">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="6" id="f-295">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from disposal of assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ProceedsFromSaleOfProductiveAssets" scale="6" id="f-296">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:ProceedsFromSaleOfProductiveAssets" scale="6" id="f-297">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:ProceedsFromSaleOfProductiveAssets" scale="6" id="f-298">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from unwinding of derivative instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ProceedsFromDerivativeInstrumentInvestingActivities" format="ixt:fixed-zero" scale="6" id="f-299">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:ProceedsFromDerivativeInstrumentInvestingActivities" scale="6" id="f-300">173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:ProceedsFromDerivativeInstrumentInvestingActivities" format="ixt:fixed-zero" scale="6" id="f-301">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash provided by the Merger with N&amp;B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="iff:ProceedsFromBusinessCombination" format="ixt:fixed-zero" scale="6" id="f-302">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="iff:ProceedsFromBusinessCombination" scale="6" id="f-303">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="iff:ProceedsFromBusinessCombination" scale="6" id="f-304">246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net proceeds received from business divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="6" id="f-305">1,050</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="6" id="f-306">1,169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="f-307">115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by (used in) investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="f-308">574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="f-309">745</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="f-310">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash dividends paid to shareholders</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="f-311">826</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="f-312">810</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="f-313">667</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividends paid to redeemable non-controlling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:PaymentsOfDividendsMinorityInterest" scale="6" id="f-314">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:PaymentsOfDividendsMinorityInterest" format="ixt:fixed-zero" scale="6" id="f-315">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:PaymentsOfDividendsMinorityInterest" scale="6" id="f-316">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Decrease) increase in revolving credit facility and short term borrowings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="f-317">99</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="f-318">104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" sign="-" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="f-319">105</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from issuance of commercial paper (maturities after three months)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="iff:ProceedsFromIssuanceOfCommercialPaperMaturingInMoreThanThreeMonths" format="ixt:fixed-zero" scale="6" id="f-320">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="iff:ProceedsFromIssuanceOfCommercialPaperMaturingInMoreThanThreeMonths" scale="6" id="f-321">225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="iff:ProceedsFromIssuanceOfCommercialPaperMaturingInMoreThanThreeMonths" format="ixt:fixed-zero" scale="6" id="f-322">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayments of commercial paper (maturities after three months)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="iff:RepaymentsOfCommercialPaperMaturingInMoreThanThreeMonths" format="ixt:fixed-zero" scale="6" id="f-323">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="iff:RepaymentsOfCommercialPaperMaturingInMoreThanThreeMonths" scale="6" id="f-324">421</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="iff:RepaymentsOfCommercialPaperMaturingInMoreThanThreeMonths" format="ixt:fixed-zero" scale="6" id="f-325">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (repayments) borrowings of commercial paper (maturities less than three months)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="iff:NetBorrowingsRepaymentsOfCommercialPaperMaturingInLessThanThreeMonths" scale="6" id="f-326">187</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="iff:NetBorrowingsRepaymentsOfCommercialPaperMaturingInLessThanThreeMonths" scale="6" id="f-327">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="iff:NetBorrowingsRepaymentsOfCommercialPaperMaturingInLessThanThreeMonths" scale="6" id="f-328">324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:PaymentsOfFinancingCosts" scale="6" id="f-329">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:PaymentsOfFinancingCosts" format="ixt:fixed-zero" scale="6" id="f-330">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:PaymentsOfFinancingCosts" scale="6" id="f-331">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayments of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="f-332">655</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="f-333">300</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="f-334">828</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of redeemable non-controlling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" scale="6" id="f-335">39</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" scale="6" id="f-336">47</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="f-337">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from issuance of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:fixed-zero" scale="6" id="f-338">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:fixed-zero" scale="6" id="f-339">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="f-340">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred consideration paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="6" id="f-341">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" format="ixt:fixed-zero" scale="6" id="f-342">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="6" id="f-343">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Employee withholding taxes paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="f-344">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="f-345">21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="f-346">21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="f-347">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="f-348">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="f-349">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-350">1,851</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-351">1,229</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-352">1,304</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-353">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-354">77</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-355">59</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net change in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="f-356">183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="f-357">164</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="f-358">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at beginning of year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-359">552</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-360">716</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-361">660</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash, cash equivalents and restricted cash at end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-362">735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-363">552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-364">716</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supplemental Disclosures:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest paid, net of amounts capitalized</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="f-365">370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="f-366">310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="f-367">310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncomeTaxesPaid" scale="6" id="f-368">578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:IncomeTaxesPaid" scale="6" id="f-369">329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:IncomeTaxesPaid" scale="6" id="f-370">289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued capital expenditures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="f-371">109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="f-372">150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="f-373">117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Notes to Consolidated Financial Statements</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_112"></div><hr style="page-break-after:always"/><div style="min-height:22.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTERNATIONAL FLAVORS&#160;&amp; FRAGRANCES INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF SHAREHOLDERS&#8217; EQUITY</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:21.357%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.364%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.114%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.364%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.527%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.364%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.210%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.506%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.634%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.506%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.364%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.114%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.364%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.950%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.364%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.550%"/><td style="width:0.1%"/></tr><tr style="height:18pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common<br/>stock</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Capital&#160;in<br/>excess&#160;of<br/>par&#160;value</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>earnings (accumulated deficit)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated other<br/>comprehensive<br/>(loss) income</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-controlling<br/>interest</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:18pt"><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-15" decimals="INF" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-374">128,526,137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-375">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-376">3,853</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-377">4,156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-378">698</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-19" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-379">21,588,147</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-380">1,017</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-381">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-382">6,322</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-6" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="f-383">270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-6" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="f-384">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="f-385">273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cumulative translation adjustment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="f-386">848</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="f-387">848</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain on derivatives qualifying as hedges; net of tax $(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="f-388">1</ix:nonFraction>)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="f-389">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="f-390">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pension liability and postretirement adjustment; net of tax $(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="f-391">4</ix:nonFraction>)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="f-392">115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="f-393">115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash dividends declared ($<ix:nonFraction unitRef="usdPerShare" contextRef="c-10" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-394">3.12</ix:nonFraction> per share)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="f-395">785</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="f-396">785</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock options/SSARs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="f-397">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-25" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-398">159,222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="f-399">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="f-400">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impact of N&amp;B Merger</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-26" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" format="ixt:num-dot-decimal" scale="0" id="f-401">141,740,461</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="6" id="f-402">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="6" id="f-403">15,936</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="6" id="f-404">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="6" id="f-405">15,976</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Conversion of tangible equity units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-26" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" format="ixt:num-dot-decimal" scale="0" id="f-406">5,460,031</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" scale="6" id="f-407">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" scale="6" id="f-408">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" format="ixt:fixed-zero" scale="6" id="f-409">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vested restricted stock units and awards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="6" id="f-410">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-25" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="f-411">276,280</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="6" id="f-412">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="6" id="f-413">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-414">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-415">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Redeemable NCI</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-6" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="f-416">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="f-417">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends on non-controlling interest and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="f-418">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="f-419">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-27" decimals="INF" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-420">275,726,629</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-421">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-422">19,826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-423">3,641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-424">1,423</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-31" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-425">21,152,645</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-426">997</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-427">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-428">21,117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-6" sign="-" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-429">1,871</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-6" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="f-430">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" sign="-" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-431">1,868</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cumulative translation adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="f-432">933</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="f-433">933</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pension liability and postretirement adjustment; net of tax $(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="f-434">4</ix:nonFraction>)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="f-435">158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="f-436">158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash dividends declared ($<ix:nonFraction unitRef="usdPerShare" contextRef="c-9" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-437">3.20</ix:nonFraction> per share)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="f-438">815</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="f-439">815</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock options/SSARs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="f-440">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-37" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-441">85,728</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="f-442">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="f-443">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vested restricted stock units and awards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="6" id="f-444">41</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-37" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="f-445">308,751</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="6" id="f-446">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="6" id="f-447">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-448">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-449">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of NCI</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-6" sign="-" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="6" id="f-450">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="6" id="f-451">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="6" id="f-452">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Redeemable NCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-6" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="f-453">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="f-454">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends on non-controlling interest and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="f-455">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="f-456">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-38" decimals="INF" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-457">275,726,629</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-458">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-459">19,841</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-460">955</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-461">2,198</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-42" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-462">20,758,166</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-463">978</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-464">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-465">17,685</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-6" sign="-" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-466">2,567</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-6" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="f-467">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-468">2,563</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cumulative translation adjustment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="f-469">414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="f-470">414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pension liability and postretirement adjustment; net of tax $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="f-471">3</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="f-472">112</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="f-473">112</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash dividends declared ($<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-474">3.24</ix:nonFraction> per share)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="f-475">827</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="f-476">827</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock options/SSARs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="f-477">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-48" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-478">89,850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="f-479">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:fixed-zero" scale="6" id="f-480">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vested restricted stock units and awards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="6" id="f-481">22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-48" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="f-482">230,222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="6" id="f-483">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="6" id="f-484">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-485">65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-486">65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Redeemable NCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-6" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="f-487">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="f-488">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends on non-controlling interest and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="f-489">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="f-490">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-49" decimals="INF" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" id="f-491">275,726,629</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-492">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-493">19,874</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-494">2,439</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-495">1,896</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-53" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-496">20,438,094</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-497">963</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-498">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-499">14,642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Notes to Consolidated Financial Statements</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_118"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTERNATIONAL FLAVORS&#160;&amp; FRAGRANCES INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_121"></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 1.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" id="f-500" continuedAt="f-500-1" escape="true">NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><ix:continuation id="f-500-1" continuedAt="f-500-2"><ix:nonNumeric contextRef="c-1" name="iff:NatureOfOperationsPolicyTextBlock" id="f-501" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nature of Operations</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International Flavors &amp; Fragrances Inc. and its subsidiaries (the &#8220;Registrant,&#8221; &#8220;IFF,&#8221; &#8220;the Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; and &#8220;our&#8221;) is a leading creator and manufacturer of food, beverage, health &amp; biosciences, scent and pharma solutions and complementary adjacent products, including cosmetic active and natural health ingredients, which are used in a wide variety of consumer products. Our products are sold principally to manufacturers of perfumes and cosmetics, hair and other personal care products, soaps and detergents, cleaning products, dairy, meat and other processed foods, beverages, snacks and savory foods, sweet and baked goods, sweeteners, dietary supplements, food protection, infant and elderly nutrition, functional food, and pharmaceutical excipients and oral care products.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="f-502" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 1, 2021 (the &#8220;Closing Date&#8221;), the Company completed the combination (the &#8220;Merger&#8221;) of IFF and DuPont de Nemours, Inc (&#8220;DuPont&#8221;) nutrition and biosciences business (the &#8220;N&amp;B Business&#8221;), which had been transferred to Nutrition and Biosciences, Inc., a Delaware corporation and wholly owned subsidiary of DuPont (&#8220;N&amp;B&#8221;) in a Reverse Morris Trust transaction. See Note 3 for additional information. As a result, the Company&#8217;s Consolidated Financial Statements for the periods ended December&#160;31, 2023 and 2022 reflect the results of N&amp;B for the full twelve months of 2023 and 2022, whereas the period ended December&#160;31, 2021 only reflect the results of N&amp;B from the Closing Date.</span></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Correction of Prior Year Consolidated Financial Statements</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company revised its Operating lease right-of-use assets from $<ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="f-503">636</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="f-504">743</ix:nonFraction> million and Operating lease liabilities from $<ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-505">565</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-506">672</ix:nonFraction> million on its Consolidated Balance Sheets as of December&#160;31, 2022. This reflects the correction of an error of $<ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-507">107</ix:nonFraction> million related to a lease renewal that was not correctly reflected in the prior year period.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company revised its Goodwill from $<ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="9" id="f-508">13.355</ix:nonFraction>&#160;billion to $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="9" id="f-509">13.373</ix:nonFraction>&#160;billion and Deferred income tax liabilities from $<ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="9" id="f-510">2.265</ix:nonFraction> billion to $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="9" id="f-511">2.283</ix:nonFraction> billion on its Consolidated Balance Sheets as of December&#160;31, 2022. This reflects the correction of an error of $<ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="f-512">18</ix:nonFraction> million related to deferred income tax liabilities as part of purchase accounting for the Merger with N&amp;B.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also corrected an error related to the fair value of derivative assets and liabilities of cross currency swaps. As a result of this correction, the Company revised its Other assets from $<ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-513">699</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-514">689</ix:nonFraction> million, which included a $<ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-6" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="f-515">9</ix:nonFraction> million impact to deferred income taxes, Other liabilities from $<ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-516">472</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-517">491</ix:nonFraction> million and Accumulated other comprehensive loss from $<ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="9" id="f-518">2.169</ix:nonFraction> billion to $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="9" id="f-519">2.198</ix:nonFraction> billion on its Consolidated Balance Sheets as of December&#160;31, 2022. The Company also revised its Cumulative translation adjustment from $(<ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="f-520">904</ix:nonFraction>)&#160;million to $(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="f-521">933</ix:nonFraction>)&#160;million on its Consolidated Statements of Shareholders&#8217; Equity for the year ended December&#160;31, 2022.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also adjusted the disclosure of its total receivables factored for the years ended December&#160;31, 2022 and 2021 from $<ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-6" name="iff:ProceedsFromSaleOfAccountsReceivable" format="ixt:num-dot-decimal" scale="9" id="f-522">1.030</ix:nonFraction> billion to $<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="iff:ProceedsFromSaleOfAccountsReceivable" format="ixt:num-dot-decimal" scale="9" id="f-523">1.451</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-6" name="iff:ProceedsFromSaleOfAccountsReceivable" format="ixt:num-dot-decimal" scale="6" id="f-524">668</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="iff:ProceedsFromSaleOfAccountsReceivable" format="ixt:num-dot-decimal" scale="9" id="f-525">1.167</ix:nonFraction> billion, respectively, and the outstanding principal amounts of receivables from $<ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-6" name="us-gaap:TradeReceivablesHeldForSaleAmount" format="ixt:num-dot-decimal" scale="6" id="f-526">212</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:TradeReceivablesHeldForSaleAmount" format="ixt:num-dot-decimal" scale="6" id="f-527">157</ix:nonFraction> million as of December&#160;31, 2022.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impacts of these corrections are also presented in the related footnotes.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FiscalPeriod" id="f-528" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fiscal Year End</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a calendar year of the twelve-month period from January 1 to December 31.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:UseOfEstimates" id="f-529" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) requires management to make estimates and judgments that affect the amounts reported in the Consolidated Financial Statements and accompanying notes. The inputs into the Company&#8217;s judgments and estimates take into account ongoing global current events and adverse macroeconomic impacts on the critical and significant accounting estimates, including estimates associated with future cash flows that are used in assessing the risk of impairment of certain assets. Actual results could differ from those estimates.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ConsolidationPolicyTextBlock" id="f-530" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Consolidated Financial Statements include the accounts of International Flavors&#160;&amp; Fragrances Inc. and those of its subsidiaries. Significant intercompany balances and transactions have been eliminated. To the extent a subsidiary is not wholly owned, any related non-controlling interests are included as a separate component of Shareholders&#8217; Equity.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:continuation id="f-500-2" continuedAt="f-500-3"><ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="f-531" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue from contracts with customers when the contract or purchase order has received approval and commitment from both parties, has the rights of the parties and payment terms (which can vary by customer) identified, has commercial substance, collectability of consideration is probable, and control has transferred. The revenue recognized reflects the consideration the Company expects to be entitled to in exchange for those goods. Sales, value added, and other taxes the Company collects are excluded from revenues. The Company receives payment in accordance with standard customer terms.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales are reduced, at the time revenue is recognized, for applicable discounts, rebates and sales allowances based on historical experience. Related accruals are included in Other current liabilities in the accompanying Consolidated Balance Sheets. The Company considers shipping and handling activities undertaken after the customer has obtained control of the related goods as a fulfillment activity. Net sales include shipping and handling charges billed to customers. Cost of goods sold includes all costs incurred in connection with shipping and handling.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="f-532" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract Assets and Liabilities</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to a small number of contracts for the sale of compounds, the Company has an &#8220;enforceable right to payment for performance to date&#8221; and as the products do not have an alternative use, the Company recognizes revenue for these contracts over time and records a contract asset using the output method. The output method recognizes revenue on the basis of direct measurements of the value to the customer of the goods or services transferred to date relative to the remaining goods or services promised under the contract.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023 and 2022, the Company&#8217;s gross accounts receivable was $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:AccountsReceivableGross" format="ixt:num-dot-decimal" scale="9" id="f-533">1.778</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:AccountsReceivableGross" format="ixt:num-dot-decimal" scale="9" id="f-534">1.871</ix:nonFraction>&#160;billion, respectively. The Company&#8217;s contract assets and contract liabilities as of December&#160;31, 2023 and 2022 were not material.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="f-535" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Translation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company translates the assets and liabilities of non-U.S. subsidiaries into U.S. dollars at year-end exchange rates. Income and expense items are translated at average exchange rates during the year. Cumulative translation adjustments are shown as a separate component of Shareholders&#8217; Equity.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="f-536" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development (&#8220;R&amp;D&#8221;) expenses relate to the development of new and improved products, technical product support and compliance with governmental regulation. All research and development costs are expensed as incurred.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="f-537" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents include highly liquid investments with maturities of three months or less at date of purchase.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="f-538" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Cash</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash is comprised of cash or cash equivalents which has been placed into an account that is restricted for a specific use and from which the Company cannot withdraw the cash on demand.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock" id="f-539" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of cash, cash equivalents and restricted cash reported on the Company&#8217;s balance sheets as of December&#160;31, 2023, 2022 and 2021 to the amounts reported on the Company&#8217;s statement of cash flows periods ended December&#160;31, 2023, 2022 and 2021.</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.391%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.391%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.394%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-540">703</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-541">483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-542">711</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents included in Assets held for sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" scale="6" id="f-543">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" scale="6" id="f-544">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="f-545">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:RestrictedCashCurrent" scale="6" id="f-546">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:RestrictedCashCurrent" scale="6" id="f-547">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:RestrictedCashCurrent" scale="6" id="f-548">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:RestrictedCashNoncurrent" format="ixt:fixed-zero" scale="6" id="f-549">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="f-550">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="f-551">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-552">735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-553">552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-554">716</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ReceivablesPolicyTextBlock" id="f-555" continuedAt="f-555-1" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts Receivable</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has various factoring agreements globally under which it can factor up to approximately $<ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-6" name="iff:AccountsReceivableFactoringReceivableProgramMaximumAmount" format="ixt:num-dot-decimal" scale="6" id="f-556">300</ix:nonFraction>&#160;million of its trade receivables (&#8220;Company&#8217;s own factoring agreements&#8221;). In addition, the Company utilizes factoring agreements sponsored by certain customers. Under all of the arrangements, the Company sells the trade receivables on a non-recourse basis to </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:continuation id="f-500-3" continuedAt="f-500-4"><ix:continuation id="f-555-1"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">unrelated financial institutions and accounts for the transactions as sales of receivables. The applicable receivables are removed from the Company&#8217;s Consolidated Balance Sheets when the cash proceeds are received by the Company.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sold approximately $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="iff:ProceedsFromSaleOfAccountsReceivable" format="ixt:num-dot-decimal" scale="9" id="f-557">1.752</ix:nonFraction>&#160;billion, $<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="iff:ProceedsFromSaleOfAccountsReceivable" format="ixt:num-dot-decimal" scale="9" id="f-558">1.451</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="iff:ProceedsFromSaleOfAccountsReceivable" format="ixt:num-dot-decimal" scale="9" id="f-559">1.167</ix:nonFraction>&#160;billion of receivables in 2023, 2022 and 2021, respectively, under the Company&#8217;s own factoring agreements and customer sponsored factoring agreements. The cost of participating in these programs was approximately $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="iff:PaymentsToParticipateInFactoringReceivableProgram" format="ixt:num-dot-decimal" scale="6" id="f-560">25</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="iff:PaymentsToParticipateInFactoringReceivableProgram" format="ixt:num-dot-decimal" scale="6" id="f-561">12</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="iff:PaymentsToParticipateInFactoringReceivableProgram" format="ixt:num-dot-decimal" scale="6" id="f-562">6</ix:nonFraction> million, in 2023, 2022 and 2021, respectively, and is included as a component of interest expense. Under the Company&#8217;s own factoring agreements for which the Company has continued responsibility to collect receivables and provide to its sponsor, it sold approximately $<ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-6" name="iff:ProceedsFromSaleOfAccountsReceivable" format="ixt:num-dot-decimal" scale="6" id="f-563">843</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-6" name="iff:ProceedsFromSaleOfAccountsReceivable" format="ixt:num-dot-decimal" scale="6" id="f-564">547</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-6" name="iff:ProceedsFromSaleOfAccountsReceivable" format="ixt:num-dot-decimal" scale="6" id="f-565">197</ix:nonFraction>&#160;million of receivables in 2023, 2022 and 2021, respectively. The outstanding principal amounts of receivables under the Company&#8217;s own factoring agreements amounted to approximately $<ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-6" name="us-gaap:TradeReceivablesHeldForSaleAmount" format="ixt:num-dot-decimal" scale="6" id="f-566">196</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-6" name="us-gaap:TradeReceivablesHeldForSaleAmount" format="ixt:num-dot-decimal" scale="6" id="f-567">157</ix:nonFraction> million as of December&#160;31, 2023 and 2022, respectively. The proceeds from the sales of receivables are included in net cash from operating activities in the Consolidated Statements of Cash Flows.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:CreditLossFinancialInstrumentPolicyTextBlock" id="f-568" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Expected Credit Losses</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to credit losses primarily through its sales of products. To determine the appropriate allowance for expected credit losses, the Company considers certain credit quality indicators, such as aging of customer receivable balances, loss history and creditworthiness of debtors. The Company also considers current and anticipated future conditions of the general economy in the determination of allowances, including significant aspects of a geographic location and the industries in which the Company operates. The Company&#8217;s general allowance for credit losses is calculated using a loss rate model that is primarily based on historical write-off experiences and applied to trade receivables. As necessary, additional reserves are established based on other factors, such as aging of receivables, customer credit quality and account collectability and country risk. These allowances are reviewed and approved by the Regional and Global Credit committees.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, the Company reported $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="9" id="f-569">1.726</ix:nonFraction> billion of trade receivables, net of allowances of $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="6" id="f-570">52</ix:nonFraction> million. Based on the aging analysis as of December&#160;31, 2023, approximately <ix:nonFraction unitRef="number" contextRef="c-11" decimals="2" name="iff:AccountsReceivablesOutstandingByOver365Days" scale="-2" id="f-571">1</ix:nonFraction>% of the Company&#8217;s accounts receivable were past due by over 365 days based on the payment terms of the invoice.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock" id="f-572" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a roll forward of the Company&#8217;s allowances for bad debts for the years ended December 31, 2022 and 2023:</span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:83.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.544%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Allowance for Bad Debts</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="f-573">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad debt expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="f-574">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" sign="-" name="iff:AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation" scale="6" id="f-575">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="f-576">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad debt expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="f-577">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="6" id="f-578">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="iff:AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation" scale="6" id="f-579">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="f-580">52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Bad debt expense included approximately $<ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-6" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="6" id="f-581">11</ix:nonFraction>&#160;million related to expected credit losses on receivables from customers located in Russia and Ukraine (for export and domestic sales) due to the events in those countries.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Bad debt expense included approximately $<ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-6" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="6" id="f-582">13</ix:nonFraction> million related to expected credit losses on receivables from certain customers in Egypt, offset by approximately $<ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-6" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="6" id="f-583">8</ix:nonFraction> million of reversals of allowances on receivables from customers located in Russia and Ukraine. The Company will continue to evaluate its credit exposure related to Egypt, Russia and Ukraine.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:InventoryPolicyTextBlock" id="f-584" continuedAt="f-584-1" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventories</span></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-584-1">Inventories are stated at the lower of cost (on a weighted-average basis) or net realizable value.</ix:continuation> <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="f-585" continuedAt="f-585-1" escape="true">The Company&#8217;s inventories consisted of the following:</ix:nonNumeric></span></div><ix:continuation id="f-585-1"><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="f-586">779</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:InventoryRawMaterialsNetOfReserves" format="ixt:num-dot-decimal" scale="6" id="f-587">1,073</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="f-588">406</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="f-589">442</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="6" id="f-590">1,292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="6" id="f-591">1,636</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="f-592">2,477</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="f-593">3,151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:continuation id="f-500-4" continuedAt="f-500-5"><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeLeasesPolicyTextBlock" id="f-594" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if an arrangement is a lease at contract inception. A lease exists when a contract conveys to the customer the right to control the use of identified property, plant or equipment for a period of time in exchange for consideration. The definition of a lease embodies two conditions: (1) there is an identified asset in the contract that is land or a depreciable asset (i.e., property, plant, and equipment), and (2) the customer has the right to control the use of the identified asset.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When the Company determines the arrangement is a lease, or contains a lease, at inception, it then determines whether the lease is an operating lease or a finance lease at the commencement date.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases property and equipment principally under operating leases and records a right-of-use asset and related obligation at the present value of lease payments. Over the term of the lease, the Company depreciates the right-of-use asset and accretes the related obligation to future value. Some of the leases include rental escalation clauses, renewal options and/or termination options that are factored into the determination of lease payments when appropriate. The Company has elected not to separate non-lease components from lease components for all classes of leased assets.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When available, the Company uses the rate implicit in the lease to discount lease payments to present value, however, most of the Company&#8217;s leases do not provide a readily determinable implicit rate and the Company calculates the applicable incremental borrowing rate to discount the lease payments based on the term of the lease at lease commencement. The incremental borrowing rate is determined based on the Company&#8217;s credit rating, currency and lease terms.</span></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Long-Lived Assets</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="f-595" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Property, Plant and Equipment</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment are recorded at cost. Depreciation is calculated on a straight-line basis, principally over the following estimated useful lives: buildings and improvements, <ix:nonNumeric contextRef="c-67" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-596">1</ix:nonNumeric> to <ix:nonNumeric contextRef="c-68" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-597">40</ix:nonNumeric> years; machinery and equipment, <ix:nonNumeric contextRef="c-69" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-598">1</ix:nonNumeric> to <ix:nonNumeric contextRef="c-70" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-599">20</ix:nonNumeric> years; information technology hardware and software, <ix:nonNumeric contextRef="c-71" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-600">1</ix:nonNumeric> to <ix:nonNumeric contextRef="c-72" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-601">7</ix:nonNumeric> years; and leasehold improvements which are included in buildings and improvements, the estimated life of the improvements or the remaining term of the lease, whichever is shorter.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest incurred during the construction period of certain property, plant and equipment is capitalized until the underlying assets are placed in service, at which time straight-line amortization of the capitalized interest begins over the estimated useful lives of the related assets. Capitalized interest was approximately $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:InterestCostsCapitalized" format="ixt:num-dot-decimal" scale="6" id="f-602">17</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:InterestCostsCapitalized" format="ixt:num-dot-decimal" scale="6" id="f-603">13</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:InterestCostsCapitalized" format="ixt:num-dot-decimal" scale="6" id="f-604">9</ix:nonFraction> million for the years ended December&#160;31, 2023, 2022 and 2021, respectively.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" id="f-605" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Finite-Lived Intangible Assets</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finite-lived intangible assets include customer relationships, patents, trade names, technological know-how and other intellectual property valued at acquisition and are amortized on a straight-line basis over the following estimated useful lives: customer relationships, <ix:nonNumeric contextRef="c-73" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-606">10</ix:nonNumeric> to <ix:nonNumeric contextRef="c-74" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-607">27</ix:nonNumeric> years; patents, <ix:nonNumeric contextRef="c-75" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-608">11</ix:nonNumeric> to <ix:nonNumeric contextRef="c-76" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-609">15</ix:nonNumeric> years; trade names, <ix:nonNumeric contextRef="c-77" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-610">4</ix:nonNumeric> to <ix:nonNumeric contextRef="c-78" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-611">28</ix:nonNumeric> years; and technological know-how, <ix:nonNumeric contextRef="c-79" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-612">5</ix:nonNumeric> to <ix:nonNumeric contextRef="c-80" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-613">28</ix:nonNumeric> years.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews long-lived assets for impairment when events or changes in business conditions indicate that their carrying value may not be recovered. An estimate of undiscounted future cash flows produced by an asset or group of assets is compared to the carrying value to determine whether impairment exists. If assets are determined to be impaired, the loss is measured based on an estimate of fair value using various valuation techniques, including a discounted estimate of future cash flows.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="iff:UnusualOrInfrequentItemsOrBothDisclosurePolicyTextBlock" id="f-614" continuedAt="f-614-1" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Israel-Hamas War</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains operations in Israel and, additionally, exports products to customers in Israel from operations outside the region. The Company will continue to evaluate the current events and any potential impacts related to this matter, but does not expect there to be a material impact to its Consolidated Financial Statements.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Russia-Ukraine War</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains operations in both Russia and Ukraine and, additionally, exports products to customers in Russia and Ukraine from operations outside the region. In response to the events in Ukraine, the Company has limited the production and supply of ingredients in and to Russia to only those that meet the essential needs of people, including food, hygiene and medicine.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowances for Bad Debts</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, the Company had a reserve of approximately $<ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="6" id="f-615">3</ix:nonFraction>&#160;million related to expected credit losses on receivables from customers located in Russia and Ukraine. The Company will continue to evaluate its credit exposure related to Russia and Ukraine.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:continuation id="f-500-5" continuedAt="f-500-6"><ix:continuation id="f-614-1"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impairment of Long-Lived Assets</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2022, the sales and margins declined for certain entities within Russia due to supply chain issues, reduced product demand and exchange rate volatility. Further, it was determined that such declines in operating performance were not expected to reverse in the near future. Additionally, future growth was expected to be limited given operating conditions in Russia, which inhibit the required future investment.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with uncertainties related to the Company&#8217;s operations in Russia and Ukraine, the Company updated its analysis of the undiscounted cash flows of the applicable asset groups to determine if the cash flows exceeded the carrying values of the applicable asset groups. With respect to an asset group in the Nourish segment, that manufactures and sells in Russia and related markets, it was determined that the undiscounted cash flows were insufficient to cover the carrying value and that an impairment charge was required to write-down the long-lived assets to their fair values. The fair value of such asset group was determined based on a discounted cash flow approach which involved estimating the future cash flows for the business discounted to their present values. The discount rate used in the determination of such fair value was based on consideration of the risks inherent in the cash flows and market as of the valuation date.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of this assessment, the Company recognized an impairment charge of $<ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="6" id="f-616">120</ix:nonFraction> million in the Consolidated Statements of (Loss) Income and Comprehensive Loss for the year ended December 31, 2022, which was allocated on a pro rata basis to intangible assets and property, plant and equipment within the asset group in the amounts of approximately $<ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-6" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="f-617">92</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-6" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="f-618">28</ix:nonFraction> million, respectively.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy" id="f-619" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the difference between the total purchase price and the fair value of identifiable assets and liabilities acquired in business acquisitions.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company tests goodwill for impairment at the reporting unit level as of November 30 every year or more frequently if events or changes in circumstances indicate the asset might be impaired. A reporting unit is an operating segment or one level below an operating segment (referred to as a component) to which goodwill is assigned when initially recorded.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company identifies their reporting units by assessing whether the components of their reporting units constitute businesses for which discrete financial information is available and management of each reporting unit regularly reviews the operating results of those components. The Company determined that it has <ix:nonFraction unitRef="reporting_unit" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfReportingUnits" format="ixt-sec:numwordsen" scale="0" id="f-620">six</ix:nonFraction> reporting units under the Nourish, Health &amp; Biosciences, Scent and Pharma Solutions segments: (1) Nourish, (2) Fragrance Compounds, (3) Fragrance Ingredients, (4) Cosmetic Ingredients, (5) Health &amp; Biosciences and (6) Pharma Solutions. These reporting units were determined based on the level at which the performance is measured and reviewed by segment management. In cases where the components of an operating segment have similar economic characteristics, they are aggregated into a single reporting unit.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When testing goodwill for impairment, the Company has the option of first performing a qualitative assessment to determine whether it is more likely than not that the fair value of a reporting unit is less than the carrying amount. If the Company elects to bypass the qualitative assessment for any reporting units, or if a qualitative assessment indicates it is more likely than not that the estimated carrying value of a reporting unit exceeds its fair value, the Company performs a quantitative goodwill impairment test.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the quantitative goodwill impairment test, if a reporting unit&#8217;s carrying amount exceeds its fair value, the Company will record an impairment charge based on that difference, and the impairment charge will be limited to the amount of goodwill allocated to that reporting unit.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2023, the Company determined that the carrying value of the Nourish reporting unit exceeded its fair value and recorded an impairment charge of $<ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="9" id="f-621">2.623</ix:nonFraction>&#160;billion in the Consolidated Statements of (Loss) Income and Comprehensive Loss for the year ended December 31, 2023. During 2022, the Company determined that the carrying value of the Health &amp; Biosciences reporting unit exceeded its fair value and recorded a goodwill impairment charge of $<ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="9" id="f-622">2.250</ix:nonFraction> billion in the Consolidated Statements of (Loss) Income and Comprehensive Loss for the year ended December 31, 2022. See Note 6 for additional information.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxPolicyTextBlock" id="f-623" continuedAt="f-623-1" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for taxes under the asset and liability method. Under this method, deferred income taxes are recognized for temporary differences between the financial statement and tax return bases of assets and liabilities, based on enacted tax rates and other provisions of the tax law. The effect of a change in tax laws or rates on deferred tax assets and liabilities is recognized as income in the period in which such change is enacted. Future tax benefits are recognized to the extent that the realization of such benefits is more likely than not, and a valuation allowance is established for any portion of a deferred tax asset that management believes may not be realized.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:continuation id="f-500-6" continuedAt="f-500-7"><ix:continuation id="f-623-1"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes uncertain tax positions that it has taken or expects to take on a tax return. Pursuant to accounting requirements, the Company first determines whether it is &#8220;more likely than not&#8221; its tax position will be sustained if the relevant tax authority were to audit the position with full knowledge of all the relevant facts and other information. For those tax positions that meet this threshold, the Company measures the amount of tax benefit based on the largest amount of tax benefit that it has a greater than <ix:nonFraction unitRef="number" contextRef="c-11" decimals="INF" name="iff:MinimumPercentageLikelihoodOfTaxBenefitToBeRealizedUponFinalSettlement" scale="-2" id="f-624">50</ix:nonFraction>% chance of realizing in a final settlement with the relevant authority. Those tax positions failing to qualify for initial recognition are recognized in the first interim period in which they meet the more likely than not standard. The Company maintains a cumulative risk portfolio relating to all of its uncertainties in income taxes in order to perform this analysis, but the evaluation of its tax positions requires significant judgment and estimation in part because, in certain cases, tax law is subject to varied interpretation, and whether a tax position will ultimately be sustained may be uncertain.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest and penalties related to unrecognized tax benefits are recognized as a component of income tax expense.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:PensionAndOtherPostretirementPlansPolicy" id="f-625" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Retirement Benefits</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current service costs of retirement plans and postretirement health care and life insurance benefits are accrued. Prior service costs resulting from plan improvements are amortized over periods ranging from <ix:nonNumeric contextRef="c-1" name="iff:PriorServiceCostsFromPlanImprovementsAmortizationPeriodMinimum" format="ixt-sec:duryear" id="f-626">10</ix:nonNumeric> to <ix:nonNumeric contextRef="c-1" name="iff:PriorServiceCostsFromPlanImprovementsAmortizationPeriodMaximum" format="ixt-sec:duryear" id="f-627">20</ix:nonNumeric> years.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="f-628" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Instruments</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative financial instruments are used to manage interest and foreign currency exposures. The gain or loss on the hedging instrument is recorded in earnings at the same time as the transaction being hedged is recorded in earnings. The associated asset or liability related to the open hedge instrument is recorded in Prepaid expenses and Other current assets or Other current liabilities, as applicable.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records all derivative financial instruments on the balance sheet at fair value. Changes in a derivative&#8217;s fair value are recognized in earnings unless specific hedge criteria are met. If the derivative is designated as a fair value hedge, the changes in the fair value of the derivative and of the hedged item attributable to the hedged risk are recognized in Net (loss) income. If the derivative is designated as a cash flow hedge, the effective portions of changes in the fair value of the derivative are recorded in Accumulated other comprehensive income (loss) (&#8220;AOCI&#8221;) in the accompanying Consolidated Balance Sheets and are subsequently recognized in Net (loss) income when the hedged item affects earnings. Ineffective portions of changes in the fair value of cash flow hedges, if any, are recognized as a charge or credit to earnings.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:InternalUseSoftwarePolicy" id="f-629" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Software Costs</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes direct internal and external development costs for certain significant projects associated with internal-use software and amortizes these costs over <ix:nonNumeric contextRef="c-1" name="iff:AmortizationPeriodOfInternalAndExternalDevelopmentCosts" format="ixt-sec:durwordsen" id="f-630">seven years</ix:nonNumeric>. Neither preliminary evaluation costs nor costs associated with the software after implementation are capitalized. Costs related to projects that are not significant are expensed as incurred.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerSharePolicyTextBlock" id="f-631" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net (Loss) Income Per Share</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the two-class method, earnings are adjusted by accretion of amounts to redeemable non-controlling interests recorded at redemption value. The adjustments represent in-substance dividend distributions to the non-controlling interest holders as the holders have a contractual right to receive a specified amount upon redemption. As a result, earnings are adjusted to reflect this in-substance distribution that is different from other common shareholders.&#160;In addition, the Company has unvested share based payment awards with a right to receive nonforfeitable dividends and thus are considered participating securities which are required to be included in the computation of basic and diluted earnings per share.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic (loss) income per share represents the amount of earnings available to each share of common stock outstanding during the period. Basic (loss) income per share includes the effect of issuing shares of common stock, where (i) for 2021, the prepaid stock purchase contracts (&#8220;SPCs&#8221;) were converted using the final settlement rate on September 14, 2021 (see Note 11 for additional information), and (ii) an adjustment to (loss) income to reflect adjustments made to record the redeemable value of redeemable non-controlling interests. Diluted (loss) income per share also includes the effect of issuing shares of common stock, assuming (i) stock options and warrants are exercised, (ii) restricted stock units are fully vested under the treasury stock method, and (iii) for 2021, the incremental effect of the prepaid SPCs were converted using the final settlement rate on September 14, 2021 (see Note 11 for additional information).</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:CompensationRelatedCostsPolicyTextBlock" id="f-632" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation cost of all stock-based awards is measured at fair value on the date of grant and recognized over the service period for which awards are expected to vest. The cost of such stock-based awards is principally recognized on a straight-line attribution basis over their respective vesting periods, net of estimated forfeitures.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:DebtPolicyTextBlock" id="f-633" continuedAt="f-633-1" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financing Costs</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs incurred in the issuance of debt are deferred and amortized as part of interest expense over the stated life of the applicable debt instrument. Unamortized deferred financing costs relating to debt are presented as a reduction in the amount of </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:continuation id="f-500-7" continuedAt="f-500-8"><ix:continuation id="f-633-1"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">debt outstanding on the Consolidated Balance Sheets. Unamortized deferred financing costs relating to the revolving credit facility are recorded in Other assets on the Consolidated Balance Sheets.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" id="f-634" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Redeemable Non-controlling Interests</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-controlling interests in subsidiaries that are redeemable for cash or other assets outside of the Company&#8217;s control are classified as mezzanine equity, outside of equity and liabilities, at the greater of the carrying value or the redemption value. The increases or decreases in the estimated redemption amount are recorded with corresponding adjustments against Capital in excess of par value and are reflected in the computation of earnings per share using the two-class method. As of December 31, 2023, the Company has acquired or sold all of its remaining redeemable non-controlling interests. See Note 20 for additional information.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy" id="f-635" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Held for Sale</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities to be disposed of by sale (&#8220;disposal groups&#8221;) are reclassified into assets and liabilities held for sale on the Company&#8217;s Consolidated Balance Sheets. The reclassification occurs when an agreement to sell exists, or management has committed to a plan to sell the assets within one year. Disposal groups are measured at the lower of carrying value or fair value less costs to sell and are not depreciated or amortized. When the net realizable value of a disposal group increases during a period, a gain can be recognized to the extent that it does not increase the value of the disposal group beyond its original carrying value when the disposal group was reclassified as held for sale. The fair value of a disposal group, less any costs to sell, is assessed each reporting period it remains classified as held for sale and any remeasurement to the lower of carrying value or fair value less costs to sell is reported as an adjustment to the carrying value of the disposal group. See Note 21 for additional information.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="iff:SupplierFinanceProgramPolicyPolicyTextBlock" id="f-636" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supply Chain Financing Program</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2023, the Company entered into a supply chain financing (&#8220;SCF&#8221;) program. The program is expected to be available to U.S. based suppliers starting in the second quarter of 2024. The Company makes continuous efforts to improve working capital efficiency and has worked with suppliers to optimize payment terms and conditions. The Company&#8217;s current payment terms with a majority of suppliers generally range from 0 to 180 days, which is deemed to be commercially reasonable. The Company&#8217;s voluntary SCF program will allow its suppliers to elect to sell the receivables owed to them by the Company to a third-party financial institution. The suppliers, at their own discretion, will determine the invoices they want to sell and directly negotiate the arrangements with the participating third-party financial institution. Supplier participation in the program is solely the decision of the supplier and has no bearing on the Company&#8217;s payment terms and amounts due with the supplier. The Company&#8217;s responsibility will be limited to making payments based upon the agreed upon contractual terms and arrangements. The Company will not provide any form of guarantees under the SCF program and will have no economic interest in the suppliers&#8217; decision to participate in the SCF program. Amounts due to suppliers that elect to participate in the SCF program will be included in Accounts payable on the Consolidated Balance Sheets. The Company, or the third-party financial institution, may choose to terminate the agreement of the program at any time upon 30 days&#8217; prior written notice. The third-party financial institution may also terminate the agreement of the program at any time upon three business days&#8217; prior written notice in the event there are insufficient funds available for disbursements. As of December&#160;31, 2023 and 2022, there were <ix:nonFraction unitRef="usd" contextRef="c-11" decimals="INF" name="us-gaap:SupplierFinanceProgramObligation" format="ixt-sec:numwordsen" scale="6" id="f-637"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="INF" name="us-gaap:SupplierFinanceProgramObligation" format="ixt-sec:numwordsen" scale="6" id="f-638">no</ix:nonFraction></ix:nonFraction> amounts outstanding related to suppliers&#8217; participation in the SCF program.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="f-639" continuedAt="f-639-1" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2023-09, &#8220;Income Taxes (Topic 740): Improvements to Income Tax Disclosures.&#8221; The ASU was issued to further enhance income tax disclosures, primarily through standardization and disaggregation of rate reconciliation categories and income taxes paid by jurisdiction. This guidance is effective for fiscal years beginning after December 15, 2024, with early adoption permitted, and may be applied either prospectively or retrospectively. The Company is currently evaluating the impact that this guidance will have on its Consolidated Financial Statements and income tax disclosures.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the FASB issued ASU 2023-07, &#8220;Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.&#8221; The ASU intends to improve reportable segment disclosure requirements, primarily through enhanced disclosures of significant segment expenses that are regularly provided to the Chief Operating Decision Maker and included within segment profit and loss. This guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted, and applied retrospectively to all prior periods presented in the financial statements. The Company is currently evaluating the impact that this guidance will have on its Consolidated Financial Statements and reportable segment disclosures.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:continuation id="f-639-1"><ix:continuation id="f-500-8"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, the FASB issued ASU 2022-06, &#8220;Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848.&#8221; The ASU was issued to provide an update on ASU 2020-04 and ASU 2021-01 that were issued in March 2020 and January 2021, respectively, which provided optional accounting guidance for a limited period of time to ease the potential burden in accounting for reference rate reform. The guidance provides optional expedients and exceptions to existing accounting requirements for contract modifications and hedge accounting related to transitioning from discontinued reference rates, such as London Interbank Offered Rate (&#8220;LIBOR&#8221;), to alternative reference rates, if certain criteria are met. With the issuance of ASU 2022-06, the sunset date of Topic 848 has been deferred from December 31, 2022 to December 31, 2024, after which entities will no longer be permitted to apply the relief in Topic 848. The Company has adopted this guidance on January 1, 2023, which did not have a material impact on its Consolidated Financial Statements. On March 23, 2023, the Company amended certain existing debt agreements where the interest rate benchmark was updated from LIBOR to the Secured Overnight Financing Rate (&#8220;Term SOFR&#8221;). The Company applied Topic 848 to its recent amendments of its debt agreements. See Note 9 for additional information on the amendments to the debt agreements.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, the FASB issued ASU 2022-04, &#8220;Liabilities - Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations.&#8221; The ASU requires that a buyer in a supplier finance program disclose sufficient information about the program to allow users of the financial statements to understand the program&#8217;s nature, activity during the period, changes from period to period and potential magnitude. The buyer should disclose qualitative and quantitative information about its supplier finance programs. The ASU requires the buyer&#8217;s annual disclosure to include a roll forward of the obligations under the supplier finance programs during the annual period, including the amount of obligations confirmed and subsequently paid. This guidance is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the amendment on roll forward information, which is effective for fiscal years beginning after December 15, 2023, and early adoption is permitted. The Company has adopted this guidance on January 1, 2023, which did not have a material impact on its Consolidated Financial Statements.</span></div></ix:continuation></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_124"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 2.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="f-640" continuedAt="f-640-1" escape="true">RESTRUCTURING AND OTHER CHARGES</ix:nonNumeric></span></div><ix:continuation id="f-640-1" continuedAt="f-640-2"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring and other charges primarily consist of separation costs for employees including severance, outplacement and other employee benefit costs (&#8220;Severance&#8221;), charges related to the write-down of fixed assets of plants to be closed (&#8220;Fixed asset write-down&#8221;) and all other related restructuring (&#8220;Other&#8221;) costs. All restructuring and other charges are separately stated on the Consolidated Statements of (Loss) Income and Comprehensive Loss.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Frutarom Integration Initiative</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the acquisition of Frutarom, the Company executed an integration plan that, among other initiatives, sought to optimize its manufacturing network (the &#8220;Frutarom Integration Initiative&#8221;). Since the inception of the initiative, the Company closed <ix:nonFraction unitRef="facility" contextRef="c-86" decimals="INF" name="iff:RestructuringAndRelatedCostNumberOfSitesClosed" scale="0" id="f-641">22</ix:nonFraction> sites and expensed total costs of approximately $<ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-6" name="us-gaap:RestructuringAndRelatedCostCostIncurredToDate1" format="ixt:num-dot-decimal" scale="6" id="f-642">36</ix:nonFraction> million. As of the first quarter of 2023, the Frutarom Integration Initiative was completed.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2019 Severance Program</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2019, the Company incurred severance charges related to approximately <ix:nonFraction unitRef="position" contextRef="c-88" decimals="INF" name="us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated" scale="0" id="f-643">190</ix:nonFraction> headcount reductions, excluding those previously mentioned under the Frutarom Integration Initiative. The headcount reductions were primarily related to the Scent segment associated with the establishment of a new shared service center in Europe. Since the program&#8217;s inception, the Company expensed approximately $<ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-6" name="us-gaap:RestructuringAndRelatedCostCostIncurredToDate1" format="ixt:num-dot-decimal" scale="6" id="f-644">15</ix:nonFraction> million. As of the third quarter of 2022, the program was completed.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N&amp;B Merger Restructuring Liability</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2023, the Company incurred approximately $<ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-6" name="us-gaap:RestructuringReserveAccrualAdjustment1" format="ixt:num-dot-decimal" scale="6" id="f-645">2</ix:nonFraction> million of charges related to a lease impairment. Since the inception of the restructuring activities, there have been a total of approximately <ix:nonFraction unitRef="position" contextRef="c-91" decimals="INF" name="us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated" scale="0" id="f-646">215</ix:nonFraction> headcount reductions and the Company has expensed approximately $<ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-6" name="us-gaap:RestructuringAndRelatedCostCostIncurredToDate1" format="ixt:num-dot-decimal" scale="6" id="f-647">47</ix:nonFraction>&#160;million. As of December 31, 2023, the restructuring activities were completed related to employee exits. The Company continues to evaluate its owned and leased properties following the Merger with N&amp;B and may incur additional costs to further consolidate its footprint.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restructuring Program</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, the Company announced a restructuring program mainly related to headcount reduction to improve its organizational and operating structure, drive efficiencies and achieve cost savings. For the year ended December 31, 2023, the Company incurred approximately $<ix:nonFraction unitRef="usd" contextRef="c-93" decimals="-6" name="us-gaap:SeveranceCosts1" format="ixt:num-dot-decimal" scale="6" id="f-648">70</ix:nonFraction> million of charges related to severance and there have been a total of approximately <ix:nonFraction unitRef="position2" contextRef="c-93" decimals="INF" name="us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated" scale="0" id="f-649">680</ix:nonFraction> actual and planned headcount reductions.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:continuation id="f-640-2" continuedAt="f-640-3"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Restructuring Liability</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="f-650" continuedAt="f-650-1" escape="true"><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in restructuring liabilities during 2021, 2022 and 2023 were as follows:</span></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:33.599%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.541%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.519%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at January 1, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Additional Charges (Reversals), Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-Cash Charges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Payments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Frutarom Integration Initiative</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="f-651">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-6" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="6" id="f-652">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" format="ixt:fixed-zero" scale="6" id="f-653">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="f-654">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="f-655">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed asset write down</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:fixed-zero" scale="6" id="f-656">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-6" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="6" id="f-657">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="f-658">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-6" name="us-gaap:PaymentsForRestructuring" format="ixt:fixed-zero" scale="6" id="f-659">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:fixed-zero" scale="6" id="f-660">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="f-661">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-6" name="us-gaap:RestructuringReserveAccrualAdjustment1" format="ixt:fixed-zero" scale="6" id="f-662">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" format="ixt:fixed-zero" scale="6" id="f-663">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-6" name="us-gaap:PaymentsForRestructuring" format="ixt:fixed-zero" scale="6" id="f-664">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="f-665">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">2019 Severance Program</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="f-666">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-6" name="us-gaap:RestructuringReserveAccrualAdjustment1" format="ixt:fixed-zero" scale="6" id="f-667">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" format="ixt:fixed-zero" scale="6" id="f-668">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="f-669">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="f-670">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Other Restructuring Charges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="f-671">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-6" name="us-gaap:RestructuringReserveAccrualAdjustment1" format="ixt:fixed-zero" scale="6" id="f-672">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" format="ixt:fixed-zero" scale="6" id="f-673">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="f-674">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="f-675">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:fixed-zero" scale="6" id="f-676">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-6" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="6" id="f-677">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" format="ixt:fixed-zero" scale="6" id="f-678">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="f-679">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:fixed-zero" scale="6" id="f-680">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">N&amp;B Merger Restructuring Liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:fixed-zero" scale="6" id="f-681">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-6" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="6" id="f-682">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" format="ixt:fixed-zero" scale="6" id="f-683">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="f-684">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="f-685">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:fixed-zero" scale="6" id="f-686">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-6" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="6" id="f-687">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="f-688">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-6" name="us-gaap:PaymentsForRestructuring" format="ixt:fixed-zero" scale="6" id="f-689">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:fixed-zero" scale="6" id="f-690">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Restructuring and other charges</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="f-691">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="6" id="f-692">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="f-693">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="f-694">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="f-695">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:33.599%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.541%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.519%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at January 1, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Additional Charges (Reversals), Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-Cash Charges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Payments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Frutarom Integration Initiative</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="f-696">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-6" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="6" id="f-697">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" format="ixt:fixed-zero" scale="6" id="f-698">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="f-699">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="f-700">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed asset write down</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:fixed-zero" scale="6" id="f-701">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-6" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="6" id="f-702">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="f-703">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-6" name="us-gaap:PaymentsForRestructuring" format="ixt:fixed-zero" scale="6" id="f-704">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:fixed-zero" scale="6" id="f-705">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="f-706">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-6" sign="-" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="6" id="f-707">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" format="ixt:fixed-zero" scale="6" id="f-708">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="f-709">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:fixed-zero" scale="6" id="f-710">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">2019 Severance Program</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="f-711">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-6" sign="-" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="6" id="f-712">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" format="ixt:fixed-zero" scale="6" id="f-713">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-6" name="us-gaap:PaymentsForRestructuring" format="ixt:fixed-zero" scale="6" id="f-714">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:fixed-zero" scale="6" id="f-715">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Other Restructuring Charges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="f-716">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-6" name="us-gaap:RestructuringReserveAccrualAdjustment1" format="ixt:fixed-zero" scale="6" id="f-717">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" format="ixt:fixed-zero" scale="6" id="f-718">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-6" name="us-gaap:PaymentsForRestructuring" format="ixt:fixed-zero" scale="6" id="f-719">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="f-720">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">N&amp;B Merger Restructuring Liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="f-721">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-6" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="6" id="f-722">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" format="ixt:fixed-zero" scale="6" id="f-723">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="f-724">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="f-725">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:fixed-zero" scale="6" id="f-726">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-6" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="6" id="f-727">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="f-728">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="f-729">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="f-730">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Restructuring and other charges</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="f-731">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="6" id="f-732">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="f-733">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="f-734">21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="f-735">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.503%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at January 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Additional Charges (Reversals), Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-Cash Charges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Payments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2023</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Frutarom Integration Initiative</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="f-736">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-6" sign="-" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="6" id="f-737">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" format="ixt:fixed-zero" scale="6" id="f-738">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="f-739">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:fixed-zero" scale="6" id="f-740">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Other Restructuring Charges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="f-741">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-6" sign="-" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="6" id="f-742">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" format="ixt:fixed-zero" scale="6" id="f-743">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-6" name="us-gaap:PaymentsForRestructuring" format="ixt:fixed-zero" scale="6" id="f-744">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:fixed-zero" scale="6" id="f-745">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">N&amp;B Merger Restructuring Liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="f-746">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-6" name="us-gaap:RestructuringReserveAccrualAdjustment1" format="ixt:fixed-zero" scale="6" id="f-747">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" format="ixt:fixed-zero" scale="6" id="f-748">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="f-749">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:fixed-zero" scale="6" id="f-750">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="f-751">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-6" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="6" id="f-752">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="f-753">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="f-754">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:fixed-zero" scale="6" id="f-755">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">2023 Restructuring Program</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:fixed-zero" scale="6" id="f-756">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-6" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="6" id="f-757">70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" format="ixt:fixed-zero" scale="6" id="f-758">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="f-759">56</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="f-760">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Restructuring and other charges</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="f-761">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="6" id="f-762">68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="f-763">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="f-764">67</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="f-765">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:continuation id="f-650-1"><ix:continuation id="f-640-3"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes supplier contract termination costs, consulting and advisory fees.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes charges related to legal settlement costs.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes lease impairment charges and losses incurred from restructuring activities related to the Merger with N&amp;B.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Charges by Segment</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the total amount of costs incurred in connection with these restructuring programs and activities by segment:</span></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:59.047%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.694%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.694%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.695%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nourish</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="f-766">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="f-767">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="f-768">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health &amp; Biosciences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="f-769">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="f-770">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="f-771">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Scent</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="f-772">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="f-773">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="f-774">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharma Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="f-775">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="f-776">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="f-777">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Restructuring and other charges</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="f-778">68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="f-779">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="f-780">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_127"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 3.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="f-781" continuedAt="f-781-1" escape="true">ACQUISITIONS</ix:nonNumeric></span></div><ix:continuation id="f-781-1" continuedAt="f-781-2"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisition of Health Wright Products, Inc.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2022 (&#8220;Acquisition Date&#8221;), the Company completed its acquisition of Health Wright Products, Inc. (&#8220;Health Wright&#8221;). IFF acquired <ix:nonFraction unitRef="number" contextRef="c-154" decimals="INF" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="f-782">100</ix:nonFraction>% of the equity of Health Wright pursuant to a purchase agreement entered into on February 16, 2022. Health Wright is known in the consumer Health and Nutrition industries for providing high quality nutritional supplements. The acquisition was made in order to strengthen formulation and finished format capabilities to IFF&#8217;s Health &amp; Biosciences probiotics, natural extracts and botanical businesses.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition was accounted for under the purchase method. The fair value of consideration transferred was approximately $<ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="f-783">157</ix:nonFraction> million, including cash and estimated contingent consideration of $<ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="f-784">31</ix:nonFraction> million. The purchase price allocation was performed and resulted in intangible assets of approximately $<ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-785">75</ix:nonFraction> million, and approximately $<ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-786">45</ix:nonFraction> million of goodwill (which is deductible for income tax purposes). The intangible assets primarily consisted of customer relationships of approximately $<ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-787">74</ix:nonFraction> million that have been fair valued using the Multi-Period Excess Earning Method and which are being amortized over a period of approximately <ix:nonNumeric contextRef="c-156" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-788">19</ix:nonNumeric> years.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purchase price allocation was finalized as of the end of 2022 when the Company finalized the valuation of the acquired goodwill, intangible assets (trade names and customer relationships) and inventory, in addition to ensuring all other assets and liabilities and contingencies have been identified and recorded. The measurement period adjustments were recorded during the year ended December 31, 2022.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2022, the Company remeasured the fair value of contingent consideration obligations, and, as a result, recognized a credit of approximately $<ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="f-789">5</ix:nonFraction> million presented in Selling and administrative expenses on the Consolidated Statements of (Loss) Income and Comprehensive Loss. The reduction in the fair value of contingent consideration primarily resulted from changes in the probability assessment of achieving the performance targets. As of December 31, 2022, there was approximately $<ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-6" name="iff:EarnOutsPayableOther" format="ixt:num-dot-decimal" scale="6" id="f-790">26</ix:nonFraction>&#160;million of earnout liabilities presented in Other liabilities on the Consolidated Balance Sheets.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2023, the Company remeasured the fair value of contingent consideration obligations, and, as a result, recognized an expense of approximately $<ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="f-791">6</ix:nonFraction>&#160;million presented in Selling and administrative expenses on the Consolidated Statements of (Loss) Income and Comprehensive Loss. As of December 31, 2023, there was approximately $<ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-6" name="iff:EarnOutsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="f-792">32</ix:nonFraction>&#160;million of earnout liabilities presented in Other current liabilities on the Consolidated Balance Sheets.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No pro forma information for 2022 was presented as the acquisition was not material to the Consolidated Financial Statements.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Transaction with Nutrition &amp; Biosciences, Inc.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 1, 2021, IFF completed the Merger with N&amp;B. Pursuant to the transaction related agreements, DuPont transferred its N&amp;B Business to N&amp;B, a wholly-owned subsidiary of DuPont, and N&amp;B merged with and into a wholly owned subsidiary of IFF in exchange for <ix:nonFraction unitRef="shares" contextRef="c-161" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-793">141,740,461</ix:nonFraction> shares of IFF common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="c-162" decimals="3" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-794">0.125</ix:nonFraction> per share (&#8220;IFF Common Stock&#8221;).</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:continuation id="f-781-2" continuedAt="f-781-3"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company completed its Merger with N&amp;B in a Reverse Morris Trust transaction (the &#8220;Transactions&#8221;), pursuant to which the Company acquired the N&amp;B Business of DuPont.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Transactions, among other steps (i) DuPont transferred the N&amp;B Business to N&amp;B (the &#8220;Separation&#8221;); (ii) N&amp;B made a cash distribution to DuPont of approximately $<ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="9" id="f-795">7.359</ix:nonFraction> billion, subject to certain adjustments (the &#8220;Special Cash Payment&#8221;); (iii) DuPont distributed to its stockholders all of the issued and outstanding shares of N&amp;B common stock by way of an exchange offer (the &#8220;Distribution&#8221;), and; (iv) N&amp;B merged with and into a wholly owned subsidiary of IFF. As a result of the Merger, the existing shares of N&amp;B common stock were automatically converted into the right to receive a number of shares of IFF Common Stock. Immediately after the Merger, holders of DuPont&#8217;s common stock that received shares of N&amp;B common stock in the Distribution owned approximately <ix:nonFraction unitRef="number" contextRef="c-163" decimals="3" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="f-796">55.4</ix:nonFraction>% of the outstanding shares of IFF Common Stock on a fully diluted basis and existing holders of IFF Common Stock owned approximately <ix:nonFraction unitRef="number" contextRef="c-164" decimals="3" name="us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction" scale="-2" id="f-797">44.6</ix:nonFraction>% of the outstanding shares of IFF on a fully diluted basis.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Merger was accounted for using the purchase method of accounting in accordance with ASC Topic 805, Business Combinations, with IFF identified as the acquirer. As a result of the Merger, N&amp;B&#8217;s assets, liabilities and the operating results of N&amp;B were included in the Company&#8217;s financial statements from the Closing Date. N&amp;B contributed net sales of approximately $<ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-6" name="iff:BusinessAcquisitionNetSales" format="ixt:num-dot-decimal" scale="9" id="f-798">6.084</ix:nonFraction> billion and net income of approximately $<ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-6" name="iff:BusinessAcquisitionNetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-799">11</ix:nonFraction> million for the year ended December&#160;31, 2021, which included the effects of purchase accounting adjustments, primarily related to changes in amortization of intangible assets, depreciation of property, plant and equipment and amortization of stepped up inventory.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Distribution, N&amp;B incurred new indebtedness in the form of term loans and senior notes in an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="9" id="f-800">7.500</ix:nonFraction> billion to pay the Special Cash Payment made to DuPont stockholders. See Note 9 for additional information regarding the term loans and senior notes incurred by N&amp;B and subsequently assumed by IFF.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Purchase Price</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="f-801" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the aggregate purchase price consideration paid to acquire N&amp;B (in millions, except share and per share data):</span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of common stock issued to DuPont stockholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" format="ixt:num-dot-decimal" scale="6" id="f-802">15,929</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value attributable to pre-merger service for replacement equity awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-6" name="iff:BusinessCombinationConsiderationTransferredReplacementEquityAwardsIssued" scale="6" id="f-803">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension funding adjustment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-6" name="iff:BusinessCombinationPensionFundingAdjustment" scale="6" id="f-804">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase consideration</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="f-805">15,942</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________&#160;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The fair value of common stock issued to DuPont stockholders represents <ix:nonFraction unitRef="shares" contextRef="c-161" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-806">141,740,461</ix:nonFraction> shares of the Company's common stock determined based on the number of fully diluted shares of IFF common stock, immediately prior to the Closing Date, multiplied by the quotient of <ix:nonFraction unitRef="number" contextRef="c-167" decimals="3" name="iff:DilutiveSharesQuotientMultiplier" scale="-2" id="f-807">55.4</ix:nonFraction>%/<ix:nonFraction unitRef="number" contextRef="c-168" decimals="3" name="iff:DilutiveSharesQuotientMultiplier" scale="-2" id="f-808">44.6</ix:nonFraction>% and IFF common stock closing share price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-169" decimals="INF" name="us-gaap:BusinessAcquisitionSharePrice" scale="0" id="f-809">112.38</ix:nonFraction> on the New York Stock Exchange on the Closing Date.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">At the time of the Transactions, each outstanding stock option, cash-settled stock appreciation right (&#8220;SAR&#8221;), restricted stock unit (&#8220;RSU&#8221;) award, and restricted stock award (&#8220;RSA&#8221;) with respect to DuPont common stock held by employees of N&amp;B were canceled and converted into similar classes of equity awards of IFF&#8217;s Class A Common Stock. Further, each outstanding Performance Share Unit (&#8220;PSU&#8221;) award with respect to DuPont common stock held by employees of N&amp;B were canceled and converted into IFF&#8217;s RSU awards. The conversion was based on the ratio of the volume-weighted average per share closing price of DuPont stock on the twenty trading days prior to the Closing Date and IFF&#8217;s stock on the twenty trading days following the Closing Date. The fair value of replacement equity-based awards attributable to pre-Merger service was recorded as part of the consideration transferred in the Merger (see Note 13 for additional information).</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Merger related agreements provided that if the net pension balance of N&amp;B as of the Closing Date differs from $<ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-6" name="iff:BusinessCombinationNetPensionBalanceDifferentialAmountSettledInCash" format="ixt:num-dot-decimal" scale="6" id="f-810">220</ix:nonFraction>&#160;million, such differential amount would be settled in cash. The Company estimated the amount that it would receive and, accordingly, made an adjustment of $<ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-6" name="iff:BusinessCombinationPensionFundingAdjustment" format="ixt:num-dot-decimal" scale="6" id="f-811">12</ix:nonFraction>&#160;million to the total purchase consideration.</span></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company incurred transaction-related costs of approximately $<ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-6" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="f-812">91</ix:nonFraction>&#160;million in 2021, which primarily consisted of merger and acquisition advisory, legal and professional fees.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pro Forma Financial Information</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following unaudited pro forma financial information presents the combined results of operations of IFF and N&amp;B as if the Merger had been completed as of January 1, 2020. The unaudited pro forma financial information is presented for informational purposes and is not indicative of the results of operations that would have been achieved if the Merger and related borrowings had taken place on January 1, 2020, nor are they indicative of future results. The unaudited pro forma financial information for the year ended December&#160;31, 2021 includes IFF results, including the post-Merger results of N&amp;B, since February 1, 2021, and pre-Merger results of N&amp;B for the period January 1, 2021 through January 31, 2021.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:continuation id="f-781-3"><ix:nonNumeric contextRef="c-1" name="us-gaap:BusinessAcquisitionProFormaInformationTextBlock" id="f-813" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma results for the year ended December&#160;31, 2021 were as follows:</span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.778%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unaudited pro forma net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-6" name="us-gaap:BusinessAcquisitionsProFormaRevenue" format="ixt:num-dot-decimal" scale="6" id="f-814">12,163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unaudited pro forma net income attributable to the Company</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-6" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" scale="6" id="f-815">687</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma results for all periods include adjustments made to account for certain costs and transactions that would have been incurred had the Merger been completed as of January 1, 2020, including amortization charges for acquired intangibles assets, adjustments for transaction costs, adjustments for depreciation expense for property, plant and equipment, inventory step-up and adjustments to interest expense. These adjustments are net of any applicable tax impact and were included to arrive at the pro forma results above.</span></div></ix:continuation><div><span><br/></span></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_130"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 4.    <ix:nonNumeric contextRef="c-1" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" id="f-816" continuedAt="f-816-1" escape="true">BUSINESS DIVESTITURES</ix:nonNumeric></span></div><ix:continuation id="f-816-1" continuedAt="f-816-2"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Divestiture of the Flavor Specialty Ingredients Business</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2022, the Company announced it had entered into an agreement to sell its Flavor Specialty Ingredients (&#8220;FSI&#8221;) business, which was a part of the Scent segment. The Company completed the divestiture on August 1, 2023 and received cash proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="6" id="f-817">205</ix:nonFraction> million, which included $<ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-6" name="iff:DisposalGroupIncludingDiscontinuedOperationAdvanceReceiptForBusinessToBeTransferred" format="ixt:num-dot-decimal" scale="6" id="f-818">1</ix:nonFraction> million related to the delayed transfer of the control of specific assets and liabilities of non-U.S. jurisdiction business. In addition, approximately $<ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-6" name="iff:DisposalGroupIncludingDiscontinuedOperationAmountHeldInEscrow" format="ixt:num-dot-decimal" scale="6" id="f-819">15</ix:nonFraction> million of proceeds were held in escrow and have been released upon satisfaction of certain conditions. Concurrent with the completion of the business divestiture, the Company entered into a supply agreement arrangement with the buyer. Based on the terms of the supply agreement, an adjustment of $<ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-6" name="iff:DisposalGroupIncludingDiscontinuedOperationProceedsAttributableToSupplyAgreement" format="ixt:num-dot-decimal" scale="6" id="f-820">4</ix:nonFraction> million was made against the fair value of sale consideration. The sale consideration is subject to certain post-closing adjustments, which is primarily related to cash, indebtedness and working capital balances.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="f-821" continuedAt="f-821-1" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of sale consideration received in connection with the business divestiture:</span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:68.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.208%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash proceeds from the buyer</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-6" name="iff:ProceedsFromDivestitureOfBusinessesGross" scale="6" id="f-822">205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advance receipt for business to be transferred</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-6" name="iff:DisposalGroupIncludingDiscontinuedOperationAdvanceReceiptForBusinessToBeTransferred" scale="6" id="f-823">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct costs to sell</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-6" name="iff:DisposalGroupIncludingDiscontinuedOperationTransactionCost" scale="6" id="f-824">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds attributable to supply agreement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-6" name="iff:DisposalGroupIncludingDiscontinuedOperationProceedsAttributableToSupplyAgreement" scale="6" id="f-825">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of sale consideration</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" scale="6" id="f-826">195</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net proceeds received from the business divestiture presented under Cash flows from investing activities represent the cash portion of the sale consideration, which was determined as the fair value of sale consideration adjusted by the direct costs to sell, advance receipt for business to be transferred and the cash transferred to the buyer as part of the transaction. <ix:continuation id="f-821-1" continuedAt="f-821-2">The following table summarizes the different components of net proceeds received from business divestiture presented under Cash flows from investing activities:</ix:continuation></span></div><ix:continuation id="f-821-2" continuedAt="f-821-3"><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:68.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.208%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of sale consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" scale="6" id="f-827">195</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct costs to sell</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-6" name="iff:DisposalGroupIncludingDiscontinuedOperationTransactionCostCredits" scale="6" id="f-828">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advance receipt for business to be transferred</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-6" name="iff:DisposalGroupIncludingDiscontinuedOperationConsiderationAdvanceReceiptForBusinessToBeTransferred" scale="6" id="f-829">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash transferred to the buyer</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-6" sign="-" name="iff:DisposalGroupIncludingDiscontinuedOperationCashTransferredToBuyer" scale="6" id="f-830">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net proceeds received from business divestiture</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-6" name="iff:ProceedsFromDivestitureOfBusinessNet" scale="6" id="f-831">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount of net assets associated with the business unit, adjusted for currency translation adjustment, was approximately $<ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-6" name="iff:DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNetAsset" format="ixt:num-dot-decimal" scale="6" id="f-832">205</ix:nonFraction> million. <ix:continuation id="f-821-3" continuedAt="f-821-4">The major classes of assets and liabilities sold consisted of the following:</ix:continuation></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:continuation id="f-816-2" continuedAt="f-816-3"><ix:continuation id="f-821-4" continuedAt="f-821-5"><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:68.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.208%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">August 1, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-833">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-6" name="us-gaap:ReceivablesNetCurrent" scale="6" id="f-834">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-6" name="us-gaap:InventoryNet" scale="6" id="f-835">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="f-836">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-6" name="us-gaap:Goodwill" scale="6" id="f-837">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-838">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="f-839">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-6" name="us-gaap:Assets" scale="6" id="f-840">215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-6" name="us-gaap:AccountsPayableCurrent" scale="6" id="f-841">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="f-842">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="f-843">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-6" name="us-gaap:Liabilities" scale="6" id="f-844">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive income - currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="f-845">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="f-846">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of net assets (adjusted for currency translation adjustment)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-6" name="iff:DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNetAsset" scale="6" id="f-847">205</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the business divestiture, the Company recognized a pre-tax loss of approximately $<ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-6" sign="-" name="iff:DisposalGroupNotDiscontinuedOperationGainLossOnDisposalBeforeIncomeTax" format="ixt:num-dot-decimal" scale="6" id="f-848">10</ix:nonFraction> million, subject to certain post-closing adjustments, presented in Other expense (income), net on the Consolidated Statements of (Loss) Income and Comprehensive Loss for the year ended December 31, 2023. The Company has also recognized income tax effects associated with the business divestiture across multiple periods. The total income tax expense recognized was approximately $<ix:nonFraction unitRef="usd" contextRef="c-173" decimals="-6" name="iff:DisposalGroupNotDiscontinuedOperationTaxEffectOfGainLossFromDivestiture" format="ixt:num-dot-decimal" scale="6" id="f-849">21</ix:nonFraction> million, with approximately $<ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-6" name="iff:DisposalGroupNotDiscontinuedOperationTaxEffectOfGainLossFromDivestiture" format="ixt:num-dot-decimal" scale="6" id="f-850">3</ix:nonFraction> million that was recognized during the year ended December 31, 2022.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Divestiture of a Portion of the Savory Solutions Business</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2022, the Company announced it had entered into an agreement to sell a portion of its Savory Solutions business, which was part of the Nourish segment. The Company completed the divestiture on May 31, 2023 and received cash proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-175" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="6" id="f-851">840</ix:nonFraction> million. In addition, a receivable of approximately $<ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-6" name="iff:DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" format="ixt:num-dot-decimal" scale="6" id="f-852">37</ix:nonFraction> million was recorded, which reflected the remaining sale consideration that was received in January 2024.</span></div><ix:continuation id="f-821-5" continuedAt="f-821-6"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of sale consideration received in connection with the business divestiture:</span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:68.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.208%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash proceeds from the buyer</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-6" name="iff:ProceedsFromDivestitureOfBusinessesGross" scale="6" id="f-853">840</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivable from the buyer</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-6" name="iff:DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" scale="6" id="f-854">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct costs to sell</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-6" name="iff:DisposalGroupIncludingDiscontinuedOperationTransactionCost" scale="6" id="f-855">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of sale consideration</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" scale="6" id="f-856">857</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net proceeds received from the business divestiture presented under Cash flows from investing activities represent the cash portion of the sale consideration, which was determined as the fair value of sale consideration adjusted by the amount receivable from the buyer, direct costs to sell and the cash transferred to the buyer as part of the transaction. <ix:continuation id="f-821-6" continuedAt="f-821-7">The following table summarizes the different components of net proceeds received from business divestiture presented under Cash flows from investing activities:</ix:continuation></span></div><ix:continuation id="f-821-7" continuedAt="f-821-8"><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:68.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.208%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of sale consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" scale="6" id="f-857">857</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct costs to sell</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-6" name="iff:DisposalGroupIncludingDiscontinuedOperationTransactionCostCredits" scale="6" id="f-858">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivable from the buyer</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-6" sign="-" name="iff:DisposalGroupIncludingDiscontinuedOperationConsiderationPayableReceivable" scale="6" id="f-859">37</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash transferred to the buyer (including restricted cash)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-6" sign="-" name="iff:DisposalGroupIncludingDiscontinuedOperationCashTransferredToBuyer" scale="6" id="f-860">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net proceeds received from business divestiture</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-6" name="iff:ProceedsFromDivestitureOfBusinessNet" scale="6" id="f-861">821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:continuation id="f-816-3" continuedAt="f-816-4"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount of net assets associated with the business unit, adjusted for currency translation and pension adjustments, was approximately $<ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-6" name="iff:DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNetAsset" format="ixt:num-dot-decimal" scale="6" id="f-862">860</ix:nonFraction> million. <ix:continuation id="f-821-8" continuedAt="f-821-9">The major classes of assets and liabilities sold consisted of the following:</ix:continuation></span></div><ix:continuation id="f-821-9" continuedAt="f-821-10"><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:68.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.208%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">May 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-863">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-6" name="us-gaap:RestrictedCashCurrent" scale="6" id="f-864">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-6" name="us-gaap:ReceivablesNetCurrent" scale="6" id="f-865">69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-6" name="us-gaap:InventoryNet" scale="6" id="f-866">116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="f-867">77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-6" name="us-gaap:Goodwill" scale="6" id="f-868">317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-869">367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="f-870">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="f-871">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-872">1,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-6" name="us-gaap:AccountsPayableCurrent" scale="6" id="f-873">44</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="f-874">92</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="f-875">54</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-6" name="us-gaap:Liabilities" scale="6" id="f-876">190</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive income - currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="f-877">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive income - pension liability and postretirement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-6" sign="-" name="iff:AccumulatedOtherComprehensiveIncomeLossPensionLiabilityAndPostretirementAfterTax" scale="6" id="f-878">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="f-879">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of net assets (adjusted for currency translation and pension adjustments)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-6" name="iff:DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNetAsset" scale="6" id="f-880">860</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the business divestiture, the Company recognized a pre-tax loss of approximately $<ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-6" sign="-" name="iff:DisposalGroupNotDiscontinuedOperationGainLossOnDisposalBeforeIncomeTax" format="ixt:num-dot-decimal" scale="6" id="f-881">3</ix:nonFraction> million presented in Other expense (income), net on the Consolidated Statements of (Loss) Income and Comprehensive Loss for the year ended December 31, 2023. The Company has also recognized income tax effects associated with the business divestiture across multiple periods. The total income tax expense recognized was approximately $<ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-6" name="iff:DisposalGroupNotDiscontinuedOperationTaxEffectOfGainLossFromDivestiture" format="ixt:num-dot-decimal" scale="6" id="f-882">108</ix:nonFraction> million, with approximately $<ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-6" name="iff:DisposalGroupNotDiscontinuedOperationTaxEffectOfGainLossFromDivestiture" format="ixt:num-dot-decimal" scale="6" id="f-883">72</ix:nonFraction> million that was recognized during the year ended December 31, 2022.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liquidation of a Business in Russia</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the liquidation of a business in Russia for the sale of the portion of the Savory Solutions business, the Company recognized a pre-tax loss of approximately $<ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-6" sign="-" name="iff:DisposalGroupNotDiscontinuedOperationGainLossOnLiquidationBeforeIncomeTax" format="ixt:num-dot-decimal" scale="6" id="f-884">10</ix:nonFraction>&#160;million presented in the Other expense (income), net, and tax benefits of approximately $<ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-6" name="iff:DisposalGroupNotDiscontinuedOperationLiquidationTaxEffect" format="ixt:num-dot-decimal" scale="6" id="f-885">2</ix:nonFraction>&#160;million presented in Provision for income taxes on the Consolidated Statements of (Loss) Income and Comprehensive Loss for the year ended December 31, 2023.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Divestiture of Microbial Control</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, the Company announced it had entered into an agreement to sell its Microbial Control business unit, which was a part of the Health &amp; Biosciences segment. The Company acquired the Microbial Control business unit as part of the Merger with N&amp;B.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company completed the divestiture on July 1, 2022 and received cash proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="9" id="f-886">1.254</ix:nonFraction> billion, of which approximately $<ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-6" name="iff:TransitionServicesAgreementFairValue" format="ixt:num-dot-decimal" scale="6" id="f-887">36</ix:nonFraction> million was attributable to future services to be provided under certain transition service agreements as described below. Certain transaction costs related to the divestiture of approximately $<ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-6" name="iff:DisposalGroupIncludingDiscontinuedOperationTransactionCost" format="ixt:num-dot-decimal" scale="6" id="f-888">11</ix:nonFraction> million, which was contingent upon the consummation of the divestiture, were determined to be direct costs to sell and, as such, were adjusted against the fair value of the sale consideration. In addition, approximately $<ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-6" name="us-gaap:EscrowDeposit" format="ixt:num-dot-decimal" scale="6" id="f-889">15</ix:nonFraction> million of cash proceeds held in escrow were released to the Company upon satisfaction of certain conditions. The sale consideration was further reduced by approximately $<ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-6" sign="-" name="iff:DisposalGroupIncludingDiscontinuedOperationPostClosingAdjustments" format="ixt:num-dot-decimal" scale="6" id="f-890">3</ix:nonFraction> million for certain post-closing adjustments, which were primarily related to cash, indebtedness and working capital balances.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company entered into transition services agreements with the buyer for providing certain general accounting, information technology and other services up to <ix:nonNumeric contextRef="c-180" name="iff:TransitionServicesAgreementTerm" format="ixt-sec:durmonth" id="f-891">19</ix:nonNumeric> months following the date of the sale for minimal consideration. The fair value of these transition services agreements was determined to be approximately $<ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-6" name="iff:TransitionServicesAgreementFairValue" format="ixt:num-dot-decimal" scale="6" id="f-892">36</ix:nonFraction> million, which was adjusted against the sale consideration and recognized as deferred transition services income.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:continuation id="f-816-4" continuedAt="f-816-5"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2023 and 2022, the transition services income under the transition services agreements were approximately $<ix:nonFraction unitRef="usd" contextRef="c-182" decimals="-6" name="iff:TransitionServicesAgreementIncomeReductionToCostsNotIncludedInRevenue" format="ixt:num-dot-decimal" scale="6" id="f-893">25</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-6" name="iff:TransitionServicesAgreementIncomeReductionToCostsNotIncludedInRevenue" format="ixt:num-dot-decimal" scale="6" id="f-894">11</ix:nonFraction>&#160;million, respectively, and was recognized as a reduction to the costs incurred to provide services under the transition services agreements, which was included in Selling and administrative expenses on the Consolidated Statements of (Loss) Income and Comprehensive Loss.</span></div><ix:continuation id="f-821-10" continuedAt="f-821-11"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of the sale consideration received in connection with the business divestiture:</span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:68.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.208%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash proceeds from the buyer</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-6" name="iff:ProceedsFromDivestitureOfBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="f-895">1,254</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Escrow proceeds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-6" name="us-gaap:EscrowDeposit" scale="6" id="f-896">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds attributable to transition service agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-6" name="iff:TransitionServicesAgreementFairValue" scale="6" id="f-897">36</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct costs to sell</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-6" name="iff:DisposalGroupIncludingDiscontinuedOperationTransactionCost" scale="6" id="f-898">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash settlement for post-closing adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-6" sign="-" name="iff:DisposalGroupIncludingDiscontinuedOperationPostClosingAdjustments" scale="6" id="f-899">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of sale consideration</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" format="ixt:num-dot-decimal" scale="6" id="f-900">1,219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net proceeds received from business divestiture presented under Cash flows from investing activities represent the cash portion of the sale consideration, which was determined as the fair value of sale consideration reduced by the amount held in escrow and the Cash transferred to the buyer on the closing balance sheet as part of the transaction. <ix:continuation id="f-821-11" continuedAt="f-821-12">The following table summarizes the different components of net proceeds received from business divestiture presented under Cash flows from investing activities:</ix:continuation></span></div><ix:continuation id="f-821-12" continuedAt="f-821-13"><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:68.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.208%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of sale consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" format="ixt:num-dot-decimal" scale="6" id="f-901">1,219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash transferred to the buyer on the closing balance sheet</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-6" sign="-" name="iff:CashTransferredToTheBuyerOnTheClosingBalanceSheet" scale="6" id="f-902">49</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee reimbursement receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-6" sign="-" name="iff:EmployeeReimbursementReceivable" scale="6" id="f-903">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net proceeds received from business divestiture</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-6" name="iff:ProceedsFromDivestitureOfBusinessNet" format="ixt:num-dot-decimal" scale="6" id="f-904">1,169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount of net assets associated with the Microbial Control business unit was approximately $<ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-6" name="iff:DisposalGroupIncludingDiscontinuedOperationNetAssets" format="ixt:num-dot-decimal" scale="9" id="f-905">1.208</ix:nonFraction> billion. The major classes of assets and liabilities sold consisted of the following:</span></div><ix:continuation id="f-821-13" continuedAt="f-821-14"><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:68.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.208%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="f-906">263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and other intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-6" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" scale="6" id="f-907">867</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="f-908">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets" scale="6" id="f-909">80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="6" id="f-910">1,284</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayable" scale="6" id="f-911">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" scale="6" id="f-912">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" scale="6" id="f-913">76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of net assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-6" name="iff:DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNetAsset" format="ixt:num-dot-decimal" scale="6" id="f-914">1,208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the business divestiture, the Company recognized a pre-tax gain of approximately $<ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-6" name="us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" format="ixt:num-dot-decimal" scale="6" id="f-915">11</ix:nonFraction>&#160;million presented in Other expense (income), net on the Consolidated Statements of (Loss) Income and Comprehensive Loss for the year ended December 31, 2022. The Company also recognized the income tax expense associated with the divestiture of approximately $<ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-6" name="iff:DisposalGroupNotDiscontinuedOperationTaxEffectOfGainLossFromDivestiture" format="ixt:num-dot-decimal" scale="6" id="f-916">96</ix:nonFraction>&#160;million during the year ended December 31, 2022.</span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 71</span></div></div></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_133"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 5.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="f-917" continuedAt="f-917-1" escape="true">PROPERTY, PLANT AND EQUIPMENT, NET</ix:nonNumeric></span></div><ix:continuation id="f-917-1"><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="f-918" escape="true"><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment, net consisted of the following amounts:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-919">195</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-920">199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-187" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="f-921">1,822</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="f-922">1,697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="f-923">3,752</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-190" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="f-924">3,344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Information technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-925">473</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-192" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-926">291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-193" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-927">400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-194" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-928">649</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="f-929">6,642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="f-930">6,180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-931">2,402</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-932">1,977</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Property, plant and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="f-933">4,240</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="f-934">4,203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Depreciation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="f-935">462</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="f-936">452</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="f-937">424</ix:nonFraction> million for the years ended December 31, 2023, 2022 and 2021, respectively.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairment of Property, Plant and Equipment</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 1, for the year ended December 31, 2022, an impairment charge of approximately $<ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-6" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="f-938">28</ix:nonFraction> million was recorded in connection with property, plant and equipment, primarily buildings and improvements, of an asset group that operates primarily in Russia.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_136"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 6. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="f-939" continuedAt="f-939-1" escape="true">GOODWILL AND OTHER INTANGIBLE ASSETS, NET</ix:nonNumeric></span></div><ix:continuation id="f-939-1" continuedAt="f-939-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfGoodwillTextBlock" id="f-940" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Movements in goodwill attributable to each reportable segment during the years ended December 31, 2022 and 2023 were as follows:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nourish</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Health &amp; Biosciences</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Scent</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pharma Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-195" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-941">6,559</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-196" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-942">6,763</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-197" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-943">1,828</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-198" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-944">1,282</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-945">16,432</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="6" id="f-946">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="f-947">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="6" id="f-948">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="6" id="f-949">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="f-950">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="f-951">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="f-952">2,250</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="f-953">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="f-954">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="f-955">2,250</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transferred to assets held for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-6" sign="-" name="us-gaap:GoodwillTransfers" scale="6" id="f-956">306</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-6" name="us-gaap:GoodwillTransfers" format="ixt:fixed-zero" scale="6" id="f-957">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-6" sign="-" name="us-gaap:GoodwillTransfers" scale="6" id="f-958">42</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-6" name="us-gaap:GoodwillTransfers" format="ixt:fixed-zero" scale="6" id="f-959">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" sign="-" name="us-gaap:GoodwillTransfers" scale="6" id="f-960">348</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="f-961">199</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="f-962">223</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="f-963">41</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="f-964">43</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="f-965">506</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-199" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-966">6,054</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-967">4,335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-201" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-968">1,745</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-202" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-969">1,239</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-970">13,373</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="f-971">2,623</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="f-972">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="f-973">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="f-974">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="f-975">2,623</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transferred to assets held for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-6" name="us-gaap:GoodwillTransfers" format="ixt:fixed-zero" scale="6" id="f-976">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-6" name="us-gaap:GoodwillTransfers" format="ixt:fixed-zero" scale="6" id="f-977">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-6" sign="-" name="us-gaap:GoodwillTransfers" scale="6" id="f-978">267</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-6" name="us-gaap:GoodwillTransfers" format="ixt:fixed-zero" scale="6" id="f-979">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:GoodwillTransfers" scale="6" id="f-980">267</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reduction from business divestiture</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-6" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" scale="6" id="f-981">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-6" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" format="ixt:fixed-zero" scale="6" id="f-982">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-6" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" format="ixt:fixed-zero" scale="6" id="f-983">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-6" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" format="ixt:fixed-zero" scale="6" id="f-984">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" scale="6" id="f-985">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="f-986">72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="f-987">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="f-988">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="f-989">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="f-990">166</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-203" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-991">3,489</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-204" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-992">4,391</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-205" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-993">1,490</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-206" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-994">1,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-995">10,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-top:3pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt">Related to the acquisition of Health Wright. See Note 3 for additional information.</span></div><div style="margin-top:3pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt">Related to the portion of the Savory Solutions business and FSI business that were classified as held for sale as of December 31, 2022. The Company completed the divestitures of the businesses on May 31, 2023 and August 1, 2023, respectively. See Note 4 and Note 21 for additional information.</span></div><div style="margin-top:3pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt">Related to the Cosmetic Ingredients business that was classified as held for sale as of December&#160;31, 2023. See Note 21 for additional information.</span></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The goodwill balance at December&#160;31, 2023 included $<ix:nonFraction unitRef="usd" contextRef="c-203" decimals="-6" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="9" id="f-996">2.623</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="c-207" decimals="-6" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="9" id="f-997">2.250</ix:nonFraction> billion of accumulated impairment related to the Nourish and Health &amp; Biosciences reportable segments, respectively. The goodwill balance at December&#160;31, 2022 </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:continuation id="f-939-2" continuedAt="f-939-3"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">included $<ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-6" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="9" id="f-998">2.250</ix:nonFraction>&#160;billion of accumulated impairment related to the Health &amp; Biosciences reportable segment. The accumulated impairment relates to impairment charges recorded in 2023 and 2022.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill Impairment Test</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the annual impairment test as of November 30, 2023, the Company first utilized Step 0 of the guidance in ASC Topic 350, Intangibles &#8211; Goodwill and Other, which allows for the assessment of qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. If, based on a review of qualitative factors, it is more likely than not that the fair value of a reporting unit is less than its carrying value, a quantitative impairment test is performed by comparing the fair value of a reporting unit with its carrying amount. Based on a review of qualitative factors, the Company determined that for one of the reporting units, Cosmetic Ingredients, a quantitative (Step 1) impairment analysis was not necessary to determine if the carrying values of the reporting unit exceeded its fair values. For the other five reporting units, the Company determined that a Step 1 test was necessary.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assessed the fair value of the reporting units using an income approach. Under the income approach, the Company determined the fair value by using a discounted cash flow method at a rate of return that reflects the relative risk of the projected future cash flows of each reporting unit, as well as a terminal value. The Company used the most current actual and forecasted operating data available. Key estimates and assumptions used in these valuations include revenue growth rates, gross margins, adjusted operating EBITDA margins, terminal growth rates and discount rates.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the quantitative impairment test, the Company determined that the fair value of four of the five reporting units exceeded their carrying values and determined that there was no further impairment of goodwill in these reporting units as of November 30, 2023.&#160;The Company determined that the carrying value of the Nourish reporting unit exceeded its fair value and recorded an impairment charge of $<ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="9" id="f-999">2.623</ix:nonFraction>&#160;billion in the Consolidated Statements of (Loss) Income and Comprehensive Loss for the year ended December 31, 2023. The primary drivers of the impairment charge was a decrease in fair value due to declines in projections of the reporting unit, impacts of continued inflation and increases in interest rates. Based on the quantitative impairment test performed, the Company determined that the Health &amp; Biosciences, Fragrance Ingredients and Pharma Solutions reporting units had excess fair value over carrying value of less than <ix:nonFraction unitRef="number" contextRef="c-208" decimals="2" name="us-gaap:ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount" scale="-2" id="f-1000">25</ix:nonFraction>%. As of November 30, 2023, the Health &amp; Biosciences, Fragrance Ingredients and Pharma Solutions reporting units had excess fair value over carrying value of approximately <ix:nonFraction unitRef="number" contextRef="c-209" decimals="2" name="us-gaap:ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount" scale="-2" id="f-1001">8</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="c-210" decimals="2" name="us-gaap:ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount" scale="-2" id="f-1002">18</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-211" decimals="2" name="us-gaap:ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount" scale="-2" id="f-1003">8</ix:nonFraction>%, respectively, and goodwill of approximately $<ix:nonFraction unitRef="usd" contextRef="c-209" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="9" id="f-1004">4.381</ix:nonFraction>&#160;billion, $<ix:nonFraction unitRef="usd" contextRef="c-210" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-1005">295</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-211" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="9" id="f-1006">1.263</ix:nonFraction>&#160;billion, respectively.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While management believes that the assumptions used in the impairment test were reasonable, changes in key assumptions, including lower revenue growth, operating margin, terminal growth rates or increase in discount rates could result in a future impairment. Such charge could have a material effect on the Consolidated Statements of Operations and Balance Sheets.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, the Company determined that goodwill impairment triggering events occurred for its Nourish, Health &amp; Biosciences and Pharma Solutions reporting units. The primary indicators that were deemed to be triggering events were declines in the Company&#8217;s projections across various reporting units and ongoing adverse macroeconomic impacts such as inflation, increases in interest rates and unfavorable effects from exchange rates.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the quantitative impairment test, using the income approach, the Company determined that the carrying value of the Health &amp; Biosciences reporting unit exceeded its fair value and recorded a goodwill impairment charge of $<ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="9" id="f-1007">2.250</ix:nonFraction> billion in the Consolidated Statements of (Loss) Income and Comprehensive Loss for the year ended December 31, 2022.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:continuation id="f-939-3"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Intangible Assets</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="f-1008" escape="true"><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other intangible assets, net consisted of the following amounts:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.716%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.200%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset Type</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-212" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="f-1009">8,211</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-213" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="f-1010">8,318</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technological know-how</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-214" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="f-1011">2,355</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-215" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="f-1012">2,339</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names &amp; patents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-216" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-1013">337</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-217" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-1014">358</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-218" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-1015">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-219" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-1016">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total carrying value </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="f-1017">10,947</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="f-1018">11,062</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-212" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="f-1019">1,619</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-213" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="f-1020">1,252</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technological know-how</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-214" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-1021">813</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-215" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-1022">589</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names &amp; patents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-216" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-1023">117</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-217" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-1024">97</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-218" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-1025">41</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-219" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-1026">42</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="f-1027">2,590</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="f-1028">1,980</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="f-1029">8,357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="f-1030">9,082</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amortization</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="f-1031">680</ix:nonFraction> million for the year ended December&#160;31, 2023, $<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="f-1032">727</ix:nonFraction> million for the year ended December 31, 2022 and $<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="f-1033">732</ix:nonFraction> million for the year ended December&#160;31, 2021. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="f-1034" continuedAt="f-1034-1" escape="true">Amortization expense for the next five years, based on valuations and determinations of useful lives, is expected to be as follows:</ix:nonNumeric></span></div><ix:continuation id="f-1034-1"><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.613%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.579%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2028</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated future intangible amortization expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="f-1035">678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="f-1036">676</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="f-1037">674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="f-1038">577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="6" id="f-1039">558</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairment of Intangible Assets</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 1, for the year ended December 31, 2022, an impairment charge of approximately $<ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-6" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="f-1040">92</ix:nonFraction> million was recorded in connection with intangible assets, primarily customer relationships and technological know-how, of an asset group that operated primarily in Russia, which was included within accumulated amortization.</span></div></ix:continuation><div><span><br/></span></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_139"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 7.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="iff:OtherAssetsAndLiabilitiesDisclosureCurrentAndNoncurrentTextBlock" id="f-1041" continuedAt="f-1041-1" escape="true">OTHER CURRENT ASSETS AND LIABILITIES, AND OTHER ASSETS</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock" id="f-1042" escape="true"><ix:continuation id="f-1041-1" continuedAt="f-1041-2"><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets consisted of the following amounts:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value-added tax receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:ValueAddedTaxReceivableCurrent" scale="6" id="f-1043">187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:ValueAddedTaxReceivableCurrent" scale="6" id="f-1044">212</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:IncomeTaxesReceivable" scale="6" id="f-1045">178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:IncomeTaxesReceivable" scale="6" id="f-1046">129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Packaging materials and supplies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:Supplies" scale="6" id="f-1047">161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:Supplies" scale="6" id="f-1048">148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:PrepaidExpenseCurrent" scale="6" id="f-1049">184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:PrepaidExpenseCurrent" scale="6" id="f-1050">144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:AccountsAndOtherReceivablesNetCurrent" scale="6" id="f-1051">165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:AccountsAndOtherReceivablesNetCurrent" scale="6" id="f-1052">137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="f-1053">875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="f-1054">770</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:continuation id="f-1041-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfOtherAssetsTableTextBlock" id="f-1055" escape="true"><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets consisted of the following amounts:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right-of-use assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="f-1056">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="f-1057">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:DeferredIncomeTaxesAndOtherAssetsNoncurrent" scale="6" id="f-1058">278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:DeferredIncomeTaxesAndOtherAssetsNoncurrent" scale="6" id="f-1059">167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Overfunded pension plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="f-1060">139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="f-1061">180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:CashSurrenderValueOfLifeInsurance" scale="6" id="f-1062">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:CashSurrenderValueOfLifeInsurance" scale="6" id="f-1063">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="f-1064">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="f-1065">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:OtherAssetsMiscellaneousNoncurrent" scale="6" id="f-1066">261</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:OtherAssetsMiscellaneousNoncurrent" scale="6" id="f-1067">265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="f-1068">764</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="f-1069">689</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________&#160;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes land usage rights in China, long-term deposits and receivables on certain derivative instruments.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:OtherCurrentLiabilitiesTableTextBlock" id="f-1070" escape="true"><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current liabilities consisted of the following amounts:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates and incentives payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="iff:RebatesAndIncentivesPayableCurrent" scale="6" id="f-1071">105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="iff:RebatesAndIncentivesPayableCurrent" scale="6" id="f-1072">99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value-added tax payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:SalesAndExciseTaxPayableCurrent" scale="6" id="f-1073">77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:SalesAndExciseTaxPayableCurrent" scale="6" id="f-1074">65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:InterestPayableCurrent" scale="6" id="f-1075">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:InterestPayableCurrent" scale="6" id="f-1076">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current pension and other postretirement benefit obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent" scale="6" id="f-1077">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent" scale="6" id="f-1078">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued insurance (including workers&#8217; compensation)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:AccruedInsuranceCurrent" scale="6" id="f-1079">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:AccruedInsuranceCurrent" scale="6" id="f-1080">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earn outs payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="iff:EarnOutsPayableCurrent" scale="6" id="f-1081">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="iff:EarnOutsPayableCurrent" format="ixt:fixed-zero" scale="6" id="f-1082">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued restructuring</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="f-1083">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="f-1084">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1085"><span style="-sec-ix-hidden:f-1086">Current operating lease obligation</span></span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="f-1087">85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="f-1088">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued freight</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="iff:AccruedFreightCurrent" scale="6" id="f-1089">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="iff:AccruedFreightCurrent" scale="6" id="f-1090">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued commissions payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="iff:AccruedCommissionsPayableCurrent" scale="6" id="f-1091">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="iff:AccruedCommissionsPayableCurrent" scale="6" id="f-1092">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="f-1093">194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="f-1094">313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:OtherAccountsPayableAndAccruedLiabilities" scale="6" id="f-1095">262</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:OtherAccountsPayableAndAccruedLiabilities" scale="6" id="f-1096">256</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:OtherSundryLiabilitiesCurrent" scale="6" id="f-1097">97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:OtherSundryLiabilitiesCurrent" scale="6" id="f-1098">91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="f-1099">977</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-1100">1,028</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.936%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_142"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 8.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeasesTextBlock" id="f-1101" continuedAt="f-1101-1" escape="true">LEASES</ix:nonNumeric></span></div><ix:continuation id="f-1101-1" continuedAt="f-1101-2"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has leases for corporate offices, manufacturing facilities, research and development facilities and certain transportation and office equipment, the majority of which are operating leases. The Company&#8217;s leases have remaining lease terms of up to <ix:nonNumeric contextRef="c-11" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" format="ixt-sec:duryear" id="f-1102">50</ix:nonNumeric> years, some of which include options to extend the leases for up to <ix:nonNumeric contextRef="c-11" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:duryear" id="f-1103">15</ix:nonNumeric> years.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LeaseCostTableTextBlock" id="f-1104" continuedAt="f-1104-1" escape="true"><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:55.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.978%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:OperatingLeaseCost" scale="6" id="f-1105">137</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:OperatingLeaseCost" scale="6" id="f-1106">134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:OperatingLeaseCost" scale="6" id="f-1107">133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:VariableLeaseCost" scale="6" id="f-1108">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:VariableLeaseCost" scale="6" id="f-1109">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:VariableLeaseCost" scale="6" id="f-1110">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease cost</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:LeaseCost" scale="6" id="f-1111">193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:LeaseCost" scale="6" id="f-1112">187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:LeaseCost" scale="6" id="f-1113">168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="iff:FinanceLeaseCost" scale="6" id="f-1114">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="iff:FinanceLeaseCost" scale="6" id="f-1115">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="iff:FinanceLeaseCost" scale="6" id="f-1116">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:continuation id="f-1101-2" continuedAt="f-1101-3"><ix:continuation id="f-1104-1" continuedAt="f-1104-2"><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:55.287%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.996%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.996%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.000%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows for operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:OperatingLeasePayments" scale="6" id="f-1117">122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:OperatingLeasePayments" scale="6" id="f-1118">135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:OperatingLeasePayments" scale="6" id="f-1119">129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows for finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="6" id="f-1120">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" format="ixt:fixed-zero" scale="6" id="f-1121">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" format="ixt:fixed-zero" scale="6" id="f-1122">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows for finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="f-1123">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="f-1124">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="f-1125">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="f-1126">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="f-1127">174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="f-1128">88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" id="f-1129">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" id="f-1130">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" id="f-1131">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="iff:AssetsAndLiabilitiesLesseeTableTextBlock" id="f-1132" escape="true"><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.014%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.977%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="f-1133">689</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="f-1134">743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current operating lease obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="f-1135">85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="f-1136">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="f-1137">642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="f-1138">672</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:OperatingLeaseLiability" scale="6" id="f-1139">727</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:OperatingLeaseLiability" scale="6" id="f-1140">758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="-sec-ix-hidden:f-1141"><span style="-sec-ix-hidden:f-1142"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right-of-use assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></span></span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="f-1143">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="f-1144">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="-sec-ix-hidden:f-1145"><span style="-sec-ix-hidden:f-1146"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current finance lease obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></span></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="f-1147">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="f-1148">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="-sec-ix-hidden:f-1149"><span style="-sec-ix-hidden:f-1150"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></span></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="f-1151">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="f-1152">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:FinanceLeaseLiability" scale="6" id="f-1153">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:FinanceLeaseLiability" scale="6" id="f-1154">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Presented in Other assets on the Consolidated Balance Sheets.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Presented in Other current liabilities on the Consolidated Balance Sheets.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Presented in Other liabilities on the Consolidated Balance Sheets.</span></div></ix:nonNumeric><ix:continuation id="f-1104-2"><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average remaining lease term and discount rate were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.014%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.977%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average remaining lease term in years</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-11" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-1155">9.9</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-12" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-1156">10.6</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-11" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-1157">3.5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-12" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-1158">4.0</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-11" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-1159">4.24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-12" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-1160">3.83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-11" decimals="4" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-1161">4.33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-12" decimals="4" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-1162">2.59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:continuation></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:continuation id="f-1101-3"><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="f-1163" escape="true"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities as of December&#160;31, 2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:50.290%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.444%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.444%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.958%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="f-1164">113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="f-1165">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="iff:LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearOne" scale="6" id="f-1166">122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="6" id="f-1167">110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" scale="6" id="f-1168">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="iff:LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearTwo" scale="6" id="f-1169">118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="6" id="f-1170">101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" scale="6" id="f-1171">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="iff:LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearThree" scale="6" id="f-1172">108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="6" id="f-1173">87</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" scale="6" id="f-1174">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="iff:LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFour" scale="6" id="f-1175">91</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="6" id="f-1176">77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" format="ixt:fixed-zero" scale="6" id="f-1177">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="iff:LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFive" scale="6" id="f-1178">77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="f-1179">410</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:fixed-zero" scale="6" id="f-1180">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="iff:LesseeOperatingAndFinanceLeaseLiabilityToBePaidAfterYearFive" scale="6" id="f-1181">410</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total undiscounted liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="6" id="f-1182">898</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" scale="6" id="f-1183">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="iff:LesseeOperatingAndFinanceLeasePaymentsDue" scale="6" id="f-1184">926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="6" id="f-1185">171</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="6" id="f-1186">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="iff:LesseeOperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount" scale="6" id="f-1187">174</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:OperatingLeaseLiability" scale="6" id="f-1188">727</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:FinanceLeaseLiability" scale="6" id="f-1189">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="iff:OperatingAndFinanceLeaseLiability" scale="6" id="f-1190">752</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use assets and lease liabilities acquired from N&amp;B were remeasured at the present value of the future minimum lease payments over the remaining lease term utilizing an updated incremental borrowing rate of the Company as if the acquired leases were new leases as of the Closing Date. Right-of-use assets were further adjusted for any off-market terms of the lease. The remaining lease term is based on the remaining term at the Closing Date plus any renewal or extension options that the Company is reasonably certain will be exercised. Additionally, the Company has elected short-term lease treatment for those acquired lease contracts which, at the Closing Date, have a remaining lease term of 12 months or less. For the leases acquired through the Transactions, the Company will retain the previous lease classification. This resulted in an increase in both operating lease right-of-use assets and operating lease liabilities of approximately $<ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="f-1191">525</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-6" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="f-1192">523</ix:nonFraction> million, respectively, as of the Closing Date.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the Company&#8217;s acquisition of Health Wright, there was an increase of approximately $<ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="f-1193">22</ix:nonFraction>&#160;million in finance lease right-of-use assets and $<ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-6" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="f-1194">21</ix:nonFraction>&#160;million in finance lease liabilities as of the Acquisition Date. In the fourth quarter of 2022, the Company exercised its option to purchase the asset and, as such, de-recognized the finance lease right-of-use assets and finance lease liabilities.</span></div></ix:continuation><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.014%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.977%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_145"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 9.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:DebtDisclosureTextBlock" id="f-1195" continuedAt="f-1195-1" escape="true">DEBT</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDebtTableTextBlock" id="f-1196" continuedAt="f-1196-1" escape="true"><ix:continuation id="f-1195-1" continuedAt="f-1195-2"><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt consisted of the following at December&#160;31:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:49.560%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.584%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.493%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.495%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Effective Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-220" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1197">3.30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-220" decimals="-6" name="us-gaap:SeniorNotesCurrent" format="ixt:fixed-zero" scale="6" id="f-1198">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-221" decimals="-6" name="us-gaap:SeniorNotesCurrent" scale="6" id="f-1199">300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Euro Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-222" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1200">1.88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-222" decimals="-6" name="us-gaap:SeniorNotesCurrent" scale="6" id="f-1201">552</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-223" decimals="-6" name="us-gaap:SeniorLongTermNotes" scale="6" id="f-1202">532</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-224" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1203">1.22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-224" decimals="-6" name="us-gaap:SeniorLongTermNotes" format="ixt:num-dot-decimal" scale="6" id="f-1204">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-225" decimals="-6" name="us-gaap:SeniorLongTermNotes" format="ixt:num-dot-decimal" scale="6" id="f-1205">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Euro Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-226" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1206">1.93</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-226" decimals="-6" name="us-gaap:SeniorLongTermNotes" scale="6" id="f-1207">879</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-227" decimals="-6" name="us-gaap:SeniorLongTermNotes" scale="6" id="f-1208">845</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-228" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1209">1.56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-228" decimals="-6" name="us-gaap:SeniorLongTermNotes" format="ixt:num-dot-decimal" scale="6" id="f-1210">1,212</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-229" decimals="-6" name="us-gaap:SeniorLongTermNotes" format="ixt:num-dot-decimal" scale="6" id="f-1211">1,215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-230" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1212">4.57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-6" name="us-gaap:SeniorLongTermNotes" scale="6" id="f-1213">398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-231" decimals="-6" name="us-gaap:SeniorLongTermNotes" scale="6" id="f-1214">398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2030 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-232" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1215">2.21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-232" decimals="-6" name="us-gaap:SeniorLongTermNotes" format="ixt:num-dot-decimal" scale="6" id="f-1216">1,508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-233" decimals="-6" name="us-gaap:SeniorLongTermNotes" format="ixt:num-dot-decimal" scale="6" id="f-1217">1,510</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2040 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-234" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1218">3.04</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-234" decimals="-6" name="us-gaap:SeniorLongTermNotes" scale="6" id="f-1219">773</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-235" decimals="-6" name="us-gaap:SeniorLongTermNotes" scale="6" id="f-1220">774</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2047 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-236" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1221">4.44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-236" decimals="-6" name="us-gaap:SeniorLongTermNotes" scale="6" id="f-1222">495</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-237" decimals="-6" name="us-gaap:SeniorLongTermNotes" scale="6" id="f-1223">495</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2048 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-238" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1224">5.12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-6" name="us-gaap:SeniorLongTermNotes" scale="6" id="f-1225">787</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-239" decimals="-6" name="us-gaap:SeniorLongTermNotes" scale="6" id="f-1226">787</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2050 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-240" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1227">3.21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-240" decimals="-6" name="us-gaap:SeniorLongTermNotes" format="ixt:num-dot-decimal" scale="6" id="f-1228">1,569</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-241" decimals="-6" name="us-gaap:SeniorLongTermNotes" format="ixt:num-dot-decimal" scale="6" id="f-1229">1,571</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Term Loan Facility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-242" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1230">3.75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-242" decimals="-6" name="us-gaap:SeniorNotesCurrent" scale="6" id="f-1231">270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-243" decimals="-6" name="us-gaap:SeniorLongTermNotes" scale="6" id="f-1232">625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Term Loan Facility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-244" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1233">5.83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-244" decimals="-6" name="us-gaap:SeniorLongTermNotes" scale="6" id="f-1234">625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-245" decimals="-6" name="us-gaap:SeniorLongTermNotes" scale="6" id="f-1235">625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial Paper</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:CommercialPaper" format="ixt:fixed-zero" scale="6" id="f-1236">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:CommercialPaper" scale="6" id="f-1237">187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving Credit Facility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-246" decimals="-6" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="6" id="f-1238">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-247" decimals="-6" name="us-gaap:LineOfCredit" scale="6" id="f-1239">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank overdrafts and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-248" decimals="-6" name="us-gaap:ShortTermBorrowings" scale="6" id="f-1240">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-249" decimals="-6" name="us-gaap:ShortTermBorrowings" scale="6" id="f-1241">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" format="ixt:num-dot-decimal" scale="6" id="f-1242">10,071</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" format="ixt:num-dot-decimal" scale="6" id="f-1243">10,970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Short term borrowings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:LongTermDebtCurrent" scale="6" id="f-1244">885</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:LongTermDebtCurrent" scale="6" id="f-1245">597</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-1246">9,186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-1247">10,373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amount is net of unamortized discount and debt issuance costs.</span></div></ix:continuation></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:continuation id="f-1195-2" continuedAt="f-1195-3"><ix:continuation id="f-1196-1"><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amount is recorded at fair value.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The effective interest rate of commercial paper issuances fluctuate as short-term interest rates and demand fluctuate, and deferred debt issuance costs are immaterial. Additionally, the effective interest rate of commercial paper is not meaningful as issuances do not materially differ from short-term interest rates.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The interest rate on the Revolving Credit Facility is, at the applicable borrower&#8217;s option, a per annum rate equal to either (x) an eurocurrency rate plus an applicable margin varying from <ix:nonFraction unitRef="number" contextRef="c-250" decimals="5" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1248">1.125</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-251" decimals="5" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1249">1.750</ix:nonFraction>% or (y) a base rate plus an applicable margin varying from <ix:nonFraction unitRef="number" contextRef="c-252" decimals="5" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1250">0.125</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-253" decimals="5" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1251">0.750</ix:nonFraction>%, in each case depending on the public debt ratings for&#160;non-credit&#160;enhanced long-term senior unsecured debt issued by the Company.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes bank borrowings, overdrafts, current portion of long-term debt and commercial paper.</span></div></ix:continuation><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Term Loan Facility and Senior Notes assumed as part of the N&amp;B Merger</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the Merger, the Company assumed the indebtedness incurred by N&amp;B in the debt financings completed prior to the Distribution. This indebtedness includes (i) a Term Loan Facility of $<ix:nonFraction unitRef="usd" contextRef="c-254" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="f-1252">1.250</ix:nonFraction>&#160;billion pursuant to the term loan credit agreement (the &#8220;N&amp;B Term Loan Facility&#8221;) and (ii) a series of Senior Notes in the aggregate amount of $<ix:nonFraction unitRef="usd" contextRef="c-255" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="f-1253">6.250</ix:nonFraction>&#160;billion with maturities ranging from <ix:nonNumeric contextRef="c-256" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:duryear" id="f-1254">2</ix:nonNumeric> to <ix:nonNumeric contextRef="c-257" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:duryear" id="f-1255">30</ix:nonNumeric> years as further described below. N&amp;B&#8217;s indebtedness raised prior to the Merger was used to finance the Special Cash Payment to DuPont, which has been paid, and for the satisfaction of the related transaction fees and expenses. See Note 3 for additional information.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">N&amp;B Term Loan Facility</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The N&amp;B Term Loan Facility was funded on February 1, 2021, and provides for a senior unsecured term loan credit facility in an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-254" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="f-1256">1.250</ix:nonFraction>&#160;billion, comprised of a $<ix:nonFraction unitRef="usd" contextRef="c-258" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-1257">625</ix:nonFraction>&#160;million three-year tranche (&#8220;2024 Term Loan Facility&#8221;) and a $<ix:nonFraction unitRef="usd" contextRef="c-259" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-1258">625</ix:nonFraction>&#160;million five-year tranche (&#8220;2026 Term Loan Facility&#8221;). Interest for each tranche equals, at the Company&#8217;s option, a per annum rate equal to either (x) an adjusted LIBOR rate plus an applicable margin varying from <ix:nonFraction unitRef="number" contextRef="c-260" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1259">0.750</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-261" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1260">2.000</ix:nonFraction>% for the three-year tranche and from <ix:nonFraction unitRef="number" contextRef="c-262" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1261">1.125</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-263" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1262">2.375</ix:nonFraction>% for the five-year tranche or (y) a base rate plus an applicable margin varying from <ix:nonFraction unitRef="number" contextRef="c-264" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1263">0.000</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-265" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1264">1.000</ix:nonFraction>% for the three-year tranche and from <ix:nonFraction unitRef="number" contextRef="c-266" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1265">0.125</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-267" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1266">1.375</ix:nonFraction>% for the five-year tranche, in each case depending on the class of IFF&#8217;s non-credit-enhanced, senior unsecured long-term debt credit rating.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2024 Term Loan Facility and 2026 Term Loan Facility are subject to customary affirmative and negative covenants and events of default after the Closing Date of the Merger. On and after the Closing Date of the N&amp;B Transaction, the 2024 Term Loan Facility and 2026 Term Loan Facility are also subject to financial covenant maintenance requirements.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 19, 2023, the Company entered into Amendment No. 5 (&#8220;Term Loan Amendment No. 5&#8221;) to amend that certain term loan credit agreement, dated January 17, 2020 (as amended by that certain Amendment No. 1 to Credit Agreement, dated as of August 25, 2020, as further supplemented by that certain Icon Debt Assumption Supplement, dated as of March 4, 2021, as further amended by that certain Amendment No. 2 to Credit Agreement, dated as of August 4, 2022, as further amended by that certain Amendment No. 3 (&#8220;Term Loan Amendment No. 3&#8221;) to Credit Agreement, dated as of March 23, 2023, as further amended by that certain Amendment No. 4 (&#8220;Term Loan Amendment No. 4&#8221;) to Credit Agreement, dated as of March 23, 2023, the &#8220;Existing Term Loan Credit Agreement&#8221;, and the Existing Term Loan Credit Agreement, as amended by the Term Loan Amendment, the &#8220;Term Loan Credit Agreement&#8221;), among the Company (as successor to Nutrition &amp; Biosciences, Inc.), the lenders party thereto and Morgan Stanley Senior Funding, Inc., as administrative agent. The related deferred financing costs for the amendments in 2023 were not material.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Term Loan Amendment No. 3, among other things, extended the period during which certain relief was provided with respect to the financial covenant contained in the Existing Term Loan Credit Agreement which has been superseded by Term Loan Amendment No. 5.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Term Loan Amendment No. 4, among other things, replaces LIBOR with Term SOFR (as defined in the Term Loan Credit Agreement) as the reference rate for U.S. dollar-denominated loans. From March 23, 2023, loans under the Term Loan Credit Agreement now bear interest at a base rate or a rate equal to Term SOFR plus an adjustment of <ix:nonFraction unitRef="number" contextRef="c-268" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1267">0.10</ix:nonFraction>% per annum, plus, in each case, an applicable margin based on the Company's public debt rating. Loans may be prepaid without premium or penalty, subject to customary breakage costs.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Term Loan Amendment No. 5, among other things, extends the period during which certain relief is provided with respect to the financial covenant contained in the Existing Term Loan Credit Agreement through December 31, 2025, or such earlier date on which the Company elects to terminate such period (the &#8220;Term Loan Covenant Relief Period&#8221;), by providing that during the Term Loan Covenant Relief Period, the Company&#8217;s Leverage Ratio (as defined in the Term Loan Credit Agreement) shall not exceed as of the end of the fiscal quarter for the period of the four fiscal quarters then ended: (i) <ix:nonFraction unitRef="number" contextRef="c-269" decimals="2" name="iff:DebtInstrumentCovenantMaximumConsolidatedLeverageRatio" scale="0" id="f-1268">5.25</ix:nonFraction>x for any fiscal quarter ending on or before March 31, 2024, (ii) <ix:nonFraction unitRef="number" contextRef="c-270" decimals="2" name="iff:DebtInstrumentCovenantMaximumConsolidatedLeverageRatio" scale="0" id="f-1269">4.75</ix:nonFraction>x for the fiscal quarter ending June 30, 2024, (iii) <ix:nonFraction unitRef="number" contextRef="c-271" decimals="2" name="iff:DebtInstrumentCovenantMaximumConsolidatedLeverageRatio" scale="0" id="f-1270">4.50</ix:nonFraction>x for the fiscal quarter ending September 30, 2024, (iv) <ix:nonFraction unitRef="number" contextRef="c-272" decimals="2" name="iff:DebtInstrumentCovenantMaximumConsolidatedLeverageRatio" scale="0" id="f-1271">4.25</ix:nonFraction>x for any subsequent fiscal quarter ending on or before March 31, 2025, (v) <ix:nonFraction unitRef="number" contextRef="c-273" decimals="2" name="iff:DebtInstrumentCovenantMaximumConsolidatedLeverageRatio" scale="0" id="f-1272">4.00</ix:nonFraction>x for any subsequent fiscal quarter ending on or before September 30, 2025 and (vi) <ix:nonFraction unitRef="number" contextRef="c-274" decimals="2" name="iff:DebtInstrumentCovenantMaximumConsolidatedLeverageRatio" scale="0" id="f-1273">3.75</ix:nonFraction>x for the fiscal quarter ending December 31, 2025. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:continuation id="f-1195-3" continuedAt="f-1195-4"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the Term Loan Covenant Relief Period, the amendments prohibit the Company from (i) effecting share repurchases, (ii) declaring and paying dividends in cash on common stock in excess of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-275" decimals="2" name="iff:CommonStockDividendsPerShareMaximumDividendThresholdPerQuarter" scale="0" id="f-1274">0.81</ix:nonFraction> per share per fiscal quarter (for an aggregate amount of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-275" decimals="2" name="iff:CommonStockDividendsPerShareMaximumDividendThresholdPerYear" scale="0" id="f-1275">3.24</ix:nonFraction> per fiscal year) and (iii) creating liens to secure debt in excess of the greater of $<ix:nonFraction unitRef="usd" contextRef="c-276" decimals="-6" name="iff:DebtInstrumentCovenantLienThresholdAmount" format="ixt:num-dot-decimal" scale="6" id="f-1276">300</ix:nonFraction>&#160;million and <ix:nonFraction unitRef="number" contextRef="c-276" decimals="4" name="iff:DebtInstrumentCovenantLienThresholdPercentageOfConsolidatedNetTangibleAssets" scale="-2" id="f-1277">3.65</ix:nonFraction>% of Consolidated Net Tangible Assets (as defined in the Term Loan Credit Agreement), subject to certain exceptions set forth in the Term Loan Amendment No. 5. The Company was in compliance with all covenants as of December&#160;31, 2023.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loans may be prepaid without premium or penalty, subject to customary breakage costs, and during the Term Loan Covenant Relief Period, there will be a mandatory prepayment of the loans with <ix:nonFraction unitRef="number" contextRef="c-276" decimals="2" name="iff:DebtInstrumentCovenantPercentageOfProceedsFromNonOrdinaryAssetsSalesRequiredToBeUsedAsPrepayment" scale="-2" id="f-1278">100</ix:nonFraction>% of the net cash proceeds from non-ordinary course asset sales, subject to certain exceptions set forth in the Term Loan Amendment No. 5 and by a Term Loan Amendment No. 6, dated January 26, 2024, which provides additional exceptions to the mandatory prepayment requirements with respect to the sale of the Company&#8217;s Cosmetic Ingredients business. The applicable margin for the loans, which is based on the Company&#8217;s Public Debt Rating (as defined in the Term Loan Credit Agreement), will also increase by <ix:nonFraction unitRef="number" contextRef="c-276" decimals="5" name="iff:DebtInstrumentCovenantBasisSpreadIncreaseOnVariableRate" scale="-2" id="f-1279">0.125</ix:nonFraction>% for the duration of the Term Loan Covenant Relief Period.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2023, the Company made voluntary debt repayments of $<ix:nonFraction unitRef="usd" contextRef="c-277" decimals="-6" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="6" id="f-1280">355</ix:nonFraction>&#160;million related to the 2024 Term Loan Facility.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">N&amp;B Senior Notes</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 16, 2020, N&amp;B issued $<ix:nonFraction unitRef="usd" contextRef="c-278" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="f-1281">6.250</ix:nonFraction>&#160;billion in aggregate principal amount of senior unsecured notes consisting of: (i) $<ix:nonFraction unitRef="usd" contextRef="c-279" decimals="-6" name="us-gaap:SeniorNotesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-1282">300</ix:nonFraction>&#160;million senior unsecured notes which matured on September 15, 2022 (the &#8220;2022 Notes&#8221;), bearing interest at a rate of <ix:nonFraction unitRef="number" contextRef="c-279" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1283">0.697</ix:nonFraction>% per year, payable semi-annually on March 15 and September 15 of each year, beginning March 15, 2021; (ii) $<ix:nonFraction unitRef="usd" contextRef="c-280" decimals="-6" name="us-gaap:SeniorLongTermNotes" format="ixt:num-dot-decimal" scale="9" id="f-1284">1.000</ix:nonFraction>&#160;billion senior unsecured notes maturing on October 1, 2025 (the &#8220;2025 Notes&#8221;), bearing interest at a rate of <ix:nonFraction unitRef="number" contextRef="c-280" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1285">1.230</ix:nonFraction>% per year, payable semi-annually on April 1 and October 1 of each year, beginning April 1, 2021; (iii) $<ix:nonFraction unitRef="usd" contextRef="c-281" decimals="-6" name="us-gaap:SeniorLongTermNotes" format="ixt:num-dot-decimal" scale="9" id="f-1286">1.200</ix:nonFraction>&#160;billion senior unsecured notes maturing on October 15, 2027 (the &#8220;2027 Notes&#8221;), bearing interest at a rate of <ix:nonFraction unitRef="number" contextRef="c-281" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1287">1.832</ix:nonFraction>% per year, payable semi-annually on April 15 and October 15 of each year, beginning April 15, 2021; (iv) $<ix:nonFraction unitRef="usd" contextRef="c-282" decimals="-6" name="us-gaap:SeniorLongTermNotes" format="ixt:num-dot-decimal" scale="9" id="f-1288">1.500</ix:nonFraction>&#160;billion senior unsecured notes maturing on November 1, 2030 (the &#8220;2030 Notes&#8221;), bearing interest at a rate of <ix:nonFraction unitRef="number" contextRef="c-282" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1289">2.300</ix:nonFraction>% per year, payable semi-annually on May 1 and November 1 of each year, beginning May 1, 2021; (v) $<ix:nonFraction unitRef="usd" contextRef="c-283" decimals="-6" name="us-gaap:SeniorLongTermNotes" format="ixt:num-dot-decimal" scale="6" id="f-1290">750</ix:nonFraction>&#160;million senior unsecured notes maturing on November 15, 2040 (the &#8220;2040 Notes&#8221;), bearing interest at a rate of <ix:nonFraction unitRef="number" contextRef="c-283" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1291">3.268</ix:nonFraction>% per year, payable semi-annually on May 15 and November 15 of each year, beginning May 15, 2021, and; (vi) $<ix:nonFraction unitRef="usd" contextRef="c-284" decimals="-6" name="us-gaap:SeniorLongTermNotes" format="ixt:num-dot-decimal" scale="9" id="f-1292">1.500</ix:nonFraction>&#160;billion senior unsecured notes maturing on December 1, 2050 (the &#8220;2050 Notes&#8221;), bearing interest at a rate of <ix:nonFraction unitRef="number" contextRef="c-284" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1293">3.468</ix:nonFraction>% per year, payable semi-annually on June 1 and December 1 of each year, beginning June 1, 2021.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest on each series of notes began accruing from September 16, 2020 payable semi-annually in arrears as described above. Interest is computed on the basis of a 360-day year comprised of twelve 30-day months.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 15, 2022, the Company repaid the full $<ix:nonFraction unitRef="usd" contextRef="c-285" decimals="-6" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="6" id="f-1294">300</ix:nonFraction>&#160;million outstanding of its 2022 Notes at maturity.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revolving Credit Facility</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Revolving Credit Facility is available for general corporate purposes of each borrower and its subsidiaries. The obligations under the Revolving Credit Facility are unsecured and the Company has guaranteed the obligations of each other borrower under the Revolving Credit Facility. The Company pays a commitment fee on the aggregate unused commitments; such fee is not material. The Revolving Credit Agreement contains various covenants, limitations and events of default customary for similar facilities for similarly rated borrowers, including a maximum permitted ratio of Net Debt to Consolidated EBITDA. In connection with the initial issuance of the Revolving Credit Facility, the Company incurred&#160;$<ix:nonFraction unitRef="usd" contextRef="c-286" decimals="-6" name="us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="f-1295">1</ix:nonFraction>&#160;million of debt issuance costs.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 19, 2023, the Company and certain of its subsidiaries (collectively, the &#8220;Loan Parties&#8221;) entered into Amendment No. 4 (the &#8220;Revolver Amendment No. 4&#8221;) to amend that certain Third Amended and Restated Credit Agreement, dated July 28, 2021 (as amended by that certain Amendment No. 1 to Credit Agreement, dated August 4, 2022, as further amended by that certain Amendment No. 2 (&#8220;Revolver Amendment No. 2&#8221;) to Credit Agreement, dated as of March 23, 2023, as further amended by that certain Amendment No. 3 (&#8220;Revolver Amendment No. 3&#8221;) to Credit Agreement, dated as of March 23, 2023, the &#8220;Existing Revolving Credit Agreement&#8221;, and the Existing Revolving Credit Agreement, as amended by the Revolver Amendment, the &#8220;Revolving Credit Agreement&#8221;), among the Loan Parties, the lenders party thereto and Citibank, N.A., as administrative agent. The related deferred financing costs for the amendments in 2023 were not material.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolver Amendment No. 2, among other things, extended the period during which certain relief was provided with respect to the financial covenant contained in the Existing Revolving Credit Agreement which has been superseded by Revolver Amendment No. 4.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:continuation id="f-1195-4" continuedAt="f-1195-5"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolver Amendment No. 3, among other things, replaces LIBOR with Term SOFR (as defined in the Revolving Credit Agreement) as the reference rate for U.S. dollar-denominated loans. From March 23, 2023, loans under the Revolving Credit Agreement now bear interest at a base rate or, in the case of U.S. dollar-denominated loans, a rate equal to Term SOFR plus an adjustment of <ix:nonFraction unitRef="number" contextRef="c-287" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1296"><ix:nonFraction unitRef="number" contextRef="c-288" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1297">0.10</ix:nonFraction></ix:nonFraction>% per annum or, in the case of Euro-denominated loans, the Euro interbank offered rate, plus, in each case, an applicable margin based on the Company&#8217;s public debt rating. Loans may be prepaid without premium or penalty, subject to customary breakage costs.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolver Amendment No. 4, among other things, extends the period during which certain relief is provided with respect to the financial covenant contained in the Existing Revolving Credit Agreement through December 31, 2025, or such earlier date on which the Company elects to terminate such period (the &#8220;Revolver Covenant Relief Period&#8221;), by providing that during the Revolver Covenant Relief Period, the Company&#8217;s Leverage Ratio (as defined in the Revolving Credit Agreement) shall not exceed as of the end of the fiscal quarter for the period of the four fiscal quarters then ended: (i) <ix:nonFraction unitRef="number" contextRef="c-289" decimals="2" name="iff:DebtInstrumentCovenantMaximumConsolidatedLeverageRatio" scale="0" id="f-1298">5.25</ix:nonFraction>x for any fiscal quarter ending on or before March 31, 2024, (ii) <ix:nonFraction unitRef="number" contextRef="c-290" decimals="2" name="iff:DebtInstrumentCovenantMaximumConsolidatedLeverageRatio" scale="0" id="f-1299">4.75</ix:nonFraction>x for the fiscal quarter ending June 30, 2024, (iii) <ix:nonFraction unitRef="number" contextRef="c-291" decimals="2" name="iff:DebtInstrumentCovenantMaximumConsolidatedLeverageRatio" scale="0" id="f-1300">4.50</ix:nonFraction>x for the fiscal quarter ending September 30, 2024, (iv) <ix:nonFraction unitRef="number" contextRef="c-292" decimals="2" name="iff:DebtInstrumentCovenantMaximumConsolidatedLeverageRatio" scale="0" id="f-1301">4.25</ix:nonFraction>x for any subsequent fiscal quarter ending on or before March 31, 2025, (v) <ix:nonFraction unitRef="number" contextRef="c-293" decimals="2" name="iff:DebtInstrumentCovenantMaximumConsolidatedLeverageRatio" scale="0" id="f-1302">4.00</ix:nonFraction>x for any subsequent fiscal quarter ending on or before September 30, 2025 and (vi) <ix:nonFraction unitRef="number" contextRef="c-294" decimals="2" name="iff:DebtInstrumentCovenantMaximumConsolidatedLeverageRatio" scale="0" id="f-1303">3.75</ix:nonFraction>x for the fiscal quarter ending December 31, 2025. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the Revolver Covenant Relief Period, the amendments prohibit (i) the Company from effecting share repurchases, (ii) the Company from declaring and paying dividends in cash on common stock in excess of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-295" decimals="2" name="iff:CommonStockDividendsPerShareMaximumDividendThresholdPerQuarter" scale="0" id="f-1304">0.81</ix:nonFraction> per share per fiscal quarter (for an aggregate amount of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-295" decimals="2" name="iff:CommonStockDividendsPerShareMaximumDividendThresholdPerYear" scale="0" id="f-1305">3.24</ix:nonFraction> per fiscal year) and (iii) the Loan Parties from creating liens to secure debt in excess of the greater of $<ix:nonFraction unitRef="usd" contextRef="c-296" decimals="-6" name="iff:DebtInstrumentCovenantLienThresholdAmount" format="ixt:num-dot-decimal" scale="6" id="f-1306">300</ix:nonFraction>&#160;million and <ix:nonFraction unitRef="number" contextRef="c-296" decimals="4" name="iff:DebtInstrumentCovenantLienThresholdPercentageOfConsolidatedNetTangibleAssets" scale="-2" id="f-1307">3.65</ix:nonFraction>% of Consolidated Net Tangible Assets (as defined in the Revolving Credit Agreement), subject to certain exceptions set forth in the Revolver Amendment No. 4. The Company was in compliance with all covenants as of December&#160;31, 2023.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loans may be prepaid without premium or penalty, subject to customary breakage costs, and during the Revolver Covenant Relief Period, the applicable margin for the loans, which is based on the Company&#8217;s Public Debt Rating (as defined in the Revolving Credit Agreement), will increase by <ix:nonFraction unitRef="number" contextRef="c-296" decimals="5" name="iff:DebtInstrumentCovenantBasisSpreadIncreaseOnVariableRate" scale="-2" id="f-1308">0.125</ix:nonFraction>%.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, total capacity under the Revolving Credit Facility was&#160;$<ix:nonFraction unitRef="usd" contextRef="c-297" decimals="-6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="f-1309">2.000</ix:nonFraction> billion, with&#160;<ix:nonFraction unitRef="usd" contextRef="c-297" decimals="-6" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="6" id="f-1310">no</ix:nonFraction> outstanding borrowings. Under the amended terms of the Revolver Credit Agreement, the Revolving Credit Facility increased from $<ix:nonFraction unitRef="usd" contextRef="c-298" decimals="-6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="f-1311">1.000</ix:nonFraction> billion to $<ix:nonFraction unitRef="usd" contextRef="c-299" decimals="-6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="f-1312">2.000</ix:nonFraction> billion, maturing on July 28, 2026. At the option of the Company, the facility may be increased to $<ix:nonFraction unitRef="usd" contextRef="c-300" decimals="-6" name="us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet" format="ixt:num-dot-decimal" scale="9" id="f-1313">2.500</ix:nonFraction>&#160;billion subject to certain conditions. As the Revolving Credit Facility is a multi-year revolving credit agreement, the Company classifies as long-term debt the portion that it has the intent and ability to maintain outstanding longer than 12&#160;months.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2023, the Company had drawdowns of $<ix:nonFraction unitRef="usd" contextRef="c-301" decimals="-6" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="6" id="f-1314">800</ix:nonFraction>&#160;million and repayments of $<ix:nonFraction unitRef="usd" contextRef="c-301" decimals="-6" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="6" id="f-1315">900</ix:nonFraction>&#160;million under the Revolving Credit Facility. During 2022, the Company had drawdowns of $<ix:nonFraction unitRef="usd" contextRef="c-302" decimals="-6" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="6" id="f-1316">550</ix:nonFraction>&#160;million and repayments of $<ix:nonFraction unitRef="usd" contextRef="c-302" decimals="-6" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="6" id="f-1317">450</ix:nonFraction>&#160;million under the Revolving Credit Facility.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2018 Senior Unsecured Notes</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 25, 2018, the Company issued &#8364;<ix:nonFraction unitRef="eur" contextRef="c-303" decimals="-6" name="us-gaap:SeniorLongTermNotes" format="ixt:num-dot-decimal" scale="6" id="f-1318">800</ix:nonFraction>&#160;million aggregate principal amount of senior unsecured notes that mature on September 25, 2026 (the &#8220;2026 Euro Notes&#8221;). The 2026 Euro Notes bear interest at a rate of <ix:nonFraction unitRef="number" contextRef="c-303" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1319">1.8</ix:nonFraction>% per year, payable annually on September 25 of each year, beginning September 25, 2019. Total proceeds from the issuance of the 2026 Notes, net of underwriting discounts and offering costs, were &#8364;<ix:nonFraction unitRef="eur" contextRef="c-304" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="f-1320">794</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usd" contextRef="c-304" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="f-1321">932</ix:nonFraction>&#160;million in USD).</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 26, 2018, the Company issued $<ix:nonFraction unitRef="usd" contextRef="c-305" decimals="-6" name="us-gaap:SeniorLongTermNotes" format="ixt:num-dot-decimal" scale="6" id="f-1322">400</ix:nonFraction>&#160;million aggregate principal amount of senior unsecured notes that mature on September 26, 2028 (the &#8220;2028 Notes&#8221;). The 2028 Notes bear interest at a rate of <ix:nonFraction unitRef="number" contextRef="c-305" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1323">4.45</ix:nonFraction>% per year, payable semi-annually on March 26 and September 26 of each year, beginning March 26, 2019. Total proceeds from the issuance of the 2028 Notes, net of underwriting discounts and offering costs, were $<ix:nonFraction unitRef="usd" contextRef="c-306" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="f-1324">397</ix:nonFraction>&#160;million.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 26, 2018, the Company issued $<ix:nonFraction unitRef="usd" contextRef="c-307" decimals="-6" name="us-gaap:SeniorLongTermNotes" format="ixt:num-dot-decimal" scale="6" id="f-1325">800</ix:nonFraction>&#160;million aggregate principal amount of senior unsecured notes that mature on September 26, 2048 (the &#8220;2048 Notes&#8221; and collectively with the 2026 Euro Notes, 2020 Notes, 2028 Notes, the &#8220;2018 Senior Unsecured Notes&#8221;). The 2048 Notes bear interest at a rate of <ix:nonFraction unitRef="number" contextRef="c-307" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1326">5.0</ix:nonFraction>% per year, payable semi-annually on March 26 and September 26 of each year, beginning March 26, 2019. Total proceeds from the issuance of the 2048 Notes, net of underwriting discounts and offering costs, were $<ix:nonFraction unitRef="usd" contextRef="c-308" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="f-1327">787</ix:nonFraction>&#160;million.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 16, the 2026 Euro Notes have been designated as a hedge of the Company&#8217;s net investment in certain subsidiaries.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023 Notes</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;4, 2013, the Company issued $<ix:nonFraction unitRef="usd" contextRef="c-309" decimals="-6" name="us-gaap:SeniorLongTermNotes" format="ixt:num-dot-decimal" scale="6" id="f-1328">300</ix:nonFraction>&#160;million aggregate principal amount of senior unsecured notes that mature on May 1, 2023 (&#8220;2023 Notes&#8221;). The 2023 Notes bear interest at a rate of <ix:nonFraction unitRef="number" contextRef="c-309" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1329">3.20</ix:nonFraction>% per year, payable semi-annually on May 1 and </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:continuation id="f-1195-5" continuedAt="f-1195-6"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">November 1 of each year, beginning November 1, 2013. Total proceeds from the issuance of the 2023 Notes, net of underwriting discounts and offering costs, were $<ix:nonFraction unitRef="usd" contextRef="c-310" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfDebt" format="ixt:num-dot-decimal" scale="6" id="f-1330">298</ix:nonFraction>&#160;million.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 1, 2023, the Company repaid the full $<ix:nonFraction unitRef="usd" contextRef="c-311" decimals="-6" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="6" id="f-1331">300</ix:nonFraction>&#160;million outstanding of its 2023 Notes at maturity.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024 Euro Notes</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 14, 2016, the Company issued &#8364;<ix:nonFraction unitRef="eur" contextRef="c-312" decimals="-6" name="us-gaap:SeniorLongTermNotes" format="ixt:num-dot-decimal" scale="6" id="f-1332">500</ix:nonFraction> million aggregate principal amount of senior unsecured notes that mature on March 14, 2024 (&#8220;2024 Euro Notes&#8221;). The 2024 Euro Notes bear interest at a rate of <ix:nonFraction unitRef="number" contextRef="c-312" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1333">1.75</ix:nonFraction>% per year, payable annually on March 14 of each year, beginning March 14, 2017. Total proceeds from the issuance of the 2024 Euro Notes, net of underwriting discounts and offering costs, were &#8364;<ix:nonFraction unitRef="eur" contextRef="c-313" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfDebt" format="ixt:num-dot-decimal" scale="6" id="f-1334">496</ix:nonFraction> million. In connection with the debt issuance, the Company entered into pre-issuance hedging transactions that were settled upon issuance of the debt and resulted in a loss of approximately $<ix:nonFraction unitRef="usd" contextRef="c-313" decimals="-6" sign="-" name="us-gaap:GainLossOnOilAndGasHedgingActivity" format="ixt:num-dot-decimal" scale="6" id="f-1335">3</ix:nonFraction> million. The discount, deferred financing costs and pre-issuance hedge loss are being amortized as interest expense over the <ix:nonNumeric contextRef="c-313" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="f-1336">eight year</ix:nonNumeric> term of the debt.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 16, the 2024 Euro Notes have been designated as a hedge of the Company&#8217;s net investment in certain subsidiaries.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2047 Notes</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 18, 2017, the Company issued $<ix:nonFraction unitRef="usd" contextRef="c-314" decimals="-6" name="us-gaap:SeniorLongTermNotes" format="ixt:num-dot-decimal" scale="6" id="f-1337">500</ix:nonFraction>&#160;million aggregate principal amount of senior unsecured notes that mature on June 1, 2047 (&#8220;2047 Notes&#8221;). The 2047 Notes bear interest at a rate of <ix:nonFraction unitRef="number" contextRef="c-314" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1338">4.375</ix:nonFraction>% per year, payable semi-annually on June 1 and December 1 of each year, beginning December 1, 2017. Total proceeds from the issuance of the 2047 Notes, net of underwriting discounts and offering costs, were $<ix:nonFraction unitRef="usd" contextRef="c-315" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfDebt" format="ixt:num-dot-decimal" scale="6" id="f-1339">494</ix:nonFraction>&#160;million. In addition, the Company incurred $<ix:nonFraction unitRef="usd" contextRef="c-314" decimals="-6" name="us-gaap:OtherDeferredCostsGross" format="ixt:num-dot-decimal" scale="6" id="f-1340">1</ix:nonFraction>&#160;million in legal and professional costs associated with the issuance and such costs were recorded as deferred financing costs. In connection with the debt issuance, the Company entered into pre-issuance hedging transactions that were settled upon issuance of the debt and resulted in a loss of approximately $<ix:nonFraction unitRef="usd" contextRef="c-315" decimals="-6" sign="-" name="us-gaap:GainLossOnOilAndGasHedgingActivity" format="ixt:num-dot-decimal" scale="6" id="f-1341">5</ix:nonFraction>&#160;million. The discount, deferred financing costs and pre-issuance hedge loss are being amortized as interest expense over the 30 year term of the debt.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commercial Paper</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2023, the Company had gross issuances of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfCommercialPaper" format="ixt:num-dot-decimal" scale="9" id="f-1342">5.694</ix:nonFraction> billion and repayments of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:RepaymentsOfCommercialPaper" format="ixt:num-dot-decimal" scale="9" id="f-1343">5.881</ix:nonFraction> billion under the commercial paper program. The commercial paper issued had original maturities of less than 86 days. During 2022, the Company had gross issuances of $<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfCommercialPaper" format="ixt:num-dot-decimal" scale="9" id="f-1344">6.040</ix:nonFraction>&#160;billion and repayments of $<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:RepaymentsOfCommercialPaper" format="ixt:num-dot-decimal" scale="9" id="f-1345">6.177</ix:nonFraction>&#160;billion under the commercial paper program.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Commercial Paper Program is backed by the borrowing capacity available under the Revolving Credit Facility. The effective interest rate of commercial paper issuances does not materially differ from short-term interest rates, which fluctuate due to market conditions and as a result may impact our interest expense.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Redemption Provisions</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2024 Euro Notes, 2026 Euro Notes, 2028 Notes, 2047 Notes, and 2048 Notes (collectively, the &#8220;Notes&#8221;) share the same redemption provisions. Upon 30 days&#8217; notice to holders of the Notes, the Company may redeem the Notes at any time at the greater of <ix:nonFraction unitRef="number" contextRef="c-316" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="f-1346">100</ix:nonFraction>% or the discounted present value of the remaining scheduled payments of principal and interest from the redemption date to the maturity date at the Treasury Rate or the Comparable Government Bond Rate (as defined in the applicable agreements) plus (i) <ix:nonFraction unitRef="number" contextRef="c-317" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-4" id="f-1347">30</ix:nonFraction> basis points in the case of the 2024 Euro Notes, (ii) <ix:nonFraction unitRef="number" contextRef="c-318" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-4" id="f-1348">25</ix:nonFraction> basis points in the case of the 2026 Euro Notes, (iii) <ix:nonFraction unitRef="number" contextRef="c-319" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-4" id="f-1349">25</ix:nonFraction> basis points in the case of the 2028 Notes, (iv) <ix:nonFraction unitRef="number" contextRef="c-320" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-4" id="f-1350">25</ix:nonFraction> basis points in the case of the 2047 Notes and (v) <ix:nonFraction unitRef="number" contextRef="c-321" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-4" id="f-1351">30</ix:nonFraction> basis points in the case of the 2048 Notes. <ix:nonNumeric contextRef="c-1" name="us-gaap:DebtInstrumentRedemptionTableTextBlock" id="f-1352" continuedAt="f-1352-1" escape="true">The redemption dates of each of the Notes are provided in the below table:</ix:nonNumeric></span></div><ix:continuation id="f-1352-1"><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:51.462%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:45.606%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Note</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redemption Date</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Euro Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 14, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Euro Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 25, 2026</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 26, 2028</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2047 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 1, 2046</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2048 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 26, 2048</span></td></tr></table></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:continuation id="f-1195-6"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2025 Notes, 2027 Notes, 2030 Notes, 2040 Notes and 2050 Notes (collectively, the &#8220;N&amp;B Senior Notes&#8221;) were assumed as a result of the Merger and share the same redemption provisions. Upon 15 days&#8217; notice to holders of the N&amp;B Senior Notes, the Company may redeem the N&amp;B Senior Notes at any time at the greater of <ix:nonFraction unitRef="number" contextRef="c-322" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="f-1353">100</ix:nonFraction>% or the discounted present value of the remaining scheduled payments of principal and interest from the redemption date to the maturity date at the Treasury Rate (as defined in the applicable agreements) plus (i) <ix:nonFraction unitRef="number" contextRef="c-323" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-4" id="f-1354">15</ix:nonFraction> basis points in the case of the 2025 Notes, (ii) <ix:nonFraction unitRef="number" contextRef="c-324" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-4" id="f-1355">25</ix:nonFraction> basis points in the case of the 2027 Notes, (iii) <ix:nonFraction unitRef="number" contextRef="c-325" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-4" id="f-1356">25</ix:nonFraction> basis points in the case of the 2030 Notes, (iv) <ix:nonFraction unitRef="number" contextRef="c-326" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-4" id="f-1357">30</ix:nonFraction> basis points in the case of the 2040 Notes and (v) <ix:nonFraction unitRef="number" contextRef="c-327" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-4" id="f-1358">30</ix:nonFraction> basis points in the case of the 2050 Notes. <ix:nonNumeric contextRef="c-90" name="us-gaap:DebtInstrumentRedemptionTableTextBlock" id="f-1359" continuedAt="f-1359-1" escape="true">The redemption dates of each of the N&amp;B Senior Notes are provided in the table below:</ix:nonNumeric></span></div><ix:continuation id="f-1359-1"><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:51.462%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:45.606%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Note</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redemption Date</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 1, 2025</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 15, 2027</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2030 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 1, 2030</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2040 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 15, 2040</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2050 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 1, 2050</span></td></tr></table></div></ix:continuation><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or after the applicable redemption dates, each series of the Notes and N&amp;B Senior Notes (collectively, the &#8220;IFF Notes&#8221;) may be redeemed by the issuer at a redemption price equal to <ix:nonFraction unitRef="number" contextRef="c-322" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="f-1360">100</ix:nonFraction>% of the principal amount of the IFF Notes to be redeemed, plus accrued and unpaid interest on the notes to be redeemed to, but excluding, the redemption date.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The indenture of the IFF Notes provides for customary events of default and contains certain negative covenants that limit the ability of the Company and its subsidiaries to grant liens on assets, or to enter into sale-leaseback transactions. In addition, subject to certain limitations, in the event of the occurrence of both (1) a change of control of the Company and (2) ratings of the IFF Notes is under publicly announced consideration or is downgraded below investment grade by either Moody&#8217;s Investors Services, Inc. or Standard &amp; Poor&#8217;s Ratings Services within a specified time period, the Company will be required to make an offer to repurchase the IFF Notes at a price equal to <ix:nonFraction unitRef="number" contextRef="c-1" decimals="INF" name="iff:RepurchasePriceAsPercentageOfPrincipalAmountOfSeniorNotes" scale="-2" id="f-1361">101</ix:nonFraction>% of the principal amount of the IFF Notes, plus accrued and unpaid interest to the date of repurchase.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Outstanding Borrowings</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="f-1362" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the contractual maturities of the Company&#8217;s long-term debt as of December&#160;31, 2023.</span></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:37.225%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.651%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Payments&#160;Due&#160;by&#160;Period</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less than 1 Year</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1-3 Years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3-5 Years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">More than<br/>5 Years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Outstanding Borrowings</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="f-1363">9,980</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="6" id="f-1364">885</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:LongTermDebtMaturingInYearsTwoAndThree" format="ixt:num-dot-decimal" scale="6" id="f-1365">2,445</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:LongTermDebtMaturingInYearsFourAndFive" format="ixt:num-dot-decimal" scale="6" id="f-1366">1,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" format="ixt:num-dot-decimal" scale="6" id="f-1367">5,050</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Subsequent Event</span></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 1, 2024, the Company repaid the remaining $<ix:nonFraction unitRef="usd" contextRef="c-328" decimals="-6" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="6" id="f-1368">270</ix:nonFraction>&#160;million outstanding on its 2024 Term Loan Facility.</span></div></ix:continuation><div style="margin-top:1pt"><span><br/></span></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_148"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 10.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxDisclosureTextBlock" id="f-1369" continuedAt="f-1369-1" escape="true">INCOME TAXES</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="f-1370" escape="true"><ix:continuation id="f-1369-1" continuedAt="f-1369-2"><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings before income taxes consisted of the following:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. loss before taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="6" id="f-1371">1,777</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="6" id="f-1372">1,918</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="f-1373">493</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign (loss) income before taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="f-1374">741</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="f-1375">293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="f-1376">847</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total (loss) income before taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-1377">2,518</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-1378">1,625</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-1379">354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:continuation id="f-1369-2" continuedAt="f-1369-3"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="f-1380" escape="true"><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax provision consisted of the following:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current tax provision</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="f-1381">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="f-1382">102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" sign="-" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="f-1383">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" format="ixt:fixed-zero" scale="6" id="f-1384">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="f-1385">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="f-1386">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="f-1387">359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="f-1388">325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="f-1389">303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current tax provision</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="f-1390">414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="f-1391">476</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="f-1392">311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax provision</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="f-1393">113</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="f-1394">77</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="f-1395">121</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="f-1396">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="f-1397">111</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="f-1398">34</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="f-1399">288</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="f-1400">49</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="f-1401">81</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax benefit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="f-1402">369</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="f-1403">237</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="f-1404">236</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-1405">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-1406">239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-1407">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Effective Tax Rate Reconciliation</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="f-1408" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reconciliation between the U.S. federal statutory income tax rate to the actual effective tax rate was as follows:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"/><td style="width:59.107%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.769%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.773%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statutory tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="f-1409">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-9" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="f-1410">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-10" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="f-1411">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effect of non-deductible goodwill impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" scale="-2" id="f-1412">20.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-9" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" scale="-2" id="f-1413">29.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-10" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" format="ixt:fixed-zero" scale="-2" id="f-1414">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Difference in effective tax rate on foreign earnings and remittances</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" scale="-2" id="f-1415">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-9" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" format="ixt:fixed-zero" scale="-2" id="f-1416">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-10" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" scale="-2" id="f-1417">8.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit from supply chain optimization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="iff:EffectiveIncomeTaxRateReconciliationTaxBenefitFromSupplyChainOptimizationPercent" scale="-2" id="f-1418">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-9" decimals="3" name="iff:EffectiveIncomeTaxRateReconciliationTaxBenefitFromSupplyChainOptimizationPercent" scale="-2" id="f-1419">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-10" decimals="3" sign="-" name="iff:EffectiveIncomeTaxRateReconciliationTaxBenefitFromSupplyChainOptimizationPercent" scale="-2" id="f-1420">5.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefit, net of reversals</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxExemptIncome" scale="-2" id="f-1421">0.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-9" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxExemptIncome" scale="-2" id="f-1422">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-10" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxExemptIncome" scale="-2" id="f-1423">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax impact on business divestitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" scale="-2" id="f-1424">3.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-9" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" scale="-2" id="f-1425">5.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-10" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" scale="-2" id="f-1426">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred taxes on deemed repatriation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="iff:EffectiveIncomeTaxRateReconciliationDeferredTaxesonDeemedRepatriationPercent" scale="-2" id="f-1427">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-9" decimals="3" sign="-" name="iff:EffectiveIncomeTaxRateReconciliationDeferredTaxesonDeemedRepatriationPercent" scale="-2" id="f-1428">5.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-10" decimals="3" name="iff:EffectiveIncomeTaxRateReconciliationDeferredTaxesonDeemedRepatriationPercent" scale="-2" id="f-1429">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Global intangible low-taxed income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationGiltiPercent" scale="-2" id="f-1430">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-9" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationGiltiPercent" scale="-2" id="f-1431">0.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-10" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationGiltiPercent" scale="-2" id="f-1432">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign-derived intangible income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationFdiiPercent" format="ixt:fixed-zero" scale="-2" id="f-1433">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-9" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationFdiiPercent" scale="-2" id="f-1434">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-10" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationFdiiPercent" scale="-2" id="f-1435">1.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. foreign tax credit - general limitation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" scale="-2" id="f-1436">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-9" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" scale="-2" id="f-1437">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-10" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" scale="-2" id="f-1438">3.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="f-1439">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-9" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="f-1440">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-10" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="f-1441">1.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="iff:EffectiveIncomeTaxRateReconciliationAcquisitionCostsPercent" format="ixt:fixed-zero" scale="-2" id="f-1442">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-9" decimals="3" name="iff:EffectiveIncomeTaxRateReconciliationAcquisitionCostsPercent" format="ixt:fixed-zero" scale="-2" id="f-1443">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-10" decimals="3" name="iff:EffectiveIncomeTaxRateReconciliationAcquisitionCostsPercent" scale="-2" id="f-1444">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Establishment (release) of valuation allowance on state deferred</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:fixed-zero" scale="-2" id="f-1445">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-9" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:fixed-zero" scale="-2" id="f-1446">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-10" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="f-1447">3.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local taxes including rate changes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="f-1448">1.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-9" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="f-1449">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-10" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="f-1450">4.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax impact on internal asset transfer</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="iff:EffectiveIncomeTaxRateReconciliationTaxImpactOnInternalAssetTransferPercent" scale="-2" id="f-1451">5.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-9" decimals="3" name="iff:EffectiveIncomeTaxRateReconciliationTaxImpactOnInternalAssetTransferPercent" format="ixt:fixed-zero" scale="-2" id="f-1452">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-10" decimals="3" name="iff:EffectiveIncomeTaxRateReconciliationTaxImpactOnInternalAssetTransferPercent" format="ixt:fixed-zero" scale="-2" id="f-1453">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="f-1454">2.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-9" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="f-1455">2.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-10" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="f-1456">2.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-1457">1.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-9" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-1458">14.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-10" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-1459">21.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________ </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For 2021, the rate includes rate change impacts related to the Netherlands and United Kingdom.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For 2022 and 2023, the rate includes the establishment of the held for sale deferred tax liabilities due to a change in assertion.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For 2022 and 2023, the rate includes rate change impacts related to the remeasurement of the state tax rate on deferred taxes.</span></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rate reflects the recording of the tax effects of the divestitures of the portion of the Savory Solutions business and Flavor Specialty Ingredients business and book to tax differences related to the impairment of goodwill in the Nourish reporting unit.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has elected to treat global intangible low-taxed income (&#8220;GILTI&#8221;) as a current period cost if and when incurred. This tax position resulted in a net income tax expense of approximately $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:EffectiveIncomeTaxRateReconciliationGiltiAmount" format="ixt:num-dot-decimal" scale="6" id="f-1460">64</ix:nonFraction> million for the year ended December&#160;31, 2023, offset in part by foreign tax credits of approximately $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:EffectiveIncomeTaxRateReconciliationFdiiAmount" format="ixt:num-dot-decimal" scale="6" id="f-1461">54</ix:nonFraction> million.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:continuation id="f-1369-3" continuedAt="f-1369-4"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Deferred Taxes</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="f-1462" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The deferred tax assets and liabilities consisted of the following amounts:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee and retiree benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits" scale="6" id="f-1463">118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits" scale="6" id="f-1464">61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credit and net operating loss carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:OperatingLossCarryforwards" scale="6" id="f-1465">332</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:OperatingLossCarryforwards" scale="6" id="f-1466">315</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortizable research and development expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" scale="6" id="f-1467">125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" scale="6" id="f-1468">84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest limitation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="iff:DeferredTaxAssetsInterestLimitations" scale="6" id="f-1469">127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="iff:DeferredTaxAssetsInterestLimitations" scale="6" id="f-1470">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:DeferredTaxAssetsInventory" scale="6" id="f-1471">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:DeferredTaxAssetsInventory" scale="6" id="f-1472">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="iff:DeferredTaxAssetsLeaseObligations" scale="6" id="f-1473">170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="iff:DeferredTaxAssetsLeaseObligations" scale="6" id="f-1474">151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="f-1475">114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="f-1476">131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="6" id="f-1477">1,021</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:DeferredTaxAssetsGross" scale="6" id="f-1478">764</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="6" id="f-1479">239</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="6" id="f-1480">229</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="f-1481">1,792</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="f-1482">2,049</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="iff:DeferredTaxLiabilitiesRightOfUseAssets" scale="6" id="f-1483">170</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="iff:DeferredTaxLiabilitiesRightOfUseAssets" scale="6" id="f-1484">151</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="iff:DeferredTaxLiabilitiesGainLossOnForeignCurrencyTranslation" format="ixt:fixed-zero" scale="6" id="f-1485">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="iff:DeferredTaxLiabilitiesGainLossOnForeignCurrencyTranslation" scale="6" id="f-1486">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred taxes on deemed repatriation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="iff:DeferredTaxLiabilitiesDeemedRepatriation" scale="6" id="f-1487">155</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="iff:DeferredTaxLiabilitiesDeemedRepatriation" scale="6" id="f-1488">166</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-1489">2,356</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-1490">2,618</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="f-1491">324</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="f-1492">262</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net deferred tax liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-1493">1,659</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-1494">2,116</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes deferred taxes on intangible assets owned by a fully consolidated partnership.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net operating loss carryforwards were approximately $<ix:nonFraction unitRef="usd" contextRef="c-329" decimals="-6" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-1495">311</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-330" decimals="-6" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-1496">301</ix:nonFraction> million as of December&#160;31, 2023 and 2022, respectively. If unused, approximately $<ix:nonFraction unitRef="usd" contextRef="c-329" decimals="-6" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" format="ixt:num-dot-decimal" scale="6" id="f-1497">106</ix:nonFraction> million will expire between 2024 and 2043. The remainder, totaling approximately $<ix:nonFraction unitRef="usd" contextRef="c-331" decimals="-6" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-1498">205</ix:nonFraction> million, may be carried forward indefinitely. Tax credit carryforwards were approximately $<ix:nonFraction unitRef="usd" contextRef="c-329" decimals="-6" name="us-gaap:TaxCreditCarryforwardAmount" format="ixt:num-dot-decimal" scale="6" id="f-1499">21</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-330" decimals="-6" name="us-gaap:TaxCreditCarryforwardAmount" format="ixt:num-dot-decimal" scale="6" id="f-1500">14</ix:nonFraction> million as of December&#160;31, 2023 and 2022, respectively. If unused, the $<ix:nonFraction unitRef="usd" contextRef="c-329" decimals="-6" name="us-gaap:TaxCreditCarryforwardAmount" format="ixt:num-dot-decimal" scale="6" id="f-1501">21</ix:nonFraction> million will expire between 2024 and 2043.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Of the deferred tax assets at December&#160;31, 2023, the Company considers it unlikely that a portion of the tax benefit will be realized. Accordingly, a valuation allowance of approximately $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:OperatingLossCarryforwardsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="f-1502">324</ix:nonFraction> million has been established against these deferred tax assets.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Uncertain Tax Positions</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:SummaryOfIncomeTaxContingenciesTextBlock" id="f-1503" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance of unrecognized tax benefits at beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="f-1504">112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="f-1505">130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="f-1506">99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amount of increases in unrecognized tax benefits as a result of positions taken during a prior year</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="f-1507">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="f-1508">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="f-1509">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amount of decreases in unrecognized tax benefits as a result of positions taken during a prior year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" format="ixt:fixed-zero" scale="6" id="f-1510">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="f-1511">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="f-1512">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amount of increases in unrecognized tax benefits as a result of positions taken during the current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="f-1513">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="f-1514">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="f-1515">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The amounts of decreases in unrecognized benefits relating to settlements with taxing authorities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="f-1516">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="f-1517">27</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="f-1518">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reduction in unrecognized tax benefits due to the lapse of applicable statute of limitation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="f-1519">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="f-1520">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="f-1521">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance of unrecognized tax benefits at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="f-1522">123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="f-1523">112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="f-1524">130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For 2021, the amount includes positions related to N&amp;B opening balance sheet amounts.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:continuation id="f-1369-4"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, 2022 and 2021, there were approximately $<ix:nonFraction unitRef="usd" contextRef="c-332" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="f-1525">123</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-333" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="f-1526">98</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-334" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="f-1527">130</ix:nonFraction> million, respectively, of unrecognized tax benefits recorded to Other liabilities. There were <ix:nonFraction unitRef="usd" contextRef="c-335" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:fixed-zero" scale="6" id="f-1528">no</ix:nonFraction> amounts recorded to Other current liabilities for 2023. There were approximately $<ix:nonFraction unitRef="usd" contextRef="c-336" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="f-1529">14</ix:nonFraction> million and less than $<ix:nonFraction unitRef="usd" contextRef="c-337" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="f-1530">1</ix:nonFraction> million recorded to Other current liabilities for 2022 and 2021, respectively. If these unrecognized tax benefits were recognized, all the benefits and related interest and penalties would be recorded as a benefit to income tax expense.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company increased its liabilities for interest and penalties by approximately $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="iff:AccruedInterestOrPenaltiesRelatedToTaxAmounts" format="ixt:num-dot-decimal" scale="6" id="f-1531">12</ix:nonFraction> million, net, for the year ended December&#160;31, 2023. The Company decreased its liabilities for interest and penalties by approximately $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="iff:AccruedInterestOrPenaltiesRelatedToTaxAmounts" format="ixt:num-dot-decimal" scale="6" id="f-1532">1</ix:nonFraction> million, net, and increased its liabilities for interest and penalties by approximately $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="iff:AccruedInterestOrPenaltiesRelatedToTaxAmounts" format="ixt:num-dot-decimal" scale="6" id="f-1533">19</ix:nonFraction> million, net, for the years ended December&#160;31, 2022 and 2021, respectively. As of December&#160;31, 2023, 2022 and 2021, the Company had accrued approximately $<ix:nonFraction unitRef="usd" contextRef="c-338" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="f-1534">47</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-339" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="f-1535">31</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-340" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="f-1536">36</ix:nonFraction> million, respectively, of interest and penalties classified as Other liabilities. As of December&#160;31, 2023, the Company had <ix:nonFraction unitRef="usd" contextRef="c-341" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:fixed-zero" scale="6" id="f-1537">no</ix:nonFraction> accruals of interest and penalties classified as Other current liabilities. As of December&#160;31, 2022 and 2021, the Company had accrued approximately $<ix:nonFraction unitRef="usd" contextRef="c-342" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="f-1538">4</ix:nonFraction> million and less than $<ix:nonFraction unitRef="usd" contextRef="c-343" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="f-1539">1</ix:nonFraction> million, respectively, of interest and penalties classified as Other current liabilities.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, the Company&#8217;s aggregate provision for unrecognized tax benefits, including interest and penalties, was approximately $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="iff:UnrecognizedTaxBenefitsIncludingInterestAndPenalties" format="ixt:num-dot-decimal" scale="6" id="f-1540">170</ix:nonFraction> million associated with various tax positions principally asserted in foreign jurisdictions. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, all the unrecognized tax benefits, if recognized, would affect the effective tax rate. The total changes to uncertain tax positions over the next 12 months is impracticable to estimate and is dependent on the resolution of new or existing tax disputes.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax benefits credited to Shareholders&#8217; equity were not material for the years ended December 31, 2023, 2022 and 2021 associated with stock option exercises and PRSU dividends.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company regularly repatriates earnings from non-U.S. subsidiaries. As the Company repatriates these funds to the U.S.,&#160;there will be required income taxes payable in certain U.S. states and applicable foreign withholding taxes during the period when such repatriation occurs.&#160;Accordingly, as of&#160;December 31, 2023, the Company had a deferred tax liability of approximately $<ix:nonFraction unitRef="usd" contextRef="c-344" decimals="-6" name="iff:DeferredTaxLiabilitiesDeemedRepatriation" format="ixt:num-dot-decimal" scale="6" id="f-1541">155</ix:nonFraction> million for the effect of repatriating the funds to the U.S., attributable to various non-U.S. subsidiaries. There is <ix:nonFraction unitRef="usd" contextRef="c-345" decimals="-6" name="iff:DeferredTaxLiabilitiesDeemedRepatriation" format="ixt:fixed-zero" scale="0" id="f-1542">no</ix:nonFraction> deferred tax liability associated with non-U.S. subsidiaries where the Company intends to indefinitely reinvest the earnings to fund local operations and/or capital projects.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has ongoing income tax audits and legal proceedings which are at various stages of administrative or judicial review. In addition, the Company has other ongoing tax audits and legal proceedings that relate to indirect taxes, such as value-added taxes, capital tax, sales and use and property taxes, which are discussed in Note 19.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has several other tax audits in process and has open tax years with various taxing jurisdictions that range primarily from 2010 to 2022.</span></div></ix:continuation><div><span><br/></span></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_151"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 11.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerShareTextBlock" id="f-1543" continuedAt="f-1543-1" escape="true">NET (LOSS) INCOME PER SHARE</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" id="f-1544" continuedAt="f-1544-1" escape="true"><ix:continuation id="f-1543-1" continuedAt="f-1543-2"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted net (loss) income per share is based on the weighted average number of shares outstanding. A reconciliation of shares used in the computation of basic and diluted net (loss) income per share is as follows:</span></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:53.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.541%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.541%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.542%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(AMOUNTS IN MILLIONS EXCEPT PER SHARE AMOUNTS)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net (Loss) Income</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income attributable to IFF shareholders</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="6" id="f-1545">2,567</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="6" id="f-1546">1,871</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="f-1547">270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustment related to decrease (increase) in redemption value of redeemable non-controlling interests in excess of earnings allocated</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="iff:IncreaseDecreaseInRedemptionValueRedeemableNoncontrollingInterest" scale="6" id="f-1548">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" sign="-" name="iff:IncreaseDecreaseInRedemptionValueRedeemableNoncontrollingInterest" scale="6" id="f-1549">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="iff:IncreaseDecreaseInRedemptionValueRedeemableNoncontrollingInterest" scale="6" id="f-1550">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income available to IFF shareholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="iff:NetIncomeLossAvailableToCommonStockholdersAdjustment" format="ixt:num-dot-decimal" scale="6" id="f-1551">2,565</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" sign="-" name="iff:NetIncomeLossAvailableToCommonStockholdersAdjustment" format="ixt:num-dot-decimal" scale="6" id="f-1552">1,868</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="iff:NetIncomeLossAvailableToCommonStockholdersAdjustment" scale="6" id="f-1553">268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding (basic)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-1554">255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-9" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-1555">255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-1556">243</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares assuming dilution (diluted)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-1557">255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-9" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-1558">255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-1559">243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net (Loss) Income per Share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income per share - basic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1560">10.05</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-9" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1561">7.32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-10" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1562">1.11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income per share - diluted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1563">10.05</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-9" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1564">7.32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-10" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1565">1.10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 85</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:continuation id="f-1543-2"><ix:continuation id="f-1544-1"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________&#160;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">On September 15, 2021, additional shares of IFF&#8217;s common stock were issued in settlement of the SPC portion of the TEUs. See below for additional information.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For the years ended December&#160;31, 2023, 2022 and 2021, the basic net (loss) income per share cannot be recalculated based on the information presented in the table above due to the effects of rounding.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For the years ended December&#160;31, 2023 and 2022, the diluted net loss per share cannot be recalculated based on the information presented in the table above due to the effects of rounding.</span></div></ix:continuation><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the effective time of the Merger, each issued and outstanding share of common stock of N&amp;B (except for shares of common stock of N&amp;B held by N&amp;B as treasury stock or by DuPont, which were canceled and ceased to exist and no consideration was delivered in exchange therefor) was converted into the right to receive one share of common stock of IFF. The Merger was completed in exchange for <ix:nonFraction unitRef="shares" contextRef="c-161" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-1566">141,740,461</ix:nonFraction> shares of IFF common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="c-169" decimals="3" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-1567">0.125</ix:nonFraction> per share (or cash payment in lieu of fractional shares), which had been approved in the special shareholder meeting that occurred on August 27, 2020 where IFF shareholders voted to approve the issuance of shares of IFF common stock in connection with the N&amp;B Transaction, pursuant to the Merger Agreement. The shares issued in the Merger represented approximately <ix:nonFraction unitRef="number" contextRef="c-163" decimals="3" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="f-1568">55.4</ix:nonFraction>% of the common stock of IFF on a fully diluted basis, after giving effect to the Merger, as of February 1, 2021.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company issued&#160;<ix:nonFraction unitRef="shares" contextRef="c-346" decimals="0" name="iff:TangibleEquityUnitsIssued" format="ixt:num-dot-decimal" scale="0" id="f-1569">16,500,000</ix:nonFraction>&#160;TEUs, consisting of a prepaid SPC and a senior amortizing note, for net proceeds of&#160;approximately $<ix:nonFraction unitRef="usd" contextRef="c-346" decimals="-6" name="iff:TangibleEquityUnitsProceeds" format="ixt:num-dot-decimal" scale="6" id="f-1570">800</ix:nonFraction> million on September 17, 2018. On September 14, 2021, the Company notified holders of the TEUs that the final settlement rate in respect of each SPC was <ix:nonFraction unitRef="usdPerShare" contextRef="c-347" decimals="6" name="iff:TangibleEquityUnitsFinalSettlementRate" scale="0" id="f-1571">0.330911</ix:nonFraction> shares of IFF&#8217;s common stock. On September 15, 2021, <ix:nonFraction unitRef="shares" contextRef="c-348" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" format="ixt:num-dot-decimal" scale="0" id="f-1572">5,460,031</ix:nonFraction> shares of IFF's common stock were issued in settlement of the SPCs. The SPC conversion factor is based on the volume-weighted average price (&#8220;VWAP&#8221;) per share of the Company&#8217;s common stock. For purposes of calculating basic net income per share, the settlement rate of <ix:nonFraction unitRef="usdPerShare" contextRef="c-10" decimals="6" name="iff:TangibleEquityUnitsPriceforSharesBasic" scale="0" id="f-1573">0.330911</ix:nonFraction> shares per SPC, the final settlement rate, was used on December 31, 2021. For purposes of calculating diluted net income per share, the settlement rate of <ix:nonFraction unitRef="usdPerShare" contextRef="c-10" decimals="6" name="iff:TangibleEquityUnitsPriceforSharesDiluted" scale="0" id="f-1574">0.330911</ix:nonFraction> shares per SPC, the final settlement rate, was used on December 31, 2021.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has issued shares of Purchased Restricted Stock Units (&#8220;PRSUs&#8221;) which contain non-forfeitable rights to dividends and thus are considered participating securities which are required to be included in the computation of basic and diluted earnings per share pursuant to the two-class method. The two-class method was not presented since there was <ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="INF" name="iff:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenBasicNetIncomeLossPerShare" format="ixt-sec:numwordsen" scale="0" id="f-1575"><ix:nonFraction unitRef="usdPerShare" contextRef="c-9" decimals="INF" name="iff:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenBasicNetIncomeLossPerShare" format="ixt-sec:numwordsen" scale="0" id="f-1576"><ix:nonFraction unitRef="usdPerShare" contextRef="c-10" decimals="INF" name="iff:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenBasicNetIncomeLossPerShare" format="ixt-sec:numwordsen" scale="0" id="f-1577">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> difference between basic net (loss) income per share for both common shareholders and PRSU holders for the years ended December 31, 2023, 2022 and 2021, and there was <ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="INF" name="iff:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenDilutedNetIncomeLossPerShare" format="ixt-sec:numwordsen" scale="0" id="f-1578"><ix:nonFraction unitRef="usdPerShare" contextRef="c-9" decimals="INF" name="iff:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenDilutedNetIncomeLossPerShare" format="ixt-sec:numwordsen" scale="0" id="f-1579">no</ix:nonFraction></ix:nonFraction> difference between diluted net loss per share for both common shareholders and PRSU holders for the years ended December&#160;31, 2023 and 2022. The difference between diluted net income per share for both common shareholders and PRSU holders was less than $<ix:nonFraction unitRef="usdPerShare" contextRef="c-10" decimals="INF" name="iff:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenDilutedNetIncomeLossPerShare" scale="0" id="f-1580">0.01</ix:nonFraction> per share for the year ended December 31, 2021. In addition, for each year, the number of PRSUs outstanding as of December&#160;31, 2023, 2022 and 2021 was not material. Net loss allocated to such PRSUs during 2023 and 2022 was not material and net income allocated to such PRSUs during 2021 was not material.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were approximately <ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="f-1581">0.2</ix:nonFraction>&#160;million and <ix:nonFraction unitRef="shares" contextRef="c-9" decimals="INF" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="f-1582">0.3</ix:nonFraction>&#160;million potentially dilutive securities excluded from the computation of diluted net loss per share for the years ended December&#160;31, 2023 and 2022, respectively, because there was a net loss attributable to IFF for the periods and, as such, the inclusion of these securities would have been anti-dilutive.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2023 and 2022, there were approximately <ix:nonFraction unitRef="shares" contextRef="c-349" decimals="INF" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="f-1583">0.4</ix:nonFraction>&#160;million and <ix:nonFraction unitRef="shares" contextRef="c-350" decimals="INF" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="f-1584">0.3</ix:nonFraction>&#160;million share equivalents that had an anti-dilutive effect and therefore were excluded from the computation of diluted net loss per share. There were <ix:nonFraction unitRef="shares" contextRef="c-351" decimals="INF" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt-sec:numwordsen" scale="6" id="f-1585">no</ix:nonFraction> share equivalents excluded from the computation of diluted net income per share for the year ended December&#160;31, 2021.</span></div></ix:continuation><div style="text-indent:24.75pt"><span><br/></span></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_154"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 12.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="f-1586" continuedAt="f-1586-1" escape="true">SHAREHOLDERS&#8217; EQUITY </ix:nonNumeric></span></div><ix:continuation id="f-1586-1"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash dividends declared per share were $<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-1587">3.24</ix:nonFraction>, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-9" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-1588">3.20</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="c-10" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-1589">3.12</ix:nonFraction> for the years ended December 31, 2023, 2022 and 2021, respectively. The Consolidated Balance Sheets reflect $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:DividendsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="f-1590">207</ix:nonFraction> million of dividends payable at December&#160;31, 2023. This amount relates to a cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-11" decimals="INF" name="us-gaap:DividendsPayableAmountPerShare" scale="0" id="f-1591">0.81</ix:nonFraction> per share declared in December 2023 and paid in January 2024. Dividends declared, but not paid as of December&#160;31, 2022 and December&#160;31, 2021 were $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:DividendsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="f-1592">206</ix:nonFraction> million ($<ix:nonFraction unitRef="usdPerShare" contextRef="c-12" decimals="INF" name="us-gaap:DividendsPayableAmountPerShare" scale="0" id="f-1593">0.81</ix:nonFraction> per share) and $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:DividendsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="f-1594">201</ix:nonFraction> million ($<ix:nonFraction unitRef="usdPerShare" contextRef="c-13" decimals="INF" name="us-gaap:DividendsPayableAmountPerShare" scale="0" id="f-1595">0.79</ix:nonFraction> per share), respectively.</span></div></ix:continuation><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:47.798%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.346%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.349%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_157"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 13.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="f-1596" continuedAt="f-1596-1" escape="true">STOCK COMPENSATION PLANS</ix:nonNumeric></span></div><ix:continuation id="f-1596-1" continuedAt="f-1596-2"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has various equity plans under which its officers, senior management, other key employees and Board of Directors may be granted options to purchase IFF common stock or other forms of stock-based awards.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cost of all employee stock-based awards are principally recognized on a straight-line attribution basis over their respective vesting periods, net of estimated forfeitures. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" id="f-1597" continuedAt="f-1597-1" escape="true">Total stock-based compensation expense included in the Consolidated Statements of (Loss) Income and Comprehensive Loss was as follows:</ix:nonNumeric></span><ix:continuation id="f-1597-1" continuedAt="f-1597-2"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></ix:continuation></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 86</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:continuation id="f-1596-2" continuedAt="f-1596-3"><ix:continuation id="f-1597-2"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity-based awards</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-352" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-1598">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-353" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-1599">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-354" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-1600">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability-based awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-355" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-1601">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-356" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-1602">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-357" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-1603">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-1604">67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-1605">51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-1606">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="f-1607">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="f-1608">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="f-1609">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation, net of tax</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="f-1610">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="f-1611">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="f-1612">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The shareholders of the Company approved the Company&#8217;s 2021 Stock Award and Incentive Plan (the &#8220;2021 Plan&#8221;) on May 5, 2021.&#160;The 2021 Plan replaced the Company&#8217;s 2015 Stock Award and Incentive Plan (the &#8220;2015 Plan&#8221;) and the Company&#8217;s 2010 Stock Award and Incentive Plan (the &#8220;2010 Plan&#8221;), and provides the source for future deferrals of cash into deferred stock under the Company&#8217;s Deferred Compensation Plan (with the Deferred Compensation Plan being deemed a subplan under the 2010 Plan for the sole purpose of funding deferrals under the IFF Share Fund).</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the 2021 Plan, a total of <ix:nonFraction unitRef="shares" contextRef="c-358" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-1613">2,290,000</ix:nonFraction> shares were authorized for issuance. As of December&#160;31, 2023, <ix:nonFraction unitRef="shares" contextRef="c-11" decimals="INF" name="iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesSubjectToOutstandingAwards" format="ixt:num-dot-decimal" scale="0" id="f-1614">1,817,519</ix:nonFraction> shares were subject to outstanding awards and <ix:nonFraction unitRef="shares" contextRef="c-11" decimals="INF" name="iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-1615">748,082</ix:nonFraction> shares remained available for future awards under all of the Company&#8217;s equity award plans, including the 2015 Plan and 2010 Plan (excluding shares not yet issued under open cycles of the Company&#8217;s Long-Term Incentive Plan).</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers a Long-Term Incentive Plan (&#8220;LTIP&#8221;) for senior management. The targeted payout is principally <ix:nonFraction unitRef="number" contextRef="c-359" decimals="INF" name="iff:TargetPayoutCash" scale="-2" id="f-1616">50</ix:nonFraction>% cash and <ix:nonFraction unitRef="number" contextRef="c-359" decimals="INF" name="iff:TargetPayoutStock" scale="-2" id="f-1617">50</ix:nonFraction>% IFF common stock at the end of the <ix:nonNumeric contextRef="c-9" name="iff:TargetPayoutPeriodOfCycle" format="ixt-sec:durwordsen" id="f-1618">three-year</ix:nonNumeric> cycle. Beginning 2023, the targeted payout for all new cycles is <ix:nonFraction unitRef="number" contextRef="c-360" decimals="INF" name="iff:TargetPayoutStock" scale="-2" id="f-1619">100</ix:nonFraction>% IFF common stock at the end of the <ix:nonNumeric contextRef="c-1" name="iff:TargetPayoutPeriodOfCycle" format="ixt-sec:durwordsen" id="f-1620">three-year</ix:nonNumeric> cycle.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the 2021-2023 cycle, the LTIP awards are earned based on the achievement of: (i) an annual Leverage Ratio for 2021, 2022 and 2023 (representing one-half of the award value) and (ii) Relative TSR targets (representing one-half of the award value). For the 2022-2024 and 2023-2025 cycles, the LTIP awards are earned based on the achievement of: (i) 3-year cumulative Return on Invested Capital (&#8220;ROIC&#8221;) (representing one-half of the award value) and (ii) Relative TSR targets (representing one-half of the award value).</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Leverage Ratio measures Net debt as compared to a measure profitability. The ROIC measures adjusted net operating profit after tax against average invested capital. When the award is granted, <ix:nonFraction unitRef="number" contextRef="c-1" decimals="INF" name="iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetDollarValueOfAwardIsConvertedToNumberOfNotionalSharesWhenAwardIsGranted" scale="-2" id="f-1621">50</ix:nonFraction>% of the target dollar value of the award is converted to a number of &#8220;notional&#8221; shares based on the closing price at the beginning of the cycle. For those shares whose payout is based on Relative TSR, compensation expense is recognized using a graded-vesting attribution method, while compensation expense for the remainder of the performance shares (Leverage Ratio or ROIC targets for the applicable cycle) is recognized on a straight-line basis over the vesting period based on the probable outcome of the performance condition.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2019-2021 cycle concluded at the end of 2021 and <ix:nonFraction unitRef="shares" contextRef="c-361" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:fixed-zero" scale="0" id="f-1622">no</ix:nonFraction> shares of common stock were issued in March 2022. The 2020-2022 cycle concluded at the end of 2022 and <ix:nonFraction unitRef="shares" contextRef="c-362" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:fixed-zero" scale="0" id="f-1623">no</ix:nonFraction> shares of common stock were issued in March 2023. The 2021-2023 cycle concluded at the end of 2023 and <ix:nonFraction unitRef="shares" contextRef="c-363" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-1624">5,333</ix:nonFraction> shares of common stock will be issued in March 2024.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2006, the Board of Directors approved the Equity Choice Program (the &#8220;Program&#8221;) for senior management. This program continued under the 2021 Plan. Eligible employees were allowed to choose from among three equity alternatives and were granted such equity awards up to certain dollar awards depending on the participant&#8217;s employment grade level. A participant was able to choose among (1)&#160;Stock-Settled Appreciation Rights (&#8220;SSARs&#8221;), (2)&#160;Restricted Stock Units (&#8220;RSUs&#8221;) or (3)&#160;PRSUs. Beginning 2023, the Company no longer offers the choice from among three equity alternatives and all eligible employees are granted RSUs.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Transaction with Nutrition and Biosciences, Inc.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Merger, N&amp;B employees&#8217; outstanding (unvested and/or vested and unexercised) equity awards were converted into equity awards denominated in shares of the Company&#8217;s common stock based on a defined exchange ratio. N&amp;B employees&#8217; equity awards were converted into <ix:nonFraction unitRef="shares" contextRef="c-364" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-1625">335,347</ix:nonFraction> IFF stock options, <ix:nonFraction unitRef="shares" contextRef="c-365" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-1626">258,572</ix:nonFraction> IFF RSU awards and <ix:nonFraction unitRef="shares" contextRef="c-366" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-1627">5,816</ix:nonFraction> IFF SAR awards.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For converted RSU awards, the fair value of the equity award is based on the Closing Date market price of IFF stock. For converted stock options and SAR awards, the exercise price per share of the converted award is equal to the exercise price per share of the N&amp;B award immediately prior to the Merger divided by the exchange ratio. The fair value of the IFF stock options and SAR awards that the Company issued in connection with the Merger was estimated using the Black Scholes model.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The converted awards were generally issued with the same terms and conditions as were applicable prior to the Transaction. At the Closing Date, approximately $<ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-6" name="us-gaap:EquityIssuedInBusinessCombinationFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-1628">25</ix:nonFraction>&#160;million of the fair value of the replacement awards granted to N&amp;B employees was attributable to pre-combination service and was included in the purchase price. As of December&#160;31, 2023, there </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 87</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:continuation id="f-1596-3" continuedAt="f-1596-4"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was <ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:fixed-zero" scale="6" id="f-1629">no</ix:nonFraction> remaining post-combination expense to be recognized related to the replacement awards over the remaining post-combination service period, which was approximately up to <ix:nonNumeric contextRef="c-90" name="iff:BusinessAcquisitionPostCombinationServicePeriod" format="ixt-sec:durwordsen" id="f-1630">three years</ix:nonNumeric>.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SSARs and Options</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SSARs are a contractual right to receive the value, in shares of Company stock, of the appreciation in our stock price from the grant date to the date the SSARs are exercised by the participant. SSARs granted become exercisable on the third anniversary of the grant date and have a maximum term of <ix:nonNumeric contextRef="c-367" name="iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTerm" format="ixt-sec:durwordsen" id="f-1631">seven years</ix:nonNumeric>. SSARs do not require a financial investment by the SSARs grantee. Stock options require the participant to pay the exercise price at the time they exercise their stock options. No stock options were granted in 2023, 2022 or 2021.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock" id="f-1632" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SSARs and options activity was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:49.926%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.735%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.735%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.738%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(SHARE AMOUNTS IN THOUSANDS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares&#160;Subject&#160;to<br/>SSARs/Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average&#160;Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SSARs/<br/>Options<br/>Exercisable</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-368" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="f-1633">331</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-368" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-1634">115.35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-368" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="3" id="f-1635">182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-369" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" format="ixt:fixed-zero" scale="3" id="f-1636">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-369" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" format="ixt:fixed-zero" scale="0" id="f-1637">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-369" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="f-1638">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-369" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-1639">68.67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-369" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="3" id="f-1640">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-369" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="f-1641">122.28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-370" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="f-1642">315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-370" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-1643">116.26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-370" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="3" id="f-1644">194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected to Vest at December&#160;31, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-370" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" scale="3" id="f-1645">118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-370" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="f-1646">126.99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average exercise price of SSARs and options exercisable at December&#160;31, 2023, 2022 and 2021 were $<ix:nonFraction unitRef="usdPerShare" contextRef="c-370" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="f-1647">109.59</ix:nonFraction>, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-368" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="f-1648">109.50</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="c-371" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="f-1649">109.77</ix:nonFraction>, respectively.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" id="f-1650" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SSARs and options outstanding at December&#160;31, 2023 was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:30.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.298%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.444%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.298%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.300%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Price Range</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number<br/>Outstanding<br/>(in&#160;thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Remaining<br/>Contractual Life<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise&#160;Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic&#160;Value<br/>(in millions)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Over $65</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-372" decimals="-3" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" scale="3" id="f-1651">315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-373" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-1652">4.71</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-372" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" scale="0" id="f-1653">116.26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-372" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:fixed-zero" scale="6" id="f-1654">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SSARs and options exercisable as of December&#160;31, 2023 was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.917%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.279%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Price Range</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number<br/>Exercisable<br/>(in&#160;thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Remaining<br/>Contractual&#160;Life<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise&#160;Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic&#160;Value<br/>(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Over $65</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-372" decimals="-3" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" scale="3" id="f-1655">194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-373" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-1656">4.33</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-372" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" scale="0" id="f-1657">109.59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-372" decimals="-6" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:fixed-zero" scale="6" id="f-1658">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total intrinsic value of options/SSARs exercised during 2023 was less than $<ix:nonFraction unitRef="usd" contextRef="c-369" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="f-1659">1</ix:nonFraction>&#160;million and approximately $<ix:nonFraction unitRef="usd" contextRef="c-374" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="f-1660">2</ix:nonFraction>&#160;million for 2022 and $<ix:nonFraction unitRef="usd" contextRef="c-375" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="f-1661">3</ix:nonFraction>&#160;million for 2021.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, the total unrecognized compensation cost related to non-vested SSARs granted was approximately $<ix:nonFraction unitRef="usd" contextRef="c-376" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="f-1662">1</ix:nonFraction> million; such cost is expected to be recognized over a weighted average period of approximately <ix:nonNumeric contextRef="c-367" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="f-1663">1.14</ix:nonNumeric> years.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Stock Units</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has granted RSUs to eligible employees and members of the Board of Directors. The Company has granted both time-based RSUs, which contain no performance criteria provisions, and performance-based RSUs. Such RSUs are subject to forfeitures or adjustments if certain conditions are not met, including service period or pre-established cumulative performance targets. RSUs principally vest <ix:nonFraction unitRef="number" contextRef="c-377" decimals="INF" name="iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentage" scale="-2" id="f-1664">100</ix:nonFraction>% at the end of <ix:nonNumeric contextRef="c-377" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-1665">three years</ix:nonNumeric>. An RSU&#8217;s fair value is calculated based on the market price of the Company&#8217;s stock at date of grant, with an adjustment to reflect the fact that such awards do not participate in dividend rights. The aggregate fair value is amortized to expense ratably over the vesting period.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 88</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:continuation id="f-1596-4" continuedAt="f-1596-5"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" id="f-1666" continuedAt="f-1666-1" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSU activity was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:55.644%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.160%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.163%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(SHARE AMOUNTS IN THOUSANDS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number&#160;of Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Grant Date Fair<br/>Value Per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-378" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="f-1667">937</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-378" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-1668">120.81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-377" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="f-1669">843</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-377" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1670">87.31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-377" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="f-1671">315</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-377" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1672">119.15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-377" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="f-1673">78</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-377" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-1674">105.63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change due to performance conditions, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-377" decimals="-3" name="iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsChangeDueToPerformanceConditions" scale="3" id="f-1675">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-377" decimals="2" name="iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsChangeDueToPerformanceConditionsWeightedAverageGrantDateFairValue" scale="0" id="f-1676">134.04</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-379" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="3" id="f-1677">1,367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-379" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-1678">101.50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total fair value of RSUs that vested during the year ended December&#160;31, 2023 was approximately $<ix:nonFraction unitRef="usd" contextRef="c-377" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="f-1679">38</ix:nonFraction> million.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, there was approximately $<ix:nonFraction unitRef="usd" contextRef="c-379" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="f-1680">67</ix:nonFraction> million of total unrecognized compensation cost related to non-vested RSUs granted under the equity incentive plans; such cost is expected to be recognized over a weighted average period of approximately <ix:nonNumeric contextRef="c-377" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="f-1681">1.94</ix:nonNumeric> years.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Purchased Restricted Stock Units</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The grant of awards under the Program provided for eligible employees to purchase shares of IFF common stock and deposit them into an escrow account. For each share deposited in escrow by the eligible employee, the Company matched with the grant of a restricted stock unit. The shares of restricted stock units generally vest on the third anniversary of the grant date, are subject to continued employment and other specified conditions, and pay dividends if and when paid by the Company. Holders of restricted stock units have, in most instances, all of the rights of shareholders, except that they may not sell, assign, pledge or otherwise encumber such shares. PRSUs pay dividend equivalents and do not have voting rights.</span></div><ix:nonNumeric contextRef="c-1" name="iff:ShareBasedPaymentArrangementPurchasedRestrictedStockUnitActivityTableTextBlock" id="f-1682" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s PRSU activity for the years ended December 31, 2023, 2022 and 2021:</span></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:35.317%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:22.541%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:17.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Issued Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate Purchases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Covered Shares</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-380" decimals="INF" name="iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedPurchasedByEmployees" format="ixt:fixed-zero" scale="0" id="f-1683">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-380" decimals="-6" name="iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValueOfSharesPurchasedByEmployees" format="ixt:fixed-zero" scale="6" id="f-1684">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-380" decimals="INF" name="iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesPurchasedByEmployees" format="ixt:fixed-zero" scale="0" id="f-1685">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-381" decimals="INF" name="iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedPurchasedByEmployees" format="ixt:num-dot-decimal" scale="0" id="f-1686">43,690</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-381" decimals="-6" name="iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValueOfSharesPurchasedByEmployees" scale="6" id="f-1687">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-381" decimals="INF" name="iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesPurchasedByEmployees" format="ixt:num-dot-decimal" scale="0" id="f-1688">21,845</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-382" decimals="INF" name="iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedPurchasedByEmployees" format="ixt:num-dot-decimal" scale="0" id="f-1689">61,870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-382" decimals="-6" name="iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValueOfSharesPurchasedByEmployees" scale="6" id="f-1690">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-382" decimals="INF" name="iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesPurchasedByEmployees" format="ixt:num-dot-decimal" scale="0" id="f-1691">30,935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PRSU activity was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:55.938%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.014%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.015%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(SHARE AMOUNTS IN THOUSANDS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Grant Date Fair<br/>Value Per Share</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-383" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="f-1692">90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-383" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-1693">133.36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-380" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:fixed-zero" scale="3" id="f-1694">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-380" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="f-1695">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-380" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="f-1696">26</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-380" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1697">131.31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-380" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="f-1698">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-380" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-1699">138.98</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-384" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="f-1700">61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-384" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-1701">133.96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total fair value of PRSUs that vested during the year ended December&#160;31, 2023 was approximately $<ix:nonFraction unitRef="usd" contextRef="c-380" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="f-1702">3</ix:nonFraction> million.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, there was approximately $<ix:nonFraction unitRef="usd" contextRef="c-384" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="f-1703">1</ix:nonFraction> million of total unrecognized compensation cost related to non-vested PRSUs granted under the equity incentive plans; such cost is expected to be recognized over a weighted average period of approximately <ix:nonNumeric contextRef="c-380" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="f-1704">1.06</ix:nonNumeric> years.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liability Awards</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has granted cash-settled RSUs (&#8220;Cash RSUs&#8221;) to eligible employees that are paid out <ix:nonFraction unitRef="number" contextRef="c-385" decimals="INF" name="iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentageGrantedInCashToEligibleEmployees" scale="-2" id="f-1705">100</ix:nonFraction>% in cash upon vesting. Such RSUs are subject to forfeiture if certain conditions are not met. Cash RSUs principally vest <ix:nonFraction unitRef="number" contextRef="c-385" decimals="INF" name="iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentage" scale="-2" id="f-1706">100</ix:nonFraction>% at the end of <ix:nonNumeric contextRef="c-385" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-1707">three years</ix:nonNumeric> and contain no performance criteria provisions. A Cash RSU&#8217;s fair value is calculated based on the market price of the Company&#8217;s stock at the date of the closing period and is accounted for as a liability award. The aggregate fair value is amortized to expense ratably over the vesting period.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 89</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:continuation id="f-1596-5"><ix:continuation id="f-1666-1"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash RSU activity was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:57.111%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.429%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(SHARE AMOUNTS IN THOUSANDS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash&#160;RSUs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted&#160;Average&#160;<br/>Fair<br/>Value&#160;Per&#160;Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-386" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="f-1708">119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-386" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-1709">104.84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-385" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="f-1710">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-385" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1711">80.97</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-385" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="f-1712">40</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-385" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1713">94.72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-385" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="f-1714">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-385" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-1715">82.24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-387" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="f-1716">91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-387" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-1717">80.97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total fair value of Cash RSUs that vested during the year ended December&#160;31, 2023 was approximately $<ix:nonFraction unitRef="usd" contextRef="c-385" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="f-1718">4</ix:nonFraction> million.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, there was approximately $<ix:nonFraction unitRef="usd" contextRef="c-387" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="f-1719">2</ix:nonFraction> million of total unrecognized compensation cost related to non-vested Cash RSUs granted under the equity incentive plans; such cost is expected to be recognized over a weighted average period of approximately <ix:nonNumeric contextRef="c-385" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="f-1720">1.45</ix:nonNumeric> years. The aggregate compensation cost will be adjusted based on changes in the Company&#8217;s stock price.</span></div></ix:continuation><div><span><br/></span></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_163"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 14.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingDisclosureTextBlock" id="f-1721" continuedAt="f-1721-1" escape="true">SEGMENT INFORMATION</ix:nonNumeric></span></div><ix:continuation id="f-1721-1" continuedAt="f-1721-2"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is organized into <ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" id="f-1722">four</ix:nonFraction> reportable operating segments: Nourish, Health &amp; Biosciences, Scent and Pharma Solutions. These segments align with the internal structure to manage these businesses. The Company&#8217;s Chief Operating Decision Maker regularly reviews financial information to allocate resources and assess performance utilizing these segments.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nourish is comprised of Ingredients, Flavors and Food Designs, with a diversified portfolio across natural and plant-based specialty food ingredients, flavor compounds, and systems and inclusions, respectively. Ingredients provide texturizing solutions to the food industry, food protection solutions used in food and beverage products, specialty soy and pea protein with value-added formulations, emulsifiers and sweeteners. Flavors provide a range of flavor compounds and natural taste solutions that are ultimately used by IFF&#8217;s customers in savory products, beverages, sweets and dairy products. Flavors also provide value-added spices and seasoning ingredients for meat, food service, convenience, alternative protein and culinary products. Food Designs provide blends and systems that combine key ingredients tailored to IFF customers&#8217; specific needs. Additionally, Food Designs provide inclusion products that help with taste and texture by, among other things, combining flavorings with fruit, vegetables, and other natural ingredients for a wide range of food products, such as health snacks, baked goods, cereals, pastries, ice cream and other dairy products.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health &amp; Biosciences is comprised of Health, Cultures &amp; Food Enzymes, Home &amp; Personal Care, Animal Nutrition and Grain Processing, with a biotechnology-driven portfolio of products that serve the health and wellness, food, consumer and industrial markets. Products within this portfolio range from enzymes, food cultures, probiotics and specialty ingredients for non-food applications. Health provides ingredients for dietary supplements, food and beverage, specialized nutrition and pharma. Cultures &amp; Food Enzymes provide products that aim to serve the global demand for healthy, natural, clean label and fermented food for fresh dairy, cheese, bakery and brewing products. This is accomplished by providing IFF&#8217;s customers with products that allow for extended shelf life and stability, which help to improve customers&#8217; products and performance. The enzyme solution also allows IFF&#8217;s customers to provide low sugar, high fiber and lactose-free dairy products. Home &amp; Personal Care produces enzymes for detergents, cleaning and textile processing products in the laundry, dishwashing, textiles and industrials and personal care markets that help to enhance product and process performances. Animal Nutrition produces enzymes that help to improve the product and process performance of animal feed products, which aim to lessen environmental impact by reducing farm waste. Grain Processing produces enzymes for biofuel production and carbohydrate processing.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Scent is comprised of (1) Fragrance Compounds, which are ultimately used by IFF&#8217;s customers in <ix:nonFraction unitRef="category" contextRef="c-1" decimals="INF" name="iff:NumberOfFragranceCategories" format="ixt-sec:numwordsen" id="f-1723">two</ix:nonFraction> broad categories: Fine Fragrances, including perfumes and colognes, and Consumer Fragrances, including fragrance compounds for personal care (e.g., soaps), household products (e.g., detergents and cleaning agents) and beauty care, including toiletries; (2) Fragrance Ingredients, consisting of synthetic and natural ingredients that can be combined with other materials to create unique fine fragrance and consumer fragrance compounds; and (3) Cosmetic Ingredients, consisting of active and functional ingredients, botanicals and delivery systems to support our customers&#8217; cosmetic and personal care product lines. Major fragrance customers include the cosmetics industry, including perfume and toiletries manufacturers, and the household products industry, including manufacturers of soaps, detergents, fabric care, household cleaners and air fresheners.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pharma Solutions is comprised of a vast portfolio, including cellulosics and seaweed-based pharmaceutical excipients, used to improve the functionality and delivery of active pharmaceutical ingredients, including controlled or modified drug release formulations, and enabling the development of more effective pharmaceutical finished dosage formats. Pharma Solutions excipients are used in prescription and over-the-counter pharmaceuticals and dietary supplements. Pharma Solutions products </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:continuation id="f-1721-2" continuedAt="f-1721-3"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">also serve a variety of other specialty and industrial end-uses including coatings, inks, electronics, agriculture and consumer products.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Chief Operating Decision Maker evaluates the performance of these reportable segments based on Segment Adjusted Operating EBITDA, which is defined as (Loss) Income Before Taxes before depreciation and amortization expense, interest expense, restructuring and other charges and certain items that are not related to recurring operations.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="f-1724" continuedAt="f-1724-1" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reportable segment information is as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:60.979%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nourish</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-388" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1725">6,060</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-389" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1726">6,829</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-390" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1727">6,264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health &amp; Biosciences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-391" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1728">2,081</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-392" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1729">2,339</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-393" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1730">2,329</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Scent</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-394" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1731">2,393</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-395" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1732">2,301</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-396" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1733">2,254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharma Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-397" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1734">945</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-398" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1735">971</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-399" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1736">809</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1737">11,479</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1738">12,440</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1739">11,656</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.863%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nourish</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-400" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-1740">12,893</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-401" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-1741">17,062</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health &amp; Biosciences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-402" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-1742">10,666</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-403" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-1743">10,924</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Scent</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-404" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-1744">4,274</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-405" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-1745">4,309</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharma Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-406" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-1746">3,145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-407" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-1747">3,227</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-1748">30,978</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-1749">35,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:60.979%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Adjusted Operating EBITDA:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nourish</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-388" decimals="-6" name="iff:SegmentAdjustedOperatingEBITDA" scale="6" id="f-1750">732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-389" decimals="-6" name="iff:SegmentAdjustedOperatingEBITDA" format="ixt:num-dot-decimal" scale="6" id="f-1751">1,176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-390" decimals="-6" name="iff:SegmentAdjustedOperatingEBITDA" format="ixt:num-dot-decimal" scale="6" id="f-1752">1,172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health &amp; Biosciences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-391" decimals="-6" name="iff:SegmentAdjustedOperatingEBITDA" scale="6" id="f-1753">588</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-392" decimals="-6" name="iff:SegmentAdjustedOperatingEBITDA" scale="6" id="f-1754">634</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-393" decimals="-6" name="iff:SegmentAdjustedOperatingEBITDA" scale="6" id="f-1755">625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Scent</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-394" decimals="-6" name="iff:SegmentAdjustedOperatingEBITDA" scale="6" id="f-1756">461</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-395" decimals="-6" name="iff:SegmentAdjustedOperatingEBITDA" scale="6" id="f-1757">423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-396" decimals="-6" name="iff:SegmentAdjustedOperatingEBITDA" scale="6" id="f-1758">463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharma Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-397" decimals="-6" name="iff:SegmentAdjustedOperatingEBITDA" scale="6" id="f-1759">199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-398" decimals="-6" name="iff:SegmentAdjustedOperatingEBITDA" scale="6" id="f-1760">222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-399" decimals="-6" name="iff:SegmentAdjustedOperatingEBITDA" scale="6" id="f-1761">165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="iff:SegmentAdjustedOperatingEBITDA" format="ixt:num-dot-decimal" scale="6" id="f-1762">1,980</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="iff:SegmentAdjustedOperatingEBITDA" format="ixt:num-dot-decimal" scale="6" id="f-1763">2,455</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="iff:SegmentAdjustedOperatingEBITDA" format="ixt:num-dot-decimal" scale="6" id="f-1764">2,425</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation &amp; Amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:OtherDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-1765">1,142</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:OtherDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-1766">1,179</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:OtherDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-1767">1,156</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="f-1768">380</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="f-1769">336</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="f-1770">289</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (Expense) Income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-1771">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-1772">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-1773">58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and Other Charges (a)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="f-1774">68</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="f-1775">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="f-1776">41</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of Goodwill (b)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="f-1777">2,623</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="f-1778">2,250</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="f-1779">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of Long-Lived Assets (c)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:fixed-zero" scale="6" id="f-1780">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" scale="6" id="f-1781">120</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:fixed-zero" scale="6" id="f-1782">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition, Divestiture and Integration Related Costs (d)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="iff:BusinessCombinationDivestituresAndIntegrationCosts" scale="6" id="f-1783">174</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="iff:BusinessCombinationDivestituresAndIntegrationCosts" scale="6" id="f-1784">201</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="iff:BusinessCombinationDivestituresAndIntegrationCosts" scale="6" id="f-1785">240</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Strategic Initiatives Costs (e)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="iff:StrategicInitiativesCosts" scale="6" id="f-1786">31</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="iff:StrategicInitiativesCosts" scale="6" id="f-1787">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="iff:StrategicInitiativesCosts" format="ixt:fixed-zero" scale="6" id="f-1788">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Regulatory Costs (f)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:LegalFees" scale="6" id="f-1789">50</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:LegalFees" format="ixt:fixed-zero" scale="6" id="f-1790">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:LegalFees" format="ixt:fixed-zero" scale="6" id="f-1791">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&amp;B Inventory Step-Up Costs (g)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-6" name="iff:BusinessCombinationInventoryStepUpCosts" format="ixt:fixed-zero" scale="6" id="f-1792">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-408" decimals="-6" name="iff:BusinessCombinationInventoryStepUpCosts" format="ixt:fixed-zero" scale="6" id="f-1793">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-6" name="iff:BusinessCombinationInventoryStepUpCosts" scale="6" id="f-1794">368</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (h)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="iff:OtherCostsCredits" scale="6" id="f-1795">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="iff:OtherCostsCredits" scale="6" id="f-1796">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="iff:OtherCostsCredits" scale="6" id="f-1797">35</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) Income Before Taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-1798">2,518</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-1799">1,625</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-1800">354</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:2.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:94.801%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Represents costs primarily related to severance as part of the Company's restructuring efforts.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(b)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">For 2023, represents costs related to the impairment of goodwill in the Nourish reporting unit. For 2022, represents costs related to the impairment of goodwill in the Health &amp; Biosciences reporting unit.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(c)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Represents costs related to the impairment of intangible and fixed assets of an asset group that operated primarily in Russia.</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 91</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:continuation id="f-1721-3" continuedAt="f-1721-4"><ix:continuation id="f-1724-1" continuedAt="f-1724-2"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:2.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:94.801%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(d)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">For 2023, 2022 and 2021, primarily represents costs related to the Company's actual and planned acquisitions and divestitures and integration related activities primarily for N&amp;B. These costs primarily consisted of external consulting fees, professional and legal fees and salaries of individuals who are fully dedicated to such efforts. For 2023, acquisition costs primarily relate to earn-out adjustments. For 2022, acquisition costs primarily relate to consulting fees, legal fees and earn-out adjustments. For 2021, acquisition costs primarily relate to legal and professional fees for the transaction with N&amp;B. Tax expenses for business divestiture costs included establishments of deferred tax liabilities related to planned sales of businesses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">For 2023, business divestiture, integration and acquisition related costs were approximately $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="iff:BusinessDivestitureCosts" format="ixt:num-dot-decimal" scale="6" id="f-1801">108</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="f-1802">59</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="f-1803">7</ix:nonFraction> million, respectively. For 2022, business divestiture, integration and acquisition related costs were approximately $<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="iff:BusinessDivestitureCosts" format="ixt:num-dot-decimal" scale="6" id="f-1804">110</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="f-1805">94</ix:nonFraction> million and a credit of $<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" sign="-" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="f-1806">3</ix:nonFraction> million, respectively. For 2021, business divestiture, integration and acquisition related costs were approximately $<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="iff:BusinessDivestitureCosts" format="ixt:num-dot-decimal" scale="6" id="f-1807">42</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="f-1808">105</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="f-1809">93</ix:nonFraction> million, respectively.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(e)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Represents costs related to the Company's strategic assessment and business portfolio optimization efforts and reorganizing the Global Shared Services Centers, primarily consulting fees.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(f)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Represents costs primarily related to legal fees incurred for the ongoing investigations of the fragrance businesses.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(g)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Represents costs related to fair value step-up of inventory for the acquired inventory through the Merger with N&amp;B.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(h)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">For 2023, represents gains from sale of assets and costs related to severance, including accelerated stock compensation expense, for a certain executive who will separate from the Company in 2024. For 2022 and 2021, represents gains from sale of assets, costs related to severance, including accelerated stock compensation expense, for certain employees and executives who have been separated from the Company in 2022 and 2021, respectively, and shareholder activist related costs, primarily professional fees.</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has not disclosed revenues at a lower level than provided herein, such as revenues from external customers by product, as it is impracticable for it to do so.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had <ix:nonFraction unitRef="customer" contextRef="c-409" decimals="INF" name="iff:NumberOfCustomers" format="ixt:fixed-zero" scale="0" id="f-1810"><ix:nonFraction unitRef="customer" contextRef="c-410" decimals="INF" name="iff:NumberOfCustomers" format="ixt:fixed-zero" scale="0" id="f-1811"><ix:nonFraction unitRef="customer" contextRef="c-411" decimals="INF" name="iff:NumberOfCustomers" format="ixt:fixed-zero" scale="0" id="f-1812">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> customers that accounted for greater than <ix:nonFraction unitRef="number" contextRef="c-412" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-1813"><ix:nonFraction unitRef="number" contextRef="c-413" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-1814"><ix:nonFraction unitRef="number" contextRef="c-414" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-1815">10</ix:nonFraction></ix:nonFraction></ix:nonFraction>% of consolidated net sales in 2023, 2022 and 2021.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock" id="f-1816" escape="true"><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets, net, by country, consisted as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-415" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="f-1817">1,742</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-416" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="f-1818">1,771</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-417" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="f-1819">228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-418" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="f-1820">258</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denmark</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-419" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="f-1821">262</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-420" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="f-1822">250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finland</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-421" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="f-1823">214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-422" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="f-1824">212</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-423" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="f-1825">199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="f-1826">187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-425" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="f-1827">171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-426" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="f-1828">181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-427" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="f-1829">1,424</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-428" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="f-1830">1,344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="f-1831">4,240</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="f-1832">4,203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><ix:continuation id="f-1724-2"><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment capital expenditures and depreciation and amortization consisted as follows:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:26.988%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Capital Expenditures</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Depreciation and Amortization</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nourish</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-388" decimals="-6" name="us-gaap:SegmentExpenditureAdditionToLongLivedAssets" scale="6" id="f-1833">252</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-389" decimals="-6" name="us-gaap:SegmentExpenditureAdditionToLongLivedAssets" scale="6" id="f-1834">215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-390" decimals="-6" name="us-gaap:SegmentExpenditureAdditionToLongLivedAssets" scale="6" id="f-1835">183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-388" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-1836">553</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-389" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-1837">596</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-390" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-1838">594</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health &amp; Biosciences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-391" decimals="-6" name="us-gaap:SegmentExpenditureAdditionToLongLivedAssets" scale="6" id="f-1839">85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-392" decimals="-6" name="us-gaap:SegmentExpenditureAdditionToLongLivedAssets" scale="6" id="f-1840">160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-393" decimals="-6" name="us-gaap:SegmentExpenditureAdditionToLongLivedAssets" scale="6" id="f-1841">139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-391" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-1842">374</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-392" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-1843">363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-393" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-1844">353</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Scent</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-394" decimals="-6" name="us-gaap:SegmentExpenditureAdditionToLongLivedAssets" scale="6" id="f-1845">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-395" decimals="-6" name="us-gaap:SegmentExpenditureAdditionToLongLivedAssets" scale="6" id="f-1846">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-396" decimals="-6" name="us-gaap:SegmentExpenditureAdditionToLongLivedAssets" scale="6" id="f-1847">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-394" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-1848">78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-395" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-1849">81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-396" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-1850">84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharma Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-397" decimals="-6" name="us-gaap:SegmentExpenditureAdditionToLongLivedAssets" scale="6" id="f-1851">104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-398" decimals="-6" name="us-gaap:SegmentExpenditureAdditionToLongLivedAssets" scale="6" id="f-1852">73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-399" decimals="-6" name="us-gaap:SegmentExpenditureAdditionToLongLivedAssets" scale="6" id="f-1853">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-397" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-1854">137</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-398" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-1855">139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-399" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-1856">125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:SegmentExpenditureAdditionToLongLivedAssets" scale="6" id="f-1857">503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:SegmentExpenditureAdditionToLongLivedAssets" scale="6" id="f-1858">504</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:SegmentExpenditureAdditionToLongLivedAssets" scale="6" id="f-1859">393</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-1860">1,142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-1861">1,179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-1862">1,156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock" id="f-1863" continuedAt="f-1863-1" escape="true"><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales are attributed to individual regions based upon the destination of product delivery and are as follows:</span></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales by Geographic Area</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe, Africa and Middle East</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-429" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1864">3,834</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-430" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1865">4,219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-431" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1866">4,093</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater Asia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-432" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1867">2,677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-433" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1868">2,876</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-434" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1869">2,728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-435" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1870">3,477</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-436" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1871">3,853</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-437" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1872">3,499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-438" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1873">1,491</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-439" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1874">1,492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-440" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1875">1,336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1876">11,479</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1877">12,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1878">11,656</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 92</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:continuation id="f-1721-4"><ix:continuation id="f-1863-1"><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:59.047%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.694%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.694%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.695%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales by Geographic Area</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales related to the U.S.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-441" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1879">3,185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-442" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1880">3,611</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-443" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1881">3,211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales attributed to all foreign countries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-444" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1882">8,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-445" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1883">8,829</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-446" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1884">8,445</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No non-U.S. country had net sales greater than <ix:nonFraction unitRef="number" contextRef="c-447" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-1885">7</ix:nonFraction>% of total consolidated net sales for 2023 and net sales greater than <ix:nonFraction unitRef="number" contextRef="c-448" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-1886">6</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-449" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-1887">7</ix:nonFraction>% of total consolidated net sales for 2022 and 2021, respectively.</span></div></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_166"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 15.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="f-1888" continuedAt="f-1888-1" escape="true">EMPLOYEE BENEFITS</ix:nonNumeric></span></div><ix:continuation id="f-1888-1" continuedAt="f-1888-2"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has pension and/or other retirement benefit plans covering approximately <ix:nonFraction unitRef="number" contextRef="c-1" decimals="2" name="iff:PercentageofActiveEmployeeswithPensionandorOtherRetirementBenefitPlansCovered" scale="-2" id="f-1889">20</ix:nonFraction>% of active employees. In 2007, the Company amended its U.S. qualified and non-qualified pension plans under which accrual of future benefits was suspended for all participants that did not meet the rule of 70 (age plus years of service equal to at least 70 as of December&#160;31, 2007). Pension benefits are generally based on years of service and compensation during the final years of employment. Plan assets consist primarily of equity securities and corporate and government fixed income securities. Substantially all pension benefit costs are funded as accrued; such funding is limited, where applicable, to amounts deductible for income tax purposes. Certain other retirement benefits are provided by general corporate assets.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the Closing Date of the Merger with N&amp;B, the Company assumed responsibility for approximately <ix:nonFraction unitRef="benefit_plan" contextRef="c-169" decimals="0" name="iff:BusinessCombinationDefinedBenefitPlanNumberOfPlansAssumed" scale="0" id="f-1890">20</ix:nonFraction> additional defined benefit plans and recognized liabilities in the aggregate amount of $<ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-1891">221</ix:nonFraction> million.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sponsors a qualified defined contribution plan covering substantially all U.S. employees. Under this plan, effective January 1, 2023, the Company matches <ix:nonFraction unitRef="number" contextRef="c-1" decimals="INF" name="iff:DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBelowLowRange" scale="-2" id="f-1892">100</ix:nonFraction>% of the first <ix:nonFraction unitRef="number" contextRef="c-1" decimals="INF" name="iff:DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRange" scale="-2" id="f-1893">6</ix:nonFraction>% of participants&#8217; contributions. Prior to this, the Company matched <ix:nonFraction unitRef="number" contextRef="c-9" decimals="INF" name="iff:DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBelowLowRange" scale="-2" id="f-1894">100</ix:nonFraction>% of participants&#8217; contributions up to <ix:nonFraction unitRef="number" contextRef="c-9" decimals="INF" name="iff:DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRange" scale="-2" id="f-1895">4</ix:nonFraction>% of compensation and <ix:nonFraction unitRef="number" contextRef="c-9" decimals="INF" name="iff:DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBetweenHighRangeAndLowRange" scale="-2" id="f-1896">75</ix:nonFraction>% of participants&#8217; contributions from over <ix:nonFraction unitRef="number" contextRef="c-9" decimals="INF" name="iff:DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRangeLow" scale="-2" id="f-1897">4</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-9" decimals="INF" name="iff:DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRangeHigh" scale="-2" id="f-1898">8</ix:nonFraction>%. Employees that are still eligible to accrue benefits under the pension plans are limited to a <ix:nonFraction unitRef="number" contextRef="c-1" decimals="INF" name="iff:DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageReachesAverageRate" scale="-2" id="f-1899">50</ix:nonFraction>% match of up to <ix:nonFraction unitRef="number" contextRef="c-1" decimals="INF" name="iff:DefinedContributionPlanMatchingParticipantContributionAveragePercentageOnCompensation" scale="-2" id="f-1900">6</ix:nonFraction>% of the participants&#8217; compensation.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to pension benefits, certain health care and life insurance benefits are provided to qualifying U.S. employees upon retirement from IFF. Such coverage is provided through insurance plans with premiums based on benefits paid. The Company does not generally provide health care or life insurance coverage for retired employees of foreign subsidiaries; such benefits are provided in most foreign countries by government-sponsored plans, and the cost of these programs is not material.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers a non-qualified Deferred Compensation Plan (&#8220;DCP&#8221;) for certain key employees and non-employee directors. Eligible employees and non-employee directors may elect to defer receipt of salary, incentive payments and Board of Directors&#8217; fees into participant-directed investments which are generally invested by the Company in individual variable life insurance contracts it owns that are designed to informally fund savings plans of this nature. The cash surrender value of life insurance is based on the net asset values of the underlying funds available to plan participants. At December&#160;31, 2023 and December&#160;31, 2022, the Consolidated Balance Sheets reflect liabilities of approximately $<ix:nonFraction unitRef="usd" contextRef="c-450" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-1901">52</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-451" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-1902">53</ix:nonFraction> million, respectively, related to the DCP in Other liabilities and approximately $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="iff:AdjustmentsToAdditionalPaidInCapitalDeferredCompensation" format="ixt:num-dot-decimal" scale="6" id="f-1903">17</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="iff:AdjustmentsToAdditionalPaidInCapitalDeferredCompensation" format="ixt:num-dot-decimal" scale="6" id="f-1904">25</ix:nonFraction> million, respectively, included in Capital in excess of par value related to the portion of the DCP that will be paid out in IFF shares.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total cash surrender value of life insurance contracts the Company owns in relation to the DCP and post-retirement life insurance benefits amounted to $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:CashSurrenderValueOfLifeInsurance" format="ixt:num-dot-decimal" scale="6" id="f-1905">49</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:CashSurrenderValueOfLifeInsurance" format="ixt:num-dot-decimal" scale="6" id="f-1906">45</ix:nonFraction> million at December&#160;31, 2023 and 2022, respectively, and are recorded in Other assets in the Consolidated Balance Sheets.</span></div><ix:nonNumeric contextRef="c-1" name="iff:PensionExpensesTableTextBlock" id="f-1907" continuedAt="f-1907-1" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The plan assets and benefit obligations of the defined benefit pension plans are measured at December&#160;31 of each year.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 93</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:continuation id="f-1888-2" continuedAt="f-1888-3"><ix:continuation id="f-1907-1"><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:36.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.714%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Components of net periodic benefit cost</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost for benefits earned</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-452" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" format="ixt:fixed-zero" scale="6" id="f-1908">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-453" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="f-1909">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-454" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="f-1910">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-455" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="f-1911">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-456" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="f-1912">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-457" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="f-1913">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost on projected benefit obligation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-452" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="f-1914">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-458" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="f-1915">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-454" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="f-1916">71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-455" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="f-1917">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-459" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="f-1918">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-457" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="f-1919">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-452" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="f-1920">31</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-453" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="f-1921">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-454" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="f-1922">106</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-455" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="f-1923">47</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-459" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="f-1924">42</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-457" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="f-1925">55</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amortization of deferrals</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-452" decimals="-6" name="iff:DefinedBenefitPlanAmortizationAndDeferralsNet" scale="6" id="f-1926">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-453" decimals="-6" name="iff:DefinedBenefitPlanAmortizationAndDeferralsNet" scale="6" id="f-1927">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-454" decimals="-6" name="iff:DefinedBenefitPlanAmortizationAndDeferralsNet" scale="6" id="f-1928">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-455" decimals="-6" sign="-" name="iff:DefinedBenefitPlanAmortizationAndDeferralsNet" scale="6" id="f-1929">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-459" decimals="-6" name="iff:DefinedBenefitPlanAmortizationAndDeferralsNet" scale="6" id="f-1930">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-457" decimals="-6" name="iff:DefinedBenefitPlanAmortizationAndDeferralsNet" scale="6" id="f-1931">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements and curtailments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-452" decimals="-6" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" format="ixt:fixed-zero" scale="6" id="f-1932">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-453" decimals="-6" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" format="ixt:fixed-zero" scale="6" id="f-1933">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-454" decimals="-6" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" format="ixt:fixed-zero" scale="6" id="f-1934">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-455" decimals="-6" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" scale="6" id="f-1935">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-459" decimals="-6" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" format="ixt:fixed-zero" scale="6" id="f-1936">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-457" decimals="-6" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" scale="6" id="f-1937">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit (income) cost</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-452" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="f-1938">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-453" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="f-1939">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-454" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="f-1940">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-455" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="f-1941">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-459" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="f-1942">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-457" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="f-1943">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined contribution and other retirement plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-452" decimals="-6" name="iff:DefinedContributionAndOtherRetirementPlans" scale="6" id="f-1944">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-453" decimals="-6" name="iff:DefinedContributionAndOtherRetirementPlans" scale="6" id="f-1945">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-454" decimals="-6" name="iff:DefinedContributionAndOtherRetirementPlans" scale="6" id="f-1946">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-455" decimals="-6" name="iff:DefinedContributionAndOtherRetirementPlans" scale="6" id="f-1947">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-459" decimals="-6" name="iff:DefinedContributionAndOtherRetirementPlans" scale="6" id="f-1948">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-457" decimals="-6" name="iff:DefinedContributionAndOtherRetirementPlans" scale="6" id="f-1949">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-452" decimals="-6" name="us-gaap:PensionAndOtherPostretirementBenefitExpense" scale="6" id="f-1950">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-453" decimals="-6" name="us-gaap:PensionAndOtherPostretirementBenefitExpense" scale="6" id="f-1951">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-454" decimals="-6" name="us-gaap:PensionAndOtherPostretirementBenefitExpense" scale="6" id="f-1952">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-455" decimals="-6" name="us-gaap:PensionAndOtherPostretirementBenefitExpense" scale="6" id="f-1953">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-459" decimals="-6" name="us-gaap:PensionAndOtherPostretirementBenefitExpense" scale="6" id="f-1954">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-457" decimals="-6" name="us-gaap:PensionAndOtherPostretirementBenefitExpense" scale="6" id="f-1955">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Changes in plan assets and benefit obligations recognized in OCI</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss (gain)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-452" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax" scale="6" id="f-1956">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-453" decimals="-6" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax" format="ixt:fixed-zero" scale="6" id="f-1957">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-455" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax" scale="6" id="f-1958">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-459" decimals="-6" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax" scale="6" id="f-1959">143</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized actuarial (loss) gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-452" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="f-1960">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-453" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="f-1961">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-455" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="f-1962">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-459" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="f-1963">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized prior service credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-452" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" format="ixt:fixed-zero" scale="6" id="f-1964">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-453" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" format="ixt:fixed-zero" scale="6" id="f-1965">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-455" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" scale="6" id="f-1966">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-459" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" scale="6" id="f-1967">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-452" decimals="-6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" format="ixt:fixed-zero" scale="6" id="f-1968">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-453" decimals="-6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" format="ixt:fixed-zero" scale="6" id="f-1969">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-455" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" scale="6" id="f-1970">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-459" decimals="-6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" scale="6" id="f-1971">27</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total loss (gain) recognized in OCI (before tax effects)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-452" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="f-1972">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-453" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="f-1973">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-455" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="f-1974">89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-459" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="f-1975">181</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________&#160;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Included as a component of Operating (loss) profit.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Included as a component of Other expense (income), net.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="iff:ScheduleOfAmountsExpectedToBeRecognizedInNetPeriodicCostTableTableTextBlock" id="f-1976" escape="true"><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Postretirement Benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Components of net periodic benefit cost</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost for benefits earned</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-460" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" format="ixt:fixed-zero" scale="6" id="f-1977">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-461" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="f-1978">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-462" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="f-1979">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost on projected benefit obligation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-460" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="f-1980">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-461" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="f-1981">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-462" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="f-1982">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amortization and deferrals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-460" decimals="-6" sign="-" name="iff:DefinedBenefitPlanAmortizationAndDeferralsNet" scale="6" id="f-1983">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-461" decimals="-6" sign="-" name="iff:DefinedBenefitPlanAmortizationAndDeferralsNet" scale="6" id="f-1984">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-462" decimals="-6" sign="-" name="iff:DefinedBenefitPlanAmortizationAndDeferralsNet" scale="6" id="f-1985">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total credit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-460" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="f-1986">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-461" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="f-1987">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-462" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="f-1988">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Changes in plan assets and benefit obligations recognized in OCI</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss (gain)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-460" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax" scale="6" id="f-1989">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-461" decimals="-6" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax" scale="6" id="f-1990">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-460" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" format="ixt:fixed-zero" scale="6" id="f-1991">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-461" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="f-1992">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized prior service credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-460" decimals="-6" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" scale="6" id="f-1993">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-461" decimals="-6" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" scale="6" id="f-1994">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total recognized in OCI (before tax effects)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-460" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="f-1995">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-461" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="f-1996">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div></ix:nonNumeric><div style="text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAssumptionsUsedTableTextBlock" id="f-1997" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average actuarial assumptions used to determine expense at December&#160;31 of each year are:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:31.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.488%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.488%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.488%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.488%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.638%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-452" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="f-1998">5.42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-453" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="f-1999">2.86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-454" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="f-2000">2.51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-455" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="f-2001">3.98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-459" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="f-2002">1.43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-457" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="f-2003">0.85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-452" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="f-2004">6.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-453" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="f-2005">3.80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-454" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="f-2006">3.80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-455" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="f-2007">4.92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-459" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="f-2008">3.52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-457" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="f-2009">4.21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-452" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="f-2010">3.75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-453" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="f-2011">3.25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-454" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="f-2012">3.25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-455" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="f-2013">3.01</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-459" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="f-2014">2.72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-457" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="f-2015">2.56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 94</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:continuation id="f-1888-3" continuedAt="f-1888-4"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfChangesInAccumulatedPostemploymentBenefitObligationsTableTextBlock" id="f-2016" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the postretirement benefit obligation and plan assets, as applicable, are detailed in the following table:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:35.996%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.727%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Postretirement Benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-463" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="f-2017">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-464" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="f-2018">662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-465" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="f-2019">930</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-466" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="f-2020">1,501</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-467" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="f-2021">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-468" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="f-2022">66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost for benefits earned</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-452" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" format="ixt:fixed-zero" scale="6" id="f-2023">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-453" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="f-2024">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-455" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="f-2025">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-459" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="f-2026">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-460" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" format="ixt:fixed-zero" scale="6" id="f-2027">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-461" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="f-2028">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost on projected benefit obligation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-452" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="f-2029">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-453" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="f-2030">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-455" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="f-2031">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-459" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="f-2032">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-469" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="f-2033">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-470" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="f-2034">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial (gain) loss </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-452" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="f-2035">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-453" decimals="-6" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="f-2036">139</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-455" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="f-2037">77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-459" decimals="-6" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="f-2038">468</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-460" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="f-2039">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-461" decimals="-6" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="f-2040">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments for expense/tax contained in service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-452" decimals="-6" name="iff:DefinedBenefitPlanAdjustmentsForExpenseOrTaxContainedInServiceCost" format="ixt:fixed-zero" scale="6" id="f-2041">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-453" decimals="-6" name="iff:DefinedBenefitPlanAdjustmentsForExpenseOrTaxContainedInServiceCost" format="ixt:fixed-zero" scale="6" id="f-2042">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-455" decimals="-6" name="iff:DefinedBenefitPlanAdjustmentsForExpenseOrTaxContainedInServiceCost" scale="6" id="f-2043">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-459" decimals="-6" name="iff:DefinedBenefitPlanAdjustmentsForExpenseOrTaxContainedInServiceCost" scale="6" id="f-2044">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-460" decimals="-6" name="iff:DefinedBenefitPlanAdjustmentsForExpenseOrTaxContainedInServiceCost" format="ixt:fixed-zero" scale="6" id="f-2045">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-461" decimals="-6" name="iff:DefinedBenefitPlanAdjustmentsForExpenseOrTaxContainedInServiceCost" format="ixt:fixed-zero" scale="6" id="f-2046">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan participants&#8217; contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-452" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" format="ixt:fixed-zero" scale="6" id="f-2047">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-453" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" format="ixt:fixed-zero" scale="6" id="f-2048">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-455" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" scale="6" id="f-2049">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-459" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" scale="6" id="f-2050">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-460" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" format="ixt:fixed-zero" scale="6" id="f-2051">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-461" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" format="ixt:fixed-zero" scale="6" id="f-2052">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-452" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="f-2053">39</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-453" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="f-2054">38</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-455" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="f-2055">33</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-459" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="f-2056">32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-460" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="f-2057">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-461" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="f-2058">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Curtailments/settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-452" decimals="-6" name="iff:DefinedBenefitPlanCurtailmentsAndSettlementsBenefitObligation" scale="6" id="f-2059">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-453" decimals="-6" name="iff:DefinedBenefitPlanCurtailmentsAndSettlementsBenefitObligation" format="ixt:fixed-zero" scale="6" id="f-2060">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-455" decimals="-6" name="iff:DefinedBenefitPlanCurtailmentsAndSettlementsBenefitObligation" scale="6" id="f-2061">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-459" decimals="-6" name="iff:DefinedBenefitPlanCurtailmentsAndSettlementsBenefitObligation" scale="6" id="f-2062">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-460" decimals="-6" name="iff:DefinedBenefitPlanCurtailmentsAndSettlementsBenefitObligation" format="ixt:fixed-zero" scale="6" id="f-2063">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-461" decimals="-6" name="iff:DefinedBenefitPlanCurtailmentsAndSettlementsBenefitObligation" format="ixt:fixed-zero" scale="6" id="f-2064">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-452" decimals="-6" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" format="ixt:fixed-zero" scale="6" id="f-2065">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-453" decimals="-6" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" format="ixt:fixed-zero" scale="6" id="f-2066">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-455" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="6" id="f-2067">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-459" decimals="-6" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="6" id="f-2068">104</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-460" decimals="-6" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" format="ixt:fixed-zero" scale="6" id="f-2069">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-461" decimals="-6" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" format="ixt:fixed-zero" scale="6" id="f-2070">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-452" decimals="-6" name="iff:DefinedBenefitPlanBenefitObligationOther" scale="6" id="f-2071">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-453" decimals="-6" sign="-" name="iff:DefinedBenefitPlanBenefitObligationOther" scale="6" id="f-2072">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-455" decimals="-6" sign="-" name="iff:DefinedBenefitPlanBenefitObligationOther" scale="6" id="f-2073">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-459" decimals="-6" name="iff:DefinedBenefitPlanBenefitObligationOther" scale="6" id="f-2074">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-460" decimals="-6" sign="-" name="iff:DefinedBenefitPlanBenefitObligationOther" scale="6" id="f-2075">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-461" decimals="-6" sign="-" name="iff:DefinedBenefitPlanBenefitObligationOther" scale="6" id="f-2076">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-471" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="f-2077">524</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-463" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="f-2078">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-472" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="f-2079">1,056</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-465" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="f-2080">930</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-473" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="f-2081">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-467" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="f-2082">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-463" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2083">498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-464" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2084">649</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-465" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2085">920</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-466" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="f-2086">1,320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-452" decimals="-6" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="f-2087">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-453" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="f-2088">118</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-455" decimals="-6" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="f-2089">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-459" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="f-2090">286</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-452" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="f-2091">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-453" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="f-2092">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-455" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="f-2093">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-459" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="f-2094">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participants&#8217; contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-452" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" format="ixt:fixed-zero" scale="6" id="f-2095">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-453" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" format="ixt:fixed-zero" scale="6" id="f-2096">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-455" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" scale="6" id="f-2097">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-459" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" scale="6" id="f-2098">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-452" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="f-2099">39</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-453" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="f-2100">38</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-455" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="f-2101">33</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-459" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="f-2102">32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-452" decimals="-6" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" format="ixt:fixed-zero" scale="6" id="f-2103">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-453" decimals="-6" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" format="ixt:fixed-zero" scale="6" id="f-2104">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-455" decimals="-6" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="6" id="f-2105">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-459" decimals="-6" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="6" id="f-2106">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-452" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" format="ixt:fixed-zero" scale="6" id="f-2107">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-453" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" format="ixt:fixed-zero" scale="6" id="f-2108">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-455" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="6" id="f-2109">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-459" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="6" id="f-2110">96</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-452" decimals="-6" name="iff:DefinedBenefitPlanPlanAssetsOther" format="ixt:fixed-zero" scale="6" id="f-2111">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-453" decimals="-6" name="iff:DefinedBenefitPlanPlanAssetsOther" format="ixt:fixed-zero" scale="6" id="f-2112">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-455" decimals="-6" name="iff:DefinedBenefitPlanPlanAssetsOther" scale="6" id="f-2113">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-459" decimals="-6" name="iff:DefinedBenefitPlanPlanAssetsOther" format="ixt:fixed-zero" scale="6" id="f-2114">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-471" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2115">505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-463" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2116">498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-472" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="f-2117">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-465" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2118">920</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-471" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="f-2119">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-463" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="f-2120">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-472" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="f-2121">56</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-465" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="f-2122">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" id="f-2123" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts recognized in the balance sheet are detailed in the following table:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-471" decimals="-6" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="f-2124">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-463" decimals="-6" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="f-2125">51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-472" decimals="-6" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="f-2126">109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-465" decimals="-6" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="f-2127">129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-471" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="f-2128">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-463" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="f-2129">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-472" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="f-2130">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-465" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="f-2131">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retirement liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-471" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="f-2132">44</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-463" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="f-2133">47</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-472" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="f-2134">161</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-465" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="f-2135">138</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amount recognized</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-471" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet" scale="6" id="f-2136">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-463" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet" scale="6" id="f-2137">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-472" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet" scale="6" id="f-2138">56</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-465" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet" scale="6" id="f-2139">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" id="f-2140" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts recognized in AOCI are detailed in the following table:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:36.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.714%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Postretirement Benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial (gain) loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-471" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="f-2141">155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-463" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="f-2142">129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-472" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="f-2143">198</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-465" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="f-2144">110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-473" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" format="ixt:fixed-zero" scale="6" id="f-2145">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-467" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="f-2146">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost (credit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-471" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" format="ixt:fixed-zero" scale="6" id="f-2147">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-463" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" format="ixt:fixed-zero" scale="6" id="f-2148">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-472" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" scale="6" id="f-2149">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-465" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" scale="6" id="f-2150">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-473" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" scale="6" id="f-2151">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-467" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" scale="6" id="f-2152">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total AOCI (before tax effects)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-471" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" scale="6" id="f-2153">155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-463" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" scale="6" id="f-2154">129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-472" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" scale="6" id="f-2155">196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-465" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" scale="6" id="f-2156">107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-473" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" scale="6" id="f-2157">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-467" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" scale="6" id="f-2158">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 95</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:continuation id="f-1888-4" continuedAt="f-1888-5"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccumulatedAndProjectedBenefitObligationsTableTextBlock" id="f-2159" escape="true"><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Benefit Obligation &#8212; end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-471" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="f-2160">520</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-463" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="f-2161">495</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-472" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="f-2162">988</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-465" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="f-2163">870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Information for Pension Plans with an Accumulated Benefit Obligation (&#8220;ABO&#8221;) in excess of Plan Assets:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated benefit obligation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-471" decimals="-6" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" scale="6" id="f-2164">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-463" decimals="-6" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" scale="6" id="f-2165">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-472" decimals="-6" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" scale="6" id="f-2166">165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-465" decimals="-6" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" scale="6" id="f-2167">150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-471" decimals="-6" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2168">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-463" decimals="-6" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2169">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-472" decimals="-6" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" scale="6" id="f-2170">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-465" decimals="-6" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" scale="6" id="f-2171">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Information for Pension Plans with a Projected Benefit Obligation (&#8220;PBO&#8221;) in excess of Plan Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-471" decimals="-6" name="us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation" scale="6" id="f-2172">47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-463" decimals="-6" name="us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation" scale="6" id="f-2173">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-472" decimals="-6" name="us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation" scale="6" id="f-2174">185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-465" decimals="-6" name="us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation" scale="6" id="f-2175">169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-471" decimals="-6" name="us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2176">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-463" decimals="-6" name="us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2177">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-472" decimals="-6" name="us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets" scale="6" id="f-2178">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-465" decimals="-6" name="us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets" scale="6" id="f-2179">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average assumptions used to determine obligations at December&#160;31</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-471" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="f-2180">4.47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-463" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="f-2181">5.42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-472" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="f-2182">3.59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-465" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="f-2183">4.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-471" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="f-2184">3.75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-463" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="f-2185">3.75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-472" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="f-2186">2.83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-465" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="f-2187">3.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock" id="f-2188" escape="true"><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S.&#160;Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Postretirement<br/>Benefits</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Estimated Future Benefit Payments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-471" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" scale="6" id="f-2189">99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-472" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" scale="6" id="f-2190">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-473" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" scale="6" id="f-2191">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-471" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" scale="6" id="f-2192">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-472" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" scale="6" id="f-2193">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-473" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" scale="6" id="f-2194">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-471" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" scale="6" id="f-2195">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-472" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" scale="6" id="f-2196">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-473" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" scale="6" id="f-2197">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-471" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" scale="6" id="f-2198">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-472" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" scale="6" id="f-2199">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-473" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" scale="6" id="f-2200">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-471" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" scale="6" id="f-2201">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-472" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" scale="6" id="f-2202">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-473" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" scale="6" id="f-2203">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 - 2033</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-471" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" scale="6" id="f-2204">166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-472" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" scale="6" id="f-2205">239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-473" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" scale="6" id="f-2206">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contributions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Required Company Contributions in the Following Year (2024)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-471" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" scale="6" id="f-2207">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-472" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" scale="6" id="f-2208">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-473" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" format="ixt:fixed-zero" scale="6" id="f-2209">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers a number of factors in determining and selecting assumptions for the overall expected long-term rate of return on plan assets. The Company considers the historical long-term return experience of its assets, the current and expected allocation of its plan assets and expected long-term rates of return. The Company derives these expected long-term rates of return with the assistance of its investment advisors. The Company bases its expected allocation of plan assets on a diversified portfolio consisting of domestic and international equity securities, fixed income, property and alternative asset classes. The asset allocation is monitored on an ongoing basis.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers a variety of factors in determining and selecting its assumptions for the discount rate at December&#160;31. For the U.S. plans, the discount rate was based on the internal rate of return for a portfolio of high quality bonds rated Aa or higher by either Moody&#8217;s or Standard &amp; Poor&#8217;s with maturities that are consistent with the projected future benefit payment obligations of the plan. For the Non-U.S. Plans, the discount rates were determined by region and are based on high quality long-term corporate bonds.&#160;Consideration has been given to the duration of the liabilities in each plan when selecting the bonds to be used in determining the discount rate. The rate of compensation increase for all plans and the medical cost trend rate for the applicable U.S. plans are based on plan experience.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock" id="f-2210" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The percentage of assets in the Company&#8217;s pension plans, by type, is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S.&#160;Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-474" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-2211">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-475" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-2212">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-476" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-2213">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-477" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-2214">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-478" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-2215">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-479" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-2216">47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-480" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-2217">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-481" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-2218">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-482" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-2219">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-483" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-2220">51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-484" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-2221">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-485" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-2222">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-486" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" format="ixt:fixed-zero" scale="-2" id="f-2223">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-487" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" format="ixt:fixed-zero" scale="-2" id="f-2224">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-488" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-2225">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-489" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-2226">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alternative and other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-490" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" format="ixt:fixed-zero" scale="-2" id="f-2227">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-491" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" format="ixt:fixed-zero" scale="-2" id="f-2228">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-492" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-2229">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-493" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-2230">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to the U.S. plans, the expected return on plan assets was determined based on an asset allocation model using the current target allocation, real rates of return by asset class and an anticipated inflation rate. The target investment allocation is <ix:nonFraction unitRef="number" contextRef="c-494" decimals="INF" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="f-2231">10</ix:nonFraction>% equity securities and <ix:nonFraction unitRef="number" contextRef="c-495" decimals="INF" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="f-2232">90</ix:nonFraction>% fixed income securities.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 96</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:continuation id="f-1888-5" continuedAt="f-1888-6"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The expected annual rate of return for the non-U.S. plans employs a similar set of criteria adapted for local investments, inflation rates and in certain cases specific government requirements. Each plan has its own target asset allocation, which is reviewed periodically and rebalanced when necessary.</span></div><ix:nonNumeric contextRef="c-1" name="iff:ScheduleOfFairValueOfPensionPlanAssetsByAssetCategoryTableTableTextBlock" id="f-2233" continuedAt="f-2233-1" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the Company&#8217;s plan assets for the U.S. and non-U.S. plans using the fair value hierarchy as of December&#160;31, 2023 and 2022. The plans&#8217; assets were accounted for at fair value and are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement requires judgment, and may affect the valuation of fair value assets and their placement within the fair value hierarchy levels. For more information on a description of the fair value hierarchy, see Note 16.</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans for the Year Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Cash Equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-496" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2234">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-497" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2235">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-498" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2236">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-474" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2237">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Fixed Income Securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government&#160;&amp; Government Agency Bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-499" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2238">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-500" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2239">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-501" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2240">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-502" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2241">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate Bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-503" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2242">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-504" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2243">82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-505" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2244">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-506" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2245">82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal Bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-507" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2246">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-508" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2247">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-509" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2248">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-510" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2249">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Assets measured at net asset value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-511" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2250">406</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-512" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2251">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-513" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2252">98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-514" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2253">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-515" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2254">504</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-516" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2255">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-471" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2256">505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans for the Year Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Cash Equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-517" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2257">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-518" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2258">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-519" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2259">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-475" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2260">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Fixed Income Securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government&#160;&amp; Government Agency Bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-520" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2261">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-521" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2262">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-522" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2263">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-523" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2264">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate Bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-524" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2265">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-525" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2266">73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-526" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2267">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-527" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2268">73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal Bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-528" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2269">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-529" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2270">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-530" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2271">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-531" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2272">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Assets measured at net asset value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-532" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2273">404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-533" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2274">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-534" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2275">93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-535" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2276">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-536" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2277">497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-537" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2278">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-463" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2279">498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________&#160;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy. The fair value amounts presented in the table above are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Balance Sheets. The total amount measured at net asset value includes approximately $<ix:nonFraction unitRef="usd" contextRef="c-538" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="f-2280">65</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-539" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="f-2281">234</ix:nonFraction> million in pooled equity funds and $<ix:nonFraction unitRef="usd" contextRef="c-540" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="f-2282">341</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-541" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="f-2283">170</ix:nonFraction> million in fixed income mutual funds for the years ended December&#160;31, 2023 and 2022, respectively.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 97</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:continuation id="f-2233-1" continuedAt="f-2233-2"><ix:continuation id="f-1888-6" continuedAt="f-1888-7"><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans for the Year Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-542" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2284">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-543" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2285">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-544" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2286">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-545" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2287">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Equity Securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Large Cap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-546" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2288">90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-547" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2289">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-548" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2290">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-549" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2291">90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Mid Cap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-550" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2292">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-551" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2293">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-552" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2294">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-553" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2295">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Small Cap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-554" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2296">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-555" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2297">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-556" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2298">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-557" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2299">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Large Cap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-558" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2300">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-559" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2301">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-560" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2302">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-561" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2303">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Mid Cap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-562" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2304">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-563" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2305">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-564" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2306">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-565" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2307">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Small Cap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-566" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2308">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-567" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2309">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-568" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2310">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-569" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2311">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Markets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-570" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2312">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-571" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2313">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-572" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2314">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-573" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2315">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Fixed Income Securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Corporate Bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-574" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2316">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-575" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2317">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-576" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2318">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-577" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2319">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Treasuries/Government Bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-578" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2320">194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-579" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2321">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-580" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2322">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-581" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2323">194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Corporate Bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-582" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2324">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-583" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2325">88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-584" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2326">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-585" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2327">138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Asset-Backed Securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-586" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2328">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-587" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2329">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-588" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2330">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-589" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2331">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Other Fixed Income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-590" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2332">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-591" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2333">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-592" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2334">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-593" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2335">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Alternative Types of Investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance Contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-594" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2336">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-595" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2337">247</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-596" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2338">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-597" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2339">247</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative Financial Instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-598" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2340">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-599" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2341">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-600" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2342">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-601" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2343">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Absolute Return Funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-602" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2344">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-603" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2345">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-604" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2346">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-605" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2347">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private Equity Funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-606" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2348">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-607" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2349">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-608" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2350">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-609" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2351">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Property</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Property</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-610" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2352">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-611" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2353">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-612" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2354">77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-488" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2355">84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-613" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2356">475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-614" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2357">448</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-615" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2358">77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-616" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="f-2359">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 98</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:continuation id="f-1888-7" continuedAt="f-1888-8"><ix:continuation id="f-2233-2"><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans for the Year Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-617" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2360">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-618" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2361">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-619" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2362">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-620" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2363">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Equity Securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Large Cap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-621" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2364">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-622" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2365">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-623" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2366">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-624" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2367">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Mid Cap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-625" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2368">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-626" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2369">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-627" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2370">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-628" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2371">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Large Cap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-629" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2372">79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-630" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2373">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-631" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2374">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-632" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2375">79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Mid Cap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-633" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2376">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-634" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2377">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-635" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2378">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-636" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2379">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Small Cap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-637" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2380">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-638" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2381">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-639" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2382">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-640" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2383">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Markets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-641" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2384">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-642" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2385">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-643" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2386">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-644" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2387">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Fixed Income Securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Corporate Bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-645" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2388">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-646" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2389">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-647" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2390">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-648" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2391">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Treasuries/Government Bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-649" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2392">144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-650" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2393">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-651" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2394">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-652" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2395">144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Corporate Bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-653" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2396">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-654" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2397">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-655" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2398">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-656" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2399">109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Asset-Backed Securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-657" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2400">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-658" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2401">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-659" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2402">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-660" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2403">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Other Fixed Income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-661" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2404">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-662" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2405">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-663" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2406">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-664" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2407">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Alternative Types of Investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance Contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-665" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2408">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-666" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2409">177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-667" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2410">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-668" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2411">177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative Financial Instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-669" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2412">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-670" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2413">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-671" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2414">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-672" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2415">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Absolute Return Funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-673" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2416">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-674" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2417">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-675" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2418">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-676" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2419">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-677" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2420">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-678" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2421">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-679" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2422">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-680" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2423">67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Property</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Property</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-681" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2424">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-682" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2425">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-683" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2426">81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-489" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2427">85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-684" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2428">407</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-685" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2429">429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-686" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2430">84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-687" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2431">920</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents are primarily held in registered money market funds which are valued using a market approach based on the quoted market prices of identical instruments. Other cash and cash equivalents are valued daily by the fund using a market approach with inputs that include quoted market prices for similar instruments.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity securities are primarily valued using a market approach based on the quoted market prices of identical instruments. Pooled funds are typically common or collective trusts valued at their net asset values (NAVs).</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fixed income securities are primarily valued using a market approach with inputs that include broker quotes and benchmark yields.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative instruments are valued by the custodian using closing market swap curves and market derived inputs.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property values are primarily based on valuation of the underlying investments, which include inputs such as cost, discounted future cash flows, independent appraisals and market comparable data.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hedge funds are valued based on valuation of the underlying securities and instruments within the funds. Quoted market prices are used when available and NAVs are used for unquoted securities within the funds.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Absolute return funds are actively managed funds mainly invested in debt and equity securities and are valued at their NAVs.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock" id="f-2432" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a reconciliation of Level 3 non-U.S. plan assets held during the year ended December&#160;31, 2023:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hedge<br/>Funds</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-683" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2433">81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-679" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2434">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-686" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2435">84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-688" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld" scale="6" id="f-2436">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-689" decimals="-6" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld" format="ixt:fixed-zero" scale="6" id="f-2437">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-690" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld" scale="6" id="f-2438">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases, sales and settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-688" decimals="-6" name="us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements" format="ixt:fixed-zero" scale="6" id="f-2439">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-689" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements" scale="6" id="f-2440">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-690" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements" scale="6" id="f-2441">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance as of December 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-612" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2442">77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-691" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2443">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-615" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-2444">77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 99</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:continuation id="f-1888-8"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfHealthCareCostTrendRatesTableTextBlock" id="f-2445" escape="true"><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following weighted average assumptions were used to determine the postretirement benefit expense and obligation for the years ended December&#160;31:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.315%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.032%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.885%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.032%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.034%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-692" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="f-2446">5.40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-693" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="f-2447">2.90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-694" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="f-2448">5.10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-695" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="f-2449">5.40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current medical cost trend rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-696" decimals="4" name="iff:DefinedBenefitPlanCurrentMedicalCareCostTrendRate" scale="-2" id="f-2450">6.50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-697" decimals="4" name="iff:DefinedBenefitPlanCurrentMedicalCareCostTrendRate" scale="-2" id="f-2451">6.75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-698" decimals="4" name="iff:DefinedBenefitPlanCurrentMedicalCareCostTrendRate" scale="-2" id="f-2452">7.25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-699" decimals="4" name="iff:DefinedBenefitPlanCurrentMedicalCareCostTrendRate" scale="-2" id="f-2453">6.50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ultimate medical cost trend rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-692" decimals="4" name="us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate1" scale="-2" id="f-2454">4.75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-693" decimals="4" name="us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate1" scale="-2" id="f-2455">4.75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-694" decimals="4" name="us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate1" scale="-2" id="f-2456">4.75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-695" decimals="4" name="us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate1" scale="-2" id="f-2457">4.75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical cost trend rate decreases to ultimate rate in year</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2030</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2034</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2030</span></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company contributed $<ix:nonFraction unitRef="usd" contextRef="c-455" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="f-2458">31</ix:nonFraction> million to its non-U.S. pension plans in 2023. <ix:nonFraction unitRef="usd" contextRef="c-700" decimals="INF" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt-sec:numwordsen" scale="0" id="f-2459">No</ix:nonFraction> contributions were made to the Company&#8217;s qualified U.S. pension plans in 2023. The Company contributed $<ix:nonFraction unitRef="usd" contextRef="c-701" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="f-2460">5</ix:nonFraction> million with respect to its non-qualified U.S. pension plan. In addition, $<ix:nonFraction unitRef="usd" contextRef="c-460" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="f-2461">3</ix:nonFraction> million of payments were made with respect to the Company&#8217;s other postretirement plans.</span></div></ix:continuation><div style="text-indent:24.75pt"><span><br/></span></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_172"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 16.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:FinancialInstrumentsDisclosureTextBlock" id="f-2462" continuedAt="f-2462-1" escape="true">FINANCIAL INSTRUMENTS</ix:nonNumeric></span></div><ix:continuation id="f-2462-1" continuedAt="f-2462-2"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounting guidance on fair value measurements specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company&#8217;s market assumptions. These two types of inputs create the following fair value hierarchy:</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 &#8212; Quoted prices for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">identical</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> instruments in active markets.</span></div><div style="margin-top:3pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 &#8212; Quoted prices for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">similar</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets.</span></div><div style="margin-top:3pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 &#8212; Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This hierarchy requires the Company to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value. The Company determines the fair value of structured liabilities (where performance is linked to structured interest rates, inflation or currency risks) using the Term SOFR swap curve and forward interest and exchange rates at period end. Such instruments are classified as Level 2 based on the observability of significant inputs to the model. The Company does not have any instruments classified as Level 3, other than those included in pension asset trusts included in Note 15. These valuations take into consideration the Company's credit risk and its counterparties&#8217; credit risk.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 100</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:continuation id="f-2462-2" continuedAt="f-2462-3"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="f-2463" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value and the estimated fair values of financial instruments at December&#160;31 consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LEVEL 1</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-702" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="f-2464">703</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-703" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="f-2465">703</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-704" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="f-2466">483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-705" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="f-2467">483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LEVEL 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credit facilities and bank overdrafts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-702" decimals="-6" name="us-gaap:LoansPayableFairValueDisclosure" scale="6" id="f-2468">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-703" decimals="-6" name="us-gaap:LoansPayableFairValueDisclosure" scale="6" id="f-2469">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-704" decimals="-6" name="us-gaap:LoansPayableFairValueDisclosure" scale="6" id="f-2470">106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-705" decimals="-6" name="us-gaap:LoansPayableFairValueDisclosure" scale="6" id="f-2471">106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="-sec-ix-hidden:f-2472"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-702" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="f-2473">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-703" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="f-2474">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-704" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="f-2475">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-705" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="f-2476">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="-sec-ix-hidden:f-2477"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-702" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="f-2478">165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-703" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="f-2479">165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-704" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="f-2480">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-705" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="f-2481">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-702" decimals="-6" name="us-gaap:CommercialPaper" format="ixt:fixed-zero" scale="6" id="f-2482">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-703" decimals="-6" name="us-gaap:CommercialPaper" format="ixt:fixed-zero" scale="6" id="f-2483">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-704" decimals="-6" name="us-gaap:CommercialPaper" scale="6" id="f-2484">187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-705" decimals="-6" name="us-gaap:CommercialPaper" scale="6" id="f-2485">187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-706" decimals="-6" name="us-gaap:SeniorNotesCurrent" format="ixt:fixed-zero" scale="6" id="f-2486">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-707" decimals="-6" name="us-gaap:SeniorNotesCurrent" format="ixt:fixed-zero" scale="6" id="f-2487">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-708" decimals="-6" name="us-gaap:SeniorNotesCurrent" scale="6" id="f-2488">300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-709" decimals="-6" name="us-gaap:SeniorNotesCurrent" scale="6" id="f-2489">298</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Euro Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-710" decimals="-6" name="us-gaap:SeniorNotesCurrent" scale="6" id="f-2490">552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-711" decimals="-6" name="us-gaap:SeniorNotesCurrent" scale="6" id="f-2491">549</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-712" decimals="-6" name="us-gaap:SeniorLongTermNotes" scale="6" id="f-2492">532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-713" decimals="-6" name="us-gaap:SeniorLongTermNotes" scale="6" id="f-2493">519</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-714" decimals="-6" name="us-gaap:SeniorLongTermNotes" format="ixt:num-dot-decimal" scale="6" id="f-2494">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-715" decimals="-6" name="us-gaap:SeniorLongTermNotes" scale="6" id="f-2495">924</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-716" decimals="-6" name="us-gaap:SeniorLongTermNotes" format="ixt:num-dot-decimal" scale="6" id="f-2496">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-717" decimals="-6" name="us-gaap:SeniorLongTermNotes" scale="6" id="f-2497">884</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Euro Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-718" decimals="-6" name="us-gaap:SeniorLongTermNotes" scale="6" id="f-2498">879</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-719" decimals="-6" name="us-gaap:SeniorLongTermNotes" scale="6" id="f-2499">835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-720" decimals="-6" name="us-gaap:SeniorLongTermNotes" scale="6" id="f-2500">845</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-721" decimals="-6" name="us-gaap:SeniorLongTermNotes" scale="6" id="f-2501">774</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-722" decimals="-6" name="us-gaap:SeniorLongTermNotes" format="ixt:num-dot-decimal" scale="6" id="f-2502">1,212</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-723" decimals="-6" name="us-gaap:SeniorLongTermNotes" format="ixt:num-dot-decimal" scale="6" id="f-2503">1,049</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-724" decimals="-6" name="us-gaap:SeniorLongTermNotes" format="ixt:num-dot-decimal" scale="6" id="f-2504">1,215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-725" decimals="-6" name="us-gaap:SeniorLongTermNotes" format="ixt:num-dot-decimal" scale="6" id="f-2505">1,006</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-726" decimals="-6" name="us-gaap:SeniorLongTermNotes" scale="6" id="f-2506">398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-727" decimals="-6" name="us-gaap:SeniorLongTermNotes" scale="6" id="f-2507">389</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-728" decimals="-6" name="us-gaap:SeniorLongTermNotes" scale="6" id="f-2508">398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-729" decimals="-6" name="us-gaap:SeniorLongTermNotes" scale="6" id="f-2509">380</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2030 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-730" decimals="-6" name="us-gaap:SeniorLongTermNotes" format="ixt:num-dot-decimal" scale="6" id="f-2510">1,508</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-731" decimals="-6" name="us-gaap:SeniorLongTermNotes" format="ixt:num-dot-decimal" scale="6" id="f-2511">1,240</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-732" decimals="-6" name="us-gaap:SeniorLongTermNotes" format="ixt:num-dot-decimal" scale="6" id="f-2512">1,510</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-733" decimals="-6" name="us-gaap:SeniorLongTermNotes" format="ixt:num-dot-decimal" scale="6" id="f-2513">1,188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2040 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-734" decimals="-6" name="us-gaap:SeniorLongTermNotes" scale="6" id="f-2514">773</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-735" decimals="-6" name="us-gaap:SeniorLongTermNotes" scale="6" id="f-2515">536</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-736" decimals="-6" name="us-gaap:SeniorLongTermNotes" scale="6" id="f-2516">774</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-737" decimals="-6" name="us-gaap:SeniorLongTermNotes" scale="6" id="f-2517">535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2047 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-738" decimals="-6" name="us-gaap:SeniorLongTermNotes" scale="6" id="f-2518">495</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-739" decimals="-6" name="us-gaap:SeniorLongTermNotes" scale="6" id="f-2519">382</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-740" decimals="-6" name="us-gaap:SeniorLongTermNotes" scale="6" id="f-2520">495</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-741" decimals="-6" name="us-gaap:SeniorLongTermNotes" scale="6" id="f-2521">390</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2048 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-742" decimals="-6" name="us-gaap:SeniorLongTermNotes" scale="6" id="f-2522">787</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-743" decimals="-6" name="us-gaap:SeniorLongTermNotes" scale="6" id="f-2523">678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-744" decimals="-6" name="us-gaap:SeniorLongTermNotes" scale="6" id="f-2524">787</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-745" decimals="-6" name="us-gaap:SeniorLongTermNotes" scale="6" id="f-2525">685</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2050 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-746" decimals="-6" name="us-gaap:SeniorLongTermNotes" format="ixt:num-dot-decimal" scale="6" id="f-2526">1,569</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-747" decimals="-6" name="us-gaap:SeniorLongTermNotes" format="ixt:num-dot-decimal" scale="6" id="f-2527">1,029</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-748" decimals="-6" name="us-gaap:SeniorLongTermNotes" format="ixt:num-dot-decimal" scale="6" id="f-2528">1,571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-749" decimals="-6" name="us-gaap:SeniorLongTermNotes" format="ixt:num-dot-decimal" scale="6" id="f-2529">1,021</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Term Loan Facility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-750" decimals="-6" name="us-gaap:SeniorNotesCurrent" scale="6" id="f-2530">270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-751" decimals="-6" name="us-gaap:SeniorNotesCurrent" scale="6" id="f-2531">270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-752" decimals="-6" name="us-gaap:SeniorLongTermNotes" scale="6" id="f-2532">625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-753" decimals="-6" name="us-gaap:SeniorLongTermNotes" scale="6" id="f-2533">625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Term Loan Facility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-754" decimals="-6" name="us-gaap:SeniorLongTermNotes" scale="6" id="f-2534">625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-755" decimals="-6" name="us-gaap:SeniorLongTermNotes" scale="6" id="f-2535">625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-756" decimals="-6" name="us-gaap:SeniorLongTermNotes" scale="6" id="f-2536">625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-757" decimals="-6" name="us-gaap:SeniorLongTermNotes" scale="6" id="f-2537">625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The carrying amount of cash and cash equivalents approximates fair value due to the short maturity of those instruments.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The carrying amount approximates fair value as the interest rate is reset frequently based on current market rates as well as the short maturity of those instruments.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The carrying amount approximates fair value as the instruments are marked-to-market and held at fair value on the Consolidated Balance Sheets.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The fair value of the Note is obtained from pricing services engaged by the Company, and the Company receives one price for each security. The fair value provided by the pricing services are estimated using pricing models, where the inputs to those models are based on observable market inputs or recent trades of similar securities. The inputs to the valuation techniques applied by the pricing services are typically benchmark yields, benchmark security prices, credit spreads, reported trades and broker-dealer quotes, all with reasonable levels of transparency.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The carrying amount approximates fair value as the Term Loans were assumed at fair value and the interest rate is reset frequently based on current market rates.</span></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivatives</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Forward Contracts</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company periodically enters into foreign currency forward contracts with the objective of managing our exchange rate risk related to foreign currency denominated monetary assets and liabilities of our operations. These contracts generally involve the exchange of one currency for a second currency at a future date, have maturities not exceeding twelve months and are with counterparties which are major international financial institutions.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commodity Contracts</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes options that are not designated as hedging instruments to reduce exposure to commodity price fluctuations on purchases of inventory such as soybeans, soybean oil and soybean meal.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also uses options, futures and swaps that are designated as hedging instruments to reduce exposure to commodity price fluctuations on purchases of natural gas used in our manufacturing process.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 101</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:continuation id="f-2462-3" continuedAt="f-2462-4"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flow Hedges</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through the third quarter of 2021, the Company maintained several forward currency contracts which qualified as cash flow hedges. The objective of these hedges is to protect against the currency risk associated with forecasted U.S. dollar (&#8220;USD&#8221;) denominated raw material purchases made by Euro (&#8220;EUR&#8221;) functional currency entities which result from changes in the EUR/USD exchange rate. The effective portions of cash flow hedges are recorded in other comprehensive income (&#8220;OCI&#8221;) as a component of Gains on derivatives qualifying as hedges in the accompanying Consolidated Statements of (Loss) Income and Comprehensive Loss. Realized gains/(losses) in accumulated other comprehensive income (loss) (&#8220;AOCI&#8221;) related to cash flow hedges of raw material purchases are recognized as a component of Cost of goods sold in the accompanying Consolidated Statements of (Loss) Income and Comprehensive Loss in the same period as the related costs are recognized.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no cash flow hedges as of December&#160;31, 2023 and December&#160;31, 2022.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hedges Related to Issuances of Debt</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the issuance of the 2026 Euro Notes during the third quarter of 2018, the Company designated the debt as a hedge of a portion of its net European investments. Accordingly, the change in the value of the debt that is attributable to foreign exchange movements is recorded in OCI as a component of foreign currency translation adjustments in the accompanying Consolidated Statements of (Loss) Income and Comprehensive Loss.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the issuance of the 2024 Euro Notes during the first quarter of 2016, the Company designated the debt as a hedge of a portion of its net European investments. Accordingly, the change in the value of the debt that is attributable to foreign exchange movements is recorded in OCI as a component of foreign currency translation adjustments in the accompanying Consolidated Statements of (Loss) Income and Comprehensive Loss.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2016, the Company entered into and terminated <ix:nonFraction unitRef="agreement" contextRef="c-758" decimals="INF" name="us-gaap:NumberOfInterestRateDerivativesHeld" format="ixt-sec:numwordsen" scale="0" id="f-2538">two</ix:nonFraction> Euro interest rate swap agreements to hedge the anticipated issuance of fixed-rate debt. These swaps were designated as cash flow hedges. The effective portions of cash flow hedges are recorded in OCI as a component of Losses on derivatives qualifying as hedges in the accompanying Consolidated Statements of (Loss) Income and Comprehensive Loss. The Company incurred a loss of &#8364;<ix:nonFraction unitRef="eur" contextRef="c-759" decimals="-6" sign="-" name="iff:DeferredGainLossOnTerminatedInterestRateContracts" format="ixt:num-dot-decimal" scale="6" id="f-2539">3</ix:nonFraction> million ($<ix:nonFraction unitRef="usd" contextRef="c-759" decimals="-6" sign="-" name="iff:DeferredGainLossOnTerminatedInterestRateContracts" format="ixt:num-dot-decimal" scale="6" id="f-2540">3</ix:nonFraction> million) due to the termination of these swaps. The loss is being amortized as interest expense over the life of the 2024 Euro Notes as discussed in Note 9.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2016 and the first quarter of 2017, the Company entered into interest rate swap agreements to hedge the anticipated issuance of fixed-rate debt, which are designated as cash flow hedges. The various hedge instruments were settled upon issuance of the debt on May 18, 2017 and resulted in a loss of approximately $<ix:nonFraction unitRef="usd" contextRef="c-760" decimals="-6" name="us-gaap:GainLossOnSaleOfDerivatives" format="ixt:num-dot-decimal" scale="6" id="f-2541">5</ix:nonFraction> million. As discussed in Note 9, the loss is being amortized as interest expense over the life of the 2047 Notes.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cross Currency Swaps</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2022, the Company entered into a transaction to unwind the <ix:nonFraction unitRef="swap" contextRef="c-761" decimals="INF" name="us-gaap:NumberOfForeignCurrencyDerivativesHeld" format="ixt-sec:numwordsen" scale="0" id="f-2542">fourteen</ix:nonFraction> outstanding EUR/USD cross currency swaps designated as net investment hedges issued between the third quarter of 2019 and the first quarter of 2022. The Company received proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-762" decimals="-6" name="us-gaap:ProceedsFromDerivativeInstrumentInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="f-2543">183</ix:nonFraction> million, including $<ix:nonFraction unitRef="usd" contextRef="c-762" decimals="-6" name="us-gaap:InterestIncomeExpenseNet" format="ixt:num-dot-decimal" scale="6" id="f-2544">11</ix:nonFraction> million of interest income. The gain arising from the termination of the swaps has been included as a component of Accumulated other comprehensive loss. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the unwinding of the existing swaps, during the third quarter of 2022, the Company entered into <ix:nonFraction unitRef="swap" contextRef="c-763" decimals="INF" name="us-gaap:NumberOfForeignCurrencyDerivativesHeld" format="ixt-sec:numwordsen" scale="0" id="f-2545">twelve</ix:nonFraction> new EUR/USD cross currency swaps, with a notional value of $<ix:nonFraction unitRef="usd" contextRef="c-764" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="f-2546">1.400</ix:nonFraction>&#160;billion that mature through November 2030. The swaps all qualified as net investment hedges in order to mitigate a portion of the Company&#8217;s net European investments from foreign currency risk. As of December&#160;31, 2023, the <ix:nonFraction unitRef="swap" contextRef="c-765" decimals="INF" name="us-gaap:NumberOfForeignCurrencyDerivativesHeld" format="ixt-sec:numwordsen" scale="0" id="f-2547">twelve</ix:nonFraction> remaining swaps were in a liability position with an aggregate fair value of $<ix:nonFraction unitRef="usd" contextRef="c-765" decimals="-6" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" format="ixt:num-dot-decimal" scale="6" id="f-2548">161</ix:nonFraction> million which were classified as Other liabilities on the Consolidated Balance Sheets. Changes in fair value related to cross currency swaps are recorded in OCI.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" id="f-2549" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the notional amount of the Company&#8217;s derivative instruments outstanding as of December&#160;31, 2023 and December&#160;31, 2022:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:68.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.562%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.564%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-766" decimals="-6" sign="-" name="iff:DerivativeNotionalAmountNet" format="ixt:num-dot-decimal" scale="6" id="f-2550">1,400</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-767" decimals="-6" name="iff:DerivativeNotionalAmountNet" scale="6" id="f-2551">92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-768" decimals="-6" name="iff:DerivativeNotionalAmountNet" scale="6" id="f-2552">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-769" decimals="-6" sign="-" name="iff:DerivativeNotionalAmountNet" scale="6" id="f-2553">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-770" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-2554">1,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-771" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-2555">1,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________</span></div><div style="margin-top:3pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt">Foreign currency contracts and commodity contracts are presented net of contracts bought and sold.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 102</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:continuation id="f-2462-4" continuedAt="f-2462-5"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="f-2556" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables show the Company&#8217;s derivative instruments measured at fair value (Level 2 of the fair value hierarchy) as reflected in the Consolidated Balance Sheets as of December&#160;31, 2023 and December&#160;31, 2022:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:42.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.640%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.055%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.057%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value of Derivatives<br/>Designated&#160;as Hedging<br/>Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value of Derivatives Not Designated as Hedging Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-772" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="f-2557">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-773" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="f-2558">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-774" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="f-2559">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivative assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-775" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="f-2560">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-776" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="f-2561">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="f-2562">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-772" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="f-2563">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-773" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-2564">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-774" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-2565">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swaps</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-777" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-2566">161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-778" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="f-2567">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-770" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-2568">161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivative liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-775" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-2569">161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-776" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-2570">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-2571">165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:42.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.282%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.988%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.284%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair&#160;Value&#160;of Derivatives Designated&#160;as Hedging Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair&#160;Value&#160;of Derivatives&#160;Not Designated as Hedging Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total&#160;Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-779" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="f-2572">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-780" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="f-2573">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-781" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="f-2574">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swaps</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-782" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-2575">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-783" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="f-2576">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-771" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-2577">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Derivative assets are recorded to Prepaid expenses and other current assets on the Consolidated Balance Sheets.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Derivative liabilities are recorded to Other current liabilities and Other liabilities on the Consolidated Balance Sheets.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="f-2578" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the effect of the Company&#8217;s derivative instruments which were not designated as hedging instruments in the Consolidated Statements of (Loss) Income and Comprehensive Loss for the years ended December&#160;31, 2023 and 2022:</span></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.759%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.805%"/><td style="width:0.1%"/></tr><tr style="height:32pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount&#160;of&#160;Gain (Loss)<br/>For the year ended<br/>December&#160;31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location&#160;of&#160;Gain (Loss)<br/>Recognized in<br/>Income on Derivative</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-784" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="f-2579">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-785" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="f-2580">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-2581"><span style="-sec-ix-hidden:f-2582">Other expense (income), net</span></span></span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-788" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="f-2583">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-789" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="3" id="f-2584">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-2585">Cost of goods sold</span></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-791" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="f-2586">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-792" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="f-2587">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-top:3pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt">The foreign currency contract net gains (losses) offset any recognized gains (losses) arising from the revaluation of the related intercompany loans during the same respective periods.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 103</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:continuation id="f-2462-5"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" id="f-2588" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the effect of the Company&#8217;s derivative instruments designated as net investment hedging instruments, net of tax, in the Consolidated Statements of (Loss) Income and Comprehensive Loss for the years ended December&#160;31, 2023 and 2022:</span></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:36.694%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.638%"/><td style="width:0.1%"/></tr><tr style="height:36pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain (Loss)<br/>Recognized&#160;in OCI on Derivative and Non-Derivative<br/>(Effective Portion)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location&#160;of&#160;Gain<br/>(Loss) Reclassified<br/>from AOCI into Income<br/>(Effective Portion)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Reclassified from AOCI<br/>into Income<br/>(Effective Portion)</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the years ended<br/>December&#160;31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the years ended<br/>December&#160;31,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives in Net Investment Hedging Relationships:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swaps</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-793" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" scale="6" id="f-2589">67</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-794" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" scale="6" id="f-2590">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-Derivatives in Net Investment Hedging Relationships:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Euro Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-795" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" scale="6" id="f-2591">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-796" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" scale="6" id="f-2592">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Euro Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-797" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" scale="6" id="f-2593">26</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-798" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" scale="6" id="f-2594">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" scale="6" id="f-2595">109</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" scale="6" id="f-2596">54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" format="ixt:fixed-zero" scale="6" id="f-2597">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" format="ixt:fixed-zero" scale="6" id="f-2598">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ineffective portion of the above noted net investment hedges was approximately $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:DerivativeNetHedgeIneffectivenessGainLoss" format="ixt:num-dot-decimal" scale="6" id="f-2599">15</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:DerivativeNetHedgeIneffectivenessGainLoss" format="ixt:num-dot-decimal" scale="6" id="f-2600">10</ix:nonFraction> million for the years ended December&#160;31, 2023 and 2022, respectively, and was recorded as a reduction to interest expense on the Consolidated Statements of (Loss) Income and Comprehensive Loss.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2023, based on current market rates, the Company does not expect any derivative losses (net of tax), included in AOCI, to be reclassified into earnings within the next 12 months.</span></div></ix:continuation><div style="text-indent:24.75pt"><span><br/></span></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_175"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 17.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="iff:AccumulatedOtherComprehensiveIncomeLossTextBlock" id="f-2601" continuedAt="f-2601-1" escape="true">ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="f-2602" continuedAt="f-2602-1" escape="true"><ix:continuation id="f-2601-1" continuedAt="f-2601-2"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present changes in the accumulated balances for each component of other comprehensive income (loss), including current period other comprehensive income (loss) and reclassifications out of accumulated other comprehensive income (loss):</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:43.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.988%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.403%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gains&#160;(Losses)&#160;on Derivatives<br/>Qualifying as<br/>Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension and<br/>Postretirement<br/>Liability<br/>Adjustment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive (loss) income, net of tax, as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-799" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-2603">2,066</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-800" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="f-2604">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-801" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-2605">133</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-2606">2,198</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCI before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-802" decimals="-6" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="f-2607">367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-803" decimals="-6" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="f-2608">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-804" decimals="-6" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="f-2609">100</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-6" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="f-2610">267</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassifications due to business divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-802" decimals="-6" name="iff:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIDueToBusinessDivestitures" scale="6" id="f-2611">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-803" decimals="-6" name="iff:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIDueToBusinessDivestitures" format="ixt:fixed-zero" scale="6" id="f-2612">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-804" decimals="-6" sign="-" name="iff:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIDueToBusinessDivestitures" scale="6" id="f-2613">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-6" name="iff:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIDueToBusinessDivestitures" scale="6" id="f-2614">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-802" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="f-2615">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-803" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="f-2616">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-804" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="f-2617">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="f-2618">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-802" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-2619">414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-803" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:fixed-zero" scale="6" id="f-2620">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-804" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-2621">112</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-2622">302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive (loss) income, net of tax, as of December 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-805" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-2623">1,652</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-806" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="f-2624">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-807" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-2625">245</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-2626">1,896</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:43.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.988%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.403%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gains&#160;(Losses)&#160;on Derivatives<br/>Qualifying as<br/>Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension and<br/>Postretirement<br/>Liability<br/>Adjustment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive (loss) income, net of tax, as of December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-808" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-2627">1,133</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-809" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="f-2628">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-810" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-2629">291</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-2630">1,423</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCI before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-811" decimals="-6" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="f-2631">933</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-812" decimals="-6" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="f-2632">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-813" decimals="-6" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="f-2633">148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-6" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="f-2634">785</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-811" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="f-2635">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-812" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="f-2636">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-813" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="f-2637">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="f-2638">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-811" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-2639">933</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-812" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:fixed-zero" scale="6" id="f-2640">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-813" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-2641">158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-2642">775</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive (loss) income, net of tax, as of December 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-799" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-2643">2,066</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-800" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="f-2644">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-801" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-2645">133</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-2646">2,198</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 104</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:continuation id="f-2601-2"><ix:continuation id="f-2602-1"><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:43.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.988%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.403%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gains&#160;(Losses)&#160;on Derivatives<br/>Qualifying as<br/>Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension and<br/>Postretirement<br/>Liability<br/>Adjustment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive (loss) income, net of tax, as of December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-814" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-2647">285</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-815" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-2648">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-816" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-2649">406</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-2650">698</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCI before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-817" decimals="-6" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="f-2651">848</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-818" decimals="-6" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="f-2652">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-819" decimals="-6" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="f-2653">97</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-6" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="f-2654">750</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-817" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="f-2655">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-818" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="f-2656">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-819" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="f-2657">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="f-2658">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-817" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-2659">848</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-818" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-2660">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-819" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-2661">115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-2662">725</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive (loss) income, net of tax, as of December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-808" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-2663">1,133</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-809" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="f-2664">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-810" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-2665">291</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-2666">1,423</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" id="f-2667" escape="true"><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides details about reclassifications out of Accumulated other comprehensive loss to the Consolidated Statements of (Loss) Income and Comprehensive Loss:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:36.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.466%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.466%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.466%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.525%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Affected Line Item in the Consolidated Statements of (Loss) Income and Comprehensive Loss</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains (losses) on derivatives qualifying as hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-820" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:fixed-zero" scale="6" id="f-2668">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-821" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:fixed-zero" scale="6" id="f-2669">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-822" decimals="-6" sign="-" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-2670">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-823" decimals="-6" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="6" id="f-2671">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-824" decimals="-6" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="6" id="f-2672">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-825" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="f-2673">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-803" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="6" id="f-2674">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-812" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="6" id="f-2675">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-818" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-2676">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision&#160;for&#160;income&#160;taxes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-826" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="f-2677">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-827" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="f-2678">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-828" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="f-2679">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total, net of income taxes</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains (losses) on pension and postretirement liability adjustments</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-829" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="f-2680">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-830" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="f-2681">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-831" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="f-2682">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gains (losses)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-832" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="f-2683">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-833" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="f-2684">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-834" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="f-2685">38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-835" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" format="ixt:fixed-zero" scale="6" id="f-2686">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-836" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" format="ixt:fixed-zero" scale="6" id="f-2687">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-837" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="f-2688">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-804" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-2689">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-813" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-2690">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-819" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-2691">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-838" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="f-2692">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-839" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="f-2693">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-840" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="f-2694">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total,&#160;net&#160;of&#160;income&#160;taxes</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The amortization of prior service cost and actuarial loss is included in the computation of net periodic benefit cost. See Note 15 for additional information regarding net periodic benefit cost.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents certain amounts of pension income that were corrected in 2021.</span></div></ix:nonNumeric></ix:continuation><div style="text-indent:-4.5pt"><span><br/></span></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_178"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 18.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:ConcentrationRiskDisclosureTextBlock" id="f-2695" continuedAt="f-2695-1" escape="true">CONCENTRATIONS OF CREDIT RISK</ix:nonNumeric></span></div><ix:continuation id="f-2695-1"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not have significant concentrations of risk in financial instruments. Temporary investments are made in a well-diversified portfolio of high-quality, liquid obligations of government, corporate and financial institutions. There are also limited concentrations of credit risk with respect to trade receivables because the Company has a large number of customers who are spread across many industries and geographic regions. The Company&#8217;s larger customers are each spread across many sub-categories of its segments and geographical regions. The Company had <ix:nonFraction unitRef="customer" contextRef="c-841" decimals="0" name="iff:EntityWideRevenueMajorCustomerNumberOfCustomers" format="ixt-sec:numwordsen" scale="0" id="f-2696"><ix:nonFraction unitRef="customer" contextRef="c-842" decimals="0" name="iff:EntityWideRevenueMajorCustomerNumberOfCustomers" format="ixt-sec:numwordsen" scale="0" id="f-2697"><ix:nonFraction unitRef="customer" contextRef="c-843" decimals="0" name="iff:EntityWideRevenueMajorCustomerNumberOfCustomers" format="ixt-sec:numwordsen" scale="0" id="f-2698">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> customer that accounted for more than <ix:nonFraction unitRef="number" contextRef="c-844" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-2699"><ix:nonFraction unitRef="number" contextRef="c-845" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-2700"><ix:nonFraction unitRef="number" contextRef="c-846" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-2701">10</ix:nonFraction></ix:nonFraction></ix:nonFraction>% of its consolidated net sales for the years ended 2023, 2022 and 2021.</span></div></ix:continuation><div style="text-indent:24.75pt"><span><br/></span></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_181"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 19.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="f-2702" continuedAt="f-2702-1" escape="true">COMMITMENTS AND CONTINGENCIES</ix:nonNumeric></span></div><ix:continuation id="f-2702-1" continuedAt="f-2702-2"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Guarantees and Letters of Credit</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has various bank guarantees, letters of credit and surety bonds which are used to support its ongoing business operations, satisfy governmental requirements associated with pending litigation in various jurisdictions and the payment of customs duties. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, the Company had a total capacity of approximately $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="iff:BankGuaranteesCommercialGuaranteesStandbyLettersOfCreditAndSuretyBondsFacilityAmounts" format="ixt:num-dot-decimal" scale="6" id="f-2703">229</ix:nonFraction> million of bank guarantees, commercial guarantees, standby letters of credit and surety bonds with various financial institutions. Included in the above aggregate amount was a total of approximately $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="iff:BankGuaranteesRelatedToAppealsOnIncomeTaxAndIndirectTaxCases" format="ixt:num-dot-decimal" scale="6" id="f-2704">11</ix:nonFraction> million for other assessments in Brazil for various income tax and indirect </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 105</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:continuation id="f-2702-2" continuedAt="f-2702-3"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">tax disputes related to fiscal years 1998-2011. There was a total of approximately $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="iff:BankGuaranteesStandbyLettersOfCreditAndCommercialGuaranteesAmountOutstanding" format="ixt:num-dot-decimal" scale="6" id="f-2705">61</ix:nonFraction>&#160;million outstanding under the bank guarantees, standby letters of credit and commercial guarantees as of December&#160;31, 2023.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to challenge the assessments in these cases in Brazil, the Company has been required to, and has separately pledged assets, principally property, plant and equipment, to cover assessments in the amount of approximately $<ix:nonFraction unitRef="usd" contextRef="c-847" decimals="-6" name="iff:AmountOfPledgedAssetsPrincipallyPropertyPlantAndEquipmentToCoverIncomeTaxAndIndirectTaxAssessments" format="ixt:num-dot-decimal" scale="6" id="f-2706">8</ix:nonFraction> million as of December&#160;31, 2023.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lines of Credit</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has various lines of credit which are available to support its ongoing business operations. As of December&#160;31, 2023, the Company had a total capacity of approximately $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="iff:AmountOfAvailableLinesOfCredit" format="ixt:num-dot-decimal" scale="9" id="f-2707">1.848</ix:nonFraction> billion of lines of credit with various financial institutions, in addition to the $<ix:nonFraction unitRef="usd" contextRef="c-297" decimals="-6" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="f-2708">1.548</ix:nonFraction>&#160;billion of capacity under the Revolving Credit Facility. Pursuant to these lines of credit as of December&#160;31, 2023, the total drawdowns were not material.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Litigation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses contingencies related to litigation and/or other matters to determine the degree of probability and range of possible loss. A loss contingency is accrued in the Company&#8217;s Consolidated Financial Statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because litigation is inherently unpredictable and unfavorable resolutions could occur, assessing contingencies is highly sensitive and requires judgments about future events. On at least a quarterly basis, the Company reviews contingencies related to litigation to determine the adequacy of accruals. The amount of ultimate loss may differ from these estimates and further events may require the Company to increase or decrease the amounts it has accrued on any matter.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Periodically, the Company assesses its insurance coverage for all known claims, where applicable, taking into account aggregate coverage by occurrence, limits of coverage, self-insured retentions and deductibles, historical claims experience and claims experience with its insurance carriers. The liabilities are recorded at management&#8217;s best estimate of the probable outcome of the lawsuits and claims, taking into consideration the facts and circumstances of the individual matters as well as past experience on similar matters. At each balance sheet date, the key issues that management assesses are whether it is probable that a loss as to asserted or unasserted claims has been incurred and if so, whether the amount of loss can be reasonably estimated. The Company records the expected liability with respect to claims in Other liabilities and expected recoveries from its insurance carriers in Other assets. The Company recognizes a receivable when it believes that realization of the insurance receivable is probable under the terms of the insurance policies and its payment experience to date.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation Matters</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 12, 2019, Marc Jansen filed a putative securities class action against IFF, its then Chairman and CEO, and its then-CFO, in the United States District Court for the Southern District of New York. The lawsuit was filed after IFF disclosed that preliminary results of investigations indicated that Frutarom businesses operating principally in Russia and Ukraine had made improper payments to representatives of customers. On March 16, 2020, an amended complaint was filed, which added Frutarom and certain former officers of Frutarom as defendants. The amended complaint alleges, among other things, that defendants made materially false and misleading statements or omissions concerning IFF&#8217;s acquisition of Frutarom, the integration of the two companies, and the companies&#8217; financial reporting and results. The amended complaint asserts claims under Section 10(b) of the Securities Exchange Act of 1934 and SEC Rule 10b-5, and under the Israeli Securities Act-1968, against all defendants, and under Section 20(a) of the Securities Exchange Act of 1934 against the individual defendants, on behalf of a putative class of persons and entities who purchased or otherwise acquired IFF securities on the New York Stock Exchange between May 7, 2018 and August 12, 2019 and persons and entities who purchased or otherwise acquired IFF securities on the Tel Aviv Stock Exchange between October 9, 2018 and August 12, 2019. The amended complaint seeks an award of unspecified compensatory damages, costs, and expenses. IFF, its officers, and Frutarom filed a motion to dismiss the case on June 26, 2020, which was granted on March 30, 2021. On April 28, 2021, lead plaintiffs filed a notice of appeal to the United States Court of Appeals for the Second Circuit. Lead plaintiffs are pursuing the appeal only against Frutarom and certain former officers of Frutarom. The parties have submitted their briefs to the Court of Appeals. The Second Circuit held oral argument on February 10, 2022. On September 30, 2022, the Second Circuit affirmed the dismissal of Plaintiffs&#8217; claims. On October 14, 2022, Plaintiffs filed a Petition for Rehearing En Banc, which the Second Circuit denied on January 4, 2023. Plaintiffs did not seek review in the United States Supreme Court. The matter is therefore fully resolved in defendants&#8217; favor.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 106</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:continuation id="f-2702-3" continuedAt="f-2702-4"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Two motions to approve securities class actions were filed in the Tel Aviv District Court, Israel, in August 2019, similarly alleging, among other things, false and misleading statements largely in connection with IFF&#8217;s acquisition of Frutarom and the above-mentioned improper payments.&#160;One motion (&#8220;Borg&#8221;) asserts claims under the U.S. federal securities laws against IFF, its former Chairman and CEO, and its former CFO. On November 8, 2020, IFF and its officers filed their response to the Borg motion. On April 20, 2021, Mr. Borg filed a motion to stay the proceeding pending an appellate decision in the U.S. proceeding. On June 15, 2021, August 11, 2021, November 9, 2021, January 9, 2022, April 7, 2022 and July 10, 2022, the U.S. lead plaintiffs filed update notices with the Israeli court regarding the appeal in the U.S. proceeding. On June 12, 2023, the petitioner filed a withdrawal motion, which the court then granted. The Borg case is now dismissed. The other motion (&#8220;Oman&#8221;) (following an initial amendment) asserted claims under the Israeli Securities Act-1968 against IFF, its former Chairman and CEO, and its former CFO, and against Frutarom and certain former Frutarom officers and directors, as well as claims under the Israeli Companies Act-1999 against certain former Frutarom officers and directors. On February 17, 2021, the court granted a motion by the Oman plaintiff to remove IFF and its officers from the motion and to add factual allegations from the US amended complaint. The amended Oman motion was filed on July 4, 2021. On August 29, 2021, the former Frutarom officers and certain former Frutarom directors filed a motion to dismiss the case. On September 30, 2021, Frutarom notified the court that it joins the legal arguments made in the motion to dismiss. On February 22, 2022, the court denied the motion to dismiss. On July 14, 2022, the court approved the parties&#8217; motion to mediate the dispute, which postpones all case deadlines until after the mediation. In addition, a request to appeal the court&#8217;s denial of the motion to dismiss filed by the former Frutarom officers and certain former Frutarom directors has been stayed. The parties held mediation meetings on September 13, 2022, November 22, 2022, March 1, 2023 and November 2023.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 29, 2019, IFF and Frutarom filed a claim in the Tel Aviv District Court, Israel, against Ori Yehudai, the former President and CEO of Frutarom, and against certain former directors of Frutarom, challenging the bonus of US $<ix:nonFraction unitRef="usd" contextRef="c-848" decimals="-6" name="us-gaap:DeferredCompensationArrangementWithIndividualCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="f-2709">20</ix:nonFraction>&#160;million granted to Yehudai in 2018.&#160;IFF and Frutarom allege, among other things, that Yehudai was not entitled to receive the bonus because he breached his fiduciary duty by, among other things, knowing of the above-mentioned improper payments and failing to prevent them from being made. The parties agreed, pursuant to the court&#8217;s recommendation, to attempt to resolve the dispute through mediation, and a court decision is pending with regard to the order in which this claim and the class action described below will be heard.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 11, 2020, an IFF shareholder filed a motion to approve a class action in Israel against, among others, Frutarom, Yehudai, and Frutarom&#8217;s former board of directors, alleging that former minority shareholders of Frutarom were harmed as a result of the US $<ix:nonFraction unitRef="usd" contextRef="c-849" decimals="-6" name="us-gaap:DeferredCompensationArrangementWithIndividualCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="f-2710">20</ix:nonFraction>&#160;million bonus paid to Yehudai. The parties to this motion agreed to attempt to resolve the dispute through mediation to take place regarding the aforesaid claim against Yehudai. On July 27, 2021, counsel to the movant in the class action filed a notice with the court that the mediation process ended without an agreement. On August 26, 2021, a motion to dismiss the class action application was filed by Yehudai and certain former directors of Frutarom. On September 9, 2021, an additional motion to dismiss was filed by other former directors of Frutarom together with ICC Industries, Inc. and its affiliates. On December 9, 2021, the court denied the motions to dismiss. Responses to the class action motion were filed in May 2022, and applicant&#8217;s response was filed in December 2022. An evidentiary hearing is set for March 2024.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since March 2023, various putative class action lawsuits have been filed against IFF, Firmenich International SA, Givaudan SA, and Symrise AG and/or certain affiliates thereof in the Quebec Superior Court, the Federal Court of Canada, Ontario Superior Court, Supreme Court of British Columbia and, in several cases, the United States District Court for the District of New Jersey. These actions allege violations of the Canadian Competition Act and the Sherman Act, as applicable, and other related claims, and seek damages and other relief. IFF may face additional civil suits, in the United States or elsewhere, relating to such alleged conduct. At this time, IFF is unable to predict the potential outcome of these lawsuits or any potential effect they may have on the Company&#8217;s results of operations, liquidity or financial condition.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investigation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 3, 2020, the Israel Police&#8217;s National Fraud Investigation Unit and the Israeli Securities Authority commenced an investigation into Frutarom and certain of its former executives, based on suspected bribery of foreign officials, money laundering, and violations of the Israeli Securities Act-1968. As part of the investigation, the National Fraud Investigation Unit and the Israeli Securities Authority have provided IFF and Frutarom with various orders, mainly requesting that IFF and Frutarom provide certain documents and materials. In addition, a seizure of assets was imposed on Frutarom and certain of its affiliates. IFF has been working to ensure compliance with such orders, all in accordance with, and subject to, Israeli law. On August 25, 2021, the Israeli Police informed Frutarom that they have decided to remove the temporary criminal seizure of assets order from the real estate assets of Frutarom and its related companies, which was done in parallel with the transfer of the case to the District Attorney&#8217;s Office in Israel. On February 26, 2024, the Israeli authorities informed Frutarom that the authorities decided to close the criminal investigation.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 107</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:continuation id="f-2702-4" continuedAt="f-2702-5"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 7, 2023, the European Commission (&#8220;EC&#8221;) and the United Kingdom Competition and Markets Authority (&#8220;CMA&#8221;) carried out unannounced inspections of certain of IFF&#8217;s facilities. On the same day, IFF was served with a grand jury subpoena by the Antitrust Division of the U.S. Department of Justice (&#8220;DOJ&#8221;). IFF understands the EC, CMA, DOJ and the Swiss Competition Commission are investigating potential anticompetitive conduct as it relates to IFF&#8217;s fragrance businesses. IFF has been and intends to continue cooperating with these investigations. IFF is unable, however, to predict or determine at this time the duration or outcome of the investigations, or whether the outcome of the investigations will materially impact the Company&#8217;s results of operations, liquidity or financial condition.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">China Facilities</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Zhejiang Ingredients Plant</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2017, the Company concluded discussions with the government regarding the relocation of its Fragrance Ingredients plant in Zhejiang and, based on the agreements reached, expects to receive total compensation payments up to approximately $<ix:nonFraction unitRef="usd" contextRef="c-850" decimals="-6" name="iff:GainContingencyExpectedRelocationPayments" format="ixt:num-dot-decimal" scale="6" id="f-2711">50</ix:nonFraction> million. The relocation compensation will be paid to the Company over the period of the relocation. The Company received payments totaling $<ix:nonFraction unitRef="usd" contextRef="c-851" decimals="-6" name="iff:GainContingencyRelocationPaymentsReceived" format="ixt:num-dot-decimal" scale="6" id="f-2712">30</ix:nonFraction> million through the end of 2019. Production at the facility ceased during 2019. In the second quarter of 2020, the Company transferred ownership of the site to the government and the remaining net book value of the plant was written off. In the third quarter of 2020, the Company received a payment of approximately $<ix:nonFraction unitRef="usd" contextRef="c-852" decimals="-6" name="iff:GainContingencyRelocationPaymentsReceived" format="ixt:num-dot-decimal" scale="6" id="f-2713">13</ix:nonFraction> million. The land remediation activities were completed in November 2022 and the final land restoration activities to restore the land to its original height, per the government&#8217;s request, were completed in April 2023. Upon completion of these activities, the land was returned to the government in April 2023 and a final payment of approximately $<ix:nonFraction unitRef="usd" contextRef="c-853" decimals="-6" name="iff:GainContingencyRelocationPaymentsReceived" format="ixt:num-dot-decimal" scale="6" id="f-2714">5</ix:nonFraction>&#160;million was received in June 2023.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2023, the Company recognized a pre-tax gain of approximately $<ix:nonFraction unitRef="usd" contextRef="c-854" decimals="-6" name="iff:GainLossOnPlantRelocation" format="ixt:num-dot-decimal" scale="6" id="f-2715">22</ix:nonFraction>&#160;million related to this transaction presented in Other expense (income), net on the Consolidated Statements of (Loss) Income and Comprehensive Loss. The Company also recognized approximately $<ix:nonFraction unitRef="usd" contextRef="c-854" decimals="-6" name="iff:EstimatedIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="f-2716">6</ix:nonFraction> million of income taxes presented in Provision for income taxes on the Consolidated Statements of (Loss) Income and Comprehensive Loss. The calculation of the applicable income taxes related to this transaction was sent to the local tax authorities for review and final approval was received in the fourth quarter of 2023.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Products previously manufactured at the Zhejiang Ingredients plant are now being produced at the Company&#8217;s Ingredients plant in Jiande, China.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Total China Operations</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total net book value of all plants in China was approximately $<ix:nonFraction unitRef="usd" contextRef="c-855" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="f-2717">215</ix:nonFraction> million as of December&#160;31, 2023.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company is required to close a plant, or operate one at significantly reduced production levels on a permanent basis, the Company may be required to record charges that could have a material impact on its consolidated financial results of operations, financial position and cash flows in future periods.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Environmental Proceedings</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is reporting the following environmental matter in compliance with SEC requirements to disclose environmental proceedings where a governmental authority is a party and that involve potential monetary sanctions of $300,000 or greater. On May 27, 2022, the Solae, LLC Memphis site (&#8220;Solae&#8221;) was served an Administrative Order and Assessment (the &#8220;Order&#8221;) by the City of Memphis related to alleged wastewater discharge violations. Solae submitted an appeal of the Order on June 24, 2022. Discussions with the City regarding potential resolution of the violations and penalties related to said violations are ongoing. Additionally, the Solae facility has undertaken capital project efforts, some of which began prior to the issuance of the Order, that are anticipated to address, on a schedule consistent with the Order, deadlines for attaining compliance with current wastewater permit requirements. This matter is not expected to have a material adverse effect on the Company&#8217;s financial position, cash flows or results of operations.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Contingencies</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has contingencies involving third parties (such as labor, contract, technology or product-related claims or litigation) as well as government-related items in various jurisdictions in which it operates pertaining to such items as value-added taxes, other indirect taxes, customs and duties and sales and use taxes. It is possible that cash flows or results of operations, in any period, could be materially affected by the unfavorable resolution of one or more of these contingencies.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The most significant government-related contingencies exist in Brazil. With regard to the Brazilian matters, the Company believes it has valid defenses for the underlying positions under dispute; however, in order to pursue these defenses, the Company is required to, and has provided, bank guarantees and pledged assets in the aggregate amount of approximately $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="iff:BankGuaranteesAndPledgedAssetsToPursueDefensesRelatedToOtherContingencies" format="ixt:num-dot-decimal" scale="6" id="f-2718">19</ix:nonFraction> million. The Brazilian matters take an extended period of time to proceed through the judicial process and there are a limited number of rulings to date.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 108</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:continuation id="f-2702-5"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Brazil Tax Credits</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2017, the Brazilian Supreme Court (&#8220;BSC&#8221;) ruled that Brazilian tax authorities should not include a value added tax known as &#8220;ICMS&#8221; in the calculation of certain indirect taxes (&#8220;PIS/COFINS&#8221;). By removing the ICMS from the calculation of the indirect tax base, the Court effectively eliminated a &#8220;tax on tax.&#8221; The Brazilian tax authorities filed an appeal seeking clarification of certain matters, including the amount of ICMS to which taxpayers would be entitled in order to reduce their indirect tax base (i.e. the gross rate or the net rate). In light of the BSC&#8217;s decision, in November 2017, the Company filed suit consistent with the BSC decision to require that ICMS be excluded from the PIS/COFINS calculation and received a favorable preliminary decision that was confirmed by the BSC in September 2018. This preliminary ruling granted the Company the right to prospectively exclude ICMS amounts from the PIS/COFINS calculation, but left open the issue of whether the Company could recover the gross or net amount of ICMS amounts paid on PIS/COFINS for the period from November 2011 to December 2018.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the Company was informed of a favorable ruling from the Brazilian tax authorities confirming that the Company was entitled to recover the overpayments of PIS/COFINS for the period from November 2011 to December 2018, plus interest on the amount of the overpayments. The overpayments arose from the inclusion of a value added tax known as ICMS in the calculation of the PIS/COFINS tax. The ruling did not, however, settle the question of whether the Company is eligible to recover overpayments based on the gross or the net amount of ICMS amounts paid on PIS/COFINS. The Company calculated the amount of overpayments using the gross method which yields a higher amount than the application of the net method. A final ruling on the gross versus net amount issue was made by the BSC who affirmed the use of the gross calculation with respect to claims submitted prior to March 2017. Although the Company had not submitted a claim until after March 2017, the Company believes that the Supreme Court, whilst confirming the use of the gross method of calculation, does not override the January 2020 ruling by the Brazilian tax authorities with respect to the timeframe for the calculation.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the $<ix:nonFraction unitRef="usd" contextRef="c-856" decimals="-6" name="us-gaap:ProceedsFromIncomeTaxRefunds" format="ixt:num-dot-decimal" scale="6" id="f-2719">8</ix:nonFraction> million recognized in the fourth quarter of 2019, during the first quarter of 2020 the Company recognized $<ix:nonFraction unitRef="usd" contextRef="c-857" decimals="-6" name="us-gaap:ProceedsFromIncomeTaxRefunds" format="ixt:num-dot-decimal" scale="6" id="f-2720">4</ix:nonFraction> million as an additional recovery on the existing claim. During 2020, the Company also recognized $<ix:nonFraction unitRef="usd" contextRef="c-858" decimals="-6" name="us-gaap:ProceedsFromIncomeTaxRefunds" format="ixt:num-dot-decimal" scale="6" id="f-2721">3</ix:nonFraction>&#160;million related to a claim from another of its subsidiaries in Brazil. The income was recognized as a reduction in Selling and administrative expenses.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2023, the BSC made an unfavorable court resolution for the Company related to the use of the gross method, which was only granted to claims submitted prior to March 2017. As a result of this unfavorable court resolution, the Company wrote off its remaining receivables of approximately $<ix:nonFraction unitRef="usd" contextRef="c-859" decimals="-6" name="iff:LossContingencyReceivableWrittenOff" format="ixt:num-dot-decimal" scale="6" id="f-2722">6</ix:nonFraction>&#160;million related to this matter during the first quarter of 2023.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Avicel&#174; PH NF (Pharma Solutions)</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has determined that certain grades of microcrystalline cellulose (Avicel&#174; PH 101, 102, and 200 NF and Avicel&#174; RC-591 NF) were found to be out-of-specification (collectively, &#8220;OOS Avicel&#174; NF&#8221;). The Company does not expect the OOS conductivity issue to affect the functionality of Avicel&#174; NF grades or to pose a human health hazard. Corrective actions have been implemented to improve operational and laboratory conditions. Based on the information available, as of December&#160;31, 2023, payments associated with this matter were approximately $<ix:nonFraction unitRef="usd" contextRef="c-206" decimals="-6" name="iff:MalpracticeLossContingencyPaymentsInceptionToDate" format="ixt:num-dot-decimal" scale="6" id="f-2723">46</ix:nonFraction> million, and the Company no longer had an accrual related to this matter. The total amount of exposure may increase if additional customers present claims or other exposures are identified.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines estimates of reasonably possible losses or ranges of reasonably possible losses in excess of related accrued liabilities, if any, when it has determined that either a loss is reasonably possible or a loss in excess of accrued amounts is reasonably possible and the amount of losses or range of losses is determinable. For all third party contingencies (including labor, contract, technology, tax, product-related claims and business litigation), the Company currently estimates that the aggregate range of reasonably possible losses in excess of any accrued liabilities is $<ix:nonFraction unitRef="usd" contextRef="c-860" decimals="0" name="us-gaap:LossContingencyEstimateOfPossibleLoss" scale="6" id="f-2724">0</ix:nonFraction> to approximately $<ix:nonFraction unitRef="usd" contextRef="c-861" decimals="-6" name="us-gaap:LossContingencyEstimateOfPossibleLoss" format="ixt:num-dot-decimal" scale="6" id="f-2725">75</ix:nonFraction> million. The estimates included in this amount are based on the Company&#8217;s analysis of currently available information and, as new information is obtained, these estimates may change. Due to the inherent subjectivity of the assessments and the unpredictability of outcomes of legal proceedings, any amounts accrued or included in this aggregate amount may not represent the ultimate loss to the Company from the matters in question. Thus, the Company&#8217;s exposure and ultimate losses may be higher or lower, and possibly significantly so, than the amounts accrued or the range disclosed above.</span></div></ix:continuation><div style="text-indent:18pt"><span><br/></span></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_184"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 20.&#160;&#160;  <ix:nonNumeric contextRef="c-1" name="us-gaap:MinorityInterestDisclosureTextBlock" id="f-2726" continuedAt="f-2726-1" escape="true">REDEEMABLE NON-CONTROLLING INTERESTS</ix:nonNumeric></span></div><ix:continuation id="f-2726-1" continuedAt="f-2726-2"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through certain subsidiaries of the Company&#8217;s Frutarom acquisition, there were certain non-controlling interests that carried redemption features. The non-controlling interest holders had the right, over a stipulated period of time, to sell their respective interests to Frutarom, and Frutarom had the option to purchase these interests (subject to the same timing). In most cases, these options carried similar price and conditions of exercise, and were settled on a pre-agreed formula based on a multiple of the average EBITDA of consecutive quarters to be achieved during the period ending prior to the exercise date.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 109</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:RedeemableNoncontrollingInterestTableTextBlock" id="f-2727" escape="true"><ix:continuation id="f-2726-2"><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the details of the Company&#8217;s&#160;redeemable&#160;non-controlling interests:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:67.860%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.208%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable <br/>Non-controlling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-862" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="f-2728">98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign exchange translation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-863" decimals="-6" sign="-" name="iff:NoncontrollingInterestImpactOfForeignExchangeTranslation" scale="6" id="f-2729">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of profit or loss attributable to redeemable non-controlling interests</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-863" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="f-2730">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemption value adjustment for the current period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-863" decimals="-6" name="us-gaap:MinorityInterestChangeInRedemptionValue" scale="6" id="f-2731">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-863" decimals="-6" sign="-" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="f-2732">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-864" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="f-2733">105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign exchange translation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-865" decimals="-6" name="iff:NoncontrollingInterestImpactOfForeignExchangeTranslation" scale="6" id="f-2734">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of profit or loss attributable to redeemable non-controlling interests</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-865" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="f-2735">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemption value adjustment for the current period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-865" decimals="-6" name="us-gaap:MinorityInterestChangeInRedemptionValue" scale="6" id="f-2736">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercises of redeemable non-controlling interests</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-865" decimals="-6" sign="-" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="6" id="f-2737">49</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-866" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="f-2738">59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign exchange translation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-867" decimals="-6" name="iff:NoncontrollingInterestImpactOfForeignExchangeTranslation" scale="6" id="f-2739">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemption value adjustment for the current period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-867" decimals="-6" sign="-" name="us-gaap:MinorityInterestChangeInRedemptionValue" scale="6" id="f-2740">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-867" decimals="-6" sign="-" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="f-2741">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercises of redeemable non-controlling interests</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-867" decimals="-6" sign="-" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="6" id="f-2742">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposal of redeemable non-controlling interests</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-867" decimals="-6" sign="-" name="iff:NoncontrollingInterestDecreaseFromDisposal" scale="6" id="f-2743">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-868" decimals="-6" name="us-gaap:MinorityInterest" format="ixt:fixed-zero" scale="6" id="f-2744">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________&#160;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The disposal of redeemable non-controlling interests was related to the sale of the Company&#8217;s investment in the Sonarome business. The total proceeds received from the sale transaction was approximately $<ix:nonFraction unitRef="usd" contextRef="c-869" decimals="-6" name="us-gaap:ProceedsFromSaleOfLongtermInvestments" format="ixt:num-dot-decimal" scale="6" id="f-2745">29</ix:nonFraction>&#160;million.</span></div></ix:continuation></ix:nonNumeric><div style="margin-top:3pt;text-align:center"><span><br/></span></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_187"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 21.    <ix:continuation id="f-816-5" continuedAt="f-816-6">ASSETS AND LIABILITIES HELD FOR SALE</ix:continuation></span></div><ix:continuation id="f-816-6" continuedAt="f-816-7"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2023, the Company announced the sale process of its Cosmetic Ingredients business within the Scent segment, and in the fourth quarter of 2023, the Company entered into an agreement to sell its Cosmetic Ingredients business. The transaction is subject to customary closing conditions and is expected to close in the first quarter of 2024.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The planned sale does not constitute a strategic shift of the Company&#8217;s operations and does not have major effects on the Company&#8217;s operations and financial results. Therefore, the transaction does not meet the discontinued operations criteria.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined that the assets and liabilities of the business met the criteria to be presented as &#8220;held for sale.&#8221; As a result, as of December&#160;31, 2023, such assets and liabilities were classified as held for sale and are reported on the Consolidated Balance Sheets. The Company expects that the sale proceeds less costs to sell will exceed the preliminary estimate of the carrying value of the net assets for the business. The carrying value is subject to change based on developments leading up to the closing date.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 110</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><ix:continuation id="f-821-14"><ix:continuation id="f-816-7"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in the Company&#8217;s Consolidated Balance Sheets as of December&#160;31, 2023 and 2022 are the following carrying amounts of the assets and liabilities held for sale:</span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.490%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.239%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.241%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-870" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" scale="6" id="f-2746">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-871" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" scale="6" id="f-2747">52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-870" decimals="-6" name="iff:DisposalGroupIncludingDiscontinuedOperationTradeReceivablesNet" scale="6" id="f-2748">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-871" decimals="-6" name="iff:DisposalGroupIncludingDiscontinuedOperationTradeReceivablesNet" scale="6" id="f-2749">85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-870" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1" scale="6" id="f-2750">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-871" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1" scale="6" id="f-2751">157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-870" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" scale="6" id="f-2752">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-871" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" scale="6" id="f-2753">92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-870" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1" scale="6" id="f-2754">276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-871" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1" scale="6" id="f-2755">348</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-870" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" scale="6" id="f-2756">146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-871" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" scale="6" id="f-2757">428</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-870" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="f-2758">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-871" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="f-2759">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-870" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets" scale="6" id="f-2760">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-871" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets" scale="6" id="f-2761">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held-for-sale</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-870" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" scale="6" id="f-2762">506</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-871" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="6" id="f-2763">1,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-870" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayable" scale="6" id="f-2764">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-871" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayable" scale="6" id="f-2765">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-870" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities" scale="6" id="f-2766">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-871" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities" scale="6" id="f-2767">92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-870" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" scale="6" id="f-2768">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-871" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" scale="6" id="f-2769">64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities held-for-sale</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-870" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" scale="6" id="f-2770">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-871" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" scale="6" id="f-2771">212</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company is currently analyzing the tax impact of the sale of the Cosmetic Ingredients business and has included preliminary numbers for the deferred tax liability, which are subject to further updates.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The amounts for December&#160;31, 2022 represent the carrying amounts of the portion of the Savory Solutions business and FSI business that were classified as held for sale. The Company completed the divestitures of the businesses on May 31, 2023 and August 1, 2023, respectively. See Note 4 for additional information.</span></div></ix:continuation></ix:continuation><div style="margin-top:3pt;text-align:justify"><span><br/></span></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_1702"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 22.    <ix:nonNumeric contextRef="c-1" name="us-gaap:OtherNonoperatingIncomeAndExpenseTextBlock" id="f-2772" continuedAt="f-2772-1" escape="true">OTHER (EXPENSE) INCOME, NET</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" id="f-2773" escape="true"><ix:continuation id="f-2772-1"><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other (expense) income, net consisted of the following:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange (losses) gains</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="f-2774">77</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="f-2775">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="f-2776">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="f-2777">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="f-2778">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="f-2779">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Losses) gains on business divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="f-2780">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="f-2781">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="f-2782">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on China facility relocation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="iff:GainLossOnChinaFacilityRelocation" scale="6" id="f-2783">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="iff:GainLossOnChinaFacilityRelocation" format="ixt:fixed-zero" scale="6" id="f-2784">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="iff:GainLossOnChinaFacilityRelocation" format="ixt:fixed-zero" scale="6" id="f-2785">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension-related benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="f-2786">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="f-2787">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="f-2788">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="iff:OtherComponentsOfOtherNonoperatingIncomeExpense" scale="6" id="f-2789">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="iff:OtherComponentsOfOtherNonoperatingIncomeExpense" scale="6" id="f-2790">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="iff:OtherComponentsOfOtherNonoperatingIncomeExpense" format="ixt:fixed-zero" scale="6" id="f-2791">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (expense) income, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-2792">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-2793">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-2794">58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 111</span></div></div></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_199"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="-sec-extract:summary;margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)(3) EXHIBITS</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.760%"><tr><td style="width:1.0%"/><td style="width:8.670%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:89.130%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit Number</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000119312518157733/d541104dex21.htm">Agreement and Plan of Merger, dated May 7, 2018, by and among the Registrant, Frutarom Industries Ltd. and Icon Newco Ltd., incorporated by reference to Exhibit 2.1 to the Registrant&#8217;s Current Report on Form 8-K filed on May 9, 2018.</a></span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000119312518258153/d474311dex21.htm">Amendment No.&#160;1 to Agreement and Plan of Merger, dated August&#160;25, 2018, by and among International Flavors &amp; Fragrances, Inc., Frutarom Industries Ltd. and Icon Newco Ltd. incorporated by reference to Exhibit 2.1 to the Registrant&#8217;s Current Report on Form&#160;8-K filed on August&#160;27, 2018.</a></span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000119312519316726/d851060dex21.htm">Agreement and Plan of Merger, dated December 15, 2019, by and among DuPont de Nemours Inc., Nutrition &amp; Biosciences, Inc., International Flavors &amp; Fragrances Inc. and Neptune Merger Sub I Inc., incorporated by reference to Exhibit 2.1 to the Registrant&#8217;s Current Report on Form 8-K filed on December 18, 2019.</a></span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000119312519316726/d851060dex22.htm">Separation and Distribution Agreement, dated as of December 15, 2019, by and among DuPont de Nemours Inc., Nutrition &amp; Biosciences, Inc. and International Flavors &amp; Fragrances Inc., incorporated by reference to Exhibit 2.2 to the Registrant&#8217;s Current Report on Form 8-K filed on December 18, 2019.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4(i)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000051253/000119312521015368/d112975dex21.htm">Amendment No. 1 to the Separation and Distribution Agreement, dated January 22, 2021, by and among DuPont de Nemours, Inc., Nutrition &amp; Biosciences, Inc., International Flavors &amp; Fragrances Inc. and Neptune Merger Sub II LLC, incorporated by reference to Exhibit 2.1 to the Registrant&#8217;s Current Report on Form 8-K filed on January 25, 2021.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4(ii)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000051253/000119312521027533/d70626dex24.htm">Amendment No. 2 to the Separation and Distribution Agreement, dated February 1, 2021, by and among DuPont de Nemours, Inc., Nutrition &amp; Biosciences, Inc., International Flavors &amp; Fragrances Inc. and Neptune Merger Sub II LLC, incorporated by reference to Exhibit 2.4 to the Registrant&#8217;s Current Report on Form 8-K filed on February 3, 2021.</a></span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000095013602002297/file007.txt">Restated Certificate of Incorporation of the Registrant, incorporated by reference to Exhibit&#160;10(g) to the Registrant&#8217;s Quarterly Report on Form&#160;10-Q filed on August&#160;12, 2002.</a></span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000119312523272442/d582222dex31.htm">Bylaws of International Flavors &amp; Fragrances Inc., effective as of November 1, 2023, incorporated by reference to Exhibit 3.1 to the Registrant</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000119312513142141/d516642dex41.htm">&#8217;</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000119312523272442/d582222dex31.htm">s Current Report on Form 8-K filed on November 7, 2023</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000119312523272442/d582222dex31.htm">.</a></span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000119312513142141/d516642dex41.htm">Indenture, dated as of April 4, 2013, between the Registrant and U.S. Bank National Association, as Trustee (including the form of Notes), incorporated by reference to Exhibit&#160;4.1 to the Registrant&#8217;s Current Report on Form&#160;8-K filed on April 4, 2013.</a></span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000119312516490137/d136061dex41.htm">Indenture, dated as of March 2, 2016, between the Registrant and U.S. Bank National Association, as Trustee (including the form of Debt Security), incorporated by reference to Exhibit 4.1 to the Registrant&#8217;s Registration Statement on Form S-3 (Registration No. 333-209889) filed on March 2, 2016.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2(i)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000119312516502266/d156962dex47.htm">First Supplemental Indenture, dated as of March 14, 2016, between the Registrant and U.S. Bank National Association, as Trustee (including the form of Notes), incorporated by reference to Exhibit 4.7 to the Registrant&#8217;s Current Report on Form 8-K filed on March 14, 2016.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2(ii)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000119312517175295/d392732dex47.htm">Second Supplemental Indenture, dated as of May 18, 2017, between the Registrant and U.S. Bank National Association, as Trustee (including the form of Notes), incorporated by reference to Exhibit 4.7 to the Registrant&#8217;s Current Report on Form 8-K filed on May 18, 2017.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2(iii)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000119312518275350/d599457dex45.htm">Third Supplemental Indenture, dated as of September 17, 2018, between International Flavors &amp; Fragrances Inc. and U.S. Bank National Association, as trustee, incorporated by reference to Exhibit 4.5 to the Registrant&#8217;s Current Report on Form 8-K filed on September 17, 2018.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2(iv)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000119312518282495/d614128dex42.htm">Fourth</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000119312518282495/d614128dex42.htm"> Supplemental Indenture, dated as of September </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000119312518282495/d614128dex42.htm">25</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000119312518282495/d614128dex42.htm">, 2018, between International Flavors &amp; Fragrances Inc. and U.S. Bank National Association, as trustee, incorporated by reference to Exhibit 4.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000119312518282495/d614128dex42.htm">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000119312518282495/d614128dex42.htm"> to the Registrant&#8217;s Current Report on Form 8-K filed on September </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000119312518282495/d614128dex42.htm">25</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000119312518282495/d614128dex42.htm">, 2018.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2(v)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000119312518283834/d625848dex42.htm">F</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000119312518283834/d625848dex42.htm">ifth</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000119312518283834/d625848dex42.htm"> Supplemental Indenture, dated as of September 2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000119312518283834/d625848dex42.htm">6</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000119312518283834/d625848dex42.htm">, 2018, between International Flavors &amp; Fragrances Inc. and U.S. Bank National Association, as trustee, incorporated by reference to Exhibit 4.2 to the Registrant&#8217;s Current Report on Form 8-K filed on September 2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000119312518283834/d625848dex42.htm">6</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000119312518283834/d625848dex42.htm">, 2018.</a></span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000119312518275350/d599457dex45.htm">Form of Amortizing Note, incorporated by reference to Exhibit 4.5 to the Registrant&#8217;s Current Report on Form 8-K filed on September 17, 2018.</a></span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000119312518275350/d599457dex41.htm">Purchase Contract Agreement, dated September 17, 2018, between International Flavors &amp; Fragrances Inc. and U.S. Bank National Association, as purchase contract agent, as attorney-in-fact for holders of the purchase contracts referred to therein and as trustee under the indenture referred to therein, incorporated by reference to Exhibit 4.1 to the Registrant&#8217;s Current Report on Form 8-K filed on September 17, 2018.</a></span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000119312518275350/d599457dex41.htm">Form of Unit, incorporated by reference to Exhibit 4.1 to the Registrant&#8217;s Current Report on Form 8-K filed on September 17, 2018.</a></span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000119312518275350/d599457dex41.htm">Form of Purchase Contract, incorporated by reference to Exhibit 4.1 to the Registrant&#8217;s Current Report on Form 8-K filed on September 17, 2018.</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 112</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.760%"><tr><td style="width:1.0%"/><td style="width:8.670%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:89.130%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit Number</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000119312518282495/d614128dex42.htm">Form of Global Note for the 2021 Notes, incorporated by reference to Exhibit 4.2 to the Registrant&#8217;s Current Report on Form 8-K filed on September 25, 2018.</a></span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000119312518282495/d614128dex42.htm">Form of Global Note for the 2026 Notes, incorporated by reference to Exhibit 4.2 to the Registrant&#8217;s Current Report on Form 8-K filed on September 25, 2018.</a></span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000119312518283834/d625848dex42.htm">Form of Global Note for the 2020 Notes, incorporated by reference to Exhibit 4.2 to the Registrant&#8217;s Current Report on Form 8-K filed on September 26, 2018.</a></span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000119312518283834/d625848dex42.htm">Form of Global Note for the 2028 Notes, incorporated by reference to Exhibit 4.2 to the Registrant&#8217;s Current Report on Form 8-K filed on September 26, 2018.</a></span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000119312518283834/d625848dex42.htm">Form of Global Notes for the 2048 Notes, incorporated by reference to Exhibit 4.2 to the Registrant&#8217;s Current Report on Form 8-K filed on September 26, 2018.</a></span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000119312520263904/d792766dex9916.htm">Indenture, dated as of September 16, 2020, between the N&amp;B and U.S. Bank National Association, as Trustee (including the form of Notes), incorporated by reference to Exhibit 99.16 to the Registrant&#8217;s Registration Statement on Form S-4 (Registration No. 333-238072) filed on October 5, 2020.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.12(i)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000119312521027533/d70626dex42.htm">First Supplemental Indenture, dated as of February 1, 2021, among Nutrition &amp; Biosciences, Inc., International Flavors &amp; Fragrances Inc. and U.S. Bank National Association, as Trustee. Incorporated by reference to Exhibit 4.2 to the Registrant&#8217;s Current Report on Form 8-K filed on February 4, 2021.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.12(ii)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000119312521069776/d11494dex41.htm">Second Supplemental Indenture, dated as of March 4, 2021, among Nutrition &amp; Biosciences, Inc., International Flavors &amp; Fragrances Inc. and U.S. Bank National Association, as trustee, incorporated by reference to Exhibit 4.1 to the Registrant's Current Report on Form 8-K filed on March 4, 2021.</a></span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000119312521069776/d11494dex42.htm">Icon Debt Assumption Supplement, dated as of March 4, 2021, among Neptune Merger Sub II LLC (as successor by merger to Nutrition &amp; Biosciences, Inc.) and International Flavors &amp; Fragrances Inc., and as acknowledged by Morgan Stanley Senior Funding, Inc., as administrative agent, incorporated by reference to Exhibit 4.2 to the Registrant&#8217;s Current Report on Form 8-K filed on March 4, 2021.</a></span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000005125320000007/iff10k2019exhibit417.htm">Description of Securities, incorporated by reference to Exhibit 4.17 to the Registrant's Annual Report on Form 10-K filed on March 3, 2020.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:6.75pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*10.1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000119312522012884/d272955dex101.htm">Letter Agreement between International Flavors &amp; Fragrances Inc. and Franklin K. Clyburn, Jr., effective January 18, 2022, incorporated by reference to Exhibit 10.1 to the Registrant&#8217;s Current Report on Form 8-K filed on January 20, 2022.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:6.75pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*10.2</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000095013608000919/file2.htm">Supplemental Retirement Plan, incorporated by reference to Exhibit 10.5 to the Registrant&#8217;s Annual Report on Form&#160;10-K filed on February&#160;27, 2008.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*10.3</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000119312521091238/d87231ddef14a.htm#rom87231_65">2021 Stock Award and Incentive Plan, incorporated by reference to Annex 1 to the Registrant&#8217;s Proxy Statement filed with the Commission on March 23, 2021.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*10.4</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000005125322000007/iff10k2021exhibit105.htm">Form of Restricted Stock Units Agreement &#8211; Non-Employee Director under the 2021 Stock Award and Incentive Plan, incorporated by reference to Exhibit 10.5 to the Registrant&#8217;s Annual Report on Form 10-K, filed on February 28, 2022.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*10.5</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000005125322000007/iff10k2021exhibit106.htm">Form of Restricted Stock Units Award Agreement under the 2021 Stock Award and Incentive Plan, incorporated by reference to Exhibit 10.6 to the Registrant&#8217;s Annual Report on Form 10-K, filed on February 28, 2022.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*10.6</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000005125322000007/iff10k2021exhibit107.htm">Form of Equity Choice Program Award Agreement under the 2021 Stock Award and Incentive Plan, incorporated by reference to Exhibit 10.7 to the Registrant&#8217;s Annual Report on Form 10-K, filed on February 28, 2022.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*10.7</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000005125322000007/iff10k2021exhibit108.htm">Form of Performance-Based Restricted Stock Units Award Agreement under the 2021 Stock Award and Incentive Plan, incorporated by reference to Exhibit 10.8 to the Registrant&#8217;s Annual Report on Form 10-K, filed on February 28, 2022.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*10.8</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000005125317000004/iff10k2016exhibit1013.htm">2015 Stock Award and Incentive Plan, as amended and restated February 7, 2017, incorporated by reference to Exhibit 10.13 to the Registrant&#8217;s Annual Report on Form 10-K filed on February 28, 2017.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*10.9</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000005125315000008/iff33115exhibit103.htm">Form of Annual Incentive Plan Award Agreement under the 2015 Stock Award and Incentive Plan, incorporated by reference to Exhibit 10.3 to the Registrant&#8217;s Quarterly Report on Form 10-Q filed on May 12, 2015.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*10.10</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000005125315000008/iff33115exhibit104.htm">Form of Long-Term Incentive Plan Award Agreement under the 2015 Stock Award and Incentive Plan, incorporated by reference to Exhibit 10.4 to the Registrant&#8217;s Quarterly Report on Form 10-Q filed on May 12, 2015.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*10.11</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000005125315000008/iff33115exhibit105.htm">Form of Equity Choice Program Award Agreement under the 2015 Stock Award and Incentive Plan, incorporated by reference to Exhibit 10.5 to the Registrant&#8217;s Quarterly Report on Form 10-Q filed on May 12, 2015.</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 113</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.760%"><tr><td style="width:1.0%"/><td style="width:8.670%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:89.130%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit Number</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*10.12</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000005125315000008/iff33115exhibit106.htm">Form of Restricted Stock Units Award Agreement under the 2015 Stock Award and Incentive Plan, incorporated by reference to Exhibit 10.6 to the Registrant&#8217;s Quarterly Report on Form 10-Q filed on May 12, 2015.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*10.13</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000005125315000008/iff33115exhibit107.htm">Form of Non-Employee Director Restricted Stock Units Award Agreement under the 2015 Stock Award and Incentive Plan, incorporated by reference to Exhibit 10.7 to the Registrant&#8217;s Quarterly Report on Form 10-Q filed on May 12, 2015.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*10.14</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000005125315000022/iff93015exhibit101.htm">Form of Equity Choice Program Award Agreement under the 2015 Stock Award and Incentive Plan, incorporated by reference to Exhibit 10.1 to the Registrant&#8217;s Quarterly Report on Form 10-Q filed on November 9, 2015.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*10.15</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000005125316000026/iff10k2015exhibit1025.htm">Form of Long-Term Incentive Plan Award Agreement under the 2015 Stock Award and Incentive Plan, incorporated by reference to Exhibit 10.25 to the Registrant&#8217;s Annual Report on Form 10-K filed on March 1, 2016.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*10.16</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000005125318000005/iff10k2017exhibit1017.htm">Amended and Restated Executive Severance Policy, as amended through and including November 1, 2017, incorporated by reference to Exhibit 10.17 to the Registrant&#8217;s Annual Report on Form 10-K filed on February 27, 2018 (the &#8220;Executive Severance Policy&#8221;).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*10.17</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000005125321000011/iff10k2020exhibit1018.htm">Amendment to the Executive Severance Policy dated November 3, 2020, incorporated by reference to Exhibit 10.18 to the Registrant&#8217;s Annual Report on Form 10-K filed on February 22, 2021.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*10.18</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000005125323000019/iff033123exhibit106.htm">Amended and Restated Executive Severance Policy, as amended </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000005125323000019/iff033123exhibit106.htm">and </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000005125323000019/iff033123exhibit106.htm">r</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000005125323000019/iff033123exhibit106.htm">estated on</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000005125323000019/iff033123exhibit106.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000005125323000019/iff033123exhibit106.htm">February</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000005125323000019/iff033123exhibit106.htm"> 1, 20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000005125323000019/iff033123exhibit106.htm">23 </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000005125323000019/iff033123exhibit106.htm">(the &#8220;Executive Severance Policy&#8221;)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000005125323000019/iff033123exhibit106.htm">, incorporated by reference to Exhibit 10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000005125323000019/iff033123exhibit106.htm">6</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000005125323000019/iff033123exhibit106.htm"> to the Registrant&#8217;s </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000005125323000019/iff033123exhibit106.htm">Q</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000005125323000019/iff033123exhibit106.htm">uarterly</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000005125323000019/iff033123exhibit106.htm"> Report on Form 10-</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000005125323000019/iff033123exhibit106.htm">Q</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000005125323000019/iff033123exhibit106.htm"> filed on </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000005125323000019/iff033123exhibit106.htm">May</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000005125323000019/iff033123exhibit106.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000005125323000019/iff033123exhibit106.htm">10</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000005125323000019/iff033123exhibit106.htm">, 20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000005125323000019/iff033123exhibit106.htm">23</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000005125323000019/iff033123exhibit106.htm">.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*10.19</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000116923208002739/d74603_ex10-1.htm">Form of Director/Officer Indemnification Agreement, incorporated by reference to Exhibit 10.1 to the Registrant&#8217;s Current Report on Form 8-K filed on July 28, 2008.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*10.20</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000119312512084851/d280956dex1027.htm">Form of Executive Death Benefit Program - Plan Agreement, incorporated by reference to Exhibit 10.27 to the Registrant&#8217;s Annual Report on Form 10-K filed on February 28, 2012.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*10.21</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000119312522294271/d419757dex43.htm">Deferred Compensation Plan (the &#8220;2023 Deferred Compensation Plan&#8221;), incorporated by reference to Exhibit 4.3 to the Registrant</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000005125315000008/iff33115exhibit107.htm">&#8217;</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000119312522294271/d419757dex43.htm">s Registration Statement on Form S-8 filed on November 29, 2022.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000119312516785250/d306603dex1028.htm">Credit Agreement, dated as of November 9, 2011, amended and restated as of December 2, 2016, among the Registrant, International Flavors &amp; Fragrances (Luxembourg) S.&#224;.r.l., International Flavors &amp; Fragrances (Nederland) Holding B.V., International Flavors &amp; Fragrances I.F.F. (Nederland) B.V. and International Flavors &amp; Fragrances (Greater Asia) PTE. Ltd., as borrowers, the banks, financial institutions and other institutional lenders party thereto, and Citibank, N.A., as administrative agent, incorporated by reference to Exhibit 10.28 to the Registrant&#8217;s Current Report on Form 8-K filed on December 5, 2016.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22(i)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000119312518173622/d586040dex101.htm">Amendment No. 1 to Credit Agreement, dated as of May 21, 2018, among the Registrant, International Flavors &amp; Fragrances (Nederland) Holding B.V., International Flavors &amp; Fragrances I.F.F. (Nederland) B.V. and International Flavors &amp; Fragrances (Greater Asia) PTE. Ltd., as borrowers, the lenders signatory thereto and Citibank, N.A., as administrative agent, incorporated by reference to Exhibit 10.1 to the Registrant&#8217;s Current Report on Form 8-K filed on May 24, 2018.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22(ii)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000119312518188155/d599355dex102.htm">Amendment No. 2 to Credit Agreement, dated as of June 6, 2018, among the Registrant, International Flavors &amp; Fragrances (Nederland) Holding B.V., International Flavors &amp; Fragrances I.F.F. (Nederland) B.V. and International Flavors &amp; Fragrances (Greater Asia) PTE. Ltd., as borrowers, the lenders signatory thereto and Citibank, N.A., as administrative agent, incorporated by reference to Exhibit 10.2 to the Registrant&#8217;s Current Report on Form 8-K filed on June 8, 2018.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22(iii)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000005125318000017/iff63018exhibit104.htm">Amendment No. 3 to Credit Agreement, dated as of July 13, 2018, among the Registrant, International Flavors &amp; Fragrances (Nederland) Holding B.V., International Flavors &amp; Fragrances I.F.F. (Nederland) B.V. and International Flavors &amp; Fragrances (Greater Asia) PTE. Ltd., as borrowers, the lenders signatory thereto and Citibank, N.A., as administrative agent, incorporated by reference to Exhibit 10.4 to the Registrant&#8217;s Quarterly Report on Form 10-Q filed on August 7, 2018.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22(iv)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000119312520012057/d876068dex101.htm">Amendment No. 4 to Credit Agreement, dated as of January 17, 2020 among International Flavors &amp; Fragrances Inc., International Flavors &amp; Fragrances (Nederland) Holding B.V., International Flavors &amp; Fragrances I.F.F. (Nederland) B.V. and International Flavors &amp; Fragrances (Greater Asia) PTE. Ltd., as borrowers, the lenders signatory thereto and Citibank, N.A., as administrative agent, incorporated by reference to Exhibit 10.1 to the Registrant&#8217;s Current Report on Form 8-K filed on January 22, 2020.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22(v)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000119312520234877/d32016dex101.htm">Second Amended and Restated Credit Agreement, dated as of August 25, 2020 among International Flavors &amp; Fragrances Inc., International Flavors &amp; Fragrances (Nederland) Holding B.V. and International Flavors &amp; Fragrances I.F.F. (Nederland) B.V., as borrowers, the lenders signatory thereto and Citibank, N.A., as administrative agent, incorporated by reference to Exhibit 10.1 to the Registrant&#8217;s Current Report on Form 8-K filed on August 28, 2020.</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 114</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.760%"><tr><td style="width:1.0%"/><td style="width:8.670%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:89.130%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit Number</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22(vi)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000119312521227550/d206865dex101.htm">Third Amended and Restated Credit Agreement, dated as of July 28, 2021 among International Flavors &amp; Fragrances Inc., International Flavors &amp; Fragrances (Nederland) Holding B.V. and International Flavors &amp; Fragrances I.F.F. (Nederland) B.V., as borrowers, the lenders signatory thereto and Citibank, N.A., as administrative agent, incorporated by reference to Exhibit 10.1 to the Registrant's Current Report on 8-K filed on July 28, 2021.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22(vii)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000005125322000022/iff063022exhibit102.htm">Amendment No.1 to Third Amended and Restated Credit Agreement, dated as of August 4, 2022, among the Registrant, International Flavors &amp; Fragrances (Nederland) Holding B.V. and International Flavors &amp; Fragrances I.F.F. (Nederland) B.V., as borrowers, the lenders signatory thereto and Citibank, N.A., as administrative agent, incorporated by reference to Exhibit 10.2 to the Registrant&#8217;s Current Report on Form 8-K filed on August 8, 2022.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22(viii)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000119312523079779/d489877dex103.htm">Amendment No. 2 to Third Amended and Restated Revolving Credit Agreement, dated as of March 23, 2023, among the Registrant, International Flavors &amp; Fragrances (Nederland) Holding B.V. and International Flavors &amp; Fragrances I.F.F. (Nederland) B.V., as borrowers, the lenders signatory thereto and Citibank, N.A., as administrative agent, incorporated by reference to Exhibit 10.3 to the Registrant&#8217;s Current Report on Form 8-K filed on March 27, 2023.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22(ix)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000119312523079779/d489877dex104.htm">Amendment No. 3 to Third Amended and Restated Revolving Credit Agreement, dated as of March 23, 2023, among the Registrant, International Flavors &amp; Fragrances (Nederland) Holding B.V. and International Flavors &amp; Fragrances I.F.F. (Nederland) B.V., as borrowers, the lenders signatory thereto and Citibank, N.A., as administrative agent, incorporated by reference to Exhibit 10.4 to the Registrant&#8217;s Current Report on Form 8-K filed on March 27, 2023.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22(x)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000005125323000036/iff093023exhibit102.htm">Amendment No. 4 to Third Amended and Restated Revolving Credit Agreement, dated as of September 19, 2023, among the Registrant, International Flavors &amp; Fragrances (Nederland) Holding B.V. and International Flavors &amp; Fragrances I.F.F. (Nederland) B.V., as borrowers, the lenders signatory thereto and Citibank, N.A., as administrative agent, incorporated by reference to Exhibit 10.2 to the Registrant&#8217;s Quarterly Report on Form 10-Q filed on November 8, 2023.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.23</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000119312518188155/d599355dex101.htm">Term Loan Credit Agreement, dated as of June 6, 2018, among the Registrant, as borrower, the lenders signatory thereto and Morgan Stanley Senior Funding, Inc. as administrative agent, incorporated by reference to Exhibit 10.1 to the Registrant&#8217;s Current Report on Form 8-K filed on June 8, 2018. </a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.23(i)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000005125318000017/iff63018exhibit106.htm">Amendment No 1. to Credit Agreement, dated as of July 13, 2018, among the Registrant, as borrower, the lenders signatory thereto and Morgan Stanley Senior Funding, Inc. as administrative agent, incorporated by reference to Exhibit 10.6 to the Registrant&#8217;s Quarterly Report on Form 10-Q filed on August 7, 2018.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.23(ii)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000119312520012057/d876068dex102.htm">Amendment No. 2 to Credit Agreement, dated as of January 17, 2020 among International Flavors &amp; Fragrances Inc., as borrower, the lenders signatory thereto and Morgan Stanley Senior Funding, Inc. as administrative agent, incorporated by reference to Exhibit 10.2 to the Registrant&#8217;s Current Report filed on Form 8-K filed on January 22, 2020.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.23(iii)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000119312520234877/d32016dex102.htm">Amendment No. 3 to Credit Agreement, dated as of August 25, 2020 among International Flavors &amp; Fragrances Inc., as borrower, the lenders signatory thereto and Morgan Stanley Senior Funding, Inc. as administrative agent, incorporated by reference to Exhibit 10.2 to the Registrant&#8217;s Current Report on Form 8-K filed on August 28, 2020.</a></span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.24&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000119312519316726/d851060dex101.htm">Employee Matters Agreement, dated as of December 15, 2019, by and among DuPont de Nemours Inc., Nutrition &amp; Biosciences, Inc. and International Flavors &amp; Fragrances Inc, incorporated by reference to</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000119312519316726/d851060dex101.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000119312519316726/d851060dex101.htm">Exhibit 10.1 to the </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000119312519316726/d851060dex101.htm">Registrant</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000119312520234877/d32016dex102.htm">&#8217;</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000119312519316726/d851060dex101.htm">s Current Report on Form 8-K filed on December 18, 2019.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.24(i)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000051253/000119312521015368/d112975dex101.htm">Amendment to the Employee Matters Agreement, dated January 22, 2021, by and among International Flavors &amp; Fragrances Inc., DuPont de Nemours, Inc. and Nutrition &amp; Biosciences, Inc., incorporated by reference to </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000051253/000119312521015368/d112975dex101.htm">Exhibit</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000051253/000119312521015368/d112975dex101.htm"> 10.1 to</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000051253/000119312521015368/d112975dex101.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000051253/000119312521015368/d112975dex101.htm">the Registrant&#8217;s Current Report on Form 8-K filed on January 25, 2021.</a></span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000119312520148682/d933138dex101.htm">Term Loan Credit Agreement, dated as of May 15, 2020 among International Flavors &amp; Fragrances Inc., as borrower, the lenders signatory thereto and China Construction Bank Corporation, New York Branch, as administrative agent, incorporated by reference to Exhibit 10.1 to the Registrant&#8217;s Current Report on Form 8-K filed on May 21, 2020.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.25(i)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000119312520234877/d32016dex103.htm">Amendment No. 1 to Credit Agreement, dated as of August 25, 2020, among the Company, as borrower, the lenders signatory thereto and China Construction Bank Corporation, New York Branch as administrative agent, incorporated by reference to Exhibit 10.3 to the Registrant&#8217;s Current Report on Form 8-K filed on August 28, 2020.</a></span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000119312520263904/d792766dex9914.htm">Term Loan Credit Agreement, dated as of January 17, 2020, by and among Nutrition &amp; Biosciences, Inc., as borrower, and Morgan Stanley Senior Funding Inc., as administrative agent, and the other lenders party thereto, incorporated by reference to Exhibit 99.14 to the Registrant&#8217;s Form S-4 Registration Statement filed on October 5, 2020.</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 115</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.760%"><tr><td style="width:1.0%"/><td style="width:8.670%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:89.130%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit Number</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.26(i)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000119312520263904/d792766dex9915.htm">Amendment No. 1 to Credit Agreement, dated as of August 25, 2020, by and among Nutrition &amp; Biosciences, Inc., the lenders signatory thereto and Morgan Stanley Senior Fund, Inc., as administrative agent, incorporated by reference to Exhibit 99.15 to the Registrant&#8217;s Form S-4 Registration Statement filed on October 5, 2020.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.26(ii)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000005125322000022/iff063022exhibit101.htm">Amendment No. 2 to Term Loan Credit Agreement, dated as of August 4, 2022, among International Flavors &amp; Fragrances Inc., as borrower, the lenders signatory thereto and Morgan Stanley Senior Funding, Inc., as administrative agent, incorporated by reference to Exhibit 10.1 to the Registrant&#8217;s Current Report on Form 8-K filed on August 8, 2022.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.26(iii)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000119312523079779/d489877dex101.htm">Amendment No. 3 to Term Loan Credit Agreement, dated as of March 23, 2023, among International Flavors &amp; Fragrances Inc., as borrower, the lenders signatory thereto and Morgan Stanley Senior Funding, Inc., as administrative agent, incorporated by reference to Exhibit 10.1 to the Registrant&#8217;s Current Report on Form 8-K filed on March 27, 2023.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.26(iv)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000119312523079779/d489877dex102.htm">Amendment No. 4 to Term Loan Credit Agreement, dated as of March 23, 2023, among International Flavors &amp; Fragrances Inc., as borrower, the lenders signatory thereto and Morgan Stanley Senior Funding, Inc., as administrative agent, incorporated by reference to Exhibit 10.2 to the Registrant&#8217;s Current Report on Form 8-K filed on March 27, 2023.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.26(v)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000005125323000036/iff093023exhibit101.htm">Amendment No. 5 to Term Loan Credit Agreement, dated as of September 19, 2023, among International Flavors &amp; Fragrances Inc., as borrower, the lenders signatory thereto and Morgan Stanley Senior Funding, Inc., as administrative agent, incorporated by reference to Exhibit 10.1 to the Registrant&#8217;s Quarterly Report on Form 10-Q filed on November 8, 2023.</a></span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/51253/000119312523022096/d452488dex101.htm">Cooperation Agreement, dated as of February 1, 2023, by and among International Flavors &amp; Fragrances Inc. and Icahn Group, incorporated by reference to Exhibit 10.1 to the Registrant&#8217;s Current Report on Form 8-K filed on February 2, 2023.</a></span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000119312521027533/d70626dex101.htm">Tax Matters Agreement, dated as of February 1, 2021, by and among DuPont de Nemours, Inc., Nutrition &amp; Biosciences, Inc. and International Flavors &amp; Fragrances Inc., incorporated by reference to Exhibit 10.1 to the Registrant&#8217;s Current Report on Form 8-K filed on February 4, 2021.</a></span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.29&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/51253/000119312521027533/d70626dex102.htm">Intellectual Property Cross-License Agreement, dated as of February 1, 2021, by and between Nutrition &amp; Biosciences, Inc. and DuPont de Nemours, Inc., incorporated by reference to Exhibit 10.2 to the Registrant&#8217;s Current Report on Form 8-K filed on February 4, 2021.</a></span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iff10-k2023exhibit21.htm">List of Principal Subsidiaries.</a></span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iff10-k2023exhibit23.htm">Consent of PricewaterhouseCoopers LLP.</a></span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iff10-k2023exhibit311.htm">Certification of</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iff10-k2023exhibit311.htm"> J</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iff10-k2023exhibit311.htm">. </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iff10-k2023exhibit311.htm">Erik </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iff10-k2023exhibit311.htm">F</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iff10-k2023exhibit311.htm">yrwald</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iff10-k2023exhibit311.htm"> pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iff10-k2023exhibit312.htm">Certification of Glenn Richter pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iff10-k2023exhibit32.htm">Certification of</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iff10-k2023exhibit32.htm"> J</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iff10-k2023exhibit32.htm">. </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iff10-k2023exhibit32.htm">E</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iff10-k2023exhibit32.htm">rik F</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iff10-k2023exhibit32.htm">yrwald</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iff10-k2023exhibit32.htm"> and Glenn Richter pursuant to 18 U.S.C. Section&#160;1350 as adopted pursuant to the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iff10-k2023exhibit97.htm">International Flavors &amp; Fragrances Inc. Policy for the Recovery of Erroneously Awarded Compensation</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extensions Schema</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase</span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">____________________</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13pt">Management contract or compensatory plan or arrangement</span></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_202"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;16.&#160;&#160;&#160;&#160;FORM 10-K SUMMARY.</span></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;None.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 116</span></div></div></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_205"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="text-align:center;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="text-align:center;text-indent:24.75pt"><span><br/></span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section&#160;13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:41.861%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.671%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.168%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INTERNATIONAL&#160;FLAVORS&#160;&amp;&#160;FRAGRANCES INC.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Glenn Richter</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Glenn Richter</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Executive Vice President, Chief Financial &amp; Business Transformation Officer</span></td></tr></table></div><div style="margin-top:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated: February&#160;28, 2024</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">117</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:37.927%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:42.640%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.661%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Signature</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Title</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Date</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ J. Erik Fyrwald</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer and Director (Principal Executive Officer)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2024</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">J. Erik Fyrwald</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Glenn Richter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Chief Financial &amp; Business Transformation Officer (Principal Financial Officer)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2024</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Glenn Richter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Beril Yildiz</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President, Corporate Controller and Chief Accounting Officer (Principal Accounting Officer)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2024</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Beril Yildiz</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Roger W. Ferguson, Jr.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman of the Board, Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2024</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Roger W. Ferguson, Jr.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Kathryn J. Boor</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2024</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Kathryn J. Boor</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Barry A. Bruno</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2024</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Barry A. Bruno</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Mark J. Costa</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2024</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Mark J. Costa</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Carol Anthony (John) Davidson</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2024</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carol Anthony (John) Davidson</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ John F. Ferraro</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2024</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">John F. Ferraro</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Christina Gold</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2024</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Christina Gold</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Gary Hu</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2024</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gary Hu</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Dawn C. Willoughby</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2024</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Dawn C. Willoughby</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Kevin O&#8217;Byrne</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2024</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Kevin O&#8217;Byrne</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">118</span></div></div></div><div id="i2f76b3bf6f194379a886ecfc128c8f1b_208"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2f76b3bf6f194379a886ecfc128c8f1b_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTERNATIONAL FLAVORS&#160;&amp; FRAGRANCES INC. AND SUBSIDIARIES</span></div><ix:nonNumeric contextRef="c-1" name="srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" id="f-2795" escape="true"><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE II &#8212; VALUATION AND QUALIFYING ACCOUNTS AND RESERVES</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(IN MILLIONS)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:21.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.287%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at<br/>beginning<br/>of period</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additions (deductions) charged to costs and expenses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Acquisitions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accounts<br/>written off</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Translation<br/>adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at end of period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-872" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="f-2796">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-873" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="f-2797">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-873" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired" format="ixt:fixed-zero" scale="6" id="f-2798">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-873" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="f-2799">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-873" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesAdjustments" scale="6" id="f-2800">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-873" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" format="ixt:fixed-zero" scale="6" id="f-2801">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-874" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="f-2802">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance on credit and operating loss carryforwards and other net deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-875" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="f-2803">262</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-876" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="f-2804">76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-876" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired" format="ixt:fixed-zero" scale="6" id="f-2805">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-876" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:fixed-zero" scale="6" id="f-2806">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-876" decimals="-6" sign="-" name="us-gaap:ValuationAllowancesAndReservesAdjustments" scale="6" id="f-2807">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-876" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="6" id="f-2808">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-877" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="f-2809">324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at<br/>beginning<br/>of period</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additions charged to costs and expenses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Acquisitions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accounts<br/>written off</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Translation<br/>adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at<br/>end of<br/>period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-878" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="f-2810">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-879" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="f-2811">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-879" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired" format="ixt:fixed-zero" scale="6" id="f-2812">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-879" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:fixed-zero" scale="6" id="f-2813">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-879" decimals="-6" sign="-" name="us-gaap:ValuationAllowancesAndReservesAdjustments" scale="6" id="f-2814">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-879" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" format="ixt:fixed-zero" scale="6" id="f-2815">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-872" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="f-2816">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance on credit and operating loss carryforwards and other net deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-880" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="f-2817">232</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-881" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="f-2818">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-881" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired" format="ixt:fixed-zero" scale="6" id="f-2819">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-881" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:fixed-zero" scale="6" id="f-2820">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-881" decimals="-6" sign="-" name="us-gaap:ValuationAllowancesAndReservesAdjustments" scale="6" id="f-2821">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-881" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" format="ixt:fixed-zero" scale="6" id="f-2822">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-875" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="f-2823">262</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at<br/>beginning<br/>of period</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additions charged to costs and expenses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Acquisitions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accounts<br/>written off</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Translation<br/>adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at<br/>end of<br/>period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-882" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="f-2824">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-883" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="f-2825">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-883" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired" format="ixt:fixed-zero" scale="6" id="f-2826">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-883" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="f-2827">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-883" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesAdjustments" format="ixt:fixed-zero" scale="6" id="f-2828">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-883" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="6" id="f-2829">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-878" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="f-2830">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance on credit and operating loss carryforwards and other net deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-884" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="f-2831">257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-885" decimals="-6" sign="-" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="f-2832">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-885" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired" scale="6" id="f-2833">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-885" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:fixed-zero" scale="6" id="f-2834">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-885" decimals="-6" sign="-" name="us-gaap:ValuationAllowancesAndReservesAdjustments" scale="6" id="f-2835">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-885" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" format="ixt:fixed-zero" scale="6" id="f-2836">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-880" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="f-2837">232</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________&#160;</span></div><div style="margin-top:3pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt">The amount relates to adjustment to allowances for bad debts as a result of purchase price allocation related to the Merger with N&amp;B.</span></div></ix:nonNumeric><div style="text-indent:-4.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-1</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21
<SEQUENCE>2
<FILENAME>iff10-k2023exhibit21.htm
<DESCRIPTION>EX-21
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i6fa6f6b6c10744699474bb1865233a08_1"></div><div style="min-height:45pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Exhibit 21</font></div></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:138%">LIST OF SUBSIDIARIES OF INTERNATIONAL FLAVORS &#38; FRAGRANCES INC.</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">(the &#8220;Company&#8221;)</font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.368%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of Entity</font></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danisco Argentina S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Argentina</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Flavors &#38; Fragrances S.R.L.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Argentina</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solae Argentina S.A.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Argentina</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">KELP INDUSTRIES PTY. LTD.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danisco Australia Pty Limited</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solae Australia Pty Limited</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nutrition &#38; Biosciences Australia Pty Ltd</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Enzymotec Australia Pty Ltd</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFF Australia Holdings Pty Limited</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Southern Cross Botanicals Pty Ltd</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lucas Meyer Cosmetics Australia Pty Ltd</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Flavours &#38; Fragrances (Australia) Pty Ltd</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bush Boake Allen Australia Pty Ltd</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taura Natural Ingredients Holdings Pty Limited</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danisco Austria GmbH</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Austria</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Frutarom GmbH</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Austria</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFF Austria GmbH</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Austria</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PTI-BEL TUE</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Belarus</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Genencor International BV</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Belgium</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solae Belgium N.V.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Belgium</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Frutarom Belgium N.V.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Belgium</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taura Natural Ingredients NV</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Belgium</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danisco Ingredients Belgium N.V.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Belgium</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TNI Investments NV</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Belgium</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danisco Brasil Ltda.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nutrition &#38; Biosciences Brasil Ingredientes Ltda</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solae Do Brasil Ind&#250;stria E Com&#233;rcio De Alimentos Ltda</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solae Investimentos Ltda</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solae Do Brasil Holdings Ltda</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bremil S&#47;A Industria de Produtos Alimenticios</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bremil Industria E Comercio de Ingredientes Alimenticios Ltda</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Envoltec Industria de Embalagens Ltda</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sabormax Industria de Alimentos E Representacao Ltda</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Frutarom do Brazil Industria e Comercio Ltda.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nutrition &#38; Biosciences Brasil Ingredientes Ltda.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFF Ess&#234;ncias e Frangr&#226;ncias Ltda.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bush Boake Allen Do Brasil Ind&#250;stria e Com&#233;rcio Ltda.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFF (BVI) Limited</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">British Virgin Islands</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fragrance Resources Asia Pacific Limited</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">British Virgin Islands</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David Michael &#38; Company (Canada) 1986 Ltd.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danisco Canada Inc.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Flavors &#38; Fragrances (Canada) Ltd.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.368%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of Entity</font></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lucas Meyer Cosmetics Canada Inc.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danisco Chile S.A.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Frutarom Chile S.A.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Flavors &#38; Fragrances I.F.F. (Chile) Limitada</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bush Boake Allen Chile S.A.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Genencor (China) Bio-Products Co., Ltd.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danisco (China) Holding Company Limited</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danisco (Zhangjiagang) Textural Ingredients Co., Ltd.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danisco Health Foods (Beijing) Co., Ltd.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danisco (China) Co., Ltd.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danisco Shineway Luohe Soy Industry Company Limited</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solae Trading (Shanghai) Co., Ltd.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danisco Shineway Luohe Food Company Limited</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Frutarom F&#38;F Trading (Shanghai) Co., Ltd.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tastepoint Flavors (Shanghai) Co., Ltd.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Frutarom Flavors (Kushan) Co., Ltd.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventive Food Technology (ZQ) Ltd.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danisco Biosciences (Shanghai) Co., Ltd.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Flavors &#38; Fragrances (China) Ltd.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Flavors &#38; Fragrances (Hangzhou) Co., Ltd.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fragrance Resources (Shanghai) Co., Ltd</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Flavors &#38; Fragrances (Zhejiang) Co., Ltd.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Flavors &#38; Fragrances (ZhangJiagang) Co., Ltd.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFF Bio Technology (Nanjing) Co., Ltd.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFF Flavors &#38; Fragrances (Hangzhou) Trading Co., Ltd.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danisco Colombia Ltda.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colombia</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Flavors And Fragrances Colombia S.A.S.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colombia</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Products Balkans d.o.o.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Croatia</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cupressus Limited</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cyprus</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vantodio Holdings Limited</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cyprus</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alpris Holdings Ltd.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cyprus</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danisco Czech Republic, a.s.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Czech Republic</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tastepoint CZ, s.r.o.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Czech Republic</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solae Denmark ApS</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denmark</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International N&#38;H Denmark ApS</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denmark</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cometra ApS</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denmark</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FYMSA del Caribe, S.R.L</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dominican Republic</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danisco Egypt Trading LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Egypt</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MISR Company for Aromatic Products (S.A.E.)</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Egypt</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aromco Ltd.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">England</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Flavours and Essences UK Limited</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">England</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FoodBlenders Limited</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">England</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hagelin Flv (UK) Ltd.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">England</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Frutarom UK Investments Limited</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">England</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Flavours &#38; Fragrances (CIL) Limited</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">England</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.368%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of Entity</font></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bush Boake Allen Enterprises Limited</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">England</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bush Boake Allen (Pension Trustees) Limited</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">England</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bush Boake Allen Limited</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">England</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Flavours &#38; Fragrances (GB) Holdings Limited</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">England</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Flavours &#38; Fragrances I.F.F. (Great Britain) Limited</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">England</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A. Boake, Roberts And Company (Holding), Limited</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">England</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bush Boake Allen Holdings (U.K.) Limited</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">England</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Frutarom (UK) Ltd.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">England</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Frutarom &#8211; Etol (UK) Limited</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">England</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Flavours &#38; Fragrances (Pension Trustees) Limited</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">England</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Savoury Flavours (Holding) Limited</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">England</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Savoury Flavours Ltd.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">England</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danisco UK Ltd.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">England</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danisco Holdings (UK) Ltd.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">England</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International N&#38;H Manufacturing UK Limited</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">England</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solae (UK) Limited</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">England</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finnfeeds Oy</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finland</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Genencor International Oy</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finland</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danisco Sweeteners Oy</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finland</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finnfeeds Finland Oy</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finland</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danisco France SAS</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nutrition &#38; Biosciences (France) SAS</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rene Laurent SAS</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Atelier du Parfumeur IFF Grasse SAS</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Institut Europ&#233;en de Biologie Cellulaire</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lucas Meyer Cosmetics</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Flavors &#38; Fragrances France Holding I SAS</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Flavors &#38; Fragrances IFF (France) SAS</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solae Deutschland GmbH</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#38;B Real Estate GmbH &#38; Co. KG</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#38;B Real Estate Verwaltungs-GmbH</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#38;B Produktions- und Verwaltungs-GmbH</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danisco Deutschland GmbH</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">extrakt chemie Dr. Bruno Stellmach GmbH</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFF N&#38;H Germany GmbH &#38; Co. KG</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Frutarom Germany GmbH</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFF Fragrance GmbH</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Flavors &#38; Fragrances IFF (Deutschland) G.M.B.H.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leagel GmbH</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danisco Nutrition &#38; Bioscience Greece Ltd</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greece</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danisco Guatemala S.A.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Guatemala</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danisco Centro America S.A.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Guatemala</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aroma S.A.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Guatemala</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manseg S.A.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Guatemala</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VAYA Pharma Hong Kong Ltd</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hong Kong</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.368%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of Entity</font></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Frutarom (Asia Pacific) Limited</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hong Kong</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prowin International Ltd.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hong Kong</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventive Technology Ltd.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hong Kong</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nutrition &#38; Biosciences Hong Kong Limited</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hong Kong</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Flavors &#38; Fragrances (Hong Kong) Limited</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hong Kong</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nutrition &#38; Biosciences Hungary Kft.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hungary</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFF Hungary Global Korl&#225;tolt Felel&#337;ss&#233;g&#369; T&#225;rsas&#225;g</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hungary</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Flavors &#38; Fragrances I.F.F. (Hungary) Korl&#225;tolt Felel&#337;ss&#233;g&#369; T&#225;rsas&#225;g</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hungary</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thorverk Ltd &#47;  Thorungaverksmidjan hf. &#47; &#222;&#246;rungaverksmi&#240;jan hf.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Iceland</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solae Company India Private Limited</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">India</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danisco (India) Private Limited</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">India</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danisco Nutrition and Biosciences India Private Limited</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">India</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Flavours &#38; Fragrances India Private Limited</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">India</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">P.T. Essence Indonesia</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indonesia</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PT. INTERNATIONAL FLAVORS FRAGRANCES INDONESIA</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indonesia</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International N&#38;H Mfg. Ireland</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Flavors &#38; Fragrances Irish Acquisition Company Limited</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFF Capital Services</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Irish Flavours and Fragrances (CIL) Limited</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aromatics Holdings Limited</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFF N&#38;H Ireland HC Limited</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cytisus Pharma Company Limited </font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Seamair Pharma Company Limited </font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trifolium Pharma Company Limited </font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shamrock Pharma Company Limited </font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arvin Company</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Isle of Man</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Belden Company</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Isle of Man</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Frutarom (UK) Holdings Limited</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Frutarom Ltd.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Frutarom Trade &#38; Marketing (1990) Ltd.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Frutarom Industries Ltd.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Flavors and Fragrances Ingredients Ltd</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Flavors &#38; Fragrances I.F.F. (Israel) Ltd.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Frutarom Global Ltd.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BKF Vision Ltd</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">K - Vision Consulting and Investments Ltd</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">M.P. Equity Holdings Ltd</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lucas Meyer Cosmetics Israel Ltd</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nutra-Lease Ltd.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danisco Italy S.p.A.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Italy</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nutrition &#38; Biosciences Italy S.r.l.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Italy</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Flavors e Fragrances IFF (Italia) S.R.L.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Italy</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nutrition &#38; Biosciences Japan K.K.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danisco Japan Limited</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Flavors &#38; Fragrances (Japan) Ltd.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.368%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of Entity</font></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PTI Astana LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kazakhstan</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFF N&#38;H Kenya Limited</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kenya</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Frutarom Kenya Limited</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kenya</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danisco Nutrition &#38; Biosciences Korea Ltd.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Korea</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFF (Korea) Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Korea</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Frutarom Finance EUR AG</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lichtenstein</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nutrition &#38; Bioscience (Luxembourg) S&#224;rl</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Luxembourg</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Flavors &#38; Fragrances (Luxembourg) S.a.r.l.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Luxembourg</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Flavors &#38; Fragrances Ardenne S.a.r.l.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Luxembourg</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">L&#8217;Atelier Vanille Madagascar</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Madagascar</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danisco Malaysia Sdn. Bhd.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Malaysia</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Flavors &#38; Fragrances (Malaysia) Sdn. Bhd.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Malaysia</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Flavours &#38; Fragrances (Mauritius) Ltd</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mauritius</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Genencor Mauritius Ltd</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mauritius</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFF Nutrition Mexico SA de CV</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mexico</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFF Nutrition Mexicana S.A De C.V.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mexico</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solae De Mexico S. A. De C.V.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mexico</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danisco Mexicana S.A. de C.V.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mexico</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Flavors &#38; Fragrances (Mexico), SA de CV</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mexico</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bush Boake Allen Controladora, S.A. DE C.V.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mexico</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PTI-MOL LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Moldova</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ERELEM</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Morocco</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Flavors &#38; Fragrances (Myanmar) Limited</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Myanmar</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bush Boake Allen Benelux B.V.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danisco Zaandam BV</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Genencor International B.V.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Asia Holdco B.V.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#38;B EMEA Holding B.V.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#38;H LA Holding B.V.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Genencor International Holding B.V.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#38;H EMEA Holding B.V.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IB EMEA Holding 2 B.V.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#38;H International Holding 1 B.V.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#38;H EMEA Holding 1 B.V.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#38;H EMEA Holding 2 B.V.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SP EMEA Holding 8 B.V.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solae Overseas B.V.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nutrition &#38; Biosciences Netherlands B.V.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danisco Holland B.V.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Frutarom Netherlands B.V.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Flavors &#38; Fragrances I.F.F. (Nederland) B.V.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Flavors &#38; Fragrances (Nederland) Holding B.V.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#38;B Services B.V.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#38;B International Holding B.V.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MC (Netherlands) B.V.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.368%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of Entity</font></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nutrition &#38; Biosciences New Zealand Limited</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Zealand</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taura Natural Ingredients Limited</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Zealand</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danisco New Zealand Limited</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Zealand</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Flavours &#38; Fragrances (NZ) Limited</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Zealand</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFF Nutrition Nigeria Limited</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nigeria</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFF West Africa Limited</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nigeria</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Frutarom Nigeria Limited</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nigeria</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Etol Skopje DRU&#352;TVO ZA TRGOVIJA ETOL UVOZ-IZVOZ DOOEL</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Macedonia</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ingrediants dooel Skopje</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Macedonia</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFF N&#38;H Norway AS</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Norway</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nutrition &#38; Bioscience Pakistan (Private) Ltd</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pakistan</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danisco Per&#250; S.A.C</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peru</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFF Per&#250; S.A. (Montana Food activity)</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peru</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFF Nutrition Philippines, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Philippines</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Flavors &#38; Fragrances (Philippines), Inc.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Philippines</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danisco Poland Sp. z.o.o</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Poland</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tastepoint Polska Z.o.o.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Poland</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Flavors &#38; Fragrances (Poland) Sp. z o.o.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Poland</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chemical Process Materials and Equipment S.A.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Republic of Panama</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Aroma Group</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Republic of Panama</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark Services Holdings Inc.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Republic of Panama</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Frutarom Etol RO SRL</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Romania</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Frutarom (Marketing) S.R.L</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Romania</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">ZAO Danisco (Closed Joint Stock Company &#8220;Danisco&#8221;)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Russia</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tekhnomol Soya Products LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Russia</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PTI Center LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Russia</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Platinum Absolut LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Russia</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LLC PTI Group of companies (short name GK PTI)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Russia</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PTI-NN LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Russia</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;Tastepoint OOO&#8221; (Tastepoint Russia Ltd)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Russia</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Flavors &#38; Fragrances I.F.F. (Rus)</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Russia</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ETOL-RUS, Ltd.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Russia</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leagel S.r.l.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">San Marino</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tastepoint JVE d.o.o. Novi Sad</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Serbia</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Flavors &#38; Fragrances (Greater Asia) Pte. Ltd.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Singapore</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Enzymotec Singapore Pte Ltd</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Singapore</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vaya Pharma Pte Ltd</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Singapore</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danisco Singapore Pte. Ltd.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Singapore</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ETOL SK, s.r.o</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Slovakia</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VITIVA proizvodnja in storitve d.d. (Short name&#58; VITIVA d.d.)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Slovenia</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tastepoint d.o.o.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Slovenia</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Etol Proizvodnja Arom D.O.O</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Slovenia</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danisco South Africa (Pty) Ltd.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Africa</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tastepoint SA (Pty) Ltd</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Africa</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Flavors and Fragrances IFF (South Africa) (Proprietary) Limited</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Africa</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.368%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of Entity</font></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFF Protein Technologies International Sales, LLC South Africa Branch</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Africa</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unique Flavors Proprietary Limited</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Africa</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unique Food Solutions Proprietary Limited</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Africa</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFF Nutrition and Biosciences Iberica S.L.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spain</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFF Murcia Natural Ingredients, S.L.U</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spain</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFF Benicarl&#243;, S.L.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spain</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Flavors &#38; Fragrances I.F.F. (Espa&#241;a), S.A.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spain</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFF Latin American Holdings (Espa&#241;a), S.L.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spain</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFF Lanka Private Limited</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sri Lanka</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nutrition &#38; Biosciences (Sweden) AB</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sweden</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danisco Cultor Sweden AB</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sweden</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Flavors &#38; Fragrances I.F.F. (Norden) AB</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sweden</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Speximo AB</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sweden</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danisco Cultor (Switzerland) AG</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danisco Switzerland AG</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solae Europe Sarl</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nutrition &#38; Biosciences (Switzerland) GmbH</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Frutarom Switzerland Finance USD AG</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Frutarom Switzerland Finance CHF AG</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Frutarom Switzerland Finance GBP AG</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Frutarom Switzerland Finance MXN AG</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Frutarom Switzerland Ltd.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Flavors &#38; Fragrances Taiwan Limited</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taiwan</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International N&#38;H (Thailand) Co. Ltd</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thailand</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nutrition &#38; Bioscience (Thailand) Co., Ltd.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thailand</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International N&#38;H (Thailand) Co. Ltd- branch</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thailand</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Flavours &#38; Fragrances (Thailand) Limited</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thailand</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danisco Dis Ticaret Limited Sirketi</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Turkey</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International NH Dis Ticaret Limited Sirketi</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Turkey</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Etol Aroma Ve Baharat Gida &#220;r&#252;nleri San.ve Tic.a.&#350;.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Turkey</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Frutarom Gida &#220;r&#252;nleri Sanayi Ve Ticaret Limited Sirketi</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Turkey</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">WIBERG Baharat Sanayi Ve Ticaret Anonim &#350;irketi</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Turkey</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFF Turkey Aroma ve Esans &#220;r&#252;nleri Satis Ticaret Anonim Sirketi</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Turkey</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFF Aroma Esans Sanayi Ve Ticaret Anonim &#350;irketi</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Turkey</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danisco Ukraine LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ukraine</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PARMA FA</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ukraine</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PTI-Ukraine LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ukraine</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Flavors &#38; Fragrances (Middle East) FZ-LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Arab Emirates</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agtech Products, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asian Investments, Inc.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bush Boake Allen Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Butamax Advanced Biofuels, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CitraSource Holdings, L.L.C.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Columbia PhytoTechnology LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Crestmont Investment Co.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.368%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of Entity</font></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danisco Holding USA Inc.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danisco US Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danisco USA Inc.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFF US Holding LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFF N&#38;H USA, Inc.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eden Essentials, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Enzymotec USA Inc.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finnsugar Bioproducts, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Flavor Systems International, Inc.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Frutarom USA Holding, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Frutarom USA Inc.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Genencor International Wisconsin, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Genentech Ventures, Inc. GTVI</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grow Company Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Wright Products, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">iDrug Delivery, Inc.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(9)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFF Acquisition, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFF Augusta Holdings LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFF Chemical Holdings Inc.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFF Electronics Holding, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFF International Inc.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFF Protein Technologies International Sales, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFF S&#38;C Holding, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFF US Holding, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFF Worldwide LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Flavors &#38; Fragrances (Caribe) Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Flavors &#38; Fragrances Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Frutarom Corporation</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MC (US) 1 LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MC (US) 2 LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neptune Merger Sub II LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nutrition &#38; Biosciences USA 1, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nutrition &#38; Biosciences USA 3, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nutrition &#38; Biosciences USA 4, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PM Taiwan, Inc.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pointer Specialty Chemicals, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solae Holdings LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solae, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SP Holding IB, Inc.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SP Nutrition and Health (Singapore), Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Products N&#38;H, Inc.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Products US, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sweeteners (US) LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tastepoint Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taura Natural Ingredients (North America) Inc.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.368%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of Entity</font></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Additive Advantage LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Foote &#38; Jenks Corporation</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UFC America Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">van Ameringen-Haebler, Inc.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vaya Pharma Inc</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">W.W. Holdings Inc.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PTI CA LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uzbekistan</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Venezuelan Protein Technologies International -Pti, C.A.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Venezuela</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nutrition &#38; Biosciences Vietnam Company Limited</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vietnam</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Flavors &#38; Fragrances (Vietnam) Limited Liability Company</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vietnam</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bush Boake Allen Zimbabwe (Private) Limited</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zimbabwe</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Flavors &#38; Fragrances (Zimbabwe) (Private) Ltd.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zimbabwe</font></td></tr></table></div><div style="margin-top:7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The companies listed above constitute all subsidiaries of the Company as of February&#160;28, 2024.&#160;Except as otherwise indicated, such subsidiaries are wholly owned, directly or indirectly, by the Company.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________________</font></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">60% of the voting stock of Danisco Shineway Luohe Soy Industry Company Limited is owned indirectly by the Company.</font></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">52% of the voting stock of Danisco Shineway Luohe Food Company Limited is owned indirectly by the Company.</font></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">95% of the voting stock of International Flavors &#38; Fragrances (Hangzhou) Co., Ltd. is owned indirectly by the Company.</font></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">74.85% of the voting stock of FYMSA del Caribe, S.R.L is owned indirectly by the Company.</font></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">71.59% of the voting stock of Thorverk Ltd &#47; Thorungaverksmidjan hf. &#47; &#222;&#246;rungaverksmi&#240;jan hf. is owned indirectly by the Company.</font></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">93.36% of the voting stock of International Flavours &#38; Fragrances India Private Limited is owned indirectly by the Company.</font></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">56.9% of the voting stock of Nutra-Lease Ltd. is owned indirectly by the Company.</font></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">80% of the voting stock of Vaya Pharma Pte Ltd is owned indirectly by the Company.</font></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">65% of the voting stock of iDrug Delivery, Inc. is owned indirectly by the Company.</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23
<SEQUENCE>3
<FILENAME>iff10-k2023exhibit23.htm
<DESCRIPTION>EX-23
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i9459543faffc47bdaf6e485efc530cfe_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit 23 </font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-268580, No. 333-255780, No. 333-252650, No. 033-54423, No. 333-120158, No. 333-126421, No. 333-51436, and No. 333-50752) of International Flavors &#38; Fragrances Inc. of our report dated February&#160;28, 2024 relating to the financial statements, financial statement schedule and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:315.00pt"><tr><td style="width:1.0pt"></td><td style="width:313.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; PricewaterhouseCoopers LLP</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York, New York</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2024</font></td></tr></table></div><div style="margin-bottom:5pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>iff10-k2023exhibit311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i4b03e3424b4d497cb04b2983026fb776_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit 31.1 </font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION </font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, J. Erik Fyrwald, certify that&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">I have reviewed this Annual Report on Form 10-K of International Flavors &#38; Fragrances Inc.&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:99pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:99pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:99pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:99pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58; </font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:99pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:99pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; February&#160;28, 2024</font></div><div style="margin-top:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:369.75pt"><tr><td style="width:1.0pt"></td><td style="width:52.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:313.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; J. Erik Fyrwald</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">J. Erik Fyrwald</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div style="margin-bottom:5pt;text-align:right"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>iff10-k2023exhibit312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="ia0662e5402754ba9b6f1d67542e4a7c9_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit 31.2</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION </font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Glenn Richter, certify that&#58; </font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">I have reviewed this Annual Report on Form 10-K of International Flavors &#38; Fragrances Inc.&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:99pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:99pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:99pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:99pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58; </font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:99pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:99pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; February&#160;28, 2024</font></div><div style="margin-top:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:390.00pt"><tr><td style="width:1.0pt"></td><td style="width:52.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:333.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Glenn Richter</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glenn Richter</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Chief Financial &#38; Business Transformation Officer</font></td></tr></table></div><div style="margin-bottom:5pt;text-align:right"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>6
<FILENAME>iff10-k2023exhibit32.htm
<DESCRIPTION>EX-32
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i9cfea588ace84fe18537b5b656901683_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit 32 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350, </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 </font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report on Form 10-K of International Flavors &#38; Fragrances Inc. (the &#8220;Company&#8221;) for the fiscal year ended December&#160;31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), J. Erik Fyrwald, as Chief Executive Officer of the Company, and Glenn Richter, as Chief Financial &#38; Business Transformation Officer, each hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of his knowledge&#58; </font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and </font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. </font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58; February&#160;28, 2024</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:76.023%"><tr><td style="width:1.0%"></td><td style="width:12.938%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.862%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; J. Erik Fyrwald</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">J. Erik Fyrwald</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:76.023%"><tr><td style="width:1.0%"></td><td style="width:12.938%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.862%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Glenn Richter</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glenn Richter</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Chief Financial &#38; Business Transformation Officer</font></td></tr></table></div><div style="margin-bottom:5pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-97
<SEQUENCE>7
<FILENAME>iff10-k2023exhibit97.htm
<DESCRIPTION>EX-97
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>iff10-k2023exhibit97</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- iff10-k2023exhibit97001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="iff10-k2023exhibit97001.jpg" title="slide1" width="1055" height="5460">
<DIV><FONT size="1" style="font-size:1pt;color:white">INTERNATIONAL FLAVORS &amp; FRAGRANCES INC.  POLICY FOR THE  RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION  1. Purpose. The purpose of this Policy is to describe the circumstances in which Executive Officers will be required to repay or return Erroneously Awarded Compensation to the Company in accordance with the Clawback Rules. Each Executive Officer shall be required to sign and return to the Company the Acknowledgement and Acceptance Form attached hereto as Exhibit A pursuant to which such Executive Officer will acknowledge that he or she is bound by the terms of this Policy; provided, however, that this Policy shall apply to, and be enforceable against, any Executive Officer and his or her successors (as specified in Section 11 of this Policy) regardless of whether or not such Executive Officer properly signs and returns to the Company such Acknowledgement and Acceptance Form and regardless of whether or not such Executive Officer is aware of his or her status as such. 2. Administration. Except as specifically set forth herein, this Policy shall be administered by the Administrator. Any determinations made by the Administrator shall be final and binding on all affected individuals and need not be uniform with respect to each individual covered by this Policy. Subject to any limitation under applicable law, the Administrator may authorize and empower any officer or employee of the Company to take any and all actions necessary or appropriate to carry out the purpose and intent of this Policy (other than with respect to any recovery under this Policy involving such officer or employee). 3. Definitions. For purposes of this Policy, the following capitalized terms shall have the meanings set forth below. (a) &#8220;Accounting Restatement&#8221; shall mean an accounting restatement: due to the material noncompliance of the Company with any financial reporting requirement under the  securities laws, including any required accounting restatement to correct an error in previously  issued financial statements that is material to the previously issued financial statements (a &#8220;Big R&#8221;  restatement), or that would result in a material misstatement if the error were corrected in the  current period or left uncorrected in the current period (a &#8220;little r&#8221; restatement).  (b) &#8220;Administrator&#8221; shall mean the Committee or any other committee designated by the Board to administer the Policy, and in the absence of such designation, the Board.  (c) &#8220;Board&#8221; shall mean the Board of Directors of the Company. (d) &#8220;Clawback Eligible Incentive Compensation&#8221; shall mean, with respect to each individual who served as an Executive Officer at any time during the applicable performance  period for any Incentive-based Compensation (whether or not such individual is serving as an  Executive Officer at the time the Erroneously Awarded Compensation is required to be repaid to  the Company), all Incentive-based Compensation Received by such individual: (i) on or after the  Effective Date; (ii) after beginning service as an Executive Officer; (iii) while the Company has a  class of securities listed on the Listing Exchange; and (iv) during the applicable Clawback Period.  (e) &#8220;Clawback Period&#8221; shall mean, with respect to any Accounting Restatement, the three completed fiscal years of the Company immediately preceding the Restatement Date and any  Exhibit 97 transition period (that results from a change in the Company&#8217;s fiscal year) of less than nine months  within or immediately following those three completed fiscal years.  (f) &#8220;Clawback Rules&#8221; shall mean Section 10D of the Exchange Act and any applicable rules or standards adopted by the SEC thereunder (including Rule 10D-1 under the Exchange Act)  or the Listing Exchange pursuant to Rule 10D-1 under the Exchange Act (including Section  303A.14 of the New York Stock Exchange Listed Company Manual), in each case as may be in  effect from time to time.  (g) &#8220;Committee&#8221; shall mean the Human Capital &amp; Compensation Committee of the Board.  (h) &#8220;Company&#8221; shall mean International Flavors and Fragrances Inc. (and as the Administrator determines is applicable, together with each of its direct and indirect subsidiaries).  (i) &#8220;Effective Date&#8221; shall mean October 2, 2023. (j) &#8220;Erroneously Awarded Compensation&#8221; shall mean, with respect to each Executive Officer in connection with an Accounting Restatement, the amount of Clawback Eligible Incentive  Compensation that exceeds the amount of Clawback Eligible Incentive Compensation that  otherwise would have been Received had it been determined based on the restated amounts,  computed without regard to any taxes paid.  (k) &#8220;Executive Officer&#8221; shall mean any individual who is or was an executive officer as determined by the Administrator in accordance with the definition of &#8220;executive officer&#8221; as set  forth in the Clawback Rules and any other senior executive, employee or other personnel of the  Company who may from time to time be deemed subject to the Policy by the Administrator. For  the avoidance of doubt, the Administrator shall have full discretion to determine which individuals  in the Company shall be considered an &#8220;Executive Officer&#8221; for purposes of this Policy. A list of  senior executives, employees or other personnel of the Company Group who have been determined  by the Administrator to be &#8220;Executive Officers&#8221; for purposes of this policy is set forth in Exhibit  B, which may be revised from time to time at the sole discretion of the Administrator.   (l) &#8220;Exchange Act&#8221; shall mean the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.  (m) &#8220;Financial Reporting Measures&#8221; shall mean measures that are determined and presented in accordance with the accounting principles used in preparing the Company&#8217;s financial  statements, and any measures that are derived wholly or in part from such measures. Stock price  and total shareholder return shall for purposes of this Policy be considered Financial Reporting  Measures. For the avoidance of doubt, a Financial Reporting Measure need not be presented within  the Company&#8217;s financial statements or included in a filing with the SEC.  (n) &#8220;Incentive-based Compensation&#8221; shall mean any compensation that is granted, earned or vested based wholly or in part upon the attainment of a Financial Reporting Measure.  (o) &#8220;Impracticable&#8221; shall mean, in accordance with the good faith determination of the Committee, or if the Committee does not consist of independent directors, a majority of the  independent directors serving on the Board, that either: (i) the direct expenses paid to a third party  to assist in enforcing the Policy against an Executive Officer would exceed the amount to be  recovered, after the Company has made a reasonable attempt to recover the applicable Erroneously  Awarded Compensation, documented such reasonable attempt(s) and provided such  documentation to the Listing Exchange; (ii) recovery would violate the Company&#8217;s home country  law where that law was adopted prior to November 28, 2022, provided that, before concluding that  it would be Impracticable to recover any amount of Erroneously Awarded Compensation based on  violation of home country law, the Company has obtained an opinion of home country counsel,  acceptable to the Listing Exchange, that recovery would result in such a violation and a copy of  the opinion is provided to the Listing Exchange; or (iii) recovery would likely cause an otherwise  tax-qualified retirement plan, under which benefits are broadly available to employees of the  Company, to fail to meet the requirements of 26 U.S.C. 401(a)(13) or 26 U.S.C. 411(a) and  regulations thereunder.  (p) &#8220;Listing Exchange&#8221; shall mean the New York Stock Exchange or such other U.S.  national securities exchange or national securities association on which the Company&#8217;s securities  are listed.  (q) &#8220;Method of Recovery&#8221; shall include, but is not limited to: (i) requiring  reimbursement of Erroneously Awarded Compensation; (ii) seeking recovery of any gain  realized on the vesting, exercise, settlement, sale, transfer, or other disposition of any  equity-based awards; (iii) offsetting the Erroneously Awarded Compensation from any  compensation otherwise owed by the Company to the Executive Officer; (iv) cancelling  outstanding vested or unvested equity awards; and/or (v) taking any other remedial and recovery  action permitted by applicable law, as determined by the Administrator.  (r) &#8220;Policy&#8221; shall mean this Policy for the Recovery of Erroneously Awarded  Compensation, as the same may be amended and/or restated from time to time.  (s) &#8220;Received&#8221; shall, with respect to any Incentive-based Compensation, mean deemed  receipt and Incentive-based Compensation shall be deemed received in the Company&#8217;s fiscal  period during which the Financial Reporting Measure specified in the Incentive-based  Compensation award is attained, even if the payment or grant of the Incentive-based Compensation  occurs after the end of that period. For the avoidance of doubt, Incentive-Based Compensation that  is subject to both a Financial Reporting Measure vesting condition and a service-based vesting  condition shall be considered received when the Financial Reporting Measure is achieved, even if  the Incentive-Based Compensation continues to be subject to the service-based vesting condition.  (t) &#8220;Restatement Date&#8221; shall mean the earlier to occur of: (i) the date the Board, a  committee of the Board or the officer or officers of the Company authorized to take such action if  Board action is not required, concludes, or reasonably should have concluded, that the Company  is required to prepare an Accounting Restatement; or (ii) the date a court, regulator or other legally  authorized body directs the Company to prepare an Accounting Restatement.  (u) &#8220;SEC&#8221; shall mean the U.S. Securities and Exchange Commission. 4. Repayment of Erroneously Awarded Compensation. (a) In the event the Company is required to prepare an Accounting Restatement, the  Administrator shall reasonably promptly (in accordance with the applicable Clawback Rules)  determine the amount of any Erroneously Awarded Compensation for each Executive Officer in  connection with such Accounting Restatement and shall reasonably promptly thereafter provide  each Executive Officer with written notice containing the amount of Erroneously Awarded  Compensation and a demand for repayment or return, as applicable. For Clawback Eligible  Incentive Compensation based on stock price or total shareholder return where the amount of  Erroneously Awarded Compensation is not subject to mathematical recalculation directly from the  information in the applicable Accounting Restatement, the amount shall be determined by the  Administrator based on a reasonable estimate of the effect of the Accounting Restatement on the  stock price or total shareholder return upon which the Clawback Eligible Incentive Compensation  was Received (in which case, the Company shall maintain documentation of such determination  of that reasonable estimate and provide such documentation to the Listing Exchange).  The  Administrator is authorized to engage, on behalf of the Company, any third-party advisors it deems  advisable in order to perform any calculations contemplated by this Policy. For the avoidance of  doubt, recovery under this Policy with respect to an Executive Officer shall not require the finding  of any misconduct by such Executive Officer or such Executive Officer being found responsible  for the accounting error leading to an Accounting Restatement.  (b) In the event that any repayment of Erroneously Awarded Compensation is owed to  the Company, the Administrator shall recover reasonably promptly the Erroneously Awarded  Compensation through any Method of Recovery it deems reasonable and appropriate in its  discretion based on all applicable facts and circumstances and taking into account the time value  of money and the cost to shareholders of delaying recovery. For the avoidance of doubt, except to  the extent permitted pursuant to the Clawback Rules, in no event may the Company accept an  amount that is less than the amount of Erroneously Awarded Compensation in satisfaction of an  Executive Officer&#8217;s obligations hereunder. Notwithstanding anything herein to the contrary, the  Company shall not be required to take the actions contemplated in this Section 4(b) if recovery  would be Impracticable. In implementing the actions contemplated in this Section 4(b), the  Administrator will act in accordance with the listing standards and requirements of the Listing  Exchange and with the applicable Clawback Rules.   (c) Subject to the discretion of the Administrator, an applicable Executive Officer may  be required to reimburse the Company for any and all expenses reasonably incurred (including  legal fees) by the Company in recovering Erroneously Awarded Compensation in accordance with  Section 4(b).  5. Reporting and Disclosure. The Company shall file all disclosures with respect to this Policy in accordance with the requirements of U.S. federal securities laws, including any disclosure required by applicable SEC rules. 6. Indemnification Prohibition. The Company shall not be permitted to indemnify any Executive Officer against the loss of any Erroneously Awarded Compensation that is repaid, returned or recovered pursuant to the terms of this Policy and/or pursuant to the Clawback Rules or to pay or reimburse any Executive Officer for the cost of third-party insurance purchased by an Executive Officer to cover any such loss under this Policy and/or pursuant to the Clawback Rules. Further, the Company shall not enter into any agreement that exempts any Incentive-based </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- iff10-k2023exhibit97002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="iff10-k2023exhibit97002.jpg" title="slide2" width="1055" height="5460">
<DIV><FONT size="1" style="font-size:1pt;color:white">Compensation from the application of this Policy or that waives the Company&#8217;s right to recovery  of any Erroneously Awarded Compensation and this Policy shall supersede any such agreement  (whether entered into before, on or after the Effective Date). Any such purported indemnification  (whether oral or in writing) shall be null and void.   7. Interpretation. The Administrator is authorized to interpret and construe this Policy and to make all determinations necessary, appropriate, or advisable for the administration of this Policy. It is intended that this Policy be interpreted in a manner that is consistent with the requirements of the Clawback Rules. The terms of this Policy shall also be construed and enforced in such a manner as to comply with applicable law, including the Sarbanes-Oxley Act of 2002, the Dodd-Frank Wall Street Reform and Consumer Protection Act, and any other law or regulation that the Administrator determines is applicable. In the event any provision of this Policy is determined to be unenforceable or invalid under applicable law, such provision shall be applied to the maximum extent permitted by applicable law and shall automatically be deemed amended in a manner consistent with its objectives to the extent necessary to conform to any limitations required by applicable law. 8. Effective Date. This Policy shall be effective as of the Effective Date. 9. Amendment; Termination. The Administrator may modify or amend this Policy, in whole or in part, from time to time in its discretion and shall amend any or all of the provisions of this Policy as it deems necessary, including as and when it determines that it is legally required by the Clawback Rules, or any federal securities law, SEC rule, or Listing Exchange rule. The Administrator may terminate this Policy at any time, and this Policy shall remain in effect only so long as the Clawback Rules apply to the Company. Notwithstanding anything in this Section 9 to the contrary, no amendment or termination of this Policy shall be effective if such amendment or termination would (after taking into account any actions taken by the Company contemporaneously with such amendment or termination) cause the Company to violate the Clawback Rules, or any federal securities law, SEC rule, or Listing Exchange rule.  Furthermore, unless otherwise determined by the Administrator or as otherwise amended, this Policy shall automatically be deemed amended in a manner necessary to comply with any change in the Clawback Rules. 10. Other Recoupment Rights; No Additional Payments. The Administrator intends that this Policy will be applied to the fullest extent permitted by applicable law. The Administrator may require that any employment agreement, equity award agreement, or any other agreement entered into on or after the Effective Date shall, as a condition to the grant of any benefit thereunder, require an Executive Officer to agree to abide by the terms of this Policy.1 Executive Officers shall be deemed to have accepted continuing employment on terms that include compliance with the Policy, to the extent of its otherwise applicable provisions, and to be contractually bound by its enforcement provisions. Executive Officers who cease employment or service with the Company shall continue to be bound by the terms of the Policy with respect to Clawback Eligible Incentive Compensation. Any right of recoupment under this Policy is in addition to, and not in lieu of, any other remedies or rights of recoupment that may be available to the Company under applicable law, regulation or rule or pursuant to the terms of any similar policy in any employment agreement, cash-based bonus plan, equity award agreement or similar agreement and any other legal remedies  available to the Company. To the extent that an Executive Officer has already reimbursed the  Company for any Erroneously Awarded Compensation Received under any duplicative recovery  obligations established by the Company or applicable law, it shall be appropriate for any such  reimbursed amount to be credited to the amount of Erroneously Awarded Compensation that is  subject to recovery under this Policy, as determined by the Administrator in its sole discretion.  Nothing in this Policy precludes the Company from implementing any additional clawback or  recoupment policies with respect to Executive Officers or any other service provider of the  Company. Application of this Policy does not preclude the Company from taking any other action  to enforce any Executive Officer&#8217;s obligations to the Company, including termination of  employment or institution of civil or criminal proceedings or any other remedies that may be  available to the Company with respect to any Executive Officer.  11. Successors. This Policy shall be binding and enforceable against all Executive Officers and  their beneficiaries, estates, heirs, executors, administrators or other legal representatives to the  extent required by the Clawback Rules or as otherwise determined by the Administrator. * * *  Exhibit A  INTERNATIONAL FLAVORS &amp; FRAGRANCES INC.POLICY FOR THE  RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION  ACKNOWLEDGEMENT AND ACCEPTANCE FORM  Capitalized terms used but not otherwise defined in this Acknowledgement and Acceptance Form  shall have the meanings ascribed to such terms in the International Flavors and Fragrances Inc.  Policy for the Recovery of Erroneously Awarded Compensation (the &#8220;Policy&#8221;). By signing below,  the undersigned executive officer (the &#8220;Executive Officer&#8221;) acknowledges and confirms that the  Executive Officer has received and reviewed a copy of the Policy and, in addition, the Executive  Officer acknowledges and agrees as follows:  (a) the Executive Officer is and will continue to be subject to the Policy and that the  Policy will apply both during and after the Executive Officer&#8217;s employment with the Company;  (b) to the extent necessary to comply with the Policy, the Policy hereby amends any  employment agreement, equity award agreement or similar agreement that the Executive Officer  is a party to with the Company and shall apply and govern Incentive-based Compensation  Received by any Executive Officer, notwithstanding any contrary or supplemental term or  condition in any document, plan or agreement including without limitation any employment  contract, indemnification agreement equity agreement, or equity plan document.  The foregoing  notwithstanding, unless otherwise expressly required to comply with the Clawback Rules, this  Policy will not amend or otherwise modify or replace any other remedies or rights of recoupment  that may be available to the Company under applicable law, regulation or rule or pursuant to the  terms of any similar policy in any employment agreement, cash-based bonus plan, equity award  agreement or similar agreement and any other legal remedies available to the Company;  (c) the Executive Officer shall abide by the terms of the Policy, including, without  limitation, by returning any Erroneously Awarded Compensation to the Company to the extent  required by, and in a manner permitted by, the Policy;  (d) any amounts payable to the Executive Officer, including any Incentive-based  Compensation, shall be subject to the Policy as may be in effect and modified from time to time  in the sole discretion of the Administrator or as required by applicable law or the requirements of  the Listing Exchange, and that such modification will be deemed to amend this acknowledgment;  (e) the Company may recover compensation paid to the Executive Officer through any  Method of Recovery the Administrator deems appropriate, and the Executive Officer agrees to  comply with any request or demand for repayment by the Company in order to comply with the  Policy;   (f) the recovery of Erroneously Awarded Compensation under this Policy will not give  rise to any right to voluntarily terminate employment for &#8220;good reason,&#8221; or due to a &#8220;constructive  termination&#8221; (or any similar term of like effect) under any plan, program or policy of or agreement  with the Company;   (g) the Company may, to the greatest extent permitted by applicable law, reduce any  amount that may become payable to the Executive Officer by any amount to be recovered by the  Company pursuant to the Policy to the extent such amount has not been returned by the Executive  Officer to the Company prior to the date that any subsequent amount becomes payable to the  Executive Officer; and  (h) any assertion or application of any rights under federal, state, local or foreign law  or in contract or equity that would otherwise conflict with or narrow the Company&#8217;s authority to  interpret, apply and enforce the Policy to its fullest extent, including but not limited to, the  Company&#8217;s authority to withhold or divert wages pursuant to the Policy, is hereby waived by the  Executive Officer.  This Acknowledgment may be electronically signed and any digital or electronic signatures  (including pdf, facsimile or electronically imaged signatures provided by DocuSign or any other  digital signature provider) appearing on this Acknowledgment are the same as handwritten  signatures for the purposes of validity, enforceability and admissibility, and that delivery of any  such electronic signature to, or a signed copy of, this Acknowledgment may be made by facsimile,  email or other electronic transmission.  Signature  Print Name  Date  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>iff-20231231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:0b208b7a-5cd8-4cb9-aadf-23532e94abd0,g:23e07c85-fb0b-44f9-a3e5-5e9f1b6ef71a-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iff="http://www.iff.com/20231231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.iff.com/20231231">
  <xs:import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2023" schemaLocation="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="iff-20231231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="iff-20231231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="iff-20231231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="iff-20231231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.iff.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://www.iff.com/role/AuditInformation">
        <link:definition>0000002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME" roleURI="http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME">
        <link:definition>0000003 - Statement - CONSOLIDATED STATEMENT OF INCOME AND COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEET" roleURI="http://www.iff.com/role/CONSOLIDATEDBALANCESHEET">
        <link:definition>0000004 - Statement - CONSOLIDATED BALANCE SHEET</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETParenthetical" roleURI="http://www.iff.com/role/CONSOLIDATEDBALANCESHEETParenthetical">
        <link:definition>0000005 - Statement - CONSOLIDATED BALANCE SHEET (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTOFCASHFLOWS" roleURI="http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS">
        <link:definition>0000006 - Statement - CONSOLIDATED STATEMENT OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY" roleURI="http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY">
        <link:definition>0000007 - Statement - CONSOLIDATED STATEMENT OF SHAREHOLDERS EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITYParenthetical" roleURI="http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITYParenthetical">
        <link:definition>0000008 - Statement - CONSOLIDATED STATEMENT OF SHAREHOLDERS EQUITY (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NatureofOperationsandSummaryofSignificantAccountingPolicies" roleURI="http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPolicies">
        <link:definition>0000009 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringandOtherCharges" roleURI="http://www.iff.com/role/RestructuringandOtherCharges">
        <link:definition>0000010 - Disclosure - Restructuring and Other Charges</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsNotes" roleURI="http://www.iff.com/role/AcquisitionsNotes">
        <link:definition>0000011 - Disclosure - Acquisitions (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessDivestiture" roleURI="http://www.iff.com/role/BusinessDivestiture">
        <link:definition>0000012 - Disclosure - Business Divestiture</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentNet" roleURI="http://www.iff.com/role/PropertyPlantandEquipmentNet">
        <link:definition>0000013 - Disclosure - Property, Plant and Equipment, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsNet" roleURI="http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNet">
        <link:definition>0000014 - Disclosure - Goodwill and Other Intangible Assets, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAssetsAndLiabilitiesCurrentandNoncurrent" roleURI="http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrent">
        <link:definition>0000015 - Disclosure - Other Assets And Liabilities, Current and Noncurrent</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt" roleURI="http://www.iff.com/role/Debt">
        <link:definition>0000016 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNotes" roleURI="http://www.iff.com/role/LeasesNotes">
        <link:definition>0000017 - Disclosure - Leases (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.iff.com/role/IncomeTaxes">
        <link:definition>0000018 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShare" roleURI="http://www.iff.com/role/NetIncomePerShare">
        <link:definition>0000019 - Disclosure - Net Income Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquity" roleURI="http://www.iff.com/role/ShareholdersEquity">
        <link:definition>0000020 - Disclosure - Shareholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockCompensationPlans" roleURI="http://www.iff.com/role/StockCompensationPlans">
        <link:definition>0000021 - Disclosure - Stock Compensation Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformation" roleURI="http://www.iff.com/role/SegmentInformation">
        <link:definition>0000022 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefits" roleURI="http://www.iff.com/role/EmployeeBenefits">
        <link:definition>0000023 - Disclosure - Employee Benefits</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstruments" roleURI="http://www.iff.com/role/FinancialInstruments">
        <link:definition>0000024 - Disclosure - Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeLoss" roleURI="http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLoss">
        <link:definition>0000025 - Disclosure - Accumulated Other Comprehensive Income (Loss)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConcentrationsofCreditRisk" roleURI="http://www.iff.com/role/ConcentrationsofCreditRisk">
        <link:definition>0000026 - Disclosure - Concentrations of Credit Risk</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.iff.com/role/CommitmentsandContingencies">
        <link:definition>0000027 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableNoncontrollingInterests" roleURI="http://www.iff.com/role/RedeemableNoncontrollingInterests">
        <link:definition>0000028 - Disclosure - Redeemable Noncontrolling Interests</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AssetsandLiabilitiesHeldForSale" roleURI="http://www.iff.com/role/AssetsandLiabilitiesHeldForSale">
        <link:definition>0000029 - Disclosure - Assets and Liabilities Held For Sale</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherIncomeandExpenses" roleURI="http://www.iff.com/role/OtherIncomeandExpenses">
        <link:definition>0000030 - Disclosure - Other Income and Expenses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TangibleEquityUnits" roleURI="http://www.iff.com/role/TangibleEquityUnits">
        <link:definition>0000031 - Disclosure - Tangible Equity Units</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIIValuationandQualifyingAccountsandReserves" roleURI="http://www.iff.com/role/ScheduleIIValuationandQualifyingAccountsandReserves">
        <link:definition>0000032 - Disclosure - Schedule II - Valuation and Qualifying Accounts and Reserves</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>9954471 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NatureofOperationsandSummaryofSignificantAccountingPoliciesTables" roleURI="http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesTables">
        <link:definition>9954472 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringandOtherChargesTables" roleURI="http://www.iff.com/role/RestructuringandOtherChargesTables">
        <link:definition>9954473 - Disclosure - Restructuring and Other Charges (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsTables" roleURI="http://www.iff.com/role/AcquisitionsTables">
        <link:definition>9954474 - Disclosure - Acquisitions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DiscontinuedOperationsandDisposalGroupsTables" roleURI="http://www.iff.com/role/DiscontinuedOperationsandDisposalGroupsTables">
        <link:definition>9954475 - Disclosure - Discontinued Operations and Disposal Groups (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentNetTables" roleURI="http://www.iff.com/role/PropertyPlantandEquipmentNetTables">
        <link:definition>9954476 - Disclosure - Property, Plant and Equipment, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsNetTables" roleURI="http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetTables">
        <link:definition>9954477 - Disclosure - Goodwill and Other Intangible Assets, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAssetsAndLiabilitiesCurrentandNoncurrentTables" roleURI="http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentTables">
        <link:definition>9954478 - Disclosure - Other Assets And Liabilities, Current and Noncurrent (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtTables" roleURI="http://www.iff.com/role/DebtTables">
        <link:definition>9954479 - Disclosure - Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.iff.com/role/LeasesTables">
        <link:definition>9954480 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.iff.com/role/IncomeTaxesTables">
        <link:definition>9954481 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShareTables" roleURI="http://www.iff.com/role/NetIncomePerShareTables">
        <link:definition>9954482 - Disclosure - Net Income Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityTables" roleURI="http://www.iff.com/role/ShareholdersEquityTables">
        <link:definition>9954483 - Disclosure - Shareholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockCompensationPlansTables" roleURI="http://www.iff.com/role/StockCompensationPlansTables">
        <link:definition>9954484 - Disclosure - Stock Compensation Plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationTables" roleURI="http://www.iff.com/role/SegmentInformationTables">
        <link:definition>9954485 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsTables" roleURI="http://www.iff.com/role/EmployeeBenefitsTables">
        <link:definition>9954486 - Disclosure - Employee Benefits (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsTables" roleURI="http://www.iff.com/role/FinancialInstrumentsTables">
        <link:definition>9954487 - Disclosure - Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeLossTables" roleURI="http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossTables">
        <link:definition>9954488 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableNoncontrollingInterestsTables" roleURI="http://www.iff.com/role/RedeemableNoncontrollingInterestsTables">
        <link:definition>9954489 - Disclosure - Redeemable Noncontrolling Interests (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AssetsandLiabilitiesHeldForSaleTables" roleURI="http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleTables">
        <link:definition>9954490 - Disclosure - Assets and Liabilities Held For Sale (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherExpenseIncomeNetTables" roleURI="http://www.iff.com/role/OtherExpenseIncomeNetTables">
        <link:definition>9954491 - Disclosure - Other (Expense) Income, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TangibleEquityUnitsTables" roleURI="http://www.iff.com/role/TangibleEquityUnitsTables">
        <link:definition>9954492 - Disclosure - Tangible Equity Units (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail" roleURI="http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail">
        <link:definition>9954493 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NatureofOperationsandSummaryofSignificantAccountingPoliciesScheduleofInventoryDetail" roleURI="http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesScheduleofInventoryDetail">
        <link:definition>9954494 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies - Schedule of Inventory (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringandOtherChargesAdditionalInformationDetails" roleURI="http://www.iff.com/role/RestructuringandOtherChargesAdditionalInformationDetails">
        <link:definition>9954495 - Disclosure - Restructuring and Other Charges - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringandOtherChargesMovementsinRestructuringandRelatedAccrualsDetail" roleURI="http://www.iff.com/role/RestructuringandOtherChargesMovementsinRestructuringandRelatedAccrualsDetail">
        <link:definition>9954496 - Disclosure - Restructuring and Other Charges - Movements in Restructuring and Related Accruals (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsHealthWrightProductsDetails" roleURI="http://www.iff.com/role/AcquisitionsHealthWrightProductsDetails">
        <link:definition>9954497 - Disclosure - Acquisitions - Health Wright Products (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsNutritionBiosciencesIncDetails" roleURI="http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails">
        <link:definition>9954498 - Disclosure - Acquisitions - Nutrition &amp; Biosciences, Inc (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessDivestitureDetails" roleURI="http://www.iff.com/role/BusinessDivestitureDetails">
        <link:definition>9954499 - Disclosure - Business Divestiture (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetail" roleURI="http://www.iff.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetail">
        <link:definition>9954500 - Disclosure - Property, Plant and Equipment, Net - Schedule of Property, Plant and Equipment (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsNetNarrativeDetails" roleURI="http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetNarrativeDetails">
        <link:definition>9954501 - Disclosure - Goodwill and Other Intangible Assets, Net - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsNetGoodwillRollforwardDetails" roleURI="http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetGoodwillRollforwardDetails">
        <link:definition>9954502 - Disclosure - Goodwill and Other Intangible Assets, Net - Goodwill Rollforward (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsNetTrademarkandOtherIntangibleAssetsDetail" roleURI="http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetTrademarkandOtherIntangibleAssetsDetail">
        <link:definition>9954503 - Disclosure - Goodwill and Other Intangible Assets, Net - Trademark and Other Intangible Assets (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsNetAmortizationExpenseDetail" roleURI="http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetAmortizationExpenseDetail">
        <link:definition>9954504 - Disclosure - Goodwill and Other Intangible Assets, Net - Amortization Expense (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherAssetsDetail" roleURI="http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherAssetsDetail">
        <link:definition>9954505 - Disclosure - Other Assets And Liabilities, Current and Noncurrent - Schedule of Other Assets (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherCurrentLiabilitiesDetails" roleURI="http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherCurrentLiabilitiesDetails">
        <link:definition>9954506 - Disclosure - Other Assets And Liabilities, Current and Noncurrent - Schedule of Other Current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtComponentsofDebtDetail" roleURI="http://www.iff.com/role/DebtComponentsofDebtDetail">
        <link:definition>9954507 - Disclosure - Debt - Components of Debt (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail" roleURI="http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail">
        <link:definition>9954508 - Disclosure - Debt - Additional Information - Term Loan and Senior Notes Assumed (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtAdditionalInformationRevolvingCreditFacilityDetail" roleURI="http://www.iff.com/role/DebtAdditionalInformationRevolvingCreditFacilityDetail">
        <link:definition>9954509 - Disclosure - Debt - Additional Information - Revolving Credit Facility (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtAdditionalInformationSeniorUnsecuredNotesDetail" roleURI="http://www.iff.com/role/DebtAdditionalInformationSeniorUnsecuredNotesDetail">
        <link:definition>9954510 - Disclosure - Debt - Additional Information - Senior Unsecured Notes (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtAdditionalInformationCommercialPaperandRedemptionProvisionsDetail" roleURI="http://www.iff.com/role/DebtAdditionalInformationCommercialPaperandRedemptionProvisionsDetail">
        <link:definition>9954511 - Disclosure - Debt - Additional Information - Commercial Paper and Redemption Provisions (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtScheduleofDebtMaturitiesDetails" roleURI="http://www.iff.com/role/DebtScheduleofDebtMaturitiesDetails">
        <link:definition>9954512 - Disclosure - Debt - Schedule of Debt Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesDetails" roleURI="http://www.iff.com/role/LeasesDetails">
        <link:definition>9954513 - Disclosure - Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofLeaseExpenseDetails" roleURI="http://www.iff.com/role/LeasesScheduleofLeaseExpenseDetails">
        <link:definition>9954514 - Disclosure - Leases - Schedule of Lease Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofRentalExpenseDetails" roleURI="http://www.iff.com/role/LeasesScheduleofRentalExpenseDetails">
        <link:definition>9954515 - Disclosure - Leases - Schedule of Rental Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesCashFlowDetails" roleURI="http://www.iff.com/role/LeasesCashFlowDetails">
        <link:definition>9954516 - Disclosure - Leases - Cash Flow (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesBalanceSheetDetails" roleURI="http://www.iff.com/role/LeasesBalanceSheetDetails">
        <link:definition>9954517 - Disclosure - Leases - Balance Sheet (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesWeightedAverageDetails" roleURI="http://www.iff.com/role/LeasesWeightedAverageDetails">
        <link:definition>9954518 - Disclosure - Leases - Weighted Average (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofLeaseMaturitiesDetails" roleURI="http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails">
        <link:definition>9954519 - Disclosure - Leases - Schedule of Lease Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofLeaseMaturitiesDetails_1" roleURI="http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails_1">
        <link:definition>9954519 - Disclosure - Leases - Schedule of Lease Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesAdditionalInformationDetails" roleURI="http://www.iff.com/role/LeasesAdditionalInformationDetails">
        <link:definition>9954520 - Disclosure - Leases - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetail" roleURI="http://www.iff.com/role/IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetail">
        <link:definition>9954521 - Disclosure - Income Taxes - Schedule of Earnings before Income Taxes (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofIncomeTaxProvisionDetail" roleURI="http://www.iff.com/role/IncomeTaxesScheduleofIncomeTaxProvisionDetail">
        <link:definition>9954522 - Disclosure - Income Taxes - Schedule of Income Tax Provision (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesReconciliationofEffectiveIncomeTaxRateDetails" roleURI="http://www.iff.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxRateDetails">
        <link:definition>9954523 - Disclosure - Income Taxes - Reconciliation of Effective Income Tax Rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofReconciliationbetweenUSFederalStatutoryIncomeTaxRatetoActualEffectiveTaxRateDetail" roleURI="http://www.iff.com/role/IncomeTaxesScheduleofReconciliationbetweenUSFederalStatutoryIncomeTaxRatetoActualEffectiveTaxRateDetail">
        <link:definition>9954524 - Disclosure - Income Taxes - Schedule of Reconciliation between U.S. Federal Statutory Income Tax Rate to Actual Effective Tax Rate (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesAdditionalInformationDetail" roleURI="http://www.iff.com/role/IncomeTaxesAdditionalInformationDetail">
        <link:definition>9954525 - Disclosure - Income Taxes - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetail" roleURI="http://www.iff.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetail">
        <link:definition>9954526 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesReconciliationofBeginningandEndingAmountofUnrecognizedTaxBenefitsDetail" roleURI="http://www.iff.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofUnrecognizedTaxBenefitsDetail">
        <link:definition>9954527 - Disclosure - Income Taxes - Reconciliation of Beginning and Ending Amount of Unrecognized Tax Benefits (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShareReconciliationofSharesUsedinComputationofBasicandDilutedNetIncomePerShareDetail" roleURI="http://www.iff.com/role/NetIncomePerShareReconciliationofSharesUsedinComputationofBasicandDilutedNetIncomePerShareDetail">
        <link:definition>9954528 - Disclosure - Net Income Per Share - Reconciliation of Shares Used in Computation of Basic and Diluted Net Income Per Share (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShareAdditionalInformationDetail" roleURI="http://www.iff.com/role/NetIncomePerShareAdditionalInformationDetail">
        <link:definition>9954529 - Disclosure - Net Income Per Share - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShareTEUDetails" roleURI="http://www.iff.com/role/NetIncomePerShareTEUDetails">
        <link:definition>9954530 - Disclosure - Net Income Per Share - TEU (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityAdditionalInformationDetail" roleURI="http://www.iff.com/role/ShareholdersEquityAdditionalInformationDetail">
        <link:definition>9954531 - Disclosure - Shareholders' Equity - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockCompensationPlansAdditionalInformationDetail" roleURI="http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail">
        <link:definition>9954532 - Disclosure - Stock Compensation Plans - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockCompensationPlansStockBasedCompensationExpenseIncludedinConsolidatedStatementofIncomeandComprehensiveIncomeDetail" roleURI="http://www.iff.com/role/StockCompensationPlansStockBasedCompensationExpenseIncludedinConsolidatedStatementofIncomeandComprehensiveIncomeDetail">
        <link:definition>9954533 - Disclosure - Stock Compensation Plans - Stock-Based Compensation Expense Included in Consolidated Statement of Income and Comprehensive Income (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockCompensationPlansSSARsandStockOptionAdditionalInformationDetail" roleURI="http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionAdditionalInformationDetail">
        <link:definition>9954534 - Disclosure - Stock Compensation Plans - SSAR's and Stock Option - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockCompensationPlansSSARsandStockOptionActivityDetail" roleURI="http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionActivityDetail">
        <link:definition>9954535 - Disclosure - Stock Compensation Plans - SSAR's and Stock Option Activity (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockCompensationPlansSSARsandStockOptionOutstandingDetail" roleURI="http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionOutstandingDetail">
        <link:definition>9954536 - Disclosure - Stock Compensation Plans - SSAR's and Stock Option Outstanding (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockCompensationPlansSSARsandStockOptionExercisableDetail" roleURI="http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionExercisableDetail">
        <link:definition>9954537 - Disclosure - Stock Compensation Plans - SSAR's and Stock Option Exercisable (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockCompensationPlansRestrictedStockUnitsPlanAdditionalInformationDetail" roleURI="http://www.iff.com/role/StockCompensationPlansRestrictedStockUnitsPlanAdditionalInformationDetail">
        <link:definition>9954538 - Disclosure - Stock Compensation Plans - Restricted Stock Units Plan - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockCompensationPlansRSUPRSandCashRSUActivityDetail" roleURI="http://www.iff.com/role/StockCompensationPlansRSUPRSandCashRSUActivityDetail">
        <link:definition>9954539 - Disclosure - Stock Compensation Plans - RSU, PRS and Cash RSU Activity (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockCompensationPlansPurchasedRestrictedStockPlanAdditionalInformationDetail" roleURI="http://www.iff.com/role/StockCompensationPlansPurchasedRestrictedStockPlanAdditionalInformationDetail">
        <link:definition>9954540 - Disclosure - Stock Compensation Plans - Purchased Restricted Stock Plan - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockCompensationPlansLiabilityAwardsAdditionalInformationDetail" roleURI="http://www.iff.com/role/StockCompensationPlansLiabilityAwardsAdditionalInformationDetail">
        <link:definition>9954541 - Disclosure - Stock Compensation Plans - Liability Awards - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationAdditionalInformationDetail" roleURI="http://www.iff.com/role/SegmentInformationAdditionalInformationDetail">
        <link:definition>9954542 - Disclosure - Segment Information - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationReportableSegmentInformationDetail" roleURI="http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail">
        <link:definition>9954543 - Disclosure - Segment Information - Reportable Segment Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationCapitalExpenditureandDepreciationandAmortizationbySegmentDetail" roleURI="http://www.iff.com/role/SegmentInformationCapitalExpenditureandDepreciationandAmortizationbySegmentDetail">
        <link:definition>9954544 - Disclosure - Segment Information - Capital Expenditure and Depreciation and Amortization by Segment (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationNetSalesbyGeographicAreaDetail" roleURI="http://www.iff.com/role/SegmentInformationNetSalesbyGeographicAreaDetail">
        <link:definition>9954545 - Disclosure - Segment Information - Net Sales by Geographic Area (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationSegmentInformationScheduleofLongLivedAssetsDetails" roleURI="http://www.iff.com/role/SegmentInformationSegmentInformationScheduleofLongLivedAssetsDetails">
        <link:definition>9954546 - Disclosure - Segment Information Segment Information - Schedule of Long Lived Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsAdditionalInformationDetail" roleURI="http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail">
        <link:definition>9954547 - Disclosure - Employee Benefits - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail" roleURI="http://www.iff.com/role/EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail">
        <link:definition>9954548 - Disclosure - Employee Benefits - Plan Assets and Benefit Obligations of Defined Benefit Pension Plans (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsComponentsofNetPeriodicBenefitCostandChangesinPlanAssetsandBenefitObligationsRecognizedinOCIDetail" roleURI="http://www.iff.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostandChangesinPlanAssetsandBenefitObligationsRecognizedinOCIDetail">
        <link:definition>9954549 - Disclosure - Employee Benefits - Components of Net Periodic Benefit Cost and Changes in Plan Assets and Benefit Obligations Recognized in OCI (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsWeightedAverageActuarialAssumptionUsedtoDetermineExpenseDetail" roleURI="http://www.iff.com/role/EmployeeBenefitsWeightedAverageActuarialAssumptionUsedtoDetermineExpenseDetail">
        <link:definition>9954550 - Disclosure - Employee Benefits - Weighted-Average Actuarial Assumption Used to Determine Expense (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail" roleURI="http://www.iff.com/role/EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail">
        <link:definition>9954551 - Disclosure - Employee Benefits - Changes in Postretirement Benefit Obligation and Plan Assets (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsAmountsRecognizedinBalanceSheetDetail" roleURI="http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinBalanceSheetDetail">
        <link:definition>9954552 - Disclosure - Employee Benefits - Amounts Recognized in Balance Sheet (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetail" roleURI="http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetail">
        <link:definition>9954553 - Disclosure - Employee Benefits - Amounts Recognized in Accumulated Other Comprehensive Income (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsAccumulatedBenefitObligationDetail" roleURI="http://www.iff.com/role/EmployeeBenefitsAccumulatedBenefitObligationDetail">
        <link:definition>9954554 - Disclosure - Employee Benefits - Accumulated Benefit Obligation (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsEstimatedFutureBenefitPaymentsDetail" roleURI="http://www.iff.com/role/EmployeeBenefitsEstimatedFutureBenefitPaymentsDetail">
        <link:definition>9954555 - Disclosure - Employee Benefits - Estimated Future Benefit Payments (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsPercentageofAssetsInvestedDetail" roleURI="http://www.iff.com/role/EmployeeBenefitsPercentageofAssetsInvestedDetail">
        <link:definition>9954556 - Disclosure - Employee Benefits - Percentage of Assets Invested (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail" roleURI="http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail">
        <link:definition>9954557 - Disclosure - Employee Benefits - Fair Value Hierarchy of Plan Assets (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsReconciliationofLevel3NonUSPlanAssetsHeldDetail" roleURI="http://www.iff.com/role/EmployeeBenefitsReconciliationofLevel3NonUSPlanAssetsHeldDetail">
        <link:definition>9954558 - Disclosure - Employee Benefits - Reconciliation of Level 3 Non-U.S. Plan Assets Held (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsWeightedAverageAssumptionsUsedtoDeterminePostretirementBenefitExpenseandObligationDetail" roleURI="http://www.iff.com/role/EmployeeBenefitsWeightedAverageAssumptionsUsedtoDeterminePostretirementBenefitExpenseandObligationDetail">
        <link:definition>9954559 - Disclosure - Employee Benefits - Weighted Average Assumptions Used to Determine Postretirement Benefit Expense and Obligation (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsSensitivityofDisclosurestoChangesinSelectedAssumptionsDetail" roleURI="http://www.iff.com/role/EmployeeBenefitsSensitivityofDisclosurestoChangesinSelectedAssumptionsDetail">
        <link:definition>9954560 - Disclosure - Employee Benefits - Sensitivity of Disclosures to Changes in Selected Assumptions (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsCarryingAmountandEstimatedFairValueofFinancialInstrumentsDetail" roleURI="http://www.iff.com/role/FinancialInstrumentsCarryingAmountandEstimatedFairValueofFinancialInstrumentsDetail">
        <link:definition>9954561 - Disclosure - Financial Instruments - Carrying Amount and Estimated Fair Value of Financial Instruments (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsDerivativeInstrumentsNotionalAmountOutstandingDetail" roleURI="http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsNotionalAmountOutstandingDetail">
        <link:definition>9954562 - Disclosure - Financial Instruments - Derivative Instruments Notional Amount Outstanding (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsDerivativeInstrumentsMeasuredatFairValueDetail" roleURI="http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsMeasuredatFairValueDetail">
        <link:definition>9954563 - Disclosure - Financial Instruments - Derivative Instruments Measured at Fair Value (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsDerivativeInstrumentsWhichWereNotDesignatedasHedgingInstrumentsDetail" roleURI="http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsWhichWereNotDesignatedasHedgingInstrumentsDetail">
        <link:definition>9954564 - Disclosure - Financial Instruments - Derivative Instruments Which Were Not Designated as Hedging Instruments (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowandNetInvestmentHedgingInstrumentsDetail" roleURI="http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowandNetInvestmentHedgingInstrumentsDetail">
        <link:definition>9954565 - Disclosure - Financial Instruments - Derivative Instruments Designated as Cash Flow and Net Investment Hedging Instruments (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsAdditionalInformationDetail" roleURI="http://www.iff.com/role/FinancialInstrumentsAdditionalInformationDetail">
        <link:definition>9954566 - Disclosure - Financial Instruments - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeLossScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossDetail" roleURI="http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossDetail">
        <link:definition>9954567 - Disclosure - Accumulated Other Comprehensive Income (Loss) - Schedule of Changes in Accumulated Other Comprehensive Income (Loss) (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeLossReclassificationsofAccumulatedOtherComprehensiveIncometoConsolidatedStatementofComprehensiveIncomeDetail" roleURI="http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossReclassificationsofAccumulatedOtherComprehensiveIncometoConsolidatedStatementofComprehensiveIncomeDetail">
        <link:definition>9954568 - Disclosure - Accumulated Other Comprehensive Income (Loss) - Reclassifications of Accumulated Other Comprehensive Income to Consolidated Statement of Comprehensive Income (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeLossReclassificationsofAccumulatedOtherComprehensiveIncometoConsolidatedStatementofComprehensiveIncomeDetail_1" roleURI="http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossReclassificationsofAccumulatedOtherComprehensiveIncometoConsolidatedStatementofComprehensiveIncomeDetail_1">
        <link:definition>9954568 - Disclosure - Accumulated Other Comprehensive Income (Loss) - Reclassifications of Accumulated Other Comprehensive Income to Consolidated Statement of Comprehensive Income (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConcentrationsOfCreditRiskAdditionalInformationDetail" roleURI="http://www.iff.com/role/ConcentrationsOfCreditRiskAdditionalInformationDetail">
        <link:definition>9954569 - Disclosure - Concentrations Of Credit Risk - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesAdditionalInformationDetail" roleURI="http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail">
        <link:definition>9954570 - Disclosure - Commitments and Contingencies - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableNoncontrollingInterestsDetails" roleURI="http://www.iff.com/role/RedeemableNoncontrollingInterestsDetails">
        <link:definition>9954571 - Disclosure - Redeemable Noncontrolling Interests (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AssetsandLiabilitiesHeldForSaleDetails" roleURI="http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleDetails">
        <link:definition>9954572 - Disclosure - Assets and Liabilities Held For Sale (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherExpenseIncomeNetDetails" roleURI="http://www.iff.com/role/OtherExpenseIncomeNetDetails">
        <link:definition>9954573 - Disclosure - Other (Expense) Income, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TangibleEquityUnitsDetails" roleURI="http://www.iff.com/role/TangibleEquityUnitsDetails">
        <link:definition>9954574 - Disclosure - Tangible Equity Units (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TangibleEquityUnitsAllocationofTEUDetails" roleURI="http://www.iff.com/role/TangibleEquityUnitsAllocationofTEUDetails">
        <link:definition>9954575 - Disclosure - Tangible Equity Units (Allocation of TEU) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TangibleEquityUnitsTangibleEquitySettlementofSharesDetails" roleURI="http://www.iff.com/role/TangibleEquityUnitsTangibleEquitySettlementofSharesDetails">
        <link:definition>9954576 - Disclosure - Tangible Equity Units Tangible Equity - Settlement of Shares (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIIValuationandQualifyingAccountsandReservesDetail" roleURI="http://www.iff.com/role/ScheduleIIValuationandQualifyingAccountsandReservesDetail">
        <link:definition>9954577 - Disclosure - Schedule II - Valuation and Qualifying Accounts and Reserves (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="iff_BankGuaranteesStandbyLettersOfCreditAndCommercialGuaranteesAmountOutstanding" abstract="false" name="BankGuaranteesStandbyLettersOfCreditAndCommercialGuaranteesAmountOutstanding" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_GuangzhouFlavorsPlantMember" abstract="true" name="GuangzhouFlavorsPlantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRange" abstract="false" name="DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRange" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="iff_A2017ProductivityProgramMember" abstract="true" name="A2017ProductivityProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsLineItems" abstract="true" name="ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInProjectedBenefitObligation" abstract="false" name="DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInProjectedBenefitObligation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_SeniorNotesDueTwoThousandThirtyMember" abstract="true" name="SeniorNotesDueTwoThousandThirtyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_A1.750SeniorNotesDue2024Member" abstract="true" name="A1.750SeniorNotesDue2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalBeforeIncomeTax" abstract="false" name="DisposalGroupNotDiscontinuedOperationGainLossOnDisposalBeforeIncomeTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumptionsInPeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumptionsInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember" abstract="true" name="SeniorNotesEuroNotesDueTwoThousandTwentyFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_ScheduleofAllocationofTangibleEquityUnitsTableTextBlock" abstract="false" name="ScheduleofAllocationofTangibleEquityUnitsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="iff_DifferenceAmountBetweenBasicAndDilutedNetIncomePerShare" abstract="false" name="DifferenceAmountBetweenBasicAndDilutedNetIncomePerShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="iff_PercentageofActiveEmployeeswithPensionandorOtherRetirementBenefitPlansCovered" abstract="false" name="PercentageofActiveEmployeeswithPensionandorOtherRetirementBenefitPlansCovered" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="iff_TargetPayoutStock" abstract="false" name="TargetPayoutStock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedPurchasedByEmployees" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedPurchasedByEmployees" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="iff_AssetsAndLiabilitiesLesseeTableTextBlock" abstract="false" name="AssetsAndLiabilitiesLesseeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="iff_InternationalFlavorsFragrancesIncSeniorNotesMember" abstract="true" name="InternationalFlavorsFragrancesIncSeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iff_NetBorrowingsRepaymentsOfCommercialPaperMaturingInLessThanThreeMonths" abstract="false" name="NetBorrowingsRepaymentsOfCommercialPaperMaturingInLessThanThreeMonths" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_RebatesAndIncentivesPayableCurrent" abstract="false" name="RebatesAndIncentivesPayableCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_StockRepurchasedDuringPeriodAsPercentageOfSharesOutstanding" abstract="false" name="StockRepurchasedDuringPeriodAsPercentageOfSharesOutstanding" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="iff_GuangzhouChinaMember" abstract="true" name="GuangzhouChinaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_PharmaSolutionsMember" abstract="true" name="PharmaSolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_SavorySolutionsBusinessMember" abstract="true" name="SavorySolutionsBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_NetIncomeLossAvailableToCommonStockholdersAdjustment" abstract="false" name="NetIncomeLossAvailableToCommonStockholdersAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_SonaromeMember" abstract="true" name="SonaromeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iff_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPayrollAndEmployeeBenefits" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPayrollAndEmployeeBenefits" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_EmployeeReimbursementReceivable" abstract="false" name="EmployeeReimbursementReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_ScheduleofStockPurchaseContractTableTextBlock" abstract="false" name="ScheduleofStockPurchaseContractTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="iff_TangibleEquityUnitsFinalSettlementRate" abstract="false" name="TangibleEquityUnitsFinalSettlementRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="iff_TwoThousandTenPlanMember" abstract="true" name="TwoThousandTenPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_BusinessCombinationInventoryStepUpCosts" abstract="false" name="BusinessCombinationInventoryStepUpCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_ProductLiabilityContingencyLossExposureinExcessofAccrualAmountPaid" abstract="false" name="ProductLiabilityContingencyLossExposureinExcessofAccrualAmountPaid" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_AccountsReceivableFactoringReceivableProgramMaximumAmount" abstract="false" name="AccountsReceivableFactoringReceivableProgramMaximumAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFive" abstract="false" name="LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFive" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_DisposalGroupIncludingDiscontinuedOperationProceedsAttributableToSupplyAgreement" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationProceedsAttributableToSupplyAgreement" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_InsuranceContractsMember" abstract="true" name="InsuranceContractsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_TwoThousandFifteenPlanMember" abstract="true" name="TwoThousandFifteenPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_ConditionThreeMember" abstract="true" name="ConditionThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_RussiaUkraineWarMember" abstract="true" name="RussiaUkraineWarMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_UnrecognizedTaxBenefitsOtherCurrentLiabilitiesMember" abstract="true" name="UnrecognizedTaxBenefitsOtherCurrentLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_TopOneCustomerMember" abstract="true" name="TopOneCustomerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_PriorServiceCostsFromPlanImprovementsAmortizationPeriodMaximum" abstract="false" name="PriorServiceCostsFromPlanImprovementsAmortizationPeriodMaximum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="iff_LesseeOperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount" abstract="false" name="LesseeOperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_IncomeTaxesDisclosureLineItems" abstract="true" name="IncomeTaxesDisclosureLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iff_DisposalGroupIncludingDiscontinuedOperationConsiderationAdvanceReceiptForBusinessToBeTransferred" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationConsiderationAdvanceReceiptForBusinessToBeTransferred" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_FinanceLeaseCost" abstract="false" name="FinanceLeaseCost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_DebtInstrumentCovenantPercentageOfProceedsFromNonOrdinaryAssetsSalesRequiredToBeUsedAsPrepayment" abstract="false" name="DebtInstrumentCovenantPercentageOfProceedsFromNonOrdinaryAssetsSalesRequiredToBeUsedAsPrepayment" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="iff_TransitionServicesAgreementIncomeReductionToCostsNotIncludedInRevenue" abstract="false" name="TransitionServicesAgreementIncomeReductionToCostsNotIncludedInRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_TwoThousandNineteenToTwoThousandTwentyOneCycleMember" abstract="true" name="TwoThousandNineteenToTwoThousandTwentyOneCycleMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_TangibleEquityUnitsPriceforSharesBasic" abstract="false" name="TangibleEquityUnitsPriceforSharesBasic" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="iff_TasteMember" abstract="true" name="TasteMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_DisposalGroupIncludingDiscontinuedOperationTradeReceivablesNet" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationTradeReceivablesNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_LongTermIncentivePlanMember" abstract="true" name="LongTermIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_NonUSAssetBackedSecuritiesMember" abstract="true" name="NonUSAssetBackedSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_DefinedBenefitPlanPlanAssetsOther" abstract="false" name="DefinedBenefitPlanPlanAssetsOther" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_SeniorNotesDueTwoThousandFortyMember" abstract="true" name="SeniorNotesDueTwoThousandFortyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_EmployeeStockOptionAndRestrictedStockMember" abstract="true" name="EmployeeStockOptionAndRestrictedStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_A2019SeveranceInitiativesMember" abstract="true" name="A2019SeveranceInitiativesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_EquityBasedAwardsMember" abstract="true" name="EquityBasedAwardsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_SeniorNotesEuroNotesMaturing2021And2026Member" abstract="true" name="SeniorNotesEuroNotesMaturing2021And2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_A2024TermLoanMember" abstract="true" name="A2024TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_NumberOfFragranceCategories" abstract="false" name="NumberOfFragranceCategories" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="iff_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIDueToBusinessDivestitures" abstract="false" name="OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIDueToBusinessDivestitures" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_DeferredTaxLiabilitiesGainLossOnForeignCurrencyTranslation" abstract="false" name="DeferredTaxLiabilitiesGainLossOnForeignCurrencyTranslation" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_CommercialPaperCurrent" abstract="false" name="CommercialPaperCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_EurocurrencyRateMember" abstract="true" name="EurocurrencyRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_AccumulatedDefinedBenefitPlansAdjustmentSettlementsCurtailmentsAttributableToParentMember" abstract="true" name="AccumulatedDefinedBenefitPlansAdjustmentSettlementsCurtailmentsAttributableToParentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_ThreeHundredSixtyFourDaySeniorUnsecuredBridgeFacilityMember" abstract="true" name="ThreeHundredSixtyFourDaySeniorUnsecuredBridgeFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_BankGuaranteesMember" abstract="true" name="BankGuaranteesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValueOfSharesPurchasedByEmployees" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValueOfSharesPurchasedByEmployees" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_NumberOfCustomers" abstract="false" name="NumberOfCustomers" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="iff_TangibleEquityUnitsProceeds" abstract="false" name="TangibleEquityUnitsProceeds" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_BusinessCombinationDefinedBenefitPlanNumberOfPlansAssumed" abstract="false" name="BusinessCombinationDefinedBenefitPlanNumberOfPlansAssumed" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="iff_PledgedAssetsMember" abstract="true" name="PledgedAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_ConsolidatedNetSalesMember" abstract="true" name="ConsolidatedNetSalesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBelowLowRange" abstract="false" name="DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBelowLowRange" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="iff_AccruedFreightCurrent" abstract="false" name="AccruedFreightCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_CommercialGuaranteesAmountOutstanding" abstract="false" name="CommercialGuaranteesAmountOutstanding" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_MinimumPercentageLikelihoodOfTaxBenefitToBeRealizedUponFinalSettlement" abstract="false" name="MinimumPercentageLikelihoodOfTaxBenefitToBeRealizedUponFinalSettlement" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="iff_NoncontrollingInterestImpactOfForeignExchangeTranslation" abstract="false" name="NoncontrollingInterestImpactOfForeignExchangeTranslation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentage" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="iff_AllForeignCountriesMember" abstract="true" name="AllForeignCountriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_CommonStockDividendsPerShareMaximumDividendThresholdPerQuarter" abstract="false" name="CommonStockDividendsPerShareMaximumDividendThresholdPerQuarter" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="iff_StockOptionsAndStockSettledAppreciationRightsMember" abstract="true" name="StockOptionsAndStockSettledAppreciationRightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_TwoThousandTwentyTwoToTwoThousandFortyOneMember" abstract="true" name="TwoThousandTwentyTwoToTwoThousandFortyOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_DisposalGroupIncludingDiscontinuedOperationPostClosingAdjustments" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationPostClosingAdjustments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_AccumulatedOtherComprehensiveIncomeLossPensionLiabilityAndPostretirementAfterTax" abstract="false" name="AccumulatedOtherComprehensiveIncomeLossPensionLiabilityAndPostretirementAfterTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_DefinedContributionPlanMatchingParticipantContributionAveragePercentageOnCompensation" abstract="false" name="DefinedContributionPlanMatchingParticipantContributionAveragePercentageOnCompensation" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="iff_EstimatedIncomeTaxExpenseBenefit" abstract="false" name="EstimatedIncomeTaxExpenseBenefit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_DefinedBenefitPlanCurrentMedicalCareCostTrendRate" abstract="false" name="DefinedBenefitPlanCurrentMedicalCareCostTrendRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="iff_TwoThousandEightToTwoThousandTwentyOneCycleMember" abstract="true" name="TwoThousandEightToTwoThousandTwentyOneCycleMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_OtherIncomeExpenseNetMember" abstract="true" name="OtherIncomeExpenseNetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFour" abstract="false" name="LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_BuildingsAndImprovementsMember" abstract="true" name="BuildingsAndImprovementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_SubsequentFiscalQuarterEndingOnOrBeforeMarch312025Member" abstract="true" name="SubsequentFiscalQuarterEndingOnOrBeforeMarch312025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iff_SubsequentFiscalQuarterEndingOnOrBeforeSeptember302025Member" abstract="true" name="SubsequentFiscalQuarterEndingOnOrBeforeSeptember302025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iff_PaymentsToParticipateInFactoringReceivableProgram" abstract="false" name="PaymentsToParticipateInFactoringReceivableProgram" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_NumberofFacilities" abstract="false" name="NumberofFacilities" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="iff_LesseeOperatingAndFinanceLeasePaymentsDue" abstract="false" name="LesseeOperatingAndFinanceLeasePaymentsDue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_IncomeTaxesDisclosureTable" abstract="true" name="IncomeTaxesDisclosureTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="iff_MicrobialControlMember" abstract="true" name="MicrobialControlMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_BusinessDivestitureCosts" abstract="false" name="BusinessDivestitureCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_DebtCovenantPeriodAxis" abstract="true" name="DebtCovenantPeriodAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="iff_TangibleEquityUnitsStatedRate" abstract="false" name="TangibleEquityUnitsStatedRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="iff_TradeAccountsReceivableWithFactoringAgreementsMember" abstract="true" name="TradeAccountsReceivableWithFactoringAgreementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_TangibleEquityUnitsPriceforSharesDiluted" abstract="false" name="TangibleEquityUnitsPriceforSharesDiluted" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="iff_RestructuringAndRelatedCostExpectedNumberOfSitesClosedPeriod" abstract="false" name="RestructuringAndRelatedCostExpectedNumberOfSitesClosedPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="iff_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_DebtInstrumentCovenantMaximumConsolidatedLeverageRatio" abstract="false" name="DebtInstrumentCovenantMaximumConsolidatedLeverageRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="iff_TangibleEquityUnitsPricePerUnit" abstract="false" name="TangibleEquityUnitsPricePerUnit" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="iff_AccumulatedOtherComprehensiveIncomeLossTextBlock" abstract="false" name="AccumulatedOtherComprehensiveIncomeLossTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="iff_TerminationFee" abstract="false" name="TerminationFee" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_OtherCountriesMember" abstract="true" name="OtherCountriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_BankGuaranteesCommercialGuaranteesStandbyLettersOfCreditAndSuretyBondsMember" abstract="true" name="BankGuaranteesCommercialGuaranteesStandbyLettersOfCreditAndSuretyBondsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_ShareEquivalentsMember" abstract="true" name="ShareEquivalentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_NatureOfOperationsPolicyTextBlock" abstract="false" name="NatureOfOperationsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="iff_DisposalGroupIncludingDiscontinuedOperationAmountHeldInEscrow" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationAmountHeldInEscrow" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_SeniorUnsecuredBridgeTermLoanMember" abstract="true" name="SeniorUnsecuredBridgeTermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesSubjectToOutstandingAwards" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesSubjectToOutstandingAwards" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="iff_AmountOfAvailableLinesOfCredit" abstract="false" name="AmountOfAvailableLinesOfCredit" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_BankGuaranteesCommercialGuaranteesStandbyLettersOfCreditAndSuretyBondsFacilityAmounts" abstract="false" name="BankGuaranteesCommercialGuaranteesStandbyLettersOfCreditAndSuretyBondsFacilityAmounts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_AmortizationOfInventoryStepUp" abstract="false" name="AmortizationOfInventoryStepUp" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentageGrantedInCashToEligibleEmployees" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentageGrantedInCashToEligibleEmployees" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="iff_TwoThousandTwentyOnePlanMember" abstract="true" name="TwoThousandTwentyOnePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_SeniorNotesDueTwoThousandFiftyMember" abstract="true" name="SeniorNotesDueTwoThousandFiftyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_SeniorNotesDueTwoThousandFortySevenMember" abstract="true" name="SeniorNotesDueTwoThousandFortySevenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_UnrecognizedTaxBenefitsIncludingInterestAndPenalties" abstract="false" name="UnrecognizedTaxBenefitsIncludingInterestAndPenalties" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_DealContingentSwapsMember" abstract="true" name="DealContingentSwapsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_FiscalQuarterEndingOnOrBeforeMarch312024Member" abstract="true" name="FiscalQuarterEndingOnOrBeforeMarch312024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iff_A2019And2022CrossCurrencySwapsMember" abstract="true" name="A2019And2022CrossCurrencySwapsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_TangibleEquityUnitsIssued" abstract="false" name="TangibleEquityUnitsIssued" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="iff_InternationalFlavorsFragrancesIncMember" abstract="true" name="InternationalFlavorsFragrancesIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_ExpenseMember" abstract="true" name="ExpenseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_FiscalQuarterEndingJune302024Member" abstract="true" name="FiscalQuarterEndingJune302024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_BusinessCombinationPensionFundingAdjustment" abstract="false" name="BusinessCombinationPensionFundingAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_HealthBiosciencesMember" abstract="true" name="HealthBiosciencesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_TechnologicalKnowHowsMember" abstract="true" name="TechnologicalKnowHowsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_AccruedCommissionsPayableCurrent" abstract="false" name="AccruedCommissionsPayableCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_FiscalQuarterEndingSeptember302024Member" abstract="true" name="FiscalQuarterEndingSeptember302024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBetweenHighRangeAndLowRange" abstract="false" name="DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBetweenHighRangeAndLowRange" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="iff_ProceedsFromIssuanceOfCommercialPaperMaturingInMoreThanThreeMonths" abstract="false" name="ProceedsFromIssuanceOfCommercialPaperMaturingInMoreThanThreeMonths" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_HealthWrightProductsIncHealthWrightMember" abstract="true" name="HealthWrightProductsIncHealthWrightMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_IndefiniteMember" abstract="true" name="IndefiniteMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_FlavorSpecialtyIngredientsMember" abstract="true" name="FlavorSpecialtyIngredientsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iff_DebtInstrumentCovenantLienThresholdAmount" abstract="false" name="DebtInstrumentCovenantLienThresholdAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_TangibleEquityUnitsTable" abstract="true" name="TangibleEquityUnitsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="iff_TransitionServicesAgreementFairValue" abstract="false" name="TransitionServicesAgreementFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_TwoThousandEighteenToTwoThousandTwentyCycleMember" abstract="true" name="TwoThousandEighteenToTwoThousandTwentyCycleMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_ProceedsFromBusinessCombination" abstract="false" name="ProceedsFromBusinessCombination" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_CommitmentsAndContingenciesLineItems" abstract="true" name="CommitmentsAndContingenciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iff_AmortizingNoteMember" abstract="true" name="AmortizingNoteMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_EffectiveIncomeTaxRateReconciliationDeferredTaxesonDeemedRepatriationPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationDeferredTaxesonDeemedRepatriationPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="iff_FragrancesMember" abstract="true" name="FragrancesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_EmergingMarketsMember" abstract="true" name="EmergingMarketsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_A1.800SeniorNotesDue2026Member" abstract="true" name="A1.800SeniorNotesDue2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumptionsInPeriodWeightedAverageExercisePrice" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumptionsInPeriodWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="iff_NutritionBiosciencesIncSeniorNotesMember" abstract="true" name="NutritionBiosciencesIncSeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_TwoThousandEightToTwoThousandTwentyCycleMember" abstract="true" name="TwoThousandEightToTwoThousandTwentyCycleMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_SecuredOvernightFinancingRateSOFRMember" abstract="true" name="SecuredOvernightFinancingRateSOFRMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iff_CrossCurrencySwapsMember" abstract="true" name="CrossCurrencySwapsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_AlternativeTypeOfInvestmentsMember" abstract="true" name="AlternativeTypeOfInvestmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_GlobalSharedServicesImplementationCosts" abstract="false" name="GlobalSharedServicesImplementationCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_ProductLiabilityContingencyLossExposureinExcessofAccrualAggregateAmountPaid" abstract="false" name="ProductLiabilityContingencyLossExposureinExcessofAccrualAggregateAmountPaid" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_BusinessAcquisitionNetIncomeLoss" abstract="false" name="BusinessAcquisitionNetIncomeLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_FlavorsMember" abstract="true" name="FlavorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNetAsset" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNetAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_ZhejiangIngredientsPlantMember" abstract="true" name="ZhejiangIngredientsPlantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_SeniorNotesDueTwoThousandTwentyEightMember" abstract="true" name="SeniorNotesDueTwoThousandTwentyEightMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_BusinessCombinationNetPensionBalanceDifferentialAmountSettledInCash" abstract="false" name="BusinessCombinationNetPensionBalanceDifferentialAmountSettledInCash" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_LondonInterbankOfferedRateLIBOR1Member" abstract="true" name="LondonInterbankOfferedRateLIBOR1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iff_DuPontdeNemoursIncMember" abstract="true" name="DuPontdeNemoursIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_ForeignCurrencyContractAndInterestRateSwapMember" abstract="true" name="ForeignCurrencyContractAndInterestRateSwapMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation" abstract="false" name="AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_TwoThousandTwentyOneToTwoThousandTwentyThreeCycleMember" abstract="true" name="TwoThousandTwentyOneToTwoThousandTwentyThreeCycleMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iff_SavorySolutionsAndFlavorSpecialtyIngredientsMember" abstract="true" name="SavorySolutionsAndFlavorSpecialtyIngredientsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_InformationTechnologyHardwareAndSoftwareMember" abstract="true" name="InformationTechnologyHardwareAndSoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_AccruedInterestOrPenaltiesRelatedToTaxAmounts" abstract="false" name="AccruedInterestOrPenaltiesRelatedToTaxAmounts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_EarnOutsPayableCurrent" abstract="false" name="EarnOutsPayableCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesPurchasedByEmployees" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesPurchasedByEmployees" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="iff_DifferenceAmountBetweenDilutedNetIncomeLossPerShare" abstract="false" name="DifferenceAmountBetweenDilutedNetIncomeLossPerShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="iff_ZhejiangChinaMember" abstract="true" name="ZhejiangChinaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_ProceedsFromDivestitureOfBusinessesGross" abstract="false" name="ProceedsFromDivestitureOfBusinessesGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_TwoThousandTwentyToTwoThousandTwentyTwoCycleMember" abstract="true" name="TwoThousandTwentyToTwoThousandTwentyTwoCycleMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_StrategicInitiativesCosts" abstract="false" name="StrategicInitiativesCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_StockPurchaseContractMember" abstract="true" name="StockPurchaseContractMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_DefinedContributionAndOtherRetirementPlans" abstract="false" name="DefinedContributionAndOtherRetirementPlans" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_SeniorNotesDueTwoThousandTwentyFiveMember" abstract="true" name="SeniorNotesDueTwoThousandTwentyFiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_SeniorNotesDueTwoThousandTwentySevenMember" abstract="true" name="SeniorNotesDueTwoThousandTwentySevenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_UnusualOrInfrequentItemsOrBothDisclosurePolicyTextBlock" abstract="false" name="UnusualOrInfrequentItemsOrBothDisclosurePolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="iff_TangibleEquityUnitsTextBlock" abstract="false" name="TangibleEquityUnitsTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="iff_OperatingEBITDAMargin" abstract="false" name="OperatingEBITDAMargin" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="iff_DisposalGroupIncludingDiscontinuedOperationConsiderationPayableReceivable" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationConsiderationPayableReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_AccountsReceivablesOutstandingLessThan90Days" abstract="false" name="AccountsReceivablesOutstandingLessThan90Days" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearTwo" abstract="false" name="LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearTwo" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_RestructuringandOtherCharges" abstract="false" name="RestructuringandOtherCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_DisposalGroupIncludingDiscontinuedOperationCashTransferredToBuyer" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationCashTransferredToBuyer" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember" abstract="true" name="SeniorNotesEuroNotesDueTwoThousandTwentySixMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenBasicNetIncomeLossPerShare" abstract="false" name="ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenBasicNetIncomeLossPerShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="iff_CosmeticIngredientsMember" abstract="true" name="CosmeticIngredientsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iff_RedeemableNoncontrollingInterestMember" abstract="true" name="RedeemableNoncontrollingInterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_MalpracticeLossContingencyPaymentsInceptionToDate" abstract="false" name="MalpracticeLossContingencyPaymentsInceptionToDate" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_NonUSTreasuriesOrGovernmentBondsMember" abstract="true" name="NonUSTreasuriesOrGovernmentBondsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_SeniorUnsecuredNotesMember" abstract="true" name="SeniorUnsecuredNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_BrazilTaxCreditsMember" abstract="true" name="BrazilTaxCreditsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_TangibleEquityUnitsConditionsAxis" abstract="true" name="TangibleEquityUnitsConditionsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="iff_BusinessCombinationDivestituresAndIntegrationCosts" abstract="false" name="BusinessCombinationDivestituresAndIntegrationCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_CommitmentsAndContingenciesTable" abstract="true" name="CommitmentsAndContingenciesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="iff_FragranceIngredientsMember" abstract="true" name="FragranceIngredientsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_LiabilityBasedAwardsMember" abstract="true" name="LiabilityBasedAwardsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_PurchasedRestrictedStockUnitMember" abstract="true" name="PurchasedRestrictedStockUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_DisposalGroupIncludingDiscontinuedOperationTransactionCostCredits" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationTransactionCostCredits" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_TangibleEquityRateSettlementRate" abstract="false" name="TangibleEquityRateSettlementRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="iff_BankGuaranteesAndPledgedAssetsToPursueDefensesRelatedToOtherContingencies" abstract="false" name="BankGuaranteesAndPledgedAssetsToPursueDefensesRelatedToOtherContingencies" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_NourishAndHealthBiosciencesMember" abstract="true" name="NourishAndHealthBiosciencesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iff_ProceedsFromDivestitureOfBusinessNet" abstract="false" name="ProceedsFromDivestitureOfBusinessNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_OtherAssetsAndLiabilitiesDisclosureCurrentAndNoncurrentTextBlock" abstract="false" name="OtherAssetsAndLiabilitiesDisclosureCurrentAndNoncurrentTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="iff_EffectiveIncomeTaxRateReconciliationAcquisitionCostsPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationAcquisitionCostsPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="iff_TangibleEquityUnitsLineItems" abstract="true" name="TangibleEquityUnitsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iff_EarnOutsPayableOther" abstract="false" name="EarnOutsPayableOther" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_ScheduleOfFairValueOfPensionPlanAssetsByAssetCategoryTableTableTextBlock" abstract="false" name="ScheduleOfFairValueOfPensionPlanAssetsByAssetCategoryTableTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="iff_TradeAccountsReceivableWithTheCompanysOwnFactoringAgreementsMember" abstract="true" name="TradeAccountsReceivableWithTheCompanysOwnFactoringAgreementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearOne" abstract="false" name="LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearOne" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_NumberOfSegments" abstract="false" name="NumberOfSegments" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:decimalItemType"/>
  <xs:element id="iff_OtherCostsCredits" abstract="false" name="OtherCostsCredits" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_A2022CrossCurrencySwapsMember" abstract="true" name="A2022CrossCurrencySwapsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_CommonStockDividendsPerShareMaximumDividendThresholdPerYear" abstract="false" name="CommonStockDividendsPerShareMaximumDividendThresholdPerYear" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="iff_FragranceCompoundsMember" abstract="true" name="FragranceCompoundsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_CashTransferredToTheBuyerOnTheClosingBalanceSheet" abstract="false" name="CashTransferredToTheBuyerOnTheClosingBalanceSheet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRangeHigh" abstract="false" name="DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRangeHigh" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="iff_RepaymentsOfCommercialPaperMaturingInMoreThanThreeMonths" abstract="false" name="RepaymentsOfCommercialPaperMaturingInMoreThanThreeMonths" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_StockOptionsAndSsarsMember" abstract="true" name="StockOptionsAndSsarsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_DisposalGroupIncludingDiscontinuedOperationTransactionCost" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationTransactionCost" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_DifferenceAmountBetweenBasicNetIncomeLossPerShare" abstract="false" name="DifferenceAmountBetweenBasicNetIncomeLossPerShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="iff_DisposalGroupNotDiscontinuedOperationLiquidationTaxEffect" abstract="false" name="DisposalGroupNotDiscontinuedOperationLiquidationTaxEffect" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_PandemicMember" abstract="true" name="PandemicMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_ConditionOneMember" abstract="true" name="ConditionOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_BusinessCombinationAdjustmentOnCashPayment" abstract="false" name="BusinessCombinationAdjustmentOnCashPayment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_NonUSCorporateBondsMember" abstract="true" name="NonUSCorporateBondsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearThree" abstract="false" name="LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearThree" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRangeLow" abstract="false" name="DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRangeLow" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="iff_BusinessCombinationRestructuringLiabilities" abstract="false" name="BusinessCombinationRestructuringLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_DerivativeNotionalAmountNet" abstract="false" name="DerivativeNotionalAmountNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_CashRestrictedStockUnitMember" abstract="true" name="CashRestrictedStockUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_EntityWideRevenueMajorCustomerNumberOfCustomers" abstract="false" name="EntityWideRevenueMajorCustomerNumberOfCustomers" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="iff_GainContingencyRelocationPaymentsReceived" abstract="false" name="GainContingencyRelocationPaymentsReceived" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_TransitionServicesAgreementTerm" abstract="false" name="TransitionServicesAgreementTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="iff_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenDilutedNetIncomeLossPerShare" abstract="false" name="ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenDilutedNetIncomeLossPerShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="iff_DisposalGroupIncludingDiscontinuedOperationAdvanceReceiptForBusinessToBeTransferred" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationAdvanceReceiptForBusinessToBeTransferred" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_ForeignCurrencyContractsMember" abstract="true" name="ForeignCurrencyContractsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_AccumulatedDefinedBenefitPlansAdjustmentOtherItemsAttributableToParentMember" abstract="true" name="AccumulatedDefinedBenefitPlansAdjustmentOtherItemsAttributableToParentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_AdjustmentsToAdditionalPaidInCapitalDeferredCompensation" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalDeferredCompensation" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_DefinedBenefitPlanAdjustmentsForExpenseOrTaxContainedInServiceCost" abstract="false" name="DefinedBenefitPlanAdjustmentsForExpenseOrTaxContainedInServiceCost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInLongTermRateOfReturnInPensionExpense" abstract="false" name="DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInLongTermRateOfReturnInPensionExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_EffectiveIncomeTaxRateReconciliationTaxBenefitFromSupplyChainOptimizationPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationTaxBenefitFromSupplyChainOptimizationPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="iff_EffectiveIncomeTaxRateReconciliationTaxImpactOnInternalAssetTransferPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationTaxImpactOnInternalAssetTransferPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="iff_FinanceLeaseLiabilityPaymentsDueYearTwoAndThree" abstract="false" name="FinanceLeaseLiabilityPaymentsDueYearTwoAndThree" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_DefinedBenefitPlanAssetsCategoryMember" abstract="true" name="DefinedBenefitPlanAssetsCategoryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_AmortizationPeriodOfInternalAndExternalDevelopmentCosts" abstract="false" name="AmortizationPeriodOfInternalAndExternalDevelopmentCosts" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="iff_StockOptionsOrStockSettledAppreciationRightsMember" abstract="true" name="StockOptionsOrStockSettledAppreciationRightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_BusinessAcquisitionPostCombinationServicePeriod" abstract="false" name="BusinessAcquisitionPostCombinationServicePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="iff_TangibleEquityUnitsInitialPrincipalAmount" abstract="false" name="TangibleEquityUnitsInitialPrincipalAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_AccountsReceivablesOutstandingByOver365Days" abstract="false" name="AccountsReceivablesOutstandingByOver365Days" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="iff_DebtCovenantPeriodDomain" abstract="true" name="DebtCovenantPeriodDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iff_DilutiveSharesQuotientMultiplier" abstract="false" name="DilutiveSharesQuotientMultiplier" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="iff_StockRepurchaseProgramAdditionalAuthorizedAmount" abstract="false" name="StockRepurchaseProgramAdditionalAuthorizedAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_OrganizationAndSummaryOfSignificantAccountingPoliciesTable" abstract="true" name="OrganizationAndSummaryOfSignificantAccountingPoliciesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="iff_ConditionTwoMember" abstract="true" name="ConditionTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_UnrecognizedTaxBenefitsReductionResultingFromLapseOfApplicableStatueOfLimitationsNextTwelveMonths" abstract="false" name="UnrecognizedTaxBenefitsReductionResultingFromLapseOfApplicableStatueOfLimitationsNextTwelveMonths" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_GuangzhouFragrancePlantMember" abstract="true" name="GuangzhouFragrancePlantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_DeferredTaxAssetsLeaseObligations" abstract="false" name="DeferredTaxAssetsLeaseObligations" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_RestructuringAndRelatedCostExpectedNumberOfSitesClosed" abstract="false" name="RestructuringAndRelatedCostExpectedNumberOfSitesClosed" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageReachesAverageRate" abstract="false" name="DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageReachesAverageRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsChangeDueToPerformanceConditions" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsChangeDueToPerformanceConditions" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="iff_IncreaseDecreaseInRedemptionValueRedeemableNoncontrollingInterest" abstract="false" name="IncreaseDecreaseInRedemptionValueRedeemableNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_TwoThousandTwentyThreeToTwoThousandFortyTwoMember" abstract="true" name="TwoThousandTwentyThreeToTwoThousandFortyTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_DebtInstrumentCovenantBasisSpreadIncreaseOnVariableRate" abstract="false" name="DebtInstrumentCovenantBasisSpreadIncreaseOnVariableRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="iff_DefinedBenefitPlanBenefitObligationOther" abstract="false" name="DefinedBenefitPlanBenefitObligationOther" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_FixedAssetWriteDownMember" abstract="true" name="FixedAssetWriteDownMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionExercisableByExercisePriceRangeTableTextBlock" abstract="false" name="ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionExercisableByExercisePriceRangeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="iff_Over65Member" abstract="true" name="Over65Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_TermLoanCreditAgreementMember" abstract="true" name="TermLoanCreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_PensionExpensesTableTextBlock" abstract="false" name="PensionExpensesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="iff_PooledFundsMember" abstract="true" name="PooledFundsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_OperatingAndFinanceLeaseLiability" abstract="false" name="OperatingAndFinanceLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_TangibleEquityUnitsConditionalValue" abstract="false" name="TangibleEquityUnitsConditionalValue" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTerm" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="iff_GainLossOnPlantRelocation" abstract="false" name="GainLossOnPlantRelocation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_FinanceLeaseLiabilityPaymentsDueYearFourAndFive" abstract="false" name="FinanceLeaseLiabilityPaymentsDueYearFourAndFive" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_LossContingencyReceivableWrittenOff" abstract="false" name="LossContingencyReceivableWrittenOff" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_ReceivablesMember" abstract="true" name="ReceivablesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisablePeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisablePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="iff_NoncontrollingInterestDecreaseFromDisposal" abstract="false" name="NoncontrollingInterestDecreaseFromDisposal" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_DisposalGroupIncludingDiscontinuedOperationNetAssets" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationNetAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_ProceedsFromSaleOfAccountsReceivable" abstract="false" name="ProceedsFromSaleOfAccountsReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_HangzhouChinaMember" abstract="true" name="HangzhouChinaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_ZhangjiagangFlavorsPlantMember" abstract="true" name="ZhangjiagangFlavorsPlantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_SharedITCorporateCostsMember" abstract="true" name="SharedITCorporateCostsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsChangeDueToPerformanceConditionsWeightedAverageGrantDateFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsChangeDueToPerformanceConditionsWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="iff_A2026TermLoanMember" abstract="true" name="A2026TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_GainContingencyExpectedRelocationPayments" abstract="false" name="GainContingencyExpectedRelocationPayments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_AbsoluteReturnHedgeFundsMember" abstract="true" name="AbsoluteReturnHedgeFundsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_FiscalQuarterEndingDecember312025Member" abstract="true" name="FiscalQuarterEndingDecember312025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iff_ScentMember" abstract="true" name="ScentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_CosmeticActivesMember" abstract="true" name="CosmeticActivesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_DefinedBenefitPlanAmortizationAndDeferralsNet" abstract="false" name="DefinedBenefitPlanAmortizationAndDeferralsNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_TargetPayoutPeriodOfCycle" abstract="false" name="TargetPayoutPeriodOfCycle" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="iff_BusinessCombinationLeaseAdjustment" abstract="false" name="BusinessCombinationLeaseAdjustment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_LinesOfCreditFacilityTotalAmountDrawnDown" abstract="false" name="LinesOfCreditFacilityTotalAmountDrawnDown" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_A2023RestructuringProgramMember" abstract="true" name="A2023RestructuringProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_PriorServiceCostsFromPlanImprovementsAmortizationPeriodMinimum" abstract="false" name="PriorServiceCostsFromPlanImprovementsAmortizationPeriodMinimum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="iff_RestructuringAndRelatedCostNumberOfSitesClosed" abstract="false" name="RestructuringAndRelatedCostNumberOfSitesClosed" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="iff_FullThreeYearPeriodMember" abstract="true" name="FullThreeYearPeriodMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_FrutaromIntegrationInitiativeMember" abstract="true" name="FrutaromIntegrationInitiativeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_UnrecognizedTaxBenefitsOtherLiabilitiesMember" abstract="true" name="UnrecognizedTaxBenefitsOtherLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_FairValueOfPlanAssetsBeforeReceivablesMember" abstract="true" name="FairValueOfPlanAssetsBeforeReceivablesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_ShareholderActivismRelatedCosts" abstract="false" name="ShareholderActivismRelatedCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_SeniorNotesDueTwoThousandTwentyTwoMember" abstract="true" name="SeniorNotesDueTwoThousandTwentyTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_BusinessCombinationConsiderationTransferredReplacementEquityAwardsIssued" abstract="false" name="BusinessCombinationConsiderationTransferredReplacementEquityAwardsIssued" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_MicrocrystallineCelluloseMember" abstract="true" name="MicrocrystallineCelluloseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_A2015SeveranceInitiativesMember" abstract="true" name="A2015SeveranceInitiativesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_EuroSeniorNotes2016Member" abstract="true" name="EuroSeniorNotes2016Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_RepurchasePriceAsPercentageOfPrincipalAmountOfSeniorNotes" abstract="false" name="RepurchasePriceAsPercentageOfPrincipalAmountOfSeniorNotes" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" abstract="true" name="OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInAccumulatedBenefitObligation" abstract="false" name="DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInAccumulatedBenefitObligation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_NourishMember" abstract="true" name="NourishMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsTable" abstract="true" name="ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="iff_IncomeTaxesLineItems" abstract="true" name="IncomeTaxesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iff_TangibleEquityUnitsAllocationAxis" abstract="true" name="TangibleEquityUnitsAllocationAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="iff_EachTwelveMonthPeriodMember" abstract="true" name="EachTwelveMonthPeriodMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_DefinedBenefitPlanCurtailmentsAndSettlementsBenefitObligation" abstract="false" name="DefinedBenefitPlanCurtailmentsAndSettlementsBenefitObligation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_ReserveforTaxAssessment" abstract="false" name="ReserveforTaxAssessment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_NutritionBiosciencesIncMember" abstract="true" name="NutritionBiosciencesIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_SupplierFinanceProgramPolicyPolicyTextBlock" abstract="false" name="SupplierFinanceProgramPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="iff_BankGuaranteesRelatedToAppealsOnIncomeTaxAndIndirectTaxCases" abstract="false" name="BankGuaranteesRelatedToAppealsOnIncomeTaxAndIndirectTaxCases" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_SegmentAdjustedOperatingEBITDA" abstract="false" name="SegmentAdjustedOperatingEBITDA" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_TwoThousandSixteenToTwoThousandEighteenCycleMember" abstract="true" name="TwoThousandSixteenToTwoThousandEighteenCycleMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_AuditInformationAbstract" abstract="true" name="AuditInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetDollarValueOfAwardIsConvertedToNumberOfNotionalSharesWhenAwardIsGranted" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetDollarValueOfAwardIsConvertedToNumberOfNotionalSharesWhenAwardIsGranted" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="iff_EuroInterbankOfferedRateMember" abstract="true" name="EuroInterbankOfferedRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_SeniorUnsecuredTermLoanFacilitiesMember" abstract="true" name="SeniorUnsecuredTermLoanFacilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_StockRepurchaseProgramRemainingAuthorizedAmendedRepurchaseAmount" abstract="false" name="StockRepurchaseProgramRemainingAuthorizedAmendedRepurchaseAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfSharesAvailableForGrant" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfSharesAvailableForGrant" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="iff_BankBorrowingsAndOverdraftsMember" abstract="true" name="BankBorrowingsAndOverdraftsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_TangibleEquityUnitsAllocationDomain" abstract="true" name="TangibleEquityUnitsAllocationDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_DeferredTaxLiabilitiesRightOfUseAssets" abstract="false" name="DeferredTaxLiabilitiesRightOfUseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingPercentage" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="iff_SharebasedCompensationSharesAuthorizedunderStockOptionPlansExercisePriceRangeExercisableOptionsUpperRangeLimit" abstract="false" name="SharebasedCompensationSharesAuthorizedunderStockOptionPlansExercisePriceRangeExercisableOptionsUpperRangeLimit" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="iff_ShareBasedPaymentArrangementPurchasedRestrictedStockUnitActivityTableTextBlock" abstract="false" name="ShareBasedPaymentArrangementPurchasedRestrictedStockUnitActivityTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="iff_ZhangjiagangChinaMember" abstract="true" name="ZhangjiagangChinaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_TargetPayoutCash" abstract="false" name="TargetPayoutCash" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="iff_USCorporateBondsMember" abstract="true" name="USCorporateBondsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_ScheduleOfAmountsExpectedToBeRecognizedInNetPeriodicCostTableTableTextBlock" abstract="false" name="ScheduleOfAmountsExpectedToBeRecognizedInNetPeriodicCostTableTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="iff_CitibankN.AMember" abstract="true" name="CitibankN.AMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInPensionExpense" abstract="false" name="DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInPensionExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_SeniorNotesDueTwoThousandTwentyThreeMember" abstract="true" name="SeniorNotesDueTwoThousandTwentyThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_DeferredGainLossOnTerminatedInterestRateContracts" abstract="false" name="DeferredGainLossOnTerminatedInterestRateContracts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_OtherComponentsOfOtherNonoperatingIncomeExpense" abstract="false" name="OtherComponentsOfOtherNonoperatingIncomeExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_DisposalGroupNotDiscontinuedOperationTaxEffectOfGainLossFromDivestiture" abstract="false" name="DisposalGroupNotDiscontinuedOperationTaxEffectOfGainLossFromDivestiture" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_DeferredTaxLiabilitiesDeemedRepatriation" abstract="false" name="DeferredTaxLiabilitiesDeemedRepatriation" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_NonUSOtherFixedIncomeMember" abstract="true" name="NonUSOtherFixedIncomeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_GainLossOnChinaFacilityRelocation" abstract="false" name="GainLossOnChinaFacilityRelocation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidAfterYearFive" abstract="false" name="LesseeOperatingAndFinanceLeaseLiabilityToBePaidAfterYearFive" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_DeferredTaxAssetsInterestLimitations" abstract="false" name="DeferredTaxAssetsInterestLimitations" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_AmountOfPledgedAssetsPrincipallyPropertyPlantAndEquipmentToCoverIncomeTaxAndIndirectTaxAssessments" abstract="false" name="AmountOfPledgedAssetsPrincipallyPropertyPlantAndEquipmentToCoverIncomeTaxAndIndirectTaxAssessments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_DisposalGroupNotDiscontinuedOperationGainLossOnLiquidationBeforeIncomeTax" abstract="false" name="DisposalGroupNotDiscontinuedOperationGainLossOnLiquidationBeforeIncomeTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iff_GovernmentAndGovernmentAgencyBondsMember" abstract="true" name="GovernmentAndGovernmentAgencyBondsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_DebtInstrumentCovenantLienThresholdPercentageOfConsolidatedNetTangibleAssets" abstract="false" name="DebtInstrumentCovenantLienThresholdPercentageOfConsolidatedNetTangibleAssets" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="iff_SeniorNotesDueTwoThousandFortyEightMember" abstract="true" name="SeniorNotesDueTwoThousandFortyEightMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_TangibleEquityUnitsConditionsDomain" abstract="true" name="TangibleEquityUnitsConditionsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iff_BusinessAcquisitionNetSales" abstract="false" name="BusinessAcquisitionNetSales" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>iff-20231231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:0b208b7a-5cd8-4cb9-aadf-23532e94abd0,g:23e07c85-fb0b-44f9-a3e5-5e9f1b6ef71a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="iff-20231231.xsd#CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME"/>
  <link:calculationLink xlink:role="http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1ed8b8c9-939c-4e05-b460-ce3c162e4c1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_d26ec5bd-303e-4cb3-a2de-f2b4d202620a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1ed8b8c9-939c-4e05-b460-ce3c162e4c1b" xlink:to="loc_us-gaap_OperatingIncomeLoss_d26ec5bd-303e-4cb3-a2de-f2b4d202620a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_70b9bafd-add8-4bbe-88d2-c5c2b5f5a1f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1ed8b8c9-939c-4e05-b460-ce3c162e4c1b" xlink:to="loc_us-gaap_InterestExpense_70b9bafd-add8-4bbe-88d2-c5c2b5f5a1f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_1b1b73f3-7dfa-48ef-86d2-db299e67fccf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1ed8b8c9-939c-4e05-b460-ce3c162e4c1b" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_1b1b73f3-7dfa-48ef-86d2-db299e67fccf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_eefb39bb-35a6-4a0a-9f2e-b7f9233ca83e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_85c58ae2-34b9-4d41-9ff5-30e9cebd1cae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_eefb39bb-35a6-4a0a-9f2e-b7f9233ca83e" xlink:to="loc_us-gaap_ProfitLoss_85c58ae2-34b9-4d41-9ff5-30e9cebd1cae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8197cec7-de46-42ce-b5c6-0a5d4f7b4644" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_eefb39bb-35a6-4a0a-9f2e-b7f9233ca83e" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8197cec7-de46-42ce-b5c6-0a5d4f7b4644" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_824122a3-9224-40ec-b4e3-3c50b18cfe95" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b8c8d89b-8981-4677-9dd6-53b7302654f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_824122a3-9224-40ec-b4e3-3c50b18cfe95" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b8c8d89b-8981-4677-9dd6-53b7302654f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_d5164887-673b-49ed-9bbd-ba12f27b00f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_824122a3-9224-40ec-b4e3-3c50b18cfe95" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_d5164887-673b-49ed-9bbd-ba12f27b00f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_77400575-c696-402c-a700-9a3ce8f554fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_dbc1bdcd-b852-4204-9d20-8975f82f9ce0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_77400575-c696-402c-a700-9a3ce8f554fb" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_dbc1bdcd-b852-4204-9d20-8975f82f9ce0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_678f0f09-d221-4bb5-80dc-40ec6f664d0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_77400575-c696-402c-a700-9a3ce8f554fb" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_678f0f09-d221-4bb5-80dc-40ec6f664d0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_1edf6bd9-e3a9-4864-ab31-69655e54e21b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_abcf02e6-ddda-45f8-a7c9-a8ce118ded8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_1edf6bd9-e3a9-4864-ab31-69655e54e21b" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_abcf02e6-ddda-45f8-a7c9-a8ce118ded8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_c69cd449-a75e-4926-bdf0-79dc3748dc13" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_1edf6bd9-e3a9-4864-ab31-69655e54e21b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_c69cd449-a75e-4926-bdf0-79dc3748dc13" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_4decb9c9-06c1-49ed-ac9b-ea0c74589a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_1edf6bd9-e3a9-4864-ab31-69655e54e21b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_4decb9c9-06c1-49ed-ac9b-ea0c74589a1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_5d0bcd33-41d2-4bde-8a9d-68b8da34f2ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_1edf6bd9-e3a9-4864-ab31-69655e54e21b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_5d0bcd33-41d2-4bde-8a9d-68b8da34f2ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_71880398-37a3-41e5-a352-20103b4bab31" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_f884edfe-af5e-4039-a0bb-a36f963e51db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_71880398-37a3-41e5-a352-20103b4bab31" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_f884edfe-af5e-4039-a0bb-a36f963e51db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_2dae0751-20db-4799-879d-1d3f4571bf28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_71880398-37a3-41e5-a352-20103b4bab31" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_2dae0751-20db-4799-879d-1d3f4571bf28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_7c564cb6-44e0-4140-b65b-5f6e4aafcfa0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_71880398-37a3-41e5-a352-20103b4bab31" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_7c564cb6-44e0-4140-b65b-5f6e4aafcfa0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_0b142ec3-8668-4de6-8bea-8a4f75328c75" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_71880398-37a3-41e5-a352-20103b4bab31" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_0b142ec3-8668-4de6-8bea-8a4f75328c75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_e339a316-cae1-4272-ba77-a215462de47a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_71880398-37a3-41e5-a352-20103b4bab31" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_e339a316-cae1-4272-ba77-a215462de47a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_RestructuringandOtherCharges_3c21b301-06f1-45af-b199-8c152a4738ee" xlink:href="iff-20231231.xsd#iff_RestructuringandOtherCharges"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_71880398-37a3-41e5-a352-20103b4bab31" xlink:to="loc_iff_RestructuringandOtherCharges_3c21b301-06f1-45af-b199-8c152a4738ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_e3ee8b38-b6bd-4b15-99d2-27081abed668" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_71880398-37a3-41e5-a352-20103b4bab31" xlink:to="loc_us-gaap_GrossProfit_e3ee8b38-b6bd-4b15-99d2-27081abed668" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_f6b84d4f-19cd-4322-9b5f-c30816695745" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_71880398-37a3-41e5-a352-20103b4bab31" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_f6b84d4f-19cd-4322-9b5f-c30816695745" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iff.com/role/CONSOLIDATEDBALANCESHEET" xlink:type="simple" xlink:href="iff-20231231.xsd#CONSOLIDATEDBALANCESHEET"/>
  <link:calculationLink xlink:role="http://www.iff.com/role/CONSOLIDATEDBALANCESHEET" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_3a4c5a59-10a8-4fa4-9c2f-99c74b4f0f97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent_9220961d-c3e8-4307-b755-290faadff486" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_3a4c5a59-10a8-4fa4-9c2f-99c74b4f0f97" xlink:to="loc_us-gaap_DividendsPayableCurrent_9220961d-c3e8-4307-b755-290faadff486" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_d215dffe-d719-41d0-a33f-e5c648b44ef8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_3a4c5a59-10a8-4fa4-9c2f-99c74b4f0f97" xlink:to="loc_us-gaap_AccountsPayableCurrent_d215dffe-d719-41d0-a33f-e5c648b44ef8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_64a1e612-2dc6-4f46-b67b-969b1bf52e59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_3a4c5a59-10a8-4fa4-9c2f-99c74b4f0f97" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_64a1e612-2dc6-4f46-b67b-969b1bf52e59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b70e1523-23f3-4788-951d-98490b61ab6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_3a4c5a59-10a8-4fa4-9c2f-99c74b4f0f97" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b70e1523-23f3-4788-951d-98490b61ab6f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_CommercialPaperCurrent_767bffd3-5c52-47fd-9b0f-4353b13b36d5" xlink:href="iff-20231231.xsd#iff_CommercialPaperCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_3a4c5a59-10a8-4fa4-9c2f-99c74b4f0f97" xlink:to="loc_iff_CommercialPaperCurrent_767bffd3-5c52-47fd-9b0f-4353b13b36d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_41832618-027f-4b08-a151-27276dfabd16" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_3a4c5a59-10a8-4fa4-9c2f-99c74b4f0f97" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_41832618-027f-4b08-a151-27276dfabd16" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_798cd441-7b0c-4b9c-a0d7-10be5b73a15c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_3a4c5a59-10a8-4fa4-9c2f-99c74b4f0f97" xlink:to="loc_us-gaap_DebtCurrent_798cd441-7b0c-4b9c-a0d7-10be5b73a15c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_602adf9b-f472-4698-b052-766aa910f4e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_92678024-f20c-4b6e-85e4-2bf6b6c8bfb7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_602adf9b-f472-4698-b052-766aa910f4e8" xlink:to="loc_us-gaap_CommonStockValue_92678024-f20c-4b6e-85e4-2bf6b6c8bfb7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_0b379250-48a2-4f16-9956-f040863edf48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_602adf9b-f472-4698-b052-766aa910f4e8" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_0b379250-48a2-4f16-9956-f040863edf48" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_448b4e16-186e-46aa-8cf0-0f2f1e9fc97d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_602adf9b-f472-4698-b052-766aa910f4e8" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_448b4e16-186e-46aa-8cf0-0f2f1e9fc97d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4cbf3752-aad9-4934-b588-b05d60c9e8f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_602adf9b-f472-4698-b052-766aa910f4e8" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4cbf3752-aad9-4934-b588-b05d60c9e8f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_095969de-4400-4884-a095-06faaf77608f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_602adf9b-f472-4698-b052-766aa910f4e8" xlink:to="loc_us-gaap_TreasuryStockValue_095969de-4400-4884-a095-06faaf77608f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_6f46fb8d-5361-4141-9f0c-9af49ef290f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_7c87708d-fcd0-42ea-8f9c-57500af84a6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6f46fb8d-5361-4141-9f0c-9af49ef290f0" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_7c87708d-fcd0-42ea-8f9c-57500af84a6f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_2ca1012b-1161-48c6-8ab5-6de6ed1c16e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6f46fb8d-5361-4141-9f0c-9af49ef290f0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_2ca1012b-1161-48c6-8ab5-6de6ed1c16e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e441b606-24e8-4119-b10e-dfa08850cd3a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6f46fb8d-5361-4141-9f0c-9af49ef290f0" xlink:to="loc_us-gaap_Goodwill_e441b606-24e8-4119-b10e-dfa08850cd3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_decbfe0e-b159-436e-adb6-6ce854fb9627" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6f46fb8d-5361-4141-9f0c-9af49ef290f0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_decbfe0e-b159-436e-adb6-6ce854fb9627" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_c411be80-6284-4b17-ba7f-7b5b54a11d8f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6f46fb8d-5361-4141-9f0c-9af49ef290f0" xlink:to="loc_us-gaap_AssetsCurrent_c411be80-6284-4b17-ba7f-7b5b54a11d8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_f3e07b7f-f6e3-4aad-8be5-a98ba21e8e85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6f46fb8d-5361-4141-9f0c-9af49ef290f0" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_f3e07b7f-f6e3-4aad-8be5-a98ba21e8e85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_3f926c9f-baea-4888-9adf-47eaf9310e9d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_026dad11-07e1-44b7-9298-ef442d5706d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3f926c9f-baea-4888-9adf-47eaf9310e9d" xlink:to="loc_us-gaap_ReceivablesNetCurrent_026dad11-07e1-44b7-9298-ef442d5706d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_57ccf10e-d131-4f5d-ba91-3ef9a90644c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3f926c9f-baea-4888-9adf-47eaf9310e9d" xlink:to="loc_us-gaap_OtherAssetsCurrent_57ccf10e-d131-4f5d-ba91-3ef9a90644c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_93572cb7-1761-4bfd-9415-67f3a38d9122" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3f926c9f-baea-4888-9adf-47eaf9310e9d" xlink:to="loc_us-gaap_InventoryNet_93572cb7-1761-4bfd-9415-67f3a38d9122" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c3bbce3e-5c08-435f-a890-8c20ef0ffc2b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3f926c9f-baea-4888-9adf-47eaf9310e9d" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c3bbce3e-5c08-435f-a890-8c20ef0ffc2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_9259c658-c0cd-4f47-8ac6-551cef5576d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3f926c9f-baea-4888-9adf-47eaf9310e9d" xlink:to="loc_us-gaap_RestrictedCashCurrent_9259c658-c0cd-4f47-8ac6-551cef5576d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_a80081a6-29d4-4900-a2c8-0af39ef5da06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3f926c9f-baea-4888-9adf-47eaf9310e9d" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_a80081a6-29d4-4900-a2c8-0af39ef5da06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1c2dda32-29ca-4e51-83ea-ab2ad831ee81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_32e0f34e-d00e-49f7-8e3a-6abba9f006bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1c2dda32-29ca-4e51-83ea-ab2ad831ee81" xlink:to="loc_us-gaap_StockholdersEquity_32e0f34e-d00e-49f7-8e3a-6abba9f006bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_756c7f77-9772-4a15-b564-8d483c712cb3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1c2dda32-29ca-4e51-83ea-ab2ad831ee81" xlink:to="loc_us-gaap_MinorityInterest_756c7f77-9772-4a15-b564-8d483c712cb3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_5c3a5539-d497-47de-afef-b8730f9d07f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_4ee82c0b-c6e9-42d3-8cdf-743db6215592" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_5c3a5539-d497-47de-afef-b8730f9d07f7" xlink:to="loc_us-gaap_LiabilitiesCurrent_4ee82c0b-c6e9-42d3-8cdf-743db6215592" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_74331289-210f-4835-95b1-3aa181162a2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_5c3a5539-d497-47de-afef-b8730f9d07f7" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_74331289-210f-4835-95b1-3aa181162a2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b1d48b37-1890-48b4-8d67-9329fca9f47d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_5c3a5539-d497-47de-afef-b8730f9d07f7" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b1d48b37-1890-48b4-8d67-9329fca9f47d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_9924d942-866e-437a-b654-d2a1bdd6f8a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_5c3a5539-d497-47de-afef-b8730f9d07f7" xlink:to="loc_us-gaap_CommitmentsAndContingencies_9924d942-866e-437a-b654-d2a1bdd6f8a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_92dd46a2-2ca8-4662-8f0e-7947e387d4a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_5c3a5539-d497-47de-afef-b8730f9d07f7" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_92dd46a2-2ca8-4662-8f0e-7947e387d4a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_ea7fc561-9d04-455b-aa5b-b446170d01df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d91f1d35-9461-4a41-82bb-5be51048a8d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_ea7fc561-9d04-455b-aa5b-b446170d01df" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d91f1d35-9461-4a41-82bb-5be51048a8d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_563fd265-efe0-417b-823e-431aeea53959" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_ea7fc561-9d04-455b-aa5b-b446170d01df" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_563fd265-efe0-417b-823e-431aeea53959" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_b3b582c3-17d7-47d6-be38-badc2383a306" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_ea7fc561-9d04-455b-aa5b-b446170d01df" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_b3b582c3-17d7-47d6-be38-badc2383a306" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_11be5153-ad00-454a-8973-78d7c82dcb23" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_ea7fc561-9d04-455b-aa5b-b446170d01df" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_11be5153-ad00-454a-8973-78d7c82dcb23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_ca5be43c-d78d-46e1-bba9-c3b8403aa498" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_ea7fc561-9d04-455b-aa5b-b446170d01df" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_ca5be43c-d78d-46e1-bba9-c3b8403aa498" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS" xlink:type="simple" xlink:href="iff-20231231.xsd#CONSOLIDATEDSTATEMENTOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dad0bfc2-1ed4-44b8-9583-df11808f2d14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_6dbf496b-5cb4-4f12-b320-334ef7fd5b2d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dad0bfc2-1ed4-44b8-9583-df11808f2d14" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_6dbf496b-5cb4-4f12-b320-334ef7fd5b2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_68c12577-1919-434b-9d15-3f076c311c97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dad0bfc2-1ed4-44b8-9583-df11808f2d14" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_68c12577-1919-434b-9d15-3f076c311c97" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts_2a5cc2bd-a71d-463a-8c91-ae3b805cfc10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dad0bfc2-1ed4-44b8-9583-df11808f2d14" xlink:to="loc_us-gaap_PaymentsOfFinancingCosts_2a5cc2bd-a71d-463a-8c91-ae3b805cfc10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_ef641088-246a-45e9-a48a-4f7d0820aad5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dad0bfc2-1ed4-44b8-9583-df11808f2d14" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_ef641088-246a-45e9-a48a-4f7d0820aad5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NetBorrowingsRepaymentsOfCommercialPaperMaturingInLessThanThreeMonths_b28f0c95-690c-4b1a-a396-62c0ba98d3d3" xlink:href="iff-20231231.xsd#iff_NetBorrowingsRepaymentsOfCommercialPaperMaturingInLessThanThreeMonths"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dad0bfc2-1ed4-44b8-9583-df11808f2d14" xlink:to="loc_iff_NetBorrowingsRepaymentsOfCommercialPaperMaturingInLessThanThreeMonths_b28f0c95-690c-4b1a-a396-62c0ba98d3d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_RepaymentsOfCommercialPaperMaturingInMoreThanThreeMonths_4bdfae2a-cb42-4130-9409-cc9a3ac72467" xlink:href="iff-20231231.xsd#iff_RepaymentsOfCommercialPaperMaturingInMoreThanThreeMonths"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dad0bfc2-1ed4-44b8-9583-df11808f2d14" xlink:to="loc_iff_RepaymentsOfCommercialPaperMaturingInMoreThanThreeMonths_4bdfae2a-cb42-4130-9409-cc9a3ac72467" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_c51db570-cf6a-4af3-9f2a-83c927693f57" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dad0bfc2-1ed4-44b8-9583-df11808f2d14" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_c51db570-cf6a-4af3-9f2a-83c927693f57" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_0b7ad68e-9c62-43e3-93ac-a56d257e512b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dad0bfc2-1ed4-44b8-9583-df11808f2d14" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_0b7ad68e-9c62-43e3-93ac-a56d257e512b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ProceedsFromIssuanceOfCommercialPaperMaturingInMoreThanThreeMonths_1c859aa3-7c64-4e7e-b64b-325f35940924" xlink:href="iff-20231231.xsd#iff_ProceedsFromIssuanceOfCommercialPaperMaturingInMoreThanThreeMonths"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dad0bfc2-1ed4-44b8-9583-df11808f2d14" xlink:to="loc_iff_ProceedsFromIssuanceOfCommercialPaperMaturingInMoreThanThreeMonths_1c859aa3-7c64-4e7e-b64b-325f35940924" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_25b2f7d9-14d7-483b-a17c-1104ee746e3a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dad0bfc2-1ed4-44b8-9583-df11808f2d14" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_25b2f7d9-14d7-483b-a17c-1104ee746e3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_5ff53894-a2d4-440b-aec8-cdc6dfc439d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dad0bfc2-1ed4-44b8-9583-df11808f2d14" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_5ff53894-a2d4-440b-aec8-cdc6dfc439d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_8fba2f24-67c5-473a-b402-4a9b9158cd67" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dad0bfc2-1ed4-44b8-9583-df11808f2d14" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_8fba2f24-67c5-473a-b402-4a9b9158cd67" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_f4cb36ea-3712-4790-9e7f-062c322db849" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dad0bfc2-1ed4-44b8-9583-df11808f2d14" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_f4cb36ea-3712-4790-9e7f-062c322db849" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsMinorityInterest_e90fbc79-3802-4ce7-94ea-c5ccaa577c1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividendsMinorityInterest"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dad0bfc2-1ed4-44b8-9583-df11808f2d14" xlink:to="loc_us-gaap_PaymentsOfDividendsMinorityInterest_e90fbc79-3802-4ce7-94ea-c5ccaa577c1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a88ac2f6-dcb4-416f-8375-516f659a8a2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8ab65db6-a405-4c2a-8139-8b00297906c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a88ac2f6-dcb4-416f-8375-516f659a8a2a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8ab65db6-a405-4c2a-8139-8b00297906c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9b32ebff-2092-4f50-b957-06e516ecdcc8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a88ac2f6-dcb4-416f-8375-516f659a8a2a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9b32ebff-2092-4f50-b957-06e516ecdcc8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ceb09207-2717-4c58-9101-241f57e33d8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a88ac2f6-dcb4-416f-8375-516f659a8a2a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ceb09207-2717-4c58-9101-241f57e33d8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_49f403ff-bd71-4ebc-96fe-7af8a840605b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a88ac2f6-dcb4-416f-8375-516f659a8a2a" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_49f403ff-bd71-4ebc-96fe-7af8a840605b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f164efc7-fb95-46a6-8a98-2919efcf5c4c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities_4d13e101-7d1c-4b5a-b7df-73db84b5824e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f164efc7-fb95-46a6-8a98-2919efcf5c4c" xlink:to="loc_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities_4d13e101-7d1c-4b5a-b7df-73db84b5824e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_f8b448a3-852c-4ce5-90e8-44c30756e111" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f164efc7-fb95-46a6-8a98-2919efcf5c4c" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_f8b448a3-852c-4ce5-90e8-44c30756e111" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_e7cdf82d-f303-42e6-8d7d-998b2d914120" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f164efc7-fb95-46a6-8a98-2919efcf5c4c" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_e7cdf82d-f303-42e6-8d7d-998b2d914120" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ProceedsFromBusinessCombination_ffe68c92-213a-4330-bade-d7c490bbb71f" xlink:href="iff-20231231.xsd#iff_ProceedsFromBusinessCombination"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f164efc7-fb95-46a6-8a98-2919efcf5c4c" xlink:to="loc_iff_ProceedsFromBusinessCombination_ffe68c92-213a-4330-bade-d7c490bbb71f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_51cd1793-189d-4b65-a16b-3428800de112" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f164efc7-fb95-46a6-8a98-2919efcf5c4c" xlink:to="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_51cd1793-189d-4b65-a16b-3428800de112" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_497baac5-f7a2-49cd-8957-b222260a93a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f164efc7-fb95-46a6-8a98-2919efcf5c4c" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_497baac5-f7a2-49cd-8957-b222260a93a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_02d34d11-ee62-441a-bcbb-e60d6940454c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f164efc7-fb95-46a6-8a98-2919efcf5c4c" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_02d34d11-ee62-441a-bcbb-e60d6940454c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8500ce56-83eb-4982-92ce-df3a4827e116" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_156d71e5-ebf8-447d-9a17-f7ae26b6fa1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8500ce56-83eb-4982-92ce-df3a4827e116" xlink:to="loc_us-gaap_ShareBasedCompensation_156d71e5-ebf8-447d-9a17-f7ae26b6fa1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_8cbf690e-30c6-4174-9b9f-fb5107697c5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8500ce56-83eb-4982-92ce-df3a4827e116" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_8cbf690e-30c6-4174-9b9f-fb5107697c5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_2dc1afb9-e598-4691-a14f-42ab3cc4eb8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8500ce56-83eb-4982-92ce-df3a4827e116" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_2dc1afb9-e598-4691-a14f-42ab3cc4eb8d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AmortizationOfInventoryStepUp_7eade6b4-605e-4e31-a105-a262f6e4174f" xlink:href="iff-20231231.xsd#iff_AmortizationOfInventoryStepUp"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8500ce56-83eb-4982-92ce-df3a4827e116" xlink:to="loc_iff_AmortizationOfInventoryStepUp_7eade6b4-605e-4e31-a105-a262f6e4174f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_1721ae5a-6cb6-4111-a896-be77848012bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWriteDown"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8500ce56-83eb-4982-92ce-df3a4827e116" xlink:to="loc_us-gaap_InventoryWriteDown_1721ae5a-6cb6-4111-a896-be77848012bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_e2b554a7-1ccc-440c-8114-12b5ca231d6a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8500ce56-83eb-4982-92ce-df3a4827e116" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_e2b554a7-1ccc-440c-8114-12b5ca231d6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_be0ed4f8-a0ab-47ff-a3a7-78f52471e9d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8500ce56-83eb-4982-92ce-df3a4827e116" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_be0ed4f8-a0ab-47ff-a3a7-78f52471e9d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_36c715a4-c383-4a91-aae7-8ce45c83d6ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8500ce56-83eb-4982-92ce-df3a4827e116" xlink:to="loc_us-gaap_ProfitLoss_36c715a4-c383-4a91-aae7-8ce45c83d6ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_c2be20fa-f833-4654-83cd-4dae13ad793e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8500ce56-83eb-4982-92ce-df3a4827e116" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_c2be20fa-f833-4654-83cd-4dae13ad793e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_1e2149f0-dde6-4a35-9288-5a2cecd07838" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8500ce56-83eb-4982-92ce-df3a4827e116" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_1e2149f0-dde6-4a35-9288-5a2cecd07838" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_5b1d28a0-c6aa-403d-b7f4-95b4633be7bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8500ce56-83eb-4982-92ce-df3a4827e116" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_5b1d28a0-c6aa-403d-b7f4-95b4633be7bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_eb6547b7-4518-4e08-8e34-084c109ad3cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8500ce56-83eb-4982-92ce-df3a4827e116" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_eb6547b7-4518-4e08-8e34-084c109ad3cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_62a3c7b0-24d9-4e62-8b38-f6b8406131f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8500ce56-83eb-4982-92ce-df3a4827e116" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_62a3c7b0-24d9-4e62-8b38-f6b8406131f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_1ad28944-2616-4cf2-a8cb-87f3e39d6c5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8500ce56-83eb-4982-92ce-df3a4827e116" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_1ad28944-2616-4cf2-a8cb-87f3e39d6c5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_09cbe00b-ff36-430c-9ff1-b7794c53f54f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8500ce56-83eb-4982-92ce-df3a4827e116" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_09cbe00b-ff36-430c-9ff1-b7794c53f54f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_ffa5f621-6ef5-4798-bb7c-5ab7d0344a38" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8500ce56-83eb-4982-92ce-df3a4827e116" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_ffa5f621-6ef5-4798-bb7c-5ab7d0344a38" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionContributions_c88e8074-f064-4170-9455-6bcfa3aac2af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionContributions"/>
    <link:calculationArc order="17" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8500ce56-83eb-4982-92ce-df3a4827e116" xlink:to="loc_us-gaap_PensionContributions_c88e8074-f064-4170-9455-6bcfa3aac2af" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesScheduleofInventoryDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#NatureofOperationsandSummaryofSignificantAccountingPoliciesScheduleofInventoryDetail"/>
  <link:calculationLink xlink:role="http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesScheduleofInventoryDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_6e1eeb1b-3356-469a-835b-b934730ccb6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_7cca60a2-dab4-45ae-a420-35a9b2c78e87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_6e1eeb1b-3356-469a-835b-b934730ccb6c" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_7cca60a2-dab4-45ae-a420-35a9b2c78e87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_97abf975-8979-4440-8e9c-b14b27d25530" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_6e1eeb1b-3356-469a-835b-b934730ccb6c" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_97abf975-8979-4440-8e9c-b14b27d25530" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_5c3c9a1e-2bdd-4e9d-9877-f127832ce623" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_6e1eeb1b-3356-469a-835b-b934730ccb6c" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_5c3c9a1e-2bdd-4e9d-9877-f127832ce623" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails" xlink:type="simple" xlink:href="iff-20231231.xsd#AcquisitionsNutritionBiosciencesIncDetails"/>
  <link:calculationLink xlink:role="http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_bb5fe95e-af7d-42b7-8449-e7f137d39113" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_6d7d03a9-7ae1-4923-af9a-193419055b09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_bb5fe95e-af7d-42b7-8449-e7f137d39113" xlink:to="loc_us-gaap_Goodwill_6d7d03a9-7ae1-4923-af9a-193419055b09" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_1633a864-57d2-4c9d-a821-1cc6646ce011" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_bb5fe95e-af7d-42b7-8449-e7f137d39113" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_1633a864-57d2-4c9d-a821-1cc6646ce011" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_13dfed6c-764c-42fc-a122-596b2b98a353" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_bb5fe95e-af7d-42b7-8449-e7f137d39113" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_13dfed6c-764c-42fc-a122-596b2b98a353" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_ddde01c1-57a9-4c27-999f-03b142eee313" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_0c0bb55a-fa82-4e29-be78-504d7f30d48a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_ddde01c1-57a9-4c27-999f-03b142eee313" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_0c0bb55a-fa82-4e29-be78-504d7f30d48a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPayrollAndEmployeeBenefits_46d17aaf-789c-4dea-a2f4-c5150d3a5bbd" xlink:href="iff-20231231.xsd#iff_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPayrollAndEmployeeBenefits"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_ddde01c1-57a9-4c27-999f-03b142eee313" xlink:to="loc_iff_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPayrollAndEmployeeBenefits_46d17aaf-789c-4dea-a2f4-c5150d3a5bbd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_e33d293e-5271-4feb-aeed-7e94d727a99d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_ddde01c1-57a9-4c27-999f-03b142eee313" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_e33d293e-5271-4feb-aeed-7e94d727a99d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_888af564-b2e7-4dc4-9e85-9310700a5f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_ddde01c1-57a9-4c27-999f-03b142eee313" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_888af564-b2e7-4dc4-9e85-9310700a5f2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_fff20028-9255-42e6-a37b-c9602a8ac4ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_ddde01c1-57a9-4c27-999f-03b142eee313" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_fff20028-9255-42e6-a37b-c9602a8ac4ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_08167a2c-e1b8-4b27-b41c-f96fc26db077" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_ddde01c1-57a9-4c27-999f-03b142eee313" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_08167a2c-e1b8-4b27-b41c-f96fc26db077" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_ec7bb579-b7d4-4f16-8813-8c30d88a700e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_ddde01c1-57a9-4c27-999f-03b142eee313" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_ec7bb579-b7d4-4f16-8813-8c30d88a700e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_723ac84e-ab0d-4caf-9362-d8c401749145" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_ddde01c1-57a9-4c27-999f-03b142eee313" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_723ac84e-ab0d-4caf-9362-d8c401749145" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_806a29d8-25b0-4825-ac60-6732d13c1de7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_ddde01c1-57a9-4c27-999f-03b142eee313" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_806a29d8-25b0-4825-ac60-6732d13c1de7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_c0c3c358-a611-4d4b-9a6c-e36ee03cc0b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_ddde01c1-57a9-4c27-999f-03b142eee313" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_c0c3c358-a611-4d4b-9a6c-e36ee03cc0b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_2ed880bd-e6af-46e1-bab0-23052e98b05f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_ddde01c1-57a9-4c27-999f-03b142eee313" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_2ed880bd-e6af-46e1-bab0-23052e98b05f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_7cc79f9f-0680-4ea0-b504-a90091808090" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_ddde01c1-57a9-4c27-999f-03b142eee313" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_7cc79f9f-0680-4ea0-b504-a90091808090" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_1dce71ec-b427-4e8d-9509-590390ddfe2d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_ddde01c1-57a9-4c27-999f-03b142eee313" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_1dce71ec-b427-4e8d-9509-590390ddfe2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_08a20633-b70c-4378-92f6-ecbfb9a09f81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BusinessCombinationPensionFundingAdjustment_12d42e31-0438-447e-912d-4cdd2effd1d2" xlink:href="iff-20231231.xsd#iff_BusinessCombinationPensionFundingAdjustment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_08a20633-b70c-4378-92f6-ecbfb9a09f81" xlink:to="loc_iff_BusinessCombinationPensionFundingAdjustment_12d42e31-0438-447e-912d-4cdd2effd1d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_3bb284b8-36bf-4aba-b16a-8a787580f062" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_08a20633-b70c-4378-92f6-ecbfb9a09f81" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_3bb284b8-36bf-4aba-b16a-8a787580f062" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BusinessCombinationConsiderationTransferredReplacementEquityAwardsIssued_5003250e-7af3-4c71-bcb5-b7b5ced4efd9" xlink:href="iff-20231231.xsd#iff_BusinessCombinationConsiderationTransferredReplacementEquityAwardsIssued"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_08a20633-b70c-4378-92f6-ecbfb9a09f81" xlink:to="loc_iff_BusinessCombinationConsiderationTransferredReplacementEquityAwardsIssued_5003250e-7af3-4c71-bcb5-b7b5ced4efd9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iff.com/role/BusinessDivestitureDetails" xlink:type="simple" xlink:href="iff-20231231.xsd#BusinessDivestitureDetails"/>
  <link:calculationLink xlink:role="http://www.iff.com/role/BusinessDivestitureDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_b98e5d75-f22c-4c02-8b19-96e47372aa1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_5fe0bf52-4a89-42a5-b2a6-80e612a6ddba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_b98e5d75-f22c-4c02-8b19-96e47372aa1b" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_5fe0bf52-4a89-42a5-b2a6-80e612a6ddba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_e4cd09b5-6b92-4009-9bff-c8e869a3b5b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_b98e5d75-f22c-4c02-8b19-96e47372aa1b" xlink:to="loc_us-gaap_AccountsPayableCurrent_e4cd09b5-6b92-4009-9bff-c8e869a3b5b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_49274ac4-2e71-4d72-aace-91e1cc1fb5a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_b98e5d75-f22c-4c02-8b19-96e47372aa1b" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_49274ac4-2e71-4d72-aace-91e1cc1fb5a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ProceedsFromDivestitureOfBusinessNet_0c5bd29e-3733-4743-92d7-1d5a74c6d84d" xlink:href="iff-20231231.xsd#iff_ProceedsFromDivestitureOfBusinessNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_CashTransferredToTheBuyerOnTheClosingBalanceSheet_3dbf5c8a-5ef9-45f7-9b61-94e9d3befac9" xlink:href="iff-20231231.xsd#iff_CashTransferredToTheBuyerOnTheClosingBalanceSheet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iff_ProceedsFromDivestitureOfBusinessNet_0c5bd29e-3733-4743-92d7-1d5a74c6d84d" xlink:to="loc_iff_CashTransferredToTheBuyerOnTheClosingBalanceSheet_3dbf5c8a-5ef9-45f7-9b61-94e9d3befac9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupIncludingDiscontinuedOperationCashTransferredToBuyer_08cd0aad-98c0-4a6e-bc00-70a6a8812036" xlink:href="iff-20231231.xsd#iff_DisposalGroupIncludingDiscontinuedOperationCashTransferredToBuyer"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iff_ProceedsFromDivestitureOfBusinessNet_0c5bd29e-3733-4743-92d7-1d5a74c6d84d" xlink:to="loc_iff_DisposalGroupIncludingDiscontinuedOperationCashTransferredToBuyer_08cd0aad-98c0-4a6e-bc00-70a6a8812036" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupIncludingDiscontinuedOperationConsiderationPayableReceivable_a3b8efef-1561-46e9-b086-beb445dc381e" xlink:href="iff-20231231.xsd#iff_DisposalGroupIncludingDiscontinuedOperationConsiderationPayableReceivable"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iff_ProceedsFromDivestitureOfBusinessNet_0c5bd29e-3733-4743-92d7-1d5a74c6d84d" xlink:to="loc_iff_DisposalGroupIncludingDiscontinuedOperationConsiderationPayableReceivable_a3b8efef-1561-46e9-b086-beb445dc381e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_b66e140b-16dd-4160-bd87-3925ae80c7b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iff_ProceedsFromDivestitureOfBusinessNet_0c5bd29e-3733-4743-92d7-1d5a74c6d84d" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_b66e140b-16dd-4160-bd87-3925ae80c7b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EmployeeReimbursementReceivable_4ce833bb-2a57-441d-8e8e-7bb18ad06545" xlink:href="iff-20231231.xsd#iff_EmployeeReimbursementReceivable"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iff_ProceedsFromDivestitureOfBusinessNet_0c5bd29e-3733-4743-92d7-1d5a74c6d84d" xlink:to="loc_iff_EmployeeReimbursementReceivable_4ce833bb-2a57-441d-8e8e-7bb18ad06545" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupIncludingDiscontinuedOperationConsiderationAdvanceReceiptForBusinessToBeTransferred_607333c1-6ca1-4853-8db6-e2fe3e02ca4c" xlink:href="iff-20231231.xsd#iff_DisposalGroupIncludingDiscontinuedOperationConsiderationAdvanceReceiptForBusinessToBeTransferred"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iff_ProceedsFromDivestitureOfBusinessNet_0c5bd29e-3733-4743-92d7-1d5a74c6d84d" xlink:to="loc_iff_DisposalGroupIncludingDiscontinuedOperationConsiderationAdvanceReceiptForBusinessToBeTransferred_607333c1-6ca1-4853-8db6-e2fe3e02ca4c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupIncludingDiscontinuedOperationTransactionCostCredits_f66d8d79-771b-454a-ab5f-7b6a446562d6" xlink:href="iff-20231231.xsd#iff_DisposalGroupIncludingDiscontinuedOperationTransactionCostCredits"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iff_ProceedsFromDivestitureOfBusinessNet_0c5bd29e-3733-4743-92d7-1d5a74c6d84d" xlink:to="loc_iff_DisposalGroupIncludingDiscontinuedOperationTransactionCostCredits_f66d8d79-771b-454a-ab5f-7b6a446562d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_25921a87-ccf9-4268-92ac-dddf51ba8982" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupIncludingDiscontinuedOperationTransactionCost_9a1c436c-5f95-4556-b856-08dd617edaf2" xlink:href="iff-20231231.xsd#iff_DisposalGroupIncludingDiscontinuedOperationTransactionCost"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_25921a87-ccf9-4268-92ac-dddf51ba8982" xlink:to="loc_iff_DisposalGroupIncludingDiscontinuedOperationTransactionCost_9a1c436c-5f95-4556-b856-08dd617edaf2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ProceedsFromDivestitureOfBusinessesGross_35aadffa-82bf-47bc-b6c4-10d6725ea955" xlink:href="iff-20231231.xsd#iff_ProceedsFromDivestitureOfBusinessesGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_25921a87-ccf9-4268-92ac-dddf51ba8982" xlink:to="loc_iff_ProceedsFromDivestitureOfBusinessesGross_35aadffa-82bf-47bc-b6c4-10d6725ea955" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EscrowDeposit_e7b5e23d-f140-4fae-b755-f7d5fb3f20e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EscrowDeposit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_25921a87-ccf9-4268-92ac-dddf51ba8982" xlink:to="loc_us-gaap_EscrowDeposit_e7b5e23d-f140-4fae-b755-f7d5fb3f20e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TransitionServicesAgreementFairValue_78b1706a-3a89-4a0d-b27a-f48d9f4a00ee" xlink:href="iff-20231231.xsd#iff_TransitionServicesAgreementFairValue"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_25921a87-ccf9-4268-92ac-dddf51ba8982" xlink:to="loc_iff_TransitionServicesAgreementFairValue_78b1706a-3a89-4a0d-b27a-f48d9f4a00ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupIncludingDiscontinuedOperationPostClosingAdjustments_5016e27b-b04e-45dd-bd8f-18e5e0b6f1a7" xlink:href="iff-20231231.xsd#iff_DisposalGroupIncludingDiscontinuedOperationPostClosingAdjustments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_25921a87-ccf9-4268-92ac-dddf51ba8982" xlink:to="loc_iff_DisposalGroupIncludingDiscontinuedOperationPostClosingAdjustments_5016e27b-b04e-45dd-bd8f-18e5e0b6f1a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable_4930a0a8-b7b3-4d26-8600-24b08bcfad15" xlink:href="iff-20231231.xsd#iff_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_25921a87-ccf9-4268-92ac-dddf51ba8982" xlink:to="loc_iff_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable_4930a0a8-b7b3-4d26-8600-24b08bcfad15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupIncludingDiscontinuedOperationProceedsAttributableToSupplyAgreement_3cd639a1-3243-4881-9888-b9d253d1fe0c" xlink:href="iff-20231231.xsd#iff_DisposalGroupIncludingDiscontinuedOperationProceedsAttributableToSupplyAgreement"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_25921a87-ccf9-4268-92ac-dddf51ba8982" xlink:to="loc_iff_DisposalGroupIncludingDiscontinuedOperationProceedsAttributableToSupplyAgreement_3cd639a1-3243-4881-9888-b9d253d1fe0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupIncludingDiscontinuedOperationAdvanceReceiptForBusinessToBeTransferred_dd97fb5e-3a38-4a79-8db0-f7c109579fa8" xlink:href="iff-20231231.xsd#iff_DisposalGroupIncludingDiscontinuedOperationAdvanceReceiptForBusinessToBeTransferred"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_25921a87-ccf9-4268-92ac-dddf51ba8982" xlink:to="loc_iff_DisposalGroupIncludingDiscontinuedOperationAdvanceReceiptForBusinessToBeTransferred_dd97fb5e-3a38-4a79-8db0-f7c109579fa8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iff.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetail"/>
  <link:calculationLink xlink:role="http://www.iff.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_c1ed562b-576a-45c5-9b74-c420afe18a3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_32ce9d98-3e69-4ef9-9869-0531e9e9b426" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_c1ed562b-576a-45c5-9b74-c420afe18a3f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_32ce9d98-3e69-4ef9-9869-0531e9e9b426" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_a8dd4acc-01e6-4ffa-8793-2d0727e8ca63" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_c1ed562b-576a-45c5-9b74-c420afe18a3f" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_a8dd4acc-01e6-4ffa-8793-2d0727e8ca63" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetTrademarkandOtherIntangibleAssetsDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#GoodwillandOtherIntangibleAssetsNetTrademarkandOtherIntangibleAssetsDetail"/>
  <link:calculationLink xlink:role="http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetTrademarkandOtherIntangibleAssetsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f546fd37-31bd-4c56-815d-fafcacf91fcd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_b35d73ba-d227-405e-8a00-a0247f3b55aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f546fd37-31bd-4c56-815d-fafcacf91fcd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_b35d73ba-d227-405e-8a00-a0247f3b55aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_9e6979f1-6e23-4186-864e-f2523e313d61" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f546fd37-31bd-4c56-815d-fafcacf91fcd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_9e6979f1-6e23-4186-864e-f2523e313d61" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherAssetsDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherAssetsDetail"/>
  <link:calculationLink xlink:role="http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherAssetsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_a7a0c15d-6dcd-4ede-8ab8-6bdbcdb01809" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValueAddedTaxReceivableCurrent_ffecd180-ff60-4341-b31f-c0be9728a74c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValueAddedTaxReceivableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_a7a0c15d-6dcd-4ede-8ab8-6bdbcdb01809" xlink:to="loc_us-gaap_ValueAddedTaxReceivableCurrent_ffecd180-ff60-4341-b31f-c0be9728a74c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_1efbf2f4-0871-4af7-ae17-82bad70cd23f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_a7a0c15d-6dcd-4ede-8ab8-6bdbcdb01809" xlink:to="loc_us-gaap_IncomeTaxesReceivable_1efbf2f4-0871-4af7-ae17-82bad70cd23f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Supplies_af5a25f6-ad80-4444-a2ac-e0df9eb04623" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Supplies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_a7a0c15d-6dcd-4ede-8ab8-6bdbcdb01809" xlink:to="loc_us-gaap_Supplies_af5a25f6-ad80-4444-a2ac-e0df9eb04623" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_d1c686bc-bf61-46bc-a4a3-4fefc7e3e7ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_a7a0c15d-6dcd-4ede-8ab8-6bdbcdb01809" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_d1c686bc-bf61-46bc-a4a3-4fefc7e3e7ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent_4fa3081f-2641-4402-9cc7-a5fd6d5ff420" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_a7a0c15d-6dcd-4ede-8ab8-6bdbcdb01809" xlink:to="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent_4fa3081f-2641-4402-9cc7-a5fd6d5ff420" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_566438b8-5564-4685-9d88-6f7f403bd4c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_b48af7c9-6c93-40bc-ba08-62b95e547e2b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_566438b8-5564-4685-9d88-6f7f403bd4c5" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_b48af7c9-6c93-40bc-ba08-62b95e547e2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_a0e829de-6cdc-41de-87e3-950782748993" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_566438b8-5564-4685-9d88-6f7f403bd4c5" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_a0e829de-6cdc-41de-87e3-950782748993" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent_237d8190-6f99-40f0-bd51-9e9aa9fe330d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_566438b8-5564-4685-9d88-6f7f403bd4c5" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent_237d8190-6f99-40f0-bd51-9e9aa9fe330d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueOfLifeInsurance_2f5d2c62-b76f-421f-b470-7315665886c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashSurrenderValueOfLifeInsurance"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_566438b8-5564-4685-9d88-6f7f403bd4c5" xlink:to="loc_us-gaap_CashSurrenderValueOfLifeInsurance_2f5d2c62-b76f-421f-b470-7315665886c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_099e61fa-9a84-46e4-a2f5-2175340d1f5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_566438b8-5564-4685-9d88-6f7f403bd4c5" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_099e61fa-9a84-46e4-a2f5-2175340d1f5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_baea4fd7-8cf2-445b-b76d-a14b4b806b7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_566438b8-5564-4685-9d88-6f7f403bd4c5" xlink:to="loc_us-gaap_EquityMethodInvestments_baea4fd7-8cf2-445b-b76d-a14b4b806b7a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="iff-20231231.xsd#OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherCurrentLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_cdaf4094-02ec-4d61-b10d-bacc90e2a3f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_RebatesAndIncentivesPayableCurrent_71651d8e-d851-4f4c-aa7d-705ec854b56a" xlink:href="iff-20231231.xsd#iff_RebatesAndIncentivesPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_cdaf4094-02ec-4d61-b10d-bacc90e2a3f0" xlink:to="loc_iff_RebatesAndIncentivesPayableCurrent_71651d8e-d851-4f4c-aa7d-705ec854b56a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesAndExciseTaxPayableCurrent_72e158c1-b0f6-4eeb-a44e-b5841a6826e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesAndExciseTaxPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_cdaf4094-02ec-4d61-b10d-bacc90e2a3f0" xlink:to="loc_us-gaap_SalesAndExciseTaxPayableCurrent_72e158c1-b0f6-4eeb-a44e-b5841a6826e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_8f887e02-b03e-418c-b81b-9fdde83af484" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPayableCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_cdaf4094-02ec-4d61-b10d-bacc90e2a3f0" xlink:to="loc_us-gaap_InterestPayableCurrent_8f887e02-b03e-418c-b81b-9fdde83af484" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent_0c461eba-9752-4de9-8d6c-fa8437b29327" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_cdaf4094-02ec-4d61-b10d-bacc90e2a3f0" xlink:to="loc_us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent_0c461eba-9752-4de9-8d6c-fa8437b29327" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedInsuranceCurrent_26a54ad2-84f4-43b8-afe6-ae530b7763af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedInsuranceCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_cdaf4094-02ec-4d61-b10d-bacc90e2a3f0" xlink:to="loc_us-gaap_AccruedInsuranceCurrent_26a54ad2-84f4-43b8-afe6-ae530b7763af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EarnOutsPayableCurrent_0063994e-6773-4f53-ad4d-b5f7bc2f2fb9" xlink:href="iff-20231231.xsd#iff_EarnOutsPayableCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_cdaf4094-02ec-4d61-b10d-bacc90e2a3f0" xlink:to="loc_iff_EarnOutsPayableCurrent_0063994e-6773-4f53-ad4d-b5f7bc2f2fb9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_9991acc6-c5d6-4673-9191-502886db9952" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserve"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_cdaf4094-02ec-4d61-b10d-bacc90e2a3f0" xlink:to="loc_us-gaap_RestructuringReserve_9991acc6-c5d6-4673-9191-502886db9952" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_5e2480b0-e4f3-462e-adbd-214dbc4c75ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_cdaf4094-02ec-4d61-b10d-bacc90e2a3f0" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_5e2480b0-e4f3-462e-adbd-214dbc4c75ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AccruedFreightCurrent_b1028da2-4499-4aff-8340-6bd6aa57dc5b" xlink:href="iff-20231231.xsd#iff_AccruedFreightCurrent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_cdaf4094-02ec-4d61-b10d-bacc90e2a3f0" xlink:to="loc_iff_AccruedFreightCurrent_b1028da2-4499-4aff-8340-6bd6aa57dc5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AccruedCommissionsPayableCurrent_3736eb5e-207a-4b72-b4cc-65264787a1b8" xlink:href="iff-20231231.xsd#iff_AccruedCommissionsPayableCurrent"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_cdaf4094-02ec-4d61-b10d-bacc90e2a3f0" xlink:to="loc_iff_AccruedCommissionsPayableCurrent_3736eb5e-207a-4b72-b4cc-65264787a1b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_6b91fe43-5202-4b1a-a44f-dadf97240dac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_cdaf4094-02ec-4d61-b10d-bacc90e2a3f0" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_6b91fe43-5202-4b1a-a44f-dadf97240dac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccountsPayableAndAccruedLiabilities_26a730e4-33fd-42c1-9d5d-8c5d21a01918" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_cdaf4094-02ec-4d61-b10d-bacc90e2a3f0" xlink:to="loc_us-gaap_OtherAccountsPayableAndAccruedLiabilities_26a730e4-33fd-42c1-9d5d-8c5d21a01918" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent_13acef46-5726-4df3-a3a5-20ccba12aa97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_cdaf4094-02ec-4d61-b10d-bacc90e2a3f0" xlink:to="loc_us-gaap_OtherSundryLiabilitiesCurrent_13acef46-5726-4df3-a3a5-20ccba12aa97" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iff.com/role/DebtScheduleofDebtMaturitiesDetails" xlink:type="simple" xlink:href="iff-20231231.xsd#DebtScheduleofDebtMaturitiesDetails"/>
  <link:calculationLink xlink:role="http://www.iff.com/role/DebtScheduleofDebtMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_8ea2d2d3-dbd1-482f-b0fc-d00b4ab17128" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_b086270a-d169-4324-8787-f9d41f78dc53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_8ea2d2d3-dbd1-482f-b0fc-d00b4ab17128" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_b086270a-d169-4324-8787-f9d41f78dc53" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturingInYearsTwoAndThree_aa3c2543-eabd-4103-bea2-4c416c7d9066" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturingInYearsTwoAndThree"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_8ea2d2d3-dbd1-482f-b0fc-d00b4ab17128" xlink:to="loc_us-gaap_LongTermDebtMaturingInYearsTwoAndThree_aa3c2543-eabd-4103-bea2-4c416c7d9066" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturingInYearsFourAndFive_4cbab6b2-4d6e-4a0f-9efc-af3de245e109" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturingInYearsFourAndFive"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_8ea2d2d3-dbd1-482f-b0fc-d00b4ab17128" xlink:to="loc_us-gaap_LongTermDebtMaturingInYearsFourAndFive_4cbab6b2-4d6e-4a0f-9efc-af3de245e109" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_8427bca2-d5ed-406a-b166-1409b1fb3e40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_8ea2d2d3-dbd1-482f-b0fc-d00b4ab17128" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_8427bca2-d5ed-406a-b166-1409b1fb3e40" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iff.com/role/LeasesBalanceSheetDetails" xlink:type="simple" xlink:href="iff-20231231.xsd#LeasesBalanceSheetDetails"/>
  <link:calculationLink xlink:role="http://www.iff.com/role/LeasesBalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_f1bb4fd5-df23-4994-8732-48511f278f0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_ba3e5033-abfd-4fce-8ee1-a237ed112f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_f1bb4fd5-df23-4994-8732-48511f278f0a" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_ba3e5033-abfd-4fce-8ee1-a237ed112f8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_811731a6-7ce2-435e-b1aa-c913687ca8ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_f1bb4fd5-df23-4994-8732-48511f278f0a" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_811731a6-7ce2-435e-b1aa-c913687ca8ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_8aa7f3dc-e31f-4bbe-9d70-bcd53281d884" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_b794f64d-2a91-423a-ba07-6c13cb94c7d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_8aa7f3dc-e31f-4bbe-9d70-bcd53281d884" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_b794f64d-2a91-423a-ba07-6c13cb94c7d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_56c8a94e-aa39-41dd-9fdc-d244119cbebd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_8aa7f3dc-e31f-4bbe-9d70-bcd53281d884" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_56c8a94e-aa39-41dd-9fdc-d244119cbebd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails" xlink:type="simple" xlink:href="iff-20231231.xsd#LeasesScheduleofLeaseMaturitiesDetails"/>
  <link:calculationLink xlink:role="http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6ef38278-b931-4c29-a1fa-622613bc38b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_25c8df55-14c8-4d38-a0df-bd1cb96b29d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6ef38278-b931-4c29-a1fa-622613bc38b9" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_25c8df55-14c8-4d38-a0df-bd1cb96b29d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_488cd83d-3784-4bfd-adb8-8f00794c0565" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6ef38278-b931-4c29-a1fa-622613bc38b9" xlink:to="loc_us-gaap_OperatingLeaseLiability_488cd83d-3784-4bfd-adb8-8f00794c0565" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_67a28179-cfee-4283-8e3f-ae03cd509a62" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_2d6cb7dd-45c5-4504-8c74-147c0bfdee14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_67a28179-cfee-4283-8e3f-ae03cd509a62" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_2d6cb7dd-45c5-4504-8c74-147c0bfdee14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_578239c4-fca7-4a6a-b57e-a842150b10b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_67a28179-cfee-4283-8e3f-ae03cd509a62" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_578239c4-fca7-4a6a-b57e-a842150b10b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_127bbb26-40ca-4548-ba85-b51fa649f418" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_67a28179-cfee-4283-8e3f-ae03cd509a62" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_127bbb26-40ca-4548-ba85-b51fa649f418" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_7bb6d11f-f016-4ccf-92ad-4118a89a2589" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_67a28179-cfee-4283-8e3f-ae03cd509a62" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_7bb6d11f-f016-4ccf-92ad-4118a89a2589" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_5d9c7bdd-62b3-4807-ba74-954f675f16ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_67a28179-cfee-4283-8e3f-ae03cd509a62" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_5d9c7bdd-62b3-4807-ba74-954f675f16ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_6bb15eb9-b3f9-47b1-9a82-a556b719fccb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_67a28179-cfee-4283-8e3f-ae03cd509a62" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_6bb15eb9-b3f9-47b1-9a82-a556b719fccb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_LesseeOperatingAndFinanceLeasePaymentsDue_89888eba-2d34-4115-abf7-7baaa3f501d1" xlink:href="iff-20231231.xsd#iff_LesseeOperatingAndFinanceLeasePaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearOne_2d8fe3e5-8e17-4a85-8ee9-373308b7985f" xlink:href="iff-20231231.xsd#iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearOne"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iff_LesseeOperatingAndFinanceLeasePaymentsDue_89888eba-2d34-4115-abf7-7baaa3f501d1" xlink:to="loc_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearOne_2d8fe3e5-8e17-4a85-8ee9-373308b7985f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidAfterYearFive_9f46988c-338b-4501-b508-f015ae65c3cb" xlink:href="iff-20231231.xsd#iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidAfterYearFive"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iff_LesseeOperatingAndFinanceLeasePaymentsDue_89888eba-2d34-4115-abf7-7baaa3f501d1" xlink:to="loc_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidAfterYearFive_9f46988c-338b-4501-b508-f015ae65c3cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFour_471b0e3e-384c-4efd-a6d3-6f72b0fe76f0" xlink:href="iff-20231231.xsd#iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFour"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iff_LesseeOperatingAndFinanceLeasePaymentsDue_89888eba-2d34-4115-abf7-7baaa3f501d1" xlink:to="loc_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFour_471b0e3e-384c-4efd-a6d3-6f72b0fe76f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearThree_f2ac978c-02da-4ba7-b224-d2575e3aed69" xlink:href="iff-20231231.xsd#iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iff_LesseeOperatingAndFinanceLeasePaymentsDue_89888eba-2d34-4115-abf7-7baaa3f501d1" xlink:to="loc_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearThree_f2ac978c-02da-4ba7-b224-d2575e3aed69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearTwo_0fb02ab4-1f4c-428b-933a-2732cd3baeef" xlink:href="iff-20231231.xsd#iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearTwo"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iff_LesseeOperatingAndFinanceLeasePaymentsDue_89888eba-2d34-4115-abf7-7baaa3f501d1" xlink:to="loc_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearTwo_0fb02ab4-1f4c-428b-933a-2732cd3baeef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFive_da30b8bf-2a1e-443e-b1f1-ac89c12d3847" xlink:href="iff-20231231.xsd#iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iff_LesseeOperatingAndFinanceLeasePaymentsDue_89888eba-2d34-4115-abf7-7baaa3f501d1" xlink:to="loc_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFive_da30b8bf-2a1e-443e-b1f1-ac89c12d3847" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails_1" xlink:type="simple" xlink:href="iff-20231231.xsd#LeasesScheduleofLeaseMaturitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_b364deae-7e92-44ca-825d-ddbf323f53a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_7318e9b7-8c87-4a6a-bd7a-7a0bfc2df67c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_b364deae-7e92-44ca-825d-ddbf323f53a2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_7318e9b7-8c87-4a6a-bd7a-7a0bfc2df67c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_88776ee3-2f59-46fd-ab8e-25a33e0e237d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_b364deae-7e92-44ca-825d-ddbf323f53a2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_88776ee3-2f59-46fd-ab8e-25a33e0e237d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_476db8b1-1c03-4b54-b754-aca4df18cb57" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_b364deae-7e92-44ca-825d-ddbf323f53a2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_476db8b1-1c03-4b54-b754-aca4df18cb57" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_40dbd021-57dd-4e1f-8163-4a8172a74177" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_b364deae-7e92-44ca-825d-ddbf323f53a2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_40dbd021-57dd-4e1f-8163-4a8172a74177" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_be6910ee-eb1a-4fb7-9429-eea29b5cae53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_b364deae-7e92-44ca-825d-ddbf323f53a2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_be6910ee-eb1a-4fb7-9429-eea29b5cae53" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_07b447d0-c5e0-4e16-b40e-e0209c809948" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_b364deae-7e92-44ca-825d-ddbf323f53a2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_07b447d0-c5e0-4e16-b40e-e0209c809948" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_LesseeOperatingAndFinanceLeasePaymentsDue_83efe938-d3a7-4747-905c-67aaf2bd8813" xlink:href="iff-20231231.xsd#iff_LesseeOperatingAndFinanceLeasePaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_LesseeOperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount_f3fb31a3-127b-447f-8046-f42dcbe6cd5f" xlink:href="iff-20231231.xsd#iff_LesseeOperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iff_LesseeOperatingAndFinanceLeasePaymentsDue_83efe938-d3a7-4747-905c-67aaf2bd8813" xlink:to="loc_iff_LesseeOperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount_f3fb31a3-127b-447f-8046-f42dcbe6cd5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_OperatingAndFinanceLeaseLiability_b5c7471a-35b1-4147-9004-c502bec50f65" xlink:href="iff-20231231.xsd#iff_OperatingAndFinanceLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iff_LesseeOperatingAndFinanceLeasePaymentsDue_83efe938-d3a7-4747-905c-67aaf2bd8813" xlink:to="loc_iff_OperatingAndFinanceLeaseLiability_b5c7471a-35b1-4147-9004-c502bec50f65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_f676c8f3-d899-46bf-84ac-52360ca1d760" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_1ec65df0-8037-4db0-b1aa-547e50d21694" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_f676c8f3-d899-46bf-84ac-52360ca1d760" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_1ec65df0-8037-4db0-b1aa-547e50d21694" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_8fd07e44-37f3-4c7f-aa75-a078e2753d46" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_f676c8f3-d899-46bf-84ac-52360ca1d760" xlink:to="loc_us-gaap_FinanceLeaseLiability_8fd07e44-37f3-4c7f-aa75-a078e2753d46" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iff.com/role/IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetail"/>
  <link:calculationLink xlink:role="http://www.iff.com/role/IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2a015f6f-7f37-4ee4-8a1b-19da59a713ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_a071e6d8-a158-4ee9-baa6-4a4794208545" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2a015f6f-7f37-4ee4-8a1b-19da59a713ad" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_a071e6d8-a158-4ee9-baa6-4a4794208545" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_aaacf0d9-ad4d-4df9-b064-715bf55cf26c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2a015f6f-7f37-4ee4-8a1b-19da59a713ad" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_aaacf0d9-ad4d-4df9-b064-715bf55cf26c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iff.com/role/IncomeTaxesScheduleofIncomeTaxProvisionDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#IncomeTaxesScheduleofIncomeTaxProvisionDetail"/>
  <link:calculationLink xlink:role="http://www.iff.com/role/IncomeTaxesScheduleofIncomeTaxProvisionDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_aff54fe9-a43c-4dff-8418-a3079dde1ece" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_87b3e55e-63d1-44c1-8a4d-5102eb4b037a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_aff54fe9-a43c-4dff-8418-a3079dde1ece" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_87b3e55e-63d1-44c1-8a4d-5102eb4b037a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_106c787b-667f-4f39-8cd2-88b926b6c060" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_aff54fe9-a43c-4dff-8418-a3079dde1ece" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_106c787b-667f-4f39-8cd2-88b926b6c060" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_2b3e7776-f97a-470a-8618-c9c967e22e63" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_aff54fe9-a43c-4dff-8418-a3079dde1ece" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_2b3e7776-f97a-470a-8618-c9c967e22e63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e289304a-2e2e-4357-b34e-b5fa073b60c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_b4f8f221-ee61-4fe1-ae69-7ff40d0e2034" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e289304a-2e2e-4357-b34e-b5fa073b60c4" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_b4f8f221-ee61-4fe1-ae69-7ff40d0e2034" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_015ebb6b-ac7c-4fdd-bfc5-cc073fcd280f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e289304a-2e2e-4357-b34e-b5fa073b60c4" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_015ebb6b-ac7c-4fdd-bfc5-cc073fcd280f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_440594c8-2098-4da1-928a-be9575e0993f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e289304a-2e2e-4357-b34e-b5fa073b60c4" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_440594c8-2098-4da1-928a-be9575e0993f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_5cdac69a-56eb-4def-8465-d15a1f45b678" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_1554fba5-86ea-4483-a96f-a6e4a9629996" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_5cdac69a-56eb-4def-8465-d15a1f45b678" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_1554fba5-86ea-4483-a96f-a6e4a9629996" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_05c25cb9-9888-4316-93f2-1e61974103b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_5cdac69a-56eb-4def-8465-d15a1f45b678" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_05c25cb9-9888-4316-93f2-1e61974103b1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iff.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxRateDetails" xlink:type="simple" xlink:href="iff-20231231.xsd#IncomeTaxesReconciliationofEffectiveIncomeTaxRateDetails"/>
  <link:calculationLink xlink:role="http://www.iff.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_83dddca6-2211-4df8-b5f2-a72fbea0b0f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_39d3ec90-db7b-472f-bf75-7fd49bf60975" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_83dddca6-2211-4df8-b5f2-a72fbea0b0f1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_39d3ec90-db7b-472f-bf75-7fd49bf60975" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_94c74330-5edb-4e8e-9aa2-00147696e244" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_83dddca6-2211-4df8-b5f2-a72fbea0b0f1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_94c74330-5edb-4e8e-9aa2-00147696e244" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EffectiveIncomeTaxRateReconciliationDeferredTaxesonDeemedRepatriationPercent_58f6df92-55bf-41ee-98c6-3b29fa7a3d1a" xlink:href="iff-20231231.xsd#iff_EffectiveIncomeTaxRateReconciliationDeferredTaxesonDeemedRepatriationPercent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_83dddca6-2211-4df8-b5f2-a72fbea0b0f1" xlink:to="loc_iff_EffectiveIncomeTaxRateReconciliationDeferredTaxesonDeemedRepatriationPercent_58f6df92-55bf-41ee-98c6-3b29fa7a3d1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent_47573153-1092-49ee-a496-a6e3cb0bd30b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_83dddca6-2211-4df8-b5f2-a72fbea0b0f1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent_47573153-1092-49ee-a496-a6e3cb0bd30b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness_fad17325-ba53-442a-bba5-9a06ed9fc289" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_83dddca6-2211-4df8-b5f2-a72fbea0b0f1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness_fad17325-ba53-442a-bba5-9a06ed9fc289" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_37561334-328b-421f-8c25-3dae17fe1e14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_83dddca6-2211-4df8-b5f2-a72fbea0b0f1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_37561334-328b-421f-8c25-3dae17fe1e14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_9f594684-e93d-4f2b-a21d-2cbb6968232b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_83dddca6-2211-4df8-b5f2-a72fbea0b0f1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_9f594684-e93d-4f2b-a21d-2cbb6968232b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_bf918082-0c40-4d5e-bfdb-955cf5ed75c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_83dddca6-2211-4df8-b5f2-a72fbea0b0f1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_bf918082-0c40-4d5e-bfdb-955cf5ed75c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_faca118f-eb5d-4719-9e20-add65f5128fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_83dddca6-2211-4df8-b5f2-a72fbea0b0f1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_faca118f-eb5d-4719-9e20-add65f5128fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EffectiveIncomeTaxRateReconciliationAcquisitionCostsPercent_ed1f3b43-f310-45c5-a2f4-836b886138d3" xlink:href="iff-20231231.xsd#iff_EffectiveIncomeTaxRateReconciliationAcquisitionCostsPercent"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_83dddca6-2211-4df8-b5f2-a72fbea0b0f1" xlink:to="loc_iff_EffectiveIncomeTaxRateReconciliationAcquisitionCostsPercent_ed1f3b43-f310-45c5-a2f4-836b886138d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiPercent_6d92d0bf-4b98-40ac-8d0d-d1e1ddbaf0bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationGiltiPercent"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_83dddca6-2211-4df8-b5f2-a72fbea0b0f1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiPercent_6d92d0bf-4b98-40ac-8d0d-d1e1ddbaf0bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign_b42a29fe-f37d-471f-9b5d-9e3665d5218d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_83dddca6-2211-4df8-b5f2-a72fbea0b0f1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign_b42a29fe-f37d-471f-9b5d-9e3665d5218d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome_1075bfbb-f5e2-4737-a9d5-0e4bedd04fe9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_83dddca6-2211-4df8-b5f2-a72fbea0b0f1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome_1075bfbb-f5e2-4737-a9d5-0e4bedd04fe9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_b5076a5e-88bc-4f9c-87ac-ac56f3315b59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_83dddca6-2211-4df8-b5f2-a72fbea0b0f1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_b5076a5e-88bc-4f9c-87ac-ac56f3315b59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EffectiveIncomeTaxRateReconciliationTaxBenefitFromSupplyChainOptimizationPercent_25fc708b-8ddc-4d7b-a1c7-0248cdc72753" xlink:href="iff-20231231.xsd#iff_EffectiveIncomeTaxRateReconciliationTaxBenefitFromSupplyChainOptimizationPercent"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_83dddca6-2211-4df8-b5f2-a72fbea0b0f1" xlink:to="loc_iff_EffectiveIncomeTaxRateReconciliationTaxBenefitFromSupplyChainOptimizationPercent_25fc708b-8ddc-4d7b-a1c7-0248cdc72753" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EffectiveIncomeTaxRateReconciliationTaxImpactOnInternalAssetTransferPercent_d7e5c8c9-b3a4-4ec8-9c3d-cb7989cce802" xlink:href="iff-20231231.xsd#iff_EffectiveIncomeTaxRateReconciliationTaxImpactOnInternalAssetTransferPercent"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_83dddca6-2211-4df8-b5f2-a72fbea0b0f1" xlink:to="loc_iff_EffectiveIncomeTaxRateReconciliationTaxImpactOnInternalAssetTransferPercent_d7e5c8c9-b3a4-4ec8-9c3d-cb7989cce802" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iff.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetail"/>
  <link:calculationLink xlink:role="http://www.iff.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_7c5f0e95-e295-4be0-b4ad-5a5ac0cc98b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DeferredTaxLiabilitiesGainLossOnForeignCurrencyTranslation_a6a8b912-2d4b-47be-b585-be9579f3d549" xlink:href="iff-20231231.xsd#iff_DeferredTaxLiabilitiesGainLossOnForeignCurrencyTranslation"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_7c5f0e95-e295-4be0-b4ad-5a5ac0cc98b7" xlink:to="loc_iff_DeferredTaxLiabilitiesGainLossOnForeignCurrencyTranslation_a6a8b912-2d4b-47be-b585-be9579f3d549" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_50d92dd5-d91a-4070-8a30-7700fb31162e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_7c5f0e95-e295-4be0-b4ad-5a5ac0cc98b7" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_50d92dd5-d91a-4070-8a30-7700fb31162e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_9daf9c6a-1957-4f22-8621-ef52e2ec0a37" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_7c5f0e95-e295-4be0-b4ad-5a5ac0cc98b7" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_9daf9c6a-1957-4f22-8621-ef52e2ec0a37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DeferredTaxLiabilitiesDeemedRepatriation_e4e27b57-ca27-4d89-8e4e-7cc682717a68" xlink:href="iff-20231231.xsd#iff_DeferredTaxLiabilitiesDeemedRepatriation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_7c5f0e95-e295-4be0-b4ad-5a5ac0cc98b7" xlink:to="loc_iff_DeferredTaxLiabilitiesDeemedRepatriation_e4e27b57-ca27-4d89-8e4e-7cc682717a68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DeferredTaxLiabilitiesRightOfUseAssets_3d870082-5d6a-4f67-b33e-f19773fdc42d" xlink:href="iff-20231231.xsd#iff_DeferredTaxLiabilitiesRightOfUseAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_7c5f0e95-e295-4be0-b4ad-5a5ac0cc98b7" xlink:to="loc_iff_DeferredTaxLiabilitiesRightOfUseAssets_3d870082-5d6a-4f67-b33e-f19773fdc42d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_f68d0f63-f629-4d7d-ba4b-87e761951824" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_288edbbc-03f4-4654-9e9d-eb43b2548153" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_f68d0f63-f629-4d7d-ba4b-87e761951824" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_288edbbc-03f4-4654-9e9d-eb43b2548153" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_f32ab45e-e14b-4d32-8274-329223d46afd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_f68d0f63-f629-4d7d-ba4b-87e761951824" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_f32ab45e-e14b-4d32-8274-329223d46afd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_16b2e07f-557b-4878-8692-68ecc50e8a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_f68d0f63-f629-4d7d-ba4b-87e761951824" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_16b2e07f-557b-4878-8692-68ecc50e8a1e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_955a9662-0ff9-4ffc-8710-b3efc71161e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits_1eead654-a052-4d68-b889-6471377b77ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_955a9662-0ff9-4ffc-8710-b3efc71161e2" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits_1eead654-a052-4d68-b889-6471377b77ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_86344836-1bde-497d-9696-8b749e12c81c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_955a9662-0ff9-4ffc-8710-b3efc71161e2" xlink:to="loc_us-gaap_OperatingLossCarryforwards_86344836-1bde-497d-9696-8b749e12c81c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_79ce5619-7e26-4382-8396-058ac62df696" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_955a9662-0ff9-4ffc-8710-b3efc71161e2" xlink:to="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_79ce5619-7e26-4382-8396-058ac62df696" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DeferredTaxAssetsInterestLimitations_9357c2eb-2743-4219-95ea-ab586c3cc327" xlink:href="iff-20231231.xsd#iff_DeferredTaxAssetsInterestLimitations"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_955a9662-0ff9-4ffc-8710-b3efc71161e2" xlink:to="loc_iff_DeferredTaxAssetsInterestLimitations_9357c2eb-2743-4219-95ea-ab586c3cc327" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_22281fdd-b608-4d37-af9b-346a9bb30fab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_955a9662-0ff9-4ffc-8710-b3efc71161e2" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_22281fdd-b608-4d37-af9b-346a9bb30fab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DeferredTaxAssetsLeaseObligations_916f4602-b6e6-4c19-846f-342290c36968" xlink:href="iff-20231231.xsd#iff_DeferredTaxAssetsLeaseObligations"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_955a9662-0ff9-4ffc-8710-b3efc71161e2" xlink:to="loc_iff_DeferredTaxAssetsLeaseObligations_916f4602-b6e6-4c19-846f-342290c36968" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_a9186909-d72b-4d3c-8ea7-13598de32564" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_955a9662-0ff9-4ffc-8710-b3efc71161e2" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_a9186909-d72b-4d3c-8ea7-13598de32564" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iff.com/role/NetIncomePerShareReconciliationofSharesUsedinComputationofBasicandDilutedNetIncomePerShareDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#NetIncomePerShareReconciliationofSharesUsedinComputationofBasicandDilutedNetIncomePerShareDetail"/>
  <link:calculationLink xlink:role="http://www.iff.com/role/NetIncomePerShareReconciliationofSharesUsedinComputationofBasicandDilutedNetIncomePerShareDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_iff_NetIncomeLossAvailableToCommonStockholdersAdjustment_767794fc-1049-416d-afca-8e6f1266da6d" xlink:href="iff-20231231.xsd#iff_NetIncomeLossAvailableToCommonStockholdersAdjustment"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_IncreaseDecreaseInRedemptionValueRedeemableNoncontrollingInterest_c117a341-aac4-4bbb-b514-c3fc77cf389c" xlink:href="iff-20231231.xsd#iff_IncreaseDecreaseInRedemptionValueRedeemableNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iff_NetIncomeLossAvailableToCommonStockholdersAdjustment_767794fc-1049-416d-afca-8e6f1266da6d" xlink:to="loc_iff_IncreaseDecreaseInRedemptionValueRedeemableNoncontrollingInterest_c117a341-aac4-4bbb-b514-c3fc77cf389c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_bd701547-1700-4bfb-9306-d943a8c544ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iff_NetIncomeLossAvailableToCommonStockholdersAdjustment_767794fc-1049-416d-afca-8e6f1266da6d" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_bd701547-1700-4bfb-9306-d943a8c544ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_26a7e69d-647f-40f9-8baa-52fc5bf90d19" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_cf6a66ae-b0fb-4b51-a196-039e771ec74d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_26a7e69d-647f-40f9-8baa-52fc5bf90d19" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_cf6a66ae-b0fb-4b51-a196-039e771ec74d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_c235bb11-06fa-499a-b5ce-af2b4fe57e8f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_26a7e69d-647f-40f9-8baa-52fc5bf90d19" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_c235bb11-06fa-499a-b5ce-af2b4fe57e8f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iff.com/role/StockCompensationPlansStockBasedCompensationExpenseIncludedinConsolidatedStatementofIncomeandComprehensiveIncomeDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#StockCompensationPlansStockBasedCompensationExpenseIncludedinConsolidatedStatementofIncomeandComprehensiveIncomeDetail"/>
  <link:calculationLink xlink:role="http://www.iff.com/role/StockCompensationPlansStockBasedCompensationExpenseIncludedinConsolidatedStatementofIncomeandComprehensiveIncomeDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_e7856061-a1c2-4270-817d-b8692057ca3a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_1a9e5744-b658-4739-9533-defd488ff8a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_e7856061-a1c2-4270-817d-b8692057ca3a" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_1a9e5744-b658-4739-9533-defd488ff8a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_17609974-97ad-4c21-bece-5aa7984df712" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_e7856061-a1c2-4270-817d-b8692057ca3a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_17609974-97ad-4c21-bece-5aa7984df712" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iff.com/role/EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail"/>
  <link:calculationLink xlink:role="http://www.iff.com/role/EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_a74d52c9-a27d-421b-af03-8e8056763a6e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_dfbc22d2-11b5-4a64-8606-658d486f605f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_a74d52c9-a27d-421b-af03-8e8056763a6e" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_dfbc22d2-11b5-4a64-8606-658d486f605f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_61eafa2d-b641-49b0-a09a-6227409b02ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_a74d52c9-a27d-421b-af03-8e8056763a6e" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_61eafa2d-b641-49b0-a09a-6227409b02ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_9fc20871-de28-4b9f-9099-0179192bbab3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_a74d52c9-a27d-421b-af03-8e8056763a6e" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_9fc20871-de28-4b9f-9099-0179192bbab3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedBenefitPlanAmortizationAndDeferralsNet_136a54db-f9ef-45c6-9f98-419127da7b40" xlink:href="iff-20231231.xsd#iff_DefinedBenefitPlanAmortizationAndDeferralsNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_a74d52c9-a27d-421b-af03-8e8056763a6e" xlink:to="loc_iff_DefinedBenefitPlanAmortizationAndDeferralsNet_136a54db-f9ef-45c6-9f98-419127da7b40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_c61a02f5-df8d-4d6f-8274-3c7ed14941d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_a74d52c9-a27d-421b-af03-8e8056763a6e" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_c61a02f5-df8d-4d6f-8274-3c7ed14941d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_8046cca3-53f4-4094-bba5-fe0e2b904deb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax_c2f0420d-5767-4868-acf7-0c1a5c2ffee6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_8046cca3-53f4-4094-bba5-fe0e2b904deb" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax_c2f0420d-5767-4868-acf7-0c1a5c2ffee6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_40707ee4-43f4-4197-bed6-2ae02575fba1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_8046cca3-53f4-4094-bba5-fe0e2b904deb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_40707ee4-43f4-4197-bed6-2ae02575fba1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_07c1acf2-fcc3-4b35-a6a8-ed35068b9c14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_8046cca3-53f4-4094-bba5-fe0e2b904deb" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_07c1acf2-fcc3-4b35-a6a8-ed35068b9c14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax_b188842a-db7d-4360-a69e-f7d2f5f3295e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_8046cca3-53f4-4094-bba5-fe0e2b904deb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax_b188842a-db7d-4360-a69e-f7d2f5f3295e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_02fc12eb-12ef-4d01-a6de-ed4035514d8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_8046cca3-53f4-4094-bba5-fe0e2b904deb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_02fc12eb-12ef-4d01-a6de-ed4035514d8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitExpense_6d39bb29-ee81-4d4e-a044-513e5bb298c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementBenefitExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2748cbbe-6218-4378-81d0-f047249b05a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitExpense_6d39bb29-ee81-4d4e-a044-513e5bb298c8" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2748cbbe-6218-4378-81d0-f047249b05a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedContributionAndOtherRetirementPlans_06c68adb-c5bb-4b39-af62-05ae8b740aca" xlink:href="iff-20231231.xsd#iff_DefinedContributionAndOtherRetirementPlans"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitExpense_6d39bb29-ee81-4d4e-a044-513e5bb298c8" xlink:to="loc_iff_DefinedContributionAndOtherRetirementPlans_06c68adb-c5bb-4b39-af62-05ae8b740aca" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iff.com/role/EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail"/>
  <link:calculationLink xlink:role="http://www.iff.com/role/EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_77b9269a-ad5c-408d-b5b6-335133772382" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_720371cc-db85-4ecd-b1c9-d9be9587af26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_77b9269a-ad5c-408d-b5b6-335133772382" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_720371cc-db85-4ecd-b1c9-d9be9587af26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_00dcdb96-a1ae-45b9-b6f6-38cbbb1c41ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_77b9269a-ad5c-408d-b5b6-335133772382" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_00dcdb96-a1ae-45b9-b6f6-38cbbb1c41ad" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinBalanceSheetDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#EmployeeBenefitsAmountsRecognizedinBalanceSheetDetail"/>
  <link:calculationLink xlink:role="http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinBalanceSheetDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_4ff13d94-f8f2-4cf8-9c8f-f7a22e23b556" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_f73230e8-86a5-4867-ab7c-1ba6a4078632" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_4ff13d94-f8f2-4cf8-9c8f-f7a22e23b556" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_f73230e8-86a5-4867-ab7c-1ba6a4078632" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_216d8e01-1a23-4a9a-b25c-1a950e54bae0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_4ff13d94-f8f2-4cf8-9c8f-f7a22e23b556" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_216d8e01-1a23-4a9a-b25c-1a950e54bae0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_6e5f795c-09ca-40ba-ac69-5d2c154b16de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_4ff13d94-f8f2-4cf8-9c8f-f7a22e23b556" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_6e5f795c-09ca-40ba-ac69-5d2c154b16de" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetail"/>
  <link:calculationLink xlink:role="http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_3c293f71-9d57-40e7-85d7-2e684229aa36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_fee5a7b8-77d5-4619-b70d-02f5f9cd9748" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_3c293f71-9d57-40e7-85d7-2e684229aa36" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_fee5a7b8-77d5-4619-b70d-02f5f9cd9748" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_95776937-debd-4cd9-80bf-661357494ae3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_3c293f71-9d57-40e7-85d7-2e684229aa36" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_95776937-debd-4cd9-80bf-661357494ae3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossReclassificationsofAccumulatedOtherComprehensiveIncometoConsolidatedStatementofComprehensiveIncomeDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#AccumulatedOtherComprehensiveIncomeLossReclassificationsofAccumulatedOtherComprehensiveIncometoConsolidatedStatementofComprehensiveIncomeDetail"/>
  <link:calculationLink xlink:role="http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossReclassificationsofAccumulatedOtherComprehensiveIncometoConsolidatedStatementofComprehensiveIncomeDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_1936cb1e-2c16-443f-af6a-e74bba681cae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_03d80f62-7bb7-4411-a511-8e20018fe599" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_1936cb1e-2c16-443f-af6a-e74bba681cae" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_03d80f62-7bb7-4411-a511-8e20018fe599" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_3418ea85-abd6-4274-b967-6ba33ffc986e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_1936cb1e-2c16-443f-af6a-e74bba681cae" xlink:to="loc_us-gaap_InterestExpense_3418ea85-abd6-4274-b967-6ba33ffc986e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_dde95e71-680f-4dc6-96b1-8de9b993c4f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_1936cb1e-2c16-443f-af6a-e74bba681cae" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_dde95e71-680f-4dc6-96b1-8de9b993c4f0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossReclassificationsofAccumulatedOtherComprehensiveIncometoConsolidatedStatementofComprehensiveIncomeDetail_1" xlink:type="simple" xlink:href="iff-20231231.xsd#AccumulatedOtherComprehensiveIncomeLossReclassificationsofAccumulatedOtherComprehensiveIncometoConsolidatedStatementofComprehensiveIncomeDetail_1"/>
  <link:calculationLink xlink:role="http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossReclassificationsofAccumulatedOtherComprehensiveIncometoConsolidatedStatementofComprehensiveIncomeDetail_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_964fa885-48c7-4e65-9db1-f92e9e4130a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_db073268-8f2e-4556-a063-9569909aa741" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_964fa885-48c7-4e65-9db1-f92e9e4130a9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_db073268-8f2e-4556-a063-9569909aa741" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_1949aba8-e2b3-46b2-95be-9b452cd3b0d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_964fa885-48c7-4e65-9db1-f92e9e4130a9" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_1949aba8-e2b3-46b2-95be-9b452cd3b0d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_9be82341-29f2-4d09-bc7a-a904ce63aa3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_964fa885-48c7-4e65-9db1-f92e9e4130a9" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_9be82341-29f2-4d09-bc7a-a904ce63aa3c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleDetails" xlink:type="simple" xlink:href="iff-20231231.xsd#AssetsandLiabilitiesHeldForSaleDetails"/>
  <link:calculationLink xlink:role="http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_6a3c4528-a3a4-4c24-808c-4f0f15f05f21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities_0f0e051a-23ab-4483-872c-441afb7d31dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_6a3c4528-a3a4-4c24-808c-4f0f15f05f21" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities_0f0e051a-23ab-4483-872c-441afb7d31dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_1c9d2776-2ad1-48e4-8505-4ebcbaefaba8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_6a3c4528-a3a4-4c24-808c-4f0f15f05f21" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_1c9d2776-2ad1-48e4-8505-4ebcbaefaba8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_a6c738b8-b2a9-4a6e-b3d1-272b824f562f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_6a3c4528-a3a4-4c24-808c-4f0f15f05f21" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_a6c738b8-b2a9-4a6e-b3d1-272b824f562f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_aab26a7c-2dea-433d-80ec-f93c81cc9b80" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_1aa5c7c1-fa74-423e-a921-d75d8ab050db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_aab26a7c-2dea-433d-80ec-f93c81cc9b80" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_1aa5c7c1-fa74-423e-a921-d75d8ab050db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_bb145402-eb32-43fc-9da1-e58d7098a655" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_aab26a7c-2dea-433d-80ec-f93c81cc9b80" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_bb145402-eb32-43fc-9da1-e58d7098a655" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_42db8d70-cd61-465b-97ab-ffcfbcd958be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_aab26a7c-2dea-433d-80ec-f93c81cc9b80" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_42db8d70-cd61-465b-97ab-ffcfbcd958be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_cde08141-5a5f-4956-a30c-9b8a0753a467" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_aab26a7c-2dea-433d-80ec-f93c81cc9b80" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_cde08141-5a5f-4956-a30c-9b8a0753a467" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupIncludingDiscontinuedOperationTradeReceivablesNet_c4b4e5d0-849e-4a60-b646-085bfa502311" xlink:href="iff-20231231.xsd#iff_DisposalGroupIncludingDiscontinuedOperationTradeReceivablesNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_aab26a7c-2dea-433d-80ec-f93c81cc9b80" xlink:to="loc_iff_DisposalGroupIncludingDiscontinuedOperationTradeReceivablesNet_c4b4e5d0-849e-4a60-b646-085bfa502311" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_990dd710-6e6d-4ab8-b256-50c29353433e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_aab26a7c-2dea-433d-80ec-f93c81cc9b80" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_990dd710-6e6d-4ab8-b256-50c29353433e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_53301b59-3fe9-4647-95df-45208d7384fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_aab26a7c-2dea-433d-80ec-f93c81cc9b80" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_53301b59-3fe9-4647-95df-45208d7384fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_7a8b95a0-38d4-4d77-a060-7b0cc09e17f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_aab26a7c-2dea-433d-80ec-f93c81cc9b80" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_7a8b95a0-38d4-4d77-a060-7b0cc09e17f6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iff.com/role/OtherExpenseIncomeNetDetails" xlink:type="simple" xlink:href="iff-20231231.xsd#OtherExpenseIncomeNetDetails"/>
  <link:calculationLink xlink:role="http://www.iff.com/role/OtherExpenseIncomeNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_842d025e-f76c-4608-b95a-9713a09bd7b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_40be19bb-0aaa-4c4e-9b87-e5f1acda517c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_842d025e-f76c-4608-b95a-9713a09bd7b2" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_40be19bb-0aaa-4c4e-9b87-e5f1acda517c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_e3c4ddc5-a271-44ff-a642-035b516c9a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_842d025e-f76c-4608-b95a-9713a09bd7b2" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_e3c4ddc5-a271-44ff-a642-035b516c9a1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_GainLossOnChinaFacilityRelocation_1da6216e-8ad2-4dd2-9bdf-d4aec37e1447" xlink:href="iff-20231231.xsd#iff_GainLossOnChinaFacilityRelocation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_842d025e-f76c-4608-b95a-9713a09bd7b2" xlink:to="loc_iff_GainLossOnChinaFacilityRelocation_1da6216e-8ad2-4dd2-9bdf-d4aec37e1447" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_6a82c1cd-9bad-4bef-a198-f2f90cce1f6a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_842d025e-f76c-4608-b95a-9713a09bd7b2" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_6a82c1cd-9bad-4bef-a198-f2f90cce1f6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_OtherComponentsOfOtherNonoperatingIncomeExpense_0298cc19-675b-4d35-a677-63988384cff2" xlink:href="iff-20231231.xsd#iff_OtherComponentsOfOtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_842d025e-f76c-4608-b95a-9713a09bd7b2" xlink:to="loc_iff_OtherComponentsOfOtherNonoperatingIncomeExpense_0298cc19-675b-4d35-a677-63988384cff2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_a2cdbfeb-61f9-4c64-b223-5a6197eef6a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_842d025e-f76c-4608-b95a-9713a09bd7b2" xlink:to="loc_us-gaap_InvestmentIncomeInterest_a2cdbfeb-61f9-4c64-b223-5a6197eef6a1" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>iff-20231231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:0b208b7a-5cd8-4cb9-aadf-23532e94abd0,g:23e07c85-fb0b-44f9-a3e5-5e9f1b6ef71a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.iff.com/role/CoverPage" xlink:type="simple" xlink:href="iff-20231231.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_ebfb42fc-4c8e-4cd4-81aa-d0808b8c1b64" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_DocumentInformationTable_ebfb42fc-4c8e-4cd4-81aa-d0808b8c1b64" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1897cad8-a980-4ef4-a5a2-1bc85f3723b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_ebfb42fc-4c8e-4cd4-81aa-d0808b8c1b64" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1897cad8-a980-4ef4-a5a2-1bc85f3723b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_1897cad8-a980-4ef4-a5a2-1bc85f3723b6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1897cad8-a980-4ef4-a5a2-1bc85f3723b6" xlink:to="loc_us-gaap_ClassOfStockDomain_1897cad8-a980-4ef4-a5a2-1bc85f3723b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_dd46a53f-39a2-47b7-876f-6a527af56ddb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1897cad8-a980-4ef4-a5a2-1bc85f3723b6" xlink:to="loc_us-gaap_ClassOfStockDomain_dd46a53f-39a2-47b7-876f-6a527af56ddb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_cdbd69c6-56eb-4da3-bf99-117784b14ff4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_dd46a53f-39a2-47b7-876f-6a527af56ddb" xlink:to="loc_us-gaap_CommonStockMember_cdbd69c6-56eb-4da3-bf99-117784b14ff4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_A1.750SeniorNotesDue2024Member_b7d4aed0-25bb-4469-89c4-71521f4dce23" xlink:href="iff-20231231.xsd#iff_A1.750SeniorNotesDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_dd46a53f-39a2-47b7-876f-6a527af56ddb" xlink:to="loc_iff_A1.750SeniorNotesDue2024Member_b7d4aed0-25bb-4469-89c4-71521f4dce23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_A1.800SeniorNotesDue2026Member_b90bbdde-9e3d-47a6-bd95-808a7ce84c96" xlink:href="iff-20231231.xsd#iff_A1.800SeniorNotesDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_dd46a53f-39a2-47b7-876f-6a527af56ddb" xlink:to="loc_iff_A1.800SeniorNotesDue2026Member_b90bbdde-9e3d-47a6-bd95-808a7ce84c96" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_4bbef374-8abb-48ec-b40d-20cec347e94b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_ebfb42fc-4c8e-4cd4-81aa-d0808b8c1b64" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_4bbef374-8abb-48ec-b40d-20cec347e94b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_4bbef374-8abb-48ec-b40d-20cec347e94b_default" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_4bbef374-8abb-48ec-b40d-20cec347e94b" xlink:to="loc_dei_AddressTypeDomain_4bbef374-8abb-48ec-b40d-20cec347e94b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_1d95a69e-9942-4429-a56c-0d5da7ef9003" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_4bbef374-8abb-48ec-b40d-20cec347e94b" xlink:to="loc_dei_AddressTypeDomain_1d95a69e-9942-4429-a56c-0d5da7ef9003" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_OtherAddressMember_dafc47c4-4ecb-4b48-96c4-b8fc467c20c6" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherAddressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_AddressTypeDomain_1d95a69e-9942-4429-a56c-0d5da7ef9003" xlink:to="loc_dei_OtherAddressMember_dafc47c4-4ecb-4b48-96c4-b8fc467c20c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_d47b2c20-4a98-47fc-863c-7408c9c8cb04" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_DocumentType_d47b2c20-4a98-47fc-863c-7408c9c8cb04" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_7ac24b03-07a3-4fb6-b494-7f2532b8a5bf" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_DocumentAnnualReport_7ac24b03-07a3-4fb6-b494-7f2532b8a5bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_57c3bfcd-3473-4613-bb01-8c7e00bc02a1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_DocumentPeriodEndDate_57c3bfcd-3473-4613-bb01-8c7e00bc02a1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_94cab76e-f7dc-4e63-8b40-8b7a803887ff" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_CurrentFiscalYearEndDate_94cab76e-f7dc-4e63-8b40-8b7a803887ff" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_a5294a99-8095-4b11-9f65-660656fe8e80" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_DocumentTransitionReport_a5294a99-8095-4b11-9f65-660656fe8e80" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_0d959dda-3617-4163-82df-c27bf5cbd0cd" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_EntityFileNumber_0d959dda-3617-4163-82df-c27bf5cbd0cd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_e86993db-8857-4295-825e-8dad80e5a816" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_EntityRegistrantName_e86993db-8857-4295-825e-8dad80e5a816" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_c6ab3f96-d349-4646-abfa-139306be1491" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_EntityCentralIndexKey_c6ab3f96-d349-4646-abfa-139306be1491" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_f6a92611-7a1a-4180-b2b3-d1850d7a9489" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_DocumentFiscalYearFocus_f6a92611-7a1a-4180-b2b3-d1850d7a9489" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_2284d63d-f6fd-4c92-bc77-de2ec2ad008b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_DocumentFiscalPeriodFocus_2284d63d-f6fd-4c92-bc77-de2ec2ad008b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_f0a0d801-c0a1-4982-917b-caace96db7fa" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_AmendmentFlag_f0a0d801-c0a1-4982-917b-caace96db7fa" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_13ef29cb-9309-4ed2-b92e-a869e2c8f0f4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_EntityIncorporationStateCountryCode_13ef29cb-9309-4ed2-b92e-a869e2c8f0f4" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_d0427821-d5c6-4779-920c-e2c86e15bc78" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_EntityTaxIdentificationNumber_d0427821-d5c6-4779-920c-e2c86e15bc78" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_78b9d812-2017-4ee9-a522-fbde7f17ced5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_EntityAddressAddressLine1_78b9d812-2017-4ee9-a522-fbde7f17ced5" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_c4f85636-49b8-4e34-a51d-10818b4d68ad" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_EntityAddressCityOrTown_c4f85636-49b8-4e34-a51d-10818b4d68ad" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_a6fd1152-48cc-4877-98a7-02491a6349b3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_EntityAddressStateOrProvince_a6fd1152-48cc-4877-98a7-02491a6349b3" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_dbfe1a16-216a-4219-8821-73743ea018a0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_EntityAddressPostalZipCode_dbfe1a16-216a-4219-8821-73743ea018a0" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_27f310ab-e411-461c-8afd-efad43814eff" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_CityAreaCode_27f310ab-e411-461c-8afd-efad43814eff" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_76a91cea-9bff-45c0-b391-5e3e35db268e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_LocalPhoneNumber_76a91cea-9bff-45c0-b391-5e3e35db268e" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_08dee9f1-c102-4a09-8e5c-23be343f8721" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_Security12bTitle_08dee9f1-c102-4a09-8e5c-23be343f8721" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_ab3a75ab-aee9-4569-a89e-4ce835b0c86c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_TradingSymbol_ab3a75ab-aee9-4569-a89e-4ce835b0c86c" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_da078dbf-25e7-4849-be3c-1699bb074873" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_SecurityExchangeName_da078dbf-25e7-4849-be3c-1699bb074873" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_7f9f1a16-0021-4e77-8af5-d7ddb0fe44fe" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_7f9f1a16-0021-4e77-8af5-d7ddb0fe44fe" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_6bc47fbb-6524-47fb-816a-d1f31a0de8ed" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_EntityVoluntaryFilers_6bc47fbb-6524-47fb-816a-d1f31a0de8ed" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_b3027adc-4460-4620-9f26-844f42e901be" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_EntityCurrentReportingStatus_b3027adc-4460-4620-9f26-844f42e901be" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_ac217b41-0bf9-4f29-af32-95d8ab2bf01f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_EntityInteractiveDataCurrent_ac217b41-0bf9-4f29-af32-95d8ab2bf01f" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_af3c49a2-0c5c-4a0c-8efd-455bac946497" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_EntityFilerCategory_af3c49a2-0c5c-4a0c-8efd-455bac946497" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_6f46ffad-f23c-49c4-8506-51119234b43f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_EntitySmallBusiness_6f46ffad-f23c-49c4-8506-51119234b43f" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_14fd5a29-58e7-4f71-a8f0-b79ba9ea179e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_EntityEmergingGrowthCompany_14fd5a29-58e7-4f71-a8f0-b79ba9ea179e" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_0f9f0801-f090-4a93-9a6e-e0145d1af82c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_IcfrAuditorAttestationFlag_0f9f0801-f090-4a93-9a6e-e0145d1af82c" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_57ff8681-9ce3-4c23-afc8-9e1d3ddeef59" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_EntityShellCompany_57ff8681-9ce3-4c23-afc8-9e1d3ddeef59" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_3302b35c-0dc9-47da-90a6-c229bbc79613" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_EntityPublicFloat_3302b35c-0dc9-47da-90a6-c229bbc79613" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_135173f1-468b-4e90-98e6-b836d915dc48" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_135173f1-468b-4e90-98e6-b836d915dc48" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_d66abdbd-99fc-4283-a531-0dd9038826a0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_d66abdbd-99fc-4283-a531-0dd9038826a0" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag_aee09ff4-8577-4055-bf93-d5edcf6ccbf7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_DocumentFinStmtErrorCorrectionFlag_aee09ff4-8577-4055-bf93-d5edcf6ccbf7" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag_8477d86e-d56f-4a3c-9353-0615c2d4f34d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtRestatementRecoveryAnalysisFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag_8477d86e-d56f-4a3c-9353-0615c2d4f34d" xlink:type="arc" order="35"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY" xlink:type="simple" xlink:href="iff-20231231.xsd#CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_42a75bb2-fcd0-4188-b3f5-ab462983f720" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_20f481a3-8948-4455-bd20-92fda26d5864" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_42a75bb2-fcd0-4188-b3f5-ab462983f720" xlink:to="loc_us-gaap_StatementTable_20f481a3-8948-4455-bd20-92fda26d5864" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_14a78eca-3075-49c9-955b-07184e4ab94c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_20f481a3-8948-4455-bd20-92fda26d5864" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_14a78eca-3075-49c9-955b-07184e4ab94c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_14a78eca-3075-49c9-955b-07184e4ab94c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_14a78eca-3075-49c9-955b-07184e4ab94c" xlink:to="loc_us-gaap_EquityComponentDomain_14a78eca-3075-49c9-955b-07184e4ab94c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f2c19b30-eed7-43a0-a02f-577da1a613a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_14a78eca-3075-49c9-955b-07184e4ab94c" xlink:to="loc_us-gaap_EquityComponentDomain_f2c19b30-eed7-43a0-a02f-577da1a613a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_7d0aa8f4-14c0-4b31-acf8-b3ce5010cd47" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f2c19b30-eed7-43a0-a02f-577da1a613a6" xlink:to="loc_us-gaap_CommonStockMember_7d0aa8f4-14c0-4b31-acf8-b3ce5010cd47" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_7a27c90c-c0b1-490a-b94a-cd9c2f02f9d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f2c19b30-eed7-43a0-a02f-577da1a613a6" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_7a27c90c-c0b1-490a-b94a-cd9c2f02f9d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_730d134f-850c-408b-b692-ad284f4e2a48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f2c19b30-eed7-43a0-a02f-577da1a613a6" xlink:to="loc_us-gaap_RetainedEarningsMember_730d134f-850c-408b-b692-ad284f4e2a48" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9503bb81-127b-455e-86a2-8b7770621b2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f2c19b30-eed7-43a0-a02f-577da1a613a6" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9503bb81-127b-455e-86a2-8b7770621b2c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_5ccbddf2-55b6-4509-b748-aefccc8c8bac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f2c19b30-eed7-43a0-a02f-577da1a613a6" xlink:to="loc_us-gaap_TreasuryStockCommonMember_5ccbddf2-55b6-4509-b748-aefccc8c8bac" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_43b936ec-793a-45a1-a425-3c03196b4509" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f2c19b30-eed7-43a0-a02f-577da1a613a6" xlink:to="loc_us-gaap_NoncontrollingInterestMember_43b936ec-793a-45a1-a425-3c03196b4509" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b04f925-8ee6-432c-985c-3ab539070cd2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_42a75bb2-fcd0-4188-b3f5-ab462983f720" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b04f925-8ee6-432c-985c-3ab539070cd2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_bcad983e-569c-43f1-968e-598923a2c591" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b04f925-8ee6-432c-985c-3ab539070cd2" xlink:to="loc_us-gaap_SharesOutstanding_bcad983e-569c-43f1-968e-598923a2c591" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_04bcf33b-3a39-4fb9-a865-50a6b3fd5652" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b04f925-8ee6-432c-985c-3ab539070cd2" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_04bcf33b-3a39-4fb9-a865-50a6b3fd5652" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_10dcb2db-9217-40d3-b794-6b39e464acf9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b04f925-8ee6-432c-985c-3ab539070cd2" xlink:to="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_10dcb2db-9217-40d3-b794-6b39e464acf9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_e54907b0-efb1-4da3-b9c0-02f6323a1c7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b04f925-8ee6-432c-985c-3ab539070cd2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_e54907b0-efb1-4da3-b9c0-02f6323a1c7f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_49176e0b-9514-4672-958c-4ec23be855c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b04f925-8ee6-432c-985c-3ab539070cd2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_49176e0b-9514-4672-958c-4ec23be855c3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_4ff2abcc-4487-4bdb-98ab-e8c16ed25f95" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b04f925-8ee6-432c-985c-3ab539070cd2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_4ff2abcc-4487-4bdb-98ab-e8c16ed25f95" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_e769169b-8eb0-476a-b072-f02e6a89cae3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b04f925-8ee6-432c-985c-3ab539070cd2" xlink:to="loc_us-gaap_DividendsCommonStockCash_e769169b-8eb0-476a-b072-f02e6a89cae3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_419d1798-de81-42ec-80ff-354259385fa9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b04f925-8ee6-432c-985c-3ab539070cd2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_419d1798-de81-42ec-80ff-354259385fa9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_89604052-b9f6-481f-926c-84228d527fba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b04f925-8ee6-432c-985c-3ab539070cd2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_89604052-b9f6-481f-926c-84228d527fba" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_b9569477-8c64-4797-9b3a-a85ee7e93b2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b04f925-8ee6-432c-985c-3ab539070cd2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_b9569477-8c64-4797-9b3a-a85ee7e93b2c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_0eb95cc3-6fbb-4401-8a65-244185b30f27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b04f925-8ee6-432c-985c-3ab539070cd2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_0eb95cc3-6fbb-4401-8a65-244185b30f27" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_c4bd911c-f2a6-48c0-b034-ce007d311b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b04f925-8ee6-432c-985c-3ab539070cd2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_c4bd911c-f2a6-48c0-b034-ce007d311b9b" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_af7f5e25-e600-4e68-b7e7-fe9cb9ab63ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b04f925-8ee6-432c-985c-3ab539070cd2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_af7f5e25-e600-4e68-b7e7-fe9cb9ab63ab" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_a4ab4886-3bae-4318-b287-7fecfedf8856" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b04f925-8ee6-432c-985c-3ab539070cd2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_a4ab4886-3bae-4318-b287-7fecfedf8856" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_ff2bb80a-c540-4202-a36a-f9feef68c2b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b04f925-8ee6-432c-985c-3ab539070cd2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_ff2bb80a-c540-4202-a36a-f9feef68c2b6" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4f2618b6-1868-4746-b648-44edc605f7a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b04f925-8ee6-432c-985c-3ab539070cd2" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4f2618b6-1868-4746-b648-44edc605f7a9" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_56de3d06-b4c7-45a2-a501-8019c177eeac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b04f925-8ee6-432c-985c-3ab539070cd2" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_56de3d06-b4c7-45a2-a501-8019c177eeac" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_c2498ee4-af1a-4bd7-a076-3c986c266ace" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b04f925-8ee6-432c-985c-3ab539070cd2" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_c2498ee4-af1a-4bd7-a076-3c986c266ace" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_224e1c4c-5f45-46c1-af3a-c8090331fb59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b04f925-8ee6-432c-985c-3ab539070cd2" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_224e1c4c-5f45-46c1-af3a-c8090331fb59" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_ebb38968-58b1-40ab-a22d-e9206252ff73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5c6ebe73-85b6-4484-bfaf-a5ba1b2b2629" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_18562c7c-49fa-4c4e-9403-00e30eaddac3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_42a75bb2-fcd0-4188-b3f5-ab462983f720" xlink:to="loc_us-gaap_TreasuryStockCommonShares_18562c7c-49fa-4c4e-9403-00e30eaddac3" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/DebtTables" xlink:type="simple" xlink:href="iff-20231231.xsd#DebtTables"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/DebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_76e56df4-b911-4667-aba5-faf8385acb1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionTable_2497f438-c093-44e3-abd3-91268d1dbcb6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_76e56df4-b911-4667-aba5-faf8385acb1b" xlink:to="loc_us-gaap_DebtInstrumentRedemptionTable_2497f438-c093-44e3-abd3-91268d1dbcb6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e89b0cd0-ae55-4ba0-87aa-3d3841ec798a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentRedemptionTable_2497f438-c093-44e3-abd3-91268d1dbcb6" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e89b0cd0-ae55-4ba0-87aa-3d3841ec798a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e89b0cd0-ae55-4ba0-87aa-3d3841ec798a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e89b0cd0-ae55-4ba0-87aa-3d3841ec798a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e89b0cd0-ae55-4ba0-87aa-3d3841ec798a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_85106d62-adb9-403d-bfd3-16b3770a178f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e89b0cd0-ae55-4ba0-87aa-3d3841ec798a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_85106d62-adb9-403d-bfd3-16b3770a178f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NutritionBiosciencesIncMember_77b74bc1-e82a-4bda-85c2-6a644bed2925" xlink:href="iff-20231231.xsd#iff_NutritionBiosciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_85106d62-adb9-403d-bfd3-16b3770a178f" xlink:to="loc_iff_NutritionBiosciencesIncMember_77b74bc1-e82a-4bda-85c2-6a644bed2925" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_b7c8a511-b52e-476d-a373-b67f5b1dfdc7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_76e56df4-b911-4667-aba5-faf8385acb1b" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_b7c8a511-b52e-476d-a373-b67f5b1dfdc7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionTableTextBlock_6099e8a0-7574-4cdb-bcf5-5231a02d5849" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_76e56df4-b911-4667-aba5-faf8385acb1b" xlink:to="loc_us-gaap_DebtInstrumentRedemptionTableTextBlock_6099e8a0-7574-4cdb-bcf5-5231a02d5849" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_d0d557c7-d303-43d9-8abb-d08b819c6e3d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_76e56df4-b911-4667-aba5-faf8385acb1b" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_d0d557c7-d303-43d9-8abb-d08b819c6e3d" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:href="iff-20231231.xsd#iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_fff5ec03-9964-4706-9263-2a01b683ab4f" xlink:href="iff-20231231.xsd#iff_OrganizationAndSummaryOfSignificantAccountingPoliciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_fff5ec03-9964-4706-9263-2a01b683ab4f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_5d8eb3cf-d0d2-44a2-a78b-2ff0bd7b35a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_fff5ec03-9964-4706-9263-2a01b683ab4f" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_5d8eb3cf-d0d2-44a2-a78b-2ff0bd7b35a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_5d8eb3cf-d0d2-44a2-a78b-2ff0bd7b35a1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_5d8eb3cf-d0d2-44a2-a78b-2ff0bd7b35a1" xlink:to="loc_us-gaap_ReceivableTypeDomain_5d8eb3cf-d0d2-44a2-a78b-2ff0bd7b35a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_7cc98c90-18f2-4a20-921d-1876127592cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_5d8eb3cf-d0d2-44a2-a78b-2ff0bd7b35a1" xlink:to="loc_us-gaap_ReceivableTypeDomain_7cc98c90-18f2-4a20-921d-1876127592cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TradeAccountsReceivableWithFactoringAgreementsMember_b281b5b5-5ab1-41f6-a7d8-95e538d88380" xlink:href="iff-20231231.xsd#iff_TradeAccountsReceivableWithFactoringAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_7cc98c90-18f2-4a20-921d-1876127592cc" xlink:to="loc_iff_TradeAccountsReceivableWithFactoringAgreementsMember_b281b5b5-5ab1-41f6-a7d8-95e538d88380" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TradeAccountsReceivableWithTheCompanysOwnFactoringAgreementsMember_8e7fe6e1-f263-4dc3-9356-15743a4fb8ab" xlink:href="iff-20231231.xsd#iff_TradeAccountsReceivableWithTheCompanysOwnFactoringAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_7cc98c90-18f2-4a20-921d-1876127592cc" xlink:to="loc_iff_TradeAccountsReceivableWithTheCompanysOwnFactoringAgreementsMember_8e7fe6e1-f263-4dc3-9356-15743a4fb8ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_06e4d1d5-f81a-4d97-90bd-8a8116568b6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_fff5ec03-9964-4706-9263-2a01b683ab4f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_06e4d1d5-f81a-4d97-90bd-8a8116568b6f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_06e4d1d5-f81a-4d97-90bd-8a8116568b6f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_06e4d1d5-f81a-4d97-90bd-8a8116568b6f" xlink:to="loc_us-gaap_EquityComponentDomain_06e4d1d5-f81a-4d97-90bd-8a8116568b6f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_83221f3b-2a22-4ee1-815e-8e6f21dd7b7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_06e4d1d5-f81a-4d97-90bd-8a8116568b6f" xlink:to="loc_us-gaap_EquityComponentDomain_83221f3b-2a22-4ee1-815e-8e6f21dd7b7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_6860fe5a-996b-420a-ac6a-4a7780eca394" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_83221f3b-2a22-4ee1-815e-8e6f21dd7b7a" xlink:to="loc_us-gaap_RetainedEarningsMember_6860fe5a-996b-420a-ac6a-4a7780eca394" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_0584a602-696d-4e42-a8dd-6cc3f4769a10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_fff5ec03-9964-4706-9263-2a01b683ab4f" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_0584a602-696d-4e42-a8dd-6cc3f4769a10" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_0584a602-696d-4e42-a8dd-6cc3f4769a10_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_0584a602-696d-4e42-a8dd-6cc3f4769a10" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_0584a602-696d-4e42-a8dd-6cc3f4769a10_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_15baf339-d2cf-460c-8071-41e346de963c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_0584a602-696d-4e42-a8dd-6cc3f4769a10" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_15baf339-d2cf-460c-8071-41e346de963c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_93cc8b0b-b96e-462a-96b1-46c44b5bd903" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_fff5ec03-9964-4706-9263-2a01b683ab4f" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_93cc8b0b-b96e-462a-96b1-46c44b5bd903" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_93cc8b0b-b96e-462a-96b1-46c44b5bd903_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_93cc8b0b-b96e-462a-96b1-46c44b5bd903" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_93cc8b0b-b96e-462a-96b1-46c44b5bd903_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_549ced6a-4286-46e3-85ff-89f7626fb902" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_93cc8b0b-b96e-462a-96b1-46c44b5bd903" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_549ced6a-4286-46e3-85ff-89f7626fb902" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_75803e35-a86c-4655-b939-93cafc46699b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_549ced6a-4286-46e3-85ff-89f7626fb902" xlink:to="loc_us-gaap_RetainedEarningsMember_75803e35-a86c-4655-b939-93cafc46699b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_22198719-1bc5-4e4e-80be-b675fe70855c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_fff5ec03-9964-4706-9263-2a01b683ab4f" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_22198719-1bc5-4e4e-80be-b675fe70855c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_22198719-1bc5-4e4e-80be-b675fe70855c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_22198719-1bc5-4e4e-80be-b675fe70855c" xlink:to="loc_us-gaap_TypeOfAdoptionMember_22198719-1bc5-4e4e-80be-b675fe70855c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_8af24614-8cc6-4bf9-ae59-098e8b64672e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_22198719-1bc5-4e4e-80be-b675fe70855c" xlink:to="loc_us-gaap_TypeOfAdoptionMember_8af24614-8cc6-4bf9-ae59-098e8b64672e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_5b67db85-b7a1-4ad1-9707-7f2a5b7df98e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_8af24614-8cc6-4bf9-ae59-098e8b64672e" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_5b67db85-b7a1-4ad1-9707-7f2a5b7df98e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201712Member_eb5da3fd-36f4-4e1c-8c27-3c9198530d9b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingStandardsUpdate201712Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_8af24614-8cc6-4bf9-ae59-098e8b64672e" xlink:to="loc_us-gaap_AccountingStandardsUpdate201712Member_eb5da3fd-36f4-4e1c-8c27-3c9198530d9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member_f1533d9c-a83d-40f4-94f0-70aa6a68f59b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_8af24614-8cc6-4bf9-ae59-098e8b64672e" xlink:to="loc_us-gaap_AccountingStandardsUpdate201613Member_f1533d9c-a83d-40f4-94f0-70aa6a68f59b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_1638e8c8-a983-4b0c-a1bd-b46046243a88" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_fff5ec03-9964-4706-9263-2a01b683ab4f" xlink:to="loc_srt_StatementScenarioAxis_1638e8c8-a983-4b0c-a1bd-b46046243a88" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_1638e8c8-a983-4b0c-a1bd-b46046243a88_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_1638e8c8-a983-4b0c-a1bd-b46046243a88" xlink:to="loc_srt_ScenarioUnspecifiedDomain_1638e8c8-a983-4b0c-a1bd-b46046243a88_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_9fa45d6f-14bd-475c-8377-ced924fa93e9" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_1638e8c8-a983-4b0c-a1bd-b46046243a88" xlink:to="loc_srt_ScenarioUnspecifiedDomain_9fa45d6f-14bd-475c-8377-ced924fa93e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e2362cd3-bac7-4898-8ef0-ecf6a4724ca4" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_fff5ec03-9964-4706-9263-2a01b683ab4f" xlink:to="loc_srt_RangeAxis_e2362cd3-bac7-4898-8ef0-ecf6a4724ca4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e2362cd3-bac7-4898-8ef0-ecf6a4724ca4_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_e2362cd3-bac7-4898-8ef0-ecf6a4724ca4" xlink:to="loc_srt_RangeMember_e2362cd3-bac7-4898-8ef0-ecf6a4724ca4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ce196187-f20f-4506-8b7c-95495df304e1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_e2362cd3-bac7-4898-8ef0-ecf6a4724ca4" xlink:to="loc_srt_RangeMember_ce196187-f20f-4506-8b7c-95495df304e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_60ee3c5e-f1fd-4a31-a43b-a154e2141ff0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ce196187-f20f-4506-8b7c-95495df304e1" xlink:to="loc_srt_MinimumMember_60ee3c5e-f1fd-4a31-a43b-a154e2141ff0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4be55c7c-e398-46cd-88cb-54435439dc4f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ce196187-f20f-4506-8b7c-95495df304e1" xlink:to="loc_srt_MaximumMember_4be55c7c-e398-46cd-88cb-54435439dc4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1cb7c5a0-c35f-40c6-b273-814eb47b26b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_fff5ec03-9964-4706-9263-2a01b683ab4f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1cb7c5a0-c35f-40c6-b273-814eb47b26b3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1cb7c5a0-c35f-40c6-b273-814eb47b26b3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1cb7c5a0-c35f-40c6-b273-814eb47b26b3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1cb7c5a0-c35f-40c6-b273-814eb47b26b3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_35ec04e2-76c3-4baf-87d2-9e194ca97c87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1cb7c5a0-c35f-40c6-b273-814eb47b26b3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_35ec04e2-76c3-4baf-87d2-9e194ca97c87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BuildingsAndImprovementsMember_03412518-1cd5-4c73-b3f4-b5777494e9be" xlink:href="iff-20231231.xsd#iff_BuildingsAndImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_35ec04e2-76c3-4baf-87d2-9e194ca97c87" xlink:to="loc_iff_BuildingsAndImprovementsMember_03412518-1cd5-4c73-b3f4-b5777494e9be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_8a2f4b22-1004-4e3a-aec6-9c56850a6d64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_35ec04e2-76c3-4baf-87d2-9e194ca97c87" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_8a2f4b22-1004-4e3a-aec6-9c56850a6d64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_InformationTechnologyHardwareAndSoftwareMember_416b2811-b104-4295-8ec7-6f5b6604d63d" xlink:href="iff-20231231.xsd#iff_InformationTechnologyHardwareAndSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_35ec04e2-76c3-4baf-87d2-9e194ca97c87" xlink:to="loc_iff_InformationTechnologyHardwareAndSoftwareMember_416b2811-b104-4295-8ec7-6f5b6604d63d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_bbb63c32-105f-4b51-8ac2-86d6f5ebb7d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_fff5ec03-9964-4706-9263-2a01b683ab4f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_bbb63c32-105f-4b51-8ac2-86d6f5ebb7d5" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bbb63c32-105f-4b51-8ac2-86d6f5ebb7d5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_bbb63c32-105f-4b51-8ac2-86d6f5ebb7d5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bbb63c32-105f-4b51-8ac2-86d6f5ebb7d5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ada2d51a-a00c-48db-a1a4-168054292d0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_bbb63c32-105f-4b51-8ac2-86d6f5ebb7d5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ada2d51a-a00c-48db-a1a4-168054292d0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_47938dfe-e3e5-47e7-9f83-8a44ab3d4408" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ada2d51a-a00c-48db-a1a4-168054292d0d" xlink:to="loc_us-gaap_CustomerRelationshipsMember_47938dfe-e3e5-47e7-9f83-8a44ab3d4408" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_8b36f4eb-615d-474e-a160-3de3740734b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PatentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ada2d51a-a00c-48db-a1a4-168054292d0d" xlink:to="loc_us-gaap_PatentsMember_8b36f4eb-615d-474e-a160-3de3740734b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_4d86f36e-93da-4138-82d8-12fcfa4fac0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ada2d51a-a00c-48db-a1a4-168054292d0d" xlink:to="loc_us-gaap_TradeNamesMember_4d86f36e-93da-4138-82d8-12fcfa4fac0a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntellectualPropertyMember_f70c9d99-5c5f-4be8-a7ec-a0b949ae80a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntellectualPropertyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ada2d51a-a00c-48db-a1a4-168054292d0d" xlink:to="loc_us-gaap_IntellectualPropertyMember_f70c9d99-5c5f-4be8-a7ec-a0b949ae80a9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_b4eecaff-9d01-4ccd-bebb-a2dcaa820875" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_fff5ec03-9964-4706-9263-2a01b683ab4f" xlink:to="loc_srt_RestatementAxis_b4eecaff-9d01-4ccd-bebb-a2dcaa820875" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_b4eecaff-9d01-4ccd-bebb-a2dcaa820875_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_b4eecaff-9d01-4ccd-bebb-a2dcaa820875" xlink:to="loc_srt_RestatementDomain_b4eecaff-9d01-4ccd-bebb-a2dcaa820875_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_a4db8031-c70e-4dfb-bd99-538d3a689c93" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_b4eecaff-9d01-4ccd-bebb-a2dcaa820875" xlink:to="loc_srt_RestatementDomain_a4db8031-c70e-4dfb-bd99-538d3a689c93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_2d7c408a-cdc2-44da-823e-fa6009bef995" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_a4db8031-c70e-4dfb-bd99-538d3a689c93" xlink:to="loc_srt_RestatementAdjustmentMember_2d7c408a-cdc2-44da-823e-fa6009bef995" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_5f9411cb-9344-4f29-bcba-9e0b5a870a46" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_a4db8031-c70e-4dfb-bd99-538d3a689c93" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_5f9411cb-9344-4f29-bcba-9e0b5a870a46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForCatastropheClaimsByCatastrophicEventAxis_c96e9f2a-fbf4-4620-a470-9614c6238404" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForCatastropheClaimsByCatastrophicEventAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_fff5ec03-9964-4706-9263-2a01b683ab4f" xlink:to="loc_us-gaap_LiabilityForCatastropheClaimsByCatastrophicEventAxis_c96e9f2a-fbf4-4620-a470-9614c6238404" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CatastrophicEventDomain_c96e9f2a-fbf4-4620-a470-9614c6238404_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CatastrophicEventDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LiabilityForCatastropheClaimsByCatastrophicEventAxis_c96e9f2a-fbf4-4620-a470-9614c6238404" xlink:to="loc_us-gaap_CatastrophicEventDomain_c96e9f2a-fbf4-4620-a470-9614c6238404_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CatastrophicEventDomain_615422ba-c4fd-4616-be78-3c565b811035" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CatastrophicEventDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LiabilityForCatastropheClaimsByCatastrophicEventAxis_c96e9f2a-fbf4-4620-a470-9614c6238404" xlink:to="loc_us-gaap_CatastrophicEventDomain_615422ba-c4fd-4616-be78-3c565b811035" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_PandemicMember_81e99fbe-adba-4d87-8175-66eb22a0e859" xlink:href="iff-20231231.xsd#iff_PandemicMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CatastrophicEventDomain_615422ba-c4fd-4616-be78-3c565b811035" xlink:to="loc_iff_PandemicMember_81e99fbe-adba-4d87-8175-66eb22a0e859" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_7da11f3f-a16c-40e1-93ed-d71ac391e306" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_fff5ec03-9964-4706-9263-2a01b683ab4f" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_7da11f3f-a16c-40e1-93ed-d71ac391e306" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_7da11f3f-a16c-40e1-93ed-d71ac391e306_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_7da11f3f-a16c-40e1-93ed-d71ac391e306" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_7da11f3f-a16c-40e1-93ed-d71ac391e306_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_e0c9aeb9-0e4a-4910-844d-cf2837ea5cb8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_7da11f3f-a16c-40e1-93ed-d71ac391e306" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_e0c9aeb9-0e4a-4910-844d-cf2837ea5cb8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_3c4decf5-e94d-4516-b295-810a2314b031" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_e0c9aeb9-0e4a-4910-844d-cf2837ea5cb8" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_3c4decf5-e94d-4516-b295-810a2314b031" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_cad93ed7-0086-4188-8b78-f538d9038338" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_fff5ec03-9964-4706-9263-2a01b683ab4f" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_cad93ed7-0086-4188-8b78-f538d9038338" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_cad93ed7-0086-4188-8b78-f538d9038338_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_cad93ed7-0086-4188-8b78-f538d9038338" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_cad93ed7-0086-4188-8b78-f538d9038338_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_2dc7538d-3cdf-4485-ab01-2001ccb7b994" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_cad93ed7-0086-4188-8b78-f538d9038338" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_2dc7538d-3cdf-4485-ab01-2001ccb7b994" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_RussiaUkraineWarMember_8aab6cb3-b394-4357-a4d4-0e0d56d56d7a" xlink:href="iff-20231231.xsd#iff_RussiaUkraineWarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_2dc7538d-3cdf-4485-ab01-2001ccb7b994" xlink:to="loc_iff_RussiaUkraineWarMember_8aab6cb3-b394-4357-a4d4-0e0d56d56d7a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_790ea133-1769-4081-8003-29f6d47c15e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_fff5ec03-9964-4706-9263-2a01b683ab4f" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_790ea133-1769-4081-8003-29f6d47c15e5" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_790ea133-1769-4081-8003-29f6d47c15e5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_790ea133-1769-4081-8003-29f6d47c15e5" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_790ea133-1769-4081-8003-29f6d47c15e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_a3d1971d-f59b-4ccf-aa42-820f2bfd5b74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_790ea133-1769-4081-8003-29f6d47c15e5" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_a3d1971d-f59b-4ccf-aa42-820f2bfd5b74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMember_0de2ad99-55c4-4398-b282-f481255b7c0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_a3d1971d-f59b-4ccf-aa42-820f2bfd5b74" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMember_0de2ad99-55c4-4398-b282-f481255b7c0a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_5267c267-2c37-4e74-8ecd-f3db3442be3d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_a3d1971d-f59b-4ccf-aa42-820f2bfd5b74" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_5267c267-2c37-4e74-8ecd-f3db3442be3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_f93772fb-5e41-4211-b426-35245cf29aba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReportingUnitAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_fff5ec03-9964-4706-9263-2a01b683ab4f" xlink:to="loc_us-gaap_ReportingUnitAxis_f93772fb-5e41-4211-b426-35245cf29aba" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_f93772fb-5e41-4211-b426-35245cf29aba_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReportingUnitAxis_f93772fb-5e41-4211-b426-35245cf29aba" xlink:to="loc_us-gaap_ReportingUnitDomain_f93772fb-5e41-4211-b426-35245cf29aba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_6283c0b3-d044-46cb-9312-77b661c68b61" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReportingUnitAxis_f93772fb-5e41-4211-b426-35245cf29aba" xlink:to="loc_us-gaap_ReportingUnitDomain_6283c0b3-d044-46cb-9312-77b661c68b61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_HealthBiosciencesMember_d4f37ec9-5a4b-4e74-899b-04baa1e3844f" xlink:href="iff-20231231.xsd#iff_HealthBiosciencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_6283c0b3-d044-46cb-9312-77b661c68b61" xlink:to="loc_iff_HealthBiosciencesMember_d4f37ec9-5a4b-4e74-899b-04baa1e3844f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_0c9f939c-6003-43fe-9e55-c5e7d002a6d1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_fff5ec03-9964-4706-9263-2a01b683ab4f" xlink:to="loc_srt_StatementGeographicalAxis_0c9f939c-6003-43fe-9e55-c5e7d002a6d1" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_0c9f939c-6003-43fe-9e55-c5e7d002a6d1_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_0c9f939c-6003-43fe-9e55-c5e7d002a6d1" xlink:to="loc_srt_SegmentGeographicalDomain_0c9f939c-6003-43fe-9e55-c5e7d002a6d1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_6cef9c16-396a-43e3-b814-932971b3b63d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_0c9f939c-6003-43fe-9e55-c5e7d002a6d1" xlink:to="loc_srt_SegmentGeographicalDomain_6cef9c16-396a-43e3-b814-932971b3b63d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_EG_422a5af7-03c1-4e92-a1dd-6696b81169d4" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_EG"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_6cef9c16-396a-43e3-b814-932971b3b63d" xlink:to="loc_country_EG_422a5af7-03c1-4e92-a1dd-6696b81169d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGross_646c5314-a939-4c04-a601-c57c05a98b40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_AccountsReceivableGross_646c5314-a939-4c04-a601-c57c05a98b40" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e7c618c6-d0f7-402e-9165-0515f18ad2e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e7c618c6-d0f7-402e-9165-0515f18ad2e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_8ee40af0-1008-4b86-a114-4c9bb8fd0bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_RestrictedCashCurrent_8ee40af0-1008-4b86-a114-4c9bb8fd0bd0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_c4ffde03-7b2e-49b7-a628-705e132f0acc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_c4ffde03-7b2e-49b7-a628-705e132f0acc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_1925cd14-427b-46d6-ad01-54b61f340375" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_1925cd14-427b-46d6-ad01-54b61f340375" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_20aef4d4-afcf-474f-9f4d-c61848d1aaf0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_20aef4d4-afcf-474f-9f4d-c61848d1aaf0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AccountsReceivableFactoringReceivableProgramMaximumAmount_e7fc7033-f60d-46f3-87b4-233ca08180b6" xlink:href="iff-20231231.xsd#iff_AccountsReceivableFactoringReceivableProgramMaximumAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_iff_AccountsReceivableFactoringReceivableProgramMaximumAmount_e7fc7033-f60d-46f3-87b4-233ca08180b6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ProceedsFromSaleOfAccountsReceivable_b69f4df2-0b33-4c0e-bcfa-ec0006ebb3d2" xlink:href="iff-20231231.xsd#iff_ProceedsFromSaleOfAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_iff_ProceedsFromSaleOfAccountsReceivable_b69f4df2-0b33-4c0e-bcfa-ec0006ebb3d2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeReceivablesHeldForSaleAmount_65f44042-576f-4895-b2b2-d8a3f5681b37" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeReceivablesHeldForSaleAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_TradeReceivablesHeldForSaleAmount_65f44042-576f-4895-b2b2-d8a3f5681b37" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_PaymentsToParticipateInFactoringReceivableProgram_31600fe1-f50e-417c-a06d-8a9e555e09e1" xlink:href="iff-20231231.xsd#iff_PaymentsToParticipateInFactoringReceivableProgram"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_iff_PaymentsToParticipateInFactoringReceivableProgram_31600fe1-f50e-417c-a06d-8a9e555e09e1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_950c56ed-e527-4cb2-9a83-63de1b0d15a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_ReceivablesNetCurrent_950c56ed-e527-4cb2-9a83-63de1b0d15a6" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_2b1c5d97-fe0b-4a60-86d5-8348e47d5b8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_2b1c5d97-fe0b-4a60-86d5-8348e47d5b8e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AccountsReceivablesOutstandingByOver365Days_36882d95-98df-4430-b59e-97b341d0e471" xlink:href="iff-20231231.xsd#iff_AccountsReceivablesOutstandingByOver365Days"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_iff_AccountsReceivablesOutstandingByOver365Days_36882d95-98df-4430-b59e-97b341d0e471" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_a48aa743-a51a-469a-822f-05c8f4ed4f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_a48aa743-a51a-469a-822f-05c8f4ed4f5a" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_2306f1da-d3ee-4e97-9d88-6b1996653493" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_2306f1da-d3ee-4e97-9d88-6b1996653493" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_deabcd81-d258-4524-af39-6fe364310a4f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_deabcd81-d258-4524-af39-6fe364310a4f" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation_5e823d32-4754-47d4-b9f7-6bf3f4016824" xlink:href="iff-20231231.xsd#iff_AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_iff_AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation_5e823d32-4754-47d4-b9f7-6bf3f4016824" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNet_b8c7e3b3-0389-4b76-ae08-b90bd5a3408c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_AccountsReceivableNet_b8c7e3b3-0389-4b76-ae08-b90bd5a3408c" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_79297894-98b9-47fc-8431-9fcaaecccd5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_79297894-98b9-47fc-8431-9fcaaecccd5a" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_29ac571f-c6bb-432d-adaa-e7e26b1553d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_29ac571f-c6bb-432d-adaa-e7e26b1553d2" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_daf5b1ff-0d90-41f4-8260-614c7df069ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_daf5b1ff-0d90-41f4-8260-614c7df069ca" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_11167559-4cf3-4657-8821-d62ebcedd629" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_11167559-4cf3-4657-8821-d62ebcedd629" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalized_bee049aa-4eab-4a39-886e-4676079f6010" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestCostsCapitalized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_InterestCostsCapitalized_bee049aa-4eab-4a39-886e-4676079f6010" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_7ed74880-4a85-4cc7-9862-2275c75050ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_7ed74880-4a85-4cc7-9862-2275c75050ef" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_891d970b-b448-4d44-ba3c-291dfbadeeb4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_891d970b-b448-4d44-ba3c-291dfbadeeb4" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_08083913-09c2-457e-82a2-c3e98f5ef1fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_AssetImpairmentCharges_08083913-09c2-457e-82a2-c3e98f5ef1fe" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_d2c02fba-1de6-460d-84a4-e0f5c04f5f34" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_NumberOfReportingUnits_d2c02fba-1de6-460d-84a4-e0f5c04f5f34" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_77d9170e-f1ed-4e97-ae2b-945bc47c10fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_77d9170e-f1ed-4e97-ae2b-945bc47c10fb" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_MinimumPercentageLikelihoodOfTaxBenefitToBeRealizedUponFinalSettlement_b2f57256-0049-4525-a78a-7c0bdc50074c" xlink:href="iff-20231231.xsd#iff_MinimumPercentageLikelihoodOfTaxBenefitToBeRealizedUponFinalSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_iff_MinimumPercentageLikelihoodOfTaxBenefitToBeRealizedUponFinalSettlement_b2f57256-0049-4525-a78a-7c0bdc50074c" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_PriorServiceCostsFromPlanImprovementsAmortizationPeriodMinimum_abffdce9-887b-4adb-a293-93597fb70bca" xlink:href="iff-20231231.xsd#iff_PriorServiceCostsFromPlanImprovementsAmortizationPeriodMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_iff_PriorServiceCostsFromPlanImprovementsAmortizationPeriodMinimum_abffdce9-887b-4adb-a293-93597fb70bca" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_PriorServiceCostsFromPlanImprovementsAmortizationPeriodMaximum_3a227262-d885-4445-b9da-dfa7a8a8bd7b" xlink:href="iff-20231231.xsd#iff_PriorServiceCostsFromPlanImprovementsAmortizationPeriodMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_iff_PriorServiceCostsFromPlanImprovementsAmortizationPeriodMaximum_3a227262-d885-4445-b9da-dfa7a8a8bd7b" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AmortizationPeriodOfInternalAndExternalDevelopmentCosts_e7652064-78a4-4fc7-ae3f-ce5b0b4fe2ab" xlink:href="iff-20231231.xsd#iff_AmortizationPeriodOfInternalAndExternalDevelopmentCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_iff_AmortizationPeriodOfInternalAndExternalDevelopmentCosts_e7652064-78a4-4fc7-ae3f-ce5b0b4fe2ab" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierFinanceProgramObligation_a929c4a2-bd5f-4c0c-801f-df3799fc2ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplierFinanceProgramObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_SupplierFinanceProgramObligation_a929c4a2-bd5f-4c0c-801f-df3799fc2ed7" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DifferenceAmountBetweenBasicAndDilutedNetIncomePerShare_93b40d30-2b08-406b-84e5-7447e3c9f074" xlink:href="iff-20231231.xsd#iff_DifferenceAmountBetweenBasicAndDilutedNetIncomePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_iff_DifferenceAmountBetweenBasicAndDilutedNetIncomePerShare_93b40d30-2b08-406b-84e5-7447e3c9f074" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_001e1c42-b676-4332-b352-15546fe1b3ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_InventoryNet_001e1c42-b676-4332-b352-15546fe1b3ec" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AccountsReceivablesOutstandingLessThan90Days_7e23e2f5-5a4c-44fe-a6a6-c1ae1971c8e1" xlink:href="iff-20231231.xsd#iff_AccountsReceivablesOutstandingLessThan90Days"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_iff_AccountsReceivablesOutstandingLessThan90Days_7e23e2f5-5a4c-44fe-a6a6-c1ae1971c8e1" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_d89c7115-2bed-4bf2-a7a3-5bc0e5cab6b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_d89c7115-2bed-4bf2-a7a3-5bc0e5cab6b1" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_98efbea4-aed3-4e92-8409-06a8948eb9c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_98efbea4-aed3-4e92-8409-06a8948eb9c5" xlink:type="arc" order="37"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_ede82328-6c7e-4fb0-b584-aaba99ded015" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_ede82328-6c7e-4fb0-b584-aaba99ded015" xlink:type="arc" order="38"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_5a51609b-23b9-4cdd-943b-023c37a4accf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_5a51609b-23b9-4cdd-943b-023c37a4accf" xlink:type="arc" order="39"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3977a9df-05e7-47f2-861d-48dc86e213f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3977a9df-05e7-47f2-861d-48dc86e213f9" xlink:type="arc" order="40"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d1ffce2b-681d-487a-9018-e3bcbc3a582f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_Goodwill_d1ffce2b-681d-487a-9018-e3bcbc3a582f" xlink:type="arc" order="41"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_795deb87-3b5e-4627-b639-94b4242c2f69" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_795deb87-3b5e-4627-b639-94b4242c2f69" xlink:type="arc" order="42"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/RestructuringandOtherChargesAdditionalInformationDetails" xlink:type="simple" xlink:href="iff-20231231.xsd#RestructuringandOtherChargesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/RestructuringandOtherChargesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_09a72d88-a77b-4845-b8df-e08e29191e5f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e850a8cd-3658-4647-af14-f0102558f109" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_09a72d88-a77b-4845-b8df-e08e29191e5f" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e850a8cd-3658-4647-af14-f0102558f109" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_e9f82456-0d1e-499f-b0ed-b29e69ca8930" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e850a8cd-3658-4647-af14-f0102558f109" xlink:to="loc_srt_StatementGeographicalAxis_e9f82456-0d1e-499f-b0ed-b29e69ca8930" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e9f82456-0d1e-499f-b0ed-b29e69ca8930_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_e9f82456-0d1e-499f-b0ed-b29e69ca8930" xlink:to="loc_srt_SegmentGeographicalDomain_e9f82456-0d1e-499f-b0ed-b29e69ca8930_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f08fca14-e54a-49b9-9cbc-3c6edfe335fe" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_e9f82456-0d1e-499f-b0ed-b29e69ca8930" xlink:to="loc_srt_SegmentGeographicalDomain_f08fca14-e54a-49b9-9cbc-3c6edfe335fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaMember_e497e331-f172-4332-bb60-8b397e790d1e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AsiaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f08fca14-e54a-49b9-9cbc-3c6edfe335fe" xlink:to="loc_srt_AsiaMember_e497e331-f172-4332-bb60-8b397e790d1e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_e0d27d6b-6cdd-4892-87aa-b0ea177292f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EMEAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f08fca14-e54a-49b9-9cbc-3c6edfe335fe" xlink:to="loc_us-gaap_EMEAMember_e0d27d6b-6cdd-4892-87aa-b0ea177292f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LatinAmericaMember_c39fc9f9-cc5c-4f8a-951a-739fcf65f5ad" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LatinAmericaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f08fca14-e54a-49b9-9cbc-3c6edfe335fe" xlink:to="loc_srt_LatinAmericaMember_c39fc9f9-cc5c-4f8a-951a-739fcf65f5ad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NorthAmericaMember_e36b9427-411b-46e9-99a7-1ad24afc1352" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NorthAmericaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f08fca14-e54a-49b9-9cbc-3c6edfe335fe" xlink:to="loc_srt_NorthAmericaMember_e36b9427-411b-46e9-99a7-1ad24afc1352" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_dabf205a-f6f1-4b1a-8c6b-0e5f93e15939" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e850a8cd-3658-4647-af14-f0102558f109" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_dabf205a-f6f1-4b1a-8c6b-0e5f93e15939" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_dabf205a-f6f1-4b1a-8c6b-0e5f93e15939_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_dabf205a-f6f1-4b1a-8c6b-0e5f93e15939" xlink:to="loc_us-gaap_SegmentDomain_dabf205a-f6f1-4b1a-8c6b-0e5f93e15939_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2ec88173-ec09-41f7-ac1c-632a7f5fa85b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_dabf205a-f6f1-4b1a-8c6b-0e5f93e15939" xlink:to="loc_us-gaap_SegmentDomain_2ec88173-ec09-41f7-ac1c-632a7f5fa85b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ScentMember_a0fd03c2-4c8f-4ad1-9552-b125b4ad6f52" xlink:href="iff-20231231.xsd#iff_ScentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_2ec88173-ec09-41f7-ac1c-632a7f5fa85b" xlink:to="loc_iff_ScentMember_a0fd03c2-4c8f-4ad1-9552-b125b4ad6f52" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SharedITCorporateCostsMember_afab5898-465a-4565-aa0d-479ee0e645c0" xlink:href="iff-20231231.xsd#iff_SharedITCorporateCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_2ec88173-ec09-41f7-ac1c-632a7f5fa85b" xlink:to="loc_iff_SharedITCorporateCostsMember_afab5898-465a-4565-aa0d-479ee0e645c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_1a6f74ba-dbbe-416d-b4df-cf01e9261550" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e850a8cd-3658-4647-af14-f0102558f109" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_1a6f74ba-dbbe-416d-b4df-cf01e9261550" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_1a6f74ba-dbbe-416d-b4df-cf01e9261550_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_1a6f74ba-dbbe-416d-b4df-cf01e9261550" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_1a6f74ba-dbbe-416d-b4df-cf01e9261550_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_47203bf3-7347-4954-a699-ef7acb33ee1e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_1a6f74ba-dbbe-416d-b4df-cf01e9261550" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_47203bf3-7347-4954-a699-ef7acb33ee1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_4b72fd97-769d-4211-82f9-8ae713a40eec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_47203bf3-7347-4954-a699-ef7acb33ee1e" xlink:to="loc_us-gaap_EmployeeSeveranceMember_4b72fd97-769d-4211-82f9-8ae713a40eec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_d5983b28-8091-4fa2-8fd2-3fae934ed35e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherRestructuringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_47203bf3-7347-4954-a699-ef7acb33ee1e" xlink:to="loc_us-gaap_OtherRestructuringMember_d5983b28-8091-4fa2-8fd2-3fae934ed35e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FixedAssetWriteDownMember_54df373f-00c8-4bc1-9576-1efb0550f6bb" xlink:href="iff-20231231.xsd#iff_FixedAssetWriteDownMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_47203bf3-7347-4954-a699-ef7acb33ee1e" xlink:to="loc_iff_FixedAssetWriteDownMember_54df373f-00c8-4bc1-9576-1efb0550f6bb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_5ed4fcc4-11fe-4361-846f-d0bbb3505eaf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e850a8cd-3658-4647-af14-f0102558f109" xlink:to="loc_us-gaap_RestructuringPlanAxis_5ed4fcc4-11fe-4361-846f-d0bbb3505eaf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_5ed4fcc4-11fe-4361-846f-d0bbb3505eaf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_5ed4fcc4-11fe-4361-846f-d0bbb3505eaf" xlink:to="loc_us-gaap_RestructuringPlanDomain_5ed4fcc4-11fe-4361-846f-d0bbb3505eaf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_0c42fb13-29b9-4fb3-bdb1-151c60471574" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_5ed4fcc4-11fe-4361-846f-d0bbb3505eaf" xlink:to="loc_us-gaap_RestructuringPlanDomain_0c42fb13-29b9-4fb3-bdb1-151c60471574" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FrutaromIntegrationInitiativeMember_653e9182-fbc0-4194-a9f2-cf94519da142" xlink:href="iff-20231231.xsd#iff_FrutaromIntegrationInitiativeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_0c42fb13-29b9-4fb3-bdb1-151c60471574" xlink:to="loc_iff_FrutaromIntegrationInitiativeMember_653e9182-fbc0-4194-a9f2-cf94519da142" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_A2019SeveranceInitiativesMember_c99d37bb-d4a2-4da6-802d-b1e789b5df5e" xlink:href="iff-20231231.xsd#iff_A2019SeveranceInitiativesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_0c42fb13-29b9-4fb3-bdb1-151c60471574" xlink:to="loc_iff_A2019SeveranceInitiativesMember_c99d37bb-d4a2-4da6-802d-b1e789b5df5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_A2017ProductivityProgramMember_6d545ca4-9ead-4766-80d1-2ae800e5d9f7" xlink:href="iff-20231231.xsd#iff_A2017ProductivityProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_0c42fb13-29b9-4fb3-bdb1-151c60471574" xlink:to="loc_iff_A2017ProductivityProgramMember_6d545ca4-9ead-4766-80d1-2ae800e5d9f7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_94adbf33-6a7b-468f-9b94-9eedbf58c5e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherRestructuringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_0c42fb13-29b9-4fb3-bdb1-151c60471574" xlink:to="loc_us-gaap_OtherRestructuringMember_94adbf33-6a7b-468f-9b94-9eedbf58c5e0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_A2023RestructuringProgramMember_8e4ba444-2717-4096-b96c-f8645e958de3" xlink:href="iff-20231231.xsd#iff_A2023RestructuringProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_0c42fb13-29b9-4fb3-bdb1-151c60471574" xlink:to="loc_iff_A2023RestructuringProgramMember_8e4ba444-2717-4096-b96c-f8645e958de3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b541f0cd-373e-4cf3-b153-c3cda9654655" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e850a8cd-3658-4647-af14-f0102558f109" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b541f0cd-373e-4cf3-b153-c3cda9654655" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b541f0cd-373e-4cf3-b153-c3cda9654655_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b541f0cd-373e-4cf3-b153-c3cda9654655" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b541f0cd-373e-4cf3-b153-c3cda9654655_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_91facc83-7659-4a39-8f8e-47b00814f21f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b541f0cd-373e-4cf3-b153-c3cda9654655" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_91facc83-7659-4a39-8f8e-47b00814f21f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NutritionBiosciencesIncMember_9af3c51f-3770-42ea-87c5-1ec94427b569" xlink:href="iff-20231231.xsd#iff_NutritionBiosciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_91facc83-7659-4a39-8f8e-47b00814f21f" xlink:to="loc_iff_NutritionBiosciencesIncMember_9af3c51f-3770-42ea-87c5-1ec94427b569" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_RestructuringAndRelatedCostExpectedNumberOfSitesClosed_2cc83b5e-ecee-4a94-885c-ce190d7d0225" xlink:href="iff-20231231.xsd#iff_RestructuringAndRelatedCostExpectedNumberOfSitesClosed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_09a72d88-a77b-4845-b8df-e08e29191e5f" xlink:to="loc_iff_RestructuringAndRelatedCostExpectedNumberOfSitesClosed_2cc83b5e-ecee-4a94-885c-ce190d7d0225" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_RestructuringAndRelatedCostExpectedNumberOfSitesClosedPeriod_130cbb46-544c-44ce-a2bd-83ae62302e85" xlink:href="iff-20231231.xsd#iff_RestructuringAndRelatedCostExpectedNumberOfSitesClosedPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_09a72d88-a77b-4845-b8df-e08e29191e5f" xlink:to="loc_iff_RestructuringAndRelatedCostExpectedNumberOfSitesClosedPeriod_130cbb46-544c-44ce-a2bd-83ae62302e85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_RestructuringAndRelatedCostNumberOfSitesClosed_64c63364-a476-4fbe-8b47-53efb7de46fc" xlink:href="iff-20231231.xsd#iff_RestructuringAndRelatedCostNumberOfSitesClosed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_09a72d88-a77b-4845-b8df-e08e29191e5f" xlink:to="loc_iff_RestructuringAndRelatedCostNumberOfSitesClosed_64c63364-a476-4fbe-8b47-53efb7de46fc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_4d6de003-ff16-4e61-beda-c5826e2d6558" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_09a72d88-a77b-4845-b8df-e08e29191e5f" xlink:to="loc_us-gaap_RestructuringCharges_4d6de003-ff16-4e61-beda-c5826e2d6558" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts_c82c724a-915c-4cf6-96ff-983ca5daaf83" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_09a72d88-a77b-4845-b8df-e08e29191e5f" xlink:to="loc_us-gaap_OtherRestructuringCosts_c82c724a-915c-4cf6-96ff-983ca5daaf83" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated_b80495ee-2baf-4525-a45b-32f64b9e82a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_09a72d88-a77b-4845-b8df-e08e29191e5f" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated_b80495ee-2baf-4525-a45b-32f64b9e82a4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_bd984896-f26a-44a9-9541-9179bf1dbec1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeveranceCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_09a72d88-a77b-4845-b8df-e08e29191e5f" xlink:to="loc_us-gaap_SeveranceCosts1_bd984896-f26a-44a9-9541-9179bf1dbec1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_cfb927de-c320-4227-8293-9f0844cfa781" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_09a72d88-a77b-4845-b8df-e08e29191e5f" xlink:to="loc_us-gaap_RestructuringReserveRollForward_cfb927de-c320-4227-8293-9f0844cfa781" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_e9235a3e-2759-447f-ab96-08cfba29aa95" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_cfb927de-c320-4227-8293-9f0844cfa781" xlink:to="loc_us-gaap_RestructuringReserve_e9235a3e-2759-447f-ab96-08cfba29aa95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1_7dfbad93-4bf5-4365-af71-d79d783b5e36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_cfb927de-c320-4227-8293-9f0844cfa781" xlink:to="loc_us-gaap_RestructuringReserveAccrualAdjustment1_7dfbad93-4bf5-4365-af71-d79d783b5e36" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_7d47d368-ca07-440e-aacf-b2e713e50723" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_cfb927de-c320-4227-8293-9f0844cfa781" xlink:to="loc_us-gaap_RestructuringReserveSettledWithoutCash2_7d47d368-ca07-440e-aacf-b2e713e50723" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_f8792aa9-7d18-444d-a1ca-f27e0e0c7c04" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_cfb927de-c320-4227-8293-9f0844cfa781" xlink:to="loc_us-gaap_PaymentsForRestructuring_f8792aa9-7d18-444d-a1ca-f27e0e0c7c04" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_c8346d69-de5b-4319-a973-0c2012fd623c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BusinessCombinationRestructuringLiabilities_96cf6701-aef2-4bc2-8510-ab2c000db122" xlink:href="iff-20231231.xsd#iff_BusinessCombinationRestructuringLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_09a72d88-a77b-4845-b8df-e08e29191e5f" xlink:to="loc_iff_BusinessCombinationRestructuringLiabilities_96cf6701-aef2-4bc2-8510-ab2c000db122" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_3b2cdad6-51f8-4404-8d37-785efadaf744" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_09a72d88-a77b-4845-b8df-e08e29191e5f" xlink:to="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_3b2cdad6-51f8-4404-8d37-785efadaf744" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_bcc71ac4-f8b2-470b-8aaa-6b19ee8da6cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_09a72d88-a77b-4845-b8df-e08e29191e5f" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_bcc71ac4-f8b2-470b-8aaa-6b19ee8da6cf" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_097e49ff-d384-40fa-84cc-a35f509c8775" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_09a72d88-a77b-4845-b8df-e08e29191e5f" xlink:to="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_097e49ff-d384-40fa-84cc-a35f509c8775" xlink:type="arc" order="11"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/RestructuringandOtherChargesMovementsinRestructuringandRelatedAccrualsDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#RestructuringandOtherChargesMovementsinRestructuringandRelatedAccrualsDetail"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/RestructuringandOtherChargesMovementsinRestructuringandRelatedAccrualsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_a9f30af5-d4ff-4138-89a3-6082a1b33329" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_21795d73-e19b-4a84-95ac-cfb032642c90" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_a9f30af5-d4ff-4138-89a3-6082a1b33329" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_21795d73-e19b-4a84-95ac-cfb032642c90" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_60404389-4fd8-4068-8fa4-37268a68d1f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_21795d73-e19b-4a84-95ac-cfb032642c90" xlink:to="loc_us-gaap_RestructuringPlanAxis_60404389-4fd8-4068-8fa4-37268a68d1f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_60404389-4fd8-4068-8fa4-37268a68d1f3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_60404389-4fd8-4068-8fa4-37268a68d1f3" xlink:to="loc_us-gaap_RestructuringPlanDomain_60404389-4fd8-4068-8fa4-37268a68d1f3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_2381e571-044a-4291-8376-30bfa3c99580" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_60404389-4fd8-4068-8fa4-37268a68d1f3" xlink:to="loc_us-gaap_RestructuringPlanDomain_2381e571-044a-4291-8376-30bfa3c99580" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_A2015SeveranceInitiativesMember_d6fb6305-a330-47db-9ad6-26d6cc206402" xlink:href="iff-20231231.xsd#iff_A2015SeveranceInitiativesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_2381e571-044a-4291-8376-30bfa3c99580" xlink:to="loc_iff_A2015SeveranceInitiativesMember_d6fb6305-a330-47db-9ad6-26d6cc206402" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FrutaromIntegrationInitiativeMember_14ab7ab3-8b6c-4e8d-ac96-defad75c851d" xlink:href="iff-20231231.xsd#iff_FrutaromIntegrationInitiativeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_2381e571-044a-4291-8376-30bfa3c99580" xlink:to="loc_iff_FrutaromIntegrationInitiativeMember_14ab7ab3-8b6c-4e8d-ac96-defad75c851d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_A2019SeveranceInitiativesMember_48817994-f4d8-4a12-8bb4-291c9c1b142c" xlink:href="iff-20231231.xsd#iff_A2019SeveranceInitiativesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_2381e571-044a-4291-8376-30bfa3c99580" xlink:to="loc_iff_A2019SeveranceInitiativesMember_48817994-f4d8-4a12-8bb4-291c9c1b142c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_A2017ProductivityProgramMember_be57d476-7911-4723-bd8a-94c5c28be506" xlink:href="iff-20231231.xsd#iff_A2017ProductivityProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_2381e571-044a-4291-8376-30bfa3c99580" xlink:to="loc_iff_A2017ProductivityProgramMember_be57d476-7911-4723-bd8a-94c5c28be506" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_190aefe2-4903-478f-ab8d-e33cf98fdd74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherRestructuringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_2381e571-044a-4291-8376-30bfa3c99580" xlink:to="loc_us-gaap_OtherRestructuringMember_190aefe2-4903-478f-ab8d-e33cf98fdd74" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_38d02d54-0e9c-43b0-bcb2-d3b26d4f97d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_21795d73-e19b-4a84-95ac-cfb032642c90" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_38d02d54-0e9c-43b0-bcb2-d3b26d4f97d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_38d02d54-0e9c-43b0-bcb2-d3b26d4f97d7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_38d02d54-0e9c-43b0-bcb2-d3b26d4f97d7" xlink:to="loc_us-gaap_SegmentDomain_38d02d54-0e9c-43b0-bcb2-d3b26d4f97d7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_94b38dd6-59df-4084-8a83-1b13eb141c79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_38d02d54-0e9c-43b0-bcb2-d3b26d4f97d7" xlink:to="loc_us-gaap_SegmentDomain_94b38dd6-59df-4084-8a83-1b13eb141c79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TasteMember_8b3697cc-4095-4072-8ba2-34854319aefb" xlink:href="iff-20231231.xsd#iff_TasteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_94b38dd6-59df-4084-8a83-1b13eb141c79" xlink:to="loc_iff_TasteMember_8b3697cc-4095-4072-8ba2-34854319aefb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ScentMember_51642451-1a67-4d92-b0d7-332221f1bfb9" xlink:href="iff-20231231.xsd#iff_ScentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_94b38dd6-59df-4084-8a83-1b13eb141c79" xlink:to="loc_iff_ScentMember_51642451-1a67-4d92-b0d7-332221f1bfb9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SharedITCorporateCostsMember_a72e0811-51ee-4dc4-a95b-e4c1e0fc09d9" xlink:href="iff-20231231.xsd#iff_SharedITCorporateCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_94b38dd6-59df-4084-8a83-1b13eb141c79" xlink:to="loc_iff_SharedITCorporateCostsMember_a72e0811-51ee-4dc4-a95b-e4c1e0fc09d9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_PharmaSolutionsMember_74ba45a2-fecd-46e6-9afd-2ac6c30c928e" xlink:href="iff-20231231.xsd#iff_PharmaSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_94b38dd6-59df-4084-8a83-1b13eb141c79" xlink:to="loc_iff_PharmaSolutionsMember_74ba45a2-fecd-46e6-9afd-2ac6c30c928e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NourishMember_8a335c2e-65d2-4110-836e-9d60f882b482" xlink:href="iff-20231231.xsd#iff_NourishMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_94b38dd6-59df-4084-8a83-1b13eb141c79" xlink:to="loc_iff_NourishMember_8a335c2e-65d2-4110-836e-9d60f882b482" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_HealthBiosciencesMember_a8863e7a-13d6-4f8b-821d-49f37e10b88e" xlink:href="iff-20231231.xsd#iff_HealthBiosciencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_94b38dd6-59df-4084-8a83-1b13eb141c79" xlink:to="loc_iff_HealthBiosciencesMember_a8863e7a-13d6-4f8b-821d-49f37e10b88e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_2ed76e17-1b94-4e3c-a93d-2f90ad0cd15d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_21795d73-e19b-4a84-95ac-cfb032642c90" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_2ed76e17-1b94-4e3c-a93d-2f90ad0cd15d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_2ed76e17-1b94-4e3c-a93d-2f90ad0cd15d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_2ed76e17-1b94-4e3c-a93d-2f90ad0cd15d" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_2ed76e17-1b94-4e3c-a93d-2f90ad0cd15d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_e8ae341a-69b1-4b2b-9516-f1051f980437" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_2ed76e17-1b94-4e3c-a93d-2f90ad0cd15d" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_e8ae341a-69b1-4b2b-9516-f1051f980437" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_6045ab3f-f6f9-4b4d-af9f-06298ccdf1ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_e8ae341a-69b1-4b2b-9516-f1051f980437" xlink:to="loc_us-gaap_EmployeeSeveranceMember_6045ab3f-f6f9-4b4d-af9f-06298ccdf1ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FixedAssetWriteDownMember_21d1ca76-3e83-48df-bb2a-78e61fea9258" xlink:href="iff-20231231.xsd#iff_FixedAssetWriteDownMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_e8ae341a-69b1-4b2b-9516-f1051f980437" xlink:to="loc_iff_FixedAssetWriteDownMember_21d1ca76-3e83-48df-bb2a-78e61fea9258" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_f8e97731-b03e-44d4-9599-d135e4a17e63" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherRestructuringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_e8ae341a-69b1-4b2b-9516-f1051f980437" xlink:to="loc_us-gaap_OtherRestructuringMember_f8e97731-b03e-44d4-9599-d135e4a17e63" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5d37ee25-1c81-49b9-a978-6b9a4ff7b8f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_21795d73-e19b-4a84-95ac-cfb032642c90" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5d37ee25-1c81-49b9-a978-6b9a4ff7b8f5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5d37ee25-1c81-49b9-a978-6b9a4ff7b8f5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5d37ee25-1c81-49b9-a978-6b9a4ff7b8f5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5d37ee25-1c81-49b9-a978-6b9a4ff7b8f5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_31c54379-117a-4dca-985f-d81565c16c23" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5d37ee25-1c81-49b9-a978-6b9a4ff7b8f5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_31c54379-117a-4dca-985f-d81565c16c23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NutritionBiosciencesIncMember_ab56ad0d-db75-48df-9113-20fbe1503598" xlink:href="iff-20231231.xsd#iff_NutritionBiosciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_31c54379-117a-4dca-985f-d81565c16c23" xlink:to="loc_iff_NutritionBiosciencesIncMember_ab56ad0d-db75-48df-9113-20fbe1503598" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_680b8f48-bc99-46a9-a582-3ec820ffcc11" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_a9f30af5-d4ff-4138-89a3-6082a1b33329" xlink:to="loc_us-gaap_RestructuringReserveRollForward_680b8f48-bc99-46a9-a582-3ec820ffcc11" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_7a83773a-0bdf-45dd-9c24-3aecce07f634" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_680b8f48-bc99-46a9-a582-3ec820ffcc11" xlink:to="loc_us-gaap_RestructuringReserve_7a83773a-0bdf-45dd-9c24-3aecce07f634" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1_01ff5d60-74bc-4267-9835-eced564f025e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_680b8f48-bc99-46a9-a582-3ec820ffcc11" xlink:to="loc_us-gaap_RestructuringReserveAccrualAdjustment1_01ff5d60-74bc-4267-9835-eced564f025e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_c34aa5a8-c841-4d95-ae4e-ac11c73b75a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_680b8f48-bc99-46a9-a582-3ec820ffcc11" xlink:to="loc_us-gaap_RestructuringReserveSettledWithoutCash2_c34aa5a8-c841-4d95-ae4e-ac11c73b75a6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_aab067df-d979-41aa-96a1-7d4d70aaf0f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_680b8f48-bc99-46a9-a582-3ec820ffcc11" xlink:to="loc_us-gaap_PaymentsForRestructuring_aab067df-d979-41aa-96a1-7d4d70aaf0f0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_08093611-7ad7-400c-b119-f460ad34baf0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_4fa157ee-74fb-43b5-8628-194182281ca5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_680b8f48-bc99-46a9-a582-3ec820ffcc11" xlink:to="loc_us-gaap_RestructuringCharges_4fa157ee-74fb-43b5-8628-194182281ca5" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/AcquisitionsHealthWrightProductsDetails" xlink:type="simple" xlink:href="iff-20231231.xsd#AcquisitionsHealthWrightProductsDetails"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/AcquisitionsHealthWrightProductsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_000aacdf-8ee1-4115-938c-489f1692a0d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e9ae381a-2758-4cf8-8e87-a26f284cdae5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_000aacdf-8ee1-4115-938c-489f1692a0d8" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e9ae381a-2758-4cf8-8e87-a26f284cdae5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_23e0e728-a59a-47f0-ada9-6e0f21032dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e9ae381a-2758-4cf8-8e87-a26f284cdae5" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_23e0e728-a59a-47f0-ada9-6e0f21032dd8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_23e0e728-a59a-47f0-ada9-6e0f21032dd8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_23e0e728-a59a-47f0-ada9-6e0f21032dd8" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_23e0e728-a59a-47f0-ada9-6e0f21032dd8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_04a45116-c040-4dc0-8698-7b4049a009e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_23e0e728-a59a-47f0-ada9-6e0f21032dd8" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_04a45116-c040-4dc0-8698-7b4049a009e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_HealthWrightProductsIncHealthWrightMember_bc652737-be11-4715-ad21-56079ab6dfd1" xlink:href="iff-20231231.xsd#iff_HealthWrightProductsIncHealthWrightMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_04a45116-c040-4dc0-8698-7b4049a009e8" xlink:to="loc_iff_HealthWrightProductsIncHealthWrightMember_bc652737-be11-4715-ad21-56079ab6dfd1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e38234fe-06f4-4af7-bfc4-243d0bbaf5f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e9ae381a-2758-4cf8-8e87-a26f284cdae5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e38234fe-06f4-4af7-bfc4-243d0bbaf5f2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e38234fe-06f4-4af7-bfc4-243d0bbaf5f2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e38234fe-06f4-4af7-bfc4-243d0bbaf5f2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e38234fe-06f4-4af7-bfc4-243d0bbaf5f2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_26ea312a-7607-4f4e-975e-f9e3d7a4a2e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e38234fe-06f4-4af7-bfc4-243d0bbaf5f2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_26ea312a-7607-4f4e-975e-f9e3d7a4a2e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_78b08dc0-9b09-407f-a7c5-d0e0de53712d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_26ea312a-7607-4f4e-975e-f9e3d7a4a2e4" xlink:to="loc_us-gaap_CustomerRelationshipsMember_78b08dc0-9b09-407f-a7c5-d0e0de53712d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_b3d01657-d5ed-483a-96af-da8284d479fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_000aacdf-8ee1-4115-938c-489f1692a0d8" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_b3d01657-d5ed-483a-96af-da8284d479fb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_697dcda7-d7d9-4987-bd28-7522ecc6926a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_000aacdf-8ee1-4115-938c-489f1692a0d8" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_697dcda7-d7d9-4987-bd28-7522ecc6926a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_d210f51c-5bf5-4596-8d1b-ebbba0eec172" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_000aacdf-8ee1-4115-938c-489f1692a0d8" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_d210f51c-5bf5-4596-8d1b-ebbba0eec172" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_af8a4dbb-0704-425a-8c9b-a879c4a33db4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_000aacdf-8ee1-4115-938c-489f1692a0d8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_af8a4dbb-0704-425a-8c9b-a879c4a33db4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_95ff4627-03ed-4c3f-acdb-af7b99d64a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_000aacdf-8ee1-4115-938c-489f1692a0d8" xlink:to="loc_us-gaap_Goodwill_95ff4627-03ed-4c3f-acdb-af7b99d64a7d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_d826f09e-adb3-4da8-b3ec-fe45c8f4e168" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_000aacdf-8ee1-4115-938c-489f1692a0d8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_d826f09e-adb3-4da8-b3ec-fe45c8f4e168" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_7d7f5edb-9f64-481a-996a-c5d81043bb37" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_000aacdf-8ee1-4115-938c-489f1692a0d8" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_7d7f5edb-9f64-481a-996a-c5d81043bb37" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EarnOutsPayableOther_2d9c1598-a548-4d95-a4dc-77284857b43b" xlink:href="iff-20231231.xsd#iff_EarnOutsPayableOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_000aacdf-8ee1-4115-938c-489f1692a0d8" xlink:to="loc_iff_EarnOutsPayableOther_2d9c1598-a548-4d95-a4dc-77284857b43b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EarnOutsPayableCurrent_c101b421-5a83-44bd-874e-6768483ae203" xlink:href="iff-20231231.xsd#iff_EarnOutsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_000aacdf-8ee1-4115-938c-489f1692a0d8" xlink:to="loc_iff_EarnOutsPayableCurrent_c101b421-5a83-44bd-874e-6768483ae203" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails" xlink:type="simple" xlink:href="iff-20231231.xsd#AcquisitionsNutritionBiosciencesIncDetails"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e1a94af2-55be-4092-be17-00fd9e0e328a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e1a94af2-55be-4092-be17-00fd9e0e328a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_70132b22-ad04-4e04-8ed9-d0c2232e6c41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e1a94af2-55be-4092-be17-00fd9e0e328a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_70132b22-ad04-4e04-8ed9-d0c2232e6c41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_70132b22-ad04-4e04-8ed9-d0c2232e6c41_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_70132b22-ad04-4e04-8ed9-d0c2232e6c41" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_70132b22-ad04-4e04-8ed9-d0c2232e6c41_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c7a5d5d8-4cc3-44f6-832f-5e76aa489701" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_70132b22-ad04-4e04-8ed9-d0c2232e6c41" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c7a5d5d8-4cc3-44f6-832f-5e76aa489701" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NutritionBiosciencesIncMember_74c8b1cd-a3be-4d31-b2ee-68ce587266f5" xlink:href="iff-20231231.xsd#iff_NutritionBiosciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c7a5d5d8-4cc3-44f6-832f-5e76aa489701" xlink:to="loc_iff_NutritionBiosciencesIncMember_74c8b1cd-a3be-4d31-b2ee-68ce587266f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_6d8fa17a-635b-423c-9144-aa5f9c3b7429" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e1a94af2-55be-4092-be17-00fd9e0e328a" xlink:to="loc_srt_OwnershipAxis_6d8fa17a-635b-423c-9144-aa5f9c3b7429" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_6d8fa17a-635b-423c-9144-aa5f9c3b7429_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_6d8fa17a-635b-423c-9144-aa5f9c3b7429" xlink:to="loc_srt_OwnershipDomain_6d8fa17a-635b-423c-9144-aa5f9c3b7429_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_7fdcebfc-c72e-406e-9f63-d2b419adab45" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_6d8fa17a-635b-423c-9144-aa5f9c3b7429" xlink:to="loc_srt_OwnershipDomain_7fdcebfc-c72e-406e-9f63-d2b419adab45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_InternationalFlavorsFragrancesIncMember_0525d050-6e26-4b6c-a990-7e40947ff145" xlink:href="iff-20231231.xsd#iff_InternationalFlavorsFragrancesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_7fdcebfc-c72e-406e-9f63-d2b419adab45" xlink:to="loc_iff_InternationalFlavorsFragrancesIncMember_0525d050-6e26-4b6c-a990-7e40947ff145" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_0f35a520-b59f-457c-9b22-5d1f71752103" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e1a94af2-55be-4092-be17-00fd9e0e328a" xlink:to="loc_dei_LegalEntityAxis_0f35a520-b59f-457c-9b22-5d1f71752103" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_0f35a520-b59f-457c-9b22-5d1f71752103_default" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_0f35a520-b59f-457c-9b22-5d1f71752103" xlink:to="loc_dei_EntityDomain_0f35a520-b59f-457c-9b22-5d1f71752103_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_f7d4eaee-a26b-4403-a478-2d61f462e3d2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_0f35a520-b59f-457c-9b22-5d1f71752103" xlink:to="loc_dei_EntityDomain_f7d4eaee-a26b-4403-a478-2d61f462e3d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DuPontdeNemoursIncMember_3ac76244-db68-4d9c-aff8-d2e4c2593067" xlink:href="iff-20231231.xsd#iff_DuPontdeNemoursIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_f7d4eaee-a26b-4403-a478-2d61f462e3d2" xlink:to="loc_iff_DuPontdeNemoursIncMember_3ac76244-db68-4d9c-aff8-d2e4c2593067" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e6afbd86-2752-4d7c-afc9-82de2b2b29a8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e1a94af2-55be-4092-be17-00fd9e0e328a" xlink:to="loc_srt_RangeAxis_e6afbd86-2752-4d7c-afc9-82de2b2b29a8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e6afbd86-2752-4d7c-afc9-82de2b2b29a8_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_e6afbd86-2752-4d7c-afc9-82de2b2b29a8" xlink:to="loc_srt_RangeMember_e6afbd86-2752-4d7c-afc9-82de2b2b29a8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_eca78339-0dd1-4a48-90ca-a1ce04c77a04" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_e6afbd86-2752-4d7c-afc9-82de2b2b29a8" xlink:to="loc_srt_RangeMember_eca78339-0dd1-4a48-90ca-a1ce04c77a04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_82c3ab80-2281-4f78-a88b-a049fa22f387" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_eca78339-0dd1-4a48-90ca-a1ce04c77a04" xlink:to="loc_srt_MinimumMember_82c3ab80-2281-4f78-a88b-a049fa22f387" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b511e475-0e80-4a9e-bb43-c956f3da29ad" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_eca78339-0dd1-4a48-90ca-a1ce04c77a04" xlink:to="loc_srt_MaximumMember_b511e475-0e80-4a9e-bb43-c956f3da29ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_6d344d71-026b-4488-978c-bc3a161422cb" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e1a94af2-55be-4092-be17-00fd9e0e328a" xlink:to="loc_srt_RestatementAxis_6d344d71-026b-4488-978c-bc3a161422cb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_6d344d71-026b-4488-978c-bc3a161422cb_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_6d344d71-026b-4488-978c-bc3a161422cb" xlink:to="loc_srt_RestatementDomain_6d344d71-026b-4488-978c-bc3a161422cb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_092953ea-693b-48bf-93ab-1f233364f5f4" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_6d344d71-026b-4488-978c-bc3a161422cb" xlink:to="loc_srt_RestatementDomain_092953ea-693b-48bf-93ab-1f233364f5f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_48bda81d-b844-40fa-a229-9d7312259af2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_092953ea-693b-48bf-93ab-1f233364f5f4" xlink:to="loc_srt_RestatementAdjustmentMember_48bda81d-b844-40fa-a229-9d7312259af2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_9dafd854-acb8-4b38-857f-3adfa9edc61e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e1a94af2-55be-4092-be17-00fd9e0e328a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_9dafd854-acb8-4b38-857f-3adfa9edc61e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9dafd854-acb8-4b38-857f-3adfa9edc61e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9dafd854-acb8-4b38-857f-3adfa9edc61e" xlink:to="loc_us-gaap_SegmentDomain_9dafd854-acb8-4b38-857f-3adfa9edc61e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d324718c-00cb-4c2a-acfc-83ccb939e9e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9dafd854-acb8-4b38-857f-3adfa9edc61e" xlink:to="loc_us-gaap_SegmentDomain_d324718c-00cb-4c2a-acfc-83ccb939e9e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NourishMember_3683fdef-229c-4031-afb0-188a5aefcac1" xlink:href="iff-20231231.xsd#iff_NourishMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d324718c-00cb-4c2a-acfc-83ccb939e9e8" xlink:to="loc_iff_NourishMember_3683fdef-229c-4031-afb0-188a5aefcac1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_HealthBiosciencesMember_d0f9bc47-bc16-4ec0-a719-21380176da14" xlink:href="iff-20231231.xsd#iff_HealthBiosciencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d324718c-00cb-4c2a-acfc-83ccb939e9e8" xlink:to="loc_iff_HealthBiosciencesMember_d0f9bc47-bc16-4ec0-a719-21380176da14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_PharmaSolutionsMember_b39a237f-0a56-4c3d-913a-bc00efa65d22" xlink:href="iff-20231231.xsd#iff_PharmaSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d324718c-00cb-4c2a-acfc-83ccb939e9e8" xlink:to="loc_iff_PharmaSolutionsMember_b39a237f-0a56-4c3d-913a-bc00efa65d22" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ScentMember_38a0bb04-b27b-4d0f-beef-677f1d3ac48b" xlink:href="iff-20231231.xsd#iff_ScentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d324718c-00cb-4c2a-acfc-83ccb939e9e8" xlink:to="loc_iff_ScentMember_38a0bb04-b27b-4d0f-beef-677f1d3ac48b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c64ec588-dcba-4974-91b8-04b09295fe1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e1a94af2-55be-4092-be17-00fd9e0e328a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c64ec588-dcba-4974-91b8-04b09295fe1d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c64ec588-dcba-4974-91b8-04b09295fe1d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c64ec588-dcba-4974-91b8-04b09295fe1d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c64ec588-dcba-4974-91b8-04b09295fe1d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_efa77a62-701b-4f11-a047-5e8bcd6210dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c64ec588-dcba-4974-91b8-04b09295fe1d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_efa77a62-701b-4f11-a047-5e8bcd6210dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_2d73dc69-09f5-42c8-ab36-8f757e96ad9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_efa77a62-701b-4f11-a047-5e8bcd6210dd" xlink:to="loc_us-gaap_TradeNamesMember_2d73dc69-09f5-42c8-ab36-8f757e96ad9f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_4ee6bc3a-31a6-420d-85a6-8939c764e37b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_efa77a62-701b-4f11-a047-5e8bcd6210dd" xlink:to="loc_us-gaap_CustomerRelationshipsMember_4ee6bc3a-31a6-420d-85a6-8939c764e37b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TechnologicalKnowHowsMember_fb916ce4-e1a1-46d8-83e1-c1684d61c633" xlink:href="iff-20231231.xsd#iff_TechnologicalKnowHowsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_efa77a62-701b-4f11-a047-5e8bcd6210dd" xlink:to="loc_iff_TechnologicalKnowHowsMember_fb916ce4-e1a1-46d8-83e1-c1684d61c633" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_acea1e5d-c312-4f8c-8bb2-c0362012a73d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_efa77a62-701b-4f11-a047-5e8bcd6210dd" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_acea1e5d-c312-4f8c-8bb2-c0362012a73d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionTypeAxis_e86cb261-416b-42f6-90ad-b27ba2274c35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransactionTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e1a94af2-55be-4092-be17-00fd9e0e328a" xlink:to="loc_us-gaap_TransactionTypeAxis_e86cb261-416b-42f6-90ad-b27ba2274c35" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionDomain_e86cb261-416b-42f6-90ad-b27ba2274c35_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TransactionTypeAxis_e86cb261-416b-42f6-90ad-b27ba2274c35" xlink:to="loc_us-gaap_TransactionDomain_e86cb261-416b-42f6-90ad-b27ba2274c35_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionDomain_11dd774a-f941-4f1f-ad03-7b1406e867a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TransactionTypeAxis_e86cb261-416b-42f6-90ad-b27ba2274c35" xlink:to="loc_us-gaap_TransactionDomain_11dd774a-f941-4f1f-ad03-7b1406e867a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_MicrocrystallineCelluloseMember_9d386341-bf13-42cd-9460-bb3caf7b55f1" xlink:href="iff-20231231.xsd#iff_MicrocrystallineCelluloseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransactionDomain_11dd774a-f941-4f1f-ad03-7b1406e867a5" xlink:to="loc_iff_MicrocrystallineCelluloseMember_9d386341-bf13-42cd-9460-bb3caf7b55f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_208c4215-325e-44f3-8554-a682c6513783" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e1a94af2-55be-4092-be17-00fd9e0e328a" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_208c4215-325e-44f3-8554-a682c6513783" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_208c4215-325e-44f3-8554-a682c6513783_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_208c4215-325e-44f3-8554-a682c6513783" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_208c4215-325e-44f3-8554-a682c6513783_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9e8e2f68-f32d-40a0-a4e6-e0ce6e75f140" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_208c4215-325e-44f3-8554-a682c6513783" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9e8e2f68-f32d-40a0-a4e6-e0ce6e75f140" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_a8d7ef46-18c2-4e97-a7df-7246064352f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9e8e2f68-f32d-40a0-a4e6-e0ce6e75f140" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_a8d7ef46-18c2-4e97-a7df-7246064352f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_56854115-bbe9-4b0f-992e-a9e3460fe73d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_56854115-bbe9-4b0f-992e-a9e3460fe73d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_0f4bd02d-d424-4aaf-a732-073e80750447" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_0f4bd02d-d424-4aaf-a732-073e80750447" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_50005fc6-acda-4894-854c-4d785caf1e25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_50005fc6-acda-4894-854c-4d785caf1e25" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_92d1789c-529a-49d6-82b2-a51c345c911c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_92d1789c-529a-49d6-82b2-a51c345c911c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_458eb7e9-64ab-492c-b8e2-37b105e1f0ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_458eb7e9-64ab-492c-b8e2-37b105e1f0ce" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BusinessAcquisitionNetSales_91aebda5-3328-4458-bfc9-d17ec25f07c8" xlink:href="iff-20231231.xsd#iff_BusinessAcquisitionNetSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_iff_BusinessAcquisitionNetSales_91aebda5-3328-4458-bfc9-d17ec25f07c8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BusinessAcquisitionNetIncomeLoss_6660c610-04b5-43a2-8f4a-da3e362bcdfe" xlink:href="iff-20231231.xsd#iff_BusinessAcquisitionNetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_iff_BusinessAcquisitionNetIncomeLoss_6660c610-04b5-43a2-8f4a-da3e362bcdfe" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_0d1f7573-4c39-4d83-b3dc-4d4deed81d88" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_0d1f7573-4c39-4d83-b3dc-4d4deed81d88" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BusinessCombinationConsiderationTransferredReplacementEquityAwardsIssued_5f240e7d-e752-4b38-9228-f8e32032e51e" xlink:href="iff-20231231.xsd#iff_BusinessCombinationConsiderationTransferredReplacementEquityAwardsIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_iff_BusinessCombinationConsiderationTransferredReplacementEquityAwardsIssued_5f240e7d-e752-4b38-9228-f8e32032e51e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BusinessCombinationPensionFundingAdjustment_ee8aaf59-c91d-4570-affb-e40a22e5e016" xlink:href="iff-20231231.xsd#iff_BusinessCombinationPensionFundingAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_iff_BusinessCombinationPensionFundingAdjustment_ee8aaf59-c91d-4570-affb-e40a22e5e016" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_f2c7fb7a-5d4d-45e2-8434-311534c34913" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_f2c7fb7a-5d4d-45e2-8434-311534c34913" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DilutiveSharesQuotientMultiplier_e6ecc19c-cc60-43c0-b175-6ed9cf7b420b" xlink:href="iff-20231231.xsd#iff_DilutiveSharesQuotientMultiplier"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_iff_DilutiveSharesQuotientMultiplier_e6ecc19c-cc60-43c0-b175-6ed9cf7b420b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_1f46fdb8-91aa-4088-b54b-f872f346d0e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_1f46fdb8-91aa-4088-b54b-f872f346d0e8" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BusinessCombinationNetPensionBalanceDifferentialAmountSettledInCash_41a3bbae-b781-45d0-989f-94423fffedc7" xlink:href="iff-20231231.xsd#iff_BusinessCombinationNetPensionBalanceDifferentialAmountSettledInCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_iff_BusinessCombinationNetPensionBalanceDifferentialAmountSettledInCash_41a3bbae-b781-45d0-989f-94423fffedc7" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_04abcd4c-c095-42d6-9102-1c6da7524747" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_04abcd4c-c095-42d6-9102-1c6da7524747" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_2cd8d6e7-8e4f-4091-ac0a-e76e55a9650c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_2cd8d6e7-8e4f-4091-ac0a-e76e55a9650c" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_9bb64ad7-d88f-49bb-841c-c17df59d1979" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_9bb64ad7-d88f-49bb-841c-c17df59d1979" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_4455b0cf-d6b9-4d0f-aadf-e1bd4e480bcf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_4455b0cf-d6b9-4d0f-aadf-e1bd4e480bcf" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_b24c9306-10e6-474c-8ecb-f03d75375435" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_b24c9306-10e6-474c-8ecb-f03d75375435" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_14a33423-7aa1-4a5d-988e-8c7cd4334f25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_14a33423-7aa1-4a5d-988e-8c7cd4334f25" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_8b48f122-956b-454c-9871-c7fcfc040b5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_8b48f122-956b-454c-9871-c7fcfc040b5a" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_1de4fb09-a156-4f15-aff9-3c9f20562ad5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_1de4fb09-a156-4f15-aff9-3c9f20562ad5" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_d0b8354d-bb19-492c-8e70-08444f47e968" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_d0b8354d-bb19-492c-8e70-08444f47e968" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPayrollAndEmployeeBenefits_80bf59a0-554d-4d3d-957b-c704fc350bb0" xlink:href="iff-20231231.xsd#iff_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPayrollAndEmployeeBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_iff_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPayrollAndEmployeeBenefits_80bf59a0-554d-4d3d-957b-c704fc350bb0" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_78376d27-7f68-49b5-9e82-aff07b52f8dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_78376d27-7f68-49b5-9e82-aff07b52f8dd" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_ecf47560-37a7-4778-b377-579213e49eca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_ecf47560-37a7-4778-b377-579213e49eca" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_4105a1b9-fa69-46ee-abf2-e41e6d911705" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_4105a1b9-fa69-46ee-abf2-e41e6d911705" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_9096c76d-0585-4b41-a4c3-b973e8562d82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_9096c76d-0585-4b41-a4c3-b973e8562d82" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_73a6bc18-7042-4623-97d9-72a0d6913d79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_73a6bc18-7042-4623-97d9-72a0d6913d79" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_50861565-d9cb-49cd-8cef-b363554409e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_Goodwill_50861565-d9cb-49cd-8cef-b363554409e9" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_0e464839-1c7b-4a97-b24f-c4956a7ae46b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_0e464839-1c7b-4a97-b24f-c4956a7ae46b" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BusinessCombinationAdjustmentOnCashPayment_c98af10c-7e32-4428-b32c-b536169d0312" xlink:href="iff-20231231.xsd#iff_BusinessCombinationAdjustmentOnCashPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_iff_BusinessCombinationAdjustmentOnCashPayment_c98af10c-7e32-4428-b32c-b536169d0312" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_f8970ef8-a1f2-4d0b-8928-77a70de7ec27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefinitelivedIntangibleAssetsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_f8970ef8-a1f2-4d0b-8928-77a70de7ec27" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_4b326235-4821-491a-9e34-33ca6816dd78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_4b326235-4821-491a-9e34-33ca6816dd78" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BusinessCombinationLeaseAdjustment_22bf2503-a6b5-4d61-b836-82e5e4c44aac" xlink:href="iff-20231231.xsd#iff_BusinessCombinationLeaseAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_iff_BusinessCombinationLeaseAdjustment_22bf2503-a6b5-4d61-b836-82e5e4c44aac" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_8e751aaf-830b-4fdf-8792-2b106991609b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_8e751aaf-830b-4fdf-8792-2b106991609b" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_8253ed9e-f4da-4370-b47c-7cd7bc761db7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_8253ed9e-f4da-4370-b47c-7cd7bc761db7" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_7779920c-8934-436f-a379-95ea183451e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_7779920c-8934-436f-a379-95ea183451e0" xlink:type="arc" order="37"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_2e53f564-93e3-4e45-bc10-b8daba9a99ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_2e53f564-93e3-4e45-bc10-b8daba9a99ec" xlink:type="arc" order="38"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_e11ec8b6-5945-4a97-92bb-945ec8ce3419" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_e11ec8b6-5945-4a97-92bb-945ec8ce3419" xlink:type="arc" order="39"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_101baa71-103b-4eba-9f5f-1ca84da6ac33" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_101baa71-103b-4eba-9f5f-1ca84da6ac33" xlink:type="arc" order="40"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_11dffef6-b3d7-4e0e-bbf4-afd6501fe6c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_11dffef6-b3d7-4e0e-bbf4-afd6501fe6c5" xlink:type="arc" order="41"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/BusinessDivestitureDetails" xlink:type="simple" xlink:href="iff-20231231.xsd#BusinessDivestitureDetails"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/BusinessDivestitureDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d47500f9-61a8-43fd-9341-ac81cb2e65d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d47500f9-61a8-43fd-9341-ac81cb2e65d1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f01d2424-747b-4fae-8bd5-1255a8c07634" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d47500f9-61a8-43fd-9341-ac81cb2e65d1" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f01d2424-747b-4fae-8bd5-1255a8c07634" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f01d2424-747b-4fae-8bd5-1255a8c07634_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f01d2424-747b-4fae-8bd5-1255a8c07634" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f01d2424-747b-4fae-8bd5-1255a8c07634_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d6c06d8e-089d-47c0-a61b-f565f797324d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f01d2424-747b-4fae-8bd5-1255a8c07634" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d6c06d8e-089d-47c0-a61b-f565f797324d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_MicrobialControlMember_37e9697f-d12c-4c84-b05c-06c238745f66" xlink:href="iff-20231231.xsd#iff_MicrobialControlMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d6c06d8e-089d-47c0-a61b-f565f797324d" xlink:to="loc_iff_MicrobialControlMember_37e9697f-d12c-4c84-b05c-06c238745f66" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FlavorSpecialtyIngredientsMember_b595001d-f08f-4e36-aca9-c2c93714dc01" xlink:href="iff-20231231.xsd#iff_FlavorSpecialtyIngredientsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d6c06d8e-089d-47c0-a61b-f565f797324d" xlink:to="loc_iff_FlavorSpecialtyIngredientsMember_b595001d-f08f-4e36-aca9-c2c93714dc01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SavorySolutionsBusinessMember_c14dc409-1ec8-435b-9957-caf50111fc17" xlink:href="iff-20231231.xsd#iff_SavorySolutionsBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d6c06d8e-089d-47c0-a61b-f565f797324d" xlink:to="loc_iff_SavorySolutionsBusinessMember_c14dc409-1ec8-435b-9957-caf50111fc17" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_844373de-fd39-491b-af21-a0e7f6abcea0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d47500f9-61a8-43fd-9341-ac81cb2e65d1" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_844373de-fd39-491b-af21-a0e7f6abcea0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_844373de-fd39-491b-af21-a0e7f6abcea0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_844373de-fd39-491b-af21-a0e7f6abcea0" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_844373de-fd39-491b-af21-a0e7f6abcea0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_3aef7066-a067-4571-9251-608b5df50dd3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_844373de-fd39-491b-af21-a0e7f6abcea0" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_3aef7066-a067-4571-9251-608b5df50dd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember_52c13141-48d3-47f1-a7a3-904e1b7b2d3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_3aef7066-a067-4571-9251-608b5df50dd3" xlink:to="loc_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember_52c13141-48d3-47f1-a7a3-904e1b7b2d3b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ProceedsFromDivestitureOfBusinessesGross_1a64b66e-0ae6-4d42-a6c1-697e2fd7ef7c" xlink:href="iff-20231231.xsd#iff_ProceedsFromDivestitureOfBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_iff_ProceedsFromDivestitureOfBusinessesGross_1a64b66e-0ae6-4d42-a6c1-697e2fd7ef7c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable_ead7a66e-6e1b-41af-aa45-799b2badbe97" xlink:href="iff-20231231.xsd#iff_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_iff_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable_ead7a66e-6e1b-41af-aa45-799b2badbe97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupIncludingDiscontinuedOperationAdvanceReceiptForBusinessToBeTransferred_85c86c1f-d31e-43f5-8153-68bf2564820d" xlink:href="iff-20231231.xsd#iff_DisposalGroupIncludingDiscontinuedOperationAdvanceReceiptForBusinessToBeTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_iff_DisposalGroupIncludingDiscontinuedOperationAdvanceReceiptForBusinessToBeTransferred_85c86c1f-d31e-43f5-8153-68bf2564820d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TransitionServicesAgreementFairValue_8dfa0d18-e766-4136-9a7e-3004acd68ada" xlink:href="iff-20231231.xsd#iff_TransitionServicesAgreementFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_iff_TransitionServicesAgreementFairValue_8dfa0d18-e766-4136-9a7e-3004acd68ada" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EscrowDeposit_3c0fbbbb-e813-49ac-9abf-d5573cace60e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EscrowDeposit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_EscrowDeposit_3c0fbbbb-e813-49ac-9abf-d5573cace60e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupIncludingDiscontinuedOperationPostClosingAdjustments_09f6111c-9591-453c-a6fa-84cbaf041975" xlink:href="iff-20231231.xsd#iff_DisposalGroupIncludingDiscontinuedOperationPostClosingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_iff_DisposalGroupIncludingDiscontinuedOperationPostClosingAdjustments_09f6111c-9591-453c-a6fa-84cbaf041975" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TransitionServicesAgreementTerm_14452047-0ca4-49d9-8fe7-abebcfb4a142" xlink:href="iff-20231231.xsd#iff_TransitionServicesAgreementTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_iff_TransitionServicesAgreementTerm_14452047-0ca4-49d9-8fe7-abebcfb4a142" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TransitionServicesAgreementIncomeReductionToCostsNotIncludedInRevenue_979ac867-9389-49b8-8314-ca8e2153709a" xlink:href="iff-20231231.xsd#iff_TransitionServicesAgreementIncomeReductionToCostsNotIncludedInRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_iff_TransitionServicesAgreementIncomeReductionToCostsNotIncludedInRevenue_979ac867-9389-49b8-8314-ca8e2153709a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_b7dc9766-3a0d-4b82-bd1d-779914e8532a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_b7dc9766-3a0d-4b82-bd1d-779914e8532a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_CashTransferredToTheBuyerOnTheClosingBalanceSheet_7ada75f9-5a5c-4b3b-a72a-97dde9fa1d70" xlink:href="iff-20231231.xsd#iff_CashTransferredToTheBuyerOnTheClosingBalanceSheet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_iff_CashTransferredToTheBuyerOnTheClosingBalanceSheet_7ada75f9-5a5c-4b3b-a72a-97dde9fa1d70" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupIncludingDiscontinuedOperationConsiderationAdvanceReceiptForBusinessToBeTransferred_159f8fa3-bdb6-4b98-ac14-4015a2693442" xlink:href="iff-20231231.xsd#iff_DisposalGroupIncludingDiscontinuedOperationConsiderationAdvanceReceiptForBusinessToBeTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_iff_DisposalGroupIncludingDiscontinuedOperationConsiderationAdvanceReceiptForBusinessToBeTransferred_159f8fa3-bdb6-4b98-ac14-4015a2693442" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EmployeeReimbursementReceivable_5065371a-c77d-4b8e-82c3-cf92d1bd8a2c" xlink:href="iff-20231231.xsd#iff_EmployeeReimbursementReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_iff_EmployeeReimbursementReceivable_5065371a-c77d-4b8e-82c3-cf92d1bd8a2c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ProceedsFromDivestitureOfBusinessNet_3efffa96-8dbd-4412-a802-436f1b631c72" xlink:href="iff-20231231.xsd#iff_ProceedsFromDivestitureOfBusinessNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_iff_ProceedsFromDivestitureOfBusinessNet_3efffa96-8dbd-4412-a802-436f1b631c72" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_2a5c014c-e702-4b2c-bbe8-45ddb4c6aed1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_2a5c014c-e702-4b2c-bbe8-45ddb4c6aed1" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_80a3c141-e65c-4666-9cb9-7d1c86998fd9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_80a3c141-e65c-4666-9cb9-7d1c86998fd9" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_5f66b4ff-7c2e-4c48-8180-26d0453af44f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_EquityMethodInvestments_5f66b4ff-7c2e-4c48-8180-26d0453af44f" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_510044cb-bca6-4782-b938-c6204cc674a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_510044cb-bca6-4782-b938-c6204cc674a9" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_4cebe0b8-49ed-4b8f-8259-95dab1b0fbcd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_4cebe0b8-49ed-4b8f-8259-95dab1b0fbcd" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_ffb9fcd2-6c7d-44b4-8412-7048a8c0ad73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_ffb9fcd2-6c7d-44b4-8412-7048a8c0ad73" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_152fb035-99ae-4e16-a8b6-07c0c5a20478" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_152fb035-99ae-4e16-a8b6-07c0c5a20478" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_82542d2f-b742-48e5-b808-5c177324b12c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_82542d2f-b742-48e5-b808-5c177324b12c" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_074da73d-d0fd-469d-8b08-c4d8fc866098" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_074da73d-d0fd-469d-8b08-c4d8fc866098" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupIncludingDiscontinuedOperationNetAssets_f68d53bb-470c-4bce-89a6-54ee76eded57" xlink:href="iff-20231231.xsd#iff_DisposalGroupIncludingDiscontinuedOperationNetAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_iff_DisposalGroupIncludingDiscontinuedOperationNetAssets_f68d53bb-470c-4bce-89a6-54ee76eded57" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_ab81a790-d571-4cd4-bbe1-f450fc98e08f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_ab81a790-d571-4cd4-bbe1-f450fc98e08f" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupIncludingDiscontinuedOperationAmountHeldInEscrow_8aefd0ba-cd43-4ca6-9deb-590f2636cfd5" xlink:href="iff-20231231.xsd#iff_DisposalGroupIncludingDiscontinuedOperationAmountHeldInEscrow"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_iff_DisposalGroupIncludingDiscontinuedOperationAmountHeldInEscrow_8aefd0ba-cd43-4ca6-9deb-590f2636cfd5" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupIncludingDiscontinuedOperationTransactionCostCredits_45e05925-cfe6-4361-be74-7355a9d3f0d7" xlink:href="iff-20231231.xsd#iff_DisposalGroupIncludingDiscontinuedOperationTransactionCostCredits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_iff_DisposalGroupIncludingDiscontinuedOperationTransactionCostCredits_45e05925-cfe6-4361-be74-7355a9d3f0d7" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupIncludingDiscontinuedOperationConsiderationPayableReceivable_4c56f197-e395-4524-9e2d-546b801809ac" xlink:href="iff-20231231.xsd#iff_DisposalGroupIncludingDiscontinuedOperationConsiderationPayableReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_iff_DisposalGroupIncludingDiscontinuedOperationConsiderationPayableReceivable_4c56f197-e395-4524-9e2d-546b801809ac" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupIncludingDiscontinuedOperationProceedsAttributableToSupplyAgreement_fbe50789-864b-4c26-a063-3b9a43242bbd" xlink:href="iff-20231231.xsd#iff_DisposalGroupIncludingDiscontinuedOperationProceedsAttributableToSupplyAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_iff_DisposalGroupIncludingDiscontinuedOperationProceedsAttributableToSupplyAgreement_fbe50789-864b-4c26-a063-3b9a43242bbd" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupIncludingDiscontinuedOperationCashTransferredToBuyer_2194ee0a-9187-4c39-94bc-9b95e1be7cd5" xlink:href="iff-20231231.xsd#iff_DisposalGroupIncludingDiscontinuedOperationCashTransferredToBuyer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_iff_DisposalGroupIncludingDiscontinuedOperationCashTransferredToBuyer_2194ee0a-9187-4c39-94bc-9b95e1be7cd5" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a41b0e5c-27dd-4bcb-b620-19707ccfd9e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a41b0e5c-27dd-4bcb-b620-19707ccfd9e9" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_7907c4a3-9762-4f6f-85b5-bcedfd9dcad8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_ReceivablesNetCurrent_7907c4a3-9762-4f6f-85b5-bcedfd9dcad8" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_26b006c6-10c7-4a14-b545-964e1d116711" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_InventoryNet_26b006c6-10c7-4a14-b545-964e1d116711" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_e5133b46-93b4-4be5-87d4-abc7de7b9903" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_e5133b46-93b4-4be5-87d4-abc7de7b9903" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_139fe0a6-f19d-4f64-bcaa-82f994363112" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_Goodwill_139fe0a6-f19d-4f64-bcaa-82f994363112" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f3535362-1e5b-4212-824c-34b098e10abf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f3535362-1e5b-4212-824c-34b098e10abf" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_5d306998-b8e8-4e30-8130-5d6f0452e64b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_5d306998-b8e8-4e30-8130-5d6f0452e64b" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_5612e46c-877a-4698-8c48-4fd8397edebb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_Assets_5612e46c-877a-4698-8c48-4fd8397edebb" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_e5aa0e33-9a72-4b87-ba01-d25d5cbb0c17" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_AccountsPayableCurrent_e5aa0e33-9a72-4b87-ba01-d25d5cbb0c17" xlink:type="arc" order="37"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_84b42f61-5d9a-4ede-a6c9-25855a3966a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_84b42f61-5d9a-4ede-a6c9-25855a3966a2" xlink:type="arc" order="38"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_377b199a-93f5-4081-abe0-af6202ef1d7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_377b199a-93f5-4081-abe0-af6202ef1d7a" xlink:type="arc" order="39"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_dc09a2a5-ac02-4ab9-abb4-c42c785e616f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_Liabilities_dc09a2a5-ac02-4ab9-abb4-c42c785e616f" xlink:type="arc" order="40"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_2426a046-db32-4c08-a150-b5977e740cb3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_2426a046-db32-4c08-a150-b5977e740cb3" xlink:type="arc" order="41"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0d1b85ed-7aab-4206-bc4e-621f5d0c5cd3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_StockholdersEquity_0d1b85ed-7aab-4206-bc4e-621f5d0c5cd3" xlink:type="arc" order="42"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNetAsset_136a4d64-00e5-40bf-a7ae-b37f458eaf08" xlink:href="iff-20231231.xsd#iff_DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNetAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_iff_DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNetAsset_136a4d64-00e5-40bf-a7ae-b37f458eaf08" xlink:type="arc" order="43"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalBeforeIncomeTax_1bcb85e9-87b5-41f8-8934-964574a13bf7" xlink:href="iff-20231231.xsd#iff_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalBeforeIncomeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_iff_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalBeforeIncomeTax_1bcb85e9-87b5-41f8-8934-964574a13bf7" xlink:type="arc" order="44"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupNotDiscontinuedOperationTaxEffectOfGainLossFromDivestiture_8b286c5c-3165-4785-9d27-6c278da3938d" xlink:href="iff-20231231.xsd#iff_DisposalGroupNotDiscontinuedOperationTaxEffectOfGainLossFromDivestiture"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_iff_DisposalGroupNotDiscontinuedOperationTaxEffectOfGainLossFromDivestiture_8b286c5c-3165-4785-9d27-6c278da3938d" xlink:type="arc" order="45"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupIncludingDiscontinuedOperationTransactionCost_e33ce15a-6d90-4740-8d04-022cc3c7315d" xlink:href="iff-20231231.xsd#iff_DisposalGroupIncludingDiscontinuedOperationTransactionCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_iff_DisposalGroupIncludingDiscontinuedOperationTransactionCost_e33ce15a-6d90-4740-8d04-022cc3c7315d" xlink:type="arc" order="46"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_939596e2-d86c-414f-bd4b-67ffda4307b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_RestrictedCashCurrent_939596e2-d86c-414f-bd4b-67ffda4307b0" xlink:type="arc" order="47"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_e7bfad6c-38e2-41c9-89da-23317caaaaf9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_e7bfad6c-38e2-41c9-89da-23317caaaaf9" xlink:type="arc" order="48"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AccumulatedOtherComprehensiveIncomeLossPensionLiabilityAndPostretirementAfterTax_c04e0d2c-7680-437f-b3c5-5691a197f552" xlink:href="iff-20231231.xsd#iff_AccumulatedOtherComprehensiveIncomeLossPensionLiabilityAndPostretirementAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_iff_AccumulatedOtherComprehensiveIncomeLossPensionLiabilityAndPostretirementAfterTax_c04e0d2c-7680-437f-b3c5-5691a197f552" xlink:type="arc" order="49"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupNotDiscontinuedOperationLiquidationTaxEffect_163b2e3f-50b4-4dc4-b548-dc96ba8d07ba" xlink:href="iff-20231231.xsd#iff_DisposalGroupNotDiscontinuedOperationLiquidationTaxEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_iff_DisposalGroupNotDiscontinuedOperationLiquidationTaxEffect_163b2e3f-50b4-4dc4-b548-dc96ba8d07ba" xlink:type="arc" order="50"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupNotDiscontinuedOperationGainLossOnLiquidationBeforeIncomeTax_7cf17ee5-1017-4b0c-ab48-7055853d5549" xlink:href="iff-20231231.xsd#iff_DisposalGroupNotDiscontinuedOperationGainLossOnLiquidationBeforeIncomeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_iff_DisposalGroupNotDiscontinuedOperationGainLossOnLiquidationBeforeIncomeTax_7cf17ee5-1017-4b0c-ab48-7055853d5549" xlink:type="arc" order="51"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetail"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_31960016-16d4-4ce3-9a7b-5a6490b12ed8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4d4ec245-ce74-49da-8e96-8d6205d3999e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_31960016-16d4-4ce3-9a7b-5a6490b12ed8" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4d4ec245-ce74-49da-8e96-8d6205d3999e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6da3f784-1f23-4bf3-b9d5-02440670ccc8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4d4ec245-ce74-49da-8e96-8d6205d3999e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6da3f784-1f23-4bf3-b9d5-02440670ccc8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6da3f784-1f23-4bf3-b9d5-02440670ccc8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6da3f784-1f23-4bf3-b9d5-02440670ccc8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6da3f784-1f23-4bf3-b9d5-02440670ccc8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e9f5cfd4-2a58-4517-ba33-42859b6b6be1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6da3f784-1f23-4bf3-b9d5-02440670ccc8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e9f5cfd4-2a58-4517-ba33-42859b6b6be1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_f00f477a-7fde-47b2-9d4e-4631ae377166" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e9f5cfd4-2a58-4517-ba33-42859b6b6be1" xlink:to="loc_us-gaap_LandMember_f00f477a-7fde-47b2-9d4e-4631ae377166" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_46382e72-db17-48c6-abf5-a42dfc98df9d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e9f5cfd4-2a58-4517-ba33-42859b6b6be1" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_46382e72-db17-48c6-abf5-a42dfc98df9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_798013f0-ca0c-4ef8-bc86-5927c07d76d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e9f5cfd4-2a58-4517-ba33-42859b6b6be1" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_798013f0-ca0c-4ef8-bc86-5927c07d76d6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyEquipmentMember_5d123568-266f-4005-a9c3-161fc80af993" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TechnologyEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e9f5cfd4-2a58-4517-ba33-42859b6b6be1" xlink:to="loc_us-gaap_TechnologyEquipmentMember_5d123568-266f-4005-a9c3-161fc80af993" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_3b230919-a2d3-423b-b2c1-fa3e83848e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e9f5cfd4-2a58-4517-ba33-42859b6b6be1" xlink:to="loc_us-gaap_ConstructionInProgressMember_3b230919-a2d3-423b-b2c1-fa3e83848e9a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_81a63fdb-1807-4e0f-92ca-8077dbf61f53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4d4ec245-ce74-49da-8e96-8d6205d3999e" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_81a63fdb-1807-4e0f-92ca-8077dbf61f53" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_81a63fdb-1807-4e0f-92ca-8077dbf61f53_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_81a63fdb-1807-4e0f-92ca-8077dbf61f53" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_81a63fdb-1807-4e0f-92ca-8077dbf61f53_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_9bb75310-8652-4cbf-806a-b2b60b4076aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_81a63fdb-1807-4e0f-92ca-8077dbf61f53" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_9bb75310-8652-4cbf-806a-b2b60b4076aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_e0c0892f-c8c6-4ebd-9fe2-e05979bd62f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_9bb75310-8652-4cbf-806a-b2b60b4076aa" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_e0c0892f-c8c6-4ebd-9fe2-e05979bd62f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_99e9c96e-844b-439b-a0ef-51a37e12a2c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4d4ec245-ce74-49da-8e96-8d6205d3999e" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_99e9c96e-844b-439b-a0ef-51a37e12a2c6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_99e9c96e-844b-439b-a0ef-51a37e12a2c6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_99e9c96e-844b-439b-a0ef-51a37e12a2c6" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_99e9c96e-844b-439b-a0ef-51a37e12a2c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_8f7c3cc9-64ae-4d55-aa62-ccb67018935c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_99e9c96e-844b-439b-a0ef-51a37e12a2c6" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_8f7c3cc9-64ae-4d55-aa62-ccb67018935c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_RussiaUkraineWarMember_26f819dc-4ac0-441f-b0e4-77adddb9445e" xlink:href="iff-20231231.xsd#iff_RussiaUkraineWarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_8f7c3cc9-64ae-4d55-aa62-ccb67018935c" xlink:to="loc_iff_RussiaUkraineWarMember_26f819dc-4ac0-441f-b0e4-77adddb9445e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_100de830-4e6d-4da5-9bb9-e33aee5724a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_31960016-16d4-4ce3-9a7b-5a6490b12ed8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_100de830-4e6d-4da5-9bb9-e33aee5724a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_225548cf-4662-4844-8873-559bbda9cfd0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_31960016-16d4-4ce3-9a7b-5a6490b12ed8" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_225548cf-4662-4844-8873-559bbda9cfd0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f46a2d3f-a575-4283-8f44-2851217e12bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_31960016-16d4-4ce3-9a7b-5a6490b12ed8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_f46a2d3f-a575-4283-8f44-2851217e12bc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_472d9c86-ede4-4dee-929c-4ab8cbcea985" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_31960016-16d4-4ce3-9a7b-5a6490b12ed8" xlink:to="loc_us-gaap_Depreciation_472d9c86-ede4-4dee-929c-4ab8cbcea985" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_f6b22944-77c4-427d-be2d-a913c2dfe191" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_31960016-16d4-4ce3-9a7b-5a6490b12ed8" xlink:to="loc_us-gaap_AssetImpairmentCharges_f6b22944-77c4-427d-be2d-a913c2dfe191" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetNarrativeDetails" xlink:type="simple" xlink:href="iff-20231231.xsd#GoodwillandOtherIntangibleAssetsNetNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_d369fbc4-8be8-4710-9321-4b99151a5540" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_8477f250-af8d-460e-972f-b3125664df9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_d369fbc4-8be8-4710-9321-4b99151a5540" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_8477f250-af8d-460e-972f-b3125664df9f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6058b874-3860-4250-902e-29ea89c02663" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_8477f250-af8d-460e-972f-b3125664df9f" xlink:to="loc_srt_RangeAxis_6058b874-3860-4250-902e-29ea89c02663" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6058b874-3860-4250-902e-29ea89c02663_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_6058b874-3860-4250-902e-29ea89c02663" xlink:to="loc_srt_RangeMember_6058b874-3860-4250-902e-29ea89c02663_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f6da15f9-210f-49cf-9ad0-2d635e24c729" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_6058b874-3860-4250-902e-29ea89c02663" xlink:to="loc_srt_RangeMember_f6da15f9-210f-49cf-9ad0-2d635e24c729" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_509482b0-a51e-49ee-9413-29a07fad45ca" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f6da15f9-210f-49cf-9ad0-2d635e24c729" xlink:to="loc_srt_MinimumMember_509482b0-a51e-49ee-9413-29a07fad45ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_bcd44173-2810-4e9e-b960-4f9c6f983aff" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f6da15f9-210f-49cf-9ad0-2d635e24c729" xlink:to="loc_srt_MaximumMember_bcd44173-2810-4e9e-b960-4f9c6f983aff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_9a3a6419-4618-43aa-9bd5-a9ed21967b0e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReportingUnitAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_8477f250-af8d-460e-972f-b3125664df9f" xlink:to="loc_us-gaap_ReportingUnitAxis_9a3a6419-4618-43aa-9bd5-a9ed21967b0e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_9a3a6419-4618-43aa-9bd5-a9ed21967b0e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReportingUnitAxis_9a3a6419-4618-43aa-9bd5-a9ed21967b0e" xlink:to="loc_us-gaap_ReportingUnitDomain_9a3a6419-4618-43aa-9bd5-a9ed21967b0e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_ec5127d0-94a6-486d-941f-d6560ea7fc96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReportingUnitAxis_9a3a6419-4618-43aa-9bd5-a9ed21967b0e" xlink:to="loc_us-gaap_ReportingUnitDomain_ec5127d0-94a6-486d-941f-d6560ea7fc96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NourishMember_dd967002-7920-48d7-ba72-bbe5f09d4e78" xlink:href="iff-20231231.xsd#iff_NourishMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_ec5127d0-94a6-486d-941f-d6560ea7fc96" xlink:to="loc_iff_NourishMember_dd967002-7920-48d7-ba72-bbe5f09d4e78" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ScentMember_2a99e65b-64cb-4772-be07-b38c9a0c52bf" xlink:href="iff-20231231.xsd#iff_ScentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_ec5127d0-94a6-486d-941f-d6560ea7fc96" xlink:to="loc_iff_ScentMember_2a99e65b-64cb-4772-be07-b38c9a0c52bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_HealthBiosciencesMember_6e445b7f-db37-4880-8f7f-f10f8aacbf35" xlink:href="iff-20231231.xsd#iff_HealthBiosciencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_ec5127d0-94a6-486d-941f-d6560ea7fc96" xlink:to="loc_iff_HealthBiosciencesMember_6e445b7f-db37-4880-8f7f-f10f8aacbf35" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_PharmaSolutionsMember_cfc04062-cba2-4720-bf12-7b56a3c602ad" xlink:href="iff-20231231.xsd#iff_PharmaSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_ec5127d0-94a6-486d-941f-d6560ea7fc96" xlink:to="loc_iff_PharmaSolutionsMember_cfc04062-cba2-4720-bf12-7b56a3c602ad" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FragranceCompoundsMember_4ce9a0a5-0a96-421d-bb04-5bb3527c716e" xlink:href="iff-20231231.xsd#iff_FragranceCompoundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_ec5127d0-94a6-486d-941f-d6560ea7fc96" xlink:to="loc_iff_FragranceCompoundsMember_4ce9a0a5-0a96-421d-bb04-5bb3527c716e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FragranceIngredientsMember_a0d45648-d14e-4fed-b662-23b6f80504f3" xlink:href="iff-20231231.xsd#iff_FragranceIngredientsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_ec5127d0-94a6-486d-941f-d6560ea7fc96" xlink:to="loc_iff_FragranceIngredientsMember_a0d45648-d14e-4fed-b662-23b6f80504f3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_CosmeticActivesMember_3c196f80-ecce-4d92-8d53-e0d3cd5ab2f1" xlink:href="iff-20231231.xsd#iff_CosmeticActivesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_ec5127d0-94a6-486d-941f-d6560ea7fc96" xlink:to="loc_iff_CosmeticActivesMember_3c196f80-ecce-4d92-8d53-e0d3cd5ab2f1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_6b829b23-d3fa-4955-bbbc-3846718e6f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_8477f250-af8d-460e-972f-b3125664df9f" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_6b829b23-d3fa-4955-bbbc-3846718e6f8c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_6b829b23-d3fa-4955-bbbc-3846718e6f8c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_6b829b23-d3fa-4955-bbbc-3846718e6f8c" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_6b829b23-d3fa-4955-bbbc-3846718e6f8c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_cbdc349a-5f52-46c8-bb3f-3bff3e5eb791" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_6b829b23-d3fa-4955-bbbc-3846718e6f8c" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_cbdc349a-5f52-46c8-bb3f-3bff3e5eb791" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMember_9c454998-1dd9-42c2-8340-6bbe59cefbef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_cbdc349a-5f52-46c8-bb3f-3bff3e5eb791" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMember_9c454998-1dd9-42c2-8340-6bbe59cefbef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_d1f34566-be3a-4d0b-803b-c74f62672e6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_8477f250-af8d-460e-972f-b3125664df9f" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_d1f34566-be3a-4d0b-803b-c74f62672e6f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_d1f34566-be3a-4d0b-803b-c74f62672e6f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_d1f34566-be3a-4d0b-803b-c74f62672e6f" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_d1f34566-be3a-4d0b-803b-c74f62672e6f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_136eddfd-1704-40f1-985d-171787f12e6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_d1f34566-be3a-4d0b-803b-c74f62672e6f" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_136eddfd-1704-40f1-985d-171787f12e6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_RussiaUkraineWarMember_5e24ee8b-8c40-458f-a6f0-de1ac75331c2" xlink:href="iff-20231231.xsd#iff_RussiaUkraineWarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_136eddfd-1704-40f1-985d-171787f12e6b" xlink:to="loc_iff_RussiaUkraineWarMember_5e24ee8b-8c40-458f-a6f0-de1ac75331c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_efb942ea-7fe9-48e0-aba3-411f11b336a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_8477f250-af8d-460e-972f-b3125664df9f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_efb942ea-7fe9-48e0-aba3-411f11b336a5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_efb942ea-7fe9-48e0-aba3-411f11b336a5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_efb942ea-7fe9-48e0-aba3-411f11b336a5" xlink:to="loc_us-gaap_SegmentDomain_efb942ea-7fe9-48e0-aba3-411f11b336a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8be27981-ef53-4a72-85af-c8f575df7bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_efb942ea-7fe9-48e0-aba3-411f11b336a5" xlink:to="loc_us-gaap_SegmentDomain_8be27981-ef53-4a72-85af-c8f575df7bf9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_HealthBiosciencesMember_5e1c6148-3bb9-4bc2-8931-ee9fc31a830c" xlink:href="iff-20231231.xsd#iff_HealthBiosciencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8be27981-ef53-4a72-85af-c8f575df7bf9" xlink:to="loc_iff_HealthBiosciencesMember_5e1c6148-3bb9-4bc2-8931-ee9fc31a830c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_PharmaSolutionsMember_edf8aa34-8e73-4767-848d-d1559d549958" xlink:href="iff-20231231.xsd#iff_PharmaSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8be27981-ef53-4a72-85af-c8f575df7bf9" xlink:to="loc_iff_PharmaSolutionsMember_edf8aa34-8e73-4767-848d-d1559d549958" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NourishAndHealthBiosciencesMember_219a8a7e-6dbe-4276-a3e1-fbe34f90ea50" xlink:href="iff-20231231.xsd#iff_NourishAndHealthBiosciencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8be27981-ef53-4a72-85af-c8f575df7bf9" xlink:to="loc_iff_NourishAndHealthBiosciencesMember_219a8a7e-6dbe-4276-a3e1-fbe34f90ea50" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NourishMember_1dc403b4-9c29-4645-83ac-ab8a519df655" xlink:href="iff-20231231.xsd#iff_NourishMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8be27981-ef53-4a72-85af-c8f575df7bf9" xlink:to="loc_iff_NourishMember_1dc403b4-9c29-4645-83ac-ab8a519df655" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPeriodIncreaseDecrease_18cca023-0447-4c64-ab7e-1cc6ec8e77a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_d369fbc4-8be8-4710-9321-4b99151a5540" xlink:to="loc_us-gaap_GoodwillPeriodIncreaseDecrease_18cca023-0447-4c64-ab7e-1cc6ec8e77a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_28801ec2-3d59-4be0-be16-a9a6892e7047" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_d369fbc4-8be8-4710-9321-4b99151a5540" xlink:to="loc_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_28801ec2-3d59-4be0-be16-a9a6892e7047" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_8a52b92f-f153-4813-b595-c5630e083408" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_d369fbc4-8be8-4710-9321-4b99151a5540" xlink:to="loc_us-gaap_AssetImpairmentCharges_8a52b92f-f153-4813-b595-c5630e083408" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_4a9b029c-30fc-460c-bfa3-f6fcb8edde7e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_d369fbc4-8be8-4710-9321-4b99151a5540" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_4a9b029c-30fc-460c-bfa3-f6fcb8edde7e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_16b214e5-b7de-4f60-b607-0651dc1609d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_d369fbc4-8be8-4710-9321-4b99151a5540" xlink:to="loc_us-gaap_Goodwill_16b214e5-b7de-4f60-b607-0651dc1609d5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_67023871-e476-4218-94e3-a1edf46ff578" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_d369fbc4-8be8-4710-9321-4b99151a5540" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_67023871-e476-4218-94e3-a1edf46ff578" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetGoodwillRollforwardDetails" xlink:type="simple" xlink:href="iff-20231231.xsd#GoodwillandOtherIntangibleAssetsNetGoodwillRollforwardDetails"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetGoodwillRollforwardDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_5fb1dc1f-6bd2-4d44-af3c-f5a131def1c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_8b726c66-fd7f-4fc5-8f45-631bb891ce6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_5fb1dc1f-6bd2-4d44-af3c-f5a131def1c2" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_8b726c66-fd7f-4fc5-8f45-631bb891ce6b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_2d3aa30c-70f0-4d80-af83-23377915e002" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_8b726c66-fd7f-4fc5-8f45-631bb891ce6b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_2d3aa30c-70f0-4d80-af83-23377915e002" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2d3aa30c-70f0-4d80-af83-23377915e002_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_2d3aa30c-70f0-4d80-af83-23377915e002" xlink:to="loc_us-gaap_SegmentDomain_2d3aa30c-70f0-4d80-af83-23377915e002_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ce92f8d5-66e1-4c79-80fd-17257d7d4ae8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_2d3aa30c-70f0-4d80-af83-23377915e002" xlink:to="loc_us-gaap_SegmentDomain_ce92f8d5-66e1-4c79-80fd-17257d7d4ae8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NourishMember_919a9c38-6f84-4248-9d28-16a9fab30dd6" xlink:href="iff-20231231.xsd#iff_NourishMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ce92f8d5-66e1-4c79-80fd-17257d7d4ae8" xlink:to="loc_iff_NourishMember_919a9c38-6f84-4248-9d28-16a9fab30dd6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_HealthBiosciencesMember_a5635972-d9a3-4508-abe6-232ff26d4a14" xlink:href="iff-20231231.xsd#iff_HealthBiosciencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ce92f8d5-66e1-4c79-80fd-17257d7d4ae8" xlink:to="loc_iff_HealthBiosciencesMember_a5635972-d9a3-4508-abe6-232ff26d4a14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ScentMember_22ad4786-f5ca-41d3-86f2-3e82d99dce94" xlink:href="iff-20231231.xsd#iff_ScentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ce92f8d5-66e1-4c79-80fd-17257d7d4ae8" xlink:to="loc_iff_ScentMember_22ad4786-f5ca-41d3-86f2-3e82d99dce94" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_PharmaSolutionsMember_361cd3b6-71f3-47d6-8f80-3f53159bfec2" xlink:href="iff-20231231.xsd#iff_PharmaSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ce92f8d5-66e1-4c79-80fd-17257d7d4ae8" xlink:to="loc_iff_PharmaSolutionsMember_361cd3b6-71f3-47d6-8f80-3f53159bfec2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_81eb384c-2620-4929-b3ac-a75be8818707" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReportingUnitAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_8b726c66-fd7f-4fc5-8f45-631bb891ce6b" xlink:to="loc_us-gaap_ReportingUnitAxis_81eb384c-2620-4929-b3ac-a75be8818707" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_81eb384c-2620-4929-b3ac-a75be8818707_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReportingUnitAxis_81eb384c-2620-4929-b3ac-a75be8818707" xlink:to="loc_us-gaap_ReportingUnitDomain_81eb384c-2620-4929-b3ac-a75be8818707_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_e252a350-945e-4acd-b5dc-c8130c971e71" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReportingUnitAxis_81eb384c-2620-4929-b3ac-a75be8818707" xlink:to="loc_us-gaap_ReportingUnitDomain_e252a350-945e-4acd-b5dc-c8130c971e71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NourishMember_48b7b6a6-8cf9-4caf-b850-6a3e799670cc" xlink:href="iff-20231231.xsd#iff_NourishMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_e252a350-945e-4acd-b5dc-c8130c971e71" xlink:to="loc_iff_NourishMember_48b7b6a6-8cf9-4caf-b850-6a3e799670cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_HealthBiosciencesMember_95ec12ae-e173-454a-906a-1bc53c1f70a2" xlink:href="iff-20231231.xsd#iff_HealthBiosciencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_e252a350-945e-4acd-b5dc-c8130c971e71" xlink:to="loc_iff_HealthBiosciencesMember_95ec12ae-e173-454a-906a-1bc53c1f70a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ScentMember_55a176fb-9823-4b52-917a-48c9fd1310d2" xlink:href="iff-20231231.xsd#iff_ScentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_e252a350-945e-4acd-b5dc-c8130c971e71" xlink:to="loc_iff_ScentMember_55a176fb-9823-4b52-917a-48c9fd1310d2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_PharmaSolutionsMember_d245a267-d42f-47af-81bb-06111410b08a" xlink:href="iff-20231231.xsd#iff_PharmaSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_e252a350-945e-4acd-b5dc-c8130c971e71" xlink:to="loc_iff_PharmaSolutionsMember_d245a267-d42f-47af-81bb-06111410b08a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_05838f31-ce4a-45a7-87a0-203d9f9bf2bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_5fb1dc1f-6bd2-4d44-af3c-f5a131def1c2" xlink:to="loc_us-gaap_GoodwillRollForward_05838f31-ce4a-45a7-87a0-203d9f9bf2bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f642004f-b83b-45bb-9e15-972f6dd0dbcd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_05838f31-ce4a-45a7-87a0-203d9f9bf2bb" xlink:to="loc_us-gaap_Goodwill_f642004f-b83b-45bb-9e15-972f6dd0dbcd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_399cc763-8f7d-4a68-a349-2a7572e41f87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_05838f31-ce4a-45a7-87a0-203d9f9bf2bb" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_399cc763-8f7d-4a68-a349-2a7572e41f87" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_b3d83df8-3dce-4940-b827-05b749e762b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_05838f31-ce4a-45a7-87a0-203d9f9bf2bb" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_b3d83df8-3dce-4940-b827-05b749e762b8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPeriodIncreaseDecrease_fd7f138f-ce38-48b1-a602-fab7d3945efc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_05838f31-ce4a-45a7-87a0-203d9f9bf2bb" xlink:to="loc_us-gaap_GoodwillPeriodIncreaseDecrease_fd7f138f-ce38-48b1-a602-fab7d3945efc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_905e12a0-595b-46b2-9b64-c66db3c2603c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_05838f31-ce4a-45a7-87a0-203d9f9bf2bb" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_905e12a0-595b-46b2-9b64-c66db3c2603c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTransfers_e1602584-c14c-4be0-bcd5-f62a86e5f736" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillTransfers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_05838f31-ce4a-45a7-87a0-203d9f9bf2bb" xlink:to="loc_us-gaap_GoodwillTransfers_e1602584-c14c-4be0-bcd5-f62a86e5f736" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_0a8544ce-2714-4188-bcf6-d8b61c3f2725" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_05838f31-ce4a-45a7-87a0-203d9f9bf2bb" xlink:to="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_0a8544ce-2714-4188-bcf6-d8b61c3f2725" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_0ecb8701-ca2d-4759-97d0-c76562ad85c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_e3ec9d28-932f-40ff-a149-0f5dcd941871" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_5fb1dc1f-6bd2-4d44-af3c-f5a131def1c2" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_e3ec9d28-932f-40ff-a149-0f5dcd941871" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetTrademarkandOtherIntangibleAssetsDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#GoodwillandOtherIntangibleAssetsNetTrademarkandOtherIntangibleAssetsDetail"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetTrademarkandOtherIntangibleAssetsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5ccebaa3-401e-4463-95ee-8af0ba37c588" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_d626c56e-b60c-4bba-bf64-426786e9e21c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5ccebaa3-401e-4463-95ee-8af0ba37c588" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_d626c56e-b60c-4bba-bf64-426786e9e21c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e8c5470f-2c21-4481-a18a-b9e2cc6beb84" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_d626c56e-b60c-4bba-bf64-426786e9e21c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e8c5470f-2c21-4481-a18a-b9e2cc6beb84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e8c5470f-2c21-4481-a18a-b9e2cc6beb84_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e8c5470f-2c21-4481-a18a-b9e2cc6beb84" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e8c5470f-2c21-4481-a18a-b9e2cc6beb84_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3efa56bd-8222-4434-a95f-68057f9b7fdb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e8c5470f-2c21-4481-a18a-b9e2cc6beb84" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3efa56bd-8222-4434-a95f-68057f9b7fdb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_435f7acb-28f3-4a20-a4b0-aa4b28913afc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3efa56bd-8222-4434-a95f-68057f9b7fdb" xlink:to="loc_us-gaap_CustomerRelationshipsMember_435f7acb-28f3-4a20-a4b0-aa4b28913afc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_f45e2768-a0e3-4c62-9faf-4a1d70d5634f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3efa56bd-8222-4434-a95f-68057f9b7fdb" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_f45e2768-a0e3-4c62-9faf-4a1d70d5634f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_79cdb908-d78c-4005-8789-bd69fb6c1e0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3efa56bd-8222-4434-a95f-68057f9b7fdb" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_79cdb908-d78c-4005-8789-bd69fb6c1e0a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_c817c952-f10c-4c91-beb9-c3077829dbbd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3efa56bd-8222-4434-a95f-68057f9b7fdb" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_c817c952-f10c-4c91-beb9-c3077829dbbd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_eb152e7b-682a-43b5-af31-8439d9d3d115" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5ccebaa3-401e-4463-95ee-8af0ba37c588" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_eb152e7b-682a-43b5-af31-8439d9d3d115" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_a819be96-ba34-4ede-bc4b-bf8fbf14594b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5ccebaa3-401e-4463-95ee-8af0ba37c588" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_a819be96-ba34-4ede-bc4b-bf8fbf14594b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1bcb4e79-f0f2-4ccb-92c4-f0eedbc61fab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5ccebaa3-401e-4463-95ee-8af0ba37c588" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1bcb4e79-f0f2-4ccb-92c4-f0eedbc61fab" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/DebtComponentsofDebtDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#DebtComponentsofDebtDetail"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/DebtComponentsofDebtDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_fcd17446-8f74-4840-889b-952f33a8abbc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_e6e538a5-ea92-4e1e-9007-29190ea13dfa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fcd17446-8f74-4840-889b-952f33a8abbc" xlink:to="loc_us-gaap_DebtInstrumentTable_e6e538a5-ea92-4e1e-9007-29190ea13dfa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e73ae5c5-eaa4-4103-b412-9da5b95a6d85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e6e538a5-ea92-4e1e-9007-29190ea13dfa" xlink:to="loc_us-gaap_DebtInstrumentAxis_e73ae5c5-eaa4-4103-b412-9da5b95a6d85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e73ae5c5-eaa4-4103-b412-9da5b95a6d85_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_e73ae5c5-eaa4-4103-b412-9da5b95a6d85" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e73ae5c5-eaa4-4103-b412-9da5b95a6d85_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d72fb76d-91d9-4fbc-b227-e7e7a53ba4db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_e73ae5c5-eaa4-4103-b412-9da5b95a6d85" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d72fb76d-91d9-4fbc-b227-e7e7a53ba4db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandTwentyThreeMember_b0474a69-dedf-4a5e-bb1a-cfc3b9cba2d7" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandTwentyThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d72fb76d-91d9-4fbc-b227-e7e7a53ba4db" xlink:to="loc_iff_SeniorNotesDueTwoThousandTwentyThreeMember_b0474a69-dedf-4a5e-bb1a-cfc3b9cba2d7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember_6d133fa6-b200-484e-859c-c35ba6368ab4" xlink:href="iff-20231231.xsd#iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d72fb76d-91d9-4fbc-b227-e7e7a53ba4db" xlink:to="loc_iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember_6d133fa6-b200-484e-859c-c35ba6368ab4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandTwentyFiveMember_afa42449-0ce6-4695-87da-ef23b5851fab" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandTwentyFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d72fb76d-91d9-4fbc-b227-e7e7a53ba4db" xlink:to="loc_iff_SeniorNotesDueTwoThousandTwentyFiveMember_afa42449-0ce6-4695-87da-ef23b5851fab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember_bbbf6213-2f0f-4587-b875-990e467d5e32" xlink:href="iff-20231231.xsd#iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d72fb76d-91d9-4fbc-b227-e7e7a53ba4db" xlink:to="loc_iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember_bbbf6213-2f0f-4587-b875-990e467d5e32" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandTwentySevenMember_bfa8740e-de2f-4dd9-a7af-93f9edc64a6f" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandTwentySevenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d72fb76d-91d9-4fbc-b227-e7e7a53ba4db" xlink:to="loc_iff_SeniorNotesDueTwoThousandTwentySevenMember_bfa8740e-de2f-4dd9-a7af-93f9edc64a6f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandTwentyEightMember_048bec46-5d2a-491f-a631-3ab1e8b1ac18" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandTwentyEightMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d72fb76d-91d9-4fbc-b227-e7e7a53ba4db" xlink:to="loc_iff_SeniorNotesDueTwoThousandTwentyEightMember_048bec46-5d2a-491f-a631-3ab1e8b1ac18" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandThirtyMember_4480c4d3-0f6c-4a63-95fc-694d319100f7" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandThirtyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d72fb76d-91d9-4fbc-b227-e7e7a53ba4db" xlink:to="loc_iff_SeniorNotesDueTwoThousandThirtyMember_4480c4d3-0f6c-4a63-95fc-694d319100f7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandFortyMember_5d1da95b-b1f1-4674-9870-9bfb117c660e" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandFortyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d72fb76d-91d9-4fbc-b227-e7e7a53ba4db" xlink:to="loc_iff_SeniorNotesDueTwoThousandFortyMember_5d1da95b-b1f1-4674-9870-9bfb117c660e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandFortySevenMember_a0579068-66a2-427f-a10e-19f6db36e3d8" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandFortySevenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d72fb76d-91d9-4fbc-b227-e7e7a53ba4db" xlink:to="loc_iff_SeniorNotesDueTwoThousandFortySevenMember_a0579068-66a2-427f-a10e-19f6db36e3d8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandFortyEightMember_53e21008-86b6-41be-8272-ae7fdbb4c33d" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandFortyEightMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d72fb76d-91d9-4fbc-b227-e7e7a53ba4db" xlink:to="loc_iff_SeniorNotesDueTwoThousandFortyEightMember_53e21008-86b6-41be-8272-ae7fdbb4c33d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandFiftyMember_fd1507c0-befe-4832-84b3-0c0678fd1dd7" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandFiftyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d72fb76d-91d9-4fbc-b227-e7e7a53ba4db" xlink:to="loc_iff_SeniorNotesDueTwoThousandFiftyMember_fd1507c0-befe-4832-84b3-0c0678fd1dd7" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_A2024TermLoanMember_5e965a12-2cef-4577-977d-d1c13bca4ff5" xlink:href="iff-20231231.xsd#iff_A2024TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d72fb76d-91d9-4fbc-b227-e7e7a53ba4db" xlink:to="loc_iff_A2024TermLoanMember_5e965a12-2cef-4577-977d-d1c13bca4ff5" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_A2026TermLoanMember_95f0bb33-e6a7-4b12-ab80-d04d60c68871" xlink:href="iff-20231231.xsd#iff_A2026TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d72fb76d-91d9-4fbc-b227-e7e7a53ba4db" xlink:to="loc_iff_A2026TermLoanMember_95f0bb33-e6a7-4b12-ab80-d04d60c68871" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_b0902123-142f-4752-84bf-2892f0886c5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d72fb76d-91d9-4fbc-b227-e7e7a53ba4db" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_b0902123-142f-4752-84bf-2892f0886c5d" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BankBorrowingsAndOverdraftsMember_e992e1cf-e1a0-4023-9c27-24ba4864ce3d" xlink:href="iff-20231231.xsd#iff_BankBorrowingsAndOverdraftsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d72fb76d-91d9-4fbc-b227-e7e7a53ba4db" xlink:to="loc_iff_BankBorrowingsAndOverdraftsMember_e992e1cf-e1a0-4023-9c27-24ba4864ce3d" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_4bbed907-dad7-4cad-ae6b-65e8f177896b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e6e538a5-ea92-4e1e-9007-29190ea13dfa" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_4bbed907-dad7-4cad-ae6b-65e8f177896b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_4bbed907-dad7-4cad-ae6b-65e8f177896b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_4bbed907-dad7-4cad-ae6b-65e8f177896b" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_4bbed907-dad7-4cad-ae6b-65e8f177896b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_2eb5b594-9ee8-4d5a-acd5-290ed03e6746" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_4bbed907-dad7-4cad-ae6b-65e8f177896b" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_2eb5b594-9ee8-4d5a-acd5-290ed03e6746" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_b28afe76-cb81-4597-af05-9f9c4ca289ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_2eb5b594-9ee8-4d5a-acd5-290ed03e6746" xlink:to="loc_us-gaap_LoansPayableMember_b28afe76-cb81-4597-af05-9f9c4ca289ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_7dfb4c6f-35c5-4a66-9027-09e8e9779c2d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e6e538a5-ea92-4e1e-9007-29190ea13dfa" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_7dfb4c6f-35c5-4a66-9027-09e8e9779c2d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_7dfb4c6f-35c5-4a66-9027-09e8e9779c2d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7dfb4c6f-35c5-4a66-9027-09e8e9779c2d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_7dfb4c6f-35c5-4a66-9027-09e8e9779c2d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_16fd0e69-9663-4e8a-b1f9-9d6979444c1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7dfb4c6f-35c5-4a66-9027-09e8e9779c2d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_16fd0e69-9663-4e8a-b1f9-9d6979444c1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_01b98aa1-1221-4130-88ff-9eb13dad8b06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_16fd0e69-9663-4e8a-b1f9-9d6979444c1b" xlink:to="loc_us-gaap_LoansPayableMember_01b98aa1-1221-4130-88ff-9eb13dad8b06" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3e6ecaf7-c7f1-4771-ad7f-41b4139fa279" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e6e538a5-ea92-4e1e-9007-29190ea13dfa" xlink:to="loc_srt_RangeAxis_3e6ecaf7-c7f1-4771-ad7f-41b4139fa279" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3e6ecaf7-c7f1-4771-ad7f-41b4139fa279_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_3e6ecaf7-c7f1-4771-ad7f-41b4139fa279" xlink:to="loc_srt_RangeMember_3e6ecaf7-c7f1-4771-ad7f-41b4139fa279_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_27ec2eda-3c90-484d-8b39-8cc22c72e3c7" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_3e6ecaf7-c7f1-4771-ad7f-41b4139fa279" xlink:to="loc_srt_RangeMember_27ec2eda-3c90-484d-8b39-8cc22c72e3c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_70000030-b8c9-4f16-be1e-d4ca583f1fce" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_27ec2eda-3c90-484d-8b39-8cc22c72e3c7" xlink:to="loc_srt_MinimumMember_70000030-b8c9-4f16-be1e-d4ca583f1fce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a3132c20-408e-4440-85f3-3184d182ccf9" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_27ec2eda-3c90-484d-8b39-8cc22c72e3c7" xlink:to="loc_srt_MaximumMember_a3132c20-408e-4440-85f3-3184d182ccf9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_1b88d5be-d8e3-472d-a86d-bab15ddb83a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e6e538a5-ea92-4e1e-9007-29190ea13dfa" xlink:to="loc_us-gaap_CreditFacilityAxis_1b88d5be-d8e3-472d-a86d-bab15ddb83a3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_1b88d5be-d8e3-472d-a86d-bab15ddb83a3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_1b88d5be-d8e3-472d-a86d-bab15ddb83a3" xlink:to="loc_us-gaap_CreditFacilityDomain_1b88d5be-d8e3-472d-a86d-bab15ddb83a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_bcee1a91-df7b-4778-844b-123a4673cbee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_1b88d5be-d8e3-472d-a86d-bab15ddb83a3" xlink:to="loc_us-gaap_CreditFacilityDomain_bcee1a91-df7b-4778-844b-123a4673cbee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_e6e45377-688a-46f0-a381-3386bee0757f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_bcee1a91-df7b-4778-844b-123a4673cbee" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_e6e45377-688a-46f0-a381-3386bee0757f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_f6fb1ca7-1eb4-46fd-bb1d-cbf55e4a967e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e6e538a5-ea92-4e1e-9007-29190ea13dfa" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_f6fb1ca7-1eb4-46fd-bb1d-cbf55e4a967e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_f6fb1ca7-1eb4-46fd-bb1d-cbf55e4a967e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_f6fb1ca7-1eb4-46fd-bb1d-cbf55e4a967e" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_f6fb1ca7-1eb4-46fd-bb1d-cbf55e4a967e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_64126117-aaaa-4fdd-9b12-fe3327e97687" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_f6fb1ca7-1eb4-46fd-bb1d-cbf55e4a967e" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_64126117-aaaa-4fdd-9b12-fe3327e97687" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_CitibankN.AMember_c7bfbbba-125a-4c35-9593-4e115affde4a" xlink:href="iff-20231231.xsd#iff_CitibankN.AMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_64126117-aaaa-4fdd-9b12-fe3327e97687" xlink:to="loc_iff_CitibankN.AMember_c7bfbbba-125a-4c35-9593-4e115affde4a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_96516bc4-c96e-462e-9694-5c26d109962f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e6e538a5-ea92-4e1e-9007-29190ea13dfa" xlink:to="loc_us-gaap_VariableRateAxis_96516bc4-c96e-462e-9694-5c26d109962f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_96516bc4-c96e-462e-9694-5c26d109962f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_96516bc4-c96e-462e-9694-5c26d109962f" xlink:to="loc_us-gaap_VariableRateDomain_96516bc4-c96e-462e-9694-5c26d109962f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_cc98d02d-c87b-49cc-884c-092da61b120d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_96516bc4-c96e-462e-9694-5c26d109962f" xlink:to="loc_us-gaap_VariableRateDomain_cc98d02d-c87b-49cc-884c-092da61b120d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EurocurrencyRateMember_d31fd4cb-a34e-4f18-8b52-cfdde901c85f" xlink:href="iff-20231231.xsd#iff_EurocurrencyRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_cc98d02d-c87b-49cc-884c-092da61b120d" xlink:to="loc_iff_EurocurrencyRateMember_d31fd4cb-a34e-4f18-8b52-cfdde901c85f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_20b7f71b-e535-45fe-b6ec-59736803f0e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_cc98d02d-c87b-49cc-884c-092da61b120d" xlink:to="loc_us-gaap_BaseRateMember_20b7f71b-e535-45fe-b6ec-59736803f0e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_814168f5-a346-4538-849f-b6013eec6a3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fcd17446-8f74-4840-889b-952f33a8abbc" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_814168f5-a346-4538-849f-b6013eec6a3b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesCurrent_27647760-0105-4035-9bc2-10d986a47f5f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fcd17446-8f74-4840-889b-952f33a8abbc" xlink:to="loc_us-gaap_SeniorNotesCurrent_27647760-0105-4035-9bc2-10d986a47f5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorLongTermNotes_4c2c76d6-2dd8-4829-868d-e5cf6aafb811" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorLongTermNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fcd17446-8f74-4840-889b-952f33a8abbc" xlink:to="loc_us-gaap_SeniorLongTermNotes_4c2c76d6-2dd8-4829-868d-e5cf6aafb811" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper_cada7fd7-5618-4fcd-8c7f-e984379fd6c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fcd17446-8f74-4840-889b-952f33a8abbc" xlink:to="loc_us-gaap_CommercialPaper_cada7fd7-5618-4fcd-8c7f-e984379fd6c9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_eb30f5dc-ee0a-413b-99c7-37af4dfaf444" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fcd17446-8f74-4840-889b-952f33a8abbc" xlink:to="loc_us-gaap_LineOfCredit_eb30f5dc-ee0a-413b-99c7-37af4dfaf444" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_f515acd4-4fa2-47a1-b9ef-741e879b068c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fcd17446-8f74-4840-889b-952f33a8abbc" xlink:to="loc_us-gaap_ShortTermBorrowings_f515acd4-4fa2-47a1-b9ef-741e879b068c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_ea44c1c3-8d6b-4236-9f34-9b18c3d470e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fcd17446-8f74-4840-889b-952f33a8abbc" xlink:to="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_ea44c1c3-8d6b-4236-9f34-9b18c3d470e9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_03747e41-3d64-46ea-b94d-9ce9cdfeb0ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fcd17446-8f74-4840-889b-952f33a8abbc" xlink:to="loc_us-gaap_LongTermDebtCurrent_03747e41-3d64-46ea-b94d-9ce9cdfeb0ff" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_4e1f2652-0f90-480c-812f-f9be741137ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fcd17446-8f74-4840-889b-952f33a8abbc" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_4e1f2652-0f90-480c-812f-f9be741137ca" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_a5e413d0-8e75-422b-9719-91ad83e2e1dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fcd17446-8f74-4840-889b-952f33a8abbc" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_a5e413d0-8e75-422b-9719-91ad83e2e1dd" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_d1ad57a6-1cd9-4c2b-9303-3c3a07d6e530" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_9c609b1f-8772-497a-8528-a2c991cf3a4b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1ad57a6-1cd9-4c2b-9303-3c3a07d6e530" xlink:to="loc_us-gaap_DebtInstrumentTable_9c609b1f-8772-497a-8528-a2c991cf3a4b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d9263cb0-5cb7-4d52-aa99-ca16b1a18d6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9c609b1f-8772-497a-8528-a2c991cf3a4b" xlink:to="loc_us-gaap_DebtInstrumentAxis_d9263cb0-5cb7-4d52-aa99-ca16b1a18d6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d9263cb0-5cb7-4d52-aa99-ca16b1a18d6c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_d9263cb0-5cb7-4d52-aa99-ca16b1a18d6c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d9263cb0-5cb7-4d52-aa99-ca16b1a18d6c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1374ee1f-7ba0-4e29-81be-c88feefd8e99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_d9263cb0-5cb7-4d52-aa99-ca16b1a18d6c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1374ee1f-7ba0-4e29-81be-c88feefd8e99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorUnsecuredTermLoanFacilitiesMember_635ff85f-209f-48fc-abaa-c5a9ef17ace8" xlink:href="iff-20231231.xsd#iff_SeniorUnsecuredTermLoanFacilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1374ee1f-7ba0-4e29-81be-c88feefd8e99" xlink:to="loc_iff_SeniorUnsecuredTermLoanFacilitiesMember_635ff85f-209f-48fc-abaa-c5a9ef17ace8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorUnsecuredNotesMember_b2ad2e05-1969-438a-8ba8-f8b47b74d3b6" xlink:href="iff-20231231.xsd#iff_SeniorUnsecuredNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1374ee1f-7ba0-4e29-81be-c88feefd8e99" xlink:to="loc_iff_SeniorUnsecuredNotesMember_b2ad2e05-1969-438a-8ba8-f8b47b74d3b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_A2024TermLoanMember_63bfc2e1-ebac-4e29-8bfa-6b33fd67cb6c" xlink:href="iff-20231231.xsd#iff_A2024TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1374ee1f-7ba0-4e29-81be-c88feefd8e99" xlink:to="loc_iff_A2024TermLoanMember_63bfc2e1-ebac-4e29-8bfa-6b33fd67cb6c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_A2026TermLoanMember_33056ab8-492b-47c4-9c6a-594f125019e7" xlink:href="iff-20231231.xsd#iff_A2026TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1374ee1f-7ba0-4e29-81be-c88feefd8e99" xlink:to="loc_iff_A2026TermLoanMember_33056ab8-492b-47c4-9c6a-594f125019e7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TermLoanCreditAgreementMember_1d8b0657-c53f-48d8-b579-9985bc63afd4" xlink:href="iff-20231231.xsd#iff_TermLoanCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1374ee1f-7ba0-4e29-81be-c88feefd8e99" xlink:to="loc_iff_TermLoanCreditAgreementMember_1d8b0657-c53f-48d8-b579-9985bc63afd4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandTwentyTwoMember_928bd009-211b-46d4-9368-03a72a3a8e41" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandTwentyTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1374ee1f-7ba0-4e29-81be-c88feefd8e99" xlink:to="loc_iff_SeniorNotesDueTwoThousandTwentyTwoMember_928bd009-211b-46d4-9368-03a72a3a8e41" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandTwentyFiveMember_b9cfefb0-2781-4e6d-b80b-cbae710430f0" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandTwentyFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1374ee1f-7ba0-4e29-81be-c88feefd8e99" xlink:to="loc_iff_SeniorNotesDueTwoThousandTwentyFiveMember_b9cfefb0-2781-4e6d-b80b-cbae710430f0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandTwentySevenMember_a7934a4e-7aa2-447e-894a-865ca4dae99c" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandTwentySevenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1374ee1f-7ba0-4e29-81be-c88feefd8e99" xlink:to="loc_iff_SeniorNotesDueTwoThousandTwentySevenMember_a7934a4e-7aa2-447e-894a-865ca4dae99c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandThirtyMember_a5cf7994-2f8e-4588-a89e-9dc05534f4e5" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandThirtyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1374ee1f-7ba0-4e29-81be-c88feefd8e99" xlink:to="loc_iff_SeniorNotesDueTwoThousandThirtyMember_a5cf7994-2f8e-4588-a89e-9dc05534f4e5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandFortyMember_5add4294-b14e-405a-86ec-d7f574252543" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandFortyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1374ee1f-7ba0-4e29-81be-c88feefd8e99" xlink:to="loc_iff_SeniorNotesDueTwoThousandFortyMember_5add4294-b14e-405a-86ec-d7f574252543" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandFiftyMember_586fe9f3-2989-461e-8fd1-a585c01d7267" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandFiftyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1374ee1f-7ba0-4e29-81be-c88feefd8e99" xlink:to="loc_iff_SeniorNotesDueTwoThousandFiftyMember_586fe9f3-2989-461e-8fd1-a585c01d7267" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_49c2c700-1076-451f-8467-ce5157e2c16b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9c609b1f-8772-497a-8528-a2c991cf3a4b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_49c2c700-1076-451f-8467-ce5157e2c16b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_49c2c700-1076-451f-8467-ce5157e2c16b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_49c2c700-1076-451f-8467-ce5157e2c16b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_49c2c700-1076-451f-8467-ce5157e2c16b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b100dcc8-4c66-4ace-8498-280bb80a6d34" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_49c2c700-1076-451f-8467-ce5157e2c16b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b100dcc8-4c66-4ace-8498-280bb80a6d34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_ee8bcb11-b676-4bed-8778-9270382db3b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b100dcc8-4c66-4ace-8498-280bb80a6d34" xlink:to="loc_us-gaap_UnsecuredDebtMember_ee8bcb11-b676-4bed-8778-9270382db3b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_b114438a-31c4-4bcf-b474-ff1ce9558b48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b100dcc8-4c66-4ace-8498-280bb80a6d34" xlink:to="loc_us-gaap_LoansPayableMember_b114438a-31c4-4bcf-b474-ff1ce9558b48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_bccdcdc2-9716-495a-a45c-0aa7eb4defb2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9c609b1f-8772-497a-8528-a2c991cf3a4b" xlink:to="loc_dei_LegalEntityAxis_bccdcdc2-9716-495a-a45c-0aa7eb4defb2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_bccdcdc2-9716-495a-a45c-0aa7eb4defb2_default" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_bccdcdc2-9716-495a-a45c-0aa7eb4defb2" xlink:to="loc_dei_EntityDomain_bccdcdc2-9716-495a-a45c-0aa7eb4defb2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_6c5be03d-f80e-41f8-8440-a82628c941d4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_bccdcdc2-9716-495a-a45c-0aa7eb4defb2" xlink:to="loc_dei_EntityDomain_6c5be03d-f80e-41f8-8440-a82628c941d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NutritionBiosciencesIncMember_f78a80a6-71ba-4a92-b998-202ddf39dfd7" xlink:href="iff-20231231.xsd#iff_NutritionBiosciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_6c5be03d-f80e-41f8-8440-a82628c941d4" xlink:to="loc_iff_NutritionBiosciencesIncMember_f78a80a6-71ba-4a92-b998-202ddf39dfd7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4bf40b35-0ca3-4f32-b0b6-b269def6a35b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9c609b1f-8772-497a-8528-a2c991cf3a4b" xlink:to="loc_srt_RangeAxis_4bf40b35-0ca3-4f32-b0b6-b269def6a35b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4bf40b35-0ca3-4f32-b0b6-b269def6a35b_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_4bf40b35-0ca3-4f32-b0b6-b269def6a35b" xlink:to="loc_srt_RangeMember_4bf40b35-0ca3-4f32-b0b6-b269def6a35b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_baeed4fa-e739-4bb5-b020-e1d64098a8f2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_4bf40b35-0ca3-4f32-b0b6-b269def6a35b" xlink:to="loc_srt_RangeMember_baeed4fa-e739-4bb5-b020-e1d64098a8f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2435427d-de28-4427-91b4-f8f1faf03c93" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_baeed4fa-e739-4bb5-b020-e1d64098a8f2" xlink:to="loc_srt_MinimumMember_2435427d-de28-4427-91b4-f8f1faf03c93" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_36f555d4-8654-435e-a207-bf527dc95524" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_baeed4fa-e739-4bb5-b020-e1d64098a8f2" xlink:to="loc_srt_MaximumMember_36f555d4-8654-435e-a207-bf527dc95524" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_d0d95fe0-6b45-4892-80aa-ad6aaaf96206" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9c609b1f-8772-497a-8528-a2c991cf3a4b" xlink:to="loc_us-gaap_VariableRateAxis_d0d95fe0-6b45-4892-80aa-ad6aaaf96206" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_d0d95fe0-6b45-4892-80aa-ad6aaaf96206_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_d0d95fe0-6b45-4892-80aa-ad6aaaf96206" xlink:to="loc_us-gaap_VariableRateDomain_d0d95fe0-6b45-4892-80aa-ad6aaaf96206_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_16296ad8-3987-4f0e-a77b-c990430f517f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_d0d95fe0-6b45-4892-80aa-ad6aaaf96206" xlink:to="loc_us-gaap_VariableRateDomain_16296ad8-3987-4f0e-a77b-c990430f517f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_LondonInterbankOfferedRateLIBOR1Member_3d4702cd-e3c9-488d-8ae6-c6398f66e987" xlink:href="iff-20231231.xsd#iff_LondonInterbankOfferedRateLIBOR1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_16296ad8-3987-4f0e-a77b-c990430f517f" xlink:to="loc_iff_LondonInterbankOfferedRateLIBOR1Member_3d4702cd-e3c9-488d-8ae6-c6398f66e987" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_8b2e49e5-3fdb-4943-8d7a-ddb4f5a63a53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_16296ad8-3987-4f0e-a77b-c990430f517f" xlink:to="loc_us-gaap_BaseRateMember_8b2e49e5-3fdb-4943-8d7a-ddb4f5a63a53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SecuredOvernightFinancingRateSOFRMember_8915205d-52e6-43a4-bde7-45219aacd0aa" xlink:href="iff-20231231.xsd#iff_SecuredOvernightFinancingRateSOFRMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_16296ad8-3987-4f0e-a77b-c990430f517f" xlink:to="loc_iff_SecuredOvernightFinancingRateSOFRMember_8915205d-52e6-43a4-bde7-45219aacd0aa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DebtCovenantPeriodAxis_7e0cf58e-f224-4109-9dad-3b493b036bac" xlink:href="iff-20231231.xsd#iff_DebtCovenantPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9c609b1f-8772-497a-8528-a2c991cf3a4b" xlink:to="loc_iff_DebtCovenantPeriodAxis_7e0cf58e-f224-4109-9dad-3b493b036bac" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DebtCovenantPeriodDomain_7e0cf58e-f224-4109-9dad-3b493b036bac_default" xlink:href="iff-20231231.xsd#iff_DebtCovenantPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_iff_DebtCovenantPeriodAxis_7e0cf58e-f224-4109-9dad-3b493b036bac" xlink:to="loc_iff_DebtCovenantPeriodDomain_7e0cf58e-f224-4109-9dad-3b493b036bac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DebtCovenantPeriodDomain_a5d4f07e-416e-4869-b836-8ea0052bda98" xlink:href="iff-20231231.xsd#iff_DebtCovenantPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_iff_DebtCovenantPeriodAxis_7e0cf58e-f224-4109-9dad-3b493b036bac" xlink:to="loc_iff_DebtCovenantPeriodDomain_a5d4f07e-416e-4869-b836-8ea0052bda98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FiscalQuarterEndingOnOrBeforeMarch312024Member_7d29d9e4-d72e-4771-b9a7-7eeb0a99afcb" xlink:href="iff-20231231.xsd#iff_FiscalQuarterEndingOnOrBeforeMarch312024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_DebtCovenantPeriodDomain_a5d4f07e-416e-4869-b836-8ea0052bda98" xlink:to="loc_iff_FiscalQuarterEndingOnOrBeforeMarch312024Member_7d29d9e4-d72e-4771-b9a7-7eeb0a99afcb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FiscalQuarterEndingJune302024Member_ff4346fa-ba0c-4a54-8670-221b282522e6" xlink:href="iff-20231231.xsd#iff_FiscalQuarterEndingJune302024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_DebtCovenantPeriodDomain_a5d4f07e-416e-4869-b836-8ea0052bda98" xlink:to="loc_iff_FiscalQuarterEndingJune302024Member_ff4346fa-ba0c-4a54-8670-221b282522e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FiscalQuarterEndingSeptember302024Member_96ddbf85-7ef4-4bf0-9432-e9aa1b941540" xlink:href="iff-20231231.xsd#iff_FiscalQuarterEndingSeptember302024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_DebtCovenantPeriodDomain_a5d4f07e-416e-4869-b836-8ea0052bda98" xlink:to="loc_iff_FiscalQuarterEndingSeptember302024Member_96ddbf85-7ef4-4bf0-9432-e9aa1b941540" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SubsequentFiscalQuarterEndingOnOrBeforeMarch312025Member_aed00565-6b1e-4a9b-9c62-b8b9f7ca0794" xlink:href="iff-20231231.xsd#iff_SubsequentFiscalQuarterEndingOnOrBeforeMarch312025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_DebtCovenantPeriodDomain_a5d4f07e-416e-4869-b836-8ea0052bda98" xlink:to="loc_iff_SubsequentFiscalQuarterEndingOnOrBeforeMarch312025Member_aed00565-6b1e-4a9b-9c62-b8b9f7ca0794" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SubsequentFiscalQuarterEndingOnOrBeforeSeptember302025Member_1108dd61-f6f3-4517-accb-ba75a54ca2d7" xlink:href="iff-20231231.xsd#iff_SubsequentFiscalQuarterEndingOnOrBeforeSeptember302025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_DebtCovenantPeriodDomain_a5d4f07e-416e-4869-b836-8ea0052bda98" xlink:to="loc_iff_SubsequentFiscalQuarterEndingOnOrBeforeSeptember302025Member_1108dd61-f6f3-4517-accb-ba75a54ca2d7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FiscalQuarterEndingDecember312025Member_98a0e791-e470-4aed-ac66-7cc64fe9e990" xlink:href="iff-20231231.xsd#iff_FiscalQuarterEndingDecember312025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_DebtCovenantPeriodDomain_a5d4f07e-416e-4869-b836-8ea0052bda98" xlink:to="loc_iff_FiscalQuarterEndingDecember312025Member_98a0e791-e470-4aed-ac66-7cc64fe9e990" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_4d2de1d7-06af-445a-a207-a016fa6d7ddd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9c609b1f-8772-497a-8528-a2c991cf3a4b" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_4d2de1d7-06af-445a-a207-a016fa6d7ddd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_4d2de1d7-06af-445a-a207-a016fa6d7ddd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_4d2de1d7-06af-445a-a207-a016fa6d7ddd" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_4d2de1d7-06af-445a-a207-a016fa6d7ddd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_31067a62-1118-4cf7-a2d4-3c223371dfd8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_4d2de1d7-06af-445a-a207-a016fa6d7ddd" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_31067a62-1118-4cf7-a2d4-3c223371dfd8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_26c76762-5964-4cb6-b6dc-700e008fd2e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_31067a62-1118-4cf7-a2d4-3c223371dfd8" xlink:to="loc_us-gaap_LoansPayableMember_26c76762-5964-4cb6-b6dc-700e008fd2e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_64997e26-16d7-488c-a3b6-3e7914bd1b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9c609b1f-8772-497a-8528-a2c991cf3a4b" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_64997e26-16d7-488c-a3b6-3e7914bd1b9b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_64997e26-16d7-488c-a3b6-3e7914bd1b9b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_64997e26-16d7-488c-a3b6-3e7914bd1b9b" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_64997e26-16d7-488c-a3b6-3e7914bd1b9b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_8b13cc50-ffcb-4358-bf19-5635b6919db8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_64997e26-16d7-488c-a3b6-3e7914bd1b9b" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_8b13cc50-ffcb-4358-bf19-5635b6919db8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_2cac0ed6-61dc-4a8c-b62e-ffa61f66d763" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_8b13cc50-ffcb-4358-bf19-5635b6919db8" xlink:to="loc_us-gaap_SubsequentEventMember_2cac0ed6-61dc-4a8c-b62e-ffa61f66d763" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_89aea16f-30d1-42fe-82f7-de9443983da9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1ad57a6-1cd9-4c2b-9303-3c3a07d6e530" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_89aea16f-30d1-42fe-82f7-de9443983da9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_73cd4d3b-92a9-4906-a50f-7464747d8fa4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1ad57a6-1cd9-4c2b-9303-3c3a07d6e530" xlink:to="loc_us-gaap_DebtInstrumentTerm_73cd4d3b-92a9-4906-a50f-7464747d8fa4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b942ce54-611e-4d36-9e36-a759ab2a43f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1ad57a6-1cd9-4c2b-9303-3c3a07d6e530" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b942ce54-611e-4d36-9e36-a759ab2a43f3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_6f4a54e8-4aa7-4119-8b5d-fdd8c38d5003" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1ad57a6-1cd9-4c2b-9303-3c3a07d6e530" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_6f4a54e8-4aa7-4119-8b5d-fdd8c38d5003" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DebtInstrumentCovenantMaximumConsolidatedLeverageRatio_85dec27a-f5a6-4a43-9cde-c72d4139e257" xlink:href="iff-20231231.xsd#iff_DebtInstrumentCovenantMaximumConsolidatedLeverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1ad57a6-1cd9-4c2b-9303-3c3a07d6e530" xlink:to="loc_iff_DebtInstrumentCovenantMaximumConsolidatedLeverageRatio_85dec27a-f5a6-4a43-9cde-c72d4139e257" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_CommonStockDividendsPerShareMaximumDividendThresholdPerQuarter_ecce0efa-dbfe-4c7e-b7ee-bdc81ddd19b0" xlink:href="iff-20231231.xsd#iff_CommonStockDividendsPerShareMaximumDividendThresholdPerQuarter"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1ad57a6-1cd9-4c2b-9303-3c3a07d6e530" xlink:to="loc_iff_CommonStockDividendsPerShareMaximumDividendThresholdPerQuarter_ecce0efa-dbfe-4c7e-b7ee-bdc81ddd19b0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_CommonStockDividendsPerShareMaximumDividendThresholdPerYear_17d3df1b-142d-46c3-8dfb-d36f9157d99a" xlink:href="iff-20231231.xsd#iff_CommonStockDividendsPerShareMaximumDividendThresholdPerYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1ad57a6-1cd9-4c2b-9303-3c3a07d6e530" xlink:to="loc_iff_CommonStockDividendsPerShareMaximumDividendThresholdPerYear_17d3df1b-142d-46c3-8dfb-d36f9157d99a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DebtInstrumentCovenantLienThresholdAmount_fc505fcd-2553-4dd5-a977-ecc506bf0ee0" xlink:href="iff-20231231.xsd#iff_DebtInstrumentCovenantLienThresholdAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1ad57a6-1cd9-4c2b-9303-3c3a07d6e530" xlink:to="loc_iff_DebtInstrumentCovenantLienThresholdAmount_fc505fcd-2553-4dd5-a977-ecc506bf0ee0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DebtInstrumentCovenantLienThresholdPercentageOfConsolidatedNetTangibleAssets_17e00843-30d8-483a-98df-45e895aee65f" xlink:href="iff-20231231.xsd#iff_DebtInstrumentCovenantLienThresholdPercentageOfConsolidatedNetTangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1ad57a6-1cd9-4c2b-9303-3c3a07d6e530" xlink:to="loc_iff_DebtInstrumentCovenantLienThresholdPercentageOfConsolidatedNetTangibleAssets_17e00843-30d8-483a-98df-45e895aee65f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DebtInstrumentCovenantPercentageOfProceedsFromNonOrdinaryAssetsSalesRequiredToBeUsedAsPrepayment_4178a2a0-6550-407b-9d58-0d2bad17dd54" xlink:href="iff-20231231.xsd#iff_DebtInstrumentCovenantPercentageOfProceedsFromNonOrdinaryAssetsSalesRequiredToBeUsedAsPrepayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1ad57a6-1cd9-4c2b-9303-3c3a07d6e530" xlink:to="loc_iff_DebtInstrumentCovenantPercentageOfProceedsFromNonOrdinaryAssetsSalesRequiredToBeUsedAsPrepayment_4178a2a0-6550-407b-9d58-0d2bad17dd54" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DebtInstrumentCovenantBasisSpreadIncreaseOnVariableRate_0318c364-da04-46c7-b6e6-a028a64d37a6" xlink:href="iff-20231231.xsd#iff_DebtInstrumentCovenantBasisSpreadIncreaseOnVariableRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1ad57a6-1cd9-4c2b-9303-3c3a07d6e530" xlink:to="loc_iff_DebtInstrumentCovenantBasisSpreadIncreaseOnVariableRate_0318c364-da04-46c7-b6e6-a028a64d37a6" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_2ed1606e-0759-48fe-be34-dcb7faf5746a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1ad57a6-1cd9-4c2b-9303-3c3a07d6e530" xlink:to="loc_us-gaap_RepaymentsOfDebt_2ed1606e-0759-48fe-be34-dcb7faf5746a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesCurrent_5250d809-abab-42fa-b742-306c51742797" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1ad57a6-1cd9-4c2b-9303-3c3a07d6e530" xlink:to="loc_us-gaap_SeniorNotesCurrent_5250d809-abab-42fa-b742-306c51742797" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorLongTermNotes_d83364ca-f250-4e13-87b9-066d3bfab3ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorLongTermNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1ad57a6-1cd9-4c2b-9303-3c3a07d6e530" xlink:to="loc_us-gaap_SeniorLongTermNotes_d83364ca-f250-4e13-87b9-066d3bfab3ca" xlink:type="arc" order="13"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/DebtAdditionalInformationRevolvingCreditFacilityDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#DebtAdditionalInformationRevolvingCreditFacilityDetail"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/DebtAdditionalInformationRevolvingCreditFacilityDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_7a3d5cd2-cfc0-4632-b91b-531a893403df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_1c21a94b-974d-42d8-9e29-67007c7e73c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a3d5cd2-cfc0-4632-b91b-531a893403df" xlink:to="loc_us-gaap_DebtInstrumentTable_1c21a94b-974d-42d8-9e29-67007c7e73c8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_5079d0ec-a0e8-40ad-ac34-8a4405dae751" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1c21a94b-974d-42d8-9e29-67007c7e73c8" xlink:to="loc_us-gaap_CreditFacilityAxis_5079d0ec-a0e8-40ad-ac34-8a4405dae751" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_5079d0ec-a0e8-40ad-ac34-8a4405dae751_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_5079d0ec-a0e8-40ad-ac34-8a4405dae751" xlink:to="loc_us-gaap_CreditFacilityDomain_5079d0ec-a0e8-40ad-ac34-8a4405dae751_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_431eb152-6f69-473f-afe7-f97c1cb3502c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_5079d0ec-a0e8-40ad-ac34-8a4405dae751" xlink:to="loc_us-gaap_CreditFacilityDomain_431eb152-6f69-473f-afe7-f97c1cb3502c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_b73c517d-c586-4306-978a-c2a9b7a847fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_431eb152-6f69-473f-afe7-f97c1cb3502c" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_b73c517d-c586-4306-978a-c2a9b7a847fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_4bdc0c7e-5336-424d-b9e7-74e203e7ef2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1c21a94b-974d-42d8-9e29-67007c7e73c8" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_4bdc0c7e-5336-424d-b9e7-74e203e7ef2a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_4bdc0c7e-5336-424d-b9e7-74e203e7ef2a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_4bdc0c7e-5336-424d-b9e7-74e203e7ef2a" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_4bdc0c7e-5336-424d-b9e7-74e203e7ef2a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_bb2bbdb1-d3c7-4c37-ac6d-cd248e3cf433" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_4bdc0c7e-5336-424d-b9e7-74e203e7ef2a" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_bb2bbdb1-d3c7-4c37-ac6d-cd248e3cf433" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_CitibankN.AMember_f7e82add-b149-41f1-86b8-d6c093eff99d" xlink:href="iff-20231231.xsd#iff_CitibankN.AMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_bb2bbdb1-d3c7-4c37-ac6d-cd248e3cf433" xlink:to="loc_iff_CitibankN.AMember_f7e82add-b149-41f1-86b8-d6c093eff99d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_261c005c-43dd-4603-8b0a-b9361866b00f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1c21a94b-974d-42d8-9e29-67007c7e73c8" xlink:to="loc_us-gaap_DebtInstrumentAxis_261c005c-43dd-4603-8b0a-b9361866b00f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_261c005c-43dd-4603-8b0a-b9361866b00f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_261c005c-43dd-4603-8b0a-b9361866b00f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_261c005c-43dd-4603-8b0a-b9361866b00f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9baca0cd-8908-48ee-890b-ba34fe5d94ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_261c005c-43dd-4603-8b0a-b9361866b00f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9baca0cd-8908-48ee-890b-ba34fe5d94ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_153b27e0-c56f-4435-b12d-12162cac183b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9baca0cd-8908-48ee-890b-ba34fe5d94ca" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_153b27e0-c56f-4435-b12d-12162cac183b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_bc02a8ee-84bc-435c-99a6-e35b6da56ad8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1c21a94b-974d-42d8-9e29-67007c7e73c8" xlink:to="loc_us-gaap_VariableRateAxis_bc02a8ee-84bc-435c-99a6-e35b6da56ad8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_bc02a8ee-84bc-435c-99a6-e35b6da56ad8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_bc02a8ee-84bc-435c-99a6-e35b6da56ad8" xlink:to="loc_us-gaap_VariableRateDomain_bc02a8ee-84bc-435c-99a6-e35b6da56ad8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_4c63acf3-8ad5-4922-8193-19d908892d8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_bc02a8ee-84bc-435c-99a6-e35b6da56ad8" xlink:to="loc_us-gaap_VariableRateDomain_4c63acf3-8ad5-4922-8193-19d908892d8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EuroInterbankOfferedRateMember_1d8c7aa2-f6cb-4bb3-9b13-a68aad20dfc3" xlink:href="iff-20231231.xsd#iff_EuroInterbankOfferedRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_4c63acf3-8ad5-4922-8193-19d908892d8e" xlink:to="loc_iff_EuroInterbankOfferedRateMember_1d8c7aa2-f6cb-4bb3-9b13-a68aad20dfc3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SecuredOvernightFinancingRateSOFRMember_652f65c9-86fe-4019-bad6-937173f49740" xlink:href="iff-20231231.xsd#iff_SecuredOvernightFinancingRateSOFRMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_4c63acf3-8ad5-4922-8193-19d908892d8e" xlink:to="loc_iff_SecuredOvernightFinancingRateSOFRMember_652f65c9-86fe-4019-bad6-937173f49740" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DebtCovenantPeriodAxis_5da2c711-eba7-45e5-84d9-2d110a4874d2" xlink:href="iff-20231231.xsd#iff_DebtCovenantPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1c21a94b-974d-42d8-9e29-67007c7e73c8" xlink:to="loc_iff_DebtCovenantPeriodAxis_5da2c711-eba7-45e5-84d9-2d110a4874d2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DebtCovenantPeriodDomain_5da2c711-eba7-45e5-84d9-2d110a4874d2_default" xlink:href="iff-20231231.xsd#iff_DebtCovenantPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_iff_DebtCovenantPeriodAxis_5da2c711-eba7-45e5-84d9-2d110a4874d2" xlink:to="loc_iff_DebtCovenantPeriodDomain_5da2c711-eba7-45e5-84d9-2d110a4874d2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DebtCovenantPeriodDomain_5acd5a37-7456-41ab-8412-0a152dbf8e30" xlink:href="iff-20231231.xsd#iff_DebtCovenantPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_iff_DebtCovenantPeriodAxis_5da2c711-eba7-45e5-84d9-2d110a4874d2" xlink:to="loc_iff_DebtCovenantPeriodDomain_5acd5a37-7456-41ab-8412-0a152dbf8e30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FiscalQuarterEndingOnOrBeforeMarch312024Member_c10e2228-d32e-4297-856f-1e6239e47aab" xlink:href="iff-20231231.xsd#iff_FiscalQuarterEndingOnOrBeforeMarch312024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_DebtCovenantPeriodDomain_5acd5a37-7456-41ab-8412-0a152dbf8e30" xlink:to="loc_iff_FiscalQuarterEndingOnOrBeforeMarch312024Member_c10e2228-d32e-4297-856f-1e6239e47aab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FiscalQuarterEndingJune302024Member_8461c2b2-2c13-4b53-8f8c-414e4aaa6110" xlink:href="iff-20231231.xsd#iff_FiscalQuarterEndingJune302024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_DebtCovenantPeriodDomain_5acd5a37-7456-41ab-8412-0a152dbf8e30" xlink:to="loc_iff_FiscalQuarterEndingJune302024Member_8461c2b2-2c13-4b53-8f8c-414e4aaa6110" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FiscalQuarterEndingSeptember302024Member_e794c5fd-21db-4260-84c5-ed2fe83b24c1" xlink:href="iff-20231231.xsd#iff_FiscalQuarterEndingSeptember302024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_DebtCovenantPeriodDomain_5acd5a37-7456-41ab-8412-0a152dbf8e30" xlink:to="loc_iff_FiscalQuarterEndingSeptember302024Member_e794c5fd-21db-4260-84c5-ed2fe83b24c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SubsequentFiscalQuarterEndingOnOrBeforeMarch312025Member_e0b541e9-0be6-4046-9c49-cd5edb9c494d" xlink:href="iff-20231231.xsd#iff_SubsequentFiscalQuarterEndingOnOrBeforeMarch312025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_DebtCovenantPeriodDomain_5acd5a37-7456-41ab-8412-0a152dbf8e30" xlink:to="loc_iff_SubsequentFiscalQuarterEndingOnOrBeforeMarch312025Member_e0b541e9-0be6-4046-9c49-cd5edb9c494d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SubsequentFiscalQuarterEndingOnOrBeforeSeptember302025Member_a30ebfc5-d252-4217-a92a-c1a9ae5f15eb" xlink:href="iff-20231231.xsd#iff_SubsequentFiscalQuarterEndingOnOrBeforeSeptember302025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_DebtCovenantPeriodDomain_5acd5a37-7456-41ab-8412-0a152dbf8e30" xlink:to="loc_iff_SubsequentFiscalQuarterEndingOnOrBeforeSeptember302025Member_a30ebfc5-d252-4217-a92a-c1a9ae5f15eb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FiscalQuarterEndingDecember312025Member_e72c6894-5a70-4aa8-9f0e-d974725c4427" xlink:href="iff-20231231.xsd#iff_FiscalQuarterEndingDecember312025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_DebtCovenantPeriodDomain_5acd5a37-7456-41ab-8412-0a152dbf8e30" xlink:to="loc_iff_FiscalQuarterEndingDecember312025Member_e72c6894-5a70-4aa8-9f0e-d974725c4427" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts_c32060e6-26fa-4b27-b854-1cef63310f85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a3d5cd2-cfc0-4632-b91b-531a893403df" xlink:to="loc_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts_c32060e6-26fa-4b27-b854-1cef63310f85" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_db1a0ad7-0544-4cab-9910-90afad8c3a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a3d5cd2-cfc0-4632-b91b-531a893403df" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_db1a0ad7-0544-4cab-9910-90afad8c3a8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DebtInstrumentCovenantMaximumConsolidatedLeverageRatio_9f6000a6-dbe2-4e10-a13d-0a8d3664e8fa" xlink:href="iff-20231231.xsd#iff_DebtInstrumentCovenantMaximumConsolidatedLeverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a3d5cd2-cfc0-4632-b91b-531a893403df" xlink:to="loc_iff_DebtInstrumentCovenantMaximumConsolidatedLeverageRatio_9f6000a6-dbe2-4e10-a13d-0a8d3664e8fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_CommonStockDividendsPerShareMaximumDividendThresholdPerQuarter_c3b1bebf-07c8-410f-89e2-622ed4d5414b" xlink:href="iff-20231231.xsd#iff_CommonStockDividendsPerShareMaximumDividendThresholdPerQuarter"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a3d5cd2-cfc0-4632-b91b-531a893403df" xlink:to="loc_iff_CommonStockDividendsPerShareMaximumDividendThresholdPerQuarter_c3b1bebf-07c8-410f-89e2-622ed4d5414b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_CommonStockDividendsPerShareMaximumDividendThresholdPerYear_d0ae5aa9-a253-417a-b9d7-782b47b42948" xlink:href="iff-20231231.xsd#iff_CommonStockDividendsPerShareMaximumDividendThresholdPerYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a3d5cd2-cfc0-4632-b91b-531a893403df" xlink:to="loc_iff_CommonStockDividendsPerShareMaximumDividendThresholdPerYear_d0ae5aa9-a253-417a-b9d7-782b47b42948" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DebtInstrumentCovenantLienThresholdAmount_74f04f75-0c92-4c3a-8f0a-0734ae42c133" xlink:href="iff-20231231.xsd#iff_DebtInstrumentCovenantLienThresholdAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a3d5cd2-cfc0-4632-b91b-531a893403df" xlink:to="loc_iff_DebtInstrumentCovenantLienThresholdAmount_74f04f75-0c92-4c3a-8f0a-0734ae42c133" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DebtInstrumentCovenantLienThresholdPercentageOfConsolidatedNetTangibleAssets_ff3bb77e-cc94-4999-83ae-62dadd10c61c" xlink:href="iff-20231231.xsd#iff_DebtInstrumentCovenantLienThresholdPercentageOfConsolidatedNetTangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a3d5cd2-cfc0-4632-b91b-531a893403df" xlink:to="loc_iff_DebtInstrumentCovenantLienThresholdPercentageOfConsolidatedNetTangibleAssets_ff3bb77e-cc94-4999-83ae-62dadd10c61c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DebtInstrumentCovenantBasisSpreadIncreaseOnVariableRate_a5f57aae-54d7-4e98-887c-1dc97d5c2fde" xlink:href="iff-20231231.xsd#iff_DebtInstrumentCovenantBasisSpreadIncreaseOnVariableRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a3d5cd2-cfc0-4632-b91b-531a893403df" xlink:to="loc_iff_DebtInstrumentCovenantBasisSpreadIncreaseOnVariableRate_a5f57aae-54d7-4e98-887c-1dc97d5c2fde" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_449d1ae0-6598-4c86-82da-eadcdad1ea6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a3d5cd2-cfc0-4632-b91b-531a893403df" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_449d1ae0-6598-4c86-82da-eadcdad1ea6b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_9d704868-70b6-407d-b33f-ea27dba9877e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a3d5cd2-cfc0-4632-b91b-531a893403df" xlink:to="loc_us-gaap_LineOfCredit_9d704868-70b6-407d-b33f-ea27dba9877e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet_151448a8-c106-4b72-8525-02db1731a1d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a3d5cd2-cfc0-4632-b91b-531a893403df" xlink:to="loc_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet_151448a8-c106-4b72-8525-02db1731a1d1" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_0c78bb9e-54dc-400a-bb7c-751a51d6b363" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a3d5cd2-cfc0-4632-b91b-531a893403df" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_0c78bb9e-54dc-400a-bb7c-751a51d6b363" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_07e74d48-ea7f-4e54-8584-0e5125ff288f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a3d5cd2-cfc0-4632-b91b-531a893403df" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_07e74d48-ea7f-4e54-8584-0e5125ff288f" xlink:type="arc" order="12"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/DebtAdditionalInformationSeniorUnsecuredNotesDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#DebtAdditionalInformationSeniorUnsecuredNotesDetail"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/DebtAdditionalInformationSeniorUnsecuredNotesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_21d85898-0bcf-40b8-ad35-14430ece9465" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_fd29dc13-f19b-4ebe-a4f0-9e6315368e2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21d85898-0bcf-40b8-ad35-14430ece9465" xlink:to="loc_us-gaap_DebtInstrumentTable_fd29dc13-f19b-4ebe-a4f0-9e6315368e2e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_366fb935-8410-4380-b689-94914b1d1ba6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_fd29dc13-f19b-4ebe-a4f0-9e6315368e2e" xlink:to="loc_us-gaap_DebtInstrumentAxis_366fb935-8410-4380-b689-94914b1d1ba6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_366fb935-8410-4380-b689-94914b1d1ba6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_366fb935-8410-4380-b689-94914b1d1ba6" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_366fb935-8410-4380-b689-94914b1d1ba6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_99194487-0133-4c93-bedc-bbea084bacad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_366fb935-8410-4380-b689-94914b1d1ba6" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_99194487-0133-4c93-bedc-bbea084bacad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember_01a2678a-ad56-47e0-b640-7ba3401e7380" xlink:href="iff-20231231.xsd#iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_99194487-0133-4c93-bedc-bbea084bacad" xlink:to="loc_iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember_01a2678a-ad56-47e0-b640-7ba3401e7380" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandTwentyEightMember_30262bc2-cd6b-4c60-9593-101c00680385" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandTwentyEightMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_99194487-0133-4c93-bedc-bbea084bacad" xlink:to="loc_iff_SeniorNotesDueTwoThousandTwentyEightMember_30262bc2-cd6b-4c60-9593-101c00680385" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandFortyEightMember_4114ed9d-2c33-41c9-bbea-f03fabd479a3" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandFortyEightMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_99194487-0133-4c93-bedc-bbea084bacad" xlink:to="loc_iff_SeniorNotesDueTwoThousandFortyEightMember_4114ed9d-2c33-41c9-bbea-f03fabd479a3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandTwentyThreeMember_7f5b6ec3-774f-48ec-8640-b351343c5c87" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandTwentyThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_99194487-0133-4c93-bedc-bbea084bacad" xlink:to="loc_iff_SeniorNotesDueTwoThousandTwentyThreeMember_7f5b6ec3-774f-48ec-8640-b351343c5c87" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember_fda2a51f-bae5-4f9a-9869-d231650d01e3" xlink:href="iff-20231231.xsd#iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_99194487-0133-4c93-bedc-bbea084bacad" xlink:to="loc_iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember_fda2a51f-bae5-4f9a-9869-d231650d01e3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandFortySevenMember_a5b912b6-235d-4179-9269-fe220d645857" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandFortySevenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_99194487-0133-4c93-bedc-bbea084bacad" xlink:to="loc_iff_SeniorNotesDueTwoThousandFortySevenMember_a5b912b6-235d-4179-9269-fe220d645857" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_ed21140e-7d21-4d02-8b47-ff703d318c7b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_fd29dc13-f19b-4ebe-a4f0-9e6315368e2e" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_ed21140e-7d21-4d02-8b47-ff703d318c7b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ed21140e-7d21-4d02-8b47-ff703d318c7b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ed21140e-7d21-4d02-8b47-ff703d318c7b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ed21140e-7d21-4d02-8b47-ff703d318c7b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_baedb7f8-d433-4c07-ad48-a49669970d9b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ed21140e-7d21-4d02-8b47-ff703d318c7b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_baedb7f8-d433-4c07-ad48-a49669970d9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember_5d47e51b-5bfa-443b-ae90-4ec327746ec7" xlink:href="iff-20231231.xsd#iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_baedb7f8-d433-4c07-ad48-a49669970d9b" xlink:to="loc_iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember_5d47e51b-5bfa-443b-ae90-4ec327746ec7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandTwentyEightMember_4f9232f5-a7a9-4f48-935b-7d2e6a945d57" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandTwentyEightMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_baedb7f8-d433-4c07-ad48-a49669970d9b" xlink:to="loc_iff_SeniorNotesDueTwoThousandTwentyEightMember_4f9232f5-a7a9-4f48-935b-7d2e6a945d57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandFortyEightMember_7e851fbb-1b79-4000-a549-130136367a4f" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandFortyEightMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_baedb7f8-d433-4c07-ad48-a49669970d9b" xlink:to="loc_iff_SeniorNotesDueTwoThousandFortyEightMember_7e851fbb-1b79-4000-a549-130136367a4f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_bdd0e13a-c63a-4cbc-a2bf-1f8c5e3a1555" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_fd29dc13-f19b-4ebe-a4f0-9e6315368e2e" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_bdd0e13a-c63a-4cbc-a2bf-1f8c5e3a1555" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_bdd0e13a-c63a-4cbc-a2bf-1f8c5e3a1555_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_bdd0e13a-c63a-4cbc-a2bf-1f8c5e3a1555" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_bdd0e13a-c63a-4cbc-a2bf-1f8c5e3a1555_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_39a1ec0c-dda1-45e5-9d7b-8e0bc57f0019" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_bdd0e13a-c63a-4cbc-a2bf-1f8c5e3a1555" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_39a1ec0c-dda1-45e5-9d7b-8e0bc57f0019" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_033f8427-8a3f-4ae3-a8b6-103d4d00acf0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_39a1ec0c-dda1-45e5-9d7b-8e0bc57f0019" xlink:to="loc_us-gaap_LoansPayableMember_033f8427-8a3f-4ae3-a8b6-103d4d00acf0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorLongTermNotes_064ce7e3-0ab7-4314-b39d-0ccea58899bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorLongTermNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21d85898-0bcf-40b8-ad35-14430ece9465" xlink:to="loc_us-gaap_SeniorLongTermNotes_064ce7e3-0ab7-4314-b39d-0ccea58899bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c663dfb1-2f29-413d-904e-cda384163bed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21d85898-0bcf-40b8-ad35-14430ece9465" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c663dfb1-2f29-413d-904e-cda384163bed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_4c4c861d-6364-4f4b-8fee-c0deda8e66db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21d85898-0bcf-40b8-ad35-14430ece9465" xlink:to="loc_us-gaap_LongTermDebt_4c4c861d-6364-4f4b-8fee-c0deda8e66db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_e1bc6e5f-4237-4ae7-8d06-7e26366ceab3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21d85898-0bcf-40b8-ad35-14430ece9465" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_e1bc6e5f-4237-4ae7-8d06-7e26366ceab3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_b6050138-4c39-4665-86d2-4b4588790c89" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21d85898-0bcf-40b8-ad35-14430ece9465" xlink:to="loc_us-gaap_RepaymentsOfDebt_b6050138-4c39-4665-86d2-4b4588790c89" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnOilAndGasHedgingActivity_7f5233a8-3e9e-459b-bcc6-ef14be77505e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnOilAndGasHedgingActivity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21d85898-0bcf-40b8-ad35-14430ece9465" xlink:to="loc_us-gaap_GainLossOnOilAndGasHedgingActivity_7f5233a8-3e9e-459b-bcc6-ef14be77505e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_bf8aa541-a56f-4c57-aaa1-666d506abd48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21d85898-0bcf-40b8-ad35-14430ece9465" xlink:to="loc_us-gaap_DebtInstrumentTerm_bf8aa541-a56f-4c57-aaa1-666d506abd48" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDeferredCostsGross_4189e567-a1c0-4a72-b6ff-aa22863865b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherDeferredCostsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21d85898-0bcf-40b8-ad35-14430ece9465" xlink:to="loc_us-gaap_OtherDeferredCostsGross_4189e567-a1c0-4a72-b6ff-aa22863865b1" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/DebtAdditionalInformationCommercialPaperandRedemptionProvisionsDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#DebtAdditionalInformationCommercialPaperandRedemptionProvisionsDetail"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/DebtAdditionalInformationCommercialPaperandRedemptionProvisionsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_df6f6d3f-ebad-4481-a011-01bb8c288420" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_02f22f0a-8bd4-48dc-8353-3f3b5aafaff6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_df6f6d3f-ebad-4481-a011-01bb8c288420" xlink:to="loc_us-gaap_DebtInstrumentTable_02f22f0a-8bd4-48dc-8353-3f3b5aafaff6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c7bc696b-45a3-4b51-97cc-2e36ff1eeacf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_02f22f0a-8bd4-48dc-8353-3f3b5aafaff6" xlink:to="loc_us-gaap_DebtInstrumentAxis_c7bc696b-45a3-4b51-97cc-2e36ff1eeacf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c7bc696b-45a3-4b51-97cc-2e36ff1eeacf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_c7bc696b-45a3-4b51-97cc-2e36ff1eeacf" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c7bc696b-45a3-4b51-97cc-2e36ff1eeacf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_827e4ac2-c039-4bc8-b78d-374c53ebf5a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_c7bc696b-45a3-4b51-97cc-2e36ff1eeacf" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_827e4ac2-c039-4bc8-b78d-374c53ebf5a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_InternationalFlavorsFragrancesIncSeniorNotesMember_2d1a795d-0a03-415c-b09f-c0f47937ab17" xlink:href="iff-20231231.xsd#iff_InternationalFlavorsFragrancesIncSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_827e4ac2-c039-4bc8-b78d-374c53ebf5a2" xlink:to="loc_iff_InternationalFlavorsFragrancesIncSeniorNotesMember_2d1a795d-0a03-415c-b09f-c0f47937ab17" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember_08616397-76b6-4a4f-8df6-866c0dfaab6c" xlink:href="iff-20231231.xsd#iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_827e4ac2-c039-4bc8-b78d-374c53ebf5a2" xlink:to="loc_iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember_08616397-76b6-4a4f-8df6-866c0dfaab6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember_868bbe7c-e17e-435e-b104-59e660ac848c" xlink:href="iff-20231231.xsd#iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_827e4ac2-c039-4bc8-b78d-374c53ebf5a2" xlink:to="loc_iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember_868bbe7c-e17e-435e-b104-59e660ac848c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandTwentyEightMember_4d9452cc-a6ab-4dae-9d9c-0647f0b1e64f" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandTwentyEightMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_827e4ac2-c039-4bc8-b78d-374c53ebf5a2" xlink:to="loc_iff_SeniorNotesDueTwoThousandTwentyEightMember_4d9452cc-a6ab-4dae-9d9c-0647f0b1e64f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandFortySevenMember_7ee61a80-4446-4cf6-ac26-1a451cfe2bef" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandFortySevenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_827e4ac2-c039-4bc8-b78d-374c53ebf5a2" xlink:to="loc_iff_SeniorNotesDueTwoThousandFortySevenMember_7ee61a80-4446-4cf6-ac26-1a451cfe2bef" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandFortyEightMember_10c46cb1-274b-4ae8-ad84-2dd4b574a14f" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandFortyEightMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_827e4ac2-c039-4bc8-b78d-374c53ebf5a2" xlink:to="loc_iff_SeniorNotesDueTwoThousandFortyEightMember_10c46cb1-274b-4ae8-ad84-2dd4b574a14f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NutritionBiosciencesIncSeniorNotesMember_25350cb4-878f-46e6-9551-69cace8f0902" xlink:href="iff-20231231.xsd#iff_NutritionBiosciencesIncSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_827e4ac2-c039-4bc8-b78d-374c53ebf5a2" xlink:to="loc_iff_NutritionBiosciencesIncSeniorNotesMember_25350cb4-878f-46e6-9551-69cace8f0902" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandTwentyFiveMember_c96051b8-fd5b-4dc1-895d-c73349a6bf09" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandTwentyFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_827e4ac2-c039-4bc8-b78d-374c53ebf5a2" xlink:to="loc_iff_SeniorNotesDueTwoThousandTwentyFiveMember_c96051b8-fd5b-4dc1-895d-c73349a6bf09" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandTwentySevenMember_7fe92659-9b30-4da8-8d56-5be45323b94c" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandTwentySevenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_827e4ac2-c039-4bc8-b78d-374c53ebf5a2" xlink:to="loc_iff_SeniorNotesDueTwoThousandTwentySevenMember_7fe92659-9b30-4da8-8d56-5be45323b94c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandThirtyMember_7f4afa74-5f91-45cb-86fe-1b04bab94726" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandThirtyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_827e4ac2-c039-4bc8-b78d-374c53ebf5a2" xlink:to="loc_iff_SeniorNotesDueTwoThousandThirtyMember_7f4afa74-5f91-45cb-86fe-1b04bab94726" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandFortyMember_a1a1079f-6ef6-4cf3-8c4a-025bddfe63e7" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandFortyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_827e4ac2-c039-4bc8-b78d-374c53ebf5a2" xlink:to="loc_iff_SeniorNotesDueTwoThousandFortyMember_a1a1079f-6ef6-4cf3-8c4a-025bddfe63e7" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandFiftyMember_f0bed5d3-05f8-4915-85aa-c2cccf1e60e2" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandFiftyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_827e4ac2-c039-4bc8-b78d-374c53ebf5a2" xlink:to="loc_iff_SeniorNotesDueTwoThousandFiftyMember_f0bed5d3-05f8-4915-85aa-c2cccf1e60e2" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_9c0153a4-0b95-45d1-b101-1854c2e69618" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_02f22f0a-8bd4-48dc-8353-3f3b5aafaff6" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_9c0153a4-0b95-45d1-b101-1854c2e69618" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9c0153a4-0b95-45d1-b101-1854c2e69618_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9c0153a4-0b95-45d1-b101-1854c2e69618" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9c0153a4-0b95-45d1-b101-1854c2e69618_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_cacda0f2-16c3-4762-9d34-7e65f757356e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9c0153a4-0b95-45d1-b101-1854c2e69618" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_cacda0f2-16c3-4762-9d34-7e65f757356e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_d97c6cad-d9fe-436b-b3c3-ff513bcbbf67" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_cacda0f2-16c3-4762-9d34-7e65f757356e" xlink:to="loc_us-gaap_LoansPayableMember_d97c6cad-d9fe-436b-b3c3-ff513bcbbf67" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_4bdeee3e-e039-41e0-9419-e05fd26b452d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_02f22f0a-8bd4-48dc-8353-3f3b5aafaff6" xlink:to="loc_dei_LegalEntityAxis_4bdeee3e-e039-41e0-9419-e05fd26b452d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_4bdeee3e-e039-41e0-9419-e05fd26b452d_default" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_4bdeee3e-e039-41e0-9419-e05fd26b452d" xlink:to="loc_dei_EntityDomain_4bdeee3e-e039-41e0-9419-e05fd26b452d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_1bb7d2d7-48f2-4552-9744-a16e6075c18a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_4bdeee3e-e039-41e0-9419-e05fd26b452d" xlink:to="loc_dei_EntityDomain_1bb7d2d7-48f2-4552-9744-a16e6075c18a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_InternationalFlavorsFragrancesIncMember_af01a5bb-ccf3-4c0c-af4c-3d075230ad4e" xlink:href="iff-20231231.xsd#iff_InternationalFlavorsFragrancesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_1bb7d2d7-48f2-4552-9744-a16e6075c18a" xlink:to="loc_iff_InternationalFlavorsFragrancesIncMember_af01a5bb-ccf3-4c0c-af4c-3d075230ad4e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NutritionBiosciencesIncMember_a72d4621-4517-4359-9c6b-ea978883c058" xlink:href="iff-20231231.xsd#iff_NutritionBiosciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_1bb7d2d7-48f2-4552-9744-a16e6075c18a" xlink:to="loc_iff_NutritionBiosciencesIncMember_a72d4621-4517-4359-9c6b-ea978883c058" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_f2d68d23-5248-43ee-8c7d-e56e020c89d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_df6f6d3f-ebad-4481-a011-01bb8c288420" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_f2d68d23-5248-43ee-8c7d-e56e020c89d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfCommercialPaper_c66554dd-84b5-4430-894b-cc62c5fe5c77" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfCommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_df6f6d3f-ebad-4481-a011-01bb8c288420" xlink:to="loc_us-gaap_RepaymentsOfCommercialPaper_c66554dd-84b5-4430-894b-cc62c5fe5c77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_a5b2950f-b6b5-44cd-8fe6-8be9dec754cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_df6f6d3f-ebad-4481-a011-01bb8c288420" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_a5b2950f-b6b5-44cd-8fe6-8be9dec754cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_0e334c3f-6cc9-4a6f-8c04-a7141d61f64d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_df6f6d3f-ebad-4481-a011-01bb8c288420" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_0e334c3f-6cc9-4a6f-8c04-a7141d61f64d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_RepurchasePriceAsPercentageOfPrincipalAmountOfSeniorNotes_3189d41c-3513-48e1-99c0-1bfeff50e080" xlink:href="iff-20231231.xsd#iff_RepurchasePriceAsPercentageOfPrincipalAmountOfSeniorNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_df6f6d3f-ebad-4481-a011-01bb8c288420" xlink:to="loc_iff_RepurchasePriceAsPercentageOfPrincipalAmountOfSeniorNotes_3189d41c-3513-48e1-99c0-1bfeff50e080" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/LeasesDetails" xlink:type="simple" xlink:href="iff-20231231.xsd#LeasesDetails"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/LeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_05b72c09-dcbb-472d-bad9-19664fafffb6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_51f93ce1-adb6-40b6-a9e5-4d034fb9d5ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_05b72c09-dcbb-472d-bad9-19664fafffb6" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_51f93ce1-adb6-40b6-a9e5-4d034fb9d5ca" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_eb5aa0e6-af9f-4d4f-aa78-4b9f6d588574" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_51f93ce1-adb6-40b6-a9e5-4d034fb9d5ca" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_eb5aa0e6-af9f-4d4f-aa78-4b9f6d588574" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_eb5aa0e6-af9f-4d4f-aa78-4b9f6d588574_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_eb5aa0e6-af9f-4d4f-aa78-4b9f6d588574" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_eb5aa0e6-af9f-4d4f-aa78-4b9f6d588574_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_216f4391-2c6e-4974-8c10-ddd7f60290ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_eb5aa0e6-af9f-4d4f-aa78-4b9f6d588574" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_216f4391-2c6e-4974-8c10-ddd7f60290ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NutritionBiosciencesIncMember_ca548c22-e9ed-4cac-bf2f-067d8fdbd358" xlink:href="iff-20231231.xsd#iff_NutritionBiosciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_216f4391-2c6e-4974-8c10-ddd7f60290ec" xlink:to="loc_iff_NutritionBiosciencesIncMember_ca548c22-e9ed-4cac-bf2f-067d8fdbd358" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_HealthWrightProductsIncHealthWrightMember_690ee299-6d5f-40e1-87f4-fced4f80fe22" xlink:href="iff-20231231.xsd#iff_HealthWrightProductsIncHealthWrightMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_216f4391-2c6e-4974-8c10-ddd7f60290ec" xlink:to="loc_iff_HealthWrightProductsIncHealthWrightMember_690ee299-6d5f-40e1-87f4-fced4f80fe22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_cb7cf598-c382-426b-9813-408c9becaef8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_05b72c09-dcbb-472d-bad9-19664fafffb6" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_cb7cf598-c382-426b-9813-408c9becaef8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_ef368912-7899-4b82-81bb-d0024ebcb612" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_05b72c09-dcbb-472d-bad9-19664fafffb6" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_ef368912-7899-4b82-81bb-d0024ebcb612" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_4e8de986-40c5-4ee0-9d7a-99f823196d37" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_05b72c09-dcbb-472d-bad9-19664fafffb6" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_4e8de986-40c5-4ee0-9d7a-99f823196d37" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_5739cd74-3624-44ed-8875-47222ff54659" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_05b72c09-dcbb-472d-bad9-19664fafffb6" xlink:to="loc_us-gaap_OperatingLeaseLiability_5739cd74-3624-44ed-8875-47222ff54659" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_0649a9fb-21f6-4ac8-9c8a-5328a17f555e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_05b72c09-dcbb-472d-bad9-19664fafffb6" xlink:to="loc_us-gaap_FinanceLeaseLiability_0649a9fb-21f6-4ac8-9c8a-5328a17f555e" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/LeasesAdditionalInformationDetails" xlink:type="simple" xlink:href="iff-20231231.xsd#LeasesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/LeasesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_9bcfbb34-4189-4de8-a33e-958bac393f8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_ae8190eb-bab8-491b-9ac2-a4828f4b9d31" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_9bcfbb34-4189-4de8-a33e-958bac393f8e" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_ae8190eb-bab8-491b-9ac2-a4828f4b9d31" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_ab5c0400-1b41-4da4-b64b-0d5a15530ade" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_ae8190eb-bab8-491b-9ac2-a4828f4b9d31" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_ab5c0400-1b41-4da4-b64b-0d5a15530ade" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ab5c0400-1b41-4da4-b64b-0d5a15530ade_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ab5c0400-1b41-4da4-b64b-0d5a15530ade" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ab5c0400-1b41-4da4-b64b-0d5a15530ade_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7baaec84-47e2-4282-a787-24d3c668a11d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ab5c0400-1b41-4da4-b64b-0d5a15530ade" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7baaec84-47e2-4282-a787-24d3c668a11d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NutritionBiosciencesIncMember_69de2d78-8b65-4b9c-b765-d27e0cb7556e" xlink:href="iff-20231231.xsd#iff_NutritionBiosciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7baaec84-47e2-4282-a787-24d3c668a11d" xlink:to="loc_iff_NutritionBiosciencesIncMember_69de2d78-8b65-4b9c-b765-d27e0cb7556e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_HealthWrightProductsIncHealthWrightMember_57f158f0-b2f2-4f81-b1ee-57b64c8b600d" xlink:href="iff-20231231.xsd#iff_HealthWrightProductsIncHealthWrightMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7baaec84-47e2-4282-a787-24d3c668a11d" xlink:to="loc_iff_HealthWrightProductsIncHealthWrightMember_57f158f0-b2f2-4f81-b1ee-57b64c8b600d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_16e0027f-a9eb-4581-99c1-b83ff9275310" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_ae8190eb-bab8-491b-9ac2-a4828f4b9d31" xlink:to="loc_srt_CounterpartyNameAxis_16e0027f-a9eb-4581-99c1-b83ff9275310" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_16e0027f-a9eb-4581-99c1-b83ff9275310_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_16e0027f-a9eb-4581-99c1-b83ff9275310" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_16e0027f-a9eb-4581-99c1-b83ff9275310_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_feaf3194-2372-48ff-818d-e3be82b07ba8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_16e0027f-a9eb-4581-99c1-b83ff9275310" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_feaf3194-2372-48ff-818d-e3be82b07ba8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b515079e-bd4e-41bb-8c70-6a61497a0209" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_ae8190eb-bab8-491b-9ac2-a4828f4b9d31" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b515079e-bd4e-41bb-8c70-6a61497a0209" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b515079e-bd4e-41bb-8c70-6a61497a0209_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b515079e-bd4e-41bb-8c70-6a61497a0209" xlink:to="loc_us-gaap_SegmentDomain_b515079e-bd4e-41bb-8c70-6a61497a0209_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f5f71bc5-b17e-4604-85c4-22e1a60fecce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b515079e-bd4e-41bb-8c70-6a61497a0209" xlink:to="loc_us-gaap_SegmentDomain_f5f71bc5-b17e-4604-85c4-22e1a60fecce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionAxis_f3c67231-7320-4ead-92f5-4989a8e6ab64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_ae8190eb-bab8-491b-9ac2-a4828f4b9d31" xlink:to="loc_us-gaap_GeographicDistributionAxis_f3c67231-7320-4ead-92f5-4989a8e6ab64" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomain_f3c67231-7320-4ead-92f5-4989a8e6ab64_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_GeographicDistributionAxis_f3c67231-7320-4ead-92f5-4989a8e6ab64" xlink:to="loc_us-gaap_GeographicDistributionDomain_f3c67231-7320-4ead-92f5-4989a8e6ab64_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomain_00c87cc7-d4fb-4808-ba8a-0be39eb6b258" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_GeographicDistributionAxis_f3c67231-7320-4ead-92f5-4989a8e6ab64" xlink:to="loc_us-gaap_GeographicDistributionDomain_00c87cc7-d4fb-4808-ba8a-0be39eb6b258" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cc6b2e28-7c89-4c39-9d94-4f36c54ec106" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_ae8190eb-bab8-491b-9ac2-a4828f4b9d31" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cc6b2e28-7c89-4c39-9d94-4f36c54ec106" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_cc6b2e28-7c89-4c39-9d94-4f36c54ec106_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cc6b2e28-7c89-4c39-9d94-4f36c54ec106" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_cc6b2e28-7c89-4c39-9d94-4f36c54ec106_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_edfaf9ad-e479-48ec-acfd-41bca7474b18" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cc6b2e28-7c89-4c39-9d94-4f36c54ec106" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_edfaf9ad-e479-48ec-acfd-41bca7474b18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermAxis_bf77d5e0-b644-4dcc-8194-60a7308c37c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseContractualTermAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_ae8190eb-bab8-491b-9ac2-a4828f4b9d31" xlink:to="loc_us-gaap_LeaseContractualTermAxis_bf77d5e0-b644-4dcc-8194-60a7308c37c1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain_bf77d5e0-b644-4dcc-8194-60a7308c37c1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LeaseContractualTermAxis_bf77d5e0-b644-4dcc-8194-60a7308c37c1" xlink:to="loc_us-gaap_LeaseContractualTermDomain_bf77d5e0-b644-4dcc-8194-60a7308c37c1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain_847f1657-dde5-4c8c-888a-399f1fb100c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LeaseContractualTermAxis_bf77d5e0-b644-4dcc-8194-60a7308c37c1" xlink:to="loc_us-gaap_LeaseContractualTermDomain_847f1657-dde5-4c8c-888a-399f1fb100c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_719e1a5f-0c6b-4e0d-bfdc-16589523b637" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_9bcfbb34-4189-4de8-a33e-958bac393f8e" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_719e1a5f-0c6b-4e0d-bfdc-16589523b637" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_a1e224cc-931a-4098-932b-ff3a1ec63731" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_9bcfbb34-4189-4de8-a33e-958bac393f8e" xlink:to="loc_us-gaap_OperatingLeaseLiability_a1e224cc-931a-4098-932b-ff3a1ec63731" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_1895e914-f86e-4d5e-8a52-e6a805ccb249" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_9bcfbb34-4189-4de8-a33e-958bac393f8e" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_1895e914-f86e-4d5e-8a52-e6a805ccb249" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_0d7c680b-a176-4b8f-8148-67a44aec4171" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_9bcfbb34-4189-4de8-a33e-958bac393f8e" xlink:to="loc_us-gaap_FinanceLeaseLiability_0d7c680b-a176-4b8f-8148-67a44aec4171" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/IncomeTaxesAdditionalInformationDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#IncomeTaxesAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/IncomeTaxesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_iff_IncomeTaxesLineItems_be6ecbdf-883a-4efd-800f-1a67aeaeeb98" xlink:href="iff-20231231.xsd#iff_IncomeTaxesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_IncomeTaxesDisclosureTable_0e644298-a6b1-4e0d-a964-2ebace714767" xlink:href="iff-20231231.xsd#iff_IncomeTaxesDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_iff_IncomeTaxesLineItems_be6ecbdf-883a-4efd-800f-1a67aeaeeb98" xlink:to="loc_iff_IncomeTaxesDisclosureTable_0e644298-a6b1-4e0d-a964-2ebace714767" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_fd50489e-ee02-4440-bd77-d8f9f57e9d40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iff_IncomeTaxesDisclosureTable_0e644298-a6b1-4e0d-a964-2ebace714767" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_fd50489e-ee02-4440-bd77-d8f9f57e9d40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_fd50489e-ee02-4440-bd77-d8f9f57e9d40_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_fd50489e-ee02-4440-bd77-d8f9f57e9d40" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_fd50489e-ee02-4440-bd77-d8f9f57e9d40_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_ac176753-f45b-441a-9248-90dfda485dea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_fd50489e-ee02-4440-bd77-d8f9f57e9d40" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_ac176753-f45b-441a-9248-90dfda485dea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_36b8e772-5798-4648-b7f3-8c7ec65b1b93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_ac176753-f45b-441a-9248-90dfda485dea" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_36b8e772-5798-4648-b7f3-8c7ec65b1b93" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_b902bf2c-e381-4e15-a6b9-50839573c5c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_ac176753-f45b-441a-9248-90dfda485dea" xlink:to="loc_us-gaap_DomesticCountryMember_b902bf2c-e381-4e15-a6b9-50839573c5c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_9bc0bb31-10b8-4ec7-9197-9d05bd56ac72" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_ac176753-f45b-441a-9248-90dfda485dea" xlink:to="loc_us-gaap_ForeignCountryMember_9bc0bb31-10b8-4ec7-9197-9d05bd56ac72" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_d7f84146-8aff-4518-b532-38e612ab2474" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iff_IncomeTaxesDisclosureTable_0e644298-a6b1-4e0d-a964-2ebace714767" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_d7f84146-8aff-4518-b532-38e612ab2474" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d7f84146-8aff-4518-b532-38e612ab2474_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_d7f84146-8aff-4518-b532-38e612ab2474" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d7f84146-8aff-4518-b532-38e612ab2474_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_63ec9de4-76c5-4d6a-b389-b9436ea4a612" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_d7f84146-8aff-4518-b532-38e612ab2474" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_63ec9de4-76c5-4d6a-b389-b9436ea4a612" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_075a6111-3d93-41ab-8dcb-6f7db7ef8cf9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_63ec9de4-76c5-4d6a-b389-b9436ea4a612" xlink:to="loc_us-gaap_OtherLiabilitiesMember_075a6111-3d93-41ab-8dcb-6f7db7ef8cf9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_9485c31d-365a-468e-84ca-765b6aac624a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_63ec9de4-76c5-4d6a-b389-b9436ea4a612" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_9485c31d-365a-468e-84ca-765b6aac624a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_db9c3108-8207-438d-8945-fc741f0fd3a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iff_IncomeTaxesDisclosureTable_0e644298-a6b1-4e0d-a964-2ebace714767" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_db9c3108-8207-438d-8945-fc741f0fd3a2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_db9c3108-8207-438d-8945-fc741f0fd3a2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_db9c3108-8207-438d-8945-fc741f0fd3a2" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_db9c3108-8207-438d-8945-fc741f0fd3a2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_ad022f2d-fb94-4d23-86b2-522c4c564db8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_db9c3108-8207-438d-8945-fc741f0fd3a2" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_ad022f2d-fb94-4d23-86b2-522c4c564db8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TwoThousandTwentyThreeToTwoThousandFortyTwoMember_a4a40d2e-5c79-419c-be12-dcf9196f697f" xlink:href="iff-20231231.xsd#iff_TwoThousandTwentyThreeToTwoThousandFortyTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_ad022f2d-fb94-4d23-86b2-522c4c564db8" xlink:to="loc_iff_TwoThousandTwentyThreeToTwoThousandFortyTwoMember_a4a40d2e-5c79-419c-be12-dcf9196f697f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_IndefiniteMember_6dc98d0f-c8b4-4770-88eb-6e9178045265" xlink:href="iff-20231231.xsd#iff_IndefiniteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_ad022f2d-fb94-4d23-86b2-522c4c564db8" xlink:to="loc_iff_IndefiniteMember_6dc98d0f-c8b4-4770-88eb-6e9178045265" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TwoThousandTwentyTwoToTwoThousandFortyOneMember_cde575fe-cd07-4fb1-b2c8-365e47aa868e" xlink:href="iff-20231231.xsd#iff_TwoThousandTwentyTwoToTwoThousandFortyOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_ad022f2d-fb94-4d23-86b2-522c4c564db8" xlink:to="loc_iff_TwoThousandTwentyTwoToTwoThousandFortyOneMember_cde575fe-cd07-4fb1-b2c8-365e47aa868e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis_d8d5a8c0-f649-4f3d-8318-5a16ede80a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iff_IncomeTaxesDisclosureTable_0e644298-a6b1-4e0d-a964-2ebace714767" xlink:to="loc_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis_d8d5a8c0-f649-4f3d-8318-5a16ede80a7a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain_d8d5a8c0-f649-4f3d-8318-5a16ede80a7a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis_d8d5a8c0-f649-4f3d-8318-5a16ede80a7a" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain_d8d5a8c0-f649-4f3d-8318-5a16ede80a7a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain_2954df44-8205-49ac-a99d-d057966300ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis_d8d5a8c0-f649-4f3d-8318-5a16ede80a7a" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain_2954df44-8205-49ac-a99d-d057966300ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_UnrecognizedTaxBenefitsOtherLiabilitiesMember_fa0c52b2-8b4c-405a-8a17-4e58b831a654" xlink:href="iff-20231231.xsd#iff_UnrecognizedTaxBenefitsOtherLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain_2954df44-8205-49ac-a99d-d057966300ad" xlink:to="loc_iff_UnrecognizedTaxBenefitsOtherLiabilitiesMember_fa0c52b2-8b4c-405a-8a17-4e58b831a654" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_UnrecognizedTaxBenefitsOtherCurrentLiabilitiesMember_d465694c-2a9b-4e5a-897a-11ac8393e1a1" xlink:href="iff-20231231.xsd#iff_UnrecognizedTaxBenefitsOtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain_2954df44-8205-49ac-a99d-d057966300ad" xlink:to="loc_iff_UnrecognizedTaxBenefitsOtherCurrentLiabilitiesMember_d465694c-2a9b-4e5a-897a-11ac8393e1a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount_8e1d3510-f4e1-4ba2-a6d6-7bf749819dc8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_IncomeTaxesLineItems_be6ecbdf-883a-4efd-800f-1a67aeaeeb98" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount_8e1d3510-f4e1-4ba2-a6d6-7bf749819dc8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiAmount_774c3d68-551f-437e-ae30-3838cd9455ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationFdiiAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_IncomeTaxesLineItems_be6ecbdf-883a-4efd-800f-1a67aeaeeb98" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiAmount_774c3d68-551f-437e-ae30-3838cd9455ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_4f439589-630b-4f4e-a627-d3e95e285fe0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_IncomeTaxesLineItems_be6ecbdf-883a-4efd-800f-1a67aeaeeb98" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_4f439589-630b-4f4e-a627-d3e95e285fe0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsDividends_c213f0b1-9b70-421e-a9d0-6322f8493c60" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsDividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_IncomeTaxesLineItems_be6ecbdf-883a-4efd-800f-1a67aeaeeb98" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsDividends_c213f0b1-9b70-421e-a9d0-6322f8493c60" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_091eee47-c0c2-4588-a50d-cc845e74b098" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_IncomeTaxesLineItems_be6ecbdf-883a-4efd-800f-1a67aeaeeb98" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_091eee47-c0c2-4588-a50d-cc845e74b098" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_74543778-a2c2-4864-a221-59c9ce5f9ea5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_IncomeTaxesLineItems_be6ecbdf-883a-4efd-800f-1a67aeaeeb98" xlink:to="loc_us-gaap_OperatingLossCarryforwards_74543778-a2c2-4864-a221-59c9ce5f9ea5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_48922a4f-c5a2-4f83-9035-60a7a5a0f878" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_IncomeTaxesLineItems_be6ecbdf-883a-4efd-800f-1a67aeaeeb98" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_48922a4f-c5a2-4f83-9035-60a7a5a0f878" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_9c935f16-bed9-4170-9847-ce9e1bdd79c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_IncomeTaxesLineItems_be6ecbdf-883a-4efd-800f-1a67aeaeeb98" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_9c935f16-bed9-4170-9847-ce9e1bdd79c9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_42716e80-c317-4680-bb86-3e1fbb23cb7d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_IncomeTaxesLineItems_be6ecbdf-883a-4efd-800f-1a67aeaeeb98" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_42716e80-c317-4680-bb86-3e1fbb23cb7d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance_647bdf41-9012-4177-937c-ff55d8199e84" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_IncomeTaxesLineItems_be6ecbdf-883a-4efd-800f-1a67aeaeeb98" xlink:to="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance_647bdf41-9012-4177-937c-ff55d8199e84" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_f98627a6-0317-4e5b-8639-ec76c099d516" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_IncomeTaxesLineItems_be6ecbdf-883a-4efd-800f-1a67aeaeeb98" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_f98627a6-0317-4e5b-8639-ec76c099d516" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AccruedInterestOrPenaltiesRelatedToTaxAmounts_96826f99-176d-43a0-aa6a-9180e34cd444" xlink:href="iff-20231231.xsd#iff_AccruedInterestOrPenaltiesRelatedToTaxAmounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_IncomeTaxesLineItems_be6ecbdf-883a-4efd-800f-1a67aeaeeb98" xlink:to="loc_iff_AccruedInterestOrPenaltiesRelatedToTaxAmounts_96826f99-176d-43a0-aa6a-9180e34cd444" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_ed5cf056-4ae6-49f3-8032-56f4521d26b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_IncomeTaxesLineItems_be6ecbdf-883a-4efd-800f-1a67aeaeeb98" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_ed5cf056-4ae6-49f3-8032-56f4521d26b6" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_UnrecognizedTaxBenefitsIncludingInterestAndPenalties_b59ae448-4e35-46dc-8fba-08555a7a2ca8" xlink:href="iff-20231231.xsd#iff_UnrecognizedTaxBenefitsIncludingInterestAndPenalties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_IncomeTaxesLineItems_be6ecbdf-883a-4efd-800f-1a67aeaeeb98" xlink:to="loc_iff_UnrecognizedTaxBenefitsIncludingInterestAndPenalties_b59ae448-4e35-46dc-8fba-08555a7a2ca8" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardValuationAllowance_96156838-3e26-47e8-965b-51e32b8d9c3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxCreditCarryforwardValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_IncomeTaxesLineItems_be6ecbdf-883a-4efd-800f-1a67aeaeeb98" xlink:to="loc_us-gaap_TaxCreditCarryforwardValuationAllowance_96156838-3e26-47e8-965b-51e32b8d9c3f" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DeferredTaxLiabilitiesDeemedRepatriation_e401021f-ee7f-4020-a765-facb88533a3e" xlink:href="iff-20231231.xsd#iff_DeferredTaxLiabilitiesDeemedRepatriation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_IncomeTaxesLineItems_be6ecbdf-883a-4efd-800f-1a67aeaeeb98" xlink:to="loc_iff_DeferredTaxLiabilitiesDeemedRepatriation_e401021f-ee7f-4020-a765-facb88533a3e" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_bf4d9751-67ff-4dc6-848a-e35d98039c97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_IncomeTaxesLineItems_be6ecbdf-883a-4efd-800f-1a67aeaeeb98" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_bf4d9751-67ff-4dc6-848a-e35d98039c97" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_UnrecognizedTaxBenefitsReductionResultingFromLapseOfApplicableStatueOfLimitationsNextTwelveMonths_e256b4b2-c3a2-40c8-b94c-03232a950b1b" xlink:href="iff-20231231.xsd#iff_UnrecognizedTaxBenefitsReductionResultingFromLapseOfApplicableStatueOfLimitationsNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_IncomeTaxesLineItems_be6ecbdf-883a-4efd-800f-1a67aeaeeb98" xlink:to="loc_iff_UnrecognizedTaxBenefitsReductionResultingFromLapseOfApplicableStatueOfLimitationsNextTwelveMonths_e256b4b2-c3a2-40c8-b94c-03232a950b1b" xlink:type="arc" order="17"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofUnrecognizedTaxBenefitsDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#IncomeTaxesReconciliationofBeginningandEndingAmountofUnrecognizedTaxBenefitsDetail"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofUnrecognizedTaxBenefitsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_iff_IncomeTaxesDisclosureLineItems_97f4e3c9-3061-43b8-89b3-fecfd7cc671c" xlink:href="iff-20231231.xsd#iff_IncomeTaxesDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_IncomeTaxesDisclosureTable_a7c0207f-b562-40ea-b412-f1285964c83b" xlink:href="iff-20231231.xsd#iff_IncomeTaxesDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_iff_IncomeTaxesDisclosureLineItems_97f4e3c9-3061-43b8-89b3-fecfd7cc671c" xlink:to="loc_iff_IncomeTaxesDisclosureTable_a7c0207f-b562-40ea-b412-f1285964c83b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis_8ee2d01a-0772-424a-b6b4-2931f2dfde33" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iff_IncomeTaxesDisclosureTable_a7c0207f-b562-40ea-b412-f1285964c83b" xlink:to="loc_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis_8ee2d01a-0772-424a-b6b4-2931f2dfde33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain_8ee2d01a-0772-424a-b6b4-2931f2dfde33_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis_8ee2d01a-0772-424a-b6b4-2931f2dfde33" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain_8ee2d01a-0772-424a-b6b4-2931f2dfde33_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain_090125e3-5d5f-47ac-88f1-2f33cd4aa08e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis_8ee2d01a-0772-424a-b6b4-2931f2dfde33" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain_090125e3-5d5f-47ac-88f1-2f33cd4aa08e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_UnrecognizedTaxBenefitsOtherCurrentLiabilitiesMember_df726c6e-a180-4aef-96db-e807a235fbe4" xlink:href="iff-20231231.xsd#iff_UnrecognizedTaxBenefitsOtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain_090125e3-5d5f-47ac-88f1-2f33cd4aa08e" xlink:to="loc_iff_UnrecognizedTaxBenefitsOtherCurrentLiabilitiesMember_df726c6e-a180-4aef-96db-e807a235fbe4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_d8a08b96-3899-4b75-86ac-24a162e2f602" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iff_IncomeTaxesDisclosureTable_a7c0207f-b562-40ea-b412-f1285964c83b" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_d8a08b96-3899-4b75-86ac-24a162e2f602" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d8a08b96-3899-4b75-86ac-24a162e2f602_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_d8a08b96-3899-4b75-86ac-24a162e2f602" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d8a08b96-3899-4b75-86ac-24a162e2f602_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_64767b47-d67c-4a8c-8995-317206101720" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_d8a08b96-3899-4b75-86ac-24a162e2f602" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_64767b47-d67c-4a8c-8995-317206101720" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_ea2d2a09-87b6-462c-9352-2812010eb196" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_64767b47-d67c-4a8c-8995-317206101720" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_ea2d2a09-87b6-462c-9352-2812010eb196" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_99f77ca4-15a5-45e6-9c59-ac5a597b2f22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_IncomeTaxesDisclosureLineItems_97f4e3c9-3061-43b8-89b3-fecfd7cc671c" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_99f77ca4-15a5-45e6-9c59-ac5a597b2f22" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_956fa7a2-c7d9-4f19-ab5c-1d22f4f56208" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_IncomeTaxesDisclosureLineItems_97f4e3c9-3061-43b8-89b3-fecfd7cc671c" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_956fa7a2-c7d9-4f19-ab5c-1d22f4f56208" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_f18d7a8b-6e44-499a-9e49-614c371b6e24" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_IncomeTaxesDisclosureLineItems_97f4e3c9-3061-43b8-89b3-fecfd7cc671c" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_f18d7a8b-6e44-499a-9e49-614c371b6e24" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_f0b00153-7e50-4124-8607-07d1ef046453" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_IncomeTaxesDisclosureLineItems_97f4e3c9-3061-43b8-89b3-fecfd7cc671c" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_f0b00153-7e50-4124-8607-07d1ef046453" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/NetIncomePerShareReconciliationofSharesUsedinComputationofBasicandDilutedNetIncomePerShareDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#NetIncomePerShareReconciliationofSharesUsedinComputationofBasicandDilutedNetIncomePerShareDetail"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/NetIncomePerShareReconciliationofSharesUsedinComputationofBasicandDilutedNetIncomePerShareDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_3101b032-130d-4e50-8f45-a89f1395a8f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_e95f047d-6323-473f-8d25-31e0cd3d454f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_3101b032-130d-4e50-8f45-a89f1395a8f6" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_e95f047d-6323-473f-8d25-31e0cd3d454f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_66b34c67-4d03-4862-8745-520fc0458e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_e95f047d-6323-473f-8d25-31e0cd3d454f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_66b34c67-4d03-4862-8745-520fc0458e5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_66b34c67-4d03-4862-8745-520fc0458e5d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_66b34c67-4d03-4862-8745-520fc0458e5d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_66b34c67-4d03-4862-8745-520fc0458e5d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_cadfb0c2-7f23-419c-8d85-a7e503d284d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_66b34c67-4d03-4862-8745-520fc0458e5d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_cadfb0c2-7f23-419c-8d85-a7e503d284d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EmployeeStockOptionAndRestrictedStockMember_57572129-cf48-4fac-9f01-12fb44d6e762" xlink:href="iff-20231231.xsd#iff_EmployeeStockOptionAndRestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_cadfb0c2-7f23-419c-8d85-a7e503d284d5" xlink:to="loc_iff_EmployeeStockOptionAndRestrictedStockMember_57572129-cf48-4fac-9f01-12fb44d6e762" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_StockPurchaseContractMember_afa34cc7-958c-4cd9-87c3-c0ce9b2331f9" xlink:href="iff-20231231.xsd#iff_StockPurchaseContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_cadfb0c2-7f23-419c-8d85-a7e503d284d5" xlink:to="loc_iff_StockPurchaseContractMember_afa34cc7-958c-4cd9-87c3-c0ce9b2331f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_18f827d0-bcf4-4667-a4b4-706e25e7f81d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_3101b032-130d-4e50-8f45-a89f1395a8f6" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_18f827d0-bcf4-4667-a4b4-706e25e7f81d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_50f3265c-ebfe-4559-b46c-55e5ba66cea2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_18f827d0-bcf4-4667-a4b4-706e25e7f81d" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_50f3265c-ebfe-4559-b46c-55e5ba66cea2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NetIncomeLossAvailableToCommonStockholdersAdjustment_02819d71-8f5e-45c0-b14d-42d4de0bab87" xlink:href="iff-20231231.xsd#iff_NetIncomeLossAvailableToCommonStockholdersAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_18f827d0-bcf4-4667-a4b4-706e25e7f81d" xlink:to="loc_iff_NetIncomeLossAvailableToCommonStockholdersAdjustment_02819d71-8f5e-45c0-b14d-42d4de0bab87" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_d5f21c3d-cbf1-4b68-b30a-b5e657ddf92a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_3101b032-130d-4e50-8f45-a89f1395a8f6" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_d5f21c3d-cbf1-4b68-b30a-b5e657ddf92a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d87e088a-e3a6-4da0-808a-395eef395508" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_d5f21c3d-cbf1-4b68-b30a-b5e657ddf92a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d87e088a-e3a6-4da0-808a-395eef395508" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_52ea4fbb-7f59-403f-a907-78cbd6b28622" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_d5f21c3d-cbf1-4b68-b30a-b5e657ddf92a" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_52ea4fbb-7f59-403f-a907-78cbd6b28622" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4706505e-49d2-4fa2-bd30-3bf8c441843a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_d5f21c3d-cbf1-4b68-b30a-b5e657ddf92a" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4706505e-49d2-4fa2-bd30-3bf8c441843a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_76ef8694-be36-4cd3-89cd-a02fcdfca3e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_3101b032-130d-4e50-8f45-a89f1395a8f6" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_76ef8694-be36-4cd3-89cd-a02fcdfca3e0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_9866203d-dd9d-4734-83d0-78c3b55e51dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_76ef8694-be36-4cd3-89cd-a02fcdfca3e0" xlink:to="loc_us-gaap_EarningsPerShareBasic_9866203d-dd9d-4734-83d0-78c3b55e51dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_b3747b28-bba6-4211-8106-1348dd522af2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_76ef8694-be36-4cd3-89cd-a02fcdfca3e0" xlink:to="loc_us-gaap_EarningsPerShareDiluted_b3747b28-bba6-4211-8106-1348dd522af2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_IncreaseDecreaseInRedemptionValueRedeemableNoncontrollingInterest_c0e72f4c-661f-4be4-8e5b-c1a7458b5d09" xlink:href="iff-20231231.xsd#iff_IncreaseDecreaseInRedemptionValueRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_3101b032-130d-4e50-8f45-a89f1395a8f6" xlink:to="loc_iff_IncreaseDecreaseInRedemptionValueRedeemableNoncontrollingInterest_c0e72f4c-661f-4be4-8e5b-c1a7458b5d09" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/NetIncomePerShareAdditionalInformationDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#NetIncomePerShareAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/NetIncomePerShareAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4a7e182b-9c99-4e58-8989-bc401cc4b814" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_06e74db6-4cb2-45a1-86f1-4e8a417493a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4a7e182b-9c99-4e58-8989-bc401cc4b814" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_06e74db6-4cb2-45a1-86f1-4e8a417493a3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_134bee69-ce38-43d6-866b-8d2401ac1bed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_06e74db6-4cb2-45a1-86f1-4e8a417493a3" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_134bee69-ce38-43d6-866b-8d2401ac1bed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_134bee69-ce38-43d6-866b-8d2401ac1bed_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_134bee69-ce38-43d6-866b-8d2401ac1bed" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_134bee69-ce38-43d6-866b-8d2401ac1bed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b961abf8-d03d-4010-83a7-651a2a3d57e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_134bee69-ce38-43d6-866b-8d2401ac1bed" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b961abf8-d03d-4010-83a7-651a2a3d57e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NutritionBiosciencesIncMember_9b886107-c1c9-460b-8aa2-a7d6582e4e7c" xlink:href="iff-20231231.xsd#iff_NutritionBiosciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b961abf8-d03d-4010-83a7-651a2a3d57e6" xlink:to="loc_iff_NutritionBiosciencesIncMember_9b886107-c1c9-460b-8aa2-a7d6582e4e7c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_288f7e51-06ce-4c1b-8310-384e56cb139a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_06e74db6-4cb2-45a1-86f1-4e8a417493a3" xlink:to="loc_us-gaap_AwardTypeAxis_288f7e51-06ce-4c1b-8310-384e56cb139a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_288f7e51-06ce-4c1b-8310-384e56cb139a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_288f7e51-06ce-4c1b-8310-384e56cb139a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_288f7e51-06ce-4c1b-8310-384e56cb139a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e9b21714-3bd5-4566-a83d-7ad6f24f4bf0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_288f7e51-06ce-4c1b-8310-384e56cb139a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e9b21714-3bd5-4566-a83d-7ad6f24f4bf0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_b932ec29-7b21-44a1-af85-2248b81a01e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e9b21714-3bd5-4566-a83d-7ad6f24f4bf0" xlink:to="loc_us-gaap_RestrictedStockMember_b932ec29-7b21-44a1-af85-2248b81a01e3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_StockOptionsOrStockSettledAppreciationRightsMember_4fa3c61e-6d46-40ce-906a-953ea0754c37" xlink:href="iff-20231231.xsd#iff_StockOptionsOrStockSettledAppreciationRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e9b21714-3bd5-4566-a83d-7ad6f24f4bf0" xlink:to="loc_iff_StockOptionsOrStockSettledAppreciationRightsMember_4fa3c61e-6d46-40ce-906a-953ea0754c37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareEquivalentsMember_3f0f486f-25b6-40a3-858a-26700ae44ed4" xlink:href="iff-20231231.xsd#iff_ShareEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e9b21714-3bd5-4566-a83d-7ad6f24f4bf0" xlink:to="loc_iff_ShareEquivalentsMember_3f0f486f-25b6-40a3-858a-26700ae44ed4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_6fe18435-3284-4a31-a4fd-340fd553e059" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_06e74db6-4cb2-45a1-86f1-4e8a417493a3" xlink:to="loc_srt_OwnershipAxis_6fe18435-3284-4a31-a4fd-340fd553e059" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_6fe18435-3284-4a31-a4fd-340fd553e059_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_6fe18435-3284-4a31-a4fd-340fd553e059" xlink:to="loc_srt_OwnershipDomain_6fe18435-3284-4a31-a4fd-340fd553e059_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_1a82a646-5e46-4828-9db7-f2a4aa1d468d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_6fe18435-3284-4a31-a4fd-340fd553e059" xlink:to="loc_srt_OwnershipDomain_1a82a646-5e46-4828-9db7-f2a4aa1d468d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_InternationalFlavorsFragrancesIncMember_30e2ee61-4527-4b9f-b45b-c84b286fcde3" xlink:href="iff-20231231.xsd#iff_InternationalFlavorsFragrancesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_1a82a646-5e46-4828-9db7-f2a4aa1d468d" xlink:to="loc_iff_InternationalFlavorsFragrancesIncMember_30e2ee61-4527-4b9f-b45b-c84b286fcde3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_1e45e5d0-7fee-4e9d-8bc0-9193a56f064c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_06e74db6-4cb2-45a1-86f1-4e8a417493a3" xlink:to="loc_dei_LegalEntityAxis_1e45e5d0-7fee-4e9d-8bc0-9193a56f064c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_1e45e5d0-7fee-4e9d-8bc0-9193a56f064c_default" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1e45e5d0-7fee-4e9d-8bc0-9193a56f064c" xlink:to="loc_dei_EntityDomain_1e45e5d0-7fee-4e9d-8bc0-9193a56f064c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_e1cec76b-5858-4c7b-8bb3-00539280b564" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1e45e5d0-7fee-4e9d-8bc0-9193a56f064c" xlink:to="loc_dei_EntityDomain_e1cec76b-5858-4c7b-8bb3-00539280b564" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DuPontdeNemoursIncMember_d0dacdcb-fc34-4ce3-a674-a99e52ad4167" xlink:href="iff-20231231.xsd#iff_DuPontdeNemoursIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_e1cec76b-5858-4c7b-8bb3-00539280b564" xlink:to="loc_iff_DuPontdeNemoursIncMember_d0dacdcb-fc34-4ce3-a674-a99e52ad4167" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DifferenceAmountBetweenBasicAndDilutedNetIncomePerShare_98b07764-275e-422e-aa01-c994e3a47299" xlink:href="iff-20231231.xsd#iff_DifferenceAmountBetweenBasicAndDilutedNetIncomePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4a7e182b-9c99-4e58-8989-bc401cc4b814" xlink:to="loc_iff_DifferenceAmountBetweenBasicAndDilutedNetIncomePerShare_98b07764-275e-422e-aa01-c994e3a47299" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_06748058-31d8-49ce-9611-fdebf408703c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4a7e182b-9c99-4e58-8989-bc401cc4b814" xlink:to="loc_us-gaap_NetIncomeLoss_06748058-31d8-49ce-9611-fdebf408703c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_120e1743-5741-4a57-8d98-93dfd3290528" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4a7e182b-9c99-4e58-8989-bc401cc4b814" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_120e1743-5741-4a57-8d98-93dfd3290528" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_54c8a819-30a9-4560-b122-253471d0db03" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4a7e182b-9c99-4e58-8989-bc401cc4b814" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_54c8a819-30a9-4560-b122-253471d0db03" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_44f88a46-891a-4dc6-bb07-75ecbbf68970" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4a7e182b-9c99-4e58-8989-bc401cc4b814" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_44f88a46-891a-4dc6-bb07-75ecbbf68970" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_44a2b604-3f1d-4245-b3eb-0f1f8c40743b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4a7e182b-9c99-4e58-8989-bc401cc4b814" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_44a2b604-3f1d-4245-b3eb-0f1f8c40743b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DifferenceAmountBetweenBasicNetIncomeLossPerShare_44fb44a2-4271-4804-9137-8beec2e918f1" xlink:href="iff-20231231.xsd#iff_DifferenceAmountBetweenBasicNetIncomeLossPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4a7e182b-9c99-4e58-8989-bc401cc4b814" xlink:to="loc_iff_DifferenceAmountBetweenBasicNetIncomeLossPerShare_44fb44a2-4271-4804-9137-8beec2e918f1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DifferenceAmountBetweenDilutedNetIncomeLossPerShare_5e617cde-fe30-4618-810c-7ca90d2bee55" xlink:href="iff-20231231.xsd#iff_DifferenceAmountBetweenDilutedNetIncomeLossPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4a7e182b-9c99-4e58-8989-bc401cc4b814" xlink:to="loc_iff_DifferenceAmountBetweenDilutedNetIncomeLossPerShare_5e617cde-fe30-4618-810c-7ca90d2bee55" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenBasicNetIncomeLossPerShare_4630e0cb-7a7a-4653-b391-6efe4351ac37" xlink:href="iff-20231231.xsd#iff_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenBasicNetIncomeLossPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4a7e182b-9c99-4e58-8989-bc401cc4b814" xlink:to="loc_iff_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenBasicNetIncomeLossPerShare_4630e0cb-7a7a-4653-b391-6efe4351ac37" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenDilutedNetIncomeLossPerShare_d59e515d-2460-4691-8e6c-23ae6e081f9a" xlink:href="iff-20231231.xsd#iff_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenDilutedNetIncomeLossPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4a7e182b-9c99-4e58-8989-bc401cc4b814" xlink:to="loc_iff_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenDilutedNetIncomeLossPerShare_d59e515d-2460-4691-8e6c-23ae6e081f9a" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#StockCompensationPlansAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_65135d2d-893e-4491-a974-a317767c88b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_56c592c9-5954-4327-bad7-356df549ff97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_65135d2d-893e-4491-a974-a317767c88b8" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_56c592c9-5954-4327-bad7-356df549ff97" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_060c9c45-0eb0-484f-88aa-1b7e09291ffa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_56c592c9-5954-4327-bad7-356df549ff97" xlink:to="loc_us-gaap_VestingAxis_060c9c45-0eb0-484f-88aa-1b7e09291ffa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_060c9c45-0eb0-484f-88aa-1b7e09291ffa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_060c9c45-0eb0-484f-88aa-1b7e09291ffa" xlink:to="loc_us-gaap_VestingDomain_060c9c45-0eb0-484f-88aa-1b7e09291ffa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_216b2eb7-8b02-4f28-a304-a11fb49d115f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_060c9c45-0eb0-484f-88aa-1b7e09291ffa" xlink:to="loc_us-gaap_VestingDomain_216b2eb7-8b02-4f28-a304-a11fb49d115f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EachTwelveMonthPeriodMember_569e5008-888e-4f9e-b65e-ceff5506ca94" xlink:href="iff-20231231.xsd#iff_EachTwelveMonthPeriodMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_216b2eb7-8b02-4f28-a304-a11fb49d115f" xlink:to="loc_iff_EachTwelveMonthPeriodMember_569e5008-888e-4f9e-b65e-ceff5506ca94" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FullThreeYearPeriodMember_02cbb872-2c72-49e4-921f-942d4ed57722" xlink:href="iff-20231231.xsd#iff_FullThreeYearPeriodMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_216b2eb7-8b02-4f28-a304-a11fb49d115f" xlink:to="loc_iff_FullThreeYearPeriodMember_02cbb872-2c72-49e4-921f-942d4ed57722" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_267823a5-c29a-4d0f-ac0a-8094e19baa77" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_56c592c9-5954-4327-bad7-356df549ff97" xlink:to="loc_us-gaap_AwardTypeAxis_267823a5-c29a-4d0f-ac0a-8094e19baa77" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_267823a5-c29a-4d0f-ac0a-8094e19baa77_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_267823a5-c29a-4d0f-ac0a-8094e19baa77" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_267823a5-c29a-4d0f-ac0a-8094e19baa77_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5245fbb0-b188-4b0c-9f99-6af811cee3f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_267823a5-c29a-4d0f-ac0a-8094e19baa77" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5245fbb0-b188-4b0c-9f99-6af811cee3f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_9dd03a9b-5620-476f-bb3b-fc127d58f91a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5245fbb0-b188-4b0c-9f99-6af811cee3f6" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_9dd03a9b-5620-476f-bb3b-fc127d58f91a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_ce9b93e5-60b8-4ef7-a478-0e2756dc946d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5245fbb0-b188-4b0c-9f99-6af811cee3f6" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_ce9b93e5-60b8-4ef7-a478-0e2756dc946d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_74f31b00-7865-41f1-b04a-62adee3d3ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5245fbb0-b188-4b0c-9f99-6af811cee3f6" xlink:to="loc_us-gaap_EmployeeStockOptionMember_74f31b00-7865-41f1-b04a-62adee3d3ae4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_3e7a0b46-ea4a-4f77-9717-e029a9ab9525" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_56c592c9-5954-4327-bad7-356df549ff97" xlink:to="loc_us-gaap_PlanNameAxis_3e7a0b46-ea4a-4f77-9717-e029a9ab9525" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_3e7a0b46-ea4a-4f77-9717-e029a9ab9525_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_3e7a0b46-ea4a-4f77-9717-e029a9ab9525" xlink:to="loc_us-gaap_PlanNameDomain_3e7a0b46-ea4a-4f77-9717-e029a9ab9525_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_3a8937ad-8555-4dc3-84b3-38b40b204a13" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_3e7a0b46-ea4a-4f77-9717-e029a9ab9525" xlink:to="loc_us-gaap_PlanNameDomain_3a8937ad-8555-4dc3-84b3-38b40b204a13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TwoThousandFifteenPlanMember_05fb1a08-d401-4edd-915e-6cf27b46943c" xlink:href="iff-20231231.xsd#iff_TwoThousandFifteenPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_3a8937ad-8555-4dc3-84b3-38b40b204a13" xlink:to="loc_iff_TwoThousandFifteenPlanMember_05fb1a08-d401-4edd-915e-6cf27b46943c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TwoThousandTenPlanMember_8177fbff-ba4f-4111-bb3f-58e31bd37b34" xlink:href="iff-20231231.xsd#iff_TwoThousandTenPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_3a8937ad-8555-4dc3-84b3-38b40b204a13" xlink:to="loc_iff_TwoThousandTenPlanMember_8177fbff-ba4f-4111-bb3f-58e31bd37b34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_LongTermIncentivePlanMember_12e594d8-21ba-40f9-a158-e98ae27f4ace" xlink:href="iff-20231231.xsd#iff_LongTermIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_3a8937ad-8555-4dc3-84b3-38b40b204a13" xlink:to="loc_iff_LongTermIncentivePlanMember_12e594d8-21ba-40f9-a158-e98ae27f4ace" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TwoThousandEightToTwoThousandTwentyCycleMember_d99a2cce-a4fa-426a-baa8-9143c85c648e" xlink:href="iff-20231231.xsd#iff_TwoThousandEightToTwoThousandTwentyCycleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_3a8937ad-8555-4dc3-84b3-38b40b204a13" xlink:to="loc_iff_TwoThousandEightToTwoThousandTwentyCycleMember_d99a2cce-a4fa-426a-baa8-9143c85c648e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TwoThousandSixteenToTwoThousandEighteenCycleMember_844af6ae-d441-4020-b81e-a55528965a2b" xlink:href="iff-20231231.xsd#iff_TwoThousandSixteenToTwoThousandEighteenCycleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_3a8937ad-8555-4dc3-84b3-38b40b204a13" xlink:to="loc_iff_TwoThousandSixteenToTwoThousandEighteenCycleMember_844af6ae-d441-4020-b81e-a55528965a2b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TwoThousandEighteenToTwoThousandTwentyCycleMember_05ac6966-0690-48c1-b26a-4af169e751e4" xlink:href="iff-20231231.xsd#iff_TwoThousandEighteenToTwoThousandTwentyCycleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_3a8937ad-8555-4dc3-84b3-38b40b204a13" xlink:to="loc_iff_TwoThousandEighteenToTwoThousandTwentyCycleMember_05ac6966-0690-48c1-b26a-4af169e751e4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TwoThousandNineteenToTwoThousandTwentyOneCycleMember_dcba6e32-d2d3-4cc8-9094-0eb9ea59974a" xlink:href="iff-20231231.xsd#iff_TwoThousandNineteenToTwoThousandTwentyOneCycleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_3a8937ad-8555-4dc3-84b3-38b40b204a13" xlink:to="loc_iff_TwoThousandNineteenToTwoThousandTwentyOneCycleMember_dcba6e32-d2d3-4cc8-9094-0eb9ea59974a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TwoThousandTwentyOnePlanMember_dd799bf2-c28b-4bd5-a32b-90aa64ac6590" xlink:href="iff-20231231.xsd#iff_TwoThousandTwentyOnePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_3a8937ad-8555-4dc3-84b3-38b40b204a13" xlink:to="loc_iff_TwoThousandTwentyOnePlanMember_dd799bf2-c28b-4bd5-a32b-90aa64ac6590" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TwoThousandEightToTwoThousandTwentyOneCycleMember_b631b1c5-cfe9-4ff2-8d3b-a3041983ca50" xlink:href="iff-20231231.xsd#iff_TwoThousandEightToTwoThousandTwentyOneCycleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_3a8937ad-8555-4dc3-84b3-38b40b204a13" xlink:to="loc_iff_TwoThousandEightToTwoThousandTwentyOneCycleMember_b631b1c5-cfe9-4ff2-8d3b-a3041983ca50" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TwoThousandTwentyToTwoThousandTwentyTwoCycleMember_d859b0ea-eefb-4179-9a87-da19757cc0bc" xlink:href="iff-20231231.xsd#iff_TwoThousandTwentyToTwoThousandTwentyTwoCycleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_3a8937ad-8555-4dc3-84b3-38b40b204a13" xlink:to="loc_iff_TwoThousandTwentyToTwoThousandTwentyTwoCycleMember_d859b0ea-eefb-4179-9a87-da19757cc0bc" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TwoThousandTwentyOneToTwoThousandTwentyThreeCycleMember_30b39fb7-36f6-4d59-b31e-083e7a4b3aa7" xlink:href="iff-20231231.xsd#iff_TwoThousandTwentyOneToTwoThousandTwentyThreeCycleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_3a8937ad-8555-4dc3-84b3-38b40b204a13" xlink:to="loc_iff_TwoThousandTwentyOneToTwoThousandTwentyThreeCycleMember_30b39fb7-36f6-4d59-b31e-083e7a4b3aa7" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_60c18b5e-8bf1-4b6b-adc6-4e6a44d38a85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_56c592c9-5954-4327-bad7-356df549ff97" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_60c18b5e-8bf1-4b6b-adc6-4e6a44d38a85" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_60c18b5e-8bf1-4b6b-adc6-4e6a44d38a85_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_60c18b5e-8bf1-4b6b-adc6-4e6a44d38a85" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_60c18b5e-8bf1-4b6b-adc6-4e6a44d38a85_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_3db6e6e4-a233-4f59-91db-899f9f555a25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_60c18b5e-8bf1-4b6b-adc6-4e6a44d38a85" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_3db6e6e4-a233-4f59-91db-899f9f555a25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_e7c6478b-4c96-4eab-ae8c-9c2737e93e3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_3db6e6e4-a233-4f59-91db-899f9f555a25" xlink:to="loc_us-gaap_SubsequentEventMember_e7c6478b-4c96-4eab-ae8c-9c2737e93e3c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0b4b598e-e2f0-4439-81ca-a202054542cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_56c592c9-5954-4327-bad7-356df549ff97" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0b4b598e-e2f0-4439-81ca-a202054542cb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0b4b598e-e2f0-4439-81ca-a202054542cb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0b4b598e-e2f0-4439-81ca-a202054542cb" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0b4b598e-e2f0-4439-81ca-a202054542cb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ddf60edb-812f-465d-ab3f-34d1419a0718" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0b4b598e-e2f0-4439-81ca-a202054542cb" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ddf60edb-812f-465d-ab3f-34d1419a0718" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NutritionBiosciencesIncMember_740696bd-caf1-4023-885c-573afbecdd30" xlink:href="iff-20231231.xsd#iff_NutritionBiosciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ddf60edb-812f-465d-ab3f-34d1419a0718" xlink:to="loc_iff_NutritionBiosciencesIncMember_740696bd-caf1-4023-885c-573afbecdd30" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_4ff7a7e1-9394-475d-aa1a-455a4f583f35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_65135d2d-893e-4491-a974-a317767c88b8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_4ff7a7e1-9394-475d-aa1a-455a4f583f35" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_9020fdfe-53a8-4164-a39d-9d323e43a519" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_65135d2d-893e-4491-a974-a317767c88b8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_9020fdfe-53a8-4164-a39d-9d323e43a519" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_a62a68b3-2173-439d-8216-3fdf97140d92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_65135d2d-893e-4491-a974-a317767c88b8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_a62a68b3-2173-439d-8216-3fdf97140d92" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesSubjectToOutstandingAwards_d67b62e4-5288-4f31-b16a-cb464c473bb6" xlink:href="iff-20231231.xsd#iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesSubjectToOutstandingAwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_65135d2d-893e-4491-a974-a317767c88b8" xlink:to="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesSubjectToOutstandingAwards_d67b62e4-5288-4f31-b16a-cb464c473bb6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfSharesAvailableForGrant_5e55dcb5-7e20-40b5-a4c9-cb69e81bec35" xlink:href="iff-20231231.xsd#iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_65135d2d-893e-4491-a974-a317767c88b8" xlink:to="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfSharesAvailableForGrant_5e55dcb5-7e20-40b5-a4c9-cb69e81bec35" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TargetPayoutCash_72623a93-09bc-4c50-a4a6-405a02db9d62" xlink:href="iff-20231231.xsd#iff_TargetPayoutCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_65135d2d-893e-4491-a974-a317767c88b8" xlink:to="loc_iff_TargetPayoutCash_72623a93-09bc-4c50-a4a6-405a02db9d62" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TargetPayoutStock_2f538a04-003d-494c-a258-e023c59fb33d" xlink:href="iff-20231231.xsd#iff_TargetPayoutStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_65135d2d-893e-4491-a974-a317767c88b8" xlink:to="loc_iff_TargetPayoutStock_2f538a04-003d-494c-a258-e023c59fb33d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TargetPayoutPeriodOfCycle_a3e519da-4199-4a55-a14f-34a87cad592e" xlink:href="iff-20231231.xsd#iff_TargetPayoutPeriodOfCycle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_65135d2d-893e-4491-a974-a317767c88b8" xlink:to="loc_iff_TargetPayoutPeriodOfCycle_a3e519da-4199-4a55-a14f-34a87cad592e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingPercentage_5d762a27-50be-4fdf-98c6-177166a26304" xlink:href="iff-20231231.xsd#iff_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_65135d2d-893e-4491-a974-a317767c88b8" xlink:to="loc_iff_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingPercentage_5d762a27-50be-4fdf-98c6-177166a26304" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetDollarValueOfAwardIsConvertedToNumberOfNotionalSharesWhenAwardIsGranted_2c10fefe-55fe-42e3-9d80-4182403546cd" xlink:href="iff-20231231.xsd#iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetDollarValueOfAwardIsConvertedToNumberOfNotionalSharesWhenAwardIsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_65135d2d-893e-4491-a974-a317767c88b8" xlink:to="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetDollarValueOfAwardIsConvertedToNumberOfNotionalSharesWhenAwardIsGranted_2c10fefe-55fe-42e3-9d80-4182403546cd" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_161910f2-156e-4525-8c79-a288779e1f4f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_65135d2d-893e-4491-a974-a317767c88b8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_161910f2-156e-4525-8c79-a288779e1f4f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_6f895894-293e-4ad9-ad8d-082e9f6b8a0e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_65135d2d-893e-4491-a974-a317767c88b8" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_6f895894-293e-4ad9-ad8d-082e9f6b8a0e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure_4f9222e1-35ff-4539-914a-e384cdcace4d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_65135d2d-893e-4491-a974-a317767c88b8" xlink:to="loc_us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure_4f9222e1-35ff-4539-914a-e384cdcace4d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_9a1e4d5e-9eb4-4979-8fe4-97a27a7bd8c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_65135d2d-893e-4491-a974-a317767c88b8" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_9a1e4d5e-9eb4-4979-8fe4-97a27a7bd8c1" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BusinessAcquisitionPostCombinationServicePeriod_a638d56b-31e0-42cf-aa4b-61164d3365ac" xlink:href="iff-20231231.xsd#iff_BusinessAcquisitionPostCombinationServicePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_65135d2d-893e-4491-a974-a317767c88b8" xlink:to="loc_iff_BusinessAcquisitionPostCombinationServicePeriod_a638d56b-31e0-42cf-aa4b-61164d3365ac" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTerm_ad13749f-375b-4c72-84a0-7b99dd48609d" xlink:href="iff-20231231.xsd#iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_65135d2d-893e-4491-a974-a317767c88b8" xlink:to="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTerm_ad13749f-375b-4c72-84a0-7b99dd48609d" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_df67d3d5-d4f3-4969-81fa-9368d66ff1f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_65135d2d-893e-4491-a974-a317767c88b8" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_df67d3d5-d4f3-4969-81fa-9368d66ff1f6" xlink:type="arc" order="16"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/StockCompensationPlansStockBasedCompensationExpenseIncludedinConsolidatedStatementofIncomeandComprehensiveIncomeDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#StockCompensationPlansStockBasedCompensationExpenseIncludedinConsolidatedStatementofIncomeandComprehensiveIncomeDetail"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/StockCompensationPlansStockBasedCompensationExpenseIncludedinConsolidatedStatementofIncomeandComprehensiveIncomeDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9873bcf3-48c0-4a6c-b7a6-2efbee2a8938" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_19bf03f9-1ac5-4e32-b124-6e2ff5604ad8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9873bcf3-48c0-4a6c-b7a6-2efbee2a8938" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_19bf03f9-1ac5-4e32-b124-6e2ff5604ad8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_a484d67c-5c96-4c42-ad6a-2f1c98b6dde5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_19bf03f9-1ac5-4e32-b124-6e2ff5604ad8" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_a484d67c-5c96-4c42-ad6a-2f1c98b6dde5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_a484d67c-5c96-4c42-ad6a-2f1c98b6dde5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_a484d67c-5c96-4c42-ad6a-2f1c98b6dde5" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_a484d67c-5c96-4c42-ad6a-2f1c98b6dde5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_dc932a50-546b-4722-9f7e-b048266fdfda" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_a484d67c-5c96-4c42-ad6a-2f1c98b6dde5" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_dc932a50-546b-4722-9f7e-b048266fdfda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EquityBasedAwardsMember_6a207e0d-b6e7-4b2d-a658-2efd0cc3753f" xlink:href="iff-20231231.xsd#iff_EquityBasedAwardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_dc932a50-546b-4722-9f7e-b048266fdfda" xlink:to="loc_iff_EquityBasedAwardsMember_6a207e0d-b6e7-4b2d-a658-2efd0cc3753f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_LiabilityBasedAwardsMember_31f8979b-758a-4b0d-acfd-bb11c49f4e5a" xlink:href="iff-20231231.xsd#iff_LiabilityBasedAwardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_dc932a50-546b-4722-9f7e-b048266fdfda" xlink:to="loc_iff_LiabilityBasedAwardsMember_31f8979b-758a-4b0d-acfd-bb11c49f4e5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_49c5259c-d99d-4d8d-bc29-06b401aefe62" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9873bcf3-48c0-4a6c-b7a6-2efbee2a8938" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_49c5259c-d99d-4d8d-bc29-06b401aefe62" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_0cd9db3e-176b-41b7-953f-da566c4d2fa0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9873bcf3-48c0-4a6c-b7a6-2efbee2a8938" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_0cd9db3e-176b-41b7-953f-da566c4d2fa0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_1c322249-6704-4861-9c73-6309db6d9e2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9873bcf3-48c0-4a6c-b7a6-2efbee2a8938" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_1c322249-6704-4861-9c73-6309db6d9e2c" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionAdditionalInformationDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#StockCompensationPlansSSARsandStockOptionAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1459c5d4-eb88-4c93-a4e3-90782eed32f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e61a51b4-d716-45f8-9f52-0e265f670fec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1459c5d4-eb88-4c93-a4e3-90782eed32f6" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e61a51b4-d716-45f8-9f52-0e265f670fec" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_239e6b20-1be2-4ef9-a0d8-f5a99b87dcc9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e61a51b4-d716-45f8-9f52-0e265f670fec" xlink:to="loc_us-gaap_AwardTypeAxis_239e6b20-1be2-4ef9-a0d8-f5a99b87dcc9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_239e6b20-1be2-4ef9-a0d8-f5a99b87dcc9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_239e6b20-1be2-4ef9-a0d8-f5a99b87dcc9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_239e6b20-1be2-4ef9-a0d8-f5a99b87dcc9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_20daa446-2a53-4ed5-b78a-4e786509eb96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_239e6b20-1be2-4ef9-a0d8-f5a99b87dcc9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_20daa446-2a53-4ed5-b78a-4e786509eb96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_26b6a0cb-75f3-411c-bfd6-161a8423bac4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_20daa446-2a53-4ed5-b78a-4e786509eb96" xlink:to="loc_us-gaap_StockOptionMember_26b6a0cb-75f3-411c-bfd6-161a8423bac4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_5b8413ee-8b85-46d5-8a6f-bb2f615e626c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_20daa446-2a53-4ed5-b78a-4e786509eb96" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_5b8413ee-8b85-46d5-8a6f-bb2f615e626c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_StockOptionsAndStockSettledAppreciationRightsMember_2b18379c-c328-4f7e-a664-f4ee4809af9a" xlink:href="iff-20231231.xsd#iff_StockOptionsAndStockSettledAppreciationRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_20daa446-2a53-4ed5-b78a-4e786509eb96" xlink:to="loc_iff_StockOptionsAndStockSettledAppreciationRightsMember_2b18379c-c328-4f7e-a664-f4ee4809af9a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_StockOptionsAndSsarsMember_df95ad1a-986c-4033-9500-135a069e4e1f" xlink:href="iff-20231231.xsd#iff_StockOptionsAndSsarsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_20daa446-2a53-4ed5-b78a-4e786509eb96" xlink:to="loc_iff_StockOptionsAndSsarsMember_df95ad1a-986c-4033-9500-135a069e4e1f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTerm_6fed74fe-f5e9-471d-be5e-73fd3ced2cf9" xlink:href="iff-20231231.xsd#iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1459c5d4-eb88-4c93-a4e3-90782eed32f6" xlink:to="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTerm_6fed74fe-f5e9-471d-be5e-73fd3ced2cf9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2bafd269-5338-4506-9b55-d58eda9df713" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1459c5d4-eb88-4c93-a4e3-90782eed32f6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2bafd269-5338-4506-9b55-d58eda9df713" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_a5fad8e9-48ef-456d-8ec8-4befeb700fa0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1459c5d4-eb88-4c93-a4e3-90782eed32f6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_a5fad8e9-48ef-456d-8ec8-4befeb700fa0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2b3e9d79-21d3-4bc3-9c18-76c8b13447b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1459c5d4-eb88-4c93-a4e3-90782eed32f6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2b3e9d79-21d3-4bc3-9c18-76c8b13447b5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_7cabed02-bace-4d59-88c8-f840b29b58c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1459c5d4-eb88-4c93-a4e3-90782eed32f6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_7cabed02-bace-4d59-88c8-f840b29b58c9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_2f9001da-ba83-498e-a8e7-0cbe65a97cfa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1459c5d4-eb88-4c93-a4e3-90782eed32f6" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_2f9001da-ba83-498e-a8e7-0cbe65a97cfa" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_227ba942-f31d-46b3-873b-03c153860396" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1459c5d4-eb88-4c93-a4e3-90782eed32f6" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_227ba942-f31d-46b3-873b-03c153860396" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionActivityDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#StockCompensationPlansSSARsandStockOptionActivityDetail"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionActivityDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d465629-b7d3-4b72-bd30-bc31efc7626e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d7e6d826-0bd1-4302-aa87-985e25cafad0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d465629-b7d3-4b72-bd30-bc31efc7626e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d7e6d826-0bd1-4302-aa87-985e25cafad0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_ad8f6d3e-cf61-4109-acb7-7ac9d9d1be2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d7e6d826-0bd1-4302-aa87-985e25cafad0" xlink:to="loc_us-gaap_AwardTypeAxis_ad8f6d3e-cf61-4109-acb7-7ac9d9d1be2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ad8f6d3e-cf61-4109-acb7-7ac9d9d1be2e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_ad8f6d3e-cf61-4109-acb7-7ac9d9d1be2e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ad8f6d3e-cf61-4109-acb7-7ac9d9d1be2e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_85ad6251-3643-4905-961e-9f0f90eb774a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_ad8f6d3e-cf61-4109-acb7-7ac9d9d1be2e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_85ad6251-3643-4905-961e-9f0f90eb774a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_StockOptionsAndSsarsMember_8bc19300-d65d-41b2-950a-eafba5d47843" xlink:href="iff-20231231.xsd#iff_StockOptionsAndSsarsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_85ad6251-3643-4905-961e-9f0f90eb774a" xlink:to="loc_iff_StockOptionsAndSsarsMember_8bc19300-d65d-41b2-950a-eafba5d47843" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_StockOptionsAndStockSettledAppreciationRightsMember_ea8d5a10-b1a8-4cc8-b3f5-9ab0d6f8da49" xlink:href="iff-20231231.xsd#iff_StockOptionsAndStockSettledAppreciationRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_85ad6251-3643-4905-961e-9f0f90eb774a" xlink:to="loc_iff_StockOptionsAndStockSettledAppreciationRightsMember_ea8d5a10-b1a8-4cc8-b3f5-9ab0d6f8da49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_9913e60d-2595-4f8e-a01d-ef57ceff84be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d465629-b7d3-4b72-bd30-bc31efc7626e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_9913e60d-2595-4f8e-a01d-ef57ceff84be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_05af472b-aa46-4a5a-a10a-5ace86bee732" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_9913e60d-2595-4f8e-a01d-ef57ceff84be" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_05af472b-aa46-4a5a-a10a-5ace86bee732" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_37becfe8-1ad4-4a60-9c1b-d4f146f584cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_9913e60d-2595-4f8e-a01d-ef57ceff84be" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_37becfe8-1ad4-4a60-9c1b-d4f146f584cc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_a3365e12-8c1f-4c72-a8c4-b9282bd1df72" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_9913e60d-2595-4f8e-a01d-ef57ceff84be" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_a3365e12-8c1f-4c72-a8c4-b9282bd1df72" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_fc260e1d-af24-4e98-a1f1-c8a7e48b1994" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_9913e60d-2595-4f8e-a01d-ef57ceff84be" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_fc260e1d-af24-4e98-a1f1-c8a7e48b1994" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumptionsInPeriod_b9bd06bb-d145-4420-a6ac-27cf58ae160d" xlink:href="iff-20231231.xsd#iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumptionsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_9913e60d-2595-4f8e-a01d-ef57ceff84be" xlink:to="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumptionsInPeriod_b9bd06bb-d145-4420-a6ac-27cf58ae160d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_86060273-7ff1-4e2f-bf2c-77173d2961e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_c01cb4ce-8c61-4df2-b774-d16d65604e78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d465629-b7d3-4b72-bd30-bc31efc7626e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_c01cb4ce-8c61-4df2-b774-d16d65604e78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_84f8893d-d9aa-4950-bd6f-acd2056e7fd0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_c01cb4ce-8c61-4df2-b774-d16d65604e78" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_84f8893d-d9aa-4950-bd6f-acd2056e7fd0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_4264b261-7c0a-4de9-8731-a03a36a2f924" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_c01cb4ce-8c61-4df2-b774-d16d65604e78" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_4264b261-7c0a-4de9-8731-a03a36a2f924" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_b93fcf03-ea45-4d5a-ab16-a71236a257fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_c01cb4ce-8c61-4df2-b774-d16d65604e78" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_b93fcf03-ea45-4d5a-ab16-a71236a257fd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_64487aa5-ee15-47cb-93b8-92922b18ac65" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_c01cb4ce-8c61-4df2-b774-d16d65604e78" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_64487aa5-ee15-47cb-93b8-92922b18ac65" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumptionsInPeriodWeightedAverageExercisePrice_a237f3d0-7a3f-4842-acd7-f6c18f5aea36" xlink:href="iff-20231231.xsd#iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumptionsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_c01cb4ce-8c61-4df2-b774-d16d65604e78" xlink:to="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumptionsInPeriodWeightedAverageExercisePrice_a237f3d0-7a3f-4842-acd7-f6c18f5aea36" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_ee6567ca-3645-44cd-a112-2ede093c7b4c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_8591200c-cffe-40af-a4b1-890a470df297" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d465629-b7d3-4b72-bd30-bc31efc7626e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_8591200c-cffe-40af-a4b1-890a470df297" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_6349681e-6746-4a5f-93d5-94a797fa98e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d465629-b7d3-4b72-bd30-bc31efc7626e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_6349681e-6746-4a5f-93d5-94a797fa98e4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_83275d83-6abb-4278-aa09-7da5d2e6f7e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d465629-b7d3-4b72-bd30-bc31efc7626e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_83275d83-6abb-4278-aa09-7da5d2e6f7e5" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionOutstandingDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#StockCompensationPlansSSARsandStockOptionOutstandingDetail"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionOutstandingDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_87ef4357-8adc-4daa-bf7e-36c77d728cc0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1739fe2f-cfa3-497a-8c25-ef8578c5690f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_87ef4357-8adc-4daa-bf7e-36c77d728cc0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1739fe2f-cfa3-497a-8c25-ef8578c5690f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_9da973a0-2b37-4a81-ba44-4b7af021e9b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1739fe2f-cfa3-497a-8c25-ef8578c5690f" xlink:to="loc_us-gaap_AwardTypeAxis_9da973a0-2b37-4a81-ba44-4b7af021e9b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9da973a0-2b37-4a81-ba44-4b7af021e9b6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_9da973a0-2b37-4a81-ba44-4b7af021e9b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9da973a0-2b37-4a81-ba44-4b7af021e9b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_49678250-6366-4376-89f7-d05dd59a8bc9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_9da973a0-2b37-4a81-ba44-4b7af021e9b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_49678250-6366-4376-89f7-d05dd59a8bc9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_StockOptionsAndSsarsMember_832a440f-4cb9-431c-909d-8fa50ba1ed92" xlink:href="iff-20231231.xsd#iff_StockOptionsAndSsarsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_49678250-6366-4376-89f7-d05dd59a8bc9" xlink:to="loc_iff_StockOptionsAndSsarsMember_832a440f-4cb9-431c-909d-8fa50ba1ed92" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_StockOptionsAndStockSettledAppreciationRightsMember_677243a9-5063-473e-8ed0-18c999bcba76" xlink:href="iff-20231231.xsd#iff_StockOptionsAndStockSettledAppreciationRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_49678250-6366-4376-89f7-d05dd59a8bc9" xlink:to="loc_iff_StockOptionsAndStockSettledAppreciationRightsMember_677243a9-5063-473e-8ed0-18c999bcba76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_ecbbfe2d-6974-4444-b66e-ae61a491fbc9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1739fe2f-cfa3-497a-8c25-ef8578c5690f" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_ecbbfe2d-6974-4444-b66e-ae61a491fbc9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_ecbbfe2d-6974-4444-b66e-ae61a491fbc9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_ecbbfe2d-6974-4444-b66e-ae61a491fbc9" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_ecbbfe2d-6974-4444-b66e-ae61a491fbc9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_63480130-89df-490e-9286-d9fe61afa4a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_ecbbfe2d-6974-4444-b66e-ae61a491fbc9" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_63480130-89df-490e-9286-d9fe61afa4a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_Over65Member_c108dc72-72cf-419c-981a-069f4fde2722" xlink:href="iff-20231231.xsd#iff_Over65Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_63480130-89df-490e-9286-d9fe61afa4a6" xlink:to="loc_iff_Over65Member_c108dc72-72cf-419c-981a-069f4fde2722" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_79acb2de-5e99-4305-85cc-9fcebc20ed12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_87ef4357-8adc-4daa-bf7e-36c77d728cc0" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_79acb2de-5e99-4305-85cc-9fcebc20ed12" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_f0490c27-61d8-4c11-afba-4394db83d1ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_87ef4357-8adc-4daa-bf7e-36c77d728cc0" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_f0490c27-61d8-4c11-afba-4394db83d1ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_464432f2-8b8f-49dc-b45d-a6245ec1881e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_87ef4357-8adc-4daa-bf7e-36c77d728cc0" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_464432f2-8b8f-49dc-b45d-a6245ec1881e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_1d70a195-d50b-41aa-ac6e-dbfa3d26d058" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_87ef4357-8adc-4daa-bf7e-36c77d728cc0" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_1d70a195-d50b-41aa-ac6e-dbfa3d26d058" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_3fdf2b7b-f667-4d5a-ad31-3758c3b71a35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_87ef4357-8adc-4daa-bf7e-36c77d728cc0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_3fdf2b7b-f667-4d5a-ad31-3758c3b71a35" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_79d675c5-f60d-43af-b68c-efaa6a5d23c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_87ef4357-8adc-4daa-bf7e-36c77d728cc0" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_79d675c5-f60d-43af-b68c-efaa6a5d23c3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_6d0588ce-dc5a-44bb-9930-ede55cc8f35d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_87ef4357-8adc-4daa-bf7e-36c77d728cc0" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_6d0588ce-dc5a-44bb-9930-ede55cc8f35d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_f07cbe54-23f7-488e-8675-e68870267acc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_87ef4357-8adc-4daa-bf7e-36c77d728cc0" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_f07cbe54-23f7-488e-8675-e68870267acc" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_750094b9-d80b-4ae5-ab3d-7b78a9075578" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_87ef4357-8adc-4daa-bf7e-36c77d728cc0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_750094b9-d80b-4ae5-ab3d-7b78a9075578" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionExercisableDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#StockCompensationPlansSSARsandStockOptionExercisableDetail"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionExercisableDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a52eb0d9-ccda-4235-af6f-245dd41950e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1ea563bc-2675-4661-8a7f-84a3d3056bb0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a52eb0d9-ccda-4235-af6f-245dd41950e9" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1ea563bc-2675-4661-8a7f-84a3d3056bb0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_cfc17a27-41e5-4e7b-b425-79c8ec20af13" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1ea563bc-2675-4661-8a7f-84a3d3056bb0" xlink:to="loc_us-gaap_AwardTypeAxis_cfc17a27-41e5-4e7b-b425-79c8ec20af13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cfc17a27-41e5-4e7b-b425-79c8ec20af13_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_cfc17a27-41e5-4e7b-b425-79c8ec20af13" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cfc17a27-41e5-4e7b-b425-79c8ec20af13_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d6d66324-af2a-4922-ac47-f6816d44e92f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_cfc17a27-41e5-4e7b-b425-79c8ec20af13" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d6d66324-af2a-4922-ac47-f6816d44e92f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_StockOptionsAndSsarsMember_25b5a042-f24f-4de6-86e8-70ec23c9b512" xlink:href="iff-20231231.xsd#iff_StockOptionsAndSsarsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d6d66324-af2a-4922-ac47-f6816d44e92f" xlink:to="loc_iff_StockOptionsAndSsarsMember_25b5a042-f24f-4de6-86e8-70ec23c9b512" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_StockOptionsAndStockSettledAppreciationRightsMember_5075cf93-fbca-4207-bfcd-713d84f7d6bf" xlink:href="iff-20231231.xsd#iff_StockOptionsAndStockSettledAppreciationRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d6d66324-af2a-4922-ac47-f6816d44e92f" xlink:to="loc_iff_StockOptionsAndStockSettledAppreciationRightsMember_5075cf93-fbca-4207-bfcd-713d84f7d6bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_eab167ab-991c-4016-8f79-0c19ecdb1e69" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1ea563bc-2675-4661-8a7f-84a3d3056bb0" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_eab167ab-991c-4016-8f79-0c19ecdb1e69" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_eab167ab-991c-4016-8f79-0c19ecdb1e69_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_eab167ab-991c-4016-8f79-0c19ecdb1e69" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_eab167ab-991c-4016-8f79-0c19ecdb1e69_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_7a3b9bce-75da-4355-9eaa-53798df6ef0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_eab167ab-991c-4016-8f79-0c19ecdb1e69" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_7a3b9bce-75da-4355-9eaa-53798df6ef0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_Over65Member_dbe26aa6-163c-4916-b10a-792e779eb4d6" xlink:href="iff-20231231.xsd#iff_Over65Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_7a3b9bce-75da-4355-9eaa-53798df6ef0d" xlink:to="loc_iff_Over65Member_dbe26aa6-163c-4916-b10a-792e779eb4d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SharebasedCompensationSharesAuthorizedunderStockOptionPlansExercisePriceRangeExercisableOptionsUpperRangeLimit_2b08b673-a268-48a4-9c69-4e8fe576317f" xlink:href="iff-20231231.xsd#iff_SharebasedCompensationSharesAuthorizedunderStockOptionPlansExercisePriceRangeExercisableOptionsUpperRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a52eb0d9-ccda-4235-af6f-245dd41950e9" xlink:to="loc_iff_SharebasedCompensationSharesAuthorizedunderStockOptionPlansExercisePriceRangeExercisableOptionsUpperRangeLimit_2b08b673-a268-48a4-9c69-4e8fe576317f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_2f25b4bd-f895-4195-b878-8d8d1a98284e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a52eb0d9-ccda-4235-af6f-245dd41950e9" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_2f25b4bd-f895-4195-b878-8d8d1a98284e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_5016037f-1a05-422b-a234-afa5132f542b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a52eb0d9-ccda-4235-af6f-245dd41950e9" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_5016037f-1a05-422b-a234-afa5132f542b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_b051b134-c487-412e-90df-de5458e192bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a52eb0d9-ccda-4235-af6f-245dd41950e9" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_b051b134-c487-412e-90df-de5458e192bd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_226542d2-0764-4ea0-bfb8-88af24d07e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a52eb0d9-ccda-4235-af6f-245dd41950e9" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_226542d2-0764-4ea0-bfb8-88af24d07e5b" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/StockCompensationPlansRestrictedStockUnitsPlanAdditionalInformationDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#StockCompensationPlansRestrictedStockUnitsPlanAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/StockCompensationPlansRestrictedStockUnitsPlanAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_eaf35f3c-dd33-4d17-aa4d-ee4af6dd9df2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9149435d-2fa5-4228-905f-3c39f46ed6e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_eaf35f3c-dd33-4d17-aa4d-ee4af6dd9df2" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9149435d-2fa5-4228-905f-3c39f46ed6e6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e040b028-cef4-4ddb-8927-6cc01e46bb5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9149435d-2fa5-4228-905f-3c39f46ed6e6" xlink:to="loc_us-gaap_AwardTypeAxis_e040b028-cef4-4ddb-8927-6cc01e46bb5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e040b028-cef4-4ddb-8927-6cc01e46bb5c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_e040b028-cef4-4ddb-8927-6cc01e46bb5c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e040b028-cef4-4ddb-8927-6cc01e46bb5c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_56825369-7825-4dac-95f2-7fb67b9df737" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_e040b028-cef4-4ddb-8927-6cc01e46bb5c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_56825369-7825-4dac-95f2-7fb67b9df737" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_2f5a0bca-426d-4585-a6e2-5333fedd854d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_56825369-7825-4dac-95f2-7fb67b9df737" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_2f5a0bca-426d-4585-a6e2-5333fedd854d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_PurchasedRestrictedStockUnitMember_4f7c0dd5-a42a-42d3-95d0-284bf7e0dbab" xlink:href="iff-20231231.xsd#iff_PurchasedRestrictedStockUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_56825369-7825-4dac-95f2-7fb67b9df737" xlink:to="loc_iff_PurchasedRestrictedStockUnitMember_4f7c0dd5-a42a-42d3-95d0-284bf7e0dbab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentage_89be117c-840c-4ed3-9e3d-c0679f5ef550" xlink:href="iff-20231231.xsd#iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_eaf35f3c-dd33-4d17-aa4d-ee4af6dd9df2" xlink:to="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentage_89be117c-840c-4ed3-9e3d-c0679f5ef550" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_31a48c2c-e60e-4bfe-8b9b-e8f36309cde1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_eaf35f3c-dd33-4d17-aa4d-ee4af6dd9df2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_31a48c2c-e60e-4bfe-8b9b-e8f36309cde1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_940dd70f-2b25-4c03-aac7-4e88c824f313" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_eaf35f3c-dd33-4d17-aa4d-ee4af6dd9df2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_940dd70f-2b25-4c03-aac7-4e88c824f313" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_73a000c6-aa58-4a0c-a8b5-d5813c9df110" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_eaf35f3c-dd33-4d17-aa4d-ee4af6dd9df2" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_73a000c6-aa58-4a0c-a8b5-d5813c9df110" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisablePeriod_213b4775-f107-4abf-b8db-63117a69726f" xlink:href="iff-20231231.xsd#iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisablePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_eaf35f3c-dd33-4d17-aa4d-ee4af6dd9df2" xlink:to="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisablePeriod_213b4775-f107-4abf-b8db-63117a69726f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_f0e32787-a5dc-4b49-9bfb-39e489e067f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_eaf35f3c-dd33-4d17-aa4d-ee4af6dd9df2" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_f0e32787-a5dc-4b49-9bfb-39e489e067f3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_9e483579-54af-438e-b755-f9986cb5d2f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_eaf35f3c-dd33-4d17-aa4d-ee4af6dd9df2" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_9e483579-54af-438e-b755-f9986cb5d2f5" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/StockCompensationPlansRSUPRSandCashRSUActivityDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#StockCompensationPlansRSUPRSandCashRSUActivityDetail"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/StockCompensationPlansRSUPRSandCashRSUActivityDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_123ab662-7147-42dd-9a9f-18ea1051d59b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d03e983-3259-4c0f-8690-e38721ac470d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_123ab662-7147-42dd-9a9f-18ea1051d59b" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d03e983-3259-4c0f-8690-e38721ac470d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_de4896b0-daf3-4194-ab51-f868a370791a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d03e983-3259-4c0f-8690-e38721ac470d" xlink:to="loc_us-gaap_AwardTypeAxis_de4896b0-daf3-4194-ab51-f868a370791a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_de4896b0-daf3-4194-ab51-f868a370791a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_de4896b0-daf3-4194-ab51-f868a370791a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_de4896b0-daf3-4194-ab51-f868a370791a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_390a7593-3f8a-4d34-b828-83e6eced6d71" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_de4896b0-daf3-4194-ab51-f868a370791a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_390a7593-3f8a-4d34-b828-83e6eced6d71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_4880c768-839c-4a7a-a9fc-7a50134f3074" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_390a7593-3f8a-4d34-b828-83e6eced6d71" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_4880c768-839c-4a7a-a9fc-7a50134f3074" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_235cbf21-7691-42bd-a24a-1cd8281a627f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_390a7593-3f8a-4d34-b828-83e6eced6d71" xlink:to="loc_us-gaap_RestrictedStockMember_235cbf21-7691-42bd-a24a-1cd8281a627f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_CashRestrictedStockUnitMember_940e5362-6b63-4b82-b23b-33cbe23125ba" xlink:href="iff-20231231.xsd#iff_CashRestrictedStockUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_390a7593-3f8a-4d34-b828-83e6eced6d71" xlink:to="loc_iff_CashRestrictedStockUnitMember_940e5362-6b63-4b82-b23b-33cbe23125ba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_PurchasedRestrictedStockUnitMember_8210181e-e20f-4c77-9d86-d664af128361" xlink:href="iff-20231231.xsd#iff_PurchasedRestrictedStockUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_390a7593-3f8a-4d34-b828-83e6eced6d71" xlink:to="loc_iff_PurchasedRestrictedStockUnitMember_8210181e-e20f-4c77-9d86-d664af128361" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_af1ad121-7a78-43b9-ae28-dced4ab1c514" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_123ab662-7147-42dd-9a9f-18ea1051d59b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_af1ad121-7a78-43b9-ae28-dced4ab1c514" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_9e13d4a9-3fe5-48af-8486-48fe5ad11203" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_af1ad121-7a78-43b9-ae28-dced4ab1c514" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_9e13d4a9-3fe5-48af-8486-48fe5ad11203" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_a3ee7189-e8e0-421a-8755-e3fc4d8c88e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_af1ad121-7a78-43b9-ae28-dced4ab1c514" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_a3ee7189-e8e0-421a-8755-e3fc4d8c88e5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_5a762ab4-9f16-4301-93b4-d5f0295e173c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_af1ad121-7a78-43b9-ae28-dced4ab1c514" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_5a762ab4-9f16-4301-93b4-d5f0295e173c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2fa0ec1f-1524-47fc-9011-644db3bc760b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_af1ad121-7a78-43b9-ae28-dced4ab1c514" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2fa0ec1f-1524-47fc-9011-644db3bc760b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsChangeDueToPerformanceConditions_0788388b-2f5d-484e-b1a9-24f6e9e009d4" xlink:href="iff-20231231.xsd#iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsChangeDueToPerformanceConditions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_af1ad121-7a78-43b9-ae28-dced4ab1c514" xlink:to="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsChangeDueToPerformanceConditions_0788388b-2f5d-484e-b1a9-24f6e9e009d4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d24cd442-f5fa-44b7-96d5-7ff0261f2382" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0e5a0836-895e-460e-b336-d25ca368b3ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_123ab662-7147-42dd-9a9f-18ea1051d59b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0e5a0836-895e-460e-b336-d25ca368b3ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_f45602d9-0e46-4ed3-abd9-a7fda388dad0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0e5a0836-895e-460e-b336-d25ca368b3ed" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_f45602d9-0e46-4ed3-abd9-a7fda388dad0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_aba4a056-feaa-4eab-9eab-806e51f50c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0e5a0836-895e-460e-b336-d25ca368b3ed" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_aba4a056-feaa-4eab-9eab-806e51f50c8e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_fd132169-e0b3-4e8a-8b12-a25a271b8b21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0e5a0836-895e-460e-b336-d25ca368b3ed" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_fd132169-e0b3-4e8a-8b12-a25a271b8b21" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_93cff158-1001-423d-87ac-91541e94f257" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0e5a0836-895e-460e-b336-d25ca368b3ed" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_93cff158-1001-423d-87ac-91541e94f257" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsChangeDueToPerformanceConditionsWeightedAverageGrantDateFairValue_3f24ccb8-2c19-4cbd-89a7-d1ca55e8ac63" xlink:href="iff-20231231.xsd#iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsChangeDueToPerformanceConditionsWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0e5a0836-895e-460e-b336-d25ca368b3ed" xlink:to="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsChangeDueToPerformanceConditionsWeightedAverageGrantDateFairValue_3f24ccb8-2c19-4cbd-89a7-d1ca55e8ac63" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e50e631d-7a34-4b63-9bf9-5fdfc0259368" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedPurchasedByEmployees_6b5a126e-68da-4c1a-9be5-0f01059a024b" xlink:href="iff-20231231.xsd#iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedPurchasedByEmployees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_123ab662-7147-42dd-9a9f-18ea1051d59b" xlink:to="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedPurchasedByEmployees_6b5a126e-68da-4c1a-9be5-0f01059a024b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValueOfSharesPurchasedByEmployees_8dccd86d-4ad7-40c5-b1b6-ea6006579df1" xlink:href="iff-20231231.xsd#iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValueOfSharesPurchasedByEmployees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_123ab662-7147-42dd-9a9f-18ea1051d59b" xlink:to="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValueOfSharesPurchasedByEmployees_8dccd86d-4ad7-40c5-b1b6-ea6006579df1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesPurchasedByEmployees_f537f912-01c0-4f7e-b084-d817fd5ad09c" xlink:href="iff-20231231.xsd#iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesPurchasedByEmployees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_123ab662-7147-42dd-9a9f-18ea1051d59b" xlink:to="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesPurchasedByEmployees_f537f912-01c0-4f7e-b084-d817fd5ad09c" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/StockCompensationPlansPurchasedRestrictedStockPlanAdditionalInformationDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#StockCompensationPlansPurchasedRestrictedStockPlanAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/StockCompensationPlansPurchasedRestrictedStockPlanAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_57c1f7be-387f-42c4-9131-6eaf58a3dce9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c25af1df-c183-4c96-a1b6-2b6caa52d476" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_57c1f7be-387f-42c4-9131-6eaf58a3dce9" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c25af1df-c183-4c96-a1b6-2b6caa52d476" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_5fa0c9a8-6cd5-4452-a1d1-82e07ed59da5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c25af1df-c183-4c96-a1b6-2b6caa52d476" xlink:to="loc_us-gaap_AwardTypeAxis_5fa0c9a8-6cd5-4452-a1d1-82e07ed59da5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5fa0c9a8-6cd5-4452-a1d1-82e07ed59da5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_5fa0c9a8-6cd5-4452-a1d1-82e07ed59da5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5fa0c9a8-6cd5-4452-a1d1-82e07ed59da5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c9d7e6c1-6d91-45c5-8c97-f3e300b0a37e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_5fa0c9a8-6cd5-4452-a1d1-82e07ed59da5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c9d7e6c1-6d91-45c5-8c97-f3e300b0a37e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_79422f83-a525-4ca8-9612-0d4f31271d68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c9d7e6c1-6d91-45c5-8c97-f3e300b0a37e" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_79422f83-a525-4ca8-9612-0d4f31271d68" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_be045a8b-f904-48a8-b047-62a1badf8e21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c9d7e6c1-6d91-45c5-8c97-f3e300b0a37e" xlink:to="loc_us-gaap_RestrictedStockMember_be045a8b-f904-48a8-b047-62a1badf8e21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_PurchasedRestrictedStockUnitMember_33e882a7-305f-41b2-861b-6f6134488636" xlink:href="iff-20231231.xsd#iff_PurchasedRestrictedStockUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c9d7e6c1-6d91-45c5-8c97-f3e300b0a37e" xlink:to="loc_iff_PurchasedRestrictedStockUnitMember_33e882a7-305f-41b2-861b-6f6134488636" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedPurchasedByEmployees_1142f56b-fba3-4995-a50a-0b7d4a3b9f41" xlink:href="iff-20231231.xsd#iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedPurchasedByEmployees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_57c1f7be-387f-42c4-9131-6eaf58a3dce9" xlink:to="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedPurchasedByEmployees_1142f56b-fba3-4995-a50a-0b7d4a3b9f41" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValueOfSharesPurchasedByEmployees_071ba21d-19f1-4f27-b118-262a1df50efe" xlink:href="iff-20231231.xsd#iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValueOfSharesPurchasedByEmployees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_57c1f7be-387f-42c4-9131-6eaf58a3dce9" xlink:to="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValueOfSharesPurchasedByEmployees_071ba21d-19f1-4f27-b118-262a1df50efe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesPurchasedByEmployees_abeda8f4-de5a-440e-a508-06d55032a68f" xlink:href="iff-20231231.xsd#iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesPurchasedByEmployees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_57c1f7be-387f-42c4-9131-6eaf58a3dce9" xlink:to="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesPurchasedByEmployees_abeda8f4-de5a-440e-a508-06d55032a68f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_ef778911-850d-4fe4-822f-62dc0bbaabc5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_57c1f7be-387f-42c4-9131-6eaf58a3dce9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_ef778911-850d-4fe4-822f-62dc0bbaabc5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_cb2a9624-8d1f-4ccc-be2d-bddd842960cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_57c1f7be-387f-42c4-9131-6eaf58a3dce9" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_cb2a9624-8d1f-4ccc-be2d-bddd842960cc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_61bd6526-a60d-4e14-93c6-3516db28413b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_57c1f7be-387f-42c4-9131-6eaf58a3dce9" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_61bd6526-a60d-4e14-93c6-3516db28413b" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/StockCompensationPlansLiabilityAwardsAdditionalInformationDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#StockCompensationPlansLiabilityAwardsAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/StockCompensationPlansLiabilityAwardsAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0cfd8c66-874d-4099-9041-881ba8aa2a33" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e85de9a0-cc4f-48f2-bb06-219951954bdf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0cfd8c66-874d-4099-9041-881ba8aa2a33" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e85de9a0-cc4f-48f2-bb06-219951954bdf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f5ac6d79-3dcf-45d3-bec7-8ab661c3ca5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e85de9a0-cc4f-48f2-bb06-219951954bdf" xlink:to="loc_us-gaap_AwardTypeAxis_f5ac6d79-3dcf-45d3-bec7-8ab661c3ca5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f5ac6d79-3dcf-45d3-bec7-8ab661c3ca5c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_f5ac6d79-3dcf-45d3-bec7-8ab661c3ca5c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f5ac6d79-3dcf-45d3-bec7-8ab661c3ca5c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e8e0615a-9755-4fa6-9de0-f00b2a6ba30a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_f5ac6d79-3dcf-45d3-bec7-8ab661c3ca5c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e8e0615a-9755-4fa6-9de0-f00b2a6ba30a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_CashRestrictedStockUnitMember_12094f74-cff3-41ab-b7ab-c4e791e33016" xlink:href="iff-20231231.xsd#iff_CashRestrictedStockUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e8e0615a-9755-4fa6-9de0-f00b2a6ba30a" xlink:to="loc_iff_CashRestrictedStockUnitMember_12094f74-cff3-41ab-b7ab-c4e791e33016" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentageGrantedInCashToEligibleEmployees_f4b96cd6-f163-4a60-88b6-fca31d21308a" xlink:href="iff-20231231.xsd#iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentageGrantedInCashToEligibleEmployees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0cfd8c66-874d-4099-9041-881ba8aa2a33" xlink:to="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentageGrantedInCashToEligibleEmployees_f4b96cd6-f163-4a60-88b6-fca31d21308a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentage_5b9844bc-0735-467b-959b-43de8cb9d3c4" xlink:href="iff-20231231.xsd#iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0cfd8c66-874d-4099-9041-881ba8aa2a33" xlink:to="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentage_5b9844bc-0735-467b-959b-43de8cb9d3c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_6f9207d4-a2cc-494c-ab7d-aeddb7fcfddd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0cfd8c66-874d-4099-9041-881ba8aa2a33" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_6f9207d4-a2cc-494c-ab7d-aeddb7fcfddd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_8f10037c-eedd-4151-9e97-96e471b514ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0cfd8c66-874d-4099-9041-881ba8aa2a33" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_8f10037c-eedd-4151-9e97-96e471b514ee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_bf88b828-6253-4342-9367-f093027dfc68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0cfd8c66-874d-4099-9041-881ba8aa2a33" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_bf88b828-6253-4342-9367-f093027dfc68" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_5743c642-0f00-4888-9351-ca96f0dd371c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0cfd8c66-874d-4099-9041-881ba8aa2a33" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_5743c642-0f00-4888-9351-ca96f0dd371c" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/SegmentInformationAdditionalInformationDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#SegmentInformationAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/SegmentInformationAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_877df4d0-14b9-4b9c-b314-399a29949139" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d549fb83-d509-49b2-a842-454cb0fa27bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_877df4d0-14b9-4b9c-b314-399a29949139" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d549fb83-d509-49b2-a842-454cb0fa27bb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_3c231af1-a902-466a-89c6-3b88f3b6c75b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d549fb83-d509-49b2-a842-454cb0fa27bb" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_3c231af1-a902-466a-89c6-3b88f3b6c75b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_3c231af1-a902-466a-89c6-3b88f3b6c75b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_3c231af1-a902-466a-89c6-3b88f3b6c75b" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_3c231af1-a902-466a-89c6-3b88f3b6c75b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_ae28f6ac-bb68-486a-9cf5-f5bf09c6625f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_3c231af1-a902-466a-89c6-3b88f3b6c75b" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_ae28f6ac-bb68-486a-9cf5-f5bf09c6625f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_a4ad5853-578e-4037-b5a5-314c2a5c0736" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_ae28f6ac-bb68-486a-9cf5-f5bf09c6625f" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_a4ad5853-578e-4037-b5a5-314c2a5c0736" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_e894211b-7c84-4d58-a66a-12a15cee9721" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d549fb83-d509-49b2-a842-454cb0fa27bb" xlink:to="loc_srt_StatementGeographicalAxis_e894211b-7c84-4d58-a66a-12a15cee9721" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e894211b-7c84-4d58-a66a-12a15cee9721_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_e894211b-7c84-4d58-a66a-12a15cee9721" xlink:to="loc_srt_SegmentGeographicalDomain_e894211b-7c84-4d58-a66a-12a15cee9721_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d792790c-3e02-4b54-a7a3-ac5f37aa1fa8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_e894211b-7c84-4d58-a66a-12a15cee9721" xlink:to="loc_srt_SegmentGeographicalDomain_d792790c-3e02-4b54-a7a3-ac5f37aa1fa8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_08a8bcd5-c9ab-469a-bb00-0260766d0794" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_d792790c-3e02-4b54-a7a3-ac5f37aa1fa8" xlink:to="loc_country_US_08a8bcd5-c9ab-469a-bb00-0260766d0794" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_NL_dda8390c-02ac-4587-b513-2ae2026c1819" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_NL"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_d792790c-3e02-4b54-a7a3-ac5f37aa1fa8" xlink:to="loc_country_NL_dda8390c-02ac-4587-b513-2ae2026c1819" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_SG_3242bc81-0341-41ce-b53d-c233d2c95dfa" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_SG"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_d792790c-3e02-4b54-a7a3-ac5f37aa1fa8" xlink:to="loc_country_SG_3242bc81-0341-41ce-b53d-c233d2c95dfa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN_e4732aad-28a0-459e-9377-549b34ef51a2" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CN"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_d792790c-3e02-4b54-a7a3-ac5f37aa1fa8" xlink:to="loc_country_CN_e4732aad-28a0-459e-9377-549b34ef51a2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_51808864-736e-49a5-8bed-d8329c8f27de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_d792790c-3e02-4b54-a7a3-ac5f37aa1fa8" xlink:to="loc_us-gaap_NonUsMember_51808864-736e-49a5-8bed-d8329c8f27de" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_45545765-c5f5-4e80-b18b-552fbf6cf123" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d549fb83-d509-49b2-a842-454cb0fa27bb" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_45545765-c5f5-4e80-b18b-552fbf6cf123" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_45545765-c5f5-4e80-b18b-552fbf6cf123_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_45545765-c5f5-4e80-b18b-552fbf6cf123" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_45545765-c5f5-4e80-b18b-552fbf6cf123_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6ae382ef-3e80-447f-9bbc-66180f19dd40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_45545765-c5f5-4e80-b18b-552fbf6cf123" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6ae382ef-3e80-447f-9bbc-66180f19dd40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember_b47914d8-cf6c-47ef-834d-384fa1b1c670" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6ae382ef-3e80-447f-9bbc-66180f19dd40" xlink:to="loc_us-gaap_SalesMember_b47914d8-cf6c-47ef-834d-384fa1b1c670" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_de39dbff-2027-470a-96f0-d3160866dff5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6ae382ef-3e80-447f-9bbc-66180f19dd40" xlink:to="loc_us-gaap_SalesRevenueNetMember_de39dbff-2027-470a-96f0-d3160866dff5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ConsolidatedNetSalesMember_9d9fefe2-66c1-424f-b931-430b0023a58f" xlink:href="iff-20231231.xsd#iff_ConsolidatedNetSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6ae382ef-3e80-447f-9bbc-66180f19dd40" xlink:to="loc_iff_ConsolidatedNetSalesMember_9d9fefe2-66c1-424f-b931-430b0023a58f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_7f3c3aae-29f7-4229-8e11-a155f14150e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6ae382ef-3e80-447f-9bbc-66180f19dd40" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_7f3c3aae-29f7-4229-8e11-a155f14150e3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_8b1f0681-5073-4108-be84-f411608651a1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d549fb83-d509-49b2-a842-454cb0fa27bb" xlink:to="loc_srt_MajorCustomersAxis_8b1f0681-5073-4108-be84-f411608651a1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_8b1f0681-5073-4108-be84-f411608651a1_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_8b1f0681-5073-4108-be84-f411608651a1" xlink:to="loc_srt_NameOfMajorCustomerDomain_8b1f0681-5073-4108-be84-f411608651a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_59a0a6aa-c0a8-429f-bfcd-719613b8df8f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_8b1f0681-5073-4108-be84-f411608651a1" xlink:to="loc_srt_NameOfMajorCustomerDomain_59a0a6aa-c0a8-429f-bfcd-719613b8df8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TopOneCustomerMember_d9ba3ce3-870b-4328-998c-e602001e9ee4" xlink:href="iff-20231231.xsd#iff_TopOneCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_59a0a6aa-c0a8-429f-bfcd-719613b8df8f" xlink:to="loc_iff_TopOneCustomerMember_d9ba3ce3-870b-4328-998c-e602001e9ee4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_6296c598-aa11-4c5c-bf7a-be9d9d2f4ef2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d549fb83-d509-49b2-a842-454cb0fa27bb" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_6296c598-aa11-4c5c-bf7a-be9d9d2f4ef2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6296c598-aa11-4c5c-bf7a-be9d9d2f4ef2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6296c598-aa11-4c5c-bf7a-be9d9d2f4ef2" xlink:to="loc_us-gaap_SegmentDomain_6296c598-aa11-4c5c-bf7a-be9d9d2f4ef2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ef2356ba-7633-4dee-874f-617f294ff430" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6296c598-aa11-4c5c-bf7a-be9d9d2f4ef2" xlink:to="loc_us-gaap_SegmentDomain_ef2356ba-7633-4dee-874f-617f294ff430" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateAndOtherMember_a446c625-ff5d-4836-863d-52cdefa8a58b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ef2356ba-7633-4dee-874f-617f294ff430" xlink:to="loc_us-gaap_CorporateAndOtherMember_a446c625-ff5d-4836-863d-52cdefa8a58b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_d45376ef-429d-4725-902d-906c821ed4d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d549fb83-d509-49b2-a842-454cb0fa27bb" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_d45376ef-429d-4725-902d-906c821ed4d3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d45376ef-429d-4725-902d-906c821ed4d3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d45376ef-429d-4725-902d-906c821ed4d3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d45376ef-429d-4725-902d-906c821ed4d3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_29ec55ac-ebf4-469d-a1f6-3382185a33a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d45376ef-429d-4725-902d-906c821ed4d3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_29ec55ac-ebf4-469d-a1f6-3382185a33a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NutritionBiosciencesIncMember_770c25d9-5aa2-4cba-bee7-7f3dbf90e301" xlink:href="iff-20231231.xsd#iff_NutritionBiosciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_29ec55ac-ebf4-469d-a1f6-3382185a33a0" xlink:to="loc_iff_NutritionBiosciencesIncMember_770c25d9-5aa2-4cba-bee7-7f3dbf90e301" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NumberOfSegments_9226360b-c67f-406c-8094-bbd7f7080a00" xlink:href="iff-20231231.xsd#iff_NumberOfSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_877df4d0-14b9-4b9c-b314-399a29949139" xlink:to="loc_iff_NumberOfSegments_9226360b-c67f-406c-8094-bbd7f7080a00" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NumberOfFragranceCategories_b38fc781-39e2-403a-8a21-3ab0134213bc" xlink:href="iff-20231231.xsd#iff_NumberOfFragranceCategories"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_877df4d0-14b9-4b9c-b314-399a29949139" xlink:to="loc_iff_NumberOfFragranceCategories_b38fc781-39e2-403a-8a21-3ab0134213bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EntityWideRevenueMajorCustomerNumberOfCustomers_425bade4-2b47-4c88-ab86-d5e07b023e8b" xlink:href="iff-20231231.xsd#iff_EntityWideRevenueMajorCustomerNumberOfCustomers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_877df4d0-14b9-4b9c-b314-399a29949139" xlink:to="loc_iff_EntityWideRevenueMajorCustomerNumberOfCustomers_425bade4-2b47-4c88-ab86-d5e07b023e8b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_30a9be71-cb14-4513-a161-a13ee9977927" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_877df4d0-14b9-4b9c-b314-399a29949139" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_30a9be71-cb14-4513-a161-a13ee9977927" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_32f53dec-51a1-44f1-85dc-094e00c12014" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_877df4d0-14b9-4b9c-b314-399a29949139" xlink:to="loc_us-gaap_Revenues_32f53dec-51a1-44f1-85dc-094e00c12014" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_31ab6a93-f225-46e5-ab22-8183c597ea79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_877df4d0-14b9-4b9c-b314-399a29949139" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_31ab6a93-f225-46e5-ab22-8183c597ea79" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_b6e0dae1-dd07-4624-ba93-edb42a6f0883" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_877df4d0-14b9-4b9c-b314-399a29949139" xlink:to="loc_us-gaap_NumberOfOperatingSegments_b6e0dae1-dd07-4624-ba93-edb42a6f0883" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_StrategicInitiativesCosts_996e3188-825c-422e-9734-51a3722417c1" xlink:href="iff-20231231.xsd#iff_StrategicInitiativesCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_877df4d0-14b9-4b9c-b314-399a29949139" xlink:to="loc_iff_StrategicInitiativesCosts_996e3188-825c-422e-9734-51a3722417c1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NumberOfCustomers_5f2fb66a-0f06-452f-bec7-531c02e2f657" xlink:href="iff-20231231.xsd#iff_NumberOfCustomers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_877df4d0-14b9-4b9c-b314-399a29949139" xlink:to="loc_iff_NumberOfCustomers_5f2fb66a-0f06-452f-bec7-531c02e2f657" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_d1d19eec-7119-4a04-9ed4-e6c2992fb925" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_877df4d0-14b9-4b9c-b314-399a29949139" xlink:to="loc_us-gaap_RestructuringCharges_d1d19eec-7119-4a04-9ed4-e6c2992fb925" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_8f051ac9-7046-4888-8b0c-222960a5bcc0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_877df4d0-14b9-4b9c-b314-399a29949139" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_8f051ac9-7046-4888-8b0c-222960a5bcc0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_adb055ba-1245-474c-8d37-ae5ed01a8460" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_877df4d0-14b9-4b9c-b314-399a29949139" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_adb055ba-1245-474c-8d37-ae5ed01a8460" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BusinessCombinationDivestituresAndIntegrationCosts_ca7e4698-0cdd-4a26-9010-a9754b92b49a" xlink:href="iff-20231231.xsd#iff_BusinessCombinationDivestituresAndIntegrationCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_877df4d0-14b9-4b9c-b314-399a29949139" xlink:to="loc_iff_BusinessCombinationDivestituresAndIntegrationCosts_ca7e4698-0cdd-4a26-9010-a9754b92b49a" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalFees_743a3c9a-9418-4665-83e8-078f5bcd625e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LegalFees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_877df4d0-14b9-4b9c-b314-399a29949139" xlink:to="loc_us-gaap_LegalFees_743a3c9a-9418-4665-83e8-078f5bcd625e" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BusinessCombinationInventoryStepUpCosts_c4b2f244-5d01-4687-a180-890d06af731d" xlink:href="iff-20231231.xsd#iff_BusinessCombinationInventoryStepUpCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_877df4d0-14b9-4b9c-b314-399a29949139" xlink:to="loc_iff_BusinessCombinationInventoryStepUpCosts_c4b2f244-5d01-4687-a180-890d06af731d" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_OtherCostsCredits_7212d1f3-0446-4937-a885-51199759d8af" xlink:href="iff-20231231.xsd#iff_OtherCostsCredits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_877df4d0-14b9-4b9c-b314-399a29949139" xlink:to="loc_iff_OtherCostsCredits_7212d1f3-0446-4937-a885-51199759d8af" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BusinessDivestitureCosts_b57285ff-3d64-42d0-b79b-7059b3e2b4e0" xlink:href="iff-20231231.xsd#iff_BusinessDivestitureCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_877df4d0-14b9-4b9c-b314-399a29949139" xlink:to="loc_iff_BusinessDivestitureCosts_b57285ff-3d64-42d0-b79b-7059b3e2b4e0" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_6b5168d8-cb6c-468a-89d8-16dc379d347d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_877df4d0-14b9-4b9c-b314-399a29949139" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_6b5168d8-cb6c-468a-89d8-16dc379d347d" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_5ae1dbc4-224d-4572-9aea-74730ac4ce68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_877df4d0-14b9-4b9c-b314-399a29949139" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_5ae1dbc4-224d-4572-9aea-74730ac4ce68" xlink:type="arc" order="18"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#SegmentInformationReportableSegmentInformationDetail"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2cf2cf60-9122-489e-96d5-a576f75bd638" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2cf2cf60-9122-489e-96d5-a576f75bd638" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_d6e48072-0829-4987-8ad5-fa0c81d41330" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2cf2cf60-9122-489e-96d5-a576f75bd638" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_d6e48072-0829-4987-8ad5-fa0c81d41330" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_d6e48072-0829-4987-8ad5-fa0c81d41330_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_d6e48072-0829-4987-8ad5-fa0c81d41330" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_d6e48072-0829-4987-8ad5-fa0c81d41330_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_8e21afe4-8389-4f95-b52c-e5d2e725fa5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_d6e48072-0829-4987-8ad5-fa0c81d41330" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_8e21afe4-8389-4f95-b52c-e5d2e725fa5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_b65459e7-efb0-4364-ad93-a557a494a1b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_8e21afe4-8389-4f95-b52c-e5d2e725fa5a" xlink:to="loc_us-gaap_ForeignPlanMember_b65459e7-efb0-4364-ad93-a557a494a1b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_11262d0a-5f2e-40fe-ac70-09608afbb602" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_b65459e7-efb0-4364-ad93-a557a494a1b8" xlink:to="loc_country_GB_11262d0a-5f2e-40fe-ac70-09608afbb602" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrecurringAdjustmentAxis_2eccc7f6-b648-4c96-96c9-584151542962" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonrecurringAdjustmentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2cf2cf60-9122-489e-96d5-a576f75bd638" xlink:to="loc_us-gaap_NonrecurringAdjustmentAxis_2eccc7f6-b648-4c96-96c9-584151542962" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrecurringAdjustmentDomain_2eccc7f6-b648-4c96-96c9-584151542962_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonrecurringAdjustmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_NonrecurringAdjustmentAxis_2eccc7f6-b648-4c96-96c9-584151542962" xlink:to="loc_us-gaap_NonrecurringAdjustmentDomain_2eccc7f6-b648-4c96-96c9-584151542962_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrecurringAdjustmentDomain_64b08ec2-d6fb-4450-ac82-2f144db442ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonrecurringAdjustmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_NonrecurringAdjustmentAxis_2eccc7f6-b648-4c96-96c9-584151542962" xlink:to="loc_us-gaap_NonrecurringAdjustmentDomain_64b08ec2-d6fb-4450-ac82-2f144db442ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquisitionRelatedCostsMember_4a54dd59-fe2f-4852-998a-a2ec0010c792" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcquisitionRelatedCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonrecurringAdjustmentDomain_64b08ec2-d6fb-4450-ac82-2f144db442ee" xlink:to="loc_us-gaap_AcquisitionRelatedCostsMember_4a54dd59-fe2f-4852-998a-a2ec0010c792" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_21aeff89-cfc8-45df-ae4d-82a5e5d34afb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2cf2cf60-9122-489e-96d5-a576f75bd638" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_21aeff89-cfc8-45df-ae4d-82a5e5d34afb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_21aeff89-cfc8-45df-ae4d-82a5e5d34afb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_21aeff89-cfc8-45df-ae4d-82a5e5d34afb" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_21aeff89-cfc8-45df-ae4d-82a5e5d34afb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_04a6bd58-240c-4963-b7a5-87853b6d4f9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_21aeff89-cfc8-45df-ae4d-82a5e5d34afb" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_04a6bd58-240c-4963-b7a5-87853b6d4f9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NutritionBiosciencesIncMember_57b50ae0-2259-403d-912b-a64d9c6671ab" xlink:href="iff-20231231.xsd#iff_NutritionBiosciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_04a6bd58-240c-4963-b7a5-87853b6d4f9a" xlink:to="loc_iff_NutritionBiosciencesIncMember_57b50ae0-2259-403d-912b-a64d9c6671ab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_873305b9-a5f0-4d03-9ff9-f0fd2116efca" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2cf2cf60-9122-489e-96d5-a576f75bd638" xlink:to="loc_srt_ConsolidationItemsAxis_873305b9-a5f0-4d03-9ff9-f0fd2116efca" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_873305b9-a5f0-4d03-9ff9-f0fd2116efca_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_873305b9-a5f0-4d03-9ff9-f0fd2116efca" xlink:to="loc_srt_ConsolidationItemsDomain_873305b9-a5f0-4d03-9ff9-f0fd2116efca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_5f4a52f5-0850-4d39-8c64-c34b3d387e83" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_873305b9-a5f0-4d03-9ff9-f0fd2116efca" xlink:to="loc_srt_ConsolidationItemsDomain_5f4a52f5-0850-4d39-8c64-c34b3d387e83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_fcd9a602-614d-4451-82cf-cd7346f58862" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_5f4a52f5-0850-4d39-8c64-c34b3d387e83" xlink:to="loc_us-gaap_OperatingSegmentsMember_fcd9a602-614d-4451-82cf-cd7346f58862" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d547bb72-6f37-45e1-a310-bf3f625d9893" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2cf2cf60-9122-489e-96d5-a576f75bd638" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d547bb72-6f37-45e1-a310-bf3f625d9893" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d547bb72-6f37-45e1-a310-bf3f625d9893_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d547bb72-6f37-45e1-a310-bf3f625d9893" xlink:to="loc_us-gaap_SegmentDomain_d547bb72-6f37-45e1-a310-bf3f625d9893_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_cd409072-42f0-4caa-9b40-0630116edf93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d547bb72-6f37-45e1-a310-bf3f625d9893" xlink:to="loc_us-gaap_SegmentDomain_cd409072-42f0-4caa-9b40-0630116edf93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateAndOtherMember_303d27a3-d1e0-4887-bb30-c71d594545ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_cd409072-42f0-4caa-9b40-0630116edf93" xlink:to="loc_us-gaap_CorporateAndOtherMember_303d27a3-d1e0-4887-bb30-c71d594545ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NourishMember_8478025a-745a-4511-8e2a-d0851e8c066b" xlink:href="iff-20231231.xsd#iff_NourishMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_cd409072-42f0-4caa-9b40-0630116edf93" xlink:to="loc_iff_NourishMember_8478025a-745a-4511-8e2a-d0851e8c066b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_HealthBiosciencesMember_0b1bd960-2330-4e18-bb24-a0db7307da87" xlink:href="iff-20231231.xsd#iff_HealthBiosciencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_cd409072-42f0-4caa-9b40-0630116edf93" xlink:to="loc_iff_HealthBiosciencesMember_0b1bd960-2330-4e18-bb24-a0db7307da87" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ScentMember_f0e04342-b082-4202-b087-d8e564b2eabf" xlink:href="iff-20231231.xsd#iff_ScentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_cd409072-42f0-4caa-9b40-0630116edf93" xlink:to="loc_iff_ScentMember_f0e04342-b082-4202-b087-d8e564b2eabf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_PharmaSolutionsMember_f83920dd-6852-490f-9ffe-16d1a620b7f5" xlink:href="iff-20231231.xsd#iff_PharmaSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_cd409072-42f0-4caa-9b40-0630116edf93" xlink:to="loc_iff_PharmaSolutionsMember_f83920dd-6852-490f-9ffe-16d1a620b7f5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_9e4aa7bd-c66e-44c6-9c94-8f2255052b8b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_us-gaap_Assets_9e4aa7bd-c66e-44c6-9c94-8f2255052b8b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_OperatingEBITDAMargin_53092df8-d109-49d1-aff5-c7ed88552ed4" xlink:href="iff-20231231.xsd#iff_OperatingEBITDAMargin"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_iff_OperatingEBITDAMargin_53092df8-d109-49d1-aff5-c7ed88552ed4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_6ab67462-dc3c-4467-95b1-192af3b3cfaa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_6ab67462-dc3c-4467-95b1-192af3b3cfaa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_9c92d68e-ffd1-44f2-a33f-dafb1b4c2553" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_9c92d68e-ffd1-44f2-a33f-dafb1b4c2553" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a4c6e1a1-9b72-40a9-9832-751f2eed6171" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a4c6e1a1-9b72-40a9-9832-751f2eed6171" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_e389b87b-de3b-4bf7-99ab-1ece26b6b9e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_e389b87b-de3b-4bf7-99ab-1ece26b6b9e8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ReserveforTaxAssessment_2c9f0178-ba7c-4a81-8514-e0e9220efb65" xlink:href="iff-20231231.xsd#iff_ReserveforTaxAssessment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_iff_ReserveforTaxAssessment_2c9f0178-ba7c-4a81-8514-e0e9220efb65" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_d12b6e97-a7fa-4ef5-a028-5d53b66a2b2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_us-gaap_RestructuringCharges_d12b6e97-a7fa-4ef5-a028-5d53b66a2b2c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_d371fe89-9d30-4ce0-8923-7c9b32a098d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_d371fe89-9d30-4ce0-8923-7c9b32a098d4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_72a6adad-bc3d-4108-a14a-f21ad9b223f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeveranceCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_us-gaap_SeveranceCosts1_72a6adad-bc3d-4108-a14a-f21ad9b223f6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionExpense_3eb381d2-f450-4fed-9c2f-504511c63072" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_us-gaap_PensionExpense_3eb381d2-f450-4fed-9c2f-504511c63072" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_80f2cee9-1988-435a-96b1-16d6d6a8fca5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_us-gaap_InterestExpense_80f2cee9-1988-435a-96b1-16d6d6a8fca5" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_628f769b-7120-485d-897c-0df91845746f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_628f769b-7120-485d-897c-0df91845746f" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_75238993-7b32-4162-af0e-493f5a714c4c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_75238993-7b32-4162-af0e-493f5a714c4c" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_f1efdb83-009b-4a09-b70a-0ee16b68a802" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_us-gaap_AdjustmentForAmortization_f1efdb83-009b-4a09-b70a-0ee16b68a802" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_67da8a7d-3f36-4087-b327-a76fbdf52438" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_67da8a7d-3f36-4087-b327-a76fbdf52438" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalFees_8427ec64-eee1-4b4f-bf17-634441cd03de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LegalFees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_us-gaap_LegalFees_8427ec64-eee1-4b4f-bf17-634441cd03de" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b0829ee0-2aa5-4506-b281-c37f6420184e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b0829ee0-2aa5-4506-b281-c37f6420184e" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SegmentAdjustedOperatingEBITDA_f01a50ff-ded9-402c-a9f8-a00117f28390" xlink:href="iff-20231231.xsd#iff_SegmentAdjustedOperatingEBITDA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_iff_SegmentAdjustedOperatingEBITDA_f01a50ff-ded9-402c-a9f8-a00117f28390" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareholderActivismRelatedCosts_02ff9b98-021d-48be-80eb-b6d3a38911df" xlink:href="iff-20231231.xsd#iff_ShareholderActivismRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_iff_ShareholderActivismRelatedCosts_02ff9b98-021d-48be-80eb-b6d3a38911df" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BusinessDivestitureCosts_e3cdb964-81b8-4574-b45b-b43ec42ab813" xlink:href="iff-20231231.xsd#iff_BusinessDivestitureCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_iff_BusinessDivestitureCosts_e3cdb964-81b8-4574-b45b-b43ec42ab813" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BusinessCombinationInventoryStepUpCosts_1a42178b-21fd-4258-bf83-9fb81b08e986" xlink:href="iff-20231231.xsd#iff_BusinessCombinationInventoryStepUpCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_iff_BusinessCombinationInventoryStepUpCosts_1a42178b-21fd-4258-bf83-9fb81b08e986" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization_6bb4093d-aee0-42d4-a714-cd1f3a52890b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_us-gaap_OtherDepreciationAndAmortization_6bb4093d-aee0-42d4-a714-cd1f3a52890b" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_cdaf2f9b-9470-4ca9-aee3-011654734a4b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_cdaf2f9b-9470-4ca9-aee3-011654734a4b" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_1e84783a-ce51-45b1-bcd9-5c28d622e504" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_1e84783a-ce51-45b1-bcd9-5c28d622e504" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_GlobalSharedServicesImplementationCosts_10ca72d2-bf65-4a24-a9db-60a82145e9db" xlink:href="iff-20231231.xsd#iff_GlobalSharedServicesImplementationCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_iff_GlobalSharedServicesImplementationCosts_10ca72d2-bf65-4a24-a9db-60a82145e9db" xlink:type="arc" order="25"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/SegmentInformationCapitalExpenditureandDepreciationandAmortizationbySegmentDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#SegmentInformationCapitalExpenditureandDepreciationandAmortizationbySegmentDetail"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/SegmentInformationCapitalExpenditureandDepreciationandAmortizationbySegmentDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_232f2578-0a0e-49c3-ad6e-3fb1d4d03a45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fda012af-6caa-42c5-88e0-fb833c40ac1e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_232f2578-0a0e-49c3-ad6e-3fb1d4d03a45" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fda012af-6caa-42c5-88e0-fb833c40ac1e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_7b341d40-03fb-4c57-ab4b-4d771e47e453" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fda012af-6caa-42c5-88e0-fb833c40ac1e" xlink:to="loc_srt_ConsolidationItemsAxis_7b341d40-03fb-4c57-ab4b-4d771e47e453" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_7b341d40-03fb-4c57-ab4b-4d771e47e453_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_7b341d40-03fb-4c57-ab4b-4d771e47e453" xlink:to="loc_srt_ConsolidationItemsDomain_7b341d40-03fb-4c57-ab4b-4d771e47e453_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_a767ab4c-5aa8-4d52-bfce-198c3f70a556" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_7b341d40-03fb-4c57-ab4b-4d771e47e453" xlink:to="loc_srt_ConsolidationItemsDomain_a767ab4c-5aa8-4d52-bfce-198c3f70a556" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_c15b4c48-ce46-45e9-bed8-1bacc44c038d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_a767ab4c-5aa8-4d52-bfce-198c3f70a556" xlink:to="loc_us-gaap_OperatingSegmentsMember_c15b4c48-ce46-45e9-bed8-1bacc44c038d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_1944ac41-08b8-402c-89d3-d72262b4aa59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_a767ab4c-5aa8-4d52-bfce-198c3f70a556" xlink:to="loc_us-gaap_CorporateNonSegmentMember_1944ac41-08b8-402c-89d3-d72262b4aa59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_01ca9903-94a9-4920-a870-dc6cacbe4e38" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fda012af-6caa-42c5-88e0-fb833c40ac1e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_01ca9903-94a9-4920-a870-dc6cacbe4e38" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_01ca9903-94a9-4920-a870-dc6cacbe4e38_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_01ca9903-94a9-4920-a870-dc6cacbe4e38" xlink:to="loc_us-gaap_SegmentDomain_01ca9903-94a9-4920-a870-dc6cacbe4e38_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e3abd2aa-fd53-4ffc-a632-caf45015b12e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_01ca9903-94a9-4920-a870-dc6cacbe4e38" xlink:to="loc_us-gaap_SegmentDomain_e3abd2aa-fd53-4ffc-a632-caf45015b12e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FlavorsMember_e02b41cf-6136-42ac-9381-47ced5c49616" xlink:href="iff-20231231.xsd#iff_FlavorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e3abd2aa-fd53-4ffc-a632-caf45015b12e" xlink:to="loc_iff_FlavorsMember_e02b41cf-6136-42ac-9381-47ced5c49616" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FragrancesMember_f167d085-4476-4ae0-bb58-0b4663277cc1" xlink:href="iff-20231231.xsd#iff_FragrancesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e3abd2aa-fd53-4ffc-a632-caf45015b12e" xlink:to="loc_iff_FragrancesMember_f167d085-4476-4ae0-bb58-0b4663277cc1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NourishMember_6584c1f1-c484-4acc-a26d-69d39bb161ef" xlink:href="iff-20231231.xsd#iff_NourishMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e3abd2aa-fd53-4ffc-a632-caf45015b12e" xlink:to="loc_iff_NourishMember_6584c1f1-c484-4acc-a26d-69d39bb161ef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_HealthBiosciencesMember_d1f69ee0-69a5-475d-b915-4865791cec43" xlink:href="iff-20231231.xsd#iff_HealthBiosciencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e3abd2aa-fd53-4ffc-a632-caf45015b12e" xlink:to="loc_iff_HealthBiosciencesMember_d1f69ee0-69a5-475d-b915-4865791cec43" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ScentMember_3a9a378d-225e-4922-8c92-6e22d64216aa" xlink:href="iff-20231231.xsd#iff_ScentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e3abd2aa-fd53-4ffc-a632-caf45015b12e" xlink:to="loc_iff_ScentMember_3a9a378d-225e-4922-8c92-6e22d64216aa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_PharmaSolutionsMember_1a444a0c-cd65-4ca9-98bc-7b2aa841e00e" xlink:href="iff-20231231.xsd#iff_PharmaSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e3abd2aa-fd53-4ffc-a632-caf45015b12e" xlink:to="loc_iff_PharmaSolutionsMember_1a444a0c-cd65-4ca9-98bc-7b2aa841e00e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentExpenditureAdditionToLongLivedAssets_512adb2a-410e-4fc9-b8ea-1e0e3affc119" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentExpenditureAdditionToLongLivedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_232f2578-0a0e-49c3-ad6e-3fb1d4d03a45" xlink:to="loc_us-gaap_SegmentExpenditureAdditionToLongLivedAssets_512adb2a-410e-4fc9-b8ea-1e0e3affc119" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_b4be2309-b0e1-4678-9877-8613c294c2dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_232f2578-0a0e-49c3-ad6e-3fb1d4d03a45" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_b4be2309-b0e1-4678-9877-8613c294c2dc" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/SegmentInformationNetSalesbyGeographicAreaDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#SegmentInformationNetSalesbyGeographicAreaDetail"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/SegmentInformationNetSalesbyGeographicAreaDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_231eff14-0e57-4c23-9852-2779a779c9ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_eda64eee-ed1c-440e-b788-bfb64c12845d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_231eff14-0e57-4c23-9852-2779a779c9ed" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_eda64eee-ed1c-440e-b788-bfb64c12845d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionAxis_2466c8e5-0922-407e-817d-8a79219d590a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_eda64eee-ed1c-440e-b788-bfb64c12845d" xlink:to="loc_us-gaap_GeographicDistributionAxis_2466c8e5-0922-407e-817d-8a79219d590a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomain_2466c8e5-0922-407e-817d-8a79219d590a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_GeographicDistributionAxis_2466c8e5-0922-407e-817d-8a79219d590a" xlink:to="loc_us-gaap_GeographicDistributionDomain_2466c8e5-0922-407e-817d-8a79219d590a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomain_d10adbfc-c7c9-45c3-bc4e-787aa9b5295e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_GeographicDistributionAxis_2466c8e5-0922-407e-817d-8a79219d590a" xlink:to="loc_us-gaap_GeographicDistributionDomain_d10adbfc-c7c9-45c3-bc4e-787aa9b5295e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomesticMember_d298b228-0bc1-4a8c-ac70-ab6d7a770c3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionDomesticMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GeographicDistributionDomain_d10adbfc-c7c9-45c3-bc4e-787aa9b5295e" xlink:to="loc_us-gaap_GeographicDistributionDomesticMember_d298b228-0bc1-4a8c-ac70-ab6d7a770c3c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionForeignMember_c02cb25d-d7ee-4900-93ca-8abe2faa76ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionForeignMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GeographicDistributionDomain_d10adbfc-c7c9-45c3-bc4e-787aa9b5295e" xlink:to="loc_us-gaap_GeographicDistributionForeignMember_c02cb25d-d7ee-4900-93ca-8abe2faa76ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_c75aba80-83b4-4458-9e58-519eaed30907" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_eda64eee-ed1c-440e-b788-bfb64c12845d" xlink:to="loc_srt_StatementGeographicalAxis_c75aba80-83b4-4458-9e58-519eaed30907" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_c75aba80-83b4-4458-9e58-519eaed30907_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_c75aba80-83b4-4458-9e58-519eaed30907" xlink:to="loc_srt_SegmentGeographicalDomain_c75aba80-83b4-4458-9e58-519eaed30907_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_9fa0f9e7-b8ab-4afe-8ef5-17029251e1ed" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_c75aba80-83b4-4458-9e58-519eaed30907" xlink:to="loc_srt_SegmentGeographicalDomain_9fa0f9e7-b8ab-4afe-8ef5-17029251e1ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_3c1df8a7-e79f-4802-8f41-896060a5a346" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EMEAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_9fa0f9e7-b8ab-4afe-8ef5-17029251e1ed" xlink:to="loc_us-gaap_EMEAMember_3c1df8a7-e79f-4802-8f41-896060a5a346" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaMember_f63ca314-1ef2-48d5-885d-c0ea697f82fb" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AsiaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_9fa0f9e7-b8ab-4afe-8ef5-17029251e1ed" xlink:to="loc_srt_AsiaMember_f63ca314-1ef2-48d5-885d-c0ea697f82fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NorthAmericaMember_9bb6c208-22f8-4620-9d0b-329fbcaacd13" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NorthAmericaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_9fa0f9e7-b8ab-4afe-8ef5-17029251e1ed" xlink:to="loc_srt_NorthAmericaMember_9bb6c208-22f8-4620-9d0b-329fbcaacd13" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LatinAmericaMember_74929eb7-1598-4908-9ad7-c5fb11df7bb4" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LatinAmericaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_9fa0f9e7-b8ab-4afe-8ef5-17029251e1ed" xlink:to="loc_srt_LatinAmericaMember_74929eb7-1598-4908-9ad7-c5fb11df7bb4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b3f776fb-a776-4d5c-98c8-1e2135c893b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_231eff14-0e57-4c23-9852-2779a779c9ed" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b3f776fb-a776-4d5c-98c8-1e2135c893b6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/SegmentInformationSegmentInformationScheduleofLongLivedAssetsDetails" xlink:type="simple" xlink:href="iff-20231231.xsd#SegmentInformationSegmentInformationScheduleofLongLivedAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/SegmentInformationSegmentInformationScheduleofLongLivedAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_eb214732-7d88-422e-a6b7-b242ac63607f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_e2b80791-77e3-4154-9446-e7a12bbd106e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_eb214732-7d88-422e-a6b7-b242ac63607f" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_e2b80791-77e3-4154-9446-e7a12bbd106e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_96293630-ed6f-4cf3-9d19-f3565d1366c1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_e2b80791-77e3-4154-9446-e7a12bbd106e" xlink:to="loc_srt_StatementGeographicalAxis_96293630-ed6f-4cf3-9d19-f3565d1366c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_96293630-ed6f-4cf3-9d19-f3565d1366c1_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_96293630-ed6f-4cf3-9d19-f3565d1366c1" xlink:to="loc_srt_SegmentGeographicalDomain_96293630-ed6f-4cf3-9d19-f3565d1366c1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_4db1c422-b22b-40e6-bd0e-c8204ed912fe" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_96293630-ed6f-4cf3-9d19-f3565d1366c1" xlink:to="loc_srt_SegmentGeographicalDomain_4db1c422-b22b-40e6-bd0e-c8204ed912fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_20d39c33-fbc9-4662-ab2f-e87a9b2c4297" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_4db1c422-b22b-40e6-bd0e-c8204ed912fe" xlink:to="loc_country_US_20d39c33-fbc9-4662-ab2f-e87a9b2c4297" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_NL_1a4bd724-f979-4073-bb95-28b991017588" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_NL"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_4db1c422-b22b-40e6-bd0e-c8204ed912fe" xlink:to="loc_country_NL_1a4bd724-f979-4073-bb95-28b991017588" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_SG_bb7ed0a1-02f7-4e67-9196-52b0ce44156e" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_SG"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_4db1c422-b22b-40e6-bd0e-c8204ed912fe" xlink:to="loc_country_SG_bb7ed0a1-02f7-4e67-9196-52b0ce44156e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN_a679b6ac-cc51-4b79-b90d-d9afb0ce09ad" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CN"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_4db1c422-b22b-40e6-bd0e-c8204ed912fe" xlink:to="loc_country_CN_a679b6ac-cc51-4b79-b90d-d9afb0ce09ad" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_OtherCountriesMember_37b51212-965a-49f2-9b0c-b9246bd47ffb" xlink:href="iff-20231231.xsd#iff_OtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_4db1c422-b22b-40e6-bd0e-c8204ed912fe" xlink:to="loc_iff_OtherCountriesMember_37b51212-965a-49f2-9b0c-b9246bd47ffb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_DK_d212b802-ad8d-4814-a326-d0e27a499e4d" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_DK"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_4db1c422-b22b-40e6-bd0e-c8204ed912fe" xlink:to="loc_country_DK_d212b802-ad8d-4814-a326-d0e27a499e4d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FI_a6678bb7-c562-4fe0-ab84-8ffc0ebe5535" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_FI"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_4db1c422-b22b-40e6-bd0e-c8204ed912fe" xlink:to="loc_country_FI_a6678bb7-c562-4fe0-ab84-8ffc0ebe5535" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_3b79f95f-0f5a-4adc-8637-ddb5d02db687" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_FR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_4db1c422-b22b-40e6-bd0e-c8204ed912fe" xlink:to="loc_country_FR_3b79f95f-0f5a-4adc-8637-ddb5d02db687" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE_817abb1c-55dd-47c2-8c70-547c98af1f54" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_DE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_4db1c422-b22b-40e6-bd0e-c8204ed912fe" xlink:to="loc_country_DE_817abb1c-55dd-47c2-8c70-547c98af1f54" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_3e042b17-fa4d-44b9-870b-c8b9b147dca9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_eb214732-7d88-422e-a6b7-b242ac63607f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_3e042b17-fa4d-44b9-870b-c8b9b147dca9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#EmployeeBenefitsAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_951bcb36-d748-430d-8703-12d66e44ff3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_32f6e4ba-4f2a-4351-9e64-81dfd1920073" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_951bcb36-d748-430d-8703-12d66e44ff3b" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_32f6e4ba-4f2a-4351-9e64-81dfd1920073" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_70bba82e-d117-41ab-995e-bcdb49037613" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_32f6e4ba-4f2a-4351-9e64-81dfd1920073" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_70bba82e-d117-41ab-995e-bcdb49037613" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_70bba82e-d117-41ab-995e-bcdb49037613_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_70bba82e-d117-41ab-995e-bcdb49037613" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_70bba82e-d117-41ab-995e-bcdb49037613_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_8e1cfe64-6bd4-410b-b512-1cd3f8783cc4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_70bba82e-d117-41ab-995e-bcdb49037613" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_8e1cfe64-6bd4-410b-b512-1cd3f8783cc4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_72dfd6df-104d-4735-b195-cf876903950f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_8e1cfe64-6bd4-410b-b512-1cd3f8783cc4" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_72dfd6df-104d-4735-b195-cf876903950f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_e00e2552-dbbe-484c-b1fa-78dda41d5a13" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_8e1cfe64-6bd4-410b-b512-1cd3f8783cc4" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_e00e2552-dbbe-484c-b1fa-78dda41d5a13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_fd2f3ecf-a0ce-4bdf-b594-3cb84cdb94d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_32f6e4ba-4f2a-4351-9e64-81dfd1920073" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_fd2f3ecf-a0ce-4bdf-b594-3cb84cdb94d8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_fd2f3ecf-a0ce-4bdf-b594-3cb84cdb94d8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_fd2f3ecf-a0ce-4bdf-b594-3cb84cdb94d8" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_fd2f3ecf-a0ce-4bdf-b594-3cb84cdb94d8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_728ace2f-67ee-4995-bef6-a60f38bcb31c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_fd2f3ecf-a0ce-4bdf-b594-3cb84cdb94d8" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_728ace2f-67ee-4995-bef6-a60f38bcb31c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_8a212402-0a66-4630-9ec7-977d92e8cbd4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_728ace2f-67ee-4995-bef6-a60f38bcb31c" xlink:to="loc_us-gaap_DomesticPlanMember_8a212402-0a66-4630-9ec7-977d92e8cbd4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_461b79ee-9e7f-4ba9-ae0d-71df7755a66b" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_8a212402-0a66-4630-9ec7-977d92e8cbd4" xlink:to="loc_country_US_461b79ee-9e7f-4ba9-ae0d-71df7755a66b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_a7b75108-38ce-435f-a079-273ca95d8308" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_728ace2f-67ee-4995-bef6-a60f38bcb31c" xlink:to="loc_us-gaap_ForeignPlanMember_a7b75108-38ce-435f-a079-273ca95d8308" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTaxStatusAxis_0a30e2bf-7ea8-4f0a-a5fc-2dd051354710" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTaxStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_32f6e4ba-4f2a-4351-9e64-81dfd1920073" xlink:to="loc_us-gaap_RetirementPlanTaxStatusAxis_0a30e2bf-7ea8-4f0a-a5fc-2dd051354710" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTaxStatusDomain_0a30e2bf-7ea8-4f0a-a5fc-2dd051354710_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTaxStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTaxStatusAxis_0a30e2bf-7ea8-4f0a-a5fc-2dd051354710" xlink:to="loc_us-gaap_RetirementPlanTaxStatusDomain_0a30e2bf-7ea8-4f0a-a5fc-2dd051354710_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTaxStatusDomain_f29885e3-16d4-4eaf-8ff1-a7d264b1efc9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTaxStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTaxStatusAxis_0a30e2bf-7ea8-4f0a-a5fc-2dd051354710" xlink:to="loc_us-gaap_RetirementPlanTaxStatusDomain_f29885e3-16d4-4eaf-8ff1-a7d264b1efc9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QualifiedPlanMember_b118e4e0-dbb1-45c6-b93e-30f2c10ce6fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_QualifiedPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTaxStatusDomain_f29885e3-16d4-4eaf-8ff1-a7d264b1efc9" xlink:to="loc_us-gaap_QualifiedPlanMember_b118e4e0-dbb1-45c6-b93e-30f2c10ce6fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonqualifiedPlanMember_4ceb79f7-0df7-46c3-adf6-a0f770b3673d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonqualifiedPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTaxStatusDomain_f29885e3-16d4-4eaf-8ff1-a7d264b1efc9" xlink:to="loc_us-gaap_NonqualifiedPlanMember_4ceb79f7-0df7-46c3-adf6-a0f770b3673d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis_ea1d94ab-cb21-498a-b8e4-98e2a661dfd4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_32f6e4ba-4f2a-4351-9e64-81dfd1920073" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis_ea1d94ab-cb21-498a-b8e4-98e2a661dfd4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain_ea1d94ab-cb21-498a-b8e4-98e2a661dfd4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis_ea1d94ab-cb21-498a-b8e4-98e2a661dfd4" xlink:to="loc_us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain_ea1d94ab-cb21-498a-b8e4-98e2a661dfd4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain_1543dabb-d352-4722-b3d5-7114229e4295" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis_ea1d94ab-cb21-498a-b8e4-98e2a661dfd4" xlink:to="loc_us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain_1543dabb-d352-4722-b3d5-7114229e4295" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualByTypeOfCompensationPensionAndOtherPostretirementBenefitsMember_78293f5e-e343-4e33-8228-4599bd02d846" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCompensationArrangementWithIndividualByTypeOfCompensationPensionAndOtherPostretirementBenefitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain_1543dabb-d352-4722-b3d5-7114229e4295" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualByTypeOfCompensationPensionAndOtherPostretirementBenefitsMember_78293f5e-e343-4e33-8228-4599bd02d846" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_a5543404-da59-4cc1-966f-f146bbee39a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_32f6e4ba-4f2a-4351-9e64-81dfd1920073" xlink:to="loc_us-gaap_FinancialInstrumentAxis_a5543404-da59-4cc1-966f-f146bbee39a7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a5543404-da59-4cc1-966f-f146bbee39a7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a5543404-da59-4cc1-966f-f146bbee39a7" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a5543404-da59-4cc1-966f-f146bbee39a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4461086c-c225-4be9-b9fe-c3fb2de43f45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a5543404-da59-4cc1-966f-f146bbee39a7" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4461086c-c225-4be9-b9fe-c3fb2de43f45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_f8501a2b-630b-47df-b3d1-e409e1dd8fdf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4461086c-c225-4be9-b9fe-c3fb2de43f45" xlink:to="loc_us-gaap_EquitySecuritiesMember_f8501a2b-630b-47df-b3d1-e409e1dd8fdf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember_2ff09106-0964-408b-b648-4bc68c4d2804" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4461086c-c225-4be9-b9fe-c3fb2de43f45" xlink:to="loc_us-gaap_FixedIncomeSecuritiesMember_2ff09106-0964-408b-b648-4bc68c4d2804" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AlternativeTypeOfInvestmentsMember_7494b03a-8055-4f9b-96e3-82d129305393" xlink:href="iff-20231231.xsd#iff_AlternativeTypeOfInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4461086c-c225-4be9-b9fe-c3fb2de43f45" xlink:to="loc_iff_AlternativeTypeOfInvestmentsMember_7494b03a-8055-4f9b-96e3-82d129305393" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_510bb73e-992b-4e8c-a4a2-e78954723ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_32f6e4ba-4f2a-4351-9e64-81dfd1920073" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_510bb73e-992b-4e8c-a4a2-e78954723ccf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_510bb73e-992b-4e8c-a4a2-e78954723ccf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_510bb73e-992b-4e8c-a4a2-e78954723ccf" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_510bb73e-992b-4e8c-a4a2-e78954723ccf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_863d27df-bfa6-440b-be6d-475c37a62a33" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_510bb73e-992b-4e8c-a4a2-e78954723ccf" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_863d27df-bfa6-440b-be6d-475c37a62a33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedBenefitPlanAssetsCategoryMember_07f854d9-de9e-4711-93bf-7a4130bfbe4a" xlink:href="iff-20231231.xsd#iff_DefinedBenefitPlanAssetsCategoryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_863d27df-bfa6-440b-be6d-475c37a62a33" xlink:to="loc_iff_DefinedBenefitPlanAssetsCategoryMember_07f854d9-de9e-4711-93bf-7a4130bfbe4a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateMember_ec65f68d-db11-4d73-aad9-eb3561aee0fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealEstateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_07f854d9-de9e-4711-93bf-7a4130bfbe4a" xlink:to="loc_us-gaap_RealEstateMember_ec65f68d-db11-4d73-aad9-eb3561aee0fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b9f1fbc1-e4b5-44ef-87df-23b3a62ca944" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_32f6e4ba-4f2a-4351-9e64-81dfd1920073" xlink:to="loc_srt_RangeAxis_b9f1fbc1-e4b5-44ef-87df-23b3a62ca944" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b9f1fbc1-e4b5-44ef-87df-23b3a62ca944_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_b9f1fbc1-e4b5-44ef-87df-23b3a62ca944" xlink:to="loc_srt_RangeMember_b9f1fbc1-e4b5-44ef-87df-23b3a62ca944_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_47e3ac63-e6bb-4157-9667-53b0a0b63d0d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_b9f1fbc1-e4b5-44ef-87df-23b3a62ca944" xlink:to="loc_srt_RangeMember_47e3ac63-e6bb-4157-9667-53b0a0b63d0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e792eb4f-61b4-469c-9710-3adb192e41ae" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_47e3ac63-e6bb-4157-9667-53b0a0b63d0d" xlink:to="loc_srt_MinimumMember_e792eb4f-61b4-469c-9710-3adb192e41ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e623e154-ba88-4327-93dd-91da3ec90b64" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_47e3ac63-e6bb-4157-9667-53b0a0b63d0d" xlink:to="loc_srt_MaximumMember_e623e154-ba88-4327-93dd-91da3ec90b64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_7466a3ba-6389-4977-9335-7601161af923" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_32f6e4ba-4f2a-4351-9e64-81dfd1920073" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_7466a3ba-6389-4977-9335-7601161af923" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7466a3ba-6389-4977-9335-7601161af923_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7466a3ba-6389-4977-9335-7601161af923" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7466a3ba-6389-4977-9335-7601161af923_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_17c3f248-f7f2-45bb-b868-a57387baacb2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7466a3ba-6389-4977-9335-7601161af923" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_17c3f248-f7f2-45bb-b868-a57387baacb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NutritionBiosciencesIncMember_2f6313e0-8a94-4fa0-a9c1-8f9f3dfd9c40" xlink:href="iff-20231231.xsd#iff_NutritionBiosciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_17c3f248-f7f2-45bb-b868-a57387baacb2" xlink:to="loc_iff_NutritionBiosciencesIncMember_2f6313e0-8a94-4fa0-a9c1-8f9f3dfd9c40" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_285c078d-a167-46ff-b1a4-cd9a0da55f11" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_951bcb36-d748-430d-8703-12d66e44ff3b" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_285c078d-a167-46ff-b1a4-cd9a0da55f11" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BusinessCombinationDefinedBenefitPlanNumberOfPlansAssumed_45ac26ad-ebf8-4675-aa81-49881543c4a7" xlink:href="iff-20231231.xsd#iff_BusinessCombinationDefinedBenefitPlanNumberOfPlansAssumed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_951bcb36-d748-430d-8703-12d66e44ff3b" xlink:to="loc_iff_BusinessCombinationDefinedBenefitPlanNumberOfPlansAssumed_45ac26ad-ebf8-4675-aa81-49881543c4a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBelowLowRange_b976f090-009a-41b2-8d4b-031f053ca269" xlink:href="iff-20231231.xsd#iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBelowLowRange"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_951bcb36-d748-430d-8703-12d66e44ff3b" xlink:to="loc_iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBelowLowRange_b976f090-009a-41b2-8d4b-031f053ca269" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRange_92acb7be-58d4-4e52-b807-05035a7228f3" xlink:href="iff-20231231.xsd#iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRange"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_951bcb36-d748-430d-8703-12d66e44ff3b" xlink:to="loc_iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRange_92acb7be-58d4-4e52-b807-05035a7228f3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBetweenHighRangeAndLowRange_2c4681af-3a82-4230-b2b9-2ba51ea50243" xlink:href="iff-20231231.xsd#iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBetweenHighRangeAndLowRange"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_951bcb36-d748-430d-8703-12d66e44ff3b" xlink:to="loc_iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBetweenHighRangeAndLowRange_2c4681af-3a82-4230-b2b9-2ba51ea50243" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRangeLow_fa201154-3f1d-4cab-8763-98dae9512bb6" xlink:href="iff-20231231.xsd#iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRangeLow"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_951bcb36-d748-430d-8703-12d66e44ff3b" xlink:to="loc_iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRangeLow_fa201154-3f1d-4cab-8763-98dae9512bb6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRangeHigh_448223be-9378-4fe1-ac62-9dfc03e12e39" xlink:href="iff-20231231.xsd#iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRangeHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_951bcb36-d748-430d-8703-12d66e44ff3b" xlink:to="loc_iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRangeHigh_448223be-9378-4fe1-ac62-9dfc03e12e39" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageReachesAverageRate_cb9240ed-45b0-4f49-b318-c27139144cbc" xlink:href="iff-20231231.xsd#iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageReachesAverageRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_951bcb36-d748-430d-8703-12d66e44ff3b" xlink:to="loc_iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageReachesAverageRate_cb9240ed-45b0-4f49-b318-c27139144cbc" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedContributionPlanMatchingParticipantContributionAveragePercentageOnCompensation_91b124ec-5c45-4279-b01f-6582a5e77886" xlink:href="iff-20231231.xsd#iff_DefinedContributionPlanMatchingParticipantContributionAveragePercentageOnCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_951bcb36-d748-430d-8703-12d66e44ff3b" xlink:to="loc_iff_DefinedContributionPlanMatchingParticipantContributionAveragePercentageOnCompensation_91b124ec-5c45-4279-b01f-6582a5e77886" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_92174740-0238-47d5-8d26-b06f2cdb4f36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_951bcb36-d748-430d-8703-12d66e44ff3b" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_92174740-0238-47d5-8d26-b06f2cdb4f36" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AdjustmentsToAdditionalPaidInCapitalDeferredCompensation_ebf534a6-0d8a-4c0c-9149-3e61ba07e1c2" xlink:href="iff-20231231.xsd#iff_AdjustmentsToAdditionalPaidInCapitalDeferredCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_951bcb36-d748-430d-8703-12d66e44ff3b" xlink:to="loc_iff_AdjustmentsToAdditionalPaidInCapitalDeferredCompensation_ebf534a6-0d8a-4c0c-9149-3e61ba07e1c2" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueOfLifeInsurance_e20a45f9-f931-4ea5-ab19-ab0b78f5ee35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashSurrenderValueOfLifeInsurance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_951bcb36-d748-430d-8703-12d66e44ff3b" xlink:to="loc_us-gaap_CashSurrenderValueOfLifeInsurance_e20a45f9-f931-4ea5-ab19-ab0b78f5ee35" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_6c2109e6-3d32-4472-ab78-68815f72f45f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_951bcb36-d748-430d-8703-12d66e44ff3b" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_6c2109e6-3d32-4472-ab78-68815f72f45f" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_dd549174-cd92-4d35-a24e-7b09453a20d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_951bcb36-d748-430d-8703-12d66e44ff3b" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_dd549174-cd92-4d35-a24e-7b09453a20d2" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_PercentageofActiveEmployeeswithPensionandorOtherRetirementBenefitPlansCovered_3824fe9a-e420-493c-ad6b-24be34a07c6c" xlink:href="iff-20231231.xsd#iff_PercentageofActiveEmployeeswithPensionandorOtherRetirementBenefitPlansCovered"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_951bcb36-d748-430d-8703-12d66e44ff3b" xlink:to="loc_iff_PercentageofActiveEmployeeswithPensionandorOtherRetirementBenefitPlansCovered_3824fe9a-e420-493c-ad6b-24be34a07c6c" xlink:type="arc" order="14"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e7371a01-ddcc-466c-bdbf-0929a265a589" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_26b523ff-e0a6-4b7d-ad5b-2f8066eac61c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e7371a01-ddcc-466c-bdbf-0929a265a589" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_26b523ff-e0a6-4b7d-ad5b-2f8066eac61c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_28bcf87a-a966-4346-9539-0baaef7cfe9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_26b523ff-e0a6-4b7d-ad5b-2f8066eac61c" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_28bcf87a-a966-4346-9539-0baaef7cfe9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_28bcf87a-a966-4346-9539-0baaef7cfe9f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_28bcf87a-a966-4346-9539-0baaef7cfe9f" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_28bcf87a-a966-4346-9539-0baaef7cfe9f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_2d681ef9-47e7-4cad-a7a4-f3dfffa7528e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_28bcf87a-a966-4346-9539-0baaef7cfe9f" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_2d681ef9-47e7-4cad-a7a4-f3dfffa7528e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_92085e14-ca78-4d95-ad03-8b27b4274665" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_2d681ef9-47e7-4cad-a7a4-f3dfffa7528e" xlink:to="loc_us-gaap_DomesticPlanMember_92085e14-ca78-4d95-ad03-8b27b4274665" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_dd7c110a-ba72-4496-98d8-eea860e9536a" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_92085e14-ca78-4d95-ad03-8b27b4274665" xlink:to="loc_country_US_dd7c110a-ba72-4496-98d8-eea860e9536a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_53f0b286-29d0-4768-b7f1-7e6b466c9794" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_2d681ef9-47e7-4cad-a7a4-f3dfffa7528e" xlink:to="loc_us-gaap_ForeignPlanMember_53f0b286-29d0-4768-b7f1-7e6b466c9794" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_ece965a3-4c7a-4e85-b23b-c5161a6a363c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_26b523ff-e0a6-4b7d-ad5b-2f8066eac61c" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_ece965a3-4c7a-4e85-b23b-c5161a6a363c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_ece965a3-4c7a-4e85-b23b-c5161a6a363c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_ece965a3-4c7a-4e85-b23b-c5161a6a363c" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_ece965a3-4c7a-4e85-b23b-c5161a6a363c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_e834b089-7e18-4f34-b2b9-55f677dda2c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_ece965a3-4c7a-4e85-b23b-c5161a6a363c" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_e834b089-7e18-4f34-b2b9-55f677dda2c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_ac43b593-ad54-4747-8e30-5b632f7ab975" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_e834b089-7e18-4f34-b2b9-55f677dda2c4" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_ac43b593-ad54-4747-8e30-5b632f7ab975" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_f56b52da-124c-4655-881f-4cdcd09659f8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_26b523ff-e0a6-4b7d-ad5b-2f8066eac61c" xlink:to="loc_srt_RestatementAxis_f56b52da-124c-4655-881f-4cdcd09659f8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_f56b52da-124c-4655-881f-4cdcd09659f8_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_f56b52da-124c-4655-881f-4cdcd09659f8" xlink:to="loc_srt_RestatementDomain_f56b52da-124c-4655-881f-4cdcd09659f8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_736dd8da-8a47-47ed-885f-b74107ce8ac7" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_f56b52da-124c-4655-881f-4cdcd09659f8" xlink:to="loc_srt_RestatementDomain_736dd8da-8a47-47ed-885f-b74107ce8ac7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_468587b6-5a82-4cf7-b22b-a3307909e4d6" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_736dd8da-8a47-47ed-885f-b74107ce8ac7" xlink:to="loc_srt_RestatementAdjustmentMember_468587b6-5a82-4cf7-b22b-a3307909e4d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_32ccc878-1442-4cb6-9274-46ff1d91c7f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e7371a01-ddcc-466c-bdbf-0929a265a589" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_32ccc878-1442-4cb6-9274-46ff1d91c7f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_718031d2-618d-4155-b8a5-1201a23c55a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e7371a01-ddcc-466c-bdbf-0929a265a589" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_718031d2-618d-4155-b8a5-1201a23c55a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_65efca0e-ce52-4223-ba8f-9c7c3542e934" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e7371a01-ddcc-466c-bdbf-0929a265a589" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_65efca0e-ce52-4223-ba8f-9c7c3542e934" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedBenefitPlanAmortizationAndDeferralsNet_7d7d67c5-746d-497d-9cdf-3ea2c768d10f" xlink:href="iff-20231231.xsd#iff_DefinedBenefitPlanAmortizationAndDeferralsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e7371a01-ddcc-466c-bdbf-0929a265a589" xlink:to="loc_iff_DefinedBenefitPlanAmortizationAndDeferralsNet_7d7d67c5-746d-497d-9cdf-3ea2c768d10f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_b1b43691-5ead-4862-8600-5a7c2782a8ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e7371a01-ddcc-466c-bdbf-0929a265a589" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_b1b43691-5ead-4862-8600-5a7c2782a8ff" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_6e648d0e-f4d8-4225-ac6a-e2addee4b900" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e7371a01-ddcc-466c-bdbf-0929a265a589" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_6e648d0e-f4d8-4225-ac6a-e2addee4b900" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedContributionAndOtherRetirementPlans_a00a8a23-e101-466b-974c-eaf08aa382cb" xlink:href="iff-20231231.xsd#iff_DefinedContributionAndOtherRetirementPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e7371a01-ddcc-466c-bdbf-0929a265a589" xlink:to="loc_iff_DefinedContributionAndOtherRetirementPlans_a00a8a23-e101-466b-974c-eaf08aa382cb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitExpense_bbedf437-3d43-405f-b848-9894d5cee5b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementBenefitExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e7371a01-ddcc-466c-bdbf-0929a265a589" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitExpense_bbedf437-3d43-405f-b848-9894d5cee5b7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax_2c77e0c3-254d-43b4-a555-61a907f65c94" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e7371a01-ddcc-466c-bdbf-0929a265a589" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax_2c77e0c3-254d-43b4-a555-61a907f65c94" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_11765eb6-44b9-40f5-91fd-1b7f6be30af0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e7371a01-ddcc-466c-bdbf-0929a265a589" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_11765eb6-44b9-40f5-91fd-1b7f6be30af0" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_5121d4e2-ad0f-4eba-ba3e-5ede36394803" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e7371a01-ddcc-466c-bdbf-0929a265a589" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_5121d4e2-ad0f-4eba-ba3e-5ede36394803" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax_cf3a30a1-01ad-4236-8526-2a145edae085" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e7371a01-ddcc-466c-bdbf-0929a265a589" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax_cf3a30a1-01ad-4236-8526-2a145edae085" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_8821ae4e-b9df-4808-b11a-b853f8dd1045" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e7371a01-ddcc-466c-bdbf-0929a265a589" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_8821ae4e-b9df-4808-b11a-b853f8dd1045" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_e287f5e4-f3a3-4691-91a9-2981e01fa57f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e7371a01-ddcc-466c-bdbf-0929a265a589" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_e287f5e4-f3a3-4691-91a9-2981e01fa57f" xlink:type="arc" order="13"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostandChangesinPlanAssetsandBenefitObligationsRecognizedinOCIDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#EmployeeBenefitsComponentsofNetPeriodicBenefitCostandChangesinPlanAssetsandBenefitObligationsRecognizedinOCIDetail"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostandChangesinPlanAssetsandBenefitObligationsRecognizedinOCIDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5e4a0c03-bed5-4b9c-ac31-d25c902434ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a8fad96d-ad58-4530-9970-8517abc04507" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5e4a0c03-bed5-4b9c-ac31-d25c902434ce" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a8fad96d-ad58-4530-9970-8517abc04507" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_05fe91a1-2e5e-46b6-8be6-04c945526e11" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a8fad96d-ad58-4530-9970-8517abc04507" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_05fe91a1-2e5e-46b6-8be6-04c945526e11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_05fe91a1-2e5e-46b6-8be6-04c945526e11_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_05fe91a1-2e5e-46b6-8be6-04c945526e11" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_05fe91a1-2e5e-46b6-8be6-04c945526e11_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_8bb0f110-7868-4e93-a678-bd6eb9f4e371" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_05fe91a1-2e5e-46b6-8be6-04c945526e11" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_8bb0f110-7868-4e93-a678-bd6eb9f4e371" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_8df86486-3964-4ee3-b691-2c87916ac1e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_8bb0f110-7868-4e93-a678-bd6eb9f4e371" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_8df86486-3964-4ee3-b691-2c87916ac1e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_ae9e7293-9ad6-4088-9e6b-839609b0b58c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5e4a0c03-bed5-4b9c-ac31-d25c902434ce" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_ae9e7293-9ad6-4088-9e6b-839609b0b58c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_141ba3e1-10e4-447a-bc1a-d9eaee18bfa4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5e4a0c03-bed5-4b9c-ac31-d25c902434ce" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_141ba3e1-10e4-447a-bc1a-d9eaee18bfa4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedBenefitPlanAmortizationAndDeferralsNet_91de4ff9-798a-42be-903a-9cd756899235" xlink:href="iff-20231231.xsd#iff_DefinedBenefitPlanAmortizationAndDeferralsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5e4a0c03-bed5-4b9c-ac31-d25c902434ce" xlink:to="loc_iff_DefinedBenefitPlanAmortizationAndDeferralsNet_91de4ff9-798a-42be-903a-9cd756899235" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_a321640f-5c5a-4c16-83fe-b1b5b0f13b78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5e4a0c03-bed5-4b9c-ac31-d25c902434ce" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_a321640f-5c5a-4c16-83fe-b1b5b0f13b78" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax_5af93cd3-a6c9-4c78-94ff-2f5245ac7d62" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5e4a0c03-bed5-4b9c-ac31-d25c902434ce" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax_5af93cd3-a6c9-4c78-94ff-2f5245ac7d62" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_653e8a15-bb18-49c9-babe-259aad75cb84" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5e4a0c03-bed5-4b9c-ac31-d25c902434ce" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_653e8a15-bb18-49c9-babe-259aad75cb84" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_0426ad25-86ae-40e4-8d8f-f95de186a5a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5e4a0c03-bed5-4b9c-ac31-d25c902434ce" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_0426ad25-86ae-40e4-8d8f-f95de186a5a5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_90b7c720-4b6d-4ac2-9672-fee4999e74b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5e4a0c03-bed5-4b9c-ac31-d25c902434ce" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_90b7c720-4b6d-4ac2-9672-fee4999e74b6" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/EmployeeBenefitsWeightedAverageActuarialAssumptionUsedtoDetermineExpenseDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#EmployeeBenefitsWeightedAverageActuarialAssumptionUsedtoDetermineExpenseDetail"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/EmployeeBenefitsWeightedAverageActuarialAssumptionUsedtoDetermineExpenseDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_385cd0e9-3f49-4964-94d2-1c65f634515b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_dfbdd8d5-8e67-4c16-86e9-5f9b24e5731b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_385cd0e9-3f49-4964-94d2-1c65f634515b" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_dfbdd8d5-8e67-4c16-86e9-5f9b24e5731b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_0f5de62a-2281-4f3e-9c1a-26e262e25619" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_dfbdd8d5-8e67-4c16-86e9-5f9b24e5731b" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_0f5de62a-2281-4f3e-9c1a-26e262e25619" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_0f5de62a-2281-4f3e-9c1a-26e262e25619_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_0f5de62a-2281-4f3e-9c1a-26e262e25619" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_0f5de62a-2281-4f3e-9c1a-26e262e25619_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_df6ea7dd-8e3b-4b6e-b2d3-3c81fd888130" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_0f5de62a-2281-4f3e-9c1a-26e262e25619" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_df6ea7dd-8e3b-4b6e-b2d3-3c81fd888130" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_9fd3e46a-cebe-4475-8740-393beaed53c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_df6ea7dd-8e3b-4b6e-b2d3-3c81fd888130" xlink:to="loc_us-gaap_DomesticPlanMember_9fd3e46a-cebe-4475-8740-393beaed53c9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_a07f035d-28bd-4b58-a726-d1ca3011ae38" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_9fd3e46a-cebe-4475-8740-393beaed53c9" xlink:to="loc_country_US_a07f035d-28bd-4b58-a726-d1ca3011ae38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_4c050aac-5e3c-454c-a86c-a892ddba88ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_df6ea7dd-8e3b-4b6e-b2d3-3c81fd888130" xlink:to="loc_us-gaap_ForeignPlanMember_4c050aac-5e3c-454c-a86c-a892ddba88ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_d7d28685-ed81-4b1c-ad8c-fd90141ddb24" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_dfbdd8d5-8e67-4c16-86e9-5f9b24e5731b" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_d7d28685-ed81-4b1c-ad8c-fd90141ddb24" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_d7d28685-ed81-4b1c-ad8c-fd90141ddb24_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_d7d28685-ed81-4b1c-ad8c-fd90141ddb24" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_d7d28685-ed81-4b1c-ad8c-fd90141ddb24_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_e4bdd72a-a0c2-409c-9b35-b299960492e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_d7d28685-ed81-4b1c-ad8c-fd90141ddb24" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_e4bdd72a-a0c2-409c-9b35-b299960492e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_b6cb90e7-90b2-461a-a7a3-2ee8316e8684" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_e4bdd72a-a0c2-409c-9b35-b299960492e3" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_b6cb90e7-90b2-461a-a7a3-2ee8316e8684" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_f581dea1-6000-4b0b-9d00-fe9a890d1fcc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_385cd0e9-3f49-4964-94d2-1c65f634515b" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_f581dea1-6000-4b0b-9d00-fe9a890d1fcc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_0a97a7c9-fd8c-4a1c-8f9b-8d82a2aca1ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_385cd0e9-3f49-4964-94d2-1c65f634515b" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_0a97a7c9-fd8c-4a1c-8f9b-8d82a2aca1ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_7803363f-a5e5-49c8-80f5-457e453a45b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_385cd0e9-3f49-4964-94d2-1c65f634515b" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_7803363f-a5e5-49c8-80f5-457e453a45b8" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_27e45024-c6d1-4b59-bcba-75328e7887e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_da27d602-9aac-474b-8f12-446ef917aa53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_27e45024-c6d1-4b59-bcba-75328e7887e6" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_da27d602-9aac-474b-8f12-446ef917aa53" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_570f450e-3881-4d5f-9030-077d2cd1d985" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_da27d602-9aac-474b-8f12-446ef917aa53" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_570f450e-3881-4d5f-9030-077d2cd1d985" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_570f450e-3881-4d5f-9030-077d2cd1d985_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_570f450e-3881-4d5f-9030-077d2cd1d985" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_570f450e-3881-4d5f-9030-077d2cd1d985_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_5cc035b8-4bae-47ee-b239-a54a656e9f31" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_570f450e-3881-4d5f-9030-077d2cd1d985" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_5cc035b8-4bae-47ee-b239-a54a656e9f31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_fa6300ca-e1b4-46c5-b963-61a93b52604a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_5cc035b8-4bae-47ee-b239-a54a656e9f31" xlink:to="loc_us-gaap_DomesticPlanMember_fa6300ca-e1b4-46c5-b963-61a93b52604a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_07fad338-c19e-4e4f-abf3-c2700e46189b" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_fa6300ca-e1b4-46c5-b963-61a93b52604a" xlink:to="loc_country_US_07fad338-c19e-4e4f-abf3-c2700e46189b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_a83006ae-0b6f-4b7b-8626-38ba57b1fa5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_5cc035b8-4bae-47ee-b239-a54a656e9f31" xlink:to="loc_us-gaap_ForeignPlanMember_a83006ae-0b6f-4b7b-8626-38ba57b1fa5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_9678d72f-fc73-4d73-b463-e539d5fefd91" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_da27d602-9aac-474b-8f12-446ef917aa53" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_9678d72f-fc73-4d73-b463-e539d5fefd91" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_9678d72f-fc73-4d73-b463-e539d5fefd91_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_9678d72f-fc73-4d73-b463-e539d5fefd91" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_9678d72f-fc73-4d73-b463-e539d5fefd91_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_f87c66b4-7c87-42eb-96a6-0b9c932d0174" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_9678d72f-fc73-4d73-b463-e539d5fefd91" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_f87c66b4-7c87-42eb-96a6-0b9c932d0174" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_9de6bf21-3556-4a5d-ab7c-054ceb38ad8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_f87c66b4-7c87-42eb-96a6-0b9c932d0174" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_9de6bf21-3556-4a5d-ab7c-054ceb38ad8d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_339f28de-6024-4ea1-b41f-7ffa968b0169" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_f87c66b4-7c87-42eb-96a6-0b9c932d0174" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_339f28de-6024-4ea1-b41f-7ffa968b0169" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_ec115617-c02a-4001-9bd9-dcc33d1546f1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_da27d602-9aac-474b-8f12-446ef917aa53" xlink:to="loc_srt_RestatementAxis_ec115617-c02a-4001-9bd9-dcc33d1546f1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_ec115617-c02a-4001-9bd9-dcc33d1546f1_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_ec115617-c02a-4001-9bd9-dcc33d1546f1" xlink:to="loc_srt_RestatementDomain_ec115617-c02a-4001-9bd9-dcc33d1546f1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_a0b0ed01-40d1-40e5-91ff-a515d6b21ee7" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_ec115617-c02a-4001-9bd9-dcc33d1546f1" xlink:to="loc_srt_RestatementDomain_a0b0ed01-40d1-40e5-91ff-a515d6b21ee7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_b666ac60-399a-4fb1-b875-231dd764fbf5" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_a0b0ed01-40d1-40e5-91ff-a515d6b21ee7" xlink:to="loc_srt_RestatementAdjustmentMember_b666ac60-399a-4fb1-b875-231dd764fbf5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_6e73f507-d8ae-4152-9224-ad738748b4dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_27e45024-c6d1-4b59-bcba-75328e7887e6" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_6e73f507-d8ae-4152-9224-ad738748b4dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_ba4fd693-770e-4437-a42b-d20c7853a212" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_6e73f507-d8ae-4152-9224-ad738748b4dc" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_ba4fd693-770e-4437-a42b-d20c7853a212" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_6ec366e0-8f87-4921-9567-54c224ae6ca1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_6e73f507-d8ae-4152-9224-ad738748b4dc" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_6ec366e0-8f87-4921-9567-54c224ae6ca1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_df91f3b7-4e05-4481-98e2-518573b1226e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_6e73f507-d8ae-4152-9224-ad738748b4dc" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_df91f3b7-4e05-4481-98e2-518573b1226e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_e7af6c7b-e2ef-4655-8fb0-3bea6d1526ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_6e73f507-d8ae-4152-9224-ad738748b4dc" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_e7af6c7b-e2ef-4655-8fb0-3bea6d1526ca" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAmendments_f6c8fab9-f82e-49fa-b9f0-0d723811c57f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPlanAmendments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_6e73f507-d8ae-4152-9224-ad738748b4dc" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAmendments_f6c8fab9-f82e-49fa-b9f0-0d723811c57f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedBenefitPlanAdjustmentsForExpenseOrTaxContainedInServiceCost_925b1fd7-0e61-45e6-9a6a-85bf72e6fb2b" xlink:href="iff-20231231.xsd#iff_DefinedBenefitPlanAdjustmentsForExpenseOrTaxContainedInServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_6e73f507-d8ae-4152-9224-ad738748b4dc" xlink:to="loc_iff_DefinedBenefitPlanAdjustmentsForExpenseOrTaxContainedInServiceCost_925b1fd7-0e61-45e6-9a6a-85bf72e6fb2b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_58c7dea9-66cd-474b-98ec-ea032cc473c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_6e73f507-d8ae-4152-9224-ad738748b4dc" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_58c7dea9-66cd-474b-98ec-ea032cc473c2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_700f1162-8bf1-4ac8-b8e4-0696e22be167" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_6e73f507-d8ae-4152-9224-ad738748b4dc" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_700f1162-8bf1-4ac8-b8e4-0696e22be167" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedBenefitPlanCurtailmentsAndSettlementsBenefitObligation_c504a6c9-51c1-4f05-ba27-da8c46b4cba8" xlink:href="iff-20231231.xsd#iff_DefinedBenefitPlanCurtailmentsAndSettlementsBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_6e73f507-d8ae-4152-9224-ad738748b4dc" xlink:to="loc_iff_DefinedBenefitPlanCurtailmentsAndSettlementsBenefitObligation_c504a6c9-51c1-4f05-ba27-da8c46b4cba8" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_ad9cf6e8-fa4e-4cba-91b7-5e48f8fa765c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_6e73f507-d8ae-4152-9224-ad738748b4dc" xlink:to="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_ad9cf6e8-fa4e-4cba-91b7-5e48f8fa765c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation_4a255194-5ad5-4213-9116-c67f7c6eb64a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_6e73f507-d8ae-4152-9224-ad738748b4dc" xlink:to="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation_4a255194-5ad5-4213-9116-c67f7c6eb64a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedBenefitPlanBenefitObligationOther_f038f2de-4471-4b0b-a369-63490137361c" xlink:href="iff-20231231.xsd#iff_DefinedBenefitPlanBenefitObligationOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_6e73f507-d8ae-4152-9224-ad738748b4dc" xlink:to="loc_iff_DefinedBenefitPlanBenefitObligationOther_f038f2de-4471-4b0b-a369-63490137361c" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_28b02179-4f80-41c0-8e08-e92a8240d091" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_0df6b19d-264a-489a-8be0-228954dac8a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_27e45024-c6d1-4b59-bcba-75328e7887e6" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_0df6b19d-264a-489a-8be0-228954dac8a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_dee9f017-cd3c-40a5-8056-d20645a32981" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_0df6b19d-264a-489a-8be0-228954dac8a9" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_dee9f017-cd3c-40a5-8056-d20645a32981" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_7a72b607-9a1e-4be4-895c-89a0c57895a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_0df6b19d-264a-489a-8be0-228954dac8a9" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_7a72b607-9a1e-4be4-895c-89a0c57895a7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_e5292611-f8be-4d9a-b915-fda22144a7d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_0df6b19d-264a-489a-8be0-228954dac8a9" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_e5292611-f8be-4d9a-b915-fda22144a7d8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_d5fb76d1-d280-43d2-a891-001acb13dd90" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_0df6b19d-264a-489a-8be0-228954dac8a9" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_d5fb76d1-d280-43d2-a891-001acb13dd90" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_39e11114-0659-49f3-b77c-baf952b212a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_0df6b19d-264a-489a-8be0-228954dac8a9" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_39e11114-0659-49f3-b77c-baf952b212a4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_cf2dd391-23be-40b8-9c0d-9200a63df781" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_0df6b19d-264a-489a-8be0-228954dac8a9" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_cf2dd391-23be-40b8-9c0d-9200a63df781" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_fd9e3c7f-9b2f-40c0-9a93-56bd56847f62" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_0df6b19d-264a-489a-8be0-228954dac8a9" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_fd9e3c7f-9b2f-40c0-9a93-56bd56847f62" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets_4c002bf9-6dce-4a5f-b713-69d5f405584e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_0df6b19d-264a-489a-8be0-228954dac8a9" xlink:to="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets_4c002bf9-6dce-4a5f-b713-69d5f405584e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedBenefitPlanPlanAssetsOther_96aaea65-f48d-469e-8ef9-a2aa66b3d2b2" xlink:href="iff-20231231.xsd#iff_DefinedBenefitPlanPlanAssetsOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_0df6b19d-264a-489a-8be0-228954dac8a9" xlink:to="loc_iff_DefinedBenefitPlanPlanAssetsOther_96aaea65-f48d-469e-8ef9-a2aa66b3d2b2" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_cfceb92e-ed22-4e1e-b25e-59547e41b089" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_5fa63072-f480-46ba-8dd0-e36eb168cfe2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_27e45024-c6d1-4b59-bcba-75328e7887e6" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_5fa63072-f480-46ba-8dd0-e36eb168cfe2" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinBalanceSheetDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#EmployeeBenefitsAmountsRecognizedinBalanceSheetDetail"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinBalanceSheetDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_65eac803-833c-41ff-9897-37389b76ced3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ec62d093-ce4d-44e9-88b3-63919f1d22d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_65eac803-833c-41ff-9897-37389b76ced3" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ec62d093-ce4d-44e9-88b3-63919f1d22d2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_345895df-7e67-4c2e-9968-d5b76f1db1c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ec62d093-ce4d-44e9-88b3-63919f1d22d2" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_345895df-7e67-4c2e-9968-d5b76f1db1c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_345895df-7e67-4c2e-9968-d5b76f1db1c2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_345895df-7e67-4c2e-9968-d5b76f1db1c2" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_345895df-7e67-4c2e-9968-d5b76f1db1c2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_2e31e464-0dbe-4b8a-8859-01174078b3c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_345895df-7e67-4c2e-9968-d5b76f1db1c2" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_2e31e464-0dbe-4b8a-8859-01174078b3c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_62a1616d-458f-4bc8-a051-cf3d28f3963a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_2e31e464-0dbe-4b8a-8859-01174078b3c9" xlink:to="loc_us-gaap_DomesticPlanMember_62a1616d-458f-4bc8-a051-cf3d28f3963a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_6a7c19dd-d601-41d1-96a6-9a854ba95deb" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_62a1616d-458f-4bc8-a051-cf3d28f3963a" xlink:to="loc_country_US_6a7c19dd-d601-41d1-96a6-9a854ba95deb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_4392f41c-9ec0-487e-8453-020e3fcd3371" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_2e31e464-0dbe-4b8a-8859-01174078b3c9" xlink:to="loc_us-gaap_ForeignPlanMember_4392f41c-9ec0-487e-8453-020e3fcd3371" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_88fb0fe9-4fa8-40cd-b1d7-82c330976749" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ec62d093-ce4d-44e9-88b3-63919f1d22d2" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_88fb0fe9-4fa8-40cd-b1d7-82c330976749" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_88fb0fe9-4fa8-40cd-b1d7-82c330976749_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_88fb0fe9-4fa8-40cd-b1d7-82c330976749" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_88fb0fe9-4fa8-40cd-b1d7-82c330976749_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_b14b257b-1711-4a8f-9db6-000ca7a9dd05" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_88fb0fe9-4fa8-40cd-b1d7-82c330976749" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_b14b257b-1711-4a8f-9db6-000ca7a9dd05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_7895b380-e4eb-4972-92aa-c31e196a09ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_b14b257b-1711-4a8f-9db6-000ca7a9dd05" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_7895b380-e4eb-4972-92aa-c31e196a09ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_8e617d34-2602-4405-968e-80c3624a7b28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_65eac803-833c-41ff-9897-37389b76ced3" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_8e617d34-2602-4405-968e-80c3624a7b28" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_1a000289-d727-4095-adca-b908a172f824" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_65eac803-833c-41ff-9897-37389b76ced3" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_1a000289-d727-4095-adca-b908a172f824" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_f4d30744-babb-469b-8326-2b2e48e71dd4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_65eac803-833c-41ff-9897-37389b76ced3" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_f4d30744-babb-469b-8326-2b2e48e71dd4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_58404385-1e1f-48ad-80f7-74a3e560ca2f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_65eac803-833c-41ff-9897-37389b76ced3" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_58404385-1e1f-48ad-80f7-74a3e560ca2f" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetail"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_894b22a4-8a14-43cc-bb7e-03a9874ff2b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_86960c21-4e71-471e-83dd-a62be533d30f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_894b22a4-8a14-43cc-bb7e-03a9874ff2b1" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_86960c21-4e71-471e-83dd-a62be533d30f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_3072d009-1b49-48a7-a7e5-cdae74b49fbe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_86960c21-4e71-471e-83dd-a62be533d30f" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_3072d009-1b49-48a7-a7e5-cdae74b49fbe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_3072d009-1b49-48a7-a7e5-cdae74b49fbe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_3072d009-1b49-48a7-a7e5-cdae74b49fbe" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_3072d009-1b49-48a7-a7e5-cdae74b49fbe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_d23dd8df-4be9-4f4e-8458-9e0b63afdd3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_3072d009-1b49-48a7-a7e5-cdae74b49fbe" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_d23dd8df-4be9-4f4e-8458-9e0b63afdd3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_4a149028-0e63-452e-b634-76284bfe60c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_d23dd8df-4be9-4f4e-8458-9e0b63afdd3b" xlink:to="loc_us-gaap_DomesticPlanMember_4a149028-0e63-452e-b634-76284bfe60c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_3cc90853-4def-4b10-b393-761a493227de" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_4a149028-0e63-452e-b634-76284bfe60c5" xlink:to="loc_country_US_3cc90853-4def-4b10-b393-761a493227de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_13da4726-f61a-42f0-9fb8-1dbd57676db1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_d23dd8df-4be9-4f4e-8458-9e0b63afdd3b" xlink:to="loc_us-gaap_ForeignPlanMember_13da4726-f61a-42f0-9fb8-1dbd57676db1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_f5fcd089-55ec-4bc9-8cf6-64fddc214249" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_86960c21-4e71-471e-83dd-a62be533d30f" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_f5fcd089-55ec-4bc9-8cf6-64fddc214249" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_f5fcd089-55ec-4bc9-8cf6-64fddc214249_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_f5fcd089-55ec-4bc9-8cf6-64fddc214249" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_f5fcd089-55ec-4bc9-8cf6-64fddc214249_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_1331a5e3-17e1-4271-a34d-56e5a086c550" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_f5fcd089-55ec-4bc9-8cf6-64fddc214249" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_1331a5e3-17e1-4271-a34d-56e5a086c550" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_03082c0e-1e14-47bb-bad7-67c32a2de825" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_1331a5e3-17e1-4271-a34d-56e5a086c550" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_03082c0e-1e14-47bb-bad7-67c32a2de825" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_a5a341fe-5c84-4f65-b0ed-0e1cb34e6c64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_1331a5e3-17e1-4271-a34d-56e5a086c550" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_a5a341fe-5c84-4f65-b0ed-0e1cb34e6c64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_20c70db0-5207-4a13-8f90-0338d34902a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_894b22a4-8a14-43cc-bb7e-03a9874ff2b1" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_20c70db0-5207-4a13-8f90-0338d34902a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_67dd32aa-aec0-46ba-8e60-7cb10b8d29c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_894b22a4-8a14-43cc-bb7e-03a9874ff2b1" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_67dd32aa-aec0-46ba-8e60-7cb10b8d29c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_3f456cfe-a03a-4294-bfe6-6282f558c487" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_894b22a4-8a14-43cc-bb7e-03a9874ff2b1" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_3f456cfe-a03a-4294-bfe6-6282f558c487" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/EmployeeBenefitsAccumulatedBenefitObligationDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#EmployeeBenefitsAccumulatedBenefitObligationDetail"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/EmployeeBenefitsAccumulatedBenefitObligationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_98337317-a02d-417d-bf1b-6abb99e72c86" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_afd66d65-e27e-435b-87cb-350d705a9407" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_98337317-a02d-417d-bf1b-6abb99e72c86" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_afd66d65-e27e-435b-87cb-350d705a9407" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_0378840a-0469-484d-9033-61e0f7a8b4a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_afd66d65-e27e-435b-87cb-350d705a9407" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_0378840a-0469-484d-9033-61e0f7a8b4a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_0378840a-0469-484d-9033-61e0f7a8b4a7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_0378840a-0469-484d-9033-61e0f7a8b4a7" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_0378840a-0469-484d-9033-61e0f7a8b4a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_6db5d747-ed74-41a9-a752-26a6ec14fdea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_0378840a-0469-484d-9033-61e0f7a8b4a7" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_6db5d747-ed74-41a9-a752-26a6ec14fdea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_20d2b065-75d8-4d76-9135-10031a5369f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_6db5d747-ed74-41a9-a752-26a6ec14fdea" xlink:to="loc_us-gaap_DomesticPlanMember_20d2b065-75d8-4d76-9135-10031a5369f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_989b8e0d-2e2b-4c48-860e-7f6d5139a59b" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_20d2b065-75d8-4d76-9135-10031a5369f8" xlink:to="loc_country_US_989b8e0d-2e2b-4c48-860e-7f6d5139a59b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_dfaa1fbe-2a35-4110-ac94-f9e4d834f319" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_6db5d747-ed74-41a9-a752-26a6ec14fdea" xlink:to="loc_us-gaap_ForeignPlanMember_dfaa1fbe-2a35-4110-ac94-f9e4d834f319" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_7082b8fd-bbc8-40a4-9968-8a8418c612f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_afd66d65-e27e-435b-87cb-350d705a9407" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_7082b8fd-bbc8-40a4-9968-8a8418c612f9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_7082b8fd-bbc8-40a4-9968-8a8418c612f9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_7082b8fd-bbc8-40a4-9968-8a8418c612f9" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_7082b8fd-bbc8-40a4-9968-8a8418c612f9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_de290e28-a0fe-4e6d-8384-ace9a67a3aeb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_7082b8fd-bbc8-40a4-9968-8a8418c612f9" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_de290e28-a0fe-4e6d-8384-ace9a67a3aeb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_2c2ec969-5ae5-49a7-bbb0-398884dc2c89" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_de290e28-a0fe-4e6d-8384-ace9a67a3aeb" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_2c2ec969-5ae5-49a7-bbb0-398884dc2c89" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_79878529-54f1-4380-a9a0-f66212193cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_98337317-a02d-417d-bf1b-6abb99e72c86" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_79878529-54f1-4380-a9a0-f66212193cd4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets_56601ccb-72cb-48d7-beb6-bf8e54aee11c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_98337317-a02d-417d-bf1b-6abb99e72c86" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets_56601ccb-72cb-48d7-beb6-bf8e54aee11c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_374850a8-d223-4980-9ca0-d76f68346d9b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_98337317-a02d-417d-bf1b-6abb99e72c86" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_374850a8-d223-4980-9ca0-d76f68346d9b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets_fb3afd1e-dc3c-418d-869a-f80fafcaba16" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_98337317-a02d-417d-bf1b-6abb99e72c86" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets_fb3afd1e-dc3c-418d-869a-f80fafcaba16" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation_95cfe76d-14b0-4279-a83b-2a120866ebd2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_98337317-a02d-417d-bf1b-6abb99e72c86" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation_95cfe76d-14b0-4279-a83b-2a120866ebd2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_ca9c8c1b-8f0b-4386-8592-4496913d9f33" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_98337317-a02d-417d-bf1b-6abb99e72c86" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_ca9c8c1b-8f0b-4386-8592-4496913d9f33" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_16fdb968-d450-49d9-9cd8-6c18a2f2a056" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_98337317-a02d-417d-bf1b-6abb99e72c86" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_16fdb968-d450-49d9-9cd8-6c18a2f2a056" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/EmployeeBenefitsEstimatedFutureBenefitPaymentsDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#EmployeeBenefitsEstimatedFutureBenefitPaymentsDetail"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/EmployeeBenefitsEstimatedFutureBenefitPaymentsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_8c7183e2-3d56-4f2e-8912-c79a76fc497d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f27ea069-c211-42db-83bd-79e2b33b36e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_8c7183e2-3d56-4f2e-8912-c79a76fc497d" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f27ea069-c211-42db-83bd-79e2b33b36e3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_009526f7-0beb-4174-865e-0f8fe9855c6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f27ea069-c211-42db-83bd-79e2b33b36e3" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_009526f7-0beb-4174-865e-0f8fe9855c6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_009526f7-0beb-4174-865e-0f8fe9855c6c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_009526f7-0beb-4174-865e-0f8fe9855c6c" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_009526f7-0beb-4174-865e-0f8fe9855c6c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_74e865b0-d529-4ffb-8b4e-ca3f0837e3e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_009526f7-0beb-4174-865e-0f8fe9855c6c" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_74e865b0-d529-4ffb-8b4e-ca3f0837e3e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_435801fe-501f-4eb7-96bc-6c9dde0263dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_74e865b0-d529-4ffb-8b4e-ca3f0837e3e5" xlink:to="loc_us-gaap_DomesticPlanMember_435801fe-501f-4eb7-96bc-6c9dde0263dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_b118c228-41f3-4534-8e22-ff6a8effd54e" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_435801fe-501f-4eb7-96bc-6c9dde0263dc" xlink:to="loc_country_US_b118c228-41f3-4534-8e22-ff6a8effd54e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_13793903-4e1a-423c-a943-5e9bf3af91e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_74e865b0-d529-4ffb-8b4e-ca3f0837e3e5" xlink:to="loc_us-gaap_ForeignPlanMember_13793903-4e1a-423c-a943-5e9bf3af91e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_08678804-867f-4ee9-8127-055bc30778ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f27ea069-c211-42db-83bd-79e2b33b36e3" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_08678804-867f-4ee9-8127-055bc30778ad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_08678804-867f-4ee9-8127-055bc30778ad_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_08678804-867f-4ee9-8127-055bc30778ad" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_08678804-867f-4ee9-8127-055bc30778ad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_f75ed2a3-da30-4879-9cb8-78de7c9d6a16" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_08678804-867f-4ee9-8127-055bc30778ad" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_f75ed2a3-da30-4879-9cb8-78de7c9d6a16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_674dd10b-c7d8-45f7-ab41-dc337c8cb39a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_f75ed2a3-da30-4879-9cb8-78de7c9d6a16" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_674dd10b-c7d8-45f7-ab41-dc337c8cb39a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_17492b87-f9ba-49a6-8e74-1d3fd0dcf543" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_f75ed2a3-da30-4879-9cb8-78de7c9d6a16" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_17492b87-f9ba-49a6-8e74-1d3fd0dcf543" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_6c81525a-7bc9-4c4c-ae7c-389d3eab9b56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_8c7183e2-3d56-4f2e-8912-c79a76fc497d" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_6c81525a-7bc9-4c4c-ae7c-389d3eab9b56" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_577451b1-3d73-4791-ba3c-003a7c8dca85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_8c7183e2-3d56-4f2e-8912-c79a76fc497d" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_577451b1-3d73-4791-ba3c-003a7c8dca85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_b8ad9829-4d61-4d01-b5d5-be3a20a9dd6e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_8c7183e2-3d56-4f2e-8912-c79a76fc497d" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_b8ad9829-4d61-4d01-b5d5-be3a20a9dd6e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_57a316af-0f0d-478a-a814-d9083c59cd01" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_8c7183e2-3d56-4f2e-8912-c79a76fc497d" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_57a316af-0f0d-478a-a814-d9083c59cd01" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_2c2c7cf7-b533-497e-9e19-74a34422eb58" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_8c7183e2-3d56-4f2e-8912-c79a76fc497d" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_2c2c7cf7-b533-497e-9e19-74a34422eb58" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_e5562190-2eb4-4990-9f65-04b5f45919bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_8c7183e2-3d56-4f2e-8912-c79a76fc497d" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_e5562190-2eb4-4990-9f65-04b5f45919bb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_d758a71d-9671-48e4-b97c-5206409835ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_8c7183e2-3d56-4f2e-8912-c79a76fc497d" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_d758a71d-9671-48e4-b97c-5206409835ad" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/EmployeeBenefitsPercentageofAssetsInvestedDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#EmployeeBenefitsPercentageofAssetsInvestedDetail"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/EmployeeBenefitsPercentageofAssetsInvestedDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0456572c-5087-48e0-84e9-fcb24808ae8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b58ebd73-de91-4074-b4d6-41d7786830da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0456572c-5087-48e0-84e9-fcb24808ae8c" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b58ebd73-de91-4074-b4d6-41d7786830da" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_75f4a062-26b7-451e-aec2-b99f6764da7d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b58ebd73-de91-4074-b4d6-41d7786830da" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_75f4a062-26b7-451e-aec2-b99f6764da7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_75f4a062-26b7-451e-aec2-b99f6764da7d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_75f4a062-26b7-451e-aec2-b99f6764da7d" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_75f4a062-26b7-451e-aec2-b99f6764da7d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_db812b7c-c7bb-4281-952f-1449cd47221b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_75f4a062-26b7-451e-aec2-b99f6764da7d" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_db812b7c-c7bb-4281-952f-1449cd47221b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_a220d08e-7fe9-4aef-825f-65c2a06b318c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_db812b7c-c7bb-4281-952f-1449cd47221b" xlink:to="loc_us-gaap_DomesticPlanMember_a220d08e-7fe9-4aef-825f-65c2a06b318c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_fdc8893c-7ad8-4d4b-adec-aa14cb626cbc" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_a220d08e-7fe9-4aef-825f-65c2a06b318c" xlink:to="loc_country_US_fdc8893c-7ad8-4d4b-adec-aa14cb626cbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_8597c08a-0d10-46ac-817b-874222375180" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_db812b7c-c7bb-4281-952f-1449cd47221b" xlink:to="loc_us-gaap_ForeignPlanMember_8597c08a-0d10-46ac-817b-874222375180" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_6a911b6d-e11d-4cd7-9ff4-044f27b2116b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b58ebd73-de91-4074-b4d6-41d7786830da" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_6a911b6d-e11d-4cd7-9ff4-044f27b2116b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_6a911b6d-e11d-4cd7-9ff4-044f27b2116b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_6a911b6d-e11d-4cd7-9ff4-044f27b2116b" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_6a911b6d-e11d-4cd7-9ff4-044f27b2116b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_d1deaf8b-10fd-496a-bb40-92c75d58e403" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_6a911b6d-e11d-4cd7-9ff4-044f27b2116b" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_d1deaf8b-10fd-496a-bb40-92c75d58e403" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_ef11ac04-db33-4153-9034-10fcba426a87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_d1deaf8b-10fd-496a-bb40-92c75d58e403" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_ef11ac04-db33-4153-9034-10fcba426a87" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_ae0f269f-f591-4c5f-8e89-978e99b5ee7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b58ebd73-de91-4074-b4d6-41d7786830da" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_ae0f269f-f591-4c5f-8e89-978e99b5ee7f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_ae0f269f-f591-4c5f-8e89-978e99b5ee7f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_ae0f269f-f591-4c5f-8e89-978e99b5ee7f" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_ae0f269f-f591-4c5f-8e89-978e99b5ee7f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_60a09e35-6a92-4d8f-a420-cecd3d87496e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_ae0f269f-f591-4c5f-8e89-978e99b5ee7f" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_60a09e35-6a92-4d8f-a420-cecd3d87496e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedBenefitPlanAssetsCategoryMember_28aa8234-75b5-4dcb-877f-098dc10028cf" xlink:href="iff-20231231.xsd#iff_DefinedBenefitPlanAssetsCategoryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_60a09e35-6a92-4d8f-a420-cecd3d87496e" xlink:to="loc_iff_DefinedBenefitPlanAssetsCategoryMember_28aa8234-75b5-4dcb-877f-098dc10028cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_7cef7183-acd6-4620-92e0-27fd72078c59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_28aa8234-75b5-4dcb-877f-098dc10028cf" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_7cef7183-acd6-4620-92e0-27fd72078c59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_683fe49d-b772-4ecc-b9be-d28f35a98904" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_28aa8234-75b5-4dcb-877f-098dc10028cf" xlink:to="loc_us-gaap_EquitySecuritiesMember_683fe49d-b772-4ecc-b9be-d28f35a98904" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_8ad16029-ecfe-48b4-88e5-d0c29c882c1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_28aa8234-75b5-4dcb-877f-098dc10028cf" xlink:to="loc_us-gaap_DebtSecuritiesMember_8ad16029-ecfe-48b4-88e5-d0c29c882c1d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateMember_4a17fc9c-0db4-4dc0-9169-2fe28215dfe5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealEstateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_28aa8234-75b5-4dcb-877f-098dc10028cf" xlink:to="loc_us-gaap_RealEstateMember_4a17fc9c-0db4-4dc0-9169-2fe28215dfe5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentCompaniesMember_bcf4a93f-f2bc-48f6-a1df-7bd4a1b2261a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInvestmentCompaniesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_28aa8234-75b5-4dcb-877f-098dc10028cf" xlink:to="loc_us-gaap_OtherInvestmentCompaniesMember_bcf4a93f-f2bc-48f6-a1df-7bd4a1b2261a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_63d0972b-314d-42cb-b326-bd8b0a3962fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0456572c-5087-48e0-84e9-fcb24808ae8c" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_63d0972b-314d-42cb-b326-bd8b0a3962fd" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c89406b8-d9c5-444d-a8e0-3e3ac359d18c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_cac3e5ff-9bbc-4478-8d89-0689e2da2b77" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c89406b8-d9c5-444d-a8e0-3e3ac359d18c" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_cac3e5ff-9bbc-4478-8d89-0689e2da2b77" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_bcc2b767-9b44-4ab4-af45-fe4b2ec902f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_cac3e5ff-9bbc-4478-8d89-0689e2da2b77" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_bcc2b767-9b44-4ab4-af45-fe4b2ec902f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_bcc2b767-9b44-4ab4-af45-fe4b2ec902f3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_bcc2b767-9b44-4ab4-af45-fe4b2ec902f3" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_bcc2b767-9b44-4ab4-af45-fe4b2ec902f3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_c4f716d1-30a5-4886-b52d-e3dfb15e8c96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_bcc2b767-9b44-4ab4-af45-fe4b2ec902f3" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_c4f716d1-30a5-4886-b52d-e3dfb15e8c96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_12fb0a8c-82aa-4ca6-b114-2f037dc01b19" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_c4f716d1-30a5-4886-b52d-e3dfb15e8c96" xlink:to="loc_us-gaap_DomesticPlanMember_12fb0a8c-82aa-4ca6-b114-2f037dc01b19" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_ef380f07-f56e-4103-bd7f-ebc0b2a8c22e" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_12fb0a8c-82aa-4ca6-b114-2f037dc01b19" xlink:to="loc_country_US_ef380f07-f56e-4103-bd7f-ebc0b2a8c22e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_5a8e01d1-06a7-4fe7-80da-9853341276b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_c4f716d1-30a5-4886-b52d-e3dfb15e8c96" xlink:to="loc_us-gaap_ForeignPlanMember_5a8e01d1-06a7-4fe7-80da-9853341276b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_0a2682f4-6949-4afd-953f-2d204c2e9be9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_cac3e5ff-9bbc-4478-8d89-0689e2da2b77" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_0a2682f4-6949-4afd-953f-2d204c2e9be9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_0a2682f4-6949-4afd-953f-2d204c2e9be9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_0a2682f4-6949-4afd-953f-2d204c2e9be9" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_0a2682f4-6949-4afd-953f-2d204c2e9be9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_ab476e27-efad-4f88-a6e3-19e1ef28229d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_0a2682f4-6949-4afd-953f-2d204c2e9be9" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_ab476e27-efad-4f88-a6e3-19e1ef28229d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_d32ede24-722d-43bc-91cd-932f30ffc3b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_ab476e27-efad-4f88-a6e3-19e1ef28229d" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_d32ede24-722d-43bc-91cd-932f30ffc3b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ae21a752-9e26-4a9b-8c0c-e54cc2552775" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_cac3e5ff-9bbc-4478-8d89-0689e2da2b77" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ae21a752-9e26-4a9b-8c0c-e54cc2552775" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ae21a752-9e26-4a9b-8c0c-e54cc2552775_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ae21a752-9e26-4a9b-8c0c-e54cc2552775" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ae21a752-9e26-4a9b-8c0c-e54cc2552775_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cefd89e6-da7a-417e-94c2-49ea4ba8f6d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ae21a752-9e26-4a9b-8c0c-e54cc2552775" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cefd89e6-da7a-417e-94c2-49ea4ba8f6d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel12And3Member_0c34e270-5473-4de9-87e0-d309ac590eaf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel12And3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cefd89e6-da7a-417e-94c2-49ea4ba8f6d4" xlink:to="loc_us-gaap_FairValueInputsLevel12And3Member_0c34e270-5473-4de9-87e0-d309ac590eaf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_30b33098-e69e-46f1-8b08-5f9a0ffa35f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueInputsLevel12And3Member_0c34e270-5473-4de9-87e0-d309ac590eaf" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_30b33098-e69e-46f1-8b08-5f9a0ffa35f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_9a8edf69-627e-4ee0-b62b-da4c67507ec6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueInputsLevel12And3Member_0c34e270-5473-4de9-87e0-d309ac590eaf" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_9a8edf69-627e-4ee0-b62b-da4c67507ec6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_d3d8cbcb-f830-44b7-a151-38a484a11f8b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueInputsLevel12And3Member_0c34e270-5473-4de9-87e0-d309ac590eaf" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_d3d8cbcb-f830-44b7-a151-38a484a11f8b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_a4cdcc36-cd13-449b-88e5-c94873e23d92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cefd89e6-da7a-417e-94c2-49ea4ba8f6d4" xlink:to="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_a4cdcc36-cd13-449b-88e5-c94873e23d92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_dd762f20-8ed5-4906-9257-9f3018cd6e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_cac3e5ff-9bbc-4478-8d89-0689e2da2b77" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_dd762f20-8ed5-4906-9257-9f3018cd6e5b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_dd762f20-8ed5-4906-9257-9f3018cd6e5b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_dd762f20-8ed5-4906-9257-9f3018cd6e5b" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_dd762f20-8ed5-4906-9257-9f3018cd6e5b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_ce8dd720-9170-4e9b-93d0-9293689bd8f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_dd762f20-8ed5-4906-9257-9f3018cd6e5b" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_ce8dd720-9170-4e9b-93d0-9293689bd8f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedBenefitPlanAssetsCategoryMember_4d50958b-e8fa-4190-bd7e-e36426fda693" xlink:href="iff-20231231.xsd#iff_DefinedBenefitPlanAssetsCategoryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_ce8dd720-9170-4e9b-93d0-9293689bd8f6" xlink:to="loc_iff_DefinedBenefitPlanAssetsCategoryMember_4d50958b-e8fa-4190-bd7e-e36426fda693" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FairValueOfPlanAssetsBeforeReceivablesMember_c268ab57-721a-47be-8b45-cc6eccb02601" xlink:href="iff-20231231.xsd#iff_FairValueOfPlanAssetsBeforeReceivablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_4d50958b-e8fa-4190-bd7e-e36426fda693" xlink:to="loc_iff_FairValueOfPlanAssetsBeforeReceivablesMember_c268ab57-721a-47be-8b45-cc6eccb02601" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_031200e9-f564-47eb-9cfb-34c77e9ce076" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_FairValueOfPlanAssetsBeforeReceivablesMember_c268ab57-721a-47be-8b45-cc6eccb02601" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_031200e9-f564-47eb-9cfb-34c77e9ce076" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_GovernmentAndGovernmentAgencyBondsMember_f43271bb-16c1-4369-822d-52d7a41c0cdc" xlink:href="iff-20231231.xsd#iff_GovernmentAndGovernmentAgencyBondsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_FairValueOfPlanAssetsBeforeReceivablesMember_c268ab57-721a-47be-8b45-cc6eccb02601" xlink:to="loc_iff_GovernmentAndGovernmentAgencyBondsMember_f43271bb-16c1-4369-822d-52d7a41c0cdc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_c7dd2562-ed1c-45e8-b5b6-f8ce44b4f30c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_FairValueOfPlanAssetsBeforeReceivablesMember_c268ab57-721a-47be-8b45-cc6eccb02601" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_c7dd2562-ed1c-45e8-b5b6-f8ce44b4f30c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_cea90925-a596-46b7-81d8-377067240647" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MunicipalBondsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_FairValueOfPlanAssetsBeforeReceivablesMember_c268ab57-721a-47be-8b45-cc6eccb02601" xlink:to="loc_us-gaap_MunicipalBondsMember_cea90925-a596-46b7-81d8-377067240647" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_PooledFundsMember_992004a3-fb10-4bd4-9d36-5a342b4f139f" xlink:href="iff-20231231.xsd#iff_PooledFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_FairValueOfPlanAssetsBeforeReceivablesMember_c268ab57-721a-47be-8b45-cc6eccb02601" xlink:to="loc_iff_PooledFundsMember_992004a3-fb10-4bd4-9d36-5a342b4f139f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ReceivablesMember_8c571ebb-9e51-4bdf-9d71-c808451dbdca" xlink:href="iff-20231231.xsd#iff_ReceivablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_4d50958b-e8fa-4190-bd7e-e36426fda693" xlink:to="loc_iff_ReceivablesMember_8c571ebb-9e51-4bdf-9d71-c808451dbdca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember_249b02d8-45ee-42a5-bba9-dc262eca3b83" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_4d50958b-e8fa-4190-bd7e-e36426fda693" xlink:to="loc_us-gaap_CashMember_249b02d8-45ee-42a5-bba9-dc262eca3b83" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember_03c60589-163a-48dc-9c21-eb71e236abe2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_4d50958b-e8fa-4190-bd7e-e36426fda693" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember_03c60589-163a-48dc-9c21-eb71e236abe2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMidCapMember_10566e6d-4fa9-4e49-b4ab-9d4e893ce195" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesUsMidCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_4d50958b-e8fa-4190-bd7e-e36426fda693" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMidCapMember_10566e6d-4fa9-4e49-b4ab-9d4e893ce195" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsSmallCapMember_d3ad708d-1dc3-44f4-9d24-aae5aff88634" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesUsSmallCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_4d50958b-e8fa-4190-bd7e-e36426fda693" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsSmallCapMember_d3ad708d-1dc3-44f4-9d24-aae5aff88634" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesLargeCapMember_5bada8fa-f558-4aa3-9e6b-f224216f534b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesLargeCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_4d50958b-e8fa-4190-bd7e-e36426fda693" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesLargeCapMember_5bada8fa-f558-4aa3-9e6b-f224216f534b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMidCapMember_b04d1982-42ac-4f9f-9526-bc70a8b8de45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMidCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_4d50958b-e8fa-4190-bd7e-e36426fda693" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMidCapMember_b04d1982-42ac-4f9f-9526-bc70a8b8de45" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesSmallCapMember_d62cd9ee-6a8d-47bf-83f1-d40922d30bc8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesSmallCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_4d50958b-e8fa-4190-bd7e-e36426fda693" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesSmallCapMember_d62cd9ee-6a8d-47bf-83f1-d40922d30bc8" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EmergingMarketsMember_581b4677-6a57-41b5-9c1e-3fad4c50b52d" xlink:href="iff-20231231.xsd#iff_EmergingMarketsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_4d50958b-e8fa-4190-bd7e-e36426fda693" xlink:to="loc_iff_EmergingMarketsMember_581b4677-6a57-41b5-9c1e-3fad4c50b52d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_USCorporateBondsMember_f3526f16-282c-40f9-8511-6b810b1b88bd" xlink:href="iff-20231231.xsd#iff_USCorporateBondsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_4d50958b-e8fa-4190-bd7e-e36426fda693" xlink:to="loc_iff_USCorporateBondsMember_f3526f16-282c-40f9-8511-6b810b1b88bd" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NonUSTreasuriesOrGovernmentBondsMember_25e75f1e-1242-428b-812b-f71df491db4a" xlink:href="iff-20231231.xsd#iff_NonUSTreasuriesOrGovernmentBondsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_4d50958b-e8fa-4190-bd7e-e36426fda693" xlink:to="loc_iff_NonUSTreasuriesOrGovernmentBondsMember_25e75f1e-1242-428b-812b-f71df491db4a" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NonUSCorporateBondsMember_2ce335a1-7ed2-4736-9353-99abba7b75c8" xlink:href="iff-20231231.xsd#iff_NonUSCorporateBondsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_4d50958b-e8fa-4190-bd7e-e36426fda693" xlink:to="loc_iff_NonUSCorporateBondsMember_2ce335a1-7ed2-4736-9353-99abba7b75c8" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NonUSAssetBackedSecuritiesMember_9b2f498d-fd4c-4117-a230-84faf146adac" xlink:href="iff-20231231.xsd#iff_NonUSAssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_4d50958b-e8fa-4190-bd7e-e36426fda693" xlink:to="loc_iff_NonUSAssetBackedSecuritiesMember_9b2f498d-fd4c-4117-a230-84faf146adac" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NonUSOtherFixedIncomeMember_ee5d8f08-1bc8-486c-87c9-47ecc3600e0e" xlink:href="iff-20231231.xsd#iff_NonUSOtherFixedIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_4d50958b-e8fa-4190-bd7e-e36426fda693" xlink:to="loc_iff_NonUSOtherFixedIncomeMember_ee5d8f08-1bc8-486c-87c9-47ecc3600e0e" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_InsuranceContractsMember_f88708a5-fd5e-45d4-b90e-fd26636eaa52" xlink:href="iff-20231231.xsd#iff_InsuranceContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_4d50958b-e8fa-4190-bd7e-e36426fda693" xlink:to="loc_iff_InsuranceContractsMember_f88708a5-fd5e-45d4-b90e-fd26636eaa52" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeMember_4a5f7bbd-3d9c-46df-85e6-9a96dd36dd26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_4d50958b-e8fa-4190-bd7e-e36426fda693" xlink:to="loc_us-gaap_DerivativeMember_4a5f7bbd-3d9c-46df-85e6-9a96dd36dd26" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AbsoluteReturnHedgeFundsMember_50eab2c1-7b7c-439c-9e65-c7969660fa9a" xlink:href="iff-20231231.xsd#iff_AbsoluteReturnHedgeFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_4d50958b-e8fa-4190-bd7e-e36426fda693" xlink:to="loc_iff_AbsoluteReturnHedgeFundsMember_50eab2c1-7b7c-439c-9e65-c7969660fa9a" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivateEquityFundsMember_8203b8a0-eb31-4ea1-a913-f8a24629e785" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrivateEquityFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_4d50958b-e8fa-4190-bd7e-e36426fda693" xlink:to="loc_us-gaap_PrivateEquityFundsMember_8203b8a0-eb31-4ea1-a913-f8a24629e785" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgeFundsMember_4a3cb18d-f5dd-4404-b4da-20fa64daaa1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgeFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_4d50958b-e8fa-4190-bd7e-e36426fda693" xlink:to="loc_us-gaap_HedgeFundsMember_4a3cb18d-f5dd-4404-b4da-20fa64daaa1d" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateMember_593b42cb-dbe9-4fe4-9830-54e082335a6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealEstateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_4d50958b-e8fa-4190-bd7e-e36426fda693" xlink:to="loc_us-gaap_RealEstateMember_593b42cb-dbe9-4fe4-9830-54e082335a6f" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeFundsMember_78efcf0e-09a7-419c-bfa4-7ca09f736356" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FixedIncomeFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_ce8dd720-9170-4e9b-93d0-9293689bd8f6" xlink:to="loc_us-gaap_FixedIncomeFundsMember_78efcf0e-09a7-419c-bfa4-7ca09f736356" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_ec23c42b-6dad-4f7d-ab07-a853900860ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c89406b8-d9c5-444d-a8e0-3e3ac359d18c" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_ec23c42b-6dad-4f7d-ab07-a853900860ac" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/EmployeeBenefitsReconciliationofLevel3NonUSPlanAssetsHeldDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#EmployeeBenefitsReconciliationofLevel3NonUSPlanAssetsHeldDetail"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/EmployeeBenefitsReconciliationofLevel3NonUSPlanAssetsHeldDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_66d41016-c534-4d85-ad20-6817afb7c1c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6ba278eb-650f-4011-9201-e16bc3ddf433" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_66d41016-c534-4d85-ad20-6817afb7c1c0" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6ba278eb-650f-4011-9201-e16bc3ddf433" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_075c1002-6c92-46ca-a514-fc261c98bd8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6ba278eb-650f-4011-9201-e16bc3ddf433" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_075c1002-6c92-46ca-a514-fc261c98bd8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_075c1002-6c92-46ca-a514-fc261c98bd8e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_075c1002-6c92-46ca-a514-fc261c98bd8e" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_075c1002-6c92-46ca-a514-fc261c98bd8e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_37144cf3-3004-44c2-9620-6872867110e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_075c1002-6c92-46ca-a514-fc261c98bd8e" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_37144cf3-3004-44c2-9620-6872867110e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_203cac15-de69-4edd-9a07-8211a05b4c42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_37144cf3-3004-44c2-9620-6872867110e3" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_203cac15-de69-4edd-9a07-8211a05b4c42" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_cd6ce91c-2e80-43e6-adc1-f1fb6bb4c8ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6ba278eb-650f-4011-9201-e16bc3ddf433" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_cd6ce91c-2e80-43e6-adc1-f1fb6bb4c8ef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cd6ce91c-2e80-43e6-adc1-f1fb6bb4c8ef_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_cd6ce91c-2e80-43e6-adc1-f1fb6bb4c8ef" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cd6ce91c-2e80-43e6-adc1-f1fb6bb4c8ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d9b80e65-44eb-41be-ba9e-d482c909a29c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_cd6ce91c-2e80-43e6-adc1-f1fb6bb4c8ef" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d9b80e65-44eb-41be-ba9e-d482c909a29c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel12And3Member_b1f2b77c-5431-48d4-94f1-bea00555d5b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel12And3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d9b80e65-44eb-41be-ba9e-d482c909a29c" xlink:to="loc_us-gaap_FairValueInputsLevel12And3Member_b1f2b77c-5431-48d4-94f1-bea00555d5b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_17df385a-0be5-4591-9cbf-75f62175f579" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueInputsLevel12And3Member_b1f2b77c-5431-48d4-94f1-bea00555d5b7" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_17df385a-0be5-4591-9cbf-75f62175f579" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_a01f8b70-7e48-4ab3-a6d0-dcfb0f7c5f67" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6ba278eb-650f-4011-9201-e16bc3ddf433" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_a01f8b70-7e48-4ab3-a6d0-dcfb0f7c5f67" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_a01f8b70-7e48-4ab3-a6d0-dcfb0f7c5f67_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_a01f8b70-7e48-4ab3-a6d0-dcfb0f7c5f67" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_a01f8b70-7e48-4ab3-a6d0-dcfb0f7c5f67_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_f2ab74dc-093e-4c72-8cf2-40c3c0b385b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_a01f8b70-7e48-4ab3-a6d0-dcfb0f7c5f67" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_f2ab74dc-093e-4c72-8cf2-40c3c0b385b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_69bf043f-2f47-4a8f-ab52-2e12f4416555" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_f2ab74dc-093e-4c72-8cf2-40c3c0b385b9" xlink:to="loc_us-gaap_ForeignPlanMember_69bf043f-2f47-4a8f-ab52-2e12f4416555" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_62766d82-27e5-4bcb-84a9-f06c2ea0720e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6ba278eb-650f-4011-9201-e16bc3ddf433" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_62766d82-27e5-4bcb-84a9-f06c2ea0720e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_62766d82-27e5-4bcb-84a9-f06c2ea0720e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_62766d82-27e5-4bcb-84a9-f06c2ea0720e" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_62766d82-27e5-4bcb-84a9-f06c2ea0720e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_8309f004-a79a-498c-b940-cfe6a3c8f9b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_62766d82-27e5-4bcb-84a9-f06c2ea0720e" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_8309f004-a79a-498c-b940-cfe6a3c8f9b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateMember_b8b2718d-3b34-4b58-8a47-16d9b76da3e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealEstateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_8309f004-a79a-498c-b940-cfe6a3c8f9b2" xlink:to="loc_us-gaap_RealEstateMember_b8b2718d-3b34-4b58-8a47-16d9b76da3e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgeFundsMember_f7af3240-4fdc-45b0-a3c6-25af59ac2ece" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgeFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_8309f004-a79a-498c-b940-cfe6a3c8f9b2" xlink:to="loc_us-gaap_HedgeFundsMember_f7af3240-4fdc-45b0-a3c6-25af59ac2ece" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7c398eec-1e47-4980-be8c-c52b7693d711" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_66d41016-c534-4d85-ad20-6817afb7c1c0" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7c398eec-1e47-4980-be8c-c52b7693d711" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_bc847698-9f78-40ee-9934-76910620c5a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7c398eec-1e47-4980-be8c-c52b7693d711" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_bc847698-9f78-40ee-9934-76910620c5a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld_14fba17d-01fe-4477-a55c-e4c9b50c9548" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7c398eec-1e47-4980-be8c-c52b7693d711" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld_14fba17d-01fe-4477-a55c-e4c9b50c9548" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements_2fc3a2e3-ef1d-4e8c-ad9e-7b3833e3f386" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7c398eec-1e47-4980-be8c-c52b7693d711" xlink:to="loc_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements_2fc3a2e3-ef1d-4e8c-ad9e-7b3833e3f386" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_83c246a8-be3e-4cc4-b1d5-f650e645d2b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/EmployeeBenefitsWeightedAverageAssumptionsUsedtoDeterminePostretirementBenefitExpenseandObligationDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#EmployeeBenefitsWeightedAverageAssumptionsUsedtoDeterminePostretirementBenefitExpenseandObligationDetail"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/EmployeeBenefitsWeightedAverageAssumptionsUsedtoDeterminePostretirementBenefitExpenseandObligationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f24fd08d-2efb-449c-9dc5-814bc636f872" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_1b9208f0-759b-4ebd-a665-935a5c24a2c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f24fd08d-2efb-449c-9dc5-814bc636f872" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_1b9208f0-759b-4ebd-a665-935a5c24a2c0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_049ad004-8662-447a-93e3-0dc29249a286" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_1b9208f0-759b-4ebd-a665-935a5c24a2c0" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_049ad004-8662-447a-93e3-0dc29249a286" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_049ad004-8662-447a-93e3-0dc29249a286_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_049ad004-8662-447a-93e3-0dc29249a286" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_049ad004-8662-447a-93e3-0dc29249a286_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_489c442d-c12a-47e5-896a-8a0cf13dbd6e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_049ad004-8662-447a-93e3-0dc29249a286" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_489c442d-c12a-47e5-896a-8a0cf13dbd6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ExpenseMember_735c8b83-d089-45d5-b75d-c720d85d5af3" xlink:href="iff-20231231.xsd#iff_ExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_489c442d-c12a-47e5-896a-8a0cf13dbd6e" xlink:to="loc_iff_ExpenseMember_735c8b83-d089-45d5-b75d-c720d85d5af3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_e94a9351-a7dc-4bad-abee-40e3b5d4f5e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_1b9208f0-759b-4ebd-a665-935a5c24a2c0" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_e94a9351-a7dc-4bad-abee-40e3b5d4f5e2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_e94a9351-a7dc-4bad-abee-40e3b5d4f5e2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_e94a9351-a7dc-4bad-abee-40e3b5d4f5e2" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_e94a9351-a7dc-4bad-abee-40e3b5d4f5e2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_3e78337a-ce4a-4fb7-a73a-6bc72404d7aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_e94a9351-a7dc-4bad-abee-40e3b5d4f5e2" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_3e78337a-ce4a-4fb7-a73a-6bc72404d7aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityMember_ad6637a5-6e7e-4ed8-935e-192ca9f47790" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3e78337a-ce4a-4fb7-a73a-6bc72404d7aa" xlink:to="loc_us-gaap_LiabilityMember_ad6637a5-6e7e-4ed8-935e-192ca9f47790" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_8b8a1778-bae1-4087-b7da-d99ccfa45269" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f24fd08d-2efb-449c-9dc5-814bc636f872" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_8b8a1778-bae1-4087-b7da-d99ccfa45269" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedBenefitPlanCurrentMedicalCareCostTrendRate_e5701fd1-244c-4c9d-b63d-a0a2fefa6367" xlink:href="iff-20231231.xsd#iff_DefinedBenefitPlanCurrentMedicalCareCostTrendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f24fd08d-2efb-449c-9dc5-814bc636f872" xlink:to="loc_iff_DefinedBenefitPlanCurrentMedicalCareCostTrendRate_e5701fd1-244c-4c9d-b63d-a0a2fefa6367" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1_cdabed67-0320-43ca-94bb-a16d8e984c4c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f24fd08d-2efb-449c-9dc5-814bc636f872" xlink:to="loc_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1_cdabed67-0320-43ca-94bb-a16d8e984c4c" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/EmployeeBenefitsSensitivityofDisclosurestoChangesinSelectedAssumptionsDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#EmployeeBenefitsSensitivityofDisclosurestoChangesinSelectedAssumptionsDetail"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/EmployeeBenefitsSensitivityofDisclosurestoChangesinSelectedAssumptionsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f407edf5-892c-47c3-be86-fcd743ec6213" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_07618b5d-fc0b-402a-9dbb-7777036c21b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f407edf5-892c-47c3-be86-fcd743ec6213" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_07618b5d-fc0b-402a-9dbb-7777036c21b4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_09375f00-e041-47e8-ba63-3cf2b0700759" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_07618b5d-fc0b-402a-9dbb-7777036c21b4" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_09375f00-e041-47e8-ba63-3cf2b0700759" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_09375f00-e041-47e8-ba63-3cf2b0700759_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_09375f00-e041-47e8-ba63-3cf2b0700759" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_09375f00-e041-47e8-ba63-3cf2b0700759_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_4c7212fa-9571-4bac-9942-1ba3905b8280" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_09375f00-e041-47e8-ba63-3cf2b0700759" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_4c7212fa-9571-4bac-9942-1ba3905b8280" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_64efedd1-e3b2-489e-b713-2bd7974e5340" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_4c7212fa-9571-4bac-9942-1ba3905b8280" xlink:to="loc_us-gaap_DomesticPlanMember_64efedd1-e3b2-489e-b713-2bd7974e5340" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_8fcaf107-ef01-484f-ae99-5f6ab514e558" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_64efedd1-e3b2-489e-b713-2bd7974e5340" xlink:to="loc_country_US_8fcaf107-ef01-484f-ae99-5f6ab514e558" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_3b04df3d-5d8f-4df2-95b9-02acb95b23f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_4c7212fa-9571-4bac-9942-1ba3905b8280" xlink:to="loc_us-gaap_ForeignPlanMember_3b04df3d-5d8f-4df2-95b9-02acb95b23f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_4452cd79-0b20-4e4d-9519-30e0ab61e633" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_07618b5d-fc0b-402a-9dbb-7777036c21b4" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_4452cd79-0b20-4e4d-9519-30e0ab61e633" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_4452cd79-0b20-4e4d-9519-30e0ab61e633_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_4452cd79-0b20-4e4d-9519-30e0ab61e633" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_4452cd79-0b20-4e4d-9519-30e0ab61e633_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_3a3d2ad4-98a7-4463-b370-05828d0db69d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_4452cd79-0b20-4e4d-9519-30e0ab61e633" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_3a3d2ad4-98a7-4463-b370-05828d0db69d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_b0410b9f-856c-416a-b513-68f62c55363e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_3a3d2ad4-98a7-4463-b370-05828d0db69d" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_b0410b9f-856c-416a-b513-68f62c55363e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_e34dbb0d-1a5d-445f-a5d4-0d4eb2c697c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_3a3d2ad4-98a7-4463-b370-05828d0db69d" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_e34dbb0d-1a5d-445f-a5d4-0d4eb2c697c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInProjectedBenefitObligation_17737b24-0920-451f-9160-1e2ac2d0ba79" xlink:href="iff-20231231.xsd#iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInProjectedBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f407edf5-892c-47c3-be86-fcd743ec6213" xlink:to="loc_iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInProjectedBenefitObligation_17737b24-0920-451f-9160-1e2ac2d0ba79" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInAccumulatedBenefitObligation_712a3109-6c49-4c6a-9b91-6965350562a7" xlink:href="iff-20231231.xsd#iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInAccumulatedBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f407edf5-892c-47c3-be86-fcd743ec6213" xlink:to="loc_iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInAccumulatedBenefitObligation_712a3109-6c49-4c6a-9b91-6965350562a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInPensionExpense_a609d688-9f53-41ee-933e-9b978de859bd" xlink:href="iff-20231231.xsd#iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInPensionExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f407edf5-892c-47c3-be86-fcd743ec6213" xlink:to="loc_iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInPensionExpense_a609d688-9f53-41ee-933e-9b978de859bd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInLongTermRateOfReturnInPensionExpense_64246e51-e2e9-4e6a-b377-3a0d8c9ad562" xlink:href="iff-20231231.xsd#iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInLongTermRateOfReturnInPensionExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f407edf5-892c-47c3-be86-fcd743ec6213" xlink:to="loc_iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInLongTermRateOfReturnInPensionExpense_64246e51-e2e9-4e6a-b377-3a0d8c9ad562" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/FinancialInstrumentsCarryingAmountandEstimatedFairValueofFinancialInstrumentsDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#FinancialInstrumentsCarryingAmountandEstimatedFairValueofFinancialInstrumentsDetail"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/FinancialInstrumentsCarryingAmountandEstimatedFairValueofFinancialInstrumentsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7aa769e7-0f19-4f3f-92d2-842e06a7b766" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d1c84d45-e654-4fae-b162-4fc9265f3136" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7aa769e7-0f19-4f3f-92d2-842e06a7b766" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d1c84d45-e654-4fae-b162-4fc9265f3136" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_36997da0-9cda-41e8-a35c-5730007e13ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d1c84d45-e654-4fae-b162-4fc9265f3136" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_36997da0-9cda-41e8-a35c-5730007e13ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_36997da0-9cda-41e8-a35c-5730007e13ef_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_36997da0-9cda-41e8-a35c-5730007e13ef" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_36997da0-9cda-41e8-a35c-5730007e13ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ee1112c3-47ff-4b4b-b07e-32320b4b8ec6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_36997da0-9cda-41e8-a35c-5730007e13ef" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ee1112c3-47ff-4b4b-b07e-32320b4b8ec6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandTwentyThreeMember_c55697af-7e7d-4c69-8a91-e908a1bfc43e" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandTwentyThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ee1112c3-47ff-4b4b-b07e-32320b4b8ec6" xlink:to="loc_iff_SeniorNotesDueTwoThousandTwentyThreeMember_c55697af-7e7d-4c69-8a91-e908a1bfc43e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember_338c6049-ee90-4c4e-8594-aa2e6e5fdb58" xlink:href="iff-20231231.xsd#iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ee1112c3-47ff-4b4b-b07e-32320b4b8ec6" xlink:to="loc_iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember_338c6049-ee90-4c4e-8594-aa2e6e5fdb58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember_71bd59d7-1669-4c4f-a5d9-52fc604c366b" xlink:href="iff-20231231.xsd#iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ee1112c3-47ff-4b4b-b07e-32320b4b8ec6" xlink:to="loc_iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember_71bd59d7-1669-4c4f-a5d9-52fc604c366b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandTwentyEightMember_ba0c9017-eaf9-4f77-9da8-c426fa7498e9" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandTwentyEightMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ee1112c3-47ff-4b4b-b07e-32320b4b8ec6" xlink:to="loc_iff_SeniorNotesDueTwoThousandTwentyEightMember_ba0c9017-eaf9-4f77-9da8-c426fa7498e9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandFortySevenMember_53c8f7a5-b7be-4eaf-a8b4-e87e1d174830" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandFortySevenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ee1112c3-47ff-4b4b-b07e-32320b4b8ec6" xlink:to="loc_iff_SeniorNotesDueTwoThousandFortySevenMember_53c8f7a5-b7be-4eaf-a8b4-e87e1d174830" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandFortyEightMember_efe768db-a39a-4d23-83f6-1d726802341c" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandFortyEightMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ee1112c3-47ff-4b4b-b07e-32320b4b8ec6" xlink:to="loc_iff_SeniorNotesDueTwoThousandFortyEightMember_efe768db-a39a-4d23-83f6-1d726802341c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TermLoanCreditAgreementMember_ed382fa9-cfe1-4643-b37b-d26577386b6e" xlink:href="iff-20231231.xsd#iff_TermLoanCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ee1112c3-47ff-4b4b-b07e-32320b4b8ec6" xlink:to="loc_iff_TermLoanCreditAgreementMember_ed382fa9-cfe1-4643-b37b-d26577386b6e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AmortizingNoteMember_5dae299c-0f19-4249-98f2-76eff4e2d05e" xlink:href="iff-20231231.xsd#iff_AmortizingNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ee1112c3-47ff-4b4b-b07e-32320b4b8ec6" xlink:to="loc_iff_AmortizingNoteMember_5dae299c-0f19-4249-98f2-76eff4e2d05e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandTwentyFiveMember_354d5680-d7b5-4c75-af66-55dfb474e109" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandTwentyFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ee1112c3-47ff-4b4b-b07e-32320b4b8ec6" xlink:to="loc_iff_SeniorNotesDueTwoThousandTwentyFiveMember_354d5680-d7b5-4c75-af66-55dfb474e109" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandTwentySevenMember_d832e830-85fe-4bd6-b26c-0a960339d291" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandTwentySevenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ee1112c3-47ff-4b4b-b07e-32320b4b8ec6" xlink:to="loc_iff_SeniorNotesDueTwoThousandTwentySevenMember_d832e830-85fe-4bd6-b26c-0a960339d291" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandThirtyMember_12c8d737-665b-497a-a087-e3ffe8e7ac9e" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandThirtyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ee1112c3-47ff-4b4b-b07e-32320b4b8ec6" xlink:to="loc_iff_SeniorNotesDueTwoThousandThirtyMember_12c8d737-665b-497a-a087-e3ffe8e7ac9e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandFortyMember_26856da0-c540-4de9-bbfa-70a649f64baa" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandFortyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ee1112c3-47ff-4b4b-b07e-32320b4b8ec6" xlink:to="loc_iff_SeniorNotesDueTwoThousandFortyMember_26856da0-c540-4de9-bbfa-70a649f64baa" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandFiftyMember_cbdbe92a-272c-4b43-87ef-bcc8da2643cb" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandFiftyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ee1112c3-47ff-4b4b-b07e-32320b4b8ec6" xlink:to="loc_iff_SeniorNotesDueTwoThousandFiftyMember_cbdbe92a-272c-4b43-87ef-bcc8da2643cb" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_A2024TermLoanMember_1a46652b-29cd-4449-afe8-d9036e5b05cc" xlink:href="iff-20231231.xsd#iff_A2024TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ee1112c3-47ff-4b4b-b07e-32320b4b8ec6" xlink:to="loc_iff_A2024TermLoanMember_1a46652b-29cd-4449-afe8-d9036e5b05cc" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_A2026TermLoanMember_c6a3e475-9605-4de2-90d6-0ec2f33ae200" xlink:href="iff-20231231.xsd#iff_A2026TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ee1112c3-47ff-4b4b-b07e-32320b4b8ec6" xlink:to="loc_iff_A2026TermLoanMember_c6a3e475-9605-4de2-90d6-0ec2f33ae200" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandTwentyTwoMember_af1735e7-42b3-4b9b-826b-ef9373273c23" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandTwentyTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ee1112c3-47ff-4b4b-b07e-32320b4b8ec6" xlink:to="loc_iff_SeniorNotesDueTwoThousandTwentyTwoMember_af1735e7-42b3-4b9b-826b-ef9373273c23" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_151209ce-b49b-4009-bf34-b13aa1acb24c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d1c84d45-e654-4fae-b162-4fc9265f3136" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_151209ce-b49b-4009-bf34-b13aa1acb24c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_151209ce-b49b-4009-bf34-b13aa1acb24c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_151209ce-b49b-4009-bf34-b13aa1acb24c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_151209ce-b49b-4009-bf34-b13aa1acb24c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_623ecc5b-40f3-4135-8f39-ab53175d8c6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_151209ce-b49b-4009-bf34-b13aa1acb24c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_623ecc5b-40f3-4135-8f39-ab53175d8c6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_52019e97-2d63-47a2-bfb6-aac2272604d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_623ecc5b-40f3-4135-8f39-ab53175d8c6c" xlink:to="loc_us-gaap_CurrencySwapMember_52019e97-2d63-47a2-bfb6-aac2272604d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_689e575c-7a90-4bcd-91af-bd64ebd9cb0b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d1c84d45-e654-4fae-b162-4fc9265f3136" xlink:to="loc_us-gaap_HedgingDesignationAxis_689e575c-7a90-4bcd-91af-bd64ebd9cb0b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_689e575c-7a90-4bcd-91af-bd64ebd9cb0b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_689e575c-7a90-4bcd-91af-bd64ebd9cb0b" xlink:to="loc_us-gaap_HedgingDesignationDomain_689e575c-7a90-4bcd-91af-bd64ebd9cb0b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_5f2d21ac-f4ec-4c9e-8250-cf8a49f34f00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_689e575c-7a90-4bcd-91af-bd64ebd9cb0b" xlink:to="loc_us-gaap_HedgingDesignationDomain_5f2d21ac-f4ec-4c9e-8250-cf8a49f34f00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_3cd7fe4b-150b-43f6-a076-6ed971007d23" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_5f2d21ac-f4ec-4c9e-8250-cf8a49f34f00" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_3cd7fe4b-150b-43f6-a076-6ed971007d23" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_263d1fe9-d88e-44a9-b4e8-d19cc661943e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d1c84d45-e654-4fae-b162-4fc9265f3136" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_263d1fe9-d88e-44a9-b4e8-d19cc661943e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_263d1fe9-d88e-44a9-b4e8-d19cc661943e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_263d1fe9-d88e-44a9-b4e8-d19cc661943e" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_263d1fe9-d88e-44a9-b4e8-d19cc661943e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_e22ce633-88b0-441a-9fec-9af962c16fd5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_263d1fe9-d88e-44a9-b4e8-d19cc661943e" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_e22ce633-88b0-441a-9fec-9af962c16fd5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_cadd0aee-8432-4d88-add9-4e1633d22871" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_e22ce633-88b0-441a-9fec-9af962c16fd5" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_cadd0aee-8432-4d88-add9-4e1633d22871" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_73845fc2-2bc0-4b11-bee0-d611b9f4c12f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_e22ce633-88b0-441a-9fec-9af962c16fd5" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_73845fc2-2bc0-4b11-bee0-d611b9f4c12f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_e9aa53ac-19a5-4f92-9dfa-1c8f5b83d8f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_e22ce633-88b0-441a-9fec-9af962c16fd5" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_e9aa53ac-19a5-4f92-9dfa-1c8f5b83d8f0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_bcb527a7-92a2-4d28-9eaa-939d2105fec6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7aa769e7-0f19-4f3f-92d2-842e06a7b766" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_bcb527a7-92a2-4d28-9eaa-939d2105fec6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableFairValueDisclosure_5cb9d8ac-a8a7-4b16-82e1-a306bbb15b80" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LoansPayableFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7aa769e7-0f19-4f3f-92d2-842e06a7b766" xlink:to="loc_us-gaap_LoansPayableFairValueDisclosure_5cb9d8ac-a8a7-4b16-82e1-a306bbb15b80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration_84def275-6d80-4bb5-823d-cf975e38471b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7aa769e7-0f19-4f3f-92d2-842e06a7b766" xlink:to="loc_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration_84def275-6d80-4bb5-823d-cf975e38471b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_85cae31b-2d9c-4ab6-92cb-d68392a9b1f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7aa769e7-0f19-4f3f-92d2-842e06a7b766" xlink:to="loc_us-gaap_DerivativeAssets_85cae31b-2d9c-4ab6-92cb-d68392a9b1f0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration_c63d75b6-8818-4ef9-aeb2-8071bd12707a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7aa769e7-0f19-4f3f-92d2-842e06a7b766" xlink:to="loc_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration_c63d75b6-8818-4ef9-aeb2-8071bd12707a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_95346ad1-305c-47db-be06-61864ef06b22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7aa769e7-0f19-4f3f-92d2-842e06a7b766" xlink:to="loc_us-gaap_DerivativeLiabilities_95346ad1-305c-47db-be06-61864ef06b22" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorLongTermNotes_9354d77f-de0f-4c15-9118-85ea2af7ce3e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorLongTermNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7aa769e7-0f19-4f3f-92d2-842e06a7b766" xlink:to="loc_us-gaap_SeniorLongTermNotes_9354d77f-de0f-4c15-9118-85ea2af7ce3e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper_1bf4839d-54aa-4652-892c-cfd9d0832a09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7aa769e7-0f19-4f3f-92d2-842e06a7b766" xlink:to="loc_us-gaap_CommercialPaper_1bf4839d-54aa-4652-892c-cfd9d0832a09" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesCurrent_cae67024-b504-404d-b9a1-0b9d6724ae52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7aa769e7-0f19-4f3f-92d2-842e06a7b766" xlink:to="loc_us-gaap_SeniorNotesCurrent_cae67024-b504-404d-b9a1-0b9d6724ae52" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromHedgeInvestingActivities_c7b4c01c-956f-485e-949c-2b0a4d5b824c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForProceedsFromHedgeInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7aa769e7-0f19-4f3f-92d2-842e06a7b766" xlink:to="loc_us-gaap_PaymentsForProceedsFromHedgeInvestingActivities_c7b4c01c-956f-485e-949c-2b0a4d5b824c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_6ff94f2d-23d0-443a-9455-1007b4aed547" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7aa769e7-0f19-4f3f-92d2-842e06a7b766" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_6ff94f2d-23d0-443a-9455-1007b4aed547" xlink:type="arc" order="10"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsNotionalAmountOutstandingDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#FinancialInstrumentsDerivativeInstrumentsNotionalAmountOutstandingDetail"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsNotionalAmountOutstandingDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_iff_ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsLineItems_ab39400d-4410-44ff-9fd9-8f740dce5943" xlink:href="iff-20231231.xsd#iff_ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsTable_3ee5f6d6-9c8f-4385-8116-4f5e5df8591e" xlink:href="iff-20231231.xsd#iff_ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_iff_ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsLineItems_ab39400d-4410-44ff-9fd9-8f740dce5943" xlink:to="loc_iff_ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsTable_3ee5f6d6-9c8f-4385-8116-4f5e5df8591e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8b16c043-ed97-415a-89ed-8a24932a921d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iff_ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsTable_3ee5f6d6-9c8f-4385-8116-4f5e5df8591e" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8b16c043-ed97-415a-89ed-8a24932a921d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8b16c043-ed97-415a-89ed-8a24932a921d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8b16c043-ed97-415a-89ed-8a24932a921d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8b16c043-ed97-415a-89ed-8a24932a921d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_d9579586-96c2-4811-8a64-4f35e37eed18" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8b16c043-ed97-415a-89ed-8a24932a921d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_d9579586-96c2-4811-8a64-4f35e37eed18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember_853cc371-3ea6-414d-896a-e841d4b90369" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForwardContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d9579586-96c2-4811-8a64-4f35e37eed18" xlink:to="loc_us-gaap_ForwardContractsMember_853cc371-3ea6-414d-896a-e841d4b90369" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_521a15f0-ff30-4dbf-9dd8-4dea277a0367" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d9579586-96c2-4811-8a64-4f35e37eed18" xlink:to="loc_us-gaap_CurrencySwapMember_521a15f0-ff30-4dbf-9dd8-4dea277a0367" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_cce0c558-5e3e-4083-b745-57ea20e2f854" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d9579586-96c2-4811-8a64-4f35e37eed18" xlink:to="loc_us-gaap_InterestRateSwapMember_cce0c558-5e3e-4083-b745-57ea20e2f854" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember_ff7f625a-f922-468e-ae60-2aa6fa94777c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommodityContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d9579586-96c2-4811-8a64-4f35e37eed18" xlink:to="loc_us-gaap_CommodityContractMember_ff7f625a-f922-468e-ae60-2aa6fa94777c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_f24c3c07-592a-499a-a1c9-4d81f8c9fc1c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iff_ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsTable_3ee5f6d6-9c8f-4385-8116-4f5e5df8591e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_f24c3c07-592a-499a-a1c9-4d81f8c9fc1c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_f24c3c07-592a-499a-a1c9-4d81f8c9fc1c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_f24c3c07-592a-499a-a1c9-4d81f8c9fc1c" xlink:to="loc_us-gaap_HedgingRelationshipDomain_f24c3c07-592a-499a-a1c9-4d81f8c9fc1c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_ff8ffa3b-37d1-4d81-9d3a-6a4a7155e3fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_f24c3c07-592a-499a-a1c9-4d81f8c9fc1c" xlink:to="loc_us-gaap_HedgingRelationshipDomain_ff8ffa3b-37d1-4d81-9d3a-6a4a7155e3fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_87659a47-47db-4e69-a921-ab1d80cf74f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_ff8ffa3b-37d1-4d81-9d3a-6a4a7155e3fb" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_87659a47-47db-4e69-a921-ab1d80cf74f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DerivativeNotionalAmountNet_91191406-5051-45ae-bdd5-1ba7298acdce" xlink:href="iff-20231231.xsd#iff_DerivativeNotionalAmountNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsLineItems_ab39400d-4410-44ff-9fd9-8f740dce5943" xlink:to="loc_iff_DerivativeNotionalAmountNet_91191406-5051-45ae-bdd5-1ba7298acdce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_534ea20c-13f1-4c88-8d4f-32527ccc7b6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsLineItems_ab39400d-4410-44ff-9fd9-8f740dce5943" xlink:to="loc_us-gaap_DerivativeNotionalAmount_534ea20c-13f1-4c88-8d4f-32527ccc7b6f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsMeasuredatFairValueDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#FinancialInstrumentsDerivativeInstrumentsMeasuredatFairValueDetail"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsMeasuredatFairValueDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_865073f5-6c57-443c-b8d3-d8f5be8f9e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_71256ed6-c10e-4a1a-83a9-844eb5da0df8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_865073f5-6c57-443c-b8d3-d8f5be8f9e5c" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_71256ed6-c10e-4a1a-83a9-844eb5da0df8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_48402b32-e841-4489-80f4-9c284b25150f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_71256ed6-c10e-4a1a-83a9-844eb5da0df8" xlink:to="loc_us-gaap_HedgingDesignationAxis_48402b32-e841-4489-80f4-9c284b25150f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_48402b32-e841-4489-80f4-9c284b25150f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_48402b32-e841-4489-80f4-9c284b25150f" xlink:to="loc_us-gaap_HedgingDesignationDomain_48402b32-e841-4489-80f4-9c284b25150f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_499b3b75-f1a6-481e-bc81-e594edf80e04" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_48402b32-e841-4489-80f4-9c284b25150f" xlink:to="loc_us-gaap_HedgingDesignationDomain_499b3b75-f1a6-481e-bc81-e594edf80e04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_fcbeb3c0-0c4e-4366-8565-4eb92bf9c4d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_499b3b75-f1a6-481e-bc81-e594edf80e04" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_fcbeb3c0-0c4e-4366-8565-4eb92bf9c4d7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_f6153a14-783b-4273-b474-7bd00f167047" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_499b3b75-f1a6-481e-bc81-e594edf80e04" xlink:to="loc_us-gaap_NondesignatedMember_f6153a14-783b-4273-b474-7bd00f167047" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_3bbace99-b381-4f6d-981d-6106af482f93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_71256ed6-c10e-4a1a-83a9-844eb5da0df8" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_3bbace99-b381-4f6d-981d-6106af482f93" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3bbace99-b381-4f6d-981d-6106af482f93_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3bbace99-b381-4f6d-981d-6106af482f93" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3bbace99-b381-4f6d-981d-6106af482f93_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_eaea2592-729e-427a-8d22-a602a839046f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3bbace99-b381-4f6d-981d-6106af482f93" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_eaea2592-729e-427a-8d22-a602a839046f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_67ca4279-dbca-4788-9632-cb2440b291c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_eaea2592-729e-427a-8d22-a602a839046f" xlink:to="loc_us-gaap_InterestRateSwapMember_67ca4279-dbca-4788-9632-cb2440b291c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_7106755a-5719-46d7-989f-3a86630bad53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_eaea2592-729e-427a-8d22-a602a839046f" xlink:to="loc_us-gaap_ForeignExchangeContractMember_7106755a-5719-46d7-989f-3a86630bad53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_020cfb52-2dc5-4288-ab9a-fe5d531ecd07" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_eaea2592-729e-427a-8d22-a602a839046f" xlink:to="loc_us-gaap_CurrencySwapMember_020cfb52-2dc5-4288-ab9a-fe5d531ecd07" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_833d0f90-3048-4f7d-a61b-007b7cc232a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_865073f5-6c57-443c-b8d3-d8f5be8f9e5c" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_833d0f90-3048-4f7d-a61b-007b7cc232a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_dc19edb6-a513-4959-9146-512dfceb91dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_865073f5-6c57-443c-b8d3-d8f5be8f9e5c" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_dc19edb6-a513-4959-9146-512dfceb91dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration_a9f0038d-7baf-462a-af97-f76d1b5dd092" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_865073f5-6c57-443c-b8d3-d8f5be8f9e5c" xlink:to="loc_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration_a9f0038d-7baf-462a-af97-f76d1b5dd092" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsWhichWereNotDesignatedasHedgingInstrumentsDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#FinancialInstrumentsDerivativeInstrumentsWhichWereNotDesignatedasHedgingInstrumentsDetail"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsWhichWereNotDesignatedasHedgingInstrumentsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e3baf406-76f8-4bc9-a45c-8e82e2bba2e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_d29ace01-5266-4aa2-b278-27be3f3cf782" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e3baf406-76f8-4bc9-a45c-8e82e2bba2e1" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_d29ace01-5266-4aa2-b278-27be3f3cf782" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnderlyingAssetClassAxis_81319eb4-7e36-4b01-9d00-6cb2e0704380" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnderlyingAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_d29ace01-5266-4aa2-b278-27be3f3cf782" xlink:to="loc_us-gaap_UnderlyingAssetClassAxis_81319eb4-7e36-4b01-9d00-6cb2e0704380" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnderlyingAssetClassDomain_81319eb4-7e36-4b01-9d00-6cb2e0704380_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnderlyingAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_UnderlyingAssetClassAxis_81319eb4-7e36-4b01-9d00-6cb2e0704380" xlink:to="loc_us-gaap_UnderlyingAssetClassDomain_81319eb4-7e36-4b01-9d00-6cb2e0704380_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnderlyingAssetClassDomain_7058565d-0683-4219-83b3-64740d181dcc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnderlyingAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_UnderlyingAssetClassAxis_81319eb4-7e36-4b01-9d00-6cb2e0704380" xlink:to="loc_us-gaap_UnderlyingAssetClassDomain_7058565d-0683-4219-83b3-64740d181dcc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DealContingentSwapsMember_95b411a6-bc99-4bf1-b947-e10b5ca9441b" xlink:href="iff-20231231.xsd#iff_DealContingentSwapsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnderlyingAssetClassDomain_7058565d-0683-4219-83b3-64740d181dcc" xlink:to="loc_iff_DealContingentSwapsMember_95b411a6-bc99-4bf1-b947-e10b5ca9441b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_354c5349-397f-4f38-9421-5ec8559810f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_d29ace01-5266-4aa2-b278-27be3f3cf782" xlink:to="loc_us-gaap_HedgingDesignationAxis_354c5349-397f-4f38-9421-5ec8559810f6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_354c5349-397f-4f38-9421-5ec8559810f6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_354c5349-397f-4f38-9421-5ec8559810f6" xlink:to="loc_us-gaap_HedgingDesignationDomain_354c5349-397f-4f38-9421-5ec8559810f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_2090bd68-af26-4df6-b92d-8c247122590a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_354c5349-397f-4f38-9421-5ec8559810f6" xlink:to="loc_us-gaap_HedgingDesignationDomain_2090bd68-af26-4df6-b92d-8c247122590a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_3238d6bb-15a2-44e2-a526-d995c2862547" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_2090bd68-af26-4df6-b92d-8c247122590a" xlink:to="loc_us-gaap_NondesignatedMember_3238d6bb-15a2-44e2-a526-d995c2862547" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_21606b82-c47e-46fd-8a03-ffc53107e139" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_d29ace01-5266-4aa2-b278-27be3f3cf782" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_21606b82-c47e-46fd-8a03-ffc53107e139" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_21606b82-c47e-46fd-8a03-ffc53107e139_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_21606b82-c47e-46fd-8a03-ffc53107e139" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_21606b82-c47e-46fd-8a03-ffc53107e139_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c7b02cc4-5e22-495a-b015-cbb1f8e28ef7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_21606b82-c47e-46fd-8a03-ffc53107e139" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c7b02cc4-5e22-495a-b015-cbb1f8e28ef7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ForeignCurrencyContractsMember_51dbd7df-1513-4e67-899b-8f9d18b6ef3d" xlink:href="iff-20231231.xsd#iff_ForeignCurrencyContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c7b02cc4-5e22-495a-b015-cbb1f8e28ef7" xlink:to="loc_iff_ForeignCurrencyContractsMember_51dbd7df-1513-4e67-899b-8f9d18b6ef3d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_1455a18c-0210-4d51-9925-add3638bc171" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c7b02cc4-5e22-495a-b015-cbb1f8e28ef7" xlink:to="loc_us-gaap_InterestRateSwapMember_1455a18c-0210-4d51-9925-add3638bc171" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_9195bec0-c57a-4415-bba1-f0a22bb48b54" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c7b02cc4-5e22-495a-b015-cbb1f8e28ef7" xlink:to="loc_us-gaap_ForeignExchangeContractMember_9195bec0-c57a-4415-bba1-f0a22bb48b54" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember_07444f88-7ba0-4795-b2ff-5110a69354ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommodityContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c7b02cc4-5e22-495a-b015-cbb1f8e28ef7" xlink:to="loc_us-gaap_CommodityContractMember_07444f88-7ba0-4795-b2ff-5110a69354ed" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_4dd60a70-ad73-4cd3-ab98-f96855ca23f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_d29ace01-5266-4aa2-b278-27be3f3cf782" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_4dd60a70-ad73-4cd3-ab98-f96855ca23f0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_4dd60a70-ad73-4cd3-ab98-f96855ca23f0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_4dd60a70-ad73-4cd3-ab98-f96855ca23f0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_4dd60a70-ad73-4cd3-ab98-f96855ca23f0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_dc68c0e9-5dd3-48f9-8c99-05300c582145" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_4dd60a70-ad73-4cd3-ab98-f96855ca23f0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_dc68c0e9-5dd3-48f9-8c99-05300c582145" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_0c4b009e-5447-49ef-9ea6-8aa4475caec8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_dc68c0e9-5dd3-48f9-8c99-05300c582145" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_0c4b009e-5447-49ef-9ea6-8aa4475caec8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_OtherIncomeExpenseNetMember_ecc180cb-2a81-4ede-9223-582cbce5a129" xlink:href="iff-20231231.xsd#iff_OtherIncomeExpenseNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_dc68c0e9-5dd3-48f9-8c99-05300c582145" xlink:to="loc_iff_OtherIncomeExpenseNetMember_ecc180cb-2a81-4ede-9223-582cbce5a129" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_98cf1d9c-9a07-4483-8bfb-56652d879a9c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_dc68c0e9-5dd3-48f9-8c99-05300c582145" xlink:to="loc_us-gaap_InterestExpenseMember_98cf1d9c-9a07-4483-8bfb-56652d879a9c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_64bb1b10-d585-4d96-a817-5f181b917e2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e3baf406-76f8-4bc9-a45c-8e82e2bba2e1" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_64bb1b10-d585-4d96-a817-5f181b917e2e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_7e8f6109-59f0-4750-a67f-0386b8e59e4f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e3baf406-76f8-4bc9-a45c-8e82e2bba2e1" xlink:to="loc_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_7e8f6109-59f0-4750-a67f-0386b8e59e4f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowandNetInvestmentHedgingInstrumentsDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#FinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowandNetInvestmentHedgingInstrumentsDetail"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowandNetInvestmentHedgingInstrumentsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_9db9e8c9-b995-4c0a-b803-6e734e25149a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_e3efeee7-5710-4092-89c9-a0722153a93f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_9db9e8c9-b995-4c0a-b803-6e734e25149a" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_e3efeee7-5710-4092-89c9-a0722153a93f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_921c2184-8c2b-4f9b-8cbe-c6b63b12d094" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_e3efeee7-5710-4092-89c9-a0722153a93f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_921c2184-8c2b-4f9b-8cbe-c6b63b12d094" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_921c2184-8c2b-4f9b-8cbe-c6b63b12d094_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_921c2184-8c2b-4f9b-8cbe-c6b63b12d094" xlink:to="loc_us-gaap_EquityComponentDomain_921c2184-8c2b-4f9b-8cbe-c6b63b12d094_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_657b594d-9931-4bfe-876e-cd715e48619f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_921c2184-8c2b-4f9b-8cbe-c6b63b12d094" xlink:to="loc_us-gaap_EquityComponentDomain_657b594d-9931-4bfe-876e-cd715e48619f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_e0c6049e-2562-47a4-ba63-0fd4a2073473" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_e3efeee7-5710-4092-89c9-a0722153a93f" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_e0c6049e-2562-47a4-ba63-0fd4a2073473" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e0c6049e-2562-47a4-ba63-0fd4a2073473_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e0c6049e-2562-47a4-ba63-0fd4a2073473" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e0c6049e-2562-47a4-ba63-0fd4a2073473_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_44757217-c69f-437d-8c6d-dc5551c4f863" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e0c6049e-2562-47a4-ba63-0fd4a2073473" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_44757217-c69f-437d-8c6d-dc5551c4f863" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember_e48fdec7-42d9-47ae-a1b8-5bbb35ba55ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForwardContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_44757217-c69f-437d-8c6d-dc5551c4f863" xlink:to="loc_us-gaap_ForwardContractsMember_e48fdec7-42d9-47ae-a1b8-5bbb35ba55ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_309b7d25-e71d-46de-b0ed-6b86a978b85e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_44757217-c69f-437d-8c6d-dc5551c4f863" xlink:to="loc_us-gaap_InterestRateSwapMember_309b7d25-e71d-46de-b0ed-6b86a978b85e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EuroSeniorNotes2016Member_aed18a51-5f33-4608-9173-adf97bc037d0" xlink:href="iff-20231231.xsd#iff_EuroSeniorNotes2016Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_44757217-c69f-437d-8c6d-dc5551c4f863" xlink:to="loc_iff_EuroSeniorNotes2016Member_aed18a51-5f33-4608-9173-adf97bc037d0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesEuroNotesMaturing2021And2026Member_65aace43-7575-46c0-af7e-22367a6c91cc" xlink:href="iff-20231231.xsd#iff_SeniorNotesEuroNotesMaturing2021And2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_44757217-c69f-437d-8c6d-dc5551c4f863" xlink:to="loc_iff_SeniorNotesEuroNotesMaturing2021And2026Member_65aace43-7575-46c0-af7e-22367a6c91cc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ForeignCurrencyContractsMember_bae5d325-a1f9-4a4a-bc73-d265e89d87b3" xlink:href="iff-20231231.xsd#iff_ForeignCurrencyContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_44757217-c69f-437d-8c6d-dc5551c4f863" xlink:to="loc_iff_ForeignCurrencyContractsMember_bae5d325-a1f9-4a4a-bc73-d265e89d87b3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember_07779429-6291-4351-9d3a-03559beee890" xlink:href="iff-20231231.xsd#iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_44757217-c69f-437d-8c6d-dc5551c4f863" xlink:to="loc_iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember_07779429-6291-4351-9d3a-03559beee890" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_CrossCurrencySwapsMember_b5ad12b3-332c-4ecd-9a79-135f8520dd9f" xlink:href="iff-20231231.xsd#iff_CrossCurrencySwapsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_44757217-c69f-437d-8c6d-dc5551c4f863" xlink:to="loc_iff_CrossCurrencySwapsMember_b5ad12b3-332c-4ecd-9a79-135f8520dd9f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_81b4a434-a144-48c0-b9f5-e3fbfdbc4224" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_44757217-c69f-437d-8c6d-dc5551c4f863" xlink:to="loc_us-gaap_ForeignExchangeContractMember_81b4a434-a144-48c0-b9f5-e3fbfdbc4224" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_2d5a817b-c30d-4ae6-93ca-9ddf1318fcc4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_44757217-c69f-437d-8c6d-dc5551c4f863" xlink:to="loc_us-gaap_CurrencySwapMember_2d5a817b-c30d-4ae6-93ca-9ddf1318fcc4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_6c2ff78a-f527-49b3-a9f4-d283e32f8762" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_e3efeee7-5710-4092-89c9-a0722153a93f" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_6c2ff78a-f527-49b3-a9f4-d283e32f8762" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_6c2ff78a-f527-49b3-a9f4-d283e32f8762_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_6c2ff78a-f527-49b3-a9f4-d283e32f8762" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_6c2ff78a-f527-49b3-a9f4-d283e32f8762_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_9bad2976-c64e-472a-8b61-0f712d07a111" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_6c2ff78a-f527-49b3-a9f4-d283e32f8762" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_9bad2976-c64e-472a-8b61-0f712d07a111" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_61cb1d5f-d1d4-47da-9f4d-df83c6c5445d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9bad2976-c64e-472a-8b61-0f712d07a111" xlink:to="loc_us-gaap_CostOfSalesMember_61cb1d5f-d1d4-47da-9f4d-df83c6c5445d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_b8a6ddf6-5965-45ea-a624-066de28b1a55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9bad2976-c64e-472a-8b61-0f712d07a111" xlink:to="loc_us-gaap_InterestExpenseMember_b8a6ddf6-5965-45ea-a624-066de28b1a55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_ae720ff6-c853-4ad9-a4a0-e0a07afb870b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_e3efeee7-5710-4092-89c9-a0722153a93f" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_ae720ff6-c853-4ad9-a4a0-e0a07afb870b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_ae720ff6-c853-4ad9-a4a0-e0a07afb870b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_ae720ff6-c853-4ad9-a4a0-e0a07afb870b" xlink:to="loc_us-gaap_HedgingRelationshipDomain_ae720ff6-c853-4ad9-a4a0-e0a07afb870b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_e024be14-ff18-45ff-bdd6-a46d6af8849f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_ae720ff6-c853-4ad9-a4a0-e0a07afb870b" xlink:to="loc_us-gaap_HedgingRelationshipDomain_e024be14-ff18-45ff-bdd6-a46d6af8849f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_6bce57e2-4cf9-49ed-95ae-2aa3e9d8f612" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_e024be14-ff18-45ff-bdd6-a46d6af8849f" xlink:to="loc_us-gaap_CashFlowHedgingMember_6bce57e2-4cf9-49ed-95ae-2aa3e9d8f612" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_7d930efc-4029-425f-a99f-d95d22a4386a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_e024be14-ff18-45ff-bdd6-a46d6af8849f" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_7d930efc-4029-425f-a99f-d95d22a4386a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_15100f95-e822-4cb2-ae02-5dbfaed77786" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_e3efeee7-5710-4092-89c9-a0722153a93f" xlink:to="loc_us-gaap_HedgingDesignationAxis_15100f95-e822-4cb2-ae02-5dbfaed77786" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_15100f95-e822-4cb2-ae02-5dbfaed77786_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_15100f95-e822-4cb2-ae02-5dbfaed77786" xlink:to="loc_us-gaap_HedgingDesignationDomain_15100f95-e822-4cb2-ae02-5dbfaed77786_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_466d42a8-39b6-4d4e-9328-c1d357208d8f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_15100f95-e822-4cb2-ae02-5dbfaed77786" xlink:to="loc_us-gaap_HedgingDesignationDomain_466d42a8-39b6-4d4e-9328-c1d357208d8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_933d92d9-141e-41f1-b64c-bcfcd2944ba7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_466d42a8-39b6-4d4e-9328-c1d357208d8f" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_933d92d9-141e-41f1-b64c-bcfcd2944ba7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_44ef4124-324d-41c5-b90e-b089525598be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_466d42a8-39b6-4d4e-9328-c1d357208d8f" xlink:to="loc_us-gaap_NondesignatedMember_44ef4124-324d-41c5-b90e-b089525598be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_1d5b1180-885b-4db7-81d2-9ecbd2c746cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_9db9e8c9-b995-4c0a-b803-6e734e25149a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_1d5b1180-885b-4db7-81d2-9ecbd2c746cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_56c8b4d7-dcb1-444e-87df-f4ee2b64974c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_9db9e8c9-b995-4c0a-b803-6e734e25149a" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_56c8b4d7-dcb1-444e-87df-f4ee2b64974c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_9c7e73c2-dda5-48e3-862f-baa63838210e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_9db9e8c9-b995-4c0a-b803-6e734e25149a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_9c7e73c2-dda5-48e3-862f-baa63838210e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_5b4c4c50-e6c0-47a8-8bda-15a3efa93eab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_9db9e8c9-b995-4c0a-b803-6e734e25149a" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_5b4c4c50-e6c0-47a8-8bda-15a3efa93eab" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_d5cef4b4-7051-48ef-bc81-046ed50a6a84" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_9db9e8c9-b995-4c0a-b803-6e734e25149a" xlink:to="loc_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_d5cef4b4-7051-48ef-bc81-046ed50a6a84" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/FinancialInstrumentsAdditionalInformationDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#FinancialInstrumentsAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/FinancialInstrumentsAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_0e612799-d9a6-4c02-8179-decb718a95a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_64a15c8a-8bc8-4b97-a208-3de78fa56d87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_0e612799-d9a6-4c02-8179-decb718a95a3" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_64a15c8a-8bc8-4b97-a208-3de78fa56d87" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_d6f3ab5b-6170-4002-934f-ea4b72c1c136" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_64a15c8a-8bc8-4b97-a208-3de78fa56d87" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_d6f3ab5b-6170-4002-934f-ea4b72c1c136" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d6f3ab5b-6170-4002-934f-ea4b72c1c136_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_d6f3ab5b-6170-4002-934f-ea4b72c1c136" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d6f3ab5b-6170-4002-934f-ea4b72c1c136_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_5d58afc8-9720-4bde-b6dd-dea54c598cc9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_d6f3ab5b-6170-4002-934f-ea4b72c1c136" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_5d58afc8-9720-4bde-b6dd-dea54c598cc9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_OtherIncomeExpenseNetMember_586b8822-42b2-4591-ab59-115fa692b517" xlink:href="iff-20231231.xsd#iff_OtherIncomeExpenseNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5d58afc8-9720-4bde-b6dd-dea54c598cc9" xlink:to="loc_iff_OtherIncomeExpenseNetMember_586b8822-42b2-4591-ab59-115fa692b517" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_d35e72e8-2c54-450b-8c45-13c5f0d8d34a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5d58afc8-9720-4bde-b6dd-dea54c598cc9" xlink:to="loc_us-gaap_InterestExpenseMember_d35e72e8-2c54-450b-8c45-13c5f0d8d34a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnderlyingAssetClassAxis_134ccda8-4866-46ab-b98c-f7fe0582cf12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnderlyingAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_64a15c8a-8bc8-4b97-a208-3de78fa56d87" xlink:to="loc_us-gaap_UnderlyingAssetClassAxis_134ccda8-4866-46ab-b98c-f7fe0582cf12" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnderlyingAssetClassDomain_134ccda8-4866-46ab-b98c-f7fe0582cf12_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnderlyingAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_UnderlyingAssetClassAxis_134ccda8-4866-46ab-b98c-f7fe0582cf12" xlink:to="loc_us-gaap_UnderlyingAssetClassDomain_134ccda8-4866-46ab-b98c-f7fe0582cf12_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnderlyingAssetClassDomain_0f73a53a-a833-4e0e-b385-2a6d5d795cb8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnderlyingAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_UnderlyingAssetClassAxis_134ccda8-4866-46ab-b98c-f7fe0582cf12" xlink:to="loc_us-gaap_UnderlyingAssetClassDomain_0f73a53a-a833-4e0e-b385-2a6d5d795cb8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DealContingentSwapsMember_60c82ccc-bd76-41bd-a67e-6e37fecbbdf6" xlink:href="iff-20231231.xsd#iff_DealContingentSwapsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnderlyingAssetClassDomain_0f73a53a-a833-4e0e-b385-2a6d5d795cb8" xlink:to="loc_iff_DealContingentSwapsMember_60c82ccc-bd76-41bd-a67e-6e37fecbbdf6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_d845b587-3de8-4784-80fb-f72aa95a2729" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_64a15c8a-8bc8-4b97-a208-3de78fa56d87" xlink:to="loc_us-gaap_HedgingDesignationAxis_d845b587-3de8-4784-80fb-f72aa95a2729" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_d845b587-3de8-4784-80fb-f72aa95a2729_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_d845b587-3de8-4784-80fb-f72aa95a2729" xlink:to="loc_us-gaap_HedgingDesignationDomain_d845b587-3de8-4784-80fb-f72aa95a2729_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_5902ec16-07de-40b8-830b-ffa0bf122d88" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_d845b587-3de8-4784-80fb-f72aa95a2729" xlink:to="loc_us-gaap_HedgingDesignationDomain_5902ec16-07de-40b8-830b-ffa0bf122d88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_9d5cd5d9-a7f3-4199-9af1-96332d8461e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_5902ec16-07de-40b8-830b-ffa0bf122d88" xlink:to="loc_us-gaap_NondesignatedMember_9d5cd5d9-a7f3-4199-9af1-96332d8461e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_927096ea-e44e-478b-912e-70384e627a89" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_5902ec16-07de-40b8-830b-ffa0bf122d88" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_927096ea-e44e-478b-912e-70384e627a89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_1c4124db-5a92-4c85-aa2b-60510206c2a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_64a15c8a-8bc8-4b97-a208-3de78fa56d87" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_1c4124db-5a92-4c85-aa2b-60510206c2a2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_1c4124db-5a92-4c85-aa2b-60510206c2a2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_1c4124db-5a92-4c85-aa2b-60510206c2a2" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_1c4124db-5a92-4c85-aa2b-60510206c2a2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f114b3ef-d846-4dfa-ac1c-e47ed40dcc41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_1c4124db-5a92-4c85-aa2b-60510206c2a2" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f114b3ef-d846-4dfa-ac1c-e47ed40dcc41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember_ef6750a5-313d-4b8c-ba8f-db82ea307942" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForwardContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f114b3ef-d846-4dfa-ac1c-e47ed40dcc41" xlink:to="loc_us-gaap_ForwardContractsMember_ef6750a5-313d-4b8c-ba8f-db82ea307942" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_c311b588-e5dd-4f2c-8415-7dc088caf435" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f114b3ef-d846-4dfa-ac1c-e47ed40dcc41" xlink:to="loc_us-gaap_CurrencySwapMember_c311b588-e5dd-4f2c-8415-7dc088caf435" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_5173dc22-719c-46bb-adef-e921ac30ba79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f114b3ef-d846-4dfa-ac1c-e47ed40dcc41" xlink:to="loc_us-gaap_InterestRateSwapMember_5173dc22-719c-46bb-adef-e921ac30ba79" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ForeignCurrencyContractAndInterestRateSwapMember_dd2c7972-ddae-409c-af3c-800603a20694" xlink:href="iff-20231231.xsd#iff_ForeignCurrencyContractAndInterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f114b3ef-d846-4dfa-ac1c-e47ed40dcc41" xlink:to="loc_iff_ForeignCurrencyContractAndInterestRateSwapMember_dd2c7972-ddae-409c-af3c-800603a20694" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ForeignCurrencyContractsMember_2416300b-62a3-41d3-8c09-7f8cd36f7deb" xlink:href="iff-20231231.xsd#iff_ForeignCurrencyContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f114b3ef-d846-4dfa-ac1c-e47ed40dcc41" xlink:to="loc_iff_ForeignCurrencyContractsMember_2416300b-62a3-41d3-8c09-7f8cd36f7deb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_A2019And2022CrossCurrencySwapsMember_61bebbf6-9c02-4f48-9001-2c6b61c9381c" xlink:href="iff-20231231.xsd#iff_A2019And2022CrossCurrencySwapsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f114b3ef-d846-4dfa-ac1c-e47ed40dcc41" xlink:to="loc_iff_A2019And2022CrossCurrencySwapsMember_61bebbf6-9c02-4f48-9001-2c6b61c9381c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_A2022CrossCurrencySwapsMember_11fb446f-3d73-4ca2-b935-4890a56ad0f7" xlink:href="iff-20231231.xsd#iff_A2022CrossCurrencySwapsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f114b3ef-d846-4dfa-ac1c-e47ed40dcc41" xlink:to="loc_iff_A2022CrossCurrencySwapsMember_11fb446f-3d73-4ca2-b935-4890a56ad0f7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d05e4461-1896-4701-a393-8c2869308016" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_64a15c8a-8bc8-4b97-a208-3de78fa56d87" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d05e4461-1896-4701-a393-8c2869308016" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_d05e4461-1896-4701-a393-8c2869308016_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d05e4461-1896-4701-a393-8c2869308016" xlink:to="loc_us-gaap_HedgingRelationshipDomain_d05e4461-1896-4701-a393-8c2869308016_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_3c662577-ba8f-4d6a-aad7-5fc7e8f1e786" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d05e4461-1896-4701-a393-8c2869308016" xlink:to="loc_us-gaap_HedgingRelationshipDomain_3c662577-ba8f-4d6a-aad7-5fc7e8f1e786" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_6c1d4222-8784-438a-ab40-af4631077e3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_3c662577-ba8f-4d6a-aad7-5fc7e8f1e786" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_6c1d4222-8784-438a-ab40-af4631077e3f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_40e169a2-1efe-41b8-b293-45ee1dd0667b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_0e612799-d9a6-4c02-8179-decb718a95a3" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_40e169a2-1efe-41b8-b293-45ee1dd0667b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DeferredGainLossOnTerminatedInterestRateContracts_3d2e29a5-37c0-4380-803b-64fbe3beebc2" xlink:href="iff-20231231.xsd#iff_DeferredGainLossOnTerminatedInterestRateContracts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_0e612799-d9a6-4c02-8179-decb718a95a3" xlink:to="loc_iff_DeferredGainLossOnTerminatedInterestRateContracts_3d2e29a5-37c0-4380-803b-64fbe3beebc2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfDerivatives_061ae71d-7aac-42b6-9a1d-cbce61f86c1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfDerivatives"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_0e612799-d9a6-4c02-8179-decb718a95a3" xlink:to="loc_us-gaap_GainLossOnSaleOfDerivatives_061ae71d-7aac-42b6-9a1d-cbce61f86c1b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld_1e4fd31d-3d72-4f0d-9bf6-9174aed37b58" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_0e612799-d9a6-4c02-8179-decb718a95a3" xlink:to="loc_us-gaap_NumberOfInterestRateDerivativesHeld_1e4fd31d-3d72-4f0d-9bf6-9174aed37b58" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_196ff3ca-6578-4e0b-9f19-8a020a4240ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_0e612799-d9a6-4c02-8179-decb718a95a3" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_196ff3ca-6578-4e0b-9f19-8a020a4240ad" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_db0ca283-1c18-4996-a14d-6bf20ac622d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_0e612799-d9a6-4c02-8179-decb718a95a3" xlink:to="loc_us-gaap_DerivativeNotionalAmount_db0ca283-1c18-4996-a14d-6bf20ac622d9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_2b988462-e708-4ffa-91d4-09568ed43661" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_0e612799-d9a6-4c02-8179-decb718a95a3" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_2b988462-e708-4ffa-91d4-09568ed43661" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_35726c36-3430-4810-9b34-0eaf85683f03" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_0e612799-d9a6-4c02-8179-decb718a95a3" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_35726c36-3430-4810-9b34-0eaf85683f03" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfForeignCurrencyDerivativesHeld_1e4c4b07-2a3e-419e-86d8-7917aca8ee11" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfForeignCurrencyDerivativesHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_0e612799-d9a6-4c02-8179-decb718a95a3" xlink:to="loc_us-gaap_NumberOfForeignCurrencyDerivativesHeld_1e4c4b07-2a3e-419e-86d8-7917aca8ee11" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities_da426d50-142b-4788-a69b-de11f2d2f939" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_0e612799-d9a6-4c02-8179-decb718a95a3" xlink:to="loc_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities_da426d50-142b-4788-a69b-de11f2d2f939" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromHedgeInvestingActivities_02d2023f-c554-4022-a8aa-6f55287d8963" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForProceedsFromHedgeInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_0e612799-d9a6-4c02-8179-decb718a95a3" xlink:to="loc_us-gaap_PaymentsForProceedsFromHedgeInvestingActivities_02d2023f-c554-4022-a8aa-6f55287d8963" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivable_73835796-77ba-4c50-a778-38b551b0c699" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_0e612799-d9a6-4c02-8179-decb718a95a3" xlink:to="loc_us-gaap_InterestReceivable_73835796-77ba-4c50-a778-38b551b0c699" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_eba27dd1-c98c-4cbf-89db-f81388217dda" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_0e612799-d9a6-4c02-8179-decb718a95a3" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_eba27dd1-c98c-4cbf-89db-f81388217dda" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_656a615f-31a0-4d7b-9d2e-949089e09a32" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_0e612799-d9a6-4c02-8179-decb718a95a3" xlink:to="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_656a615f-31a0-4d7b-9d2e-949089e09a32" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNetHedgeIneffectivenessGainLoss_6cf8cfcb-f934-4781-a946-8a2bd812a499" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeNetHedgeIneffectivenessGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_0e612799-d9a6-4c02-8179-decb718a95a3" xlink:to="loc_us-gaap_DerivativeNetHedgeIneffectivenessGainLoss_6cf8cfcb-f934-4781-a946-8a2bd812a499" xlink:type="arc" order="14"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#AccumulatedOtherComprehensiveIncomeLossScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossDetail"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_2de21060-4fbd-465d-9fe3-ad0d2ccf3ee6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e23865f8-2772-47c7-9d0f-822c0cf8d0f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_2de21060-4fbd-465d-9fe3-ad0d2ccf3ee6" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e23865f8-2772-47c7-9d0f-822c0cf8d0f7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_5ecf1c70-38ac-485c-85f5-664be486547d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e23865f8-2772-47c7-9d0f-822c0cf8d0f7" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_5ecf1c70-38ac-485c-85f5-664be486547d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5ecf1c70-38ac-485c-85f5-664be486547d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5ecf1c70-38ac-485c-85f5-664be486547d" xlink:to="loc_us-gaap_EquityComponentDomain_5ecf1c70-38ac-485c-85f5-664be486547d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_722683fa-d9fc-490e-b2a6-6d02ea578627" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5ecf1c70-38ac-485c-85f5-664be486547d" xlink:to="loc_us-gaap_EquityComponentDomain_722683fa-d9fc-490e-b2a6-6d02ea578627" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_31e268b7-3931-4472-b5d4-d6f39696fef2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_722683fa-d9fc-490e-b2a6-6d02ea578627" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_31e268b7-3931-4472-b5d4-d6f39696fef2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_3006b085-9a23-4149-b553-52e3c5f3c833" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_722683fa-d9fc-490e-b2a6-6d02ea578627" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_3006b085-9a23-4149-b553-52e3c5f3c833" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_a7c3b733-f683-4587-848e-e173e9580658" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_722683fa-d9fc-490e-b2a6-6d02ea578627" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_a7c3b733-f683-4587-848e-e173e9580658" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_196ecac6-e39f-413e-8fb8-e0dc05f28496" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_722683fa-d9fc-490e-b2a6-6d02ea578627" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_196ecac6-e39f-413e-8fb8-e0dc05f28496" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_13b94be1-dbf3-4709-8964-47b0944a4647" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_2de21060-4fbd-465d-9fe3-ad0d2ccf3ee6" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_13b94be1-dbf3-4709-8964-47b0944a4647" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1a6779cb-c861-4b53-b5b5-fe2543f27340" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_13b94be1-dbf3-4709-8964-47b0944a4647" xlink:to="loc_us-gaap_StockholdersEquity_1a6779cb-c861-4b53-b5b5-fe2543f27340" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_8dd81f31-db13-40e7-a3ea-de57f382807c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_13b94be1-dbf3-4709-8964-47b0944a4647" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_8dd81f31-db13-40e7-a3ea-de57f382807c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_73937ece-7e05-4af9-9409-7833fc177c36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_13b94be1-dbf3-4709-8964-47b0944a4647" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_73937ece-7e05-4af9-9409-7833fc177c36" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_0ace1428-f3c2-4c12-a1be-a24f0a2280dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_13b94be1-dbf3-4709-8964-47b0944a4647" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_0ace1428-f3c2-4c12-a1be-a24f0a2280dc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_21916b48-c07a-45c9-977d-a9bac08b5191" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIDueToBusinessDivestitures_e3b0f6fd-c4e8-46aa-a1e9-3e0dc4357e2f" xlink:href="iff-20231231.xsd#iff_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIDueToBusinessDivestitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_2de21060-4fbd-465d-9fe3-ad0d2ccf3ee6" xlink:to="loc_iff_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIDueToBusinessDivestitures_e3b0f6fd-c4e8-46aa-a1e9-3e0dc4357e2f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossReclassificationsofAccumulatedOtherComprehensiveIncometoConsolidatedStatementofComprehensiveIncomeDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#AccumulatedOtherComprehensiveIncomeLossReclassificationsofAccumulatedOtherComprehensiveIncometoConsolidatedStatementofComprehensiveIncomeDetail"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossReclassificationsofAccumulatedOtherComprehensiveIncometoConsolidatedStatementofComprehensiveIncomeDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_a25c63e0-9422-4b61-b932-ff4c682e8fe7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_2a469cea-2dd2-4428-b3e4-842b2f8b6587" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_a25c63e0-9422-4b61-b932-ff4c682e8fe7" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_2a469cea-2dd2-4428-b3e4-842b2f8b6587" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_db02281c-27de-41d5-a527-cd5c54a3be95" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_2a469cea-2dd2-4428-b3e4-842b2f8b6587" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_db02281c-27de-41d5-a527-cd5c54a3be95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_db02281c-27de-41d5-a527-cd5c54a3be95_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_db02281c-27de-41d5-a527-cd5c54a3be95" xlink:to="loc_us-gaap_EquityComponentDomain_db02281c-27de-41d5-a527-cd5c54a3be95_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ac563f2e-e97f-457a-9d62-05815c8f62a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_db02281c-27de-41d5-a527-cd5c54a3be95" xlink:to="loc_us-gaap_EquityComponentDomain_ac563f2e-e97f-457a-9d62-05815c8f62a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_93332961-9569-4468-8365-e8a17077131d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ac563f2e-e97f-457a-9d62-05815c8f62a4" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_93332961-9569-4468-8365-e8a17077131d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_b74d95f9-1216-4f9b-8f71-6572f6e75801" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ac563f2e-e97f-457a-9d62-05815c8f62a4" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_b74d95f9-1216-4f9b-8f71-6572f6e75801" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AccumulatedDefinedBenefitPlansAdjustmentSettlementsCurtailmentsAttributableToParentMember_1813cff5-775c-49e1-906f-e2313c039ca9" xlink:href="iff-20231231.xsd#iff_AccumulatedDefinedBenefitPlansAdjustmentSettlementsCurtailmentsAttributableToParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_b74d95f9-1216-4f9b-8f71-6572f6e75801" xlink:to="loc_iff_AccumulatedDefinedBenefitPlansAdjustmentSettlementsCurtailmentsAttributableToParentMember_1813cff5-775c-49e1-906f-e2313c039ca9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_80681eb3-cc5e-4f7e-9493-11592eaf78db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_b74d95f9-1216-4f9b-8f71-6572f6e75801" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_80681eb3-cc5e-4f7e-9493-11592eaf78db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_d4f239b3-e0fb-44fa-8c27-19095b3544ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_b74d95f9-1216-4f9b-8f71-6572f6e75801" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_d4f239b3-e0fb-44fa-8c27-19095b3544ce" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AccumulatedDefinedBenefitPlansAdjustmentOtherItemsAttributableToParentMember_419cd518-6781-436f-87d3-d44670e96dec" xlink:href="iff-20231231.xsd#iff_AccumulatedDefinedBenefitPlansAdjustmentOtherItemsAttributableToParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_b74d95f9-1216-4f9b-8f71-6572f6e75801" xlink:to="loc_iff_AccumulatedDefinedBenefitPlansAdjustmentOtherItemsAttributableToParentMember_419cd518-6781-436f-87d3-d44670e96dec" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_5b03e71f-ed84-40ef-a23d-a001c0753ac2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_2a469cea-2dd2-4428-b3e4-842b2f8b6587" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_5b03e71f-ed84-40ef-a23d-a001c0753ac2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_5b03e71f-ed84-40ef-a23d-a001c0753ac2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_5b03e71f-ed84-40ef-a23d-a001c0753ac2" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_5b03e71f-ed84-40ef-a23d-a001c0753ac2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_2c08a382-3b60-42e2-957a-718305701c47" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_5b03e71f-ed84-40ef-a23d-a001c0753ac2" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_2c08a382-3b60-42e2-957a-718305701c47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_8e0f9fcd-ae76-48e2-a1c3-7950b9e29943" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_2c08a382-3b60-42e2-957a-718305701c47" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_8e0f9fcd-ae76-48e2-a1c3-7950b9e29943" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8a417669-5aa6-432b-b294-8aa3ce7453ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_2a469cea-2dd2-4428-b3e4-842b2f8b6587" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8a417669-5aa6-432b-b294-8aa3ce7453ff" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8a417669-5aa6-432b-b294-8aa3ce7453ff_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8a417669-5aa6-432b-b294-8aa3ce7453ff" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8a417669-5aa6-432b-b294-8aa3ce7453ff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ada5942c-d200-42c8-98f1-4b2480c40317" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8a417669-5aa6-432b-b294-8aa3ce7453ff" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ada5942c-d200-42c8-98f1-4b2480c40317" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_2be3bce6-3106-4f98-9826-94f923a4b82f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ada5942c-d200-42c8-98f1-4b2480c40317" xlink:to="loc_us-gaap_ForeignExchangeContractMember_2be3bce6-3106-4f98-9826-94f923a4b82f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_84a5334e-e5e9-457b-8d3c-db747db6dc55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ada5942c-d200-42c8-98f1-4b2480c40317" xlink:to="loc_us-gaap_InterestRateSwapMember_84a5334e-e5e9-457b-8d3c-db747db6dc55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_8671442c-01f7-47c9-9d90-6f2b2ce20332" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_a25c63e0-9422-4b61-b932-ff4c682e8fe7" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_8671442c-01f7-47c9-9d90-6f2b2ce20332" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_44494722-52f8-4253-8ca8-0e52a54f65e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_a25c63e0-9422-4b61-b932-ff4c682e8fe7" xlink:to="loc_us-gaap_InterestExpense_44494722-52f8-4253-8ca8-0e52a54f65e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c6aa7671-dc4b-4ad8-a983-4ebb39145c9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_a25c63e0-9422-4b61-b932-ff4c682e8fe7" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c6aa7671-dc4b-4ad8-a983-4ebb39145c9f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_100219cf-d240-41c9-8d34-40dbda5aa7df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_a25c63e0-9422-4b61-b932-ff4c682e8fe7" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_100219cf-d240-41c9-8d34-40dbda5aa7df" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_1762edf5-9e1f-49cf-9642-47a93f4f6806" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_a25c63e0-9422-4b61-b932-ff4c682e8fe7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_1762edf5-9e1f-49cf-9642-47a93f4f6806" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_75571c8b-ca42-4a23-88cd-f935e842ceee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_a25c63e0-9422-4b61-b932-ff4c682e8fe7" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_75571c8b-ca42-4a23-88cd-f935e842ceee" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/ConcentrationsOfCreditRiskAdditionalInformationDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#ConcentrationsOfCreditRiskAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/ConcentrationsOfCreditRiskAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_ea823884-52f7-4bcd-8ed3-9128ed40a1b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_45365271-3626-40c9-88ed-181b6da2913e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_ea823884-52f7-4bcd-8ed3-9128ed40a1b5" xlink:to="loc_us-gaap_ConcentrationRiskTable_45365271-3626-40c9-88ed-181b6da2913e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_d9bf3921-f9e1-440f-8476-ecb38dd5d85b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_45365271-3626-40c9-88ed-181b6da2913e" xlink:to="loc_srt_StatementGeographicalAxis_d9bf3921-f9e1-440f-8476-ecb38dd5d85b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d9bf3921-f9e1-440f-8476-ecb38dd5d85b_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_d9bf3921-f9e1-440f-8476-ecb38dd5d85b" xlink:to="loc_srt_SegmentGeographicalDomain_d9bf3921-f9e1-440f-8476-ecb38dd5d85b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_1b839fae-904d-4688-9e8a-7e093a2c6252" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_d9bf3921-f9e1-440f-8476-ecb38dd5d85b" xlink:to="loc_srt_SegmentGeographicalDomain_1b839fae-904d-4688-9e8a-7e093a2c6252" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AllForeignCountriesMember_da941f43-3a1d-49cd-83fd-ed15fb2a83da" xlink:href="iff-20231231.xsd#iff_AllForeignCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1b839fae-904d-4688-9e8a-7e093a2c6252" xlink:to="loc_iff_AllForeignCountriesMember_da941f43-3a1d-49cd-83fd-ed15fb2a83da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_6c809bf8-f6f2-4a00-a026-776b98d1d7a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_45365271-3626-40c9-88ed-181b6da2913e" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_6c809bf8-f6f2-4a00-a026-776b98d1d7a1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6c809bf8-f6f2-4a00-a026-776b98d1d7a1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_6c809bf8-f6f2-4a00-a026-776b98d1d7a1" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6c809bf8-f6f2-4a00-a026-776b98d1d7a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_0652f8f6-c43d-49e3-b689-d190823d090c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_6c809bf8-f6f2-4a00-a026-776b98d1d7a1" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_0652f8f6-c43d-49e3-b689-d190823d090c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember_f51e3005-cbd2-4f82-a08e-30c52a2f0ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_0652f8f6-c43d-49e3-b689-d190823d090c" xlink:to="loc_us-gaap_SalesMember_f51e3005-cbd2-4f82-a08e-30c52a2f0ae4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_99894969-732f-4884-ac34-115baa6c8146" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_45365271-3626-40c9-88ed-181b6da2913e" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_99894969-732f-4884-ac34-115baa6c8146" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_99894969-732f-4884-ac34-115baa6c8146_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_99894969-732f-4884-ac34-115baa6c8146" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_99894969-732f-4884-ac34-115baa6c8146_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_375d4c6d-3953-4e47-8b74-43a736a2287a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_99894969-732f-4884-ac34-115baa6c8146" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_375d4c6d-3953-4e47-8b74-43a736a2287a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_c380741e-5461-49b3-8fbe-d9f407277023" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_375d4c6d-3953-4e47-8b74-43a736a2287a" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_c380741e-5461-49b3-8fbe-d9f407277023" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EntityWideRevenueMajorCustomerNumberOfCustomers_472f9303-f269-451b-b65f-22c2c3c29c92" xlink:href="iff-20231231.xsd#iff_EntityWideRevenueMajorCustomerNumberOfCustomers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_ea823884-52f7-4bcd-8ed3-9128ed40a1b5" xlink:to="loc_iff_EntityWideRevenueMajorCustomerNumberOfCustomers_472f9303-f269-451b-b65f-22c2c3c29c92" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_e9748246-259f-4e1c-be1a-553c31bb2e26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_ea823884-52f7-4bcd-8ed3-9128ed40a1b5" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_e9748246-259f-4e1c-be1a-553c31bb2e26" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#CommitmentsandContingenciesAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:href="iff-20231231.xsd#iff_CommitmentsAndContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_CommitmentsAndContingenciesTable_8adf3480-5a95-45bc-84eb-235f49a1bd84" xlink:href="iff-20231231.xsd#iff_CommitmentsAndContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_iff_CommitmentsAndContingenciesTable_8adf3480-5a95-45bc-84eb-235f49a1bd84" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2f1d1644-abae-4583-ac58-cbfe7f130668" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iff_CommitmentsAndContingenciesTable_8adf3480-5a95-45bc-84eb-235f49a1bd84" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2f1d1644-abae-4583-ac58-cbfe7f130668" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_2f1d1644-abae-4583-ac58-cbfe7f130668_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2f1d1644-abae-4583-ac58-cbfe7f130668" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_2f1d1644-abae-4583-ac58-cbfe7f130668_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_6d9bbf09-524c-4048-b891-8a0e18b84663" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2f1d1644-abae-4583-ac58-cbfe7f130668" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_6d9bbf09-524c-4048-b891-8a0e18b84663" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ZhejiangIngredientsPlantMember_9c5cc681-486d-4721-9103-ffc3a91f1095" xlink:href="iff-20231231.xsd#iff_ZhejiangIngredientsPlantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_6d9bbf09-524c-4048-b891-8a0e18b84663" xlink:to="loc_iff_ZhejiangIngredientsPlantMember_9c5cc681-486d-4721-9103-ffc3a91f1095" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_GuangzhouFlavorsPlantMember_9f6c6342-4198-4d82-8222-7352a81c0715" xlink:href="iff-20231231.xsd#iff_GuangzhouFlavorsPlantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_6d9bbf09-524c-4048-b891-8a0e18b84663" xlink:to="loc_iff_GuangzhouFlavorsPlantMember_9f6c6342-4198-4d82-8222-7352a81c0715" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_GuangzhouFragrancePlantMember_6d91ec6f-3944-45b9-a562-df14de4eb9f0" xlink:href="iff-20231231.xsd#iff_GuangzhouFragrancePlantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_6d9bbf09-524c-4048-b891-8a0e18b84663" xlink:to="loc_iff_GuangzhouFragrancePlantMember_6d91ec6f-3944-45b9-a562-df14de4eb9f0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ZhangjiagangFlavorsPlantMember_60742af9-655e-46f4-b5ec-291d60bb67a3" xlink:href="iff-20231231.xsd#iff_ZhangjiagangFlavorsPlantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_6d9bbf09-524c-4048-b891-8a0e18b84663" xlink:to="loc_iff_ZhangjiagangFlavorsPlantMember_60742af9-655e-46f4-b5ec-291d60bb67a3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_4ab0890a-136a-4169-b62f-374628b72aeb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iff_CommitmentsAndContingenciesTable_8adf3480-5a95-45bc-84eb-235f49a1bd84" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_4ab0890a-136a-4169-b62f-374628b72aeb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_4ab0890a-136a-4169-b62f-374628b72aeb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_4ab0890a-136a-4169-b62f-374628b72aeb" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_4ab0890a-136a-4169-b62f-374628b72aeb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_1dbc9f70-9ac0-4f3e-8995-3ac115048bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_4ab0890a-136a-4169-b62f-374628b72aeb" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_1dbc9f70-9ac0-4f3e-8995-3ac115048bdd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_BR_ef50e3ae-f1e5-4be8-98b0-6c8a527f6456" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_BR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_1dbc9f70-9ac0-4f3e-8995-3ac115048bdd" xlink:to="loc_country_BR_ef50e3ae-f1e5-4be8-98b0-6c8a527f6456" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_141171ad-2397-478e-be7f-bb1588ef0e36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iff_CommitmentsAndContingenciesTable_8adf3480-5a95-45bc-84eb-235f49a1bd84" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_141171ad-2397-478e-be7f-bb1588ef0e36" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_141171ad-2397-478e-be7f-bb1588ef0e36_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_141171ad-2397-478e-be7f-bb1588ef0e36" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_141171ad-2397-478e-be7f-bb1588ef0e36_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_ffbe2120-30c1-4489-adda-ad32a6b8f3db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_141171ad-2397-478e-be7f-bb1588ef0e36" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_ffbe2120-30c1-4489-adda-ad32a6b8f3db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_395b2709-ce90-4ba9-aced-4d698b7e0b4c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_ffbe2120-30c1-4489-adda-ad32a6b8f3db" xlink:to="loc_us-gaap_ForeignCountryMember_395b2709-ce90-4ba9-aced-4d698b7e0b4c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_77eade0d-ef07-4bbc-8ba7-b572eb2dfa24" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iff_CommitmentsAndContingenciesTable_8adf3480-5a95-45bc-84eb-235f49a1bd84" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_77eade0d-ef07-4bbc-8ba7-b572eb2dfa24" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_77eade0d-ef07-4bbc-8ba7-b572eb2dfa24_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_77eade0d-ef07-4bbc-8ba7-b572eb2dfa24" xlink:to="loc_us-gaap_SegmentDomain_77eade0d-ef07-4bbc-8ba7-b572eb2dfa24_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0208de51-950f-40b3-a171-a038f0fd964d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_77eade0d-ef07-4bbc-8ba7-b572eb2dfa24" xlink:to="loc_us-gaap_SegmentDomain_0208de51-950f-40b3-a171-a038f0fd964d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TasteMember_3cbc5e7c-46ab-46dd-bbc0-96b93f458004" xlink:href="iff-20231231.xsd#iff_TasteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0208de51-950f-40b3-a171-a038f0fd964d" xlink:to="loc_iff_TasteMember_3cbc5e7c-46ab-46dd-bbc0-96b93f458004" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ScentMember_0b1135b7-14e4-4290-8581-7ac6ceedc9d6" xlink:href="iff-20231231.xsd#iff_ScentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0208de51-950f-40b3-a171-a038f0fd964d" xlink:to="loc_iff_ScentMember_0b1135b7-14e4-4290-8581-7ac6ceedc9d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_PharmaSolutionsMember_683fb1c9-aa8b-42c5-abd5-00e99e69b776" xlink:href="iff-20231231.xsd#iff_PharmaSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0208de51-950f-40b3-a171-a038f0fd964d" xlink:to="loc_iff_PharmaSolutionsMember_683fb1c9-aa8b-42c5-abd5-00e99e69b776" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_6a09abc1-be40-4e2d-b872-ce894871288e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iff_CommitmentsAndContingenciesTable_8adf3480-5a95-45bc-84eb-235f49a1bd84" xlink:to="loc_dei_LegalEntityAxis_6a09abc1-be40-4e2d-b872-ce894871288e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_6a09abc1-be40-4e2d-b872-ce894871288e_default" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_6a09abc1-be40-4e2d-b872-ce894871288e" xlink:to="loc_dei_EntityDomain_6a09abc1-be40-4e2d-b872-ce894871288e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_ee708372-baf2-43d6-b28c-a19040c0544f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_6a09abc1-be40-4e2d-b872-ce894871288e" xlink:to="loc_dei_EntityDomain_ee708372-baf2-43d6-b28c-a19040c0544f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NutritionBiosciencesIncMember_4b52eb7f-300e-412c-9bdd-aab31c9e5299" xlink:href="iff-20231231.xsd#iff_NutritionBiosciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_ee708372-baf2-43d6-b28c-a19040c0544f" xlink:to="loc_iff_NutritionBiosciencesIncMember_4b52eb7f-300e-412c-9bdd-aab31c9e5299" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ca5a88f4-d11d-436b-9123-c06b402fdc03" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iff_CommitmentsAndContingenciesTable_8adf3480-5a95-45bc-84eb-235f49a1bd84" xlink:to="loc_us-gaap_DebtInstrumentAxis_ca5a88f4-d11d-436b-9123-c06b402fdc03" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ca5a88f4-d11d-436b-9123-c06b402fdc03_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_ca5a88f4-d11d-436b-9123-c06b402fdc03" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ca5a88f4-d11d-436b-9123-c06b402fdc03_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_35d2b7b9-fa76-405b-aed8-2305212dc917" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_ca5a88f4-d11d-436b-9123-c06b402fdc03" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_35d2b7b9-fa76-405b-aed8-2305212dc917" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorUnsecuredBridgeTermLoanMember_2f08f852-7d69-4a4d-9799-51863a7a7ec9" xlink:href="iff-20231231.xsd#iff_SeniorUnsecuredBridgeTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35d2b7b9-fa76-405b-aed8-2305212dc917" xlink:to="loc_iff_SeniorUnsecuredBridgeTermLoanMember_2f08f852-7d69-4a4d-9799-51863a7a7ec9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ThreeHundredSixtyFourDaySeniorUnsecuredBridgeFacilityMember_f09295fb-a7eb-4ac6-92ba-72f8d120992d" xlink:href="iff-20231231.xsd#iff_ThreeHundredSixtyFourDaySeniorUnsecuredBridgeFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35d2b7b9-fa76-405b-aed8-2305212dc917" xlink:to="loc_iff_ThreeHundredSixtyFourDaySeniorUnsecuredBridgeFacilityMember_f09295fb-a7eb-4ac6-92ba-72f8d120992d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorUnsecuredNotesMember_762f0210-2825-4521-a209-1a1a9771c5f9" xlink:href="iff-20231231.xsd#iff_SeniorUnsecuredNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35d2b7b9-fa76-405b-aed8-2305212dc917" xlink:to="loc_iff_SeniorUnsecuredNotesMember_762f0210-2825-4521-a209-1a1a9771c5f9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_c13a04ec-29bf-4adc-acd9-2477e09326d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iff_CommitmentsAndContingenciesTable_8adf3480-5a95-45bc-84eb-235f49a1bd84" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_c13a04ec-29bf-4adc-acd9-2477e09326d7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_c13a04ec-29bf-4adc-acd9-2477e09326d7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_c13a04ec-29bf-4adc-acd9-2477e09326d7" xlink:to="loc_us-gaap_LossContingencyNatureDomain_c13a04ec-29bf-4adc-acd9-2477e09326d7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_0d1229c4-df5c-4149-878c-69e9ad6d62bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_c13a04ec-29bf-4adc-acd9-2477e09326d7" xlink:to="loc_us-gaap_LossContingencyNatureDomain_0d1229c4-df5c-4149-878c-69e9ad6d62bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_PledgedAssetsMember_a52d8f35-681b-4b76-a29e-934bf55a0908" xlink:href="iff-20231231.xsd#iff_PledgedAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_0d1229c4-df5c-4149-878c-69e9ad6d62bf" xlink:to="loc_iff_PledgedAssetsMember_a52d8f35-681b-4b76-a29e-934bf55a0908" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BankGuaranteesMember_89571ea0-d266-43de-8140-1039e09a911c" xlink:href="iff-20231231.xsd#iff_BankGuaranteesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_0d1229c4-df5c-4149-878c-69e9ad6d62bf" xlink:to="loc_iff_BankGuaranteesMember_89571ea0-d266-43de-8140-1039e09a911c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DamagesFromProductDefectsMember_e0527d55-c948-43c1-be0d-4ac7cc1a00d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DamagesFromProductDefectsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_0d1229c4-df5c-4149-878c-69e9ad6d62bf" xlink:to="loc_us-gaap_DamagesFromProductDefectsMember_e0527d55-c948-43c1-be0d-4ac7cc1a00d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BankGuaranteesCommercialGuaranteesStandbyLettersOfCreditAndSuretyBondsMember_073bf59d-d569-4788-a375-c601070b44d8" xlink:href="iff-20231231.xsd#iff_BankGuaranteesCommercialGuaranteesStandbyLettersOfCreditAndSuretyBondsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_0d1229c4-df5c-4149-878c-69e9ad6d62bf" xlink:to="loc_iff_BankGuaranteesCommercialGuaranteesStandbyLettersOfCreditAndSuretyBondsMember_073bf59d-d569-4788-a375-c601070b44d8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BrazilTaxCreditsMember_a0e4a539-37da-43b1-aec3-0e28faa1cced" xlink:href="iff-20231231.xsd#iff_BrazilTaxCreditsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_0d1229c4-df5c-4149-878c-69e9ad6d62bf" xlink:to="loc_iff_BrazilTaxCreditsMember_a0e4a539-37da-43b1-aec3-0e28faa1cced" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_dd3d3410-a38a-4081-a6a3-2a9364119c64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iff_CommitmentsAndContingenciesTable_8adf3480-5a95-45bc-84eb-235f49a1bd84" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_dd3d3410-a38a-4081-a6a3-2a9364119c64" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_dd3d3410-a38a-4081-a6a3-2a9364119c64_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_dd3d3410-a38a-4081-a6a3-2a9364119c64" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_dd3d3410-a38a-4081-a6a3-2a9364119c64_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_84b0c62f-2a42-44fd-b05d-b8be963bdc1e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_dd3d3410-a38a-4081-a6a3-2a9364119c64" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_84b0c62f-2a42-44fd-b05d-b8be963bdc1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ZhejiangIngredientsPlantMember_27017a41-4d79-4244-bd7b-e95abdf09077" xlink:href="iff-20231231.xsd#iff_ZhejiangIngredientsPlantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_84b0c62f-2a42-44fd-b05d-b8be963bdc1e" xlink:to="loc_iff_ZhejiangIngredientsPlantMember_27017a41-4d79-4244-bd7b-e95abdf09077" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManufacturingFacilityMember_79d22cc2-307d-49de-a4c9-fdc658f1b497" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ManufacturingFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_84b0c62f-2a42-44fd-b05d-b8be963bdc1e" xlink:to="loc_us-gaap_ManufacturingFacilityMember_79d22cc2-307d-49de-a4c9-fdc658f1b497" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_561a89c1-3389-4a99-9423-0429602940eb" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iff_CommitmentsAndContingenciesTable_8adf3480-5a95-45bc-84eb-235f49a1bd84" xlink:to="loc_srt_StatementGeographicalAxis_561a89c1-3389-4a99-9423-0429602940eb" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_561a89c1-3389-4a99-9423-0429602940eb_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_561a89c1-3389-4a99-9423-0429602940eb" xlink:to="loc_srt_SegmentGeographicalDomain_561a89c1-3389-4a99-9423-0429602940eb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_dc4480f0-8f0f-4648-ad2d-776f60a79e24" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_561a89c1-3389-4a99-9423-0429602940eb" xlink:to="loc_srt_SegmentGeographicalDomain_dc4480f0-8f0f-4648-ad2d-776f60a79e24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_HangzhouChinaMember_a868ed94-1431-4cb8-98ae-2d5c219b298f" xlink:href="iff-20231231.xsd#iff_HangzhouChinaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_dc4480f0-8f0f-4648-ad2d-776f60a79e24" xlink:to="loc_iff_HangzhouChinaMember_a868ed94-1431-4cb8-98ae-2d5c219b298f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_GuangzhouChinaMember_85401b30-319f-46ec-85d5-acf89cd7ce21" xlink:href="iff-20231231.xsd#iff_GuangzhouChinaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_dc4480f0-8f0f-4648-ad2d-776f60a79e24" xlink:to="loc_iff_GuangzhouChinaMember_85401b30-319f-46ec-85d5-acf89cd7ce21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ZhejiangChinaMember_7b72d51e-d987-476b-bc86-33cef0fe5347" xlink:href="iff-20231231.xsd#iff_ZhejiangChinaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_dc4480f0-8f0f-4648-ad2d-776f60a79e24" xlink:to="loc_iff_ZhejiangChinaMember_7b72d51e-d987-476b-bc86-33cef0fe5347" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN_5e582a7f-7c56-4a9f-809b-177cc4561914" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CN"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_dc4480f0-8f0f-4648-ad2d-776f60a79e24" xlink:to="loc_country_CN_5e582a7f-7c56-4a9f-809b-177cc4561914" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_BR_ee52d298-38be-4b13-9d2c-f839a1836d6e" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_BR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_dc4480f0-8f0f-4648-ad2d-776f60a79e24" xlink:to="loc_country_BR_ee52d298-38be-4b13-9d2c-f839a1836d6e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ZhangjiagangChinaMember_0ccff540-5f15-4caa-b50c-acc990d77c29" xlink:href="iff-20231231.xsd#iff_ZhangjiagangChinaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_dc4480f0-8f0f-4648-ad2d-776f60a79e24" xlink:to="loc_iff_ZhangjiagangChinaMember_0ccff540-5f15-4caa-b50c-acc990d77c29" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ec26c4ef-6cc2-463f-ad40-a932bcc505a0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iff_CommitmentsAndContingenciesTable_8adf3480-5a95-45bc-84eb-235f49a1bd84" xlink:to="loc_srt_RangeAxis_ec26c4ef-6cc2-463f-ad40-a932bcc505a0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ec26c4ef-6cc2-463f-ad40-a932bcc505a0_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_ec26c4ef-6cc2-463f-ad40-a932bcc505a0" xlink:to="loc_srt_RangeMember_ec26c4ef-6cc2-463f-ad40-a932bcc505a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_19278376-cf65-4206-8011-8fac08dac064" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_ec26c4ef-6cc2-463f-ad40-a932bcc505a0" xlink:to="loc_srt_RangeMember_19278376-cf65-4206-8011-8fac08dac064" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_34bbe0f4-0758-46fe-a604-f0ac4b53eca0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_19278376-cf65-4206-8011-8fac08dac064" xlink:to="loc_srt_MinimumMember_34bbe0f4-0758-46fe-a604-f0ac4b53eca0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a804fe80-8e38-4943-a37a-698d0d55b6a9" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_19278376-cf65-4206-8011-8fac08dac064" xlink:to="loc_srt_MaximumMember_a804fe80-8e38-4943-a37a-698d0d55b6a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_a1c8728c-d950-4a08-a0e4-d2bd9483945a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iff_CommitmentsAndContingenciesTable_8adf3480-5a95-45bc-84eb-235f49a1bd84" xlink:to="loc_srt_TitleOfIndividualAxis_a1c8728c-d950-4a08-a0e4-d2bd9483945a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_a1c8728c-d950-4a08-a0e4-d2bd9483945a_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_a1c8728c-d950-4a08-a0e4-d2bd9483945a" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_a1c8728c-d950-4a08-a0e4-d2bd9483945a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_c338b23e-bef0-4f1c-b95d-a3d082494866" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_a1c8728c-d950-4a08-a0e4-d2bd9483945a" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_c338b23e-bef0-4f1c-b95d-a3d082494866" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_aba7a1d7-e206-414f-9924-b709b7e8fb7b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_c338b23e-bef0-4f1c-b95d-a3d082494866" xlink:to="loc_srt_ChiefExecutiveOfficerMember_aba7a1d7-e206-414f-9924-b709b7e8fb7b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_7d575e77-a873-49b1-90bd-8124d98b82ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iff_CommitmentsAndContingenciesTable_8adf3480-5a95-45bc-84eb-235f49a1bd84" xlink:to="loc_us-gaap_CreditFacilityAxis_7d575e77-a873-49b1-90bd-8124d98b82ec" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_7d575e77-a873-49b1-90bd-8124d98b82ec_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_7d575e77-a873-49b1-90bd-8124d98b82ec" xlink:to="loc_us-gaap_CreditFacilityDomain_7d575e77-a873-49b1-90bd-8124d98b82ec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_c7d8c51d-d55f-4265-a6e3-9c72b8026c30" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_7d575e77-a873-49b1-90bd-8124d98b82ec" xlink:to="loc_us-gaap_CreditFacilityDomain_c7d8c51d-d55f-4265-a6e3-9c72b8026c30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_28d0cf92-1701-4962-92f5-b039338336e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_c7d8c51d-d55f-4265-a6e3-9c72b8026c30" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_28d0cf92-1701-4962-92f5-b039338336e6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_56c4c346-1d4c-4c3d-8d24-cdfc7abc9b27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iff_CommitmentsAndContingenciesTable_8adf3480-5a95-45bc-84eb-235f49a1bd84" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_56c4c346-1d4c-4c3d-8d24-cdfc7abc9b27" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_56c4c346-1d4c-4c3d-8d24-cdfc7abc9b27_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_56c4c346-1d4c-4c3d-8d24-cdfc7abc9b27" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_56c4c346-1d4c-4c3d-8d24-cdfc7abc9b27_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_feba3e8a-0fa9-4a8f-852b-158f3bfddb6a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_56c4c346-1d4c-4c3d-8d24-cdfc7abc9b27" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_feba3e8a-0fa9-4a8f-852b-158f3bfddb6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_CitibankN.AMember_5e8e4778-d0c3-4a2f-930e-f5ad9fe3ab26" xlink:href="iff-20231231.xsd#iff_CitibankN.AMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_feba3e8a-0fa9-4a8f-852b-158f3bfddb6a" xlink:to="loc_iff_CitibankN.AMember_5e8e4778-d0c3-4a2f-930e-f5ad9fe3ab26" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_CommercialGuaranteesAmountOutstanding_7f5d9614-3ba6-45c0-8972-5ce29aa7232c" xlink:href="iff-20231231.xsd#iff_CommercialGuaranteesAmountOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_iff_CommercialGuaranteesAmountOutstanding_7f5d9614-3ba6-45c0-8972-5ce29aa7232c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BankGuaranteesRelatedToAppealsOnIncomeTaxAndIndirectTaxCases_811a6080-1800-4bd6-b927-3d65b4f53552" xlink:href="iff-20231231.xsd#iff_BankGuaranteesRelatedToAppealsOnIncomeTaxAndIndirectTaxCases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_iff_BankGuaranteesRelatedToAppealsOnIncomeTaxAndIndirectTaxCases_811a6080-1800-4bd6-b927-3d65b4f53552" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AmountOfPledgedAssetsPrincipallyPropertyPlantAndEquipmentToCoverIncomeTaxAndIndirectTaxAssessments_c4aef6d6-6f31-41c6-acb7-55ce8858da42" xlink:href="iff-20231231.xsd#iff_AmountOfPledgedAssetsPrincipallyPropertyPlantAndEquipmentToCoverIncomeTaxAndIndirectTaxAssessments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_iff_AmountOfPledgedAssetsPrincipallyPropertyPlantAndEquipmentToCoverIncomeTaxAndIndirectTaxAssessments_c4aef6d6-6f31-41c6-acb7-55ce8858da42" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfLandHeldForUse_0efac8e7-edb1-44a7-83ab-7112de58b515" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfLandHeldForUse"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_us-gaap_ProceedsFromSaleOfLandHeldForUse_0efac8e7-edb1-44a7-83ab-7112de58b515" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AmountOfAvailableLinesOfCredit_87d9d33d-6158-4225-865b-a1680d52af9f" xlink:href="iff-20231231.xsd#iff_AmountOfAvailableLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_iff_AmountOfAvailableLinesOfCredit_87d9d33d-6158-4225-865b-a1680d52af9f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_a80eb38a-918e-42dd-b44f-20cd40f9c9ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_a80eb38a-918e-42dd-b44f-20cd40f9c9ba" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BankGuaranteesAndPledgedAssetsToPursueDefensesRelatedToOtherContingencies_f2780b0b-b651-4c27-9906-d719b9b85956" xlink:href="iff-20231231.xsd#iff_BankGuaranteesAndPledgedAssetsToPursueDefensesRelatedToOtherContingencies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_iff_BankGuaranteesAndPledgedAssetsToPursueDefensesRelatedToOtherContingencies_f2780b0b-b651-4c27-9906-d719b9b85956" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityAccrualPeriodExpense_ad028c8d-6bca-4aa7-bba6-91f6afe7249c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductLiabilityAccrualPeriodExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_us-gaap_ProductLiabilityAccrualPeriodExpense_ad028c8d-6bca-4aa7-bba6-91f6afe7249c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NumberofFacilities_b6465359-3184-4a2e-a387-75de8fbf3361" xlink:href="iff-20231231.xsd#iff_NumberofFacilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_iff_NumberofFacilities_b6465359-3184-4a2e-a387-75de8fbf3361" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ProductLiabilityContingencyLossExposureinExcessofAccrualAggregateAmountPaid_211fca67-72a6-479b-b8b2-fe28cf49d7bc" xlink:href="iff-20231231.xsd#iff_ProductLiabilityContingencyLossExposureinExcessofAccrualAggregateAmountPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_iff_ProductLiabilityContingencyLossExposureinExcessofAccrualAggregateAmountPaid_211fca67-72a6-479b-b8b2-fe28cf49d7bc" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ProductLiabilityContingencyLossExposureinExcessofAccrualAmountPaid_e3f92190-ef2e-40d9-bb9b-161751f0a8ee" xlink:href="iff-20231231.xsd#iff_ProductLiabilityContingencyLossExposureinExcessofAccrualAmountPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_iff_ProductLiabilityContingencyLossExposureinExcessofAccrualAmountPaid_e3f92190-ef2e-40d9-bb9b-161751f0a8ee" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIncomeTaxRefunds_b1b9ada8-91a3-483f-97c8-f1b95b967de0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIncomeTaxRefunds"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_us-gaap_ProceedsFromIncomeTaxRefunds_b1b9ada8-91a3-483f-97c8-f1b95b967de0" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_GainContingencyRelocationPaymentsReceived_048e2660-0c45-416d-ab8a-7b554199e7c8" xlink:href="iff-20231231.xsd#iff_GainContingencyRelocationPaymentsReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_iff_GainContingencyRelocationPaymentsReceived_048e2660-0c45-416d-ab8a-7b554199e7c8" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_cb92ef72-e182-4b13-82b5-97f05c5e1f4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_cb92ef72-e182-4b13-82b5-97f05c5e1f4e" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense_b649325b-5fc0-49a3-a7bf-dc856ad1b39c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense_b649325b-5fc0-49a3-a7bf-dc856ad1b39c" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_7d2a1bc0-db14-47d6-ad5e-87058930db01" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_7d2a1bc0-db14-47d6-ad5e-87058930db01" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_GainContingencyExpectedRelocationPayments_c642c48a-bdaa-4ac5-a4f1-146848ca8633" xlink:href="iff-20231231.xsd#iff_GainContingencyExpectedRelocationPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_iff_GainContingencyExpectedRelocationPayments_c642c48a-bdaa-4ac5-a4f1-146848ca8633" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TerminationFee_d2e363dd-f4f5-403e-8984-8a23a4d11120" xlink:href="iff-20231231.xsd#iff_TerminationFee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_iff_TerminationFee_d2e363dd-f4f5-403e-8984-8a23a4d11120" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalExpenseAndLiabilities_a6ff6fc0-ad1d-4ef2-934d-512f5665701b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EnvironmentalExpenseAndLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_us-gaap_EnvironmentalExpenseAndLiabilities_a6ff6fc0-ad1d-4ef2-934d-512f5665701b" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BankGuaranteesStandbyLettersOfCreditAndCommercialGuaranteesAmountOutstanding_acd516c9-fbea-402d-b750-c2badd761bf5" xlink:href="iff-20231231.xsd#iff_BankGuaranteesStandbyLettersOfCreditAndCommercialGuaranteesAmountOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_iff_BankGuaranteesStandbyLettersOfCreditAndCommercialGuaranteesAmountOutstanding_acd516c9-fbea-402d-b750-c2badd761bf5" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_LinesOfCreditFacilityTotalAmountDrawnDown_39ae5a6c-c659-4531-accd-7a48516a0fae" xlink:href="iff-20231231.xsd#iff_LinesOfCreditFacilityTotalAmountDrawnDown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_iff_LinesOfCreditFacilityTotalAmountDrawnDown_39ae5a6c-c659-4531-accd-7a48516a0fae" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BankGuaranteesCommercialGuaranteesStandbyLettersOfCreditAndSuretyBondsFacilityAmounts_ed534808-7529-4f9e-a588-b557e3e475a5" xlink:href="iff-20231231.xsd#iff_BankGuaranteesCommercialGuaranteesStandbyLettersOfCreditAndSuretyBondsFacilityAmounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_iff_BankGuaranteesCommercialGuaranteesStandbyLettersOfCreditAndSuretyBondsFacilityAmounts_ed534808-7529-4f9e-a588-b557e3e475a5" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper_b333849b-46fd-4967-af5e-1e879b92e0ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_us-gaap_CommercialPaper_b333849b-46fd-4967-af5e-1e879b92e0ea" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscounted_e9789327-0d01-46df-a5f5-0f352806a924" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MalpracticeLossContingencyAccrualUndiscounted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscounted_e9789327-0d01-46df-a5f5-0f352806a924" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MalpracticeLossContingencyPeriodCost_60c91b0e-9f1a-436a-905a-0534f4735a9b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MalpracticeLossContingencyPeriodCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_us-gaap_MalpracticeLossContingencyPeriodCost_60c91b0e-9f1a-436a-905a-0534f4735a9b" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MalpracticeLossContingencyPeriodIncreaseDecrease_1acc0d38-70bf-466b-9551-0107db55045d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MalpracticeLossContingencyPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_us-gaap_MalpracticeLossContingencyPeriodIncreaseDecrease_1acc0d38-70bf-466b-9551-0107db55045d" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_MalpracticeLossContingencyPaymentsInceptionToDate_541ca78c-b672-46d1-8abb-eba63eeb1470" xlink:href="iff-20231231.xsd#iff_MalpracticeLossContingencyPaymentsInceptionToDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_iff_MalpracticeLossContingencyPaymentsInceptionToDate_541ca78c-b672-46d1-8abb-eba63eeb1470" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_LossContingencyReceivableWrittenOff_0a7b318b-72a7-43c6-8291-c607e8f4536f" xlink:href="iff-20231231.xsd#iff_LossContingencyReceivableWrittenOff"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_iff_LossContingencyReceivableWrittenOff_0a7b318b-72a7-43c6-8291-c607e8f4536f" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_GainLossOnPlantRelocation_be731ccb-cdbb-41bf-8db9-75afeb31a7bb" xlink:href="iff-20231231.xsd#iff_GainLossOnPlantRelocation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_iff_GainLossOnPlantRelocation_be731ccb-cdbb-41bf-8db9-75afeb31a7bb" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EstimatedIncomeTaxExpenseBenefit_d7d3b4b5-3866-4213-b041-a0d287cf26f7" xlink:href="iff-20231231.xsd#iff_EstimatedIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_iff_EstimatedIncomeTaxExpenseBenefit_d7d3b4b5-3866-4213-b041-a0d287cf26f7" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_c0656bde-266a-48f8-8e7a-be33d6cd6f9d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_c0656bde-266a-48f8-8e7a-be33d6cd6f9d" xlink:type="arc" order="30"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/RedeemableNoncontrollingInterestsDetails" xlink:type="simple" xlink:href="iff-20231231.xsd#RedeemableNoncontrollingInterestsDetails"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/RedeemableNoncontrollingInterestsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_7cd82ee2-57ba-4b6d-baf2-08d6c3577e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_7ade68ff-69db-431a-9905-ea2f19255ccb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_MinorityInterestLineItems_7cd82ee2-57ba-4b6d-baf2-08d6c3577e8a" xlink:to="loc_us-gaap_MinorityInterestTable_7ade68ff-69db-431a-9905-ea2f19255ccb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_4e89266d-0834-41b0-a390-c4a0bf68edf0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_7ade68ff-69db-431a-9905-ea2f19255ccb" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_4e89266d-0834-41b0-a390-c4a0bf68edf0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_4e89266d-0834-41b0-a390-c4a0bf68edf0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4e89266d-0834-41b0-a390-c4a0bf68edf0" xlink:to="loc_us-gaap_EquityComponentDomain_4e89266d-0834-41b0-a390-c4a0bf68edf0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_dc5f2be0-1943-4269-b634-df2a3b15e0ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4e89266d-0834-41b0-a390-c4a0bf68edf0" xlink:to="loc_us-gaap_EquityComponentDomain_dc5f2be0-1943-4269-b634-df2a3b15e0ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_RedeemableNoncontrollingInterestMember_110e809b-ff3c-403a-bc46-799ae16d7a04" xlink:href="iff-20231231.xsd#iff_RedeemableNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_dc5f2be0-1943-4269-b634-df2a3b15e0ca" xlink:to="loc_iff_RedeemableNoncontrollingInterestMember_110e809b-ff3c-403a-bc46-799ae16d7a04" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_87d150b9-9604-4708-98a3-950e0d2d5aed" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_7ade68ff-69db-431a-9905-ea2f19255ccb" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_87d150b9-9604-4708-98a3-950e0d2d5aed" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_87d150b9-9604-4708-98a3-950e0d2d5aed_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_87d150b9-9604-4708-98a3-950e0d2d5aed" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_87d150b9-9604-4708-98a3-950e0d2d5aed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_bd5c0b36-819f-448c-8bd1-96fa00923167" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_87d150b9-9604-4708-98a3-950e0d2d5aed" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_bd5c0b36-819f-448c-8bd1-96fa00923167" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SonaromeMember_a206373a-153a-4467-b4e0-3e4ea860c099" xlink:href="iff-20231231.xsd#iff_SonaromeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_bd5c0b36-819f-448c-8bd1-96fa00923167" xlink:to="loc_iff_SonaromeMember_a206373a-153a-4467-b4e0-3e4ea860c099" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInMinorityInterestRollForward_eb242cc0-8b22-44c9-9dc4-9b86489621c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MovementInMinorityInterestRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_7cd82ee2-57ba-4b6d-baf2-08d6c3577e8a" xlink:to="loc_us-gaap_MovementInMinorityInterestRollForward_eb242cc0-8b22-44c9-9dc4-9b86489621c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_92fbd3fc-19ae-4963-90f7-152c3d09b15e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_eb242cc0-8b22-44c9-9dc4-9b86489621c4" xlink:to="loc_us-gaap_MinorityInterest_92fbd3fc-19ae-4963-90f7-152c3d09b15e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NoncontrollingInterestImpactOfForeignExchangeTranslation_03fe20bd-b43d-4ee8-8e86-6254e9a54f4f" xlink:href="iff-20231231.xsd#iff_NoncontrollingInterestImpactOfForeignExchangeTranslation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_eb242cc0-8b22-44c9-9dc4-9b86489621c4" xlink:to="loc_iff_NoncontrollingInterestImpactOfForeignExchangeTranslation_03fe20bd-b43d-4ee8-8e86-6254e9a54f4f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_14ec66da-cfc8-4f4b-903c-63c91b5740c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_eb242cc0-8b22-44c9-9dc4-9b86489621c4" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_14ec66da-cfc8-4f4b-903c-63c91b5740c5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestChangeInRedemptionValue_2caaf6b5-a911-4c7d-8af8-1547ef795b8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestChangeInRedemptionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_eb242cc0-8b22-44c9-9dc4-9b86489621c4" xlink:to="loc_us-gaap_MinorityInterestChangeInRedemptionValue_2caaf6b5-a911-4c7d-8af8-1547ef795b8e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_07156bb8-9ca6-4742-b2f4-a8a165a75472" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_eb242cc0-8b22-44c9-9dc4-9b86489621c4" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_07156bb8-9ca6-4742-b2f4-a8a165a75472" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_50c822c0-0fbe-415c-a456-66f0f04045cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_eb242cc0-8b22-44c9-9dc4-9b86489621c4" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_50c822c0-0fbe-415c-a456-66f0f04045cf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NoncontrollingInterestDecreaseFromDisposal_5778382c-aa1e-4fa6-9153-3639fa45c502" xlink:href="iff-20231231.xsd#iff_NoncontrollingInterestDecreaseFromDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_eb242cc0-8b22-44c9-9dc4-9b86489621c4" xlink:to="loc_iff_NoncontrollingInterestDecreaseFromDisposal_5778382c-aa1e-4fa6-9153-3639fa45c502" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_766bcc71-8c4c-4f60-951d-d3ea1db02fab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfLongtermInvestments_cff99da8-8c7c-4dde-8671-94a4ac5c12dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfLongtermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_7cd82ee2-57ba-4b6d-baf2-08d6c3577e8a" xlink:to="loc_us-gaap_ProceedsFromSaleOfLongtermInvestments_cff99da8-8c7c-4dde-8671-94a4ac5c12dc" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleDetails" xlink:type="simple" xlink:href="iff-20231231.xsd#AssetsandLiabilitiesHeldForSaleDetails"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7cd99014-a6ab-4f9f-b1e4-fc172fbcd96c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c4e8d47c-b772-4b13-b955-2cf77a4508ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7cd99014-a6ab-4f9f-b1e4-fc172fbcd96c" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c4e8d47c-b772-4b13-b955-2cf77a4508ee" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_d07f6c94-d158-4cfe-8e01-df2f84b391c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c4e8d47c-b772-4b13-b955-2cf77a4508ee" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_d07f6c94-d158-4cfe-8e01-df2f84b391c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_d07f6c94-d158-4cfe-8e01-df2f84b391c8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_d07f6c94-d158-4cfe-8e01-df2f84b391c8" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_d07f6c94-d158-4cfe-8e01-df2f84b391c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_6eb39b09-49b2-432e-9657-adeae5fd8c34" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_d07f6c94-d158-4cfe-8e01-df2f84b391c8" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_6eb39b09-49b2-432e-9657-adeae5fd8c34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_5709fb3a-c644-4174-809a-cfbb14515df1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_6eb39b09-49b2-432e-9657-adeae5fd8c34" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_5709fb3a-c644-4174-809a-cfbb14515df1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_15f5549b-6905-4dd2-86bc-fe50c1619c70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c4e8d47c-b772-4b13-b955-2cf77a4508ee" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_15f5549b-6905-4dd2-86bc-fe50c1619c70" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_15f5549b-6905-4dd2-86bc-fe50c1619c70_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_15f5549b-6905-4dd2-86bc-fe50c1619c70" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_15f5549b-6905-4dd2-86bc-fe50c1619c70_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9b3c0e10-205e-479a-81aa-43d8a73f1a82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_15f5549b-6905-4dd2-86bc-fe50c1619c70" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9b3c0e10-205e-479a-81aa-43d8a73f1a82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SavorySolutionsAndFlavorSpecialtyIngredientsMember_34585c2b-08ba-405c-a70c-11f670664f43" xlink:href="iff-20231231.xsd#iff_SavorySolutionsAndFlavorSpecialtyIngredientsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9b3c0e10-205e-479a-81aa-43d8a73f1a82" xlink:to="loc_iff_SavorySolutionsAndFlavorSpecialtyIngredientsMember_34585c2b-08ba-405c-a70c-11f670664f43" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_MicrobialControlMember_a2194bdf-da78-488a-a76f-34b9ab8bd243" xlink:href="iff-20231231.xsd#iff_MicrobialControlMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9b3c0e10-205e-479a-81aa-43d8a73f1a82" xlink:to="loc_iff_MicrobialControlMember_a2194bdf-da78-488a-a76f-34b9ab8bd243" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_CosmeticIngredientsMember_070897f6-c338-4ee0-825c-e73684c40ddb" xlink:href="iff-20231231.xsd#iff_CosmeticIngredientsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9b3c0e10-205e-479a-81aa-43d8a73f1a82" xlink:to="loc_iff_CosmeticIngredientsMember_070897f6-c338-4ee0-825c-e73684c40ddb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_55c433dc-1f98-41ef-98f0-0b26831f324f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7cd99014-a6ab-4f9f-b1e4-fc172fbcd96c" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_55c433dc-1f98-41ef-98f0-0b26831f324f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_36ca6e4c-849d-4ff5-8dfb-7095907216b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_55c433dc-1f98-41ef-98f0-0b26831f324f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_36ca6e4c-849d-4ff5-8dfb-7095907216b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupIncludingDiscontinuedOperationTradeReceivablesNet_1ed223ee-6676-4eb0-8c02-d147af9805df" xlink:href="iff-20231231.xsd#iff_DisposalGroupIncludingDiscontinuedOperationTradeReceivablesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_55c433dc-1f98-41ef-98f0-0b26831f324f" xlink:to="loc_iff_DisposalGroupIncludingDiscontinuedOperationTradeReceivablesNet_1ed223ee-6676-4eb0-8c02-d147af9805df" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_9311863e-eaf3-4b0c-8dd7-1d277f875f54" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_55c433dc-1f98-41ef-98f0-0b26831f324f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_9311863e-eaf3-4b0c-8dd7-1d277f875f54" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_454e831a-c96b-4be3-aa15-b19ff99dc6e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_55c433dc-1f98-41ef-98f0-0b26831f324f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_454e831a-c96b-4be3-aa15-b19ff99dc6e4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_e1724b44-e15d-4706-9c8a-b543fc10f41a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_55c433dc-1f98-41ef-98f0-0b26831f324f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_e1724b44-e15d-4706-9c8a-b543fc10f41a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_536b4a81-46ab-4a0a-8e00-87363a2432c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_55c433dc-1f98-41ef-98f0-0b26831f324f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_536b4a81-46ab-4a0a-8e00-87363a2432c9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_2b90b0d0-5df7-403f-b347-c01d15a1b264" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_55c433dc-1f98-41ef-98f0-0b26831f324f" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_2b90b0d0-5df7-403f-b347-c01d15a1b264" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_0128963b-e4c3-400d-a576-1c17d106af72" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_55c433dc-1f98-41ef-98f0-0b26831f324f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_0128963b-e4c3-400d-a576-1c17d106af72" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_18bb6f56-29a3-4203-8c7d-a2c1617dae36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_55c433dc-1f98-41ef-98f0-0b26831f324f" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_18bb6f56-29a3-4203-8c7d-a2c1617dae36" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_940b100a-2636-4875-9a13-f37a81115a06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7cd99014-a6ab-4f9f-b1e4-fc172fbcd96c" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_940b100a-2636-4875-9a13-f37a81115a06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_93b50a5c-c3e5-4b24-88f7-ce1e2996eeb6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_940b100a-2636-4875-9a13-f37a81115a06" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_93b50a5c-c3e5-4b24-88f7-ce1e2996eeb6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities_c91b1d1c-47c0-4804-b9ff-5aebaccde38f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_940b100a-2636-4875-9a13-f37a81115a06" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities_c91b1d1c-47c0-4804-b9ff-5aebaccde38f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_2ad505ab-c7ab-44e1-9e93-49a918d5284e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_940b100a-2636-4875-9a13-f37a81115a06" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_2ad505ab-c7ab-44e1-9e93-49a918d5284e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_7c73d32b-ecd1-495d-b396-6d9e4b2d0e98" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_940b100a-2636-4875-9a13-f37a81115a06" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_7c73d32b-ecd1-495d-b396-6d9e4b2d0e98" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/TangibleEquityUnitsAllocationofTEUDetails" xlink:type="simple" xlink:href="iff-20231231.xsd#TangibleEquityUnitsAllocationofTEUDetails"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/TangibleEquityUnitsAllocationofTEUDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityUnitsLineItems_7ea628d2-1579-427d-b00b-2498575407aa" xlink:href="iff-20231231.xsd#iff_TangibleEquityUnitsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityUnitsTable_0fd5b710-4920-489e-9af8-78e0ae3dd75a" xlink:href="iff-20231231.xsd#iff_TangibleEquityUnitsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_iff_TangibleEquityUnitsLineItems_7ea628d2-1579-427d-b00b-2498575407aa" xlink:to="loc_iff_TangibleEquityUnitsTable_0fd5b710-4920-489e-9af8-78e0ae3dd75a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityUnitsAllocationAxis_f4275684-be36-4017-8ff4-3bd19dbd702e" xlink:href="iff-20231231.xsd#iff_TangibleEquityUnitsAllocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iff_TangibleEquityUnitsTable_0fd5b710-4920-489e-9af8-78e0ae3dd75a" xlink:to="loc_iff_TangibleEquityUnitsAllocationAxis_f4275684-be36-4017-8ff4-3bd19dbd702e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityUnitsAllocationDomain_f4275684-be36-4017-8ff4-3bd19dbd702e_default" xlink:href="iff-20231231.xsd#iff_TangibleEquityUnitsAllocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_iff_TangibleEquityUnitsAllocationAxis_f4275684-be36-4017-8ff4-3bd19dbd702e" xlink:to="loc_iff_TangibleEquityUnitsAllocationDomain_f4275684-be36-4017-8ff4-3bd19dbd702e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityUnitsAllocationDomain_517ce192-76b0-4880-bdfd-e0c3b9e9beb3" xlink:href="iff-20231231.xsd#iff_TangibleEquityUnitsAllocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_iff_TangibleEquityUnitsAllocationAxis_f4275684-be36-4017-8ff4-3bd19dbd702e" xlink:to="loc_iff_TangibleEquityUnitsAllocationDomain_517ce192-76b0-4880-bdfd-e0c3b9e9beb3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_StockPurchaseContractMember_ccd6920d-1a26-4d08-835f-d278c7786a4a" xlink:href="iff-20231231.xsd#iff_StockPurchaseContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_TangibleEquityUnitsAllocationDomain_517ce192-76b0-4880-bdfd-e0c3b9e9beb3" xlink:to="loc_iff_StockPurchaseContractMember_ccd6920d-1a26-4d08-835f-d278c7786a4a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityUnitsInitialPrincipalAmount_b8da441e-c6f2-42ac-baf4-7ad8612ec8af" xlink:href="iff-20231231.xsd#iff_TangibleEquityUnitsInitialPrincipalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_TangibleEquityUnitsLineItems_7ea628d2-1579-427d-b00b-2498575407aa" xlink:to="loc_iff_TangibleEquityUnitsInitialPrincipalAmount_b8da441e-c6f2-42ac-baf4-7ad8612ec8af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_74e866fd-df50-46b4-99b1-9bce3fba3a99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_TangibleEquityUnitsLineItems_7ea628d2-1579-427d-b00b-2498575407aa" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_74e866fd-df50-46b4-99b1-9bce3fba3a99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityUnitsProceeds_1a7fff9b-c1e9-4276-a788-426a445f4c6e" xlink:href="iff-20231231.xsd#iff_TangibleEquityUnitsProceeds"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_TangibleEquityUnitsLineItems_7ea628d2-1579-427d-b00b-2498575407aa" xlink:to="loc_iff_TangibleEquityUnitsProceeds_1a7fff9b-c1e9-4276-a788-426a445f4c6e" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/TangibleEquityUnitsTangibleEquitySettlementofSharesDetails" xlink:type="simple" xlink:href="iff-20231231.xsd#TangibleEquityUnitsTangibleEquitySettlementofSharesDetails"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/TangibleEquityUnitsTangibleEquitySettlementofSharesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_4b9a6339-77b0-4ca9-8ffa-8d588d2b008b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_55bf647f-fe66-4d00-9584-b0decefba38c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_4b9a6339-77b0-4ca9-8ffa-8d588d2b008b" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_55bf647f-fe66-4d00-9584-b0decefba38c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1aa0cd44-9de3-48fc-8f9e-e2ffb42b9b9a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_55bf647f-fe66-4d00-9584-b0decefba38c" xlink:to="loc_srt_RangeAxis_1aa0cd44-9de3-48fc-8f9e-e2ffb42b9b9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1aa0cd44-9de3-48fc-8f9e-e2ffb42b9b9a_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_1aa0cd44-9de3-48fc-8f9e-e2ffb42b9b9a" xlink:to="loc_srt_RangeMember_1aa0cd44-9de3-48fc-8f9e-e2ffb42b9b9a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7621f865-b3f7-4031-a4a6-40cd4c855680" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_1aa0cd44-9de3-48fc-8f9e-e2ffb42b9b9a" xlink:to="loc_srt_RangeMember_7621f865-b3f7-4031-a4a6-40cd4c855680" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e6f982be-a907-482e-8ac5-644dfed6044f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7621f865-b3f7-4031-a4a6-40cd4c855680" xlink:to="loc_srt_MinimumMember_e6f982be-a907-482e-8ac5-644dfed6044f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_04a2e6d2-7748-4291-bf83-cc1e357e2139" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7621f865-b3f7-4031-a4a6-40cd4c855680" xlink:to="loc_srt_MaximumMember_04a2e6d2-7748-4291-bf83-cc1e357e2139" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityUnitsConditionsAxis_3e3b21f7-070a-499f-8970-bb87a0a6727d" xlink:href="iff-20231231.xsd#iff_TangibleEquityUnitsConditionsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_55bf647f-fe66-4d00-9584-b0decefba38c" xlink:to="loc_iff_TangibleEquityUnitsConditionsAxis_3e3b21f7-070a-499f-8970-bb87a0a6727d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityUnitsConditionsDomain_3e3b21f7-070a-499f-8970-bb87a0a6727d_default" xlink:href="iff-20231231.xsd#iff_TangibleEquityUnitsConditionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_iff_TangibleEquityUnitsConditionsAxis_3e3b21f7-070a-499f-8970-bb87a0a6727d" xlink:to="loc_iff_TangibleEquityUnitsConditionsDomain_3e3b21f7-070a-499f-8970-bb87a0a6727d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityUnitsConditionsDomain_c3b87af2-711b-40d3-bf66-b3be245d4d48" xlink:href="iff-20231231.xsd#iff_TangibleEquityUnitsConditionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_iff_TangibleEquityUnitsConditionsAxis_3e3b21f7-070a-499f-8970-bb87a0a6727d" xlink:to="loc_iff_TangibleEquityUnitsConditionsDomain_c3b87af2-711b-40d3-bf66-b3be245d4d48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ConditionOneMember_0990550a-dabb-441a-8840-817a70010b8e" xlink:href="iff-20231231.xsd#iff_ConditionOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_TangibleEquityUnitsConditionsDomain_c3b87af2-711b-40d3-bf66-b3be245d4d48" xlink:to="loc_iff_ConditionOneMember_0990550a-dabb-441a-8840-817a70010b8e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ConditionTwoMember_f482eb36-d66f-4f2a-8ed7-e8a4fe04920b" xlink:href="iff-20231231.xsd#iff_ConditionTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_TangibleEquityUnitsConditionsDomain_c3b87af2-711b-40d3-bf66-b3be245d4d48" xlink:to="loc_iff_ConditionTwoMember_f482eb36-d66f-4f2a-8ed7-e8a4fe04920b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ConditionThreeMember_fc4516f7-a806-4850-a22e-0cf40aac5083" xlink:href="iff-20231231.xsd#iff_ConditionThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iff_TangibleEquityUnitsConditionsDomain_c3b87af2-711b-40d3-bf66-b3be245d4d48" xlink:to="loc_iff_ConditionThreeMember_fc4516f7-a806-4850-a22e-0cf40aac5083" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_9e2108f9-7884-46d6-99ba-08d68f82ee2f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_4b9a6339-77b0-4ca9-8ffa-8d588d2b008b" xlink:to="loc_us-gaap_SharePrice_9e2108f9-7884-46d6-99ba-08d68f82ee2f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityUnitsConditionalValue_316c6dc5-f2a3-439f-873e-fe517c620bb1" xlink:href="iff-20231231.xsd#iff_TangibleEquityUnitsConditionalValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_4b9a6339-77b0-4ca9-8ffa-8d588d2b008b" xlink:to="loc_iff_TangibleEquityUnitsConditionalValue_316c6dc5-f2a3-439f-873e-fe517c620bb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityRateSettlementRate_f59325a9-f488-4485-95a2-6d22d52d0adf" xlink:href="iff-20231231.xsd#iff_TangibleEquityRateSettlementRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_4b9a6339-77b0-4ca9-8ffa-8d588d2b008b" xlink:to="loc_iff_TangibleEquityRateSettlementRate_f59325a9-f488-4485-95a2-6d22d52d0adf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_18d7e01e-fb2a-4f59-8cd9-753d58c122d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_4b9a6339-77b0-4ca9-8ffa-8d588d2b008b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_18d7e01e-fb2a-4f59-8cd9-753d58c122d3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityUnitsFinalSettlementRate_5ab7db14-71d2-4958-840f-586259120139" xlink:href="iff-20231231.xsd#iff_TangibleEquityUnitsFinalSettlementRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_4b9a6339-77b0-4ca9-8ffa-8d588d2b008b" xlink:to="loc_iff_TangibleEquityUnitsFinalSettlementRate_5ab7db14-71d2-4958-840f-586259120139" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iff.com/role/ScheduleIIValuationandQualifyingAccountsandReservesDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#ScheduleIIValuationandQualifyingAccountsandReservesDetail"/>
  <link:definitionLink xlink:role="http://www.iff.com/role/ScheduleIIValuationandQualifyingAccountsandReservesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_edbffdbe-1aed-4908-9f52-a4fae81a134d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_44fa91c9-aff0-4ba6-9359-186ebf0558b6" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_edbffdbe-1aed-4908-9f52-a4fae81a134d" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_44fa91c9-aff0-4ba6-9359-186ebf0558b6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_2bc572f5-bc4c-4655-baba-e1aed4197e07" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_44fa91c9-aff0-4ba6-9359-186ebf0558b6" xlink:to="loc_srt_StatementScenarioAxis_2bc572f5-bc4c-4655-baba-e1aed4197e07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_2bc572f5-bc4c-4655-baba-e1aed4197e07_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_2bc572f5-bc4c-4655-baba-e1aed4197e07" xlink:to="loc_srt_ScenarioUnspecifiedDomain_2bc572f5-bc4c-4655-baba-e1aed4197e07_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_b6f19fe0-79e2-4727-a631-1f325767aa2a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_2bc572f5-bc4c-4655-baba-e1aed4197e07" xlink:to="loc_srt_ScenarioUnspecifiedDomain_b6f19fe0-79e2-4727-a631-1f325767aa2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScenarioAdjustmentMember_3b703bde-2664-4960-b6e4-1905ffd159fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScenarioAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_b6f19fe0-79e2-4727-a631-1f325767aa2a" xlink:to="loc_us-gaap_ScenarioAdjustmentMember_3b703bde-2664-4960-b6e4-1905ffd159fd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_5e32c8d2-692a-4623-b4fc-b1ab14876f84" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_44fa91c9-aff0-4ba6-9359-186ebf0558b6" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_5e32c8d2-692a-4623-b4fc-b1ab14876f84" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_5e32c8d2-692a-4623-b4fc-b1ab14876f84_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_5e32c8d2-692a-4623-b4fc-b1ab14876f84" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_5e32c8d2-692a-4623-b4fc-b1ab14876f84_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_fdab11bb-8810-4bde-bfa4-5f248b2883fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_5e32c8d2-692a-4623-b4fc-b1ab14876f84" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_fdab11bb-8810-4bde-bfa4-5f248b2883fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_6053f7eb-0d43-454e-a7fd-cedce3cd13ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_fdab11bb-8810-4bde-bfa4-5f248b2883fd" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_6053f7eb-0d43-454e-a7fd-cedce3cd13ee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_bce8cdd4-ea33-4d0a-863a-aa35fe853aff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_fdab11bb-8810-4bde-bfa4-5f248b2883fd" xlink:to="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_bce8cdd4-ea33-4d0a-863a-aa35fe853aff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_a51c5a1d-e38f-40be-9462-0f1a6a5044be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_edbffdbe-1aed-4908-9f52-a4fae81a134d" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_a51c5a1d-e38f-40be-9462-0f1a6a5044be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_affde360-107a-478c-931f-fd06e332fc09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_a51c5a1d-e38f-40be-9462-0f1a6a5044be" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_affde360-107a-478c-931f-fd06e332fc09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_a0bd2eab-5eaa-4c53-b3f7-4f79dff9d4c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_a51c5a1d-e38f-40be-9462-0f1a6a5044be" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_a0bd2eab-5eaa-4c53-b3f7-4f79dff9d4c5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired_ba0630b1-4396-48d7-89b3-88527bfac90f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_a51c5a1d-e38f-40be-9462-0f1a6a5044be" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired_ba0630b1-4396-48d7-89b3-88527bfac90f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_8fe4e877-2403-4afc-9a10-229160f381de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_a51c5a1d-e38f-40be-9462-0f1a6a5044be" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_8fe4e877-2403-4afc-9a10-229160f381de" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesAdjustments_af15c45c-ffe6-418e-bcc0-3240c6b25645" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_a51c5a1d-e38f-40be-9462-0f1a6a5044be" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesAdjustments_af15c45c-ffe6-418e-bcc0-3240c6b25645" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_689dfba4-3e7c-4ac9-b123-f54b3c66b0f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_a51c5a1d-e38f-40be-9462-0f1a6a5044be" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_689dfba4-3e7c-4ac9-b123-f54b3c66b0f2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_91a836a7-1fee-48d4-b4d0-b87bf4cf58dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_52f8012d-7cbe-495c-8520-c912367c2064" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_edbffdbe-1aed-4908-9f52-a4fae81a134d" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_52f8012d-7cbe-495c-8520-c912367c2064" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#AwardTypeOnly"/>
  <link:definitionLink xlink:role="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareEquivalentsMember_bb66113c-d7b9-45b7-ae94-e54e3a0f0e24" xlink:href="iff-20231231.xsd#iff_ShareEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_iff_ShareEquivalentsMember_bb66113c-d7b9-45b7-ae94-e54e3a0f0e24" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_StockOptionsAndStockSettledAppreciationRightsMember_65d3700b-281e-4e9e-8d36-6692e70ad999" xlink:href="iff-20231231.xsd#iff_StockOptionsAndStockSettledAppreciationRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_iff_StockOptionsAndStockSettledAppreciationRightsMember_65d3700b-281e-4e9e-8d36-6692e70ad999" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_PurchasedRestrictedStockUnitMember_8c53659b-2054-483c-b134-6431ddc98813" xlink:href="iff-20231231.xsd#iff_PurchasedRestrictedStockUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_iff_PurchasedRestrictedStockUnitMember_8c53659b-2054-483c-b134-6431ddc98813" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_CashRestrictedStockUnitMember_76435068-4e5d-452b-bd85-5c3876aa58fa" xlink:href="iff-20231231.xsd#iff_CashRestrictedStockUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_iff_CashRestrictedStockUnitMember_76435068-4e5d-452b-bd85-5c3876aa58fa" xlink:type="arc" order="8"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>iff-20231231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:0b208b7a-5cd8-4cb9-aadf-23532e94abd0,g:23e07c85-fb0b-44f9-a3e5-5e9f1b6ef71a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_ManufacturingFacilityMember_d2233979-722f-489d-80a4-2c57c8b48e50_terseLabel_en-US" xlink:label="lab_us-gaap_ManufacturingFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing Facility [Member]</link:label>
    <link:label id="lab_us-gaap_ManufacturingFacilityMember_label_en-US" xlink:label="lab_us-gaap_ManufacturingFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManufacturingFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ManufacturingFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ManufacturingFacilityMember" xlink:to="lab_us-gaap_ManufacturingFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_6124bbd6-1d90-4da3-9aac-686baff288a7_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SSAR's [Member]</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_ace471cf-3e12-4b51-a528-c3b6f2a69bd0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SSAR's and Stock Option Outstanding</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_NourishMember_42f2636d-e4d7-43c9-bb7e-d5db5094d003_terseLabel_en-US" xlink:label="lab_iff_NourishMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nourish</link:label>
    <link:label id="lab_iff_NourishMember_label_en-US" xlink:label="lab_iff_NourishMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nourish [Member]</link:label>
    <link:label id="lab_iff_NourishMember_documentation_en-US" xlink:label="lab_iff_NourishMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nourish [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NourishMember" xlink:href="iff-20231231.xsd#iff_NourishMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_NourishMember" xlink:to="lab_iff_NourishMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_AccountsReceivableFactoringReceivableProgramMaximumAmount_10dd34d5-9ee4-4639-be6f-ab64e033141c_terseLabel_en-US" xlink:label="lab_iff_AccountsReceivableFactoringReceivableProgramMaximumAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, factoring receivable program, maximum amount</link:label>
    <link:label id="lab_iff_AccountsReceivableFactoringReceivableProgramMaximumAmount_label_en-US" xlink:label="lab_iff_AccountsReceivableFactoringReceivableProgramMaximumAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Factoring Receivable Program, Maximum Amount</link:label>
    <link:label id="lab_iff_AccountsReceivableFactoringReceivableProgramMaximumAmount_documentation_en-US" xlink:label="lab_iff_AccountsReceivableFactoringReceivableProgramMaximumAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Factoring Receivable Program, Maximum Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AccountsReceivableFactoringReceivableProgramMaximumAmount" xlink:href="iff-20231231.xsd#iff_AccountsReceivableFactoringReceivableProgramMaximumAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_AccountsReceivableFactoringReceivableProgramMaximumAmount" xlink:to="lab_iff_AccountsReceivableFactoringReceivableProgramMaximumAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_fa8f58c5-a7b8-4b0c-9457-97061bdc7efd_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving credit facility</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_b3733cbd-c711-4283-a61e-d3d3be550a2d_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expenses</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b346138b-e859-47cc-be66-729a88b464c8_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in assets and liabilities, net of acquisitions:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_TopOneCustomerMember_8568efcc-dfe7-4ab8-a49b-3430b0931c35_terseLabel_en-US" xlink:label="lab_iff_TopOneCustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer One</link:label>
    <link:label id="lab_iff_TopOneCustomerMember_label_en-US" xlink:label="lab_iff_TopOneCustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Top One Customer [Member]</link:label>
    <link:label id="lab_iff_TopOneCustomerMember_documentation_en-US" xlink:label="lab_iff_TopOneCustomerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Top One Customer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TopOneCustomerMember" xlink:href="iff-20231231.xsd#iff_TopOneCustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_TopOneCustomerMember" xlink:to="lab_iff_TopOneCustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DuPontdeNemoursIncMember_0f3c7dd4-2ed6-47f5-bd08-6723c5010f74_terseLabel_en-US" xlink:label="lab_iff_DuPontdeNemoursIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DuPont de Nemours, Inc [Member]</link:label>
    <link:label id="lab_iff_DuPontdeNemoursIncMember_label_en-US" xlink:label="lab_iff_DuPontdeNemoursIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DuPont de Nemours, Inc [Member]</link:label>
    <link:label id="lab_iff_DuPontdeNemoursIncMember_documentation_en-US" xlink:label="lab_iff_DuPontdeNemoursIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DuPont de Nemours, Inc [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DuPontdeNemoursIncMember" xlink:href="iff-20231231.xsd#iff_DuPontdeNemoursIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DuPontdeNemoursIncMember" xlink:to="lab_iff_DuPontdeNemoursIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201602Member_c9d0f0f9-0476-4e0d-8d3c-d7450620cf30_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-02 [Member]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201602Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-02 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201602Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f05840b6-307d-45ce-aa5e-c065e4d8448f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardGrantDateFairValue_terseLabel_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value as of Grant Date</link:label>
    <link:label id="lab_ecd_AwardGrantDateFairValue_label_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardGrantDateFairValue" xlink:to="lab_ecd_AwardGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_b6cb0144-9cb1-4f66-abae-fa1e1c5e764e_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy_854a6b3c-d70d-4c72-be48-a33e791563e9_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and Other Postretirement Plans, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementPlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:to="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_AccumulatedOtherComprehensiveIncomeLossPensionLiabilityAndPostretirementAfterTax_7e45d470-5176-4a3b-8965-ff31c934d9a8_terseLabel_en-US" xlink:label="lab_iff_AccumulatedOtherComprehensiveIncomeLossPensionLiabilityAndPostretirementAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension liability and postretirement, after tax</link:label>
    <link:label id="lab_iff_AccumulatedOtherComprehensiveIncomeLossPensionLiabilityAndPostretirementAfterTax_label_en-US" xlink:label="lab_iff_AccumulatedOtherComprehensiveIncomeLossPensionLiabilityAndPostretirementAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Pension Liability And Postretirement, after Tax</link:label>
    <link:label id="lab_iff_AccumulatedOtherComprehensiveIncomeLossPensionLiabilityAndPostretirementAfterTax_documentation_en-US" xlink:label="lab_iff_AccumulatedOtherComprehensiveIncomeLossPensionLiabilityAndPostretirementAfterTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Pension Liability And Postretirement, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AccumulatedOtherComprehensiveIncomeLossPensionLiabilityAndPostretirementAfterTax" xlink:href="iff-20231231.xsd#iff_AccumulatedOtherComprehensiveIncomeLossPensionLiabilityAndPostretirementAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_AccumulatedOtherComprehensiveIncomeLossPensionLiabilityAndPostretirementAfterTax" xlink:to="lab_iff_AccumulatedOtherComprehensiveIncomeLossPensionLiabilityAndPostretirementAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_959112e5-b64f-4584-b86a-3602e84c0a14_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid to acquire business</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_TechnologicalKnowHowsMember_fc549d41-cdad-4ad7-b2e3-dcddd66f5dd7_terseLabel_en-US" xlink:label="lab_iff_TechnologicalKnowHowsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technological Know-Hows</link:label>
    <link:label id="lab_iff_TechnologicalKnowHowsMember_label_en-US" xlink:label="lab_iff_TechnologicalKnowHowsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technological Know-Hows [Member]</link:label>
    <link:label id="lab_iff_TechnologicalKnowHowsMember_documentation_en-US" xlink:label="lab_iff_TechnologicalKnowHowsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technological Know-Hows</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TechnologicalKnowHowsMember" xlink:href="iff-20231231.xsd#iff_TechnologicalKnowHowsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_TechnologicalKnowHowsMember" xlink:to="lab_iff_TechnologicalKnowHowsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DefinedBenefitPlanAssetsCategoryMember_b88eb5db-1c6e-4ad2-a218-3304e370bad2_terseLabel_en-US" xlink:label="lab_iff_DefinedBenefitPlanAssetsCategoryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assets Category</link:label>
    <link:label id="lab_iff_DefinedBenefitPlanAssetsCategoryMember_label_en-US" xlink:label="lab_iff_DefinedBenefitPlanAssetsCategoryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assets Category [Member]</link:label>
    <link:label id="lab_iff_DefinedBenefitPlanAssetsCategoryMember_documentation_en-US" xlink:label="lab_iff_DefinedBenefitPlanAssetsCategoryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assets Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedBenefitPlanAssetsCategoryMember" xlink:href="iff-20231231.xsd#iff_DefinedBenefitPlanAssetsCategoryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember" xlink:to="lab_iff_DefinedBenefitPlanAssetsCategoryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionContributions_25cb50c5-9838-4f6b-9439-236e6a5008bc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PensionContributions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension contributions</link:label>
    <link:label id="lab_us-gaap_PensionContributions_label_en-US" xlink:label="lab_us-gaap_PensionContributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Pension Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionContributions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionContributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionContributions" xlink:to="lab_us-gaap_PensionContributions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_4ff9a5d2-e69e-4d61-ab83-da579b29f972_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Future Minimum Rental Payments for Operating Leases</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_9647229e-bfc3-4274-9fb0-492ff8279c09_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_efafb865-b431-4f3e-bd95-3a43bac9f791_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent_6d71511a-d4d5-4abf-8f78-0f976bb6aa90_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign-derived intangible income</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, FDII, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_8a8307a4-8d79-4b68-9b8c-2b073b6a4c50_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_NumberOfCustomers_57f931be-a543-48bc-83b3-4fe84c743243_terseLabel_en-US" xlink:label="lab_iff_NumberOfCustomers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Customers</link:label>
    <link:label id="lab_iff_NumberOfCustomers_label_en-US" xlink:label="lab_iff_NumberOfCustomers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Customers</link:label>
    <link:label id="lab_iff_NumberOfCustomers_documentation_en-US" xlink:label="lab_iff_NumberOfCustomers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Customers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NumberOfCustomers" xlink:href="iff-20231231.xsd#iff_NumberOfCustomers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_NumberOfCustomers" xlink:to="lab_iff_NumberOfCustomers" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingPoliciesProcLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_a2a2b300-685f-445d-a059-4ba844fe817a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SSARs/ Options Exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:to="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMidCapMember_787a510c-217c-4fa4-9134-a04296944579_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMidCapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S. Mid Cap</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMidCapMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMidCapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Equity Securities, Mid Cap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMidCapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMidCapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMidCapMember" xlink:to="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMidCapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_a0dd8921-2765-41d2-93c0-280fa1711906_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_terseLabel_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement does not require Recovery</link:label>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_label_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Does Not Require Recovery [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_917bacb5-9799-4c36-8aa5-7c6387fe7472_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_EarnOutsPayableCurrent_7b6f9cc3-a6d1-46a3-abe9-6baec60ae59c_terseLabel_en-US" xlink:label="lab_iff_EarnOutsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earn Outs Payable, Current</link:label>
    <link:label id="lab_iff_EarnOutsPayableCurrent_label_en-US" xlink:label="lab_iff_EarnOutsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earn Outs Payable, Current</link:label>
    <link:label id="lab_iff_EarnOutsPayableCurrent_documentation_en-US" xlink:label="lab_iff_EarnOutsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earn Outs Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EarnOutsPayableCurrent" xlink:href="iff-20231231.xsd#iff_EarnOutsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_EarnOutsPayableCurrent" xlink:to="lab_iff_EarnOutsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_TargetPayoutStock_e40155b3-e432-434e-8d37-ffea9588cb4b_terseLabel_en-US" xlink:label="lab_iff_TargetPayoutStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Target payout percentage, stock</link:label>
    <link:label id="lab_iff_TargetPayoutStock_label_en-US" xlink:label="lab_iff_TargetPayoutStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Target Payout Stock</link:label>
    <link:label id="lab_iff_TargetPayoutStock_documentation_en-US" xlink:label="lab_iff_TargetPayoutStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Target payout stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TargetPayoutStock" xlink:href="iff-20231231.xsd#iff_TargetPayoutStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_TargetPayoutStock" xlink:to="lab_iff_TargetPayoutStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWriteDown_ac539640-4b85-4649-8754-3d72eadb7790_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Write-down</link:label>
    <link:label id="lab_us-gaap_InventoryWriteDown_label_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Write-down</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWriteDown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWriteDown" xlink:to="lab_us-gaap_InventoryWriteDown" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_TwoThousandTenPlanMember_022ab69f-8c11-411d-9b14-7edfdc6bff73_terseLabel_en-US" xlink:label="lab_iff_TwoThousandTenPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2010 Plan [Member]</link:label>
    <link:label id="lab_iff_TwoThousandTenPlanMember_label_en-US" xlink:label="lab_iff_TwoThousandTenPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Ten Plan [Member]</link:label>
    <link:label id="lab_iff_TwoThousandTenPlanMember_documentation_en-US" xlink:label="lab_iff_TwoThousandTenPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2010 Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TwoThousandTenPlanMember" xlink:href="iff-20231231.xsd#iff_TwoThousandTenPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_TwoThousandTenPlanMember" xlink:to="lab_iff_TwoThousandTenPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_e56bbf01-6a2e-4cdb-861d-52ad2221e455_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_31f94b20-7724-4561-8e2a-17542fbfb2e7_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested restricted stock units and awards (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_ReserveforTaxAssessment_2c12a2e5-207e-455e-a49e-e8a77defc499_negatedTerseLabel_en-US" xlink:label="lab_iff_ReserveforTaxAssessment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax assessment</link:label>
    <link:label id="lab_iff_ReserveforTaxAssessment_label_en-US" xlink:label="lab_iff_ReserveforTaxAssessment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserve for Tax Assessment</link:label>
    <link:label id="lab_iff_ReserveforTaxAssessment_documentation_en-US" xlink:label="lab_iff_ReserveforTaxAssessment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserve for Tax Assessment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ReserveforTaxAssessment" xlink:href="iff-20231231.xsd#iff_ReserveforTaxAssessment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_ReserveforTaxAssessment" xlink:to="lab_iff_ReserveforTaxAssessment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitDomain_17b97d6e-16ff-443a-b8ce-6f7e49461207_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitDomain_label_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReportingUnitDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitDomain" xlink:to="lab_us-gaap_ReportingUnitDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_730b48c9-937a-4706-9568-8aa9545e8cb0_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_d81ac862-8fb3-493d-94fe-dba211724b36_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Actuarial Assumption Used to Determine Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_ed78656d-78b7-416d-8c91-ff6b688ef452_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestTable_7881b202-57b0-4d32-be68-fe240f9fd63f_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Table]</link:label>
    <link:label id="lab_us-gaap_MinorityInterestTable_label_en-US" xlink:label="lab_us-gaap_MinorityInterestTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestTable" xlink:to="lab_us-gaap_MinorityInterestTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_5e25c0b6-142a-4e61-b3d1-b4a73768f3b8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_e2b92ace-f51f-4625-9288-089cbe694793_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_TwoThousandFifteenPlanMember_47a5b656-a310-46f2-a7c8-8d6fd1c89500_terseLabel_en-US" xlink:label="lab_iff_TwoThousandFifteenPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2015 Plan [Member]</link:label>
    <link:label id="lab_iff_TwoThousandFifteenPlanMember_label_en-US" xlink:label="lab_iff_TwoThousandFifteenPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Fifteen Plan [Member]</link:label>
    <link:label id="lab_iff_TwoThousandFifteenPlanMember_documentation_en-US" xlink:label="lab_iff_TwoThousandFifteenPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Fifteen Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TwoThousandFifteenPlanMember" xlink:href="iff-20231231.xsd#iff_TwoThousandFifteenPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_TwoThousandFifteenPlanMember" xlink:to="lab_iff_TwoThousandFifteenPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_b4b6a328-7584-41ec-b236-3b32c29785b9_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_c29af333-fde4-4899-acb8-4585a4e3fa5b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds received from business divestitures</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_7792e079-b162-4ca2-9920-15602958ef6a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancelled (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_71139c7c-fba4-48a6-9dbe-649c63ffc213_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends paid to shareholders</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_34b09b7d-a8db-4d90-af3d-e8dc2a6aa365_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_6c875430-21b4-47e6-a64c-2960ef9de50c_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share - diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_21ce19b8-81ec-4562-aad6-e5e931ee9ecc_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of long-lived assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_3ecb9cd8-57f1-4ec2-a1b1-55be70ee8f93_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment, Long-Lived Asset, Held-for-Use</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment, Long-Lived Asset, Held-for-Use</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:to="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_107b3a46-7958-4753-9bc0-621da599142a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_7c9d821a-a815-459b-b247-85988339fdf3_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, value</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivableTypeDomain_80c49944-0dcf-4e96-ae94-54d0709c8fff_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Domain]</link:label>
    <link:label id="lab_us-gaap_ReceivableTypeDomain_label_en-US" xlink:label="lab_us-gaap_ReceivableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivableTypeDomain" xlink:to="lab_us-gaap_ReceivableTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_92fa4714-6d7e-4342-8b66-8f2d83149b69_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rate of compensation increase</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_IncomeTaxesDisclosureTable_1d537671-5bb4-4cab-9f81-47ebecf82285_terseLabel_en-US" xlink:label="lab_iff_IncomeTaxesDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Disclosure [Table]</link:label>
    <link:label id="lab_iff_IncomeTaxesDisclosureTable_label_en-US" xlink:label="lab_iff_IncomeTaxesDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Disclosure [Table]</link:label>
    <link:label id="lab_iff_IncomeTaxesDisclosureTable_documentation_en-US" xlink:label="lab_iff_IncomeTaxesDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_IncomeTaxesDisclosureTable" xlink:href="iff-20231231.xsd#iff_IncomeTaxesDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_IncomeTaxesDisclosureTable" xlink:to="lab_iff_IncomeTaxesDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNetAsset_cdef7d1f-0dda-4bd7-bbeb-1a58b87b2f5a_terseLabel_en-US" xlink:label="lab_iff_DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNetAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value of net asset</link:label>
    <link:label id="lab_iff_DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNetAsset_label_en-US" xlink:label="lab_iff_DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNetAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Carrying Value Of Net Asset</link:label>
    <link:label id="lab_iff_DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNetAsset_documentation_en-US" xlink:label="lab_iff_DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNetAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Carrying Value Of Net Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNetAsset" xlink:href="iff-20231231.xsd#iff_DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNetAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNetAsset" xlink:to="lab_iff_DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNetAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsLineItems_8eef1fc7-82a5-4e36-81bc-8bc063851e1c_terseLabel_en-US" xlink:label="lab_iff_ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Information By Major Category Of Credit Derivatives Contracts [Line Items]</link:label>
    <link:label id="lab_iff_ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsLineItems_label_en-US" xlink:label="lab_iff_ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Information By Major Category Of Credit Derivatives Contracts [Line Items]</link:label>
    <link:label id="lab_iff_ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsLineItems_documentation_en-US" xlink:label="lab_iff_ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Information By Major Category Of Credit Derivatives Contracts [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsLineItems" xlink:href="iff-20231231.xsd#iff_ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsLineItems" xlink:to="lab_iff_ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DeferredTaxLiabilitiesGainLossOnForeignCurrencyTranslation_cfda3a36-dd8f-4f7f-8229-2dfdcb2c0504_negatedTerseLabel_en-US" xlink:label="lab_iff_DeferredTaxLiabilitiesGainLossOnForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on foreign currency translation</link:label>
    <link:label id="lab_iff_DeferredTaxLiabilitiesGainLossOnForeignCurrencyTranslation_label_en-US" xlink:label="lab_iff_DeferredTaxLiabilitiesGainLossOnForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gain (Loss) On Foreign Currency Translation</link:label>
    <link:label id="lab_iff_DeferredTaxLiabilitiesGainLossOnForeignCurrencyTranslation_documentation_en-US" xlink:label="lab_iff_DeferredTaxLiabilitiesGainLossOnForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gain (Loss) On Foreign Currency Translation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DeferredTaxLiabilitiesGainLossOnForeignCurrencyTranslation" xlink:href="iff-20231231.xsd#iff_DeferredTaxLiabilitiesGainLossOnForeignCurrencyTranslation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DeferredTaxLiabilitiesGainLossOnForeignCurrencyTranslation" xlink:to="lab_iff_DeferredTaxLiabilitiesGainLossOnForeignCurrencyTranslation" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_CommercialPaperCurrent_829e62c1-e57b-413a-84b3-477b7608195d_terseLabel_en-US" xlink:label="lab_iff_CommercialPaperCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_iff_CommercialPaperCurrent_label_en-US" xlink:label="lab_iff_CommercialPaperCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper, Current</link:label>
    <link:label id="lab_iff_CommercialPaperCurrent_documentation_en-US" xlink:label="lab_iff_CommercialPaperCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_CommercialPaperCurrent" xlink:href="iff-20231231.xsd#iff_CommercialPaperCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_CommercialPaperCurrent" xlink:to="lab_iff_CommercialPaperCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_BuildingsAndImprovementsMember_e97f98a5-a08e-494b-b9ba-128a69abb34a_terseLabel_en-US" xlink:label="lab_iff_BuildingsAndImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings And Improvements [Member]</link:label>
    <link:label id="lab_iff_BuildingsAndImprovementsMember_label_en-US" xlink:label="lab_iff_BuildingsAndImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings And Improvements [Member]</link:label>
    <link:label id="lab_iff_BuildingsAndImprovementsMember_documentation_en-US" xlink:label="lab_iff_BuildingsAndImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings And Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BuildingsAndImprovementsMember" xlink:href="iff-20231231.xsd#iff_BuildingsAndImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_BuildingsAndImprovementsMember" xlink:to="lab_iff_BuildingsAndImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration_a2fe6724-56e9-463f-b6d8-0afa37b67318_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration" xlink:to="lab_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRange_d8a9042e-9028-425e-b622-9b9b479a2521_terseLabel_en-US" xlink:label="lab_iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRange" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Matching participant's contribution, percentage on compensation</link:label>
    <link:label id="lab_iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRange_label_en-US" xlink:label="lab_iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRange" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan Matching Participant Contribution Percentage On Compensation Range</link:label>
    <link:label id="lab_iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRange_documentation_en-US" xlink:label="lab_iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRange" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined contribution plan matching participant contribution percentage on compensation range</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRange" xlink:href="iff-20231231.xsd#iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRange"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRange" xlink:to="lab_iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRange" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_3ecb6cee-a101-4a41-aa9d-3e60f6707ce4_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:to="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_5aae95a2-0745-41e4-822f-928cc158bcd9_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable non-controlling interests</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_69fd6d48-fe18-4db4-b393-704e7bd1f6e4_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DisposalGroupNotDiscontinuedOperationGainLossOnLiquidationBeforeIncomeTax_20465fa7-dac2-4680-b7b6-4bb35ab94589_negatedTerseLabel_en-US" xlink:label="lab_iff_DisposalGroupNotDiscontinuedOperationGainLossOnLiquidationBeforeIncomeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on liquidation, before taxes</link:label>
    <link:label id="lab_iff_DisposalGroupNotDiscontinuedOperationGainLossOnLiquidationBeforeIncomeTax_label_en-US" xlink:label="lab_iff_DisposalGroupNotDiscontinuedOperationGainLossOnLiquidationBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Gain (Loss) On Liquidation, Before Income Tax</link:label>
    <link:label id="lab_iff_DisposalGroupNotDiscontinuedOperationGainLossOnLiquidationBeforeIncomeTax_documentation_en-US" xlink:label="lab_iff_DisposalGroupNotDiscontinuedOperationGainLossOnLiquidationBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Gain (Loss) On Liquidation, Before Income Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupNotDiscontinuedOperationGainLossOnLiquidationBeforeIncomeTax" xlink:href="iff-20231231.xsd#iff_DisposalGroupNotDiscontinuedOperationGainLossOnLiquidationBeforeIncomeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DisposalGroupNotDiscontinuedOperationGainLossOnLiquidationBeforeIncomeTax" xlink:to="lab_iff_DisposalGroupNotDiscontinuedOperationGainLossOnLiquidationBeforeIncomeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_8bd1f37b-a771-49db-8bf4-b9138ff19f45_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_BusinessCombinationPensionFundingAdjustment_d87e83c9-f6e4-4505-b18c-e6817d7e6d4d_negatedTerseLabel_en-US" xlink:label="lab_iff_BusinessCombinationPensionFundingAdjustment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension funding adjustment</link:label>
    <link:label id="lab_iff_BusinessCombinationPensionFundingAdjustment_label_en-US" xlink:label="lab_iff_BusinessCombinationPensionFundingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Pension Funding Adjustment</link:label>
    <link:label id="lab_iff_BusinessCombinationPensionFundingAdjustment_documentation_en-US" xlink:label="lab_iff_BusinessCombinationPensionFundingAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Pension Funding Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BusinessCombinationPensionFundingAdjustment" xlink:href="iff-20231231.xsd#iff_BusinessCombinationPensionFundingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_BusinessCombinationPensionFundingAdjustment" xlink:to="lab_iff_BusinessCombinationPensionFundingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_f12b079e-0616-476f-b766-875f95b499b6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_66e5ca98-4a67-4c21-8cf4-ac6f433b12e4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed income</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesMember" xlink:to="lab_us-gaap_DebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_5e231f1e-b22f-431b-b208-1b2dc01e23e7_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_d077dab0-4585-42d2-aead-35f435276233_terseLabel_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash acquired from acquisition</link:label>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_label_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Acquired from Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAcquiredFromAcquisition" xlink:to="lab_us-gaap_CashAcquiredFromAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_55b466de-e1a9-4bec-89e7-1f09a5053667_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_3880aa34-dfe2-4079-bbf9-11b9ee70c942_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and equipment [Member]</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentMember" xlink:to="lab_us-gaap_MachineryAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_3b31e79b-4d04-49e2-9cc2-f976f03b1a48_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_c3ce3ca0-17b5-4605-9e81-6773175d0cd6_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_dae02618-166e-4943-b1bf-7880ca538634_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders&#8217; Equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_OperatingEBITDAMargin_5d4cd517-8cdb-45d3-8e75-890bef4a63cf_terseLabel_en-US" xlink:label="lab_iff_OperatingEBITDAMargin" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating EBITDA Margin</link:label>
    <link:label id="lab_iff_OperatingEBITDAMargin_label_en-US" xlink:label="lab_iff_OperatingEBITDAMargin" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating EBITDA Margin</link:label>
    <link:label id="lab_iff_OperatingEBITDAMargin_documentation_en-US" xlink:label="lab_iff_OperatingEBITDAMargin" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating EBITDA Margin</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_OperatingEBITDAMargin" xlink:href="iff-20231231.xsd#iff_OperatingEBITDAMargin"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_OperatingEBITDAMargin" xlink:to="lab_iff_OperatingEBITDAMargin" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent_4f4fb0a8-8e77-40b4-a1b6-6b66f2efcc7e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Miscellaneous, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:to="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeReceivablesHeldForSaleAmount_6ce70b52-2ccf-46c0-802d-4dd8f4aed457_terseLabel_en-US" xlink:label="lab_us-gaap_TradeReceivablesHeldForSaleAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade receivables, held-for-sale, amount</link:label>
    <link:label id="lab_us-gaap_TradeReceivablesHeldForSaleAmount_label_en-US" xlink:label="lab_us-gaap_TradeReceivablesHeldForSaleAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Held-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeReceivablesHeldForSaleAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeReceivablesHeldForSaleAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeReceivablesHeldForSaleAmount" xlink:to="lab_us-gaap_TradeReceivablesHeldForSaleAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_1d99ddea-c1c7-4db3-a6e3-f7bb8624fcce_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other [Member]</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsAbstract_cd2c1f04-4d28-4d1a-9291-10c66288cd21_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_OtherAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsAbstract" xlink:to="lab_us-gaap_OtherAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_2f1fc2d8-b11b-41fd-96f2-490d0dc8fddf_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</link:label>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_label_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:to="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_7dfd1264-861c-46d8-a703-160da8600b17_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost for benefits earned</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_SonaromeMember_8a0309b7-99ef-4817-b798-a9f62f30a42e_terseLabel_en-US" xlink:label="lab_iff_SonaromeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sonarome</link:label>
    <link:label id="lab_iff_SonaromeMember_label_en-US" xlink:label="lab_iff_SonaromeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sonarome [Member]</link:label>
    <link:label id="lab_iff_SonaromeMember_documentation_en-US" xlink:label="lab_iff_SonaromeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sonarome</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SonaromeMember" xlink:href="iff-20231231.xsd#iff_SonaromeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_SonaromeMember" xlink:to="lab_iff_SonaromeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration_05a0913a-d7fe-46c5-a126-8ce043a3f1e8_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration" xlink:to="lab_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_AccruedFreightCurrent_699d6ef5-baec-43b1-b4b8-b174e7dc26cd_terseLabel_en-US" xlink:label="lab_iff_AccruedFreightCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued freight</link:label>
    <link:label id="lab_iff_AccruedFreightCurrent_label_en-US" xlink:label="lab_iff_AccruedFreightCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Freight, Current</link:label>
    <link:label id="lab_iff_AccruedFreightCurrent_documentation_en-US" xlink:label="lab_iff_AccruedFreightCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Freight, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AccruedFreightCurrent" xlink:href="iff-20231231.xsd#iff_AccruedFreightCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_AccruedFreightCurrent" xlink:to="lab_iff_AccruedFreightCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign_f78f125a-fd1c-4132-9a51-66f6c433cbb7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. foreign tax credit - general limitation</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_terseLabel_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Category:</link:label>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_label_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="lab_ecd_ExecutiveCategoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_316209e3-c3d1-417e-8db1-b6bed37b3694_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Shares Used in Computations of Basic and Diluted Net Income Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Weighted Average Number of Shares [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a567b7a7-2ac6-4aa0-aea9-b202bc652890_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number&#160;of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_EffectiveIncomeTaxRateReconciliationAcquisitionCostsPercent_849dbe21-b629-4d71-8313-fb6e015b286a_terseLabel_en-US" xlink:label="lab_iff_EffectiveIncomeTaxRateReconciliationAcquisitionCostsPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition costs</link:label>
    <link:label id="lab_iff_EffectiveIncomeTaxRateReconciliationAcquisitionCostsPercent_label_en-US" xlink:label="lab_iff_EffectiveIncomeTaxRateReconciliationAcquisitionCostsPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Acquisition Costs, Percent</link:label>
    <link:label id="lab_iff_EffectiveIncomeTaxRateReconciliationAcquisitionCostsPercent_documentation_en-US" xlink:label="lab_iff_EffectiveIncomeTaxRateReconciliationAcquisitionCostsPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Acquisition Costs, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EffectiveIncomeTaxRateReconciliationAcquisitionCostsPercent" xlink:href="iff-20231231.xsd#iff_EffectiveIncomeTaxRateReconciliationAcquisitionCostsPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_EffectiveIncomeTaxRateReconciliationAcquisitionCostsPercent" xlink:to="lab_iff_EffectiveIncomeTaxRateReconciliationAcquisitionCostsPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_77837f1b-a9fc-41e3-93df-ce2319ec4e9c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service cost (credit)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, Prior Service Cost (Credit), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_RepurchasePriceAsPercentageOfPrincipalAmountOfSeniorNotes_83c929c2-589b-4fac-883e-670bb8037618_terseLabel_en-US" xlink:label="lab_iff_RepurchasePriceAsPercentageOfPrincipalAmountOfSeniorNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase price of principal amount of Senior Notes in percentage</link:label>
    <link:label id="lab_iff_RepurchasePriceAsPercentageOfPrincipalAmountOfSeniorNotes_label_en-US" xlink:label="lab_iff_RepurchasePriceAsPercentageOfPrincipalAmountOfSeniorNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase Price As Percentage Of Principal Amount Of Senior Notes</link:label>
    <link:label id="lab_iff_RepurchasePriceAsPercentageOfPrincipalAmountOfSeniorNotes_documentation_en-US" xlink:label="lab_iff_RepurchasePriceAsPercentageOfPrincipalAmountOfSeniorNotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase Price As Percentage Of Principal Amount Of Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_RepurchasePriceAsPercentageOfPrincipalAmountOfSeniorNotes" xlink:href="iff-20231231.xsd#iff_RepurchasePriceAsPercentageOfPrincipalAmountOfSeniorNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_RepurchasePriceAsPercentageOfPrincipalAmountOfSeniorNotes" xlink:to="lab_iff_RepurchasePriceAsPercentageOfPrincipalAmountOfSeniorNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_44789b53-68b0-4194-af2b-390fb005402e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_fc9d38b4-2fa0-46a8-91f3-58973317f27e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_c93fccd0-2b2a-4695-abbf-a0992d32c283_terseLabel_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Amount [Member]</link:label>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_d9b5dfb2-cfdd-4a81-b364-6cd5da711f40_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_76777934-502a-4a08-90ba-5a6d6e2387ec_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f50dfbdc-13c6-464f-b54d-e0244a85abd9_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_label_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional 402(v) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Additional402vDisclosureTextBlock" xlink:to="lab_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditLossFinancialInstrumentPolicyTextBlock_45b6f3db-4afa-46ce-837b-a738fde7ffc6_terseLabel_en-US" xlink:label="lab_us-gaap_CreditLossFinancialInstrumentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Credit Loss</link:label>
    <link:label id="lab_us-gaap_CreditLossFinancialInstrumentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CreditLossFinancialInstrumentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Loss, Financial Instrument [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditLossFinancialInstrumentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditLossFinancialInstrumentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditLossFinancialInstrumentPolicyTextBlock" xlink:to="lab_us-gaap_CreditLossFinancialInstrumentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_ba5b0bce-c1ab-41c0-ac83-60e611c691dd_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_1e6d1fdc-45e5-4692-ba75-999dccd79354_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares remaining available for issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_BusinessCombinationDefinedBenefitPlanNumberOfPlansAssumed_c41e2d91-04c3-42e9-89b0-549ca461b963_terseLabel_en-US" xlink:label="lab_iff_BusinessCombinationDefinedBenefitPlanNumberOfPlansAssumed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of defined benefit plans assumed</link:label>
    <link:label id="lab_iff_BusinessCombinationDefinedBenefitPlanNumberOfPlansAssumed_label_en-US" xlink:label="lab_iff_BusinessCombinationDefinedBenefitPlanNumberOfPlansAssumed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Defined Benefit Plan, Number Of Plans Assumed</link:label>
    <link:label id="lab_iff_BusinessCombinationDefinedBenefitPlanNumberOfPlansAssumed_documentation_en-US" xlink:label="lab_iff_BusinessCombinationDefinedBenefitPlanNumberOfPlansAssumed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Defined Benefit Plan, Number Of Plans Assumed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BusinessCombinationDefinedBenefitPlanNumberOfPlansAssumed" xlink:href="iff-20231231.xsd#iff_BusinessCombinationDefinedBenefitPlanNumberOfPlansAssumed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_BusinessCombinationDefinedBenefitPlanNumberOfPlansAssumed" xlink:to="lab_iff_BusinessCombinationDefinedBenefitPlanNumberOfPlansAssumed" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_EachTwelveMonthPeriodMember_dfa9f4e3-9a53-4301-aed1-bdd90e1979c3_terseLabel_en-US" xlink:label="lab_iff_EachTwelveMonthPeriodMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Each twelve-month period [Member]</link:label>
    <link:label id="lab_iff_EachTwelveMonthPeriodMember_label_en-US" xlink:label="lab_iff_EachTwelveMonthPeriodMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Each Twelve Month Period [Member]</link:label>
    <link:label id="lab_iff_EachTwelveMonthPeriodMember_documentation_en-US" xlink:label="lab_iff_EachTwelveMonthPeriodMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Each Twelve Month Period [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EachTwelveMonthPeriodMember" xlink:href="iff-20231231.xsd#iff_EachTwelveMonthPeriodMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_EachTwelveMonthPeriodMember" xlink:to="lab_iff_EachTwelveMonthPeriodMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2d26060f-7a35-4762-b313-57ec17f7a749_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options, granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_4eb91062-d7dc-4b2b-922c-688974d5b48d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_c2acb7f4-a55d-41f9-8a9f-a77124c60270_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_08e61a75-088c-4d0c-b8fe-3a7cf7491539_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_69829c6c-da9f-4bff-9fcf-38159e006d8d_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RecoveryOfErrCompDisclosureLineItems_label_en-US" xlink:label="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recovery of Erroneously Awarded Compensation Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_e9c6e5c7-c681-4e77-99cc-58b128da8620_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Five</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DisposalGroupIncludingDiscontinuedOperationConsiderationPayableReceivable_49692704-b825-4818-a13c-df25e0d1317e_terseLabel_en-US" xlink:label="lab_iff_DisposalGroupIncludingDiscontinuedOperationConsiderationPayableReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable from the buyer</link:label>
    <link:label id="lab_iff_DisposalGroupIncludingDiscontinuedOperationConsiderationPayableReceivable_label_en-US" xlink:label="lab_iff_DisposalGroupIncludingDiscontinuedOperationConsiderationPayableReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration Payable (Receivable)</link:label>
    <link:label id="lab_iff_DisposalGroupIncludingDiscontinuedOperationConsiderationPayableReceivable_documentation_en-US" xlink:label="lab_iff_DisposalGroupIncludingDiscontinuedOperationConsiderationPayableReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration Payable (Receivable)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupIncludingDiscontinuedOperationConsiderationPayableReceivable" xlink:href="iff-20231231.xsd#iff_DisposalGroupIncludingDiscontinuedOperationConsiderationPayableReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DisposalGroupIncludingDiscontinuedOperationConsiderationPayableReceivable" xlink:to="lab_iff_DisposalGroupIncludingDiscontinuedOperationConsiderationPayableReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_4f5a6102-b6e6-4270-bf94-f7c79a1704f8_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative instruments outstanding</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplierFinanceProgramObligation_3d0a1f47-d8b0-45f7-aa9a-29a432365ea9_terseLabel_en-US" xlink:label="lab_us-gaap_SupplierFinanceProgramObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supply chain financing, obligation</link:label>
    <link:label id="lab_us-gaap_SupplierFinanceProgramObligation_label_en-US" xlink:label="lab_us-gaap_SupplierFinanceProgramObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Finance Program, Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierFinanceProgramObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplierFinanceProgramObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplierFinanceProgramObligation" xlink:to="lab_us-gaap_SupplierFinanceProgramObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfCommercialPaper_c0d76651-e33b-40c3-b3d6-070f73630b8e_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of commercial paper</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfCommercialPaper_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfCommercialPaper" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfCommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfCommercialPaper" xlink:to="lab_us-gaap_RepaymentsOfCommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_UnusualOrInfrequentItemsOrBothDisclosurePolicyTextBlock_5dc1b210-919f-4262-ad10-5a01766b3bf4_terseLabel_en-US" xlink:label="lab_iff_UnusualOrInfrequentItemsOrBothDisclosurePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Items, or Both, Disclosure</link:label>
    <link:label id="lab_iff_UnusualOrInfrequentItemsOrBothDisclosurePolicyTextBlock_label_en-US" xlink:label="lab_iff_UnusualOrInfrequentItemsOrBothDisclosurePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Items, or Both, Disclosure [Policy Text Block]</link:label>
    <link:label id="lab_iff_UnusualOrInfrequentItemsOrBothDisclosurePolicyTextBlock_documentation_en-US" xlink:label="lab_iff_UnusualOrInfrequentItemsOrBothDisclosurePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Items, or Both, Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_UnusualOrInfrequentItemsOrBothDisclosurePolicyTextBlock" xlink:href="iff-20231231.xsd#iff_UnusualOrInfrequentItemsOrBothDisclosurePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_UnusualOrInfrequentItemsOrBothDisclosurePolicyTextBlock" xlink:to="lab_iff_UnusualOrInfrequentItemsOrBothDisclosurePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_1efc8f31-01d2-4a2f-9deb-d2f7b63e4b2e_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations and Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_db634421-902c-412d-8635-55fcef40f06b_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_a8b9e480-9f1e-4293-819a-3bc6c731bc9c_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSU's [Member]</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_50648b9f-0078-4545-9e4f-24b33e75831d_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PRSUs [Member]</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_269aa3dd-3462-4be3-8c55-bd16b4c13ea9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSU Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_27444796-4892-4e2f-b87b-c8cd6ba165c3_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash RSU Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_LiabilityBasedAwardsMember_647bd518-65cb-4e74-919b-aae0f41e32e8_terseLabel_en-US" xlink:label="lab_iff_LiabilityBasedAwardsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability-based awards [Member]</link:label>
    <link:label id="lab_iff_LiabilityBasedAwardsMember_label_en-US" xlink:label="lab_iff_LiabilityBasedAwardsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Based Awards [Member]</link:label>
    <link:label id="lab_iff_LiabilityBasedAwardsMember_documentation_en-US" xlink:label="lab_iff_LiabilityBasedAwardsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability-based awards [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_LiabilityBasedAwardsMember" xlink:href="iff-20231231.xsd#iff_LiabilityBasedAwardsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_LiabilityBasedAwardsMember" xlink:to="lab_iff_LiabilityBasedAwardsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_679392b7-1cc6-4f3a-9609-0ae17d7fb3d6_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_e92f454e-88fb-47a8-8046-97cab1627d77_terseLabel_en-US" xlink:label="lab_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization And Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_label_en-US" xlink:label="lab_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization And Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_documentation_en-US" xlink:label="lab_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization And Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:href="iff-20231231.xsd#iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:to="lab_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_6b35d94e-0ddb-4037-8af7-f619d07770dd_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_StockOptionsAndSsarsMember_cf85bc0e-8810-4f20-a0c2-fd14b09b15f0_terseLabel_en-US" xlink:label="lab_iff_StockOptionsAndSsarsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SSAR's and Stock Options [Member]</link:label>
    <link:label id="lab_iff_StockOptionsAndSsarsMember_label_en-US" xlink:label="lab_iff_StockOptionsAndSsarsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options And Ssars [Member]</link:label>
    <link:label id="lab_iff_StockOptionsAndSsarsMember_documentation_en-US" xlink:label="lab_iff_StockOptionsAndSsarsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options and SSARs Member.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_StockOptionsAndSsarsMember" xlink:href="iff-20231231.xsd#iff_StockOptionsAndSsarsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_StockOptionsAndSsarsMember" xlink:to="lab_iff_StockOptionsAndSsarsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_c923e669-d456-46fa-b128-d23165555204_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransactionTypeAxis_252d61ad-a589-4563-80fa-047827251dec_terseLabel_en-US" xlink:label="lab_us-gaap_TransactionTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction Type [Axis]</link:label>
    <link:label id="lab_us-gaap_TransactionTypeAxis_label_en-US" xlink:label="lab_us-gaap_TransactionTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransactionTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransactionTypeAxis" xlink:to="lab_us-gaap_TransactionTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_ThreeHundredSixtyFourDaySeniorUnsecuredBridgeFacilityMember_f406c36c-f372-4e09-8f45-bdc2496ad200_terseLabel_en-US" xlink:label="lab_iff_ThreeHundredSixtyFourDaySeniorUnsecuredBridgeFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Hundred Sixty Four Day Senior Unsecured Bridge Facility [Member]</link:label>
    <link:label id="lab_iff_ThreeHundredSixtyFourDaySeniorUnsecuredBridgeFacilityMember_label_en-US" xlink:label="lab_iff_ThreeHundredSixtyFourDaySeniorUnsecuredBridgeFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Hundred Sixty Four Day Senior Unsecured Bridge Facility [Member]</link:label>
    <link:label id="lab_iff_ThreeHundredSixtyFourDaySeniorUnsecuredBridgeFacilityMember_documentation_en-US" xlink:label="lab_iff_ThreeHundredSixtyFourDaySeniorUnsecuredBridgeFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Hundred Sixty Four Day Senior Unsecured Bridge Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ThreeHundredSixtyFourDaySeniorUnsecuredBridgeFacilityMember" xlink:href="iff-20231231.xsd#iff_ThreeHundredSixtyFourDaySeniorUnsecuredBridgeFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_ThreeHundredSixtyFourDaySeniorUnsecuredBridgeFacilityMember" xlink:to="lab_iff_ThreeHundredSixtyFourDaySeniorUnsecuredBridgeFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_2c392f21-59c7-4c4c-8003-fa3f72cff331_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development credit</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_2a6239a4-338f-46fd-ad98-271d111caf26_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of tangible equity units</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_LinesOfCreditFacilityTotalAmountDrawnDown_52e7d8d2-93c1-440c-bbb2-d2ccb5c0e341_terseLabel_en-US" xlink:label="lab_iff_LinesOfCreditFacilityTotalAmountDrawnDown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lines of Credit Facility, Current Borrowing Amount/Total Amount Drawn Down</link:label>
    <link:label id="lab_iff_LinesOfCreditFacilityTotalAmountDrawnDown_label_en-US" xlink:label="lab_iff_LinesOfCreditFacilityTotalAmountDrawnDown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lines Of Credit Facility, Total Amount Drawn Down</link:label>
    <link:label id="lab_iff_LinesOfCreditFacilityTotalAmountDrawnDown_documentation_en-US" xlink:label="lab_iff_LinesOfCreditFacilityTotalAmountDrawnDown" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lines Of Credit Facility, Total Amount Drawn Down</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_LinesOfCreditFacilityTotalAmountDrawnDown" xlink:href="iff-20231231.xsd#iff_LinesOfCreditFacilityTotalAmountDrawnDown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_LinesOfCreditFacilityTotalAmountDrawnDown" xlink:to="lab_iff_LinesOfCreditFacilityTotalAmountDrawnDown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_ae61ef33-ed34-41ed-880f-afb1200d7c2e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:to="lab_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_09af3a4d-90e6-4550-901b-b25362901aee_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Including Goodwill)</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Including Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201712Member_c49c41c2-ad68-4c5c-9793-fa824e3ef105_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201712Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2017-12 [Member]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201712Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201712Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2017-12 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201712Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingStandardsUpdate201712Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201712Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201712Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_f6d01cd3-6578-4f8a-af73-e3a7230da760_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_e70449e8-3d41-46cb-ba8d-acd017ebcb71_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_d8a9e60c-1626-49da-a468-35ed697dcacf_verboseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_5ff1c501-aba8-4a5f-b361-86ae002039f9_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued income taxes</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MalpracticeLossContingencyPeriodCost_b85afa85-fefb-4d30-a9d2-2421fe3691a4_terseLabel_en-US" xlink:label="lab_us-gaap_MalpracticeLossContingencyPeriodCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current associated costs</link:label>
    <link:label id="lab_us-gaap_MalpracticeLossContingencyPeriodCost_label_en-US" xlink:label="lab_us-gaap_MalpracticeLossContingencyPeriodCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Malpractice Loss Contingency, Period Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MalpracticeLossContingencyPeriodCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MalpracticeLossContingencyPeriodCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MalpracticeLossContingencyPeriodCost" xlink:to="lab_us-gaap_MalpracticeLossContingencyPeriodCost" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_TangibleEquityUnitsTable_05f2d146-4e44-42b0-bb50-f05fe7b9a097_terseLabel_en-US" xlink:label="lab_iff_TangibleEquityUnitsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Equity Units [Table]</link:label>
    <link:label id="lab_iff_TangibleEquityUnitsTable_label_en-US" xlink:label="lab_iff_TangibleEquityUnitsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Equity Units [Table]</link:label>
    <link:label id="lab_iff_TangibleEquityUnitsTable_documentation_en-US" xlink:label="lab_iff_TangibleEquityUnitsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Equity Units [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityUnitsTable" xlink:href="iff-20231231.xsd#iff_TangibleEquityUnitsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_TangibleEquityUnitsTable" xlink:to="lab_iff_TangibleEquityUnitsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DisposalGroupIncludingDiscontinuedOperationTradeReceivablesNet_0964560b-699e-4b67-9c50-ed708c607ccf_terseLabel_en-US" xlink:label="lab_iff_DisposalGroupIncludingDiscontinuedOperationTradeReceivablesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade receivables, net</link:label>
    <link:label id="lab_iff_DisposalGroupIncludingDiscontinuedOperationTradeReceivablesNet_label_en-US" xlink:label="lab_iff_DisposalGroupIncludingDiscontinuedOperationTradeReceivablesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Trade Receivables, Net</link:label>
    <link:label id="lab_iff_DisposalGroupIncludingDiscontinuedOperationTradeReceivablesNet_documentation_en-US" xlink:label="lab_iff_DisposalGroupIncludingDiscontinuedOperationTradeReceivablesNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Trade Receivables, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupIncludingDiscontinuedOperationTradeReceivablesNet" xlink:href="iff-20231231.xsd#iff_DisposalGroupIncludingDiscontinuedOperationTradeReceivablesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DisposalGroupIncludingDiscontinuedOperationTradeReceivablesNet" xlink:to="lab_iff_DisposalGroupIncludingDiscontinuedOperationTradeReceivablesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_d0278294-8308-4e04-95c8-6c3daed981e1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_d7ef8cab-e15f-41a9-b50c-c29e0d44a2d5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_terseLabel_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Available</link:label>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_label_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement, Securities Aggregate Available Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticPlanMember_3df59757-e344-4ec7-99cc-d4814d319706_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Plan</link:label>
    <link:label id="lab_us-gaap_DomesticPlanMember_label_en-US" xlink:label="lab_us-gaap_DomesticPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticPlanMember" xlink:to="lab_us-gaap_DomesticPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_8104f4f1-f4db-47fd-816d-a40ba905f59e_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current payables and accrued expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_b75a8b4e-432e-4b35-9de3-b3e3530778df_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_8eca2337-413c-46ca-9ad6-6d42e2ee9d5d_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_0a135383-be7a-486b-a601-eb0adc57c6f1_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued restructuring</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_0eacec7a-53c1-41b9-b23a-390d95f99931_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition related costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_7516ccba-a09d-4268-8619-dfb63b043b69_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition Related Costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_a41c79e8-cc16-4a33-89a6-d51ab4ed0336_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_d68b3622-3391-4d0a-a0a9-788520c437cd_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_691225b6-cd6c-4b33-a5c9-09eddf1f8789_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_CitibankN.AMember_1c5305ad-0053-4688-ab5f-5158dc3f0c0b_terseLabel_en-US" xlink:label="lab_iff_CitibankN.AMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Citibank, N.A</link:label>
    <link:label id="lab_iff_CitibankN.AMember_label_en-US" xlink:label="lab_iff_CitibankN.AMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Citibank, N.A [Member]</link:label>
    <link:label id="lab_iff_CitibankN.AMember_documentation_en-US" xlink:label="lab_iff_CitibankN.AMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Citibank, N.A [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_CitibankN.AMember" xlink:href="iff-20231231.xsd#iff_CitibankN.AMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_CitibankN.AMember" xlink:to="lab_iff_CitibankN.AMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_5c5f9dd2-f3f3-44f6-8785-0b413f9240eb_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_28e6d461-0cf9-4f88-b2a6-031399db04ff_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Fair Value Hierarchy [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_58248930-71f3-4da6-b754-9ef7c3f4d0a9_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_a13b6dc2-946f-4e4b-9f3e-4fd6ad180871_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_91ca72ac-31b7-4eea-982c-7b347ef280be_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_7aade2fd-1b8c-414c-ba3a-6d63cb18af0c_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_ade2f0bb-0cc3-427f-a943-d82c6ebb8144_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_4ff2402b-a639-4061-b16b-228c40906077_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less Imputed Interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_36ee5a79-bc0e-46cb-8067-425bf8aef794_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution to the plans</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_d7145f17-b8d0-4e58-afa2-5a2146fbc446_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_label_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoActuallyPaidCompAmt" xlink:to="lab_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_e87f7695-4ffe-40af-91dc-122d937a8ea6_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesFairValueLineItems" xlink:to="lab_us-gaap_DerivativesFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_e7c886d1-ff5f-41b6-aab3-06d6c559f26b_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_fc8c7a5c-0ea3-46d8-bb71-0d32d0948057_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income Tax Provision</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveSettledWithoutCash2_10db6964-38b6-4481-9188-346459f1f636_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Cash Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveSettledWithoutCash2_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Settled without Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:to="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_AmortizationPeriodOfInternalAndExternalDevelopmentCosts_37d7d091-9bda-4c5e-a603-7480ea98962b_terseLabel_en-US" xlink:label="lab_iff_AmortizationPeriodOfInternalAndExternalDevelopmentCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization period of internal and external development costs, years</link:label>
    <link:label id="lab_iff_AmortizationPeriodOfInternalAndExternalDevelopmentCosts_label_en-US" xlink:label="lab_iff_AmortizationPeriodOfInternalAndExternalDevelopmentCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization Period Of Internal And External Development Costs</link:label>
    <link:label id="lab_iff_AmortizationPeriodOfInternalAndExternalDevelopmentCosts_documentation_en-US" xlink:label="lab_iff_AmortizationPeriodOfInternalAndExternalDevelopmentCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization period of internal and external development costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AmortizationPeriodOfInternalAndExternalDevelopmentCosts" xlink:href="iff-20231231.xsd#iff_AmortizationPeriodOfInternalAndExternalDevelopmentCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_AmortizationPeriodOfInternalAndExternalDevelopmentCosts" xlink:to="lab_iff_AmortizationPeriodOfInternalAndExternalDevelopmentCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_110fb31b-cd4e-41ad-9a3c-faef3369e3cb_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting unit in excess of carrying amount</link:label>
    <link:label id="lab_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_label_en-US" xlink:label="lab_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount" xlink:to="lab_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_622dbedb-5ed1-4350-85fd-7ae0ef3268e7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_FlavorSpecialtyIngredientsMember_0a77ebab-08ec-4e07-8986-ec9bcaca4769_terseLabel_en-US" xlink:label="lab_iff_FlavorSpecialtyIngredientsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Flavor Specialty Ingredients</link:label>
    <link:label id="lab_iff_FlavorSpecialtyIngredientsMember_label_en-US" xlink:label="lab_iff_FlavorSpecialtyIngredientsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Flavor Specialty Ingredients [Member]</link:label>
    <link:label id="lab_iff_FlavorSpecialtyIngredientsMember_documentation_en-US" xlink:label="lab_iff_FlavorSpecialtyIngredientsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Flavor Specialty Ingredients</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FlavorSpecialtyIngredientsMember" xlink:href="iff-20231231.xsd#iff_FlavorSpecialtyIngredientsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_FlavorSpecialtyIngredientsMember" xlink:to="lab_iff_FlavorSpecialtyIngredientsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_02aaef10-a745-4f6f-88f1-0121308cd16f_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumptionsInPeriod_0575ac33-e4ce-48d6-81ac-42f32d6b1f9b_terseLabel_en-US" xlink:label="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumptionsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed (in shares)</link:label>
    <link:label id="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumptionsInPeriod_label_en-US" xlink:label="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumptionsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Assumptions In Period</link:label>
    <link:label id="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumptionsInPeriod_documentation_en-US" xlink:label="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumptionsInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Assumptions In Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumptionsInPeriod" xlink:href="iff-20231231.xsd#iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumptionsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumptionsInPeriod" xlink:to="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumptionsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_6a4216a1-8b32-4cea-9438-136158788363_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current operating lease obligation</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_fb771f13-4797-42b9-8838-cb8fdae9b136_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent" xlink:to="lab_us-gaap_PrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation_301c3ad7-6b98-47da-9ef4-3bf02221dfef_terseLabel_en-US" xlink:label="lab_iff_AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Foreign Currency Translation</link:label>
    <link:label id="lab_iff_AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation_label_en-US" xlink:label="lab_iff_AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Foreign Currency Translation</link:label>
    <link:label id="lab_iff_AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation_documentation_en-US" xlink:label="lab_iff_AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Foreign Currency Translation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation" xlink:href="iff-20231231.xsd#iff_AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation" xlink:to="lab_iff_AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock_133deb8f-4fde-46be-bc7c-002ac814db7f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOtherAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInAccumulatedBenefitObligation_e78e5e76-205b-445e-a62f-1020fbc0c6fd_terseLabel_en-US" xlink:label="lab_iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">25 BP decrease in discount rate, change in ABO</link:label>
    <link:label id="lab_iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInAccumulatedBenefitObligation_label_en-US" xlink:label="lab_iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Effect Of Twenty Five Base Point Decrease In Discount Rate In Accumulated Benefit Obligation</link:label>
    <link:label id="lab_iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInAccumulatedBenefitObligation_documentation_en-US" xlink:label="lab_iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit plan, effect of twenty five base point decrease in discount rate in accumulated benefit obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInAccumulatedBenefitObligation" xlink:href="iff-20231231.xsd#iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInAccumulatedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInAccumulatedBenefitObligation" xlink:to="lab_iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInAccumulatedBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_ae28dc7c-8915-4000-bdf6-8783c45c6061_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentageGrantedInCashToEligibleEmployees_d784d813-f2b2-4524-9875-f407106ad6a6_terseLabel_en-US" xlink:label="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentageGrantedInCashToEligibleEmployees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting percentage granted in cash to eligible employees</link:label>
    <link:label id="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentageGrantedInCashToEligibleEmployees_label_en-US" xlink:label="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentageGrantedInCashToEligibleEmployees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Vesting Percentage, Granted In Cash To Eligible Employees</link:label>
    <link:label id="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentageGrantedInCashToEligibleEmployees_documentation_en-US" xlink:label="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentageGrantedInCashToEligibleEmployees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation arrangement by share-based payment award, vesting percentage granted in cash to eligible employees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentageGrantedInCashToEligibleEmployees" xlink:href="iff-20231231.xsd#iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentageGrantedInCashToEligibleEmployees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentageGrantedInCashToEligibleEmployees" xlink:to="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentageGrantedInCashToEligibleEmployees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_030a5fc3-7bd3-406e-95aa-c56031eb3511_terseLabel_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI before reclassifications</link:label>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, before Reclassifications, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:to="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet_58807458-8fd5-432e-a388-06b2d7891b40_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Increase (Decrease), Net</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Increase (Decrease), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:to="lab_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_3f237680-08fc-4d3b-bc26-8c0ff32d528f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_8694f5ed-49d5-4ec6-9563-7f4cfdf9d6c9_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_f4abbe12-8872-4adc-9540-bc7817e4d82b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_2462c8cd-bda8-4bd3-a807-4857680559a5_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_2ba32129-53d9-44d8-a426-764df34808ed_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:to="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_a80f8699-a363-494b-bcfd-1286fe628d83_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Required Company Contributions in the Following Year (2024)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_BusinessCombinationConsiderationTransferredReplacementEquityAwardsIssued_2c6dc858-616d-4cf7-b9a7-d63730d25cb8_terseLabel_en-US" xlink:label="lab_iff_BusinessCombinationConsiderationTransferredReplacementEquityAwardsIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value attributable to pre-merger service for replacement equity awards</link:label>
    <link:label id="lab_iff_BusinessCombinationConsiderationTransferredReplacementEquityAwardsIssued_label_en-US" xlink:label="lab_iff_BusinessCombinationConsiderationTransferredReplacementEquityAwardsIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Replacement Equity Awards Issued</link:label>
    <link:label id="lab_iff_BusinessCombinationConsiderationTransferredReplacementEquityAwardsIssued_documentation_en-US" xlink:label="lab_iff_BusinessCombinationConsiderationTransferredReplacementEquityAwardsIssued" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Replacement Equity Awards Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BusinessCombinationConsiderationTransferredReplacementEquityAwardsIssued" xlink:href="iff-20231231.xsd#iff_BusinessCombinationConsiderationTransferredReplacementEquityAwardsIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_BusinessCombinationConsiderationTransferredReplacementEquityAwardsIssued" xlink:to="lab_iff_BusinessCombinationConsiderationTransferredReplacementEquityAwardsIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfDerivatives_8dfbc147-15b4-47b6-a318-7c29c4a15715_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfDerivatives" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on deal contingent derivatives</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfDerivatives_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfDerivatives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Sale of Derivatives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfDerivatives" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfDerivatives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfDerivatives" xlink:to="lab_us-gaap_GainLossOnSaleOfDerivatives" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_3f0651a4-4acb-4bdd-a25c-0ab78935d6e4_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DisposalGroupIncludingDiscontinuedOperationTransactionCost_de3f46df-689d-4054-85db-fa9f4b194c23_negatedTerseLabel_en-US" xlink:label="lab_iff_DisposalGroupIncludingDiscontinuedOperationTransactionCost" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct costs to sell</link:label>
    <link:label id="lab_iff_DisposalGroupIncludingDiscontinuedOperationTransactionCost_label_en-US" xlink:label="lab_iff_DisposalGroupIncludingDiscontinuedOperationTransactionCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Transaction Cost</link:label>
    <link:label id="lab_iff_DisposalGroupIncludingDiscontinuedOperationTransactionCost_documentation_en-US" xlink:label="lab_iff_DisposalGroupIncludingDiscontinuedOperationTransactionCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Transaction Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupIncludingDiscontinuedOperationTransactionCost" xlink:href="iff-20231231.xsd#iff_DisposalGroupIncludingDiscontinuedOperationTransactionCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DisposalGroupIncludingDiscontinuedOperationTransactionCost" xlink:to="lab_iff_DisposalGroupIncludingDiscontinuedOperationTransactionCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_4eb61974-a5e3-44d6-9177-a4c798884228_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValueOfSharesPurchasedByEmployees_e92d5df4-6f46-4176-aff2-eacd45fb54f0_terseLabel_en-US" xlink:label="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValueOfSharesPurchasedByEmployees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate purchase price (in dollars per share)</link:label>
    <link:label id="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValueOfSharesPurchasedByEmployees_65d80c8b-8c13-4d80-ab8d-3d32c5e22830_verboseLabel_en-US" xlink:label="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValueOfSharesPurchasedByEmployees" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Purchases</link:label>
    <link:label id="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValueOfSharesPurchasedByEmployees_label_en-US" xlink:label="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValueOfSharesPurchasedByEmployees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Value Of Shares Purchased By Employees</link:label>
    <link:label id="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValueOfSharesPurchasedByEmployees_documentation_en-US" xlink:label="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValueOfSharesPurchasedByEmployees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate employee purchase price for share based compensation arrangement by share based payment award equity instruments other than option grants in period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValueOfSharesPurchasedByEmployees" xlink:href="iff-20231231.xsd#iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValueOfSharesPurchasedByEmployees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValueOfSharesPurchasedByEmployees" xlink:to="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValueOfSharesPurchasedByEmployees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_79ec61a5-1ce1-491a-9e6b-ecfe687532f4_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInMinorityInterestRollForward_97ae3b22-650e-4365-966c-b18239838e5c_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInMinorityInterestRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInMinorityInterestRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInMinorityInterestRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Attributable to Noncontrolling Interest [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInMinorityInterestRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MovementInMinorityInterestRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward" xlink:to="lab_us-gaap_MovementInMinorityInterestRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_A2017ProductivityProgramMember_b111d9a1-bd6a-4ba7-8d1c-583d7e4ddf47_terseLabel_en-US" xlink:label="lab_iff_A2017ProductivityProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017 Productivity Program [Member]</link:label>
    <link:label id="lab_iff_A2017ProductivityProgramMember_label_en-US" xlink:label="lab_iff_A2017ProductivityProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017 Productivity Program [Member]</link:label>
    <link:label id="lab_iff_A2017ProductivityProgramMember_documentation_en-US" xlink:label="lab_iff_A2017ProductivityProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017 Productivity Program [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_A2017ProductivityProgramMember" xlink:href="iff-20231231.xsd#iff_A2017ProductivityProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_A2017ProductivityProgramMember" xlink:to="lab_iff_A2017ProductivityProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableGross_4a48c2da-d3b1-47b5-8c6f-f04ccea25f29_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, before allowance for credit loss</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableGross_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableGross" xlink:to="lab_us-gaap_AccountsReceivableGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_94c5cf42-a053-4b75-91e7-44f8c1526031_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings before Income Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_141edb3f-7ffb-45d6-8b6c-24edaa3beb2a_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_label_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Price or TSR Estimation Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_52bc2b20-50d1-4c11-ac98-f38a3a9ada22_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign (loss) income before taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_4e3dde3e-c352-4189-b7ae-21ca48eb3e31_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_e13e9719-07f5-45b0-9752-7ae4aad9cf5f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, consideration transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_1df5a417-3aa2-49d8-b1f4-2aec0334ce18_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, consideration transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_a42ce171-eab9-40b6-8214-20c103c9748a_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_AccruedCommissionsPayableCurrent_75e295a8-ce68-44ef-8133-2015ab7a66ef_terseLabel_en-US" xlink:label="lab_iff_AccruedCommissionsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Commissions Payable, Current</link:label>
    <link:label id="lab_iff_AccruedCommissionsPayableCurrent_label_en-US" xlink:label="lab_iff_AccruedCommissionsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Commissions Payable, Current</link:label>
    <link:label id="lab_iff_AccruedCommissionsPayableCurrent_documentation_en-US" xlink:label="lab_iff_AccruedCommissionsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Commissions Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AccruedCommissionsPayableCurrent" xlink:href="iff-20231231.xsd#iff_AccruedCommissionsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_AccruedCommissionsPayableCurrent" xlink:to="lab_iff_AccruedCommissionsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_ShareBasedPaymentArrangementPurchasedRestrictedStockUnitActivityTableTextBlock_14fd53c5-c5fd-41a6-a7a4-8cae5bba5510_terseLabel_en-US" xlink:label="lab_iff_ShareBasedPaymentArrangementPurchasedRestrictedStockUnitActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PRSU Activity</link:label>
    <link:label id="lab_iff_ShareBasedPaymentArrangementPurchasedRestrictedStockUnitActivityTableTextBlock_label_en-US" xlink:label="lab_iff_ShareBasedPaymentArrangementPurchasedRestrictedStockUnitActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Purchased Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:label id="lab_iff_ShareBasedPaymentArrangementPurchasedRestrictedStockUnitActivityTableTextBlock_documentation_en-US" xlink:label="lab_iff_ShareBasedPaymentArrangementPurchasedRestrictedStockUnitActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Purchased Restricted Stock Unit, Activity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedPaymentArrangementPurchasedRestrictedStockUnitActivityTableTextBlock" xlink:href="iff-20231231.xsd#iff_ShareBasedPaymentArrangementPurchasedRestrictedStockUnitActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_ShareBasedPaymentArrangementPurchasedRestrictedStockUnitActivityTableTextBlock" xlink:to="lab_iff_ShareBasedPaymentArrangementPurchasedRestrictedStockUnitActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_435c5814-ba13-472e-a243-7a4c0bed3b69_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_36df1975-2930-4c04-9ffa-632cd447e246_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsDividends_3f3789ca-f058-4af3-ace7-bf20efc943c5_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsDividends" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend deduction percentage</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsDividends_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Deduction, Dividend, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsDividends" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d9421471-d346-492f-936d-b85c1aef09ef_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_fe150eac-381f-4547-89fe-2927d04738d1_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_FixedAssetWriteDownMember_e2210cbc-824f-4fba-9c83-7c53fce8c964_terseLabel_en-US" xlink:label="lab_iff_FixedAssetWriteDownMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed asset write down</link:label>
    <link:label id="lab_iff_FixedAssetWriteDownMember_label_en-US" xlink:label="lab_iff_FixedAssetWriteDownMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Asset Write Down [Member]</link:label>
    <link:label id="lab_iff_FixedAssetWriteDownMember_documentation_en-US" xlink:label="lab_iff_FixedAssetWriteDownMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Asset Write Down [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FixedAssetWriteDownMember" xlink:href="iff-20231231.xsd#iff_FixedAssetWriteDownMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_FixedAssetWriteDownMember" xlink:to="lab_iff_FixedAssetWriteDownMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_c3013413-97fd-44a1-93bc-7e79ad29fe96_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:to="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_FinanceLeaseCost_017bc7fa-ffcb-495f-89b0-057e4a53ee9f_terseLabel_en-US" xlink:label="lab_iff_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease cost</link:label>
    <link:label id="lab_iff_FinanceLeaseCost_label_en-US" xlink:label="lab_iff_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Cost</link:label>
    <link:label id="lab_iff_FinanceLeaseCost_documentation_en-US" xlink:label="lab_iff_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FinanceLeaseCost" xlink:href="iff-20231231.xsd#iff_FinanceLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_FinanceLeaseCost" xlink:to="lab_iff_FinanceLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_53b713bb-195c-41a9-88da-3145c085ae0b_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Cost Incurred to Date</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Cost Incurred to Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_dbe31e21-9298-4f16-8e43-c695f1397692_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_8fdeb62e-5a86-4d3e-8f28-1cb954d22600_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation cost related to non-vested stock options and SSAR, RSU, PRS and Cash RSU awards granted</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract_172d2297-fc70-4a1d-856f-5e8be1f026eb_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_2c54b9de-7477-48a2-afe1-0a911952bfd4_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_BankGuaranteesAndPledgedAssetsToPursueDefensesRelatedToOtherContingencies_d94ad533-538b-41cb-9a8b-972cdde4d7a0_terseLabel_en-US" xlink:label="lab_iff_BankGuaranteesAndPledgedAssetsToPursueDefensesRelatedToOtherContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank guarantees and pledged assets to pursue defenses related to other contingencies</link:label>
    <link:label id="lab_iff_BankGuaranteesAndPledgedAssetsToPursueDefensesRelatedToOtherContingencies_label_en-US" xlink:label="lab_iff_BankGuaranteesAndPledgedAssetsToPursueDefensesRelatedToOtherContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank Guarantees And Pledged Assets To Pursue Defenses Related To Other Contingencies</link:label>
    <link:label id="lab_iff_BankGuaranteesAndPledgedAssetsToPursueDefensesRelatedToOtherContingencies_documentation_en-US" xlink:label="lab_iff_BankGuaranteesAndPledgedAssetsToPursueDefensesRelatedToOtherContingencies" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank guarantees and pledged assets to pursue defenses related to other contingencies.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BankGuaranteesAndPledgedAssetsToPursueDefensesRelatedToOtherContingencies" xlink:href="iff-20231231.xsd#iff_BankGuaranteesAndPledgedAssetsToPursueDefensesRelatedToOtherContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_BankGuaranteesAndPledgedAssetsToPursueDefensesRelatedToOtherContingencies" xlink:to="lab_iff_BankGuaranteesAndPledgedAssetsToPursueDefensesRelatedToOtherContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts_fe145b13-14ed-48f8-b34b-e85de42fbd40_terseLabel_en-US" xlink:label="lab_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt related commitment fees and debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Related Commitment Fees and Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts" xlink:to="lab_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_d904aadb-1518-468a-8136-4a22a989dd5b_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_b5e0c7ef-ab2b-4fdd-b346-06ad84e095f8_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TabularListTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular List, Table</link:label>
    <link:label id="lab_ecd_TabularListTableTextBlock_label_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular List [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TabularListTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TabularListTableTextBlock" xlink:to="lab_ecd_TabularListTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_27838087-158c-44d1-82fd-7a0283c4c534_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial losses</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrencySwapMember_f16ac7c8-ba42-4adb-999f-85f92fda05e3_terseLabel_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Swap</link:label>
    <link:label id="lab_us-gaap_CurrencySwapMember_label_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrencySwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrencySwapMember" xlink:to="lab_us-gaap_CurrencySwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EMEAMember_cd00a382-6320-4ddc-9536-bc3f6b3b5db0_terseLabel_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMEA</link:label>
    <link:label id="lab_us-gaap_EMEAMember_9fe5c604-4ddb-41da-bf78-c1af348d3018_verboseLabel_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe, Africa and Middle East [Member]</link:label>
    <link:label id="lab_us-gaap_EMEAMember_label_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMEA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EMEAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EMEAMember" xlink:to="lab_us-gaap_EMEAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_754aa907-351a-43df-895c-a7b6875d1732_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_8e3328fb-aab5-4205-aad5-614b530eb4b6_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">More than 5 Years</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_c698e640-3459-448c-83d7-f33daba17f20_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_8d3f1eef-b413-40f9-90ba-c8041190948c_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_bebe14ec-e966-4974-8a6b-7abb88c16bce_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_c1d39553-a8a2-4221-b964-19d59d8c3e04_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_PensionExpensesTableTextBlock_7e9a9921-f353-4067-81ce-d22ac90d68cf_terseLabel_en-US" xlink:label="lab_iff_PensionExpensesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Assets and Benefit Obligations of Defined Benefit Pension Plans</link:label>
    <link:label id="lab_iff_PensionExpensesTableTextBlock_label_en-US" xlink:label="lab_iff_PensionExpensesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Expenses [Table Text Block]</link:label>
    <link:label id="lab_iff_PensionExpensesTableTextBlock_documentation_en-US" xlink:label="lab_iff_PensionExpensesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Table for Net Periodic Benefit Cost and Changes in Plan Assets and Benefit Obligations Recognized in OCI.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_PensionExpensesTableTextBlock" xlink:href="iff-20231231.xsd#iff_PensionExpensesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_PensionExpensesTableTextBlock" xlink:to="lab_iff_PensionExpensesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ChiefExecutiveOfficerMember_d5c541ab-b70d-419a-9340-14424d5341db_terseLabel_en-US" xlink:label="lab_srt_ChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chief Executive Officer [Member]</link:label>
    <link:label id="lab_srt_ChiefExecutiveOfficerMember_label_en-US" xlink:label="lab_srt_ChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chief Executive Officer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ChiefExecutiveOfficerMember" xlink:to="lab_srt_ChiefExecutiveOfficerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_BusinessAcquisitionPostCombinationServicePeriod_aa0a88c0-1daa-4506-b0d5-bd3da3ddb996_terseLabel_en-US" xlink:label="lab_iff_BusinessAcquisitionPostCombinationServicePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Post-Combination Service Period</link:label>
    <link:label id="lab_iff_BusinessAcquisitionPostCombinationServicePeriod_label_en-US" xlink:label="lab_iff_BusinessAcquisitionPostCombinationServicePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Post-Combination Service Period</link:label>
    <link:label id="lab_iff_BusinessAcquisitionPostCombinationServicePeriod_documentation_en-US" xlink:label="lab_iff_BusinessAcquisitionPostCombinationServicePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Post-Combination Service Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BusinessAcquisitionPostCombinationServicePeriod" xlink:href="iff-20231231.xsd#iff_BusinessAcquisitionPostCombinationServicePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_BusinessAcquisitionPostCombinationServicePeriod" xlink:to="lab_iff_BusinessAcquisitionPostCombinationServicePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember_bcaf048d-46d5-4b80-a90f-2953ff24e1be_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Large Cap</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Equity Securities, US, Large Cap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember" xlink:to="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_4e376d5c-79d6-4f8f-9195-2092d420645c_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Compensation Plans</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_7f8c5c9e-49c6-4b06-84a3-ae431abd8120_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_51f33906-9d1f-45c4-981b-7d53d9b62d03_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_TangibleEquityUnitsConditionsAxis_5a7944da-0b9e-453b-935b-41536390d4ca_terseLabel_en-US" xlink:label="lab_iff_TangibleEquityUnitsConditionsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Equity Units, Conditions [Axis]</link:label>
    <link:label id="lab_iff_TangibleEquityUnitsConditionsAxis_label_en-US" xlink:label="lab_iff_TangibleEquityUnitsConditionsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Equity Units, Conditions [Axis]</link:label>
    <link:label id="lab_iff_TangibleEquityUnitsConditionsAxis_documentation_en-US" xlink:label="lab_iff_TangibleEquityUnitsConditionsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Equity Units, Conditions [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityUnitsConditionsAxis" xlink:href="iff-20231231.xsd#iff_TangibleEquityUnitsConditionsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_TangibleEquityUnitsConditionsAxis" xlink:to="lab_iff_TangibleEquityUnitsConditionsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_ZhangjiagangChinaMember_100edef0-14e2-4b62-9cc8-eaa729b62d56_terseLabel_en-US" xlink:label="lab_iff_ZhangjiagangChinaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zhangjiagang, China</link:label>
    <link:label id="lab_iff_ZhangjiagangChinaMember_label_en-US" xlink:label="lab_iff_ZhangjiagangChinaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zhangjiagang, China [Member]</link:label>
    <link:label id="lab_iff_ZhangjiagangChinaMember_documentation_en-US" xlink:label="lab_iff_ZhangjiagangChinaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zhangjiagang, China</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ZhangjiagangChinaMember" xlink:href="iff-20231231.xsd#iff_ZhangjiagangChinaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_ZhangjiagangChinaMember" xlink:to="lab_iff_ZhangjiagangChinaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DisposalGroupIncludingDiscontinuedOperationCashTransferredToBuyer_2845af7f-b262-42a9-984c-480bb7be0665_terseLabel_en-US" xlink:label="lab_iff_DisposalGroupIncludingDiscontinuedOperationCashTransferredToBuyer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash transferred to buyer</link:label>
    <link:label id="lab_iff_DisposalGroupIncludingDiscontinuedOperationCashTransferredToBuyer_label_en-US" xlink:label="lab_iff_DisposalGroupIncludingDiscontinuedOperationCashTransferredToBuyer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Cash (Transferred To) Buyer</link:label>
    <link:label id="lab_iff_DisposalGroupIncludingDiscontinuedOperationCashTransferredToBuyer_documentation_en-US" xlink:label="lab_iff_DisposalGroupIncludingDiscontinuedOperationCashTransferredToBuyer" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Cash (Transferred To) Buyer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupIncludingDiscontinuedOperationCashTransferredToBuyer" xlink:href="iff-20231231.xsd#iff_DisposalGroupIncludingDiscontinuedOperationCashTransferredToBuyer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DisposalGroupIncludingDiscontinuedOperationCashTransferredToBuyer" xlink:to="lab_iff_DisposalGroupIncludingDiscontinuedOperationCashTransferredToBuyer" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_UnrecognizedTaxBenefitsReductionResultingFromLapseOfApplicableStatueOfLimitationsNextTwelveMonths_26576f44-c7e0-4369-a98c-dede7ec201af_terseLabel_en-US" xlink:label="lab_iff_UnrecognizedTaxBenefitsReductionResultingFromLapseOfApplicableStatueOfLimitationsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting From Lapse Of Applicable Statue of Limitations, Next Twelve Months</link:label>
    <link:label id="lab_iff_UnrecognizedTaxBenefitsReductionResultingFromLapseOfApplicableStatueOfLimitationsNextTwelveMonths_label_en-US" xlink:label="lab_iff_UnrecognizedTaxBenefitsReductionResultingFromLapseOfApplicableStatueOfLimitationsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting From Lapse Of Applicable Statue Of Limitations, Next Twelve Months</link:label>
    <link:label id="lab_iff_UnrecognizedTaxBenefitsReductionResultingFromLapseOfApplicableStatueOfLimitationsNextTwelveMonths_documentation_en-US" xlink:label="lab_iff_UnrecognizedTaxBenefitsReductionResultingFromLapseOfApplicableStatueOfLimitationsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting From Lapse Of Applicable Statue Of Limitations, Next Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_UnrecognizedTaxBenefitsReductionResultingFromLapseOfApplicableStatueOfLimitationsNextTwelveMonths" xlink:href="iff-20231231.xsd#iff_UnrecognizedTaxBenefitsReductionResultingFromLapseOfApplicableStatueOfLimitationsNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_UnrecognizedTaxBenefitsReductionResultingFromLapseOfApplicableStatueOfLimitationsNextTwelveMonths" xlink:to="lab_iff_UnrecognizedTaxBenefitsReductionResultingFromLapseOfApplicableStatueOfLimitationsNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_PriorServiceCostsFromPlanImprovementsAmortizationPeriodMinimum_53212ed0-9b71-43f8-8461-79ede4ec3d31_terseLabel_en-US" xlink:label="lab_iff_PriorServiceCostsFromPlanImprovementsAmortizationPeriodMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service costs from plan improvements amortization period, minimum, years</link:label>
    <link:label id="lab_iff_PriorServiceCostsFromPlanImprovementsAmortizationPeriodMinimum_label_en-US" xlink:label="lab_iff_PriorServiceCostsFromPlanImprovementsAmortizationPeriodMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior Service Costs From Plan Improvements, Amortization Period, Minimum</link:label>
    <link:label id="lab_iff_PriorServiceCostsFromPlanImprovementsAmortizationPeriodMinimum_documentation_en-US" xlink:label="lab_iff_PriorServiceCostsFromPlanImprovementsAmortizationPeriodMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service costs from plan improvements, amortization period, minimum.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_PriorServiceCostsFromPlanImprovementsAmortizationPeriodMinimum" xlink:href="iff-20231231.xsd#iff_PriorServiceCostsFromPlanImprovementsAmortizationPeriodMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_PriorServiceCostsFromPlanImprovementsAmortizationPeriodMinimum" xlink:to="lab_iff_PriorServiceCostsFromPlanImprovementsAmortizationPeriodMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_365290b1-ad41-4aec-83c5-32b6e48e9126_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashSurrenderValueOfLifeInsurance_10663137-f121-49b1-b19e-079c860e3f4e_terseLabel_en-US" xlink:label="lab_us-gaap_CashSurrenderValueOfLifeInsurance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash surrender value of life insurance contracts</link:label>
    <link:label id="lab_us-gaap_CashSurrenderValueOfLifeInsurance_fc1f2ad5-1958-4c54-adf7-5a8bbe68fb33_verboseLabel_en-US" xlink:label="lab_us-gaap_CashSurrenderValueOfLifeInsurance" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash surrender value of life insurance contracts</link:label>
    <link:label id="lab_us-gaap_CashSurrenderValueOfLifeInsurance_label_en-US" xlink:label="lab_us-gaap_CashSurrenderValueOfLifeInsurance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Surrender Value of Life Insurance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueOfLifeInsurance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashSurrenderValueOfLifeInsurance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashSurrenderValueOfLifeInsurance" xlink:to="lab_us-gaap_CashSurrenderValueOfLifeInsurance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_070f607b-5a15-44f3-b948-b2b52e7f05a7_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade receivables, allowance for credit losses</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_29bce06a-28a8-4728-9d17-f8e1425a6355_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names and Patents [Member]</link:label>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:to="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_NourishAndHealthBiosciencesMember_bcc325cc-aea1-44f1-8989-22ca51555e54_terseLabel_en-US" xlink:label="lab_iff_NourishAndHealthBiosciencesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nourish and Health &amp; Biosciences</link:label>
    <link:label id="lab_iff_NourishAndHealthBiosciencesMember_label_en-US" xlink:label="lab_iff_NourishAndHealthBiosciencesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nourish and Health &amp; Biosciences [Member]</link:label>
    <link:label id="lab_iff_NourishAndHealthBiosciencesMember_documentation_en-US" xlink:label="lab_iff_NourishAndHealthBiosciencesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nourish and Health &amp; Biosciences</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NourishAndHealthBiosciencesMember" xlink:href="iff-20231231.xsd#iff_NourishAndHealthBiosciencesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_NourishAndHealthBiosciencesMember" xlink:to="lab_iff_NourishAndHealthBiosciencesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_NumberofFacilities_d229dbce-5fa1-4f74-a3aa-1f5913fb2b16_terseLabel_en-US" xlink:label="lab_iff_NumberofFacilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of plants</link:label>
    <link:label id="lab_iff_NumberofFacilities_label_en-US" xlink:label="lab_iff_NumberofFacilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Facilities</link:label>
    <link:label id="lab_iff_NumberofFacilities_documentation_en-US" xlink:label="lab_iff_NumberofFacilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Facilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NumberofFacilities" xlink:href="iff-20231231.xsd#iff_NumberofFacilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_NumberofFacilities" xlink:to="lab_iff_NumberofFacilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_20a5a7d0-7ecf-4d74-9a07-58557d3f9b50_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_a8837c60-b7f7-4c36-8b63-5c6f925f7a6f_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Noncurrent</link:label>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashNoncurrent" xlink:to="lab_us-gaap_RestrictedCashNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_d2af9e11-3726-4df0-a861-c6fedbf64f20_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and local</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_e552c070-5ab3-4d54-a5a7-55a98071b3d1_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_TradeAccountsReceivableWithFactoringAgreementsMember_9ac5d066-bb74-4a2a-8446-cf12c909689f_terseLabel_en-US" xlink:label="lab_iff_TradeAccountsReceivableWithFactoringAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Accounts Receivable With Factoring Agreements [Member]</link:label>
    <link:label id="lab_iff_TradeAccountsReceivableWithFactoringAgreementsMember_label_en-US" xlink:label="lab_iff_TradeAccountsReceivableWithFactoringAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Accounts Receivable With Factoring Agreements [Member]</link:label>
    <link:label id="lab_iff_TradeAccountsReceivableWithFactoringAgreementsMember_documentation_en-US" xlink:label="lab_iff_TradeAccountsReceivableWithFactoringAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Accounts Receivable With Factoring Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TradeAccountsReceivableWithFactoringAgreementsMember" xlink:href="iff-20231231.xsd#iff_TradeAccountsReceivableWithFactoringAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_TradeAccountsReceivableWithFactoringAgreementsMember" xlink:to="lab_iff_TradeAccountsReceivableWithFactoringAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashMember_c669ae63-97b0-4c56-b46b-e33a13964a73_terseLabel_en-US" xlink:label="lab_us-gaap_CashMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_CashMember_label_en-US" xlink:label="lab_us-gaap_CashMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashMember" xlink:to="lab_us-gaap_CashMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonrecurringAdjustmentDomain_acb41d93-e498-4b48-bf90-aa02b3363e2a_terseLabel_en-US" xlink:label="lab_us-gaap_NonrecurringAdjustmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonrecurring Adjustment [Domain]</link:label>
    <link:label id="lab_us-gaap_NonrecurringAdjustmentDomain_label_en-US" xlink:label="lab_us-gaap_NonrecurringAdjustmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonrecurring Adjustment [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrecurringAdjustmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonrecurringAdjustmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonrecurringAdjustmentDomain" xlink:to="lab_us-gaap_NonrecurringAdjustmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_9f540993-7904-4cc1-9557-67e2440f7ade_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValueAddedTaxReceivableCurrent_629f6db1-b188-4be5-9486-83d39cb7fa01_terseLabel_en-US" xlink:label="lab_us-gaap_ValueAddedTaxReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value-added tax receivable</link:label>
    <link:label id="lab_us-gaap_ValueAddedTaxReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_ValueAddedTaxReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value Added Tax Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValueAddedTaxReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValueAddedTaxReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValueAddedTaxReceivableCurrent" xlink:to="lab_us-gaap_ValueAddedTaxReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_ae36ab84-997a-4f76-a30c-cdafeb18d649_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_f493c18e-9de9-4c0a-8b59-5f4487de319a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_984c61d8-6e32-4e30-9564-dc03ad54fd61_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRangeLow_d6da7ad1-d5d7-48e4-a9d6-7be6f508d265_terseLabel_en-US" xlink:label="lab_iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRangeLow" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Matching participant's contribution, percentage on compensation, range low</link:label>
    <link:label id="lab_iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRangeLow_label_en-US" xlink:label="lab_iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRangeLow" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan Matching Participant Contribution Percentage On Compensation Range Low</link:label>
    <link:label id="lab_iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRangeLow_documentation_en-US" xlink:label="lab_iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRangeLow" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined contribution plan, matching participant contribution, percentage on compensation, range low</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRangeLow" xlink:href="iff-20231231.xsd#iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRangeLow"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRangeLow" xlink:to="lab_iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRangeLow" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_b4c125fd-bf23-4edf-a9a0-bcd75857cc5e_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain" xlink:to="lab_us-gaap_LossContingencyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesLargeCapMember_4f75343d-62c4-474b-93bc-829a888d48ee_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesLargeCapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S. Large Cap</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesLargeCapMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesLargeCapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Equity Securities, Large Cap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesLargeCapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesLargeCapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesLargeCapMember" xlink:to="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesLargeCapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_0d43a226-d9fd-4430-b1ac-920b7f0a2a02_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial (gain) loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_522a235a-5192-4ee4-8736-5ef9055ef801_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_NonUSCorporateBondsMember_0a5ffa04-02f9-40b9-a92e-52c05423aba2_terseLabel_en-US" xlink:label="lab_iff_NonUSCorporateBondsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S. Corporate Bonds</link:label>
    <link:label id="lab_iff_NonUSCorporateBondsMember_label_en-US" xlink:label="lab_iff_NonUSCorporateBondsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non U S Corporate Bonds [Member]</link:label>
    <link:label id="lab_iff_NonUSCorporateBondsMember_documentation_en-US" xlink:label="lab_iff_NonUSCorporateBondsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non U.S. Corporate Bonds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NonUSCorporateBondsMember" xlink:href="iff-20231231.xsd#iff_NonUSCorporateBondsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_NonUSCorporateBondsMember" xlink:to="lab_iff_NonUSCorporateBondsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsMinorityInterest_9f24e9f3-169a-4303-a52e-8761127f76ba_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsMinorityInterest_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividendsMinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:to="lab_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_SecuredOvernightFinancingRateSOFRMember_ccddb93c-0222-4fb7-a219-9677779cf496_terseLabel_en-US" xlink:label="lab_iff_SecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR)</link:label>
    <link:label id="lab_iff_SecuredOvernightFinancingRateSOFRMember_label_en-US" xlink:label="lab_iff_SecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) [Member]</link:label>
    <link:label id="lab_iff_SecuredOvernightFinancingRateSOFRMember_documentation_en-US" xlink:label="lab_iff_SecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SecuredOvernightFinancingRateSOFRMember" xlink:href="iff-20231231.xsd#iff_SecuredOvernightFinancingRateSOFRMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_SecuredOvernightFinancingRateSOFRMember" xlink:to="lab_iff_SecuredOvernightFinancingRateSOFRMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_label_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_47dacb2f-ac43-48d8-9f5c-518b7136a4fe_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_58fb5b31-5cce-4ff4-bb64-e7fbf846da42_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3658255a-a67c-4e1a-ad44-b036efaff48e_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_588c7618-f623-47a8-abdb-c982620b7807_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_SeniorNotesDueTwoThousandTwentyEightMember_c2087246-494a-4650-b4cf-803c562e555c_terseLabel_en-US" xlink:label="lab_iff_SeniorNotesDueTwoThousandTwentyEightMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes - 2028</link:label>
    <link:label id="lab_iff_SeniorNotesDueTwoThousandTwentyEightMember_label_en-US" xlink:label="lab_iff_SeniorNotesDueTwoThousandTwentyEightMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, Due Two Thousand Twenty Eight [Member]</link:label>
    <link:label id="lab_iff_SeniorNotesDueTwoThousandTwentyEightMember_documentation_en-US" xlink:label="lab_iff_SeniorNotesDueTwoThousandTwentyEightMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, Due Two Thousand Twenty Eight [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandTwentyEightMember" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandTwentyEightMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_SeniorNotesDueTwoThousandTwentyEightMember" xlink:to="lab_iff_SeniorNotesDueTwoThousandTwentyEightMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_NetBorrowingsRepaymentsOfCommercialPaperMaturingInLessThanThreeMonths_8f58ef14-ce00-47fd-83ed-d43eb08a3c39_terseLabel_en-US" xlink:label="lab_iff_NetBorrowingsRepaymentsOfCommercialPaperMaturingInLessThanThreeMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (repayments) borrowings of commercial paper (maturities less than three months)</link:label>
    <link:label id="lab_iff_NetBorrowingsRepaymentsOfCommercialPaperMaturingInLessThanThreeMonths_label_en-US" xlink:label="lab_iff_NetBorrowingsRepaymentsOfCommercialPaperMaturingInLessThanThreeMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Borrowings (Repayments) Of Commercial Paper, Maturing In Less Than Three Months</link:label>
    <link:label id="lab_iff_NetBorrowingsRepaymentsOfCommercialPaperMaturingInLessThanThreeMonths_documentation_en-US" xlink:label="lab_iff_NetBorrowingsRepaymentsOfCommercialPaperMaturingInLessThanThreeMonths" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Borrowings (Repayments) Of Commercial Paper, Maturing In Less Than Three Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NetBorrowingsRepaymentsOfCommercialPaperMaturingInLessThanThreeMonths" xlink:href="iff-20231231.xsd#iff_NetBorrowingsRepaymentsOfCommercialPaperMaturingInLessThanThreeMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_NetBorrowingsRepaymentsOfCommercialPaperMaturingInLessThanThreeMonths" xlink:to="lab_iff_NetBorrowingsRepaymentsOfCommercialPaperMaturingInLessThanThreeMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a3315f5c-9404-40ad-a8cb-4281c9aac922_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_InsuranceContractsMember_747089a5-7360-4cb7-9c82-599e7abacbc8_terseLabel_en-US" xlink:label="lab_iff_InsuranceContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Contracts</link:label>
    <link:label id="lab_iff_InsuranceContractsMember_label_en-US" xlink:label="lab_iff_InsuranceContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Contracts [Member]</link:label>
    <link:label id="lab_iff_InsuranceContractsMember_documentation_en-US" xlink:label="lab_iff_InsuranceContractsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Contracts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_InsuranceContractsMember" xlink:href="iff-20231231.xsd#iff_InsuranceContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_InsuranceContractsMember" xlink:to="lab_iff_InsuranceContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_bf9c5346-9501-46d2-b9ec-cb5826aac549_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_b26127f0-a00c-4575-a947-22747892b4d6_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DamagesFromProductDefectsMember_312e28a8-7aff-4364-bf5b-e097df0a4da3_terseLabel_en-US" xlink:label="lab_us-gaap_DamagesFromProductDefectsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Damages from Product Defects [Member]</link:label>
    <link:label id="lab_us-gaap_DamagesFromProductDefectsMember_label_en-US" xlink:label="lab_us-gaap_DamagesFromProductDefectsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Damages from Product Defects [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DamagesFromProductDefectsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DamagesFromProductDefectsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DamagesFromProductDefectsMember" xlink:to="lab_us-gaap_DamagesFromProductDefectsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_FiscalQuarterEndingJune302024Member_37e5f983-3be8-4fc0-94bf-c097e78e9cbc_terseLabel_en-US" xlink:label="lab_iff_FiscalQuarterEndingJune302024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Quarter Ending June 30, 2024</link:label>
    <link:label id="lab_iff_FiscalQuarterEndingJune302024Member_label_en-US" xlink:label="lab_iff_FiscalQuarterEndingJune302024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Quarter Ending June 30, 2024 [Member]</link:label>
    <link:label id="lab_iff_FiscalQuarterEndingJune302024Member_documentation_en-US" xlink:label="lab_iff_FiscalQuarterEndingJune302024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Quarter Ending June 30, 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FiscalQuarterEndingJune302024Member" xlink:href="iff-20231231.xsd#iff_FiscalQuarterEndingJune302024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_FiscalQuarterEndingJune302024Member" xlink:to="lab_iff_FiscalQuarterEndingJune302024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_e3355f29-779c-4d47-b2d1-5520f07fcf1c_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInventory_34b7edcd-53e8-443d-b78d-39b27253001a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInventory_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsInventory" xlink:to="lab_us-gaap_DeferredTaxAssetsInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_041ba129-928a-4df5-9824-76a05b4346d9_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_942f34a6-3f81-447f-97ab-c62c3f5d8f82_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognized prior service credit</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Reclassification Adjustment, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_74c9b889-1c3e-4fe1-95a8-638a9e9f96f2_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_QualifiedPlanMember_3dbad4d2-fcb2-440a-bbb0-9535cb55e1d5_terseLabel_en-US" xlink:label="lab_us-gaap_QualifiedPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Qualified Plan</link:label>
    <link:label id="lab_us-gaap_QualifiedPlanMember_label_en-US" xlink:label="lab_us-gaap_QualifiedPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Qualified Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QualifiedPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_QualifiedPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_QualifiedPlanMember" xlink:to="lab_us-gaap_QualifiedPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_e1a4ac68-d593-4e5c-b2c0-23d744bc14d8_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_54911fc2-3ea6-40d0-953f-027c0b02ac4c_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_452a536c-18e3-4f42-a64f-c7e6706f1943_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Non-controlling Interests</link:label>
    <link:label id="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_label_en-US" xlink:label="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:to="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_a60b3cfa-a167-494e-8f96-4b2dc0bbe78a_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_8ff5d08d-a2ed-4c75-ab30-c1120cb358a1_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansPayableFairValueDisclosure_64681827-5fa8-464f-aa1b-4deb702df77d_terseLabel_en-US" xlink:label="lab_us-gaap_LoansPayableFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit facilities and bank overdrafts</link:label>
    <link:label id="lab_us-gaap_LoansPayableFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LoansPayableFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LoansPayableFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansPayableFairValueDisclosure" xlink:to="lab_us-gaap_LoansPayableFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_PercentageofActiveEmployeeswithPensionandorOtherRetirementBenefitPlansCovered_60d1be2b-990f-4f67-a9b9-1515a1360103_terseLabel_en-US" xlink:label="lab_iff_PercentageofActiveEmployeeswithPensionandorOtherRetirementBenefitPlansCovered" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of active employees with pension and or other retirement benefit plans covered</link:label>
    <link:label id="lab_iff_PercentageofActiveEmployeeswithPensionandorOtherRetirementBenefitPlansCovered_label_en-US" xlink:label="lab_iff_PercentageofActiveEmployeeswithPensionandorOtherRetirementBenefitPlansCovered" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Active Employees with Pension and or Other Retirement Benefit Plans Covered</link:label>
    <link:label id="lab_iff_PercentageofActiveEmployeeswithPensionandorOtherRetirementBenefitPlansCovered_documentation_en-US" xlink:label="lab_iff_PercentageofActiveEmployeeswithPensionandorOtherRetirementBenefitPlansCovered" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Active Employees with Pension and or Other Retirement Benefit Plans Covered</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_PercentageofActiveEmployeeswithPensionandorOtherRetirementBenefitPlansCovered" xlink:href="iff-20231231.xsd#iff_PercentageofActiveEmployeeswithPensionandorOtherRetirementBenefitPlansCovered"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_PercentageofActiveEmployeeswithPensionandorOtherRetirementBenefitPlansCovered" xlink:to="lab_iff_PercentageofActiveEmployeeswithPensionandorOtherRetirementBenefitPlansCovered" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_f0e896a7-b3f4-4c72-aa89-1110e04cdbd8_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_country_FI_bb266174-e963-474a-90f5-c4835fa1313c_terseLabel_en-US" xlink:label="lab_country_FI" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINLAND</link:label>
    <link:label id="lab_country_FI_label_en-US" xlink:label="lab_country_FI" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINLAND</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_FI" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_FI"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_FI" xlink:to="lab_country_FI" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4a028b4f-5213-463b-b208-955f718b1201_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_InternationalFlavorsFragrancesIncSeniorNotesMember_da773637-ea87-44a1-9f42-a117902b940c_terseLabel_en-US" xlink:label="lab_iff_InternationalFlavorsFragrancesIncSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Flavors &amp; Fragrances Inc Senior Notes</link:label>
    <link:label id="lab_iff_InternationalFlavorsFragrancesIncSeniorNotesMember_label_en-US" xlink:label="lab_iff_InternationalFlavorsFragrancesIncSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Flavors &amp; Fragrances Inc Senior Notes [Member]</link:label>
    <link:label id="lab_iff_InternationalFlavorsFragrancesIncSeniorNotesMember_documentation_en-US" xlink:label="lab_iff_InternationalFlavorsFragrancesIncSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Flavors &amp; Fragrances Inc Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_InternationalFlavorsFragrancesIncSeniorNotesMember" xlink:href="iff-20231231.xsd#iff_InternationalFlavorsFragrancesIncSeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_InternationalFlavorsFragrancesIncSeniorNotesMember" xlink:to="lab_iff_InternationalFlavorsFragrancesIncSeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureAxis_terseLabel_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measure:</link:label>
    <link:label id="lab_ecd_MeasureAxis_label_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measure [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureAxis" xlink:to="lab_ecd_MeasureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_84b4977b-1d82-4c15-bc23-b8e5aefad740_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Charges/Credits, net</link:label>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_label_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) Related to Litigation Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:to="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c2dfc554-7045-4673-80ed-6b41f813fb20_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryIndName" xlink:to="lab_ecd_OutstandingRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonrecurringAdjustmentAxis_d72dcfc8-e118-4d68-9dcb-d1a59df26675_terseLabel_en-US" xlink:label="lab_us-gaap_NonrecurringAdjustmentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonrecurring Adjustment [Axis]</link:label>
    <link:label id="lab_us-gaap_NonrecurringAdjustmentAxis_label_en-US" xlink:label="lab_us-gaap_NonrecurringAdjustmentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonrecurring Adjustment [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrecurringAdjustmentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonrecurringAdjustmentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonrecurringAdjustmentAxis" xlink:to="lab_us-gaap_NonrecurringAdjustmentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_NutritionBiosciencesIncMember_e0c57c62-9519-458f-bb2c-50f40dce628b_terseLabel_en-US" xlink:label="lab_iff_NutritionBiosciencesIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nutrition &amp; Biosciences, Inc</link:label>
    <link:label id="lab_iff_NutritionBiosciencesIncMember_label_en-US" xlink:label="lab_iff_NutritionBiosciencesIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nutrition &amp; Biosciences, Inc [Member]</link:label>
    <link:label id="lab_iff_NutritionBiosciencesIncMember_documentation_en-US" xlink:label="lab_iff_NutritionBiosciencesIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nutrition &amp; Biosciences, Inc [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NutritionBiosciencesIncMember" xlink:href="iff-20231231.xsd#iff_NutritionBiosciencesIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_NutritionBiosciencesIncMember" xlink:to="lab_iff_NutritionBiosciencesIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_a763c47e-ac2e-4e25-9f37-9f72f9e70d11_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_0d2be8c8-d1bb-4dd2-a4ab-762990ac996b_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements and curtailments</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:to="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_c28a1c9c-f67f-4f3e-a213-b9c6d009ae82_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_PaymentsToParticipateInFactoringReceivableProgram_1a539367-9740-411b-b061-0ec7c5a44740_terseLabel_en-US" xlink:label="lab_iff_PaymentsToParticipateInFactoringReceivableProgram" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to participate in factoring receivable program</link:label>
    <link:label id="lab_iff_PaymentsToParticipateInFactoringReceivableProgram_label_en-US" xlink:label="lab_iff_PaymentsToParticipateInFactoringReceivableProgram" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments To Participate In Factoring Receivable Program</link:label>
    <link:label id="lab_iff_PaymentsToParticipateInFactoringReceivableProgram_documentation_en-US" xlink:label="lab_iff_PaymentsToParticipateInFactoringReceivableProgram" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments To Participate In Factoring Receivable Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_PaymentsToParticipateInFactoringReceivableProgram" xlink:href="iff-20231231.xsd#iff_PaymentsToParticipateInFactoringReceivableProgram"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_PaymentsToParticipateInFactoringReceivableProgram" xlink:to="lab_iff_PaymentsToParticipateInFactoringReceivableProgram" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_a08d0b89-a6ad-480d-81d8-94e9d8d751ec_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets held-for-sale</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_f2fa44fe-31c5-46e9-8756-0c305b4155ec_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets held-for-sale</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_3d5c2ab6-22a8-4faa-bc7d-9b5e41d58c2b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_AlternativeTypeOfInvestmentsMember_9bb7a579-eb07-4703-b25f-25fadc639fef_terseLabel_en-US" xlink:label="lab_iff_AlternativeTypeOfInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alternative Type of Investments</link:label>
    <link:label id="lab_iff_AlternativeTypeOfInvestmentsMember_label_en-US" xlink:label="lab_iff_AlternativeTypeOfInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alternative Type Of Investments [Member]</link:label>
    <link:label id="lab_iff_AlternativeTypeOfInvestmentsMember_documentation_en-US" xlink:label="lab_iff_AlternativeTypeOfInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alternative Type Of Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AlternativeTypeOfInvestmentsMember" xlink:href="iff-20231231.xsd#iff_AlternativeTypeOfInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_AlternativeTypeOfInvestmentsMember" xlink:to="lab_iff_AlternativeTypeOfInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_ce325528-f65c-403b-a886-0676a8bc9f8f_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_SeniorNotesDueTwoThousandTwentyThreeMember_967bc0c0-ad8b-4b0e-ab2c-2148bba2b488_terseLabel_en-US" xlink:label="lab_iff_SeniorNotesDueTwoThousandTwentyThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes - 2023</link:label>
    <link:label id="lab_iff_SeniorNotesDueTwoThousandTwentyThreeMember_label_en-US" xlink:label="lab_iff_SeniorNotesDueTwoThousandTwentyThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, Due Two Thousand Twenty Three [Member]</link:label>
    <link:label id="lab_iff_SeniorNotesDueTwoThousandTwentyThreeMember_documentation_en-US" xlink:label="lab_iff_SeniorNotesDueTwoThousandTwentyThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, Due Two Thousand Twenty Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandTwentyThreeMember" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandTwentyThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_SeniorNotesDueTwoThousandTwentyThreeMember" xlink:to="lab_iff_SeniorNotesDueTwoThousandTwentyThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_HealthBiosciencesMember_943d7d16-4fd2-4b2f-a32a-a631d05c494e_terseLabel_en-US" xlink:label="lab_iff_HealthBiosciencesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health &amp; Biosciences</link:label>
    <link:label id="lab_iff_HealthBiosciencesMember_label_en-US" xlink:label="lab_iff_HealthBiosciencesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health &amp; Biosciences [Member]</link:label>
    <link:label id="lab_iff_HealthBiosciencesMember_documentation_en-US" xlink:label="lab_iff_HealthBiosciencesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health &amp; Biosciences</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_HealthBiosciencesMember" xlink:href="iff-20231231.xsd#iff_HealthBiosciencesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_HealthBiosciencesMember" xlink:to="lab_iff_HealthBiosciencesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemDomain_c4c61d33-87b2-4954-8d2f-e3348a2d14e5_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Domain]</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemDomain_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain" xlink:to="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_ProceedsFromBusinessCombination_f14a19b2-f711-4503-b8ae-1f707a0f6768_terseLabel_en-US" xlink:label="lab_iff_ProceedsFromBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash acquired from acquisition</link:label>
    <link:label id="lab_iff_ProceedsFromBusinessCombination_label_en-US" xlink:label="lab_iff_ProceedsFromBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Business Combination</link:label>
    <link:label id="lab_iff_ProceedsFromBusinessCombination_documentation_en-US" xlink:label="lab_iff_ProceedsFromBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Business Combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ProceedsFromBusinessCombination" xlink:href="iff-20231231.xsd#iff_ProceedsFromBusinessCombination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_ProceedsFromBusinessCombination" xlink:to="lab_iff_ProceedsFromBusinessCombination" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIDueToBusinessDivestitures_e81ffe07-54a4-4254-9907-0bf8cef51747_terseLabel_en-US" xlink:label="lab_iff_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIDueToBusinessDivestitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment From AOCI Due To Business Divestitures</link:label>
    <link:label id="lab_iff_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIDueToBusinessDivestitures_label_en-US" xlink:label="lab_iff_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIDueToBusinessDivestitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment From AOCI Due To Business Divestitures</link:label>
    <link:label id="lab_iff_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIDueToBusinessDivestitures_documentation_en-US" xlink:label="lab_iff_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIDueToBusinessDivestitures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment From AOCI Due To Business Divestitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIDueToBusinessDivestitures" xlink:href="iff-20231231.xsd#iff_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIDueToBusinessDivestitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIDueToBusinessDivestitures" xlink:to="lab_iff_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIDueToBusinessDivestitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_3beba6bf-7caf-4ab1-b10d-fa56c28b76d8_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_46d8abde-651e-4f4c-b3ce-ee6cd800b628_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_59877f6e-54c1-47d0-8f6a-2ebf7901d02e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows for operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_69591272-f1e1-40ca-85c8-673f5bd93070_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation Expense Included in Consolidated Statement of Income and Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Cost by Plan [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_dd4fabe3-bc25-4a11-a633-851826db4fe1_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DerivativeNotionalAmountNet_cd3d54ce-6575-4c32-aeaa-ce4f585801aa_terseLabel_en-US" xlink:label="lab_iff_DerivativeNotionalAmountNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative instruments outstanding, net</link:label>
    <link:label id="lab_iff_DerivativeNotionalAmountNet_label_en-US" xlink:label="lab_iff_DerivativeNotionalAmountNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount, Net</link:label>
    <link:label id="lab_iff_DerivativeNotionalAmountNet_documentation_en-US" xlink:label="lab_iff_DerivativeNotionalAmountNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DerivativeNotionalAmountNet" xlink:href="iff-20231231.xsd#iff_DerivativeNotionalAmountNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DerivativeNotionalAmountNet" xlink:to="lab_iff_DerivativeNotionalAmountNet" xlink:type="arc" order="1"/>
    <link:label id="lab_country_EG_041be819-89f0-4c5f-aa98-5301a239bd40_terseLabel_en-US" xlink:label="lab_country_EG" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EGYPT</link:label>
    <link:label id="lab_country_EG_label_en-US" xlink:label="lab_country_EG" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EGYPT</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_EG" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_EG"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_EG" xlink:to="lab_country_EG" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMidCapMember_0f7bfd55-4fc6-41e8-ac80-9ac67a28582f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMidCapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Mid Cap</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMidCapMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMidCapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Equity Securities, US, Mid Cap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMidCapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesUsMidCapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMidCapMember" xlink:to="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMidCapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_TwoThousandSixteenToTwoThousandEighteenCycleMember_7d91c752-2122-4984-a302-851a8a70cc0a_terseLabel_en-US" xlink:label="lab_iff_TwoThousandSixteenToTwoThousandEighteenCycleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016-2018 Cycle [Member]</link:label>
    <link:label id="lab_iff_TwoThousandSixteenToTwoThousandEighteenCycleMember_label_en-US" xlink:label="lab_iff_TwoThousandSixteenToTwoThousandEighteenCycleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Sixteen To Two Thousand Eighteen Cycle [Member]</link:label>
    <link:label id="lab_iff_TwoThousandSixteenToTwoThousandEighteenCycleMember_documentation_en-US" xlink:label="lab_iff_TwoThousandSixteenToTwoThousandEighteenCycleMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Sixteen To Two Thousand Eighteen Cycle [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TwoThousandSixteenToTwoThousandEighteenCycleMember" xlink:href="iff-20231231.xsd#iff_TwoThousandSixteenToTwoThousandEighteenCycleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_TwoThousandSixteenToTwoThousandEighteenCycleMember" xlink:to="lab_iff_TwoThousandSixteenToTwoThousandEighteenCycleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_49525e5e-2095-4cea-9fec-0842a26d2224_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost on projected benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoMember_terseLabel_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO</link:label>
    <link:label id="lab_ecd_PeoMember_label_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoMember" xlink:to="lab_ecd_PeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyEstimateOfPossibleLoss_22372bc2-32c1-478a-b30d-8fdedcbf24f8_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated maximum future costs of environmental liabilities for identified sites (less than $5 million)</link:label>
    <link:label id="lab_us-gaap_LossContingencyEstimateOfPossibleLoss_label_en-US" xlink:label="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Estimate of Possible Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:to="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_6bbb14bf-afaf-488f-aaae-7698a13510ab_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_4fc21f88-821b-4281-8565-7adc149f99a9_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_aa833832-268e-4378-89ce-ccaf0d8685ff_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Benefits</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_3a981ff3-6149-43ae-a3e7-800ce0a16ded_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_f5524bf3-54ba-432d-998c-a3f8365fc7e4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_IncomeTaxesDisclosureLineItems_13c3346e-d8cb-4fba-96ce-37cb892c6572_terseLabel_en-US" xlink:label="lab_iff_IncomeTaxesDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Disclosure [Line Items]</link:label>
    <link:label id="lab_iff_IncomeTaxesDisclosureLineItems_label_en-US" xlink:label="lab_iff_IncomeTaxesDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Disclosure [Line Items]</link:label>
    <link:label id="lab_iff_IncomeTaxesDisclosureLineItems_documentation_en-US" xlink:label="lab_iff_IncomeTaxesDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_IncomeTaxesDisclosureLineItems" xlink:href="iff-20231231.xsd#iff_IncomeTaxesDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_IncomeTaxesDisclosureLineItems" xlink:to="lab_iff_IncomeTaxesDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_005dc41d-b2d2-4fb1-b213-ba799b23468b_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance , common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_415c194b-ffcc-40d1-8773-dbbacc61ff08_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_b5822d63-568d-44c2-840a-101e0e546689_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to foreign net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_BusinessCombinationNetPensionBalanceDifferentialAmountSettledInCash_1566cfb1-c353-4c15-a04a-c60952666062_terseLabel_en-US" xlink:label="lab_iff_BusinessCombinationNetPensionBalanceDifferentialAmountSettledInCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net pension balance differential amount settled in cash</link:label>
    <link:label id="lab_iff_BusinessCombinationNetPensionBalanceDifferentialAmountSettledInCash_label_en-US" xlink:label="lab_iff_BusinessCombinationNetPensionBalanceDifferentialAmountSettledInCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Net Pension Balance Differential Amount Settled In Cash</link:label>
    <link:label id="lab_iff_BusinessCombinationNetPensionBalanceDifferentialAmountSettledInCash_documentation_en-US" xlink:label="lab_iff_BusinessCombinationNetPensionBalanceDifferentialAmountSettledInCash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Net Pension Balance Differential Amount Settled In Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BusinessCombinationNetPensionBalanceDifferentialAmountSettledInCash" xlink:href="iff-20231231.xsd#iff_BusinessCombinationNetPensionBalanceDifferentialAmountSettledInCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_BusinessCombinationNetPensionBalanceDifferentialAmountSettledInCash" xlink:to="lab_iff_BusinessCombinationNetPensionBalanceDifferentialAmountSettledInCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_b2bb8794-9877-4987-b6ad-872fd4418925_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_BusinessCombinationLeaseAdjustment_c437760e-d527-4ed4-a86f-684b7adcdc32_terseLabel_en-US" xlink:label="lab_iff_BusinessCombinationLeaseAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease adjustment</link:label>
    <link:label id="lab_iff_BusinessCombinationLeaseAdjustment_label_en-US" xlink:label="lab_iff_BusinessCombinationLeaseAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Lease Adjustment</link:label>
    <link:label id="lab_iff_BusinessCombinationLeaseAdjustment_documentation_en-US" xlink:label="lab_iff_BusinessCombinationLeaseAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Lease Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BusinessCombinationLeaseAdjustment" xlink:href="iff-20231231.xsd#iff_BusinessCombinationLeaseAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_BusinessCombinationLeaseAdjustment" xlink:to="lab_iff_BusinessCombinationLeaseAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_012df2bf-085c-4e12-89c5-de110a02510d_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_b8a024cf-2bdb-499f-a184-3b44e2ab3edd_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_314a51c7-32a7-404d-a103-3495688aa241_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_country_DE_520f9f6d-d3a5-4ef6-be21-505ae447e268_terseLabel_en-US" xlink:label="lab_country_DE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GERMANY</link:label>
    <link:label id="lab_country_DE_label_en-US" xlink:label="lab_country_DE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GERMANY</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_DE"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_DE" xlink:to="lab_country_DE" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_3fdd1af4-e112-4db3-8e15-e433d312ade4_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities held-for-sale</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_1c93407e-1f57-4a64-a03e-ab8eb3827a8e_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities held-for-sale</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPeriodIncreaseDecrease_62be0bd2-836c-4e3f-975f-c2eb12c69f3b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, period increase (decrease)</link:label>
    <link:label id="lab_us-gaap_GoodwillPeriodIncreaseDecrease_cfa32962-bdec-4ca0-bd94-ba49c0caf453_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reallocation</link:label>
    <link:label id="lab_us-gaap_GoodwillPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:to="lab_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingAggtErrCompAmt" xlink:to="lab_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_2362ad7c-925b-433e-a874-c4cdbaedb59b_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_country_DK_beeacdb9-028d-4a86-99f6-9545e341dd5d_terseLabel_en-US" xlink:label="lab_country_DK" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DENMARK</link:label>
    <link:label id="lab_country_DK_label_en-US" xlink:label="lab_country_DK" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DENMARK</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_DK" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_DK"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_DK" xlink:to="lab_country_DK" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForCatastropheClaimsByCatastrophicEventAxis_58012a2d-f0d1-4ba1-a4b7-6a1639dface0_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForCatastropheClaimsByCatastrophicEventAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Catastrophic Event [Axis]</link:label>
    <link:label id="lab_us-gaap_LiabilityForCatastropheClaimsByCatastrophicEventAxis_label_en-US" xlink:label="lab_us-gaap_LiabilityForCatastropheClaimsByCatastrophicEventAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Catastrophic Event [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForCatastropheClaimsByCatastrophicEventAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForCatastropheClaimsByCatastrophicEventAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForCatastropheClaimsByCatastrophicEventAxis" xlink:to="lab_us-gaap_LiabilityForCatastropheClaimsByCatastrophicEventAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_86c95542-35bc-46ca-ab6b-6746cf4c8a2b_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_326f106f-2918-45c4-ad73-fe4f5698fd8f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_a22f74cf-d631-48c5-9360-d9c8a19f07f2_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_bf8bb8d9-ea74-45ca-8cc5-30a6c4184845_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-Term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_d00081b9-e78e-48d7-bb7d-caf21e6eced4_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current income tax provision</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_TerminationFee_4d0cb7cd-efe2-41ba-927e-ee60682c5330_terseLabel_en-US" xlink:label="lab_iff_TerminationFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Termination Fee</link:label>
    <link:label id="lab_iff_TerminationFee_label_en-US" xlink:label="lab_iff_TerminationFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Termination Fee</link:label>
    <link:label id="lab_iff_TerminationFee_documentation_en-US" xlink:label="lab_iff_TerminationFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Termination Fee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TerminationFee" xlink:href="iff-20231231.xsd#iff_TerminationFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_TerminationFee" xlink:to="lab_iff_TerminationFee" xlink:type="arc" order="1"/>
    <link:label id="lab_country_BR_d73260cb-cc42-4e20-bfa4-9d6e71baefc7_terseLabel_en-US" xlink:label="lab_country_BR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BRAZIL</link:label>
    <link:label id="lab_country_BR_label_en-US" xlink:label="lab_country_BR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BRAZIL</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_BR" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_BR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_BR" xlink:to="lab_country_BR" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_ccdb60f1-fcab-4dfb-8337-4bdbe8557771_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DebtInstrumentCovenantPercentageOfProceedsFromNonOrdinaryAssetsSalesRequiredToBeUsedAsPrepayment_c4550e2d-cf4b-40f3-ac43-674585ff5252_terseLabel_en-US" xlink:label="lab_iff_DebtInstrumentCovenantPercentageOfProceedsFromNonOrdinaryAssetsSalesRequiredToBeUsedAsPrepayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of proceeds from non-ordinary assets sales required to be used as prepayment</link:label>
    <link:label id="lab_iff_DebtInstrumentCovenantPercentageOfProceedsFromNonOrdinaryAssetsSalesRequiredToBeUsedAsPrepayment_label_en-US" xlink:label="lab_iff_DebtInstrumentCovenantPercentageOfProceedsFromNonOrdinaryAssetsSalesRequiredToBeUsedAsPrepayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Percentage Of Proceeds From Non-Ordinary Assets Sales Required To Be Used As Prepayment</link:label>
    <link:label id="lab_iff_DebtInstrumentCovenantPercentageOfProceedsFromNonOrdinaryAssetsSalesRequiredToBeUsedAsPrepayment_documentation_en-US" xlink:label="lab_iff_DebtInstrumentCovenantPercentageOfProceedsFromNonOrdinaryAssetsSalesRequiredToBeUsedAsPrepayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Percentage Of Proceeds From Non-Ordinary Assets Sales Required To Be Used As Prepayment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DebtInstrumentCovenantPercentageOfProceedsFromNonOrdinaryAssetsSalesRequiredToBeUsedAsPrepayment" xlink:href="iff-20231231.xsd#iff_DebtInstrumentCovenantPercentageOfProceedsFromNonOrdinaryAssetsSalesRequiredToBeUsedAsPrepayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DebtInstrumentCovenantPercentageOfProceedsFromNonOrdinaryAssetsSalesRequiredToBeUsedAsPrepayment" xlink:to="lab_iff_DebtInstrumentCovenantPercentageOfProceedsFromNonOrdinaryAssetsSalesRequiredToBeUsedAsPrepayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_0a417e95-9e4d-4633-9ae2-eaa0f008ec61_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_6f43a4bf-8485-4616-8368-1a6cf92a8cca_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:to="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_ScheduleofAllocationofTangibleEquityUnitsTableTextBlock_432572ac-0eb5-413a-b24d-a0173481869a_terseLabel_en-US" xlink:label="lab_iff_ScheduleofAllocationofTangibleEquityUnitsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Allocation of Tangible Equity Units</link:label>
    <link:label id="lab_iff_ScheduleofAllocationofTangibleEquityUnitsTableTextBlock_label_en-US" xlink:label="lab_iff_ScheduleofAllocationofTangibleEquityUnitsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Allocation of Tangible Equity Units [Table Text Block]</link:label>
    <link:label id="lab_iff_ScheduleofAllocationofTangibleEquityUnitsTableTextBlock_documentation_en-US" xlink:label="lab_iff_ScheduleofAllocationofTangibleEquityUnitsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Allocation of Tangible Equity Units [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ScheduleofAllocationofTangibleEquityUnitsTableTextBlock" xlink:href="iff-20231231.xsd#iff_ScheduleofAllocationofTangibleEquityUnitsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_ScheduleofAllocationofTangibleEquityUnitsTableTextBlock" xlink:to="lab_iff_ScheduleofAllocationofTangibleEquityUnitsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_3cc00f38-72f7-4f50-99bc-83fd6ce4c7e3_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, in Process Research and Development</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, in Process Research and Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:to="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NorthAmericaMember_85fda6c0-09e7-4b8d-abc3-f70fbf2ea70b_terseLabel_en-US" xlink:label="lab_srt_NorthAmericaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North America [Member]</link:label>
    <link:label id="lab_srt_NorthAmericaMember_label_en-US" xlink:label="lab_srt_NorthAmericaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North America [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NorthAmericaMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NorthAmericaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NorthAmericaMember" xlink:to="lab_srt_NorthAmericaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_7e994e00-edd8-457d-a6b5-b89d76b05625_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_BusinessAcquisitionNetSales_62714659-cc83-4cd2-b4ac-880178c25054_terseLabel_en-US" xlink:label="lab_iff_BusinessAcquisitionNetSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Net Sales</link:label>
    <link:label id="lab_iff_BusinessAcquisitionNetSales_label_en-US" xlink:label="lab_iff_BusinessAcquisitionNetSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Net Sales</link:label>
    <link:label id="lab_iff_BusinessAcquisitionNetSales_documentation_en-US" xlink:label="lab_iff_BusinessAcquisitionNetSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Net Sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BusinessAcquisitionNetSales" xlink:href="iff-20231231.xsd#iff_BusinessAcquisitionNetSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_BusinessAcquisitionNetSales" xlink:to="lab_iff_BusinessAcquisitionNetSales" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_FrutaromIntegrationInitiativeMember_7f3630b4-1aca-4de7-acbf-4d13bfd4fee0_terseLabel_en-US" xlink:label="lab_iff_FrutaromIntegrationInitiativeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Frutarom Integration Initiative [Member]</link:label>
    <link:label id="lab_iff_FrutaromIntegrationInitiativeMember_label_en-US" xlink:label="lab_iff_FrutaromIntegrationInitiativeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Frutarom Integration Initiative [Member]</link:label>
    <link:label id="lab_iff_FrutaromIntegrationInitiativeMember_documentation_en-US" xlink:label="lab_iff_FrutaromIntegrationInitiativeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Frutarom Integration Initiative [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FrutaromIntegrationInitiativeMember" xlink:href="iff-20231231.xsd#iff_FrutaromIntegrationInitiativeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_FrutaromIntegrationInitiativeMember" xlink:to="lab_iff_FrutaromIntegrationInitiativeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_37e4e12f-aac7-4088-95c5-69526341af8d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_SharedITCorporateCostsMember_04e0be69-8cad-485e-8bc3-899c63e0828c_terseLabel_en-US" xlink:label="lab_iff_SharedITCorporateCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shared IT &amp; Corporate Costs [Member]</link:label>
    <link:label id="lab_iff_SharedITCorporateCostsMember_label_en-US" xlink:label="lab_iff_SharedITCorporateCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shared IT &amp; Corporate Costs [Member]</link:label>
    <link:label id="lab_iff_SharedITCorporateCostsMember_documentation_en-US" xlink:label="lab_iff_SharedITCorporateCostsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shared IT &amp; Corporate Costs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SharedITCorporateCostsMember" xlink:href="iff-20231231.xsd#iff_SharedITCorporateCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_SharedITCorporateCostsMember" xlink:to="lab_iff_SharedITCorporateCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_RebatesAndIncentivesPayableCurrent_f86e6ab7-82f4-4761-a1e3-c9a746777723_terseLabel_en-US" xlink:label="lab_iff_RebatesAndIncentivesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rebates and incentives payable</link:label>
    <link:label id="lab_iff_RebatesAndIncentivesPayableCurrent_label_en-US" xlink:label="lab_iff_RebatesAndIncentivesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rebates And Incentives Payable, Current</link:label>
    <link:label id="lab_iff_RebatesAndIncentivesPayableCurrent_documentation_en-US" xlink:label="lab_iff_RebatesAndIncentivesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rebates And Incentives Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_RebatesAndIncentivesPayableCurrent" xlink:href="iff-20231231.xsd#iff_RebatesAndIncentivesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_RebatesAndIncentivesPayableCurrent" xlink:to="lab_iff_RebatesAndIncentivesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_3b64cdca-9e07-412e-9877-fdc0bf91f338_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfLongtermInvestments_b0c350a8-540d-4b4a-a4b3-fbd5636e0cf2_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfLongtermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of long-term investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfLongtermInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfLongtermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Long-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfLongtermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfLongtermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfLongtermInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleOfLongtermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CN_4777eeec-9a36-493d-9db7-bc13eeab57e4_terseLabel_en-US" xlink:label="lab_country_CN" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CHINA</link:label>
    <link:label id="lab_country_CN_label_en-US" xlink:label="lab_country_CN" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CHINA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CN"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CN" xlink:to="lab_country_CN" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_9bb15e0e-810b-4aba-ad90-fe97544e6c51_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_ScentMember_06fcdc02-4d92-4af9-90c6-110e283950dc_terseLabel_en-US" xlink:label="lab_iff_ScentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scent [Member]</link:label>
    <link:label id="lab_iff_ScentMember_label_en-US" xlink:label="lab_iff_ScentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scent [Member]</link:label>
    <link:label id="lab_iff_ScentMember_documentation_en-US" xlink:label="lab_iff_ScentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ScentMember" xlink:href="iff-20231231.xsd#iff_ScentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_ScentMember" xlink:to="lab_iff_ScentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_NumberOfFragranceCategories_be9d06d4-96b3-4edf-9275-c2577a720827_terseLabel_en-US" xlink:label="lab_iff_NumberOfFragranceCategories" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of fragrance categories</link:label>
    <link:label id="lab_iff_NumberOfFragranceCategories_label_en-US" xlink:label="lab_iff_NumberOfFragranceCategories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Fragrance Categories</link:label>
    <link:label id="lab_iff_NumberOfFragranceCategories_documentation_en-US" xlink:label="lab_iff_NumberOfFragranceCategories" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of fragrance categories.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NumberOfFragranceCategories" xlink:href="iff-20231231.xsd#iff_NumberOfFragranceCategories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_NumberOfFragranceCategories" xlink:to="lab_iff_NumberOfFragranceCategories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_ad4b5802-dbb9-43bc-9d20-651c1fa8e914_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and local</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_A2026TermLoanMember_69ccc386-55ec-4b66-b528-186c5939ec1f_terseLabel_en-US" xlink:label="lab_iff_A2026TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026 Term Loan</link:label>
    <link:label id="lab_iff_A2026TermLoanMember_label_en-US" xlink:label="lab_iff_A2026TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026 Term Loan [Member]</link:label>
    <link:label id="lab_iff_A2026TermLoanMember_documentation_en-US" xlink:label="lab_iff_A2026TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026 Term Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_A2026TermLoanMember" xlink:href="iff-20231231.xsd#iff_A2026TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_A2026TermLoanMember" xlink:to="lab_iff_A2026TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_SeniorNotesEuroNotesMaturing2021And2026Member_c0fa1cb7-aa1e-4519-9297-a8f5529dc4ab_terseLabel_en-US" xlink:label="lab_iff_SeniorNotesEuroNotesMaturing2021And2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Maturing 2021 through 2026 [Member]</link:label>
    <link:label id="lab_iff_SeniorNotesEuroNotesMaturing2021And2026Member_label_en-US" xlink:label="lab_iff_SeniorNotesEuroNotesMaturing2021And2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, Euro Notes, Maturing 2021 and 2026 [Member]</link:label>
    <link:label id="lab_iff_SeniorNotesEuroNotesMaturing2021And2026Member_documentation_en-US" xlink:label="lab_iff_SeniorNotesEuroNotesMaturing2021And2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Maturing 2021 through 2026 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesEuroNotesMaturing2021And2026Member" xlink:href="iff-20231231.xsd#iff_SeniorNotesEuroNotesMaturing2021And2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_SeniorNotesEuroNotesMaturing2021And2026Member" xlink:to="lab_iff_SeniorNotesEuroNotesMaturing2021And2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_353987c2-77ab-4b66-a42a-2e1d2bc03a51_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Current Assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_PandemicMember_dcad73db-28e6-4b11-9ca9-4a80bdd2e589_terseLabel_en-US" xlink:label="lab_iff_PandemicMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pandemic [Member]</link:label>
    <link:label id="lab_iff_PandemicMember_label_en-US" xlink:label="lab_iff_PandemicMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pandemic [Member]</link:label>
    <link:label id="lab_iff_PandemicMember_documentation_en-US" xlink:label="lab_iff_PandemicMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pandemic [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_PandemicMember" xlink:href="iff-20231231.xsd#iff_PandemicMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_PandemicMember" xlink:to="lab_iff_PandemicMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_434660d4-c312-478d-8e62-10e2d39a6864_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic benefit (income) cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_ade884ce-6348-44ba-9e72-56b49bffa5b8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension-related benefit</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_7d4f6d29-a83b-4b3f-a9dc-0233cd614bdd_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains&#160;(Losses)&#160;on Derivatives Qualifying as Hedges</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:to="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_86267c82-1010-4244-8b2c-5aebf6222c60_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset impairment charges</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_6c3285c1-4ca4-40e2-80f4-fb48211257a7_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesMember" xlink:to="lab_us-gaap_EquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_cfdc4201-53a5-4e4a-9adb-9b819fc319b1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration, liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_aa06f775-ec9f-424e-8860-3cc1045010ac_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Disclosures:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_53976576-85ce-42b4-83de-da99f90bd128_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfSharesAvailableForGrant_56d20bb9-58d3-4c68-82f4-5874c014388e_terseLabel_en-US" xlink:label="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares remaining available for future awards (in shares)</link:label>
    <link:label id="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award, Equity Instruments Other Than Options, Number Of Shares Available For Grant</link:label>
    <link:label id="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfSharesAvailableForGrant_documentation_en-US" xlink:label="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation arrangement by share-based payment award equity instruments other than options, number of shares available for grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfSharesAvailableForGrant" xlink:href="iff-20231231.xsd#iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfSharesAvailableForGrant" xlink:to="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets_4f4e7cdb-6190-43e0-8e20-d6db8d44d033_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_a475d2b6-c3f1-471d-949a-a28644ff343b_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_4effc469-4311-4554-8d38-f2eb88202d59_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_label_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentForAmortization" xlink:to="lab_us-gaap_AdjustmentForAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_e32510fb-f0d4-4b7e-8a26-103ed8c392f0_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_7c22d15d-db66-4b54-9b01-e99a01021902_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain" xlink:to="lab_us-gaap_ShortTermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyEquipmentMember_80ce5727-977d-41fc-9e8b-3155673e157d_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information technology [Member]</link:label>
    <link:label id="lab_us-gaap_TechnologyEquipmentMember_label_en-US" xlink:label="lab_us-gaap_TechnologyEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TechnologyEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyEquipmentMember" xlink:to="lab_us-gaap_TechnologyEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_58110955-4b36-45d8-bfda-d08d6d5bc8a4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_542dfe4a-e3e9-4e36-bd31-492a9a189804_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_719d4de4-10e9-4bb8-b467-4929f8dfe1a8_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Other Intangible Assets, Net</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_3f3e351b-174c-45a2-8d44-44487b5c4fda_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Number of Positions Eliminated</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Number of Positions Eliminated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:to="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_GainLossOnChinaFacilityRelocation_cc4d0a07-79b3-470a-8511-e339b55ed89d_terseLabel_en-US" xlink:label="lab_iff_GainLossOnChinaFacilityRelocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on China facility relocation</link:label>
    <link:label id="lab_iff_GainLossOnChinaFacilityRelocation_label_en-US" xlink:label="lab_iff_GainLossOnChinaFacilityRelocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On China Facility Relocation</link:label>
    <link:label id="lab_iff_GainLossOnChinaFacilityRelocation_documentation_en-US" xlink:label="lab_iff_GainLossOnChinaFacilityRelocation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On China Facility Relocation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_GainLossOnChinaFacilityRelocation" xlink:href="iff-20231231.xsd#iff_GainLossOnChinaFacilityRelocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_GainLossOnChinaFacilityRelocation" xlink:to="lab_iff_GainLossOnChinaFacilityRelocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_968980e8-8826-4bd0-8989-f02776e92f40_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk threshold</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_fcdb9bb1-6aad-4563-8225-2384e700ac74_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current tax provision</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_e9b0f50d-beb6-4e01-9d2e-f3d5a1a140ec_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_c94e409f-97a0-4dc9-8699-bfcabba6ca32_verboseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and local taxes including rate changes(3)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_761d0da1-66e1-461c-9b4a-5962f4638073_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and local taxes</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7bfd0d0b-6c00-46cd-82af-537c7d4bac66_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_6cea5c77-ea9f-4e21-9855-2a5bb6fb0be2_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_OtherAddressMember_fd9af21c-3e85-4f66-a58c-320af794ccd4_terseLabel_en-US" xlink:label="lab_dei_OtherAddressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Address</link:label>
    <link:label id="lab_dei_OtherAddressMember_label_en-US" xlink:label="lab_dei_OtherAddressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Address [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_OtherAddressMember" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherAddressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_OtherAddressMember" xlink:to="lab_dei_OtherAddressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities_f58ea655-1ec4-4041-b10f-f1d6ebdd91ea_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from unwinding of derivative instruments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Derivative Instrument, Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities" xlink:to="lab_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_2720fb8f-c071-4194-a588-03b9f822377d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Postretirement Benefits</link:label>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:to="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_97006d28-4c9d-4368-afaf-165660147adf_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_003d7fbf-66eb-451d-90b9-e21784dcc11c_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForwardContractsMember_b3ed4a2f-6a10-4751-9547-d239d694f899_terseLabel_en-US" xlink:label="lab_us-gaap_ForwardContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Currency Contracts</link:label>
    <link:label id="lab_us-gaap_ForwardContractsMember_label_en-US" xlink:label="lab_us-gaap_ForwardContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Contracts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForwardContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForwardContractsMember" xlink:to="lab_us-gaap_ForwardContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_73467d3c-318d-4ed7-b5a2-835355a5498c_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_90e505ad-7748-439b-8c7c-18496912b6d7_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation cost related to non-vested stock options and SSAR, RSU, PRS and Cash RSU awards granted</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_aa8877eb-819c-461b-9901-3e78c8eb2001_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_0512511f-a465-42b0-be8f-a7ce1f79a341_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompRecoveryTable_terseLabel_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Erroneously Awarded Compensation Recovery</link:label>
    <link:label id="lab_ecd_ErrCompRecoveryTable_label_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompRecoveryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="lab_ecd_ErrCompRecoveryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_AssetsAndLiabilitiesLesseeTableTextBlock_73df995c-ef81-49a7-95f0-22e44b06afdf_terseLabel_en-US" xlink:label="lab_iff_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information</link:label>
    <link:label id="lab_iff_AssetsAndLiabilitiesLesseeTableTextBlock_label_en-US" xlink:label="lab_iff_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:label id="lab_iff_AssetsAndLiabilitiesLesseeTableTextBlock_documentation_en-US" xlink:label="lab_iff_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:href="iff-20231231.xsd#iff_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:to="lab_iff_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DebtInstrumentCovenantBasisSpreadIncreaseOnVariableRate_97aa4d25-c34c-4111-a197-50f386af2db5_terseLabel_en-US" xlink:label="lab_iff_DebtInstrumentCovenantBasisSpreadIncreaseOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, covenant, basis spread increase on variable rate</link:label>
    <link:label id="lab_iff_DebtInstrumentCovenantBasisSpreadIncreaseOnVariableRate_label_en-US" xlink:label="lab_iff_DebtInstrumentCovenantBasisSpreadIncreaseOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Basis Spread Increase On Variable Rate</link:label>
    <link:label id="lab_iff_DebtInstrumentCovenantBasisSpreadIncreaseOnVariableRate_documentation_en-US" xlink:label="lab_iff_DebtInstrumentCovenantBasisSpreadIncreaseOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Basis Spread Increase On Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DebtInstrumentCovenantBasisSpreadIncreaseOnVariableRate" xlink:href="iff-20231231.xsd#iff_DebtInstrumentCovenantBasisSpreadIncreaseOnVariableRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DebtInstrumentCovenantBasisSpreadIncreaseOnVariableRate" xlink:to="lab_iff_DebtInstrumentCovenantBasisSpreadIncreaseOnVariableRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent_beaa49f8-8f5a-4625-b65c-1035f9261335_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Other Assets, Noncurrent</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent" xlink:to="lab_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsAndOtherReceivablesNetCurrent_a4de8d3a-8298-4a5b-8224-3eeea77df102_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts and Other Receivables, Net, Current</link:label>
    <link:label id="lab_us-gaap_AccountsAndOtherReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts and Other Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:to="lab_us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_fb303be2-5e02-49b6-9eb7-2ec19ba474b9_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_PurchasedRestrictedStockUnitMember_7a9eb595-551b-458f-bf2a-a65d848421b9_terseLabel_en-US" xlink:label="lab_iff_PurchasedRestrictedStockUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchased Restricted Stock Unit</link:label>
    <link:label id="lab_iff_PurchasedRestrictedStockUnitMember_label_en-US" xlink:label="lab_iff_PurchasedRestrictedStockUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchased Restricted Stock Unit [Member]</link:label>
    <link:label id="lab_iff_PurchasedRestrictedStockUnitMember_documentation_en-US" xlink:label="lab_iff_PurchasedRestrictedStockUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchased Restricted Stock Unit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_PurchasedRestrictedStockUnitMember" xlink:href="iff-20231231.xsd#iff_PurchasedRestrictedStockUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_PurchasedRestrictedStockUnitMember" xlink:to="lab_iff_PurchasedRestrictedStockUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing, How MNPI Considered [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseContractualTermDomain_ef172164-dcfd-4e92-87f5-6a498eb3d1af_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseContractualTermDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Contractual Term [Domain]</link:label>
    <link:label id="lab_us-gaap_LeaseContractualTermDomain_label_en-US" xlink:label="lab_us-gaap_LeaseContractualTermDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Contractual Term [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseContractualTermDomain" xlink:to="lab_us-gaap_LeaseContractualTermDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_958e5840-b60d-4fe5-b53d-c7b5dc21ce09_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForCreditLossMember_d729a998-adf7-4d3f-92c0-260381a2bd97_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts [Member]</link:label>
    <link:label id="lab_us-gaap_AllowanceForCreditLossMember_label_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Credit Loss [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForCreditLossMember" xlink:to="lab_us-gaap_AllowanceForCreditLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_293901b5-8ac5-48ce-a8a7-645f5d9e0c02_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_AccumulatedDefinedBenefitPlansAdjustmentSettlementsCurtailmentsAttributableToParentMember_1f41fc75-4b61-4dff-8d66-d80e55e013a8_terseLabel_en-US" xlink:label="lab_iff_AccumulatedDefinedBenefitPlansAdjustmentSettlementsCurtailmentsAttributableToParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements / Curtailments</link:label>
    <link:label id="lab_iff_AccumulatedDefinedBenefitPlansAdjustmentSettlementsCurtailmentsAttributableToParentMember_label_en-US" xlink:label="lab_iff_AccumulatedDefinedBenefitPlansAdjustmentSettlementsCurtailmentsAttributableToParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Settlements/Curtailments Attributable To Parent [Member]</link:label>
    <link:label id="lab_iff_AccumulatedDefinedBenefitPlansAdjustmentSettlementsCurtailmentsAttributableToParentMember_documentation_en-US" xlink:label="lab_iff_AccumulatedDefinedBenefitPlansAdjustmentSettlementsCurtailmentsAttributableToParentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Settlements/Curtailments Attributable To Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AccumulatedDefinedBenefitPlansAdjustmentSettlementsCurtailmentsAttributableToParentMember" xlink:href="iff-20231231.xsd#iff_AccumulatedDefinedBenefitPlansAdjustmentSettlementsCurtailmentsAttributableToParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_AccumulatedDefinedBenefitPlansAdjustmentSettlementsCurtailmentsAttributableToParentMember" xlink:to="lab_iff_AccumulatedDefinedBenefitPlansAdjustmentSettlementsCurtailmentsAttributableToParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_26e63520-b29d-40e3-828c-446191912c3c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unaudited pro forma net sales</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_TangibleEquityUnitsConditionsDomain_519bc9fe-b811-43fc-b385-c38bb8fcf677_terseLabel_en-US" xlink:label="lab_iff_TangibleEquityUnitsConditionsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Equity Units, Conditions [Domain]</link:label>
    <link:label id="lab_iff_TangibleEquityUnitsConditionsDomain_label_en-US" xlink:label="lab_iff_TangibleEquityUnitsConditionsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Equity Units, Conditions [Domain]</link:label>
    <link:label id="lab_iff_TangibleEquityUnitsConditionsDomain_documentation_en-US" xlink:label="lab_iff_TangibleEquityUnitsConditionsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Tangible Equity Units, Conditions [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityUnitsConditionsDomain" xlink:href="iff-20231231.xsd#iff_TangibleEquityUnitsConditionsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_TangibleEquityUnitsConditionsDomain" xlink:to="lab_iff_TangibleEquityUnitsConditionsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_3497211b-7a7d-47a5-ac68-3d4bd9d58352_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_513ec28a-0ae1-4c01-9573-08858bbc2fc9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_806345ba-309c-4da5-ade0-873fae061003_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts Recognized in Balance Sheet</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amounts Recognized in Balance Sheet [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DefinedBenefitPlanCurrentMedicalCareCostTrendRate_ec96bd87-ded0-45c8-9792-f8eb20ee3aca_terseLabel_en-US" xlink:label="lab_iff_DefinedBenefitPlanCurrentMedicalCareCostTrendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current medical cost trend rate</link:label>
    <link:label id="lab_iff_DefinedBenefitPlanCurrentMedicalCareCostTrendRate_label_en-US" xlink:label="lab_iff_DefinedBenefitPlanCurrentMedicalCareCostTrendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Current Medical Care Cost Trend Rate</link:label>
    <link:label id="lab_iff_DefinedBenefitPlanCurrentMedicalCareCostTrendRate_documentation_en-US" xlink:label="lab_iff_DefinedBenefitPlanCurrentMedicalCareCostTrendRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The current medical cost trend rate utilized to determine postretirement benefit expense.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedBenefitPlanCurrentMedicalCareCostTrendRate" xlink:href="iff-20231231.xsd#iff_DefinedBenefitPlanCurrentMedicalCareCostTrendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DefinedBenefitPlanCurrentMedicalCareCostTrendRate" xlink:to="lab_iff_DefinedBenefitPlanCurrentMedicalCareCostTrendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_63cf3486-cfaa-4e8d-a132-42242e3e0e13_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_63151a89-73e1-4fa5-84aa-52c493e53b34_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a9c0649a-2f2a-4aa1-8140-7f39db91ab0e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_cf14f5ec-c181-4fa7-861a-1fcb43345b25_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:to="lab_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesPurchasedByEmployees_9eaec8ef-9c20-4da3-9033-7eb688aa2221_terseLabel_en-US" xlink:label="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesPurchasedByEmployees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covered shares (in shares)</link:label>
    <link:label id="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesPurchasedByEmployees_f07cbd34-aad9-44a4-9beb-af5b8ee59db3_verboseLabel_en-US" xlink:label="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesPurchasedByEmployees" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covered shares (in shares)</link:label>
    <link:label id="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesPurchasedByEmployees_label_en-US" xlink:label="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesPurchasedByEmployees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Shares Purchased By Employees</link:label>
    <link:label id="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesPurchasedByEmployees_documentation_en-US" xlink:label="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesPurchasedByEmployees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate number of nonvested shares effectively purchased by employees for share based compensation arrangement by share based payment award equity instruments other than option grants in period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesPurchasedByEmployees" xlink:href="iff-20231231.xsd#iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesPurchasedByEmployees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesPurchasedByEmployees" xlink:to="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesPurchasedByEmployees" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_b971b9dd-3344-408f-b349-d44b542de76f_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_5113b00a-8c2a-47bb-bc8f-7d760be63a5f_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_721d98a0-f13a-4058-9bcd-c7faeea4db5b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_LesseeOperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount_9c573661-1e35-4e68-bb21-5b3b4d597c0a_terseLabel_en-US" xlink:label="lab_iff_LesseeOperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:label id="lab_iff_LesseeOperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_iff_LesseeOperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:label id="lab_iff_LesseeOperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount_documentation_en-US" xlink:label="lab_iff_LesseeOperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_LesseeOperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="iff-20231231.xsd#iff_LesseeOperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_LesseeOperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_iff_LesseeOperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DefinedBenefitPlanAmortizationAndDeferralsNet_26c0be7d-d3d0-484a-b7fe-f5ecbf017a4d_terseLabel_en-US" xlink:label="lab_iff_DefinedBenefitPlanAmortizationAndDeferralsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net amortization and deferrals</link:label>
    <link:label id="lab_iff_DefinedBenefitPlanAmortizationAndDeferralsNet_label_en-US" xlink:label="lab_iff_DefinedBenefitPlanAmortizationAndDeferralsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Amortization And Deferrals Net</link:label>
    <link:label id="lab_iff_DefinedBenefitPlanAmortizationAndDeferralsNet_documentation_en-US" xlink:label="lab_iff_DefinedBenefitPlanAmortizationAndDeferralsNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit plan amortization and deferrals, net.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedBenefitPlanAmortizationAndDeferralsNet" xlink:href="iff-20231231.xsd#iff_DefinedBenefitPlanAmortizationAndDeferralsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DefinedBenefitPlanAmortizationAndDeferralsNet" xlink:to="lab_iff_DefinedBenefitPlanAmortizationAndDeferralsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_dde363d2-657b-4750-9e6c-1b40aedc6a3d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DisposalGroupIncludingDiscontinuedOperationAmountHeldInEscrow_f61d4272-7491-4b19-a28e-8f1574037596_terseLabel_en-US" xlink:label="lab_iff_DisposalGroupIncludingDiscontinuedOperationAmountHeldInEscrow" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount held in escrow</link:label>
    <link:label id="lab_iff_DisposalGroupIncludingDiscontinuedOperationAmountHeldInEscrow_label_en-US" xlink:label="lab_iff_DisposalGroupIncludingDiscontinuedOperationAmountHeldInEscrow" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Amount Held In Escrow</link:label>
    <link:label id="lab_iff_DisposalGroupIncludingDiscontinuedOperationAmountHeldInEscrow_documentation_en-US" xlink:label="lab_iff_DisposalGroupIncludingDiscontinuedOperationAmountHeldInEscrow" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Amount Held In Escrow</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupIncludingDiscontinuedOperationAmountHeldInEscrow" xlink:href="iff-20231231.xsd#iff_DisposalGroupIncludingDiscontinuedOperationAmountHeldInEscrow"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DisposalGroupIncludingDiscontinuedOperationAmountHeldInEscrow" xlink:to="lab_iff_DisposalGroupIncludingDiscontinuedOperationAmountHeldInEscrow" xlink:type="arc" order="1"/>
    <link:label id="lab_country_FR_bc2039c2-016f-4f1f-a974-fbe57fa8f0fb_terseLabel_en-US" xlink:label="lab_country_FR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FRANCE</link:label>
    <link:label id="lab_country_FR_label_en-US" xlink:label="lab_country_FR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FRANCE</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_FR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_FR" xlink:to="lab_country_FR" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_OtherComponentsOfOtherNonoperatingIncomeExpense_2bcd5e76-f6f1-4667-8dcf-d019781a8d76_terseLabel_en-US" xlink:label="lab_iff_OtherComponentsOfOtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_iff_OtherComponentsOfOtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_iff_OtherComponentsOfOtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Components Of Other Nonoperating Income (Expense)</link:label>
    <link:label id="lab_iff_OtherComponentsOfOtherNonoperatingIncomeExpense_documentation_en-US" xlink:label="lab_iff_OtherComponentsOfOtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Components Of Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_OtherComponentsOfOtherNonoperatingIncomeExpense" xlink:href="iff-20231231.xsd#iff_OtherComponentsOfOtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_OtherComponentsOfOtherNonoperatingIncomeExpense" xlink:to="lab_iff_OtherComponentsOfOtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_TransitionServicesAgreementFairValue_255d30a4-d93e-4c97-b573-324f5e22a94b_negatedTerseLabel_en-US" xlink:label="lab_iff_TransitionServicesAgreementFairValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition Services Agreement, Fair Value</link:label>
    <link:label id="lab_iff_TransitionServicesAgreementFairValue_label_en-US" xlink:label="lab_iff_TransitionServicesAgreementFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition Services Agreement, Fair Value</link:label>
    <link:label id="lab_iff_TransitionServicesAgreementFairValue_documentation_en-US" xlink:label="lab_iff_TransitionServicesAgreementFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition Services Agreement, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TransitionServicesAgreementFairValue" xlink:href="iff-20231231.xsd#iff_TransitionServicesAgreementFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_TransitionServicesAgreementFairValue" xlink:to="lab_iff_TransitionServicesAgreementFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_513411dc-f132-48dd-ad31-4e9eec9b4f5e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_ProceedsFromDivestitureOfBusinessesGross_d0769864-2fda-4274-8989-e217966898d7_terseLabel_en-US" xlink:label="lab_iff_ProceedsFromDivestitureOfBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses, Gross</link:label>
    <link:label id="lab_iff_ProceedsFromDivestitureOfBusinessesGross_label_en-US" xlink:label="lab_iff_ProceedsFromDivestitureOfBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses, Gross</link:label>
    <link:label id="lab_iff_ProceedsFromDivestitureOfBusinessesGross_documentation_en-US" xlink:label="lab_iff_ProceedsFromDivestitureOfBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ProceedsFromDivestitureOfBusinessesGross" xlink:href="iff-20231231.xsd#iff_ProceedsFromDivestitureOfBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_ProceedsFromDivestitureOfBusinessesGross" xlink:to="lab_iff_ProceedsFromDivestitureOfBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingPercentage_8cc5d422-8d25-4c13-9149-87c5c1cfb60f_terseLabel_en-US" xlink:label="lab_iff_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award vesting percentage</link:label>
    <link:label id="lab_iff_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingPercentage_label_en-US" xlink:label="lab_iff_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Percentage</link:label>
    <link:label id="lab_iff_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingPercentage_documentation_en-US" xlink:label="lab_iff_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingPercentage" xlink:href="iff-20231231.xsd#iff_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingPercentage" xlink:to="lab_iff_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_651323bd-3673-4d77-8bd9-46843760bff5_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_country_GB_5d11ccab-2ac0-451c-942e-cf101d6b56f7_terseLabel_en-US" xlink:label="lab_country_GB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED KINGDOM</link:label>
    <link:label id="lab_country_GB_label_en-US" xlink:label="lab_country_GB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED KINGDOM</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_GB"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_GB" xlink:to="lab_country_GB" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_GovernmentAndGovernmentAgencyBondsMember_9a8ef6c1-c347-4e77-83d8-e52e0bfee392_terseLabel_en-US" xlink:label="lab_iff_GovernmentAndGovernmentAgencyBondsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government&#160;&amp; Government Agency Bonds</link:label>
    <link:label id="lab_iff_GovernmentAndGovernmentAgencyBondsMember_label_en-US" xlink:label="lab_iff_GovernmentAndGovernmentAgencyBondsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government And Government Agency Bonds [Member]</link:label>
    <link:label id="lab_iff_GovernmentAndGovernmentAgencyBondsMember_documentation_en-US" xlink:label="lab_iff_GovernmentAndGovernmentAgencyBondsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government And Government Agency Bonds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_GovernmentAndGovernmentAgencyBondsMember" xlink:href="iff-20231231.xsd#iff_GovernmentAndGovernmentAgencyBondsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_GovernmentAndGovernmentAgencyBondsMember" xlink:to="lab_iff_GovernmentAndGovernmentAgencyBondsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_8b4750fc-11d4-4f5f-8b68-e53d690e9d49_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_95992a44-00e3-4477-a81b-bf2351a77b90_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromHedgeInvestingActivities_096fd3b9-027c-4944-82b8-3bdf054ff679_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromHedgeInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Hedge, Investing Activities</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromHedgeInvestingActivities_4e52605d-50b5-41ed-85e0-042718cbc404_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromHedgeInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Hedge, Investing Activities</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromHedgeInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromHedgeInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Hedge, Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromHedgeInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForProceedsFromHedgeInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromHedgeInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromHedgeInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_EquityBasedAwardsMember_7b536c4e-4bd1-4d4b-93ac-a1ad853ffc6f_terseLabel_en-US" xlink:label="lab_iff_EquityBasedAwardsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity-based awards [Member]</link:label>
    <link:label id="lab_iff_EquityBasedAwardsMember_label_en-US" xlink:label="lab_iff_EquityBasedAwardsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Based Awards [Member]</link:label>
    <link:label id="lab_iff_EquityBasedAwardsMember_documentation_en-US" xlink:label="lab_iff_EquityBasedAwardsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity-based awards [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EquityBasedAwardsMember" xlink:href="iff-20231231.xsd#iff_EquityBasedAwardsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_EquityBasedAwardsMember" xlink:to="lab_iff_EquityBasedAwardsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember_edf96315-f8d7-4fd4-9077-ec8bb575d654_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Held-for-Sale or Disposed of by Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_78ce5756-8a3c-46ef-b50e-de921403c8bf_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, less than 1 year</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
    <link:label id="lab_ecd_PvpTableTextBlock_label_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTableTextBlock" xlink:to="lab_ecd_PvpTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f8380ea3-a593-4774-992e-f56551549b37_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndTitle_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title</link:label>
    <link:label id="lab_ecd_TrdArrIndTitle_label_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement, Individual Title</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndTitle" xlink:to="lab_ecd_TrdArrIndTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DisposalGroupIncludingDiscontinuedOperationPostClosingAdjustments_dd78f13c-d648-4c52-88be-922215792ea4_terseLabel_en-US" xlink:label="lab_iff_DisposalGroupIncludingDiscontinuedOperationPostClosingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Post-closing adjustments</link:label>
    <link:label id="lab_iff_DisposalGroupIncludingDiscontinuedOperationPostClosingAdjustments_label_en-US" xlink:label="lab_iff_DisposalGroupIncludingDiscontinuedOperationPostClosingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Post-Closing Adjustments</link:label>
    <link:label id="lab_iff_DisposalGroupIncludingDiscontinuedOperationPostClosingAdjustments_documentation_en-US" xlink:label="lab_iff_DisposalGroupIncludingDiscontinuedOperationPostClosingAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Post-Closing Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupIncludingDiscontinuedOperationPostClosingAdjustments" xlink:href="iff-20231231.xsd#iff_DisposalGroupIncludingDiscontinuedOperationPostClosingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DisposalGroupIncludingDiscontinuedOperationPostClosingAdjustments" xlink:to="lab_iff_DisposalGroupIncludingDiscontinuedOperationPostClosingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_b84374da-21f6-4c1a-bf91-e5f64cba4deb_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_AllForeignCountriesMember_291a6427-8333-407e-9745-a7eae5bb59d9_terseLabel_en-US" xlink:label="lab_iff_AllForeignCountriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Foreign Countries [Member]</link:label>
    <link:label id="lab_iff_AllForeignCountriesMember_label_en-US" xlink:label="lab_iff_AllForeignCountriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Foreign Countries [Member]</link:label>
    <link:label id="lab_iff_AllForeignCountriesMember_documentation_en-US" xlink:label="lab_iff_AllForeignCountriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Foreign Countries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AllForeignCountriesMember" xlink:href="iff-20231231.xsd#iff_AllForeignCountriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_AllForeignCountriesMember" xlink:to="lab_iff_AllForeignCountriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIncomeTaxRefunds_f62f0d29-d14f-443d-96ec-42943f3be4fa_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIncomeTaxRefunds" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Income Tax Refunds</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIncomeTaxRefunds_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIncomeTaxRefunds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Income Tax Refunds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIncomeTaxRefunds" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIncomeTaxRefunds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIncomeTaxRefunds" xlink:to="lab_us-gaap_ProceedsFromIncomeTaxRefunds" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_dcfaefeb-9440-4572-bb62-8249a9a8a0b6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_AccountsReceivablesOutstandingLessThan90Days_c067406f-583d-4bf7-9ae3-f983fdf8bd92_terseLabel_en-US" xlink:label="lab_iff_AccountsReceivablesOutstandingLessThan90Days" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivables, Outstanding Less Than 90 Days</link:label>
    <link:label id="lab_iff_AccountsReceivablesOutstandingLessThan90Days_label_en-US" xlink:label="lab_iff_AccountsReceivablesOutstandingLessThan90Days" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivables, Outstanding Less Than 90 Days</link:label>
    <link:label id="lab_iff_AccountsReceivablesOutstandingLessThan90Days_documentation_en-US" xlink:label="lab_iff_AccountsReceivablesOutstandingLessThan90Days" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivables, Outstanding Less Than 90 Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AccountsReceivablesOutstandingLessThan90Days" xlink:href="iff-20231231.xsd#iff_AccountsReceivablesOutstandingLessThan90Days"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_AccountsReceivablesOutstandingLessThan90Days" xlink:to="lab_iff_AccountsReceivablesOutstandingLessThan90Days" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_8b51db9b-8117-4002-9b66-8554514912c0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and postretirement liability adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_e614e701-f526-42f9-a9ef-b5c3ef3f12c6_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension liability and postretirement adjustment; net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_IndividualAxis_terseLabel_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual:</link:label>
    <link:label id="lab_ecd_IndividualAxis_label_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_IndividualAxis" xlink:to="lab_ecd_IndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_806aa6a9-2005-4d1b-bcf4-c982edd0a9a4_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_7a405e16-6789-426d-bf88-e0bb59342f3d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccountsPayableAndAccruedLiabilities_454114b4-b7ad-4d46-acc7-0931c1b6f610_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses payable</link:label>
    <link:label id="lab_us-gaap_OtherAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_OtherAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_OtherAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_country_NL_a5a93de7-db84-41fc-92a7-0bd3aabc89c0_terseLabel_en-US" xlink:label="lab_country_NL" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NETHERLANDS</link:label>
    <link:label id="lab_country_NL_label_en-US" xlink:label="lab_country_NL" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NETHERLANDS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_NL" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_NL"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_NL" xlink:to="lab_country_NL" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_53d804ff-2e15-48d5-8be7-20a15732396a_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Service Share-based Compensation, Allocation of Recognized Period Costs, Report Line [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_0f55e8aa-1454-46e3-88d3-8c8f7516a0fb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_3051f0ba-d81f-4174-8754-d7b365509ebb_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_7960c3c6-362b-4c10-9e88-9eec6ca4366c_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction in unrecognized tax benefits due to the lapse of applicable statute of limitation</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_20714ae2-0152-49e5-8b8f-f1062e32eb9a_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturingInYearsTwoAndThree_48e2e368-463c-4ec2-84d5-d575090ab7cb_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturingInYearsTwoAndThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1-3 Years</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturingInYearsTwoAndThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturingInYearsTwoAndThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two and Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturingInYearsTwoAndThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturingInYearsTwoAndThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturingInYearsTwoAndThree" xlink:to="lab_us-gaap_LongTermDebtMaturingInYearsTwoAndThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7dbd036c-0ba4-4fc4-9086-aac1e928b142_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholders&#8217; Equity including non-controlling interest</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_22666981-9713-4451-8592-dda0c67a23d2_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_496506f6-94ff-421b-88c4-38b218616210_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_bc1d6ce3-d7e9-4d9e-a60e-4f0467f26ab6_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative adjustment relating to the adoption of ASC 2016-16</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DisposalGroupIncludingDiscontinuedOperationAdvanceReceiptForBusinessToBeTransferred_4b38aa30-9f19-4309-a75f-43dbcb678508_negatedTerseLabel_en-US" xlink:label="lab_iff_DisposalGroupIncludingDiscontinuedOperationAdvanceReceiptForBusinessToBeTransferred" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advance receipt for business to be transferred</link:label>
    <link:label id="lab_iff_DisposalGroupIncludingDiscontinuedOperationAdvanceReceiptForBusinessToBeTransferred_label_en-US" xlink:label="lab_iff_DisposalGroupIncludingDiscontinuedOperationAdvanceReceiptForBusinessToBeTransferred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Advance Receipt For Business To Be Transferred</link:label>
    <link:label id="lab_iff_DisposalGroupIncludingDiscontinuedOperationAdvanceReceiptForBusinessToBeTransferred_documentation_en-US" xlink:label="lab_iff_DisposalGroupIncludingDiscontinuedOperationAdvanceReceiptForBusinessToBeTransferred" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Advance Receipt For Business To Be Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupIncludingDiscontinuedOperationAdvanceReceiptForBusinessToBeTransferred" xlink:href="iff-20231231.xsd#iff_DisposalGroupIncludingDiscontinuedOperationAdvanceReceiptForBusinessToBeTransferred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DisposalGroupIncludingDiscontinuedOperationAdvanceReceiptForBusinessToBeTransferred" xlink:to="lab_iff_DisposalGroupIncludingDiscontinuedOperationAdvanceReceiptForBusinessToBeTransferred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_b63a76c6-352a-449f-8cf3-a99510181cb9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends on non-controlling interest and other</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_24f55d95-a6c1-4084-a7a2-e07a59298338_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercises of redeemable non-controlling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductLiabilityAccrualPeriodExpense_9dfce7d2-849a-407f-be69-6c04487bf049_terseLabel_en-US" xlink:label="lab_us-gaap_ProductLiabilityAccrualPeriodExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability accrual period expense</link:label>
    <link:label id="lab_us-gaap_ProductLiabilityAccrualPeriodExpense_label_en-US" xlink:label="lab_us-gaap_ProductLiabilityAccrualPeriodExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Accrual, Period Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityAccrualPeriodExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductLiabilityAccrualPeriodExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductLiabilityAccrualPeriodExpense" xlink:to="lab_us-gaap_ProductLiabilityAccrualPeriodExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_431086e1-b8aa-4863-af3e-e5691faaeb42_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_d5c732c8-03f6-4529-89d8-14de7e3f7452_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_ce6e9bad-0986-472f-b904-6beaee91b34f_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_2876b9c4-2f7b-43d2-a0f7-dfafe6975e80_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_0fc51fa8-7149-4343-94d0-0b7e4d52fb8c_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_b04d0a6b-1346-4af2-8b0d-552891a08643_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, net, current</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesNetCurrent" xlink:to="lab_us-gaap_ReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f36a3e99-099a-4192-94dc-14b6f1843123_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_56eda344-8f92-4ea3-ad3b-63b79d6e110d_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative gains included in AOCI</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:to="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_362f9561-f0f3-47be-a246-d9f1c2cc6db3_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_fbd59569-5a07-4db2-b848-ed066fa12883_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_91f03291-e369-4a30-b88f-ece2fd8f8d31_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit obligation at beginning of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_8f1f1777-9c42-467f-a475-4a5f948061ce_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit obligation at end of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_84c9eff7-f984-4b51-a3fc-b6a7b57733db_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing MNPI Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:to="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommodityContractMember_ddf06391-7e2a-4238-8550-c60577dc6eb0_terseLabel_en-US" xlink:label="lab_us-gaap_CommodityContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity Contracts</link:label>
    <link:label id="lab_us-gaap_CommodityContractMember_label_en-US" xlink:label="lab_us-gaap_CommodityContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommodityContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommodityContractMember" xlink:to="lab_us-gaap_CommodityContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_982a10a0-1e3e-40c3-b59a-be89a34c5d4c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_f5ed4e14-8ad0-4776-86ac-600e8bea9e53_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_cb8314be-9fce-4c65-90c9-c5bd44e768f7_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange (losses) gains</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss), Foreign Currency Transaction, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedInsuranceCurrent_465ad024-3701-440c-8806-c120a8b1d31a_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedInsuranceCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued insurance (including workers&#8217; compensation)</link:label>
    <link:label id="lab_us-gaap_AccruedInsuranceCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedInsuranceCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Insurance, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedInsuranceCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedInsuranceCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedInsuranceCurrent" xlink:to="lab_us-gaap_AccruedInsuranceCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_ea90be34-14fd-470c-ae45-29fecb5b62aa_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Measured at Fair Value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_SeniorNotesDueTwoThousandTwentySevenMember_58888c6d-ca00-41ae-b816-c9db666126aa_terseLabel_en-US" xlink:label="lab_iff_SeniorNotesDueTwoThousandTwentySevenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, Due Two Thousand Twenty Seven</link:label>
    <link:label id="lab_iff_SeniorNotesDueTwoThousandTwentySevenMember_label_en-US" xlink:label="lab_iff_SeniorNotesDueTwoThousandTwentySevenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, Due Two Thousand Twenty Seven [Member]</link:label>
    <link:label id="lab_iff_SeniorNotesDueTwoThousandTwentySevenMember_documentation_en-US" xlink:label="lab_iff_SeniorNotesDueTwoThousandTwentySevenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, Due Two Thousand Twenty Seven</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandTwentySevenMember" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandTwentySevenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_SeniorNotesDueTwoThousandTwentySevenMember" xlink:to="lab_iff_SeniorNotesDueTwoThousandTwentySevenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestCostsCapitalized_4efb4be2-ac41-431d-b57c-99e2f3ccaa6b_terseLabel_en-US" xlink:label="lab_us-gaap_InterestCostsCapitalized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized interest costs</link:label>
    <link:label id="lab_us-gaap_InterestCostsCapitalized_label_en-US" xlink:label="lab_us-gaap_InterestCostsCapitalized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Costs Capitalized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestCostsCapitalized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestCostsCapitalized" xlink:to="lab_us-gaap_InterestCostsCapitalized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_02e34d66-9ce9-40f9-8057-15253d234a26_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee withholding taxes paid</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherInvestmentCompaniesMember_b7c0538a-9537-4d11-a445-4ca8eb7da5a0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherInvestmentCompaniesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alternative and other investments</link:label>
    <link:label id="lab_us-gaap_OtherInvestmentCompaniesMember_label_en-US" xlink:label="lab_us-gaap_OtherInvestmentCompaniesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Investment Companies [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentCompaniesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInvestmentCompaniesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherInvestmentCompaniesMember" xlink:to="lab_us-gaap_OtherInvestmentCompaniesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_4a80f187-de8a-4d49-8fee-3073a1521694_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule II - Valuation and Qualifying Accounts and Reserves</link:label>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_label_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:to="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_4407e45d-a08e-4d3d-bafd-933482747285_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_e413e9fa-646d-44ed-bb8f-3bec3f8ad467_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Accumulated Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_SeniorUnsecuredTermLoanFacilitiesMember_04d1c3a4-4ad4-4ac5-86ac-e83f4a3ae968_terseLabel_en-US" xlink:label="lab_iff_SeniorUnsecuredTermLoanFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Term Loan Facilities</link:label>
    <link:label id="lab_iff_SeniorUnsecuredTermLoanFacilitiesMember_label_en-US" xlink:label="lab_iff_SeniorUnsecuredTermLoanFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Term Loan Facilities [Member]</link:label>
    <link:label id="lab_iff_SeniorUnsecuredTermLoanFacilitiesMember_documentation_en-US" xlink:label="lab_iff_SeniorUnsecuredTermLoanFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Term Loan Facilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorUnsecuredTermLoanFacilitiesMember" xlink:href="iff-20231231.xsd#iff_SeniorUnsecuredTermLoanFacilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_SeniorUnsecuredTermLoanFacilitiesMember" xlink:to="lab_iff_SeniorUnsecuredTermLoanFacilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_RestructuringAndRelatedCostNumberOfSitesClosed_7881261d-7371-48f0-a992-10d06d6108d8_terseLabel_en-US" xlink:label="lab_iff_RestructuringAndRelatedCostNumberOfSitesClosed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Sites Closed</link:label>
    <link:label id="lab_iff_RestructuringAndRelatedCostNumberOfSitesClosed_label_en-US" xlink:label="lab_iff_RestructuringAndRelatedCostNumberOfSitesClosed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring And Related Cost, Number Of Sites Closed</link:label>
    <link:label id="lab_iff_RestructuringAndRelatedCostNumberOfSitesClosed_documentation_en-US" xlink:label="lab_iff_RestructuringAndRelatedCostNumberOfSitesClosed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring And Related Cost, Number Of Sites Closed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_RestructuringAndRelatedCostNumberOfSitesClosed" xlink:href="iff-20231231.xsd#iff_RestructuringAndRelatedCostNumberOfSitesClosed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_RestructuringAndRelatedCostNumberOfSitesClosed" xlink:to="lab_iff_RestructuringAndRelatedCostNumberOfSitesClosed" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_d58c925d-b0d9-49c5-a96e-79b6790398e2_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_82cbce7b-ade7-49b4-97ea-c22556fa9100_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_de4cd873-c404-403c-a125-14863cf59356_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_FlavorsMember_7665069a-eaf5-4031-86ed-b77345244dd5_terseLabel_en-US" xlink:label="lab_iff_FlavorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Flavors [Member]</link:label>
    <link:label id="lab_iff_FlavorsMember_label_en-US" xlink:label="lab_iff_FlavorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Flavors [Member]</link:label>
    <link:label id="lab_iff_FlavorsMember_documentation_en-US" xlink:label="lab_iff_FlavorsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Flavors</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FlavorsMember" xlink:href="iff-20231231.xsd#iff_FlavorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_FlavorsMember" xlink:to="lab_iff_FlavorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_e7334acd-7ef6-4be9-8b11-3a442ebac61c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_a9660386-c360-4aee-9d57-877d8582c244_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_abfef3f3-6c6a-424c-8958-416687f5df54_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of voting interest acquired</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemAxis_bfda7c05-bc76-4fa0-817e-3c4506ca236e_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Axis]</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemAxis_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis" xlink:to="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_7a616765-e85b-4fe2-9d5d-3505a6d6ed34_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings (accumulated deficit)</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_b681cf52-ab15-4742-a25f-2e9451d54869_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current maturities of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable_a60e2e8a-e60e-43d1-b37b-470ba2e1d953_terseLabel_en-US" xlink:label="lab_iff_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration receivable</link:label>
    <link:label id="lab_iff_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable_label_en-US" xlink:label="lab_iff_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration Receivable</link:label>
    <link:label id="lab_iff_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable_documentation_en-US" xlink:label="lab_iff_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" xlink:href="iff-20231231.xsd#iff_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" xlink:to="lab_iff_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_NonUSTreasuriesOrGovernmentBondsMember_39ae4ad6-83e9-4a6b-bbfd-4b8fd45d72d3_terseLabel_en-US" xlink:label="lab_iff_NonUSTreasuriesOrGovernmentBondsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S. Treasuries/Government Bonds</link:label>
    <link:label id="lab_iff_NonUSTreasuriesOrGovernmentBondsMember_label_en-US" xlink:label="lab_iff_NonUSTreasuriesOrGovernmentBondsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non U S Treasuries Or Government Bonds [Member]</link:label>
    <link:label id="lab_iff_NonUSTreasuriesOrGovernmentBondsMember_documentation_en-US" xlink:label="lab_iff_NonUSTreasuriesOrGovernmentBondsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non U.S. Treasuries Or Government Bonds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NonUSTreasuriesOrGovernmentBondsMember" xlink:href="iff-20231231.xsd#iff_NonUSTreasuriesOrGovernmentBondsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_NonUSTreasuriesOrGovernmentBondsMember" xlink:to="lab_iff_NonUSTreasuriesOrGovernmentBondsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_51d284d9-04ba-42f6-a711-37a1cd9ea952_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise&#160;Price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_eb7c4060-147c-4c34-a543-93e69748c697_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Translation adjustments</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_03c21228-670e-41d2-ab51-7aa7cc946734_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share - basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_7dd492d2-0b3c-4777-895b-28f29b5df295_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains on derivatives qualifying as hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_5915a0b5-0963-496c-b1d8-163ba770711b_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (losses) on derivatives qualifying as hedges, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_4fbb64d7-2e21-4ff1-a951-932596a0ace3_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DeferredTaxLiabilitiesDeemedRepatriation_b08d196a-79cf-44ae-9a20-dee43ae300fc_terseLabel_en-US" xlink:label="lab_iff_DeferredTaxLiabilitiesDeemedRepatriation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Deemed Repatriation</link:label>
    <link:label id="lab_iff_DeferredTaxLiabilitiesDeemedRepatriation_91ea6e7b-2ccd-4685-83e1-98d83811141d_negatedTerseLabel_en-US" xlink:label="lab_iff_DeferredTaxLiabilitiesDeemedRepatriation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred taxes on deemed repatriation</link:label>
    <link:label id="lab_iff_DeferredTaxLiabilitiesDeemedRepatriation_label_en-US" xlink:label="lab_iff_DeferredTaxLiabilitiesDeemedRepatriation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Deemed Repatriation</link:label>
    <link:label id="lab_iff_DeferredTaxLiabilitiesDeemedRepatriation_documentation_en-US" xlink:label="lab_iff_DeferredTaxLiabilitiesDeemedRepatriation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Deemed Repatriation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DeferredTaxLiabilitiesDeemedRepatriation" xlink:href="iff-20231231.xsd#iff_DeferredTaxLiabilitiesDeemedRepatriation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DeferredTaxLiabilitiesDeemedRepatriation" xlink:to="lab_iff_DeferredTaxLiabilitiesDeemedRepatriation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockOptionMember_a9a812ea-095f-4d7f-87a7-3d9d7f148419_terseLabel_en-US" xlink:label="lab_us-gaap_StockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options [Member]</link:label>
    <link:label id="lab_us-gaap_StockOptionMember_label_en-US" xlink:label="lab_us-gaap_StockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockOptionMember" xlink:to="lab_us-gaap_StockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveAccrualAdjustment1_2919d95c-6298-4263-8107-af47a97918e2_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Charges (Reversals), Net</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveAccrualAdjustment1_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Accrual Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:to="lab_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_label_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Erroneous Compensation Analysis [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompAnalysisTextBlock" xlink:to="lab_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_bf35a6de-db55-4355-b178-44d9e859a653_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets at beginning of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_2242414e-8a4e-4364-a244-4c032935c96e_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets at end of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_9058cbe8-891b-4b80-a591-7f404ccf4716_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_5e42e760-1f1d-44d2-8727-b5f6588cb161_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intrinsic value of options/SSAR's exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidAfterYearFive_46a474ee-0625-4b2a-9b08-5d2c4d46966b_terseLabel_en-US" xlink:label="lab_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, to be Paid, after Year Five</link:label>
    <link:label id="lab_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidAfterYearFive_label_en-US" xlink:label="lab_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, to be Paid, after Year Five</link:label>
    <link:label id="lab_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidAfterYearFive_documentation_en-US" xlink:label="lab_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidAfterYearFive" xlink:href="iff-20231231.xsd#iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidAfterYearFive" xlink:to="lab_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrivateEquityFundsMember_0dcd031d-4d71-40e8-80d8-b5f739895326_terseLabel_en-US" xlink:label="lab_us-gaap_PrivateEquityFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Equity Funds</link:label>
    <link:label id="lab_us-gaap_PrivateEquityFundsMember_label_en-US" xlink:label="lab_us-gaap_PrivateEquityFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Equity Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivateEquityFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrivateEquityFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrivateEquityFundsMember" xlink:to="lab_us-gaap_PrivateEquityFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_d7ae97ef-87cc-4b57-af89-7a3cacaa1af1_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted&#160;Average Remaining Contractual&#160;Life (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_7cbc73ad-1ee7-489f-8461-0d09ee109aeb_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness_7644ddaf-8ef1-4d6c-b834-f578a0870f09_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax impact on business divestitures</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Disposition of Business, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_SeniorNotesDueTwoThousandThirtyMember_a0e141d8-3140-49b0-bcb8-5832fb2c2114_terseLabel_en-US" xlink:label="lab_iff_SeniorNotesDueTwoThousandThirtyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, Due Two Thousand Thirty</link:label>
    <link:label id="lab_iff_SeniorNotesDueTwoThousandThirtyMember_label_en-US" xlink:label="lab_iff_SeniorNotesDueTwoThousandThirtyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, Due Two Thousand Thirty [Member]</link:label>
    <link:label id="lab_iff_SeniorNotesDueTwoThousandThirtyMember_documentation_en-US" xlink:label="lab_iff_SeniorNotesDueTwoThousandThirtyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, Due Two Thousand Thirty</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandThirtyMember" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandThirtyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_SeniorNotesDueTwoThousandThirtyMember" xlink:to="lab_iff_SeniorNotesDueTwoThousandThirtyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_CashTransferredToTheBuyerOnTheClosingBalanceSheet_606fe286-1b0c-4888-ade0-b0c9c21d9825_terseLabel_en-US" xlink:label="lab_iff_CashTransferredToTheBuyerOnTheClosingBalanceSheet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Transferred to the Buyer on the Closing Balance Sheet</link:label>
    <link:label id="lab_iff_CashTransferredToTheBuyerOnTheClosingBalanceSheet_label_en-US" xlink:label="lab_iff_CashTransferredToTheBuyerOnTheClosingBalanceSheet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Transferred to the Buyer on the Closing Balance Sheet</link:label>
    <link:label id="lab_iff_CashTransferredToTheBuyerOnTheClosingBalanceSheet_documentation_en-US" xlink:label="lab_iff_CashTransferredToTheBuyerOnTheClosingBalanceSheet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Transferred to the Buyer on the Closing Balance Sheet</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_CashTransferredToTheBuyerOnTheClosingBalanceSheet" xlink:href="iff-20231231.xsd#iff_CashTransferredToTheBuyerOnTheClosingBalanceSheet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_CashTransferredToTheBuyerOnTheClosingBalanceSheet" xlink:to="lab_iff_CashTransferredToTheBuyerOnTheClosingBalanceSheet" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_MicrocrystallineCelluloseMember_96f0351c-8c37-48ba-845e-20ea721523b1_terseLabel_en-US" xlink:label="lab_iff_MicrocrystallineCelluloseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Microcrystalline Cellulose</link:label>
    <link:label id="lab_iff_MicrocrystallineCelluloseMember_label_en-US" xlink:label="lab_iff_MicrocrystallineCelluloseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Microcrystalline Cellulose [Member]</link:label>
    <link:label id="lab_iff_MicrocrystallineCelluloseMember_documentation_en-US" xlink:label="lab_iff_MicrocrystallineCelluloseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Microcrystalline Cellulose</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_MicrocrystallineCelluloseMember" xlink:href="iff-20231231.xsd#iff_MicrocrystallineCelluloseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_MicrocrystallineCelluloseMember" xlink:to="lab_iff_MicrocrystallineCelluloseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_4685745c-7734-46ad-92b9-63428d9a3f6b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes paid</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_e2c96477-cd22-43f9-8afb-e0eec014e3f7_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_UnrecognizedTaxBenefitsOtherLiabilitiesMember_d7a03881-4ebe-483a-9e2c-e9feac3523e9_terseLabel_en-US" xlink:label="lab_iff_UnrecognizedTaxBenefitsOtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities [Member]</link:label>
    <link:label id="lab_iff_UnrecognizedTaxBenefitsOtherLiabilitiesMember_label_en-US" xlink:label="lab_iff_UnrecognizedTaxBenefitsOtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Other Liabilities [Member]</link:label>
    <link:label id="lab_iff_UnrecognizedTaxBenefitsOtherLiabilitiesMember_documentation_en-US" xlink:label="lab_iff_UnrecognizedTaxBenefitsOtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits, other liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_UnrecognizedTaxBenefitsOtherLiabilitiesMember" xlink:href="iff-20231231.xsd#iff_UnrecognizedTaxBenefitsOtherLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_UnrecognizedTaxBenefitsOtherLiabilitiesMember" xlink:to="lab_iff_UnrecognizedTaxBenefitsOtherLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_9c6e0202-3b1a-43ad-b782-68b1049a0cb9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_3055aa91-14a1-402e-807c-e5ca31763bd1_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Other Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrent" xlink:to="lab_us-gaap_LiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_6bc00f75-86ef-4a46-840a-35cd01ec5230_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds related to the issuance of senior notes</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_34a22044-b154-498e-9fa8-e631694f242c_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Predetermined</link:label>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_label_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Predetermined [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgPredtrmndFlag" xlink:to="lab_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInPensionExpense_b5deb008-e6db-4cd2-99df-49cab545e413_terseLabel_en-US" xlink:label="lab_iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInPensionExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">25 BP decrease in discount rate, change in pension expense</link:label>
    <link:label id="lab_iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInPensionExpense_label_en-US" xlink:label="lab_iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInPensionExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Effect Of Twenty Five Base Point Decrease In Discount Rate In Pension Expense</link:label>
    <link:label id="lab_iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInPensionExpense_documentation_en-US" xlink:label="lab_iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInPensionExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit plan, effect of twenty five base point decrease in discount rate in pension expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInPensionExpense" xlink:href="iff-20231231.xsd#iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInPensionExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInPensionExpense" xlink:to="lab_iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInPensionExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTaxStatusDomain_7466af98-ef55-47d3-b3f1-df4f894150a6_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTaxStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Tax Status [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTaxStatusDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTaxStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Tax Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTaxStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTaxStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTaxStatusDomain" xlink:to="lab_us-gaap_RetirementPlanTaxStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_6f7f6c3a-9455-4c8f-a876-0000c442a399_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement period adjustment</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_5ca9b0ad-a03e-444e-bc7a-f4d57a83113a_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_98bcc95d-4f22-4fd5-8231-b65372431c59_terseLabel_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt</link:label>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnsecuredDebtMember" xlink:to="lab_us-gaap_UnsecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a059cd59-e334-40f8-857b-490445d01980_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_A1.800SeniorNotesDue2026Member_4209d093-3bb7-4a2f-926d-9976e56698a1_terseLabel_en-US" xlink:label="lab_iff_A1.800SeniorNotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.800% Senior Notes Due 2026 [Member]</link:label>
    <link:label id="lab_iff_A1.800SeniorNotesDue2026Member_label_en-US" xlink:label="lab_iff_A1.800SeniorNotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.800% Senior Notes Due 2026 [Member]</link:label>
    <link:label id="lab_iff_A1.800SeniorNotesDue2026Member_documentation_en-US" xlink:label="lab_iff_A1.800SeniorNotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.800% Senior Notes Due 2026 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_A1.800SeniorNotesDue2026Member" xlink:href="iff-20231231.xsd#iff_A1.800SeniorNotesDue2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_A1.800SeniorNotesDue2026Member" xlink:to="lab_iff_A1.800SeniorNotesDue2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_c9bb7cad-f1de-47fd-9ae6-211ac14ef8fd_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technological Know-how [Member]</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_SupplierFinanceProgramPolicyPolicyTextBlock_d1b136aa-9761-4e70-b4e1-111db4383f54_terseLabel_en-US" xlink:label="lab_iff_SupplierFinanceProgramPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supply Chain Financing Program</link:label>
    <link:label id="lab_iff_SupplierFinanceProgramPolicyPolicyTextBlock_label_en-US" xlink:label="lab_iff_SupplierFinanceProgramPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Finance Program, Policy [Policy Text Block]</link:label>
    <link:label id="lab_iff_SupplierFinanceProgramPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_iff_SupplierFinanceProgramPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Finance Program, Policy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SupplierFinanceProgramPolicyPolicyTextBlock" xlink:href="iff-20231231.xsd#iff_SupplierFinanceProgramPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_SupplierFinanceProgramPolicyPolicyTextBlock" xlink:to="lab_iff_SupplierFinanceProgramPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_976e44f3-997b-461c-aeae-af88406448e4_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicDistributionDomesticMember_5197c46f-b354-4558-a4ce-79fffcda158d_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicDistributionDomesticMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Distribution, Domestic [Member]</link:label>
    <link:label id="lab_us-gaap_GeographicDistributionDomesticMember_label_en-US" xlink:label="lab_us-gaap_GeographicDistributionDomesticMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Distribution, Domestic [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomesticMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionDomesticMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicDistributionDomesticMember" xlink:to="lab_us-gaap_GeographicDistributionDomesticMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherDepreciationAndAmortization_3b299a17-522b-4ecc-9bad-4c34e1de4895_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Depreciation and Amortization</link:label>
    <link:label id="lab_us-gaap_OtherDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_OtherDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherDepreciationAndAmortization" xlink:to="lab_us-gaap_OtherDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenBasicNetIncomeLossPerShare_aadb61ca-0c93-426d-8ed0-382a18260401_terseLabel_en-US" xlink:label="lab_iff_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenBasicNetIncomeLossPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participating Securities, Distributed And Undistributed Earnings (Loss), Difference Between Basic Net Income (Loss) Per Share</link:label>
    <link:label id="lab_iff_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenBasicNetIncomeLossPerShare_label_en-US" xlink:label="lab_iff_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenBasicNetIncomeLossPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participating Securities, Distributed And Undistributed Earnings (Loss), Difference Between Basic Net Income (Loss) Per Share</link:label>
    <link:label id="lab_iff_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenBasicNetIncomeLossPerShare_documentation_en-US" xlink:label="lab_iff_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenBasicNetIncomeLossPerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participating Securities, Distributed And Undistributed Earnings (Loss), Difference Between Basic Net Income (Loss) Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenBasicNetIncomeLossPerShare" xlink:href="iff-20231231.xsd#iff_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenBasicNetIncomeLossPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenBasicNetIncomeLossPerShare" xlink:to="lab_iff_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenBasicNetIncomeLossPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_d09df090-9c7e-4c48-83af-647514ffc8a6_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Lines of Credit</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_3373b0ba-be0c-4d2a-96a3-88afb25fe6d3_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Beginning and Ending Amount of Unrecognized Tax Benefits</link:label>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Income Tax Contingencies [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:to="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_ShareEquivalentsMember_e44c59a4-7f15-4a3a-a8f5-f953667762d1_terseLabel_en-US" xlink:label="lab_iff_ShareEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Equivalents</link:label>
    <link:label id="lab_iff_ShareEquivalentsMember_label_en-US" xlink:label="lab_iff_ShareEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Equivalents [Member]</link:label>
    <link:label id="lab_iff_ShareEquivalentsMember_documentation_en-US" xlink:label="lab_iff_ShareEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareEquivalentsMember" xlink:href="iff-20231231.xsd#iff_ShareEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_ShareEquivalentsMember" xlink:to="lab_iff_ShareEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_BankGuaranteesCommercialGuaranteesStandbyLettersOfCreditAndSuretyBondsFacilityAmounts_2f66d177-cb52-4a3d-aa44-7a2f7ab46f70_terseLabel_en-US" xlink:label="lab_iff_BankGuaranteesCommercialGuaranteesStandbyLettersOfCreditAndSuretyBondsFacilityAmounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank Guarantees, Commercial Guarantees, Letters Of Credit and Surety Bonds, Facility Amounts</link:label>
    <link:label id="lab_iff_BankGuaranteesCommercialGuaranteesStandbyLettersOfCreditAndSuretyBondsFacilityAmounts_label_en-US" xlink:label="lab_iff_BankGuaranteesCommercialGuaranteesStandbyLettersOfCreditAndSuretyBondsFacilityAmounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank Guarantees, Commercial Guarantees, Standby Letters Of Credit and Surety Bonds, Facility Amounts</link:label>
    <link:label id="lab_iff_BankGuaranteesCommercialGuaranteesStandbyLettersOfCreditAndSuretyBondsFacilityAmounts_documentation_en-US" xlink:label="lab_iff_BankGuaranteesCommercialGuaranteesStandbyLettersOfCreditAndSuretyBondsFacilityAmounts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank Guarantees, Commercial Guarantees, Standby Letters Of Credit and Surety Bonds, Facility Amounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BankGuaranteesCommercialGuaranteesStandbyLettersOfCreditAndSuretyBondsFacilityAmounts" xlink:href="iff-20231231.xsd#iff_BankGuaranteesCommercialGuaranteesStandbyLettersOfCreditAndSuretyBondsFacilityAmounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_BankGuaranteesCommercialGuaranteesStandbyLettersOfCreditAndSuretyBondsFacilityAmounts" xlink:to="lab_iff_BankGuaranteesCommercialGuaranteesStandbyLettersOfCreditAndSuretyBondsFacilityAmounts" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_RestructuringandOtherCharges_fa59a7dd-ecee-410c-9f03-70a59d90e871_verboseLabel_en-US" xlink:label="lab_iff_RestructuringandOtherCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and other charges</link:label>
    <link:label id="lab_iff_RestructuringandOtherCharges_label_en-US" xlink:label="lab_iff_RestructuringandOtherCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Other Charges</link:label>
    <link:label id="lab_iff_RestructuringandOtherCharges_documentation_en-US" xlink:label="lab_iff_RestructuringandOtherCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Other Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_RestructuringandOtherCharges" xlink:href="iff-20231231.xsd#iff_RestructuringandOtherCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_RestructuringandOtherCharges" xlink:to="lab_iff_RestructuringandOtherCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_TradeAccountsReceivableWithTheCompanysOwnFactoringAgreementsMember_e1c1409c-9f7a-4039-a42d-44514c2fd36c_terseLabel_en-US" xlink:label="lab_iff_TradeAccountsReceivableWithTheCompanysOwnFactoringAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Accounts Receivable With The Company's Own Factoring Agreements</link:label>
    <link:label id="lab_iff_TradeAccountsReceivableWithTheCompanysOwnFactoringAgreementsMember_label_en-US" xlink:label="lab_iff_TradeAccountsReceivableWithTheCompanysOwnFactoringAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Accounts Receivable With The Company's Own Factoring Agreements [Member]</link:label>
    <link:label id="lab_iff_TradeAccountsReceivableWithTheCompanysOwnFactoringAgreementsMember_documentation_en-US" xlink:label="lab_iff_TradeAccountsReceivableWithTheCompanysOwnFactoringAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Accounts Receivable With Factoring Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TradeAccountsReceivableWithTheCompanysOwnFactoringAgreementsMember" xlink:href="iff-20231231.xsd#iff_TradeAccountsReceivableWithTheCompanysOwnFactoringAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_TradeAccountsReceivableWithTheCompanysOwnFactoringAgreementsMember" xlink:to="lab_iff_TradeAccountsReceivableWithTheCompanysOwnFactoringAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_659a4b12-4e1e-4564-abee-e7bcb5d7f461_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureAbstract_01524457-4efa-4359-83e3-b36978d6e331_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:to="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestLineItems_76f30bd3-86d2-4701-94bb-b2a938517a16_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Line Items]</link:label>
    <link:label id="lab_us-gaap_MinorityInterestLineItems_label_en-US" xlink:label="lab_us-gaap_MinorityInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestLineItems" xlink:to="lab_us-gaap_MinorityInterestLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_GainContingencyRelocationPaymentsReceived_d206f797-154b-4e5f-8af8-e58d5f711fe0_terseLabel_en-US" xlink:label="lab_iff_GainContingencyRelocationPaymentsReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingency, Relocation Payments Received</link:label>
    <link:label id="lab_iff_GainContingencyRelocationPaymentsReceived_label_en-US" xlink:label="lab_iff_GainContingencyRelocationPaymentsReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingency, Relocation Payments Received</link:label>
    <link:label id="lab_iff_GainContingencyRelocationPaymentsReceived_documentation_en-US" xlink:label="lab_iff_GainContingencyRelocationPaymentsReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingency, Relocation Payments Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_GainContingencyRelocationPaymentsReceived" xlink:href="iff-20231231.xsd#iff_GainContingencyRelocationPaymentsReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_GainContingencyRelocationPaymentsReceived" xlink:to="lab_iff_GainContingencyRelocationPaymentsReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_ed568155-4547-4f90-892b-77a4164f24b6_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument Risk [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_NonUSAssetBackedSecuritiesMember_426749cf-5ec4-448e-b4cc-2feebde894ac_terseLabel_en-US" xlink:label="lab_iff_NonUSAssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S. Asset-Backed Securities</link:label>
    <link:label id="lab_iff_NonUSAssetBackedSecuritiesMember_label_en-US" xlink:label="lab_iff_NonUSAssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non U S Asset Backed Securities [Member]</link:label>
    <link:label id="lab_iff_NonUSAssetBackedSecuritiesMember_documentation_en-US" xlink:label="lab_iff_NonUSAssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non U.S. Asset Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NonUSAssetBackedSecuritiesMember" xlink:href="iff-20231231.xsd#iff_NonUSAssetBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_NonUSAssetBackedSecuritiesMember" xlink:to="lab_iff_NonUSAssetBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_34ea0f55-0885-47c6-a396-b37fb1eb9675_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_OtherIncomeExpenseNetMember_7742dafc-eb29-4b55-bf4e-e57c21ecb076_terseLabel_en-US" xlink:label="lab_iff_OtherIncomeExpenseNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income Expense Net [Member]</link:label>
    <link:label id="lab_iff_OtherIncomeExpenseNetMember_label_en-US" xlink:label="lab_iff_OtherIncomeExpenseNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income Expense Net [Member]</link:label>
    <link:label id="lab_iff_OtherIncomeExpenseNetMember_documentation_en-US" xlink:label="lab_iff_OtherIncomeExpenseNetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income Expense, Net.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_OtherIncomeExpenseNetMember" xlink:href="iff-20231231.xsd#iff_OtherIncomeExpenseNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_OtherIncomeExpenseNetMember" xlink:to="lab_iff_OtherIncomeExpenseNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_BrazilTaxCreditsMember_0d9fbcaa-ddeb-43fc-9959-ea3cae8ab899_terseLabel_en-US" xlink:label="lab_iff_BrazilTaxCreditsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Brazil Tax Credits</link:label>
    <link:label id="lab_iff_BrazilTaxCreditsMember_label_en-US" xlink:label="lab_iff_BrazilTaxCreditsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Brazil Tax Credits [Member]</link:label>
    <link:label id="lab_iff_BrazilTaxCreditsMember_documentation_en-US" xlink:label="lab_iff_BrazilTaxCreditsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Brazil Tax Credits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BrazilTaxCreditsMember" xlink:href="iff-20231231.xsd#iff_BrazilTaxCreditsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_BrazilTaxCreditsMember" xlink:to="lab_iff_BrazilTaxCreditsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_82dc1293-cea7-42fe-97d9-bdf6c945bdd2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllTradingArrangementsMember_terseLabel_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Trading Arrangements</link:label>
    <link:label id="lab_ecd_AllTradingArrangementsMember_label_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Trading Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllTradingArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllTradingArrangementsMember" xlink:to="lab_ecd_AllTradingArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_SavorySolutionsAndFlavorSpecialtyIngredientsMember_78ff6f72-c8f1-40a3-bb11-6d8ed80d177f_terseLabel_en-US" xlink:label="lab_iff_SavorySolutionsAndFlavorSpecialtyIngredientsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Savory Solutions and Fine and Specialty Ingredients</link:label>
    <link:label id="lab_iff_SavorySolutionsAndFlavorSpecialtyIngredientsMember_label_en-US" xlink:label="lab_iff_SavorySolutionsAndFlavorSpecialtyIngredientsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Savory Solutions and Flavor Specialty Ingredients [Member]</link:label>
    <link:label id="lab_iff_SavorySolutionsAndFlavorSpecialtyIngredientsMember_documentation_en-US" xlink:label="lab_iff_SavorySolutionsAndFlavorSpecialtyIngredientsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Savory Solutions and Flavor Specialty Ingredients</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SavorySolutionsAndFlavorSpecialtyIngredientsMember" xlink:href="iff-20231231.xsd#iff_SavorySolutionsAndFlavorSpecialtyIngredientsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_SavorySolutionsAndFlavorSpecialtyIngredientsMember" xlink:to="lab_iff_SavorySolutionsAndFlavorSpecialtyIngredientsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock_0f0fd684-8dc7-4cd8-bc10-4c4f1ef36354_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SSAR's and Stock Option Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option and Stock Appreciation Rights, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllAdjToCompMember_terseLabel_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Adjustments to Compensation</link:label>
    <link:label id="lab_ecd_AllAdjToCompMember_label_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Adjustments to Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllAdjToCompMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="lab_ecd_AllAdjToCompMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_b5583dc7-9cde-4ebb-a330-acc80362161e_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_db87b079-860b-4c27-88c8-ee9d8218d883_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Recovery Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryCompAmt" xlink:to="lab_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_StockRepurchaseProgramRemainingAuthorizedAmendedRepurchaseAmount_aab24a36-5367-4cab-99ab-3fa31ae8f615_terseLabel_en-US" xlink:label="lab_iff_StockRepurchaseProgramRemainingAuthorizedAmendedRepurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining authorized amended repurchase amount</link:label>
    <link:label id="lab_iff_StockRepurchaseProgramRemainingAuthorizedAmendedRepurchaseAmount_label_en-US" xlink:label="lab_iff_StockRepurchaseProgramRemainingAuthorizedAmendedRepurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Amended Repurchase Amount</link:label>
    <link:label id="lab_iff_StockRepurchaseProgramRemainingAuthorizedAmendedRepurchaseAmount_documentation_en-US" xlink:label="lab_iff_StockRepurchaseProgramRemainingAuthorizedAmendedRepurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Amended Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_StockRepurchaseProgramRemainingAuthorizedAmendedRepurchaseAmount" xlink:href="iff-20231231.xsd#iff_StockRepurchaseProgramRemainingAuthorizedAmendedRepurchaseAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_StockRepurchaseProgramRemainingAuthorizedAmendedRepurchaseAmount" xlink:to="lab_iff_StockRepurchaseProgramRemainingAuthorizedAmendedRepurchaseAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedPurchasedByEmployees_4311f261-c21d-4cd0-a2b8-4d4d1d9fc880_terseLabel_en-US" xlink:label="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedPurchasedByEmployees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issued Shares (in shares)</link:label>
    <link:label id="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedPurchasedByEmployees_label_en-US" xlink:label="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedPurchasedByEmployees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Issued, Purchased By Employees</link:label>
    <link:label id="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedPurchasedByEmployees_documentation_en-US" xlink:label="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedPurchasedByEmployees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Issued, Purchased By Employees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedPurchasedByEmployees" xlink:href="iff-20231231.xsd#iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedPurchasedByEmployees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedPurchasedByEmployees" xlink:to="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedPurchasedByEmployees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_198775d2-f7af-405c-a114-b600a2d91429_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DifferenceAmountBetweenDilutedNetIncomeLossPerShare_b20bbd28-dab9-4eea-977b-3941f8fb783f_terseLabel_en-US" xlink:label="lab_iff_DifferenceAmountBetweenDilutedNetIncomeLossPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Difference Amount Between Diluted Net Income (Loss) Per Share</link:label>
    <link:label id="lab_iff_DifferenceAmountBetweenDilutedNetIncomeLossPerShare_label_en-US" xlink:label="lab_iff_DifferenceAmountBetweenDilutedNetIncomeLossPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Difference Amount Between Diluted Net Income (Loss) Per Share</link:label>
    <link:label id="lab_iff_DifferenceAmountBetweenDilutedNetIncomeLossPerShare_documentation_en-US" xlink:label="lab_iff_DifferenceAmountBetweenDilutedNetIncomeLossPerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Difference Amount Between Diluted Net Income (Loss) Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DifferenceAmountBetweenDilutedNetIncomeLossPerShare" xlink:href="iff-20231231.xsd#iff_DifferenceAmountBetweenDilutedNetIncomeLossPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DifferenceAmountBetweenDilutedNetIncomeLossPerShare" xlink:to="lab_iff_DifferenceAmountBetweenDilutedNetIncomeLossPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_22de2160-0331-4ac1-a15e-a77f14e7895a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), after tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_b7f400c6-3885-4cb1-aa97-3d2cb0e5b7e3_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative assets(3)</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_fb861153-7060-4ad0-89ed-fa556053dd4b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_87037417-4e61-4d53-bbd7-a82e887d8df7_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_64c07ce2-5833-4b2a-b079-9261ceb9dbdd_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred income tax provision</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_2e64410d-dcbe-4802-be3b-167b26f653fa_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionExercisableByExercisePriceRangeTableTextBlock_1b09b28e-f730-416c-900e-2e46ad9ddd24_terseLabel_en-US" xlink:label="lab_iff_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionExercisableByExercisePriceRangeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SSAR's and Stock Option Exercisable</link:label>
    <link:label id="lab_iff_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionExercisableByExercisePriceRangeTableTextBlock_label_en-US" xlink:label="lab_iff_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionExercisableByExercisePriceRangeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share Based Compensation, Shares Authorized Under Stock Option, Exercisable, By Exercise Price Range Table [Text Block]</link:label>
    <link:label id="lab_iff_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionExercisableByExercisePriceRangeTableTextBlock_documentation_en-US" xlink:label="lab_iff_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionExercisableByExercisePriceRangeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share-Based Compensation, Shares Authorized Under Stock Option, Exercisable, By Exercise Price Range [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionExercisableByExercisePriceRangeTableTextBlock" xlink:href="iff-20231231.xsd#iff_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionExercisableByExercisePriceRangeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionExercisableByExercisePriceRangeTableTextBlock" xlink:to="lab_iff_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionExercisableByExercisePriceRangeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_StockOptionsOrStockSettledAppreciationRightsMember_eb6e09a3-1843-46a6-98c9-90f49bbce520_terseLabel_en-US" xlink:label="lab_iff_StockOptionsOrStockSettledAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options or Stock-Settled Appreciation Rights</link:label>
    <link:label id="lab_iff_StockOptionsOrStockSettledAppreciationRightsMember_label_en-US" xlink:label="lab_iff_StockOptionsOrStockSettledAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options or Stock-Settled Appreciation Rights [Member]</link:label>
    <link:label id="lab_iff_StockOptionsOrStockSettledAppreciationRightsMember_documentation_en-US" xlink:label="lab_iff_StockOptionsOrStockSettledAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options or Stock-Settled Appreciation Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_StockOptionsOrStockSettledAppreciationRightsMember" xlink:href="iff-20231231.xsd#iff_StockOptionsOrStockSettledAppreciationRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_StockOptionsOrStockSettledAppreciationRightsMember" xlink:to="lab_iff_StockOptionsOrStockSettledAppreciationRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicDistributionForeignMember_35d326c6-5c32-4800-9482-72b5b683533d_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicDistributionForeignMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Distribution, Foreign [Member]</link:label>
    <link:label id="lab_us-gaap_GeographicDistributionForeignMember_label_en-US" xlink:label="lab_us-gaap_GeographicDistributionForeignMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Distribution, Foreign [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionForeignMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionForeignMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicDistributionForeignMember" xlink:to="lab_us-gaap_GeographicDistributionForeignMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_64a98562-93a4-430f-a80a-6701a2e5d7a7_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_c34ac317-d8b0-4a28-856d-3a5af1955d9a_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFinStmtErrorCorrectionFlag_3d9dcb82-c3a9-498c-b7f5-e24f6be7182a_terseLabel_en-US" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
    <link:label id="lab_dei_DocumentFinStmtErrorCorrectionFlag_label_en-US" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_9e18e3dc-2c35-4976-929f-7d7827b999fb_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_30f01f45-8af5-4780-997e-411919d5c25d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition, equity interest issued or issuable, number of shares</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_ConditionTwoMember_b7b9a718-538f-4fb4-a9dd-54528fda3002_terseLabel_en-US" xlink:label="lab_iff_ConditionTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condition Two [Member]</link:label>
    <link:label id="lab_iff_ConditionTwoMember_label_en-US" xlink:label="lab_iff_ConditionTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condition Two [Member]</link:label>
    <link:label id="lab_iff_ConditionTwoMember_documentation_en-US" xlink:label="lab_iff_ConditionTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condition Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ConditionTwoMember" xlink:href="iff-20231231.xsd#iff_ConditionTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_ConditionTwoMember" xlink:to="lab_iff_ConditionTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_ad7f76de-1454-4534-8ba9-66c9038d9a39_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Benefit Obligation &#8212; end of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_4d9e4aa5-0d30-43a4-a8f6-9aa152ee1b68_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets_20a10aa6-aa5c-4b4d-8c42-2c0274939af3_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions/Transferred Assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Business Combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_1a2bcd05-47cc-46c4-9950-e286b76747e8_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than 1 Year</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharePrice_88eeb048-e1f3-49cf-93bc-254c43cf0685_terseLabel_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Price</link:label>
    <link:label id="lab_us-gaap_SharePrice_label_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice" xlink:to="lab_us-gaap_SharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_985c107f-6acf-4310-b9f4-7fd55763f565_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_AmortizingNoteMember_d1707f12-47c3-4d69-81cd-c0a11ec245b7_terseLabel_en-US" xlink:label="lab_iff_AmortizingNoteMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortizing Note</link:label>
    <link:label id="lab_iff_AmortizingNoteMember_label_en-US" xlink:label="lab_iff_AmortizingNoteMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortizing Note [Member]</link:label>
    <link:label id="lab_iff_AmortizingNoteMember_documentation_en-US" xlink:label="lab_iff_AmortizingNoteMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortizing Note [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AmortizingNoteMember" xlink:href="iff-20231231.xsd#iff_AmortizingNoteMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_AmortizingNoteMember" xlink:to="lab_iff_AmortizingNoteMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesCurrent_51b11dc4-1507-4cc5-a798-778f679b0a39_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes, current</link:label>
    <link:label id="lab_us-gaap_SeniorNotesCurrent_label_en-US" xlink:label="lab_us-gaap_SeniorNotesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesCurrent" xlink:to="lab_us-gaap_SeniorNotesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsChangeDueToPerformanceConditionsWeightedAverageGrantDateFairValue_ff234e94-5cf6-485b-a0a8-dd62ab08f4d6_terseLabel_en-US" xlink:label="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsChangeDueToPerformanceConditionsWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change due to performance conditions, net (in dollars per share)</link:label>
    <link:label id="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsChangeDueToPerformanceConditionsWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsChangeDueToPerformanceConditionsWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Change Due To Performance Conditions, Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsChangeDueToPerformanceConditionsWeightedAverageGrantDateFairValue_documentation_en-US" xlink:label="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsChangeDueToPerformanceConditionsWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Change Due To Performance Conditions, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsChangeDueToPerformanceConditionsWeightedAverageGrantDateFairValue" xlink:href="iff-20231231.xsd#iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsChangeDueToPerformanceConditionsWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsChangeDueToPerformanceConditionsWeightedAverageGrantDateFairValue" xlink:to="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsChangeDueToPerformanceConditionsWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LegalFees_ddde911d-c8c0-4195-b880-325a55da4067_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LegalFees" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Fees</link:label>
    <link:label id="lab_us-gaap_LegalFees_a518bad6-868b-4577-91d6-a6354d91c01a_terseLabel_en-US" xlink:label="lab_us-gaap_LegalFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Fees</link:label>
    <link:label id="lab_us-gaap_LegalFees_label_en-US" xlink:label="lab_us-gaap_LegalFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalFees" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LegalFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LegalFees" xlink:to="lab_us-gaap_LegalFees" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearTwo_431d7dad-f957-49b1-b56c-b65a75ccfd75_terseLabel_en-US" xlink:label="lab_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:label id="lab_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearTwo_label_en-US" xlink:label="lab_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:label id="lab_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearTwo_documentation_en-US" xlink:label="lab_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearTwo" xlink:href="iff-20231231.xsd#iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearTwo" xlink:to="lab_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumptionsInPeriodWeightedAverageExercisePrice_5176f3f6-3a54-4317-b20b-9d1fb9bff0ff_terseLabel_en-US" xlink:label="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumptionsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed (in dollars per share)</link:label>
    <link:label id="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumptionsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumptionsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Assumptions In Period, Weighted Average Exercise Price</link:label>
    <link:label id="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumptionsInPeriodWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumptionsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Assumptions In Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumptionsInPeriodWeightedAverageExercisePrice" xlink:href="iff-20231231.xsd#iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumptionsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumptionsInPeriodWeightedAverageExercisePrice" xlink:to="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumptionsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_ac51b5fc-bf2f-4bef-8b26-b536cbd145af_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment for assumed dilution (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_AmountOfAvailableLinesOfCredit_7f677913-f9d8-4d43-b061-aff35a51821e_terseLabel_en-US" xlink:label="lab_iff_AmountOfAvailableLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available lines of credit</link:label>
    <link:label id="lab_iff_AmountOfAvailableLinesOfCredit_label_en-US" xlink:label="lab_iff_AmountOfAvailableLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount Of Available Lines Of Credit</link:label>
    <link:label id="lab_iff_AmountOfAvailableLinesOfCredit_documentation_en-US" xlink:label="lab_iff_AmountOfAvailableLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount Of Available Lines Of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AmountOfAvailableLinesOfCredit" xlink:href="iff-20231231.xsd#iff_AmountOfAvailableLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_AmountOfAvailableLinesOfCredit" xlink:to="lab_iff_AmountOfAvailableLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_afd09b5d-dab6-4f8b-9fd2-ad5779be094c_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of N&amp;B Merger (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_3d557628-bd7f-4d5a-ab45-82b0e2e45c89_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Price Range, upper limit</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_BusinessCombinationAdjustmentOnCashPayment_dbe779ca-b6a5-47d1-b28a-f8b7b378a9e1_terseLabel_en-US" xlink:label="lab_iff_BusinessCombinationAdjustmentOnCashPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment on cash payment from DuPont</link:label>
    <link:label id="lab_iff_BusinessCombinationAdjustmentOnCashPayment_label_en-US" xlink:label="lab_iff_BusinessCombinationAdjustmentOnCashPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Adjustment On Cash Payment</link:label>
    <link:label id="lab_iff_BusinessCombinationAdjustmentOnCashPayment_documentation_en-US" xlink:label="lab_iff_BusinessCombinationAdjustmentOnCashPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Adjustment On Cash Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BusinessCombinationAdjustmentOnCashPayment" xlink:href="iff-20231231.xsd#iff_BusinessCombinationAdjustmentOnCashPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_BusinessCombinationAdjustmentOnCashPayment" xlink:to="lab_iff_BusinessCombinationAdjustmentOnCashPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_BusinessCombinationRestructuringLiabilities_eedffc3f-525d-473b-a66a-b6ae2c59510f_terseLabel_en-US" xlink:label="lab_iff_BusinessCombinationRestructuringLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Restructuring Liabilities</link:label>
    <link:label id="lab_iff_BusinessCombinationRestructuringLiabilities_label_en-US" xlink:label="lab_iff_BusinessCombinationRestructuringLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Restructuring Liabilities</link:label>
    <link:label id="lab_iff_BusinessCombinationRestructuringLiabilities_documentation_en-US" xlink:label="lab_iff_BusinessCombinationRestructuringLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Restructuring Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BusinessCombinationRestructuringLiabilities" xlink:href="iff-20231231.xsd#iff_BusinessCombinationRestructuringLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_BusinessCombinationRestructuringLiabilities" xlink:to="lab_iff_BusinessCombinationRestructuringLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_CommitmentsAndContingenciesLineItems_bc82373b-3521-4a4c-aa2d-3811f4d4b29c_terseLabel_en-US" xlink:label="lab_iff_CommitmentsAndContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Line Items]</link:label>
    <link:label id="lab_iff_CommitmentsAndContingenciesLineItems_label_en-US" xlink:label="lab_iff_CommitmentsAndContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Line Items]</link:label>
    <link:label id="lab_iff_CommitmentsAndContingenciesLineItems_documentation_en-US" xlink:label="lab_iff_CommitmentsAndContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_CommitmentsAndContingenciesLineItems" xlink:href="iff-20231231.xsd#iff_CommitmentsAndContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems" xlink:to="lab_iff_CommitmentsAndContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_7539482f-6a3d-4a7c-b33d-61bfa77c53f5_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_b04050fb-901e-47d2-b2a0-f2c8f55506c7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Payments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_71b28650-aefa-431a-a11c-d10a48e55325_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_CosmeticActivesMember_d3a658ac-8ab8-4d94-af37-b991892e9478_terseLabel_en-US" xlink:label="lab_iff_CosmeticActivesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cosmetic Actives</link:label>
    <link:label id="lab_iff_CosmeticActivesMember_label_en-US" xlink:label="lab_iff_CosmeticActivesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cosmetic Actives [Member]</link:label>
    <link:label id="lab_iff_CosmeticActivesMember_documentation_en-US" xlink:label="lab_iff_CosmeticActivesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cosmetic Actives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_CosmeticActivesMember" xlink:href="iff-20231231.xsd#iff_CosmeticActivesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_CosmeticActivesMember" xlink:to="lab_iff_CosmeticActivesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrAdoptionDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adoption Date</link:label>
    <link:label id="lab_ecd_TrdArrAdoptionDate_label_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement Adoption Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrAdoptionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrAdoptionDate" xlink:to="lab_ecd_TrdArrAdoptionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_6a354c31-bcbc-4982-a559-0eb52bdc389f_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer Benchmark</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesMember_ff134f59-23f5-45de-a108-1ebf7c9b1272_terseLabel_en-US" xlink:label="lab_us-gaap_SalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales [Member]</link:label>
    <link:label id="lab_us-gaap_SalesMember_label_en-US" xlink:label="lab_us-gaap_SalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesMember" xlink:to="lab_us-gaap_SalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_d47d1b5a-c722-4422-8da3-e52f3da1e8a4_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease weighted average discount rate</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_5c553445-ec92-45b5-bbca-c37eab5a7082_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_d257c2a5-e1b1-4abf-84f8-0ed5e2712725_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unaudited pro forma information</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_d6490060-a186-41a0-b45b-a712a8ca8bd2_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:to="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_a1cd18b6-3dff-4ab7-ae9e-be4c5dabc9ee_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember" xlink:to="lab_us-gaap_TreasuryStockCommonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_8b56dd31-1f11-4baf-b671-526d08e40d8e_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Member]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_58245a0e-7048-47e3-bf6e-9840b7811073_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskDisclosureTextBlock_8cf0fe48-2dc9-4342-92b2-9ed8a530d0ae_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentrations of Credit Risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:to="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DefinedBenefitPlanBenefitObligationOther_c35f229a-f2da-4daa-9329-8d2d2530d91b_terseLabel_en-US" xlink:label="lab_iff_DefinedBenefitPlanBenefitObligationOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_iff_DefinedBenefitPlanBenefitObligationOther_label_en-US" xlink:label="lab_iff_DefinedBenefitPlanBenefitObligationOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Other</link:label>
    <link:label id="lab_iff_DefinedBenefitPlanBenefitObligationOther_documentation_en-US" xlink:label="lab_iff_DefinedBenefitPlanBenefitObligationOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedBenefitPlanBenefitObligationOther" xlink:href="iff-20231231.xsd#iff_DefinedBenefitPlanBenefitObligationOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DefinedBenefitPlanBenefitObligationOther" xlink:to="lab_iff_DefinedBenefitPlanBenefitObligationOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_15dc4504-9924-42f0-8677-dd6f9419db71_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains on sale of assets</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_98805b91-670d-4a9f-bea8-c9aada8c8ad7_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on Sale of Assets</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_0c6dc891-ea28-4b70-8a3c-fd978f4f1259_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_496c9523-fec9-48c4-b8ff-ec465bdf1586_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_5e740a84-b8fd-4a87-ba49-bd81eb6fb330_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_eed7153b-0335-4403-b2f1-250f36af1427_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInProjectedBenefitObligation_2b47ce26-76c1-4f02-b447-30c977a22565_terseLabel_en-US" xlink:label="lab_iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInProjectedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">25 BP decrease in discount rate, change in ABO</link:label>
    <link:label id="lab_iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInProjectedBenefitObligation_label_en-US" xlink:label="lab_iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInProjectedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Effect Of Twenty Five Base Point Decrease In Discount Rate In Projected Benefit Obligation</link:label>
    <link:label id="lab_iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInProjectedBenefitObligation_documentation_en-US" xlink:label="lab_iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInProjectedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit plan, effect of twenty five base point decrease in discount rate in projected benefit obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInProjectedBenefitObligation" xlink:href="iff-20231231.xsd#iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInProjectedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInProjectedBenefitObligation" xlink:to="lab_iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInProjectedBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_5f8e3ab6-8b20-44ec-9dec-7b2aa83d2109_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_260cbc2b-c74d-408d-b972-44fb1b0796bc_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_e7e3bbd3-e110-4629-99a3-f1b5d7532e28_verboseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Derivatives Designated as Hedging Instrument [Member]</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_724b996d-920f-478d-8410-d630c750e5f6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Writeoff</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Writeoff</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_AmountOfPledgedAssetsPrincipallyPropertyPlantAndEquipmentToCoverIncomeTaxAndIndirectTaxAssessments_62110d7e-53af-4a7d-b7af-75464bead8a4_terseLabel_en-US" xlink:label="lab_iff_AmountOfPledgedAssetsPrincipallyPropertyPlantAndEquipmentToCoverIncomeTaxAndIndirectTaxAssessments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of pledged assets, principally PP&amp;E to cover income tax and indirect tax assessments</link:label>
    <link:label id="lab_iff_AmountOfPledgedAssetsPrincipallyPropertyPlantAndEquipmentToCoverIncomeTaxAndIndirectTaxAssessments_label_en-US" xlink:label="lab_iff_AmountOfPledgedAssetsPrincipallyPropertyPlantAndEquipmentToCoverIncomeTaxAndIndirectTaxAssessments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount Of Pledged Assets Principally Property, Plant And Equipment To Cover Income Tax And Indirect Tax Assessments</link:label>
    <link:label id="lab_iff_AmountOfPledgedAssetsPrincipallyPropertyPlantAndEquipmentToCoverIncomeTaxAndIndirectTaxAssessments_documentation_en-US" xlink:label="lab_iff_AmountOfPledgedAssetsPrincipallyPropertyPlantAndEquipmentToCoverIncomeTaxAndIndirectTaxAssessments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of pledged assets, principally PP&amp;E to cover income tax and indirect tax assessments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AmountOfPledgedAssetsPrincipallyPropertyPlantAndEquipmentToCoverIncomeTaxAndIndirectTaxAssessments" xlink:href="iff-20231231.xsd#iff_AmountOfPledgedAssetsPrincipallyPropertyPlantAndEquipmentToCoverIncomeTaxAndIndirectTaxAssessments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_AmountOfPledgedAssetsPrincipallyPropertyPlantAndEquipmentToCoverIncomeTaxAndIndirectTaxAssessments" xlink:to="lab_iff_AmountOfPledgedAssetsPrincipallyPropertyPlantAndEquipmentToCoverIncomeTaxAndIndirectTaxAssessments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_39bf6412-1349-4fbe-b184-691f1bbb747f_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_a8555d49-d335-44db-8e8b-fee1e2081407_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_RestructuringAndRelatedCostExpectedNumberOfSitesClosed_0de1270a-36cd-4551-85c5-271a2a607f04_terseLabel_en-US" xlink:label="lab_iff_RestructuringAndRelatedCostExpectedNumberOfSitesClosed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected number of sites closed</link:label>
    <link:label id="lab_iff_RestructuringAndRelatedCostExpectedNumberOfSitesClosed_label_en-US" xlink:label="lab_iff_RestructuringAndRelatedCostExpectedNumberOfSitesClosed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring And Related Cost, Expected Number Of Sites Closed</link:label>
    <link:label id="lab_iff_RestructuringAndRelatedCostExpectedNumberOfSitesClosed_documentation_en-US" xlink:label="lab_iff_RestructuringAndRelatedCostExpectedNumberOfSitesClosed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring And Related Cost, Expected Number Of Sites Closed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_RestructuringAndRelatedCostExpectedNumberOfSitesClosed" xlink:href="iff-20231231.xsd#iff_RestructuringAndRelatedCostExpectedNumberOfSitesClosed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_RestructuringAndRelatedCostExpectedNumberOfSitesClosed" xlink:to="lab_iff_RestructuringAndRelatedCostExpectedNumberOfSitesClosed" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScenarioAdjustmentMember_ef0b0683-6f91-4c3b-bf8b-64c0d3a89d77_terseLabel_en-US" xlink:label="lab_us-gaap_ScenarioAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario, Adjustment [Member]</link:label>
    <link:label id="lab_us-gaap_ScenarioAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_ScenarioAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScenarioAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScenarioAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScenarioAdjustmentMember" xlink:to="lab_us-gaap_ScenarioAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_A2022CrossCurrencySwapsMember_0e64b9b7-5d34-4bfe-a240-7b7fb5955e00_terseLabel_en-US" xlink:label="lab_iff_A2022CrossCurrencySwapsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Cross Currency Swaps</link:label>
    <link:label id="lab_iff_A2022CrossCurrencySwapsMember_label_en-US" xlink:label="lab_iff_A2022CrossCurrencySwapsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Cross Currency Swaps [Member]</link:label>
    <link:label id="lab_iff_A2022CrossCurrencySwapsMember_documentation_en-US" xlink:label="lab_iff_A2022CrossCurrencySwapsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Cross Currency Swaps</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_A2022CrossCurrencySwapsMember" xlink:href="iff-20231231.xsd#iff_A2022CrossCurrencySwapsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_A2022CrossCurrencySwapsMember" xlink:to="lab_iff_A2022CrossCurrencySwapsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingAxis_22ae3f41-09b9-4c92-b956-3770306d3777_terseLabel_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:label id="lab_us-gaap_VestingAxis_label_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingAxis" xlink:to="lab_us-gaap_VestingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_68fed025-185e-4ea5-8c40-07a5bfa28fb7_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_c0574f7b-c4b3-4320-918f-5f430d7a5142_totalLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_A1.750SeniorNotesDue2024Member_42b11100-6f80-4f16-98dd-8e3b1ff136f6_terseLabel_en-US" xlink:label="lab_iff_A1.750SeniorNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.750% Senior Notes Due 2024 [Member]</link:label>
    <link:label id="lab_iff_A1.750SeniorNotesDue2024Member_label_en-US" xlink:label="lab_iff_A1.750SeniorNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.750% Senior Notes Due 2024 [Member]</link:label>
    <link:label id="lab_iff_A1.750SeniorNotesDue2024Member_documentation_en-US" xlink:label="lab_iff_A1.750SeniorNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.750% Senior Notes Due 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_A1.750SeniorNotesDue2024Member" xlink:href="iff-20231231.xsd#iff_A1.750SeniorNotesDue2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_A1.750SeniorNotesDue2024Member" xlink:to="lab_iff_A1.750SeniorNotesDue2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsValuationAllowance_538b812b-2371-4193-8807-1f579f9ffb2a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance for net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:to="lab_us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_PooledFundsMember_deb166d7-1d20-4410-b487-72f306c3d357_terseLabel_en-US" xlink:label="lab_iff_PooledFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pooled Funds</link:label>
    <link:label id="lab_iff_PooledFundsMember_label_en-US" xlink:label="lab_iff_PooledFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pooled Funds [Member]</link:label>
    <link:label id="lab_iff_PooledFundsMember_documentation_en-US" xlink:label="lab_iff_PooledFundsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pooled Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_PooledFundsMember" xlink:href="iff-20231231.xsd#iff_PooledFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_PooledFundsMember" xlink:to="lab_iff_PooledFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_c33d79bd-3020-423a-80a3-ee2b86b6f327_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis" xlink:to="lab_us-gaap_LineOfCreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfLandHeldForUse_deb5ef7e-fda3-4007-8724-83a791656b8c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfLandHeldForUse" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Land Held-for-use</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfLandHeldForUse_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfLandHeldForUse" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale, Land, Held-for-Use</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfLandHeldForUse" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfLandHeldForUse"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfLandHeldForUse" xlink:to="lab_us-gaap_ProceedsFromSaleOfLandHeldForUse" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_d817b8f2-3fa7-45f5-a3c2-8dde6ccd0d76_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_b1ba6e63-09f7-4665-a3e8-d1970f6e3ce3_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease weighted average remaining lease term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DefinedContributionPlanMatchingParticipantContributionAveragePercentageOnCompensation_b1de137e-5819-4edc-af57-604053adbb06_terseLabel_en-US" xlink:label="lab_iff_DefinedContributionPlanMatchingParticipantContributionAveragePercentageOnCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Matching participant's contribution, average percentage on compensation</link:label>
    <link:label id="lab_iff_DefinedContributionPlanMatchingParticipantContributionAveragePercentageOnCompensation_label_en-US" xlink:label="lab_iff_DefinedContributionPlanMatchingParticipantContributionAveragePercentageOnCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan Matching Participant Contribution Average Percentage On Compensation</link:label>
    <link:label id="lab_iff_DefinedContributionPlanMatchingParticipantContributionAveragePercentageOnCompensation_documentation_en-US" xlink:label="lab_iff_DefinedContributionPlanMatchingParticipantContributionAveragePercentageOnCompensation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined contribution plan, matching participant contribution, average percentage on compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedContributionPlanMatchingParticipantContributionAveragePercentageOnCompensation" xlink:href="iff-20231231.xsd#iff_DefinedContributionPlanMatchingParticipantContributionAveragePercentageOnCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DefinedContributionPlanMatchingParticipantContributionAveragePercentageOnCompensation" xlink:to="lab_iff_DefinedContributionPlanMatchingParticipantContributionAveragePercentageOnCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_e7148300-eeb4-46db-9e3b-fa9b06d27105_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net defined benefit plan liabilities</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_TargetPayoutPeriodOfCycle_bb698cdf-cff9-45d4-ab17-0a075616b51a_terseLabel_en-US" xlink:label="lab_iff_TargetPayoutPeriodOfCycle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Target payout, cycle</link:label>
    <link:label id="lab_iff_TargetPayoutPeriodOfCycle_label_en-US" xlink:label="lab_iff_TargetPayoutPeriodOfCycle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Target Payout, Period of Cycle</link:label>
    <link:label id="lab_iff_TargetPayoutPeriodOfCycle_documentation_en-US" xlink:label="lab_iff_TargetPayoutPeriodOfCycle" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Target Payout, Period of Cycle</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TargetPayoutPeriodOfCycle" xlink:href="iff-20231231.xsd#iff_TargetPayoutPeriodOfCycle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_TargetPayoutPeriodOfCycle" xlink:to="lab_iff_TargetPayoutPeriodOfCycle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestTableTextBlock_7309397a-4ec3-415f-8d54-97d248d5c8c9_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Redeemable Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RedeemableNoncontrollingInterestTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_HealthWrightProductsIncHealthWrightMember_f8336531-0307-4567-8206-32d84f887caa_terseLabel_en-US" xlink:label="lab_iff_HealthWrightProductsIncHealthWrightMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Wright Products, Inc. (&#8220;Health Wright&#8221;)</link:label>
    <link:label id="lab_iff_HealthWrightProductsIncHealthWrightMember_label_en-US" xlink:label="lab_iff_HealthWrightProductsIncHealthWrightMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Wright Products, Inc. (&#8220;Health Wright&#8221;) [Member]</link:label>
    <link:label id="lab_iff_HealthWrightProductsIncHealthWrightMember_documentation_en-US" xlink:label="lab_iff_HealthWrightProductsIncHealthWrightMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Wright Products, Inc. (&#8220;Health Wright&#8221;)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_HealthWrightProductsIncHealthWrightMember" xlink:href="iff-20231231.xsd#iff_HealthWrightProductsIncHealthWrightMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_HealthWrightProductsIncHealthWrightMember" xlink:to="lab_iff_HealthWrightProductsIncHealthWrightMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_EmployeeStockOptionAndRestrictedStockMember_f08e2b81-d846-41bb-9c83-6de6168f93e0_terseLabel_en-US" xlink:label="lab_iff_EmployeeStockOptionAndRestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Option And Restricted Stock [Member]</link:label>
    <link:label id="lab_iff_EmployeeStockOptionAndRestrictedStockMember_label_en-US" xlink:label="lab_iff_EmployeeStockOptionAndRestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Option And Restricted Stock [Member]</link:label>
    <link:label id="lab_iff_EmployeeStockOptionAndRestrictedStockMember_documentation_en-US" xlink:label="lab_iff_EmployeeStockOptionAndRestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Option And Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EmployeeStockOptionAndRestrictedStockMember" xlink:href="iff-20231231.xsd#iff_EmployeeStockOptionAndRestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_EmployeeStockOptionAndRestrictedStockMember" xlink:to="lab_iff_EmployeeStockOptionAndRestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_9e18d716-f4f8-4533-bb19-bff8b0aee38e_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credit carryforwards</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:to="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_AccumulatedOtherComprehensiveIncomeLossTextBlock_e2f84c3b-c90b-4dc7-ab65-33e92225a391_terseLabel_en-US" xlink:label="lab_iff_AccumulatedOtherComprehensiveIncomeLossTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income Loss</link:label>
    <link:label id="lab_iff_AccumulatedOtherComprehensiveIncomeLossTextBlock_label_en-US" xlink:label="lab_iff_AccumulatedOtherComprehensiveIncomeLossTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Text Block]</link:label>
    <link:label id="lab_iff_AccumulatedOtherComprehensiveIncomeLossTextBlock_documentation_en-US" xlink:label="lab_iff_AccumulatedOtherComprehensiveIncomeLossTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AccumulatedOtherComprehensiveIncomeLossTextBlock" xlink:href="iff-20231231.xsd#iff_AccumulatedOtherComprehensiveIncomeLossTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_AccumulatedOtherComprehensiveIncomeLossTextBlock" xlink:to="lab_iff_AccumulatedOtherComprehensiveIncomeLossTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_5ee1b343-3e99-4906-9096-26f823fec533_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_3ef0e5a7-0e43-4e67-8bf3-7662a56b41a0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for acquisitions, net of cash received</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DilutiveSharesQuotientMultiplier_6bdd3fa6-160f-4b1d-998c-44090de35dbb_terseLabel_en-US" xlink:label="lab_iff_DilutiveSharesQuotientMultiplier" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive Shares Quotient Multiplier</link:label>
    <link:label id="lab_iff_DilutiveSharesQuotientMultiplier_label_en-US" xlink:label="lab_iff_DilutiveSharesQuotientMultiplier" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive Shares Quotient Multiplier</link:label>
    <link:label id="lab_iff_DilutiveSharesQuotientMultiplier_documentation_en-US" xlink:label="lab_iff_DilutiveSharesQuotientMultiplier" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive Shares Quotient Multiplier</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DilutiveSharesQuotientMultiplier" xlink:href="iff-20231231.xsd#iff_DilutiveSharesQuotientMultiplier"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DilutiveSharesQuotientMultiplier" xlink:to="lab_iff_DilutiveSharesQuotientMultiplier" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_c0da1b34-86e8-403c-af9c-ae1921905cd9_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_a0a6ab37-a1ae-4c03-8bdd-1a1857431d40_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate of Return on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_d0e191d5-99d4-45ba-b97f-ba6207218856_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_ScheduleOfFairValueOfPensionPlanAssetsByAssetCategoryTableTableTextBlock_29bdbf3c-6c7f-4d68-98a9-f8bdb9c73f73_terseLabel_en-US" xlink:label="lab_iff_ScheduleOfFairValueOfPensionPlanAssetsByAssetCategoryTableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy of Plan Assets</link:label>
    <link:label id="lab_iff_ScheduleOfFairValueOfPensionPlanAssetsByAssetCategoryTableTableTextBlock_label_en-US" xlink:label="lab_iff_ScheduleOfFairValueOfPensionPlanAssetsByAssetCategoryTableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Fair Value Of Pension Plan Assets By Asset Category Table [Table Text Block]</link:label>
    <link:label id="lab_iff_ScheduleOfFairValueOfPensionPlanAssetsByAssetCategoryTableTableTextBlock_documentation_en-US" xlink:label="lab_iff_ScheduleOfFairValueOfPensionPlanAssetsByAssetCategoryTableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Fair Value Of Pension Plan Assets By Asset Category [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ScheduleOfFairValueOfPensionPlanAssetsByAssetCategoryTableTableTextBlock" xlink:href="iff-20231231.xsd#iff_ScheduleOfFairValueOfPensionPlanAssetsByAssetCategoryTableTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_ScheduleOfFairValueOfPensionPlanAssetsByAssetCategoryTableTableTextBlock" xlink:to="lab_iff_ScheduleOfFairValueOfPensionPlanAssetsByAssetCategoryTableTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_AuditInformationAbstract_label_en-US" xlink:label="lab_iff_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_iff_AuditInformationAbstract_documentation_en-US" xlink:label="lab_iff_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AuditInformationAbstract" xlink:href="iff-20231231.xsd#iff_AuditInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_AuditInformationAbstract" xlink:to="lab_iff_AuditInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_7e4ec795-ca1e-4798-a49c-0b940c04d2a2_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities held for sale</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_f7355bde-ee51-4e70-afe9-062c05d63f16_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Margin on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_3acc2e8b-217e-4143-b2ad-6f0411b103bf_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated useful life of property, plant and equipment, years</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Other Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_1c720d1c-4494-49f5-aa3d-b81a8a6ffdd1_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (Loss) Income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_bb844484-ceef-45bb-bb3e-f4bf00480e2a_verboseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Establishment (release) of valuation allowance on state deferred</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_310d8eb7-6dc7-42c4-9f3a-7149b96a70ce_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Release of valuation allowance on state deferred</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_97403ba2-bb83-49ea-b436-aa7da6bf5104_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_BankGuaranteesRelatedToAppealsOnIncomeTaxAndIndirectTaxCases_849bfd31-0e46-49cc-9980-b87a4f84695a_terseLabel_en-US" xlink:label="lab_iff_BankGuaranteesRelatedToAppealsOnIncomeTaxAndIndirectTaxCases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank guarantees related to appeals on income tax and indirect tax cases</link:label>
    <link:label id="lab_iff_BankGuaranteesRelatedToAppealsOnIncomeTaxAndIndirectTaxCases_label_en-US" xlink:label="lab_iff_BankGuaranteesRelatedToAppealsOnIncomeTaxAndIndirectTaxCases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank Guarantees Related To Appeals On Income Tax And Indirect Tax Cases</link:label>
    <link:label id="lab_iff_BankGuaranteesRelatedToAppealsOnIncomeTaxAndIndirectTaxCases_documentation_en-US" xlink:label="lab_iff_BankGuaranteesRelatedToAppealsOnIncomeTaxAndIndirectTaxCases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of bank guarantees related to appeals on income tax and indirect tax cases.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BankGuaranteesRelatedToAppealsOnIncomeTaxAndIndirectTaxCases" xlink:href="iff-20231231.xsd#iff_BankGuaranteesRelatedToAppealsOnIncomeTaxAndIndirectTaxCases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_BankGuaranteesRelatedToAppealsOnIncomeTaxAndIndirectTaxCases" xlink:to="lab_iff_BankGuaranteesRelatedToAppealsOnIncomeTaxAndIndirectTaxCases" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_FullThreeYearPeriodMember_9e9ac5ea-954d-432d-b8cb-bda94e8f5fc5_terseLabel_en-US" xlink:label="lab_iff_FullThreeYearPeriodMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Full three-year period [Member]</link:label>
    <link:label id="lab_iff_FullThreeYearPeriodMember_label_en-US" xlink:label="lab_iff_FullThreeYearPeriodMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Full Three Year Period [Member]</link:label>
    <link:label id="lab_iff_FullThreeYearPeriodMember_documentation_en-US" xlink:label="lab_iff_FullThreeYearPeriodMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Full Three Year Period [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FullThreeYearPeriodMember" xlink:href="iff-20231231.xsd#iff_FullThreeYearPeriodMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_FullThreeYearPeriodMember" xlink:to="lab_iff_FullThreeYearPeriodMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_IncreaseDecreaseInRedemptionValueRedeemableNoncontrollingInterest_93cbf8fe-a279-46e5-8384-b2da670370aa_negatedTerseLabel_en-US" xlink:label="lab_iff_IncreaseDecreaseInRedemptionValueRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Increase) Decrease In Redemption Value, Redeemable Noncontrolling Interest</link:label>
    <link:label id="lab_iff_IncreaseDecreaseInRedemptionValueRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_iff_IncreaseDecreaseInRedemptionValueRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Increase) Decrease In Redemption Value, Redeemable Noncontrolling Interest</link:label>
    <link:label id="lab_iff_IncreaseDecreaseInRedemptionValueRedeemableNoncontrollingInterest_documentation_en-US" xlink:label="lab_iff_IncreaseDecreaseInRedemptionValueRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Increase) Decrease In Redemption Value, Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_IncreaseDecreaseInRedemptionValueRedeemableNoncontrollingInterest" xlink:href="iff-20231231.xsd#iff_IncreaseDecreaseInRedemptionValueRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_IncreaseDecreaseInRedemptionValueRedeemableNoncontrollingInterest" xlink:to="lab_iff_IncreaseDecreaseInRedemptionValueRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_AccruedInterestOrPenaltiesRelatedToTaxAmounts_5cdd8eb6-e0c1-4f17-bcd3-a813ccedeecf_terseLabel_en-US" xlink:label="lab_iff_AccruedInterestOrPenaltiesRelatedToTaxAmounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction in accrual for interest and penalties</link:label>
    <link:label id="lab_iff_AccruedInterestOrPenaltiesRelatedToTaxAmounts_label_en-US" xlink:label="lab_iff_AccruedInterestOrPenaltiesRelatedToTaxAmounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Interest Or Penalties Related To Tax Amounts</link:label>
    <link:label id="lab_iff_AccruedInterestOrPenaltiesRelatedToTaxAmounts_documentation_en-US" xlink:label="lab_iff_AccruedInterestOrPenaltiesRelatedToTaxAmounts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Interest Or Penalties Related To Tax Amounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AccruedInterestOrPenaltiesRelatedToTaxAmounts" xlink:href="iff-20231231.xsd#iff_AccruedInterestOrPenaltiesRelatedToTaxAmounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_AccruedInterestOrPenaltiesRelatedToTaxAmounts" xlink:to="lab_iff_AccruedInterestOrPenaltiesRelatedToTaxAmounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_70afbdb1-188f-4bdc-811b-cf69347cbd0c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalBeforeIncomeTax_99a374d3-4724-4e05-aaf0-f825eda62634_terseLabel_en-US" xlink:label="lab_iff_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on disposal, before income tax</link:label>
    <link:label id="lab_iff_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalBeforeIncomeTax_label_en-US" xlink:label="lab_iff_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Gain (Loss) On Disposal, Before Income Tax</link:label>
    <link:label id="lab_iff_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalBeforeIncomeTax_documentation_en-US" xlink:label="lab_iff_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Gain (Loss) On Disposal, Before Income Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalBeforeIncomeTax" xlink:href="iff-20231231.xsd#iff_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalBeforeIncomeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalBeforeIncomeTax" xlink:to="lab_iff_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalBeforeIncomeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_716f37ae-6906-4270-8f0f-32060efca167_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of redeemable non-controlling interests</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_0cae735c-bfd3-4a18-b241-1d10b64a64a1_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_7e9553e9-c5d2-4a23-9692-dfdd8af8b0c2_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualByTypeOfCompensationPensionAndOtherPostretirementBenefitsMember_ce65084f-52ab-4add-b41a-11c38b277927_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualByTypeOfCompensationPensionAndOtherPostretirementBenefitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Plan</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualByTypeOfCompensationPensionAndOtherPostretirementBenefitsMember_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualByTypeOfCompensationPensionAndOtherPostretirementBenefitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement with Individual, by Type of Compensation, Pension and Other Postretirement Benefits [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualByTypeOfCompensationPensionAndOtherPostretirementBenefitsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCompensationArrangementWithIndividualByTypeOfCompensationPensionAndOtherPostretirementBenefitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualByTypeOfCompensationPensionAndOtherPostretirementBenefitsMember" xlink:to="lab_us-gaap_DeferredCompensationArrangementWithIndividualByTypeOfCompensationPensionAndOtherPostretirementBenefitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_c85dbc61-a0fc-44f6-8718-f06a26d9ce8b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less Imputed Interest</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_fe094f96-d2cf-4981-ae03-6c2c0c1872cc_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amounts of decreases in unrecognized benefits relating to settlements with taxing authorities</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_e22f2c2b-c237-4269-b830-2acf3e43a7c8_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital in excess of par value</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesSubjectToOutstandingAwards_85ee2350-9bf1-4319-8da9-2dc526140091_terseLabel_en-US" xlink:label="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesSubjectToOutstandingAwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares subject to outstanding awards (in shares)</link:label>
    <link:label id="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesSubjectToOutstandingAwards_label_en-US" xlink:label="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesSubjectToOutstandingAwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award, Shares Subject To Outstanding Awards</link:label>
    <link:label id="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesSubjectToOutstandingAwards_documentation_en-US" xlink:label="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesSubjectToOutstandingAwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Shares Subject To Outstanding Awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesSubjectToOutstandingAwards" xlink:href="iff-20231231.xsd#iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesSubjectToOutstandingAwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesSubjectToOutstandingAwards" xlink:to="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesSubjectToOutstandingAwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_8ddb0102-9494-4a3f-bd7e-6808937fc389_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital&#160;in excess&#160;of par&#160;value</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_b69127ad-0828-40bc-b486-0f1dd244c3e7_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DebtInstrumentCovenantLienThresholdPercentageOfConsolidatedNetTangibleAssets_0f1a5298-56d7-4a9d-8495-bac56c85573c_terseLabel_en-US" xlink:label="lab_iff_DebtInstrumentCovenantLienThresholdPercentageOfConsolidatedNetTangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lien threshold, percentage of consolidated net tangible assets</link:label>
    <link:label id="lab_iff_DebtInstrumentCovenantLienThresholdPercentageOfConsolidatedNetTangibleAssets_label_en-US" xlink:label="lab_iff_DebtInstrumentCovenantLienThresholdPercentageOfConsolidatedNetTangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Lien Threshold, Percentage Of Consolidated Net Tangible Assets</link:label>
    <link:label id="lab_iff_DebtInstrumentCovenantLienThresholdPercentageOfConsolidatedNetTangibleAssets_documentation_en-US" xlink:label="lab_iff_DebtInstrumentCovenantLienThresholdPercentageOfConsolidatedNetTangibleAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Lien Threshold, Percentage Of Consolidated Net Tangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DebtInstrumentCovenantLienThresholdPercentageOfConsolidatedNetTangibleAssets" xlink:href="iff-20231231.xsd#iff_DebtInstrumentCovenantLienThresholdPercentageOfConsolidatedNetTangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DebtInstrumentCovenantLienThresholdPercentageOfConsolidatedNetTangibleAssets" xlink:to="lab_iff_DebtInstrumentCovenantLienThresholdPercentageOfConsolidatedNetTangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_6f41d371-584a-4f2d-999d-4423a35e3add_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of tangible equity units (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DefinedBenefitPlanAdjustmentsForExpenseOrTaxContainedInServiceCost_0b4ee391-050a-47e0-9aa8-bfbbe9b23286_negatedLabel_en-US" xlink:label="lab_iff_DefinedBenefitPlanAdjustmentsForExpenseOrTaxContainedInServiceCost" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for expense/tax contained in service cost</link:label>
    <link:label id="lab_iff_DefinedBenefitPlanAdjustmentsForExpenseOrTaxContainedInServiceCost_label_en-US" xlink:label="lab_iff_DefinedBenefitPlanAdjustmentsForExpenseOrTaxContainedInServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Adjustments For Expense Or Tax Contained In Service Cost</link:label>
    <link:label id="lab_iff_DefinedBenefitPlanAdjustmentsForExpenseOrTaxContainedInServiceCost_documentation_en-US" xlink:label="lab_iff_DefinedBenefitPlanAdjustmentsForExpenseOrTaxContainedInServiceCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit plan, adjustments for expense or tax contained in service cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedBenefitPlanAdjustmentsForExpenseOrTaxContainedInServiceCost" xlink:href="iff-20231231.xsd#iff_DefinedBenefitPlanAdjustmentsForExpenseOrTaxContainedInServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DefinedBenefitPlanAdjustmentsForExpenseOrTaxContainedInServiceCost" xlink:to="lab_iff_DefinedBenefitPlanAdjustmentsForExpenseOrTaxContainedInServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_5034738b-2a53-4902-b684-33366e46799b_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_f0c44f29-e30a-43bf-9c5d-46b02a748da6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities [Member]</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesMember" xlink:to="lab_us-gaap_OtherLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesInvestments_31c04819-fc44-4a06-bd83-bdcc6aa0f5ef_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Investments</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesInvestments_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesInvestments" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementAxis_ec3fc236-cbe0-403b-a309-5ede6279c292_terseLabel_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement [Axis]</link:label>
    <link:label id="lab_srt_RestatementAxis_label_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAxis" xlink:to="lab_srt_RestatementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_CashRestrictedStockUnitMember_a88ba84c-e804-42f6-9ca1-22bb28cca016_terseLabel_en-US" xlink:label="lab_iff_CashRestrictedStockUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash RSU's [Member]</link:label>
    <link:label id="lab_iff_CashRestrictedStockUnitMember_label_en-US" xlink:label="lab_iff_CashRestrictedStockUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Restricted Stock Unit [Member]</link:label>
    <link:label id="lab_iff_CashRestrictedStockUnitMember_documentation_en-US" xlink:label="lab_iff_CashRestrictedStockUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Restricted Stock Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_CashRestrictedStockUnitMember" xlink:href="iff-20231231.xsd#iff_CashRestrictedStockUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_CashRestrictedStockUnitMember" xlink:to="lab_iff_CashRestrictedStockUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_TransitionServicesAgreementTerm_941d2ef3-b37e-4036-bf95-84354a9f38af_terseLabel_en-US" xlink:label="lab_iff_TransitionServicesAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition Services Agreement, Term</link:label>
    <link:label id="lab_iff_TransitionServicesAgreementTerm_label_en-US" xlink:label="lab_iff_TransitionServicesAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition Services Agreement, Term</link:label>
    <link:label id="lab_iff_TransitionServicesAgreementTerm_documentation_en-US" xlink:label="lab_iff_TransitionServicesAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition Services Agreement, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TransitionServicesAgreementTerm" xlink:href="iff-20231231.xsd#iff_TransitionServicesAgreementTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_TransitionServicesAgreementTerm" xlink:to="lab_iff_TransitionServicesAgreementTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome_eaaeb6f9-e1dd-4e11-bb0d-ffe3010d1460_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefit, net of reversals</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Exempt Income, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_4cf22822-940d-4b60-b624-d3ae325bd307_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_5366832d-8d0c-42f6-8495-0e629c240ed0_verboseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Plans</link:label>
    <link:label id="lab_country_US_2e1dc0b6-a8c1-4f1f-9cd1-2e33cdbd47d2_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Pension Plans [Member]</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_ad1b5267-8d37-4df0-b8a4-b5826b412419_verboseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Tax Carryforward, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfForeignCurrencyDerivativesHeld_6f607b55-4887-4872-a552-7d896f61eadc_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfForeignCurrencyDerivativesHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Foreign Currency Derivatives Held</link:label>
    <link:label id="lab_us-gaap_NumberOfForeignCurrencyDerivativesHeld_label_en-US" xlink:label="lab_us-gaap_NumberOfForeignCurrencyDerivativesHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Foreign Currency Derivatives Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfForeignCurrencyDerivativesHeld" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfForeignCurrencyDerivativesHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfForeignCurrencyDerivativesHeld" xlink:to="lab_us-gaap_NumberOfForeignCurrencyDerivativesHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_TangibleEquityUnitsProceeds_e30827ce-54ed-43b0-b324-f23bd2e1b34f_terseLabel_en-US" xlink:label="lab_iff_TangibleEquityUnitsProceeds" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible equity units proceeds</link:label>
    <link:label id="lab_iff_TangibleEquityUnitsProceeds_label_en-US" xlink:label="lab_iff_TangibleEquityUnitsProceeds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Equity Units Proceeds</link:label>
    <link:label id="lab_iff_TangibleEquityUnitsProceeds_documentation_en-US" xlink:label="lab_iff_TangibleEquityUnitsProceeds" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Equity Units Proceeds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityUnitsProceeds" xlink:href="iff-20231231.xsd#iff_TangibleEquityUnitsProceeds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_TangibleEquityUnitsProceeds" xlink:to="lab_iff_TangibleEquityUnitsProceeds" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_9c75dd2c-8de0-4c15-85ac-04aaa5f4497e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_05e08b69-b22a-4fe3-85ee-905588aa17c0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_1d4f05c4-cb89-430c-98b8-cd4bfad0958b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_da419a26-445c-4680-b20e-d2ced24bdcb2_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancelled (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7295c736-ee88-4e98-bb91-8d3d8c03575f_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Total</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_InternationalFlavorsFragrancesIncMember_5e2b7472-79bb-476b-9ced-7a822fc01e62_terseLabel_en-US" xlink:label="lab_iff_InternationalFlavorsFragrancesIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Flavors &amp; Fragrances Inc</link:label>
    <link:label id="lab_iff_InternationalFlavorsFragrancesIncMember_label_en-US" xlink:label="lab_iff_InternationalFlavorsFragrancesIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Flavors &amp; Fragrances Inc [Member]</link:label>
    <link:label id="lab_iff_InternationalFlavorsFragrancesIncMember_documentation_en-US" xlink:label="lab_iff_InternationalFlavorsFragrancesIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Flavors &amp; Fragrances Inc [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_InternationalFlavorsFragrancesIncMember" xlink:href="iff-20231231.xsd#iff_InternationalFlavorsFragrancesIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_InternationalFlavorsFragrancesIncMember" xlink:to="lab_iff_InternationalFlavorsFragrancesIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_7a1c2e2b-241a-434a-b5b9-662a9d6408a2_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income) expense, net [Member]</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DefinedBenefitPlanCurtailmentsAndSettlementsBenefitObligation_db6128ba-477a-495c-bdab-bda69c94c715_negatedLabel_en-US" xlink:label="lab_iff_DefinedBenefitPlanCurtailmentsAndSettlementsBenefitObligation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Curtailments/settlements</link:label>
    <link:label id="lab_iff_DefinedBenefitPlanCurtailmentsAndSettlementsBenefitObligation_label_en-US" xlink:label="lab_iff_DefinedBenefitPlanCurtailmentsAndSettlementsBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Curtailments And Settlements Benefit Obligation</link:label>
    <link:label id="lab_iff_DefinedBenefitPlanCurtailmentsAndSettlementsBenefitObligation_documentation_en-US" xlink:label="lab_iff_DefinedBenefitPlanCurtailmentsAndSettlementsBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Curtailments And Settlements, Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedBenefitPlanCurtailmentsAndSettlementsBenefitObligation" xlink:href="iff-20231231.xsd#iff_DefinedBenefitPlanCurtailmentsAndSettlementsBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DefinedBenefitPlanCurtailmentsAndSettlementsBenefitObligation" xlink:to="lab_iff_DefinedBenefitPlanCurtailmentsAndSettlementsBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquisitionRelatedCostsMember_c04fd277-36d7-40ce-9890-afb4f0fe8fee_terseLabel_en-US" xlink:label="lab_us-gaap_AcquisitionRelatedCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-related Costs [Member]</link:label>
    <link:label id="lab_us-gaap_AcquisitionRelatedCostsMember_label_en-US" xlink:label="lab_us-gaap_AcquisitionRelatedCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-related Costs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquisitionRelatedCostsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcquisitionRelatedCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquisitionRelatedCostsMember" xlink:to="lab_us-gaap_AcquisitionRelatedCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_41831cba-5862-4cb2-affc-93f94e716487_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_EmployeeReimbursementReceivable_652c5d32-94e0-499f-9ff4-5c553585570e_terseLabel_en-US" xlink:label="lab_iff_EmployeeReimbursementReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Reimbursement Receivable</link:label>
    <link:label id="lab_iff_EmployeeReimbursementReceivable_label_en-US" xlink:label="lab_iff_EmployeeReimbursementReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Reimbursement Receivable</link:label>
    <link:label id="lab_iff_EmployeeReimbursementReceivable_documentation_en-US" xlink:label="lab_iff_EmployeeReimbursementReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Reimbursement Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EmployeeReimbursementReceivable" xlink:href="iff-20231231.xsd#iff_EmployeeReimbursementReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_EmployeeReimbursementReceivable" xlink:to="lab_iff_EmployeeReimbursementReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_2802c813-f007-45da-911b-6430f28bdcbf_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DebtInstrumentCovenantLienThresholdAmount_06184ba1-2629-4200-b798-06adf5868df2_terseLabel_en-US" xlink:label="lab_iff_DebtInstrumentCovenantLienThresholdAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lien threshold</link:label>
    <link:label id="lab_iff_DebtInstrumentCovenantLienThresholdAmount_label_en-US" xlink:label="lab_iff_DebtInstrumentCovenantLienThresholdAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Lien Threshold, Amount</link:label>
    <link:label id="lab_iff_DebtInstrumentCovenantLienThresholdAmount_documentation_en-US" xlink:label="lab_iff_DebtInstrumentCovenantLienThresholdAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Lien Threshold, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DebtInstrumentCovenantLienThresholdAmount" xlink:href="iff-20231231.xsd#iff_DebtInstrumentCovenantLienThresholdAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DebtInstrumentCovenantLienThresholdAmount" xlink:to="lab_iff_DebtInstrumentCovenantLienThresholdAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3f4b2218-77fa-4b99-9e20-322a4166970b_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_58229747-bc39-495b-b67f-e135e25551c5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_SubsequentFiscalQuarterEndingOnOrBeforeMarch312025Member_1f5425fa-8b05-4008-a7f0-3c451c6c27f7_terseLabel_en-US" xlink:label="lab_iff_SubsequentFiscalQuarterEndingOnOrBeforeMarch312025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Fiscal Quarter Ending On Or Before March 31, 2025</link:label>
    <link:label id="lab_iff_SubsequentFiscalQuarterEndingOnOrBeforeMarch312025Member_label_en-US" xlink:label="lab_iff_SubsequentFiscalQuarterEndingOnOrBeforeMarch312025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Fiscal Quarter Ending On Or Before March 31, 2025 [Member]</link:label>
    <link:label id="lab_iff_SubsequentFiscalQuarterEndingOnOrBeforeMarch312025Member_documentation_en-US" xlink:label="lab_iff_SubsequentFiscalQuarterEndingOnOrBeforeMarch312025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Fiscal Quarter Ending On Or Before March 31, 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SubsequentFiscalQuarterEndingOnOrBeforeMarch312025Member" xlink:href="iff-20231231.xsd#iff_SubsequentFiscalQuarterEndingOnOrBeforeMarch312025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_SubsequentFiscalQuarterEndingOnOrBeforeMarch312025Member" xlink:to="lab_iff_SubsequentFiscalQuarterEndingOnOrBeforeMarch312025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_bf46069a-1a1a-4660-b667-7b7b8bd11fae_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renewal term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_619ea64d-d827-4fb8-a950-553cb7b22020_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_278849d8-102e-4967-8175-9b0d66b5f849_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current financing lease obligation</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_A2023RestructuringProgramMember_09fe8b87-43be-4b92-8abd-c3a4c98b6b98_terseLabel_en-US" xlink:label="lab_iff_A2023RestructuringProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 Restructuring Program</link:label>
    <link:label id="lab_iff_A2023RestructuringProgramMember_label_en-US" xlink:label="lab_iff_A2023RestructuringProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 Restructuring Program [Member]</link:label>
    <link:label id="lab_iff_A2023RestructuringProgramMember_documentation_en-US" xlink:label="lab_iff_A2023RestructuringProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 Restructuring Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_A2023RestructuringProgramMember" xlink:href="iff-20231231.xsd#iff_A2023RestructuringProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_A2023RestructuringProgramMember" xlink:to="lab_iff_A2023RestructuringProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_Over65Member_8e1506fa-2f3d-48db-bc81-669ee045bd7e_terseLabel_en-US" xlink:label="lab_iff_Over65Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Over $65</link:label>
    <link:label id="lab_iff_Over65Member_label_en-US" xlink:label="lab_iff_Over65Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Over $65 [Member]</link:label>
    <link:label id="lab_iff_Over65Member_documentation_en-US" xlink:label="lab_iff_Over65Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Over $65</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_Over65Member" xlink:href="iff-20231231.xsd#iff_Over65Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_Over65Member" xlink:to="lab_iff_Over65Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_54e2c2d9-af59-41c3-95c9-202b97b30288_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_7595b8ba-7567-4295-b590-6d0b69f8fbca_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_ForeignCurrencyContractAndInterestRateSwapMember_363f79b1-b4cf-42e5-aeed-65da97858346_terseLabel_en-US" xlink:label="lab_iff_ForeignCurrencyContractAndInterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contract And Interest Rate Swap</link:label>
    <link:label id="lab_iff_ForeignCurrencyContractAndInterestRateSwapMember_label_en-US" xlink:label="lab_iff_ForeignCurrencyContractAndInterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contract And Interest Rate Swap [Member]</link:label>
    <link:label id="lab_iff_ForeignCurrencyContractAndInterestRateSwapMember_documentation_en-US" xlink:label="lab_iff_ForeignCurrencyContractAndInterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contract And Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ForeignCurrencyContractAndInterestRateSwapMember" xlink:href="iff-20231231.xsd#iff_ForeignCurrencyContractAndInterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_ForeignCurrencyContractAndInterestRateSwapMember" xlink:to="lab_iff_ForeignCurrencyContractAndInterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_NutritionBiosciencesIncSeniorNotesMember_93fc2691-05ab-4258-9494-483498347ee9_terseLabel_en-US" xlink:label="lab_iff_NutritionBiosciencesIncSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nutrition &amp; Biosciences, Inc Senior Notes</link:label>
    <link:label id="lab_iff_NutritionBiosciencesIncSeniorNotesMember_label_en-US" xlink:label="lab_iff_NutritionBiosciencesIncSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nutrition &amp; Biosciences, Inc Senior Notes [Member]</link:label>
    <link:label id="lab_iff_NutritionBiosciencesIncSeniorNotesMember_documentation_en-US" xlink:label="lab_iff_NutritionBiosciencesIncSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nutrition &amp; Biosciences, Inc Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NutritionBiosciencesIncSeniorNotesMember" xlink:href="iff-20231231.xsd#iff_NutritionBiosciencesIncSeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_NutritionBiosciencesIncSeniorNotesMember" xlink:to="lab_iff_NutritionBiosciencesIncSeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-GAAP Measure Description</link:label>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_label_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-GAAP Measure Description [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsTable_d507e43f-6ce8-4054-b147-b00735c649b3_terseLabel_en-US" xlink:label="lab_iff_ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Information By Major Category Of Credit Derivatives Contracts [Table]</link:label>
    <link:label id="lab_iff_ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsTable_label_en-US" xlink:label="lab_iff_ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Information By Major Category Of Credit Derivatives Contracts [Table]</link:label>
    <link:label id="lab_iff_ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsTable_documentation_en-US" xlink:label="lab_iff_ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Information By Major Category Of Credit Derivatives Contracts [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsTable" xlink:href="iff-20231231.xsd#iff_ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsTable" xlink:to="lab_iff_ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_72fa0573-d032-4150-80ad-7de262b49c2e_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_bf40f499-1a59-4581-a0b9-74982b9976b5_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_OtherCostsCredits_d4a59743-8d3a-45ed-861b-23a54fad9bfa_negatedTerseLabel_en-US" xlink:label="lab_iff_OtherCostsCredits" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (Costs) Credits</link:label>
    <link:label id="lab_iff_OtherCostsCredits_label_en-US" xlink:label="lab_iff_OtherCostsCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (Costs) Credits</link:label>
    <link:label id="lab_iff_OtherCostsCredits_documentation_en-US" xlink:label="lab_iff_OtherCostsCredits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (Costs) Credits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_OtherCostsCredits" xlink:href="iff-20231231.xsd#iff_OtherCostsCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_OtherCostsCredits" xlink:to="lab_iff_OtherCostsCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_4e75654c-b54b-4403-b902-8dbd894502d3_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating (loss) profit</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportingUnits_560cb3f7-eb27-4c61-9f8b-edffad3a81ae_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportingUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reporting units</link:label>
    <link:label id="lab_us-gaap_NumberOfReportingUnits_label_en-US" xlink:label="lab_us-gaap_NumberOfReportingUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reporting Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportingUnits" xlink:to="lab_us-gaap_NumberOfReportingUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_68cc08cc-e951-41bb-82fe-53825da0425f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rate of compensation increase</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnOilAndGasHedgingActivity_319e6226-da25-48e6-9f0e-b2b3d3170384_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnOilAndGasHedgingActivity" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on hedging activity</link:label>
    <link:label id="lab_us-gaap_GainLossOnOilAndGasHedgingActivity_label_en-US" xlink:label="lab_us-gaap_GainLossOnOilAndGasHedgingActivity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Hedging Activity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnOilAndGasHedgingActivity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnOilAndGasHedgingActivity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnOilAndGasHedgingActivity" xlink:to="lab_us-gaap_GainLossOnOilAndGasHedgingActivity" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_TangibleEquityUnitsAllocationAxis_6bc220da-3cd0-43d2-97d4-9e37a94a7bd1_terseLabel_en-US" xlink:label="lab_iff_TangibleEquityUnitsAllocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Equity Units, Allocation [Axis]</link:label>
    <link:label id="lab_iff_TangibleEquityUnitsAllocationAxis_label_en-US" xlink:label="lab_iff_TangibleEquityUnitsAllocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Equity Units, Allocation [Axis]</link:label>
    <link:label id="lab_iff_TangibleEquityUnitsAllocationAxis_documentation_en-US" xlink:label="lab_iff_TangibleEquityUnitsAllocationAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Equity Units, Allocation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityUnitsAllocationAxis" xlink:href="iff-20231231.xsd#iff_TangibleEquityUnitsAllocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_TangibleEquityUnitsAllocationAxis" xlink:to="lab_iff_TangibleEquityUnitsAllocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_a82f45fa-acf0-498a-b5e8-3d249b815909_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsMember" xlink:to="lab_us-gaap_CashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_e02b9dd8-74d4-409b-bd57-2a53de0fc02c_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CatastrophicEventDomain_d5cc3350-7838-4fb5-abb5-f55edb5b28e5_terseLabel_en-US" xlink:label="lab_us-gaap_CatastrophicEventDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Catastrophic Event [Domain]</link:label>
    <link:label id="lab_us-gaap_CatastrophicEventDomain_label_en-US" xlink:label="lab_us-gaap_CatastrophicEventDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Catastrophic Event [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CatastrophicEventDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CatastrophicEventDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CatastrophicEventDomain" xlink:to="lab_us-gaap_CatastrophicEventDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_b2f2812e-75af-487e-87b6-b69e806216dc_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan participants&#8217; contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_CrossCurrencySwapsMember_c4025916-88ff-4cd6-8281-afa413516be0_terseLabel_en-US" xlink:label="lab_iff_CrossCurrencySwapsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Swaps [Member]</link:label>
    <link:label id="lab_iff_CrossCurrencySwapsMember_label_en-US" xlink:label="lab_iff_CrossCurrencySwapsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Swaps [Member]</link:label>
    <link:label id="lab_iff_CrossCurrencySwapsMember_documentation_en-US" xlink:label="lab_iff_CrossCurrencySwapsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Swaps [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_CrossCurrencySwapsMember" xlink:href="iff-20231231.xsd#iff_CrossCurrencySwapsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_CrossCurrencySwapsMember" xlink:to="lab_iff_CrossCurrencySwapsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_country_SG_7cf4b26e-86b9-450b-9a60-e146b2f38d94_terseLabel_en-US" xlink:label="lab_country_SG" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SINGAPORE</link:label>
    <link:label id="lab_country_SG_label_en-US" xlink:label="lab_country_SG" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SINGAPORE</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_SG" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_SG"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_SG" xlink:to="lab_country_SG" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_217fdf77-3cb6-481d-a94a-c858f1af2d6b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_acaf1556-dd4f-4a8b-bb05-efa6b2298787_verboseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_055fa47e-540a-4203-a18e-93dfa094d580_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value [Member]</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_BusinessDivestitureCosts_4ca55a10-491a-4371-a972-f024a318b688_terseLabel_en-US" xlink:label="lab_iff_BusinessDivestitureCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Divestiture Costs</link:label>
    <link:label id="lab_iff_BusinessDivestitureCosts_fd15b1b4-e56c-4e82-bde8-9b74ad414431_negatedTerseLabel_en-US" xlink:label="lab_iff_BusinessDivestitureCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Divestiture Costs</link:label>
    <link:label id="lab_iff_BusinessDivestitureCosts_label_en-US" xlink:label="lab_iff_BusinessDivestitureCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Divestiture Costs</link:label>
    <link:label id="lab_iff_BusinessDivestitureCosts_documentation_en-US" xlink:label="lab_iff_BusinessDivestitureCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Divestiture Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BusinessDivestitureCosts" xlink:href="iff-20231231.xsd#iff_BusinessDivestitureCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_BusinessDivestitureCosts" xlink:to="lab_iff_BusinessDivestitureCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember_c150e7da-d414-475b-bbf6-b84961afc405_terseLabel_en-US" xlink:label="lab_iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, Euro Notes, 2024</link:label>
    <link:label id="lab_iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember_label_en-US" xlink:label="lab_iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, Euro Notes, Due Two Thousand Twenty Four [Member]</link:label>
    <link:label id="lab_iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember_documentation_en-US" xlink:label="lab_iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, Euro Note, Due Two Thousand Twenty Four [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember" xlink:href="iff-20231231.xsd#iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember" xlink:to="lab_iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_d92f2074-4de6-464c-a833-bbe645706420_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_3f83f0c1-2396-47f2-85d3-824b84a0651a_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_7b64cc61-c202-4f42-90fc-b990823de097_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_LesseeOperatingAndFinanceLeasePaymentsDue_10136667-33d8-4a21-9de3-6eae0a16e188_totalLabel_en-US" xlink:label="lab_iff_LesseeOperatingAndFinanceLeasePaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Payments, Due</link:label>
    <link:label id="lab_iff_LesseeOperatingAndFinanceLeasePaymentsDue_label_en-US" xlink:label="lab_iff_LesseeOperatingAndFinanceLeasePaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Payments, Due</link:label>
    <link:label id="lab_iff_LesseeOperatingAndFinanceLeasePaymentsDue_documentation_en-US" xlink:label="lab_iff_LesseeOperatingAndFinanceLeasePaymentsDue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Payments, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_LesseeOperatingAndFinanceLeasePaymentsDue" xlink:href="iff-20231231.xsd#iff_LesseeOperatingAndFinanceLeasePaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_LesseeOperatingAndFinanceLeasePaymentsDue" xlink:to="lab_iff_LesseeOperatingAndFinanceLeasePaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_4cbdd36a-bdae-40e9-ac4f-04c50d875221_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_e0ccbd19-b160-4558-89c0-81c3e681ccfd_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_AccountsReceivablesOutstandingByOver365Days_1ffce453-15c5-4940-9056-4524eb937cd3_terseLabel_en-US" xlink:label="lab_iff_AccountsReceivablesOutstandingByOver365Days" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivables, Outstanding By Over 365 Days</link:label>
    <link:label id="lab_iff_AccountsReceivablesOutstandingByOver365Days_label_en-US" xlink:label="lab_iff_AccountsReceivablesOutstandingByOver365Days" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivables, Outstanding By Over 365 Days</link:label>
    <link:label id="lab_iff_AccountsReceivablesOutstandingByOver365Days_documentation_en-US" xlink:label="lab_iff_AccountsReceivablesOutstandingByOver365Days" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivables, Outstanding By Over 365 Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AccountsReceivablesOutstandingByOver365Days" xlink:href="iff-20231231.xsd#iff_AccountsReceivablesOutstandingByOver365Days"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_AccountsReceivablesOutstandingByOver365Days" xlink:to="lab_iff_AccountsReceivablesOutstandingByOver365Days" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_b2b3dcc8-6de7-4924-9814-a07b6b744455_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_AbsoluteReturnHedgeFundsMember_42ca0bdd-d2c0-44ea-9281-563bdc7a0641_terseLabel_en-US" xlink:label="lab_iff_AbsoluteReturnHedgeFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Absolute Return Funds</link:label>
    <link:label id="lab_iff_AbsoluteReturnHedgeFundsMember_label_en-US" xlink:label="lab_iff_AbsoluteReturnHedgeFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Absolute Return Hedge Funds [Member]</link:label>
    <link:label id="lab_iff_AbsoluteReturnHedgeFundsMember_documentation_en-US" xlink:label="lab_iff_AbsoluteReturnHedgeFundsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Absolute Return Hedge Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AbsoluteReturnHedgeFundsMember" xlink:href="iff-20231231.xsd#iff_AbsoluteReturnHedgeFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_AbsoluteReturnHedgeFundsMember" xlink:to="lab_iff_AbsoluteReturnHedgeFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherRestructuringCosts_452ca9a3-ccfb-416a-a7f6-3938ab168b43_terseLabel_en-US" xlink:label="lab_us-gaap_OtherRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring Costs</link:label>
    <link:label id="lab_us-gaap_OtherRestructuringCosts_label_en-US" xlink:label="lab_us-gaap_OtherRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherRestructuringCosts" xlink:to="lab_us-gaap_OtherRestructuringCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DisposalGroupIncludingDiscontinuedOperationConsiderationAdvanceReceiptForBusinessToBeTransferred_1fd9ef21-cb4b-41d4-b20d-e8e3b0b42b48_terseLabel_en-US" xlink:label="lab_iff_DisposalGroupIncludingDiscontinuedOperationConsiderationAdvanceReceiptForBusinessToBeTransferred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advance receipt for business to be transferred</link:label>
    <link:label id="lab_iff_DisposalGroupIncludingDiscontinuedOperationConsiderationAdvanceReceiptForBusinessToBeTransferred_label_en-US" xlink:label="lab_iff_DisposalGroupIncludingDiscontinuedOperationConsiderationAdvanceReceiptForBusinessToBeTransferred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration, Advance Receipt For Business To Be Transferred</link:label>
    <link:label id="lab_iff_DisposalGroupIncludingDiscontinuedOperationConsiderationAdvanceReceiptForBusinessToBeTransferred_documentation_en-US" xlink:label="lab_iff_DisposalGroupIncludingDiscontinuedOperationConsiderationAdvanceReceiptForBusinessToBeTransferred" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration, Advance Receipt For Business To Be Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupIncludingDiscontinuedOperationConsiderationAdvanceReceiptForBusinessToBeTransferred" xlink:href="iff-20231231.xsd#iff_DisposalGroupIncludingDiscontinuedOperationConsiderationAdvanceReceiptForBusinessToBeTransferred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DisposalGroupIncludingDiscontinuedOperationConsiderationAdvanceReceiptForBusinessToBeTransferred" xlink:to="lab_iff_DisposalGroupIncludingDiscontinuedOperationConsiderationAdvanceReceiptForBusinessToBeTransferred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_5fa86b61-fe15-4263-86a2-3a0401496d79_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_e619bb4d-ad11-4551-a6ec-a162821e90f9_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to non-controlling interest</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_acef2b76-387a-4582-abdc-886c3cbe6e1c_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of a subsidiary with redeemable non-controlling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PayVsPerformanceDisclosureLineItems_label_en-US" xlink:label="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_815f5f02-bc25-45cb-9211-8106b1773c00_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LatinAmericaMember_f30682df-12af-46d2-b0d7-d677e7df2671_terseLabel_en-US" xlink:label="lab_srt_LatinAmericaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latin America</link:label>
    <link:label id="lab_srt_LatinAmericaMember_label_en-US" xlink:label="lab_srt_LatinAmericaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latin America [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LatinAmericaMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LatinAmericaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LatinAmericaMember" xlink:to="lab_srt_LatinAmericaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_e391094e-742a-43cf-890b-c6ca619371bb_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_terseLabel_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underlying Security Market Price Change</link:label>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_label_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underlying Security Market Price Change, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:to="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_009bfaf4-7321-40ad-bfee-2e65df1829e3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesSmallCapMember_74bb0dd7-6adc-4445-887a-02b75c1c0293_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesSmallCapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S. Small Cap</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesSmallCapMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesSmallCapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Equity Securities, Small Cap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesSmallCapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesSmallCapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesSmallCapMember" xlink:to="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesSmallCapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_de534013-256e-4873-a6b8-05982bef77c8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0bda7337-2a63-4c92-ab60-3287cae24290_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_eca915be-e215-4c3a-80cc-f0af9166d70c_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_4417f7f2-8b5d-4117-81f4-1bcd7d88038d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining term lease</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_64ce2066-45cd-40df-8a0a-f28729311705_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_31e6a037-a3c0-4a2e-9382-30eb5f87b3ee_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_57ea65d5-a2c3-421f-bc68-9f0f4f17087a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_82870b0b-53f8-42a3-82b4-b6397c617c67_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_0da5b50b-8e9a-4f17-947b-583135da0e60_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Loan Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgeFundsMember_96e0fe28-02b1-4f59-a0af-e92959a912c4_terseLabel_en-US" xlink:label="lab_us-gaap_HedgeFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_HedgeFundsMember_label_en-US" xlink:label="lab_us-gaap_HedgeFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgeFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgeFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgeFundsMember" xlink:to="lab_us-gaap_HedgeFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_55ea7d75-a173-4d32-b33b-9e082084f003_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_terseLabel_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_label_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:to="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentage_9966c3c5-7d13-457e-bb87-0d918f49a3df_terseLabel_en-US" xlink:label="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting percentage</link:label>
    <link:label id="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentage_label_en-US" xlink:label="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Vesting Percentage</link:label>
    <link:label id="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentage_documentation_en-US" xlink:label="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation arrangement by share-based payment award, vesting percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentage" xlink:href="iff-20231231.xsd#iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentage" xlink:to="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_dce29e6f-ac95-4ec8-8ae1-c90cca8213aa_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_dfd7dcb7-9bce-4ea0-a2f5-2a6b1adfe5cf_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_3b6454d5-2d76-48a9-9bd8-fb14a97ecda5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDateAxis_terseLabel_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Determination Date:</link:label>
    <link:label id="lab_ecd_RestatementDateAxis_label_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDateAxis" xlink:to="lab_ecd_RestatementDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_522b2f03-606b-43dc-8f9a-66b777e729f3_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_83e9b7fa-3084-4956-a669-138bae175c7f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Which Were Not Designated as Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Not Designated as Hedging Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_EffectiveIncomeTaxRateReconciliationDeferredTaxesonDeemedRepatriationPercent_3133ca37-7cfe-4132-b2ca-f7688f15030e_terseLabel_en-US" xlink:label="lab_iff_EffectiveIncomeTaxRateReconciliationDeferredTaxesonDeemedRepatriationPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred taxes on deemed repatriation(2)</link:label>
    <link:label id="lab_iff_EffectiveIncomeTaxRateReconciliationDeferredTaxesonDeemedRepatriationPercent_label_en-US" xlink:label="lab_iff_EffectiveIncomeTaxRateReconciliationDeferredTaxesonDeemedRepatriationPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Deferred Taxes on Deemed Repatriation, Percent</link:label>
    <link:label id="lab_iff_EffectiveIncomeTaxRateReconciliationDeferredTaxesonDeemedRepatriationPercent_documentation_en-US" xlink:label="lab_iff_EffectiveIncomeTaxRateReconciliationDeferredTaxesonDeemedRepatriationPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Deferred Taxes on Deemed Repatriation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EffectiveIncomeTaxRateReconciliationDeferredTaxesonDeemedRepatriationPercent" xlink:href="iff-20231231.xsd#iff_EffectiveIncomeTaxRateReconciliationDeferredTaxesonDeemedRepatriationPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_EffectiveIncomeTaxRateReconciliationDeferredTaxesonDeemedRepatriationPercent" xlink:to="lab_iff_EffectiveIncomeTaxRateReconciliationDeferredTaxesonDeemedRepatriationPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_A2015SeveranceInitiativesMember_363e7702-2ff1-40ee-aaf1-196005876b9a_terseLabel_en-US" xlink:label="lab_iff_A2015SeveranceInitiativesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2015 Severance Initiatives [Member]</link:label>
    <link:label id="lab_iff_A2015SeveranceInitiativesMember_label_en-US" xlink:label="lab_iff_A2015SeveranceInitiativesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2015 Severance Initiatives [Member]</link:label>
    <link:label id="lab_iff_A2015SeveranceInitiativesMember_documentation_en-US" xlink:label="lab_iff_A2015SeveranceInitiativesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2015 Severance Initiatives [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_A2015SeveranceInitiativesMember" xlink:href="iff-20231231.xsd#iff_A2015SeveranceInitiativesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_A2015SeveranceInitiativesMember" xlink:to="lab_iff_A2015SeveranceInitiativesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_b6879d2c-dba2-4e4b-956b-5a0d32d11946_verboseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_e4e00c5a-dcb4-4923-ba54-ec4aa796f4c2_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_43c21074-fb5b-4c6e-b374-49cb11ad2910_netLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. federal tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_NetIncomeLossAvailableToCommonStockholdersAdjustment_4541ce71-1a12-4541-b51a-58e7df82b2de_totalLabel_en-US" xlink:label="lab_iff_NetIncomeLossAvailableToCommonStockholdersAdjustment" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income available to IFF shareholders</link:label>
    <link:label id="lab_iff_NetIncomeLossAvailableToCommonStockholdersAdjustment_label_en-US" xlink:label="lab_iff_NetIncomeLossAvailableToCommonStockholdersAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available To Common Stockholders, Adjustment</link:label>
    <link:label id="lab_iff_NetIncomeLossAvailableToCommonStockholdersAdjustment_documentation_en-US" xlink:label="lab_iff_NetIncomeLossAvailableToCommonStockholdersAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available To Common Stockholders, Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NetIncomeLossAvailableToCommonStockholdersAdjustment" xlink:href="iff-20231231.xsd#iff_NetIncomeLossAvailableToCommonStockholdersAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_NetIncomeLossAvailableToCommonStockholdersAdjustment" xlink:to="lab_iff_NetIncomeLossAvailableToCommonStockholdersAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_3778ffca-27a2-43ef-8c59-3983e6fda549_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies (Note 19)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioPreviouslyReportedMember_6fe81f1f-82fe-46f7-95a9-608415649b64_terseLabel_en-US" xlink:label="lab_srt_ScenarioPreviouslyReportedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Previously Reported</link:label>
    <link:label id="lab_srt_ScenarioPreviouslyReportedMember_label_en-US" xlink:label="lab_srt_ScenarioPreviouslyReportedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Previously Reported [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioPreviouslyReportedMember" xlink:to="lab_srt_ScenarioPreviouslyReportedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFive_2ba4de51-eeed-4fee-8eba-f9658ea1db96_terseLabel_en-US" xlink:label="lab_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, to be Paid, Year Five</link:label>
    <link:label id="lab_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFive_label_en-US" xlink:label="lab_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, to be Paid, Year Five</link:label>
    <link:label id="lab_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFive_documentation_en-US" xlink:label="lab_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFive" xlink:href="iff-20231231.xsd#iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFive" xlink:to="lab_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentExpenditureAdditionToLongLivedAssets_ad32c84a-764f-41e5-a771-c9fda16268fd_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentExpenditureAdditionToLongLivedAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures</link:label>
    <link:label id="lab_us-gaap_SegmentExpenditureAdditionToLongLivedAssets_label_en-US" xlink:label="lab_us-gaap_SegmentExpenditureAdditionToLongLivedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment, Expenditure, Addition to Long-Lived Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentExpenditureAdditionToLongLivedAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentExpenditureAdditionToLongLivedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentExpenditureAdditionToLongLivedAssets" xlink:to="lab_us-gaap_SegmentExpenditureAdditionToLongLivedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DisposalGroupIncludingDiscontinuedOperationProceedsAttributableToSupplyAgreement_4053275c-28a0-4898-8c36-34d7c2defe0a_negatedTerseLabel_en-US" xlink:label="lab_iff_DisposalGroupIncludingDiscontinuedOperationProceedsAttributableToSupplyAgreement" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds attributable to supply agreement</link:label>
    <link:label id="lab_iff_DisposalGroupIncludingDiscontinuedOperationProceedsAttributableToSupplyAgreement_label_en-US" xlink:label="lab_iff_DisposalGroupIncludingDiscontinuedOperationProceedsAttributableToSupplyAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Proceeds Attributable To Supply Agreement</link:label>
    <link:label id="lab_iff_DisposalGroupIncludingDiscontinuedOperationProceedsAttributableToSupplyAgreement_documentation_en-US" xlink:label="lab_iff_DisposalGroupIncludingDiscontinuedOperationProceedsAttributableToSupplyAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Proceeds Attributable To Supply Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupIncludingDiscontinuedOperationProceedsAttributableToSupplyAgreement" xlink:href="iff-20231231.xsd#iff_DisposalGroupIncludingDiscontinuedOperationProceedsAttributableToSupplyAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DisposalGroupIncludingDiscontinuedOperationProceedsAttributableToSupplyAgreement" xlink:to="lab_iff_DisposalGroupIncludingDiscontinuedOperationProceedsAttributableToSupplyAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired_cae1bd2e-8ab4-4d54-9803-5e64a4652f56_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Business Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_82ff9dda-fc1e-4dec-9efb-3f8e9c9fb0d8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_d5ae95d2-d376-4441-b6f8-e0db76e0702a_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_ProductLiabilityContingencyLossExposureinExcessofAccrualAggregateAmountPaid_1320b1c1-6682-443e-aa03-055e72303b36_terseLabel_en-US" xlink:label="lab_iff_ProductLiabilityContingencyLossExposureinExcessofAccrualAggregateAmountPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate amount paid</link:label>
    <link:label id="lab_iff_ProductLiabilityContingencyLossExposureinExcessofAccrualAggregateAmountPaid_label_en-US" xlink:label="lab_iff_ProductLiabilityContingencyLossExposureinExcessofAccrualAggregateAmountPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Contingency, Loss Exposure in Excess of Accrual, Aggregate Amount Paid</link:label>
    <link:label id="lab_iff_ProductLiabilityContingencyLossExposureinExcessofAccrualAggregateAmountPaid_documentation_en-US" xlink:label="lab_iff_ProductLiabilityContingencyLossExposureinExcessofAccrualAggregateAmountPaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Contingency, Loss Exposure in Excess of Accrual, Aggregate Amount Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ProductLiabilityContingencyLossExposureinExcessofAccrualAggregateAmountPaid" xlink:href="iff-20231231.xsd#iff_ProductLiabilityContingencyLossExposureinExcessofAccrualAggregateAmountPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_ProductLiabilityContingencyLossExposureinExcessofAccrualAggregateAmountPaid" xlink:to="lab_iff_ProductLiabilityContingencyLossExposureinExcessofAccrualAggregateAmountPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DeferredGainLossOnTerminatedInterestRateContracts_2dca6368-5eb2-4e59-9817-a96d9720f708_negatedTerseLabel_en-US" xlink:label="lab_iff_DeferredGainLossOnTerminatedInterestRateContracts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss incurred on termination of interest rate swaps</link:label>
    <link:label id="lab_iff_DeferredGainLossOnTerminatedInterestRateContracts_label_en-US" xlink:label="lab_iff_DeferredGainLossOnTerminatedInterestRateContracts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Gain Loss On Terminated Interest Rate Contracts</link:label>
    <link:label id="lab_iff_DeferredGainLossOnTerminatedInterestRateContracts_documentation_en-US" xlink:label="lab_iff_DeferredGainLossOnTerminatedInterestRateContracts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Gain Loss On Terminated Interest Rate Contracts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DeferredGainLossOnTerminatedInterestRateContracts" xlink:href="iff-20231231.xsd#iff_DeferredGainLossOnTerminatedInterestRateContracts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DeferredGainLossOnTerminatedInterestRateContracts" xlink:to="lab_iff_DeferredGainLossOnTerminatedInterestRateContracts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignPlanMember_91d07206-ec2a-42d6-bfb8-986ab7c77d82_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S.&#160;Plans</link:label>
    <link:label id="lab_us-gaap_ForeignPlanMember_label_en-US" xlink:label="lab_us-gaap_ForeignPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignPlanMember" xlink:to="lab_us-gaap_ForeignPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_TwoThousandNineteenToTwoThousandTwentyOneCycleMember_7e542acb-41ad-430b-af6c-710ba57470a5_terseLabel_en-US" xlink:label="lab_iff_TwoThousandNineteenToTwoThousandTwentyOneCycleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018-2020 Cycle [Member]</link:label>
    <link:label id="lab_iff_TwoThousandNineteenToTwoThousandTwentyOneCycleMember_label_en-US" xlink:label="lab_iff_TwoThousandNineteenToTwoThousandTwentyOneCycleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Nineteen To Two Thousand Twenty-One Cycle [Member]</link:label>
    <link:label id="lab_iff_TwoThousandNineteenToTwoThousandTwentyOneCycleMember_documentation_en-US" xlink:label="lab_iff_TwoThousandNineteenToTwoThousandTwentyOneCycleMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Eighteen To Two Thousand Twenty Cycle [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TwoThousandNineteenToTwoThousandTwentyOneCycleMember" xlink:href="iff-20231231.xsd#iff_TwoThousandNineteenToTwoThousandTwentyOneCycleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_TwoThousandNineteenToTwoThousandTwentyOneCycleMember" xlink:to="lab_iff_TwoThousandNineteenToTwoThousandTwentyOneCycleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_393cf8c0-a193-4d6e-bbc4-31871fbe3695_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_a94a3817-4457-4f8a-b9d3-a678815e81a0_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_TangibleEquityUnitsIssued_99c87439-dbef-4499-a7d7-16cbceb7a8a9_terseLabel_en-US" xlink:label="lab_iff_TangibleEquityUnitsIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible equity units issued</link:label>
    <link:label id="lab_iff_TangibleEquityUnitsIssued_label_en-US" xlink:label="lab_iff_TangibleEquityUnitsIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Equity Units Issued</link:label>
    <link:label id="lab_iff_TangibleEquityUnitsIssued_documentation_en-US" xlink:label="lab_iff_TangibleEquityUnitsIssued" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Equity Units Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityUnitsIssued" xlink:href="iff-20231231.xsd#iff_TangibleEquityUnitsIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_TangibleEquityUnitsIssued" xlink:to="lab_iff_TangibleEquityUnitsIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_f63c8cc2-5943-4710-a8bc-5f93f8ab42be_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_us-gaap_ConcentrationRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonqualifiedPlanMember_df7cbaf1-65c1-401a-87b8-ce78add702b0_terseLabel_en-US" xlink:label="lab_us-gaap_NonqualifiedPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonqualified Plan</link:label>
    <link:label id="lab_us-gaap_NonqualifiedPlanMember_label_en-US" xlink:label="lab_us-gaap_NonqualifiedPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonqualified Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonqualifiedPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonqualifiedPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonqualifiedPlanMember" xlink:to="lab_us-gaap_NonqualifiedPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_66c574bd-50d6-46bd-83f3-abf2703d4b00_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfInterestRateDerivativesHeld_a2584ca9-311b-43f5-9cc1-c5954b642f09_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of interest rate derivatives held</link:label>
    <link:label id="lab_us-gaap_NumberOfInterestRateDerivativesHeld_label_en-US" xlink:label="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Interest Rate Derivatives Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:to="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_32c70aa2-14a3-4b5a-abb6-99628c2a41bd_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_9c23fc08-46fa-42a3-b23b-d53649890de2_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestAbstract_61adc409-556c-47e2-a945-e206428ce972_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Abstract]</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract" xlink:to="lab_us-gaap_NoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicDistributionDomain_87c280a8-e8e9-448a-8e1b-bbc1bce3b4a3_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicDistributionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Distribution [Domain]</link:label>
    <link:label id="lab_us-gaap_GeographicDistributionDomain_label_en-US" xlink:label="lab_us-gaap_GeographicDistributionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Distribution [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicDistributionDomain" xlink:to="lab_us-gaap_GeographicDistributionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_d0d3bfd4-eb14-4e12-ab69-bd56fc1f6baf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of intangible assets acquired</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_16914dad-cf2d-4b48-abc8-b00d422fdd75_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a551aa19-797a-4f47-86dc-c6cb9b9c91d7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted&#160;Average Grant Date Fair Value Per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_TwoThousandTwentyOneToTwoThousandTwentyThreeCycleMember_2c19324e-4429-44c3-8287-b97e30000b92_terseLabel_en-US" xlink:label="lab_iff_TwoThousandTwentyOneToTwoThousandTwentyThreeCycleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Twenty-One To Two Thousand Twenty-Three Cycle</link:label>
    <link:label id="lab_iff_TwoThousandTwentyOneToTwoThousandTwentyThreeCycleMember_label_en-US" xlink:label="lab_iff_TwoThousandTwentyOneToTwoThousandTwentyThreeCycleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Twenty-One To Two Thousand Twenty-Three Cycle [Member]</link:label>
    <link:label id="lab_iff_TwoThousandTwentyOneToTwoThousandTwentyThreeCycleMember_documentation_en-US" xlink:label="lab_iff_TwoThousandTwentyOneToTwoThousandTwentyThreeCycleMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Twenty-One To Two Thousand Twenty-Three Cycle</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TwoThousandTwentyOneToTwoThousandTwentyThreeCycleMember" xlink:href="iff-20231231.xsd#iff_TwoThousandTwentyOneToTwoThousandTwentyThreeCycleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_TwoThousandTwentyOneToTwoThousandTwentyThreeCycleMember" xlink:to="lab_iff_TwoThousandTwentyOneToTwoThousandTwentyThreeCycleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_dbe8725a-ebf1-4563-ad17-325540acbb25_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred consideration paid</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_EuroInterbankOfferedRateMember_8ac692ad-ead7-4ef1-8a57-4f355921262c_terseLabel_en-US" xlink:label="lab_iff_EuroInterbankOfferedRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Interbank Offered Rate</link:label>
    <link:label id="lab_iff_EuroInterbankOfferedRateMember_label_en-US" xlink:label="lab_iff_EuroInterbankOfferedRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Interbank Offered Rate [Member]</link:label>
    <link:label id="lab_iff_EuroInterbankOfferedRateMember_documentation_en-US" xlink:label="lab_iff_EuroInterbankOfferedRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Interbank Offered Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EuroInterbankOfferedRateMember" xlink:href="iff-20231231.xsd#iff_EuroInterbankOfferedRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_EuroInterbankOfferedRateMember" xlink:to="lab_iff_EuroInterbankOfferedRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_SegmentAdjustedOperatingEBITDA_e08d585a-0482-4242-9654-17c48332af36_terseLabel_en-US" xlink:label="lab_iff_SegmentAdjustedOperatingEBITDA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Adjusted Operating EBITDA</link:label>
    <link:label id="lab_iff_SegmentAdjustedOperatingEBITDA_label_en-US" xlink:label="lab_iff_SegmentAdjustedOperatingEBITDA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Adjusted Operating EBITDA</link:label>
    <link:label id="lab_iff_SegmentAdjustedOperatingEBITDA_documentation_en-US" xlink:label="lab_iff_SegmentAdjustedOperatingEBITDA" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Adjusted Operating EBITDA is defined as income (loss) before taxes, depreciation and amortization expense, interest expense, restructuring and other charges, net and certain non-recurring items.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SegmentAdjustedOperatingEBITDA" xlink:href="iff-20231231.xsd#iff_SegmentAdjustedOperatingEBITDA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_SegmentAdjustedOperatingEBITDA" xlink:to="lab_iff_SegmentAdjustedOperatingEBITDA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_33e23a26-3ae6-4d79-b4f4-4f49c95a5472_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Fair Value, Derivative Liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_d493a433-ea94-4599-8bb4-495c57cebc0d_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liability, fair value, gross liability</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoTotalCompAmt_label_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoTotalCompAmt" xlink:to="lab_ecd_PeoTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_ProceedsFromDivestitureOfBusinessNet_e6df2a3d-74de-4f3f-bf26-b2a698e3a47e_totalLabel_en-US" xlink:label="lab_iff_ProceedsFromDivestitureOfBusinessNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Divestiture Of Business, Net</link:label>
    <link:label id="lab_iff_ProceedsFromDivestitureOfBusinessNet_label_en-US" xlink:label="lab_iff_ProceedsFromDivestitureOfBusinessNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Divestiture Of Business, Net</link:label>
    <link:label id="lab_iff_ProceedsFromDivestitureOfBusinessNet_documentation_en-US" xlink:label="lab_iff_ProceedsFromDivestitureOfBusinessNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Divestiture Of Business, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ProceedsFromDivestitureOfBusinessNet" xlink:href="iff-20231231.xsd#iff_ProceedsFromDivestitureOfBusinessNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_ProceedsFromDivestitureOfBusinessNet" xlink:to="lab_iff_ProceedsFromDivestitureOfBusinessNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_24e5644c-9920-4d06-92c5-55df6659be23_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_136075dc-487f-42d0-ad3a-e6efb019634f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense_52165569-29df-4794-a86d-8f1422f7aca6_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Compensation Expense</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Compensation Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense" xlink:to="lab_us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_TangibleEquityUnitsPricePerUnit_be79f735-f711-45e6-b497-6f6c9203fa84_terseLabel_en-US" xlink:label="lab_iff_TangibleEquityUnitsPricePerUnit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Price per unit</link:label>
    <link:label id="lab_iff_TangibleEquityUnitsPricePerUnit_label_en-US" xlink:label="lab_iff_TangibleEquityUnitsPricePerUnit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Equity Units Price Per Unit</link:label>
    <link:label id="lab_iff_TangibleEquityUnitsPricePerUnit_documentation_en-US" xlink:label="lab_iff_TangibleEquityUnitsPricePerUnit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Equity Units Price Per Unit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityUnitsPricePerUnit" xlink:href="iff-20231231.xsd#iff_TangibleEquityUnitsPricePerUnit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_TangibleEquityUnitsPricePerUnit" xlink:to="lab_iff_TangibleEquityUnitsPricePerUnit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_564c7c52-d8e4-4dec-9981-80157191d821_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_f8fbff20-5e0e-4258-ae3c-5665c5e3d183_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected to Vest (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_6bc29c92-55d4-46e5-a9aa-a6f97d0389e1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition share price</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionSharePrice" xlink:to="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_aba7ce38-91a9-40db-b242-3eaf7db64345_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Assets Invested</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Allocation of Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrByIndTable_terseLabel_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangements, by Individual</link:label>
    <link:label id="lab_ecd_TradingArrByIndTable_label_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrByIndTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="lab_ecd_TradingArrByIndTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_c3146de6-4634-4fa3-b4cd-16b2e0885bc1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_EffectiveIncomeTaxRateReconciliationTaxImpactOnInternalAssetTransferPercent_a233c07c-db7b-4132-9502-e9e33c8ab0d4_terseLabel_en-US" xlink:label="lab_iff_EffectiveIncomeTaxRateReconciliationTaxImpactOnInternalAssetTransferPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax impact on internal asset transfer</link:label>
    <link:label id="lab_iff_EffectiveIncomeTaxRateReconciliationTaxImpactOnInternalAssetTransferPercent_label_en-US" xlink:label="lab_iff_EffectiveIncomeTaxRateReconciliationTaxImpactOnInternalAssetTransferPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Impact On Internal Asset Transfer, Percent</link:label>
    <link:label id="lab_iff_EffectiveIncomeTaxRateReconciliationTaxImpactOnInternalAssetTransferPercent_documentation_en-US" xlink:label="lab_iff_EffectiveIncomeTaxRateReconciliationTaxImpactOnInternalAssetTransferPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Impact On Internal Asset Transfer, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EffectiveIncomeTaxRateReconciliationTaxImpactOnInternalAssetTransferPercent" xlink:href="iff-20231231.xsd#iff_EffectiveIncomeTaxRateReconciliationTaxImpactOnInternalAssetTransferPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_EffectiveIncomeTaxRateReconciliationTaxImpactOnInternalAssetTransferPercent" xlink:to="lab_iff_EffectiveIncomeTaxRateReconciliationTaxImpactOnInternalAssetTransferPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_4796a62b-8c68-4f8b-a2b0-27c3ac30ba7f_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_6ec456b8-80cd-46a2-9bbf-7c93c0d641f3_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_51b08b82-df22-4bcc-b86a-4a0a27e3db64_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_59a8a503-56f8-4ae2-be86-c0dbc87bb646_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_SeniorNotesDueTwoThousandFiftyMember_a6932bb6-1c27-4733-8175-b96b88f5f3a4_terseLabel_en-US" xlink:label="lab_iff_SeniorNotesDueTwoThousandFiftyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, Due Two Thousand Fifty</link:label>
    <link:label id="lab_iff_SeniorNotesDueTwoThousandFiftyMember_label_en-US" xlink:label="lab_iff_SeniorNotesDueTwoThousandFiftyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, Due Two Thousand Fifty [Member]</link:label>
    <link:label id="lab_iff_SeniorNotesDueTwoThousandFiftyMember_documentation_en-US" xlink:label="lab_iff_SeniorNotesDueTwoThousandFiftyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, Due Two Thousand Fifty</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandFiftyMember" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandFiftyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_SeniorNotesDueTwoThousandFiftyMember" xlink:to="lab_iff_SeniorNotesDueTwoThousandFiftyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_c56ca070-36f0-4298-95d5-9d969b9d4507_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and improvements [Member]</link:label>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_label_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and Building Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:to="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_43c7139e-9f17-4538-b180-c016ea91ef84_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options/SSARs</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_PriorServiceCostsFromPlanImprovementsAmortizationPeriodMaximum_6ff818a0-cc2e-445d-93b9-593c050dcf21_terseLabel_en-US" xlink:label="lab_iff_PriorServiceCostsFromPlanImprovementsAmortizationPeriodMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service costs from plan improvements amortization period, maximum, years</link:label>
    <link:label id="lab_iff_PriorServiceCostsFromPlanImprovementsAmortizationPeriodMaximum_label_en-US" xlink:label="lab_iff_PriorServiceCostsFromPlanImprovementsAmortizationPeriodMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior Service Costs From Plan Improvements, Amortization Period, Maximum</link:label>
    <link:label id="lab_iff_PriorServiceCostsFromPlanImprovementsAmortizationPeriodMaximum_documentation_en-US" xlink:label="lab_iff_PriorServiceCostsFromPlanImprovementsAmortizationPeriodMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service costs from plan improvements, amortization period, maximum.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_PriorServiceCostsFromPlanImprovementsAmortizationPeriodMaximum" xlink:href="iff-20231231.xsd#iff_PriorServiceCostsFromPlanImprovementsAmortizationPeriodMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_PriorServiceCostsFromPlanImprovementsAmortizationPeriodMaximum" xlink:to="lab_iff_PriorServiceCostsFromPlanImprovementsAmortizationPeriodMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_CommercialGuaranteesAmountOutstanding_6d230797-2218-47fa-99ce-fa5cfc2201a6_terseLabel_en-US" xlink:label="lab_iff_CommercialGuaranteesAmountOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Guarantees, Amount Outstanding</link:label>
    <link:label id="lab_iff_CommercialGuaranteesAmountOutstanding_label_en-US" xlink:label="lab_iff_CommercialGuaranteesAmountOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Guarantees, Amount Outstanding</link:label>
    <link:label id="lab_iff_CommercialGuaranteesAmountOutstanding_documentation_en-US" xlink:label="lab_iff_CommercialGuaranteesAmountOutstanding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Guarantees, Amount Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_CommercialGuaranteesAmountOutstanding" xlink:href="iff-20231231.xsd#iff_CommercialGuaranteesAmountOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_CommercialGuaranteesAmountOutstanding" xlink:to="lab_iff_CommercialGuaranteesAmountOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_815712b2-190c-46cf-89d1-42b756e8580f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Current Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Current Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_BankBorrowingsAndOverdraftsMember_07e877b1-330f-4512-8f37-09960268371e_terseLabel_en-US" xlink:label="lab_iff_BankBorrowingsAndOverdraftsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank overdrafts and other</link:label>
    <link:label id="lab_iff_BankBorrowingsAndOverdraftsMember_label_en-US" xlink:label="lab_iff_BankBorrowingsAndOverdraftsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank Borrowings And Overdrafts [Member]</link:label>
    <link:label id="lab_iff_BankBorrowingsAndOverdraftsMember_documentation_en-US" xlink:label="lab_iff_BankBorrowingsAndOverdraftsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank borrowings and overdrafts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BankBorrowingsAndOverdraftsMember" xlink:href="iff-20231231.xsd#iff_BankBorrowingsAndOverdraftsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_BankBorrowingsAndOverdraftsMember" xlink:to="lab_iff_BankBorrowingsAndOverdraftsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_415948fa-84d3-40ad-aab2-68ba8446037b_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_87c5551a-9c7a-4dce-b98f-937be9c7152c_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Current Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_7ea3641d-ad04-4008-9ded-505795dff000_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract Type [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_31b278c3-7fd0-4052-b43d-971954f99f5a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Notional Amount Outstanding</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_A2019And2022CrossCurrencySwapsMember_ebb189fe-21d8-401b-bbd6-2d06d1b6455f_terseLabel_en-US" xlink:label="lab_iff_A2019And2022CrossCurrencySwapsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Cross Currency Swaps</link:label>
    <link:label id="lab_iff_A2019And2022CrossCurrencySwapsMember_label_en-US" xlink:label="lab_iff_A2019And2022CrossCurrencySwapsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 And 2022 Cross Currency Swaps [Member]</link:label>
    <link:label id="lab_iff_A2019And2022CrossCurrencySwapsMember_documentation_en-US" xlink:label="lab_iff_A2019And2022CrossCurrencySwapsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 And 2022 Cross Currency Swaps</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_A2019And2022CrossCurrencySwapsMember" xlink:href="iff-20231231.xsd#iff_A2019And2022CrossCurrencySwapsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_A2019And2022CrossCurrencySwapsMember" xlink:to="lab_iff_A2019And2022CrossCurrencySwapsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_ca872c04-0666-4649-b03d-d592cc450e35_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_ec683ebb-cbfc-494d-bd84-6ff2d627c89c_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_label_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changed Peer Group, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:to="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureName_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureName_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureName" xlink:to="lab_ecd_CoSelectedMeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRangeHigh_f0e1799e-08d6-4fd1-999f-f96c534d629f_terseLabel_en-US" xlink:label="lab_iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRangeHigh" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Matching participant's contribution, percentage on compensation, range high</link:label>
    <link:label id="lab_iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRangeHigh_label_en-US" xlink:label="lab_iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRangeHigh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan Matching Participant Contribution Percentage On Compensation Range High</link:label>
    <link:label id="lab_iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRangeHigh_documentation_en-US" xlink:label="lab_iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRangeHigh" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined contribution plan, matching participant contribution, percentage on compensation, range high</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRangeHigh" xlink:href="iff-20231231.xsd#iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRangeHigh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRangeHigh" xlink:to="lab_iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRangeHigh" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_MinimumPercentageLikelihoodOfTaxBenefitToBeRealizedUponFinalSettlement_982d7b5b-5544-4efc-a239-6a5025d3ded9_terseLabel_en-US" xlink:label="lab_iff_MinimumPercentageLikelihoodOfTaxBenefitToBeRealizedUponFinalSettlement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum percentage chance of tax benefit realization in final settlement</link:label>
    <link:label id="lab_iff_MinimumPercentageLikelihoodOfTaxBenefitToBeRealizedUponFinalSettlement_label_en-US" xlink:label="lab_iff_MinimumPercentageLikelihoodOfTaxBenefitToBeRealizedUponFinalSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum Percentage Likelihood Of Tax Benefit To Be Realized Upon Final Settlement</link:label>
    <link:label id="lab_iff_MinimumPercentageLikelihoodOfTaxBenefitToBeRealizedUponFinalSettlement_documentation_en-US" xlink:label="lab_iff_MinimumPercentageLikelihoodOfTaxBenefitToBeRealizedUponFinalSettlement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum percentage likelihood of tax benefit to be realized upon final settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_MinimumPercentageLikelihoodOfTaxBenefitToBeRealizedUponFinalSettlement" xlink:href="iff-20231231.xsd#iff_MinimumPercentageLikelihoodOfTaxBenefitToBeRealizedUponFinalSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_MinimumPercentageLikelihoodOfTaxBenefitToBeRealizedUponFinalSettlement" xlink:to="lab_iff_MinimumPercentageLikelihoodOfTaxBenefitToBeRealizedUponFinalSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_6934ca40-8edf-4d72-88b4-d510caff20cd_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaper_15492a5e-1f9c-410c-9f47-d98271549310_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaper" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaper_label_en-US" xlink:label="lab_us-gaap_CommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaper" xlink:to="lab_us-gaap_CommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateBondSecuritiesMember_3eca114d-5a18-49c9-a381-7dbb0899ed0d_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateBondSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Bonds</link:label>
    <link:label id="lab_us-gaap_CorporateBondSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateBondSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Bond Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateBondSecuritiesMember" xlink:to="lab_us-gaap_CorporateBondSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPayableCurrent_dcd9a233-9ccd-4f7a-8619-324d7881948e_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest payable</link:label>
    <link:label id="lab_us-gaap_InterestPayableCurrent_label_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPayableCurrent" xlink:to="lab_us-gaap_InterestPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain_00969298-82df-4639-a2e7-424970cdc670_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Nature of Uncertainty [Domain]</link:label>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain_label_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Nature of Uncertainty [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain" xlink:to="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bbfacb8d-a90a-48a6-92c6-35d16ed6fff3_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_e591efc4-80b9-477e-b3fa-951f47b0bf75_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_4690bbab-e777-4112-bb65-9fbae9865d00_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Translation adjustments</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ecba2550-8d29-4df6-a271-9b1cbf6a4c57_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_3aeb49d8-3c04-4713-bbf9-bf744a8b6456_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified from AOCI</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel12And3Member_485c3f0a-c05e-4724-8d5e-d038346d1e5f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel12And3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1, 2 and 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel12And3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel12And3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1, Level 2, and Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel12And3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel12And3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel12And3Member" xlink:to="lab_us-gaap_FairValueInputsLevel12And3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_c1dae71c-6c33-46c5-a855-6cf849c7d578_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_456a1c3f-196b-40ea-83cb-53cca61d7af1_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options/SSARs (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_174daf40-0c60-4287-9f69-081b8bf5b83f_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_6ff86e7c-5fe0-492f-a0ca-406f5dfb0990_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. loss before taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_b9854f17-5159-4e98-9a37-000d0f7805ae_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_bd690844-77a4-489d-92d2-876005e3b08a_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of goods sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_88f383a6-ac7c-45dd-88b6-0c1496311630_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net amount recognized</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:to="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_a6e08816-820f-4e93-a403-9caae1a5a1f9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting period, in years</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfProductiveAssets_fe068daf-9f19-4db5-ba08-53d60e991cd7_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from disposal of assets</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfProductiveAssets_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:to="lab_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_798e8eb1-04d3-4d35-b601-17f3b3634eec_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_e8d6af1a-a816-4f5d-829e-547b5a27303f_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureName_terseLabel_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_MeasureName_label_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureName" xlink:to="lab_ecd_MeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_11763b2f-f350-4973-9910-0554d8438766_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Current Borrowing Capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Current Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PatentsMember_1e543228-35d9-4cd4-a318-ddab41383f50_terseLabel_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents [Member]</link:label>
    <link:label id="lab_us-gaap_PatentsMember_label_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PatentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PatentsMember" xlink:to="lab_us-gaap_PatentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryIndName" xlink:to="lab_ecd_ForgoneRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_StockRepurchasedDuringPeriodAsPercentageOfSharesOutstanding_e28ae9cb-a767-423d-b7c5-7e6a0fd93afd_terseLabel_en-US" xlink:label="lab_iff_StockRepurchasedDuringPeriodAsPercentageOfSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchased during period as percentage of shares outstanding</link:label>
    <link:label id="lab_iff_StockRepurchasedDuringPeriodAsPercentageOfSharesOutstanding_label_en-US" xlink:label="lab_iff_StockRepurchasedDuringPeriodAsPercentageOfSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period As Percentage Of Shares Outstanding</link:label>
    <link:label id="lab_iff_StockRepurchasedDuringPeriodAsPercentageOfSharesOutstanding_documentation_en-US" xlink:label="lab_iff_StockRepurchasedDuringPeriodAsPercentageOfSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period As Percentage Of Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_StockRepurchasedDuringPeriodAsPercentageOfSharesOutstanding" xlink:href="iff-20231231.xsd#iff_StockRepurchasedDuringPeriodAsPercentageOfSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_StockRepurchasedDuringPeriodAsPercentageOfSharesOutstanding" xlink:to="lab_iff_StockRepurchasedDuringPeriodAsPercentageOfSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_c42decac-789c-47ef-af4c-94a62e4ee6da_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_2c534ff7-65c0-4eea-827e-291539b60de6_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_fe171b01-0609-4670-83ac-7f87d300c1f2_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_74e482dd-780c-46bd-a237-032edf6504c7_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross amount of increases in unrecognized tax benefits as a result of positions taken during a prior year(1)</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_NatureOfOperationsPolicyTextBlock_99c3236b-ab43-4aaf-b736-9dfd412c3c7e_terseLabel_en-US" xlink:label="lab_iff_NatureOfOperationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations</link:label>
    <link:label id="lab_iff_NatureOfOperationsPolicyTextBlock_label_en-US" xlink:label="lab_iff_NatureOfOperationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations [Policy Text Block]</link:label>
    <link:label id="lab_iff_NatureOfOperationsPolicyTextBlock_documentation_en-US" xlink:label="lab_iff_NatureOfOperationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NatureOfOperationsPolicyTextBlock" xlink:href="iff-20231231.xsd#iff_NatureOfOperationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_NatureOfOperationsPolicyTextBlock" xlink:to="lab_iff_NatureOfOperationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_a8c41227-70fa-4ce9-a1e6-93a494b15567_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative assets (liabilities), at fair value, net</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Assets (Liabilities), at Fair Value, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:to="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_1e137341-0c70-432a-ad51-753720540be0_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_51da634b-6b40-4a34-bd1b-94a5f080823c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_terseLabel_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underlying Securities</link:label>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_label_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Underlying Securities Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:to="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionExpense_7df5626f-619f-49e3-b894-9e72f5eb5f35_negatedLabel_en-US" xlink:label="lab_us-gaap_PensionExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UK Pension Settlement Charges</link:label>
    <link:label id="lab_us-gaap_PensionExpense_label_en-US" xlink:label="lab_us-gaap_PensionExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Cost (Reversal of Cost)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionExpense" xlink:to="lab_us-gaap_PensionExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain_3ccc480e-b460-4f24-b235-718d7861d2e1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Deferred Compensation, All Types [Domain]</link:label>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain_label_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits, Individual Contracts, Type of Deferred Compensation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain" xlink:to="lab_us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_32b8ab60-d419-41cb-84d5-50f0c481de03_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade receivables</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_4f3d4d00-a37d-4f89-abd8-0bd5fd97de39_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DefinedContributionAndOtherRetirementPlans_d3a0595e-88a6-4f79-9ecc-47583ddde66a_terseLabel_en-US" xlink:label="lab_iff_DefinedContributionAndOtherRetirementPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined contribution and other retirement plans</link:label>
    <link:label id="lab_iff_DefinedContributionAndOtherRetirementPlans_label_en-US" xlink:label="lab_iff_DefinedContributionAndOtherRetirementPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution And Other Retirement Plans</link:label>
    <link:label id="lab_iff_DefinedContributionAndOtherRetirementPlans_documentation_en-US" xlink:label="lab_iff_DefinedContributionAndOtherRetirementPlans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined contribution and other retirement plans expense.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedContributionAndOtherRetirementPlans" xlink:href="iff-20231231.xsd#iff_DefinedContributionAndOtherRetirementPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DefinedContributionAndOtherRetirementPlans" xlink:to="lab_iff_DefinedContributionAndOtherRetirementPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransactionDomain_081d8092-d239-49d6-a7dc-1ccca20bae43_terseLabel_en-US" xlink:label="lab_us-gaap_TransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_TransactionDomain_label_en-US" xlink:label="lab_us-gaap_TransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransactionDomain" xlink:to="lab_us-gaap_TransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_SeniorNotesDueTwoThousandTwentyTwoMember_e4676b3b-f5d0-4264-9052-60f687ae9777_terseLabel_en-US" xlink:label="lab_iff_SeniorNotesDueTwoThousandTwentyTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, Due Two Thousand Twenty Two</link:label>
    <link:label id="lab_iff_SeniorNotesDueTwoThousandTwentyTwoMember_label_en-US" xlink:label="lab_iff_SeniorNotesDueTwoThousandTwentyTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, Due Two Thousand Twenty Two [Member]</link:label>
    <link:label id="lab_iff_SeniorNotesDueTwoThousandTwentyTwoMember_documentation_en-US" xlink:label="lab_iff_SeniorNotesDueTwoThousandTwentyTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, Due Two Thousand Twenty Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandTwentyTwoMember" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandTwentyTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_SeniorNotesDueTwoThousandTwentyTwoMember" xlink:to="lab_iff_SeniorNotesDueTwoThousandTwentyTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_5f7c2917-a201-4b49-9607-c40b91c547f1_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_6f461147-6c4e-452b-b436-9b6979a7bba7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_eacf0324-c083-4774-8ccc-c7f28234300f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_278f986c-5408-4a38-8b0c-e7882c40e443_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_1028edba-1faf-4e78-b98c-215c0ab499be_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Losses) gains on pension and postretirement liability adjustments</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_8f1b1127-b07b-40bd-8470-cede0b44f10b_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_ef2511ab-428d-4173-8f35-54b8a5b95804_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Axis]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_22b9ea96-75d3-42f9-b7f4-89b464721cba_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs, by Report Line [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_de1a7fa6-5e8b-48f3-8a3a-a1d96521a832_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_BankGuaranteesStandbyLettersOfCreditAndCommercialGuaranteesAmountOutstanding_c7bd330c-17f0-4a97-9712-e72202b23f01_terseLabel_en-US" xlink:label="lab_iff_BankGuaranteesStandbyLettersOfCreditAndCommercialGuaranteesAmountOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank Guarantees and Standby Letters of Credit, Amount Outstanding</link:label>
    <link:label id="lab_iff_BankGuaranteesStandbyLettersOfCreditAndCommercialGuaranteesAmountOutstanding_label_en-US" xlink:label="lab_iff_BankGuaranteesStandbyLettersOfCreditAndCommercialGuaranteesAmountOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank Guarantees, Standby Letters Of Credit And Commercial Guarantees, Amount Outstanding</link:label>
    <link:label id="lab_iff_BankGuaranteesStandbyLettersOfCreditAndCommercialGuaranteesAmountOutstanding_documentation_en-US" xlink:label="lab_iff_BankGuaranteesStandbyLettersOfCreditAndCommercialGuaranteesAmountOutstanding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank Guarantees, Standby Letters Of Credit And Commercial Guarantees, Amount Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BankGuaranteesStandbyLettersOfCreditAndCommercialGuaranteesAmountOutstanding" xlink:href="iff-20231231.xsd#iff_BankGuaranteesStandbyLettersOfCreditAndCommercialGuaranteesAmountOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_BankGuaranteesStandbyLettersOfCreditAndCommercialGuaranteesAmountOutstanding" xlink:to="lab_iff_BankGuaranteesStandbyLettersOfCreditAndCommercialGuaranteesAmountOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_4a2de868-671c-4cf9-8c22-57e624a07803_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_beaa47f7-379e-469c-bc3f-1e645622cb02_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement liabilities</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_2335457e-2161-47ed-ab10-5725ede7f0f6_negatedLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement liabilities</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_3e0d9377-f81f-4e90-936f-9b01531d9729_totalLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stock-based compensation, net of tax</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardValuationAllowance_bc9bd2eb-a8c1-4cae-8c70-14d617512b86_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Valuation Allowance</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardValuationAllowance_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxCreditCarryforwardValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardValuationAllowance" xlink:to="lab_us-gaap_TaxCreditCarryforwardValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_TangibleEquityUnitsPriceforSharesDiluted_39db15f8-3e0a-4141-9a2c-6ade4d69b907_terseLabel_en-US" xlink:label="lab_iff_TangibleEquityUnitsPriceforSharesDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Price for diluted share (usd per share)</link:label>
    <link:label id="lab_iff_TangibleEquityUnitsPriceforSharesDiluted_label_en-US" xlink:label="lab_iff_TangibleEquityUnitsPriceforSharesDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Equity Units, Price for Shares Diluted</link:label>
    <link:label id="lab_iff_TangibleEquityUnitsPriceforSharesDiluted_documentation_en-US" xlink:label="lab_iff_TangibleEquityUnitsPriceforSharesDiluted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Equity Units, Price for Shares Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityUnitsPriceforSharesDiluted" xlink:href="iff-20231231.xsd#iff_TangibleEquityUnitsPriceforSharesDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_TangibleEquityUnitsPriceforSharesDiluted" xlink:to="lab_iff_TangibleEquityUnitsPriceforSharesDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_63c41794-72b9-44e0-b769-31e149fc0a6b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_GuangzhouChinaMember_c8acbae0-1ee8-4c55-a521-b5309eefd92f_terseLabel_en-US" xlink:label="lab_iff_GuangzhouChinaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guangzhou, China [Member]</link:label>
    <link:label id="lab_iff_GuangzhouChinaMember_label_en-US" xlink:label="lab_iff_GuangzhouChinaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guangzhou, China [Member]</link:label>
    <link:label id="lab_iff_GuangzhouChinaMember_documentation_en-US" xlink:label="lab_iff_GuangzhouChinaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guangzhou, China [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_GuangzhouChinaMember" xlink:href="iff-20231231.xsd#iff_GuangzhouChinaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_GuangzhouChinaMember" xlink:to="lab_iff_GuangzhouChinaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_d9e8f8e3-1116-40df-8343-8d30b8836faa_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_7f144a3a-fc0e-4d1a-941a-cd8f724b8b39_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DefinedBenefitPlanPlanAssetsOther_34cabeee-3cfc-49cd-9541-0d4dd6cd0788_terseLabel_en-US" xlink:label="lab_iff_DefinedBenefitPlanPlanAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_iff_DefinedBenefitPlanPlanAssetsOther_label_en-US" xlink:label="lab_iff_DefinedBenefitPlanPlanAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Other</link:label>
    <link:label id="lab_iff_DefinedBenefitPlanPlanAssetsOther_documentation_en-US" xlink:label="lab_iff_DefinedBenefitPlanPlanAssetsOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedBenefitPlanPlanAssetsOther" xlink:href="iff-20231231.xsd#iff_DefinedBenefitPlanPlanAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DefinedBenefitPlanPlanAssetsOther" xlink:to="lab_iff_DefinedBenefitPlanPlanAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_label_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OtherPerfMeasureAmt" xlink:to="lab_ecd_OtherPerfMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_FragrancesMember_fe73d591-30df-4ae0-acb1-16f717a109aa_terseLabel_en-US" xlink:label="lab_iff_FragrancesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fragrances [Member]</link:label>
    <link:label id="lab_iff_FragrancesMember_label_en-US" xlink:label="lab_iff_FragrancesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fragrances [Member]</link:label>
    <link:label id="lab_iff_FragrancesMember_documentation_en-US" xlink:label="lab_iff_FragrancesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fragrances.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FragrancesMember" xlink:href="iff-20231231.xsd#iff_FragrancesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_FragrancesMember" xlink:to="lab_iff_FragrancesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_2c700682-24cc-4a5b-9dd7-69a2f2d27a24_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Costs</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_094c913e-7747-4d97-beb3-022b3cf2cfa4_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_RussiaUkraineWarMember_b6105c9d-d1de-47c6-b1d8-ccf0d53f0a06_terseLabel_en-US" xlink:label="lab_iff_RussiaUkraineWarMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Russia And Ukraine Conflict</link:label>
    <link:label id="lab_iff_RussiaUkraineWarMember_label_en-US" xlink:label="lab_iff_RussiaUkraineWarMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Russia-Ukraine War [Member]</link:label>
    <link:label id="lab_iff_RussiaUkraineWarMember_documentation_en-US" xlink:label="lab_iff_RussiaUkraineWarMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Russia-Ukraine War</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_RussiaUkraineWarMember" xlink:href="iff-20231231.xsd#iff_RussiaUkraineWarMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_RussiaUkraineWarMember" xlink:to="lab_iff_RussiaUkraineWarMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_05211fab-4355-4a8d-9b08-e6c5d6b2e69d_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f1777abb-c51d-4316-bfe4-3b86aeb6fce1_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_NonUSOtherFixedIncomeMember_90ed644c-bc61-4a23-a18c-9f4aef0a8ef1_terseLabel_en-US" xlink:label="lab_iff_NonUSOtherFixedIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S. Other Fixed Income</link:label>
    <link:label id="lab_iff_NonUSOtherFixedIncomeMember_label_en-US" xlink:label="lab_iff_NonUSOtherFixedIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non U S Other Fixed Income [Member]</link:label>
    <link:label id="lab_iff_NonUSOtherFixedIncomeMember_documentation_en-US" xlink:label="lab_iff_NonUSOtherFixedIncomeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non U.S. Other Fixed Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NonUSOtherFixedIncomeMember" xlink:href="iff-20231231.xsd#iff_NonUSOtherFixedIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_NonUSOtherFixedIncomeMember" xlink:to="lab_iff_NonUSOtherFixedIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_64b4dc4e-b398-4eca-b91e-4be99ff60f28_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_TwoThousandEighteenToTwoThousandTwentyCycleMember_1558b375-32ff-4787-90ea-b742cae82154_terseLabel_en-US" xlink:label="lab_iff_TwoThousandEighteenToTwoThousandTwentyCycleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017 - 2019 Cycle [Member]</link:label>
    <link:label id="lab_iff_TwoThousandEighteenToTwoThousandTwentyCycleMember_label_en-US" xlink:label="lab_iff_TwoThousandEighteenToTwoThousandTwentyCycleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Eighteen To Two Thousand Twenty Cycle [Member]</link:label>
    <link:label id="lab_iff_TwoThousandEighteenToTwoThousandTwentyCycleMember_documentation_en-US" xlink:label="lab_iff_TwoThousandEighteenToTwoThousandTwentyCycleMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Eighteen To Two Thousand Twenty Cycle</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TwoThousandEighteenToTwoThousandTwentyCycleMember" xlink:href="iff-20231231.xsd#iff_TwoThousandEighteenToTwoThousandTwentyCycleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_TwoThousandEighteenToTwoThousandTwentyCycleMember" xlink:to="lab_iff_TwoThousandEighteenToTwoThousandTwentyCycleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_280b9d98-1b3f-4b62-88b2-1c53fd29e153_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesReceivable" xlink:to="lab_us-gaap_IncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure_41f94a46-66ab-4d02-a5f9-44b3cd2b6739_terseLabel_en-US" xlink:label="lab_us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Issued in Business Combination, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Issued in Business Combination, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure" xlink:to="lab_us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_cb92d321-27be-4b11-a9bf-10a524291b3a_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_04902e3d-5d3a-4d02-8473-794a743dc9ca_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_cb3e110c-8b82-4cd6-a43f-87e4d76bc34c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_ad0f8d25-428f-4ea9-adc9-eac6949ea7d3_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued capital expenditures</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_02edb16d-e457-4f1a-baeb-47436d08139f_terseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FixedIncomeSecuritiesMember_daa1b4a1-5094-4825-8744-c921315f29b8_terseLabel_en-US" xlink:label="lab_us-gaap_FixedIncomeSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Income Securities</link:label>
    <link:label id="lab_us-gaap_FixedIncomeSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_FixedIncomeSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Income Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FixedIncomeSecuritiesMember" xlink:to="lab_us-gaap_FixedIncomeSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_367955a7-2877-4647-84e2-0c8a9d017cdf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares authorized for issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_4d56fbff-57b0-4692-9022-824f1573aab2_terseLabel_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_label_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:to="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_EntityWideRevenueMajorCustomerNumberOfCustomers_08bbae3d-cc25-4b21-9618-5a87d0fd9574_terseLabel_en-US" xlink:label="lab_iff_EntityWideRevenueMajorCustomerNumberOfCustomers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of customers that accounted for more than 10% of consolidated net sales</link:label>
    <link:label id="lab_iff_EntityWideRevenueMajorCustomerNumberOfCustomers_label_en-US" xlink:label="lab_iff_EntityWideRevenueMajorCustomerNumberOfCustomers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Wide Revenue Major Customer Number Of Customers</link:label>
    <link:label id="lab_iff_EntityWideRevenueMajorCustomerNumberOfCustomers_documentation_en-US" xlink:label="lab_iff_EntityWideRevenueMajorCustomerNumberOfCustomers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of customers whose net sales accounted for more than 10% of consolidated net sales.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EntityWideRevenueMajorCustomerNumberOfCustomers" xlink:href="iff-20231231.xsd#iff_EntityWideRevenueMajorCustomerNumberOfCustomers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_EntityWideRevenueMajorCustomerNumberOfCustomers" xlink:to="lab_iff_EntityWideRevenueMajorCustomerNumberOfCustomers" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrAxis_terseLabel_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement:</link:label>
    <link:label id="lab_ecd_TradingArrAxis_label_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrAxis" xlink:to="lab_ecd_TradingArrAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_85f8b5b9-c3c2-4b94-8b70-303bc44144ae_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_CommitmentsAndContingenciesTable_b3fa0ac9-baf1-441c-b9a1-94190e5e2397_terseLabel_en-US" xlink:label="lab_iff_CommitmentsAndContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Table]</link:label>
    <link:label id="lab_iff_CommitmentsAndContingenciesTable_label_en-US" xlink:label="lab_iff_CommitmentsAndContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Table]</link:label>
    <link:label id="lab_iff_CommitmentsAndContingenciesTable_documentation_en-US" xlink:label="lab_iff_CommitmentsAndContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_CommitmentsAndContingenciesTable" xlink:href="iff-20231231.xsd#iff_CommitmentsAndContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_CommitmentsAndContingenciesTable" xlink:to="lab_iff_CommitmentsAndContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_48e6c5ef-83b0-41d4-8229-b8a7bcd09cc4_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_444aba56-a285-4a09-9124-b9485422ee5d_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherDeferredCostsGross_b55e7ab6-68e6-400e-bc7a-a5827c1d6e4e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherDeferredCostsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other deferred costs</link:label>
    <link:label id="lab_us-gaap_OtherDeferredCostsGross_label_en-US" xlink:label="lab_us-gaap_OtherDeferredCostsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Deferred Costs, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDeferredCostsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherDeferredCostsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherDeferredCostsGross" xlink:to="lab_us-gaap_OtherDeferredCostsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DifferenceAmountBetweenBasicNetIncomeLossPerShare_3c3d3fa3-bd41-453a-8055-76bbf8db602a_terseLabel_en-US" xlink:label="lab_iff_DifferenceAmountBetweenBasicNetIncomeLossPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Difference Amount Between Basic Net Income (Loss) Per Share</link:label>
    <link:label id="lab_iff_DifferenceAmountBetweenBasicNetIncomeLossPerShare_label_en-US" xlink:label="lab_iff_DifferenceAmountBetweenBasicNetIncomeLossPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Difference Amount Between Basic Net Income (Loss) Per Share</link:label>
    <link:label id="lab_iff_DifferenceAmountBetweenBasicNetIncomeLossPerShare_documentation_en-US" xlink:label="lab_iff_DifferenceAmountBetweenBasicNetIncomeLossPerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Difference Amount Between Basic Net Income (Loss) Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DifferenceAmountBetweenBasicNetIncomeLossPerShare" xlink:href="iff-20231231.xsd#iff_DifferenceAmountBetweenBasicNetIncomeLossPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DifferenceAmountBetweenBasicNetIncomeLossPerShare" xlink:to="lab_iff_DifferenceAmountBetweenBasicNetIncomeLossPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPayrollAndEmployeeBenefits_a3a27957-0b17-494f-8636-b35964950255_negatedTerseLabel_en-US" xlink:label="lab_iff_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPayrollAndEmployeeBenefits" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued payroll and employee benefits</link:label>
    <link:label id="lab_iff_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPayrollAndEmployeeBenefits_label_en-US" xlink:label="lab_iff_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPayrollAndEmployeeBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Payroll And Employee Benefits</link:label>
    <link:label id="lab_iff_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPayrollAndEmployeeBenefits_documentation_en-US" xlink:label="lab_iff_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPayrollAndEmployeeBenefits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Payroll And Employee Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPayrollAndEmployeeBenefits" xlink:href="iff-20231231.xsd#iff_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPayrollAndEmployeeBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPayrollAndEmployeeBenefits" xlink:to="lab_iff_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPayrollAndEmployeeBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_3277f12f-154c-4640-bd72-b5d68f597cf2_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, After 5 years</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_MicrobialControlMember_01867c2f-4c4e-47ad-a92b-38043cf5d0e3_terseLabel_en-US" xlink:label="lab_iff_MicrobialControlMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Microbial Control</link:label>
    <link:label id="lab_iff_MicrobialControlMember_label_en-US" xlink:label="lab_iff_MicrobialControlMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Microbial Control [Member]</link:label>
    <link:label id="lab_iff_MicrobialControlMember_documentation_en-US" xlink:label="lab_iff_MicrobialControlMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Microbial Control</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_MicrobialControlMember" xlink:href="iff-20231231.xsd#iff_MicrobialControlMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_MicrobialControlMember" xlink:to="lab_iff_MicrobialControlMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisablePeriod_670c3f56-ee64-4d7a-885b-96b304583cf5_terseLabel_en-US" xlink:label="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisablePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation cost related to non-vested stock options and SSAR, RSU, PRS and Cash RSU awards granted, weighted average period, in years</link:label>
    <link:label id="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisablePeriod_label_en-US" xlink:label="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisablePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Period</link:label>
    <link:label id="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisablePeriod_documentation_en-US" xlink:label="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisablePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisablePeriod" xlink:href="iff-20231231.xsd#iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisablePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisablePeriod" xlink:to="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisablePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_e1d957d4-3778-4317-af61-5c367d961161_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross amount of decreases in unrecognized tax benefits as a result of positions taken during a prior year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_16f38f2b-7738-43c4-b320-2948d1f2efef_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_e79614c6-648a-494f-9d6e-8ff4779f9201_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_ProceedsFromIssuanceOfCommercialPaperMaturingInMoreThanThreeMonths_7052e150-97fa-400a-a967-7372660576e8_terseLabel_en-US" xlink:label="lab_iff_ProceedsFromIssuanceOfCommercialPaperMaturingInMoreThanThreeMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of commercial paper (maturities after three months)</link:label>
    <link:label id="lab_iff_ProceedsFromIssuanceOfCommercialPaperMaturingInMoreThanThreeMonths_label_en-US" xlink:label="lab_iff_ProceedsFromIssuanceOfCommercialPaperMaturingInMoreThanThreeMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Issuance Of Commercial Paper, Maturing In More Than Three Months</link:label>
    <link:label id="lab_iff_ProceedsFromIssuanceOfCommercialPaperMaturingInMoreThanThreeMonths_documentation_en-US" xlink:label="lab_iff_ProceedsFromIssuanceOfCommercialPaperMaturingInMoreThanThreeMonths" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Issuance Of Commercial Paper, Maturing In More Than Three Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ProceedsFromIssuanceOfCommercialPaperMaturingInMoreThanThreeMonths" xlink:href="iff-20231231.xsd#iff_ProceedsFromIssuanceOfCommercialPaperMaturingInMoreThanThreeMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_ProceedsFromIssuanceOfCommercialPaperMaturingInMoreThanThreeMonths" xlink:to="lab_iff_ProceedsFromIssuanceOfCommercialPaperMaturingInMoreThanThreeMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_93e73ba5-35ee-4871-a4ff-b43352f58570_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of acquisition-related intangibles</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_7ebf86f8-0aef-4b52-98af-84eddf4f6cbe_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Supplies_da40b438-7279-491d-8ee9-012f95c5caff_terseLabel_en-US" xlink:label="lab_us-gaap_Supplies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Packaging materials and supplies</link:label>
    <link:label id="lab_us-gaap_Supplies_label_en-US" xlink:label="lab_us-gaap_Supplies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Supplies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Supplies" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Supplies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Supplies" xlink:to="lab_us-gaap_Supplies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_7333a157-b3af-4b10-b732-6afa53465a30_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling interest</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementAdjustmentMember_6042df08-0ad0-442d-b009-a873f8fd927e_terseLabel_en-US" xlink:label="lab_srt_RestatementAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Adjustment</link:label>
    <link:label id="lab_srt_RestatementAdjustmentMember_label_en-US" xlink:label="lab_srt_RestatementAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAdjustmentMember" xlink:to="lab_srt_RestatementAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_1d9b1e2a-7d75-47fb-b78d-8d5f33092a9c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDeterminationDate_terseLabel_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:label id="lab_ecd_RestatementDeterminationDate_label_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDeterminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDeterminationDate" xlink:to="lab_ecd_RestatementDeterminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_363a847c-37ef-4c25-a197-1e51a90c9c67_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross amount of increases in unrecognized tax benefits as a result of positions taken during the current year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:to="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_3b90c7fe-1e7b-455c-80c1-a71384622a2e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8253350b-5a33-4fce-bdbf-57f381d910b9_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at beginning of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7b83916f-98be-45dd-a01c-943b8fed0614_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at end of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_86f09d05-533d-4a43-a521-7f590ffb4529_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_10feb540-3ff3-458a-ab0f-7f0005c0e7d7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByAssetClassAxis" xlink:to="lab_us-gaap_FairValueByAssetClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_4bdbf9b1-5e91-463c-8f61-a979742381c0_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of assets invested</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:to="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_SubsequentFiscalQuarterEndingOnOrBeforeSeptember302025Member_82241446-5c85-4191-aa5d-772cc5a8a525_terseLabel_en-US" xlink:label="lab_iff_SubsequentFiscalQuarterEndingOnOrBeforeSeptember302025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Fiscal Quarter Ending On Or Before September 30, 2025</link:label>
    <link:label id="lab_iff_SubsequentFiscalQuarterEndingOnOrBeforeSeptember302025Member_label_en-US" xlink:label="lab_iff_SubsequentFiscalQuarterEndingOnOrBeforeSeptember302025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Fiscal Quarter Ending On Or Before September 30, 2025 [Member]</link:label>
    <link:label id="lab_iff_SubsequentFiscalQuarterEndingOnOrBeforeSeptember302025Member_documentation_en-US" xlink:label="lab_iff_SubsequentFiscalQuarterEndingOnOrBeforeSeptember302025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Fiscal Quarter Ending On Or Before September 30, 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SubsequentFiscalQuarterEndingOnOrBeforeSeptember302025Member" xlink:href="iff-20231231.xsd#iff_SubsequentFiscalQuarterEndingOnOrBeforeSeptember302025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_SubsequentFiscalQuarterEndingOnOrBeforeSeptember302025Member" xlink:to="lab_iff_SubsequentFiscalQuarterEndingOnOrBeforeSeptember302025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_38b5336c-8d4c-4c65-be60-a06d6ee4486a_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansPayableMember_ba1a7dd5-ef11-46b3-b402-e991820fe036_terseLabel_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable</link:label>
    <link:label id="lab_us-gaap_LoansPayableMember_label_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LoansPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansPayableMember" xlink:to="lab_us-gaap_LoansPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_TwoThousandEightToTwoThousandTwentyCycleMember_72eaf21e-2872-4bc6-83d7-88b5572ca490_terseLabel_en-US" xlink:label="lab_iff_TwoThousandEightToTwoThousandTwentyCycleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2008-2020 Cycle (Cycle VIII) [Member]</link:label>
    <link:label id="lab_iff_TwoThousandEightToTwoThousandTwentyCycleMember_label_en-US" xlink:label="lab_iff_TwoThousandEightToTwoThousandTwentyCycleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Eight To Two Thousand Twenty Cycle [Member]</link:label>
    <link:label id="lab_iff_TwoThousandEightToTwoThousandTwentyCycleMember_documentation_en-US" xlink:label="lab_iff_TwoThousandEightToTwoThousandTwentyCycleMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Eight To Two Thousand Twenty Cycle [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TwoThousandEightToTwoThousandTwentyCycleMember" xlink:href="iff-20231231.xsd#iff_TwoThousandEightToTwoThousandTwentyCycleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_TwoThousandEightToTwoThousandTwentyCycleMember" xlink:to="lab_iff_TwoThousandEightToTwoThousandTwentyCycleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_FinanceLeaseLiabilityPaymentsDueYearFourAndFive_cad0644e-3389-4494-b6f5-c3f95627e46f_terseLabel_en-US" xlink:label="lab_iff_FinanceLeaseLiabilityPaymentsDueYearFourAndFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing lease, 3-5 years</link:label>
    <link:label id="lab_iff_FinanceLeaseLiabilityPaymentsDueYearFourAndFive_label_en-US" xlink:label="lab_iff_FinanceLeaseLiabilityPaymentsDueYearFourAndFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payments, Due Year Four And Five</link:label>
    <link:label id="lab_iff_FinanceLeaseLiabilityPaymentsDueYearFourAndFive_documentation_en-US" xlink:label="lab_iff_FinanceLeaseLiabilityPaymentsDueYearFourAndFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payments, Due Year Four And Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FinanceLeaseLiabilityPaymentsDueYearFourAndFive" xlink:href="iff-20231231.xsd#iff_FinanceLeaseLiabilityPaymentsDueYearFourAndFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_FinanceLeaseLiabilityPaymentsDueYearFourAndFive" xlink:to="lab_iff_FinanceLeaseLiabilityPaymentsDueYearFourAndFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_50f25f01-0b5e-4f63-ba5e-e1b419f63cbb_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturingInYearsFourAndFive_f4ec8a57-1ab8-4a7e-9413-e2367b6b0e71_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturingInYearsFourAndFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3-5 Years</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturingInYearsFourAndFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturingInYearsFourAndFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four and Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturingInYearsFourAndFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturingInYearsFourAndFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturingInYearsFourAndFive" xlink:to="lab_us-gaap_LongTermDebtMaturingInYearsFourAndFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_191db3af-b391-40eb-bbe5-381e2f463d7f_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Long-Lived Assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_bd280fb3-4830-4b37-aa2f-21138a709966_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_ConditionThreeMember_6534fb7d-2fdd-4c17-b7d3-6664ab8e34e0_terseLabel_en-US" xlink:label="lab_iff_ConditionThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condition Three [Member]</link:label>
    <link:label id="lab_iff_ConditionThreeMember_label_en-US" xlink:label="lab_iff_ConditionThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condition Three [Member]</link:label>
    <link:label id="lab_iff_ConditionThreeMember_documentation_en-US" xlink:label="lab_iff_ConditionThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condition Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ConditionThreeMember" xlink:href="iff-20231231.xsd#iff_ConditionThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_ConditionThreeMember" xlink:to="lab_iff_ConditionThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_6fe8abfb-a349-4202-8f77-11d235fcd301_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net actuarial (gain) loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_f6c370aa-b274-4c8f-b042-fc1b6f880536_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeveranceCosts1_7f47fff3-00d5-46f0-a769-14de4cdca044_terseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance costs</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_8db3dc20-c037-4c2d-9a79-75f4a12ddd1a_verboseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee separation costs</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_label_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeveranceCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1" xlink:to="lab_us-gaap_SeveranceCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_3d71ceef-fc81-4bd7-9625-4a1b38047983_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_fdafda61-8b84-4f94-b13e-99ed2ce49d35_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_EstimatedIncomeTaxExpenseBenefit_97aec227-97fd-49f0-b217-6e809bd44134_terseLabel_en-US" xlink:label="lab_iff_EstimatedIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_iff_EstimatedIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_iff_EstimatedIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_iff_EstimatedIncomeTaxExpenseBenefit_documentation_en-US" xlink:label="lab_iff_EstimatedIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EstimatedIncomeTaxExpenseBenefit" xlink:href="iff-20231231.xsd#iff_EstimatedIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_EstimatedIncomeTaxExpenseBenefit" xlink:to="lab_iff_EstimatedIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_2f22ce06-bdfe-41c8-be4f-85f43efadbb9_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Adjustments</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DifferenceAmountBetweenBasicAndDilutedNetIncomePerShare_fe267a8b-d690-4173-8389-764c04642f2d_terseLabel_en-US" xlink:label="lab_iff_DifferenceAmountBetweenBasicAndDilutedNetIncomePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Difference amount between basic and diluted net income per share (in dollars per share)</link:label>
    <link:label id="lab_iff_DifferenceAmountBetweenBasicAndDilutedNetIncomePerShare_label_en-US" xlink:label="lab_iff_DifferenceAmountBetweenBasicAndDilutedNetIncomePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Difference Amount Between Basic And Diluted Net Income Per Share</link:label>
    <link:label id="lab_iff_DifferenceAmountBetweenBasicAndDilutedNetIncomePerShare_documentation_en-US" xlink:label="lab_iff_DifferenceAmountBetweenBasicAndDilutedNetIncomePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Difference amount between basic and diluted net income per share.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DifferenceAmountBetweenBasicAndDilutedNetIncomePerShare" xlink:href="iff-20231231.xsd#iff_DifferenceAmountBetweenBasicAndDilutedNetIncomePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DifferenceAmountBetweenBasicAndDilutedNetIncomePerShare" xlink:to="lab_iff_DifferenceAmountBetweenBasicAndDilutedNetIncomePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_d3552292-dacf-4cbd-bee8-6a98c33ae5a1_periodStartLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_39133fac-d0d3-4848-b2cf-2b90f40415fa_periodEndLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_FiscalQuarterEndingDecember312025Member_bb68cd2d-0d28-487c-8a7e-1d16fc2595c1_terseLabel_en-US" xlink:label="lab_iff_FiscalQuarterEndingDecember312025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Quarter Ending December 31, 2025</link:label>
    <link:label id="lab_iff_FiscalQuarterEndingDecember312025Member_label_en-US" xlink:label="lab_iff_FiscalQuarterEndingDecember312025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Quarter Ending December 31, 2025 [Member]</link:label>
    <link:label id="lab_iff_FiscalQuarterEndingDecember312025Member_documentation_en-US" xlink:label="lab_iff_FiscalQuarterEndingDecember312025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Quarter Ending December 31, 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FiscalQuarterEndingDecember312025Member" xlink:href="iff-20231231.xsd#iff_FiscalQuarterEndingDecember312025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_FiscalQuarterEndingDecember312025Member" xlink:to="lab_iff_FiscalQuarterEndingDecember312025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_db24b9aa-aee8-4ef1-8b9f-df8410e00d30_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation cost related to non-vested stock options and SSAR, RSU, PRS and Cash RSU awards granted, weighted average period, in years</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDisclosureTextBlock_92b9eea9-221b-402c-b8ef-81b776130cb5_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDisclosureTextBlock" xlink:to="lab_us-gaap_MinorityInterestDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_fc12b2ac-8329-4d31-81f9-48bd766a90df_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_5f09b37c-e07f-44d7-a14a-82121d4934c7_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss attributable to IFF shareholders</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_1fe37fda-ace6-48e6-8f7a-7f7a107036f5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Future Benefit Payments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Expected Benefit Payments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_StockRepurchaseProgramAdditionalAuthorizedAmount_0b7650d3-44e4-4829-a0b7-4912d870fb77_terseLabel_en-US" xlink:label="lab_iff_StockRepurchaseProgramAdditionalAuthorizedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional authorized amount</link:label>
    <link:label id="lab_iff_StockRepurchaseProgramAdditionalAuthorizedAmount_label_en-US" xlink:label="lab_iff_StockRepurchaseProgramAdditionalAuthorizedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Additional Authorized Amount</link:label>
    <link:label id="lab_iff_StockRepurchaseProgramAdditionalAuthorizedAmount_documentation_en-US" xlink:label="lab_iff_StockRepurchaseProgramAdditionalAuthorizedAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Additional Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_StockRepurchaseProgramAdditionalAuthorizedAmount" xlink:href="iff-20231231.xsd#iff_StockRepurchaseProgramAdditionalAuthorizedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_StockRepurchaseProgramAdditionalAuthorizedAmount" xlink:to="lab_iff_StockRepurchaseProgramAdditionalAuthorizedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_ebf97fbc-e44c-4c19-ad4c-7a08debf1ad2_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funded status at end of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funded (Unfunded) Status of Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:to="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageReachesAverageRate_05aa487f-5a61-4102-abea-6017c42c2903_terseLabel_en-US" xlink:label="lab_iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageReachesAverageRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of employees eligible to accrue benefits under the defined plan</link:label>
    <link:label id="lab_iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageReachesAverageRate_label_en-US" xlink:label="lab_iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageReachesAverageRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan Percentage Of Matching Contribution If Compensation Percentage Reaches Average Rate</link:label>
    <link:label id="lab_iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageReachesAverageRate_documentation_en-US" xlink:label="lab_iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageReachesAverageRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined contribution plan, percentage of matching contribution if compensation percentage reaches average rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageReachesAverageRate" xlink:href="iff-20231231.xsd#iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageReachesAverageRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageReachesAverageRate" xlink:to="lab_iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageReachesAverageRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_e0f0d0b2-e4db-4028-9500-dd9e81ec8424_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_d7ca806f-e752-4a26-ab37-965976a88221_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_30888097-b168-4c03-b853-8d049a872b30_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of NCI</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfHealthCareCostTrendRatesTableTextBlock_4a24fd5d-b638-4863-8e76-f7085b11cc77_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfHealthCareCostTrendRatesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Assumptions Used to Determine Postretirement Benefit Expense and Obligation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfHealthCareCostTrendRatesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfHealthCareCostTrendRatesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Health Care Cost Trend Rates [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfHealthCareCostTrendRatesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfHealthCareCostTrendRatesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfHealthCareCostTrendRatesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfHealthCareCostTrendRatesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_5b061879-49a3-4188-b8ae-40dc7ce8e4fc_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_210e44ee-f6c2-4038-b013-095a03e19cab_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_label_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitExpense_5dc29fba-b91d-457e-b721-761283c516b9_totalLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total expense</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitExpense_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and Other Postretirement Benefits Cost (Reversal of Cost)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementBenefitExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitExpense" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_A2024TermLoanMember_b1ec2971-6492-418d-bc27-e73c7f157658_terseLabel_en-US" xlink:label="lab_iff_A2024TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024 Term Loan</link:label>
    <link:label id="lab_iff_A2024TermLoanMember_label_en-US" xlink:label="lab_iff_A2024TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024 Term Loan [Member]</link:label>
    <link:label id="lab_iff_A2024TermLoanMember_documentation_en-US" xlink:label="lab_iff_A2024TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024 Term Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_A2024TermLoanMember" xlink:href="iff-20231231.xsd#iff_A2024TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_A2024TermLoanMember" xlink:to="lab_iff_A2024TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets_1db1ace9-ec15-4e8f-8f69-1d0b1edf7208_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_FragranceCompoundsMember_cb067a1a-dc09-41ac-9d0d-0d20a8ea2f9e_terseLabel_en-US" xlink:label="lab_iff_FragranceCompoundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fragrance Compounds [Member]</link:label>
    <link:label id="lab_iff_FragranceCompoundsMember_label_en-US" xlink:label="lab_iff_FragranceCompoundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fragrance Compounds [Member]</link:label>
    <link:label id="lab_iff_FragranceCompoundsMember_documentation_en-US" xlink:label="lab_iff_FragranceCompoundsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fragrance Compounds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FragranceCompoundsMember" xlink:href="iff-20231231.xsd#iff_FragranceCompoundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_FragranceCompoundsMember" xlink:to="lab_iff_FragranceCompoundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_CommonStockDividendsPerShareMaximumDividendThresholdPerQuarter_829255b3-b2ca-44e9-ad49-3759beb7006f_terseLabel_en-US" xlink:label="lab_iff_CommonStockDividendsPerShareMaximumDividendThresholdPerQuarter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum dividend threshold per quarter</link:label>
    <link:label id="lab_iff_CommonStockDividendsPerShareMaximumDividendThresholdPerQuarter_label_en-US" xlink:label="lab_iff_CommonStockDividendsPerShareMaximumDividendThresholdPerQuarter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends Per Share, Maximum Dividend Threshold Per Quarter</link:label>
    <link:label id="lab_iff_CommonStockDividendsPerShareMaximumDividendThresholdPerQuarter_documentation_en-US" xlink:label="lab_iff_CommonStockDividendsPerShareMaximumDividendThresholdPerQuarter" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends Per Share, Maximum Dividend Threshold Per Quarter</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_CommonStockDividendsPerShareMaximumDividendThresholdPerQuarter" xlink:href="iff-20231231.xsd#iff_CommonStockDividendsPerShareMaximumDividendThresholdPerQuarter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_CommonStockDividendsPerShareMaximumDividendThresholdPerQuarter" xlink:to="lab_iff_CommonStockDividendsPerShareMaximumDividendThresholdPerQuarter" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_FiscalQuarterEndingSeptember302024Member_f1f5ef72-0308-4fd8-97f3-86313450c699_terseLabel_en-US" xlink:label="lab_iff_FiscalQuarterEndingSeptember302024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Quarter Ending September 30, 2024</link:label>
    <link:label id="lab_iff_FiscalQuarterEndingSeptember302024Member_label_en-US" xlink:label="lab_iff_FiscalQuarterEndingSeptember302024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Quarter Ending September 30, 2024 [Member]</link:label>
    <link:label id="lab_iff_FiscalQuarterEndingSeptember302024Member_documentation_en-US" xlink:label="lab_iff_FiscalQuarterEndingSeptember302024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Quarter Ending September 30, 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FiscalQuarterEndingSeptember302024Member" xlink:href="iff-20231231.xsd#iff_FiscalQuarterEndingSeptember302024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_FiscalQuarterEndingSeptember302024Member" xlink:to="lab_iff_FiscalQuarterEndingSeptember302024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_314539cd-3b2b-4c4a-bb5e-7e1ed8ce0e88_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing lease, less than 1 year</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_41846639-490d-4434-9fa9-5a742aba4d2e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average&#160;Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_4b1e5a49-83d2-4c00-9c6d-56e9573b8906_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_c4accf28-a1c7-4961-a90b-6a9ca0f88d85_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total AOCI (before tax effects)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_6f042d0f-5233-4691-b4f5-2469d1b18fdf_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_29e6802e-9e3b-46d2-a584-107005fd601a_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_7cdb4903-a150-49da-9d31-4d45ba9a920f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit and net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_7b8fd4c6-7739-4f1c-a503-dfa4a86b195f_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest and penalties</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_6faba939-1d58-48bb-887e-158c86c8819f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable NCI</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_380995a0-cf6e-4625-9e23-f632c303bc28_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_3efa3c8f-5bbf-4586-88da-51a2084e703a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_2e911f5e-e436-4a9d-85f9-063034fb0829_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DisposalGroupNotDiscontinuedOperationTaxEffectOfGainLossFromDivestiture_6128b9b6-96a2-482b-a7d2-bd9dba5fe535_terseLabel_en-US" xlink:label="lab_iff_DisposalGroupNotDiscontinuedOperationTaxEffectOfGainLossFromDivestiture" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax effect of gain (loss) on divestiture</link:label>
    <link:label id="lab_iff_DisposalGroupNotDiscontinuedOperationTaxEffectOfGainLossFromDivestiture_label_en-US" xlink:label="lab_iff_DisposalGroupNotDiscontinuedOperationTaxEffectOfGainLossFromDivestiture" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Tax Effect Of Gain (Loss) From Divestiture</link:label>
    <link:label id="lab_iff_DisposalGroupNotDiscontinuedOperationTaxEffectOfGainLossFromDivestiture_documentation_en-US" xlink:label="lab_iff_DisposalGroupNotDiscontinuedOperationTaxEffectOfGainLossFromDivestiture" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Tax Effect Of Gain (Loss) From Divestiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupNotDiscontinuedOperationTaxEffectOfGainLossFromDivestiture" xlink:href="iff-20231231.xsd#iff_DisposalGroupNotDiscontinuedOperationTaxEffectOfGainLossFromDivestiture"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DisposalGroupNotDiscontinuedOperationTaxEffectOfGainLossFromDivestiture" xlink:to="lab_iff_DisposalGroupNotDiscontinuedOperationTaxEffectOfGainLossFromDivestiture" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_090db62e-55c4-4583-aaa4-e3ddfbb14032_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_TasteMember_5a1fc6a4-b26e-450a-b5a0-77614197d816_terseLabel_en-US" xlink:label="lab_iff_TasteMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taste [Member]</link:label>
    <link:label id="lab_iff_TasteMember_label_en-US" xlink:label="lab_iff_TasteMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taste [Member]</link:label>
    <link:label id="lab_iff_TasteMember_documentation_en-US" xlink:label="lab_iff_TasteMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taste [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TasteMember" xlink:href="iff-20231231.xsd#iff_TasteMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_TasteMember" xlink:to="lab_iff_TasteMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_a5e84170-134e-4fdd-a078-3d9147fa90c2_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:to="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_d60df5d4-aefe-495d-ac42-02d9f85641e5_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_6ef7dca2-6c16-4ce3-9db1-4513a60c7d80_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_061be19f-2b7b-4a1e-86bb-7cc065146b64_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movements in Restructuring and Related Accruals</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DeferredTaxLiabilitiesRightOfUseAssets_ea901d01-c185-440a-94ea-ce24b6054918_negatedTerseLabel_en-US" xlink:label="lab_iff_DeferredTaxLiabilitiesRightOfUseAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Right of Use Assets</link:label>
    <link:label id="lab_iff_DeferredTaxLiabilitiesRightOfUseAssets_label_en-US" xlink:label="lab_iff_DeferredTaxLiabilitiesRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Right-of-Use Assets</link:label>
    <link:label id="lab_iff_DeferredTaxLiabilitiesRightOfUseAssets_documentation_en-US" xlink:label="lab_iff_DeferredTaxLiabilitiesRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Right-of-Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DeferredTaxLiabilitiesRightOfUseAssets" xlink:href="iff-20231231.xsd#iff_DeferredTaxLiabilitiesRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DeferredTaxLiabilitiesRightOfUseAssets" xlink:to="lab_iff_DeferredTaxLiabilitiesRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionTableTextBlock_2bb7b031-0319-4ec6-90e4-80aa29fb82cd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Redemption</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Redemption [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionTableTextBlock" xlink:to="lab_us-gaap_DebtInstrumentRedemptionTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_63ade5e7-bd38-482b-a370-cd7635865989_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liabilities(3)</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_EmergingMarketsMember_03521031-76bb-4663-b164-7471048f6c47_terseLabel_en-US" xlink:label="lab_iff_EmergingMarketsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Markets</link:label>
    <link:label id="lab_iff_EmergingMarketsMember_label_en-US" xlink:label="lab_iff_EmergingMarketsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Markets [Member]</link:label>
    <link:label id="lab_iff_EmergingMarketsMember_documentation_en-US" xlink:label="lab_iff_EmergingMarketsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Markets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EmergingMarketsMember" xlink:href="iff-20231231.xsd#iff_EmergingMarketsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_EmergingMarketsMember" xlink:to="lab_iff_EmergingMarketsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_UnrecognizedTaxBenefitsOtherCurrentLiabilitiesMember_59914a25-eb25-4b57-b8d2-789114806dc8_terseLabel_en-US" xlink:label="lab_iff_UnrecognizedTaxBenefitsOtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:label id="lab_iff_UnrecognizedTaxBenefitsOtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_iff_UnrecognizedTaxBenefitsOtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Other Current Liabilities [Member]</link:label>
    <link:label id="lab_iff_UnrecognizedTaxBenefitsOtherCurrentLiabilitiesMember_documentation_en-US" xlink:label="lab_iff_UnrecognizedTaxBenefitsOtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits, other current liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_UnrecognizedTaxBenefitsOtherCurrentLiabilitiesMember" xlink:href="iff-20231231.xsd#iff_UnrecognizedTaxBenefitsOtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_UnrecognizedTaxBenefitsOtherCurrentLiabilitiesMember" xlink:to="lab_iff_UnrecognizedTaxBenefitsOtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_0d45e19a-5619-4167-a6cc-21e2155179e1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unaudited pro forma net income attributable to the Company</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableCurrent_51d6b9b8-f592-46d2-a6bf-f682f8fd2b43_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends payable</link:label>
    <link:label id="lab_us-gaap_DividendsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableCurrent" xlink:to="lab_us-gaap_DividendsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_8b7ef4fd-2e4e-40c2-86c9-e8711006fedc_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_a55d037d-55d0-424e-9ed4-c755873d0628_totalLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTaxStatusAxis_bd549477-293d-49ac-a659-8ea8d14f0910_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTaxStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Tax Status [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTaxStatusAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTaxStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Tax Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTaxStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTaxStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTaxStatusAxis" xlink:to="lab_us-gaap_RetirementPlanTaxStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_6e1fd1d2-6455-4708-ad50-86974af896bc_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_TangibleEquityUnitsPriceforSharesBasic_862e3fd6-1b12-4d51-bcc3-def8d326f40e_terseLabel_en-US" xlink:label="lab_iff_TangibleEquityUnitsPriceforSharesBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Price for basic share (in dollars per share)</link:label>
    <link:label id="lab_iff_TangibleEquityUnitsPriceforSharesBasic_label_en-US" xlink:label="lab_iff_TangibleEquityUnitsPriceforSharesBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Equity Units, Price for Shares Basic</link:label>
    <link:label id="lab_iff_TangibleEquityUnitsPriceforSharesBasic_documentation_en-US" xlink:label="lab_iff_TangibleEquityUnitsPriceforSharesBasic" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Equity Units, Price for Shares Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityUnitsPriceforSharesBasic" xlink:href="iff-20231231.xsd#iff_TangibleEquityUnitsPriceforSharesBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_TangibleEquityUnitsPriceforSharesBasic" xlink:to="lab_iff_TangibleEquityUnitsPriceforSharesBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsChangeDueToPerformanceConditions_15276196-389d-4dd4-a577-bf59772f2bfc_negatedTerseLabel_en-US" xlink:label="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsChangeDueToPerformanceConditions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change due to performance conditions, net (in shares)</link:label>
    <link:label id="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsChangeDueToPerformanceConditions_label_en-US" xlink:label="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsChangeDueToPerformanceConditions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Change Due To Performance Conditions</link:label>
    <link:label id="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsChangeDueToPerformanceConditions_documentation_en-US" xlink:label="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsChangeDueToPerformanceConditions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Change Due To Performance Conditions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsChangeDueToPerformanceConditions" xlink:href="iff-20231231.xsd#iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsChangeDueToPerformanceConditions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsChangeDueToPerformanceConditions" xlink:to="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsChangeDueToPerformanceConditions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_c1422b57-677b-4e41-ac53-3dedfb5b9cb0_netLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net defined benefit plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_e0b135b2-ff51-4b42-8ca9-388f7c2749bb_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Overfunded pension plans</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_dcf223fa-af84-4595-829d-d72cad7d4c80_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets for Plan Benefits, Defined Benefit Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:to="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_1254a83d-793b-4f48-b16d-032e6bbdb313_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:to="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax_b016752b-694a-48df-835a-e8f461a19d40_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognized prior service credit</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_6dc34583-59c2-48ef-b026-d212e8e741ff_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount_0d611533-f033-4a2b-a9d4-4900c7e9c57f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, long-term and short-term, combined</link:label>
    <link:label id="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount_label_en-US" xlink:label="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Long-Term and Short-Term, Combined Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:to="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_1aa79c12-0583-4041-9c63-49326736f139_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_7cc55ea7-fcbd-4661-8145-4d8cd6f785cc_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetDollarValueOfAwardIsConvertedToNumberOfNotionalSharesWhenAwardIsGranted_5277db5d-ad46-42b9-a8ac-f813dfef5e5b_terseLabel_en-US" xlink:label="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetDollarValueOfAwardIsConvertedToNumberOfNotionalSharesWhenAwardIsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of target dollar value of the award converted to a number of notional shares</link:label>
    <link:label id="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetDollarValueOfAwardIsConvertedToNumberOfNotionalSharesWhenAwardIsGranted_label_en-US" xlink:label="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetDollarValueOfAwardIsConvertedToNumberOfNotionalSharesWhenAwardIsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award, Percentage Of Target Dollar Value Of Award Is Converted To Number Of Notional Shares When Award Is Granted</link:label>
    <link:label id="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetDollarValueOfAwardIsConvertedToNumberOfNotionalSharesWhenAwardIsGranted_documentation_en-US" xlink:label="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetDollarValueOfAwardIsConvertedToNumberOfNotionalSharesWhenAwardIsGranted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation arrangement by share-based payment award, percentage of target dollar value of the award is converted to a number of notional shares when award is granted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetDollarValueOfAwardIsConvertedToNumberOfNotionalSharesWhenAwardIsGranted" xlink:href="iff-20231231.xsd#iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetDollarValueOfAwardIsConvertedToNumberOfNotionalSharesWhenAwardIsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetDollarValueOfAwardIsConvertedToNumberOfNotionalSharesWhenAwardIsGranted" xlink:to="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetDollarValueOfAwardIsConvertedToNumberOfNotionalSharesWhenAwardIsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandMember_3f80dfd1-5e78-49d9-b446-1209891e5f95_terseLabel_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land [Member]</link:label>
    <link:label id="lab_us-gaap_LandMember_label_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LandMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandMember" xlink:to="lab_us-gaap_LandMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectOfOnePercentagePointChangeInAssumedHealthCareCostTrendRatesTableTextBlock_b4cbf7b9-100f-4dac-9d66-20d80d918530_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectOfOnePercentagePointChangeInAssumedHealthCareCostTrendRatesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity of Disclosures to Changes in Selected Assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectOfOnePercentagePointChangeInAssumedHealthCareCostTrendRatesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectOfOnePercentagePointChangeInAssumedHealthCareCostTrendRatesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effect of One-Percentage-Point Change in Assumed Health Care Cost Trend Rates [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectOfOnePercentagePointChangeInAssumedHealthCareCostTrendRatesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectOfOnePercentagePointChangeInAssumedHealthCareCostTrendRatesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectOfOnePercentagePointChangeInAssumedHealthCareCostTrendRatesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectOfOnePercentagePointChangeInAssumedHealthCareCostTrendRatesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_ZhejiangChinaMember_4c9a7126-1d28-4df7-91f6-edca38219b02_terseLabel_en-US" xlink:label="lab_iff_ZhejiangChinaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zhejiang, China [Member]</link:label>
    <link:label id="lab_iff_ZhejiangChinaMember_label_en-US" xlink:label="lab_iff_ZhejiangChinaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zhejiang, China [Member]</link:label>
    <link:label id="lab_iff_ZhejiangChinaMember_documentation_en-US" xlink:label="lab_iff_ZhejiangChinaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zhejiang, China [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ZhejiangChinaMember" xlink:href="iff-20231231.xsd#iff_ZhejiangChinaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_ZhejiangChinaMember" xlink:to="lab_iff_ZhejiangChinaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_PledgedAssetsMember_36c65b5a-c5f4-4ffb-868b-9620473572eb_terseLabel_en-US" xlink:label="lab_iff_PledgedAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pledged assets [Member]</link:label>
    <link:label id="lab_iff_PledgedAssetsMember_label_en-US" xlink:label="lab_iff_PledgedAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pledged Assets [Member]</link:label>
    <link:label id="lab_iff_PledgedAssetsMember_documentation_en-US" xlink:label="lab_iff_PledgedAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pledged Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_PledgedAssetsMember" xlink:href="iff-20231231.xsd#iff_PledgedAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_PledgedAssetsMember" xlink:to="lab_iff_PledgedAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_677cad97-0d8b-4903-a3cc-eaf5f4821799_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_d0a90aad-2ac1-4db8-9404-b1f1eda648c5_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Divestiture</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_d893be42-21e9-4604-b89d-7719e56991a0_verboseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets and Liabilities Held For Sale</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_BusinessCombinationInventoryStepUpCosts_81269527-c075-4c87-95a6-3123e1547fbb_negatedTerseLabel_en-US" xlink:label="lab_iff_BusinessCombinationInventoryStepUpCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Inventory Step-Up Costs</link:label>
    <link:label id="lab_iff_BusinessCombinationInventoryStepUpCosts_label_en-US" xlink:label="lab_iff_BusinessCombinationInventoryStepUpCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Inventory Step-Up Costs</link:label>
    <link:label id="lab_iff_BusinessCombinationInventoryStepUpCosts_documentation_en-US" xlink:label="lab_iff_BusinessCombinationInventoryStepUpCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Inventory Step-Up Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BusinessCombinationInventoryStepUpCosts" xlink:href="iff-20231231.xsd#iff_BusinessCombinationInventoryStepUpCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_BusinessCombinationInventoryStepUpCosts" xlink:to="lab_iff_BusinessCombinationInventoryStepUpCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_SeniorNotesDueTwoThousandTwentyFiveMember_57417ad4-39a5-4391-8f23-a9eab4946bb5_terseLabel_en-US" xlink:label="lab_iff_SeniorNotesDueTwoThousandTwentyFiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, Due Two Thousand Twenty Five</link:label>
    <link:label id="lab_iff_SeniorNotesDueTwoThousandTwentyFiveMember_label_en-US" xlink:label="lab_iff_SeniorNotesDueTwoThousandTwentyFiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, Due Two Thousand Twenty Five [Member]</link:label>
    <link:label id="lab_iff_SeniorNotesDueTwoThousandTwentyFiveMember_documentation_en-US" xlink:label="lab_iff_SeniorNotesDueTwoThousandTwentyFiveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, Due Two Thousand Twenty Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandTwentyFiveMember" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandTwentyFiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_SeniorNotesDueTwoThousandTwentyFiveMember" xlink:to="lab_iff_SeniorNotesDueTwoThousandTwentyFiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestReceivable_0467229c-e8a2-4d3a-b04d-592b04af1e57_terseLabel_en-US" xlink:label="lab_us-gaap_InterestReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Receivable</link:label>
    <link:label id="lab_us-gaap_InterestReceivable_label_en-US" xlink:label="lab_us-gaap_InterestReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestReceivable" xlink:to="lab_us-gaap_InterestReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeMember_a55f37ab-a103-4f58-b05d-03e023171eb7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeMember_label_en-US" xlink:label="lab_us-gaap_DerivativeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeMember" xlink:to="lab_us-gaap_DerivativeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_26bea632-430f-4215-b14f-c77f7774910e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_TangibleEquityUnitsAllocationDomain_edbc6568-1bc1-491e-9330-8313c918bf93_terseLabel_en-US" xlink:label="lab_iff_TangibleEquityUnitsAllocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Equity Units, Allocation [Domain]</link:label>
    <link:label id="lab_iff_TangibleEquityUnitsAllocationDomain_label_en-US" xlink:label="lab_iff_TangibleEquityUnitsAllocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Equity Units, Allocation [Domain]</link:label>
    <link:label id="lab_iff_TangibleEquityUnitsAllocationDomain_documentation_en-US" xlink:label="lab_iff_TangibleEquityUnitsAllocationDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Tangible Equity Units, Allocation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityUnitsAllocationDomain" xlink:href="iff-20231231.xsd#iff_TangibleEquityUnitsAllocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_TangibleEquityUnitsAllocationDomain" xlink:to="lab_iff_TangibleEquityUnitsAllocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressesAddressTypeAxis_416c6f1b-65d8-4911-ad22-b723ec105acc_terseLabel_en-US" xlink:label="lab_dei_EntityAddressesAddressTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Addresses, Address Type [Axis]</link:label>
    <link:label id="lab_dei_EntityAddressesAddressTypeAxis_label_en-US" xlink:label="lab_dei_EntityAddressesAddressTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Addresses, Address Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressesAddressTypeAxis" xlink:to="lab_dei_EntityAddressesAddressTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnAmt" xlink:to="lab_ecd_TotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_0461dc3f-a3f4-4c84-b642-6d6c2a6e5dd0_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_070c0199-4f5f-42b7-a384-d548ad29c16c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_ef6e00a3-32ec-4b33-b4e7-3dfe26cde7b2_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToPeoCompFnTextBlock" xlink:to="lab_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_0ff58be0-ee11-47bf-8e84-6edb69683867_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FixedIncomeFundsMember_27ac03ee-6fca-47c7-8390-1b1b273cca55_terseLabel_en-US" xlink:label="lab_us-gaap_FixedIncomeFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Income Funds</link:label>
    <link:label id="lab_us-gaap_FixedIncomeFundsMember_label_en-US" xlink:label="lab_us-gaap_FixedIncomeFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Income Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FixedIncomeFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FixedIncomeFundsMember" xlink:to="lab_us-gaap_FixedIncomeFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_a286e944-76a7-40b2-93b1-ee9dfcba7263_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax effect of pension liability and postretirement adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_11495263-2125-4d03-9ed5-7680601911a1_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_IncomeTaxesLineItems_dd8884a4-3032-49d8-b49b-47a9016807b0_terseLabel_en-US" xlink:label="lab_iff_IncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Line Items]</link:label>
    <link:label id="lab_iff_IncomeTaxesLineItems_label_en-US" xlink:label="lab_iff_IncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Line Items]</link:label>
    <link:label id="lab_iff_IncomeTaxesLineItems_documentation_en-US" xlink:label="lab_iff_IncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_IncomeTaxesLineItems" xlink:href="iff-20231231.xsd#iff_IncomeTaxesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_IncomeTaxesLineItems" xlink:to="lab_iff_IncomeTaxesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_83540746-22a5-443d-aa99-6e6779ebdda1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis_65cff511-f79a-40be-90df-47f635e5489f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Postretirement Benefits, Type of Deferred Compensation [Axis]</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits, Individual Contracts, Type of Deferred Compensation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis" xlink:to="lab_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_a734a6de-ad8a-4ad6-a24b-9662f2836bdf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other (Expense) Income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Nonoperating Income (Expense) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_6ee8c309-7a0a-491d-9719-5b6bb95cedb8_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_8530eab8-280a-4021-9519-a9f007381a0a_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Accumulated deficit) retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_afe0de5c-1d46-4c28-abf3-75b628350be8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_a097cfa7-cf84-4431-ae47-971192854cc7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenDilutedNetIncomeLossPerShare_e50dfb0a-73c8-414e-866d-399fd241ba93_terseLabel_en-US" xlink:label="lab_iff_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenDilutedNetIncomeLossPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participating Securities, Distributed And Undistributed Earnings (Loss), Difference Between Diluted Net Income (Loss) Per Share</link:label>
    <link:label id="lab_iff_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenDilutedNetIncomeLossPerShare_label_en-US" xlink:label="lab_iff_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenDilutedNetIncomeLossPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participating Securities, Distributed And Undistributed Earnings (Loss), Difference Between Diluted Net Income (Loss) Per Share</link:label>
    <link:label id="lab_iff_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenDilutedNetIncomeLossPerShare_documentation_en-US" xlink:label="lab_iff_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenDilutedNetIncomeLossPerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participating Securities, Distributed And Undistributed Earnings (Loss), Difference Between Diluted Net Income (Loss) Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenDilutedNetIncomeLossPerShare" xlink:href="iff-20231231.xsd#iff_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenDilutedNetIncomeLossPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenDilutedNetIncomeLossPerShare" xlink:to="lab_iff_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenDilutedNetIncomeLossPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_b74142d6-5444-4ca7-9fa4-d954045a01ba_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_5cb1e7f8-497f-4512-abff-8b66b1f3b17a_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_85023c75-6d93-4321-b5f3-c5eab774c479_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_SeniorNotesDueTwoThousandFortySevenMember_4f45b246-ff7f-4719-85e2-4e1102f9fa94_terseLabel_en-US" xlink:label="lab_iff_SeniorNotesDueTwoThousandFortySevenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes - 2047</link:label>
    <link:label id="lab_iff_SeniorNotesDueTwoThousandFortySevenMember_label_en-US" xlink:label="lab_iff_SeniorNotesDueTwoThousandFortySevenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, Due Two Thousand Forty Seven [Member]</link:label>
    <link:label id="lab_iff_SeniorNotesDueTwoThousandFortySevenMember_documentation_en-US" xlink:label="lab_iff_SeniorNotesDueTwoThousandFortySevenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, Due Two Thousand Forty Seven [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandFortySevenMember" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandFortySevenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_SeniorNotesDueTwoThousandFortySevenMember" xlink:to="lab_iff_SeniorNotesDueTwoThousandFortySevenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_FragranceIngredientsMember_46d8d78f-df4e-4642-8853-089475a290c7_terseLabel_en-US" xlink:label="lab_iff_FragranceIngredientsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fragrance Ingredients [Member]</link:label>
    <link:label id="lab_iff_FragranceIngredientsMember_label_en-US" xlink:label="lab_iff_FragranceIngredientsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fragrance Ingredients [Member]</link:label>
    <link:label id="lab_iff_FragranceIngredientsMember_documentation_en-US" xlink:label="lab_iff_FragranceIngredientsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fragrance Ingredients [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FragranceIngredientsMember" xlink:href="iff-20231231.xsd#iff_FragranceIngredientsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_FragranceIngredientsMember" xlink:to="lab_iff_FragranceIngredientsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_addcbba9-eaa9-4dda-84f5-8fc34d3e8794_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_bb346228-7ae1-4f6b-b7e2-8241ea3fc060_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_8d0469f6-ff9e-4b6f-b7e7-4d9816904eb4_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due, Total</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillTransfers_af579e0e-c734-4297-a249-cc042b2f074d_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillTransfers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transferred to assets held for sale(3)</link:label>
    <link:label id="lab_us-gaap_GoodwillTransfers_label_en-US" xlink:label="lab_us-gaap_GoodwillTransfers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Transfers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTransfers" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillTransfers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillTransfers" xlink:to="lab_us-gaap_GoodwillTransfers" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_BusinessAcquisitionNetIncomeLoss_5dabcd98-9451-4140-8daf-d1f06e7f4177_terseLabel_en-US" xlink:label="lab_iff_BusinessAcquisitionNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Net Income (Loss)</link:label>
    <link:label id="lab_iff_BusinessAcquisitionNetIncomeLoss_label_en-US" xlink:label="lab_iff_BusinessAcquisitionNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Net Income (Loss)</link:label>
    <link:label id="lab_iff_BusinessAcquisitionNetIncomeLoss_documentation_en-US" xlink:label="lab_iff_BusinessAcquisitionNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BusinessAcquisitionNetIncomeLoss" xlink:href="iff-20231231.xsd#iff_BusinessAcquisitionNetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_BusinessAcquisitionNetIncomeLoss" xlink:to="lab_iff_BusinessAcquisitionNetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0c691057-c15d-47e5-9da6-1b10ac345e80_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_TangibleEquityUnitsFinalSettlementRate_e6ca6425-1219-4222-9e9e-d6f717cd170b_terseLabel_en-US" xlink:label="lab_iff_TangibleEquityUnitsFinalSettlementRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Equity Units Final Settlement Rate</link:label>
    <link:label id="lab_iff_TangibleEquityUnitsFinalSettlementRate_label_en-US" xlink:label="lab_iff_TangibleEquityUnitsFinalSettlementRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Equity Units Final Settlement Rate</link:label>
    <link:label id="lab_iff_TangibleEquityUnitsFinalSettlementRate_documentation_en-US" xlink:label="lab_iff_TangibleEquityUnitsFinalSettlementRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Equity Units Final Settlement Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityUnitsFinalSettlementRate" xlink:href="iff-20231231.xsd#iff_TangibleEquityUnitsFinalSettlementRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_TangibleEquityUnitsFinalSettlementRate" xlink:to="lab_iff_TangibleEquityUnitsFinalSettlementRate" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_RepaymentsOfCommercialPaperMaturingInMoreThanThreeMonths_83aa9f12-a8ef-4a44-aa81-a70082037f40_negatedTerseLabel_en-US" xlink:label="lab_iff_RepaymentsOfCommercialPaperMaturingInMoreThanThreeMonths" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of commercial paper (maturities after three months)</link:label>
    <link:label id="lab_iff_RepaymentsOfCommercialPaperMaturingInMoreThanThreeMonths_label_en-US" xlink:label="lab_iff_RepaymentsOfCommercialPaperMaturingInMoreThanThreeMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments Of Commercial Paper, Maturing In More Than Three Months</link:label>
    <link:label id="lab_iff_RepaymentsOfCommercialPaperMaturingInMoreThanThreeMonths_documentation_en-US" xlink:label="lab_iff_RepaymentsOfCommercialPaperMaturingInMoreThanThreeMonths" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments Of Commercial Paper, Maturing In More Than Three Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_RepaymentsOfCommercialPaperMaturingInMoreThanThreeMonths" xlink:href="iff-20231231.xsd#iff_RepaymentsOfCommercialPaperMaturingInMoreThanThreeMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_RepaymentsOfCommercialPaperMaturingInMoreThanThreeMonths" xlink:to="lab_iff_RepaymentsOfCommercialPaperMaturingInMoreThanThreeMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_ShareholderActivismRelatedCosts_6d372e50-ab8d-4a0c-b86c-5168e5c80761_negatedTerseLabel_en-US" xlink:label="lab_iff_ShareholderActivismRelatedCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholder Activism Related Costs</link:label>
    <link:label id="lab_iff_ShareholderActivismRelatedCosts_label_en-US" xlink:label="lab_iff_ShareholderActivismRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholder Activism Related Costs</link:label>
    <link:label id="lab_iff_ShareholderActivismRelatedCosts_documentation_en-US" xlink:label="lab_iff_ShareholderActivismRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholder Activism Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareholderActivismRelatedCosts" xlink:href="iff-20231231.xsd#iff_ShareholderActivismRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_ShareholderActivismRelatedCosts" xlink:to="lab_iff_ShareholderActivismRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestChangeInRedemptionValue_49875025-c6d5-48d4-bc9d-a01869097c38_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption value adjustment for the current period</link:label>
    <link:label id="lab_us-gaap_MinorityInterestChangeInRedemptionValue_label_en-US" xlink:label="lab_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Change in Redemption Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestChangeInRedemptionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:to="lab_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ea9b62a5-4d71-4743-88a7-fad75ae33883_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_05462513-dda5-4ce2-9fc8-73a024abb49f_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share - basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DeferredTaxAssetsInterestLimitations_beaca98d-a979-43bf-aa03-121503221dca_terseLabel_en-US" xlink:label="lab_iff_DeferredTaxAssetsInterestLimitations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest limitation</link:label>
    <link:label id="lab_iff_DeferredTaxAssetsInterestLimitations_label_en-US" xlink:label="lab_iff_DeferredTaxAssetsInterestLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Interest Limitations</link:label>
    <link:label id="lab_iff_DeferredTaxAssetsInterestLimitations_documentation_en-US" xlink:label="lab_iff_DeferredTaxAssetsInterestLimitations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Interest Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DeferredTaxAssetsInterestLimitations" xlink:href="iff-20231231.xsd#iff_DeferredTaxAssetsInterestLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DeferredTaxAssetsInterestLimitations" xlink:to="lab_iff_DeferredTaxAssetsInterestLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionTable_d6acf696-787a-4190-ad48-2f8032e788c0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Redemption [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Redemption [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionTable" xlink:to="lab_us-gaap_DebtInstrumentRedemptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_HangzhouChinaMember_d83c148f-1317-454a-966a-949d575b04ec_terseLabel_en-US" xlink:label="lab_iff_HangzhouChinaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hangzhou, China [Member]</link:label>
    <link:label id="lab_iff_HangzhouChinaMember_label_en-US" xlink:label="lab_iff_HangzhouChinaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hangzhou, China [Member]</link:label>
    <link:label id="lab_iff_HangzhouChinaMember_documentation_en-US" xlink:label="lab_iff_HangzhouChinaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hangzhou, China [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_HangzhouChinaMember" xlink:href="iff-20231231.xsd#iff_HangzhouChinaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_HangzhouChinaMember" xlink:to="lab_iff_HangzhouChinaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMember_6494f6cb-2cda-4eab-8e38-41ffbf34d06b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMember" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_560dff74-6344-432f-aaa0-f89b4cbd6096_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Percentage of Ownership after Transaction</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Percentage of Ownership after Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:to="lab_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_RedeemableNoncontrollingInterestMember_53bb47b3-0a44-4609-aaa6-9505cf2eb498_terseLabel_en-US" xlink:label="lab_iff_RedeemableNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest</link:label>
    <link:label id="lab_iff_RedeemableNoncontrollingInterestMember_label_en-US" xlink:label="lab_iff_RedeemableNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest [Member]</link:label>
    <link:label id="lab_iff_RedeemableNoncontrollingInterestMember_documentation_en-US" xlink:label="lab_iff_RedeemableNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_RedeemableNoncontrollingInterestMember" xlink:href="iff-20231231.xsd#iff_RedeemableNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_RedeemableNoncontrollingInterestMember" xlink:to="lab_iff_RedeemableNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_05af439d-a38a-4533-9c37-d3f8662bf87d_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_dd417a52-ff7b-4863-9e90-3b7f18d195ad_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_StockPurchaseContractMember_ea62754b-6d51-45fa-8fbe-f250b8afb4d8_terseLabel_en-US" xlink:label="lab_iff_StockPurchaseContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SPC</link:label>
    <link:label id="lab_iff_StockPurchaseContractMember_label_en-US" xlink:label="lab_iff_StockPurchaseContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Purchase Contract [Member]</link:label>
    <link:label id="lab_iff_StockPurchaseContractMember_documentation_en-US" xlink:label="lab_iff_StockPurchaseContractMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Purchase Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_StockPurchaseContractMember" xlink:href="iff-20231231.xsd#iff_StockPurchaseContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_StockPurchaseContractMember" xlink:to="lab_iff_StockPurchaseContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_1ac2a487-bf06-497b-828e-5edd7a266764_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Fair Value, Derivative Assets</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_ce79bf37-2924-4238-8aed-84154187b1e5_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total fair value, derivative assets</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_OtherCountriesMember_9ad53cd8-e32e-4d63-9fc3-5930ba1c176d_terseLabel_en-US" xlink:label="lab_iff_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Countries [Member]</link:label>
    <link:label id="lab_iff_OtherCountriesMember_label_en-US" xlink:label="lab_iff_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Countries [Member]</link:label>
    <link:label id="lab_iff_OtherCountriesMember_documentation_en-US" xlink:label="lab_iff_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Countries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_OtherCountriesMember" xlink:href="iff-20231231.xsd#iff_OtherCountriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_OtherCountriesMember" xlink:to="lab_iff_OtherCountriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_SharebasedCompensationSharesAuthorizedunderStockOptionPlansExercisePriceRangeExercisableOptionsUpperRangeLimit_511b57e1-9317-4636-82ba-37fcdeac453b_terseLabel_en-US" xlink:label="lab_iff_SharebasedCompensationSharesAuthorizedunderStockOptionPlansExercisePriceRangeExercisableOptionsUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable options, upper range limit</link:label>
    <link:label id="lab_iff_SharebasedCompensationSharesAuthorizedunderStockOptionPlansExercisePriceRangeExercisableOptionsUpperRangeLimit_label_en-US" xlink:label="lab_iff_SharebasedCompensationSharesAuthorizedunderStockOptionPlansExercisePriceRangeExercisableOptionsUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Upper Range Limit</link:label>
    <link:label id="lab_iff_SharebasedCompensationSharesAuthorizedunderStockOptionPlansExercisePriceRangeExercisableOptionsUpperRangeLimit_documentation_en-US" xlink:label="lab_iff_SharebasedCompensationSharesAuthorizedunderStockOptionPlansExercisePriceRangeExercisableOptionsUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Upper Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SharebasedCompensationSharesAuthorizedunderStockOptionPlansExercisePriceRangeExercisableOptionsUpperRangeLimit" xlink:href="iff-20231231.xsd#iff_SharebasedCompensationSharesAuthorizedunderStockOptionPlansExercisePriceRangeExercisableOptionsUpperRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_SharebasedCompensationSharesAuthorizedunderStockOptionPlansExercisePriceRangeExercisableOptionsUpperRangeLimit" xlink:to="lab_iff_SharebasedCompensationSharesAuthorizedunderStockOptionPlansExercisePriceRangeExercisableOptionsUpperRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_eb2c3404-1322-4123-b0b1-ae0e30b0f6a6_verboseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_fa9b6a08-42df-47c9-a1ca-ba3bb11379af_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_dda68f70-dc80-43f2-947c-90b5a50f03ab_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_633bde66-56c1-489e-bd20-1f539b116dbd_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_6022afc7-03e0-4c3f-92db-e17c41ccff7c_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications of Accumulated Other Comprehensive Income to Consolidated Statement of Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_cd39a7d9-c741-46b1-bb8d-541183c98696_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_fc86bf49-f006-49bc-9b4b-f66460ee7f41_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income available to IFF common shareholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_10d9e931-2b72-4a2e-b611-e82f3636012d_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income available to IFF shareholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_851c16b1-042e-46ec-8603-015ecb0e9194_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7c85e4fa-529a-4c80-8722-8fc8fc361701_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares&#160;Subject&#160;to SSARs/Options</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_TangibleEquityUnitsStatedRate_3e341b6f-13a0-44ff-9409-ec8c96434860_terseLabel_en-US" xlink:label="lab_iff_TangibleEquityUnitsStatedRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stated rate</link:label>
    <link:label id="lab_iff_TangibleEquityUnitsStatedRate_label_en-US" xlink:label="lab_iff_TangibleEquityUnitsStatedRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Equity Units Stated Rate</link:label>
    <link:label id="lab_iff_TangibleEquityUnitsStatedRate_documentation_en-US" xlink:label="lab_iff_TangibleEquityUnitsStatedRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Equity Units Stated Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityUnitsStatedRate" xlink:href="iff-20231231.xsd#iff_TangibleEquityUnitsStatedRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_TangibleEquityUnitsStatedRate" xlink:to="lab_iff_TangibleEquityUnitsStatedRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits_e5b04f38-c541-4091-8805-02b7ba72e4c6_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee and retiree benefits</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Postretirement Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ebdbc8bb-85d0-4a07-bb24-170532424ea5_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_c6559202-8f2a-4512-8a82-233c852bf15c_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_31188540-6ce2-4353-8f18-ac0361c4afc0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_0694ac6c-86dd-479e-99ad-710c18154447_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFour_0c0e6bcb-059b-4f4c-b550-558939901dd1_terseLabel_en-US" xlink:label="lab_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:label id="lab_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFour_label_en-US" xlink:label="lab_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:label id="lab_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFour_documentation_en-US" xlink:label="lab_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFour" xlink:href="iff-20231231.xsd#iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFour" xlink:to="lab_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_2b3735f4-6c31-4b60-adcd-ad154f788be4_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total loss (gain) recognized in OCI (before tax effects)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_BusinessCombinationDivestituresAndIntegrationCosts_2f6e9dc2-59af-4b33-8592-8866a1647c2d_negatedTerseLabel_en-US" xlink:label="lab_iff_BusinessCombinationDivestituresAndIntegrationCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Divestitures And Integration Costs</link:label>
    <link:label id="lab_iff_BusinessCombinationDivestituresAndIntegrationCosts_label_en-US" xlink:label="lab_iff_BusinessCombinationDivestituresAndIntegrationCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Divestitures And Integration Costs</link:label>
    <link:label id="lab_iff_BusinessCombinationDivestituresAndIntegrationCosts_documentation_en-US" xlink:label="lab_iff_BusinessCombinationDivestituresAndIntegrationCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Divestitures And Integration Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BusinessCombinationDivestituresAndIntegrationCosts" xlink:href="iff-20231231.xsd#iff_BusinessCombinationDivestituresAndIntegrationCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_BusinessCombinationDivestituresAndIntegrationCosts" xlink:to="lab_iff_BusinessCombinationDivestituresAndIntegrationCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_FinanceLeaseLiabilityPaymentsDueYearTwoAndThree_45053fc0-8425-429e-95f9-056dce9341e6_terseLabel_en-US" xlink:label="lab_iff_FinanceLeaseLiabilityPaymentsDueYearTwoAndThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing lease, 1-3 years</link:label>
    <link:label id="lab_iff_FinanceLeaseLiabilityPaymentsDueYearTwoAndThree_label_en-US" xlink:label="lab_iff_FinanceLeaseLiabilityPaymentsDueYearTwoAndThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payments, Due Year Two And Three</link:label>
    <link:label id="lab_iff_FinanceLeaseLiabilityPaymentsDueYearTwoAndThree_documentation_en-US" xlink:label="lab_iff_FinanceLeaseLiabilityPaymentsDueYearTwoAndThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payments, Due Year Two And Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FinanceLeaseLiabilityPaymentsDueYearTwoAndThree" xlink:href="iff-20231231.xsd#iff_FinanceLeaseLiabilityPaymentsDueYearTwoAndThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_FinanceLeaseLiabilityPaymentsDueYearTwoAndThree" xlink:to="lab_iff_FinanceLeaseLiabilityPaymentsDueYearTwoAndThree" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_AccumulatedDefinedBenefitPlansAdjustmentOtherItemsAttributableToParentMember_eb516abf-40c9-4579-b3e2-0908e3d7f2af_terseLabel_en-US" xlink:label="lab_iff_AccumulatedDefinedBenefitPlansAdjustmentOtherItemsAttributableToParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other items</link:label>
    <link:label id="lab_iff_AccumulatedDefinedBenefitPlansAdjustmentOtherItemsAttributableToParentMember_label_en-US" xlink:label="lab_iff_AccumulatedDefinedBenefitPlansAdjustmentOtherItemsAttributableToParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Other Items Attributable To Parent [Member]</link:label>
    <link:label id="lab_iff_AccumulatedDefinedBenefitPlansAdjustmentOtherItemsAttributableToParentMember_documentation_en-US" xlink:label="lab_iff_AccumulatedDefinedBenefitPlansAdjustmentOtherItemsAttributableToParentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Other Items Attributable To Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AccumulatedDefinedBenefitPlansAdjustmentOtherItemsAttributableToParentMember" xlink:href="iff-20231231.xsd#iff_AccumulatedDefinedBenefitPlansAdjustmentOtherItemsAttributableToParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_AccumulatedDefinedBenefitPlansAdjustmentOtherItemsAttributableToParentMember" xlink:to="lab_iff_AccumulatedDefinedBenefitPlansAdjustmentOtherItemsAttributableToParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholder Return Vs Peer Group [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_f6408667-97c7-4d51-9315-b66aed67e019_totalLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_347759a5-e5ad-4154-aa97-1fa3cd52540d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingDomain_c2343d91-9da0-4f77-adf0-16b15d0e8568_terseLabel_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:label id="lab_us-gaap_VestingDomain_label_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingDomain" xlink:to="lab_us-gaap_VestingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f346bf0d-2d8c-42f4-9d10-d529d4624d6f_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d779a2d7-3c7b-4b9e-80c7-cd3994fe9f15_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_AggtErrCompAmt_label_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompAmt" xlink:to="lab_ecd_AggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_9ae6f7e1-5eb5-491e-b0e0-23daf77471cf_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions (deductions) charged to costs and expenses</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_TwoThousandTwentyOnePlanMember_aa654eaf-d5de-429d-beae-2fa625280008_terseLabel_en-US" xlink:label="lab_iff_TwoThousandTwentyOnePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Twenty-One Plan [Domain]</link:label>
    <link:label id="lab_iff_TwoThousandTwentyOnePlanMember_label_en-US" xlink:label="lab_iff_TwoThousandTwentyOnePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Twenty-One Plan [Member]</link:label>
    <link:label id="lab_iff_TwoThousandTwentyOnePlanMember_documentation_en-US" xlink:label="lab_iff_TwoThousandTwentyOnePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Twenty-One Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TwoThousandTwentyOnePlanMember" xlink:href="iff-20231231.xsd#iff_TwoThousandTwentyOnePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_TwoThousandTwentyOnePlanMember" xlink:to="lab_iff_TwoThousandTwentyOnePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_terseLabel_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Executive Categories</link:label>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_label_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Executive Categories [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="lab_ecd_AllExecutiveCategoriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBelowLowRange_ee1bfb49-9455-4b3c-bfe5-c9d04514c1b9_terseLabel_en-US" xlink:label="lab_iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBelowLowRange" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of matching contribution if compensation percentage below low range</link:label>
    <link:label id="lab_iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBelowLowRange_label_en-US" xlink:label="lab_iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBelowLowRange" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan Percentage Of Matching Contribution If Compensation Percentage Below Low Range</link:label>
    <link:label id="lab_iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBelowLowRange_documentation_en-US" xlink:label="lab_iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBelowLowRange" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined contribution plan, percentage of matching contribution if compensation percentage below low range</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBelowLowRange" xlink:href="iff-20231231.xsd#iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBelowLowRange"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBelowLowRange" xlink:to="lab_iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBelowLowRange" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_ReceivablesMember_3e1391bd-64fb-47b2-91f6-55b21ee844fa_terseLabel_en-US" xlink:label="lab_iff_ReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_iff_ReceivablesMember_label_en-US" xlink:label="lab_iff_ReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables [Member]</link:label>
    <link:label id="lab_iff_ReceivablesMember_documentation_en-US" xlink:label="lab_iff_ReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ReceivablesMember" xlink:href="iff-20231231.xsd#iff_ReceivablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_ReceivablesMember" xlink:to="lab_iff_ReceivablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_57cf0aba-abf3-4671-9945-b12a91894544_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_TangibleEquityRateSettlementRate_5af00741-4693-490c-a68e-4066869fd5ef_terseLabel_en-US" xlink:label="lab_iff_TangibleEquityRateSettlementRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Equity Rate, Settlement Rate</link:label>
    <link:label id="lab_iff_TangibleEquityRateSettlementRate_label_en-US" xlink:label="lab_iff_TangibleEquityRateSettlementRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Equity Rate, Settlement Rate</link:label>
    <link:label id="lab_iff_TangibleEquityRateSettlementRate_documentation_en-US" xlink:label="lab_iff_TangibleEquityRateSettlementRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Equity Rate, Settlement Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityRateSettlementRate" xlink:href="iff-20231231.xsd#iff_TangibleEquityRateSettlementRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_TangibleEquityRateSettlementRate" xlink:to="lab_iff_TangibleEquityRateSettlementRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_747c3cab-740b-455d-82c1-656fc3e99ab3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_EarnOutsPayableOther_b02f3aef-8447-43ba-932b-44e5a345fdc9_terseLabel_en-US" xlink:label="lab_iff_EarnOutsPayableOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earn Outs Payable, Current</link:label>
    <link:label id="lab_iff_EarnOutsPayableOther_label_en-US" xlink:label="lab_iff_EarnOutsPayableOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earn Outs Payable, Other</link:label>
    <link:label id="lab_iff_EarnOutsPayableOther_documentation_en-US" xlink:label="lab_iff_EarnOutsPayableOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earn Outs Payable, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EarnOutsPayableOther" xlink:href="iff-20231231.xsd#iff_EarnOutsPayableOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_EarnOutsPayableOther" xlink:to="lab_iff_EarnOutsPayableOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_551c5e6a-b1a1-4335-af6c-495e305e3572_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and Postretirement Liability Adjustment</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_036285f8-6775-49ab-9c13-234e3c6c8e0d_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Losses) gains on pension and postretirement liability adjustments</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_1b7a14a0-3486-4024-9383-68c957355541_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_807bfd52-7dcd-4d75-bd42-05413c7526b3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_cf0aede5-7fc6-4b5e-b6ed-61d77b4be1e7_negatedLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less tax benefit</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_RestructuringAndRelatedCostExpectedNumberOfSitesClosedPeriod_f42c5d11-523d-4ba2-abb8-dc6514627d6f_terseLabel_en-US" xlink:label="lab_iff_RestructuringAndRelatedCostExpectedNumberOfSitesClosedPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Number Of Sites Closed, Period</link:label>
    <link:label id="lab_iff_RestructuringAndRelatedCostExpectedNumberOfSitesClosedPeriod_label_en-US" xlink:label="lab_iff_RestructuringAndRelatedCostExpectedNumberOfSitesClosedPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring And Related Cost, Expected Number Of Sites Closed, Period</link:label>
    <link:label id="lab_iff_RestructuringAndRelatedCostExpectedNumberOfSitesClosedPeriod_documentation_en-US" xlink:label="lab_iff_RestructuringAndRelatedCostExpectedNumberOfSitesClosedPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring And Related Cost, Expected Number Of Sites Closed, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_RestructuringAndRelatedCostExpectedNumberOfSitesClosedPeriod" xlink:href="iff-20231231.xsd#iff_RestructuringAndRelatedCostExpectedNumberOfSitesClosedPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_RestructuringAndRelatedCostExpectedNumberOfSitesClosedPeriod" xlink:to="lab_iff_RestructuringAndRelatedCostExpectedNumberOfSitesClosedPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_46b80852-8e3a-4294-905c-e0a0d8e0c0e1_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, value, issued</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_c76a69af-3a2c-4c44-b5fa-dcdb15df36a9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, redemption price, percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_8764eddd-ef72-4754-8820-356714807c14_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measured at Net Asset Value Per Share</link:label>
    <link:label id="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measured at Net Asset Value Per Share [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:to="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8138330c-1383-4d1c-b7d0-c3d9a9d04be8_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_d441fb6b-9efb-4e64-b6ef-f59f8b278557_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_3e6911ae-dd8f-4913-9ce9-62804166a342_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_StrategicInitiativesCosts_56e99f68-8b5f-42b8-b50a-d0a1f28cd520_terseLabel_en-US" xlink:label="lab_iff_StrategicInitiativesCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Initiative Costs</link:label>
    <link:label id="lab_iff_StrategicInitiativesCosts_label_en-US" xlink:label="lab_iff_StrategicInitiativesCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Initiatives Costs</link:label>
    <link:label id="lab_iff_StrategicInitiativesCosts_documentation_en-US" xlink:label="lab_iff_StrategicInitiativesCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Initiatives Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_StrategicInitiativesCosts" xlink:href="iff-20231231.xsd#iff_StrategicInitiativesCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_StrategicInitiativesCosts" xlink:to="lab_iff_StrategicInitiativesCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_SavorySolutionsBusinessMember_c7b2aaf2-52bd-4f09-b5e6-c42080326449_terseLabel_en-US" xlink:label="lab_iff_SavorySolutionsBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Savory Solutions Business</link:label>
    <link:label id="lab_iff_SavorySolutionsBusinessMember_label_en-US" xlink:label="lab_iff_SavorySolutionsBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Savory Solutions Business [Member]</link:label>
    <link:label id="lab_iff_SavorySolutionsBusinessMember_documentation_en-US" xlink:label="lab_iff_SavorySolutionsBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Savory Solutions Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SavorySolutionsBusinessMember" xlink:href="iff-20231231.xsd#iff_SavorySolutionsBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_SavorySolutionsBusinessMember" xlink:to="lab_iff_SavorySolutionsBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_ed2b043f-0a4d-4d68-aeb6-98c288c474ca_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax provision</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b448ce1c-e592-426c-922c-2f08269004c4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_cf109fc6-e64a-44d5-97d0-4c749b6750f3_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing cash flows for finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiPercent_62cdfd31-6d63-412c-a243-cabb5d472382_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiPercent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global intangible low-taxed income</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiPercent_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, GILTI, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationGiltiPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiPercent" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DisposalGroupIncludingDiscontinuedOperationTransactionCostCredits_1c047b4e-1e1c-4ef0-9346-af488095d079_negatedTerseLabel_en-US" xlink:label="lab_iff_DisposalGroupIncludingDiscontinuedOperationTransactionCostCredits" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction costs</link:label>
    <link:label id="lab_iff_DisposalGroupIncludingDiscontinuedOperationTransactionCostCredits_label_en-US" xlink:label="lab_iff_DisposalGroupIncludingDiscontinuedOperationTransactionCostCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Transaction (Cost) Credits</link:label>
    <link:label id="lab_iff_DisposalGroupIncludingDiscontinuedOperationTransactionCostCredits_documentation_en-US" xlink:label="lab_iff_DisposalGroupIncludingDiscontinuedOperationTransactionCostCredits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Transaction (Cost) Credits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupIncludingDiscontinuedOperationTransactionCostCredits" xlink:href="iff-20231231.xsd#iff_DisposalGroupIncludingDiscontinuedOperationTransactionCostCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DisposalGroupIncludingDiscontinuedOperationTransactionCostCredits" xlink:to="lab_iff_DisposalGroupIncludingDiscontinuedOperationTransactionCostCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNet_45a31f4a-141e-4abf-b7f2-a8c5a220e10f_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNet_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNet" xlink:to="lab_us-gaap_AccountsReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllIndividualsMember_terseLabel_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Individuals</link:label>
    <link:label id="lab_ecd_AllIndividualsMember_label_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Individuals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="lab_ecd_AllIndividualsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_SeniorNotesDueTwoThousandFortyMember_117aef8a-e0df-437a-a07d-a9d54f2db8a3_terseLabel_en-US" xlink:label="lab_iff_SeniorNotesDueTwoThousandFortyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, Due Two Thousand Forty</link:label>
    <link:label id="lab_iff_SeniorNotesDueTwoThousandFortyMember_label_en-US" xlink:label="lab_iff_SeniorNotesDueTwoThousandFortyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, Due Two Thousand Forty [Member]</link:label>
    <link:label id="lab_iff_SeniorNotesDueTwoThousandFortyMember_documentation_en-US" xlink:label="lab_iff_SeniorNotesDueTwoThousandFortyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, Due Two Thousand Forty</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandFortyMember" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandFortyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_SeniorNotesDueTwoThousandFortyMember" xlink:to="lab_iff_SeniorNotesDueTwoThousandFortyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_1648ea97-cd6c-4354-a8b3-144d450a648f_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_6817e7cc-fd47-4497-9275-ecd69856d55e_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense (income), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_c6fb74be-8f3d-4c84-94c1-0500113c4c62_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (expense) income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_c7138891-ca6e-4f8c-b792-c1e206130631_totalLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (expense) income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_d6795c01-799e-42b2-a43c-44a71b326168_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_c4af88f5-e4d0-4289-91fb-677700614e0c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock Repurchase Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_90f3b4f0-0ce4-4501-91f4-f6a757fb1836_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_c6c94aa4-712b-419b-8c3d-dc34670a851a_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_fe1c9a13-f6c0-44a1-ba31-0f7a30a66974_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Held-for-sale, Not Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Held-for-Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_f7b637a7-b175-4236-85cc-c5ada6edc1ee_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares authorized under repurchase program</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesAndExciseTaxPayableCurrent_be9cfdd6-c007-479e-ad4a-404d191b5a21_terseLabel_en-US" xlink:label="lab_us-gaap_SalesAndExciseTaxPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value-added tax payable</link:label>
    <link:label id="lab_us-gaap_SalesAndExciseTaxPayableCurrent_label_en-US" xlink:label="lab_us-gaap_SalesAndExciseTaxPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and Excise Tax Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesAndExciseTaxPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesAndExciseTaxPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesAndExciseTaxPayableCurrent" xlink:to="lab_us-gaap_SalesAndExciseTaxPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock_6598774d-ef53-479a-b843-599c6a328b4c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Level 3 Non-U.S. Plan Assets Held</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effect of Significant Unobservable Inputs, Changes in Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_c92fcaa6-af77-459c-9cf6-5e0c74d3089f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reconciliation between U.S. Federal Statutory Income Tax Rate to Actual Effective Tax Rate</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_78174533-7edf-4cc1-998c-7e86b5d6ea80_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance of unrecognized tax benefits at beginning of year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_94112440-a6b2-4657-a2a9-f383e052183f_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance of unrecognized tax benefits at end of year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_7c009890-6d79-4e1b-b76f-82515bbde6ed_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AddressTypeDomain_23646ae4-8b36-4a8f-94e1-f093e3974424_terseLabel_en-US" xlink:label="lab_dei_AddressTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Address Type [Domain]</link:label>
    <link:label id="lab_dei_AddressTypeDomain_label_en-US" xlink:label="lab_dei_AddressTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Address Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AddressTypeDomain" xlink:to="lab_dei_AddressTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoName_terseLabel_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Name</link:label>
    <link:label id="lab_ecd_PeoName_label_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoName" xlink:to="lab_ecd_PeoName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_b0799465-dba6-444b-9313-aeca875a5ca5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesCurrent_a0d6a684-a153-457c-a17d-fe6a60545739_terseLabel_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Sundry Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherSundryLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtPolicyTextBlock_d6656ac1-3048-46bf-9497-aada9e25dd01_terseLabel_en-US" xlink:label="lab_us-gaap_DebtPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Costs</link:label>
    <link:label id="lab_us-gaap_DebtPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtPolicyTextBlock" xlink:to="lab_us-gaap_DebtPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BaseRateMember_765580ac-30e6-48bd-aabc-7e7407949c3a_terseLabel_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate</link:label>
    <link:label id="lab_us-gaap_BaseRateMember_label_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BaseRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember" xlink:to="lab_us-gaap_BaseRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation_f8e9cfdf-9ddb-4499-8824-6b6510cc1aca_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions/Transferred Liabilities</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Business Combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_2f5a0024-57ad-494b-b6e8-19a20dba41c3_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent" xlink:to="lab_us-gaap_RestrictedCashCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_9f6238fe-6a28-4036-8a2d-ec8091b1719d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2029 - 2033</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_OperatingAndFinanceLeaseLiability_0e4d281e-3a57-4b49-9057-d9f01a575b63_terseLabel_en-US" xlink:label="lab_iff_OperatingAndFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating and Finance Lease, Liability</link:label>
    <link:label id="lab_iff_OperatingAndFinanceLeaseLiability_label_en-US" xlink:label="lab_iff_OperatingAndFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating and Finance Lease, Liability</link:label>
    <link:label id="lab_iff_OperatingAndFinanceLeaseLiability_documentation_en-US" xlink:label="lab_iff_OperatingAndFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating and Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_OperatingAndFinanceLeaseLiability" xlink:href="iff-20231231.xsd#iff_OperatingAndFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_OperatingAndFinanceLeaseLiability" xlink:to="lab_iff_OperatingAndFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_6aaa71a4-a912-40b1-9def-738dae7156d9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill by Operating Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock_1e671b21-22c5-43d0-991c-9b68336719e9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (Expense) Income, Net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income and Expense [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock" xlink:to="lab_us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_OtherAssetsAndLiabilitiesDisclosureCurrentAndNoncurrentTextBlock_01acab7e-b6eb-4c19-a507-b499caf81eab_terseLabel_en-US" xlink:label="lab_iff_OtherAssetsAndLiabilitiesDisclosureCurrentAndNoncurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets and Liabilities, and Other Assets</link:label>
    <link:label id="lab_iff_OtherAssetsAndLiabilitiesDisclosureCurrentAndNoncurrentTextBlock_label_en-US" xlink:label="lab_iff_OtherAssetsAndLiabilitiesDisclosureCurrentAndNoncurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets And Liabilities Disclosure, Current And Noncurrent [Text Block]</link:label>
    <link:label id="lab_iff_OtherAssetsAndLiabilitiesDisclosureCurrentAndNoncurrentTextBlock_documentation_en-US" xlink:label="lab_iff_OtherAssetsAndLiabilitiesDisclosureCurrentAndNoncurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets And Liabilities Disclosure, Current And Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_OtherAssetsAndLiabilitiesDisclosureCurrentAndNoncurrentTextBlock" xlink:href="iff-20231231.xsd#iff_OtherAssetsAndLiabilitiesDisclosureCurrentAndNoncurrentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_OtherAssetsAndLiabilitiesDisclosureCurrentAndNoncurrentTextBlock" xlink:to="lab_iff_OtherAssetsAndLiabilitiesDisclosureCurrentAndNoncurrentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_0e895e4e-3085-49a4-9deb-6611bcd696f5_negatedLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts written off</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_209e446a-6030-497d-b3b8-f9209319a201_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service cost</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Net Prior Service Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_StockOptionsAndStockSettledAppreciationRightsMember_3e775b61-4dfa-4cac-b39b-3fbff237f084_terseLabel_en-US" xlink:label="lab_iff_StockOptionsAndStockSettledAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SSAR's and Options [Member]</link:label>
    <link:label id="lab_iff_StockOptionsAndStockSettledAppreciationRightsMember_label_en-US" xlink:label="lab_iff_StockOptionsAndStockSettledAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options And Stock Settled Appreciation Rights [Member]</link:label>
    <link:label id="lab_iff_StockOptionsAndStockSettledAppreciationRightsMember_documentation_en-US" xlink:label="lab_iff_StockOptionsAndStockSettledAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options And Stock Settled Appreciation Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_StockOptionsAndStockSettledAppreciationRightsMember" xlink:href="iff-20231231.xsd#iff_StockOptionsAndStockSettledAppreciationRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_StockOptionsAndStockSettledAppreciationRightsMember" xlink:to="lab_iff_StockOptionsAndStockSettledAppreciationRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_GuangzhouFragrancePlantMember_2f686086-1e36-432d-b7bf-1a810d12dc6e_terseLabel_en-US" xlink:label="lab_iff_GuangzhouFragrancePlantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guangzhou Fragrance Plant [Member]</link:label>
    <link:label id="lab_iff_GuangzhouFragrancePlantMember_label_en-US" xlink:label="lab_iff_GuangzhouFragrancePlantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guangzhou Fragrance Plant [Member]</link:label>
    <link:label id="lab_iff_GuangzhouFragrancePlantMember_documentation_en-US" xlink:label="lab_iff_GuangzhouFragrancePlantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guangzhou Fragrance Plant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_GuangzhouFragrancePlantMember" xlink:href="iff-20231231.xsd#iff_GuangzhouFragrancePlantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_GuangzhouFragrancePlantMember" xlink:to="lab_iff_GuangzhouFragrancePlantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_149aeb38-56bf-40d8-9d5f-2f41f0f00db1_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognized actuarial (loss) gain</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_2a7417ae-f7c1-49d5-baf4-2ff97e652658_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_74cd601f-4b5a-43b0-9fd1-fed2f4013b06_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_5bcced32-6612-4f3d-8b5d-08a7938ffc36_verboseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unallocated assets [Member]</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfOperations_7ed9a1e6-89b5-47f0-98e5-9b4c5cdfe1a8_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations</link:label>
    <link:label id="lab_us-gaap_NatureOfOperations_label_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NatureOfOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations" xlink:to="lab_us-gaap_NatureOfOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_6c8d7af4-93c2-4354-a36a-9fd445612705_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets/liabilities, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities_5637ded0-1d5c-4faf-bca2-49c18a06aec9_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liability</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_8689d7ad-2f85-42ae-b2f7-ca4cd92c6fab_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate of debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_d4490dc9-622e-475c-a2c2-cf488656ee3c_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accruals for incentive compensation</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Employee Related Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_5ccf940b-d26a-4161-ace7-28db04132a80_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_TransitionServicesAgreementIncomeReductionToCostsNotIncludedInRevenue_aefd52f2-deaa-4524-866d-3eaf042bd37d_terseLabel_en-US" xlink:label="lab_iff_TransitionServicesAgreementIncomeReductionToCostsNotIncludedInRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition Services Agreement, Income, Reduction To Costs Not Included In Revenue</link:label>
    <link:label id="lab_iff_TransitionServicesAgreementIncomeReductionToCostsNotIncludedInRevenue_label_en-US" xlink:label="lab_iff_TransitionServicesAgreementIncomeReductionToCostsNotIncludedInRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition Services Agreement, Income, Reduction To Costs Not Included In Revenue</link:label>
    <link:label id="lab_iff_TransitionServicesAgreementIncomeReductionToCostsNotIncludedInRevenue_documentation_en-US" xlink:label="lab_iff_TransitionServicesAgreementIncomeReductionToCostsNotIncludedInRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition Services Agreement, Income, Reduction To Costs Not Included In Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TransitionServicesAgreementIncomeReductionToCostsNotIncludedInRevenue" xlink:href="iff-20231231.xsd#iff_TransitionServicesAgreementIncomeReductionToCostsNotIncludedInRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_TransitionServicesAgreementIncomeReductionToCostsNotIncludedInRevenue" xlink:to="lab_iff_TransitionServicesAgreementIncomeReductionToCostsNotIncludedInRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_9dae9087-62f4-4fa9-b8e0-99abea10edca_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Losses (gains) on business divestitures</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_90f9152d-6baa-4fdc-9ce8-d3cf8fb7fc87_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Losses) gains on business divestitures</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:to="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_SeniorUnsecuredBridgeTermLoanMember_016eafe4-d4ac-4756-8b5a-f85857349d4d_terseLabel_en-US" xlink:label="lab_iff_SeniorUnsecuredBridgeTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Bridge Term Loan [Member]</link:label>
    <link:label id="lab_iff_SeniorUnsecuredBridgeTermLoanMember_label_en-US" xlink:label="lab_iff_SeniorUnsecuredBridgeTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Bridge Term Loan [Member]</link:label>
    <link:label id="lab_iff_SeniorUnsecuredBridgeTermLoanMember_documentation_en-US" xlink:label="lab_iff_SeniorUnsecuredBridgeTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Bridge Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorUnsecuredBridgeTermLoanMember" xlink:href="iff-20231231.xsd#iff_SeniorUnsecuredBridgeTermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_SeniorUnsecuredBridgeTermLoanMember" xlink:to="lab_iff_SeniorUnsecuredBridgeTermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_e0b247be-c65f-43f6-976d-10586b372959_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_5384cb78-650d-4098-811f-31b9f4a87425_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_e1d2a58f-8b0c-49d3-b2ab-4c40458b9aa6_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_8c3b73ea-d050-472f-8916-aaf71d0c5b4e_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss, net of tax</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_0b3ce4ef-dd1a-4913-ac24-3899601203e2_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss, net of tax</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_06620693-f271-4b35-aa85-be35d6d0be45_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_e1e2de4d-7c38-4b0d-8247-7d7297131628_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits that would impact effective tax rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_f0208329-dc27-484d-a2a2-035e5bcf5923_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_UnrecognizedTaxBenefitsIncludingInterestAndPenalties_88587daa-85e8-45fb-928b-5f914158b111_terseLabel_en-US" xlink:label="lab_iff_UnrecognizedTaxBenefitsIncludingInterestAndPenalties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits, including interest</link:label>
    <link:label id="lab_iff_UnrecognizedTaxBenefitsIncludingInterestAndPenalties_label_en-US" xlink:label="lab_iff_UnrecognizedTaxBenefitsIncludingInterestAndPenalties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Including Interest And Penalties</link:label>
    <link:label id="lab_iff_UnrecognizedTaxBenefitsIncludingInterestAndPenalties_documentation_en-US" xlink:label="lab_iff_UnrecognizedTaxBenefitsIncludingInterestAndPenalties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Including Interest And Penalties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_UnrecognizedTaxBenefitsIncludingInterestAndPenalties" xlink:href="iff-20231231.xsd#iff_UnrecognizedTaxBenefitsIncludingInterestAndPenalties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_UnrecognizedTaxBenefitsIncludingInterestAndPenalties" xlink:to="lab_iff_UnrecognizedTaxBenefitsIncludingInterestAndPenalties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_9aabd316-6acc-4f99-b241-1f18f2320888_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_8a17cb3f-8385-4174-b135-ac1478118964_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Difference in effective tax rate on foreign earnings and remittances(1)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_ExpenseMember_0b33ff89-3dc6-49ec-957e-26bddcc197b6_terseLabel_en-US" xlink:label="lab_iff_ExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense</link:label>
    <link:label id="lab_iff_ExpenseMember_label_en-US" xlink:label="lab_iff_ExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense [Member]</link:label>
    <link:label id="lab_iff_ExpenseMember_documentation_en-US" xlink:label="lab_iff_ExpenseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ExpenseMember" xlink:href="iff-20231231.xsd#iff_ExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_ExpenseMember" xlink:to="lab_iff_ExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitAxis_548a2152-d1e0-42a6-80e8-04a99a9988c7_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitAxis_label_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReportingUnitAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitAxis" xlink:to="lab_us-gaap_ReportingUnitAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_345c6c18-f13b-49f1-a498-0b71534eabf9_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_6eba4d62-40e9-4343-8746-93b7e10c2e4e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_6b0059e6-3a27-43b9-ac9a-05f28031110b_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementDomain_a79364ad-3913-4f4f-82bd-b3be927f579e_terseLabel_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement [Domain]</link:label>
    <link:label id="lab_srt_RestatementDomain_label_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementDomain" xlink:to="lab_srt_RestatementDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e2f79ea6-e2fe-44be-acc3-a87f59274618_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Loss) income before taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_831a4211-c532-4324-8895-be9b0d592d76_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_cfbbed62-dd72-4a9d-8cd8-d860e8796d2e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions to intangible assets</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicDistributionAxis_b49740f2-e773-4ed7-8ae1-73f319a52aa9_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicDistributionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Distribution [Axis]</link:label>
    <link:label id="lab_us-gaap_GeographicDistributionAxis_label_en-US" xlink:label="lab_us-gaap_GeographicDistributionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Distribution [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicDistributionAxis" xlink:to="lab_us-gaap_GeographicDistributionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_LossContingencyReceivableWrittenOff_fea14c3d-66f3-47cd-8591-45485f72ff8a_terseLabel_en-US" xlink:label="lab_iff_LossContingencyReceivableWrittenOff" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Receivable Written Off</link:label>
    <link:label id="lab_iff_LossContingencyReceivableWrittenOff_label_en-US" xlink:label="lab_iff_LossContingencyReceivableWrittenOff" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Receivable Written Off</link:label>
    <link:label id="lab_iff_LossContingencyReceivableWrittenOff_documentation_en-US" xlink:label="lab_iff_LossContingencyReceivableWrittenOff" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Receivable Written Off</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_LossContingencyReceivableWrittenOff" xlink:href="iff-20231231.xsd#iff_LossContingencyReceivableWrittenOff"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_LossContingencyReceivableWrittenOff" xlink:to="lab_iff_LossContingencyReceivableWrittenOff" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_77a555a6-2cec-42ee-89c9-09e224a3b9e3_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Derivatives Not Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_GainContingencyExpectedRelocationPayments_f1e222c9-1f28-4a3f-89b8-67df9fb17c5b_terseLabel_en-US" xlink:label="lab_iff_GainContingencyExpectedRelocationPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingency, Expected Relocation Payments</link:label>
    <link:label id="lab_iff_GainContingencyExpectedRelocationPayments_label_en-US" xlink:label="lab_iff_GainContingencyExpectedRelocationPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingency, Expected Relocation Payments</link:label>
    <link:label id="lab_iff_GainContingencyExpectedRelocationPayments_documentation_en-US" xlink:label="lab_iff_GainContingencyExpectedRelocationPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingency, Expected Relocation Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_GainContingencyExpectedRelocationPayments" xlink:href="iff-20231231.xsd#iff_GainContingencyExpectedRelocationPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_GainContingencyExpectedRelocationPayments" xlink:to="lab_iff_GainContingencyExpectedRelocationPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_bdd0f12d-1b73-4b64-a15a-e6bbc1f1f94e_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Other Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_fe181145-07b3-4075-b4f3-b001fa1c7e87_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts Recognized in Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_1a44272e-0f5d-4d6f-8840-3f04992c8b50_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_9ee014bc-dc70-4dfa-8c94-ec7a80c5ff5f_negatedLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_AdjustmentsToAdditionalPaidInCapitalDeferredCompensation_f0dad71e-0b1c-499b-a734-87d725c9ccee_terseLabel_en-US" xlink:label="lab_iff_AdjustmentsToAdditionalPaidInCapitalDeferredCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital in excess of par value related to deferred compensation plan</link:label>
    <link:label id="lab_iff_AdjustmentsToAdditionalPaidInCapitalDeferredCompensation_label_en-US" xlink:label="lab_iff_AdjustmentsToAdditionalPaidInCapitalDeferredCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments To Additional Paid In Capital Deferred Compensation</link:label>
    <link:label id="lab_iff_AdjustmentsToAdditionalPaidInCapitalDeferredCompensation_documentation_en-US" xlink:label="lab_iff_AdjustmentsToAdditionalPaidInCapitalDeferredCompensation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion of Deferred Compensation Plan to be paid out in shares.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AdjustmentsToAdditionalPaidInCapitalDeferredCompensation" xlink:href="iff-20231231.xsd#iff_AdjustmentsToAdditionalPaidInCapitalDeferredCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_AdjustmentsToAdditionalPaidInCapitalDeferredCompensation" xlink:to="lab_iff_AdjustmentsToAdditionalPaidInCapitalDeferredCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_48585b61-6921-438f-9cec-db2ef265208c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_d249031a-4a2c-4e7b-a4c3-276c280b364e_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgingMember" xlink:to="lab_us-gaap_NetInvestmentHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_8942865e-8443-4c7d-b53f-a930189ed2a9_terseLabel_en-US" xlink:label="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-lived Assets by Geographic Areas</link:label>
    <link:label id="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_9d78ab52-6400-43df-8c16-07c37bc7009e_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1d6721c2-3fa7-4eea-80d4-b8b845551bcf_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total identifiable net assets assumed</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d7f05f1e-9a70-4582-ba95-f6e543c99e90_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_label_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBetweenHighRangeAndLowRange_ecf47271-dd3a-4939-8dd4-ce03b2f1be32_terseLabel_en-US" xlink:label="lab_iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBetweenHighRangeAndLowRange" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of matching contribution if compensation percentage between high range and low range</link:label>
    <link:label id="lab_iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBetweenHighRangeAndLowRange_label_en-US" xlink:label="lab_iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBetweenHighRangeAndLowRange" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan Percentage Of Matching Contribution If Compensation Percentage Between High Range And Low Range</link:label>
    <link:label id="lab_iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBetweenHighRangeAndLowRange_documentation_en-US" xlink:label="lab_iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBetweenHighRangeAndLowRange" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined contribution plan, percentage of matching contribution if compensation percentage between high range and low range</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBetweenHighRangeAndLowRange" xlink:href="iff-20231231.xsd#iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBetweenHighRangeAndLowRange"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBetweenHighRangeAndLowRange" xlink:to="lab_iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBetweenHighRangeAndLowRange" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DisposalGroupNotDiscontinuedOperationLiquidationTaxEffect_243f3b69-a06e-4f74-bc9b-98260625bbd7_terseLabel_en-US" xlink:label="lab_iff_DisposalGroupNotDiscontinuedOperationLiquidationTaxEffect" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liquidation tax effect</link:label>
    <link:label id="lab_iff_DisposalGroupNotDiscontinuedOperationLiquidationTaxEffect_label_en-US" xlink:label="lab_iff_DisposalGroupNotDiscontinuedOperationLiquidationTaxEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Liquidation Tax Effect</link:label>
    <link:label id="lab_iff_DisposalGroupNotDiscontinuedOperationLiquidationTaxEffect_documentation_en-US" xlink:label="lab_iff_DisposalGroupNotDiscontinuedOperationLiquidationTaxEffect" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Liquidation Tax Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupNotDiscontinuedOperationLiquidationTaxEffect" xlink:href="iff-20231231.xsd#iff_DisposalGroupNotDiscontinuedOperationLiquidationTaxEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DisposalGroupNotDiscontinuedOperationLiquidationTaxEffect" xlink:to="lab_iff_DisposalGroupNotDiscontinuedOperationLiquidationTaxEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_ae4dba44-ba55-4589-b7ef-5ee84bbb1cba_terseLabel_en-US" xlink:label="lab_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization And Summary Of Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_label_en-US" xlink:label="lab_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization And Summary Of Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_documentation_en-US" xlink:label="lab_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization And Summary Of Significant Accounting Policies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesTable" xlink:href="iff-20231231.xsd#iff_OrganizationAndSummaryOfSignificantAccountingPoliciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesTable" xlink:to="lab_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_3f2f3d7a-484e-4f41-8db3-b1841610f1f5_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableAmountPerShare_7d562d89-3d53-4e8d-a828-d60651250519_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableAmountPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend per share declared (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_DividendsPayableAmountPerShare_label_en-US" xlink:label="lab_us-gaap_DividendsPayableAmountPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Amount Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableAmountPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableAmountPerShare" xlink:to="lab_us-gaap_DividendsPayableAmountPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_76bd8121-a783-4991-994a-422664877855_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets amortized period, years</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember_b00e2c9d-90da-4222-a7dc-91e3da232b0c_terseLabel_en-US" xlink:label="lab_iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, Euro Notes, 2026</link:label>
    <link:label id="lab_iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember_label_en-US" xlink:label="lab_iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, Euro Notes, Due Two Thousand Twenty Six [Member]</link:label>
    <link:label id="lab_iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember_documentation_en-US" xlink:label="lab_iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, Euro Notes, Due Two Thousand Twenty Six [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember" xlink:href="iff-20231231.xsd#iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember" xlink:to="lab_iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_c32f7f17-7590-4d45-9c54-286da04c80f3_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3ab31774-97e9-479e-a398-8656b7155ef0_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_45c30609-d163-4fee-921f-cffac8bf44e2_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_55ab08c5-5c9e-49a6-a64d-135322888ebe_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_f57eb4eb-883b-4f67-b276-5d35db9497ed_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Sales by Geographic Area</link:label>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_BankGuaranteesMember_2182bb8e-d969-4d69-a712-d09e6f6d5a44_terseLabel_en-US" xlink:label="lab_iff_BankGuaranteesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank guarantees [Member]</link:label>
    <link:label id="lab_iff_BankGuaranteesMember_label_en-US" xlink:label="lab_iff_BankGuaranteesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank Guarantees [Member]</link:label>
    <link:label id="lab_iff_BankGuaranteesMember_documentation_en-US" xlink:label="lab_iff_BankGuaranteesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank Guarantees [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BankGuaranteesMember" xlink:href="iff-20231231.xsd#iff_BankGuaranteesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_BankGuaranteesMember" xlink:to="lab_iff_BankGuaranteesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_c08e37e3-4eea-424f-9b95-e194ed19ffb6_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_8b31d0b5-c73a-4b30-bd23-99f7257cd45e_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_6a09354e-a9ab-4ba8-9071-8b5c312adc18_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated_29f38925-b3dc-4f41-b8ee-54a9f57e14db_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Number of Positions Eliminated</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Number of Positions Eliminated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated" xlink:to="lab_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_A2019SeveranceInitiativesMember_05338ba8-c404-4f58-86d0-0c52cd7c160c_terseLabel_en-US" xlink:label="lab_iff_A2019SeveranceInitiativesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Severance Initiatives [Member]</link:label>
    <link:label id="lab_iff_A2019SeveranceInitiativesMember_label_en-US" xlink:label="lab_iff_A2019SeveranceInitiativesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Severance Initiatives [Member]</link:label>
    <link:label id="lab_iff_A2019SeveranceInitiativesMember_documentation_en-US" xlink:label="lab_iff_A2019SeveranceInitiativesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Severance Initiatives [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_A2019SeveranceInitiativesMember" xlink:href="iff-20231231.xsd#iff_A2019SeveranceInitiativesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_A2019SeveranceInitiativesMember" xlink:to="lab_iff_A2019SeveranceInitiativesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_ae2b1501-d900-4dbe-90de-73bc4f9f8815_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_ProceedsFromSaleOfAccountsReceivable_18864c22-941b-416b-abd9-362a03a6eb3c_terseLabel_en-US" xlink:label="lab_iff_ProceedsFromSaleOfAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of accounts receivable</link:label>
    <link:label id="lab_iff_ProceedsFromSaleOfAccountsReceivable_label_en-US" xlink:label="lab_iff_ProceedsFromSaleOfAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Sale Of Accounts Receivable</link:label>
    <link:label id="lab_iff_ProceedsFromSaleOfAccountsReceivable_documentation_en-US" xlink:label="lab_iff_ProceedsFromSaleOfAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Sale Of Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ProceedsFromSaleOfAccountsReceivable" xlink:href="iff-20231231.xsd#iff_ProceedsFromSaleOfAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_ProceedsFromSaleOfAccountsReceivable" xlink:to="lab_iff_ProceedsFromSaleOfAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_a844cd78-4d98-45c5-8baf-4b79a980fd65_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag_68c975aa-dc02-41cf-9ff4-6f3e42384711_terseLabel_en-US" xlink:label="lab_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Financial Statement Restatement Recovery Analysis [Flag]</link:label>
    <link:label id="lab_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag_label_en-US" xlink:label="lab_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Financial Statement Restatement Recovery Analysis [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtRestatementRecoveryAnalysisFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag" xlink:to="lab_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock_da36e9be-4138-4e95-9f1f-a06b41ed5b35_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Related Costs, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:to="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_NoncontrollingInterestDecreaseFromDisposal_db5601f8-9f11-4a2d-98b5-bec0b214c6d8_terseLabel_en-US" xlink:label="lab_iff_NoncontrollingInterestDecreaseFromDisposal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal of redeemable non-controlling interests</link:label>
    <link:label id="lab_iff_NoncontrollingInterestDecreaseFromDisposal_label_en-US" xlink:label="lab_iff_NoncontrollingInterestDecreaseFromDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease From Disposal</link:label>
    <link:label id="lab_iff_NoncontrollingInterestDecreaseFromDisposal_documentation_en-US" xlink:label="lab_iff_NoncontrollingInterestDecreaseFromDisposal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease From Disposal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NoncontrollingInterestDecreaseFromDisposal" xlink:href="iff-20231231.xsd#iff_NoncontrollingInterestDecreaseFromDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_NoncontrollingInterestDecreaseFromDisposal" xlink:to="lab_iff_NoncontrollingInterestDecreaseFromDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_ZhangjiagangFlavorsPlantMember_a55594ba-46e4-4546-b1c5-120ecaea1c2c_terseLabel_en-US" xlink:label="lab_iff_ZhangjiagangFlavorsPlantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zhangjiagang Flavors Plant</link:label>
    <link:label id="lab_iff_ZhangjiagangFlavorsPlantMember_label_en-US" xlink:label="lab_iff_ZhangjiagangFlavorsPlantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zhangjiagang Flavors Plant [Member]</link:label>
    <link:label id="lab_iff_ZhangjiagangFlavorsPlantMember_documentation_en-US" xlink:label="lab_iff_ZhangjiagangFlavorsPlantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zhangjiagang Flavors Plant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ZhangjiagangFlavorsPlantMember" xlink:href="iff-20231231.xsd#iff_ZhangjiagangFlavorsPlantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_ZhangjiagangFlavorsPlantMember" xlink:to="lab_iff_ZhangjiagangFlavorsPlantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityMember_9857e255-40b7-447f-b91b-02e7b33dad76_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability</link:label>
    <link:label id="lab_us-gaap_LiabilityMember_label_en-US" xlink:label="lab_us-gaap_LiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityMember" xlink:to="lab_us-gaap_LiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardExrcPrice_terseLabel_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price</link:label>
    <link:label id="lab_ecd_AwardExrcPrice_label_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardExrcPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardExrcPrice" xlink:to="lab_ecd_AwardExrcPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a1b1f957-783c-4983-bb67-c66d594a2a71_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AsiaMember_0ff91ea2-7aaf-4b21-af54-3fbb76a7dbba_terseLabel_en-US" xlink:label="lab_srt_AsiaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia</link:label>
    <link:label id="lab_srt_AsiaMember_a13d5b32-49fb-4c44-ace7-d0ff00c59177_verboseLabel_en-US" xlink:label="lab_srt_AsiaMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater Asia [Member]</link:label>
    <link:label id="lab_srt_AsiaMember_label_en-US" xlink:label="lab_srt_AsiaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AsiaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AsiaMember" xlink:to="lab_srt_AsiaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_088aa3a1-cc95-4bf3-a09f-51d137232285_negatedLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends declared</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_60b54608-2fac-4fb6-8afe-b28bacb58f62_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnderlyingAssetClassAxis_16757bbc-b5e3-4a93-8e1d-739986c1a774_terseLabel_en-US" xlink:label="lab_us-gaap_UnderlyingAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underlying Asset Class [Axis]</link:label>
    <link:label id="lab_us-gaap_UnderlyingAssetClassAxis_label_en-US" xlink:label="lab_us-gaap_UnderlyingAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underlying Asset Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnderlyingAssetClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnderlyingAssetClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnderlyingAssetClassAxis" xlink:to="lab_us-gaap_UnderlyingAssetClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiscalPeriod_67907b73-3d15-4469-8268-a1046324a9fa_terseLabel_en-US" xlink:label="lab_us-gaap_FiscalPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Year End</link:label>
    <link:label id="lab_us-gaap_FiscalPeriod_label_en-US" xlink:label="lab_us-gaap_FiscalPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Period, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiscalPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiscalPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiscalPeriod" xlink:to="lab_us-gaap_FiscalPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_209d6384-a732-4ffc-ae38-527cb3e2978f_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_29662385-fec1-4391-ace4-90f2a3a561be_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_ForeignCurrencyContractsMember_077eb795-5f68-4cf1-9802-7d6621e46070_terseLabel_en-US" xlink:label="lab_iff_ForeignCurrencyContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contracts</link:label>
    <link:label id="lab_iff_ForeignCurrencyContractsMember_label_en-US" xlink:label="lab_iff_ForeignCurrencyContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contracts [Member]</link:label>
    <link:label id="lab_iff_ForeignCurrencyContractsMember_documentation_en-US" xlink:label="lab_iff_ForeignCurrencyContractsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contracts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ForeignCurrencyContractsMember" xlink:href="iff-20231231.xsd#iff_ForeignCurrencyContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_ForeignCurrencyContractsMember" xlink:to="lab_iff_ForeignCurrencyContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentMember_6da7738b-3b1c-403b-98bd-3e0044555636_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentMember" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_420f7cb4-df15-417f-a765-dcfcb9e7f94d_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Liabilities and Shareholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_660e44b1-c441-4967-abe0-1310a3afde63_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_58500cc6-e29f-43d2-b15d-f2ec48febc25_totalLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_a7e41220-210c-44bf-b204-6b50f2f2a20a_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_d6a238a0-c4cd-4596-9e3f-10ab4a3229b4_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_33abb0f1-a619-4476-bc46-b242bbeb4199_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_SeniorUnsecuredNotesMember_6aef009b-e0e5-495e-8197-6786e2442e9e_terseLabel_en-US" xlink:label="lab_iff_SeniorUnsecuredNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes</link:label>
    <link:label id="lab_iff_SeniorUnsecuredNotesMember_label_en-US" xlink:label="lab_iff_SeniorUnsecuredNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes [Member]</link:label>
    <link:label id="lab_iff_SeniorUnsecuredNotesMember_documentation_en-US" xlink:label="lab_iff_SeniorUnsecuredNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorUnsecuredNotesMember" xlink:href="iff-20231231.xsd#iff_SeniorUnsecuredNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_SeniorUnsecuredNotesMember" xlink:to="lab_iff_SeniorUnsecuredNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy_8ae62a75-6523-444b-9112-3d3277130872_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held for Sale</link:label>
    <link:label id="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy_label_en-US" xlink:label="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs Associated with Exit or Disposal Activity or Restructuring [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy" xlink:to="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_label_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_0bff0d56-ee39-4a0e-8103-19c718130222_negatedLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_AmortizationOfInventoryStepUp_50d7ebfa-eb63-4dc7-abd1-910225ed54a5_terseLabel_en-US" xlink:label="lab_iff_AmortizationOfInventoryStepUp" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization Of Inventory Step-Up</link:label>
    <link:label id="lab_iff_AmortizationOfInventoryStepUp_label_en-US" xlink:label="lab_iff_AmortizationOfInventoryStepUp" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization Of Inventory Step-Up</link:label>
    <link:label id="lab_iff_AmortizationOfInventoryStepUp_documentation_en-US" xlink:label="lab_iff_AmortizationOfInventoryStepUp" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization Of Inventory Step-Up</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AmortizationOfInventoryStepUp" xlink:href="iff-20231231.xsd#iff_AmortizationOfInventoryStepUp"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_AmortizationOfInventoryStepUp" xlink:to="lab_iff_AmortizationOfInventoryStepUp" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_ScheduleOfAmountsExpectedToBeRecognizedInNetPeriodicCostTableTableTextBlock_301b4bb4-3871-411d-ad9f-98e7a54adb72_terseLabel_en-US" xlink:label="lab_iff_ScheduleOfAmountsExpectedToBeRecognizedInNetPeriodicCostTableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts Expected to be Recognized in Net Periodic Cost</link:label>
    <link:label id="lab_iff_ScheduleOfAmountsExpectedToBeRecognizedInNetPeriodicCostTableTableTextBlock_label_en-US" xlink:label="lab_iff_ScheduleOfAmountsExpectedToBeRecognizedInNetPeriodicCostTableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Amounts Expected To Be Recognized In Net Periodic Cost Table [Table Text Block]</link:label>
    <link:label id="lab_iff_ScheduleOfAmountsExpectedToBeRecognizedInNetPeriodicCostTableTableTextBlock_documentation_en-US" xlink:label="lab_iff_ScheduleOfAmountsExpectedToBeRecognizedInNetPeriodicCostTableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Amounts Expected To Be Recognized In Net Periodic Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ScheduleOfAmountsExpectedToBeRecognizedInNetPeriodicCostTableTableTextBlock" xlink:href="iff-20231231.xsd#iff_ScheduleOfAmountsExpectedToBeRecognizedInNetPeriodicCostTableTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_ScheduleOfAmountsExpectedToBeRecognizedInNetPeriodicCostTableTableTextBlock" xlink:to="lab_iff_ScheduleOfAmountsExpectedToBeRecognizedInNetPeriodicCostTableTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_b67b78aa-7710-451f-8c93-12787dc8249b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_5816075c-2b13-475b-8fc8-32149fb76c0a_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_8cb96431-6843-438e-984b-d105c555d15e_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Cost</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrDuration_terseLabel_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arrangement Duration</link:label>
    <link:label id="lab_ecd_TrdArrDuration_label_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrDuration" xlink:to="lab_ecd_TrdArrDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_b99c67f3-f203-4870-ba32-c618d0bdd9ab_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearThree_373da78d-9b30-48a3-b4cf-145fff1fc7f6_terseLabel_en-US" xlink:label="lab_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:label id="lab_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearThree_label_en-US" xlink:label="lab_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:label id="lab_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearThree_documentation_en-US" xlink:label="lab_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearThree" xlink:href="iff-20231231.xsd#iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearThree" xlink:to="lab_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_823d74e6-8c8a-4f95-83e3-94771d611eb9_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" xlink:to="lab_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_794002c2-d471-49d3-a715-1f0c93007394_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing MNPI Considered [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_74955950-bdf6-4dc7-852b-387c21b29f33_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan participants&#8217; contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Plan Participant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_TwoThousandTwentyThreeToTwoThousandFortyTwoMember_c806667a-33d4-47cd-b7dd-d0a2c67b0829_terseLabel_en-US" xlink:label="lab_iff_TwoThousandTwentyThreeToTwoThousandFortyTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 to 2037 [Member]</link:label>
    <link:label id="lab_iff_TwoThousandTwentyThreeToTwoThousandFortyTwoMember_label_en-US" xlink:label="lab_iff_TwoThousandTwentyThreeToTwoThousandFortyTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Twenty Three To Two Thousand Forty Two [Member]</link:label>
    <link:label id="lab_iff_TwoThousandTwentyThreeToTwoThousandFortyTwoMember_documentation_en-US" xlink:label="lab_iff_TwoThousandTwentyThreeToTwoThousandFortyTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Twenty Three To Two Thousand Forty Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TwoThousandTwentyThreeToTwoThousandFortyTwoMember" xlink:href="iff-20231231.xsd#iff_TwoThousandTwentyThreeToTwoThousandFortyTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_TwoThousandTwentyThreeToTwoThousandFortyTwoMember" xlink:to="lab_iff_TwoThousandTwentyThreeToTwoThousandFortyTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_6e5c4acd-d888-4785-8356-a1ac585dac3f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reportable Segment Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_GainLossOnPlantRelocation_d1b2f921-09df-4ff8-b755-846eab02dd9e_terseLabel_en-US" xlink:label="lab_iff_GainLossOnPlantRelocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On Plant Relocation</link:label>
    <link:label id="lab_iff_GainLossOnPlantRelocation_label_en-US" xlink:label="lab_iff_GainLossOnPlantRelocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On Plant Relocation</link:label>
    <link:label id="lab_iff_GainLossOnPlantRelocation_documentation_en-US" xlink:label="lab_iff_GainLossOnPlantRelocation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On Plant Relocation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_GainLossOnPlantRelocation" xlink:href="iff-20231231.xsd#iff_GainLossOnPlantRelocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_GainLossOnPlantRelocation" xlink:to="lab_iff_GainLossOnPlantRelocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_27c211ef-7e07-4e4c-a1e8-0d5e782e96c7_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_TangibleEquityUnitsLineItems_7c87171d-36ff-43f5-8907-4e2a3ebd30f7_terseLabel_en-US" xlink:label="lab_iff_TangibleEquityUnitsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Equity Units [Line Items]</link:label>
    <link:label id="lab_iff_TangibleEquityUnitsLineItems_label_en-US" xlink:label="lab_iff_TangibleEquityUnitsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Equity Units [Line Items]</link:label>
    <link:label id="lab_iff_TangibleEquityUnitsLineItems_documentation_en-US" xlink:label="lab_iff_TangibleEquityUnitsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Tangible Equity Units [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityUnitsLineItems" xlink:href="iff-20231231.xsd#iff_TangibleEquityUnitsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_TangibleEquityUnitsLineItems" xlink:to="lab_iff_TangibleEquityUnitsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_d30a0b66-95ba-4e8f-99d6-66f367f5465e_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional charges, net</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_aa0231f9-dd49-4518-94ad-dcb1a97e0fce_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Other Charges, net</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation_80db218d-149b-49e8-ab88-ac99cfcc58e9_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_63ddac61-f995-42da-a76c-fe3ce970582f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_908026bd-9f3b-4d78-a8ee-67ec9f94cf74_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining authorized repurchase amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_4e72ff72-4676-4f73-9959-d3ce4b64755e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of NCI</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_d3e76f52-e1c0-4ed2-82ac-c3951b2a801a_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercises of redeemable non-controlling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrTerminationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Termination Date</link:label>
    <link:label id="lab_ecd_TrdArrTerminationDate_label_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement Termination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrTerminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrTerminationDate" xlink:to="lab_ecd_TrdArrTerminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_NumberOfSegments_0a632258-5992-462d-ad78-110e8e1af9a6_terseLabel_en-US" xlink:label="lab_iff_NumberOfSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of segments</link:label>
    <link:label id="lab_iff_NumberOfSegments_label_en-US" xlink:label="lab_iff_NumberOfSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Segments</link:label>
    <link:label id="lab_iff_NumberOfSegments_documentation_en-US" xlink:label="lab_iff_NumberOfSegments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NumberOfSegments" xlink:href="iff-20231231.xsd#iff_NumberOfSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_NumberOfSegments" xlink:to="lab_iff_NumberOfSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_4a094498-3acd-43bc-a2a8-2a85d4d4906d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction costs</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Transaction Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:to="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_aeff34db-f10b-48af-9bc1-bc78a2442ea7_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency gain (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_830c9654-5f81-4d8f-8d34-3a23b19c8df1_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_SeniorNotesDueTwoThousandFortyEightMember_c9841995-46ed-4061-8855-9ce55f99ff28_terseLabel_en-US" xlink:label="lab_iff_SeniorNotesDueTwoThousandFortyEightMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes - 2048</link:label>
    <link:label id="lab_iff_SeniorNotesDueTwoThousandFortyEightMember_label_en-US" xlink:label="lab_iff_SeniorNotesDueTwoThousandFortyEightMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, Due Two Thousand Forty Eight [Member]</link:label>
    <link:label id="lab_iff_SeniorNotesDueTwoThousandFortyEightMember_documentation_en-US" xlink:label="lab_iff_SeniorNotesDueTwoThousandFortyEightMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, Due Two Thousand Forty Eight [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandFortyEightMember" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandFortyEightMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_SeniorNotesDueTwoThousandFortyEightMember" xlink:to="lab_iff_SeniorNotesDueTwoThousandFortyEightMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationTable_496b2faf-456a-456a-851a-fda23ebfbd05_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationTable_label_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_bd4a6aa1-5755-4b01-8edf-37a2249ca0ea_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowings_b14954de-c80b-4ef0-ad94-55438f24775b_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank overdrafts and other</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowings" xlink:to="lab_us-gaap_ShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_f0b37eb0-383b-4993-9669-9387bc0fb4ac_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:to="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent_9d740638-0794-402f-b405-a4e1a42ff758_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current pension and other postretirement benefit obligation</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Pension and Other Postretirement and Postemployment Benefits, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent" xlink:to="lab_us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_a4f321b7-c1de-4fba-a922-fb7b368cf188_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInLongTermRateOfReturnInPensionExpense_c29d1757-1471-4f35-8e50-dc72117454e9_terseLabel_en-US" xlink:label="lab_iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInLongTermRateOfReturnInPensionExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">25 BP decrease in long-term rate of return, change in pension expense</link:label>
    <link:label id="lab_iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInLongTermRateOfReturnInPensionExpense_label_en-US" xlink:label="lab_iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInLongTermRateOfReturnInPensionExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Effect Of Twenty Five Base Point Decrease In Long Term Rate Of Return In Pension Expense</link:label>
    <link:label id="lab_iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInLongTermRateOfReturnInPensionExpense_documentation_en-US" xlink:label="lab_iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInLongTermRateOfReturnInPensionExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit plan, effect of twenty five base point decrease in long term rate of return in pension expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInLongTermRateOfReturnInPensionExpense" xlink:href="iff-20231231.xsd#iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInLongTermRateOfReturnInPensionExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInLongTermRateOfReturnInPensionExpense" xlink:to="lab_iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInLongTermRateOfReturnInPensionExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnderlyingAssetClassDomain_0f0697e8-b646-4a86-8e8b-75e9fc9b6bcd_terseLabel_en-US" xlink:label="lab_us-gaap_UnderlyingAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underlying Asset Class [Domain]</link:label>
    <link:label id="lab_us-gaap_UnderlyingAssetClassDomain_label_en-US" xlink:label="lab_us-gaap_UnderlyingAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underlying Asset Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnderlyingAssetClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnderlyingAssetClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnderlyingAssetClassDomain" xlink:to="lab_us-gaap_UnderlyingAssetClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2152e9d2-f25b-4c08-a401-8f58ffae9fc8_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgDiscLineItems_label_en-US" xlink:label="lab_ecd_AwardTmgDiscLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="lab_ecd_AwardTmgDiscLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_InformationTechnologyHardwareAndSoftwareMember_86ac740b-518c-40cf-971f-7c7c67bc38a6_terseLabel_en-US" xlink:label="lab_iff_InformationTechnologyHardwareAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information Technology Hardware And Software [Member]</link:label>
    <link:label id="lab_iff_InformationTechnologyHardwareAndSoftwareMember_label_en-US" xlink:label="lab_iff_InformationTechnologyHardwareAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information Technology Hardware And Software [Member]</link:label>
    <link:label id="lab_iff_InformationTechnologyHardwareAndSoftwareMember_documentation_en-US" xlink:label="lab_iff_InformationTechnologyHardwareAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information Technology Hardware And Software [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_InformationTechnologyHardwareAndSoftwareMember" xlink:href="iff-20231231.xsd#iff_InformationTechnologyHardwareAndSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_InformationTechnologyHardwareAndSoftwareMember" xlink:to="lab_iff_InformationTechnologyHardwareAndSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_4f73478d-c73c-42ea-89fc-836c21b3c324_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_TangibleEquityUnitsInitialPrincipalAmount_3140c925-7044-46e8-848e-2be84439b165_terseLabel_en-US" xlink:label="lab_iff_TangibleEquityUnitsInitialPrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value per TEU</link:label>
    <link:label id="lab_iff_TangibleEquityUnitsInitialPrincipalAmount_label_en-US" xlink:label="lab_iff_TangibleEquityUnitsInitialPrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Equity Units Initial Principal Amount</link:label>
    <link:label id="lab_iff_TangibleEquityUnitsInitialPrincipalAmount_documentation_en-US" xlink:label="lab_iff_TangibleEquityUnitsInitialPrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Equity Units Initial Principal Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityUnitsInitialPrincipalAmount" xlink:href="iff-20231231.xsd#iff_TangibleEquityUnitsInitialPrincipalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_TangibleEquityUnitsInitialPrincipalAmount" xlink:to="lab_iff_TangibleEquityUnitsInitialPrincipalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_FiscalQuarterEndingOnOrBeforeMarch312024Member_edfacdb4-81b2-4a2d-a8aa-bce585ba789f_terseLabel_en-US" xlink:label="lab_iff_FiscalQuarterEndingOnOrBeforeMarch312024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Quarter Ending On Or Before March 31, 2024</link:label>
    <link:label id="lab_iff_FiscalQuarterEndingOnOrBeforeMarch312024Member_label_en-US" xlink:label="lab_iff_FiscalQuarterEndingOnOrBeforeMarch312024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Quarter Ending On Or Before March 31, 2024 [Member]</link:label>
    <link:label id="lab_iff_FiscalQuarterEndingOnOrBeforeMarch312024Member_documentation_en-US" xlink:label="lab_iff_FiscalQuarterEndingOnOrBeforeMarch312024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Quarter Ending On Or Before March 31, 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FiscalQuarterEndingOnOrBeforeMarch312024Member" xlink:href="iff-20231231.xsd#iff_FiscalQuarterEndingOnOrBeforeMarch312024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_FiscalQuarterEndingOnOrBeforeMarch312024Member" xlink:to="lab_iff_FiscalQuarterEndingOnOrBeforeMarch312024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_48652421-99b0-464c-95f9-8cb5f48f5c02_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total fair value of vested</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EscrowDeposit_1a05ea00-e2ce-48bc-ad9d-b14c890e2083_terseLabel_en-US" xlink:label="lab_us-gaap_EscrowDeposit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Escrow Deposit</link:label>
    <link:label id="lab_us-gaap_EscrowDeposit_label_en-US" xlink:label="lab_us-gaap_EscrowDeposit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Escrow Deposit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EscrowDeposit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EscrowDeposit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EscrowDeposit" xlink:to="lab_us-gaap_EscrowDeposit" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_TangibleEquityUnitsTextBlock_cd2b1f0a-86c3-4c11-8a8b-3f03e26d2c60_terseLabel_en-US" xlink:label="lab_iff_TangibleEquityUnitsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Equity Units</link:label>
    <link:label id="lab_iff_TangibleEquityUnitsTextBlock_label_en-US" xlink:label="lab_iff_TangibleEquityUnitsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Equity Units [Text Block]</link:label>
    <link:label id="lab_iff_TangibleEquityUnitsTextBlock_documentation_en-US" xlink:label="lab_iff_TangibleEquityUnitsTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Equity Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityUnitsTextBlock" xlink:href="iff-20231231.xsd#iff_TangibleEquityUnitsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_TangibleEquityUnitsTextBlock" xlink:to="lab_iff_TangibleEquityUnitsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAmendments_253ba748-8630-40b8-bbc9-b6dcd03db58e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan amendments</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAmendments_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Plan Amendment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPlanAmendments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_ConsolidatedNetSalesMember_8f8b8845-1da7-47a1-8818-d67bbde36e3b_terseLabel_en-US" xlink:label="lab_iff_ConsolidatedNetSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Net Sales</link:label>
    <link:label id="lab_iff_ConsolidatedNetSalesMember_label_en-US" xlink:label="lab_iff_ConsolidatedNetSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Net Sales [Member]</link:label>
    <link:label id="lab_iff_ConsolidatedNetSalesMember_documentation_en-US" xlink:label="lab_iff_ConsolidatedNetSalesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Net Sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ConsolidatedNetSalesMember" xlink:href="iff-20231231.xsd#iff_ConsolidatedNetSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_ConsolidatedNetSalesMember" xlink:to="lab_iff_ConsolidatedNetSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_13298e56-9e0b-4cbb-85df-f4c571abfab4_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_ConditionOneMember_427cde1d-9547-4e5e-9b86-f90c5635da5a_terseLabel_en-US" xlink:label="lab_iff_ConditionOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condition One [Member]</link:label>
    <link:label id="lab_iff_ConditionOneMember_label_en-US" xlink:label="lab_iff_ConditionOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condition One [Member]</link:label>
    <link:label id="lab_iff_ConditionOneMember_documentation_en-US" xlink:label="lab_iff_ConditionOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condition One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ConditionOneMember" xlink:href="iff-20231231.xsd#iff_ConditionOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_ConditionOneMember" xlink:to="lab_iff_ConditionOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld_43853bcc-41e3-4a21-918e-7c3376e3fb42_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Actual Return (Loss) on Plan Assets Still Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld" xlink:to="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_NoncontrollingInterestImpactOfForeignExchangeTranslation_50a08366-0194-4b02-9a03-f85b6fb4d9f8_negatedLabel_en-US" xlink:label="lab_iff_NoncontrollingInterestImpactOfForeignExchangeTranslation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of foreign exchange translation</link:label>
    <link:label id="lab_iff_NoncontrollingInterestImpactOfForeignExchangeTranslation_label_en-US" xlink:label="lab_iff_NoncontrollingInterestImpactOfForeignExchangeTranslation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Impact Of Foreign Exchange Translation</link:label>
    <link:label id="lab_iff_NoncontrollingInterestImpactOfForeignExchangeTranslation_documentation_en-US" xlink:label="lab_iff_NoncontrollingInterestImpactOfForeignExchangeTranslation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Impact Of Foreign Exchange Translation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NoncontrollingInterestImpactOfForeignExchangeTranslation" xlink:href="iff-20231231.xsd#iff_NoncontrollingInterestImpactOfForeignExchangeTranslation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_NoncontrollingInterestImpactOfForeignExchangeTranslation" xlink:to="lab_iff_NoncontrollingInterestImpactOfForeignExchangeTranslation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_34655fab-6020-48da-8d2c-8bb206152f89_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1_f0c57028-e543-410a-b0c6-c85cd8a8a26f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ultimate medical cost trend rate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Ultimate Health Care Cost Trend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1" xlink:to="lab_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets_66e404f9-e566-4434-a9b9-6f043b564bd9_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains on sale of assets</link:label>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets_label_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDispositionOfAssets" xlink:to="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_54db606b-bc7b-4d19-b0f3-4bafa6ab96ec_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis" xlink:to="lab_us-gaap_ShortTermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_91391872-3520-4cc7-8532-0e365bb55722_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtCurrent_44387bd9-0680-4c66-8ef8-7188c45c6ab9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank borrowings, overdrafts and current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_label_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtCurrent" xlink:to="lab_us-gaap_DebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_ZhejiangIngredientsPlantMember_ea720241-61c8-406c-8156-200e64d9654d_terseLabel_en-US" xlink:label="lab_iff_ZhejiangIngredientsPlantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zhejiang Ingredients Plant [Member]</link:label>
    <link:label id="lab_iff_ZhejiangIngredientsPlantMember_label_en-US" xlink:label="lab_iff_ZhejiangIngredientsPlantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zhejiang Ingredients Plant [Member]</link:label>
    <link:label id="lab_iff_ZhejiangIngredientsPlantMember_documentation_en-US" xlink:label="lab_iff_ZhejiangIngredientsPlantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zhejiang Ingredients Plant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ZhejiangIngredientsPlantMember" xlink:href="iff-20231231.xsd#iff_ZhejiangIngredientsPlantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_ZhejiangIngredientsPlantMember" xlink:to="lab_iff_ZhejiangIngredientsPlantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DeferredTaxAssetsLeaseObligations_48f06343-74d2-4422-a855-7f99bd4a6926_terseLabel_en-US" xlink:label="lab_iff_DeferredTaxAssetsLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset Lease Obligations</link:label>
    <link:label id="lab_iff_DeferredTaxAssetsLeaseObligations_label_en-US" xlink:label="lab_iff_DeferredTaxAssetsLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Lease Obligations</link:label>
    <link:label id="lab_iff_DeferredTaxAssetsLeaseObligations_documentation_en-US" xlink:label="lab_iff_DeferredTaxAssetsLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Lease Obligations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DeferredTaxAssetsLeaseObligations" xlink:href="iff-20231231.xsd#iff_DeferredTaxAssetsLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DeferredTaxAssetsLeaseObligations" xlink:to="lab_iff_DeferredTaxAssetsLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_e99398cd-5b6c-445a-8214-3395c73ba1a8_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MunicipalBondsMember_7518e9a7-f8b2-4524-88de-9d8e8e9b9fe3_terseLabel_en-US" xlink:label="lab_us-gaap_MunicipalBondsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Municipal Bonds</link:label>
    <link:label id="lab_us-gaap_MunicipalBondsMember_label_en-US" xlink:label="lab_us-gaap_MunicipalBondsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Municipal Bonds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MunicipalBondsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MunicipalBondsMember" xlink:to="lab_us-gaap_MunicipalBondsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DisposalGroupIncludingDiscontinuedOperationNetAssets_79387862-af93-425f-8de0-0439eaee1253_terseLabel_en-US" xlink:label="lab_iff_DisposalGroupIncludingDiscontinuedOperationNetAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Net Assets</link:label>
    <link:label id="lab_iff_DisposalGroupIncludingDiscontinuedOperationNetAssets_label_en-US" xlink:label="lab_iff_DisposalGroupIncludingDiscontinuedOperationNetAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Net Assets</link:label>
    <link:label id="lab_iff_DisposalGroupIncludingDiscontinuedOperationNetAssets_documentation_en-US" xlink:label="lab_iff_DisposalGroupIncludingDiscontinuedOperationNetAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Net Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupIncludingDiscontinuedOperationNetAssets" xlink:href="iff-20231231.xsd#iff_DisposalGroupIncludingDiscontinuedOperationNetAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DisposalGroupIncludingDiscontinuedOperationNetAssets" xlink:to="lab_iff_DisposalGroupIncludingDiscontinuedOperationNetAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MalpracticeLossContingencyPeriodIncreaseDecrease_964b9506-da47-4afd-b839-32bf050e99b5_terseLabel_en-US" xlink:label="lab_us-gaap_MalpracticeLossContingencyPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Malpractice Loss Contingency, Period Increase (Decrease)</link:label>
    <link:label id="lab_us-gaap_MalpracticeLossContingencyPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_MalpracticeLossContingencyPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Malpractice Loss Contingency, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MalpracticeLossContingencyPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MalpracticeLossContingencyPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MalpracticeLossContingencyPeriodIncreaseDecrease" xlink:to="lab_us-gaap_MalpracticeLossContingencyPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_TargetPayoutCash_21520d5b-21cb-42c0-bcf0-5d7bcf02ce30_terseLabel_en-US" xlink:label="lab_iff_TargetPayoutCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Target payout percentage, cash</link:label>
    <link:label id="lab_iff_TargetPayoutCash_label_en-US" xlink:label="lab_iff_TargetPayoutCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Target Payout Cash</link:label>
    <link:label id="lab_iff_TargetPayoutCash_documentation_en-US" xlink:label="lab_iff_TargetPayoutCash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Target payout cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TargetPayoutCash" xlink:href="iff-20231231.xsd#iff_TargetPayoutCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_TargetPayoutCash" xlink:to="lab_iff_TargetPayoutCash" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingArrLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingArrLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Arrangements [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="lab_ecd_InsiderTradingArrLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_da14d14a-4ccf-451c-a245-520e2c9c8aff_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_BankGuaranteesCommercialGuaranteesStandbyLettersOfCreditAndSuretyBondsMember_f9db4fdf-850a-4328-96bb-cf25c3d56af6_terseLabel_en-US" xlink:label="lab_iff_BankGuaranteesCommercialGuaranteesStandbyLettersOfCreditAndSuretyBondsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank Guarantees, Commercial Guarantees, Standby Letters Of Credit and Surety Bonds</link:label>
    <link:label id="lab_iff_BankGuaranteesCommercialGuaranteesStandbyLettersOfCreditAndSuretyBondsMember_label_en-US" xlink:label="lab_iff_BankGuaranteesCommercialGuaranteesStandbyLettersOfCreditAndSuretyBondsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank Guarantees, Commercial Guarantees, Standby Letters Of Credit and Surety Bonds [Member]</link:label>
    <link:label id="lab_iff_BankGuaranteesCommercialGuaranteesStandbyLettersOfCreditAndSuretyBondsMember_documentation_en-US" xlink:label="lab_iff_BankGuaranteesCommercialGuaranteesStandbyLettersOfCreditAndSuretyBondsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank Guarantees, Commercial Guarantees, Standby Letters Of Credit and Surety Bonds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BankGuaranteesCommercialGuaranteesStandbyLettersOfCreditAndSuretyBondsMember" xlink:href="iff-20231231.xsd#iff_BankGuaranteesCommercialGuaranteesStandbyLettersOfCreditAndSuretyBondsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_BankGuaranteesCommercialGuaranteesStandbyLettersOfCreditAndSuretyBondsMember" xlink:to="lab_iff_BankGuaranteesCommercialGuaranteesStandbyLettersOfCreditAndSuretyBondsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_2401587b-f75f-4312-9f47-901d70b1bcff_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining number of shares authorized to be repurchase</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_TwoThousandEightToTwoThousandTwentyOneCycleMember_92330717-dd23-4d02-adbe-f552eaf20caf_terseLabel_en-US" xlink:label="lab_iff_TwoThousandEightToTwoThousandTwentyOneCycleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Eight To Two Thousand Twenty-One Cycle</link:label>
    <link:label id="lab_iff_TwoThousandEightToTwoThousandTwentyOneCycleMember_label_en-US" xlink:label="lab_iff_TwoThousandEightToTwoThousandTwentyOneCycleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Eight To Two Thousand Twenty-One Cycle [Member]</link:label>
    <link:label id="lab_iff_TwoThousandEightToTwoThousandTwentyOneCycleMember_documentation_en-US" xlink:label="lab_iff_TwoThousandEightToTwoThousandTwentyOneCycleMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Eight To Two Thousand Twenty-One Cycle</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TwoThousandEightToTwoThousandTwentyOneCycleMember" xlink:href="iff-20231231.xsd#iff_TwoThousandEightToTwoThousandTwentyOneCycleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_TwoThousandEightToTwoThousandTwentyOneCycleMember" xlink:to="lab_iff_TwoThousandEightToTwoThousandTwentyOneCycleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_148d3b95-b76d-4c9d-ab2c-b57e65625b10_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesAdjustments_30383044-246c-4e3a-ad21-c8c2807ab40d_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Translation adjustments</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesAdjustments_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Increase (Decrease) Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesAdjustments" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_ed054937-75f5-4bd0-b2cd-b24d2aef00b3_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation, shares (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_LongTermIncentivePlanMember_ba09174f-0f96-443b-b300-7a693ce4b4e6_terseLabel_en-US" xlink:label="lab_iff_LongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Incentive Plan [Member]</link:label>
    <link:label id="lab_iff_LongTermIncentivePlanMember_label_en-US" xlink:label="lab_iff_LongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Incentive Plan [Member]</link:label>
    <link:label id="lab_iff_LongTermIncentivePlanMember_documentation_en-US" xlink:label="lab_iff_LongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term incentive plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_LongTermIncentivePlanMember" xlink:href="iff-20231231.xsd#iff_LongTermIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_LongTermIncentivePlanMember" xlink:to="lab_iff_LongTermIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntellectualPropertyMember_3feac5ba-2fcc-450f-bc6f-abecb0427661_terseLabel_en-US" xlink:label="lab_us-gaap_IntellectualPropertyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technological Know-how [Member]</link:label>
    <link:label id="lab_us-gaap_IntellectualPropertyMember_label_en-US" xlink:label="lab_us-gaap_IntellectualPropertyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intellectual Property [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntellectualPropertyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntellectualPropertyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntellectualPropertyMember" xlink:to="lab_us-gaap_IntellectualPropertyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_88982991-89b4-4bdd-8d7f-c32cb6436365_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_terseLabel_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_label_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Terms of Trading Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Method</link:label>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMethodTextBlock" xlink:to="lab_ecd_AwardTmgMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_01bf20ff-98a0-4082-9bac-59117bcc6c6a_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
    <link:label id="lab_ecd_AdjToCompAmt_label_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAmt" xlink:to="lab_ecd_AdjToCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_885abc31-67d4-476c-b259-a49a461550b1_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of goods sold [Member]</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_c8746a98-d21d-46a8-a574-18f06c0da1f7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_TwoThousandTwentyTwoToTwoThousandFortyOneMember_3e559a14-6f4b-417a-83f8-c0853ed9eb6f_terseLabel_en-US" xlink:label="lab_iff_TwoThousandTwentyTwoToTwoThousandFortyOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Twenty Two To Two Thousand Forty One</link:label>
    <link:label id="lab_iff_TwoThousandTwentyTwoToTwoThousandFortyOneMember_label_en-US" xlink:label="lab_iff_TwoThousandTwentyTwoToTwoThousandFortyOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Twenty Two To Two Thousand Forty One [Member]</link:label>
    <link:label id="lab_iff_TwoThousandTwentyTwoToTwoThousandFortyOneMember_documentation_en-US" xlink:label="lab_iff_TwoThousandTwentyTwoToTwoThousandFortyOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Twenty Two To Two Thousand Forty One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TwoThousandTwentyTwoToTwoThousandFortyOneMember" xlink:href="iff-20231231.xsd#iff_TwoThousandTwentyTwoToTwoThousandFortyOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_TwoThousandTwentyTwoToTwoThousandFortyOneMember" xlink:to="lab_iff_TwoThousandTwentyTwoToTwoThousandFortyOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseContractualTermAxis_83a0da83-d3f7-41ef-93c3-93c954142279_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseContractualTermAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Contractual Term [Axis]</link:label>
    <link:label id="lab_us-gaap_LeaseContractualTermAxis_label_en-US" xlink:label="lab_us-gaap_LeaseContractualTermAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Contractual Term [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseContractualTermAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseContractualTermAxis" xlink:to="lab_us-gaap_LeaseContractualTermAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_cbfdbef1-e008-4944-8d6d-163a18ce239f_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_label_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeSeveranceMember" xlink:to="lab_us-gaap_EmployeeSeveranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_750b959f-4760-4b26-9564-8ae60a185657_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_e1cafa10-6e16-4f06-9597-7a8e3edb2c3a_periodStartLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_75fb8633-729e-4310-9c38-e1724979bbcd_periodEndLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_f72e2538-eb58-4298-a484-c4615ac56a9a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Decrease) increase in revolving credit facility and short term borrowings</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_a344fa74-c32a-4913-9365-8ac3757bcbc6_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_7e56d932-7c44-45ca-b5e0-f396499e642d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Lines of Credit</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Net Income [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DebtCovenantPeriodAxis_fb134421-bce5-4843-9ba6-36e29609622f_terseLabel_en-US" xlink:label="lab_iff_DebtCovenantPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period [Axis]</link:label>
    <link:label id="lab_iff_DebtCovenantPeriodAxis_label_en-US" xlink:label="lab_iff_DebtCovenantPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period [Axis]</link:label>
    <link:label id="lab_iff_DebtCovenantPeriodAxis_documentation_en-US" xlink:label="lab_iff_DebtCovenantPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DebtCovenantPeriodAxis" xlink:href="iff-20231231.xsd#iff_DebtCovenantPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DebtCovenantPeriodAxis" xlink:to="lab_iff_DebtCovenantPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_ScheduleofStockPurchaseContractTableTextBlock_5672cb64-3310-4052-b4dc-dbdcefcff28c_terseLabel_en-US" xlink:label="lab_iff_ScheduleofStockPurchaseContractTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock Purchase Contract</link:label>
    <link:label id="lab_iff_ScheduleofStockPurchaseContractTableTextBlock_label_en-US" xlink:label="lab_iff_ScheduleofStockPurchaseContractTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock Purchase Contract [Table Text Block]</link:label>
    <link:label id="lab_iff_ScheduleofStockPurchaseContractTableTextBlock_documentation_en-US" xlink:label="lab_iff_ScheduleofStockPurchaseContractTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock Purchase Contract [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ScheduleofStockPurchaseContractTableTextBlock" xlink:href="iff-20231231.xsd#iff_ScheduleofStockPurchaseContractTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_ScheduleofStockPurchaseContractTableTextBlock" xlink:to="lab_iff_ScheduleofStockPurchaseContractTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_label_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peer Group Issuers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:to="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_98436338-72fe-4742-a339-83c230e0e06f_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_d4b7cc48-bb26-425d-b29b-8b51c37ba31b_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested restricted stock units and awards</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_1a40a5a3-82bf-4c22-b6e2-4d9dde9b98c3_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Amount</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1a80c685-b3a1-4c97-b79f-f4328c5d0216_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_e938a6e5-c3d0-4213-a0e7-804c55361a99_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Amount and Estimated Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_aa3b7bbd-ea4d-4b34-b3a7-21ceb81d0682_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price, exercisable (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InternalUseSoftwarePolicy_00782eee-c522-4ee7-a44c-1b698a73f45f_terseLabel_en-US" xlink:label="lab_us-gaap_InternalUseSoftwarePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software Costs</link:label>
    <link:label id="lab_us-gaap_InternalUseSoftwarePolicy_label_en-US" xlink:label="lab_us-gaap_InternalUseSoftwarePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Use Software, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalUseSoftwarePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InternalUseSoftwarePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InternalUseSoftwarePolicy" xlink:to="lab_us-gaap_InternalUseSoftwarePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateAndOtherMember_64743c0b-91cb-47c8-89a3-a44390097bba_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate and Other [Member]</link:label>
    <link:label id="lab_us-gaap_CorporateAndOtherMember_label_en-US" xlink:label="lab_us-gaap_CorporateAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate and Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateAndOtherMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateAndOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateAndOtherMember" xlink:to="lab_us-gaap_CorporateAndOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_b645c031-db47-4e96-bc0c-d63386906598_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_a45170e9-01f7-4aab-9817-15b1c30c827f_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_8a9f2cb5-d080-4b11-878b-404f6b161f7c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements / Curtailments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_981170ba-8f28-4590-b644-46c0cc78eac0_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of gain or (loss) on derivative</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_f5746473-e033-405c-b96b-06eb70b931ea_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:to="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_e22dd086-10cc-4376-8869-d14e17283055_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross carrying value</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis_48ea6eb4-2db5-4c6f-829b-3ff808d49073_terseLabel_en-US" xlink:label="lab_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Uncertainty [Axis]</link:label>
    <link:label id="lab_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis_label_en-US" xlink:label="lab_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Uncertainty [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis" xlink:to="lab_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_dd3bb9bb-dd93-495b-98cc-8a2fd6a4d1d9_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock_76f9b872-eb17-4d7d-8d4d-bc156558efa7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Designated as Cash Flow and Net Investment Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_f41a9817-8603-431d-8552-beb16b68e421_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_e290679d-8bc1-4d56-a121-28d8c34f76f6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements_a1879000-2e13-477c-a275-02362d623960_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases, sales and settlements</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Purchase, Sale, and Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements" xlink:to="lab_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_3b9274f5-8e0d-4cb7-8dc7-85b1f8e85258_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued payroll and bonus</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_64c3ece0-2b90-443d-b605-ee8dd61ed795_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Integration Related Costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_787dfb09-3c7e-407a-804d-56f9d4a8790e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Integration Related Costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Integration Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfFinancingCosts_a25c8453-ba08-48e9-8d88-25f54193880d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfFinancingCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred financing costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Financing Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfFinancingCosts" xlink:to="lab_us-gaap_PaymentsOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedAndProjectedBenefitObligationsTableTextBlock_9297772f-6c85-417a-ba60-96e9540a05c2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedAndProjectedBenefitObligationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Benefit Obligation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedAndProjectedBenefitObligationsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedAndProjectedBenefitObligationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated and Projected Benefit Obligations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedAndProjectedBenefitObligationsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccumulatedAndProjectedBenefitObligationsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedAndProjectedBenefitObligationsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedAndProjectedBenefitObligationsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_ProductLiabilityContingencyLossExposureinExcessofAccrualAmountPaid_622d6aaf-d79b-4614-a2ab-25693fbfd1b3_terseLabel_en-US" xlink:label="lab_iff_ProductLiabilityContingencyLossExposureinExcessofAccrualAmountPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount paid</link:label>
    <link:label id="lab_iff_ProductLiabilityContingencyLossExposureinExcessofAccrualAmountPaid_label_en-US" xlink:label="lab_iff_ProductLiabilityContingencyLossExposureinExcessofAccrualAmountPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Contingency, Loss Exposure in Excess of Accrual, Amount Paid</link:label>
    <link:label id="lab_iff_ProductLiabilityContingencyLossExposureinExcessofAccrualAmountPaid_documentation_en-US" xlink:label="lab_iff_ProductLiabilityContingencyLossExposureinExcessofAccrualAmountPaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Contingency, Loss Exposure in Excess of Accrual, Amount Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ProductLiabilityContingencyLossExposureinExcessofAccrualAmountPaid" xlink:href="iff-20231231.xsd#iff_ProductLiabilityContingencyLossExposureinExcessofAccrualAmountPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_ProductLiabilityContingencyLossExposureinExcessofAccrualAmountPaid" xlink:to="lab_iff_ProductLiabilityContingencyLossExposureinExcessofAccrualAmountPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_374a4b92-481c-4997-955b-a4cf87d1047c_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_TwoThousandTwentyToTwoThousandTwentyTwoCycleMember_a024bc42-e9ba-4d25-b98b-c6572fa99cf1_terseLabel_en-US" xlink:label="lab_iff_TwoThousandTwentyToTwoThousandTwentyTwoCycleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Nineteen To Two Thousand Twenty-One Cycle</link:label>
    <link:label id="lab_iff_TwoThousandTwentyToTwoThousandTwentyTwoCycleMember_label_en-US" xlink:label="lab_iff_TwoThousandTwentyToTwoThousandTwentyTwoCycleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Twenty To Two Thousand Twenty-Two Cycle [Member]</link:label>
    <link:label id="lab_iff_TwoThousandTwentyToTwoThousandTwentyTwoCycleMember_documentation_en-US" xlink:label="lab_iff_TwoThousandTwentyToTwoThousandTwentyTwoCycleMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Twenty To Two Thousand Twenty-Two Cycle</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TwoThousandTwentyToTwoThousandTwentyTwoCycleMember" xlink:href="iff-20231231.xsd#iff_TwoThousandTwentyToTwoThousandTwentyTwoCycleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_TwoThousandTwentyToTwoThousandTwentyTwoCycleMember" xlink:to="lab_iff_TwoThousandTwentyToTwoThousandTwentyTwoCycleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherRestructuringMember_78e77da7-bac7-4ec5-ac58-88478dd08c47_terseLabel_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other(1)</link:label>
    <link:label id="lab_us-gaap_OtherRestructuringMember_label_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherRestructuringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherRestructuringMember" xlink:to="lab_us-gaap_OtherRestructuringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndName_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_TrdArrIndName_label_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndName" xlink:to="lab_ecd_TrdArrIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_4d295ce0-e903-4402-8e61-1ed5d0c19d49_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net current period other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RisksAndUncertaintiesAbstract_498f908a-f658-47ca-9d13-0aa3d3f35ab7_terseLabel_en-US" xlink:label="lab_us-gaap_RisksAndUncertaintiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risks and Uncertainties [Abstract]</link:label>
    <link:label id="lab_us-gaap_RisksAndUncertaintiesAbstract_label_en-US" xlink:label="lab_us-gaap_RisksAndUncertaintiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risks and Uncertainties [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract" xlink:to="lab_us-gaap_RisksAndUncertaintiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_CosmeticIngredientsMember_5647f008-7ee4-4c7b-86c0-0ad2feebf5f5_terseLabel_en-US" xlink:label="lab_iff_CosmeticIngredientsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cosmetic Ingredients</link:label>
    <link:label id="lab_iff_CosmeticIngredientsMember_label_en-US" xlink:label="lab_iff_CosmeticIngredientsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cosmetic Ingredients [Member]</link:label>
    <link:label id="lab_iff_CosmeticIngredientsMember_documentation_en-US" xlink:label="lab_iff_CosmeticIngredientsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cosmetic Ingredients</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_CosmeticIngredientsMember" xlink:href="iff-20231231.xsd#iff_CosmeticIngredientsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_CosmeticIngredientsMember" xlink:to="lab_iff_CosmeticIngredientsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e90c3919-6bed-4851-ba44-03a401f37501_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5abda16e-cf4e-46ee-a9a9-f3e13e524a0e_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_cb2288c1-f686-4e89-939d-cf4aeec147e5_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_USCorporateBondsMember_d2798bc3-e05a-4875-ab62-da75d8da83ab_terseLabel_en-US" xlink:label="lab_iff_USCorporateBondsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Corporate Bonds</link:label>
    <link:label id="lab_iff_USCorporateBondsMember_label_en-US" xlink:label="lab_iff_USCorporateBondsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U S Corporate Bonds [Member]</link:label>
    <link:label id="lab_iff_USCorporateBondsMember_documentation_en-US" xlink:label="lab_iff_USCorporateBondsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Corporate Bonds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_USCorporateBondsMember" xlink:href="iff-20231231.xsd#iff_USCorporateBondsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_USCorporateBondsMember" xlink:to="lab_iff_USCorporateBondsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_78dd784a-d4d2-4df1-8819-dad30c9c884d_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_aac8cad9-63b7-4ddc-a1ee-72f5eed34a10_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_95421372-90b5-4bec-b8a5-ea37438cf563_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNetHedgeIneffectivenessGainLoss_80e3d00b-6db1-4760-a62b-55d6cb65846e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNetHedgeIneffectivenessGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, net hedge ineffectiveness gain (loss)</link:label>
    <link:label id="lab_us-gaap_DerivativeNetHedgeIneffectivenessGainLoss_label_en-US" xlink:label="lab_us-gaap_DerivativeNetHedgeIneffectivenessGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Net Hedge Ineffectiveness Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNetHedgeIneffectivenessGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeNetHedgeIneffectivenessGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNetHedgeIneffectivenessGainLoss" xlink:to="lab_us-gaap_DerivativeNetHedgeIneffectivenessGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_5326bd8d-c5fa-45db-9af6-2d78b6d2e0e7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease weighted average discount rate</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_57f1a03f-894b-4f47-8768-2ac7e02b83fc_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:to="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_8986a8c7-8a44-417e-aaa3-7f009e517d4b_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_a5a7fd58-daf8-4e2b-9711-fac7f8b0a692_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid, net of amounts capitalized</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_PharmaSolutionsMember_28c4a403-9467-4072-a6b3-eb22d7437904_terseLabel_en-US" xlink:label="lab_iff_PharmaSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharma Solutions</link:label>
    <link:label id="lab_iff_PharmaSolutionsMember_label_en-US" xlink:label="lab_iff_PharmaSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharma Solutions [Member]</link:label>
    <link:label id="lab_iff_PharmaSolutionsMember_documentation_en-US" xlink:label="lab_iff_PharmaSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharma Solutions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_PharmaSolutionsMember" xlink:href="iff-20231231.xsd#iff_PharmaSolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_PharmaSolutionsMember" xlink:to="lab_iff_PharmaSolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTerm_c1333efb-0c4b-42e8-9e1b-6faa0acae3dd_terseLabel_en-US" xlink:label="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual term, in years</link:label>
    <link:label id="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTerm_label_en-US" xlink:label="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award, Contractual Term</link:label>
    <link:label id="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTerm_documentation_en-US" xlink:label="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum term of options or units granted.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTerm" xlink:href="iff-20231231.xsd#iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTerm" xlink:to="lab_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscounted_e958fcd3-432c-4ce6-b96f-b56c54c78a1e_terseLabel_en-US" xlink:label="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscounted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current accrual</link:label>
    <link:label id="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscounted_label_en-US" xlink:label="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscounted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Malpractice Loss Contingency, Accrual, Undiscounted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscounted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MalpracticeLossContingencyAccrualUndiscounted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscounted" xlink:to="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscounted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_ff2a1c9c-33c1-44c0-b339-a16cb325b959_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_9370535a-b02f-4ab0-af46-b122a15d5779_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Issued for Services</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Issued for Services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_29219cc1-47f8-4bb3-bebb-8a98a568fbba_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_c86f0b06-7583-412a-8c70-5cb9c192439c_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease weighted average remaining lease term</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_543f31bc-e4d7-48a5-9432-4b23a73efff4_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_fcf78c8e-a911-41c1-8b02-e5cbb883879f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_3bd0651a-be60-4545-ac96-40b5c36fc982_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorLongTermNotes_addb4f82-eba3-4584-b10f-5c26d1d28ce6_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorLongTermNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes</link:label>
    <link:label id="lab_us-gaap_SeniorLongTermNotes_label_en-US" xlink:label="lab_us-gaap_SeniorLongTermNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorLongTermNotes" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorLongTermNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorLongTermNotes" xlink:to="lab_us-gaap_SeniorLongTermNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4eb9641a-f998-4755-b896-b6397baa843e_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average number of shares outstanding - diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5cb3452b-d4d7-417d-9277-78cadfdb29ec_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average number of shares outstanding - diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax_e42778da-f87d-4df9-bc91-4f8877df310e_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net actuarial loss (gain)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), after Reclassification Adjustment, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_98c9620d-1f94-40cd-9be0-a4a426dcd916_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount_8cc622b8-59f6-49af-892a-49c9718e93b4_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global intangible low-taxed income expense</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, GILTI, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_bc9263e5-d6e4-4419-b08c-9e278c90f753_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_0ffe0500-c212-4498-a60a-9d3294847738_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets and Liabilities Held for Sale</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_fcae42e6-8b6c-46a0-8410-6368d65348b6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction from business divestiture</link:label>
    <link:label id="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_label_en-US" xlink:label="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Written off Related to Sale of Business Unit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:to="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DebtCovenantPeriodDomain_c3763eac-36c9-40c6-bb16-341a432daf39_terseLabel_en-US" xlink:label="lab_iff_DebtCovenantPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period [Domain]</link:label>
    <link:label id="lab_iff_DebtCovenantPeriodDomain_label_en-US" xlink:label="lab_iff_DebtCovenantPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period [Domain]</link:label>
    <link:label id="lab_iff_DebtCovenantPeriodDomain_documentation_en-US" xlink:label="lab_iff_DebtCovenantPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DebtCovenantPeriodDomain" xlink:href="iff-20231231.xsd#iff_DebtCovenantPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DebtCovenantPeriodDomain" xlink:to="lab_iff_DebtCovenantPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired_d3a38e5d-eb2a-485b-8c49-f2a6f1985770_terseLabel_en-US" xlink:label="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired_label_en-US" xlink:label="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefinitelivedIntangibleAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:to="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_61eecc82-f54a-4699-a2bf-253f9fa6d821_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions to property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureAmt" xlink:to="lab_ecd_CoSelectedMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_FairValueOfPlanAssetsBeforeReceivablesMember_077c1da8-1ad9-42bf-b8c4-de6e3f0e25ed_terseLabel_en-US" xlink:label="lab_iff_FairValueOfPlanAssetsBeforeReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Of Plan Assets Before Receivables</link:label>
    <link:label id="lab_iff_FairValueOfPlanAssetsBeforeReceivablesMember_label_en-US" xlink:label="lab_iff_FairValueOfPlanAssetsBeforeReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Of Plan Assets Before Receivables [Member]</link:label>
    <link:label id="lab_iff_FairValueOfPlanAssetsBeforeReceivablesMember_documentation_en-US" xlink:label="lab_iff_FairValueOfPlanAssetsBeforeReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Of Plan Assets Before Receivables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FairValueOfPlanAssetsBeforeReceivablesMember" xlink:href="iff-20231231.xsd#iff_FairValueOfPlanAssetsBeforeReceivablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_FairValueOfPlanAssetsBeforeReceivablesMember" xlink:to="lab_iff_FairValueOfPlanAssetsBeforeReceivablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201613Member_fac4caa8-94db-467d-9f3f-31fce52e7bdc_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-13 [Member]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201613Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-13 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201613Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_088aed22-a167-4cd6-965a-67cc29b453b7_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted&#160;Average Remaining Contractual Life (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_EuroSeniorNotes2016Member_e9c2d091-df9c-4c90-bdd4-dc6330628c6c_terseLabel_en-US" xlink:label="lab_iff_EuroSeniorNotes2016Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Senior Notes 2016 [Member]</link:label>
    <link:label id="lab_iff_EuroSeniorNotes2016Member_label_en-US" xlink:label="lab_iff_EuroSeniorNotes2016Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Senior Notes 2016 [Member]</link:label>
    <link:label id="lab_iff_EuroSeniorNotes2016Member_documentation_en-US" xlink:label="lab_iff_EuroSeniorNotes2016Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Senior Notes 2016 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EuroSeniorNotes2016Member" xlink:href="iff-20231231.xsd#iff_EuroSeniorNotes2016Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_EuroSeniorNotes2016Member" xlink:to="lab_iff_EuroSeniorNotes2016Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_8aa6663a-e419-4134-85ff-542f27ec5330_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_IndefiniteMember_ae6b2b63-daeb-4be4-8fca-fa72dd7be03b_terseLabel_en-US" xlink:label="lab_iff_IndefiniteMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite [Member]</link:label>
    <link:label id="lab_iff_IndefiniteMember_label_en-US" xlink:label="lab_iff_IndefiniteMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite [Member]</link:label>
    <link:label id="lab_iff_IndefiniteMember_documentation_en-US" xlink:label="lab_iff_IndefiniteMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_IndefiniteMember" xlink:href="iff-20231231.xsd#iff_IndefiniteMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_IndefiniteMember" xlink:to="lab_iff_IndefiniteMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_0f0dbb78-0118-4128-9cc8-f1397676f1a2_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Assets</link:label>
    <link:label id="lab_us-gaap_Assets_b242f75e-9b26-45d1-86cd-bfb03ed171b7_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_Assets_f6fb96fa-9b99-4af6-96f2-9bbf5e584209_verboseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:to="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_c263502c-bc18-441a-b7d3-1509d6e71a08_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing lease, After 5 years</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper_c4f131c4-6567-4ff5-ada3-592295c701b0_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of commercial paper</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DebtInstrumentCovenantMaximumConsolidatedLeverageRatio_3a540f37-00fe-425f-b436-bacabdbfe25f_terseLabel_en-US" xlink:label="lab_iff_DebtInstrumentCovenantMaximumConsolidatedLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum consolidated leverage ratio</link:label>
    <link:label id="lab_iff_DebtInstrumentCovenantMaximumConsolidatedLeverageRatio_label_en-US" xlink:label="lab_iff_DebtInstrumentCovenantMaximumConsolidatedLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Maximum Consolidated Leverage Ratio</link:label>
    <link:label id="lab_iff_DebtInstrumentCovenantMaximumConsolidatedLeverageRatio_documentation_en-US" xlink:label="lab_iff_DebtInstrumentCovenantMaximumConsolidatedLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Maximum Consolidated Leverage Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DebtInstrumentCovenantMaximumConsolidatedLeverageRatio" xlink:href="iff-20231231.xsd#iff_DebtInstrumentCovenantMaximumConsolidatedLeverageRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DebtInstrumentCovenantMaximumConsolidatedLeverageRatio" xlink:to="lab_iff_DebtInstrumentCovenantMaximumConsolidatedLeverageRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_7381ab0d-6854-4960-856a-85083b7e692b_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_279eca50-71bf-4b5a-9e25-02a993377bd1_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_7df31fad-dc65-4fb5-be2b-01901a90522b_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows for finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_cbc1fd44-1b76-4623-9b6b-e328f4d817cc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonNeosMember_terseLabel_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-NEOs</link:label>
    <link:label id="lab_ecd_NonNeosMember_label_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-NEOs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonNeosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonNeosMember" xlink:to="lab_ecd_NonNeosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_d21f0bb1-0dcd-431a-adcc-26ba60063d9b_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in process [Member]</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_TermLoanCreditAgreementMember_b4b4e8fa-16cd-466a-be90-f603cafb78ad_terseLabel_en-US" xlink:label="lab_iff_TermLoanCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Credit Agreement</link:label>
    <link:label id="lab_iff_TermLoanCreditAgreementMember_label_en-US" xlink:label="lab_iff_TermLoanCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Credit Agreement [Member]</link:label>
    <link:label id="lab_iff_TermLoanCreditAgreementMember_documentation_en-US" xlink:label="lab_iff_TermLoanCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Credit Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TermLoanCreditAgreementMember" xlink:href="iff-20231231.xsd#iff_TermLoanCreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_TermLoanCreditAgreementMember" xlink:to="lab_iff_TermLoanCreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_8ddf4bcc-b7b3-4105-9667-f80c34831ccb_terseLabel_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_label_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain" xlink:to="lab_us-gaap_PlanAssetCategoriesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_48ea6e63-68c7-4567-9f68-c586d567a261_terseLabel_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan</link:label>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:to="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_LondonInterbankOfferedRateLIBOR1Member_d971e2c4-25a1-4bba-9f29-797a436e0b81_terseLabel_en-US" xlink:label="lab_iff_LondonInterbankOfferedRateLIBOR1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR)</link:label>
    <link:label id="lab_iff_LondonInterbankOfferedRateLIBOR1Member_label_en-US" xlink:label="lab_iff_LondonInterbankOfferedRateLIBOR1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR)1 [Member]</link:label>
    <link:label id="lab_iff_LondonInterbankOfferedRateLIBOR1Member_documentation_en-US" xlink:label="lab_iff_LondonInterbankOfferedRateLIBOR1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR)1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_LondonInterbankOfferedRateLIBOR1Member" xlink:href="iff-20231231.xsd#iff_LondonInterbankOfferedRateLIBOR1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_LondonInterbankOfferedRateLIBOR1Member" xlink:to="lab_iff_LondonInterbankOfferedRateLIBOR1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_39d01608-7c1c-4626-9489-38273467481f_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoMember_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO</link:label>
    <link:label id="lab_ecd_NonPeoNeoMember_label_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoMember" xlink:to="lab_ecd_NonPeoNeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_a19eed57-c3b4-478a-b0f0-0ae3ad91e922_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Target percentage of investment in equity securities</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAxis_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Compensation:</link:label>
    <link:label id="lab_ecd_AdjToCompAxis_label_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="lab_ecd_AdjToCompAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_MalpracticeLossContingencyPaymentsInceptionToDate_cbac42e9-5b23-4022-9643-8f15460f5cb0_terseLabel_en-US" xlink:label="lab_iff_MalpracticeLossContingencyPaymentsInceptionToDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Malpractice Loss Contingency, Payments, Inception-to-date</link:label>
    <link:label id="lab_iff_MalpracticeLossContingencyPaymentsInceptionToDate_label_en-US" xlink:label="lab_iff_MalpracticeLossContingencyPaymentsInceptionToDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Malpractice Loss Contingency, Payments, Inception-to-date</link:label>
    <link:label id="lab_iff_MalpracticeLossContingencyPaymentsInceptionToDate_documentation_en-US" xlink:label="lab_iff_MalpracticeLossContingencyPaymentsInceptionToDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Malpractice Loss Contingency, Payments, Inception-to-date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_MalpracticeLossContingencyPaymentsInceptionToDate" xlink:href="iff-20231231.xsd#iff_MalpracticeLossContingencyPaymentsInceptionToDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_MalpracticeLossContingencyPaymentsInceptionToDate" xlink:to="lab_iff_MalpracticeLossContingencyPaymentsInceptionToDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_aeb69f54-4001-400c-9ab2-e6a7747a9a8a_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of common stock issued to DuPont stockholders</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfChangesInAccumulatedPostemploymentBenefitObligationsTableTextBlock_680871a0-0f67-4506-8a6f-a79743c6f34b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfChangesInAccumulatedPostemploymentBenefitObligationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Postretirement Benefit Obligation and Plan Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfChangesInAccumulatedPostemploymentBenefitObligationsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfChangesInAccumulatedPostemploymentBenefitObligationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Accumulated Postemployment Benefit Obligations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangesInAccumulatedPostemploymentBenefitObligationsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfChangesInAccumulatedPostemploymentBenefitObligationsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfChangesInAccumulatedPostemploymentBenefitObligationsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfChangesInAccumulatedPostemploymentBenefitObligationsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_4085c2fa-2c0f-41e0-ad8a-80b6ec8b7eb4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax asset</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_5cf147be-c0f5-468a-970d-259cd8438915_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_d30abfa9-5aa3-40ea-979e-0db3db6f5bad_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4d9a39d1-5760-4029-9195-d0725cbafb5e_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average number of shares outstanding - basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_GuangzhouFlavorsPlantMember_d4be87d1-a086-4c94-8b7d-e7516eee3104_terseLabel_en-US" xlink:label="lab_iff_GuangzhouFlavorsPlantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guangzhou Flavors Plant [Member]</link:label>
    <link:label id="lab_iff_GuangzhouFlavorsPlantMember_label_en-US" xlink:label="lab_iff_GuangzhouFlavorsPlantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guangzhou Flavors Plant [Member]</link:label>
    <link:label id="lab_iff_GuangzhouFlavorsPlantMember_documentation_en-US" xlink:label="lab_iff_GuangzhouFlavorsPlantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guangzhou Flavors Plant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_GuangzhouFlavorsPlantMember" xlink:href="iff-20231231.xsd#iff_GuangzhouFlavorsPlantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_GuangzhouFlavorsPlantMember" xlink:to="lab_iff_GuangzhouFlavorsPlantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearOne_16eba9a8-6a93-472d-87db-6ea599e2e939_terseLabel_en-US" xlink:label="lab_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearOne" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:label id="lab_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearOne_label_en-US" xlink:label="lab_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:label id="lab_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearOne_documentation_en-US" xlink:label="lab_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearOne" xlink:href="iff-20231231.xsd#iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearOne" xlink:to="lab_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearOne" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_8cabd464-b833-42c7-a31b-d909950fd5b4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstateMember_96933d36-151a-4f89-b49e-35620336ebb4_terseLabel_en-US" xlink:label="lab_us-gaap_RealEstateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property</link:label>
    <link:label id="lab_us-gaap_RealEstateMember_label_en-US" xlink:label="lab_us-gaap_RealEstateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealEstateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstateMember" xlink:to="lab_us-gaap_RealEstateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_9ffc823b-c8d5-4aa1-928f-a2c224043dff_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EnvironmentalExpenseAndLiabilities_6981bf65-0dc9-493a-bcb6-124b4e4122a5_terseLabel_en-US" xlink:label="lab_us-gaap_EnvironmentalExpenseAndLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental expense and liabilities</link:label>
    <link:label id="lab_us-gaap_EnvironmentalExpenseAndLiabilities_label_en-US" xlink:label="lab_us-gaap_EnvironmentalExpenseAndLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Expense and Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalExpenseAndLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EnvironmentalExpenseAndLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EnvironmentalExpenseAndLiabilities" xlink:to="lab_us-gaap_EnvironmentalExpenseAndLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_EurocurrencyRateMember_1f4c2ce4-8f86-4a8c-b9ee-c6dd520ac8da_terseLabel_en-US" xlink:label="lab_iff_EurocurrencyRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eurocurrency Rate</link:label>
    <link:label id="lab_iff_EurocurrencyRateMember_label_en-US" xlink:label="lab_iff_EurocurrencyRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eurocurrency Rate [Member]</link:label>
    <link:label id="lab_iff_EurocurrencyRateMember_documentation_en-US" xlink:label="lab_iff_EurocurrencyRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eurocurrency Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EurocurrencyRateMember" xlink:href="iff-20231231.xsd#iff_EurocurrencyRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_EurocurrencyRateMember" xlink:to="lab_iff_EurocurrencyRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_b0dd262e-fc7c-4879-ae3b-83b866215612_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of stock in connection with stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTable_terseLabel_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance Disclosure</link:label>
    <link:label id="lab_ecd_PvpTable_label_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTable" xlink:to="lab_ecd_PvpTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_DealContingentSwapsMember_6e4f0ba9-8d8b-4f23-b94a-657fd8dd6bc9_terseLabel_en-US" xlink:label="lab_iff_DealContingentSwapsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deal Contingent Swaps [Member]</link:label>
    <link:label id="lab_iff_DealContingentSwapsMember_label_en-US" xlink:label="lab_iff_DealContingentSwapsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deal Contingent Swaps [Member]</link:label>
    <link:label id="lab_iff_DealContingentSwapsMember_documentation_en-US" xlink:label="lab_iff_DealContingentSwapsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deal Contingent Swaps [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DealContingentSwapsMember" xlink:href="iff-20231231.xsd#iff_DealContingentSwapsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_DealContingentSwapsMember" xlink:to="lab_iff_DealContingentSwapsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_fdbd1ad1-4698-4279-a086-d785515e7caa_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_GlobalSharedServicesImplementationCosts_d8623620-5583-4091-9a4d-206bede88e87_negatedTerseLabel_en-US" xlink:label="lab_iff_GlobalSharedServicesImplementationCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Shared Services Implementation Costs</link:label>
    <link:label id="lab_iff_GlobalSharedServicesImplementationCosts_label_en-US" xlink:label="lab_iff_GlobalSharedServicesImplementationCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Shared Services Implementation Costs</link:label>
    <link:label id="lab_iff_GlobalSharedServicesImplementationCosts_documentation_en-US" xlink:label="lab_iff_GlobalSharedServicesImplementationCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Shared Services Implementation Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_GlobalSharedServicesImplementationCosts" xlink:href="iff-20231231.xsd#iff_GlobalSharedServicesImplementationCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_GlobalSharedServicesImplementationCosts" xlink:to="lab_iff_GlobalSharedServicesImplementationCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_CommonStockDividendsPerShareMaximumDividendThresholdPerYear_113ec51b-421e-4bbf-838c-e67c8fb55ae8_terseLabel_en-US" xlink:label="lab_iff_CommonStockDividendsPerShareMaximumDividendThresholdPerYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum dividend threshold per year</link:label>
    <link:label id="lab_iff_CommonStockDividendsPerShareMaximumDividendThresholdPerYear_label_en-US" xlink:label="lab_iff_CommonStockDividendsPerShareMaximumDividendThresholdPerYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends Per Share, Maximum Dividend Threshold Per Year</link:label>
    <link:label id="lab_iff_CommonStockDividendsPerShareMaximumDividendThresholdPerYear_documentation_en-US" xlink:label="lab_iff_CommonStockDividendsPerShareMaximumDividendThresholdPerYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends Per Share, Maximum Dividend Threshold Per Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_CommonStockDividendsPerShareMaximumDividendThresholdPerYear" xlink:href="iff-20231231.xsd#iff_CommonStockDividendsPerShareMaximumDividendThresholdPerYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_CommonStockDividendsPerShareMaximumDividendThresholdPerYear" xlink:to="lab_iff_CommonStockDividendsPerShareMaximumDividendThresholdPerYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_38a6e7ed-934c-4864-ab96-d55dfdc917c2_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_65f4cabb-06e3-47d3-bb22-400ab8554317_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected to Vest (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiAmount_2d4711d5-43f0-45f1-8802-570853e81537_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign derived intangible income expense</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiAmount_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, FDII, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationFdiiAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiAmount" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_7c5ca62b-90a3-4e1e-ac6d-61430c198504_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets(1)</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_TangibleEquityUnitsConditionalValue_4d51b265-5414-4f28-a47c-84ef4099f2ee_terseLabel_en-US" xlink:label="lab_iff_TangibleEquityUnitsConditionalValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Equity Units, Conditional Value</link:label>
    <link:label id="lab_iff_TangibleEquityUnitsConditionalValue_label_en-US" xlink:label="lab_iff_TangibleEquityUnitsConditionalValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Equity Units, Conditional Value</link:label>
    <link:label id="lab_iff_TangibleEquityUnitsConditionalValue_documentation_en-US" xlink:label="lab_iff_TangibleEquityUnitsConditionalValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Equity Units, Conditional Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityUnitsConditionalValue" xlink:href="iff-20231231.xsd#iff_TangibleEquityUnitsConditionalValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_TangibleEquityUnitsConditionalValue" xlink:to="lab_iff_TangibleEquityUnitsConditionalValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_ae138771-24ee-4076-8e67-01e1163031ae_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iff_EffectiveIncomeTaxRateReconciliationTaxBenefitFromSupplyChainOptimizationPercent_f5e6d37e-94f0-467c-8fa8-b9658d7c1d3c_terseLabel_en-US" xlink:label="lab_iff_EffectiveIncomeTaxRateReconciliationTaxBenefitFromSupplyChainOptimizationPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefit from supply chain optimization</link:label>
    <link:label id="lab_iff_EffectiveIncomeTaxRateReconciliationTaxBenefitFromSupplyChainOptimizationPercent_label_en-US" xlink:label="lab_iff_EffectiveIncomeTaxRateReconciliationTaxBenefitFromSupplyChainOptimizationPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Benefit From Supply Chain Optimization, Percent</link:label>
    <link:label id="lab_iff_EffectiveIncomeTaxRateReconciliationTaxBenefitFromSupplyChainOptimizationPercent_documentation_en-US" xlink:label="lab_iff_EffectiveIncomeTaxRateReconciliationTaxBenefitFromSupplyChainOptimizationPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Benefit From Supply Chain Optimization, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EffectiveIncomeTaxRateReconciliationTaxBenefitFromSupplyChainOptimizationPercent" xlink:href="iff-20231231.xsd#iff_EffectiveIncomeTaxRateReconciliationTaxBenefitFromSupplyChainOptimizationPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iff_EffectiveIncomeTaxRateReconciliationTaxBenefitFromSupplyChainOptimizationPercent" xlink:to="lab_iff_EffectiveIncomeTaxRateReconciliationTaxBenefitFromSupplyChainOptimizationPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_e34091fc-b14e-49c3-ae2b-d6355a18bd83_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Domain]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesUsSmallCapMember_8826272a-cf74-4da7-ae08-5a2d4025cb5f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesUsSmallCapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Small Cap</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesUsSmallCapMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesUsSmallCapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Equity Securities, US, Small Cap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsSmallCapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesUsSmallCapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsSmallCapMember" xlink:to="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesUsSmallCapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_d4b9c21e-8dce-4fc4-ba92-6528cda4ea43_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling interest</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_e6739c30-8306-4d67-9de6-45cd9160b7e6_verboseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Tax Carryforward [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:to="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>iff-20231231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:0b208b7a-5cd8-4cb9-aadf-23532e94abd0,g:23e07c85-fb0b-44f9-a3e5-5e9f1b6ef71a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.iff.com/role/CoverPage" xlink:type="simple" xlink:href="iff-20231231.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_5d0bdc5a-e3e4-44a2-9623-8deae4deefbf" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_ebfb42fc-4c8e-4cd4-81aa-d0808b8c1b64" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5d0bdc5a-e3e4-44a2-9623-8deae4deefbf" xlink:to="loc_dei_DocumentInformationTable_ebfb42fc-4c8e-4cd4-81aa-d0808b8c1b64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1897cad8-a980-4ef4-a5a2-1bc85f3723b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_ebfb42fc-4c8e-4cd4-81aa-d0808b8c1b64" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1897cad8-a980-4ef4-a5a2-1bc85f3723b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_dd46a53f-39a2-47b7-876f-6a527af56ddb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1897cad8-a980-4ef4-a5a2-1bc85f3723b6" xlink:to="loc_us-gaap_ClassOfStockDomain_dd46a53f-39a2-47b7-876f-6a527af56ddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_cdbd69c6-56eb-4da3-bf99-117784b14ff4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_dd46a53f-39a2-47b7-876f-6a527af56ddb" xlink:to="loc_us-gaap_CommonStockMember_cdbd69c6-56eb-4da3-bf99-117784b14ff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_A1.750SeniorNotesDue2024Member_b7d4aed0-25bb-4469-89c4-71521f4dce23" xlink:href="iff-20231231.xsd#iff_A1.750SeniorNotesDue2024Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_dd46a53f-39a2-47b7-876f-6a527af56ddb" xlink:to="loc_iff_A1.750SeniorNotesDue2024Member_b7d4aed0-25bb-4469-89c4-71521f4dce23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_A1.800SeniorNotesDue2026Member_b90bbdde-9e3d-47a6-bd95-808a7ce84c96" xlink:href="iff-20231231.xsd#iff_A1.800SeniorNotesDue2026Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_dd46a53f-39a2-47b7-876f-6a527af56ddb" xlink:to="loc_iff_A1.800SeniorNotesDue2026Member_b90bbdde-9e3d-47a6-bd95-808a7ce84c96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_4bbef374-8abb-48ec-b40d-20cec347e94b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_ebfb42fc-4c8e-4cd4-81aa-d0808b8c1b64" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_4bbef374-8abb-48ec-b40d-20cec347e94b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_1d95a69e-9942-4429-a56c-0d5da7ef9003" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_4bbef374-8abb-48ec-b40d-20cec347e94b" xlink:to="loc_dei_AddressTypeDomain_1d95a69e-9942-4429-a56c-0d5da7ef9003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_OtherAddressMember_dafc47c4-4ecb-4b48-96c4-b8fc467c20c6" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherAddressMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_AddressTypeDomain_1d95a69e-9942-4429-a56c-0d5da7ef9003" xlink:to="loc_dei_OtherAddressMember_dafc47c4-4ecb-4b48-96c4-b8fc467c20c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_ebfb42fc-4c8e-4cd4-81aa-d0808b8c1b64" xlink:to="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_d47b2c20-4a98-47fc-863c-7408c9c8cb04" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_DocumentType_d47b2c20-4a98-47fc-863c-7408c9c8cb04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_7ac24b03-07a3-4fb6-b494-7f2532b8a5bf" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_DocumentAnnualReport_7ac24b03-07a3-4fb6-b494-7f2532b8a5bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_57c3bfcd-3473-4613-bb01-8c7e00bc02a1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_DocumentPeriodEndDate_57c3bfcd-3473-4613-bb01-8c7e00bc02a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_94cab76e-f7dc-4e63-8b40-8b7a803887ff" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_CurrentFiscalYearEndDate_94cab76e-f7dc-4e63-8b40-8b7a803887ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_a5294a99-8095-4b11-9f65-660656fe8e80" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_DocumentTransitionReport_a5294a99-8095-4b11-9f65-660656fe8e80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_0d959dda-3617-4163-82df-c27bf5cbd0cd" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_EntityFileNumber_0d959dda-3617-4163-82df-c27bf5cbd0cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_e86993db-8857-4295-825e-8dad80e5a816" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_EntityRegistrantName_e86993db-8857-4295-825e-8dad80e5a816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_c6ab3f96-d349-4646-abfa-139306be1491" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_EntityCentralIndexKey_c6ab3f96-d349-4646-abfa-139306be1491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_f6a92611-7a1a-4180-b2b3-d1850d7a9489" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_DocumentFiscalYearFocus_f6a92611-7a1a-4180-b2b3-d1850d7a9489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_2284d63d-f6fd-4c92-bc77-de2ec2ad008b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_DocumentFiscalPeriodFocus_2284d63d-f6fd-4c92-bc77-de2ec2ad008b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_f0a0d801-c0a1-4982-917b-caace96db7fa" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_AmendmentFlag_f0a0d801-c0a1-4982-917b-caace96db7fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_13ef29cb-9309-4ed2-b92e-a869e2c8f0f4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_EntityIncorporationStateCountryCode_13ef29cb-9309-4ed2-b92e-a869e2c8f0f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_d0427821-d5c6-4779-920c-e2c86e15bc78" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_EntityTaxIdentificationNumber_d0427821-d5c6-4779-920c-e2c86e15bc78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_78b9d812-2017-4ee9-a522-fbde7f17ced5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_EntityAddressAddressLine1_78b9d812-2017-4ee9-a522-fbde7f17ced5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_c4f85636-49b8-4e34-a51d-10818b4d68ad" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_EntityAddressCityOrTown_c4f85636-49b8-4e34-a51d-10818b4d68ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_a6fd1152-48cc-4877-98a7-02491a6349b3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_EntityAddressStateOrProvince_a6fd1152-48cc-4877-98a7-02491a6349b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_dbfe1a16-216a-4219-8821-73743ea018a0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_EntityAddressPostalZipCode_dbfe1a16-216a-4219-8821-73743ea018a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_27f310ab-e411-461c-8afd-efad43814eff" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_CityAreaCode_27f310ab-e411-461c-8afd-efad43814eff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_76a91cea-9bff-45c0-b391-5e3e35db268e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_LocalPhoneNumber_76a91cea-9bff-45c0-b391-5e3e35db268e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_08dee9f1-c102-4a09-8e5c-23be343f8721" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_Security12bTitle_08dee9f1-c102-4a09-8e5c-23be343f8721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_ab3a75ab-aee9-4569-a89e-4ce835b0c86c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_TradingSymbol_ab3a75ab-aee9-4569-a89e-4ce835b0c86c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_da078dbf-25e7-4849-be3c-1699bb074873" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_SecurityExchangeName_da078dbf-25e7-4849-be3c-1699bb074873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_7f9f1a16-0021-4e77-8af5-d7ddb0fe44fe" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_7f9f1a16-0021-4e77-8af5-d7ddb0fe44fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_6bc47fbb-6524-47fb-816a-d1f31a0de8ed" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_EntityVoluntaryFilers_6bc47fbb-6524-47fb-816a-d1f31a0de8ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_b3027adc-4460-4620-9f26-844f42e901be" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_EntityCurrentReportingStatus_b3027adc-4460-4620-9f26-844f42e901be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_ac217b41-0bf9-4f29-af32-95d8ab2bf01f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_EntityInteractiveDataCurrent_ac217b41-0bf9-4f29-af32-95d8ab2bf01f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_af3c49a2-0c5c-4a0c-8efd-455bac946497" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_EntityFilerCategory_af3c49a2-0c5c-4a0c-8efd-455bac946497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_6f46ffad-f23c-49c4-8506-51119234b43f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_EntitySmallBusiness_6f46ffad-f23c-49c4-8506-51119234b43f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_14fd5a29-58e7-4f71-a8f0-b79ba9ea179e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_EntityEmergingGrowthCompany_14fd5a29-58e7-4f71-a8f0-b79ba9ea179e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_0f9f0801-f090-4a93-9a6e-e0145d1af82c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_IcfrAuditorAttestationFlag_0f9f0801-f090-4a93-9a6e-e0145d1af82c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_57ff8681-9ce3-4c23-afc8-9e1d3ddeef59" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_EntityShellCompany_57ff8681-9ce3-4c23-afc8-9e1d3ddeef59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_3302b35c-0dc9-47da-90a6-c229bbc79613" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_EntityPublicFloat_3302b35c-0dc9-47da-90a6-c229bbc79613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_135173f1-468b-4e90-98e6-b836d915dc48" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_135173f1-468b-4e90-98e6-b836d915dc48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_d66abdbd-99fc-4283-a531-0dd9038826a0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_d66abdbd-99fc-4283-a531-0dd9038826a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag_aee09ff4-8577-4055-bf93-d5edcf6ccbf7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_DocumentFinStmtErrorCorrectionFlag_aee09ff4-8577-4055-bf93-d5edcf6ccbf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag_8477d86e-d56f-4a3c-9353-0615c2d4f34d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtRestatementRecoveryAnalysisFlag"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3d90d598-b27f-4f4e-ae48-7ecbdcea68d1" xlink:to="loc_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag_8477d86e-d56f-4a3c-9353-0615c2d4f34d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/AuditInformation" xlink:type="simple" xlink:href="iff-20231231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_iff_AuditInformationAbstract_9d59b340-46c3-4a8a-8453-59c4133cbec8" xlink:href="iff-20231231.xsd#iff_AuditInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_b79a7b1a-f724-4a87-ac2c-1c7b581dfd63" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_AuditInformationAbstract_9d59b340-46c3-4a8a-8453-59c4133cbec8" xlink:to="loc_dei_AuditorName_b79a7b1a-f724-4a87-ac2c-1c7b581dfd63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_c2ab78b1-89f7-4177-85b5-452435be53e1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_AuditInformationAbstract_9d59b340-46c3-4a8a-8453-59c4133cbec8" xlink:to="loc_dei_AuditorLocation_c2ab78b1-89f7-4177-85b5-452435be53e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_2c445a99-cae5-4582-8357-c1332c43d9f0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_AuditInformationAbstract_9d59b340-46c3-4a8a-8453-59c4133cbec8" xlink:to="loc_dei_AuditorFirmId_2c445a99-cae5-4582-8357-c1332c43d9f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="iff-20231231.xsd#CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_f7b54bf2-c447-474c-8eeb-62f5d4da55f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8ed452c2-9116-47ad-b2b5-84df8c1d9609" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f7b54bf2-c447-474c-8eeb-62f5d4da55f9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8ed452c2-9116-47ad-b2b5-84df8c1d9609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_92bcd574-c484-4a5c-a0b9-9fb43083c81d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f7b54bf2-c447-474c-8eeb-62f5d4da55f9" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_92bcd574-c484-4a5c-a0b9-9fb43083c81d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_621e1ea0-5271-41eb-b827-5e12c28baa5f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f7b54bf2-c447-474c-8eeb-62f5d4da55f9" xlink:to="loc_us-gaap_GrossProfit_621e1ea0-5271-41eb-b827-5e12c28baa5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_763c4cc9-7090-49f0-a9e6-85d83eda498c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f7b54bf2-c447-474c-8eeb-62f5d4da55f9" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_763c4cc9-7090-49f0-a9e6-85d83eda498c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_859ee83f-f7b5-4787-86bc-17af8d86024a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f7b54bf2-c447-474c-8eeb-62f5d4da55f9" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_859ee83f-f7b5-4787-86bc-17af8d86024a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_RestructuringandOtherCharges_83146d35-f2ec-4e0a-9f67-67162404dc5f" xlink:href="iff-20231231.xsd#iff_RestructuringandOtherCharges"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f7b54bf2-c447-474c-8eeb-62f5d4da55f9" xlink:to="loc_iff_RestructuringandOtherCharges_83146d35-f2ec-4e0a-9f67-67162404dc5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_82a31327-0783-4232-9e18-f70b7ea5fc64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f7b54bf2-c447-474c-8eeb-62f5d4da55f9" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_82a31327-0783-4232-9e18-f70b7ea5fc64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_9ede5a70-433e-4995-a43c-fb9e550fb968" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f7b54bf2-c447-474c-8eeb-62f5d4da55f9" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_9ede5a70-433e-4995-a43c-fb9e550fb968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_6403564b-9e61-4f2c-9c9c-ed82d7d066ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f7b54bf2-c447-474c-8eeb-62f5d4da55f9" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_6403564b-9e61-4f2c-9c9c-ed82d7d066ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_40ee51da-ba73-42b1-a84c-d6d316b217fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f7b54bf2-c447-474c-8eeb-62f5d4da55f9" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_40ee51da-ba73-42b1-a84c-d6d316b217fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_450f837e-d80d-4da2-bf7e-d9282e810ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f7b54bf2-c447-474c-8eeb-62f5d4da55f9" xlink:to="loc_us-gaap_OperatingIncomeLoss_450f837e-d80d-4da2-bf7e-d9282e810ec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_66c02633-8838-497a-bdd6-afeed25c420b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f7b54bf2-c447-474c-8eeb-62f5d4da55f9" xlink:to="loc_us-gaap_InterestExpense_66c02633-8838-497a-bdd6-afeed25c420b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_5ed89741-1397-40df-a220-6098284874d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f7b54bf2-c447-474c-8eeb-62f5d4da55f9" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_5ed89741-1397-40df-a220-6098284874d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a5c16787-c87b-4012-8aa3-e57932937f11" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f7b54bf2-c447-474c-8eeb-62f5d4da55f9" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a5c16787-c87b-4012-8aa3-e57932937f11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_6a31c5c2-fe43-406b-aa94-f6b452c4fd75" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f7b54bf2-c447-474c-8eeb-62f5d4da55f9" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_6a31c5c2-fe43-406b-aa94-f6b452c4fd75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_0ce11b08-f882-4413-8dc9-90006a8a550c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f7b54bf2-c447-474c-8eeb-62f5d4da55f9" xlink:to="loc_us-gaap_ProfitLoss_0ce11b08-f882-4413-8dc9-90006a8a550c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_df850c0a-7d85-4704-84d4-9f771f523abf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f7b54bf2-c447-474c-8eeb-62f5d4da55f9" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_df850c0a-7d85-4704-84d4-9f771f523abf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_ab7132cb-f103-418d-b838-b9df8468471c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f7b54bf2-c447-474c-8eeb-62f5d4da55f9" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_ab7132cb-f103-418d-b838-b9df8468471c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_49489b17-48ac-4361-823e-edfff2fb29e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f7b54bf2-c447-474c-8eeb-62f5d4da55f9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_49489b17-48ac-4361-823e-edfff2fb29e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_0a386c60-77e6-4611-8b8b-a83b6925fc5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_49489b17-48ac-4361-823e-edfff2fb29e5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_0a386c60-77e6-4611-8b8b-a83b6925fc5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_e6628868-f327-4c30-87cc-dd2feeb87ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_49489b17-48ac-4361-823e-edfff2fb29e5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_e6628868-f327-4c30-87cc-dd2feeb87ab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_9a41fe30-51c3-4390-9e21-73ba4c97f9a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_49489b17-48ac-4361-823e-edfff2fb29e5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_9a41fe30-51c3-4390-9e21-73ba4c97f9a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4b37c00c-0f85-4637-b4b2-dffad8766151" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_49489b17-48ac-4361-823e-edfff2fb29e5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4b37c00c-0f85-4637-b4b2-dffad8766151" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_67b0a928-d9d2-46fe-9d8e-539740fbf66c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_49489b17-48ac-4361-823e-edfff2fb29e5" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_67b0a928-d9d2-46fe-9d8e-539740fbf66c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_ff42dc76-9a4b-45f4-aff6-aaf34d3f0585" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_49489b17-48ac-4361-823e-edfff2fb29e5" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_ff42dc76-9a4b-45f4-aff6-aaf34d3f0585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_57a4a888-318b-4e1a-8637-acaa8d122b91" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f7b54bf2-c447-474c-8eeb-62f5d4da55f9" xlink:to="loc_us-gaap_EarningsPerShareBasic_57a4a888-318b-4e1a-8637-acaa8d122b91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_8e701783-cd95-48d4-8d07-4b85dcc06aef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f7b54bf2-c447-474c-8eeb-62f5d4da55f9" xlink:to="loc_us-gaap_EarningsPerShareDiluted_8e701783-cd95-48d4-8d07-4b85dcc06aef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8213326b-1d98-4c6b-b937-5f81e18e5ce4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f7b54bf2-c447-474c-8eeb-62f5d4da55f9" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8213326b-1d98-4c6b-b937-5f81e18e5ce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2c0625b1-cd49-406e-91e3-7cebc1d64c87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f7b54bf2-c447-474c-8eeb-62f5d4da55f9" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2c0625b1-cd49-406e-91e3-7cebc1d64c87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/CONSOLIDATEDBALANCESHEET" xlink:type="simple" xlink:href="iff-20231231.xsd#CONSOLIDATEDBALANCESHEET"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/CONSOLIDATEDBALANCESHEET" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_ce420a99-5d7a-4fc8-ae80-5c6bc4125ea1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_e5aee394-d081-433b-bc84-b9aadf896726" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ce420a99-5d7a-4fc8-ae80-5c6bc4125ea1" xlink:to="loc_us-gaap_AssetsAbstract_e5aee394-d081-433b-bc84-b9aadf896726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_f32420ec-ed13-4734-964a-868ed1f04c9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e5aee394-d081-433b-bc84-b9aadf896726" xlink:to="loc_us-gaap_AssetsCurrentAbstract_f32420ec-ed13-4734-964a-868ed1f04c9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_83671078-c2e9-4198-a4a8-3ab264ea3fa4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f32420ec-ed13-4734-964a-868ed1f04c9f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_83671078-c2e9-4198-a4a8-3ab264ea3fa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_898d767f-3cc6-4c3f-bc11-f89a4520d541" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f32420ec-ed13-4734-964a-868ed1f04c9f" xlink:to="loc_us-gaap_RestrictedCashCurrent_898d767f-3cc6-4c3f-bc11-f89a4520d541" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_38e8bf4c-0007-4429-810f-853b874fcb34" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f32420ec-ed13-4734-964a-868ed1f04c9f" xlink:to="loc_us-gaap_ReceivablesNetCurrent_38e8bf4c-0007-4429-810f-853b874fcb34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_cf5edc51-e7cd-4914-8edc-bbe520046df1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f32420ec-ed13-4734-964a-868ed1f04c9f" xlink:to="loc_us-gaap_InventoryNet_cf5edc51-e7cd-4914-8edc-bbe520046df1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_23d11c35-1b44-402f-b6a5-4c1d68383d68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f32420ec-ed13-4734-964a-868ed1f04c9f" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_23d11c35-1b44-402f-b6a5-4c1d68383d68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_49598948-bb0a-430b-8f3d-be4370ad4959" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f32420ec-ed13-4734-964a-868ed1f04c9f" xlink:to="loc_us-gaap_OtherAssetsCurrent_49598948-bb0a-430b-8f3d-be4370ad4959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_1f60ca81-4f12-4bd8-8f4f-937748e964ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f32420ec-ed13-4734-964a-868ed1f04c9f" xlink:to="loc_us-gaap_AssetsCurrent_1f60ca81-4f12-4bd8-8f4f-937748e964ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_44dd936b-3ad5-4906-9086-17cdb19e4534" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e5aee394-d081-433b-bc84-b9aadf896726" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_44dd936b-3ad5-4906-9086-17cdb19e4534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d90a6a35-41e8-4004-85a8-4e0b35491da7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e5aee394-d081-433b-bc84-b9aadf896726" xlink:to="loc_us-gaap_Goodwill_d90a6a35-41e8-4004-85a8-4e0b35491da7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_a24ab1a9-2670-42ec-aa49-62a5b615230e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e5aee394-d081-433b-bc84-b9aadf896726" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_a24ab1a9-2670-42ec-aa49-62a5b615230e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_3761f6b3-daae-4371-aa17-5e5d50680ad3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e5aee394-d081-433b-bc84-b9aadf896726" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_3761f6b3-daae-4371-aa17-5e5d50680ad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_d95657da-2e3c-4ac4-ad85-5fcaf3bf43ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e5aee394-d081-433b-bc84-b9aadf896726" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_d95657da-2e3c-4ac4-ad85-5fcaf3bf43ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_3123b612-edf6-4383-9609-6f10d6adf4e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e5aee394-d081-433b-bc84-b9aadf896726" xlink:to="loc_us-gaap_Assets_3123b612-edf6-4383-9609-6f10d6adf4e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_25df89ec-5787-4e43-acae-fce4d8fc76e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ce420a99-5d7a-4fc8-ae80-5c6bc4125ea1" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_25df89ec-5787-4e43-acae-fce4d8fc76e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_23581f93-caa8-44bc-8118-97e6901dd2b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_25df89ec-5787-4e43-acae-fce4d8fc76e4" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_23581f93-caa8-44bc-8118-97e6901dd2b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_f1823007-da2c-4cb7-a7b3-46bdd705c8f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_23581f93-caa8-44bc-8118-97e6901dd2b9" xlink:to="loc_us-gaap_DebtCurrent_f1823007-da2c-4cb7-a7b3-46bdd705c8f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_CommercialPaperCurrent_092981e7-cf87-45a5-bcf4-e1e5c5e74138" xlink:href="iff-20231231.xsd#iff_CommercialPaperCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_23581f93-caa8-44bc-8118-97e6901dd2b9" xlink:to="loc_iff_CommercialPaperCurrent_092981e7-cf87-45a5-bcf4-e1e5c5e74138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_2cb739d6-08e1-48c6-843a-736b2e8ed2f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_23581f93-caa8-44bc-8118-97e6901dd2b9" xlink:to="loc_us-gaap_AccountsPayableCurrent_2cb739d6-08e1-48c6-843a-736b2e8ed2f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_ef3e0012-135d-432b-826a-06f0d6fc8790" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_23581f93-caa8-44bc-8118-97e6901dd2b9" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_ef3e0012-135d-432b-826a-06f0d6fc8790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent_3302271f-964c-4073-a46e-7cc718924261" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_23581f93-caa8-44bc-8118-97e6901dd2b9" xlink:to="loc_us-gaap_DividendsPayableCurrent_3302271f-964c-4073-a46e-7cc718924261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_bf3db252-2b83-449a-bfe1-8f2a5c174288" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_23581f93-caa8-44bc-8118-97e6901dd2b9" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_bf3db252-2b83-449a-bfe1-8f2a5c174288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_9796c830-1fe3-40c9-a7ad-03ff25c5f7e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_23581f93-caa8-44bc-8118-97e6901dd2b9" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_9796c830-1fe3-40c9-a7ad-03ff25c5f7e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_31a60d01-2a4b-4390-b356-fdd7749f45ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_23581f93-caa8-44bc-8118-97e6901dd2b9" xlink:to="loc_us-gaap_LiabilitiesCurrent_31a60d01-2a4b-4390-b356-fdd7749f45ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_057e92dc-fe15-4266-a42e-8bde5299393b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_25df89ec-5787-4e43-acae-fce4d8fc76e4" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_057e92dc-fe15-4266-a42e-8bde5299393b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_f4e5a188-d971-4d03-97a4-53ccf89fbe3d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_057e92dc-fe15-4266-a42e-8bde5299393b" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_f4e5a188-d971-4d03-97a4-53ccf89fbe3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_2f8e06d3-d276-44d2-9cfa-0eec2460237c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_057e92dc-fe15-4266-a42e-8bde5299393b" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_2f8e06d3-d276-44d2-9cfa-0eec2460237c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_44eb2cca-b93b-46e0-a273-00616594ebe1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_057e92dc-fe15-4266-a42e-8bde5299393b" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_44eb2cca-b93b-46e0-a273-00616594ebe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_fef97116-b96f-47a5-8894-985fd6e614fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_057e92dc-fe15-4266-a42e-8bde5299393b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_fef97116-b96f-47a5-8894-985fd6e614fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_66774b2f-5f91-4c14-b012-6f6d7630ad97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_057e92dc-fe15-4266-a42e-8bde5299393b" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_66774b2f-5f91-4c14-b012-6f6d7630ad97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_b3624162-de6c-439d-9e6d-6e5c8a49a5d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_057e92dc-fe15-4266-a42e-8bde5299393b" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_b3624162-de6c-439d-9e6d-6e5c8a49a5d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_09c28387-c2ae-42e0-a9f1-d5f7027908e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_25df89ec-5787-4e43-acae-fce4d8fc76e4" xlink:to="loc_us-gaap_CommitmentsAndContingencies_09c28387-c2ae-42e0-a9f1-d5f7027908e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_8fd67f10-83ad-4729-ab75-e5d518561574" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_25df89ec-5787-4e43-acae-fce4d8fc76e4" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_8fd67f10-83ad-4729-ab75-e5d518561574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_ea006c33-efc9-4e48-8ced-74ba6154c991" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_25df89ec-5787-4e43-acae-fce4d8fc76e4" xlink:to="loc_us-gaap_StockholdersEquityAbstract_ea006c33-efc9-4e48-8ced-74ba6154c991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_80eaad60-834f-484c-8648-fc870bd05f4b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_ea006c33-efc9-4e48-8ced-74ba6154c991" xlink:to="loc_us-gaap_CommonStockValue_80eaad60-834f-484c-8648-fc870bd05f4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_235f26af-8c9b-41a6-a399-9aa07d5fe16f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_ea006c33-efc9-4e48-8ced-74ba6154c991" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_235f26af-8c9b-41a6-a399-9aa07d5fe16f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_44d78a85-c83c-4bec-a969-8162dff80695" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_ea006c33-efc9-4e48-8ced-74ba6154c991" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_44d78a85-c83c-4bec-a969-8162dff80695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e7ffe49d-629d-4361-8f18-ae19a4b2b14a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_ea006c33-efc9-4e48-8ced-74ba6154c991" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e7ffe49d-629d-4361-8f18-ae19a4b2b14a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_9bdd83fc-1703-4932-94de-b86848b97c08" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_ea006c33-efc9-4e48-8ced-74ba6154c991" xlink:to="loc_us-gaap_TreasuryStockValue_9bdd83fc-1703-4932-94de-b86848b97c08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7f040a3b-f54b-4663-8a24-d679385532c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_ea006c33-efc9-4e48-8ced-74ba6154c991" xlink:to="loc_us-gaap_StockholdersEquity_7f040a3b-f54b-4663-8a24-d679385532c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_0b10bc12-adc8-45bb-bb12-943d15e723fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_25df89ec-5787-4e43-acae-fce4d8fc76e4" xlink:to="loc_us-gaap_MinorityInterest_0b10bc12-adc8-45bb-bb12-943d15e723fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_71ae9143-346e-48c1-a656-1388302bc11f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_25df89ec-5787-4e43-acae-fce4d8fc76e4" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_71ae9143-346e-48c1-a656-1388302bc11f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_0723be3c-acd1-4f6b-a98b-723ceb23304c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_25df89ec-5787-4e43-acae-fce4d8fc76e4" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_0723be3c-acd1-4f6b-a98b-723ceb23304c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/CONSOLIDATEDBALANCESHEETParenthetical" xlink:type="simple" xlink:href="iff-20231231.xsd#CONSOLIDATEDBALANCESHEETParenthetical"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/CONSOLIDATEDBALANCESHEETParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_b1861654-e3f2-471f-b213-c30a37fe3dd9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_70c7a29b-a1a8-4d14-bce5-9ed6980fef3e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_b1861654-e3f2-471f-b213-c30a37fe3dd9" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_70c7a29b-a1a8-4d14-bce5-9ed6980fef3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_b1b84995-23d3-4e4c-bfbf-e415b126cf96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_b1861654-e3f2-471f-b213-c30a37fe3dd9" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_b1b84995-23d3-4e4c-bfbf-e415b126cf96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_11595c80-52b4-46ed-b002-d2d95aa350d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_b1861654-e3f2-471f-b213-c30a37fe3dd9" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_11595c80-52b4-46ed-b002-d2d95aa350d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_7c1a77e5-cf31-4983-9e3d-6bf2db26f4bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_b1861654-e3f2-471f-b213-c30a37fe3dd9" xlink:to="loc_us-gaap_CommonStockSharesIssued_7c1a77e5-cf31-4983-9e3d-6bf2db26f4bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_55f50b1f-9713-4704-9c56-952bf2f1642a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_b1861654-e3f2-471f-b213-c30a37fe3dd9" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_55f50b1f-9713-4704-9c56-952bf2f1642a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_a8ee3305-583b-4500-9b2a-16443457cd7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_b1861654-e3f2-471f-b213-c30a37fe3dd9" xlink:to="loc_us-gaap_TreasuryStockCommonShares_a8ee3305-583b-4500-9b2a-16443457cd7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS" xlink:type="simple" xlink:href="iff-20231231.xsd#CONSOLIDATEDSTATEMENTOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_e37c7f6c-0592-42b7-8138-5c4ab6524941" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_4b74856b-8e35-4ff5-ab32-e881f0dde7fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e37c7f6c-0592-42b7-8138-5c4ab6524941" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_4b74856b-8e35-4ff5-ab32-e881f0dde7fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_b9bb00cd-116a-47ec-a303-07aab7be4ddd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_4b74856b-8e35-4ff5-ab32-e881f0dde7fd" xlink:to="loc_us-gaap_ProfitLoss_b9bb00cd-116a-47ec-a303-07aab7be4ddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7808e108-d48f-4150-bb73-a24d9783accb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_4b74856b-8e35-4ff5-ab32-e881f0dde7fd" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7808e108-d48f-4150-bb73-a24d9783accb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_bd6c3282-d580-4634-b07a-b4e7b4577288" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7808e108-d48f-4150-bb73-a24d9783accb" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_bd6c3282-d580-4634-b07a-b4e7b4577288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4c30b403-a4ef-4377-a95a-8842baa37265" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7808e108-d48f-4150-bb73-a24d9783accb" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4c30b403-a4ef-4377-a95a-8842baa37265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_5edc731c-082e-4597-afd8-236a854f17d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7808e108-d48f-4150-bb73-a24d9783accb" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_5edc731c-082e-4597-afd8-236a854f17d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_f33d097a-e8e4-4c5c-80f1-87c2bd27e3a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7808e108-d48f-4150-bb73-a24d9783accb" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_f33d097a-e8e4-4c5c-80f1-87c2bd27e3a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_741cd05e-2336-4476-8c5b-4e18a9b8dbae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7808e108-d48f-4150-bb73-a24d9783accb" xlink:to="loc_us-gaap_ShareBasedCompensation_741cd05e-2336-4476-8c5b-4e18a9b8dbae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionContributions_9a1e4458-3ed7-4ad2-8197-45d7667d0c02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionContributions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7808e108-d48f-4150-bb73-a24d9783accb" xlink:to="loc_us-gaap_PensionContributions_9a1e4458-3ed7-4ad2-8197-45d7667d0c02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AmortizationOfInventoryStepUp_7dacfc23-6417-4b22-a80c-f4d8f8ac4434" xlink:href="iff-20231231.xsd#iff_AmortizationOfInventoryStepUp"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7808e108-d48f-4150-bb73-a24d9783accb" xlink:to="loc_iff_AmortizationOfInventoryStepUp_7dacfc23-6417-4b22-a80c-f4d8f8ac4434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_93735da0-ac19-4a71-bb56-28978d15303a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7808e108-d48f-4150-bb73-a24d9783accb" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_93735da0-ac19-4a71-bb56-28978d15303a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_5e9104e4-ca3d-4f9a-8437-5ddb5b6cff9d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7808e108-d48f-4150-bb73-a24d9783accb" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_5e9104e4-ca3d-4f9a-8437-5ddb5b6cff9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_1f634f13-cab4-42b7-b10a-e8c8985b798c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWriteDown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7808e108-d48f-4150-bb73-a24d9783accb" xlink:to="loc_us-gaap_InventoryWriteDown_1f634f13-cab4-42b7-b10a-e8c8985b798c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6a1b8d16-8d8a-43ea-bf86-95be4ce9d1d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7808e108-d48f-4150-bb73-a24d9783accb" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6a1b8d16-8d8a-43ea-bf86-95be4ce9d1d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_b838aded-eedb-49bc-a090-a1c2a99fca9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6a1b8d16-8d8a-43ea-bf86-95be4ce9d1d6" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_b838aded-eedb-49bc-a090-a1c2a99fca9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_0bd137a0-e9a3-40de-8775-524741dd8c30" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6a1b8d16-8d8a-43ea-bf86-95be4ce9d1d6" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_0bd137a0-e9a3-40de-8775-524741dd8c30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_35c1d816-2e76-46b7-a0c7-a9d7fb41241b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6a1b8d16-8d8a-43ea-bf86-95be4ce9d1d6" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_35c1d816-2e76-46b7-a0c7-a9d7fb41241b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_d4f0da2b-0bd3-4e1a-9375-f747edbc0c6d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6a1b8d16-8d8a-43ea-bf86-95be4ce9d1d6" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_d4f0da2b-0bd3-4e1a-9375-f747edbc0c6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_c26c186b-7c73-4906-b941-506ce6056ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6a1b8d16-8d8a-43ea-bf86-95be4ce9d1d6" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_c26c186b-7c73-4906-b941-506ce6056ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_2a0fd09b-1d09-4437-9a09-293eabe464ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6a1b8d16-8d8a-43ea-bf86-95be4ce9d1d6" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_2a0fd09b-1d09-4437-9a09-293eabe464ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d49ccfeb-18b7-4098-aadc-0b45cddeae17" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_4b74856b-8e35-4ff5-ab32-e881f0dde7fd" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d49ccfeb-18b7-4098-aadc-0b45cddeae17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_305400a6-7eea-4d9e-a433-bb06b5b05708" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e37c7f6c-0592-42b7-8138-5c4ab6524941" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_305400a6-7eea-4d9e-a433-bb06b5b05708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_62af8977-b85e-41f4-bf0d-686763693886" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_305400a6-7eea-4d9e-a433-bb06b5b05708" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_62af8977-b85e-41f4-bf0d-686763693886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ea27eba8-5adb-43c7-9dec-d12910b8678c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_305400a6-7eea-4d9e-a433-bb06b5b05708" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ea27eba8-5adb-43c7-9dec-d12910b8678c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_e3d4a2a2-21de-4609-8bea-853f4da18adb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_305400a6-7eea-4d9e-a433-bb06b5b05708" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_e3d4a2a2-21de-4609-8bea-853f4da18adb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_d6f9906b-6eea-49fa-9600-47fcb216e122" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_305400a6-7eea-4d9e-a433-bb06b5b05708" xlink:to="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_d6f9906b-6eea-49fa-9600-47fcb216e122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities_469f66a5-20b4-49c8-b2a4-79ab22e43d39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_305400a6-7eea-4d9e-a433-bb06b5b05708" xlink:to="loc_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities_469f66a5-20b4-49c8-b2a4-79ab22e43d39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ProceedsFromBusinessCombination_78462aa5-1d8c-41aa-891e-82f5f1b52fe9" xlink:href="iff-20231231.xsd#iff_ProceedsFromBusinessCombination"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_305400a6-7eea-4d9e-a433-bb06b5b05708" xlink:to="loc_iff_ProceedsFromBusinessCombination_78462aa5-1d8c-41aa-891e-82f5f1b52fe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_21b2689d-f3b9-4383-8c3e-6f972eeec5b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_305400a6-7eea-4d9e-a433-bb06b5b05708" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_21b2689d-f3b9-4383-8c3e-6f972eeec5b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_634f73f4-b538-45f1-9e8e-183b6f8bf9a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_305400a6-7eea-4d9e-a433-bb06b5b05708" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_634f73f4-b538-45f1-9e8e-183b6f8bf9a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6457f363-094f-4d5f-8488-38b25f0573ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e37c7f6c-0592-42b7-8138-5c4ab6524941" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6457f363-094f-4d5f-8488-38b25f0573ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_4f5eb319-68db-456c-ba2c-54857036c013" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6457f363-094f-4d5f-8488-38b25f0573ec" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_4f5eb319-68db-456c-ba2c-54857036c013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsMinorityInterest_0c0c7b13-4a3c-412b-858d-8ab92e777cda" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividendsMinorityInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6457f363-094f-4d5f-8488-38b25f0573ec" xlink:to="loc_us-gaap_PaymentsOfDividendsMinorityInterest_0c0c7b13-4a3c-412b-858d-8ab92e777cda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_1b0f14b4-1c52-41c0-b2bb-c95cf9a30650" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6457f363-094f-4d5f-8488-38b25f0573ec" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_1b0f14b4-1c52-41c0-b2bb-c95cf9a30650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ProceedsFromIssuanceOfCommercialPaperMaturingInMoreThanThreeMonths_8e78101f-8f82-4aa9-8616-ede2bffc3ba8" xlink:href="iff-20231231.xsd#iff_ProceedsFromIssuanceOfCommercialPaperMaturingInMoreThanThreeMonths"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6457f363-094f-4d5f-8488-38b25f0573ec" xlink:to="loc_iff_ProceedsFromIssuanceOfCommercialPaperMaturingInMoreThanThreeMonths_8e78101f-8f82-4aa9-8616-ede2bffc3ba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_RepaymentsOfCommercialPaperMaturingInMoreThanThreeMonths_e68cbeaa-24e0-4939-96aa-e03177549a68" xlink:href="iff-20231231.xsd#iff_RepaymentsOfCommercialPaperMaturingInMoreThanThreeMonths"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6457f363-094f-4d5f-8488-38b25f0573ec" xlink:to="loc_iff_RepaymentsOfCommercialPaperMaturingInMoreThanThreeMonths_e68cbeaa-24e0-4939-96aa-e03177549a68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NetBorrowingsRepaymentsOfCommercialPaperMaturingInLessThanThreeMonths_6c0e3979-f27f-4cb9-9954-bfc7568a6bef" xlink:href="iff-20231231.xsd#iff_NetBorrowingsRepaymentsOfCommercialPaperMaturingInLessThanThreeMonths"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6457f363-094f-4d5f-8488-38b25f0573ec" xlink:to="loc_iff_NetBorrowingsRepaymentsOfCommercialPaperMaturingInLessThanThreeMonths_6c0e3979-f27f-4cb9-9954-bfc7568a6bef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts_da6eb156-adde-4095-b6ef-242958e1dda4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6457f363-094f-4d5f-8488-38b25f0573ec" xlink:to="loc_us-gaap_PaymentsOfFinancingCosts_da6eb156-adde-4095-b6ef-242958e1dda4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_72036727-070a-4208-8435-9f2e384f2983" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6457f363-094f-4d5f-8488-38b25f0573ec" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_72036727-070a-4208-8435-9f2e384f2983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_05c5eb86-75c3-4b23-ab4b-c87a585c4dee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6457f363-094f-4d5f-8488-38b25f0573ec" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_05c5eb86-75c3-4b23-ab4b-c87a585c4dee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_0b946e3a-ebbf-4ecb-bc5e-a4df9ee45355" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6457f363-094f-4d5f-8488-38b25f0573ec" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_0b946e3a-ebbf-4ecb-bc5e-a4df9ee45355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_3cbfcb95-c384-4e3d-b834-c11c064dad8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6457f363-094f-4d5f-8488-38b25f0573ec" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_3cbfcb95-c384-4e3d-b834-c11c064dad8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_69645b36-d0b3-43b2-a6b1-c528307efa33" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6457f363-094f-4d5f-8488-38b25f0573ec" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_69645b36-d0b3-43b2-a6b1-c528307efa33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_0e4382b6-12ba-48e2-b369-48c45664a2e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6457f363-094f-4d5f-8488-38b25f0573ec" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_0e4382b6-12ba-48e2-b369-48c45664a2e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_c6bdf441-e769-4a1a-84e9-f2bc542863fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6457f363-094f-4d5f-8488-38b25f0573ec" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_c6bdf441-e769-4a1a-84e9-f2bc542863fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_791ad882-d314-4b9d-854e-c2030ae063b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6457f363-094f-4d5f-8488-38b25f0573ec" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_791ad882-d314-4b9d-854e-c2030ae063b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fcca6d9f-b8e1-43dd-bc2f-d54b80236e26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e37c7f6c-0592-42b7-8138-5c4ab6524941" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fcca6d9f-b8e1-43dd-bc2f-d54b80236e26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_947eef08-db5d-4f30-9dfa-647a2fe4deef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e37c7f6c-0592-42b7-8138-5c4ab6524941" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_947eef08-db5d-4f30-9dfa-647a2fe4deef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4f1434ef-814a-4be8-bb21-87061991f638" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e37c7f6c-0592-42b7-8138-5c4ab6524941" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4f1434ef-814a-4be8-bb21-87061991f638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2088fb6c-6917-4a27-b975-a8acaf09e788" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e37c7f6c-0592-42b7-8138-5c4ab6524941" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2088fb6c-6917-4a27-b975-a8acaf09e788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_b746c2a8-e49e-4b68-80eb-b56dfaf7c2c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e37c7f6c-0592-42b7-8138-5c4ab6524941" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_b746c2a8-e49e-4b68-80eb-b56dfaf7c2c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_4ca02513-083b-4c32-a68e-c54526761119" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_b746c2a8-e49e-4b68-80eb-b56dfaf7c2c8" xlink:to="loc_us-gaap_InterestPaidNet_4ca02513-083b-4c32-a68e-c54526761119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_3fe38605-efb9-40a2-88d2-6dd43af51c4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_b746c2a8-e49e-4b68-80eb-b56dfaf7c2c8" xlink:to="loc_us-gaap_IncomeTaxesPaid_3fe38605-efb9-40a2-88d2-6dd43af51c4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_ec288e7b-5d7e-44fa-adcc-9d004a67720c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_b746c2a8-e49e-4b68-80eb-b56dfaf7c2c8" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_ec288e7b-5d7e-44fa-adcc-9d004a67720c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY" xlink:type="simple" xlink:href="iff-20231231.xsd#CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_e6b2ef26-5cc9-42e5-b78d-fde45cc17a82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_20f481a3-8948-4455-bd20-92fda26d5864" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_e6b2ef26-5cc9-42e5-b78d-fde45cc17a82" xlink:to="loc_us-gaap_StatementTable_20f481a3-8948-4455-bd20-92fda26d5864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_14a78eca-3075-49c9-955b-07184e4ab94c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_20f481a3-8948-4455-bd20-92fda26d5864" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_14a78eca-3075-49c9-955b-07184e4ab94c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f2c19b30-eed7-43a0-a02f-577da1a613a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_14a78eca-3075-49c9-955b-07184e4ab94c" xlink:to="loc_us-gaap_EquityComponentDomain_f2c19b30-eed7-43a0-a02f-577da1a613a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_7d0aa8f4-14c0-4b31-acf8-b3ce5010cd47" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f2c19b30-eed7-43a0-a02f-577da1a613a6" xlink:to="loc_us-gaap_CommonStockMember_7d0aa8f4-14c0-4b31-acf8-b3ce5010cd47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_7a27c90c-c0b1-490a-b94a-cd9c2f02f9d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f2c19b30-eed7-43a0-a02f-577da1a613a6" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_7a27c90c-c0b1-490a-b94a-cd9c2f02f9d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_730d134f-850c-408b-b692-ad284f4e2a48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f2c19b30-eed7-43a0-a02f-577da1a613a6" xlink:to="loc_us-gaap_RetainedEarningsMember_730d134f-850c-408b-b692-ad284f4e2a48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9503bb81-127b-455e-86a2-8b7770621b2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f2c19b30-eed7-43a0-a02f-577da1a613a6" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9503bb81-127b-455e-86a2-8b7770621b2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_5ccbddf2-55b6-4509-b748-aefccc8c8bac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f2c19b30-eed7-43a0-a02f-577da1a613a6" xlink:to="loc_us-gaap_TreasuryStockCommonMember_5ccbddf2-55b6-4509-b748-aefccc8c8bac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_43b936ec-793a-45a1-a425-3c03196b4509" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f2c19b30-eed7-43a0-a02f-577da1a613a6" xlink:to="loc_us-gaap_NoncontrollingInterestMember_43b936ec-793a-45a1-a425-3c03196b4509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_42a75bb2-fcd0-4188-b3f5-ab462983f720" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_20f481a3-8948-4455-bd20-92fda26d5864" xlink:to="loc_us-gaap_StatementLineItems_42a75bb2-fcd0-4188-b3f5-ab462983f720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b04f925-8ee6-432c-985c-3ab539070cd2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_42a75bb2-fcd0-4188-b3f5-ab462983f720" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b04f925-8ee6-432c-985c-3ab539070cd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_bcad983e-569c-43f1-968e-598923a2c591" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b04f925-8ee6-432c-985c-3ab539070cd2" xlink:to="loc_us-gaap_SharesOutstanding_bcad983e-569c-43f1-968e-598923a2c591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_04bcf33b-3a39-4fb9-a865-50a6b3fd5652" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b04f925-8ee6-432c-985c-3ab539070cd2" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_04bcf33b-3a39-4fb9-a865-50a6b3fd5652" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_10dcb2db-9217-40d3-b794-6b39e464acf9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b04f925-8ee6-432c-985c-3ab539070cd2" xlink:to="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_10dcb2db-9217-40d3-b794-6b39e464acf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_e54907b0-efb1-4da3-b9c0-02f6323a1c7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b04f925-8ee6-432c-985c-3ab539070cd2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_e54907b0-efb1-4da3-b9c0-02f6323a1c7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_49176e0b-9514-4672-958c-4ec23be855c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b04f925-8ee6-432c-985c-3ab539070cd2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_49176e0b-9514-4672-958c-4ec23be855c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_4ff2abcc-4487-4bdb-98ab-e8c16ed25f95" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b04f925-8ee6-432c-985c-3ab539070cd2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_4ff2abcc-4487-4bdb-98ab-e8c16ed25f95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_e769169b-8eb0-476a-b072-f02e6a89cae3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b04f925-8ee6-432c-985c-3ab539070cd2" xlink:to="loc_us-gaap_DividendsCommonStockCash_e769169b-8eb0-476a-b072-f02e6a89cae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_419d1798-de81-42ec-80ff-354259385fa9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b04f925-8ee6-432c-985c-3ab539070cd2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_419d1798-de81-42ec-80ff-354259385fa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_89604052-b9f6-481f-926c-84228d527fba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b04f925-8ee6-432c-985c-3ab539070cd2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_89604052-b9f6-481f-926c-84228d527fba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_b9569477-8c64-4797-9b3a-a85ee7e93b2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b04f925-8ee6-432c-985c-3ab539070cd2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_b9569477-8c64-4797-9b3a-a85ee7e93b2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_0eb95cc3-6fbb-4401-8a65-244185b30f27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b04f925-8ee6-432c-985c-3ab539070cd2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_0eb95cc3-6fbb-4401-8a65-244185b30f27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_c4bd911c-f2a6-48c0-b034-ce007d311b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b04f925-8ee6-432c-985c-3ab539070cd2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_c4bd911c-f2a6-48c0-b034-ce007d311b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_af7f5e25-e600-4e68-b7e7-fe9cb9ab63ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b04f925-8ee6-432c-985c-3ab539070cd2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_af7f5e25-e600-4e68-b7e7-fe9cb9ab63ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_a4ab4886-3bae-4318-b287-7fecfedf8856" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b04f925-8ee6-432c-985c-3ab539070cd2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_a4ab4886-3bae-4318-b287-7fecfedf8856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_ff2bb80a-c540-4202-a36a-f9feef68c2b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b04f925-8ee6-432c-985c-3ab539070cd2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_ff2bb80a-c540-4202-a36a-f9feef68c2b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4f2618b6-1868-4746-b648-44edc605f7a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b04f925-8ee6-432c-985c-3ab539070cd2" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4f2618b6-1868-4746-b648-44edc605f7a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_56de3d06-b4c7-45a2-a501-8019c177eeac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b04f925-8ee6-432c-985c-3ab539070cd2" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_56de3d06-b4c7-45a2-a501-8019c177eeac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_c2498ee4-af1a-4bd7-a076-3c986c266ace" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b04f925-8ee6-432c-985c-3ab539070cd2" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_c2498ee4-af1a-4bd7-a076-3c986c266ace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_224e1c4c-5f45-46c1-af3a-c8090331fb59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b04f925-8ee6-432c-985c-3ab539070cd2" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_224e1c4c-5f45-46c1-af3a-c8090331fb59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_ebb38968-58b1-40ab-a22d-e9206252ff73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b04f925-8ee6-432c-985c-3ab539070cd2" xlink:to="loc_us-gaap_SharesOutstanding_ebb38968-58b1-40ab-a22d-e9206252ff73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5c6ebe73-85b6-4484-bfaf-a5ba1b2b2629" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b04f925-8ee6-432c-985c-3ab539070cd2" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5c6ebe73-85b6-4484-bfaf-a5ba1b2b2629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_18562c7c-49fa-4c4e-9403-00e30eaddac3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_42a75bb2-fcd0-4188-b3f5-ab462983f720" xlink:to="loc_us-gaap_TreasuryStockCommonShares_18562c7c-49fa-4c4e-9403-00e30eaddac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITYParenthetical" xlink:type="simple" xlink:href="iff-20231231.xsd#CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITYParenthetical"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITYParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_02dda0c4-78cf-4590-9f2d-359419cb0e41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_8fa06741-9964-4633-9d9c-0766cb2b2283" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_02dda0c4-78cf-4590-9f2d-359419cb0e41" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_8fa06741-9964-4633-9d9c-0766cb2b2283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_a8d97728-c7e1-4519-aa51-0f1c10335960" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_02dda0c4-78cf-4590-9f2d-359419cb0e41" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_a8d97728-c7e1-4519-aa51-0f1c10335960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_34ecb5d1-cbcc-4bc2-99e1-73528f592985" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_02dda0c4-78cf-4590-9f2d-359419cb0e41" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_34ecb5d1-cbcc-4bc2-99e1-73528f592985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="iff-20231231.xsd#NatureofOperationsandSummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e8295176-28f6-4bfa-88f7-074c8221b722" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_9d7e89d2-7305-4867-a211-d30705cebbdb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e8295176-28f6-4bfa-88f7-074c8221b722" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_9d7e89d2-7305-4867-a211-d30705cebbdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_9a2227a0-6672-44b7-a363-89287a3d7b37" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e8295176-28f6-4bfa-88f7-074c8221b722" xlink:to="loc_us-gaap_NatureOfOperations_9a2227a0-6672-44b7-a363-89287a3d7b37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/RestructuringandOtherCharges" xlink:type="simple" xlink:href="iff-20231231.xsd#RestructuringandOtherCharges"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/RestructuringandOtherCharges" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_fa18ee43-2ed7-4586-81bd-77a8c242e1c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_929ee3c8-1d3d-4ee1-a792-e1ced8279335" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_fa18ee43-2ed7-4586-81bd-77a8c242e1c1" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_929ee3c8-1d3d-4ee1-a792-e1ced8279335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/AcquisitionsNotes" xlink:type="simple" xlink:href="iff-20231231.xsd#AcquisitionsNotes"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/AcquisitionsNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_7996f942-e26d-4780-bf99-5807d35c0742" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_e8f554d2-703b-4b2a-a5a1-5910f156c8ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_7996f942-e26d-4780-bf99-5807d35c0742" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_e8f554d2-703b-4b2a-a5a1-5910f156c8ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/BusinessDivestiture" xlink:type="simple" xlink:href="iff-20231231.xsd#BusinessDivestiture"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/BusinessDivestiture" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_6b9f3b59-4b3f-46bf-ad06-0a4b21da56ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_be1a631f-09ee-4558-af1f-3112f5e4b6be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_6b9f3b59-4b3f-46bf-ad06-0a4b21da56ad" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_be1a631f-09ee-4558-af1f-3112f5e4b6be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/PropertyPlantandEquipmentNet" xlink:type="simple" xlink:href="iff-20231231.xsd#PropertyPlantandEquipmentNet"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/PropertyPlantandEquipmentNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_904b373d-34a0-4ed4-8601-7d5fb924cbb7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_45ead299-7458-42ba-9bbd-780b66042752" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_904b373d-34a0-4ed4-8601-7d5fb924cbb7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_45ead299-7458-42ba-9bbd-780b66042752" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNet" xlink:type="simple" xlink:href="iff-20231231.xsd#GoodwillandOtherIntangibleAssetsNet"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_058a16c8-761a-43e3-b91e-3372b4c7f4f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_d9e5a0c2-acaf-42b7-989b-4fcc6b15eb31" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_058a16c8-761a-43e3-b91e-3372b4c7f4f1" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_d9e5a0c2-acaf-42b7-989b-4fcc6b15eb31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrent" xlink:type="simple" xlink:href="iff-20231231.xsd#OtherAssetsAndLiabilitiesCurrentandNoncurrent"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrent" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsAbstract_f9920e84-6774-45f6-ae6f-bfe50a2e7c3e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_OtherAssetsAndLiabilitiesDisclosureCurrentAndNoncurrentTextBlock_5af0fe9b-d072-4aed-9599-b8def27cbb58" xlink:href="iff-20231231.xsd#iff_OtherAssetsAndLiabilitiesDisclosureCurrentAndNoncurrentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_f9920e84-6774-45f6-ae6f-bfe50a2e7c3e" xlink:to="loc_iff_OtherAssetsAndLiabilitiesDisclosureCurrentAndNoncurrentTextBlock_5af0fe9b-d072-4aed-9599-b8def27cbb58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/Debt" xlink:type="simple" xlink:href="iff-20231231.xsd#Debt"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/Debt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_9e754c58-7bb8-4619-b871-026141bcfbdb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_483f1a09-f7e8-4d0d-a6d4-b0c7898d801a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_9e754c58-7bb8-4619-b871-026141bcfbdb" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_483f1a09-f7e8-4d0d-a6d4-b0c7898d801a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/LeasesNotes" xlink:type="simple" xlink:href="iff-20231231.xsd#LeasesNotes"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/LeasesNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_a97e01f8-dbcd-4207-b9b1-732fe233b800" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_15ef9ae7-9f40-444b-b5f4-b366768bdb0e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a97e01f8-dbcd-4207-b9b1-732fe233b800" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_15ef9ae7-9f40-444b-b5f4-b366768bdb0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/IncomeTaxes" xlink:type="simple" xlink:href="iff-20231231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_a841d004-9d74-44fc-bdcd-4c720bceb84f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_fef7a7e0-63b9-498d-a5be-ad023d14d924" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a841d004-9d74-44fc-bdcd-4c720bceb84f" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_fef7a7e0-63b9-498d-a5be-ad023d14d924" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/NetIncomePerShare" xlink:type="simple" xlink:href="iff-20231231.xsd#NetIncomePerShare"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/NetIncomePerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_50dcf777-266f-4a90-aa84-60cfe5e13590" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_8c6314f3-02e9-4139-99b7-dfb728e41b85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_50dcf777-266f-4a90-aa84-60cfe5e13590" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_8c6314f3-02e9-4139-99b7-dfb728e41b85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/ShareholdersEquity" xlink:type="simple" xlink:href="iff-20231231.xsd#ShareholdersEquity"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/ShareholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_239c29a6-5dfe-4fbd-997f-c5159069499d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_abe7ce72-e9de-45c8-bfaa-362710414de0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_239c29a6-5dfe-4fbd-997f-c5159069499d" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_abe7ce72-e9de-45c8-bfaa-362710414de0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/StockCompensationPlans" xlink:type="simple" xlink:href="iff-20231231.xsd#StockCompensationPlans"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/StockCompensationPlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_08f702fa-2266-4188-92e9-77779d29643d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_27aace44-6e5f-46da-b68d-67831aa7426a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_08f702fa-2266-4188-92e9-77779d29643d" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_27aace44-6e5f-46da-b68d-67831aa7426a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionExercisableByExercisePriceRangeTableTextBlock_57f527c2-b2d3-42b0-b910-e0d1e857392b" xlink:href="iff-20231231.xsd#iff_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionExercisableByExercisePriceRangeTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_08f702fa-2266-4188-92e9-77779d29643d" xlink:to="loc_iff_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionExercisableByExercisePriceRangeTableTextBlock_57f527c2-b2d3-42b0-b910-e0d1e857392b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/SegmentInformation" xlink:type="simple" xlink:href="iff-20231231.xsd#SegmentInformation"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/SegmentInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_19026a22-5711-45fa-912a-ca1bddacde03" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_9a49eafc-27d3-4913-8fd9-8656bb231256" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_19026a22-5711-45fa-912a-ca1bddacde03" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_9a49eafc-27d3-4913-8fd9-8656bb231256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/EmployeeBenefits" xlink:type="simple" xlink:href="iff-20231231.xsd#EmployeeBenefits"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/EmployeeBenefits" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e700b4d4-3069-4cb0-bbd3-0fc60c2fd473" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_dea05381-e30e-4a7a-8b48-7386293103c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e700b4d4-3069-4cb0-bbd3-0fc60c2fd473" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_dea05381-e30e-4a7a-8b48-7386293103c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/FinancialInstruments" xlink:type="simple" xlink:href="iff-20231231.xsd#FinancialInstruments"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/FinancialInstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_01621baf-3ef3-44f6-9844-cfa9634180fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_e0afbed9-3a97-4e2d-a52f-b4190adec46e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_01621baf-3ef3-44f6-9844-cfa9634180fd" xlink:to="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_e0afbed9-3a97-4e2d-a52f-b4190adec46e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLoss" xlink:type="simple" xlink:href="iff-20231231.xsd#AccumulatedOtherComprehensiveIncomeLoss"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_07df96d1-06c6-4a17-8e0b-59cd83342bc5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AccumulatedOtherComprehensiveIncomeLossTextBlock_3e3b5085-ecfe-40a6-98e7-f069c999e2cf" xlink:href="iff-20231231.xsd#iff_AccumulatedOtherComprehensiveIncomeLossTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_07df96d1-06c6-4a17-8e0b-59cd83342bc5" xlink:to="loc_iff_AccumulatedOtherComprehensiveIncomeLossTextBlock_3e3b5085-ecfe-40a6-98e7-f069c999e2cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/ConcentrationsofCreditRisk" xlink:type="simple" xlink:href="iff-20231231.xsd#ConcentrationsofCreditRisk"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/ConcentrationsofCreditRisk" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_f0a67d00-0089-4c9f-8771-63f6e96997f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskDisclosureTextBlock_1a667bc1-f1f1-4e0e-a150-d5510dffb757" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_f0a67d00-0089-4c9f-8771-63f6e96997f4" xlink:to="loc_us-gaap_ConcentrationRiskDisclosureTextBlock_1a667bc1-f1f1-4e0e-a150-d5510dffb757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="iff-20231231.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c5ed229d-1a92-401b-a96a-e18069a012a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_84e183ee-7899-4fe0-8cb3-8b9d2a79e4b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c5ed229d-1a92-401b-a96a-e18069a012a5" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_84e183ee-7899-4fe0-8cb3-8b9d2a79e4b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/RedeemableNoncontrollingInterests" xlink:type="simple" xlink:href="iff-20231231.xsd#RedeemableNoncontrollingInterests"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/RedeemableNoncontrollingInterests" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_c6947e79-07be-479c-8ac8-2b599eeab769" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDisclosureTextBlock_34961c69-5f50-4adf-9bec-0d1aef304886" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_c6947e79-07be-479c-8ac8-2b599eeab769" xlink:to="loc_us-gaap_MinorityInterestDisclosureTextBlock_34961c69-5f50-4adf-9bec-0d1aef304886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/AssetsandLiabilitiesHeldForSale" xlink:type="simple" xlink:href="iff-20231231.xsd#AssetsandLiabilitiesHeldForSale"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/AssetsandLiabilitiesHeldForSale" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_2db9e3e5-fc1c-4b2f-a384-9050c27beaf4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_3fad22d1-218a-4a4a-85ac-bf27ee9d4987" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_2db9e3e5-fc1c-4b2f-a384-9050c27beaf4" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_3fad22d1-218a-4a4a-85ac-bf27ee9d4987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/OtherIncomeandExpenses" xlink:type="simple" xlink:href="iff-20231231.xsd#OtherIncomeandExpenses"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/OtherIncomeandExpenses" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_b861c416-8a2e-454a-8d6d-559ab3b9cfac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock_fc0ba2f2-c40d-435a-95fe-5a428a1b5ea4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_b861c416-8a2e-454a-8d6d-559ab3b9cfac" xlink:to="loc_us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock_fc0ba2f2-c40d-435a-95fe-5a428a1b5ea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/TangibleEquityUnits" xlink:type="simple" xlink:href="iff-20231231.xsd#TangibleEquityUnits"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/TangibleEquityUnits" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_2f0d4a3a-d06c-4338-bf1f-046b53082bf5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_3d6e5b7d-946e-4f84-8986-b0663b7e8224" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2f0d4a3a-d06c-4338-bf1f-046b53082bf5" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_3d6e5b7d-946e-4f84-8986-b0663b7e8224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityUnitsTextBlock_a55521ef-6210-454e-ab47-f1215a49ea5b" xlink:href="iff-20231231.xsd#iff_TangibleEquityUnitsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2f0d4a3a-d06c-4338-bf1f-046b53082bf5" xlink:to="loc_iff_TangibleEquityUnitsTextBlock_a55521ef-6210-454e-ab47-f1215a49ea5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/ScheduleIIValuationandQualifyingAccountsandReserves" xlink:type="simple" xlink:href="iff-20231231.xsd#ScheduleIIValuationandQualifyingAccountsandReserves"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/ScheduleIIValuationandQualifyingAccountsandReserves" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_f830569e-03b5-4547-a6b0-b31386fef95c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_8781ddbd-8535-421d-8c82-fcd1407b8b39" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_f830569e-03b5-4547-a6b0-b31386fef95c" xlink:to="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_8781ddbd-8535-421d-8c82-fcd1407b8b39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="iff-20231231.xsd#NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0119567d-1627-4e64-8e22-59f4d1873b5e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NatureOfOperationsPolicyTextBlock_c1131ff8-3b77-49c4-a0fa-f1a0259b64f2" xlink:href="iff-20231231.xsd#iff_NatureOfOperationsPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0119567d-1627-4e64-8e22-59f4d1873b5e" xlink:to="loc_iff_NatureOfOperationsPolicyTextBlock_c1131ff8-3b77-49c4-a0fa-f1a0259b64f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_b3c26dc0-041e-441a-be6f-c1e390438258" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0119567d-1627-4e64-8e22-59f4d1873b5e" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_b3c26dc0-041e-441a-be6f-c1e390438258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiscalPeriod_f13c3462-f3a1-4902-9ce7-4bbcae192afa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiscalPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0119567d-1627-4e64-8e22-59f4d1873b5e" xlink:to="loc_us-gaap_FiscalPeriod_f13c3462-f3a1-4902-9ce7-4bbcae192afa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_8f513b9b-9e54-45fd-b3f4-a76695297082" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0119567d-1627-4e64-8e22-59f4d1873b5e" xlink:to="loc_us-gaap_UseOfEstimates_8f513b9b-9e54-45fd-b3f4-a76695297082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_258d7e22-c99b-49f1-8719-26fcc2706645" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0119567d-1627-4e64-8e22-59f4d1873b5e" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_258d7e22-c99b-49f1-8719-26fcc2706645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_ad95ec8c-64ff-4c95-a8c2-1715de01d92f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0119567d-1627-4e64-8e22-59f4d1873b5e" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_ad95ec8c-64ff-4c95-a8c2-1715de01d92f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_8fa1c3b7-3b2d-4b59-9fa0-e4ce7eed26fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0119567d-1627-4e64-8e22-59f4d1873b5e" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_8fa1c3b7-3b2d-4b59-9fa0-e4ce7eed26fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_51fe3cfe-6878-4e2a-96eb-6bbe26ded38f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0119567d-1627-4e64-8e22-59f4d1873b5e" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_51fe3cfe-6878-4e2a-96eb-6bbe26ded38f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_4bd23adb-c439-4d98-b8c1-bf667fab1631" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0119567d-1627-4e64-8e22-59f4d1873b5e" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_4bd23adb-c439-4d98-b8c1-bf667fab1631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_67e4ac76-6616-4e20-aad6-b09073da2872" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0119567d-1627-4e64-8e22-59f4d1873b5e" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_67e4ac76-6616-4e20-aad6-b09073da2872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_4733b52b-193a-4bdb-9672-710dd0ef0d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0119567d-1627-4e64-8e22-59f4d1873b5e" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_4733b52b-193a-4bdb-9672-710dd0ef0d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditLossFinancialInstrumentPolicyTextBlock_0092189d-7263-4dba-a154-73722941c26f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditLossFinancialInstrumentPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0119567d-1627-4e64-8e22-59f4d1873b5e" xlink:to="loc_us-gaap_CreditLossFinancialInstrumentPolicyTextBlock_0092189d-7263-4dba-a154-73722941c26f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_6f1916e6-6a6b-47c5-b549-144ba172e4f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0119567d-1627-4e64-8e22-59f4d1873b5e" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_6f1916e6-6a6b-47c5-b549-144ba172e4f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_775b61d5-fe5f-49da-8e33-0a4c1cc97130" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0119567d-1627-4e64-8e22-59f4d1873b5e" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_775b61d5-fe5f-49da-8e33-0a4c1cc97130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_873846c1-810c-4e85-8394-356f8a8f0d25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0119567d-1627-4e64-8e22-59f4d1873b5e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_873846c1-810c-4e85-8394-356f8a8f0d25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_154244e2-71a3-4396-ae49-f94f35fc8f87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0119567d-1627-4e64-8e22-59f4d1873b5e" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_154244e2-71a3-4396-ae49-f94f35fc8f87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_9a2e84ec-41ec-4a0a-bc2b-5a7b8ba65d43" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0119567d-1627-4e64-8e22-59f4d1873b5e" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_9a2e84ec-41ec-4a0a-bc2b-5a7b8ba65d43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_2b57d547-5253-40d7-a66b-2f5524ee9569" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0119567d-1627-4e64-8e22-59f4d1873b5e" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_2b57d547-5253-40d7-a66b-2f5524ee9569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_8497cf8a-2126-47a3-8f87-e3c3175fe1f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0119567d-1627-4e64-8e22-59f4d1873b5e" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_8497cf8a-2126-47a3-8f87-e3c3175fe1f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy_fdef35df-3b20-46a9-863a-8adceaf20f7c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementPlansPolicy"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0119567d-1627-4e64-8e22-59f4d1873b5e" xlink:to="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy_fdef35df-3b20-46a9-863a-8adceaf20f7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_1c47342d-0110-4ece-872f-ad4abeec510b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0119567d-1627-4e64-8e22-59f4d1873b5e" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_1c47342d-0110-4ece-872f-ad4abeec510b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalUseSoftwarePolicy_25c04edf-8d6f-4183-ba18-e412c6389f3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InternalUseSoftwarePolicy"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0119567d-1627-4e64-8e22-59f4d1873b5e" xlink:to="loc_us-gaap_InternalUseSoftwarePolicy_25c04edf-8d6f-4183-ba18-e412c6389f3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_814078b3-10f8-4e06-9cd4-7e10eb9f1fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0119567d-1627-4e64-8e22-59f4d1873b5e" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_814078b3-10f8-4e06-9cd4-7e10eb9f1fc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_9f7f149b-f75d-4d21-8d41-5e54e7fe4e7d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0119567d-1627-4e64-8e22-59f4d1873b5e" xlink:to="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_9f7f149b-f75d-4d21-8d41-5e54e7fe4e7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtPolicyTextBlock_af2760de-07f5-40c3-8948-b3684e61119d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtPolicyTextBlock"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0119567d-1627-4e64-8e22-59f4d1873b5e" xlink:to="loc_us-gaap_DebtPolicyTextBlock_af2760de-07f5-40c3-8948-b3684e61119d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_03a4de23-d904-4e73-8214-2f67d6625ed3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0119567d-1627-4e64-8e22-59f4d1873b5e" xlink:to="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_03a4de23-d904-4e73-8214-2f67d6625ed3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy_35bfcf7c-a9dc-4108-8880-f01f4225e526" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0119567d-1627-4e64-8e22-59f4d1873b5e" xlink:to="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy_35bfcf7c-a9dc-4108-8880-f01f4225e526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SupplierFinanceProgramPolicyPolicyTextBlock_a12ddda5-2bf5-4d0b-ba04-e3acfa36fb2f" xlink:href="iff-20231231.xsd#iff_SupplierFinanceProgramPolicyPolicyTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0119567d-1627-4e64-8e22-59f4d1873b5e" xlink:to="loc_iff_SupplierFinanceProgramPolicyPolicyTextBlock_a12ddda5-2bf5-4d0b-ba04-e3acfa36fb2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_c87c7bef-8dd2-4281-ae6e-5c94310c9cd3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0119567d-1627-4e64-8e22-59f4d1873b5e" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_c87c7bef-8dd2-4281-ae6e-5c94310c9cd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_UnusualOrInfrequentItemsOrBothDisclosurePolicyTextBlock_97c16b6f-dcf3-4ffc-ab75-60fbe7570869" xlink:href="iff-20231231.xsd#iff_UnusualOrInfrequentItemsOrBothDisclosurePolicyTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0119567d-1627-4e64-8e22-59f4d1873b5e" xlink:to="loc_iff_UnusualOrInfrequentItemsOrBothDisclosurePolicyTextBlock_97c16b6f-dcf3-4ffc-ab75-60fbe7570869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="iff-20231231.xsd#NatureofOperationsandSummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_54df51e0-c2e7-4abc-98bb-1736fb37174a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_f4d1a209-d107-4bc2-ae2c-1a6f7a349fa8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_54df51e0-c2e7-4abc-98bb-1736fb37174a" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_f4d1a209-d107-4bc2-ae2c-1a6f7a349fa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_ffee37be-ce95-4a25-9fb9-82c6455f347c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_54df51e0-c2e7-4abc-98bb-1736fb37174a" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_ffee37be-ce95-4a25-9fb9-82c6455f347c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_823cd2b8-5861-4d1b-af32-e8f3b8ec8f8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_54df51e0-c2e7-4abc-98bb-1736fb37174a" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_823cd2b8-5861-4d1b-af32-e8f3b8ec8f8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_a079f7d5-4b1c-434e-bf5b-6c9744ed8656" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_54df51e0-c2e7-4abc-98bb-1736fb37174a" xlink:to="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_a079f7d5-4b1c-434e-bf5b-6c9744ed8656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/RestructuringandOtherChargesTables" xlink:type="simple" xlink:href="iff-20231231.xsd#RestructuringandOtherChargesTables"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/RestructuringandOtherChargesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_f2a554ec-226f-4642-a6ab-f84db54b906c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_c09610e9-df30-4d04-9b69-e2dd5aaf972e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_f2a554ec-226f-4642-a6ab-f84db54b906c" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_c09610e9-df30-4d04-9b69-e2dd5aaf972e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/AcquisitionsTables" xlink:type="simple" xlink:href="iff-20231231.xsd#AcquisitionsTables"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/AcquisitionsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_5e93688d-9b08-43ec-bf62-f99a776e72d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_0201004b-c3eb-4f2b-b056-8288f626cfef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_5e93688d-9b08-43ec-bf62-f99a776e72d2" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_0201004b-c3eb-4f2b-b056-8288f626cfef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_7825ad44-613c-4a20-b5b9-a731d1ae52c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_5e93688d-9b08-43ec-bf62-f99a776e72d2" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_7825ad44-613c-4a20-b5b9-a731d1ae52c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_286ae4ae-5dc5-47d9-97a1-a7b5898b3a57" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_5e93688d-9b08-43ec-bf62-f99a776e72d2" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_286ae4ae-5dc5-47d9-97a1-a7b5898b3a57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/DiscontinuedOperationsandDisposalGroupsTables" xlink:type="simple" xlink:href="iff-20231231.xsd#DiscontinuedOperationsandDisposalGroupsTables"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/DiscontinuedOperationsandDisposalGroupsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_b2ad5cda-73e1-43bc-98fe-cc24ebf7a5fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_86978b6e-a8d2-45db-8c6b-9e4116579b13" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_b2ad5cda-73e1-43bc-98fe-cc24ebf7a5fd" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_86978b6e-a8d2-45db-8c6b-9e4116579b13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/PropertyPlantandEquipmentNetTables" xlink:type="simple" xlink:href="iff-20231231.xsd#PropertyPlantandEquipmentNetTables"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/PropertyPlantandEquipmentNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_0a49e2ef-b7c2-4101-b464-de76e9e5d966" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_1aad2579-bb02-4f30-b96a-da71c8b1e51a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_0a49e2ef-b7c2-4101-b464-de76e9e5d966" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_1aad2579-bb02-4f30-b96a-da71c8b1e51a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetTables" xlink:type="simple" xlink:href="iff-20231231.xsd#GoodwillandOtherIntangibleAssetsNetTables"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a8c1177b-3750-453a-8c4f-2af78cdf3c57" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_6a6b8319-297b-47ee-b15e-14541fcb3ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a8c1177b-3750-453a-8c4f-2af78cdf3c57" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_6a6b8319-297b-47ee-b15e-14541fcb3ef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_71f818c4-77d3-4039-84e1-b1de62099252" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a8c1177b-3750-453a-8c4f-2af78cdf3c57" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_71f818c4-77d3-4039-84e1-b1de62099252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_e2c5fd69-570e-47d8-9458-a4bcdfeb7326" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a8c1177b-3750-453a-8c4f-2af78cdf3c57" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_e2c5fd69-570e-47d8-9458-a4bcdfeb7326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentTables" xlink:type="simple" xlink:href="iff-20231231.xsd#OtherAssetsAndLiabilitiesCurrentandNoncurrentTables"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsAbstract_38e8a65c-2dc4-4fce-a84e-797ecfd17d7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock_1a8f1a08-0b2a-4ab6-bc91-dd07ca7363b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOtherAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_38e8a65c-2dc4-4fce-a84e-797ecfd17d7f" xlink:to="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock_1a8f1a08-0b2a-4ab6-bc91-dd07ca7363b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_c46937fa-4847-4bb2-97a5-3e7326b4a842" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_38e8a65c-2dc4-4fce-a84e-797ecfd17d7f" xlink:to="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_c46937fa-4847-4bb2-97a5-3e7326b4a842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_be46f4a0-bb83-4004-9b85-952c6dc34ae0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_38e8a65c-2dc4-4fce-a84e-797ecfd17d7f" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_be46f4a0-bb83-4004-9b85-952c6dc34ae0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/DebtTables" xlink:type="simple" xlink:href="iff-20231231.xsd#DebtTables"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/DebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_c29cfe63-65c7-4c21-89ab-b94e2c440185" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionTable_2497f438-c093-44e3-abd3-91268d1dbcb6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_c29cfe63-65c7-4c21-89ab-b94e2c440185" xlink:to="loc_us-gaap_DebtInstrumentRedemptionTable_2497f438-c093-44e3-abd3-91268d1dbcb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e89b0cd0-ae55-4ba0-87aa-3d3841ec798a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionTable_2497f438-c093-44e3-abd3-91268d1dbcb6" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e89b0cd0-ae55-4ba0-87aa-3d3841ec798a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_85106d62-adb9-403d-bfd3-16b3770a178f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e89b0cd0-ae55-4ba0-87aa-3d3841ec798a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_85106d62-adb9-403d-bfd3-16b3770a178f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NutritionBiosciencesIncMember_77b74bc1-e82a-4bda-85c2-6a644bed2925" xlink:href="iff-20231231.xsd#iff_NutritionBiosciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_85106d62-adb9-403d-bfd3-16b3770a178f" xlink:to="loc_iff_NutritionBiosciencesIncMember_77b74bc1-e82a-4bda-85c2-6a644bed2925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_76e56df4-b911-4667-aba5-faf8385acb1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionTable_2497f438-c093-44e3-abd3-91268d1dbcb6" xlink:to="loc_us-gaap_DebtInstrumentLineItems_76e56df4-b911-4667-aba5-faf8385acb1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_b7c8a511-b52e-476d-a373-b67f5b1dfdc7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_76e56df4-b911-4667-aba5-faf8385acb1b" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_b7c8a511-b52e-476d-a373-b67f5b1dfdc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionTableTextBlock_6099e8a0-7574-4cdb-bcf5-5231a02d5849" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_76e56df4-b911-4667-aba5-faf8385acb1b" xlink:to="loc_us-gaap_DebtInstrumentRedemptionTableTextBlock_6099e8a0-7574-4cdb-bcf5-5231a02d5849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_d0d557c7-d303-43d9-8abb-d08b819c6e3d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_76e56df4-b911-4667-aba5-faf8385acb1b" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_d0d557c7-d303-43d9-8abb-d08b819c6e3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/LeasesTables" xlink:type="simple" xlink:href="iff-20231231.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_7e3891aa-f779-4c9c-bbbe-4ef5191c4870" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_48864ea2-acc3-4a4a-a63f-3f2cf11b9513" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7e3891aa-f779-4c9c-bbbe-4ef5191c4870" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_48864ea2-acc3-4a4a-a63f-3f2cf11b9513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AssetsAndLiabilitiesLesseeTableTextBlock_bbd5603a-184f-4400-9796-cf777a04670d" xlink:href="iff-20231231.xsd#iff_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7e3891aa-f779-4c9c-bbbe-4ef5191c4870" xlink:to="loc_iff_AssetsAndLiabilitiesLesseeTableTextBlock_bbd5603a-184f-4400-9796-cf777a04670d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_17d83207-938e-4917-81bc-3c526b64ed2d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7e3891aa-f779-4c9c-bbbe-4ef5191c4870" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_17d83207-938e-4917-81bc-3c526b64ed2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_a24bb2e8-b7ac-4e0c-b9e1-33a93d2e33f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7e3891aa-f779-4c9c-bbbe-4ef5191c4870" xlink:to="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_a24bb2e8-b7ac-4e0c-b9e1-33a93d2e33f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="iff-20231231.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_d0ef52f3-d1a0-423d-8508-75ef85ca9b51" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_fae712d0-d755-4607-b258-b81e80db495a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d0ef52f3-d1a0-423d-8508-75ef85ca9b51" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_fae712d0-d755-4607-b258-b81e80db495a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_51fe8414-4109-4e06-8577-4605a40ca835" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d0ef52f3-d1a0-423d-8508-75ef85ca9b51" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_51fe8414-4109-4e06-8577-4605a40ca835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_c107978f-dd1d-4287-bb64-0ef9551018f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d0ef52f3-d1a0-423d-8508-75ef85ca9b51" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_c107978f-dd1d-4287-bb64-0ef9551018f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_5f0661c9-fe77-44f4-b472-3c64912f9df4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d0ef52f3-d1a0-423d-8508-75ef85ca9b51" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_5f0661c9-fe77-44f4-b472-3c64912f9df4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_03637cae-2ad7-4e47-b057-f4f1df039ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d0ef52f3-d1a0-423d-8508-75ef85ca9b51" xlink:to="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_03637cae-2ad7-4e47-b057-f4f1df039ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/NetIncomePerShareTables" xlink:type="simple" xlink:href="iff-20231231.xsd#NetIncomePerShareTables"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/NetIncomePerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_26c1d8f9-8379-45a9-8e5f-51233ae2c32a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_abe0db6c-be75-4af8-8b52-ac8444d8c7b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_26c1d8f9-8379-45a9-8e5f-51233ae2c32a" xlink:to="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_abe0db6c-be75-4af8-8b52-ac8444d8c7b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/ShareholdersEquityTables" xlink:type="simple" xlink:href="iff-20231231.xsd#ShareholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/ShareholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_641f17c4-41e4-4f06-9362-2330b52ccb84" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_e520b5d5-3bc1-465a-9e97-189298137b8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_641f17c4-41e4-4f06-9362-2330b52ccb84" xlink:to="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_e520b5d5-3bc1-465a-9e97-189298137b8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/StockCompensationPlansTables" xlink:type="simple" xlink:href="iff-20231231.xsd#StockCompensationPlansTables"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/StockCompensationPlansTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5e91811d-71d3-44ff-a875-5e7b8ffc88a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_87d90e7f-8904-46a9-8590-cd4ce866d0d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5e91811d-71d3-44ff-a875-5e7b8ffc88a3" xlink:to="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_87d90e7f-8904-46a9-8590-cd4ce866d0d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock_e11801d6-d524-452e-9713-4a6c8b316917" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5e91811d-71d3-44ff-a875-5e7b8ffc88a3" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock_e11801d6-d524-452e-9713-4a6c8b316917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_a3af0f4e-9c54-444a-992d-14e81f09d851" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5e91811d-71d3-44ff-a875-5e7b8ffc88a3" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_a3af0f4e-9c54-444a-992d-14e81f09d851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_f41f21e1-b86c-4206-bf43-177829ba2668" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5e91811d-71d3-44ff-a875-5e7b8ffc88a3" xlink:to="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_f41f21e1-b86c-4206-bf43-177829ba2668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedPaymentArrangementPurchasedRestrictedStockUnitActivityTableTextBlock_9e6578dc-bda4-4186-9a9a-c5115cf12a6a" xlink:href="iff-20231231.xsd#iff_ShareBasedPaymentArrangementPurchasedRestrictedStockUnitActivityTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5e91811d-71d3-44ff-a875-5e7b8ffc88a3" xlink:to="loc_iff_ShareBasedPaymentArrangementPurchasedRestrictedStockUnitActivityTableTextBlock_9e6578dc-bda4-4186-9a9a-c5115cf12a6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_860e52d1-f995-41ef-a769-98976799cdb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5e91811d-71d3-44ff-a875-5e7b8ffc88a3" xlink:to="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_860e52d1-f995-41ef-a769-98976799cdb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/SegmentInformationTables" xlink:type="simple" xlink:href="iff-20231231.xsd#SegmentInformationTables"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/SegmentInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_5f06c35d-63e7-4792-8d37-060fe47a916b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_dd95e497-ed92-408e-948b-19f9ff114c64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_5f06c35d-63e7-4792-8d37-060fe47a916b" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_dd95e497-ed92-408e-948b-19f9ff114c64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_d027b2af-c4dc-4d29-a5ea-9b682c0ca4f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_5f06c35d-63e7-4792-8d37-060fe47a916b" xlink:to="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_d027b2af-c4dc-4d29-a5ea-9b682c0ca4f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_41823061-7851-4d60-b457-c1935f244a01" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_5f06c35d-63e7-4792-8d37-060fe47a916b" xlink:to="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_41823061-7851-4d60-b457-c1935f244a01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/EmployeeBenefitsTables" xlink:type="simple" xlink:href="iff-20231231.xsd#EmployeeBenefitsTables"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/EmployeeBenefitsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3ede66d7-663e-4f2f-a0e5-c0b7b0f25311" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_PensionExpensesTableTextBlock_da5a44b9-bb98-4895-bbcd-cc631426ba7a" xlink:href="iff-20231231.xsd#iff_PensionExpensesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3ede66d7-663e-4f2f-a0e5-c0b7b0f25311" xlink:to="loc_iff_PensionExpensesTableTextBlock_da5a44b9-bb98-4895-bbcd-cc631426ba7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ScheduleOfAmountsExpectedToBeRecognizedInNetPeriodicCostTableTableTextBlock_6205eb80-49fa-479f-819b-30fedc44c07f" xlink:href="iff-20231231.xsd#iff_ScheduleOfAmountsExpectedToBeRecognizedInNetPeriodicCostTableTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3ede66d7-663e-4f2f-a0e5-c0b7b0f25311" xlink:to="loc_iff_ScheduleOfAmountsExpectedToBeRecognizedInNetPeriodicCostTableTableTextBlock_6205eb80-49fa-479f-819b-30fedc44c07f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_d264ee3e-6e74-4529-9046-5d7279c169a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3ede66d7-663e-4f2f-a0e5-c0b7b0f25311" xlink:to="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_d264ee3e-6e74-4529-9046-5d7279c169a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangesInAccumulatedPostemploymentBenefitObligationsTableTextBlock_aaa6e8ad-99e9-43e3-8b38-24462a8eb542" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfChangesInAccumulatedPostemploymentBenefitObligationsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3ede66d7-663e-4f2f-a0e5-c0b7b0f25311" xlink:to="loc_us-gaap_ScheduleOfChangesInAccumulatedPostemploymentBenefitObligationsTableTextBlock_aaa6e8ad-99e9-43e3-8b38-24462a8eb542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_c5172b5a-ace1-40d8-9cd5-7bbc3ffba0e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3ede66d7-663e-4f2f-a0e5-c0b7b0f25311" xlink:to="loc_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_c5172b5a-ace1-40d8-9cd5-7bbc3ffba0e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_499b1bb2-3d66-4c1f-b2cf-3bb4c483a4e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3ede66d7-663e-4f2f-a0e5-c0b7b0f25311" xlink:to="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_499b1bb2-3d66-4c1f-b2cf-3bb4c483a4e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedAndProjectedBenefitObligationsTableTextBlock_47c24c1b-a8a3-486c-bd46-c56ef600cbf8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccumulatedAndProjectedBenefitObligationsTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3ede66d7-663e-4f2f-a0e5-c0b7b0f25311" xlink:to="loc_us-gaap_ScheduleOfAccumulatedAndProjectedBenefitObligationsTableTextBlock_47c24c1b-a8a3-486c-bd46-c56ef600cbf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_d06ab392-511b-441a-95c0-0d85347563bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3ede66d7-663e-4f2f-a0e5-c0b7b0f25311" xlink:to="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_d06ab392-511b-441a-95c0-0d85347563bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_f1df092e-4ded-47c3-a3c0-4394c627f830" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3ede66d7-663e-4f2f-a0e5-c0b7b0f25311" xlink:to="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_f1df092e-4ded-47c3-a3c0-4394c627f830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ScheduleOfFairValueOfPensionPlanAssetsByAssetCategoryTableTableTextBlock_006b2708-d510-46a2-bfb4-7cdbc3061fe1" xlink:href="iff-20231231.xsd#iff_ScheduleOfFairValueOfPensionPlanAssetsByAssetCategoryTableTableTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3ede66d7-663e-4f2f-a0e5-c0b7b0f25311" xlink:to="loc_iff_ScheduleOfFairValueOfPensionPlanAssetsByAssetCategoryTableTableTextBlock_006b2708-d510-46a2-bfb4-7cdbc3061fe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock_0b78d4b0-dcb9-4f8b-a9fb-f7518f282ed9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3ede66d7-663e-4f2f-a0e5-c0b7b0f25311" xlink:to="loc_us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock_0b78d4b0-dcb9-4f8b-a9fb-f7518f282ed9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfHealthCareCostTrendRatesTableTextBlock_77256093-42ec-40df-9452-29d2080d83e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfHealthCareCostTrendRatesTableTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3ede66d7-663e-4f2f-a0e5-c0b7b0f25311" xlink:to="loc_us-gaap_ScheduleOfHealthCareCostTrendRatesTableTextBlock_77256093-42ec-40df-9452-29d2080d83e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectOfOnePercentagePointChangeInAssumedHealthCareCostTrendRatesTableTextBlock_fa74bade-6baf-432a-bfb8-f7ff7fd6ee59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectOfOnePercentagePointChangeInAssumedHealthCareCostTrendRatesTableTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3ede66d7-663e-4f2f-a0e5-c0b7b0f25311" xlink:to="loc_us-gaap_ScheduleOfEffectOfOnePercentagePointChangeInAssumedHealthCareCostTrendRatesTableTextBlock_fa74bade-6baf-432a-bfb8-f7ff7fd6ee59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/FinancialInstrumentsTables" xlink:type="simple" xlink:href="iff-20231231.xsd#FinancialInstrumentsTables"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/FinancialInstrumentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_190958b9-d0f3-4802-9e1e-1e35b0e765a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_94715f51-9888-40b0-909c-3a837e6cbbd0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_190958b9-d0f3-4802-9e1e-1e35b0e765a3" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_94715f51-9888-40b0-909c-3a837e6cbbd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_6eae1b2e-94fc-4546-a3f1-f52c49c4d46c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_190958b9-d0f3-4802-9e1e-1e35b0e765a3" xlink:to="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_6eae1b2e-94fc-4546-a3f1-f52c49c4d46c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_b7ac39db-5730-482b-89be-6d73a8936833" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_190958b9-d0f3-4802-9e1e-1e35b0e765a3" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_b7ac39db-5730-482b-89be-6d73a8936833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_79513bd8-0f02-45dc-9ea8-c2e175cb45e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_190958b9-d0f3-4802-9e1e-1e35b0e765a3" xlink:to="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_79513bd8-0f02-45dc-9ea8-c2e175cb45e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock_0cb56add-7618-4fd6-aae7-7ef9f6c8d5d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_190958b9-d0f3-4802-9e1e-1e35b0e765a3" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock_0cb56add-7618-4fd6-aae7-7ef9f6c8d5d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossTables" xlink:type="simple" xlink:href="iff-20231231.xsd#AccumulatedOtherComprehensiveIncomeLossTables"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_5db12bbd-7106-40f9-9c25-d400b67ecc09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_cad7e517-8fe4-4077-9769-883f6367ba19" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5db12bbd-7106-40f9-9c25-d400b67ecc09" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_cad7e517-8fe4-4077-9769-883f6367ba19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_856e56b3-abf5-4b6f-b7c4-8093b441a6e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5db12bbd-7106-40f9-9c25-d400b67ecc09" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_856e56b3-abf5-4b6f-b7c4-8093b441a6e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/RedeemableNoncontrollingInterestsTables" xlink:type="simple" xlink:href="iff-20231231.xsd#RedeemableNoncontrollingInterestsTables"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/RedeemableNoncontrollingInterestsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_2d368af5-7734-43ed-8b42-89da182e454a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestTableTextBlock_79e22e9e-5913-485a-839c-5d457f456c1f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RedeemableNoncontrollingInterestTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_2d368af5-7734-43ed-8b42-89da182e454a" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestTableTextBlock_79e22e9e-5913-485a-839c-5d457f456c1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleTables" xlink:type="simple" xlink:href="iff-20231231.xsd#AssetsandLiabilitiesHeldForSaleTables"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_f5491a17-9099-48bb-b1f4-00e88704bdbe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_4232962d-abe4-41a5-9c65-2d26a7dfe210" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_f5491a17-9099-48bb-b1f4-00e88704bdbe" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_4232962d-abe4-41a5-9c65-2d26a7dfe210" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/OtherExpenseIncomeNetTables" xlink:type="simple" xlink:href="iff-20231231.xsd#OtherExpenseIncomeNetTables"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/OtherExpenseIncomeNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_5afcc245-a2ed-4edb-b194-c31181767614" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_f969479e-eb87-4988-abbf-ee35e4c75d32" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_5afcc245-a2ed-4edb-b194-c31181767614" xlink:to="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_f969479e-eb87-4988-abbf-ee35e4c75d32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/TangibleEquityUnitsTables" xlink:type="simple" xlink:href="iff-20231231.xsd#TangibleEquityUnitsTables"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/TangibleEquityUnitsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_2e839779-4351-4325-b40f-203bf773c903" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ScheduleofAllocationofTangibleEquityUnitsTableTextBlock_6161a652-07be-4465-ab13-68ba38b6a357" xlink:href="iff-20231231.xsd#iff_ScheduleofAllocationofTangibleEquityUnitsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2e839779-4351-4325-b40f-203bf773c903" xlink:to="loc_iff_ScheduleofAllocationofTangibleEquityUnitsTableTextBlock_6161a652-07be-4465-ab13-68ba38b6a357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ScheduleofStockPurchaseContractTableTextBlock_07c1886a-ef81-43e3-b52b-d70b50de54bf" xlink:href="iff-20231231.xsd#iff_ScheduleofStockPurchaseContractTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2e839779-4351-4325-b40f-203bf773c903" xlink:to="loc_iff_ScheduleofStockPurchaseContractTableTextBlock_07c1886a-ef81-43e3-b52b-d70b50de54bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_13ad2b60-cab9-443e-8668-a85dcf3c7e46" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_fff5ec03-9964-4706-9263-2a01b683ab4f" xlink:href="iff-20231231.xsd#iff_OrganizationAndSummaryOfSignificantAccountingPoliciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_13ad2b60-cab9-443e-8668-a85dcf3c7e46" xlink:to="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_fff5ec03-9964-4706-9263-2a01b683ab4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_5d8eb3cf-d0d2-44a2-a78b-2ff0bd7b35a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_fff5ec03-9964-4706-9263-2a01b683ab4f" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_5d8eb3cf-d0d2-44a2-a78b-2ff0bd7b35a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_7cc98c90-18f2-4a20-921d-1876127592cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_5d8eb3cf-d0d2-44a2-a78b-2ff0bd7b35a1" xlink:to="loc_us-gaap_ReceivableTypeDomain_7cc98c90-18f2-4a20-921d-1876127592cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TradeAccountsReceivableWithFactoringAgreementsMember_b281b5b5-5ab1-41f6-a7d8-95e538d88380" xlink:href="iff-20231231.xsd#iff_TradeAccountsReceivableWithFactoringAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_7cc98c90-18f2-4a20-921d-1876127592cc" xlink:to="loc_iff_TradeAccountsReceivableWithFactoringAgreementsMember_b281b5b5-5ab1-41f6-a7d8-95e538d88380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TradeAccountsReceivableWithTheCompanysOwnFactoringAgreementsMember_8e7fe6e1-f263-4dc3-9356-15743a4fb8ab" xlink:href="iff-20231231.xsd#iff_TradeAccountsReceivableWithTheCompanysOwnFactoringAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_7cc98c90-18f2-4a20-921d-1876127592cc" xlink:to="loc_iff_TradeAccountsReceivableWithTheCompanysOwnFactoringAgreementsMember_8e7fe6e1-f263-4dc3-9356-15743a4fb8ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_06e4d1d5-f81a-4d97-90bd-8a8116568b6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_fff5ec03-9964-4706-9263-2a01b683ab4f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_06e4d1d5-f81a-4d97-90bd-8a8116568b6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_83221f3b-2a22-4ee1-815e-8e6f21dd7b7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_06e4d1d5-f81a-4d97-90bd-8a8116568b6f" xlink:to="loc_us-gaap_EquityComponentDomain_83221f3b-2a22-4ee1-815e-8e6f21dd7b7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_6860fe5a-996b-420a-ac6a-4a7780eca394" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_83221f3b-2a22-4ee1-815e-8e6f21dd7b7a" xlink:to="loc_us-gaap_RetainedEarningsMember_6860fe5a-996b-420a-ac6a-4a7780eca394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_0584a602-696d-4e42-a8dd-6cc3f4769a10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_fff5ec03-9964-4706-9263-2a01b683ab4f" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_0584a602-696d-4e42-a8dd-6cc3f4769a10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_15baf339-d2cf-460c-8071-41e346de963c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_0584a602-696d-4e42-a8dd-6cc3f4769a10" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_15baf339-d2cf-460c-8071-41e346de963c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_93cc8b0b-b96e-462a-96b1-46c44b5bd903" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_fff5ec03-9964-4706-9263-2a01b683ab4f" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_93cc8b0b-b96e-462a-96b1-46c44b5bd903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_549ced6a-4286-46e3-85ff-89f7626fb902" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_93cc8b0b-b96e-462a-96b1-46c44b5bd903" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_549ced6a-4286-46e3-85ff-89f7626fb902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_75803e35-a86c-4655-b939-93cafc46699b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_549ced6a-4286-46e3-85ff-89f7626fb902" xlink:to="loc_us-gaap_RetainedEarningsMember_75803e35-a86c-4655-b939-93cafc46699b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_22198719-1bc5-4e4e-80be-b675fe70855c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_fff5ec03-9964-4706-9263-2a01b683ab4f" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_22198719-1bc5-4e4e-80be-b675fe70855c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_8af24614-8cc6-4bf9-ae59-098e8b64672e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_22198719-1bc5-4e4e-80be-b675fe70855c" xlink:to="loc_us-gaap_TypeOfAdoptionMember_8af24614-8cc6-4bf9-ae59-098e8b64672e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_5b67db85-b7a1-4ad1-9707-7f2a5b7df98e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_8af24614-8cc6-4bf9-ae59-098e8b64672e" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_5b67db85-b7a1-4ad1-9707-7f2a5b7df98e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201712Member_eb5da3fd-36f4-4e1c-8c27-3c9198530d9b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingStandardsUpdate201712Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_8af24614-8cc6-4bf9-ae59-098e8b64672e" xlink:to="loc_us-gaap_AccountingStandardsUpdate201712Member_eb5da3fd-36f4-4e1c-8c27-3c9198530d9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member_f1533d9c-a83d-40f4-94f0-70aa6a68f59b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_8af24614-8cc6-4bf9-ae59-098e8b64672e" xlink:to="loc_us-gaap_AccountingStandardsUpdate201613Member_f1533d9c-a83d-40f4-94f0-70aa6a68f59b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_1638e8c8-a983-4b0c-a1bd-b46046243a88" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_fff5ec03-9964-4706-9263-2a01b683ab4f" xlink:to="loc_srt_StatementScenarioAxis_1638e8c8-a983-4b0c-a1bd-b46046243a88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_9fa45d6f-14bd-475c-8377-ced924fa93e9" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_1638e8c8-a983-4b0c-a1bd-b46046243a88" xlink:to="loc_srt_ScenarioUnspecifiedDomain_9fa45d6f-14bd-475c-8377-ced924fa93e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e2362cd3-bac7-4898-8ef0-ecf6a4724ca4" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_fff5ec03-9964-4706-9263-2a01b683ab4f" xlink:to="loc_srt_RangeAxis_e2362cd3-bac7-4898-8ef0-ecf6a4724ca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ce196187-f20f-4506-8b7c-95495df304e1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_e2362cd3-bac7-4898-8ef0-ecf6a4724ca4" xlink:to="loc_srt_RangeMember_ce196187-f20f-4506-8b7c-95495df304e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_60ee3c5e-f1fd-4a31-a43b-a154e2141ff0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ce196187-f20f-4506-8b7c-95495df304e1" xlink:to="loc_srt_MinimumMember_60ee3c5e-f1fd-4a31-a43b-a154e2141ff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4be55c7c-e398-46cd-88cb-54435439dc4f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ce196187-f20f-4506-8b7c-95495df304e1" xlink:to="loc_srt_MaximumMember_4be55c7c-e398-46cd-88cb-54435439dc4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1cb7c5a0-c35f-40c6-b273-814eb47b26b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_fff5ec03-9964-4706-9263-2a01b683ab4f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1cb7c5a0-c35f-40c6-b273-814eb47b26b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_35ec04e2-76c3-4baf-87d2-9e194ca97c87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1cb7c5a0-c35f-40c6-b273-814eb47b26b3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_35ec04e2-76c3-4baf-87d2-9e194ca97c87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BuildingsAndImprovementsMember_03412518-1cd5-4c73-b3f4-b5777494e9be" xlink:href="iff-20231231.xsd#iff_BuildingsAndImprovementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_35ec04e2-76c3-4baf-87d2-9e194ca97c87" xlink:to="loc_iff_BuildingsAndImprovementsMember_03412518-1cd5-4c73-b3f4-b5777494e9be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_8a2f4b22-1004-4e3a-aec6-9c56850a6d64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_35ec04e2-76c3-4baf-87d2-9e194ca97c87" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_8a2f4b22-1004-4e3a-aec6-9c56850a6d64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_InformationTechnologyHardwareAndSoftwareMember_416b2811-b104-4295-8ec7-6f5b6604d63d" xlink:href="iff-20231231.xsd#iff_InformationTechnologyHardwareAndSoftwareMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_35ec04e2-76c3-4baf-87d2-9e194ca97c87" xlink:to="loc_iff_InformationTechnologyHardwareAndSoftwareMember_416b2811-b104-4295-8ec7-6f5b6604d63d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_bbb63c32-105f-4b51-8ac2-86d6f5ebb7d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_fff5ec03-9964-4706-9263-2a01b683ab4f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_bbb63c32-105f-4b51-8ac2-86d6f5ebb7d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ada2d51a-a00c-48db-a1a4-168054292d0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_bbb63c32-105f-4b51-8ac2-86d6f5ebb7d5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ada2d51a-a00c-48db-a1a4-168054292d0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_47938dfe-e3e5-47e7-9f83-8a44ab3d4408" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ada2d51a-a00c-48db-a1a4-168054292d0d" xlink:to="loc_us-gaap_CustomerRelationshipsMember_47938dfe-e3e5-47e7-9f83-8a44ab3d4408" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_8b36f4eb-615d-474e-a160-3de3740734b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PatentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ada2d51a-a00c-48db-a1a4-168054292d0d" xlink:to="loc_us-gaap_PatentsMember_8b36f4eb-615d-474e-a160-3de3740734b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_4d86f36e-93da-4138-82d8-12fcfa4fac0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ada2d51a-a00c-48db-a1a4-168054292d0d" xlink:to="loc_us-gaap_TradeNamesMember_4d86f36e-93da-4138-82d8-12fcfa4fac0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntellectualPropertyMember_f70c9d99-5c5f-4be8-a7ec-a0b949ae80a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntellectualPropertyMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ada2d51a-a00c-48db-a1a4-168054292d0d" xlink:to="loc_us-gaap_IntellectualPropertyMember_f70c9d99-5c5f-4be8-a7ec-a0b949ae80a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_b4eecaff-9d01-4ccd-bebb-a2dcaa820875" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_fff5ec03-9964-4706-9263-2a01b683ab4f" xlink:to="loc_srt_RestatementAxis_b4eecaff-9d01-4ccd-bebb-a2dcaa820875" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_a4db8031-c70e-4dfb-bd99-538d3a689c93" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_b4eecaff-9d01-4ccd-bebb-a2dcaa820875" xlink:to="loc_srt_RestatementDomain_a4db8031-c70e-4dfb-bd99-538d3a689c93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_2d7c408a-cdc2-44da-823e-fa6009bef995" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_a4db8031-c70e-4dfb-bd99-538d3a689c93" xlink:to="loc_srt_RestatementAdjustmentMember_2d7c408a-cdc2-44da-823e-fa6009bef995" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_5f9411cb-9344-4f29-bcba-9e0b5a870a46" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_a4db8031-c70e-4dfb-bd99-538d3a689c93" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_5f9411cb-9344-4f29-bcba-9e0b5a870a46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForCatastropheClaimsByCatastrophicEventAxis_c96e9f2a-fbf4-4620-a470-9614c6238404" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForCatastropheClaimsByCatastrophicEventAxis"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_fff5ec03-9964-4706-9263-2a01b683ab4f" xlink:to="loc_us-gaap_LiabilityForCatastropheClaimsByCatastrophicEventAxis_c96e9f2a-fbf4-4620-a470-9614c6238404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CatastrophicEventDomain_615422ba-c4fd-4616-be78-3c565b811035" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CatastrophicEventDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForCatastropheClaimsByCatastrophicEventAxis_c96e9f2a-fbf4-4620-a470-9614c6238404" xlink:to="loc_us-gaap_CatastrophicEventDomain_615422ba-c4fd-4616-be78-3c565b811035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_PandemicMember_81e99fbe-adba-4d87-8175-66eb22a0e859" xlink:href="iff-20231231.xsd#iff_PandemicMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CatastrophicEventDomain_615422ba-c4fd-4616-be78-3c565b811035" xlink:to="loc_iff_PandemicMember_81e99fbe-adba-4d87-8175-66eb22a0e859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_7da11f3f-a16c-40e1-93ed-d71ac391e306" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_fff5ec03-9964-4706-9263-2a01b683ab4f" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_7da11f3f-a16c-40e1-93ed-d71ac391e306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_e0c9aeb9-0e4a-4910-844d-cf2837ea5cb8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_7da11f3f-a16c-40e1-93ed-d71ac391e306" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_e0c9aeb9-0e4a-4910-844d-cf2837ea5cb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_3c4decf5-e94d-4516-b295-810a2314b031" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_e0c9aeb9-0e4a-4910-844d-cf2837ea5cb8" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_3c4decf5-e94d-4516-b295-810a2314b031" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_cad93ed7-0086-4188-8b78-f538d9038338" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_fff5ec03-9964-4706-9263-2a01b683ab4f" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_cad93ed7-0086-4188-8b78-f538d9038338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_2dc7538d-3cdf-4485-ab01-2001ccb7b994" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_cad93ed7-0086-4188-8b78-f538d9038338" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_2dc7538d-3cdf-4485-ab01-2001ccb7b994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_RussiaUkraineWarMember_8aab6cb3-b394-4357-a4d4-0e0d56d56d7a" xlink:href="iff-20231231.xsd#iff_RussiaUkraineWarMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_2dc7538d-3cdf-4485-ab01-2001ccb7b994" xlink:to="loc_iff_RussiaUkraineWarMember_8aab6cb3-b394-4357-a4d4-0e0d56d56d7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_790ea133-1769-4081-8003-29f6d47c15e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_fff5ec03-9964-4706-9263-2a01b683ab4f" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_790ea133-1769-4081-8003-29f6d47c15e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_a3d1971d-f59b-4ccf-aa42-820f2bfd5b74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_790ea133-1769-4081-8003-29f6d47c15e5" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_a3d1971d-f59b-4ccf-aa42-820f2bfd5b74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMember_0de2ad99-55c4-4398-b282-f481255b7c0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_a3d1971d-f59b-4ccf-aa42-820f2bfd5b74" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMember_0de2ad99-55c4-4398-b282-f481255b7c0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_5267c267-2c37-4e74-8ecd-f3db3442be3d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_a3d1971d-f59b-4ccf-aa42-820f2bfd5b74" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_5267c267-2c37-4e74-8ecd-f3db3442be3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_f93772fb-5e41-4211-b426-35245cf29aba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReportingUnitAxis"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_fff5ec03-9964-4706-9263-2a01b683ab4f" xlink:to="loc_us-gaap_ReportingUnitAxis_f93772fb-5e41-4211-b426-35245cf29aba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_6283c0b3-d044-46cb-9312-77b661c68b61" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReportingUnitDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitAxis_f93772fb-5e41-4211-b426-35245cf29aba" xlink:to="loc_us-gaap_ReportingUnitDomain_6283c0b3-d044-46cb-9312-77b661c68b61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_HealthBiosciencesMember_d4f37ec9-5a4b-4e74-899b-04baa1e3844f" xlink:href="iff-20231231.xsd#iff_HealthBiosciencesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_6283c0b3-d044-46cb-9312-77b661c68b61" xlink:to="loc_iff_HealthBiosciencesMember_d4f37ec9-5a4b-4e74-899b-04baa1e3844f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_0c9f939c-6003-43fe-9e55-c5e7d002a6d1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_fff5ec03-9964-4706-9263-2a01b683ab4f" xlink:to="loc_srt_StatementGeographicalAxis_0c9f939c-6003-43fe-9e55-c5e7d002a6d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_6cef9c16-396a-43e3-b814-932971b3b63d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_0c9f939c-6003-43fe-9e55-c5e7d002a6d1" xlink:to="loc_srt_SegmentGeographicalDomain_6cef9c16-396a-43e3-b814-932971b3b63d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_EG_422a5af7-03c1-4e92-a1dd-6696b81169d4" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_EG"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_6cef9c16-396a-43e3-b814-932971b3b63d" xlink:to="loc_country_EG_422a5af7-03c1-4e92-a1dd-6696b81169d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:href="iff-20231231.xsd#iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_fff5ec03-9964-4706-9263-2a01b683ab4f" xlink:to="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGross_646c5314-a939-4c04-a601-c57c05a98b40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_AccountsReceivableGross_646c5314-a939-4c04-a601-c57c05a98b40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e7c618c6-d0f7-402e-9165-0515f18ad2e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e7c618c6-d0f7-402e-9165-0515f18ad2e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_8ee40af0-1008-4b86-a114-4c9bb8fd0bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_RestrictedCashCurrent_8ee40af0-1008-4b86-a114-4c9bb8fd0bd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_c4ffde03-7b2e-49b7-a628-705e132f0acc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_c4ffde03-7b2e-49b7-a628-705e132f0acc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_1925cd14-427b-46d6-ad01-54b61f340375" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_1925cd14-427b-46d6-ad01-54b61f340375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_20aef4d4-afcf-474f-9f4d-c61848d1aaf0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_20aef4d4-afcf-474f-9f4d-c61848d1aaf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AccountsReceivableFactoringReceivableProgramMaximumAmount_e7fc7033-f60d-46f3-87b4-233ca08180b6" xlink:href="iff-20231231.xsd#iff_AccountsReceivableFactoringReceivableProgramMaximumAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_iff_AccountsReceivableFactoringReceivableProgramMaximumAmount_e7fc7033-f60d-46f3-87b4-233ca08180b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ProceedsFromSaleOfAccountsReceivable_b69f4df2-0b33-4c0e-bcfa-ec0006ebb3d2" xlink:href="iff-20231231.xsd#iff_ProceedsFromSaleOfAccountsReceivable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_iff_ProceedsFromSaleOfAccountsReceivable_b69f4df2-0b33-4c0e-bcfa-ec0006ebb3d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeReceivablesHeldForSaleAmount_65f44042-576f-4895-b2b2-d8a3f5681b37" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeReceivablesHeldForSaleAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_TradeReceivablesHeldForSaleAmount_65f44042-576f-4895-b2b2-d8a3f5681b37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_PaymentsToParticipateInFactoringReceivableProgram_31600fe1-f50e-417c-a06d-8a9e555e09e1" xlink:href="iff-20231231.xsd#iff_PaymentsToParticipateInFactoringReceivableProgram"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_iff_PaymentsToParticipateInFactoringReceivableProgram_31600fe1-f50e-417c-a06d-8a9e555e09e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_950c56ed-e527-4cb2-9a83-63de1b0d15a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_ReceivablesNetCurrent_950c56ed-e527-4cb2-9a83-63de1b0d15a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_2b1c5d97-fe0b-4a60-86d5-8348e47d5b8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_2b1c5d97-fe0b-4a60-86d5-8348e47d5b8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AccountsReceivablesOutstandingByOver365Days_36882d95-98df-4430-b59e-97b341d0e471" xlink:href="iff-20231231.xsd#iff_AccountsReceivablesOutstandingByOver365Days"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_iff_AccountsReceivablesOutstandingByOver365Days_36882d95-98df-4430-b59e-97b341d0e471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_a48aa743-a51a-469a-822f-05c8f4ed4f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_a48aa743-a51a-469a-822f-05c8f4ed4f5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_2306f1da-d3ee-4e97-9d88-6b1996653493" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_2306f1da-d3ee-4e97-9d88-6b1996653493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_deabcd81-d258-4524-af39-6fe364310a4f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_deabcd81-d258-4524-af39-6fe364310a4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation_5e823d32-4754-47d4-b9f7-6bf3f4016824" xlink:href="iff-20231231.xsd#iff_AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_iff_AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation_5e823d32-4754-47d4-b9f7-6bf3f4016824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNet_b8c7e3b3-0389-4b76-ae08-b90bd5a3408c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNet"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_AccountsReceivableNet_b8c7e3b3-0389-4b76-ae08-b90bd5a3408c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_79297894-98b9-47fc-8431-9fcaaecccd5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_79297894-98b9-47fc-8431-9fcaaecccd5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_29ac571f-c6bb-432d-adaa-e7e26b1553d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_29ac571f-c6bb-432d-adaa-e7e26b1553d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_daf5b1ff-0d90-41f4-8260-614c7df069ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_daf5b1ff-0d90-41f4-8260-614c7df069ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_11167559-4cf3-4657-8821-d62ebcedd629" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_11167559-4cf3-4657-8821-d62ebcedd629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalized_bee049aa-4eab-4a39-886e-4676079f6010" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestCostsCapitalized"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_InterestCostsCapitalized_bee049aa-4eab-4a39-886e-4676079f6010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_7ed74880-4a85-4cc7-9862-2275c75050ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_7ed74880-4a85-4cc7-9862-2275c75050ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_891d970b-b448-4d44-ba3c-291dfbadeeb4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_891d970b-b448-4d44-ba3c-291dfbadeeb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_08083913-09c2-457e-82a2-c3e98f5ef1fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_AssetImpairmentCharges_08083913-09c2-457e-82a2-c3e98f5ef1fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_d2c02fba-1de6-460d-84a4-e0f5c04f5f34" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_NumberOfReportingUnits_d2c02fba-1de6-460d-84a4-e0f5c04f5f34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_77d9170e-f1ed-4e97-ae2b-945bc47c10fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_77d9170e-f1ed-4e97-ae2b-945bc47c10fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_MinimumPercentageLikelihoodOfTaxBenefitToBeRealizedUponFinalSettlement_b2f57256-0049-4525-a78a-7c0bdc50074c" xlink:href="iff-20231231.xsd#iff_MinimumPercentageLikelihoodOfTaxBenefitToBeRealizedUponFinalSettlement"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_iff_MinimumPercentageLikelihoodOfTaxBenefitToBeRealizedUponFinalSettlement_b2f57256-0049-4525-a78a-7c0bdc50074c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_PriorServiceCostsFromPlanImprovementsAmortizationPeriodMinimum_abffdce9-887b-4adb-a293-93597fb70bca" xlink:href="iff-20231231.xsd#iff_PriorServiceCostsFromPlanImprovementsAmortizationPeriodMinimum"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_iff_PriorServiceCostsFromPlanImprovementsAmortizationPeriodMinimum_abffdce9-887b-4adb-a293-93597fb70bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_PriorServiceCostsFromPlanImprovementsAmortizationPeriodMaximum_3a227262-d885-4445-b9da-dfa7a8a8bd7b" xlink:href="iff-20231231.xsd#iff_PriorServiceCostsFromPlanImprovementsAmortizationPeriodMaximum"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_iff_PriorServiceCostsFromPlanImprovementsAmortizationPeriodMaximum_3a227262-d885-4445-b9da-dfa7a8a8bd7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AmortizationPeriodOfInternalAndExternalDevelopmentCosts_e7652064-78a4-4fc7-ae3f-ce5b0b4fe2ab" xlink:href="iff-20231231.xsd#iff_AmortizationPeriodOfInternalAndExternalDevelopmentCosts"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_iff_AmortizationPeriodOfInternalAndExternalDevelopmentCosts_e7652064-78a4-4fc7-ae3f-ce5b0b4fe2ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierFinanceProgramObligation_a929c4a2-bd5f-4c0c-801f-df3799fc2ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplierFinanceProgramObligation"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_SupplierFinanceProgramObligation_a929c4a2-bd5f-4c0c-801f-df3799fc2ed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DifferenceAmountBetweenBasicAndDilutedNetIncomePerShare_93b40d30-2b08-406b-84e5-7447e3c9f074" xlink:href="iff-20231231.xsd#iff_DifferenceAmountBetweenBasicAndDilutedNetIncomePerShare"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_iff_DifferenceAmountBetweenBasicAndDilutedNetIncomePerShare_93b40d30-2b08-406b-84e5-7447e3c9f074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_001e1c42-b676-4332-b352-15546fe1b3ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_InventoryNet_001e1c42-b676-4332-b352-15546fe1b3ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AccountsReceivablesOutstandingLessThan90Days_7e23e2f5-5a4c-44fe-a6a6-c1ae1971c8e1" xlink:href="iff-20231231.xsd#iff_AccountsReceivablesOutstandingLessThan90Days"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_iff_AccountsReceivablesOutstandingLessThan90Days_7e23e2f5-5a4c-44fe-a6a6-c1ae1971c8e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_d89c7115-2bed-4bf2-a7a3-5bc0e5cab6b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_d89c7115-2bed-4bf2-a7a3-5bc0e5cab6b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_98efbea4-aed3-4e92-8409-06a8948eb9c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_98efbea4-aed3-4e92-8409-06a8948eb9c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_ede82328-6c7e-4fb0-b584-aaba99ded015" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="39" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_ede82328-6c7e-4fb0-b584-aaba99ded015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_5a51609b-23b9-4cdd-943b-023c37a4accf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_5a51609b-23b9-4cdd-943b-023c37a4accf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3977a9df-05e7-47f2-861d-48dc86e213f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="41" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3977a9df-05e7-47f2-861d-48dc86e213f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d1ffce2b-681d-487a-9018-e3bcbc3a582f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="42" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_Goodwill_d1ffce2b-681d-487a-9018-e3bcbc3a582f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_795deb87-3b5e-4627-b639-94b4242c2f69" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="43" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_0b4094bd-591a-46cd-abf9-f770c6db9e63" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_795deb87-3b5e-4627-b639-94b4242c2f69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesScheduleofInventoryDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#NatureofOperationsandSummaryofSignificantAccountingPoliciesScheduleofInventoryDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesScheduleofInventoryDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e2cf61eb-f910-4c03-8a8d-5f291ecc0df6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_b14d6899-466d-43f1-860c-470c0d6fe852" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e2cf61eb-f910-4c03-8a8d-5f291ecc0df6" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_b14d6899-466d-43f1-860c-470c0d6fe852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_bca05eb6-44a2-4092-9045-181e059ef15a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e2cf61eb-f910-4c03-8a8d-5f291ecc0df6" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_bca05eb6-44a2-4092-9045-181e059ef15a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_a15f54bc-6c52-420b-b68c-21d41c0445c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e2cf61eb-f910-4c03-8a8d-5f291ecc0df6" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_a15f54bc-6c52-420b-b68c-21d41c0445c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_79d23619-f721-4891-b6c5-c3cf7a804861" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e2cf61eb-f910-4c03-8a8d-5f291ecc0df6" xlink:to="loc_us-gaap_InventoryNet_79d23619-f721-4891-b6c5-c3cf7a804861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/RestructuringandOtherChargesAdditionalInformationDetails" xlink:type="simple" xlink:href="iff-20231231.xsd#RestructuringandOtherChargesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/RestructuringandOtherChargesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_4d884993-fc53-49a1-bd4b-9168806307da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e850a8cd-3658-4647-af14-f0102558f109" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_4d884993-fc53-49a1-bd4b-9168806307da" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e850a8cd-3658-4647-af14-f0102558f109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_e9f82456-0d1e-499f-b0ed-b29e69ca8930" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e850a8cd-3658-4647-af14-f0102558f109" xlink:to="loc_srt_StatementGeographicalAxis_e9f82456-0d1e-499f-b0ed-b29e69ca8930" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f08fca14-e54a-49b9-9cbc-3c6edfe335fe" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_e9f82456-0d1e-499f-b0ed-b29e69ca8930" xlink:to="loc_srt_SegmentGeographicalDomain_f08fca14-e54a-49b9-9cbc-3c6edfe335fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaMember_e497e331-f172-4332-bb60-8b397e790d1e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AsiaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f08fca14-e54a-49b9-9cbc-3c6edfe335fe" xlink:to="loc_srt_AsiaMember_e497e331-f172-4332-bb60-8b397e790d1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_e0d27d6b-6cdd-4892-87aa-b0ea177292f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EMEAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f08fca14-e54a-49b9-9cbc-3c6edfe335fe" xlink:to="loc_us-gaap_EMEAMember_e0d27d6b-6cdd-4892-87aa-b0ea177292f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LatinAmericaMember_c39fc9f9-cc5c-4f8a-951a-739fcf65f5ad" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LatinAmericaMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f08fca14-e54a-49b9-9cbc-3c6edfe335fe" xlink:to="loc_srt_LatinAmericaMember_c39fc9f9-cc5c-4f8a-951a-739fcf65f5ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NorthAmericaMember_e36b9427-411b-46e9-99a7-1ad24afc1352" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NorthAmericaMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f08fca14-e54a-49b9-9cbc-3c6edfe335fe" xlink:to="loc_srt_NorthAmericaMember_e36b9427-411b-46e9-99a7-1ad24afc1352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_dabf205a-f6f1-4b1a-8c6b-0e5f93e15939" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e850a8cd-3658-4647-af14-f0102558f109" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_dabf205a-f6f1-4b1a-8c6b-0e5f93e15939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2ec88173-ec09-41f7-ac1c-632a7f5fa85b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_dabf205a-f6f1-4b1a-8c6b-0e5f93e15939" xlink:to="loc_us-gaap_SegmentDomain_2ec88173-ec09-41f7-ac1c-632a7f5fa85b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ScentMember_a0fd03c2-4c8f-4ad1-9552-b125b4ad6f52" xlink:href="iff-20231231.xsd#iff_ScentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_2ec88173-ec09-41f7-ac1c-632a7f5fa85b" xlink:to="loc_iff_ScentMember_a0fd03c2-4c8f-4ad1-9552-b125b4ad6f52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SharedITCorporateCostsMember_afab5898-465a-4565-aa0d-479ee0e645c0" xlink:href="iff-20231231.xsd#iff_SharedITCorporateCostsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_2ec88173-ec09-41f7-ac1c-632a7f5fa85b" xlink:to="loc_iff_SharedITCorporateCostsMember_afab5898-465a-4565-aa0d-479ee0e645c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_1a6f74ba-dbbe-416d-b4df-cf01e9261550" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e850a8cd-3658-4647-af14-f0102558f109" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_1a6f74ba-dbbe-416d-b4df-cf01e9261550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_47203bf3-7347-4954-a699-ef7acb33ee1e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_1a6f74ba-dbbe-416d-b4df-cf01e9261550" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_47203bf3-7347-4954-a699-ef7acb33ee1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_4b72fd97-769d-4211-82f9-8ae713a40eec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_47203bf3-7347-4954-a699-ef7acb33ee1e" xlink:to="loc_us-gaap_EmployeeSeveranceMember_4b72fd97-769d-4211-82f9-8ae713a40eec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_d5983b28-8091-4fa2-8fd2-3fae934ed35e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherRestructuringMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_47203bf3-7347-4954-a699-ef7acb33ee1e" xlink:to="loc_us-gaap_OtherRestructuringMember_d5983b28-8091-4fa2-8fd2-3fae934ed35e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FixedAssetWriteDownMember_54df373f-00c8-4bc1-9576-1efb0550f6bb" xlink:href="iff-20231231.xsd#iff_FixedAssetWriteDownMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_47203bf3-7347-4954-a699-ef7acb33ee1e" xlink:to="loc_iff_FixedAssetWriteDownMember_54df373f-00c8-4bc1-9576-1efb0550f6bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_5ed4fcc4-11fe-4361-846f-d0bbb3505eaf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e850a8cd-3658-4647-af14-f0102558f109" xlink:to="loc_us-gaap_RestructuringPlanAxis_5ed4fcc4-11fe-4361-846f-d0bbb3505eaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_0c42fb13-29b9-4fb3-bdb1-151c60471574" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_5ed4fcc4-11fe-4361-846f-d0bbb3505eaf" xlink:to="loc_us-gaap_RestructuringPlanDomain_0c42fb13-29b9-4fb3-bdb1-151c60471574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FrutaromIntegrationInitiativeMember_653e9182-fbc0-4194-a9f2-cf94519da142" xlink:href="iff-20231231.xsd#iff_FrutaromIntegrationInitiativeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_0c42fb13-29b9-4fb3-bdb1-151c60471574" xlink:to="loc_iff_FrutaromIntegrationInitiativeMember_653e9182-fbc0-4194-a9f2-cf94519da142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_A2019SeveranceInitiativesMember_c99d37bb-d4a2-4da6-802d-b1e789b5df5e" xlink:href="iff-20231231.xsd#iff_A2019SeveranceInitiativesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_0c42fb13-29b9-4fb3-bdb1-151c60471574" xlink:to="loc_iff_A2019SeveranceInitiativesMember_c99d37bb-d4a2-4da6-802d-b1e789b5df5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_A2017ProductivityProgramMember_6d545ca4-9ead-4766-80d1-2ae800e5d9f7" xlink:href="iff-20231231.xsd#iff_A2017ProductivityProgramMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_0c42fb13-29b9-4fb3-bdb1-151c60471574" xlink:to="loc_iff_A2017ProductivityProgramMember_6d545ca4-9ead-4766-80d1-2ae800e5d9f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_94adbf33-6a7b-468f-9b94-9eedbf58c5e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherRestructuringMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_0c42fb13-29b9-4fb3-bdb1-151c60471574" xlink:to="loc_us-gaap_OtherRestructuringMember_94adbf33-6a7b-468f-9b94-9eedbf58c5e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_A2023RestructuringProgramMember_8e4ba444-2717-4096-b96c-f8645e958de3" xlink:href="iff-20231231.xsd#iff_A2023RestructuringProgramMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_0c42fb13-29b9-4fb3-bdb1-151c60471574" xlink:to="loc_iff_A2023RestructuringProgramMember_8e4ba444-2717-4096-b96c-f8645e958de3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b541f0cd-373e-4cf3-b153-c3cda9654655" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e850a8cd-3658-4647-af14-f0102558f109" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b541f0cd-373e-4cf3-b153-c3cda9654655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_91facc83-7659-4a39-8f8e-47b00814f21f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b541f0cd-373e-4cf3-b153-c3cda9654655" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_91facc83-7659-4a39-8f8e-47b00814f21f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NutritionBiosciencesIncMember_9af3c51f-3770-42ea-87c5-1ec94427b569" xlink:href="iff-20231231.xsd#iff_NutritionBiosciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_91facc83-7659-4a39-8f8e-47b00814f21f" xlink:to="loc_iff_NutritionBiosciencesIncMember_9af3c51f-3770-42ea-87c5-1ec94427b569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_09a72d88-a77b-4845-b8df-e08e29191e5f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e850a8cd-3658-4647-af14-f0102558f109" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_09a72d88-a77b-4845-b8df-e08e29191e5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_RestructuringAndRelatedCostExpectedNumberOfSitesClosed_2cc83b5e-ecee-4a94-885c-ce190d7d0225" xlink:href="iff-20231231.xsd#iff_RestructuringAndRelatedCostExpectedNumberOfSitesClosed"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_09a72d88-a77b-4845-b8df-e08e29191e5f" xlink:to="loc_iff_RestructuringAndRelatedCostExpectedNumberOfSitesClosed_2cc83b5e-ecee-4a94-885c-ce190d7d0225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_RestructuringAndRelatedCostExpectedNumberOfSitesClosedPeriod_130cbb46-544c-44ce-a2bd-83ae62302e85" xlink:href="iff-20231231.xsd#iff_RestructuringAndRelatedCostExpectedNumberOfSitesClosedPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_09a72d88-a77b-4845-b8df-e08e29191e5f" xlink:to="loc_iff_RestructuringAndRelatedCostExpectedNumberOfSitesClosedPeriod_130cbb46-544c-44ce-a2bd-83ae62302e85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_RestructuringAndRelatedCostNumberOfSitesClosed_64c63364-a476-4fbe-8b47-53efb7de46fc" xlink:href="iff-20231231.xsd#iff_RestructuringAndRelatedCostNumberOfSitesClosed"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_09a72d88-a77b-4845-b8df-e08e29191e5f" xlink:to="loc_iff_RestructuringAndRelatedCostNumberOfSitesClosed_64c63364-a476-4fbe-8b47-53efb7de46fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_4d6de003-ff16-4e61-beda-c5826e2d6558" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_09a72d88-a77b-4845-b8df-e08e29191e5f" xlink:to="loc_us-gaap_RestructuringCharges_4d6de003-ff16-4e61-beda-c5826e2d6558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts_c82c724a-915c-4cf6-96ff-983ca5daaf83" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_09a72d88-a77b-4845-b8df-e08e29191e5f" xlink:to="loc_us-gaap_OtherRestructuringCosts_c82c724a-915c-4cf6-96ff-983ca5daaf83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated_b80495ee-2baf-4525-a45b-32f64b9e82a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_09a72d88-a77b-4845-b8df-e08e29191e5f" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated_b80495ee-2baf-4525-a45b-32f64b9e82a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_bd984896-f26a-44a9-9541-9179bf1dbec1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_09a72d88-a77b-4845-b8df-e08e29191e5f" xlink:to="loc_us-gaap_SeveranceCosts1_bd984896-f26a-44a9-9541-9179bf1dbec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_cfb927de-c320-4227-8293-9f0844cfa781" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_09a72d88-a77b-4845-b8df-e08e29191e5f" xlink:to="loc_us-gaap_RestructuringReserveRollForward_cfb927de-c320-4227-8293-9f0844cfa781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_e9235a3e-2759-447f-ab96-08cfba29aa95" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_cfb927de-c320-4227-8293-9f0844cfa781" xlink:to="loc_us-gaap_RestructuringReserve_e9235a3e-2759-447f-ab96-08cfba29aa95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1_7dfbad93-4bf5-4365-af71-d79d783b5e36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_cfb927de-c320-4227-8293-9f0844cfa781" xlink:to="loc_us-gaap_RestructuringReserveAccrualAdjustment1_7dfbad93-4bf5-4365-af71-d79d783b5e36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_7d47d368-ca07-440e-aacf-b2e713e50723" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_cfb927de-c320-4227-8293-9f0844cfa781" xlink:to="loc_us-gaap_RestructuringReserveSettledWithoutCash2_7d47d368-ca07-440e-aacf-b2e713e50723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_f8792aa9-7d18-444d-a1ca-f27e0e0c7c04" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_cfb927de-c320-4227-8293-9f0844cfa781" xlink:to="loc_us-gaap_PaymentsForRestructuring_f8792aa9-7d18-444d-a1ca-f27e0e0c7c04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_c8346d69-de5b-4319-a973-0c2012fd623c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_cfb927de-c320-4227-8293-9f0844cfa781" xlink:to="loc_us-gaap_RestructuringReserve_c8346d69-de5b-4319-a973-0c2012fd623c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BusinessCombinationRestructuringLiabilities_96cf6701-aef2-4bc2-8510-ab2c000db122" xlink:href="iff-20231231.xsd#iff_BusinessCombinationRestructuringLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_09a72d88-a77b-4845-b8df-e08e29191e5f" xlink:to="loc_iff_BusinessCombinationRestructuringLiabilities_96cf6701-aef2-4bc2-8510-ab2c000db122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_3b2cdad6-51f8-4404-8d37-785efadaf744" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_09a72d88-a77b-4845-b8df-e08e29191e5f" xlink:to="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_3b2cdad6-51f8-4404-8d37-785efadaf744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_bcc71ac4-f8b2-470b-8aaa-6b19ee8da6cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_09a72d88-a77b-4845-b8df-e08e29191e5f" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_bcc71ac4-f8b2-470b-8aaa-6b19ee8da6cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_097e49ff-d384-40fa-84cc-a35f509c8775" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_09a72d88-a77b-4845-b8df-e08e29191e5f" xlink:to="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_097e49ff-d384-40fa-84cc-a35f509c8775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/RestructuringandOtherChargesMovementsinRestructuringandRelatedAccrualsDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#RestructuringandOtherChargesMovementsinRestructuringandRelatedAccrualsDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/RestructuringandOtherChargesMovementsinRestructuringandRelatedAccrualsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_c3d18256-3f3c-490e-ab8c-48f8b0956cf3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_21795d73-e19b-4a84-95ac-cfb032642c90" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_c3d18256-3f3c-490e-ab8c-48f8b0956cf3" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_21795d73-e19b-4a84-95ac-cfb032642c90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_60404389-4fd8-4068-8fa4-37268a68d1f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_21795d73-e19b-4a84-95ac-cfb032642c90" xlink:to="loc_us-gaap_RestructuringPlanAxis_60404389-4fd8-4068-8fa4-37268a68d1f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_2381e571-044a-4291-8376-30bfa3c99580" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_60404389-4fd8-4068-8fa4-37268a68d1f3" xlink:to="loc_us-gaap_RestructuringPlanDomain_2381e571-044a-4291-8376-30bfa3c99580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_A2015SeveranceInitiativesMember_d6fb6305-a330-47db-9ad6-26d6cc206402" xlink:href="iff-20231231.xsd#iff_A2015SeveranceInitiativesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_2381e571-044a-4291-8376-30bfa3c99580" xlink:to="loc_iff_A2015SeveranceInitiativesMember_d6fb6305-a330-47db-9ad6-26d6cc206402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FrutaromIntegrationInitiativeMember_14ab7ab3-8b6c-4e8d-ac96-defad75c851d" xlink:href="iff-20231231.xsd#iff_FrutaromIntegrationInitiativeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_2381e571-044a-4291-8376-30bfa3c99580" xlink:to="loc_iff_FrutaromIntegrationInitiativeMember_14ab7ab3-8b6c-4e8d-ac96-defad75c851d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_A2019SeveranceInitiativesMember_48817994-f4d8-4a12-8bb4-291c9c1b142c" xlink:href="iff-20231231.xsd#iff_A2019SeveranceInitiativesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_2381e571-044a-4291-8376-30bfa3c99580" xlink:to="loc_iff_A2019SeveranceInitiativesMember_48817994-f4d8-4a12-8bb4-291c9c1b142c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_A2017ProductivityProgramMember_be57d476-7911-4723-bd8a-94c5c28be506" xlink:href="iff-20231231.xsd#iff_A2017ProductivityProgramMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_2381e571-044a-4291-8376-30bfa3c99580" xlink:to="loc_iff_A2017ProductivityProgramMember_be57d476-7911-4723-bd8a-94c5c28be506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_190aefe2-4903-478f-ab8d-e33cf98fdd74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherRestructuringMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_2381e571-044a-4291-8376-30bfa3c99580" xlink:to="loc_us-gaap_OtherRestructuringMember_190aefe2-4903-478f-ab8d-e33cf98fdd74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_38d02d54-0e9c-43b0-bcb2-d3b26d4f97d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_21795d73-e19b-4a84-95ac-cfb032642c90" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_38d02d54-0e9c-43b0-bcb2-d3b26d4f97d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_94b38dd6-59df-4084-8a83-1b13eb141c79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_38d02d54-0e9c-43b0-bcb2-d3b26d4f97d7" xlink:to="loc_us-gaap_SegmentDomain_94b38dd6-59df-4084-8a83-1b13eb141c79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TasteMember_8b3697cc-4095-4072-8ba2-34854319aefb" xlink:href="iff-20231231.xsd#iff_TasteMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_94b38dd6-59df-4084-8a83-1b13eb141c79" xlink:to="loc_iff_TasteMember_8b3697cc-4095-4072-8ba2-34854319aefb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ScentMember_51642451-1a67-4d92-b0d7-332221f1bfb9" xlink:href="iff-20231231.xsd#iff_ScentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_94b38dd6-59df-4084-8a83-1b13eb141c79" xlink:to="loc_iff_ScentMember_51642451-1a67-4d92-b0d7-332221f1bfb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SharedITCorporateCostsMember_a72e0811-51ee-4dc4-a95b-e4c1e0fc09d9" xlink:href="iff-20231231.xsd#iff_SharedITCorporateCostsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_94b38dd6-59df-4084-8a83-1b13eb141c79" xlink:to="loc_iff_SharedITCorporateCostsMember_a72e0811-51ee-4dc4-a95b-e4c1e0fc09d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_PharmaSolutionsMember_74ba45a2-fecd-46e6-9afd-2ac6c30c928e" xlink:href="iff-20231231.xsd#iff_PharmaSolutionsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_94b38dd6-59df-4084-8a83-1b13eb141c79" xlink:to="loc_iff_PharmaSolutionsMember_74ba45a2-fecd-46e6-9afd-2ac6c30c928e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NourishMember_8a335c2e-65d2-4110-836e-9d60f882b482" xlink:href="iff-20231231.xsd#iff_NourishMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_94b38dd6-59df-4084-8a83-1b13eb141c79" xlink:to="loc_iff_NourishMember_8a335c2e-65d2-4110-836e-9d60f882b482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_HealthBiosciencesMember_a8863e7a-13d6-4f8b-821d-49f37e10b88e" xlink:href="iff-20231231.xsd#iff_HealthBiosciencesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_94b38dd6-59df-4084-8a83-1b13eb141c79" xlink:to="loc_iff_HealthBiosciencesMember_a8863e7a-13d6-4f8b-821d-49f37e10b88e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_2ed76e17-1b94-4e3c-a93d-2f90ad0cd15d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_21795d73-e19b-4a84-95ac-cfb032642c90" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_2ed76e17-1b94-4e3c-a93d-2f90ad0cd15d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_e8ae341a-69b1-4b2b-9516-f1051f980437" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_2ed76e17-1b94-4e3c-a93d-2f90ad0cd15d" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_e8ae341a-69b1-4b2b-9516-f1051f980437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_6045ab3f-f6f9-4b4d-af9f-06298ccdf1ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_e8ae341a-69b1-4b2b-9516-f1051f980437" xlink:to="loc_us-gaap_EmployeeSeveranceMember_6045ab3f-f6f9-4b4d-af9f-06298ccdf1ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FixedAssetWriteDownMember_21d1ca76-3e83-48df-bb2a-78e61fea9258" xlink:href="iff-20231231.xsd#iff_FixedAssetWriteDownMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_e8ae341a-69b1-4b2b-9516-f1051f980437" xlink:to="loc_iff_FixedAssetWriteDownMember_21d1ca76-3e83-48df-bb2a-78e61fea9258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_f8e97731-b03e-44d4-9599-d135e4a17e63" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherRestructuringMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_e8ae341a-69b1-4b2b-9516-f1051f980437" xlink:to="loc_us-gaap_OtherRestructuringMember_f8e97731-b03e-44d4-9599-d135e4a17e63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5d37ee25-1c81-49b9-a978-6b9a4ff7b8f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_21795d73-e19b-4a84-95ac-cfb032642c90" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5d37ee25-1c81-49b9-a978-6b9a4ff7b8f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_31c54379-117a-4dca-985f-d81565c16c23" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5d37ee25-1c81-49b9-a978-6b9a4ff7b8f5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_31c54379-117a-4dca-985f-d81565c16c23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NutritionBiosciencesIncMember_ab56ad0d-db75-48df-9113-20fbe1503598" xlink:href="iff-20231231.xsd#iff_NutritionBiosciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_31c54379-117a-4dca-985f-d81565c16c23" xlink:to="loc_iff_NutritionBiosciencesIncMember_ab56ad0d-db75-48df-9113-20fbe1503598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_a9f30af5-d4ff-4138-89a3-6082a1b33329" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_21795d73-e19b-4a84-95ac-cfb032642c90" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_a9f30af5-d4ff-4138-89a3-6082a1b33329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_680b8f48-bc99-46a9-a582-3ec820ffcc11" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_a9f30af5-d4ff-4138-89a3-6082a1b33329" xlink:to="loc_us-gaap_RestructuringReserveRollForward_680b8f48-bc99-46a9-a582-3ec820ffcc11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_7a83773a-0bdf-45dd-9c24-3aecce07f634" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_680b8f48-bc99-46a9-a582-3ec820ffcc11" xlink:to="loc_us-gaap_RestructuringReserve_7a83773a-0bdf-45dd-9c24-3aecce07f634" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1_01ff5d60-74bc-4267-9835-eced564f025e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_680b8f48-bc99-46a9-a582-3ec820ffcc11" xlink:to="loc_us-gaap_RestructuringReserveAccrualAdjustment1_01ff5d60-74bc-4267-9835-eced564f025e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_c34aa5a8-c841-4d95-ae4e-ac11c73b75a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_680b8f48-bc99-46a9-a582-3ec820ffcc11" xlink:to="loc_us-gaap_RestructuringReserveSettledWithoutCash2_c34aa5a8-c841-4d95-ae4e-ac11c73b75a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_aab067df-d979-41aa-96a1-7d4d70aaf0f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_680b8f48-bc99-46a9-a582-3ec820ffcc11" xlink:to="loc_us-gaap_PaymentsForRestructuring_aab067df-d979-41aa-96a1-7d4d70aaf0f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_08093611-7ad7-400c-b119-f460ad34baf0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_680b8f48-bc99-46a9-a582-3ec820ffcc11" xlink:to="loc_us-gaap_RestructuringReserve_08093611-7ad7-400c-b119-f460ad34baf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_4fa157ee-74fb-43b5-8628-194182281ca5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_680b8f48-bc99-46a9-a582-3ec820ffcc11" xlink:to="loc_us-gaap_RestructuringCharges_4fa157ee-74fb-43b5-8628-194182281ca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/AcquisitionsHealthWrightProductsDetails" xlink:type="simple" xlink:href="iff-20231231.xsd#AcquisitionsHealthWrightProductsDetails"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/AcquisitionsHealthWrightProductsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_18dd2108-8842-44df-9674-060517ce8e01" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e9ae381a-2758-4cf8-8e87-a26f284cdae5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_18dd2108-8842-44df-9674-060517ce8e01" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e9ae381a-2758-4cf8-8e87-a26f284cdae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_23e0e728-a59a-47f0-ada9-6e0f21032dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e9ae381a-2758-4cf8-8e87-a26f284cdae5" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_23e0e728-a59a-47f0-ada9-6e0f21032dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_04a45116-c040-4dc0-8698-7b4049a009e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_23e0e728-a59a-47f0-ada9-6e0f21032dd8" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_04a45116-c040-4dc0-8698-7b4049a009e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_HealthWrightProductsIncHealthWrightMember_bc652737-be11-4715-ad21-56079ab6dfd1" xlink:href="iff-20231231.xsd#iff_HealthWrightProductsIncHealthWrightMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_04a45116-c040-4dc0-8698-7b4049a009e8" xlink:to="loc_iff_HealthWrightProductsIncHealthWrightMember_bc652737-be11-4715-ad21-56079ab6dfd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e38234fe-06f4-4af7-bfc4-243d0bbaf5f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e9ae381a-2758-4cf8-8e87-a26f284cdae5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e38234fe-06f4-4af7-bfc4-243d0bbaf5f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_26ea312a-7607-4f4e-975e-f9e3d7a4a2e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e38234fe-06f4-4af7-bfc4-243d0bbaf5f2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_26ea312a-7607-4f4e-975e-f9e3d7a4a2e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_78b08dc0-9b09-407f-a7c5-d0e0de53712d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_26ea312a-7607-4f4e-975e-f9e3d7a4a2e4" xlink:to="loc_us-gaap_CustomerRelationshipsMember_78b08dc0-9b09-407f-a7c5-d0e0de53712d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_000aacdf-8ee1-4115-938c-489f1692a0d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e9ae381a-2758-4cf8-8e87-a26f284cdae5" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_000aacdf-8ee1-4115-938c-489f1692a0d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_b3d01657-d5ed-483a-96af-da8284d479fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_000aacdf-8ee1-4115-938c-489f1692a0d8" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_b3d01657-d5ed-483a-96af-da8284d479fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_697dcda7-d7d9-4987-bd28-7522ecc6926a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_000aacdf-8ee1-4115-938c-489f1692a0d8" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_697dcda7-d7d9-4987-bd28-7522ecc6926a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_d210f51c-5bf5-4596-8d1b-ebbba0eec172" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_000aacdf-8ee1-4115-938c-489f1692a0d8" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_d210f51c-5bf5-4596-8d1b-ebbba0eec172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_af8a4dbb-0704-425a-8c9b-a879c4a33db4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_000aacdf-8ee1-4115-938c-489f1692a0d8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_af8a4dbb-0704-425a-8c9b-a879c4a33db4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_95ff4627-03ed-4c3f-acdb-af7b99d64a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_000aacdf-8ee1-4115-938c-489f1692a0d8" xlink:to="loc_us-gaap_Goodwill_95ff4627-03ed-4c3f-acdb-af7b99d64a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_d826f09e-adb3-4da8-b3ec-fe45c8f4e168" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_000aacdf-8ee1-4115-938c-489f1692a0d8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_d826f09e-adb3-4da8-b3ec-fe45c8f4e168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_7d7f5edb-9f64-481a-996a-c5d81043bb37" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_000aacdf-8ee1-4115-938c-489f1692a0d8" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_7d7f5edb-9f64-481a-996a-c5d81043bb37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EarnOutsPayableOther_2d9c1598-a548-4d95-a4dc-77284857b43b" xlink:href="iff-20231231.xsd#iff_EarnOutsPayableOther"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_000aacdf-8ee1-4115-938c-489f1692a0d8" xlink:to="loc_iff_EarnOutsPayableOther_2d9c1598-a548-4d95-a4dc-77284857b43b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EarnOutsPayableCurrent_c101b421-5a83-44bd-874e-6768483ae203" xlink:href="iff-20231231.xsd#iff_EarnOutsPayableCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_000aacdf-8ee1-4115-938c-489f1692a0d8" xlink:to="loc_iff_EarnOutsPayableCurrent_c101b421-5a83-44bd-874e-6768483ae203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails" xlink:type="simple" xlink:href="iff-20231231.xsd#AcquisitionsNutritionBiosciencesIncDetails"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_44e7ca98-3865-4600-9fbe-ba82bf4e0fbd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e1a94af2-55be-4092-be17-00fd9e0e328a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_44e7ca98-3865-4600-9fbe-ba82bf4e0fbd" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e1a94af2-55be-4092-be17-00fd9e0e328a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_70132b22-ad04-4e04-8ed9-d0c2232e6c41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e1a94af2-55be-4092-be17-00fd9e0e328a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_70132b22-ad04-4e04-8ed9-d0c2232e6c41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c7a5d5d8-4cc3-44f6-832f-5e76aa489701" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_70132b22-ad04-4e04-8ed9-d0c2232e6c41" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c7a5d5d8-4cc3-44f6-832f-5e76aa489701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NutritionBiosciencesIncMember_74c8b1cd-a3be-4d31-b2ee-68ce587266f5" xlink:href="iff-20231231.xsd#iff_NutritionBiosciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c7a5d5d8-4cc3-44f6-832f-5e76aa489701" xlink:to="loc_iff_NutritionBiosciencesIncMember_74c8b1cd-a3be-4d31-b2ee-68ce587266f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_6d8fa17a-635b-423c-9144-aa5f9c3b7429" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e1a94af2-55be-4092-be17-00fd9e0e328a" xlink:to="loc_srt_OwnershipAxis_6d8fa17a-635b-423c-9144-aa5f9c3b7429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_7fdcebfc-c72e-406e-9f63-d2b419adab45" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_6d8fa17a-635b-423c-9144-aa5f9c3b7429" xlink:to="loc_srt_OwnershipDomain_7fdcebfc-c72e-406e-9f63-d2b419adab45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_InternationalFlavorsFragrancesIncMember_0525d050-6e26-4b6c-a990-7e40947ff145" xlink:href="iff-20231231.xsd#iff_InternationalFlavorsFragrancesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_7fdcebfc-c72e-406e-9f63-d2b419adab45" xlink:to="loc_iff_InternationalFlavorsFragrancesIncMember_0525d050-6e26-4b6c-a990-7e40947ff145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_0f35a520-b59f-457c-9b22-5d1f71752103" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e1a94af2-55be-4092-be17-00fd9e0e328a" xlink:to="loc_dei_LegalEntityAxis_0f35a520-b59f-457c-9b22-5d1f71752103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_f7d4eaee-a26b-4403-a478-2d61f462e3d2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_0f35a520-b59f-457c-9b22-5d1f71752103" xlink:to="loc_dei_EntityDomain_f7d4eaee-a26b-4403-a478-2d61f462e3d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DuPontdeNemoursIncMember_3ac76244-db68-4d9c-aff8-d2e4c2593067" xlink:href="iff-20231231.xsd#iff_DuPontdeNemoursIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_f7d4eaee-a26b-4403-a478-2d61f462e3d2" xlink:to="loc_iff_DuPontdeNemoursIncMember_3ac76244-db68-4d9c-aff8-d2e4c2593067" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e6afbd86-2752-4d7c-afc9-82de2b2b29a8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e1a94af2-55be-4092-be17-00fd9e0e328a" xlink:to="loc_srt_RangeAxis_e6afbd86-2752-4d7c-afc9-82de2b2b29a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_eca78339-0dd1-4a48-90ca-a1ce04c77a04" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_e6afbd86-2752-4d7c-afc9-82de2b2b29a8" xlink:to="loc_srt_RangeMember_eca78339-0dd1-4a48-90ca-a1ce04c77a04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_82c3ab80-2281-4f78-a88b-a049fa22f387" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_eca78339-0dd1-4a48-90ca-a1ce04c77a04" xlink:to="loc_srt_MinimumMember_82c3ab80-2281-4f78-a88b-a049fa22f387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b511e475-0e80-4a9e-bb43-c956f3da29ad" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_eca78339-0dd1-4a48-90ca-a1ce04c77a04" xlink:to="loc_srt_MaximumMember_b511e475-0e80-4a9e-bb43-c956f3da29ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_6d344d71-026b-4488-978c-bc3a161422cb" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e1a94af2-55be-4092-be17-00fd9e0e328a" xlink:to="loc_srt_RestatementAxis_6d344d71-026b-4488-978c-bc3a161422cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_092953ea-693b-48bf-93ab-1f233364f5f4" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_6d344d71-026b-4488-978c-bc3a161422cb" xlink:to="loc_srt_RestatementDomain_092953ea-693b-48bf-93ab-1f233364f5f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_48bda81d-b844-40fa-a229-9d7312259af2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_092953ea-693b-48bf-93ab-1f233364f5f4" xlink:to="loc_srt_RestatementAdjustmentMember_48bda81d-b844-40fa-a229-9d7312259af2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_9dafd854-acb8-4b38-857f-3adfa9edc61e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e1a94af2-55be-4092-be17-00fd9e0e328a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_9dafd854-acb8-4b38-857f-3adfa9edc61e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d324718c-00cb-4c2a-acfc-83ccb939e9e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9dafd854-acb8-4b38-857f-3adfa9edc61e" xlink:to="loc_us-gaap_SegmentDomain_d324718c-00cb-4c2a-acfc-83ccb939e9e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NourishMember_3683fdef-229c-4031-afb0-188a5aefcac1" xlink:href="iff-20231231.xsd#iff_NourishMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d324718c-00cb-4c2a-acfc-83ccb939e9e8" xlink:to="loc_iff_NourishMember_3683fdef-229c-4031-afb0-188a5aefcac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_HealthBiosciencesMember_d0f9bc47-bc16-4ec0-a719-21380176da14" xlink:href="iff-20231231.xsd#iff_HealthBiosciencesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d324718c-00cb-4c2a-acfc-83ccb939e9e8" xlink:to="loc_iff_HealthBiosciencesMember_d0f9bc47-bc16-4ec0-a719-21380176da14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_PharmaSolutionsMember_b39a237f-0a56-4c3d-913a-bc00efa65d22" xlink:href="iff-20231231.xsd#iff_PharmaSolutionsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d324718c-00cb-4c2a-acfc-83ccb939e9e8" xlink:to="loc_iff_PharmaSolutionsMember_b39a237f-0a56-4c3d-913a-bc00efa65d22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ScentMember_38a0bb04-b27b-4d0f-beef-677f1d3ac48b" xlink:href="iff-20231231.xsd#iff_ScentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d324718c-00cb-4c2a-acfc-83ccb939e9e8" xlink:to="loc_iff_ScentMember_38a0bb04-b27b-4d0f-beef-677f1d3ac48b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c64ec588-dcba-4974-91b8-04b09295fe1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e1a94af2-55be-4092-be17-00fd9e0e328a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c64ec588-dcba-4974-91b8-04b09295fe1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_efa77a62-701b-4f11-a047-5e8bcd6210dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c64ec588-dcba-4974-91b8-04b09295fe1d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_efa77a62-701b-4f11-a047-5e8bcd6210dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_2d73dc69-09f5-42c8-ab36-8f757e96ad9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_efa77a62-701b-4f11-a047-5e8bcd6210dd" xlink:to="loc_us-gaap_TradeNamesMember_2d73dc69-09f5-42c8-ab36-8f757e96ad9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_4ee6bc3a-31a6-420d-85a6-8939c764e37b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_efa77a62-701b-4f11-a047-5e8bcd6210dd" xlink:to="loc_us-gaap_CustomerRelationshipsMember_4ee6bc3a-31a6-420d-85a6-8939c764e37b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TechnologicalKnowHowsMember_fb916ce4-e1a1-46d8-83e1-c1684d61c633" xlink:href="iff-20231231.xsd#iff_TechnologicalKnowHowsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_efa77a62-701b-4f11-a047-5e8bcd6210dd" xlink:to="loc_iff_TechnologicalKnowHowsMember_fb916ce4-e1a1-46d8-83e1-c1684d61c633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_acea1e5d-c312-4f8c-8bb2-c0362012a73d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_efa77a62-701b-4f11-a047-5e8bcd6210dd" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_acea1e5d-c312-4f8c-8bb2-c0362012a73d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionTypeAxis_e86cb261-416b-42f6-90ad-b27ba2274c35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransactionTypeAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e1a94af2-55be-4092-be17-00fd9e0e328a" xlink:to="loc_us-gaap_TransactionTypeAxis_e86cb261-416b-42f6-90ad-b27ba2274c35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionDomain_11dd774a-f941-4f1f-ad03-7b1406e867a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransactionTypeAxis_e86cb261-416b-42f6-90ad-b27ba2274c35" xlink:to="loc_us-gaap_TransactionDomain_11dd774a-f941-4f1f-ad03-7b1406e867a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_MicrocrystallineCelluloseMember_9d386341-bf13-42cd-9460-bb3caf7b55f1" xlink:href="iff-20231231.xsd#iff_MicrocrystallineCelluloseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransactionDomain_11dd774a-f941-4f1f-ad03-7b1406e867a5" xlink:to="loc_iff_MicrocrystallineCelluloseMember_9d386341-bf13-42cd-9460-bb3caf7b55f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_208c4215-325e-44f3-8554-a682c6513783" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e1a94af2-55be-4092-be17-00fd9e0e328a" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_208c4215-325e-44f3-8554-a682c6513783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9e8e2f68-f32d-40a0-a4e6-e0ce6e75f140" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_208c4215-325e-44f3-8554-a682c6513783" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9e8e2f68-f32d-40a0-a4e6-e0ce6e75f140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_a8d7ef46-18c2-4e97-a7df-7246064352f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9e8e2f68-f32d-40a0-a4e6-e0ce6e75f140" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_a8d7ef46-18c2-4e97-a7df-7246064352f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e1a94af2-55be-4092-be17-00fd9e0e328a" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_56854115-bbe9-4b0f-992e-a9e3460fe73d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_56854115-bbe9-4b0f-992e-a9e3460fe73d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_0f4bd02d-d424-4aaf-a732-073e80750447" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_0f4bd02d-d424-4aaf-a732-073e80750447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_50005fc6-acda-4894-854c-4d785caf1e25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_50005fc6-acda-4894-854c-4d785caf1e25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_92d1789c-529a-49d6-82b2-a51c345c911c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_92d1789c-529a-49d6-82b2-a51c345c911c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_458eb7e9-64ab-492c-b8e2-37b105e1f0ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_458eb7e9-64ab-492c-b8e2-37b105e1f0ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BusinessAcquisitionNetSales_91aebda5-3328-4458-bfc9-d17ec25f07c8" xlink:href="iff-20231231.xsd#iff_BusinessAcquisitionNetSales"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_iff_BusinessAcquisitionNetSales_91aebda5-3328-4458-bfc9-d17ec25f07c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BusinessAcquisitionNetIncomeLoss_6660c610-04b5-43a2-8f4a-da3e362bcdfe" xlink:href="iff-20231231.xsd#iff_BusinessAcquisitionNetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_iff_BusinessAcquisitionNetIncomeLoss_6660c610-04b5-43a2-8f4a-da3e362bcdfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_0d1f7573-4c39-4d83-b3dc-4d4deed81d88" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_0d1f7573-4c39-4d83-b3dc-4d4deed81d88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BusinessCombinationConsiderationTransferredReplacementEquityAwardsIssued_5f240e7d-e752-4b38-9228-f8e32032e51e" xlink:href="iff-20231231.xsd#iff_BusinessCombinationConsiderationTransferredReplacementEquityAwardsIssued"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_iff_BusinessCombinationConsiderationTransferredReplacementEquityAwardsIssued_5f240e7d-e752-4b38-9228-f8e32032e51e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BusinessCombinationPensionFundingAdjustment_ee8aaf59-c91d-4570-affb-e40a22e5e016" xlink:href="iff-20231231.xsd#iff_BusinessCombinationPensionFundingAdjustment"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_iff_BusinessCombinationPensionFundingAdjustment_ee8aaf59-c91d-4570-affb-e40a22e5e016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_f2c7fb7a-5d4d-45e2-8434-311534c34913" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_f2c7fb7a-5d4d-45e2-8434-311534c34913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DilutiveSharesQuotientMultiplier_e6ecc19c-cc60-43c0-b175-6ed9cf7b420b" xlink:href="iff-20231231.xsd#iff_DilutiveSharesQuotientMultiplier"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_iff_DilutiveSharesQuotientMultiplier_e6ecc19c-cc60-43c0-b175-6ed9cf7b420b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_1f46fdb8-91aa-4088-b54b-f872f346d0e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_1f46fdb8-91aa-4088-b54b-f872f346d0e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BusinessCombinationNetPensionBalanceDifferentialAmountSettledInCash_41a3bbae-b781-45d0-989f-94423fffedc7" xlink:href="iff-20231231.xsd#iff_BusinessCombinationNetPensionBalanceDifferentialAmountSettledInCash"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_iff_BusinessCombinationNetPensionBalanceDifferentialAmountSettledInCash_41a3bbae-b781-45d0-989f-94423fffedc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_04abcd4c-c095-42d6-9102-1c6da7524747" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_04abcd4c-c095-42d6-9102-1c6da7524747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_2cd8d6e7-8e4f-4091-ac0a-e76e55a9650c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_2cd8d6e7-8e4f-4091-ac0a-e76e55a9650c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_9bb64ad7-d88f-49bb-841c-c17df59d1979" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_9bb64ad7-d88f-49bb-841c-c17df59d1979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_4455b0cf-d6b9-4d0f-aadf-e1bd4e480bcf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_4455b0cf-d6b9-4d0f-aadf-e1bd4e480bcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_b24c9306-10e6-474c-8ecb-f03d75375435" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_b24c9306-10e6-474c-8ecb-f03d75375435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_14a33423-7aa1-4a5d-988e-8c7cd4334f25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_14a33423-7aa1-4a5d-988e-8c7cd4334f25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_8b48f122-956b-454c-9871-c7fcfc040b5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_8b48f122-956b-454c-9871-c7fcfc040b5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_1de4fb09-a156-4f15-aff9-3c9f20562ad5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_1de4fb09-a156-4f15-aff9-3c9f20562ad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_d0b8354d-bb19-492c-8e70-08444f47e968" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_d0b8354d-bb19-492c-8e70-08444f47e968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPayrollAndEmployeeBenefits_80bf59a0-554d-4d3d-957b-c704fc350bb0" xlink:href="iff-20231231.xsd#iff_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPayrollAndEmployeeBenefits"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_iff_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPayrollAndEmployeeBenefits_80bf59a0-554d-4d3d-957b-c704fc350bb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_78376d27-7f68-49b5-9e82-aff07b52f8dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_78376d27-7f68-49b5-9e82-aff07b52f8dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_ecf47560-37a7-4778-b377-579213e49eca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_ecf47560-37a7-4778-b377-579213e49eca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_4105a1b9-fa69-46ee-abf2-e41e6d911705" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_4105a1b9-fa69-46ee-abf2-e41e6d911705" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_9096c76d-0585-4b41-a4c3-b973e8562d82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_9096c76d-0585-4b41-a4c3-b973e8562d82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_73a6bc18-7042-4623-97d9-72a0d6913d79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_73a6bc18-7042-4623-97d9-72a0d6913d79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_50861565-d9cb-49cd-8cef-b363554409e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_Goodwill_50861565-d9cb-49cd-8cef-b363554409e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_0e464839-1c7b-4a97-b24f-c4956a7ae46b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_0e464839-1c7b-4a97-b24f-c4956a7ae46b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BusinessCombinationAdjustmentOnCashPayment_c98af10c-7e32-4428-b32c-b536169d0312" xlink:href="iff-20231231.xsd#iff_BusinessCombinationAdjustmentOnCashPayment"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_iff_BusinessCombinationAdjustmentOnCashPayment_c98af10c-7e32-4428-b32c-b536169d0312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_f8970ef8-a1f2-4d0b-8928-77a70de7ec27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefinitelivedIntangibleAssetsAcquired"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_f8970ef8-a1f2-4d0b-8928-77a70de7ec27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_4b326235-4821-491a-9e34-33ca6816dd78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_4b326235-4821-491a-9e34-33ca6816dd78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BusinessCombinationLeaseAdjustment_22bf2503-a6b5-4d61-b836-82e5e4c44aac" xlink:href="iff-20231231.xsd#iff_BusinessCombinationLeaseAdjustment"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_iff_BusinessCombinationLeaseAdjustment_22bf2503-a6b5-4d61-b836-82e5e4c44aac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_8e751aaf-830b-4fdf-8792-2b106991609b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_8e751aaf-830b-4fdf-8792-2b106991609b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_8253ed9e-f4da-4370-b47c-7cd7bc761db7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_8253ed9e-f4da-4370-b47c-7cd7bc761db7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_7779920c-8934-436f-a379-95ea183451e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_7779920c-8934-436f-a379-95ea183451e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_2e53f564-93e3-4e45-bc10-b8daba9a99ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:presentationArc order="39" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_2e53f564-93e3-4e45-bc10-b8daba9a99ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_e11ec8b6-5945-4a97-92bb-945ec8ce3419" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_e11ec8b6-5945-4a97-92bb-945ec8ce3419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_101baa71-103b-4eba-9f5f-1ca84da6ac33" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:presentationArc order="41" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_101baa71-103b-4eba-9f5f-1ca84da6ac33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_11dffef6-b3d7-4e0e-bbf4-afd6501fe6c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="42" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7dc957e9-6d0c-4060-9f6c-c81ad713bb0c" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_11dffef6-b3d7-4e0e-bbf4-afd6501fe6c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/BusinessDivestitureDetails" xlink:type="simple" xlink:href="iff-20231231.xsd#BusinessDivestitureDetails"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/BusinessDivestitureDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_0a2320d0-21cb-4a81-bdbf-ec991de3ab53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d47500f9-61a8-43fd-9341-ac81cb2e65d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_0a2320d0-21cb-4a81-bdbf-ec991de3ab53" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d47500f9-61a8-43fd-9341-ac81cb2e65d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f01d2424-747b-4fae-8bd5-1255a8c07634" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d47500f9-61a8-43fd-9341-ac81cb2e65d1" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f01d2424-747b-4fae-8bd5-1255a8c07634" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d6c06d8e-089d-47c0-a61b-f565f797324d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f01d2424-747b-4fae-8bd5-1255a8c07634" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d6c06d8e-089d-47c0-a61b-f565f797324d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_MicrobialControlMember_37e9697f-d12c-4c84-b05c-06c238745f66" xlink:href="iff-20231231.xsd#iff_MicrobialControlMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d6c06d8e-089d-47c0-a61b-f565f797324d" xlink:to="loc_iff_MicrobialControlMember_37e9697f-d12c-4c84-b05c-06c238745f66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FlavorSpecialtyIngredientsMember_b595001d-f08f-4e36-aca9-c2c93714dc01" xlink:href="iff-20231231.xsd#iff_FlavorSpecialtyIngredientsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d6c06d8e-089d-47c0-a61b-f565f797324d" xlink:to="loc_iff_FlavorSpecialtyIngredientsMember_b595001d-f08f-4e36-aca9-c2c93714dc01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SavorySolutionsBusinessMember_c14dc409-1ec8-435b-9957-caf50111fc17" xlink:href="iff-20231231.xsd#iff_SavorySolutionsBusinessMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d6c06d8e-089d-47c0-a61b-f565f797324d" xlink:to="loc_iff_SavorySolutionsBusinessMember_c14dc409-1ec8-435b-9957-caf50111fc17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_844373de-fd39-491b-af21-a0e7f6abcea0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d47500f9-61a8-43fd-9341-ac81cb2e65d1" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_844373de-fd39-491b-af21-a0e7f6abcea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_3aef7066-a067-4571-9251-608b5df50dd3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_844373de-fd39-491b-af21-a0e7f6abcea0" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_3aef7066-a067-4571-9251-608b5df50dd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember_52c13141-48d3-47f1-a7a3-904e1b7b2d3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_3aef7066-a067-4571-9251-608b5df50dd3" xlink:to="loc_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember_52c13141-48d3-47f1-a7a3-904e1b7b2d3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d47500f9-61a8-43fd-9341-ac81cb2e65d1" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ProceedsFromDivestitureOfBusinessesGross_1a64b66e-0ae6-4d42-a6c1-697e2fd7ef7c" xlink:href="iff-20231231.xsd#iff_ProceedsFromDivestitureOfBusinessesGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_iff_ProceedsFromDivestitureOfBusinessesGross_1a64b66e-0ae6-4d42-a6c1-697e2fd7ef7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable_ead7a66e-6e1b-41af-aa45-799b2badbe97" xlink:href="iff-20231231.xsd#iff_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_iff_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable_ead7a66e-6e1b-41af-aa45-799b2badbe97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupIncludingDiscontinuedOperationAdvanceReceiptForBusinessToBeTransferred_85c86c1f-d31e-43f5-8153-68bf2564820d" xlink:href="iff-20231231.xsd#iff_DisposalGroupIncludingDiscontinuedOperationAdvanceReceiptForBusinessToBeTransferred"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_iff_DisposalGroupIncludingDiscontinuedOperationAdvanceReceiptForBusinessToBeTransferred_85c86c1f-d31e-43f5-8153-68bf2564820d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TransitionServicesAgreementFairValue_8dfa0d18-e766-4136-9a7e-3004acd68ada" xlink:href="iff-20231231.xsd#iff_TransitionServicesAgreementFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_iff_TransitionServicesAgreementFairValue_8dfa0d18-e766-4136-9a7e-3004acd68ada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EscrowDeposit_3c0fbbbb-e813-49ac-9abf-d5573cace60e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EscrowDeposit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_EscrowDeposit_3c0fbbbb-e813-49ac-9abf-d5573cace60e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupIncludingDiscontinuedOperationPostClosingAdjustments_09f6111c-9591-453c-a6fa-84cbaf041975" xlink:href="iff-20231231.xsd#iff_DisposalGroupIncludingDiscontinuedOperationPostClosingAdjustments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_iff_DisposalGroupIncludingDiscontinuedOperationPostClosingAdjustments_09f6111c-9591-453c-a6fa-84cbaf041975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TransitionServicesAgreementTerm_14452047-0ca4-49d9-8fe7-abebcfb4a142" xlink:href="iff-20231231.xsd#iff_TransitionServicesAgreementTerm"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_iff_TransitionServicesAgreementTerm_14452047-0ca4-49d9-8fe7-abebcfb4a142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TransitionServicesAgreementIncomeReductionToCostsNotIncludedInRevenue_979ac867-9389-49b8-8314-ca8e2153709a" xlink:href="iff-20231231.xsd#iff_TransitionServicesAgreementIncomeReductionToCostsNotIncludedInRevenue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_iff_TransitionServicesAgreementIncomeReductionToCostsNotIncludedInRevenue_979ac867-9389-49b8-8314-ca8e2153709a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_b7dc9766-3a0d-4b82-bd1d-779914e8532a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_b7dc9766-3a0d-4b82-bd1d-779914e8532a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_CashTransferredToTheBuyerOnTheClosingBalanceSheet_7ada75f9-5a5c-4b3b-a72a-97dde9fa1d70" xlink:href="iff-20231231.xsd#iff_CashTransferredToTheBuyerOnTheClosingBalanceSheet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_iff_CashTransferredToTheBuyerOnTheClosingBalanceSheet_7ada75f9-5a5c-4b3b-a72a-97dde9fa1d70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupIncludingDiscontinuedOperationConsiderationAdvanceReceiptForBusinessToBeTransferred_159f8fa3-bdb6-4b98-ac14-4015a2693442" xlink:href="iff-20231231.xsd#iff_DisposalGroupIncludingDiscontinuedOperationConsiderationAdvanceReceiptForBusinessToBeTransferred"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_iff_DisposalGroupIncludingDiscontinuedOperationConsiderationAdvanceReceiptForBusinessToBeTransferred_159f8fa3-bdb6-4b98-ac14-4015a2693442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EmployeeReimbursementReceivable_5065371a-c77d-4b8e-82c3-cf92d1bd8a2c" xlink:href="iff-20231231.xsd#iff_EmployeeReimbursementReceivable"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_iff_EmployeeReimbursementReceivable_5065371a-c77d-4b8e-82c3-cf92d1bd8a2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ProceedsFromDivestitureOfBusinessNet_3efffa96-8dbd-4412-a802-436f1b631c72" xlink:href="iff-20231231.xsd#iff_ProceedsFromDivestitureOfBusinessNet"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_iff_ProceedsFromDivestitureOfBusinessNet_3efffa96-8dbd-4412-a802-436f1b631c72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_2a5c014c-e702-4b2c-bbe8-45ddb4c6aed1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_2a5c014c-e702-4b2c-bbe8-45ddb4c6aed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_80a3c141-e65c-4666-9cb9-7d1c86998fd9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_80a3c141-e65c-4666-9cb9-7d1c86998fd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_5f66b4ff-7c2e-4c48-8180-26d0453af44f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_EquityMethodInvestments_5f66b4ff-7c2e-4c48-8180-26d0453af44f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_510044cb-bca6-4782-b938-c6204cc674a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_510044cb-bca6-4782-b938-c6204cc674a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_4cebe0b8-49ed-4b8f-8259-95dab1b0fbcd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_4cebe0b8-49ed-4b8f-8259-95dab1b0fbcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_ffb9fcd2-6c7d-44b4-8412-7048a8c0ad73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_ffb9fcd2-6c7d-44b4-8412-7048a8c0ad73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_152fb035-99ae-4e16-a8b6-07c0c5a20478" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_152fb035-99ae-4e16-a8b6-07c0c5a20478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_82542d2f-b742-48e5-b808-5c177324b12c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_82542d2f-b742-48e5-b808-5c177324b12c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_074da73d-d0fd-469d-8b08-c4d8fc866098" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_074da73d-d0fd-469d-8b08-c4d8fc866098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupIncludingDiscontinuedOperationNetAssets_f68d53bb-470c-4bce-89a6-54ee76eded57" xlink:href="iff-20231231.xsd#iff_DisposalGroupIncludingDiscontinuedOperationNetAssets"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_iff_DisposalGroupIncludingDiscontinuedOperationNetAssets_f68d53bb-470c-4bce-89a6-54ee76eded57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_ab81a790-d571-4cd4-bbe1-f450fc98e08f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_ab81a790-d571-4cd4-bbe1-f450fc98e08f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupIncludingDiscontinuedOperationAmountHeldInEscrow_8aefd0ba-cd43-4ca6-9deb-590f2636cfd5" xlink:href="iff-20231231.xsd#iff_DisposalGroupIncludingDiscontinuedOperationAmountHeldInEscrow"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_iff_DisposalGroupIncludingDiscontinuedOperationAmountHeldInEscrow_8aefd0ba-cd43-4ca6-9deb-590f2636cfd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupIncludingDiscontinuedOperationTransactionCostCredits_45e05925-cfe6-4361-be74-7355a9d3f0d7" xlink:href="iff-20231231.xsd#iff_DisposalGroupIncludingDiscontinuedOperationTransactionCostCredits"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_iff_DisposalGroupIncludingDiscontinuedOperationTransactionCostCredits_45e05925-cfe6-4361-be74-7355a9d3f0d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupIncludingDiscontinuedOperationConsiderationPayableReceivable_4c56f197-e395-4524-9e2d-546b801809ac" xlink:href="iff-20231231.xsd#iff_DisposalGroupIncludingDiscontinuedOperationConsiderationPayableReceivable"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_iff_DisposalGroupIncludingDiscontinuedOperationConsiderationPayableReceivable_4c56f197-e395-4524-9e2d-546b801809ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupIncludingDiscontinuedOperationProceedsAttributableToSupplyAgreement_fbe50789-864b-4c26-a063-3b9a43242bbd" xlink:href="iff-20231231.xsd#iff_DisposalGroupIncludingDiscontinuedOperationProceedsAttributableToSupplyAgreement"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_iff_DisposalGroupIncludingDiscontinuedOperationProceedsAttributableToSupplyAgreement_fbe50789-864b-4c26-a063-3b9a43242bbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupIncludingDiscontinuedOperationCashTransferredToBuyer_2194ee0a-9187-4c39-94bc-9b95e1be7cd5" xlink:href="iff-20231231.xsd#iff_DisposalGroupIncludingDiscontinuedOperationCashTransferredToBuyer"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_iff_DisposalGroupIncludingDiscontinuedOperationCashTransferredToBuyer_2194ee0a-9187-4c39-94bc-9b95e1be7cd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a41b0e5c-27dd-4bcb-b620-19707ccfd9e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a41b0e5c-27dd-4bcb-b620-19707ccfd9e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_7907c4a3-9762-4f6f-85b5-bcedfd9dcad8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_ReceivablesNetCurrent_7907c4a3-9762-4f6f-85b5-bcedfd9dcad8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_26b006c6-10c7-4a14-b545-964e1d116711" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_InventoryNet_26b006c6-10c7-4a14-b545-964e1d116711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_e5133b46-93b4-4be5-87d4-abc7de7b9903" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_e5133b46-93b4-4be5-87d4-abc7de7b9903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_139fe0a6-f19d-4f64-bcaa-82f994363112" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_Goodwill_139fe0a6-f19d-4f64-bcaa-82f994363112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f3535362-1e5b-4212-824c-34b098e10abf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f3535362-1e5b-4212-824c-34b098e10abf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_5d306998-b8e8-4e30-8130-5d6f0452e64b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_5d306998-b8e8-4e30-8130-5d6f0452e64b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_5612e46c-877a-4698-8c48-4fd8397edebb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_Assets_5612e46c-877a-4698-8c48-4fd8397edebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_e5aa0e33-9a72-4b87-ba01-d25d5cbb0c17" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_AccountsPayableCurrent_e5aa0e33-9a72-4b87-ba01-d25d5cbb0c17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_84b42f61-5d9a-4ede-a6c9-25855a3966a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="39" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_84b42f61-5d9a-4ede-a6c9-25855a3966a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_377b199a-93f5-4081-abe0-af6202ef1d7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_377b199a-93f5-4081-abe0-af6202ef1d7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_dc09a2a5-ac02-4ab9-abb4-c42c785e616f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="41" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_Liabilities_dc09a2a5-ac02-4ab9-abb4-c42c785e616f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_2426a046-db32-4c08-a150-b5977e740cb3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="42" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_2426a046-db32-4c08-a150-b5977e740cb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0d1b85ed-7aab-4206-bc4e-621f5d0c5cd3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="43" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_StockholdersEquity_0d1b85ed-7aab-4206-bc4e-621f5d0c5cd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNetAsset_136a4d64-00e5-40bf-a7ae-b37f458eaf08" xlink:href="iff-20231231.xsd#iff_DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNetAsset"/>
    <link:presentationArc order="44" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_iff_DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNetAsset_136a4d64-00e5-40bf-a7ae-b37f458eaf08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalBeforeIncomeTax_1bcb85e9-87b5-41f8-8934-964574a13bf7" xlink:href="iff-20231231.xsd#iff_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalBeforeIncomeTax"/>
    <link:presentationArc order="45" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_iff_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalBeforeIncomeTax_1bcb85e9-87b5-41f8-8934-964574a13bf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupNotDiscontinuedOperationTaxEffectOfGainLossFromDivestiture_8b286c5c-3165-4785-9d27-6c278da3938d" xlink:href="iff-20231231.xsd#iff_DisposalGroupNotDiscontinuedOperationTaxEffectOfGainLossFromDivestiture"/>
    <link:presentationArc order="46" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_iff_DisposalGroupNotDiscontinuedOperationTaxEffectOfGainLossFromDivestiture_8b286c5c-3165-4785-9d27-6c278da3938d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupIncludingDiscontinuedOperationTransactionCost_e33ce15a-6d90-4740-8d04-022cc3c7315d" xlink:href="iff-20231231.xsd#iff_DisposalGroupIncludingDiscontinuedOperationTransactionCost"/>
    <link:presentationArc order="47" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_iff_DisposalGroupIncludingDiscontinuedOperationTransactionCost_e33ce15a-6d90-4740-8d04-022cc3c7315d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_939596e2-d86c-414f-bd4b-67ffda4307b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="48" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_RestrictedCashCurrent_939596e2-d86c-414f-bd4b-67ffda4307b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_e7bfad6c-38e2-41c9-89da-23317caaaaf9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="49" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_e7bfad6c-38e2-41c9-89da-23317caaaaf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AccumulatedOtherComprehensiveIncomeLossPensionLiabilityAndPostretirementAfterTax_c04e0d2c-7680-437f-b3c5-5691a197f552" xlink:href="iff-20231231.xsd#iff_AccumulatedOtherComprehensiveIncomeLossPensionLiabilityAndPostretirementAfterTax"/>
    <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_iff_AccumulatedOtherComprehensiveIncomeLossPensionLiabilityAndPostretirementAfterTax_c04e0d2c-7680-437f-b3c5-5691a197f552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupNotDiscontinuedOperationLiquidationTaxEffect_163b2e3f-50b4-4dc4-b548-dc96ba8d07ba" xlink:href="iff-20231231.xsd#iff_DisposalGroupNotDiscontinuedOperationLiquidationTaxEffect"/>
    <link:presentationArc order="51" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_iff_DisposalGroupNotDiscontinuedOperationLiquidationTaxEffect_163b2e3f-50b4-4dc4-b548-dc96ba8d07ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupNotDiscontinuedOperationGainLossOnLiquidationBeforeIncomeTax_7cf17ee5-1017-4b0c-ab48-7055853d5549" xlink:href="iff-20231231.xsd#iff_DisposalGroupNotDiscontinuedOperationGainLossOnLiquidationBeforeIncomeTax"/>
    <link:presentationArc order="52" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a6d12488-bc2a-4694-b22e-81d8cca80447" xlink:to="loc_iff_DisposalGroupNotDiscontinuedOperationGainLossOnLiquidationBeforeIncomeTax_7cf17ee5-1017-4b0c-ab48-7055853d5549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_e1065f40-c09e-4526-a3ee-4ed965d614a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4d4ec245-ce74-49da-8e96-8d6205d3999e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_e1065f40-c09e-4526-a3ee-4ed965d614a9" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4d4ec245-ce74-49da-8e96-8d6205d3999e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6da3f784-1f23-4bf3-b9d5-02440670ccc8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4d4ec245-ce74-49da-8e96-8d6205d3999e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6da3f784-1f23-4bf3-b9d5-02440670ccc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e9f5cfd4-2a58-4517-ba33-42859b6b6be1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6da3f784-1f23-4bf3-b9d5-02440670ccc8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e9f5cfd4-2a58-4517-ba33-42859b6b6be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_f00f477a-7fde-47b2-9d4e-4631ae377166" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LandMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e9f5cfd4-2a58-4517-ba33-42859b6b6be1" xlink:to="loc_us-gaap_LandMember_f00f477a-7fde-47b2-9d4e-4631ae377166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_46382e72-db17-48c6-abf5-a42dfc98df9d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e9f5cfd4-2a58-4517-ba33-42859b6b6be1" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_46382e72-db17-48c6-abf5-a42dfc98df9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_798013f0-ca0c-4ef8-bc86-5927c07d76d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e9f5cfd4-2a58-4517-ba33-42859b6b6be1" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_798013f0-ca0c-4ef8-bc86-5927c07d76d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyEquipmentMember_5d123568-266f-4005-a9c3-161fc80af993" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TechnologyEquipmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e9f5cfd4-2a58-4517-ba33-42859b6b6be1" xlink:to="loc_us-gaap_TechnologyEquipmentMember_5d123568-266f-4005-a9c3-161fc80af993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_3b230919-a2d3-423b-b2c1-fa3e83848e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e9f5cfd4-2a58-4517-ba33-42859b6b6be1" xlink:to="loc_us-gaap_ConstructionInProgressMember_3b230919-a2d3-423b-b2c1-fa3e83848e9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_81a63fdb-1807-4e0f-92ca-8077dbf61f53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4d4ec245-ce74-49da-8e96-8d6205d3999e" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_81a63fdb-1807-4e0f-92ca-8077dbf61f53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_9bb75310-8652-4cbf-806a-b2b60b4076aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_81a63fdb-1807-4e0f-92ca-8077dbf61f53" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_9bb75310-8652-4cbf-806a-b2b60b4076aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_e0c0892f-c8c6-4ebd-9fe2-e05979bd62f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_9bb75310-8652-4cbf-806a-b2b60b4076aa" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_e0c0892f-c8c6-4ebd-9fe2-e05979bd62f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_99e9c96e-844b-439b-a0ef-51a37e12a2c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4d4ec245-ce74-49da-8e96-8d6205d3999e" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_99e9c96e-844b-439b-a0ef-51a37e12a2c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_8f7c3cc9-64ae-4d55-aa62-ccb67018935c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_99e9c96e-844b-439b-a0ef-51a37e12a2c6" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_8f7c3cc9-64ae-4d55-aa62-ccb67018935c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_RussiaUkraineWarMember_26f819dc-4ac0-441f-b0e4-77adddb9445e" xlink:href="iff-20231231.xsd#iff_RussiaUkraineWarMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_8f7c3cc9-64ae-4d55-aa62-ccb67018935c" xlink:to="loc_iff_RussiaUkraineWarMember_26f819dc-4ac0-441f-b0e4-77adddb9445e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_31960016-16d4-4ce3-9a7b-5a6490b12ed8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4d4ec245-ce74-49da-8e96-8d6205d3999e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_31960016-16d4-4ce3-9a7b-5a6490b12ed8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_100de830-4e6d-4da5-9bb9-e33aee5724a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_31960016-16d4-4ce3-9a7b-5a6490b12ed8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_100de830-4e6d-4da5-9bb9-e33aee5724a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_225548cf-4662-4844-8873-559bbda9cfd0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_31960016-16d4-4ce3-9a7b-5a6490b12ed8" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_225548cf-4662-4844-8873-559bbda9cfd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f46a2d3f-a575-4283-8f44-2851217e12bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_31960016-16d4-4ce3-9a7b-5a6490b12ed8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_f46a2d3f-a575-4283-8f44-2851217e12bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_472d9c86-ede4-4dee-929c-4ab8cbcea985" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_31960016-16d4-4ce3-9a7b-5a6490b12ed8" xlink:to="loc_us-gaap_Depreciation_472d9c86-ede4-4dee-929c-4ab8cbcea985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_f6b22944-77c4-427d-be2d-a913c2dfe191" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_31960016-16d4-4ce3-9a7b-5a6490b12ed8" xlink:to="loc_us-gaap_AssetImpairmentCharges_f6b22944-77c4-427d-be2d-a913c2dfe191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetNarrativeDetails" xlink:type="simple" xlink:href="iff-20231231.xsd#GoodwillandOtherIntangibleAssetsNetNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_60bc856f-5802-4d6c-8a79-1a52a331f122" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_8477f250-af8d-460e-972f-b3125664df9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_60bc856f-5802-4d6c-8a79-1a52a331f122" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_8477f250-af8d-460e-972f-b3125664df9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6058b874-3860-4250-902e-29ea89c02663" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_8477f250-af8d-460e-972f-b3125664df9f" xlink:to="loc_srt_RangeAxis_6058b874-3860-4250-902e-29ea89c02663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f6da15f9-210f-49cf-9ad0-2d635e24c729" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_6058b874-3860-4250-902e-29ea89c02663" xlink:to="loc_srt_RangeMember_f6da15f9-210f-49cf-9ad0-2d635e24c729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_509482b0-a51e-49ee-9413-29a07fad45ca" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f6da15f9-210f-49cf-9ad0-2d635e24c729" xlink:to="loc_srt_MinimumMember_509482b0-a51e-49ee-9413-29a07fad45ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_bcd44173-2810-4e9e-b960-4f9c6f983aff" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f6da15f9-210f-49cf-9ad0-2d635e24c729" xlink:to="loc_srt_MaximumMember_bcd44173-2810-4e9e-b960-4f9c6f983aff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_9a3a6419-4618-43aa-9bd5-a9ed21967b0e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReportingUnitAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_8477f250-af8d-460e-972f-b3125664df9f" xlink:to="loc_us-gaap_ReportingUnitAxis_9a3a6419-4618-43aa-9bd5-a9ed21967b0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_ec5127d0-94a6-486d-941f-d6560ea7fc96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReportingUnitDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitAxis_9a3a6419-4618-43aa-9bd5-a9ed21967b0e" xlink:to="loc_us-gaap_ReportingUnitDomain_ec5127d0-94a6-486d-941f-d6560ea7fc96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NourishMember_dd967002-7920-48d7-ba72-bbe5f09d4e78" xlink:href="iff-20231231.xsd#iff_NourishMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_ec5127d0-94a6-486d-941f-d6560ea7fc96" xlink:to="loc_iff_NourishMember_dd967002-7920-48d7-ba72-bbe5f09d4e78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ScentMember_2a99e65b-64cb-4772-be07-b38c9a0c52bf" xlink:href="iff-20231231.xsd#iff_ScentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_ec5127d0-94a6-486d-941f-d6560ea7fc96" xlink:to="loc_iff_ScentMember_2a99e65b-64cb-4772-be07-b38c9a0c52bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_HealthBiosciencesMember_6e445b7f-db37-4880-8f7f-f10f8aacbf35" xlink:href="iff-20231231.xsd#iff_HealthBiosciencesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_ec5127d0-94a6-486d-941f-d6560ea7fc96" xlink:to="loc_iff_HealthBiosciencesMember_6e445b7f-db37-4880-8f7f-f10f8aacbf35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_PharmaSolutionsMember_cfc04062-cba2-4720-bf12-7b56a3c602ad" xlink:href="iff-20231231.xsd#iff_PharmaSolutionsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_ec5127d0-94a6-486d-941f-d6560ea7fc96" xlink:to="loc_iff_PharmaSolutionsMember_cfc04062-cba2-4720-bf12-7b56a3c602ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FragranceCompoundsMember_4ce9a0a5-0a96-421d-bb04-5bb3527c716e" xlink:href="iff-20231231.xsd#iff_FragranceCompoundsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_ec5127d0-94a6-486d-941f-d6560ea7fc96" xlink:to="loc_iff_FragranceCompoundsMember_4ce9a0a5-0a96-421d-bb04-5bb3527c716e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FragranceIngredientsMember_a0d45648-d14e-4fed-b662-23b6f80504f3" xlink:href="iff-20231231.xsd#iff_FragranceIngredientsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_ec5127d0-94a6-486d-941f-d6560ea7fc96" xlink:to="loc_iff_FragranceIngredientsMember_a0d45648-d14e-4fed-b662-23b6f80504f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_CosmeticActivesMember_3c196f80-ecce-4d92-8d53-e0d3cd5ab2f1" xlink:href="iff-20231231.xsd#iff_CosmeticActivesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_ec5127d0-94a6-486d-941f-d6560ea7fc96" xlink:to="loc_iff_CosmeticActivesMember_3c196f80-ecce-4d92-8d53-e0d3cd5ab2f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_6b829b23-d3fa-4955-bbbc-3846718e6f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_8477f250-af8d-460e-972f-b3125664df9f" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_6b829b23-d3fa-4955-bbbc-3846718e6f8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_cbdc349a-5f52-46c8-bb3f-3bff3e5eb791" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_6b829b23-d3fa-4955-bbbc-3846718e6f8c" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_cbdc349a-5f52-46c8-bb3f-3bff3e5eb791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMember_9c454998-1dd9-42c2-8340-6bbe59cefbef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_cbdc349a-5f52-46c8-bb3f-3bff3e5eb791" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMember_9c454998-1dd9-42c2-8340-6bbe59cefbef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_d1f34566-be3a-4d0b-803b-c74f62672e6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_8477f250-af8d-460e-972f-b3125664df9f" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_d1f34566-be3a-4d0b-803b-c74f62672e6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_136eddfd-1704-40f1-985d-171787f12e6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_d1f34566-be3a-4d0b-803b-c74f62672e6f" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_136eddfd-1704-40f1-985d-171787f12e6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_RussiaUkraineWarMember_5e24ee8b-8c40-458f-a6f0-de1ac75331c2" xlink:href="iff-20231231.xsd#iff_RussiaUkraineWarMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_136eddfd-1704-40f1-985d-171787f12e6b" xlink:to="loc_iff_RussiaUkraineWarMember_5e24ee8b-8c40-458f-a6f0-de1ac75331c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_efb942ea-7fe9-48e0-aba3-411f11b336a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_8477f250-af8d-460e-972f-b3125664df9f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_efb942ea-7fe9-48e0-aba3-411f11b336a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8be27981-ef53-4a72-85af-c8f575df7bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_efb942ea-7fe9-48e0-aba3-411f11b336a5" xlink:to="loc_us-gaap_SegmentDomain_8be27981-ef53-4a72-85af-c8f575df7bf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_HealthBiosciencesMember_5e1c6148-3bb9-4bc2-8931-ee9fc31a830c" xlink:href="iff-20231231.xsd#iff_HealthBiosciencesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8be27981-ef53-4a72-85af-c8f575df7bf9" xlink:to="loc_iff_HealthBiosciencesMember_5e1c6148-3bb9-4bc2-8931-ee9fc31a830c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_PharmaSolutionsMember_edf8aa34-8e73-4767-848d-d1559d549958" xlink:href="iff-20231231.xsd#iff_PharmaSolutionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8be27981-ef53-4a72-85af-c8f575df7bf9" xlink:to="loc_iff_PharmaSolutionsMember_edf8aa34-8e73-4767-848d-d1559d549958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NourishAndHealthBiosciencesMember_219a8a7e-6dbe-4276-a3e1-fbe34f90ea50" xlink:href="iff-20231231.xsd#iff_NourishAndHealthBiosciencesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8be27981-ef53-4a72-85af-c8f575df7bf9" xlink:to="loc_iff_NourishAndHealthBiosciencesMember_219a8a7e-6dbe-4276-a3e1-fbe34f90ea50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NourishMember_1dc403b4-9c29-4645-83ac-ab8a519df655" xlink:href="iff-20231231.xsd#iff_NourishMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8be27981-ef53-4a72-85af-c8f575df7bf9" xlink:to="loc_iff_NourishMember_1dc403b4-9c29-4645-83ac-ab8a519df655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_d369fbc4-8be8-4710-9321-4b99151a5540" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_8477f250-af8d-460e-972f-b3125664df9f" xlink:to="loc_us-gaap_GoodwillLineItems_d369fbc4-8be8-4710-9321-4b99151a5540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPeriodIncreaseDecrease_18cca023-0447-4c64-ab7e-1cc6ec8e77a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillPeriodIncreaseDecrease"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_d369fbc4-8be8-4710-9321-4b99151a5540" xlink:to="loc_us-gaap_GoodwillPeriodIncreaseDecrease_18cca023-0447-4c64-ab7e-1cc6ec8e77a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_28801ec2-3d59-4be0-be16-a9a6892e7047" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_d369fbc4-8be8-4710-9321-4b99151a5540" xlink:to="loc_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_28801ec2-3d59-4be0-be16-a9a6892e7047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_8a52b92f-f153-4813-b595-c5630e083408" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_d369fbc4-8be8-4710-9321-4b99151a5540" xlink:to="loc_us-gaap_AssetImpairmentCharges_8a52b92f-f153-4813-b595-c5630e083408" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_4a9b029c-30fc-460c-bfa3-f6fcb8edde7e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_d369fbc4-8be8-4710-9321-4b99151a5540" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_4a9b029c-30fc-460c-bfa3-f6fcb8edde7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_16b214e5-b7de-4f60-b607-0651dc1609d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_d369fbc4-8be8-4710-9321-4b99151a5540" xlink:to="loc_us-gaap_Goodwill_16b214e5-b7de-4f60-b607-0651dc1609d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_67023871-e476-4218-94e3-a1edf46ff578" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_d369fbc4-8be8-4710-9321-4b99151a5540" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_67023871-e476-4218-94e3-a1edf46ff578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetGoodwillRollforwardDetails" xlink:type="simple" xlink:href="iff-20231231.xsd#GoodwillandOtherIntangibleAssetsNetGoodwillRollforwardDetails"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetGoodwillRollforwardDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_bb149edd-4781-4379-94f0-dca401cc81bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_8b726c66-fd7f-4fc5-8f45-631bb891ce6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_bb149edd-4781-4379-94f0-dca401cc81bc" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_8b726c66-fd7f-4fc5-8f45-631bb891ce6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_2d3aa30c-70f0-4d80-af83-23377915e002" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_8b726c66-fd7f-4fc5-8f45-631bb891ce6b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_2d3aa30c-70f0-4d80-af83-23377915e002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ce92f8d5-66e1-4c79-80fd-17257d7d4ae8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_2d3aa30c-70f0-4d80-af83-23377915e002" xlink:to="loc_us-gaap_SegmentDomain_ce92f8d5-66e1-4c79-80fd-17257d7d4ae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NourishMember_919a9c38-6f84-4248-9d28-16a9fab30dd6" xlink:href="iff-20231231.xsd#iff_NourishMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ce92f8d5-66e1-4c79-80fd-17257d7d4ae8" xlink:to="loc_iff_NourishMember_919a9c38-6f84-4248-9d28-16a9fab30dd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_HealthBiosciencesMember_a5635972-d9a3-4508-abe6-232ff26d4a14" xlink:href="iff-20231231.xsd#iff_HealthBiosciencesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ce92f8d5-66e1-4c79-80fd-17257d7d4ae8" xlink:to="loc_iff_HealthBiosciencesMember_a5635972-d9a3-4508-abe6-232ff26d4a14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ScentMember_22ad4786-f5ca-41d3-86f2-3e82d99dce94" xlink:href="iff-20231231.xsd#iff_ScentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ce92f8d5-66e1-4c79-80fd-17257d7d4ae8" xlink:to="loc_iff_ScentMember_22ad4786-f5ca-41d3-86f2-3e82d99dce94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_PharmaSolutionsMember_361cd3b6-71f3-47d6-8f80-3f53159bfec2" xlink:href="iff-20231231.xsd#iff_PharmaSolutionsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ce92f8d5-66e1-4c79-80fd-17257d7d4ae8" xlink:to="loc_iff_PharmaSolutionsMember_361cd3b6-71f3-47d6-8f80-3f53159bfec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_81eb384c-2620-4929-b3ac-a75be8818707" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReportingUnitAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_8b726c66-fd7f-4fc5-8f45-631bb891ce6b" xlink:to="loc_us-gaap_ReportingUnitAxis_81eb384c-2620-4929-b3ac-a75be8818707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_e252a350-945e-4acd-b5dc-c8130c971e71" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReportingUnitDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitAxis_81eb384c-2620-4929-b3ac-a75be8818707" xlink:to="loc_us-gaap_ReportingUnitDomain_e252a350-945e-4acd-b5dc-c8130c971e71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NourishMember_48b7b6a6-8cf9-4caf-b850-6a3e799670cc" xlink:href="iff-20231231.xsd#iff_NourishMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_e252a350-945e-4acd-b5dc-c8130c971e71" xlink:to="loc_iff_NourishMember_48b7b6a6-8cf9-4caf-b850-6a3e799670cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_HealthBiosciencesMember_95ec12ae-e173-454a-906a-1bc53c1f70a2" xlink:href="iff-20231231.xsd#iff_HealthBiosciencesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_e252a350-945e-4acd-b5dc-c8130c971e71" xlink:to="loc_iff_HealthBiosciencesMember_95ec12ae-e173-454a-906a-1bc53c1f70a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ScentMember_55a176fb-9823-4b52-917a-48c9fd1310d2" xlink:href="iff-20231231.xsd#iff_ScentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_e252a350-945e-4acd-b5dc-c8130c971e71" xlink:to="loc_iff_ScentMember_55a176fb-9823-4b52-917a-48c9fd1310d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_PharmaSolutionsMember_d245a267-d42f-47af-81bb-06111410b08a" xlink:href="iff-20231231.xsd#iff_PharmaSolutionsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_e252a350-945e-4acd-b5dc-c8130c971e71" xlink:to="loc_iff_PharmaSolutionsMember_d245a267-d42f-47af-81bb-06111410b08a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_5fb1dc1f-6bd2-4d44-af3c-f5a131def1c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_8b726c66-fd7f-4fc5-8f45-631bb891ce6b" xlink:to="loc_us-gaap_GoodwillLineItems_5fb1dc1f-6bd2-4d44-af3c-f5a131def1c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_05838f31-ce4a-45a7-87a0-203d9f9bf2bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_5fb1dc1f-6bd2-4d44-af3c-f5a131def1c2" xlink:to="loc_us-gaap_GoodwillRollForward_05838f31-ce4a-45a7-87a0-203d9f9bf2bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f642004f-b83b-45bb-9e15-972f6dd0dbcd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_05838f31-ce4a-45a7-87a0-203d9f9bf2bb" xlink:to="loc_us-gaap_Goodwill_f642004f-b83b-45bb-9e15-972f6dd0dbcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_399cc763-8f7d-4a68-a349-2a7572e41f87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_05838f31-ce4a-45a7-87a0-203d9f9bf2bb" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_399cc763-8f7d-4a68-a349-2a7572e41f87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_b3d83df8-3dce-4940-b827-05b749e762b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_05838f31-ce4a-45a7-87a0-203d9f9bf2bb" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_b3d83df8-3dce-4940-b827-05b749e762b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPeriodIncreaseDecrease_fd7f138f-ce38-48b1-a602-fab7d3945efc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillPeriodIncreaseDecrease"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_05838f31-ce4a-45a7-87a0-203d9f9bf2bb" xlink:to="loc_us-gaap_GoodwillPeriodIncreaseDecrease_fd7f138f-ce38-48b1-a602-fab7d3945efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_905e12a0-595b-46b2-9b64-c66db3c2603c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_05838f31-ce4a-45a7-87a0-203d9f9bf2bb" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_905e12a0-595b-46b2-9b64-c66db3c2603c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTransfers_e1602584-c14c-4be0-bcd5-f62a86e5f736" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillTransfers"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_05838f31-ce4a-45a7-87a0-203d9f9bf2bb" xlink:to="loc_us-gaap_GoodwillTransfers_e1602584-c14c-4be0-bcd5-f62a86e5f736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_0a8544ce-2714-4188-bcf6-d8b61c3f2725" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_05838f31-ce4a-45a7-87a0-203d9f9bf2bb" xlink:to="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_0a8544ce-2714-4188-bcf6-d8b61c3f2725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_0ecb8701-ca2d-4759-97d0-c76562ad85c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_05838f31-ce4a-45a7-87a0-203d9f9bf2bb" xlink:to="loc_us-gaap_Goodwill_0ecb8701-ca2d-4759-97d0-c76562ad85c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_e3ec9d28-932f-40ff-a149-0f5dcd941871" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_5fb1dc1f-6bd2-4d44-af3c-f5a131def1c2" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_e3ec9d28-932f-40ff-a149-0f5dcd941871" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetTrademarkandOtherIntangibleAssetsDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#GoodwillandOtherIntangibleAssetsNetTrademarkandOtherIntangibleAssetsDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetTrademarkandOtherIntangibleAssetsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f7a80517-08c3-40b4-ba13-f89c3b76263a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_d626c56e-b60c-4bba-bf64-426786e9e21c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f7a80517-08c3-40b4-ba13-f89c3b76263a" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_d626c56e-b60c-4bba-bf64-426786e9e21c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e8c5470f-2c21-4481-a18a-b9e2cc6beb84" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_d626c56e-b60c-4bba-bf64-426786e9e21c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e8c5470f-2c21-4481-a18a-b9e2cc6beb84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3efa56bd-8222-4434-a95f-68057f9b7fdb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e8c5470f-2c21-4481-a18a-b9e2cc6beb84" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3efa56bd-8222-4434-a95f-68057f9b7fdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_435f7acb-28f3-4a20-a4b0-aa4b28913afc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3efa56bd-8222-4434-a95f-68057f9b7fdb" xlink:to="loc_us-gaap_CustomerRelationshipsMember_435f7acb-28f3-4a20-a4b0-aa4b28913afc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_f45e2768-a0e3-4c62-9faf-4a1d70d5634f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3efa56bd-8222-4434-a95f-68057f9b7fdb" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_f45e2768-a0e3-4c62-9faf-4a1d70d5634f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_79cdb908-d78c-4005-8789-bd69fb6c1e0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3efa56bd-8222-4434-a95f-68057f9b7fdb" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_79cdb908-d78c-4005-8789-bd69fb6c1e0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_c817c952-f10c-4c91-beb9-c3077829dbbd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3efa56bd-8222-4434-a95f-68057f9b7fdb" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_c817c952-f10c-4c91-beb9-c3077829dbbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5ccebaa3-401e-4463-95ee-8af0ba37c588" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_d626c56e-b60c-4bba-bf64-426786e9e21c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5ccebaa3-401e-4463-95ee-8af0ba37c588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_eb152e7b-682a-43b5-af31-8439d9d3d115" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5ccebaa3-401e-4463-95ee-8af0ba37c588" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_eb152e7b-682a-43b5-af31-8439d9d3d115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_a819be96-ba34-4ede-bc4b-bf8fbf14594b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5ccebaa3-401e-4463-95ee-8af0ba37c588" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_a819be96-ba34-4ede-bc4b-bf8fbf14594b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1bcb4e79-f0f2-4ccb-92c4-f0eedbc61fab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5ccebaa3-401e-4463-95ee-8af0ba37c588" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1bcb4e79-f0f2-4ccb-92c4-f0eedbc61fab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetAmortizationExpenseDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#GoodwillandOtherIntangibleAssetsNetAmortizationExpenseDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetAmortizationExpenseDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_46bde4e6-db9a-46fe-b4c7-10c2fc1f620d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_774d7489-30ef-4b0d-8e57-20d148b0584e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_46bde4e6-db9a-46fe-b4c7-10c2fc1f620d" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_774d7489-30ef-4b0d-8e57-20d148b0584e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_e90aa019-c506-42b5-a021-1b9a374210c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_46bde4e6-db9a-46fe-b4c7-10c2fc1f620d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_e90aa019-c506-42b5-a021-1b9a374210c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_be600260-f43d-4ca8-9ad0-dea6b247ba73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_46bde4e6-db9a-46fe-b4c7-10c2fc1f620d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_be600260-f43d-4ca8-9ad0-dea6b247ba73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_6f119bb4-83af-4c8c-8ea0-1b73abdaf930" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_46bde4e6-db9a-46fe-b4c7-10c2fc1f620d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_6f119bb4-83af-4c8c-8ea0-1b73abdaf930" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_d136e393-0881-4112-956a-1bbf5f6b9fbe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_46bde4e6-db9a-46fe-b4c7-10c2fc1f620d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_d136e393-0881-4112-956a-1bbf5f6b9fbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_fc8c2609-50d2-47f1-8391-04ac2d0f82d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_46bde4e6-db9a-46fe-b4c7-10c2fc1f620d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_fc8c2609-50d2-47f1-8391-04ac2d0f82d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_d7285376-7bc5-41f3-b1c5-5a46175a5398" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_46bde4e6-db9a-46fe-b4c7-10c2fc1f620d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_d7285376-7bc5-41f3-b1c5-5a46175a5398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherAssetsDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherAssetsDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherAssetsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsAbstract_7cabf64d-1b90-4b4c-8dbf-31ad67ff3bea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValueAddedTaxReceivableCurrent_9d50f20b-c05e-430e-a902-916fa0e72133" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValueAddedTaxReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_7cabf64d-1b90-4b4c-8dbf-31ad67ff3bea" xlink:to="loc_us-gaap_ValueAddedTaxReceivableCurrent_9d50f20b-c05e-430e-a902-916fa0e72133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_931f309f-d589-4e7b-b34c-7c7e9d0cff0f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_7cabf64d-1b90-4b4c-8dbf-31ad67ff3bea" xlink:to="loc_us-gaap_IncomeTaxesReceivable_931f309f-d589-4e7b-b34c-7c7e9d0cff0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Supplies_db1f0020-4797-4b0d-ac0c-f0e1b0776173" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Supplies"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_7cabf64d-1b90-4b4c-8dbf-31ad67ff3bea" xlink:to="loc_us-gaap_Supplies_db1f0020-4797-4b0d-ac0c-f0e1b0776173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_becb9d84-545c-4cc0-8afb-c2ca003e5b4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_7cabf64d-1b90-4b4c-8dbf-31ad67ff3bea" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_becb9d84-545c-4cc0-8afb-c2ca003e5b4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent_77aad574-9660-4ffd-bbd9-d4600d649f31" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_7cabf64d-1b90-4b4c-8dbf-31ad67ff3bea" xlink:to="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent_77aad574-9660-4ffd-bbd9-d4600d649f31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_0b307269-9afc-4ff5-ae1a-f8543eb9fb1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_7cabf64d-1b90-4b4c-8dbf-31ad67ff3bea" xlink:to="loc_us-gaap_OtherAssetsCurrent_0b307269-9afc-4ff5-ae1a-f8543eb9fb1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_cf802c5b-35d6-4054-8cd7-4498d74c1c56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_7cabf64d-1b90-4b4c-8dbf-31ad67ff3bea" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_cf802c5b-35d6-4054-8cd7-4498d74c1c56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent_6c4d5633-d60b-470c-976f-17b34378be6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_7cabf64d-1b90-4b4c-8dbf-31ad67ff3bea" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent_6c4d5633-d60b-470c-976f-17b34378be6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_4aef4977-01fb-45e5-a226-71569c2c74e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_7cabf64d-1b90-4b4c-8dbf-31ad67ff3bea" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_4aef4977-01fb-45e5-a226-71569c2c74e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueOfLifeInsurance_812029e7-61b3-45e2-b92c-a87ca2c4a238" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashSurrenderValueOfLifeInsurance"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_7cabf64d-1b90-4b4c-8dbf-31ad67ff3bea" xlink:to="loc_us-gaap_CashSurrenderValueOfLifeInsurance_812029e7-61b3-45e2-b92c-a87ca2c4a238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_f48943c9-da8b-4cc8-a623-c02a1f530310" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_7cabf64d-1b90-4b4c-8dbf-31ad67ff3bea" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_f48943c9-da8b-4cc8-a623-c02a1f530310" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_d1de7f6a-5350-4674-bcfd-aab0203c68b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_7cabf64d-1b90-4b4c-8dbf-31ad67ff3bea" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_d1de7f6a-5350-4674-bcfd-aab0203c68b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_37bb0258-248f-4f52-9526-b0efd4695bcc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_7cabf64d-1b90-4b4c-8dbf-31ad67ff3bea" xlink:to="loc_us-gaap_EquityMethodInvestments_37bb0258-248f-4f52-9526-b0efd4695bcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="iff-20231231.xsd#OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherCurrentLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_249ae5a1-103a-40e4-af20-99bfd71aebca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_RebatesAndIncentivesPayableCurrent_00a580a3-a825-4348-8481-d1acc43e55f6" xlink:href="iff-20231231.xsd#iff_RebatesAndIncentivesPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_249ae5a1-103a-40e4-af20-99bfd71aebca" xlink:to="loc_iff_RebatesAndIncentivesPayableCurrent_00a580a3-a825-4348-8481-d1acc43e55f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesAndExciseTaxPayableCurrent_6c3e84d8-9c2e-4760-bc45-ff00dc83a8fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesAndExciseTaxPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_249ae5a1-103a-40e4-af20-99bfd71aebca" xlink:to="loc_us-gaap_SalesAndExciseTaxPayableCurrent_6c3e84d8-9c2e-4760-bc45-ff00dc83a8fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_260c9e31-aabc-4ed4-a8e4-19c46eb520a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPayableCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_249ae5a1-103a-40e4-af20-99bfd71aebca" xlink:to="loc_us-gaap_InterestPayableCurrent_260c9e31-aabc-4ed4-a8e4-19c46eb520a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent_cb44656c-3469-41bf-92ca-e5b628e0f283" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_249ae5a1-103a-40e4-af20-99bfd71aebca" xlink:to="loc_us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent_cb44656c-3469-41bf-92ca-e5b628e0f283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedInsuranceCurrent_146fac6b-cf2a-4926-bffe-ab0104601a41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedInsuranceCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_249ae5a1-103a-40e4-af20-99bfd71aebca" xlink:to="loc_us-gaap_AccruedInsuranceCurrent_146fac6b-cf2a-4926-bffe-ab0104601a41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EarnOutsPayableCurrent_a08b0389-598b-49a8-afce-e5dd887b1ad1" xlink:href="iff-20231231.xsd#iff_EarnOutsPayableCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_249ae5a1-103a-40e4-af20-99bfd71aebca" xlink:to="loc_iff_EarnOutsPayableCurrent_a08b0389-598b-49a8-afce-e5dd887b1ad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_b0b8c351-95c2-42d5-ae20-33ec8c5b6cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_249ae5a1-103a-40e4-af20-99bfd71aebca" xlink:to="loc_us-gaap_RestructuringReserve_b0b8c351-95c2-42d5-ae20-33ec8c5b6cd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_ea89bc7e-949c-4a36-a03a-8bed75294759" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_249ae5a1-103a-40e4-af20-99bfd71aebca" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_ea89bc7e-949c-4a36-a03a-8bed75294759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_d05ef0de-e6f3-433d-a921-703753a85708" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_249ae5a1-103a-40e4-af20-99bfd71aebca" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_d05ef0de-e6f3-433d-a921-703753a85708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AccruedFreightCurrent_a26bf4e8-efe9-41d4-a333-8c0a61d03ce9" xlink:href="iff-20231231.xsd#iff_AccruedFreightCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_249ae5a1-103a-40e4-af20-99bfd71aebca" xlink:to="loc_iff_AccruedFreightCurrent_a26bf4e8-efe9-41d4-a333-8c0a61d03ce9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AccruedCommissionsPayableCurrent_62e6c644-b3fb-428a-927f-31fda24f916e" xlink:href="iff-20231231.xsd#iff_AccruedCommissionsPayableCurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_249ae5a1-103a-40e4-af20-99bfd71aebca" xlink:to="loc_iff_AccruedCommissionsPayableCurrent_62e6c644-b3fb-428a-927f-31fda24f916e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_d88a9543-a7d1-4702-bff5-7e4ddf559471" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_249ae5a1-103a-40e4-af20-99bfd71aebca" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_d88a9543-a7d1-4702-bff5-7e4ddf559471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccountsPayableAndAccruedLiabilities_5aafa08f-be14-4210-ac2b-92d5e324dc2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_249ae5a1-103a-40e4-af20-99bfd71aebca" xlink:to="loc_us-gaap_OtherAccountsPayableAndAccruedLiabilities_5aafa08f-be14-4210-ac2b-92d5e324dc2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent_865b2565-4d3d-4d8c-ad99-dc6d745bdbf7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_249ae5a1-103a-40e4-af20-99bfd71aebca" xlink:to="loc_us-gaap_OtherSundryLiabilitiesCurrent_865b2565-4d3d-4d8c-ad99-dc6d745bdbf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_e6a98f05-2f0b-450e-8f61-2eb7389d8435" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_249ae5a1-103a-40e4-af20-99bfd71aebca" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_e6a98f05-2f0b-450e-8f61-2eb7389d8435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/DebtComponentsofDebtDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#DebtComponentsofDebtDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/DebtComponentsofDebtDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_2ee3f615-11f6-4f27-8840-be7169a9e510" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_e6e538a5-ea92-4e1e-9007-29190ea13dfa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2ee3f615-11f6-4f27-8840-be7169a9e510" xlink:to="loc_us-gaap_DebtInstrumentTable_e6e538a5-ea92-4e1e-9007-29190ea13dfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e73ae5c5-eaa4-4103-b412-9da5b95a6d85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e6e538a5-ea92-4e1e-9007-29190ea13dfa" xlink:to="loc_us-gaap_DebtInstrumentAxis_e73ae5c5-eaa4-4103-b412-9da5b95a6d85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d72fb76d-91d9-4fbc-b227-e7e7a53ba4db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_e73ae5c5-eaa4-4103-b412-9da5b95a6d85" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d72fb76d-91d9-4fbc-b227-e7e7a53ba4db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandTwentyThreeMember_b0474a69-dedf-4a5e-bb1a-cfc3b9cba2d7" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandTwentyThreeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d72fb76d-91d9-4fbc-b227-e7e7a53ba4db" xlink:to="loc_iff_SeniorNotesDueTwoThousandTwentyThreeMember_b0474a69-dedf-4a5e-bb1a-cfc3b9cba2d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember_6d133fa6-b200-484e-859c-c35ba6368ab4" xlink:href="iff-20231231.xsd#iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d72fb76d-91d9-4fbc-b227-e7e7a53ba4db" xlink:to="loc_iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember_6d133fa6-b200-484e-859c-c35ba6368ab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandTwentyFiveMember_afa42449-0ce6-4695-87da-ef23b5851fab" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandTwentyFiveMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d72fb76d-91d9-4fbc-b227-e7e7a53ba4db" xlink:to="loc_iff_SeniorNotesDueTwoThousandTwentyFiveMember_afa42449-0ce6-4695-87da-ef23b5851fab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember_bbbf6213-2f0f-4587-b875-990e467d5e32" xlink:href="iff-20231231.xsd#iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d72fb76d-91d9-4fbc-b227-e7e7a53ba4db" xlink:to="loc_iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember_bbbf6213-2f0f-4587-b875-990e467d5e32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandTwentySevenMember_bfa8740e-de2f-4dd9-a7af-93f9edc64a6f" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandTwentySevenMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d72fb76d-91d9-4fbc-b227-e7e7a53ba4db" xlink:to="loc_iff_SeniorNotesDueTwoThousandTwentySevenMember_bfa8740e-de2f-4dd9-a7af-93f9edc64a6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandTwentyEightMember_048bec46-5d2a-491f-a631-3ab1e8b1ac18" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandTwentyEightMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d72fb76d-91d9-4fbc-b227-e7e7a53ba4db" xlink:to="loc_iff_SeniorNotesDueTwoThousandTwentyEightMember_048bec46-5d2a-491f-a631-3ab1e8b1ac18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandThirtyMember_4480c4d3-0f6c-4a63-95fc-694d319100f7" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandThirtyMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d72fb76d-91d9-4fbc-b227-e7e7a53ba4db" xlink:to="loc_iff_SeniorNotesDueTwoThousandThirtyMember_4480c4d3-0f6c-4a63-95fc-694d319100f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandFortyMember_5d1da95b-b1f1-4674-9870-9bfb117c660e" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandFortyMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d72fb76d-91d9-4fbc-b227-e7e7a53ba4db" xlink:to="loc_iff_SeniorNotesDueTwoThousandFortyMember_5d1da95b-b1f1-4674-9870-9bfb117c660e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandFortySevenMember_a0579068-66a2-427f-a10e-19f6db36e3d8" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandFortySevenMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d72fb76d-91d9-4fbc-b227-e7e7a53ba4db" xlink:to="loc_iff_SeniorNotesDueTwoThousandFortySevenMember_a0579068-66a2-427f-a10e-19f6db36e3d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandFortyEightMember_53e21008-86b6-41be-8272-ae7fdbb4c33d" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandFortyEightMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d72fb76d-91d9-4fbc-b227-e7e7a53ba4db" xlink:to="loc_iff_SeniorNotesDueTwoThousandFortyEightMember_53e21008-86b6-41be-8272-ae7fdbb4c33d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandFiftyMember_fd1507c0-befe-4832-84b3-0c0678fd1dd7" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandFiftyMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d72fb76d-91d9-4fbc-b227-e7e7a53ba4db" xlink:to="loc_iff_SeniorNotesDueTwoThousandFiftyMember_fd1507c0-befe-4832-84b3-0c0678fd1dd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_A2024TermLoanMember_5e965a12-2cef-4577-977d-d1c13bca4ff5" xlink:href="iff-20231231.xsd#iff_A2024TermLoanMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d72fb76d-91d9-4fbc-b227-e7e7a53ba4db" xlink:to="loc_iff_A2024TermLoanMember_5e965a12-2cef-4577-977d-d1c13bca4ff5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_A2026TermLoanMember_95f0bb33-e6a7-4b12-ab80-d04d60c68871" xlink:href="iff-20231231.xsd#iff_A2026TermLoanMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d72fb76d-91d9-4fbc-b227-e7e7a53ba4db" xlink:to="loc_iff_A2026TermLoanMember_95f0bb33-e6a7-4b12-ab80-d04d60c68871" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_b0902123-142f-4752-84bf-2892f0886c5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d72fb76d-91d9-4fbc-b227-e7e7a53ba4db" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_b0902123-142f-4752-84bf-2892f0886c5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BankBorrowingsAndOverdraftsMember_e992e1cf-e1a0-4023-9c27-24ba4864ce3d" xlink:href="iff-20231231.xsd#iff_BankBorrowingsAndOverdraftsMember"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d72fb76d-91d9-4fbc-b227-e7e7a53ba4db" xlink:to="loc_iff_BankBorrowingsAndOverdraftsMember_e992e1cf-e1a0-4023-9c27-24ba4864ce3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_4bbed907-dad7-4cad-ae6b-65e8f177896b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e6e538a5-ea92-4e1e-9007-29190ea13dfa" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_4bbed907-dad7-4cad-ae6b-65e8f177896b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_2eb5b594-9ee8-4d5a-acd5-290ed03e6746" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_4bbed907-dad7-4cad-ae6b-65e8f177896b" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_2eb5b594-9ee8-4d5a-acd5-290ed03e6746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_b28afe76-cb81-4597-af05-9f9c4ca289ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_2eb5b594-9ee8-4d5a-acd5-290ed03e6746" xlink:to="loc_us-gaap_LoansPayableMember_b28afe76-cb81-4597-af05-9f9c4ca289ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_7dfb4c6f-35c5-4a66-9027-09e8e9779c2d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e6e538a5-ea92-4e1e-9007-29190ea13dfa" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_7dfb4c6f-35c5-4a66-9027-09e8e9779c2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_16fd0e69-9663-4e8a-b1f9-9d6979444c1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7dfb4c6f-35c5-4a66-9027-09e8e9779c2d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_16fd0e69-9663-4e8a-b1f9-9d6979444c1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_01b98aa1-1221-4130-88ff-9eb13dad8b06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_16fd0e69-9663-4e8a-b1f9-9d6979444c1b" xlink:to="loc_us-gaap_LoansPayableMember_01b98aa1-1221-4130-88ff-9eb13dad8b06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3e6ecaf7-c7f1-4771-ad7f-41b4139fa279" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e6e538a5-ea92-4e1e-9007-29190ea13dfa" xlink:to="loc_srt_RangeAxis_3e6ecaf7-c7f1-4771-ad7f-41b4139fa279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_27ec2eda-3c90-484d-8b39-8cc22c72e3c7" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_3e6ecaf7-c7f1-4771-ad7f-41b4139fa279" xlink:to="loc_srt_RangeMember_27ec2eda-3c90-484d-8b39-8cc22c72e3c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_70000030-b8c9-4f16-be1e-d4ca583f1fce" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_27ec2eda-3c90-484d-8b39-8cc22c72e3c7" xlink:to="loc_srt_MinimumMember_70000030-b8c9-4f16-be1e-d4ca583f1fce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a3132c20-408e-4440-85f3-3184d182ccf9" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_27ec2eda-3c90-484d-8b39-8cc22c72e3c7" xlink:to="loc_srt_MaximumMember_a3132c20-408e-4440-85f3-3184d182ccf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_1b88d5be-d8e3-472d-a86d-bab15ddb83a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e6e538a5-ea92-4e1e-9007-29190ea13dfa" xlink:to="loc_us-gaap_CreditFacilityAxis_1b88d5be-d8e3-472d-a86d-bab15ddb83a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_bcee1a91-df7b-4778-844b-123a4673cbee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_1b88d5be-d8e3-472d-a86d-bab15ddb83a3" xlink:to="loc_us-gaap_CreditFacilityDomain_bcee1a91-df7b-4778-844b-123a4673cbee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_e6e45377-688a-46f0-a381-3386bee0757f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_bcee1a91-df7b-4778-844b-123a4673cbee" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_e6e45377-688a-46f0-a381-3386bee0757f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_f6fb1ca7-1eb4-46fd-bb1d-cbf55e4a967e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e6e538a5-ea92-4e1e-9007-29190ea13dfa" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_f6fb1ca7-1eb4-46fd-bb1d-cbf55e4a967e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_64126117-aaaa-4fdd-9b12-fe3327e97687" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_f6fb1ca7-1eb4-46fd-bb1d-cbf55e4a967e" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_64126117-aaaa-4fdd-9b12-fe3327e97687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_CitibankN.AMember_c7bfbbba-125a-4c35-9593-4e115affde4a" xlink:href="iff-20231231.xsd#iff_CitibankN.AMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_64126117-aaaa-4fdd-9b12-fe3327e97687" xlink:to="loc_iff_CitibankN.AMember_c7bfbbba-125a-4c35-9593-4e115affde4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_96516bc4-c96e-462e-9694-5c26d109962f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e6e538a5-ea92-4e1e-9007-29190ea13dfa" xlink:to="loc_us-gaap_VariableRateAxis_96516bc4-c96e-462e-9694-5c26d109962f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_cc98d02d-c87b-49cc-884c-092da61b120d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_96516bc4-c96e-462e-9694-5c26d109962f" xlink:to="loc_us-gaap_VariableRateDomain_cc98d02d-c87b-49cc-884c-092da61b120d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EurocurrencyRateMember_d31fd4cb-a34e-4f18-8b52-cfdde901c85f" xlink:href="iff-20231231.xsd#iff_EurocurrencyRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_cc98d02d-c87b-49cc-884c-092da61b120d" xlink:to="loc_iff_EurocurrencyRateMember_d31fd4cb-a34e-4f18-8b52-cfdde901c85f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_20b7f71b-e535-45fe-b6ec-59736803f0e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_cc98d02d-c87b-49cc-884c-092da61b120d" xlink:to="loc_us-gaap_BaseRateMember_20b7f71b-e535-45fe-b6ec-59736803f0e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_fcd17446-8f74-4840-889b-952f33a8abbc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e6e538a5-ea92-4e1e-9007-29190ea13dfa" xlink:to="loc_us-gaap_DebtInstrumentLineItems_fcd17446-8f74-4840-889b-952f33a8abbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_814168f5-a346-4538-849f-b6013eec6a3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fcd17446-8f74-4840-889b-952f33a8abbc" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_814168f5-a346-4538-849f-b6013eec6a3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesCurrent_27647760-0105-4035-9bc2-10d986a47f5f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fcd17446-8f74-4840-889b-952f33a8abbc" xlink:to="loc_us-gaap_SeniorNotesCurrent_27647760-0105-4035-9bc2-10d986a47f5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorLongTermNotes_4c2c76d6-2dd8-4829-868d-e5cf6aafb811" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorLongTermNotes"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fcd17446-8f74-4840-889b-952f33a8abbc" xlink:to="loc_us-gaap_SeniorLongTermNotes_4c2c76d6-2dd8-4829-868d-e5cf6aafb811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper_cada7fd7-5618-4fcd-8c7f-e984379fd6c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommercialPaper"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fcd17446-8f74-4840-889b-952f33a8abbc" xlink:to="loc_us-gaap_CommercialPaper_cada7fd7-5618-4fcd-8c7f-e984379fd6c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_eb30f5dc-ee0a-413b-99c7-37af4dfaf444" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fcd17446-8f74-4840-889b-952f33a8abbc" xlink:to="loc_us-gaap_LineOfCredit_eb30f5dc-ee0a-413b-99c7-37af4dfaf444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_f515acd4-4fa2-47a1-b9ef-741e879b068c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fcd17446-8f74-4840-889b-952f33a8abbc" xlink:to="loc_us-gaap_ShortTermBorrowings_f515acd4-4fa2-47a1-b9ef-741e879b068c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_ea44c1c3-8d6b-4236-9f34-9b18c3d470e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fcd17446-8f74-4840-889b-952f33a8abbc" xlink:to="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_ea44c1c3-8d6b-4236-9f34-9b18c3d470e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_03747e41-3d64-46ea-b94d-9ce9cdfeb0ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fcd17446-8f74-4840-889b-952f33a8abbc" xlink:to="loc_us-gaap_LongTermDebtCurrent_03747e41-3d64-46ea-b94d-9ce9cdfeb0ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_4e1f2652-0f90-480c-812f-f9be741137ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fcd17446-8f74-4840-889b-952f33a8abbc" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_4e1f2652-0f90-480c-812f-f9be741137ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_a5e413d0-8e75-422b-9719-91ad83e2e1dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fcd17446-8f74-4840-889b-952f33a8abbc" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_a5e413d0-8e75-422b-9719-91ad83e2e1dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_e92286be-ce60-42aa-8e54-d9bf6d292bac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_9c609b1f-8772-497a-8528-a2c991cf3a4b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e92286be-ce60-42aa-8e54-d9bf6d292bac" xlink:to="loc_us-gaap_DebtInstrumentTable_9c609b1f-8772-497a-8528-a2c991cf3a4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d9263cb0-5cb7-4d52-aa99-ca16b1a18d6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9c609b1f-8772-497a-8528-a2c991cf3a4b" xlink:to="loc_us-gaap_DebtInstrumentAxis_d9263cb0-5cb7-4d52-aa99-ca16b1a18d6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1374ee1f-7ba0-4e29-81be-c88feefd8e99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_d9263cb0-5cb7-4d52-aa99-ca16b1a18d6c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1374ee1f-7ba0-4e29-81be-c88feefd8e99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorUnsecuredTermLoanFacilitiesMember_635ff85f-209f-48fc-abaa-c5a9ef17ace8" xlink:href="iff-20231231.xsd#iff_SeniorUnsecuredTermLoanFacilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1374ee1f-7ba0-4e29-81be-c88feefd8e99" xlink:to="loc_iff_SeniorUnsecuredTermLoanFacilitiesMember_635ff85f-209f-48fc-abaa-c5a9ef17ace8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorUnsecuredNotesMember_b2ad2e05-1969-438a-8ba8-f8b47b74d3b6" xlink:href="iff-20231231.xsd#iff_SeniorUnsecuredNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1374ee1f-7ba0-4e29-81be-c88feefd8e99" xlink:to="loc_iff_SeniorUnsecuredNotesMember_b2ad2e05-1969-438a-8ba8-f8b47b74d3b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_A2024TermLoanMember_63bfc2e1-ebac-4e29-8bfa-6b33fd67cb6c" xlink:href="iff-20231231.xsd#iff_A2024TermLoanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1374ee1f-7ba0-4e29-81be-c88feefd8e99" xlink:to="loc_iff_A2024TermLoanMember_63bfc2e1-ebac-4e29-8bfa-6b33fd67cb6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_A2026TermLoanMember_33056ab8-492b-47c4-9c6a-594f125019e7" xlink:href="iff-20231231.xsd#iff_A2026TermLoanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1374ee1f-7ba0-4e29-81be-c88feefd8e99" xlink:to="loc_iff_A2026TermLoanMember_33056ab8-492b-47c4-9c6a-594f125019e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TermLoanCreditAgreementMember_1d8b0657-c53f-48d8-b579-9985bc63afd4" xlink:href="iff-20231231.xsd#iff_TermLoanCreditAgreementMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1374ee1f-7ba0-4e29-81be-c88feefd8e99" xlink:to="loc_iff_TermLoanCreditAgreementMember_1d8b0657-c53f-48d8-b579-9985bc63afd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandTwentyTwoMember_928bd009-211b-46d4-9368-03a72a3a8e41" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandTwentyTwoMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1374ee1f-7ba0-4e29-81be-c88feefd8e99" xlink:to="loc_iff_SeniorNotesDueTwoThousandTwentyTwoMember_928bd009-211b-46d4-9368-03a72a3a8e41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandTwentyFiveMember_b9cfefb0-2781-4e6d-b80b-cbae710430f0" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandTwentyFiveMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1374ee1f-7ba0-4e29-81be-c88feefd8e99" xlink:to="loc_iff_SeniorNotesDueTwoThousandTwentyFiveMember_b9cfefb0-2781-4e6d-b80b-cbae710430f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandTwentySevenMember_a7934a4e-7aa2-447e-894a-865ca4dae99c" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandTwentySevenMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1374ee1f-7ba0-4e29-81be-c88feefd8e99" xlink:to="loc_iff_SeniorNotesDueTwoThousandTwentySevenMember_a7934a4e-7aa2-447e-894a-865ca4dae99c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandThirtyMember_a5cf7994-2f8e-4588-a89e-9dc05534f4e5" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandThirtyMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1374ee1f-7ba0-4e29-81be-c88feefd8e99" xlink:to="loc_iff_SeniorNotesDueTwoThousandThirtyMember_a5cf7994-2f8e-4588-a89e-9dc05534f4e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandFortyMember_5add4294-b14e-405a-86ec-d7f574252543" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandFortyMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1374ee1f-7ba0-4e29-81be-c88feefd8e99" xlink:to="loc_iff_SeniorNotesDueTwoThousandFortyMember_5add4294-b14e-405a-86ec-d7f574252543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandFiftyMember_586fe9f3-2989-461e-8fd1-a585c01d7267" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandFiftyMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1374ee1f-7ba0-4e29-81be-c88feefd8e99" xlink:to="loc_iff_SeniorNotesDueTwoThousandFiftyMember_586fe9f3-2989-461e-8fd1-a585c01d7267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_49c2c700-1076-451f-8467-ce5157e2c16b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9c609b1f-8772-497a-8528-a2c991cf3a4b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_49c2c700-1076-451f-8467-ce5157e2c16b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b100dcc8-4c66-4ace-8498-280bb80a6d34" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_49c2c700-1076-451f-8467-ce5157e2c16b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b100dcc8-4c66-4ace-8498-280bb80a6d34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_ee8bcb11-b676-4bed-8778-9270382db3b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b100dcc8-4c66-4ace-8498-280bb80a6d34" xlink:to="loc_us-gaap_UnsecuredDebtMember_ee8bcb11-b676-4bed-8778-9270382db3b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_b114438a-31c4-4bcf-b474-ff1ce9558b48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b100dcc8-4c66-4ace-8498-280bb80a6d34" xlink:to="loc_us-gaap_LoansPayableMember_b114438a-31c4-4bcf-b474-ff1ce9558b48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_bccdcdc2-9716-495a-a45c-0aa7eb4defb2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9c609b1f-8772-497a-8528-a2c991cf3a4b" xlink:to="loc_dei_LegalEntityAxis_bccdcdc2-9716-495a-a45c-0aa7eb4defb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_6c5be03d-f80e-41f8-8440-a82628c941d4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_bccdcdc2-9716-495a-a45c-0aa7eb4defb2" xlink:to="loc_dei_EntityDomain_6c5be03d-f80e-41f8-8440-a82628c941d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NutritionBiosciencesIncMember_f78a80a6-71ba-4a92-b998-202ddf39dfd7" xlink:href="iff-20231231.xsd#iff_NutritionBiosciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_6c5be03d-f80e-41f8-8440-a82628c941d4" xlink:to="loc_iff_NutritionBiosciencesIncMember_f78a80a6-71ba-4a92-b998-202ddf39dfd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4bf40b35-0ca3-4f32-b0b6-b269def6a35b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9c609b1f-8772-497a-8528-a2c991cf3a4b" xlink:to="loc_srt_RangeAxis_4bf40b35-0ca3-4f32-b0b6-b269def6a35b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_baeed4fa-e739-4bb5-b020-e1d64098a8f2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_4bf40b35-0ca3-4f32-b0b6-b269def6a35b" xlink:to="loc_srt_RangeMember_baeed4fa-e739-4bb5-b020-e1d64098a8f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2435427d-de28-4427-91b4-f8f1faf03c93" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_baeed4fa-e739-4bb5-b020-e1d64098a8f2" xlink:to="loc_srt_MinimumMember_2435427d-de28-4427-91b4-f8f1faf03c93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_36f555d4-8654-435e-a207-bf527dc95524" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_baeed4fa-e739-4bb5-b020-e1d64098a8f2" xlink:to="loc_srt_MaximumMember_36f555d4-8654-435e-a207-bf527dc95524" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_d0d95fe0-6b45-4892-80aa-ad6aaaf96206" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9c609b1f-8772-497a-8528-a2c991cf3a4b" xlink:to="loc_us-gaap_VariableRateAxis_d0d95fe0-6b45-4892-80aa-ad6aaaf96206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_16296ad8-3987-4f0e-a77b-c990430f517f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_d0d95fe0-6b45-4892-80aa-ad6aaaf96206" xlink:to="loc_us-gaap_VariableRateDomain_16296ad8-3987-4f0e-a77b-c990430f517f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_LondonInterbankOfferedRateLIBOR1Member_3d4702cd-e3c9-488d-8ae6-c6398f66e987" xlink:href="iff-20231231.xsd#iff_LondonInterbankOfferedRateLIBOR1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_16296ad8-3987-4f0e-a77b-c990430f517f" xlink:to="loc_iff_LondonInterbankOfferedRateLIBOR1Member_3d4702cd-e3c9-488d-8ae6-c6398f66e987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_8b2e49e5-3fdb-4943-8d7a-ddb4f5a63a53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_16296ad8-3987-4f0e-a77b-c990430f517f" xlink:to="loc_us-gaap_BaseRateMember_8b2e49e5-3fdb-4943-8d7a-ddb4f5a63a53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SecuredOvernightFinancingRateSOFRMember_8915205d-52e6-43a4-bde7-45219aacd0aa" xlink:href="iff-20231231.xsd#iff_SecuredOvernightFinancingRateSOFRMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_16296ad8-3987-4f0e-a77b-c990430f517f" xlink:to="loc_iff_SecuredOvernightFinancingRateSOFRMember_8915205d-52e6-43a4-bde7-45219aacd0aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DebtCovenantPeriodAxis_7e0cf58e-f224-4109-9dad-3b493b036bac" xlink:href="iff-20231231.xsd#iff_DebtCovenantPeriodAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9c609b1f-8772-497a-8528-a2c991cf3a4b" xlink:to="loc_iff_DebtCovenantPeriodAxis_7e0cf58e-f224-4109-9dad-3b493b036bac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DebtCovenantPeriodDomain_a5d4f07e-416e-4869-b836-8ea0052bda98" xlink:href="iff-20231231.xsd#iff_DebtCovenantPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_DebtCovenantPeriodAxis_7e0cf58e-f224-4109-9dad-3b493b036bac" xlink:to="loc_iff_DebtCovenantPeriodDomain_a5d4f07e-416e-4869-b836-8ea0052bda98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FiscalQuarterEndingOnOrBeforeMarch312024Member_7d29d9e4-d72e-4771-b9a7-7eeb0a99afcb" xlink:href="iff-20231231.xsd#iff_FiscalQuarterEndingOnOrBeforeMarch312024Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_DebtCovenantPeriodDomain_a5d4f07e-416e-4869-b836-8ea0052bda98" xlink:to="loc_iff_FiscalQuarterEndingOnOrBeforeMarch312024Member_7d29d9e4-d72e-4771-b9a7-7eeb0a99afcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FiscalQuarterEndingJune302024Member_ff4346fa-ba0c-4a54-8670-221b282522e6" xlink:href="iff-20231231.xsd#iff_FiscalQuarterEndingJune302024Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_DebtCovenantPeriodDomain_a5d4f07e-416e-4869-b836-8ea0052bda98" xlink:to="loc_iff_FiscalQuarterEndingJune302024Member_ff4346fa-ba0c-4a54-8670-221b282522e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FiscalQuarterEndingSeptember302024Member_96ddbf85-7ef4-4bf0-9432-e9aa1b941540" xlink:href="iff-20231231.xsd#iff_FiscalQuarterEndingSeptember302024Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_DebtCovenantPeriodDomain_a5d4f07e-416e-4869-b836-8ea0052bda98" xlink:to="loc_iff_FiscalQuarterEndingSeptember302024Member_96ddbf85-7ef4-4bf0-9432-e9aa1b941540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SubsequentFiscalQuarterEndingOnOrBeforeMarch312025Member_aed00565-6b1e-4a9b-9c62-b8b9f7ca0794" xlink:href="iff-20231231.xsd#iff_SubsequentFiscalQuarterEndingOnOrBeforeMarch312025Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_DebtCovenantPeriodDomain_a5d4f07e-416e-4869-b836-8ea0052bda98" xlink:to="loc_iff_SubsequentFiscalQuarterEndingOnOrBeforeMarch312025Member_aed00565-6b1e-4a9b-9c62-b8b9f7ca0794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SubsequentFiscalQuarterEndingOnOrBeforeSeptember302025Member_1108dd61-f6f3-4517-accb-ba75a54ca2d7" xlink:href="iff-20231231.xsd#iff_SubsequentFiscalQuarterEndingOnOrBeforeSeptember302025Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_DebtCovenantPeriodDomain_a5d4f07e-416e-4869-b836-8ea0052bda98" xlink:to="loc_iff_SubsequentFiscalQuarterEndingOnOrBeforeSeptember302025Member_1108dd61-f6f3-4517-accb-ba75a54ca2d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FiscalQuarterEndingDecember312025Member_98a0e791-e470-4aed-ac66-7cc64fe9e990" xlink:href="iff-20231231.xsd#iff_FiscalQuarterEndingDecember312025Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_DebtCovenantPeriodDomain_a5d4f07e-416e-4869-b836-8ea0052bda98" xlink:to="loc_iff_FiscalQuarterEndingDecember312025Member_98a0e791-e470-4aed-ac66-7cc64fe9e990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_4d2de1d7-06af-445a-a207-a016fa6d7ddd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9c609b1f-8772-497a-8528-a2c991cf3a4b" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_4d2de1d7-06af-445a-a207-a016fa6d7ddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_31067a62-1118-4cf7-a2d4-3c223371dfd8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_4d2de1d7-06af-445a-a207-a016fa6d7ddd" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_31067a62-1118-4cf7-a2d4-3c223371dfd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_26c76762-5964-4cb6-b6dc-700e008fd2e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_31067a62-1118-4cf7-a2d4-3c223371dfd8" xlink:to="loc_us-gaap_LoansPayableMember_26c76762-5964-4cb6-b6dc-700e008fd2e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_64997e26-16d7-488c-a3b6-3e7914bd1b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9c609b1f-8772-497a-8528-a2c991cf3a4b" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_64997e26-16d7-488c-a3b6-3e7914bd1b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_8b13cc50-ffcb-4358-bf19-5635b6919db8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_64997e26-16d7-488c-a3b6-3e7914bd1b9b" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_8b13cc50-ffcb-4358-bf19-5635b6919db8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_2cac0ed6-61dc-4a8c-b62e-ffa61f66d763" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_8b13cc50-ffcb-4358-bf19-5635b6919db8" xlink:to="loc_us-gaap_SubsequentEventMember_2cac0ed6-61dc-4a8c-b62e-ffa61f66d763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_d1ad57a6-1cd9-4c2b-9303-3c3a07d6e530" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9c609b1f-8772-497a-8528-a2c991cf3a4b" xlink:to="loc_us-gaap_DebtInstrumentLineItems_d1ad57a6-1cd9-4c2b-9303-3c3a07d6e530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_89aea16f-30d1-42fe-82f7-de9443983da9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1ad57a6-1cd9-4c2b-9303-3c3a07d6e530" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_89aea16f-30d1-42fe-82f7-de9443983da9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_73cd4d3b-92a9-4906-a50f-7464747d8fa4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1ad57a6-1cd9-4c2b-9303-3c3a07d6e530" xlink:to="loc_us-gaap_DebtInstrumentTerm_73cd4d3b-92a9-4906-a50f-7464747d8fa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b942ce54-611e-4d36-9e36-a759ab2a43f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1ad57a6-1cd9-4c2b-9303-3c3a07d6e530" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b942ce54-611e-4d36-9e36-a759ab2a43f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_6f4a54e8-4aa7-4119-8b5d-fdd8c38d5003" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1ad57a6-1cd9-4c2b-9303-3c3a07d6e530" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_6f4a54e8-4aa7-4119-8b5d-fdd8c38d5003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DebtInstrumentCovenantMaximumConsolidatedLeverageRatio_85dec27a-f5a6-4a43-9cde-c72d4139e257" xlink:href="iff-20231231.xsd#iff_DebtInstrumentCovenantMaximumConsolidatedLeverageRatio"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1ad57a6-1cd9-4c2b-9303-3c3a07d6e530" xlink:to="loc_iff_DebtInstrumentCovenantMaximumConsolidatedLeverageRatio_85dec27a-f5a6-4a43-9cde-c72d4139e257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_CommonStockDividendsPerShareMaximumDividendThresholdPerQuarter_ecce0efa-dbfe-4c7e-b7ee-bdc81ddd19b0" xlink:href="iff-20231231.xsd#iff_CommonStockDividendsPerShareMaximumDividendThresholdPerQuarter"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1ad57a6-1cd9-4c2b-9303-3c3a07d6e530" xlink:to="loc_iff_CommonStockDividendsPerShareMaximumDividendThresholdPerQuarter_ecce0efa-dbfe-4c7e-b7ee-bdc81ddd19b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_CommonStockDividendsPerShareMaximumDividendThresholdPerYear_17d3df1b-142d-46c3-8dfb-d36f9157d99a" xlink:href="iff-20231231.xsd#iff_CommonStockDividendsPerShareMaximumDividendThresholdPerYear"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1ad57a6-1cd9-4c2b-9303-3c3a07d6e530" xlink:to="loc_iff_CommonStockDividendsPerShareMaximumDividendThresholdPerYear_17d3df1b-142d-46c3-8dfb-d36f9157d99a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DebtInstrumentCovenantLienThresholdAmount_fc505fcd-2553-4dd5-a977-ecc506bf0ee0" xlink:href="iff-20231231.xsd#iff_DebtInstrumentCovenantLienThresholdAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1ad57a6-1cd9-4c2b-9303-3c3a07d6e530" xlink:to="loc_iff_DebtInstrumentCovenantLienThresholdAmount_fc505fcd-2553-4dd5-a977-ecc506bf0ee0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DebtInstrumentCovenantLienThresholdPercentageOfConsolidatedNetTangibleAssets_17e00843-30d8-483a-98df-45e895aee65f" xlink:href="iff-20231231.xsd#iff_DebtInstrumentCovenantLienThresholdPercentageOfConsolidatedNetTangibleAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1ad57a6-1cd9-4c2b-9303-3c3a07d6e530" xlink:to="loc_iff_DebtInstrumentCovenantLienThresholdPercentageOfConsolidatedNetTangibleAssets_17e00843-30d8-483a-98df-45e895aee65f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DebtInstrumentCovenantPercentageOfProceedsFromNonOrdinaryAssetsSalesRequiredToBeUsedAsPrepayment_4178a2a0-6550-407b-9d58-0d2bad17dd54" xlink:href="iff-20231231.xsd#iff_DebtInstrumentCovenantPercentageOfProceedsFromNonOrdinaryAssetsSalesRequiredToBeUsedAsPrepayment"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1ad57a6-1cd9-4c2b-9303-3c3a07d6e530" xlink:to="loc_iff_DebtInstrumentCovenantPercentageOfProceedsFromNonOrdinaryAssetsSalesRequiredToBeUsedAsPrepayment_4178a2a0-6550-407b-9d58-0d2bad17dd54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DebtInstrumentCovenantBasisSpreadIncreaseOnVariableRate_0318c364-da04-46c7-b6e6-a028a64d37a6" xlink:href="iff-20231231.xsd#iff_DebtInstrumentCovenantBasisSpreadIncreaseOnVariableRate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1ad57a6-1cd9-4c2b-9303-3c3a07d6e530" xlink:to="loc_iff_DebtInstrumentCovenantBasisSpreadIncreaseOnVariableRate_0318c364-da04-46c7-b6e6-a028a64d37a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_2ed1606e-0759-48fe-be34-dcb7faf5746a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1ad57a6-1cd9-4c2b-9303-3c3a07d6e530" xlink:to="loc_us-gaap_RepaymentsOfDebt_2ed1606e-0759-48fe-be34-dcb7faf5746a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesCurrent_5250d809-abab-42fa-b742-306c51742797" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesCurrent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1ad57a6-1cd9-4c2b-9303-3c3a07d6e530" xlink:to="loc_us-gaap_SeniorNotesCurrent_5250d809-abab-42fa-b742-306c51742797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorLongTermNotes_d83364ca-f250-4e13-87b9-066d3bfab3ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorLongTermNotes"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1ad57a6-1cd9-4c2b-9303-3c3a07d6e530" xlink:to="loc_us-gaap_SeniorLongTermNotes_d83364ca-f250-4e13-87b9-066d3bfab3ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/DebtAdditionalInformationRevolvingCreditFacilityDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#DebtAdditionalInformationRevolvingCreditFacilityDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/DebtAdditionalInformationRevolvingCreditFacilityDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_5468c672-0ae9-49dd-b47a-22605b902c27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_1c21a94b-974d-42d8-9e29-67007c7e73c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_5468c672-0ae9-49dd-b47a-22605b902c27" xlink:to="loc_us-gaap_DebtInstrumentTable_1c21a94b-974d-42d8-9e29-67007c7e73c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_5079d0ec-a0e8-40ad-ac34-8a4405dae751" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1c21a94b-974d-42d8-9e29-67007c7e73c8" xlink:to="loc_us-gaap_CreditFacilityAxis_5079d0ec-a0e8-40ad-ac34-8a4405dae751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_431eb152-6f69-473f-afe7-f97c1cb3502c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_5079d0ec-a0e8-40ad-ac34-8a4405dae751" xlink:to="loc_us-gaap_CreditFacilityDomain_431eb152-6f69-473f-afe7-f97c1cb3502c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_b73c517d-c586-4306-978a-c2a9b7a847fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_431eb152-6f69-473f-afe7-f97c1cb3502c" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_b73c517d-c586-4306-978a-c2a9b7a847fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_4bdc0c7e-5336-424d-b9e7-74e203e7ef2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1c21a94b-974d-42d8-9e29-67007c7e73c8" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_4bdc0c7e-5336-424d-b9e7-74e203e7ef2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_bb2bbdb1-d3c7-4c37-ac6d-cd248e3cf433" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_4bdc0c7e-5336-424d-b9e7-74e203e7ef2a" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_bb2bbdb1-d3c7-4c37-ac6d-cd248e3cf433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_CitibankN.AMember_f7e82add-b149-41f1-86b8-d6c093eff99d" xlink:href="iff-20231231.xsd#iff_CitibankN.AMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_bb2bbdb1-d3c7-4c37-ac6d-cd248e3cf433" xlink:to="loc_iff_CitibankN.AMember_f7e82add-b149-41f1-86b8-d6c093eff99d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_261c005c-43dd-4603-8b0a-b9361866b00f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1c21a94b-974d-42d8-9e29-67007c7e73c8" xlink:to="loc_us-gaap_DebtInstrumentAxis_261c005c-43dd-4603-8b0a-b9361866b00f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9baca0cd-8908-48ee-890b-ba34fe5d94ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_261c005c-43dd-4603-8b0a-b9361866b00f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9baca0cd-8908-48ee-890b-ba34fe5d94ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_153b27e0-c56f-4435-b12d-12162cac183b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9baca0cd-8908-48ee-890b-ba34fe5d94ca" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_153b27e0-c56f-4435-b12d-12162cac183b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_bc02a8ee-84bc-435c-99a6-e35b6da56ad8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1c21a94b-974d-42d8-9e29-67007c7e73c8" xlink:to="loc_us-gaap_VariableRateAxis_bc02a8ee-84bc-435c-99a6-e35b6da56ad8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_4c63acf3-8ad5-4922-8193-19d908892d8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_bc02a8ee-84bc-435c-99a6-e35b6da56ad8" xlink:to="loc_us-gaap_VariableRateDomain_4c63acf3-8ad5-4922-8193-19d908892d8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EuroInterbankOfferedRateMember_1d8c7aa2-f6cb-4bb3-9b13-a68aad20dfc3" xlink:href="iff-20231231.xsd#iff_EuroInterbankOfferedRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_4c63acf3-8ad5-4922-8193-19d908892d8e" xlink:to="loc_iff_EuroInterbankOfferedRateMember_1d8c7aa2-f6cb-4bb3-9b13-a68aad20dfc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SecuredOvernightFinancingRateSOFRMember_652f65c9-86fe-4019-bad6-937173f49740" xlink:href="iff-20231231.xsd#iff_SecuredOvernightFinancingRateSOFRMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_4c63acf3-8ad5-4922-8193-19d908892d8e" xlink:to="loc_iff_SecuredOvernightFinancingRateSOFRMember_652f65c9-86fe-4019-bad6-937173f49740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DebtCovenantPeriodAxis_5da2c711-eba7-45e5-84d9-2d110a4874d2" xlink:href="iff-20231231.xsd#iff_DebtCovenantPeriodAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1c21a94b-974d-42d8-9e29-67007c7e73c8" xlink:to="loc_iff_DebtCovenantPeriodAxis_5da2c711-eba7-45e5-84d9-2d110a4874d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DebtCovenantPeriodDomain_5acd5a37-7456-41ab-8412-0a152dbf8e30" xlink:href="iff-20231231.xsd#iff_DebtCovenantPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_DebtCovenantPeriodAxis_5da2c711-eba7-45e5-84d9-2d110a4874d2" xlink:to="loc_iff_DebtCovenantPeriodDomain_5acd5a37-7456-41ab-8412-0a152dbf8e30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FiscalQuarterEndingOnOrBeforeMarch312024Member_c10e2228-d32e-4297-856f-1e6239e47aab" xlink:href="iff-20231231.xsd#iff_FiscalQuarterEndingOnOrBeforeMarch312024Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_DebtCovenantPeriodDomain_5acd5a37-7456-41ab-8412-0a152dbf8e30" xlink:to="loc_iff_FiscalQuarterEndingOnOrBeforeMarch312024Member_c10e2228-d32e-4297-856f-1e6239e47aab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FiscalQuarterEndingJune302024Member_8461c2b2-2c13-4b53-8f8c-414e4aaa6110" xlink:href="iff-20231231.xsd#iff_FiscalQuarterEndingJune302024Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_DebtCovenantPeriodDomain_5acd5a37-7456-41ab-8412-0a152dbf8e30" xlink:to="loc_iff_FiscalQuarterEndingJune302024Member_8461c2b2-2c13-4b53-8f8c-414e4aaa6110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FiscalQuarterEndingSeptember302024Member_e794c5fd-21db-4260-84c5-ed2fe83b24c1" xlink:href="iff-20231231.xsd#iff_FiscalQuarterEndingSeptember302024Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_DebtCovenantPeriodDomain_5acd5a37-7456-41ab-8412-0a152dbf8e30" xlink:to="loc_iff_FiscalQuarterEndingSeptember302024Member_e794c5fd-21db-4260-84c5-ed2fe83b24c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SubsequentFiscalQuarterEndingOnOrBeforeMarch312025Member_e0b541e9-0be6-4046-9c49-cd5edb9c494d" xlink:href="iff-20231231.xsd#iff_SubsequentFiscalQuarterEndingOnOrBeforeMarch312025Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_DebtCovenantPeriodDomain_5acd5a37-7456-41ab-8412-0a152dbf8e30" xlink:to="loc_iff_SubsequentFiscalQuarterEndingOnOrBeforeMarch312025Member_e0b541e9-0be6-4046-9c49-cd5edb9c494d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SubsequentFiscalQuarterEndingOnOrBeforeSeptember302025Member_a30ebfc5-d252-4217-a92a-c1a9ae5f15eb" xlink:href="iff-20231231.xsd#iff_SubsequentFiscalQuarterEndingOnOrBeforeSeptember302025Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_DebtCovenantPeriodDomain_5acd5a37-7456-41ab-8412-0a152dbf8e30" xlink:to="loc_iff_SubsequentFiscalQuarterEndingOnOrBeforeSeptember302025Member_a30ebfc5-d252-4217-a92a-c1a9ae5f15eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FiscalQuarterEndingDecember312025Member_e72c6894-5a70-4aa8-9f0e-d974725c4427" xlink:href="iff-20231231.xsd#iff_FiscalQuarterEndingDecember312025Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_DebtCovenantPeriodDomain_5acd5a37-7456-41ab-8412-0a152dbf8e30" xlink:to="loc_iff_FiscalQuarterEndingDecember312025Member_e72c6894-5a70-4aa8-9f0e-d974725c4427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_7a3d5cd2-cfc0-4632-b91b-531a893403df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1c21a94b-974d-42d8-9e29-67007c7e73c8" xlink:to="loc_us-gaap_DebtInstrumentLineItems_7a3d5cd2-cfc0-4632-b91b-531a893403df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts_c32060e6-26fa-4b27-b854-1cef63310f85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a3d5cd2-cfc0-4632-b91b-531a893403df" xlink:to="loc_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts_c32060e6-26fa-4b27-b854-1cef63310f85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_db1a0ad7-0544-4cab-9910-90afad8c3a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a3d5cd2-cfc0-4632-b91b-531a893403df" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_db1a0ad7-0544-4cab-9910-90afad8c3a8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DebtInstrumentCovenantMaximumConsolidatedLeverageRatio_9f6000a6-dbe2-4e10-a13d-0a8d3664e8fa" xlink:href="iff-20231231.xsd#iff_DebtInstrumentCovenantMaximumConsolidatedLeverageRatio"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a3d5cd2-cfc0-4632-b91b-531a893403df" xlink:to="loc_iff_DebtInstrumentCovenantMaximumConsolidatedLeverageRatio_9f6000a6-dbe2-4e10-a13d-0a8d3664e8fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_CommonStockDividendsPerShareMaximumDividendThresholdPerQuarter_c3b1bebf-07c8-410f-89e2-622ed4d5414b" xlink:href="iff-20231231.xsd#iff_CommonStockDividendsPerShareMaximumDividendThresholdPerQuarter"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a3d5cd2-cfc0-4632-b91b-531a893403df" xlink:to="loc_iff_CommonStockDividendsPerShareMaximumDividendThresholdPerQuarter_c3b1bebf-07c8-410f-89e2-622ed4d5414b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_CommonStockDividendsPerShareMaximumDividendThresholdPerYear_d0ae5aa9-a253-417a-b9d7-782b47b42948" xlink:href="iff-20231231.xsd#iff_CommonStockDividendsPerShareMaximumDividendThresholdPerYear"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a3d5cd2-cfc0-4632-b91b-531a893403df" xlink:to="loc_iff_CommonStockDividendsPerShareMaximumDividendThresholdPerYear_d0ae5aa9-a253-417a-b9d7-782b47b42948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DebtInstrumentCovenantLienThresholdAmount_74f04f75-0c92-4c3a-8f0a-0734ae42c133" xlink:href="iff-20231231.xsd#iff_DebtInstrumentCovenantLienThresholdAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a3d5cd2-cfc0-4632-b91b-531a893403df" xlink:to="loc_iff_DebtInstrumentCovenantLienThresholdAmount_74f04f75-0c92-4c3a-8f0a-0734ae42c133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DebtInstrumentCovenantLienThresholdPercentageOfConsolidatedNetTangibleAssets_ff3bb77e-cc94-4999-83ae-62dadd10c61c" xlink:href="iff-20231231.xsd#iff_DebtInstrumentCovenantLienThresholdPercentageOfConsolidatedNetTangibleAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a3d5cd2-cfc0-4632-b91b-531a893403df" xlink:to="loc_iff_DebtInstrumentCovenantLienThresholdPercentageOfConsolidatedNetTangibleAssets_ff3bb77e-cc94-4999-83ae-62dadd10c61c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DebtInstrumentCovenantBasisSpreadIncreaseOnVariableRate_a5f57aae-54d7-4e98-887c-1dc97d5c2fde" xlink:href="iff-20231231.xsd#iff_DebtInstrumentCovenantBasisSpreadIncreaseOnVariableRate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a3d5cd2-cfc0-4632-b91b-531a893403df" xlink:to="loc_iff_DebtInstrumentCovenantBasisSpreadIncreaseOnVariableRate_a5f57aae-54d7-4e98-887c-1dc97d5c2fde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_449d1ae0-6598-4c86-82da-eadcdad1ea6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a3d5cd2-cfc0-4632-b91b-531a893403df" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_449d1ae0-6598-4c86-82da-eadcdad1ea6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_9d704868-70b6-407d-b33f-ea27dba9877e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a3d5cd2-cfc0-4632-b91b-531a893403df" xlink:to="loc_us-gaap_LineOfCredit_9d704868-70b6-407d-b33f-ea27dba9877e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet_151448a8-c106-4b72-8525-02db1731a1d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a3d5cd2-cfc0-4632-b91b-531a893403df" xlink:to="loc_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet_151448a8-c106-4b72-8525-02db1731a1d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_0c78bb9e-54dc-400a-bb7c-751a51d6b363" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a3d5cd2-cfc0-4632-b91b-531a893403df" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_0c78bb9e-54dc-400a-bb7c-751a51d6b363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_07e74d48-ea7f-4e54-8584-0e5125ff288f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a3d5cd2-cfc0-4632-b91b-531a893403df" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_07e74d48-ea7f-4e54-8584-0e5125ff288f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/DebtAdditionalInformationSeniorUnsecuredNotesDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#DebtAdditionalInformationSeniorUnsecuredNotesDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/DebtAdditionalInformationSeniorUnsecuredNotesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_5f3dcc77-e360-491e-af6f-33bbd61ae535" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_fd29dc13-f19b-4ebe-a4f0-9e6315368e2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_5f3dcc77-e360-491e-af6f-33bbd61ae535" xlink:to="loc_us-gaap_DebtInstrumentTable_fd29dc13-f19b-4ebe-a4f0-9e6315368e2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_366fb935-8410-4380-b689-94914b1d1ba6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_fd29dc13-f19b-4ebe-a4f0-9e6315368e2e" xlink:to="loc_us-gaap_DebtInstrumentAxis_366fb935-8410-4380-b689-94914b1d1ba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_99194487-0133-4c93-bedc-bbea084bacad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_366fb935-8410-4380-b689-94914b1d1ba6" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_99194487-0133-4c93-bedc-bbea084bacad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember_01a2678a-ad56-47e0-b640-7ba3401e7380" xlink:href="iff-20231231.xsd#iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_99194487-0133-4c93-bedc-bbea084bacad" xlink:to="loc_iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember_01a2678a-ad56-47e0-b640-7ba3401e7380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandTwentyEightMember_30262bc2-cd6b-4c60-9593-101c00680385" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandTwentyEightMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_99194487-0133-4c93-bedc-bbea084bacad" xlink:to="loc_iff_SeniorNotesDueTwoThousandTwentyEightMember_30262bc2-cd6b-4c60-9593-101c00680385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandFortyEightMember_4114ed9d-2c33-41c9-bbea-f03fabd479a3" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandFortyEightMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_99194487-0133-4c93-bedc-bbea084bacad" xlink:to="loc_iff_SeniorNotesDueTwoThousandFortyEightMember_4114ed9d-2c33-41c9-bbea-f03fabd479a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandTwentyThreeMember_7f5b6ec3-774f-48ec-8640-b351343c5c87" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandTwentyThreeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_99194487-0133-4c93-bedc-bbea084bacad" xlink:to="loc_iff_SeniorNotesDueTwoThousandTwentyThreeMember_7f5b6ec3-774f-48ec-8640-b351343c5c87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember_fda2a51f-bae5-4f9a-9869-d231650d01e3" xlink:href="iff-20231231.xsd#iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_99194487-0133-4c93-bedc-bbea084bacad" xlink:to="loc_iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember_fda2a51f-bae5-4f9a-9869-d231650d01e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandFortySevenMember_a5b912b6-235d-4179-9269-fe220d645857" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandFortySevenMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_99194487-0133-4c93-bedc-bbea084bacad" xlink:to="loc_iff_SeniorNotesDueTwoThousandFortySevenMember_a5b912b6-235d-4179-9269-fe220d645857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_ed21140e-7d21-4d02-8b47-ff703d318c7b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_fd29dc13-f19b-4ebe-a4f0-9e6315368e2e" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_ed21140e-7d21-4d02-8b47-ff703d318c7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_baedb7f8-d433-4c07-ad48-a49669970d9b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ed21140e-7d21-4d02-8b47-ff703d318c7b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_baedb7f8-d433-4c07-ad48-a49669970d9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember_5d47e51b-5bfa-443b-ae90-4ec327746ec7" xlink:href="iff-20231231.xsd#iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_baedb7f8-d433-4c07-ad48-a49669970d9b" xlink:to="loc_iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember_5d47e51b-5bfa-443b-ae90-4ec327746ec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandTwentyEightMember_4f9232f5-a7a9-4f48-935b-7d2e6a945d57" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandTwentyEightMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_baedb7f8-d433-4c07-ad48-a49669970d9b" xlink:to="loc_iff_SeniorNotesDueTwoThousandTwentyEightMember_4f9232f5-a7a9-4f48-935b-7d2e6a945d57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandFortyEightMember_7e851fbb-1b79-4000-a549-130136367a4f" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandFortyEightMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_baedb7f8-d433-4c07-ad48-a49669970d9b" xlink:to="loc_iff_SeniorNotesDueTwoThousandFortyEightMember_7e851fbb-1b79-4000-a549-130136367a4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_bdd0e13a-c63a-4cbc-a2bf-1f8c5e3a1555" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_fd29dc13-f19b-4ebe-a4f0-9e6315368e2e" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_bdd0e13a-c63a-4cbc-a2bf-1f8c5e3a1555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_39a1ec0c-dda1-45e5-9d7b-8e0bc57f0019" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_bdd0e13a-c63a-4cbc-a2bf-1f8c5e3a1555" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_39a1ec0c-dda1-45e5-9d7b-8e0bc57f0019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_033f8427-8a3f-4ae3-a8b6-103d4d00acf0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_39a1ec0c-dda1-45e5-9d7b-8e0bc57f0019" xlink:to="loc_us-gaap_LoansPayableMember_033f8427-8a3f-4ae3-a8b6-103d4d00acf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_21d85898-0bcf-40b8-ad35-14430ece9465" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_fd29dc13-f19b-4ebe-a4f0-9e6315368e2e" xlink:to="loc_us-gaap_DebtInstrumentLineItems_21d85898-0bcf-40b8-ad35-14430ece9465" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorLongTermNotes_064ce7e3-0ab7-4314-b39d-0ccea58899bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorLongTermNotes"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21d85898-0bcf-40b8-ad35-14430ece9465" xlink:to="loc_us-gaap_SeniorLongTermNotes_064ce7e3-0ab7-4314-b39d-0ccea58899bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c663dfb1-2f29-413d-904e-cda384163bed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21d85898-0bcf-40b8-ad35-14430ece9465" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c663dfb1-2f29-413d-904e-cda384163bed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_4c4c861d-6364-4f4b-8fee-c0deda8e66db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21d85898-0bcf-40b8-ad35-14430ece9465" xlink:to="loc_us-gaap_LongTermDebt_4c4c861d-6364-4f4b-8fee-c0deda8e66db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_e1bc6e5f-4237-4ae7-8d06-7e26366ceab3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21d85898-0bcf-40b8-ad35-14430ece9465" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_e1bc6e5f-4237-4ae7-8d06-7e26366ceab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_b6050138-4c39-4665-86d2-4b4588790c89" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21d85898-0bcf-40b8-ad35-14430ece9465" xlink:to="loc_us-gaap_RepaymentsOfDebt_b6050138-4c39-4665-86d2-4b4588790c89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnOilAndGasHedgingActivity_7f5233a8-3e9e-459b-bcc6-ef14be77505e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnOilAndGasHedgingActivity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21d85898-0bcf-40b8-ad35-14430ece9465" xlink:to="loc_us-gaap_GainLossOnOilAndGasHedgingActivity_7f5233a8-3e9e-459b-bcc6-ef14be77505e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_bf8aa541-a56f-4c57-aaa1-666d506abd48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21d85898-0bcf-40b8-ad35-14430ece9465" xlink:to="loc_us-gaap_DebtInstrumentTerm_bf8aa541-a56f-4c57-aaa1-666d506abd48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDeferredCostsGross_4189e567-a1c0-4a72-b6ff-aa22863865b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherDeferredCostsGross"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21d85898-0bcf-40b8-ad35-14430ece9465" xlink:to="loc_us-gaap_OtherDeferredCostsGross_4189e567-a1c0-4a72-b6ff-aa22863865b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/DebtAdditionalInformationCommercialPaperandRedemptionProvisionsDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#DebtAdditionalInformationCommercialPaperandRedemptionProvisionsDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/DebtAdditionalInformationCommercialPaperandRedemptionProvisionsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_480ac870-8a68-4559-9346-60490bcedbdc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_02f22f0a-8bd4-48dc-8353-3f3b5aafaff6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_480ac870-8a68-4559-9346-60490bcedbdc" xlink:to="loc_us-gaap_DebtInstrumentTable_02f22f0a-8bd4-48dc-8353-3f3b5aafaff6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c7bc696b-45a3-4b51-97cc-2e36ff1eeacf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_02f22f0a-8bd4-48dc-8353-3f3b5aafaff6" xlink:to="loc_us-gaap_DebtInstrumentAxis_c7bc696b-45a3-4b51-97cc-2e36ff1eeacf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_827e4ac2-c039-4bc8-b78d-374c53ebf5a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_c7bc696b-45a3-4b51-97cc-2e36ff1eeacf" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_827e4ac2-c039-4bc8-b78d-374c53ebf5a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_InternationalFlavorsFragrancesIncSeniorNotesMember_2d1a795d-0a03-415c-b09f-c0f47937ab17" xlink:href="iff-20231231.xsd#iff_InternationalFlavorsFragrancesIncSeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_827e4ac2-c039-4bc8-b78d-374c53ebf5a2" xlink:to="loc_iff_InternationalFlavorsFragrancesIncSeniorNotesMember_2d1a795d-0a03-415c-b09f-c0f47937ab17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember_08616397-76b6-4a4f-8df6-866c0dfaab6c" xlink:href="iff-20231231.xsd#iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_827e4ac2-c039-4bc8-b78d-374c53ebf5a2" xlink:to="loc_iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember_08616397-76b6-4a4f-8df6-866c0dfaab6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember_868bbe7c-e17e-435e-b104-59e660ac848c" xlink:href="iff-20231231.xsd#iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_827e4ac2-c039-4bc8-b78d-374c53ebf5a2" xlink:to="loc_iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember_868bbe7c-e17e-435e-b104-59e660ac848c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandTwentyEightMember_4d9452cc-a6ab-4dae-9d9c-0647f0b1e64f" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandTwentyEightMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_827e4ac2-c039-4bc8-b78d-374c53ebf5a2" xlink:to="loc_iff_SeniorNotesDueTwoThousandTwentyEightMember_4d9452cc-a6ab-4dae-9d9c-0647f0b1e64f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandFortySevenMember_7ee61a80-4446-4cf6-ac26-1a451cfe2bef" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandFortySevenMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_827e4ac2-c039-4bc8-b78d-374c53ebf5a2" xlink:to="loc_iff_SeniorNotesDueTwoThousandFortySevenMember_7ee61a80-4446-4cf6-ac26-1a451cfe2bef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandFortyEightMember_10c46cb1-274b-4ae8-ad84-2dd4b574a14f" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandFortyEightMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_827e4ac2-c039-4bc8-b78d-374c53ebf5a2" xlink:to="loc_iff_SeniorNotesDueTwoThousandFortyEightMember_10c46cb1-274b-4ae8-ad84-2dd4b574a14f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NutritionBiosciencesIncSeniorNotesMember_25350cb4-878f-46e6-9551-69cace8f0902" xlink:href="iff-20231231.xsd#iff_NutritionBiosciencesIncSeniorNotesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_827e4ac2-c039-4bc8-b78d-374c53ebf5a2" xlink:to="loc_iff_NutritionBiosciencesIncSeniorNotesMember_25350cb4-878f-46e6-9551-69cace8f0902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandTwentyFiveMember_c96051b8-fd5b-4dc1-895d-c73349a6bf09" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandTwentyFiveMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_827e4ac2-c039-4bc8-b78d-374c53ebf5a2" xlink:to="loc_iff_SeniorNotesDueTwoThousandTwentyFiveMember_c96051b8-fd5b-4dc1-895d-c73349a6bf09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandTwentySevenMember_7fe92659-9b30-4da8-8d56-5be45323b94c" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandTwentySevenMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_827e4ac2-c039-4bc8-b78d-374c53ebf5a2" xlink:to="loc_iff_SeniorNotesDueTwoThousandTwentySevenMember_7fe92659-9b30-4da8-8d56-5be45323b94c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandThirtyMember_7f4afa74-5f91-45cb-86fe-1b04bab94726" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandThirtyMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_827e4ac2-c039-4bc8-b78d-374c53ebf5a2" xlink:to="loc_iff_SeniorNotesDueTwoThousandThirtyMember_7f4afa74-5f91-45cb-86fe-1b04bab94726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandFortyMember_a1a1079f-6ef6-4cf3-8c4a-025bddfe63e7" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandFortyMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_827e4ac2-c039-4bc8-b78d-374c53ebf5a2" xlink:to="loc_iff_SeniorNotesDueTwoThousandFortyMember_a1a1079f-6ef6-4cf3-8c4a-025bddfe63e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandFiftyMember_f0bed5d3-05f8-4915-85aa-c2cccf1e60e2" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandFiftyMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_827e4ac2-c039-4bc8-b78d-374c53ebf5a2" xlink:to="loc_iff_SeniorNotesDueTwoThousandFiftyMember_f0bed5d3-05f8-4915-85aa-c2cccf1e60e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_9c0153a4-0b95-45d1-b101-1854c2e69618" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_02f22f0a-8bd4-48dc-8353-3f3b5aafaff6" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_9c0153a4-0b95-45d1-b101-1854c2e69618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_cacda0f2-16c3-4762-9d34-7e65f757356e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9c0153a4-0b95-45d1-b101-1854c2e69618" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_cacda0f2-16c3-4762-9d34-7e65f757356e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_d97c6cad-d9fe-436b-b3c3-ff513bcbbf67" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_cacda0f2-16c3-4762-9d34-7e65f757356e" xlink:to="loc_us-gaap_LoansPayableMember_d97c6cad-d9fe-436b-b3c3-ff513bcbbf67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_4bdeee3e-e039-41e0-9419-e05fd26b452d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_02f22f0a-8bd4-48dc-8353-3f3b5aafaff6" xlink:to="loc_dei_LegalEntityAxis_4bdeee3e-e039-41e0-9419-e05fd26b452d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_1bb7d2d7-48f2-4552-9744-a16e6075c18a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_4bdeee3e-e039-41e0-9419-e05fd26b452d" xlink:to="loc_dei_EntityDomain_1bb7d2d7-48f2-4552-9744-a16e6075c18a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_InternationalFlavorsFragrancesIncMember_af01a5bb-ccf3-4c0c-af4c-3d075230ad4e" xlink:href="iff-20231231.xsd#iff_InternationalFlavorsFragrancesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_1bb7d2d7-48f2-4552-9744-a16e6075c18a" xlink:to="loc_iff_InternationalFlavorsFragrancesIncMember_af01a5bb-ccf3-4c0c-af4c-3d075230ad4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NutritionBiosciencesIncMember_a72d4621-4517-4359-9c6b-ea978883c058" xlink:href="iff-20231231.xsd#iff_NutritionBiosciencesIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_1bb7d2d7-48f2-4552-9744-a16e6075c18a" xlink:to="loc_iff_NutritionBiosciencesIncMember_a72d4621-4517-4359-9c6b-ea978883c058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_df6f6d3f-ebad-4481-a011-01bb8c288420" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_02f22f0a-8bd4-48dc-8353-3f3b5aafaff6" xlink:to="loc_us-gaap_DebtInstrumentLineItems_df6f6d3f-ebad-4481-a011-01bb8c288420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_f2d68d23-5248-43ee-8c7d-e56e020c89d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommercialPaper"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_df6f6d3f-ebad-4481-a011-01bb8c288420" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_f2d68d23-5248-43ee-8c7d-e56e020c89d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfCommercialPaper_c66554dd-84b5-4430-894b-cc62c5fe5c77" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfCommercialPaper"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_df6f6d3f-ebad-4481-a011-01bb8c288420" xlink:to="loc_us-gaap_RepaymentsOfCommercialPaper_c66554dd-84b5-4430-894b-cc62c5fe5c77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_a5b2950f-b6b5-44cd-8fe6-8be9dec754cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_df6f6d3f-ebad-4481-a011-01bb8c288420" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_a5b2950f-b6b5-44cd-8fe6-8be9dec754cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_0e334c3f-6cc9-4a6f-8c04-a7141d61f64d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_df6f6d3f-ebad-4481-a011-01bb8c288420" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_0e334c3f-6cc9-4a6f-8c04-a7141d61f64d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_RepurchasePriceAsPercentageOfPrincipalAmountOfSeniorNotes_3189d41c-3513-48e1-99c0-1bfeff50e080" xlink:href="iff-20231231.xsd#iff_RepurchasePriceAsPercentageOfPrincipalAmountOfSeniorNotes"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_df6f6d3f-ebad-4481-a011-01bb8c288420" xlink:to="loc_iff_RepurchasePriceAsPercentageOfPrincipalAmountOfSeniorNotes_3189d41c-3513-48e1-99c0-1bfeff50e080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/DebtScheduleofDebtMaturitiesDetails" xlink:type="simple" xlink:href="iff-20231231.xsd#DebtScheduleofDebtMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/DebtScheduleofDebtMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_4dd482aa-0d7e-4865-b904-af84782f91cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_5d77df39-b574-45b0-8f5f-bb3f0f8efeec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_4dd482aa-0d7e-4865-b904-af84782f91cb" xlink:to="loc_us-gaap_LongTermDebt_5d77df39-b574-45b0-8f5f-bb3f0f8efeec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_6bdbe053-6ec8-4b25-865d-c627d230cf61" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_4dd482aa-0d7e-4865-b904-af84782f91cb" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_6bdbe053-6ec8-4b25-865d-c627d230cf61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturingInYearsTwoAndThree_423e2150-117c-47d1-be9e-a09982c594fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturingInYearsTwoAndThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_4dd482aa-0d7e-4865-b904-af84782f91cb" xlink:to="loc_us-gaap_LongTermDebtMaturingInYearsTwoAndThree_423e2150-117c-47d1-be9e-a09982c594fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturingInYearsFourAndFive_501df0ce-49b7-4e9d-b8e7-4e31eb03ff72" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturingInYearsFourAndFive"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_4dd482aa-0d7e-4865-b904-af84782f91cb" xlink:to="loc_us-gaap_LongTermDebtMaturingInYearsFourAndFive_501df0ce-49b7-4e9d-b8e7-4e31eb03ff72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_698eeb0a-87ef-46b4-a36d-e41984e5725a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_4dd482aa-0d7e-4865-b904-af84782f91cb" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_698eeb0a-87ef-46b4-a36d-e41984e5725a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/LeasesDetails" xlink:type="simple" xlink:href="iff-20231231.xsd#LeasesDetails"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/LeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_2dd4ab59-9cdb-4c9e-b59c-215a976bdfbb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_51f93ce1-adb6-40b6-a9e5-4d034fb9d5ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2dd4ab59-9cdb-4c9e-b59c-215a976bdfbb" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_51f93ce1-adb6-40b6-a9e5-4d034fb9d5ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_eb5aa0e6-af9f-4d4f-aa78-4b9f6d588574" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_51f93ce1-adb6-40b6-a9e5-4d034fb9d5ca" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_eb5aa0e6-af9f-4d4f-aa78-4b9f6d588574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_216f4391-2c6e-4974-8c10-ddd7f60290ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_eb5aa0e6-af9f-4d4f-aa78-4b9f6d588574" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_216f4391-2c6e-4974-8c10-ddd7f60290ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NutritionBiosciencesIncMember_ca548c22-e9ed-4cac-bf2f-067d8fdbd358" xlink:href="iff-20231231.xsd#iff_NutritionBiosciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_216f4391-2c6e-4974-8c10-ddd7f60290ec" xlink:to="loc_iff_NutritionBiosciencesIncMember_ca548c22-e9ed-4cac-bf2f-067d8fdbd358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_HealthWrightProductsIncHealthWrightMember_690ee299-6d5f-40e1-87f4-fced4f80fe22" xlink:href="iff-20231231.xsd#iff_HealthWrightProductsIncHealthWrightMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_216f4391-2c6e-4974-8c10-ddd7f60290ec" xlink:to="loc_iff_HealthWrightProductsIncHealthWrightMember_690ee299-6d5f-40e1-87f4-fced4f80fe22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_05b72c09-dcbb-472d-bad9-19664fafffb6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_51f93ce1-adb6-40b6-a9e5-4d034fb9d5ca" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_05b72c09-dcbb-472d-bad9-19664fafffb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_cb7cf598-c382-426b-9813-408c9becaef8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_05b72c09-dcbb-472d-bad9-19664fafffb6" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_cb7cf598-c382-426b-9813-408c9becaef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_ef368912-7899-4b82-81bb-d0024ebcb612" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_05b72c09-dcbb-472d-bad9-19664fafffb6" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_ef368912-7899-4b82-81bb-d0024ebcb612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_4e8de986-40c5-4ee0-9d7a-99f823196d37" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_05b72c09-dcbb-472d-bad9-19664fafffb6" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_4e8de986-40c5-4ee0-9d7a-99f823196d37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_5739cd74-3624-44ed-8875-47222ff54659" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_05b72c09-dcbb-472d-bad9-19664fafffb6" xlink:to="loc_us-gaap_OperatingLeaseLiability_5739cd74-3624-44ed-8875-47222ff54659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_0649a9fb-21f6-4ac8-9c8a-5328a17f555e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_05b72c09-dcbb-472d-bad9-19664fafffb6" xlink:to="loc_us-gaap_FinanceLeaseLiability_0649a9fb-21f6-4ac8-9c8a-5328a17f555e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/LeasesScheduleofLeaseExpenseDetails" xlink:type="simple" xlink:href="iff-20231231.xsd#LeasesScheduleofLeaseExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/LeasesScheduleofLeaseExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_2fff3f2f-59f3-41db-a02b-0629bb3aa650" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_e8142dd3-949e-4df1-a71a-cafef4420a78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2fff3f2f-59f3-41db-a02b-0629bb3aa650" xlink:to="loc_us-gaap_OperatingLeaseCost_e8142dd3-949e-4df1-a71a-cafef4420a78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FinanceLeaseCost_575b5f7f-fbc1-4de5-a732-3bc18c3b56bd" xlink:href="iff-20231231.xsd#iff_FinanceLeaseCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2fff3f2f-59f3-41db-a02b-0629bb3aa650" xlink:to="loc_iff_FinanceLeaseCost_575b5f7f-fbc1-4de5-a732-3bc18c3b56bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_6d9ef653-ec1c-425e-bc9b-53a33b47ec89" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2fff3f2f-59f3-41db-a02b-0629bb3aa650" xlink:to="loc_us-gaap_VariableLeaseCost_6d9ef653-ec1c-425e-bc9b-53a33b47ec89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_1db5de3e-b3d8-4d24-b901-522d657c8cc2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2fff3f2f-59f3-41db-a02b-0629bb3aa650" xlink:to="loc_us-gaap_LeaseCost_1db5de3e-b3d8-4d24-b901-522d657c8cc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/LeasesScheduleofRentalExpenseDetails" xlink:type="simple" xlink:href="iff-20231231.xsd#LeasesScheduleofRentalExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/LeasesScheduleofRentalExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_45f5728e-b66a-4d93-992f-00f4d634ec30" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/LeasesCashFlowDetails" xlink:type="simple" xlink:href="iff-20231231.xsd#LeasesCashFlowDetails"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/LeasesCashFlowDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_ead6d479-4fb7-477a-9093-b046a6c029ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_c0f7b4a2-3cb7-4d98-9440-22100a2a611c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ead6d479-4fb7-477a-9093-b046a6c029ce" xlink:to="loc_us-gaap_OperatingLeasePayments_c0f7b4a2-3cb7-4d98-9440-22100a2a611c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_d4072c93-ac38-44e1-8f90-4010844a83f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ead6d479-4fb7-477a-9093-b046a6c029ce" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_d4072c93-ac38-44e1-8f90-4010844a83f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_4eb9bfca-358b-4892-b9a8-1adc8ccd5160" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ead6d479-4fb7-477a-9093-b046a6c029ce" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_4eb9bfca-358b-4892-b9a8-1adc8ccd5160" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_0fcb8419-7d77-461a-9801-242f1fb03046" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ead6d479-4fb7-477a-9093-b046a6c029ce" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_0fcb8419-7d77-461a-9801-242f1fb03046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_46fd5f23-91f2-4c19-b190-8926ac78fa38" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ead6d479-4fb7-477a-9093-b046a6c029ce" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_46fd5f23-91f2-4c19-b190-8926ac78fa38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/LeasesBalanceSheetDetails" xlink:type="simple" xlink:href="iff-20231231.xsd#LeasesBalanceSheetDetails"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/LeasesBalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_eaa4aae6-f63c-412b-953a-657a317e8487" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_3fb280d5-07ad-47ff-a710-192da53ee46f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_eaa4aae6-f63c-412b-953a-657a317e8487" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_3fb280d5-07ad-47ff-a710-192da53ee46f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_264110a7-6579-4542-9c97-679b24e630ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_eaa4aae6-f63c-412b-953a-657a317e8487" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_264110a7-6579-4542-9c97-679b24e630ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1c0b3ab7-3d3e-4d8f-bdbb-c533ec6a59d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_eaa4aae6-f63c-412b-953a-657a317e8487" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1c0b3ab7-3d3e-4d8f-bdbb-c533ec6a59d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_93554079-fb20-432f-80e5-0071c3cbc2e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_eaa4aae6-f63c-412b-953a-657a317e8487" xlink:to="loc_us-gaap_OperatingLeaseLiability_93554079-fb20-432f-80e5-0071c3cbc2e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_5f09c41d-3956-423f-b6d5-9a1adeeb02fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_eaa4aae6-f63c-412b-953a-657a317e8487" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_5f09c41d-3956-423f-b6d5-9a1adeeb02fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_d85aa7a5-e581-4124-8e5c-04d11a78cf9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_eaa4aae6-f63c-412b-953a-657a317e8487" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_d85aa7a5-e581-4124-8e5c-04d11a78cf9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_6cc6bad0-2e5a-4ab7-9d0c-e3a63898c25f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_eaa4aae6-f63c-412b-953a-657a317e8487" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_6cc6bad0-2e5a-4ab7-9d0c-e3a63898c25f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_2f5c28e5-52e2-450b-8ee7-d8a37e6718a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_eaa4aae6-f63c-412b-953a-657a317e8487" xlink:to="loc_us-gaap_FinanceLeaseLiability_2f5c28e5-52e2-450b-8ee7-d8a37e6718a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_d093ce16-1f0f-43b0-8651-4c23e75e2a18" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_eaa4aae6-f63c-412b-953a-657a317e8487" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_d093ce16-1f0f-43b0-8651-4c23e75e2a18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_77a4ed15-8207-48f7-923b-5427cedab868" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_eaa4aae6-f63c-412b-953a-657a317e8487" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_77a4ed15-8207-48f7-923b-5427cedab868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_ff1db0cd-1690-4707-8218-3cec969ce54a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_eaa4aae6-f63c-412b-953a-657a317e8487" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_ff1db0cd-1690-4707-8218-3cec969ce54a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/LeasesWeightedAverageDetails" xlink:type="simple" xlink:href="iff-20231231.xsd#LeasesWeightedAverageDetails"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/LeasesWeightedAverageDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_e20ee244-7665-4477-a980-7d96403339b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_32c4c294-e55f-43fe-b18f-36c742c6c79a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e20ee244-7665-4477-a980-7d96403339b5" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_32c4c294-e55f-43fe-b18f-36c742c6c79a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_b96fe8d1-7a4f-4a8f-bb75-ff8871d6657b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e20ee244-7665-4477-a980-7d96403339b5" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_b96fe8d1-7a4f-4a8f-bb75-ff8871d6657b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_a8493dba-a13a-4775-a286-84394828f88d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e20ee244-7665-4477-a980-7d96403339b5" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_a8493dba-a13a-4775-a286-84394828f88d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_5ca05688-1da3-4782-a34c-fb40b34c6ea4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e20ee244-7665-4477-a980-7d96403339b5" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_5ca05688-1da3-4782-a34c-fb40b34c6ea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails" xlink:type="simple" xlink:href="iff-20231231.xsd#LeasesScheduleofLeaseMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_fe33ba65-c163-49a0-a485-f241f18b33cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c6d9e8d6-a1f9-4815-bd32-cf84a11b2e02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fe33ba65-c163-49a0-a485-f241f18b33cd" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c6d9e8d6-a1f9-4815-bd32-cf84a11b2e02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_a53d3d3a-2f5d-49be-bcf0-625c3375d769" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fe33ba65-c163-49a0-a485-f241f18b33cd" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_a53d3d3a-2f5d-49be-bcf0-625c3375d769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_3360a213-9e12-4e57-86dd-ccd125a38b51" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fe33ba65-c163-49a0-a485-f241f18b33cd" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_3360a213-9e12-4e57-86dd-ccd125a38b51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_1d737cd2-8271-4aaf-827d-1557e9338959" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fe33ba65-c163-49a0-a485-f241f18b33cd" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_1d737cd2-8271-4aaf-827d-1557e9338959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_19cd6b6c-e85d-4d12-87f0-460eb2f25ca1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fe33ba65-c163-49a0-a485-f241f18b33cd" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_19cd6b6c-e85d-4d12-87f0-460eb2f25ca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_36fc500d-91f3-4219-94e3-f10274637797" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fe33ba65-c163-49a0-a485-f241f18b33cd" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_36fc500d-91f3-4219-94e3-f10274637797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_35e3b016-2b72-4c57-a89d-c3f913f485f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fe33ba65-c163-49a0-a485-f241f18b33cd" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_35e3b016-2b72-4c57-a89d-c3f913f485f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_2c5decfe-60ee-44d4-ad24-090e484f9595" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fe33ba65-c163-49a0-a485-f241f18b33cd" xlink:to="loc_us-gaap_OperatingLeaseLiability_2c5decfe-60ee-44d4-ad24-090e484f9595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9771efe7-10d5-4616-a1ab-603e7cd049a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fe33ba65-c163-49a0-a485-f241f18b33cd" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9771efe7-10d5-4616-a1ab-603e7cd049a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_9418c3dd-803d-4652-95c9-df5828f3721f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fe33ba65-c163-49a0-a485-f241f18b33cd" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_9418c3dd-803d-4652-95c9-df5828f3721f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_4a04ddfe-74ef-4896-b130-ef5e20110c47" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fe33ba65-c163-49a0-a485-f241f18b33cd" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_4a04ddfe-74ef-4896-b130-ef5e20110c47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_4f794b69-b688-41ba-af11-57298cd3b0fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fe33ba65-c163-49a0-a485-f241f18b33cd" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_4f794b69-b688-41ba-af11-57298cd3b0fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_fa427f1f-2b19-4472-b48a-46fe27cbf094" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fe33ba65-c163-49a0-a485-f241f18b33cd" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_fa427f1f-2b19-4472-b48a-46fe27cbf094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_fdcd9e7f-2da7-43c2-8c4f-043317107661" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fe33ba65-c163-49a0-a485-f241f18b33cd" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_fdcd9e7f-2da7-43c2-8c4f-043317107661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FinanceLeaseLiabilityPaymentsDueYearTwoAndThree_2e2a3e0f-1cc0-4686-8716-e3349112bfa8" xlink:href="iff-20231231.xsd#iff_FinanceLeaseLiabilityPaymentsDueYearTwoAndThree"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fe33ba65-c163-49a0-a485-f241f18b33cd" xlink:to="loc_iff_FinanceLeaseLiabilityPaymentsDueYearTwoAndThree_2e2a3e0f-1cc0-4686-8716-e3349112bfa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FinanceLeaseLiabilityPaymentsDueYearFourAndFive_e6cf945a-31b5-49fb-9aa1-d67ed7a0abd6" xlink:href="iff-20231231.xsd#iff_FinanceLeaseLiabilityPaymentsDueYearFourAndFive"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fe33ba65-c163-49a0-a485-f241f18b33cd" xlink:to="loc_iff_FinanceLeaseLiabilityPaymentsDueYearFourAndFive_e6cf945a-31b5-49fb-9aa1-d67ed7a0abd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_5fdc8f26-b81b-4fe8-bc28-1af740574778" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fe33ba65-c163-49a0-a485-f241f18b33cd" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_5fdc8f26-b81b-4fe8-bc28-1af740574778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_43049f0f-4e08-4a13-8854-7ece861d12c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fe33ba65-c163-49a0-a485-f241f18b33cd" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_43049f0f-4e08-4a13-8854-7ece861d12c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_e8292dbf-5783-4255-8791-35d65dd9a6da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fe33ba65-c163-49a0-a485-f241f18b33cd" xlink:to="loc_us-gaap_FinanceLeaseLiability_e8292dbf-5783-4255-8791-35d65dd9a6da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_395a8b82-2167-4426-8709-a60925d1676e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fe33ba65-c163-49a0-a485-f241f18b33cd" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_395a8b82-2167-4426-8709-a60925d1676e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearOne_c7f90f93-b8c1-4dde-9a91-ff9bec1b916b" xlink:href="iff-20231231.xsd#iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearOne"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fe33ba65-c163-49a0-a485-f241f18b33cd" xlink:to="loc_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearOne_c7f90f93-b8c1-4dde-9a91-ff9bec1b916b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearTwo_de947b6f-563e-4f19-9920-7d5adb9c2570" xlink:href="iff-20231231.xsd#iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearTwo"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fe33ba65-c163-49a0-a485-f241f18b33cd" xlink:to="loc_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearTwo_de947b6f-563e-4f19-9920-7d5adb9c2570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearThree_c62e1944-e222-4cd6-87f5-2243bc0bc394" xlink:href="iff-20231231.xsd#iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearThree"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fe33ba65-c163-49a0-a485-f241f18b33cd" xlink:to="loc_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearThree_c62e1944-e222-4cd6-87f5-2243bc0bc394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFour_8b78e691-7d5f-42ff-81a9-d754fa0bb08b" xlink:href="iff-20231231.xsd#iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFour"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fe33ba65-c163-49a0-a485-f241f18b33cd" xlink:to="loc_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFour_8b78e691-7d5f-42ff-81a9-d754fa0bb08b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFive_7449056a-888f-4e31-bd63-be0216fce1d5" xlink:href="iff-20231231.xsd#iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFive"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fe33ba65-c163-49a0-a485-f241f18b33cd" xlink:to="loc_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFive_7449056a-888f-4e31-bd63-be0216fce1d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidAfterYearFive_91b762a8-632c-454f-bcdc-6c953490b632" xlink:href="iff-20231231.xsd#iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidAfterYearFive"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fe33ba65-c163-49a0-a485-f241f18b33cd" xlink:to="loc_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidAfterYearFive_91b762a8-632c-454f-bcdc-6c953490b632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_LesseeOperatingAndFinanceLeasePaymentsDue_cbf68721-2c8f-462f-98c5-41d326492543" xlink:href="iff-20231231.xsd#iff_LesseeOperatingAndFinanceLeasePaymentsDue"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fe33ba65-c163-49a0-a485-f241f18b33cd" xlink:to="loc_iff_LesseeOperatingAndFinanceLeasePaymentsDue_cbf68721-2c8f-462f-98c5-41d326492543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_LesseeOperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount_2819426d-9e3b-404b-8c8b-35143d1b5c31" xlink:href="iff-20231231.xsd#iff_LesseeOperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fe33ba65-c163-49a0-a485-f241f18b33cd" xlink:to="loc_iff_LesseeOperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount_2819426d-9e3b-404b-8c8b-35143d1b5c31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_OperatingAndFinanceLeaseLiability_0055b61e-15b6-4219-96f0-281cf1118b0d" xlink:href="iff-20231231.xsd#iff_OperatingAndFinanceLeaseLiability"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fe33ba65-c163-49a0-a485-f241f18b33cd" xlink:to="loc_iff_OperatingAndFinanceLeaseLiability_0055b61e-15b6-4219-96f0-281cf1118b0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails_1" xlink:type="simple" xlink:href="iff-20231231.xsd#LeasesScheduleofLeaseMaturitiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.iff.com/role/LeasesAdditionalInformationDetails" xlink:type="simple" xlink:href="iff-20231231.xsd#LeasesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/LeasesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_542d91ad-976f-440e-8a99-a49f4e8d2e2f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_ae8190eb-bab8-491b-9ac2-a4828f4b9d31" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_542d91ad-976f-440e-8a99-a49f4e8d2e2f" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_ae8190eb-bab8-491b-9ac2-a4828f4b9d31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_ab5c0400-1b41-4da4-b64b-0d5a15530ade" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_ae8190eb-bab8-491b-9ac2-a4828f4b9d31" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_ab5c0400-1b41-4da4-b64b-0d5a15530ade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7baaec84-47e2-4282-a787-24d3c668a11d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ab5c0400-1b41-4da4-b64b-0d5a15530ade" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7baaec84-47e2-4282-a787-24d3c668a11d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NutritionBiosciencesIncMember_69de2d78-8b65-4b9c-b765-d27e0cb7556e" xlink:href="iff-20231231.xsd#iff_NutritionBiosciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7baaec84-47e2-4282-a787-24d3c668a11d" xlink:to="loc_iff_NutritionBiosciencesIncMember_69de2d78-8b65-4b9c-b765-d27e0cb7556e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_HealthWrightProductsIncHealthWrightMember_57f158f0-b2f2-4f81-b1ee-57b64c8b600d" xlink:href="iff-20231231.xsd#iff_HealthWrightProductsIncHealthWrightMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7baaec84-47e2-4282-a787-24d3c668a11d" xlink:to="loc_iff_HealthWrightProductsIncHealthWrightMember_57f158f0-b2f2-4f81-b1ee-57b64c8b600d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_16e0027f-a9eb-4581-99c1-b83ff9275310" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_ae8190eb-bab8-491b-9ac2-a4828f4b9d31" xlink:to="loc_srt_CounterpartyNameAxis_16e0027f-a9eb-4581-99c1-b83ff9275310" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_feaf3194-2372-48ff-818d-e3be82b07ba8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_16e0027f-a9eb-4581-99c1-b83ff9275310" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_feaf3194-2372-48ff-818d-e3be82b07ba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b515079e-bd4e-41bb-8c70-6a61497a0209" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_ae8190eb-bab8-491b-9ac2-a4828f4b9d31" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b515079e-bd4e-41bb-8c70-6a61497a0209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f5f71bc5-b17e-4604-85c4-22e1a60fecce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b515079e-bd4e-41bb-8c70-6a61497a0209" xlink:to="loc_us-gaap_SegmentDomain_f5f71bc5-b17e-4604-85c4-22e1a60fecce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionAxis_f3c67231-7320-4ead-92f5-4989a8e6ab64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_ae8190eb-bab8-491b-9ac2-a4828f4b9d31" xlink:to="loc_us-gaap_GeographicDistributionAxis_f3c67231-7320-4ead-92f5-4989a8e6ab64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomain_00c87cc7-d4fb-4808-ba8a-0be39eb6b258" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeographicDistributionAxis_f3c67231-7320-4ead-92f5-4989a8e6ab64" xlink:to="loc_us-gaap_GeographicDistributionDomain_00c87cc7-d4fb-4808-ba8a-0be39eb6b258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cc6b2e28-7c89-4c39-9d94-4f36c54ec106" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_ae8190eb-bab8-491b-9ac2-a4828f4b9d31" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cc6b2e28-7c89-4c39-9d94-4f36c54ec106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_edfaf9ad-e479-48ec-acfd-41bca7474b18" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cc6b2e28-7c89-4c39-9d94-4f36c54ec106" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_edfaf9ad-e479-48ec-acfd-41bca7474b18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermAxis_bf77d5e0-b644-4dcc-8194-60a7308c37c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseContractualTermAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_ae8190eb-bab8-491b-9ac2-a4828f4b9d31" xlink:to="loc_us-gaap_LeaseContractualTermAxis_bf77d5e0-b644-4dcc-8194-60a7308c37c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain_847f1657-dde5-4c8c-888a-399f1fb100c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseContractualTermAxis_bf77d5e0-b644-4dcc-8194-60a7308c37c1" xlink:to="loc_us-gaap_LeaseContractualTermDomain_847f1657-dde5-4c8c-888a-399f1fb100c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_9bcfbb34-4189-4de8-a33e-958bac393f8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_ae8190eb-bab8-491b-9ac2-a4828f4b9d31" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_9bcfbb34-4189-4de8-a33e-958bac393f8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_719e1a5f-0c6b-4e0d-bfdc-16589523b637" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_9bcfbb34-4189-4de8-a33e-958bac393f8e" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_719e1a5f-0c6b-4e0d-bfdc-16589523b637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_a1e224cc-931a-4098-932b-ff3a1ec63731" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_9bcfbb34-4189-4de8-a33e-958bac393f8e" xlink:to="loc_us-gaap_OperatingLeaseLiability_a1e224cc-931a-4098-932b-ff3a1ec63731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_1895e914-f86e-4d5e-8a52-e6a805ccb249" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_9bcfbb34-4189-4de8-a33e-958bac393f8e" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_1895e914-f86e-4d5e-8a52-e6a805ccb249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_0d7c680b-a176-4b8f-8148-67a44aec4171" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_9bcfbb34-4189-4de8-a33e-958bac393f8e" xlink:to="loc_us-gaap_FinanceLeaseLiability_0d7c680b-a176-4b8f-8148-67a44aec4171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_7f315a68-cb51-47d4-b121-ef5aaaa3254d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_6f2f7c94-25e2-4043-8f83-090be389b798" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7f315a68-cb51-47d4-b121-ef5aaaa3254d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_6f2f7c94-25e2-4043-8f83-090be389b798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_f2923444-404c-406f-b20e-e63e4e01adc0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7f315a68-cb51-47d4-b121-ef5aaaa3254d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_f2923444-404c-406f-b20e-e63e4e01adc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_546d9ea1-935b-48a2-8980-8bc1db73b2d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7f315a68-cb51-47d4-b121-ef5aaaa3254d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_546d9ea1-935b-48a2-8980-8bc1db73b2d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/IncomeTaxesScheduleofIncomeTaxProvisionDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#IncomeTaxesScheduleofIncomeTaxProvisionDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/IncomeTaxesScheduleofIncomeTaxProvisionDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_adf9976f-7827-4cc9-b151-08c1c4ba2966" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_5f5aa6a1-c285-4424-8477-38c9b30d18ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_adf9976f-7827-4cc9-b151-08c1c4ba2966" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_5f5aa6a1-c285-4424-8477-38c9b30d18ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_ce3a0ec7-e26f-4531-bd55-2bd66116942d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_5f5aa6a1-c285-4424-8477-38c9b30d18ad" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_ce3a0ec7-e26f-4531-bd55-2bd66116942d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_1112599f-eb73-465c-92d2-19d4359e7122" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_5f5aa6a1-c285-4424-8477-38c9b30d18ad" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_1112599f-eb73-465c-92d2-19d4359e7122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_521de428-59d1-465e-bf7b-7ae456af0220" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_5f5aa6a1-c285-4424-8477-38c9b30d18ad" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_521de428-59d1-465e-bf7b-7ae456af0220" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_c74eba14-9951-40cf-a040-22ceff34ffd8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_5f5aa6a1-c285-4424-8477-38c9b30d18ad" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_c74eba14-9951-40cf-a040-22ceff34ffd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_c32680b9-e00f-4ef6-86ed-45a4bb67392b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_adf9976f-7827-4cc9-b151-08c1c4ba2966" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_c32680b9-e00f-4ef6-86ed-45a4bb67392b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_c7c43e18-b924-4a06-ad20-309e05943778" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_c32680b9-e00f-4ef6-86ed-45a4bb67392b" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_c7c43e18-b924-4a06-ad20-309e05943778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_e21a7b8f-f3ce-4170-9950-95d8abc7ae45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_c32680b9-e00f-4ef6-86ed-45a4bb67392b" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_e21a7b8f-f3ce-4170-9950-95d8abc7ae45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_2a82047a-6994-4157-99e3-9df5d3d9d58c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_c32680b9-e00f-4ef6-86ed-45a4bb67392b" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_2a82047a-6994-4157-99e3-9df5d3d9d58c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_1f86abb0-74a0-47ba-8fe9-4b412c7487a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_c32680b9-e00f-4ef6-86ed-45a4bb67392b" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_1f86abb0-74a0-47ba-8fe9-4b412c7487a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d32763fd-5a43-47a4-b52e-35f7accb8d0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_adf9976f-7827-4cc9-b151-08c1c4ba2966" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_d32763fd-5a43-47a4-b52e-35f7accb8d0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_9a87f525-63c4-42dd-9de5-c5bbe890b75a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_adf9976f-7827-4cc9-b151-08c1c4ba2966" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_9a87f525-63c4-42dd-9de5-c5bbe890b75a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxRateDetails" xlink:type="simple" xlink:href="iff-20231231.xsd#IncomeTaxesReconciliationofEffectiveIncomeTaxRateDetails"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_5eb51fd5-903d-46b8-b7b2-194b270da70f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_e4d37e8b-7ad6-4415-94ff-6012f12ff7b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5eb51fd5-903d-46b8-b7b2-194b270da70f" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_e4d37e8b-7ad6-4415-94ff-6012f12ff7b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_f4b4bc79-3f31-4098-b851-0a6a2131b7d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5eb51fd5-903d-46b8-b7b2-194b270da70f" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_f4b4bc79-3f31-4098-b851-0a6a2131b7d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_59821d51-7b5f-4168-91c6-97324f56b868" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5eb51fd5-903d-46b8-b7b2-194b270da70f" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_59821d51-7b5f-4168-91c6-97324f56b868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EffectiveIncomeTaxRateReconciliationTaxBenefitFromSupplyChainOptimizationPercent_74f1aeac-cb36-4322-a3c2-06670a1a6962" xlink:href="iff-20231231.xsd#iff_EffectiveIncomeTaxRateReconciliationTaxBenefitFromSupplyChainOptimizationPercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5eb51fd5-903d-46b8-b7b2-194b270da70f" xlink:to="loc_iff_EffectiveIncomeTaxRateReconciliationTaxBenefitFromSupplyChainOptimizationPercent_74f1aeac-cb36-4322-a3c2-06670a1a6962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome_c13ea7a8-4f4d-48de-804e-10ab312a5c84" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5eb51fd5-903d-46b8-b7b2-194b270da70f" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome_c13ea7a8-4f4d-48de-804e-10ab312a5c84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness_166d6937-9178-4b17-b2ef-4bacc24875f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5eb51fd5-903d-46b8-b7b2-194b270da70f" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness_166d6937-9178-4b17-b2ef-4bacc24875f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EffectiveIncomeTaxRateReconciliationDeferredTaxesonDeemedRepatriationPercent_d7de0b83-5523-410b-9208-2952b03451c4" xlink:href="iff-20231231.xsd#iff_EffectiveIncomeTaxRateReconciliationDeferredTaxesonDeemedRepatriationPercent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5eb51fd5-903d-46b8-b7b2-194b270da70f" xlink:to="loc_iff_EffectiveIncomeTaxRateReconciliationDeferredTaxesonDeemedRepatriationPercent_d7de0b83-5523-410b-9208-2952b03451c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiPercent_445cfa7c-9198-4f39-9d9f-fdf05d769e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationGiltiPercent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5eb51fd5-903d-46b8-b7b2-194b270da70f" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiPercent_445cfa7c-9198-4f39-9d9f-fdf05d769e9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent_ebb52e88-d83d-4730-8ea7-d4edf0db55c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5eb51fd5-903d-46b8-b7b2-194b270da70f" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent_ebb52e88-d83d-4730-8ea7-d4edf0db55c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign_9b68ae17-6b65-4397-b6a3-ab4ee9d29fa6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5eb51fd5-903d-46b8-b7b2-194b270da70f" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign_9b68ae17-6b65-4397-b6a3-ab4ee9d29fa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_cb9b0a37-bbcd-41d8-8fdc-86ffbc650aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5eb51fd5-903d-46b8-b7b2-194b270da70f" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_cb9b0a37-bbcd-41d8-8fdc-86ffbc650aa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EffectiveIncomeTaxRateReconciliationAcquisitionCostsPercent_eef28370-5cd3-4a43-9c0c-05ba5969c94e" xlink:href="iff-20231231.xsd#iff_EffectiveIncomeTaxRateReconciliationAcquisitionCostsPercent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5eb51fd5-903d-46b8-b7b2-194b270da70f" xlink:to="loc_iff_EffectiveIncomeTaxRateReconciliationAcquisitionCostsPercent_eef28370-5cd3-4a43-9c0c-05ba5969c94e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_5d321f24-da47-40a1-9a04-a4acc120cb70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5eb51fd5-903d-46b8-b7b2-194b270da70f" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_5d321f24-da47-40a1-9a04-a4acc120cb70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_82e52bc6-ea5f-4a21-803a-0b09ae6e6e72" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5eb51fd5-903d-46b8-b7b2-194b270da70f" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_82e52bc6-ea5f-4a21-803a-0b09ae6e6e72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EffectiveIncomeTaxRateReconciliationTaxImpactOnInternalAssetTransferPercent_bb6f6b11-f0f5-4f32-bd47-10fb4ed54dd8" xlink:href="iff-20231231.xsd#iff_EffectiveIncomeTaxRateReconciliationTaxImpactOnInternalAssetTransferPercent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5eb51fd5-903d-46b8-b7b2-194b270da70f" xlink:to="loc_iff_EffectiveIncomeTaxRateReconciliationTaxImpactOnInternalAssetTransferPercent_bb6f6b11-f0f5-4f32-bd47-10fb4ed54dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_734fd82f-70f3-45cb-af5b-c1b80536a627" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5eb51fd5-903d-46b8-b7b2-194b270da70f" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_734fd82f-70f3-45cb-af5b-c1b80536a627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_070df7f1-43e5-45b7-b78e-1229da79c7a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5eb51fd5-903d-46b8-b7b2-194b270da70f" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_070df7f1-43e5-45b7-b78e-1229da79c7a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/IncomeTaxesScheduleofReconciliationbetweenUSFederalStatutoryIncomeTaxRatetoActualEffectiveTaxRateDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#IncomeTaxesScheduleofReconciliationbetweenUSFederalStatutoryIncomeTaxRatetoActualEffectiveTaxRateDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/IncomeTaxesScheduleofReconciliationbetweenUSFederalStatutoryIncomeTaxRatetoActualEffectiveTaxRateDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_6d923052-6e13-455d-949b-275c9a50edb2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_14fd1a12-23dd-4674-b334-168cf1beb4a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6d923052-6e13-455d-949b-275c9a50edb2" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_14fd1a12-23dd-4674-b334-168cf1beb4a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_20ad3ecf-44f2-4f54-9426-f318909e6fa3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6d923052-6e13-455d-949b-275c9a50edb2" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_20ad3ecf-44f2-4f54-9426-f318909e6fa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_8420bea5-4035-472a-8d0f-298803c69730" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6d923052-6e13-455d-949b-275c9a50edb2" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_8420bea5-4035-472a-8d0f-298803c69730" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_ec42593b-9c09-41fc-a8a5-25cc9103730b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6d923052-6e13-455d-949b-275c9a50edb2" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_ec42593b-9c09-41fc-a8a5-25cc9103730b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_41245bed-989e-4358-81d4-08df4a641211" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6d923052-6e13-455d-949b-275c9a50edb2" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_41245bed-989e-4358-81d4-08df4a641211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/IncomeTaxesAdditionalInformationDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#IncomeTaxesAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/IncomeTaxesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_2136bd06-0372-459c-8f33-189188cf3f13" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_IncomeTaxesDisclosureTable_0e644298-a6b1-4e0d-a964-2ebace714767" xlink:href="iff-20231231.xsd#iff_IncomeTaxesDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2136bd06-0372-459c-8f33-189188cf3f13" xlink:to="loc_iff_IncomeTaxesDisclosureTable_0e644298-a6b1-4e0d-a964-2ebace714767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_fd50489e-ee02-4440-bd77-d8f9f57e9d40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_IncomeTaxesDisclosureTable_0e644298-a6b1-4e0d-a964-2ebace714767" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_fd50489e-ee02-4440-bd77-d8f9f57e9d40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_ac176753-f45b-441a-9248-90dfda485dea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_fd50489e-ee02-4440-bd77-d8f9f57e9d40" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_ac176753-f45b-441a-9248-90dfda485dea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_36b8e772-5798-4648-b7f3-8c7ec65b1b93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_ac176753-f45b-441a-9248-90dfda485dea" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_36b8e772-5798-4648-b7f3-8c7ec65b1b93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_b902bf2c-e381-4e15-a6b9-50839573c5c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_ac176753-f45b-441a-9248-90dfda485dea" xlink:to="loc_us-gaap_DomesticCountryMember_b902bf2c-e381-4e15-a6b9-50839573c5c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_9bc0bb31-10b8-4ec7-9197-9d05bd56ac72" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_ac176753-f45b-441a-9248-90dfda485dea" xlink:to="loc_us-gaap_ForeignCountryMember_9bc0bb31-10b8-4ec7-9197-9d05bd56ac72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_d7f84146-8aff-4518-b532-38e612ab2474" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_IncomeTaxesDisclosureTable_0e644298-a6b1-4e0d-a964-2ebace714767" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_d7f84146-8aff-4518-b532-38e612ab2474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_63ec9de4-76c5-4d6a-b389-b9436ea4a612" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_d7f84146-8aff-4518-b532-38e612ab2474" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_63ec9de4-76c5-4d6a-b389-b9436ea4a612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_075a6111-3d93-41ab-8dcb-6f7db7ef8cf9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_63ec9de4-76c5-4d6a-b389-b9436ea4a612" xlink:to="loc_us-gaap_OtherLiabilitiesMember_075a6111-3d93-41ab-8dcb-6f7db7ef8cf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_9485c31d-365a-468e-84ca-765b6aac624a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_63ec9de4-76c5-4d6a-b389-b9436ea4a612" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_9485c31d-365a-468e-84ca-765b6aac624a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_db9c3108-8207-438d-8945-fc741f0fd3a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_IncomeTaxesDisclosureTable_0e644298-a6b1-4e0d-a964-2ebace714767" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_db9c3108-8207-438d-8945-fc741f0fd3a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_ad022f2d-fb94-4d23-86b2-522c4c564db8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_db9c3108-8207-438d-8945-fc741f0fd3a2" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_ad022f2d-fb94-4d23-86b2-522c4c564db8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TwoThousandTwentyThreeToTwoThousandFortyTwoMember_a4a40d2e-5c79-419c-be12-dcf9196f697f" xlink:href="iff-20231231.xsd#iff_TwoThousandTwentyThreeToTwoThousandFortyTwoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_ad022f2d-fb94-4d23-86b2-522c4c564db8" xlink:to="loc_iff_TwoThousandTwentyThreeToTwoThousandFortyTwoMember_a4a40d2e-5c79-419c-be12-dcf9196f697f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_IndefiniteMember_6dc98d0f-c8b4-4770-88eb-6e9178045265" xlink:href="iff-20231231.xsd#iff_IndefiniteMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_ad022f2d-fb94-4d23-86b2-522c4c564db8" xlink:to="loc_iff_IndefiniteMember_6dc98d0f-c8b4-4770-88eb-6e9178045265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TwoThousandTwentyTwoToTwoThousandFortyOneMember_cde575fe-cd07-4fb1-b2c8-365e47aa868e" xlink:href="iff-20231231.xsd#iff_TwoThousandTwentyTwoToTwoThousandFortyOneMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_ad022f2d-fb94-4d23-86b2-522c4c564db8" xlink:to="loc_iff_TwoThousandTwentyTwoToTwoThousandFortyOneMember_cde575fe-cd07-4fb1-b2c8-365e47aa868e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis_d8d5a8c0-f649-4f3d-8318-5a16ede80a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_IncomeTaxesDisclosureTable_0e644298-a6b1-4e0d-a964-2ebace714767" xlink:to="loc_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis_d8d5a8c0-f649-4f3d-8318-5a16ede80a7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain_2954df44-8205-49ac-a99d-d057966300ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis_d8d5a8c0-f649-4f3d-8318-5a16ede80a7a" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain_2954df44-8205-49ac-a99d-d057966300ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_UnrecognizedTaxBenefitsOtherLiabilitiesMember_fa0c52b2-8b4c-405a-8a17-4e58b831a654" xlink:href="iff-20231231.xsd#iff_UnrecognizedTaxBenefitsOtherLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain_2954df44-8205-49ac-a99d-d057966300ad" xlink:to="loc_iff_UnrecognizedTaxBenefitsOtherLiabilitiesMember_fa0c52b2-8b4c-405a-8a17-4e58b831a654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_UnrecognizedTaxBenefitsOtherCurrentLiabilitiesMember_d465694c-2a9b-4e5a-897a-11ac8393e1a1" xlink:href="iff-20231231.xsd#iff_UnrecognizedTaxBenefitsOtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain_2954df44-8205-49ac-a99d-d057966300ad" xlink:to="loc_iff_UnrecognizedTaxBenefitsOtherCurrentLiabilitiesMember_d465694c-2a9b-4e5a-897a-11ac8393e1a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_IncomeTaxesLineItems_be6ecbdf-883a-4efd-800f-1a67aeaeeb98" xlink:href="iff-20231231.xsd#iff_IncomeTaxesLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_IncomeTaxesDisclosureTable_0e644298-a6b1-4e0d-a964-2ebace714767" xlink:to="loc_iff_IncomeTaxesLineItems_be6ecbdf-883a-4efd-800f-1a67aeaeeb98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount_8e1d3510-f4e1-4ba2-a6d6-7bf749819dc8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_IncomeTaxesLineItems_be6ecbdf-883a-4efd-800f-1a67aeaeeb98" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount_8e1d3510-f4e1-4ba2-a6d6-7bf749819dc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiAmount_774c3d68-551f-437e-ae30-3838cd9455ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationFdiiAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_IncomeTaxesLineItems_be6ecbdf-883a-4efd-800f-1a67aeaeeb98" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiAmount_774c3d68-551f-437e-ae30-3838cd9455ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_4f439589-630b-4f4e-a627-d3e95e285fe0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_IncomeTaxesLineItems_be6ecbdf-883a-4efd-800f-1a67aeaeeb98" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_4f439589-630b-4f4e-a627-d3e95e285fe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsDividends_c213f0b1-9b70-421e-a9d0-6322f8493c60" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsDividends"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_IncomeTaxesLineItems_be6ecbdf-883a-4efd-800f-1a67aeaeeb98" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsDividends_c213f0b1-9b70-421e-a9d0-6322f8493c60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_091eee47-c0c2-4588-a50d-cc845e74b098" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_IncomeTaxesLineItems_be6ecbdf-883a-4efd-800f-1a67aeaeeb98" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_091eee47-c0c2-4588-a50d-cc845e74b098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_74543778-a2c2-4864-a221-59c9ce5f9ea5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_IncomeTaxesLineItems_be6ecbdf-883a-4efd-800f-1a67aeaeeb98" xlink:to="loc_us-gaap_OperatingLossCarryforwards_74543778-a2c2-4864-a221-59c9ce5f9ea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_48922a4f-c5a2-4f83-9035-60a7a5a0f878" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_IncomeTaxesLineItems_be6ecbdf-883a-4efd-800f-1a67aeaeeb98" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_48922a4f-c5a2-4f83-9035-60a7a5a0f878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_9c935f16-bed9-4170-9847-ce9e1bdd79c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_IncomeTaxesLineItems_be6ecbdf-883a-4efd-800f-1a67aeaeeb98" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_9c935f16-bed9-4170-9847-ce9e1bdd79c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_42716e80-c317-4680-bb86-3e1fbb23cb7d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_IncomeTaxesLineItems_be6ecbdf-883a-4efd-800f-1a67aeaeeb98" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_42716e80-c317-4680-bb86-3e1fbb23cb7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance_647bdf41-9012-4177-937c-ff55d8199e84" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsValuationAllowance"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_IncomeTaxesLineItems_be6ecbdf-883a-4efd-800f-1a67aeaeeb98" xlink:to="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance_647bdf41-9012-4177-937c-ff55d8199e84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_f98627a6-0317-4e5b-8639-ec76c099d516" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_IncomeTaxesLineItems_be6ecbdf-883a-4efd-800f-1a67aeaeeb98" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_f98627a6-0317-4e5b-8639-ec76c099d516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AccruedInterestOrPenaltiesRelatedToTaxAmounts_96826f99-176d-43a0-aa6a-9180e34cd444" xlink:href="iff-20231231.xsd#iff_AccruedInterestOrPenaltiesRelatedToTaxAmounts"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_IncomeTaxesLineItems_be6ecbdf-883a-4efd-800f-1a67aeaeeb98" xlink:to="loc_iff_AccruedInterestOrPenaltiesRelatedToTaxAmounts_96826f99-176d-43a0-aa6a-9180e34cd444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_ed5cf056-4ae6-49f3-8032-56f4521d26b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_IncomeTaxesLineItems_be6ecbdf-883a-4efd-800f-1a67aeaeeb98" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_ed5cf056-4ae6-49f3-8032-56f4521d26b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_UnrecognizedTaxBenefitsIncludingInterestAndPenalties_b59ae448-4e35-46dc-8fba-08555a7a2ca8" xlink:href="iff-20231231.xsd#iff_UnrecognizedTaxBenefitsIncludingInterestAndPenalties"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_IncomeTaxesLineItems_be6ecbdf-883a-4efd-800f-1a67aeaeeb98" xlink:to="loc_iff_UnrecognizedTaxBenefitsIncludingInterestAndPenalties_b59ae448-4e35-46dc-8fba-08555a7a2ca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardValuationAllowance_96156838-3e26-47e8-965b-51e32b8d9c3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxCreditCarryforwardValuationAllowance"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_IncomeTaxesLineItems_be6ecbdf-883a-4efd-800f-1a67aeaeeb98" xlink:to="loc_us-gaap_TaxCreditCarryforwardValuationAllowance_96156838-3e26-47e8-965b-51e32b8d9c3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DeferredTaxLiabilitiesDeemedRepatriation_e401021f-ee7f-4020-a765-facb88533a3e" xlink:href="iff-20231231.xsd#iff_DeferredTaxLiabilitiesDeemedRepatriation"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_IncomeTaxesLineItems_be6ecbdf-883a-4efd-800f-1a67aeaeeb98" xlink:to="loc_iff_DeferredTaxLiabilitiesDeemedRepatriation_e401021f-ee7f-4020-a765-facb88533a3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_bf4d9751-67ff-4dc6-848a-e35d98039c97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_IncomeTaxesLineItems_be6ecbdf-883a-4efd-800f-1a67aeaeeb98" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_bf4d9751-67ff-4dc6-848a-e35d98039c97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_UnrecognizedTaxBenefitsReductionResultingFromLapseOfApplicableStatueOfLimitationsNextTwelveMonths_e256b4b2-c3a2-40c8-b94c-03232a950b1b" xlink:href="iff-20231231.xsd#iff_UnrecognizedTaxBenefitsReductionResultingFromLapseOfApplicableStatueOfLimitationsNextTwelveMonths"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_IncomeTaxesLineItems_be6ecbdf-883a-4efd-800f-1a67aeaeeb98" xlink:to="loc_iff_UnrecognizedTaxBenefitsReductionResultingFromLapseOfApplicableStatueOfLimitationsNextTwelveMonths_e256b4b2-c3a2-40c8-b94c-03232a950b1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_60d760e4-e4d6-422d-99af-c5c462071d3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits_b6efe6a1-4763-4d6a-b9a6-e0cd62e0cddb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_60d760e4-e4d6-422d-99af-c5c462071d3c" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits_b6efe6a1-4763-4d6a-b9a6-e0cd62e0cddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_9f8c0634-c783-4e17-9708-fd50fdcd32ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_60d760e4-e4d6-422d-99af-c5c462071d3c" xlink:to="loc_us-gaap_OperatingLossCarryforwards_9f8c0634-c783-4e17-9708-fd50fdcd32ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_416cf118-bcc0-4cda-84f1-8347163ead6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_60d760e4-e4d6-422d-99af-c5c462071d3c" xlink:to="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_416cf118-bcc0-4cda-84f1-8347163ead6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DeferredTaxAssetsInterestLimitations_b96b7ff7-b125-42c7-9ea0-3d4c6b16f027" xlink:href="iff-20231231.xsd#iff_DeferredTaxAssetsInterestLimitations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_60d760e4-e4d6-422d-99af-c5c462071d3c" xlink:to="loc_iff_DeferredTaxAssetsInterestLimitations_b96b7ff7-b125-42c7-9ea0-3d4c6b16f027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_6ef713e3-8a4f-4582-93a9-3c7c3dc9b5fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_60d760e4-e4d6-422d-99af-c5c462071d3c" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_6ef713e3-8a4f-4582-93a9-3c7c3dc9b5fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DeferredTaxAssetsLeaseObligations_e874b502-d5fb-44d9-b5e4-7af6ed8c1b0e" xlink:href="iff-20231231.xsd#iff_DeferredTaxAssetsLeaseObligations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_60d760e4-e4d6-422d-99af-c5c462071d3c" xlink:to="loc_iff_DeferredTaxAssetsLeaseObligations_e874b502-d5fb-44d9-b5e4-7af6ed8c1b0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_40ba92e9-332c-4210-94aa-91ffa37a7905" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_60d760e4-e4d6-422d-99af-c5c462071d3c" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_40ba92e9-332c-4210-94aa-91ffa37a7905" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_6944c073-c932-49a6-9b9c-4a98c417d54e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_60d760e4-e4d6-422d-99af-c5c462071d3c" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_6944c073-c932-49a6-9b9c-4a98c417d54e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_a4349f9f-31cc-4733-bc52-3ee086106960" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_60d760e4-e4d6-422d-99af-c5c462071d3c" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_a4349f9f-31cc-4733-bc52-3ee086106960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesInvestments_4d663db1-f298-4a8d-a78a-ac31267552f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesInvestments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_60d760e4-e4d6-422d-99af-c5c462071d3c" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesInvestments_4d663db1-f298-4a8d-a78a-ac31267552f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_e3e70109-fe25-4f5b-b76e-877096585bd5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_60d760e4-e4d6-422d-99af-c5c462071d3c" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_e3e70109-fe25-4f5b-b76e-877096585bd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DeferredTaxLiabilitiesRightOfUseAssets_ed111f67-7216-4ea2-bc2f-4681b80fe56f" xlink:href="iff-20231231.xsd#iff_DeferredTaxLiabilitiesRightOfUseAssets"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_60d760e4-e4d6-422d-99af-c5c462071d3c" xlink:to="loc_iff_DeferredTaxLiabilitiesRightOfUseAssets_ed111f67-7216-4ea2-bc2f-4681b80fe56f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DeferredTaxLiabilitiesGainLossOnForeignCurrencyTranslation_7c7c6df4-464f-42f6-9f41-9fe6b1027cb4" xlink:href="iff-20231231.xsd#iff_DeferredTaxLiabilitiesGainLossOnForeignCurrencyTranslation"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_60d760e4-e4d6-422d-99af-c5c462071d3c" xlink:to="loc_iff_DeferredTaxLiabilitiesGainLossOnForeignCurrencyTranslation_7c7c6df4-464f-42f6-9f41-9fe6b1027cb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DeferredTaxLiabilitiesDeemedRepatriation_79c533df-2efa-4f54-be15-f0206ada60a4" xlink:href="iff-20231231.xsd#iff_DeferredTaxLiabilitiesDeemedRepatriation"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_60d760e4-e4d6-422d-99af-c5c462071d3c" xlink:to="loc_iff_DeferredTaxLiabilitiesDeemedRepatriation_79c533df-2efa-4f54-be15-f0206ada60a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_023b4b69-539f-4285-b2ca-958a1d576b59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_60d760e4-e4d6-422d-99af-c5c462071d3c" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_023b4b69-539f-4285-b2ca-958a1d576b59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_b94b99ef-74d0-4b9c-8629-8757f740de90" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_60d760e4-e4d6-422d-99af-c5c462071d3c" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_b94b99ef-74d0-4b9c-8629-8757f740de90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_a3792aea-e1fa-47be-85df-6f6f2d3390ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_60d760e4-e4d6-422d-99af-c5c462071d3c" xlink:to="loc_us-gaap_DeferredTaxLiabilities_a3792aea-e1fa-47be-85df-6f6f2d3390ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofUnrecognizedTaxBenefitsDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#IncomeTaxesReconciliationofBeginningandEndingAmountofUnrecognizedTaxBenefitsDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofUnrecognizedTaxBenefitsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_673de849-5d20-4226-ad7a-b13a844661d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_681cda40-2673-4948-9234-cd550fc079f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_673de849-5d20-4226-ad7a-b13a844661d9" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_681cda40-2673-4948-9234-cd550fc079f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_620c7d84-5984-4383-9bbd-368fba797ed5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_681cda40-2673-4948-9234-cd550fc079f4" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_620c7d84-5984-4383-9bbd-368fba797ed5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_23364a26-3f67-4a13-982a-0fa71552f04e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_681cda40-2673-4948-9234-cd550fc079f4" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_23364a26-3f67-4a13-982a-0fa71552f04e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_4c541368-d92a-4adb-9ba6-d44177322f38" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_681cda40-2673-4948-9234-cd550fc079f4" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_4c541368-d92a-4adb-9ba6-d44177322f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_5299a154-e91c-4a6e-847b-daf094a88195" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_681cda40-2673-4948-9234-cd550fc079f4" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_5299a154-e91c-4a6e-847b-daf094a88195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_e883a1f0-b5d5-45c0-83fa-a2ccbd2b326e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_681cda40-2673-4948-9234-cd550fc079f4" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_e883a1f0-b5d5-45c0-83fa-a2ccbd2b326e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_590bc5e9-4454-4018-8b3c-3099518f9489" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_681cda40-2673-4948-9234-cd550fc079f4" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_590bc5e9-4454-4018-8b3c-3099518f9489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_f84d51e6-82aa-4a05-9bd5-73e644d4d024" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_681cda40-2673-4948-9234-cd550fc079f4" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_f84d51e6-82aa-4a05-9bd5-73e644d4d024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_IncomeTaxesDisclosureTable_a7c0207f-b562-40ea-b412-f1285964c83b" xlink:href="iff-20231231.xsd#iff_IncomeTaxesDisclosureTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_673de849-5d20-4226-ad7a-b13a844661d9" xlink:to="loc_iff_IncomeTaxesDisclosureTable_a7c0207f-b562-40ea-b412-f1285964c83b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis_8ee2d01a-0772-424a-b6b4-2931f2dfde33" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_IncomeTaxesDisclosureTable_a7c0207f-b562-40ea-b412-f1285964c83b" xlink:to="loc_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis_8ee2d01a-0772-424a-b6b4-2931f2dfde33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain_090125e3-5d5f-47ac-88f1-2f33cd4aa08e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis_8ee2d01a-0772-424a-b6b4-2931f2dfde33" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain_090125e3-5d5f-47ac-88f1-2f33cd4aa08e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_UnrecognizedTaxBenefitsOtherCurrentLiabilitiesMember_df726c6e-a180-4aef-96db-e807a235fbe4" xlink:href="iff-20231231.xsd#iff_UnrecognizedTaxBenefitsOtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain_090125e3-5d5f-47ac-88f1-2f33cd4aa08e" xlink:to="loc_iff_UnrecognizedTaxBenefitsOtherCurrentLiabilitiesMember_df726c6e-a180-4aef-96db-e807a235fbe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_d8a08b96-3899-4b75-86ac-24a162e2f602" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_IncomeTaxesDisclosureTable_a7c0207f-b562-40ea-b412-f1285964c83b" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_d8a08b96-3899-4b75-86ac-24a162e2f602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_64767b47-d67c-4a8c-8995-317206101720" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_d8a08b96-3899-4b75-86ac-24a162e2f602" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_64767b47-d67c-4a8c-8995-317206101720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_ea2d2a09-87b6-462c-9352-2812010eb196" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_64767b47-d67c-4a8c-8995-317206101720" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_ea2d2a09-87b6-462c-9352-2812010eb196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_IncomeTaxesDisclosureLineItems_97f4e3c9-3061-43b8-89b3-fecfd7cc671c" xlink:href="iff-20231231.xsd#iff_IncomeTaxesDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_IncomeTaxesDisclosureTable_a7c0207f-b562-40ea-b412-f1285964c83b" xlink:to="loc_iff_IncomeTaxesDisclosureLineItems_97f4e3c9-3061-43b8-89b3-fecfd7cc671c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_99f77ca4-15a5-45e6-9c59-ac5a597b2f22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_IncomeTaxesDisclosureLineItems_97f4e3c9-3061-43b8-89b3-fecfd7cc671c" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_99f77ca4-15a5-45e6-9c59-ac5a597b2f22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_956fa7a2-c7d9-4f19-ab5c-1d22f4f56208" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_IncomeTaxesDisclosureLineItems_97f4e3c9-3061-43b8-89b3-fecfd7cc671c" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_956fa7a2-c7d9-4f19-ab5c-1d22f4f56208" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_f18d7a8b-6e44-499a-9e49-614c371b6e24" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_IncomeTaxesDisclosureLineItems_97f4e3c9-3061-43b8-89b3-fecfd7cc671c" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_f18d7a8b-6e44-499a-9e49-614c371b6e24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_f0b00153-7e50-4124-8607-07d1ef046453" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_IncomeTaxesDisclosureLineItems_97f4e3c9-3061-43b8-89b3-fecfd7cc671c" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_f0b00153-7e50-4124-8607-07d1ef046453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/NetIncomePerShareReconciliationofSharesUsedinComputationofBasicandDilutedNetIncomePerShareDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#NetIncomePerShareReconciliationofSharesUsedinComputationofBasicandDilutedNetIncomePerShareDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/NetIncomePerShareReconciliationofSharesUsedinComputationofBasicandDilutedNetIncomePerShareDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_b56ff5ae-9d8d-4c8f-baa2-a15fdb99cd0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_e95f047d-6323-473f-8d25-31e0cd3d454f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b56ff5ae-9d8d-4c8f-baa2-a15fdb99cd0c" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_e95f047d-6323-473f-8d25-31e0cd3d454f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_66b34c67-4d03-4862-8745-520fc0458e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_e95f047d-6323-473f-8d25-31e0cd3d454f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_66b34c67-4d03-4862-8745-520fc0458e5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_cadfb0c2-7f23-419c-8d85-a7e503d284d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_66b34c67-4d03-4862-8745-520fc0458e5d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_cadfb0c2-7f23-419c-8d85-a7e503d284d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EmployeeStockOptionAndRestrictedStockMember_57572129-cf48-4fac-9f01-12fb44d6e762" xlink:href="iff-20231231.xsd#iff_EmployeeStockOptionAndRestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_cadfb0c2-7f23-419c-8d85-a7e503d284d5" xlink:to="loc_iff_EmployeeStockOptionAndRestrictedStockMember_57572129-cf48-4fac-9f01-12fb44d6e762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_StockPurchaseContractMember_afa34cc7-958c-4cd9-87c3-c0ce9b2331f9" xlink:href="iff-20231231.xsd#iff_StockPurchaseContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_cadfb0c2-7f23-419c-8d85-a7e503d284d5" xlink:to="loc_iff_StockPurchaseContractMember_afa34cc7-958c-4cd9-87c3-c0ce9b2331f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_3101b032-130d-4e50-8f45-a89f1395a8f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_e95f047d-6323-473f-8d25-31e0cd3d454f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_3101b032-130d-4e50-8f45-a89f1395a8f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_18f827d0-bcf4-4667-a4b4-706e25e7f81d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_3101b032-130d-4e50-8f45-a89f1395a8f6" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_18f827d0-bcf4-4667-a4b4-706e25e7f81d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_50f3265c-ebfe-4559-b46c-55e5ba66cea2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_18f827d0-bcf4-4667-a4b4-706e25e7f81d" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_50f3265c-ebfe-4559-b46c-55e5ba66cea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NetIncomeLossAvailableToCommonStockholdersAdjustment_02819d71-8f5e-45c0-b14d-42d4de0bab87" xlink:href="iff-20231231.xsd#iff_NetIncomeLossAvailableToCommonStockholdersAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_18f827d0-bcf4-4667-a4b4-706e25e7f81d" xlink:to="loc_iff_NetIncomeLossAvailableToCommonStockholdersAdjustment_02819d71-8f5e-45c0-b14d-42d4de0bab87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_d5f21c3d-cbf1-4b68-b30a-b5e657ddf92a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_3101b032-130d-4e50-8f45-a89f1395a8f6" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_d5f21c3d-cbf1-4b68-b30a-b5e657ddf92a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d87e088a-e3a6-4da0-808a-395eef395508" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_d5f21c3d-cbf1-4b68-b30a-b5e657ddf92a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d87e088a-e3a6-4da0-808a-395eef395508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_52ea4fbb-7f59-403f-a907-78cbd6b28622" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_d5f21c3d-cbf1-4b68-b30a-b5e657ddf92a" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_52ea4fbb-7f59-403f-a907-78cbd6b28622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4706505e-49d2-4fa2-bd30-3bf8c441843a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_d5f21c3d-cbf1-4b68-b30a-b5e657ddf92a" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4706505e-49d2-4fa2-bd30-3bf8c441843a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_76ef8694-be36-4cd3-89cd-a02fcdfca3e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_3101b032-130d-4e50-8f45-a89f1395a8f6" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_76ef8694-be36-4cd3-89cd-a02fcdfca3e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_9866203d-dd9d-4734-83d0-78c3b55e51dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_76ef8694-be36-4cd3-89cd-a02fcdfca3e0" xlink:to="loc_us-gaap_EarningsPerShareBasic_9866203d-dd9d-4734-83d0-78c3b55e51dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_b3747b28-bba6-4211-8106-1348dd522af2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_76ef8694-be36-4cd3-89cd-a02fcdfca3e0" xlink:to="loc_us-gaap_EarningsPerShareDiluted_b3747b28-bba6-4211-8106-1348dd522af2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_IncreaseDecreaseInRedemptionValueRedeemableNoncontrollingInterest_c0e72f4c-661f-4be4-8e5b-c1a7458b5d09" xlink:href="iff-20231231.xsd#iff_IncreaseDecreaseInRedemptionValueRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_3101b032-130d-4e50-8f45-a89f1395a8f6" xlink:to="loc_iff_IncreaseDecreaseInRedemptionValueRedeemableNoncontrollingInterest_c0e72f4c-661f-4be4-8e5b-c1a7458b5d09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/NetIncomePerShareAdditionalInformationDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#NetIncomePerShareAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/NetIncomePerShareAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_beeb8ffd-7b86-4fd9-99b3-e106d51c0cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_06e74db6-4cb2-45a1-86f1-4e8a417493a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_beeb8ffd-7b86-4fd9-99b3-e106d51c0cd8" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_06e74db6-4cb2-45a1-86f1-4e8a417493a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_134bee69-ce38-43d6-866b-8d2401ac1bed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_06e74db6-4cb2-45a1-86f1-4e8a417493a3" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_134bee69-ce38-43d6-866b-8d2401ac1bed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b961abf8-d03d-4010-83a7-651a2a3d57e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_134bee69-ce38-43d6-866b-8d2401ac1bed" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b961abf8-d03d-4010-83a7-651a2a3d57e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NutritionBiosciencesIncMember_9b886107-c1c9-460b-8aa2-a7d6582e4e7c" xlink:href="iff-20231231.xsd#iff_NutritionBiosciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b961abf8-d03d-4010-83a7-651a2a3d57e6" xlink:to="loc_iff_NutritionBiosciencesIncMember_9b886107-c1c9-460b-8aa2-a7d6582e4e7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_288f7e51-06ce-4c1b-8310-384e56cb139a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_06e74db6-4cb2-45a1-86f1-4e8a417493a3" xlink:to="loc_us-gaap_AwardTypeAxis_288f7e51-06ce-4c1b-8310-384e56cb139a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e9b21714-3bd5-4566-a83d-7ad6f24f4bf0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_288f7e51-06ce-4c1b-8310-384e56cb139a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e9b21714-3bd5-4566-a83d-7ad6f24f4bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_b932ec29-7b21-44a1-af85-2248b81a01e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e9b21714-3bd5-4566-a83d-7ad6f24f4bf0" xlink:to="loc_us-gaap_RestrictedStockMember_b932ec29-7b21-44a1-af85-2248b81a01e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_StockOptionsOrStockSettledAppreciationRightsMember_4fa3c61e-6d46-40ce-906a-953ea0754c37" xlink:href="iff-20231231.xsd#iff_StockOptionsOrStockSettledAppreciationRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e9b21714-3bd5-4566-a83d-7ad6f24f4bf0" xlink:to="loc_iff_StockOptionsOrStockSettledAppreciationRightsMember_4fa3c61e-6d46-40ce-906a-953ea0754c37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareEquivalentsMember_3f0f486f-25b6-40a3-858a-26700ae44ed4" xlink:href="iff-20231231.xsd#iff_ShareEquivalentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e9b21714-3bd5-4566-a83d-7ad6f24f4bf0" xlink:to="loc_iff_ShareEquivalentsMember_3f0f486f-25b6-40a3-858a-26700ae44ed4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_6fe18435-3284-4a31-a4fd-340fd553e059" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_06e74db6-4cb2-45a1-86f1-4e8a417493a3" xlink:to="loc_srt_OwnershipAxis_6fe18435-3284-4a31-a4fd-340fd553e059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_1a82a646-5e46-4828-9db7-f2a4aa1d468d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_6fe18435-3284-4a31-a4fd-340fd553e059" xlink:to="loc_srt_OwnershipDomain_1a82a646-5e46-4828-9db7-f2a4aa1d468d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_InternationalFlavorsFragrancesIncMember_30e2ee61-4527-4b9f-b45b-c84b286fcde3" xlink:href="iff-20231231.xsd#iff_InternationalFlavorsFragrancesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_1a82a646-5e46-4828-9db7-f2a4aa1d468d" xlink:to="loc_iff_InternationalFlavorsFragrancesIncMember_30e2ee61-4527-4b9f-b45b-c84b286fcde3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_1e45e5d0-7fee-4e9d-8bc0-9193a56f064c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_06e74db6-4cb2-45a1-86f1-4e8a417493a3" xlink:to="loc_dei_LegalEntityAxis_1e45e5d0-7fee-4e9d-8bc0-9193a56f064c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_e1cec76b-5858-4c7b-8bb3-00539280b564" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1e45e5d0-7fee-4e9d-8bc0-9193a56f064c" xlink:to="loc_dei_EntityDomain_e1cec76b-5858-4c7b-8bb3-00539280b564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DuPontdeNemoursIncMember_d0dacdcb-fc34-4ce3-a674-a99e52ad4167" xlink:href="iff-20231231.xsd#iff_DuPontdeNemoursIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_e1cec76b-5858-4c7b-8bb3-00539280b564" xlink:to="loc_iff_DuPontdeNemoursIncMember_d0dacdcb-fc34-4ce3-a674-a99e52ad4167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4a7e182b-9c99-4e58-8989-bc401cc4b814" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_06e74db6-4cb2-45a1-86f1-4e8a417493a3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4a7e182b-9c99-4e58-8989-bc401cc4b814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DifferenceAmountBetweenBasicAndDilutedNetIncomePerShare_98b07764-275e-422e-aa01-c994e3a47299" xlink:href="iff-20231231.xsd#iff_DifferenceAmountBetweenBasicAndDilutedNetIncomePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4a7e182b-9c99-4e58-8989-bc401cc4b814" xlink:to="loc_iff_DifferenceAmountBetweenBasicAndDilutedNetIncomePerShare_98b07764-275e-422e-aa01-c994e3a47299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_06748058-31d8-49ce-9611-fdebf408703c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4a7e182b-9c99-4e58-8989-bc401cc4b814" xlink:to="loc_us-gaap_NetIncomeLoss_06748058-31d8-49ce-9611-fdebf408703c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_120e1743-5741-4a57-8d98-93dfd3290528" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4a7e182b-9c99-4e58-8989-bc401cc4b814" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_120e1743-5741-4a57-8d98-93dfd3290528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_54c8a819-30a9-4560-b122-253471d0db03" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4a7e182b-9c99-4e58-8989-bc401cc4b814" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_54c8a819-30a9-4560-b122-253471d0db03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_44f88a46-891a-4dc6-bb07-75ecbbf68970" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4a7e182b-9c99-4e58-8989-bc401cc4b814" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_44f88a46-891a-4dc6-bb07-75ecbbf68970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_44a2b604-3f1d-4245-b3eb-0f1f8c40743b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4a7e182b-9c99-4e58-8989-bc401cc4b814" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_44a2b604-3f1d-4245-b3eb-0f1f8c40743b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DifferenceAmountBetweenBasicNetIncomeLossPerShare_44fb44a2-4271-4804-9137-8beec2e918f1" xlink:href="iff-20231231.xsd#iff_DifferenceAmountBetweenBasicNetIncomeLossPerShare"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4a7e182b-9c99-4e58-8989-bc401cc4b814" xlink:to="loc_iff_DifferenceAmountBetweenBasicNetIncomeLossPerShare_44fb44a2-4271-4804-9137-8beec2e918f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DifferenceAmountBetweenDilutedNetIncomeLossPerShare_5e617cde-fe30-4618-810c-7ca90d2bee55" xlink:href="iff-20231231.xsd#iff_DifferenceAmountBetweenDilutedNetIncomeLossPerShare"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4a7e182b-9c99-4e58-8989-bc401cc4b814" xlink:to="loc_iff_DifferenceAmountBetweenDilutedNetIncomeLossPerShare_5e617cde-fe30-4618-810c-7ca90d2bee55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenBasicNetIncomeLossPerShare_4630e0cb-7a7a-4653-b391-6efe4351ac37" xlink:href="iff-20231231.xsd#iff_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenBasicNetIncomeLossPerShare"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4a7e182b-9c99-4e58-8989-bc401cc4b814" xlink:to="loc_iff_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenBasicNetIncomeLossPerShare_4630e0cb-7a7a-4653-b391-6efe4351ac37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenDilutedNetIncomeLossPerShare_d59e515d-2460-4691-8e6c-23ae6e081f9a" xlink:href="iff-20231231.xsd#iff_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenDilutedNetIncomeLossPerShare"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4a7e182b-9c99-4e58-8989-bc401cc4b814" xlink:to="loc_iff_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenDilutedNetIncomeLossPerShare_d59e515d-2460-4691-8e6c-23ae6e081f9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/NetIncomePerShareTEUDetails" xlink:type="simple" xlink:href="iff-20231231.xsd#NetIncomePerShareTEUDetails"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/NetIncomePerShareTEUDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_7dbb92cb-6de2-46ea-830d-39dd8c961526" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityUnitsIssued_afcd283b-0b22-456a-8843-7f1599cb1bdc" xlink:href="iff-20231231.xsd#iff_TangibleEquityUnitsIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7dbb92cb-6de2-46ea-830d-39dd8c961526" xlink:to="loc_iff_TangibleEquityUnitsIssued_afcd283b-0b22-456a-8843-7f1599cb1bdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityUnitsProceeds_13d9275e-362b-444e-b42b-f1d1396bf499" xlink:href="iff-20231231.xsd#iff_TangibleEquityUnitsProceeds"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7dbb92cb-6de2-46ea-830d-39dd8c961526" xlink:to="loc_iff_TangibleEquityUnitsProceeds_13d9275e-362b-444e-b42b-f1d1396bf499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityUnitsPriceforSharesBasic_496cb545-ccee-48ed-bc4d-b63d4e955b9b" xlink:href="iff-20231231.xsd#iff_TangibleEquityUnitsPriceforSharesBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7dbb92cb-6de2-46ea-830d-39dd8c961526" xlink:to="loc_iff_TangibleEquityUnitsPriceforSharesBasic_496cb545-ccee-48ed-bc4d-b63d4e955b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityUnitsPriceforSharesDiluted_30e82185-f4b5-4cb4-99b2-833c746f43fd" xlink:href="iff-20231231.xsd#iff_TangibleEquityUnitsPriceforSharesDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7dbb92cb-6de2-46ea-830d-39dd8c961526" xlink:to="loc_iff_TangibleEquityUnitsPriceforSharesDiluted_30e82185-f4b5-4cb4-99b2-833c746f43fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_b667597b-660d-4e84-bd2b-0ea9d1b5dc41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7dbb92cb-6de2-46ea-830d-39dd8c961526" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_b667597b-660d-4e84-bd2b-0ea9d1b5dc41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityUnitsFinalSettlementRate_7dbf7a2a-6a15-4dda-ae71-f759af15934b" xlink:href="iff-20231231.xsd#iff_TangibleEquityUnitsFinalSettlementRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7dbb92cb-6de2-46ea-830d-39dd8c961526" xlink:to="loc_iff_TangibleEquityUnitsFinalSettlementRate_7dbf7a2a-6a15-4dda-ae71-f759af15934b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/ShareholdersEquityAdditionalInformationDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#ShareholdersEquityAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/ShareholdersEquityAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_df4a38c6-a89d-4611-8fa0-009e78b1374f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_aae530b7-bc64-4007-bef3-54795770ef41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_df4a38c6-a89d-4611-8fa0-009e78b1374f" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_aae530b7-bc64-4007-bef3-54795770ef41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent_68545afa-b9c6-4f4c-8576-24330f15cb52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_df4a38c6-a89d-4611-8fa0-009e78b1374f" xlink:to="loc_us-gaap_DividendsPayableCurrent_68545afa-b9c6-4f4c-8576-24330f15cb52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableAmountPerShare_69941f54-ca90-48b3-8510-668f0c2388fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_df4a38c6-a89d-4611-8fa0-009e78b1374f" xlink:to="loc_us-gaap_DividendsPayableAmountPerShare_69941f54-ca90-48b3-8510-668f0c2388fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_8bb37236-a2b8-45b6-890e-83bff7947871" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_df4a38c6-a89d-4611-8fa0-009e78b1374f" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_8bb37236-a2b8-45b6-890e-83bff7947871" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_StockRepurchaseProgramAdditionalAuthorizedAmount_0ac37ad2-6519-4d18-b634-6e57548d87e8" xlink:href="iff-20231231.xsd#iff_StockRepurchaseProgramAdditionalAuthorizedAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_df4a38c6-a89d-4611-8fa0-009e78b1374f" xlink:to="loc_iff_StockRepurchaseProgramAdditionalAuthorizedAmount_0ac37ad2-6519-4d18-b634-6e57548d87e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_StockRepurchaseProgramRemainingAuthorizedAmendedRepurchaseAmount_46fc2e8e-a7fb-4f98-ad48-bb85b9f2720d" xlink:href="iff-20231231.xsd#iff_StockRepurchaseProgramRemainingAuthorizedAmendedRepurchaseAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_df4a38c6-a89d-4611-8fa0-009e78b1374f" xlink:to="loc_iff_StockRepurchaseProgramRemainingAuthorizedAmendedRepurchaseAmount_46fc2e8e-a7fb-4f98-ad48-bb85b9f2720d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_b7142544-4155-4b93-abb6-e0ef8058a87b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_df4a38c6-a89d-4611-8fa0-009e78b1374f" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_b7142544-4155-4b93-abb6-e0ef8058a87b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_3e7988ea-36d9-4b76-80bd-d34a6f289f12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_df4a38c6-a89d-4611-8fa0-009e78b1374f" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_3e7988ea-36d9-4b76-80bd-d34a6f289f12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_StockRepurchasedDuringPeriodAsPercentageOfSharesOutstanding_beb6f61b-3bf7-45eb-95f8-6f1af5fe92b3" xlink:href="iff-20231231.xsd#iff_StockRepurchasedDuringPeriodAsPercentageOfSharesOutstanding"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_df4a38c6-a89d-4611-8fa0-009e78b1374f" xlink:to="loc_iff_StockRepurchasedDuringPeriodAsPercentageOfSharesOutstanding_beb6f61b-3bf7-45eb-95f8-6f1af5fe92b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#StockCompensationPlansAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a2dcd344-88b3-454b-ae06-5e3104a692c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_56c592c9-5954-4327-bad7-356df549ff97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a2dcd344-88b3-454b-ae06-5e3104a692c7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_56c592c9-5954-4327-bad7-356df549ff97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_060c9c45-0eb0-484f-88aa-1b7e09291ffa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_56c592c9-5954-4327-bad7-356df549ff97" xlink:to="loc_us-gaap_VestingAxis_060c9c45-0eb0-484f-88aa-1b7e09291ffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_216b2eb7-8b02-4f28-a304-a11fb49d115f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_060c9c45-0eb0-484f-88aa-1b7e09291ffa" xlink:to="loc_us-gaap_VestingDomain_216b2eb7-8b02-4f28-a304-a11fb49d115f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EachTwelveMonthPeriodMember_569e5008-888e-4f9e-b65e-ceff5506ca94" xlink:href="iff-20231231.xsd#iff_EachTwelveMonthPeriodMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_216b2eb7-8b02-4f28-a304-a11fb49d115f" xlink:to="loc_iff_EachTwelveMonthPeriodMember_569e5008-888e-4f9e-b65e-ceff5506ca94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FullThreeYearPeriodMember_02cbb872-2c72-49e4-921f-942d4ed57722" xlink:href="iff-20231231.xsd#iff_FullThreeYearPeriodMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_216b2eb7-8b02-4f28-a304-a11fb49d115f" xlink:to="loc_iff_FullThreeYearPeriodMember_02cbb872-2c72-49e4-921f-942d4ed57722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_267823a5-c29a-4d0f-ac0a-8094e19baa77" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_56c592c9-5954-4327-bad7-356df549ff97" xlink:to="loc_us-gaap_AwardTypeAxis_267823a5-c29a-4d0f-ac0a-8094e19baa77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5245fbb0-b188-4b0c-9f99-6af811cee3f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_267823a5-c29a-4d0f-ac0a-8094e19baa77" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5245fbb0-b188-4b0c-9f99-6af811cee3f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_9dd03a9b-5620-476f-bb3b-fc127d58f91a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5245fbb0-b188-4b0c-9f99-6af811cee3f6" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_9dd03a9b-5620-476f-bb3b-fc127d58f91a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_ce9b93e5-60b8-4ef7-a478-0e2756dc946d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5245fbb0-b188-4b0c-9f99-6af811cee3f6" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_ce9b93e5-60b8-4ef7-a478-0e2756dc946d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_74f31b00-7865-41f1-b04a-62adee3d3ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5245fbb0-b188-4b0c-9f99-6af811cee3f6" xlink:to="loc_us-gaap_EmployeeStockOptionMember_74f31b00-7865-41f1-b04a-62adee3d3ae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_3e7a0b46-ea4a-4f77-9717-e029a9ab9525" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_56c592c9-5954-4327-bad7-356df549ff97" xlink:to="loc_us-gaap_PlanNameAxis_3e7a0b46-ea4a-4f77-9717-e029a9ab9525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_3a8937ad-8555-4dc3-84b3-38b40b204a13" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_3e7a0b46-ea4a-4f77-9717-e029a9ab9525" xlink:to="loc_us-gaap_PlanNameDomain_3a8937ad-8555-4dc3-84b3-38b40b204a13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TwoThousandFifteenPlanMember_05fb1a08-d401-4edd-915e-6cf27b46943c" xlink:href="iff-20231231.xsd#iff_TwoThousandFifteenPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_3a8937ad-8555-4dc3-84b3-38b40b204a13" xlink:to="loc_iff_TwoThousandFifteenPlanMember_05fb1a08-d401-4edd-915e-6cf27b46943c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TwoThousandTenPlanMember_8177fbff-ba4f-4111-bb3f-58e31bd37b34" xlink:href="iff-20231231.xsd#iff_TwoThousandTenPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_3a8937ad-8555-4dc3-84b3-38b40b204a13" xlink:to="loc_iff_TwoThousandTenPlanMember_8177fbff-ba4f-4111-bb3f-58e31bd37b34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_LongTermIncentivePlanMember_12e594d8-21ba-40f9-a158-e98ae27f4ace" xlink:href="iff-20231231.xsd#iff_LongTermIncentivePlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_3a8937ad-8555-4dc3-84b3-38b40b204a13" xlink:to="loc_iff_LongTermIncentivePlanMember_12e594d8-21ba-40f9-a158-e98ae27f4ace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TwoThousandEightToTwoThousandTwentyCycleMember_d99a2cce-a4fa-426a-baa8-9143c85c648e" xlink:href="iff-20231231.xsd#iff_TwoThousandEightToTwoThousandTwentyCycleMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_3a8937ad-8555-4dc3-84b3-38b40b204a13" xlink:to="loc_iff_TwoThousandEightToTwoThousandTwentyCycleMember_d99a2cce-a4fa-426a-baa8-9143c85c648e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TwoThousandSixteenToTwoThousandEighteenCycleMember_844af6ae-d441-4020-b81e-a55528965a2b" xlink:href="iff-20231231.xsd#iff_TwoThousandSixteenToTwoThousandEighteenCycleMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_3a8937ad-8555-4dc3-84b3-38b40b204a13" xlink:to="loc_iff_TwoThousandSixteenToTwoThousandEighteenCycleMember_844af6ae-d441-4020-b81e-a55528965a2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TwoThousandEighteenToTwoThousandTwentyCycleMember_05ac6966-0690-48c1-b26a-4af169e751e4" xlink:href="iff-20231231.xsd#iff_TwoThousandEighteenToTwoThousandTwentyCycleMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_3a8937ad-8555-4dc3-84b3-38b40b204a13" xlink:to="loc_iff_TwoThousandEighteenToTwoThousandTwentyCycleMember_05ac6966-0690-48c1-b26a-4af169e751e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TwoThousandNineteenToTwoThousandTwentyOneCycleMember_dcba6e32-d2d3-4cc8-9094-0eb9ea59974a" xlink:href="iff-20231231.xsd#iff_TwoThousandNineteenToTwoThousandTwentyOneCycleMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_3a8937ad-8555-4dc3-84b3-38b40b204a13" xlink:to="loc_iff_TwoThousandNineteenToTwoThousandTwentyOneCycleMember_dcba6e32-d2d3-4cc8-9094-0eb9ea59974a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TwoThousandTwentyOnePlanMember_dd799bf2-c28b-4bd5-a32b-90aa64ac6590" xlink:href="iff-20231231.xsd#iff_TwoThousandTwentyOnePlanMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_3a8937ad-8555-4dc3-84b3-38b40b204a13" xlink:to="loc_iff_TwoThousandTwentyOnePlanMember_dd799bf2-c28b-4bd5-a32b-90aa64ac6590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TwoThousandEightToTwoThousandTwentyOneCycleMember_b631b1c5-cfe9-4ff2-8d3b-a3041983ca50" xlink:href="iff-20231231.xsd#iff_TwoThousandEightToTwoThousandTwentyOneCycleMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_3a8937ad-8555-4dc3-84b3-38b40b204a13" xlink:to="loc_iff_TwoThousandEightToTwoThousandTwentyOneCycleMember_b631b1c5-cfe9-4ff2-8d3b-a3041983ca50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TwoThousandTwentyToTwoThousandTwentyTwoCycleMember_d859b0ea-eefb-4179-9a87-da19757cc0bc" xlink:href="iff-20231231.xsd#iff_TwoThousandTwentyToTwoThousandTwentyTwoCycleMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_3a8937ad-8555-4dc3-84b3-38b40b204a13" xlink:to="loc_iff_TwoThousandTwentyToTwoThousandTwentyTwoCycleMember_d859b0ea-eefb-4179-9a87-da19757cc0bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TwoThousandTwentyOneToTwoThousandTwentyThreeCycleMember_30b39fb7-36f6-4d59-b31e-083e7a4b3aa7" xlink:href="iff-20231231.xsd#iff_TwoThousandTwentyOneToTwoThousandTwentyThreeCycleMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_3a8937ad-8555-4dc3-84b3-38b40b204a13" xlink:to="loc_iff_TwoThousandTwentyOneToTwoThousandTwentyThreeCycleMember_30b39fb7-36f6-4d59-b31e-083e7a4b3aa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_60c18b5e-8bf1-4b6b-adc6-4e6a44d38a85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_56c592c9-5954-4327-bad7-356df549ff97" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_60c18b5e-8bf1-4b6b-adc6-4e6a44d38a85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_3db6e6e4-a233-4f59-91db-899f9f555a25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_60c18b5e-8bf1-4b6b-adc6-4e6a44d38a85" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_3db6e6e4-a233-4f59-91db-899f9f555a25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_e7c6478b-4c96-4eab-ae8c-9c2737e93e3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_3db6e6e4-a233-4f59-91db-899f9f555a25" xlink:to="loc_us-gaap_SubsequentEventMember_e7c6478b-4c96-4eab-ae8c-9c2737e93e3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0b4b598e-e2f0-4439-81ca-a202054542cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_56c592c9-5954-4327-bad7-356df549ff97" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0b4b598e-e2f0-4439-81ca-a202054542cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ddf60edb-812f-465d-ab3f-34d1419a0718" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0b4b598e-e2f0-4439-81ca-a202054542cb" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ddf60edb-812f-465d-ab3f-34d1419a0718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NutritionBiosciencesIncMember_740696bd-caf1-4023-885c-573afbecdd30" xlink:href="iff-20231231.xsd#iff_NutritionBiosciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ddf60edb-812f-465d-ab3f-34d1419a0718" xlink:to="loc_iff_NutritionBiosciencesIncMember_740696bd-caf1-4023-885c-573afbecdd30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_65135d2d-893e-4491-a974-a317767c88b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_56c592c9-5954-4327-bad7-356df549ff97" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_65135d2d-893e-4491-a974-a317767c88b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_4ff7a7e1-9394-475d-aa1a-455a4f583f35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_65135d2d-893e-4491-a974-a317767c88b8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_4ff7a7e1-9394-475d-aa1a-455a4f583f35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_9020fdfe-53a8-4164-a39d-9d323e43a519" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_65135d2d-893e-4491-a974-a317767c88b8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_9020fdfe-53a8-4164-a39d-9d323e43a519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_a62a68b3-2173-439d-8216-3fdf97140d92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_65135d2d-893e-4491-a974-a317767c88b8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_a62a68b3-2173-439d-8216-3fdf97140d92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesSubjectToOutstandingAwards_d67b62e4-5288-4f31-b16a-cb464c473bb6" xlink:href="iff-20231231.xsd#iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesSubjectToOutstandingAwards"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_65135d2d-893e-4491-a974-a317767c88b8" xlink:to="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesSubjectToOutstandingAwards_d67b62e4-5288-4f31-b16a-cb464c473bb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfSharesAvailableForGrant_5e55dcb5-7e20-40b5-a4c9-cb69e81bec35" xlink:href="iff-20231231.xsd#iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_65135d2d-893e-4491-a974-a317767c88b8" xlink:to="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfSharesAvailableForGrant_5e55dcb5-7e20-40b5-a4c9-cb69e81bec35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TargetPayoutCash_72623a93-09bc-4c50-a4a6-405a02db9d62" xlink:href="iff-20231231.xsd#iff_TargetPayoutCash"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_65135d2d-893e-4491-a974-a317767c88b8" xlink:to="loc_iff_TargetPayoutCash_72623a93-09bc-4c50-a4a6-405a02db9d62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TargetPayoutStock_2f538a04-003d-494c-a258-e023c59fb33d" xlink:href="iff-20231231.xsd#iff_TargetPayoutStock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_65135d2d-893e-4491-a974-a317767c88b8" xlink:to="loc_iff_TargetPayoutStock_2f538a04-003d-494c-a258-e023c59fb33d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TargetPayoutPeriodOfCycle_a3e519da-4199-4a55-a14f-34a87cad592e" xlink:href="iff-20231231.xsd#iff_TargetPayoutPeriodOfCycle"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_65135d2d-893e-4491-a974-a317767c88b8" xlink:to="loc_iff_TargetPayoutPeriodOfCycle_a3e519da-4199-4a55-a14f-34a87cad592e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingPercentage_5d762a27-50be-4fdf-98c6-177166a26304" xlink:href="iff-20231231.xsd#iff_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingPercentage"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_65135d2d-893e-4491-a974-a317767c88b8" xlink:to="loc_iff_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingPercentage_5d762a27-50be-4fdf-98c6-177166a26304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetDollarValueOfAwardIsConvertedToNumberOfNotionalSharesWhenAwardIsGranted_2c10fefe-55fe-42e3-9d80-4182403546cd" xlink:href="iff-20231231.xsd#iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetDollarValueOfAwardIsConvertedToNumberOfNotionalSharesWhenAwardIsGranted"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_65135d2d-893e-4491-a974-a317767c88b8" xlink:to="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetDollarValueOfAwardIsConvertedToNumberOfNotionalSharesWhenAwardIsGranted_2c10fefe-55fe-42e3-9d80-4182403546cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_161910f2-156e-4525-8c79-a288779e1f4f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_65135d2d-893e-4491-a974-a317767c88b8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_161910f2-156e-4525-8c79-a288779e1f4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_6f895894-293e-4ad9-ad8d-082e9f6b8a0e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_65135d2d-893e-4491-a974-a317767c88b8" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_6f895894-293e-4ad9-ad8d-082e9f6b8a0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure_4f9222e1-35ff-4539-914a-e384cdcace4d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_65135d2d-893e-4491-a974-a317767c88b8" xlink:to="loc_us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure_4f9222e1-35ff-4539-914a-e384cdcace4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_9a1e4d5e-9eb4-4979-8fe4-97a27a7bd8c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_65135d2d-893e-4491-a974-a317767c88b8" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_9a1e4d5e-9eb4-4979-8fe4-97a27a7bd8c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BusinessAcquisitionPostCombinationServicePeriod_a638d56b-31e0-42cf-aa4b-61164d3365ac" xlink:href="iff-20231231.xsd#iff_BusinessAcquisitionPostCombinationServicePeriod"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_65135d2d-893e-4491-a974-a317767c88b8" xlink:to="loc_iff_BusinessAcquisitionPostCombinationServicePeriod_a638d56b-31e0-42cf-aa4b-61164d3365ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTerm_ad13749f-375b-4c72-84a0-7b99dd48609d" xlink:href="iff-20231231.xsd#iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTerm"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_65135d2d-893e-4491-a974-a317767c88b8" xlink:to="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTerm_ad13749f-375b-4c72-84a0-7b99dd48609d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_df67d3d5-d4f3-4969-81fa-9368d66ff1f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_65135d2d-893e-4491-a974-a317767c88b8" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_df67d3d5-d4f3-4969-81fa-9368d66ff1f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/StockCompensationPlansStockBasedCompensationExpenseIncludedinConsolidatedStatementofIncomeandComprehensiveIncomeDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#StockCompensationPlansStockBasedCompensationExpenseIncludedinConsolidatedStatementofIncomeandComprehensiveIncomeDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/StockCompensationPlansStockBasedCompensationExpenseIncludedinConsolidatedStatementofIncomeandComprehensiveIncomeDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_057bf9b3-1ffc-490e-be7f-9d5bb65eb16d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_19bf03f9-1ac5-4e32-b124-6e2ff5604ad8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_057bf9b3-1ffc-490e-be7f-9d5bb65eb16d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_19bf03f9-1ac5-4e32-b124-6e2ff5604ad8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_a484d67c-5c96-4c42-ad6a-2f1c98b6dde5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_19bf03f9-1ac5-4e32-b124-6e2ff5604ad8" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_a484d67c-5c96-4c42-ad6a-2f1c98b6dde5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_dc932a50-546b-4722-9f7e-b048266fdfda" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_a484d67c-5c96-4c42-ad6a-2f1c98b6dde5" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_dc932a50-546b-4722-9f7e-b048266fdfda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EquityBasedAwardsMember_6a207e0d-b6e7-4b2d-a658-2efd0cc3753f" xlink:href="iff-20231231.xsd#iff_EquityBasedAwardsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_dc932a50-546b-4722-9f7e-b048266fdfda" xlink:to="loc_iff_EquityBasedAwardsMember_6a207e0d-b6e7-4b2d-a658-2efd0cc3753f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_LiabilityBasedAwardsMember_31f8979b-758a-4b0d-acfd-bb11c49f4e5a" xlink:href="iff-20231231.xsd#iff_LiabilityBasedAwardsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_dc932a50-546b-4722-9f7e-b048266fdfda" xlink:to="loc_iff_LiabilityBasedAwardsMember_31f8979b-758a-4b0d-acfd-bb11c49f4e5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9873bcf3-48c0-4a6c-b7a6-2efbee2a8938" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_19bf03f9-1ac5-4e32-b124-6e2ff5604ad8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9873bcf3-48c0-4a6c-b7a6-2efbee2a8938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_49c5259c-d99d-4d8d-bc29-06b401aefe62" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9873bcf3-48c0-4a6c-b7a6-2efbee2a8938" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_49c5259c-d99d-4d8d-bc29-06b401aefe62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_0cd9db3e-176b-41b7-953f-da566c4d2fa0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9873bcf3-48c0-4a6c-b7a6-2efbee2a8938" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_0cd9db3e-176b-41b7-953f-da566c4d2fa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_1c322249-6704-4861-9c73-6309db6d9e2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9873bcf3-48c0-4a6c-b7a6-2efbee2a8938" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_1c322249-6704-4861-9c73-6309db6d9e2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_ce2461f6-885f-4707-8baf-b94a6fc6855c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_057bf9b3-1ffc-490e-be7f-9d5bb65eb16d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_ce2461f6-885f-4707-8baf-b94a6fc6855c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionAdditionalInformationDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#StockCompensationPlansSSARsandStockOptionAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ad8f48cf-30d6-4963-80c9-46f987d26a63" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e61a51b4-d716-45f8-9f52-0e265f670fec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ad8f48cf-30d6-4963-80c9-46f987d26a63" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e61a51b4-d716-45f8-9f52-0e265f670fec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_239e6b20-1be2-4ef9-a0d8-f5a99b87dcc9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e61a51b4-d716-45f8-9f52-0e265f670fec" xlink:to="loc_us-gaap_AwardTypeAxis_239e6b20-1be2-4ef9-a0d8-f5a99b87dcc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_20daa446-2a53-4ed5-b78a-4e786509eb96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_239e6b20-1be2-4ef9-a0d8-f5a99b87dcc9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_20daa446-2a53-4ed5-b78a-4e786509eb96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_26b6a0cb-75f3-411c-bfd6-161a8423bac4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_20daa446-2a53-4ed5-b78a-4e786509eb96" xlink:to="loc_us-gaap_StockOptionMember_26b6a0cb-75f3-411c-bfd6-161a8423bac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_5b8413ee-8b85-46d5-8a6f-bb2f615e626c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_20daa446-2a53-4ed5-b78a-4e786509eb96" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_5b8413ee-8b85-46d5-8a6f-bb2f615e626c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_StockOptionsAndStockSettledAppreciationRightsMember_2b18379c-c328-4f7e-a664-f4ee4809af9a" xlink:href="iff-20231231.xsd#iff_StockOptionsAndStockSettledAppreciationRightsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_20daa446-2a53-4ed5-b78a-4e786509eb96" xlink:to="loc_iff_StockOptionsAndStockSettledAppreciationRightsMember_2b18379c-c328-4f7e-a664-f4ee4809af9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_StockOptionsAndSsarsMember_df95ad1a-986c-4033-9500-135a069e4e1f" xlink:href="iff-20231231.xsd#iff_StockOptionsAndSsarsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_20daa446-2a53-4ed5-b78a-4e786509eb96" xlink:to="loc_iff_StockOptionsAndSsarsMember_df95ad1a-986c-4033-9500-135a069e4e1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1459c5d4-eb88-4c93-a4e3-90782eed32f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e61a51b4-d716-45f8-9f52-0e265f670fec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1459c5d4-eb88-4c93-a4e3-90782eed32f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTerm_6fed74fe-f5e9-471d-be5e-73fd3ced2cf9" xlink:href="iff-20231231.xsd#iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1459c5d4-eb88-4c93-a4e3-90782eed32f6" xlink:to="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTerm_6fed74fe-f5e9-471d-be5e-73fd3ced2cf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2bafd269-5338-4506-9b55-d58eda9df713" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1459c5d4-eb88-4c93-a4e3-90782eed32f6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2bafd269-5338-4506-9b55-d58eda9df713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_a5fad8e9-48ef-456d-8ec8-4befeb700fa0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1459c5d4-eb88-4c93-a4e3-90782eed32f6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_a5fad8e9-48ef-456d-8ec8-4befeb700fa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2b3e9d79-21d3-4bc3-9c18-76c8b13447b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1459c5d4-eb88-4c93-a4e3-90782eed32f6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2b3e9d79-21d3-4bc3-9c18-76c8b13447b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_7cabed02-bace-4d59-88c8-f840b29b58c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1459c5d4-eb88-4c93-a4e3-90782eed32f6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_7cabed02-bace-4d59-88c8-f840b29b58c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_2f9001da-ba83-498e-a8e7-0cbe65a97cfa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1459c5d4-eb88-4c93-a4e3-90782eed32f6" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_2f9001da-ba83-498e-a8e7-0cbe65a97cfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_227ba942-f31d-46b3-873b-03c153860396" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1459c5d4-eb88-4c93-a4e3-90782eed32f6" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_227ba942-f31d-46b3-873b-03c153860396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionActivityDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#StockCompensationPlansSSARsandStockOptionActivityDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionActivityDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_30cfa71a-eb8f-4fe8-911a-7a35f2ca75f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d7e6d826-0bd1-4302-aa87-985e25cafad0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_30cfa71a-eb8f-4fe8-911a-7a35f2ca75f6" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d7e6d826-0bd1-4302-aa87-985e25cafad0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_ad8f6d3e-cf61-4109-acb7-7ac9d9d1be2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d7e6d826-0bd1-4302-aa87-985e25cafad0" xlink:to="loc_us-gaap_AwardTypeAxis_ad8f6d3e-cf61-4109-acb7-7ac9d9d1be2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_85ad6251-3643-4905-961e-9f0f90eb774a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_ad8f6d3e-cf61-4109-acb7-7ac9d9d1be2e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_85ad6251-3643-4905-961e-9f0f90eb774a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_StockOptionsAndSsarsMember_8bc19300-d65d-41b2-950a-eafba5d47843" xlink:href="iff-20231231.xsd#iff_StockOptionsAndSsarsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_85ad6251-3643-4905-961e-9f0f90eb774a" xlink:to="loc_iff_StockOptionsAndSsarsMember_8bc19300-d65d-41b2-950a-eafba5d47843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_StockOptionsAndStockSettledAppreciationRightsMember_ea8d5a10-b1a8-4cc8-b3f5-9ab0d6f8da49" xlink:href="iff-20231231.xsd#iff_StockOptionsAndStockSettledAppreciationRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_85ad6251-3643-4905-961e-9f0f90eb774a" xlink:to="loc_iff_StockOptionsAndStockSettledAppreciationRightsMember_ea8d5a10-b1a8-4cc8-b3f5-9ab0d6f8da49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d465629-b7d3-4b72-bd30-bc31efc7626e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d7e6d826-0bd1-4302-aa87-985e25cafad0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d465629-b7d3-4b72-bd30-bc31efc7626e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_9913e60d-2595-4f8e-a01d-ef57ceff84be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d465629-b7d3-4b72-bd30-bc31efc7626e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_9913e60d-2595-4f8e-a01d-ef57ceff84be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_05af472b-aa46-4a5a-a10a-5ace86bee732" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_9913e60d-2595-4f8e-a01d-ef57ceff84be" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_05af472b-aa46-4a5a-a10a-5ace86bee732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_37becfe8-1ad4-4a60-9c1b-d4f146f584cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_9913e60d-2595-4f8e-a01d-ef57ceff84be" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_37becfe8-1ad4-4a60-9c1b-d4f146f584cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_a3365e12-8c1f-4c72-a8c4-b9282bd1df72" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_9913e60d-2595-4f8e-a01d-ef57ceff84be" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_a3365e12-8c1f-4c72-a8c4-b9282bd1df72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_fc260e1d-af24-4e98-a1f1-c8a7e48b1994" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_9913e60d-2595-4f8e-a01d-ef57ceff84be" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_fc260e1d-af24-4e98-a1f1-c8a7e48b1994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumptionsInPeriod_b9bd06bb-d145-4420-a6ac-27cf58ae160d" xlink:href="iff-20231231.xsd#iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumptionsInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_9913e60d-2595-4f8e-a01d-ef57ceff84be" xlink:to="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumptionsInPeriod_b9bd06bb-d145-4420-a6ac-27cf58ae160d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_86060273-7ff1-4e2f-bf2c-77173d2961e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_9913e60d-2595-4f8e-a01d-ef57ceff84be" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_86060273-7ff1-4e2f-bf2c-77173d2961e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_c01cb4ce-8c61-4df2-b774-d16d65604e78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d465629-b7d3-4b72-bd30-bc31efc7626e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_c01cb4ce-8c61-4df2-b774-d16d65604e78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_84f8893d-d9aa-4950-bd6f-acd2056e7fd0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_c01cb4ce-8c61-4df2-b774-d16d65604e78" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_84f8893d-d9aa-4950-bd6f-acd2056e7fd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_4264b261-7c0a-4de9-8731-a03a36a2f924" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_c01cb4ce-8c61-4df2-b774-d16d65604e78" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_4264b261-7c0a-4de9-8731-a03a36a2f924" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_b93fcf03-ea45-4d5a-ab16-a71236a257fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_c01cb4ce-8c61-4df2-b774-d16d65604e78" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_b93fcf03-ea45-4d5a-ab16-a71236a257fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_64487aa5-ee15-47cb-93b8-92922b18ac65" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_c01cb4ce-8c61-4df2-b774-d16d65604e78" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_64487aa5-ee15-47cb-93b8-92922b18ac65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumptionsInPeriodWeightedAverageExercisePrice_a237f3d0-7a3f-4842-acd7-f6c18f5aea36" xlink:href="iff-20231231.xsd#iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumptionsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_c01cb4ce-8c61-4df2-b774-d16d65604e78" xlink:to="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumptionsInPeriodWeightedAverageExercisePrice_a237f3d0-7a3f-4842-acd7-f6c18f5aea36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_ee6567ca-3645-44cd-a112-2ede093c7b4c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_c01cb4ce-8c61-4df2-b774-d16d65604e78" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_ee6567ca-3645-44cd-a112-2ede093c7b4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_8591200c-cffe-40af-a4b1-890a470df297" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d465629-b7d3-4b72-bd30-bc31efc7626e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_8591200c-cffe-40af-a4b1-890a470df297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_6349681e-6746-4a5f-93d5-94a797fa98e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d465629-b7d3-4b72-bd30-bc31efc7626e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_6349681e-6746-4a5f-93d5-94a797fa98e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_83275d83-6abb-4278-aa09-7da5d2e6f7e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d465629-b7d3-4b72-bd30-bc31efc7626e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_83275d83-6abb-4278-aa09-7da5d2e6f7e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionOutstandingDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#StockCompensationPlansSSARsandStockOptionOutstandingDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionOutstandingDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_78a0a985-de2a-470a-9fd3-f01cc6b491cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1739fe2f-cfa3-497a-8c25-ef8578c5690f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_78a0a985-de2a-470a-9fd3-f01cc6b491cb" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1739fe2f-cfa3-497a-8c25-ef8578c5690f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_9da973a0-2b37-4a81-ba44-4b7af021e9b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1739fe2f-cfa3-497a-8c25-ef8578c5690f" xlink:to="loc_us-gaap_AwardTypeAxis_9da973a0-2b37-4a81-ba44-4b7af021e9b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_49678250-6366-4376-89f7-d05dd59a8bc9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_9da973a0-2b37-4a81-ba44-4b7af021e9b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_49678250-6366-4376-89f7-d05dd59a8bc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_StockOptionsAndSsarsMember_832a440f-4cb9-431c-909d-8fa50ba1ed92" xlink:href="iff-20231231.xsd#iff_StockOptionsAndSsarsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_49678250-6366-4376-89f7-d05dd59a8bc9" xlink:to="loc_iff_StockOptionsAndSsarsMember_832a440f-4cb9-431c-909d-8fa50ba1ed92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_StockOptionsAndStockSettledAppreciationRightsMember_677243a9-5063-473e-8ed0-18c999bcba76" xlink:href="iff-20231231.xsd#iff_StockOptionsAndStockSettledAppreciationRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_49678250-6366-4376-89f7-d05dd59a8bc9" xlink:to="loc_iff_StockOptionsAndStockSettledAppreciationRightsMember_677243a9-5063-473e-8ed0-18c999bcba76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_ecbbfe2d-6974-4444-b66e-ae61a491fbc9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1739fe2f-cfa3-497a-8c25-ef8578c5690f" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_ecbbfe2d-6974-4444-b66e-ae61a491fbc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_63480130-89df-490e-9286-d9fe61afa4a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_ecbbfe2d-6974-4444-b66e-ae61a491fbc9" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_63480130-89df-490e-9286-d9fe61afa4a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_Over65Member_c108dc72-72cf-419c-981a-069f4fde2722" xlink:href="iff-20231231.xsd#iff_Over65Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_63480130-89df-490e-9286-d9fe61afa4a6" xlink:to="loc_iff_Over65Member_c108dc72-72cf-419c-981a-069f4fde2722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_87ef4357-8adc-4daa-bf7e-36c77d728cc0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1739fe2f-cfa3-497a-8c25-ef8578c5690f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_87ef4357-8adc-4daa-bf7e-36c77d728cc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_79acb2de-5e99-4305-85cc-9fcebc20ed12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_87ef4357-8adc-4daa-bf7e-36c77d728cc0" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_79acb2de-5e99-4305-85cc-9fcebc20ed12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_f0490c27-61d8-4c11-afba-4394db83d1ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_87ef4357-8adc-4daa-bf7e-36c77d728cc0" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_f0490c27-61d8-4c11-afba-4394db83d1ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_464432f2-8b8f-49dc-b45d-a6245ec1881e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_87ef4357-8adc-4daa-bf7e-36c77d728cc0" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_464432f2-8b8f-49dc-b45d-a6245ec1881e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_1d70a195-d50b-41aa-ac6e-dbfa3d26d058" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_87ef4357-8adc-4daa-bf7e-36c77d728cc0" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_1d70a195-d50b-41aa-ac6e-dbfa3d26d058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_3fdf2b7b-f667-4d5a-ad31-3758c3b71a35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_87ef4357-8adc-4daa-bf7e-36c77d728cc0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_3fdf2b7b-f667-4d5a-ad31-3758c3b71a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_79d675c5-f60d-43af-b68c-efaa6a5d23c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_87ef4357-8adc-4daa-bf7e-36c77d728cc0" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_79d675c5-f60d-43af-b68c-efaa6a5d23c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_6d0588ce-dc5a-44bb-9930-ede55cc8f35d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_87ef4357-8adc-4daa-bf7e-36c77d728cc0" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_6d0588ce-dc5a-44bb-9930-ede55cc8f35d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_f07cbe54-23f7-488e-8675-e68870267acc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_87ef4357-8adc-4daa-bf7e-36c77d728cc0" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_f07cbe54-23f7-488e-8675-e68870267acc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_750094b9-d80b-4ae5-ab3d-7b78a9075578" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_87ef4357-8adc-4daa-bf7e-36c77d728cc0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_750094b9-d80b-4ae5-ab3d-7b78a9075578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionExercisableDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#StockCompensationPlansSSARsandStockOptionExercisableDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionExercisableDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fa5b3437-a272-486e-8a0e-74351b2add6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1ea563bc-2675-4661-8a7f-84a3d3056bb0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fa5b3437-a272-486e-8a0e-74351b2add6b" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1ea563bc-2675-4661-8a7f-84a3d3056bb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_cfc17a27-41e5-4e7b-b425-79c8ec20af13" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1ea563bc-2675-4661-8a7f-84a3d3056bb0" xlink:to="loc_us-gaap_AwardTypeAxis_cfc17a27-41e5-4e7b-b425-79c8ec20af13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d6d66324-af2a-4922-ac47-f6816d44e92f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_cfc17a27-41e5-4e7b-b425-79c8ec20af13" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d6d66324-af2a-4922-ac47-f6816d44e92f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_StockOptionsAndSsarsMember_25b5a042-f24f-4de6-86e8-70ec23c9b512" xlink:href="iff-20231231.xsd#iff_StockOptionsAndSsarsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d6d66324-af2a-4922-ac47-f6816d44e92f" xlink:to="loc_iff_StockOptionsAndSsarsMember_25b5a042-f24f-4de6-86e8-70ec23c9b512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_StockOptionsAndStockSettledAppreciationRightsMember_5075cf93-fbca-4207-bfcd-713d84f7d6bf" xlink:href="iff-20231231.xsd#iff_StockOptionsAndStockSettledAppreciationRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d6d66324-af2a-4922-ac47-f6816d44e92f" xlink:to="loc_iff_StockOptionsAndStockSettledAppreciationRightsMember_5075cf93-fbca-4207-bfcd-713d84f7d6bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_eab167ab-991c-4016-8f79-0c19ecdb1e69" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1ea563bc-2675-4661-8a7f-84a3d3056bb0" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_eab167ab-991c-4016-8f79-0c19ecdb1e69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_7a3b9bce-75da-4355-9eaa-53798df6ef0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_eab167ab-991c-4016-8f79-0c19ecdb1e69" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_7a3b9bce-75da-4355-9eaa-53798df6ef0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_Over65Member_dbe26aa6-163c-4916-b10a-792e779eb4d6" xlink:href="iff-20231231.xsd#iff_Over65Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_7a3b9bce-75da-4355-9eaa-53798df6ef0d" xlink:to="loc_iff_Over65Member_dbe26aa6-163c-4916-b10a-792e779eb4d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a52eb0d9-ccda-4235-af6f-245dd41950e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1ea563bc-2675-4661-8a7f-84a3d3056bb0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a52eb0d9-ccda-4235-af6f-245dd41950e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SharebasedCompensationSharesAuthorizedunderStockOptionPlansExercisePriceRangeExercisableOptionsUpperRangeLimit_2b08b673-a268-48a4-9c69-4e8fe576317f" xlink:href="iff-20231231.xsd#iff_SharebasedCompensationSharesAuthorizedunderStockOptionPlansExercisePriceRangeExercisableOptionsUpperRangeLimit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a52eb0d9-ccda-4235-af6f-245dd41950e9" xlink:to="loc_iff_SharebasedCompensationSharesAuthorizedunderStockOptionPlansExercisePriceRangeExercisableOptionsUpperRangeLimit_2b08b673-a268-48a4-9c69-4e8fe576317f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_2f25b4bd-f895-4195-b878-8d8d1a98284e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a52eb0d9-ccda-4235-af6f-245dd41950e9" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_2f25b4bd-f895-4195-b878-8d8d1a98284e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_5016037f-1a05-422b-a234-afa5132f542b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a52eb0d9-ccda-4235-af6f-245dd41950e9" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_5016037f-1a05-422b-a234-afa5132f542b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_b051b134-c487-412e-90df-de5458e192bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a52eb0d9-ccda-4235-af6f-245dd41950e9" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_b051b134-c487-412e-90df-de5458e192bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_226542d2-0764-4ea0-bfb8-88af24d07e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a52eb0d9-ccda-4235-af6f-245dd41950e9" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_226542d2-0764-4ea0-bfb8-88af24d07e5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/StockCompensationPlansRestrictedStockUnitsPlanAdditionalInformationDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#StockCompensationPlansRestrictedStockUnitsPlanAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/StockCompensationPlansRestrictedStockUnitsPlanAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8b28f1e2-9968-4a2b-9c3f-e077410e8194" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9149435d-2fa5-4228-905f-3c39f46ed6e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8b28f1e2-9968-4a2b-9c3f-e077410e8194" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9149435d-2fa5-4228-905f-3c39f46ed6e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e040b028-cef4-4ddb-8927-6cc01e46bb5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9149435d-2fa5-4228-905f-3c39f46ed6e6" xlink:to="loc_us-gaap_AwardTypeAxis_e040b028-cef4-4ddb-8927-6cc01e46bb5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_56825369-7825-4dac-95f2-7fb67b9df737" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_e040b028-cef4-4ddb-8927-6cc01e46bb5c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_56825369-7825-4dac-95f2-7fb67b9df737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_2f5a0bca-426d-4585-a6e2-5333fedd854d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_56825369-7825-4dac-95f2-7fb67b9df737" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_2f5a0bca-426d-4585-a6e2-5333fedd854d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_PurchasedRestrictedStockUnitMember_4f7c0dd5-a42a-42d3-95d0-284bf7e0dbab" xlink:href="iff-20231231.xsd#iff_PurchasedRestrictedStockUnitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_56825369-7825-4dac-95f2-7fb67b9df737" xlink:to="loc_iff_PurchasedRestrictedStockUnitMember_4f7c0dd5-a42a-42d3-95d0-284bf7e0dbab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_eaf35f3c-dd33-4d17-aa4d-ee4af6dd9df2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9149435d-2fa5-4228-905f-3c39f46ed6e6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_eaf35f3c-dd33-4d17-aa4d-ee4af6dd9df2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentage_89be117c-840c-4ed3-9e3d-c0679f5ef550" xlink:href="iff-20231231.xsd#iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_eaf35f3c-dd33-4d17-aa4d-ee4af6dd9df2" xlink:to="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentage_89be117c-840c-4ed3-9e3d-c0679f5ef550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_31a48c2c-e60e-4bfe-8b9b-e8f36309cde1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_eaf35f3c-dd33-4d17-aa4d-ee4af6dd9df2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_31a48c2c-e60e-4bfe-8b9b-e8f36309cde1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_940dd70f-2b25-4c03-aac7-4e88c824f313" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_eaf35f3c-dd33-4d17-aa4d-ee4af6dd9df2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_940dd70f-2b25-4c03-aac7-4e88c824f313" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_73a000c6-aa58-4a0c-a8b5-d5813c9df110" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_eaf35f3c-dd33-4d17-aa4d-ee4af6dd9df2" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_73a000c6-aa58-4a0c-a8b5-d5813c9df110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisablePeriod_213b4775-f107-4abf-b8db-63117a69726f" xlink:href="iff-20231231.xsd#iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisablePeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_eaf35f3c-dd33-4d17-aa4d-ee4af6dd9df2" xlink:to="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisablePeriod_213b4775-f107-4abf-b8db-63117a69726f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_f0e32787-a5dc-4b49-9bfb-39e489e067f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_eaf35f3c-dd33-4d17-aa4d-ee4af6dd9df2" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_f0e32787-a5dc-4b49-9bfb-39e489e067f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_9e483579-54af-438e-b755-f9986cb5d2f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_eaf35f3c-dd33-4d17-aa4d-ee4af6dd9df2" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_9e483579-54af-438e-b755-f9986cb5d2f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/StockCompensationPlansRSUPRSandCashRSUActivityDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#StockCompensationPlansRSUPRSandCashRSUActivityDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/StockCompensationPlansRSUPRSandCashRSUActivityDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ef4fff78-3b1b-4ebf-9b02-3209e0dc8c1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d03e983-3259-4c0f-8690-e38721ac470d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ef4fff78-3b1b-4ebf-9b02-3209e0dc8c1b" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d03e983-3259-4c0f-8690-e38721ac470d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_de4896b0-daf3-4194-ab51-f868a370791a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d03e983-3259-4c0f-8690-e38721ac470d" xlink:to="loc_us-gaap_AwardTypeAxis_de4896b0-daf3-4194-ab51-f868a370791a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_390a7593-3f8a-4d34-b828-83e6eced6d71" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_de4896b0-daf3-4194-ab51-f868a370791a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_390a7593-3f8a-4d34-b828-83e6eced6d71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_4880c768-839c-4a7a-a9fc-7a50134f3074" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_390a7593-3f8a-4d34-b828-83e6eced6d71" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_4880c768-839c-4a7a-a9fc-7a50134f3074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_235cbf21-7691-42bd-a24a-1cd8281a627f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_390a7593-3f8a-4d34-b828-83e6eced6d71" xlink:to="loc_us-gaap_RestrictedStockMember_235cbf21-7691-42bd-a24a-1cd8281a627f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_CashRestrictedStockUnitMember_940e5362-6b63-4b82-b23b-33cbe23125ba" xlink:href="iff-20231231.xsd#iff_CashRestrictedStockUnitMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_390a7593-3f8a-4d34-b828-83e6eced6d71" xlink:to="loc_iff_CashRestrictedStockUnitMember_940e5362-6b63-4b82-b23b-33cbe23125ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_PurchasedRestrictedStockUnitMember_8210181e-e20f-4c77-9d86-d664af128361" xlink:href="iff-20231231.xsd#iff_PurchasedRestrictedStockUnitMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_390a7593-3f8a-4d34-b828-83e6eced6d71" xlink:to="loc_iff_PurchasedRestrictedStockUnitMember_8210181e-e20f-4c77-9d86-d664af128361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_123ab662-7147-42dd-9a9f-18ea1051d59b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d03e983-3259-4c0f-8690-e38721ac470d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_123ab662-7147-42dd-9a9f-18ea1051d59b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_af1ad121-7a78-43b9-ae28-dced4ab1c514" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_123ab662-7147-42dd-9a9f-18ea1051d59b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_af1ad121-7a78-43b9-ae28-dced4ab1c514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_9e13d4a9-3fe5-48af-8486-48fe5ad11203" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_af1ad121-7a78-43b9-ae28-dced4ab1c514" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_9e13d4a9-3fe5-48af-8486-48fe5ad11203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_a3ee7189-e8e0-421a-8755-e3fc4d8c88e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_af1ad121-7a78-43b9-ae28-dced4ab1c514" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_a3ee7189-e8e0-421a-8755-e3fc4d8c88e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_5a762ab4-9f16-4301-93b4-d5f0295e173c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_af1ad121-7a78-43b9-ae28-dced4ab1c514" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_5a762ab4-9f16-4301-93b4-d5f0295e173c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2fa0ec1f-1524-47fc-9011-644db3bc760b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_af1ad121-7a78-43b9-ae28-dced4ab1c514" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2fa0ec1f-1524-47fc-9011-644db3bc760b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsChangeDueToPerformanceConditions_0788388b-2f5d-484e-b1a9-24f6e9e009d4" xlink:href="iff-20231231.xsd#iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsChangeDueToPerformanceConditions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_af1ad121-7a78-43b9-ae28-dced4ab1c514" xlink:to="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsChangeDueToPerformanceConditions_0788388b-2f5d-484e-b1a9-24f6e9e009d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d24cd442-f5fa-44b7-96d5-7ff0261f2382" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_af1ad121-7a78-43b9-ae28-dced4ab1c514" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d24cd442-f5fa-44b7-96d5-7ff0261f2382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0e5a0836-895e-460e-b336-d25ca368b3ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_123ab662-7147-42dd-9a9f-18ea1051d59b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0e5a0836-895e-460e-b336-d25ca368b3ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_f45602d9-0e46-4ed3-abd9-a7fda388dad0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0e5a0836-895e-460e-b336-d25ca368b3ed" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_f45602d9-0e46-4ed3-abd9-a7fda388dad0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_aba4a056-feaa-4eab-9eab-806e51f50c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0e5a0836-895e-460e-b336-d25ca368b3ed" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_aba4a056-feaa-4eab-9eab-806e51f50c8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_fd132169-e0b3-4e8a-8b12-a25a271b8b21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0e5a0836-895e-460e-b336-d25ca368b3ed" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_fd132169-e0b3-4e8a-8b12-a25a271b8b21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_93cff158-1001-423d-87ac-91541e94f257" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0e5a0836-895e-460e-b336-d25ca368b3ed" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_93cff158-1001-423d-87ac-91541e94f257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsChangeDueToPerformanceConditionsWeightedAverageGrantDateFairValue_3f24ccb8-2c19-4cbd-89a7-d1ca55e8ac63" xlink:href="iff-20231231.xsd#iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsChangeDueToPerformanceConditionsWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0e5a0836-895e-460e-b336-d25ca368b3ed" xlink:to="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsChangeDueToPerformanceConditionsWeightedAverageGrantDateFairValue_3f24ccb8-2c19-4cbd-89a7-d1ca55e8ac63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e50e631d-7a34-4b63-9bf9-5fdfc0259368" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0e5a0836-895e-460e-b336-d25ca368b3ed" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e50e631d-7a34-4b63-9bf9-5fdfc0259368" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedPurchasedByEmployees_6b5a126e-68da-4c1a-9be5-0f01059a024b" xlink:href="iff-20231231.xsd#iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedPurchasedByEmployees"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_123ab662-7147-42dd-9a9f-18ea1051d59b" xlink:to="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedPurchasedByEmployees_6b5a126e-68da-4c1a-9be5-0f01059a024b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValueOfSharesPurchasedByEmployees_8dccd86d-4ad7-40c5-b1b6-ea6006579df1" xlink:href="iff-20231231.xsd#iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValueOfSharesPurchasedByEmployees"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_123ab662-7147-42dd-9a9f-18ea1051d59b" xlink:to="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValueOfSharesPurchasedByEmployees_8dccd86d-4ad7-40c5-b1b6-ea6006579df1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesPurchasedByEmployees_f537f912-01c0-4f7e-b084-d817fd5ad09c" xlink:href="iff-20231231.xsd#iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesPurchasedByEmployees"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_123ab662-7147-42dd-9a9f-18ea1051d59b" xlink:to="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesPurchasedByEmployees_f537f912-01c0-4f7e-b084-d817fd5ad09c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/StockCompensationPlansPurchasedRestrictedStockPlanAdditionalInformationDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#StockCompensationPlansPurchasedRestrictedStockPlanAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/StockCompensationPlansPurchasedRestrictedStockPlanAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6b143b4e-104d-4baf-ba1d-937a93039be7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c25af1df-c183-4c96-a1b6-2b6caa52d476" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6b143b4e-104d-4baf-ba1d-937a93039be7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c25af1df-c183-4c96-a1b6-2b6caa52d476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_5fa0c9a8-6cd5-4452-a1d1-82e07ed59da5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c25af1df-c183-4c96-a1b6-2b6caa52d476" xlink:to="loc_us-gaap_AwardTypeAxis_5fa0c9a8-6cd5-4452-a1d1-82e07ed59da5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c9d7e6c1-6d91-45c5-8c97-f3e300b0a37e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_5fa0c9a8-6cd5-4452-a1d1-82e07ed59da5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c9d7e6c1-6d91-45c5-8c97-f3e300b0a37e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_79422f83-a525-4ca8-9612-0d4f31271d68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c9d7e6c1-6d91-45c5-8c97-f3e300b0a37e" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_79422f83-a525-4ca8-9612-0d4f31271d68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_be045a8b-f904-48a8-b047-62a1badf8e21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c9d7e6c1-6d91-45c5-8c97-f3e300b0a37e" xlink:to="loc_us-gaap_RestrictedStockMember_be045a8b-f904-48a8-b047-62a1badf8e21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_PurchasedRestrictedStockUnitMember_33e882a7-305f-41b2-861b-6f6134488636" xlink:href="iff-20231231.xsd#iff_PurchasedRestrictedStockUnitMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c9d7e6c1-6d91-45c5-8c97-f3e300b0a37e" xlink:to="loc_iff_PurchasedRestrictedStockUnitMember_33e882a7-305f-41b2-861b-6f6134488636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_57c1f7be-387f-42c4-9131-6eaf58a3dce9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c25af1df-c183-4c96-a1b6-2b6caa52d476" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_57c1f7be-387f-42c4-9131-6eaf58a3dce9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedPurchasedByEmployees_1142f56b-fba3-4995-a50a-0b7d4a3b9f41" xlink:href="iff-20231231.xsd#iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedPurchasedByEmployees"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_57c1f7be-387f-42c4-9131-6eaf58a3dce9" xlink:to="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedPurchasedByEmployees_1142f56b-fba3-4995-a50a-0b7d4a3b9f41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValueOfSharesPurchasedByEmployees_071ba21d-19f1-4f27-b118-262a1df50efe" xlink:href="iff-20231231.xsd#iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValueOfSharesPurchasedByEmployees"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_57c1f7be-387f-42c4-9131-6eaf58a3dce9" xlink:to="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValueOfSharesPurchasedByEmployees_071ba21d-19f1-4f27-b118-262a1df50efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesPurchasedByEmployees_abeda8f4-de5a-440e-a508-06d55032a68f" xlink:href="iff-20231231.xsd#iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesPurchasedByEmployees"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_57c1f7be-387f-42c4-9131-6eaf58a3dce9" xlink:to="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesPurchasedByEmployees_abeda8f4-de5a-440e-a508-06d55032a68f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_ef778911-850d-4fe4-822f-62dc0bbaabc5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_57c1f7be-387f-42c4-9131-6eaf58a3dce9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_ef778911-850d-4fe4-822f-62dc0bbaabc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_cb2a9624-8d1f-4ccc-be2d-bddd842960cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_57c1f7be-387f-42c4-9131-6eaf58a3dce9" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_cb2a9624-8d1f-4ccc-be2d-bddd842960cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_61bd6526-a60d-4e14-93c6-3516db28413b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_57c1f7be-387f-42c4-9131-6eaf58a3dce9" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_61bd6526-a60d-4e14-93c6-3516db28413b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/StockCompensationPlansLiabilityAwardsAdditionalInformationDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#StockCompensationPlansLiabilityAwardsAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/StockCompensationPlansLiabilityAwardsAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d1f912b8-5d48-49d4-83d6-45007cff8a72" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e85de9a0-cc4f-48f2-bb06-219951954bdf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d1f912b8-5d48-49d4-83d6-45007cff8a72" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e85de9a0-cc4f-48f2-bb06-219951954bdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f5ac6d79-3dcf-45d3-bec7-8ab661c3ca5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e85de9a0-cc4f-48f2-bb06-219951954bdf" xlink:to="loc_us-gaap_AwardTypeAxis_f5ac6d79-3dcf-45d3-bec7-8ab661c3ca5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e8e0615a-9755-4fa6-9de0-f00b2a6ba30a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_f5ac6d79-3dcf-45d3-bec7-8ab661c3ca5c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e8e0615a-9755-4fa6-9de0-f00b2a6ba30a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_CashRestrictedStockUnitMember_12094f74-cff3-41ab-b7ab-c4e791e33016" xlink:href="iff-20231231.xsd#iff_CashRestrictedStockUnitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e8e0615a-9755-4fa6-9de0-f00b2a6ba30a" xlink:to="loc_iff_CashRestrictedStockUnitMember_12094f74-cff3-41ab-b7ab-c4e791e33016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0cfd8c66-874d-4099-9041-881ba8aa2a33" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e85de9a0-cc4f-48f2-bb06-219951954bdf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0cfd8c66-874d-4099-9041-881ba8aa2a33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentageGrantedInCashToEligibleEmployees_f4b96cd6-f163-4a60-88b6-fca31d21308a" xlink:href="iff-20231231.xsd#iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentageGrantedInCashToEligibleEmployees"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0cfd8c66-874d-4099-9041-881ba8aa2a33" xlink:to="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentageGrantedInCashToEligibleEmployees_f4b96cd6-f163-4a60-88b6-fca31d21308a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentage_5b9844bc-0735-467b-959b-43de8cb9d3c4" xlink:href="iff-20231231.xsd#iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0cfd8c66-874d-4099-9041-881ba8aa2a33" xlink:to="loc_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentage_5b9844bc-0735-467b-959b-43de8cb9d3c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_6f9207d4-a2cc-494c-ab7d-aeddb7fcfddd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0cfd8c66-874d-4099-9041-881ba8aa2a33" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_6f9207d4-a2cc-494c-ab7d-aeddb7fcfddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_8f10037c-eedd-4151-9e97-96e471b514ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0cfd8c66-874d-4099-9041-881ba8aa2a33" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_8f10037c-eedd-4151-9e97-96e471b514ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_bf88b828-6253-4342-9367-f093027dfc68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0cfd8c66-874d-4099-9041-881ba8aa2a33" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_bf88b828-6253-4342-9367-f093027dfc68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_5743c642-0f00-4888-9351-ca96f0dd371c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0cfd8c66-874d-4099-9041-881ba8aa2a33" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_5743c642-0f00-4888-9351-ca96f0dd371c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/SegmentInformationAdditionalInformationDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#SegmentInformationAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/SegmentInformationAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_a25f6ed7-233f-4195-af8e-9a45f76ca522" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d549fb83-d509-49b2-a842-454cb0fa27bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a25f6ed7-233f-4195-af8e-9a45f76ca522" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d549fb83-d509-49b2-a842-454cb0fa27bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_3c231af1-a902-466a-89c6-3b88f3b6c75b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d549fb83-d509-49b2-a842-454cb0fa27bb" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_3c231af1-a902-466a-89c6-3b88f3b6c75b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_ae28f6ac-bb68-486a-9cf5-f5bf09c6625f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_3c231af1-a902-466a-89c6-3b88f3b6c75b" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_ae28f6ac-bb68-486a-9cf5-f5bf09c6625f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_a4ad5853-578e-4037-b5a5-314c2a5c0736" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_ae28f6ac-bb68-486a-9cf5-f5bf09c6625f" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_a4ad5853-578e-4037-b5a5-314c2a5c0736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_e894211b-7c84-4d58-a66a-12a15cee9721" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d549fb83-d509-49b2-a842-454cb0fa27bb" xlink:to="loc_srt_StatementGeographicalAxis_e894211b-7c84-4d58-a66a-12a15cee9721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d792790c-3e02-4b54-a7a3-ac5f37aa1fa8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_e894211b-7c84-4d58-a66a-12a15cee9721" xlink:to="loc_srt_SegmentGeographicalDomain_d792790c-3e02-4b54-a7a3-ac5f37aa1fa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_08a8bcd5-c9ab-469a-bb00-0260766d0794" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_d792790c-3e02-4b54-a7a3-ac5f37aa1fa8" xlink:to="loc_country_US_08a8bcd5-c9ab-469a-bb00-0260766d0794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_NL_dda8390c-02ac-4587-b513-2ae2026c1819" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_NL"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_d792790c-3e02-4b54-a7a3-ac5f37aa1fa8" xlink:to="loc_country_NL_dda8390c-02ac-4587-b513-2ae2026c1819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_SG_3242bc81-0341-41ce-b53d-c233d2c95dfa" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_SG"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_d792790c-3e02-4b54-a7a3-ac5f37aa1fa8" xlink:to="loc_country_SG_3242bc81-0341-41ce-b53d-c233d2c95dfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN_e4732aad-28a0-459e-9377-549b34ef51a2" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CN"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_d792790c-3e02-4b54-a7a3-ac5f37aa1fa8" xlink:to="loc_country_CN_e4732aad-28a0-459e-9377-549b34ef51a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_51808864-736e-49a5-8bed-d8329c8f27de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_d792790c-3e02-4b54-a7a3-ac5f37aa1fa8" xlink:to="loc_us-gaap_NonUsMember_51808864-736e-49a5-8bed-d8329c8f27de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_45545765-c5f5-4e80-b18b-552fbf6cf123" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d549fb83-d509-49b2-a842-454cb0fa27bb" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_45545765-c5f5-4e80-b18b-552fbf6cf123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6ae382ef-3e80-447f-9bbc-66180f19dd40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_45545765-c5f5-4e80-b18b-552fbf6cf123" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6ae382ef-3e80-447f-9bbc-66180f19dd40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember_b47914d8-cf6c-47ef-834d-384fa1b1c670" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6ae382ef-3e80-447f-9bbc-66180f19dd40" xlink:to="loc_us-gaap_SalesMember_b47914d8-cf6c-47ef-834d-384fa1b1c670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_de39dbff-2027-470a-96f0-d3160866dff5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6ae382ef-3e80-447f-9bbc-66180f19dd40" xlink:to="loc_us-gaap_SalesRevenueNetMember_de39dbff-2027-470a-96f0-d3160866dff5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ConsolidatedNetSalesMember_9d9fefe2-66c1-424f-b931-430b0023a58f" xlink:href="iff-20231231.xsd#iff_ConsolidatedNetSalesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6ae382ef-3e80-447f-9bbc-66180f19dd40" xlink:to="loc_iff_ConsolidatedNetSalesMember_9d9fefe2-66c1-424f-b931-430b0023a58f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_7f3c3aae-29f7-4229-8e11-a155f14150e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6ae382ef-3e80-447f-9bbc-66180f19dd40" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_7f3c3aae-29f7-4229-8e11-a155f14150e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_8b1f0681-5073-4108-be84-f411608651a1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d549fb83-d509-49b2-a842-454cb0fa27bb" xlink:to="loc_srt_MajorCustomersAxis_8b1f0681-5073-4108-be84-f411608651a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_59a0a6aa-c0a8-429f-bfcd-719613b8df8f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_8b1f0681-5073-4108-be84-f411608651a1" xlink:to="loc_srt_NameOfMajorCustomerDomain_59a0a6aa-c0a8-429f-bfcd-719613b8df8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TopOneCustomerMember_d9ba3ce3-870b-4328-998c-e602001e9ee4" xlink:href="iff-20231231.xsd#iff_TopOneCustomerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_59a0a6aa-c0a8-429f-bfcd-719613b8df8f" xlink:to="loc_iff_TopOneCustomerMember_d9ba3ce3-870b-4328-998c-e602001e9ee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_6296c598-aa11-4c5c-bf7a-be9d9d2f4ef2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d549fb83-d509-49b2-a842-454cb0fa27bb" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_6296c598-aa11-4c5c-bf7a-be9d9d2f4ef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ef2356ba-7633-4dee-874f-617f294ff430" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6296c598-aa11-4c5c-bf7a-be9d9d2f4ef2" xlink:to="loc_us-gaap_SegmentDomain_ef2356ba-7633-4dee-874f-617f294ff430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateAndOtherMember_a446c625-ff5d-4836-863d-52cdefa8a58b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateAndOtherMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ef2356ba-7633-4dee-874f-617f294ff430" xlink:to="loc_us-gaap_CorporateAndOtherMember_a446c625-ff5d-4836-863d-52cdefa8a58b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_d45376ef-429d-4725-902d-906c821ed4d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d549fb83-d509-49b2-a842-454cb0fa27bb" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_d45376ef-429d-4725-902d-906c821ed4d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_29ec55ac-ebf4-469d-a1f6-3382185a33a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d45376ef-429d-4725-902d-906c821ed4d3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_29ec55ac-ebf4-469d-a1f6-3382185a33a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NutritionBiosciencesIncMember_770c25d9-5aa2-4cba-bee7-7f3dbf90e301" xlink:href="iff-20231231.xsd#iff_NutritionBiosciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_29ec55ac-ebf4-469d-a1f6-3382185a33a0" xlink:to="loc_iff_NutritionBiosciencesIncMember_770c25d9-5aa2-4cba-bee7-7f3dbf90e301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_877df4d0-14b9-4b9c-b314-399a29949139" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d549fb83-d509-49b2-a842-454cb0fa27bb" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_877df4d0-14b9-4b9c-b314-399a29949139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NumberOfSegments_9226360b-c67f-406c-8094-bbd7f7080a00" xlink:href="iff-20231231.xsd#iff_NumberOfSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_877df4d0-14b9-4b9c-b314-399a29949139" xlink:to="loc_iff_NumberOfSegments_9226360b-c67f-406c-8094-bbd7f7080a00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NumberOfFragranceCategories_b38fc781-39e2-403a-8a21-3ab0134213bc" xlink:href="iff-20231231.xsd#iff_NumberOfFragranceCategories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_877df4d0-14b9-4b9c-b314-399a29949139" xlink:to="loc_iff_NumberOfFragranceCategories_b38fc781-39e2-403a-8a21-3ab0134213bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EntityWideRevenueMajorCustomerNumberOfCustomers_425bade4-2b47-4c88-ab86-d5e07b023e8b" xlink:href="iff-20231231.xsd#iff_EntityWideRevenueMajorCustomerNumberOfCustomers"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_877df4d0-14b9-4b9c-b314-399a29949139" xlink:to="loc_iff_EntityWideRevenueMajorCustomerNumberOfCustomers_425bade4-2b47-4c88-ab86-d5e07b023e8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_30a9be71-cb14-4513-a161-a13ee9977927" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_877df4d0-14b9-4b9c-b314-399a29949139" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_30a9be71-cb14-4513-a161-a13ee9977927" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_32f53dec-51a1-44f1-85dc-094e00c12014" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_877df4d0-14b9-4b9c-b314-399a29949139" xlink:to="loc_us-gaap_Revenues_32f53dec-51a1-44f1-85dc-094e00c12014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_31ab6a93-f225-46e5-ab22-8183c597ea79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_877df4d0-14b9-4b9c-b314-399a29949139" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_31ab6a93-f225-46e5-ab22-8183c597ea79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_b6e0dae1-dd07-4624-ba93-edb42a6f0883" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_877df4d0-14b9-4b9c-b314-399a29949139" xlink:to="loc_us-gaap_NumberOfOperatingSegments_b6e0dae1-dd07-4624-ba93-edb42a6f0883" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_StrategicInitiativesCosts_996e3188-825c-422e-9734-51a3722417c1" xlink:href="iff-20231231.xsd#iff_StrategicInitiativesCosts"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_877df4d0-14b9-4b9c-b314-399a29949139" xlink:to="loc_iff_StrategicInitiativesCosts_996e3188-825c-422e-9734-51a3722417c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NumberOfCustomers_5f2fb66a-0f06-452f-bec7-531c02e2f657" xlink:href="iff-20231231.xsd#iff_NumberOfCustomers"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_877df4d0-14b9-4b9c-b314-399a29949139" xlink:to="loc_iff_NumberOfCustomers_5f2fb66a-0f06-452f-bec7-531c02e2f657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_d1d19eec-7119-4a04-9ed4-e6c2992fb925" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_877df4d0-14b9-4b9c-b314-399a29949139" xlink:to="loc_us-gaap_RestructuringCharges_d1d19eec-7119-4a04-9ed4-e6c2992fb925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_8f051ac9-7046-4888-8b0c-222960a5bcc0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_877df4d0-14b9-4b9c-b314-399a29949139" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_8f051ac9-7046-4888-8b0c-222960a5bcc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_adb055ba-1245-474c-8d37-ae5ed01a8460" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_877df4d0-14b9-4b9c-b314-399a29949139" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_adb055ba-1245-474c-8d37-ae5ed01a8460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BusinessCombinationDivestituresAndIntegrationCosts_ca7e4698-0cdd-4a26-9010-a9754b92b49a" xlink:href="iff-20231231.xsd#iff_BusinessCombinationDivestituresAndIntegrationCosts"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_877df4d0-14b9-4b9c-b314-399a29949139" xlink:to="loc_iff_BusinessCombinationDivestituresAndIntegrationCosts_ca7e4698-0cdd-4a26-9010-a9754b92b49a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalFees_743a3c9a-9418-4665-83e8-078f5bcd625e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LegalFees"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_877df4d0-14b9-4b9c-b314-399a29949139" xlink:to="loc_us-gaap_LegalFees_743a3c9a-9418-4665-83e8-078f5bcd625e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BusinessCombinationInventoryStepUpCosts_c4b2f244-5d01-4687-a180-890d06af731d" xlink:href="iff-20231231.xsd#iff_BusinessCombinationInventoryStepUpCosts"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_877df4d0-14b9-4b9c-b314-399a29949139" xlink:to="loc_iff_BusinessCombinationInventoryStepUpCosts_c4b2f244-5d01-4687-a180-890d06af731d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_OtherCostsCredits_7212d1f3-0446-4937-a885-51199759d8af" xlink:href="iff-20231231.xsd#iff_OtherCostsCredits"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_877df4d0-14b9-4b9c-b314-399a29949139" xlink:to="loc_iff_OtherCostsCredits_7212d1f3-0446-4937-a885-51199759d8af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BusinessDivestitureCosts_b57285ff-3d64-42d0-b79b-7059b3e2b4e0" xlink:href="iff-20231231.xsd#iff_BusinessDivestitureCosts"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_877df4d0-14b9-4b9c-b314-399a29949139" xlink:to="loc_iff_BusinessDivestitureCosts_b57285ff-3d64-42d0-b79b-7059b3e2b4e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_6b5168d8-cb6c-468a-89d8-16dc379d347d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_877df4d0-14b9-4b9c-b314-399a29949139" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_6b5168d8-cb6c-468a-89d8-16dc379d347d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_5ae1dbc4-224d-4572-9aea-74730ac4ce68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_877df4d0-14b9-4b9c-b314-399a29949139" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_5ae1dbc4-224d-4572-9aea-74730ac4ce68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#SegmentInformationReportableSegmentInformationDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_baa77bed-2e0d-4d62-bb2d-5fd2ebc5e089" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2cf2cf60-9122-489e-96d5-a576f75bd638" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_baa77bed-2e0d-4d62-bb2d-5fd2ebc5e089" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2cf2cf60-9122-489e-96d5-a576f75bd638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_d6e48072-0829-4987-8ad5-fa0c81d41330" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2cf2cf60-9122-489e-96d5-a576f75bd638" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_d6e48072-0829-4987-8ad5-fa0c81d41330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_8e21afe4-8389-4f95-b52c-e5d2e725fa5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_d6e48072-0829-4987-8ad5-fa0c81d41330" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_8e21afe4-8389-4f95-b52c-e5d2e725fa5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_b65459e7-efb0-4364-ad93-a557a494a1b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_8e21afe4-8389-4f95-b52c-e5d2e725fa5a" xlink:to="loc_us-gaap_ForeignPlanMember_b65459e7-efb0-4364-ad93-a557a494a1b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_11262d0a-5f2e-40fe-ac70-09608afbb602" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_GB"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_b65459e7-efb0-4364-ad93-a557a494a1b8" xlink:to="loc_country_GB_11262d0a-5f2e-40fe-ac70-09608afbb602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrecurringAdjustmentAxis_2eccc7f6-b648-4c96-96c9-584151542962" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonrecurringAdjustmentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2cf2cf60-9122-489e-96d5-a576f75bd638" xlink:to="loc_us-gaap_NonrecurringAdjustmentAxis_2eccc7f6-b648-4c96-96c9-584151542962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrecurringAdjustmentDomain_64b08ec2-d6fb-4450-ac82-2f144db442ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonrecurringAdjustmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonrecurringAdjustmentAxis_2eccc7f6-b648-4c96-96c9-584151542962" xlink:to="loc_us-gaap_NonrecurringAdjustmentDomain_64b08ec2-d6fb-4450-ac82-2f144db442ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquisitionRelatedCostsMember_4a54dd59-fe2f-4852-998a-a2ec0010c792" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcquisitionRelatedCostsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonrecurringAdjustmentDomain_64b08ec2-d6fb-4450-ac82-2f144db442ee" xlink:to="loc_us-gaap_AcquisitionRelatedCostsMember_4a54dd59-fe2f-4852-998a-a2ec0010c792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_21aeff89-cfc8-45df-ae4d-82a5e5d34afb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2cf2cf60-9122-489e-96d5-a576f75bd638" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_21aeff89-cfc8-45df-ae4d-82a5e5d34afb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_04a6bd58-240c-4963-b7a5-87853b6d4f9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_21aeff89-cfc8-45df-ae4d-82a5e5d34afb" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_04a6bd58-240c-4963-b7a5-87853b6d4f9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NutritionBiosciencesIncMember_57b50ae0-2259-403d-912b-a64d9c6671ab" xlink:href="iff-20231231.xsd#iff_NutritionBiosciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_04a6bd58-240c-4963-b7a5-87853b6d4f9a" xlink:to="loc_iff_NutritionBiosciencesIncMember_57b50ae0-2259-403d-912b-a64d9c6671ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_873305b9-a5f0-4d03-9ff9-f0fd2116efca" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2cf2cf60-9122-489e-96d5-a576f75bd638" xlink:to="loc_srt_ConsolidationItemsAxis_873305b9-a5f0-4d03-9ff9-f0fd2116efca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_5f4a52f5-0850-4d39-8c64-c34b3d387e83" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_873305b9-a5f0-4d03-9ff9-f0fd2116efca" xlink:to="loc_srt_ConsolidationItemsDomain_5f4a52f5-0850-4d39-8c64-c34b3d387e83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_fcd9a602-614d-4451-82cf-cd7346f58862" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_5f4a52f5-0850-4d39-8c64-c34b3d387e83" xlink:to="loc_us-gaap_OperatingSegmentsMember_fcd9a602-614d-4451-82cf-cd7346f58862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d547bb72-6f37-45e1-a310-bf3f625d9893" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2cf2cf60-9122-489e-96d5-a576f75bd638" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d547bb72-6f37-45e1-a310-bf3f625d9893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_cd409072-42f0-4caa-9b40-0630116edf93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d547bb72-6f37-45e1-a310-bf3f625d9893" xlink:to="loc_us-gaap_SegmentDomain_cd409072-42f0-4caa-9b40-0630116edf93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateAndOtherMember_303d27a3-d1e0-4887-bb30-c71d594545ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateAndOtherMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_cd409072-42f0-4caa-9b40-0630116edf93" xlink:to="loc_us-gaap_CorporateAndOtherMember_303d27a3-d1e0-4887-bb30-c71d594545ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NourishMember_8478025a-745a-4511-8e2a-d0851e8c066b" xlink:href="iff-20231231.xsd#iff_NourishMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_cd409072-42f0-4caa-9b40-0630116edf93" xlink:to="loc_iff_NourishMember_8478025a-745a-4511-8e2a-d0851e8c066b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_HealthBiosciencesMember_0b1bd960-2330-4e18-bb24-a0db7307da87" xlink:href="iff-20231231.xsd#iff_HealthBiosciencesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_cd409072-42f0-4caa-9b40-0630116edf93" xlink:to="loc_iff_HealthBiosciencesMember_0b1bd960-2330-4e18-bb24-a0db7307da87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ScentMember_f0e04342-b082-4202-b087-d8e564b2eabf" xlink:href="iff-20231231.xsd#iff_ScentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_cd409072-42f0-4caa-9b40-0630116edf93" xlink:to="loc_iff_ScentMember_f0e04342-b082-4202-b087-d8e564b2eabf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_PharmaSolutionsMember_f83920dd-6852-490f-9ffe-16d1a620b7f5" xlink:href="iff-20231231.xsd#iff_PharmaSolutionsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_cd409072-42f0-4caa-9b40-0630116edf93" xlink:to="loc_iff_PharmaSolutionsMember_f83920dd-6852-490f-9ffe-16d1a620b7f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2cf2cf60-9122-489e-96d5-a576f75bd638" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_9e4aa7bd-c66e-44c6-9c94-8f2255052b8b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_us-gaap_Assets_9e4aa7bd-c66e-44c6-9c94-8f2255052b8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_OperatingEBITDAMargin_53092df8-d109-49d1-aff5-c7ed88552ed4" xlink:href="iff-20231231.xsd#iff_OperatingEBITDAMargin"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_iff_OperatingEBITDAMargin_53092df8-d109-49d1-aff5-c7ed88552ed4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_6ab67462-dc3c-4467-95b1-192af3b3cfaa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_6ab67462-dc3c-4467-95b1-192af3b3cfaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_9c92d68e-ffd1-44f2-a33f-dafb1b4c2553" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_9c92d68e-ffd1-44f2-a33f-dafb1b4c2553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a4c6e1a1-9b72-40a9-9832-751f2eed6171" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a4c6e1a1-9b72-40a9-9832-751f2eed6171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_e389b87b-de3b-4bf7-99ab-1ece26b6b9e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_e389b87b-de3b-4bf7-99ab-1ece26b6b9e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ReserveforTaxAssessment_2c9f0178-ba7c-4a81-8514-e0e9220efb65" xlink:href="iff-20231231.xsd#iff_ReserveforTaxAssessment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_iff_ReserveforTaxAssessment_2c9f0178-ba7c-4a81-8514-e0e9220efb65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_d12b6e97-a7fa-4ef5-a028-5d53b66a2b2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_us-gaap_RestructuringCharges_d12b6e97-a7fa-4ef5-a028-5d53b66a2b2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_d371fe89-9d30-4ce0-8923-7c9b32a098d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_d371fe89-9d30-4ce0-8923-7c9b32a098d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_72a6adad-bc3d-4108-a14a-f21ad9b223f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_us-gaap_SeveranceCosts1_72a6adad-bc3d-4108-a14a-f21ad9b223f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionExpense_3eb381d2-f450-4fed-9c2f-504511c63072" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_us-gaap_PensionExpense_3eb381d2-f450-4fed-9c2f-504511c63072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_80f2cee9-1988-435a-96b1-16d6d6a8fca5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_us-gaap_InterestExpense_80f2cee9-1988-435a-96b1-16d6d6a8fca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_628f769b-7120-485d-897c-0df91845746f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_628f769b-7120-485d-897c-0df91845746f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_75238993-7b32-4162-af0e-493f5a714c4c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_75238993-7b32-4162-af0e-493f5a714c4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_f1efdb83-009b-4a09-b70a-0ee16b68a802" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_us-gaap_AdjustmentForAmortization_f1efdb83-009b-4a09-b70a-0ee16b68a802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_67da8a7d-3f36-4087-b327-a76fbdf52438" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_67da8a7d-3f36-4087-b327-a76fbdf52438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalFees_8427ec64-eee1-4b4f-bf17-634441cd03de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LegalFees"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_us-gaap_LegalFees_8427ec64-eee1-4b4f-bf17-634441cd03de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b0829ee0-2aa5-4506-b281-c37f6420184e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b0829ee0-2aa5-4506-b281-c37f6420184e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SegmentAdjustedOperatingEBITDA_f01a50ff-ded9-402c-a9f8-a00117f28390" xlink:href="iff-20231231.xsd#iff_SegmentAdjustedOperatingEBITDA"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_iff_SegmentAdjustedOperatingEBITDA_f01a50ff-ded9-402c-a9f8-a00117f28390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareholderActivismRelatedCosts_02ff9b98-021d-48be-80eb-b6d3a38911df" xlink:href="iff-20231231.xsd#iff_ShareholderActivismRelatedCosts"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_iff_ShareholderActivismRelatedCosts_02ff9b98-021d-48be-80eb-b6d3a38911df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BusinessDivestitureCosts_e3cdb964-81b8-4574-b45b-b43ec42ab813" xlink:href="iff-20231231.xsd#iff_BusinessDivestitureCosts"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_iff_BusinessDivestitureCosts_e3cdb964-81b8-4574-b45b-b43ec42ab813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BusinessCombinationInventoryStepUpCosts_1a42178b-21fd-4258-bf83-9fb81b08e986" xlink:href="iff-20231231.xsd#iff_BusinessCombinationInventoryStepUpCosts"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_iff_BusinessCombinationInventoryStepUpCosts_1a42178b-21fd-4258-bf83-9fb81b08e986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization_6bb4093d-aee0-42d4-a714-cd1f3a52890b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_us-gaap_OtherDepreciationAndAmortization_6bb4093d-aee0-42d4-a714-cd1f3a52890b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_cdaf2f9b-9470-4ca9-aee3-011654734a4b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_cdaf2f9b-9470-4ca9-aee3-011654734a4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_1e84783a-ce51-45b1-bcd9-5c28d622e504" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_1e84783a-ce51-45b1-bcd9-5c28d622e504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_GlobalSharedServicesImplementationCosts_10ca72d2-bf65-4a24-a9db-60a82145e9db" xlink:href="iff-20231231.xsd#iff_GlobalSharedServicesImplementationCosts"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_76159734-3cd5-4237-a054-d44c85a62270" xlink:to="loc_iff_GlobalSharedServicesImplementationCosts_10ca72d2-bf65-4a24-a9db-60a82145e9db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/SegmentInformationCapitalExpenditureandDepreciationandAmortizationbySegmentDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#SegmentInformationCapitalExpenditureandDepreciationandAmortizationbySegmentDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/SegmentInformationCapitalExpenditureandDepreciationandAmortizationbySegmentDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_3634d93d-a5ac-4a7a-bdae-70e1d9a5f16b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fda012af-6caa-42c5-88e0-fb833c40ac1e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_3634d93d-a5ac-4a7a-bdae-70e1d9a5f16b" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fda012af-6caa-42c5-88e0-fb833c40ac1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_7b341d40-03fb-4c57-ab4b-4d771e47e453" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fda012af-6caa-42c5-88e0-fb833c40ac1e" xlink:to="loc_srt_ConsolidationItemsAxis_7b341d40-03fb-4c57-ab4b-4d771e47e453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_a767ab4c-5aa8-4d52-bfce-198c3f70a556" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_7b341d40-03fb-4c57-ab4b-4d771e47e453" xlink:to="loc_srt_ConsolidationItemsDomain_a767ab4c-5aa8-4d52-bfce-198c3f70a556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_c15b4c48-ce46-45e9-bed8-1bacc44c038d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_a767ab4c-5aa8-4d52-bfce-198c3f70a556" xlink:to="loc_us-gaap_OperatingSegmentsMember_c15b4c48-ce46-45e9-bed8-1bacc44c038d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_1944ac41-08b8-402c-89d3-d72262b4aa59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_a767ab4c-5aa8-4d52-bfce-198c3f70a556" xlink:to="loc_us-gaap_CorporateNonSegmentMember_1944ac41-08b8-402c-89d3-d72262b4aa59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_01ca9903-94a9-4920-a870-dc6cacbe4e38" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fda012af-6caa-42c5-88e0-fb833c40ac1e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_01ca9903-94a9-4920-a870-dc6cacbe4e38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e3abd2aa-fd53-4ffc-a632-caf45015b12e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_01ca9903-94a9-4920-a870-dc6cacbe4e38" xlink:to="loc_us-gaap_SegmentDomain_e3abd2aa-fd53-4ffc-a632-caf45015b12e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FlavorsMember_e02b41cf-6136-42ac-9381-47ced5c49616" xlink:href="iff-20231231.xsd#iff_FlavorsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e3abd2aa-fd53-4ffc-a632-caf45015b12e" xlink:to="loc_iff_FlavorsMember_e02b41cf-6136-42ac-9381-47ced5c49616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FragrancesMember_f167d085-4476-4ae0-bb58-0b4663277cc1" xlink:href="iff-20231231.xsd#iff_FragrancesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e3abd2aa-fd53-4ffc-a632-caf45015b12e" xlink:to="loc_iff_FragrancesMember_f167d085-4476-4ae0-bb58-0b4663277cc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NourishMember_6584c1f1-c484-4acc-a26d-69d39bb161ef" xlink:href="iff-20231231.xsd#iff_NourishMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e3abd2aa-fd53-4ffc-a632-caf45015b12e" xlink:to="loc_iff_NourishMember_6584c1f1-c484-4acc-a26d-69d39bb161ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_HealthBiosciencesMember_d1f69ee0-69a5-475d-b915-4865791cec43" xlink:href="iff-20231231.xsd#iff_HealthBiosciencesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e3abd2aa-fd53-4ffc-a632-caf45015b12e" xlink:to="loc_iff_HealthBiosciencesMember_d1f69ee0-69a5-475d-b915-4865791cec43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ScentMember_3a9a378d-225e-4922-8c92-6e22d64216aa" xlink:href="iff-20231231.xsd#iff_ScentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e3abd2aa-fd53-4ffc-a632-caf45015b12e" xlink:to="loc_iff_ScentMember_3a9a378d-225e-4922-8c92-6e22d64216aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_PharmaSolutionsMember_1a444a0c-cd65-4ca9-98bc-7b2aa841e00e" xlink:href="iff-20231231.xsd#iff_PharmaSolutionsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e3abd2aa-fd53-4ffc-a632-caf45015b12e" xlink:to="loc_iff_PharmaSolutionsMember_1a444a0c-cd65-4ca9-98bc-7b2aa841e00e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_232f2578-0a0e-49c3-ad6e-3fb1d4d03a45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fda012af-6caa-42c5-88e0-fb833c40ac1e" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_232f2578-0a0e-49c3-ad6e-3fb1d4d03a45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentExpenditureAdditionToLongLivedAssets_512adb2a-410e-4fc9-b8ea-1e0e3affc119" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentExpenditureAdditionToLongLivedAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_232f2578-0a0e-49c3-ad6e-3fb1d4d03a45" xlink:to="loc_us-gaap_SegmentExpenditureAdditionToLongLivedAssets_512adb2a-410e-4fc9-b8ea-1e0e3affc119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_b4be2309-b0e1-4678-9877-8613c294c2dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_232f2578-0a0e-49c3-ad6e-3fb1d4d03a45" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_b4be2309-b0e1-4678-9877-8613c294c2dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/SegmentInformationNetSalesbyGeographicAreaDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#SegmentInformationNetSalesbyGeographicAreaDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/SegmentInformationNetSalesbyGeographicAreaDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_686d66eb-4d51-4e25-9aef-1ab83b7c40b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_eda64eee-ed1c-440e-b788-bfb64c12845d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_686d66eb-4d51-4e25-9aef-1ab83b7c40b2" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_eda64eee-ed1c-440e-b788-bfb64c12845d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionAxis_2466c8e5-0922-407e-817d-8a79219d590a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_eda64eee-ed1c-440e-b788-bfb64c12845d" xlink:to="loc_us-gaap_GeographicDistributionAxis_2466c8e5-0922-407e-817d-8a79219d590a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomain_d10adbfc-c7c9-45c3-bc4e-787aa9b5295e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeographicDistributionAxis_2466c8e5-0922-407e-817d-8a79219d590a" xlink:to="loc_us-gaap_GeographicDistributionDomain_d10adbfc-c7c9-45c3-bc4e-787aa9b5295e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomesticMember_d298b228-0bc1-4a8c-ac70-ab6d7a770c3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionDomesticMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeographicDistributionDomain_d10adbfc-c7c9-45c3-bc4e-787aa9b5295e" xlink:to="loc_us-gaap_GeographicDistributionDomesticMember_d298b228-0bc1-4a8c-ac70-ab6d7a770c3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionForeignMember_c02cb25d-d7ee-4900-93ca-8abe2faa76ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionForeignMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeographicDistributionDomain_d10adbfc-c7c9-45c3-bc4e-787aa9b5295e" xlink:to="loc_us-gaap_GeographicDistributionForeignMember_c02cb25d-d7ee-4900-93ca-8abe2faa76ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_c75aba80-83b4-4458-9e58-519eaed30907" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_eda64eee-ed1c-440e-b788-bfb64c12845d" xlink:to="loc_srt_StatementGeographicalAxis_c75aba80-83b4-4458-9e58-519eaed30907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_9fa0f9e7-b8ab-4afe-8ef5-17029251e1ed" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_c75aba80-83b4-4458-9e58-519eaed30907" xlink:to="loc_srt_SegmentGeographicalDomain_9fa0f9e7-b8ab-4afe-8ef5-17029251e1ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_3c1df8a7-e79f-4802-8f41-896060a5a346" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EMEAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_9fa0f9e7-b8ab-4afe-8ef5-17029251e1ed" xlink:to="loc_us-gaap_EMEAMember_3c1df8a7-e79f-4802-8f41-896060a5a346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaMember_f63ca314-1ef2-48d5-885d-c0ea697f82fb" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AsiaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_9fa0f9e7-b8ab-4afe-8ef5-17029251e1ed" xlink:to="loc_srt_AsiaMember_f63ca314-1ef2-48d5-885d-c0ea697f82fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NorthAmericaMember_9bb6c208-22f8-4620-9d0b-329fbcaacd13" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NorthAmericaMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_9fa0f9e7-b8ab-4afe-8ef5-17029251e1ed" xlink:to="loc_srt_NorthAmericaMember_9bb6c208-22f8-4620-9d0b-329fbcaacd13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LatinAmericaMember_74929eb7-1598-4908-9ad7-c5fb11df7bb4" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LatinAmericaMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_9fa0f9e7-b8ab-4afe-8ef5-17029251e1ed" xlink:to="loc_srt_LatinAmericaMember_74929eb7-1598-4908-9ad7-c5fb11df7bb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_231eff14-0e57-4c23-9852-2779a779c9ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_eda64eee-ed1c-440e-b788-bfb64c12845d" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_231eff14-0e57-4c23-9852-2779a779c9ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b3f776fb-a776-4d5c-98c8-1e2135c893b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_231eff14-0e57-4c23-9852-2779a779c9ed" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b3f776fb-a776-4d5c-98c8-1e2135c893b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/SegmentInformationSegmentInformationScheduleofLongLivedAssetsDetails" xlink:type="simple" xlink:href="iff-20231231.xsd#SegmentInformationSegmentInformationScheduleofLongLivedAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/SegmentInformationSegmentInformationScheduleofLongLivedAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_a382f2d0-ad1c-49a8-8e3f-c87d53c9668f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_e2b80791-77e3-4154-9446-e7a12bbd106e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a382f2d0-ad1c-49a8-8e3f-c87d53c9668f" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_e2b80791-77e3-4154-9446-e7a12bbd106e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_96293630-ed6f-4cf3-9d19-f3565d1366c1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_e2b80791-77e3-4154-9446-e7a12bbd106e" xlink:to="loc_srt_StatementGeographicalAxis_96293630-ed6f-4cf3-9d19-f3565d1366c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_4db1c422-b22b-40e6-bd0e-c8204ed912fe" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_96293630-ed6f-4cf3-9d19-f3565d1366c1" xlink:to="loc_srt_SegmentGeographicalDomain_4db1c422-b22b-40e6-bd0e-c8204ed912fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_20d39c33-fbc9-4662-ab2f-e87a9b2c4297" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_4db1c422-b22b-40e6-bd0e-c8204ed912fe" xlink:to="loc_country_US_20d39c33-fbc9-4662-ab2f-e87a9b2c4297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_NL_1a4bd724-f979-4073-bb95-28b991017588" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_NL"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_4db1c422-b22b-40e6-bd0e-c8204ed912fe" xlink:to="loc_country_NL_1a4bd724-f979-4073-bb95-28b991017588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_SG_bb7ed0a1-02f7-4e67-9196-52b0ce44156e" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_SG"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_4db1c422-b22b-40e6-bd0e-c8204ed912fe" xlink:to="loc_country_SG_bb7ed0a1-02f7-4e67-9196-52b0ce44156e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN_a679b6ac-cc51-4b79-b90d-d9afb0ce09ad" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CN"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_4db1c422-b22b-40e6-bd0e-c8204ed912fe" xlink:to="loc_country_CN_a679b6ac-cc51-4b79-b90d-d9afb0ce09ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_OtherCountriesMember_37b51212-965a-49f2-9b0c-b9246bd47ffb" xlink:href="iff-20231231.xsd#iff_OtherCountriesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_4db1c422-b22b-40e6-bd0e-c8204ed912fe" xlink:to="loc_iff_OtherCountriesMember_37b51212-965a-49f2-9b0c-b9246bd47ffb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_DK_d212b802-ad8d-4814-a326-d0e27a499e4d" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_DK"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_4db1c422-b22b-40e6-bd0e-c8204ed912fe" xlink:to="loc_country_DK_d212b802-ad8d-4814-a326-d0e27a499e4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FI_a6678bb7-c562-4fe0-ab84-8ffc0ebe5535" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_FI"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_4db1c422-b22b-40e6-bd0e-c8204ed912fe" xlink:to="loc_country_FI_a6678bb7-c562-4fe0-ab84-8ffc0ebe5535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_3b79f95f-0f5a-4adc-8637-ddb5d02db687" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_FR"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_4db1c422-b22b-40e6-bd0e-c8204ed912fe" xlink:to="loc_country_FR_3b79f95f-0f5a-4adc-8637-ddb5d02db687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE_817abb1c-55dd-47c2-8c70-547c98af1f54" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_DE"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_4db1c422-b22b-40e6-bd0e-c8204ed912fe" xlink:to="loc_country_DE_817abb1c-55dd-47c2-8c70-547c98af1f54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_eb214732-7d88-422e-a6b7-b242ac63607f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_e2b80791-77e3-4154-9446-e7a12bbd106e" xlink:to="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_eb214732-7d88-422e-a6b7-b242ac63607f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_3e042b17-fa4d-44b9-870b-c8b9b147dca9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_eb214732-7d88-422e-a6b7-b242ac63607f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_3e042b17-fa4d-44b9-870b-c8b9b147dca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#EmployeeBenefitsAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_fa96c499-233f-4258-bc97-791a0c634210" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_32f6e4ba-4f2a-4351-9e64-81dfd1920073" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_fa96c499-233f-4258-bc97-791a0c634210" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_32f6e4ba-4f2a-4351-9e64-81dfd1920073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_70bba82e-d117-41ab-995e-bcdb49037613" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_32f6e4ba-4f2a-4351-9e64-81dfd1920073" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_70bba82e-d117-41ab-995e-bcdb49037613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_8e1cfe64-6bd4-410b-b512-1cd3f8783cc4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_70bba82e-d117-41ab-995e-bcdb49037613" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_8e1cfe64-6bd4-410b-b512-1cd3f8783cc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_72dfd6df-104d-4735-b195-cf876903950f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_8e1cfe64-6bd4-410b-b512-1cd3f8783cc4" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_72dfd6df-104d-4735-b195-cf876903950f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_e00e2552-dbbe-484c-b1fa-78dda41d5a13" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_8e1cfe64-6bd4-410b-b512-1cd3f8783cc4" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_e00e2552-dbbe-484c-b1fa-78dda41d5a13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_fd2f3ecf-a0ce-4bdf-b594-3cb84cdb94d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_32f6e4ba-4f2a-4351-9e64-81dfd1920073" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_fd2f3ecf-a0ce-4bdf-b594-3cb84cdb94d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_728ace2f-67ee-4995-bef6-a60f38bcb31c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_fd2f3ecf-a0ce-4bdf-b594-3cb84cdb94d8" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_728ace2f-67ee-4995-bef6-a60f38bcb31c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_8a212402-0a66-4630-9ec7-977d92e8cbd4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_728ace2f-67ee-4995-bef6-a60f38bcb31c" xlink:to="loc_us-gaap_DomesticPlanMember_8a212402-0a66-4630-9ec7-977d92e8cbd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_461b79ee-9e7f-4ba9-ae0d-71df7755a66b" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_8a212402-0a66-4630-9ec7-977d92e8cbd4" xlink:to="loc_country_US_461b79ee-9e7f-4ba9-ae0d-71df7755a66b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_a7b75108-38ce-435f-a079-273ca95d8308" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_728ace2f-67ee-4995-bef6-a60f38bcb31c" xlink:to="loc_us-gaap_ForeignPlanMember_a7b75108-38ce-435f-a079-273ca95d8308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTaxStatusAxis_0a30e2bf-7ea8-4f0a-a5fc-2dd051354710" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTaxStatusAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_32f6e4ba-4f2a-4351-9e64-81dfd1920073" xlink:to="loc_us-gaap_RetirementPlanTaxStatusAxis_0a30e2bf-7ea8-4f0a-a5fc-2dd051354710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTaxStatusDomain_f29885e3-16d4-4eaf-8ff1-a7d264b1efc9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTaxStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTaxStatusAxis_0a30e2bf-7ea8-4f0a-a5fc-2dd051354710" xlink:to="loc_us-gaap_RetirementPlanTaxStatusDomain_f29885e3-16d4-4eaf-8ff1-a7d264b1efc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QualifiedPlanMember_b118e4e0-dbb1-45c6-b93e-30f2c10ce6fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_QualifiedPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTaxStatusDomain_f29885e3-16d4-4eaf-8ff1-a7d264b1efc9" xlink:to="loc_us-gaap_QualifiedPlanMember_b118e4e0-dbb1-45c6-b93e-30f2c10ce6fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonqualifiedPlanMember_4ceb79f7-0df7-46c3-adf6-a0f770b3673d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonqualifiedPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTaxStatusDomain_f29885e3-16d4-4eaf-8ff1-a7d264b1efc9" xlink:to="loc_us-gaap_NonqualifiedPlanMember_4ceb79f7-0df7-46c3-adf6-a0f770b3673d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis_ea1d94ab-cb21-498a-b8e4-98e2a661dfd4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_32f6e4ba-4f2a-4351-9e64-81dfd1920073" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis_ea1d94ab-cb21-498a-b8e4-98e2a661dfd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain_1543dabb-d352-4722-b3d5-7114229e4295" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis_ea1d94ab-cb21-498a-b8e4-98e2a661dfd4" xlink:to="loc_us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain_1543dabb-d352-4722-b3d5-7114229e4295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualByTypeOfCompensationPensionAndOtherPostretirementBenefitsMember_78293f5e-e343-4e33-8228-4599bd02d846" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCompensationArrangementWithIndividualByTypeOfCompensationPensionAndOtherPostretirementBenefitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain_1543dabb-d352-4722-b3d5-7114229e4295" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualByTypeOfCompensationPensionAndOtherPostretirementBenefitsMember_78293f5e-e343-4e33-8228-4599bd02d846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_a5543404-da59-4cc1-966f-f146bbee39a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_32f6e4ba-4f2a-4351-9e64-81dfd1920073" xlink:to="loc_us-gaap_FinancialInstrumentAxis_a5543404-da59-4cc1-966f-f146bbee39a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4461086c-c225-4be9-b9fe-c3fb2de43f45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a5543404-da59-4cc1-966f-f146bbee39a7" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4461086c-c225-4be9-b9fe-c3fb2de43f45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_f8501a2b-630b-47df-b3d1-e409e1dd8fdf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4461086c-c225-4be9-b9fe-c3fb2de43f45" xlink:to="loc_us-gaap_EquitySecuritiesMember_f8501a2b-630b-47df-b3d1-e409e1dd8fdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember_2ff09106-0964-408b-b648-4bc68c4d2804" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4461086c-c225-4be9-b9fe-c3fb2de43f45" xlink:to="loc_us-gaap_FixedIncomeSecuritiesMember_2ff09106-0964-408b-b648-4bc68c4d2804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AlternativeTypeOfInvestmentsMember_7494b03a-8055-4f9b-96e3-82d129305393" xlink:href="iff-20231231.xsd#iff_AlternativeTypeOfInvestmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4461086c-c225-4be9-b9fe-c3fb2de43f45" xlink:to="loc_iff_AlternativeTypeOfInvestmentsMember_7494b03a-8055-4f9b-96e3-82d129305393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_510bb73e-992b-4e8c-a4a2-e78954723ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_32f6e4ba-4f2a-4351-9e64-81dfd1920073" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_510bb73e-992b-4e8c-a4a2-e78954723ccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_863d27df-bfa6-440b-be6d-475c37a62a33" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_510bb73e-992b-4e8c-a4a2-e78954723ccf" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_863d27df-bfa6-440b-be6d-475c37a62a33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedBenefitPlanAssetsCategoryMember_07f854d9-de9e-4711-93bf-7a4130bfbe4a" xlink:href="iff-20231231.xsd#iff_DefinedBenefitPlanAssetsCategoryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_863d27df-bfa6-440b-be6d-475c37a62a33" xlink:to="loc_iff_DefinedBenefitPlanAssetsCategoryMember_07f854d9-de9e-4711-93bf-7a4130bfbe4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateMember_ec65f68d-db11-4d73-aad9-eb3561aee0fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealEstateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_07f854d9-de9e-4711-93bf-7a4130bfbe4a" xlink:to="loc_us-gaap_RealEstateMember_ec65f68d-db11-4d73-aad9-eb3561aee0fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b9f1fbc1-e4b5-44ef-87df-23b3a62ca944" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_32f6e4ba-4f2a-4351-9e64-81dfd1920073" xlink:to="loc_srt_RangeAxis_b9f1fbc1-e4b5-44ef-87df-23b3a62ca944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_47e3ac63-e6bb-4157-9667-53b0a0b63d0d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_b9f1fbc1-e4b5-44ef-87df-23b3a62ca944" xlink:to="loc_srt_RangeMember_47e3ac63-e6bb-4157-9667-53b0a0b63d0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e792eb4f-61b4-469c-9710-3adb192e41ae" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_47e3ac63-e6bb-4157-9667-53b0a0b63d0d" xlink:to="loc_srt_MinimumMember_e792eb4f-61b4-469c-9710-3adb192e41ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e623e154-ba88-4327-93dd-91da3ec90b64" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_47e3ac63-e6bb-4157-9667-53b0a0b63d0d" xlink:to="loc_srt_MaximumMember_e623e154-ba88-4327-93dd-91da3ec90b64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_7466a3ba-6389-4977-9335-7601161af923" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_32f6e4ba-4f2a-4351-9e64-81dfd1920073" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_7466a3ba-6389-4977-9335-7601161af923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_17c3f248-f7f2-45bb-b868-a57387baacb2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7466a3ba-6389-4977-9335-7601161af923" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_17c3f248-f7f2-45bb-b868-a57387baacb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NutritionBiosciencesIncMember_2f6313e0-8a94-4fa0-a9c1-8f9f3dfd9c40" xlink:href="iff-20231231.xsd#iff_NutritionBiosciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_17c3f248-f7f2-45bb-b868-a57387baacb2" xlink:to="loc_iff_NutritionBiosciencesIncMember_2f6313e0-8a94-4fa0-a9c1-8f9f3dfd9c40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_951bcb36-d748-430d-8703-12d66e44ff3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_32f6e4ba-4f2a-4351-9e64-81dfd1920073" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_951bcb36-d748-430d-8703-12d66e44ff3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_285c078d-a167-46ff-b1a4-cd9a0da55f11" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_951bcb36-d748-430d-8703-12d66e44ff3b" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_285c078d-a167-46ff-b1a4-cd9a0da55f11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BusinessCombinationDefinedBenefitPlanNumberOfPlansAssumed_45ac26ad-ebf8-4675-aa81-49881543c4a7" xlink:href="iff-20231231.xsd#iff_BusinessCombinationDefinedBenefitPlanNumberOfPlansAssumed"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_951bcb36-d748-430d-8703-12d66e44ff3b" xlink:to="loc_iff_BusinessCombinationDefinedBenefitPlanNumberOfPlansAssumed_45ac26ad-ebf8-4675-aa81-49881543c4a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBelowLowRange_b976f090-009a-41b2-8d4b-031f053ca269" xlink:href="iff-20231231.xsd#iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBelowLowRange"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_951bcb36-d748-430d-8703-12d66e44ff3b" xlink:to="loc_iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBelowLowRange_b976f090-009a-41b2-8d4b-031f053ca269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRange_92acb7be-58d4-4e52-b807-05035a7228f3" xlink:href="iff-20231231.xsd#iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRange"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_951bcb36-d748-430d-8703-12d66e44ff3b" xlink:to="loc_iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRange_92acb7be-58d4-4e52-b807-05035a7228f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBetweenHighRangeAndLowRange_2c4681af-3a82-4230-b2b9-2ba51ea50243" xlink:href="iff-20231231.xsd#iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBetweenHighRangeAndLowRange"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_951bcb36-d748-430d-8703-12d66e44ff3b" xlink:to="loc_iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBetweenHighRangeAndLowRange_2c4681af-3a82-4230-b2b9-2ba51ea50243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRangeLow_fa201154-3f1d-4cab-8763-98dae9512bb6" xlink:href="iff-20231231.xsd#iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRangeLow"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_951bcb36-d748-430d-8703-12d66e44ff3b" xlink:to="loc_iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRangeLow_fa201154-3f1d-4cab-8763-98dae9512bb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRangeHigh_448223be-9378-4fe1-ac62-9dfc03e12e39" xlink:href="iff-20231231.xsd#iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRangeHigh"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_951bcb36-d748-430d-8703-12d66e44ff3b" xlink:to="loc_iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRangeHigh_448223be-9378-4fe1-ac62-9dfc03e12e39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageReachesAverageRate_cb9240ed-45b0-4f49-b318-c27139144cbc" xlink:href="iff-20231231.xsd#iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageReachesAverageRate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_951bcb36-d748-430d-8703-12d66e44ff3b" xlink:to="loc_iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageReachesAverageRate_cb9240ed-45b0-4f49-b318-c27139144cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedContributionPlanMatchingParticipantContributionAveragePercentageOnCompensation_91b124ec-5c45-4279-b01f-6582a5e77886" xlink:href="iff-20231231.xsd#iff_DefinedContributionPlanMatchingParticipantContributionAveragePercentageOnCompensation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_951bcb36-d748-430d-8703-12d66e44ff3b" xlink:to="loc_iff_DefinedContributionPlanMatchingParticipantContributionAveragePercentageOnCompensation_91b124ec-5c45-4279-b01f-6582a5e77886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_92174740-0238-47d5-8d26-b06f2cdb4f36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_951bcb36-d748-430d-8703-12d66e44ff3b" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_92174740-0238-47d5-8d26-b06f2cdb4f36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AdjustmentsToAdditionalPaidInCapitalDeferredCompensation_ebf534a6-0d8a-4c0c-9149-3e61ba07e1c2" xlink:href="iff-20231231.xsd#iff_AdjustmentsToAdditionalPaidInCapitalDeferredCompensation"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_951bcb36-d748-430d-8703-12d66e44ff3b" xlink:to="loc_iff_AdjustmentsToAdditionalPaidInCapitalDeferredCompensation_ebf534a6-0d8a-4c0c-9149-3e61ba07e1c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueOfLifeInsurance_e20a45f9-f931-4ea5-ab19-ab0b78f5ee35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashSurrenderValueOfLifeInsurance"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_951bcb36-d748-430d-8703-12d66e44ff3b" xlink:to="loc_us-gaap_CashSurrenderValueOfLifeInsurance_e20a45f9-f931-4ea5-ab19-ab0b78f5ee35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_6c2109e6-3d32-4472-ab78-68815f72f45f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_951bcb36-d748-430d-8703-12d66e44ff3b" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_6c2109e6-3d32-4472-ab78-68815f72f45f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_dd549174-cd92-4d35-a24e-7b09453a20d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_951bcb36-d748-430d-8703-12d66e44ff3b" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_dd549174-cd92-4d35-a24e-7b09453a20d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_PercentageofActiveEmployeeswithPensionandorOtherRetirementBenefitPlansCovered_3824fe9a-e420-493c-ad6b-24be34a07c6c" xlink:href="iff-20231231.xsd#iff_PercentageofActiveEmployeeswithPensionandorOtherRetirementBenefitPlansCovered"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_951bcb36-d748-430d-8703-12d66e44ff3b" xlink:to="loc_iff_PercentageofActiveEmployeeswithPensionandorOtherRetirementBenefitPlansCovered_3824fe9a-e420-493c-ad6b-24be34a07c6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ad38fa3c-e14f-486b-92a8-8fd05989d7a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_26b523ff-e0a6-4b7d-ad5b-2f8066eac61c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ad38fa3c-e14f-486b-92a8-8fd05989d7a4" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_26b523ff-e0a6-4b7d-ad5b-2f8066eac61c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_28bcf87a-a966-4346-9539-0baaef7cfe9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_26b523ff-e0a6-4b7d-ad5b-2f8066eac61c" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_28bcf87a-a966-4346-9539-0baaef7cfe9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_2d681ef9-47e7-4cad-a7a4-f3dfffa7528e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_28bcf87a-a966-4346-9539-0baaef7cfe9f" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_2d681ef9-47e7-4cad-a7a4-f3dfffa7528e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_92085e14-ca78-4d95-ad03-8b27b4274665" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_2d681ef9-47e7-4cad-a7a4-f3dfffa7528e" xlink:to="loc_us-gaap_DomesticPlanMember_92085e14-ca78-4d95-ad03-8b27b4274665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_dd7c110a-ba72-4496-98d8-eea860e9536a" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_92085e14-ca78-4d95-ad03-8b27b4274665" xlink:to="loc_country_US_dd7c110a-ba72-4496-98d8-eea860e9536a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_53f0b286-29d0-4768-b7f1-7e6b466c9794" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_2d681ef9-47e7-4cad-a7a4-f3dfffa7528e" xlink:to="loc_us-gaap_ForeignPlanMember_53f0b286-29d0-4768-b7f1-7e6b466c9794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_ece965a3-4c7a-4e85-b23b-c5161a6a363c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_26b523ff-e0a6-4b7d-ad5b-2f8066eac61c" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_ece965a3-4c7a-4e85-b23b-c5161a6a363c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_e834b089-7e18-4f34-b2b9-55f677dda2c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_ece965a3-4c7a-4e85-b23b-c5161a6a363c" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_e834b089-7e18-4f34-b2b9-55f677dda2c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_ac43b593-ad54-4747-8e30-5b632f7ab975" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_e834b089-7e18-4f34-b2b9-55f677dda2c4" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_ac43b593-ad54-4747-8e30-5b632f7ab975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_f56b52da-124c-4655-881f-4cdcd09659f8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_26b523ff-e0a6-4b7d-ad5b-2f8066eac61c" xlink:to="loc_srt_RestatementAxis_f56b52da-124c-4655-881f-4cdcd09659f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_736dd8da-8a47-47ed-885f-b74107ce8ac7" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_f56b52da-124c-4655-881f-4cdcd09659f8" xlink:to="loc_srt_RestatementDomain_736dd8da-8a47-47ed-885f-b74107ce8ac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_468587b6-5a82-4cf7-b22b-a3307909e4d6" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_736dd8da-8a47-47ed-885f-b74107ce8ac7" xlink:to="loc_srt_RestatementAdjustmentMember_468587b6-5a82-4cf7-b22b-a3307909e4d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e7371a01-ddcc-466c-bdbf-0929a265a589" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_26b523ff-e0a6-4b7d-ad5b-2f8066eac61c" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e7371a01-ddcc-466c-bdbf-0929a265a589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_32ccc878-1442-4cb6-9274-46ff1d91c7f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e7371a01-ddcc-466c-bdbf-0929a265a589" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_32ccc878-1442-4cb6-9274-46ff1d91c7f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_718031d2-618d-4155-b8a5-1201a23c55a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e7371a01-ddcc-466c-bdbf-0929a265a589" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_718031d2-618d-4155-b8a5-1201a23c55a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_65efca0e-ce52-4223-ba8f-9c7c3542e934" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e7371a01-ddcc-466c-bdbf-0929a265a589" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_65efca0e-ce52-4223-ba8f-9c7c3542e934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedBenefitPlanAmortizationAndDeferralsNet_7d7d67c5-746d-497d-9cdf-3ea2c768d10f" xlink:href="iff-20231231.xsd#iff_DefinedBenefitPlanAmortizationAndDeferralsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e7371a01-ddcc-466c-bdbf-0929a265a589" xlink:to="loc_iff_DefinedBenefitPlanAmortizationAndDeferralsNet_7d7d67c5-746d-497d-9cdf-3ea2c768d10f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_b1b43691-5ead-4862-8600-5a7c2782a8ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e7371a01-ddcc-466c-bdbf-0929a265a589" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_b1b43691-5ead-4862-8600-5a7c2782a8ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_6e648d0e-f4d8-4225-ac6a-e2addee4b900" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e7371a01-ddcc-466c-bdbf-0929a265a589" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_6e648d0e-f4d8-4225-ac6a-e2addee4b900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedContributionAndOtherRetirementPlans_a00a8a23-e101-466b-974c-eaf08aa382cb" xlink:href="iff-20231231.xsd#iff_DefinedContributionAndOtherRetirementPlans"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e7371a01-ddcc-466c-bdbf-0929a265a589" xlink:to="loc_iff_DefinedContributionAndOtherRetirementPlans_a00a8a23-e101-466b-974c-eaf08aa382cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitExpense_bbedf437-3d43-405f-b848-9894d5cee5b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementBenefitExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e7371a01-ddcc-466c-bdbf-0929a265a589" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitExpense_bbedf437-3d43-405f-b848-9894d5cee5b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax_2c77e0c3-254d-43b4-a555-61a907f65c94" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e7371a01-ddcc-466c-bdbf-0929a265a589" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax_2c77e0c3-254d-43b4-a555-61a907f65c94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_11765eb6-44b9-40f5-91fd-1b7f6be30af0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e7371a01-ddcc-466c-bdbf-0929a265a589" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_11765eb6-44b9-40f5-91fd-1b7f6be30af0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_5121d4e2-ad0f-4eba-ba3e-5ede36394803" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e7371a01-ddcc-466c-bdbf-0929a265a589" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_5121d4e2-ad0f-4eba-ba3e-5ede36394803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax_cf3a30a1-01ad-4236-8526-2a145edae085" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e7371a01-ddcc-466c-bdbf-0929a265a589" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax_cf3a30a1-01ad-4236-8526-2a145edae085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_8821ae4e-b9df-4808-b11a-b853f8dd1045" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e7371a01-ddcc-466c-bdbf-0929a265a589" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_8821ae4e-b9df-4808-b11a-b853f8dd1045" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_e287f5e4-f3a3-4691-91a9-2981e01fa57f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e7371a01-ddcc-466c-bdbf-0929a265a589" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_e287f5e4-f3a3-4691-91a9-2981e01fa57f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostandChangesinPlanAssetsandBenefitObligationsRecognizedinOCIDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#EmployeeBenefitsComponentsofNetPeriodicBenefitCostandChangesinPlanAssetsandBenefitObligationsRecognizedinOCIDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostandChangesinPlanAssetsandBenefitObligationsRecognizedinOCIDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_35f0681d-9e66-4c06-bbbb-07ac427ab0d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a8fad96d-ad58-4530-9970-8517abc04507" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_35f0681d-9e66-4c06-bbbb-07ac427ab0d9" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a8fad96d-ad58-4530-9970-8517abc04507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_05fe91a1-2e5e-46b6-8be6-04c945526e11" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a8fad96d-ad58-4530-9970-8517abc04507" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_05fe91a1-2e5e-46b6-8be6-04c945526e11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_8bb0f110-7868-4e93-a678-bd6eb9f4e371" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_05fe91a1-2e5e-46b6-8be6-04c945526e11" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_8bb0f110-7868-4e93-a678-bd6eb9f4e371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_8df86486-3964-4ee3-b691-2c87916ac1e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_8bb0f110-7868-4e93-a678-bd6eb9f4e371" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_8df86486-3964-4ee3-b691-2c87916ac1e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5e4a0c03-bed5-4b9c-ac31-d25c902434ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a8fad96d-ad58-4530-9970-8517abc04507" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5e4a0c03-bed5-4b9c-ac31-d25c902434ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_ae9e7293-9ad6-4088-9e6b-839609b0b58c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5e4a0c03-bed5-4b9c-ac31-d25c902434ce" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_ae9e7293-9ad6-4088-9e6b-839609b0b58c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_141ba3e1-10e4-447a-bc1a-d9eaee18bfa4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5e4a0c03-bed5-4b9c-ac31-d25c902434ce" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_141ba3e1-10e4-447a-bc1a-d9eaee18bfa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedBenefitPlanAmortizationAndDeferralsNet_91de4ff9-798a-42be-903a-9cd756899235" xlink:href="iff-20231231.xsd#iff_DefinedBenefitPlanAmortizationAndDeferralsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5e4a0c03-bed5-4b9c-ac31-d25c902434ce" xlink:to="loc_iff_DefinedBenefitPlanAmortizationAndDeferralsNet_91de4ff9-798a-42be-903a-9cd756899235" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_a321640f-5c5a-4c16-83fe-b1b5b0f13b78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5e4a0c03-bed5-4b9c-ac31-d25c902434ce" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_a321640f-5c5a-4c16-83fe-b1b5b0f13b78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax_5af93cd3-a6c9-4c78-94ff-2f5245ac7d62" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5e4a0c03-bed5-4b9c-ac31-d25c902434ce" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax_5af93cd3-a6c9-4c78-94ff-2f5245ac7d62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_653e8a15-bb18-49c9-babe-259aad75cb84" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5e4a0c03-bed5-4b9c-ac31-d25c902434ce" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_653e8a15-bb18-49c9-babe-259aad75cb84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_0426ad25-86ae-40e4-8d8f-f95de186a5a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5e4a0c03-bed5-4b9c-ac31-d25c902434ce" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_0426ad25-86ae-40e4-8d8f-f95de186a5a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_90b7c720-4b6d-4ac2-9672-fee4999e74b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5e4a0c03-bed5-4b9c-ac31-d25c902434ce" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_90b7c720-4b6d-4ac2-9672-fee4999e74b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/EmployeeBenefitsWeightedAverageActuarialAssumptionUsedtoDetermineExpenseDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#EmployeeBenefitsWeightedAverageActuarialAssumptionUsedtoDetermineExpenseDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/EmployeeBenefitsWeightedAverageActuarialAssumptionUsedtoDetermineExpenseDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_362caa13-2fbf-498f-b88f-1ad0a6da2938" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_dfbdd8d5-8e67-4c16-86e9-5f9b24e5731b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_362caa13-2fbf-498f-b88f-1ad0a6da2938" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_dfbdd8d5-8e67-4c16-86e9-5f9b24e5731b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_0f5de62a-2281-4f3e-9c1a-26e262e25619" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_dfbdd8d5-8e67-4c16-86e9-5f9b24e5731b" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_0f5de62a-2281-4f3e-9c1a-26e262e25619" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_df6ea7dd-8e3b-4b6e-b2d3-3c81fd888130" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_0f5de62a-2281-4f3e-9c1a-26e262e25619" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_df6ea7dd-8e3b-4b6e-b2d3-3c81fd888130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_9fd3e46a-cebe-4475-8740-393beaed53c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_df6ea7dd-8e3b-4b6e-b2d3-3c81fd888130" xlink:to="loc_us-gaap_DomesticPlanMember_9fd3e46a-cebe-4475-8740-393beaed53c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_a07f035d-28bd-4b58-a726-d1ca3011ae38" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_9fd3e46a-cebe-4475-8740-393beaed53c9" xlink:to="loc_country_US_a07f035d-28bd-4b58-a726-d1ca3011ae38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_4c050aac-5e3c-454c-a86c-a892ddba88ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_df6ea7dd-8e3b-4b6e-b2d3-3c81fd888130" xlink:to="loc_us-gaap_ForeignPlanMember_4c050aac-5e3c-454c-a86c-a892ddba88ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_d7d28685-ed81-4b1c-ad8c-fd90141ddb24" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_dfbdd8d5-8e67-4c16-86e9-5f9b24e5731b" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_d7d28685-ed81-4b1c-ad8c-fd90141ddb24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_e4bdd72a-a0c2-409c-9b35-b299960492e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_d7d28685-ed81-4b1c-ad8c-fd90141ddb24" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_e4bdd72a-a0c2-409c-9b35-b299960492e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_b6cb90e7-90b2-461a-a7a3-2ee8316e8684" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_e4bdd72a-a0c2-409c-9b35-b299960492e3" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_b6cb90e7-90b2-461a-a7a3-2ee8316e8684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_385cd0e9-3f49-4964-94d2-1c65f634515b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_dfbdd8d5-8e67-4c16-86e9-5f9b24e5731b" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_385cd0e9-3f49-4964-94d2-1c65f634515b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_f581dea1-6000-4b0b-9d00-fe9a890d1fcc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_385cd0e9-3f49-4964-94d2-1c65f634515b" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_f581dea1-6000-4b0b-9d00-fe9a890d1fcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_0a97a7c9-fd8c-4a1c-8f9b-8d82a2aca1ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_385cd0e9-3f49-4964-94d2-1c65f634515b" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_0a97a7c9-fd8c-4a1c-8f9b-8d82a2aca1ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_7803363f-a5e5-49c8-80f5-457e453a45b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_385cd0e9-3f49-4964-94d2-1c65f634515b" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_7803363f-a5e5-49c8-80f5-457e453a45b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_278b9bbe-a9ef-4ca0-a3d0-bb7bbfb071fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_da27d602-9aac-474b-8f12-446ef917aa53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_278b9bbe-a9ef-4ca0-a3d0-bb7bbfb071fd" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_da27d602-9aac-474b-8f12-446ef917aa53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_570f450e-3881-4d5f-9030-077d2cd1d985" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_da27d602-9aac-474b-8f12-446ef917aa53" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_570f450e-3881-4d5f-9030-077d2cd1d985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_5cc035b8-4bae-47ee-b239-a54a656e9f31" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_570f450e-3881-4d5f-9030-077d2cd1d985" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_5cc035b8-4bae-47ee-b239-a54a656e9f31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_fa6300ca-e1b4-46c5-b963-61a93b52604a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_5cc035b8-4bae-47ee-b239-a54a656e9f31" xlink:to="loc_us-gaap_DomesticPlanMember_fa6300ca-e1b4-46c5-b963-61a93b52604a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_07fad338-c19e-4e4f-abf3-c2700e46189b" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_fa6300ca-e1b4-46c5-b963-61a93b52604a" xlink:to="loc_country_US_07fad338-c19e-4e4f-abf3-c2700e46189b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_a83006ae-0b6f-4b7b-8626-38ba57b1fa5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_5cc035b8-4bae-47ee-b239-a54a656e9f31" xlink:to="loc_us-gaap_ForeignPlanMember_a83006ae-0b6f-4b7b-8626-38ba57b1fa5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_9678d72f-fc73-4d73-b463-e539d5fefd91" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_da27d602-9aac-474b-8f12-446ef917aa53" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_9678d72f-fc73-4d73-b463-e539d5fefd91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_f87c66b4-7c87-42eb-96a6-0b9c932d0174" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_9678d72f-fc73-4d73-b463-e539d5fefd91" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_f87c66b4-7c87-42eb-96a6-0b9c932d0174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_9de6bf21-3556-4a5d-ab7c-054ceb38ad8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_f87c66b4-7c87-42eb-96a6-0b9c932d0174" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_9de6bf21-3556-4a5d-ab7c-054ceb38ad8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_339f28de-6024-4ea1-b41f-7ffa968b0169" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_f87c66b4-7c87-42eb-96a6-0b9c932d0174" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_339f28de-6024-4ea1-b41f-7ffa968b0169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_ec115617-c02a-4001-9bd9-dcc33d1546f1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_da27d602-9aac-474b-8f12-446ef917aa53" xlink:to="loc_srt_RestatementAxis_ec115617-c02a-4001-9bd9-dcc33d1546f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_a0b0ed01-40d1-40e5-91ff-a515d6b21ee7" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_ec115617-c02a-4001-9bd9-dcc33d1546f1" xlink:to="loc_srt_RestatementDomain_a0b0ed01-40d1-40e5-91ff-a515d6b21ee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_b666ac60-399a-4fb1-b875-231dd764fbf5" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_a0b0ed01-40d1-40e5-91ff-a515d6b21ee7" xlink:to="loc_srt_RestatementAdjustmentMember_b666ac60-399a-4fb1-b875-231dd764fbf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_27e45024-c6d1-4b59-bcba-75328e7887e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_da27d602-9aac-474b-8f12-446ef917aa53" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_27e45024-c6d1-4b59-bcba-75328e7887e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_6e73f507-d8ae-4152-9224-ad738748b4dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_27e45024-c6d1-4b59-bcba-75328e7887e6" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_6e73f507-d8ae-4152-9224-ad738748b4dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_ba4fd693-770e-4437-a42b-d20c7853a212" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_6e73f507-d8ae-4152-9224-ad738748b4dc" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_ba4fd693-770e-4437-a42b-d20c7853a212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_6ec366e0-8f87-4921-9567-54c224ae6ca1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_6e73f507-d8ae-4152-9224-ad738748b4dc" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_6ec366e0-8f87-4921-9567-54c224ae6ca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_df91f3b7-4e05-4481-98e2-518573b1226e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_6e73f507-d8ae-4152-9224-ad738748b4dc" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_df91f3b7-4e05-4481-98e2-518573b1226e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_e7af6c7b-e2ef-4655-8fb0-3bea6d1526ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_6e73f507-d8ae-4152-9224-ad738748b4dc" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_e7af6c7b-e2ef-4655-8fb0-3bea6d1526ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAmendments_f6c8fab9-f82e-49fa-b9f0-0d723811c57f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPlanAmendments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_6e73f507-d8ae-4152-9224-ad738748b4dc" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAmendments_f6c8fab9-f82e-49fa-b9f0-0d723811c57f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedBenefitPlanAdjustmentsForExpenseOrTaxContainedInServiceCost_925b1fd7-0e61-45e6-9a6a-85bf72e6fb2b" xlink:href="iff-20231231.xsd#iff_DefinedBenefitPlanAdjustmentsForExpenseOrTaxContainedInServiceCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_6e73f507-d8ae-4152-9224-ad738748b4dc" xlink:to="loc_iff_DefinedBenefitPlanAdjustmentsForExpenseOrTaxContainedInServiceCost_925b1fd7-0e61-45e6-9a6a-85bf72e6fb2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_58c7dea9-66cd-474b-98ec-ea032cc473c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_6e73f507-d8ae-4152-9224-ad738748b4dc" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_58c7dea9-66cd-474b-98ec-ea032cc473c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_700f1162-8bf1-4ac8-b8e4-0696e22be167" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_6e73f507-d8ae-4152-9224-ad738748b4dc" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_700f1162-8bf1-4ac8-b8e4-0696e22be167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedBenefitPlanCurtailmentsAndSettlementsBenefitObligation_c504a6c9-51c1-4f05-ba27-da8c46b4cba8" xlink:href="iff-20231231.xsd#iff_DefinedBenefitPlanCurtailmentsAndSettlementsBenefitObligation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_6e73f507-d8ae-4152-9224-ad738748b4dc" xlink:to="loc_iff_DefinedBenefitPlanCurtailmentsAndSettlementsBenefitObligation_c504a6c9-51c1-4f05-ba27-da8c46b4cba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_ad9cf6e8-fa4e-4cba-91b7-5e48f8fa765c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_6e73f507-d8ae-4152-9224-ad738748b4dc" xlink:to="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_ad9cf6e8-fa4e-4cba-91b7-5e48f8fa765c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation_4a255194-5ad5-4213-9116-c67f7c6eb64a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_6e73f507-d8ae-4152-9224-ad738748b4dc" xlink:to="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation_4a255194-5ad5-4213-9116-c67f7c6eb64a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedBenefitPlanBenefitObligationOther_f038f2de-4471-4b0b-a369-63490137361c" xlink:href="iff-20231231.xsd#iff_DefinedBenefitPlanBenefitObligationOther"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_6e73f507-d8ae-4152-9224-ad738748b4dc" xlink:to="loc_iff_DefinedBenefitPlanBenefitObligationOther_f038f2de-4471-4b0b-a369-63490137361c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_28b02179-4f80-41c0-8e08-e92a8240d091" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_6e73f507-d8ae-4152-9224-ad738748b4dc" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_28b02179-4f80-41c0-8e08-e92a8240d091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_0df6b19d-264a-489a-8be0-228954dac8a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_27e45024-c6d1-4b59-bcba-75328e7887e6" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_0df6b19d-264a-489a-8be0-228954dac8a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_dee9f017-cd3c-40a5-8056-d20645a32981" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_0df6b19d-264a-489a-8be0-228954dac8a9" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_dee9f017-cd3c-40a5-8056-d20645a32981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_7a72b607-9a1e-4be4-895c-89a0c57895a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_0df6b19d-264a-489a-8be0-228954dac8a9" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_7a72b607-9a1e-4be4-895c-89a0c57895a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_e5292611-f8be-4d9a-b915-fda22144a7d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_0df6b19d-264a-489a-8be0-228954dac8a9" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_e5292611-f8be-4d9a-b915-fda22144a7d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_d5fb76d1-d280-43d2-a891-001acb13dd90" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_0df6b19d-264a-489a-8be0-228954dac8a9" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_d5fb76d1-d280-43d2-a891-001acb13dd90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_39e11114-0659-49f3-b77c-baf952b212a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_0df6b19d-264a-489a-8be0-228954dac8a9" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_39e11114-0659-49f3-b77c-baf952b212a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_cf2dd391-23be-40b8-9c0d-9200a63df781" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_0df6b19d-264a-489a-8be0-228954dac8a9" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_cf2dd391-23be-40b8-9c0d-9200a63df781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_fd9e3c7f-9b2f-40c0-9a93-56bd56847f62" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_0df6b19d-264a-489a-8be0-228954dac8a9" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_fd9e3c7f-9b2f-40c0-9a93-56bd56847f62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets_4c002bf9-6dce-4a5f-b713-69d5f405584e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_0df6b19d-264a-489a-8be0-228954dac8a9" xlink:to="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets_4c002bf9-6dce-4a5f-b713-69d5f405584e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedBenefitPlanPlanAssetsOther_96aaea65-f48d-469e-8ef9-a2aa66b3d2b2" xlink:href="iff-20231231.xsd#iff_DefinedBenefitPlanPlanAssetsOther"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_0df6b19d-264a-489a-8be0-228954dac8a9" xlink:to="loc_iff_DefinedBenefitPlanPlanAssetsOther_96aaea65-f48d-469e-8ef9-a2aa66b3d2b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_cfceb92e-ed22-4e1e-b25e-59547e41b089" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_0df6b19d-264a-489a-8be0-228954dac8a9" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_cfceb92e-ed22-4e1e-b25e-59547e41b089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_5fa63072-f480-46ba-8dd0-e36eb168cfe2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_27e45024-c6d1-4b59-bcba-75328e7887e6" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_5fa63072-f480-46ba-8dd0-e36eb168cfe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinBalanceSheetDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#EmployeeBenefitsAmountsRecognizedinBalanceSheetDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinBalanceSheetDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f9b7ef13-f783-4ac6-ae77-91a190f4fb74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ec62d093-ce4d-44e9-88b3-63919f1d22d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f9b7ef13-f783-4ac6-ae77-91a190f4fb74" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ec62d093-ce4d-44e9-88b3-63919f1d22d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_345895df-7e67-4c2e-9968-d5b76f1db1c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ec62d093-ce4d-44e9-88b3-63919f1d22d2" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_345895df-7e67-4c2e-9968-d5b76f1db1c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_2e31e464-0dbe-4b8a-8859-01174078b3c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_345895df-7e67-4c2e-9968-d5b76f1db1c2" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_2e31e464-0dbe-4b8a-8859-01174078b3c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_62a1616d-458f-4bc8-a051-cf3d28f3963a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_2e31e464-0dbe-4b8a-8859-01174078b3c9" xlink:to="loc_us-gaap_DomesticPlanMember_62a1616d-458f-4bc8-a051-cf3d28f3963a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_6a7c19dd-d601-41d1-96a6-9a854ba95deb" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_62a1616d-458f-4bc8-a051-cf3d28f3963a" xlink:to="loc_country_US_6a7c19dd-d601-41d1-96a6-9a854ba95deb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_4392f41c-9ec0-487e-8453-020e3fcd3371" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_2e31e464-0dbe-4b8a-8859-01174078b3c9" xlink:to="loc_us-gaap_ForeignPlanMember_4392f41c-9ec0-487e-8453-020e3fcd3371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_88fb0fe9-4fa8-40cd-b1d7-82c330976749" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ec62d093-ce4d-44e9-88b3-63919f1d22d2" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_88fb0fe9-4fa8-40cd-b1d7-82c330976749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_b14b257b-1711-4a8f-9db6-000ca7a9dd05" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_88fb0fe9-4fa8-40cd-b1d7-82c330976749" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_b14b257b-1711-4a8f-9db6-000ca7a9dd05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_7895b380-e4eb-4972-92aa-c31e196a09ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_b14b257b-1711-4a8f-9db6-000ca7a9dd05" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_7895b380-e4eb-4972-92aa-c31e196a09ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_65eac803-833c-41ff-9897-37389b76ced3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ec62d093-ce4d-44e9-88b3-63919f1d22d2" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_65eac803-833c-41ff-9897-37389b76ced3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_8e617d34-2602-4405-968e-80c3624a7b28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_65eac803-833c-41ff-9897-37389b76ced3" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_8e617d34-2602-4405-968e-80c3624a7b28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_1a000289-d727-4095-adca-b908a172f824" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_65eac803-833c-41ff-9897-37389b76ced3" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_1a000289-d727-4095-adca-b908a172f824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_f4d30744-babb-469b-8326-2b2e48e71dd4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_65eac803-833c-41ff-9897-37389b76ced3" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_f4d30744-babb-469b-8326-2b2e48e71dd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_58404385-1e1f-48ad-80f7-74a3e560ca2f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_65eac803-833c-41ff-9897-37389b76ced3" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_58404385-1e1f-48ad-80f7-74a3e560ca2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a769a28c-a810-4e8a-aa51-d3479f48126e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_86960c21-4e71-471e-83dd-a62be533d30f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a769a28c-a810-4e8a-aa51-d3479f48126e" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_86960c21-4e71-471e-83dd-a62be533d30f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_3072d009-1b49-48a7-a7e5-cdae74b49fbe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_86960c21-4e71-471e-83dd-a62be533d30f" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_3072d009-1b49-48a7-a7e5-cdae74b49fbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_d23dd8df-4be9-4f4e-8458-9e0b63afdd3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_3072d009-1b49-48a7-a7e5-cdae74b49fbe" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_d23dd8df-4be9-4f4e-8458-9e0b63afdd3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_4a149028-0e63-452e-b634-76284bfe60c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_d23dd8df-4be9-4f4e-8458-9e0b63afdd3b" xlink:to="loc_us-gaap_DomesticPlanMember_4a149028-0e63-452e-b634-76284bfe60c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_3cc90853-4def-4b10-b393-761a493227de" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_4a149028-0e63-452e-b634-76284bfe60c5" xlink:to="loc_country_US_3cc90853-4def-4b10-b393-761a493227de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_13da4726-f61a-42f0-9fb8-1dbd57676db1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_d23dd8df-4be9-4f4e-8458-9e0b63afdd3b" xlink:to="loc_us-gaap_ForeignPlanMember_13da4726-f61a-42f0-9fb8-1dbd57676db1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_f5fcd089-55ec-4bc9-8cf6-64fddc214249" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_86960c21-4e71-471e-83dd-a62be533d30f" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_f5fcd089-55ec-4bc9-8cf6-64fddc214249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_1331a5e3-17e1-4271-a34d-56e5a086c550" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_f5fcd089-55ec-4bc9-8cf6-64fddc214249" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_1331a5e3-17e1-4271-a34d-56e5a086c550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_03082c0e-1e14-47bb-bad7-67c32a2de825" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_1331a5e3-17e1-4271-a34d-56e5a086c550" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_03082c0e-1e14-47bb-bad7-67c32a2de825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_a5a341fe-5c84-4f65-b0ed-0e1cb34e6c64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_1331a5e3-17e1-4271-a34d-56e5a086c550" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_a5a341fe-5c84-4f65-b0ed-0e1cb34e6c64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_894b22a4-8a14-43cc-bb7e-03a9874ff2b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_86960c21-4e71-471e-83dd-a62be533d30f" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_894b22a4-8a14-43cc-bb7e-03a9874ff2b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_20c70db0-5207-4a13-8f90-0338d34902a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_894b22a4-8a14-43cc-bb7e-03a9874ff2b1" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_20c70db0-5207-4a13-8f90-0338d34902a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_67dd32aa-aec0-46ba-8e60-7cb10b8d29c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_894b22a4-8a14-43cc-bb7e-03a9874ff2b1" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_67dd32aa-aec0-46ba-8e60-7cb10b8d29c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_3f456cfe-a03a-4294-bfe6-6282f558c487" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_894b22a4-8a14-43cc-bb7e-03a9874ff2b1" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_3f456cfe-a03a-4294-bfe6-6282f558c487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/EmployeeBenefitsAccumulatedBenefitObligationDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#EmployeeBenefitsAccumulatedBenefitObligationDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/EmployeeBenefitsAccumulatedBenefitObligationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_03a5f61b-0439-499a-841c-d426720011b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_afd66d65-e27e-435b-87cb-350d705a9407" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_03a5f61b-0439-499a-841c-d426720011b6" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_afd66d65-e27e-435b-87cb-350d705a9407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_0378840a-0469-484d-9033-61e0f7a8b4a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_afd66d65-e27e-435b-87cb-350d705a9407" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_0378840a-0469-484d-9033-61e0f7a8b4a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_6db5d747-ed74-41a9-a752-26a6ec14fdea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_0378840a-0469-484d-9033-61e0f7a8b4a7" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_6db5d747-ed74-41a9-a752-26a6ec14fdea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_20d2b065-75d8-4d76-9135-10031a5369f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_6db5d747-ed74-41a9-a752-26a6ec14fdea" xlink:to="loc_us-gaap_DomesticPlanMember_20d2b065-75d8-4d76-9135-10031a5369f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_989b8e0d-2e2b-4c48-860e-7f6d5139a59b" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_20d2b065-75d8-4d76-9135-10031a5369f8" xlink:to="loc_country_US_989b8e0d-2e2b-4c48-860e-7f6d5139a59b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_dfaa1fbe-2a35-4110-ac94-f9e4d834f319" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_6db5d747-ed74-41a9-a752-26a6ec14fdea" xlink:to="loc_us-gaap_ForeignPlanMember_dfaa1fbe-2a35-4110-ac94-f9e4d834f319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_7082b8fd-bbc8-40a4-9968-8a8418c612f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_afd66d65-e27e-435b-87cb-350d705a9407" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_7082b8fd-bbc8-40a4-9968-8a8418c612f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_de290e28-a0fe-4e6d-8384-ace9a67a3aeb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_7082b8fd-bbc8-40a4-9968-8a8418c612f9" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_de290e28-a0fe-4e6d-8384-ace9a67a3aeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_2c2ec969-5ae5-49a7-bbb0-398884dc2c89" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_de290e28-a0fe-4e6d-8384-ace9a67a3aeb" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_2c2ec969-5ae5-49a7-bbb0-398884dc2c89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_98337317-a02d-417d-bf1b-6abb99e72c86" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_afd66d65-e27e-435b-87cb-350d705a9407" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_98337317-a02d-417d-bf1b-6abb99e72c86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_79878529-54f1-4380-a9a0-f66212193cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_98337317-a02d-417d-bf1b-6abb99e72c86" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_79878529-54f1-4380-a9a0-f66212193cd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets_56601ccb-72cb-48d7-beb6-bf8e54aee11c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_98337317-a02d-417d-bf1b-6abb99e72c86" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets_56601ccb-72cb-48d7-beb6-bf8e54aee11c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_374850a8-d223-4980-9ca0-d76f68346d9b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_98337317-a02d-417d-bf1b-6abb99e72c86" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_374850a8-d223-4980-9ca0-d76f68346d9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets_fb3afd1e-dc3c-418d-869a-f80fafcaba16" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_98337317-a02d-417d-bf1b-6abb99e72c86" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets_fb3afd1e-dc3c-418d-869a-f80fafcaba16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation_95cfe76d-14b0-4279-a83b-2a120866ebd2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_98337317-a02d-417d-bf1b-6abb99e72c86" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation_95cfe76d-14b0-4279-a83b-2a120866ebd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_ca9c8c1b-8f0b-4386-8592-4496913d9f33" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_98337317-a02d-417d-bf1b-6abb99e72c86" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_ca9c8c1b-8f0b-4386-8592-4496913d9f33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_16fdb968-d450-49d9-9cd8-6c18a2f2a056" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_98337317-a02d-417d-bf1b-6abb99e72c86" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_16fdb968-d450-49d9-9cd8-6c18a2f2a056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/EmployeeBenefitsEstimatedFutureBenefitPaymentsDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#EmployeeBenefitsEstimatedFutureBenefitPaymentsDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/EmployeeBenefitsEstimatedFutureBenefitPaymentsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e9bd41a4-d267-430f-95f5-191c4c242269" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f27ea069-c211-42db-83bd-79e2b33b36e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e9bd41a4-d267-430f-95f5-191c4c242269" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f27ea069-c211-42db-83bd-79e2b33b36e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_009526f7-0beb-4174-865e-0f8fe9855c6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f27ea069-c211-42db-83bd-79e2b33b36e3" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_009526f7-0beb-4174-865e-0f8fe9855c6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_74e865b0-d529-4ffb-8b4e-ca3f0837e3e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_009526f7-0beb-4174-865e-0f8fe9855c6c" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_74e865b0-d529-4ffb-8b4e-ca3f0837e3e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_435801fe-501f-4eb7-96bc-6c9dde0263dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_74e865b0-d529-4ffb-8b4e-ca3f0837e3e5" xlink:to="loc_us-gaap_DomesticPlanMember_435801fe-501f-4eb7-96bc-6c9dde0263dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_b118c228-41f3-4534-8e22-ff6a8effd54e" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_435801fe-501f-4eb7-96bc-6c9dde0263dc" xlink:to="loc_country_US_b118c228-41f3-4534-8e22-ff6a8effd54e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_13793903-4e1a-423c-a943-5e9bf3af91e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_74e865b0-d529-4ffb-8b4e-ca3f0837e3e5" xlink:to="loc_us-gaap_ForeignPlanMember_13793903-4e1a-423c-a943-5e9bf3af91e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_08678804-867f-4ee9-8127-055bc30778ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f27ea069-c211-42db-83bd-79e2b33b36e3" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_08678804-867f-4ee9-8127-055bc30778ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_f75ed2a3-da30-4879-9cb8-78de7c9d6a16" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_08678804-867f-4ee9-8127-055bc30778ad" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_f75ed2a3-da30-4879-9cb8-78de7c9d6a16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_674dd10b-c7d8-45f7-ab41-dc337c8cb39a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_f75ed2a3-da30-4879-9cb8-78de7c9d6a16" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_674dd10b-c7d8-45f7-ab41-dc337c8cb39a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_17492b87-f9ba-49a6-8e74-1d3fd0dcf543" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_f75ed2a3-da30-4879-9cb8-78de7c9d6a16" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_17492b87-f9ba-49a6-8e74-1d3fd0dcf543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_8c7183e2-3d56-4f2e-8912-c79a76fc497d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f27ea069-c211-42db-83bd-79e2b33b36e3" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_8c7183e2-3d56-4f2e-8912-c79a76fc497d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_6c81525a-7bc9-4c4c-ae7c-389d3eab9b56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_8c7183e2-3d56-4f2e-8912-c79a76fc497d" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_6c81525a-7bc9-4c4c-ae7c-389d3eab9b56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_577451b1-3d73-4791-ba3c-003a7c8dca85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_8c7183e2-3d56-4f2e-8912-c79a76fc497d" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_577451b1-3d73-4791-ba3c-003a7c8dca85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_b8ad9829-4d61-4d01-b5d5-be3a20a9dd6e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_8c7183e2-3d56-4f2e-8912-c79a76fc497d" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_b8ad9829-4d61-4d01-b5d5-be3a20a9dd6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_57a316af-0f0d-478a-a814-d9083c59cd01" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_8c7183e2-3d56-4f2e-8912-c79a76fc497d" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_57a316af-0f0d-478a-a814-d9083c59cd01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_2c2c7cf7-b533-497e-9e19-74a34422eb58" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_8c7183e2-3d56-4f2e-8912-c79a76fc497d" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_2c2c7cf7-b533-497e-9e19-74a34422eb58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_e5562190-2eb4-4990-9f65-04b5f45919bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_8c7183e2-3d56-4f2e-8912-c79a76fc497d" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_e5562190-2eb4-4990-9f65-04b5f45919bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_d758a71d-9671-48e4-b97c-5206409835ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_8c7183e2-3d56-4f2e-8912-c79a76fc497d" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_d758a71d-9671-48e4-b97c-5206409835ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/EmployeeBenefitsPercentageofAssetsInvestedDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#EmployeeBenefitsPercentageofAssetsInvestedDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/EmployeeBenefitsPercentageofAssetsInvestedDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_5be84990-f1d9-41c2-9b39-0354cca6075a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b58ebd73-de91-4074-b4d6-41d7786830da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_5be84990-f1d9-41c2-9b39-0354cca6075a" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b58ebd73-de91-4074-b4d6-41d7786830da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_75f4a062-26b7-451e-aec2-b99f6764da7d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b58ebd73-de91-4074-b4d6-41d7786830da" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_75f4a062-26b7-451e-aec2-b99f6764da7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_db812b7c-c7bb-4281-952f-1449cd47221b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_75f4a062-26b7-451e-aec2-b99f6764da7d" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_db812b7c-c7bb-4281-952f-1449cd47221b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_a220d08e-7fe9-4aef-825f-65c2a06b318c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_db812b7c-c7bb-4281-952f-1449cd47221b" xlink:to="loc_us-gaap_DomesticPlanMember_a220d08e-7fe9-4aef-825f-65c2a06b318c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_fdc8893c-7ad8-4d4b-adec-aa14cb626cbc" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_a220d08e-7fe9-4aef-825f-65c2a06b318c" xlink:to="loc_country_US_fdc8893c-7ad8-4d4b-adec-aa14cb626cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_8597c08a-0d10-46ac-817b-874222375180" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_db812b7c-c7bb-4281-952f-1449cd47221b" xlink:to="loc_us-gaap_ForeignPlanMember_8597c08a-0d10-46ac-817b-874222375180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_6a911b6d-e11d-4cd7-9ff4-044f27b2116b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b58ebd73-de91-4074-b4d6-41d7786830da" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_6a911b6d-e11d-4cd7-9ff4-044f27b2116b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_d1deaf8b-10fd-496a-bb40-92c75d58e403" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_6a911b6d-e11d-4cd7-9ff4-044f27b2116b" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_d1deaf8b-10fd-496a-bb40-92c75d58e403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_ef11ac04-db33-4153-9034-10fcba426a87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_d1deaf8b-10fd-496a-bb40-92c75d58e403" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_ef11ac04-db33-4153-9034-10fcba426a87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_ae0f269f-f591-4c5f-8e89-978e99b5ee7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b58ebd73-de91-4074-b4d6-41d7786830da" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_ae0f269f-f591-4c5f-8e89-978e99b5ee7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_60a09e35-6a92-4d8f-a420-cecd3d87496e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_ae0f269f-f591-4c5f-8e89-978e99b5ee7f" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_60a09e35-6a92-4d8f-a420-cecd3d87496e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedBenefitPlanAssetsCategoryMember_28aa8234-75b5-4dcb-877f-098dc10028cf" xlink:href="iff-20231231.xsd#iff_DefinedBenefitPlanAssetsCategoryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_60a09e35-6a92-4d8f-a420-cecd3d87496e" xlink:to="loc_iff_DefinedBenefitPlanAssetsCategoryMember_28aa8234-75b5-4dcb-877f-098dc10028cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_7cef7183-acd6-4620-92e0-27fd72078c59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_28aa8234-75b5-4dcb-877f-098dc10028cf" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_7cef7183-acd6-4620-92e0-27fd72078c59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_683fe49d-b772-4ecc-b9be-d28f35a98904" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_28aa8234-75b5-4dcb-877f-098dc10028cf" xlink:to="loc_us-gaap_EquitySecuritiesMember_683fe49d-b772-4ecc-b9be-d28f35a98904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_8ad16029-ecfe-48b4-88e5-d0c29c882c1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_28aa8234-75b5-4dcb-877f-098dc10028cf" xlink:to="loc_us-gaap_DebtSecuritiesMember_8ad16029-ecfe-48b4-88e5-d0c29c882c1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateMember_4a17fc9c-0db4-4dc0-9169-2fe28215dfe5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealEstateMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_28aa8234-75b5-4dcb-877f-098dc10028cf" xlink:to="loc_us-gaap_RealEstateMember_4a17fc9c-0db4-4dc0-9169-2fe28215dfe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentCompaniesMember_bcf4a93f-f2bc-48f6-a1df-7bd4a1b2261a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInvestmentCompaniesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_28aa8234-75b5-4dcb-877f-098dc10028cf" xlink:to="loc_us-gaap_OtherInvestmentCompaniesMember_bcf4a93f-f2bc-48f6-a1df-7bd4a1b2261a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0456572c-5087-48e0-84e9-fcb24808ae8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b58ebd73-de91-4074-b4d6-41d7786830da" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0456572c-5087-48e0-84e9-fcb24808ae8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_63d0972b-314d-42cb-b326-bd8b0a3962fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0456572c-5087-48e0-84e9-fcb24808ae8c" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_63d0972b-314d-42cb-b326-bd8b0a3962fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a244814e-9e5e-4b6c-a4a0-4f3435cbacca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_cac3e5ff-9bbc-4478-8d89-0689e2da2b77" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a244814e-9e5e-4b6c-a4a0-4f3435cbacca" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_cac3e5ff-9bbc-4478-8d89-0689e2da2b77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_bcc2b767-9b44-4ab4-af45-fe4b2ec902f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_cac3e5ff-9bbc-4478-8d89-0689e2da2b77" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_bcc2b767-9b44-4ab4-af45-fe4b2ec902f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_c4f716d1-30a5-4886-b52d-e3dfb15e8c96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_bcc2b767-9b44-4ab4-af45-fe4b2ec902f3" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_c4f716d1-30a5-4886-b52d-e3dfb15e8c96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_12fb0a8c-82aa-4ca6-b114-2f037dc01b19" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_c4f716d1-30a5-4886-b52d-e3dfb15e8c96" xlink:to="loc_us-gaap_DomesticPlanMember_12fb0a8c-82aa-4ca6-b114-2f037dc01b19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_ef380f07-f56e-4103-bd7f-ebc0b2a8c22e" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_12fb0a8c-82aa-4ca6-b114-2f037dc01b19" xlink:to="loc_country_US_ef380f07-f56e-4103-bd7f-ebc0b2a8c22e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_5a8e01d1-06a7-4fe7-80da-9853341276b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_c4f716d1-30a5-4886-b52d-e3dfb15e8c96" xlink:to="loc_us-gaap_ForeignPlanMember_5a8e01d1-06a7-4fe7-80da-9853341276b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_0a2682f4-6949-4afd-953f-2d204c2e9be9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_cac3e5ff-9bbc-4478-8d89-0689e2da2b77" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_0a2682f4-6949-4afd-953f-2d204c2e9be9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_ab476e27-efad-4f88-a6e3-19e1ef28229d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_0a2682f4-6949-4afd-953f-2d204c2e9be9" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_ab476e27-efad-4f88-a6e3-19e1ef28229d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_d32ede24-722d-43bc-91cd-932f30ffc3b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_ab476e27-efad-4f88-a6e3-19e1ef28229d" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_d32ede24-722d-43bc-91cd-932f30ffc3b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ae21a752-9e26-4a9b-8c0c-e54cc2552775" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_cac3e5ff-9bbc-4478-8d89-0689e2da2b77" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ae21a752-9e26-4a9b-8c0c-e54cc2552775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cefd89e6-da7a-417e-94c2-49ea4ba8f6d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ae21a752-9e26-4a9b-8c0c-e54cc2552775" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cefd89e6-da7a-417e-94c2-49ea4ba8f6d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel12And3Member_0c34e270-5473-4de9-87e0-d309ac590eaf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel12And3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cefd89e6-da7a-417e-94c2-49ea4ba8f6d4" xlink:to="loc_us-gaap_FairValueInputsLevel12And3Member_0c34e270-5473-4de9-87e0-d309ac590eaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_30b33098-e69e-46f1-8b08-5f9a0ffa35f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueInputsLevel12And3Member_0c34e270-5473-4de9-87e0-d309ac590eaf" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_30b33098-e69e-46f1-8b08-5f9a0ffa35f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_9a8edf69-627e-4ee0-b62b-da4c67507ec6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueInputsLevel12And3Member_0c34e270-5473-4de9-87e0-d309ac590eaf" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_9a8edf69-627e-4ee0-b62b-da4c67507ec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_d3d8cbcb-f830-44b7-a151-38a484a11f8b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueInputsLevel12And3Member_0c34e270-5473-4de9-87e0-d309ac590eaf" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_d3d8cbcb-f830-44b7-a151-38a484a11f8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_a4cdcc36-cd13-449b-88e5-c94873e23d92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cefd89e6-da7a-417e-94c2-49ea4ba8f6d4" xlink:to="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_a4cdcc36-cd13-449b-88e5-c94873e23d92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_dd762f20-8ed5-4906-9257-9f3018cd6e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_cac3e5ff-9bbc-4478-8d89-0689e2da2b77" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_dd762f20-8ed5-4906-9257-9f3018cd6e5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_ce8dd720-9170-4e9b-93d0-9293689bd8f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_dd762f20-8ed5-4906-9257-9f3018cd6e5b" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_ce8dd720-9170-4e9b-93d0-9293689bd8f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedBenefitPlanAssetsCategoryMember_4d50958b-e8fa-4190-bd7e-e36426fda693" xlink:href="iff-20231231.xsd#iff_DefinedBenefitPlanAssetsCategoryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_ce8dd720-9170-4e9b-93d0-9293689bd8f6" xlink:to="loc_iff_DefinedBenefitPlanAssetsCategoryMember_4d50958b-e8fa-4190-bd7e-e36426fda693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_FairValueOfPlanAssetsBeforeReceivablesMember_c268ab57-721a-47be-8b45-cc6eccb02601" xlink:href="iff-20231231.xsd#iff_FairValueOfPlanAssetsBeforeReceivablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_4d50958b-e8fa-4190-bd7e-e36426fda693" xlink:to="loc_iff_FairValueOfPlanAssetsBeforeReceivablesMember_c268ab57-721a-47be-8b45-cc6eccb02601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_031200e9-f564-47eb-9cfb-34c77e9ce076" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_FairValueOfPlanAssetsBeforeReceivablesMember_c268ab57-721a-47be-8b45-cc6eccb02601" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_031200e9-f564-47eb-9cfb-34c77e9ce076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_GovernmentAndGovernmentAgencyBondsMember_f43271bb-16c1-4369-822d-52d7a41c0cdc" xlink:href="iff-20231231.xsd#iff_GovernmentAndGovernmentAgencyBondsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_FairValueOfPlanAssetsBeforeReceivablesMember_c268ab57-721a-47be-8b45-cc6eccb02601" xlink:to="loc_iff_GovernmentAndGovernmentAgencyBondsMember_f43271bb-16c1-4369-822d-52d7a41c0cdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_c7dd2562-ed1c-45e8-b5b6-f8ce44b4f30c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_FairValueOfPlanAssetsBeforeReceivablesMember_c268ab57-721a-47be-8b45-cc6eccb02601" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_c7dd2562-ed1c-45e8-b5b6-f8ce44b4f30c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_cea90925-a596-46b7-81d8-377067240647" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MunicipalBondsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_FairValueOfPlanAssetsBeforeReceivablesMember_c268ab57-721a-47be-8b45-cc6eccb02601" xlink:to="loc_us-gaap_MunicipalBondsMember_cea90925-a596-46b7-81d8-377067240647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_PooledFundsMember_992004a3-fb10-4bd4-9d36-5a342b4f139f" xlink:href="iff-20231231.xsd#iff_PooledFundsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_FairValueOfPlanAssetsBeforeReceivablesMember_c268ab57-721a-47be-8b45-cc6eccb02601" xlink:to="loc_iff_PooledFundsMember_992004a3-fb10-4bd4-9d36-5a342b4f139f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ReceivablesMember_8c571ebb-9e51-4bdf-9d71-c808451dbdca" xlink:href="iff-20231231.xsd#iff_ReceivablesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_4d50958b-e8fa-4190-bd7e-e36426fda693" xlink:to="loc_iff_ReceivablesMember_8c571ebb-9e51-4bdf-9d71-c808451dbdca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember_249b02d8-45ee-42a5-bba9-dc262eca3b83" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_4d50958b-e8fa-4190-bd7e-e36426fda693" xlink:to="loc_us-gaap_CashMember_249b02d8-45ee-42a5-bba9-dc262eca3b83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember_03c60589-163a-48dc-9c21-eb71e236abe2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_4d50958b-e8fa-4190-bd7e-e36426fda693" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember_03c60589-163a-48dc-9c21-eb71e236abe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMidCapMember_10566e6d-4fa9-4e49-b4ab-9d4e893ce195" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesUsMidCapMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_4d50958b-e8fa-4190-bd7e-e36426fda693" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMidCapMember_10566e6d-4fa9-4e49-b4ab-9d4e893ce195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsSmallCapMember_d3ad708d-1dc3-44f4-9d24-aae5aff88634" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesUsSmallCapMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_4d50958b-e8fa-4190-bd7e-e36426fda693" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsSmallCapMember_d3ad708d-1dc3-44f4-9d24-aae5aff88634" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesLargeCapMember_5bada8fa-f558-4aa3-9e6b-f224216f534b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesLargeCapMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_4d50958b-e8fa-4190-bd7e-e36426fda693" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesLargeCapMember_5bada8fa-f558-4aa3-9e6b-f224216f534b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMidCapMember_b04d1982-42ac-4f9f-9526-bc70a8b8de45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMidCapMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_4d50958b-e8fa-4190-bd7e-e36426fda693" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMidCapMember_b04d1982-42ac-4f9f-9526-bc70a8b8de45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesSmallCapMember_d62cd9ee-6a8d-47bf-83f1-d40922d30bc8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesSmallCapMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_4d50958b-e8fa-4190-bd7e-e36426fda693" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesSmallCapMember_d62cd9ee-6a8d-47bf-83f1-d40922d30bc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EmergingMarketsMember_581b4677-6a57-41b5-9c1e-3fad4c50b52d" xlink:href="iff-20231231.xsd#iff_EmergingMarketsMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_4d50958b-e8fa-4190-bd7e-e36426fda693" xlink:to="loc_iff_EmergingMarketsMember_581b4677-6a57-41b5-9c1e-3fad4c50b52d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_USCorporateBondsMember_f3526f16-282c-40f9-8511-6b810b1b88bd" xlink:href="iff-20231231.xsd#iff_USCorporateBondsMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_4d50958b-e8fa-4190-bd7e-e36426fda693" xlink:to="loc_iff_USCorporateBondsMember_f3526f16-282c-40f9-8511-6b810b1b88bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NonUSTreasuriesOrGovernmentBondsMember_25e75f1e-1242-428b-812b-f71df491db4a" xlink:href="iff-20231231.xsd#iff_NonUSTreasuriesOrGovernmentBondsMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_4d50958b-e8fa-4190-bd7e-e36426fda693" xlink:to="loc_iff_NonUSTreasuriesOrGovernmentBondsMember_25e75f1e-1242-428b-812b-f71df491db4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NonUSCorporateBondsMember_2ce335a1-7ed2-4736-9353-99abba7b75c8" xlink:href="iff-20231231.xsd#iff_NonUSCorporateBondsMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_4d50958b-e8fa-4190-bd7e-e36426fda693" xlink:to="loc_iff_NonUSCorporateBondsMember_2ce335a1-7ed2-4736-9353-99abba7b75c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NonUSAssetBackedSecuritiesMember_9b2f498d-fd4c-4117-a230-84faf146adac" xlink:href="iff-20231231.xsd#iff_NonUSAssetBackedSecuritiesMember"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_4d50958b-e8fa-4190-bd7e-e36426fda693" xlink:to="loc_iff_NonUSAssetBackedSecuritiesMember_9b2f498d-fd4c-4117-a230-84faf146adac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NonUSOtherFixedIncomeMember_ee5d8f08-1bc8-486c-87c9-47ecc3600e0e" xlink:href="iff-20231231.xsd#iff_NonUSOtherFixedIncomeMember"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_4d50958b-e8fa-4190-bd7e-e36426fda693" xlink:to="loc_iff_NonUSOtherFixedIncomeMember_ee5d8f08-1bc8-486c-87c9-47ecc3600e0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_InsuranceContractsMember_f88708a5-fd5e-45d4-b90e-fd26636eaa52" xlink:href="iff-20231231.xsd#iff_InsuranceContractsMember"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_4d50958b-e8fa-4190-bd7e-e36426fda693" xlink:to="loc_iff_InsuranceContractsMember_f88708a5-fd5e-45d4-b90e-fd26636eaa52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeMember_4a5f7bbd-3d9c-46df-85e6-9a96dd36dd26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeMember"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_4d50958b-e8fa-4190-bd7e-e36426fda693" xlink:to="loc_us-gaap_DerivativeMember_4a5f7bbd-3d9c-46df-85e6-9a96dd36dd26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AbsoluteReturnHedgeFundsMember_50eab2c1-7b7c-439c-9e65-c7969660fa9a" xlink:href="iff-20231231.xsd#iff_AbsoluteReturnHedgeFundsMember"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_4d50958b-e8fa-4190-bd7e-e36426fda693" xlink:to="loc_iff_AbsoluteReturnHedgeFundsMember_50eab2c1-7b7c-439c-9e65-c7969660fa9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivateEquityFundsMember_8203b8a0-eb31-4ea1-a913-f8a24629e785" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrivateEquityFundsMember"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_4d50958b-e8fa-4190-bd7e-e36426fda693" xlink:to="loc_us-gaap_PrivateEquityFundsMember_8203b8a0-eb31-4ea1-a913-f8a24629e785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgeFundsMember_4a3cb18d-f5dd-4404-b4da-20fa64daaa1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgeFundsMember"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_4d50958b-e8fa-4190-bd7e-e36426fda693" xlink:to="loc_us-gaap_HedgeFundsMember_4a3cb18d-f5dd-4404-b4da-20fa64daaa1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateMember_593b42cb-dbe9-4fe4-9830-54e082335a6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealEstateMember"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_DefinedBenefitPlanAssetsCategoryMember_4d50958b-e8fa-4190-bd7e-e36426fda693" xlink:to="loc_us-gaap_RealEstateMember_593b42cb-dbe9-4fe4-9830-54e082335a6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeFundsMember_78efcf0e-09a7-419c-bfa4-7ca09f736356" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FixedIncomeFundsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_ce8dd720-9170-4e9b-93d0-9293689bd8f6" xlink:to="loc_us-gaap_FixedIncomeFundsMember_78efcf0e-09a7-419c-bfa4-7ca09f736356" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c89406b8-d9c5-444d-a8e0-3e3ac359d18c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_cac3e5ff-9bbc-4478-8d89-0689e2da2b77" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c89406b8-d9c5-444d-a8e0-3e3ac359d18c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_ec23c42b-6dad-4f7d-ab07-a853900860ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c89406b8-d9c5-444d-a8e0-3e3ac359d18c" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_ec23c42b-6dad-4f7d-ab07-a853900860ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/EmployeeBenefitsReconciliationofLevel3NonUSPlanAssetsHeldDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#EmployeeBenefitsReconciliationofLevel3NonUSPlanAssetsHeldDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/EmployeeBenefitsReconciliationofLevel3NonUSPlanAssetsHeldDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_7802cece-b9b7-4886-9c97-a34fb3cece0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6ba278eb-650f-4011-9201-e16bc3ddf433" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_7802cece-b9b7-4886-9c97-a34fb3cece0c" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6ba278eb-650f-4011-9201-e16bc3ddf433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_075c1002-6c92-46ca-a514-fc261c98bd8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6ba278eb-650f-4011-9201-e16bc3ddf433" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_075c1002-6c92-46ca-a514-fc261c98bd8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_37144cf3-3004-44c2-9620-6872867110e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_075c1002-6c92-46ca-a514-fc261c98bd8e" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_37144cf3-3004-44c2-9620-6872867110e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_203cac15-de69-4edd-9a07-8211a05b4c42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_37144cf3-3004-44c2-9620-6872867110e3" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_203cac15-de69-4edd-9a07-8211a05b4c42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_cd6ce91c-2e80-43e6-adc1-f1fb6bb4c8ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6ba278eb-650f-4011-9201-e16bc3ddf433" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_cd6ce91c-2e80-43e6-adc1-f1fb6bb4c8ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d9b80e65-44eb-41be-ba9e-d482c909a29c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_cd6ce91c-2e80-43e6-adc1-f1fb6bb4c8ef" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d9b80e65-44eb-41be-ba9e-d482c909a29c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel12And3Member_b1f2b77c-5431-48d4-94f1-bea00555d5b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel12And3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d9b80e65-44eb-41be-ba9e-d482c909a29c" xlink:to="loc_us-gaap_FairValueInputsLevel12And3Member_b1f2b77c-5431-48d4-94f1-bea00555d5b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_17df385a-0be5-4591-9cbf-75f62175f579" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueInputsLevel12And3Member_b1f2b77c-5431-48d4-94f1-bea00555d5b7" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_17df385a-0be5-4591-9cbf-75f62175f579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_a01f8b70-7e48-4ab3-a6d0-dcfb0f7c5f67" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6ba278eb-650f-4011-9201-e16bc3ddf433" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_a01f8b70-7e48-4ab3-a6d0-dcfb0f7c5f67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_f2ab74dc-093e-4c72-8cf2-40c3c0b385b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_a01f8b70-7e48-4ab3-a6d0-dcfb0f7c5f67" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_f2ab74dc-093e-4c72-8cf2-40c3c0b385b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_69bf043f-2f47-4a8f-ab52-2e12f4416555" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_f2ab74dc-093e-4c72-8cf2-40c3c0b385b9" xlink:to="loc_us-gaap_ForeignPlanMember_69bf043f-2f47-4a8f-ab52-2e12f4416555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_62766d82-27e5-4bcb-84a9-f06c2ea0720e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6ba278eb-650f-4011-9201-e16bc3ddf433" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_62766d82-27e5-4bcb-84a9-f06c2ea0720e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_8309f004-a79a-498c-b940-cfe6a3c8f9b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_62766d82-27e5-4bcb-84a9-f06c2ea0720e" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_8309f004-a79a-498c-b940-cfe6a3c8f9b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateMember_b8b2718d-3b34-4b58-8a47-16d9b76da3e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealEstateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_8309f004-a79a-498c-b940-cfe6a3c8f9b2" xlink:to="loc_us-gaap_RealEstateMember_b8b2718d-3b34-4b58-8a47-16d9b76da3e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgeFundsMember_f7af3240-4fdc-45b0-a3c6-25af59ac2ece" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgeFundsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_8309f004-a79a-498c-b940-cfe6a3c8f9b2" xlink:to="loc_us-gaap_HedgeFundsMember_f7af3240-4fdc-45b0-a3c6-25af59ac2ece" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_66d41016-c534-4d85-ad20-6817afb7c1c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6ba278eb-650f-4011-9201-e16bc3ddf433" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_66d41016-c534-4d85-ad20-6817afb7c1c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7c398eec-1e47-4980-be8c-c52b7693d711" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_66d41016-c534-4d85-ad20-6817afb7c1c0" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7c398eec-1e47-4980-be8c-c52b7693d711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_bc847698-9f78-40ee-9934-76910620c5a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7c398eec-1e47-4980-be8c-c52b7693d711" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_bc847698-9f78-40ee-9934-76910620c5a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld_14fba17d-01fe-4477-a55c-e4c9b50c9548" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7c398eec-1e47-4980-be8c-c52b7693d711" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld_14fba17d-01fe-4477-a55c-e4c9b50c9548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements_2fc3a2e3-ef1d-4e8c-ad9e-7b3833e3f386" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7c398eec-1e47-4980-be8c-c52b7693d711" xlink:to="loc_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements_2fc3a2e3-ef1d-4e8c-ad9e-7b3833e3f386" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_83c246a8-be3e-4cc4-b1d5-f650e645d2b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7c398eec-1e47-4980-be8c-c52b7693d711" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_83c246a8-be3e-4cc4-b1d5-f650e645d2b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/EmployeeBenefitsWeightedAverageAssumptionsUsedtoDeterminePostretirementBenefitExpenseandObligationDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#EmployeeBenefitsWeightedAverageAssumptionsUsedtoDeterminePostretirementBenefitExpenseandObligationDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/EmployeeBenefitsWeightedAverageAssumptionsUsedtoDeterminePostretirementBenefitExpenseandObligationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_d0f7df87-3489-4510-b926-05f8a4b44b7c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_1b9208f0-759b-4ebd-a665-935a5c24a2c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_d0f7df87-3489-4510-b926-05f8a4b44b7c" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_1b9208f0-759b-4ebd-a665-935a5c24a2c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_049ad004-8662-447a-93e3-0dc29249a286" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_1b9208f0-759b-4ebd-a665-935a5c24a2c0" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_049ad004-8662-447a-93e3-0dc29249a286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_489c442d-c12a-47e5-896a-8a0cf13dbd6e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_049ad004-8662-447a-93e3-0dc29249a286" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_489c442d-c12a-47e5-896a-8a0cf13dbd6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ExpenseMember_735c8b83-d089-45d5-b75d-c720d85d5af3" xlink:href="iff-20231231.xsd#iff_ExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_489c442d-c12a-47e5-896a-8a0cf13dbd6e" xlink:to="loc_iff_ExpenseMember_735c8b83-d089-45d5-b75d-c720d85d5af3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_e94a9351-a7dc-4bad-abee-40e3b5d4f5e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_1b9208f0-759b-4ebd-a665-935a5c24a2c0" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_e94a9351-a7dc-4bad-abee-40e3b5d4f5e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_3e78337a-ce4a-4fb7-a73a-6bc72404d7aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_e94a9351-a7dc-4bad-abee-40e3b5d4f5e2" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_3e78337a-ce4a-4fb7-a73a-6bc72404d7aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityMember_ad6637a5-6e7e-4ed8-935e-192ca9f47790" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3e78337a-ce4a-4fb7-a73a-6bc72404d7aa" xlink:to="loc_us-gaap_LiabilityMember_ad6637a5-6e7e-4ed8-935e-192ca9f47790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f24fd08d-2efb-449c-9dc5-814bc636f872" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_1b9208f0-759b-4ebd-a665-935a5c24a2c0" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f24fd08d-2efb-449c-9dc5-814bc636f872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_8b8a1778-bae1-4087-b7da-d99ccfa45269" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f24fd08d-2efb-449c-9dc5-814bc636f872" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_8b8a1778-bae1-4087-b7da-d99ccfa45269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedBenefitPlanCurrentMedicalCareCostTrendRate_e5701fd1-244c-4c9d-b63d-a0a2fefa6367" xlink:href="iff-20231231.xsd#iff_DefinedBenefitPlanCurrentMedicalCareCostTrendRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f24fd08d-2efb-449c-9dc5-814bc636f872" xlink:to="loc_iff_DefinedBenefitPlanCurrentMedicalCareCostTrendRate_e5701fd1-244c-4c9d-b63d-a0a2fefa6367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1_cdabed67-0320-43ca-94bb-a16d8e984c4c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f24fd08d-2efb-449c-9dc5-814bc636f872" xlink:to="loc_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1_cdabed67-0320-43ca-94bb-a16d8e984c4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/EmployeeBenefitsSensitivityofDisclosurestoChangesinSelectedAssumptionsDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#EmployeeBenefitsSensitivityofDisclosurestoChangesinSelectedAssumptionsDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/EmployeeBenefitsSensitivityofDisclosurestoChangesinSelectedAssumptionsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0c368b95-f893-4115-91c9-900293a08d3d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_07618b5d-fc0b-402a-9dbb-7777036c21b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0c368b95-f893-4115-91c9-900293a08d3d" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_07618b5d-fc0b-402a-9dbb-7777036c21b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_09375f00-e041-47e8-ba63-3cf2b0700759" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_07618b5d-fc0b-402a-9dbb-7777036c21b4" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_09375f00-e041-47e8-ba63-3cf2b0700759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_4c7212fa-9571-4bac-9942-1ba3905b8280" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_09375f00-e041-47e8-ba63-3cf2b0700759" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_4c7212fa-9571-4bac-9942-1ba3905b8280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_64efedd1-e3b2-489e-b713-2bd7974e5340" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_4c7212fa-9571-4bac-9942-1ba3905b8280" xlink:to="loc_us-gaap_DomesticPlanMember_64efedd1-e3b2-489e-b713-2bd7974e5340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_8fcaf107-ef01-484f-ae99-5f6ab514e558" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_64efedd1-e3b2-489e-b713-2bd7974e5340" xlink:to="loc_country_US_8fcaf107-ef01-484f-ae99-5f6ab514e558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_3b04df3d-5d8f-4df2-95b9-02acb95b23f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_4c7212fa-9571-4bac-9942-1ba3905b8280" xlink:to="loc_us-gaap_ForeignPlanMember_3b04df3d-5d8f-4df2-95b9-02acb95b23f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_4452cd79-0b20-4e4d-9519-30e0ab61e633" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_07618b5d-fc0b-402a-9dbb-7777036c21b4" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_4452cd79-0b20-4e4d-9519-30e0ab61e633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_3a3d2ad4-98a7-4463-b370-05828d0db69d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_4452cd79-0b20-4e4d-9519-30e0ab61e633" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_3a3d2ad4-98a7-4463-b370-05828d0db69d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_b0410b9f-856c-416a-b513-68f62c55363e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_3a3d2ad4-98a7-4463-b370-05828d0db69d" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_b0410b9f-856c-416a-b513-68f62c55363e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_e34dbb0d-1a5d-445f-a5d4-0d4eb2c697c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_3a3d2ad4-98a7-4463-b370-05828d0db69d" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_e34dbb0d-1a5d-445f-a5d4-0d4eb2c697c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f407edf5-892c-47c3-be86-fcd743ec6213" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_07618b5d-fc0b-402a-9dbb-7777036c21b4" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f407edf5-892c-47c3-be86-fcd743ec6213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInProjectedBenefitObligation_17737b24-0920-451f-9160-1e2ac2d0ba79" xlink:href="iff-20231231.xsd#iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInProjectedBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f407edf5-892c-47c3-be86-fcd743ec6213" xlink:to="loc_iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInProjectedBenefitObligation_17737b24-0920-451f-9160-1e2ac2d0ba79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInAccumulatedBenefitObligation_712a3109-6c49-4c6a-9b91-6965350562a7" xlink:href="iff-20231231.xsd#iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInAccumulatedBenefitObligation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f407edf5-892c-47c3-be86-fcd743ec6213" xlink:to="loc_iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInAccumulatedBenefitObligation_712a3109-6c49-4c6a-9b91-6965350562a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInPensionExpense_a609d688-9f53-41ee-933e-9b978de859bd" xlink:href="iff-20231231.xsd#iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInPensionExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f407edf5-892c-47c3-be86-fcd743ec6213" xlink:to="loc_iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInPensionExpense_a609d688-9f53-41ee-933e-9b978de859bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInLongTermRateOfReturnInPensionExpense_64246e51-e2e9-4e6a-b377-3a0d8c9ad562" xlink:href="iff-20231231.xsd#iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInLongTermRateOfReturnInPensionExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f407edf5-892c-47c3-be86-fcd743ec6213" xlink:to="loc_iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInLongTermRateOfReturnInPensionExpense_64246e51-e2e9-4e6a-b377-3a0d8c9ad562" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/FinancialInstrumentsCarryingAmountandEstimatedFairValueofFinancialInstrumentsDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#FinancialInstrumentsCarryingAmountandEstimatedFairValueofFinancialInstrumentsDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/FinancialInstrumentsCarryingAmountandEstimatedFairValueofFinancialInstrumentsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8548484d-b969-456b-b3b9-36e160849e03" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d1c84d45-e654-4fae-b162-4fc9265f3136" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8548484d-b969-456b-b3b9-36e160849e03" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d1c84d45-e654-4fae-b162-4fc9265f3136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_36997da0-9cda-41e8-a35c-5730007e13ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d1c84d45-e654-4fae-b162-4fc9265f3136" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_36997da0-9cda-41e8-a35c-5730007e13ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ee1112c3-47ff-4b4b-b07e-32320b4b8ec6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_36997da0-9cda-41e8-a35c-5730007e13ef" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ee1112c3-47ff-4b4b-b07e-32320b4b8ec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandTwentyThreeMember_c55697af-7e7d-4c69-8a91-e908a1bfc43e" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandTwentyThreeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ee1112c3-47ff-4b4b-b07e-32320b4b8ec6" xlink:to="loc_iff_SeniorNotesDueTwoThousandTwentyThreeMember_c55697af-7e7d-4c69-8a91-e908a1bfc43e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember_338c6049-ee90-4c4e-8594-aa2e6e5fdb58" xlink:href="iff-20231231.xsd#iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ee1112c3-47ff-4b4b-b07e-32320b4b8ec6" xlink:to="loc_iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember_338c6049-ee90-4c4e-8594-aa2e6e5fdb58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember_71bd59d7-1669-4c4f-a5d9-52fc604c366b" xlink:href="iff-20231231.xsd#iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ee1112c3-47ff-4b4b-b07e-32320b4b8ec6" xlink:to="loc_iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember_71bd59d7-1669-4c4f-a5d9-52fc604c366b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandTwentyEightMember_ba0c9017-eaf9-4f77-9da8-c426fa7498e9" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandTwentyEightMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ee1112c3-47ff-4b4b-b07e-32320b4b8ec6" xlink:to="loc_iff_SeniorNotesDueTwoThousandTwentyEightMember_ba0c9017-eaf9-4f77-9da8-c426fa7498e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandFortySevenMember_53c8f7a5-b7be-4eaf-a8b4-e87e1d174830" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandFortySevenMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ee1112c3-47ff-4b4b-b07e-32320b4b8ec6" xlink:to="loc_iff_SeniorNotesDueTwoThousandFortySevenMember_53c8f7a5-b7be-4eaf-a8b4-e87e1d174830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandFortyEightMember_efe768db-a39a-4d23-83f6-1d726802341c" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandFortyEightMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ee1112c3-47ff-4b4b-b07e-32320b4b8ec6" xlink:to="loc_iff_SeniorNotesDueTwoThousandFortyEightMember_efe768db-a39a-4d23-83f6-1d726802341c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TermLoanCreditAgreementMember_ed382fa9-cfe1-4643-b37b-d26577386b6e" xlink:href="iff-20231231.xsd#iff_TermLoanCreditAgreementMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ee1112c3-47ff-4b4b-b07e-32320b4b8ec6" xlink:to="loc_iff_TermLoanCreditAgreementMember_ed382fa9-cfe1-4643-b37b-d26577386b6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AmortizingNoteMember_5dae299c-0f19-4249-98f2-76eff4e2d05e" xlink:href="iff-20231231.xsd#iff_AmortizingNoteMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ee1112c3-47ff-4b4b-b07e-32320b4b8ec6" xlink:to="loc_iff_AmortizingNoteMember_5dae299c-0f19-4249-98f2-76eff4e2d05e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandTwentyFiveMember_354d5680-d7b5-4c75-af66-55dfb474e109" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandTwentyFiveMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ee1112c3-47ff-4b4b-b07e-32320b4b8ec6" xlink:to="loc_iff_SeniorNotesDueTwoThousandTwentyFiveMember_354d5680-d7b5-4c75-af66-55dfb474e109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandTwentySevenMember_d832e830-85fe-4bd6-b26c-0a960339d291" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandTwentySevenMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ee1112c3-47ff-4b4b-b07e-32320b4b8ec6" xlink:to="loc_iff_SeniorNotesDueTwoThousandTwentySevenMember_d832e830-85fe-4bd6-b26c-0a960339d291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandThirtyMember_12c8d737-665b-497a-a087-e3ffe8e7ac9e" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandThirtyMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ee1112c3-47ff-4b4b-b07e-32320b4b8ec6" xlink:to="loc_iff_SeniorNotesDueTwoThousandThirtyMember_12c8d737-665b-497a-a087-e3ffe8e7ac9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandFortyMember_26856da0-c540-4de9-bbfa-70a649f64baa" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandFortyMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ee1112c3-47ff-4b4b-b07e-32320b4b8ec6" xlink:to="loc_iff_SeniorNotesDueTwoThousandFortyMember_26856da0-c540-4de9-bbfa-70a649f64baa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandFiftyMember_cbdbe92a-272c-4b43-87ef-bcc8da2643cb" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandFiftyMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ee1112c3-47ff-4b4b-b07e-32320b4b8ec6" xlink:to="loc_iff_SeniorNotesDueTwoThousandFiftyMember_cbdbe92a-272c-4b43-87ef-bcc8da2643cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_A2024TermLoanMember_1a46652b-29cd-4449-afe8-d9036e5b05cc" xlink:href="iff-20231231.xsd#iff_A2024TermLoanMember"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ee1112c3-47ff-4b4b-b07e-32320b4b8ec6" xlink:to="loc_iff_A2024TermLoanMember_1a46652b-29cd-4449-afe8-d9036e5b05cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_A2026TermLoanMember_c6a3e475-9605-4de2-90d6-0ec2f33ae200" xlink:href="iff-20231231.xsd#iff_A2026TermLoanMember"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ee1112c3-47ff-4b4b-b07e-32320b4b8ec6" xlink:to="loc_iff_A2026TermLoanMember_c6a3e475-9605-4de2-90d6-0ec2f33ae200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesDueTwoThousandTwentyTwoMember_af1735e7-42b3-4b9b-826b-ef9373273c23" xlink:href="iff-20231231.xsd#iff_SeniorNotesDueTwoThousandTwentyTwoMember"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ee1112c3-47ff-4b4b-b07e-32320b4b8ec6" xlink:to="loc_iff_SeniorNotesDueTwoThousandTwentyTwoMember_af1735e7-42b3-4b9b-826b-ef9373273c23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_151209ce-b49b-4009-bf34-b13aa1acb24c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d1c84d45-e654-4fae-b162-4fc9265f3136" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_151209ce-b49b-4009-bf34-b13aa1acb24c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_623ecc5b-40f3-4135-8f39-ab53175d8c6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_151209ce-b49b-4009-bf34-b13aa1acb24c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_623ecc5b-40f3-4135-8f39-ab53175d8c6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_52019e97-2d63-47a2-bfb6-aac2272604d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_623ecc5b-40f3-4135-8f39-ab53175d8c6c" xlink:to="loc_us-gaap_CurrencySwapMember_52019e97-2d63-47a2-bfb6-aac2272604d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_689e575c-7a90-4bcd-91af-bd64ebd9cb0b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d1c84d45-e654-4fae-b162-4fc9265f3136" xlink:to="loc_us-gaap_HedgingDesignationAxis_689e575c-7a90-4bcd-91af-bd64ebd9cb0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_5f2d21ac-f4ec-4c9e-8250-cf8a49f34f00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_689e575c-7a90-4bcd-91af-bd64ebd9cb0b" xlink:to="loc_us-gaap_HedgingDesignationDomain_5f2d21ac-f4ec-4c9e-8250-cf8a49f34f00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_3cd7fe4b-150b-43f6-a076-6ed971007d23" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_5f2d21ac-f4ec-4c9e-8250-cf8a49f34f00" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_3cd7fe4b-150b-43f6-a076-6ed971007d23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_263d1fe9-d88e-44a9-b4e8-d19cc661943e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d1c84d45-e654-4fae-b162-4fc9265f3136" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_263d1fe9-d88e-44a9-b4e8-d19cc661943e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_e22ce633-88b0-441a-9fec-9af962c16fd5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_263d1fe9-d88e-44a9-b4e8-d19cc661943e" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_e22ce633-88b0-441a-9fec-9af962c16fd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_cadd0aee-8432-4d88-add9-4e1633d22871" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_e22ce633-88b0-441a-9fec-9af962c16fd5" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_cadd0aee-8432-4d88-add9-4e1633d22871" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_73845fc2-2bc0-4b11-bee0-d611b9f4c12f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_e22ce633-88b0-441a-9fec-9af962c16fd5" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_73845fc2-2bc0-4b11-bee0-d611b9f4c12f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_e9aa53ac-19a5-4f92-9dfa-1c8f5b83d8f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_e22ce633-88b0-441a-9fec-9af962c16fd5" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_e9aa53ac-19a5-4f92-9dfa-1c8f5b83d8f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7aa769e7-0f19-4f3f-92d2-842e06a7b766" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d1c84d45-e654-4fae-b162-4fc9265f3136" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7aa769e7-0f19-4f3f-92d2-842e06a7b766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_bcb527a7-92a2-4d28-9eaa-939d2105fec6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7aa769e7-0f19-4f3f-92d2-842e06a7b766" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_bcb527a7-92a2-4d28-9eaa-939d2105fec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableFairValueDisclosure_5cb9d8ac-a8a7-4b16-82e1-a306bbb15b80" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LoansPayableFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7aa769e7-0f19-4f3f-92d2-842e06a7b766" xlink:to="loc_us-gaap_LoansPayableFairValueDisclosure_5cb9d8ac-a8a7-4b16-82e1-a306bbb15b80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration_84def275-6d80-4bb5-823d-cf975e38471b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7aa769e7-0f19-4f3f-92d2-842e06a7b766" xlink:to="loc_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration_84def275-6d80-4bb5-823d-cf975e38471b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_85cae31b-2d9c-4ab6-92cb-d68392a9b1f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7aa769e7-0f19-4f3f-92d2-842e06a7b766" xlink:to="loc_us-gaap_DerivativeAssets_85cae31b-2d9c-4ab6-92cb-d68392a9b1f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration_c63d75b6-8818-4ef9-aeb2-8071bd12707a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7aa769e7-0f19-4f3f-92d2-842e06a7b766" xlink:to="loc_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration_c63d75b6-8818-4ef9-aeb2-8071bd12707a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_95346ad1-305c-47db-be06-61864ef06b22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7aa769e7-0f19-4f3f-92d2-842e06a7b766" xlink:to="loc_us-gaap_DerivativeLiabilities_95346ad1-305c-47db-be06-61864ef06b22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorLongTermNotes_9354d77f-de0f-4c15-9118-85ea2af7ce3e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorLongTermNotes"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7aa769e7-0f19-4f3f-92d2-842e06a7b766" xlink:to="loc_us-gaap_SeniorLongTermNotes_9354d77f-de0f-4c15-9118-85ea2af7ce3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper_1bf4839d-54aa-4652-892c-cfd9d0832a09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommercialPaper"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7aa769e7-0f19-4f3f-92d2-842e06a7b766" xlink:to="loc_us-gaap_CommercialPaper_1bf4839d-54aa-4652-892c-cfd9d0832a09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesCurrent_cae67024-b504-404d-b9a1-0b9d6724ae52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7aa769e7-0f19-4f3f-92d2-842e06a7b766" xlink:to="loc_us-gaap_SeniorNotesCurrent_cae67024-b504-404d-b9a1-0b9d6724ae52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromHedgeInvestingActivities_c7b4c01c-956f-485e-949c-2b0a4d5b824c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForProceedsFromHedgeInvestingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7aa769e7-0f19-4f3f-92d2-842e06a7b766" xlink:to="loc_us-gaap_PaymentsForProceedsFromHedgeInvestingActivities_c7b4c01c-956f-485e-949c-2b0a4d5b824c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_6ff94f2d-23d0-443a-9455-1007b4aed547" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7aa769e7-0f19-4f3f-92d2-842e06a7b766" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_6ff94f2d-23d0-443a-9455-1007b4aed547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsNotionalAmountOutstandingDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#FinancialInstrumentsDerivativeInstrumentsNotionalAmountOutstandingDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsNotionalAmountOutstandingDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b7f87ac6-7ff8-4ffc-bf88-cb03156fa766" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsTable_3ee5f6d6-9c8f-4385-8116-4f5e5df8591e" xlink:href="iff-20231231.xsd#iff_ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b7f87ac6-7ff8-4ffc-bf88-cb03156fa766" xlink:to="loc_iff_ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsTable_3ee5f6d6-9c8f-4385-8116-4f5e5df8591e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8b16c043-ed97-415a-89ed-8a24932a921d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsTable_3ee5f6d6-9c8f-4385-8116-4f5e5df8591e" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8b16c043-ed97-415a-89ed-8a24932a921d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_d9579586-96c2-4811-8a64-4f35e37eed18" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8b16c043-ed97-415a-89ed-8a24932a921d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_d9579586-96c2-4811-8a64-4f35e37eed18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember_853cc371-3ea6-414d-896a-e841d4b90369" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForwardContractsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d9579586-96c2-4811-8a64-4f35e37eed18" xlink:to="loc_us-gaap_ForwardContractsMember_853cc371-3ea6-414d-896a-e841d4b90369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_521a15f0-ff30-4dbf-9dd8-4dea277a0367" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d9579586-96c2-4811-8a64-4f35e37eed18" xlink:to="loc_us-gaap_CurrencySwapMember_521a15f0-ff30-4dbf-9dd8-4dea277a0367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_cce0c558-5e3e-4083-b745-57ea20e2f854" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d9579586-96c2-4811-8a64-4f35e37eed18" xlink:to="loc_us-gaap_InterestRateSwapMember_cce0c558-5e3e-4083-b745-57ea20e2f854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember_ff7f625a-f922-468e-ae60-2aa6fa94777c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommodityContractMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d9579586-96c2-4811-8a64-4f35e37eed18" xlink:to="loc_us-gaap_CommodityContractMember_ff7f625a-f922-468e-ae60-2aa6fa94777c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_f24c3c07-592a-499a-a1c9-4d81f8c9fc1c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsTable_3ee5f6d6-9c8f-4385-8116-4f5e5df8591e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_f24c3c07-592a-499a-a1c9-4d81f8c9fc1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_ff8ffa3b-37d1-4d81-9d3a-6a4a7155e3fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_f24c3c07-592a-499a-a1c9-4d81f8c9fc1c" xlink:to="loc_us-gaap_HedgingRelationshipDomain_ff8ffa3b-37d1-4d81-9d3a-6a4a7155e3fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_87659a47-47db-4e69-a921-ab1d80cf74f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_ff8ffa3b-37d1-4d81-9d3a-6a4a7155e3fb" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_87659a47-47db-4e69-a921-ab1d80cf74f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsLineItems_ab39400d-4410-44ff-9fd9-8f740dce5943" xlink:href="iff-20231231.xsd#iff_ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsTable_3ee5f6d6-9c8f-4385-8116-4f5e5df8591e" xlink:to="loc_iff_ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsLineItems_ab39400d-4410-44ff-9fd9-8f740dce5943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DerivativeNotionalAmountNet_91191406-5051-45ae-bdd5-1ba7298acdce" xlink:href="iff-20231231.xsd#iff_DerivativeNotionalAmountNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsLineItems_ab39400d-4410-44ff-9fd9-8f740dce5943" xlink:to="loc_iff_DerivativeNotionalAmountNet_91191406-5051-45ae-bdd5-1ba7298acdce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_534ea20c-13f1-4c88-8d4f-32527ccc7b6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsLineItems_ab39400d-4410-44ff-9fd9-8f740dce5943" xlink:to="loc_us-gaap_DerivativeNotionalAmount_534ea20c-13f1-4c88-8d4f-32527ccc7b6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsMeasuredatFairValueDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#FinancialInstrumentsDerivativeInstrumentsMeasuredatFairValueDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsMeasuredatFairValueDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d2e51089-35cb-4331-93de-8f9ff7a6ab53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_71256ed6-c10e-4a1a-83a9-844eb5da0df8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d2e51089-35cb-4331-93de-8f9ff7a6ab53" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_71256ed6-c10e-4a1a-83a9-844eb5da0df8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_48402b32-e841-4489-80f4-9c284b25150f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_71256ed6-c10e-4a1a-83a9-844eb5da0df8" xlink:to="loc_us-gaap_HedgingDesignationAxis_48402b32-e841-4489-80f4-9c284b25150f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_499b3b75-f1a6-481e-bc81-e594edf80e04" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_48402b32-e841-4489-80f4-9c284b25150f" xlink:to="loc_us-gaap_HedgingDesignationDomain_499b3b75-f1a6-481e-bc81-e594edf80e04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_fcbeb3c0-0c4e-4366-8565-4eb92bf9c4d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_499b3b75-f1a6-481e-bc81-e594edf80e04" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_fcbeb3c0-0c4e-4366-8565-4eb92bf9c4d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_f6153a14-783b-4273-b474-7bd00f167047" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_499b3b75-f1a6-481e-bc81-e594edf80e04" xlink:to="loc_us-gaap_NondesignatedMember_f6153a14-783b-4273-b474-7bd00f167047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_3bbace99-b381-4f6d-981d-6106af482f93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_71256ed6-c10e-4a1a-83a9-844eb5da0df8" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_3bbace99-b381-4f6d-981d-6106af482f93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_eaea2592-729e-427a-8d22-a602a839046f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3bbace99-b381-4f6d-981d-6106af482f93" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_eaea2592-729e-427a-8d22-a602a839046f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_67ca4279-dbca-4788-9632-cb2440b291c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_eaea2592-729e-427a-8d22-a602a839046f" xlink:to="loc_us-gaap_InterestRateSwapMember_67ca4279-dbca-4788-9632-cb2440b291c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_7106755a-5719-46d7-989f-3a86630bad53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_eaea2592-729e-427a-8d22-a602a839046f" xlink:to="loc_us-gaap_ForeignExchangeContractMember_7106755a-5719-46d7-989f-3a86630bad53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_020cfb52-2dc5-4288-ab9a-fe5d531ecd07" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_eaea2592-729e-427a-8d22-a602a839046f" xlink:to="loc_us-gaap_CurrencySwapMember_020cfb52-2dc5-4288-ab9a-fe5d531ecd07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_865073f5-6c57-443c-b8d3-d8f5be8f9e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_71256ed6-c10e-4a1a-83a9-844eb5da0df8" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_865073f5-6c57-443c-b8d3-d8f5be8f9e5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_833d0f90-3048-4f7d-a61b-007b7cc232a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_865073f5-6c57-443c-b8d3-d8f5be8f9e5c" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_833d0f90-3048-4f7d-a61b-007b7cc232a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_dc19edb6-a513-4959-9146-512dfceb91dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_865073f5-6c57-443c-b8d3-d8f5be8f9e5c" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_dc19edb6-a513-4959-9146-512dfceb91dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration_a9f0038d-7baf-462a-af97-f76d1b5dd092" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_865073f5-6c57-443c-b8d3-d8f5be8f9e5c" xlink:to="loc_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration_a9f0038d-7baf-462a-af97-f76d1b5dd092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsWhichWereNotDesignatedasHedgingInstrumentsDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#FinancialInstrumentsDerivativeInstrumentsWhichWereNotDesignatedasHedgingInstrumentsDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsWhichWereNotDesignatedasHedgingInstrumentsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4cce9fed-a922-4c87-bee2-f57af7fcf4ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_d29ace01-5266-4aa2-b278-27be3f3cf782" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4cce9fed-a922-4c87-bee2-f57af7fcf4ac" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_d29ace01-5266-4aa2-b278-27be3f3cf782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnderlyingAssetClassAxis_81319eb4-7e36-4b01-9d00-6cb2e0704380" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnderlyingAssetClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_d29ace01-5266-4aa2-b278-27be3f3cf782" xlink:to="loc_us-gaap_UnderlyingAssetClassAxis_81319eb4-7e36-4b01-9d00-6cb2e0704380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnderlyingAssetClassDomain_7058565d-0683-4219-83b3-64740d181dcc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnderlyingAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnderlyingAssetClassAxis_81319eb4-7e36-4b01-9d00-6cb2e0704380" xlink:to="loc_us-gaap_UnderlyingAssetClassDomain_7058565d-0683-4219-83b3-64740d181dcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DealContingentSwapsMember_95b411a6-bc99-4bf1-b947-e10b5ca9441b" xlink:href="iff-20231231.xsd#iff_DealContingentSwapsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnderlyingAssetClassDomain_7058565d-0683-4219-83b3-64740d181dcc" xlink:to="loc_iff_DealContingentSwapsMember_95b411a6-bc99-4bf1-b947-e10b5ca9441b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_354c5349-397f-4f38-9421-5ec8559810f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_d29ace01-5266-4aa2-b278-27be3f3cf782" xlink:to="loc_us-gaap_HedgingDesignationAxis_354c5349-397f-4f38-9421-5ec8559810f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_2090bd68-af26-4df6-b92d-8c247122590a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_354c5349-397f-4f38-9421-5ec8559810f6" xlink:to="loc_us-gaap_HedgingDesignationDomain_2090bd68-af26-4df6-b92d-8c247122590a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_3238d6bb-15a2-44e2-a526-d995c2862547" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_2090bd68-af26-4df6-b92d-8c247122590a" xlink:to="loc_us-gaap_NondesignatedMember_3238d6bb-15a2-44e2-a526-d995c2862547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_21606b82-c47e-46fd-8a03-ffc53107e139" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_d29ace01-5266-4aa2-b278-27be3f3cf782" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_21606b82-c47e-46fd-8a03-ffc53107e139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c7b02cc4-5e22-495a-b015-cbb1f8e28ef7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_21606b82-c47e-46fd-8a03-ffc53107e139" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c7b02cc4-5e22-495a-b015-cbb1f8e28ef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ForeignCurrencyContractsMember_51dbd7df-1513-4e67-899b-8f9d18b6ef3d" xlink:href="iff-20231231.xsd#iff_ForeignCurrencyContractsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c7b02cc4-5e22-495a-b015-cbb1f8e28ef7" xlink:to="loc_iff_ForeignCurrencyContractsMember_51dbd7df-1513-4e67-899b-8f9d18b6ef3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_1455a18c-0210-4d51-9925-add3638bc171" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c7b02cc4-5e22-495a-b015-cbb1f8e28ef7" xlink:to="loc_us-gaap_InterestRateSwapMember_1455a18c-0210-4d51-9925-add3638bc171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_9195bec0-c57a-4415-bba1-f0a22bb48b54" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c7b02cc4-5e22-495a-b015-cbb1f8e28ef7" xlink:to="loc_us-gaap_ForeignExchangeContractMember_9195bec0-c57a-4415-bba1-f0a22bb48b54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember_07444f88-7ba0-4795-b2ff-5110a69354ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommodityContractMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c7b02cc4-5e22-495a-b015-cbb1f8e28ef7" xlink:to="loc_us-gaap_CommodityContractMember_07444f88-7ba0-4795-b2ff-5110a69354ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_4dd60a70-ad73-4cd3-ab98-f96855ca23f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_d29ace01-5266-4aa2-b278-27be3f3cf782" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_4dd60a70-ad73-4cd3-ab98-f96855ca23f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_dc68c0e9-5dd3-48f9-8c99-05300c582145" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_4dd60a70-ad73-4cd3-ab98-f96855ca23f0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_dc68c0e9-5dd3-48f9-8c99-05300c582145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_0c4b009e-5447-49ef-9ea6-8aa4475caec8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_dc68c0e9-5dd3-48f9-8c99-05300c582145" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_0c4b009e-5447-49ef-9ea6-8aa4475caec8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_OtherIncomeExpenseNetMember_ecc180cb-2a81-4ede-9223-582cbce5a129" xlink:href="iff-20231231.xsd#iff_OtherIncomeExpenseNetMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_dc68c0e9-5dd3-48f9-8c99-05300c582145" xlink:to="loc_iff_OtherIncomeExpenseNetMember_ecc180cb-2a81-4ede-9223-582cbce5a129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_98cf1d9c-9a07-4483-8bfb-56652d879a9c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_dc68c0e9-5dd3-48f9-8c99-05300c582145" xlink:to="loc_us-gaap_InterestExpenseMember_98cf1d9c-9a07-4483-8bfb-56652d879a9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e3baf406-76f8-4bc9-a45c-8e82e2bba2e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_d29ace01-5266-4aa2-b278-27be3f3cf782" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e3baf406-76f8-4bc9-a45c-8e82e2bba2e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_64bb1b10-d585-4d96-a817-5f181b917e2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e3baf406-76f8-4bc9-a45c-8e82e2bba2e1" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_64bb1b10-d585-4d96-a817-5f181b917e2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_7e8f6109-59f0-4750-a67f-0386b8e59e4f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e3baf406-76f8-4bc9-a45c-8e82e2bba2e1" xlink:to="loc_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_7e8f6109-59f0-4750-a67f-0386b8e59e4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowandNetInvestmentHedgingInstrumentsDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#FinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowandNetInvestmentHedgingInstrumentsDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowandNetInvestmentHedgingInstrumentsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_fe7cb490-6f2e-4eb0-81a5-f102e76f5119" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_e3efeee7-5710-4092-89c9-a0722153a93f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_fe7cb490-6f2e-4eb0-81a5-f102e76f5119" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_e3efeee7-5710-4092-89c9-a0722153a93f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_921c2184-8c2b-4f9b-8cbe-c6b63b12d094" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_e3efeee7-5710-4092-89c9-a0722153a93f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_921c2184-8c2b-4f9b-8cbe-c6b63b12d094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_657b594d-9931-4bfe-876e-cd715e48619f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_921c2184-8c2b-4f9b-8cbe-c6b63b12d094" xlink:to="loc_us-gaap_EquityComponentDomain_657b594d-9931-4bfe-876e-cd715e48619f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_e0c6049e-2562-47a4-ba63-0fd4a2073473" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_e3efeee7-5710-4092-89c9-a0722153a93f" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_e0c6049e-2562-47a4-ba63-0fd4a2073473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_44757217-c69f-437d-8c6d-dc5551c4f863" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e0c6049e-2562-47a4-ba63-0fd4a2073473" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_44757217-c69f-437d-8c6d-dc5551c4f863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember_e48fdec7-42d9-47ae-a1b8-5bbb35ba55ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForwardContractsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_44757217-c69f-437d-8c6d-dc5551c4f863" xlink:to="loc_us-gaap_ForwardContractsMember_e48fdec7-42d9-47ae-a1b8-5bbb35ba55ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_309b7d25-e71d-46de-b0ed-6b86a978b85e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_44757217-c69f-437d-8c6d-dc5551c4f863" xlink:to="loc_us-gaap_InterestRateSwapMember_309b7d25-e71d-46de-b0ed-6b86a978b85e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EuroSeniorNotes2016Member_aed18a51-5f33-4608-9173-adf97bc037d0" xlink:href="iff-20231231.xsd#iff_EuroSeniorNotes2016Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_44757217-c69f-437d-8c6d-dc5551c4f863" xlink:to="loc_iff_EuroSeniorNotes2016Member_aed18a51-5f33-4608-9173-adf97bc037d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesEuroNotesMaturing2021And2026Member_65aace43-7575-46c0-af7e-22367a6c91cc" xlink:href="iff-20231231.xsd#iff_SeniorNotesEuroNotesMaturing2021And2026Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_44757217-c69f-437d-8c6d-dc5551c4f863" xlink:to="loc_iff_SeniorNotesEuroNotesMaturing2021And2026Member_65aace43-7575-46c0-af7e-22367a6c91cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ForeignCurrencyContractsMember_bae5d325-a1f9-4a4a-bc73-d265e89d87b3" xlink:href="iff-20231231.xsd#iff_ForeignCurrencyContractsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_44757217-c69f-437d-8c6d-dc5551c4f863" xlink:to="loc_iff_ForeignCurrencyContractsMember_bae5d325-a1f9-4a4a-bc73-d265e89d87b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember_07779429-6291-4351-9d3a-03559beee890" xlink:href="iff-20231231.xsd#iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_44757217-c69f-437d-8c6d-dc5551c4f863" xlink:to="loc_iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember_07779429-6291-4351-9d3a-03559beee890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_CrossCurrencySwapsMember_b5ad12b3-332c-4ecd-9a79-135f8520dd9f" xlink:href="iff-20231231.xsd#iff_CrossCurrencySwapsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_44757217-c69f-437d-8c6d-dc5551c4f863" xlink:to="loc_iff_CrossCurrencySwapsMember_b5ad12b3-332c-4ecd-9a79-135f8520dd9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_81b4a434-a144-48c0-b9f5-e3fbfdbc4224" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_44757217-c69f-437d-8c6d-dc5551c4f863" xlink:to="loc_us-gaap_ForeignExchangeContractMember_81b4a434-a144-48c0-b9f5-e3fbfdbc4224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_2d5a817b-c30d-4ae6-93ca-9ddf1318fcc4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_44757217-c69f-437d-8c6d-dc5551c4f863" xlink:to="loc_us-gaap_CurrencySwapMember_2d5a817b-c30d-4ae6-93ca-9ddf1318fcc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_6c2ff78a-f527-49b3-a9f4-d283e32f8762" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_e3efeee7-5710-4092-89c9-a0722153a93f" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_6c2ff78a-f527-49b3-a9f4-d283e32f8762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_9bad2976-c64e-472a-8b61-0f712d07a111" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_6c2ff78a-f527-49b3-a9f4-d283e32f8762" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_9bad2976-c64e-472a-8b61-0f712d07a111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_61cb1d5f-d1d4-47da-9f4d-df83c6c5445d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9bad2976-c64e-472a-8b61-0f712d07a111" xlink:to="loc_us-gaap_CostOfSalesMember_61cb1d5f-d1d4-47da-9f4d-df83c6c5445d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_b8a6ddf6-5965-45ea-a624-066de28b1a55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9bad2976-c64e-472a-8b61-0f712d07a111" xlink:to="loc_us-gaap_InterestExpenseMember_b8a6ddf6-5965-45ea-a624-066de28b1a55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_ae720ff6-c853-4ad9-a4a0-e0a07afb870b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_e3efeee7-5710-4092-89c9-a0722153a93f" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_ae720ff6-c853-4ad9-a4a0-e0a07afb870b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_e024be14-ff18-45ff-bdd6-a46d6af8849f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_ae720ff6-c853-4ad9-a4a0-e0a07afb870b" xlink:to="loc_us-gaap_HedgingRelationshipDomain_e024be14-ff18-45ff-bdd6-a46d6af8849f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_6bce57e2-4cf9-49ed-95ae-2aa3e9d8f612" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_e024be14-ff18-45ff-bdd6-a46d6af8849f" xlink:to="loc_us-gaap_CashFlowHedgingMember_6bce57e2-4cf9-49ed-95ae-2aa3e9d8f612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_7d930efc-4029-425f-a99f-d95d22a4386a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_e024be14-ff18-45ff-bdd6-a46d6af8849f" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_7d930efc-4029-425f-a99f-d95d22a4386a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_15100f95-e822-4cb2-ae02-5dbfaed77786" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_e3efeee7-5710-4092-89c9-a0722153a93f" xlink:to="loc_us-gaap_HedgingDesignationAxis_15100f95-e822-4cb2-ae02-5dbfaed77786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_466d42a8-39b6-4d4e-9328-c1d357208d8f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_15100f95-e822-4cb2-ae02-5dbfaed77786" xlink:to="loc_us-gaap_HedgingDesignationDomain_466d42a8-39b6-4d4e-9328-c1d357208d8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_933d92d9-141e-41f1-b64c-bcfcd2944ba7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_466d42a8-39b6-4d4e-9328-c1d357208d8f" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_933d92d9-141e-41f1-b64c-bcfcd2944ba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_44ef4124-324d-41c5-b90e-b089525598be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_466d42a8-39b6-4d4e-9328-c1d357208d8f" xlink:to="loc_us-gaap_NondesignatedMember_44ef4124-324d-41c5-b90e-b089525598be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_9db9e8c9-b995-4c0a-b803-6e734e25149a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_e3efeee7-5710-4092-89c9-a0722153a93f" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_9db9e8c9-b995-4c0a-b803-6e734e25149a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_1d5b1180-885b-4db7-81d2-9ecbd2c746cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_9db9e8c9-b995-4c0a-b803-6e734e25149a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_1d5b1180-885b-4db7-81d2-9ecbd2c746cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_56c8b4d7-dcb1-444e-87df-f4ee2b64974c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_9db9e8c9-b995-4c0a-b803-6e734e25149a" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_56c8b4d7-dcb1-444e-87df-f4ee2b64974c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_9c7e73c2-dda5-48e3-862f-baa63838210e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_9db9e8c9-b995-4c0a-b803-6e734e25149a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_9c7e73c2-dda5-48e3-862f-baa63838210e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_5b4c4c50-e6c0-47a8-8bda-15a3efa93eab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_9db9e8c9-b995-4c0a-b803-6e734e25149a" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_5b4c4c50-e6c0-47a8-8bda-15a3efa93eab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_d5cef4b4-7051-48ef-bc81-046ed50a6a84" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_9db9e8c9-b995-4c0a-b803-6e734e25149a" xlink:to="loc_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_d5cef4b4-7051-48ef-bc81-046ed50a6a84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromHedgeInvestingActivities_fc3a5d9a-5ab7-411e-b4db-0397db52f3cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForProceedsFromHedgeInvestingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_fe7cb490-6f2e-4eb0-81a5-f102e76f5119" xlink:to="loc_us-gaap_PaymentsForProceedsFromHedgeInvestingActivities_fc3a5d9a-5ab7-411e-b4db-0397db52f3cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivable_e7794f71-69f0-4d85-abca-ad90c9194496" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_fe7cb490-6f2e-4eb0-81a5-f102e76f5119" xlink:to="loc_us-gaap_InterestReceivable_e7794f71-69f0-4d85-abca-ad90c9194496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfForeignCurrencyDerivativesHeld_4e3a3e6d-8a39-40a9-b0db-69cb5424dc59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfForeignCurrencyDerivativesHeld"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_fe7cb490-6f2e-4eb0-81a5-f102e76f5119" xlink:to="loc_us-gaap_NumberOfForeignCurrencyDerivativesHeld_4e3a3e6d-8a39-40a9-b0db-69cb5424dc59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/FinancialInstrumentsAdditionalInformationDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#FinancialInstrumentsAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/FinancialInstrumentsAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_7bde3a3c-5918-4217-8d3f-91f2349ff3f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_64a15c8a-8bc8-4b97-a208-3de78fa56d87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_7bde3a3c-5918-4217-8d3f-91f2349ff3f7" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_64a15c8a-8bc8-4b97-a208-3de78fa56d87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_d6f3ab5b-6170-4002-934f-ea4b72c1c136" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_64a15c8a-8bc8-4b97-a208-3de78fa56d87" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_d6f3ab5b-6170-4002-934f-ea4b72c1c136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_5d58afc8-9720-4bde-b6dd-dea54c598cc9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_d6f3ab5b-6170-4002-934f-ea4b72c1c136" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_5d58afc8-9720-4bde-b6dd-dea54c598cc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_OtherIncomeExpenseNetMember_586b8822-42b2-4591-ab59-115fa692b517" xlink:href="iff-20231231.xsd#iff_OtherIncomeExpenseNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5d58afc8-9720-4bde-b6dd-dea54c598cc9" xlink:to="loc_iff_OtherIncomeExpenseNetMember_586b8822-42b2-4591-ab59-115fa692b517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_d35e72e8-2c54-450b-8c45-13c5f0d8d34a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5d58afc8-9720-4bde-b6dd-dea54c598cc9" xlink:to="loc_us-gaap_InterestExpenseMember_d35e72e8-2c54-450b-8c45-13c5f0d8d34a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnderlyingAssetClassAxis_134ccda8-4866-46ab-b98c-f7fe0582cf12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnderlyingAssetClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_64a15c8a-8bc8-4b97-a208-3de78fa56d87" xlink:to="loc_us-gaap_UnderlyingAssetClassAxis_134ccda8-4866-46ab-b98c-f7fe0582cf12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnderlyingAssetClassDomain_0f73a53a-a833-4e0e-b385-2a6d5d795cb8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnderlyingAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnderlyingAssetClassAxis_134ccda8-4866-46ab-b98c-f7fe0582cf12" xlink:to="loc_us-gaap_UnderlyingAssetClassDomain_0f73a53a-a833-4e0e-b385-2a6d5d795cb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DealContingentSwapsMember_60c82ccc-bd76-41bd-a67e-6e37fecbbdf6" xlink:href="iff-20231231.xsd#iff_DealContingentSwapsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnderlyingAssetClassDomain_0f73a53a-a833-4e0e-b385-2a6d5d795cb8" xlink:to="loc_iff_DealContingentSwapsMember_60c82ccc-bd76-41bd-a67e-6e37fecbbdf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_d845b587-3de8-4784-80fb-f72aa95a2729" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_64a15c8a-8bc8-4b97-a208-3de78fa56d87" xlink:to="loc_us-gaap_HedgingDesignationAxis_d845b587-3de8-4784-80fb-f72aa95a2729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_5902ec16-07de-40b8-830b-ffa0bf122d88" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_d845b587-3de8-4784-80fb-f72aa95a2729" xlink:to="loc_us-gaap_HedgingDesignationDomain_5902ec16-07de-40b8-830b-ffa0bf122d88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_9d5cd5d9-a7f3-4199-9af1-96332d8461e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_5902ec16-07de-40b8-830b-ffa0bf122d88" xlink:to="loc_us-gaap_NondesignatedMember_9d5cd5d9-a7f3-4199-9af1-96332d8461e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_927096ea-e44e-478b-912e-70384e627a89" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_5902ec16-07de-40b8-830b-ffa0bf122d88" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_927096ea-e44e-478b-912e-70384e627a89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_1c4124db-5a92-4c85-aa2b-60510206c2a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_64a15c8a-8bc8-4b97-a208-3de78fa56d87" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_1c4124db-5a92-4c85-aa2b-60510206c2a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f114b3ef-d846-4dfa-ac1c-e47ed40dcc41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_1c4124db-5a92-4c85-aa2b-60510206c2a2" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f114b3ef-d846-4dfa-ac1c-e47ed40dcc41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember_ef6750a5-313d-4b8c-ba8f-db82ea307942" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForwardContractsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f114b3ef-d846-4dfa-ac1c-e47ed40dcc41" xlink:to="loc_us-gaap_ForwardContractsMember_ef6750a5-313d-4b8c-ba8f-db82ea307942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_c311b588-e5dd-4f2c-8415-7dc088caf435" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f114b3ef-d846-4dfa-ac1c-e47ed40dcc41" xlink:to="loc_us-gaap_CurrencySwapMember_c311b588-e5dd-4f2c-8415-7dc088caf435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_5173dc22-719c-46bb-adef-e921ac30ba79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f114b3ef-d846-4dfa-ac1c-e47ed40dcc41" xlink:to="loc_us-gaap_InterestRateSwapMember_5173dc22-719c-46bb-adef-e921ac30ba79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ForeignCurrencyContractAndInterestRateSwapMember_dd2c7972-ddae-409c-af3c-800603a20694" xlink:href="iff-20231231.xsd#iff_ForeignCurrencyContractAndInterestRateSwapMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f114b3ef-d846-4dfa-ac1c-e47ed40dcc41" xlink:to="loc_iff_ForeignCurrencyContractAndInterestRateSwapMember_dd2c7972-ddae-409c-af3c-800603a20694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ForeignCurrencyContractsMember_2416300b-62a3-41d3-8c09-7f8cd36f7deb" xlink:href="iff-20231231.xsd#iff_ForeignCurrencyContractsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f114b3ef-d846-4dfa-ac1c-e47ed40dcc41" xlink:to="loc_iff_ForeignCurrencyContractsMember_2416300b-62a3-41d3-8c09-7f8cd36f7deb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_A2019And2022CrossCurrencySwapsMember_61bebbf6-9c02-4f48-9001-2c6b61c9381c" xlink:href="iff-20231231.xsd#iff_A2019And2022CrossCurrencySwapsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f114b3ef-d846-4dfa-ac1c-e47ed40dcc41" xlink:to="loc_iff_A2019And2022CrossCurrencySwapsMember_61bebbf6-9c02-4f48-9001-2c6b61c9381c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_A2022CrossCurrencySwapsMember_11fb446f-3d73-4ca2-b935-4890a56ad0f7" xlink:href="iff-20231231.xsd#iff_A2022CrossCurrencySwapsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f114b3ef-d846-4dfa-ac1c-e47ed40dcc41" xlink:to="loc_iff_A2022CrossCurrencySwapsMember_11fb446f-3d73-4ca2-b935-4890a56ad0f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d05e4461-1896-4701-a393-8c2869308016" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_64a15c8a-8bc8-4b97-a208-3de78fa56d87" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d05e4461-1896-4701-a393-8c2869308016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_3c662577-ba8f-4d6a-aad7-5fc7e8f1e786" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d05e4461-1896-4701-a393-8c2869308016" xlink:to="loc_us-gaap_HedgingRelationshipDomain_3c662577-ba8f-4d6a-aad7-5fc7e8f1e786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_6c1d4222-8784-438a-ab40-af4631077e3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_3c662577-ba8f-4d6a-aad7-5fc7e8f1e786" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_6c1d4222-8784-438a-ab40-af4631077e3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_0e612799-d9a6-4c02-8179-decb718a95a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_64a15c8a-8bc8-4b97-a208-3de78fa56d87" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_0e612799-d9a6-4c02-8179-decb718a95a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_40e169a2-1efe-41b8-b293-45ee1dd0667b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_0e612799-d9a6-4c02-8179-decb718a95a3" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_40e169a2-1efe-41b8-b293-45ee1dd0667b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DeferredGainLossOnTerminatedInterestRateContracts_3d2e29a5-37c0-4380-803b-64fbe3beebc2" xlink:href="iff-20231231.xsd#iff_DeferredGainLossOnTerminatedInterestRateContracts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_0e612799-d9a6-4c02-8179-decb718a95a3" xlink:to="loc_iff_DeferredGainLossOnTerminatedInterestRateContracts_3d2e29a5-37c0-4380-803b-64fbe3beebc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfDerivatives_061ae71d-7aac-42b6-9a1d-cbce61f86c1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfDerivatives"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_0e612799-d9a6-4c02-8179-decb718a95a3" xlink:to="loc_us-gaap_GainLossOnSaleOfDerivatives_061ae71d-7aac-42b6-9a1d-cbce61f86c1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld_1e4fd31d-3d72-4f0d-9bf6-9174aed37b58" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_0e612799-d9a6-4c02-8179-decb718a95a3" xlink:to="loc_us-gaap_NumberOfInterestRateDerivativesHeld_1e4fd31d-3d72-4f0d-9bf6-9174aed37b58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_196ff3ca-6578-4e0b-9f19-8a020a4240ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_0e612799-d9a6-4c02-8179-decb718a95a3" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_196ff3ca-6578-4e0b-9f19-8a020a4240ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_db0ca283-1c18-4996-a14d-6bf20ac622d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_0e612799-d9a6-4c02-8179-decb718a95a3" xlink:to="loc_us-gaap_DerivativeNotionalAmount_db0ca283-1c18-4996-a14d-6bf20ac622d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_2b988462-e708-4ffa-91d4-09568ed43661" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_0e612799-d9a6-4c02-8179-decb718a95a3" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_2b988462-e708-4ffa-91d4-09568ed43661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_35726c36-3430-4810-9b34-0eaf85683f03" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_0e612799-d9a6-4c02-8179-decb718a95a3" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_35726c36-3430-4810-9b34-0eaf85683f03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfForeignCurrencyDerivativesHeld_1e4c4b07-2a3e-419e-86d8-7917aca8ee11" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfForeignCurrencyDerivativesHeld"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_0e612799-d9a6-4c02-8179-decb718a95a3" xlink:to="loc_us-gaap_NumberOfForeignCurrencyDerivativesHeld_1e4c4b07-2a3e-419e-86d8-7917aca8ee11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities_da426d50-142b-4788-a69b-de11f2d2f939" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_0e612799-d9a6-4c02-8179-decb718a95a3" xlink:to="loc_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities_da426d50-142b-4788-a69b-de11f2d2f939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromHedgeInvestingActivities_02d2023f-c554-4022-a8aa-6f55287d8963" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForProceedsFromHedgeInvestingActivities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_0e612799-d9a6-4c02-8179-decb718a95a3" xlink:to="loc_us-gaap_PaymentsForProceedsFromHedgeInvestingActivities_02d2023f-c554-4022-a8aa-6f55287d8963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivable_73835796-77ba-4c50-a778-38b551b0c699" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestReceivable"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_0e612799-d9a6-4c02-8179-decb718a95a3" xlink:to="loc_us-gaap_InterestReceivable_73835796-77ba-4c50-a778-38b551b0c699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_eba27dd1-c98c-4cbf-89db-f81388217dda" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_0e612799-d9a6-4c02-8179-decb718a95a3" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_eba27dd1-c98c-4cbf-89db-f81388217dda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_656a615f-31a0-4d7b-9d2e-949089e09a32" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_0e612799-d9a6-4c02-8179-decb718a95a3" xlink:to="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_656a615f-31a0-4d7b-9d2e-949089e09a32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNetHedgeIneffectivenessGainLoss_6cf8cfcb-f934-4781-a946-8a2bd812a499" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeNetHedgeIneffectivenessGainLoss"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_0e612799-d9a6-4c02-8179-decb718a95a3" xlink:to="loc_us-gaap_DerivativeNetHedgeIneffectivenessGainLoss_6cf8cfcb-f934-4781-a946-8a2bd812a499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#AccumulatedOtherComprehensiveIncomeLossScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_cffe065c-d50c-4ed6-b83d-f2473ed5151c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e23865f8-2772-47c7-9d0f-822c0cf8d0f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_cffe065c-d50c-4ed6-b83d-f2473ed5151c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e23865f8-2772-47c7-9d0f-822c0cf8d0f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_5ecf1c70-38ac-485c-85f5-664be486547d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e23865f8-2772-47c7-9d0f-822c0cf8d0f7" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_5ecf1c70-38ac-485c-85f5-664be486547d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_722683fa-d9fc-490e-b2a6-6d02ea578627" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5ecf1c70-38ac-485c-85f5-664be486547d" xlink:to="loc_us-gaap_EquityComponentDomain_722683fa-d9fc-490e-b2a6-6d02ea578627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_31e268b7-3931-4472-b5d4-d6f39696fef2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_722683fa-d9fc-490e-b2a6-6d02ea578627" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_31e268b7-3931-4472-b5d4-d6f39696fef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_3006b085-9a23-4149-b553-52e3c5f3c833" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_722683fa-d9fc-490e-b2a6-6d02ea578627" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_3006b085-9a23-4149-b553-52e3c5f3c833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_a7c3b733-f683-4587-848e-e173e9580658" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_722683fa-d9fc-490e-b2a6-6d02ea578627" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_a7c3b733-f683-4587-848e-e173e9580658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_196ecac6-e39f-413e-8fb8-e0dc05f28496" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_722683fa-d9fc-490e-b2a6-6d02ea578627" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_196ecac6-e39f-413e-8fb8-e0dc05f28496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_2de21060-4fbd-465d-9fe3-ad0d2ccf3ee6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e23865f8-2772-47c7-9d0f-822c0cf8d0f7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_2de21060-4fbd-465d-9fe3-ad0d2ccf3ee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_13b94be1-dbf3-4709-8964-47b0944a4647" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_2de21060-4fbd-465d-9fe3-ad0d2ccf3ee6" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_13b94be1-dbf3-4709-8964-47b0944a4647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1a6779cb-c861-4b53-b5b5-fe2543f27340" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_13b94be1-dbf3-4709-8964-47b0944a4647" xlink:to="loc_us-gaap_StockholdersEquity_1a6779cb-c861-4b53-b5b5-fe2543f27340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_8dd81f31-db13-40e7-a3ea-de57f382807c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_13b94be1-dbf3-4709-8964-47b0944a4647" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_8dd81f31-db13-40e7-a3ea-de57f382807c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_73937ece-7e05-4af9-9409-7833fc177c36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_13b94be1-dbf3-4709-8964-47b0944a4647" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_73937ece-7e05-4af9-9409-7833fc177c36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_0ace1428-f3c2-4c12-a1be-a24f0a2280dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_13b94be1-dbf3-4709-8964-47b0944a4647" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_0ace1428-f3c2-4c12-a1be-a24f0a2280dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_21916b48-c07a-45c9-977d-a9bac08b5191" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_13b94be1-dbf3-4709-8964-47b0944a4647" xlink:to="loc_us-gaap_StockholdersEquity_21916b48-c07a-45c9-977d-a9bac08b5191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIDueToBusinessDivestitures_e3b0f6fd-c4e8-46aa-a1e9-3e0dc4357e2f" xlink:href="iff-20231231.xsd#iff_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIDueToBusinessDivestitures"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_2de21060-4fbd-465d-9fe3-ad0d2ccf3ee6" xlink:to="loc_iff_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIDueToBusinessDivestitures_e3b0f6fd-c4e8-46aa-a1e9-3e0dc4357e2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossReclassificationsofAccumulatedOtherComprehensiveIncometoConsolidatedStatementofComprehensiveIncomeDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#AccumulatedOtherComprehensiveIncomeLossReclassificationsofAccumulatedOtherComprehensiveIncometoConsolidatedStatementofComprehensiveIncomeDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossReclassificationsofAccumulatedOtherComprehensiveIncometoConsolidatedStatementofComprehensiveIncomeDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_35ed90f8-7dbc-4b41-91f1-4f11107bc469" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_2a469cea-2dd2-4428-b3e4-842b2f8b6587" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_35ed90f8-7dbc-4b41-91f1-4f11107bc469" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_2a469cea-2dd2-4428-b3e4-842b2f8b6587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_db02281c-27de-41d5-a527-cd5c54a3be95" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_2a469cea-2dd2-4428-b3e4-842b2f8b6587" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_db02281c-27de-41d5-a527-cd5c54a3be95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ac563f2e-e97f-457a-9d62-05815c8f62a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_db02281c-27de-41d5-a527-cd5c54a3be95" xlink:to="loc_us-gaap_EquityComponentDomain_ac563f2e-e97f-457a-9d62-05815c8f62a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_93332961-9569-4468-8365-e8a17077131d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ac563f2e-e97f-457a-9d62-05815c8f62a4" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_93332961-9569-4468-8365-e8a17077131d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_b74d95f9-1216-4f9b-8f71-6572f6e75801" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ac563f2e-e97f-457a-9d62-05815c8f62a4" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_b74d95f9-1216-4f9b-8f71-6572f6e75801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AccumulatedDefinedBenefitPlansAdjustmentSettlementsCurtailmentsAttributableToParentMember_1813cff5-775c-49e1-906f-e2313c039ca9" xlink:href="iff-20231231.xsd#iff_AccumulatedDefinedBenefitPlansAdjustmentSettlementsCurtailmentsAttributableToParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_b74d95f9-1216-4f9b-8f71-6572f6e75801" xlink:to="loc_iff_AccumulatedDefinedBenefitPlansAdjustmentSettlementsCurtailmentsAttributableToParentMember_1813cff5-775c-49e1-906f-e2313c039ca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_80681eb3-cc5e-4f7e-9493-11592eaf78db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_b74d95f9-1216-4f9b-8f71-6572f6e75801" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_80681eb3-cc5e-4f7e-9493-11592eaf78db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_d4f239b3-e0fb-44fa-8c27-19095b3544ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_b74d95f9-1216-4f9b-8f71-6572f6e75801" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_d4f239b3-e0fb-44fa-8c27-19095b3544ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AccumulatedDefinedBenefitPlansAdjustmentOtherItemsAttributableToParentMember_419cd518-6781-436f-87d3-d44670e96dec" xlink:href="iff-20231231.xsd#iff_AccumulatedDefinedBenefitPlansAdjustmentOtherItemsAttributableToParentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_b74d95f9-1216-4f9b-8f71-6572f6e75801" xlink:to="loc_iff_AccumulatedDefinedBenefitPlansAdjustmentOtherItemsAttributableToParentMember_419cd518-6781-436f-87d3-d44670e96dec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_5b03e71f-ed84-40ef-a23d-a001c0753ac2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_2a469cea-2dd2-4428-b3e4-842b2f8b6587" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_5b03e71f-ed84-40ef-a23d-a001c0753ac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_2c08a382-3b60-42e2-957a-718305701c47" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_5b03e71f-ed84-40ef-a23d-a001c0753ac2" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_2c08a382-3b60-42e2-957a-718305701c47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_8e0f9fcd-ae76-48e2-a1c3-7950b9e29943" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_2c08a382-3b60-42e2-957a-718305701c47" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_8e0f9fcd-ae76-48e2-a1c3-7950b9e29943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8a417669-5aa6-432b-b294-8aa3ce7453ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_2a469cea-2dd2-4428-b3e4-842b2f8b6587" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8a417669-5aa6-432b-b294-8aa3ce7453ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ada5942c-d200-42c8-98f1-4b2480c40317" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8a417669-5aa6-432b-b294-8aa3ce7453ff" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ada5942c-d200-42c8-98f1-4b2480c40317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_2be3bce6-3106-4f98-9826-94f923a4b82f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ada5942c-d200-42c8-98f1-4b2480c40317" xlink:to="loc_us-gaap_ForeignExchangeContractMember_2be3bce6-3106-4f98-9826-94f923a4b82f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_84a5334e-e5e9-457b-8d3c-db747db6dc55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ada5942c-d200-42c8-98f1-4b2480c40317" xlink:to="loc_us-gaap_InterestRateSwapMember_84a5334e-e5e9-457b-8d3c-db747db6dc55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_a25c63e0-9422-4b61-b932-ff4c682e8fe7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_2a469cea-2dd2-4428-b3e4-842b2f8b6587" xlink:to="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_a25c63e0-9422-4b61-b932-ff4c682e8fe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_8671442c-01f7-47c9-9d90-6f2b2ce20332" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_a25c63e0-9422-4b61-b932-ff4c682e8fe7" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_8671442c-01f7-47c9-9d90-6f2b2ce20332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_44494722-52f8-4253-8ca8-0e52a54f65e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_a25c63e0-9422-4b61-b932-ff4c682e8fe7" xlink:to="loc_us-gaap_InterestExpense_44494722-52f8-4253-8ca8-0e52a54f65e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c6aa7671-dc4b-4ad8-a983-4ebb39145c9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_a25c63e0-9422-4b61-b932-ff4c682e8fe7" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c6aa7671-dc4b-4ad8-a983-4ebb39145c9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_100219cf-d240-41c9-8d34-40dbda5aa7df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_a25c63e0-9422-4b61-b932-ff4c682e8fe7" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_100219cf-d240-41c9-8d34-40dbda5aa7df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_1762edf5-9e1f-49cf-9642-47a93f4f6806" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_a25c63e0-9422-4b61-b932-ff4c682e8fe7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_1762edf5-9e1f-49cf-9642-47a93f4f6806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_75571c8b-ca42-4a23-88cd-f935e842ceee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_a25c63e0-9422-4b61-b932-ff4c682e8fe7" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_75571c8b-ca42-4a23-88cd-f935e842ceee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossReclassificationsofAccumulatedOtherComprehensiveIncometoConsolidatedStatementofComprehensiveIncomeDetail_1" xlink:type="simple" xlink:href="iff-20231231.xsd#AccumulatedOtherComprehensiveIncomeLossReclassificationsofAccumulatedOtherComprehensiveIncometoConsolidatedStatementofComprehensiveIncomeDetail_1"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossReclassificationsofAccumulatedOtherComprehensiveIncometoConsolidatedStatementofComprehensiveIncomeDetail_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.iff.com/role/ConcentrationsOfCreditRiskAdditionalInformationDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#ConcentrationsOfCreditRiskAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/ConcentrationsOfCreditRiskAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_84e4375f-b07d-4a5c-b9aa-9618c01b1011" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_45365271-3626-40c9-88ed-181b6da2913e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_84e4375f-b07d-4a5c-b9aa-9618c01b1011" xlink:to="loc_us-gaap_ConcentrationRiskTable_45365271-3626-40c9-88ed-181b6da2913e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_d9bf3921-f9e1-440f-8476-ecb38dd5d85b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_45365271-3626-40c9-88ed-181b6da2913e" xlink:to="loc_srt_StatementGeographicalAxis_d9bf3921-f9e1-440f-8476-ecb38dd5d85b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_1b839fae-904d-4688-9e8a-7e093a2c6252" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_d9bf3921-f9e1-440f-8476-ecb38dd5d85b" xlink:to="loc_srt_SegmentGeographicalDomain_1b839fae-904d-4688-9e8a-7e093a2c6252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AllForeignCountriesMember_da941f43-3a1d-49cd-83fd-ed15fb2a83da" xlink:href="iff-20231231.xsd#iff_AllForeignCountriesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1b839fae-904d-4688-9e8a-7e093a2c6252" xlink:to="loc_iff_AllForeignCountriesMember_da941f43-3a1d-49cd-83fd-ed15fb2a83da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_6c809bf8-f6f2-4a00-a026-776b98d1d7a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_45365271-3626-40c9-88ed-181b6da2913e" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_6c809bf8-f6f2-4a00-a026-776b98d1d7a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_0652f8f6-c43d-49e3-b689-d190823d090c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_6c809bf8-f6f2-4a00-a026-776b98d1d7a1" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_0652f8f6-c43d-49e3-b689-d190823d090c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember_f51e3005-cbd2-4f82-a08e-30c52a2f0ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_0652f8f6-c43d-49e3-b689-d190823d090c" xlink:to="loc_us-gaap_SalesMember_f51e3005-cbd2-4f82-a08e-30c52a2f0ae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_99894969-732f-4884-ac34-115baa6c8146" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_45365271-3626-40c9-88ed-181b6da2913e" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_99894969-732f-4884-ac34-115baa6c8146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_375d4c6d-3953-4e47-8b74-43a736a2287a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_99894969-732f-4884-ac34-115baa6c8146" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_375d4c6d-3953-4e47-8b74-43a736a2287a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_c380741e-5461-49b3-8fbe-d9f407277023" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_375d4c6d-3953-4e47-8b74-43a736a2287a" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_c380741e-5461-49b3-8fbe-d9f407277023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_ea823884-52f7-4bcd-8ed3-9128ed40a1b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_45365271-3626-40c9-88ed-181b6da2913e" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_ea823884-52f7-4bcd-8ed3-9128ed40a1b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EntityWideRevenueMajorCustomerNumberOfCustomers_472f9303-f269-451b-b65f-22c2c3c29c92" xlink:href="iff-20231231.xsd#iff_EntityWideRevenueMajorCustomerNumberOfCustomers"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_ea823884-52f7-4bcd-8ed3-9128ed40a1b5" xlink:to="loc_iff_EntityWideRevenueMajorCustomerNumberOfCustomers_472f9303-f269-451b-b65f-22c2c3c29c92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_e9748246-259f-4e1c-be1a-553c31bb2e26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_ea823884-52f7-4bcd-8ed3-9128ed40a1b5" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_e9748246-259f-4e1c-be1a-553c31bb2e26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#CommitmentsandContingenciesAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_26dc18ba-6a13-4041-828b-6d56065d8267" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_CommitmentsAndContingenciesTable_8adf3480-5a95-45bc-84eb-235f49a1bd84" xlink:href="iff-20231231.xsd#iff_CommitmentsAndContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_26dc18ba-6a13-4041-828b-6d56065d8267" xlink:to="loc_iff_CommitmentsAndContingenciesTable_8adf3480-5a95-45bc-84eb-235f49a1bd84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2f1d1644-abae-4583-ac58-cbfe7f130668" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_CommitmentsAndContingenciesTable_8adf3480-5a95-45bc-84eb-235f49a1bd84" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2f1d1644-abae-4583-ac58-cbfe7f130668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_6d9bbf09-524c-4048-b891-8a0e18b84663" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2f1d1644-abae-4583-ac58-cbfe7f130668" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_6d9bbf09-524c-4048-b891-8a0e18b84663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ZhejiangIngredientsPlantMember_9c5cc681-486d-4721-9103-ffc3a91f1095" xlink:href="iff-20231231.xsd#iff_ZhejiangIngredientsPlantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_6d9bbf09-524c-4048-b891-8a0e18b84663" xlink:to="loc_iff_ZhejiangIngredientsPlantMember_9c5cc681-486d-4721-9103-ffc3a91f1095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_GuangzhouFlavorsPlantMember_9f6c6342-4198-4d82-8222-7352a81c0715" xlink:href="iff-20231231.xsd#iff_GuangzhouFlavorsPlantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_6d9bbf09-524c-4048-b891-8a0e18b84663" xlink:to="loc_iff_GuangzhouFlavorsPlantMember_9f6c6342-4198-4d82-8222-7352a81c0715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_GuangzhouFragrancePlantMember_6d91ec6f-3944-45b9-a562-df14de4eb9f0" xlink:href="iff-20231231.xsd#iff_GuangzhouFragrancePlantMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_6d9bbf09-524c-4048-b891-8a0e18b84663" xlink:to="loc_iff_GuangzhouFragrancePlantMember_6d91ec6f-3944-45b9-a562-df14de4eb9f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ZhangjiagangFlavorsPlantMember_60742af9-655e-46f4-b5ec-291d60bb67a3" xlink:href="iff-20231231.xsd#iff_ZhangjiagangFlavorsPlantMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_6d9bbf09-524c-4048-b891-8a0e18b84663" xlink:to="loc_iff_ZhangjiagangFlavorsPlantMember_60742af9-655e-46f4-b5ec-291d60bb67a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_4ab0890a-136a-4169-b62f-374628b72aeb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_CommitmentsAndContingenciesTable_8adf3480-5a95-45bc-84eb-235f49a1bd84" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_4ab0890a-136a-4169-b62f-374628b72aeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_1dbc9f70-9ac0-4f3e-8995-3ac115048bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_4ab0890a-136a-4169-b62f-374628b72aeb" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_1dbc9f70-9ac0-4f3e-8995-3ac115048bdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_BR_ef50e3ae-f1e5-4be8-98b0-6c8a527f6456" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_BR"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_1dbc9f70-9ac0-4f3e-8995-3ac115048bdd" xlink:to="loc_country_BR_ef50e3ae-f1e5-4be8-98b0-6c8a527f6456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_141171ad-2397-478e-be7f-bb1588ef0e36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_CommitmentsAndContingenciesTable_8adf3480-5a95-45bc-84eb-235f49a1bd84" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_141171ad-2397-478e-be7f-bb1588ef0e36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_ffbe2120-30c1-4489-adda-ad32a6b8f3db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_141171ad-2397-478e-be7f-bb1588ef0e36" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_ffbe2120-30c1-4489-adda-ad32a6b8f3db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_395b2709-ce90-4ba9-aced-4d698b7e0b4c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_ffbe2120-30c1-4489-adda-ad32a6b8f3db" xlink:to="loc_us-gaap_ForeignCountryMember_395b2709-ce90-4ba9-aced-4d698b7e0b4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_77eade0d-ef07-4bbc-8ba7-b572eb2dfa24" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_CommitmentsAndContingenciesTable_8adf3480-5a95-45bc-84eb-235f49a1bd84" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_77eade0d-ef07-4bbc-8ba7-b572eb2dfa24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0208de51-950f-40b3-a171-a038f0fd964d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_77eade0d-ef07-4bbc-8ba7-b572eb2dfa24" xlink:to="loc_us-gaap_SegmentDomain_0208de51-950f-40b3-a171-a038f0fd964d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TasteMember_3cbc5e7c-46ab-46dd-bbc0-96b93f458004" xlink:href="iff-20231231.xsd#iff_TasteMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0208de51-950f-40b3-a171-a038f0fd964d" xlink:to="loc_iff_TasteMember_3cbc5e7c-46ab-46dd-bbc0-96b93f458004" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ScentMember_0b1135b7-14e4-4290-8581-7ac6ceedc9d6" xlink:href="iff-20231231.xsd#iff_ScentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0208de51-950f-40b3-a171-a038f0fd964d" xlink:to="loc_iff_ScentMember_0b1135b7-14e4-4290-8581-7ac6ceedc9d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_PharmaSolutionsMember_683fb1c9-aa8b-42c5-abd5-00e99e69b776" xlink:href="iff-20231231.xsd#iff_PharmaSolutionsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0208de51-950f-40b3-a171-a038f0fd964d" xlink:to="loc_iff_PharmaSolutionsMember_683fb1c9-aa8b-42c5-abd5-00e99e69b776" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_6a09abc1-be40-4e2d-b872-ce894871288e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_CommitmentsAndContingenciesTable_8adf3480-5a95-45bc-84eb-235f49a1bd84" xlink:to="loc_dei_LegalEntityAxis_6a09abc1-be40-4e2d-b872-ce894871288e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_ee708372-baf2-43d6-b28c-a19040c0544f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_6a09abc1-be40-4e2d-b872-ce894871288e" xlink:to="loc_dei_EntityDomain_ee708372-baf2-43d6-b28c-a19040c0544f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NutritionBiosciencesIncMember_4b52eb7f-300e-412c-9bdd-aab31c9e5299" xlink:href="iff-20231231.xsd#iff_NutritionBiosciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_ee708372-baf2-43d6-b28c-a19040c0544f" xlink:to="loc_iff_NutritionBiosciencesIncMember_4b52eb7f-300e-412c-9bdd-aab31c9e5299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ca5a88f4-d11d-436b-9123-c06b402fdc03" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_CommitmentsAndContingenciesTable_8adf3480-5a95-45bc-84eb-235f49a1bd84" xlink:to="loc_us-gaap_DebtInstrumentAxis_ca5a88f4-d11d-436b-9123-c06b402fdc03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_35d2b7b9-fa76-405b-aed8-2305212dc917" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_ca5a88f4-d11d-436b-9123-c06b402fdc03" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_35d2b7b9-fa76-405b-aed8-2305212dc917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorUnsecuredBridgeTermLoanMember_2f08f852-7d69-4a4d-9799-51863a7a7ec9" xlink:href="iff-20231231.xsd#iff_SeniorUnsecuredBridgeTermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35d2b7b9-fa76-405b-aed8-2305212dc917" xlink:to="loc_iff_SeniorUnsecuredBridgeTermLoanMember_2f08f852-7d69-4a4d-9799-51863a7a7ec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ThreeHundredSixtyFourDaySeniorUnsecuredBridgeFacilityMember_f09295fb-a7eb-4ac6-92ba-72f8d120992d" xlink:href="iff-20231231.xsd#iff_ThreeHundredSixtyFourDaySeniorUnsecuredBridgeFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35d2b7b9-fa76-405b-aed8-2305212dc917" xlink:to="loc_iff_ThreeHundredSixtyFourDaySeniorUnsecuredBridgeFacilityMember_f09295fb-a7eb-4ac6-92ba-72f8d120992d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SeniorUnsecuredNotesMember_762f0210-2825-4521-a209-1a1a9771c5f9" xlink:href="iff-20231231.xsd#iff_SeniorUnsecuredNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35d2b7b9-fa76-405b-aed8-2305212dc917" xlink:to="loc_iff_SeniorUnsecuredNotesMember_762f0210-2825-4521-a209-1a1a9771c5f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_c13a04ec-29bf-4adc-acd9-2477e09326d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_CommitmentsAndContingenciesTable_8adf3480-5a95-45bc-84eb-235f49a1bd84" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_c13a04ec-29bf-4adc-acd9-2477e09326d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_0d1229c4-df5c-4149-878c-69e9ad6d62bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_c13a04ec-29bf-4adc-acd9-2477e09326d7" xlink:to="loc_us-gaap_LossContingencyNatureDomain_0d1229c4-df5c-4149-878c-69e9ad6d62bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_PledgedAssetsMember_a52d8f35-681b-4b76-a29e-934bf55a0908" xlink:href="iff-20231231.xsd#iff_PledgedAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_0d1229c4-df5c-4149-878c-69e9ad6d62bf" xlink:to="loc_iff_PledgedAssetsMember_a52d8f35-681b-4b76-a29e-934bf55a0908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BankGuaranteesMember_89571ea0-d266-43de-8140-1039e09a911c" xlink:href="iff-20231231.xsd#iff_BankGuaranteesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_0d1229c4-df5c-4149-878c-69e9ad6d62bf" xlink:to="loc_iff_BankGuaranteesMember_89571ea0-d266-43de-8140-1039e09a911c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DamagesFromProductDefectsMember_e0527d55-c948-43c1-be0d-4ac7cc1a00d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DamagesFromProductDefectsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_0d1229c4-df5c-4149-878c-69e9ad6d62bf" xlink:to="loc_us-gaap_DamagesFromProductDefectsMember_e0527d55-c948-43c1-be0d-4ac7cc1a00d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BankGuaranteesCommercialGuaranteesStandbyLettersOfCreditAndSuretyBondsMember_073bf59d-d569-4788-a375-c601070b44d8" xlink:href="iff-20231231.xsd#iff_BankGuaranteesCommercialGuaranteesStandbyLettersOfCreditAndSuretyBondsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_0d1229c4-df5c-4149-878c-69e9ad6d62bf" xlink:to="loc_iff_BankGuaranteesCommercialGuaranteesStandbyLettersOfCreditAndSuretyBondsMember_073bf59d-d569-4788-a375-c601070b44d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BrazilTaxCreditsMember_a0e4a539-37da-43b1-aec3-0e28faa1cced" xlink:href="iff-20231231.xsd#iff_BrazilTaxCreditsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_0d1229c4-df5c-4149-878c-69e9ad6d62bf" xlink:to="loc_iff_BrazilTaxCreditsMember_a0e4a539-37da-43b1-aec3-0e28faa1cced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_dd3d3410-a38a-4081-a6a3-2a9364119c64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_CommitmentsAndContingenciesTable_8adf3480-5a95-45bc-84eb-235f49a1bd84" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_dd3d3410-a38a-4081-a6a3-2a9364119c64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_84b0c62f-2a42-44fd-b05d-b8be963bdc1e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_dd3d3410-a38a-4081-a6a3-2a9364119c64" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_84b0c62f-2a42-44fd-b05d-b8be963bdc1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ZhejiangIngredientsPlantMember_27017a41-4d79-4244-bd7b-e95abdf09077" xlink:href="iff-20231231.xsd#iff_ZhejiangIngredientsPlantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_84b0c62f-2a42-44fd-b05d-b8be963bdc1e" xlink:to="loc_iff_ZhejiangIngredientsPlantMember_27017a41-4d79-4244-bd7b-e95abdf09077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManufacturingFacilityMember_79d22cc2-307d-49de-a4c9-fdc658f1b497" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ManufacturingFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_84b0c62f-2a42-44fd-b05d-b8be963bdc1e" xlink:to="loc_us-gaap_ManufacturingFacilityMember_79d22cc2-307d-49de-a4c9-fdc658f1b497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_561a89c1-3389-4a99-9423-0429602940eb" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_CommitmentsAndContingenciesTable_8adf3480-5a95-45bc-84eb-235f49a1bd84" xlink:to="loc_srt_StatementGeographicalAxis_561a89c1-3389-4a99-9423-0429602940eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_dc4480f0-8f0f-4648-ad2d-776f60a79e24" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_561a89c1-3389-4a99-9423-0429602940eb" xlink:to="loc_srt_SegmentGeographicalDomain_dc4480f0-8f0f-4648-ad2d-776f60a79e24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_HangzhouChinaMember_a868ed94-1431-4cb8-98ae-2d5c219b298f" xlink:href="iff-20231231.xsd#iff_HangzhouChinaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_dc4480f0-8f0f-4648-ad2d-776f60a79e24" xlink:to="loc_iff_HangzhouChinaMember_a868ed94-1431-4cb8-98ae-2d5c219b298f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_GuangzhouChinaMember_85401b30-319f-46ec-85d5-acf89cd7ce21" xlink:href="iff-20231231.xsd#iff_GuangzhouChinaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_dc4480f0-8f0f-4648-ad2d-776f60a79e24" xlink:to="loc_iff_GuangzhouChinaMember_85401b30-319f-46ec-85d5-acf89cd7ce21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ZhejiangChinaMember_7b72d51e-d987-476b-bc86-33cef0fe5347" xlink:href="iff-20231231.xsd#iff_ZhejiangChinaMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_dc4480f0-8f0f-4648-ad2d-776f60a79e24" xlink:to="loc_iff_ZhejiangChinaMember_7b72d51e-d987-476b-bc86-33cef0fe5347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN_5e582a7f-7c56-4a9f-809b-177cc4561914" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CN"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_dc4480f0-8f0f-4648-ad2d-776f60a79e24" xlink:to="loc_country_CN_5e582a7f-7c56-4a9f-809b-177cc4561914" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_BR_ee52d298-38be-4b13-9d2c-f839a1836d6e" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_BR"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_dc4480f0-8f0f-4648-ad2d-776f60a79e24" xlink:to="loc_country_BR_ee52d298-38be-4b13-9d2c-f839a1836d6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ZhangjiagangChinaMember_0ccff540-5f15-4caa-b50c-acc990d77c29" xlink:href="iff-20231231.xsd#iff_ZhangjiagangChinaMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_dc4480f0-8f0f-4648-ad2d-776f60a79e24" xlink:to="loc_iff_ZhangjiagangChinaMember_0ccff540-5f15-4caa-b50c-acc990d77c29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ec26c4ef-6cc2-463f-ad40-a932bcc505a0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_CommitmentsAndContingenciesTable_8adf3480-5a95-45bc-84eb-235f49a1bd84" xlink:to="loc_srt_RangeAxis_ec26c4ef-6cc2-463f-ad40-a932bcc505a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_19278376-cf65-4206-8011-8fac08dac064" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_ec26c4ef-6cc2-463f-ad40-a932bcc505a0" xlink:to="loc_srt_RangeMember_19278376-cf65-4206-8011-8fac08dac064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_34bbe0f4-0758-46fe-a604-f0ac4b53eca0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_19278376-cf65-4206-8011-8fac08dac064" xlink:to="loc_srt_MinimumMember_34bbe0f4-0758-46fe-a604-f0ac4b53eca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a804fe80-8e38-4943-a37a-698d0d55b6a9" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_19278376-cf65-4206-8011-8fac08dac064" xlink:to="loc_srt_MaximumMember_a804fe80-8e38-4943-a37a-698d0d55b6a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_a1c8728c-d950-4a08-a0e4-d2bd9483945a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_CommitmentsAndContingenciesTable_8adf3480-5a95-45bc-84eb-235f49a1bd84" xlink:to="loc_srt_TitleOfIndividualAxis_a1c8728c-d950-4a08-a0e4-d2bd9483945a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_c338b23e-bef0-4f1c-b95d-a3d082494866" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_a1c8728c-d950-4a08-a0e4-d2bd9483945a" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_c338b23e-bef0-4f1c-b95d-a3d082494866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_aba7a1d7-e206-414f-9924-b709b7e8fb7b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_c338b23e-bef0-4f1c-b95d-a3d082494866" xlink:to="loc_srt_ChiefExecutiveOfficerMember_aba7a1d7-e206-414f-9924-b709b7e8fb7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_7d575e77-a873-49b1-90bd-8124d98b82ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_CommitmentsAndContingenciesTable_8adf3480-5a95-45bc-84eb-235f49a1bd84" xlink:to="loc_us-gaap_CreditFacilityAxis_7d575e77-a873-49b1-90bd-8124d98b82ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_c7d8c51d-d55f-4265-a6e3-9c72b8026c30" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_7d575e77-a873-49b1-90bd-8124d98b82ec" xlink:to="loc_us-gaap_CreditFacilityDomain_c7d8c51d-d55f-4265-a6e3-9c72b8026c30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_28d0cf92-1701-4962-92f5-b039338336e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_c7d8c51d-d55f-4265-a6e3-9c72b8026c30" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_28d0cf92-1701-4962-92f5-b039338336e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_56c4c346-1d4c-4c3d-8d24-cdfc7abc9b27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_CommitmentsAndContingenciesTable_8adf3480-5a95-45bc-84eb-235f49a1bd84" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_56c4c346-1d4c-4c3d-8d24-cdfc7abc9b27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_feba3e8a-0fa9-4a8f-852b-158f3bfddb6a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_56c4c346-1d4c-4c3d-8d24-cdfc7abc9b27" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_feba3e8a-0fa9-4a8f-852b-158f3bfddb6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_CitibankN.AMember_5e8e4778-d0c3-4a2f-930e-f5ad9fe3ab26" xlink:href="iff-20231231.xsd#iff_CitibankN.AMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_feba3e8a-0fa9-4a8f-852b-158f3bfddb6a" xlink:to="loc_iff_CitibankN.AMember_5e8e4778-d0c3-4a2f-930e-f5ad9fe3ab26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:href="iff-20231231.xsd#iff_CommitmentsAndContingenciesLineItems"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_CommitmentsAndContingenciesTable_8adf3480-5a95-45bc-84eb-235f49a1bd84" xlink:to="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_CommercialGuaranteesAmountOutstanding_7f5d9614-3ba6-45c0-8972-5ce29aa7232c" xlink:href="iff-20231231.xsd#iff_CommercialGuaranteesAmountOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_iff_CommercialGuaranteesAmountOutstanding_7f5d9614-3ba6-45c0-8972-5ce29aa7232c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BankGuaranteesRelatedToAppealsOnIncomeTaxAndIndirectTaxCases_811a6080-1800-4bd6-b927-3d65b4f53552" xlink:href="iff-20231231.xsd#iff_BankGuaranteesRelatedToAppealsOnIncomeTaxAndIndirectTaxCases"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_iff_BankGuaranteesRelatedToAppealsOnIncomeTaxAndIndirectTaxCases_811a6080-1800-4bd6-b927-3d65b4f53552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AmountOfPledgedAssetsPrincipallyPropertyPlantAndEquipmentToCoverIncomeTaxAndIndirectTaxAssessments_c4aef6d6-6f31-41c6-acb7-55ce8858da42" xlink:href="iff-20231231.xsd#iff_AmountOfPledgedAssetsPrincipallyPropertyPlantAndEquipmentToCoverIncomeTaxAndIndirectTaxAssessments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_iff_AmountOfPledgedAssetsPrincipallyPropertyPlantAndEquipmentToCoverIncomeTaxAndIndirectTaxAssessments_c4aef6d6-6f31-41c6-acb7-55ce8858da42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfLandHeldForUse_0efac8e7-edb1-44a7-83ab-7112de58b515" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfLandHeldForUse"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_us-gaap_ProceedsFromSaleOfLandHeldForUse_0efac8e7-edb1-44a7-83ab-7112de58b515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_AmountOfAvailableLinesOfCredit_87d9d33d-6158-4225-865b-a1680d52af9f" xlink:href="iff-20231231.xsd#iff_AmountOfAvailableLinesOfCredit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_iff_AmountOfAvailableLinesOfCredit_87d9d33d-6158-4225-865b-a1680d52af9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_a80eb38a-918e-42dd-b44f-20cd40f9c9ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_a80eb38a-918e-42dd-b44f-20cd40f9c9ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BankGuaranteesAndPledgedAssetsToPursueDefensesRelatedToOtherContingencies_f2780b0b-b651-4c27-9906-d719b9b85956" xlink:href="iff-20231231.xsd#iff_BankGuaranteesAndPledgedAssetsToPursueDefensesRelatedToOtherContingencies"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_iff_BankGuaranteesAndPledgedAssetsToPursueDefensesRelatedToOtherContingencies_f2780b0b-b651-4c27-9906-d719b9b85956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityAccrualPeriodExpense_ad028c8d-6bca-4aa7-bba6-91f6afe7249c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductLiabilityAccrualPeriodExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_us-gaap_ProductLiabilityAccrualPeriodExpense_ad028c8d-6bca-4aa7-bba6-91f6afe7249c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NumberofFacilities_b6465359-3184-4a2e-a387-75de8fbf3361" xlink:href="iff-20231231.xsd#iff_NumberofFacilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_iff_NumberofFacilities_b6465359-3184-4a2e-a387-75de8fbf3361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ProductLiabilityContingencyLossExposureinExcessofAccrualAggregateAmountPaid_211fca67-72a6-479b-b8b2-fe28cf49d7bc" xlink:href="iff-20231231.xsd#iff_ProductLiabilityContingencyLossExposureinExcessofAccrualAggregateAmountPaid"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_iff_ProductLiabilityContingencyLossExposureinExcessofAccrualAggregateAmountPaid_211fca67-72a6-479b-b8b2-fe28cf49d7bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ProductLiabilityContingencyLossExposureinExcessofAccrualAmountPaid_e3f92190-ef2e-40d9-bb9b-161751f0a8ee" xlink:href="iff-20231231.xsd#iff_ProductLiabilityContingencyLossExposureinExcessofAccrualAmountPaid"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_iff_ProductLiabilityContingencyLossExposureinExcessofAccrualAmountPaid_e3f92190-ef2e-40d9-bb9b-161751f0a8ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIncomeTaxRefunds_b1b9ada8-91a3-483f-97c8-f1b95b967de0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIncomeTaxRefunds"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_us-gaap_ProceedsFromIncomeTaxRefunds_b1b9ada8-91a3-483f-97c8-f1b95b967de0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_GainContingencyRelocationPaymentsReceived_048e2660-0c45-416d-ab8a-7b554199e7c8" xlink:href="iff-20231231.xsd#iff_GainContingencyRelocationPaymentsReceived"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_iff_GainContingencyRelocationPaymentsReceived_048e2660-0c45-416d-ab8a-7b554199e7c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_cb92ef72-e182-4b13-82b5-97f05c5e1f4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_cb92ef72-e182-4b13-82b5-97f05c5e1f4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense_b649325b-5fc0-49a3-a7bf-dc856ad1b39c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense_b649325b-5fc0-49a3-a7bf-dc856ad1b39c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_7d2a1bc0-db14-47d6-ad5e-87058930db01" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_7d2a1bc0-db14-47d6-ad5e-87058930db01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_GainContingencyExpectedRelocationPayments_c642c48a-bdaa-4ac5-a4f1-146848ca8633" xlink:href="iff-20231231.xsd#iff_GainContingencyExpectedRelocationPayments"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_iff_GainContingencyExpectedRelocationPayments_c642c48a-bdaa-4ac5-a4f1-146848ca8633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TerminationFee_d2e363dd-f4f5-403e-8984-8a23a4d11120" xlink:href="iff-20231231.xsd#iff_TerminationFee"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_iff_TerminationFee_d2e363dd-f4f5-403e-8984-8a23a4d11120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalExpenseAndLiabilities_a6ff6fc0-ad1d-4ef2-934d-512f5665701b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EnvironmentalExpenseAndLiabilities"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_us-gaap_EnvironmentalExpenseAndLiabilities_a6ff6fc0-ad1d-4ef2-934d-512f5665701b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BankGuaranteesStandbyLettersOfCreditAndCommercialGuaranteesAmountOutstanding_acd516c9-fbea-402d-b750-c2badd761bf5" xlink:href="iff-20231231.xsd#iff_BankGuaranteesStandbyLettersOfCreditAndCommercialGuaranteesAmountOutstanding"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_iff_BankGuaranteesStandbyLettersOfCreditAndCommercialGuaranteesAmountOutstanding_acd516c9-fbea-402d-b750-c2badd761bf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_LinesOfCreditFacilityTotalAmountDrawnDown_39ae5a6c-c659-4531-accd-7a48516a0fae" xlink:href="iff-20231231.xsd#iff_LinesOfCreditFacilityTotalAmountDrawnDown"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_iff_LinesOfCreditFacilityTotalAmountDrawnDown_39ae5a6c-c659-4531-accd-7a48516a0fae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_BankGuaranteesCommercialGuaranteesStandbyLettersOfCreditAndSuretyBondsFacilityAmounts_ed534808-7529-4f9e-a588-b557e3e475a5" xlink:href="iff-20231231.xsd#iff_BankGuaranteesCommercialGuaranteesStandbyLettersOfCreditAndSuretyBondsFacilityAmounts"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_iff_BankGuaranteesCommercialGuaranteesStandbyLettersOfCreditAndSuretyBondsFacilityAmounts_ed534808-7529-4f9e-a588-b557e3e475a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper_b333849b-46fd-4967-af5e-1e879b92e0ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommercialPaper"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_us-gaap_CommercialPaper_b333849b-46fd-4967-af5e-1e879b92e0ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscounted_e9789327-0d01-46df-a5f5-0f352806a924" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MalpracticeLossContingencyAccrualUndiscounted"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscounted_e9789327-0d01-46df-a5f5-0f352806a924" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MalpracticeLossContingencyPeriodCost_60c91b0e-9f1a-436a-905a-0534f4735a9b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MalpracticeLossContingencyPeriodCost"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_us-gaap_MalpracticeLossContingencyPeriodCost_60c91b0e-9f1a-436a-905a-0534f4735a9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MalpracticeLossContingencyPeriodIncreaseDecrease_1acc0d38-70bf-466b-9551-0107db55045d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MalpracticeLossContingencyPeriodIncreaseDecrease"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_us-gaap_MalpracticeLossContingencyPeriodIncreaseDecrease_1acc0d38-70bf-466b-9551-0107db55045d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_MalpracticeLossContingencyPaymentsInceptionToDate_541ca78c-b672-46d1-8abb-eba63eeb1470" xlink:href="iff-20231231.xsd#iff_MalpracticeLossContingencyPaymentsInceptionToDate"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_iff_MalpracticeLossContingencyPaymentsInceptionToDate_541ca78c-b672-46d1-8abb-eba63eeb1470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_LossContingencyReceivableWrittenOff_0a7b318b-72a7-43c6-8291-c607e8f4536f" xlink:href="iff-20231231.xsd#iff_LossContingencyReceivableWrittenOff"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_iff_LossContingencyReceivableWrittenOff_0a7b318b-72a7-43c6-8291-c607e8f4536f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_GainLossOnPlantRelocation_be731ccb-cdbb-41bf-8db9-75afeb31a7bb" xlink:href="iff-20231231.xsd#iff_GainLossOnPlantRelocation"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_iff_GainLossOnPlantRelocation_be731ccb-cdbb-41bf-8db9-75afeb31a7bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_EstimatedIncomeTaxExpenseBenefit_d7d3b4b5-3866-4213-b041-a0d287cf26f7" xlink:href="iff-20231231.xsd#iff_EstimatedIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_iff_EstimatedIncomeTaxExpenseBenefit_d7d3b4b5-3866-4213-b041-a0d287cf26f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_c0656bde-266a-48f8-8e7a-be33d6cd6f9d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_CommitmentsAndContingenciesLineItems_aed2588d-5a58-4a35-8dbf-198fe555e104" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_c0656bde-266a-48f8-8e7a-be33d6cd6f9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/RedeemableNoncontrollingInterestsDetails" xlink:type="simple" xlink:href="iff-20231231.xsd#RedeemableNoncontrollingInterestsDetails"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/RedeemableNoncontrollingInterestsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_bc7e92fb-6c19-4f24-ae33-1cdee046f9e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_7ade68ff-69db-431a-9905-ea2f19255ccb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_bc7e92fb-6c19-4f24-ae33-1cdee046f9e1" xlink:to="loc_us-gaap_MinorityInterestTable_7ade68ff-69db-431a-9905-ea2f19255ccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_4e89266d-0834-41b0-a390-c4a0bf68edf0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_7ade68ff-69db-431a-9905-ea2f19255ccb" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_4e89266d-0834-41b0-a390-c4a0bf68edf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_dc5f2be0-1943-4269-b634-df2a3b15e0ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4e89266d-0834-41b0-a390-c4a0bf68edf0" xlink:to="loc_us-gaap_EquityComponentDomain_dc5f2be0-1943-4269-b634-df2a3b15e0ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_RedeemableNoncontrollingInterestMember_110e809b-ff3c-403a-bc46-799ae16d7a04" xlink:href="iff-20231231.xsd#iff_RedeemableNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_dc5f2be0-1943-4269-b634-df2a3b15e0ca" xlink:to="loc_iff_RedeemableNoncontrollingInterestMember_110e809b-ff3c-403a-bc46-799ae16d7a04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_87d150b9-9604-4708-98a3-950e0d2d5aed" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_7ade68ff-69db-431a-9905-ea2f19255ccb" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_87d150b9-9604-4708-98a3-950e0d2d5aed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_bd5c0b36-819f-448c-8bd1-96fa00923167" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_87d150b9-9604-4708-98a3-950e0d2d5aed" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_bd5c0b36-819f-448c-8bd1-96fa00923167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SonaromeMember_a206373a-153a-4467-b4e0-3e4ea860c099" xlink:href="iff-20231231.xsd#iff_SonaromeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_bd5c0b36-819f-448c-8bd1-96fa00923167" xlink:to="loc_iff_SonaromeMember_a206373a-153a-4467-b4e0-3e4ea860c099" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_7cd82ee2-57ba-4b6d-baf2-08d6c3577e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_7ade68ff-69db-431a-9905-ea2f19255ccb" xlink:to="loc_us-gaap_MinorityInterestLineItems_7cd82ee2-57ba-4b6d-baf2-08d6c3577e8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInMinorityInterestRollForward_eb242cc0-8b22-44c9-9dc4-9b86489621c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MovementInMinorityInterestRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_7cd82ee2-57ba-4b6d-baf2-08d6c3577e8a" xlink:to="loc_us-gaap_MovementInMinorityInterestRollForward_eb242cc0-8b22-44c9-9dc4-9b86489621c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_92fbd3fc-19ae-4963-90f7-152c3d09b15e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_eb242cc0-8b22-44c9-9dc4-9b86489621c4" xlink:to="loc_us-gaap_MinorityInterest_92fbd3fc-19ae-4963-90f7-152c3d09b15e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NoncontrollingInterestImpactOfForeignExchangeTranslation_03fe20bd-b43d-4ee8-8e86-6254e9a54f4f" xlink:href="iff-20231231.xsd#iff_NoncontrollingInterestImpactOfForeignExchangeTranslation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_eb242cc0-8b22-44c9-9dc4-9b86489621c4" xlink:to="loc_iff_NoncontrollingInterestImpactOfForeignExchangeTranslation_03fe20bd-b43d-4ee8-8e86-6254e9a54f4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_14ec66da-cfc8-4f4b-903c-63c91b5740c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_eb242cc0-8b22-44c9-9dc4-9b86489621c4" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_14ec66da-cfc8-4f4b-903c-63c91b5740c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestChangeInRedemptionValue_2caaf6b5-a911-4c7d-8af8-1547ef795b8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestChangeInRedemptionValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_eb242cc0-8b22-44c9-9dc4-9b86489621c4" xlink:to="loc_us-gaap_MinorityInterestChangeInRedemptionValue_2caaf6b5-a911-4c7d-8af8-1547ef795b8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_07156bb8-9ca6-4742-b2f4-a8a165a75472" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_eb242cc0-8b22-44c9-9dc4-9b86489621c4" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_07156bb8-9ca6-4742-b2f4-a8a165a75472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_50c822c0-0fbe-415c-a456-66f0f04045cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_eb242cc0-8b22-44c9-9dc4-9b86489621c4" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_50c822c0-0fbe-415c-a456-66f0f04045cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_NoncontrollingInterestDecreaseFromDisposal_5778382c-aa1e-4fa6-9153-3639fa45c502" xlink:href="iff-20231231.xsd#iff_NoncontrollingInterestDecreaseFromDisposal"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_eb242cc0-8b22-44c9-9dc4-9b86489621c4" xlink:to="loc_iff_NoncontrollingInterestDecreaseFromDisposal_5778382c-aa1e-4fa6-9153-3639fa45c502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_766bcc71-8c4c-4f60-951d-d3ea1db02fab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_eb242cc0-8b22-44c9-9dc4-9b86489621c4" xlink:to="loc_us-gaap_MinorityInterest_766bcc71-8c4c-4f60-951d-d3ea1db02fab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfLongtermInvestments_cff99da8-8c7c-4dde-8671-94a4ac5c12dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfLongtermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_7cd82ee2-57ba-4b6d-baf2-08d6c3577e8a" xlink:to="loc_us-gaap_ProceedsFromSaleOfLongtermInvestments_cff99da8-8c7c-4dde-8671-94a4ac5c12dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleDetails" xlink:type="simple" xlink:href="iff-20231231.xsd#AssetsandLiabilitiesHeldForSaleDetails"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_f14bf6e2-8775-4ebd-a2ef-3f3b28c8b057" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c4e8d47c-b772-4b13-b955-2cf77a4508ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_f14bf6e2-8775-4ebd-a2ef-3f3b28c8b057" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c4e8d47c-b772-4b13-b955-2cf77a4508ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_d07f6c94-d158-4cfe-8e01-df2f84b391c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c4e8d47c-b772-4b13-b955-2cf77a4508ee" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_d07f6c94-d158-4cfe-8e01-df2f84b391c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_6eb39b09-49b2-432e-9657-adeae5fd8c34" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_d07f6c94-d158-4cfe-8e01-df2f84b391c8" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_6eb39b09-49b2-432e-9657-adeae5fd8c34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_5709fb3a-c644-4174-809a-cfbb14515df1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_6eb39b09-49b2-432e-9657-adeae5fd8c34" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_5709fb3a-c644-4174-809a-cfbb14515df1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_15f5549b-6905-4dd2-86bc-fe50c1619c70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c4e8d47c-b772-4b13-b955-2cf77a4508ee" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_15f5549b-6905-4dd2-86bc-fe50c1619c70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9b3c0e10-205e-479a-81aa-43d8a73f1a82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_15f5549b-6905-4dd2-86bc-fe50c1619c70" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9b3c0e10-205e-479a-81aa-43d8a73f1a82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_SavorySolutionsAndFlavorSpecialtyIngredientsMember_34585c2b-08ba-405c-a70c-11f670664f43" xlink:href="iff-20231231.xsd#iff_SavorySolutionsAndFlavorSpecialtyIngredientsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9b3c0e10-205e-479a-81aa-43d8a73f1a82" xlink:to="loc_iff_SavorySolutionsAndFlavorSpecialtyIngredientsMember_34585c2b-08ba-405c-a70c-11f670664f43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_MicrobialControlMember_a2194bdf-da78-488a-a76f-34b9ab8bd243" xlink:href="iff-20231231.xsd#iff_MicrobialControlMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9b3c0e10-205e-479a-81aa-43d8a73f1a82" xlink:to="loc_iff_MicrobialControlMember_a2194bdf-da78-488a-a76f-34b9ab8bd243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_CosmeticIngredientsMember_070897f6-c338-4ee0-825c-e73684c40ddb" xlink:href="iff-20231231.xsd#iff_CosmeticIngredientsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9b3c0e10-205e-479a-81aa-43d8a73f1a82" xlink:to="loc_iff_CosmeticIngredientsMember_070897f6-c338-4ee0-825c-e73684c40ddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7cd99014-a6ab-4f9f-b1e4-fc172fbcd96c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c4e8d47c-b772-4b13-b955-2cf77a4508ee" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7cd99014-a6ab-4f9f-b1e4-fc172fbcd96c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_55c433dc-1f98-41ef-98f0-0b26831f324f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7cd99014-a6ab-4f9f-b1e4-fc172fbcd96c" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_55c433dc-1f98-41ef-98f0-0b26831f324f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_36ca6e4c-849d-4ff5-8dfb-7095907216b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_55c433dc-1f98-41ef-98f0-0b26831f324f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_36ca6e4c-849d-4ff5-8dfb-7095907216b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_DisposalGroupIncludingDiscontinuedOperationTradeReceivablesNet_1ed223ee-6676-4eb0-8c02-d147af9805df" xlink:href="iff-20231231.xsd#iff_DisposalGroupIncludingDiscontinuedOperationTradeReceivablesNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_55c433dc-1f98-41ef-98f0-0b26831f324f" xlink:to="loc_iff_DisposalGroupIncludingDiscontinuedOperationTradeReceivablesNet_1ed223ee-6676-4eb0-8c02-d147af9805df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_9311863e-eaf3-4b0c-8dd7-1d277f875f54" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_55c433dc-1f98-41ef-98f0-0b26831f324f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_9311863e-eaf3-4b0c-8dd7-1d277f875f54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_454e831a-c96b-4be3-aa15-b19ff99dc6e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_55c433dc-1f98-41ef-98f0-0b26831f324f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_454e831a-c96b-4be3-aa15-b19ff99dc6e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_e1724b44-e15d-4706-9c8a-b543fc10f41a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_55c433dc-1f98-41ef-98f0-0b26831f324f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_e1724b44-e15d-4706-9c8a-b543fc10f41a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_536b4a81-46ab-4a0a-8e00-87363a2432c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_55c433dc-1f98-41ef-98f0-0b26831f324f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_536b4a81-46ab-4a0a-8e00-87363a2432c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_2b90b0d0-5df7-403f-b347-c01d15a1b264" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_55c433dc-1f98-41ef-98f0-0b26831f324f" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_2b90b0d0-5df7-403f-b347-c01d15a1b264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_0128963b-e4c3-400d-a576-1c17d106af72" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_55c433dc-1f98-41ef-98f0-0b26831f324f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_0128963b-e4c3-400d-a576-1c17d106af72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_18bb6f56-29a3-4203-8c7d-a2c1617dae36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_55c433dc-1f98-41ef-98f0-0b26831f324f" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_18bb6f56-29a3-4203-8c7d-a2c1617dae36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_940b100a-2636-4875-9a13-f37a81115a06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7cd99014-a6ab-4f9f-b1e4-fc172fbcd96c" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_940b100a-2636-4875-9a13-f37a81115a06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_93b50a5c-c3e5-4b24-88f7-ce1e2996eeb6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_940b100a-2636-4875-9a13-f37a81115a06" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_93b50a5c-c3e5-4b24-88f7-ce1e2996eeb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities_c91b1d1c-47c0-4804-b9ff-5aebaccde38f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_940b100a-2636-4875-9a13-f37a81115a06" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities_c91b1d1c-47c0-4804-b9ff-5aebaccde38f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_2ad505ab-c7ab-44e1-9e93-49a918d5284e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_940b100a-2636-4875-9a13-f37a81115a06" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_2ad505ab-c7ab-44e1-9e93-49a918d5284e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_7c73d32b-ecd1-495d-b396-6d9e4b2d0e98" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_940b100a-2636-4875-9a13-f37a81115a06" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_7c73d32b-ecd1-495d-b396-6d9e4b2d0e98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/OtherExpenseIncomeNetDetails" xlink:type="simple" xlink:href="iff-20231231.xsd#OtherExpenseIncomeNetDetails"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/OtherExpenseIncomeNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_b161724f-8bfa-413a-8125-33ee6a3980a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_190cdf65-d68b-4e01-a274-6099231bec14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_b161724f-8bfa-413a-8125-33ee6a3980a1" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_190cdf65-d68b-4e01-a274-6099231bec14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_efc364fb-79a9-4842-8ab1-9ad5663621c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_b161724f-8bfa-413a-8125-33ee6a3980a1" xlink:to="loc_us-gaap_InvestmentIncomeInterest_efc364fb-79a9-4842-8ab1-9ad5663621c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_8a8e5099-c418-4d97-af0b-1752872ccd9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_b161724f-8bfa-413a-8125-33ee6a3980a1" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_8a8e5099-c418-4d97-af0b-1752872ccd9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_GainLossOnChinaFacilityRelocation_8cf0a154-404c-4653-a55b-6e63809fd4e0" xlink:href="iff-20231231.xsd#iff_GainLossOnChinaFacilityRelocation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_b161724f-8bfa-413a-8125-33ee6a3980a1" xlink:to="loc_iff_GainLossOnChinaFacilityRelocation_8cf0a154-404c-4653-a55b-6e63809fd4e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_5a0f938b-8da1-4f83-9608-42ad63d76b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_b161724f-8bfa-413a-8125-33ee6a3980a1" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_5a0f938b-8da1-4f83-9608-42ad63d76b2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_OtherComponentsOfOtherNonoperatingIncomeExpense_38ab1d5f-3bd7-418b-9d88-aa1867324850" xlink:href="iff-20231231.xsd#iff_OtherComponentsOfOtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_b161724f-8bfa-413a-8125-33ee6a3980a1" xlink:to="loc_iff_OtherComponentsOfOtherNonoperatingIncomeExpense_38ab1d5f-3bd7-418b-9d88-aa1867324850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_dac48cc0-ab64-4dd0-ae91-d7121fe85a79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_b161724f-8bfa-413a-8125-33ee6a3980a1" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_dac48cc0-ab64-4dd0-ae91-d7121fe85a79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/TangibleEquityUnitsDetails" xlink:type="simple" xlink:href="iff-20231231.xsd#TangibleEquityUnitsDetails"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/TangibleEquityUnitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_d15e32d9-e264-4277-b6a6-148da528dab9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityUnitsIssued_9613a21f-c49d-4c20-a785-117fa9d1cbf3" xlink:href="iff-20231231.xsd#iff_TangibleEquityUnitsIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_d15e32d9-e264-4277-b6a6-148da528dab9" xlink:to="loc_iff_TangibleEquityUnitsIssued_9613a21f-c49d-4c20-a785-117fa9d1cbf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityUnitsStatedRate_ea3105f3-2900-4b49-b9e9-2b2ea0b88f67" xlink:href="iff-20231231.xsd#iff_TangibleEquityUnitsStatedRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_d15e32d9-e264-4277-b6a6-148da528dab9" xlink:to="loc_iff_TangibleEquityUnitsStatedRate_ea3105f3-2900-4b49-b9e9-2b2ea0b88f67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityUnitsPricePerUnit_29994481-f7a1-480c-a4a2-5fe513ed05e6" xlink:href="iff-20231231.xsd#iff_TangibleEquityUnitsPricePerUnit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_d15e32d9-e264-4277-b6a6-148da528dab9" xlink:to="loc_iff_TangibleEquityUnitsPricePerUnit_29994481-f7a1-480c-a4a2-5fe513ed05e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityUnitsProceeds_e5f6ed0f-ecb0-43dd-94cf-04458d31fb08" xlink:href="iff-20231231.xsd#iff_TangibleEquityUnitsProceeds"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_d15e32d9-e264-4277-b6a6-148da528dab9" xlink:to="loc_iff_TangibleEquityUnitsProceeds_e5f6ed0f-ecb0-43dd-94cf-04458d31fb08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_0fa8bf7c-e6d2-4957-b411-163ec8b4fa39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_d15e32d9-e264-4277-b6a6-148da528dab9" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_0fa8bf7c-e6d2-4957-b411-163ec8b4fa39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityUnitsInitialPrincipalAmount_a7726237-9f30-4ad0-8c3a-691847137a93" xlink:href="iff-20231231.xsd#iff_TangibleEquityUnitsInitialPrincipalAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_d15e32d9-e264-4277-b6a6-148da528dab9" xlink:to="loc_iff_TangibleEquityUnitsInitialPrincipalAmount_a7726237-9f30-4ad0-8c3a-691847137a93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityUnitsPriceforSharesBasic_01279f6b-589c-474b-804f-66849e0b7f0c" xlink:href="iff-20231231.xsd#iff_TangibleEquityUnitsPriceforSharesBasic"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_d15e32d9-e264-4277-b6a6-148da528dab9" xlink:to="loc_iff_TangibleEquityUnitsPriceforSharesBasic_01279f6b-589c-474b-804f-66849e0b7f0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/TangibleEquityUnitsAllocationofTEUDetails" xlink:type="simple" xlink:href="iff-20231231.xsd#TangibleEquityUnitsAllocationofTEUDetails"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/TangibleEquityUnitsAllocationofTEUDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_b39e8c76-bb61-418e-9f7c-d8a5fdda30e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityUnitsTable_0fd5b710-4920-489e-9af8-78e0ae3dd75a" xlink:href="iff-20231231.xsd#iff_TangibleEquityUnitsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_b39e8c76-bb61-418e-9f7c-d8a5fdda30e2" xlink:to="loc_iff_TangibleEquityUnitsTable_0fd5b710-4920-489e-9af8-78e0ae3dd75a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityUnitsAllocationAxis_f4275684-be36-4017-8ff4-3bd19dbd702e" xlink:href="iff-20231231.xsd#iff_TangibleEquityUnitsAllocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_TangibleEquityUnitsTable_0fd5b710-4920-489e-9af8-78e0ae3dd75a" xlink:to="loc_iff_TangibleEquityUnitsAllocationAxis_f4275684-be36-4017-8ff4-3bd19dbd702e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityUnitsAllocationDomain_517ce192-76b0-4880-bdfd-e0c3b9e9beb3" xlink:href="iff-20231231.xsd#iff_TangibleEquityUnitsAllocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_TangibleEquityUnitsAllocationAxis_f4275684-be36-4017-8ff4-3bd19dbd702e" xlink:to="loc_iff_TangibleEquityUnitsAllocationDomain_517ce192-76b0-4880-bdfd-e0c3b9e9beb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_StockPurchaseContractMember_ccd6920d-1a26-4d08-835f-d278c7786a4a" xlink:href="iff-20231231.xsd#iff_StockPurchaseContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_TangibleEquityUnitsAllocationDomain_517ce192-76b0-4880-bdfd-e0c3b9e9beb3" xlink:to="loc_iff_StockPurchaseContractMember_ccd6920d-1a26-4d08-835f-d278c7786a4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityUnitsLineItems_7ea628d2-1579-427d-b00b-2498575407aa" xlink:href="iff-20231231.xsd#iff_TangibleEquityUnitsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_TangibleEquityUnitsTable_0fd5b710-4920-489e-9af8-78e0ae3dd75a" xlink:to="loc_iff_TangibleEquityUnitsLineItems_7ea628d2-1579-427d-b00b-2498575407aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityUnitsInitialPrincipalAmount_b8da441e-c6f2-42ac-baf4-7ad8612ec8af" xlink:href="iff-20231231.xsd#iff_TangibleEquityUnitsInitialPrincipalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_TangibleEquityUnitsLineItems_7ea628d2-1579-427d-b00b-2498575407aa" xlink:to="loc_iff_TangibleEquityUnitsInitialPrincipalAmount_b8da441e-c6f2-42ac-baf4-7ad8612ec8af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_74e866fd-df50-46b4-99b1-9bce3fba3a99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_TangibleEquityUnitsLineItems_7ea628d2-1579-427d-b00b-2498575407aa" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_74e866fd-df50-46b4-99b1-9bce3fba3a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityUnitsProceeds_1a7fff9b-c1e9-4276-a788-426a445f4c6e" xlink:href="iff-20231231.xsd#iff_TangibleEquityUnitsProceeds"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_TangibleEquityUnitsLineItems_7ea628d2-1579-427d-b00b-2498575407aa" xlink:to="loc_iff_TangibleEquityUnitsProceeds_1a7fff9b-c1e9-4276-a788-426a445f4c6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/TangibleEquityUnitsTangibleEquitySettlementofSharesDetails" xlink:type="simple" xlink:href="iff-20231231.xsd#TangibleEquityUnitsTangibleEquitySettlementofSharesDetails"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/TangibleEquityUnitsTangibleEquitySettlementofSharesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_e3617506-fa0a-48bd-b122-326ccc4762ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_55bf647f-fe66-4d00-9584-b0decefba38c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e3617506-fa0a-48bd-b122-326ccc4762ef" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_55bf647f-fe66-4d00-9584-b0decefba38c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1aa0cd44-9de3-48fc-8f9e-e2ffb42b9b9a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_55bf647f-fe66-4d00-9584-b0decefba38c" xlink:to="loc_srt_RangeAxis_1aa0cd44-9de3-48fc-8f9e-e2ffb42b9b9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7621f865-b3f7-4031-a4a6-40cd4c855680" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_1aa0cd44-9de3-48fc-8f9e-e2ffb42b9b9a" xlink:to="loc_srt_RangeMember_7621f865-b3f7-4031-a4a6-40cd4c855680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e6f982be-a907-482e-8ac5-644dfed6044f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7621f865-b3f7-4031-a4a6-40cd4c855680" xlink:to="loc_srt_MinimumMember_e6f982be-a907-482e-8ac5-644dfed6044f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_04a2e6d2-7748-4291-bf83-cc1e357e2139" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7621f865-b3f7-4031-a4a6-40cd4c855680" xlink:to="loc_srt_MaximumMember_04a2e6d2-7748-4291-bf83-cc1e357e2139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityUnitsConditionsAxis_3e3b21f7-070a-499f-8970-bb87a0a6727d" xlink:href="iff-20231231.xsd#iff_TangibleEquityUnitsConditionsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_55bf647f-fe66-4d00-9584-b0decefba38c" xlink:to="loc_iff_TangibleEquityUnitsConditionsAxis_3e3b21f7-070a-499f-8970-bb87a0a6727d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityUnitsConditionsDomain_c3b87af2-711b-40d3-bf66-b3be245d4d48" xlink:href="iff-20231231.xsd#iff_TangibleEquityUnitsConditionsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_TangibleEquityUnitsConditionsAxis_3e3b21f7-070a-499f-8970-bb87a0a6727d" xlink:to="loc_iff_TangibleEquityUnitsConditionsDomain_c3b87af2-711b-40d3-bf66-b3be245d4d48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ConditionOneMember_0990550a-dabb-441a-8840-817a70010b8e" xlink:href="iff-20231231.xsd#iff_ConditionOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_TangibleEquityUnitsConditionsDomain_c3b87af2-711b-40d3-bf66-b3be245d4d48" xlink:to="loc_iff_ConditionOneMember_0990550a-dabb-441a-8840-817a70010b8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ConditionTwoMember_f482eb36-d66f-4f2a-8ed7-e8a4fe04920b" xlink:href="iff-20231231.xsd#iff_ConditionTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_TangibleEquityUnitsConditionsDomain_c3b87af2-711b-40d3-bf66-b3be245d4d48" xlink:to="loc_iff_ConditionTwoMember_f482eb36-d66f-4f2a-8ed7-e8a4fe04920b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ConditionThreeMember_fc4516f7-a806-4850-a22e-0cf40aac5083" xlink:href="iff-20231231.xsd#iff_ConditionThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iff_TangibleEquityUnitsConditionsDomain_c3b87af2-711b-40d3-bf66-b3be245d4d48" xlink:to="loc_iff_ConditionThreeMember_fc4516f7-a806-4850-a22e-0cf40aac5083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_4b9a6339-77b0-4ca9-8ffa-8d588d2b008b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_55bf647f-fe66-4d00-9584-b0decefba38c" xlink:to="loc_us-gaap_ClassOfStockLineItems_4b9a6339-77b0-4ca9-8ffa-8d588d2b008b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_9e2108f9-7884-46d6-99ba-08d68f82ee2f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_4b9a6339-77b0-4ca9-8ffa-8d588d2b008b" xlink:to="loc_us-gaap_SharePrice_9e2108f9-7884-46d6-99ba-08d68f82ee2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityUnitsConditionalValue_316c6dc5-f2a3-439f-873e-fe517c620bb1" xlink:href="iff-20231231.xsd#iff_TangibleEquityUnitsConditionalValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_4b9a6339-77b0-4ca9-8ffa-8d588d2b008b" xlink:to="loc_iff_TangibleEquityUnitsConditionalValue_316c6dc5-f2a3-439f-873e-fe517c620bb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityRateSettlementRate_f59325a9-f488-4485-95a2-6d22d52d0adf" xlink:href="iff-20231231.xsd#iff_TangibleEquityRateSettlementRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_4b9a6339-77b0-4ca9-8ffa-8d588d2b008b" xlink:to="loc_iff_TangibleEquityRateSettlementRate_f59325a9-f488-4485-95a2-6d22d52d0adf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_18d7e01e-fb2a-4f59-8cd9-753d58c122d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_4b9a6339-77b0-4ca9-8ffa-8d588d2b008b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_18d7e01e-fb2a-4f59-8cd9-753d58c122d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_TangibleEquityUnitsFinalSettlementRate_5ab7db14-71d2-4958-840f-586259120139" xlink:href="iff-20231231.xsd#iff_TangibleEquityUnitsFinalSettlementRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_4b9a6339-77b0-4ca9-8ffa-8d588d2b008b" xlink:to="loc_iff_TangibleEquityUnitsFinalSettlementRate_5ab7db14-71d2-4958-840f-586259120139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iff.com/role/ScheduleIIValuationandQualifyingAccountsandReservesDetail" xlink:type="simple" xlink:href="iff-20231231.xsd#ScheduleIIValuationandQualifyingAccountsandReservesDetail"/>
  <link:presentationLink xlink:role="http://www.iff.com/role/ScheduleIIValuationandQualifyingAccountsandReservesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_2868f001-5754-4269-8a31-56ea3b3f1141" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_44fa91c9-aff0-4ba6-9359-186ebf0558b6" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_2868f001-5754-4269-8a31-56ea3b3f1141" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_44fa91c9-aff0-4ba6-9359-186ebf0558b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_2bc572f5-bc4c-4655-baba-e1aed4197e07" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_44fa91c9-aff0-4ba6-9359-186ebf0558b6" xlink:to="loc_srt_StatementScenarioAxis_2bc572f5-bc4c-4655-baba-e1aed4197e07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_b6f19fe0-79e2-4727-a631-1f325767aa2a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_2bc572f5-bc4c-4655-baba-e1aed4197e07" xlink:to="loc_srt_ScenarioUnspecifiedDomain_b6f19fe0-79e2-4727-a631-1f325767aa2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScenarioAdjustmentMember_3b703bde-2664-4960-b6e4-1905ffd159fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScenarioAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_b6f19fe0-79e2-4727-a631-1f325767aa2a" xlink:to="loc_us-gaap_ScenarioAdjustmentMember_3b703bde-2664-4960-b6e4-1905ffd159fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_5e32c8d2-692a-4623-b4fc-b1ab14876f84" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_44fa91c9-aff0-4ba6-9359-186ebf0558b6" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_5e32c8d2-692a-4623-b4fc-b1ab14876f84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_fdab11bb-8810-4bde-bfa4-5f248b2883fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_5e32c8d2-692a-4623-b4fc-b1ab14876f84" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_fdab11bb-8810-4bde-bfa4-5f248b2883fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_6053f7eb-0d43-454e-a7fd-cedce3cd13ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_fdab11bb-8810-4bde-bfa4-5f248b2883fd" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_6053f7eb-0d43-454e-a7fd-cedce3cd13ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_bce8cdd4-ea33-4d0a-863a-aa35fe853aff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_fdab11bb-8810-4bde-bfa4-5f248b2883fd" xlink:to="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_bce8cdd4-ea33-4d0a-863a-aa35fe853aff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_edbffdbe-1aed-4908-9f52-a4fae81a134d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_44fa91c9-aff0-4ba6-9359-186ebf0558b6" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_edbffdbe-1aed-4908-9f52-a4fae81a134d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_a51c5a1d-e38f-40be-9462-0f1a6a5044be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_edbffdbe-1aed-4908-9f52-a4fae81a134d" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_a51c5a1d-e38f-40be-9462-0f1a6a5044be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_affde360-107a-478c-931f-fd06e332fc09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_a51c5a1d-e38f-40be-9462-0f1a6a5044be" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_affde360-107a-478c-931f-fd06e332fc09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_a0bd2eab-5eaa-4c53-b3f7-4f79dff9d4c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_a51c5a1d-e38f-40be-9462-0f1a6a5044be" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_a0bd2eab-5eaa-4c53-b3f7-4f79dff9d4c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired_ba0630b1-4396-48d7-89b3-88527bfac90f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_a51c5a1d-e38f-40be-9462-0f1a6a5044be" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired_ba0630b1-4396-48d7-89b3-88527bfac90f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_8fe4e877-2403-4afc-9a10-229160f381de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_a51c5a1d-e38f-40be-9462-0f1a6a5044be" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_8fe4e877-2403-4afc-9a10-229160f381de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesAdjustments_af15c45c-ffe6-418e-bcc0-3240c6b25645" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesAdjustments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_a51c5a1d-e38f-40be-9462-0f1a6a5044be" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesAdjustments_af15c45c-ffe6-418e-bcc0-3240c6b25645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_689dfba4-3e7c-4ac9-b123-f54b3c66b0f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_a51c5a1d-e38f-40be-9462-0f1a6a5044be" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_689dfba4-3e7c-4ac9-b123-f54b3c66b0f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_91a836a7-1fee-48d4-b4d0-b87bf4cf58dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_a51c5a1d-e38f-40be-9462-0f1a6a5044be" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_91a836a7-1fee-48d4-b4d0-b87bf4cf58dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_52f8012d-7cbe-495c-8520-c912367c2064" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_edbffdbe-1aed-4908-9f52-a4fae81a134d" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_52f8012d-7cbe-495c-8520-c912367c2064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#AwardTimingDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_ShareEquivalentsMember" xlink:href="iff-20231231.xsd#iff_ShareEquivalentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_iff_ShareEquivalentsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_StockOptionsAndStockSettledAppreciationRightsMember" xlink:href="iff-20231231.xsd#iff_StockOptionsAndStockSettledAppreciationRightsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_iff_StockOptionsAndStockSettledAppreciationRightsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_PurchasedRestrictedStockUnitMember" xlink:href="iff-20231231.xsd#iff_PurchasedRestrictedStockUnitMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_iff_PurchasedRestrictedStockUnitMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_iff_CashRestrictedStockUnitMember" xlink:href="iff-20231231.xsd#iff_CashRestrictedStockUnitMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_iff_CashRestrictedStockUnitMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaap_AwardTypeAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockOptionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardExrcPrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardExrcPrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardGrantDateFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ErrCompDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompRecoveryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompRecoveryTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_RestatementDateAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonNeosMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ecd_NonNeosMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDeterminationDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDeterminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompAmt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_ExecutiveCategoryAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="loc_ecd_AllExecutiveCategoriesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_PeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_NonPeoNeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_AdjToCompAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllAdjToCompMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="loc_ecd_AllAdjToCompMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_MeasureAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoTotalCompAmt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TabularListTableTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TabularListTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_us-gaap_NetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_OtherPerfMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAmt"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoName"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureName"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_MeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#InsiderTradingArrangements"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrByIndTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TradingArrByIndTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_TradingArrAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllTradingArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrAxis" xlink:to="loc_ecd_AllTradingArrangementsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndTitle"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndTitle" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrAdoptionDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrAdoptionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrTerminationDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrTerminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrDuration"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrDuration" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#InsiderTradingPoliciesProc"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>iff-20231231_g1.jpg
<TEXT>
begin 644 iff-20231231_g1.jpg
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M#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _
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M_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _ '_B$V_X*F?\ 27;_ ,J&N?\
MQZC_ (A-O^"IG_27;_RH:Y_\>K]_J* /P!_XA-O^"IG_ $EV_P#*AKG_ ,>H
M_P"(3;_@J9_TEV_\J&N?_'J_?ZB@#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\
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M_P!)=O\ RH:Y_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _ '_B$V_X*F?\
M27;_ ,J&N?\ QZC_ (A-O^"IG_27;_RH:Y_\>K]_J* /P!_XA-O^"IG_ $EV
M_P#*AKG_ ,>H_P"(3;_@J9_TEV_\J&N?_'J_?ZB@#\ ?^(3;_@J9_P!)=O\
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M#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _
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M_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _ '_B$V_X*F?\ 27;_ ,J&N?\
MQZC_ (A-O^"IG_27;_RH:Y_\>K]_J* /P!_XA-O^"IG_ $EV_P#*AKG_ ,>H
M_P"(3;_@J9_TEV_\J&N?_'J_?ZB@#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\
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M%"]_[Z6@#8HK'_X275_^A0O?^^EH_P"$EU?_ *%"]_[Z6@#8HK'_ .$EU?\
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MH V**Q_^$EU?_H4+W_OI:/\ A)=7_P"A0O?^^EH V**Q_P#A)=7_ .A0O?\
MOI:/^$EU?_H4+W_OI: -BBL?_A)=7_Z%"]_[Z6C_ (275_\ H4+W_OI: -BB
ML?\ X275_P#H4+W_ +Z6C_A)=7_Z%"]_[Z6@#8HK'_X275_^A0O?^^EH_P"$
MEU?_ *%"]_[Z6@#8HK'_ .$EU?\ Z%"]_P"^EH_X275_^A0O?^^EH V**Q_^
M$EU?_H4+W_OI:/\ A)=7_P"A0O?^^EH V**Q_P#A)=7_ .A0O?\ OI:/^$EU
M?_H4+W_OI: -BBL?_A)=7_Z%"]_[Z6C_ (275_\ H4+W_OI: -BBL?\ X275
M_P#H4+W_ +Z6C_A)=7_Z%"]_[Z6@#8HK'_X275_^A0O?^^EH_P"$EU?_ *%"
M]_[Z6@#8HK'_ .$EU?\ Z%"]_P"^EH_X275_^A0O?^^EH V**Q_^$EU?_H4+
MW_OI:/\ A)=7_P"A0O?^^EH V**Q_P#A)=7_ .A0O?\ OI:/^$EU?_H4+W_O
MI: -BBL?_A)=7_Z%"]_[Z6C_ (275_\ H4+W_OI: -BBL?\ X275_P#H4+W_
M +Z6C_A)=7_Z%"]_[Z6@#8HK'_X275_^A0O?^^EH_P"$EU?_ *%"]_[Z6@#8
MHK'_ .$EU?\ Z%"]_P"^EH_X275_^A0O?^^EH V**Q_^$EU?_H4+W_OI:/\
MA)=7_P"A0O?^^EH V**Q_P#A)=7_ .A0O?\ OI:/^$EU?_H4+W_OI: -BBL?
M_A)=7_Z%"]_[Z6C_ (275_\ H4+W_OI: -BBL?\ X275_P#H4+W_ +Z6C_A)
M=7_Z%"]_[Z6@#8HK'_X275_^A0O?^^EH_P"$EU?_ *%"]_[Z6@#8HK'_ .$E
MU?\ Z%"]_P"^EH_X275_^A0O?^^EH V**Q_^$EU?_H4+W_OI:/\ A)=7_P"A
M0O?^^EH V**Q_P#A)=7_ .A0O?\ OI:/^$EU?_H4+W_OI: -BBL?_A)=7_Z%
M"]_[Z6C_ (275_\ H4+W_OI: -BBL?\ X275_P#H4+W_ +Z6C_A)=7_Z%"]_
M[Z6@#8HK'_X275_^A0O?^^EH_P"$EU?_ *%"]_[Z6@#8HK'_ .$EU?\ Z%"]
M_P"^EH_X275_^A0O?^^EH V**Q_^$EU?_H4+W_OI:/\ A)=7_P"A0O?^^EH
MV**Q_P#A)=7_ .A0O?\ OI:/^$EU?_H4+W_OI: -BBL?_A)=7_Z%"]_[Z6C_
M (275_\ H4+W_OI: -BBL?\ X275_P#H4+W_ +Z6C_A)=7_Z%"]_[Z6@#8HK
M'_X275_^A0O?^^EH_P"$EU?_ *%"]_[Z6@#8HK'_ .$EU?\ Z%"]_P"^EH_X
M275_^A0O?^^EH V**Q_^$EU?_H4+W_OI:/\ A)=7_P"A0O?^^EH V**Q_P#A
M)=7_ .A0O?\ OI:/^$EU?_H4+W_OI: -BBL?_A)=7_Z%"]_[Z6C_ (275_\
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M^!__ &/<O_I,U>Z4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 5\@?\%^/^4-G[0G_ &3^;_T=%7U_7R!_P7X_Y0V?
MM"?]D_F_]'14 ?QA4444 ?O]_P &FW_*4S]KO_MX_P#3Y/7[_5^ /_!IM_RE
M,_:[_P"WC_T^3U^_U !1110 4444 %%%% !1110 4444 %%%% !1110!X7^U
MA_R6SX'_ /8]R_\ I,U>Z5X7^UA_R6SX'_\ 8]R_^DS5[I0 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7R!_P7X_Y
M0V?M"?\ 9/YO_1T5?7]?('_!?C_E#9^T)_V3^;_T=%0!_&%1110!^_W_  :;
M?\I3/VN_^WC_ -/D]?O]7X _\&FW_*4S]KO_ +>/_3Y/7[_4 %%%% !1110
M4444 %%%% !1110 4444 %%%% 'A?[6'_);/@?\ ]CW+_P"DS5[I7A?[6'_)
M;/@?_P!CW+_Z3-7NE !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %?('_!?C_E#9^T)_P!D_F_]'15]?U\@?\%^/^4-
MG[0G_9/YO_1T5 '\85%%% '[_?\ !IM_RE,_:[_[>/\ T^3U^_U?@#_P:;?\
MI3/VN_\ MX_]/D]?O]0 4444 %%%% !1110 4444 %%%% !1110 4444 >%_
MM8?\EL^!_P#V/<O_ *3-7NE>%_M8?\EL^!__ &/<O_I,U>Z4 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\@?\%^/
M^4-G[0G_ &3^;_T=%7U_7R!_P7X_Y0V?M"?]D_F_]'14 ?QA4444 ?O]_P &
MFW_*4S]KO_MX_P#3Y/7[_5^ /_!IM_RE,_:[_P"WC_T^3U^_U !1110 4444
M %%%% !1110 4444 %%%% !1110!X7^UA_R6SX'_ /8]R_\ I,U>Z5X7^UA_
MR6SX'_\ 8]R_^DS5[I0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !7R!_P7X_Y0V?M"?\ 9/YO_1T5?7]?('_!?C_E
M#9^T)_V3^;_T=%0!_&%1110!^_W_  :;?\I3/VN_^WC_ -/D]?O]7X _\&FW
M_*4S]KO_ +>/_3Y/7[_4 %%%% !1110 4444 %%%% !1110 4444 %%%% 'A
M?[6'_);/@?\ ]CW+_P"DS5[I7A?[6'_);/@?_P!CW+_Z3-7NE !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?('_!?
MC_E#9^T)_P!D_F_]'15]?U\@?\%^/^4-G[0G_9/YO_1T5 '\85%%% '[_?\
M!IM_RE,_:[_[>/\ T^3U^_U?@#_P:;?\I3/VN_\ MX_]/D]?O]0 4444 %%%
M% !1110 4444 %%%% !1110 4444 >%_M8?\EL^!_P#V/<O_ *3-7NE>%_M8
M?\EL^!__ &/<O_I,U>Z4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 5\@?\%^/^4-G[0G_ &3^;_T=%7U_7R!_P7X_
MY0V?M"?]D_F_]'14 ?QA4444 ?O]_P &FW_*4S]KO_MX_P#3Y/7[_5^ /_!I
MM_RE,_:[_P"WC_T^3U^_U !1110 4444 %%%% !1110 4444 %%%% !1110!
MX7^UA_R6SX'_ /8]R_\ I,U>Z5X7^UA_R6SX'_\ 8]R_^DS5[I0 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%"]_[Z6MBB@#'_X275_^A0O?^^EH_P"$EU?_ *%"]_[Z6MBB@#'_ .$EU?\
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MK8HH Q_^$EU?_H4+W_OI:/\ A)=7_P"A0O?^^EK8HH Q_P#A)=7_ .A0O?\
MOI:/^$EU?_H4+W_OI:V** ,?_A)=7_Z%"]_[Z6OSM_X+5?L.?&/XV2)^U+\.
MEUW4T\/Z3Y.L^%KB7S4M+5,LUS:(.G=I4P2<;@>"*^UOVF?VQ_@E^RMI=L/B
M#K4]YKVID)H'@_0X#=:KJTI.U4AMUYP6XWMM3/&<D ^,6_[/7[4W[>5PGB#]
MLK4KCX>_#>1Q)9?![PWJ!%YJ4><K_:MVF"0>,P)CMGRW7)]S*)8C+Z\<:VH0
M75J_,NJBMWZJR75H^;S^&%S7#3R]1<YOI%VY7T<I;)>3NVMHL_#JBOTW_P""
MJ7_!'K3?#NC7'[0_['W@_P BTL;8-XE\$Z>A;9$BX-U:KR3@#,D7)ZNO\0JU
M_P $D_\ @DEC^S/VI_VI_#//R77A#PA?P_\  DO+I&_ QQ'V9AT%?HKXDRS^
MSOK:EY<OVK]K?KM8_)%P?G']K_47'SYOL\O\U_TWOH<S_P $'_AQHGA?XG:]
M\0M4^*DT'B9+5[!?AM;WGV:XFBP&-S<PRX,RKD% @(0DLS G;7ZF_P#"2ZO_
M -"A>_\ ?2UP'[1W[%?[//[4<45[\3/!GE:Y9X.E^+=$F-GJU@Z_=:*YC^8[
M3R%?<@/.VO(_M7_!0O\ 8KXOX)?VA/A[;_\ +>!5M_%NFPCU7E-0P/3,KGD[
M!7Y[CZT,\Q+KQGRS?V967RC+1/\ [>L_4_5\KP\^&\(L-.FY4U=\\;MZ]90U
M:_[=YEZ'TW_PDNK_ /0H7O\ WTM'_"2ZO_T*%[_WTM<-^SE^V5^SU^U-8RGX
M4>.HWU6T!&J>&=3C-KJFGL#AEFMI,.-IX++N3/ 8UZC7B5:-6A4<*D6FNCT/
MHZ%>CB::J4I*47U3NC'_ .$EU?\ Z%"]_P"^EH_X275_^A0O?^^EK8HK,U,?
M_A)=7_Z%"]_[Z6C_ (275_\ H4+W_OI:V** ,?\ X275_P#H4+W_ +Z6C_A)
M=7_Z%"]_[Z6MBB@#'_X275_^A0O?^^EH_P"$EU?_ *%"]_[Z6MBB@#'_ .$E
MU?\ Z%"]_P"^EH_X275_^A0O?^^EK8HH Q_^$EU?_H4+W_OI:/\ A)=7_P"A
M0O?^^EK8HH Q_P#A)=7_ .A0O?\ OI:/^$EU?_H4+W_OI:V** ,?_A)=7_Z%
M"]_[Z6C_ (275_\ H4+W_OI:V** ,?\ X275_P#H4+W_ +Z6C_A)=7_Z%"]_
M[Z6MBB@#'_X275_^A0O?^^EH_P"$EU?_ *%"]_[Z6MBB@#'_ .$EU?\ Z%"]
M_P"^EH_X275_^A0O?^^EK8HH Q_^$EU?_H4+W_OI:/\ A)=7_P"A0O?^^EK8
MHH Q_P#A)=7_ .A0O?\ OI:/^$EU?_H4+W_OI:V** ,?_A)=7_Z%"]_[Z6C_
M (275_\ H4+W_OI:V** ,?\ X275_P#H4+W_ +Z6C_A)=7_Z%"]_[Z6MBB@#
M'_X275_^A0O?^^EH_P"$EU?_ *%"]_[Z6MBB@#'_ .$EU?\ Z%"]_P"^EH_X
M275_^A0O?^^EK8HH Q_^$EU?_H4+W_OI:/\ A)=7_P"A0O?^^EK8HH Q_P#A
M)=7_ .A0O?\ OI:/^$EU?_H4+W_OI:V** ,?_A)=7_Z%"]_[Z6C_ (275_\
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MOW^K\ ?^#3;_ )2F?M=_]O'_ *?)Z_?Z@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH \+_:P_P"2V? __L>Y?_29J]TKPO\ :P_Y+9\#_P#L>Y?_ $F:
MO=* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MM?1>*_%'A^YT3Q;9D-I?CGPK=&PU>S<#"L)X_P#6;>PD# 9. #S7EH\<?\%
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M? __ +'N7_TF:O=* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MXLKVSG2>SO+29HY8)5(971U(*L" 00<@BOS[_7G%^WO[*/)VN[_?M^!_3_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M#_BW1;GPWXJT.SU/3KV(Q7EAJ%LDT,Z'JKHX*L/8C%>BL?[9<N*CSKOM-?\
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M7^)'QW\;Z)%-K'Q \&Z-;6FG>!M-OD#'5-5U5(QLG\MS)':Y:5I% 90=J/\
MH[0 4444 %%%% !1110 4444 %%%% 'A?[6'_);/@?\ ]CW+_P"DS5[I7A?[
M6'_);/@?_P!CW+_Z3-7NE !1110 4444 %%%% !1110 4444 %%%% !1110
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M;71_%5]=ZSXKU;">'O WARW-WJVIR'A0D*\JI((WOA>"!D_*?(;+]F+]I?\
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M(;_LT_LMFS\>?%V.'XC>-8MLJW>JV@_LVPDZ_N+5LAV!Z22[CD!E6,\5]N@
M# & .@%>>LNS'-GS9A+DI_\ /N+_ /2I=?1:>A])+BKA;@J+I<,4O;8E:/%5
MH[/O1IO2/E*6O1J2U/!OV-/^";_[+7[#NC(/A+X(6Z\0/#Y=_P",-:"SZC<9
M'S 28 A0_P#/.(*IP,[CS7O-%?"?_!9K]OWQ7^SQX=T_]GKX-:Y)IWBCQ+8-
M=ZOK%L^V;3M/+-&JQ,/N2RLL@WCE%C)&"RLOT%##T,-25.E%1BNB/S+,<SS#
M-\7+%8VK*I4EO*3;?X]%T2T70^DOC+^W9^R'^S_J\GA[XL_'K0]-U*$XN-,@
M=[NZ@/7$D-NLCQG_ '@,T?!K]NW]D/\ : U>/P]\)_CUH>I:E,<6^F3N]I<S
MGTCAN5C>0^R@U_/O---<3/<7$K22.Q9W=LEB>223U-$,TMO*MQ;RLDB,&1T;
M!4CD$$=#6QPG],5?)O\ P4*_X)&_ #]N>PN/&-E#%X2^(2Q?Z-XKT^V!6\(&
M%2]B&!.O  ?B10!ABHV'A/\ @C)^W[XL_:&\/ZA^SQ\9M<DU'Q/X;L!=Z/K%
MR^Z;4=/#+&RRL?ORQ,T8WGYG5P3DHS-]VUSXK"8;&T72KQ4HOO\ UH_,]3)\
MZS7A_'QQF7U73J1ZK\FMFGU333['X_?!/]O3]M__ ()!_$*S_9G_ &\?!6I^
M)_ 0;R]$UB*8SRP6RD#S+"Z?"W,*@C-O(5>,%1F+&T_JA\"_C]\'_P!I7X>6
MGQ3^"'CRQ\0:)>#"W-F_S0O@$Q2QMAX9!D91P&&1QR*D^-GP*^$?[1OP^O/A
M;\:_ EAXAT.^'[VSOH\F-\$"2-QAHI!DX="&&>#7Y7_'3_@GQ^VQ_P $E?B'
M=_M/_P#!/[QOJGB/P2A\S6M$DB\^>"V4DF.]MEPMW  3^^C >,%CB/'F'Y^V
M8Y#M>MA_OG!?^W)?AY(_3K\*^)6_)@<S?RH5Y?\ N.;?R;_F;T_7VBOD;_@G
ME_P5\^ ?[<5G;>"-:EA\'_$018F\,7]R/*OV ^9[*4X\T=_*.)%YX95WGZYK
MW\+B\-C:*JT)*47_ %KV?D?F6<Y)FO#V/E@LPI.G4CT?5=T]FGT:;3"BBBND
M\H**** "BBB@ HHHH **** "LSQAX,\(?$+PY=>#_'?A?3]9TJ]CV7FFZI9I
M/!,OHR."#^5:=%--Q=UN*48RBTU=,^4M3_8)^+/[..HS^,O^"=WQHD\,PO*T
MUU\+_%\LM]X=O&)RPBR3+9LQZLA.>!E5K4^'O_!2#P[H'BJV^$?[:?PXO_@[
MXPF;R[:77)!+H>J,."]KJ"_NB.Y#E0N0NYC7TS6)\0OAOX ^+/A6Y\#_ !-\
M&:;KVD7:XN-.U6S2>)O0[6!PP[,,$'D$&O16.AB-,7'F_O+2?W[2_P"WDWYH
M\EY;4PKYL#/D_N/6#]%O'_MUI=7%FQ;7-M>VT=Y9W"2PRH'BEB<,KJ1D,"."
M".<T^OD^Y_8E_:"_96N)/$7_  3X^,QBT97,LWPD\?W$EYH\@SDK:7!)FLR>
MPR0S'YG &*Z#X5_\%(/A]=^+8?@]^U-X*U+X.^.W^5-)\6NHT^_;.-UG?C$,
MZDX )*Y)PNZIEE\IQ<\-+VD5VTDO6._S5UYE0S2-.:IXR/LI/9O6#])[>BER
MR\CZ0HI$=)%#HP96&00<@BJGB+Q#H7A+0;WQ3XGU:WL-.TZUDN;^]NI0D4$*
M*6=V8\!0 23[5YYZI<HK\M/VK?\ @O/XZO?$=WX6_9)\+V-AI$$C1IXHUZT,
MUS=X_P"6D4#$)"AYP) [$8)"'*CQWP9_P6U_;Y\,ZRFI:_XZT3Q%;A\OIVJ^
M&K:.-AZ;K587'UW?G0!^UM%?.7[ O_!1[X7?MQZ%<:99Z<?#_C'2X!+JWAN>
MX$@:+(7[1;R8'FQ9(!X#(6 (P59OHV@ K'\>?$#P/\+O"EYXZ^(WBS3]$T>P
MCWWFI:G=+##$.V68CDG@ <DD  DUX;\</^"@GAW0/&TWP%_9=\$77Q6^)8RD
MNBZ#,!8:0<[?,O[S_5P*IZKG=D;6V$@UC> OV!/%?Q>\5V?QG_X*&>/X?B!K
MUM)Y^D>!K%&B\,Z$Q_ACMS_Q].!P9)<Y'#!\!J]"&!5."J8J7)%[+[3]%T7F
M[+M?8\JIF4JM1TL%'VDEHWM"/K+J_P"[&[[VW,JY_:=_:A_;@N9/#?[#7AM_
M!O@5W,5[\9_%VFL&N4SACI5DX#3'KB63"]0?+8 GU?\ 9G_8B^"W[,L]SXKT
M6WO?$7C/5,MKOCWQ1<&[U6_=OO9E;_5H?[B8! &[<1FO7K:VMK*VCL[.W2*&
M) D442!510,!0!P !QBGU-;'2=-TJ,>2'9;O_$]WZ:+LD50RV*JJOB)>TJ+9
MO:/^".T?763ZR84445PGIA1110 4444 %%%% !1110 4444 %%%% !1110 4
M45D^/O&_ASX9^!]8^(GC"^^S:5H6F3W^HSXR4ABC+N0.YPIP.YXH 3QQX^\#
M_#/PY/XP^(OC#3-"TJVQY^HZO?1V\*$] 7<@9/8=3VKP_P#X>N_\$^/[9_L+
M_AI33?/W[=_]E7WDYSC_ %WD>7CWW8K\@?VS/VR_BI^V;\5+GQSXYU.:#28)
MG7P[X=28FWTRW)X4#HTA !>0C+'T4*H\@H _I-\#^/\ P-\3?#D'C#X=>,-,
MUW2KG/D:CI%]'<0N1U ="1D=QU'>M>OY^?V-?VROBI^QE\5+7QUX%U.:;2II
MD7Q%X=>8BWU.W!Y5AT60 DI(!E3ZJ65OWO\  'CCPY\3? VC_$7P?>_:=*UW
M3(+_ $Z?&"\,L8="1V.&&1V/% &O1110 4444 %?('_!?C_E#9^T)_V3^;_T
M=%7U_7R!_P %^/\ E#9^T)_V3^;_ -'14 ?QA4444 ?O]_P:;?\ *4S]KO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !116!\3OBI\.?@QX,N_B'\5?&>GZ#HMBN;G4-1G$
M: ]E'=W/0(H+,> ":J,93DHQ5VR9SA3BY2=DMVS?KPW]I/\ ;O\ AK\"?$4/
MPE\&Z'?^/_B7J"XTKX?^%AYMUDC(>Y< K:1 $$L_(4[@I )'FK?&3]K;_@H
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M2TI:);):)>B_7=]6SMPF!P^#3<%>3WD]92]7^2V71)!1117,=@4444 %%%%
M!14=U=6MC:R7U]<QPPPQEYII7"JB@9+$G@ #DDU\"?MO?\%ZO@?\%+JX^&7[
M*NFP_$GQBTGV=+ZW=FTBUF)P!YD?S7C9QA(2%.?]:",5QXW,,'E]+VF(FHK\
M7Z+=GNY!PSGG$^,^K9;1=275[1BN\I/2*]7KTNS[=^*?Q;^&7P0\%W?Q%^+O
MCK3/#NB62YN-2U6Z6*,'G"#/+N<8"+EF/ !-?FC^TI_P7%^-'[1'C5OV=O\
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M7V)>JZ/S7_!/TW)N.\/B\!')^**3Q.%6D)_\OJ/G"3W2_EEI:RV7*>3^"_\
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ML^9A_P %:OV/YN=/O/&-VH^\]OX$U A3Z',0H_X>O_LP2\:?X>^(=WC[XMO
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M675[G6KV1UM[%I$D^SH1&C32R%]D,4<C$DI@^<_MX_\ !)?2/VHOB/>_M7?
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MV**Q_L7C?_H-V7_@,?\ &C[%XW_Z#=E_X#'_ !H V**Q_L7C?_H-V7_@,?\
M&C[%XW_Z#=E_X#'_ !H V**Q_L7C?_H-V7_@,?\ &C[%XW_Z#=E_X#'_ !H
MV**Q_L7C?_H-V7_@,?\ &C[%XW_Z#=E_X#'_ !H V**Q_L7C?_H-V7_@,?\
M&C[%XW_Z#=E_X#'_ !H V**Q_L7C?_H-V7_@,?\ &C[%XW_Z#=E_X#'_ !H
MV**Q_L7C?_H-V7_@,?\ &C[%XW_Z#=E_X#'_ !H V**Q_L7C?_H-V7_@,?\
M&C[%XW_Z#=E_X#'_ !H V**Q_L7C?_H-V7_@,?\ &C[%XW_Z#=E_X#'_ !H
MV**Q_L7C?_H-V7_@,?\ &C[%XW_Z#=E_X#'_ !H V**Q_L7C?_H-V7_@,?\
M&C[%XW_Z#=E_X#'_ !H V**Q_L7C?_H-V7_@,?\ &C[%XW_Z#=E_X#'_ !H
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MBL?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QH V**Q_L7C?\ Z#=E_P"
MQ_QH^Q>-_P#H-V7_ (#'_&@#8HK'^Q>-_P#H-V7_ (#'_&C[%XW_ .@W9?\
M@,?\: -BBL?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QH V**Q_L7C?\
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M/VN_^WC_ -/D]?O]7X _\&FW_*4S]KO_ +>/_3Y/7[_4 %?G;^V]_P $>?\
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M_%?@#PU\,8/#S>(6?49=4>+4M0:^G(M5GD=F2-44JH/R,B,OZ'  # & .@H
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M<QA/I6WU? 4/XM3F?:"_]N=E]RD<_P!:S/$_P*/(OYJC_*$;M_.46<#_ ,/
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M!')$R2R-G]7Z "BBB@ HHHH **** "BBB@ HHHH \+_:P_Y+9\#_ /L>Y?\
MTF:O=*\+_:P_Y+9\#_\ L>Y?_29J]TH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **R/&_Q
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MG^(-"U*+9>:;J4 >-_1AW1P>5=2&4@$$$9KQ,=DT:U;ZSA9>SK=UM+RDNO\
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M)0>Y\M#[]Z^QO@1_P3,_87_9R\FY^&O[.6@&_@P4UC6X#J5X'_OK+=%S&?\
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M<<D\-KJ(>/S9)+R"-@MS&RRH)8Y@S;A$GZVQ.98ED,;(64$HW5?8T .HHHH
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M8_Q9_P %2_@#<:Y-X'_9T\-^*?C!XBB.UM/^'NBR7-M$QZ&6[8+"L?\ MJ7
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M\8?N_P!G_P#9T^+'Q$W_ .IOM"\%RPV)]"T]P4V ^I6C_A=/_!3WXD<?#_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M 4444 %%%% !1110 4444 %%%% !7R!_P7X_Y0V?M"?]D_F_]'15]?U\@?\
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M;_"ZWO1XC_:;_:)\0>*;Z5_-NK/P_;K91.YZAYYC-)*#_> C;Z5^F5%7#AO
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M% !1110 4444 %%%% !1110 4444 %%%-FFBMXFN+B54C12SN[8"@<DDGH*
M'45\Y?$__@I?\%=$\42_"[]GW0-8^,'C5>/[ \ P?:8+<YQNN;SF&% 00S N
M5(Y45SO_  H']OG]J_\ TG]IOXUQ?"GPI<?>\ _"^YW:C-&?^6=UJ;9P<9#"
M$%&!Z"O0CEU2,5.NU3CY[OTCN_6R7F>5/-J,Y.&%BZLE_+\*]9OW5YJ[EY'H
M_P"T!^WW^S3^SOJH\'>(O%\NN^+)G\NS\$^$+4ZEJUQ+VC\B+_5L>WF%,]LU
MYQ]K_P""E/[6_%A::?\ L]^"[C_EM<JNI^*+N(^B<16>X>N)$)XW5IP>(/\
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MY5T(93R"*ZFBNV<(5(N,E=/H?/T:];#5HU:4G&46FFG9IK9IK5-=S\QOB/\
M\&S?P?UKQ')J'PL_:=U[P_IDDA8:=J_AZ+4GC!.=JRI-!P.@W*QXY)ZU]!?L
M/?\ !&O]E?\ 8J\10?$BU^W>,?&-N/\ 1/$'B%$"6#$8+6UN@VQ,?[[%W&2%
M8 D'ZWHKRJ&0Y1AJ_MJ=%*7S=O1-V7R1]GF/B3QSFN7O XK'3E2:LU:,6UVE
M**4I)]4V[]0HHHKUSX<**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MBO**7F:4\+3A+GE[TN[W^71?*P4445Z9TA1110 4444 %%%% !1110 4444
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M_#>W[)W_ $5;_P H5_\ _&*/^&]OV3O^BK?^4*__ /C%?F_17PW_ !$W/O\
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MX_Y0V?M"?]D_F_\ 1T5?7]?('_!?C_E#9^T)_P!D_F_]'14 ?QA4444 ?O\
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MR\(C^43QX8L%<DA"Q%?:EI:6EA:Q6%A;1P001K'##"@5(T P%4#@  8 %24
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M#_WZ%345WG00_P!G:?\ \^,/_?H4?V=I_P#SXP_]^A4U% $/]G:?_P ^,/\
MWZ%']G:?_P ^,/\ WZ%344 0_P!G:?\ \^,/_?H4?V=I_P#SXP_]^A4U% $/
M]G:?_P ^,/\ WZ%']G:?_P ^,/\ WZ%344 0_P!G:?\ \^,/_?H4?V=I_P#S
MXP_]^A4U% $/]G:?_P ^,/\ WZ%']G:?_P ^,/\ WZ%344 0_P!G:?\ \^,/
M_?H4?V=I_P#SXP_]^A4U% $/]G:?_P ^,/\ WZ%']G:?_P ^,/\ WZ%344 0
M_P!G:?\ \^,/_?H4?V=I_P#SXP_]^A4U% $/]G:?_P ^,/\ WZ%']G:?_P ^
M,/\ WZ%344 0_P!G:?\ \^,/_?H4?V=I_P#SXP_]^A4U<G\4?C?\,/@Y8+>>
M/O%4%K+*/]%L(\R7-R>@$<2Y9LGC., GDBLJ]>AAJ3J59*,5NV[+[V1.I"E%
MRF[+S.F_L[3_ /GQA_[]"N0^*?QE^#_P;M%E\<ZS:0W,P'V33+>$2W=R3P D
M2@L<GC)PN>I%<1_PD/[3WQ\^3PCI!^&OAF7_ )BNKPB75[F,]XX/NP9'=CN'
M!4FNO^%G[-_PO^%%V^O:9IDVIZ[.2UWXCUN8W-],QZGS&^YGN% SWS7E?7L;
MCM,%3Y8_SS32_P"W8:2E\^5=4V<OMZ]?^#&R_FE^BW?SLO4XKS?VD?C[\N@Z
M%%\,O#,O_+[?VRS:S=)_LQ?=MLCCYOF'!!-=K\+?V;/A/\)F;4=$T$WVKS9-
MWK^LO]IO9V/4F1ONY[A0H/<5WM%;4,JH4ZJK5FZM1?:EK;_"OAC\E?NV73PD
M(RYYOFEW?3T6R^1#_9VG_P#/C#_WZ%']G:?_ ,^,/_?H5-17J'40_P!G:?\
M\^,/_?H4?V=I_P#SXP_]^A4U% $/]G:?_P ^,/\ WZ%']G:?_P ^,/\ WZ%3
M44 0_P!G:?\ \^,/_?H4?V=I_P#SXP_]^A4U% $/]G:?_P ^,/\ WZ%']G:?
M_P ^,/\ WZ%344 0_P!G:?\ \^,/_?H4?V=I_P#SXP_]^A4U% $/]G:?_P ^
M,/\ WZ%']G:?_P ^,/\ WZ%344 0_P!G:?\ \^,/_?H4?V=I_P#SXP_]^A4U
M% $/]G:?_P ^,/\ WZ%']G:?_P ^,/\ WZ%344 0_P!G:?\ \^,/_?H4?V=I
M_P#SXP_]^A4U% $/]G:?_P ^,/\ WZ%']G:?_P ^,/\ WZ%344 0_P!G:?\
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M"?\ 9/YO_1T5 '\85%%% '[_ '_!IM_RE,_:[_[>/_3Y/7[_ %?@#_P:;?\
M*4S]KO\ [>/_ $^3U^_U !1110 4444 %%%% !1110 4444 %%%% !1110!X
M7^UA_P EL^!__8]R_P#I,U>Z5X7^UA_R6SX'_P#8]R_^DS5[I0 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7C_P#PP3^R
M=_T2G_RNW_\ \?KV"BN/%9?@,=;ZS2C4MMS14K7WM=.U[(QJX?#U[>U@I6[I
M/\SQ_P#X8)_9._Z)3_Y7;_\ ^/T?\,$_LG?]$I_\KM__ /'Z]@HKD_U?R'_H
M$I?^"X_Y&/\ 9^ _Y]1_\!7^1Q_PH^ GPF^!_P!O_P"%7^%/[+_M3ROMW^G3
MS^;Y>_9_KI&VX\Q^F,YYS@5V%%%>C0P^'PM)4J,%&*V222771+3?4Z:=.G2@
MHP2271:(****V+"BBB@"*\L;+4;=K/4+.*>)Q\\4T896^H/!KAO%/[+/[._C
M+<=<^#^B;W^_+9V@M7;W+0[&)]\UWU%<^(PF$Q<>6O3C-?WDG^9G4HTJJM.*
M?JKGCH_8U\+:%\WPR^*_CGPMM_U=OIGB)WMQ[&.4-N'MFC_A6G[7_A7GPK^T
M-HOB"-?]7:^*?#8BP/0RVYW-]:]BHK@_L/+X?P5*G_@G**^Y-1^]'/\ 4<.O
M@O'T;7X)V_ \=_X6=^U[X4X\6?LZZ1K\:_ZRZ\+>)%CP/417 WM]*/\ ALSP
MCH?R?$WX6^./"NW_ %D^J^'': >ZR1%MP]\5[%12^H9C2_@XJ3\IQC)?@H2^
M^0?5\1'X*K^:3_*S_$X+PM^U%^SSXRVKH7Q?T,N_W(KN\%M(WL$FVL3[8KN;
M2]L]0MUN["[BGB<926&0,K#V(X-<]XI^#?PF\;;F\6_#70]0=^LUUI<32?4/
MMW ^X-</>?L1? J*X:^\&V^M^%[ESDW/AS7[B!L^H#,RC\!3Y\]I;PIU/1R@
M_N:FO_)D'-CH;J,O1N/X6?YGKM%>._\ "@?CYX8^;X>_M8ZT\:_=M?%.DP:A
MO'H93M8?4#-!U?\ ;@\)_P#']X/\#>+85^[_ &9J$UA<./?SLQ@_3BC^U*U/
M^/AJD?-)37_DCE+_ ,E0?6IQ^.E)?<_R;?X'L5%>._\ #4OC+PY\OQ,_9>\;
MZ7C_ %D^D6\>IP1^YDB(X]\5H:#^VA^S;KEQ]@F^(\6F72G$EMK5I-:-&?0F
M5 OZTXYYE,I<LJRB^T[P?W328UCL(W9S2?GH_N=CU*BLWP]XR\(>+H?M/A3Q
M5INIQXSYFGWT<RX^J$UI5ZD)PJ1YHNZ\CJ4HR5TPHHHJAA117S?\>_\ @H+_
M ,*/^+.K?"__ (5'_:G]E^1_IW]O^1YOF01S?<\AMN/,Q]XYQGC.*\[,\VR_
M)L.JV,GRQ;LG9O6S=M$WLF<V*Q>'P=-3K2LF[;-Z_(^D**^/_P#AZY_U07_R
MZ?\ [EH_X>N?]4%_\NG_ .Y:\+_7OA3_ *"/_)*G_P B</\ ;V5?\_/PE_D?
M8%%?-_P$_P""@O\ PO#XLZ3\+_\ A4?]E_VIY_\ IW]O^?Y7EP23?<\A=V?+
MQ]X8SGG&*]J^)GQA^&WP?TG^V/B'XLM=/1P?(@=MTTY](XUR[GZ#COBO8P6>
M93F.#EBJ%5.G%V<G>*323^TET:\CLH8["8BBZL)^ZM&WI^=NYTU<M\3_ (T?
M#/X.Z8-2^(/BNWL3(/\ 1K3)>XN#TQ'$N6;GC(&!W(KSS_A.?VE/CU^Y^&7A
MH_#_ ,.2_P#,Q^(K<2:C<(?XH+7I'D="YY'(8&NI^&'[,OPT^&NIGQ7+;W.O
M>(Y3NN/$OB";[3=N_JI;B/\ X" <<$FL_K^,QVF!IVC_ #S34?\ MV.DI?\
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MMB8RC*-KP:2D[M+W;OEDE?5QDU8SK9IA\/1<ZB::^SUWMIK9_)GUQ17YO_\
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M T;P!XJCT35;C[4MOJLEJ)_LR_9)O,8(W#-Y>\#/<@U]Z_#3]F'X;_#W5O\
MA,-26Z\2>)9"&G\2>(IOM-SN]4W?+$!VVC('&37Q+^P3_P G9>%/^W[_ -(+
MBOT@K]G\-\!A*^53KU(\THU':^J7NPU2V3\[7MI<^TX;H4IX1SDKM2=K]-%L
MMK^>X4445^HGU 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_-_Z.BH _C"HHHH _?[_ (--O^4IG[7?_;Q_Z?)Z_?ZOP!_X--O^4IG[7?\
MV\?^GR>OW^H **** "BBB@ HHHH **** "BBB@ HHHH **** /"_VL/^2V?
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MO_1T5 '\85%%% '[_?\ !IM_RE,_:[_[>/\ T^3U^_U?@#_P:;?\I3/VN_\
MMX_]/D]?O]0 4444 %%%% !1110 4444 %%%% !1110 4444 >%_M8?\EL^!
M_P#V/<O_ *3-7NE>%_M8?\EL^!__ &/<O_I,U>Z4 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M.J_^WDFOT?XG->#/C/\ ";XB!%\$_$;1]2D?I;VU^AF'UC)WC\1735P?C/\
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M5*D*5-SD[)*[]$=A17Q__P /7/\ J@O_ )=/_P!RT?\ #US_ *H+_P"73_\
M<M?+_P"O?"G_ $$?^25/_D3R_P"WLJ_Y^?A+_(^P**^/_P#AZY_U07_RZ?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_#7/QP_Z,9\=_P#@3!1_PUS\</\ HQGQW_X$P5[U10!X+_PUS\</^C&?'?\
MX$P4?\-<_'#_ *,9\=_^!,%>]44 >"_\-<_'#_HQGQW_ .!,%'_#7/QP_P"C
M&?'?_@3!7O5% '@O_#7/QP_Z,9\=_P#@3!1_PUS\</\ HQGQW_X$P5[U10!X
M+_PUS\</^C&?'?\ X$P4?\-<_'#_ *,9\=_^!,%>]44 >"_\-<_'#_HQGQW_
M .!,%'_#7/QP_P"C&?'?_@3!7O5% '@O_#7/QP_Z,9\=_P#@3!1_PUS\</\
MHQGQW_X$P5[U10!X+_PUS\</^C&?'?\ X$P4?\-<_'#_ *,9\=_^!,%>]44
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M]T_0X["/POXKCM!=P6]KL9FFL+@)<P*LQDG22.)C,RNRK]>T %%%% !1110
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M(^&GBNU\&Q:IXHUGQ'X(CU@WFMRJ\LFG;%E@BLK&WXB\_9--("&PAB8S]?\
M\$\?VA?CE^UC_P $_P#X<_M%_%SX?6/A3QUXO\()?WVDM%*+1)V+K%<*A8R+
M!,JQW"H6+!)E7<2-U 'N]0:?I>F:1 ;;2M.@M8VD9VCMX512Q.2V !R3U-?,
MG_!*']J7X\_M7?!_XB^)/VB[O0)O$'A#XY>*?!R-X8TN2SLOLVF78MHRD<DL
MKC)5FR\C-\W7@5T?Q/\ BW^TIX@^,'COPC^S-:Z5?OX,\,:7I5M::U&/[/;Q
M'JERLKSWCH!-Y>G:>L%TT,3H9TU+9G?Y;( >_P!%?"OPC^/?_!1C]E[_ (*/
M> OV*_VSOBKX,^+GA/XS>%==U3P=XU\+^!V\/7NA7^DI!-=6MQ:K<W"/;&.X
MB5)"Y<NZY(P08+;]O#]IS]H#X+_M"?ME_LV:[H]IX3^!WBC7-(\%^#KW24F3
MQPNA0K)J<UU<G]Y MQ()X+7R-GE&-99?/#F)0#[QHKY6\1_%+]K_ /;L^#O@
M#XD?\$]_B_X8^%WA3QCX$L?%4GC[Q;X-_P"$@NY6O$WP:9;V0N8(XWC56-Q-
M*S;2\2QHQ+E#_@E3^UM^TA^U%\&_B'X9_:D\*>'[/XE?"#XJZQX \1ZGX:66
M/2==N;*.WE2_MU<L\22)<Q[D.2&5CA=P10#ZIHKY8_X)J_M1_M"_M%>.?VBO
M!O[0U_X;N+GX6_'*[\): _A?2);.W.GQ:?93QLR2S3.9&,[,Q+D9) PH KZG
MH **** "BBB@ HHHH **** "BBB@ HHHH ***^5?^"C'[4G[1W[,WQ=_9RTK
MX67WA>/PI\3_ ([:/X(\6QZCI4L^HF*ZAN[AFMY?-6*)=EH4.Z-V/F94IMY
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M>7Y>3S',TT:!Y=S_ #G<3EN3SS0!\F?\%=YX8OVAOV)EEF52W[5-CM#-C/\
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M(_8?^$ (Z$?#32O_ )'KU#1?"OAGPY>:GJ&@:!9V4^LWPO=7FM;94>]N1#%
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M=,9+97'F^0BLY?S%=OT H  & ** "BBB@ HHHH **** "BBB@ HHHH ****
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MP/;?&?[%G[''Q&\3WGC?XA?LF?#/7M:U&02:AJ^L^ ]/NKJY? 7=)++"SN<
M#))X KI?!/P4^#GPSCTN#X<?"CPWX?BT2PNK+1H=#T2"T2PMKF:.>YAA6)%$
M22S112.J@!WC5FR0#0!Q7[3_ ,./V:/VN_!'B?\ 8Z^,'Q*=#?Z";CQ#X?\
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M110 5\0_\%G)X8O'7[&*RS*I;]M+POM#-C/_ !+-8'\R!^(K[>KD?B-^S_\
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MOAY_P7Y\>_$76(YH]%^.W[.NC:GX'U&\MW@6YFTFZ6&\LE64*PG2*YMKAHB
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MP7X_Y0V?M"?]D_F_]'14 ?QA4444 ?O]_P &FW_*4S]KO_MX_P#3Y/7[_5^
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!7R!_P %^/\ E#9^T)_V3^;_ -'15]?U\@?\%^/^4-G[0G_9/YO_ $=%0!_&
M%1110!^_W_!IM_RE,_:[_P"WC_T^3U^_U?@#_P &FW_*4S]KO_MX_P#3Y/7[
M_4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 4?$WB70/!GAO4/&'BO5H-/TO2;&6\U*_N7VQVUO$A>21S
MV554L3V K\=_VY]"_:6N_P!E_2_^"J/AC]BGXC:?\5_A[\6C\9(?$5]?: MM
M_P (MY4=J^CR)'JCWL4']@06@FC%L',T$K%$,CX_4_\ :N_9KT+]KGX(:Q\
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M%N]706N?'$XL+RUC\='3GM=0MDPFHQ/;NR[;C>L86-8EC52K?=&D^,/'MO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *^0/^"_'_*&S]H3_ +)_-_Z.BKZ_
MKY _X+\?\H;/VA/^R?S?^CHJ /XPJ*** /W^_P"#3;_E*9^UW_V\?^GR>OW^
MK\ ?^#3;_E*9^UW_ -O'_I\GK]_J "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ KY _X+\?\H;/VA/\ LG\W_HZ*OK^OD#_@OQ_RAL_:$_[)
M_-_Z.BH _C"HHHH _?[_ (--O^4IG[7?_;Q_Z?)Z_?ZOP!_X--O^4IG[7?\
MV\?^GR>OW^H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OD
M#_@OQ_RAL_:$_P"R?S?^CHJ^OZ^0/^"_'_*&S]H3_LG\W_HZ*@#^,*BBB@#]
M_O\ @TV_Y2F?M=_]O'_I\GK]_J_ '_@TV_Y2F?M=_P#;Q_Z?)Z_?Z@ HHHH
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M\8>=<0_\(G9^+K*74_,M^9T^RK*9=T?\8VY3OBO._A)_P4N_9!^-G[5WCO\
M9#\ ?&KPQ>>)? 45C'?(OB&WW7M],E[+<V=M&6W3O:16BO.T>X1F8JVUHW
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MO\(OA)HYT/Q[^T7X*^'VKZO9R_V'=^+M8M8/F&%,J0SS1>>$9UR <990>N"
M=]17R1_P2/\ VRO&/QV_X)3_  [_ &P/VQ?BSHJ:OJ]KJ<WB;Q3J(M=*LD\O
M6+RVBSM$<,2A(XHQT)P,EF))]UL?VMOV4]4^&4GQKTS]IKX>W'@V+4&L)?%L
M'C2Q?3$N@<& W0E\H2@\%-VX'M0!Z%17(:3^T%\!=>US0_#&A?&[PA>ZEXGT
MW^T/#6GVGB6UDGU:S^;_ $BVC60M/%\K?O$#+\IYX-=?0 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\@?\
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M90MR?#RZ_'O>+V^6Y[W#5*53VMIN/P[6\^Z9X_\ \)G^VM_T1?P?_P"%&_\
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M@"37_P#@M_\ LO>,/A%;VURVL_"_QU:?&E+55EBU'PFMM;?V:MXHR'A_M.X
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M&CXN67A3Q5\3RL8'AG2V4R3F*653%;W,PQ''/("L2^;+C,8*_ _Q/U7X8?\
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M60RW2U3VBT73U?56?H[]MU^9\-\,YQ4S?7FH^R?O2ZW[1Z.Z]59W=[I/G?\
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MV>? ^H>/]*C":9XXOO"=G+J]HH&%$5XT9F0 $@;6& 2!U- 'PGJW@:T^)_\
MP<M^-_"J?$37_#\R?L;Z<S77A?5Q:W6/^$A8,I;:W&)%/3()4@@X-?;/[*/[
M'W[/O[%'PTG^%7[.W@AM(TZ_UBXU?6;J[U">]OM7U*X(,]]=W5P[S7,\A R[
ML3A54850!JVW[,7[-=E\13\7[/\ 9Z\#1>+6F\YO%$7A.S743)_?^TB/S=W
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M"?\ 9/YO_1T5 '\85%%% '[_ '_!IM_RE,_:[_[>/_3Y/7[_ %?@#_P:;?\
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M5?M^FPSLEKJ/FVX"Q?:(P)?(;YXMVUB2,UVU !117@G[&7[;=]^UI\1OC/\
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M?^CHJ^OZ^0/^"_'_ "AL_:$_[)_-_P"CHJ /XPJ*** /W^_X--O^4IG[7?\
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M1;^&]\6:HT9$,-LCAO)W=/,EV[%4<\EL;48C]Z: /F?_ (>L_LY?]"+\3?\
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M<\,_'+PI9?&_XBO;?M"7EY=_$%YKO2R_G75J+2=K4BP'D;K95BQA@H4$ /\
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MGQ)\67>N/I^LQ_VG')'#/<NTL5K*;:)WA5MB8)0*.*[+X5_!C]O;Q;K/[/\
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MP_X'\#Z?\._ ]D-'TK1]*BT[1[>R Q96\40BB2,.&'R(J@;@1\HR#0!^;_\
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M^9_$W^L'A;_T):G_ (4R_P C\]_^(F;X&?\ 1LGBS_P;VO\ A7T/_P $\O\
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MI(["%6\F4,\4)<,NYUB1=PVJ1\"_M3_%+]J?XL?\$[?@/I?[6VK0:QKWPO\
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M"R7_ $.OP_\ _"$A_P#BZ /ZOJ*_E!_XB\?^"R7_ $.OP_\ _"$A_P#BZ/\
MB+Q_X+)?]#K\/_\ PA(?_BZ /ZOJ*_E!_P"(O'_@LE_T.OP__P#"$A_^+H_X
MB\?^"R7_ $.OP_\ _"$A_P#BZ /ZOJ*_E!_XB\?^"R7_ $.OP_\ _"$A_P#B
MZ/\ B+Q_X+)?]#K\/_\ PA(?_BZ /ZOJ*_E!_P"(O'_@LE_T.OP__P#"$A_^
M+H_XB\?^"R7_ $.OP_\ _"$A_P#BZ /ZOJ*_E!_XB\?^"R7_ $.OP_\ _"$A
M_P#BZ/\ B+Q_X+)?]#K\/_\ PA(?_BZ /ZOJ*_E!_P"(O'_@LE_T.OP__P#"
M$A_^+H_XB\?^"R7_ $.OP_\ _"$A_P#BZ /ZOJ*_E!_XB\?^"R7_ $.OP_\
M_"$A_P#BZ/\ B+Q_X+)?]#K\/_\ PA(?_BZ /ZOJ*_E!_P"(O'_@LE_T.OP_
M_P#"$A_^+H_XB\?^"R7_ $.OP_\ _"$A_P#BZ /ZOJ*_E!_XB\?^"R7_ $.O
MP_\ _"$A_P#BZ/\ B+Q_X+)?]#K\/_\ PA(?_BZ /ZOJ*_E!_P"(O'_@LE_T
M.OP__P#"$A_^+H_XB\?^"R7_ $.OP_\ _"$A_P#BZ /ZOJ*_E!_XB\?^"R7_
M $.OP_\ _"$A_P#BZ/\ B+Q_X+)?]#K\/_\ PA(?_BZ /ZOJ*_E!_P"(O'_@
MLE_T.OP__P#"$A_^+H_XB\?^"R7_ $.OP_\ _"$A_P#BZ /ZOJ*_E!_XB\?^
M"R7_ $.OP_\ _"$A_P#BZ/\ B+Q_X+)?]#K\/_\ PA(?_BZ /ZOJ*_E!_P"(
MO'_@LE_T.OP__P#"$A_^+H_XB\?^"R7_ $.OP_\ _"$A_P#BZ /ZOJ*_E!_X
MB\?^"R7_ $.OP_\ _"$A_P#BZ/\ B+Q_X+)?]#K\/_\ PA(?_BZ /ZOJ*_E!
M_P"(O'_@LE_T.OP__P#"$A_^+H_XB\?^"R7_ $.OP_\ _"$A_P#BZ /ZOJ*_
ME!_XB\?^"R7_ $.OP_\ _"$A_P#BZ/\ B+Q_X+)?]#K\/_\ PA(?_BZ /ZOJ
M*_E!_P"(O'_@LE_T.OP__P#"$A_^+H_XB\?^"R7_ $.OP_\ _"$A_P#BZ /Z
MOJ*_E!_XB\?^"R7_ $.OP_\ _"$A_P#BZ/\ B+Q_X+)?]#K\/_\ PA(?_BZ
M/ZOJ*_E!_P"(O'_@LE_T.OP__P#"$A_^+H_XB\?^"R7_ $.OP_\ _"$A_P#B
MZ /ZOJ*_E!_XB\?^"R7_ $.OP_\ _"$A_P#BZ/\ B+Q_X+)?]#K\/_\ PA(?
M_BZ /ZOJ*_E!_P"(O'_@LE_T.OP__P#"$A_^+H_XB\?^"R7_ $.OP_\ _"$A
M_P#BZ /ZOJ*_E!_XB\?^"R7_ $.OP_\ _"$A_P#BZ/\ B+Q_X+)?]#K\/_\
MPA(?_BZ /ZOJ*_E!_P"(O'_@LE_T.OP__P#"$A_^+H_XB\?^"R7_ $.OP_\
M_"$A_P#BZ /ZOJ*_E!_XB\?^"R7_ $.OP_\ _"$A_P#BZ/\ B+Q_X+)?]#K\
M/_\ PA(?_BZ /ZOJ*_E!_P"(O'_@LE_T.OP__P#"$A_^+H_XB\?^"R7_ $.O
MP_\ _"$A_P#BZ /ZOJ*_E!_XB\?^"R7_ $.OP_\ _"$A_P#BZ/\ B+Q_X+)?
M]#K\/_\ PA(?_BZ /ZOJ*_E!_P"(O'_@LE_T.OP__P#"$A_^+H_XB\?^"R7_
M $.OP_\ _"$A_P#BZ /ZOJ*_E!_XB\?^"R7_ $.OP_\ _"$A_P#BZ/\ B+Q_
MX+)?]#K\/_\ PA(?_BZ /ZOJ*_E!_P"(O'_@LE_T.OP__P#"$A_^+H_XB\?^
M"R7_ $.OP_\ _"$A_P#BZ /ZOJ*_E!_XB\?^"R7_ $.OP_\ _"$A_P#BZ/\
MB+Q_X+)?]#K\/_\ PA(?_BZ /ZOJ*_E!_P"(O'_@LE_T.OP__P#"$A_^+H_X
MB\?^"R7_ $.OP_\ _"$A_P#BZ /ZOJ*_E!_XB\?^"R7_ $.OP_\ _"$A_P#B
MZ/\ B+Q_X+)?]#K\/_\ PA(?_BZ /ZOJ*_E!_P"(O'_@LE_T.OP__P#"$A_^
M+H_XB\?^"R7_ $.OP_\ _"$A_P#BZ /ZOJ*_E!_XB\?^"R7_ $.OP_\ _"$A
M_P#BZ/\ B+Q_X+)?]#K\/_\ PA(?_BZ /ZOJ*_E!_P"(O'_@LE_T.OP__P#"
M$A_^+H_XB\?^"R7_ $.OP_\ _"$A_P#BZ /ZOJ*_E!_XB\?^"R7_ $.OP_\
M_"$A_P#BZ/\ B+Q_X+)?]#K\/_\ PA(?_BZ /ZOJ*_E!_P"(O'_@LE_T.OP_
M_P#"$A_^+H_XB\?^"R7_ $.OP_\ _"$A_P#BZ /ZOJ*_E!_XB\?^"R7_ $.O
MP_\ _"$A_P#BZ/\ B+Q_X+)?]#K\/_\ PA(?_BZ /ZOJ*_E!_P"(O'_@LE_T
M.OP__P#"$A_^+H_XB\?^"R7_ $.OP_\ _"$A_P#BZ /ZOJ*_E!_XB\?^"R7_
M $.OP_\ _"$A_P#BZ/\ B+Q_X+)?]#K\/_\ PA(?_BZ /ZOJ*_E!_P"(O'_@
MLE_T.OP__P#"$A_^+H_XB\?^"R7_ $.OP_\ _"$A_P#BZ /ZOJ*_E!_XB\?^
M"R7_ $.OP_\ _"$A_P#BZ/\ B+Q_X+)?]#K\/_\ PA(?_BZ /ZOJ*_E!_P"(
MO'_@LE_T.OP__P#"$A_^+H_XB\?^"R7_ $.OP_\ _"$A_P#BZ /ZOJ*_E!_X
MB\?^"R7_ $.OP_\ _"$A_P#BZ/\ B+Q_X+)?]#K\/_\ PA(?_BZ /ZOJ*_E!
M_P"(O'_@LE_T.OP__P#"$A_^+H_XB\?^"R7_ $.OP_\ _"$A_P#BZ /ZOJ*_
ME!_XB\?^"R7_ $.OP_\ _"$A_P#BZ/\ B+Q_X+)?]#K\/_\ PA(?_BZ /ZOJ
M*_E!_P"(O'_@LE_T.OP__P#"$A_^+H_XB\?^"R7_ $.OP_\ _"$A_P#BZ /Z
MOJ*_E!_XB\?^"R7_ $.OP_\ _"$A_P#BZ/\ B+Q_X+)?]#K\/_\ PA(?_BZ
M/ZOJ*_E!_P"(O'_@LE_T.OP__P#"$A_^+H_XB\?^"R7_ $.OP_\ _"$A_P#B
MZ /ZOJ*_E!_XB\?^"R7_ $.OP_\ _"$A_P#BZ/\ B+Q_X+)?]#K\/_\ PA(?
M_BZ /ZOJ*_E!_P"(O'_@LE_T.OP__P#"$A_^+H_XB\?^"R7_ $.OP_\ _"$A
M_P#BZ /ZOJ*_E!_XB\?^"R7_ $.OP_\ _"$A_P#BZ/\ B+Q_X+)?]#K\/_\
MPA(?_BZ /ZOJ*_E!_P"(O'_@LE_T.OP__P#"$A_^+H_XB\?^"R7_ $.OP_\
M_"$A_P#BZ /ZOJ*_E!_XB\?^"R7_ $.OP_\ _"$A_P#BZ/\ B+Q_X+)?]#K\
M/_\ PA(?_BZ /ZOJ*_E!_P"(O'_@LE_T.OP__P#"$A_^+H_XB\?^"R7_ $.O
MP_\ _"$A_P#BZ /ZOJ*_E!_XB\?^"R7_ $.OP_\ _"$A_P#BZ/\ B+Q_X+)?
M]#K\/_\ PA(?_BZ /ZOJ*_E!_P"(O'_@LE_T.OP__P#"$A_^+H_XB\?^"R7_
M $.OP_\ _"$A_P#BZ /ZOJ*_E!_XB\?^"R7_ $.OP_\ _"$A_P#BZ/\ B+Q_
MX+)?]#K\/_\ PA(?_BZ /ZOJ*_E!_P"(O'_@LE_T.OP__P#"$A_^+H_XB\?^
M"R7_ $.OP_\ _"$A_P#BZ /ZOJ*_E!_XB\?^"R7_ $.OP_\ _"$A_P#BZ/\
MB+Q_X+)?]#K\/_\ PA(?_BZ /ZOJ*_E!_P"(O'_@LE_T.OP__P#"$A_^+H_X
MB\?^"R7_ $.OP_\ _"$A_P#BZ /ZOJ*_E!_XB\?^"R7_ $.OP_\ _"$A_P#B
MZ/\ B+Q_X+)?]#K\/_\ PA(?_BZ /ZOJ*_E!_P"(O'_@LE_T.OP__P#"$A_^
M+H_XB\?^"R7_ $.OP_\ _"$A_P#BZ /ZOJ*_E!_XB\?^"R7_ $.OP_\ _"$A
M_P#BZ/\ B+Q_X+)?]#K\/_\ PA(?_BZ /ZOJ*_E!_P"(O'_@LE_T.OP__P#"
M$A_^+H_XB\?^"R7_ $.OP_\ _"$A_P#BZ /ZOJ*_E!_XB\?^"R7_ $.OP_\
M_"$A_P#BZ/\ B+Q_X+)?]#K\/_\ PA(?_BZ /ZOJ*_E!_P"(O'_@LE_T.OP_
M_P#"$A_^+H_XB\?^"R7_ $.OP_\ _"$A_P#BZ /ZOJ*_E!_XB\?^"R7_ $.O
MP_\ _"$A_P#BZ/\ B+Q_X+)?]#K\/_\ PA(?_BZ /ZOJ*_E!_P"(O'_@LE_T
M.OP__P#"$A_^+H_XB\?^"R7_ $.OP_\ _"$A_P#BZ /ZOJ*_E!_XB\?^"R7_
M $.OP_\ _"$A_P#BZ/\ B+Q_X+)?]#K\/_\ PA(?_BZ /ZOJ*_E!_P"(O'_@
MLE_T.OP__P#"$A_^+H_XB\?^"R7_ $.OP_\ _"$A_P#BZ /ZOJ*_E!_XB\?^
M"R7_ $.OP_\ _"$A_P#BZ/\ B+Q_X+)?]#K\/_\ PA(?_BZ /ZOJ*_E!_P"(
MO'_@LE_T.OP__P#"$A_^+H_XB\?^"R7_ $.OP_\ _"$A_P#BZ /ZOJ*_E!_X
MB\?^"R7_ $.OP_\ _"$A_P#BZ/\ B+Q_X+)?]#K\/_\ PA(?_BZ /ZOJ*_E!
M_P"(O'_@LE_T.OP__P#"$A_^+H_XB\?^"R7_ $.OP_\ _"$A_P#BZ /ZOJ^0
M/^"_'_*&S]H3_LG\W_HZ*OP _P"(O'_@LE_T.OP__P#"$A_^+KA/VGO^#F3_
M (*C_M=? 'Q3^S5\9/%?@N?POXQTMM/UJ+3_  ?%!,T)96(20,2ARHYH _/R
&BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>iff10-k2023exhibit97001.jpg
<TEXT>
begin 644 iff10-k2023exhibit97001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"!54!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]JV8)?.MHY0N"Z!MN>F1G% $E%9UMJ9$.GQZG''9W]YE5M1*),,%+, P S@
M\XHU?5XM)2U4H9;B\N%MK:('&]R">3V "L2?0="<"@#1HKG%\4R/#J4$6E3S
MZMI\R0R6$,BDN7 965VP-A4DY./ND8S3]"\0WVJ:K>:??:%/IDMM%'*WF7$<
MH(<L%'R$\_(WZ>M '04444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M-:PSV@88+D1@20M[.,C'KBI/A,T\OA6\N;BSN+-KG5+JX$-PA5U5WW#(/UH
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M6..@-;7ACX::E8^&XH9_%>L6MQ=J;B]@A$)0S2#+_>C)/IR>U '8W=K;>+]
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M=/+=MN]"V2K D=\'^<=[:+KGQ:UNPO\ 7-4L[.VL+>2&*UU%[==S9R< @=J
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M3S&SPNW?\V?3O7I% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M<C=(%4?6O5*\[^'>AQ-K_B+Q:EK/;6^IW!6PBG4JPBSN=PIY42/EL'L!7HE
M'B'A*WU?6?@]I[01W6I+%JTDE[:)<F.2Y@#,"@<D=RIQD9VXKT'P#+I+6%_#
MI/\ :=ND5SB73M1W>99,57Y &R0I^\.2.3BH=,^'B:+X7M=(TS6[^UFM+I[J
M&[0*6W-G*LA&UEPQX(]*VO#_ (?.BM>W%Q?S:AJ%](LES=2JJ;MJA5 50 H
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MRV0<@AE(8J0>HJR/!]R^F31S>)-4?4I;E+H7X95\MU&%"Q@; F.JXYR<\XP
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MO$NHV%K>QK'=6RJDH8!=F4+@E"5X)'UZUT=E9PZ?86]E;+L@MXEBC7.<*H
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MCG<?;'O"-N16]1FN6'@2S'P\E\'_ &R?[+(CH9\#>-TA<^W4XKJE7:H7T&*
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MXZ>]6=4U]=,U[0]+-N9#JLLL8D#X\O9&7SC'.<8[5R'P]_Y*)\1/^OZ#_P!
M>I_B#I\6J>+_  193R.D,UW<B38Y4LOD$E<CD!@,''8F@#T&BO%_$3OX%O\
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MYF+X@W$\*31>"?%+QR*&5A;PX(/(/^MJ[\2/^2:^(_\ L'R_^@FLG1T^(O\
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M2:*1E,ZK&S;"<\!BH!QCI76Z;IUKX6^*=OI.CQFVTW4-*DGEM$8F-98Y% D
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M:=)!6ZTZZ_<RQ.,?*W7&<Y!&0:Z;2M1&I:'8ZDR"$75O'.4+9";E#8SQG&:
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MQ!P,]Z ,N3P2\26@TKQ#JFFM!9Q64AA\MQ-'&,*2KJ0'Y/S+CK3D\ Z5#?\
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M3QG.>I-="S!5+,0 .I)K&T_Q!]O\5:SHGV;8--CMW\[?GS/-5CTQQC;ZG.:
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!X8JI.,^M7/%&CVNC0Z/X>T:!M1T^\UIY)]+:Z5(P1$T@@!QA4W -L.<X]Z
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M#3:9+X7B72;>YM;:&:6(VER?GMG#G=&>3@*<@#.,8J/XC_\ )-O$?_8/F_\
M030!0@\9^)+JWBN(? &HM%*@=&^W6PRI&0?OUV%O,9H8VD3RIBBL\)8%HR1T
M./2N&T;3/'C:'I[0^)M(2(VT916TMB0-HP"?-YJO\2)I?#=_IGB;15$OB!MU
MF+)5)^WQ;2Q! Y^0C>#VY'<4 =5XF\1?V!:V4L<*7#7&H6]DR[\;/-<+N[],
MYQ6S'/#,7$4J.4.&"L#M/H?2O(=3TG3_ /A66@/:WS7CZMK5E<7>H(=KSRR2
MC>V>JD= /X<8ZBM^#1=-\._%O2H=&LH+&&[TFX$\=N@19"CQ[20."1D\]>:
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M5]3%Q=W%Y):1VDDMQ(&+JA8@G 'S98Y-;-0"]M3=FT%S#]I SY/F#?CUV]:
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M:8O-3S NXIN&0/7'I0!R]IX&T[3;J]U(/>:G?W5DUI.;ZX#?:%)SACC Z!>
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M8,#/R\98DXK>FU&RMD9Y[RWB52%9GE50"1D Y/<5+)<0PP&>6:-(0-QD9@%
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MY9QE"1U' /(Z],4 >>VVBW<6J^"?#?B"U@^P&\U&=+(R^?&%1=T,9) W; [
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M(;@I/$S$[L..QW$$'C%;&AZ!9^'[::*U>XEDGE,T]Q<RF269\ 99C[ #T %
M''ZQI.GZQ\:]/@U*"*XACT*25895#(["=0,J>#C)//< ]JY+4(4LI->\-6H\
MG0IO%-A;R11G:B13*K2H,?=4L ,#CD^M>HZQX.TW6M8BU::6\@U"&W-O#<6L
MYC:-2VXD8[]1SD8)XJ.#P-H<7AV[T22&6XMKR4SW,L\K-++*2#YA?KN! P1C
M&!0!S^I:78>'_B;X5&BV5O8B_M[V"[CMHQ&LD:1AT+*..&Q@^]<X[*O[,-MD
M@9AA'X_:5KT?1_!]AI&I'4C<W]_?^5Y*7%_<F9HX\Y*KG@ D#/&3ZUDM\+?#
M[VDMB\NI-I[N9([(WC&&!BVXF-.@YSUSC)Q0!0LM"TS6?BSXL;4[*"\2&UL@
MD5P@= 61\MM/&<#&>H!/J:Y30[>*^L_ V@7B"723K&I!H)/F1O),IB1@>H![
M'TKV"UT6SL];U#5X@_VJ_2))B6R"(P0N!V^\:R)O 6BS:)%I8^U1)!=O>P3Q
M3E)H9F9F+*XZ<L>/0T 8>@Z98:5\9=9@TZ&."%M'@D:&(!41C*^<*.!G@X'<
MD]ZD^)EG;ZA>^#[.[YMYM;1)%)P'4Q294^QZ$=P:W]%\':9H6JS:I;O=S7UQ
M ()Y[F<R/* Q(+$]^<?0 =JL>(/#&F^)H[1-225EM)O/B\N0H5?:5!R.01NR
M".AP: .%U#PMI<OQ$U'PY96L-G8:OX<<W,-O&$02+,%CDVCC<,G\JH6^IW'C
M/1?"OA*]R;Q;MEUI"<X2S(W!O]]_+_.N\L?#]AX4_M#65_M34[Z2,+)+,YN)
MV1>D:#CC))P.M97@?09/^$B\0>+KS3'TZ?5I%6"VE $D<*J!N<#HSD;B.V!0
M!U^J6T%WI5W;W,,<T+Q,'CD4,K#'<'@UXK8:182?"+P)&MK%";[6;,7+PJ$>
M7+N,LPY)QQGK7NC*&4JP!!&"#WKD]/\ AWHVFV5M90S:@]I:WD=[;02W)=('
MC+%0@/1<L<CO0!RVNVEOX6\;:C)X?LX+!CX3NYO+M8Q&K21NNQMHXR,GFH/#
M?A[5=OA*]L/#&FZ:+9HY)M1BOP\MU"\9\P.-@+%L[N2<$5Z7-H5C<:\FLRHS
M726CV>"<H8V8,01WY45DZ9X"TC2KZUN(IM0FBLB6L[2XNFD@M201E$/H"0,Y
MP#Q0 SXEVT%S\-O$(GACE"6,LB!U#;6"DAAGH1V-<5>6&R[\#:9I_AZPOK5M
M-EO382.MO#+,$B'F-\I#, Q/(_BSVKU?4=/MM5TRZTZ\C\RVNHFAE3.,JPP>
M>W!KG5\ :8ND6=A]NU4O8R&2TO#>-]HM\J%VH_9=HQMQB@#S[Q%HNIZ=X$OK
M6\LX=+MKCQ!:RV=K:W/FBV5V3<%8 8^;<P  QNK?\2>&-%M_%_@71[;3;>#3
MGN+QI+:- J28@!^8?Q9VC.>O?-=1_P (+HQT3^RW%S)&UVM[+-).6EFF4@AW
M8]?N@?08K4O=$L[_ %?3-3G#FYTUI&MRK8 +KL;([\4 <!H'A'0+CXB^-+*?
M2K22Q@%HT-HT0,,32Q'S&5.BL=J\@9XK(\/:-J&K> ?!>IP:=9:X-/M[F-],
MOI HD4OM5T+ KN4)@;AC#'I7JUGHEG8ZSJ6JPA_M6H^5YY+9!\M2JX';@UB#
MX>Z/#ING6EG/J%BVG))';W-K<F.4([;F4M_$"<'!':@"QX&GTV;PRBZ7936$
M,,\T3V4QRUM*'.^/J1@-G&.,8Q725GZ-HUGH.FI8V2OY09G9Y'+O([$LS,QY
M+$DDFM"@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "FR2)%&TDCJB*,LS'  ]2:=7#_$Q1/9>'K"?F
MQO==M8+M#]V2,[CL;V+*HH ZNVUC2[RVEN;74K.>"'_62Q3JRI]2#@?C7)>#
MO'-YXNUW4EB72X=+M;F6VC3[06NI2F/W@7IL.:KZCI>GZ?\ %70(+"QMHHM0
MTZ\AOX(XE"21)L*;U P>21SZXJE\&].L8[#Q!<I9VZSQZ[=Q)*L2AE3Y?E!Q
MD#VZ4 =MKOBG2O#L^GPZA<*DE]<"",;U&W(8[VR1A1MQGU(JA:>,+<^(]?L;
M^XLK2RTXVHAN))0@D\V,OR2<=N,5B_$:QL[KQ%X)^T6L$V_5A&WF1AMR>6YV
MG/49YQ3-&T'2M1^*'C1KW3[:Y6%+***.:,.B*8.<*>!G 'T% '7:SJ%Y!!I\
MNF3:9MGNHTD:]F*J\1!SY9'WG/&!T/-7)]4T^UNXK2XOK6&YE_U<,DRJ[_0$
MY->&W.1\+?A_'DE8_%*1IDYPJS3@#\  *ZOQ3H[:=J7B'6;W0;#Q#HEV%DNR
ML@6\LECC4,%SU "[@ RL"30!ZE7GEAX_\2:EHW]M6O@@S:;^\.^/5$,A5&*L
M0A09/RGC/-=];2QSVL,L+%HG160G/*D9'6O)_ EOXWN_ %M;:5<Z%;:?*UPD
M<\R2O/&#-("< A20<X[=* /2;3Q%I5WH%KKGVR*"PN8EE26X<1@!AD DG /M
M5+Q1XD71_!.H^(--:WO!;P&6(A]T;X..JGI]*Y.#P]8VGQ!\-^&KF-;K3=+T
M&22U2X4,KS"1$9R#P6V\^V:PO$$,6GZ7\5],L8UAT^*&VF2&,82.62/,F .!
MG"D_6@#T:#6M2O++PU=PG2XDU&));I+B5E?#(K8A'\1R3U]JV;G5-.L[F*VN
MK^U@GF_U44LRJS_0$Y/X5Y1JW_'U\'O^ ?\ HF.M;0M$T7Q&?'-QXAMK>:0Z
MK/:R3S@;H;=$79M8_< !W COS0!Z/'<P322QQ31N\1VR*K E#Z$=JCDU&QB$
MIDO;=!"P67=*HV$] W/!/O7GDUS9>"?&]IK"76_0M;TSRY;@R;PTUO'OCD+=
M]T6X9[D5H^"?#5OJ/@IKC7K-)Y]<N3JEU%(,@,[!HU_X"H3CL10!W=47UK2H
MY(HWU.R629BD:M.H+L#@@#/)SQQ5ZO&=&\/Z)>_"[QA>7=I;S7/VC4F,\B!G
MB*,Y7:QY7'#8'<D]Z /7+K4K"QW_ &N]MK?8GF-YLJIM7.-QR>!GC/K3+O6-
M,L#$+S4;2V,W^K\Z=4W_ $R>:\MTO3X/$GQ"\,'6[=+L_P#"'Q7,L4ZAU>3S
M%&64\'EB>>^#VK;\,Z1INM>*O&DNK6%M=3QWR6:)/$KB.W6)2BJ#]T'+'CK0
M!W_VFW-P+<3Q>>4\P1[QN*YQNQUQGO5?4;T6]M<QV]Q:+?+;O-%'<2[5X!PS
M8Y"9QDUX]HK2:9X6\&>+-[/#IE_/ILTC'.ZRDF:)23W"D)BM>5/[;L/B/XJ?
MYHC8W.EV)/\ SQAC;>1[-(6_[YH ]$M-3$.@6]_K%WI\+&-3--%/_H^X_P!U
MVQD>F:H:5XE.I^+]5TJ+R'L[2UM[B*>)MWF>9OSSG&/E&,5YWH,$.H0_"G3K
MZ-)K%K&YG\F0;D>5(EV9!X) 9B*K>)8(=%O_ (E1Z.B6X-A8!XXCL6/S&8/C
M'W<JQ)QZDT >RV>IZ?J)D%C?6UT8CMD\B57V'T.#Q6!XK\8VVB:)>7.GW-E=
MWUK+#');><&*!Y4C.X Y&-WYURCZ-KVF:E#JUMH6BZ*EGIMW$RV%V7>=?+R@
MV^6N=KJIS[FL;5=#T6#X%:#?Q6MNMX18S?:%4"221Y$,F6ZG.6R#Z#TH ]MK
M \2Z_-H=WH44<43IJ.HK:2LY/R*4=MP]_E'6M^N#^)5E!J%SX0M+I/,@EUV-
M9$/1U\J7*GU!Z$=P: .RLM2L-21WL+VVNE0[6:"57"GT.#P:;!J^F7-Z]G;Z
MC:2W4>=\$<ZLZXZY4'(KS#Q-$OA[Q5XJ;0[>.R9O"+7!6V0(/,61P'P/X@._
MM3]>T72=&^'_ (6U#2+.WAOH+JP:UGB0"21G90P+#EMP9L^M 'J(OK1K1KM;
MJ VRYW3"0;!C@Y;IQ2M=VR0QS/<0K%*5$;EP%<MT /?/;UKR&Y002ZSX!Q\M
M_P"(86C0?\^DX^T2 #T'E2K^-/T1I-4N_"/A20F1M N[J6[!["U)C@/X[T/X
M4 >K#5-/;4#IXOK8WH&3;"9?, ]=N<U-!<P74?F6\T<R9*[HV##(ZC(KQ+P[
MHVOZSX)TJ]M]%T6*Z>[2^_MB2](N#-YV7+#R^I^9-N[H<5M76LM\/K[QO81@
M_OXQJVEH!G=),1$R@?\ 77;QZ-0!Z9+J^FP6ANYM1M([96V&9YE"!O3<3C/M
M4IO;00PS&ZA$4Y"Q/Y@VR$] I[Y]J\C7P]?:+K_A;P];:78:J;'199S#?3F.
M,W#2*)9!\C;FR>,C@,>:K:WH%[:>&-)TS5(;6W@N?&$)BM;*X,B00R9W1AMJ
MX^8OP ,9H ]FM;RUOH!/9W,-Q"20)(7#J2#@C(XZU%J>I6NCZ9<:A>RK%;V\
M9D=F(' '09[GM3K'3[/3+1+2PM(+6W3.V*",(HSUP!Q6/X\@BG^'_B%9HDD4
M:=.X#J" PC8@\]P0"* *$GCFWGE\+2Z>8)+/67<2L[C= ! 9<'!P&& "#TKI
M[+4;'4H6FL;VWNHE.TO!*KJ#Z9!KREM&TZXTWX66;V<(M[C$L\:H%65OLF26
M ^]G SGJ.#4^JG2?#GB?QN&LBFFR:);O/:V?[KS69I(^-N-I.0,T >EVVLZ7
M>).]KJ5G.MN,S&*=6$?^]@\=#UJGX=\3Z9XHLI+K39@ZQRR1,A92PVNR;L G
M .TD>HK@M.TZXL?B-H%I>:'HNF1W&EW<+6MA*93)$/+PLN44'!Z=<_-6K\'+
M.U@\!Q3PVT,<TEU<J\B1@,P6=P 2.N!TH Z;4O%>DZ3KNGZ/=W*1W5\)&3+J
M @0 _-D\9S@>IJCHWC&VNI=875;BRL19ZK+80&28)YH14.?F/)^;M6+XHTZQ
MNOB]X/\ M%G;R^9;7N_S(E;=M5"N<CG&3CTK-T;P_I6HVGQ$NKZP@N9CJ=W$
M'FC#E%$2D;<_=Y.<CV]!0!Z!J5Y?0:MI4-K)IJVT[N+@7,I65@ ,>2!PQZYS
M[5:;5-/6_%@U]:B](R+<S+YA'^[G->/^:\UQ\%Y)&+.8'RQ/)_<QUJW^F)X=
MO[V^U?0K'5M%N=6^V#5K:7;=6CM*-H8=2$;"Y5N@P1U% 'INH7?V#3;J\V;_
M "(7EV9QNV@G&?PKA8OB'KZ^'X?$5YX+:/17@6Z>>#4DED2%@&W^7M4G .2,
MUV7B#_D6M5_Z\YO_ $ UYSH&C^--?^&NDZ2UYHEIH]YID,+311RO<B!HP",$
MA=Q7C/3F@#TJ?6=,M;.&\NM0M;>WF ,<L\JQJP(R,%B.U<_X_P#%TOA3P5+K
MVGQV]VRO$J!V)1@[ 9R#Z&LC3M)L+SXIZI9W]K%<0Z7I-I#I\5P@=4C8OO8
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M>7;\6)/XULT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MWX=M;6T-Q':Q3SL9CY8&V:3!P(N>2!^- '97'AG3+K6]*UB6%S>:6CQVKAR
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MTI[2%(S%!!(3=1D@$F5<X /;':@#/U'P#H>IZA<7<ZW:K=,KW=M#=21P7+#
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MI%<R11W(7@"1%8!\#CD=..E:2:'IT6N?VREN%OA:"R$@8@"$-N"[<XZ]\9H
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MCO>0 ,>3QD =,50N_!.AW>GZ=9F">%=-B$-G+;W,D4L28"[0ZL&(( R"3G%
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MV3:C1B,;]ZG!4[0&YR,@X(J.,7OAI(M/U#0=/BU2+2;J/2=5TM\+,4BW%63
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M*N>$?$,7BGPO8ZQ&GEM.G[V+_GG(#AU_!@: )-?\,:/XHMX(-8M/M,<$GFQ
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M:['6-?TGP_;I/J^HV]E&[;4,SA=Y] .I_"L;Q%X[TC1_!5QXAM-0LKF,QO\
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MGTXKK_"B12^/?'37:HUW]HMT^<9/V?R1L'^Z3N_'-=,?#FD-H,>AFQC.F1A
MEOD[0%8,O?/! -5]9\'>'_$%TMUJ>FI-<!/+\Q7:-F3^ZQ4C<OL<B@#RS0)(
M]%T;PGXFW;=.M-6O;$/V^R32.$.?[H=5Q]:AM]1G\(:;_P ))(&2Y\3:/=7&
M!U-T93+"/KLGQ_P&O8KSP]I&H:%_8=SI\#Z7M5!:A=J *05  QC! I+_ ,-Z
M/J<%C!>Z?#-%82)+:HV<1,HPI'T]* /-+K1E\/\ CGX4:2H&;2VNXV([N(1N
M/XG)_&J=GIFNZOX,\16[WGAZTLYM3N_M=Q>"030RB8X9FSM!&$V^@VUZY=:+
MIU]JMCJ=S:I)>V._[-,2<Q[QAL=N16?=^"?#=]JYU6YTF&2\+K(S$L%=EZ,R
M [6(P.2": .?\*QQ2>.O'0U'RI+@-:QR%P,&'R!Z_P ).ZN+\&+;/:?#.,[6
MT[[=JC1A^5,@:3RNO?KCWKU;5O!OA[7-12_U+2XI[I$\OS"S+N7.=K $!Q[-
MD5E>)O#$:>&[73M(\.V&HV4-UYTEA+(8VP2S,T3Y&U]S9YXP2.* .%\8"&'7
M_B0=*VK,="@-SY79BS;\X[[,$UU5CI&LOXH\,WM]>^'((+2*5;:&P61))X6B
MQM7<3E1\C<=,5/X-\+3VNKZKJ=YHMOI5K<VT=G;Z<)%E(C4NSM(1D$LSGN?>
MM[1_!OA[0+QKO3-,C@G*&,/N9MBDYVKN)VCV7 H \G33[7_AF: ^0FZ2XCD9
M@/F+&\"YSZ[>/IQ7<:Y EK\4O"8LXDB;^SKZ)0B@#:JQE5^@/:NG'AC1AX?7
M0A81_P!EJ05MLG:"'WCOG[W-6YM,LKC4K749;=6O+572"4DY0/C<!]<#\J /
M'_#FE:]J?PZ\/A[_ ,/6EDMU#<)/(LBW N!-D@L3M\QFW*>.<D5TGAFQM99?
MB+-)!&\DNI30N67.Y!"A"_3+'\ZZB/P3X;BUK^UTTF$7OFF<-EMHD/5PF=H;
M_:QFM*VTFPM/MOD6RI]NE::YP3^\<@*2?P 'X4 >4: =]U\'B_)-C=CGVMUQ
M7?\ CZ\@LO!UXUQ817ZS-%;K;3,5C=Y)%1=Q'102"?85->^"O#FH:98:;=:7
M&]K8?\>J!V4Q<8X8$'I[UJ:CI=EJVFS:=?VR7%G,NR2)^A';^0.: /,ISJ<?
MC_4(=6N-,DNO^$6N,II\+QA5\Q=H;<S9_BQTX[<U!<6=O;?!/P<T,*(RW&F3
MJP'(D:1"S?4[C^==]!X&\-6Q@,.E1J\(D"OO<N=X"ON8G+9  ^8GH/2K[^']
M*DTBUTI[)#8VOEF&')PGED%,<YX('Y4 <=X62REOOB&VJ+&6.I.ER9<?\>PA
M39G/\.-V/QJ_\)?^25^'_P#KW/\ Z&U:^H>#/#NJ:N-5O=+AEO<*&D)8!POW
M=Z@X?'^T#6EINFV>D:=#I^GP+!:0C;'$I.%&<]_K0!YB^H:WK_Q2O-:T;18=
M5L-!5]-M_-O1;JMPV#*X.ULG'R?2I/!]WJV@>-];T/4M-CTW^VE?5-.@2Y$Z
M"4#$JAMJ\DX;&!@5Z/I.C:?H5E]CTRU2WM][2%%).68Y))/))HO='T_4+ZQO
M;JU22YL79[:4DAHBPP<8]1U% ' ^#HO#C_"/0)=:$7DB5)&=RP?[9YIYROS;
M]_'\^*=X8BT>X\.>-CXB6%H#K%Z-2,W:-2-N2.<!-NW'X5U*>!O#,>M_VPFC
MP"^\TSA\MM$G]\)G:&_VL9I=1\#^&=7U0ZE?Z1!-=L5+N2P$A7[N]0=KX_V@
M: .'L8-7O/&'BY=);1&M&CM8R-325V-L;==N""/D.7SGOG-,T'3K>R\>>"K.
M\O;:_DMO#THMKF)MR2,'7:4/?Y,\^U=_K/@[P_X@N4N=3TV.>9$\O>'9"R9S
MM;:1N7V.16)JO@V+5?'5A-<:;$^B0:1);#:P3RI/-0H% (9<!3@CIZT <'XQ
M1(]"^*Z6RJ+,75BRA1\HF(B\W\<XS7>ZW<W<WCVVL-&M-+CU"WTQKA[^_5W$
M<+R;=B(K+R2F2<] /6MR#PEH-MH$^A1:9"--N-QF@.3YA/4L2<D\#DG/ ]*I
MO\/O"TMO9P2:1&T=HK)"#*Y(5CDJ3NRRD]FR* /--)BAU#PWX(AG\BX@/BFY
MP(UQ$P#3L-JDG"^@YXK=\7B:W\8>+7L 4N'\(%\Q\%F#R 'Z@=*[J#PEH-M<
M">'38DD%V;U=I;"S$$%P,X!PQZ<<U?\ [+LO[5?5/LZ_;7@%LTO.3&&+!?3&
M230!RUA#X:3PWX0D=;=9EBC&DE20?-,)X&WKD9SGCUKB/#FE:]J?PZT$27_A
MZTLENX;A)Y%D6X6X$V2"Q.WS&;<IXYR17I>E^!_#6C:G_:.GZ1!!=#=L<%B(
M]WWMBDX3/^R!2Q^"?#<6M?VNFDPB]\TSA\MM$AZN$SM#?[6,T 0?$7_DF_B3
M_L'3_P#H!K%T+0/&;:)ILB>-XDA-M$RQ?V/&<+M'RYW\\<9KN+ZQMM3L)[&\
MB$UM<1F.6-NC*1@CBI((8[:WC@A0)%$H1%'8 8 H XCP='!+XJ\=M?+&UV=0
M6.3S "?L_DKY8.?X<;O;K7":+:Q7^F?#.WN8Q+:?VI?>2K\AHE,ACZ]1@#\*
M]8UCP9X>U^\%WJ6F1S7&SRVD#LA=/[K;2-P]CD5>?0M+>33G-E$#II/V,*-H
MARNWY0..G% ')R6EN_QRMF:%#Y'AUGB^7[C?:,9'H<$C\37.:?IUFGP]^*!6
MVB!:_P!3'W1T1,J/H"20.Q->J?V99?VN-6^SK]O$'V;SLG/E[MVWTQGFH$T#
M2X['4+);-!;:B\LEW'DXE:08<GGN/2@"#0+@1>"]+N92S!-.BD8CDG$8)KS
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MD1PK@9[D^I]S4-GX<TC3]$ET:TL8XM.E5U> $X8/G=WSSDT >0>)P!^S9H)
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MZ*@P!^%/HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MK$TME7X4?#:0D!%UNTW-V'SR#G\: /7GU.RBU$:?)=1K=^0;CRF.#Y0(!;Z
MD"J&D>+?#^OW4EKI6K6MW/&N]DC?)VYQN'J,]QQ7(^(&T^[^*5W9WMVL-O\
M\(I<I=2;P/)1I4RQ/;C)JQH;ZEHWB+0M&UN+2M1CDM98]+U2T0I*J(BE@Z'(
M 90.5..!Q0!V6JZQIVAV)O=4O(K2V#!?,E; +'H!ZGV%5H?%6@W&AR:W'JMJ
M=-B)$ER7PJ$'&#GH<D<'GD5D>,KN8:OX=TVQM;&34;JYD>VN+Y&>.V,<9+.%
M4@LV#@#(ZFN-TZR.K3^++.[UVQ@OUUVT>WNXH-L+721H57RV8YR4P1NY()H
M].T;7])\0VSW&DW\-W'&VQS&>4;T(ZC\:@UGQ7H/AZ:*'5M5MK265=R)(W)7
MINQV'N>*RO"E_>R>(-9T[6=/T^+6;>.WDFN[#.RYC;>$SN^8$;6X)/7BJNNZ
M?J0\4WNJ^'+[2Y[T64<%_IE^#M>(%V0AARA.7'((/?I0!UD6JV$U\EE%=Q/<
MO;BZ2-6R6B)P''J,]ZC.NZ4MM?7+:A;K!82-%=2,X"PL "0Q/0X(_.N"\*ZA
M9ZC\0=&O;.U6RMKGPDK06PP!&//'R#V'\JYV>X@N+35)C(CZ:WCV(7;9RAB
MC'S=MN\+[4 =]J_CG3KCP3KNK>&]3MKJXT^U>3CG8P4E=RG!P<?C5_2/&F@Z
MG=V^F1ZO:2:JT0+0*W)8#+ =B1SD#D8-8'Q%.A#1_$X3R_[>.@R%]H;=]GR<
M9_A^]TSS^%1>(+6"TLOATEO$D:Q:K;1IM&-JF"3('UP* /1J*BBN8)WE2&>.
M1X6V2*C@E&ZX..AJ6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%(2 "2< =2: %HJ*"ZM[I"]O/%,H."T;A@#^%2T %%%% !1110
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MQ)SC&>>M>>:AX4U_Q!H'CF]FT\6=_KL<,=I8R3(S*D*X7<P)4,Q+<9P..:]
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M;NV\:6WAZ\B@6SN]-6YL)E!#,Z8$D;$G!(!## ''K7"KX$\1CX$:KX:_L_\
MXFT]YYL=OYT?S+YZ/G=NV_=!/6NE^)D4^F^$],U^TV+JVBW$,ELK?\M2^(WB
MXZ[@W;TH WO#?B"\U[6?$ \J%=*L+L6=K(H.^21%_>DG.,!C@8'8UCW7B?Q%
M>>)]7TW1FT4-ICHHT^\+"XNP45RRL& 1?FP#M89!S70>#]#/ASPII^F.VZ>.
M/=</UWS,=TC?BQ-<EXVTC5=>>^L7\(0W=T>-*UF">.,VV0,,Y+"12K9.%!!P
M* +6K>+]7EUO5[/1[G1+6/20BNFHL2]U*4#E%PZ[  0-V&Y/3BLJ3Q#KNO>.
MO!]UI5U9P6-_IDMVD$T;M@$1[P^& 9AT4\8YZU->^&+G3/$&K74G@ZS\3#4?
M+FAN)!!NAF$81E?S.0A*ALKGJ>*N:EH^M:=XG\*:O8Z'#<Q6=E+:W5M82)"D
M#.%Y0.1\@(/O0!>^*_\ : ^&^LFQEMXT%L_VCS49BT>T@A,$8;IR<CKQ6!H6
MI:UH'A7PKH]C!HQU+68XQ:,EN\<<4*0AW>4!LNX&.A7)-=EXZTR[UGP-K6FV
M$7FW=S:O'%'N"[F/09) 'XU@WGA_6;33/!6IV5D+G4= @$4]CYJJ9$>$1R!6
M)V[@0",G!QUH <_BW7-'D\0Z7JZ6$VI:?I+ZI:3V\;I%.@###H6)!#* <-R#
MVKF_%.O^-+WX3W'B"273+&VNXK5XHH$D\Y4=E!.[=@$EE/?"Y')YK:NM#USQ
M%<^)=;N=+:PEN="DTJPLI9D:1]VYBSE257+%0!GMSBI]?\,:M?\ P3@\/V]N
MK:K%86B& R*,O$8RR[LX_@(SG% %+4/^$C3XGZ/%$^FOJSZ)<+)/Y3BWC'GH
M=VS=N/  QNZG.<5TW@[7=2U8:O9:PEL-0TN]-K)):AECE&U65@&)(.&Y&3TJ
MG96>KZAX]TWQ!=:3+80#2)[:6.6:-VCD,R%5.UCG*J3D?CS5SPOI-[IVO>*;
MFZA\N&^U!9K=MP.]!$BYX/'(/6@#G9/[<?XM>((=#:RBE;3;0R7%XC2(@!DP
M BD$DYZYP,'K2Q?$'4I_#VF(8].MM<O-0GT^1YF86L1A+>9)U!(PHPN1RP&:
MZ'3M)O8/B-KFJR0[;*ZLK6*&3<#N9#)N&,Y&-PZCO7'GP3J::9;75QHMOJ,U
MEKM[=G3IVC87%O,S#(W97< 58!L=.U %N_\ B'J>E^%_$\TATN\U/1/L[K-;
M!C;SQRL #MW$AA\X(W=0*T-1\3>(](T^R2__ +'AU+5[SRK,,7$5I%L+L922
M-[*%(X*@DBLO6_#.HZQ\/?$=GIOA"QT:XO3"MK:0^2DLJJZL3*R'8/XL#/ ^
MM=#XZ\/S:M'H]]!IEOJCZ9=&5["?9MN(V1D8#?\ +N&0PSQE: ,2\\:WL?AG
MQ;#?+I&HWNCVR3J\*%K:YC<';N0L2""K C=Z>M66\5ZV?^$-T_2;/34EUO3&
MG8R(PBMBL<;?*H;[H#,-O4_*,CDU!>^'K[4O _B>UL/"%CHLU[!Y-I;0B%)I
M<#K(4.P<G@9XYSUJYIWAW58-6\"3R6VV/2](EMKP^8I\N0QQ*!UYY5N1D<4
M:?A+7-5OM3US1M:6T:^TJ:-3/:(R1RI(@=3M8D@]0>:Z2Y%P;686K1K<%#Y3
M2J60-C@L 02,]<$5QC0ZIX<U?QYXB%BLL4L5O/:*TRJ)O*@(<$_PX([BNRLY
MFN;&WG>/RWEC5V3^Z2,XH \/2^UV[^#1O]1FM[P/K$;P)&K+(7%Z=P9F8C!.
M N ,#UKT.SUSQ'8>-+#1=>_LR:#4[>:6![*-T:%X]I96W,=PPW7 Y[5RMEX9
M\2IX ;PQ+HCI-9ZK'<1W'VB(I<1_:O-)4;LC"\X('Y\5VVKZ3>W7Q \-:I##
MNL[*"\2>3<!L+J@7C.3G:>E '):3X\NH_!&I:G%8:38RIKK:>KK&8[>,%T7S
MI<')QGDY&>.E=SX<N-;GBN!K#:=<("K6UY89$<Z$<_*68@@^Y!S7&^%="\1>
M'/!^K6\FAV]Y-<:S-</8S2H?/MGV@[3G;NXSAO0YK7\":'<:7J&M7::,VAZ;
M=F(V^FM*K;'4-ODVH2J;LJ, _P .: .>UF/P?)\6=7_X2XZ4(QIMK]G_ +09
M ,[I-VW=^%0Z)X@M?"^E^+;_ ,/0_:M!6]MX='A#GRGG<*L@C)_@WL#QQP<5
MV,'AZ27XBZOJM[8PRV,]A;0P22!7RZM(6&.H^\.U3^-O#T^N>$Y+'3!%'=P2
M17-JK?*F^-PX4XZ XQ^- %"'7/$FB^)-(TWQ$VEW-OJQDCBFL8GB,$RKOVL&
M9MRD @'@Y'2N,\-:BVD>#OB=J"6]O<M;ZW>R"&Y3?&^-O##C(KK/LVN^*?%.
MA7FH:%+H]CI#R7$GGW$<C33%"BJFPGY1DG)QGCBL2T\&Z]%X*^(6GO8XNM7U
M&[GLD\U/WJ/C:<YP,X[XH V4\4:K=6/A32]$M]/@U+5=-6]D:6-C!:Q*B$[4
M4@GYG 49XQS27/BOQ/H0TN37M.LHK9M4^P7EQ#NVNCC]U/'\QV+NX8-GVJNN
M@ZYHB>#]9L]--[=:;I(TZ_L4F19-I1.49CM)5DY&>0>*T[G3M4\4^"==M?$\
M,&G+>"0VT.\,;6, %&D<'!8,-W' XH OS^(+Q_B#:>'K**%K>.R>\OY7!+("
M=L2J0< DAB<@\#M53Q1XCU&Q\1:;HFG76EV,EY!),+K4E9D<H5 C0!ERQW9Z
M]!TK/^%$-]>Z!-XHU8 ZEK3(['_IE&HCC_/#-_P.M3QA%=7+Q6TWA2#Q#I$D
M9\R(-&)8I<\$"0@;2.X.0: .<UZX\0R>+_ K-:64.MO%J".I<M AVH"_')7
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M*%51@ #  I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MT5YQ?>,]=T32_%MI?_8I]6T2U2ZM[F.%DCN(W!P63<2""I!PWI74^%IM=O+
MW^M/: 72I+;V]O&08$(SM=B3N;D9(P,YH WJKP7]I<W5S:P7$<D]J56>-6RT
M98;@&';(YKASXF\0:AXGU6RTR^T:&33KI85TFZ1A/=1[58R!]PV@ACMPI''-
M4;&/Q%<?$+QQ%H5U8V>V>U=Y[J!IMS?9UP@4,N!URQSVP* /3JJZCJ=CH]C)
M?:C=PVMK'C?-,X55R<#)/N0*XFW\7:SK'@C0M7@GTK2/MN\7U[>L#%;E=R_(
MA==Q9EX^;@>M<IXX\13^(_@=XD>YFM+B:RU!+-KFS/[F<++$0Z\G&0PXR><T
M >OR:MI\.H6NGR7D"7ETK/! 7 >4*,DJ.^!6;XJTK0]5LK>'7YF2T:98UC^U
M/"DSL<!&VD;LGL:X_7/^2T^ /^O*[_\ 11K4^*TDT7AK39+>(2SIK%DT<9.
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MPC",LF>67@'*YKOZ* /,- \&:[I^E^![>ZBC,VDZA=SWC"1<!7,NUASSG>O
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M)'!.<<5QVD_#JWUO4]9UWQII<4]_>W9^SPM+N$%NH"QKE3C)')KT>B@#SP>
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MTP@5GPSDL!DGU.*VKNQ\6^)](U^VU&WM=+M[O37M+2R\Y9B96#9D>0*,#D
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M)PYFOK[:S%AC:B(S*#G)).>,5S<?CS7+SPWX>N+!M/FOKW69-+EF"DP2!?,
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MBV\<!1P6*K$R/D=OO5C/X:\6WW@NW\"75C:)8QB.VEU9;K(>W1@1MBQN#E5
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MW.F:>J-<R30.H=MHPDJ,>?HIIGC'0KO4+K1]6T^TMKZYTN9V-G<L%6>.1-K
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M*6H06[/&SJ4DSEL;<'/7T':G'XTUP'XAM%''</HDJK91K#G (.2P'+8QG\*
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MH2HFV(*1B-%8[2Q+@9_V2<5T'@/Q*_B&PU".:^M;^73[QK;[;:@".X3:K*X
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MG# [@!N)QG/.,&C<^,O$NG>$M;W3V]WJVE:W%IZ3F$(MPC-'C<HX4D.1QTH
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M=6M;V6*.0F.&*%TVH&(^8A4/.!DFNOU#Q;H6EZU;:/=Z@B:C<;3';JC.Q!.
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M5Y[DQ&VD(4%B-IWK@@X&#D'UX]8JK8Z;9Z;]I^QVZP_:9VN)MN?GD;&YC[G
MH \O71]1\,>-/">F:.L%Y/I^@3(\<SF);@!XPV&P=IR=PR#TQWS5Z]\%:[J_
MACQC+=I:0ZSXA,82W28M'"D8544O@9. 22!CFO0GTVS?5(M3:W4WL430I-SE
M48@E?Q('Y5:H X#4/!^J7.J> +B/R-FA*PO,OSS&B_+QSRI]*0Z-XOT"ZUVU
M\.PZ?-:ZM=27D-W<3E&LI9 -Y*;2' (W#!^M>@44 < ?#OB:R\1:O+:K97:Z
MO;P1/J<\FR2V*1^6Y\L+ALG+@ @9)S69I?A7Q=I4OA>\BM=/>;1-.EL98#=$
M"X!*!<-L^7(7=R#@@#OD>HEE#!2P#'H,\FEH \UN_!FNZOX>\93WD=I!J_B!
M8TCMDF+QPQQKM0%\#)^\20,<U<D\,:QI<GA_5+"RLM0N[+2ETV\LYYO+#J I
M#(^T@$,IZCD&N^I RL6 8$J<$ ]#0!F:!#J46E@ZM'9Q7;R,YBLP=D:D_*N3
MC<0,9; SZ5R-UX(U2[\5^-KX30PVVMZ8EG;2!SN1Q%L)88X&:]"JCI&KV&O:
M7#J>F7 N+.;=Y<H4KNPQ4\$ ]010!PL&A>+)+KPM=/I>EV<.AR[#9PW1/FJT
M31M(&V +C((7!SDY/2K6C^"K^Q^(]_JLSP-HH:>YLXPV76><1"4D8QCY&Q_O
MFN^HH X+P!X-U+PU>ZG/J4D,FU%LM.*,25M4=V4'T)WCC_9KH_">IWVL^%['
M4-1C@CNYU+.+?/EGYB 5R2<$ $?6MJB@#SR7PSX@AU?QI#!;6DNG^((6:*Y-
MP5>)_(,84IM.06QSG@?E5_4/"^HW/A3PGIL?D_:-+N[":XR_&V'&_:<<].*[
M2B@#S_\ L'Q+HMYJUKH^G:3=6VH7DEW!>W<I#6K2'+AH]IW@-DC!'7!KL=4&
MH)H=TNEK$VH"!EM]YVIYF, GK@ \U?HH X;PW\+O#FF^';*UU71=.U#45CW7
M5U/ LC22MRQW$9(R2![ 5DW?PUNU3Q5HVE&UM-"U:**YM$4X%M=H5.-H'W&*
MJ21TQTKT^J>JZK9:)ID^I:C.(+2 !I)"I;:"0.@!/4B@#BY=*\7Z]X@\-ZAJ
MECI]A!I5RTDT4-T96E+1LI<?*, $C"\GYCD\<OB\'ZHG@+Q9HQ\C[7JES?2V
M_P _R[9B2FXXXZ\UWO444 <CJ7AR_NY/!S1^5C2+A9+G+=A"R?+QSR16"W@3
M6#8_$.'-MNU^0M9_O#T*D?-QQU]Z[B#Q'I-QJ&J6$5V&NM+56O(]C#R@REEY
MQ@Y )XS4VCZQ8:_I4&J:7<"XLIP3'*%*[L$@\$ ]0: ,/7/#][J \*^1Y7_$
MKU"*XN-S8^18G4[?4Y85EZ3X7\0Z/JGC74+.2R2XU2ZCGL#*2RD+G(< 9&<X
MXSC.>U=]10!YY#X4U;5M2UK4;O2]/T1[[2)=.,5M/YOGR.<^;(0JCY>@ZGDU
M#9^%_$ESHO@RTOK.SMI- O83(8[HR"6&.(IO'RC!)/W?UKTAF5 "S!02!R<<
MFJ#ZWIT>O1Z(UQC49(#<)#L;F,$C.[&WJ#QG- '.ZSI.N0>.8]?TFQL;X2:>
M++%U.8C;,)"V\84Y!S@@8/RBN=/@OQ1;>&]-M$CLKJ\T?7SJ43-.4%Y&7D8Y
M^4^6W[SIR.*]4HH X4:;XGT;Q%J&MZ9IEE>#688&N[22\,9MKB--N5?80Z$8
M'0'C-4H_ 6J0:;X<0S6\U[;Z\=7U%U)5"7WE@F1DXW #.,XS7H]% !7G+>"=
M6/P@U'PQ_H_]HW$D[)^\^3#SF09./[I]*]&HH YG6="O+_Q;X7U.$QBWTPW)
MN,MAOWD6Q=H[\UQL/A#Q=#X3T[08K+2XUTB\BNEF%R<Z@T<P<9&S]WD9))R<
M@=LUZQ10!Y5\1-&DU;QEX?L[.=8;O6(&LM3A0Y)LU996;/;!#*">N_%>IHBQ
MHJ(H55& H& !6;8>'='TO4KO4K+3X(;V\8M/.!EWR<GD]L\X'%:E 'E'_"'>
M+4\(_P#".06FF(EG>"[6Z-P=U^5G$H##;\A/=B3R .AR-J'2?%>E^(];N-/L
MM/DMM;,4QFENB#92",(V5V_O!QD8(S[5WM% 'E\7@OQ#I?ACP4MI#:76HZ!.
M[S6[W!C656#*</M//([5U?AW1;^P\2^)-3O%B1-3EMY(E1]Q79"J,#P/X@<>
MHKI:* /,],\$Z]H>B>%;NT2TFU?1/M,<ML\Q6.>*9B2 ^#AA\I&1CK3]1\':
M]K^G^*K^_BM+;5-6L4L;2T28ND$:Y/S/M&268G@8''6O2:* .'\>>%-2\1_#
M)O#]CY/VTI;K^\?:GR,I/./8U#XDTCQ/=^,M-U"WTRQU'2]-BWVUO->F#_23
MP9&&QL[1POIDFN^HH XC5-*\07E[H_B--*T]M4M(YK>YTU[K=')$Y!&V4I]X
M%%/*]R*Z'P]%JB6$CZO!96]Q+*SK!9Y*Q)QM4M@;V]3@=?:M:B@#SJ\\+^)!
M<^*K"RM]/^S:\[2?VG+,?,B1H@AC,>WG&#@YP-V?:KWAGP[K%IXCT_5-1AMX
M5@T!--D2*;S/WJ2YR#@<%0#[9Q[UV]% 'F]WX'UEK+4Y[9K4:@GB7^V[!9'.
MR10JKL<@?+D;AW[5H6&D>);_ ,?V7B35K6SLK:&PFM1:PW!F9"S*0Q;: <X/
M '&!USQW%% '+>+-$O[S4-'UK2X+:ZO-,>4&UN7V)/%(H#+NP=K A2#C'%9>
MK>'_ !%K_A>6WNK73;.ZDU&WN(K:!R5BACD1B&? W-\K'@ <XKO:* .;O-#N
MY_B%I>MIY?V.VL)[>3+?-N=D(P/3Y37#^,M!U#3/#?B.5Y(HVU/Q#:7%JZG=
MM!>%06''.5/%>F:1K>G:]:R76FW'GPQRM"S;&3#KU&& -2ZCIMEJEJ+>_@2:
M%767:_0,I#*?P(!H Y(:+K_B'Q;IFHZ]8V5E9Z5#.J1V]R9C<22KL+<JNU0N
M< \Y-9'_  BGBW_A#?\ A!/*L/[-Q]G_ +6^TG?]FW9QY.W[^WY?O8KTY6#*
M&4@J1D$'@BEH \_\4^!KW5?%.CW6GM"FF^7%;ZG&[$%XH9EEC"C'/(8?0T]O
M!>H-\4AK1>'^PP_V[RMQW?:_)\G.W&,;><^M=X64,%+ ,W09Y-+0!Y^F@^)=
M%N=4L=(T[2;FUOKR2Z@OKJ0AK7S#N=6CVG?ABQ&&'49Q6Q8Z!>6WQ%U+7'\K
M['<:=!;1[3\V]&8GCL.17444 <WXXT2\U[P\MO8I#+/#=070MYVVQSB.0.8V
M.#@$#T]*YR\\.^*M4UB_U&YL]/A34-$GTP6T=R3]E)R4);:-^6)SC& 1UQSZ
M/10!Q>H>%M1N?"/A33(_)^T:7=:?-<9?Y=L.W?M..>G%8'Q)T5M5\9Z#96%R
M([K5XGL=1C7[S62LLC-[8VLN3UWXKU.LNP\.Z/IFIW>I6>GP0WUX2T]P%R[Y
M.3R>V><#B@#21%CC6-%"HH 50,  =J=110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7,>-];OM(T
M[3[?2VC2_P!4OXK"":1=RPE\DN5[X53QZXKIZYWQCX?N=?TRT-A-%#J.GWD5
M]:-,#Y9D0GY7QSM()!QZT 8HN?$.C^++7P[>:\][%J]G.UK>/:Q++;31[2>%
M 5EPV<$=17&^ =)UF;PIXNDM_$DUNBZG>K(BVD3>8X"[G)(R"1Q@<#M7?:?H
MVNZIXOM/$'B"&RLUT^VD@M+2UG:8[Y,;Y&<JO90  /QJ+PCX2U#0O#WB&PNI
M+=I=1O[JYA,;$@+( %W9 P>.>M 'GNCZGKOA/]G=-=T_6#O"(+:%K:,K;YN=
MK8.,MD$]<XKT#4-1UK6O%R^'M*U7^RX[;3DO;JZ2W261W=BJH X*@?*23C/0
M<5CW7P\UB;X&Q>"UFL_[355!<R-Y7$_F==N>GMUK=U/0M=L/$\7B'0([*YED
ML5L;NTNI6B#!6+(ZN%;D$D$$=* ,77?%.LZ%%H6C:[KEAI%Y=M<-<ZJB*P,4
M6-I56&T.^Y<@Y PV.U9D_P 0]5'A'4)-,U6UU.\L-8M[2.^2-0EU%(5(W #
M/S%20.V1722>'/%,8T;6FO++4-?L7N//AD)B@DBF()B1@I(V[4VD@YP<]:76
MO#OB7Q)X96WU"33H[TZG!=+#$S>7#"CJ=F_;EVX)S@<G'04 =1HEGJ=CI_E:
MMJO]I71<L9A L( ./E"KV'/7FN66[\0>*?$NNVVF:V=(L=)E2UC\NUCE:>8H
M'8OO!PHW 8&,^M=W7%2:-XDT+Q%K%_X>@TZ\M=79)GBO+AX3;S!0A8;5;<I
M!(X.: .=?QMXDU+2/"0L9K>TU'4;^XT^]/E!T#QAU+@'G@KO R,],UZ9IEO=
M6FG007M\U]<HN)+EHUC,ASUVKP/PKB;/X?WNGP^$(H[J&9M)O9KR^E;*F5Y
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M0&^8CKBLH^"O%J^$AX;A_LE+>RNQ=0W'G/NO2L_FJKC9^[]SEN0.U &E%?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MHN3DG"]@!BJ+>.]3@\,Z;9ZCK*6EW+J]SIUSJWD*2(H"V7"8*AVPJ]"!DG%
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M7_M_PQI>KE!&UY:QS,@Z*64$@?CFO.F\77MGKNG/_P )<FI7-QJR6=QIUM;
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M'L5?)B<YC08 SA<<GGFNDH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MX[=V;]XDC,2,J/E((]\YKKJ* .?\*Z%<Z$-:%S)$_P!NU6XOH_+).U)", Y
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M5/">N:?I=]IT5AJ&I7T4LERCF6W#2LK[ O#9'(SC!)Y/8 F?4CK/Q5^'6J%
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ME/EKA6&X;><8%;MQX=U_Q%HNKV/B/4+.)+R%8[>'3T)2W93N$A9P&9MVWC@
M+[YJYI$'BP7ZSZ]?Z8EG!"RF*Q1OW[G'[QV<?+@ _*OJ<GB@#)\%?\2[QMXT
MT&+BTAN8+Z!.R&="S@>@W*3CWKNJ\^\(17FL7'B_Q38.D3:O*(=,DE7*E($,
M:2D?W68D_2NYL5NDT^V2^DCDNUB43O&,*SX&X@=AG- %BBBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** *.H:+I6KF,ZEIEG>F/E/M,"R;?IN!Q5Q$6-%1%"HHPJJ
M, #T%.HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *AM
MK2VLHVCM;>*"-G9RL2!068Y)P.Y/)-344 %%%% %0Z7IYU(:D;&V-^$V"Y,2
M^:%]-V,X]JMT44 %1SP17,$D$\22PR*4>-U#*RG@@@]14E% #(88K>%(88TC
MBC4*B(H"J!P  .@I]%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 445C^);W5[+2U.AV"7=_-,D,8E)\N(,>9'
MQSM4<G'- &Q17&:1K7B&R\9IX<U^2PN_M-DUW;W5G$T17:P5D=2S?WA@YKLZ
M "BBB@ HHHH ***XOQ=K^OV?BSP[H.A-I\;ZHERSRWL+R!?*56& K+UR?TH
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MC!&3CC- &_16+=^+M!LM#MM9FU*+[!<E5@EC!<RL>BJJ@L3P> ,\'TK'\/\
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M4Y# \@@]Q3Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK&L2Q0Q00.',:AU9I'Q]U0%/)_H:JQVVK#QYXRCM]>T[3DVVSR+>V7G&2 0
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M]J /,[W2H]#^)WPQTJ+&RSL;J$$=]L&"?Q/-6=%@B'@?XCMY:YEU/5MYQ][
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M+0B,19@B5/D!)"\#IDD_4F@"AXYY^'WB3_L%W7_HIJX&3[9.?AB^GZG:V?\
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M+2M:M]3U%M/,L0D20>:XD0J<9&".A!'45ZREC:1WTM\EM$MW*BQR3!!O91G
M)ZD#)_.J-UX7T&]TT:=<Z/8RV0D,H@:!2H<DDL!C@DD\^YH SO!&J3:GIVH"
M[M;*&]M;^6VN7L1^YGD4*3(N>>0P!SDY!J+Q=8B]U;1FLM;BTO78#,]CYT0D
M292H$B%21G@KT.1U%='8:?9:591V>GVL-K;1C"10H$5?H!4.K:)I>O6HMM6T
M^VO85;<J3QAPI]1GH: /,9;]M;O?"RWUC8Q75MXGEAN39C]S-*D3MYJYYY..
MN3D&KGBK48]&\;^*+][..[2+PM&[V\BY27]](,..X]?;->@P:%I-M!9P0:;:
M10V3;[9$A4"%L$948X/)Y'J:EETRPGN9KB6RMY)IH/L\KO&"7BR3L)[KR>.G
M)H \WA-]!\2_"%OJ&M6-]+]ENF6"SM1"D"F-< '<20=O&>R9KE[/_DB?Q$_[
M#%U_Z%%7L-KX/\-V4,$5MH6GQ)!.+F();J-DHZ../O>]6%\/Z.MA=6"Z79BS
MNW,EQ (5V2N<99AC!)P.3Z4 ,\+_ /(I:-_UXP?^BUKG=2BCD^,VA,Z*S1Z1
M=,A(^Z=\8R/P)'XUVD,,=O#'#"BQQ1J$1%& H P !Z5&UE:O?1WS6\1NXXS&
MDQ0;U0D$J#UP2!Q[4 >4WE^=/U+QE'%;6<LEWK]C;Q&\CWPPN\<>)67OM(SU
M'.*LV6GMK'Q#\0Z)JVK0ZHT^@I;SR0VXA"9D?Y<!CDC<#G/&X5Z)<:#I%W#>
MPW&FVDL=\0UTKQ*1,0  6]2,#![8%16GAK0["6TEL](LH)+-62W>.!5,2M]X
M*0.,Y.?J: /,/#UY<^*[WPGX7O?FF\/-+<:LI_YZ6[&&$'UR?F]\5'!I^H7G
MA[QE:W?B?3-,T]M3O4OH[G3_ #)$WL=K;_,7JI4KQZ8SBO7+;2M/L[VZO;6Q
MMX;J[(-Q-'&%>4CIN(Y/7O56[\+Z!?ZK'JEWHUC/?QX*W$D"LXQTY([=O2@"
M_9Q/#8V\3RF5TC56D(QO(&,X]ZXG3Y$3XV:ZKNJL^D6VT$X)^=NE=[6==:!I
M%]JEOJEUIMK-?VW$-R\0,D?.1ANO4G\Z /)%ACB_9=;8BKF'S#@=6^TYS]:V
MU@U9O'WC1;?7=-TU#]GDD2]LO.WP>0 &!\Q<("'!Z\Y]:]"_L32O[(_LG^SK
M7^SL;?LOE#RL9SC;TZ\U#JWAG0M=FAFU;2+*]DAXC>XA5RH],D=/:@"OX+L8
M]-\%Z/9PWXU"&*U18KH(4$J8^4@$G QCO6[2*JH@1%"JHP !@ 4M !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %9^KZWIV@VD=UJETMM \R0B1@2-['"@X' SW/ [UH5P_Q2C270-)
MCD4,CZW9*RD<$&49% %V/XC^&)&GC%Y.L\05OL[V<RRRALX,:%=S@X/W0>F:
MNP^,] G\.2:^FH*-.C<QR2/&RLK@[=A0C=NR0-N,G(K%N8HV^.&GNR*670)B
MI(Y!\]!_(G\ZX>]2<6FIRPW:644'CXO+<R1"1(08U"NRD@8#LO4CDYH ]4T_
MQ=HFI65]=Q7;11V W7:W,3P/ ,;LLK@$ @$@XP<4S1_&FAZ[/+!97,PFCA^T
M>7/;20LT73>H=1N7W&>U<+JSMHJ^)=:N=>T_Q!J$6F0VTUH;$)"BM*=C2X8@
M@;G)'7'X4X2SQ?$S3(+WQ%#JLPTB\&8H$B2,GRR%&TG).,X)) P>] '60_$G
MPK<2V:Q:B[1W;(D4_P!FE$6]_NJ9"NU6.1P2#ZU8AU2$^/+S3SKKN\5@)FTK
M[-A8QN \WS,9)/3;GOTKSZ2)(_V;=*"(%^6S?@?Q&Y0D_7)-;%M_R7_6_P#L
M7D_]&+0!T$/Q*\*3O:"+4G:*[9$CG^S2B+<WW59]NU6.1P2#ZU=U7QIH.BZG
M_9U[>.MR(Q+(L<$D@A0]&D*J0@]V(KS<Q)'^S)8A$"CR[9^!_$;I"3]<UTNA
MZCIVE>.O'@U:Z@MY&EMY\SN%WP>0 ",]0"&'UH Z"7QUX>CTFUU);UYK>[DD
MBMA!;R2/,R$J^U%4L0"IYQC\Q6KI.KV.N:='?Z=.)K9R0&VE2"#@@@@$$$$$
M$9KR3P;:6EUX&\)M9ZX-#UF&34&T\S1!T>,SL)(V5L \;.,@C&1T->A>!]6G
MUC1;F2ZALUN8+V:WFELA^YG=6YD7Z]^O(- $EWXY\/6.K/IMQ>NLT<JPRR"W
MD:**1L85Y0NQ2<C@GO2ZKXX\/Z+J+V-]>.LT05IS';R2);AONF1U4JF?]HCU
MZ5QFMW@\.G7=9T36;&^T\7I;4=#O8@29LJKB-N&#' (!!!/3K5-;>[^V>.X+
MGQ79Z1;&^E>Z@N;)96:!XDVON+ E2O  '530!V-YX^L;3Q];>&3',WFVQD:9
M+>5P'+($ (4@J0Q);H,8)%7O&_B0>%?"5_J:AC<)"XMP(7D7S=C%=VT'"\<D
MX'O7(Z:D&D_%'P[:R7RRHGA401W$H\LS$2H <'N0,XZUU7Q$_P"2;^)/^P;/
M_P"@&@# \&>,X8O!::WXB\0W-T\PA+^=IYAV2.N?*B"H#+[%=V<9KIM.\8Z)
MJ=M?SP7,B'3T\R[BGMY(I8EP3DHRAL8!Q@<UP@=+71_A+>WC*FG0QQ+*[G")
M(UIB(GT^;//O5CQ#-%>^//$$UE(DL=MX2GANWC((5V<LBDC^+ 8_0T :FN?%
M?0+'PW?:GIDLE\\$*/&%MI1&[.,H"^W XZ^G0X/%,O\ Q[#!XIT.3[9-%HUW
M87,CQ-:.)))5=%4!"OF9R6P .>O-8.M0I#^S!$D2!5.DVSD*.Y9&)_,DUT-W
M);7OQ7\+SQ/%.BZ7=M'(C!@#F,9!'L2/QH ZG0O$6F>)+26YTR=I%AE,,J21
MM&\;CJK*P!!Y':N<UCQ@-"^(ZV%_=R+IKZ1YR6\4!E>2?SBORA5+D[0>!Q@$
M^].\)#'CSQV!P/MEJ<>_V=*J7EU96OQVM#=R1QO)X?9(6D( W^>3@$]\ _D:
M .BA\9^'Y_#LNO)J*C3HG,<DC(RLC@XV%"-V[) VXSR/6JEQXOLM2\*Z]=Z-
M<R)>:?:2NT<UNT4L+^6S(6210<'&1D8.*\UU(R7%UJVHV%[':Z:/&-NWVPQB
M2*-A"$:0C(! D*<YQGZ5T=UI[*?%U[=>*+?5]070'@FAM[01"-,2,A8JQ!/W
M^.N#0!M^&_&4,'PVT37/$=_F>[B4%Q%EYI23A51!DDXZ 5HQ>/?#DNGW-Z;Y
MXH[66.&X2:WDCDA9R F]"H9021@D8]Z\Z\.R1VFG_":]O&6.Q2*ZB:20X19G
MCQ'D] 3AP/K6KK>EP^+O&_BRQL726)O#L=K,\9RHNO,=XP2.X !H ]!OO$.E
M:;K.GZ1=W:QWVH;_ ++$58[]HR>0,#\2,]JEAUBQN-8NM)BGWWMK&DL\81OD
M5\[<G&,G!XSFO&AJ4OBO2-0\;*K--H5MIYBP.DD1$]R/R;:?I7;>"[^R6Q\1
M^,[ZYBAM-2U!V2YD;:OV:+$,9)]#M)_X%0!WM%("" 0<@TM !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%5K_4+32K":^OKB.WM85W22R' 44
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M@ HHHH **** "BJMCJ5GJ2SM9W"S""=[>4K_  R*<,I]P:M4 %%%% !1110
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MK-T&"_M]'A74X[.*\)9I([-2(DR20HSUP, GC)&<5I4 %%%% !1110 4444
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M?#FY\<:KJ,$L$-M,D-BMLJB602%%D=QR/F&-HXQSUJUH7C64>)].TP^+M/\
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M]F;=4C21I%C$SN.3R2Q48 !]1FK&D^-I4UMM,B\667B);C3Y[A)H(HT>VFB
M."$X*,"2,\_+U- 'J%%>1#Q)XUA\(>&_%!U6TF?49;>W?3FM5$9\WY0Y<?-N
MSAB!@<XQQSMC7];\+^*-1L-9U-=6LX]$EU9'^S)"T9B;#(-O52#QG)H ]"HK
MR70_B!.VH^'Y)_%NF:J^K3)!=:7!&BFT:125*$'<0K84[LYSGBI/[;\97WA7
MQ%K\&MP6JZ/<WHAMQ9HXN$A9CAR>G VC;@\9).> #U7(! R,GH*6O+)9-6UC
MXK^'+J'5FM89]%:[2$6Z.(U9HMZ9/7=@<]1VKU.@ HKFM#UB]O?&OBK3)Y%:
MUT]K46ZA0"N^+<V3WY]:Y"S\7^)M1T3P>UO=VZWFKWUY;3R20 J$0RA6"C'*
MA <<9(YZT >J53O]4LM,:T6\G$1N[A;:#()WRL"0O'LIZ^E>?W/BW6_"3^++
M75+Y-6;3-.BOK29X%B8ERR['"8!&Y1R.<9JKX@L_$EI<^"7UG6(]12;7+9I%
M^S+$89=C\(5ZK@L.<G@<T >K45X_JWQ'G237=0A\5Z99/IEU+#;:++&A:Z6(
MX;<Q^8,Y#;=N,<=:VY-;\1Z_X\FT;1]4BT_3AIMO?^<ULLKKN)RH!_O<<GIM
M..M 'HM)D;MN1G&<4M>;_9]5E^.\RKK#)!'H\<WE?9T(,1F(,6?<C.[KVH [
MS3-4LM9L$OM/G$]L[,JR $9*L5;KSP01^%7*\2T2Z\3Z-\)Y?$.GZO#!;:?-
M<R)8FU5UN%%P^[>Y^8$DL!MQ@ >M=!K_ (V+^*;W2U\66/AN&RMH74W$<;O<
M2R+OP=_1%&W..26ZT >FT5A>#=>;Q-X0TW6)%C66XB/F",Y7>I*MM]LJ<>U;
MM !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %<YXST*[U_3M/@LVB#V^I6UT_F,0-D<@9L8!YP.*Z.B
M@#G)=#NW^(]MKX:+[''I4EFPW'?O:57'&.F%/>N9N?!.M1P7L\"65Q./$YUJ
M"VEE*I-%L"A&;:=K=2." 0*])HH \[?PMXEU#4/$<]^-/C37M(^R$1S,WV-U
M$BJH^4;P1)DMQSG QBFVOASQ1%I?AN\:QTS^UM!C:T%L;IC%=6[1HK'?L^1L
MH"!@CCKS7HU% '!ZYX=\2>)/",UI>KIMO>RW\%Q'!"Y*0Q(Z-M+[<NWRL<X
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MH]>LI=2\.ZG80%1-<VDL*%C@;F0@9]LFM"B@#S/6/ .L7_P9L/"4+VHU&W6
M.S2$1_(V3@XS^E=5'H=VOQ&N-?+1?8Y-*CLP-QW^8LKN>,=,,.]= \B1KND=
M57(&6.!DG _6G4 >;3>"M;MUDN[>.RNKB+Q+-K$5K+,526)U*@%MIVN,Y'!
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M1RQ7T-PQG8A=J$Y' //-7;/0KJW\>:KKCO$;6[LH+>- 3O#(SDDC&,?,,<T
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M.FV=C=6+VJP6+M*2[#!E+,JXP.BCUY- '-WMWXPT;2?#.I3>(VNCJFH6<5Y
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MO,"G?G=C/&*ZB&\\1^);WQ->6.M?8K32[N2QMK(6\;I.T: N9&(W88MCY2,
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MN]1BM7\M1L6+/EC&,'&!USGO6?;ZSXDUG6_#NEVVKBTCOO#RW]U,MO&SB3*
ML@(P"2V.00 3QG%22^$O%5O:>)=%L)=+&F:Q<7-PEW+(_G0^</F38%P><@-G
M@'.#TK5T7PI?:=X@T34)I;=HK'0%TR4(S%C*&C.1Q]WY#SP>G% '">+=1URZ
M^&?BRQO=8>6;2-4CM3<+!&INH6:+:' & 1YG5<9VCWKK=8U?6]"\;>!]#_M9
M[J'4&NQ>R201JT^Q0R?=4;<9_AQGO46L^ =2U+P_XRL([FU2;6;Z.[M68L54
M)Y1 ?CC)C/3/6K=]X9U[6O%/@[7KX:=;R:2UT;R&&9W!\Q0J^62HSTYSC\:
M,N.]\6:W#XMN;?Q$;"/2+^YAM%CM8G+[$#!7+*?E&0.,'DY)XJ2U\1ZYXLO?
M#>FV.H_V2;K1%U:]N(84D<EBJA$#@@#<6/0\"M_2/#-Y8:?XIMY98"^K7]S<
MP%6.%61%50W'!R#G&:YE-$U#POJ/A(66H:1_;<.CG39;2\E=([F--K%HW"DY
M5AG!'(/:@#>\$:KK=YJ_B:PUJZCN'TV\C@A:.(("GE*=V!W;.XC)P20.*=\1
MM;U;0M%TZ?1I42ZGU2WML2*&5U=B"IR. >.1S6=\-5N'UCQC<W%S%=M)J:JT
M\(Q&SK$FY4]E)V_A6[XS\/W?B*QTR&TDA1K74[:\<RD@%(VRP& >?2@#EO$.
MO7_AN]TGP_JGC'[,US'-=7.K/:QJ^U2H6)%VE1DL>2"<+6>OCS4;CPX"-;Q:
M6VKM97>O6]H'(M_+WI)LVE5))5"<8')QS7;>(M&U5]=T[Q!H?V1[ZTBEMI;>
M[=D2>%RIQN4$J0R C@]Z8T'C9-,@N!<Z3-J'VAWFLF#+ 82,+&)-I;*\'<5Y
MY&,4 <5XP?5+WP/IDJ>+(M1MY-:MXXKNUBB/G1F1"ADP-N]&!^[@'C(K=\3:
MC>Z7?6MC=>.H],5;,,ICM4EN;F7)!=TV$+'P/N@9.:JW7@#6;GPU?B(Z9:ZI
M<ZO#JL=I$6%K&8]@V;MN<G9DMMZGIWK131/%L'B*\U:W71TEU6U@AN7:61C9
MM'N&8QL_>##9P=O(H Y6^U#6/%4GPUU$:M)8RW[2%E@AC94F6)\R ,#U!(P<
M@ ^M3ZUX\F_M/7POC"'29M*E:WL[![9'%TZ("S2DJ3AF)4!2N,9J_#X'\36&
MB>%H[5M+EOO#UU*8UDGD$=Q"RE020F5?GI@CW[5K?V)XMTB^U;^P3I+0:K-]
MJ9[J1PUI.R*KE0%(D7*@@$KSUH H1Z]KWB?Q;8:?IVJ'2["\\/0:FY2!))(W
M>0C"E@>2,#G(P#QDY&2FL>,Y_!6OZPWB-8KCP]<74"B.SC(O/(8Y:3(XR.,+
MC&,\YX[FW\/WL?C\:_+<0R0?V,E@W4.THE+EMN,!2#Z]>U9D7@W4$\%>+-&,
MUM]HUBZOIK=MS;%$Q.W<<9!&>< _C0!C:WXY$^OQ:?+XG3PW;QZ=#=M(L*2/
M-++DA1O5@%4 9XR=W6F6GC'Q!KT'@R*POX+>;5);VWNYU@#*WD@_O$#=,[2P
M'3+#.0,5NGP[X@T74X=3T)=.N99M.@LKVWNY7C4M%G9(K*K'^)@00.,59;P[
MK-UK/A/4M0O+6>?2S<M>NBE YEC*@1KCH"<<D<#/6@#E-9O=?BT7Q_H-UKTM
MR=-TY+J"\,$2R,CQR%HV"J%_@QD 'FNW\"VUS:^"])6ZOI+QGM8G1GC1-BF-
M<(-H&0/4\UFZEX.O-0U'QC+]H@2'7-,CLH#DED94D4EACI\XZ$]ZV/"-KJ]A
MX;M+'6H[)+FUC2!3:2LZLBJH#$LH()(/'TYH Y+Q=:ZE<?%GPE%;:U/:1R07
M;(J0QL(RJ+NQN4YW XYSC'&*EMKKQ/XK.O:CINOMID-A>36=E:QVT<BRF+@M
M*7!8[FSP","M7Q5H.M7?BC0-?T3[#)+IHN(Y(+R1HU=9549#*K<C;TQ5'_A'
MO%6B2ZW:>'VTN2PU2YDNHY;N5TDM))!\_P JJ0XSR.1UP: .C\(ZXWB7PCI>
MLO&(Y+NW61T7H&Z,![9!K$U&\UK7O&UYH&EZP^DVVFVD4\\T4$<DDLDI;:OS
M@@* N>F3FNB\.:+#X<\.:?H\#EX[.!8@Y&"Y Y;'N<G\:PM5T/7K+Q;-XA\.
M#3YGO+5+:[M;V1XP2A)21656Y 8@C'2@#.N-1\5RZAH'A:?4+>RU.XAGN+^_
MM(E?]U&0J[%<;0S;AG(..<5G:IXG\0:!I7C339M3^U7VD6D5W97[0(KLDF>'
M4#:2I4C..<UK2^%O$L#Z)K4>HVE_X@L%FCN1<9BAN(Y3DHI4$KM(7:<'..:K
M7O@?6M8T;Q7/?S6*:SKL$=O''$[F"WCC!VKO*[B2223M^@H KZ[JGBW0?"-C
MJO\ ;"7&H:CJ%HJP&W18H5D/,0.,D<@;CSQD8I-?UZ_\.7^E>']4\9?96N(Y
MKNYU5[2-7*@JJQ1KM*C)).2"<+71^)_#-[K7A_1["VE@66RO;6XD,C$*5B(+
M 8!YXXJ3Q#HVJMKVG^(-"^R/>VT,EK-;W;LB30N5; =02K!D!'!SDT <A9>.
M]4U/1K?3+#5()]0N-;.EQZJL PT(3S?."?=W[?EQTS4GCBQ\5:?\/_%$-[KW
MVNR6U#P7)AC6=U(*R12 *%VG((88/45NZGX<\1ZOH]C=7-YIZZ_8:A]NME16
M^SJ,%?)+8W$%2<MC.>U0ZAX<\4^)?#_B&UUF]LK9]0M1;VEG;,SPP$9.]G*A
MB6.,X' '>@#I?#5M<VGAZRBN[Z2]E\I3YLD:(<$# PH XZ5@^-=5FLM2LH'\
M5P:#9O$['RHEFNII 1@!&5AL SD@9S@5T'AV/58M$MX=9BM([R)0A%I(SH0
M #EE!R?3%8FKZ+K\7C7^WM$739?/T];&07KNI@VR,X==JG<#NY7(S@<T <S;
M>+_$6K:)X,:SOX8KK5+VYL[F?[."LBQB1?,"GH?DWXXYX/'%=%X:O=8M/&FK
M^'-3U5]4BAM8+RWN)84CD4.75E.P 'E<CBLS1? VMZ?)H$-S<V4L&CZI=70F
M$C>9/%*)""5VX#[I.1G&!UKI;;0KJ'Q_J&O,\1M;C3X;5$!.\,CNQ)&,8PP[
MT 1>/?$,OAGPI-?02Q0SR2Q6\<TRY2(R.%WL.X4$MCVKD=+\:RC4-3TZS\4K
MKT?]D3WD-TT"(]O-'C*D*H4J=P(R/X2.:[GQ9H<GB#07L[>=8+N.6*YMI77*
MI+&X=21Z97!]C6?'9^+-4M-3BU?^R[6*:R>W@MK61Y09&!'F,[*"!V"@'J:
M.0DUWQ;9_""Y\97.NAKR:P@E@@2UC"0DLH+YQ\Q8$D@\#=@#BM?4;SQ1IJZ/
MI3:VKZKK]Z0)_LJ;;&)8R\BQK_$1C +9]35G4?!>HW?P<3PA'-:C4%L8;8R,
MS>5N0KDYQG'RGM6IXJ\/7NJ+I-]I<T$>JZ3<B>#[1GRY 5*.C$<@$'J <8H
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MSL[*IYX 4"N<\'^ ;SP]XFN;R[N;>73K6.6#1X8RQ:".65I'W9& ?NJ,9X%
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ME(X*D#H/4T 8/BIKM_%'PO:^N;:ZN3=2F2>V_P!7*=B_,OL>M;^C>*[G3O\
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MEMI([":3?$%R0J$E>0>#T..>>"* -:XUO3[6^TRSDGS-J9=;7:"PDVH7/(X
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M=1C(]P,\5C6-OXEN/&.L>%F\67WV*VMX;M+OR8?M(+[ALW;-NW*D_=ST&>M
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ME*P.>W.X8KF+7P-KFDVVB7&GW&G3:AIEW>R^7<%Q$Z7#$_> )#*".WK7HU%
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MI9RV[QF9MY,A4DCY,8&W\<]JV)M:LH-;L](=V^UWD,DT("Y4JFW=S_P(5H4
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MD5O9_9;-IO.E\H,TLQ6)@V2P&WC@'UI+WQ3?7B:->:_JNJ^'--NM+CE%Q9P
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M6[K^E>*;RXOH=.O]+DTV^A$307\#,;?Y=K%-OWP>N&[]\<4 <UXDU>\M=?\
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MM8>.ZG@,2*S"(@"0%@I1L@_*=V>,'@<UI^!/"\_A+0[BPN+B.=Y;V:Y#1@@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 445B>)-<;1H;"*!$>[U&\CLK?S,[%9LDLV.2 JL<#&<
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M%#'>1SS6TXASL+QR%"5SR <9K)LKG6)?BYJMJ]_ UE!I\#I";<_*K.^0#O\
MO9498@YXX&* .JTC6=/U[3UO],N!<6K.R"0*0"58J>H'<&KU>.>']<UOPW\/
M$U>U%BVFV^K31SP2(S2RH]VR$JP("$%NF&SCMTKL]4\3:A+J>KZ=H^U)]-1
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M;&]-LA6 6\#1><V,!YCDYXSPH R<]A6-#X!U2'P'HOAM;ZS+Z9>1W/V@HV)
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M,MP?E[\ =!WJHGPZO&\*7F@RZND<:WK7NFW,$)$D$AE,JLV6PQ!.,#'&?P]
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_:@Z@KMZ[@X)_6@#T/5_'?A_0]1FTZ]NY!>Q1I)]GCMWD=PV=NT*#N/!X'0
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MTC9)=S2R$]2>HQP3C)JV-%TF;3_BF7L+5_)DF,68P?+/V96RO]T[N<CN!Z4
M>L/?6D=RML]U L[8Q$9 &.>G'6GI=6\L[PQSQ/+']]%<%E^H[5YKJD$EIX,\
M(^-[>,S7NC6D$MR0,M-:O$HF'N0#O'I@^M=CX7C%Q:W&MNFV759?M RN"(0
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M-_DWEO)Y8R^R4':/4X/%>32Z#IZ>"OA]?Z3:01:ZTU@8IX% DD!0&;<1RR[
MQ.>@%;&K&Y\&>-KLZ;;_ +GQ3&$@VIE8M07Y0S8Z*RG<?]PT >C07$-S$)8)
M8Y8ST>-@P/XBI*JZ9I]OI.EVNGVJ[8+:)8D'L!C)]ZM4 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7H$^E:==7D=Y<:?:RW47^KFDA5G3Z,1D4^;3[*XNXKN:SMY+F'_53/$I=/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MVD'TPP(R<#(-8?C06PU3P'_9XB$XU>,6_E8_X]_*?S-N/X=NW/;I7-06EO\
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M@9]ZT/B+J5SI'@34KVUD:)T\I7D0$E(VD5788(/"ECP0: .IHKSTZ-8:/?\
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M<R_>"]=C;3A@#V.165XE\+RWNBV_AC1K1+/2;VX+ZA,C!?+BW;W51G)9SQZ
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MO%LY)56SG*Y.5.23QCJ?6L&?Q_96OC(1W&I0IH4FCI=Q.4.7E:9EXXW'Y5Z
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M^#WT>ZA>TU?5(8))% =9(7_NGW]10!U6JZ/8:YI[V&I6ZW%HY!>%F(5L'(R
M>><'\*ANO#ND7US97-U8QSSV((MY9"69 <9Y)R>@ZYZ55M=0:3QK?V']MP2K
M%;(XTQ8,20YQ\Y?/(/ICO26?C;PU?ZQ_9-KK%M+>[F18U)P[+U"MC#$>@)H
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M1C.64@$<<].:;:>-?#=]K"Z3:ZO;RWSYV1#/SD#)"MC!([@'(Q0 #P7X;'B
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M6UOY*Y"3\%=S9(!'.>^.U>H:KI.GZW8/8ZG:175JY!,<JY&1R#['WJI:^%-
MLI89+;2+.)X8&MD*Q 8C8DE?<$DDY]3ZT 5O ;!OA[X;*D'_ (E=L./^N2U2
M\8W<XU?P[IEC!8_VA>7,C075[$9$MO+C)9E4$$N0<#D=36YHV@:3X=M9+;2+
M"&S@D?S&2(8!;&,_H*76-!TKQ!:I;:M8PW<*.)$65<[6'<'J#R: /&M6WW/A
MOX@07=Y;WS'6=/266"+RHW.Z!6PNYL="#R<D$UW_ (BBC3XG>!U5%4>5?QX
MP-OE)Q]/:MS_ (0_P[E\:-9+OCCB8+$ "D9!08']TJN/H*T+JPMI[J"^>UCF
MO+17^SNWWD+## 'MD "@#QZ19K6WO?A2C,K7&JJML1U739,S.1Z[0KH?J!7M
M,420Q)%$@2-%"JH&  .@KD-!T/5+WQA<^+-?L[:SNA:BRLK2*42F*+<69G?
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M49"-P;) VXSR/6@"SH_AS1?#ZR+I&EVECYIS(8(@A;'3)'6JP\&>&!<W-P-
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M(I8YX4FB=9(Y%#(ZG(8'D$'N*?0 4444 %%%% !1110 4444 %%%% !1110
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MLT?S\ A60XZ\>U:45C90R^#FM=5_M>"X\27%S]I,(C5I"DI;:!QC>"01QZ4
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M+[P_97$<=Q($"C+EE!./NYQ7,:=>0C3]'UJ5]NE1^,KN6:2086,.9!&[9^Z
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MN_[0U1!;LX\QC)NV87J<Y&*FL]7F\W1]/_MRUT""U\-VMR]XT,333AA@JK2
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MS':.\=N@F94$CHNU> .O.,'O76ZSXOTG0[F*UN#<SW,D1G$-G;/.ZQ X,C!
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M@:SXZT;1-4_LR87=Q?- EQ';VENTSRHQ8#:%Z_=8GT K3T77K'7HKN2R9_\
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MBNBEBP<@+@=23N%9^I^/=&TJ]GMITOI/LJJUY-!:/)':!AD>:P&%XY[X')H
MUY-"TB6\ENY-*L7N9D*23-;H7=2,$%L9(QQBKZJJ(%50JJ,  8 %(CK(BNC!
MD8 JP.01ZUY]I5_XJ\=K<:KI6MQ:'H@F>&RV6:3RW*HQ4R,7X4$@X '_ -<
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MX?M]"M=9FNI([.XNA9Y>)E:*7D%74C*D%3G- &Q#HVE6U@UA!IMG%9L<M;I
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M2,@U9H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %4 #O\ NA7K46F6$"0I#8VT:0,6B5(E C)ZE<#@_2I8K:"!76&&.-78LX1
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M>IFCR?UKUIH(7E\UHHVDVE-Y4$[3U&?3VIIM+8VZVYMXC"N-L>P;1CI@=.*
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M=(M]3NM.GG+9L;C[1&H ^9MK*,G&<?-GC'(%7R RE6 ((P0>] 'E?C&6*?\
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M>V(N3,PW*@3OE?F!SC'>O/-%N?#T^C:O:ZMKE]:L/$AGM=1=UCGA9H5,4SG
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M5+*5(()!!!Y!!!!'J*\SU)!9^.;.YO?$T_A^VNM"@C@NE,2I(T;,7C+2J0"
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M44 %%%% !1110 4444 %%%% !2$!E*L 0>"#WI:* (8K2W@@,$-O%'"<YC1
M%.>O HDM+:6)(I+>)XT(*HR A2.F!4U% $3VMO)YF^")O- $FY =X'0'UI!:
MVZVWV86\0@QCR@@VX],=*FHH 9##%;Q+%#&D<:]$10 /P%-GM;>Z4+<013*I
MR!(@8 ^O-2T4 ,DBCEC\N2-73^ZPR/RI]%% $*6ELEPUPEO$L[C#2! &;ZGK
M2FUMS<BY,$7G@;1+L&['IGK4M% $4MK;SR1R3012/&<HSH"5/J,]*)K:WN=G
MGP12[#N7>@;:?49Z5+10!&8(2"#$A!;>1M'WO7Z^]*\4<A4O&K%3E2PS@^HI
M]% $;6\#SK.T,;3(,+(5!91[&A8(4B,2Q(L9SE H .>O%244 10VT%O#Y,,,
M<<7]Q$ 7\A1;VUO:QF.W@BA0G)6- HSZX%2T4 ,:*-W1WC5F3[K$9*_3TH6*
M-7=UC4._WF Y;Z^M/HH A@M;>U#"WMXH0QRWEH%R?4XH6SM4CDC2VA5)"2ZA
M  V>N1WJ:B@".*"&"$0PQ)'$!@(B@*/P%-AL[6W55AMH8PI+*$0#!/4C%344
M (0&!! (/!!J."UM[6,QV\$4*$Y*QH%!/T%2T4 1^1%Y0B\I/+&,)M&/RJ2B
MB@"&.SMHO]7;0I\V_P"5 /F]?K[U)Y:>9YFQ=^-N['./3-.HH BBM;>"222*
M"*-Y#EV1 "Q]SWI\D<<R%)45T/56&0:=10!6_LZQ_P"?.W_[]+_A4PBC$IE$
M:B0C!?')'UI]% $,-I;6[N\%O%$TAR[(@4L??'6D%G:CS<6T/[TYD_=CYSZG
MUJ>B@!HC0.'"+O VAL<X]/I6=K>G75]I%S;Z7??V=>2$,EPL2N-P(.&4_>!
MP>^#6G10!R.C>&-5'B.'7-=N[!Y;2V>VM+;3X&CBC#D%W.YB2QV@8Z 5U<L,
M4Z;)8TD7.<.H(I]% %8:?9 @BSMP1T(B7_"ITC2($1HJ G)"C&3ZTZB@"%K6
MW>!H&MXFA;[T90%3]13A!"J(@B0)'@HH487'3'I4E% #?+3S/,V+OQMW8YQZ
M9J)+*TCC\M+6%4W[]JQ@#=ZX]?>IZ* &>3$(C%Y2>6<Y3:,'/7BN>UW2O$,V
MIP7NBZC8+$D7EM9:A;&2(-G(D0J0P;MCICTKI** ,+POX<'A_1'LKBX%[<7,
M\MS=S,@42RR,68[><#G&/05IRZ? ^FS6,2BWADC:/]RJKMW#&0,8SSZ5:HH
MKV%E#ING6UC;*5@MHDAC!.<*H 'Z"G?9+;S)9/L\6^4;9&V#+CT)[U-10 R.
M&*+/EQHF0 =J@<#@4UK:W> P/!$T+=8R@*GOTZ5+10!''!#%CRXD3"A1M4#
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M "EHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***HZOJ]CH6F3:CJ,
MPAMH@-S8))).  !R220 !UH O44V-_,B20*R[E!PPP1GU'8U1.M6*Z\-%>4I
M?-!]H1'4@2(#@E3T)!Z@<C(H T**** "BBB@ HHJ!KRV19V:XB58/]<2X CX
MS\WIQSS0!/16=J^O:3H%B+W5M0M[.W)PKS/C<?0#J3["JVA^+M \2M(NCZK;
MW<D0R\:-AU'J5.#CWQ0!M45EZ-XATW7WU!-/F:0V%T]I<90KME7J.>OU%:E
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MC62-U>-P&5E.0P/0@T .HHHH **** "BBF)-%)))&DB,\9 =0P)7(R,CMQ0
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M(#G?SDC!'&.^>+\<^']4A\&^+-;UAK"&[OX;2W\G3MVP*DX.]F8 LYWXSC@
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M3@>^WBNQHH \LO9XM#\0^*K:R\5Z9I]I<.+J_@O(F6XMW:,!FA)(5]P P<$
M^O0]-\,+6:S^&?A^&XC:.06BL588(#$L/T(KH;O2-,U">.>]TZTN9HO]7)-
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MN+>)X8V3>IM]^6!8\_-CBJ3W.KI=_#*TL;^&"WN+5BT<EN7!=+0G+8=21@G
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M&W2^4SJ^["X;D*0>.] 'IM%<+-KOBR_\6>(-"TD:1"=/BMY89[E)&SY@<[6
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MO;BWL$O[/[*C0[]Q9?+;<S<[E W<=>E5=-\7:HWB?1M(NY+"X;4;.:246\;
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M9(1.!&0Q&,=A@YKE&UV2WU/3-2L-=\0:E-/K,=O-<F&1--DBDEV%$4_)\H(
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MA0,FNBT>UU"SLWCU+4?M\YF=UE\D1X0L2JX'H,#/?% &A1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %1B"%9VG$48F88:0*-Q'H34E% !1110 4444
M%%%% !1110 4444 1&UMS<"X,$1G P)"@W ?7K4M%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 ,$48E,HC02, I?') [9I]%% !1110 4444
M %%%% !1110 4444 %1O!#)+'*\4;21YV,R@E<^A[5)10 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M52.Y@$C@GB-APZGZ$$?A6;8_$/0-0O8;>%KT+<;A:3R6<B1714$D1.1AS@'
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MPXM90-MU8W$CON![.H8R GJ!GL*]2JE#H^F6UT;J#3K2*X.<RI JN<]>0,T
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %9>O^(=/\,Z<M_J<C1VQF2$N%SM+G )]!ZFM2N#^+:+)
MX0MD=0RMJEF"#T(\T4 ;5AXTTZ_N--@^S:A;2:E),EJMU:M$7$:!RV#R%(/!
M[U%XA\10C2_%-C92RQZEI>F-<,X&-A:-RA4^N4-9?C6[M],\<>"=1OIH[:RC
MGNXI+B5@J(SP$*"QX&2#7/S:G::MJOQ/NK&99[;^PXE29#E),13@E3T(SD9'
M<&@#H/#7B]++X=>&[[5I+N^U#4(56.*&,RSW#X). /0 DDX K5_X3K1SHO\
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M,TLMS9D\)N8GE&X(&,\'% '4?\)II'_"&#Q7NF_LLIOSY?SXW[/N_6L1]7U
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M[GQ OA^P.@_:6O0(A),X95\M7D! P/F( R>*J://!<:=X>A\]YY8_&TK.+C
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MQU4:;>O'&FH-;8@1W. K-G/4X) (!XS0!UL&GV5JJK;V=O$%8NHCB"X8\$C
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MWMGY<G!!.,T =?)86<J1)):0.D)S$K1@A#ZKZ?A3OLEMYAD^SQ>86#EM@R6
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M%"W4A1C)]SUJX\:2C$B*XZX89H \ST.3X166MVD^CW6E)J/F!+<QW#EM[?*
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M(K::YE,;0XRS*JO&BAF&3GKC<*[?RTVLNQ=K9R,<'/6DBBC@C$<4:1H.BHH
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M=0EC2-K6%0SV12/YFE!^X%(V^O/&:X"W1W^&7Q'*(S^7XEDE8*,G:DT+,?P
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MCQ7R76.%*J 6.[@D@BM=M1.D?$_PU=>(ITMI[GP[]F>1^%>Z,B%D!'&<YXH
MW[OXCV%NU]-%I.K76F6$K17>I6\*M#&R\/U8,P7N54@8-7M6\96FGW=K965C
M>ZO>7-O]J2"P56*PYP)&+,H )X'.37 Z;K^G>'?AMK/A74I=FNPF]MUL2I,M
MTTKN8RBXRP8.O(JWHT\/@'Q+8MXEG6TM[CP[:6J74O\ JQ-#D/'NZ \@CUH
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M:!.<;8PH)!+;E((."#G-8\/B:[U/XGZ'9/:ZGIF+"Z>>RNB 'YCV/\C%6_B
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MKT4 (JA0 H  Z 4M%% !@>E%%% "*JH,*H4>@&*38NTKM&T]1CBG44 (  ,
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M(XU\MI4&-S* 1SC^ ]J]@HH \]UWQ5;>+O"OBJQT&WGO;:/2)C]MC0A'E96
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0G_;9%(!]LYK?TO5;#6M.AU#3;J*ZM)AE)8SD'_ ^U<]\,;.UL_AOH1M0O\
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MEF"C@<GDB@#2HKD(?B9X8DN88)[B\LFF<1QM>V,T",QZ#<R@#\377T %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ML=(GD87=Y')+& N0J1@%F8_PCGO6-:_$;0[NXM@J:A'9W<P@MK^6T=+:9R<
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M?8]*MT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M!R7PH*#P28XBOEQ:A>(BKT5?/? 'MS7;U#;V=M9JRVUO# &.2(D"Y_*IJ /
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M!$D48Z)&H4#\!44>G645X]W'9VZ7+_>F6)0[?5L9- '&>%$4?%3X@2;1OW6
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M(4ANK.WGB0@HDL2L%QZ CB@#$\!VEG9^#[-=/OI[ZTD:6:.XFB\MGWR,Q.W
MP,DXP,8QCBNDI  H    X %+0 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !117&_$S6;C3?"IL-./_
M !-M8E73K, \AI."WMA<G/8XH YG3_'>MS>++;69KA#X.U'4I=*M4\M1M90!
M'-OQDAW5QR<"N_\ $'B6R\.I:BXBN;FYO)?*MK6TC\R69@,G R!@ 9)) %<)
M??#3Q--X''AA/$NG-8PPJL,:Z64;<AW*=_FG!W#EL=S5*U\6Q:A?^ ?$^KR+
M;10"]T_4)9?E6WNRBK\YZ+N*-C/K0!M:;XW3_A*/%M_=-?QZ=IFGVTSV<T95
MX&_>%_D)QD@ \'!&#G%:A^)NB)<VT<UKJD4-XI-E<O:'R[L@9VQXY9CVXY[9
MR*XC6-4LM8NOBA=Z?(LULVAP*DZ<I+A)064_Q#.1D<?+72:VB^=\-5VC O$P
M,=,6S4 ;EOXPT[6=-UV)HM3TVXTV M=131".XB1D8ATY(Z D'/454T_QIHNE
M>%?#]P]UJEY#J0:.UFN$\R>5@"P#!>K'&!@<DBL?5?\ D;OB#_V+T7_H$U8W
MAM0WA_X2@@$>?*>?^N,M '>VOC#3]8L]:@:'4]-N=/MS)<PSQ".=$96(=.2#
MT.#GJ.:IZ5XPTNQ\(:'<6[ZSJQOU86B/&);N?;DL6Q@< <DD=JR]7_Y'KQC_
M -BPG\YJPO#XT4_#+P3_ &GK%QHEXL<K6.IQN$6)\G<C,WRX8'[K==I]* .F
MU[XEI9:?H]UINFWTQO=32RFCDM2'A(;#QE<C$N,[1R#UK4O?B#IMEJ:Z6;#5
M9M2:"*<6D%KOEV/GJ >-N#NSP./6N$U?7[B^\,>'M0U6_@NK;3_%\$?]J(@C
MBG@3=^^./E R2"1QD5T^C36U[\9M5O+:2.:*30[9HIHV#*R,['((Z@\&@#4O
M_B%I.GW]S!);:C):VDZV]W?Q6^ZWMY#CY7;.>-RYP"!GFH!XWG/Q+E\,#2KP
MVT=HDAF6#.'9R-Y.?]7@=<=<UY[XQUEM6\->+!>^(KJ/4(KFXMX="M?+4"*-
MN'D7:78%!O+Y QTKJ8M7TX?&*60ZC;1IJ6@0I92F4!9V,K8"'^(\]!0!MR?$
MK18S)/\ 9=2;2XYO(?55MLVJL&VGY\YVAN-P&/>K.K^.],TC6VT8VNHWFHB)
M)EM[.W\UG1BPR,'H-IR3@#CUKSR#7-,MO@9-X7EFB&OI;2:<=+R/M!N"Q4 )
MU.20V>F*Z;0+9K;XO7,4V&GA\-VL;-UY$A!_44 =YJ.H6NDZ;<ZA>S"&UMHV
MEED/\*@9->?ZIXW?4M8\)06EOJVF?:]34E+N$Q?:8/*<G&"01G;D'!Y'%;7Q
M2M+B^^&>NP6L;22^0'V*,EE5U9A_WR#7.^(?%6A^(/$/@9=(O8+P_P!J+*S0
M,&\D&)\*^/NL?[IY^4^E '33_$#2+>_E@:WU!K2"Y%I-J*V^;6*7(7:SYSPQ
M )Q@'J:K6'CB:[^(FJ>'7TR[2ULXH\3F# 5CO+.[;L!"%7:<<\UY_:6FFCP[
MJ.@:[XQU.SG^WSV\VCP+"7D+S,5,:&,R,&#*V03U//%=#-+#'\2/&>E/=QPW
MNI:1;Q6*RN%:=O+D7Y<]2">U '4Z;X_TK4[ZT@CMM0AM[US'97L]N4@N6 )P
MC9SR 2,@9QQFEM/'NF7^MSZ39VFHSSVUS+;7+QV^8X&3^)VS@*<$#N<'BN"\
M,QZ1J%AX3LKGQEJ=Q>036[)HRK"6MYH1DJZK'O1%VD$D]._-=-\/$4#QRX W
M'Q'> GU 1,?S- $\?Q6\/R6=G?F#4X]+NF5!J+VN+>-ST5FSUSP2 0#QG@UK
M:1XSL=7UM](^Q:C8WGD?:8DOK8Q>=%D LG/J1P<'GI7G*HO_  SQX=7:-IGL
M\C'K<KFNSU/_ )+'X?\ ^P5=_P#H<= $.A>,M#TWP;/K#ZEJMW8)J!MWGO\
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MC&[/\.<^U3Z1JUCKFF0ZCITXFM9@2K8(.0<$$'D$$$$'D$4 7:*** "BBB@
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MSQ-X,U-+B!8M"CF2=3G=(7C5!MX]1WQ0!?\ B!J=YHW@'6=1T^8P7=O;EXI
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M9+"J.6\Y2 5( XP6 R>.>M '145SEUX]\+V6I/I]QJ\*3QR"*0[6,<;G^%I
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MOQLV8XQUSGVH OT4@92"0PP.O-->6.--\DB(G]YF % #Z*** "BBB@ HHHH
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M0:)81WY8OYZP*&#'JP]"?7K3M5\)^']<O(KS5-&LKRYB&U9)H0S8ZX/J/8T
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MH;N1I;B-8P%E=N&+#N3WS5;2/"N@:!/)/I.D6=G+(-KO#$%8CTSZ>W2@#B?
M5M /A]XH/E)F>_U'S3C[_+#G\!BNA^&0#?#3PXS#+"Q0 GJ!C_ZPKH;;2["S
MM9;6VM(88)F=Y(T0!79OO$CU/>I+.SMM/LXK2S@C@MH5V1Q1KM5!Z 4 3!0H
MPH &<\5Y9KQN-$U:^U:]L;76O#LVI12R7$7RW>G2HR*!@CYD#*N ,'!/;KZI
M66?#FCF[>Z-A#YLDHFD.#AY!T=EZ,PP,$C(P/2@#A3HNFZSXX^(<>I6D5TB6
MUF524;E4F!_F /&X=CU'..M5M N;?4='^'UM.&N]5.FR2PQW$@^S[0BJTD@(
M)=@.% YY;)'6O1!X=T@7-Y<#3X1->C;<R 8:8>C'O^-5Y/!_AR6VM+:31;)X
M+-BUM&T(*Q$]=H[ ]QTH \KDD'_"A/$$ EC=(-3DCC$?"J@O%P%&3A>N!FNY
MUW_DK7A#_KSO_P"45;K>$O#SVES:-HUD;>ZF\^>+R1MEDSG<P[G/K5A]!TN2
M^MKY[&)KNU7;!,PR\8]%/4#^= '*_%&UAGT[P^TB?.NO62JX)#*#( <$<BJ$
M7AK15^+MYIJZ9;"PGT..YFM!&/)EE$[*'9/NL<=R#Z]:[W4M'T[6$B34;.*Z
M6%Q)&LJY"N.C#W'K4?\ 86EC4FU$647VUH_*-QC]X4_N[NN/:@#R33M1_LWP
M=X>M)[B.#1O^$ANK29YUWQ(@:;RD<9'R;MO4X^4=JV]9TS0] TOQ-+<:K-);
MZD+8SV6FA841V<(I7DA/,Z-GJ 37=IX7T*/2[C3%TFT%A<$M+;^4"CGKDCIG
M/.:9;^$_#]IHDNBP:/9IILQS+;"(;'/'+#N>!R?0>E '#VUNB?$/Q'87$5C%
M'/H,3RVMJ,1AP[@ ]-S!<<X'&.*P].TRRL_ _P -=7@MT34GU.RB:Z'^L,;[
M@R;NNTC^'I7JD7A'P]"Z/%HUE&Z0&W5EA (C))*Y]#DY]<GUI3X5T$V=M9_V
M5;?9K6026\6SY8G'1E'8^XH THKNVFGF@BN(I)H2!+&C@M&2,C<.V1ZUPOC6
M*S\.^+=$\82P1BW)?3=1?R\GRY!^[8_1P!]&Q73:?X<L[#Q%J&LPP0PSWB*C
M^4,%\?Q.>['CZ8[Y-:EU:6][!Y-U"DT6Y7V.,C<K!E/X$ _A0!Y/X;L3;7^I
M>!;W3H8A?74>J+$(QM2T?YWC/KM=/*S_ +8Q[=##8VB_&B_A%O%Y4WAV/S(R
MH*O^_9>1T/  _"NW^R6_VT7GDI]I$?E>;CYMF<[<^F>:KKHVFKJYU9;.(:@R
M>6;G'SE?[N?3VZ4 >-1VMG#^SG(\,,,<\MPHE:-0KL!?X&2.3CH/2NS@TVRT
M;XRVL>G6T=LEWHLS7 C&/.99DP[?WFY/S'GGK73-X0\.-;7%N=$L?(N9?.FC
M\D;9'SG<P[G/-6AH6EC4HM1^Q1&]B3RXYR,NJ?W0>N/:@#D?B'86MYK_ (,$
M\0;?JOE,>FY#%(2I]CCD50>STW3O'R>%@MA9::NEB33K6Z@\V)F:60S;0S ;
MN5XY..F!FN^U#1-,U6:WFO[*&XDMVWPM(N3&WJOH?<5%K7AS1O$<,<.L:9;7
MJ1'=&)D#%#['J* .!_X1^\T[3=&MO#>I6NM2:8UT4L=1_P!7<1$J&5&Y ,9.
MT'D#<1ZUG2KI.N#P"\6FR6$+:G=VTMH[8,1"R[XLKC*[L@8[<5ZA+X>TB:.S
M1K"%19*4M3$/+,"G (0K@J" .GI7->*?##WFI^%XK'1TDTS3;IYIT1D154HR
MC:"0=P8[L_CG- '':U;2^#M1\<0^&HWMM-&EV]S+#;YVV\K2%7* ?=/E!FXQ
MV/85T+:;917-KXDT+5;-KO\ LZ=+2WTZW5$NQY99=X!.0I (]"<=Z[VTTNRL
MH)8;>V14F):7(W&0D8)8GECC YSP*IZ/X5T'P_-/-I&D6=E+/_K'@B"EAZ>P
M]NE ''^%;7PUK/A7PGK37 _M")HV,\4@$TURR[94D/5LL6+ ]AGH*L?#>QL+
M:_\ %CPVMM%,NO7,2,D:JP3;&=HQSM[XZ5T]EX4\/Z;J\NK66CV4%_+G?<1Q
M ,<]>>V>^.M6K;1M,M-2N=2MK"WBO;G GN$C >3ZGOT'Y4 <;?V.GO\ &VRE
MN+6V8G0Y92\D:GYUFC ;)[@=#VK"T^*VU[X4^)=1U55&MP37LEQ<'B6VGB9C
M&%;JNT!, =OK7I]YHVF:A>VM[>6%O/=6A)MY9(PS1D_W2>G0?E4,OAO1I[^2
M^DTVW:XE*M*VWB0K]TL.C$=B0<4 9BWNL+\+Q?NC?VV-&\XKMY^T>3GIZ[NU
M<OH&G:1JUGX5\06VM6T<T)38;2$+-.S+B2*4[B6[EL\\%J]/K&T_PGX>TK5)
M=3L-&LK:^ESOGBB"L<]<>F>^.M 'E\TME+8>%-5TK:MK/XH3RKJX<-=W&^60
M2%F&-J]1MY.W;G&,5N::NC>*9_&UAXCEB%S%?/&7D=5>"T"*8GC)^ZO5LCN2
M>]=?_P (5X7(F!T#3B)IA/(#;K\S@Y!Z>M2W_A/P_JFIP:E?Z-97%[!CRYI(
M06&.GUQVSTH Y!M-T_5?BO96UU";RS_X1<,([H%O,'GKC>I^\>_(Z\]16E\*
MQY?@^6V4GR;;4;N"%<YV(LS84>PKIGT/3)-4.IM91&_,?E?:,?/L_NYZX]J?
MIND:?H\+Q:=9Q6L<CEV2)=H+'J<>I]: .$BLC>_&_6D%W<V^W2+<YMW"D_.>
MN0:Z#^R='CT#4=!UBZ^WVZK+<W3W3;F2.1W8%F[$?-@CGY:OR^$] GOI+Z72
M;5[N08>=DR[#T+=<4]?"^AI:3VJZ5:K!<.))HQ&,2,.A;U(P* .%^',"6.M/
MH^M0L-6L+15TF2XB56>P).T@#HX)P_?@>^<W1[6S\5^$#>:EK-O9:K:7SRW4
MT< ^V6]PDIPNXMGD84#'0@ 5ZE<:'I=UJ5OJ,]C#)>VPVPSLN7C'HI[56;PE
MX>?71K;:-9'4P=PNO*&_/KGU]^M '&:='I'B>\\<:;XD>);N*]:(F5@KP6@1
M3$R$_='WFR.YR:LV,5I'\78?+&89O"RDO,/FE G'+YZG&,YKJ]0\*>']6U.'
M4M0T>RN;V'&R:6(,PQT^N.V>E2ZGX>T?6;FVN-2TVVNIK8DPO+&&*9ZCZ>W2
M@#Q];:QN/A?:,8;>6)/%6U#M5E5#>8('H",?A7::C9V5O\6O"WV6"&-6T^]C
M(B4!<+Y8 P..,FNH_P"$6T$Z=<Z>=(LOLET_F3Q>2,2OG.YO4YYS4H\/:0+R
MUNUTZW6XM$\NWD5 #$O]U?0>PH \^CM8_#?BO7O"5M;)'#XC"W=@5C&%+?)<
M#ICY!^\ Z=N]7+I;3_A8DGARY:PMK./28?[-MKJV$D3#<XEV L!NX0'J<#ZU
MZ#):6\MW#=R0HUQ K+%(1\R!L;@#VSM'Y51UKPUHOB..*/6=,MKU8CNC\Z,,
M4/?!ZB@"GX+TVWT?PS!IUKJ4NHV]L[QQSR>@8_*#W"G*CZ8[5T%1V]O#:6\=
MO;1)#!$H2..-0JJHZ  =!4E !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %8?BWQ&GA;0)-0^SM=7#.
MD%M;(<&:9SA$![<_H#6Y7$?%&&9?#^G:K%"\R:-JMMJ,\<8RS11L=V![!L_A
M0!',OQ+M+%M2-SH-W,B^8^E1VTB@CJ427<3N[ D8S6/XQ^*2P^ ]*U30IVM[
MO5GC$;R6S2^0I8J_8J64@C!Y/8&NSNO&_AJUT%M9;6;-[,1^8K),I+\<*HSD
ML>F.N:\KU;3+O2?@MX5@OHC#<R:U#</$PP8_,ED<*1V(##B@#2U_XA75G)X;
MT:P\279>[EE-]JDFC,)0B\J%B,8!/..%., GKSW&C:JEQXJ:Q_X21[R1=-BF
M.GO8B(KG;^^+[0<MG[G;/08K$\<_\E3^'7_7>]_]%+6;/'<2_&?Q9':9^TOX
M:"Q8Z[R1C]<4 =G9^/?#5_JR:;;:D'GDD:*)C$XBE<=520KL8\= 33Y/''AV
M+63I3ZABY$PMV;R7,2RGI&9=NP-[9SGCK7.>%M7\,+\._!T%Z;>9S]F@MX-@
M=UNU&"=HY!5@Q)[=:Y/3=,O;[P!>6&H>,K'3;4W\T-S;2:<'FCG^TDCYO,!+
M%MK#CN/2@#U"_P#&WA[3-4?2[J_VWR/%&T"PR.V9 2O13D8!R>@[XI/&FI)I
M7AYKJ37CHBB5%^V"U%QC)^[L(/7IG'%87A^&,_&7QA,R@RI9V**^.0"K$C\=
MH_*JOQS_ .2;2_\ 7Y;_ /H= '5ZMXPT+1+UK&^O&6\6-9?L\<$DDC*Q8 JJ
MJ2WW6Z=,9-7M&UK3_$&F1ZCI=RMQ:R$@. 5((.""" 00>Q%<O;Q(WQMOI2H+
MKH$(5L<@&>3/\A3OAP (?%"@8 \1WV!Z?,* -+4_'GAO1]2>POM1\N>+;YQ6
M%W2#=]WS'52J9_VB*FUCQAH>A745K>W;FYDC\U8;>"2=_+Z;RL:DA?<\5R/A
MO4M&TS2?'$7B&6W58]7O)+V&?!+Q. 4^4\L&3  []!5CPM<V5K\1_%'F%+9;
MBSL)K))1Y9^S+$0=H/0*V<CL: .GF\8^'H-)LM4DU6 6%\Q2WG&2KD*S$9 X
M.%;KCD8Z\5'I_C;0-4AU"6WO7']G1^==)-;R1/&F"=VQE#$8!Z UYCIT<=S;
MZ#,JJ^GW'CBXGL^/E,6)2I7VW D5T'BL >.?$N.,^#)"??\ >24 =3:_$#PS
M>:C:V,&I;I;LA8',$@CD8C.T2%=N[_9SG/'7BI-3\<>'='U)["^U#RYX]OG%
M87=(-WW?,=5*IG_:(KCM3BCA^&WP]6-%4+?Z25 '0G;D_J?SK/CM+V4>.[>Y
M\56&DV9U&X-Y!<V E?R71=K[C(IP4( X[<4 >C:WXNT3P]-##J-VRSRH9$BA
MA>9]@ZL50$A?<\5BZQ\3-%TS4] MXI3<VVJAY?M$,,D@6((Q#+M4[B64 J.1
MR2!69X7-OHGQ!U*UU&^1G.B6 M+B;]WYL4:NLC#)X^;!(SQFJEU?Z'+XJ^'-
M[HRQ6VD-<:CY1">4F3$P) .."V<'OG/>@#LM/U..?QGK%B->-P;>&)SIAM0@
MM0R@[O,Q\^[KC)QFH[3X@^&+[4(;.WU(L\\IA@E,$BPS/_=24KL8\=CSVKA9
MHKBX^(OQ0BLMS7,FB1+#LZES!\N/QQ4NMWNGWGP1T"UTV:%KJ?\ L^&RCC8;
M_.62/( ZY&&S^- ';ZEX]\-Z5<W5M=7[_:+5]L\45M+*T?RALD*I^7#*=W3G
MKFM>/5["711K$5RLFGF W FC!8&/&[( Y/';&:Y3PC#'_P )UX\DV+O:\MT9
ML<D"W7 _4_G3_A0BR?"K0T<!D,#J0>A&]AB@#;O?%NA:=H5IK=WJ*1:;>&,0
M3E6(?>,KP!D9'/(X[U8U#6;"QO+?3I[OR;R\CE>W41EB1&N6;@8& 1UZ]*\@
MTK2SXA>'X?SDLF@1ZDDI?_:S%;-_WQ,2/]VMCP;J,GB[4;O79P=VEZ#%I[;O
M^?EP7G_$;4% &K)\0[+0O!FAZA)JTFO-J%V($O19-%YB^;M=MBKP5!P!C+;>
M,\U/<^.X+'QSY5U>R+H\VC0W5O"+5FD>5Y7&0@7S"=J_=QQ@G YK@='=8_@=
MX"D=@J)X@@9F8X"@74G)->AP"&;XVSSKL<CP['L<<\&X?.#^ H ZC1M;T[Q!
MIJ:AI=R+BV<E0P4J0P.""" 00>Q%9M]XZ\.:=JKZ;=:ALGC=8Y6$,C1Q.V-J
MO(%V*3D<$CK69\.@ /%8' 'B.\X_[XKA_&&IW5_X,\8W2ZE8:;9K>W%J--@M
M%,MRZ,%+NV<[VV[L@<* <\4 >G:IXTT'1[V:RN[UQ>0JC/;Q022R8;)!"JI)
M'RG..G?&16EI.KV&NZ7!J6F7*W%G."8Y%!&<'!X/((((P:Y'05BE^+/B&X&U
MV_LNR"R#G@F0G!]\#\JF^&("^'M14#"KK%\ /0><U %CQSXCU+1X],TW08X)
M=<U6Y\JV2<$HJ*-TCL 1P!_.KW@OQ$/%/A2RU1D$=PZF.YB QY<RG:ZX[<@_
M@17"63^(_%/Q#U3Q/H*:5)8Z;NTFT.H/( 2"#*Z; <Y;C/I1H/\ ;GAGQGK>
MA:FMG%)XBMY=0L/L3N8A<JN)%7< =QX8_2@#MK?Q[X:NM733(=2#7#RF"-O*
M<122#JBRE=C-QT!HU'QYX:TK4WT^\U(1SQ,JS,(7:.$M]T22!2J$Y'WB*YKP
MCJWAF+X9>%;?4?L\K;H+>.V*;W6[#8^YU#!\G/;K4?AK4]$TSPSXOB\1R6X6
M'5[QK^&8 F17;*_+U8,I4#UZ"@#K]9\9:'H5XMG?7<GVIH_-\FWMY)W6/IO8
M1J=J^YJQ'XFT::/2Y(;^.2/56*V3H"PF(4L0"!Q@ ]<=,=:Y3PK<V=G\0?&"
MW#);/+'93VZS?NR;80X& >RL&!]#7):))' GA*_9EBTR7Q1?M:NQVH(G$H3'
MH"<XH ]:N_$6E6-S?6]S=A);&T^VW*[&/EP_-\W Y^ZW R>.E9]IX]\-7NJ6
M^G6^H[I[DE8&,$BQRL!DJLA7:6]LY[=:XCQ'>VU[XF^('V:9)1#X5\IRAR V
M)21G\15_6HHX?!WPZ2-%54U33 H Z?(10!L:3\0=/US6=>TN%Y;<V&1%.;:3
MD",,[$%<#:<@ ]<9[U8TGQ;I-EX1TO4M2\2+?07;M''J,EL81.PWGE ,+@(P
MY ^[[U@:%-$NM?$J%I$$IN-P0L-Q'V<<XKF?#L23?#3X7)(H9?[=4X(SR#<$
M?J* /5='\7Z'KLEW'8WC>;:*'GCGA>!D4]&(D .WCKTJE:_$;PI>21)#JG,\
MJPP%K>51,S,$&PE<.-Q R,@9&:Y/QS%/+XO\2I:@F9_!<H 7JW[U^/KUJ'Q)
MJ6BW7A3X>PVD]O+(=4TUK=(V!9%4J&.!T R%/N0* .U^(.O7OAGP3?ZMIPA-
MW"8A'YREE^:54.0".S'O6-K%U\0?#VD7>L2WV@:A!91-/-;"TDA9XU&6VOO.
M#@'&14OQB&[X7:L 2,O;C(ZC]_'6!XX\-WFCV%I>:GXCUW5?#HN%35[6:95/
MDMP'S&BDJ&QN'<>F* .XN?&FBV.EZ9?7DTD?]I0K-;P1PO+*RE0Q^1 3P",G
M&!3[CQGX?MM(L]4;4!):WIVVQ@B>5Y2,Y"HH+$C!SQQCG%<CK$%Y_P +2L1I
M6LV>DQ2:$$M));43)(%ERR)\R@'!C/&>![55L=%M%MK!K#QK;C66U"^N;*\6
MT @D+$">((6((W<\-GN.E '0:Y\3=%TRPTB\M96NX=1O5M@5AD^1=V)"0%R&
M7^X?F/I6EJ7CSPYI+Q)=WTBM) MR52UE<QQ-T>0*I\L?[V*X'5M9DU'2O#DU
M_%8P3VGC.&WN9[/B"9U#9E!/KD9R3R#S6GKFJW%YJWBT6NIZ=I-K8V\4<KBT
M26>^WP[ERQ/(^;:H )))QZ4 ;VM_$/2]&\2:-I3%Y8]0C>5IHH9) J!<H5VJ
M=^3Z=!R<5H7WCCP[INJMIMUJ&R>-E25A"[1PLWW0\@78A.1]XCK7G^D7,,>H
M_"&62:-4&D7*EV8 9^SQ#&?6J\-C=W.B^,[2^\6V&E6+:G>+>P7&GB215=OE
M;=Y@)RA7;QZ8SB@#TO5?&6A:+>R65[>,MXD:RFWC@DD<JV[!"JI)^ZW3ICG%
M46^)?A%8+:X_M=6M[@*5F2&1D3)VCS&"XC.1C#8K+T6U$/Q=O%D?SI8?#UK'
MYS+@M^\?)]LX!KF4@B3X%^,=L:C==W[' ZD3$ _D!^5 'I6M^+]$\/7$=OJ-
MVZSO&91%#!),RQ@X+L$4E5]S@47WC#0--ALI;K4HUCOHFFM616<3*-N=NT')
M^=<#J<\9KAH(M5_X6#K7V;Q#::0\FFV4J?:K,3>;$$8$J2ZX"MNSU^\*CT?3
M+2QU_P"&UM!?QZG;Q6^IR072P^6K!MI!523@ -@<]!0!U.H?$?0X/"6J:[93
M/<?80T;0-!(CB;:2J.I7<@/'S$8]ZW= UJW\0:-;ZC;;]DBC<'B=,-CD88 D
M>_0UYEXG'S?%L =;"S)Q_P!<&Y_2O1=&U;3H]$T6-KZW#W4$<<"^8,R,(P2%
M]3CF@"KXW\86_@S1%OIHVEEDF2**,(Q#9=0V2H., D\]<8%8UQX]M[3QQ"DU
M[(NBSZ,+F*'[*WF23&8KPFWS"=H/RXZ G'>G_%U@G@;>Q"JM_:%F/0#SEY-.
M7R+CXVI.NR3;X<^1P0<?Z3@X- &Y#XR\/S^'9-?34D_LV-BCRLC*5<'&PH1N
MW9(&W&>15C1/$>E^(4G.G7#.]NP6:*6)XI(R1D;D<!AD=#CFO);Y)Q%J4D%W
M'91Q>/=\ES+%YD<.85"LRY (WLO4CD@UW7AK3I8O&NI7MYXGM=5U 6,4$\%M
M9B$1KO9D9B'8$_?XZXH V-;\8Z%X=NEMM1NW2=H_.,<5O),R1YQO8(IVKG/)
MQT-+?^,- TR.R>ZU%%6^A,UJ41G\Y!MY7:#D_.N!U.>,UR^L:G=3^+/$$%OJ
M6GZ+#IMI!Y\[6:RSW0=68#+$?*.@&#R37/>$A'/>?"AFVN8]+O<'KM8)&/SZ
MB@#N#\3/"8L3=_VE(R*[I(BVLQDB*XW;T"[D R.2 .:T]0\6:'IFF6>H7%^I
MM[W;]E\I&E:?(R-BJ"S<<\"N8\/01#Q9\1V\M=SS0JQQU'V8''ZG\ZYKP9(E
MM??#BXOG5+9]$N(;9Y#A1.2A(R>A* @>N* /1XO&OAZ;0[K65U "RLWV7+-$
MZO"V0,,A7<#DCMWK3N]5LK&_L;*YG"7-\[);)M)\QE4LPR!@8 )YQ7CWC-EN
MQ\3;JR(DM5MM/CE>/E3*C9;D=2JXSZ5UWB34[&[^(G@.&VNHIG,]S-B-PV$-
MN^"<=,]O7!]* -2X^)/A.VYDU0[%D:.21;>5DB8.4.]@N$^8$?-C/7IS3+WQ
M_IUGX]MO##K(6EMS(TJP2-ARR!%&%(((8DMG Q@D5R6GPQK\$?&3!%!DDU1V
M..I#N 3^ 'Y5>TZ>.'XI>'&FE5-_A7:I=L;F\Q#@9ZF@#OM7UG3]!T]K[4[I
M;>W4A=S DECP% &2Q/H 36;9^-M OK6]G@NYO]""M<0O:RK-&#T/E%=Y!]0#
M6/X^=+?7O!EW=L%T^'5OWS.?E5VB<1D^GS=_>D$L5W\;(WLW63[/H3I=M&<A
M=TRF-6([\,0/2@#-^%OB_4/%TUY>ZAJ\DC,9?+TU;#RXH4#@*PEV_,W;&X]>
MG%;.L>(=<O\ Q7)X9\,+9QS6L"SW]_>(SI 'SL14!&YR 3R<8K-^"7_).H_^
MOVX_]&&EL]0MO#/Q;\01:M,EK%KL-M/93RMM1VB0QO'N/&[H<>] &SHUSXOL
MM?73==AM-0L9HF>+4[*,Q>6RX^21"QZYX(/_ -;)\"^,YKCPKKFL>)=100V.
MJSVXF:-5"1KM"KA1R<M@<$DGO72)XNTJX\30Z!9RF]NWB::9K8ATME&,>80?
MEW$X Y->5>%=1?3_  #J:Q0V;RW?BUK6.6]C\R*!F=,2LO&=N,CD<XH ].B\
M>^&Y=,OM0-^\4%B4^U":VEC>(.<*2C*&P<]<8Z^AK1U'Q!I6DW^G6-]>)#<Z
MC(8[2,J3YK#&1D# ZCKCK7G$&G-KOC;Q3H=]K46J37.@);M,D"Q!6+R< *2"
M5W Y[9QVK"BNKKQ?H5YK@5C>>&M'M53/47<<@FFQ[XA0?C0!Z'\0?%HT7P]J
M\.EWPBUJTMHKD#RMVR-I53)R"O/S#!Y[XK4TWQOX>U?5AIEG?[[IU9XE>%T6
M95ZF-F4*X'^R3ZUYAKTT6N?#WX@>*ER\&H7$-O;$=X(&1 1]6+FNM\3W=A?>
M(? *:5-#+(;YIHO)8'%N(6WGCHN-HH Z!/'7AR361I2:@3<F<VRMY,GE&8=8
MQ+MV%O;/7CK1J_CKPYH6H/8ZAJ!CGC56F"0R2+"&Z&1E4A ?]HCUKS"_U6YO
M_">B:I+JFGV=I=ZS;R0Z/:6BKY0%T"2SYSD=6. -S8[UU7AS4=*TV7Q]'KLT
M"%=3EGN$G(R]LT2;.#U4J" /PH VK?7;R;XJ3:0MTKZ7_8D=XD:JI!D,Q7<&
MQDC;COBMW2=;T[789IM,N?M$,4K0M*J,$++P=K$88#U7(]Z\@\2Z?JFN>-9+
M;PB\5K!+X4@<0LK1-)!YK$0KT\LL,+VP..*]0\&:KI>K^%K.;2+<6MM$ODM:
M;=K6SKPT;#L0?SZ]Z .<M=5\::]XA\06VE:AH]I::9>_9D6XLWD=AL5LDAQZ
M^E3>)M0\5^'/AUKNI7FIV,FHP1A[::TM=@3D Y5RP)YKG-*TG2-0\8^,I-1\
M07VFR+J@"QV^J-:AAY2<E01D^]:/C2UTVQ^#OB6VT[5Y]201[WDGO3=.I+*,
M;B20..GUH W?[;<GP;]J\0&SN-1B#-:BT#_;V\M21NQ^[P3GC&<U?O?'/AS3
MM6ETRZU$)<P[1-B)V2$M]T.X4JI/H2*X/6?^0]\(/]Q__1$=6M'OM,LO#7Q!
MMM5FA6;^U+XSPR,-\BN!Y>%ZG<N OKT% '57OB*RN;SPQ/9^(S:6VINS00"T
MW_;UV@A=Q7,>,YSQUK(LOB'9Z;K'B6VU_4'VVFHF.W2*U:0Q0B-"2WEJ2%RQ
M^9OSXKD(_P#CW^#'T/\ Z*2NJ\(7^E6GBCX@"[G@BD74!),96 S"(EY.>H!W
M?G[T 6O%OBJ[M=8\$_V-?(;#5[\),R*KK-$0",$@XZ]1BMO4_''AW1]2>POM
M0\N>/;YQ6%W2#=]WS'52J9_VB*\ELHY8O#WPA6564G4F9 W787)3_P =*UL1
MVE[*GCNWNO%5AI-F=1N3>07-@)7\IT7:^XR*<%" ..W% 'L8.1D=*X+P3X^_
MM+P,?$'B.>WM0+UK8O'&P0?.$3(Y/)(YZ?2NPT>W^QZ'I]M]H-QY-M''YQ7:
M9,*!NQVSC.*\,T.-)O@%)%(H9'UV-64]"#=1Y% 'L.D^--!US4WTZPO6>Z6/
MS522"2/S$SC<A90'7W7-1#Q[X:.L#2QJ0^T&?[,&\I_*,O\ SS\W;LW=L9SG
MCK69XC4CXH^#?+P'-MJ"@_\  (\5B^#=4\.VGPFTJUUSR)#'.+>:T=/,D^U>
M>>-G4MO^;I[T =A?^./#NFZJVG7>H;)XV5)6$+M'"S?=#R!2J$Y'WB.M.U3Q
MIH.CWL]E=WKB\A5&>WB@DEDPP)!"JI)'RG..G?&17FT5C=W&C^-+2]\6V&E6
M+:G>+>P7&GB215<_*V[S 3E"NWCL .E=5X9M5@^*&NAW\Z:'2;"+SBN"P^?)
M]LE0<4 6==^)>C:7H^BZG:2F\MM5NXX8GCBD("%PLC<*3N49^4\DC '!JXWB
M"T?Q;:HNOR)%+I9O%THV)S(F3^^WE=P..-G7CI7G#,D/A+16=E2*+QZ"23A4
M47,GY"NFNG63]H?3'1@RMX=8@@Y!_>M0!W%MK^EW?A\:]!>(^EF%KC[1@@>6
M 23@C/&#QC/%9MYX]\.6,%G--?2%;NW%U$L5M+(WDG_EHRJI*K[L!7FMTLMI
M'J7PM@+(;W6$%MMXV:?-F:0K[+LD4_6MYK74;?XE^(8;#7K+14^PV;1)<V0F
M#P*K+\I+KA5;=GKU% 'I=K=07MI#=6LJ36\R"2.1#E74C((/I4M<YX#L8--\
M%:;:VNHKJ-NJ,T5TD7EK(K.S#"Y.  <#GH*Z.@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "CK16#X
MO\1CPMX?DU!;<W5R\B06ML#@S3.=J+GMSR?8&@!\/@[PS;Z@-0A\/Z7'>!MP
MF6T0,&]0<<'WK2O=/LM2B2*^M(+F-'$BK-&'"N.C 'N/6N,GMOB596)U-=5T
MB^ND7S'TE+(QHW<HDN_=GL"1C/6MW4?%VGZ/#8KJ,=S'?WD>]+""%KB?@ L-
ML8/"YP3T]Z -:?3[*ZN[:ZN+2"6XM2Q@E>,,T188.TGD9'7%"Z=9)J,FHI9P
M+>R((WN!&!(R#HI;J1[5CCQOX>.@C6SJ 6P\\6SR/&RF.4L%VNI&5()&<@8Z
M]*J)\2/#;S30>?>)<(@D2W>QF66=2<!HD*[G!/\ =!]>E &Q!X;T.UU9]5M]
M'L8M0?):Z2W42$GJ=V,\]Z63PWH<NKKJ\FD6+ZBI!%TUNID!'0[L9S[UG1^.
M_#LF@'6S?&.Q2Y%I*TL3HT4I8+M=2,J02,YZ9S4FC^--%UO4VTZUFN$NQ'YR
M1W-K) 98\XWIO4;E]Q0!LQV-I#>3WD5M"EU.%6:94 >0+]T,>IQDXS3;_3K+
M5+8VVH6<%W 6#&*>,.N1T.#Q6)9>._#]_JD=A;W,Q::1H8)VMI%@GD7.Y4E*
M[&(P>AYQQFH+WXC>&[%[M)+BYD-E*\5UY%G+)]G*]6<JIVK[G@X.,X- '2"S
MM5O6O1;Q"[:,1-.$&\H"2%+=<9)./>BVL[6S$HM;>*'SI&FD\M N]VZL<=2>
MYK&U/QIHFE_91)-/<-=0_:(DL[:2X8P\?O"$4X7GJ:2]\;:%96EA<"XFNAJ$
M9EM8[.WDGDE0 $L%0$@#(R3B@"[>^&]#U'4(M0O='L;F\BQLGFMU9UQTP2,\
M4[5?#VC:[Y?]K:597WE<Q_:8%DV_3(XKFM?^)6F:7IVA7UD);VWU6[2%'CMY
M& 3<0_1<[Q@@)]XD'C@U?@UFVN?'=O:1ZU<K)-I0NETI[4JNPOQ*6*Y#?P[2
M?PH WFTVP9+5#96Y2T8/;KY2XA8 @%!CY2 2./6B;3;&XGEGFL[>2:6 V\DC
MQ@L\1).PGNN2>.G-<_+\1?#<5X\#W<_E1S?9WO!:RFV27.-IFV[ <\=<5:U3
MQIHNDZC-IT\MQ)?Q(DAM;:UDFD96S@A54Y'RG)[<9ZB@#6?3+"2VM[9[*W:"
MV9&@C,8*Q%/N%1T!';'2JM]X;T/4[^*^O](L;J[AQY<\UNKNN.F"1GBI=&UF
MP\0:5#J>F3B>UFSM?:5.02""#R""",&K-U<QV=I-<RB0QPH9&$:%V( R<* 2
M3[ 9H J:KH&CZZD:ZMI=G?+$<QBYA63:?;(XHO\ 0-'U2RALK_2K*YM82#%#
M- K)'@8&T$8'''%>>3_$R35_ D>LV32Z?,FIP13.\#+'Y+7)3AW7:V47YL'Y
M2>U=II'C/1=;U1]-M9;A+M8O.6.YM9(?-CSC>F]1N7)'(H UH=,L+:]FO8+*
MWBNIE5)9DB =U484%AR0!TJI;^&-!M-4;5+;1=/AOV)+7,=NBR$GJ=P&<GO6
M?I_CWP_JFIPV%K<SEIW9+>9[:1(;AESN$<A7:Q&#T/;BJOA?QY;>)=?U?3([
M:YC%G/Y<+O:RH&4(I;>64!6W$X4X.,'% '40V=K;SSSPV\4<MPP:9T0!I"!@
M%CW. !S1:6=KI]K':V=O%;V\8PD4*!%4=> .!4]<YJWCG0=%U"6RO+B?S(%5
MKEXK:22.V#?=,KJI"9Z\GISTH V8=-L;>^N+Z&SMX[NY"B>=(P'EP,#<W4X'
MK26FEZ?813Q6=C;6\<[M),D42J)';JS #DGN34$>O:=+KK:,MQ_IPMQ<K&5(
M#Q$XW*V,,,]<'BJ1\::"-*O=4-]BRLYS;23>6V&D!QM3CYSDX^7.30!>;P_H
MS:/_ &.VE61TP=+3R%\H<[ON8QUY^M2VFDZ;8.CVEA;6[QPBW1HHE4K$#D("
M!]T$DXZ5F:=XST/4K6_G2YDM_P"ST\R[CO(7@DA7!(9E< X(!YI=$\8:/K]V
M]K9R7"7 B\]8[JVD@:2+./,0.HW+G'(]10!KVUG:V?G?9K>*'SI#-+Y:!=[G
MJQQU)P.:I/X:T*2_N+]]'L&N[E#'-.UNA>12,$,<9((X/J*S]/\ '>@:GJ<5
MC;7,Q:=V2WF>VD2&X9<[A'(5VN1@]#VXS6;XE^(.DV6GZY:VEW<"]LX)8_M*
M6KM##<!"51I-I0-G'!/7CKQ0!U5EI&FZ:<V-A:VQ\M8LPQ*AV+G:O Z#)P.V
M:EMK*ULHWCM;:*!'=I&6) H9F.68@=R>2:Y6U\<Z=IV@:*=5GNI]0N=-ANYE
MMK229@I0;I'$:G:N<\G'?'2NKL[NWU"R@O+299K>=!)%(AR&4C((_"@!ECI]
MGIEHMK86D%K;J25B@C"*"3DX XZT7&GV=W<6]Q<VD$TULQ>"22,,T3'@E2>A
M^E9GB_Q''X4\+WVKO$\K01,8T6-F#/@[0VT?*N1R3P*Y6]\?J-5\(7OGW%KI
MM]'=&[A>U=6D=8TV!59=Y^9N-HYSWH [*+PWH<&KMJT6CV*:BQ):Z6W42$GJ
M=V,Y/K1=^&]#O]3CU*[T>QGOHL;+B6W5I%QT^8C/';TJIIWC/0]2T[4+Y+IX
M(M.S]L6ZA>%X.,_,K $<<CUI^B>+M)U^ZDM;-[B.Y2,3>3=6TD#O&3@.H<#<
MN>XH LZKX=T77&B;5M)LKYHO]6;F!9"OTR*FO-'TS4=-&G7FGVMQ9  "WEB5
MHQCIA2,#':KM8&M^,]&\/W@M+R2Y>X\KSWCMK62<Q19QO?8IVKP>3Z4 78/#
MVBVL#P0:38Q1/!]F9$MU :+).PC'*Y9CCIR?6K,FG6,L-M#)9P/%;.KP(T8(
MB9?NE1V([$=*R=0\::#IJV#3WI8:A"T]GY,3RF=1M^Z%!R3O7 ZG-9W_  LW
MPS]B>Y6>\<Q,RSP)8S-+;[<;C(@7* 9')P* -]] T>35'U1]+LVOW0QM<F!3
M(RD8(+8R1CCZ4^+1=+@MK6VBTVTC@M)/,MHEA4+"_/S(,84_,>1ZFJ.H>+]$
MT[3;&^DNFECU  V:6T3RR7&1N^1%!8\<]..]0Q^.= DT*\U@W<D=K9.([I9(
M'26!R0 K1D;@<L.U &Q/80O-+=PQ0QZ@T!@6Z,09U7.0,]2H/.,XKSRS\$:U
M<W>FP7VD^'=-@M+V*]N[S301)?/$24&S8H4%N3DGVKO[S5[*QU'3["XE*7.H
M.Z6R;2=Y12[<@8' /6N>F^)GA>"-I6N[AH(Y&BGFCLY6CMV#E#YC!<)R#U[<
M]"#0!U%Y96NHVKVM[;0W-N^"T4R!U;!R,@\<$ _A3YX(;JWDM[B))895*21R
M*&5U(P00>H-<G=^/K6U^(%MX8^SW#B2V\UIDMI7^<L@3!"XV88Y?H",$BNPH
M S+WP[HNHZ=#I][I-E<6<  A@E@5DCP,#:",#CCBEN_#NBWVF1:;=Z38S6,6
M/*MW@4QICIM7&!^%1:YXETSP\+=;Z24S7+%;>WMX7FEE(&3M1 2<#J>@K%UC
MX@:;%X)U/7-,>::6V66(1&UDWQ3JA8+*FW<@X&2V![T ;\GA[1IM(72)-)LG
MTU<;;0P+Y0P<\+C'6F#PSH(O+6\&C6 N;2-8K>7[.FZ)%&%53C@#MCI7-_"_
M5[W6_#:WVH:K?W]U-'')(+FR^SQQ,P)Q$0BAU]P3T]Z[F@#'E\)^')[&*QET
M+37M(I#)' UJA1&/4@8P":DNO#>AWVIQ:E=Z18SWT6-EQ+;JTBXZ88C/';TK
MD=,U3Q;XX2?5=%U.RT711*\=DTEG]IEN@I*F1LLH520< <TW7=>\6Z9\-O$=
MUJ4,5EJVG#;!>VN#%<+E<2*K9*]<$'OT]@#O5LK5;U[U;:(7;H(VG"#>R DA
M2W7 )/'O4/\ 9&F_8)K#^S[7['.6:6#R5V2%CEBRXP<GD^M82>,++2O#^AR:
MI+<3W]_:1RK#;6SS2RG8I=MB G SR>G-7K/Q=HE_)I26U[YAU596L\1L!)Y?
MWP<CY2/0X/!]* +6I^'=%UI(5U32;*]6#_5"X@5]GTR.*L_V?9>=;3?9(/-M
M5*6[^6,Q*0 0I_A!  X]!5.T\1Z5?>(+_0[>Z#ZC8*KW$6PC:& (YQ@]1T/&
M:Y'5?B#9Q>*M!DMM0D.D2B^AN%2!F,TT1C50HV[F.XD#;U]Z .Y.FV+27;M9
M6Y>\4)<L8AF90, /Q\P )'/8UE_\(CI$+Z4+&RM;*#3[IKI(K>!5!<HR=NGW
M@3Z[13;+QKH-[I%_J:WC06^GDB\6YB>*2 @9PR, P)[<<]J?HOB[2==FN(+9
M[B&X@C$LD-Y;26[^6<X<!P,KP>10!K7MC::E9R6=];0W-M*,20S('1A[@\&H
M++1=+TUHVL=.M+9HH?(C,,*J5CW;M@P.%SSCUYK'TSQ]X>U?4H;&TNIM]QN%
MM)+;21Q7.WKY;LH5\>QK*\)>+Q'X*OM:\1Z@!';ZA<Q>:RC.U92J* HY/0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !7$_%"VN6\-V6IVT#W!T?4[;4I(8QEGCC;YL#V!)_"NVHH Y:[
M^(OA6VT$ZNFLVEQ$4W10PRAI96/1%3[VXGC&..^*QH-0BA^+<-_J:FP%_P"'
MXQ:K=D(582EI(LYQN&Y20#77P^&]"M[_ .WP:+IT5[G/VA+5%DSZ[@,U8U#2
MM.U> 0:E86M["#N$=S"LB@^N&!H \:U<Q7^F^*[VWVRZ7=>)[%8F7E)65HED
M([$%N,]\5W&HQHWQHT-F4%ET>Z()'0^8@_D3^===_9EA]CCL_L-M]EB(,<'E
M+L0@Y&%Q@8/(J5K6W:Z2Z:"(W"*464H-ZJ>H!Z@' XH \3U]H(O#WC-KA<VZ
M^+8&D7&<KF MQ]*ZCQ3=0ZUX^\+1:+=0W-S'9ZA*[P2!MD;PA4)(Z N5Q]*Z
M/Q9X9;6-(%KIL=K!,VH6]Y,S#8)-DBLQ) .6PN.?:MBQT72M+EFET_3+.TDF
M.97MX%C,A_VB ,_C0!Y+X;M%OO"GA&WO/&L*11SVODZ<MBGFI<1$'RR0=P(*
ML"2.F2>M=!X<C3^P/B*VP9?5K\,<=1Y2UW,6B:3!J3ZE#I=E'?OG?=);H)6S
MUR^,G\ZL)96L23I';0HD[,\RK& )&/!+>I/<F@#RK1X8CHOABZTSQ/#HVOP^
M'K8/'=QAX;BWQD!@V.C!N5.1GGJ*DLO%-UK=UHX6]T[PT&T=KR6[$$;%QYI0
MI$9.!'\N_OP5^M>C7?A[1;^WM[>\T?3[B&W&((YK9'6(>B@C Z#I4EWHNE7_
M -G^V:997'V8Y@\Z!7\K_=R/EZ#IZ4 >+VMY"/!GA266[#+#XT+32R@1E<RS
M'+C@)G.<<8S74R.)_P!H.-[>16$GA@F-U.0<S'!!]*[V;0M'N(KF*;2K&2.Z
M<27"/;HPE8=&8$?,?<U+#I>GV\\<\%C;1310B".1(55DC'1 0.%]NE 'D=KJ
M6F0?L[7&ES31+?I:S63V98>;]J+L-NSKNWD']:Z?PO;O%\3-5%R ;J+1+"-V
M/)SE]W/U'Z5V#:#H[:F-3;2;$Z@#D71MT\W_ +[QG]:MK:VZ7+W*P1+<2*%>
M4( S = 3U(&3^= ''_#(8T35@. -;O@!Z?OFKM:BM[6WM49+>"*%7<R,(T"@
ML3DDX[D]34M 'A6FS6MQ\#]'LC)%))'K4:SP[@64&^/##MD'O7<^*9S:?$KP
MY<K$96CTS47V#J^%C.*ZM- T:*2:2/2+!'GD$LS+;(#(X.0S'')!Y!/>KCVM
MO)<QW+P1-/$"L<I0%D!Z@'J,X&?I0!XO_:DES!X$O+KQ%9RK<ZC;W(TRTMXH
MX;12K=Q\PVE@G)Y)/%==X"N8$\6>-[5IHUN&U<N(BP#E?*3D#KBNK7PUH*0S
MPIHFFK%<.'F06J!9&!R"PQR<]S5@:3IJZFVIKI]J+]EV&Z$*^:5Z8WXSC\:
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M WB.0C(]1YG--N763]H?3'1@R-X<8JRG((\YN178_P#"(>&?^A=TG_P"C_\
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M0#CI7IE>):KX@T6X^"'A[3X+NWDO1_9\1MT8&2)XY(PY9>JX((R?[P]17MM
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M!(&,9^HK3HH CMX([6VBMXAB.) B#T &!4E%% !1110 4444 %%%% !1110
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M[OPPEM!<7#A(_-60.R[CP"5(/X4_P;XCTBTE\=:]-<"'2UU19#/L)!4Q1@.
M!DAB001U!!KT6>SM;J%8;BVAFB4@A)$# $=.#3C:V[(Z&"(K)C>I08;'KZ]*
M )0<C(Z4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M'((%C5F/G\R$,0H&1T']ZNST/6;O4=0,,_A+4-*4(6%S<>3MSZ?(Q.3GT[4
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MZI;*5;[+"4^[".-VW&><9R>E=_10!PR>&_$VH^-=!\1:S<:9$FFK<(;2T9V
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MX1]RKLVA4)P%)#=,\5T'B_0Y/$OA/4=(AF2&6YC 1W&5# AAN'H2,'V-;=%
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MZI9QZA<RP364$&YK:U,+!@,D!FW$?,<?05WM07=Y;V,!GN91''D*">223@
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M=0E\M2L21H^?+3C)P. 6Z]\5VM% !1110 4444 %%%% !1110 4444 %%%%
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M*(Q51M8]LDCTIEUXC\1W/AGP[%;ZC=V]W-XB.F?;)K<Q// 0^R1HV YV[3C
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MW6I11:,NHV3WQ$DD,AD,1!( W+DJV#Z8J?PWK4T/B[2;.RU;7]5M[V.5+_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !6%XRT"3Q1X1U'1(IU@>[C""5ER%^8'I^%;M1SW$-K;R7%Q*D4,2EWD
MD8*JJ.223T% '+ZKX3O)H= N],O88-7T1"D,DT9>*560(Z, 0<' .0>,51D\
M#ZCJ-CXDGU;4;:35]:LOL2O!$RPVT05@JJ"2QY8L23S[58B^*?@^69%_M.1(
M9'V)=26LJ0,WM(5"_CG%=D"" 0<@]#0!R?B'PA/K/@&#P_#>)#=6Z6_ESLA9
M-\14C(ZX.W]:FT[P_J8\60^(=3NK1[@:6;&6.VC94+>;OW+N).,8'/>NFHH
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MUM) J[6.?O?,H....*NVFE>)KI;W^W-5LF2:T:VBMK*W9(PS=9&+$L6[8!
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M-.A9 $=@Q<ER26!48'0<]<UU$>JB379=*^PWRF.$3?:FA(@;) VA^[<]*T*
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MK5VBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M"-LD@'?<^>?]FN=\:V]GHWPXTOPFFH)-XCMDM%TN.' G>>,@)(J9)"_*V2>
M,\UWWAO18O#OAO3](B.X6L*HS_WVZLWXL2?QH P+_5Y]#^)*K>7<@TB^TF25
M(V;*QS0-N<@=LQMG_@-<?I'B[6]+\&^)I]6NYI=0EL8=4T\.<L@N041%]ED
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MTR#Q%;77B>?69;L2BRCLIFL6@\W!B ";.(_X\YW#K7L&N_\ (O:E_P!>LO\
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M=!O#';S-<,&EB8(RK+C_ %F-Q'/H* /6/#NNKXBTM;]-.O[&)R/+6]C5&=2
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MIES-=:/9W5W";>>6W226)QM,;%02I!Z8.10!FZSXPT/0-6T_3-2O/)N]0;;
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M)M.PLS=><=:X#PW=6^;BVDU;Q!;ZL--E^VZ7K3._G-M&9(RWRX!S]PX(/04
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M4(U*[>"0JR6\:@LA(Y 9V"?@: /1*CN+B*TMI;F=PD,2&1V/\*@9)_*O$_\
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M'UO5H-!T2]U:Z21[>SA::18@"Q51DX!(&?QI^DZE#K.C66J6ZR+!>0)/&L@
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MSGC&<]ZQ=/\  EUI=MXB%EKLMO=:MJ;:E%/'#CR&+!MA&[YUXP>F03TKM**
M.*?P/>:I#K4FO:O'<WNI:?\ V<)+6U\E(8LL<A2S%CN;/)[8IUGX+U'SO#,^
MIZU%<S:%)(4,5IY8E1HO+"GYS@CKGOZ"M_4/$%AIFK:=IERTHN=1=H[<+$Q4
MD*6.6QM' Z9S6I0!RFH^%M3D\376K:3K:V"7]O';WB&V$CD(6VM&VX;&PY'(
M8=\5CI\-[^UT71;.QUZ*.XT2]DN+&:2SW@1."/+==_S$;C\P(^G>O0Z* ..F
M\):U::M?:AH6OP63ZDJ&]2:R\Y?-5=OFQC>-I( X.1Q1;_#^VL5\*QVEXZQ:
M#+++^\3<UPTBL&).1@EF+=#78U275K)K>.=92T<LGE1$(Q\QO]D8^8<$Y'&
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MF_Y+;:?]B]+_ .E"56B^'-Q#X.LO#J:[NBM+Y;N.5[0$X64R*N P_B/)SSV
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M >*-5,L(EC3:W'<.<XQGZ5UVIZIJ^E>,?"FE?;8YK34&N5N2T $C%(BZ\@X
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M$8# 9PH)P!ZYZ2/PK=Z;KFJ:CHFIQVD>J$27,$UMYJK*!CS$(9<$CJ#D$C-
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ML+E;BXN;;36VRS>6$"J3N4[07R0#S@5S.H2ZU:^$KNUC36=*M!KMFNFO>O\
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MK$$+PQ7(8K'(02-K%><?2M:N)^$6?^%6Z)N()V2Y([_O7KMJ "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *R=>TBYU:W@^Q:K<Z;=V\HEBFA 8$X(*NAX=2">#WP1TK6K'\0Z_'X?@
ML)9(&F%W?P60"MC:96VAOH* ,4^ %N+"[-[K%S-J]S=Q7@U)(TC:*6(!8RB
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MRW-S$8X]DQ"AI5)93M)^;!'?K5>S\73'P-J_C7[0\]MY,DUK8,$'D;!C8Q4
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M:DNK(K--%<I@)+\QVL5  W <8QP<\9 QJV]G#:RSRH"9;A]\CL<ECC 'T
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MGAC0&0Q.Y^Z^?E5U[X/4X(KK=0\(+-K>GZKIFHS:7/:6ILB(8D=7@)!V88$
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MGLM=N;>W<$YCCP!M'/H35_XD:+IVI^+_  5]LM4F\Z^>"3<3\R"-FV\'UYH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MC*&5/,+%P05*LIW8((["NOHH R]"T4:):2QM?7=]//*9I[FZ<%W<@#H  H
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MB@%!N)(QGG ZUB^"](O?A_X@ABU2WB:+Q"H8S6\?RV5R"S?9^^(\,=ON#ZT
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MEQF2V:59#&<]-R\'UX]:MT %%%% !1110 4444 %%%% !1110 4444 %%%%
M 1D8KAV\!:A=+#8:EXJO+[1(;A9Q:30J99-K[U22;.64$#L"<=:[BB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH K1V%O%J-Q?JI^TW$:1.Q8GY4+%0
M!VY=C^-6:** "BBB@ HHHH **** "BBB@ HHHH *K7EA;WX@%PI803+.@#$#
M>O*D^N#S]0*LT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Q/Q8@GF\!SM!!
M+.8;JVF=(D+ML652Q ')P.:[:B@#A=.N4U7XJPZM:),UC-X>*I,\+Q@G[3TP
MP!!XS@]N:Y/4M%NKBSURYDMM0^SVGC$WLPM-Z3-!Y*(SQE?F.-V?E_NFO9J*
M .%\$VNA2ZW?:AHZZW<;;=(#?ZC-,R2 L6*)YIW?*0"2!CYJD\2VTTOQ1\"S
MI#(\4*ZAYD@4E4S"H&3VS7;44 >>W6J0^&/BEJ=YJ4-VMKJ.G6Z6TL-K),'D
MC9]R?(I^;Y@<5Q.LV.HW/PBO$;3;J.ZD\2R3&W,9+J#.3T'4<]1Q7O%% 'E7
MB"PT_3OB!K%]KL^NVUGJ$%N]K/ILMPJ.Z*4:-A#_ !<*1GU-%[8^&+'1M"M[
M_3?$&BQI;R36>H1-*9[9W?<T3M'N(8YW88$=NHQ7JM% '/>")]4N?"%E+K!F
M:[/F#?/'Y<CQAV$;.O9BFTD>IKRKQ$LFJZ!KT=[%KU[XFCO)6-LK7"V]O;I+
ME2JC$;+Y8&.I)/XCW:B@#B?"I-Q\0/%NH1QRBUNH=/>"1XV0./*?ID#ID9':
MN,TF*YT/3O!VO7EG=?8].U+4TNPD#,\2S/(%D*@9VY YQT->TT4 >?>&;YM8
M^*.M:I#:74=A)IEO';SS0-&)@'?) 8 ]21SV&>A%6_%=M--\1/ LJ0R/%%/>
M&1U4E4S!@9/;FNVHH \N\4:?8V/Q"NM2UN?6K;3KZQA2&YTV6=%$L;/NC?R>
M<D,",\=<57BMK;PS?^$=?@TK5K?1UCO([A9T>>>W:9@ZO(!N;YBISW&X9YKU
MFL;7]$N-76UDLM7N],N[60R1RP896R,%7C;Y7&/7H>E 'E^H?:O$\WQ0^PV%
MPKW&G6?V:*2(I+*JK)@[#R"<' (SC'%;-]X@A\3:]X*;2[2^D@MK_?=2R6LD
M:PL87 0E@,GKG&0,#GD5V7ASPT-#EO[RXOYM0U+4)%>ZNI55-VT;4554850.
M@]S6]0!XU;IK>GQ_%&ZTZ"[BNI+]&@DCB.\IG#M'QR0A8C'?%6]$_LR#XCZ+
M?:5'K,VG36=Q:_;[YKF423DQMC][DKP#S@*3D=N/6J* /!7,LW[.NJ^'4M+S
M^UK!PL]L;60,"UYN&#C#<<\9Q7:33_\ ",>.;'7=1AN!I=WH<=DUQ' \@AF1
M]^'"@D AN#CJ*]&HH \:O[*\U/3=>UV.QNDM]4\06#VL4D+*[0Q-&GF%",@'
M!/(' S78>(XI_P#A9'AJYCM);B.*QU#<JKP25CPI)X!.,#-=K10!Y3X8EM+?
MQ3I,/A-]:@LY3)_:>DW<4OD6:[&(QY@PC"3:,*2#D]JVOBG,UMIGAZ=('G:+
M7[-Q%&,L^&)P!W)[5WE8_B#0$U]=,#W#0_8=0AOAA<[S&2=OMG/6@#D&OH_%
MGQ"L[_2XKIK'2M,NEFN);:2(&67:!&-X!) 4D\<5FV6@ZCJ/[.5OI5O:R"_%
MJLBV[J59F2;S-N#W.W'XUZS10!YOJFLP^.-7\+V>D6U[NL]2CU"]>>UDB%JL
M:-\C%@!N)8# ST/:J<%E=#X7_$"$VTPEFO=4:-/+.YPQ."!WSVKU2B@#S[6;
M6X?_ (5WL@E/DWD1EPA_=C[.XRWISQS6 -3.E>%_&_AJ6QOWU>YNM1>W@2UD
M82QR[BL@<#;MP<GGMCKBO8** /)C97?_  FOPKE^RS>7!ILRS-Y9Q&?LX&&/
M8YXYJ"/4W\/>!_%?ABYTZ^;4P]^85%JYCFBD+L)?,QL"@-SDYXQUXKV"N-U3
MP/>ZC)J,">*M2@TK4G+7-EM20X8898Y&!9%([#@9.,4 <A%<)M\-VVMR:RNC
MGP[:M9PZ<9U%Q<D896,."6"[, D#DFLZV,NG>#/"9N;&]B_L7Q+(U_'Y,DC0
M*9)B#G!+C#K\PSG->VVUO%9VL-M;H$AA18XT'15 P!^0J6@#QZ]M])M/%.NW
MNKR^(XH-3,5YI[:<]U&MRIB52FV/I("N,-@X(J];K:^"/%VCZE/I]]9Z+-H"
MV"9B>=K:59/,$<FS<<D-C/J*]3HH X3X=23W&H^+;V:RN+1+K5?-A2XC*,T9
MB3:V#TR.<=NAYJ+6;E=)^,NEZA=Q7 L[G1WLHYHX'D7SC,K!3M!QQW/%>@44
M >7V%G=+\(/&%N;:8322:H4C*'<^YI-N!U.>WK69/IEEINO07^ORZW:6-[HU
MFD4^GR7"!98E8-'((><X8$9']['>O8Z* /*X=)BM]6^'1T_3-1MK075[.\=Y
MN>6+?&QS(23@L3GDYY]:=XFT^PL/B%>ZCKD^M6VGW]E"(+G39;A%\R,N&C?R
M><D,I7/OBO4J* /)FBL_#5UX'UE--U2ST>'[=YXN$>::!IP"K2 ;F^8@GVSS
MBL_6S=:SIWQ.O+?3KU8;RULOL@D@97F5589"D9[9QUP1G%>TT4 <9XKMYI?$
M7@EXX9'2+46:0JI(0>0XR?09KBH]2?1_A=K_ (,ET^_DUN)+Z%(4M)&$J2-(
MXE#@;=NU\]<\8ZD5[110!X_>Z9:6.NZ9J6NR:U::=<Z%;0+<:?).FR:/)*2"
M+GD.",CJ#5G^RH8I? DFF:9J<%LVL3W,B7NYY5W(_P \A))&XX;GGGGFO5Z*
M ,^XU:*WUNSTIK>Y:6ZCDD65(\Q($QD,W8G/'K6A110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MLH'L/+0K%I\?EVL7\,?R[,COG:2O7H3ZU;N7DCM99(8_-E5"4CSC<P' S[T
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MUZZTK1M0\5Z>OB>YTR&[D>>?29+0>;<R2(,FWDSDJYP#@$@YZ=:]CI"JD@D
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M&R.6VR^: 1YG]X]?3\Z[RLJV\0V-WXBN]"B\[[;:0K-*'B*KM8D#!/7H>G%
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M6VT32;G4KSS?LUM&9)#'&SD*!DG %2V-Y%J&GVU[!N\JXB65-PP=K $9_ T
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MH<,H92,CWYJS6+_PE&G274]O:"ZO6MW,<[VEN\J1L.JE@,%AW49(]* .>LO
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MI!8*7\S:,YR!GC%3IK.LOXY\0Z3]K@$%MIT5S:@V_$;,7!W<Y;[OJ/I4>D^
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MV(8QN^?CY3V[_E41\"WMIK]]>Z+XEN],L=1E,]Y9) D@:0_>>-F_U9/<X/\
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M8/U#9(X  ^N.=CQGXEUK1+;Q#>0:C&LFGK'+:6EO")5,> 6-P2N4W$L!AEX
MQFJGP^T1O$7PN\/VEYJ4,^EH$EDMHX<.Q1]XC=]Q&T, 2-H)  SUSL:E\.Y+
M^/Q':IKUQ!8:XYFE@$",4E*A20YY*_*/EXZ=: ':AJNO7'Q L]%L]1AM;*[T
MF2Z_X]@[QL'1<@D\GYCCMSR#62NO^*KGX?:M?6MZLNJZ)J%Q;RLENG^EQ0OA
MCMP0K;<D8[CIS730^%+N+Q+8ZV^KB:6UL6LMKVP^=68,6)##!RHQQT]>M4[4
MZ;\.=/NY-;U=6@U34I)D;[*PQ++EB@"[N.#C/YF@#0L=7;6M9L&TR^9]-%@+
MN<[%/F>8?W0SC(.%D)QCHOK4NN+=Z+H&KZAI%M)=ZFX,NW&YW(P,*.^U>B]\
M=R236\!^'H/#WATQPP20?:IY+KR9#\T2NV4C]MJ;1CL0:VM6LI]0TV2VMKQK
M.<LC).JABA5@W0]>F,>] &#X-\0V_B&2]GL]<?4+9%C7R+B)8KBVER^\.H5>
MORXX['FLOQ_;7$OB?P;Y5_- KZF5"HB$(PAD.X94\XXYR/:NBTSPX+3Q#=Z]
M=30RZA<V\=LY@@\E-BDG)!9B6)/4GH /JSQ!X<GUO5-'O8]06V&EW'VE$,&_
MS'VE<$[AQ@GI^= %"/5-73XE2:"U[&]G_8GVN/, W"7S0FYB#ST)P,#FN4A\
M5>*U\ VGBJ;58&,.H^1-:K:*%GC-T83D]5(!&,>G.<UW+>'+G_A-#XD74(Q)
M_9_V$0&W)7;OW[L[\YW?IQ[UC?\ "O)O^$&_X1?^V1Y/VK[3Y_V7Y\^=YV,;
M\?>_3\Z #Q=K6KZ=)K;P:DMN+33_ +3906L2S2.X#EFG!4[$RJ@'*Y^;G-03
M^(M?O=9\&06EY;6L.N:?+/.OV?>498D?()//+\#CH,YZ5?OO T]WJFN72:Y-
M!#K=JD%[ ENIRRQF,,C,25&#R.?J.M.L_!-S:7OAJY;6?..A6[V\8>V \U71
M4.<,,8"C'ZYH QK;QEJ^GZ/J]M>W$5WJ%MKJ:1;73Q!%82E-KNJX'RASG&,X
M'3K74P6?B2VU6[0ZI#<Z8]J#!)<1+YT5QGD;4559,<\G.?:LF;X=PWVG^(+*
M_P!0:1-7NQ>[X8O+>WF 4*R'<>FQ?U]:U-'T'5[&-Y-3\12:I>B(Q02R6JQI
M&#C)**?F8X&23VXQDY .>T7Q+K.J?#_PUJUQJ%O;R7TO^FW&P>85R^%A3:0S
MDA1C!XSQWJG/KE]K/PU\?PWTCRMIYO+6*22(1R/&(0R[U  #?-C@#IT%:EK\
M.IK'1?#MG::X\5SH,KO;7'V8,'5P0RNA;!.&(R",5,O@&5-,\36(UR9X]==W
MD,MNA,9= CGC&20O'0#T- '1^'?^19TK_KSA_P#0!6E5/2K-].TFTLI)A,UO
M$L7F!-FX*, XR<<#UJY0 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !2%0W4 _6EKE/']AJ-_HEJMC;
M3WD,5VDM[903^3)<P -N16R.Y4XR,[<4 =!J6IV>C:>][?S""VC*JSD$X+,%
M P.>20/QJW7A_B>VT&]^&]\M@-5A%KJML&T[4))%DL6=XPR $YVD'<,EADDC
M%=-XBTW1SKMIH<>F:UK'V.QW+IMI<[(H SG$KR/(I+G! !8\ G H [^^U.ST
MU[1;N81-=SBW@!!.^0@D+Q[*?RJW7ACVL?B'P[\-Y]6-Q//)J;VDC/<.':-3
M* "5;[WRCYAS[UH:@IUCQ'XC@FT3Q#J']GR)9:=)I]P%2SVQ*=PS*I+EFW$D
M'@ 9[4 >QT5Y3;V=_P"(/&N@:?XB:ZB9_#)EU"T29HQ+*)4!#;".YSP>V.G%
M9=IX<M[OPCXV:XN[^0:'=WL.E W<@^R+&GF+MPW)RW5L\ "@#VJBO';G4YM?
MUC1K75=*U?6;1/#]M>-;6$@0&>7.9'S(F<!<#DX)-*8-9N+?P9I>J2:G9;]6
MNH/WLV)Y+41R% [*QYV84D'/&0<\T >O32QP0R32L%CC4LS'H !DFHK"^M]3
MT^VO[.3S+:YB6:)\$;D89!P>1P>]>5:CHUIIE]XX\/VWGKI1T)+]+=KB1A',
M/,Y4ELC)121G!QSQ3+7P\\7P]\'SV>EWVI:4;=+G5+"UNW629G@4*Z@N,A2,
M[ 0.1QQ0![!17-^!IM-F\. :5<WTMM'/(GE7^[SK9@>86W?,-O0 DG&.3Q6[
M?3QVNGW-Q--Y$443.\N,[% )+?AUH GHKQK1673_ !#X2O--TW7;>/4+AHI]
M0U&Y!_M!&A=LM'YC$'*AAE1C]*CCT.+4OA_XLUN\N[Z2_L;K47L9!=2+]F\M
MW9=H! ZCJ>V!T H ]IK(T+7H]=?55C@:+^SK^2Q;<V=Y0*=P]!\U</9PKXU\
M9V]KK3S36EGH5M=+;I,\:M/*3ND.TC) 7 ],UI?"ZW-I;^*K8SR3^5XAN4$D
MC;G8!8P-Q[G'4]Z .]HKS[QE'I^I^*H-/FT_6-:GAL_,.G64PAAA#.0)78NG
MS':0!D]"<=ZYG39;W7M-^'%K>7UZGVF>_@N&6<B22.-9 %9E/)*H 2#GJ0<\
MT >ST5Y++X;D.I>-O"VBW%S;1"QM;RQC%PY\FX^<_*220&*+GFK<GB"3QU#X
M*L+61XC>M_:&I"-BI1(.'C..S2X7\* /3Z*Q?&+O'X(U^2-F1UTVX*LIP01&
MW(->9W>@BTT3P'JEOJ&H1ZGJES:VM[=K=/NEBEA8NN,X'0!<#C (YYH ]FHK
MR'596\":SXOM]">:*W3P\M_'$\SR".?>Z;QN)QP 3ZXJ?P[:7FG^(M#GTS0/
M$-E$P=-6N=0G5X[A#&2)&_>M\X< Y '!(H ]7HKQ..XABO-!US2;/7G:[UJ*
M-]<O+A52[BED*LOE>9G80?E^08V@\5IW]K%I?BF[NO$]OK5M)+J0DL=>M)V:
M"*(LOEQ.H.(Q_ 0RX.2<\YH ]9HKA_"T\KWOCH22NPBU1U3<Q.P>1&<#T%<5
M9Q7&M6/PJT^:^NTAOK2[%T8YF5I4$2L5+ YYQC/7!.* /;:*\BU.WMY?&-_H
M<N@ZYJFEZ/96T-G;Z?<86$N&8NQ:56+<  Y.-II);#7I]&\/W7B?1=7U6RM[
M6:"ZL[>?%PD@DQ',ZJX\PF->Q)!)- 'KU9LVN622:G!')YMSIL*S7$(!!4,K
M,O.,<A35;PA-97'A2PDTZ^N;ZTV$1SW1)E(#$;6R <J1MYY^7G/6N TW0]/C
M\??$>Y6*3S;6"%H29W(4R6SE\C.#DD]<X[8H ]*T'5DUWP_I^K1Q-$E[;I.L
M;')4, <$_C6A7B<&B0Z1\-/"/B6VN+L:NLFG_O\ [0^#&[(IBV9V[-IQC';/
M4FK7C9K6[E\4ZC96>O:C?:?&P2_AN5A@TV2.,-M3,B[L'YFPK'G'M0!ZN^IV
M<>K0Z6\P%[-"\\<6#DHI4,<]!RR_G5NO*AI5EJOQBT6\NXY&FFT 7KE9G4>:
MLD8!P#C&.W0]P:[KQA=V]EX1U.>ZO;FRB\DH9[49F4L0HV?[1) 'N: -NBO+
M?"JG2_B%#8V>C:IH]E=Z5-+);WUTLOG.CQA9,"1]K88@YQG-8&@QSZ5\$I?&
M"7=Y-KLMH]M'.T[MY,;3^6 BD[<C&[)&<YYQ0![C17F/AFSNM/\ &&FG2?#N
MOZ9ITD,L>HMJ,ZNDA"YCD_UKG?N!!.!]ZMOXDSS_ -E:/IL4\L$>JZO;6-Q)
M$Y1_*8DL PY&0N/QH W+G7H[;Q58:"8&:2\MI;A90W"B,J""/?=^E:]>6W.D
MVGA7XG::VF"46Z:->RK:O*TBHRE,E=Q)&[CCIQGJ36)X=&J7%GX=UJQT+Q$V
MLSSP3WVI33H8+F&0CS05\T_)M;*C:,;1TH ]MK/TB^O+^WFDO=+ET]TF:-(Y
M)%<N@QAP5Z ^G7BN#\%Z/'JWB[Q/J5_<74YT[795LXC<.$A.Q=QV@X.00,'(
M&..M<OH[:G/\,-:UBVN;B2^T7Q#-?1 R-\Z1%2\9]5V%N.E 'N>!G.!GUI2
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M<\UZO$RO"C*_F*5!#_WAZ\4 4=<UNR\/:7)J%^SB)65%6-"[R.QPJ*HY+$D
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M_C5N@#)ET&&7Q9;^(#,XF@LWM!%@;2K.K$^N?EI/$>@0^)--CLIYI(42YBN
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MZE;Z-J4DDTVG1>7L$C_>*L5W!<\[0<9]N*Z_3K)--TRTL8V9DMH4A5FZD*H
M)_*@#S"VTRPT_P")WCO5H;0-=:?90WD!+L<2-'(S'&><GM^59]YHUOI?PBM/
M&]O-<'Q(MO;Z@U^9W+RN[(61N<%2&*[<8KT1_"*#QC-XAM]2N8?M<*0WMF%1
MHKA4!"YR"1P>QK,B^&\"6\&F2:WJ,WA^WF6:+2G\O8-K;E1GV[V0'HI/8>E
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M7MJM[8W%H[%4GB:-BO4!ACC\Z@T72XM$T.PTJ!WDBLK>.W1WQN8(H4$X[\4
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MG+Y$D-J9"5M3YB!@A)R W7'0=JL:W%I^K7NB:?/I6IZ]=1:4LYTZ&=(H(U;
M$KLS+E\J0!D]^!UK8G^'%G?>']:T[4-4O;J[UEHS>7[[!(WED%%50H55&.F.
MYJW>^"_.U*VOK'6K_3IDLTL9S;B,F>%22!\RG:P)/S#GF@#S+6+JXNOA+X.:
MZ:5I(_$J0CS7WL%2:9%4MW(50,^U>[UPS?#'3FT.VT8:C>"PM-4&I6L?R?N2
M"S>6#C)7+D\Y/O7<T >4>'[[Q-9^)?&O]AZ)9ZA#_:[,[3WQA8-Y:?*!L.>,
M<Y%5+34M1;P1XN^(9GABU2^M?(CMK?/^A>5E-K%@"9 6)/&.!CBO2]&\/V^B
M7NKW,$TLC:G=F[E#XPC%0N!CM\O>J<?@S3H[O7FW2M9ZXO\ I=D2/*WE=K.O
M<,PZ\]>: .0\.:3?:;XIT:;2_"^KZ9:E9(M4GN[N.1;A2A*NP$K$OO YQT8U
MS6GZ!;GX&CQ4;FY.NVL,ES;7OVA]T/ERMM11G&W P1CDDUZCHWA*?3+^VN+K
MQ%J>HQV<9BM()RBK&I&,ML4&1L#&6S^?-<3X'\"2:O\ #G2[6]U;4K?39RTE
MWI>U LA$K'&XKO53@$@'!YZ9H T;#3[7QSXWUY=?B>XMM-M[-+6U,C+'&98O
M,=\ CYB3C/4;:YJ\GOKGP?I>D_VA= VGC0:5#=>83+Y(=U4[NY ;&?85Z5JG
MA!KG6GU?2=8O-'O9H5@N&MDC=9D7.W*NI&X9(##M47_" Z6FC:/ID4URD6F:
MC'J2R%@TD\RL6)D)'.XL2<8]L4 <AXC\$>'K3QYX%TV&P(M)6O4D0SR$L%B+
MCDMG[S$]>].2:7_A9/Q*C\U]D>DPE%W'"GR.WI7;^)?"J^(;O2[Z'4KK3K_3
M9'>WN+=48C>NU@5<$'(J)/!5FFNZ]JQNKAI]:M4MIU.W"!4V97CKCGF@#SW^
MQ;?3/ ?@SQ-#)<'6FGT[?=M.Y9TD*JT9&<;-IQC';ZUMZ7HMOXKU7Q=JVHSW
M OK+4I+*QF6=E^QI%&I5D . 26+'U[UU4_@ZSG\+:5H#7$XM]-:V:.08W-Y!
M4KGC'.T9KC/$/]F:7XFUU)9O$E@MZJR2V=I;>;!J;;,?NV5&*$X"M\RD_K0!
MT_PLD>7X8Z \CL[M;9+,<D_,:Z^N;\ :5=:)X!T33KU/+NH;51*AZHQY(/N,
MXKI* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *QO%7B.V\)^'+G6KN">>&W* QP %V+.J#&2!U85L
MUPOQB_Y)AJ?_ %UMO_2B.@#J="UFU\0Z%9:O9%OL]W$)$#?>7U4^X.0?<5D:
M/X[TS7/&6J>&K2&X^T:<A:2=@/+?#!6"G.>&)'3L:Y*/7?\ A74GB_1V7*1+
M_:FD1X^^)VV^6!Z"8@8_VJS=!TV;P;XMOH5/F7]KX0-S,YY\RX,SNY/KEB?P
MH ]GR,XSS1D9QGGTKQ?PSH^JF/POJVF^%+NWOFE@FO\ 5WOH6-W#(/WI<;]S
M [MP!&1@8JMKHM6M+SQ-I&B7LDBZLC1^(+JZ0/D7"HRH@.XQ=4 P.* /<<\X
MHKR7Q-I,&F^(-6U;Q+HEY=V$TR36VNV,V9=.0*HV[,Y158%MR@@[CD5TOA5]
M_P 0_'.&W+YUD5YXQ]G% ':TF1C.1CUKPFSM1JG@_P"'%G)-*L5SJMU'*8W*
MEHRTVY<CD9&1D>M;FLZ3;CQM'X>@\*/J^C:;I226^G)<)''$\DC[I")&&X_+
M@=<<^M 'K9..M%>1/X;\0R>']%_M;P])JMEIT]TDFD37B-(T+,/(?.XJ[(H*
MX)[^M=UX&ETR7PQ$ND"\CM8I98_L][GS;9@YW1$'D;3P!D\8YH N^)M?M_"W
MAV\UJ[BEE@M5#.D0&XY8+QD@=ZQH/&FIS3QQMX(\01J[!3(X@VJ">IQ)T%5_
MC!_R2G7O^N4?_HU*L6M_X^:Y@6YT'1$MRZB1TU%V95SR0/+Y..U '79 (!/6
MEKRW1?#>E^,X_%6J:]!]IOEU2ZM()G8[K2.([4$?/R$?>R.I-8=FC^,KKX:1
MZS)+*EYIEW]K&\J;@($X8CG!*@GUY]: /9[N[@L;&>\N'V001M+(_HJC)/Y"
ML6X\5P)J'AJ"W@,T.N[S',6V^6HB,H.W'.0,8XQ5+QWI-@GPLUFP%JGV6TTR
M3R(NT?EQG9CZ8'Y5Q9\.Z:8/AEI\,'D6UV))KA86*^83:9?)'/S8P?8F@#V(
M$$9!S0"#T->+ZT/^$-E\>V7AY&LK<:=9S10P-M$4DCM&[IGA3CG/J :V_#6A
M7^E^+],GTSPA<:%IWDRPZBSWD,BSC;F-F57)+AAC=C/S'- 'II( R3@45POC
MJ/3]2UO2-+GTF[UNZ$<MPNFI*D=N4&U3)-NX."0%]R>*XR-+NU\!OK44$D,O
MA7Q!-)':B7S#':A\20ANX"L?P6@#VVDR,XSSZ5YGJ^H/J_C74M6LG\VT\+:-
M)- 1RKW4T98'WQ&!_P!]5B7^@V&C?"33_&-DK#Q%'#:7S:CO)EFDD9"ZLV?F
M4[R-IXH ]8BN]1;79[633 FG)"'CO?M"DR/GE/+QD8YYSVJKXJ\0#PSH$NJ?
M9_M/ERPQ^4'V?ZR14SG!Z;L].U<'/>S6/QB\7W4))DM_#@EC'4;EP1Q^%8FJ
M>%]*MO@[I.NQH1JMT;"XNKO>3)<M)+&S!SGYAEL@'IM% 'N.0,9/6BO(/&MM
M8:M>^*;RVT&\U6YL+?RWU":Z2*/3Y$BW@09.[(R&;'<]>U6UL8O%'C?PU'JQ
M:XAF\,>?<1%B%G;?'PX'49.<>H% 'J@.1D4 @]#FO%) VEZ9KGANQDEMM,E\
M56VGA8Y"/)@F$;.BGJH/(X_O&N@\5>'[+P-X8U_5?#,DFG22:?Y1LX'Q'N+@
M>< >0X#$9'XT >E@@]#1TZUYAX;T'4-+\6Z3/IGA"YT2Q$<L.HR/>PR"==F4
M9@KDLX<#YL9^8UI^+;:+7/'_ (<\/Z@#)I3V]S=S6Q)"7#IL"AAW W$XZ4 =
MK=W<5E8SWDI/E01M*Y7D[5&3C\JP/!?BB]\6Z4-5ET;^S[&8!K1VN1(\JY()
M*@#;T'<]:XN?1=.M=1\;^&H[56T:+3(M0@M"28[>8K(#L'\.=H;'2MOX/:1I
M]C\/-*OK6TCBNKRW4W$JCF0AFQG\S0!W%Y<"TLY[C;N\J-I-N<9P,U2\.ZP-
M?\-:=K'D_9Q>6Z3^47W;-PSC.!G\J\[T_0M/\2V7C77-40R:G#J-Y;6]T7(>
MUCA&U AS\N.I]<\YJEX:LX/$4O@C0-43SM*A\-_;S:L3Y<TNY$&X?Q;020#Z
MT >RT5XCXAB71M+\>Z!8EH],L[C2Y[:$,2L!ED0NJYZ#*@XZ#-=UXF8CXE>!
MEW8R]]QGK^XH VO"OB >)M BU3[/]F\R6:/RB^__ %<C)G.!UVYZ=ZN'5K-=
M<31C*?MS6QNA'@_ZL,%SGZD5XWI?A72KKX/:MKTRL=5M?MUQ:W7F$/:M'+(R
MA#GY1E<G'7<:V-*TO3]6^+^F:C>V,3W4WAF#478CI<>:H#_4  ?A0!ZU1D X
MSUHKQOQM!8ZFWB[4[/0KW4KFPC9&U6:[2)+"6.(-B 9#?*<,<#DD\F@#U^YG
M6UM9KAP2L2,Y ZD 9KB;#XC76J6$%]8^"O$,UK.@>*15@PRGH?\ 65T7GR7/
M@OSY6W22Z=O<^I,>37!> ;[QS'X"T1-/T31IK06B"*2:_='9<<$@1G!_&@#T
M&'4-3FU.TC_L9H[":U$TMS)<*'AD/_+(QC))]P<5J9''/6O-;IYS\?-#$X"2
M'0',B(V5#;VSCU^M<K'X<TZX^#>KZ_/&\FJVLEY+:71D;?;%)WVB,Y^49!/'
M7)H ]U) ZG%%>6Z_;Z?XDUUXY- N_$%Y;:;#YZR7*0VUGO!8,F<'S&ZDC. !
MR*R].A/B4_#"+5)I9X[C3;O[2"Y!G"I'@.1R02!GU[]30![,"",@Y%(6^5BH
MW$=L]Z\6U0GPM:_$'2M$=[&RCFTY84B8@6WVC:LK)_=R/3H:[VR\$:)X=U(7
MNC;]/)M9(I;6)_DN>A#.#DEE_O=>3F@#>T:ZU"\TN*?5-.&G7C%M]L)Q,$P2
M!\X !R,'\:C\0ZP-!\-ZCK'D^>+*V>?R@^W?M&<9P<?E7D/A"2SN/@IX8L+Z
MWOK^2\U"1(;"UD5#=LLDC%)"W'EX!)Y'0585)++PM\3=+&F_V5;6]FLD6GK.
M)5@+P,6VD< ' .!ZT >L:!JO]N>'=-U80^3]MMH[CRMV[9O4-C.!G&>N*YBV
M^(LU^UT=.\(ZY>P6]Q);M-"(=K,C%6QF0'J/2M;P!_R3OPW_ -@RW_\ 1:UP
M'A'4/&&GZ!KL^BZ1I=]:0ZI?2!9;EUF=A(25"A""?3GF@#TCPWXFL?$]E-/:
M1W$$MO,8+FVNH]DL$@ZJR_B.A(K9!!Z'->-.UW#\+=2\1P7HNK_Q/>V[S-9'
MRA&CND1B0L>"%RN21R?:K4.C:AI<VJ36'A2;0-(DT6YCNHC=Q.CRA<QN%1R=
MV-X)[YYH ];R,XSS2$@=3UKQ2;0+'1OA9X;\668?^WH5T^87GF,9) [1JT9.
M>4VL5V],"NAT;P[I?C;6O%E[XAMA>36^IOI]L)&/^C11HF#'S\I)8G(YS0!Z
M75%M7LDUN'1S+_ILMN]RJ <>6K*I.?JP_6O&K(3>*K3X86VJ7,TJW#:C!</Y
MA#3QQJRX8CD[E0 GODUOKX2T&V^-NGVT.EP)#!H7VB- #\LD<R*C=>H  H ]
M$TV[U&YGODOM,%G'#.4MG%PLGVB/L^ /DSZ&M#(SC/->$2.__"(?%T[VRNJ2
MX.>GS"NKU#P_I_AOQAX,OM-C:.]O+N2WO+@N2]TK0LQ,A)^8[@#ST- 'IF:;
M(XCB>0\A02<>U>*)H5EK'PF\0>+;LN->G6^F-[YA$B!'D41 YX3:NW;TYKU3
M1O\ D3-/_P"P?'_Z+% %'P1XYTWQWID][I\5Q 8)1')#< !QE0P;@G@@\?0T
MFM>.],T3Q=I/AJ:&XEO=1(VM$ 4BR2%+DGOM;IGH:\W^';CPO;^#M99@FGZ[
M9-IUXQ.%6='=H7/N1N2DV-JFM^'?%TRD/K7B5#;!ARMK''(D0QVS\S?\"H ]
MQR,XSS02!U.*\4N[&^\2WWBNY'A:[U+48]0GM;'4H[V*(V7E@",1AG!7!^8X
M'.[O6MK%I#K^JB#4?#EUKFK6FEP+>Q274<5M8R.I8E"3_K"<DD9X"X(H ]5)
MQUHKQNWT_4-<\*>$=:U'1G\3Z?'I9CN++S@)%D)7$P5B!(VU2.N><BM/2;BP
MG\5^ SI4UV]C]@U%(Q=D^:FTQ@H^><J05_#O0!ZC1D<\]*\;\7N?L_Q:PQ^6
M*QQ@]/W*U:\1Z+!HND>'M.L-.GO3K5\CZFB7&R2_*PNY#.[  %ADC(&!CVH
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M<$C'8A:W7+  _>X'/4=L9- 'IE%<?\++B:Y^&NBO<2O+(L;Q[W.20DC*N3]
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M .@]*Z*B@#*\2:!:^*/#UWHM[)-';W2A7>$@.,,&X)!'4>E:HX&*** .1O\
MP#;W5YJ$MGK.J:;;ZFV^^M;21!',Q&"PW*2A(&"5(S6@OA'3(M5T2^MQ+!_8
MUO);6L$9'E['55.[(R<!1CGZYK>K&\3>(HO"^E#4;BQOKN 2!9/L</F-$N"3
M(PSP@ Y/TH OZEI\&K:7=Z==!C;W<+P2A3@[6!!P?H:Y[2_ MOI_]B&75M1O
M6T:1VM#<-'PK1>5L.U!E0O3OGN>E=710!@W?A#2[[4=7N[L2S#5;-+.XA9AL
MV+NQMP,@_,><]AC%1:-X2_LO4(KVYUS5=3D@B,-LMY(FV)#C/"JNYN -S9-)
MJ?BS[)/?Q6&E7FJ'3FC6\6TP70N 0%4G+D*02!V(Z\XU])O9]1TN"[N;">PF
MD!+6TY!>/DCG!(YQG\: ,S7/"J:QJEIJ<&IWVFWUO$\'GV;)EXF()0AU8=5!
M!QD&F:-X,T[1++5+"":YFT_469I+6=PZH67:^#C<=W4[B>?3G/1T4 <]X4\'
M:;X1T632[-[BYBE<O+)=L'>3*A<$@ 8"J !CH*S+?X;V,*VMH^K:I/HUI,LT
M&E2R(8493N4$[=[*#R%+$<#K7:44 8,?A/3X_%U]XC+SO=7MHMG+"Y4Q; 1T
M&,YX]:P3\*]/?38]+EUO69-+MY%DM+-IDV6Y5@PP=F6 Y #$X!/?!'7WU[/:
M7%E'#I\]TMQ-Y<DD94"!<$[VR>G&./6KM ')7O@"ROM0U&5M2U&.QU)O,O-.
MCD40S/M"[C\NX9 &0&P<<\<5:T?P=:Z/?:=>B^O;J>PT]M.C:<I\T1=6&[:H
MR1M !]!SD\U9F\1Q0>+[7PZUI.);FVDN4N"5\LJA ('.<_,.H%;5 ',W/@;2
M;RUUNWG:Y=-7N5NI2'"M%(H4*T9 RI&P$9SS[<5#:> K$/?2ZM?WVM7%Y:&R
M>6^=<I >2BA%4#)P2>N0.:ZF::.W@DGF=8XHU+N[' 50,DFG@Y&10!S6C>$!
MI6H0W=QKFJZD;:(PVL=W*NV%3C/"JNYL #<V35KQ!X9M]?>RN/M5S97]B[/:
MWEJRB2,L,,/F!!4CJ".<5KS3Q6Z!YI%12RH"QQ\S$*H^I) _&I* .=TWP=9V
M%EJL<MY>7EWJRE;R]N&4RR#:5 & %4*"< # S5_P]H=MX;T"ST:SDEDM[2/R
MT:8@N1G/. !W]*TZ* .0N_A]9W-_J,L6K:G:66IN9+ZPMY%$,[D88\J67<!\
MV",T]_ -BNFZ+;V6H7]E=:-#Y%I?0LGF[" "K J58' R"O4<8KK** .47P!I
M3^']5TJ[GO+MM5;S+V\FD'GR.,;6R  -NT8 &!CI18^!88-;TW6;[6M4U*_T
M_P P0R73IC:Z%"NU5 [YSU)QDG %=74<,\5Q$)(9%D0D@,IR#@X/ZB@#B%^%
MMA'ICZ3%K>L)I4\K2W=F)4VW!9RQ!.S<H.0"%(R!ZY)V+[P?;77B:QUZVO[R
MPNK6 6I6V*!)H0X?RV#*>,CM@UT=% &+X<TV\TY=4%W//*+C49KB$32^84C;
M&%![+D$@=@0.N:RKWX>V%]=:GYFI:BFG:FYFNM.CD40O*5"E\[=W8'&[!(Y'
M:NOHH S;'1ULO#T>CO=W%S&D!@\^;;YA7&!G: ,@<=.W>ET+1[?P_H5EI%J\
MKP6<0BC:4@L0/7  S^%265[/=75]%-I\]LEO*(XY)"I$Z[0=RX/3)QSZ5=H
MPYO"UE/XSMO%#2W O;>T:T2,,/+*%B<D8SGGUJO'X*TZ/P9=^%Q/=?8KH3!Y
M"R^8/-=G;!VXZL<<5TE8MMXCBN?%UYX>^R3QSVUJER97*['5F*C;@D]0>N*
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M]0U+5&M;:WMKO^RI641).$#<_+OP&).TM@'MCBMS4? \5UJ=[?6&M:II3:@
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M0 S%"F&R.1ACTQ6K10!XGXATZW%IXDT6ULO%,=S>33?9](2(O9S2O]V99 F
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MD7QCTB_2YFN[JW,<9**2OEMT?<2 <#&W=[9[6@#@_&FLW>BZR)]0BU,>'FM
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MKR4ZA8_8)XBR!#%SP,*"""Q.<U7MO %G;WFD7CZOK$]SI4;Q022W"Y*, -K
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M5S86\K"YF;*XD,F1M1<D<D D@<]*NW7@G3;^PUFVOI;BXDUA$2[N"55R$&$
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MJYC*?(I5-HV<8!]>>^:SC\/=./A&\\--J&HFPNYFEE)>/S,L^]@#LX!;GI0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M*73+N^LKW3X0S,J/!(C'D<D#(([C\ZVM)\6:3?ZA#I$=S*;XVXF3S(759E&
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5PNN_Z'\7_  K=R\0W5G=6:L>@D^5P/J0#CZ5W
M59'B3P_;^(]+%K++)!-%*EQ;7,6-\$RG*NN?Y=P2* ,;0[:>/XG>+;AX9%AE
MM[$1R,I"N0LF<'H<9&:YVRD;1?@EXDDOHG@.=1 252I)>60)P?4L,?6O4(PZ
MQ()&#N% 9@, GN<=JQ]=\.Q>()]/6\G?[#:3BX>T"C;.Z_<WG^ZIYQW.,]*
M'>$[*73O!VB64X(FM[""*0'LRQ@$?F*V*** "BBB@ HHHH \P^)5C=W7Q!^'
MDUO:SS107\C3/'&66,;HN6(Z#@]?2MJWM9Q\:;VZ,$@MSH,48FV'86\YCMST
MSCM7:T4 >0:MH6J7X^(@M+*:28ZC975O&4(^T")8W8+GK]TCCO6_J?B!_'.E
M:GH.B:9>F*YTR=9KNZA>W6"4KA(L.HW,23G!P .IKT"B@#RCPO9:!>:EH<2:
M?XFEU.V(EG2\FNO)L9%0C+>8=AY)4!<]?2M7P39W,'@#7H9K::.5[S4&5'0A
MF!9L$ ]<]J]"HH \:@2?1M ^%VI7ME>+;:>)%N]EL[O#OA*C<B@MU]JZ#0K2
M:3XT^*+Q[686=QIUL$DDB(1_E7(R1U]17HM% 'E7@K1]0'BVWTJ]M9TL/"BW
M*6DTB$+,9G(B()X.V'(XZ9K&TC0-&M=,C\.:Q8>);G5TNF@:SAGNA;RH925E
M!!$03:0QY'(/&:]NHH YX^$H3X@_MC^V-;W^;YGV7[>_V?Z>7TV^U>>Z=K3Z
M5X"\1:)<Z3J?]HWES?I8Q)92,+GS'<*0P7 Y/.2.!GH17L=% 'D4ULVEZKI>
MC^*&UHZ5::);0VD6F_:/+GN5&V0,8>2W"X!.,&JFA1:=:>%M4TCQ%X>U46Z:
MY+/(JQS/)9HX+12AURS8QM+*21GG@\^T44 >+75A?ZGH0F\S7M2T#2];AGMI
MI1*EZ]MY160J0%D8*SD@XR0#UJ;4] T[7/"OB9_#%AK5S<?984CNM0EG;[3L
ME$IBC68[N-OIC+8%>QT4 >8ZIXA3Q5XE\&R:7IVHM;VVH&2ZEFLY(A QB<!#
MN R>N2,@8'/(KTZBB@#S73]1D^'>O:Y9ZK87SZ-J%])J%G?VML\ZHTF"\3A
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M9KQ[BRDB$#>6XVG<!GJ<L.!QSR*[+QEHQ\0>#=6TM!F6>V;RL=I!\R'_ +Z
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M0H[I+"TB>"!]0(2W7S!^_ "X+=]OZUZIKNISZ3I;W-KIUQJ-P72.*V@'+,S
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M HHHH **** "BLGPSKT7B?P[::Q!"\,5R&*QN02,,5YQ]*UJ "BBB@ HHHH
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M* "BD8D*2!D@=/6J.CWUSJ6F175YILVG3N6W6T[*S)@D#)4D<CG\: +]%%%
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MRML&82QZ+Z_C0!E7ND+X;\5^$+ZTO+U[O4+I[>_>6Y=UN086;+*3M&&7(
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MI?YW7,@&]/D5$Q_N!%Q]*FO/A]:7?PW;P:;Z987 +W6P%V;S?-9B.F2V?SH
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M4-%:XCNIM5@L;MVN'?[7'*"&+@DAFR P/;% 'H-EJEGJ%Q>P6LPDDLIO(N
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M=NY74C<,G##U-=310!4TO3X])TNVL(IIYD@0()+B0O(_NS'J35NBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MN%5VVKG#A?O;#C#XP?NDT =#17)>&/B'HOB6+5)(YXX$L)I0S2,0#"AP)22
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M>[.[:BYP^W[VQB,-COM)IOC3Q9:>"_#-QK%TGF%/EAAR5\V0@D+G!QT/..U
M'045PEYX_LX?$VD.NI0KH-U87$SR,A&Z1)$1<9&[.21@#FM.^\5:9J7@Z^U;
M2/$-M:0PG8U^\)D%NP(R&C.#GG&#CJ#0!U%%8-WXLT71+&U;5M8@1I;7SQ*R
ME1*HV@N /4L..O(%-O?''AK3S:"ZU:&,W<*W$(*L28CT<@#Y5]VP* .@HKF?
M FMW>O\ AZ6]O)4ED%[<PJR* "B2LJ]/8#FI-2\=>&-(GF@OM7ABF@?RY8]K
M,R$ ,<@ G&&7GISUH Z*BL?4?%6AZ5IUMJ%YJ4*6MUC[.Z9?SLC(V!02W'/
MH'BK0CI-KJHU2W^P74JP0SY^5I&. OL<@CG&,<T ;%%<+J'Q8\,6EQI*07J7
M,-_,Z-,H<")%5LO]WYOF4+@>N:ZS3-8T_68YY-/NDG6"9H)=N04D7JI!Z$9%
M %ZBJ>FZK8ZO!)/I]REQ%'*T+.F<!U.&'O@U<H **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MDB22"2+S5'4H74!Q_NYKC?&OA4Z)\./$ET][=:GJ%Z]O+?W<P4-)%'(F5"J
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M4+UX?/6WMI)3%_ST"J3M_'&*\K2XO/[2^'DEYJVFM'<7*S0:?86@BCMD:W?
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M@EN0>!D\$]*\_P#%&HW=]IWCN:&^TW2;.U,EE+"+,/<7S^0N"[%A][<%7@G
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M=/73X[6%;)8_*%N(QY83&-NWIC'&*Y>#Q]9W/CJ_\,K%.&MH5VR_9I>927W
MG;@* HPQ.#DX)K)\&_$O39_#&B?VYJ,CZC=*J37'V5_*$K'Y59U78K'CC(H
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M]N]O#X?TU(7E69D6V0 NOW6Z=1DX],FI=9\3:1X?EMHM3N_(DN@_D*(V<R%
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M;1CCCCBL'0/B!I^N>(=:TP)+"EA( DLEO*BLH0,Y=F4!,$D $@D#-6M.\?\
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M^C:7=:C#J-QIUI->P#$5Q)"K2(/0,1D=3^=._LK3O[-&F_V?:_8  !:^2OE
M Y'RXQUYZ=: /,S%?)XQ\;(_BBTT>-I8II8[JS27S(# H#!F8?*,,N!T(/K7
M:Z'I$:?#NSTBVOFNH6TX00W31E"Z%,*VT\C@CBM+4= T?5YHIM2TJQO)8?\
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M%XXVM(RJ,3DD#'&>] ' >'=:BO?''AO6+^"WL(;[0)H;95(6(3K."XC)_O*
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M3S[UTG_"$^%/^A8T7_P B_\ B:TH=+T^VEAE@L;:*2"'R(G2%5,<?]Q2!PO
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M!_E;^ XR#QD=#7))X@:\U/P7JFJR64<=MK%]:2WL'R6\[>4Z+(I)X#'WZ@T
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MWOPB(1B5QE/+7!",1EL'!SG@&G>(;S6;K0_$OAP:O:>(3_8K74-];1*LR*'
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M(!6[F/)1^/ECR< #'%6X[JUU#QIKVCQ:WJ:W:V<>^V7"QVP8##QMC.[G/.:
M.BOM-L-4@$&H65M=P@[A'<1+(N?7!!I)M*TZXT\:?/86LMDH %N\*M& .GRD
M8K!\#:W>:IIMW8ZJRMJVDW365VZC E*X*R =@RD'ZYJSX@\9:3X;O+>TOS<-
M<W,;R0100M(TNTJ-J@<ELL,#_"@#8MM/LK/'V6TMX,((QY487"C.%X'09/'O
M45GH^F:?-+-9:=:6TLW^M>&!49_]X@<_C6'?>/=*T]TC>VU.646R75Q'!9/(
MUI&PR#,!]P\'CKP>*LZGXRTG38K!D^TW\M_'YMK!80-/)+'@$N /X<$<GUH
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M5)+'IUKT5X(9)8Y7B1I(\['902N>N#VJ)-/LH[Q[Q+2W6Z<8:98P'8>[8R:
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M_#_PEXPLD,U_H=G!</MY::V:)1.G_?.6^JUV7A=&GL9M8E0K-JLOVK##!6+
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M_*@#T73?'>G7FJ6.F/:ZC UZI^R75Q;%(;HJNX[&SGIDC(&1TI9/B!I$>H/
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MSVZ9JSJ/CNTL]1O;.UTG5=3-@!]MEL85=("1NVDLPW-CDA<D4 ;^GZ=#96T
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M#31;-<'<H#@+G*XSC=D$8SUK5TZ]74=-M;Y(I8DN(EE6.8 .H89 8 G!Y]:
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MASHMI>Q-#<"%G:)Q@H'=G"D=B P&*Y;PQI\^H_"GQA8V:9N;J[U..,#JSDL
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M N8(]C$8+ A=S!5W$<9K7\+^'4\-Z2UL;E[NZGF>YN[IU"M/,YRS8'3L .P
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ML:3PRN@:K-X8MSXKUR_U"!TG73&:(BTDC0AO-41AD5>5Y/.1C->NJB( $55
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M'_3TM>SI&D2[8T5%SG"C%+M&,8&/2@#B-;_Y*WX?_P"P5>_SCKSZS\0:7=?
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MS# (Y]*I_$%2UQX0PI./$-N3QT^22L?Q9IUSJOCS5K&U4^==>#[B",] 7:7
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M)JVH>*O"$NKP:-=1Z?I^JVUW;JZGSKNWC=2[^61D#J1W('059N-:T_QCX_\
M"KZ!<"]@TQKBYO+B)3LA5HBBH21]YB?N]>#0!8'Q6TTZ6FL#1]6&CB;R;B^,
M:!+=M^SYAOR1G&2H(&1WR*UM-\;0WOB"WTBXTG4M/>\A>:REND0+<JF-V &)
M4X(.& ..N.E>>M$W_#--W'Y9W&27Y<<G_337:^)%)^)_@=@I("ZADXZ?NEH
MK)\5;"72O[7CT36&TF*0QW5Z(DV6Y#;3D;]S <$E00 ?7(&OK'C)--OWM+/1
M]1U5X;=;JX:R5-L49S@Y9EW$[20HR>*\RTOQ-ID7P4OO#[%O[7NEO+:ULQ&2
M]RTDL@5D&/F&6Y(Z%36Q>W;P:U=:%K6LZI:/:6%K%IEAI\C1&]<QX<@J,N=X
MV]< #)]: .QO/'VF6YT5;:UO;]]:MFN+%+:-29 H4[3N(P</GG@ ')&*K?\
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M-\W=MW8Q]W'S;NF.] 'H&H>.8;77[S0K+1]2U+4;:*.9H[94"E'!.[<S #&
M.>22,9YQE:_XRT+4?!FG:S*VL0VTVHQV_EVC^3/',&92DGS#@$'(R<\=:S;#
M7--\*_$WQ NL7*V\/]FV$?VN0'8&57^4MV+<D9Z[37*ZW!-)\-4O_(E2+4_%
MQOK='0AO)>1MI(ZC(&?QH ]4U'QK%::_=:%::1J.HZE;PQSF*W5 &1L\[F8
M8Q@Y]1C/.,;7_&6B:CX%LM:G_MFWM9;](#':/Y-Q',&*E'^8< @Y&>:O:0A_
MX6YXE<J<?V=9 ''O+7G&OQ2'X6SJ$;/_  ETIQCMY[T >KZOXN33]9&CV&E7
MVK:B(1<2PVFP"&,G +,[* 20<#J<53E^(VC1:#8ZN8;TQW5]_9Y@$/[Z&?YL
MHZ9Z@J1@9Y(QUK+?5;+PA\3=?O-=G%G9ZM:VKVMU*#Y9:(.KQ[N@;Y@<=\US
M<%O-)9Z7J;6\L=OJ?CH7ULLB%6\EE8*Q!Y&=N>?44 >B:)XN35M;N-&NM*O]
M+U"& 7*PW80^9$6V[E*,PX/!':M+7=;LO#NCSZI?LX@AP-L:[G=B0%51W))
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M]"M((9F4E99(BP=00.6Y!QUYK%L#)<:+I$S6\L1D\>O*8Y$PR O(>1V(H ]
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M3=CKVK;KEO$/C6+0M=MM%CTN\O\ 4+NW:>WBM]O[PJP!7+$ <$MD\8!J*_\
M'$EK=7-O:>']0OVL(4FU'R&C'V7<N[9\S#>X7G"^WK0!UU4=7@U*YTYXM)OH
M;*[)&V>6W\Y5'?Y=PR?QK%O_ !K C:;!HUA<:S>:C;?;((+=D3$''[QF<@*/
MF '<FJY^(5BVD6ES!IU]+J%W=/91:9M59_/3.]6R=H"@9+9QC% &QX9\/P^&
MM'6QCFDN)7D>>YN9?OSS.<N[>Y/Y  5L5Q4_Q%BL=/U>34=%O[6_TF..>YL2
MR.QA<X$B,K%64<YYXP:V=>\46>AZ98WGER77V^XAMK6.'&97D/RXSVQD_04
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M031RXRP*AD<8_A8=/I2^&_$4'B;3Y[ZT@ECMDN9;>*23&)@C;2ZX_A)!Q]*
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MF5I%\A &"D9Y SZ\\U[/10!Y+>W,>BR_"K5=066&QM+.6.XF\IF$3/:JJA@
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M#OF21-J1ER=R]QC!7MD=:Y+Q/I.HW=[\0)+2RGG=+G2[J*-4.9UB5&<+_>.
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M\-^0KLI*J1*V%+=,XQWK&OM(NE\>W'@5(6.C:I?QZZY_A6%<F6,^@:5$P/\
M:H ]8L;TW6D6]_<0FT,L"S/%(W,61D@GU'>N5L/B!)>R6%TWAZ^BT34)Q!::
MB71MQ8D*S1@[D1L<,?49QFNJU2T:_P!(O;-&VM<0/$&]"RD9_6N"\)>+GL-
M\/\ AE-'OY-<MUBLKNV>!XUMU0;6F:0KM*X&1@\Y % &M>^.Y[&ZGEE\/7JZ
M+;W8LY=1=U7#%@FX1GYBFX@;OQ -;>FZ_%J6OZUI*0.CZ4\*/(2")/,C#C'I
MC.*\?UTOJ?A[5?MT>OWGB>*^=YK8-<"WM8$GR"J#$;+Y8&.&))SVR.ML-?M=
M"\>>);BZM[YH]82SN=.,5G(_VD"$*5&%X;(Z-C&>: -6#X@G4-*T>?2]%N+N
M]U7SVAM/.2/:D+[79G;@<XP/>K<_C-X=+L'&AWW]K7T[VT.F2;4?>F=Y+$[=
M@"D[QD$$8ZUP>D6^EP?#OPS!XGL=5L7C:Z>+4;19%DLI?.;Y<Q@LNX'C(VG;
M]*+FVO[[3O#>L:Y-K4NF6-[>0&\B$D-W]F<8AF<1@/CY0#P.""1S0!Z9X>\0
M?VV+R">REL-0L91#=6LK*Q0E0RD,O#*000?K5?6_$>H6&IC3]+\/7>JS+!]H
ME9)%AC1<D !FX9S@_*/ZU0\"6ND*=4O])BU8QW$J(;O4I)&-R$7AD\P[MHW%
M<D#..*Q?$DZ2^.;VTUQM;:T%I#_9-II[SQI<R$MYF6BQ\P.T?,0 #GWH V9_
MB':F'P\^GZ;=WSZ]#)):11E58,@4E6R<#[QR<X&T]:T?#7B=]=NM3L+O39=-
MU+39$2XMWD608==R,K+P01G\J\^\&P7'VGX=1-:W"2:?%J-O=!XF7R9-J\$D
M=\\'O78^'H)H_B7XSF>)UBECL/+<J0KXC?.#WQ0!H:]XH;2]4L](T_39M3U6
MZC>9;>.18U2)2 7=VX R0!UR:Y;Q/\1+^#P%KE_IVFS6>L:9*+:ZAF>-C:,P
M&V3N)%.5QCKGIP:O:]./#OQ,M/$=]%.=*N-*;3WN(H6D$$@E$B[@H) 8$C..
MHKD_$%A?:[X2^(VMV=C=>1JK6PLHWA99)8X @:0(1G!Y(R,X% &YJFNZK#X^
M\.3/HUU]MGTV[4::DZ-EMZ8+.#L V@G/;IUXK<MO']N-#UB^U+3KFQN])G%O
M<V6Y9',C;?+"$<-NWJ!TZU0@OH=<^(WAW5K!)WLCI=VOFO \>&WQC!# $'@_
M7%8&OZ)?:@WCTPVEVY74["Z1(=RO,D:1%Q&1SNP&QCG(]: .SL_&,_VF[LM7
MT2?3+Z&R>^BB:9)5FB7AL,O 8$@$'U'6LJS^)S76FV&L-X=O(=&O)K>!;V29
M  TC;2=OWMJL<9XSVK.TVU\/W]QJ%UHP\0WTT&ESJ+N_EN'CC+C!B E.2YP#
MP.,<]JN:?H$VK? 6UT=HGCNGTE?+1E*LLRC<G'8[@* .@NO&5I:^.[/PJUO*
MTUS#YGV@$;$8ARJ'W(C<_A7.>,O&.D2Z1K$=_IEW<66F:E!:,\%R8C),0&."
MI!PNX CO6';C4=3\*7WCF>PN4U%=6M;V.V,1$AA@"Q,H7KR&G/XU5\1Z/?GX
M(V\CV<[:EJ6IIJ5S$L9+AI92_(ZC"E1^% 'HFK>+[JTU>\L-+\/W>JFPB26\
M:&5$,8<$JJJQR[8!.![<YHO_ !A.NH+8:-H5WJETEJEW<)YBP>0CYV*V_P#C
M.#\OMSBN<\;R:/'KEY,QUS1]?BMU%G>Z?'(PO>"53"!E?#<%6 /X<UE7%HMG
MXDEU/QA+K5BVIZ;9R"73);A$^T(A66)A#_%D@C/J<4 >IZ)J]KK^BVFJV>_R
M+E-ZAQAE[%2.Q!!!]Q5^L/P?96MAX4L(+.RO+* JTBV]XQ:9-[%SO)).<L3R
M<\UN4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 445QOQ,\0:MX<\+"ZTB -,]S#$9?,4>6&D4="#G
M=ROMG- '945RU[XCU^&2UM;3PI+<WTEN;B=6NUCAA&[ 02[2&<]< =.3BH1X
M^MO[*T'5VL94TK5)/)EN78#['(3M42#T+@KNS@''K0!U]%8>C^(UUO6]4L[2
MU9K+3W$#7I?Y9)OXD48YV]"<]>*=XH\11^&M)2[-M)=W$T\=M;6T9 ::9SA5
MR>!ZY] : '>*= 3Q/X;N]&DN&MUN=F957<5VN&Z?\!K8KCK7QK??\)+%H.J:
M UC>/9RWA9;H2Q[$( VL%&<DD'.,8[Y!J1_',2?#NU\7?8',=PL+"V\P97S)
M%3[V.V[/3M0!UM%<GKWBW5-*N[\67AFYO;/3H1-=7+3"$$;2Q$08?O"%'.".
M>.M<]KM^E]\7?AU=6TC&VNK:\E7MN4P9&1^- 'IM%>?:9K4 U/QP=!T)SJ=E
M<1K<%[P@7+$'YANR$P,G ZUP?A2:WM/@WJ/B'7M FOHKB+=<W3:D_F7I^T;0
M,#E-IQSWQ[T >^T5R=SXHFMI-,TK0]&:_O9K%;LP-<B)((.%!9R#DD\ 8YP>
ME5Y/B"DFEZ6]AI4]QJVHW,EI'ISRK&T<L6?-#OR %VGD9SD<<T =I17GOAC4
M;O4/BKKOVVRDL;B+3+5)+=I!(H;?(<JPX8$$<X'H1Q7<ZC=C3],N[TH7%O"\
MNP'&[:I.,_A0!0.@(?&2^(OM#;QIYL?)V\8,@?=G\,8K8KA=/^(LEWX9E\27
M&@W%MI/V>-[>3SE:2XE<A?+5."/G.T,<9Z]*LKXQU6*6[L;_ ,.FTU1+-KVU
M@^V*Z7"*0&'F #:RY&1COP30!V-%>/R^*Y+SX-6>L>+]&>^BDD@QY=WY9N"6
MX?Y -F#_  ]Z['7?&MUIOBI/#>G:%+J>H2V0O(E6X6)2-Y4[F884#&<]R0,<
MT =?17&:CXYO+>?4VL/#\U_8:2=NH7*W*H48*'=8U(_>%5(SR/09IUYXYE;Q
M FC:+H[ZG<2Z='J,+BX$4;1NS#+,0<=!ZD[AQU- '8T5YR/BA=R>'I];A\*W
M36=@[1ZD7ND5K=T;#J@Q^\V\'/ Y]<XW=2\678U;^S-!T9M6N4MDNIR;E8$B
M1R=@W$'+-M; XX')H ZFBN*F^(D+Q>'FT[2KF\EUQ)O(A#A&CDB W(^>!@E@
M3GC:>M4-5\>ZLGA?Q5LT4V6MZ-"#+$;E9$170LDJMC#8P3MQVQ0!Z)16-X5O
M]0U+PW8W>J6HM[F2)"1YHDW@J#OR  ,]<=JK>*O%8\,-I:#3YKV74;K[+%'"
MP#;RI*]>.2 .2,9SVH Z*BN+C\575^=;T/5=);2]3@T]KI$%P)DEA(9=RL .
MC#!&*Q/A[K5[IOP?\-/9Z9<ZK>W+/#'$C;5!\R0EI'((10!U/? H ]/HKB;C
MXABP\-:QJ>HZ3+;WFCW,5O=V8F#X\QDVLK@?,-L@/0'@BK5EXOOCXFLM'U;0
M)=-&HQR264IN5E+[ &9751\C;3GJ?K0!UE%%8_BC7T\,Z&^IO;M<*LT,7EJV
MT_O)%3.<=MV?PH V**Q]0U]-/\3:+HIMV=M46X990V!'Y2JW(QSG=7(CXH73
M^'?^$CC\,7#:-"[)=7!NE#1XDV$HF,N!QGIW'.,T >C45RNH>+;Q?$<NBZ)H
MK:I/;0)<7;FY6%8E?.Q02#N8@$XX&.]<OX.\5'3_  G)-#97%Y?:EKUW%9V;
M,$=F,C-AB?NA5!)/.,4 >BZMIRZMI-S8-<W-L)T*>=;2&.1/=6'0UA:9X0NH
MM<M-7UK7KC5[BQC>.S5X$A6+>,,Q"CYF(&,GWXJE=_$(Z9X?UV]U+1Y+?4-%
M,7VFR$X<,LA&QTD P5()[ Y4C%=#H&JWVKVLMS=Z3)IT3/FV$DRN\L9&0Y4?
M<)_NGD4 :U%8NL>(5T?6=$L9;9FBU2=[<7 ? BD"%E!&.=V"*I6/C2WOO'=_
MX76U=6M8BZW18;)7 C+H!ZJ)4S]: .GHKR?4O%\NJ^*_">I6.FSRJM]J=K;0
MI*/]*V)L#Y. JYR><X )YZ5T#^+AJ&A^++/7-#>UN=(LVDN[-;K>LT+Q,PVR
M* 1D*PZ9% '<45PMAXMMK'PEX8CT71I9KG58!]@T[[1]Q%3<Q>5L\*,<\DDB
ML?Q?XGN+SP_927FE7>GWNG^(;)+BU!\S?\X8>6PP'# \=.>#0!ZE17+:3XKO
MKGQ.=!UC0VTRYDM3=V["Y69945@K D ;6!8<<_6NIH P]>T*]U2YM+S3M<N]
M+N[8,H,:B2*16QD/&W!/'!ZBG>&_#D?AZVN@;N:]O+RX:YN[J8 -+(0!T PH
M    Z8KSGP=XRU'0OA\MW_PC]Q>:78W%S]LO!<JK*/M#DE$/+A589Y'<=J[7
M4/%]T=4?3_#^C-K$L%LES<.+E8417R44$@[G8 G' QCGF@#JZK:?I]MI=C%9
M6<?EP1 [5+%CR2223DDDDG)]:Y.7XAQ2MH*:5I5Q?RZW;2S6T?F",JT>W<KY
MX7&XY/;:<9)%+!\05BTK6IM5TJ:SU#2)HX)K*.59C(\@7R@C# .[<!T&* .T
MHKD[3Q7JLE[<:7>^'3:ZN+4W=K;B\5TN$#!6 DP K D9!'<=:\W\"2M-X6\5
M>(];T66\W1WWVF\;4&W2*,$P!1]T8!PPZ4 >Z5B_\(ZD7BW_ (2"TN&@DF@\
MB\A"Y6Y"_<8^C+R,\\'%<-<^+=3LM,\!1>&]'*6.I!"L#W8RRB)CY)9@3_=;
M?[8KHIO&FI&^ODL/#-Q?6>G3+!>30W"^8LFU681Q8R^T..XSSC- '8T45S.N
M>)=6T_4)K72_#5QJ*6T GGG:<0)@YPJ%@=[84D@8 XYYH N>'_#L>B/?W,EP
MUWJ&H3F>ZNG7:7[*H'.%5< #/KZUM5Q.H_$2.$^'DTS29]1EUZU>XLXUD6,Y
M54;:V>!PV2<\;3UJ>Y\7ZK]L:PT[PT][?VMK'<:A$+Q$6W9P2(E8@^8_!]!C
M'/- '7T51T75K;7=%L]5LRQM[J(2H&&&&>Q'J#P?I7&^.-1N-.^('@R2UM);
MR=UODCMHW"^8QC3&2> !R23T /7I0!Z!17$'XA26NE>(I=3T5[34M#B6:>S%
MP'62-@2K)(!R#@]N,4\^/;B'0O[5NO#]S%'=S0P:5")T:2^:3.WC_EGTS\W;
MGVH [2BN6TSQ;=/KC:+KFC/IE\ULUU (YQ<),BD!@I !W#(^7'>J^G>-;^?4
MM,AU3PW<:9::JS)9S2SJS[@I<+)'@&,E5)QD\\&@#L:YS6/"LFO:U:W&H:I,
M^E6TB3IIBQ*J/*O*L[?>8 \[>F0*Y+Q5XUO=5\$>)Y['0IFT5(+FT745N%W,
MX#(7$>,[ W&<Y[XJN\LH^*'P\568[M&F)4M@,?)/6@#UBBN9T?QI::EX/N_$
M%Q UF+'SUO+=V#-"\1.Y2>YXS^(K5T'4I=9T"QU.:T:T>[A6;R&?<4##(!.!
MSC% &C16%KNMZEI]W:V6E:'-J=S.KR$F7R88E7'WI"",DD87&3SZ5E6?Q!AN
M9=!6739K=-4N9[*1GD'^BW,61Y;8Z[BK $'M0!V5%<[?^+([/Q0=$CLI[EXM
M/DU"X>'YC&@.%4*!EF8@X'M532?%^H7.LV&GZQX?ETHZE"\MD[7*REM@#,KJ
M "C;3G'/0\\4 =;17C]_J>G7WPE\>R:3I\NGB"^N(IMUPTADE!3=("?N@Y'
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M)K^\GU""R6"T>1)S)(ZYW@%5P2<[B" ,]Q7M59'AO08O#>DG3X9WF0SS3[W
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M%&J(F2=H P!D]: .5U_QG?:;XLA\-Z9H9U&^N+$W<1-R(EX?:0Q*G  !.?7
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M621?EP0!UQBKOA2#4_"7@W6-9U/2[F;4-0U";4Y-.LQYLJ>:R@(,=2  3^-
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M[6WNFM9IH7CCN$&6B8@@,!W(ZUY=JW@CQ-IEOX4T^QU]KBUL]2C$8BTI?]&
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MC*YGMY8X+JYMF@D92%D"P*I*GO@@BN(T+3-7\.:7X'UF?1M0F73X[VVO;:"
MO/$)7)1Q'U(RHSCL:]CHH \BO-$UGQ9+X^D_LBYLTU*RLQ8)=KY9E,6\X/\
M=)('&<@,,XK6\*:7HC^(K.YT[P3J>G36\3O)=W_F1B!R-NQ Q/F$@MDC@ =>
M:]'HH X?X<6]]H'PGL([S3[E;RUAG=K0H1*Q\QV"@'N1C'UKK]/N7O=-M;N2
MVEMI)X4D:"48>(L 2K>XS@_2K-% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0OKG46D6WAL8E=B4 +<%AV/Z&JMGXWFN[V"V/A'Q- )9%0RS6B*B9.-S'><
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M=U':(84#!7=@HW$D8&36O7F7C&VUJU\+:?;ZIJ$%Y<KXCM?LTXCP?*,P\OS
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MG #AD8J<X)'4'O6O0!RM_P""AJ&E6MG/J]V\T5['?2W3JADFE0@KD8"A1@#
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M[JQM--E#E(R#]H7G*N2/XB23CO\ IOT4 %%%% !1110 4444 %%%% !1110
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M)<;1@$AE.&QQD<_SJ_<>%P[RBUU&YM;::S2R>V"HZ;%W $;@2&PQ&<D'C(-
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MH! +>0LZ')15^3Y02.V*U+WP1;W^E6EE-JFH%X+Q+Y[DLC233(05+$J1@8'
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MZ<5?N/"%K=:_J&K3WETYO['[!-;_ ""/RN>!A=P/S'G/>@#E=,US58_$?A"
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MX/B/]GQWFHW-Y;:?<BZMHYE3*R#.W+  E5W' ]ADF@#I**** "BBB@ HHHH
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MSN)],#N** /'/&WB/7=)\?:5?V\UY;V5CH\6H7^F^:65D,XCD# '#,JOG/\
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M9+EKBTLW2.%"['YXR1@<\<Y^E &SXEG;PYX@T#Q):LZ6E[-%IFH0EB59)/\
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MWS@ Y';- 'H,8=8D$C!W"@,P& 3W..U<A;_#^WCT[3],GOY9]/M;Z6_DMS&
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M'R!@/4X) /6N)\%>)O\ A%_#7BC5)[9[BU7Q9-%<.),>1&QC4R=#D D<<=:
M/9**P];\1KI.K:)ID5J;JZU6X,2*'V^7&J[GD/!R%&..^>M;E !16;X@UJV\
M.^'[_6+L_N;2%I2,XW$=%'N3@?C7G/@NZU_P[XFTN+Q)?W-PGBBS:X43R%EM
MKL$N8E!^Z/+<#'JM 'K%%8%OXHA?Q!KNE7,!M_[*BBN/-9\B6)U)+ 8XP5(/
M7I6)8?$JWO/A[J'BN739;<V1*M9M("S,0I0;L?Q"1.W>@#KM5M;N]TV6WL=0
M?3[A\;;E(ED*<\X5N#D9'XU#H&B6OAW1H--M&D=(]S-+*=SRNQ+,['N222:Y
M[5_&>LZ8M]<IX4GEL-.A66]G>Y$9QL#OY2E?W@4=3E02"!2ZSXZFL]?LM%TK
M19-3N[ZQ^V6V)Q$I&X##$CY1MR<_08R: .RHKCY/&.IS:W>Z=I?AUKX::D9O
MY/M:ILD==WEQ@C]XP'NH[9KG/ WB:73OASX9M;"Q;4=3U*2Z^SP-+Y2[$F=G
M=W(.T $=B<D"@#U.BN*E^((MM%N);C2)4UF&_33?[,6927N' *!9,8VE2&W8
MZ9XXK,M=2U*\^+^E0ZIIG]GW,>D7),:3B:-U,D>"K #/0@@@$?B* /2***XO
MQQJ.HRZIH/A?2KQ[&?6993->1XWPP1+N?9Z,<@ ]J .THKAW\ W.F2VUYX<\
M0:I!>12J94O[R2YAN4S\P=6)YQG!&.?TMWOBW4I-=O\ 2O#^@_VH^G*GVN62
M[6W179=PC7*G<V,$] ,CF@#K:*X>3XD02:?X>NK#2KBZ;6I98(X-X1XI4!RK
M9X^\I!.>!SS4=MXZUV[U#4-&A\)$ZW8;7F@^WJ(?+9<JPEV\D\@+M[')% '>
M45PK_$J)O#WAW5;72+BX;6YS;1VRR /'* PVDG@C<A&>,#FK%MX\:UN=6M/$
M>EG2KK3K+^T"J7 G26WY!96 7D$8P1U(H [*BN2TOQ=J$VK:?9:SH#:6-31W
MLI/M2S;BJ[BC@ ;&VY..1P1GBL6/XH7LGAJ/Q,/#$HT-7VW-P;Q0Z?/L+(FW
MYU!ZG*]_3- 'H]%<CJ/B_4HM8U*RTCP[)J<>EB,WCK=+&^63>%C0@[SM(/49
M/ J36?$^L6EU-'I7AB>^AM[9;F>::;[.N#D[$RIWN #D< < GF@#JJKVUC;V
MDUU-#'MDNI?-F8L26;:J@\]/E51@<<5P&J>-M9G\3^#UT/3Q/IVKVTMTJO<+
M&9QY0;:V5.W;N!]SQVJ[IFO:):^-?&['3C:3:;#!-?WIF9Q.GE%@=G1=J@CC
MK0!W5%<-;^/M02/3+_5/#;V.C:G+'%!=?:U>2,R?ZLR1@#:&R.C'&>:=-XYU
M2:]UNUT?PRU\^CSF.=GO%B5EV!AM)4Y8Y/R]L#)Y% ';T5SUIXEFU32="U/2
M]+ENK75"C2MYBH;5&7)9@?O8/&!70T %%8/C77V\+^#M3UB- \UO%^Y4]#(Q
M"IGVW,*Y#7+/3/!O@C0H-9T]]6GGU2 SR&X:-FNWW%IBPZX.>.F,#M0!Z;17
M%S7NDR_%W^R9=)WZB^B&1KUIB5,)E(,1CZ'GG/X4SP//+I>M:]X/ED>2'2Y(
MYK!G.3]FE!*ID\G80RY],4 =O117*ZMXJU*#7+K2M%T$ZI+96Z7%T3=K#M#E
MMJH"#N8[#Z#IS0!U5%<G>>+KY]0@T[1-!DO;XV:7MQ%<SBV^SH^0JL2&^<D-
M\N.,<FHV\>+=:9HTFD:9+=ZCJQD6&SEE$7E&+B7S'P<!",< Y)&.M '845Y9
MXS\0OK7@TI/:/8:A8ZY:6UW;&0/L;S$8$,,;E*L"#@=>E=I;>)UU'Q3/H^FV
MAN8+,$7U]YFV.&3M$O!WOW(&-O<YXH WZ*\P\/\ C;2-'^'QUC3=!FM[0ZL;
M5K5+@RL6:0*7!89/7.W\*Z*P\87H\1C1M=T3^RWEM7N[>47:S*Z(0'#8 VL
M0>X]Z .MHKSF?XH7MOX=7Q')X7G&C3NJVD_VI=[AG"JSIM^0'J#ENPXSFO1J
M "BLCQ3KH\,^&-0UIK<W LXO,,0?;NY QG!QUK#/C>_CTJ*]E\.RI)?W$<&D
MVYN5WW>\%@S<?N@%!8YR0/?B@#LZ*XT^/5L-/UF37=,>QOM)6-Y;6*43"99#
MB,QM@9W,"O(&#4MIXOU"WNI8?$F@2:3&MI)>+<).+B+8G+JS*HVL <XY!YP:
M .MHKA8/']^MOINIZEX;DLM#U&6..&[-VKR1B0XC:2,#Y0<CHQQGFMO0/$\>
MM'6(Y[?[%/I5X]M/&\F[Y0 5DS@?*RG(H WZ*X6R^(5SJVG:5)I>@O/?:IYT
MMM;27(C46\;;?.=]IV@Y7 P>HIUY\1XM/\,G5KG2ITG@U)=-O+,2!FAD) )!
M ^<8(88QD$=* .XHKD;+QAJ"Z_I>DZYH)TN34TF:W;[6LPW1X.QL# )4YZ]L
M5I6_B,7?C.]\/P6I=;*UCGN+K?PCN3MCVXZE06SF@#<K%\.^'H_#4-U:6EP[
M:?).TUO;,O%MNY9%/]W=D@=LFMJN1O/%^IS:UJ.G>'] _M3^S=JW<LEVL"B1
MEW>6F5.YL$9Z 9QF@#4E\.Q77BN#7;NX>9K2%HK.W*X2!F^^_NQ&!GL/K6U7
MC?Q)\4W7B'P-X?N=*M)?[+U6_@CF)N?*=FW,&MV &1RO+9XQ7I_ARS&GZ!:V
MHTU--$88?9(YO.6/+$\/WSG/XT :M%17,XMK6:<I)((D9RD2EF; SA0.I]!7
M*Z5XPU*?6--L=8\//I:ZI&[V3FY$C$JN\I(NT;&VY..>A% '7UE^(]%3Q%X<
MU#1Y)FA2\A:(R*,E<]\5QO\ PLZ_?P[+XAA\+ROI-K(Z7<IO%#J$D*,T:[?G
M  !/*]QSC-=/IOB>._\ %6IZ#);&":TABN89"^1<PN/O@8&,,-I]Z -N"(06
M\<(.0B!<^N!BI*P_#OB,>(IM6,-J8[6QO7LXYR^?/9,;V QP 3CJ<X-;E !1
M7GUU\2KJ+2-3UZW\-S7&@632QK>+=*'F9"5W"/&0A<8W9R.N.#6Q>^)]8+VD
M>C>&I;]IK-;R222X$$2!NB*Y4AGZ\<8&">M '4URVK>$]0O=3N[O3_%&I:;'
M>HJ7$"*DJ\#&8]X/EG'7'?GK6)K'BK1-4MO ^ISZ3)=#4]0B%H6F,;6LIXW$
M#AL'(QTXK1N/&FJ3:YK.D:+X;:_N-*=!*SW:PHP>,.,$J?F.2,>V21D4 =-H
M^E6FA:/::78H4M;6(11@G)P.Y/<GJ:NUE^&]=@\3>'+'6;9'CBNX@X1^J'H0
M?H016I0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !7%_$^SN;[PQ:Q6MM+<2#4[1RD2%R%$H).!V Z
MUVE% 'GWQ!T>"?Q#H.L:A::A<Z5;QSV]U]@:420[]A1\1$.5RA!QGJ.*Y?Q9
MH=O<_"/Q!_PCOA_5H6N[R$HEP9I9[I4=!YFQR748! !P<+G%>TT4 <9%9W(^
M+T=X;>7[,/#OE>=L.S?]H!V[NF<<XZUBVNFWR^ /B);FRN!-<WVIM!&8FW2A
ME^4J,98'MCK7II( R3@4F]< [A@].>M 'EMM/=:!XST+4KK2]0>P3PO':W$T
M-J\A@?S%."J@DGY<$ $C.<8!K.O=/U._T?7O$T6E7OEW&OVE_#:&$B>2W@**
M7$9YR<,0#S@5[)10!YY!J,OB#XH:)J5IINH)ID.GW4?VJXM7A#.3&<88 CH,
M$@9YQG!J+P5:SZ;\$;:VU#0KB\=8YQ/IKQ[9)$:=\C:W4[3D#OQCK7I%)D$D
M9&1U% 'C,FB3:QIFOZ/X576CH<VEDI;ZDLJ(ETLBLD<1E 8 J&![#CFMSPQ8
M>'+KQ%87&G>'_$"7=M%)))/J,MT$M'*[2F)FP[$,1\N?6O2Z* /($TG4?^&?
M--T_^S[K[:LEN6MO);S!B[5CE<9Z<_2NG\3:7<ZC\0=$\N&7[.VF7\,DZH2D
M9<(!D] 3SCZ5W%% 'C?A?0M$2+0M*O/#>OR:Y:21+<K)/="V@:+GSMQ;RBN5
M!4+G.0 *Z;0;&[BT#QW'):SH]QJE\\*M&095:-0I4=P>Q'6N^HH \BA2ZT.7
MX9:E=Z;J#6]GI4EM<^3:O(\,C0QA0R*"PY!'3M7KM(2!C) STI: .2^(>G7E
M[H5E=6%M)=3Z9J5MJ'V:,9>58WRRJ.YP20.^*S!>-XO^('AV_P!/LK^.PT=+
MF6XN+NTD@!>2/RUC4. 6(R2<# P.:] HH X'X96-W97'C$W=K/ )_$-S+$98
MROF(<89<]0?4<5WU%% 'FWC0PV?Q(T34;_1;S4=.CT^XB?[/8-<A7++MR #C
MH:V?#WB#0KK5DMM.\-ZC83RJP\Z71WMTP!G!<J .GYXKL** /+?#^F7\/[.]
MUITEC<I?-I]\HMFB82%F>7 VXSDY&/7-7]<TK4)/AUX6GMK*:>YT>6POI+-%
M_>.L2@.@4_Q $\>V*]#I 0PRI!'J* .!2[;Q?\0= U'3[*^CT_1X;F2>XN[6
M2 -)*@18U#@$D<DX&.G-80TK4?\ AG!]-^P77V[R&'V;R6\W/V@G[N,].:]<
MHH \FUG1],T_QOKMYKVFZY<0Z@(9K*73&N2'98PC1,(6 #94$;NQZ\5:M[-?
M!OB/1-:71;ZVT:31?L$D$*/=26+^9YH#[=S$'<PR,\BO3Z* /'M6TO5-8T;Q
MCXBM]+O M]?6,UK:/$5GEAMBFY]AY!;#$ \X'3I6U/JLWB+XA^&=1T[2=1-A
M:6]Z&GN+5X TC1KA?G (Z8R1@D\9P:]'HH \HT%((O%.DMX7T[7=*:69CK&F
MW$,JV<*%&)/SC8&W[=OEGGGC%6? 'AR2\\,^--)U>SG@AU#6KP 31E"T;J@#
MKGJ/0CTKTZJ&L6%UJ6G-;6>J3Z;*Q'^D0(C.!W W@@9]>M 'G?PQBU+6-6FU
M+64_?:!;_P!A1$G(>5&_>R#W($8S]:]3K-T'0[+PYHT&F6 ?R8LDO(VYY&)R
MSL>[$DDFM*@#S[X@Z9>^+=:T7PE&EW#I<K&]U&\B3"JB?<0,05W%N<'T!Q5'
MQA\.K]]!>_L/$FOW^J:8PO;&&[FCD0RQ\@86,')&0.>IKTX,"2 02.H]*6@#
MR+QI'J^JC2M7TK2[U)O$&F'2+R/R6W6HD="&<8RH4&49-3:WX?O1\0;?0[2P
MG.AZE/97UQ,L9,,?V97#(QZ MY<%>KT4 >->);&759O%UGJ.EZU?ZW*TJ:4B
M><+9+<Q#8RE2(^#N)!Y)XP<UN:#%<7?C[P[J*V5W':KX9:%I)K=X]D@E0%&W
M 8;@\=QR.*])HH \ZLM1E\(>,/$\-WI>I7"ZG<QWEA):VKRK,3&JF/<HPA#+
M_$0,'-<GI_AR6'PKX+OM>TO4S:V7VZ"^AM/.2: RRED?;&0Y7*\X[,#7N-%
M'D-WHUM%HEKKN@>'M6CALM>M[Z5+AI9+B[AC4H9%20EQ@.< X)"YQ6U9ZA-K
M_P 5M-U.UTW4(]+BTJXA6ZN;5X0\A="1A@"!C&"<9YQTKT2D#!NA!^E "UQ?
MCK3=334="\3Z1:-?7.C32>;9H0'F@E7:^S/5A@$#O7:44 <-)X[OM7:"R\,Z
M!J37TDBB674K*2""V3(W%R<9.,X"D\U5M=0;P7XM\3?VCI^HRVNIW"7EG/:6
M<EP)#Y85HSL!VL"O&< @]:]#HH \ET7P_JMA)X$>[L9DF.I7UY=(J%A;"5)&
M4.1P/O <]^*ZK0[2YB^)WBVZDMY4MYK>Q$4K(0KE5DW!3T.,C..F:["B@#Q&
MV%YHGA7X>F?3KHW$&M7+O;>41+M)G)PIY)VG('?C'6M/6].N_'^K>(;W2[2[
MBM1X?;3K>2[MWMS/.TGF84. <#: 21U->BZOH,.KZAI%Y+-)&VF7)N8U4##D
MHR8/MAJUJ /,?"]AX=NO$&ERV7A[Q E[;*TLTM_-=".R?9MV_O6VNQW$?+GC
MFJ/]E:C_ ,,XSZ=]@NOMQ@D MO);S23<$_=QGIS7KE% 'EOC1+%M4OY8]+U^
MP\21PJNGW^EQ2L+P[,J&* H0&^4A^PZX-5M3M[N_U[4K;Q)IVK7U[):6Z:5!
M;&9;7>8AYI+(0BXEW9+GA0,5ZT6"C)('UI: /&K":XTV/X::G<:7JGV?2[2Y
ML[T)8RM)#*8D0 H%W8)4X(&*N#PYJ.J^*_BE;+;30IJ=E;PVDTD96.1O(8<,
M>#@X!QTKUFB@#RJ_O[GQ5X8T3PO;Z1J<&I+/:?;A/9R1QVJQ,K.WF$;6^[\N
MTG.:Z'PQ9W4&H>-VEMIHUN-29X2Z$>8OD1C*^HR",BNTHH X+P=JG_"-> ?!
M]CJ-A?+/=B.SVB''DN<D>9D@J.*[VJ]S8VUY);27$0D:VE\Z+).%?!7.._#'
MK5B@#BOBU;RS_#75'A0NUN8KDJ.ZQRJ[?^.@G\*S_BG#/K?ACP]-I=O->(VL
M6EP#!&7_ '>&.\XZ#!'/O7H4L4<T3Q2HKQNI5E89# \$$5F>'=#3PYI*Z9!<
MS36L3M]G67DPQDY$>>X7H,\XP.U '*-87G_"_4O_ +)/]B_X1[ROM'EGR]_G
M$[=W3..<5/H7^F_%[Q3>Q<PVEG:V3,.C2?,Y'U (S]:[>3+QND<@23:0&QG:
M>QQ69X=\/VWAS2_L=O))-))(T]Q<2D&2>5CEG;'<_H !0!K5YQXX329=:D:^
MTS7;74XK<"PU72(Y6>7.3Y>8P1D-_"_'/O7H]% 'CL^D&#6[;5O&EAJ\S7^D
M6JR3::;C]W=1A@Z.MN<\[@02,9!QBI-1\,Z?;VWA74Y- UBUT6 72W5I#/.]
MS;F8AUD;RV\PY*G<,G&[D<5Z]10!XWKF@6M[X#N_^$?T36;-;O5[7]Y,TSW$
MR(RCS@)"S( ,XSCA<XKIO"]A>>!_$+^&A!<W.@7I>XT^[V%S;R=9(I6 [GYE
M8]<D9)KOJ* /$-!T;5(OA=:VLFFWB7 \313&)H&#B,3J2^,9VXYSTKM_$^EW
M6H^/M'$4,OD-I5_ \X0E(V<1A<GH">?RKN*.HH \/UO5[N+X+P^')]%U&WOK
M%;6VO&GMF2*,1S( RR'Y7W$+C:2?FST%>X5Q2_#N,F&UNO$&JW6C07 N8]-G
M=&3<&W*&?;O90W(4MV%=J"",@Y% '*?$RUN+WX;Z[;6L$L\\EL0D42%F8Y'
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MNQ+M2VC8?NP>#EVY^7C &:S;7Q]?3166KRZ(L?AN]N5MX+S[5F8!WV)(T>W
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MG<JD,#CL0<UD:=\1]1G\&3^+K[0X[?2%M0\"K<%IIYBP0*!MP%+$@'KQG'-
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MF08D)Z;?7\*<MS UPUNLT9G0;FC##<!ZD=: /.+K1-3?X,:!IBV,YOH/[/\
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MRPVT(PHX4$DEC@ 8Z5Q']BZ[)\%-;\(G0K]=2MY&V$JOEW :Z\P>6=W.%Y/
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MQZ_I6GZ_IVGVZZLDA@6UN&>2W=$WE)00 3MSR.XK(/Q \2R^%KOQ+;Z+I_\
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M'R7F90ZOOQD1[#NZ9X(K(US3+GQ WAWQ#KWA*:]^S0S6NHZ8JJ[QLVW$L8)
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M1LWY $_A5RT.L^&/%7B2*WT*ZU"'5;A;NSGA=!&CF-59926!0 J#G!R.G/%
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MW?B7PY'K%U;);I=2R-;(N<^0&(0MGN0,_B*Z"@ HHHH **** "BBB@ HHHH
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M9I9H1*A0R02%'7/=6'(/O0!Y9X5T*=?B7>Z.2CZ)X<N9;VT"G(66Z4%8R/\
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M&X5KF!9%,D8)('*@]^>E<:V@:@=6U:YTWP<=+L-2T"XL8(84AC991E@955L
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MIPS $<'O73Z)HEEX?TU;&P1EC#-([.Q9Y'8Y9V8\EB>]7V=%959U#-T!/)H
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MOI]U#:-&98)H^02&8 J<D9!XQ7I=% '&_#[3M7L5\13ZS9?9)[_5Y+N.,.'
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MSY=3G *X.1T%<E<^#-:U5_%%NFA0Z3;ZS8VS68C:+9;RP.S*DH4_>8[3E00
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M5VQ3;#*_)YPRL<#)^:N^EU"33-?T?0K>Q4V5Q;RXF$F/*\H+A=O<$'KVX]:
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MUHVHZ3<:3J]O$LYMIG6021$X#HZG##/!]#0!TM%5X[^SFN7MHKN![B/[\2R
MLOU'45SNF>*[C4/'?B3P[]EB1-)B@>.;><R&1 W/IC- '545F:+>W=QH<5WJ
MPLH;C#&7[+/YD*@,<$.0.P&??-6XKZSGA2:*[@DBD;8CI("K-Z ]S0!8HJGJ
M=^-.L9IUADN9DC9X[:+'F3%1G:@/4U@6_C=9_P"PG.BZFD.J,T32M&,6LH;;
MLDYX)8$?AF@#JZ*** "BL/Q#XC&@76CPM92SKJ5]'9"574+&S9()[GA3T'XB
MMR@ HH)P"<9]JY"/QV'\->(=9_LFX T6YGMY;?S4WMY2@LV<X Y/0GIWH Z^
MBJVG78U#3+2]";!<0I+LSG;N4'&?QJS0 4444 %%%% !1110 445DZSKT.DZ
M+JNHQQ->'3$9YX8F4,NU!(0<D#[I!_&@#6HJII5\-3TBRU 1F,74$<P0G.W<
MH;&>_6FV=W>3WU]#<:>]O! ZK!.TJL+@%020!RN#QS0!=HHHH **Y77O%FH:
M=XEM]"TK0'U6ZELVO#B[2$*@<(?O=>2/SJQX=\4MK-_>Z7?Z7<:5JMFJ22VL
MSK(&C;.UT=3AAD$>QH Z*BJ\-_9W,\D,%W!++']](Y S+]0.E<SHWBVZU?Q!
MXMTI;2"-M$:-(7:0@2ET9OF]!E1TH ZZBL_3+V>31(;S5#9PS;"TQ@FWPKSV
M<XR*LQWUI-'%)%=0/'*<1LL@(<^@/>@">BF22QQ%!)(B%VVKN8#<?0>II] !
M17+>._&*^#=$CNHX([J\GGCMX('F$8+,<;B><*,'M6KI^INFB0W>M3Z;;RMD
M.]O<;H,Y.-KL%SQCMUS0!J45%]I@\E9O.C\I\;7WC:<],'WHAN(+D.8)HY0C
M%&*,&VL.H..A]J ):*0D*"20 .23VKC=7^(-C;^$M;UG2@EU)I4S0-$[@!V5
MU0D8).WYN#0!V=%01WMK-<26\5S"\\7^LC60%D^HZBC[;:_:_LGVF'[3C=Y/
MF#?CUV]: )Z**Q?%OB%/"GA:^UR2W:X2T56,2MM+98+U_&@#:HKA[OQKXCTJ
MTDO]4\"W<-A I>>6"_AF:-!U;8""<#FNLCU:PDTN#4_M<*64\:2QS2,$5E89
M4Y/J#0!<HJ-IX5@\]I4$(7=YA8;<>N>F*2"YM[J 3V\\4T1Z21N&4_B* ):*
MK6^H65VLC6UY;S+']\QRJP7ZX/%3++&\0E616C(W!P<C'KF@!]%5I=1LH(HY
M9KRWCCE.(W>50'/L2>:DEN((,>;-''D%AO8#(')/X4 2T5#;W=M=KNMKB*9<
M YC<,.>1TIZRQO(\:2(SIC>H8$KGID=J 'T457FO[.VGC@GNX(I9/N1O(%9O
MH#UH L45R/CCQHWA;^S+6SM[>YU'4KI;:))Y_*2//\;G!('X5TNGRW$^G6\M
MU]G^T,@,GV9R\>[OM8@$CWQ0!9HK/UW5%T/P_J.K/$95LK:2X,8."X12V,]L
MXKE[3Q?XMOK."[M_ ,K0SQK+&W]K0#*L,@X/L: .XHJHE_&EI'+?&*SF,(EE
MBDE4^5TR">A )QGI3WU"RC7=)=P*/EY:0#[WW>_?MZT 6**KS7]G;W$<$UW!
M%-)]R-Y K-] >33Y;JW@W>=/%'M4N=[@84=3SV]Z ):*BBN8+BW%Q#/')"1D
M2(X*D?4<4EM=VU[%YMK<13QYQOB<,,^F10!-15>&_L[B>2""[@EFC^_&D@9E
M^H'2I%GB97994*QDAR&&%(Z@^E $E%5YK^SMXHY9[N"*.3&QWD"AL],$]:Y[
MQ%XKFT7Q7X8T>*VCECUF6:-Y&8@QA%4@CUSF@#J:*9%-'.F^*1)$SC<C BB*
M6.9-\4B2+DC*L",B@!]%%<AXW\?6_@O[(AT^:_GG625XH6 ,4,8R\ASV&1]:
M .OHJ".]MI;.*\6>/[/*JO'(6PK!NA!]\BI'FBCD2-Y$5Y,A%+ %L>@[T /H
MJ-IX5=D:5 ZKO92PR%]3[>]1P7UI=0-/;W4$L*YW21R!E&.N2.* +%%0)>VL
MCNB7,+,BAW"R E5/()] ?6L.Z\4QIXGT'2[,V]U;ZF+G?/')NV&)5; QP<[J
M .CHJ!;VU>[:U6YA-RHRT(D&\#U(ZU6U/5K;3K:Y/GP&ZC@>9(&D 9]JD].N
M.* -"BLOPWJKZYX8TO5I(EB>]M8[AHU.0I90< _C6I0 4444 %%%% !1110
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M,T 9&B7T'CCQK;ZQ%DV&FZ2GE@,05GN@&;!'0K&JCVWUW"V%HGV8);HHM01
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M_P#T6*Z.JFE:;;Z/I-IIEH&%O:0K#$&.3M48&3WX%6Z "BBB@ HHHH ****
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MB!$1N'0@'!Y[@5DZ'X8T2;7?B%#+IEJ\$4ZK#$T0*1;X%9]B]%)."2/0>@H
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M:SHK*K,H+< $]: '4444 %%%(&4L5# LO4 ]* %HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHI&944LS!5'4DX H 6BBB@ HHHH ***165L[6!P<'!Z&
M@!:*** "BBB@ HHHH **** "BBB@ HHH) !). .] !12*RNH9&#*>A!R*6@
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M;U6(>_-'B3P_86_CO4=4UGP[J.K65_;0^1)8))(T4L8961E1@1N!4@GC@\T
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MWV23> +OS"<8Z;.<_AUH ]CK)U3Q#::1J>FV%S%<>9J,ODV[H@*%\$[2<\'
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MT>V.JJMMJ<[:6VV[6&S<F,;=Q8YQA0.<GKVS6M+XBL1'8&V\R\EOXO.M8;<
MO+'@$O\ ,0 N&7DD#D#J0*XR"&Z6X^(['3[\"^&;7_1)/W_^CB/Y?EY^;C]>
ME9]@-6\-2^$->;1M2N[./04TF^MX+=FGMI!L;=Y9P2,K@D>F?2@#NK+QAI6H
MZ7'?6K3.9+AK1;;R\3&=<[H]OJ,$DYP "<XYJG<?$+1+/3-5O+M;R!]*D6.]
MMF@+2Q%N5)"Y&TCHV<>]8?BM-2O;?1/$<7AN6ZMK&]DDFTIXE,\D$D>PN4Y&
M\$E@O7!&<'.*?B6WCU?X=^(9-$\(W-A)?1111I_9_E7-RP;/S(HR%4="WOVQ
MD [.U\8:==ZV=)6&]CN6@:X@,UN46X12 QC)ZXR/3KD<5A6GC.VUWP9KM_K%
MCJ%GI\3W,,AB4EUC4E#@H20P ))Z#UQ4NHB:Y^)/A6]BLKUK6&SNDEF^RR!8
MVD";0Q*\9VGKT[UAV=KJ%O\ #?QCHDND:B+QY-0$0%NQ6;S68Q["/O [AR.!
MWQ0!V,?B;3=/?0--6*\(U.%19.R[@P";L,Q/W@O//)[9-7YM?L[::_2X$L4=
MBJ&64KE26^ZJX))8\<8SR/49Y?6M&N]4^&&G-90RQZQI<$%Y9I)&RNL\*CY"
MIP>0&7'O2>(M"U;4OAU.8+1)-9GGBU*2TD.1(ZR(_DDG@X550>NT4 ='9>)[
M.[UQ]%E@N;/41!]H2"Y0 R19QN4J2#@\$9R/2LCXK_\ )+?$/_7M_P"S"H/#
MQTSQ!,9(O!<^D-Y#Q7%Q=V2VTJ[A@QQL/F/4DL,#CU/%'Q7X%LM,^'WB*W\/
MV=[-=WEL(Q$;F6X9\," H=CCOTH T+?QAJ]IJNCPZQH<5IINKOY-I.EUODCD
MVED65-H + '[I.#Q2WOC#7-.G-]=^'D@T);Y;,S27)%QAI!&LWE[<;"Q'&[.
M#FL[4)]1\5:QX7TX:'J-F=-OTOK^>X@*0QF-& 5'Z/N9N-N>.:Y"]T.[NM!F
M,_A;5;OQ1!?BXO+Z6)F!C6X#?N&)P^4  51TS^(!Z'<>+=;EU;5(M'T&&^L]
M*G6"YS=[+B1BJL?+CVD$ ,.K#.#BEU+Q;K']I:K!H6BP7UOI 7[9)-=&)G<H
M',<0"ME@I!Y(&3BN9\6PC4KV\NK+PMKEEXGVJ--U*Q1U68%04,KC"@ \,L@X
M QS4.H^';+3_ !+KL^M^%=2UE[^1+FSFL%D9&8QJK1-M8!,,I.6XPW7B@#J9
MO&UUJ6H:;8>&-/@O9KS3UU-Y+NX,,<4#'"@E58EB<C&.,56^&5S+=R>+IY[9
MK:9M>E\R%F#%&$40(R.HR#SWJDEM/X.\766IQ^'[TZ7<:+%9&#3XS<M:2QN6
M"'')7#8W>HK4^'5OJ4?_  DUSJ>G36+WNLR7,44PY\MHX]O(X/3!QD9!H H2
M6;^//'6MV.HW=TFA:*8H$L[>=HA<3.F]FD*D$@9  S[_ %V-)\*CPEJL][8Z
MM<QZ#]G8S:?<R/,L;CG>CLQ*C&<CG/\ ++NEU3P7XWU76(-(O-4T361'),MB
MGF36TZ+MSLSEE88.1T(_.[!J&N>,)[VV72;C2=!>RE@:348MEQ/*XP"J9RJJ
M,\GKGIZ %$?$'5X]%M_$]UH$,7AJ=TQ+]K)N8XG8*LK1[-N#D' ;(!J]=>+M
M;G\3:UH6AZ';W4^F)#(TUQ=F)&61-V.%)W9X Z<$DCH>5N%UG5/AI:^ 3X?U
M*'5?)AL)IW@(M8TC9091+]UAM7( YR<8KL/#VGW5M\0_&%W+;2I;7*V(@E92
M%DVQ,&VGO@]: ,2+XF:G/X<L?%"^'D30)9(HKAY+O]^A9Q&S*FW!57..2"<9
MP!6K<^+M;N/%6L>']$T.WN9]-6&1I[F[,4961-V.$)W9R .G!)(Z'F%T+5O^
M&?+;2?[.N?[162(FU\L^8,7@<_+U^[S]*OVNN2:'\4?&<C:7J%[;2)8@M8P&
M9T<1' *CG!R>>@QSC- &G!\0)M3T?2&TS2@^LZG--;BRN)]B0/#GS2[@'Y5Q
MV&3N'%-O/B%<:7H.HW-_I 74],O8+2ZM(9]ZL)2FUXVVC(*OD @'((..M<D/
M!URFDZ#J^MZ'=7<0OKZYOM/M]S30K<MN0A5(+%=JY Y^8\<5H7F@PS>#KPZ#
MX5O=.$VJV;+'-O,T\<<J$R,C$E /FX/.!DXH Z>V\6ZM:>)(=*\0:/;V:WEK
M-<VLEM=&8_NL%T<%5^8!@>,BG>&_%&NZV=.O)]!@CTC4HS+!<6]YYKPC;N7S
M5V@#(X^4G!X-)XBLK^3XA>%[ZULWGBM;6_#MT169(]BLV#MW$$5R^DV4@\26
M%QX8\/:QH%P_FMJL$Z,EES&V, G8S>9LP4'3)- '1Q>,-<AOM-EU7P\EEI>I
M7GV.!FN2;F-CNV&2/:  VWH&.,BLK0?$/B"^O_&HU>QM)=/LI)$:(7;-LVPK
M^[4;!E6Y).1@D\&N6M](E2P\.WR^$]9?6=.O[>XUB]N(7>5R&P_EY),F2=WR
M\!173Z=#?V6L>/--ETG4,ZD\ES:W"VY,,BF  #?TW9&,=: )M$\8P6O@#PU)
MHN@QQW.K.8+'3$GQ&A!8L6<C(4!23QGFM%?&NH6#ZU8ZUI4$&J:=IKZG$MM<
MF2&YB4'.&*@J0PP01WS7*Z+HFL:1X+\!:HVE7<MSH<LWVNQ6/]\(Y0Z$JAY)
M&0<=2*T-1M=1\4:IXBUV#2K^VM4\.3Z9:QW4!CEN97)<E8S\V!A0,@9)XH T
MH/'>L :#J%[H$-OHVLS0V\4@NRT\;RCY&9-H&TG_ &LX()QTKO:\^U;2M0E\
M%^![:.SG:>TO],>XC"$M$J8WEAV [^E=;I^M"^UO5M,^R30MIYB'FO\ =F#K
MN!7V&"/J* ,;5_%6J0>,?^$9TC2(;N[;3UO5FGN3%&@\QD.["D]AC&22>P!-
M80^(^O3>'+[68/#$/DZ1)+%J:2WN&#QMAQ#A#N &#DXZX&<5N+878^+\NH?9
MI?L9T%(!/M.SS//9MN?7!SBL"'1M2'PW\=V9L;@7-W>ZD]O%Y9W2JY.PJ.X/
M;UH Z"]\5:C=:K'IOAO3+>]G%FE[/)=W!ACC1R=B\*Q+MM;T QUI(_%NI:MH
M>E7>@Z&9[J^>1)5N9C'%9M&2'$CJK'[P*C Y]JY&_P##5I::];ZCKOAW4M3L
M[K2;6%391R.]O/$"&1D0@X8,.3QD'I4E]I"6\'AI+GPKJ4?A[R[EY])LR]P8
M[AV4QF4*<MQO]0&//K0!N3_$2XM= CO)M%+7Z:PND7%I%/NQ*3U1B!N!!4C(
M'7G%:.D>)M6D\6-X?UW2K:SN)+,WMO):W1F1D#A65LJI# L/8UP6GZ'J5O9C
M3H_#UW9"/Q=;:BD*Q%HX[9@O(89!V[2&P>#7>75C=M\5]-OUMY3:)H\\33A3
ML5S+&0I/J0"?PH F\0>)+ZRUS3]!T6PAO-3O(I)S]HG,44,28!9B%8G)(  %
M<AHWB:72=7\>ZO?::ZW@O+*!;)) QDF,21JJMCD,V"#CH<X[5N>(Q=Z)\0M,
M\3)IM[?V+:?+I]P+*$RR0DNLBML')!VD9'2N5O= UCQ%!XRO)M#NHS<:A8WM
MM:3?(US%$JY3(/#%5(QGACB@#LH_&=YI=S>VOBG3X+&6WL'U%)+2X,R21(<.
MOS*I#J2O&,'-&F>+-8.IZ5!KFB06%OJX;[')%=&5D<(7$<H*@!BH)X)&1BN9
MC\+:3KMAK=KH?A._TN2;2Y8$OM1\R(F1^D81R21P"6Z<=ZG\*:1HS:QI1@\#
MZG97UNI>YNKPR)';2!<?(68B0DG V\8.?:@"0_$W5_\ A&&\3CPY"-&MIVAN
MV-X?-P)?++1KLPP'!Y(YR.V3MV?BW5T\4Z;I6L:+#9P:M%+)921W7F.IC4,5
ME7: K;3G@D=LGK7*OH6K'X ZCI(TZY_M%Y)RMMY9\PYNF887KRO/TKK/$>G7
M5WX^\'7,5M*]M;_;1<2JI*Q;H<+N/;)X% %*#Q[J$MO;:V^C0IX9NKI;>.Z^
MU$SA6?RTF:/;@(6Q_%D YJ2[\7:O?7>N1Z1HL-UIFDNUO=3R712620(&<1)M
M()4$?>(R>*Y#P]X4TS3[73]#O_!&HW>L6]PL4MT6D6U9%?(G\S=MQMPVW&<\
M8[UN6,^J>&+WQ5I/]@ZE>2ZE?S7MA<6\.Z!_.4<._1-K YSVZ9H WOA?_P D
MQ\._]>:5UM<Q\.[.YT_X>:%:7D$EO<PVJK)%(I5D/H0>E=/0 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !117.>-O$[^$= 34TM/M7^E0PF('!(=@I(]3Z"@#HZ*XR?Q)XEM_[.TR3
M2M.&O:D\KQ0BZ8P00(%):1MN2V6"X P2>M02>/;JVTJ>*XTN/_A((M232ELT
MG_=23.H9'#D9"%#NR1D8(H [JBN*F\7ZUH5AJLGB/1$66SBCDMY;"1G@NF=M
MBQAF4%7W$ @]CFK>E^(-:C\0P:+XBL+*WFO+=[BTELYVD1MA7?&VY00PW*<C
M@C- '30SPW,0E@E26,]&1@P/XBI*\H\/>.X[#X8Z-J^E>&[>!+S5!9+I]L^U
M06=AE3CJ2._K710^)_$<&NOH6J:9IL6H7%F]UI\D-R[0R%" T;DH&!&0<@'B
M@#M:R]?T&S\1Z4UA>&1!O66*:)MLD,BG*NA[,#7-_"G5-;UGP/:7^LM#)YVY
MH9EE9Y'&]\[P0 ,< 8)XKJ=:O;O3M'N+JQL'O[I /*MD8*9&) '/8#.2?0&@
M"[&K)$BL[2,J@%V RQ]3CBLNU\/VMMXBO-=>2:>^N8UA5I2"((EYV( !@$\G
MJ2:Y^/Q?K%C-K%AK5A8K?66F-J4+64[/%*@W J=R@J0P'U!JI!XYUY;;P_J]
M[HMG#HVL306Z[;EC<1M,/D<KMV[2>V<X(^@ /020 23@"FQR1S1K)$ZNC#*L
MIR"/8UPUWXJUS4I]?&CZ5:3Z5I+O:W#RW#+--(J R"-0I'RYQ\Q&3W':_P##
M'_DF7AW_ *\DH ZRBN!^-$LD/PGUJ2*1HW'DX93@C]\G>K5]XGU2RUC1M TO
M3H+JYOM.:=99YBB1E-@RY )VX)Z#.<#OD ':45P<?Q NK31-9?5=,C&KZ9>I
M8_9K68E+B63;Y6UF (!WC.1Q@_2KD?B?7-'&H-XITB"&VM;)[U;S3Y&EB(7[
MT1W*"'[CL: .PHKC=-\4:['J>DPZ_I5G:6VL!A:M;W#2/#($+B.4%0,E0>5X
MR,>]8B_$7Q#)X1?Q7'H-D-)M7=;E7NF$TBK(49HQMQ@8_B/)!]L@'IM1Q3PS
M[_)E238Q5MC [6'4''0UP7]L^))?C'_9<'V,Z6-*2X\MIW&8VEP9,;<>9P0!
MTQWYQ6;I_C:/2M \3:Q8^'[6W@T_Q"]O?"%B#(FY5><\<O\ ,#CVH ]3HKG=
M>\2OIFK:!IEE ES<ZM<E>7P$@1=TDG'7 Q@=\UAQ^.]5:RB\0MI5J/"\MT+=
M9?M#?:1&9/+$Q7;MVEL'&<X.: .^HI&4,I4YP1C@X/YBO*/"OC*S\+:'JOV^
MUU:XM8=:NTENXX6F2W3S2%,CDY/&.F2._44 >L45S]_XOL+2YDM[>"YOY8K(
M7\@M AVP'.&RS*#G!P!D\?2I5\4V$]OI<EDDUXVJ0&XM8H@JLT8"DL=[*!C>
MO&<\].M &W16,OB2VDM+25+6[:XNVD2&SVJ)B4)#Y!8* ,<DD#D#J0*J6WCC
M2+C3+N\;[1!):77V*:TE0><LY("QA02&+$C!!(.>O!H Z2BO/;*\DN/C:5>U
MOK0_V"S-#<R!E)\] &4*[*.../3FO068*I9C@ 9)H 6BO/O \K>/=.N/$VJO
M-);7%S(EA9B1EBAA1MH)4$!G)!)8Y]L5OI!!X3;5M4O-2G.E&*)D2XE>4P%=
MP95SDD$E<#DY.!V% &V;2$W@NV0M,J%%8DG:#UP.@S@9/? J>L*+Q3:_VQ!I
M5[9WEA=W432VRW*J1.%&6"E&;Y@.2IP?:LF7XEZ1'IEWJ0L-6>SLKI[:[E6V
M&("K!2S98' )[9([@<4 =G17.P^,;"77X-)>UOX'NHGEM)Y8,1W(0 MLYW9
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MN9_.F'F%$2/<< DOD]<#?UP,UNZ=JGV^:Z@:SNK66V95=+@+SN&05*L01^-
M%^BH;N=[:UDFCMY+AD&1%$5#-]-Q _6O'K1M&U7X:6OBSQ79:OO6-Y+FYM)-
MK78D=AM.Q\E%.W ;:!@ <4 >ST5CW6O06=X;""TNKRYCMA<O%;["R1DD*3N8
M9R58 #)X^E-?Q+;'[)':VUU=W5U;"[2UA""18CCYFW,%7D@<GDYQG!P ;5%<
MS:^.M)O[#2KBR2ZN)-4>2.VME0+(6C!,@.XA1MVG.3],USOCW7+;Q!\(?$%]
M9-=6\EJ6AD1F,<D4J2!61MIP?S(.: /2**:G^K7Z"G4 %%%% !1110 4444
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M^! -:ZL&4,I!4C((Z&EH XWPSKM_I^BVFDZ[HVI0ZE:1+ SP6KSPS[1@.LB
MJ 0 ?FVXS4'B>RUAM;\+^)X[&25=,GG%S90_/(L,R;-P ^\RX!(7/4@9QD]S
M10!YYJ.EW.I:[XB\1PVETL$F@G3+>)H&62XD)9BVPC< "549 []AFJ<UE?\
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M+$XRKHP96'J".M24 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MTNB+;I/D;3)YBG;ZYP* ,JW^(7B:3P;8^,)=)TV/1W:,7$/FOYY5I!&73C:
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M^'^GW>D^ =$L+Z!H+J"U5)8VQE6].*Z2@ HHHH **** "BBB@ HHHH ****
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M?FW@''X5'_PG.H/X0T:\2UMAK-_J2Z8]N=QCCE$C)*<9S@!&/7TH [RBO/\
M6O%_B+0[J:]O(-'ATR*]2 63S$WDD+2!!,I#;?XMVW'3J<U8/B;Q'?\ C[5O
M#NE6FG+;::;:26YN=^?+D7+* IY<\X/  !SF@#M9IHK>&2::1(XHU+N[L JJ
M!DDD] *07$+6PN1-&8"GF"4,-NW&=V>F,<YKS#6_$GB/7_!GBG4K*UT[^PHH
MKRU2-]_VB5$5D>4-G:.02%QR!U%=?I4WV;X:V4_EI)Y>CQOLD&5;$(."/0T
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M2E"0NP9P,?+DGKD@ 8H [BBN3UW7]9_X2NT\-Z!%8_:VM&OKBXO@[)'$&V*
MJD$L6SWX [USUU\1]9L?"WBG4KK3+2.[T.^AM/)4LRON,89LY!.=Y*].,9[T
M >FT5R$VH^-(-'266ST:.\GN?OM(PALH-N<RY(+N#\ORX!)'0"L:;XAZG9^&
M-6NI+:PN]1TO4H+-_LC$PW"R&/#)DY!P^,$G!% 'I%%<3'KWBFR\4VFBZM%I
M!;4[2>6RDMA)B*6(*2LFX_,OS#D;?I5?X47VNZEX=N+O5KBWFCDO+CRRF_S
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M8%=\(8EG:<1()G4(T@4;BHR0"?09/YFHS>VJWRV)N(A=O&95@+C>4! +!>N
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M;F%KG6[NZA!8'=$[ JW!/7TZUUM4=3UK2M%C235-2L[%)#A&N9UC#'T&XC-
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M:9X@\->)TU:QT5M4@O=+M[6YBBN(XWAFBR ?G(!4AL<'M6K\/M(U?2-/U?\
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MM=NH(P5(C7;YT89AG)  R0#SCM736^OZ[INMZQH&MS65]-%I3:E:7,-N8@Z
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M\;LZL 6& P^5AGCBNBO?#.KZWX:O/+T72]$OH[R"[T^WCVDDPL&'G.GRG)W
M8Z ]ZZW1+C1(EFT31G@4:4%ADMHO^6&0=H/UP:UJ .-4>+?$*ZC#J&G0:/82
M:?);I;M.L[RSN,!]R_=0#C'4YJWX M]6L/"-AIFL:8+&>PA2V&)UE$H50-XV
M],XZ'FNGHH XOQCI>LOXI\,:]I&GKJ']F-<K-;^>L3$2QA006XXQ52WLO%'A
M:\UVWTC1HM2MM3O)+ZVG-VD7V>20#<LBMR5##(*YR#7?U5L-1L]4MC<6-PD\
M(=HRZ=-RDJP_ @B@#.\'Z"?"_A'3-%:42O:PA7D'1G))8CVR36#J5AXBL/B-
M<>(M-TR/4+%]+CM&A%PL4C.)';*[N.,CKC.[KQ@]S5&_UC3]+GLX;V[C@DO)
M1!;JYYD<]%'O0!Y\G@K7CI!U<PVZZ_\ V\=;%F9ODV[=GD&3&,[/XL8S[5M6
M.F:UKGC*'7]7TU=+@LK*2VM;9IUFD=Y"-SL5X  4 #.>]=/%K&GSZO<:3%=Q
MO?VZ+)- #\R*W0GZYJ2YU&SL[FTMKBX2.:[<QP(W61@"Q _ $T >9:-X5\31
M^#/#V@7>E1PR:+J]M.9Q=(ZSQ+*S,X Y& 1P>3FNRN='O9?B3I^LK&ILH=,F
MMG?<,AVD1@,=>BGFNEHH Y_QOI%YKW@S4],L"OVF>(!%9MH?# E">P8 K^-<
MY9:3KK>,M$UH>&[73;"W@FM'M(IXR\0?8?,)7Y2/EP%&2,9[X'H=% %#7;66
M^\/ZE:0*&FGM98HP3C+,A Y^IJMX2T^XTGP=HNG7:A+FULH895!! 94 (R.O
M(K8HH XL^'=1/QD7Q'Y2_P!F#1?L?F;QGS?-W8V]>G>LK_A#]9_X4;/X7\A/
M[5>&1!'YB[<F8N/FZ=#7I-49-8T^+6(=(DNXUU":(S1VY/S,@ZD>W% '$W_A
M[6E\5Z]-!HUG>)J\4,<&HSRI_H2K'L92A&XX.6 7@D\D=:3PUX:URVO/!<M]
M8I;KHVFW%E<XG5^2(U1ACJ&V$^W>N^O;RVTZRGO;R98;:!#)+(W15 R2:DBE
M2:))8V#1NH96'<'H: //-9\$ZIJMUXS>(Q0O?S6-QITKMD&2!%/S <@;EQ^.
M:V;&X\7:O?.=0TN#2-/2T=&@-PD[W$S8 (*_=0<]>3GI76T4 >1Z1X)U[2?
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MM3M_!7BW39(4%UJ5SJ,ELN\899MVS)[9R.O2NOOM1L]-CB>\N$A6:9((R_\
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M7^3J>F:O=Z+%%+!?6RJT4R2=-RAB-P*L#@^E;>F^*-23Q'X9M;XP_P!GZWI
MDB*1[2MTJJ[+G^Z4)P/:H-6T'7M>\"^(K%])TW3;F^01VEK X)4#'^LD  ))
MR0 .!W-6=;\+ZG<^!]"@L%A_MS13:SVX=\(9(P%=2W]TKN'Y4 9FK>/]1M)?
M$]W;M:+I]A=6^EV;S_*ANG($CR-GA$W#/T-,M/B VEW>IV]SK^E^(H;?2I=2
MCN+'8A5HL;HF",PYRI!^O6KJ> [M?AE;:,)(&UF.9-0>27F.2Z$@E8-ZJ3E<
M^E6$T75O$%AJ]EJ.AZ9HEI=V#VJ"%Q-,9'!!?<H "#TY)/ITH YGQ ?%,NB>
M%+_6-0L[J&^UC3Y9+>*V\HVK-(& 5MQW#^$Y&<X.:[KQUK%_X>\+3:Q8;";.
M6*2=&3=NAW@2 >AVDG/M7*7&B^-=7TKP[I=YIMC:II%]:33SI>>9]J6)ADJN
MT;1@%N><X%>B:II\6K:3>:=.,PW4#P/]&4@_SH X[6O&5]9?$+3--M?)?1_W
M$=\^W+"2X\P0X/;F,?\ ?0KG?&.N:GJQU#R%ADM-/\2:?:6*$;=\RLK2;F]-
MS*/;!JYI?@7Q /A_K%MJ36Y\17+P20.LF5!MTC$/S=LF/)_WC5U?!>JCP3H]
MBRPMJ:ZS%JE^=_!;S_-DP>^ <#UQ0!:AUO7= \7C3->U&VU"SN--FODDAM?(
M:%HBNY<;CE2&XSS6%I7Q$NY'T/4;CQ'H=TFJW,4,NC6Y3SK193A"&#EF925W
M KW/3%==K'ARXU3QM87[*IT]--NK2<[L-F0IC ^@-9'AS1?$6EQZ3H\VA:,L
M&GE8Y=5+!VGB087;& &60X7))P"">: *?]N^,=3TSQ1J5EJ-A9PZ)?7D4,;V
MGF&Y6(D@,=PVC&!D<YR:[O2;^76O#-CJ,>V"6]LXYUXW"-G0,..^":Y[3/#6
MHVOAKQ=8RK'Y^J7M]/; /D%91\F3VK?\-6$^E^%=(T^Y"BXM;*&"0*<C<J!3
M@_44 >,O_:[_  ?\77=[J*7:-JK@0B#8?,%VFYMVX\'LN./4UZ"NJ>)=%\9Z
M)8ZOJ%E>6FL+.#%#;>5]E>./S/E;<2ZX!'//>L)O!_B8^#O$GAC[!;%+F_:[
MM+L70Q*&N$DVE,94A0><]:['7=$N]1\7^%]1A5#;:=)<M<;FP0'A*+@=^30!
MPUM\3+B2UM?$#>(]$>WN+M$;0E*?:(X'DV!MV_<9 "'(VXQGI7?^.O\ DGWB
M7_L%77_HIJYC0O#NOZ';V>@1:%H\EK:SX&K3.&+6X?./*V[O,V_+UQGG-=CX
MHL)]5\):SIUJ%-Q=V,\$08X&YHV49/;DT >;>'_$7PMB\-Z7'>6>G&Z2SB68
MMHSN2X0;LMY1SSGFNJBU^\_X7%)X<"0"P311=KB,!]_FA<;O3':NC\/V<VG>
M&]+L;@ 36UI%#(%.1N5 #@_45ST?AO4%^,$OB4K'_9S:,+,-O^;S/-#=/3'>
M@#E8?%WC)OAS;^.);ZP6&(J9-/%IGSX_-V,3)N^5CR0 ,<#K6[XS\0ZGI.H7
M)7Q-H>BP0VPEM8+L+)+>/@DA@6!5> HP">3]*K_\(9J__"D/^$4V0_VIY.S;
MYGR9\[?][Z5->^'=?C\2^(FLK"QFAUM8U34IIL-:*(A&R[,9;&"P (&3S0 T
M^*M>UK5/#-II+VMFFLZ,;^626+S3 ?W9RHR-WWBN">^>V#7_ .$UUS2M(UZR
MO&M;[6;'4X=.M)Q$8HYFG"&-G4$XQO)(!YQ^-6O"_AG6[+4_"]SJ%M# NEZ*
M^G3!)P^6!C"L..A"$^U1ZGX'U34'\4RQ/!#<76HVNH::[ME=\*)@.!R 2I'X
MYH U4;Q=HZZC_:=W9ZG9+823Q7:6X@:*91_JRFX[E(YS[8-8^E^*-8U#X8:%
MK!U'2=*DNV/VN^N@JQP(&<?(A(!8E0 ">Y-:\:>,-:^W_P!I6=KI=DUA)!'9
MI<+.TT[#[Y?:-J@< =\Y-<[IW@S7M'\,^"U_LZUU"ZT1I_M%B\X57,FX*ZL0
M1E<YY'<T 4-<\2S:_P#"7QK!/J%IJ1T]Q E_:*%CN$(C<-@$@$;B#@XXKTWP
MO_R*6C?]>,'_ *+6N!OO!_BB^T3QI8S6MEYNN"*>!HI\(CA44Q$$ _*%^]W]
M!G%>B:):2V&@:=9S@":"UBB< Y&Y5 /ZB@#R+PWK7@739?$Z^);2UDNEUV]<
MR3:6\^$\SC+B-ACKQFK^AZL?"GA7Q=XETVP-GH=Q=1/H]K=*8DRX5#)M/W(V
M=@W;@=J[/P?X=N=*L-=M=3BB9+_5KNY5 =P:&5N ?J.HK%C\$ZNW@K6/",LT
M1M(9E?1KF1MV$5Q(D<@ZX5E"Y[CZ4 0:=XUN8-8;3'\3:/K_ -HT^>YBFL50
M&WEB )5E5VRI!R">?E/6JL?BKQA:^"-*\;7UY8/9.+=KK3DM<$Q.RH7$F[.[
MY@V,8&<<XYW(H=;DMM0FO_#VE:1:Q:?,I$,@EEEE*]590 J 9ZY)R.E<QHNE
M>)O$OPP\/^''L;1-+G@M9)M1^T\^0I638(\9W\!>N._?  .G&I>)/$OB#6[;
M1-3M=,LM)F6U5I+3SVN)M@9MV6&U1N XY/)K'?Q[K^I:9X0?3(K2WOM7N+BS
MNDD0LD<D892PYS@,I;&>1QGO6P-.\2>&M?UNXT33+74[+5IENE$EWY#6\VP*
MV[(.Y3M!XY'(Q5*P\!ZCI@\$QK)%.=*NKBYOY0VT%Y58G:#U&YL?04 5)[;Q
M*OQ9T*SG\0P2O'I<LK.+ *&&^,.-N_@M@<]O0TO_  FVK1V'Q&N$%LLFAS,M
MH1$.P)^?^]TK=UW2=:C^(.D>(=,LH;V".TDLKB-[@1-&&=6WC(.>G2L-O VM
M'3OB+#LAWZ]*SV7[SJ"I'S>G6@"^=9\4Z5J_ANYU*]LI['6K@6TEE%;;3;,T
M;.NV3<2V-N#D#/8#M2?Q+XMO] U[Q5IUU8I86,EREMI[VQ8RQPY4R&3=D-E2
M0,8XQWS71Z[H%]J#>%# J'^S-0CN+C+8PBQ.IQZG+"N*O(M8T7P3XOTBQ?2Y
M]'C:];^T5O,M;J^YGA:,#_6 L5ZC[P/;! /3?#U[-J7AK2KZX*F>YLX9I-HP
M-S("<#ZFO'_ \K^'O'-UJA)%AK6MWVEW'HLZR%X&^IRZ_C7K7A.-HO!NAQNI
M5TT^!6!Z@B-:Y"/P'?S^"/$FDW!CBO;O5;C4+"17SL<N'B;/8Y S[$T <M\6
M97U_5[ED8FQ\.O:Q\=&NIYD)^NV, >Q>NM\0>,)_^$LO]&M_$^C: FG0Q,7U
M (S7,K@L% 9EP@7;DCG+56NO NKR_#-M,/DR:Y>Z@FHWS[\*TIF5WP?90%'^
M[6GJFAZKI_BS4=8TW0['68=3AB$D5Q,L302Q@J&!93E2I&<<Y6@"J_C&^U;P
MEH.KQ:QI&@VUZCF\O+IE<(Z_+LB5F ;+!N2> .]9Z_$#49_"MC.=4T^W#ZO+
MIMQK8AWVZH@8K*%W8&_"#DX!)K4O="\06VL:#K":5IFJ3VMA+:SVR2?9XH97
M96\R/<&X^4J>^#^%0:3I'C'0K/48#IFEZE'/J4MU-$9MBW,<HR0F00FUL<,#
MN'<=P"U=Z_KVE:/HTDU_IU^;S7+>S2\M4^2>VD;!;;DA7ZC@D<9[XK6O=<O8
M/B!:Z*AC^R2:5/=ME?F\Q9$4<^F&/%<I_P (/K*>'9Y;.PLK*[77(=8M-)2;
M]S&(]@,>\# +;6;@8!-:]GI7B/4?'</B'4[&VL;9=+FLUMDN/-=&9T8%F  .
M<'ITP.>> ##T?QKXF'PXD\<:M<V)MS:;+>Q6'9F8R"-9'DSP-V?E Z8.<UJ>
M'?%\Y\666C7'B;1_$"7]O*XDT\(K6TL8!*D*S90@G!//RT[3O ]\WP:A\)7C
MPPZ@D& V=Z+(LGF)GU&0N?QK5T"'7)-526_\.Z3I%M%"0YAD$LLLIQ@H5 VH
M!NZY)R.E %?XC^(+WP[IVB362PEKK6+>UD\V/>-C[LX]#P.:S]3\1ZW/XQU/
M2+'6]*TRXL_*^Q6%]!SJ 9 Q.\L"!N)7Y02-IS6C\1?#>H>)=/T6'3EC9[35
MX+N7>^W]VF[./4\CBJ7C+2/$&O1ZCI+^']*U*UN%(L;^6<1M9[E RRE2Q96R
MP*GG@<4 =U,\R6DCQQHTXC)5"^%+8Z9QTSWKSC0_&6H#Q9HVF7?B71=8?4A*
MEQ:V"KFRD6,R##!B67Y2O//0^U=IJ^D7-_X-O=&BNB+J>P>V6X;/WRA7<?QY
MKC+;0O%#7GA6[_L+3[&#1)?+>TBN@3*K1-&T@8*  N00O).3G% $^G:QXR\0
MZ>WB71I[!K$W3I;:5)!@SPI(8RS3%OE<[6(XQTZU3TVV\0W?C;QQ'HNI6VG*
MEW"YEEMO/:1_LZ87&0%7CD\GD8QCFUI^C^-/#VFR>&=&@LEL_M3O:ZN\X)@A
M>0N5:$J=SC<P'.#D=*Z'P_HEYIWB+Q1>W 3R=1NHI;<ALDJL*H<CMR#0!R<W
MCW4[G0?A_J*0VR2:UJ$5O=J8]P )VL4S]WD'%&M>/+LZIKWV3Q+H>E+I$AAA
ML+W89+UU0,V27!523M&T=03[5''X"UQ?#?@&Q,<'G:)J27-X/-& @<D[3W.#
M6I<:!KFD:QK9TK0M+U2#5+C[5#<7<H0VLK(JL'!4EDRH8;>>2/>@"WH/B^ZU
M'Q=!9W 1=/U72(=3TWY<,IX\R,G^(C<I^E8EU\0=2%EJ-\EU86EE=:T-)TRY
MN@!'$B ^;.YR-PRKX&1R!6WXU\.:S?:;I%]H/V9=>TMCY1_U495XRD@'7 Y!
M _V145[X&EMO!&@:9ID=M/=Z'-%<I%<'$=RZAA(K'!QNWN<X/)% &,_Q(N-)
MT_Q#'_:NF>()["UAN+.[L]H60ROY820(Q *OM/!&0PZ4_6+;Q%9^+O!$>M:E
M:ZBDFH.WF16WDF*00/E>IW*<G!X(QWSQHZCX:UKQ1X8URQN=+TS1&N8XQ911
M,)'$B-OW2.H VE@HP <8)]J2;3_%_B#Q#X:U#4M+L].M]+NFDGC2[\UI"T;+
MO&   "1@<D[CTQR >@UP/B?Q;+#XM;0H?$>E:!';VBW$MU?!&:5W9@J(K,HP
M I)/)Y XKI- U2]U*YUJ*\AAC%EJ#VT+1$D/&$1@3_M?/@X[C%8>N:'J5KXN
MDU[3='L]8BN[1+:XM9Y5B9'1F*.K,I&"&((Z\ \T 9NB^/=1OKWPO<7)M3IV
MJFXL+AH!E%NXF.UD;/*N%.!SU%2:[X\O],U/Q3<6ZP-IFAVL,.)!@27DK#&6
M[*H9<CWK0UOPUJNK^ ([1H["#7K>1+VW^RJ4ACG1]Z@9]OE)[Y)P.E5+?P+>
M7'PUU'2+V6&/6=3F>^N)?O(+DR"1<^JC:B_04 5=)\9W,6O1:7+XGT;7Q>6<
MTR26 0-;31J&VD*[90@G!//RU2A\5>,(_!6C>,KJ^L#:S/;+/IRVOWXY'6,N
M)-V0Q+;@,8'3G'/2:9::]=W$OVSP[I.DP+:O&3%()9)I6& 5( V(!GKDG(Z5
M0G\(:K)\(=,\-JD7]HVZV@D7S/E_=RHS<_130!W-_*T&G74R8W1Q.PR,C(!-
M>'>+M6U?Q-^SE;ZW<75O")3_ *7!%; "7%R%3:<_)C;D\'/M7N-_"]QIUS#'
MC?)$R+GU((KRZ;X?ZZ_P"B\'K'!_:RD97S1L_P"/@R?>_P!V@#TG1K6^LM.2
M'4+V*\F4\216X@4+V&W<>GUK0I , "EH **** "BBB@ HHHH **** "BBB@
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M%U!.>-I8#// )KH/"^I:S'XKUSP]K&H)J/V.*"X@NA L3%9-P*L%XX*\'WH
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M8),#=MSSC.<9JQ110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHJO?7UKIME+>7UQ%;6T*[I)96"JH]R: +%%9.D^)]#UVUGNM
M,U2VN8;?_7,KX\OC.6!Z# /)]*ATGQEX<UR]-GIFL6EU<A2PC1^6 ZE?[P]Q
MF@#<HKGKOQWX6L9A#=:[912&5H=K2?==6VD'TP01D\9%6+;Q9H%YK;Z-;ZO:
MRZBFX&W63+97[P'8D=P.1@T ;-%<]>>.O"UA-Y-WKME#)YK0E6D^ZZG:P/I@
M\9/%6+?Q;X?N]<;1;?5[234EW VZR9;*_> [$CN!R,4 ;-<MXRT2]O6TO6M'
MC635]'N#-!$S!1/&PVRQ9/ W+T)[@4QO%-OI+^);S4M<LKBTTYD_T>*/8]KD
M'".<G<6.,<"LQ_BYX<CT+1=2:Y@W:C-%%)")N;8LH+ECCG9N&>G44 ='>>'-
M)OM3MO$-QI;MJMM$/*99"LF!\P0X8*W/KD9JEX,T.]L?[3UG6$5-7UBX$\\2
ML&$"*-L461P=J]2.Y-7-0\9^&]*%J;[6;2#[5&)H=[_>C/1_9?<\59U?Q)HV
MA6T-QJ>I6]M%.<1%V_UG&?E Y/'/% &I14%E>VNHV<5Y97$=Q;3+NCEB8,K#
MU!%9>K^,/#N@W:VNJ:O:VMPR[_+=_F"_WB!T'N>* -NBO/\ XC_$*+POI-@-
M+OK#[?J$T2Q/,=Z)"^<S8!^91CU[UU&B:DDOAB'4;C5K:_C$;O)?0Q>5&ZJ3
MDA<G& ,=>U &Q17FU[\4K74?!FJ:GH,\ O+.\2$1L=^8S<+$)".,!E)(],UV
M&F>+?#^LZC+I^FZO:75W$"S11ODX!P2/49[C- %T:58KK+:N+=?M[6XMC-DY
M,88L%QTZDFFSZ/I]SJ]IJLMLK7UHKI#."0RJWWAP>1['-4XO%WAZ?6VT:+6+
M1]1#%/($G.X=5'8L.XZBI_$6I2:-X9U75(4626SLY;A$?HQ1"P!QVXH I+X'
M\-KK/]K#2HQ>>=]HSO;8)?\ GIY>=F[_ &L9SS22^!O#4^L'5)-+C:Z:43M^
M\?8T@Z.8\["V1G)&<US*>)O'R>%(_$SZ;X=GL39B^:WBGF27RRF\@$J5W8KK
M(O%>DCPK9>(KVZCL;&[ACF4W#!2-Z@A?<^PH 6;PCH-QKLFM2Z=&VH2Q^5++
MN;$B[2F&7.UOE)'(/%4(OAQX2BLY+5='0Q/M^]-(S(%.X!&+90 @'"D=*U=,
M\1Z-K-A-?:?J5M/;09\Z17 $6!D[L_=XYYJ+1O%>@^(998M(U6VNY(AN=(VY
M"^N.X]QQ0 B^$]#77TUQ;$+J2QB/SQ(XW*%*C<,X; .,D$U#IO@CPYH^I+J%
MAI<<-RF[RSO9EBW?>V*253/^R!4MCXP\.ZE<"WLM9M)Y?LYNB$DSB('!<GH!
M]:P-1^(6G75[H,'A[5+2[^U:K':W2K\Q\IDD.1^*#YAQ0!TH\-:.-&N](^PI
M]@NVD>>'<V'+G+'.<\DU//H]A<W%A/-;*\NGL6M6)/[LE=IQSSP2.:MS316\
M$D\\B111J6=W8!5 Y))/05CZ1XP\/:_=/:Z5J]K=3JN\QH_S%?[P!ZCW'% $
M3^!_#<FLG5GTJ,WAF$Y.]MAE'\9CSL+?[6,UIVVDV-GJ=]J-O;JEW?>7]IE!
M.9-B[5SVX''%4[/Q9H&H:C#I]IJUM/=S*[1PQOEB$)5C[8*D?@:H^*O'.D>$
M;O3+;4)HUDOIQ&0S[?*CPV9#QT! 'XT 79O"6@SZ5?Z7+IT;V6H3M<W419L2
M2L02V<Y!R >,=*T-.TZUTG3X;&RC,=O",(I=G(&<]6))Z]S7(1?$"PLO$WB"
M#6=3M+;3K7[+]B9N"XDBWM[MV/3@5TMUXDT6RT:+5[C4[5-/FV^5<>8"LF[H
M%QU)]!0!3USP1X<\27Z7VK:8MS<QQ"%9#(ZD)DG'RD=R:GT/PGH'AHR'1]*M
M[1Y>'D1<NP]"QR2/;-7=+U6PUJQ2]TV[BNK9R0)(FR,CJ/8CTJKK7B?1/#OE
M?VMJ5O:--GRTD;YGQU(4<D#UH K2^"?#DVM/J\FEQ->2.)'8LVQW'1BF=A8>
MI&:AD^'_ (7ETJVTQ]*7[):RF:!!-(#$QZ[6#9 ]@<>U9WC?XA:?X=\#2:YI
MMY9W4TZ?Z "^Y)FW '&#SMSDC/:N4U;XI3:3X2T\P>)-&U'6;Z]CB:9;<I':
MQ,/F8IN.[:1C.1UZ4 >@:CX&\-:M?_;;W2XY9RJJYWNJRA?NAU! ?'^T#70
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MU:7ER$+^7$^3M'4_J* *+:-?:M\08M7OX/)T[1XFCT]"X)FED&'E(!. %^4
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M-DC<7V^8S;E/'.37I7CO_DGWB3_L%W/_ **:GQ^#/#D.M?VQ'I%LM_YAE\T
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M3HVG:%8BRTNTCM;<,7*1CJQZDGJ3[GFJVM>%]$\1-"VJZ?%<O#D1R$E74'J
MRD'!],XH \AUX*/A#\1A;X^Q?V[)]FV_=QYL.[;[;]W3WKI_B;_R O W_8PV
M'_H+UW,GAO19?#_]@OIMO_96T+]D5=J8!W#@>XS]:FO]%TW4X;2*]LXYX[.9
M+BW5O^6<B9VL/<9- '#:M_R<#X>_[ \W_H357\'G03\(5?Q+Y7DB\F.H&3.[
M[3]I;&=OS;MVW'?I7H4FCZ=-K,.KR6D;:A!$88[@_>5#U _.L^3P3X:EUO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M'(]:\_TJ+7'\;R#3;_3;28Z!8F+[=:M,6B&_=LPZX ;KUZBIM(\/RV]EH/\
M8'BG2Y-:M(KQK<- 6M[BWDF!=0H;<H5@H!!)&,4 >E:?J%GJMA#?6%Q'<6LR
M[HY8SE6%6"0H))  Y)-<OX0UZTNM!A:X@L-,N7O9[5H(9%$<MPLC!S'TW;B&
M;UY-6?':W+> /$"VF[SSI\^P+U^X>GOB@!+#QUX8U34DT^RUBWEN9"5C R%E
M(ZA&(VM^!-2S>,?#UOJJ:7+JD*WSW M5@P2QE(!VX ]&7GIR.:XOQ,]C)\-/
M"*Z:8S(]YIW]G"/&=X9?N_1=V?QK1\$6\7_"P/'MSY:^<;V"/?CG;Y0./S-
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MD6]CJL<TAA><X1PJHI(8LQ&%P0>"0>,]* ->#3;*V-T8+:*,W<AEN-JX\UR
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M3[/3(&@LK:.WB9VD*1K@%F.6/U).:X;6?B/I]VVBQ^'=4#R7.KVT$NZW91+
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M!OCBP\8K??90R/;7$L84HXW1JQ57R5 R>NWJ* -"Q\)Z!IFEW.F66D6D-E=
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ME;:1UO;+SM\'D@;@3(N%#!P>O.?6NN\)P1:)\/\ 3HX;W^TH+:SW17"(4\Y
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MK-1(F-R$R#D9XR*KZ'X.U'_A(=)O+G0M%T*STMI9C#IK[S=3NA3<?D7:H!)
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MQSVTD)>/.-Z[U&Y<D<C/45Q5O)I#>)?BA9ZU=""SF6 3X/SB(VV&8 9/ R>
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M>^=I[@D0.UO(L4Q R0DA7:Q'H#6II.N:=KFF_P!H:?<B6U#.A=E*%60D,"&
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MHA-;;UQG*_:(\B@#:TGQKH.M:I_9ME>.;HQF6-);>2(3(.K1EU <>XS3-/\
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M5$DEAT\QHS %\1OG [XH NZ#XMTFW\)0:I?>)CJ-K)=FW74);4P9<M@*5"C
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M^%>KZ;IOPILYKV^MX([:6<3M)(!Y9:X<+N],DC\Z]'H **** "BBB@ HHHH
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MV5,3$'<"_'S$'GGOS6I110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQ++&ZM&RAE=3D$'G(/I4']I6/_/[;?\ ?U?\: +5%,CECF0/%(KH>C*<BGT
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M[WYY.2.F.G7FJ#)X\U^:VM;JWL_#]E'*DES/:WAGFF"G.R/Y0$!Q@DYXKN*
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MS\8ZUX;W^1:VMT;J%WTR.Z)62!6R\;3;1R_? Q@8[F@"=?'$H'BB%].BEN]
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M.HP: -"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "JNHZ=9ZMI\UA?VZ7%K,NV2)QD,/\
M/>K5% #8XUBB2-,[44*,DDX'N>356YTNQO+ZTO;FW66XLRS6[,2?++#!('3.
M.,]:N44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% %;4-/L]5L9;&_MHKFUF&V2*
M50RL/<5FZ7X1T/1IEFLK+;(G^K:29Y?+[?+O8[>..,5MT4 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MY]6LH[HS+;B%IU#^8P!5-N<Y((./>B'Q'HES?16,&K64MW,7$<,<ZL[;,AL
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MZ8L\ZA9)IM=FFD91T7<\)./;.*SH? WD;PG@C20C.'$9UV<I&P</E%,6$^8
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M2TQYHD,:RQ:[-"^P]5+)""5]CQ4\6FZO#-IDL/A'1HVTN-X[/9J\BB%6 5@
M(,'( ZT <[>:-;ZGXF\?Z2+NWT\7#:6\;R*/+,W+*"IP&W,J@CJ<TNIZP-.L
M_$=MXF\-6#:I_9\.\V$[+#?0O*8D!. R8=L'.3@GFMV[T;4K]M2:Z\'Z/*=3
M6-;O=K$O[P1_<_Y8<$=B,&JMMX5NK6POK)?!VE20WZ".Y,^NS2O(HZ N\);
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M,<*.#Z=16WI>DV.BVKVVGVX@A>5YF4,3EW.YCR3U)H NT444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M13)98X(7FFD2.) 6=W. H'4DGH* 'T4U'26-9(V5T8!E93D$'H0:8MS ]P]N
MLT;3HH9XPP+*#T)'4 T 2T444 %%%% !1110 4444 %%-EECAB>65UCC12SN
MYP% ZDGL*$=)8UDC971@&5E.00>A!H =1110 4444 %%%% !1110 445&EQ#
M)/) DT;31 &2,,"R ],CMG!H DHHHH ***0,I) ()'7!Z4 +1110 4444 %%
M%% !1110 445#-=VUO+#%-<11R3';$CN%+GT4'J?I0!-1110 4444 %%%% !
M14-S=VUG&)+JXB@0L%#2N%!)Z#)[U-0 4444 %%1PW$-RC/!-'*JL4)1@P#
MX(X[@U)0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !114-K=VU[ )[2XBN(B2!)$X=21UY% $U%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%1P7$-S'YEO-'+'DKNC8,,@X(R/0\5)0
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<+XU8ZUXI\-^$F/\
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M3O-L(8K]M?71+Z(.62-L,2R'C(("D9]:8L6N^&O%MQKEQI$VJ1ZKI]O'>#3
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M.IR@520%R%Y)&30!H1^,/$<$GAZ_U'3=/CTC6IXK9(XI'-Q"TJDHS9&T@XY
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M#*1FM:LGPU9_8/#ME;G2[;2V";FLK9@8X6))(!  /)YQWS6M0 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1145U<PV5I-=7$@C@@C:21VZ*H&2?R% $FY=VW(W>F:6O#+4WNG?8?B
MU<^8GV[46%Y$3_J].EVQQ9'^SM1O?=7I?BCQ!J-EJ6BZ-HD=H^HZJ\A26ZW-
M%%%&H9V(4@L>5 &1UH Z)+JWDNI+5+B)KB)5:2(."Z YP2.H!P<?2IJ\ECUK
M6-$\2>/]4O;>T.HZ?I%M(/+W>3+M$K @$[@#W&>"#R>M:=QXO\7V5SH4DVG:
M3);ZZ?*MH$:19+>0IO4R-DAAC)8*.,<$]P#T266.")Y976.-%+.[G 4#DDGL
M*;;75O>VT=S:SQ3P2#*2Q.&5AZ@C@UQ$'B?6$_X2S2M=MM-GNM*L!=1M;HXA
MGC='.UD8D]4(//(-9^G^--23PKX*?2])TZ.76V>'[.BF.&'",P*@=%!&3UXS
MCF@#TJ21(8GEE=4C0%F9C@*!U)/85EZCI^D^+M",$DB75E/AXYK>4'#*<JZ.
MO0@C@CTKF[?Q+K,5QXET?7K?39[G3].%[$]LCB*:-E?Y71B3U3!YY!K+TWQK
M>'P=X1.GVVC:7/K/F -,C):6^S)VA5(Y;L,CO0!Z9&ACB1"[.54#<W5O<X[U
MGMH5E)XBCUR422WD4!@AWME(5)RQ5>Q;C)ZX&.E<%XQU3QE!I_AE7_L^RNI]
M=AM9#$SLDWS$QL,-D1L%^93S6E<^)?%<OC.3PQIUMI)N(;&"[FNIQ((UR2'
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MEF<(BY.!DG@<D4Q]1L8[BVMWO+=9KH$V\;2J&F &3L&<M@<\5Y1XT\17.O\
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M?7KZD;>+>OSB4OY?.<#.1U/UKO+:Y@O+:*YMIHYH)4#QRQL&5U(R"".H-2T
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MT$98[!)C <KT)'.,],\4 -\.:<^D>%])TV3F2TLX8&QZJ@4_RK3HHH ****
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M8QSNICN?)1 R,.< [67D=_2MWPM8RKJLUT?!FG^'[=80BLJPFXD<G)YBR F
M.IR30!K^);S4[+2?-TE+3[0941IKQ]L4"$_-(W(W #L""<UQ;_$#5+/PYXLE
M-QI.HWVAQQ2Q75H#Y$RR#@%0Y((*L#AO2M[Q[I%YJEKI$EMIPU2&RU!+BYT\
MNJ^>@1A_&0I(9E;!X.*X_4?"OB2[M/&,4/AZ&V77+" 6L,$T06%XRP\M^1\Q
M#;LCY>HR<9(!M7OB3QGI^N:-9R0Z1(NNB1;>()(ILW50_P [;OW@"YS@+DCC
M%)_PG>JZ%9>+8]=BM+N\T(0-$]HC1)<"<?NP58L5.[@\FMK6=%O[OQ5X.O8(
M0UOITEPUT^]1L#0%%X)R?F..,UB:YX)U/6[WQT@"01ZK#8_89F<$-)""W('(
M&X*.1WXS0!=_MSQ3H&K:*GB)M+N+/5K@6A^Q0O&UM,RED&69MZG:1G />I+3
MQ?J$_@'Q'KK16PNM,>_6% K;&\@OLW#.3G:,X(_"JT]MXC\6ZMH"ZGH)TBTT
MN[6^N))+F.3S945@JQA"3MRV<MC@5DR:-XLM/#?BGPM::$)DU":]DMM0-U&(
MS'-N.TJ3N#_,5Z8S@YQ0!K-XH\1ZCXATW1M+CTZ)KS1(]2DN)XW80L6VG"AA
MN'( &1USGC!YSQ1XG\27WPYU??-96U_INL+IUW+!&X$H$D95D^;*YWC(.>,C
MC/'6:)H&IV?C+3=0GMPEM#X<CL9'WJ<3"0,5P#GH.O3WK"UCP=KMSX3\8VL%
MFK75[KHU"SB,JCSHU,)ZYPI.QNN.E 'I-@MZEC$NHRP2W8'[Q[>,HA.>RDDC
MCW-<4/$'BO7)-;O/#_\ 94-CI=S+:Q17<+O)=R1??^96 09X'!Z<UVFFW-S>
M:?#/>6,EC.X)>VDD5V3D]2I(/'/![UPMO:>)_"W]O:;IFA?VE!?WDUW972W4
M<:1&7DK*&(;"MDY4'(H Y?QOJ5_XL7X>ZE:M8I8ZA?0R0V]Q TFR;!SYF& =
M1TP #UYYKV/3XIX-/@BN3 9T0!S;QE(\]]JDD@>V37GEYX%U*STWX?:=91K<
MKHE['+>2AU4  ?,P!()&2>!S7IE 'G6H>,=>TC5(IM0N-#CMI-12T_LE7W7:
MQ/)L67<'P6Y#%=O3OFK']N^+M8U[Q'INC_V3;1Z3.B)-=0O(9=T2N$P'&.2<
MMZ$8'4URX\(^(H_#$>F1^%K8ZC9WR7D^HM-"7U#;.'^1L[@S#DE\8QCOQW?A
MC2M0L]<\47MY:F"/4;J*: %U8D"%%.=I.,,"/PH R-&\?7U_<^$KBZM;>'3=
M?M'7<H;=%=KSMW9QM8!@!C.1UK=TW7[S4_'.L:7#'#_9>EPQ))+M.][E_F*@
MYQM"8R,9R>M<=>^'KK2/@1;0ZCY=EJFAQB^B9G#".:)RZC()!R/EX_O5UOP_
MTRXT_P *Q7%\FW4=3E?4+P>DDIW;?^ KM7_@- '/?%LZ>)?"9U:W^T6']K?O
MX?),N]?*?C8 2WT IWAX?#JXUZT32/#?V>_#%H96T>6$(0"<[V0 < ]ZU/'V
MFZQ=7/AR^T?3#J,FFZC]IE@$Z1$KY;+U<@=2*GL_$/BN>]@BN? TUM \BK).
M=3@<1J3RVT')P.<"@"CX=\1>)O$/B35H$338-*TK5)K25RCF290!M"_-@$9R
M2>N1@#FLG0/'WB&X\"3^-M8M].CTN*TD9+:!7$LTJOM!R20JD@KCD]_:NE\%
M:-?Z//XF:^A$0OM;GN[?YPV^)E0!N#QT/!YK$T;P1J$WP/7PCJ"K::@]M*A!
M<,$<RLZ9*DC'W>E %IM>\5Z#=:)/XA_LJ:RU6ZCLY(K2%XWM)9 =GS,Q#KD8
M/ ZU2/BGQCJ%CXEOM.72(+?0[VZA59X9':Y6+G'#C;\N.><D]!CFQ<VOB;Q9
M<Z!::GH1TN#3KV*^O+E[F.197B!VK$%)."Q!RV, 5;TGP_J=KX;\8VDUN%GU
M*_OYK5?,4[TD&$.<X&??&.] %6[\;WFH3Z-9Z7=:9IDE]I::I-<:CEUC1\!$
M50R[F)W<YX"U%%X_U/4=-TJQL(; Z_?:A/8,Y9GMHS "9)1@Y9=H! R/O#GC
MFG_PB-[IW_".:C<>&;?7#!H<.FWEBYA+PR)@AT,AVGDNIP?0C-7;CP[K$5MX
M>URQT'3[74=+NYIGTFS9(U:&52A4-PID"[#G@$@^U #[KQ?KVA'Q%INJBPN-
M1L-'?5;*X@B=(YD7<"KH6)!# =&Y![5JZKXGO;'1_"MW%% 9-6OK2VG#*<*L
MJDL5YX/'&<_C6-/X<UKQ5?>(-4O['^RFN]$DTBRMIIED?Y]S-(Y0D#YBH !/
M -57L/%NLV7A*RN/#OV&/1[^UFNGDNXG\P1@J60*?N\D\X/0 'F@#1TWQ/XB
MUG7+T6,NC-!9:B]I-I;[ENA$K[3+NW8!(^8#;@CC.:P+*YU.R^('Q3NM'CAE
MU"""SEACF4LKE82=N 0>0"!SU(K2UW1-:UW58ED\*6\&J07R/!X@MYXU5(5D
M!R1GS"2@VE"",D\XK5\->']3T_XE>,=8NK<)8ZE]E^RR;U._9&0W .1@^H%
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M8= R%@49FP1M]<'(Z5-I?CS5FDT._O[K1)+'6)XX?L-JQ^T6GFC]V6;<0_.
MWRC!/'2I7TCQ!XG\9PZCJ6CMIFEMI-S8%'N(Y)5:0K\Q"DCGG &?N\XSBHO#
M.@7]@VCZ=<>!=(@FL2JW.KLL+"0(,!X@OS[V(4_,!CGK0!#JFO\ B7Q!X7\4
MZG8KIRZ+;+=VB6SQN9YTC5E>02;L*<@D+M.<8)'6NT\&?\B+X?\ ^P;;?^BE
MKBAI'BO2M \0^%;'1%N8;V6Z:SU'[5&L:QS9.&4G=O&XCI@G'('-=YX9LY].
M\*:/972>7<6]C##*F0=KJ@!&1P>1VH XK0=%L/''BGQ)K'B"VCOX]/U&33+&
MUN!OB@6,+N8(>"S$YR?2ME=!TCX?IK?B&P\VVT\6C33:;$0(-Z G>B_PL0-N
M!@>U4GT[Q%X0\3:K?Z'I:ZSI&K2BYFM$N%AFMY\ ,R[_ )65L XSG/TYE.E>
M)_%MCK<>NK'I%A?6+V=MIRNLS(S _OI' Z^BJ<8Z\T 53XF\6:3I^D:[K2Z4
M^F7\\,<]K;Q.LMHLQ 1MY8A\$C<-H]J2?Q-XNO[OQ3'I*Z3!%H<[*CW,,CF<
M",.$P'&#URWN..IJ&?3O%/B+1]&\-ZCH0L8;6>W>^OS=1O'*D)!_=*IW98J/
MO 8K7TK0=2MI?&QEMPHU.Y:2T^=3YBF!4!Z\<@CG% &1%XT\3&P\-^(9X--C
MTC6+JWMFLU1S-$)>%D\S=@\\XV]#USS5N+7O&.MZUXBL-'&D6T>DW7E1RW4,
MC^?F-6"$!QCDG+>XP.#44GA?6&^'G@[2A:C[;IUWI\EU'YB_(L3 N<YP<8[9
MSVJEHNI:[IOBCQNVEZ&VJQR:F BQW$<1CD$*?>WD?*<CD9(P>.: +$7Q$N];
MT_P\FG2:=IEWJ=K+=7,U^2T=N(V$;*J[EW,7) Y' )I)/B%JPT&V>VM].NM4
M77DT>?RV;R)2P)#H<Y4$%#SG'/6J5MX!O-!L/#5Q+HMKX@>RLYK6^LV\LG=)
M()=\?F84E6W#DC(-:EQX=U2\TG0C#X?L-+>'Q!#?2VEH47RH$R-SD85GQC.W
M/8#.* )AXH\1:)KFIZ9K26-^\6CRZK;-8Q/$6\MMK1$,S9R2,&K/A76_$6JP
MQ7\MQHFJ:?<6QE!TXE&@EP"(SN=MV<D9X((Y%2ZII.LGQ_\ VUIT$!6/0IK6
M*2=OD^T&5&16 .[!V\D5S?\ PC.KZIJUQ?6'AI/"UQ)IMU;W,R7$9%U+(F(\
M"(G(5LMO(!H OZ?XOUZ+Q#I.GZK>:#-)JADB:TLF+2V$HC9P'.\[Q\I4G"\]
M*Q_#^K^(;?PCX\U349].OH[.[OP('MW(:6,#CER/*P,;.OO4ECX>UN&;PI<V
MO@V#3DT:95N8DF@\V?=$T;2!@<;5)SR=S9Z<<SP>'O$4/A_QWX?;1R5U*:^N
MK*[%Q'LF,P&Q,9RIZY) ''6@"_!XLU2ZT;P=I^D6VGV^IZW9"Y9GB;[/:QK&
MK,0@()Y8!1GZFH[_ ,;Z[H>F^*;748[";5M&M([RWFBC=8;B-\@$H6)!!4@_
M-Z4V#PWKNCZ=X)U2UT\75_HVG_8KVP$R*SH\:@[&)VDJR ]<'GFJVK>&/$'B
M+3O%^J3Z:+6^U.PCL;&P:=&<(A))=@=H+,W3/ '6@#7'B'Q/IVO:!_:R::=.
MUJ4PB""-Q+:OY9=<N6(?[I!X'M75:X+\Z+=?V9-!#=A,H]Q&SH/7(5@>F<<]
M<5B>(=%O[^_\)2VT(=-/OQ-<G>HV)Y3KGD\\D=,UTUTC26DR(,LR, /<B@#Q
M3X=ZIJ7A?X2:=J,$&FW$E_,+2PB$+)(T\D[*#+)N.Y1R> #@ 5WUIK?B'2/%
MFF:+X@DTZ[BU6.4VUQ9PO"8Y8U#,C*S-D%<X.1TZ5SVD^"-<@^#^B:2\$4.N
MZ3=K?1022J49TG9PI9<CE3U]ZVX+36_$GC/1M7U'1GTBRT>.=D2:XCDDGFD4
M)P$) 51GDG))'% #?A_XB\3>++.+5[^/3;?329H?+B1_,E=7*AP2Q"K@8QR2
M03Z"M3QCXCGT.+3K6R>TCOM2N?L\4MXV(85"EW=N1G 7@9&2147PXT:_\/\
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MK2OJ_BGPYJFA_P!OW>G7MGJUR+.1;:V:)K69E)3:2[;URI!R >A]J .ZHKS
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M=CTSQ7 >(?&>LZ!?75W<ZOH,44%XD2:*6#7,T!=5\S=OR'()8+MP .:?:?\
M)Q6H?]B\O_HY: .\T[5;#5[=Y].NX;J))&B9XFW ..H^HIMAH]EIEU?W%K$4
MEOYO/N"6)W/M"YYZ<*.E<+\%/^10U+_L,7/\UK:\>>(M6T!=#CT>&WEN-1U%
M++;< [?F1B#D'@ @$^V: .NHKSS4_$FLZ=JEAX;NO$.BV-_]D:\N]2N8=L;
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M8;VRF6>VG0/%(G1E/0BK% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %<OXZ\22>'-)LS!<VEK/?7D
M=HES>'$4&X%FD;D9PJG R,G%=17->--"NM:T^QEL8[>6\TZ]CO(H+@XCFV@J
MR$X.,JS8.#SB@#G])\8ZA,^O:7:ZSHVN7=G9+=V=_&ZQPD,64K+M8A=I4'@C
M((Z5%HOCJ2VUR\LKKQ'IGB&UBTN74'GL(U0P-$1N0[6(((;()YXJ?5- \0>(
M?"^M6KZ-I6E-.L(M;1'#-)LD#N)9% &U\!0 ..<TR3P[K^K^(K:_O=)L[+3I
MM.N-+FM(;D,]NDFT^9D* Q.TC:.@ YY. "YH-UXWO8-&UR6XL+FRU+9)<:<D
M'EFUA==RLLA;+LN5R".<G%<IHUSXHT[P5XBUG2M0L[:VTW4+^<6TMMYIN=LK
M,VYMPVCL !GC.>>.HT&T\<6=MHNA2P6-K9Z:4CN-22<2&Z@C& BQE<J6 7))
MXYQ3K3PKJ</PY\2:(ZQ?;+][]H '^4B9G*9/;[PS0!V6GW8O],M;P+M%Q"DN
MWTW ''ZUQ'Q>:)/#.E-/;M<PC6K0O L?F&1=_*A?XB1QCO79Z/;266B6%K,
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M4(D5+4%1)^\*MC<.!C[O?UXK7LK3Q!<?$KQ7;:;JEM9R"UT\W%X]KYA9A&X
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M 5]L^O:L37O$&K>&Y=(T35/%EC;7-^9KB?59K5(UAC0+B-$)VDEFP"V> >M
M'I%%>2GX@:Q+H2QZ9J-AJ-_#K\&F+>QH/)NHI0"K$ X!YP=IZJ<5T=EJ/B#1
M/'%KH6K:G%JMOJ5G+/;2_9E@:*6,KN3Y<@J0V<GF@#MZ*\KT[QGJ$/B31K6X
M\6:5JLVH736UWIUE&I6U)1F#1R#E@I4 [LYSVK5TOQM=67@WQ'<ZZ\;ZKX?F
MFAGPH038YA8 = X90* ._HKS6WU/QE<:_HOAZ74H+:ZN=$-[>SFU5FBE\P [
M5Z9&X+SQU.,U2AUGQM=^&_$EV-<M89?#D]S!YBV2L;XQ#?EP3A 5*C"]\G-
M'J]%>8ZIX]>YO]*LCXAL?#<<^DQ:E-<SHCL[R?=C0.<8&&)/)Z=*B@\<ZYJV
MG>&4TVZL3=WNI7.G7-PL>^%_+5\2H,],*' SSTSB@#U.@$$9!R#7F-_J7B2U
MC\8:!=:VMQ-::4M_:WPM$1PI#[D91\I^Y@'J,YKH_AM!=P?#W1/M=[]J\RR@
M>+]T$\J,Q+A./O8]3R: .KHKGO&VOW'ASPS->64<<E])+%;6RR9V>9(X12V.
MPSG\*QQ?>(?#7BG0['5M8CU:RU=I("QM%A:"94+J5V]5.",'D<<T =S17 ^
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MY5%HOQ!N&O\ P_-/XKTK4VU:=(+G2K=$#6AD4E=A!W':V%.[.<]J /6:***
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MM&_#A>V00<5U'B3QDZ^+[_1E\5Z=X<BT^")M]S&CO<RR MC#GA%&W..<MUH
M](HK"\&Z\WB?PCIVL2+&LMQ&?,$9RF]6*MM]LJ<>U;M !1110 4444 %%%%
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MV2J[5"YP.N377W^FV>J6ZP7UND\2R)*%;H'4AE/X$ U8+J'"%@&()"YY..M
M'"^'M'\5:1#I>B/9:0+'3RL;:EO+23P)PJB+:-KD;026(&"1FKVD>&[ZQTKQ
M9;2F'S-5O[JXM]K$@)(BJN[C@Y!S6]I^MZ?JEW?6MG.9)K&7R;A3&R['],D
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MVX'E!MN>V2=HY)XH T?M'B#6_%=_H%GK\EA!HMK;BYNH[6)Y;J>12V2&!55
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MCU<:=;QQZ?-:"TMI7D*%F1@VXJ-V<'/ Q@=>34%CX*U*V^#+^#WFM3J+6<L
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M6?[>J37MC+"B0Q12+N_=%5+;UR,;B0W>JGPJL[Y)_%$]SK%U=HFMW=N8I4C
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MA@,,-O%=''J.L>,_$=_9Z;K,^BV>G6EM)^XAC>26:9#(-Q=3\JKM&!C))YH
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MXV!5-F-JDA0I;<>.U=IH'B&R\2Z?]NT]+H6Y;"M<6[P[Q@$,H8#*D'J.*U:
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MA%78^.>Q.1GM3QX.UZ[U76+S4=1L6&LZ6;&Y2%&'V<C>$\O/5</SNY)R>,X
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M%HRO\7)'/% 'GNE1:YI_PGO?$5CX@NK1M/GNYK:TB2,PN%N'+"0%26).X<$
M#''7.WKGBU;SQ5=Z==>(M0T.VL[2!XA86IE:6:12Y+GRW^51M&WC.36Y%X(N
MX_A?J'A4W4!N;D7(6;!V#S97<9[\!A4L_AS7],UF35/#MSIV^[M(;>[AOE?;
MOB!"2*5YZ$@@]<#F@#3\%:O=:]X.TW4;Y-MW(A67Y"FYE8J6VGH#MSCWK?JI
MIEO=VNF6T%_>&\NTC FN/+">8W<[1P![5;H **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHJAK>KVV
M@Z'>ZM=MB"TA:5_4X'0>Y/ ^M $$7B?19O$DWAZ/4(FU:&/S)+;!W!< ]<8Z
M,#C.>:UJ^=DUO1M-\*Z7XN77-/F\5Q:DVJ7=NEPIDDCF(62 #/:/;QVVFO4/
M$NJ7&L:WX5T;2]3FM++5TFNYKJT($C0QHK*JL0<;BXR>N!0!U%OK5G<Z[>Z/
M&7^UV<4<LH*_+MDW;<'O]TUHUXY=?VEX>U7XC.FIW$]Q:Z+;O;7<F/- "RE=
MQ  )!R,XZ 9YYJ]?1^(["[\)3Q>*+]IM=D%O>(X1HHPT1?=$NWY2N#@G/;.>
M<@'J%S.MK:37#)(ZQ(SE8UW,P S@#N?:H=,OTU338+Z.&>%)EW".XC,<B_[R
MGD&N M[S5-$O_&^C_P!KWM[%9:6E[9S73AY8F9),C< ,C*@CTK-L=;U_4O"_
MP[$>L3PW.JRR1W=P &9U\MR3R,;AC(XP"!P>E 'K%Q,+:VEG97=8D+E8UW,<
M#. .Y]J@TO4(]5TV"^BAN(4F7<([B(QR+SCYE/(K@X+K4]"UGQ;HO]L7M]!;
MZ0M_:RW;AY87(D! 8 9&5!&>E9%MKVLW7PY\(:C?ZAJRV-P)&U6^T]-\ZXW>
M63A20N1R0.P]: /69[F"V"&XGCB$CK&AD<+N=C@*,]23T%2UXWXFA.IZ!X-F
MMO%MYJ5M-XBA@BNX65&*,6*E^.94VXS@=\KFMN6#6=3^)-UX<3Q%J5KIEIIE
MM.SPNHFD<,R_>*X&[JQ YP.F: /2:B^TP?:OLOGQ_:-GF>5O&_9G&['7&>,U
MY)XP\1S:;+KFI6GB;5KC4-/G!AM;*T=K*!5VYBF8(5+'YLDL,9'3%::6#_\
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M[K\CD 9QAAGJ0:WFCU7PYX^\.6[:_?ZA!JXN8[N*Z*E Z1^8K1J -G((QZ4
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MV)881,9F@(A8$] _0MSTKR_7[275+CP R>*[R_BN+Z1$O;5D3>H60J^,$>8
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MNKWTL-Y>E+EIW#-*A53M) ' SQ5J"VU?Q+XR\6Z>_B+4;&QL)H%MDLG5&#/
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M)ZG=ZQX3TO4+^!H+R>W5IXV0H0^,-P>G()Q6S0 4444 %%%% !1110 4444
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M=:20N9]AVMY<PD/'7D#%:NM>%6UCQ-:ZFUR$@BT^YLGC ^8^;MY!]L&NEHH
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MIHX;>%"\DLC!511R22>@H X>#P%?V&EV+6&HVZ:MI^HW-[;RR1%HF69FW1N
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M)'(22H &,E1D[1TJ2Q^)?A6_O;>UCU"6)[E@MN]S:RPI,3T"NZ@'/;GFNMH
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M-Q_OX.,]L4 8GA74IX?&%O96,_B6]TNYM9#<-K%M,ODS*5*LKR*,;@6!4<9
MJY\0(TOO$O@K2[L!M/N-3>29&^Z[1QEHU;U!;MWK=T73?$D6H_:M<UJVN8TA
M,4=O9VQA1B2"9'W,Q+<8 & ,FI/%7AFV\4Z2MI-/+;3PRK<6MU#]^WF7[KK^
MO'H: +^JZ1I^MZ<]AJ=K'<VKD%HWZ9!R#[<BN.,5WXL\=:]ILNKZC8:?HR6\
M445A.83))(F]G9AR<#  Z4^X\(^*M<@33O$7B>WETH,//CL;,P2W2@YVN^X[
M0<<[1STJ]?>&-6M?$=WK7AO4K2TEOH8XKN"\MFEC8Q@A)%VLI# '&.AXH XP
MZ]K]YI&AZ?\ VQ/%>1>)Y='N+Q  TT2"0;B,8+8P>1C(!Q6E9Z1J3^/=5\,-
MXFULZ2EE#>@FZ)N%=F9=HEQN"<9P.^.V0=B#X?"UL-"@343)-I^JG5+J>2/F
MZE8/OX!^7)?CK@#OUK:M_#[0^-KWQ#]H!6YL8K00[.5*,S;LY[[NF.U 'G$6
ML^(+OPKX7M4UJYCNY/$4NF37@(\R2%3,N6[%L*.HZ@$YJ_JFK:CX!UO6;6+4
M[W4;0Z#+J4"W\OG-%/&X7 8\[3N!Q[5%XA\+W&BV7A;3(=1VW$WB=[F.X6+_
M %;.LSKE2>0"0#SSSTKI8?!-WJ>H:I?^*+^WNYKW3VTQ([. Q1Q0,<L1N9B6
M)P<YXQ0!SGAW5KR#Q!H0M+SQ1J'VLF+5!J5E,L(S&6$B%D"QX< 8'&&_&LY&
MUV?X5WWBQ_$VJKJ%B]R]LB38BVQSL-LBX^?.".>V .G/?Z)HGB:SN[)=4\0P
M7%A8QE$CM[4QO<_+M!F8L1P.<*!D\^U5H_ TD?PUO?"?V]2]RMP!<^5POFR,
M_P!W/;=CKVH Y[Q/J4\>OS3:WK&N:+ILEK"VG7M@&^S1R$'?YVT')W8X?C%6
MO$MVEQJ\=K)XDUR:6.PC=;;P_;R95SG]_(R9&&P-JDXX/7.:VM4\.^)9OM-M
MIVO6B:?>6ZP2PWEH93#A-C-$0X'(YPV1GZU5@\#:CI5_(-%UF.VL+JSM[2Z$
MMN7F40IL#1N& #%>.0<'G':@#CF^U>*M3^%]_>ZG?PW%_:W'G-;3>7AT@)WJ
M /E9LD$^G%;9\3ZCIOCSXAL]S+/::3ID-U;VSL2BL(=QP.V2.:M1?#W6++3O
M#2V.M68O?#TDRVLDMHQCDAD7;AU#YW =P0*UK?P0H\6>)=7O+I9[?7+2*UDM
MA&5VJL>QN<\YY^E '+WB:QX=\%:7XR;Q#J=U?EK6:]@FFW6\J3,@=%CQA<;^
M",'BM"UL-2\3^*O%]I/XAU2TM+*ZC2UCLY_+*,T*$DGJ0#R%Z9)SGC%F+P+K
M4^GZ=H6J:[;7.@:?)$ZHEH4N+A8B#&DC[RN!A<D+DX[5T6C: VE:UKVH&X$@
MU6X2<($QY>V-4QG//W<T 5?AYJUWKGP_T74K^3S+J:W'FR8QO()7)]SC-=-6
M)X/T!O"_A/3M$>X%PUI&4,H3:&^8GIDXZUMT %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445R'CF[
MN])E\/ZO!<S16UOJ<<-[&KD(\,W[LEQT.UF4C/2@#KZ*\RT_7]0/Q0FO9KZ;
M^P[JYN=)A@>0^4DD$2/O Z9++.,^U9UKJ,VH>&=+O-5UK6U_MK4+J\BT_3A(
MUQ-#DB.-&4YCC5=K'&!SVS0!Z]17D%IJ&NWOA"]AMSK\UKI^OFWN$1R-0^Q"
M,/MSG<6#.O0[BHZUVO@2ZL;K3+LZ=K5]J-LMP0([_=Y]H=HS$Y?YCSR-WKU(
MH M^(/&.D>&KNUM-0:Y-Q=*[PQV]K),S!<;CA >F15;3?&WAKQ%?C2%DD%W(
MN]+6^M)(3(%YRHD4!L8SQZ9KG_&=[>:?\4?"L]CI<VI3BRO +>&1$8@[,G+D
M#CZU M_J7CCQ[IMI/HYT;_A')Q>W(N9T>9RZ$(J!,C:<\G..,=: /3Z*\3N]
M>U/4UUW5+4^+'UBWO9X]-2QMYGLU6)RJHRJ-C[MIW$Y//;%=0D=UXU\8ZQ97
M>HZIIUII=K:B.WLKEK=O-F0NSN5Y)7@ 'C@\4 >B5GZOJATFVBF&GWU]YDRQ
M>791"1ES_$02,*.YKSG6[W4;37-(\-:U?Z[?Q6^F-<W,VB02++<R&38A?RSN
M50JG." 6/X5F:YKOB"U^'5F[W&L6DT7B)+6&>Z5X+B>V))4OT)R" 3WVT >T
MT5Q%KJ=QHGQ*UG3M1O96TZ^LEU&S,TA*P^7\LR+GH/NO@=,UQHU[5YM#T:XO
M;K6O*\3:G<7;1V&^2XAM$4F.*(+RH("DE<'!- 'M-9E]KMKI^MZ3I,J3&XU,
MRB%D *KY:;VW'.1QTP#7E\^O:WI_A[7K.R.NVMK+=V=OIMWJT,BSQ"=MDH#2
M#+;<$@G)&\>@K6O-!_L+XF^"(X=2U"ZMY#>_)?7+3LKB#E@S9(SGD=.!@#F@
M#TVN;7QE:W&EZCJ.GZ;J>H6]E<?9P;2%7-RP(5C$-PW*I."3@<'&<4_QYJ,V
MD^ M=OK=BL\5E(8V'56*X!_ G-<;XT$_A3X HFD7,UG-:VUHJ36[E'!+IN.1
MSSDY^IH ]24[E#8(R,X/44M>>ZA#>ZS\2[;1VU?4+;3FT$7,T5K<-&9'\[:.
M1RO7DC!. ,XS6A\/)[O[-KVG7-[<7B:9J\UI;RW,A>3R@J,H9CRQ&XC)H [*
MBN'U#69O#GQ#O'O;J8Z5=Z,]W'&[DI'+;G]X%!X&48$XZXKD-.\1Z]H_@3Q)
M;ZC?7,^L26UM=63R2$R(UX@143/0)(&QCI0!ZI::[:WGB#4M%C287.GQPR2L
MP&PB0,5VG.?X3G(%/U?5#I-O#,-/OK[S)EBV6<0=DS_$P)&%&.37G>E>&I+_
M .(.OZ==:OJ216VG:>DSV]RT<L[A' 9I =QZ,<9Y)YZ5CZEX@UJ'X6Z+*-6O
M/M<7B'["]T)2LDT22R* Y'7(49]<4 >V5F7.NVMKXBL-$=)C<WL,LT;*!L"Q
M[=V3G.?F&.#7*7%O/XM\?:WI<^J:E96&CV]L(X["Y: O+*&8NS+R<   'CKQ
M67J6B:E)XV\':5J.MSR7"Z?>K<7ML/)EE0&/&",E21M!(YZXQG@ ]2HKBO [
M7-GX@\5:#)?7=Y:Z==0FV>[E,LB+)$'*ESR0#TS3O&,]U>>)/#?AN&]N;*VU
M)[B6ZEM9#'*R0H"$5QRN2PR1S@4 =G17 :OI]QX9\.7MM=>*]26QN+R%;1E1
MI[U5)&Z!'SN9F(.TXRH)ZXK!L;W7&A\7Z1H+:Z'BL[:XLXM3<FYC+LXD",Y)
MY5/ER>&H ]=HKR%_$<&C>%O$=[H>L:W]M@M8U;3-961Y[65WV"4>9DD?-T&5
MR!6CX9NKNU\8:=;Z?'XMET^YAE2_;6H)MBR*H9)%9QA22&4@8!R.* /3:@DO
M;6*^ALGG1;F='>*(GYG5<;B!Z#<OYU/7FNM:0EW\<-(+7NH1AM,EFVQ7;H 5
M=!@ 'A3CD=#WH [?1-=M=>AO);5)D6TO)K.3S0!EXVVL1@GC/3^5:=>,V.BW
M%QX4\;ZLFLZG:366J:G-:)9W+1(C(S-E@OWR2,'=D8Z8Y)LWOB.?6M8TVUU%
MO$)M5T2VO'CT*.7<\\V<L[1<A0%X'3)/I0!Z[6+X@\5Z/X96 :E<L)K@E8+>
M&-I992.NU%!)^O2JG@.\U.\\*PG5H[Q;J*66$/>0F*66-7(C=E(!R4VY]\UC
MZ&B77QE\5SW0#7%G9V<-INZI$ZLS[?JW6@#=T+QIHOB&]EL;2:>&_B7>]G=V
M[P2A?[VUP,CW&:Z"J%Y8:>U[#JT]I%)>V<<GD3$?.BD?, ?<5Y:B:K<_"V7Q
MZ=?U--;\A]015NF^S*H8D1>3]PKM&.1G/.: /8:*\UB2[\5^/]0LYM6U*UTS
M^R;2Z%M:731$2/OY# Y'OC&<#/2N:_XG)^$][XGE\2:L^IZ5-*EJRW+*A2*;
M9B1!Q(6 .2V3R* /;%AB29YEB02N '<*,L!TR>^*?7G4MK>>(OB9JNFSZQJ5
MMI<6FVT_V>TNFBS(Q<9!4Y P#G&,\9Z5E6VKSMX6N-)U37]4#V/B"734DM$:
M2]OXD^98PR_,&P1EQV7WH ]:HKQ:ZUW5+/P5XX@LKO6+?^SI[5K)M1D87,(D
M\LLI8G<5SG&3T:NDN].NO#_CGPU#'K>JW*:O]IM[Y+BZ9E<K"7#HO2,@CC;C
M H ]%HKRFW\4ZII/PZUW2[FYFN/$FF7;:5#([$RSO*V(),GDDJX/_ 37I.D6
M4NG:-964]S+=300I')/*Y9Y6 Y8D\DDY- %VLS1==M==2^:U29!97LME)YH
MR\9PQ&">/3H?:O/=+N9;?Q3##K^KZ]IFN/J+B/SF=K"\B+MLBC'^K&4V@=&#
M>IJC8:)/>:!XZU-=9U.TEL]6U*2U2SN6A5'0EMS!?ODG P<C XQDF@#V.L3Q
M)XHL?"T6GR7T5Q(+Z]CL8O)4'#OG!;)'R\'ID^U<5?ZHFL6WAPW^IZ[)/<:1
M'=R:;H:.LC,X7]\[H1A0<@*<#/K7.ZYJ5WJWPV\"75]+++<#Q+%"TDPQ(PCE
MF0%O]K"C/OF@#U=/%%B_C23PL(KC[='9"],A4>7LW!<9SG=D^F/>MNO-[?\
MY.+N_P#L7!_Z.6MKXGWUUIOPWUJ\L;B6WN8HE:.6)RK*=Z]".10!UU%>8:MH
M^HZ;XU\-V$'B36-NM+<QZ@6NB0WEH),Q@\1$X(^4# /&*9!>3:(GCS1YO$=[
M;66G-;&VO;DM=36XFC!*KD[F.>%'8F@#U(\#-4-&U0ZQIJ7IT^^L"Y8>1?1"
M.5<'&2H)Z]1S7!>$;^6W\=2Z5;MXA6PFTIKHQZVSL_FK(J[D+DL 0_(X&1TK
MF]"UK7;[X2^%IQK5ZM_>>(([5[MI2[E&E=<$G[PQC@Y' H ]PJ"RO;;4;1+J
MSG2>!\A9$.0<$@\_4$5P$>FS:5\0)- BUG5Y=/U'1I9W$]\[R1RI(J[T<G*$
MACTKG?",<.G?!?1YY==U6S.HS(C+;M)-+)^\?]S H.8V8 Y*^A- 'L-[<FSL
M;BZ$$UP88FD\F!=TDF!G:HXRQQ@#UINGW9O]/M[LVUQ:F9 _D7*;9(\]F&3@
M_C7EUAJ][;Z+\0K.VGUJ&#3]+%S9_P!INWVF!WAESAB2V,Q@CGCFDM;S5]4T
MSX9VW]LW\#:G;S?;)HYCOE @W')/4\'!/(SD<T >MT5P_A%;C2_&_B30/[0O
M;NQMX;6YMQ>3M,\1D#A@';)()4'!/%/\;3W5WXA\+^'(;VYL[?4YYWNI;60Q
MR,D,>[8&'*@DC..<"@#HHM=M9O$MSH*I,+JWM4NG<@;"CLR@ YSG*GM6G7CN
MH3W7@KQ+XSN[:[N+M[3P_#):-=.97CR[@!F/+ ,2><G'%:FHV%[X.M/#NLPZ
M[JMW<SW]M;7Z75VTL5PLIVL0AX4@D$;<8QB@#TZBO---TW4O&JZ[JR^(=3T^
M\@U*>TT];>=EA@6)MJEHAP^X@EMV<YQQ6WX=O+Z7XA>*K.ZNY)H[:WL"D>X^
M6C,C[RJDG;DC- '845XY#J>LWWASPK&FLWT,UYXCN;6:=9B7,6Z<;<GK@ 8S
MD @<<5IV.A7,GC[6/#+>(-;.CQV<-XL9OG\T2,67 ESO"_*3MSUQ0!ZA3)H8
MKB)HIHDDC;[R.H(/X&O&8?$VIOX6\.:5=WFL3BXU&\M[FXL%:2\FAMV?:H*_
M-D_+EAS@'FI+_6-;LO!7BE+*37K2VMKBR;3+K5(Y8YP))5$B;FPSJ"#W)P^#
M0![%%#%;Q+%#&D<:\*B* !] *CM;VUOEE:UG2812M#(4.=KJ<,I]P:X*XTZY
MT#Q[X>LX=;U:XAUF*[AO%N;MG!9(PZN@Z1MG/W<#TKGO"=O%I7P\\0W[^(-2
ML&DU*XM_M!D>X*_O\92//,K9QN'.3F@#V4D 9)P!61=^(;>'1K?5+*UN]5M[
MAD$?]GQB5BK?QX)'RCN:\YLIY9-1U_1(9_$MOI\FB&\5=4FD6=)5<C<CL2P4
MC&1GL:R;A[OP]\"/#UWINIZC#/=3VA9OM3_*&X*+S\J_[(XH ]SHK@KB&?Q7
M\0]7TFXU+4+73=(M;<K#97+0&667<Q=F0@G 4 #.*YJ75]<DT:TTE-:NTN+3
MQ@-(^W!_WLD&UB-_9F 8=1@E03F@#V*BN#T:WGT'XGR:+#J>HW6GW.D&\,=[
M<M.4E68)E2Q) (;D5?\ B%J5[9:/I]GI]R]K/JNIV^G_ &F/[\*R-\S+[X!
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MUQ>B0P16=LTS,$QNX7GC<*ATGQK9:QJ4=C#IFMP/("1)=:;+%&, GEF&!TH
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M8%B&;_:/..*]+KF=(\*W6C>*=5U.WU;=8:E+]HEL6MQD2[0NX29SCCIBNFH
M\8\/SZA8_#+5?&<^JZA=:E:QWL=HLMPS1QJ)' )0G#$'G)[ #H*TO#KWEEXE
MT4Z?9>+!#,'CU675A(T4G[LE9?F8A6W@#Y<##$5U^C>"[33?!=QX8N9VN[6X
M\\2/MV$K*S,0.3C&[K[4S2/#&L6ES;_VIXGGU"SM8FBBMUMQ#O!&W,K!CYA
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M03,KQ@, I "L "5'RDGD5035]2.C?%E_[1N]UG<2BU;SVS  K8"<_+^%=D?
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M1C YH SO$NH7L/B7QC%%>7$<<'A;SHE25@(Y,S?.HSPW Y'/ K%N]-OK/2?
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M\P@=. ,\XS0!YNEK?2?!VX\6R:YJS:O:&:6UD%[(%C"3L I3.UP<'.X$\XZ
M"NBBTFWNOCJUQ)->!AH<5YM6[D"[_.(Q@-C9Q]S[N><9K?7P)&OPXN/!_P#:
M#;)DE7[5Y7(WR,_W<]MV.M2WGA"XD\8VGB&RU;[,R6:V-U;M;B19X0^_ .1L
M)R1GF@#@?[36&_T?5],NO$E[-<ZU%#+JD[,EE<122["BQE\;0#A2%ZKG-:OA
M;2(+;QMX^NH[B^\VUE01[KR1A\T&3N!;#$=B<X[8K0'PTOQHUEI1\42FUTN:
M.?3%^QJ/):-PRF3YOWN!E?X1SG!.,:]MX/N[/Q/JVJ0:SBTU9%^U6;6H.9%C
M\L,K[L@=#C!^M ' ^'-7U74_AIX%TZ35+U9=9U"6&[O!,WG&)'E8J'/()V@9
MSD"MR]2;PGXGOM'T^^OFTZ]T&YNDBGNI)C!-'@;D9R6 (;IGJ,UJV7PWBL?
MVD^'XM5E6ZTFX-U9Z@L0#)+O9LE"2",.5(SR*MVW@RYDN]0U'6=9^WZE=6+6
M$<J6PACMXFY(5-QR2<$DGL!Q0!Q8M+O3O!7@_P 5#6=4EU:>;3Q.\EXYCDBE
M*J8S'G;C#=<9)&2<FO8JY:X\&)<>#]%\/_;F5=,:T83>7S)Y!4CC/&=OKQGO
M74T >::KHUO=_'73GDGO5SI+W&([N1 &25   &P%( RO0]2#5&QL+CQ/X*U?
MQ=<:OJ<.JE[N6R:&\DCCM5B=U1!&#M(^3G(.<FNSUGPK<WWBS3O$.GZM]AN;
M6!K:5&MQ*LT3,&*\D;3D=>:RY_A_?"#4M,T[Q'+9:'J,LDD]F+57D3S/]8L<
MA/RJV3U4XR<4 =+X8U*76?"FD:G. )KNSAGD &!N9 3C\37'_%G3HKV+PJ9)
M;E-VOVL!$-P\8VNQR?E(^8;1ANHYP1FN_L[2"PLK>SMD$<%O&L4:#^%5& /R
M%8OB_P ,MXHTRU@BOFL;JSO(KVWN!$) LD9R,J2,CD\9H Y&/PW!J7Q1U?3Y
M;R_2RM])LU9(KN1'E(,@4O(#O..3UY)R<XK#37=17P]I.ASW.L7<+:Y>V4TE
MFS-=S6\!<JFX$-S\H)!!V@UZ7I/AR:P\0W6M76H?:KJZLX+:7$(C!,98EP,G
M&=W3MZFLK_A7XBTWRK759(+^+59M4M;Q80?*>0ME"I/S+M8J>1GVH C\ RWR
MZAK-H;/6K?1T,,EB-65O,4L&$B!F))4%5(R3C=7;M]P_2LG0M*U#3A=2ZIK,
MNIW5PX8MY?E11@# 5(P3M'<\DDUK$9!'K0!Y]\$?^24:5_UTN/\ T<]+\1K^
M\L_$7@>.UNYX$N-92.98I"HD7CY6 ZCV-,T'X?>)?#.CPZ5I7C@PV<)8HC:5
M$Y&YBQY+9ZDUJZAX+N]8_P"$<EU/6S<7>C7OVQIQ:JGVCG(7:#A<# R,]* .
M7U5C8^*K^7Q'>:_ILCWRMINJV\KM91P_*%C95.Q23D-O7G.<U<T'1K?_ (77
MXHN//O2T$%K,BF[DVDN),@KNP5'93PO8"MG5O!>J:L;ZRD\33?V)?2F2:SDM
MA)(%)!:-)2WRJ<<#:< X%7!X5N8/'4WB.RU;R(KN&.*\LVMP_FB/.TJ^05Z^
MAH \RTK5]9N/A"MPNKWBWS>(D@6Y:9F=5,ZC&2>5YZ'BNJN(&\&>/+%+&]U"
M>VO=,O)KB&[NY)P\D.QE<;B<$Y(.,#VJ]8?#6*Q\(IH U1W5=374?.\D Y60
M/LQN]L9S70:AX=CU#Q/INLR3<65O<0&#9D2"7;G)SQC;Z=Z /+=1L=1A^#T7
MBZ/7]5&L7<<%Q<R?;'V.LLB_($SM0#<,;0#QCH2*]MKY_P!16TO/"2^%--\1
M7UU*+M(++09K01W,!$PXF89)1%W$'@<#DXKZ H \Y\=2ZG#\2?!CZ1:V]S>"
M&_VQ7$QB0C9'G+ 'M[5TFCW7BNYO6CUO2-,M;0H?WEK>O*^[L,%%XZ\YJ#Q1
MX3O=<UK2-6TW6SI=YIJS*C_95G#"0*#PQ Z+^M&GZ'XLMKZ.:\\9+>0+G= =
M+CC#\''S*V1@X/'I0!Q,^H:M!XD;X9IK$NVXN!/'JAN2;B*T(+M!N)SYORD
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MC>XU'4$UYHKJ]@N([N15M_+9]D:H#MV80 @@YR: /8J*Y#7/$=Y;?":X\10
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MDMY8S"L\;!<X95;[C<G)'!XR.*Z:LSQ%K*>'O#NH:Q)"TR6<#3&-3@L .F:
M(;;PS86OA >&5\QK'[(UHQ9OG964AB3ZG)-<_'\/[XMI$UUXGNI[G2)5-D_V
M9%5(PI1E91]XLIP6)XP, <Y[2WF%Q;13@;1(@?'ID9J6@#@KGX;2S6.KZ3'X
MCNX=$U&2:8V20)F-Y,DXDZ[=QSM_ G!.=&[\&2OKFCZO8:Q+9W.GVGV*3]PL
M@GAR"5(/W3E>HKK*J6&J6>IFZ%G,)?LMPUM-@$;9%QE>>N,CI0!BV_@Z"W\*
MZUH(NY#'JCW;/*5&8_/W9P.^-U5[GP5*EQIU]I&L2Z=J5G8K8-/Y"RK/"N"
MZ'N",@@C&3UKK:* .,?X=VLGAQ]+DU"XDGGU!-1NKQU4O/,'#'(& !\H  Z
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M[RH2,D<]3@@<5Z]10!Q][X&>ZU359(M;N;;3-6*M?6,<2_O"$"';(>5#*H!
M_ BG:+X'_LJ_T2\EU26ZDTFP>PBS$J;XR1MSCN H'O75S2K!!)*V=J*6..N
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M2[%P@N L*@M*Q90%4L/XN21P:ZB'X?6R67B."74[RXEU^%8KN>7;OR$92PP
M!][IC P *=)X%\JUT%=,UFZL+O1[0V4=RD<;F2(JH(96!&?D4@]C0!YIJMLM
M]\.+^WO;:ZB73O$RVMM;SW)=[>)GB)C+*Q#8W$#DX[&NMU.%=*^,7@C3+)I8
MK);*[ A\UF!PC8SDG/XUIR?#&T;1M6TI=7OQ;W]S'>JS;6>*X7:3)N(RQ8H"
M0>.N,5I+X-\WQ%H>O7VJW%W?Z5#+$':-$$WF @E@H & >WI0!QFFZ);^*O!^
MN>*-1GNO[7::\:VN$N9$-F(F98U0 @ #8#TYR<T:6'\9^*O#O]K33FWNO"J7
M5U!'*T:SN9%^]M(XRV<>P[5TUW\/C(=1MK+7[^QTG4Y7EN["%(R&9_\ 6;'*
MED#=P/4XQ6S;>%[*S\16VK6S-']FTW^S8K=0-BQAPP]\C:!0!YY;:;J4WA[7
M]&TQ+J]LM+\1[?L(NV226T"(S0K(3G&6S@GD C/-=?X ET@V^HP:4FJ6GE3K
MYVF:CG?9L5'"AB2%;[WWB.N,5+)X)0+J$EGJ][9W=WJ7]I)/#MS%)L";=I&&
M3 Y#>M:'A_P\VC2WUW<ZA/J.H7S(UQ<RHJ9"#:JJJ@  #/YF@#G=<M(O$OQ-
MA\/ZF97TJUTC[=]F25HUEE:4H"VT@G:%X'JU9^K:-+9:IX5\&2ZI>W&DWUU=
MS2!I660PQIO2 N#N906]<D"NKU[PL=5U.UU:PU2XTK5;:-H%N8$1P\3$$HZ.
M"&&0"/0U0_X5Y9II%K!!J-[%J5M=O?)JF5:8SOG>S C:0P."N,8 H Y/78?^
M$8O?&&@Z7+/%ILOAB348X#,S"WE!="4))*@C!QZBI;G1H="B\#:Y:W%V=5O-
M0M;>\N'N';[0DL;;U92=N,@8 '&.*ZJ/P)%+9ZV-2U6ZO]0UBU-I/>R(BF.+
M:0%1% 50-Q/N>M:-_P"%[>_L=#M7N)572+J"YB*@9<Q*5 /L<]J /,X;6V\.
MW?Q.UK3XG2^TX_Z+(97;RRT )."<'DYYS6EX;L;ZQ\0Z%/I7AW7[)&W1ZK<W
MUPCI<H8R0[#S6^?>%(( X)'2NL_X0>'_ (2#6+[^T;@V&LIMO].9$,<I\OR\
MAL;EX]#UI^C>$KO3+VTENO$FI:A;V,9CM+:4(BJ"-N7* &0@< M]>O- 'ES:
M6/\ A3=]XH-W>'6;*ZF>SN?M+_Z.%NB JC.,'G.0<Y]ACL9-&@\-?$CPD;":
MZ\S4X[N._>6X=_M)2(.&8,2,[N>,=:W#X"LSX"NO"?VR?[-<-(S38&\;Y3(<
M=NIQ6K?^'X-0U_1=6>:19=*,QC1<;7\Q-AS]!0!Y3IWA^&]^$NJ^(I[V].K6
M?VZ>SN1=2 VWE2R%54 XP2ISD?Q>PQK17DFH?&3P?>S "6X\.-*XZ8+9)_G4
M?@[P5<ZWX%-M-K>H6>GWMW=?;;%$3$H$[C 9EW(&4#(!P?Q.>ZE\(6;^,=/\
M1++)')8V;6<=NH&S8<_CQF@#S.>>!)M.\0:18ZY*\VMPJ=>NKE52XC>?8R"/
M?DQX.T?(.@/O5R&RM-$\8?$[6K2!A>:7:Q7-JQE<A7:U=F)!.#D^N<=L5T9^
M&*G2H]+/B+4?L-G*LVFPA(P+1U?>ISMS)CD#=Q@GO@C47P4J^)[_ %<:I<&#
M4X$AU&R:)#'<[8S&"3C*\'HI% '%>&[34(-0\-WNF>'M?M[AW4:I?7EPCQW<
M3H=SL/-8D[BK#@8Y'M6;)H\&M?!;5_%UW/<G6KR&ZGDN/M#\*)&7RMN=NS:-
MN,?KBO1M'\&W.EW5CYOB34KNPT\$6=G)L15&TJ-[* TF <#/ZUF7/PPCGTW4
M-&3Q!J,.@W;R2#3D6/;&[DMP^W=M#'=MSCUR,Y .RTC_ ) MC_U[Q_\ H(KR
M#2?"UG?_  \\2:S-/=#4+6ZU"6SFCN73[*8Y'8;0I ^\"2<9.?85[-:P"UM(
M;=6++%&J GJ<#%</_P *S,>G7NF6WB34K?3=0FEEO;=4C/F^8Q+!6*Y3(.TX
MZ@>N<@&=HNJW.G^+- U:]F86?BK1XC-N;Y([N.,/GT7<A8>Y%;7PZ\_4;'4_
M$UR\A.M7CS6Z.3\ELGR1#';*C=_P*LCXC6UGK>G67@?2H+@ZGY\!A:&)PEE$
MO61GQC 3<N,Y.[%>B65I!I]C;V5L@2"WC6*-!_"JC 'Y"@#SO6-"TZ]^.>ER
M3PNS/I4EP<3.O[Q)$"G@]AVZ'OFL&V\-65_X*\;ZO<R71O+34-3ELW2X=!;L
MC,P*A2!G<,DGD\#H*]&UGPHVI^)-.UZTU6XT^]LXV@8Q1HZRQ,02I# XY'44
MMMX1M;;P]K6CK<S&+59;J61R!N0SYW ?3/% '%2ZC=W7Q$^&4LMQ(3=:9/+,
M Q =C!G)'0\TVSM(M'\40GQ+::Q::K+JC&WUR&=GMKE7D/EPMR0@*D)L*CIP
M1UKL!X(M%UKPUJ?VN?S-!M6MH4P,2!H]F6]\<\5 / LKW,,5QXBU"XTB&Z6[
MCT^54.'5]ZJ9,;V4-@@$]@,T :/CK_DG_B/_ +!=S_Z*:N*9/%GBOP%:>'%\
M-16%I>6<,,FH3W\<@6+"Y81J,EB!P..3S7H^L:;'K.B7^ERNT<=Y;R6[.O50
MZE21[\U+I]FNGZ;:V2,62WA2)6;J0H R?RH X*+2+7Q;\0/$=GK/G7%EH\=K
M;VEMY[HBEX][2$*1EB2!GMBN+\17=S-\-8+*YN);G^S/%OV"*:5MSO''(P4D
M]S@XS[5ZEJGA*6XUR76=(UJZTB]N85ANC#%'*DZKG:2K@X89(!':JEY\.-+N
MO"MCH"7-U'#:WBWIG)#232ABQ9R1R6+$F@#+N[F9/V@+:(22&$>'6?R@QVEO
M.;G'3-5?!WAA/$WA;3/%4NHWD'B&ZE^UM?).YP/,/[K83MV;1MVXKL9/"MM)
MX[B\5FXE%S'8&Q$.!L*[RV[USS6,OPVA7%@NM7X\/"Y^U#2-J>6&W[]N_&_9
MNYVYH Q[?7W\"/XTTRZ=Y%LU.JZ8)"27CFX$8]EE^7_@5=EX+T>?0O"&G6%W
M*\MXL6^YDD;<6E;YGY]B2/H!7(:W9V/CKXD:*ME!</!HCR-J5R8FCC8JRE(,
ML!O/F(&XR ![UWUYILMUJNG7J7]S EF9"]O&V([C<NT;QWV]1[T 3:A_R#;K
M_KB_\C7E_P /=:\86_P_T2*Q\(6UW:K; 1SMJRQF09/.TH<?3->JSQ">WDA)
M($BE21VR,5G^'-$A\-^';'1H)7EBM(A&LDF-S#WQ0!QPL5\9?$+4K'7XI/LN
MEZ?:M'8+<,(Q+-N9W)4C<1MV@URNHW%^/"TFCQ:C=*-/\91:?:W)E+2)"2"H
M+'EMN_'.>@KTO6/"DE[K:ZWI>KW.DZD8/LTLD4:2+-&#D!D<$9!)P>O-5?\
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MS_M5J>%P^M^.O$?B)F8VULPTBR&>,1_-,WXR'&?]F@#MZ*XP.W_"ZBFX[/\
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MZOEM[L3,&M4AW*B+S@+A>1WR<T >OT5S_@5BWP^\.,Q))TRV))[_ +I:Z"@
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M>1LV!R^>F<Y/K6L&!) (R.O/2EH Y+4/ J75]?RVFMZGIUKJ3![ZTM60),V
MI8$J60D  E2,U+J7@M+K6AJVG:QJ&DW3VZVUP;0H1-&I.W(=6PPR<,.:B\.>
M,;OQ+K^J6UIHX32M.NY+*2^DNAN:5.H$6WIR.<]ZZP.K$@,"1U /2@#S'PKX
M,AU+P==:9+)>6#V6OW-S97"'$L3)*P1QN!W#!/7.0:ZC2_!<.GZY-K5QJE]?
MZC/9FSFFN"F&7<&!"JH"XQ@ <=>I)-=/2$@#)(Q0!Q]E\.=+L?"NC>'X[N\:
MVTJ_2^AD8KO=UD9P&^7&,L>@%:NO^&DUJYL[Z"_NM.U*RWB"[MMI8*X&Y65@
M593@'!'4"ML,&4,I!!Z$5BW_ (B%GXHT31EMQ*NJ)<-YXDQY?E*IZ8YSN]1C
M'>@"SH>CKHE@;87=U>2/(TTMQ=/N>1VZG@  >@  %94O@N)O%%_K<&J7MO\
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MO$5O8VESXGT](_$]O)?222)I,%N9+:_E=>)%=4.U6;[R[QT.>.*] \=>*_\
MA#/"5UKHLQ>^0T8\GS?+W;F"_>P?7/2NB$B[%9B%!QU- &9X7T^;2?">C:=<
M8\^TL88),'(W*@!_45JT44 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MM(: S_Q>0/F\W']WR!7?6/A.VTC56UZ\U/5-5N;:W>* W;+)Y$9Y8(J*,L<
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MT*XV@JOS,<-@8S7N5 '@&B6-GH/@7XAZYIEE%#J=AJE[:VES&N'@C^1<*>P
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M\I&P'G//MQ4>G^!;:TUZRUNZU;5-1U&S22..:[E0@HPQM*JH&!R>,$D\D\8
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MG6IE:&!<!I7+NQ)R2Q/4DDG\:NT %%%% !1110 4444 %%%% !1110 4444
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MWM(6E?U( S@>YZ#ZUXE:I?:I\.]5AN_"WB)]<UBX;4A>0VJ%$FR&AVL7#!0
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M+LFA(7;D-C'(X(((/I56#P+I<6E:O933WMU+J\9BO;RXF#3R+M*@9Q@  G
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M*_O1J&(Y=IM[@<^9$0,H<C/>GV?@32(+74XKV2[U634XA#=3W\WF2/& <("
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "N)\<7$VI:QH7A""5XH]5DDEOG1L,+:(!F3(Y&\D
M+GTS7;5PNO?Z%\7O"MY+Q#=6=U9*QZ"3"N!]2 <?2@#,M]3U'2_B=XILM&T9
MM1D^RV)2'SU@BB14<?>(."<@  <X/3%2Z[K!\0> T\9Z3%+::KHCR3F&0_,O
MEDB>!\=5*AOR4\4Y=5_X1SXF^*+[4+"_&G7-O9JEW#:22KO5'^7Y 3SD\XP"
M,$C(JG;>=HOP;\4ZEJ5O):/J+7]VEO,NUT$Y81JP[$Y7CWH ])T^]BU+3;6^
M@),-S"DT9/\ =8 C]#5FL?PI92Z;X/T2QG!$UO8012 ]F5 "/S%;% !1110
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M+(H+8R #@'&?3- '40_$*,Z)=W%QI5Q#JUK?+IS:8)%9WN&QL57X!4@@[N.
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MSBN3U#PU>7-AJ]Q<Z5?3P6WB][][>(.DL]L8E0M%@@M]XD;3SM(KV$LJD!F
M+' R>M+0!Q'@FPT1=4O[[1]!U.RC\I(1>:@\X:?DDJJ2DL%4XYP,DG'2NE\0
M:C/I/A^_O[6TFO+F"%FAMX8R[2/_  @ <]<9]LUI44 >:>%/AG<6?A^"2\\2
M>(+34+S-U?1VMTL:>>_+<;#ST!Y[5@/X:UO2?#'B'PC:65[>6^EWL&I:3(R$
MBXB\Q9'B#8 +@AN.Y/2O:J* /-[C5;GQ-\0/!]Y9:-JL6GV;W1N+B[LWA".\
M! 7##/;!/3) !-9QT?4_^%&^(-/_ +/NOMLL]X8[?R6\QPUPQ&%QDY'(]J]8
M9E7&Y@,G R>II: .,UZQNYO&/@:>*VF>&VEN3/(J$K$#;D#<>V3QSWKBX]$U
M4>$/BG =,O/-O=3NGM4\AMTZD\%!CY@?45[/10!Q?B>QN[B]\$M#:S2+;:FC
MSE$)\I?)<9;T&2!D^M<]HMA>6-[\1I[WP[=7]K=7Z,MJT1'VJ(Y#%,C#X!)P
M.N,=37JM% 'DEGIL\^G>*-/\-VVMKH4^B3116NI)*H6Z8,%6$2_-C:>>V<4^
M$7>KZ/\ #H0Z5J4;:9?0Q7:W%F\9B*6^&8@C[N3C=TS7K%% 'G7B^(2^-XAK
M.G:OJ&C'3P+2"Q25HVN?,;=OV$ -MV8+$*!FN7MK/4=,\)^%UFT345?0_$<L
MEY!#:R2%(V>4ADXS(F'7YES7MM% 'G5EJ4GA;Q7K]]=Z5JTUAK7D7EI+;6,D
MK!A$%:)U4$HV0,!L=?:L:T\.ZO;V/@^6XT^=9Y?$<NHW,*H6^S))YC#>1P,
MKGW.*]>HH *X7QU%I%QJ-K'K.AZK*B1%[75-+25Y89,X*?NAN7C!&?E/X5W(
M92Q4,"R]0#TI: /,] L]>D\0^"[O5[>\>:'3KY)YID^9 SIY0D(X#E ,^X-5
M=>L=:BU'QU<6EKJ*P7-[II=[1&$LULL:";RB.20-P^7GK7JU(S*N-S 9.!D]
M30!Y1H=E;VGCJ6ZTKP_JEGI5[H\MM!-/!,3)*K!R7WY,8(X&[&2#ZC. _A_6
M3^SOHFF?V3??VA'?!WM?L[>:J_:'.2N,@8(/T->[T4 %<9J5C=2?%S0KU+:9
MK6+3;E'G"$HC%EP"W0$\\5V=-5T<91E89QD'- 'E6MZ)IMAXXUV]US1-:OH=
M0$,UE+IOVA@66,(T3")@ V5!!;C!Z\59AM&\'>(=%UN/0+Z'29-%^P2VMHKW
M4EE)YGF@-C+,/F89&>17IU% 'FNI7>LW]YX<\83Z!>10:;?7*FS1"]S]EECV
M+*8^H8$ E!D@&KVD0OXG\?7^OMI]U!I"Z2-,C^VP-"UR6D+N0C -M P,D#.3
M7>44 >3>"]"U@^*-/TS5;.Y33O":7"6EQ,A"W32.5B92>&VQ<<=":IS^']+T
M[4?$%IK'AG6]3O;N_FN+/[&]P(+J.4[@I9&")@DAMV.!GFO9:* .&TG29K+X
MJW4L=C+#8)H-O;Q2;6* K(WR!SU(&.^:[FBB@#C/#MC=0?$[QK=RVTT=M<1V
M @F9"$DVQN&VGH<$C..E<3;>&=(L([W1=6\*ZWJ.IM>RB+R9;E;:YBDE+*Y=
M6\M %;Y@<'(/!S7M-% 'D'B'2Y+_ %7Q/9:AHVKZCJ,H\O1@OF_9(X?) !W
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M6]HYU33(;"Z%H_RL[P["T9ST. 1SWJ=Y[OQAXT\.W4&D:G8V.D--<W$M_;&
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M#E-@!3<<=<X(.!TKGETZ"P\07FHZ7X6O]-TBZT"[M%EDMV5C*-K[I <E%(!
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M=AGD^]5]!\?:GJNFWNN76EVUIH>GBY%U,9BTK-$6_P!6N,$8 R21R2!TH ]
MHKCM'\1^*+FZTR;4O#T$>FZF,QO:3M+):97<OG J!@CC(/!J >/)S\*9?&7V
M"/SHXY'^S>8=IVRE/O8]LT =Q6!JWA.UUO6;6^U"]O9;>U=98]/\P"W,BG*N
MR@98@\X)QQTK-U+Q3K1\82>&]&TRTFN!I\=Z+BZG9(T!=E(;:I)Z# 'J>F*P
MQ\1O$<OA:[\01>'K-;;2Y'BU&.2[;>SQMA_)PN" .<L1W&.,D ]-HKC+[Q7K
M-SKEUIWAW3K"Z-G:174HO+EHGF$@8JL8"GLOWCQD@5G2:YXHF^+.GZ=#!;0V
M+Z1]J>VFN&!56DC#E@JD&13N &<8)Y&: /1**XB_\6^(-,N/M][HEK!H?V];
M/Y[AOM6UI!&LVW;MVEB#C.<&B7Q3XCO_ !!KVCZ%I%C(^DR1AI[RX9%D#QJX
M4!5)W9)'8  >M ';T5PD7C^YU71_#C:-IL3ZKKD<CQPW,Q6*!8Q^\9V )(!P
M!@<Y[5-+XPUJRTT07N@K'KDE^NGVT0E/V>X9EW"59"N=@4,3QD;<4 =K17"7
M7CO4-%LM9AUK3K5=5T]+>1%@N#Y$Z3/Y:/N905 ;(;(XQGFM_0KW7Y[BXM]<
MTZTAV(DD-U93F2*4'.5^8!@PP.V""* -RBL7Q!?ZU:FTM]$TV&ZGN'8/-<R%
M(+=5&<N5!))Z  5S4WQ"O+;P\MY+I"2:A%K*Z1<6T,V5,A(&Z-B!D$%2,XZ\
MT =_3))8X4WRR*BY W,<#)X%<?9^+-5L?$<^D^);&RMA_9\FH0SV4[2+L1@'
M5MRJ=PR#D<&N1\6>(?$&M_#ZVU*\TBTM]*U&ZLY+?RKAFFB0SHR&0%0N& ['
M@D>^ #V&BH;LW*V<QLTB>Y"'REF8JA;' 8@$@9] :\Y\#>)/%=W\.(M4EL(=
M3N[B=DM,7#;CNG=6,I*_*B<8QN^4=J /2G=(HVDD9411EF8X 'J32JRNH96#
M*1D$'((KS?7M?U&^\(>-]&UFUM8=0L=*>7?9RL\4L<D;X(W $$%&!!K0T/Q-
M*\/A[P_H]JEW<I86\FH3,Q$=G$8QC<1U=NR^G)P* .U2>&622..5'>,X=58$
MJ?<=JDKSBT\56]A>?$6[M-$M8;C1MLLLB,0UXPC=@7..,8QWZU<B\9:[#=Z#
M<ZEH]I!I&M3);P&.X9KB%W0LA==H7!QT!.,]: .[HK@9_'&MR1:WJNFZ+:W&
MB:1--!(SW++/,8A^\=%V[=H.>"<G!QZ5UGA_4VUKPWI>JO$(FO;2*X,:G(4N
M@;&?;- %Y)X9)9(DE1I(\;U5@2N>F1VJ2O.[7Q/;V>O?$6:VT6VBNM'@BGEG
M1L->$0NZA^.,;<=^M30^-M>C/A_4+_1K.'1]:GAMXMERS7$32KE&9=NW!(Z
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M9=_EQX4\A2.3QE@* .PHJCHNJV^N:)8ZK:Y$%Y DR!NH##.#[CI5Z@ HHHH
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MAMY4$'D8- %G2O'QUBX\)""S$<>MI=><KMEH'@'*CU^8$9]JR?B!KTM]X?\
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MI'O9'#7$P4,R)M&% R!DYYIOC>UU&+Q1X3UVSTNZU&#39KD7$5KM,@$D6U2
MQ (SUYJI8R:SX.U+Q!#%X=O]3AU.]?4+*2U,> \BKNCDW,-F&7KR,&@#K?#&
MO0^)_#5AK,$;1)=1[C&QR48$AESWP01^%:U<[X%T*X\->"M,TF[96N88V:8H
M<@.[%V ]@6(_"NBH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MOJKZ7/<3R,;.-T0OO!!!(9=NT9'+8SQ78Z#/K,UE(-<M[6*ZCE*K):.3%.F
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MN53*A#;1U)"D9P.<5N:1XBN;GQCK?A[4(8HI+-8[BT=,CSK=QC<<GJK J>U
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ML](2#1+RX@)NO,)N!& VU0I&TX_B/&3TXH ]%HJAH>IKK>@:=JJ1F-;VVCN
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MKN)IHK:"2>>1(XHU+N[G"JH&22>P I()HKF".>"1)895#I(C95E(R"".H(H
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MA0HRY7<0#@D<9KM** //[8:WX7\0ZW>P>'+S4K/66BNXEMI8@\$WEA7CDW.
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M>)=8TBZ%U;+,<)*,%7C)[!E/6NJJ*YN8+.VEN;F:.&")2\DLC!511R22> *
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MPD$VD>'O^$96]TF2U-M]HC N;@L"&VQDJN%#+NX)WT :^E^*]>/B&ST>^O\
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M4 (R.#R.U;- !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/ER%!EA@@J0/K5F7Q8L6I>'+4V3%-<1FBD$@S$5B\PAACTXR#0!T1(52S$
M9)/:FQ2QSQ)+#(LD;@,KH<AAZ@CK7#Z%XFU74;?Q;+J>E1S6UA>S6X@AF#':
MD:93#  YRS$D]R,4ZW\7V^E^%/"]Y9Z(L&EZF8+>-5F"K:&3[@;Y?N]LCO\
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M64' _.N>U/3-9MOBC8^(+'3EO;&33?[.GQ.L;09F#[\-]X8[#FNS50JA5
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M^;,HVDCG&2 >!Q2ZUX>U_P 0^!O$%B='TS3;B]$:6EK"X+!5923)( %).#@
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M]D4%S<PXC\PX4L&#8)[9QBLZTTS7-0\5Z!KFH:=%8BTLKF"XA6Y$I5G*;<$
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MUMT  # & ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MRGH>:ABUO3IM;GT:.Z1M1@B$TD&#E4/0],=Q7E6AZAXG\/\ PS\,Z\NIV_\
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MUU1H_P"U](N+B 7,"[ ;BW.^.51_#GY>GJ:[7POJK:YX4TG59 !)=VD4S@=
MS*"?US0!K49&<9Y]**\WAAU:7XZ7@&K[8(M*BD\K[.IS$96_=YSQSSNZT =[
MIFIV>L:?'?Z?.L]K(6"2*" =K%3U]P1^%5=,\-:/HU]=WUA81Q7=VVZ>;)9W
MYSC))(&>PXKR;0K[Q/H7PAC\16.IV\5GI[S.NGM;!Q<(+AMV^0G*DY;&WH /
M6NCU_P :2-XKU+2H_%FF>'8].AB*_:T1VN977?SN(P@!4<<Y)YH ]+HK%\(:
MZ?$WA+3-89%C>ZA#2*ARH<'#8]L@XK:H **** "BBB@ HHHH **** "BBB@
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M^<>O?BJ.BZ!XI\,^"]"TRQ&F7DME$\5[:32,L<X8Y!2382"/0K@Y/H* .?\
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MGN+K2Q:1K$D,K*-J.!OW*''))SCI5.33-5D_:"F2/7I8Y#HGG+(+:(E8O/\
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MC\O&"<GY3N'7OTH ] \(:A<ZMX,T74;R0275U8PS2N%"[F9 2<#@<FMJN?\
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M "L6_P#"/AS5-274;_0["YO%Q^^E@5F..F21SCWK:HH **** "BBB@ HHHH
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M4J"<@K@CN#UK"MO >O1A(;F^L9TC\11:UYX+J[CDRJ5P0IS]WD\=2,<^D44
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJ^JOIEAJL$]XJEO+7(W '!*DC# ?[)->6^,5CFB^*!@PUHS:8CE?NF8,N_\
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MX>^+M9OHD)@U^P,ML@&<W\6$"@?[093[X- 'I&G:K8ZM%-+87*3QPS/ [)G
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M/$KZP@$DABW^3(41@Y3#MMPGS CYB,_2K>G^,_#^JZP=)L]162]VLRIY;J)
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M4ECO4DBC: 1.S;I 2G !R" >>@[XI)_&_ARVUDZ3+J:+=B586'EN8UD/1&D
MV!CD<$YH U)-)L)M5AU22TB:_@0QQ7!7YT4]0#Z50F\'^'+C6UUF;1;)]1#!
M_M#1#=N'1CZD>O6H]8\;>'M O?L>I:B(IP@D=5ADD$:GHSE5(0>[8IVL>,=
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MP1X7,E[(="L2]\"+DF$?O,D,?ID@'CN :R+WP]J6O^)]*2^TZUL] T.?[1;
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M;W$">'],6&X<23(+5,.P.02,=CTK3BTZR@CN8XK2!$NG:2X58P!*S##,WJ2
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MH3S-=7$7F+#;V\D\A48W.5120HSU/%+>^,=!L=&L]5DOP]I>D+:F"-I6G)Y
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M?(D\D3?\\S+MV;^V,]>.M.U?QOH&AW[V5]=R+-$JO.8K>21;=6Z&1E4A ?\
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M&%W*21]:Z/XGQS0:7HVMI"\T.C:M!?7*(,MY(W*[ =\!L_@: &7"?$G3+/\
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MC12E@NQU(RIR1U ZYZ5YGX3U)T\*^$]/TZ2ST_[=?ZB\5]=6ZR&V5'<[45L
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MLQ0;U4G)4-UP2!Q[5-10!G6OA_1K'49=0M-)L8+V7/F7$5NBR-GKE@,G-:)
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%.T9?5-4W<=?EQ76>"2W_"OO#Q4;F_LNVP">I\I:VDL[6..:-+:%8YF9I5"
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M2K&X+N)'\V!'RX&,G(Y.!C-97B3PY<>(KK2[*1X(]"MYEN+J($[YV0YCCQC
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M+-<@'.PLVT*I(&< FO0(-+T:YMXYXM-LFCD4.A^SJ,@C([5)_8FE?] RR_\
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M8V^I^<9Z=Z[S1AX;U_34U#3K"UDMG9E5GL_+.0<'AE!_2M#^Q-*_Z!EE_P"
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MDF>X2,!Y"3DY/7KS0!H1QI%&D<:A40!54#  '04ZBB@ HHHH **** "BBB@
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M@LN  ?FVG;C[O&,UJ >*XO'C^%O^$IFDMKC3O[0-X]K")H=LFPHF%VX)*G+
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M<T6X-D*_ .""RG'3/>NACM_&MU9ZA)<7FEV%T\:+90VZM-&C*<LSLR@G=]W
M' Y'- %7P/J3ZG-<2VWB^/7[#RUW++"D=Q;RYY!557"D=F&0179-]T_2N1T/
M0M9;Q=+XBUF#2[28V7V,16#M)YN7#%W9E7IMP!@]3S77$9!% 'C'P^OI]/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M2%([$=1P: .VHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M.@KT>B@#ROQ]I5KXD\?Z#IMA=J;FXC>#5HHB&_T)'60A\?=RZ[1Z[C7J@
M P!VJG::3INGW-S<66GVMM/<L7GEAA5&E;.<L0,DY)ZU<H \TO\ P'XDNM"U
MWPY!?Z;#I=_<SW4=QM<SLTCF0(XQM W8!8$DJ,8%0Z>GB?\ X67XFGT\Z7]N
M6QL%N;>=I!"S%9.5<#=P0<9'(8]*]1J".RM8;N>[CMHDN9PJS3*@#R!<[0QZ
MG&3C/3- 'E.L>&=0T*U\'V:7T+:Q<>();V:Y\L^4T[I(Y&W.=G\/KBNILO#.
MM7FN:EKFNRV"7DVG'3K6"S+M''&269F9@"26QVX [UUL]E:W4D$EQ;12R6[^
M9"TB!C&V"-RD]#@D9'K4] 'F,GPTU-_A9HGA47MI]KT^\6XDERWEL!([8'&<
MX8=JWM2T#7[+Q3=Z[X9FTTOJ%O'#=V^H;PNZ/.R12@)SAB"#^==A10!P2>%?
M%&FZGINJV>IV.HZC'8/97<NHAU!W2>9O38#T/&TXX YK.'P]\11V=K;1ZK8E
M[+7&U:"Z=6+2;@Y(= ,9W/V/3/(->G44 <;8>&];N_$5[KVO2V"7+:>=/M8+
M)G9$0MN9F9@"6)QT' '>LO2/A_JNB^"?#EE;7MG_ &WH5Q)/#(P8P2ARX9&X
MW %7ZXX(KT:B@#'T*'7U%U-KUS9M)*X\FWLU/EP*!C&]@&8D\DD#VJEKNF^)
M?[9@U7P]J-MQ"8)M/OR_D2#.0ZE>5<=,X.1]*Z6B@#B;?PIK5]<ZSJNN75C_
M &G>Z:VFP16:OY,$9W')9OF8EFSG QBJNBZ5\1M$T.PTJ"7PL\-G;I CR"XW
M,JJ "<=^*] HH X[6_"^KZU:Z1J8OK2Q\4:8S/'/ C/;MNX>-E/S%&&/<=JC
M31?&>M7UF?$&I:=96%K,L[0:.90]RRG(#NV"J9Y('7UKM:* ,OQ+IDNM^%M6
MTJ!T26]LY;='?.U2Z%03CMS6+K/A*\U#P!8:);W4,6H6*VKPS."8S+"5(SWV
MDKC\:ZZB@#B[/P]XCNO&>F>(M:N-.3[);3VYM;,N57?M(8,P!))!STP ,9Y-
M9FE_#G4+#PA<:=]OMEU)-8.K64ZJS1HX8%0XX)! (./6O1Z* .6CL_&EU:Z@
M]UJFFV-T\2+9Q6D1ECC<')9V<!CN^[@ 8'3GFJVG:!XA?Q#=>(-2.D6^H?V<
MUE;I9;W1B6#!Y&8 G!4 #' )YKLJ* *NFK>IIEJFI2127PB47#P@A&?'S%0>
MV:M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MLKF6[:VB81LZN@CV!LOG#8P"<FNDL?%N@ZCHUQJ]MJ<+6%L66>9\IY17J&#
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MQ; [FT6R9]O=0[[B?^ @_A70>,KG2Y=9^'JVCPL[:FCVVP@_N/*;./;[GY4
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M%N ^\0/F;\3D_C6G0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M-*TQYX5%!8G@Y&.,<T@\9>'_ .Q8=7.I(MC+.+82LC#;*6V[&&,J<]=P&.]
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MVZ1RA9,\'<,<Y]ZMS:=XDN1:B:S\.R"TD$MN&$I\IP" R\<$ D?C7,WOQ/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MN+HVEK)>2+IMH'O4"73"!<SJ!M ?CYA@D8/:@#SS58HX?AY\/%C155-1TDJ
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M>TCC< C!Y STJVFDZ;%I9TN/3[5-/*%#:+"HBVGJ-F,8.3QCO0!Y[XDBALO
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M;6BQA8BY<9*$@D@. .N#0!WVC^.M!US4([&SN)Q-,ADM_/M9(5N$'5HV=0'
MZ\=N:@'Q$\-&\$ NY_*,_P!F%Y]EE^S&7.-GG;=F<\=<>]57U_PWJ=IHUI82
M6MWJ-U;.=-\I5D:W(B.6SUCX^7/'I7%R:CIC_LZQZ6DL1OFM5LA9AAYOVK>!
MMV==V_G]: /6-/UNPU2\U"TM)B]QI\PAN8V1E*,1D=1R"#P1Q6;-XXT"&SN;
MDW;NEO>MIY6.!W:2X'6-% RY_P!W(Z^E<;XIU.3X>^*7U]QNCU?26@D Z/>P
M+F+/^\I*CZ52NO#UWX9MOA_;?VHFFRQR7/VJ^EB655NIH]WS;B!DGS%!/J*
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M2 ,2K#&5(V-G('2O._#.IW T/P5I4&HV>C@Z+)=-J,\*/)@,JF.,OP.NX]>
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M?;&<\5=L[N*_LH+R L89XUEC+*5)5AD9!Y'!Z&O&FMI8KR?X4A7%O-JRW,9
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MCKL-I))Y6/,CRZNN&&1RO7@\5-H^JV&D_$?QV=0O(+4$V4R^<X7<@MP"PSU
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M]@.G1$03M:2+AA$6)=B,*<_=!QD<\TWPI\1=/FT'P[%J4MZ]S>P00M?-:O\
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MVR/6NX73K)+'["MG;K9[=OV<1*(\>FW&,4EMIEA9",6EC;0"-2J"*)5V@G)
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M9)X%=U%:V\$DLD,$4;RMND9$ +GU)'4TV[L;34(/(O;6&YAR#Y<T8=<CO@T
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M5%;)P,YP* +_ ((T)_#OA"PL)SNO"AFNW/5IG.YR3W^8D?0"N)B_Y*_X\_[
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M3S)XBT"B3"A04.."!@C%>C>(_P#DJ7@G_KGJ'_HM* -N+Q5I,WA#_A*$G/\
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MA_<Q[W3?=VB[T.&7-Q'R#ZU;LO 5C;ZG:W][JNLZM+:/YENFHW?F1Q/C&\*
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MP9XP2S^&&GZQK]Y/<7$UQ-"G!DFG?SW5$51RQP ,>@KNKJ=TTN:X16CD6%G
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MD*A=TDA'?:HZ>] '3K#$DKRK&BR/C>X4 MCID]ZCBL[6">2>&VACEE_UDB(
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MI+(Z@*TBXW!3GD#.,^M &E%#% FR&)(USG:B@#/X5&MG:I=-=+;0K<.,-*$
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M690"<' !)..E8>O_ !)BM=,\.ZAHMG<WUOJM_' 62')49(>/!((E^4@ ^AH
M[B:SM;F2.2>VAE>(YC:1 Q0^H)Z5+Y<?F^;L7S-NW?CG'IGTIMO+]HMHIC%)
M$9$#>7(,,N1G!'8BLS7O$5KH"VJRP75U=7<ACMK2TC#RRD#)P"0  .220!0!
MJI'''NV(J[FW-M&,GU/O2"&(3&81H)2-I?:-Q'IFN8D^(.BP:&=6N5N[>*.]
M6QN(98<2V\I(&'7/3D'(SP>,TMEXYM;O4+G3WTC6+6]BM6NXK>YM@KW,:G!,
M?S')R0,'!YH Z(65HMV;L6L(N2,&81C>1_O=:)+*TFN([B6UA>>/[DK1@LOT
M/45P_A?XD)J/@IM>U>QN[?$QCCV09%RS2ND:1 $EFX4'IS[5L0>.=/?3]7N+
MFSU"QFTJW-S=6EU"%F$6TD,H#%6!VL.#U&#B@#H)+*TFN([B6UA>>/[DC1@L
MOT/45/6'X<\4VOB=)IK*SOX[5%1H[FXAV1S[LY\LY^;&,$].F,UML<(Q.<8[
M4 5X]/LH2QBL[="SB1ML0&6'1CQU]ZF6*--^V-%WG+X7&X^I]:X/0/&V@Z;X
M!TS5OMVL7=A=79M8[B_Q+<%RS?>QU&5(&,GIQ6K:>.[2ZNKVR?2-8MK^UMOM
M8M+BW59)XL[=T8#$'G P2#S0!T<ME:3VPMIK6&2 8Q$\8*C'3CI3T@BCW;(D
M7< &VJ!G P,_A7"^&OB/'>^ XO$.M6=S;,S!%"09%R[.5180"2QX [<^U;NC
M>+[75M5?2I;#4--U!8?/6VOX@C21YP64JS @' /.1GI0!M6]E:VD;1VUM#"C
MG++'&%!/N!4L<:11K'&BHBC 51@#\*=7)ZG\0=+TN^O(7LM2GMK!UCO;Z"W#
M06S$ X9L@\!@3M!QGF@#IIK6WN6C:>"*5HSN0N@8J?49Z4X00B-XQ$@C?.Y=
MHPV>N1WS7.ZGXVL-.UJ71H[+4;[44@2X%O9PAR\;%AD$L  -O)) Y'4FF67C
M_1KY-'=$NXUU2XDM(_-BV^3.F<QR<_*QP0.N<4 =+]GA\Q'\F/?&-J-M&5'H
M/2F+96B7;72VL(N6&#,(QO(^O6J-SK]G:^(['0F65[V\BDG4(H*QHF,LYSP"
M2 .O-:M #9(XY4V2(KKD'##(XZ4ZN3U/X@Z7I=]>0O9:E/;6$BQWM]!;AH+9
MB <.V0> P)V@XSS5G5O&=EI>L+I45CJ.HWGDBXECL(/,\F,G 9N1UP< 9)QT
MH W)K*TN)XYYK6&26/[DCQ@LOT)Z5(\,4CH[Q(SQG*,R@E?IZ5R3?$OP\N@Q
MZWON#I\FH'3UE$7\>2-V,YV\=>OM4\GCFVBL[*1M&UG[;>M((-.-L!<LJ?><
MJ6PJ\CDD=1WH Z988DE>5(T61\;V"@%L=,GO42V=O!)-/;6T$=Q*/FD$8!8_
M[1')K!;QUI(T&+5%CO':6Y-FEDL/^DFX!(,6S/##!)R<8&<XJ-O'^DPZ#J6J
MW=O?6G]F2)'>6L\06:$N5"DC."#N!R"1C/I0 N@>'-2BU^Z\0^(+NVN=4E@%
MK"EK&RPV\(.XJNXDDLW))] *ZFN-;XDZ7'J"64VF:S#//&9+)9+3!O0"!B(9
MR3R#A@N!R<"KECXZTBZT?5-2N$NM/72G*7L%Y%MEB. 1\H)SD$8P3G- &ZFG
MV447E1V=ND>_S-BQ*!N_O8QU]ZE%O"(6A$,?E-G*;1M.>O%<]I_C:RO9KBWN
M-/U/3KF&U:[$%] $>6(=63#$'' ()!&1D50MOB9I%TNFSK8:JNGZ@\<4.H/;
M 0"1^B$[LYS\N<$9SS0!UL]E:W(C%Q;0RB,Y021AMI]1GI2BTMA,LPMXA*I8
MJ^P9!;[Q!]\#/K7(Z-XUN=3^(.M>'WTJ\2WLA$J3&$ (Q5V+.=W"MA=N!SWK
MM* (;FTMKR/R[JWBGC!SME0,,^N#3F@A:-8VB0HF"JE1@8Z8'M7GI\=WVHZA
MXRTM=-OK9--MF$%QY07RF\EF)=MW!)P5P.F*D\,?$*U_L/PU#J%MJK?;8;>V
M_M26',$MPR %2Y.XDMD9Q@GO0!Z%7->&O"R:1!>K?);74DNIW-]"_EY,8D?<
M ,C@CVJ#5/B#I>EWUY"]EJ4]M8.L=[?6]N&@MF(!PYR#P&!.T'&>:KW'C:XB
M^)D/AE-+O);5K(3--'"#EFD51(#N_P!6 6!.,YH ZZYL[:\55NK>&=5.Y1*@
M8 ^HS2FVMV5E:"(J[;F!08)]3[\"I:YO6?&EGI&HRV":?J6HSV\(GN180"06
MZ'."Y)')P2 ,G Z4 ;]Q:V]Y$8KF"*>,G.R5 P_(TDEI;2VWV:2WB>WP!Y3(
M"N!T&.E9$?B[2I=3TJS1Y"NK6YN+&YV_NI@ "5!SD-M.<$=*@/CG1ULM7O2;
M@V>ESBVDG$>5FER!LBP<N=Q"].IH WTM;>(8C@B0; F%0#Y1T'T]J9'86<4<
M<<=I D<;;T58P K>H&.#[U@6WCBPEM]3:ZL=1T^XTZU-Y-:W<(65H0"=Z88A
MA\I'7@\'%4/^%H:*ILI)K+58;*^'^BWKVO[J9]NX(N"6+'! XP3T)H ['[-!
MY'D>3'Y/_//:-OY=*22UMY9XYY+>)Y8_N2,@++]#VKG+/QYI]PFL"XL=2L+C
M2K;[7/;7<(61HL$[DPQ!'RD=>M06GQ(TF[N-.'V+5(;/476*UOYK;;;R2,.$
M#9SDG(!Q@D<$]: .LF@BN86BGB26)OO(ZA@?J#4<UA9W%NEO-:020IC;&\8*
MKCI@$8%<7I?Q#-QXA\36VH:=>6NG:3AOM#P@")5BWN9"&/)Y*@#D8K;T7Q?;
M:SJ L6TW5-/G>$W$(OK<1B:,$ E2">FY<@X/(XH Z!5"J%4 *!@ #@5$]I;2
MW"W$EO$\R#:LC("RCT!ZU-7):A\0M+TZ^NXGL]2EM+*98+S4(8 UO;N<<,V<
M\;AG .,T =3]G@,(A,,?E#&$VC:,=.*9-9VMS)')/;0RR1',;.@8H?8GI6!J
M7C>QT_6[G1HK#4K[4K>*.8V]G '+(V?F!+ 8&.<D=1C.:;8^/M&U#^Q#$+I%
MU>26&!I(MOERQYW1R<_*W! '.<4 =15>YL+.]*&ZM()RGW3+&&V_3/2J4^OV
M<'B6TT#;*][<V[W(V*"L<:D#<QSQDG Z\UJT ,DABEB,4D:/&1@HR@@_A3);
M.UF,1EMH9#"<Q%T!V'U'I^%<9INOZG-\8=<T.6Z+:9;:;%/%!L7Y7)7)SC)Z
MGJ:(?BIHL]C:ZBEAJW]ESND;:@;8>1"S-M <[L]2 2 0#QG/% '9FTMRLJFW
MBVRG,@V#YSZGUISV\,B(CPQLJ$%5900I'0CTKGM9\:V6D:E+I\>GZGJ5S!$)
MKE-/MQ)]G0YP7)(Y."0!DX'2DN?'6EI;Z;)80WFJR:C";BV@L(@[F(8RYW%0
MH!(')'/'6@#H9;:WGSYT$4FY2AWH#E3U'/;VI!9VRVGV46\(ML;?)"#9CTQT
MQ7-S?$'0X-*TW4&^UM%J$[6L4:P$R+,H;,;)U#94KCGG'KFH1\0+5[+66_LC
M58+_ $N 3R6-Q JRLC9PZX8@KP<G/&#0!U26EM&8C';Q+Y(*Q[4 V ]0/04D
M-G:V\LDL%M#%)*<R.B!2Y]R.M>=/XSAU/X=Z+K&MG6M+>XN+9#)8 1&:1ES\
MN2<Q'GWXKM]/\06>I:UJNDQ+*EWIC1B=9% !#KN5EYY!&?RH T5MX5@,"PQB
M(@@QA1M.>O%.6-$C$:HJH!M"@8 'IBN8E\?Z0D%[)'%>3FVU Z:D<,09KFX
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MY=V-N>]27_CFPL]6O-.CL=2N_L(4WMS:P;XK7(W#><@DXY.T' H Z=55%"J
MJ@8  P *6N4^&E]=:E\.=$O+VXEN+F6 M)+*Q9F.X\DGK75T %%%% !1110
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MKZ#J6GHRQR7EI+;B0C.W>I4$^PS2Z-I::7I-A:L(WGMK6.W:95P6VJ!]<<4
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M'_\ KW/_ *$U=G2*H50J@ #L!2T %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
K%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>iff10-k2023exhibit97002.jpg
<TEXT>
begin 644 iff10-k2023exhibit97002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"!54!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M$U':9T@"0OPN2W5B<\>W6IKKQ7?F'31IGAJ_NKN]@,[03D6PMU& 1(S<!LG
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MC./0ULU7L+*#3=.MK&U39;VT2PQKZ*HP!^0JQ0 4444 %%%% !1110 4444
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M_P"W&M0(@JD83<.,ENE 'L=%<&^MZ+X(\$7FMZ9J5QKUBEQ&KR/J1NB"S*A
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MP^8J<'L!@YP3D5!#\07U+2=#FTC1GN;_ %<3%+2:X6$1>2<2[GP>C<# Y]J
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MZWD9QD9]*6@#R3Q):/J6O>)K/5-.UF_OY5$>BQ1><MJ(S$/FW*0@P^XMNYX
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M:9(KB:W,+LA"R@6X!VGO@\<=Z[6B@#R4:5J/_"CO#EC]@NOM<4]F9+?R6\Q
M)U))7&1@<FFZIH^F:9XL\12ZYI6O77VZ9;FQ?37N=D^8U4Q$0D*&#*?O8X(Y
MQ7KE(""2 02.M ' Z)H[:=\0M+^SZ7/9V$/AGR%1B76%O/0^49.06 SW[5SG
MB#2-3E\&_$!(M.NI))==CN8HUB;=+&I@)9!_$,*W3T->Q44 5-,U&'5M.AOK
M=)TBE!*K/"T3C!(Y5@".G<5;HHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KF?'^NW'AWP;>WED
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M"JKM&5Z_,<<@C'>M+Q#XAN=-OM/TO2[!+[5+_P QHXY)O*CCC0#<[M@D ;E
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MA5(++;%KUI/<EFDYA,80E<8^;EB,\=*S_&&OMJ.@?$+1S;A%TO31B4/DR>;
MS=,<8QCO0!WAGB 0F5,2<(=P^;Z>M25XGJ/_ "+'P=_Z_++_ - 6O9;RX:TL
M;BX2"2=HHV<0Q#+R$#.U?<]* )Z*Y#2_$^N#7M.TWQ!H]K9?VI!)+:FWNC*R
M,@#-'("JX;#=1D<&L)/B5KDGA)?%@\.VRZ+$Q6YW7A\X@2;&:-=F"![D$X/'
M<@'IE-1TD&496 .,@YYKE+WQ/J]QXHN]%\/Z7:79T^&.:\EN[DP@&3)2-,*V
M6(&<G@53^$\QN/"%Q.8WB,FIWCF-_O+F9C@^XH [FBN?T+Q*VJ:QK^EW5LMK
M<Z3<A" ^X20NNZ.3H,9&>.V.M8%M\1;O4-(TZ>PTA)+W6+V>#2X7G*J\,><S
M2-MRHPI. #U&.M '?$A022 !R2>U(CI(@=&5E/0J<@UQB>*;IQKVC>(-*MX[
M^RT]KSRX)S)#=0$,,@E01RI4@C\ZSM(\8B#P3X530=#MX[S62T=G8>>5AA5=
MS.S-M)V@#/ SS0!Z)O0N4W+O R5SSBG5YWX;NM0N?BWK(U2SCM;N+2+>-UAE
M,D;_ +QR&1B 2"#W (((]Z]$H **** "BBB@ HHHH **** ,C7_#]OXCMK>T
MO99?L4<ZS36Z$!;C:<JC\<KG!('7 K7HHH **** "HYXVFMY8DE>)G0J)$QN
M0D=1G(R/>I** ,/P]X8MO#[7EP+JZOK^]</<WMVP:23:,*.  % Z #O6Y110
M 4444 %%%% !65#H-O!XHNM>664W%S:QVK1G&P*C,P(XSGYC6K10 4444 97
MB30K?Q-X>O-&NI98H+I0KO%C<,$'C(([5JT44 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Q'
MQ7BD_P"$(-]&A?\ LV\M[UU49)2.0%OR&3^%=O3)H8KB"2":-9(I%*.C#(92
M,$$>E '%_$&&^ETK2?$.@6SWU]IETMQ#' -S2Q2(4< =QAP?PKD]?\(:WIOA
MWP]8Z1:337%WIC:-J+QC/EB5D=I&] #YO/\ M5ZCH.BP^'](BTRVGN);:#(A
M$[!FC3/" X&57H,Y..]:5 ''6VD36GQ2BN(+21--A\/K:)*%^0,)\A,^NWG%
M<EJ7A.^O;#6I;C2)[J*#Q8=1^R#*O=6_E*C&/D9.&8CGG;BO7J* /+HO#]C>
M^'/%2>'_  C=Z8]QI<EK!->;HY;EV5LH(W)(4';R<9)]LU)I<=_J=W\/9_['
MU*U73!-!=BZMS&8R+7;G_=+' /<UZ;10!YAXI\*ZGKNK>-8H+1BMYIMD+9G^
M5)I(G=R@;\ /;-6?"FE:*WB&WN=-\$:AIDD$+M)>7V^/RG(V[$#$[\@MDC@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "LW6M5ET>R6XBTN^U)C($\FR16<9!.XAF48X]>XK2H)
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M+*QL$ALFE;R_N. Q /)4# SZ^M<W,+FZ\-:%HK7UR(K7QG)I<<XE/F&W7S5
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M\J"/!^4C[Q(ZD\UDZ*9?&-]X#_MB::5+G1;EKM!(5^T[6C WXY() 8^OT)%
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M?QKF4^)%M']GEU+P]KNF64[(BWMU;IY*EB NXH[%020,D8YJ]\1O^2;>)/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M1PPYR/<5O076I/K5U;3::D6GQHI@O!<!C*Q^\I3&5QZYYJ_N4L5##<.2,\T
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M:7-,I@C93E1]W>RJ>BLQ' H QM/\+Z3XD^('C==9M5O88[BV6.&4DHA:W3+
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M69>[F4&.(]0H15 )(!W<G@<T <=HNE6]O+=:)#H=QX5\276DSP0R13![:Z.
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MUA+=]ZYW1E')4^Q(!_"H;#PIHVM?$KQ;;:C91W%G:P6"16K_ .J7,3 ';T)
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MR74M%TO4K[X5B^T^VN1/;&*7S8@V]%M=RJ<]0&)./6O2/%2A?!FM*H  T^<
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M*^WH"-H_$9K)@L(X?!WP[TVPT.WO(-37[5>62NL"WDB6^X>8Q&&Y^8@YSL%
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M]CN+A41W5TC#MO!#[5. #_>S7H_@#3-3TC2[^UO[!;"W-\\EE:+.)1!"P4[
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MBE%E_M&>#R6!?]V!A1N"XX8A%&?04VU\&Z3:W/B"8":3^WO^/U'?Y2-I7"X
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MN(QT60C[W4\]>>M '!>(VN] \1>$XO!\;:W/!I5[%9EYUDR!M&2W 8+C&.^
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ME;:/;6FLW^JQM*;B]6-90SDH @(7:.W4Y]:OLH92IZ$8- '#?!O_ ))-H/\
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MA:O>(L=['9W31)=J!@"0#KQQD8..*T[/P[IMAJ_]IVL)BF%E'8JBG"+"A)4
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M)X68G=AQZ[B"#P12_P#"":,=%;2Y/M4J27:7LT\LY:6:92"&9CU^ZHQTP,4
M;&E:/INA60LM+LH+.V!W>7"@4$X R?4\#D\U>HHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IDTT
M5M"\T\J11(,L[L%51ZDGI3ZY/Q_+:G2].LI],&IS7NH116UH\QBB>49<&0X.
M4 0DC!S@<4 =';:E8WMH;NUO;>>V&<S12JR#'7Y@<<466HV.I1-+8WEO=1J=
MI>"57 /ID&O)[?1+S4]0\=:#(ND:7<3PZ>XAM79K;S,L0&RJGYPJJP Y![UU
M'A"2&W\37UE>^&K?1-;-I&[FRE#6]U"&(#K@  AB1\R[L$<D4 ;S^*])C\5+
MX<>Y07S6_GX+J%'S!0G7.\YR!CI5^35],BOUL)-1M$O&QMMVG42'/HN<UQ#:
M=8R?'QG>RMV<>'EG#-$I/F"Y(#]/O8 &>O%<[IFD:7J/P)U76-0M8'U2>"]N
MY[MT'FBX5Y"IW=0054#Z4 >RU4M-4TZ_FEBL[^UN)83B1(9E<I]0#Q7&^+-1
MU%/@C=7ZNZW[Z3&TCCA@65=Y]C@M5BZ\/>&]$AT_4-+BM;+4K:SF33Q 5C-S
M^Z)VD#_6= W?GF@#J1J^F-J!T\:C:&]'6V$Z^9_WSG-%UJVFV(D-WJ%I;B,J
M)#+,J;"WW0<GC.#CUKR*ZTG2K?\ 9\M]9@MX1J:6L-\M\%'G?:BZL6W]2Q8D
M=?:NBTG1]/UCXJ^+I-3L8+DQVEBHCG0.J[HWW<'C/&,_7UH [MM6TU+F"V?4
M+19[A0T,1F4-(#T*C.2/I1=:MIMB)#=ZA:6XC*AS+,J;2W0')XS@XKQ*'1M/
M@_9Z355M8CJ,=PLD=VR@RH4O BX;J $ 4#TKL]-T?2]4^+_BYM0M(+IHK6R$
M<<Z!U 9&W':>,\ 9]_>@#9\<^+9O#&CZ7?6,4%R+W4(+7+DE=DF?F!!]N*ZB
M*Y@G>1(9HY&B;9($8$HWH<=#7@FJ#ROAOIUI&2;2T\9FWM><@0K+)M ]AS7=
M:I?0>!?B-=ZI<'9I6N:>\LI["YME+?ANCS]2M 'H"75O(9@EQ$QA.)0K@^6>
MN&]/QIKW]FED+U[N!;4@$3F0!,'@?-G%<U\.M)FLO"$=S?H/[0U:1]1O 1_'
M*=VT_1=JX]J\^AL!JND67PTE8A;;5[R*7/7[-$IEC)]B9H<?2@#VJ2X@A>-)
M9HT:5ML89@"YZX'J:Y=O&"Z)X5;5_$=QIK.)_* TR;S$?+A0%+$9(SD^F#7+
M>%+^3Q;XD\*O/DMH>CO-<]\73MY&#[_NY3^-<;I]M!/^S^&FACD9-;7:74$K
MFY4'&>F1Q0!Z^_B^"/QB-,:>S73/[*-^;PR@#/FB/&[.W'/YUT=M=6][;I<6
ML\4\#C*21.&5OH1P:\_N="TNY^,EG:S6%NUK;>'V>*W,8\M6^T8!V].-Q_/-
M7?AQ!%9S>+;.WC6*V@UZ811(,+&#'&2%'89)XH ZV;5=.M[V.RGO[6*[E_U<
M#S*KO]%)R:+K5=.L1(;N_M;<1[2YEF5-N>F<GC.#CZ5X]XR"WWA_QGJFFZ#I
MJ6\-S(DVIWMRQN6GBVIF(;#M"LH"C<.?3-='9:7IVK?&'5GU&WANGCT>U:..
M= ZY)<%MIXR.F>VX^M 'H7VZT$,,OVJ#RYB!$_F#$F1D;3WX!/%0PZM8WMI/
M/I]Y;7:P@[C!*K@$#.#@\5XJ;*UETRPT>4#^RH/'LEI!%GY/)VO^['^R2S+C
MW-=E+86FD?%D0Z7;0VL=UX?F>ZB@0(K%)%",0.,\D9]* +/A_P 9:OXB^&MC
MXB@32+6^N965EO)6C@"B1DX/)SA>/>NRO=2L-,C62_O;:T1SM5IY5C!/H"37
MS\W_ ":]H_\ U_C_ -*7KTV.PL];^+6N1:O:P7:V>FVRV<5Q&'55<N9&"GC)
M( )]L4 =K=:C8V-J+J[O;>WMSC$LTJHASTY)Q6-XB\2G28]!EL_(N(=3U.&S
M:3=E1&ZN=RD'!^Z/:N3N++1TO]!T#PYIEGKDMG#<SV[7UZ3;6L>\(^<*VY@Q
MV@8RN#TKEOLT5UX5TG3;U+=+4>.FMV@MW)A5"9,QH2!\F21T'!H ]KM=4L-0
MAEDL+VVNQ%D.8)5<*?0X/%<_X"\7OXH\"VWB+4EM[,R&3S-K8C0*Y7.6/'2L
ME["ST?XO6<6E6L-JEWHD_P!JB@0(K!)$V,0.,\D9_"O/O#'VJ;X4^!+&"TM[
MR*XUF;S+:YE,<4Q4S,BN<-QN .,')44 >^6E[:ZA;K<65S#<P-P)(9 ZG\1Q
M7.6WBJYF^*%YX5-O"+:#35O%F&=Y8N%P>V.:J>#M'U;3O$>M75WI^FZ;:WD<
M+"SL;DR*)5W OC8NW<NT=.=M8@N8K+X\:]=3EA##X;$CE>H42*3C\!0!Z)#J
MVG7%Y+9PZA:RW463)"DRLZ8]5!R*D-_9BR^VF[@^R8SY_F#9C.,[LXZUX_:6
MTEK<> [ZVT#2](LKC4$^RM'<M+>/')%(2)#L (8$$_,><4V.S2YM%^&DF1&O
MB&56C_Z<E7[4OX99%H ]EDN8(A$9)XT\U@D>YP-['H!ZFI:\E\+W4OB36_!N
MGW)W2:!8SS7H/_/=&-JF??*R-7K5 &/8:C=&]U;^T+C2UL[60>2T$Y+HF#GS
ML\*?_KU=BU73IKYK**_M9+M1N:!9E,@'J5SFO&V_X]OC/^/_ **>M[5=%TW1
MX/A[=6%G#!='5+>)[A$ DD5X9"^YNK;B,G/6@#T:75-.M[V.RFO[6.[E_P!7
M \RB1_HI.37/IXJN6^*4OA0P0BU32OMWG<[]WF!,>F,&N9\.:'H.O^&?$=]X
MBAM_/EU6[^UWDI"R6XCDPN)#R@557'/%/MBA_:"F,<GF(?# VOG.X><N#GO0
M!Z-]NL_L8O/M4'V4C/G>8-G7'WNG7BFW6IZ?8RQ17E];6\DQQ$DTJH7/HH)Y
M_"O('=5_9?@W,!F&)1D]_M(XKI])TRPUSXE^-3JUG;WC6ZVEM"EQ&'$<+1;B
M%!Z L6)^E %[3O%6JZMX7@U.W72;>X;4I+5Q>2M'&8TE=/E/)+D*,#IUKJ;K
M5=.L5D:[O[6W$6WS#+,J;-V=N<GC.#CUQ7@]TL:?!OP\D+EXE\4X1B<EAY\N
M#GO7H-GH^GZI\7_$SW]I#="&PLPB3('4%A)D[3QG QGT)]30!W3WUG'9?;9+
MN!;3:'\]I $VGH=W3%%OJ%E>;/LUW;S[T\Q?*D#;DSC<,'IGC->+Z/;07-OX
M0T.YC5]('B'45-NXS&?*,IB0@\$9[5UFC:=I^F?&W58M.BCA1]$BDDAB "HY
MF.< <#( /U.>] '4W?BO2;+Q+:Z!/<HM[<1/*,NH";2H"MDY#-NX&.<&J/A_
MQC;:A!>-J=S964L>IW-E CS!#*(WV@@,>2?:L74].L9_CCI+36=O(S:/-(2\
M2DEUD0*W(Z@=#VKG['P_I5W\/_B!>W5A!/=&]U0K-*@9DV%RNTG[N#SQW)-
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M>W5W,BQO<WMR\\FP$D("Q.%R2<"LZSU[Q/;ZQ96>N>'88[:\8HEUI]RUPL#
M$@2@HI ."-PXS]:LZ1XYT#6;C5(K;4;4?V=(RR.UPF&155FD'/W!NQNZ9!H
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M/J/DEBZ!QA?+/KZUH^'/%=SJFKWNB:MI+:7JUI&DQB$XFCEB8D!T< 9Y!!!
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M"N\U34K31]+NM2OI1%:VT;2RN>R@9_$^U<;%XM\9WE@-7M/!<;:<R^9'!+J
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M;N]!CMW^Q7@D^TEI6:28N,.S.3N+'US6IIUA;Z7IEKI]HI6VM84@B4G)"*
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M7-J)(R$DF7:N=K#DA=Q''N*YOQG#%9/\2[2QC2*T;2[2>:.,859R6&<#@$J
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M['I5ROC[0M,U/3M&L8[K2;VV>WTUV8F';&-LA*C(';WW5WA\':"6UIFL0_\
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MT\AV+@JY)8'<22"6/7UH X.#0=>M=7T74(['PWIT5C;3QQKI]S(TEQ&8CM0
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MMK"T@M8%Z1PQA%'X"K-%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MG*18(_>'MU^E2W?B30[#4HM-O-8L;>^EQLMY;A5=L],*3GGMZUQ?Q=Z>#/\
ML9;3_P!FJ#Q%8SZ/-XEUA++2M?T"YD\[4[:1]MS;E(U5@K<@X50P4X(SQUH
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MM-;@F=?#&8P/[WF+C]:G\(V'AB3X7^%[K4U@4!X9TG+%7-V6Z[AR6+Y'OT-
M';3^)="MM7329]8L8M1<@+:O<*)"3T&W.<GMZUB?\)M;6'BWQ!I^M7UA8V%A
M':&"69Q&7:57+ DG!^X, #UK@?%UQ<7?@KQ3JEA8:18Z6=0<-+,SO=3SI*$\
MP'HAW+P.< =JZS1[.QN?C-XK>YBBDN4L;,1!U!(4JV_&?HM %[QUXQGT#P[I
M>J:,]I=)>ZA!;B1OWB-&^<E2I'/'!SBN@U3Q%HNB2PQ:KJUE923?ZM;B=8RW
MTR>E>(ZLJQ_#>&"' LH?&CQV8'W1")7P%]LYKL&M=;O_ (B>,4L[70[E EK
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M:7J4NGSPW'C)28+!RT,2/O+P\@8PQ<$>^* /41XL\.M9K>#7-.^S.CR+*;E
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MZ-\1-,1M2B\0ZOI]E/%JUS:6Z.X0M%&^U2<G]>E '4:MH6FZY]C_ +2M1/\
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M,CH<BGQ^'-)BT:\TA+0"PO#*9X=[?/YI)?G.1G)Z'Z5INZ11M)(RHB@LS,<
M =2363I'BK0-?EFBTG5[.\DA&Z1890Q4>OT]^E $.I^#-!U=;47=DVZTB\F&
M2&>2)UCX^3<C E>.A)K6L;&UTRQ@L;&!(+6! D<2# 4#M61'XW\+2WMM9QZ_
MIS7%T 88Q.I+YZ8^O8=ZFU/Q;X>T9YDU+6;*U>$JLB2R@,I8$J,=>0"?PH V
M:YV3P+X;EU@ZH^F@W+3"X9?.<1-*/^6ABW;"W?.,YYK+\=>,)]&\/Z+J>ASV
MMQ%?ZG;VWF_ZQ&B?=DJ0?8<UM_;YO^$U_L_^U;#R?L/F_P!G[?\ 2-V_'F9S
M]SMTZ]Z )M7\-:/KUQ87&J6*7,MA+YULS,1Y;Y!SP>>5'!R.*=K7A_3/$-O%
M#J=L91$_F1.DC1O&V,95U(93CT-0KXM\//KAT5=:L3J0;;]F$PW[O[N/7VZT
M7/BWP]9ZRFCW.LV46HN0HMWF ?)Z#'8GL.] #8/"&@VVG6MA%IZK;VUTM[&/
M,<MYZG(D9B<LV?[Q.:OOI5E)K$6K- #?10-;I+N/$;$$C&<=0.W:N7D\<VFE
M>+]?L=<U"SLM/LHK0V[RG:S/(KEAUY^Z.@XYIGCOQC-HWAC2]7T*>UN([S4(
M(!+_ *Q&C?.2"#[4 ;^@^%M&\,BY71[0VR7#;GC$SL@.2?E5B0HRQX7%;%9.
MK^*-"T":&'5M6L[*2;F-)Y0I(Z9^GOTK55E=%=&#*PR&!R"* ,"Z\$^';W5Y
MM4N=.$ES/@R@ROY<A VAFCSL+ ="1FK&E>%M'T6>":PM&CE@M?L<;M,[E8=Y
M?9\S'C<?PZ=.*QW\2WZ_%Z/PP/*_L]M'^VGY/G\SS2O7/3';%:]MXM\/7FLO
MH]MK-E+J*$J;=)@7R.HQW([CJ* *^H12>&K*[G\/:!)J%Y?W332Q1SJ@,K+@
MR,7;A?E4';^51^ _"X\(^%+?37\K[4[-/=-$,*97.3CV'"CV45J#7M);1WU<
M:C;?V<FXM=>8/+&#M.3[$$?6I9=6T^&WM+B6]@2&\=([9RXQ,S\H%]2>U %R
MN-\6^&F\0>+?"[S67VC3;;[7]J;?M\O=& AZ@YW#@CD$9XKLJS-9\1:-X>AC
MEUC4K:R24E8S/(%WD=<#OB@"G:>"_#]GI-_ID5@3;:@"+OS)I'>?(Q\TC,6/
M'OQ6A=:-IU]HQTBZM(YM/,8B,#\C:,8'KQ@<]>*6/6=,F:Q6*_MW-^K-:;)
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M:TNH78.T,<DI3+8Q@E5R*Z_2/%&A:_-/#I.K6E[+!_K$@E#%1Z_3WZ4 1_\
M"):&/[&_T$?\288T_P#>/^Y& OKSP!US5RUT>PLGOVM[<(U_*9KD[B?,<J%)
MY/'  XQ56R\5Z!J6JR:79:Q97%]'G=!',"W'7 [X[XZ5K22)#$\DC!40%F8]
M !U- &%<>"O#]UI-AICV!6VT\8M/+FD22$8Q\LBL&&1UYYI9/!GAZ7P\NA/I
ML?\ 9R/YBQAV#!\YW[\[MV2?FSGGK2Q>-/#$]_#8Q:]I[W4Z"2.,3KEE(W C
MZCGZ5/H_B?0]?DGCTC5;2]>#_6K!*&*^A^GOTH BTCPAH>A7IO=/LO+NVB,+
MSM,\CNI8-\Q8DL<@<GG@#I6W6-IWBWP]J^HR:?IVLV5U=Q@EH8I@S8'7'KCV
MJU#K>EW&F2ZG%J%L]C#O\VX$@V)M^]D]L8.: *VN^%M'\2_93JMH9GM7+P2)
M,\3QDC!PR$'!'49JIJG@7PYK-_+>WNGLT\RA9S'<21+.!P!(J, _''S \4^7
M6/.\1Z-':ZSIRV=Y \HM6&9KD;<JT9S]T=3P>*==>-O"]C.D-UKVGQ2/*T(5
MYU!WJ=K ^F#QSWH VX88[>&.&&-8XHU"(B# 51P !V%/K(M_%.@W>M2:-;ZO
M9RZE'G=;)*"X(ZC'J.X[5:35].EL[J\2]@:VM&D6XE#C;$4^^&/;&#F@#!3X
M;>$D,(72<1PN'$/VB7RW8'(9TW;7.>[ ]AVJ]K7@[0O$-TEUJ-FSW"Q^49(I
MY(6:/.=C%&&Y<]CD5->>*=!T^%9;S5[.!&MQ<JTDH&Z(D ./4$D#\1567QYX
M3AM+6ZE\0Z<L%WGR',ZX?!P?I@\'/2@#<M;:"RM8K6VB2&"%!''&@PJ*!@ #
MTJ6D5@RAE(((R".]+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !7%?$HA;#P\['"KXAL"Q/0#S.M=
MK5+5=)L-<TV73M3M8[FTF WQ/T.#D>X((SD4 <=K$T;?%VRA5U,B>'[IF4'D
M R)C/Y'\JY3[';V_[.&E/%"B.#:3A@.?,-PF6SZ\D9].*]-TWP=X?TB99K'3
M8XIEC>/S2[,Y5\;@6)).=J]?058/AS2&T&/0S8QG3(P@2WR=H"L&7OG@@&@#
MSR.TUV^\1>/(K=]"$,ERL5U_:22%Q!]G3;RI "8+$9[[JG\.Z8L/Q&\/PW4\
M%_+9>$T\NZC.Y'(E"B13[J3SZ$^M=GK'@SP]KUZ+S4],CGN @0ON9=Z@Y"N%
M(#CV;(K032;"/4TU&.UC2[2W^RK(O&V+.[8!TQD4 >2ZG&D?P[^*4:*%1=6G
M*J!P,I"3C\2:V94C;6OA='<JIM#;2N P^4SBV3R\^_W\>]=S+X;T>:RU&SDL
M8VM]2D,MY&2<3.0 2>?11T]*=?\ AW2-4TB+2KVQBFLH=OE1MG]WM&%*D'((
M'<'- 'G'BU53Q-X]%J (F\)EKO9T\[][LW?[6S]*?JEC:67PV\"PK#&EC-?Z
M:;[*C:ZD;B7]07*DY]:[VR\):%I^E7FF6NG1I:7JLMTI9F:8,,'<Q)8\'')J
MY/HVFW.B_P!CSV<4NG>4(?L[C<NP  #GTP/RH X?XEII,.B>)'LMB>('T<>=
ML+!C:>8 2P'&/O#/7&>U,^Q:M:Z[HNL:I>>'HK;3[2Y,5OIRR)+<0>5RB!CR
MHPC<=,5U^D>$M!T*&YBT[38HENAMG+DR&5<8VL7))&">.G-1Z1X,\.Z%<O<:
M;I<4,KQF+<69]J'JJ[B=J^PP* /.%DU 0_#V>2+1;#3[C4HI;&QLXW,T4;QN
M>9"V",,-V%')'-:7A>WTJ3PW\1FN$A;=JVHB[+@9V 9 /L 21[DUUD7P[\)P
M0/#'HT*HSJX^=\H5.5V'.4 /9<"EN_A]X5OI9);C1H7>65II2'=?-9FW'> ?
MF&23@Y')XH \YL6G;7_@T;G=YIT^XSNZX^SKC],4MGIFNZOX,\1V[WGAZTLY
MM3N_M=Q>"030RB8X9FSM!&$V^@VUZW<:%IEUJ.GZA-9QM=:>&%I)R/)###
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M<+Z#TKL9S(/V@KHP_P"M'A<[/KYW%=@W@OPZ\;1MI<7EM>"_V;FVB<9^<#.
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MJK;&8#&"03P/2K!\#V^K>-_$E]K>G"6RNDM!:2B4JQ*HRR %&# <C(. ??%
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M6*E7'1E8$$'W!KEO%/@+3W\):M#H&DQ)J4VGO9PA'V[P26P23@G))W-SR>:
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MK9QZ[9-/=;?)42??W<J,] 3Q@'DY%5[;Q_HMUXWNO"Z7$8N8$7#;_ORDMNC
MQU4*"3GO[5P'V6"#]FO36BB5&'V6;('.\W*9;Z\UUVBX_P"%R^*1W_L^S/\
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M _.K9X [\=JYZ'XN^&YM,UR]%U%_Q+'D$<?F<W*J%VLO' 9FVCK61*Q;XO>
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M"(Y'P0"< MV7/;.*\<M-_P#PBGPHW;MO]N'R]W_//S6V?^.XKH(++6KZ7Q]
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M6/$WB&-+ZUET:QMK6:"=2 H#K(7+-[%._3!K@_ Q4S_#$7)!A%EJ @W=/-#
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M16-I<S7?C5[:U2[!\F*0['#L!R0""<#J<56UIKY;OXC0ZC?65U=KX=C\UK.
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MAT8#T.:W*Y+P_P#$'2/$&O:KI=O*%:QDVHYW#S5" LW*@+@DCD]LT =8
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M_OG7.=OW21T)'8D9%;-8&J^-O#>B:C]@U'5H+>YPI9"&(C#="Y (3/\ M$4
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M Z.J+:/I[ZTFL-:1G44A^SK<8^81YSM^F2:I:GXOT#1[:TN+W4XDCO$\RW*
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MULT >)V6F:KJ/@77;2[\0Z/IUB^I727OVBS9IHI3.2"7\P#=]PJ=O3;UJ_\
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MI]I:W%K;V<,4%P[O-&J@*[/]XD=R>] 'E5U96K?";X<P-!&8GU#2RR%>#O\
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MIJ2O=R;C$IB=5FV_>V.0%?'^R37E>N2RFT^)T5QJT>I3KIEHK3QPK$&(,@(
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MW*,XP>.>.E7:X3P%=6MMX9NO$>HW$5L-<U*6[#S,%^5WV0KD_P"RJX'O7=T
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M.C62^O+>UC8[5:>54!/H"30!9HJI9ZKIVHEA8W]K=%>OD3*^/R-6Z "BBB@
MHHJM>:A9:=$LM]>6]K&QVJT\JH"?0$GK0!9HK)_X2CP]_P!!W3/_  +C_P :
MMVVIV-Y>7%I;74<L]L$:9$.2@<94GZ@9% %NBJ6I:OI^CQP2:C=QVR7$RV\1
MD.-\C9PH]S@U=H **1F"J68@ #))[5G0>(=$NIEAM]8T^65SA4CN49F/L :
M-*BBJ>J:K8Z+ITNH:E=1VMI%C?+(<*N2 ,_B0* +E%4)=:TV'4;+3Y;R);N]
M5GMH2?FE"C)(^@YJ_0 4444 %%%5K;4;.\N+JWM[A))K1Q'.BGF-B P!_ @T
M 6:**I:KJ^GZ'8-?:G=QVMJK!3+(< $G 'YT 7:*I2ZOI\&KP:5+=QK?W"-)
M% 3\SJ.I'TQ4E_J-GI=H;N^N$@@#*AD<X +,%4?B2!^- %FBBB@ HHHH **R
MK;Q-H=YK,VCVVJVLVHP@F6WCD#,F.#G'3'>C2O$VB:[<7%OI6J6M[+;8\Y8)
M ^S/'4?0T :M%%% !15/5-5L-$TZ34-3NH[6TBQOED.%7) 'ZD"K:L&4,IR"
M,@T +1110 4444 %%%% !15>^O[33+*6]O[F*VM8AF2:5PJJ/<FHM*U?3]<L
M%OM+NXKNU<D++$<J2.#0!=HJO>WMMIMC->WDR06T"%Y)'. JCJ34R.LL:R(P
M9& 92.X- #J**1F"J68@*!DD]!0 M%9/_"4>'O\ H.Z9_P"!<?\ C4M[KVD:
M=I0U2[U.TAL#C%RTHV-GI@]_PH T:*Q+KQCX<LM*M=3NM:LX;*Z_X]YGE $O
MKM]:V(I4FB26)@\;J&5AT(/(- #Z*** "BJ4.KZ?<:M<Z5%=QO?VR*\T /S(
MK="?K5V@ HHHH **S#XDT)93$=:TX2 [2ANDR#Z8SUK25@ZAE(*D9!!X- "T
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 5Q/Q3C5O",4LI22W@O[:::T8_\?B+("80/XBW
M8=R*[:N9\;:'?ZSI^G3:886O=,U"*_BAG8JDQ3(*$@'&0QP<=<4 <SX?GM-1
M^*BW-CI4^AK#I+)+;75N+:2[RZE2$'WE3!RW8G%>F5Q5GINO:WXUT[7M7TV'
M2K?3+::*&!;D323/+M!)*@ * O'?-=+HLNJ3:3#)K-O!;WY+>9' VY -QVX/
M^[@_6@#0HHHH **** "O+_B#+I\/Q(\+OJ>D2ZK;?8[S-M%9_:6)^3!V8/3U
M[5ZA7">+K768O&NAZYI%G:7OV&WN(989[U;<_O-N#D@^A[4 /\/R:!>WTR:+
MX2GT2_6!S%>W&A_9U0]/O8&3S]W(R :X_P"'^F^(I+CQM)::]:02IK5Q'.[:
M=O,KC&6'[P;1R<+SC/6N\TKQ#XDN=2AAU/P_I]E9MGS+B/5UE9."1A-@SDX'
M7O5'P7HUQH;^+#>S6RC4M7N+NWVS*<QOC;GT/M0!PO@'6-2\*_!O3-174+ 1
M7UP;2TCN(/+2WD>=E,DLF[YE #-C Z 9KI8_B*^C?VW%=:SIOB%;/3#J$%S8
M[4R0VPQ.%9@/F9,'T)]*ATCP;>VWPDT?0YY=/_MC2[O[;'%),&AD99V<(Q'9
ME8CVS6E-I%UXGT76]/U#3=(T*WN[/[/ L,J2S>9G.]F7 V9"_+R3CM0!HV,7
MCR.>V^UW^G7,-Y _G-':^7_9\NW*$ O^]7/!!P>]<-HNMZ[HGP+U3Q"]];7<
M@ED>"*6UX1C=LKECN._).0,#'O7;:/J/BVZU'3HM3CTW3;*T1A>21W:SF]?;
MA=@P"BY^8YY[5R7_  C&O/\ "?6?!;V]BLHD8VER+U2MP&N/,Y7&4P/6@#L+
M/Q)J$7C/2=,O?)^P:MI7GVK*F"+A,&1/IM(8?2L;4OB!J-N?$-W ]E'8P:E#
MH^GRW(VH)S@322-G[BDGT^Z:T?%&D7=YX:T6729K3^W-'EAGMQ),%5B!LD0M
MZ%2?R%4V\'^3\-M,T>"ZLI=5L9HK\^?(#'/<A_,D#'T8EAGW% %WPIXJFN_%
M%QH$^O:9K@^QB\AO+$*NW#A'1U5F'\2D'T)JM\3K>"[U+P5;W,,<T,FNQJ\<
MBAE8;&X(/!%:WAR:\;4+BYOM(TC1K81!(HH9DDF=LY8EUP O3 Y/&>.E4O']
MC?:F_A^[T9+2[FTS4ENWAENEB#*%88W'/<CM0!6\=>"M$M?"^H:UH]C;:3JV
MF6[W=M>6,2PLK1J6P=H 8$ @@YZTM_XGU.XTG0KXZ_HWAVTO=.2ZDN+W:[R3
M,JGRU1F7Y0#DGD]!Q4&KQ>+/&EDVCW\6EZ#I4Y"WDD5_]IGECSRB850N>A)[
M5-?:7>:9XQ&HZ1IVF7]J^FQ6,!N+I8_L11F.<$$E"&&=O/RT <]J6NZ[XHL?
MA_J%MJ-M9M>W[(X2W\Q/.C$J^8/F&4.#A?<'-:FK>-M0_M768+;Q-H6F'1\1
M)!?*N^^F$8=LY<%$R0HQGG//&*H0^'-?T_P_X=BCAL;N\T'5Y9]GVQ(Q=Q.7
M.\'HA^?[I]*TY=.U33-6U:YL=$T;4EU9UNE-S=(#9SF-4=6RI+IE01MYZ\=Z
M .[T+54UWP_IVK1H42\MHYPA.=NY0<?AG%2ZAI6G:M"L.I6%K>Q(VY4N85D4
M'ID!@>>35*V;58KO3+>."Q?3OLS"ZGA^7;*, "-<_=)W>N.*V* /+/!OA?P_
M<^-/&\,^A:9+%;WT*PH]I&RQ@Q D*".!GTJ:TM-:F^)GC"UT*]M=-C6&PWS2
M6WG8Q$P5%3( '7)[8  YXZ/PQH-]I7BGQ7?W2H(-2NXI;<JV256,*<CMS4VC
MZ->67C?Q-JLRH+74%M! 0V2?+1E;([<D4 <;?^/-6;P#X7U9H;/[=>:VFGW0
M,6Y.'E1F0$\$[ 1Z9K4U+Q)KEQXQU32-/UG2=.N++ROL>GWT/S:@&0,6W[@0
M,DK\H)&WFLN[\!:Y-X&\/Z2D4/VJR\0?VA,#*,"'S96R#W.'7BM;QGH^OZ]'
MJ.DR>'=+U&VN%(L-0DG$;6>5 RP(+;E;+ H>1@<4 =KJ!8Z1=%@ WD/D YP=
MIKPVPU#X>W/PFMM/^S:?<^(GTT1QQVUINNC<[?EPRKG=NQSFO<6M91HIM#(9
M9OL_E>8W5VVXR?J:SO!>DW&A^#-'TR\1%NK6U2*4(<C<!S@]Z .=CU+Q+>:K
MIWA:TO8+*\M=)ANM2O9H//8R-\H15R!R58DG/:N7\>:Y?ZI\(?%^GZMY)U'2
MKV*UEE@4JDR^;$R.%).W(;D9/(KMM6TO6M,\:_\ "2Z+8Q:BES9"SNK1IQ"X
M*L6216((/WB"#CM7.ZUX$U[5?A[XGMW2V_MS7;U+HP++^[A57CVIO(&2%3DX
MY)H V+_Q!>6/C_P7HL20&UU"UG:9GCRX*19&UNW/6H+?6/&/B"+4=9T&>P%I
M:WDEO:Z;-!DW:QMM9FEW#820V,# P,U:U/PQJ5U\0O!^LQ)&;/2[>XCN27 (
M+Q[1@=^:I6^D^,O#L.IZ)H5I926UU>2W%GJ<MP!]D65MS!XBI+E26QC@\9H
MV=#\1WC>*O$&AZR8HWM EY:,!MW6KCOSR48%2:G\#:QJ'B'P[_;%^J)'>7$L
MEG&J;2EONQ'N]20,Y]Q7)_%+2[J?4/#PTR[":OJ)DT>7CYI;:5,R/@=DV[O;
M->E6=I#86-O9VR!(+>-8HT'\*J, ?D* ."A\2:[J7BG4K.SUC2;:>QOO(31;
MJ(K+/"-N9/,W9^8$D84C@9JEID'B*Z\7>.$T34+33UCOHW,DUOYQE?R$PF-P
M"KQR>3SQC'-SQ1H7B+Q%)-IT^@Z8["Z#V6N+.$>UC#A@=N"^\ 8X."?0<5T'
MA_1;S3M=\47=PJ"+4;Q)K<ALDJ(E4Y].0: ,!?%VJ:KX,\.ZPNJ:3H,5_$7O
M;R\((C8# 6-&8 [F!ZG@#O7)^.?$4WB3X(:E/<3VUS+:ZHMH;JUXBN DHQ(H
MR< @@]36WI/A#Q!H-IX4G_LBTU2;3;":TEM9+E4$,CNK"56((/ VG'.#QFJN
MK^!/%.H>!?$.A-;V;W=WJJW\,T<P6.0.RLZ@$97:1@9ZT :^N?\ )??"W_8,
MN?\ V:M#XN.\?PZO'CC\R1;FT*IG&X_:(\#-3:GX<U&Z^*VA^(8DC.GV=E-#
M*Q?#!FSC []:M_$'0[_Q%X.N=,TPHMY)- Z-(<!=DJ.3^ 4\4 9G]L>(_#OB
MO2+/7K^ROK'5EF7,%J83:RQIOP#N.Y2 1SSP*Y^Q^)-W)!INN2Z_HDEO?7<<
M3Z)&5^T6\,C[%;=OW%URK,-N.O3%= VD^(/$GBS2+O6M,MM/L=)69CY=UYQN
M99$\OY0 "J@%CSSR.*I^'O#^OZ+!IVA?V!H[V]E*$;5Y&5C) IR,1@!A(5P,
MDX!YYZ4 =5XQU\^&/"=_JZI&\D"J(UD;:A=F"+N/8989]JY32O%.HS:_#H2^
M*]%U:74+25X+JRB5OLDR8.&17.Y""2,D'Y375^,-"?Q+X4OM*BD2.:95:)I!
ME1(C!UW>VY1GVK/\/P:U)JRS7OAO2M'MHH2&,3K+++*<<H5 VH!NZ\G(Z4 >
M>_#W3]??P9XGGM=;M8$^WW@D5M/WL[C&YMV\8!&0!VSU-'@S6=2\*_"+0[D:
MEIR1ZE.MI:?:(/+2T+22%Y)'W_. %8X^7G KM?!?A?4]#\)Z[IUZD:W%Y>W4
MT05P05D VY/:LVQ\#:M!\+O#VE/#:OJ^C7*W:V\KYBE*N^4+8.,HY&<<'% $
M0^(\NC6NOQSZIIOB!["RCN[6ZLMJK(7?R_+D"LP!#E>AZ-706MOX[M[I(;O4
M=.NH;JW??<1VGE_89@ 5PI?]ZAY'8\"J%YX:U7Q1X=US3[S2--T)+J!([1(2
M))1(K;][NH V[@G !/!/M6II,_C._P!7M#JMC::786\3BY6.=9S=R$87;\H*
M*#D]<G@4 >=Z7K^NZ!^SV_B$WEM=R,5:WBFM<B/=<E7W'<=^<Y' Q[UZ';>(
M+^'X@IHE[Y7V&^TU;JQ8)@^8AQ*A/?@AO85Q3^"?%-Q\%[SP1)IULEU;LBVT
MXN@5N5\_S"<8^3 QUZ^U=?XV\/ZM?Z;I-]H(B_MS2IA)!YC[5960I(N?0@Y_
MX#0!AWOQ!U*.#6+V*:QM[)]8CT?3)[D8C1@#YTSG(W*"&QR/NUL>$?%,M]XC
MOM"GUO3M;\JV2[AOK$*H*EBK(ZJS ,#@C!Y#57N? L]O\/\ 0])L5MY[[2)H
M;P)<']W<2KDR!C@XW;WYQU(K:\-PZH;RZN;[0M.T> HJ0P0,LDS'DLS.H"[?
MNX ST)S0 SQCJ5_IZV0M]9TO1;21G^TW]^5)3 ^541F4,2<Y.> .E<H/B#J$
MWA6TG_M/38"VKR:;<:T(M]LJ(&*RA=V!OPHY; +5T'B;2=5/B_2M=L-*M]6C
MM[6:V-M/.(O)=V0B52P(Z*5/?![UE:3I'C#0[/4H&TK3-2CN-3DNYH3,$6YC
ME7)5,C"[& X8?,.XH Z[PU+J<VF,VIWMC?'S#]GO+(82>+ PQ7) ;.1@$CC-
M8=QJGB#7O%VK:/HFH6VF6VD)")IY;7SWFED7>% + !0N,]\FK7@;0;K1+;5)
M)[&#38[Z\-Q#IUO)O2V78JD @ 9)4L0.!FJD^G:_X?\ %^KZOHVF0ZK:ZND+
M2PM="!X9HUV9R005*X]P1TH X/XA:QJWB7X2O<W,UM;R6FH_8=1MDA++),DP
M4,K%LJO&<$'KC/%>R:3;7UIIZ0ZA>0W=PI.98;?R5QV&W<<8^M>=ZQ\/]9N/
MA?-HT;6\VL7FH_VA=;7VQ[VEWL%)[ 8'OBO4J /#T76I/!7Q.EU#5HKF*.ZN
MX'C6UV%I%CC <'<=J[1C;@^N:ZR'5?$^AWGA>34+RRGT_5I4M'LH[8JUL6B+
M(1)N._&W!R!GL!VIS>%?$:Z=XZT2/3[>2VUJ:XN[6\^T@?-(J@1E,9'W>N<5
MTNNZ!?7X\)^0J'^S-0BN+C+8PBQ.IQZ\L* ./N_B5=);7^O1Z_HD=K:73QIH
MCE?M$T*2;&8MOW!R 64!<8QUS7I^I,'T:[93D&W<@_\  37!V7AS7=$^T:18
M^']'N[=[R2:WU.Z=3Y44DA<J\>-S,NY@,'!XY%>@7L+3:=<01@;GB9%'09((
M% 'C7@>]\*1^"=(2\\!WU]<BV427*>'_ #A*?4/M^;ZU<^)]G<2VG@?^S7AT
M_39M7M%@L9+#:8)&W$,RY' !P8\#G/-;'A<^//#?AC3M&_X1*QN/L<(B\W^U
MPN_'?'EG'YU=\4:)KWBFP\*3O806EW8ZU#>W=N+D2".-"V<-@;CC!QCO0!R_
MB;3/$1^+/@N";7;.2Y:*[-O-_9N%B(B^8E/,^;...1CWJ[J7C[4(WUNY@\1Z
M%:?V-*\":;<A1+?-$!YAR7!3<VX* #T[UT^N>'=0O_B7X5UR!(S9:;'=+<,7
MPP,D>U<#OS64_A[7='U#68=,\/Z3J46HW;W=O>W<BK]F:3&X2(5+, V2-IY!
MQQ0!;?Q!K/B?7O[-\.7MOIUO!I\%[/<SVWGLS39,<87< !M!)/TK!U^3Q?=>
M)/ D5W>6FF7TTMR)(D@\Z-94B?\ >??&Y60C"G[I/4UT-[I6O:%XLFUW0].M
MM2BOK**VNK7SQ;E)(B=CJ2"-N&((ZCCK5+5-#\7.?">LRQVFJ:MI=Q/+=6Z2
MB!"LJ%0J,1CY00,D9.,T *WB#7;GQQXOT33Q:">PTV*:R8P_,TK(#ACGD$\>
MU/OO'=U/\--(UG2EB.KZN\%K;1NN5%P[;7!'HNU_RJYHOAW4[7XH:_XAN(HT
MLK^TMXXL2!FW(H# CZ@\UEZ+X%U.R\?-/<>3_P ([8W-S?:<@?+":<*"I7L%
M/F8_WJ *VK>.;_\ M#7!:^)-#TX:.YACL[T+YE](J!G)RX**2=HP#R#]*]$T
M?4H]9T2PU2)2L=Y;QW"J>H#J& _6N)N= UO2-8UMM+\/Z7JL.J7'VJ"XNI50
MVLK(JL'!4EDRNX;>>2/>N]M8VAM(8G$0=(U5O*3:F0.=H[#T% 'F?PT\-:%J
MWAW4YM2T73KR5M6NU,EQ:H[$>8>,D9J?04F\)>.M?\,:1^\T\Z6-4L;2:4[+
M>3<4,88_=1C@^U-\,V?CCPI97NGV_AJQNXY;Z>YCG?4Q'P[DC*[#_.K!\!ZS
M>Z)XHN]3O[=_$>N6IMP8-P@MXPI"Q*3S@YY/?/3U (=&\6ZG-XELM&?Q1HFK
M3ZC;3EOL,:G[!.BAAG:YWIU'."=O6L3PSXCUGP_\/+O5KG4[.:2\U:2UM_M$
M7EQPS/<,&DD?=RG5L<8 QGO706^C^))?$'AK5#H%AIUIIA>![*&Y4L%D3:TF
M0H&%P,*.3S5"S\%^(1X6N]!FL;,/9:F=2T^YDG#QW+"8R!'3&5!!*G/K0!N>
M%?%4UUXIGT"?7M,UU39_;(;RQ"J5PX5XW568?Q*0?3-=S7*Z)%K9N+RZF\.Z
M7I*+;[+>&-UDEDEZDLZ@ )T&.3WXZ5O:5)?RZ5:OJD,4-^T8,\<+;D5^X![B
M@"Y1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0OY[&RU2RN+N#/FP0SJ[QX.#E0<CGBD37]'DU9M)35;%M17K:"X4RCO]W.:
M-&BLJ]\3:#IV[[;K>G6VV4PMYUTBX< $J<GK@@X]"*HZUXWT+0=6TO3[Z_MH
MWU L5=YT58T",P=B3PI*[0>Y- '1T57COK2:\EM(KJ![F%5:6%9 70-T)7J
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MU-@-S+N&#Y?/%:UMXUCMO$>NV.O7.G:=:Z>EIY<DDNS+RQLS*68X;!7C '%
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M*YU&TAL& 9;F295C(/0AB<'/:@"]15"'7-(N+>UN(=4LI(;M_+MY%N%*S/\
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MD1Q[BVW))/))/4FLZ?P9H5SKESK#VL@O;J(PW#)<2(LJ["GS(&"D[20"1D4
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M;)/O;B,DG;MSCJ3SC-06OA/0[.QU.RAL$^S:I-)/>1.S.LKO]XG<3C..@P*
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M>?5',CH"P*,^W!/3!&1[Y/>M7PW''J/Q$@;4D6>2#PU:/:"4;L!V/F. >Y(
M)KN(_#>DQ:-?:0EKBQOC,;B+S&^<RY\SG.1G)Z'CM5;4O!NB:K'9+/;2H]E'
MY5M-;W$D,L:8 V[T8,1@#@F@#R'Q:B6_PS^(]I:J%T^#7(Q B#"HQ>$NJCL
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M:5_= '!+<\ '@^]7-*UG3-=L_M>E7]O>V^XH9() X##L<=#7$^(]'TY/B1X
M@6SA6*-+U50(,82)2@QW ."/0\U<\(QI#\1/'D42A(_M%F^U1@;F@!)QZDT
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M\;2OJ.J%G903\F2O/L>1[DUIZA96UE;_  Q:WA2-UO(D#*,'#6[EN?<\GUH
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M#WQ#XI@@4[-:MO[0TQ!WO21$Z#U)9HW^F: /3[+4+/4H&FL;J&YB5VC+Q.&
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M$UAI1LM2N!:17.G32$Q3$$J&5U&0=I&1TK9O_&GAK2]2_LZ^UNRM[L$!HWE
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MO;:U\R::)I#\BDK,Z* .YPHX'O0!T%KH6FV7V[[/;!#?$&Y.]B9"%"<Y/]T
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MMZG@Y% &CJNE6.MZ;-IVI6ZW%I, 'C8D9P<@Y'(((!!'(Q61#X#\-0&-H],
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MNHW!N9[J*03Q7 N#\S/O"AMP7''3;7I>G>!/"^E2PRV6CP12PR"6)\LS(P!
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MR#<(^7,I'W<LQ)..W/':BW\$^&[72[S38M(@^R7N/M*/ES+CIN8DL<=N>.U
M'%H=23XD:E#JUYIT]V/#,I9;&!H@@\T;0VYVR>3CIP>G-.\,>%+;7/@+9Z5#
M&D4]W8^:DH&")\[D8GKPP7\!BNRMO!7ARS:W>WTF&-[<2"-P6W?.,/ELY;(
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MZ:5CM5!]2?RS6U7#?%1)(O#FG:JL3RPZ1JUKJ%PB#),2-\QQ[ Y_"@!D]_\
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M88W9]LUYWXBN->L-+U31=473=0O)= NVT_4[*(QS>6@7>KISMW J05."1TH
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MH(!()!Z@=P:NL<*3Z"E P,#I37_U;?0T <S\//$MWXO\#V&N7T,,5Q<F0,D
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M9XQFI]7\:>'M!NWM-2U)8+E%1C%Y;LQ#DA<!0<_=;ITP<T 7/^$>TC_B6_\
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MWPKX?T>^DOM-T6PM+J0$-+# JL0>HR!P* .<^*$,]Q8^'(;:Y-K.^OVJQSA
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M /R.%4K@<X!Z"MBVTK3[-KIK:QMX6NW,ER4C \YCU+>I^M4+/PYI/AZ*\N=
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MVB6$)DG2X;9 HS*A)5^G4$D@]LF@#"O0!\9M(8#!;1+D$^H$L=<-X!LK:_\
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M^0;=H"*"3GDYP/6NQH \MU::3P['K6L:5J&FZKH3:@7U'2;N+]XDQ=5<1O\
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M@7./]9CC)[XQVK=^&\BZ5/JGAK4T"^(H)FN;FX)).H(Y^6<$\D?PD?PD8XH
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MQ_"NVM=0L[Z2YCM;F.9[:4PSJC9,;@ [3Z'!'YUR/B(!OBOX,! (-MJ (/\
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MC@CO6==26U[\6_#D\3Q3HNDW;1R(0P!W1C((]B1^-<IXH&-$^+0' \VW./\
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MU0:?"UVL\D3S6YELY$6Y11EC$2N'XYXZ]LT =%%%'!$D4,:QQHH5$08"@=
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M"-(W9<\[0  ,^F>]0)XOTO2]"T5Y;N^U*6^M5EMS!:/+/<(%4F0HB_+]X$\
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M].3Q7LMQIFGWEU!=7-C;3W%N<PRRQ*SQGU4D9'X4Q='TQ-2.I+IUF+\C!N1
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M_B>YGFO]3E5UM88B[*\@RD$2*,G"C\P233/B]%)+\*M>6($D1(Y _NK(I;]
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MZ<TZ:9)#LC9<GYG!&5<=,9[5RGC37=%U30;34=-5$LK;Q1:"XO BK%*58;I
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MVTU(V%V($U*TC")= QJV2 2-R[MIP<<4 =;4=Q,+>VEG9)'$:%RL:EF; S@
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M;F5+6(2D*';L !T&2!SCD5UVJ^,=/TRXMK:*WO=2N;B#[2D&GP>:XA_YZ'D
M+G@<\]LT =#15/2=5L];TNWU*PE\VUN%W(V"#Z$$'D$$$$=B*N4 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 5Q/Q*/V:QT#4Y0WV+3M:M[F[8#(CB&Y2Y]E+*:[:D90RE6 ((P0>]
M 'F/CO6]-\6^%O$>G>'HQJ=S;64,TUW:!9(R@E#F$.#DMM5CM''/KQ4WB+7]
M)\6:KX-M- O[>^N!JL5^XMW#&&!$?>7Q]S[P&#CDXKT2WMH+2+R[>".&/.=L
M:!1GZ"DAM+:V=W@MX8GD.79$"EC[XZT >9Z4JCX7^/\  'S7FL$^_P!^J]I?
MVFE^,O =Q?W,5K!+X<,22S.$5G(C^4$\9]J]7$,01D$:!'R67:,'/7-,DM+:
M98UEMXG$9R@9 =I]O2@#Q*SM+#_A&M0T#7/&>H64OV^>VGT>&.!I'9YV*E%,
M9D8,&5L@GJ?2N[\,H%^*7C?NPCT\;CU/[IZ[)K2V:Y6Y:WB,ZC"RE!N ] >M
M2"-%=G5%#MC<P')QTS0!XJBJO[,ML  !YL9X_P"OX5T>GZ]I&B?%GQD-4O;>
MR\Z&R,<UPX16VQ-E=QXSR#CJ>?2O1?L\/D^3Y,?E?W-HV]<]/K6!9>&!%XI\
M0:I=_9[BVU/[-LA=-VPQ(5.<\<YXH \RT1UTT^$O$U[F#1'UG4Y1+(-JPI<;
MA"[9^ZIP>3Q\P]:UM=O+;7?$'C'5-*GCNM/M?"<MG-<PL&C:8EW"AAP2%ZXZ
M9KU=XHY(C$\:M&1M*$9!'IBFQ6MO#!Y$4$4<."/+1 %P>O'2@#SJXU.?1?A'
MX3-K<QV$=Q'I]O->NBL+6-T7=)AOE!Z#)X!.:Y;4+RR^V>-XX=>GU59O#++!
M=74D9\\J9=XC**H95SS@'!SS7M[P0R0&!XD:$C:8RH*X],>E-^QVNU%^S0X1
M2BC8/E4]0/0>U 'G_B-0N@_#Q5  &KV  ';]T]<I%;V$>D>(-&USQE?:>[:C
M<Q3:3%' SS"64E3&IC,C[PP.03^&*]N,4;! T:D(05!'W2.F*8]I;/<)</;Q
M-.@PLA0%E'L>HH \^T?4M.\*>/O%<.N:A#9?:UM;BUGO)!&)XDA"'!. 2K*<
MCWKF-.E33;+PKKU\?LFES^);VY268;%BAF641EL_=!ZY/K7M%Q:6UV%%S;Q3
M!3E1(@;!]1FG3017$+0S1))$W!1U!!_ T >57>JZ!K7C+Q;/<R-=:+_8,$4\
MUL"X=?,DW,A7J%)ZCH5/I5C3-8G6ZU/1+;Q/%XETLZ/-<+<_(\MJPPJH\B<-
MN#$C(W?*:]-CMX8@!'#&@"A!M4#"CM]*9!9VMJCI;VT,2N<LL:!0Q]\4 >0:
M'I-QJ/[/6BW5@/\ B9:7G4;,]_,BE=L?BNY<>]=3\/IU\3:EK'C8HRQ7[):6
M <<K;Q#!(_WI"Y_ 5O\ B/3=:O--73] O++3HY0T<\SPLSQH>\0! #=>OM6A
MHVDVNA:-9Z59)MMK2)8HP>I '4^YZGW- %ZO&=(T];WQ@? 5Q&38Z1>WU\T>
M/E\B5!Y(_.YD_P"^:]FI@BC$IE$:B1A@N!R1]: /*OAK+<:YXABFO 2_AK3!
MI#;A_P O'F,KL/?9$G_?5<GI#"+]G6SF<XBBUB.21CT51<C)/M7T"D4<98QQ
MJI<[FVC&3ZFF_9K<0&#R(O);(,>P;3^'2@#B+*[M-1^,BWEG<0W,$GAL>7-"
MX=6'VDYP1P>1^E6/A[_Q\^,/^QBN/_0(ZZ^*W@AV^5#''M7:-J@87T^E/2-(
M]VQ%7<=S8&,GU- &7XG_ +./A?4QJT<DFG&V<7*Q*6;RR/F( YX'/%><KJ-S
M)#JWAW2_$J>*-.N-"NI(W&R2>U8*%17D3AMVXXR-V5KURH;>TMK0,+:WBA#G
M+>6@7)]3B@#R&\\2Z/J7@_X?6%C?PW-TFHZ7YT4+AFAVE5;>!]WYN.>IK5T;
MQ)HWA&3QI9^(+F*&Y_M6XO5MI"-]U#(JE/+4_?R!MP.XP:](2QM(BQCM8$+L
M'8K&!N8="??WI9;2VFFCEEMXI)8^4=D!*_0]J .(\/ND_P 4]4G2V>V#:'9%
M89$"M$"TAVD#@$< @>E6?AK_ ,@S7?\ L/W_ /Z--=D(T$AD"*'(P6QR1]:$
MC2,$(BJ"2QVC&2>IH YWQ[JMUHO@K4;^S*+-&$42/'O6)6=59RO?:"6_"N#M
M[VQ3XB0;/$\^M))HMW"MW/)$8VFW1L8XS&J@MCDCG&17K[*KJ590RL,$$9!%
M0I96L<<<:6T*I%DQJL8 3/7 [4 >1LB'X&>#EVC:;O3\C'K,,UN>+;6:]^(A
MM+;_ (^)_"]]%'C^\70#]37H?D0^6L?E)Y:X*KM&!CI@4[RT,@D*+O P&QSC
MTS0!X]X:32=3M?"5K/XUU"ZN898)(M(6.#=!+$O*NJQAT5<,I)(^O-:6DJH^
M&?Q P!\U[JY/O]ZO2TM+:*=YX[>))I/OR*@#-]3U-/$,01D$:!7R67:,-GKF
M@#RCP_J=CH'B_1[O6+N&SMKWPI:1VUQ<N$C+(<NFX\9PP.*Q)KJWU'P5XMNH
M%_T>X\7PNF5QO4O;X;![$<_C7M\UG;7$2QS6\,L:$%5= P7'3 -.-O"0P,,9
M#-N8;1R?7Z\4 <;JB@_&/P\2 2-+N\'T^:.N(UB&5H_%%REQ-;06?BVVN;BX
MA4,T,8CC!D ((.TD-R#TKVLQH9!(44N!@-CD#ZT@BC&_$:C><M@?>^OK0!Y+
M?PZ7<Z?XMOK;Q9=>(+R#P[<0/)B)H8T<%@-\2 ;LJ>,YP36IKRA?"7P[50 !
MJNF  =OD->AQ6=M;P-!#;PQQ-G,:( ISUX%/,4;*BF-2$(*@C[I'3'I0!P'@
MN_M(/B#XUTZ:YBCO9M026*W=P'=/)7YE7J1]*]"J+[-!]H^T>1'Y^-OF[!NQ
MZ9ZU+0!XSINN:7I'P8U3PWJ%U"FN017EB^GLP\^6:1WV;4ZMNWJ00,<^U;/A
M^RELOBKI-M=+FYMO!L,;D\X83 -^H->CM9VSW*W+6\)G4864H-P'L>M2>6GF
M^;L7S,;=V.<>F?2@!U>>^(;^TTOXQ^'KF_N8K6"33+F))9G"*SETPN3QGVKT
M*HIK:"XV>?!'+L.Y=Z!MI]1GI0!XG%;V$>D>(-&USQE?:>[:C<Q3:3%' SS"
M60E3&IC,C[PP.03^&*[+P_ L7Q@\1KDNT>EV2!V^\1\V?SP*[E[2V>X2X>WB
M:=!A9"@+*/8]14@C02-($4.PP6 Y/XT >::0H_L+XGG R=1O03_V[I5:\4+\
M//A>  /]/TD_^0Z]3$48#@1H Y)<;1\Q]_6CR8BB(8TVH04&T87'3'I0!Y%%
M_P CG\7_ /L'0?\ I,U7M44+\,/  4  7FD8Q]4KT[R(=TC>4FZ08<[1EA[^
MM*88BBH8T*I@JNT8&.F* /$_&&LOJFA>,H[SQ%<6]W!/<VMOH=HL2EXT'#NI
M4NP*@N6R !]*Z*TUC38_C'8W,E_;+!?>&88;65I0%GD-P<*AZ,W/0<UZ/]EM
M_/:?R(O.==K2;!N*^A/I2&RM3Y.;:$^3_JOW8_=_[OI^% 'AEK;37/@/XA&&
M)YA!XJDN)8D&2\<<T;OQW^4$_A7::WK>E^*?%O@VWT&_M[^6"\:^F>VD#^3
M(F!+D?=R648/>O0TBCBW>7&B;CN;:,9/J:9!:6UJ7-O;Q0ESES&@7<?4XZT
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M<%4= P&.F : ,#P':V-KX3@.FWMU>6D\LMPD]S&$=R\C,3@   DDC Z&NEH
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ME&3@X4<G%<UX3\91VWA>_P!2NFOK][K7KFWL;=06FDRY*1J&(V@*#P2 H!H
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M\DUTM !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M57W'_O\ 3\^U>YT4 >8:M8QZ?\8_ %G;(1;VMA=0IQP%6(@#\A5&UU73]/\
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MW0]*ZOP7%H-WXGN]1TK7-7UN:&S6W>[N91) %9]VQ6"C+ KDCL#[UW](  ,
M8% %;4]0@TG2[O4;IBL%K$TLA'7"C/'O7F7@GPQXJO--G\2#Q(=+N]>D-[/;
M_8(YBJG/EKN;G 3&!VS7J]% 'A5QI6IZ1X3\9_#UF>\EAA74].98MGGPEU:1
M54<##*PP/[QKHM;\6Z/XH\0^"?[&F-VJ:HLDTB(<0$Q/A&..&//'7Y37J=
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MFM<7I";3DYN&QQ5[6K[SO%.H:=J^H:S J6EN-(L=/EEA^ULR'>=R?>._Y>2
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M'_"6ZN?BI)X=72+AK".R24N'BXW2$><<MG9@8QUR#Q7<5YU>7<&F_&Q_MK/
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MW;0/!:JEJL$<0<C>VT$Y8[0,YQCM74T4 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK;7J75TE@MM>/%':I$2J#RP=K9*Y;<#G-6O"GB'4-<\6^'Y[BXD"7?A?[5-
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MLW$H )>-MK$8)XR.*Y22VE\5_$?7+"[U'4+>QT:VMA##9W3P;I)0S&1BA!)
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M=P<#CBNJN_&%I9Z_X>TA[:=IM<21X7&-L81 YW<^A[5T$L@AA>4@D(I8@>U
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MK$T^8X;*>S>V*9$BR%23NSQ]W&,=ZY63X9ZI<>'H?#T_BIWTBTDC:TC^Q 2
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M/XU3N/ \POO#]]IVLO9W6D6?V(N;=9!/%A0003\I^7KSUH ZV<XMY".#M/\
M*O$K:RN[?X*VGC0ZSJ;Z]:P+<QS->2%-JR8\LQYVD%>#D9)).:]MG_X]Y?\
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MB+K(-Q.UP0>5QU[5F1^(]5MOAG>^'VN9'\307W]@1RLQWN[MA)<]?]4=V?\
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M("@G))P2<]J /*O"VI3VWPA\&:;$NH-#J&HW"7*:=D3R1(TKE%(((R0,D$'
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M X*S_P"2[ZG_ -@"'_T<:@\1:4FL?%S2K26XN(K<Z+.9A;RM&TB^;'\NY2&
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M,J-$J>8-T8Y3A#DD]>M=-9Z3'XO\:^*9=2NKU?[-GBM+!8+EXOLW[H.9%"D
ML6;.3GH!TH ]&HKPRR?4-1\%?#^WDU6Z66\UBY@N;B*4J\B%Y@V#VX''IQCI
M6UK=M:VOB^#PS_8VMZEHNGZ8LT5G87!)\R25P7D9I59L!<#DXR: /6:*\8N+
M[65T_P ,Z#K&FZ]/;37=Z7M8Y%%W<6\6#"LC!QGAUW?-SL[TW5&UBR\%ZU;P
MV^KZ18#5+$Z9]MD!FB5Y$#J"&;*A@2 2>&Q0![317EMYX6M+/XE:9I%M=:C'
MIVI:?/+?P?;96^TM&R[2S%MP.6YP1G&.A.<>>^N]%T+7="LI=1DM!XFBT^)(
M)BTZ6\BH[1QLS<$_,HR?XNM 'M5%>0,M]IVF^+1IVC:YI&BMX?N) E_*&\NZ
M56PT9$CD94\\CE<U+/I*Z+8^!M>M[R];5;R_LX+R>2Y=A/'*AWJ4)V@=, #C
M H ]/MM2L[R]O+.WG#W%DZI<( ?D9E# 9Z'@@\5;KS3X?Z'86WCKQE<Q1RB6
MWOUCC+7$C *T2DY!;!Y[G)':O2Z "BO$KJ:_UQ_$=]%H_B2ZUN'4+B#3;ZSE
M406WE,5C4*91QE?FRISN/6NCL+ >,_'6MIKWVI5TJVLTM[:*YDB$,DL9D=_D
M8?-G !]J /2J;(Q2)F1"[*I(4<9/I7C.@W-Y'I?A5)+Z>9SXKNHI96<YE \[
MKZC@''2NNO;B8?%#4X1-((E\-"0(&.T-YSC=CU]Z .B@U]8]%M+_ %FUDTF6
MXF6#[-,P=ED9]B+E,@Y.#[9YK8KP"WM4UGX.?#^XU"2XGF?6XX&D:X<%D>Y<
M,"0>3A1@]1C@BN_@*^#?B0MFT\JZ+K&GY@$TK.(9[=?F +$XS'R3W*F@#T"B
MN-^' NKW1;OQ#>/*9-:NWNXHY&)\J#.V)0.PV@'_ (%7-^-!9:AK&O&.TU_5
M;RQM5"O:7 @@TU]A8$$R)N<Y#'ACC ]J /5J*\MT[7Y](UG2-<U*YD:UU?PN
M+F4%OE^T0(LC$#H"4<_E6'IVKZOX=\%>)+&\NIY=4O[*VOK3>Y+"6['E%5ST
MVR#IVS0![=17DFN:=8_:;G2Q;^(-;N]*TV&#-K<B&*Q<(2)"QD3=(W#'[QP!
M4 ^U^*M4^'EM?W]TL.HZ))+?"&9HS/A(V.2I!&3U(YP2.] 'L59'AS7HO$>F
M27L4#PJES-;[7())C<H3^.,UQMCH5GX@\=Z_I]\]V;+08+.TT^&.[E3RMT6\
MOE6!+]!N.3Q6A\)4>/P2T<DIF==0O TAZN1,_/XT =S17D/C9K2\N_$]Y:VN
MOZE>Z?"0EW;7 AM],D2+=A<R+N.<,V QYQ[5H6<'_";>,EM]9FN'M++1;2X2
MWBG>%6FFW%I#L()("@#TH ].HKPV[GU.U^''B2)-6NI+NW\5_9XKMY"7P)(E
M&?ZCH>:WO$^GV^@:CX?\-VUGK6H:;>/<WE[!;7+//=.BQ@;F9U.W+;B 0,@<
M4 >J45XQ>7VLZ7X<GTT:;KUIIEYK=O;VD$DB_:Q;.FZ2)&WG'S(R@EL@/UJ2
MY%_INB>+QI^D:WI&BMH<DL:7\H)CN5!!,9$CD94@GGJM 'L=%>0:AX?%E+X(
MNK?4M2CO=6F2VU&X%W)FXC>$LPQG"],#:!M[=!3-5N9O!%QX[M-$FN([>'3+
M:YMXWF:7R)9&9&9-Y)'8]>HH ]BHKR_PW:W5AXMTK^R= \1V%E)'+%J<FIRA
MTE^3<DA_>O\ /O&,@#AC7,Q::8O@A;>+VO[]]=ME66"Z-W)^[ GVA N=NTKG
M.1SDT >UC4K-M6;2Q.#>I +AHL'(C+%0V>G4$?A5NO-++0[!_CKJL[1RF2+3
M8+E#]HDP)"[ G&[!'^ST]J]+H **\]&FP>,?B)XDM-9>XELM(CM8;6U2X>)
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MK?,'VD$ <$CVK"?3V/P@U#Q2U_?G6+&ZG>SG^U2#R MR1M"YVD'G.0>N.@&
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M;=HVTJ6*)I"V1)OC#Y [8SBMB@#EK?PC-I_B/5]6LM8N8H-3&^>S6)"/-";
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MB;^!VQTH I:-X9U&POX;G4/$M_J26T1BMX71(E .!NDV >8V .3[G&>:K_\
M"!VO_"N?^$-^VS?9O+V?:-HW_P"LW].G7BNMHH YNY\*2-XUC\2V>JS6DC6Z
M6UU;B)'2>-6+ 9(RIYQD5:\+VFHV>F3QZG//-,;R=HVG<,XB,C;!P>FW! [
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MM9:I'=1K'#Y<I5(PID!" +M(*\Y/6N^7X>^2N@/;Z_J$-WHL+6T-R$B+20'
MV,"N. H .,]^M32^ P;NZ%KKNIV>EWER;JXT^ H%:0G<VU]N]%8C) /<],T
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MG-+.$4%=P8855 7&,8''4]30!Y+9V4&J_!'P5-?*\\O]MI#O:1L['N6##KW
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 445P7Q=$C>#;=8IGAD;4[15D0\H3*!D4 =YD8)R,"EKRCQ/HE
MII.M^'?#6F>'I=0TJ5;J]GTY+D*+B51&H9VD8;L;B2">3@]JSKJPU6UTNS\/
MW^G7&E:)J?B2"&*T>Z60K;-&7>'<C'"ET.!GHV* /: 0>AHKRNXT+3M ^)RV
M^E0BVMG\.W;BVC)V(V] 64?PYP,X]/K5>[D8?L_^'VWG<1IW.>3^^CH ],CN
M]1;79K1],":<L(>.^^T*2[Y&4\O&1CGG/:M#(SCO7FU@S'X_:ZI)V_V''QGC
M[ZUR6@Z>FC_ A_%-IYK:[<69M1=^8=\<33A-J9.%  SGUYH ]V!!Z&@G R>E
M>9>&=#U#2_&&G3Z;X0N-!TTP2PZ@7O(I%FX!C8JKDEPP(W8S\QS6MX]2POM0
MT72[G3+S6+B1I9HM,BE2.&4*H!>8M@;5W# SU/0T =O1D'H:\-V3OX.?3"DV
MGQV_C.&UA@CGWM:H6C.Q7'H7;&.E==9:+I_ACXM6%MHUL+.WOM)G:YBC)VR.
MDB;7()Y;YCSUYH Z+Q/XMC\-7&FVPTR]U"YU&1XX(;0)N)5=Q^\P'3/Y5%IG
MBO4;_48;6;PAK=E'(2&N+@0[$XSD[7)]NE87Q$746\7^"!I4EM'?&[N?*:Z1
MFC!\DYW!2">,]#70Z1%XT744.LW>A26.#O6SMY4D)QQ@LY'7VH Z.@D#J:\6
MUIFTKQ5<> K+4/(T'5[F)[B9=V=/\W>6MPV,+YNWY>1C<W'(K0URR6_\>7.C
MMX5DUS3-*TVW2ULDN(XHX-Y?+X=AEL(%!&<;>V: /6>E%>106&I7DO@KPIXH
M@F6VD-])/:S3AS.D6/(61E)#85P2,\E1FKWB7P]9^&;#3+;3+B5;27Q+82)9
ME\I:Y<95.X4]<=.>* /3ZQ#X@?4/#+ZOX=L_[5<LR0P&40>:5DV-\S# QAC[
MX]ZP-:MX+[XKZ997*"6WFT2[26)NC*9(P0?UKS8:=9V/[+=[?6L"Q75T4\^5
M.&DVWNU<_0<4 ?0,99HU+KL<@%ESG!],TZO/)"?#_P 0] U,L5LM<L/[/N"3
M\JSQKOB8^Y7<OX5R=U/>:AH%WXBCAGN!XH\00VB0Q2B-Y+&,LJ(&) 7?L.3D
M9#4 >W@@C(.:P?$GBNQ\-_9898;F\O[QBEK8VD>^:8CDD#(  [DD 5SO@K2M
M1TSQ3>M!X9ET'0Y[-<VS7,4B?:%?[RJC';E#STSM%2?*OQV_TG&6\/@6F[IG
MSSYF/?&/PH NV7CQ/[6M=,UO1-2T2>\;9:O=A&BF?^X'1B WL<9I^O\ C&YT
MWQ58^&]+T<ZEJ-S;M=,&N1 D<0.,[B#DY!XQ6?\ %_:? ,BIC[:U[:BRQ][S
MO.7&WWQN_#-<_JWA?1+SX^6EO<:;!)%<:.]U,C X>7S2-Y]Z .P'C&YNO'=U
MX9TW1C<K8K$U]=O<B,0B09&U<$OQSVK<T>[U&\LWDU/3!ITXD95A%PLV4'1M
MP Z^G:O,_"?A?0X_C/XN1--@"V LI;4 ']T[1[B1[D\UA^'KNX7X2M:I/+$N
MH>)A8S2HY#+%),H?![9&1^- 'O (/0T9!Z&O-?%'A^Q\"^&M?UCPR\FG2G36
MC^R0/B,MD 38/(=03R/QJ#PWH.H:9XJT:XTSPA<Z+9A)(M2F>]AD%RA0E&<*
MY+.' .[&>30!ZCD9Q5&;5K.WUBTTJ20B\NHI)8D )RJ;=Q)[?>%>?_!S0+'_
M (1:S\02HTVI.]S"DSN28HA,XV*,X R"?J:?KN@Z7??&[17N;**5I--FF<L.
MKHR!&^HH ]+R,XSS17D>E^'=-\5>$O$/B+5XC+J[W-[Y5VSD268B9EC6,Y^0
M+M!X_'-=WX4U:2\^'VDZOJ,I61].CGN)2.^P%F_F: .AR,XSS17B>G00V.I^
M$-6TO0+VQ2^U%4.K7EVC7%_%)&Y/FHIR=W##/3 Z5/!H5CKG@+Q7XIO2XULR
MW[I>>80\"Q%U2-3GA,+@KW!.: /9:,CCGK7C4.D6VO\ B/P)IU_ODLI/# :>
M$.5$P C(5L<XW8/OBEO=-;6?%'B2U?PE<ZQ#I[16-B\=Y'$+%!"K#8'<$,2V
M[</;GB@#V0D#J:*\:N4UG4]=T;2/$7AN;79;/08II[+[5$JBX9V1I6W,%<X0
M8QG&XUWO@&TU6Q\,FSU:UEMC#<RK;0S3+*ZVY8F-6920< [>O:@#:T_5K/5)
MKZ*TD+M8W!MI^"-L@56(]^&%7L@]^E>%6UI;>&?!_P 2=7T>V2UO[75+BRMY
MX\AHH3Y0PI[8SG\*Z?6_#6E>"KSPG?Z!!]ENI-6M[&XD1CFZBE#!_,Y^<\;L
MGH10!Z=6/XIUX>&O"^H:W]G^TBSB,GE!]N_GIG!Q^59GQ DL6T.ULKV&^NOM
ME[%#%96;JC73\MY;$\!"%);D<#K7FNH1O8>&OB3IB:5_9%K%8VDT>GK.LJ1,
M^\,R[>!NV*2!Z4 >YQN)(U;ID X],U1T^[U&XN[Z.]TP6D,,NVVE%PLGVA/[
MV /D^AKS[5O#^G^%-2\&ZMI*-'J%UJ<-G=W <EKN.6-MYDY^8Y ;GIVKG)=2
MN]-T?XM7-I.\4RZBL:2*<% [;"0>V QH ]:UOQ -&OM%MOL_G?VG>_9-P?;Y
M?R,V[H<_=QCCK6UD9QGFO+-<\):+X9\2>!_[(MQ:AM3\N1$8XFQ"^'8=V'/S
M=?F-<^+'5_$5EK&JVGA:[N]=?4+C['K"WL2&W,<I6-%#.&55"@$8YYZYH ]=
M\3ZV/#GAG4=9-O\ :!9PF7RM^W?CMG!Q^5:4$HG@CDQC>@;&>F17)_$EI&^%
M6O-*NR0V#%USG!P,BN:U3P]I_A>7P9K&EHR:E<ZG;VEW<[R6NXY48/YF3\W3
M=[8XQ0!ZK17D4.L7'@KP]XN\,1%C>64X&C+GETNFQ$%]=KLP/TKT'2/#5GIO
M@RU\.S1K/;16H@E#=)3CYB?J<G\: *E[XVLH]$TK5K"(WEKJ.H16*-NV8WR&
M,OR#G!!X[^M=/D'H:\"T?1K)?@QX2DMX_LUQJ&LV@N)X25=B+AU#9[$ \&NN
MFTVR\&?$0?V#:K:QW&A74TT"$[99(V0HQ!/+<D9Z\T >GY&<9YJCJ^K6>AZ<
M]_?R&.W1D0L 2<LP51@>["O(?#.E:O-9^&-9T[PK=Q:E)+!<WNLO?0DW<4F#
M+O&_<5(8D*1D8' KJ?C+I]I>>"XI+B!)'BO[8(6_A#2JK?F.* /0R0.IHKR3
M6M-BG\=2Z&GA-]9TG3--A^S6,=Q''%"TCONDP[#).T $9Q@],U2OM)U26S\!
M:-KJ7-LYU.Y@9&N \AMMK[49T)Y,>%)!S^- 'L^1C.1CUHR..>O2O,)_"FCS
M?%.ST(V@&D0>'BPL@Q\ML7' 89Y +$X/?'I7/V_A32I_ /CF6XBDF;1;O4(M
M+WRL?L21 N@CYX^8]>IX':@#W"BO)M8TNXU#^R]=UGP]/XDTN71X%9()1YUI
M+@L\BQDC<6#+R#N&VNWAU.&#X=?VGI%S+=PPZ89K::<[GD"QDJ6]6X&?>@#H
MLC.,\UR>L^,;FR\8VOAC2]'.H7TMK]LE9KD0I%%NVYR0<G(Z?2N"O]!L-'^$
M5CXRLU;_ (2.."UOSJ/F$RS22,A=6;/S*=Q7:>*NW/A?1+G]H$P3:; \4NB&
M\=2#AIC/]_ZT >G:OJUGH>G/?W\ACMU=$+ $G+L$48'NPJG_ ,) /^$U/AS[
M-TT[[?\ :-__ $TV;=N/QSG\*Y;XR:?:7O@Z"2Y@21XM0ME0M_"&E56_,<55
MNO"NCWGQ8M])EM%.EV_AT$68)$;?Z0<!AW R3@\9P>U '?ZQ=7]GI4UQI>G#
M4;Q=OEVQG6'?D@'YR"!@9/X5<5B44N-K$#*YS@^E>$^(HQ8?!OQ[IMLSI:6&
MN^1:Q[B?*C\V!@B^P+'\ZZKQ9H<D^K6NJZCX<E\1:,-.CA\B"4>;:2 L6D2,
MD;BP*C(.X;: /3)'$<;.>B@DUP5M\4EGT>/67\*:^FDO'YIO!%$ZK'W<A7+8
M'4\5TVB3V=SX/LIM/NIKJS:S7R9ISF1UV\%C_>]?>O./!\OC+4OA7IVD:=H6
MG16MS8F!-0GU G:C @N8@F<X)XS0!ZW;W,-U:Q74$BR03()(Y >&4C((_"L;
MQGXE'A#PE?:\;7[4+0(?)$FS=N=5^]@X^]GIVKCX_#ME?^.K'PIJB_;=)T70
M(6@MION2R%S&9&7H2%0 9SC)KF/%*_8/AO\ $?0H&<Z?IM];BT5F+>4CM"YC
M!/8$G [9H ]@_M+49+O2OLVE"6RNXR]S<FY5?LWRY4;",OD\<8Q6KD9QGFO+
M-:9A\3?ABH8@&VNLC/7]P*-#\+Z;XTLM=UG5WE753JES%#?+*5ELDB?:@C/1
M<!<^^3F@#U.BO.([Z/P-X\UE;R9CI>JV!U2-SC'GPKB8#MEEVO6U\.--N++P
ME%>WX/\ :.JROJ-UGL\IW!?;"[1CVH LR3ZC#\1;2W>_+Z?<Z?<R):K& J-&
M]N Q/4M^\?T&,#'4G2\0:U!X=T"^UBYCDDALXC*Z1XW$#TR0*I77ANXN?$T&
MM#7;V)H$:*.W6*$QB-BA=,E"V"8UYSD=B*H_%#_DF/B+_KR>@"O'X[U.:))(
M_ OB%D=0RD"#D'I_RTKLH7,L,<C1M&S*&*-U7(Z'WKB--@^(G]FVGEW_ (9$
M?DIM#6D^<8'7]YUJA\1[V7P?J5GXJT<"75)T>SET_!/VR,*6#8&3F,C.?[N1
MGI0!Z30"",CD5X_JED+#P9X:L[(RZX->U)9]1DAF$;:@6C>1EW,0 I*@8R/E
M7%5M2BUOPUX<\3266BW'AS2KJ.UC@B^TQOY$KS".5HPC'9E&4]N1F@#VD$'H
M:*X2]\$:)X<L[Z^T;?IY_LRXBEMHI/DN?DR&<')++C[PYY.:Q=0<CX-^"SN.
MYI=)YSU^:.@#T>WU>SNM6OM+AD+7=DD;SICA1(&*\_\  33=&N]1O=-2?5=,
M&FW99@UL+A9MH!X.Y0 <CFN#\*Z#I<?Q?\:W2640GM3:20N!RC2PN9"/][)S
M7'>&HIXO@CH_B2WWO=:#J3WV >7A$I65?H4)/_ : /?:,C.,UYCK.I/K'C._
MU2Q?S;3POHLES"1RKW4T99?KB, _\"K'\,Z/JJGPOJFF^%+NUNS)#+J&K27T
M+F\AD7]ZT@WEFSNW $9&!B@#U?6M9L/#^DW&J:G.(+2!<NY&3Z  #J2< "N5
MD^(\EI;B_P!1\):_9:3U:\EB0^6O]YXU8NH_"F?$[:%\*-<8^PKX@MC<9^Z!
MAMN[VW8KM+\VPTZY-YL^RB)O.W_=V8.[/MC- &!XK\9V_AO0;+4K>V.I-J%Q
M%;6<<,@42O("5.\\ $#K536O&NH:,=!L&T#SM<UAY%CLEO%"1^6 6)EV^A!Z
M>M>57FC6US\*OAQ=:A:+)=2:K;VI>0?,;9I)2J?0KMKI?&'@WP[;_$SP%91:
M3;I;7;7BSQ@'$@2)2H/T)- 'IUE>ZM-JC076CK;6@MTD%T+I7S*<;H]H&>.?
MF[XK4R,XSS7DJSMH_P 6/%SV2;19>&T>"(<@;%&T8_ 5I^$O!>DR:!X:\1+/
M-!K,D<-Y<7ZR_O+II$#/'(3G<K%L8[8&,4 >CY&<9YHR!UKPG3[+6M<T(Z[8
M>$[N?Q%->/<0ZU]NA7!68C8 7#",*NS9C'7BNHL] L=>^,/BHZE&T\-DEA-%
M SD()?+;#D \D8./]XT >G45Y)9Z5;^'_$UN_B31KR*_EU0M;^([6;>MP9)#
MLCEYW(I#!-I&WC@CK78>/](OM8T2UCLK1;](+Q)[G3VF\H7<0# Q[NG4JV#P
M=O- &CXD\0#P]9V5Q]F^T?:;Z"SP'V[?-<+NZ'.,YQWK:R#T->+:K'I,_A)=
M.TJUU'1W7Q%8I<:?.=K63LR\QX) 4CY@0<9)(Q6^=+TKP=\2[0Z9&-/LKK1[
MJ6\$9)5O+9")"#G+ %N>M 'I61G&>:XZT\=BZ/C ?V<5_P"$<+9_?9^T81F_
MN_+]W'?K7#:7;PZ?K'@_4],T"]T]+Z^$;:G>7:-<7\4D4C?O44Y). W/3 Z5
M/I/W_C%]9?\ T3)0!Z9X7UP>)?#&GZR+?[.+R$2^5OW[,]LX&?RK7KD?A=_R
M3#P[_P!>:_UKKJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH *R?$7AZU\2Z='97DDT<<=Q%< PD [H
MV# <@\9'-:U8GB;7V\/V^G2K;"?[9J-O9$%]NT2OMW=#G'I0 NO^'(==-G.+
MNZL;ZR=GMKRU*AX]PPPPP(*D=01V%9TW@*PNM DTRZU#49YWNEO?[0>8?:%N
M%QM=3C:N    ,8[5U"2QR;MCJVTX;:<X/H:598VD:-74NOWE!Y'U% 'G=GX;
MFT[XK64UQ=7^IF;1ITGO+L @_O(]J?*H51C<< =R>:M)\++#^S(M+EUO6)=,
MMI4EM+5I4VVY5PPP=F6Z$?,3@$]^:[RL'Q5XD7PYHDE_'$ET\<\$+1>9MQYD
MBID\'&-V?PH =#X5LH?&-WXF6:X-Y=6BVCQEE\L("#D#&<\>M1Z=X-TO3_!2
M^$R);G31"\+>>PWLK$DY( YR>"!Z5O-+&C*KNJLYPH)P3]*))8XE#2.J G&6
M..: .>T;PF=+U&.]NM<U75)883!;B\D3;$AQGA%7<QP/F;)XJ77O"Z:W?6-_
M%J5[IM]9ATCN+0IN*/C<I#JP(.T'IP16Z6 ZD"H_M$'E>;YT?E]-^X8_.@#D
MH/AMI=OYD<=]J/V=]0@U/R6D5A]HCQEMQ7<=^T%LGD],5O3:%;3^)K37FDF%
MU:VTELB C85<J22,9S\H[UI.Z1H7=E51R6)P!2AE*;PPVXSG/&* .?\ $WA*
M#Q-/IUP^HZA87.GR/)!-9.BL"R[3]Y6[?SJM8^#;JROH;EO&'B.Z6)PQAGGB
M,;^S 1@X_&KLWB,1^+]-T..%)([RTFN?M"R?=\ME&,8YSNZY[5JW][!INGW-
M]=/LM[>)I9&]%4$G]!0!SZ> ](_X1S4M&N#<72ZE*\UU=3,#-)(QR'W   K@
M;<# VCBB]\%BXGM+RWUW5+/4H+46DE["T9DN(@<@2!D*DYR00 02:W[*_M[_
M $V#4(7_ -'GB696;C"L 1GTX-3HZ2('C974]&4Y!H YJ[\#:?<:1IEE#>7]
MM<:8YDM+^.;-PCG.XEF!#;LG((P:K-\.M,ET6]L;B]U">[O+E+N;4GD7[1YR
M8V,"%VC;@  # %:OBC7V\.V%K<K;"<SWL%IM+[=OF.%W=#TSG%;"2QR%@CJQ
M4X8*<X/O0!S>E^"H+#Q!#KUSJNHZAJ<=N]L9KETPR,5.-JJ ,%>,8ZG.:S1\
M+]._X1+4?"[:MJC:1=NK1PEX_P#1@)?-Q&=G=NN[/%=L)8VD:-9%+K]Y0>1]
M13@0PR""/44 87B/PG8^)O#R:/=S7,,<;1O%/ P66-DZ,I((!QD=.A-.NO">
MF77A:W\/$2Q6ELD2V\D3[9(6CP4=6[," <ULO-$B;WD14SC<6 %/H P]#\.'
M2+NXO;G5K_4[R=%C,UVR_*BY(55154<DDG&31XC\*:?XF2V:Y>XMKRT<O:WM
MI)Y<T#'@[6]".H((-;,DL<*[I9%1<XRQP,TYF5%+,P50,DDX H Y2P\!V\.K
M6VIZMK&IZU<VAW6HOI%\N%O[RHBJ-WN<UHR^&+.7QG!XH:6<7L-F;-8PP\LH
M6+9(QG.3Z_A6RKJZ!U8,I&0P.011')'*F^-U=?53D4 8^G^&+/3O%.K^((99
MVNM46%9D=AL41KM7: ,].N2:S++X=Z-9^$KSPV7NIK*ZG:X9Y) )$D+!@590
M,$$ CCMWKJDECDW;'5MIPVTYP?0T>='O5/,3<PRJ[AD_2@#E[/P%9+->3ZMJ
M%]K4]U:-8M)?.OR0-]Y%"*H&>,GJ<#FI=&\'#2K^WNI]<U741:1&*TBNY5V0
MJ0 ?NJN\X&,MDUK+K=B^OR:(LA-[';K<LN. C,5'/KE3Q5X2QF0QAU,@&2H/
M('TH R_#7AZU\+:#!I%E)-)!"TC*TQ!8EW9SG  ZL>U5-;\)0ZQKFG:S'J-[
M87UBKQK):LG[R-B"R,&4\<=JUM0ODL+*YFRC210O*(BV"VT$_P!*K^'=5.N^
M&M,U9H1";VUCN#$&W;-R@XSQG&: ,&]^'EK<S:@EOK&JV.GZE(TM[86TB"*5
MF^^02I9=W\6TC-=0-/M%TP::L"K9B'R!$. (]NW;],<5,\L<6/,=4W' W'&3
MZ4LDB1(7D=44=68X H XE/AG;+:V,,FOZS*=-=&TYWDCS:!.@4;,-QP2P)P.
MU<CXBL;6)O$^F0V7BF*>]EE:'2H8B]I>2N.)@ZI\JEL,REP.#D=J]E#J5#!@
M5/0YX--66-V=5D0E/O '[OU]* .;T;PA#9S:!J%Q++]OTO2UT_8K#RR-J[B>
M,YRO'-&J^"X]0U6YU"SUC4]*EO8UCO!9.@%P%& 3N4[6 XW+@XJVGB$:GH=[
M?:#"E[/;RR0)%+)Y2NZ.4;YN<#(.#WK6MY7:TADN42&9HPTB!]P0XY /< ]Z
M ,#4/!EM</I\^GZA?:5>6-O]EBN;5U9FAX^1PX8,. >1G/.:UM&TF'1-+CL8
M)KB8(69IKB3?)(S$LS,?4DGVJXLL;QB175D/1@<@_C3L@$ D9/2@#EHO 6GQ
MWVMNUY>26&LEWN].=E,)=P SCY=P.!_>_IANG^!(;6_L+F]UK5-4333FQ@O'
M0I"<;0WRJ"[ $@%B<9K;TN[U&X-[_:5E#:+%<,D!CN!)YL0^ZYX&TG^[VJ\L
ML;NR*ZEU^\H/(^M &5XB\/0^(K6VC>ZN+.XM+A;FVN;8J'BD (R-P((PQ!!'
M>L"?X9:=<IJ8EU;56;5;5;:_=I(RUP58E9#E.&&2!C"@8&.*[3S8PY3>NX#)
M7/('K3Z .4M/ MM;ZM8WEQJNI7L&FDFPL[AT,5N2-N1A0S$#@%B2*?#X"T>.
M/Q'%*;B>+Q!(9+N.1AA201\F ".N><]*Z9I8T=49U#-]U2>3]*'D2-2SNJA1
MDECC H X^V^'D"7VEWM]KNKZC/I<HDM#<R)A!M*[2%09SD9)Y^4<]<R7/@&U
MGO+MH=7U2UT^]G^TW6GP2JL4LA(+'.W>H8C+!6&>:ZLS1#9F1!O^YEA\WT]:
M5Y$C4L[JH R2QQ@4 4->T:W\0Z#>Z/=/+';W<1B=HB P!],@C]*Q+3P':V^I
MZ?<SZKJ5Y;:82UA97#H8K=MNT'A0S$ D#<3BI_'?BL^#?"-QKL=HMYY3QJ(C
M)L#;F"YS@^N>E="TT<<0DE=8UXY8X% 'G36$'C7XHZ;K4.GW<5CHD+B2YN8'
MA%S-G]VBJP!(0[FW8QDBO2>M)N7CYASTYZT%@,9(&?6@#B].^&UAIVEV^EKJ
MNIRV%I?0WMI!(\9$#1N7"@[,E26YR2>!@BN@N- M;GQ):ZY(\OVBWM9+58\C
MRV1RI.1C.?E'>M+S8_,$?F)O(W!=PR1ZXI4ECD+!'5BIPVTYP?0T <IIO@*V
MTVZM!'K&JOIME+YUIIKRKY,3<X&0H=E&>%+$"M;Q-X=M/%.A3:3>2311R,CB
M6!@'1E8,I!((Z@=JU5EC9V174NOWE!Y'UI&FB0J&D0%CM4%AR?04 <Q<^"C/
M):7<7B#5;?58(#;2:A&8O,GC+%MKJ4*'!)P0 14R^"M.5=! N+PG19GGA9Y0
M[2NP(8R$@DYW$\8Y]N*U)];L;?7+71Y)"+RZBDFC4#C:A4')[?>&/QK0H RC
MH-J?%8\1>9-]K%B;'9D;-F_?G&,YR/7&.U5(O!]A%HNO:6LUR8-;FN9KABR[
MD,ZX;9Q@ =L@_C6Z)HS*8A(AD R4W#('TH>:*)2TDB(HX)9@,4 <O<>!UW0-
MIVO:MIC):1V<IMGC/G1QC"DAD(#8)^9<5O:;I-GI6C6VDVL0%G;PB%$;YLJ!
MCG/7WJ[6?<:U8VVMVFD22$7EW%)+&H'&U-N<GM]X8]>: .;@^&]C"MM9OJVJ
M3Z+:S":#2I9$,*E6W*"=N]E!Y"EB.!6R?#%F?&@\4^;/]M%C]A\O</+V;]^<
M8SNS[X]JV3+&)1&77S",A<\D?2AI8T&7=5P0.3CKTH RO$WAVU\4Z%-I5Y+-
M%'(R.LL# /&RL&5@2".H]*@T[PO%8ZU%K$VH7EY?)8?86DG*?.GF&3<0JCYL
MG''&.W>MMIHD*AI$!8[0"PY/I2B6,R&,.ID R5SR!]* .4U+X>Z5J>@:[H\U
MS>+;ZS>_;;AD=0Z/E#A,K@#]V.H)Y/-6-2\(&\OA>6.NZII<K0+;S?9'3$J+
MG;D.K ,,GYA@\UT?F1^9Y>]?, SMSSCZ4XD 9)P* *.FZ3::3HMOI-FC):V\
M(AC!.3M QR>YJ/0-%M_#N@V6CVDDLEO:1B-&E(+$#UP /TK&U'QS:0^&$US3
MHOM<+7R66UFV<F?R6;H> <D>M=0DL<C,J.K%#A@#G!]Z ,/7/"L6KZE;:K;:
MA>:9J=O&T*W5H4RT9.2C*ZLK+D9&1P:H3_#S2;GP=J'AR6YO6BU&7S[N[,BF
M>:3<K;B2N,_*!TQ@5U8EC:1HQ(ID49*@\C\*I6&M6.I:AJ%E;2%YK"58I^.
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M6.-^X8_.I-PXY'/3GK0!SWA3P9IOA'19M+M'N+F*9RTLEVP=W^4* 2 !@*H
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MLD)&Q2 H4(, 8 'UK3U'PS8:KK4.IW1E9XK2:S\H$!'CEQNSQG/R]C6S6?\
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M\4O$\-]IUM<6MI96"0VTL8:),I( 0AXR , XX!..M 'H[31)"9FD18@-Q<L
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M13C(7GH.* /0M=NM0LM)EGTNWMKB[4KLCN9_*0@D9RV#CBFOX@T^/Q%%H3S
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M4^O>%]"T33_ 5QIEG;VT_P#;%A&985"M.""3O(^^<C.3GOZF@#UIF5%+,0%
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ML7Q(3D>6 I)&#G XID<<MGH_Q2L&TRTTJ./3$E%C9S>9%$SV\F2,*H!8*I(
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M#SUH ]0!!&1R**P/!4^FS^$;!M(BN(;)0\:07))DA*NRM&<D_=8%>O0<5OT
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 5G:SHMIKMM!;WGF;(;F*Y38V#OC8,OX9%:--DD2*-I)'5
M$499F. !ZDT .KDK[X>:3?7-ZXO-3MK74)#)>V5M=&."X8\,67&1N YVD9[U
MTD6H64]H;N*\MY+8=9DE4H/^!9Q2QZA92W<EI'=P/<QC+PK("ZCW&<B@#+N?
M">EW6N:+JQ1XY]&22.T2-@J*KKM((QZ=*;:>$-(M+S7;@1/+_;A!O8Y6W(P"
ME< =AAC6'8^.[G6/']]H.F1Z9]@TXQ+/<SW1$DQD4M^Z4 @XP1R:[!=2L7O3
M9+>VQNQU@$J[Q_P'.: .=TWP-I>@W4.I?:=5OSI\3K90W-P9A;*1@B)<==OR
MC.3CBLKPYI#:W\1;_P :SZ3<Z=$MJEG:1W<9CEE;^.9D/*\809Y(S7<2ZA96
M[%9KNWC965"'D (9ONCD]3V]:5]0LH[Q+-[NW6Z<96%I '8>RYR: ,V+2)T\
M:7&L>8PMY+".W"&0D%P[,3MZ# QSWS[5<UG2+37M&N]*OT9[6ZC,<@4X.#W!
M]:FN+^SM)8HKF[@ADE.(TDD"ESZ $\TL][:VN[[1<PP[$\QO,D"X7.,G/;/>
M@#G9/ =A+IUA;OJ6K&ZT]F:UU#[5_I,888*[L8*D #!!'%:6@^'++P]%<"V>
MXFGNI/-N;JYD\R69\8!9O8   8 ]*MMJVFI%!*^H6JQSG$+F90)#_LG//X5+
M=WMI81"6\NH;>,G:'FD" GTR: ,WQ)X:LO%%C!;7DMS"UM<)=03VTFR2*1<X
M93@^I[4[2_#MII6I76H12W,UU=000S23R;BXB!"D\=3N.3WK2:Y@39OFC7S,
ME,L!NP,G'KQS5237-,CTNXU(7]O):6ZDR2QRJRC';(.,^U &0_@32#HT>FH]
MW"(;M[V"YBFVS0RNS,S*P'^TPP01@UHZ%X>M= BN!#-=7,]S)YMQ<W<OF2RM
M@ 9/ P     !4VBZS9Z_H]KJ=B^Z"XB60 D;DW*&VL 3A@",BIKC4]/M03<7
MUM"%<(?,E5<-C..3UQVH I:]X=L_$$5N+B2XM[BUD\VWNK63RY86P02K>X)!
M!!!K-_X0'2'THZ?<2WMS%+=K>733S[WNY%Q@2G'*_*ORC ^45TDMU;P[?-GB
MCW@E=[@9 &21]!S4,NJZ=#:1W<M_:QVTGW)FF4(WT;.#0!5G\/64WB.TUX>;
M%?V\+0;HFP)8VYV.,?, >1Z&L:U^'.BVNE7NEK/J#V%S)YL=N]R=MJ^\N&AP
M 4(8YSDUU N[<F$"XB)G&8OG'[SC/R^O'I3GGBCDCCDE17D)"*S %B.N!WH
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M&ZVFV"6+<&,;C!RN1TXKH*P_%_B(>$_"]WK1M3=?9S&/)5]A8NZH.<''WLT
M4-.\ :9IUY9RK>ZG/;6+^99V-Q=%X+=L$ JN,\ D#)..U=//!%<V\D$\:R0R
MJ4=&&0RD8(/MBN1'B3QH2,^ 2!Z_VQ#_ (5UR3PRR21QRH[QD!U5@2I]QVH
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M2_#C1);V20S:@+&6Y^U2:8MR1:/+G=N*8_O#.,XSVKIX;^SN)EAANX))63S
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M[&^I(5NH$N&$,A*[-Q3INQWJS8^%M*L/"?\ PC,4+-IGD/ 8W;<2CYR,_P#
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M&#4599OF$J1X$>X'J,*IP>N!7I6J>!=)U34;F],^H6DEXH2\6RNWA6Y &!O
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M)H(T6^_X2.P74;2&;=&S.4PZ,N!AEQT .1SSS70:I!IGASXFZ?=6UI%9V_\
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MY;W%MS^^AE5TXZ_,#BFV&J:?JD;R:??VMXB':S6\RR!3Z$@G!KQKQ/$=.O\
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M>PCU&S>]C!+VZSJ9% ]5SD58M[FWN[=;BVGBF@?E9(W#*?H1Q7GGA/0/"[^
M?">I7@MK>Y'V>Y2]WB.62Z;D@OU8LQ(*D\]*Q+G4+CP?8^+/!MI\MS<3HVAI
MTREVVW:OLC[S0!Z[#>6MQ:"[AN89;8@L)D<,F!U.1QV-,?4;&*R6]DO+=+1@
M")VE4(0>GS9QS5?1M&M=%\/V>C0*#;6UNL !'W@!@D_7DGZUY!!IYUO1M/\
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M'[.LEY=23F.+_GFF\G:OL*L>'/"^F^%;22TTLW*VS-E8IKEY5B'/"!B=HY/
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M'IUA!9PM(T4""-#(Y=L 8&6/)^IJO>Z[I&G7L-G?:I96UU/_ *J&:=4=^<<
MG)YK/\$:[<^)?"%EJUY'%'/.90RQ A1MD9!C))Z*.] &9_PJ_P .+)*\1U2'
MS9&E98=2G1=S'). V!R:NR> M"GT#^Q;A+NXLOM*W6)[N21]XQCYB2<<=,XK
M2O/$V@Z=G[;K6G6VV4PGSKI$PX )4Y/7!!Q[BK%[JVG:;9"]OK^UM;4XQ/-*
MJ(<]/F)QS0!7E\/:;-XF@\0O"QU*"W-LDF\X$9))&WIU)YKRS7/"MQ?V^KZ1
M;>#M0@O[V>013+>[M-0.W-P%+X5]I)QLSGI7I.J>,-$TSPO<>(?[0MKBQB1F
M1X9T83, 2$0YP6., 5I:5JEGK.G0WUA<0SP2#(:*0. >XR.,CH: *8\,Z9_;
MMEK3Q,VH6=K]EBEWD 1GJ-O3O6/)\,O#3QO#Y-XEO-*TMQ;QWLJQ7+%BQ\Q
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M]NM:L&BV%MK,VK10[+N:W2V=@QQY:$E0%Z#&XU@^.O'-GX2\'3:U;S6ES.Z
MV<)G&+@EE&5P<L &R<=JT_"FIW6K:&EU>7VDWLQ<@R:4Q:$<#Y<ECR,\\^E
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M.WA29GBTW<%P'(4MN R1E@..E>H:OI%CKNF3:=J4'G6LN-R;BIR""""""""
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M.G,ZRSH8QM ##E58(>.F?>L'5K72E_9XT*18X0X%D\3 #/G-(GF8/J<OG\:
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M:JUDT]T[*XRIE5)#'GWSG'O6CKT-C!XR^((LUC5F\*LUPJ<8D(DZ^Y7:?QH
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M2B21>CM@9(^IKQOQ==7-WX)\6:C8V>D6&E&_D1WEWO=3SI(J>8#D!#N48'.
M* /8[;4+.]EN(K6ZAFDMI/+G2-PQC?&=K =#]:JW'B/1+6VNKFXU:RB@M)?)
MN)&G4"*3^XQSPW/3K7$:UJ</@/Q_?ZO/QI^LZ6\S#^]=6RYQ]6C./<BJ.GZ?
M<:1H/A/36TZTN_$6JW<VIM+?%A%#.4,DCLJ\LP5@H'XYXH [J_U^UNO"ESJV
MBZSI:QJO[N]GD#6Z'(!WD$?3KUK'USQ7J.F>(_!6G0M9SPZRTBW4JJ2&VHK
MQG/ ))ZYXQ7!:NUQ_P (-\4H[F2S>5;N+S/L2E8M^R(-@$D@Y'//4&M?6O\
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M5M9+!Y!$LZR#;O)"A?8Y(&/>KLM_:07UO8RW$:75RKM#$3\T@7&X@=\9'YT
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M_#.C>&[:6#2-/BMEE.Z5@2SR'U9F)9OQ-/D\1:+#96M[)JEHMK= F"<RC9(
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MM@H. 1@=N<<YJ:P\6^']3TZ[U"RU>UFM+,$W,JOQ$ ,Y;T& ?RI+3QAX<O\
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M:9-DRVY&1(3R2Q/)/ Y)SP/2HM+\&^'M&G@GT_2XH9X-_ERY9G&X -\Q))X
M'/3'% '!>!]&TJ[^"U_#>SQ6$=_)=I/>-@;,S,@))[<#C_&I=;N=5MK#7M(\
M0V.F3:B_AN]:TU*P4J9(54!D=#RIRRG@E?2O1+;0=*M-&?2(;&%=.D#A[8C<
MC!R2V0?4D_G572/!_A_0C.VG:9#$TZ>5(S%G+)_<RQ/R^W2@#B]>N8/^$3^&
MZ"5"TVIZ:8P#RP"<D>W(_,5A^,;V]O/ _C.]LTT?3M)^VS0R(\+O<W,R.$+[
MMX"L648&#@ 5Z/8^ /"NFR))::+;QO'*LT9RQ*,IW+MR?E /.!Q[5)-X'\,S
MZA=WTVC6SW%V'$[,"0^Y=K';G 8C() SSUH Q-$MX9?B_P");EXU::/3K)4<
MCD!O,SCZ[1^5<5&JQ>$?#D2@+'%XZV(HX"J+B7 'M7K^FZ#I>D2O+86BPR/%
M'"S DDHF=@))[9/YU6N?".@7FD2:3<:9"]C).;AH3G'F%BQ<'.0<D]#WH C\
M;_\ (A>(O^P9<_\ HIJXB'8\_P )%N<&R-HQ^;[GGBU7ROQ^_CWKTN+3K.'3
M%TU($^Q+%Y(A;YEV8QM.>HQQS61%X&\,P:(^C)I$']GO+YQA8LP#X #*2<J1
MCL1B@#(L@J_&O5?LH C.B0&\V=/.\UMF[_:V9_"FW1Q\<]/]_#\W_H]:Z?1O
M#^D^'H)(=*LH[996WR%<LTC>K,22?Q-,U7PSHVMWUG>ZC81SW5F<P2DD,G(/
M4$9&1T/% 'G6FV5M_P *E\?R>0A>6XU9W8KRQ4OM/X8&*32%U^?QE$=,ETI;
MC_A&['9_:,4CDQG=OV;6'\6-W_ :]+CT+2XM,O--2SC6SO#*;B+G$ADSOS]<
MG\ZJZGX0T#6+>T@O],BE2T3RX"&96C3 &T,I!Q@#C.* *G@'3FTOPC;VAOK.
M]599F26R.8@#(QV+R>%)*XSQC%>:GSC\*-96)H0A\4,LYF!,83[6N=X'.WIG
MVS7M-G9VVG6<-G9P1P6T*A(XHUVJH'8"LJ'P=X>M[K4;F/2;<2:D&6\!!*S!
MCELJ3CD]>* .4N-+UH:]>:CK&HZ&+E=#N8?LM@CI))$2"&(9CE588![;CZUS
MUU8VUM^S#&(8E0RV4#NRC!9FE0DDUZ;I7@_0-$CN4T_3(H1<IY<QW,S,G]W<
MQ)V\].E6'\/:3)H"Z$]C&=+5%C%MSM"J00.N>"!0!R7B/3;)?B9X C6VB$<*
M7HC4*,*$B0J,>QY'H:R)]+M]2\1^/M.;4(=.:34=-DMY9 "GV@1HZ@J2 VYE
M&1WS7ID^F65SJ%I?S6ZO=68<6\ISF/> &Q]0!56Z\-:+>C41<Z=!,-2V&\#C
M/FE  I/N !@CTH Q/#%_?'Q/JFG:YIVGQ:U';02O>V!)2YA+.$R&^92"&X)/
M7BJWAX(WQ7\9FY -P(;);??U$'EG.WVW[L^]=)HOAO2/#J3+I5BEOYQ!E;<6
M9\=,LQ)..W/%1:UX3T+Q#-'/JFG1W$T:E%EW,C[3U7<I!*^QXH \<U_:/@?X
MC6#'V >(919;?N^3]I&-OMG=7N6JW<=AI%[>3(TD5O!)*Z+U8*I) _*JMUX:
MT6\T)-$GTV!M,0*%M0NU!M.1@#'?FM1T61&1U#(PPRD9!'I0!X^CZBES\.I+
MC^QK2SGO%DLK"QA<20QM YP9&<AAAE!PHR2*OZ)96S>#OB1(T*,\VI:FLC$9
M+ *<#Z#)_,UUL'P^\*6T!AAT6W5/,24<ME64DKM.<J!D\# Y-:T.BZ=!:7MK
M%:(L%]))+<H,XD:3[Y/UH \U20>';/X?^,7?9;/IMOIFIR$\>5)&IC=CZ+(.
M3_M5TWPXMI)])O?$ERA6ZU^Z:]PW58?NPK] @!_X%47B[0=2UG2H/!VFZ5%!
MH<J0QSWSS+B&%&!V)'RQ;"@ G@9KM(((K:WC@A0)%$@1$'15 P!0!YGKD=QX
M?B\0ZM;?V3KGAJ:[-QJ=E-Q/#(-JN%895B-H.U@".@-):'/QO\5GUT.+_P!E
MKLKOP1X:OM7.J7.D027C.LC.<[79>C,N=K$8')!Z5?70],35KG55LXQ?7,(@
MFFYRZ#HIH \B;3K-O@#X6B-O&4DN[-V&.I>8!C]2"17:W<:1?&C23&BH6T.X
M0[1C*B6/ ^@KI/\ A'-(_L>VTG[#']@MF1H8.=J%#N4CGL1FK+Z99R:K%J;V
MZF]BB:%)N<JC$$C\2!^5 '@L7_)M?BC_ +"3_P#I1'7H<EU?3^)K&RT>'2[>
M]M=$CFGU"_C>0K$[8"(JLO="22?2NG'A#0!H-QH8TR'^S+B0R2V^3M=MP;)Y
MSU /X4:GX0\/ZQ/;3:AI<,\ELGE1%LC"?W3@_,OL<B@#R33H(-1\)_#N&?RI
MX'\0W&0JXC91),0 IS\O'3TXKV3755/#6IJJA5%I+@ 8_@-5XO"6@P3K-%ID
M*.EV;U2"<+,007 S@$Y/MS5[5X)+K1;ZWA7=++;R(@SC)*D"@#R6ZBLE_9XT
M%K%8_M -BUL4QN^TF9-V/]K._/XUU7@Q8'\1^.S?",W1U/;-YN,_9O)3RP<_
MPXW>W6I_"?P_TC3M(T*YO]'@76;.UA$C;MP294"EL [2W'WL9]ZV-8\&>'=>
MO!=ZGI<,]QL\LR992Z_W6VD;A['- 'C\6_\ X0[X79W>7_PD8$.[KY7GOL_#
M;C'MBNEE-POQ?\;&TW?:1X>4P[>N_:-N/QQ7HUUX?TF]73TGL(633I4ELU V
MB%U^Z5 X&*DBT;3H=:GUB.U1=0GB$4LXSN9!T!_*@#C?#*^&/^%<>"WOQ $'
MV4V9YS]L([;>=V[=GMUS7,:G<7'AL>)O =F=DVL74;:/_LQ73%90/0(1(?QK
MTBS\$>&K#6/[6M='MHKW<SK(H.%9NK*N=JD^H K(L=%U37/'<'B36]+BT^+3
M('@L(/.661W?[TC,O &W@+SU)XH Z:*PM]*\/+I]JFRWM;7R8U]%5<#^5>*>
M&[>&[^$/PZ@GC62)_$:AT89##S9^".XKWIU5T9&&588(]161;>%M$L].L=/M
M].BCM+"?[3:Q#.(I,D[ASURS?G0!@E%3XWH54 OX<;=@=<7"XS],FEURZO9_
M'UO8:/!ID.H6^F-<2:A?QO)LB:3;L159>24R23TQ75G3;,ZL-4^SK]N$!MQ-
MSGRRP8K],@&J.L>%=#\07$%QJNFQ7,L *HS9!VGDJ<$;E]CD4 >3Z+%#?Z)X
M&CF\BXA_X2:[(\M,1MAIV&U23A<X('-=;?:1:ZO\4-?TNX0""_\ #D238'4F
M610WU Q@^U=5!X3T*VNA<PZ;#'*+HW@*Y $Q!!<#. 2"?SJ:^M([2>YUJSTP
M7>J_9Q  L@1I4#%@FYC@<DGF@#R_1+VY\5R^%_"-_P#-<Z'<22ZP/4VIV0Y]
M0[,K>^#75?%(7+:+HR6[6X#:U:B0W2EH<;CM\P C*[]E7/!OAZ\LK[6?$&KV
M\%OJVLS*\D$+!Q!$B[43=_$V,DD=2?:NDO\ 3[35;":QO[>.YM9EVR12+E6%
M 'E_B33-6BM/&&HZOJ.C-=2>')8I+33T=&(&XI(X9B3_ !J#^%3ZUIEE]B^&
M,'V:+RDO80J[1C'D,WZD GUKM;+P;X>T[3KVPM=+B2WODV70+,S3+C&&8DL1
M@GC/&:ORZ-ITXL!+:HPT]P]KG/[I@I4$?@2* /,O%BK'KGQ'V +YGAJ-WQ_$
M0LHR?PXJSK<5DG@GX>G3EC#C4M.^R%,9P1\^/JN[/ZUUOBSPXFH^'_$+:?:(
MVK:AIKV@?=M,GRML4DG Y8_G3="\$:'ICV6H_P!DP1ZI%" 9 2=CE0'*C.T$
MG.2!S0!YQ<&Y6_\ C0;3=YWV>#&WKCR9,X_#-='XK2R3P7X+_LP1AUU+3_[/
M\O'<C.W';9NS[5WEKHFFV5_?WUM9QQW.H%3=R#),NT$+G/H":SM-\#^&M(U%
M;^PT>WAN4W>6PR1%GKL4G"9_V0* .!UO4KCP-K'BO1[,$/KT:WFD*./]*E80
MR*/?<ROCTS6BOAZST7Q[X"TE(U>/3],NPA(ZN!&"_P!223]36O)HNJ>)/'6G
MZIJ^EQ66G:(96LPTRRR7,K84/\OW5 &0#SG'I75RZ993ZG;ZE);JUY;(\<,I
MSE%;&X#ZX'Y4 >?Z%86G]J?$QOL\>9+@H_RCE3;@D?B6)_&N?\-_VU+?^!_[
M-ETY9E\,9MSJ,;NF[>@?9M(.[;L_#->O0Z186\E\\5JBM?MONB,_O3M"Y/X
M"J-WX0T"^TJSTRXTR)[2R %L@+*80!CY6!W#CCK0!YO>Z*;>PT2TO[O3;X7'
MC-99([('R8B4<M%M).,.&)!_O5T6IHJ?%B^*J 7\*R%L#[V)L#/YFNLA\-:+
M;V-C90Z=!';6$PGMHU&!'(,_,/4_,>3US5HZ99-JO]IFW0WOD?9O./7RMV[;
MZ8SS0!S?PL.?A?X>Q_SZ+_,UP7BN^O;SP)XDU&U31].T>34G7RC"[W-Q,DP4
MR%MX"L63.-IP!7J^A^&M'\-QS1Z/8QVD<S;W2,G!//0$\=3P*IR^!?#$UY>7
M<NC6SS7@<3E@2&+C#'&< D=2 "?6@##\/K:R?$3QZ;\1%Q]D4^;C'V?R/?\
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MMJD#ZT =717$76FZIX7TK6YCXME73#:!H;G4QY\MI-D@L#@;E((PIS\W3TK
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M7_F_\3"\2RA\M-W[Q\XSSP..M<EX-35M<\2^(+V]UR_^R:7K=Q;VUI'( C#
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M:U8Q^"?$4NNWL\^M7=O!>6C,!;;)HF;")CY=N!@YR>]9%[XLO;Q-:U6WU3Q
MNK6MY,FGV-K8RO:,D3E51]J%6+[3DEN"W;% 'M5<]'XQL9]'34[6SU&ZA:\:
MSV6]L9'5U<H6('105//TKGK=M0\8>-=:@;5]2TRSTF&U6""SD$9,LL?F,TF0
M=V,@;3QP>*XQ=5U71?A-ITUK?/!=OXE>&>6'Y=X,\FX?0D=* /=:*\L\0>(/
MMGC36M-N]7U[3X--CACM5TBUED#2.F]GD*(V<;E 4\<'CFJMUX@U6ZL-!O\
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MD9Y KW>J$$>DW]T][!':3W,,C0M.J*SHZ\,N[J".F* ,73?"\]OXMLM?DN%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<%X"_P"1O\>?]A5/_10KO:P- \-'1-8U^_-T)AJUV+D)Y>WRL*%QG)STZ\4
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MF(,^]HHY0PPI;/.W(!Q5N;PAJ\/B#5KO2M<BM+#5RCW<+VN^5&5 A,3[@ 2
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M<>5]_P EE;[N>,[?7C/>FW?A36X-3U2;0->AT^UU5Q+<QRVGFO%+M"M)$VX
M$A1]X$9&: .BT2[N;_0=.O+R!K>ZGMHY)H74J8W9064@\C!)&*OTR&,PP1Q&
M1Y"BA=[G+-@=3[T^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*Q(*D# .X<<5SVD:MKK?"ZX\1+J=_/<:/KLEQ*K7#L9K9& >-LGE=I)P>F*
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MA"8DF:5BWEQKDDL"P /T/%:?PW\/7/ASP5:07Y9M2N,W5ZSG+&5^Q]PH5?\
M@-:VAZW;>(8[V6&!T^Q7TUD?, R7C;:6'L:@U3Q5;:7XKT3P_+;S//JPF,4B
MXVIY:[CN[\^U $?C'PS-XHTZR@MM1_L^XL[Z*]BG\@2X>/) VDCN?TJE#H'C
M5)HVE\<0R1A@63^QHQN&>1G?Q6_8ZC/=W]_;2Z;<VL=LZK'/+MV7 (/*8.<#
M'?'6G:SJ<>BZ'?ZK,CR165O)<.B?>8(I8@9[\4 4=&\.#2->U[4Q=&4ZM/',
M8_+V^5L0)C.3G.,]JKZ%X0M])\,WVAW,_P!LM[R6X>4E-F5F8DKC)[-C-;EC
M=K?Z?;7B*52XB655;J P!P?SJQ0!PMOX"U%X=,TW5/$9O=$TV6.2&U^R!))/
M+_U:RR;CN"X'11G'-;VD^'1I=]KMR+HR_P!K7/V@KY>/*_=JF.O/W<YXZUN5
MD^'=>@\1Z4=0MXI(HQ/+#MDQG,;E">/4K0!SUMX N--T?0(M+UG[/J>C0O!'
M=O;!TFC?&Y7CW#C(4C#<$5;NO!EQJ7AT66HZ[<SZFEXM_#J C \B93E=D>2
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MFWNWM=Z.LFX,K1[NA! SN[5D^+?"D^B>#?'&L7>K/?W>J:?&)B81&%:,,/E
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M"M?#8M?&=]XA%T6-U9Q6OD%/N["3NW9YSGTKB=>M=+\<?%#1HM+G-PNF*_\
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M*K$D X[9Z"L[2]&UBZ^(/C1]/U]K"\4V,4TOV594F_T9?FV$_*0<D8/<@YH
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MD(J@GJ2223S4FA^"[N]TWPV^H:]-<Z58+!=VUB8%4B14&S?(.65<\# Z#)-
M%/PW92ZGXO\ %>HW^H7\L.DZJQM+5;EUC4^6I.0#\PZ  \#GCFL=+*YN/A/)
MX[;5M0'B(V[:BMPMW((UPQ81"+.S9M&W&*]*T/PY'HE_K5TMPTQU2\-TRLN/
M+.T+M'KTKG3\-YO[-?0$\0W"^&'E+'3A;KO"%MYB$V<A,^V<<9H SK6R/B[X
MA:M#J%Y?+IHTRRG^Q0W<D2^8X?G*$'CGC."<9S@5@7-]J\GAS2M(36+U);7Q
MFVCB\$I\UX ) -Q_B(!'7NHKHAI5_=_%?Q$^DZJ=,N(=/LT5O(6:-E/F9!0D
M=-HP01CGUK8B^'EM%I.C6?\ :$SRV&K#5YKAT!:ZFRQ;<.@R7[=,"@##\26[
M>'/%OP\TG3KR]6T>]N1(LER[F4$*WSDG+<D]>E8_C._CC3Q)K&GR>([W4=/G
M/E7\$ACM+)H]N8MID < @AOE;.XUZ-KWA2/7?$'A_5GNWA;1YI)5C" B7< ,
M$YXZ5B7WPWDOK36-+;Q!<1Z+J4TUP;-(%#)+(=Q_>=2H?YMN!Z$D<4 98TNT
M/QNOKQS=EHM$BO0JW<H&_P UAC ;!7C[OW>^*P-#U#5+W3=&UZST[Q3-KUQ<
MQ3W-RQ8VDT+O\\87?M"!"=N%!!4&O05\'7T?BBQU]->874=FEE>J;12MU&K[
MN!GY"<D<9IFF^";[2Y+:SMO$MVFA6L_G0V"1*K@;MPC,P.3&">F,D<$XH [&
MO']$\/Z?;_&?Q4V;YEL+:VNHA]NFR6V[L,=WSC/\+9';&*]@KG[#PM%8^--7
M\2"Z9WU*&*%H"@ 0(,9SGG- 'G265S/\)Y/';:MJ \1&W;45N%NY!&N&+"(1
M9V;-HVXQ6I]EE\6?$ZXM+N_OX=,_L:UO&M;>Y>,-(6;&2#TY.0.I STK4/PW
MF_LU] 7Q#<+X8:4L=.%NN\(6WF(39SLS[9QQFNAMO#<5KXPNO$"3G=<64=IY
M 0!5",2"#^/2@#<KQ;4=1CAE77M+?Q'>7/\ ;$:_VL\A2S>-K@1M"(S)@H 2
MH(3DC.:]IKSY_AG</HO]C?\ "2W"Z;;S>?80K;(# XD\Q=[9S( <@ XZ^H&
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M+$D D#C.,Y]:J^&XM16?PSJ.G:)XD6^FEB.J7]Y,K0W44B_O&(\T]"0RX48
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M8O$[:8SWUQ:2:?<_:H9(,;@X4@'D$<$YZ$'&#Q705'/+Y%O+*1G8A;'K@9H
MY>S\#1O/JEUKNHS:Q=:C:?89'DC6)4M^?D55Z9)))]<5+HOA6_TV^M9KWQ-J
M&H0649CMK=U2-0",9D*@>80.A/UQGFM/PWK2^(O#>GZPD!@6\A641%MQ7/;/
M>M2@"MJ-A;:KIMSI]Y'YEM<Q-%*GJK#!_G7,:3X'GLM1TZXU#Q#?:G;Z6I%A
M;S1H@CRNW<Y4 R,%X!/UZUV%4VU6S368M):;_3I(&N5BVGF-652<].K#_(H
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M:V2Z#D1,^XKM=EZX']W- '.CX9R?V79Z>WB6_:#3)HYM+4Q1XMF1@5+<?O"
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MIM(XD 78 <#DECZYYS797/A&TNM T72&N)Q#I,MK+$XQN<P8VAN.^.<50N_
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M]Y?.5,TLFY6W=-H^Z  !@"KMWX.L[S7?#NK/<3K+H:2) @QMD#H$.[CT';%
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M(;.>S#)9>82D#C@LA)R-W&1TXK<?X?V<VCR6T^I7TFH/>C4?[3RBS+<@!0X
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M#V<$$9'2DR"2 1D=:\,U 3VO@3QUID=JVE16NIV/V>T682BU+M Q"L.,9.[
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MP!ID46O(EU?*=9NQ>2R)*%>&4'<IC('&" ><U<T3PN-*U*;4[K5;[5-0DA$
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M!)8B1A@"0001P000:HGP)I4F@3Z5<37UP9[@7;WLL_\ I'GC&V0. -K#: ,
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M>,[C(!RY+%7!.<$5WMIX1TRTUS7-5 EEEUI(TNXY6!C*HI4 #'<$YR35/2O
M=CI=W:2G4M5O(+)66SM+NX#Q6X*E?E 4$X4E1N+8!H X_P /:1;^&-=TBVU_
MP^]OJ9NGC@\06DH9;Z1@QQ,?O@L,_*P(R.#7K5<GI_@"PT^[LG.IZK<VEA)Y
MEG8W%P&A@8 A2!M#':"0-S'%=90!X[>[K"#Q1X)0E6U'6X$MP.,079#R8]@$
MGI=.+:E#X1\&2$LVF:M<"Z[_ +JS)\O/L=\->A7G@_2[WQC8^*)?.^WV<1BC
M57 C88< LN.2/,;!SWHL/!^EZ=XMU#Q+!YWVZ_0)(K.#&O"@E1C@G8N>><4
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MUDDN'4EECW;2<*.?F.: /+(+:32_!,&OV:NQ\)Z]="- 23]B\TI)&/;8<_\
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M(HXA("P'4A@.3SS0!Z(EW;27#VZ7$33H,M&'!91[CJ*22]M(<>;=0IE]@W2
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M6AD\Z)7WIY;':<CD9YQZU'I/AG1M8^)/C4:EIUM=Q0FRCBAGC#QQ@VZY*J>
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MG&5.10DB2@F-U< X)4YYKRV76/\ A7>J^,K';^YG@.L:8F.&ED(C>,?]M2F
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M/A#5M0UO0TOM1_LT2R$,J6$YE5%*@A6) PXR<CITK>H **** "BBB@ HHHH
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M*]'K/U?1;#7+5(+^$N(I!+%(K%'BD'1T8<J1ZB@#D_C*$;X6:O$R[I)3"D*
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MQCRPQD^4C+%B<9R,*!ZYY*WU'4O$VG_#]]2NI4O?[4NK:2ZA 5I/+CE3>.,
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MENWM(]4LGN8T\QX5N$+JN,[BN<@8[UY$O_-:?^N7_M"2K^K^&](33_APJV$
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M*WA]'DCC "JY$F>!P,C!_'/>@#OM*U4OHUE/JM[I?VF<'+VDV8)",D^66Y(
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M;JYN;J'[/+<WEU)/*8O[@9B2%]ABK<'B;0;K3Y=0@UO3I+*%@DMPMTAC1B<
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M*?SY%19TCN'2*X"?=$J [7QGN/;I1I?@S1=&FL9;."96L%E2UWW#N(DDQN4
MD\?*,#MVK?HH PKV"W\.OJ>MV.DWE]>W[QF>*U(9Y"J[%(#,  !UQ6;\/?#,
MOA_2[ZZO;6*VU+5KR2^N88CN6'<<K&".NT?J377T4 %<K<?#OP[<WDT\EO<>
M3/-]HFLENI!;2R9SN:(-M)R 3Q@]ZZJB@#$U+PII>J:Y9:S,MQ'?VB[(Y;>X
M>+<F[=L8*1N7(S@\4Y/"VD1^';K05MV&G77F^='YC9;S"6?G.1DL:V:* .>U
M3P7H^JR6TL@N[>>W@^S)-:74D$AB_N,R$%E]C5B/PIHT,FC/#9B+^Q@XL51R
M!'O7:W&?FR/7/KUK9HH *S_[%L?^$A_MWRC_ &C]D^Q^9O./*W[\8Z?>[]:T
M** .;U?P-H>M:A->W4=TDEPBI=+;W<D*7*C@"158!\#CGMQ6G%H6G0:RNK16
MX2[2S%DI4D*L(;<%"].OM6C10!CKX7TE-)U33%MV^R:I)-+=IYC9=I?OD'.1
MGVZ57U+P7H^I"S+K=6\UG#]GAGM+J2&01<?(64@LO X-=!10!SUYX(T&[T>Q
MTO[(]O!I[;[1[:9XI(&YR5<'=DY.>><\TEEX&T'3X-2B@M9?^)G;_9[QY)W=
MYEPPRS$D[OG;GKS["NBHH Y^;P7HDVA6&C^1-%;Z?@V;PSNDL! QE9 =P."1
MUYJ/_A!-!_L?^S?(G"_:/M?V@7,GVCS\8\SS<[MV.,YZ<=*Z2B@#+T3P_8>'
MX)H[)9F>=_,GGN)FEEE; &6=B2>  /2I-<T2P\1://I6IP^=:3@;U#%3D$$$
M$<@@@&M"B@#&T[PQINF7T%]#]IDNX;5K-9[BX>5S$7WD$L3D[NYY[=*@N_!6
MAWMM>P26\J_;+P7\DD<[HZS@ "1&!RI 4=/ZUT%% '-VO@30+2XDGCMYVDFM
MFM;AI+F1_M*,23YN6^<_,W)Y&>.U7_#_ (>L?#.FC3].:Y-L&RBSW#R[!@ *
MI8G"@ 8 XK5HH H7^CV6IW=A=741>6PF,]N0Q&URI7/'7@GK1#H]E;ZU=:O'
M$1>W4212ON)#*F=HQT'WC5^B@#F9? 6@R:;:64<5S;K:3R7%O+;W4D<L;R$E
M\.#G!W'(SBHFT?3_  7'=:GHFBZA=W%R$B>UM)BV\@8#L'8#/ !?KZYYKJZ*
M .2^'GA=_#'AZ5;F"*&_O[F2]NHXCE8V<\1J?11@?G76T44 <>GPQ\+QQ16Z
M6UTMHCB1K07DOD2N#N#21[MK'..H[#/2M'6O!ND:[?"]N1=0W)B\F26TNI(#
M+'G.Q]A&X<GKZUOT4 065G;:=9065G"D-M @CBC08"J!@ 5/110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !7)^/9X5T_2[-M,AU&YO-1BBM8;B5DB$H#.'D(ZJH0G&#GCBNLK-UO
M0M.\0V*VFI0M)&DBRQE)&C>-UZ,K*05(R>0>] 'F46@77B#4_B#H5X-/CO)K
M.S8+8;A&DX$C(W/(;*IGVQ5G3-8;XA:WX-A<$QZ?:G5M14C@7*DQ(I]")!(V
M/05W6F>$=$T;4%OK"T>&Y$/D,XGD/F+N+9<%L.V6)W-D\GFIM'\,:/H-YJ%W
MIEDMO/J$OG73!F.]LD]R<#+-P,#F@#R?6II;KPB^LV&EZ38:5<:U'+!(\CO>
M2RBZ ,F3PI)5CC)PN173:3_R<#XA_P"P/#_Z$M;TGPY\+2_:Q)IS-'=%F:(W
M$NQ&8[F:-=V(R3SE0#6I9^&]*L-9DU>WMV%_);I:O.\SNS1KC .XG)X'/4]S
M0!Y#X+G@3X3:;:2:;#J,][K[06L%Q*T<7FARZM(1U4;"<8.< 8J76A>0P?$R
M"]&GI<#2+5I8]/#",-B3!(;G=MQGVQ7IB^!/#B>'QH<=@8[!9_M**D\@>.7.
M=ZONW*<^AJ,_#WPP4E0Z>^)K8VL_^DRYFC+%CO.[YSDD[CD\]: .8\0:=IVG
M6/P]GTJ"&.9=6M(X98E 9XGC;S.1R05Y/K7+7<D\5A\7VMVVL;R%&.2/D)P^
M2.VTMFO5;'P/X?T[5HM2MK)Q<0!A;A[B1XX-W#>6C,53/^R!5NV\,:-:RZM)
M%8INU=MU\'9G6;@CD$D 8)X&* .5TW0M;B\9:)?W4/AO3X;:WF@\K3II/,GB
M*C"A2@!56"'VS[U)\5H8I-(T(R1HV-=LURR@\&3D?C6]HO@S0] O/M=A;2B<
M1^2CSW,DQBCZ[$WL=J\#@8Z5>US0M-\1Z8^G:K;^?;,ROM#LA#*<@AE(((/H
M: .3TVTMKGXO:\EY!$QM-,M$L4= 0D3%]Y4=OF !Q4OPT588?$]K;@+8V^O7
M,=JB_=1<(2JCL Q;]:UKWP/H-_%9K-!<B2SB,,-Q%>2I,$/53(K!F!]"36MI
M6DV.B:=%I^FVR6]K$#LC3W.223R23R2>30!QFFVT!^-VN,88]PTFV<'8,AM[
MY/U]ZXJ+2[&']FF2\2UB%T5\_P _8-_F"XP&W=<@  >PQ7K=WX5TB]\16^O2
MV\@U*!!&LT<[IN4'(#*I 8 GH0:3_A$]$_X1<^&OL7_$H*[?L_F/TW;OO9W=
M>>M '"M9ZSJ?C_QDEM8:'>(!;6[C4Y) RPF$$!0J-\I8N3TYSZ5V_@RRN=.\
M&Z197=W!=S06RQF>!RZ.!PI5B!D8QS3=:\&:'K]X+N_M9?M'E^2\D%Q)"9(^
MNQ]C#<O)X.:VK:VAL[6*VMHDB@A01QQH,*B@8  ] * .&^%DT<&GZWH\K!=1
ML=6N?M,9^\0[EE?'HP(P?:F?$SQ#:S>"?%.F:?=EK^SMHOM:Q _NHY' (+=,
M[-W&<XK?UOP-X>\07RW]]8L+U5V?:;>9X)"OH60@D?6K>F>%]$T?2)M*L=-A
MCLI]WG1D%_-W#!WELEB1QR30!R?C"PT_3;OP-)I-O!!.FL000&!0#]G9'$@&
M/X=N":YV'2K";X=?$RZEM(I+@ZAJ9\QT!8;,E<$],')'N2:]"TGP-X?T6_BO
M;.TE,\"E+<SW,LP@4\$1AV(08XXQQQ5U?#6D)I>I::MIBTU.2:2[C\QOWC2_
M?.<Y&?;&.U '!WNG6>GP_#.:UMXXIOML2&55 =@]NY?)ZG<>3GJ:B\-Z5HUW
MX=^(4MY;V\KMJVHI.\B@E%7D#)Z 9+#W)->BS:!IEPFF)+;;ETR19+0;V'EL
MJE0>O/!(YS7%Z'\.[&^&N/K^GSJ]SK%U*%2Y>-;B!GW)O", Z\G ;U- &1X=
MGO-4@\-V]II6G7.KV_AV"6>]U21RB0R'"JJ#.6.S);CCOS69H-M;ZGH_PVM[
ME(9[<ZK?X1>8RJF8J #_  \# /:O4=4\%Z#K%U;W-W9'S((?LZ^3,\0:+.?+
M8(0&3/\ "<BEL_!F@V%U!<6UD8W@NI+N$><Y6.60%7*J6P 03P!CG.* .4DT
M"RU3Q_XPT0PI%;:AHML)0B@#>3*H?'J./RK'TO4;CQC'X3\*WW-UIMQ)-K29
MS@VAV(&]0[E#^%>EW=E;:;=7NOVVFS76I20)$Z0/\\J*254!F"C&X^E8?@GP
M]=6NIZYXEU2QCLM2UF=6^S*P8P1(NU58C@L>6;'&2/2@"U\1-+DU;P'JL-O_
M ,?4,7VJW(ZB2(B1<>Y*X_&O/[[5$UW6#X^@/^C:++IT<;*>D<B[KC\EN5S_
M +E>SD @@C(/4&L*R\&>'].\.7/A^TTY8]+NM_G0>8YW;AAN2<C@#H>,<4 >
M3^+D^W?"?QSXC;DZKJB"%O6"&9(H_P#T%C^-=C<VT$GQ?\.%X8V)T29B60')
M#)@_45U5QX0T*Z\*KX9FL0VCJBH+<2..%8,/F!W=0#UYHU7PEHVM7=A=WMM(
M;BPR+>6*>2)E!QE2589!P.#F@#S_ $S2-/G\#?$6YFLX99Y+_5 TCH&;"[BH
M!/3!R1[DFO0O"+M)X+T)W8L[:=;EB>I)C6IH?#VEV^G:A816NVVU"2:2Z3>Q
M\QI?OG.<C.>V,=JN6=I!I]C;V5LGEV]O&L429)VJHP!D\G@4 >1^'+&*U^&'
MC/5[2W3^U//U/R[C:#(@7> %;J .3@=R?6M#1]!UC=X/O#%X9T^SLMK0RVMQ
M)YLT+0L&090!L@[CSU7->AZ9HFG:/9S6EC;".WFEDFD0L6#.YRQ^8GJ3TZ5F
M:5X%\/:-J$=[963K+$&6!9+B21( WWA&C,53/3Y0..* .0T2RD\+7'AVPU/3
M=,U'2S=>7I>M63XE5W5RID7^+<I8%E)!ZD5DZ1I6CS? WQ/<36]N\Q;4)))&
M4%ED1WV<]01A2/K[UZ)IW@/P[I6HQ7MI92+) S/!&]S(\4#'()CC9BJGD]!Q
MGBN:\)_#?3I?#T8\0:9*MT;N>26#[2ZQRCSW:,R(K;7X*]0>,#VH R-(C\0:
MIXKO72RT>\N%T73T8:L[@JCQL7VA5;(+[MWT%2Z!I4EIXF\%Z/K$UG>PVNFW
MKVQA<RPF02J%"E@,E8B!TXP:[_6O"&BZ_<Q7-];RBXCC,0FM[B2!S&3DH2C
ME?8\4E_X.T'4=*L]-FL EO8X^R>0[1/!@8^1U(8<=>>>] '"^-M-\/6FFVL.
MD) 3_P )3:-=Q(VY8Y69=PQT7(VD@8%>J"&(0^2(T\K;MV;1MQZ8]*P&\"^'
M'\.-H)TX?V>TOGLHE?>9<Y\PR9W%L]\YK:L;.'3[*&SM]_DPJ$3S)&=L>[,2
M2?<F@#Q+3X81\%]%C>-%M+O7TAOV  W0?;'R&/IT%=SKMK;V/Q1\%M8010S3
M)>0SB)0NZ 1 @-CL&VX]S6S:^!/#=I;:E:Q:=FUU$DW-N\SO$<G)VH6(3DY^
M4#MZ"IM&\'Z+H-X]Y96\S7;1^5Y]S<R3NL><[%+L2J^PH H>/)XOLVD6/]F0
M:A=WFHQI:17,K)"DBJS[WQU"A2=N#DXKS?71=Q:1\4H+P6"7"6MDTB6 81!R
M&YP>=V N?PKV+6] T[Q%9):ZE"TB1RK-&T<C1O&XSAE92"#R>A[UE-\//##1
M7$1TYMES;?9IU%S*/.3<6^?YOF;<2=Q^;D\\T 8GB#2['2O%'@$6-K% 8[R6
M -&@!V&W?()[YQ7-75U<>&M-\2^ +1MES>7B1Z./2"[)W8]H\2\UZU>:18W]
MU8W-S!OFL)#+;-N(V,5*D\'G@D<YKD;#2+[Q%\08/%&J:*VF0:7;/;V4<[HT
MTKN?F=MA("@9 &<_,30!V.F:?;Z3I5IIUJNVWM85AC'^RHP/Y5Y=\/\ 0-<O
M_#UQ<6/BZ]TV!M1NP+:*U@=5(F;)RZD\]>M>MUQK?"SP@TLD@TZX0R.TC!+^
MX4%F.2<!\=30!#XUL+>S^',JZYJEQ<W=H1+:WPC59S=!LQ%%4 ;LD+@8R,Y[
MFN8T:XO7\'>.M3U'?'XU2UF6\CQ@VZB(F%8L$_)M^8$=6SZ5WUIX(\/V2621
M6<C)97)NK=9;F60)*1MWX9CD@#C.<=1BM!]"TV36_P"V6MA]O-N;9I0Q >+.
M=K+G##/J#B@#SW1= UEF\'70A\-6-I9%&@DM9Y/.GB:$AD * ,6!W'GJN:7P
MEIWA[4/A?+>^)$MT:2^GGO[J1MCI,+AL$N/F4C"@<]*[#2O WA[1=0COK*R=
M980P@5[B21+<-][RT9BJ9_V0..*9/X \,W.KMJ4NG$S/,+B2,32"%Y1T=H@V
MPM[D4 97A26.'Q)X^>1PJI?H[%CC"_9TY/MQ7$Z#;P3:/\)/-AC?=+.K;E!R
M/+<X/MFO3[[P1H&HZT^K7-DYNI0HFV3R(DX7[OF(&"OC_:!IMSX$\.W6B6&D
M26+K9Z>^^T$=Q(CPGGD.&#=SWH Y*RLH-0^-WB^QN$#6]QHL,,B>JL%!'Y&L
M2WN+C6/"^B?#FY<M>1ZH^GW_ +VEJ1(3[!D\H ]\UZM:>'-*L=:GUBWMBM_/
M EO),9&8M&N-HP3CL.>M)!X8T>V\2W/B*&R5=5N8A%+<;FRRC;QC.!]U>0,\
M4 ><+INL:MK7CF*&QT":*2[^S3/J4LB21PB!-@ 5" @!)!R.<UZ3X<MKFU\+
M:7;7=S%<W,5I%')<1,661@H&X$]0>N:I:QX(T#7;][V^M)#/(@CF,5Q)$)T'
M19 C .![Y]*WHHHX8DBB14C10JHHP% X  ]* .%^#\L<?@&#2F(6^TR>>VO(
MC]Y)!*QY'N"#3;<0:M\;-0DA5)[:QT-+2\. R^:TV]4/;(4$_C6WK'@+PYK>
MHMJ-U8NEZZA7GM;B2!Y .S%&&[\:T]%T'2_#M@+'2;*.UM]Q8JF268]68GEC
M[DDT >1>$+*U?]GC6YFMH6E%OJ&',8+#&_'--\400P_ ;PDT<2(TCZ<SE5 +
M';U/K7JUGX4T73_#D_A^ULO+TN=9$D@\QSN$F=_S$YYR>])=^$=#OM L]#N+
M+?IUF8S!#YKC9Y8PG(.3CW- '/:;:VVI?%?Q6NI6\5P\%G9QVJS(&Q"RN7V@
M]B_7Z"L![5/^$O\ #EEX232[W3;72KI[%;^XD:(-YRK(48!B6'3'89KOM<\'
M:)XBN8[K4+60W,<9B$T$\D+F,G)0LC E?8T7O@W0;[3;&P>Q\F&PXM#;2O"\
M'&#M="&&1UYY[T >8Z[H%S:>'-.T[4WTYHKOQE WV?3I6:*!)/OQ\@$?,7.,
M<;J]DM[>TL(H[:VA@MX^=D4:A!^ %9,?@[08M-LM/2P MK*[6]A7S'R)U)(=
MFSECDG.XG/>K]YH]A?ZC87]S!ONM/9WMGW$>667:W .#D''.: +U%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%[AMO 49/&[N*Z^U\5:O9ZS=:+KUC91WJV#W]K-9RLT4RJ<,I# %6!(]<@T
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M4@I@AE/4G&0,5WFLWEYI^C7%S86#7]XBCRK9'"[V) ZGH!G)/H#0!?)"@DD
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MOC;CS.",=,=Z .]AN(+C?Y$T<NQBC[&#;6'4''0^U25Y9IWC=-,\.^(M8LM
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MLWG1_:-GF>5N&_;G&['7&>,U+0!0AO[J77+JQ?3I8[:&)'CO"PV2LV<J!ZC
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M2Z^'1;2+F>66>QMBLL]L>D<FW(^9E'S;6RO YYKJ/^$<U3_H<M;_ ._-G_\
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MSC=P,  \],Z\.AZFOQ/\8:B;*46=YI<4-O-CY9'" $#WS7HM% 'FESH&JO\
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MEI'F.*(E&*[<=%R!G@\9J:ST2*?0O$O]D^"(]"%QILEM;[HXX[BX=D;(*H2
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M<DGH._/_ /"+:HOA^WA'@QI->LM0CN[[4Y!"9+O;.&/DR%MS%EYP=H !'7%
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M$#!BQ(/5N,5EZA\1-5TKPIK5S=6-J=8T;4(;2XBBW&*59&3#H"01E7X!/!%
M'I-%9FA'7&L7?7Q8K=-(61++<51,#"DMU8'.2, \<5IT %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M'4]2?I5W6=%OO^$ZO+^7PQ%KL5U9PPV,TS1&*S92V\.'.0"2K94$G&*]#HH
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MD(5MN&')XW9KD[OPEXCD\(>+=+CT&*":[U&#4K2*WEC$3*#"3$O(PR^6020
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M<_%R%)#/!J0EMH>[:;'F)EQV+ LY^F:[;XCVK:AX5L?%>BD2WNC2)J=JZ_\
M+6+ +K]&3GWP* .^J.*>&>/S(I4D3GYD8$<>]<;XR\7K#\.DU/1F,EWK"1V^
MFA3\S2S#"X]P"3_P&N<O_#T=K=>"_ALLSII+6\MQJ(B8H;KRP#M)'.UG))%
M'IUOJFGW<S0VU]:S2K]Y(YE9A]0#4L]U;VH4W%Q%"&X!D<+G\ZXWQ%\-_#4N
M@7!TW2K72[^VB:2TO+*,0RQ2*,J=RX)Y'.:X;7->L-=T;X9ZSXG6W:TGDE-[
MY\>Z-B(]I)7!X+#.,4 >TP7UI<N4M[J"5@,D1R!C^E.N;NVLHO-N[B*"/.-\
MKA1GZFO%/%$G@;4["*W^']I;'Q5Y\36+Z7:M$T1#C<SL% ";<YSQS75>,[9;
M7QM9ZSK7A^XUS0DL# J0VXN!:3[R6D,1Z@K@;@#C;0!Z'#/#<PK-!*DL3<J\
M;!@?H14E<?X#7PI)'J5[X3N?]%N9E:>S0;$MI N#B(@%">_KCBG_ !)U.WL?
M!&I6[:B+.]O;=X+,+DR2R$<*BKEB3TX'&: .FBO;2>9X8;J&25/O(D@++]0.
ME3UXGX:L+?Q39>'[[1]!M/#]IH<Z27VHN42X9XE_>P[5^;!.=QD(R.<5[)87
M]KJEA#?6,Z3VLZ[XY4/##U% "3:A96\ACGO+>)QSM>55/Y$T1ZA93!S%>6\@
M1=SE9 =H]3SP*\CU>X\&P?&+Q"?&"Z>T1LK7[/\ ;8@XW8.['!QVK7FG\"7'
M@?Q<W@^/2Q,ND7 N#90A#M,;XSP.X- 'H0U;3F8*NH6I)X $R\_K5RO$M U#
MX0+X/TJ/5+?1FO?L,*W'^A$RM)L&[D+DMG/3G-=C\-VN=&^'LEQJXN+6R@EN
M)K9;S/F0V8)*!L\C"@]>V* .X$\)G, EC,P&XQ[AN ]<=:DKPR".]TZTL?BU
M<+(L]UJ+2WD7]W3I<1HN.^T*C#ZUVGQ$GEU._P##'AB&ZDAM-<NG^U2POM9X
M(TWL@8= W R* .SBU73I[DVT6H6LDXX,23*6_+.:GGN8+5 ]Q-'"I. TCA03
MZ<UY_P")O#/PQTK3X].U2#2-&DE0FWG0+#.I'\:OU)!QUS[YK*^(]UHTOA7P
M3/<7Z:EHRZU;"6ZG(E$T:I(&9\##9P<\<\T >I0ZA97,GEP7=O*_7:D@8_D#
M5BO#_%4_PWU#0I[7PC96LGB-L'3QI-HT<ZRY&&W*HP!W).,5Z!XRUV^\.> 0
MP82:Y=)'96RI_'=2 +D?0Y;\* .LAGAN%+0RQRJIVDHP8 ^G%'GP^?Y'FIYV
MW=Y>X;L>N/2O,/"FE+\-O&UIX>$A;3M<L5:-R>/ML*@2?3>OS?7BJ/BG3]1D
M^*^HZSHNYM5T?3+:YB@!XN4WR"2(_P"\O3W H ]>>6.-T1Y%5G.%!."Q]O6F
MW%U;V<)FN9XH(AU>5PH'XFO/=9UFS\0ZS\.M6L)-]M=7LKH>X_</E3Z$'(/N
M*AT/2;/QUXT\2ZIK\"7UOI5\=-L;.<;H80B@N^P\%F)ZG_"@#T>VN[:\B\VU
MN(IXSQOB<,/S%1-JNG(Q5K^U5@<$&900?SK#L? FCZ/XECUK1D;3,Q-'<6EH
M D%QG[I9,8!7G!&#7EWA27P4@UP:_P"'7U"]_MF[_?#2'N?EW\#>J$>O&: /
M<H+JWNE+6\\4P7@F-PV/RJ.WU*PNYW@MKVVFE3[T<<JLR_4 \5PMSINGZM\-
M]=M_ ^E'3IK@&/ROLK6;2L-I(PP!Y4E0>G-9NER^ +[5M(L_['F\+:[:SI);
M126?V25V'!3S-NV16Z$9RV: /5JBCNK>:)I8IXGC0D,RN"%QUR:EKQ3X4_\
M)(O&/_7Y>_\ HA* /:(I8YHUDBD61&Z,AR#^-$<L<N[RY%?8Q5MIS@CJ#[UY
M/\,[B7PC;Z%I%W(S:1KUC%=Z?*YR(;DQJTL)/HQRZ_B*IS:S>Z)X%\>3Z=*8
M;V;Q/<6T4H_Y9F1HU+?4 G'OB@#UR35-/BNA:R7]JEP>!$TRAS^&<U;KC[3X
M7^#K?2!83:':79*XEN;B,-/(W=C)]X$GG@C':MSP[HO_  CVB6^EB^NKU(,A
M);I@SA<\+D#D <#/I0!;FU"RMY#'/>6\3CDJ\JJ?R)J>.1)HQ)$ZNC<AE.0?
MQKR2^;P<OQ:\3?\ "7?V3M^RV?V;^T0A&=K;MN[_ (#G'M56QU>U\/P>.]9\
M'J!X?M[.-K;RU/V?[9A@QB!XP,KNQQTH ]<N=4T^SE6*ZOK:"1ONI+,JD_0$
MU:W+MW;AMQG.>,5PWAGX=>'%\.VLNJ:7:ZKJ-W"LUW>7L8FDED8 L=S9(&3Q
MBLK04;P]KOB_PA!+(^E06*WMC'(Y8VZNK!XP3SMR,@=J /3(IHYXQ)#(DD;=
M&1@0?Q%$LT<$1DFD2.->K.P 'XFN%^"__)(]!_W9O_1TE'QI_P"21Z[_ +L/
M_HZ.@#O%970.C!E89!!R"*JQZII\MT;6._M7N!P8EF4N/PSFO-M=N;J;P+X$
M\/6US):KK?V6VN9HFVN(!$&=5/8D #\ZZ2[^%W@ZYT@V$.AVEH0N(KJWC"SQ
M-V82?>)!YY)SWH ZPSQ"<0&5/.*[A'N&['KCTI9)8X8VDE=41>2S' 'XUQ?B
MKPC?2Z1IFHZ/=23>)-#4-:W,Y&ZZ &'BD(P"''Z_4U@Q:I_PM_4+.RBMY[?P
MY8;)]5252IGN1R+;W"GEO7CIQ0!ZHK*ZAE(92,@@Y!%5/[7TT'_D(6G_ '^7
M_&K:J%4*H  & !VKP/X?7GPOB\&6B>(TT4ZJ))O.-S;AI/\ 6MMR=I_AQ0![
MS#/%<1B2&5)(ST9&!'YBH(=4TZXN3;0W]K+..L23*S#\ <UYKKTVDZK!X0\+
M^&98K70-<NIVF:P'E!XH06>,8QC<V0<>E=+J/PP\)7FDM9VVBV=C,J_N+NUB
M$<T+C[K!Q\Q(.#R>: .KGN8+5 ]Q/'"I. TCA03^-,AU"RN9-D%W!*_7:D@8
M_H:\0U?7H]=^&O@'4O$IBEB77(XKYYEW)(L?FHS,.^0N3]34_BJ;X<:CH<UK
MX/LK63Q(VTZ>-)M&CF67<,-N51@#N2<8H ]P)P,GI5/^U],_Z"-I_P!_U_QJ
M2S2?^SH([TJ\_E*LQ'1FQ\WZYKRCXG^#?#.F:?X>>QT'3K9IM>M893%;JI>-
MMV5.!R#CI0!ZM'J%E,KM%>6[A%W.5E4[1ZGG@5.CK(BNC!D895E.01ZBN)\4
M^&-"T'P!XHETG2+*QDDTJX5VMX50L/+8X.!67X0^(6EV7@O0[633M==X=/@C
M9HM*F=21&HR&"X(]Q0!Z.+F K*PGCQ%D2'>/DQUSZ5!_:^F?]!&T_P"_Z_XU
MX_HMY'J'@SXLWD22I'-/=NJS1E' ,)ZJ>0?8T_P]/\.!X9TH7GA&2:Z%G#YT
MHT"5][[!N.X)\V3DY[T >S12QS1K)%(LB-T9#D'\:?5#1(["+1;,:7:BTL6C
M#PP"'RMBMSC80-IYZ8J_0 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %87C33;K6/!.M:;8QB2ZNK.2*)"P7<Q& ,G@5NT4
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M=#GI6E/H_B+PIXKU/6/#UA%JVFZLRRW5@;A898I@,%T9OE(8=0>]=S<7,%I
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MNTN[^SL(EEO+N"WC8[0\T@0$^F350>(]"9@!K6G$G@ 72<_K0!S.K>#;[5?
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MWL&<*IV^7[CO70Z)J/BJ[O@FL:!96-H4)\Z'4/.;=V&W8/SS0!T5%(2 "2<
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MU?\ W[?_ -'I7?I_JU^@JAKFAZ=XDTB;2M5@,]E,5,D8=DSM8,.5(/4"M$#
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M7)!5P,8Q^M=QX2\-MX<L+H7%X;V_OKI[R\N-FP/(V!\J]E   %:&F:-8:/\
M;/L,)B^V73W<_P Y;=*^-S<GC.!P.*OT >>>%?\ DLWC_P#ZYZ?_ .B35?XJ
MWEWJ<NE>#M,LY+Z?4)1=7MO'*L9-K$P+#<Q 7<V!D^A%=U::%IUCK6H:Q;VY
M2^U 1BYEWL=XC&U>"<# ] *2+0=-A\07&NI;G^TIX5MWF9V/[L'(4 G"C//
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M*[*(VC^YT(Z>AK6H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MEP(P2 #UQVKI+?Q/K-CJ%UIFO6%E'>"PDO[62SF9XY53 =#N4$,"R^Q![8H
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M?Y58,I(!P0PX-84^K>)C\9TTF#[$=-72Q<&)YY!F,S*K/@+CS!@@#I@]1G%
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MP8/G[V&P%QG./<CUVB@#S=[34M(\;>&-5;2+ZZM1HO\ 9\QMD#F&4LA^<$C
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M_+EC0H4?)&T'@@GBN6@\'Z@_AG1KO6_#[WS6.K7LU[IJ89GBF9OG0$C=@[6
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MW$M.S#OCH0>M:DUKJ>F_%>WU4:3=76GWFDQV!GM]A$$@E+$N"P(4 YR,_0T
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MQG- '<JZ.,HRM]#FG5Y');^#['Q=X:_X0.6Q_M*2^VW<>F3AU:TV-YAD"DC
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M P<Y- '74A(4$L0 .YK"\&>(/^$I\(:=K#((Y9X\3(.BR*2K@>VY369\5_\
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M[@M;=2 99Y B@G@<GBN.G\3^(KWQ2F@Z1;:<COI4.H-<W0<K&69E(VJ06Z#
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M[]\?6O5I)$BC>21U1$!9F8X  ZDTRVN8+RUBN;6:.:"50\<L;!E=3R"".HH
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MIU_8_$C4M0_LVX.G-I<%K#/N0[WC9B1C=GHPY(JQ\-=.O]'\#6.G:G9R6EW
M\V^-V5N&E=P05)'1A7657M[ZTO);B*VNH9I+9_+F6-PQC;&=K =#@C@T <EX
M M'TB_\ %>DSC$JZQ)>QY_BAG 9&_,.OU4US%QX>\1'X4:YX770YVO&NIO)8
M31;9@]P9 R_-P-O7=@YQP><>J264$EY%>%,7$2E5D4X)4]5/J.^#WYJQ0!Q6
MJ:?J&H?$+0]073;E;"*PN8)YBT8\MI=F!C=D_=/0&LGPC9^(-'LK7PS>^%('
MDLB(4UG=&87A!X?'W]^WC;CD]2!7I=% !4%[&TMC<1H,N\3*H]214Q(52Q(
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M,:KJ&D2:3-'JMI)$D=H95W70D)P\9Z%0 22<8 .<8K4U7Q+%IUY%IZK ^H/
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MTX,K6TG!"'+MN&"1V((Y%+J6D:U_PL*36].@@*+H$MK#).WR?:#,KJK '=C
MY(K,T+1+Z7QO:ZTOA5/#BQV\J7[)/$PO&;&T!8R00""VY@#0!8^+MUJEEX!N
M9],N8X#YT*2LRL6*M*B_*01CDC/7C(]ZS+U?$:_%+388)M.;57T"59KDPN((
MU^T*=PCW;CT48W=3G/&*Z3XCZ+?^(/ M_I^F1+->,T,D<3.%W[)5<C)X&0IZ
MU7L+'5[[Q_9>(;O2WL8/[&EM9(Y)HW:.4SJP4[2<Y5<Y'';K0!6T[Q/XCNM
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M@L,-CD9SBO,="\;>(Y_"-]XOU0V*Z98QW*_98HB)+AT=@K;B<*. N,'H3[4
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *Y3XBZ/J.N>$S::5;K<7:W4$ZQ-($#!)%8C<>!P*ZNB@#C?\
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MNXP&!X/4&KW@S2-;LM=\2ZGK4$,+ZG<0S1)%+O"JL87:3ZC &<#)&1Q78T4
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MW<(L@=;564!1NZ$J%!STS47PCM;ZX\.2>(]682:CJWE_/@C,,2"./KZX9_\
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M)28/_=^0D<DL3R ,8.0 ;2:GXMUW6/$]GIVIV>GP:5="."1[3S6E)B5@AR0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHKG?%OB&?1+:SMM.ACGU?4K@6UE#)G9N/+.^.=BJ"
M3CV'>@#HJ*R[WQ!I&C/;V^KZQI]K=2J-JS3+$9#T)56.<9^OUK/U7Q#=:+XJ
MTNUNXX3H^J'[-#.H(>*YY*JQS@JX! P!@CWH Z2BBB@ HHHH ***X^7X@Z1/
M-XAL=/O+22_TJW:1%,RL)V$9<A0#E@N,-CH<T =A17-^'?&&F:MI^DQW&IZ<
MFL7EE#</9).H<,\8<@(26QS^5:=WX@T:PU&'3[O5K&WO9L>7;RW"K(^>F%)R
M<T :-%%<%:^+O%FKZCK$6C>'M-FMM.OY+$R7&H-&SL@!SM$9[,.] '>T5B:;
MJU_%9J_B>+3M+N);@0P)'>;UE) V@%@OS$Y^4>E:<M]:07<%I+=01W-P&,,+
MR /)M&6VKU.!UQTH L45G6_B#1KO4Y=,MM6L9K^+/F6T=PK2+CKE0<\4EQXA
MT6UU2/3+C5[&*_DQLMI+A%D;/3"DYYH TJ*ABN[:>XGMXKB&2>W*B:)'!:,L
M,C<.HR.1FN?UGQYX>T5=,>;4[-X]0N!!&Z7*;5'S!I"<XV*5()['B@#IJ*P!
MK17Q%.DFK:(-*CL/M7EB;%RO(_>M\VT18[XZXYK7-]:"P^WFZ@%GY?G?:#(/
M+V8SNW=-N.<],4 6**R[OQ+H6GBU-YK6GVXNE#6YEN47S5/0KD\CW%:@.1D4
M %%<?JGBW4YO$5QH'AC28M0O+1%:]N+F?RH+8L,JI(!+,1S@#BG:1XNOAX@7
MP_XETN/3=1EB::UEAG\V"Y5?O[6(!##J5(Z<T ==17FMA\34U3QQJ5C%J_AR
MUT/3V13-<7.9;O*%F:)MX7"D<\'_  C\-_$34/$YURX@U+PS9V]K]H6T@N)6
M,N$QMFD(<#RN>2!^- 'IU%9,.M6UGX<M-2UC4]-C1X4:2ZCF"V[L1U1F/W3V
MYZ59CUC3)M+.J1:C:/IX4L;I9E,0 ZG=G% %VBLZV\0:->Z9)J5MJUC-819\
MRY2X4QICKN;.!^-2V>K:=J,UQ#97]M<RVY F2&57,9/(#8/&<&@"Y16/JE_=
MVVNZ1;0WVE007+2":&[<B>8  @0 $ D=\@\8J8^(-%&K?V2=6L1J/_/I]H3S
M?7[N<]* -*BBLVT\0Z+?ZC+I]GJ]C<7L6?,MXKA&D7'7*@YXH TJ*R+GQ5X>
MLY$2YUW387>1HE62Z0$NIPR\GJ#P1V-6-3US2=$CCDU74[.Q24[8VN9UC#'T
M&3S0!?HKG?"OB&?7Y]=$H@\JQU)[6!X<_/&$1@Q.3D_,>1@=*VUO+5[R2S2Y
MA:ZC0.\ D!=5/0E>H!P>: )Z*JV^I6%VEP]M>VTR6SM'.T<JL(G7[RM@_*1W
M!Z5EIK#W7B2SAL]5T673;BT,PB67=<RG)PZ8.#'[XZYYH WJ*\WM?B!JLWA;
MQQJC6]F)]!O;FWM5"-M=8P-I?YLD^N"*[7PYJ,VL>%])U.X5%FO+.&>18P0H
M9T#$#))QD^M &G16=J7B#1M&DBCU35K&R>;_ %:W-PL9?Z GFGZEK6EZ/;)<
MZGJ5I9P.<+)<3*BL?0$GF@"]15)-7TR2QAODU&T:TF94BG$RF-V8X 5LX))X
M ]:KVOB;0;W[5]EUK3I_LBE[GR[E&\E1U+8/ 'J: -6BN.M_'5EK_A2_U+0M
M4TFWN+=V3.HSCRH@)2@:3:P*JP4E>F<BM^36].L;6-]2U2P@?[.)W9IU12G
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M,-MJ.K6-I//_ *J.XN%1G[< GFGZGK.F:+;K/JFHVME"S;5>YF6,$^@)/)H
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M:7]W+XIU"R>^TI[6&)&CMH7)NXR0,F09P%/;@5+#XDT.YU":P@UBPEO(03+
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MT6R\YI78F%2"%.20>0.>OO0OAG1T\3/XC6R4:L\/DM<;FR4X[9QG  SC..*
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M*M.(HAG!X)"EB/3)J?QE8Z;:K:6'AU+%GN?$D!U"UFE;R/.,;,JNHSM!*QG
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MFN9+20LP\MCC)P#@_='7/2GR:!IDOB&'7GMLZG# ;>.?>W$9))&W..I/.,T
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO 4\C@GF@#VNBO.K_P -2:/#XCN$U>.*"[TF5UTVQB>W1)(Q_KE(D.T\@$#
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M$TR]6TN(YI?+>4[59RAZ#:''7K@].,XNMV[:C\<O#@MAN%AIUQ+>D=%CD!1
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M ?AC1=6?5-.TF*WNF8L"KL51CP2J$[5..,@#BNA=%D1D=0R,,,K#((]#3J*
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 45!<WMK9^5]JN88/.<1Q^;(%WN>BC/4GTJ>@ HHHH ***@6]M
M7O)+-+F%KJ-0[PB0%U4]"5Z@4 3T5%/<P6JHUQ/'$'<1H9'"[F/ 49ZD^E2T
M %%%1/<P1W$5N\\:SRAC'&S@,X'4@=3C(S]: ):*** "B@G'6D!!Z$&@!:**
M@GO;6UEABN+F&*2=MD222!3(WHH/4_2@">BH$O;66[EM([F%[F$ R0K("Z ]
M"5ZC/O4] !1110 445$]S!%/%!)/&DTV?*C9P&? R=HZG ZXH EHHHH **"<
M=:0$'H0: %HHJ">]M;66&*XN88I)VV1))(%,C>B@]3]* )Z*@2]M9;N6TCN8
M7N80#)"L@+H#T)7J,^]3T %%%% !144-S!<^9Y$\<OE.8Y-CAMCCJIQT(STJ
M6@ HHHH **BEN8('B2:>.-YFV1J[@%VQG SU. >!4M !1110 4444 %%%% !
M1110 45%]I@^U&U\^/[0$\SRMXW[,XW8ZXSQFI: "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MO]:\+:?J>IVT5M=7<0F,,><(K<J.><[<9]ZVJ1$5$5$4*JC  & !2T %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 445SOC#Q#+X>TVU-JMN;V^NTL[<W+;8D9LDNY'.T*K'CKC% '1
M45YO=>/=5TK2_$D5T^DWNHZ78K?6\]H&\B9&)7#+N)4AE.?FY!!I]WXI\96.
MJ:)%+9Z1)'KNY+:%?,5[5]F\&1LD. N<[0.F!ZT >BT5YQ/XVU_2=-\8PZE%
MITVI:#;Q7,,L$;K#,DBD@%2Q((*D'FK7_"3^)],O]!N=9M],&E:S<):K%;AQ
M-:R2*6CW,3M?I@X P>F: .TM]0LKR>X@MKRWGFMF"3QQ2JS1-Z, ?E/L:LUY
M%X>UR'PUJ_Q3UF=#)'9WB2; <%SM;"Y[9.!^-=$?$/BO0[G19O$,>E/9:K<Q
MVC1V:2+):2R [,EF(<9&"<+UH [NL_6M&LM?TN73M0C+P28.58JR,#E64CD,
M" 0:Y[1/&DDGAW7KO7(X8+W0IYXKQ(054A!N1E!).&7&.>N:R;3Q=XNO+SP_
MI8L]+AO]5TM[Z5Y$DV6Q#KC*[LGY6 (R/F/4#B@#T6-/+B1"[.54#<W4^Y]Z
MS]1T.RU:^T^ZO%>4V$IG@B+?N_,Q@.5[D<XSTSFN$@\6^-KS2M=DAM]$CN-
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MMJR?:)9KI?,$:L251 >%4# XH ]+ZU0MM;TF\EN(K75+*>2V&9TBN$8Q#_:
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MG%80\(76GCPYJ-]X5@UX0:%#IMW9.(7D@D3#!U\P[2,EU.#Z'FO5:* //O\
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M"JHSCDGIR14T4B31)+$ZO&ZAE93D$'H10!Y]::-+=VNL"S\!V&@A]-E@B?9
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MFAU$ZCJ^G"1,SM)YC,/F.UMKNO!.#MKU*B@#Q^_\+>(;FQ\:06_AN.T36[&
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M%Y ;\1>>;;>/,$><;MO7&>,T <%I'@G4=$U7P#$B+/;:/9W<=Y.K !9)$7&
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M:C9:9XPAGA"R:EJ5U<6HW@[T>-%4]>,D'K6MX/TZYTCP7HNG7B".ZM;**&5
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MVH ]7LO^/"W_ .N2_P A7&?$1I=1O?#?A<320VNLWK+=M&Q5GAC0NT>1R-W
MKM;5&CM(4<898U!'N!7.>-?#E[KEG8W>DSQ0:QI=R+NS>;.QR 0T;8YVL#@X
M]J *]_\ #/PQ<6L":?IT.D7=LZO;WNGQK%-&0?[P'S9'!W9ZTRZUCQ!K'BS4
M]$T"XL;*'28XC<W-W;M,TLLBEE15#*  N"3[]*KW%_X_UN%-/AT&+P^[L!/J
M4E['<>6N?F\I%&2Q[;L"GRV.O>&_&.KZMIFD'6+35XX&D1+F.&2&:)=F3O(!
M5EQR.00>* ,U_B!K<VC:*UM962ZM<:T^CWD3EC$DB!P64YSMRJMW.,CKS4]M
MJ_C:;Q1J'A9KO2/M,%O'>)J7V1]HC8D;/*\S[VX==V, \$XJO:^"M9M[/P])
M+'%)>CQ#)J^HB.0;8O,$F0I.-V-RCBNDM-'O8OB5J6LO$!8SZ;!;QR;ADNKN
M2,=>C#F@#F1X^\03>&?#]Q!:6+:K?:N^E7"L&\H,OF+O7G(&4#'KQD5<?QAJ
M_AC5-6L/$K6=Z+;27U6VN+.%H=ZHVUHRI9N<E<'/0USFH:1K.@Z5X7MS;Q#4
M#XKFN(HGD&UU;SG4%AG&Y3CVS6Y=^&-8\9ZMJ][JVG_V/#+HTFEVL4DZ2N6=
MMS2G82  0H SGK0!)HWC+4UUO1;?5-4T.^BU?<GDZ?P]G+L+A2=[;U(4KG Y
MQ6</&?C*;P-<>+D_LF.UL9)M]H8'+7*1RLK$/O\ DX& ,'D$]\#9\-Z9J2:C
MIZ7/@G2-+%LA^TWR^2[2.%P##L^89/)+8XXQFJL/A36$^#&H^'3;+_:<RW82
M+S%P=\SLOS9QR&'>@"QJ7BC6[OQ3=:3H]]H]C);VT,]O;ZA&Q>_+@G"D.NU1
M@+D!CFK?B/6-?M+FW2+4="T.W-J)&FU)P_FSYYB4;TPH[MSUX%9_BK2=7U.U
MFTNY\'V6LVS6RI970GCC>U?9AMY<[AAN0R=N,9JNOAO7M-\0&XET>VUZ6?3+
M6TCO[B9-MK)&&$A97^8JQ(?Y02<8H S=1\1>(/$=W\/+_3KJTL5U(RR&*2%Y
M%698G#$X==R8)P.,'G)Z5T$'BM[;XA>*+*[MK1;72M-CNVGBAQ,_R!F#-GD=
M<"L*T\,^*-+T?P:Z:*+FZ\/74Z2VZW4:F>-U*B1&)P!ST.#[5L0^$=1O?'WB
MN_O;?R=-UC2H[1)!(K'=L"L, YXYYH KMXK\6:?X8L?&.HG2SI-P89)M/C@<
M2P02L K"4MAF 921M ZU?.L^+-9\5>(M&TB73+.'2I(0EQ<P/*9-\2OLP&'?
M.6[#'!ZUDRZ)XLU;P=8^";[1H[>WB\BWNM4%VC1O!$RG*(/GW,$ P0 ,GFNK
MT#2+VQ\7^*M0N(@MMJ$]N]LP8'>$A56X'(Y!ZT 6/!>O2^)_!^FZQ/"D,]Q&
M?-1/NAU8JV/;*FMZN9^'VCWN@^!M.TS48A%=P>9YB!@V,R,PY''0BNFH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ J&YN[:R@,]W<100C ,DKA5&?<U-7 _&)H4^'\C7 !A%[:F0%
M=P*^<N>._':@#K[;7-)O)A#:ZI93RMT2*X1F/X U?KQ7Q7>_#W6-#GTWPOI,
M$WB&<#^SUL-+>"9901AP^Q=H7J3G&*ZG6_%%]:Z[;>'O^$@TG1IH-/CN;N]O
M@K>;(Q*A$5F4?PLQ/N* /0:*\VM/'6JZ]8:!I^F26,.K:E-=0SW84S01+;G#
MNBY&[=\NWG'S=ZL:MXE\2>&=&,&L2Z8EY/J,=E9:I)B.!D=2QE=-V5*A6&,@
M$XQ0!WEU=065I-=W,JQ6\"-))(QP%4#))]@!6?X;M=)L_#UG#H14Z7L+VY5R
MX*L2V0223DDFN*A\:W:6/BFQ?5M*UJ?3M*;4+:\M%7RY!M<%)$#,,AE'0\AA
M4NC>,-4">![B\2V73M=M3%-Y<6T17.W>F.> P##'M0!Z+17GNN^/+W3-6\32
MP1P2:9H5E$K!Q@R7DK#:N[/"@%<_6HM,\;SV.NP66H^(M&UR"ZM)[@OIH56M
MI(E#LI =LJ5W8)P<K0!WNHW]GIEC)=W]PEO;*55I'. "Q"CGW) _&J6A>&-(
M\.+<?V9:F-[A@TTLDKRR2$<#<[DL<=AGBO+_ !1?>*M7^%:Z[J%S8M8ZE):R
MFRCMRK6T;3QM&1)N.\_=!! ^]QTY]GH K7.H6EI<VMO<7"1S7;F.!&/,C %B
M!^ )JS7 ?$1KY?$/@O\ LT1?;&U&58S,"44F%P6(&"0 2<9&<8R*JWOB#Q?I
M-QKVAM<65_JEKIBZK87"VIC$J!RKQLFX\\8!![B@#TFBN*U?QE-<:!X;GT Q
M&\U^XA2#S%WB.,C?*Q'&=J@@^]=K0 45S'C#4M0T\60MM8TK1K21G^TZAJ!4
M[, ;51&9023G)SP!7+KX^UJ?PMI=S8MIUW?S:_\ V.\Z ^1.OS@2+@G .%/!
M/?% 'I]%>>OJWB^QUS5/#SWMC?WS:0VHV$ZVAB D5]AC9=QR"2,'.>:EO?'=
MQ<_#K1]8T=(CJNL2P6MM%(I*K.S8<$=<+MD_[YH [VJ]Y?V>GQK)>W<%LC':
M&FD" GTR34Z@A0&.2!R<8S7G/Q9>UC;PF]]9/>VHUE3);)!YQD'EOP$P=WTH
M [:'7]&N)DA@U>PEE<X5$N49F/H #S6C7 :%<^$+G6[6*Q\#7-C=%BT=S+H!
M@6,@$Y\PJ-O3CWJ/4_&^K:!>ZEH=[:I=:U,X.A>5&52\1S@!N>#&<[^1QSWH
M ]#HKS[6O$^I6.LV'AV;Q#I&E7:V N[W4+N-=KL6*A(T9U')5B<DX %5K7QY
MJFM:?HVG:=+8)K-_>W-I+>*IEMT6W!+RH WS;AL*C./FZ\4 >E45P.I:YXL\
M.Z65U/[%/(-5M+:"]CCVK<0RNH;,>XE&&2.N.F*U]7UG4(?&NE:':20QQ7UC
M=2F1X]Y61-FP]1D?,<COZB@#>U#4+32K":^O[A+>UA&Z260X51TR:E@GBN;>
M.>%P\4JAT=>C*1D$?A7CNA:QKVD_"/Q%KTU[:WCI<W+Q12VO D^T$,6.X[@<
M\# QZFNOT_Q/J,?B7PY97JP#3]:TGS82B;2MTBAV7.?NE#D#VH [>BO-]5\?
MZA:3>)KFW%F+"PNK?2[-Y_E1KIR!(TC9X1-PS]#S5[PQXJGG\5-H-SKVE:XL
MMF;N&[L JE"K!7C=5=A_$I!X[T =9IND66D_:_L4)C^UW+W<_P Q;=*^-S<G
MC.!P.*EO=0LM-@\^^O+>UASCS)Y BY^I-6:\XT/2K+Q?XY\3:IK=M%?+IEV-
M.L;:X4/' JHK.P4\;F+=>O% '?V=]9ZC )[&[@NH2<"2"0.OYCBLK5-7\/7E
MZWAB\U2 7URNW[)'<F.8C&>-I#*<<]JY35]+M?"/Q"\.WFA0Q6$>L22V-[;P
M(%BD.PM&^P8&Y2.O<&L/P3IOB.7QYXW:#6[".ZCNHDGF?32_FG8VTJ/,&T#T
MR<T =UH^K>"_#\%UHVE:CI\"Z<CSW,,<V]HP#\[N<DD@D9).:Z2TNH+ZSAN[
M659;>>-9(I$.0ZD9!'L17B?@&;5]%^%GB36TN[*6* WLBV[V?+3*1\S/NY7C
M[N/QKL(?$^LZGIWA#3-+DM+34=8TT7UQ<O!O2WC6-"=D>1DEG &3@ &@#T*B
MO/\ 5O$_B+P[HD5OK$FF0:A<ZD+&VU*0A+=HBI8SLF[Y2 K#:6ZX[&LZ7Q]?
MV6C>*88]6TO5[S2[%+VUOK11Y<BL2"KJK$!E*]CR&% 'J-%8/A9]=NM/^WZU
M<6S?:U2:"V@B*_9U(SM9B3O/(R>.<UO4 %%<KXVUW5=%_L*+2$MVGU'4ELV^
MT E0&C<YX.>"H/N 1WK('BK6/#.L:Y8>(+JVU*.RTC^UH9X+?R&*AF5HRNYA
MU48/O0!Z#17G+Z_XMT32](\0ZO=Z?<6-]/ EU8Q6I0VJS$!2LFX[BI9<Y'//
M2L5;SQ;9:_\ $6^LM4M9I=-6&00/9G$@$.]0OS_+A<@]<GGB@#V"H+V]MM.L
MIKR\F2"V@0O)*YP%4=2:X+Q'\0+JSN?#LVEI"]A<P1W^H,XR4MI)(HU*G/7,
MA/T4T_Q+XMU.VNO%Z6:6S6>AZ2DA$L>[=<N&< \\J$ X]Z .\M;J"]M(;NVE
M66WG19(I%.0ZD9!'L0:CM]0M+NYNK:WN$DFM'"3HIYC8@, ?P(->6:I?:_JU
M_P##.>TU*ULCJ$!FV?9"Z)-]F+,V-XRN'("\8ZY/2K>F0>([GQIXWCT74+.Q
M"7<#M-/;&8R/]G3"@;AM'')Y/(QTH ]#U/2++6$MDOH3*MM<QW40W%=LJ'*G
M@\X/8\5<DC66)XW&5<%2/4&O,5\?:EJ>D^%9#J&GZ#_:]K++-?74/F1^:A5?
M*0%E +$L>3T&!S4?BF3Q5-JO@>*75+"VN9[V0,8(#+$TBI)MDY8$J4(^3L3U
M- 'I.EZ9::-I=MIMA%Y5I;((XDW%MJCH,G)/XU8FB6>&2%\['4JVUBIP1C@C
MD?A7G?C#Q1K6@SZA.?$/A_3TLH!+:V-SM:;4"$W-GYP4R<JH -7+OQ%KVI^+
M-/T;1I;6T@O=&&H-//"96A^<#A01N/S 8)'7/;! .FT/PYI7ARWEATNU\D3/
MYDKM(TCR-ZL[$L?Q-7)-0M(=0@L)+A%N[A&>*$GYG5<;B/ID?G7GG_";Z]:^
M'[ZTE^QSZ[#KJ:);W C*Q2,^TK(R9XPK$D ]13A#K5M\6_#MOK%Y;WVW3[QH
MKF&#R2V?+W*R;F'&!R#SGIQR =[IFKZ?K-N]QIUW%<Q1R-$SQG(#KU7ZBKM>
M3:?X]UG_ (5U?:U#;61O8M<%DD21[$=#*B\\]2&/-=!'K7B#0O&-EINNWUE>
MV>H6=Q<*UO:F$V[Q;2RC+-N7#=3SQ0!W-%>37OB_QK;_  \;QLDNFFWN%62/
M3S;-NMXG<*C>9N^<X(R, <G'2O6: "LO7/#NE>([>*'5+7SA"_F1.LC1O&W3
M*NI##\#5?Q7>ZA8:.)=/NK"S8S(DUY?L!';QG[SX)&X] !D<FN'?XA:C;>%/
M%<\&I:;J]SHK0&"_M4'E3I(5X*AB-P^8<'TH ]"T30-,\.VCVVEVH@CD<R2$
MNSO(YZLS,2S'W)K2KA7U3Q3I/BO1++5+VPGMM:\Z,10VQ0V<B1EUPQ8^8."#
MD#UXZ5%8^/+F+X;ZOK&J1Q+K&D/-:W,**0IN%;:@ ZX;<GYT =_15'1C?G1;
M(ZJ8SJ!A0W/EKA1(1\P ] >*RO&6NW>BZ?8Q:<D+:AJ5[%8VS3 E(V?)+L!@
MD!58X^E '1T5P>I:[XG\&Z+K5[K0M-5@MH$>SNX8_(,DKML$3Q[CCYBIW#L?
M6E?5/%'AK5M#&NW]AJ%GJUR+.18+4PM;3,I9-IW'<N5(YP>A]J .[HKRX^)?
M&5]X<\0:[:7FFVT.BW-XB0/:F0W20LQY;<-GRC' ))!/%$]YK>K?%+PW-:ZE
M#;6MQH[7:0O;%]B,8MZD[QDG PW;T- 'J-%<%X6UOQ/XBU_5V>>R@TK2M5N;
M)D$!,ER%^Z,[L+C*G.#G)Z8K/M?&>K6GB'2;?4->T&[EU"\-K<:19%6EL\AB
MK!PY+8*@-E1U[4 >FT5YWI&L^,/$FJ^(8[*[T^TM=*U"XM(B]L7:<A1L4_,-
MH4D$GOG'&*<?']T_PI37HH(_[<D(LA:D<?;2_EE=N?[V6QGI0!Z%145LLRVD
M*W+J\X11(Z# 9L<D#L,USWC#7;_2_P"RM.TD0?VEJUV+:&2=2R0J%+.Y4$;L
M <#(Y- '345PB:_KVB:WJ&AZM=6M]+_94FHV5Y';^3DH=K(Z;B#@E2"#TS5O
MP!J7B/7]%M-=UBXLUM[RU1HK2"$AE;NY<GG=R=N. 1R: .PHHKSSPWXEU[7M
M4\Z/5M((2\DAN]$:(I<6L2NR[MVXDM@ \J <\8H ]#HKB++Q7J-QX%\4:P_D
M_:M,FU!(,)\N(=VS(SS]T9JD/$GB;5?$6D:-IL]E;"]T*/49[F6W,GE,6 )5
M=PSG( !/&2><8H ]$HKRZ[\=>(M.T+48)([.XUO3-9@T]F5"D=Q'*5*MC)V$
MAL=\&MNUU;Q%HWC73-%UR]LK^VU>"9X)+>V,!AEB 9DQN;<I4\$\\4 =3IFK
MZ?K-N]QIMW%=0I(T3/&<@.O4?45=KQ+P5XCD\-?#*]G@>VCN;KQ#+:0RW;8A
MB9V&7<Y'RJH8]>U;X\=WUE;>([1=:TK6KBQTB34K2]LU4+E<ADD1789!VD8/
M(- 'IU%>97/B+QK9'PW>//I<T>ONMNMH;=E%H[QEU<ONR^,$L,#/08ZB=_&6
ML>&)?%-KKLUMJ3:58QWUM-#!Y'F!]RA&7<<?, ,YZ&@#T:BO.]"\87B^)]*T
MR]\1:'K*ZI'("NG;0UI*B;]O#MN0@,,G!R!ZUD1^,?&3?#N+QQ)<Z:MM"<R6
M M23/&)=C-YF[Y3UP #T&>M 'K=%><P?VW+\<+V(:K"+6'2XI/)-J3F(RM\@
M._AL_P >/08XJ!?&>K6.OZ9%?Z[H-Q+>Z@+.;1;4JTUJKDA6WAR6(PN[*@<G
MI0!V<W]A>(=6%LTL=S?:)<)<&-)"&MY&5@I8 ]U+<'BMJO-O W_)6OB-_P!=
M+'_T6]>DT %%>4:7JNKZ-XJ^(.K7^I0W%GI8CDDMUMBIE @W(%;>=F. >#D\
M\5=T3QM?#6M$AOO$&A:HFKDQR6UAM#V4NPNH!#L77Y2I) YQ]* /2J*\TT+Q
M-XKU?2-8UR6XL(;'36O8E@%N2\[1[MK%MWR@?*,8YPW3BJS^*O&EMHGAC7FE
MTR:/6Y;>V&G_ &=E\MID.R0R;B3S@D8X!QVS0!ZI17&Z%JNNVWCF[\-:U>6M
M^#IZ:A!<06Q@*@R%&0KN;/(!!S794 %%<,NJ>)O$NMZW%H5_8Z=9:3<?9%,]
MJ9FN9P@9MQW#:HW <9/4^U94WC_7-0T;P?<:5;VD5YK5Q-:SQS LD4B!E)&#
MG 92<=2!CWH ].HJIIL5[!IT$6HW4=U>*N)9HXO+5SGJ%R<?G5N@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "N7\?:)>^(/#(L=/1&G%W;RX=@HVI*K-S] :ZBB@#E_&OA^\U:SM-
M0T=DCUW2YA<63N<*_9XF/]UUR#^%9FLZ)J2>)X_$5MX?M-5%U8);75C/,BO"
MZL65E9@5(^=E/T!&:[NB@#@;SP_K\0\.Z]:Z?IIU;3&G\_3K9O)BDBF&"JL1
MC<NU.2 "0>E1ZIH?BGQ%I@OM1M;%;NTU**]L=*=U=!&BE&C>0#!9PS'." <5
MZ%10!PK:1K.J>'?$EN_A_3=(:\L)+:TMXF5I6=D8$R.N%"DE<#V))J&7P=J4
MOPCTS1 (X];TV&":V._Y4N(B&'S>^",^]=3<^*-$L]/U"_N-1BCM=/F^SW<A
M!Q%)\ORGCK\R_G6JDBR1JZ,"K ,I]10!P%MX&O;OX;ZKI=^\,6M:O/)?7#YW
MHLYD#H,]U&U%^@-6],TS5=2GDAU#POI6C6C6DD,TD3I++([C;^[*@;5 W?>Y
M.0,"NGLM9T[4;^^L;2Z26YL&5+F-<YB+ D _D:OT >2W7AWQM>?#^V\'MI=F
MBV1@C-[]K!6YCBD4J%3&5.%!.[^Z?7CUJBB@#D/&FCZSJ&J>'+_1HH))-,O'
MN)%FDV!E\MEVYP>3G&<'&<TW0=+UB]\:WOB?6;&/3_\ 04T^UM1.)FV!R[.Q
M7CDD  =A71:MK.G:%:+=ZG=);0-(L0=\X+-T''K4VH:?;:K836-XC/;S#:ZJ
M[(2.O52"/P- 'F7P]T)D\;ZP5E2;1O#\\UII>WE4>9A)*H/JG"?B:]6JEI6D
MV&AZ=%I^F6L=K:Q9V1QC@9Y)]23ZGFKM '&>)M(U0^,-,URRTBWUB&"TFMC;
M33K%Y+NR,)06!'12IQS@]ZP;/P?XC1+:VNK:U)@\4)J[3PR@(\3!BX53R-I(
M&#UKU&B@#FGT:\/Q,BUP*OV%='>T+;N?,,RN!CTP#S7'>%M!9OBKJ\,4J2Z)
MHEQ)=6R+TCNKE%WIZ?* _ Z;Z]0O+2&_LYK2X4M#,ACD4,5)4C!Y!!'U%5='
MT33?#]@+'2K2.UMPQ<JF268]6)/)/N3F@#0KC_'FDZQJ#Z!>:-917D^FZBMT
M\,DXB#*$9<;B#W8=J["JK:E9IJL>F-<*+V2)ITAYR44@%OP)'YT <[::WXTE
MO8([KP=:P6[R*LLRZNKF-2>6"^6,X'..]8NH>"-6\1W.I:[?S_8];AD T,))
MN6S1#E2V."9#]_KP0.U>C44 >?W^CZW)K-AXED\.V6H74NG"SOM.DF0>4ZN6
M5XW8%2,LP(X."*6\\/Z^(?#^N6VG:8NL:7//(^G6S>5$\4P*E ^,;PH3YL $
M@UW]% 'GNLZ1XP\2>'KZ6[AM+:[2]MKO3M-,H8((6#%7E Y+D'U XYZU9M=/
M\2:KX\TC7]2TR#3[.UM+B VXN1+(K/L(8D#'.,8&<;<YYP.YHH \H3PCXF_X
M5UXD\)-IT ::6:2SNA=*5GWS;P"N,K@>M=!KWAG4[GP5H::>D1US16M;BW5W
MPK/& KH6]"I8?E7;T4 >>KX#O!\,;;1]T#ZU',FHR--S'+="02L&/=2<KGTQ
M6SX<M]4;5);F[\-:9HMLL(1$B9))WD)Y.Y  $QVZD\\5U-% !7#7>C>(?#GB
MK4-;\.6EOJ5GJFQ[S3Y9_(=)E&T21N01R.H/<5W-(S!%+,< #)- '%6&C:]K
M_BNQ\0>([6WTZ#3$D%CIT,_G-YCC:TDC@ ?=X 'KU]9O"7A[4-(\6^+M1NT1
M;?4[J*6V*N"2JJ0<CMR:Z+2-8T_7M-BU'2[I+FSER$E3.&P2#U]P:O4 >9Z-
MX+UFR^$NO>'IHHAJ%ZUV85$@*GS,[<GM5B/PSKNCV7@[4]/M(;O4='TT6%Y9
M-.(_-1D0'8Y&,JR9YX(S7HE% 'GVIZ%XHU[2H=0U*VL&U"TU-;VTTMW#1B$*
M4,+2;<%B&8[L$ X[4FHZ%K>M^$/$EI_8&F:3)>6H@L[:)U,C'G<9)%PN"<8
MZ8.3S7H5% '.ZQ?W_AWPA;S6MO#-=0_9X&CD; .YD0XQU//'J<5T5(RJPPP!
MP<\CO2T <WXKT:\U:^\-RVBJR6&JI=3[FQB,1R*2/4Y8<5G:[X0N==\6:I-*
M533K[P\VF>:#EED,C-G;[ @UVM% 'F\FC>+->TK1_#NJZ9:VEI9S0/>7Z78D
M%PL)! C0#<"Q4?>QCGK6GI6CZOIOQ"\13R:=%<:/K1AD^TB< Q;(=A5HR,G)
M';L:[6B@#RWP[\.]3AT'Q'INL&)O/LO[+TYP^[%NAD,;'T.7!Q_LBK-GX0UV
M3X9^([/4$A;Q#K7G22@2 J&*A$7=Z;5'YFO2:* /.+SPUK]EIO@&ZL;&&\O-
M B$=S:FX$>[= (R5<\<'\ZZ#PYH]]8>(/$]_=Q(D>I7,4L 5PQPL*J<_B#73
MT4 >;Z3HGB/0O!.BZ-/X?T[6K6.WDCO+*29 RR%R58,V49<$@C@_7I53_A#O
M$&F:-X7FLK&WN+G2=2GNFTY;K:L44N_;&DC#!V!@/Y5ZG10!YA=^%_$<I\4V
M46CV);76>0:I-.K&!&A5/**XW$J00"..<^QU_#VA:Q%XHTG5K^T2V2#P_P#V
M?*@F#E91*I&,=057.??%=Q5"\UG3M/U&QT^[NDBN[\NMK$V<RE0"V/H"* .#
MO_!6M2V^MW%LD'VT>(HM9T])),+*(U0;6(^[G##\JT+73O$VJ^/])\0:EID&
MGV5K:7$'V<7*RR*S[3N) QSC&!G&W)ZX'=T4 >4:;X#UVV^']UH\L,(O)->6
M^51*"/*$R/G/KA3Q77:[H%UJGC30K]44V-K;7D-P=V"/-5 N!WZ&MK5M9T[0
M[5+G4[I+:%Y5A5WS@NW0<>M7Z /#-=77[7X,2:+MTV;3;7R[>/5+:\$HNT$R
MJBH@'#9P#D\8/X>YUSD?@+PO%JPU--'A%R)O/7YFV+)_?$>=@;OG&:UWU6QC
MU-M.:Y07B6_VIHN<B+.W=],\4 <_XWT>_P!2;1;NRL8M2&G7WVB6PED""8;&
M4$%N,J6##/I7):IX1\4ZC:>+HFTZSC;7+>V>%8;@;8&B8#RCP,G;SNZ9S[5Z
M9I.KV&NZ9%J.F7*7-G-GRY4SAL$J>ON"*NT <UX@T:\U#Q5X6O[=5-OIUS/)
M<$M@A6A9!@=^2*X[5M!:]^,L>G6LJ-IMTD&K:I .=LD!98\]L.2A(ZG9FO5J
MR=#\,Z/X<2==)L5MS.P:9RS.\A'3<S$DX[<\4 :U<UXUT.^UC3["?2_*.H:9
M?17]O',VU)2F04)[95F&?7%=+10!P&J:-XI\:Z+K5GJL-OH]M/;QI96OFK.P
MG1PXE=U' RJC SQDT^2P\3>*=7T+^V=)M]+L]*NA>S,MV)C<3*I5 @ X7+$G
M=SVKK8]9TZ;6IM'CND;48(A-) ,[E0]#Z=ZDO]3L],BBEO;A84EF2!"V?FD<
MX5?J30!R%EX7U.#P%XITAXXQ=ZC-J+VZAQ@B8MLR>W4?2JS>']?TSQ#X5U6S
MT^*]6STK^SKN+[2(S&3L^<$CY@-IX%>AT4 <?X8\.:CING^*K>X98)-3U:[N
M;:1&SM20 *W'0\=*Y:V\,^*(M%\-6L7AW3[7^P;F"618[I-U\R JS*<?*,$L
M=W))]N?6:* .7\&Z'>Z+/XD>]1%%_K,UY!M8',;*@!/H?E/%<C9Z"T_QFOK*
M"5)-%LY5UN:%>1'>R(8U4^YP9*]3FA2X@D@E!,<BE& )&01@\CD5@V,'AGP9
M+::/:+#8RZE*[0QDLSW#@ L2QR20".IH Z&N7\8Z)J&H-I&J:2L4FHZ3>?:8
MX)7V+,A4HZ;L':2#P?45LV>LZ=J&H7UA:722W5@RK<Q+G,18$J#]0#5^@#@E
MT/7==US4-=U.PBT]AI,NG65G]H$K%G.YG=AP.B@ 9[UT/@S2[G1?!>CZ9>JJ
MW-K:1Q2A6R P&#@]ZV994@A>:5@L:*69CV Y)JMI>JV.M:;#J.G7*7%I,"8Y
M4SAL$@]?<&@"Y7G-WH7B'6M<TJ34/#^FVU[87\<[ZY;S@&2)&R45,;_F7Y2K
M' R>37HU% 'F$GA_Q;:Z+XH\-6>F6LEMJD]W-!J+W0 5)\DH8\9W<D9Z<Y[<
MPI'K.C_$71H[&RBO+JU\*I%<6IF$9<"50=K'C(8#KP1GFO1K36=.O]2OM.M;
MI);NP*"YB&<Q%@2N?J :?_95E_;0U?R!]O%O]E\[<?\ 5;MVW&<=><XS0!Y1
MXDT36+3PS>:G?)!:ZOK'B*SG2$/YB6X#HD:LP^\1C)(]:ZVWT[7]<\;Z7K&K
MZ9#IEKI$$ZQ(MT)FGEE 4D8 PH4'K@\]*ZK4M*LM7@BAOX!-'%,DZ*6(PZ'<
MIX(Z$5<H \HTKX?:S;>!);&>"T;4K?7#JEM!*X:*8!@=C$ XW+N'MD5L7&C:
MUK'AWQ';'PYIFCF[TZ2UM88W1IGD96!+.H"A/N@#D\9..E=_10!QNI>'-1N;
M?P4D:(3I-U#+=9<#:JPLAQZ\D54U[P5>:]KGB=G9(K34](AM()2V2LJ,[9(Z
MX!*UWM% '&^'[76FU6V>]\+:/I4,$3>?/$R22328P/*V@;%ZD[N<'&.]9!\&
MZQ_PHY_"OE1?VJ860)Y@VY,Q?[W3I7I-% '$7VC:Y;_$N76+*S2>PO\ 34L9
M9A<!'M6#L=^T_>&#T%<U;>%?%,'AW0=.B\/Z? ^AW<%Q(R72EM0:-N2IQ\N0
M2Q+<YP*]<HH XSPOX<U'2_'WC'6+N-%M-5>U:V*N"3L1@V1VY(KLZ** /.I_
M"FKS^(O&5E+9QMI'B.%0M\LX#6[" I@Q]3\V.E7?#NGZ['>Z=#>^%]&L([1"
M+F]1ED:=@N 8@H!3)Y);MQCO74Z1K.G:]8"^TNZ2ZMBS()$SC(.".:OT </X
M?\,ZGIW@/7-)N(XQ=WDUZ\2AP01*6V9/;J*CN?"VJ2>$/!.FK'']ITB[L);L
M;QA5B7#X/?\ K7>44 <T-%O/^%G-KNU?L)T86>[=\WF><7QCTQWKI:** .$2
MP\2^%];UU]&TF#5++5KC[9&6NQ";>8H%<.".5)4'*\]1BJEEX$U'3+?P/;H\
M5P=(NIKB^E#;06D5RQ4'J-SD?2O1J* "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N;\9ZY>:
M-IUC#IOE#4-3OHK"WDF7<D3/DER!C.%5CCUQ725S?C/0KS6]-LY-->)=1TV]
MBOK83$A'=,Y1B.0"K,,T 8VJ:SXH\%:)K5]JTUMK%M;VZ/9W(B$#&9GV>6Z*
M>1DJ<C'&12RZAXG\+ZIH+:SJUMJ=IJEVMC/&EH(3;RNI*%"#RN5(.[FDU+0O
M%'C/2-9L]:^S:3:W-LD5I9PR"<I,K[Q,[[0>H4;1V![TY]+\4>)M5T/^W=/L
M=/L]*N1>2M!=&8W,RJ0FT;1M7+$G//0>] &1_;WC*_\ #OB36[;5;.TCT6[O
M4B@-F)/M*0LQP[9&T8&WCG()SS@:A\0ZWXE\06&EZ/>Q:7%_9,6IW4YMQ.Q,
MAPD8#$ #@DGKTJQ8^%M1M_!/BK27\G[5J<^H26^'^7$V[9DXXZC-4XO#WB+P
M]JVEZOI5E::@_P#8T.FWMK)<^3M>/E9%;:01RP(QZ4 <NNNZQX;^'WQ U93;
MC5;;7V!81[HV8^0A(4YX()(!SC-;>JC6;SXK>&!#JZ01OILTRI]E#!/]7O'7
MG=@<]J@OO 7B2^^'GB[29VLVU36-4^VQ[)"(P"8B1DC(QL8#Z#UK>U?0M<@\
M5^'-<TRTMKP65G)9W,,EQY1 ?;\P.TYQ@\4 9D?CV]L+KXB7%XD4MOH)C^RQ
MJ@4L65N&(ZY8#FK4VI^*_#3:%?ZSJEK?VVHWD-I=6J6@B^S-+PIC8$DA6P#N
MSD>E0Q_#Z\O+KX@17TD4=KXA,?V61&W%=JL,L/8D'%3R:1XK\12:'8ZY8V-G
M::9=17=S<PW1E-V\7W0B;1M!;!.3GM0!376/&&KVOBJ[LM6M+*+1;ZYA@4V@
MD,XC 8*Q)&T8P,CGD^E=SX=U-M;\,Z5JKH(WO;2*X9%Z*70,0/SK#TCPW?V6
MC^+;67RO,U2_N[BWP^1LD0!<^AR*V/"NG3Z/X1T;3+K;]HM+*&"78<C<J '!
M],B@#"^)WB&_\->%X+[3C$)GOH83YD8<;6)SP>]1WVH^(]1\?ZAX>TS4;>PM
M(+"&Y^T-;"5U9F<$ $@'.!R<XV].<B?XE>&M0\5>&8+#3?*\]+V&<^:^T;5)
M)Y]:O6>BW<'Q"U36W\O['<V$%O'AOFWHSDY'I\PH 9X%UJ_UK09SJC1/?65[
M/932Q)M64Q.5W!>V1CBM77[F\L]!O;C3VM$NXXBT;WC[(4/]YSZ#K^%9O@W1
M+O0[/5(KSR]USJMU=Q[&S^[DD++GWQ2^.-$NO$'A.ZT^R$37!DBE6*8X279(
MKE&/HP7'XT <IHOC2Z?6-3TN/Q+I_B!8](EOX[JVA5/)D1@I0A200=P([\&H
M8O$?BZW\,>'/%=YJ5F]M?26D=QIR6H *2E5WB3.=W.[&,#..V3?ET/Q3?^(Q
MJ\^G6%M#/I-QIGV..ZW&V#%65RVT!B2N, # QR>:LW7A+4YOAKH&@KY/VVQ-
MB9LO\O[ED+X..?NG% %O0_$US%J_BC3-=EC#Z3)]IBE"[0UFZ[E/N5PP)J]X
M&U'5-8\)VFJZOM6>]+7$<:IM\N%B3&ON=N#GWKC_ (FZ.^I>+- M=.N1%>:O
M')IM\B_>:RR)';VV[2/^!XKT^*)((DBB0)&BA54#  ' % '-^-];O](L-.MM
M*:)-0U2_BL8994WK#NR6<KWPJGCUQ7*O+J>A_%&&;6[V/4([3P]=3K<I"(F9
M1(A964$C(QU&.O3C)ZKQMH5_K.GZ?/I1A.HZ9?Q7T$<S%4E*9!0D XRK'GUQ
M6,GAWQ!KWC$ZOKEI:V5C+I$^G&UAN?-=-[*=Q;: 2?FZ=,#KF@#/E\1>+=.\
M&VGCF]U&TDLY1#<3Z4MJ ([>1E VR9W%PK Y/'7BM6?4?$_B+7M=M] U*UT^
MWT=UMT$MJ)C=3E [!B2-JC<J\<]3[5F/X8\6:AX1M/!%]:V":;#Y4$^J)<DM
M+;QL" L6W(<A0#DX'-:=QI7BC0-?URZ\/65C?6VL,LP^T7)A-I.$"%B-IWJ<
M*<#!X(H NZ9KVL3>.8='U"*& '0H[V:"/#;)S*4;#=UP.*P-1\:Z[!HVKW-L
M;=[FV\3KID"NF%,1:,;3[_,>>M:$^B^*M*\2Z=KULEKK=S_9(TZ^$LPM27#[
M_,7"D8R2,8]*SD\#^('T*]M[IK1[RY\2QZLQC<A/+#1LP&1GC:P /H* ++WG
MC.W\:IX8;7+.9;VQ:\6]-B%:UV/M953=ALY7&X\9[XYH-X]U;3_#MS;:AJ%A
M'J46O-HPU*:,1Q*@7>9F3.,A<\9QG%=A/HEY)\2+/75\O[%%I<MHWS?-O:1&
M''IA37-S>!]6\G5+F);1[Q?$9UBRBE?Y)D\L(4<X.TD;^QP<4 9\WQ OK/1O
M%$-KKVGZU<:;8)>VFH6R)@AF*LCJI*[E('3J&%;3ZIXHTCQ!X>;4=1M;BSUJ
M9H)+..U"?96,;.NQ\Y;&W!SU]!V35M$\1^(O"/B&RGTS3--DO+80V=M%+O8'
MJS22!0,'C  XQUYK8U_0KS4=1\+3P>7LTV]\^XW-@[?*=>/4Y84 <_\ "^+5
MSJ/BN:^U9;J*/6[B!X_LP0O(JQ#S,YX&T ;>GO7H]<!I-AX@\*2^,'^R6+V=
MS<W6JVMY)<D .R+B-TQD ;>6S79:-=SW^AZ?>740BN)[:.66-00%9E!(&?0F
M@#G_ !YK>KZ-#H::,8!<W^JQ61\]-RA75^3WX(!X],53LM3UW3/%\WAS6M0A
MU*&ZTU[RVN4MA"R,C!60@$@C# @]:C^)ZW;)X4%BT8NAK\!B\W.PL$D(#8YP
M>A(]:L:?H^NZIXPE\0ZS96U@L&GO8VEK%<^<6+L&>1FV@ <  ?6@#DOA[?7N
MG_ K19K/4=/TT&YE6:]OF&R",S29902 S=  3WJT?B!J,7@_Q=<6FK6>KSZ,
MT+6VH01*%F63;PR@D9!W#CVI=&\":_HO@?PI:FTL[Z^T6^EN9;)Y]L<P?S "
M'((W+O!&1ZT_5/!_BO5+7Q='/!8"37K>W:/R[@[8'C('E'*_,-O.[CD'CG@
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M!(#-T !(ZUPC?$'4H?"/BV>TU:RU>?1GMS;:A#$JK,LA7(902N1\PR/:NO\
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MTU6RO[N]M;6<23V3K'<( 1L9E# <CG@@\5P/PZTC3)M1\9B73K201^()T0/
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M%>4V?CO5M:TW3M*TS4[234KK6)=..JQ1!D:*)/-,JI]W<4*C'3.:NR>)]?\
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M!3Y@R-PY'7!K6M-!O(/'UUKDDD+6TNEPV@QD,9$D=B=N, 88=ZZ2B@#S74/
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MC +NJ@D %CCD\ 4Z@#BK70M=U?Q-_;VN06=D;:QDM+.TMYVFPTA&^1W*KV4
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M%=7&J6UMF1 RLKO@@@]C[8/H:ZRN?\7:%<Z_::;%:R1(UKJ=M>.920"D;AF
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MH-W%=$2NXAEV[P5W!<C[W7':@"&TTS6+WXF>*;6SUR6Q"6=AY]U'!&TLC!'
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MI^FW5L@@NX<*=WF,NYBQ+#Y6!!'2M3Q!X'GO8?!MMIDD$=MH%[!,XE)!:*,
M87 //'?'UJ/Q1X=\4^(+?4-%E.C3Z5=R9AO)MPGM$..%0+AF7G:VX=LT 8&N
M^.97UKQ B>+HM%?2Y#!9V)MTD%RZH&9I"RD[2QV@*1C&:]*T'4_[:\/:;JGE
M^6;RUCG*?W2R@D?AFN:ET/Q3H^J:N_AR32WM-5E%P6O7=7M9BBHS *I$@.T'
M!(Y]J[*W22.VB2:7S950!Y-NW>V.3@=,^E 'FWB;Q@!XRU#1Y/%B^'8-/@B*
M%8$D:XE<%LG<K?(HV\#!.3S3X_&>KCPIH'C2616TK:8M8M8XQA1O*>?&<;OE
M89*Y.5/3(S6WJ&C>(=.\3WVL>'1ILZZE#$ES!?2/'LDC!"R*55LC:<%>.@YI
M-0\,:OKLFBV>MWMM<Z7:*)[]44J;VX7[JE,8$0/S8R<D $4 <_J7B;Q-'\-]
M:\8)<_9S</#)I5H8D/DP&1%!8D'+."2<YQD8Q6E-=>(_#7BKP^NHZX=2L]7F
M>UG@:VCC6"7874Q%0#MRI&&)X[YK"\8^'K[PY\,O$^EK<1/HAEA?30&/FVRM
M.A:,@C&T'[ISG!Q73#0?$FK^)='N]>?3$LM'=YH_LCNSW4I0HK,K* @ ). 6
MY[T 8GAW7_$5QI&M^*-3U<O8:/-?(EBEO&/M"Q;B"S@9&.  /[N3G-4]!\=3
M'5?#[-XMBUB75)5AO=.6V5%MBZ$AHR%!PK *=Q.0<UUWAWP?+8^$]8T/4Y(G
M34;F[=C 2<1S$\<@<X-)H-AXSM#IUAJ%QI2:=8IY<EQ;EVFNU5=JY5E C[$X
M)Y&!P: ,+PGX@U35M:A6Z\4QQZHL\@OO#]U;)%Y<8+8$1VAV(&T[LL",YH\*
M^(-4U;7(DNO%,<6J+<2+>^'[JV2+RXP6P(CM#L0-IW98$=:OOX<\4ZMJ6CC6
MSH[1Z7=K<C4H-WVB8+G"[-H5-V1NPQ'H*63P[XIU;4M(76SH[Q:9>+<C4H=P
MN)@F<+LVA4W<;L,1UP* .2T>?6+2U^)U[H4WEZA::T]PBE%<2*AW.F"#U4$<
M<YQ79:KXJN=3?PA;>'KGRGUN5;J238KE+1$WR=00"<JN?4U8\)>&;GPUJ7BF
M]OY[4P:IJ+7<6UC\J'/#Y  //O7.?"G1$34]9U6&?[1I=M-+IVC-C@6XE:1]
MI[C>P4'OLH ]2KR[0?$'B.;2M?\ $^I:OOL-%GOD2P2WC'VA8MQ4LX&1C@ #
M^[DYS7J-<AH'@Z6S\*ZYHFIRQ.FIW5XY,!)Q',3CJ!R : .3T'QS-_:_A_=X
MMBUF35)!#>V"VRHMLS(6#1D*#A6 4[B<YS3)M<\6WOPUU+QS::^T#.DTMOI_
MV:(Q10JY5?F*[BX W9)QGC&*[#0;+QG;2:=8ZE/I2Z?8ILDFMR[RW@"[5RK*
M!'V)P3R,#BN*\1^'?$_ASX7:[H*3::="MH9Y(;D,_P!H,18N(RF-N<G!;=T[
M9H [31M:U"Z\=W.F37&^T31[6Y6/8HQ([.&;(&>0!QTKE/$'C37['X9^*M8M
M[_9?6.MS6EO+Y*'9$LZH%P5P?E)&2":WVT3Q!;>(;7Q!H(TZ9;G2H;.XAO9'
MCV%265U*JV?O$$<?6LK4?AQK=[\-=<\.M?64FH:AJ;WJSL66,AI5<Y !(/!X
M&?K0!?UW4/$=[\0[+PYI>K_V?:W&D-=32B!)&1A*!N7<.IX7G@ DXR!6)K/C
M>?\ M?7(#XQCTB726%O:6K6R/]KD6,,SRY4G:S': I7&,UVW_".W?_"Q+7Q#
MYD/V2+26L63)WES('R!C&,#U_"J$^B>*-(U?6)?#CZ6]KJTHN";UW5K6;8$9
M@%4AP0JG!(Y]J ,VR\0:SXUURRM-.U.71K5-'@U&X,$,;R/+-G"?O%8!5 /;
M)JW\+A=+;>*%O722Y7Q#<K(Z+M5V"QC<!VSUQVS4]]X?\1V/BF/7]%ET^[GG
ML$LKZ*]9H0[(25E4HK8/)RN.E7/ _AW4?#MIJRZI=07-S?ZG+?&2 $+\ZID8
M/3D'CGC'- &+\68;R6R\."UU*:T5];M8F6.-&R2X*O\ ,#RI7('0YY!J;SM>
MUOQ;>^'K7Q!/8V^C6=N;FZBMXC-=3R@D$[E*JN%S@ <GTK5\=>'[_P 0Z19)
MI<ENM[8ZA!?1+<DB-S&V=I(!(SGTJ@^B>*+#Q!+X@TN/29+K4;2*'4;.>>1(
MQ)'G:\<@0DC#$$%1TH O^!M:O]6TS4(-4D2:^TO49M/FG1-@F*8(?:. 2K+D
M#OFF>,-5U&+4-"T'2KH6=UJ]Q(C7?EAS#%'&7<JK<;C@ 9R.>E6_!_A^?P_I
M=RM[<1SZA?7<M]=R1*0GFR'D*#SM   SZ5%XLT"^U2;2=4TB6WCU72KAIH!<
MY\J564HZ,1DC(/4 X(Z4 86L:AXK\*:+<P3:C;ZA/=WUM9:5>S1 2*96"MYJ
M* IV\D$=>]68[G7/#/C/1-+O];EU>QUA9H\W$$<;P31IO!4QJ,J0",'...:9
M?>%?$OB'2;]M8U*TM]0:Y@N=.@M]TD%F\)W*22 S%C][CCM5JTT/Q!JWBK3-
M9\1#3K:/2HY?LUO8RO+YDLB[6=F95P N<  ]>M '%KXB\9#X8Q^-VUX-+;SX
M^P_98A'<1BX\HASMW GU7& !QG)KJX;GQ!H?C[1=-U#6SJ5KK%O<L\36\<:P
M21!6S&5&=OS8PQ)]S5?_ (0/4_\ A3[>$?M%I]O+EO,W-Y7_ !\^;UVY^[QT
MZUT6K:#<W_C3P[K,4D0M]-2Z696)WMYJ*%V\8_A.<D4 <!9ZQXTN?AI)XS/B
M'$UH)I5L_LD7E3QQ2,&$AV[LD*<%2,8'?)J[-,=1^.FE3P.T)N?##.C@ E-T
MC$'!X.,UE^$]&\4:Y\*8=$LY=-32M0:='N97<301F=PZA I#D_-@[A][&.,U
MVW_"(7,7Q,T_Q##) NFVFD?V>(BQ\S=O)!QC&,$=Z ,:W\<:E;_"_4[N]82>
M)-.FDTV150#?=[]D9"XP0=R-TQUKO]+BNX-*M(M0N/M-ZD*B>;:%WOCYC@
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M3VQ=FP@5$4[_ )>.5/3-:,^F^*;&QT^UTY=(O[2.PCM;BSO69%\Q1C>K!&+
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MTS"PCVRJ\3E5;Y<X3/&"/?-='XWOWL-(MR-=31HI;E(YK@)OF9,'*0KM;+G
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MMP !\H(7\* -RF--$DJ1-(BR29*(6 +8ZX'?%>;6T_B/Q/I&M^(K3Q%=:?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M["7:61&R-J2#@D$;@<>M6X?"NK:UKC:IXIDL ([&6RM[6P+LJB7 D<LX!R0
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MF0M(@8QO@C<N>AP2,CUH Y.Q\-:U=^(+_7==FL%NY-/.G6L%D7:.-"VYF9F
M)8G'0< =ZR-*\ :WH?A;PI;V=UITVJ:#-.^V<N()5EW@\@;@0'&#CKFNTO\
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MM<7L)AN!N27<AWHI9"8QSCH2 :[WX?V3V7@71E>]N;KS;.&4&X*DQ@QK\BX
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MO8#%//;% \L4@95.,;R#@$@"N]\4Z%J.I7FCZGI,]K'?Z7.\D:7:L8I%="C
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M50H!]2,5FV_@[6=%BT.ZT6]L3J-AI4>EW*W:.89XUP0P*G*D,"1UR&- &CX
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ME?R67RIHV& HR?W>T8YYR,^M=7K6@RZIXA\/:DDZ(FESRRNC Y</$R8'XG-
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M08._)XP>,#ZUK:=J^H^.]9TNR;4KO3;,:%!J5R+&3RI)9I3@#=C(4 '@=2:
M/3:*\BU'7]>T_P -:]ID>JS27VDZW:VMO>RX+O#(\9428QN.&()XR*WXXM0\
M-_$31K :YJ.H6NK6ETT\=[('"R1;"'3 &W.XC XH [ZBO*?^$@U;_AGI-:_M
M"?\ M,P*QNMWSY\\+G/TXJ7Q1J,]KXLU&/6?$&L:!;D1#2+N!,V6=@W>;@$%
MM^<AR!C&".M 'J-%-CR8DW,KG:,LHP#[BO([&'Q!JW@G7=?;Q1J<-YI]Q>FR
M2*0",+$[$"12#OS@CG@#&!UR >C7?B6PL_%.G^'9?-^W7T3S0X3*;4!)R<\=
M*V*\F_M%M7^*WP]U-U"M>:)+<%1T!>(MC]:KZKXAFLKU]4LO$6MZA=1ZM'"X
MBM7&FB)IA&8<[=F0IQNW9+#K0!Z]-#%<0R0S1I)%(I5T=0593P00>HI8XTAB
M2*)%2-%"JBC 4#H .PKSV&SU3Q+XX\7:?+X@U.RL+&6V%O'92B-E9X%8G=@G
M /.!P23G/%;GPZU6\UOP#I-_J$OG7;QLDDF,;RCLF3[G;F@#J**I:S?_ -E:
M'J&HA-_V2VDGV^NU2V/TKRO0/$5]]J\.7D&I^(M0O;Z>--3@N;&9;4)(.6C)
MC"H$8K@@\@'K0![#17D0EUS6/A]K_C2/Q#J-M>;;U[6WCD @BBB+H%V8^]A"
M=W7.#VKH/#NJW]QXVTZSFNY9+=_"\%TT;-D-*9,%S[D=Z .OUC4TT;2YK][6
M[NEBVYALX3+*V2!PHY/7)]LU/]LMQ-! \R1SSH7BA=@'8#&["]3C(SZ9%>2^
M)?$FLVOPY\>WT&I7$=U9:Z8+:57^:*/?"-J^@PS?G6AJ>FR7_P 7?#C/JFHQ
M>9I4LV(IMH4J8\@<<!OXO6@#U&BO-=/\67GASPUXNM-6N9+K4?#\K^3)*<O/
M'+\UN3ZDEMOX5V?A>SO[#PQIUMJEU+=:@L"FYEE;+&0\MSZ D@>P% &O17D/
MC379;&;Q!?V?B/6YK_3FW06^GVKFSMMJJ?+F(4HQ/.XD\9'3%:UUXIO= OO&
M8N[B214TZ+4]-1SG;O0H4'MYJC_OJ@#TBBO(UUO7[/P)=>'Y]2G;Q(NL1:3'
M=EOWG[TI('S[1LW/^S3?&6MRV$FOWMGXDUR>_P!-YMX+"UD:TMMB@[)V"E6)
M.2Q)X![8H ]>IDLBPQ/(V=J*6./05YQ?'5O$/Q-?1H]<O]-TPZ+#>2+9R!7W
MF1AA20=N<C)QGY0.]%M'JOBJ;Q7J8UV_LSI][/8V-M X$ $2C)D3'S[F)SGM
MTQ0!W>BZO;:]HMIJMGO^S7<8EC\Q<-@^HJ_7)_#'_DF7AW_KR2NLH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ KG_ !KX<D\5>&9],@NEM9S)'-%*R;E#(X<9'<'&*Z"B@#C9_#OB
M5-2AURQU+2X]8DM!:WR26KFWE569D90'W*R[B.2<Y[5+/X2OKN;PQ/>:N;JY
MTBY>XGF>(*9RRL, #A0-W'7@#KUKK:* ,(^'W/CU?$GVA?+&F&P\C;SDRA]V
M?PQBLZ#P;+#X;\5:4;Q"VN7-Y,DFPXB\]< $9YQ^M==10!Q[Z!XHL;>UM]'U
MFP-NMC%:2P7UJTB*R+M,D>UAU'56R.!6]X>T:/P]X>T_2(I6E2S@6$2,,%L#
MKCMGTK2HH XJ;PIK^G:AJ[>'-8LK6SU:8W$R75LTCV\S*%=XR& .< X;O3+[
MX>1/H_A/2["[\F#0+^"[S(FYI@F21QC!8DG-=Q10 5YO-\/-<D\.S>'4UVTC
MTN*X:YL]MJWFLWF^:JRG=@J&/\(!/![8/I%07EY;:?:275Y/'!;QC+R2-A5Y
MQR: ,;0M N=,UW6]5NKF*635&MW9(D*A&CB"'&2>"1D>E<CKVF:5X4^#T_AC
M5]2BEN6@E%JL?$LTQD+Q^6F<DAV7I^E>G5#):6TT\4\MO$\T6?+D9 63/7![
M4 8?@?1)]!\)VEM>L7U&;=<WLAZO/(=[D_B<?@*LZ]9:W<&UN-#U*"UG@9M\
M-S$9(9U(QA@I# CJ"#ZULT4 >=ZE\-[S5/#,]C<:I;K?W>KKJMS+';E8MP &
MQ%W9 PHY)))R>]=/;>'W@\;W_B W"E+JRBM1#MY4HS-G/ON_2MF>7R8))=CR
M;%+;(QEFP,X [FJ^E:A_:NF07OV.[L_-!/D7D?ERI@D?,N3CIF@#E?\ A!)O
M^%>:MX8^WIYE_+<2"?RSA/,D+@8SSC.*MS>$)9?'^E>)?MB".QL&LS!L.7)S
M\V<\=>E=76?K&J_V19K<?8+Z]W2+'Y5E#YCC/\1&1\H[F@#C5^&\ZZ5XGM5U
M.,3:OJW]J6\GDDB%A(LBJPS\PRH!Z5:7PEX@N/$46NW^KV3W+V4UA/!%;,L2
MQ-M*^7EB=VY<DMG.<8&!6]-XGL8/&-OX89)_MT]H;M&"CR]@8K@G.<Y'I6U0
M!C>$]#?PWX4TW1I)UG>SA$1E5=H;'?':N9^(%O<W7BOP3%970MKG[;<-'*R;
MU#+ Q *Y&0<8(R.">17?U&\$,LL<DD4;R1$F-F4$H2,$@]N* .,3P+<:M)KE
MUXHO8+FZU2S%@%LXC'';PC)^7<22VX[LGN!1#X1U^_N-'B\0ZS975AI,Z7$2
MVUJT<ES(@(1I26(&,YPHY-=O10!QUCX)EM-5\97IOD8>(51441D>3B-DYYY^
M]GMTJG;?#ZZL?"/AVPL]4CCU?09#+;7;0EHW+;@RLF<[65L'!SQ7>T4 <G:P
MR:#::IJGC/7[61;W:CQEC%:0H%(V1J['EADD]3^%8OP?T%M.\/7&J2M,WV^3
M;:&<8=;./*P*1VXRW_ A7H%S:6UY&([JWBG0,&"RH& (Z'![U-TH R_$FDMK
MWAG4](240M>VTD D*Y"EE(SCOUK$L/!DME+X-<WJ-_PCUI);.!&1YQ:)8\CG
MC[N>_6NOHH P]-T![#Q;KNM&X5TU..V18@N#'Y2L#D]\[OTJOXET#4=1U+2-
M6TB[MH+_ $UI=BW<3212)(H5@0I!!X!!!KI*@O+RVT^SEN[R>."VA4O)+(V%
M4>I- '!2_#O5)HM6AFUN&9-2O+6_DD:W(99HV0L!AL;"$P!U'')QSTVJZ&;K
MQ5HNO-=)%%I45RKHP^\)549SGC&VMZD95=2K %2,$$<$4 >6Z3IMAXB^,E]K
M6E70N=(LHHY9FC(:%[_:T8*D<,5B/..A(KU.HK>V@M(1#;01PQ+T2- JC\!4
MM '%:?X4\0Z1LTK3M=MH-!2Z,Z 6Q-TD9?>80Q;;MR2,E<X.*T].\-26.J^)
M;PW*N-8E1U4)CRML0CP>>>F:OVFN6M[K^I:-$LHN=/2%YF91M(D#%=ISD_=.
M>!6G0!Q1\"S'P#HOAO[<GF:=+;2-/Y9P_E.&( SQG&*Q=+L_$$GCKQQ-H.HV
M=N[7<$<B7D#2*/\ 1T(==K AAD\'(/'3%>GU''!#%)))'%&CRD&1E4 N0, D
M]^* .%E^&H71_"6G6VH870;]+V222/)N&#%GZ'Y26)/?%7KKPSKMAKVIZEX:
MU.QMTU38]S#>VS2".55V^9&58<D 9!XR*["B@#S;Q/IF@>%?A-<>&KV_WRR6
M[_9P2//N;DMO#(G4GS2#QTK1TWP;<M\*[CP_=7 34]2MI7O+AQN_TB;+.QQU
MP3CZ"NRDM+::>*>6WB>:+/ER,@+)GK@]JIW^O6&GZ?JMX\PE72XFDNHX2&=,
M)OQC/4K@@'U% &;?^%Y+R?PQ(+I5_L682L"F?-_=%,#GCKFJFI>!H]7U3Q%/
M=76+?6+&&TV(N&B,>XAP>YRP(^E=197<=_86]Y$&$=Q$LJ!A@X8 C/OS4] '
M-:1IGBE+Z.76];M)[>"%HEAL[4Q^>QQ^\D+,>1CHN!DFLT^ IC\*8_!OV^/S
M4C1/M/EG;\LH?[N?;'6NWJGJ^IP:+HU[JERKM!9P//((P"Q55). 2.<"@#!D
M\-:G#\06\1V%]:K;7-M';7EO/"S,51B048,,$YQR#5_Q9H,GB+0FLH+E;:Y2
M:*X@E=-ZB2-PZ[ER,@E<'ZU=T;58-<T6RU6U61;>\A6:,2 !@K#(R 3S5Z@#
MA&\'ZO<ZV^LZSJ=K<BYTZ;3[ZV@MG5! V"!#\Q.[(.2<YSTZ5P=Q<-J7ASPS
MH]MXLL=6CCU"TCLK.VMS'<LJ.,FX!8D!$!S\HYP2:]WJO'864-T]U%:0)</]
M^58P';ZG&30!D:1X=?3/%GB+6FN5D35FMRL07!C\J/8<GOGK638^%/$.DG^R
M]-UVVM]"%T;A!]F)NHT9][0JQ;;MR2,E<@&MO1O$]CKNJZQIUJDZS:3.(+@R
M* I8@GY<$Y''?%;5 '&7/A?Q!9ZCJK>'M9M+.RU67SYQ/;&22WE*A6>(A@.0
MH.&! -:=OX<D@\;/K[7?F*VEQV&QE^8E9&?>2..=W3%=!10!QJ>")5\%^(M!
M^W)OU:>[F6;RSB/SF) (SSC-+/X6UFPU./4_#VHV4-S)916=W'>0-)'+Y>=D
M@VL"&&YACH0?:NQHH Y=?"UX^J^&+^[U4W<^CI<">22(*UPTJ!<@#A0/3GC'
MUJ&_\%'4+OQ;(]Z$CU^QBM% 3)A*(Z[CSS]_...E==68VNVJ^)ET#9,;QK(W
MH8*-GEAPF,YSG)'&/QH Y^TM/%6DZ?X<L)+VVF:*[6"Y:TM"%>V6(XW%B=IR
MOWAC)( ZUV$T23PR0RJ&CD4JRGN#P15/1M4_MG3([W[!?6.\L/(OH?*E7!QR
MN3C.,CVJ_0!PFE^#/$6GQ:=H_P#PD:+H.G3+)$((6CNI8U.5A=PV-O0' Y Q
M5.\^'FM7.AZGX>37+:'1[B>6Y@VVQ,^]Y#($=MV"H<YX&3@=*]'HH XC5?#7
MBW5+.^TZ37=-:PU*+9<B6S9G@W(%<0_/C:<$C=D@GJ:UM%\,_P!C^(]6U-;@
M/#>P6L,<1'S((59<D]\[JZ&B@##\): _AK0_[.DN%G;[1/-O5=H_>2,^,>V[
M%9^O>%]4O?%MCXBTK4H+:XL[.2W6*>$R)*68$[L$'& >G.<'M@]97/7/B^VL
MO#VJZU>Z=J=K;:;(Z2)/ $>4+CYXP3AE.>#D9P: ,!OA_J,]C>7D^JV[>(;G
M4H-2\\0'R%>' CCV;LE H(SG/.:E/@[Q))K=SK#^(H(;Z\L?LLK06I @*L6C
M\H%CP"?F#9SD],C'9:?>Q:EIMK?P!A%<PI,@<8(5@",^^#575M<M=&GTV*Y6
M5FU&[6SA\M00'*LP+9(P,*?6@#G5\&ZEK-]=7?BF]L9C+ILNFI'I\#1#RY""
MS,69B6^48'0<U;T31?%%K<V4>JZ]:SV%E&8U2WM2DEU\NT&4LQ P.<+C)_*N
MGED6&%Y6SM12QQZ"LOPQXCLO%GAZUUO3TF2UN=VQ9U"N-K%3D D=5/>@#B;C
MX;Z])X2N_"$&OVD6@MO^SG[*QN%4MO6-FW8*@GJ!D@8XKTJ)/+A1"<E5 S3Z
M@DO+:&[@M))XUN)PQBB+89PN-Q [XR,_6@#@D\"^)++3=9TS3M?LDLM8NKB:
M<S6C-) )6.?+(8#.TXY'7GOBM&?P9>:9J&G:CX7O;:VN+33UTUXKV)I(IH$Y
M3.T@AE.>>^:[.B@#A&^'T\WAZ[M;C4TEU._U.+4KNZ\G:A9'1MBKGA0J!1DG
MUK?U'0'OO%VB:V+A4338KF-HBN3)YH0 @]L;?UJ74_$FFZ7HFI:L\IGM]-W"
MY6WPS*R@$KC(^;D<9K4AE6:&.5<[74,,]<$4 >:2_#?7Y/"$WA$:_9IHJ,3;
M,MJWGE?,WJDC;L8!]!DX'3FM[7_#WB74VU.RM-:LAI.IH8Y([NT:22V4IM81
MD, 0>H##@FNPHH AL[5+*RM[2(L8X(UC4L<G"C S^5>3>%M \0ZQX0U>PT_6
M+2VT[4=1O8K@36S/+$IE96\LA@.1ZC@DG/IV-[\2_#%E>7%M]JN;DVS%;B2T
MLY9XX2.H9T4CCOSQ70:/=Z9?Z7#>:/);R64^9$>W "L2>3QWSG/?.<T <\_@
MA4\8^'=9M;E8[31K%[-;<IEF4KM!W9XP,=JQ9/AYKK^'#X>37;2/3;6X^T6.
MVU;S&82^:HF.[!4'(^4 G@YXP?2:* ,#0] N-,U[7-5N+F*5]5>W<I&A4(8X
M5C/4G@D9%9&FZ'K'A70?#&BV%YYRQ7S+>.EOE9(6\QSDG.P#(Y[G [UVU% $
M-W;17MG/:3KNAGC:.1?56&"/R-<KH?AWQ/IC:=87&OVTFD:< L8BM2MQ<(JE
M425BQ7 &,E0"<#I7844 >5^(_"6MZ'X(\46-GK%JOA]H+N\6(VY^T(&5I#$'
MW;=A;/)&<$CWK5M?#FKR'P_XBT*_LX+H:+%8SQ7L#21O'\K@C:RD,#GZYKO9
M(XYHGBE17C=2K(PR&!Z@CN*$18T5$4*BC"JHP /04 >=WGPSN[OP+XB\/R:R
MLEQK&H?;C=O#]TEHV(*@^L9Z=,CTK8U?PMJ<WB31-<TF_M8;BPMWM)8[F%G6
M2-MN2-K @_+7744 >5ZQ8:=XN^+FE?V5>+<P6D EUGR&#Q'RWW6Z,1QNWY..
MN!7JE0V]I;6BLMM;Q0AV+,(T"[CZG'>IJ //;_P#K%W9:_HT6M6\&C:M//='
M;;$W"R2<E=V[;LW<],D<9'6I]:\ W>O7?AZ[N]1@CFL56+4%BA(2[C62.0(,
MG*C=&/7J:[NB@#CKGP.;CXD0>)_MH%JB*[V93.^=4>-9,Y[(^.G85GWW@'6+
MJTU_1XM:MX-&U>>:Z;%L3<*\@R5W;MNS=STR1QD=:]!HH Y71O"]]9^*AKU]
M>V\LS:5'821PQ%5+(Y;<,D\'/2J,G@[6[74-:CTC6;6VTG69FN+A);8O-#(Z
MA9#$P8#YL9^8'![&NXHH Q_"NBOX<\*Z;H\DZSO9P+$957:&QWQVK8HHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ KFO'-W':^'U$FKW.F+-<Q1%[.)I+B;)YBB"\AV (! ..372
MU@^*= N-<M["2QO([2^T^\6[MY)8O,0L%92K+D$@ACT(- 'F[^*=2T31/&L5
MA/JZK9PV;67]L!C/ \[&-CE\DJ" PSGO6YJ.F:EX7\3>$(+;Q%JUU:7E\8KN
M.\N3(9&$3D$$\@'G*],A< 8Y76/!$R67B/4-:UA[NWU/3U6_6WLSO5XBS(\(
M#'"J"/E().W.<DUB6]X_B'QEX-V>*K7Q!/;3/.PL8!&D$(B8%Y0&;#LQ0<XQ
MR .30!H>'9M2F;Q;XCOM9U&:+0]3OTM+$3D1,J*3AQ_$.0 .@QQUJAX?UC4_
M/\-W]M+XLO+Z\GB&IK=V<WV-HY1\S)E=B!"005QP.<YKT'0/"D>CV>N6MQ.+
MJ+5M0N+QUV;=JRXRG4YP!UX^E4=$\+^(-+;3K*;Q(LNCZ=Q#%':[)YD *HDK
M[B" ,=%&<"@#S^+Q-JE]I;^(;1_%D^M&[:2&V@M)WL3"LI7RL!=A&P<MUW=^
M*Z5;'4/$GC/QI9S:]JMI9V+V_P!EBL[EHMCM;JQ.1SC/.WH223GC&O:^#];T
MUVT_3?$26NA&Z-R(5M<W$89][1+)NP$))Y*D@'%:VF^'#I^O^(=4^U!QJ[PL
M(]F/*V1"/KGG.,]J /-8+K6O^%=^'O&LWB#4I-3>XM5DB$Q6WDC:41E6C'!)
M')8\YSTX NZUK4VJ>*?$4$MUXHA_L]UMK!=&MYGB1_+5R\GE@AR6;[K<8'3F
MNF'@%A\.]-\*?VB,V4D#_:?)^_Y<HD^[NXSC'6I[_P +ZS%K6HW_ (>UN#3U
MU0)]KCGM/.VR*NP21D,N&V@#!R. : .;M+G7/$WBG0K'4+[4=+6X\._:K^V@
M9H',HE53CNAR>HP<<=ZY[Q.MY+\-O%FGW.JZA<+H^MQV]O))<$N\3/"0LA_C
MQO.,]P/2O4K;PR]OXKM-;:_DG-OI7]G%95R\AWJWF,V>OR\C'>LC4_AZ=2T+
MQ1IW]I>6VM7RWJ2"'/D,OEX!&?FYC]NM '7:?9#3K"*T6XN;@1@CS;F4R2-S
MGECR>M>6VJ:MKGP[U#QS_P )!JEOJ>RYO+6&*X*V\*1,^R,Q?=8$)R2">:]1
MTN._ATZ)-4N8+F\&?,E@B,2-R<84DXXP.M<7)X U:/2[WP]8^((K?PY>22,T
M)M-UQ%'(Q9XDDW[=IRW)4D9[T 93W.I^+_'FEV0UC4--TZ\\,PZC/%93F-MY
ME_A/\)^89(YPN.]=YXF755\)ZDNAECJ8MF%L<C<7QQC/&?3/>JEMX4CL_&D.
MNP3A((=(72X[4)]T"3>&W9].,8_&M;5K*;4-*N;2VO9;&>1,1W,0RT;=0<'K
M].XH X#P]J%H8-9&GZ]KOVJ'3G>?2]9+_:(9 .)5+\@=0=N5R1TK&T[5]<O_
M (=_#UUUF\BN]1U/R+FZ$A,CH?.SDGJ< 8SD9 ]*[6W\)ZO=ZA<:CKNKVMS=
M'3Y;"W%I:&%$60@L[9=BQRJ\9 '/K5?3?AZVG^'O"FE'4PYT&]^U&3R,>?\
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M44 %%%% !1110 4444 %(0&!! (/!![TM% $<,$-NFR")(DSG:BA1^E2444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% ",H92K $$8(/>D1$BC5(U5$4855& !Z"G44
M %%%% $<L$4VWS8DDVG<NY0<'U'O4E%% !1110 4444 %%%% !1110 4444
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M,@)5XEVY;=T_B%8?BOQ]::#HFOW%K%+<WND[8WC$+,BR.F]-Q'\&",GWQUH
M[&BJ&C:HNL:5!?+!<0"0<I<0M$X/?Y6YQZ>M7Z "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "N%UG]U\9O##R_<FTZ\CAS_ST!1C^.VNZKGO%GAZ77;2T
MGL9TM]6TZX6ZLIW!VAQP5;'.QE)4X]<]J .>T[5].\/?$;QE_;5[;V7VI;6Y
MMWN9 @EA6+8=N>NU@PP/6J?CJ\L=2^$MC)I5FUI%?7=F+& Q"(@F=2N%' R
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MTO3[Z.*.[L;:X2(YC6:%7"'V!'%.?3[*2"2%[.W:*5M\B-$I5V]2,<G@<^U
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MW]DMY9;1E$[%"P:,=64A2 0.3@ <UYKXCOK?5/"'Q2O+5M]O+>6AC?'#KMA
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MTVG1>==0ZA"872+!/F8[KP>1Z5Y;IUY:Z=X=\!W=X0MM#X@O6=R.$&^?YCZ
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M?V9+$  #RK8\>OVE#0!Z#K'C?3-&U">S>WU"[>UC$MVUG;-*MJAY!D(Z< G
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MS*03TR,@X(STKD?%OQ$2_P#"#W&D0:Q9I/=6Z6FHM%Y<=P//0,$8'< 5#?>
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M>M>W1PQ1%C'&B;CEMJ@9/J:000AG811AGQN.T9;Z^M &7XL_Y$W7/^P?<?\
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ML)%BN5V$;&*A@,D8/!'2L_PMX<?0;>\FN[S[=JFH3FXO+K9L#M@ *J\X50
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MD1L HXPO&<FNZ\$ZO=Z[X.T[4;]"MW(C++^[*;F5BI;:>1G;G'O0!O$@ DD
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M>D6NIV3,UK=1B6)F7:2IZ<=JNUROPS_Y)GX<_P"O&/\ E754 %%%% !1110
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M5T2W,OVS2_*^T;DPO[Q=RX/?BIM6UJTT7[#]K+_Z;=QV<.Q<_O'SMSZ#@\T
M<F_@&\;X57WA+[9!]IN'F99\'8-\YD&>_0XJ_?\ A[7+'Q1>:[X<N=/WZA#'
M%>6]^K[2T>0DBLG.<'!'?'6NNHH \_D^'U_;^'K!;+4H'URUU8ZQ)<3QD13S
MMNWJ0#E5(; QSP*D'@[7+W5]7U75-0LFN-0T9]-$5NC".$DDC&>2.<DGG)/&
M*[RB@#D+WPA<W7A+PYHZW,0ETJ>REDD(.UQ!MW ?7'%0?\(KK]IXL\0W^FZG
M:6]GK4:%I&B+3VTJ1;%*@_*PS@G/;CWKMJSM&UJTUVVGN+,N4AN9;9]ZX.^-
MBK?AD4 8.FZ!K]SXHLM:\03:6)+"WEAA&GQN#*9-N2Y;H!MX49Y/6NOK/N-6
MCMM9L],:UO'DNE=EFC@+1)M&<._12>V>M:% 'EVBV_B5O$WC>30+K3T\S4Q&
MZ7R.1&PA3#J5ZGGD'@X'(YSH6?@35/#AT.7P[>6,DUAI\EA-]O1]KAW$AD7:
M<AMX/'<'&:[N&TMK:2:2"WBB>=]\K(@4R-C&6(ZG  R?2E>ZMTNH[9YXUN)5
M9XXBP#.JXW$#J0-PS]10!P2Z);>&/"7B6P\5:O:2:7J$D\_VA_DE8R+F3*GC
M=NY4+4/@?PE=W/PKN[;5II$U/7[9S<S.OSH&C\N,$>R!>/4FN]OM/T^^$;W]
MG:W @;S(VGB5_+/]X9'!]ZGM[B&ZMXKBWE2:"50\<D;!E=2,@@C@@CO0!PB>
M%?%<U[X>OKS4-)$NBR;8[>".01R1F,QNQ)YWX(P ,#GKGBE!X%\5VGA:]\-6
M^K:9_9^H23F>9XG,L"2NQ98P.&RI[XP2>O%>F5%<75O:1B2YGCA0NJ!I&"@L
MQ 49/<D@ =R: .4;P6\?CS0]<MIXTL=+TYK$0,#O/4 @].F*@TOPUXHT6.+1
MM.U6PBT.&Y,D<IA9KI82^\PX/R=RN[T[9KIH]:M)?$,^B*7^V06R7+Y7Y=C,
M5'/KE36C0 5RGBSP[JVI:YH&M:+<6<=YI+SXCO%8QR+*@4_=YR,<5U=8^O\
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MP&GNOERWEO9,EY(G0C)8HI(XW 5>OO"5]9ZO8:OX:N[>WNK:Q&G20WR-+'-
M#E<D$,&4YYYSF@#D-3\0^(--T#7=*CU662^TG6K2VM[V4#>\,K1LJR8P&(#$
M$\9%:5QIVLV?Q M/#\7BK5GL=2L)+BY>5T,J-&P'[IMN$SN&0!TSC'!%^3X?
M75QH-W#<ZE%+JM_JD.HW=R(BJ$QNI$:+DD*%0 9)/>N@N= DG\;V'B 3J([6
MRFM3%MY8NRG.?;;^M 'G=WKGB#3_  AKUG;ZQ<2WFF^(H;&UNYR&<Q,T1"N1
MC=]\@^HK<NYM1\%>,=(C?6]1U2QU.WNO/BO75MDD,?F!DPHVY (P.*SO&_AJ
M73/#.M,UY_R%_$%K<HT:X:$,\2=^I&W-=+;^%M8U#Q-::KXDO[&YCT^"6&U@
MLX&C#&4!7=]S'G:,8''/6@#B-$\6WLR:#JT6KZ[>ZG?7,/VZQ>PE%F(93AA&
M?+"KL# A@W.T\G-:L,6MZ]:>,KM_$NI6BZ7J-U%8QVKJH78@8;\@EEY "].O
MKQT&B>&O$VCKI^E+KMK_ &'I[CRREL?M,L2_=B=B2H & 2!D@=JNZ7X7ET_3
MO$ELURCG5[VXND8*1Y8E15 /KC% '%WWB*]N[#PWJ6N:GJ^EZ-=Z/%/)>Z7'
M\HNVP6\TJK%5P01QCDYZ5IZQJ"FVT"WN_&-],DMHTA_L.U9KB^/RA9?W8?:@
M&<XP"3^%:=KX<\4:+I6E6>C:OI[I:Z?%9307MNS1ED&/-3:P()Z$'(P!TJG8
M^ ]7\/SZ;/H.JV8FAT\V%PUY;,RD&0R[T56&"&9OE)QC'I0!R&HW-]XC\*^#
M)[O5=168>)A8-(,1.ZK)(JR,I7B0!!VX.<BNM&JW]E\9;?1&U"YETV+P[Y[1
MR,#OD64KO/'+$"H6^'6KQ:##I]MK%L\UAK0U:QFGA8[CN9BLN#SRYY7%;4'A
M.];X@VWBJ\N[=G72!830Q1L TF_<67).%YZ')H Y".X\07GPUF\?#Q#?Q:EY
M,E_'9JR_9%C5B1$8\<C8,9SG)SFM:*;4_%7CF^L5UJ_L-+_LNTNQ%:.$D#OO
MZ,0<#UQR<#MD%W_" ZY'H$OA*#6;1/#4C,H)MV-VD#-N,0;=M[E=Q&<'I73:
M=X<.G^+K_6$E06]S96]K' %.4\HMSGT^8?E0!2^'>H7U_P"&YH]1NGN[BRO[
MFR^T2 ;I5CD*J6QWQBNIE,@A<Q &3:=@;H3VS7%IHNL^&=#:'3+L27%UKWVE
M]D&_]S-."ZG.<85B2W;%=I,AEADC61HRRE0Z]5SW&>] 'F?@C4YKG6;&#4/$
MVJQ:_P"6QU+1]3B"K*=ISY P  &Y!4G*CD<YKFM*@U;2O@M'XGM-?OH)[$R2
MV]I$RBWV"X8%77&7+?,<D\9&.G/H%KX9\176JZ/-K^JZ?=6^D2&6&2WMF2>=
M]C(#(2Q X8DA1R<5&/ =P/A3+X.^W1^<\<B?:=AVC=*7Z=>^* ,[QCJ0.M7<
M7_"2:S#-!9K)!8Z-:O(87(8^9.51@0?EP#@8!XYS6/J>ISZSK7PAU.ZQ]HNQ
M)-*5& 6:&,G ^M=;=>$M9&O:O/I^J6L&GZRL0O-\#-/&4C$9\ILX&5 Y(.#S
M@U1M?A]J*'P4;G4K5_\ A&FD7,<3#SHRJJO4G#87F@"'P=_R67XA?2Q_]%&K
MGQ3CN);'PU':3""X?Q!:+'*5#>63O&[!X..N/:M31/"LND^./$GB![I)(]7^
MS[(0I!C\M-IR>^:D\9^&;CQ/9:;#:WXLI;/4(KU9MF\@H&Q@?4C\J .7U#4M
M1\!>([B$ZK?:K8SZ-=7R1W[B1HYH &X8 85@>GK6;X?\1W:ZEX=FM]8U_4[F
M_E6/5+>ZL)4MU#H3OC)C"H%?:!@\@UU4/@_4=5UJYU+Q3>6=QNT^33H;>RB:
M-%CD_P!8Q+$G<0 /0#UJ;0]"\4Z?)IUI>Z[:2:7IZ[%\BV*S72A=JB4L2!@8
M)VCDCM0!I>,9=5A\):C)HBRMJ"QCRA$H9\;AN* \%MNX@>N*\\O=>%MX%\3W
MV@>+M2NY+:U0FVU!<75G-NY;)"D CC!!&1P:]0UFTO;[2IH-.OS8WAVM%<;
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M"ME\1M?CU*^N9]/O)8XX[B0,CMY<85W&!DC(';@5[';QO#;1123/,Z(%:5P
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M%+#1K]'M[2";:KGRU8J_JG'W>!\Q]J /2JK?;[9GNXXI5FFM /.AB.YU)7<
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MQCKLEBVOZK8Z]K]U?Z?/F);."06%MMVYAEXV.>NXDYY[8K7&C2ZY\6/$L/\
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M[)=0 1Z&NY\3:&GB3PUJ&CR3-"MW"8Q*HSL/4''?! XK31$C14155%& JC
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M 4444 %%%% !36C1V5F169?NDC)'TIU% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !37CCD*ET5BIR,C
M.#3J* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHKDO&NK7L=QI'AW29S;ZCK,[)]H4<P0(-TKC/\ %C 'NWM0!UM%<UJO
MC+2] NFT]XM1O);6%9;DVMN\_P!GC/1I&'3(!/<X!.*S]<UR;2-:T#7K:]:X
MT#57CLIX\Y1#)S#.GIS\I[8([T =K1110 4444 %%%9'B?6_^$=\-:AJWV>6
M<VL+2!(T+G('!('1?4]ADT :]%>87'CV>9/ ^J3+>V4%Y+(+R#[.Z^>WV;<
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M(B*OR%%"L,;02.XKK)[>"ZA:&XACFB;[R2*&4_4&EAABMX5AAC2*)!A410H
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MQFHO#RC_ (1KXAG YU;4<^_[M: .FU#QGIUFNGBV@O-3FU"#[3;P6$/F.T.
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M#3/(8[!\RAA(>"N>,<X H [G6O%MGHVJ6^EK9W^H:A-$9_LUC")&2('&]LD
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M^?=6EU $F$>"0RC)# X/0UYAHVK6-AIW@.2\F(%CK6HK=K,09+<DRG,H'W2
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M7!"[L*V<\@$C( /;-9WB/X@6<>E^((+&#4V^Q0S0/J4$!,$,X0X7?G.0Q )
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MVL=_G[#=7=L8X;K S\C9SR.1N R.E<+/97.I>,_BY96:EKF?3+>.-5ZLQMR
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M5+FTO$59$W#<I^4D$$="#VJ;7_$-OX?BMO,MKJ[N;N7R;:UM$#22M@L<9(
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M]TD<CZ5QEK\3-+NAIMQ_9NK0Z;J+I%!J,L"B#S'Z*3NW#GY<XVY[XYJQJWQ
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M&"YMKE-DL,@P=K#)'0@@@D'/6F:_XFM= :T@:UN[V]O&9;:SLT#2R;1ECR0
M ,9)(ZB@#8:-'*ET5BIR,C.#ZT&-"X<HI<<!L<BN6'Q"T?\ L*34I(;V.6.[
M%BU@T/\ I/V@](@@."Q!R,'&.<U+I_C6TN[F]L[K3M0TV_M+8W;6MY&H>2$?
MQH59E89XZ\&@#I!&BNSA%#M]Y@.3]::EO!'*\L<,:22??=5 +?4]ZXE?BKHQ
MM;"_DT[5H=*OMJQ:@]L/*WD9V'#%LY!7@$9& 36EI_CBTO+^^L+G3-3TZ\M+
M0WODWD2JTL(.-R;6(Z\8.#S0!T@MX!.9Q#&)B,&3:-Q'IGK3E1%+%5 +')('
M4UQ5K\3]*NH-/O?[-U:+2[YXXX]1EMU$"N_ 5CNR/F^4G&W/>LQ?$%WI_P 6
MO%7GS7MQI]AH\=RMG$Y8 C!8HA(&XC/UH ]*J%+2VCC\M+>)4W;]H0 ;O7'K
M6/>>+]*L_!@\5.\CZ:UNDZ[%!=@^-J@9^\20,9ZUIW-\+729=0DMYB(H#,T*
M@&3A<E0,XW=NO7O0!QNJ^#?$FK0WVDW.OVCZ/>R'S96LS]L$);)A#A@N.VXK
MG%=TD,<>W8B@JNP''(7TKF-4^(.B:3X5TSQ%/]H:RU$Q^2(T!<;T+Y89X"@$
MGGC%7]6\165CJEOH\HN6N+NUGN T '[N.,#+$YXSD 8SS0!KR6\$LB220QN\
M9RC,H)4^Q[436\-PH6>&.50<@.H8 ^O->8'QZND> O#%[H=OK.I6^HWRVZSW
MQ66<KYQ#*QW#+MA@G;CDC%7/^$MNK3XB:A$;'5[H2Z3:S0Z7"H9XF+/O)4L$
M4CY03GK@<T >AS6\%RFR>&.5,YVNH89_&I    !@#M65X>U^S\2Z/'J5DLT<
M;.T;Q3IMDB=6*LK#L017/ZAXTO+3XEVGAN/2+V:V>T:622.-3N)9 '!+#Y%R
MP;C.>@- '8RP0S;?-B23:=R[U!P?44CVT$DR3/#&TJ?==E!9?H>U>8^'_B =
M*TC6)M0L]9U**SU2\%Q=0H)$M8Q*VT$LP. N#A<X&.G%=AJGC&TL+NWM+.PO
M]6NI[?[4(;"-6*0DX#L690 3P!G)P>* .CHJCH^K6FNZ3;:G8N7MKA=REEVD
M<X(([$$$$>HJ]0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !7%?$D/!8:%JK([VFEZS;W=WL4L4B 9
M2^!R0NX'Z"NUHH \P\9Z]:>-O"?B+3?#<+:D;>UBF>[MP&C<K*KF%3U9MJDX
M&>N.M2:WXBTKQIJWA&S\/7D=[/%JD6H3B+DV\,:/N\S^X26"X.#DUZ2B)&NU
M%55]%&!0L:(6*HJECDD#&: /)K=0/A5\1^.M_JQ_4UJ:R $^&@ P!>Q?^DSU
MZ/@>E&!0!X[H_BS1-&\.^.++4+E(+J35M2,,#C#76YBH"#^(Y^7 Z=ZC@L;C
M3/&/PBLKM&2X@TVX25#U5A;C(/TZ?A7I'AKPZ=!@U".65+@W6I7%\I"8V"5]
MP7ZCUK>P,YH \=\76][I/BG5?#-@KK!XT\LPN@XAD!"71_&+YC7KEK;0V5G#
M:6Z".""-8XT'1548 _(5SNG^&;]_%7]OZYJ4-Y/;QO#8000&..W1C\S<L2SD
M  GC@=*ZB@#R'5+>2'XER^$E1OLFLZG:ZR1CY=D:,TP/UD@C_P"^J/#%O)<?
M$*#PTZ,+;PO<WMV 1P1,08!^"ROC_=KU['.:,#.: /#K.*27P5\74C1G<ZI>
M$*HR3CFNBM=4T_6?%/PYN=/NHKJ%+6]C+QG(5Q!'D>Q&:]/P/2FJBH %4*!T
M &* .-\._P#)4O&__7+3O_1<E,\?:O)I^H:#:3ZQ)HVDWDLPO+^,JA4JF4CW
ML"$W'//7Y<5V^*:R*Z[74,/0C- '@TMS:-HWB>T2ZN9W?7M/N(_MK9FEA9H
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M%S+ECZ"N_P!"NK;4/BMK%[:2I/;S:-9O%*ARK*7DY!]*[HJK*5*@J>H(XH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "C SG%%% !1110!
M',LC02"%UCE92$=EW -C@D<9^E8'AWPS/I>HWVKZIJ/]I:O>A4><0B)(XESM
MC1,G R23R<DUT=% %0Z=;MJZZHP8W*0&W0EN%0L&; ]257/^Z*MT44 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MNR2;*R!K4GYACG'0>@%>Q5Q$O@S5%UWQ-/;:E:KIVOPE9HI(&,L<GDF,%6#
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MFR2/&1U&,>F* .+7Q-JTFB:)-J6HZI;0^)+^YO";.)Y9X+15S'%&%!(S\A+
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MV)B0 <?C5;P+J'GZO:07/B/64UD6['4=(U>,CS'P,M%D * V?N9!7MWKH/\
MA#IO^$\U7Q&NHF(7VFBQ5(TP\3 @[PQXSQZ5'8>&M?GUS2K[Q!JUC=)I(D-N
M;6U:.29G0H6D)8@<$\* ,_2@"AX^U#^R_%_@J\^QW=WY=S=?N+2/S)6S 1PN
M1GKGZ U U[>ZMXMC\5#0K_3;'1M,N0[W\8BDN6;:P0*"3M&PG)[FNJU;07U/
MQ'H&J+<+&NE2S2-&5R9-\13 /;&<ULS0QW$$D$JAHY%*.I[@C!% 'DL\NNZ?
M\-;?Q\WB'49=3\F*_EM6D'V5XW928A%C &UL9'.1G-:=@P;]H?4&'0^'4/\
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MG)YSVKH?#5EJFG:';V>K7-K<7$"B-9+:)HU** !D$GGCD\#VH \PDN/$%_\
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M8TQ+<NH4R-W.!P!Z#T]:N4 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M5=/&<$,T$SZ+;QW-I<3VK)YBM$SX=,KGE" PP""#SW ._1%C1410J* %51@
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MT1EE8*ISQ@DDGG/M0!W1..M%<3\2)M0AM_#JV-[]F2?7+.&5?+W;P9 1GD<
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M.0#M**S?#]YJ&H:!976JV)L=0DC_ ']MG.QQP<<G@XR/8UI4 %%%% !1110
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MSR229O\ A$[B3Q+K>J3W\30:K9)9M D!#1JH8 AMQR?G/;TK7T/7;'Q%IO\
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MB@ HHHH *XGXJ27D/@PO9WKVV;RVCDV*#O5ID4J2>@Y[=>G3-=M6)XL\/?\
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MV?1;G41IFHI?*MO97, $=W:[ERT;D?,Y7=T/!XV]Z[R.-(8DBC4)&BA551@
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M1N6FDU-=,F.,>9'.I!S_ ,"16^HJ[JO@^XU'3]*5=8==1T^^6_\ MDT <2R
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MAF2-, ! >-Q8]2"  >.>.:U+QCKNF6/C+3VFMFU+0K=;NWNW@RL\+J6&Y00
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M/3X3(3&(X?D:11T^9]W/M6!XY@T[3?!-IX+LKRXNO$),+::A<O<&429$Q/\
M" 0Y+= ,BN_\/Z/#X?\ #]AI-OS':0+$&_O$#EC[DY/XT <C]D?Q?X_\16-_
M?W\5AHZ6T-O;VEV]N"\D?F-(Q0@L>0!DXX/%<%XS-QJGPAU!M1OKRYNM%UB3
M3DF,[ 3HLZ@-(H.';&.2,Y&>IKU/4O"NH?\ "0W.MZ!K2Z9<WL*17B2VHN(Y
M=F0C@;E(8 D=2",<51U'X;6U[X ;PM'J,L9EG%S->R1AWEE\SS&8C(')_(4
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MN)VE;)4'&6)./0=JV*R_#VGW^E:-!9:CJ*:A-$ @G2W$(*@  ;<GGCKFM2@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%,EEC@A>::1(XD!9W<X"@=22>@H ?134=)8UDC971
M@&5E.00>A!IC7,"7$=N\T:S2 E(RP#,!U('4XH EHHHH **** "BBFNZ11M)
M(RHB@LS,<  =230 ZBFQ2QS1)+$ZR1NH9'0Y# ]"#W%.H ***1F"C+$ >I-
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M0 4444 %%%1SSPVL#SW$J11(,M)(P55'N3TH DHH!!&0<@T4 %%%% !1110
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MN)_+3;)'D\9PS8SQD"LV3P_)=^'?$0\->"U\/SS67DV\CB."XN&)RZ80D*N
M "3U- &S8>)O$:ZY#HVJ0:-]LOK.:>T-K*[+%+'MS'*#SCYA\P]#Q6!X2\8>
M(+7X?)JFHBUOKF^U![73U:9PS3/<.I$C-G:BXXQ_"N*ETK1VMO&?A_5M*\$2
M:/ID,<UK,!%"DY9U7#R!6Y0;<9))Y)QTSFV?A?5[CX?Q^'[SPY-+<:-JAOO*
MG,?D7Z><[%$;=U*.?O #.* .GN/'.IZ%#K4&N6EE/>V.G_VA UA(WE31[BA!
MW9*E6QD\\'-27.L^,8_#FK7,D&BR;+!KJUOK.=VAR/O(0?F)VY*L.#CG%5M(
MT];6+5KW0?AY;Z:1:B.*.Z6.&6[).7C(4L N ,%CR?;FJ&E^'9I[W6VT/P[>
MZ!IMWI,UO+:73*B373?<9(U=@H W MP#D<4 =3\.KC5KOP)I%QK$L,LLMK$\
M<B.[.Z&-2#(6ZN3G/:HM6\1:S+XDN-$\/PZ;YME;I/=3:A(P7+EMD:A><D*2
M3T''!J7X>M>Q^"]-L-0TJ[T^YL+>.U=;D+^\*( 67:QROUQ7/>)/#5M%XWO=
M8U#PB?$=E?VL2)Y44<DEO-'N&-KL/E92O(Z%>: -%?'TW]E:%KLUBD6C7KFV
MOW+$O93;B@)/0IO!4GC'![UFZ_XOUO4_ OBG6-&CM[?3;=)(K*[=G$DZJ"LD
MJ$=,-]P]\9JQ>:'J6IZ!H_A2#1(M&TRZ4RZL+9U,<$6[<8$(QEW)P2!@#/6J
M[^']>B\">)?!8MGN(8;5X]'NBRXFB8?+$W/#I]W)P",4 78?$?B*"QT#2%CT
MR36K^V:X::623R8H$5?G?^)G)8# [YYJ.Y^(.HVNB)(VF6\NJPZU'I%Q;Q2G
M8[/@JT;'LP92,],G/2LJ^T:35E\.:WJ?@VZOH+*T>PN]-N(XFF7A"LJ*6PP#
M*1U!PV<5;E\.SS:)HYTWPI%HRKXCMKMK2+8'$"-_K) O ;'4 G Q0!K6WB+Q
M/%XCN/#^HVNDB]ET][VRF@>3RLJX4I)D9_B!R/RIGPFU#6]5\"65]K$T,XF#
M-#*'=I6'F/G?N]. ,=JO7>EWLOQ/L=36!C91Z1/;O-D8$C2(0OKT!_*J?PKM
M]2TOP;;Z%JFE75E<Z;NC:2788YLNYS&58D@#&<@=>] %CQ!XEUBT\86'AW2+
M&TFEO;.2<37+LJQ%&49;;R1@G@<Y(Y S6>OC^^LM+UN'5-/MSKNEW<-H(+>4
MB*X>?;Y+ L,J#NYSG&#47B2]N]/^+>C7-I837P32+CS88"OF%/,3E0Q )!V\
M9'&>_%9=[X2U;Q)I_B?6)](\JXU"^M+FUTR[9<RQ6P4;9,$@%QO&">,C- '0
MQ>+-9T^[U#3M:@TU[R/39=1M9;%W,4@CX9&#<@@E>>X/;%9@\>^(XOA[/XRN
MM+T^.S-M!);6ZN[2LS.JN6[!3N)4 YZ9IVG:):S0:PVD^ ET,-ILL*331QQS
MRRL"-BJA/R].21SCBC4_#VK3_ BVT*.R=M42QM(VMP1N#(\989SC@ _E0!9N
MO%7B^P\1Z?H]SI.E-+K$4K6/ESOBW:/:S"8D<@*V<J.2,=\U!=>+KYO"GC*'
M7=+TZ>^T-=LT"[GMKE&C#KD-S@@\@UN:YIE[=?$+PGJ$-NSVEFEZ+B4$8C+Q
MH%S]2#7.:WX<U>Y@^):PV,CG58X!98(_?%;=5..?4$<T 5]0UOQ%)J'PZ31$
MT^SMM1M3,MJ6D2/<+8L48+_RS4,-H]0/05:TCQ#K]KXY\:RZK-:-I.DQQ231
MH\A,:>0TB^6#QDC[V<<]*9>Z5K&F6WPYU%-'NKTZ+;F*]MK8H94+VPCX#, <
M,#GFGR:+J<_B[QM83:7=K9>)K2)(+Y=ABAVVQC82?-D'=P, _ES0!HZ;XOUU
M;O19M:LM-BT_6G$<"VTS-+;.R%T63/#9"D$C&#7/>)?$_B#Q#\-_$6KV]A8?
MV!+#<00KYC_:6C4M'YO3;C()V^G?UM^%= MH+[2(3\.8+"^M /MNHRI$J(RK
M]Z%E)+EFP>@P"<UG-I_B;3_AKJG@6W\.7<]TB7,4%Z'C%O+"SLX.=V=Y#;=N
M.N,D#. #U31O^0'I_P#U[1_^@BO,?#VI>)[.+QC-H=AITMO9ZY>RR?:Y'#SD
M$$I&%&!P!R>YQCC->H:7$\.DV<4BE9$@164]B% (KSJP?Q)X>M?%=H/#%]>-
MJ6J7<]A) T>T^9POF98%1T.>>">F* -W1?')U7Q#IEH]LD5CJ^E+?V$N3N+C
M'F1-VRH(/':M+0O$-QK?B'7[6.",:=IDZ6L<X)W2S;<R#T 7(%<;XFT2;PC\
M,/#]_&T;:GX7,$JG=@2YPDL8/HVXCWP*[+P1HLN@^$K*UNN;Z0&XO'/5IY#O
M<G\21] * '^(K_7+5[2#1;6S/FES/>7TA6&  # (7YB6)XQQP<US$WQ$U*/P
MYI]W%IEM/J4NMG1IH(YCY32#>-R/_=)53DC@$]<58\9Z9+<>+-*O;WP]/K^C
MQ6LT8LXEC<1W!92LC([!2-H89.<5Q=U8:QH.E:;:/H:VMROC&.[MH(V18)%=
M9&$<;#IC&WD #C\ #N$\6:[IFL7VDZ]::?\ :1ILNHV<UD[^7($X:-@W.02#
MD=16?#X\\21>'M(\4W^E:='H=X8%GC25S<1+(0HDZ;=NX@[>N".<YPW4(M2U
M_7-0UZXTB\TRPT_0[FVB%YL$DLLG+$*K-\H"]<\DUD62ZWXE^&'AOPLFA74:
MSPV32Z@63[.MLA20,#NW%B% V[1SGMR0#9T+CX\>+C_U#K;_ -!6J_ACQN$^
M&>E7^FZ%86MYJ-^;&SL+<>5 )6=AN.!P,*S' [>]:^DZ)J5O\7_$NKRVKKI]
MU8P1PSDC#LH&0.<\8KEO#WA#Q!IWPP\/*=-;^UM&U8WYL6=0TJ;W#*#G )5\
MC)[4 =Q;:QXKM8M4@U/0H+J[MK<3VDFGR$0W1.1Y>7Y5@0,]>#FJ%KXDUDZK
M<:%KL>EM+<:;-=0R:=*S!"F%:-PW?YP0>^#Q577KCQ7XK\.:[#::)/IUHUO&
MEO#<.L=U<-O!E'RN552@*C/))ZUF6FBS0^*['4])\$OI.F/87-DR)%#'-O;8
M0\JJWW?E(!R3D'CD9 *OA?Q1XA\._#'0M9ETZP/A^WAABF4R/]I\LL$,HXVX
MR<[?3N.VG!<Q6?QZ\074[;88?#Z2.WHH=2?T%9<>F^);WX7:?X$N/#EY!>2Q
MPP37A>,V\4(<,6)W9W!1C;CKTR*WI?"^H7OQ3\07<MN\>F7^@_8DN<C&\D C
M&<\#- $VG>--;8Z+J.IV.G1:1K,R0P)#,S7%N9 3$9,_*V> <8P6'6NRU?\
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M%S-'#!&I9Y)&"JH'4DG@"N5UKQBT>BZ!<Z(D-Q<ZY<016BRY*A'&]W8 @X5
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M6]37+:/JGB ?%'Q6M[=V7]E6$-NTD>),I$4D="@S@-_>..<<4 >CTA(52S$
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MI!I&U)1?NP>ZE*!RB8(V@ @;B#R>E '>450T358=<T*PU6W4K%>6Z3JIZJ&
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M<.I2[A1PX@D'8@ H21@@CWJU8^&X-8M]6M(? ]IX;M[G3I;3[2T4*SM)(,$
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M-+MGW7-IN#;&9@Y#?= ;Y1UXI/\ A)_&&I0>);C3%TB"#1+VX@7[1#(YN1&
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MKD>RU62X3R8HI)"Y\R,G>67<PP!@\<T 0V \1S?$'QO%H,FGVQ$]J[S7L;2
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MX;>!L3RG7/)YY8=*R?$/@^]U_P 3ZZS*(K&_\/+81W!8';-YCMRN<X&Y3TH
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M5[G'/6M ZMXOL?$5UH%Q=Z;>W5SI4M[831VK1!)D8+Y;*7.5.X<Y!H [ZBN
MN/'UQ-\,+#7M/AB;6+]HK2"W<';]K9]C*1G. 0Y^@KO(@ZPH)6#2!0&8# )[
MG':@!]%<%_:_BW6O%OB31M)NM-L;?2I(1'//;-*TA>)7V8# #G.6]","LQOB
M#KU]I'A.33K2SCU#5[F>RN8Y0Q2.6,,I88.=H9=V.21QUYH ]$FU6PM]2MM-
MFNX8[VZ#-! S8>0*,L0.^!5RN!N=:U;3?B#X0T&^-A=2WMO<M<W2VVUMR(2-
MG)V@\9'-5U\1>+-9TO5_$6CSZ;!IUC-.EM93VS.]VL)(9FD#C86*M@ ''&:
M/1JQ]=\,:5XE^S+JT,EQ% Q80^<ZQOD@_.BD!QE1PV?U-<A<^,]=UC7-!L/#
MHLX(M8TC[>);J,O]G.5.2 1NX)7'J0>@KT. 2K;QK.ZO*% =E& S8Y(';F@!
MX 50J@  8 ':EKR[2M2UG3O'WCN_O]2@ET[2XH99H5MB&:,0.Z!#OPI'<X.X
M^E6'\3>+=+\/:=XMU.;39-,NG@:XT^*W97MX9F4*5E+G<PW+D%0#STH ])ID
MLL<$+S2N$CC4L[,<!0.233Z\GM6UZ7Q=\14N=3MI+2UMXU>(6S LK6S,@4[S
MMQGG@[CZ4 >IVMU!>VD-W:RI-;S()(Y$.5=2,@@^A%2UY+H>L^)] \#^$-4D
MFT]M)E6RLVL1 WF")PJ"3S=W+<@[=N.<<XS5W5_'>H_;=>GT_6-"LX-&E:%+
M"](\Z]=%#/SO&P9)5< Y(YH ]-HJKIE_%JFE6>H0@B*Z@2= >NUE##^=<K<Z
MOXAUCQGJ>C:'=6-E;Z1#"T\ES;-,9I9065  R[5"@9/7F@#K+*_M-1A::SN(
MYXUD:)FC;(#J<,/J",58KRKPCJ&KVOPZFN+1]/L;F36;H7-Q>R#RK1#,^]N2
MN\@\ 9&<U3U[Q7J^I?#WQE;0:SIMW-I853J%E'E+F"1.0H#G8X)()!(XZ4 >
MPT5YS=^(]7TPZ)H$VNZ1:7MQ:/=SZE=0;(TB4JJ(L;2?,Y+=VZ*3BNA\$^(I
M?$6E7;7,EK-=6-Y)9RS6AS#,5P0Z<G *LIQDX.: .EJO%?VD]]<645Q&]U;!
M&FB5LM&&SM)';.#CZ5POQ.DUA+KPHFF:A#:I/K,,1#P%\OABI.&&5&#E>_'(
MQ5*SA\13?$OQ1;:9?65M/]CL#<WDUL9!N"/@+'N&-Q).2QP!CG.0 >GT5P%E
MXKUS5/ 5GJ22:587INWM;Z[N6Q;VZQNZ-(JEANR5&%S_ !>U<UXC\5ZOJ?PV
M\7PPZQIUS-I;I$^H6,>8[J"1 <+ASL<%L$Y(^4\<T >R450T6._BTBW34KJ&
MYNMN6EAA,2D=OE+-VQWK"\6:IJEC>6T5OK.CZ)8M$SO>ZCM8O(",1JA=>V23
MD]J .LHKS5/'FMW_ (?\)76GPV!O-8O);.;=N:(%!("ZD'.W*;L=QQGO3[GQ
M!XPTV;Q'H[3:??ZI8Z='J5E.EJT:R*68-&R;SS\A (/>@#T>BN*U?QG--X;\
M/76@")KW7IX(K82C<(U8;I&8 C.U0V?>NUH **\^T/Q+K^N:Q*]OJ&C[(+^2
MVN-%>,K<PPK(4\PONY; #8VX(.,UH:;XHO[OPWXLU"18?.TJ]OH+<!3@K"#L
MW<\GUZ4 =2;^T745T\W$8O'B,RP;OF* @%L>F2!^-6*\G%_K>L>./"UWI\EI
M!?W_ (8,DT\L1=(0SQNS! 1NYP ,CKGMS;N/'6MZ9IFKV.H26":IINI6]G+J
M!B86Z0S ,L[INR, \C=C..: /3:*X"^\4ZUH/AB:[N[[1M0>XNH;;3=0B/EP
M/YAP6E&XA0GS$D-R!VJK%\0)M'?6;?4-4TO6_L>EMJ4%SIX"!MIVM$ZAF .2
MF#GH?:@#TFBO-[G7?&FC1>&KG4;G3+B+6-0MK>>.&U:,VPDY*@ESO&,C/!!
MZYXW-&\1WU_8^*YIEA#:5J%Q;6^U2 4CC5EW<\G)/I0!UE%>9KX[U"_L_#=H
MNJ:3I%WJ&E+J5W>WBY10< )&A=<DL6ZG@+WI!X_UFZTO2%L%TV?4)M:DTBXD
M0EK=RJ,1*A!SM(V-C)XR/>@#TVBO.YM:\4V=[X@T"[U"PEO(-*&I6E]%9L@"
M[F5D:/>>?EX.>^>>E:?PN&HGX>Z/)J%Y%<^9:QM#LB*,B;1PQ+'<??CZ4 =C
M16!XLO\ 4K"QMSI]WIU@DDVVXO\ 4&'EV\>"<A2R[F)  &>]<;)\0M5A\&:O
M>P3:;J5]INJ0V2W-L/W%TCM'AAACM.)".I (_"@#U&BO/)]6\;67B^U\/2WF
MD3-J=K)/%<K:.HLRA&X;=_[P8( Y7DY/ Q4*^.M:T_0-8AO(K2[URRU9-)MG
M1#'%.\FSRW9<DCAR2 >U 'I-%<7;ZMXAT/Q9I.CZ[>66H6^KI*(9[>V,#0RQ
MKO*D%F#*5S@\'(K/'C?5?^%+-XNV6W]I"$OMV'R\B;9TSGI[T >B45Q%SK'B
M;4O&^J^'M)N+"S@M+6WN!=36[3,I??E=H90<X'.> #P<\<GKGB+Q'K?A7PS<
M+=VEG=GQ''I]T$@9D>5)B%<?,#L^3)7OGJ,4 >QU7AO[2>]N;.*XC>YM@AGB
M5LM'N!*Y';(!Q3[59TM(4NI4EN%11+)&FQ6;')"Y. 3VR<>M>;PQZ_<?%/QA
M;Z)=6EEF&Q>6YN(#-@B-MJJH9>N3DD\8Z<\ 'IM%>9CXB7\_A_2H9)=-T[6;
MN_GL+FXN3_H]N8-WF. 6&<X7:I(Y;KQ2K\0[VUTO6+;S]-U;5;.ZMK6TN;4[
M8+@W!Q&6 9MI!#;@#_#QC- 'I=%<3/K'BCPI:ZG>^(/L>IZ;;6#W275K%]G9
M95_Y8E"[$@]F'XU3?7O%NA0:+JVMW&FW%CJ-S#;W%K!;-&UIYO"E7+G> 2 <
M@>U 'H5%>;3>(_%^H+XLFTVXTRVAT*ZE2/SK9I#<!(U?8?G&WO\ -SG<.!CD
MC\6>)T@\+Z_<G3QI>N75O;&P2%O,A68$H_F[OF/0D;0.<<]: /2:*\NU3X@:
MBKZYJ-GJ^AV]MI%Q+"FEW)'GW@B_UAW;QM)(8* IS@9ZU=O/%NL:EXDN-/T;
M5-(T]HK6"XL[;4(B7U#S%W?*V]=JC[O 8YS0!U>K>%M)UV_M+O4H'N&M2&CB
M:9_*W Y!:,':Q!]0:V:9"TC01M*@20J"Z@Y"G'(SWKAY-8\5:OXUU_0=)N=/
MLK;34MW6YGMFF8F1-VS:&4<D'GL!T.<@ [NBO/[7Q=K6J^"[6]232M,O5O)+
M/4;J[;]Q;&-F5F52PW9(& 3_ !<]*S?^%@:M!X=U'4$N=-U./1-4BBO;JS3,
M=Q:,%)= &.UUW\\D?*: /4J*Y?5_$-VOBWP_H>E>2_VQ9+N[D8;MEL@&",'J
MS, #]:YT>,M9L->TV/4M6T&5K[4!9RZ-;,&GM5<D(V\.=Q&%W?*!S0!Z%:7]
MI?&<6MQ',;>4P3;&SLD&,J?0C(_.H[K5;"QO+2SNKN&&YO&9;>)VPTI R0H[
MXR*\ST#_ (2II_&KZ#<Z?;1VVMW,@%S;M*;B3:AV9#+L7 '/)RW;',&KZVOB
M3Q'\)]96/R_MCW$K1YSM8QID?@<T >OT5Y;J?Q"U!#K>IVFKZ'!:Z3<RPII=
MP1]HNUB.)#NW@J20VT!3G SUKTVVN([NUAN8CF.5%D4^Q&10!+17F\$^MCXS
M:L)-4MEL+738I&B-LQ_<EW.T'?PV<Y;!R,# J ^+?%O_  AI\=!]._LO'V@:
M5]G;S/LV[&?.W_?V_-]W% 'I](2 "2< =:;%*D\*2QG*.H93Z@\UYSIS:]-\
M7O$D<FIVYL[>S@S#]F;)B;S"BJ=^%8$\M@Y]!0!Z#8WUKJ5E%>65Q'<6TR[H
MY8VRK#U!JQ7BWAG6?$_AWX3:'K\<VG_V5;+#&]@T#&62)I0A?S-V V6R!MQC
M&2:Z36O&6HOKVLVFFZWH>F)I&U!%J&"]Y*4#E?OKL4 A<@$YSZ4 >BT5F^']
M7CU_P[IVKQ(42\MTFV$YV[@"1^!XK2H **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K \9>'&\4>'VL
MH;C[+>Q2I<V=QC/E3(=RMCT['V-;]07=Y:V%N;B\N8;>%2 9)G"*,].3Q0!Q
M<NJ?$2ZL6L$\,V%I?.OEG4CJ"M AZ>8L8&\^H4_G5+Q!X NHOA]H'AS1%%PV
MGW]O/(\C!"X5F:1^>Y+$X]Z[)?%/AYV"KKVELQ. !>1DD_G6M0!QOBCP_J.J
M>._!VJVL2M::9+<M=,7 *AT4+@=^0>E5O^$2OKGXG:[JMQ$HTG4-'%B) XW%
MB1D;>O3/-=W10!Y_H%OXXTZPT;PZ=/M+>WT]HXI]5^T*ZSV\? "1XW!F  YZ
M<]:I:=X8U;14;18/"FCWL0O'>'5KDQLH@>0OATQO+J&*C'!P.:]-HH Y;1]$
MOK/XA^)=7FC5;*^@M$@8,"6,:L&R.HZBNIJ*YN8;.TFNKF18X(4:21VZ*H&2
M3] *987]KJEA#?64Z3VLZAXY4Z,/44 >:CP9KMUI/C+PY/9QPV^IZA-J5EJ7
MGJ5+ET>-&0?,.5Y/\ZUI;+Q+XJU?0?[7T:+2K/2KH7TS_:TF,\JJ514"]%RQ
M)+8/M7>44 %>33>$_$S>$/%WAH:5&5O;Z6\L[L72;90\R.%*]5( /7TKUFLR
MW\1Z'=WOV*WUG3IKO./(CND9\_[H.: ,WQ!H][J'BOPK?V\:M;Z?<3R7#%@"
MJM"R# [\D=*Y?3/#&K:+'_8D/A/1[R);MFBU>Y,;*(&D+_.F-Y<*2HQQP.:]
M U35]/T2Q>^U2]@M+5" 99G"KD]!]?:J%SXQ\.6>D6VJW.LVD5C='$$SR8$O
MKM[F@#<K@[C2?$7A?Q5J6K^'K"#5=.U5EENK!K@0213@;2Z,PVD, ,@]ZZNT
MU[2K_4'L+6^BFNTA2X:)3R(V *M]#D5HT <3'I7B;Q/%JX\0F+2]/O+"2RAT
MR&03%2X(,LCX +=@%XQ63+HWBS7/#NE^$]2TF"UM;:2W%YJ*W:NDT<+*P\M!
M\P9BB_> QSUKTRB@#DM(T&_M-7\97$T:B/4YT>U(<'<! J'/IR#UK'/A+5S\
M,/#6A^0GV^QN+.2=/,&%$<@9L'H>!7HM% 'E^E7VO6'C?QQ)I.CIJD;WD*^6
M+E86C<0)@G=P5.>W(QT.>([/P5K/A^'PQ*=*M]>:QMKE+FV,R((YYI!(9%W\
M$#YE]<=!7H]GI-CI][?7EK!Y<]](LMR^XG>P4*#@G X '&*NT >5VWA#Q(+=
MK2XL;8%?$]OJ_FP3*(S$2"ZJ#@C9C'(YXQ77W6CWLOQ(T_65C4V4.F3V[ON&
M0[2(P&.O136W?:C9Z9%'+>W"0)+*D*,_\3L<*OU)XJ6YMXKRTFMI@QBF1HW"
ML5)4C!P001]1S0!Y;HF@O)\7M2LXI4DT32KAM56)>?+O+A NP]N,2. .FX5Z
MO6;HF@:7X=LFM-*M%MX6<R/\Q9G8]69F)+'W)-:5 'F.GWNN6'Q$\<RZ5I"Z
MI&\]JIB%RL+(XMDP<MP5.>>XP.#GA^F^!M7TZ'P2KB*673KVYN]1=' "M*')
MVYY(!?'X9KOK32;&QU"_O[>#9<W[H]R^XG>54*IP3@84 <8J[0!Q>M^'=1O?
MBEX7UV")6L-/@N4N'+@%2Z$+@=3R:RHM(\5Z#HVK^&M+TB"[M;N:X:RU!KM4
M2!)B21(A^8E2Q^Z#GCI7I-% '"Z7X/N]'\7>'IH0LFG:9H;:>\Q8 F3<F/EZ
M\[2:[JBB@#SZ3PUJS^,O%L,M@)-&\26T<1O4G4&WVP-&04/+$D\8JG+HGBS6
M?"^F^#]1TF"VM8&MX[O4UNU=)8H64_NT'S;FV#J !DUZ;10 5Y\VAZ]:^,?%
M[Q::D^G:];Q^7="X5?)=+<Q[60\G+8Y' S7H-% ' WGA?59OAIX;T5(4-]8M
MIYG3S!A?*9"^#T.-I^M5;CPYJNDZMK8L?"NEZRFI737=M>73QK]G=U 990PW
M%0P+#;G(..*](HH BMHC!:PQ%8U*(J[8EVH,#HH[#T%<7/8>(=!\<:OJVDZ1
M'JEIK$4&\&Z6%H)8E* G=U4J1TR>.E=S10!Y/;>#?$-EX?T?[7IMOJEQ8ZU<
MWMQ8B952X63S-KJ6^7(+!@&_G3KOPCXDU"R\:6TFFVEM_;MG$]L(9EV0N@VB
M%NA)(P=V,9S7JU% 'F]SHVMW5UHWB"X\*VUS<V]F]A=:7/<1.=A*LLB.?DR"
MIX)Z-77^&+:[M]*8WVF6&FS2RLXM;(#;&O10Q'#/@#)''Y5LT4 <AX_TC5-3
MM]#NM(M%N[C3-5AO6MVE$9D10P(#'@'YAUJ7P_I6I0^,M>UF]M1;Q:C;60C3
MS5<JZ(^]3CT+ 9[UU5% 'E<?@_7++2-$:328=2.GZO>7<VG-.@$J2M)Y;@M\
MN5W X/KZU'?>#O$NHZ5XULY-.M+=M<AAFMO)F79&Z!5\D]#G"CYL8)S7K%%
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M(/7^]Q7+W/A#Q-<:?X@M'TVU0ZAJ5GJ$1@G4(@5HM\>#@Y4(>< -^.*]9HH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 @ &< #/)I:** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MMX;E"[%_N@#/<9/T!-69=;^TZOHO]F:QHCZ?>>:65YMTUSM''D%6PV#G=UH
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MJ29G0D(C$>:<'A#C()[5<@\5>'[K3KG4+?6]/FL[7_7SQW*,D?IN(.!GMZT
M:]%<]H7C71-<\,)KR7]K!:A T_FW"?Z.3_#(<X4^QK7T[4[#5[1;O3;VWO+9
MB0);>0.I(ZC(H M445R'@OQ5>>(+CQ,M^EM%'I6JS6<31@KF-.A8DGGU/ H
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MU.QM$D  EFF6-';'\)8\T\:WI)ADF&IV1BB9$D?[0FU&?&P$YX+;EQZY&.M
M%ZBLZP\0:-JEY/9Z?JME=7,'^MA@G5W3G'(!R.>*QOB/XEO?"/@:_P!;T^."
M2YMS&$6=24.Z15.0"#T)[T =5167?>(=)T>UMYM7U.RL?/ V?:)EC#''.-QY
MZU;CU&QFN4MHKRW>>2'[0D2RJ6:+.-X&<E<\9Z4 6:*KV]_97<]Q!;7<$TUL
MVR>..0,T3>C 'Y3[&EM+RUU"U2YLKF&YMWSMEAD#HV#@X(X/((_"@">BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ KA=8_>?&?PRLOW(M-O)(<_\
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M1D'(->!,[IX*^)8#,D3^)FCG93C$33('_#:2#[9KWBU@6UM(;=22L4:H">X
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MS74-Q;Q%;71(VLHB@VJ&E;S&4= <A037#:];Q?\ "-^+=/MQLTY?%5ND2QG
M1F,1D"XZ88GIT)KUW6_"VD>()8)K^WD^T6X(BG@G>&5 >H#H0<'TSBF#P?H
MT.+15TY!I\4RSK$'89D5MP8MG<QSSDDY[T <EXOTZ:U\6^#M/T/3]*6)?M<L
M=M= QP&540*<(I^8*7QQZ^E<WXTTG4=+^&'CM[]]*3[5=6TWV73969('+1!L
MAE!!;"MCWS7K>M:#IOB&T2VU*W,J1R"6-DD:-XW'1E=2&4\GH:H_\(1X>/AR
MYT!]/WZ==/YEPC3.7F?(;<S[MQ.5'.>V.E '-000WGQ6TB*]C26.#PUYMLD@
M! D,JJ[ 'OMVCZ&N-U.SL8_#7Q#L[$*MI_PD%F@6,X"_O(=RC'3!R..F*] \
M::+]HN-)D7PR^KVEJKJ3:79@NK?( &QMZ[E(&"-WI4'A/P5&VD:Q'K6DQVEO
MJ=\ES'IR2Y\B.(((@S(?O9C#'!(^O- "ZQ86FG?$_P $BRM8;8-!?0D0H%RB
MQH0O'8'I4/QP_P"22:Q_O0?^CDKMKG2;&[U.QU*>#?=V(D%O)N(V;P W .#D
M =<TS6]#T[Q'I,VEZM;?:+*8J9(M[+G:0PY4@]0.] '':@\M_P",&MM+TK2I
M+VRTJ+[5>ZF[E%BD9B(U0<?PL2W'85ROARXCT?P]\/O$\DBK;1O=:;<NO3RI
M&<Q_\!#1KCZUZ;J?@W0M8U"*^O;-GGCB$)*S.@DC!R$=58!USV;(IDG@?P[+
MH-UH<FG[M,NIS<26YFDVARP;*_-E!D9PN!UXY- 'E=GJ-QX0TR?7I R7/B?1
M;B] '5KOS2\0^NVX4?\  *]?\+Z,OA[PMI>D*!_HELD;$=V ^8_B<G\:;J7A
M;1-7BTZ.^L$F339%EM%W,!&RXQT(R.!P<CBMB@ HHHH **** "BBB@ HHHH
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MJH55&WH03D<U873_ /A)_'FE0ZR;I5O_  IY]W;)<2(OF&2+(P#\N">V.0*
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M9XY;6Z'[RWE\QF>,^P+8'MBN%\<21SZ-XTU+3GDN;BQE13?32;#92HJ'R[?
MSQG)/RC+?Q<T >OU5U#4+72[-KN\E$4*E5R>[,0J@>Y) _&N/CP?C%"A_P!7
M<>'&>5/X7;ST&2.A..,^E<3=V\%Y\,YS.HF$'BHQPESNV)]K"X'H-O'TH ].
MD\0W4?Q @\.M:0BVFT^2\6X$A+DJZKM*X 'WO4_A715YWJ>D65S\6-*TYHRM
MF-"N 88W*!AYT?RG'./;O7.VNJ7.F>%H-*2XF33CXQDTF20R-NCM1*V$W9R
M<!<YZ$B@#V:HYS*+>0P*C3!3L5SA2V. 3V&:X6XL_P"R/B?IFGZ8K0Z;JNGW
M!O;6!BB(8]NV50N-C$MM)&,_6L7P/H%I=?#"+7)YKY]1^PWD7G_;)00OF.<<
M,.Z@YZ\GUH ]%BU-[/3M..M>1;W]TR0F*)RRF9ARJD\D<$_0&M.O'/L5M?\
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M >G16^F#0!E:+%J>M:O#KFMZ(NE2V<,D%M \Z3/EV!=RR\ 810!UY;/:NIK
MM/&WAF_L[R[M=:M)(+( W+A_]4#T)'7!]>E<E\._B!-XKFU"^U'6M,AMXA,Z
M:<D6UX8D8 2O(6Z8//'<'CI0!U3^!/#3V-Y9'3 +6\E\Z>)9I KMNW= W W<
MX&!GG%77\-Z7+JEOJ<D$DEY;Q&&.5[B1L(>JX+8(/?/7O4.C^+_#VOW3VVE:
MO:W4ZKO,:-\Q7^\ >H]QQ3K?Q9H%WJ<.FV^K6TM[,9 D"/ECL)#\=L%6_(T
M48OAYX4@AMXDT>/R[>;SX5:1V$;<\+EN%Y/R_=]JU(/#VE6VMW&LPV:I?W(
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M)/05D:=XO\/:O;75QI^K6UQ':)YDY1N8UQG<1UQ@'GI0!M*H50J@!0, #M5
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M#\&:QJEF4%S:VKRQEUR-P'&14>D>,]!U2\BTR'5[274S'EX$?DL!\P'8D<Y
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M:O:W-Y$"S11ODX!P2/4 ]QF@":ST#3[$R-"DYEDC$332W,DDNP=%#LQ8#G.
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M_P"'-(A^+&EVT=C$L%_I=R;R(9VW)5T*F4?QGD_>SGO0!Z0'4IO# KC.0>*
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M2!Q[4 >S45YMKPL? ?C2U\4PVB#3-3MS970@C'R3*"T+*!_?P4X[[:[+PUI
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MUU(+EC$ '(XMVQ_M*Y?/7,?O61K;V<VD?VQI8&S_ (2>,K>W+!KF27SPK*F
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M$HM%C6SM1:QJZ8:.=L-,.?[N$4'_ 'Z .IU+5K/24MVO)0AN;B.VA7N\CL%
M []<GV!-8\/B"]/Q#N_#\\=LME%IJ7L<BYWDF0IAB>,?*>WXUD?$VSM+D>%&
MN+:&7_BH+2,F1 WR,6RO/8X&1WQ5:71]+U/XO3V5S9P3V*>'80MN5!B($\@
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M#(D6#GY.!R "?;!ZF.-(HUCC4*B *J@8  Z"J%QKVEVFJ'3+B\CCNQ:M>,C
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MM(S=H(YV5,-(H&-I/4C'4=^_6M"STVRT_3TL+2V2*T1=BPJ/E5?0#T]JM44
M0065M;6$=C#!&EI'&(4A"_*$ P%QZ8XK+TKP?X=T)[E]*TBULWN1ME:%-I8>
MF1R![#BMNB@#/L="TO3--?3K*Q@AL7#!K=5_=D-U&WISDY]:DTS2K#1;%;+3
M;2&UME.1'$N!FKE% $$MG;3W-O<RPH\]N6,,C#E-PP<'MD<406=O;2W$L$*1
MO<R>;,RC!=MH7)]\*H_"IZ* .?'@;PLJ,@T#3]K3BX*^2,>8#D']3QTYKD;_
M ,'27VO:C-K7@C3=9>XN"\-_'=+%B+ "*ZD!@54 $C=FO3J* .:M_!6DS^%[
M?1-7L+>\MH79TBD+2+#EB0J,WS84':#QP.W2K_\ PC&BC3[2Q338(K:S;?;)
M$-GDMS\RE<$'D\CGDUK44 5[*QM=/@\BTA6*,L7('5F)R6)/))/4GDUQZ^&Y
M[SXF:EJM[IDHL)K&*VAN%G56W*6+?=?<%.X<=\<BNXHH S;SP_I%_HZZ1=:=
M;R:>H4+;[ $7;TP!TQ[57C\)>'X6D:+2+1&DA%NS+'@F/GY<]<')SZYYS6U1
M0!E_\(YHXT==)&GP_P!GHP9+?'R(0<C [8(R,=#4B:'IB6EU:FSCDANP1<"7
M,AF&,?.6R6XXY/2M"B@#$L_!WAS3Y+22UT:SC>SW&W?R\F,MC)!/?Y0,]<#%
M1+X&\+(A1= T_89Q<;?)&/,&<']3QTY-=!10!E+X:T93>E;"(&_&+O!/[_\
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M/X@E\87.O^!H;R[M-,O9;FX5XT@\Z/S4CD_>_?&59#PIP5)ZFMNSUGQ1J_Q
MUK1;6ZLK;3M(FM6EE>W+O*CQJQC'S8&?G^;MQP: .]HKS1/$?BW5O#6H^+],
MN]/AT^V:=[73I+4N;B&%F!+2;@59MK8P,#CK5L^)M=U_Q39:9H5Q:V5G>:%#
MJGVB>#S7BWNPP%W $D;>O P3STH [35-6L-$T^2_U.ZCM;2,@/+(<*N3@?J1
M5L$, 0<@\BO*-9\<:W8_"[Q#J%PME/JNCZF=/:0P?NIMLB#?L)XRK],]:Z74
MM7US5/%2^'=#O+;3S;V*7EU=S6_GG+L52-5W*!]UB2?:@#LZIZKJUAHFGR7^
MIW4=K:1D!Y9#A1DX'ZD5R>H:MXGM=!TXZG>Z+H-PTTD=]?W#JT:JN=AC1F )
M?@X)^7GK7$^-_$4WB/X&^()+BYM;N2SU%;/[7:<17 66,K(HR<9##C)YS0![
M!+K&G0:I:Z9+=Q)>W:,\$!/S2*HR2/H*O5YGKW/QO\$8.#]@N^?^V9K1TKQO
M<0>"]?OM<$0U3099X;I8UVK(R\QE1V#@KCWH [NBLSPY)J<WAS3Y=9V?VE)
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M$G (P<9.,XR:WE\2:YJO_"*:1I,UI97FHZ4-1O+I[?S%B0*G")D#EGQR> *
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M **** "BBB@ HHHH **** "BBB@ HHHH **** .5\)Z#?:1KWBF[NU01:CJ
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M&U<*8E !4DX)+=.1S6*_AGQA9^"-6\$V.G6<EI(+E;747NP 8I&9PACQG?\
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M%NVHWJP0JL4F8T?R.(]Y SM!4$X'/85KWOAG7[/2O 5Q8V4-Y>>'XECN;4W
MCW9@$;;7(QP?SKN-'T33= L?L6EV<=K;[BY5,Y9CU8D\D^YYJ_0!Y=>^%?$D
MT'BO3(=*L-VMR2S+JLLX)C1XP/**XW$C!4'. #GM@WK;PUK=QXW\):Y<V<5O
M#I^F26UTGGARCE2!C'4=/SKN-.U*SU:S6\L)UGMV9D#KG!*L58<^A!'X41:E
M9S:G<:='.K7ENB22Q#.45L[2?K@_E0!;KBKG3M>T#QEJNM:/ID6JVVKQ0^="
M;D0/#+$I0$%A@J5QGOD5VM% 'FB^!=832="\PV\E^/$HUO4=CX1-Q<L$SR<
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M.*IZAX/\3S:/XI\/VEMIR0:M<W%T-3><[W$AW+&4VYSG"[LX"\@&@">Y8/\
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M:MX%UW5O!/BN*?[$NMZ_/%-Y$4A\F$(8PJ[B,D[4))QR30!J76M:[J_B/3-
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M1RI'!+ Y'((J[J'AO7=3MO"TETFGQW5CJZWUU';96-(\. JY'S$!E&>,X)H
MZS2;>^M-,A@U*_6_O%SYERL A#Y)(^0$@8&!U[5=HHH **** "BBB@ HHHH
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M0L14J$ /)'.<=.M<AXJUVX\1_#/P;J=TT;W#^(H8WDC7:LA1Y4W =L[<X]Z
M/;***XWQ[KMWHW]DHFI?V1874[I=:G]G$OD87*#!!5=QXW$8&* .CU?6].T*
MVBN-2N/(BEF6!&V,V7;H. ?2L^/P/X8BUC^UH]$LUOA)YPE"=)/[X7H&]\9K
MDO$WB;7]!\#Z9?0ZS8W\\^K16ZWUM&K+/;L6P2.5#8&#MXXXK4GOO$&O>-]7
MTK2M732[31XH-Y^RK,;B:52XW;NB!<<#!.>M '<54TW3+/2+%+*P@6"V1F98
MUS@%F+-U]22?QKS*W\8^*KKPWHDHGMHM3OO$,NFRYB#1H@\T8QP3MV@]B<=>
M:W=/U+Q!I?B[5/#][JT.IXTD:C:7%S"L C;>R%'*#&W(!SC(% '=T@96SM(.
M#@X/0UY=H/BV^F\4:7I0\7VFMMJ4,ZS_ &>V0+:2HF\-&RCYEX88;/0&L;1=
M2U[0?AUXGUN+66FG36)457MTP'-TJN_3^($\=!VH ]KHKF==UB]L?&GA338)
M MKJ$ETMPI4$L$A+KSU'/I7*Z#XE\23Z-K?BC4M3C.G:/+>H+%+9 ;D1;MI9
M^JX^4  ?PDG.: /4**\GT'Q[*=:T".7Q=I^LMJLGDW5A!$BFT=D+*4*\E0PV
MG=GJ#7K% !17"7]]XCU/XBWOA[3M673K&'3H;HS+;)+(KL[KA=PQS@<G.-O
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M?>@#NJ**\L\:>+M1T&\U>Y'BW3;::RQ):Z-'"LIF0*"1,Q&Y68[L $ #!YH
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MA09-[%N!P.<U0M/BA));6>NMXKL)&N+M%D\/B)-T<#R;!AOOF15(8Y..",4
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MRCB,2+Y@4]/N;\9'/'2I[GQ7K?A&7Q7:ZI?KJ_\ 9NFQW]I-) L39<LNQ@F
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M'AS28#/$T8EALHU>/(QN4@9!'45SVG>%_%VCKH>K(=.O=8L;!],NX9)V1+B
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MD WY4(=ZYY&".N*[VB@#S77_ (<7Y\#Z%H_A^[A2_P!+1X/M$Y*AHY8FCF/
M."=VX#V%6/$OP_N=2UK0CITD$>EP0Q6FHQ2$AI((I4EC50!SRK#G'!KT*B@#
MD+OPO?7'Q6L?$P:#[!!I;V;J6/F%R['@8QC!]:I:%HGBS0;:S\/VR:5_95I-
M\FH/(S3-;ALB/RMN-^/EW;L=\9KO*I6NKV-[J5_I]O-ONK!D6Y38PV%UW+R1
M@Y!SQF@#C!X=\4Z3>>(+'1QISZ;K-S)=+=3S,LEH\B@2?(%(?D97D>]9EOH&
MI^%I?!GV6ZTIM<MM/DT^2RN;AHTNH_E8^6X4G*D _=Y!KU.L_5]"TK7[5;;5
MM/M[V%6W*LR!MI]1Z'Z4 >5P:%JWBB#XDV"W-I+?7EQ:Q>:C$0+(B*60-@D[
M1A<XR2.@S7H.L:%=W_C'PQJT+1"WTPW7GAF(8^9$%7:,<\]>E6K%M"T"[M?#
MEA#!9RRQ//#:PPE5*J0&;(&,Y8=3DULT <%J?@:^U*]\7RBX@A.J264]C)RQ
MCDMU!&\8Z;E'3/!-:5M;^*]2CO4U6VTNQ@>S>".&VE:9I)6&-Y<JNU1_=P3S
MSTKJZS]'UJPUZT>ZTZ5Y84E:)F:)XSN7J,, ?QZ4 <M<^#]2F^&NA^'E>W^V
MV)LC*Q<[#Y+H6P<9/"G'%6;+0]:TSXDZOJT,5G-I6KQV_FNTS++ T2,O"[2&
MR2.XKL*IZKJEIHNF3ZC?R-':P &1UC9R 2!]U02>3V% %RO.[SPIXD+^*=,L
MO[.6QUZ5Y6U"21O.C5X@ACV;>>F =W .<$\5V::[ITFHVFGK<'[5=VQNH8S&
MPW1# +9Q@?>'!YYJ;4]2M='TV?4+Z1H[:!=TC*C.0/\ =4$G\!0!R6@>&=9M
MO%6E:SJ"6D2VV@_V;+'#,SGS!*&!&5'RE5S[$XYZT3:-XGT;5M9;P_!I=S:Z
MM-]I5[R9D:TF**K$J%/F*=H8#(YR*Z&X\3Z/:SZ1!/=E)=8_X\5,3_O> WI\
MO!'WL5/;:U87FL7NE02NUY9!#.AB<!0XRN&(VMQZ$XH N6Z21VT232"254 =
MU7:&;') [?2N<\?:!?>(_#!L]-:$7D5S#<Q"=BJ,8W#;20"1G'I72QR)+&LD
M;JZ,,AE.0?QIU '*:;H^KOXW7Q%J,5K 'TA;.2&&8R;91,S\$J,C:1SZ]JQW
M\#ZLMMJ-Q;RV8U!?$3ZS8B1F,;J4";)#C*Y7>. <<5Z'10!B:"/$$D]U<:W!
M86D;A5M[2U<RE,9W,TA5<DY' & ![UMT44 <!J'A_P 3ZY?6%MJEKH[1V6H1
MW2:O'(PG\M)-X58]GRL0 I.[&,]:S+KP5XKD\+ZIX9MQI<=K+=RW:7K3,9+D
MM+YJHZ[?E.< MD\# '<>BW>K6-CJ-A87$VRYOV=+9-C'>44LW(&!@ GG%7"0
MH))  Y)- ',>']$U&T\6Z_K=\MO&NIPV86**4N4>-&#@DJ,C+<'OZ"L+_A!M
M5_X4XOA/S+7^T0X;=O/E_P#'SYO7&?N^W6NVN=9T^TN]/M9K@"7479+4*I82
M$*7/(&!\H)R:OT <5=Z/XCTCQ#J]]H%MIEY!JWER.MY,T1MIE0)NX5MZD*IQ
MP<BNNL8[B&PMX[N5)KE8U$LB)L5WQR0.P)[5/34D252T;JX!*DJ<\@X(_.@#
MG?&NB7VM:98G3EMY+FQOX;U8+EBL<^PG*$@''7(.#R!6&NA^-1XBO]<C?28+
MF^L(X50R.ZVK1NS*GW!O5@Q!;@@DX!P,^@52M=7L;S4[_3H)M]W8>6+F/8PV
M;UW+R1@Y'IF@#FM T/5F\83^(M4T[3M,=K/[*8;*8RF=BX;S';8O3&!P3R>:
M[*D9@JEF. !DUS\?CCP]+X8C\21WSOI4C^6DZV\I);<5^YMW=01TH HZ9X8O
M[/0?%=E(\!EU6]O+BW*L<!95PN[C@^N,UDV/A;Q+H-[H]YIT&F7<T6A0:5-]
MHG=! \9R77"DLISR/E)P.:]%HH \WT7P1KMC)X?ANY;.2+2-5NKHSK(=\\<H
MD()7;A6W2<C)''6M#7O!%QKVM>(I)9HH[35-'CL8V!)=)%=VW$8Z#<O?L:[B
MB@#SJ?0?&FN2>&QJL>E6T6CW\-S,8+AY#<[ 07&4&W@G"\YSU&.;1\%7W_"T
M?[>$T']C$B[,&3O^UB(P[L8QC8<YSUKNZ* .$\*>"K[1/&6JZG=S0/8 2QZ9
M%&26B269II-P(P/F( QG@5:\,>%K_1_AY<:#<O ;N076&1B4_>NY7G&>C#/%
M=C6'#XOT*Y\1R>'X+TRZG$2)(HX9&6,X+89PNP' /!/M0!QR^!-=M/AUX5TN
MW-E)JNA7\5Z8WE812[&<[0VW(X?KCM6J^A^(%\?6_B!;73Y+>\TR.QOX6N6!
M@(<LQ0[/G&"0,[<^U=Q10!PF@:-XMT.VT_0(TTK^R[*0*-1:1FFDMU.0GE;<
M!\84MNQWK3T3P]>:=_PE/G-"?[4OY;F#:Q.%:)$&[C@Y4^M=110!B>#M(N-!
M\':3I-VT;7%I;)%(8R2I('."0.*VZ** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Y3Q_JU]H^B6L
M]I<RV<#WB1WM[%;^<UK 0V7"D$=0HR0<;LXKJZR=>CUQK>"709K07$4NZ2"[
M!$<\>""I8 E3D@@@'I@\&@#@O$7B;6-'^$VL:WI?BBWU5XIHOL6HQ11EPC/&
MK+(H79N&6'3H1P#6S>W^MZWXSAT#3]7?2[>VTQ+VYGA@CDDED=BJK\X("C:2
M<#G.*R=7^'FLZSX.\3V;'2[/4=;N8)A! S_9X1&4S\VW)9@I).T<X^M:&K6U
MWI?CVRO-(U#2AJ5QI8MI[+4)'C$D:/D2(RJ<D%B"/2@#$;Q;XM@\-ZL\E] ^
MIVGB>+3(W$"B-HB8AC&,X;<3UR-W!X%=#:7.NZ'X_LM(OM;?5;34;&><">".
M(PRQE?NE /E(;H<XQUKFO#6@7WB'0-:6*]M[ASXM%Z;HY6.98S$7*8SQE6 ^
MG7O7;:]X7N=8\46.H)/'%;0Z?=VDG)\P&8* 5&,<;3W':@#D-.\7WL'B#1$;
MQ?#K,M_>FUO+.WME%M$"KD&&4("=I4#ECG)JCI<VMZ/IWQ*U>/7[B6>QN+@*
M'MX</(L*;9#\G4  8'R\=*VH_"7C Z5X=M)&T6-?#\\+P1122;;K8I0L[;/D
M.TG  /).35L>"M9,_C#3FEL?['\0&659P[^?#(\83!3;M(!&?O4 :&NZYJ-E
M9>#I+>XV/J.I6T%T=BGS$>)V8<CC)4<C!K*T/5?$6J>(/$ES=:T8M)T/4I46
MWCMXRTZ! VQFQD!1T(Y)8Y/ IW_",^+]3_X1I-5DTB&+1;R&9EMI)'-P$0J6
MR5&TX/"\]3R,"MWPWX9GTJ;Q+]M>&2'5M1DND6,DD1LBKAL@<\'IF@#@-)^(
ML\IT34W\517=SJ%U%'=:*MLH2".5L (P7=N3())8YP:VM(U_5-0\4R6UQXI2
MRU2+4'1]!NK9$1[8.0/+8KO=B@#!@Q&3TQ6MH&C>,-'@TW1#=:6-(T]E07:E
MVN)X%X6,QE=JG& 6#'IP*@U'PYXIUNXM;+4VT>6SM;]+J/4EW"Z")('553;M
M5L *6#8QGB@#M;Z">YLI8;:[>SF=<)/&BLT9]0&!!_$5XCX'U#5?#'PJU+6[
M;4GG<WDMM;V4L,8B$[S*@D+!=QZYQG'M7NU><Z5\.+N+X9W_ (7OKR%+J>ZD
MN8;B#++&WF"2,\@9P5&10!9EGU_PGXA\/QW^ORZO9:K<&SG6>WBC,4I0LK1E
M%&!E2"#GBH_!-[XD\0ZOJE]?:T5T[3=6N[..S2WC'GJK$+N;&0%RN,<G:<DY
MJY'H7B76]>T>\\1_V7;VVDR-.D5C(\AN)BI4,=RKL4 D@<G/>M'P=X?NO#UM
MJ\=U)"YO=5N;V/RB3A)&R <@<^M &)\9EN?^%9ZC);WDEN$:+S%15/FJTBKM
M.02!SGC!X],U0U'3=8/Q,T2PAUR7[4=&N1-J+P1^;L\Y#\JA0@;[J_=QC)QF
MNL\=^'KCQ5X+U'1K2:.&XN%0QO+G:&5U< XYP=N/QJK8Z)K<_B[3?$&JBPBD
MATV:TFAMI7<;VD5E*EE&1M7G..?7K0!RESXTUC0="URROM5CEO+/68M-@U.>
M!1LCE56\QT4 $JI;MS@<5J^"_%?VWQ9<Z)#XB.OVALOM<=T\*QR1,'"LC;54
M$'<I'&>HJ6\\"ZA<2:_<17=M%=7.J6^IZ>YW,J/$J "08'!*D'&>#^%=!HB^
M)I+R>XUTZ=!!Y:I#:63-( V3N=G95// "@8H SOB%J^K:1I6EMHLZ0W=UJMM
M:9DC#JRR,000>W3I@^AK,?4-?\,^+(M*OM;DU2VU'3KF>"2:WC1X)H0"<;%
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MBJRU2&[OXK2SU4Q(3;J^-YE5 %+( Q P.V16K8>&_$^E6=[J5K>:<^NW]_\
M;+N)PPMWC";!"&P6&  0V,Y'(P:I#P)JMU::I?2OIUAJ]S?V]_;0VNY[>*2
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M02Q7,CI'*'A6-B&52>-N1Q0!-HWBFZTZZ\6V/B&Y\V317:[CE**A>S9=Z<
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MBI=8M;G7[2VCNPB>;Y#LH>*3  W=>< X(K<USQ!=Z5X[M+?SF_L]='N[R:
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M^)+WQ!9SV<\MU]IM?*,$L:;PR$1J K ,-ISC YH ]4ID<T4K2+'(CM&VUPK
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M8J3Q?KEUI-QJH'C6YBO-.M%>TLK2T$VYECR3=$1D N1ZJ #F@#U0    8 Z
M4M>?#4]6\8>(X],M-5N-(M;?2K>]G>S5#))+-DJN75@% 4]!DYJGKVI>(-&B
MT6U\2Z]-IUD4G%WJ^F6X;?(&40A]R,(P5))XQD8SB@#O=2UFTTJ:RBNO.W7L
MZV\7EPLXWGIN('RCW/%:%>9:[XAUG3+3P*MOKT-\-0U>.WN+RWC39=0LQQV(
M!*XSMQSG&*L%O$/B#QAXOTV'Q%<Z=9Z8UN;86T49;>\ ;!+*?ESDD=3GJ *
M/1:SX]9M)-=ET9?.^UQ0B=LPL$VD@</C:3STSFO+X-=\4-X#T+QO/KTOG2W%
MM'-8)#&+>2)I1&V?EW;SG=G.!G  KJ++7-2E^-&I:&]T3IL.D)<)!M7"R%U!
M;.,]">] '2:!XATWQ-I[WVES-+;I*T)9D*_.O48-2Z9HFEZ*LJZ9IUK9B9M\
MOD1!-[>IQUKQGPIXAF\/?"@O!="SDO?$,EG]K,?F>0K-EG"X.XA5; QUQ7:^
M"?$9N_$]]H\&M76M:>+1;J&ZNH/+DB?=M>,D(H8<JPXXR10!Z!1110 4444
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M:;1)YC2.,*S [<\9/7Y1ZFLH:YKZ>%+B";4=1E@T[Q!-I]]J-I"KW0M$!(?
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M:Y2>VDDCW+#M1$.X=_NG\ZZP9VC)R<<T +1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?_/3:8SM_&N5&I233> ;F[\1VEP)[Z*X^P6EO%%!:*T+@#(^88+;0&///''
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 451;6=+1BK:E9JP."#.H(/YTG]MZ3
M_P!!2R_\"$_QH OT50_MO2?^@I9?^!"?XT?VWI/_ $%++_P(3_&@"_15#^V]
M)_Z"EE_X$)_C1_;>D_\ 04LO_ A/\: +]%4/[;TG_H*67_@0G^-']MZ3_P!!
M2R_\"$_QH OT50_MO2?^@I9?^!"?XT?VWI/_ $%++_P(3_&@"_15#^V])_Z"
MEE_X$)_C1_;>D_\ 04LO_ A/\: +]%4/[;TG_H*67_@0G^-']MZ3_P!!2R_\
M"$_QH OT50_MO2?^@I9?^!"?XT?VWI/_ $%++_P(3_&@"_15#^V])_Z"EE_X
M$)_C1_;>D_\ 04LO_ A/\: +]%4/[;TG_H*67_@0G^-']MZ3_P!!2R_\"$_Q
MH OT50_MO2?^@I9?^!"?XT?VWI/_ $%++_P(3_&@"_15#^V])_Z"EE_X$)_C
M1_;>D_\ 04LO_ A/\: +]%4/[;TG_H*67_@0G^-']MZ3_P!!2R_\"$_QH OT
M50_MO2?^@I9?^!"?XT?VWI/_ $%++_P(3_&@"_15#^V])_Z"EE_X$)_C1_;>
MD_\ 04LO_ A/\: +]%4/[;TG_H*67_@0G^-']MZ3_P!!2R_\"$_QH OT50_M
MO2?^@I9?^!"?XT?VWI/_ $%++_P(3_&@"_15#^V])_Z"EE_X$)_C1_;>D_\
M04LO_ A/\: +]%4/[;TG_H*67_@0G^-']MZ3_P!!2R_\"$_QH OT50_MO2?^
M@I9?^!"?XT?VWI/_ $%++_P(3_&@"_15#^V])_Z"EE_X$)_C1_;>D_\ 04LO
M_ A/\: +]%4/[;TG_H*67_@0G^-']MZ3_P!!2R_\"$_QH OT50_MO2?^@I9?
M^!"?XT?VWI/_ $%++_P(3_&@"_15#^V])_Z"EE_X$)_C1_;>D_\ 04LO_ A/
M\: +]%4/[;TG_H*67_@0G^-']MZ3_P!!2R_\"$_QH OT50_MO2?^@I9?^!"?
MXT?VWI/_ $%++_P(3_&@"_14%M>6MXK-:W,,X4X)B<-C\JGH **** "BBB@
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M_P */^$>T3_H#Z?_ . R?X5I44 9O_"/:)_T!]/_ / 9/\*/^$>T3_H#Z?\
M^ R?X5I44 9O_"/:)_T!]/\ _ 9/\*/^$>T3_H#Z?_X#)_A6E10!F_\ "/:)
M_P! ?3__  &3_"C_ (1[1/\ H#Z?_P" R?X5I44 9O\ PCVB?] ?3_\ P&3_
M  H_X1[1/^@/I_\ X#)_A6E10!F_\(]HG_0'T_\ \!D_PH_X1[1/^@/I_P#X
M#)_A6E10!F_\(]HG_0'T_P#\!D_PH_X1[1/^@/I__@,G^%:5% &;_P (]HG_
M $!]/_\  9/\*/\ A'M$_P"@/I__ (#)_A6E10!F_P#"/:)_T!]/_P# 9/\
M"C_A'M$_Z ^G_P#@,G^%:5% &;_PCVB?] ?3_P#P&3_"C_A'M$_Z ^G_ /@,
MG^%:5% &;_PCVB?] ?3_ /P&3_"C_A'M$_Z ^G_^ R?X5I44 9O_  CVB?\
M0'T__P !D_PH_P"$>T3_ * ^G_\ @,G^%:5% &;_ ,(]HG_0'T__ ,!D_P *
M/^$>T3_H#Z?_ . R?X5I44 9O_"/:)_T!]/_ / 9/\*/^$>T3_H#Z?\ ^ R?
MX5I44 9O_"/:)_T!]/\ _ 9/\*/^$>T3_H#Z?_X#)_A6E10!F_\ "/:)_P!
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
<% !1110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308301822528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Feb. 21, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-4858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">INTERNATIONAL FLAVORS&#160;& FRAGRANCES INC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000051253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-1432060<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">521 West 57th Street<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New York<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10019-2960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">765-5500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,313,097,570<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">255,314,909<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Portions of the registrant&#8217;s proxy statement for the 2024 Annual Meeting of Shareholders (the &#8220;IFF 2024 Proxy Statement&#8221;) are incorporated by reference in Part III of this Form 10-K.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag', window );">Document Financial Statement Restatement Recovery Analysis [Flag]</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_OtherAddressMember', window );">Other Address</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">200 Powder Mill Road<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Wilmington<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">19803-2907<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value 12&#160;1/2&#162; per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">IFF<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=iff_A1.750SeniorNotesDue2024Member', window );">1.750% Senior Notes Due 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.750% Senior Notes due 2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">IFF 24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=iff_A1.800SeniorNotesDue2026Member', window );">1.800% Senior Notes Due 2026 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.800% Senior Notes due 2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">IFF 26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtRestatementRecoveryAnalysisFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_OtherAddressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_OtherAddressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=iff_A1.750SeniorNotesDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=iff_A1.750SeniorNotesDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=iff_A1.800SeniorNotesDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=iff_A1.800SeniorNotesDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308301776144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_AuditInformationAbstract', window );"><strong>Audit Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">PricewaterhouseCoopers LLP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">New York, New York<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">238<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_AuditInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Audit Information</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_AuditInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308300564176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENT OF INCOME AND COMPREHENSIVE INCOME - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 11,479<span></span>
</td>
<td class="nump">$ 12,440<span></span>
</td>
<td class="nump">$ 11,656<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of goods sold</a></td>
<td class="nump">7,798<span></span>
</td>
<td class="nump">8,289<span></span>
</td>
<td class="nump">7,921<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">3,681<span></span>
</td>
<td class="nump">4,151<span></span>
</td>
<td class="nump">3,735<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">636<span></span>
</td>
<td class="nump">603<span></span>
</td>
<td class="nump">629<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling and administrative expenses</a></td>
<td class="nump">1,787<span></span>
</td>
<td class="nump">1,768<span></span>
</td>
<td class="nump">1,749<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_RestructuringandOtherCharges', window );">Restructuring and other charges</a></td>
<td class="nump">68<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of acquisition-related intangibles</a></td>
<td class="nump">680<span></span>
</td>
<td class="nump">727<span></span>
</td>
<td class="nump">732<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment of goodwill</a></td>
<td class="nump">2,623<span></span>
</td>
<td class="nump">2,250<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of long-lived assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">120<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Gains on sale of assets</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating (loss) profit</a></td>
<td class="num">(2,110)<span></span>
</td>
<td class="num">(1,326)<span></span>
</td>
<td class="nump">585<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">380<span></span>
</td>
<td class="nump">336<span></span>
</td>
<td class="nump">289<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense (income), net</a></td>
<td class="nump">28<span></span>
</td>
<td class="num">(37)<span></span>
</td>
<td class="num">(58)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">(Loss) income before taxes</a></td>
<td class="num">(2,518)<span></span>
</td>
<td class="num">(1,625)<span></span>
</td>
<td class="nump">354<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">239<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss) income</a></td>
<td class="num">(2,563)<span></span>
</td>
<td class="num">(1,864)<span></span>
</td>
<td class="nump">279<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to non-controlling interest</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income available to IFF common shareholders</a></td>
<td class="num">(2,567)<span></span>
</td>
<td class="num">(1,871)<span></span>
</td>
<td class="nump">270<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive income (loss), after tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="nump">414<span></span>
</td>
<td class="num">(933)<span></span>
</td>
<td class="num">(848)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Gains on derivatives qualifying as hedges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Pension and postretirement liability adjustment</a></td>
<td class="num">(112)<span></span>
</td>
<td class="nump">158<span></span>
</td>
<td class="nump">115<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">302<span></span>
</td>
<td class="num">(775)<span></span>
</td>
<td class="num">(725)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive loss</a></td>
<td class="num">(2,261)<span></span>
</td>
<td class="num">(2,639)<span></span>
</td>
<td class="num">(446)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss attributable to IFF shareholders</a></td>
<td class="num">$ (2,265)<span></span>
</td>
<td class="num">$ (2,646)<span></span>
</td>
<td class="num">$ (455)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income per share - basic (in dollars per share)</a></td>
<td class="num">$ (10.05)<span></span>
</td>
<td class="num">$ (7.32)<span></span>
</td>
<td class="nump">$ 1.11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income per share - diluted (in dollars per share)</a></td>
<td class="num">$ (10.05)<span></span>
</td>
<td class="num">$ (7.32)<span></span>
</td>
<td class="nump">$ 1.10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Average number of shares outstanding - basic (in shares)</a></td>
<td class="nump">255<span></span>
</td>
<td class="nump">255<span></span>
</td>
<td class="nump">243<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Average number of shares outstanding - diluted (in shares)</a></td>
<td class="nump">255<span></span>
</td>
<td class="nump">255<span></span>
</td>
<td class="nump">243<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_RestructuringandOtherCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restructuring and Other Charges</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_RestructuringandOtherCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-11<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-4<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482739/220-10-55-15<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482517/912-730-25-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308299530288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEET - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 703<span></span>
</td>
<td class="nump">$ 483<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables, net, current</a></td>
<td class="nump">1,726<span></span>
</td>
<td class="nump">1,818<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">2,477<span></span>
</td>
<td class="nump">3,151<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="nump">506<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">875<span></span>
</td>
<td class="nump">770<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="nump">6,293<span></span>
</td>
<td class="nump">7,432<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">4,240<span></span>
</td>
<td class="nump">4,203<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">10,635<span></span>
</td>
<td class="nump">13,373<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Other intangible assets, net</a></td>
<td class="nump">8,357<span></span>
</td>
<td class="nump">9,082<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">689<span></span>
</td>
<td class="nump">743<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">764<span></span>
</td>
<td class="nump">689<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">30,978<span></span>
</td>
<td class="nump">35,522<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Bank borrowings, overdrafts and current portion of long-term debt</a></td>
<td class="nump">885<span></span>
</td>
<td class="nump">410<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_CommercialPaperCurrent', window );">Commercial paper</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">187<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,378<span></span>
</td>
<td class="nump">1,418<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued payroll and bonus</a></td>
<td class="nump">265<span></span>
</td>
<td class="nump">267<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrent', window );">Dividends payable</a></td>
<td class="nump">207<span></span>
</td>
<td class="nump">206<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Liabilities held for sale</a></td>
<td class="nump">46<span></span>
</td>
<td class="nump">212<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">977<span></span>
</td>
<td class="nump">1,028<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">3,758<span></span>
</td>
<td class="nump">3,728<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Other Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">9,186<span></span>
</td>
<td class="nump">10,373<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Retirement liabilities</a></td>
<td class="nump">253<span></span>
</td>
<td class="nump">231<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes</a></td>
<td class="nump">1,937<span></span>
</td>
<td class="nump">2,283<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities</a></td>
<td class="nump">642<span></span>
</td>
<td class="nump">672<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">560<span></span>
</td>
<td class="nump">491<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total Other Liabilities</a></td>
<td class="nump">12,578<span></span>
</td>
<td class="nump">14,050<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies (Note 19)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Redeemable non-controlling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, value, issued</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Capital in excess of par value</a></td>
<td class="nump">19,874<span></span>
</td>
<td class="nump">19,841<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">(Accumulated deficit) retained earnings</a></td>
<td class="num">(2,439)<span></span>
</td>
<td class="nump">955<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(1,896)<span></span>
</td>
<td class="num">(2,198)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, value</a></td>
<td class="num">(963)<span></span>
</td>
<td class="num">(978)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Shareholders&#8217; Equity</a></td>
<td class="nump">14,611<span></span>
</td>
<td class="nump">17,655<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Non-controlling interest</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total Shareholders&#8217; Equity including non-controlling interest</a></td>
<td class="nump">14,642<span></span>
</td>
<td class="nump">17,685<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Shareholders&#8217; Equity</a></td>
<td class="nump">$ 30,978<span></span>
</td>
<td class="nump">$ 35,522<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_CommercialPaperCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commercial Paper, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_CommercialPaperCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5C<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-9<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 23: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5C<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-9<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Subparagraph (12)(c)<br> -Section S99<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480244/480-10-S99-3A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Subparagraph 14<br> -Paragraph 3A<br> -Section S99<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480244/480-10-S99-3A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Subparagraph 15<br> -Paragraph 3A<br> -Section S99<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480244/480-10-S99-3A<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Subparagraph (16)(c)<br> -Paragraph 3A<br> -Section S99<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480244/480-10-S99-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-3<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 38: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 40: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 41: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-15<br><br>Reference 42: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-16<br><br>Reference 43: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481520/505-30-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308296327152">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEET (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Trade receivables, allowance for credit losses</a></td>
<td class="nump">$ 52<span></span>
</td>
<td class="nump">$ 53<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.125<span></span>
</td>
<td class="nump">$ 0.125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">275,726,629<span></span>
</td>
<td class="nump">275,726,629<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">255,288,535<span></span>
</td>
<td class="nump">254,968,463<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, shares</a></td>
<td class="nump">20,438,094<span></span>
</td>
<td class="nump">20,758,166<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479344/326-20-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308300625488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss) income</a></td>
<td class="num">$ (2,563)<span></span>
</td>
<td class="num">$ (1,864)<span></span>
</td>
<td class="nump">$ 279<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,142<span></span>
</td>
<td class="nump">1,179<span></span>
</td>
<td class="nump">1,156<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(369)<span></span>
</td>
<td class="num">(237)<span></span>
</td>
<td class="num">(236)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">Gains on sale of assets</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Losses (gains) on business divestitures</a></td>
<td class="nump">23<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">65<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="nump">54<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionContributions', window );">Pension contributions</a></td>
<td class="num">(36)<span></span>
</td>
<td class="num">(36)<span></span>
</td>
<td class="num">(37)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_AmortizationOfInventoryStepUp', window );">Amortization Of Inventory Step-Up</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">368<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment of goodwill</a></td>
<td class="nump">2,623<span></span>
</td>
<td class="nump">2,250<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of long-lived assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">120<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory Write-down</a></td>
<td class="nump">72<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities, net of acquisitions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Trade receivables</a></td>
<td class="nump">51<span></span>
</td>
<td class="num">(117)<span></span>
</td>
<td class="num">(169)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="nump">605<span></span>
</td>
<td class="num">(893)<span></span>
</td>
<td class="num">(363)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(39)<span></span>
</td>
<td class="num">(57)<span></span>
</td>
<td class="nump">419<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Accruals for incentive compensation</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(34)<span></span>
</td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities', window );">Other current payables and accrued expenses</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">92<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other assets/liabilities, net</a></td>
<td class="num">(149)<span></span>
</td>
<td class="num">(41)<span></span>
</td>
<td class="num">(120)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">1,439<span></span>
</td>
<td class="nump">397<span></span>
</td>
<td class="nump">1,437<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash paid for acquisitions, net of cash received</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(110)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Additions to property, plant and equipment</a></td>
<td class="num">(503)<span></span>
</td>
<td class="num">(504)<span></span>
</td>
<td class="num">(393)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Additions to intangible assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfProductiveAssets', window );">Proceeds from disposal of assets</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities', window );">Proceeds from unwinding of derivative instruments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">173<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_ProceedsFromBusinessCombination', window );">Cash acquired from acquisition</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">246<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Net proceeds received from business divestitures</a></td>
<td class="nump">1,050<span></span>
</td>
<td class="nump">1,169<span></span>
</td>
<td class="nump">115<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="nump">574<span></span>
</td>
<td class="nump">745<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Cash dividends paid to shareholders</a></td>
<td class="num">(826)<span></span>
</td>
<td class="num">(810)<span></span>
</td>
<td class="num">(667)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsMinorityInterest', window );">Payments of Ordinary Dividends, Noncontrolling Interest</a></td>
<td class="num">(13)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt', window );">(Decrease) increase in revolving credit facility and short term borrowings</a></td>
<td class="num">(99)<span></span>
</td>
<td class="nump">104<span></span>
</td>
<td class="num">(105)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_ProceedsFromIssuanceOfCommercialPaperMaturingInMoreThanThreeMonths', window );">Proceeds from issuance of commercial paper (maturities after three months)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">225<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_RepaymentsOfCommercialPaperMaturingInMoreThanThreeMonths', window );">Repayments of commercial paper (maturities after three months)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(421)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_NetBorrowingsRepaymentsOfCommercialPaperMaturingInLessThanThreeMonths', window );">Net (repayments) borrowings of commercial paper (maturities less than three months)</a></td>
<td class="num">(187)<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="nump">324<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfFinancingCosts', window );">Deferred financing costs</a></td>
<td class="num">(5)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of long-term debt</a></td>
<td class="num">(655)<span></span>
</td>
<td class="num">(300)<span></span>
</td>
<td class="num">(828)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest', window );">Purchases of redeemable non-controlling interests</a></td>
<td class="num">(39)<span></span>
</td>
<td class="num">(47)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuance of long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Deferred consideration paid</a></td>
<td class="num">(6)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Employee withholding taxes paid</a></td>
<td class="num">(13)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other, net</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(1,851)<span></span>
</td>
<td class="num">(1,229)<span></span>
</td>
<td class="num">(1,304)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash, cash equivalents and restricted cash</a></td>
<td class="nump">21<span></span>
</td>
<td class="num">(77)<span></span>
</td>
<td class="num">(59)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net change in cash, cash equivalents and restricted cash</a></td>
<td class="nump">183<span></span>
</td>
<td class="num">(164)<span></span>
</td>
<td class="nump">56<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at beginning of year</a></td>
<td class="nump">552<span></span>
</td>
<td class="nump">716<span></span>
</td>
<td class="nump">660<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of year</a></td>
<td class="nump">735<span></span>
</td>
<td class="nump">552<span></span>
</td>
<td class="nump">716<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Disclosures:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid, net of amounts capitalized</a></td>
<td class="nump">370<span></span>
</td>
<td class="nump">310<span></span>
</td>
<td class="nump">310<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income taxes paid</a></td>
<td class="nump">578<span></span>
</td>
<td class="nump">329<span></span>
</td>
<td class="nump">289<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Accrued capital expenditures</a></td>
<td class="nump">$ 109<span></span>
</td>
<td class="nump">$ 150<span></span>
</td>
<td class="nump">$ 117<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_AmortizationOfInventoryStepUp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization Of Inventory Step-Up</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_AmortizationOfInventoryStepUp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_NetBorrowingsRepaymentsOfCommercialPaperMaturingInLessThanThreeMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Borrowings (Repayments) Of Commercial Paper, Maturing In Less Than Three Months</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_NetBorrowingsRepaymentsOfCommercialPaperMaturingInLessThanThreeMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_ProceedsFromBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Business Combination</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_ProceedsFromBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_ProceedsFromIssuanceOfCommercialPaperMaturingInMoreThanThreeMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Issuance Of Commercial Paper, Maturing In More Than Three Months</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_ProceedsFromIssuanceOfCommercialPaperMaturingInMoreThanThreeMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_RepaymentsOfCommercialPaperMaturingInMoreThanThreeMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Repayments Of Commercial Paper, Maturing In More Than Three Months</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_RepaymentsOfCommercialPaperMaturingInMoreThanThreeMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-5<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483080/330-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (f)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period for redemption of redeemable noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsMinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsMinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for loan and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionContributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for pension benefit. Includes, but is not limited to, employer contribution to fund plan asset and payment to retiree. Excludes other postretirement benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionContributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow provided by derivative instruments during the period, which are classified as investing activities, excluding those designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308302219888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENT OF SHAREHOLDERS EQUITY - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common stock</div></th>
<th class="th"><div>Capital&#160;in excess&#160;of par&#160;value</div></th>
<th class="th"><div>Retained earnings (accumulated deficit)</div></th>
<th class="th"><div>Accumulated other comprehensive (loss) income</div></th>
<th class="th"><div>Treasury stock</div></th>
<th class="th"><div>Non-controlling interest</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,588,147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance , common stock (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(128,526,137)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="nump">$ 6,322<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">$ 3,853<span></span>
</td>
<td class="nump">$ 4,156<span></span>
</td>
<td class="num">$ (698)<span></span>
</td>
<td class="num">$ (1,017)<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net (loss) income</a></td>
<td class="nump">273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Cumulative translation adjustment</a></td>
<td class="num">(848)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(848)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Gains (losses) on derivatives qualifying as hedges, net of tax</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Pension liability and postretirement adjustment; net of tax</a></td>
<td class="nump">115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="num">(785)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(785)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock options/SSARs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">159,222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock options/SSARs</a></td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Impact of N&amp;B Merger (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">141,740,461<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Purchase of NCI</a></td>
<td class="nump">15,976<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">15,936<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits', window );">Conversion of tangible equity units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,460,031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits', window );">Conversion of tangible equity units</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Vested restricted stock units and awards</a></td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Vested restricted stock units and awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">276,280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest', window );">Redeemable NCI</a></td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Dividends on non-controlling interest and other</a></td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(275,726,629)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 31, 2021</a></td>
<td class="nump">21,117<span></span>
</td>
<td class="nump">$ 35<span></span>
</td>
<td class="nump">19,826<span></span>
</td>
<td class="nump">3,641<span></span>
</td>
<td class="num">(1,423)<span></span>
</td>
<td class="num">$ (997)<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,152,645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net (loss) income</a></td>
<td class="num">(1,868)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,871)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Cumulative translation adjustment</a></td>
<td class="num">(933)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(933)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Gains (losses) on derivatives qualifying as hedges, net of tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Pension liability and postretirement adjustment; net of tax</a></td>
<td class="nump">158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="num">(815)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(815)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock options/SSARs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,728<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock options/SSARs</a></td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Vested restricted stock units and awards</a></td>
<td class="num">(26)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(41)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Vested restricted stock units and awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">308,751<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Purchase of NCI</a></td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest', window );">Redeemable NCI</a></td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Dividends on non-controlling interest and other</a></td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(275,726,629)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 31, 2022</a></td>
<td class="nump">$ 17,685<span></span>
</td>
<td class="nump">$ 35<span></span>
</td>
<td class="nump">19,841<span></span>
</td>
<td class="nump">955<span></span>
</td>
<td class="num">(2,198)<span></span>
</td>
<td class="num">$ (978)<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, shares</a></td>
<td class="nump">20,758,166<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,758,166<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net (loss) income</a></td>
<td class="num">$ (2,563)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,567)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Cumulative translation adjustment</a></td>
<td class="nump">414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Gains (losses) on derivatives qualifying as hedges, net of tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Pension liability and postretirement adjustment; net of tax</a></td>
<td class="num">(112)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(112)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="num">(827)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(827)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock options/SSARs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock options/SSARs</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Vested restricted stock units and awards</a></td>
<td class="num">(11)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Vested restricted stock units and awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">230,222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest', window );">Redeemable NCI</a></td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Dividends on non-controlling interest and other</a></td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(275,726,629)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 31, 2023</a></td>
<td class="nump">$ 14,642<span></span>
</td>
<td class="nump">$ 35<span></span>
</td>
<td class="nump">$ 19,874<span></span>
</td>
<td class="num">$ (2,439)<span></span>
</td>
<td class="num">$ (1,896)<span></span>
</td>
<td class="num">$ (963)<span></span>
</td>
<td class="nump">$ 31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, shares</a></td>
<td class="nump">20,438,094<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,438,094<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromRedemptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-23<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromRedemptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (3)<br> -SubTopic 10<br> -Topic 480<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480244/480-10-S99-3A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-3<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 38: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 40: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 41: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-15<br><br>Reference 42: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-16<br><br>Reference 43: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308306075440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENT OF SHAREHOLDERS EQUITY (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax', window );">Other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification, tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax', window );">Tax effect of pension liability and postretirement adjustment</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="num">$ (4)<span></span>
</td>
<td class="num">$ (4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per share (in dollars per share)</a></td>
<td class="nump">$ 3.24<span></span>
</td>
<td class="nump">$ 3.20<span></span>
</td>
<td class="nump">$ 3.12<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-12<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308312774112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Operations and Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock', window );">Nature of Operations and Summary of Significant Accounting Policies</a></td>
<td class="text">NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nature of Operations</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International Flavors &amp; Fragrances Inc. and its subsidiaries (the &#8220;Registrant,&#8221; &#8220;IFF,&#8221; &#8220;the Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; and &#8220;our&#8221;) is a leading creator and manufacturer of food, beverage, health &amp; biosciences, scent and pharma solutions and complementary adjacent products, including cosmetic active and natural health ingredients, which are used in a wide variety of consumer products. Our products are sold principally to manufacturers of perfumes and cosmetics, hair and other personal care products, soaps and detergents, cleaning products, dairy, meat and other processed foods, beverages, snacks and savory foods, sweet and baked goods, sweeteners, dietary supplements, food protection, infant and elderly nutrition, functional food, and pharmaceutical excipients and oral care products.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 1, 2021 (the &#8220;Closing Date&#8221;), the Company completed the combination (the &#8220;Merger&#8221;) of IFF and DuPont de Nemours, Inc (&#8220;DuPont&#8221;) nutrition and biosciences business (the &#8220;N&amp;B Business&#8221;), which had been transferred to Nutrition and Biosciences, Inc., a Delaware corporation and wholly owned subsidiary of DuPont (&#8220;N&amp;B&#8221;) in a Reverse Morris Trust transaction. See Note 3 for additional information. As a result, the Company&#8217;s Consolidated Financial Statements for the periods ended December&#160;31, 2023 and 2022 reflect the results of N&amp;B for the full twelve months of 2023 and 2022, whereas the period ended December&#160;31, 2021 only reflect the results of N&amp;B from the Closing Date.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Correction of Prior Year Consolidated Financial Statements</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company revised its Operating lease right-of-use assets from $636 million to $743 million and Operating lease liabilities from $565 million to $672 million on its Consolidated Balance Sheets as of December&#160;31, 2022. This reflects the correction of an error of $107 million related to a lease renewal that was not correctly reflected in the prior year period.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company revised its Goodwill from $13.355&#160;billion to $13.373&#160;billion and Deferred income tax liabilities from $2.265 billion to $2.283 billion on its Consolidated Balance Sheets as of December&#160;31, 2022. This reflects the correction of an error of $18 million related to deferred income tax liabilities as part of purchase accounting for the Merger with N&amp;B.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also corrected an error related to the fair value of derivative assets and liabilities of cross currency swaps. As a result of this correction, the Company revised its Other assets from $699 million to $689 million, which included a $9 million impact to deferred income taxes, Other liabilities from $472 million to $491 million and Accumulated other comprehensive loss from $2.169 billion to $2.198 billion on its Consolidated Balance Sheets as of December&#160;31, 2022. The Company also revised its Cumulative translation adjustment from $(904)&#160;million to $(933)&#160;million on its Consolidated Statements of Shareholders&#8217; Equity for the year ended December&#160;31, 2022.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also adjusted the disclosure of its total receivables factored for the years ended December&#160;31, 2022 and 2021 from $1.030 billion to $1.451 billion and $668 million to $1.167 billion, respectively, and the outstanding principal amounts of receivables from $212 million to $157 million as of December&#160;31, 2022.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impacts of these corrections are also presented in the related footnotes.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fiscal Year End</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a calendar year of the twelve-month period from January 1 to December 31.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) requires management to make estimates and judgments that affect the amounts reported in the Consolidated Financial Statements and accompanying notes. The inputs into the Company&#8217;s judgments and estimates take into account ongoing global current events and adverse macroeconomic impacts on the critical and significant accounting estimates, including estimates associated with future cash flows that are used in assessing the risk of impairment of certain assets. Actual results could differ from those estimates.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Consolidated Financial Statements include the accounts of International Flavors&#160;&amp; Fragrances Inc. and those of its subsidiaries. Significant intercompany balances and transactions have been eliminated. To the extent a subsidiary is not wholly owned, any related non-controlling interests are included as a separate component of Shareholders&#8217; Equity.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue from contracts with customers when the contract or purchase order has received approval and commitment from both parties, has the rights of the parties and payment terms (which can vary by customer) identified, has commercial substance, collectability of consideration is probable, and control has transferred. The revenue recognized reflects the consideration the Company expects to be entitled to in exchange for those goods. Sales, value added, and other taxes the Company collects are excluded from revenues. The Company receives payment in accordance with standard customer terms.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales are reduced, at the time revenue is recognized, for applicable discounts, rebates and sales allowances based on historical experience. Related accruals are included in Other current liabilities in the accompanying Consolidated Balance Sheets. The Company considers shipping and handling activities undertaken after the customer has obtained control of the related goods as a fulfillment activity. Net sales include shipping and handling charges billed to customers. Cost of goods sold includes all costs incurred in connection with shipping and handling.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract Assets and Liabilities</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to a small number of contracts for the sale of compounds, the Company has an &#8220;enforceable right to payment for performance to date&#8221; and as the products do not have an alternative use, the Company recognizes revenue for these contracts over time and records a contract asset using the output method. The output method recognizes revenue on the basis of direct measurements of the value to the customer of the goods or services transferred to date relative to the remaining goods or services promised under the contract.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023 and 2022, the Company&#8217;s gross accounts receivable was $1.778&#160;billion and $1.871&#160;billion, respectively. The Company&#8217;s contract assets and contract liabilities as of December&#160;31, 2023 and 2022 were not material.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Translation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company translates the assets and liabilities of non-U.S. subsidiaries into U.S. dollars at year-end exchange rates. Income and expense items are translated at average exchange rates during the year. Cumulative translation adjustments are shown as a separate component of Shareholders&#8217; Equity.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development (&#8220;R&amp;D&#8221;) expenses relate to the development of new and improved products, technical product support and compliance with governmental regulation. All research and development costs are expensed as incurred.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents include highly liquid investments with maturities of three months or less at date of purchase.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Cash</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash is comprised of cash or cash equivalents which has been placed into an account that is restricted for a specific use and from which the Company cannot withdraw the cash on demand.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of cash, cash equivalents and restricted cash reported on the Company&#8217;s balance sheets as of December&#160;31, 2023, 2022 and 2021 to the amounts reported on the Company&#8217;s statement of cash flows periods ended December&#160;31, 2023, 2022 and 2021.</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.391%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.391%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.394%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">703&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">711&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents included in Assets held for sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">552&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">716&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts Receivable</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has various factoring agreements globally under which it can factor up to approximately $300&#160;million of its trade receivables (&#8220;Company&#8217;s own factoring agreements&#8221;). In addition, the Company utilizes factoring agreements sponsored by certain customers. Under all of the arrangements, the Company sells the trade receivables on a non-recourse basis to </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">unrelated financial institutions and accounts for the transactions as sales of receivables. The applicable receivables are removed from the Company&#8217;s Consolidated Balance Sheets when the cash proceeds are received by the Company.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sold approximately $1.752&#160;billion, $1.451 billion and $1.167&#160;billion of receivables in 2023, 2022 and 2021, respectively, under the Company&#8217;s own factoring agreements and customer sponsored factoring agreements. The cost of participating in these programs was approximately $25&#160;million, $12 million and $6 million, in 2023, 2022 and 2021, respectively, and is included as a component of interest expense. Under the Company&#8217;s own factoring agreements for which the Company has continued responsibility to collect receivables and provide to its sponsor, it sold approximately $843&#160;million, $547&#160;million and $197&#160;million of receivables in 2023, 2022 and 2021, respectively. The outstanding principal amounts of receivables under the Company&#8217;s own factoring agreements amounted to approximately $196 million and $157 million as of December&#160;31, 2023 and 2022, respectively. The proceeds from the sales of receivables are included in net cash from operating activities in the Consolidated Statements of Cash Flows.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Expected Credit Losses</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to credit losses primarily through its sales of products. To determine the appropriate allowance for expected credit losses, the Company considers certain credit quality indicators, such as aging of customer receivable balances, loss history and creditworthiness of debtors. The Company also considers current and anticipated future conditions of the general economy in the determination of allowances, including significant aspects of a geographic location and the industries in which the Company operates. The Company&#8217;s general allowance for credit losses is calculated using a loss rate model that is primarily based on historical write-off experiences and applied to trade receivables. As necessary, additional reserves are established based on other factors, such as aging of receivables, customer credit quality and account collectability and country risk. These allowances are reviewed and approved by the Regional and Global Credit committees.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, the Company reported $1.726 billion of trade receivables, net of allowances of $52 million. Based on the aging analysis as of December&#160;31, 2023, approximately 1% of the Company&#8217;s accounts receivable were past due by over 365 days based on the payment terms of the invoice.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a roll forward of the Company&#8217;s allowances for bad debts for the years ended December 31, 2022 and 2023:</span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:83.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.544%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Allowance for Bad Debts</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad debt expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad debt expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Bad debt expense included approximately $11&#160;million related to expected credit losses on receivables from customers located in Russia and Ukraine (for export and domestic sales) due to the events in those countries.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Bad debt expense included approximately $13 million related to expected credit losses on receivables from certain customers in Egypt, offset by approximately $8 million of reversals of allowances on receivables from customers located in Russia and Ukraine. The Company will continue to evaluate its credit exposure related to Egypt, Russia and Ukraine.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost (on a weighted-average basis) or net realizable value. The Company&#8217;s inventories consisted of the following:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">779&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,073&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">442&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,292&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,636&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,477&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,151&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if an arrangement is a lease at contract inception. A lease exists when a contract conveys to the customer the right to control the use of identified property, plant or equipment for a period of time in exchange for consideration. The definition of a lease embodies two conditions: (1) there is an identified asset in the contract that is land or a depreciable asset (i.e., property, plant, and equipment), and (2) the customer has the right to control the use of the identified asset.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When the Company determines the arrangement is a lease, or contains a lease, at inception, it then determines whether the lease is an operating lease or a finance lease at the commencement date.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases property and equipment principally under operating leases and records a right-of-use asset and related obligation at the present value of lease payments. Over the term of the lease, the Company depreciates the right-of-use asset and accretes the related obligation to future value. Some of the leases include rental escalation clauses, renewal options and/or termination options that are factored into the determination of lease payments when appropriate. The Company has elected not to separate non-lease components from lease components for all classes of leased assets.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When available, the Company uses the rate implicit in the lease to discount lease payments to present value, however, most of the Company&#8217;s leases do not provide a readily determinable implicit rate and the Company calculates the applicable incremental borrowing rate to discount the lease payments based on the term of the lease at lease commencement. The incremental borrowing rate is determined based on the Company&#8217;s credit rating, currency and lease terms.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Long-Lived Assets</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Property, Plant and Equipment</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment are recorded at cost. Depreciation is calculated on a straight-line basis, principally over the following estimated useful lives: buildings and improvements, 1 to 40 years; machinery and equipment, 1 to 20 years; information technology hardware and software, 1 to 7 years; and leasehold improvements which are included in buildings and improvements, the estimated life of the improvements or the remaining term of the lease, whichever is shorter.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest incurred during the construction period of certain property, plant and equipment is capitalized until the underlying assets are placed in service, at which time straight-line amortization of the capitalized interest begins over the estimated useful lives of the related assets. Capitalized interest was approximately $17 million, $13 million and $9 million for the years ended December&#160;31, 2023, 2022 and 2021, respectively.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Finite-Lived Intangible Assets</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finite-lived intangible assets include customer relationships, patents, trade names, technological know-how and other intellectual property valued at acquisition and are amortized on a straight-line basis over the following estimated useful lives: customer relationships, 10 to 27 years; patents, 11 to 15 years; trade names, 4 to 28 years; and technological know-how, 5 to 28 years.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews long-lived assets for impairment when events or changes in business conditions indicate that their carrying value may not be recovered. An estimate of undiscounted future cash flows produced by an asset or group of assets is compared to the carrying value to determine whether impairment exists. If assets are determined to be impaired, the loss is measured based on an estimate of fair value using various valuation techniques, including a discounted estimate of future cash flows.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Israel-Hamas War</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains operations in Israel and, additionally, exports products to customers in Israel from operations outside the region. The Company will continue to evaluate the current events and any potential impacts related to this matter, but does not expect there to be a material impact to its Consolidated Financial Statements.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Russia-Ukraine War</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains operations in both Russia and Ukraine and, additionally, exports products to customers in Russia and Ukraine from operations outside the region. In response to the events in Ukraine, the Company has limited the production and supply of ingredients in and to Russia to only those that meet the essential needs of people, including food, hygiene and medicine.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowances for Bad Debts</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, the Company had a reserve of approximately $3&#160;million related to expected credit losses on receivables from customers located in Russia and Ukraine. The Company will continue to evaluate its credit exposure related to Russia and Ukraine.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impairment of Long-Lived Assets</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2022, the sales and margins declined for certain entities within Russia due to supply chain issues, reduced product demand and exchange rate volatility. Further, it was determined that such declines in operating performance were not expected to reverse in the near future. Additionally, future growth was expected to be limited given operating conditions in Russia, which inhibit the required future investment.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with uncertainties related to the Company&#8217;s operations in Russia and Ukraine, the Company updated its analysis of the undiscounted cash flows of the applicable asset groups to determine if the cash flows exceeded the carrying values of the applicable asset groups. With respect to an asset group in the Nourish segment, that manufactures and sells in Russia and related markets, it was determined that the undiscounted cash flows were insufficient to cover the carrying value and that an impairment charge was required to write-down the long-lived assets to their fair values. The fair value of such asset group was determined based on a discounted cash flow approach which involved estimating the future cash flows for the business discounted to their present values. The discount rate used in the determination of such fair value was based on consideration of the risks inherent in the cash flows and market as of the valuation date.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of this assessment, the Company recognized an impairment charge of $120 million in the Consolidated Statements of (Loss) Income and Comprehensive Loss for the year ended December 31, 2022, which was allocated on a pro rata basis to intangible assets and property, plant and equipment within the asset group in the amounts of approximately $92 million and $28 million, respectively.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the difference between the total purchase price and the fair value of identifiable assets and liabilities acquired in business acquisitions.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company tests goodwill for impairment at the reporting unit level as of November 30 every year or more frequently if events or changes in circumstances indicate the asset might be impaired. A reporting unit is an operating segment or one level below an operating segment (referred to as a component) to which goodwill is assigned when initially recorded.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company identifies their reporting units by assessing whether the components of their reporting units constitute businesses for which discrete financial information is available and management of each reporting unit regularly reviews the operating results of those components. The Company determined that it has six reporting units under the Nourish, Health &amp; Biosciences, Scent and Pharma Solutions segments: (1) Nourish, (2) Fragrance Compounds, (3) Fragrance Ingredients, (4) Cosmetic Ingredients, (5) Health &amp; Biosciences and (6) Pharma Solutions. These reporting units were determined based on the level at which the performance is measured and reviewed by segment management. In cases where the components of an operating segment have similar economic characteristics, they are aggregated into a single reporting unit.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When testing goodwill for impairment, the Company has the option of first performing a qualitative assessment to determine whether it is more likely than not that the fair value of a reporting unit is less than the carrying amount. If the Company elects to bypass the qualitative assessment for any reporting units, or if a qualitative assessment indicates it is more likely than not that the estimated carrying value of a reporting unit exceeds its fair value, the Company performs a quantitative goodwill impairment test.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the quantitative goodwill impairment test, if a reporting unit&#8217;s carrying amount exceeds its fair value, the Company will record an impairment charge based on that difference, and the impairment charge will be limited to the amount of goodwill allocated to that reporting unit.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2023, the Company determined that the carrying value of the Nourish reporting unit exceeded its fair value and recorded an impairment charge of $2.623&#160;billion in the Consolidated Statements of (Loss) Income and Comprehensive Loss for the year ended December 31, 2023. During 2022, the Company determined that the carrying value of the Health &amp; Biosciences reporting unit exceeded its fair value and recorded a goodwill impairment charge of $2.250 billion in the Consolidated Statements of (Loss) Income and Comprehensive Loss for the year ended December 31, 2022. See Note 6 for additional information.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for taxes under the asset and liability method. Under this method, deferred income taxes are recognized for temporary differences between the financial statement and tax return bases of assets and liabilities, based on enacted tax rates and other provisions of the tax law. The effect of a change in tax laws or rates on deferred tax assets and liabilities is recognized as income in the period in which such change is enacted. Future tax benefits are recognized to the extent that the realization of such benefits is more likely than not, and a valuation allowance is established for any portion of a deferred tax asset that management believes may not be realized.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes uncertain tax positions that it has taken or expects to take on a tax return. Pursuant to accounting requirements, the Company first determines whether it is &#8220;more likely than not&#8221; its tax position will be sustained if the relevant tax authority were to audit the position with full knowledge of all the relevant facts and other information. For those tax positions that meet this threshold, the Company measures the amount of tax benefit based on the largest amount of tax benefit that it has a greater than 50% chance of realizing in a final settlement with the relevant authority. Those tax positions failing to qualify for initial recognition are recognized in the first interim period in which they meet the more likely than not standard. The Company maintains a cumulative risk portfolio relating to all of its uncertainties in income taxes in order to perform this analysis, but the evaluation of its tax positions requires significant judgment and estimation in part because, in certain cases, tax law is subject to varied interpretation, and whether a tax position will ultimately be sustained may be uncertain.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest and penalties related to unrecognized tax benefits are recognized as a component of income tax expense.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Retirement Benefits</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current service costs of retirement plans and postretirement health care and life insurance benefits are accrued. Prior service costs resulting from plan improvements are amortized over periods ranging from 10 to 20 years.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Instruments</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative financial instruments are used to manage interest and foreign currency exposures. The gain or loss on the hedging instrument is recorded in earnings at the same time as the transaction being hedged is recorded in earnings. The associated asset or liability related to the open hedge instrument is recorded in Prepaid expenses and Other current assets or Other current liabilities, as applicable.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records all derivative financial instruments on the balance sheet at fair value. Changes in a derivative&#8217;s fair value are recognized in earnings unless specific hedge criteria are met. If the derivative is designated as a fair value hedge, the changes in the fair value of the derivative and of the hedged item attributable to the hedged risk are recognized in Net (loss) income. If the derivative is designated as a cash flow hedge, the effective portions of changes in the fair value of the derivative are recorded in Accumulated other comprehensive income (loss) (&#8220;AOCI&#8221;) in the accompanying Consolidated Balance Sheets and are subsequently recognized in Net (loss) income when the hedged item affects earnings. Ineffective portions of changes in the fair value of cash flow hedges, if any, are recognized as a charge or credit to earnings.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Software Costs</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes direct internal and external development costs for certain significant projects associated with internal-use software and amortizes these costs over seven years. Neither preliminary evaluation costs nor costs associated with the software after implementation are capitalized. Costs related to projects that are not significant are expensed as incurred.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net (Loss) Income Per Share</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the two-class method, earnings are adjusted by accretion of amounts to redeemable non-controlling interests recorded at redemption value. The adjustments represent in-substance dividend distributions to the non-controlling interest holders as the holders have a contractual right to receive a specified amount upon redemption. As a result, earnings are adjusted to reflect this in-substance distribution that is different from other common shareholders.&#160;In addition, the Company has unvested share based payment awards with a right to receive nonforfeitable dividends and thus are considered participating securities which are required to be included in the computation of basic and diluted earnings per share.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic (loss) income per share represents the amount of earnings available to each share of common stock outstanding during the period. Basic (loss) income per share includes the effect of issuing shares of common stock, where (i) for 2021, the prepaid stock purchase contracts (&#8220;SPCs&#8221;) were converted using the final settlement rate on September 14, 2021 (see Note 11 for additional information), and (ii) an adjustment to (loss) income to reflect adjustments made to record the redeemable value of redeemable non-controlling interests. Diluted (loss) income per share also includes the effect of issuing shares of common stock, assuming (i) stock options and warrants are exercised, (ii) restricted stock units are fully vested under the treasury stock method, and (iii) for 2021, the incremental effect of the prepaid SPCs were converted using the final settlement rate on September 14, 2021 (see Note 11 for additional information).</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation cost of all stock-based awards is measured at fair value on the date of grant and recognized over the service period for which awards are expected to vest. The cost of such stock-based awards is principally recognized on a straight-line attribution basis over their respective vesting periods, net of estimated forfeitures.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financing Costs</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs incurred in the issuance of debt are deferred and amortized as part of interest expense over the stated life of the applicable debt instrument. Unamortized deferred financing costs relating to debt are presented as a reduction in the amount of </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">debt outstanding on the Consolidated Balance Sheets. Unamortized deferred financing costs relating to the revolving credit facility are recorded in Other assets on the Consolidated Balance Sheets.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Redeemable Non-controlling Interests</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-controlling interests in subsidiaries that are redeemable for cash or other assets outside of the Company&#8217;s control are classified as mezzanine equity, outside of equity and liabilities, at the greater of the carrying value or the redemption value. The increases or decreases in the estimated redemption amount are recorded with corresponding adjustments against Capital in excess of par value and are reflected in the computation of earnings per share using the two-class method. As of December 31, 2023, the Company has acquired or sold all of its remaining redeemable non-controlling interests. See Note 20 for additional information.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Held for Sale</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities to be disposed of by sale (&#8220;disposal groups&#8221;) are reclassified into assets and liabilities held for sale on the Company&#8217;s Consolidated Balance Sheets. The reclassification occurs when an agreement to sell exists, or management has committed to a plan to sell the assets within one year. Disposal groups are measured at the lower of carrying value or fair value less costs to sell and are not depreciated or amortized. When the net realizable value of a disposal group increases during a period, a gain can be recognized to the extent that it does not increase the value of the disposal group beyond its original carrying value when the disposal group was reclassified as held for sale. The fair value of a disposal group, less any costs to sell, is assessed each reporting period it remains classified as held for sale and any remeasurement to the lower of carrying value or fair value less costs to sell is reported as an adjustment to the carrying value of the disposal group. See Note 21 for additional information.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supply Chain Financing Program</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2023, the Company entered into a supply chain financing (&#8220;SCF&#8221;) program. The program is expected to be available to U.S. based suppliers starting in the second quarter of 2024. The Company makes continuous efforts to improve working capital efficiency and has worked with suppliers to optimize payment terms and conditions. The Company&#8217;s current payment terms with a majority of suppliers generally range from 0 to 180 days, which is deemed to be commercially reasonable. The Company&#8217;s voluntary SCF program will allow its suppliers to elect to sell the receivables owed to them by the Company to a third-party financial institution. The suppliers, at their own discretion, will determine the invoices they want to sell and directly negotiate the arrangements with the participating third-party financial institution. Supplier participation in the program is solely the decision of the supplier and has no bearing on the Company&#8217;s payment terms and amounts due with the supplier. The Company&#8217;s responsibility will be limited to making payments based upon the agreed upon contractual terms and arrangements. The Company will not provide any form of guarantees under the SCF program and will have no economic interest in the suppliers&#8217; decision to participate in the SCF program. Amounts due to suppliers that elect to participate in the SCF program will be included in Accounts payable on the Consolidated Balance Sheets. The Company, or the third-party financial institution, may choose to terminate the agreement of the program at any time upon 30 days&#8217; prior written notice. The third-party financial institution may also terminate the agreement of the program at any time upon three business days&#8217; prior written notice in the event there are insufficient funds available for disbursements. As of December&#160;31, 2023 and 2022, there were no amounts outstanding related to suppliers&#8217; participation in the SCF program.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2023-09, &#8220;Income Taxes (Topic 740): Improvements to Income Tax Disclosures.&#8221; The ASU was issued to further enhance income tax disclosures, primarily through standardization and disaggregation of rate reconciliation categories and income taxes paid by jurisdiction. This guidance is effective for fiscal years beginning after December 15, 2024, with early adoption permitted, and may be applied either prospectively or retrospectively. The Company is currently evaluating the impact that this guidance will have on its Consolidated Financial Statements and income tax disclosures.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the FASB issued ASU 2023-07, &#8220;Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.&#8221; The ASU intends to improve reportable segment disclosure requirements, primarily through enhanced disclosures of significant segment expenses that are regularly provided to the Chief Operating Decision Maker and included within segment profit and loss. This guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted, and applied retrospectively to all prior periods presented in the financial statements. The Company is currently evaluating the impact that this guidance will have on its Consolidated Financial Statements and reportable segment disclosures.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, the FASB issued ASU 2022-06, &#8220;Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848.&#8221; The ASU was issued to provide an update on ASU 2020-04 and ASU 2021-01 that were issued in March 2020 and January 2021, respectively, which provided optional accounting guidance for a limited period of time to ease the potential burden in accounting for reference rate reform. The guidance provides optional expedients and exceptions to existing accounting requirements for contract modifications and hedge accounting related to transitioning from discontinued reference rates, such as London Interbank Offered Rate (&#8220;LIBOR&#8221;), to alternative reference rates, if certain criteria are met. With the issuance of ASU 2022-06, the sunset date of Topic 848 has been deferred from December 31, 2022 to December 31, 2024, after which entities will no longer be permitted to apply the relief in Topic 848. The Company has adopted this guidance on January 1, 2023, which did not have a material impact on its Consolidated Financial Statements. On March 23, 2023, the Company amended certain existing debt agreements where the interest rate benchmark was updated from LIBOR to the Secured Overnight Financing Rate (&#8220;Term SOFR&#8221;). The Company applied Topic 848 to its recent amendments of its debt agreements. See Note 9 for additional information on the amendments to the debt agreements.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, the FASB issued ASU 2022-04, &#8220;Liabilities - Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations.&#8221; The ASU requires that a buyer in a supplier finance program disclose sufficient information about the program to allow users of the financial statements to understand the program&#8217;s nature, activity during the period, changes from period to period and potential magnitude. The buyer should disclose qualitative and quantitative information about its supplier finance programs. The ASU requires the buyer&#8217;s annual disclosure to include a roll forward of the obligations under the supplier finance programs during the annual period, including the amount of obligations confirmed and subsequently paid. This guidance is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the amendment on roll forward information, which is effective for fiscal years beginning after December 15, 2023, and early adoption is permitted. The Company has adopted this guidance on January 1, 2023, which did not have a material impact on its Consolidated Financial Statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 275<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//275/tableOfContent<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//810/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308313035552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and Other Charges<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring and Other Charges</a></td>
<td class="text">RESTRUCTURING AND OTHER CHARGES<div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring and other charges primarily consist of separation costs for employees including severance, outplacement and other employee benefit costs (&#8220;Severance&#8221;), charges related to the write-down of fixed assets of plants to be closed (&#8220;Fixed asset write-down&#8221;) and all other related restructuring (&#8220;Other&#8221;) costs. All restructuring and other charges are separately stated on the Consolidated Statements of (Loss) Income and Comprehensive Loss.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Frutarom Integration Initiative</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the acquisition of Frutarom, the Company executed an integration plan that, among other initiatives, sought to optimize its manufacturing network (the &#8220;Frutarom Integration Initiative&#8221;). Since the inception of the initiative, the Company closed 22 sites and expensed total costs of approximately $36 million. As of the first quarter of 2023, the Frutarom Integration Initiative was completed.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2019 Severance Program</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2019, the Company incurred severance charges related to approximately 190 headcount reductions, excluding those previously mentioned under the Frutarom Integration Initiative. The headcount reductions were primarily related to the Scent segment associated with the establishment of a new shared service center in Europe. Since the program&#8217;s inception, the Company expensed approximately $15 million. As of the third quarter of 2022, the program was completed.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N&amp;B Merger Restructuring Liability</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2023, the Company incurred approximately $2 million of charges related to a lease impairment. Since the inception of the restructuring activities, there have been a total of approximately 215 headcount reductions and the Company has expensed approximately $47&#160;million. As of December 31, 2023, the restructuring activities were completed related to employee exits. The Company continues to evaluate its owned and leased properties following the Merger with N&amp;B and may incur additional costs to further consolidate its footprint.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restructuring Program</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, the Company announced a restructuring program mainly related to headcount reduction to improve its organizational and operating structure, drive efficiencies and achieve cost savings. For the year ended December 31, 2023, the Company incurred approximately $70 million of charges related to severance and there have been a total of approximately 680 actual and planned headcount reductions.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Restructuring Liability</span></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in restructuring liabilities during 2021, 2022 and 2023 were as follows:</span></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:33.599%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.541%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.519%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at January 1, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Additional Charges (Reversals), Net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-Cash Charges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Payments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Frutarom Integration Initiative</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed asset write down</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">2019 Severance Program</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Other Restructuring Charges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">N&amp;B Merger Restructuring Liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Restructuring and other charges</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:33.599%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.541%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.519%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at January 1, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Additional Charges (Reversals), Net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-Cash Charges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Payments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Frutarom Integration Initiative</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed asset write down</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">2019 Severance Program</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Other Restructuring Charges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">N&amp;B Merger Restructuring Liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Restructuring and other charges</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.503%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at January 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Additional Charges (Reversals), Net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-Cash Charges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Payments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2023</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Frutarom Integration Initiative</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Other Restructuring Charges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">N&amp;B Merger Restructuring Liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">2023 Restructuring Program</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Restructuring and other charges</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes supplier contract termination costs, consulting and advisory fees.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes charges related to legal settlement costs.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes lease impairment charges and losses incurred from restructuring activities related to the Merger with N&amp;B.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Charges by Segment</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the total amount of costs incurred in connection with these restructuring programs and activities by segment:</span></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:59.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.695%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nourish</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health &amp; Biosciences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Scent</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharma Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Restructuring and other charges</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//420/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308312873568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Acquisitions</a></td>
<td class="text">ACQUISITIONS<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisition of Health Wright Products, Inc.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2022 (&#8220;Acquisition Date&#8221;), the Company completed its acquisition of Health Wright Products, Inc. (&#8220;Health Wright&#8221;). IFF acquired 100% of the equity of Health Wright pursuant to a purchase agreement entered into on February 16, 2022. Health Wright is known in the consumer Health and Nutrition industries for providing high quality nutritional supplements. The acquisition was made in order to strengthen formulation and finished format capabilities to IFF&#8217;s Health &amp; Biosciences probiotics, natural extracts and botanical businesses.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition was accounted for under the purchase method. The fair value of consideration transferred was approximately $157 million, including cash and estimated contingent consideration of $31 million. The purchase price allocation was performed and resulted in intangible assets of approximately $75 million, and approximately $45 million of goodwill (which is deductible for income tax purposes). The intangible assets primarily consisted of customer relationships of approximately $74 million that have been fair valued using the Multi-Period Excess Earning Method and which are being amortized over a period of approximately 19 years.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purchase price allocation was finalized as of the end of 2022 when the Company finalized the valuation of the acquired goodwill, intangible assets (trade names and customer relationships) and inventory, in addition to ensuring all other assets and liabilities and contingencies have been identified and recorded. The measurement period adjustments were recorded during the year ended December 31, 2022.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2022, the Company remeasured the fair value of contingent consideration obligations, and, as a result, recognized a credit of approximately $5 million presented in Selling and administrative expenses on the Consolidated Statements of (Loss) Income and Comprehensive Loss. The reduction in the fair value of contingent consideration primarily resulted from changes in the probability assessment of achieving the performance targets. As of December 31, 2022, there was approximately $26&#160;million of earnout liabilities presented in Other liabilities on the Consolidated Balance Sheets.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2023, the Company remeasured the fair value of contingent consideration obligations, and, as a result, recognized an expense of approximately $6&#160;million presented in Selling and administrative expenses on the Consolidated Statements of (Loss) Income and Comprehensive Loss. As of December 31, 2023, there was approximately $32&#160;million of earnout liabilities presented in Other current liabilities on the Consolidated Balance Sheets.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No pro forma information for 2022 was presented as the acquisition was not material to the Consolidated Financial Statements.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Transaction with Nutrition &amp; Biosciences, Inc.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 1, 2021, IFF completed the Merger with N&amp;B. Pursuant to the transaction related agreements, DuPont transferred its N&amp;B Business to N&amp;B, a wholly-owned subsidiary of DuPont, and N&amp;B merged with and into a wholly owned subsidiary of IFF in exchange for 141,740,461 shares of IFF common stock, par value $0.125 per share (&#8220;IFF Common Stock&#8221;).</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company completed its Merger with N&amp;B in a Reverse Morris Trust transaction (the &#8220;Transactions&#8221;), pursuant to which the Company acquired the N&amp;B Business of DuPont.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Transactions, among other steps (i) DuPont transferred the N&amp;B Business to N&amp;B (the &#8220;Separation&#8221;); (ii) N&amp;B made a cash distribution to DuPont of approximately $7.359 billion, subject to certain adjustments (the &#8220;Special Cash Payment&#8221;); (iii) DuPont distributed to its stockholders all of the issued and outstanding shares of N&amp;B common stock by way of an exchange offer (the &#8220;Distribution&#8221;), and; (iv) N&amp;B merged with and into a wholly owned subsidiary of IFF. As a result of the Merger, the existing shares of N&amp;B common stock were automatically converted into the right to receive a number of shares of IFF Common Stock. Immediately after the Merger, holders of DuPont&#8217;s common stock that received shares of N&amp;B common stock in the Distribution owned approximately 55.4% of the outstanding shares of IFF Common Stock on a fully diluted basis and existing holders of IFF Common Stock owned approximately 44.6% of the outstanding shares of IFF on a fully diluted basis.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Merger was accounted for using the purchase method of accounting in accordance with ASC Topic 805, Business Combinations, with IFF identified as the acquirer. As a result of the Merger, N&amp;B&#8217;s assets, liabilities and the operating results of N&amp;B were included in the Company&#8217;s financial statements from the Closing Date. N&amp;B contributed net sales of approximately $6.084 billion and net income of approximately $11 million for the year ended December&#160;31, 2021, which included the effects of purchase accounting adjustments, primarily related to changes in amortization of intangible assets, depreciation of property, plant and equipment and amortization of stepped up inventory.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Distribution, N&amp;B incurred new indebtedness in the form of term loans and senior notes in an aggregate principal amount of $7.500 billion to pay the Special Cash Payment made to DuPont stockholders. See Note 9 for additional information regarding the term loans and senior notes incurred by N&amp;B and subsequently assumed by IFF.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Purchase Price</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the aggregate purchase price consideration paid to acquire N&amp;B (in millions, except share and per share data):</span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of common stock issued to DuPont stockholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,929&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value attributable to pre-merger service for replacement equity awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension funding adjustment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase consideration</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,942&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________&#160;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The fair value of common stock issued to DuPont stockholders represents 141,740,461 shares of the Company's common stock determined based on the number of fully diluted shares of IFF common stock, immediately prior to the Closing Date, multiplied by the quotient of 55.4%/44.6% and IFF common stock closing share price of $112.38 on the New York Stock Exchange on the Closing Date.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">At the time of the Transactions, each outstanding stock option, cash-settled stock appreciation right (&#8220;SAR&#8221;), restricted stock unit (&#8220;RSU&#8221;) award, and restricted stock award (&#8220;RSA&#8221;) with respect to DuPont common stock held by employees of N&amp;B were canceled and converted into similar classes of equity awards of IFF&#8217;s Class A Common Stock. Further, each outstanding Performance Share Unit (&#8220;PSU&#8221;) award with respect to DuPont common stock held by employees of N&amp;B were canceled and converted into IFF&#8217;s RSU awards. The conversion was based on the ratio of the volume-weighted average per share closing price of DuPont stock on the twenty trading days prior to the Closing Date and IFF&#8217;s stock on the twenty trading days following the Closing Date. The fair value of replacement equity-based awards attributable to pre-Merger service was recorded as part of the consideration transferred in the Merger (see Note 13 for additional information).</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Merger related agreements provided that if the net pension balance of N&amp;B as of the Closing Date differs from $220&#160;million, such differential amount would be settled in cash. The Company estimated the amount that it would receive and, accordingly, made an adjustment of $12&#160;million to the total purchase consideration.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company incurred transaction-related costs of approximately $91&#160;million in 2021, which primarily consisted of merger and acquisition advisory, legal and professional fees.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pro Forma Financial Information</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following unaudited pro forma financial information presents the combined results of operations of IFF and N&amp;B as if the Merger had been completed as of January 1, 2020. The unaudited pro forma financial information is presented for informational purposes and is not indicative of the results of operations that would have been achieved if the Merger and related borrowings had taken place on January 1, 2020, nor are they indicative of future results. The unaudited pro forma financial information for the year ended December&#160;31, 2021 includes IFF results, including the post-Merger results of N&amp;B, since February 1, 2021, and pre-Merger results of N&amp;B for the period January 1, 2021 through January 31, 2021.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma results for the year ended December&#160;31, 2021 were as follows:</span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.778%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unaudited pro forma net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,163&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unaudited pro forma net income attributable to the Company</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma results for all periods include adjustments made to account for certain costs and transactions that would have been incurred had the Merger been completed as of January 1, 2020, including amortization charges for acquired intangibles assets, adjustments for transaction costs, adjustments for depreciation expense for property, plant and equipment, inventory step-up and adjustments to interest expense. These adjustments are net of any applicable tax impact and were included to arrive at the pro forma results above.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//805/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308313035424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Divestiture<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">Business Divestiture</a></td>
<td class="text">BUSINESS DIVESTITURES<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Divestiture of the Flavor Specialty Ingredients Business</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2022, the Company announced it had entered into an agreement to sell its Flavor Specialty Ingredients (&#8220;FSI&#8221;) business, which was a part of the Scent segment. The Company completed the divestiture on August 1, 2023 and received cash proceeds of approximately $205 million, which included $1 million related to the delayed transfer of the control of specific assets and liabilities of non-U.S. jurisdiction business. In addition, approximately $15 million of proceeds were held in escrow and have been released upon satisfaction of certain conditions. Concurrent with the completion of the business divestiture, the Company entered into a supply agreement arrangement with the buyer. Based on the terms of the supply agreement, an adjustment of $4 million was made against the fair value of sale consideration. The sale consideration is subject to certain post-closing adjustments, which is primarily related to cash, indebtedness and working capital balances.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of sale consideration received in connection with the business divestiture:</span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash proceeds from the buyer</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advance receipt for business to be transferred</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct costs to sell</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds attributable to supply agreement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of sale consideration</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net proceeds received from the business divestiture presented under Cash flows from investing activities represent the cash portion of the sale consideration, which was determined as the fair value of sale consideration adjusted by the direct costs to sell, advance receipt for business to be transferred and the cash transferred to the buyer as part of the transaction. The following table summarizes the different components of net proceeds received from business divestiture presented under Cash flows from investing activities:</span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of sale consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct costs to sell</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advance receipt for business to be transferred</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash transferred to the buyer</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net proceeds received from business divestiture</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount of net assets associated with the business unit, adjusted for currency translation adjustment, was approximately $205 million. The major classes of assets and liabilities sold consisted of the following:</span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">August 1, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive income - currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of net assets (adjusted for currency translation adjustment)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the business divestiture, the Company recognized a pre-tax loss of approximately $10 million, subject to certain post-closing adjustments, presented in Other expense (income), net on the Consolidated Statements of (Loss) Income and Comprehensive Loss for the year ended December 31, 2023. The Company has also recognized income tax effects associated with the business divestiture across multiple periods. The total income tax expense recognized was approximately $21 million, with approximately $3 million that was recognized during the year ended December 31, 2022.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Divestiture of a Portion of the Savory Solutions Business</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2022, the Company announced it had entered into an agreement to sell a portion of its Savory Solutions business, which was part of the Nourish segment. The Company completed the divestiture on May 31, 2023 and received cash proceeds of approximately $840 million. In addition, a receivable of approximately $37 million was recorded, which reflected the remaining sale consideration that was received in January 2024.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of sale consideration received in connection with the business divestiture:</span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash proceeds from the buyer</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">840&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivable from the buyer</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct costs to sell</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of sale consideration</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">857&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net proceeds received from the business divestiture presented under Cash flows from investing activities represent the cash portion of the sale consideration, which was determined as the fair value of sale consideration adjusted by the amount receivable from the buyer, direct costs to sell and the cash transferred to the buyer as part of the transaction. The following table summarizes the different components of net proceeds received from business divestiture presented under Cash flows from investing activities:</span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of sale consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">857&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct costs to sell</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivable from the buyer</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash transferred to the buyer (including restricted cash)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net proceeds received from business divestiture</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">821&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount of net assets associated with the business unit, adjusted for currency translation and pension adjustments, was approximately $860 million. The major classes of assets and liabilities sold consisted of the following:</span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">May 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,009&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(92)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(190)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive income - currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive income - pension liability and postretirement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of net assets (adjusted for currency translation and pension adjustments)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">860&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the business divestiture, the Company recognized a pre-tax loss of approximately $3 million presented in Other expense (income), net on the Consolidated Statements of (Loss) Income and Comprehensive Loss for the year ended December 31, 2023. The Company has also recognized income tax effects associated with the business divestiture across multiple periods. The total income tax expense recognized was approximately $108 million, with approximately $72 million that was recognized during the year ended December 31, 2022.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liquidation of a Business in Russia</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the liquidation of a business in Russia for the sale of the portion of the Savory Solutions business, the Company recognized a pre-tax loss of approximately $10&#160;million presented in the Other expense (income), net, and tax benefits of approximately $2&#160;million presented in Provision for income taxes on the Consolidated Statements of (Loss) Income and Comprehensive Loss for the year ended December 31, 2023.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Divestiture of Microbial Control</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, the Company announced it had entered into an agreement to sell its Microbial Control business unit, which was a part of the Health &amp; Biosciences segment. The Company acquired the Microbial Control business unit as part of the Merger with N&amp;B.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company completed the divestiture on July 1, 2022 and received cash proceeds of approximately $1.254 billion, of which approximately $36 million was attributable to future services to be provided under certain transition service agreements as described below. Certain transaction costs related to the divestiture of approximately $11 million, which was contingent upon the consummation of the divestiture, were determined to be direct costs to sell and, as such, were adjusted against the fair value of the sale consideration. In addition, approximately $15 million of cash proceeds held in escrow were released to the Company upon satisfaction of certain conditions. The sale consideration was further reduced by approximately $3 million for certain post-closing adjustments, which were primarily related to cash, indebtedness and working capital balances.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company entered into transition services agreements with the buyer for providing certain general accounting, information technology and other services up to 19 months following the date of the sale for minimal consideration. The fair value of these transition services agreements was determined to be approximately $36 million, which was adjusted against the sale consideration and recognized as deferred transition services income.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2023 and 2022, the transition services income under the transition services agreements were approximately $25&#160;million and $11&#160;million, respectively, and was recognized as a reduction to the costs incurred to provide services under the transition services agreements, which was included in Selling and administrative expenses on the Consolidated Statements of (Loss) Income and Comprehensive Loss.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of the sale consideration received in connection with the business divestiture:</span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash proceeds from the buyer</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Escrow proceeds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds attributable to transition service agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct costs to sell</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash settlement for post-closing adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of sale consideration</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,219&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net proceeds received from business divestiture presented under Cash flows from investing activities represent the cash portion of the sale consideration, which was determined as the fair value of sale consideration reduced by the amount held in escrow and the Cash transferred to the buyer on the closing balance sheet as part of the transaction. The following table summarizes the different components of net proceeds received from business divestiture presented under Cash flows from investing activities:</span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of sale consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash transferred to the buyer on the closing balance sheet</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee reimbursement receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net proceeds received from business divestiture</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,169&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount of net assets associated with the Microbial Control business unit was approximately $1.208 billion. The major classes of assets and liabilities sold consisted of the following:</span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and other intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">867&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,284&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of net assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,208&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the business divestiture, the Company recognized a pre-tax gain of approximately $11&#160;million presented in Other expense (income), net on the Consolidated Statements of (Loss) Income and Comprehensive Loss for the year ended December 31, 2022. The Company also recognized the income tax expense associated with the divestiture of approximately $96&#160;million during the year ended December 31, 2022.</span></div>ASSETS AND LIABILITIES HELD FOR SALE<div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2023, the Company announced the sale process of its Cosmetic Ingredients business within the Scent segment, and in the fourth quarter of 2023, the Company entered into an agreement to sell its Cosmetic Ingredients business. The transaction is subject to customary closing conditions and is expected to close in the first quarter of 2024.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The planned sale does not constitute a strategic shift of the Company&#8217;s operations and does not have major effects on the Company&#8217;s operations and financial results. Therefore, the transaction does not meet the discontinued operations criteria.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined that the assets and liabilities of the business met the criteria to be presented as &#8220;held for sale.&#8221; As a result, as of December&#160;31, 2023, such assets and liabilities were classified as held for sale and are reported on the Consolidated Balance Sheets. The Company expects that the sale proceeds less costs to sell will exceed the preliminary estimate of the carrying value of the net assets for the business. The carrying value is subject to change based on developments leading up to the closing date.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in the Company&#8217;s Consolidated Balance Sheets as of December&#160;31, 2023 and 2022 are the following carrying amounts of the assets and liabilities held for sale:</span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.239%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.241%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held-for-sale</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities held-for-sale</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company is currently analyzing the tax impact of the sale of the Cosmetic Ingredients business and has included preliminary numbers for the deferred tax liability, which are subject to further updates.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The amounts for December&#160;31, 2022 represent the carrying amounts of the portion of the Savory Solutions business and FSI business that were classified as held for sale. The Company completed the divestitures of the businesses on May 31, 2023 and August 1, 2023, respectively. See Note 4 for additional information.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//205-20/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//360/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308306562000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Property, Plant and Equipment, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property, Plant and Equipment, Net</a></td>
<td class="text">PROPERTY, PLANT AND EQUIPMENT, NET<div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment, net consisted of the following amounts:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,752&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,344&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Information technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">649&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,642&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,180&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,402)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,977)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Property, plant and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,240&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,203&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Depreciation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense was $462 million, $452 million and $424 million for the years ended December 31, 2023, 2022 and 2021, respectively.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairment of Property, Plant and Equipment</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 1, for the year ended December 31, 2022, an impairment charge of approximately $28 million was recorded in connection with property, plant and equipment, primarily buildings and improvements, of an asset group that operates primarily in Russia.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308306562000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Other Intangible Assets, Net</a></td>
<td class="text">GOODWILL AND OTHER INTANGIBLE ASSETS, NET<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Movements in goodwill attributable to each reportable segment during the years ended December 31, 2022 and 2023 were as follows:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nourish</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Health &amp; Biosciences</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Scent</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pharma Solutions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,559&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,763&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,828&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,282&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,432&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,250)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,250)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transferred to assets held for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(306)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(348)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(199)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(223)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(506)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,054&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,335&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,745&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,239&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,373&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,623)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,623)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transferred to assets held for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(267)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(267)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reduction from business divestiture</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,489&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,391&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,490&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,265&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,635&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-top:3pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt">Related to the acquisition of Health Wright. See Note 3 for additional information.</span></div><div style="margin-top:3pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt">Related to the portion of the Savory Solutions business and FSI business that were classified as held for sale as of December 31, 2022. The Company completed the divestitures of the businesses on May 31, 2023 and August 1, 2023, respectively. See Note 4 and Note 21 for additional information.</span></div><div style="margin-top:3pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt">Related to the Cosmetic Ingredients business that was classified as held for sale as of December&#160;31, 2023. See Note 21 for additional information.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The goodwill balance at December&#160;31, 2023 included $2.623&#160;billion and $2.250 billion of accumulated impairment related to the Nourish and Health &amp; Biosciences reportable segments, respectively. The goodwill balance at December&#160;31, 2022 </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">included $2.250&#160;billion of accumulated impairment related to the Health &amp; Biosciences reportable segment. The accumulated impairment relates to impairment charges recorded in 2023 and 2022.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill Impairment Test</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the annual impairment test as of November 30, 2023, the Company first utilized Step 0 of the guidance in ASC Topic 350, Intangibles &#8211; Goodwill and Other, which allows for the assessment of qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. If, based on a review of qualitative factors, it is more likely than not that the fair value of a reporting unit is less than its carrying value, a quantitative impairment test is performed by comparing the fair value of a reporting unit with its carrying amount. Based on a review of qualitative factors, the Company determined that for one of the reporting units, Cosmetic Ingredients, a quantitative (Step 1) impairment analysis was not necessary to determine if the carrying values of the reporting unit exceeded its fair values. For the other five reporting units, the Company determined that a Step 1 test was necessary.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assessed the fair value of the reporting units using an income approach. Under the income approach, the Company determined the fair value by using a discounted cash flow method at a rate of return that reflects the relative risk of the projected future cash flows of each reporting unit, as well as a terminal value. The Company used the most current actual and forecasted operating data available. Key estimates and assumptions used in these valuations include revenue growth rates, gross margins, adjusted operating EBITDA margins, terminal growth rates and discount rates.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the quantitative impairment test, the Company determined that the fair value of four of the five reporting units exceeded their carrying values and determined that there was no further impairment of goodwill in these reporting units as of November 30, 2023.&#160;The Company determined that the carrying value of the Nourish reporting unit exceeded its fair value and recorded an impairment charge of $2.623&#160;billion in the Consolidated Statements of (Loss) Income and Comprehensive Loss for the year ended December 31, 2023. The primary drivers of the impairment charge was a decrease in fair value due to declines in projections of the reporting unit, impacts of continued inflation and increases in interest rates. Based on the quantitative impairment test performed, the Company determined that the Health &amp; Biosciences, Fragrance Ingredients and Pharma Solutions reporting units had excess fair value over carrying value of less than 25%. As of November 30, 2023, the Health &amp; Biosciences, Fragrance Ingredients and Pharma Solutions reporting units had excess fair value over carrying value of approximately 8%, 18% and 8%, respectively, and goodwill of approximately $4.381&#160;billion, $295&#160;million and $1.263&#160;billion, respectively.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While management believes that the assumptions used in the impairment test were reasonable, changes in key assumptions, including lower revenue growth, operating margin, terminal growth rates or increase in discount rates could result in a future impairment. Such charge could have a material effect on the Consolidated Statements of Operations and Balance Sheets.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, the Company determined that goodwill impairment triggering events occurred for its Nourish, Health &amp; Biosciences and Pharma Solutions reporting units. The primary indicators that were deemed to be triggering events were declines in the Company&#8217;s projections across various reporting units and ongoing adverse macroeconomic impacts such as inflation, increases in interest rates and unfavorable effects from exchange rates.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the quantitative impairment test, using the income approach, the Company determined that the carrying value of the Health &amp; Biosciences reporting unit exceeded its fair value and recorded a goodwill impairment charge of $2.250 billion in the Consolidated Statements of (Loss) Income and Comprehensive Loss for the year ended December 31, 2022.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Intangible Assets</span></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other intangible assets, net consisted of the following amounts:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.716%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.200%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset Type</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,318&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technological know-how</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,339&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names &amp; patents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total carrying value </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,947&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,062&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,619)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,252)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technological know-how</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(813)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(589)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names &amp; patents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(117)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,590)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,980)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,357&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,082&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amortization</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense was $680 million for the year ended December&#160;31, 2023, $727 million for the year ended December 31, 2022 and $732 million for the year ended December&#160;31, 2021. Amortization expense for the next five years, based on valuations and determinations of useful lives, is expected to be as follows:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.579%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2028</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated future intangible amortization expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">678&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">558&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairment of Intangible Assets</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 1, for the year ended December 31, 2022, an impairment charge of approximately $92 million was recorded in connection with intangible assets, primarily customer relationships and technological know-how, of an asset group that operated primarily in Russia, which was included within accumulated amortization.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//350/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308313935920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Assets And Liabilities, Current and Noncurrent<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsAbstract', window );"><strong>Other Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_OtherAssetsAndLiabilitiesDisclosureCurrentAndNoncurrentTextBlock', window );">Other Current Assets and Liabilities, and Other Assets</a></td>
<td class="text">OTHER CURRENT ASSETS AND LIABILITIES, AND OTHER ASSETS<div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets consisted of the following amounts:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value-added tax receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Packaging materials and supplies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">770&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets consisted of the following amounts:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right-of-use assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Overfunded pension plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">764&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">689&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________&#160;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes land usage rights in China, long-term deposits and receivables on certain derivative instruments.</span></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current liabilities consisted of the following amounts:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates and incentives payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value-added tax payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current pension and other postretirement benefit obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued insurance (including workers&#8217; compensation)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earn outs payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued restructuring</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1085"><span style="-sec-ix-hidden:f-1086">Current operating lease obligation</span></span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued freight</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued commissions payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">977&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,028&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_OtherAssetsAndLiabilitiesDisclosureCurrentAndNoncurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Assets And Liabilities Disclosure, Current And Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_OtherAssetsAndLiabilitiesDisclosureCurrentAndNoncurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308307097872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text">DEBT<div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt consisted of the following at December&#160;31:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:49.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.584%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.493%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.495%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Effective Interest Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Euro Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">552&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Euro Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">879&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">845&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,212&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,215&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2030 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,508&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,510&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2040 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2047 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2048 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">787&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">787&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2050 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,569&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,571&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Term Loan Facility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Term Loan Facility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial Paper</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving Credit Facility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank overdrafts and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,071&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,970&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Short term borrowings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(885)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(597)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,186&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,373&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amount is net of unamortized discount and debt issuance costs.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amount is recorded at fair value.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The effective interest rate of commercial paper issuances fluctuate as short-term interest rates and demand fluctuate, and deferred debt issuance costs are immaterial. Additionally, the effective interest rate of commercial paper is not meaningful as issuances do not materially differ from short-term interest rates.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The interest rate on the Revolving Credit Facility is, at the applicable borrower&#8217;s option, a per annum rate equal to either (x) an eurocurrency rate plus an applicable margin varying from 1.125% to 1.750% or (y) a base rate plus an applicable margin varying from 0.125% to 0.750%, in each case depending on the public debt ratings for&#160;non-credit&#160;enhanced long-term senior unsecured debt issued by the Company.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes bank borrowings, overdrafts, current portion of long-term debt and commercial paper.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Term Loan Facility and Senior Notes assumed as part of the N&amp;B Merger</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the Merger, the Company assumed the indebtedness incurred by N&amp;B in the debt financings completed prior to the Distribution. This indebtedness includes (i) a Term Loan Facility of $1.250&#160;billion pursuant to the term loan credit agreement (the &#8220;N&amp;B Term Loan Facility&#8221;) and (ii) a series of Senior Notes in the aggregate amount of $6.250&#160;billion with maturities ranging from 2 to 30 years as further described below. N&amp;B&#8217;s indebtedness raised prior to the Merger was used to finance the Special Cash Payment to DuPont, which has been paid, and for the satisfaction of the related transaction fees and expenses. See Note 3 for additional information.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">N&amp;B Term Loan Facility</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The N&amp;B Term Loan Facility was funded on February 1, 2021, and provides for a senior unsecured term loan credit facility in an aggregate principal amount of $1.250&#160;billion, comprised of a $625&#160;million three-year tranche (&#8220;2024 Term Loan Facility&#8221;) and a $625&#160;million five-year tranche (&#8220;2026 Term Loan Facility&#8221;). Interest for each tranche equals, at the Company&#8217;s option, a per annum rate equal to either (x) an adjusted LIBOR rate plus an applicable margin varying from 0.750% to 2.000% for the three-year tranche and from 1.125% to 2.375% for the five-year tranche or (y) a base rate plus an applicable margin varying from 0.000% to 1.000% for the three-year tranche and from 0.125% to 1.375% for the five-year tranche, in each case depending on the class of IFF&#8217;s non-credit-enhanced, senior unsecured long-term debt credit rating.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2024 Term Loan Facility and 2026 Term Loan Facility are subject to customary affirmative and negative covenants and events of default after the Closing Date of the Merger. On and after the Closing Date of the N&amp;B Transaction, the 2024 Term Loan Facility and 2026 Term Loan Facility are also subject to financial covenant maintenance requirements.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 19, 2023, the Company entered into Amendment No. 5 (&#8220;Term Loan Amendment No. 5&#8221;) to amend that certain term loan credit agreement, dated January 17, 2020 (as amended by that certain Amendment No. 1 to Credit Agreement, dated as of August 25, 2020, as further supplemented by that certain Icon Debt Assumption Supplement, dated as of March 4, 2021, as further amended by that certain Amendment No. 2 to Credit Agreement, dated as of August 4, 2022, as further amended by that certain Amendment No. 3 (&#8220;Term Loan Amendment No. 3&#8221;) to Credit Agreement, dated as of March 23, 2023, as further amended by that certain Amendment No. 4 (&#8220;Term Loan Amendment No. 4&#8221;) to Credit Agreement, dated as of March 23, 2023, the &#8220;Existing Term Loan Credit Agreement&#8221;, and the Existing Term Loan Credit Agreement, as amended by the Term Loan Amendment, the &#8220;Term Loan Credit Agreement&#8221;), among the Company (as successor to Nutrition &amp; Biosciences, Inc.), the lenders party thereto and Morgan Stanley Senior Funding, Inc., as administrative agent. The related deferred financing costs for the amendments in 2023 were not material.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Term Loan Amendment No. 3, among other things, extended the period during which certain relief was provided with respect to the financial covenant contained in the Existing Term Loan Credit Agreement which has been superseded by Term Loan Amendment No. 5.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Term Loan Amendment No. 4, among other things, replaces LIBOR with Term SOFR (as defined in the Term Loan Credit Agreement) as the reference rate for U.S. dollar-denominated loans. From March 23, 2023, loans under the Term Loan Credit Agreement now bear interest at a base rate or a rate equal to Term SOFR plus an adjustment of 0.10% per annum, plus, in each case, an applicable margin based on the Company's public debt rating. Loans may be prepaid without premium or penalty, subject to customary breakage costs.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Term Loan Amendment No. 5, among other things, extends the period during which certain relief is provided with respect to the financial covenant contained in the Existing Term Loan Credit Agreement through December 31, 2025, or such earlier date on which the Company elects to terminate such period (the &#8220;Term Loan Covenant Relief Period&#8221;), by providing that during the Term Loan Covenant Relief Period, the Company&#8217;s Leverage Ratio (as defined in the Term Loan Credit Agreement) shall not exceed as of the end of the fiscal quarter for the period of the four fiscal quarters then ended: (i) 5.25x for any fiscal quarter ending on or before March 31, 2024, (ii) 4.75x for the fiscal quarter ending June 30, 2024, (iii) 4.50x for the fiscal quarter ending September 30, 2024, (iv) 4.25x for any subsequent fiscal quarter ending on or before March 31, 2025, (v) 4.00x for any subsequent fiscal quarter ending on or before September 30, 2025 and (vi) 3.75x for the fiscal quarter ending December 31, 2025. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the Term Loan Covenant Relief Period, the amendments prohibit the Company from (i) effecting share repurchases, (ii) declaring and paying dividends in cash on common stock in excess of $0.81 per share per fiscal quarter (for an aggregate amount of $3.24 per fiscal year) and (iii) creating liens to secure debt in excess of the greater of $300&#160;million and 3.65% of Consolidated Net Tangible Assets (as defined in the Term Loan Credit Agreement), subject to certain exceptions set forth in the Term Loan Amendment No. 5. The Company was in compliance with all covenants as of December&#160;31, 2023.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loans may be prepaid without premium or penalty, subject to customary breakage costs, and during the Term Loan Covenant Relief Period, there will be a mandatory prepayment of the loans with 100% of the net cash proceeds from non-ordinary course asset sales, subject to certain exceptions set forth in the Term Loan Amendment No. 5 and by a Term Loan Amendment No. 6, dated January 26, 2024, which provides additional exceptions to the mandatory prepayment requirements with respect to the sale of the Company&#8217;s Cosmetic Ingredients business. The applicable margin for the loans, which is based on the Company&#8217;s Public Debt Rating (as defined in the Term Loan Credit Agreement), will also increase by 0.125% for the duration of the Term Loan Covenant Relief Period.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2023, the Company made voluntary debt repayments of $355&#160;million related to the 2024 Term Loan Facility.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">N&amp;B Senior Notes</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 16, 2020, N&amp;B issued $6.250&#160;billion in aggregate principal amount of senior unsecured notes consisting of: (i) $300&#160;million senior unsecured notes which matured on September 15, 2022 (the &#8220;2022 Notes&#8221;), bearing interest at a rate of 0.697% per year, payable semi-annually on March 15 and September 15 of each year, beginning March 15, 2021; (ii) $1.000&#160;billion senior unsecured notes maturing on October 1, 2025 (the &#8220;2025 Notes&#8221;), bearing interest at a rate of 1.230% per year, payable semi-annually on April 1 and October 1 of each year, beginning April 1, 2021; (iii) $1.200&#160;billion senior unsecured notes maturing on October 15, 2027 (the &#8220;2027 Notes&#8221;), bearing interest at a rate of 1.832% per year, payable semi-annually on April 15 and October 15 of each year, beginning April 15, 2021; (iv) $1.500&#160;billion senior unsecured notes maturing on November 1, 2030 (the &#8220;2030 Notes&#8221;), bearing interest at a rate of 2.300% per year, payable semi-annually on May 1 and November 1 of each year, beginning May 1, 2021; (v) $750&#160;million senior unsecured notes maturing on November 15, 2040 (the &#8220;2040 Notes&#8221;), bearing interest at a rate of 3.268% per year, payable semi-annually on May 15 and November 15 of each year, beginning May 15, 2021, and; (vi) $1.500&#160;billion senior unsecured notes maturing on December 1, 2050 (the &#8220;2050 Notes&#8221;), bearing interest at a rate of 3.468% per year, payable semi-annually on June 1 and December 1 of each year, beginning June 1, 2021.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest on each series of notes began accruing from September 16, 2020 payable semi-annually in arrears as described above. Interest is computed on the basis of a 360-day year comprised of twelve 30-day months.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 15, 2022, the Company repaid the full $300&#160;million outstanding of its 2022 Notes at maturity.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revolving Credit Facility</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Revolving Credit Facility is available for general corporate purposes of each borrower and its subsidiaries. The obligations under the Revolving Credit Facility are unsecured and the Company has guaranteed the obligations of each other borrower under the Revolving Credit Facility. The Company pays a commitment fee on the aggregate unused commitments; such fee is not material. The Revolving Credit Agreement contains various covenants, limitations and events of default customary for similar facilities for similarly rated borrowers, including a maximum permitted ratio of Net Debt to Consolidated EBITDA. In connection with the initial issuance of the Revolving Credit Facility, the Company incurred&#160;$1&#160;million of debt issuance costs.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 19, 2023, the Company and certain of its subsidiaries (collectively, the &#8220;Loan Parties&#8221;) entered into Amendment No. 4 (the &#8220;Revolver Amendment No. 4&#8221;) to amend that certain Third Amended and Restated Credit Agreement, dated July 28, 2021 (as amended by that certain Amendment No. 1 to Credit Agreement, dated August 4, 2022, as further amended by that certain Amendment No. 2 (&#8220;Revolver Amendment No. 2&#8221;) to Credit Agreement, dated as of March 23, 2023, as further amended by that certain Amendment No. 3 (&#8220;Revolver Amendment No. 3&#8221;) to Credit Agreement, dated as of March 23, 2023, the &#8220;Existing Revolving Credit Agreement&#8221;, and the Existing Revolving Credit Agreement, as amended by the Revolver Amendment, the &#8220;Revolving Credit Agreement&#8221;), among the Loan Parties, the lenders party thereto and Citibank, N.A., as administrative agent. The related deferred financing costs for the amendments in 2023 were not material.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolver Amendment No. 2, among other things, extended the period during which certain relief was provided with respect to the financial covenant contained in the Existing Revolving Credit Agreement which has been superseded by Revolver Amendment No. 4.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolver Amendment No. 3, among other things, replaces LIBOR with Term SOFR (as defined in the Revolving Credit Agreement) as the reference rate for U.S. dollar-denominated loans. From March 23, 2023, loans under the Revolving Credit Agreement now bear interest at a base rate or, in the case of U.S. dollar-denominated loans, a rate equal to Term SOFR plus an adjustment of 0.10% per annum or, in the case of Euro-denominated loans, the Euro interbank offered rate, plus, in each case, an applicable margin based on the Company&#8217;s public debt rating. Loans may be prepaid without premium or penalty, subject to customary breakage costs.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolver Amendment No. 4, among other things, extends the period during which certain relief is provided with respect to the financial covenant contained in the Existing Revolving Credit Agreement through December 31, 2025, or such earlier date on which the Company elects to terminate such period (the &#8220;Revolver Covenant Relief Period&#8221;), by providing that during the Revolver Covenant Relief Period, the Company&#8217;s Leverage Ratio (as defined in the Revolving Credit Agreement) shall not exceed as of the end of the fiscal quarter for the period of the four fiscal quarters then ended: (i) 5.25x for any fiscal quarter ending on or before March 31, 2024, (ii) 4.75x for the fiscal quarter ending June 30, 2024, (iii) 4.50x for the fiscal quarter ending September 30, 2024, (iv) 4.25x for any subsequent fiscal quarter ending on or before March 31, 2025, (v) 4.00x for any subsequent fiscal quarter ending on or before September 30, 2025 and (vi) 3.75x for the fiscal quarter ending December 31, 2025. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the Revolver Covenant Relief Period, the amendments prohibit (i) the Company from effecting share repurchases, (ii) the Company from declaring and paying dividends in cash on common stock in excess of $0.81 per share per fiscal quarter (for an aggregate amount of $3.24 per fiscal year) and (iii) the Loan Parties from creating liens to secure debt in excess of the greater of $300&#160;million and 3.65% of Consolidated Net Tangible Assets (as defined in the Revolving Credit Agreement), subject to certain exceptions set forth in the Revolver Amendment No. 4. The Company was in compliance with all covenants as of December&#160;31, 2023.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loans may be prepaid without premium or penalty, subject to customary breakage costs, and during the Revolver Covenant Relief Period, the applicable margin for the loans, which is based on the Company&#8217;s Public Debt Rating (as defined in the Revolving Credit Agreement), will increase by 0.125%.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, total capacity under the Revolving Credit Facility was&#160;$2.000 billion, with&#160;no outstanding borrowings. Under the amended terms of the Revolver Credit Agreement, the Revolving Credit Facility increased from $1.000 billion to $2.000 billion, maturing on July 28, 2026. At the option of the Company, the facility may be increased to $2.500&#160;billion subject to certain conditions. As the Revolving Credit Facility is a multi-year revolving credit agreement, the Company classifies as long-term debt the portion that it has the intent and ability to maintain outstanding longer than 12&#160;months.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2023, the Company had drawdowns of $800&#160;million and repayments of $900&#160;million under the Revolving Credit Facility. During 2022, the Company had drawdowns of $550&#160;million and repayments of $450&#160;million under the Revolving Credit Facility.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2018 Senior Unsecured Notes</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 25, 2018, the Company issued &#8364;800&#160;million aggregate principal amount of senior unsecured notes that mature on September 25, 2026 (the &#8220;2026 Euro Notes&#8221;). The 2026 Euro Notes bear interest at a rate of 1.8% per year, payable annually on September 25 of each year, beginning September 25, 2019. Total proceeds from the issuance of the 2026 Notes, net of underwriting discounts and offering costs, were &#8364;794&#160;million ($932&#160;million in USD).</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 26, 2018, the Company issued $400&#160;million aggregate principal amount of senior unsecured notes that mature on September 26, 2028 (the &#8220;2028 Notes&#8221;). The 2028 Notes bear interest at a rate of 4.45% per year, payable semi-annually on March 26 and September 26 of each year, beginning March 26, 2019. Total proceeds from the issuance of the 2028 Notes, net of underwriting discounts and offering costs, were $397&#160;million.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 26, 2018, the Company issued $800&#160;million aggregate principal amount of senior unsecured notes that mature on September 26, 2048 (the &#8220;2048 Notes&#8221; and collectively with the 2026 Euro Notes, 2020 Notes, 2028 Notes, the &#8220;2018 Senior Unsecured Notes&#8221;). The 2048 Notes bear interest at a rate of 5.0% per year, payable semi-annually on March 26 and September 26 of each year, beginning March 26, 2019. Total proceeds from the issuance of the 2048 Notes, net of underwriting discounts and offering costs, were $787&#160;million.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 16, the 2026 Euro Notes have been designated as a hedge of the Company&#8217;s net investment in certain subsidiaries.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023 Notes</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;4, 2013, the Company issued $300&#160;million aggregate principal amount of senior unsecured notes that mature on May 1, 2023 (&#8220;2023 Notes&#8221;). The 2023 Notes bear interest at a rate of 3.20% per year, payable semi-annually on May 1 and </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">November 1 of each year, beginning November 1, 2013. Total proceeds from the issuance of the 2023 Notes, net of underwriting discounts and offering costs, were $298&#160;million.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 1, 2023, the Company repaid the full $300&#160;million outstanding of its 2023 Notes at maturity.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024 Euro Notes</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 14, 2016, the Company issued &#8364;500 million aggregate principal amount of senior unsecured notes that mature on March 14, 2024 (&#8220;2024 Euro Notes&#8221;). The 2024 Euro Notes bear interest at a rate of 1.75% per year, payable annually on March 14 of each year, beginning March 14, 2017. Total proceeds from the issuance of the 2024 Euro Notes, net of underwriting discounts and offering costs, were &#8364;496 million. In connection with the debt issuance, the Company entered into pre-issuance hedging transactions that were settled upon issuance of the debt and resulted in a loss of approximately $3 million. The discount, deferred financing costs and pre-issuance hedge loss are being amortized as interest expense over the eight year term of the debt.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 16, the 2024 Euro Notes have been designated as a hedge of the Company&#8217;s net investment in certain subsidiaries.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2047 Notes</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 18, 2017, the Company issued $500&#160;million aggregate principal amount of senior unsecured notes that mature on June 1, 2047 (&#8220;2047 Notes&#8221;). The 2047 Notes bear interest at a rate of 4.375% per year, payable semi-annually on June 1 and December 1 of each year, beginning December 1, 2017. Total proceeds from the issuance of the 2047 Notes, net of underwriting discounts and offering costs, were $494&#160;million. In addition, the Company incurred $1&#160;million in legal and professional costs associated with the issuance and such costs were recorded as deferred financing costs. In connection with the debt issuance, the Company entered into pre-issuance hedging transactions that were settled upon issuance of the debt and resulted in a loss of approximately $5&#160;million. The discount, deferred financing costs and pre-issuance hedge loss are being amortized as interest expense over the 30 year term of the debt.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commercial Paper</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2023, the Company had gross issuances of $5.694 billion and repayments of $5.881 billion under the commercial paper program. The commercial paper issued had original maturities of less than 86 days. During 2022, the Company had gross issuances of $6.040&#160;billion and repayments of $6.177&#160;billion under the commercial paper program.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Commercial Paper Program is backed by the borrowing capacity available under the Revolving Credit Facility. The effective interest rate of commercial paper issuances does not materially differ from short-term interest rates, which fluctuate due to market conditions and as a result may impact our interest expense.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Redemption Provisions</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2024 Euro Notes, 2026 Euro Notes, 2028 Notes, 2047 Notes, and 2048 Notes (collectively, the &#8220;Notes&#8221;) share the same redemption provisions. Upon 30 days&#8217; notice to holders of the Notes, the Company may redeem the Notes at any time at the greater of 100% or the discounted present value of the remaining scheduled payments of principal and interest from the redemption date to the maturity date at the Treasury Rate or the Comparable Government Bond Rate (as defined in the applicable agreements) plus (i) 30 basis points in the case of the 2024 Euro Notes, (ii) 25 basis points in the case of the 2026 Euro Notes, (iii) 25 basis points in the case of the 2028 Notes, (iv) 25 basis points in the case of the 2047 Notes and (v) 30 basis points in the case of the 2048 Notes. The redemption dates of each of the Notes are provided in the below table:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:51.462%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.606%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Note</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redemption Date</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Euro Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 14, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Euro Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 25, 2026</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 26, 2028</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2047 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 1, 2046</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2048 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 26, 2048</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2025 Notes, 2027 Notes, 2030 Notes, 2040 Notes and 2050 Notes (collectively, the &#8220;N&amp;B Senior Notes&#8221;) were assumed as a result of the Merger and share the same redemption provisions. Upon 15 days&#8217; notice to holders of the N&amp;B Senior Notes, the Company may redeem the N&amp;B Senior Notes at any time at the greater of 100% or the discounted present value of the remaining scheduled payments of principal and interest from the redemption date to the maturity date at the Treasury Rate (as defined in the applicable agreements) plus (i) 15 basis points in the case of the 2025 Notes, (ii) 25 basis points in the case of the 2027 Notes, (iii) 25 basis points in the case of the 2030 Notes, (iv) 30 basis points in the case of the 2040 Notes and (v) 30 basis points in the case of the 2050 Notes. The redemption dates of each of the N&amp;B Senior Notes are provided in the table below:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:51.462%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.606%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Note</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redemption Date</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 1, 2025</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 15, 2027</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2030 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 1, 2030</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2040 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 15, 2040</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2050 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 1, 2050</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or after the applicable redemption dates, each series of the Notes and N&amp;B Senior Notes (collectively, the &#8220;IFF Notes&#8221;) may be redeemed by the issuer at a redemption price equal to 100% of the principal amount of the IFF Notes to be redeemed, plus accrued and unpaid interest on the notes to be redeemed to, but excluding, the redemption date.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The indenture of the IFF Notes provides for customary events of default and contains certain negative covenants that limit the ability of the Company and its subsidiaries to grant liens on assets, or to enter into sale-leaseback transactions. In addition, subject to certain limitations, in the event of the occurrence of both (1) a change of control of the Company and (2) ratings of the IFF Notes is under publicly announced consideration or is downgraded below investment grade by either Moody&#8217;s Investors Services, Inc. or Standard &amp; Poor&#8217;s Ratings Services within a specified time period, the Company will be required to make an offer to repurchase the IFF Notes at a price equal to 101% of the principal amount of the IFF Notes, plus accrued and unpaid interest to the date of repurchase.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Outstanding Borrowings</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the contractual maturities of the Company&#8217;s long-term debt as of December&#160;31, 2023.</span></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:37.225%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.651%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Payments&#160;Due&#160;by&#160;Period</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less than 1 Year</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1-3 Years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3-5 Years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">More than<br/>5 Years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Outstanding Borrowings</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,980&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">885&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,445&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,600&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,050&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Subsequent Event</span></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 1, 2024, the Company repaid the remaining $270&#160;million outstanding on its 2024 Term Loan Facility.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//470/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308306303584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">LEASES<div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has leases for corporate offices, manufacturing facilities, research and development facilities and certain transportation and office equipment, the majority of which are operating leases. The Company&#8217;s leases have remaining lease terms of up to 50 years, some of which include options to extend the leases for up to 15 years.</span></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:55.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.978%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease cost</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:55.287%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.996%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.996%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.000%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows for operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows for finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows for finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:70.014%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.977%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">689&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current operating lease obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">672&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">727&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">758&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="-sec-ix-hidden:f-1141"><span style="-sec-ix-hidden:f-1142"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right-of-use assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></span></span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="-sec-ix-hidden:f-1145"><span style="-sec-ix-hidden:f-1146"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current finance lease obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></span></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="-sec-ix-hidden:f-1149"><span style="-sec-ix-hidden:f-1150"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></span></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Presented in Other assets on the Consolidated Balance Sheets.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Presented in Other current liabilities on the Consolidated Balance Sheets.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Presented in Other liabilities on the Consolidated Balance Sheets.</span></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average remaining lease term and discount rate were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:70.014%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.977%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average remaining lease term in years</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities as of December&#160;31, 2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:50.290%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.444%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.444%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.958%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total undiscounted liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">898&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(174)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">727&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">752&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use assets and lease liabilities acquired from N&amp;B were remeasured at the present value of the future minimum lease payments over the remaining lease term utilizing an updated incremental borrowing rate of the Company as if the acquired leases were new leases as of the Closing Date. Right-of-use assets were further adjusted for any off-market terms of the lease. The remaining lease term is based on the remaining term at the Closing Date plus any renewal or extension options that the Company is reasonably certain will be exercised. Additionally, the Company has elected short-term lease treatment for those acquired lease contracts which, at the Closing Date, have a remaining lease term of 12 months or less. For the leases acquired through the Transactions, the Company will retain the previous lease classification. This resulted in an increase in both operating lease right-of-use assets and operating lease liabilities of approximately $525&#160;million and $523 million, respectively, as of the Closing Date.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the Company&#8217;s acquisition of Health Wright, there was an increase of approximately $22&#160;million in finance lease right-of-use assets and $21&#160;million in finance lease liabilities as of the Acquisition Date. In the fourth quarter of 2022, the Company exercised its option to purchase the asset and, as such, de-recognized the finance lease right-of-use assets and finance lease liabilities.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308313935920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">INCOME TAXES<div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings before income taxes consisted of the following:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. loss before taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,777)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,918)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(493)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign (loss) income before taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(741)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">847&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total (loss) income before taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,518)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,625)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax provision consisted of the following:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current tax provision</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current tax provision</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax provision</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(113)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(121)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(288)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax benefit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(369)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(237)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(236)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Effective Tax Rate Reconciliation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reconciliation between the U.S. federal statutory income tax rate to the actual effective tax rate was as follows:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:59.107%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.769%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.773%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statutory tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effect of non-deductible goodwill impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Difference in effective tax rate on foreign earnings and remittances</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit from supply chain optimization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefit, net of reversals</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax impact on business divestitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred taxes on deemed repatriation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Global intangible low-taxed income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign-derived intangible income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. foreign tax credit - general limitation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Establishment (release) of valuation allowance on state deferred</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local taxes including rate changes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax impact on internal asset transfer</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________ </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For 2021, the rate includes rate change impacts related to the Netherlands and United Kingdom.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For 2022 and 2023, the rate includes the establishment of the held for sale deferred tax liabilities due to a change in assertion.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For 2022 and 2023, the rate includes rate change impacts related to the remeasurement of the state tax rate on deferred taxes.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rate reflects the recording of the tax effects of the divestitures of the portion of the Savory Solutions business and Flavor Specialty Ingredients business and book to tax differences related to the impairment of goodwill in the Nourish reporting unit.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has elected to treat global intangible low-taxed income (&#8220;GILTI&#8221;) as a current period cost if and when incurred. This tax position resulted in a net income tax expense of approximately $64 million for the year ended December&#160;31, 2023, offset in part by foreign tax credits of approximately $54 million.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Deferred Taxes</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The deferred tax assets and liabilities consisted of the following amounts:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee and retiree benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credit and net operating loss carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortizable research and development expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest limitation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,021&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">764&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(239)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(229)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,792)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,049)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(170)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred taxes on deemed repatriation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(166)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,356)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,618)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(324)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(262)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net deferred tax liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,659)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,116)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes deferred taxes on intangible assets owned by a fully consolidated partnership.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net operating loss carryforwards were approximately $311 million and $301 million as of December&#160;31, 2023 and 2022, respectively. If unused, approximately $106 million will expire between 2024 and 2043. The remainder, totaling approximately $205 million, may be carried forward indefinitely. Tax credit carryforwards were approximately $21 million and $14 million as of December&#160;31, 2023 and 2022, respectively. If unused, the $21 million will expire between 2024 and 2043.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Of the deferred tax assets at December&#160;31, 2023, the Company considers it unlikely that a portion of the tax benefit will be realized. Accordingly, a valuation allowance of approximately $324 million has been established against these deferred tax assets.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Uncertain Tax Positions</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance of unrecognized tax benefits at beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amount of increases in unrecognized tax benefits as a result of positions taken during a prior year</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amount of decreases in unrecognized tax benefits as a result of positions taken during a prior year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amount of increases in unrecognized tax benefits as a result of positions taken during the current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The amounts of decreases in unrecognized benefits relating to settlements with taxing authorities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reduction in unrecognized tax benefits due to the lapse of applicable statute of limitation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance of unrecognized tax benefits at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For 2021, the amount includes positions related to N&amp;B opening balance sheet amounts.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, 2022 and 2021, there were approximately $123 million, $98 million and $130 million, respectively, of unrecognized tax benefits recorded to Other liabilities. There were no amounts recorded to Other current liabilities for 2023. There were approximately $14 million and less than $1 million recorded to Other current liabilities for 2022 and 2021, respectively. If these unrecognized tax benefits were recognized, all the benefits and related interest and penalties would be recorded as a benefit to income tax expense.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company increased its liabilities for interest and penalties by approximately $12 million, net, for the year ended December&#160;31, 2023. The Company decreased its liabilities for interest and penalties by approximately $1 million, net, and increased its liabilities for interest and penalties by approximately $19 million, net, for the years ended December&#160;31, 2022 and 2021, respectively. As of December&#160;31, 2023, 2022 and 2021, the Company had accrued approximately $47 million, $31 million and $36 million, respectively, of interest and penalties classified as Other liabilities. As of December&#160;31, 2023, the Company had no accruals of interest and penalties classified as Other current liabilities. As of December&#160;31, 2022 and 2021, the Company had accrued approximately $4 million and less than $1 million, respectively, of interest and penalties classified as Other current liabilities.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, the Company&#8217;s aggregate provision for unrecognized tax benefits, including interest and penalties, was approximately $170 million associated with various tax positions principally asserted in foreign jurisdictions. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, all the unrecognized tax benefits, if recognized, would affect the effective tax rate. The total changes to uncertain tax positions over the next 12 months is impracticable to estimate and is dependent on the resolution of new or existing tax disputes.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax benefits credited to Shareholders&#8217; equity were not material for the years ended December 31, 2023, 2022 and 2021 associated with stock option exercises and PRSU dividends.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company regularly repatriates earnings from non-U.S. subsidiaries. As the Company repatriates these funds to the U.S.,&#160;there will be required income taxes payable in certain U.S. states and applicable foreign withholding taxes during the period when such repatriation occurs.&#160;Accordingly, as of&#160;December 31, 2023, the Company had a deferred tax liability of approximately $155 million for the effect of repatriating the funds to the U.S., attributable to various non-U.S. subsidiaries. There is no deferred tax liability associated with non-U.S. subsidiaries where the Company intends to indefinitely reinvest the earnings to fund local operations and/or capital projects.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has ongoing income tax audits and legal proceedings which are at various stages of administrative or judicial review. In addition, the Company has other ongoing tax audits and legal proceedings that relate to indirect taxes, such as value-added taxes, capital tax, sales and use and property taxes, which are discussed in Note 19.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has several other tax audits in process and has open tax years with various taxing jurisdictions that range primarily from 2010 to 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//740/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482526/740-270-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308313770080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Income Per Share</a></td>
<td class="text">NET (LOSS) INCOME PER SHARE<div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted net (loss) income per share is based on the weighted average number of shares outstanding. A reconciliation of shares used in the computation of basic and diluted net (loss) income per share is as follows:</span></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:53.512%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.541%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.541%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.542%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(AMOUNTS IN MILLIONS EXCEPT PER SHARE AMOUNTS)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net (Loss) Income</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income attributable to IFF shareholders</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,567)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,871)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustment related to decrease (increase) in redemption value of redeemable non-controlling interests in excess of earnings allocated</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income available to IFF shareholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,565)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,868)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding (basic)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares assuming dilution (diluted)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net (Loss) Income per Share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income per share - basic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.05)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income per share - diluted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.05)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________&#160;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">On September 15, 2021, additional shares of IFF&#8217;s common stock were issued in settlement of the SPC portion of the TEUs. See below for additional information.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For the years ended December&#160;31, 2023, 2022 and 2021, the basic net (loss) income per share cannot be recalculated based on the information presented in the table above due to the effects of rounding.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For the years ended December&#160;31, 2023 and 2022, the diluted net loss per share cannot be recalculated based on the information presented in the table above due to the effects of rounding.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the effective time of the Merger, each issued and outstanding share of common stock of N&amp;B (except for shares of common stock of N&amp;B held by N&amp;B as treasury stock or by DuPont, which were canceled and ceased to exist and no consideration was delivered in exchange therefor) was converted into the right to receive one share of common stock of IFF. The Merger was completed in exchange for 141,740,461 shares of IFF common stock, par value $0.125 per share (or cash payment in lieu of fractional shares), which had been approved in the special shareholder meeting that occurred on August 27, 2020 where IFF shareholders voted to approve the issuance of shares of IFF common stock in connection with the N&amp;B Transaction, pursuant to the Merger Agreement. The shares issued in the Merger represented approximately 55.4% of the common stock of IFF on a fully diluted basis, after giving effect to the Merger, as of February 1, 2021.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company issued&#160;16,500,000&#160;TEUs, consisting of a prepaid SPC and a senior amortizing note, for net proceeds of&#160;approximately $800 million on September 17, 2018. On September 14, 2021, the Company notified holders of the TEUs that the final settlement rate in respect of each SPC was 0.330911 shares of IFF&#8217;s common stock. On September 15, 2021, 5,460,031 shares of IFF's common stock were issued in settlement of the SPCs. The SPC conversion factor is based on the volume-weighted average price (&#8220;VWAP&#8221;) per share of the Company&#8217;s common stock. For purposes of calculating basic net income per share, the settlement rate of 0.330911 shares per SPC, the final settlement rate, was used on December 31, 2021. For purposes of calculating diluted net income per share, the settlement rate of 0.330911 shares per SPC, the final settlement rate, was used on December 31, 2021.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has issued shares of Purchased Restricted Stock Units (&#8220;PRSUs&#8221;) which contain non-forfeitable rights to dividends and thus are considered participating securities which are required to be included in the computation of basic and diluted earnings per share pursuant to the two-class method. The two-class method was not presented since there was no difference between basic net (loss) income per share for both common shareholders and PRSU holders for the years ended December 31, 2023, 2022 and 2021, and there was no difference between diluted net loss per share for both common shareholders and PRSU holders for the years ended December&#160;31, 2023 and 2022. The difference between diluted net income per share for both common shareholders and PRSU holders was less than $0.01 per share for the year ended December 31, 2021. In addition, for each year, the number of PRSUs outstanding as of December&#160;31, 2023, 2022 and 2021 was not material. Net loss allocated to such PRSUs during 2023 and 2022 was not material and net income allocated to such PRSUs during 2021 was not material.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were approximately 0.2&#160;million and 0.3&#160;million potentially dilutive securities excluded from the computation of diluted net loss per share for the years ended December&#160;31, 2023 and 2022, respectively, because there was a net loss attributable to IFF for the periods and, as such, the inclusion of these securities would have been anti-dilutive.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2023 and 2022, there were approximately 0.4&#160;million and 0.3&#160;million share equivalents that had an anti-dilutive effect and therefore were excluded from the computation of diluted net loss per share. There were no share equivalents excluded from the computation of diluted net income per share for the year ended December&#160;31, 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308301812816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Shareholders' Equity</a></td>
<td class="text">SHAREHOLDERS&#8217; EQUITY <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash dividends declared per share were $3.24, $3.20 and $3.12 for the years ended December 31, 2023, 2022 and 2021, respectively. The Consolidated Balance Sheets reflect $207 million of dividends payable at December&#160;31, 2023. This amount relates to a cash dividend of $0.81 per share declared in December 2023 and paid in January 2024. Dividends declared, but not paid as of December&#160;31, 2022 and December&#160;31, 2021 were $206 million ($0.81 per share) and $201 million ($0.79 per share), respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308300785376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Compensation Plans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock Compensation Plans</a></td>
<td class="text">STOCK COMPENSATION PLANS<div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has various equity plans under which its officers, senior management, other key employees and Board of Directors may be granted options to purchase IFF common stock or other forms of stock-based awards.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cost of all employee stock-based awards are principally recognized on a straight-line attribution basis over their respective vesting periods, net of estimated forfeitures. Total stock-based compensation expense included in the Consolidated Statements of (Loss) Income and Comprehensive Loss was as follows:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity-based awards</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability-based awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation, net of tax</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The shareholders of the Company approved the Company&#8217;s 2021 Stock Award and Incentive Plan (the &#8220;2021 Plan&#8221;) on May 5, 2021.&#160;The 2021 Plan replaced the Company&#8217;s 2015 Stock Award and Incentive Plan (the &#8220;2015 Plan&#8221;) and the Company&#8217;s 2010 Stock Award and Incentive Plan (the &#8220;2010 Plan&#8221;), and provides the source for future deferrals of cash into deferred stock under the Company&#8217;s Deferred Compensation Plan (with the Deferred Compensation Plan being deemed a subplan under the 2010 Plan for the sole purpose of funding deferrals under the IFF Share Fund).</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the 2021 Plan, a total of 2,290,000 shares were authorized for issuance. As of December&#160;31, 2023, 1,817,519 shares were subject to outstanding awards and 748,082 shares remained available for future awards under all of the Company&#8217;s equity award plans, including the 2015 Plan and 2010 Plan (excluding shares not yet issued under open cycles of the Company&#8217;s Long-Term Incentive Plan).</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers a Long-Term Incentive Plan (&#8220;LTIP&#8221;) for senior management. The targeted payout is principally 50% cash and 50% IFF common stock at the end of the three-year cycle. Beginning 2023, the targeted payout for all new cycles is 100% IFF common stock at the end of the three-year cycle.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the 2021-2023 cycle, the LTIP awards are earned based on the achievement of: (i) an annual Leverage Ratio for 2021, 2022 and 2023 (representing one-half of the award value) and (ii) Relative TSR targets (representing one-half of the award value). For the 2022-2024 and 2023-2025 cycles, the LTIP awards are earned based on the achievement of: (i) 3-year cumulative Return on Invested Capital (&#8220;ROIC&#8221;) (representing one-half of the award value) and (ii) Relative TSR targets (representing one-half of the award value).</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Leverage Ratio measures Net debt as compared to a measure profitability. The ROIC measures adjusted net operating profit after tax against average invested capital. When the award is granted, 50% of the target dollar value of the award is converted to a number of &#8220;notional&#8221; shares based on the closing price at the beginning of the cycle. For those shares whose payout is based on Relative TSR, compensation expense is recognized using a graded-vesting attribution method, while compensation expense for the remainder of the performance shares (Leverage Ratio or ROIC targets for the applicable cycle) is recognized on a straight-line basis over the vesting period based on the probable outcome of the performance condition.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2019-2021 cycle concluded at the end of 2021 and no shares of common stock were issued in March 2022. The 2020-2022 cycle concluded at the end of 2022 and no shares of common stock were issued in March 2023. The 2021-2023 cycle concluded at the end of 2023 and 5,333 shares of common stock will be issued in March 2024.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2006, the Board of Directors approved the Equity Choice Program (the &#8220;Program&#8221;) for senior management. This program continued under the 2021 Plan. Eligible employees were allowed to choose from among three equity alternatives and were granted such equity awards up to certain dollar awards depending on the participant&#8217;s employment grade level. A participant was able to choose among (1)&#160;Stock-Settled Appreciation Rights (&#8220;SSARs&#8221;), (2)&#160;Restricted Stock Units (&#8220;RSUs&#8221;) or (3)&#160;PRSUs. Beginning 2023, the Company no longer offers the choice from among three equity alternatives and all eligible employees are granted RSUs.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Transaction with Nutrition and Biosciences, Inc.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Merger, N&amp;B employees&#8217; outstanding (unvested and/or vested and unexercised) equity awards were converted into equity awards denominated in shares of the Company&#8217;s common stock based on a defined exchange ratio. N&amp;B employees&#8217; equity awards were converted into 335,347 IFF stock options, 258,572 IFF RSU awards and 5,816 IFF SAR awards.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For converted RSU awards, the fair value of the equity award is based on the Closing Date market price of IFF stock. For converted stock options and SAR awards, the exercise price per share of the converted award is equal to the exercise price per share of the N&amp;B award immediately prior to the Merger divided by the exchange ratio. The fair value of the IFF stock options and SAR awards that the Company issued in connection with the Merger was estimated using the Black Scholes model.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The converted awards were generally issued with the same terms and conditions as were applicable prior to the Transaction. At the Closing Date, approximately $25&#160;million of the fair value of the replacement awards granted to N&amp;B employees was attributable to pre-combination service and was included in the purchase price. As of December&#160;31, 2023, there </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was no remaining post-combination expense to be recognized related to the replacement awards over the remaining post-combination service period, which was approximately up to three years.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SSARs and Options</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SSARs are a contractual right to receive the value, in shares of Company stock, of the appreciation in our stock price from the grant date to the date the SSARs are exercised by the participant. SSARs granted become exercisable on the third anniversary of the grant date and have a maximum term of seven years. SSARs do not require a financial investment by the SSARs grantee. Stock options require the participant to pay the exercise price at the time they exercise their stock options. No stock options were granted in 2023, 2022 or 2021.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SSARs and options activity was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:49.926%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.735%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.735%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.738%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(SHARE AMOUNTS IN THOUSANDS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares&#160;Subject&#160;to<br/>SSARs/Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average&#160;Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SSARs/<br/>Options<br/>Exercisable</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115.35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122.28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.26&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected to Vest at December&#160;31, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126.99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average exercise price of SSARs and options exercisable at December&#160;31, 2023, 2022 and 2021 were $109.59, $109.50 and $109.77, respectively.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SSARs and options outstanding at December&#160;31, 2023 was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:30.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.298%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.444%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.298%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.300%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Price Range</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number<br/>Outstanding<br/>(in&#160;thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Remaining<br/>Contractual Life<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise&#160;Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic&#160;Value<br/>(in millions)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Over $65</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.71</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.26&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SSARs and options exercisable as of December&#160;31, 2023 was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.279%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Price Range</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number<br/>Exercisable<br/>(in&#160;thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Remaining<br/>Contractual&#160;Life<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise&#160;Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic&#160;Value<br/>(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Over $65</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.33</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total intrinsic value of options/SSARs exercised during 2023 was less than $1&#160;million and approximately $2&#160;million for 2022 and $3&#160;million for 2021.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, the total unrecognized compensation cost related to non-vested SSARs granted was approximately $1 million; such cost is expected to be recognized over a weighted average period of approximately 1.14 years.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Stock Units</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has granted RSUs to eligible employees and members of the Board of Directors. The Company has granted both time-based RSUs, which contain no performance criteria provisions, and performance-based RSUs. Such RSUs are subject to forfeitures or adjustments if certain conditions are not met, including service period or pre-established cumulative performance targets. RSUs principally vest 100% at the end of three years. An RSU&#8217;s fair value is calculated based on the market price of the Company&#8217;s stock at date of grant, with an adjustment to reflect the fact that such awards do not participate in dividend rights. The aggregate fair value is amortized to expense ratably over the vesting period.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSU activity was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:55.644%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.160%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.163%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(SHARE AMOUNTS IN THOUSANDS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number&#160;of Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Grant Date Fair<br/>Value Per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">937&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120.81&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">843&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(315)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change due to performance conditions, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.04&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,367&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.50&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total fair value of RSUs that vested during the year ended December&#160;31, 2023 was approximately $38 million.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, there was approximately $67 million of total unrecognized compensation cost related to non-vested RSUs granted under the equity incentive plans; such cost is expected to be recognized over a weighted average period of approximately 1.94 years.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Purchased Restricted Stock Units</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The grant of awards under the Program provided for eligible employees to purchase shares of IFF common stock and deposit them into an escrow account. For each share deposited in escrow by the eligible employee, the Company matched with the grant of a restricted stock unit. The shares of restricted stock units generally vest on the third anniversary of the grant date, are subject to continued employment and other specified conditions, and pay dividends if and when paid by the Company. Holders of restricted stock units have, in most instances, all of the rights of shareholders, except that they may not sell, assign, pledge or otherwise encumber such shares. PRSUs pay dividend equivalents and do not have voting rights.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s PRSU activity for the years ended December 31, 2023, 2022 and 2021:</span></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:35.317%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:22.541%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:17.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Issued Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate Purchases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Covered Shares</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,690&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,845&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,870&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,935&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PRSU activity was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:55.938%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.014%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.015%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(SHARE AMOUNTS IN THOUSANDS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Grant Date Fair<br/>Value Per Share</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133.36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138.98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133.96&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total fair value of PRSUs that vested during the year ended December&#160;31, 2023 was approximately $3 million.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, there was approximately $1 million of total unrecognized compensation cost related to non-vested PRSUs granted under the equity incentive plans; such cost is expected to be recognized over a weighted average period of approximately 1.06 years.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liability Awards</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has granted cash-settled RSUs (&#8220;Cash RSUs&#8221;) to eligible employees that are paid out 100% in cash upon vesting. Such RSUs are subject to forfeiture if certain conditions are not met. Cash RSUs principally vest 100% at the end of three years and contain no performance criteria provisions. A Cash RSU&#8217;s fair value is calculated based on the market price of the Company&#8217;s stock at the date of the closing period and is accounted for as a liability award. The aggregate fair value is amortized to expense ratably over the vesting period.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash RSU activity was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:57.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.429%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(SHARE AMOUNTS IN THOUSANDS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash&#160;RSUs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted&#160;Average&#160;<br/>Fair<br/>Value&#160;Per&#160;Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.97&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total fair value of Cash RSUs that vested during the year ended December&#160;31, 2023 was approximately $4 million.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, there was approximately $2 million of total unrecognized compensation cost related to non-vested Cash RSUs granted under the equity incentive plans; such cost is expected to be recognized over a weighted average period of approximately 1.45 years. The aggregate compensation cost will be adjusted based on changes in the Company&#8217;s stock price.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308306364128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Information</a></td>
<td class="text">SEGMENT INFORMATION<div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is organized into four reportable operating segments: Nourish, Health &amp; Biosciences, Scent and Pharma Solutions. These segments align with the internal structure to manage these businesses. The Company&#8217;s Chief Operating Decision Maker regularly reviews financial information to allocate resources and assess performance utilizing these segments.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nourish is comprised of Ingredients, Flavors and Food Designs, with a diversified portfolio across natural and plant-based specialty food ingredients, flavor compounds, and systems and inclusions, respectively. Ingredients provide texturizing solutions to the food industry, food protection solutions used in food and beverage products, specialty soy and pea protein with value-added formulations, emulsifiers and sweeteners. Flavors provide a range of flavor compounds and natural taste solutions that are ultimately used by IFF&#8217;s customers in savory products, beverages, sweets and dairy products. Flavors also provide value-added spices and seasoning ingredients for meat, food service, convenience, alternative protein and culinary products. Food Designs provide blends and systems that combine key ingredients tailored to IFF customers&#8217; specific needs. Additionally, Food Designs provide inclusion products that help with taste and texture by, among other things, combining flavorings with fruit, vegetables, and other natural ingredients for a wide range of food products, such as health snacks, baked goods, cereals, pastries, ice cream and other dairy products.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health &amp; Biosciences is comprised of Health, Cultures &amp; Food Enzymes, Home &amp; Personal Care, Animal Nutrition and Grain Processing, with a biotechnology-driven portfolio of products that serve the health and wellness, food, consumer and industrial markets. Products within this portfolio range from enzymes, food cultures, probiotics and specialty ingredients for non-food applications. Health provides ingredients for dietary supplements, food and beverage, specialized nutrition and pharma. Cultures &amp; Food Enzymes provide products that aim to serve the global demand for healthy, natural, clean label and fermented food for fresh dairy, cheese, bakery and brewing products. This is accomplished by providing IFF&#8217;s customers with products that allow for extended shelf life and stability, which help to improve customers&#8217; products and performance. The enzyme solution also allows IFF&#8217;s customers to provide low sugar, high fiber and lactose-free dairy products. Home &amp; Personal Care produces enzymes for detergents, cleaning and textile processing products in the laundry, dishwashing, textiles and industrials and personal care markets that help to enhance product and process performances. Animal Nutrition produces enzymes that help to improve the product and process performance of animal feed products, which aim to lessen environmental impact by reducing farm waste. Grain Processing produces enzymes for biofuel production and carbohydrate processing.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Scent is comprised of (1) Fragrance Compounds, which are ultimately used by IFF&#8217;s customers in two broad categories: Fine Fragrances, including perfumes and colognes, and Consumer Fragrances, including fragrance compounds for personal care (e.g., soaps), household products (e.g., detergents and cleaning agents) and beauty care, including toiletries; (2) Fragrance Ingredients, consisting of synthetic and natural ingredients that can be combined with other materials to create unique fine fragrance and consumer fragrance compounds; and (3) Cosmetic Ingredients, consisting of active and functional ingredients, botanicals and delivery systems to support our customers&#8217; cosmetic and personal care product lines. Major fragrance customers include the cosmetics industry, including perfume and toiletries manufacturers, and the household products industry, including manufacturers of soaps, detergents, fabric care, household cleaners and air fresheners.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pharma Solutions is comprised of a vast portfolio, including cellulosics and seaweed-based pharmaceutical excipients, used to improve the functionality and delivery of active pharmaceutical ingredients, including controlled or modified drug release formulations, and enabling the development of more effective pharmaceutical finished dosage formats. Pharma Solutions excipients are used in prescription and over-the-counter pharmaceuticals and dietary supplements. Pharma Solutions products </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">also serve a variety of other specialty and industrial end-uses including coatings, inks, electronics, agriculture and consumer products.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Chief Operating Decision Maker evaluates the performance of these reportable segments based on Segment Adjusted Operating EBITDA, which is defined as (Loss) Income Before Taxes before depreciation and amortization expense, interest expense, restructuring and other charges and certain items that are not related to recurring operations.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reportable segment information is as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:60.979%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nourish</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,060&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,829&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,264&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health &amp; Biosciences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,081&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,339&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,329&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Scent</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,393&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,301&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharma Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">971&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">809&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,479&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,440&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,656&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.863%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nourish</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,893&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,062&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health &amp; Biosciences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,666&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,924&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Scent</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharma Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,227&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,978&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,522&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:60.979%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Adjusted Operating EBITDA:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nourish</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health &amp; Biosciences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">588&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">634&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Scent</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharma Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,980&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,455&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,425&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation &amp; Amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,142)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,179)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,156)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(380)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(336)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(289)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (Expense) Income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and Other Charges (a)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of Goodwill (b)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,623)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,250)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of Long-Lived Assets (c)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(120)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition, Divestiture and Integration Related Costs (d)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(174)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(201)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(240)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Strategic Initiatives Costs (e)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Regulatory Costs (f)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&amp;B Inventory Step-Up Costs (g)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(368)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (h)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) Income Before Taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,518)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,625)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:2.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.801%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Represents costs primarily related to severance as part of the Company's restructuring efforts.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(b)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">For 2023, represents costs related to the impairment of goodwill in the Nourish reporting unit. For 2022, represents costs related to the impairment of goodwill in the Health &amp; Biosciences reporting unit.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(c)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Represents costs related to the impairment of intangible and fixed assets of an asset group that operated primarily in Russia.</span></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:2.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.801%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(d)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">For 2023, 2022 and 2021, primarily represents costs related to the Company's actual and planned acquisitions and divestitures and integration related activities primarily for N&amp;B. These costs primarily consisted of external consulting fees, professional and legal fees and salaries of individuals who are fully dedicated to such efforts. For 2023, acquisition costs primarily relate to earn-out adjustments. For 2022, acquisition costs primarily relate to consulting fees, legal fees and earn-out adjustments. For 2021, acquisition costs primarily relate to legal and professional fees for the transaction with N&amp;B. Tax expenses for business divestiture costs included establishments of deferred tax liabilities related to planned sales of businesses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">For 2023, business divestiture, integration and acquisition related costs were approximately $108 million, $59 million and $7 million, respectively. For 2022, business divestiture, integration and acquisition related costs were approximately $110 million, $94 million and a credit of $3 million, respectively. For 2021, business divestiture, integration and acquisition related costs were approximately $42 million, $105 million and $93 million, respectively.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(e)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Represents costs related to the Company's strategic assessment and business portfolio optimization efforts and reorganizing the Global Shared Services Centers, primarily consulting fees.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(f)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Represents costs primarily related to legal fees incurred for the ongoing investigations of the fragrance businesses.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(g)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Represents costs related to fair value step-up of inventory for the acquired inventory through the Merger with N&amp;B.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(h)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">For 2023, represents gains from sale of assets and costs related to severance, including accelerated stock compensation expense, for a certain executive who will separate from the Company in 2024. For 2022 and 2021, represents gains from sale of assets, costs related to severance, including accelerated stock compensation expense, for certain employees and executives who have been separated from the Company in 2022 and 2021, respectively, and shareholder activist related costs, primarily professional fees.</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has not disclosed revenues at a lower level than provided herein, such as revenues from external customers by product, as it is impracticable for it to do so.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had no customers that accounted for greater than 10% of consolidated net sales in 2023, 2022 and 2021.</span></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets, net, by country, consisted as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,742&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,771&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denmark</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finland</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,424&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,344&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,240&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,203&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment capital expenditures and depreciation and amortization consisted as follows:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:26.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Capital Expenditures</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Depreciation and Amortization</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nourish</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">553&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health &amp; Biosciences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Scent</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharma Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">393&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,142&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,179&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,156&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales are attributed to individual regions based upon the destination of product delivery and are as follows:</span></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales by Geographic Area</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe, Africa and Middle East</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,834&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,219&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,093&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater Asia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,677&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,876&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,728&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,477&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,853&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,491&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,479&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,440&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,656&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:59.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.695%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales by Geographic Area</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales related to the U.S.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,185&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,611&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,211&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales attributed to all foreign countries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,829&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,445&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No non-U.S. country had net sales greater than 7% of total consolidated net sales for 2023 and net sales greater than 6% and 7% of total consolidated net sales for 2022 and 2021, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//280/tableOfContent<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-26<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-34<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308306364128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Employee Benefits</a></td>
<td class="text">EMPLOYEE BENEFITS<div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has pension and/or other retirement benefit plans covering approximately 20% of active employees. In 2007, the Company amended its U.S. qualified and non-qualified pension plans under which accrual of future benefits was suspended for all participants that did not meet the rule of 70 (age plus years of service equal to at least 70 as of December&#160;31, 2007). Pension benefits are generally based on years of service and compensation during the final years of employment. Plan assets consist primarily of equity securities and corporate and government fixed income securities. Substantially all pension benefit costs are funded as accrued; such funding is limited, where applicable, to amounts deductible for income tax purposes. Certain other retirement benefits are provided by general corporate assets.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the Closing Date of the Merger with N&amp;B, the Company assumed responsibility for approximately 20 additional defined benefit plans and recognized liabilities in the aggregate amount of $221 million.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sponsors a qualified defined contribution plan covering substantially all U.S. employees. Under this plan, effective January 1, 2023, the Company matches 100% of the first 6% of participants&#8217; contributions. Prior to this, the Company matched 100% of participants&#8217; contributions up to 4% of compensation and 75% of participants&#8217; contributions from over 4% to 8%. Employees that are still eligible to accrue benefits under the pension plans are limited to a 50% match of up to 6% of the participants&#8217; compensation.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to pension benefits, certain health care and life insurance benefits are provided to qualifying U.S. employees upon retirement from IFF. Such coverage is provided through insurance plans with premiums based on benefits paid. The Company does not generally provide health care or life insurance coverage for retired employees of foreign subsidiaries; such benefits are provided in most foreign countries by government-sponsored plans, and the cost of these programs is not material.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers a non-qualified Deferred Compensation Plan (&#8220;DCP&#8221;) for certain key employees and non-employee directors. Eligible employees and non-employee directors may elect to defer receipt of salary, incentive payments and Board of Directors&#8217; fees into participant-directed investments which are generally invested by the Company in individual variable life insurance contracts it owns that are designed to informally fund savings plans of this nature. The cash surrender value of life insurance is based on the net asset values of the underlying funds available to plan participants. At December&#160;31, 2023 and December&#160;31, 2022, the Consolidated Balance Sheets reflect liabilities of approximately $52 million and $53 million, respectively, related to the DCP in Other liabilities and approximately $17 million and $25 million, respectively, included in Capital in excess of par value related to the portion of the DCP that will be paid out in IFF shares.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total cash surrender value of life insurance contracts the Company owns in relation to the DCP and post-retirement life insurance benefits amounted to $49 million and $45 million at December&#160;31, 2023 and 2022, respectively, and are recorded in Other assets in the Consolidated Balance Sheets.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The plan assets and benefit obligations of the defined benefit pension plans are measured at December&#160;31 of each year.</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:36.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.714%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Components of net periodic benefit cost</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost for benefits earned</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost on projected benefit obligation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amortization of deferrals</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements and curtailments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit (income) cost</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined contribution and other retirement plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Changes in plan assets and benefit obligations recognized in OCI</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss (gain)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized actuarial (loss) gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized prior service credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total loss (gain) recognized in OCI (before tax effects)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(181)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________&#160;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Included as a component of Operating (loss) profit.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Included as a component of Other expense (income), net.</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Postretirement Benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Components of net periodic benefit cost</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost for benefits earned</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost on projected benefit obligation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amortization and deferrals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total credit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Changes in plan assets and benefit obligations recognized in OCI</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss (gain)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized prior service credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total recognized in OCI (before tax effects)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:56.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average actuarial assumptions used to determine expense at December&#160;31 of each year are:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:31.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.638%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.42&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.86&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.51&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.98&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.43&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.85&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the postretirement benefit obligation and plan assets, as applicable, are detailed in the following table:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:35.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.727%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Postretirement Benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">930&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,501&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost for benefits earned</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost on projected benefit obligation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial (gain) loss </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(139)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(468)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments for expense/tax contained in service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan participants&#8217; contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Curtailments/settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,056&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">930&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">649&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">920&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,320&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(286)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participants&#8217; contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">920&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts recognized in the balance sheet are detailed in the following table:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retirement liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(138)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amount recognized</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts recognized in AOCI are detailed in the following table:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:36.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.714%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Postretirement Benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial (gain) loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost (credit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total AOCI (before tax effects)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Benefit Obligation &#8212; end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">520&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">988&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Information for Pension Plans with an Accumulated Benefit Obligation (&#8220;ABO&#8221;) in excess of Plan Assets:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated benefit obligation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Information for Pension Plans with a Projected Benefit Obligation (&#8220;PBO&#8221;) in excess of Plan Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average assumptions used to determine obligations at December&#160;31</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:56.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S.&#160;Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Postretirement<br/>Benefits</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Estimated Future Benefit Payments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 - 2033</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contributions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Required Company Contributions in the Following Year (2024)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers a number of factors in determining and selecting assumptions for the overall expected long-term rate of return on plan assets. The Company considers the historical long-term return experience of its assets, the current and expected allocation of its plan assets and expected long-term rates of return. The Company derives these expected long-term rates of return with the assistance of its investment advisors. The Company bases its expected allocation of plan assets on a diversified portfolio consisting of domestic and international equity securities, fixed income, property and alternative asset classes. The asset allocation is monitored on an ongoing basis.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers a variety of factors in determining and selecting its assumptions for the discount rate at December&#160;31. For the U.S. plans, the discount rate was based on the internal rate of return for a portfolio of high quality bonds rated Aa or higher by either Moody&#8217;s or Standard &amp; Poor&#8217;s with maturities that are consistent with the projected future benefit payment obligations of the plan. For the Non-U.S. Plans, the discount rates were determined by region and are based on high quality long-term corporate bonds.&#160;Consideration has been given to the duration of the liabilities in each plan when selecting the bonds to be used in determining the discount rate. The rate of compensation increase for all plans and the medical cost trend rate for the applicable U.S. plans are based on plan experience.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The percentage of assets in the Company&#8217;s pension plans, by type, is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S.&#160;Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alternative and other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to the U.S. plans, the expected return on plan assets was determined based on an asset allocation model using the current target allocation, real rates of return by asset class and an anticipated inflation rate. The target investment allocation is 10% equity securities and 90% fixed income securities.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The expected annual rate of return for the non-U.S. plans employs a similar set of criteria adapted for local investments, inflation rates and in certain cases specific government requirements. Each plan has its own target asset allocation, which is reviewed periodically and rebalanced when necessary.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the Company&#8217;s plan assets for the U.S. and non-U.S. plans using the fair value hierarchy as of December&#160;31, 2023 and 2022. The plans&#8217; assets were accounted for at fair value and are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement requires judgment, and may affect the valuation of fair value assets and their placement within the fair value hierarchy levels. For more information on a description of the fair value hierarchy, see Note 16.</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans for the Year Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Cash Equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Fixed Income Securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government&#160;&amp; Government Agency Bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate Bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal Bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Assets measured at net asset value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans for the Year Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Cash Equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Fixed Income Securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government&#160;&amp; Government Agency Bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate Bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal Bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Assets measured at net asset value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________&#160;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy. The fair value amounts presented in the table above are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Balance Sheets. The total amount measured at net asset value includes approximately $65 million and $234 million in pooled equity funds and $341 million and $170 million in fixed income mutual funds for the years ended December&#160;31, 2023 and 2022, respectively.</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans for the Year Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Equity Securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Large Cap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Mid Cap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Small Cap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Large Cap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Mid Cap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Small Cap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Markets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Fixed Income Securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Corporate Bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Treasuries/Government Bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Corporate Bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Asset-Backed Securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Other Fixed Income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Alternative Types of Investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance Contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative Financial Instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Absolute Return Funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private Equity Funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Property</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Property</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">448&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans for the Year Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Equity Securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Large Cap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Mid Cap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Large Cap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Mid Cap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Small Cap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Markets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Fixed Income Securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Corporate Bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Treasuries/Government Bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Corporate Bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Asset-Backed Securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Other Fixed Income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Alternative Types of Investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance Contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative Financial Instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Absolute Return Funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Property</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Property</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">920&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents are primarily held in registered money market funds which are valued using a market approach based on the quoted market prices of identical instruments. Other cash and cash equivalents are valued daily by the fund using a market approach with inputs that include quoted market prices for similar instruments.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity securities are primarily valued using a market approach based on the quoted market prices of identical instruments. Pooled funds are typically common or collective trusts valued at their net asset values (NAVs).</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fixed income securities are primarily valued using a market approach with inputs that include broker quotes and benchmark yields.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative instruments are valued by the custodian using closing market swap curves and market derived inputs.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property values are primarily based on valuation of the underlying investments, which include inputs such as cost, discounted future cash flows, independent appraisals and market comparable data.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hedge funds are valued based on valuation of the underlying securities and instruments within the funds. Quoted market prices are used when available and NAVs are used for unquoted securities within the funds.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Absolute return funds are actively managed funds mainly invested in debt and equity securities and are valued at their NAVs.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a reconciliation of Level 3 non-U.S. plan assets held during the year ended December&#160;31, 2023:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hedge<br/>Funds</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases, sales and settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance as of December 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following weighted average assumptions were used to determine the postretirement benefit expense and obligation for the years ended December&#160;31:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:56.315%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.885%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.034%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.40&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.90&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.40&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current medical cost trend rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ultimate medical cost trend rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical cost trend rate decreases to ultimate rate in year</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2030</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2034</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2030</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company contributed $31 million to its non-U.S. pension plans in 2023. No contributions were made to the Company&#8217;s qualified U.S. pension plans in 2023. The Company contributed $5 million with respect to its non-qualified U.S. pension plan. In addition, $3 million of payments were made with respect to the Company&#8217;s other postretirement plans.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 70<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480794/715-70-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//715/tableOfContent<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480126/715-20-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480266/715-60-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308306405360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsDisclosureTextBlock', window );">Financial Instruments</a></td>
<td class="text">FINANCIAL INSTRUMENTS<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounting guidance on fair value measurements specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company&#8217;s market assumptions. These two types of inputs create the following fair value hierarchy:</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 &#8212; Quoted prices for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">identical</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> instruments in active markets.</span></div><div style="margin-top:3pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 &#8212; Quoted prices for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">similar</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets.</span></div><div style="margin-top:3pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 &#8212; Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This hierarchy requires the Company to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value. The Company determines the fair value of structured liabilities (where performance is linked to structured interest rates, inflation or currency risks) using the Term SOFR swap curve and forward interest and exchange rates at period end. Such instruments are classified as Level 2 based on the observability of significant inputs to the model. The Company does not have any instruments classified as Level 3, other than those included in pension asset trusts included in Note 15. These valuations take into consideration the Company's credit risk and its counterparties&#8217; credit risk.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value and the estimated fair values of financial instruments at December&#160;31 consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LEVEL 1</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">703&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">703&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LEVEL 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credit facilities and bank overdrafts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="-sec-ix-hidden:f-2472"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="-sec-ix-hidden:f-2477"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Euro Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">924&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">884&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Euro Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">879&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">845&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,049&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,006&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2030 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,510&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2040 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">536&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2047 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2048 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">787&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">678&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">787&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">685&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2050 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,569&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,029&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,021&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Term Loan Facility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Term Loan Facility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The carrying amount of cash and cash equivalents approximates fair value due to the short maturity of those instruments.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The carrying amount approximates fair value as the interest rate is reset frequently based on current market rates as well as the short maturity of those instruments.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The carrying amount approximates fair value as the instruments are marked-to-market and held at fair value on the Consolidated Balance Sheets.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The fair value of the Note is obtained from pricing services engaged by the Company, and the Company receives one price for each security. The fair value provided by the pricing services are estimated using pricing models, where the inputs to those models are based on observable market inputs or recent trades of similar securities. The inputs to the valuation techniques applied by the pricing services are typically benchmark yields, benchmark security prices, credit spreads, reported trades and broker-dealer quotes, all with reasonable levels of transparency.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The carrying amount approximates fair value as the Term Loans were assumed at fair value and the interest rate is reset frequently based on current market rates.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivatives</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Forward Contracts</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company periodically enters into foreign currency forward contracts with the objective of managing our exchange rate risk related to foreign currency denominated monetary assets and liabilities of our operations. These contracts generally involve the exchange of one currency for a second currency at a future date, have maturities not exceeding twelve months and are with counterparties which are major international financial institutions.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commodity Contracts</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes options that are not designated as hedging instruments to reduce exposure to commodity price fluctuations on purchases of inventory such as soybeans, soybean oil and soybean meal.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also uses options, futures and swaps that are designated as hedging instruments to reduce exposure to commodity price fluctuations on purchases of natural gas used in our manufacturing process.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flow Hedges</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through the third quarter of 2021, the Company maintained several forward currency contracts which qualified as cash flow hedges. The objective of these hedges is to protect against the currency risk associated with forecasted U.S. dollar (&#8220;USD&#8221;) denominated raw material purchases made by Euro (&#8220;EUR&#8221;) functional currency entities which result from changes in the EUR/USD exchange rate. The effective portions of cash flow hedges are recorded in other comprehensive income (&#8220;OCI&#8221;) as a component of Gains on derivatives qualifying as hedges in the accompanying Consolidated Statements of (Loss) Income and Comprehensive Loss. Realized gains/(losses) in accumulated other comprehensive income (loss) (&#8220;AOCI&#8221;) related to cash flow hedges of raw material purchases are recognized as a component of Cost of goods sold in the accompanying Consolidated Statements of (Loss) Income and Comprehensive Loss in the same period as the related costs are recognized.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no cash flow hedges as of December&#160;31, 2023 and December&#160;31, 2022.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hedges Related to Issuances of Debt</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the issuance of the 2026 Euro Notes during the third quarter of 2018, the Company designated the debt as a hedge of a portion of its net European investments. Accordingly, the change in the value of the debt that is attributable to foreign exchange movements is recorded in OCI as a component of foreign currency translation adjustments in the accompanying Consolidated Statements of (Loss) Income and Comprehensive Loss.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the issuance of the 2024 Euro Notes during the first quarter of 2016, the Company designated the debt as a hedge of a portion of its net European investments. Accordingly, the change in the value of the debt that is attributable to foreign exchange movements is recorded in OCI as a component of foreign currency translation adjustments in the accompanying Consolidated Statements of (Loss) Income and Comprehensive Loss.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2016, the Company entered into and terminated two Euro interest rate swap agreements to hedge the anticipated issuance of fixed-rate debt. These swaps were designated as cash flow hedges. The effective portions of cash flow hedges are recorded in OCI as a component of Losses on derivatives qualifying as hedges in the accompanying Consolidated Statements of (Loss) Income and Comprehensive Loss. The Company incurred a loss of &#8364;3 million ($3 million) due to the termination of these swaps. The loss is being amortized as interest expense over the life of the 2024 Euro Notes as discussed in Note 9.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2016 and the first quarter of 2017, the Company entered into interest rate swap agreements to hedge the anticipated issuance of fixed-rate debt, which are designated as cash flow hedges. The various hedge instruments were settled upon issuance of the debt on May 18, 2017 and resulted in a loss of approximately $5 million. As discussed in Note 9, the loss is being amortized as interest expense over the life of the 2047 Notes.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cross Currency Swaps</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2022, the Company entered into a transaction to unwind the fourteen outstanding EUR/USD cross currency swaps designated as net investment hedges issued between the third quarter of 2019 and the first quarter of 2022. The Company received proceeds of approximately $183 million, including $11 million of interest income. The gain arising from the termination of the swaps has been included as a component of Accumulated other comprehensive loss. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the unwinding of the existing swaps, during the third quarter of 2022, the Company entered into twelve new EUR/USD cross currency swaps, with a notional value of $1.400&#160;billion that mature through November 2030. The swaps all qualified as net investment hedges in order to mitigate a portion of the Company&#8217;s net European investments from foreign currency risk. As of December&#160;31, 2023, the twelve remaining swaps were in a liability position with an aggregate fair value of $161 million which were classified as Other liabilities on the Consolidated Balance Sheets. Changes in fair value related to cross currency swaps are recorded in OCI.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the notional amount of the Company&#8217;s derivative instruments outstanding as of December&#160;31, 2023 and December&#160;31, 2022:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:68.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.564%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,400)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________</span></div><div style="margin-top:3pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt">Foreign currency contracts and commodity contracts are presented net of contracts bought and sold.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables show the Company&#8217;s derivative instruments measured at fair value (Level 2 of the fair value hierarchy) as reflected in the Consolidated Balance Sheets as of December&#160;31, 2023 and December&#160;31, 2022:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:42.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.640%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.055%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.057%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value of Derivatives<br/>Designated&#160;as Hedging<br/>Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value of Derivatives Not Designated as Hedging Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivative assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swaps</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivative liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:42.576%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.282%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.284%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair&#160;Value&#160;of Derivatives Designated&#160;as Hedging Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair&#160;Value&#160;of Derivatives&#160;Not Designated as Hedging Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total&#160;Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swaps</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Derivative assets are recorded to Prepaid expenses and other current assets on the Consolidated Balance Sheets.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Derivative liabilities are recorded to Other current liabilities and Other liabilities on the Consolidated Balance Sheets.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the effect of the Company&#8217;s derivative instruments which were not designated as hedging instruments in the Consolidated Statements of (Loss) Income and Comprehensive Loss for the years ended December&#160;31, 2023 and 2022:</span></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.805%"></td><td style="width:0.1%"></td></tr><tr style="height:32pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount&#160;of&#160;Gain (Loss)<br/>For the year ended<br/>December&#160;31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location&#160;of&#160;Gain (Loss)<br/>Recognized in<br/>Income on Derivative</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-2581"><span style="-sec-ix-hidden:f-2582">Other expense (income), net</span></span></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-2585">Cost of goods sold</span></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-top:3pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt">The foreign currency contract net gains (losses) offset any recognized gains (losses) arising from the revaluation of the related intercompany loans during the same respective periods.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the effect of the Company&#8217;s derivative instruments designated as net investment hedging instruments, net of tax, in the Consolidated Statements of (Loss) Income and Comprehensive Loss for the years ended December&#160;31, 2023 and 2022:</span></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:36.694%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.638%"></td><td style="width:0.1%"></td></tr><tr style="height:36pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain (Loss)<br/>Recognized&#160;in OCI on Derivative and Non-Derivative<br/>(Effective Portion)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location&#160;of&#160;Gain<br/>(Loss) Reclassified<br/>from AOCI into Income<br/>(Effective Portion)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Reclassified from AOCI<br/>into Income<br/>(Effective Portion)</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the years ended<br/>December&#160;31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the years ended<br/>December&#160;31,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives in Net Investment Hedging Relationships:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swaps</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-Derivatives in Net Investment Hedging Relationships:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Euro Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Euro Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ineffective portion of the above noted net investment hedges was approximately $15 million and $10 million for the years ended December&#160;31, 2023 and 2022, respectively, and was recorded as a reduction to interest expense on the Consolidated Statements of (Loss) Income and Comprehensive Loss.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2023, based on current market rates, the Company does not expect any derivative losses (net of tax), included in AOCI, to be reclassified into earnings within the next 12 months.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308306401360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Loss)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_AccumulatedOtherComprehensiveIncomeLossTextBlock', window );">Accumulated Other Comprehensive Income Loss</a></td>
<td class="text">ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)<div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present changes in the accumulated balances for each component of other comprehensive income (loss), including current period other comprehensive income (loss) and reclassifications out of accumulated other comprehensive income (loss):</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:43.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.403%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gains&#160;(Losses)&#160;on Derivatives<br/>Qualifying as<br/>Hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension and<br/>Postretirement<br/>Liability<br/>Adjustment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive (loss) income, net of tax, as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,066)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,198)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCI before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassifications due to business divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(112)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive (loss) income, net of tax, as of December 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,652)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(245)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,896)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:43.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.403%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gains&#160;(Losses)&#160;on Derivatives<br/>Qualifying as<br/>Hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension and<br/>Postretirement<br/>Liability<br/>Adjustment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive (loss) income, net of tax, as of December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,133)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(291)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,423)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCI before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(933)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(785)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(933)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(775)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive (loss) income, net of tax, as of December 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,066)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,198)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:43.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.403%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gains&#160;(Losses)&#160;on Derivatives<br/>Qualifying as<br/>Hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension and<br/>Postretirement<br/>Liability<br/>Adjustment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive (loss) income, net of tax, as of December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(285)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(406)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(698)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCI before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(848)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(750)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(848)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(725)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive (loss) income, net of tax, as of December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,133)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(291)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,423)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides details about reclassifications out of Accumulated other comprehensive loss to the Consolidated Statements of (Loss) Income and Comprehensive Loss:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:36.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.466%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.466%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.466%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.525%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Affected Line Item in the Consolidated Statements of (Loss) Income and Comprehensive Loss</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains (losses) on derivatives qualifying as hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision&#160;for&#160;income&#160;taxes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total, net of income taxes</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains (losses) on pension and postretirement liability adjustments</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gains (losses)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total,&#160;net&#160;of&#160;income&#160;taxes</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The amortization of prior service cost and actuarial loss is included in the computation of net periodic benefit cost. See Note 15 for additional information regarding net periodic benefit cost.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents certain amounts of pension income that were corrected in 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_AccumulatedOtherComprehensiveIncomeLossTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated Other Comprehensive Income (Loss) [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_AccumulatedOtherComprehensiveIncomeLossTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308306592880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Concentrations of Credit Risk<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RisksAndUncertaintiesAbstract', window );"><strong>Risks and Uncertainties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskDisclosureTextBlock', window );">Concentrations of Credit Risk</a></td>
<td class="text">CONCENTRATIONS OF CREDIT RISK<div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not have significant concentrations of risk in financial instruments. Temporary investments are made in a well-diversified portfolio of high-quality, liquid obligations of government, corporate and financial institutions. There are also limited concentrations of credit risk with respect to trade receivables because the Company has a large number of customers who are spread across many industries and geographic regions. The Company&#8217;s larger customers are each spread across many sub-categories of its segments and geographical regions. The Company had no customer that accounted for more than 10% of its consolidated net sales for the years ended 2023, 2022 and 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 275<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//275/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RisksAndUncertaintiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RisksAndUncertaintiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308294849824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIES<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Guarantees and Letters of Credit</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has various bank guarantees, letters of credit and surety bonds which are used to support its ongoing business operations, satisfy governmental requirements associated with pending litigation in various jurisdictions and the payment of customs duties. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, the Company had a total capacity of approximately $229 million of bank guarantees, commercial guarantees, standby letters of credit and surety bonds with various financial institutions. Included in the above aggregate amount was a total of approximately $11 million for other assessments in Brazil for various income tax and indirect </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">tax disputes related to fiscal years 1998-2011. There was a total of approximately $61&#160;million outstanding under the bank guarantees, standby letters of credit and commercial guarantees as of December&#160;31, 2023.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to challenge the assessments in these cases in Brazil, the Company has been required to, and has separately pledged assets, principally property, plant and equipment, to cover assessments in the amount of approximately $8 million as of December&#160;31, 2023.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lines of Credit</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has various lines of credit which are available to support its ongoing business operations. As of December&#160;31, 2023, the Company had a total capacity of approximately $1.848 billion of lines of credit with various financial institutions, in addition to the $1.548&#160;billion of capacity under the Revolving Credit Facility. Pursuant to these lines of credit as of December&#160;31, 2023, the total drawdowns were not material.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Litigation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses contingencies related to litigation and/or other matters to determine the degree of probability and range of possible loss. A loss contingency is accrued in the Company&#8217;s Consolidated Financial Statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because litigation is inherently unpredictable and unfavorable resolutions could occur, assessing contingencies is highly sensitive and requires judgments about future events. On at least a quarterly basis, the Company reviews contingencies related to litigation to determine the adequacy of accruals. The amount of ultimate loss may differ from these estimates and further events may require the Company to increase or decrease the amounts it has accrued on any matter.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Periodically, the Company assesses its insurance coverage for all known claims, where applicable, taking into account aggregate coverage by occurrence, limits of coverage, self-insured retentions and deductibles, historical claims experience and claims experience with its insurance carriers. The liabilities are recorded at management&#8217;s best estimate of the probable outcome of the lawsuits and claims, taking into consideration the facts and circumstances of the individual matters as well as past experience on similar matters. At each balance sheet date, the key issues that management assesses are whether it is probable that a loss as to asserted or unasserted claims has been incurred and if so, whether the amount of loss can be reasonably estimated. The Company records the expected liability with respect to claims in Other liabilities and expected recoveries from its insurance carriers in Other assets. The Company recognizes a receivable when it believes that realization of the insurance receivable is probable under the terms of the insurance policies and its payment experience to date.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation Matters</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 12, 2019, Marc Jansen filed a putative securities class action against IFF, its then Chairman and CEO, and its then-CFO, in the United States District Court for the Southern District of New York. The lawsuit was filed after IFF disclosed that preliminary results of investigations indicated that Frutarom businesses operating principally in Russia and Ukraine had made improper payments to representatives of customers. On March 16, 2020, an amended complaint was filed, which added Frutarom and certain former officers of Frutarom as defendants. The amended complaint alleges, among other things, that defendants made materially false and misleading statements or omissions concerning IFF&#8217;s acquisition of Frutarom, the integration of the two companies, and the companies&#8217; financial reporting and results. The amended complaint asserts claims under Section 10(b) of the Securities Exchange Act of 1934 and SEC Rule 10b-5, and under the Israeli Securities Act-1968, against all defendants, and under Section 20(a) of the Securities Exchange Act of 1934 against the individual defendants, on behalf of a putative class of persons and entities who purchased or otherwise acquired IFF securities on the New York Stock Exchange between May 7, 2018 and August 12, 2019 and persons and entities who purchased or otherwise acquired IFF securities on the Tel Aviv Stock Exchange between October 9, 2018 and August 12, 2019. The amended complaint seeks an award of unspecified compensatory damages, costs, and expenses. IFF, its officers, and Frutarom filed a motion to dismiss the case on June 26, 2020, which was granted on March 30, 2021. On April 28, 2021, lead plaintiffs filed a notice of appeal to the United States Court of Appeals for the Second Circuit. Lead plaintiffs are pursuing the appeal only against Frutarom and certain former officers of Frutarom. The parties have submitted their briefs to the Court of Appeals. The Second Circuit held oral argument on February 10, 2022. On September 30, 2022, the Second Circuit affirmed the dismissal of Plaintiffs&#8217; claims. On October 14, 2022, Plaintiffs filed a Petition for Rehearing En Banc, which the Second Circuit denied on January 4, 2023. Plaintiffs did not seek review in the United States Supreme Court. The matter is therefore fully resolved in defendants&#8217; favor.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Two motions to approve securities class actions were filed in the Tel Aviv District Court, Israel, in August 2019, similarly alleging, among other things, false and misleading statements largely in connection with IFF&#8217;s acquisition of Frutarom and the above-mentioned improper payments.&#160;One motion (&#8220;Borg&#8221;) asserts claims under the U.S. federal securities laws against IFF, its former Chairman and CEO, and its former CFO. On November 8, 2020, IFF and its officers filed their response to the Borg motion. On April 20, 2021, Mr. Borg filed a motion to stay the proceeding pending an appellate decision in the U.S. proceeding. On June 15, 2021, August 11, 2021, November 9, 2021, January 9, 2022, April 7, 2022 and July 10, 2022, the U.S. lead plaintiffs filed update notices with the Israeli court regarding the appeal in the U.S. proceeding. On June 12, 2023, the petitioner filed a withdrawal motion, which the court then granted. The Borg case is now dismissed. The other motion (&#8220;Oman&#8221;) (following an initial amendment) asserted claims under the Israeli Securities Act-1968 against IFF, its former Chairman and CEO, and its former CFO, and against Frutarom and certain former Frutarom officers and directors, as well as claims under the Israeli Companies Act-1999 against certain former Frutarom officers and directors. On February 17, 2021, the court granted a motion by the Oman plaintiff to remove IFF and its officers from the motion and to add factual allegations from the US amended complaint. The amended Oman motion was filed on July 4, 2021. On August 29, 2021, the former Frutarom officers and certain former Frutarom directors filed a motion to dismiss the case. On September 30, 2021, Frutarom notified the court that it joins the legal arguments made in the motion to dismiss. On February 22, 2022, the court denied the motion to dismiss. On July 14, 2022, the court approved the parties&#8217; motion to mediate the dispute, which postpones all case deadlines until after the mediation. In addition, a request to appeal the court&#8217;s denial of the motion to dismiss filed by the former Frutarom officers and certain former Frutarom directors has been stayed. The parties held mediation meetings on September 13, 2022, November 22, 2022, March 1, 2023 and November 2023.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 29, 2019, IFF and Frutarom filed a claim in the Tel Aviv District Court, Israel, against Ori Yehudai, the former President and CEO of Frutarom, and against certain former directors of Frutarom, challenging the bonus of US $20&#160;million granted to Yehudai in 2018.&#160;IFF and Frutarom allege, among other things, that Yehudai was not entitled to receive the bonus because he breached his fiduciary duty by, among other things, knowing of the above-mentioned improper payments and failing to prevent them from being made. The parties agreed, pursuant to the court&#8217;s recommendation, to attempt to resolve the dispute through mediation, and a court decision is pending with regard to the order in which this claim and the class action described below will be heard.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 11, 2020, an IFF shareholder filed a motion to approve a class action in Israel against, among others, Frutarom, Yehudai, and Frutarom&#8217;s former board of directors, alleging that former minority shareholders of Frutarom were harmed as a result of the US $20&#160;million bonus paid to Yehudai. The parties to this motion agreed to attempt to resolve the dispute through mediation to take place regarding the aforesaid claim against Yehudai. On July 27, 2021, counsel to the movant in the class action filed a notice with the court that the mediation process ended without an agreement. On August 26, 2021, a motion to dismiss the class action application was filed by Yehudai and certain former directors of Frutarom. On September 9, 2021, an additional motion to dismiss was filed by other former directors of Frutarom together with ICC Industries, Inc. and its affiliates. On December 9, 2021, the court denied the motions to dismiss. Responses to the class action motion were filed in May 2022, and applicant&#8217;s response was filed in December 2022. An evidentiary hearing is set for March 2024.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since March 2023, various putative class action lawsuits have been filed against IFF, Firmenich International SA, Givaudan SA, and Symrise AG and/or certain affiliates thereof in the Quebec Superior Court, the Federal Court of Canada, Ontario Superior Court, Supreme Court of British Columbia and, in several cases, the United States District Court for the District of New Jersey. These actions allege violations of the Canadian Competition Act and the Sherman Act, as applicable, and other related claims, and seek damages and other relief. IFF may face additional civil suits, in the United States or elsewhere, relating to such alleged conduct. At this time, IFF is unable to predict the potential outcome of these lawsuits or any potential effect they may have on the Company&#8217;s results of operations, liquidity or financial condition.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investigation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 3, 2020, the Israel Police&#8217;s National Fraud Investigation Unit and the Israeli Securities Authority commenced an investigation into Frutarom and certain of its former executives, based on suspected bribery of foreign officials, money laundering, and violations of the Israeli Securities Act-1968. As part of the investigation, the National Fraud Investigation Unit and the Israeli Securities Authority have provided IFF and Frutarom with various orders, mainly requesting that IFF and Frutarom provide certain documents and materials. In addition, a seizure of assets was imposed on Frutarom and certain of its affiliates. IFF has been working to ensure compliance with such orders, all in accordance with, and subject to, Israeli law. On August 25, 2021, the Israeli Police informed Frutarom that they have decided to remove the temporary criminal seizure of assets order from the real estate assets of Frutarom and its related companies, which was done in parallel with the transfer of the case to the District Attorney&#8217;s Office in Israel. On February 26, 2024, the Israeli authorities informed Frutarom that the authorities decided to close the criminal investigation.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 7, 2023, the European Commission (&#8220;EC&#8221;) and the United Kingdom Competition and Markets Authority (&#8220;CMA&#8221;) carried out unannounced inspections of certain of IFF&#8217;s facilities. On the same day, IFF was served with a grand jury subpoena by the Antitrust Division of the U.S. Department of Justice (&#8220;DOJ&#8221;). IFF understands the EC, CMA, DOJ and the Swiss Competition Commission are investigating potential anticompetitive conduct as it relates to IFF&#8217;s fragrance businesses. IFF has been and intends to continue cooperating with these investigations. IFF is unable, however, to predict or determine at this time the duration or outcome of the investigations, or whether the outcome of the investigations will materially impact the Company&#8217;s results of operations, liquidity or financial condition.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">China Facilities</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Zhejiang Ingredients Plant</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2017, the Company concluded discussions with the government regarding the relocation of its Fragrance Ingredients plant in Zhejiang and, based on the agreements reached, expects to receive total compensation payments up to approximately $50 million. The relocation compensation will be paid to the Company over the period of the relocation. The Company received payments totaling $30 million through the end of 2019. Production at the facility ceased during 2019. In the second quarter of 2020, the Company transferred ownership of the site to the government and the remaining net book value of the plant was written off. In the third quarter of 2020, the Company received a payment of approximately $13 million. The land remediation activities were completed in November 2022 and the final land restoration activities to restore the land to its original height, per the government&#8217;s request, were completed in April 2023. Upon completion of these activities, the land was returned to the government in April 2023 and a final payment of approximately $5&#160;million was received in June 2023.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2023, the Company recognized a pre-tax gain of approximately $22&#160;million related to this transaction presented in Other expense (income), net on the Consolidated Statements of (Loss) Income and Comprehensive Loss. The Company also recognized approximately $6 million of income taxes presented in Provision for income taxes on the Consolidated Statements of (Loss) Income and Comprehensive Loss. The calculation of the applicable income taxes related to this transaction was sent to the local tax authorities for review and final approval was received in the fourth quarter of 2023.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Products previously manufactured at the Zhejiang Ingredients plant are now being produced at the Company&#8217;s Ingredients plant in Jiande, China.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Total China Operations</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total net book value of all plants in China was approximately $215 million as of December&#160;31, 2023.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company is required to close a plant, or operate one at significantly reduced production levels on a permanent basis, the Company may be required to record charges that could have a material impact on its consolidated financial results of operations, financial position and cash flows in future periods.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Environmental Proceedings</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is reporting the following environmental matter in compliance with SEC requirements to disclose environmental proceedings where a governmental authority is a party and that involve potential monetary sanctions of $300,000 or greater. On May 27, 2022, the Solae, LLC Memphis site (&#8220;Solae&#8221;) was served an Administrative Order and Assessment (the &#8220;Order&#8221;) by the City of Memphis related to alleged wastewater discharge violations. Solae submitted an appeal of the Order on June 24, 2022. Discussions with the City regarding potential resolution of the violations and penalties related to said violations are ongoing. Additionally, the Solae facility has undertaken capital project efforts, some of which began prior to the issuance of the Order, that are anticipated to address, on a schedule consistent with the Order, deadlines for attaining compliance with current wastewater permit requirements. This matter is not expected to have a material adverse effect on the Company&#8217;s financial position, cash flows or results of operations.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Contingencies</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has contingencies involving third parties (such as labor, contract, technology or product-related claims or litigation) as well as government-related items in various jurisdictions in which it operates pertaining to such items as value-added taxes, other indirect taxes, customs and duties and sales and use taxes. It is possible that cash flows or results of operations, in any period, could be materially affected by the unfavorable resolution of one or more of these contingencies.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The most significant government-related contingencies exist in Brazil. With regard to the Brazilian matters, the Company believes it has valid defenses for the underlying positions under dispute; however, in order to pursue these defenses, the Company is required to, and has provided, bank guarantees and pledged assets in the aggregate amount of approximately $19 million. The Brazilian matters take an extended period of time to proceed through the judicial process and there are a limited number of rulings to date.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Brazil Tax Credits</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2017, the Brazilian Supreme Court (&#8220;BSC&#8221;) ruled that Brazilian tax authorities should not include a value added tax known as &#8220;ICMS&#8221; in the calculation of certain indirect taxes (&#8220;PIS/COFINS&#8221;). By removing the ICMS from the calculation of the indirect tax base, the Court effectively eliminated a &#8220;tax on tax.&#8221; The Brazilian tax authorities filed an appeal seeking clarification of certain matters, including the amount of ICMS to which taxpayers would be entitled in order to reduce their indirect tax base (i.e. the gross rate or the net rate). In light of the BSC&#8217;s decision, in November 2017, the Company filed suit consistent with the BSC decision to require that ICMS be excluded from the PIS/COFINS calculation and received a favorable preliminary decision that was confirmed by the BSC in September 2018. This preliminary ruling granted the Company the right to prospectively exclude ICMS amounts from the PIS/COFINS calculation, but left open the issue of whether the Company could recover the gross or net amount of ICMS amounts paid on PIS/COFINS for the period from November 2011 to December 2018.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the Company was informed of a favorable ruling from the Brazilian tax authorities confirming that the Company was entitled to recover the overpayments of PIS/COFINS for the period from November 2011 to December 2018, plus interest on the amount of the overpayments. The overpayments arose from the inclusion of a value added tax known as ICMS in the calculation of the PIS/COFINS tax. The ruling did not, however, settle the question of whether the Company is eligible to recover overpayments based on the gross or the net amount of ICMS amounts paid on PIS/COFINS. The Company calculated the amount of overpayments using the gross method which yields a higher amount than the application of the net method. A final ruling on the gross versus net amount issue was made by the BSC who affirmed the use of the gross calculation with respect to claims submitted prior to March 2017. Although the Company had not submitted a claim until after March 2017, the Company believes that the Supreme Court, whilst confirming the use of the gross method of calculation, does not override the January 2020 ruling by the Brazilian tax authorities with respect to the timeframe for the calculation.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the $8 million recognized in the fourth quarter of 2019, during the first quarter of 2020 the Company recognized $4 million as an additional recovery on the existing claim. During 2020, the Company also recognized $3&#160;million related to a claim from another of its subsidiaries in Brazil. The income was recognized as a reduction in Selling and administrative expenses.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2023, the BSC made an unfavorable court resolution for the Company related to the use of the gross method, which was only granted to claims submitted prior to March 2017. As a result of this unfavorable court resolution, the Company wrote off its remaining receivables of approximately $6&#160;million related to this matter during the first quarter of 2023.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Avicel&#174; PH NF (Pharma Solutions)</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has determined that certain grades of microcrystalline cellulose (Avicel&#174; PH 101, 102, and 200 NF and Avicel&#174; RC-591 NF) were found to be out-of-specification (collectively, &#8220;OOS Avicel&#174; NF&#8221;). The Company does not expect the OOS conductivity issue to affect the functionality of Avicel&#174; NF grades or to pose a human health hazard. Corrective actions have been implemented to improve operational and laboratory conditions. Based on the information available, as of December&#160;31, 2023, payments associated with this matter were approximately $46 million, and the Company no longer had an accrual related to this matter. The total amount of exposure may increase if additional customers present claims or other exposures are identified.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines estimates of reasonably possible losses or ranges of reasonably possible losses in excess of related accrued liabilities, if any, when it has determined that either a loss is reasonably possible or a loss in excess of accrued amounts is reasonably possible and the amount of losses or range of losses is determinable. For all third party contingencies (including labor, contract, technology, tax, product-related claims and business litigation), the Company currently estimates that the aggregate range of reasonably possible losses in excess of any accrued liabilities is $0 to approximately $75 million. The estimates included in this amount are based on the Company&#8217;s analysis of currently available information and, as new information is obtained, these estimates may change. Due to the inherent subjectivity of the assessments and the unpredictability of outcomes of legal proceedings, any amounts accrued or included in this aggregate amount may not represent the ultimate loss to the Company from the matters in question. Thus, the Company&#8217;s exposure and ultimate losses may be higher or lower, and possibly significantly so, than the amounts accrued or the range disclosed above.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//450/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480327/954-440-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308309860432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Noncontrolling Interests<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDisclosureTextBlock', window );">Redeemable Noncontrolling Interests</a></td>
<td class="text">REDEEMABLE NON-CONTROLLING INTERESTS<div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through certain subsidiaries of the Company&#8217;s Frutarom acquisition, there were certain non-controlling interests that carried redemption features. The non-controlling interest holders had the right, over a stipulated period of time, to sell their respective interests to Frutarom, and Frutarom had the option to purchase these interests (subject to the same timing). In most cases, these options carried similar price and conditions of exercise, and were settled on a pre-agreed formula based on a multiple of the average EBITDA of consecutive quarters to be achieved during the period ending prior to the exercise date.</span></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the details of the Company&#8217;s&#160;redeemable&#160;non-controlling interests:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:67.860%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable <br/>Non-controlling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign exchange translation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of profit or loss attributable to redeemable non-controlling interests</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemption value adjustment for the current period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign exchange translation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of profit or loss attributable to redeemable non-controlling interests</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemption value adjustment for the current period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercises of redeemable non-controlling interests</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign exchange translation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemption value adjustment for the current period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercises of redeemable non-controlling interests</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposal of redeemable non-controlling interests</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________&#160;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The disposal of redeemable non-controlling interests was related to the sale of the Company&#8217;s investment in the Sonarome business. The total proceeds received from the sale transaction was approximately $29&#160;million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//810/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308306397184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Assets and Liabilities Held For Sale<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">Assets and Liabilities Held For Sale</a></td>
<td class="text">BUSINESS DIVESTITURES<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Divestiture of the Flavor Specialty Ingredients Business</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2022, the Company announced it had entered into an agreement to sell its Flavor Specialty Ingredients (&#8220;FSI&#8221;) business, which was a part of the Scent segment. The Company completed the divestiture on August 1, 2023 and received cash proceeds of approximately $205 million, which included $1 million related to the delayed transfer of the control of specific assets and liabilities of non-U.S. jurisdiction business. In addition, approximately $15 million of proceeds were held in escrow and have been released upon satisfaction of certain conditions. Concurrent with the completion of the business divestiture, the Company entered into a supply agreement arrangement with the buyer. Based on the terms of the supply agreement, an adjustment of $4 million was made against the fair value of sale consideration. The sale consideration is subject to certain post-closing adjustments, which is primarily related to cash, indebtedness and working capital balances.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of sale consideration received in connection with the business divestiture:</span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash proceeds from the buyer</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advance receipt for business to be transferred</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct costs to sell</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds attributable to supply agreement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of sale consideration</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net proceeds received from the business divestiture presented under Cash flows from investing activities represent the cash portion of the sale consideration, which was determined as the fair value of sale consideration adjusted by the direct costs to sell, advance receipt for business to be transferred and the cash transferred to the buyer as part of the transaction. The following table summarizes the different components of net proceeds received from business divestiture presented under Cash flows from investing activities:</span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of sale consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct costs to sell</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advance receipt for business to be transferred</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash transferred to the buyer</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net proceeds received from business divestiture</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount of net assets associated with the business unit, adjusted for currency translation adjustment, was approximately $205 million. The major classes of assets and liabilities sold consisted of the following:</span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">August 1, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive income - currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of net assets (adjusted for currency translation adjustment)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the business divestiture, the Company recognized a pre-tax loss of approximately $10 million, subject to certain post-closing adjustments, presented in Other expense (income), net on the Consolidated Statements of (Loss) Income and Comprehensive Loss for the year ended December 31, 2023. The Company has also recognized income tax effects associated with the business divestiture across multiple periods. The total income tax expense recognized was approximately $21 million, with approximately $3 million that was recognized during the year ended December 31, 2022.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Divestiture of a Portion of the Savory Solutions Business</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2022, the Company announced it had entered into an agreement to sell a portion of its Savory Solutions business, which was part of the Nourish segment. The Company completed the divestiture on May 31, 2023 and received cash proceeds of approximately $840 million. In addition, a receivable of approximately $37 million was recorded, which reflected the remaining sale consideration that was received in January 2024.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of sale consideration received in connection with the business divestiture:</span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash proceeds from the buyer</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">840&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivable from the buyer</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct costs to sell</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of sale consideration</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">857&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net proceeds received from the business divestiture presented under Cash flows from investing activities represent the cash portion of the sale consideration, which was determined as the fair value of sale consideration adjusted by the amount receivable from the buyer, direct costs to sell and the cash transferred to the buyer as part of the transaction. The following table summarizes the different components of net proceeds received from business divestiture presented under Cash flows from investing activities:</span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of sale consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">857&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct costs to sell</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivable from the buyer</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash transferred to the buyer (including restricted cash)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net proceeds received from business divestiture</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">821&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount of net assets associated with the business unit, adjusted for currency translation and pension adjustments, was approximately $860 million. The major classes of assets and liabilities sold consisted of the following:</span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">May 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,009&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(92)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(190)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive income - currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive income - pension liability and postretirement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of net assets (adjusted for currency translation and pension adjustments)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">860&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the business divestiture, the Company recognized a pre-tax loss of approximately $3 million presented in Other expense (income), net on the Consolidated Statements of (Loss) Income and Comprehensive Loss for the year ended December 31, 2023. The Company has also recognized income tax effects associated with the business divestiture across multiple periods. The total income tax expense recognized was approximately $108 million, with approximately $72 million that was recognized during the year ended December 31, 2022.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liquidation of a Business in Russia</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the liquidation of a business in Russia for the sale of the portion of the Savory Solutions business, the Company recognized a pre-tax loss of approximately $10&#160;million presented in the Other expense (income), net, and tax benefits of approximately $2&#160;million presented in Provision for income taxes on the Consolidated Statements of (Loss) Income and Comprehensive Loss for the year ended December 31, 2023.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Divestiture of Microbial Control</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, the Company announced it had entered into an agreement to sell its Microbial Control business unit, which was a part of the Health &amp; Biosciences segment. The Company acquired the Microbial Control business unit as part of the Merger with N&amp;B.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company completed the divestiture on July 1, 2022 and received cash proceeds of approximately $1.254 billion, of which approximately $36 million was attributable to future services to be provided under certain transition service agreements as described below. Certain transaction costs related to the divestiture of approximately $11 million, which was contingent upon the consummation of the divestiture, were determined to be direct costs to sell and, as such, were adjusted against the fair value of the sale consideration. In addition, approximately $15 million of cash proceeds held in escrow were released to the Company upon satisfaction of certain conditions. The sale consideration was further reduced by approximately $3 million for certain post-closing adjustments, which were primarily related to cash, indebtedness and working capital balances.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company entered into transition services agreements with the buyer for providing certain general accounting, information technology and other services up to 19 months following the date of the sale for minimal consideration. The fair value of these transition services agreements was determined to be approximately $36 million, which was adjusted against the sale consideration and recognized as deferred transition services income.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2023 and 2022, the transition services income under the transition services agreements were approximately $25&#160;million and $11&#160;million, respectively, and was recognized as a reduction to the costs incurred to provide services under the transition services agreements, which was included in Selling and administrative expenses on the Consolidated Statements of (Loss) Income and Comprehensive Loss.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of the sale consideration received in connection with the business divestiture:</span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash proceeds from the buyer</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Escrow proceeds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds attributable to transition service agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct costs to sell</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash settlement for post-closing adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of sale consideration</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,219&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net proceeds received from business divestiture presented under Cash flows from investing activities represent the cash portion of the sale consideration, which was determined as the fair value of sale consideration reduced by the amount held in escrow and the Cash transferred to the buyer on the closing balance sheet as part of the transaction. The following table summarizes the different components of net proceeds received from business divestiture presented under Cash flows from investing activities:</span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of sale consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash transferred to the buyer on the closing balance sheet</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee reimbursement receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net proceeds received from business divestiture</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,169&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount of net assets associated with the Microbial Control business unit was approximately $1.208 billion. The major classes of assets and liabilities sold consisted of the following:</span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and other intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">867&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,284&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of net assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,208&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the business divestiture, the Company recognized a pre-tax gain of approximately $11&#160;million presented in Other expense (income), net on the Consolidated Statements of (Loss) Income and Comprehensive Loss for the year ended December 31, 2022. The Company also recognized the income tax expense associated with the divestiture of approximately $96&#160;million during the year ended December 31, 2022.</span></div>ASSETS AND LIABILITIES HELD FOR SALE<div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2023, the Company announced the sale process of its Cosmetic Ingredients business within the Scent segment, and in the fourth quarter of 2023, the Company entered into an agreement to sell its Cosmetic Ingredients business. The transaction is subject to customary closing conditions and is expected to close in the first quarter of 2024.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The planned sale does not constitute a strategic shift of the Company&#8217;s operations and does not have major effects on the Company&#8217;s operations and financial results. Therefore, the transaction does not meet the discontinued operations criteria.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined that the assets and liabilities of the business met the criteria to be presented as &#8220;held for sale.&#8221; As a result, as of December&#160;31, 2023, such assets and liabilities were classified as held for sale and are reported on the Consolidated Balance Sheets. The Company expects that the sale proceeds less costs to sell will exceed the preliminary estimate of the carrying value of the net assets for the business. The carrying value is subject to change based on developments leading up to the closing date.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in the Company&#8217;s Consolidated Balance Sheets as of December&#160;31, 2023 and 2022 are the following carrying amounts of the assets and liabilities held for sale:</span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.239%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.241%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held-for-sale</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities held-for-sale</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company is currently analyzing the tax impact of the sale of the Cosmetic Ingredients business and has included preliminary numbers for the deferred tax liability, which are subject to further updates.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The amounts for December&#160;31, 2022 represent the carrying amounts of the portion of the Savory Solutions business and FSI business that were classified as held for sale. The Company completed the divestitures of the businesses on May 31, 2023 and August 1, 2023, respectively. See Note 4 for additional information.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//205-20/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//360/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308306596032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Income and Expenses<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock', window );">Other (Expense) Income, Net</a></td>
<td class="text">OTHER (EXPENSE) INCOME, NET<div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other (expense) income, net consisted of the following:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange (losses) gains</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Losses) gains on business divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on China facility relocation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension-related benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (expense) income, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the components of non-operating income or non-operating expense, including, but not limited to, amounts earned from dividends, interest on securities, gain (loss) on securities sold, equity earnings of unconsolidated affiliates, gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308307792768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Tangible Equity Units<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Shareholders' Equity</a></td>
<td class="text">SHAREHOLDERS&#8217; EQUITY <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash dividends declared per share were $3.24, $3.20 and $3.12 for the years ended December 31, 2023, 2022 and 2021, respectively. The Consolidated Balance Sheets reflect $207 million of dividends payable at December&#160;31, 2023. This amount relates to a cash dividend of $0.81 per share declared in December 2023 and paid in January 2024. Dividends declared, but not paid as of December&#160;31, 2022 and December&#160;31, 2021 were $206 million ($0.81 per share) and $201 million ($0.79 per share), respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308312999872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule II - Valuation and Qualifying Accounts and Reserves<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsAbstract', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock', window );">Schedule II - Valuation and Qualifying Accounts and Reserves</a></td>
<td class="text"><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE II &#8212; VALUATION AND QUALIFYING ACCOUNTS AND RESERVES</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(IN MILLIONS)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.287%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at<br/>beginning<br/>of period</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additions (deductions) charged to costs and expenses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Acquisitions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accounts<br/>written off</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Translation<br/>adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at end of period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance on credit and operating loss carryforwards and other net deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at<br/>beginning<br/>of period</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additions charged to costs and expenses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Acquisitions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accounts<br/>written off</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Translation<br/>adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at<br/>end of<br/>period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance on credit and operating loss carryforwards and other net deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at<br/>beginning<br/>of period</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additions charged to costs and expenses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Acquisitions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accounts<br/>written off</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Translation<br/>adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at<br/>end of<br/>period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance on credit and operating loss carryforwards and other net deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________&#160;</span></div><div style="margin-top:3pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt">The amount relates to adjustment to allowances for bad debts as a result of purchase price allocation related to the Merger with N&amp;B.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 09<br> -Publisher SEC<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308300811008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MtrlTermsOfTrdArrTextBlock', window );">Material Terms of Trading Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the quarter ended December&#160;31, 2023, none of our directors or executive officers adopted or terminated any contract, instruction or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) (a &#8220;10b5-1 trading arrangement&#8221;) or any &#8220;non-Rule 10b5-1 trading arrangement&#8221; as defined in Item 408(c) of Regulation S-K.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MtrlTermsOfTrdArrTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MtrlTermsOfTrdArrTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308302264992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Operations and Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_NatureOfOperationsPolicyTextBlock', window );">Nature of Operations</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nature of Operations</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International Flavors &amp; Fragrances Inc. and its subsidiaries (the &#8220;Registrant,&#8221; &#8220;IFF,&#8221; &#8220;the Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; and &#8220;our&#8221;) is a leading creator and manufacturer of food, beverage, health &amp; biosciences, scent and pharma solutions and complementary adjacent products, including cosmetic active and natural health ingredients, which are used in a wide variety of consumer products. Our products are sold principally to manufacturers of perfumes and cosmetics, hair and other personal care products, soaps and detergents, cleaning products, dairy, meat and other processed foods, beverages, snacks and savory foods, sweet and baked goods, sweeteners, dietary supplements, food protection, infant and elderly nutrition, functional food, and pharmaceutical excipients and oral care products.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Accounting, Policy</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 1, 2021 (the &#8220;Closing Date&#8221;), the Company completed the combination (the &#8220;Merger&#8221;) of IFF and DuPont de Nemours, Inc (&#8220;DuPont&#8221;) nutrition and biosciences business (the &#8220;N&amp;B Business&#8221;), which had been transferred to Nutrition and Biosciences, Inc., a Delaware corporation and wholly owned subsidiary of DuPont (&#8220;N&amp;B&#8221;) in a Reverse Morris Trust transaction. See Note 3 for additional information. As a result, the Company&#8217;s Consolidated Financial Statements for the periods ended December&#160;31, 2023 and 2022 reflect the results of N&amp;B for the full twelve months of 2023 and 2022, whereas the period ended December&#160;31, 2021 only reflect the results of N&amp;B from the Closing Date.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiscalPeriod', window );">Fiscal Year End</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fiscal Year End</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a calendar year of the twelve-month period from January 1 to December 31.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) requires management to make estimates and judgments that affect the amounts reported in the Consolidated Financial Statements and accompanying notes. The inputs into the Company&#8217;s judgments and estimates take into account ongoing global current events and adverse macroeconomic impacts on the critical and significant accounting estimates, including estimates associated with future cash flows that are used in assessing the risk of impairment of certain assets. Actual results could differ from those estimates.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Consolidated Financial Statements include the accounts of International Flavors&#160;&amp; Fragrances Inc. and those of its subsidiaries. Significant intercompany balances and transactions have been eliminated. To the extent a subsidiary is not wholly owned, any related non-controlling interests are included as a separate component of Shareholders&#8217; Equity.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue from contracts with customers when the contract or purchase order has received approval and commitment from both parties, has the rights of the parties and payment terms (which can vary by customer) identified, has commercial substance, collectability of consideration is probable, and control has transferred. The revenue recognized reflects the consideration the Company expects to be entitled to in exchange for those goods. Sales, value added, and other taxes the Company collects are excluded from revenues. The Company receives payment in accordance with standard customer terms.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales are reduced, at the time revenue is recognized, for applicable discounts, rebates and sales allowances based on historical experience. Related accruals are included in Other current liabilities in the accompanying Consolidated Balance Sheets. The Company considers shipping and handling activities undertaken after the customer has obtained control of the related goods as a fulfillment activity. Net sales include shipping and handling charges billed to customers. Cost of goods sold includes all costs incurred in connection with shipping and handling.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Translation</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Translation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company translates the assets and liabilities of non-U.S. subsidiaries into U.S. dollars at year-end exchange rates. Income and expense items are translated at average exchange rates during the year. Cumulative translation adjustments are shown as a separate component of Shareholders&#8217; Equity.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development (&#8220;R&amp;D&#8221;) expenses relate to the development of new and improved products, technical product support and compliance with governmental regulation. All research and development costs are expensed as incurred.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash Equivalents</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents include highly liquid investments with maturities of three months or less at date of purchase.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Restricted Cash</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Cash</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash is comprised of cash or cash equivalents which has been placed into an account that is restricted for a specific use and from which the Company cannot withdraw the cash on demand.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Accounts Receivable</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts Receivable</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has various factoring agreements globally under which it can factor up to approximately $300&#160;million of its trade receivables (&#8220;Company&#8217;s own factoring agreements&#8221;). In addition, the Company utilizes factoring agreements sponsored by certain customers. Under all of the arrangements, the Company sells the trade receivables on a non-recourse basis to </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">unrelated financial institutions and accounts for the transactions as sales of receivables. The applicable receivables are removed from the Company&#8217;s Consolidated Balance Sheets when the cash proceeds are received by the Company.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sold approximately $1.752&#160;billion, $1.451 billion and $1.167&#160;billion of receivables in 2023, 2022 and 2021, respectively, under the Company&#8217;s own factoring agreements and customer sponsored factoring agreements. The cost of participating in these programs was approximately $25&#160;million, $12 million and $6 million, in 2023, 2022 and 2021, respectively, and is included as a component of interest expense. Under the Company&#8217;s own factoring agreements for which the Company has continued responsibility to collect receivables and provide to its sponsor, it sold approximately $843&#160;million, $547&#160;million and $197&#160;million of receivables in 2023, 2022 and 2021, respectively. The outstanding principal amounts of receivables under the Company&#8217;s own factoring agreements amounted to approximately $196 million and $157 million as of December&#160;31, 2023 and 2022, respectively. The proceeds from the sales of receivables are included in net cash from operating activities in the Consolidated Statements of Cash Flows.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditLossFinancialInstrumentPolicyTextBlock', window );">Expected Credit Loss</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Expected Credit Losses</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to credit losses primarily through its sales of products. To determine the appropriate allowance for expected credit losses, the Company considers certain credit quality indicators, such as aging of customer receivable balances, loss history and creditworthiness of debtors. The Company also considers current and anticipated future conditions of the general economy in the determination of allowances, including significant aspects of a geographic location and the industries in which the Company operates. The Company&#8217;s general allowance for credit losses is calculated using a loss rate model that is primarily based on historical write-off experiences and applied to trade receivables. As necessary, additional reserves are established based on other factors, such as aging of receivables, customer credit quality and account collectability and country risk. These allowances are reviewed and approved by the Regional and Global Credit committees.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, the Company reported $1.726 billion of trade receivables, net of allowances of $52 million. Based on the aging analysis as of December&#160;31, 2023, approximately 1% of the Company&#8217;s accounts receivable were past due by over 365 days based on the payment terms of the invoice.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventories</span></div>Inventories are stated at the lower of cost (on a weighted-average basis) or net realizable value.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if an arrangement is a lease at contract inception. A lease exists when a contract conveys to the customer the right to control the use of identified property, plant or equipment for a period of time in exchange for consideration. The definition of a lease embodies two conditions: (1) there is an identified asset in the contract that is land or a depreciable asset (i.e., property, plant, and equipment), and (2) the customer has the right to control the use of the identified asset.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When the Company determines the arrangement is a lease, or contains a lease, at inception, it then determines whether the lease is an operating lease or a finance lease at the commencement date.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases property and equipment principally under operating leases and records a right-of-use asset and related obligation at the present value of lease payments. Over the term of the lease, the Company depreciates the right-of-use asset and accretes the related obligation to future value. Some of the leases include rental escalation clauses, renewal options and/or termination options that are factored into the determination of lease payments when appropriate. The Company has elected not to separate non-lease components from lease components for all classes of leased assets.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When available, the Company uses the rate implicit in the lease to discount lease payments to present value, however, most of the Company&#8217;s leases do not provide a readily determinable implicit rate and the Company calculates the applicable incremental borrowing rate to discount the lease payments based on the term of the lease at lease commencement. The incremental borrowing rate is determined based on the Company&#8217;s credit rating, currency and lease terms.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Property, Plant and Equipment</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment are recorded at cost. Depreciation is calculated on a straight-line basis, principally over the following estimated useful lives: buildings and improvements, 1 to 40 years; machinery and equipment, 1 to 20 years; information technology hardware and software, 1 to 7 years; and leasehold improvements which are included in buildings and improvements, the estimated life of the improvements or the remaining term of the lease, whichever is shorter.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest incurred during the construction period of certain property, plant and equipment is capitalized until the underlying assets are placed in service, at which time straight-line amortization of the capitalized interest begins over the estimated useful lives of the related assets. Capitalized interest was approximately $17 million, $13 million and $9 million for the years ended December&#160;31, 2023, 2022 and 2021, respectively.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy', window );">Finite-Lived Intangible Assets</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Finite-Lived Intangible Assets</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finite-lived intangible assets include customer relationships, patents, trade names, technological know-how and other intellectual property valued at acquisition and are amortized on a straight-line basis over the following estimated useful lives: customer relationships, 10 to 27 years; patents, 11 to 15 years; trade names, 4 to 28 years; and technological know-how, 5 to 28 years.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews long-lived assets for impairment when events or changes in business conditions indicate that their carrying value may not be recovered. An estimate of undiscounted future cash flows produced by an asset or group of assets is compared to the carrying value to determine whether impairment exists. If assets are determined to be impaired, the loss is measured based on an estimate of fair value using various valuation techniques, including a discounted estimate of future cash flows.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the difference between the total purchase price and the fair value of identifiable assets and liabilities acquired in business acquisitions.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company tests goodwill for impairment at the reporting unit level as of November 30 every year or more frequently if events or changes in circumstances indicate the asset might be impaired. A reporting unit is an operating segment or one level below an operating segment (referred to as a component) to which goodwill is assigned when initially recorded.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company identifies their reporting units by assessing whether the components of their reporting units constitute businesses for which discrete financial information is available and management of each reporting unit regularly reviews the operating results of those components. The Company determined that it has six reporting units under the Nourish, Health &amp; Biosciences, Scent and Pharma Solutions segments: (1) Nourish, (2) Fragrance Compounds, (3) Fragrance Ingredients, (4) Cosmetic Ingredients, (5) Health &amp; Biosciences and (6) Pharma Solutions. These reporting units were determined based on the level at which the performance is measured and reviewed by segment management. In cases where the components of an operating segment have similar economic characteristics, they are aggregated into a single reporting unit.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When testing goodwill for impairment, the Company has the option of first performing a qualitative assessment to determine whether it is more likely than not that the fair value of a reporting unit is less than the carrying amount. If the Company elects to bypass the qualitative assessment for any reporting units, or if a qualitative assessment indicates it is more likely than not that the estimated carrying value of a reporting unit exceeds its fair value, the Company performs a quantitative goodwill impairment test.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the quantitative goodwill impairment test, if a reporting unit&#8217;s carrying amount exceeds its fair value, the Company will record an impairment charge based on that difference, and the impairment charge will be limited to the amount of goodwill allocated to that reporting unit.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2023, the Company determined that the carrying value of the Nourish reporting unit exceeded its fair value and recorded an impairment charge of $2.623&#160;billion in the Consolidated Statements of (Loss) Income and Comprehensive Loss for the year ended December 31, 2023. During 2022, the Company determined that the carrying value of the Health &amp; Biosciences reporting unit exceeded its fair value and recorded a goodwill impairment charge of $2.250 billion in the Consolidated Statements of (Loss) Income and Comprehensive Loss for the year ended December 31, 2022. See Note 6 for additional information.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for taxes under the asset and liability method. Under this method, deferred income taxes are recognized for temporary differences between the financial statement and tax return bases of assets and liabilities, based on enacted tax rates and other provisions of the tax law. The effect of a change in tax laws or rates on deferred tax assets and liabilities is recognized as income in the period in which such change is enacted. Future tax benefits are recognized to the extent that the realization of such benefits is more likely than not, and a valuation allowance is established for any portion of a deferred tax asset that management believes may not be realized.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes uncertain tax positions that it has taken or expects to take on a tax return. Pursuant to accounting requirements, the Company first determines whether it is &#8220;more likely than not&#8221; its tax position will be sustained if the relevant tax authority were to audit the position with full knowledge of all the relevant facts and other information. For those tax positions that meet this threshold, the Company measures the amount of tax benefit based on the largest amount of tax benefit that it has a greater than 50% chance of realizing in a final settlement with the relevant authority. Those tax positions failing to qualify for initial recognition are recognized in the first interim period in which they meet the more likely than not standard. The Company maintains a cumulative risk portfolio relating to all of its uncertainties in income taxes in order to perform this analysis, but the evaluation of its tax positions requires significant judgment and estimation in part because, in certain cases, tax law is subject to varied interpretation, and whether a tax position will ultimately be sustained may be uncertain.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest and penalties related to unrecognized tax benefits are recognized as a component of income tax expense.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementPlansPolicy', window );">Retirement Benefits</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Retirement Benefits</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current service costs of retirement plans and postretirement health care and life insurance benefits are accrued. Prior service costs resulting from plan improvements are amortized over periods ranging from 10 to 20 years.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Financial Instruments</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Instruments</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative financial instruments are used to manage interest and foreign currency exposures. The gain or loss on the hedging instrument is recorded in earnings at the same time as the transaction being hedged is recorded in earnings. The associated asset or liability related to the open hedge instrument is recorded in Prepaid expenses and Other current assets or Other current liabilities, as applicable.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records all derivative financial instruments on the balance sheet at fair value. Changes in a derivative&#8217;s fair value are recognized in earnings unless specific hedge criteria are met. If the derivative is designated as a fair value hedge, the changes in the fair value of the derivative and of the hedged item attributable to the hedged risk are recognized in Net (loss) income. If the derivative is designated as a cash flow hedge, the effective portions of changes in the fair value of the derivative are recorded in Accumulated other comprehensive income (loss) (&#8220;AOCI&#8221;) in the accompanying Consolidated Balance Sheets and are subsequently recognized in Net (loss) income when the hedged item affects earnings. Ineffective portions of changes in the fair value of cash flow hedges, if any, are recognized as a charge or credit to earnings.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InternalUseSoftwarePolicy', window );">Software Costs</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Software Costs</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes direct internal and external development costs for certain significant projects associated with internal-use software and amortizes these costs over seven years. Neither preliminary evaluation costs nor costs associated with the software after implementation are capitalized. Costs related to projects that are not significant are expensed as incurred.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Income (Loss) Per Share</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net (Loss) Income Per Share</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the two-class method, earnings are adjusted by accretion of amounts to redeemable non-controlling interests recorded at redemption value. The adjustments represent in-substance dividend distributions to the non-controlling interest holders as the holders have a contractual right to receive a specified amount upon redemption. As a result, earnings are adjusted to reflect this in-substance distribution that is different from other common shareholders.&#160;In addition, the Company has unvested share based payment awards with a right to receive nonforfeitable dividends and thus are considered participating securities which are required to be included in the computation of basic and diluted earnings per share.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic (loss) income per share represents the amount of earnings available to each share of common stock outstanding during the period. Basic (loss) income per share includes the effect of issuing shares of common stock, where (i) for 2021, the prepaid stock purchase contracts (&#8220;SPCs&#8221;) were converted using the final settlement rate on September 14, 2021 (see Note 11 for additional information), and (ii) an adjustment to (loss) income to reflect adjustments made to record the redeemable value of redeemable non-controlling interests. Diluted (loss) income per share also includes the effect of issuing shares of common stock, assuming (i) stock options and warrants are exercised, (ii) restricted stock units are fully vested under the treasury stock method, and (iii) for 2021, the incremental effect of the prepaid SPCs were converted using the final settlement rate on September 14, 2021 (see Note 11 for additional information).</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation cost of all stock-based awards is measured at fair value on the date of grant and recognized over the service period for which awards are expected to vest. The cost of such stock-based awards is principally recognized on a straight-line attribution basis over their respective vesting periods, net of estimated forfeitures.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtPolicyTextBlock', window );">Financing Costs</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financing Costs</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs incurred in the issuance of debt are deferred and amortized as part of interest expense over the stated life of the applicable debt instrument. Unamortized deferred financing costs relating to debt are presented as a reduction in the amount of </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">debt outstanding on the Consolidated Balance Sheets. Unamortized deferred financing costs relating to the revolving credit facility are recorded in Other assets on the Consolidated Balance Sheets.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy', window );">Redeemable Non-controlling Interests</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Redeemable Non-controlling Interests</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-controlling interests in subsidiaries that are redeemable for cash or other assets outside of the Company&#8217;s control are classified as mezzanine equity, outside of equity and liabilities, at the greater of the carrying value or the redemption value. The increases or decreases in the estimated redemption amount are recorded with corresponding adjustments against Capital in excess of par value and are reflected in the computation of earnings per share using the two-class method. As of December 31, 2023, the Company has acquired or sold all of its remaining redeemable non-controlling interests. See Note 20 for additional information.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy', window );">Held for Sale</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Held for Sale</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities to be disposed of by sale (&#8220;disposal groups&#8221;) are reclassified into assets and liabilities held for sale on the Company&#8217;s Consolidated Balance Sheets. The reclassification occurs when an agreement to sell exists, or management has committed to a plan to sell the assets within one year. Disposal groups are measured at the lower of carrying value or fair value less costs to sell and are not depreciated or amortized. When the net realizable value of a disposal group increases during a period, a gain can be recognized to the extent that it does not increase the value of the disposal group beyond its original carrying value when the disposal group was reclassified as held for sale. The fair value of a disposal group, less any costs to sell, is assessed each reporting period it remains classified as held for sale and any remeasurement to the lower of carrying value or fair value less costs to sell is reported as an adjustment to the carrying value of the disposal group. See Note 21 for additional information.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_SupplierFinanceProgramPolicyPolicyTextBlock', window );">Supply Chain Financing Program</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supply Chain Financing Program</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2023, the Company entered into a supply chain financing (&#8220;SCF&#8221;) program. The program is expected to be available to U.S. based suppliers starting in the second quarter of 2024. The Company makes continuous efforts to improve working capital efficiency and has worked with suppliers to optimize payment terms and conditions. The Company&#8217;s current payment terms with a majority of suppliers generally range from 0 to 180 days, which is deemed to be commercially reasonable. The Company&#8217;s voluntary SCF program will allow its suppliers to elect to sell the receivables owed to them by the Company to a third-party financial institution. The suppliers, at their own discretion, will determine the invoices they want to sell and directly negotiate the arrangements with the participating third-party financial institution. Supplier participation in the program is solely the decision of the supplier and has no bearing on the Company&#8217;s payment terms and amounts due with the supplier. The Company&#8217;s responsibility will be limited to making payments based upon the agreed upon contractual terms and arrangements. The Company will not provide any form of guarantees under the SCF program and will have no economic interest in the suppliers&#8217; decision to participate in the SCF program. Amounts due to suppliers that elect to participate in the SCF program will be included in Accounts payable on the Consolidated Balance Sheets. The Company, or the third-party financial institution, may choose to terminate the agreement of the program at any time upon 30 days&#8217; prior written notice. The third-party financial institution may also terminate the agreement of the program at any time upon three business days&#8217; prior written notice in the event there are insufficient funds available for disbursements. As of December&#160;31, 2023 and 2022, there were no amounts outstanding related to suppliers&#8217; participation in the SCF program.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2023-09, &#8220;Income Taxes (Topic 740): Improvements to Income Tax Disclosures.&#8221; The ASU was issued to further enhance income tax disclosures, primarily through standardization and disaggregation of rate reconciliation categories and income taxes paid by jurisdiction. This guidance is effective for fiscal years beginning after December 15, 2024, with early adoption permitted, and may be applied either prospectively or retrospectively. The Company is currently evaluating the impact that this guidance will have on its Consolidated Financial Statements and income tax disclosures.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the FASB issued ASU 2023-07, &#8220;Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.&#8221; The ASU intends to improve reportable segment disclosure requirements, primarily through enhanced disclosures of significant segment expenses that are regularly provided to the Chief Operating Decision Maker and included within segment profit and loss. This guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted, and applied retrospectively to all prior periods presented in the financial statements. The Company is currently evaluating the impact that this guidance will have on its Consolidated Financial Statements and reportable segment disclosures.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, the FASB issued ASU 2022-06, &#8220;Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848.&#8221; The ASU was issued to provide an update on ASU 2020-04 and ASU 2021-01 that were issued in March 2020 and January 2021, respectively, which provided optional accounting guidance for a limited period of time to ease the potential burden in accounting for reference rate reform. The guidance provides optional expedients and exceptions to existing accounting requirements for contract modifications and hedge accounting related to transitioning from discontinued reference rates, such as London Interbank Offered Rate (&#8220;LIBOR&#8221;), to alternative reference rates, if certain criteria are met. With the issuance of ASU 2022-06, the sunset date of Topic 848 has been deferred from December 31, 2022 to December 31, 2024, after which entities will no longer be permitted to apply the relief in Topic 848. The Company has adopted this guidance on January 1, 2023, which did not have a material impact on its Consolidated Financial Statements. On March 23, 2023, the Company amended certain existing debt agreements where the interest rate benchmark was updated from LIBOR to the Secured Overnight Financing Rate (&#8220;Term SOFR&#8221;). The Company applied Topic 848 to its recent amendments of its debt agreements. See Note 9 for additional information on the amendments to the debt agreements.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, the FASB issued ASU 2022-04, &#8220;Liabilities - Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations.&#8221; The ASU requires that a buyer in a supplier finance program disclose sufficient information about the program to allow users of the financial statements to understand the program&#8217;s nature, activity during the period, changes from period to period and potential magnitude. The buyer should disclose qualitative and quantitative information about its supplier finance programs. The ASU requires the buyer&#8217;s annual disclosure to include a roll forward of the obligations under the supplier finance programs during the annual period, including the amount of obligations confirmed and subsequently paid. This guidance is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the amendment on roll forward information, which is effective for fiscal years beginning after December 15, 2023, and early adoption is permitted. The Company has adopted this guidance on January 1, 2023, which did not have a material impact on its Consolidated Financial Statements.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_UnusualOrInfrequentItemsOrBothDisclosurePolicyTextBlock', window );">Unusual or Infrequent Items, or Both, Disclosure</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Israel-Hamas War</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains operations in Israel and, additionally, exports products to customers in Israel from operations outside the region. The Company will continue to evaluate the current events and any potential impacts related to this matter, but does not expect there to be a material impact to its Consolidated Financial Statements.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Russia-Ukraine War</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains operations in both Russia and Ukraine and, additionally, exports products to customers in Russia and Ukraine from operations outside the region. In response to the events in Ukraine, the Company has limited the production and supply of ingredients in and to Russia to only those that meet the essential needs of people, including food, hygiene and medicine.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowances for Bad Debts</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, the Company had a reserve of approximately $3&#160;million related to expected credit losses on receivables from customers located in Russia and Ukraine. The Company will continue to evaluate its credit exposure related to Russia and Ukraine.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impairment of Long-Lived Assets</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2022, the sales and margins declined for certain entities within Russia due to supply chain issues, reduced product demand and exchange rate volatility. Further, it was determined that such declines in operating performance were not expected to reverse in the near future. Additionally, future growth was expected to be limited given operating conditions in Russia, which inhibit the required future investment.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with uncertainties related to the Company&#8217;s operations in Russia and Ukraine, the Company updated its analysis of the undiscounted cash flows of the applicable asset groups to determine if the cash flows exceeded the carrying values of the applicable asset groups. With respect to an asset group in the Nourish segment, that manufactures and sells in Russia and related markets, it was determined that the undiscounted cash flows were insufficient to cover the carrying value and that an impairment charge was required to write-down the long-lived assets to their fair values. The fair value of such asset group was determined based on a discounted cash flow approach which involved estimating the future cash flows for the business discounted to their present values. The discount rate used in the determination of such fair value was based on consideration of the risks inherent in the cash flows and market as of the valuation date.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of this assessment, the Company recognized an impairment charge of $120 million in the Consolidated Statements of (Loss) Income and Comprehensive Loss for the year ended December 31, 2022, which was allocated on a pro rata basis to intangible assets and property, plant and equipment within the asset group in the amounts of approximately $92 million and $28 million, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_NatureOfOperationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nature of Operations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_NatureOfOperationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_SupplierFinanceProgramPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Supplier Finance Program, Policy</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_SupplierFinanceProgramPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_UnusualOrInfrequentItemsOrBothDisclosurePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unusual or Infrequent Items, or Both, Disclosure</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_UnusualOrInfrequentItemsOrBothDisclosurePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationRelatedCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationRelatedCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for subsidiaries or other investments that are consolidated, including the accounting treatment for intercompany accounts or transactions and any noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cost associated with exit or disposal activity or restructuring. Excludes entity newly acquired in business combination and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3,4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditLossFinancialInstrumentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit loss on financial instrument measured at amortized cost basis, net investment in lease, off-balance sheet credit exposure, and available-for-sale debt security. Includes, but is not limited to, methodology used to estimate allowance for credit loss, how writeoff of uncollectible amount is recognized, and determination of past due status and nonaccrual status.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-14<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479391/326-20-30-5A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-3C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479366/326-20-35-8A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-3D<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479344/326-20-45-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479175/326-30-30-1B<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479106/326-30-50-3C<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479106/326-30-50-3A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479106/326-30-50-3D<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 13A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479148/326-30-35-13A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 4A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479391/326-20-30-4A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 7A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479148/326-30-35-7A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-21<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479106/326-30-50-7<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-17<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.M.Q4)<br> -SubTopic 20<br> -Topic 326<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483530/326-20-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditLossFinancialInstrumentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 60<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482053/820-10-60-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiscalPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining an entity's fiscal year or other fiscal period. This disclosure may include identification of the fiscal period end-date, the length of the fiscal period, any reporting period lag between the entity and its subsidiaries, or equity investees. If a reporting lag exists, the closing date of the entity having a different period end is generally noted, along with an explanation of the necessity for using different closing dates. Any intervening events that materially affect the entity's financial position or results of operations are generally also disclosed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiscalPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//830/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//350-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-25<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-19<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InternalUseSoftwarePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs incurred when both (1) the software is acquired, internally developed, or modified solely to meet the entity's internal needs, and (2) during the software's development or modification, no substantive plan exists or is being developed to market the software externally.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -SubTopic 40<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482633/350-40-30-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 6<br> -SubTopic 50<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482610/350-50-25-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InternalUseSoftwarePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483489/210-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 330<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482105/912-330-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//330/tableOfContent<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483080/330-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483080/330-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 270<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482989/270-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementPlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for pension and other postretirement benefit plans. This accounting policy may address (1) the types of plans sponsored by the entity, and the benefits provided by each plan (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480794/715-70-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 30<br> -Topic 715<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481097/715-30-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 60<br> -Topic 715<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480266/715-60-50-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 80<br> -Topic 715<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 715<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementPlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481569/310-20-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481569/310-20-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481569/310-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483044/730-10-05-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308300166176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Operations and Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventory</a></td>
<td class="text">The Company&#8217;s inventories consisted of the following:<div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">779&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,073&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">442&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,292&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,636&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,477&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,151&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock', window );">Schedule of Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of cash, cash equivalents and restricted cash reported on the Company&#8217;s balance sheets as of December&#160;31, 2023, 2022 and 2021 to the amounts reported on the Company&#8217;s statement of cash flows periods ended December&#160;31, 2023, 2022 and 2021.</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.391%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.391%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.394%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">703&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">711&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents included in Assets held for sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">552&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">716&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Contract with Customer, Contract Asset, Contract Liability, and Receivable</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract Assets and Liabilities</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to a small number of contracts for the sale of compounds, the Company has an &#8220;enforceable right to payment for performance to date&#8221; and as the products do not have an alternative use, the Company recognizes revenue for these contracts over time and records a contract asset using the output method. The output method recognizes revenue on the basis of direct measurements of the value to the customer of the goods or services transferred to date relative to the remaining goods or services promised under the contract.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023 and 2022, the Company&#8217;s gross accounts receivable was $1.778&#160;billion and $1.871&#160;billion, respectively. The Company&#8217;s contract assets and contract liabilities as of December&#160;31, 2023 and 2022 were not material.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock', window );">Accounts Receivable, Allowance for Credit Loss</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a roll forward of the Company&#8217;s allowances for bad debts for the years ended December 31, 2022 and 2023:</span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:83.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.544%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Allowance for Bad Debts</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad debt expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad debt expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Bad debt expense included approximately $11&#160;million related to expected credit losses on receivables from customers located in Russia and Ukraine (for export and domestic sales) due to the events in those countries.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Bad debt expense included approximately $13 million related to expected credit losses on receivables from certain customers in Egypt, offset by approximately $8 million of reversals of allowances on receivables from customers located in Russia and Ukraine. The Company will continue to evaluate its credit exposure related to Egypt, Russia and Ukraine.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483489/210-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308306596032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and Other Charges (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Movements in Restructuring and Related Accruals</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in restructuring liabilities during 2021, 2022 and 2023 were as follows:</span></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:33.599%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.541%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.519%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at January 1, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Additional Charges (Reversals), Net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-Cash Charges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Payments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Frutarom Integration Initiative</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed asset write down</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">2019 Severance Program</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Other Restructuring Charges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">N&amp;B Merger Restructuring Liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Restructuring and other charges</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:33.599%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.541%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.519%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at January 1, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Additional Charges (Reversals), Net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-Cash Charges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Payments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Frutarom Integration Initiative</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed asset write down</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">2019 Severance Program</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Other Restructuring Charges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">N&amp;B Merger Restructuring Liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Restructuring and other charges</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.503%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at January 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Additional Charges (Reversals), Net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-Cash Charges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Payments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2023</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Frutarom Integration Initiative</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Other Restructuring Charges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">N&amp;B Merger Restructuring Liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">2023 Restructuring Program</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Restructuring and other charges</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes supplier contract termination costs, consulting and advisory fees.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes charges related to legal settlement costs.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes lease impairment charges and losses incurred from restructuring activities related to the Merger with N&amp;B.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Charges by Segment</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the total amount of costs incurred in connection with these restructuring programs and activities by segment:</span></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:59.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.695%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nourish</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health &amp; Biosciences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Scent</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharma Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Restructuring and other charges</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308313035424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of Business Acquisitions, by Acquisition</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the aggregate purchase price consideration paid to acquire N&amp;B (in millions, except share and per share data):</span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of common stock issued to DuPont stockholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,929&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value attributable to pre-merger service for replacement equity awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension funding adjustment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase consideration</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,942&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________&#160;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The fair value of common stock issued to DuPont stockholders represents 141,740,461 shares of the Company's common stock determined based on the number of fully diluted shares of IFF common stock, immediately prior to the Closing Date, multiplied by the quotient of 55.4%/44.6% and IFF common stock closing share price of $112.38 on the New York Stock Exchange on the Closing Date.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">At the time of the Transactions, each outstanding stock option, cash-settled stock appreciation right (&#8220;SAR&#8221;), restricted stock unit (&#8220;RSU&#8221;) award, and restricted stock award (&#8220;RSA&#8221;) with respect to DuPont common stock held by employees of N&amp;B were canceled and converted into similar classes of equity awards of IFF&#8217;s Class A Common Stock. Further, each outstanding Performance Share Unit (&#8220;PSU&#8221;) award with respect to DuPont common stock held by employees of N&amp;B were canceled and converted into IFF&#8217;s RSU awards. The conversion was based on the ratio of the volume-weighted average per share closing price of DuPont stock on the twenty trading days prior to the Closing Date and IFF&#8217;s stock on the twenty trading days following the Closing Date. The fair value of replacement equity-based awards attributable to pre-Merger service was recorded as part of the consideration transferred in the Merger (see Note 13 for additional information).</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Merger related agreements provided that if the net pension balance of N&amp;B as of the Closing Date differs from $220&#160;million, such differential amount would be settled in cash. The Company estimated the amount that it would receive and, accordingly, made an adjustment of $12&#160;million to the total purchase consideration.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">Unaudited pro forma information</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma results for the year ended December&#160;31, 2021 were as follows:</span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.778%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unaudited pro forma net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,163&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unaudited pro forma net income attributable to the Company</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -SubTopic 10<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -SubTopic 10<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308306543024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Discontinued Operations and Disposal Groups (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Assets and Liabilities Held for Sale</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of sale consideration received in connection with the business divestiture:</span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash proceeds from the buyer</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advance receipt for business to be transferred</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct costs to sell</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds attributable to supply agreement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of sale consideration</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>The following table summarizes the different components of net proceeds received from business divestiture presented under Cash flows from investing activities:<div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of sale consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct costs to sell</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advance receipt for business to be transferred</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash transferred to the buyer</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net proceeds received from business divestiture</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>The major classes of assets and liabilities sold consisted of the following:<div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">August 1, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive income - currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of net assets (adjusted for currency translation adjustment)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of sale consideration received in connection with the business divestiture:</span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash proceeds from the buyer</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">840&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivable from the buyer</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct costs to sell</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of sale consideration</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">857&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>The following table summarizes the different components of net proceeds received from business divestiture presented under Cash flows from investing activities:<div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of sale consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">857&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct costs to sell</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivable from the buyer</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash transferred to the buyer (including restricted cash)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net proceeds received from business divestiture</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">821&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>The major classes of assets and liabilities sold consisted of the following:<div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">May 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,009&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(92)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(190)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive income - currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive income - pension liability and postretirement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of net assets (adjusted for currency translation and pension adjustments)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">860&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of the sale consideration received in connection with the business divestiture:</span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash proceeds from the buyer</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Escrow proceeds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds attributable to transition service agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct costs to sell</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash settlement for post-closing adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of sale consideration</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,219&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>The following table summarizes the different components of net proceeds received from business divestiture presented under Cash flows from investing activities:<div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of sale consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash transferred to the buyer on the closing balance sheet</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee reimbursement receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net proceeds received from business divestiture</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,169&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and other intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">867&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,284&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of net assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,208&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in the Company&#8217;s Consolidated Balance Sheets as of December&#160;31, 2023 and 2022 are the following carrying amounts of the assets and liabilities held for sale:</span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.239%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.241%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held-for-sale</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities held-for-sale</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company is currently analyzing the tax impact of the sale of the Cosmetic Ingredients business and has included preliminary numbers for the deferred tax liability, which are subject to further updates.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The amounts for December&#160;31, 2022 represent the carrying amounts of the portion of the Savory Solutions business and FSI business that were classified as held for sale. The Company completed the divestitures of the businesses on May 31, 2023 and August 1, 2023, respectively. See Note 4 for additional information.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-3A<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-4A<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-4B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5A<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5C<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5D<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3A<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308300670464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Property, Plant and Equipment, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property, Plant and Equipment</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment, net consisted of the following amounts:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,752&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,344&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Information technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">649&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,642&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,180&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,402)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,977)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Property, plant and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,240&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,203&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308296335040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill by Operating Segment</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Movements in goodwill attributable to each reportable segment during the years ended December 31, 2022 and 2023 were as follows:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nourish</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Health &amp; Biosciences</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Scent</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pharma Solutions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,559&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,763&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,828&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,282&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,432&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,250)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,250)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transferred to assets held for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(306)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(348)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(199)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(223)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(506)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,054&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,335&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,745&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,239&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,373&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,623)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,623)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transferred to assets held for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(267)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(267)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reduction from business divestiture</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,489&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,391&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,490&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,265&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,635&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-top:3pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt">Related to the acquisition of Health Wright. See Note 3 for additional information.</span></div><div style="margin-top:3pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt">Related to the portion of the Savory Solutions business and FSI business that were classified as held for sale as of December 31, 2022. The Company completed the divestitures of the businesses on May 31, 2023 and August 1, 2023, respectively. See Note 4 and Note 21 for additional information.</span></div><div style="margin-top:3pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt">Related to the Cosmetic Ingredients business that was classified as held for sale as of December&#160;31, 2023. See Note 21 for additional information.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Other Intangible Assets</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other intangible assets, net consisted of the following amounts:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.716%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.200%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset Type</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,318&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technological know-how</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,339&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names &amp; patents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total carrying value </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,947&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,062&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,619)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,252)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technological know-how</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(813)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(589)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names &amp; patents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(117)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,590)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,980)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,357&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,082&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense</a></td>
<td class="text">Amortization expense for the next five years, based on valuations and determinations of useful lives, is expected to be as follows:<div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.579%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2028</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated future intangible amortization expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">678&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">558&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1A<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308301540240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Assets And Liabilities, Current and Noncurrent (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsAbstract', window );"><strong>Other Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsTableTextBlock', window );">Schedule of Other Assets</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets consisted of the following amounts:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right-of-use assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Overfunded pension plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">764&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">689&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________&#160;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes land usage rights in China, long-term deposits and receivables on certain derivative instruments.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock', window );">Schedule of Other Current Assets</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets consisted of the following amounts:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value-added tax receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Packaging materials and supplies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">770&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock', window );">Other Current Liabilities</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current liabilities consisted of the following amounts:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates and incentives payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value-added tax payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current pension and other postretirement benefit obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued insurance (including workers&#8217; compensation)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earn outs payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued restructuring</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1085"><span style="-sec-ix-hidden:f-1086">Current operating lease obligation</span></span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued freight</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued commissions payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">977&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,028&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other current liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other assets. This disclosure includes other current assets and other noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308301698224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Components of Debt</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt consisted of the following at December&#160;31:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:49.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.584%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.493%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.495%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Effective Interest Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Euro Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">552&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Euro Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">879&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">845&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,212&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,215&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2030 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,508&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,510&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2040 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2047 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2048 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">787&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">787&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2050 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,569&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,571&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Term Loan Facility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Term Loan Facility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial Paper</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving Credit Facility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank overdrafts and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,071&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,970&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Short term borrowings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(885)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(597)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,186&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,373&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amount is net of unamortized discount and debt issuance costs.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amount is recorded at fair value.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The effective interest rate of commercial paper issuances fluctuate as short-term interest rates and demand fluctuate, and deferred debt issuance costs are immaterial. Additionally, the effective interest rate of commercial paper is not meaningful as issuances do not materially differ from short-term interest rates.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The interest rate on the Revolving Credit Facility is, at the applicable borrower&#8217;s option, a per annum rate equal to either (x) an eurocurrency rate plus an applicable margin varying from 1.125% to 1.750% or (y) a base rate plus an applicable margin varying from 0.125% to 0.750%, in each case depending on the public debt ratings for&#160;non-credit&#160;enhanced long-term senior unsecured debt issued by the Company.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes bank borrowings, overdrafts, current portion of long-term debt and commercial paper.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionTableTextBlock', window );">Debt Instrument Redemption</a></td>
<td class="text">The redemption dates of each of the Notes are provided in the below table:<div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:51.462%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.606%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Note</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redemption Date</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Euro Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 14, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Euro Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 25, 2026</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 26, 2028</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2047 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 1, 2046</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2048 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 26, 2048</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Maturities of Long-term Debt</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the contractual maturities of the Company&#8217;s long-term debt as of December&#160;31, 2023.</span></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:37.225%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.651%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Payments&#160;Due&#160;by&#160;Period</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less than 1 Year</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1-3 Years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3-5 Years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">More than<br/>5 Years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Outstanding Borrowings</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,980&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">885&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,445&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,600&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,050&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iff_NutritionBiosciencesIncMember', window );">Nutrition &amp; Biosciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionTableTextBlock', window );">Debt Instrument Redemption</a></td>
<td class="text">The redemption dates of each of the N&amp;B Senior Notes are provided in the table below:<div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:51.462%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.606%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Note</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redemption Date</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 1, 2025</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 15, 2027</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2030 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 1, 2030</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2040 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 15, 2040</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2050 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 1, 2050</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of debt instruments or arrangements with redemption features. Includes, but is not limited to, description of debt redemption features, percentage price at which debt can be redeemed by the issuer, and period start and end for debt maturity or redemption.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iff_NutritionBiosciencesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iff_NutritionBiosciencesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308313211232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Lease Costs</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:55.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.978%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease cost</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:55.287%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.996%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.996%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.000%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows for operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows for finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows for finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average remaining lease term and discount rate were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:70.014%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.977%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average remaining lease term in years</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_AssetsAndLiabilitiesLesseeTableTextBlock', window );">Supplemental Balance Sheet Information</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:70.014%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.977%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">689&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current operating lease obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">672&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">727&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">758&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="-sec-ix-hidden:f-1141"><span style="-sec-ix-hidden:f-1142"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right-of-use assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></span></span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="-sec-ix-hidden:f-1145"><span style="-sec-ix-hidden:f-1146"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current finance lease obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></span></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="-sec-ix-hidden:f-1149"><span style="-sec-ix-hidden:f-1150"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></span></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Presented in Other assets on the Consolidated Balance Sheets.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Presented in Other current liabilities on the Consolidated Balance Sheets.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Presented in Other liabilities on the Consolidated Balance Sheets.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Lessee, Operating Lease, Liability, Maturity</a></td>
<td class="text"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities as of December&#160;31, 2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:50.290%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.444%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.444%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.958%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total undiscounted liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">898&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(174)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">727&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">752&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_AssetsAndLiabilitiesLesseeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Assets And Liabilities, Lessee [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_AssetsAndLiabilitiesLesseeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308301712720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of Earnings before Income Taxes</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings before income taxes consisted of the following:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. loss before taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,777)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,918)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(493)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign (loss) income before taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(741)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">847&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total (loss) income before taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,518)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,625)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Income Tax Provision</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax provision consisted of the following:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current tax provision</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current tax provision</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax provision</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(113)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(121)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(288)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax benefit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(369)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(237)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(236)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Reconciliation between U.S. Federal Statutory Income Tax Rate to Actual Effective Tax Rate</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reconciliation between the U.S. federal statutory income tax rate to the actual effective tax rate was as follows:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:59.107%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.769%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.773%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statutory tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effect of non-deductible goodwill impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Difference in effective tax rate on foreign earnings and remittances</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit from supply chain optimization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefit, net of reversals</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax impact on business divestitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred taxes on deemed repatriation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Global intangible low-taxed income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign-derived intangible income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. foreign tax credit - general limitation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Establishment (release) of valuation allowance on state deferred</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local taxes including rate changes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax impact on internal asset transfer</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________ </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For 2021, the rate includes rate change impacts related to the Netherlands and United Kingdom.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For 2022 and 2023, the rate includes the establishment of the held for sale deferred tax liabilities due to a change in assertion.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For 2022 and 2023, the rate includes rate change impacts related to the remeasurement of the state tax rate on deferred taxes.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The deferred tax assets and liabilities consisted of the following amounts:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee and retiree benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credit and net operating loss carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortizable research and development expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest limitation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,021&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">764&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(239)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(229)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,792)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,049)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(170)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred taxes on deemed repatriation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(166)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,356)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,618)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(324)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(262)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net deferred tax liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,659)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,116)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock', window );">Reconciliation of Beginning and Ending Amount of Unrecognized Tax Benefits</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance of unrecognized tax benefits at beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amount of increases in unrecognized tax benefits as a result of positions taken during a prior year</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amount of decreases in unrecognized tax benefits as a result of positions taken during a prior year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amount of increases in unrecognized tax benefits as a result of positions taken during the current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The amounts of decreases in unrecognized benefits relating to settlements with taxing authorities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reduction in unrecognized tax benefits due to the lapse of applicable statute of limitation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance of unrecognized tax benefits at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For 2021, the amount includes positions related to N&amp;B opening balance sheet amounts.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 9<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 12<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-19<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfIncomeTaxContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308301790560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock', window );">Reconciliation of Shares Used in Computations of Basic and Diluted Net Income Per Share</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted net (loss) income per share is based on the weighted average number of shares outstanding. A reconciliation of shares used in the computation of basic and diluted net (loss) income per share is as follows:</span></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:53.512%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.541%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.541%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.542%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(AMOUNTS IN MILLIONS EXCEPT PER SHARE AMOUNTS)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net (Loss) Income</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income attributable to IFF shareholders</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,567)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,871)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustment related to decrease (increase) in redemption value of redeemable non-controlling interests in excess of earnings allocated</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income available to IFF shareholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,565)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,868)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding (basic)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares assuming dilution (diluted)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net (Loss) Income per Share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income per share - basic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.05)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income per share - diluted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.05)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________&#160;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">On September 15, 2021, additional shares of IFF&#8217;s common stock were issued in settlement of the SPC portion of the TEUs. See below for additional information.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For the years ended December&#160;31, 2023, 2022 and 2021, the basic net (loss) income per share cannot be recalculated based on the information presented in the table above due to the effects of rounding.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For the years ended December&#160;31, 2023 and 2022, the diluted net loss per share cannot be recalculated based on the information presented in the table above due to the effects of rounding.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308299716992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Compensation Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Stock-Based Compensation Expense Included in Consolidated Statement of Income and Comprehensive Income</a></td>
<td class="text">Total stock-based compensation expense included in the Consolidated Statements of (Loss) Income and Comprehensive Loss was as follows:<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity-based awards</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability-based awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation, net of tax</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock', window );">SSAR's and Stock Option Activity</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SSARs and options activity was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:49.926%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.735%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.735%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.738%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(SHARE AMOUNTS IN THOUSANDS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares&#160;Subject&#160;to<br/>SSARs/Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average&#160;Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SSARs/<br/>Options<br/>Exercisable</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115.35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122.28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.26&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected to Vest at December&#160;31, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126.99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock', window );">SSAR's and Stock Option Outstanding</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SSARs and options outstanding at December&#160;31, 2023 was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:30.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.298%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.444%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.298%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.300%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Price Range</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number<br/>Outstanding<br/>(in&#160;thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Remaining<br/>Contractual Life<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise&#160;Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic&#160;Value<br/>(in millions)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Over $65</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.71</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.26&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SSARs and options exercisable as of December&#160;31, 2023 was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.279%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Price Range</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number<br/>Exercisable<br/>(in&#160;thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Remaining<br/>Contractual&#160;Life<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise&#160;Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic&#160;Value<br/>(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Over $65</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.33</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock', window );">RSU Activity</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSU activity was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:55.644%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.160%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.163%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(SHARE AMOUNTS IN THOUSANDS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number&#160;of Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Grant Date Fair<br/>Value Per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">937&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120.81&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">843&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(315)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change due to performance conditions, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.04&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,367&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.50&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash RSU activity was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:57.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.429%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(SHARE AMOUNTS IN THOUSANDS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash&#160;RSUs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted&#160;Average&#160;<br/>Fair<br/>Value&#160;Per&#160;Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.97&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_ShareBasedPaymentArrangementPurchasedRestrictedStockUnitActivityTableTextBlock', window );">PRSU Activity</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s PRSU activity for the years ended December 31, 2023, 2022 and 2021:</span></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:35.317%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:22.541%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:17.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Issued Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate Purchases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Covered Shares</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,690&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,845&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,870&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,935&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PRSU activity was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:55.938%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.014%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.015%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(SHARE AMOUNTS IN THOUSANDS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Grant Date Fair<br/>Value Per Share</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133.36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138.98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133.96&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock', window );">Cash RSU Activity</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSU activity was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:55.644%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.160%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.163%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(SHARE AMOUNTS IN THOUSANDS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number&#160;of Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Grant Date Fair<br/>Value Per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">937&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120.81&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">843&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(315)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change due to performance conditions, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.04&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,367&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.50&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash RSU activity was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:57.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.429%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(SHARE AMOUNTS IN THOUSANDS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash&#160;RSUs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted&#160;Average&#160;<br/>Fair<br/>Value&#160;Per&#160;Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.97&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_ShareBasedPaymentArrangementPurchasedRestrictedStockUnitActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Payment Arrangement, Purchased Restricted Stock Unit, Activity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_ShareBasedPaymentArrangementPurchasedRestrictedStockUnitActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock options and stock appreciation rights that were outstanding at the beginning and end of the year, exercisable at the end of the year, and the number of stock options and stock appreciation rights that were granted, exercised or converted, forfeited, and expired during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308312800656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Reportable Segment Information</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reportable segment information is as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:60.979%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nourish</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,060&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,829&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,264&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health &amp; Biosciences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,081&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,339&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,329&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Scent</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,393&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,301&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharma Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">971&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">809&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,479&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,440&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,656&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.863%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nourish</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,893&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,062&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health &amp; Biosciences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,666&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,924&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Scent</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharma Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,227&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,978&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,522&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:60.979%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Adjusted Operating EBITDA:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nourish</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health &amp; Biosciences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">588&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">634&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Scent</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharma Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,980&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,455&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,425&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation &amp; Amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,142)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,179)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,156)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(380)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(336)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(289)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (Expense) Income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and Other Charges (a)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of Goodwill (b)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,623)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,250)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of Long-Lived Assets (c)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(120)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition, Divestiture and Integration Related Costs (d)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(174)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(201)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(240)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Strategic Initiatives Costs (e)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Regulatory Costs (f)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&amp;B Inventory Step-Up Costs (g)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(368)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (h)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) Income Before Taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,518)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,625)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:2.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.801%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Represents costs primarily related to severance as part of the Company's restructuring efforts.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(b)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">For 2023, represents costs related to the impairment of goodwill in the Nourish reporting unit. For 2022, represents costs related to the impairment of goodwill in the Health &amp; Biosciences reporting unit.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(c)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Represents costs related to the impairment of intangible and fixed assets of an asset group that operated primarily in Russia.</span></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:2.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.801%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(d)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">For 2023, 2022 and 2021, primarily represents costs related to the Company's actual and planned acquisitions and divestitures and integration related activities primarily for N&amp;B. These costs primarily consisted of external consulting fees, professional and legal fees and salaries of individuals who are fully dedicated to such efforts. For 2023, acquisition costs primarily relate to earn-out adjustments. For 2022, acquisition costs primarily relate to consulting fees, legal fees and earn-out adjustments. For 2021, acquisition costs primarily relate to legal and professional fees for the transaction with N&amp;B. Tax expenses for business divestiture costs included establishments of deferred tax liabilities related to planned sales of businesses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">For 2023, business divestiture, integration and acquisition related costs were approximately $108 million, $59 million and $7 million, respectively. For 2022, business divestiture, integration and acquisition related costs were approximately $110 million, $94 million and a credit of $3 million, respectively. For 2021, business divestiture, integration and acquisition related costs were approximately $42 million, $105 million and $93 million, respectively.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(e)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Represents costs related to the Company's strategic assessment and business portfolio optimization efforts and reorganizing the Global Shared Services Centers, primarily consulting fees.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(f)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Represents costs primarily related to legal fees incurred for the ongoing investigations of the fragrance businesses.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(g)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Represents costs related to fair value step-up of inventory for the acquired inventory through the Merger with N&amp;B.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(h)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">For 2023, represents gains from sale of assets and costs related to severance, including accelerated stock compensation expense, for a certain executive who will separate from the Company in 2024. For 2022 and 2021, represents gains from sale of assets, costs related to severance, including accelerated stock compensation expense, for certain employees and executives who have been separated from the Company in 2022 and 2021, respectively, and shareholder activist related costs, primarily professional fees.</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment capital expenditures and depreciation and amortization consisted as follows:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:26.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Capital Expenditures</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Depreciation and Amortization</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nourish</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">553&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health &amp; Biosciences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Scent</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharma Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">393&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,142&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,179&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,156&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock', window );">Long-lived Assets by Geographic Areas</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets, net, by country, consisted as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,742&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,771&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denmark</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finland</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,424&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,344&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,240&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,203&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock', window );">Net Sales by Geographic Area</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales are attributed to individual regions based upon the destination of product delivery and are as follows:</span></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales by Geographic Area</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe, Africa and Middle East</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,834&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,219&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,093&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater Asia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,677&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,876&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,728&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,477&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,853&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,491&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,479&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,440&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,656&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:59.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.695%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales by Geographic Area</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales related to the U.S.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,185&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,611&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,211&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales attributed to all foreign countries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,829&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,445&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph b<br> -SubTopic 10<br> -Topic 280<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph a<br> -SubTopic 10<br> -Topic 280<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308301178928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_PensionExpensesTableTextBlock', window );">Plan Assets and Benefit Obligations of Defined Benefit Pension Plans</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The plan assets and benefit obligations of the defined benefit pension plans are measured at December&#160;31 of each year.</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:36.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.714%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Components of net periodic benefit cost</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost for benefits earned</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost on projected benefit obligation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amortization of deferrals</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements and curtailments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit (income) cost</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined contribution and other retirement plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Changes in plan assets and benefit obligations recognized in OCI</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss (gain)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized actuarial (loss) gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized prior service credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total loss (gain) recognized in OCI (before tax effects)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(181)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________&#160;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Included as a component of Operating (loss) profit.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Included as a component of Other expense (income), net.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_ScheduleOfAmountsExpectedToBeRecognizedInNetPeriodicCostTableTableTextBlock', window );">Amounts Expected to be Recognized in Net Periodic Cost</a></td>
<td class="text"><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Postretirement Benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Components of net periodic benefit cost</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost for benefits earned</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost on projected benefit obligation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amortization and deferrals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total credit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Changes in plan assets and benefit obligations recognized in OCI</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss (gain)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized prior service credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total recognized in OCI (before tax effects)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock', window );">Weighted-Average Actuarial Assumption Used to Determine Expense</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average actuarial assumptions used to determine expense at December&#160;31 of each year are:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:31.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.638%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.42&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.86&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.51&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.98&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.43&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.85&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfChangesInAccumulatedPostemploymentBenefitObligationsTableTextBlock', window );">Changes in Postretirement Benefit Obligation and Plan Assets</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the postretirement benefit obligation and plan assets, as applicable, are detailed in the following table:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:35.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.727%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Postretirement Benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">930&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,501&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost for benefits earned</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost on projected benefit obligation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial (gain) loss </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(139)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(468)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments for expense/tax contained in service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan participants&#8217; contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Curtailments/settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,056&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">930&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">649&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">920&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,320&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(286)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participants&#8217; contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">920&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock', window );">Amounts Recognized in Balance Sheet</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts recognized in the balance sheet are detailed in the following table:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retirement liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(138)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amount recognized</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock', window );">Amounts Recognized in Accumulated Other Comprehensive Income</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts recognized in AOCI are detailed in the following table:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:36.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.714%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Postretirement Benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial (gain) loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost (credit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total AOCI (before tax effects)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedAndProjectedBenefitObligationsTableTextBlock', window );">Accumulated Benefit Obligation</a></td>
<td class="text"><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Benefit Obligation &#8212; end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">520&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">988&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Information for Pension Plans with an Accumulated Benefit Obligation (&#8220;ABO&#8221;) in excess of Plan Assets:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated benefit obligation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Information for Pension Plans with a Projected Benefit Obligation (&#8220;PBO&#8221;) in excess of Plan Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average assumptions used to determine obligations at December&#160;31</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock', window );">Estimated Future Benefit Payments</a></td>
<td class="text"><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:56.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S.&#160;Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Postretirement<br/>Benefits</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Estimated Future Benefit Payments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 - 2033</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contributions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Required Company Contributions in the Following Year (2024)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock', window );">Percentage of Assets Invested</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The percentage of assets in the Company&#8217;s pension plans, by type, is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S.&#160;Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alternative and other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_ScheduleOfFairValueOfPensionPlanAssetsByAssetCategoryTableTableTextBlock', window );">Fair Value Hierarchy of Plan Assets</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the Company&#8217;s plan assets for the U.S. and non-U.S. plans using the fair value hierarchy as of December&#160;31, 2023 and 2022. The plans&#8217; assets were accounted for at fair value and are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement requires judgment, and may affect the valuation of fair value assets and their placement within the fair value hierarchy levels. For more information on a description of the fair value hierarchy, see Note 16.</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans for the Year Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Cash Equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Fixed Income Securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government&#160;&amp; Government Agency Bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate Bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal Bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Assets measured at net asset value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans for the Year Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Cash Equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Fixed Income Securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government&#160;&amp; Government Agency Bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate Bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal Bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Assets measured at net asset value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________&#160;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy. The fair value amounts presented in the table above are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Balance Sheets. The total amount measured at net asset value includes approximately $65 million and $234 million in pooled equity funds and $341 million and $170 million in fixed income mutual funds for the years ended December&#160;31, 2023 and 2022, respectively.</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans for the Year Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Equity Securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Large Cap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Mid Cap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Small Cap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Large Cap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Mid Cap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Small Cap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Markets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Fixed Income Securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Corporate Bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Treasuries/Government Bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Corporate Bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Asset-Backed Securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Other Fixed Income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Alternative Types of Investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance Contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative Financial Instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Absolute Return Funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private Equity Funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Property</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Property</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">448&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans for the Year Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Equity Securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Large Cap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Mid Cap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Large Cap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Mid Cap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Small Cap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Markets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Fixed Income Securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Corporate Bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Treasuries/Government Bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Corporate Bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Asset-Backed Securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Other Fixed Income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Alternative Types of Investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance Contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative Financial Instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Absolute Return Funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Property</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Property</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">920&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock', window );">Reconciliation of Level 3 Non-U.S. Plan Assets Held</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a reconciliation of Level 3 non-U.S. plan assets held during the year ended December&#160;31, 2023:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hedge<br/>Funds</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases, sales and settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance as of December 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfHealthCareCostTrendRatesTableTextBlock', window );">Weighted Average Assumptions Used to Determine Postretirement Benefit Expense and Obligation</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following weighted average assumptions were used to determine the postretirement benefit expense and obligation for the years ended December&#160;31:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:56.315%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.885%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.034%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.40&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.90&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.40&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current medical cost trend rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ultimate medical cost trend rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical cost trend rate decreases to ultimate rate in year</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2030</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2034</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2030</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_PensionExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Table for Net Periodic Benefit Cost and Changes in Plan Assets and Benefit Obligations Recognized in OCI.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_PensionExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_ScheduleOfAmountsExpectedToBeRecognizedInNetPeriodicCostTableTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Amounts Expected To Be Recognized In Net Periodic Cost [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_ScheduleOfAmountsExpectedToBeRecognizedInNetPeriodicCostTableTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_ScheduleOfFairValueOfPensionPlanAssetsByAssetCategoryTableTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Fair Value Of Pension Plan Assets By Asset Category [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_ScheduleOfFairValueOfPensionPlanAssetsByAssetCategoryTableTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedAndProjectedBenefitObligationsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of benefit obligations including accumulated benefit obligation and projected benefit obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 715<br> -SubTopic 20<br> -Subparagraph (e)<br> -Name Accounting Standards Codification<br> -Paragraph 1<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedAndProjectedBenefitObligationsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans. This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 715<br> -SubTopic 20<br> -Subparagraph (d)(5)<br> -Name Accounting Standards Codification<br> -Paragraph 1<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts that are recognized in the balance sheet (or statement of financial position) for pension plans and/or other employee benefit plans, showing separately the assets and current and noncurrent liabilities (if applicable) recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAssumptionsUsedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfChangesInAccumulatedPostemploymentBenefitObligationsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in the accumulated postemployment benefit obligation from the beginning to the end of the period, showing separately, if applicable, the effects of the following: service cost, interest cost, contributions by plan participants, actuarial gains and losses, foreign currency exchange rate changes, benefits paid, plan amendments, business combinations, divestitures, curtailments, settlements, and special and contractual termination benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 715<br> -SubTopic 20<br> -Subparagraph (a)<br> -Name Accounting Standards Codification<br> -Paragraph 1<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfChangesInAccumulatedPostemploymentBenefitObligationsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the effect of fair value measurements using significant unobservable inputs (Level 3) on changes in plan assets of pension plans and/or other employee benefit plans for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 715<br> -SubTopic 20<br> -Subparagraph (f)<br> -Name Accounting Standards Codification<br> -Paragraph 1<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfHealthCareCostTrendRatesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the assumed health care cost trend rates for the next year used to measure the expected cost of benefits covered by the plans, including the ultimate trend rate(s) and when that rate is expected to be achieved.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 715<br> -SubTopic 20<br> -Subparagraph (l)<br> -Name Accounting Standards Codification<br> -Paragraph 1<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfHealthCareCostTrendRatesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308301666304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Carrying Amount and Estimated Fair Value of Financial Instruments</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value and the estimated fair values of financial instruments at December&#160;31 consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LEVEL 1</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">703&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">703&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LEVEL 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credit facilities and bank overdrafts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="-sec-ix-hidden:f-2472"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="-sec-ix-hidden:f-2477"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Euro Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">924&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">884&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Euro Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">879&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">845&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,049&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,006&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2030 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,510&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2040 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">536&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2047 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2048 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">787&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">678&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">787&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">685&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2050 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,569&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,029&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,021&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Term Loan Facility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Term Loan Facility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The carrying amount of cash and cash equivalents approximates fair value due to the short maturity of those instruments.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The carrying amount approximates fair value as the interest rate is reset frequently based on current market rates as well as the short maturity of those instruments.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The carrying amount approximates fair value as the instruments are marked-to-market and held at fair value on the Consolidated Balance Sheets.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The fair value of the Note is obtained from pricing services engaged by the Company, and the Company receives one price for each security. The fair value provided by the pricing services are estimated using pricing models, where the inputs to those models are based on observable market inputs or recent trades of similar securities. The inputs to the valuation techniques applied by the pricing services are typically benchmark yields, benchmark security prices, credit spreads, reported trades and broker-dealer quotes, all with reasonable levels of transparency.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The carrying amount approximates fair value as the Term Loans were assumed at fair value and the interest rate is reset frequently based on current market rates.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock', window );">Derivative Instruments Notional Amount Outstanding</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the notional amount of the Company&#8217;s derivative instruments outstanding as of December&#160;31, 2023 and December&#160;31, 2022:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:68.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.564%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,400)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________</span></div><div style="margin-top:3pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt">Foreign currency contracts and commodity contracts are presented net of contracts bought and sold.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Derivative Instruments Measured at Fair Value</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables show the Company&#8217;s derivative instruments measured at fair value (Level 2 of the fair value hierarchy) as reflected in the Consolidated Balance Sheets as of December&#160;31, 2023 and December&#160;31, 2022:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:42.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.640%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.055%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.057%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value of Derivatives<br/>Designated&#160;as Hedging<br/>Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value of Derivatives Not Designated as Hedging Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivative assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swaps</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivative liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:42.576%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.282%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.284%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair&#160;Value&#160;of Derivatives Designated&#160;as Hedging Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair&#160;Value&#160;of Derivatives&#160;Not Designated as Hedging Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total&#160;Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swaps</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Derivative assets are recorded to Prepaid expenses and other current assets on the Consolidated Balance Sheets.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Derivative liabilities are recorded to Other current liabilities and Other liabilities on the Consolidated Balance Sheets.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Derivative Instruments Which Were Not Designated as Hedging Instruments</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the effect of the Company&#8217;s derivative instruments which were not designated as hedging instruments in the Consolidated Statements of (Loss) Income and Comprehensive Loss for the years ended December&#160;31, 2023 and 2022:</span></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.805%"></td><td style="width:0.1%"></td></tr><tr style="height:32pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount&#160;of&#160;Gain (Loss)<br/>For the year ended<br/>December&#160;31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location&#160;of&#160;Gain (Loss)<br/>Recognized in<br/>Income on Derivative</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-2581"><span style="-sec-ix-hidden:f-2582">Other expense (income), net</span></span></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-2585">Cost of goods sold</span></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock', window );">Derivative Instruments Designated as Cash Flow and Net Investment Hedging Instruments</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the effect of the Company&#8217;s derivative instruments designated as net investment hedging instruments, net of tax, in the Consolidated Statements of (Loss) Income and Comprehensive Loss for the years ended December&#160;31, 2023 and 2022:</span></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:36.694%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.638%"></td><td style="width:0.1%"></td></tr><tr style="height:36pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain (Loss)<br/>Recognized&#160;in OCI on Derivative and Non-Derivative<br/>(Effective Portion)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location&#160;of&#160;Gain<br/>(Loss) Reclassified<br/>from AOCI into Income<br/>(Effective Portion)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Reclassified from AOCI<br/>into Income<br/>(Effective Portion)</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the years ended<br/>December&#160;31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the years ended<br/>December&#160;31,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives in Net Investment Hedging Relationships:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swaps</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-Derivatives in Net Investment Hedging Relationships:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Euro Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Euro Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the effective portion of the gains and losses on derivative instruments designated (and non-derivative instruments) designated and qualifying in cash flow hedges and net investment hedges that was recognized in other comprehensive income (loss) during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the notional amounts of outstanding derivative positions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4C<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4CC<br> -SubTopic 10<br> -Topic 815<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4CC<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308306545744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Loss) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Changes in Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present changes in the accumulated balances for each component of other comprehensive income (loss), including current period other comprehensive income (loss) and reclassifications out of accumulated other comprehensive income (loss):</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:43.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.403%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gains&#160;(Losses)&#160;on Derivatives<br/>Qualifying as<br/>Hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension and<br/>Postretirement<br/>Liability<br/>Adjustment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive (loss) income, net of tax, as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,066)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,198)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCI before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassifications due to business divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(112)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive (loss) income, net of tax, as of December 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,652)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(245)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,896)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:43.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.403%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gains&#160;(Losses)&#160;on Derivatives<br/>Qualifying as<br/>Hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension and<br/>Postretirement<br/>Liability<br/>Adjustment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive (loss) income, net of tax, as of December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,133)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(291)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,423)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCI before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(933)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(785)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(933)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(775)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive (loss) income, net of tax, as of December 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,066)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,198)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:43.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.403%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gains&#160;(Losses)&#160;on Derivatives<br/>Qualifying as<br/>Hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension and<br/>Postretirement<br/>Liability<br/>Adjustment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive (loss) income, net of tax, as of December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(285)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(406)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(698)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCI before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(848)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(750)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(848)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(725)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive (loss) income, net of tax, as of December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,133)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(291)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,423)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock', window );">Reclassifications of Accumulated Other Comprehensive Income to Consolidated Statement of Comprehensive Income</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides details about reclassifications out of Accumulated other comprehensive loss to the Consolidated Statements of (Loss) Income and Comprehensive Loss:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:36.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.466%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.466%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.466%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.525%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Affected Line Item in the Consolidated Statements of (Loss) Income and Comprehensive Loss</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains (losses) on derivatives qualifying as hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision&#160;for&#160;income&#160;taxes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total, net of income taxes</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains (losses) on pension and postretirement liability adjustments</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gains (losses)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total,&#160;net&#160;of&#160;income&#160;taxes</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The amortization of prior service cost and actuarial loss is included in the computation of net periodic benefit cost. See Note 15 for additional information regarding net periodic benefit cost.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents certain amounts of pension income that were corrected in 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308301411760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Noncontrolling Interests (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestTableTextBlock', window );">Schedule of Redeemable Noncontrolling Interest</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the details of the Company&#8217;s&#160;redeemable&#160;non-controlling interests:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:67.860%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable <br/>Non-controlling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign exchange translation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of profit or loss attributable to redeemable non-controlling interests</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemption value adjustment for the current period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign exchange translation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of profit or loss attributable to redeemable non-controlling interests</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemption value adjustment for the current period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercises of redeemable non-controlling interests</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign exchange translation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemption value adjustment for the current period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercises of redeemable non-controlling interests</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposal of redeemable non-controlling interests</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________&#160;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The disposal of redeemable non-controlling interests was related to the sale of the Company&#8217;s investment in the Sonarome business. The total proceeds received from the sale transaction was approximately $29&#160;million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity. As of the date of the statement of financial position, such redeemable noncontrolling interest is currently redeemable, as defined, for cash or other assets of the entity at (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308301919744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Assets and Liabilities Held For Sale (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Assets and Liabilities Held for Sale</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of sale consideration received in connection with the business divestiture:</span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash proceeds from the buyer</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advance receipt for business to be transferred</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct costs to sell</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds attributable to supply agreement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of sale consideration</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>The following table summarizes the different components of net proceeds received from business divestiture presented under Cash flows from investing activities:<div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of sale consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct costs to sell</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advance receipt for business to be transferred</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash transferred to the buyer</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net proceeds received from business divestiture</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>The major classes of assets and liabilities sold consisted of the following:<div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">August 1, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive income - currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of net assets (adjusted for currency translation adjustment)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of sale consideration received in connection with the business divestiture:</span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash proceeds from the buyer</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">840&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivable from the buyer</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct costs to sell</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of sale consideration</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">857&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>The following table summarizes the different components of net proceeds received from business divestiture presented under Cash flows from investing activities:<div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of sale consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">857&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct costs to sell</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivable from the buyer</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash transferred to the buyer (including restricted cash)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net proceeds received from business divestiture</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">821&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>The major classes of assets and liabilities sold consisted of the following:<div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">May 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,009&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(92)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(190)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive income - currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive income - pension liability and postretirement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of net assets (adjusted for currency translation and pension adjustments)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">860&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of the sale consideration received in connection with the business divestiture:</span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash proceeds from the buyer</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Escrow proceeds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds attributable to transition service agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct costs to sell</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash settlement for post-closing adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of sale consideration</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,219&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>The following table summarizes the different components of net proceeds received from business divestiture presented under Cash flows from investing activities:<div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of sale consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash transferred to the buyer on the closing balance sheet</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee reimbursement receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net proceeds received from business divestiture</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,169&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and other intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">867&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,284&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of net assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,208&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in the Company&#8217;s Consolidated Balance Sheets as of December&#160;31, 2023 and 2022 are the following carrying amounts of the assets and liabilities held for sale:</span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.239%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.241%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held-for-sale</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities held-for-sale</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company is currently analyzing the tax impact of the sale of the Cosmetic Ingredients business and has included preliminary numbers for the deferred tax liability, which are subject to further updates.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The amounts for December&#160;31, 2022 represent the carrying amounts of the portion of the Savory Solutions business and FSI business that were classified as held for sale. The Company completed the divestitures of the businesses on May 31, 2023 and August 1, 2023, respectively. See Note 4 for additional information.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-3A<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-4A<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-4B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5A<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5C<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5D<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3A<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308312952032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other (Expense) Income, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock', window );">Schedule of Other (Expense) Income</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other (expense) income, net consisted of the following:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(DOLLARS IN MILLIONS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange (losses) gains</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Losses) gains on business divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on China facility relocation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension-related benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (expense) income, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308292308032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Operations and Summary of Significant Accounting Policies - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>reporting_unit</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableGross', window );">Accounts receivable, before allowance for credit loss</a></td>
<td class="nump">$ 1,778,000,000<span></span>
</td>
<td class="nump">$ 1,871,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">703,000,000<span></span>
</td>
<td class="nump">483,000,000<span></span>
</td>
<td class="nump">$ 711,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash</a></td>
<td class="nump">6,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">26,000,000<span></span>
</td>
<td class="nump">52,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted Cash, Noncurrent</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</a></td>
<td class="nump">735,000,000<span></span>
</td>
<td class="nump">552,000,000<span></span>
</td>
<td class="nump">716,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 660,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_ProceedsFromSaleOfAccountsReceivable', window );">Proceeds from sale of accounts receivable</a></td>
<td class="nump">1,752,000,000<span></span>
</td>
<td class="nump">1,451,000,000<span></span>
</td>
<td class="nump">1,167,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradeReceivablesHeldForSaleAmount', window );">Trade receivables, held-for-sale, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">157,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_PaymentsToParticipateInFactoringReceivableProgram', window );">Payments to participate in factoring receivable program</a></td>
<td class="nump">25,000,000<span></span>
</td>
<td class="nump">12,000,000<span></span>
</td>
<td class="nump">6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables, net, current</a></td>
<td class="nump">1,726,000,000<span></span>
</td>
<td class="nump">1,818,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Accounts Receivable, Allowance for Credit Loss</a></td>
<td class="nump">$ 52,000,000<span></span>
</td>
<td class="nump">53,000,000<span></span>
</td>
<td class="nump">46,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_AccountsReceivablesOutstandingByOver365Days', window );">Accounts Receivables, Outstanding By Over 365 Days</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Accounts Receivable, Credit Loss Expense (Reversal)</a></td>
<td class="nump">$ 9,000,000<span></span>
</td>
<td class="nump">19,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs', window );">Accounts Receivable, Allowance for Credit Loss, Writeoff</a></td>
<td class="num">(11,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation', window );">Accounts Receivable, Allowance for Credit Loss, Foreign Currency Translation</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="num">(12,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">689,000,000<span></span>
</td>
<td class="nump">743,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities</a></td>
<td class="nump">642,000,000<span></span>
</td>
<td class="nump">672,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative adjustment relating to the adoption of ASC 2016-16</a></td>
<td class="nump">14,642,000,000<span></span>
</td>
<td class="nump">17,685,000,000<span></span>
</td>
<td class="nump">21,117,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,322,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestCostsCapitalized', window );">Capitalized interest costs</a></td>
<td class="nump">17,000,000<span></span>
</td>
<td class="nump">13,000,000<span></span>
</td>
<td class="nump">9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of long-lived assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">120,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportingUnits', window );">Number of reporting units | reporting_unit</a></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment of goodwill</a></td>
<td class="nump">$ 2,623,000,000<span></span>
</td>
<td class="nump">2,250,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_MinimumPercentageLikelihoodOfTaxBenefitToBeRealizedUponFinalSettlement', window );">Minimum percentage chance of tax benefit realization in final settlement</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_PriorServiceCostsFromPlanImprovementsAmortizationPeriodMinimum', window );">Prior service costs from plan improvements amortization period, minimum, years</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_PriorServiceCostsFromPlanImprovementsAmortizationPeriodMaximum', window );">Prior service costs from plan improvements amortization period, maximum, years</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_AmortizationPeriodOfInternalAndExternalDevelopmentCosts', window );">Amortization period of internal and external development costs, years</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplierFinanceProgramObligation', window );">Supply chain financing, obligation</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">2,477,000,000<span></span>
</td>
<td class="nump">3,151,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes</a></td>
<td class="nump">1,937,000,000<span></span>
</td>
<td class="nump">2,283,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">764,000,000<span></span>
</td>
<td class="nump">689,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">560,000,000<span></span>
</td>
<td class="nump">491,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(1,896,000,000)<span></span>
</td>
<td class="num">(2,198,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">10,635,000,000<span></span>
</td>
<td class="nump">13,373,000,000<span></span>
</td>
<td class="nump">16,432,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Foreign currency gain (loss), net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(933,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_EG', window );">EGYPT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Accounts Receivable, Credit Loss Expense (Reversal)</a></td>
<td class="nump">13,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReportingUnitAxis=iff_HealthBiosciencesMember', window );">Health &amp; Biosciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment of goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">4,391,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,381,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemAxis=iff_RussiaUkraineWarMember', window );">Russia And Ukraine Conflict</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Accounts Receivable, Allowance for Credit Loss</a></td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Accounts Receivable, Credit Loss Expense (Reversal)</a></td>
<td class="nump">$ 8,000,000<span></span>
</td>
<td class="nump">11,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of long-lived assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemAxis=iff_RussiaUkraineWarMember', window );">Russia And Ukraine Conflict | Finite-Lived Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemAxis=iff_RussiaUkraineWarMember', window );">Russia And Ukraine Conflict | Property, Plant and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Restatement Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">107,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred Income Tax Assets, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_ProceedsFromSaleOfAccountsReceivable', window );">Proceeds from sale of accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,030,000,000.00<span></span>
</td>
<td class="nump">668,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradeReceivablesHeldForSaleAmount', window );">Trade receivables, held-for-sale, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">212,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">636,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">565,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,265,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">699,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">472,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,169,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,355,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Foreign currency gain (loss), net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(904,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Other intangible assets amortized period, years</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Patents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Other intangible assets amortized period, years</a></td>
<td class="text">11 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Trade Names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Other intangible assets amortized period, years</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Technological Know-how [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Other intangible assets amortized period, years</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Buildings And Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life of property, plant and equipment, years</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Machinery and equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life of property, plant and equipment, years</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Information Technology Hardware And Software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life of property, plant and equipment, years</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Other intangible assets amortized period, years</a></td>
<td class="text">27 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Patents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Other intangible assets amortized period, years</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Trade Names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Other intangible assets amortized period, years</a></td>
<td class="text">28 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Technological Know-how [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Other intangible assets amortized period, years</a></td>
<td class="text">28 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Buildings And Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life of property, plant and equipment, years</a></td>
<td class="text">40 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Machinery and equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life of property, plant and equipment, years</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Information Technology Hardware And Software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life of property, plant and equipment, years</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained earnings (accumulated deficit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative adjustment relating to the adoption of ASC 2016-16</a></td>
<td class="num">$ (2,439,000,000)<span></span>
</td>
<td class="nump">955,000,000<span></span>
</td>
<td class="nump">3,641,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,156,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=iff_TradeAccountsReceivableWithTheCompanysOwnFactoringAgreementsMember', window );">Trade Accounts Receivable With The Company's Own Factoring Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_AccountsReceivableFactoringReceivableProgramMaximumAmount', window );">Accounts receivable, factoring receivable program, maximum amount</a></td>
<td class="nump">300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_ProceedsFromSaleOfAccountsReceivable', window );">Proceeds from sale of accounts receivable</a></td>
<td class="nump">843,000,000<span></span>
</td>
<td class="nump">547,000,000<span></span>
</td>
<td class="nump">$ 197,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradeReceivablesHeldForSaleAmount', window );">Trade receivables, held-for-sale, amount</a></td>
<td class="nump">$ 196,000,000<span></span>
</td>
<td class="nump">$ 157,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable, Allowance for Credit Loss, Foreign Currency Translation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_AccountsReceivableFactoringReceivableProgramMaximumAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable, Factoring Receivable Program, Maximum Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_AccountsReceivableFactoringReceivableProgramMaximumAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_AccountsReceivablesOutstandingByOver365Days">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivables, Outstanding By Over 365 Days</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_AccountsReceivablesOutstandingByOver365Days</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_AmortizationPeriodOfInternalAndExternalDevelopmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization period of internal and external development costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_AmortizationPeriodOfInternalAndExternalDevelopmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_MinimumPercentageLikelihoodOfTaxBenefitToBeRealizedUponFinalSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum percentage likelihood of tax benefit to be realized upon final settlement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_MinimumPercentageLikelihoodOfTaxBenefitToBeRealizedUponFinalSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Organization And Summary Of Significant Accounting Policies [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_PaymentsToParticipateInFactoringReceivableProgram">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments To Participate In Factoring Receivable Program</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_PaymentsToParticipateInFactoringReceivableProgram</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_PriorServiceCostsFromPlanImprovementsAmortizationPeriodMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prior service costs from plan improvements, amortization period, maximum.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_PriorServiceCostsFromPlanImprovementsAmortizationPeriodMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_PriorServiceCostsFromPlanImprovementsAmortizationPeriodMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prior service costs from plan improvements, amortization period, minimum.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_PriorServiceCostsFromPlanImprovementsAmortizationPeriodMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_ProceedsFromSaleOfAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Sale Of Accounts Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_ProceedsFromSaleOfAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482736/825-10-45-5A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479344/326-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of direct write-downs of accounts receivable charged against the allowance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestCostsCapitalized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest capitalized during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestCostsCapitalized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportingUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportingUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -SubTopic 210<br> -Topic 954<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480632/954-210-45-5<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-3<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 38: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 40: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 41: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-15<br><br>Reference 42: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-16<br><br>Reference 43: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplierFinanceProgramObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation for supplier finance program.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147477128/405-50-55-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479468/405-50-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479468/405-50-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479468/405-50-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479468/405-50-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479468/405-50-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplierFinanceProgramObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeReceivablesHeldForSaleAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before valuation allowance, of accounts receivable held for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeReceivablesHeldForSaleAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_EG">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_EG</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=iff_HealthBiosciencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=iff_HealthBiosciencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemAxis=iff_RussiaUkraineWarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemAxis=iff_RussiaUkraineWarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_FiniteLivedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_FiniteLivedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_PropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_PropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RestatementAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RestatementAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=iff_BuildingsAndImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=iff_BuildingsAndImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=iff_InformationTechnologyHardwareAndSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=iff_InformationTechnologyHardwareAndSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=iff_TradeAccountsReceivableWithTheCompanysOwnFactoringAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=iff_TradeAccountsReceivableWithTheCompanysOwnFactoringAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308294887392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Nature of Operations and Summary of Significant Accounting Policies - Schedule of Inventory (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Inventory, Raw Materials, Net of Reserves</a></td>
<td class="nump">$ 779<span></span>
</td>
<td class="nump">$ 1,073<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Inventory, Work in Process, Net of Reserves</a></td>
<td class="nump">406<span></span>
</td>
<td class="nump">442<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Inventory, Finished Goods, Net of Reserves</a></td>
<td class="nump">1,292<span></span>
</td>
<td class="nump">1,636<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total</a></td>
<td class="nump">$ 2,477<span></span>
</td>
<td class="nump">$ 3,151<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480581/330-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480581/330-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480581/330-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308287707440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and Other Charges - Additional Information (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>Facility</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>Position </div>
<div>position</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>Position</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Additional charges, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 68<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">$ 41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="nump">$ 15<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Additional Charges (Reversals), Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-Cash Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(67)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iff_NutritionBiosciencesIncMember', window );">Nutrition &amp; Biosciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Additional Charges (Reversals), Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1', window );">Restructuring and Related Cost, Cost Incurred to Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=iff_FrutaromIntegrationInitiativeMember', window );">Frutarom Integration Initiative [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_RestructuringAndRelatedCostNumberOfSitesClosed', window );">Number Of Sites Closed | Facility</a></td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1', window );">Restructuring and Related Cost, Cost Incurred to Date</a></td>
<td class="nump">$ 36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=iff_A2023RestructuringProgramMember', window );">2023 Restructuring Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated', window );">Restructuring and Related Cost, Number of Positions Eliminated | position</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Severance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Additional Charges (Reversals), Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-Cash Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Severance | Nutrition &amp; Biosciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Additional Charges (Reversals), Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-Cash Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated', window );">Restructuring and Related Cost, Number of Positions Eliminated | Position</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Severance | Frutarom Integration Initiative [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Additional Charges (Reversals), Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-Cash Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Severance | 2019 Severance Initiatives [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Additional Charges (Reversals), Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-Cash Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1', window );">Restructuring and Related Cost, Cost Incurred to Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated', window );">Restructuring and Related Cost, Number of Positions Eliminated | Position</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Severance | 2023 Restructuring Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Additional Charges (Reversals), Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-Cash Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(56)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember', window );">Other(1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Additional Charges (Reversals), Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-Cash Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember', window );">Other(1) | Nutrition &amp; Biosciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Additional Charges (Reversals), Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-Cash Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember', window );">Other(1) | Frutarom Integration Initiative [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Additional Charges (Reversals), Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-Cash Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=iff_FixedAssetWriteDownMember', window );">Fixed asset write down | Frutarom Integration Initiative [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Additional Charges (Reversals), Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-Cash Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iff_ScentMember', window );">Scent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Additional charges, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_RestructuringAndRelatedCostNumberOfSitesClosed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restructuring And Related Cost, Number Of Sites Closed</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_RestructuringAndRelatedCostNumberOfSitesClosed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-17<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of costs incurred to date for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostCostIncurredToDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of positions eliminated during the period as a result of restructuring activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482047/420-10-45-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveAccrualAdjustment1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) which increases (decreases) the restructuring reserve from an adjustment to a previously accrued restructuring liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveAccrualAdjustment1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveSettledWithoutCash2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the reserve for full or partial settlement through consideration other than cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveSettledWithoutCash2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iff_NutritionBiosciencesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iff_NutritionBiosciencesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=iff_FrutaromIntegrationInitiativeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=iff_FrutaromIntegrationInitiativeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=iff_A2023RestructuringProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=iff_A2023RestructuringProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=iff_A2019SeveranceInitiativesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=iff_A2019SeveranceInitiativesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=iff_FixedAssetWriteDownMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=iff_FixedAssetWriteDownMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iff_ScentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iff_ScentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308294063504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and Other Charges - Movements in Restructuring and Related Accruals (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="nump">$ 15<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Additional Charges (Reversals), Net</a></td>
<td class="nump">68<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-Cash Charges</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash Payments</a></td>
<td class="num">(67)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Additional charges, net</a></td>
<td class="nump">68<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iff_NutritionBiosciencesIncMember', window );">Nutrition &amp; Biosciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Additional Charges (Reversals), Net</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Severance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Additional Charges (Reversals), Net</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-Cash Charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash Payments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Severance | Nutrition &amp; Biosciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Additional Charges (Reversals), Net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-Cash Charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash Payments</a></td>
<td class="num">(9)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember', window );">Other(1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Additional Charges (Reversals), Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-Cash Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember', window );">Other(1) | Nutrition &amp; Biosciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Additional Charges (Reversals), Net</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-Cash Charges</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash Payments</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iff_ScentMember', window );">Scent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Additional charges, net</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iff_PharmaSolutionsMember', window );">Pharma Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Additional charges, net</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iff_NourishMember', window );">Nourish</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Additional charges, net</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iff_HealthBiosciencesMember', window );">Health &amp; Biosciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Additional charges, net</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=iff_FrutaromIntegrationInitiativeMember', window );">Frutarom Integration Initiative [Member] | Severance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Additional Charges (Reversals), Net</a></td>
<td class="num">(3)<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-Cash Charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash Payments</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=iff_FrutaromIntegrationInitiativeMember', window );">Frutarom Integration Initiative [Member] | Fixed asset write down</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Additional Charges (Reversals), Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-Cash Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=iff_FrutaromIntegrationInitiativeMember', window );">Frutarom Integration Initiative [Member] | Other(1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Additional Charges (Reversals), Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-Cash Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=iff_A2019SeveranceInitiativesMember', window );">2019 Severance Initiatives [Member] | Severance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Additional Charges (Reversals), Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-Cash Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-17<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482047/420-10-45-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveAccrualAdjustment1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) which increases (decreases) the restructuring reserve from an adjustment to a previously accrued restructuring liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveAccrualAdjustment1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveSettledWithoutCash2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the reserve for full or partial settlement through consideration other than cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveSettledWithoutCash2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iff_NutritionBiosciencesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iff_NutritionBiosciencesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iff_ScentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iff_ScentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iff_PharmaSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iff_PharmaSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iff_NourishMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iff_NourishMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iff_HealthBiosciencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iff_HealthBiosciencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=iff_FrutaromIntegrationInitiativeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=iff_FrutaromIntegrationInitiativeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=iff_FixedAssetWriteDownMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=iff_FixedAssetWriteDownMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=iff_A2019SeveranceInitiativesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=iff_A2019SeveranceInitiativesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308302137744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions - Health Wright Products (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2022</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,635<span></span>
</td>
<td class="nump">$ 13,373<span></span>
</td>
<td class="nump">$ 16,432<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_EarnOutsPayableCurrent', window );">Earn Outs Payable, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iff_HealthWrightProductsIncHealthWrightMember', window );">Health Wright Products, Inc. (&#8220;Health Wright&#8221;)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of voting interest acquired</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business combination, consideration transferred</a></td>
<td class="nump">$ 157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration, liability</a></td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="nump">75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_EarnOutsPayableOther', window );">Earn Outs Payable, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_EarnOutsPayableCurrent', window );">Earn Outs Payable, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iff_HealthWrightProductsIncHealthWrightMember', window );">Health Wright Products, Inc. (&#8220;Health Wright&#8221;) | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="nump">$ 74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Other intangible assets amortized period, years</a></td>
<td class="text">19 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_EarnOutsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Earn Outs Payable, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_EarnOutsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_EarnOutsPayableOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Earn Outs Payable, Other</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_EarnOutsPayableOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479668/805-30-25-6<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479613/805-30-35-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iff_HealthWrightProductsIncHealthWrightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iff_HealthWrightProductsIncHealthWrightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308302036048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions - Nutrition &amp; Biosciences, Inc (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 01, 2021</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 15, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.125<span></span>
</td>
<td class="nump">$ 0.125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,635<span></span>
</td>
<td class="nump">$ 13,373<span></span>
</td>
<td class="nump">$ 16,432<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent', window );">Net defined benefit plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">139<span></span>
</td>
<td class="nump">180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="nump">93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid to acquire business</a></td>
<td class="nump">$ 7,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iff_NourishMember', window );">Nourish</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,489<span></span>
</td>
<td class="nump">6,054<span></span>
</td>
<td class="nump">6,559<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iff_HealthBiosciencesMember', window );">Health &amp; Biosciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,335<span></span>
</td>
<td class="nump">6,763<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iff_PharmaSolutionsMember', window );">Pharma Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,265<span></span>
</td>
<td class="nump">1,239<span></span>
</td>
<td class="nump">1,282<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iff_ScentMember', window );">Scent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,490<span></span>
</td>
<td class="nump">$ 1,745<span></span>
</td>
<td class="nump">1,828<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=iff_InternationalFlavorsFragrancesIncMember', window );">International Flavors &amp; Fragrances Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction', window );">Sale of Stock, Percentage of Ownership after Transaction</a></td>
<td class="nump">44.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iff_NutritionBiosciencesIncMember', window );">Nutrition &amp; Biosciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Business acquisition, equity interest issued or issuable, number of shares</a></td>
<td class="nump">141,740,461<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_BusinessAcquisitionNetSales', window );">Business Acquisition, Net Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,084<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_BusinessAcquisitionNetIncomeLoss', window );">Business Acquisition, Net Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Fair value of common stock issued to DuPont stockholders</a></td>
<td class="nump">$ 15,929<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_BusinessCombinationConsiderationTransferredReplacementEquityAwardsIssued', window );">Fair value attributable to pre-merger service for replacement equity awards</a></td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_BusinessCombinationPensionFundingAdjustment', window );">Pension funding adjustment</a></td>
<td class="num">(12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business combination, consideration transferred</a></td>
<td class="nump">$ 15,942<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Business acquisition share price</a></td>
<td class="nump">$ 112.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_BusinessCombinationNetPensionBalanceDifferentialAmountSettledInCash', window );">Net pension balance differential amount settled in cash</a></td>
<td class="nump">$ 220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent', window );">Net defined benefit plan liabilities</a></td>
<td class="nump">221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Unaudited pro forma net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Unaudited pro forma net income attributable to the Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 687<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid to acquire business</a></td>
<td class="nump">$ 7,359<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iff_NutritionBiosciencesIncMember', window );">Nutrition &amp; Biosciences, Inc | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DilutiveSharesQuotientMultiplier', window );">Dilutive Shares Quotient Multiplier</a></td>
<td class="nump">44.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iff_NutritionBiosciencesIncMember', window );">Nutrition &amp; Biosciences, Inc | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DilutiveSharesQuotientMultiplier', window );">Dilutive Shares Quotient Multiplier</a></td>
<td class="nump">55.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iff_NutritionBiosciencesIncMember', window );">Nutrition &amp; Biosciences, Inc | International Flavors &amp; Fragrances Inc | DuPont de Nemours, Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of voting interest acquired</a></td>
<td class="nump">55.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_BusinessAcquisitionNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Net Income (Loss)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_BusinessAcquisitionNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_BusinessAcquisitionNetSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Net Sales</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_BusinessAcquisitionNetSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_BusinessCombinationConsiderationTransferredReplacementEquityAwardsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Replacement Equity Awards Issued</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_BusinessCombinationConsiderationTransferredReplacementEquityAwardsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_BusinessCombinationNetPensionBalanceDifferentialAmountSettledInCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Net Pension Balance Differential Amount Settled In Cash</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_BusinessCombinationNetPensionBalanceDifferentialAmountSettledInCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_BusinessCombinationPensionFundingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Pension Funding Adjustment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_BusinessCombinationPensionFundingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DilutiveSharesQuotientMultiplier">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Dilutive Shares Quotient Multiplier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DilutiveSharesQuotientMultiplier</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479405/805-10-25-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(7)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of subsidiary's or equity investee's stock owned by parent company after stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iff_NourishMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iff_NourishMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iff_HealthBiosciencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iff_HealthBiosciencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iff_PharmaSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iff_PharmaSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iff_ScentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iff_ScentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=iff_InternationalFlavorsFragrancesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=iff_InternationalFlavorsFragrancesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iff_NutritionBiosciencesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iff_NutritionBiosciencesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=iff_DuPontdeNemoursIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=iff_DuPontdeNemoursIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308292666032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Divestiture (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1">24 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 01, 2023</div></th>
<th class="th"><div>May 31, 2023</div></th>
<th class="th"><div>Jul. 01, 2022</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 506<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 506<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity Method Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Net proceeds received from business divestitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,050<span></span>
</td>
<td class="nump">1,169<span></span>
</td>
<td class="nump">$ 115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">703<span></span>
</td>
<td class="nump">483<span></span>
</td>
<td class="nump">711<span></span>
</td>
<td class="nump">703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables, net, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,726<span></span>
</td>
<td class="nump">1,818<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,726<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,477<span></span>
</td>
<td class="nump">3,151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,477<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,240<span></span>
</td>
<td class="nump">4,203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,635<span></span>
</td>
<td class="nump">13,373<span></span>
</td>
<td class="nump">16,432<span></span>
</td>
<td class="nump">10,635<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Other intangible assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,357<span></span>
</td>
<td class="nump">9,082<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,357<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">764<span></span>
</td>
<td class="nump">689<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">764<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,978<span></span>
</td>
<td class="nump">35,522<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,978<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts Payable, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,378)<span></span>
</td>
<td class="num">(1,418)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,378)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred Income Tax Liabilities, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,937)<span></span>
</td>
<td class="num">(2,283)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,937)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other Liabilities, Noncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(560)<span></span>
</td>
<td class="num">(491)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(560)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Foreign currency gain (loss), net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(933)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Shareholders' equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,611<span></span>
</td>
<td class="nump">17,655<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,611<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">689<span></span>
</td>
<td class="nump">743<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">689<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=iff_MicrobialControlMember', window );">Microbial Control | Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_ProceedsFromDivestitureOfBusinessesGross', window );">Proceeds from Divestiture of Businesses, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,254<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_TransitionServicesAgreementFairValue', window );">Transition Services Agreement, Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(36)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EscrowDeposit', window );">Escrow Deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DisposalGroupIncludingDiscontinuedOperationPostClosingAdjustments', window );">Post-closing adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_TransitionServicesAgreementTerm', window );">Transition Services Agreement, Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">19 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_TransitionServicesAgreementIncomeReductionToCostsNotIncludedInRevenue', window );">Transition Services Agreement, Income, Reduction To Costs Not Included In Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Disposal Group, Including Discontinued Operation, Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_CashTransferredToTheBuyerOnTheClosingBalanceSheet', window );">Cash Transferred to the Buyer on the Closing Balance Sheet</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(49)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_EmployeeReimbursementReceivable', window );">Employee Reimbursement Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_ProceedsFromDivestitureOfBusinessNet', window );">Proceeds From Divestiture Of Business, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,169<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 263<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwill', window );">Intangible Assets, Net (Including Goodwill)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">867<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity Method Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Total assets held-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,284<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities', window );">Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Total liabilities held-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax', window );">Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DisposalGroupIncludingDiscontinuedOperationNetAssets', window );">Disposal Group, Including Discontinued Operation, Net Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,208<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Net proceeds received from business divestitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,254<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNetAsset', window );">Carrying value of net asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,208<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DisposalGroupNotDiscontinuedOperationTaxEffectOfGainLossFromDivestiture', window );">Tax effect of gain (loss) on divestiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DisposalGroupIncludingDiscontinuedOperationTransactionCost', window );">Direct costs to sell</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (11)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=iff_FlavorSpecialtyIngredientsMember', window );">Flavor Specialty Ingredients | Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_ProceedsFromDivestitureOfBusinessesGross', window );">Proceeds from Divestiture of Businesses, Gross</a></td>
<td class="nump">$ 205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DisposalGroupIncludingDiscontinuedOperationAdvanceReceiptForBusinessToBeTransferred', window );">Advance receipt for business to be transferred</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Disposal Group, Including Discontinued Operation, Consideration</a></td>
<td class="nump">195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DisposalGroupIncludingDiscontinuedOperationConsiderationAdvanceReceiptForBusinessToBeTransferred', window );">Advance receipt for business to be transferred</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_ProceedsFromDivestitureOfBusinessNet', window );">Proceeds From Divestiture Of Business, Net</a></td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Net proceeds received from business divestitures</a></td>
<td class="nump">205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DisposalGroupIncludingDiscontinuedOperationAmountHeldInEscrow', window );">Amount held in escrow</a></td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DisposalGroupIncludingDiscontinuedOperationTransactionCostCredits', window );">Transaction costs</a></td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DisposalGroupIncludingDiscontinuedOperationProceedsAttributableToSupplyAgreement', window );">Proceeds attributable to supply agreement</a></td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DisposalGroupIncludingDiscontinuedOperationCashTransferredToBuyer', window );">Cash transferred to buyer</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables, net, current</a></td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment</a></td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Other intangible assets, net</a></td>
<td class="nump">73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts Payable, Current</a></td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred Income Tax Liabilities, Net</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other Liabilities, Noncurrent</a></td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Liabilities</a></td>
<td class="num">(11)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Foreign currency gain (loss), net of tax</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Shareholders' equity</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNetAsset', window );">Carrying value of net asset</a></td>
<td class="nump">205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalBeforeIncomeTax', window );">Gain (loss) on disposal, before income tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DisposalGroupNotDiscontinuedOperationTaxEffectOfGainLossFromDivestiture', window );">Tax effect of gain (loss) on divestiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DisposalGroupIncludingDiscontinuedOperationTransactionCost', window );">Direct costs to sell</a></td>
<td class="num">$ (5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=iff_SavorySolutionsBusinessMember', window );">Savory Solutions Business | Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_ProceedsFromDivestitureOfBusinessesGross', window );">Proceeds from Divestiture of Businesses, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 840<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable', window );">Consideration receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Disposal Group, Including Discontinued Operation, Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">857<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_ProceedsFromDivestitureOfBusinessNet', window );">Proceeds From Divestiture Of Business, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">821<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Net proceeds received from business divestitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">840<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DisposalGroupIncludingDiscontinuedOperationTransactionCostCredits', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DisposalGroupIncludingDiscontinuedOperationConsiderationPayableReceivable', window );">Receivable from the buyer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(37)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DisposalGroupIncludingDiscontinuedOperationCashTransferredToBuyer', window );">Cash transferred to buyer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables, net, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">317<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Other intangible assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">367<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,009<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts Payable, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(44)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred Income Tax Liabilities, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(92)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other Liabilities, Noncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(54)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(190)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Foreign currency gain (loss), net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Shareholders' equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNetAsset', window );">Carrying value of net asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">860<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalBeforeIncomeTax', window );">Gain (loss) on disposal, before income tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DisposalGroupNotDiscontinuedOperationTaxEffectOfGainLossFromDivestiture', window );">Tax effect of gain (loss) on divestiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DisposalGroupIncludingDiscontinuedOperationTransactionCost', window );">Direct costs to sell</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_AccumulatedOtherComprehensiveIncomeLossPensionLiabilityAndPostretirementAfterTax', window );">Pension liability and postretirement, after tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DisposalGroupNotDiscontinuedOperationLiquidationTaxEffect', window );">Liquidation tax effect</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DisposalGroupNotDiscontinuedOperationGainLossOnLiquidationBeforeIncomeTax', window );">Gain (loss) on liquidation, before taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_AccumulatedOtherComprehensiveIncomeLossPensionLiabilityAndPostretirementAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated Other Comprehensive (Income) Loss, Pension Liability And Postretirement, after Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_AccumulatedOtherComprehensiveIncomeLossPensionLiabilityAndPostretirementAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_CashTransferredToTheBuyerOnTheClosingBalanceSheet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash Transferred to the Buyer on the Closing Balance Sheet</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_CashTransferredToTheBuyerOnTheClosingBalanceSheet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DisposalGroupIncludingDiscontinuedOperationAdvanceReceiptForBusinessToBeTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Advance Receipt For Business To Be Transferred</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DisposalGroupIncludingDiscontinuedOperationAdvanceReceiptForBusinessToBeTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DisposalGroupIncludingDiscontinuedOperationAmountHeldInEscrow">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Amount Held In Escrow</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DisposalGroupIncludingDiscontinuedOperationAmountHeldInEscrow</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNetAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Carrying Value Of Net Asset</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNetAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DisposalGroupIncludingDiscontinuedOperationCashTransferredToBuyer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Cash (Transferred To) Buyer</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DisposalGroupIncludingDiscontinuedOperationCashTransferredToBuyer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DisposalGroupIncludingDiscontinuedOperationConsiderationAdvanceReceiptForBusinessToBeTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Consideration, Advance Receipt For Business To Be Transferred</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DisposalGroupIncludingDiscontinuedOperationConsiderationAdvanceReceiptForBusinessToBeTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DisposalGroupIncludingDiscontinuedOperationConsiderationPayableReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Consideration Payable (Receivable)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DisposalGroupIncludingDiscontinuedOperationConsiderationPayableReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Consideration Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DisposalGroupIncludingDiscontinuedOperationNetAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Net Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DisposalGroupIncludingDiscontinuedOperationNetAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DisposalGroupIncludingDiscontinuedOperationPostClosingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Post-Closing Adjustments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DisposalGroupIncludingDiscontinuedOperationPostClosingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DisposalGroupIncludingDiscontinuedOperationProceedsAttributableToSupplyAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Proceeds Attributable To Supply Agreement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DisposalGroupIncludingDiscontinuedOperationProceedsAttributableToSupplyAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DisposalGroupIncludingDiscontinuedOperationTransactionCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Transaction Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DisposalGroupIncludingDiscontinuedOperationTransactionCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DisposalGroupIncludingDiscontinuedOperationTransactionCostCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Transaction (Cost) Credits</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DisposalGroupIncludingDiscontinuedOperationTransactionCostCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Not Discontinued Operation, Gain (Loss) On Disposal, Before Income Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DisposalGroupNotDiscontinuedOperationGainLossOnLiquidationBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Not Discontinued Operation, Gain (Loss) On Liquidation, Before Income Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DisposalGroupNotDiscontinuedOperationGainLossOnLiquidationBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DisposalGroupNotDiscontinuedOperationLiquidationTaxEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Not Discontinued Operation, Liquidation Tax Effect</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DisposalGroupNotDiscontinuedOperationLiquidationTaxEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DisposalGroupNotDiscontinuedOperationTaxEffectOfGainLossFromDivestiture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Not Discontinued Operation, Tax Effect Of Gain (Loss) From Divestiture</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DisposalGroupNotDiscontinuedOperationTaxEffectOfGainLossFromDivestiture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_EmployeeReimbursementReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employee Reimbursement Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_EmployeeReimbursementReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_ProceedsFromDivestitureOfBusinessNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Divestiture Of Business, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_ProceedsFromDivestitureOfBusinessNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_ProceedsFromDivestitureOfBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from Divestiture of Businesses, Gross</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_ProceedsFromDivestitureOfBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_TransitionServicesAgreementFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Transition Services Agreement, Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_TransitionServicesAgreementFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_TransitionServicesAgreementIncomeReductionToCostsNotIncludedInRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Transition Services Agreement, Income, Reduction To Costs Not Included In Revenue</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_TransitionServicesAgreementIncomeReductionToCostsNotIncludedInRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_TransitionServicesAgreementTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Transition Services Agreement, Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_TransitionServicesAgreementTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482736/825-10-45-5A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5C<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5C<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-9<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-3B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts payable attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EscrowDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The designation of funds furnished by a borrower to a lender to assure future payments of the borrower's real estate taxes and insurance obligations with respect to a mortgaged property. Escrow deposits may be made for a variety of other purposes such as earnest money and contingent payments. This element excludes replacement reserves which are an escrow separately provided for within the US GAAP taxonomy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480327/954-440-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EscrowDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetIncludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetIncludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5C<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=iff_MicrobialControlMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=iff_MicrobialControlMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=iff_FlavorSpecialtyIngredientsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=iff_FlavorSpecialtyIngredientsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=iff_SavorySolutionsBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=iff_SavorySolutionsBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308293137744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment, Net - Schedule of Property, Plant and Equipment (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 6,642<span></span>
</td>
<td class="nump">$ 6,180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="num">(2,402)<span></span>
</td>
<td class="num">(1,977)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">4,240<span></span>
</td>
<td class="nump">4,203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">462<span></span>
</td>
<td class="nump">452<span></span>
</td>
<td class="nump">$ 424<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_PropertyPlantAndEquipmentMember', window );">Property, Plant and Equipment | Russia And Ukraine Conflict</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember', window );">Land [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">195<span></span>
</td>
<td class="nump">199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Buildings and improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">1,822<span></span>
</td>
<td class="nump">1,697<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">3,752<span></span>
</td>
<td class="nump">3,344<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_TechnologyEquipmentMember', window );">Information technology [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">473<span></span>
</td>
<td class="nump">291<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in process [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="nump">$ 649<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_PropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_PropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemAxis=iff_RussiaUkraineWarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemAxis=iff_RussiaUkraineWarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_TechnologyEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_TechnologyEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308287599760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets, Net - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Nov. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount', window );">Reporting unit in excess of carrying amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment of goodwill</a></td>
<td class="nump">$ 2,623<span></span>
</td>
<td class="nump">$ 2,250<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">10,635<span></span>
</td>
<td class="nump">13,373<span></span>
</td>
<td class="nump">16,432<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iff_HealthBiosciencesMember', window );">Health &amp; Biosciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment of goodwill</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,335<span></span>
</td>
<td class="nump">6,763<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Goodwill, Impaired, Accumulated Impairment Loss</a></td>
<td class="nump">2,250<span></span>
</td>
<td class="nump">2,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iff_PharmaSolutionsMember', window );">Pharma Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment of goodwill</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">1,265<span></span>
</td>
<td class="nump">1,239<span></span>
</td>
<td class="nump">1,282<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iff_NourishMember', window );">Nourish</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment of goodwill</a></td>
<td class="nump">2,623<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">3,489<span></span>
</td>
<td class="nump">6,054<span></span>
</td>
<td class="nump">$ 6,559<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Goodwill, Impaired, Accumulated Impairment Loss</a></td>
<td class="nump">2,623<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_FiniteLivedIntangibleAssetsMember', window );">Finite-Lived Intangible Assets | Russia And Ukraine Conflict</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReportingUnitAxis=iff_NourishMember', window );">Nourish</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment of goodwill</a></td>
<td class="nump">2,623<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReportingUnitAxis=iff_HealthBiosciencesMember', window );">Health &amp; Biosciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount', window );">Reporting unit in excess of carrying amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment of goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 4,391<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,381<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReportingUnitAxis=iff_PharmaSolutionsMember', window );">Pharma Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount', window );">Reporting unit in excess of carrying amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,263<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReportingUnitAxis=iff_FragranceIngredientsMember', window );">Fragrance Ingredients [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount', window );">Reporting unit in excess of carrying amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 295<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of fair value of reporting unit in excess of carrying amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iff_HealthBiosciencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iff_HealthBiosciencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iff_PharmaSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iff_PharmaSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iff_NourishMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iff_NourishMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_FiniteLivedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_FiniteLivedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemAxis=iff_RussiaUkraineWarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemAxis=iff_RussiaUkraineWarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=iff_NourishMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=iff_NourishMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=iff_HealthBiosciencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=iff_HealthBiosciencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=iff_PharmaSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=iff_PharmaSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=iff_FragranceIngredientsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=iff_FragranceIngredientsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308294014528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets, Net - Goodwill Rollforward (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 13,373<span></span>
</td>
<td class="nump">$ 16,432<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign exchange</a></td>
<td class="nump">166<span></span>
</td>
<td class="num">(506)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Transferred to assets held for sale(3)</a></td>
<td class="num">(267)<span></span>
</td>
<td class="num">(348)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Reduction from business divestiture</a></td>
<td class="num">(14)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">10,635<span></span>
</td>
<td class="nump">13,373<span></span>
</td>
<td class="nump">$ 16,432<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="num">(2,623)<span></span>
</td>
<td class="num">(2,250)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReportingUnitAxis=iff_NourishMember', window );">Nourish</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="num">(2,623)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReportingUnitAxis=iff_HealthBiosciencesMember', window );">Health &amp; Biosciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">4,391<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,250)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iff_NourishMember', window );">Nourish</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">6,054<span></span>
</td>
<td class="nump">6,559<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign exchange</a></td>
<td class="nump">72<span></span>
</td>
<td class="num">(199)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Transferred to assets held for sale(3)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(306)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Reduction from business divestiture</a></td>
<td class="num">(14)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">3,489<span></span>
</td>
<td class="nump">6,054<span></span>
</td>
<td class="nump">6,559<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="num">(2,623)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iff_HealthBiosciencesMember', window );">Health &amp; Biosciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">4,335<span></span>
</td>
<td class="nump">6,763<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign exchange</a></td>
<td class="nump">56<span></span>
</td>
<td class="num">(223)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Transferred to assets held for sale(3)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Reduction from business divestiture</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,335<span></span>
</td>
<td class="nump">6,763<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,250)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iff_ScentMember', window );">Scent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">1,745<span></span>
</td>
<td class="nump">1,828<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign exchange</a></td>
<td class="nump">12<span></span>
</td>
<td class="num">(41)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Transferred to assets held for sale(3)</a></td>
<td class="num">(267)<span></span>
</td>
<td class="num">(42)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Reduction from business divestiture</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">1,490<span></span>
</td>
<td class="nump">1,745<span></span>
</td>
<td class="nump">1,828<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iff_PharmaSolutionsMember', window );">Pharma Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">1,239<span></span>
</td>
<td class="nump">1,282<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign exchange</a></td>
<td class="nump">26<span></span>
</td>
<td class="num">(43)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Transferred to assets held for sale(3)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Reduction from business divestiture</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">1,265<span></span>
</td>
<td class="nump">1,239<span></span>
</td>
<td class="nump">$ 1,282<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillTransfers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers into (out of) an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillTransfers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=iff_NourishMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=iff_NourishMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=iff_HealthBiosciencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=iff_HealthBiosciencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iff_NourishMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iff_NourishMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iff_HealthBiosciencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iff_HealthBiosciencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iff_ScentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iff_ScentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iff_PharmaSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iff_PharmaSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308299610128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets, Net - Trademark and Other Intangible Assets (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross carrying value</a></td>
<td class="nump">$ 10,947<span></span>
</td>
<td class="nump">$ 11,062<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Total accumulated amortization</a></td>
<td class="num">(2,590)<span></span>
</td>
<td class="num">(1,980)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Other intangible assets, net</a></td>
<td class="nump">8,357<span></span>
</td>
<td class="nump">9,082<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross carrying value</a></td>
<td class="nump">8,211<span></span>
</td>
<td class="nump">8,318<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Total accumulated amortization</a></td>
<td class="num">(1,619)<span></span>
</td>
<td class="num">(1,252)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technological Know-how [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross carrying value</a></td>
<td class="nump">2,355<span></span>
</td>
<td class="nump">2,339<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Total accumulated amortization</a></td>
<td class="num">(813)<span></span>
</td>
<td class="num">(589)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember', window );">Trade Names and Patents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross carrying value</a></td>
<td class="nump">337<span></span>
</td>
<td class="nump">358<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Total accumulated amortization</a></td>
<td class="num">(117)<span></span>
</td>
<td class="num">(97)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross carrying value</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Total accumulated amortization</a></td>
<td class="num">$ (41)<span></span>
</td>
<td class="num">$ (42)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 928<br> -SubTopic 340<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483147/928-340-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308296246816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets, Net - Amortization Expense (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of acquisition-related intangibles</a></td>
<td class="nump">$ 680<span></span>
</td>
<td class="nump">$ 727<span></span>
</td>
<td class="nump">$ 732<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2024</a></td>
<td class="nump">678<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2025</a></td>
<td class="nump">676<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2026</a></td>
<td class="nump">674<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2027</a></td>
<td class="nump">577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2028</a></td>
<td class="nump">$ 558<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308302100000">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Assets And Liabilities, Current and Noncurrent - Schedule of Other Assets (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsAbstract', window );"><strong>Other Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValueAddedTaxReceivableCurrent', window );">Value-added tax receivable</a></td>
<td class="nump">$ 187<span></span>
</td>
<td class="nump">$ 212<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Prepaid income taxes</a></td>
<td class="nump">178<span></span>
</td>
<td class="nump">129<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Supplies', window );">Packaging materials and supplies</a></td>
<td class="nump">161<span></span>
</td>
<td class="nump">148<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">184<span></span>
</td>
<td class="nump">144<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsAndOtherReceivablesNetCurrent', window );">Accounts and Other Receivables, Net, Current</a></td>
<td class="nump">165<span></span>
</td>
<td class="nump">137<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other Assets, Current</a></td>
<td class="nump">875<span></span>
</td>
<td class="nump">770<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance lease right-of-use assets</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent', window );">Deferred Income Taxes and Other Assets, Noncurrent</a></td>
<td class="nump">278<span></span>
</td>
<td class="nump">167<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent', window );">Overfunded pension plans</a></td>
<td class="nump">139<span></span>
</td>
<td class="nump">180<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashSurrenderValueOfLifeInsurance', window );">Cash surrender value of life insurance contracts</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsMiscellaneousNoncurrent', window );">Other</a></td>
<td class="nump">261<span></span>
</td>
<td class="nump">265<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Total</a></td>
<td class="nump">764<span></span>
</td>
<td class="nump">689<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity Method Investments</a></td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsAndOtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsAndOtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashSurrenderValueOfLifeInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts which could be received based on the terms of the insurance contract upon surrendering life policies owned by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashSurrenderValueOfLifeInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and other assets expected to be realized or consumed after one year or normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(7)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsMiscellaneousNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other miscellaneous assets expected to be realized or consumed after one year or normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsMiscellaneousNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482955/340-10-05-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483032/340-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Supplies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration paid in advance for supplies that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483032/340-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482955/340-10-05-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Supplies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValueAddedTaxReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of value added taxes due either from customers arising from sales on credit terms, or as previously overpaid to tax authorities. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValueAddedTaxReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308300629856">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Assets And Liabilities, Current and Noncurrent - Schedule of Other Current Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_RebatesAndIncentivesPayableCurrent', window );">Rebates and incentives payable</a></td>
<td class="nump">$ 105<span></span>
</td>
<td class="nump">$ 99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SalesAndExciseTaxPayableCurrent', window );">Value-added tax payable</a></td>
<td class="nump">77<span></span>
</td>
<td class="nump">65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Interest payable</a></td>
<td class="nump">65<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent', window );">Current pension and other postretirement benefit obligation</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedInsuranceCurrent', window );">Accrued insurance (including workers&#8217; compensation)</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_EarnOutsPayableCurrent', window );">Earn Outs Payable, Current</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Accrued restructuring</a></td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Total<span></span>
</td>
<td class="text">Total<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current operating lease obligation</a></td>
<td class="nump">$ 85<span></span>
</td>
<td class="nump">$ 86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_AccruedFreightCurrent', window );">Accrued freight</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_AccruedCommissionsPayableCurrent', window );">Accrued Commissions Payable, Current</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Accrued income taxes</a></td>
<td class="nump">194<span></span>
</td>
<td class="nump">313<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccountsPayableAndAccruedLiabilities', window );">Accrued expenses payable</a></td>
<td class="nump">262<span></span>
</td>
<td class="nump">256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherSundryLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">97<span></span>
</td>
<td class="nump">91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Total</a></td>
<td class="nump">$ 977<span></span>
</td>
<td class="nump">$ 1,028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_AccruedCommissionsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Commissions Payable, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_AccruedCommissionsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_AccruedFreightCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Freight, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_AccruedFreightCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_EarnOutsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Earn Outs Payable, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_EarnOutsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_RebatesAndIncentivesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rebates And Incentives Payable, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_RebatesAndIncentivesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedInsuranceCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable to insurance entities to mitigate potential loss from various risks or to satisfy a promise to provide certain coverage's to employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedInsuranceCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred and payable to vendors for goods and services received classified as other, and expenses incurred but not yet paid, payable within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSundryLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481573/470-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSundryLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for pension, other postretirement and postemployment benefits, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesAndExciseTaxPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesAndExciseTaxPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308295752736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Components of Debt (Detail)<br> &#8364; in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Jul. 28, 2021</div></th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Feb. 01, 2021</div></th>
<th class="th">
<div>Sep. 26, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 25, 2018 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>May 18, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 14, 2016 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Apr. 04, 2013 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommercialPaper', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 187<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtLongtermAndShorttermCombinedAmount', window );">Debt, long-term and short-term, combined</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,071<span></span>
</td>
<td class="nump">10,970<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current maturities of long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(885)<span></span>
</td>
<td class="num">(597)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,186<span></span>
</td>
<td class="nump">10,373<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Loan Facility | Citibank, N.A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Revolving Loan Facility | Citibank, N.A | Eurocurrency Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Margin on variable rate</a></td>
<td class="nump">1.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Revolving Loan Facility | Citibank, N.A | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Margin on variable rate</a></td>
<td class="nump">0.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Revolving Loan Facility | Citibank, N.A | Eurocurrency Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Margin on variable rate</a></td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Revolving Loan Facility | Citibank, N.A | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Margin on variable rate</a></td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandTwentyThreeMember', window );">Senior Notes - 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandTwentyThreeMember', window );">Senior Notes - 2023 | Loans Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotesCurrent', window );">Senior notes, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember', window );">Senior Notes, Euro Notes, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember', window );">Senior Notes, Euro Notes, 2024 | Loans Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">532<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember', window );">Senior Notes, Euro Notes, 2024 | Loans Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.88%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotesCurrent', window );">Senior notes, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 552<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandTwentyFiveMember', window );">Senior Notes, Due Two Thousand Twenty Five | Loans Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.22%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember', window );">Senior Notes, Euro Notes, 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember', window );">Senior Notes, Euro Notes, 2026 | Loans Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.93%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 879<span></span>
</td>
<td class="nump">845<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandTwentySevenMember', window );">Senior Notes, Due Two Thousand Twenty Seven | Loans Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.56%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,212<span></span>
</td>
<td class="nump">1,215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandTwentyEightMember', window );">Senior Notes - 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandTwentyEightMember', window );">Senior Notes - 2028 | Loans Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.57%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 398<span></span>
</td>
<td class="nump">398<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandThirtyMember', window );">Senior Notes, Due Two Thousand Thirty | Loans Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.21%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,508<span></span>
</td>
<td class="nump">1,510<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandFortyMember', window );">Senior Notes, Due Two Thousand Forty | Loans Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.04%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 773<span></span>
</td>
<td class="nump">774<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandFortySevenMember', window );">Senior notes - 2047</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandFortySevenMember', window );">Senior notes - 2047 | Loans Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.44%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 495<span></span>
</td>
<td class="nump">495<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandFortyEightMember', window );">Senior Notes - 2048</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandFortyEightMember', window );">Senior Notes - 2048 | Loans Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.12%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 787<span></span>
</td>
<td class="nump">787<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandFiftyMember', window );">Senior Notes, Due Two Thousand Fifty | Loans Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.21%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,569<span></span>
</td>
<td class="nump">1,571<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_A2024TermLoanMember', window );">2024 Term Loan | Loans Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_A2024TermLoanMember', window );">2024 Term Loan | Loans Payable | Minimum | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_A2024TermLoanMember', window );">2024 Term Loan | Loans Payable | Maximum | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_A2024TermLoanMember', window );">2024 Term Loan | Loans Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotesCurrent', window );">Senior notes, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_A2026TermLoanMember', window );">2026 Term Loan | Loans Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.83%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 625<span></span>
</td>
<td class="nump">625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_A2026TermLoanMember', window );">2026 Term Loan | Loans Payable | Minimum | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_A2026TermLoanMember', window );">2026 Term Loan | Loans Payable | Maximum | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Loan Facility | Loans Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_BankBorrowingsAndOverdraftsMember', window );">Bank overdrafts and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Bank overdrafts and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of short-term borrowings using unsecured obligations issued by banks, corporations and other borrowers to investors. The maturities of these money market securities generally do not exceed 270 days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtLongtermAndShorttermCombinedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate of total long-term debt, including current maturities and short-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtLongtermAndShorttermCombinedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeniorLongTermNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion. Senior note holders are paid off in full before any payments are made to junior note holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeniorLongTermNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeniorNotesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term notes having the highest claim on the assets of the issuer in case of bankruptcy or liquidation, due within one year or the normal operating cycle, if longer. Senior note holders are paid off in full before any payments are made to debt holders having a lesser priority of repayment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeniorNotesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=iff_CitibankN.AMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=iff_CitibankN.AMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=iff_EurocurrencyRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=iff_EurocurrencyRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandTwentyThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandTwentyThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandTwentyFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandTwentyFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandTwentySevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandTwentySevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandTwentyEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandTwentyEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandThirtyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandThirtyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandFortyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandFortyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandFortySevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandFortySevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandFortyEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandFortyEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandFiftyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandFiftyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iff_A2024TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iff_A2024TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iff_A2026TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iff_A2026TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iff_BankBorrowingsAndOverdraftsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iff_BankBorrowingsAndOverdraftsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308293487728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Additional Information - Term Loan and Senior Notes Assumed (Detail) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 01, 2024</div></th>
<th class="th"><div>Sep. 19, 2023</div></th>
<th class="th"><div>Sep. 15, 2022</div></th>
<th class="th"><div>Feb. 01, 2021</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 16, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_SeniorUnsecuredTermLoanFacilitiesMember', window );">Senior Unsecured Term Loan Facilities | Unsecured Debt | Nutrition &amp; Biosciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_SeniorUnsecuredNotesMember', window );">Senior Unsecured Notes | Unsecured Debt | Nutrition &amp; Biosciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,250<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_SeniorUnsecuredNotesMember', window );">Senior Unsecured Notes | Unsecured Debt | Nutrition &amp; Biosciences, Inc | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_SeniorUnsecuredNotesMember', window );">Senior Unsecured Notes | Unsecured Debt | Nutrition &amp; Biosciences, Inc | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_A2024TermLoanMember', window );">2024 Term Loan | Loans Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75%<span></span>
</td>
<td class="nump">3.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 355<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotesCurrent', window );">Senior notes, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 270<span></span>
</td>
<td class="nump">$ 270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_A2024TermLoanMember', window );">2024 Term Loan | Loans Payable | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of debt</a></td>
<td class="nump">$ 270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_A2024TermLoanMember', window );">2024 Term Loan | Unsecured Debt | Nutrition &amp; Biosciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_A2024TermLoanMember', window );">2024 Term Loan | Loans Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_A2024TermLoanMember', window );">2024 Term Loan | Loans Payable | Minimum | London Interbank Offered Rate (LIBOR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_A2024TermLoanMember', window );">2024 Term Loan | Loans Payable | Minimum | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_A2024TermLoanMember', window );">2024 Term Loan | Loans Payable | Maximum | London Interbank Offered Rate (LIBOR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_A2024TermLoanMember', window );">2024 Term Loan | Loans Payable | Maximum | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_A2026TermLoanMember', window );">2026 Term Loan | Unsecured Debt | Nutrition &amp; Biosciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_A2026TermLoanMember', window );">2026 Term Loan | Loans Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.83%<span></span>
</td>
<td class="nump">5.83%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 625<span></span>
</td>
<td class="nump">$ 625<span></span>
</td>
<td class="nump">625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_A2026TermLoanMember', window );">2026 Term Loan | Loans Payable | Minimum | London Interbank Offered Rate (LIBOR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_A2026TermLoanMember', window );">2026 Term Loan | Loans Payable | Minimum | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_A2026TermLoanMember', window );">2026 Term Loan | Loans Payable | Maximum | London Interbank Offered Rate (LIBOR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_A2026TermLoanMember', window );">2026 Term Loan | Loans Payable | Maximum | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_TermLoanCreditAgreementMember', window );">Term Loan Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_CommonStockDividendsPerShareMaximumDividendThresholdPerQuarter', window );">Maximum dividend threshold per quarter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_CommonStockDividendsPerShareMaximumDividendThresholdPerYear', window );">Maximum dividend threshold per year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DebtInstrumentCovenantLienThresholdAmount', window );">Lien threshold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DebtInstrumentCovenantLienThresholdPercentageOfConsolidatedNetTangibleAssets', window );">Lien threshold, percentage of consolidated net tangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DebtInstrumentCovenantPercentageOfProceedsFromNonOrdinaryAssetsSalesRequiredToBeUsedAsPrepayment', window );">Percentage of proceeds from non-ordinary assets sales required to be used as prepayment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DebtInstrumentCovenantBasisSpreadIncreaseOnVariableRate', window );">Debt instrument, covenant, basis spread increase on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_TermLoanCreditAgreementMember', window );">Term Loan Credit Agreement | Fiscal Quarter Ending On Or Before March 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DebtInstrumentCovenantMaximumConsolidatedLeverageRatio', window );">Maximum consolidated leverage ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">525.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_TermLoanCreditAgreementMember', window );">Term Loan Credit Agreement | Fiscal Quarter Ending June 30, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DebtInstrumentCovenantMaximumConsolidatedLeverageRatio', window );">Maximum consolidated leverage ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">475.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_TermLoanCreditAgreementMember', window );">Term Loan Credit Agreement | Fiscal Quarter Ending September 30, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DebtInstrumentCovenantMaximumConsolidatedLeverageRatio', window );">Maximum consolidated leverage ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">450.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_TermLoanCreditAgreementMember', window );">Term Loan Credit Agreement | Subsequent Fiscal Quarter Ending On Or Before March 31, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DebtInstrumentCovenantMaximumConsolidatedLeverageRatio', window );">Maximum consolidated leverage ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">425.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_TermLoanCreditAgreementMember', window );">Term Loan Credit Agreement | Subsequent Fiscal Quarter Ending On Or Before September 30, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DebtInstrumentCovenantMaximumConsolidatedLeverageRatio', window );">Maximum consolidated leverage ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_TermLoanCreditAgreementMember', window );">Term Loan Credit Agreement | Fiscal Quarter Ending December 31, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DebtInstrumentCovenantMaximumConsolidatedLeverageRatio', window );">Maximum consolidated leverage ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">375.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_TermLoanCreditAgreementMember', window );">Term Loan Credit Agreement | Secured Overnight Financing Rate (SOFR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Margin on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandTwentyTwoMember', window );">Senior Notes, Due Two Thousand Twenty Two | Loans Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandTwentyTwoMember', window );">Senior Notes, Due Two Thousand Twenty Two | Nutrition &amp; Biosciences, Inc | Loans Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.697%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotesCurrent', window );">Senior notes, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandTwentyFiveMember', window );">Senior Notes, Due Two Thousand Twenty Five | Loans Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.22%<span></span>
</td>
<td class="nump">1.22%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandTwentyFiveMember', window );">Senior Notes, Due Two Thousand Twenty Five | Loans Payable | Nutrition &amp; Biosciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.23%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Margin on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandTwentySevenMember', window );">Senior Notes, Due Two Thousand Twenty Seven | Loans Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.56%<span></span>
</td>
<td class="nump">1.56%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,212<span></span>
</td>
<td class="nump">$ 1,212<span></span>
</td>
<td class="nump">1,215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandTwentySevenMember', window );">Senior Notes, Due Two Thousand Twenty Seven | Loans Payable | Nutrition &amp; Biosciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.832%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Margin on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandThirtyMember', window );">Senior Notes, Due Two Thousand Thirty | Loans Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.21%<span></span>
</td>
<td class="nump">2.21%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,508<span></span>
</td>
<td class="nump">$ 1,508<span></span>
</td>
<td class="nump">1,510<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandThirtyMember', window );">Senior Notes, Due Two Thousand Thirty | Loans Payable | Nutrition &amp; Biosciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Margin on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandFortyMember', window );">Senior Notes, Due Two Thousand Forty | Loans Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.04%<span></span>
</td>
<td class="nump">3.04%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 773<span></span>
</td>
<td class="nump">$ 773<span></span>
</td>
<td class="nump">774<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandFortyMember', window );">Senior Notes, Due Two Thousand Forty | Loans Payable | Nutrition &amp; Biosciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.268%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Margin on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandFiftyMember', window );">Senior Notes, Due Two Thousand Fifty | Loans Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.21%<span></span>
</td>
<td class="nump">3.21%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,569<span></span>
</td>
<td class="nump">$ 1,569<span></span>
</td>
<td class="nump">$ 1,571<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandFiftyMember', window );">Senior Notes, Due Two Thousand Fifty | Loans Payable | Nutrition &amp; Biosciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.468%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Margin on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_CommonStockDividendsPerShareMaximumDividendThresholdPerQuarter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Dividends Per Share, Maximum Dividend Threshold Per Quarter</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_CommonStockDividendsPerShareMaximumDividendThresholdPerQuarter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_CommonStockDividendsPerShareMaximumDividendThresholdPerYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Dividends Per Share, Maximum Dividend Threshold Per Year</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_CommonStockDividendsPerShareMaximumDividendThresholdPerYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DebtInstrumentCovenantBasisSpreadIncreaseOnVariableRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Basis Spread Increase On Variable Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DebtInstrumentCovenantBasisSpreadIncreaseOnVariableRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DebtInstrumentCovenantLienThresholdAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Lien Threshold, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DebtInstrumentCovenantLienThresholdAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DebtInstrumentCovenantLienThresholdPercentageOfConsolidatedNetTangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Lien Threshold, Percentage Of Consolidated Net Tangible Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DebtInstrumentCovenantLienThresholdPercentageOfConsolidatedNetTangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DebtInstrumentCovenantMaximumConsolidatedLeverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Maximum Consolidated Leverage Ratio</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DebtInstrumentCovenantMaximumConsolidatedLeverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DebtInstrumentCovenantPercentageOfProceedsFromNonOrdinaryAssetsSalesRequiredToBeUsedAsPrepayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Percentage Of Proceeds From Non-Ordinary Assets Sales Required To Be Used As Prepayment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DebtInstrumentCovenantPercentageOfProceedsFromNonOrdinaryAssetsSalesRequiredToBeUsedAsPrepayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeniorLongTermNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion. Senior note holders are paid off in full before any payments are made to junior note holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeniorLongTermNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeniorNotesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term notes having the highest claim on the assets of the issuer in case of bankruptcy or liquidation, due within one year or the normal operating cycle, if longer. Senior note holders are paid off in full before any payments are made to debt holders having a lesser priority of repayment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeniorNotesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iff_SeniorUnsecuredTermLoanFacilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iff_SeniorUnsecuredTermLoanFacilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=iff_NutritionBiosciencesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=iff_NutritionBiosciencesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iff_SeniorUnsecuredNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iff_SeniorUnsecuredNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iff_A2024TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iff_A2024TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=iff_LondonInterbankOfferedRateLIBOR1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=iff_LondonInterbankOfferedRateLIBOR1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iff_A2026TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iff_A2026TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iff_TermLoanCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iff_TermLoanCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DebtCovenantPeriodAxis=iff_FiscalQuarterEndingOnOrBeforeMarch312024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DebtCovenantPeriodAxis=iff_FiscalQuarterEndingOnOrBeforeMarch312024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DebtCovenantPeriodAxis=iff_FiscalQuarterEndingJune302024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DebtCovenantPeriodAxis=iff_FiscalQuarterEndingJune302024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DebtCovenantPeriodAxis=iff_FiscalQuarterEndingSeptember302024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DebtCovenantPeriodAxis=iff_FiscalQuarterEndingSeptember302024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DebtCovenantPeriodAxis=iff_SubsequentFiscalQuarterEndingOnOrBeforeMarch312025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DebtCovenantPeriodAxis=iff_SubsequentFiscalQuarterEndingOnOrBeforeMarch312025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DebtCovenantPeriodAxis=iff_SubsequentFiscalQuarterEndingOnOrBeforeSeptember302025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DebtCovenantPeriodAxis=iff_SubsequentFiscalQuarterEndingOnOrBeforeSeptember302025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DebtCovenantPeriodAxis=iff_FiscalQuarterEndingDecember312025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DebtCovenantPeriodAxis=iff_FiscalQuarterEndingDecember312025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=iff_SecuredOvernightFinancingRateSOFRMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=iff_SecuredOvernightFinancingRateSOFRMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandTwentyTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandTwentyTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandTwentyFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandTwentyFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandTwentySevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandTwentySevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandThirtyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandThirtyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandFortyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandFortyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandFiftyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandFiftyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308294713968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Additional Information - Revolving Credit Facility (Detail) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 19, 2023</div></th>
<th class="th"><div>Jul. 28, 2021</div></th>
<th class="th"><div>Jun. 06, 2018</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Aug. 25, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Loan Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_CommonStockDividendsPerShareMaximumDividendThresholdPerQuarter', window );">Maximum dividend threshold per quarter</a></td>
<td class="nump">$ 0.81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_CommonStockDividendsPerShareMaximumDividendThresholdPerYear', window );">Maximum dividend threshold per year</a></td>
<td class="nump">$ 3.24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DebtInstrumentCovenantLienThresholdAmount', window );">Lien threshold</a></td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DebtInstrumentCovenantLienThresholdPercentageOfConsolidatedNetTangibleAssets', window );">Lien threshold, percentage of consolidated net tangible assets</a></td>
<td class="nump">3.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DebtInstrumentCovenantBasisSpreadIncreaseOnVariableRate', window );">Debt instrument, covenant, basis spread increase on variable rate</a></td>
<td class="nump">0.00125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Loan Facility | Fiscal Quarter Ending On Or Before March 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DebtInstrumentCovenantMaximumConsolidatedLeverageRatio', window );">Maximum consolidated leverage ratio</a></td>
<td class="nump">525.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Loan Facility | Fiscal Quarter Ending June 30, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DebtInstrumentCovenantMaximumConsolidatedLeverageRatio', window );">Maximum consolidated leverage ratio</a></td>
<td class="nump">475.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Loan Facility | Fiscal Quarter Ending September 30, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DebtInstrumentCovenantMaximumConsolidatedLeverageRatio', window );">Maximum consolidated leverage ratio</a></td>
<td class="nump">450.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Loan Facility | Subsequent Fiscal Quarter Ending On Or Before March 31, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DebtInstrumentCovenantMaximumConsolidatedLeverageRatio', window );">Maximum consolidated leverage ratio</a></td>
<td class="nump">425.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Loan Facility | Subsequent Fiscal Quarter Ending On Or Before September 30, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DebtInstrumentCovenantMaximumConsolidatedLeverageRatio', window );">Maximum consolidated leverage ratio</a></td>
<td class="nump">400.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Loan Facility | Fiscal Quarter Ending December 31, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DebtInstrumentCovenantMaximumConsolidatedLeverageRatio', window );">Maximum consolidated leverage ratio</a></td>
<td class="nump">375.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Loan Facility | Euro Interbank Offered Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Margin on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Loan Facility | Secured Overnight Financing Rate (SOFR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Margin on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Loan Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Revolving credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Loan Facility | Citibank, N.A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts', window );">Debt related commitment fees and debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Revolving credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet', window );">Line of Credit Facility, Increase (Decrease), Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Proceeds from Lines of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800<span></span>
</td>
<td class="nump">$ 550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Repayments of Lines of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900<span></span>
</td>
<td class="nump">$ 450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_CommonStockDividendsPerShareMaximumDividendThresholdPerQuarter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Dividends Per Share, Maximum Dividend Threshold Per Quarter</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_CommonStockDividendsPerShareMaximumDividendThresholdPerQuarter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_CommonStockDividendsPerShareMaximumDividendThresholdPerYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Dividends Per Share, Maximum Dividend Threshold Per Year</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_CommonStockDividendsPerShareMaximumDividendThresholdPerYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DebtInstrumentCovenantBasisSpreadIncreaseOnVariableRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Basis Spread Increase On Variable Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DebtInstrumentCovenantBasisSpreadIncreaseOnVariableRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DebtInstrumentCovenantLienThresholdAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Lien Threshold, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DebtInstrumentCovenantLienThresholdAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DebtInstrumentCovenantLienThresholdPercentageOfConsolidatedNetTangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Lien Threshold, Percentage Of Consolidated Net Tangible Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DebtInstrumentCovenantLienThresholdPercentageOfConsolidatedNetTangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DebtInstrumentCovenantMaximumConsolidatedLeverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Maximum Consolidated Leverage Ratio</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DebtInstrumentCovenantMaximumConsolidatedLeverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the charge against earnings during the period for commitment fees and debt issuance expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DebtCovenantPeriodAxis=iff_FiscalQuarterEndingOnOrBeforeMarch312024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DebtCovenantPeriodAxis=iff_FiscalQuarterEndingOnOrBeforeMarch312024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DebtCovenantPeriodAxis=iff_FiscalQuarterEndingJune302024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DebtCovenantPeriodAxis=iff_FiscalQuarterEndingJune302024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DebtCovenantPeriodAxis=iff_FiscalQuarterEndingSeptember302024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DebtCovenantPeriodAxis=iff_FiscalQuarterEndingSeptember302024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DebtCovenantPeriodAxis=iff_SubsequentFiscalQuarterEndingOnOrBeforeMarch312025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DebtCovenantPeriodAxis=iff_SubsequentFiscalQuarterEndingOnOrBeforeMarch312025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DebtCovenantPeriodAxis=iff_SubsequentFiscalQuarterEndingOnOrBeforeSeptember302025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DebtCovenantPeriodAxis=iff_SubsequentFiscalQuarterEndingOnOrBeforeSeptember302025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DebtCovenantPeriodAxis=iff_FiscalQuarterEndingDecember312025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DebtCovenantPeriodAxis=iff_FiscalQuarterEndingDecember312025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=iff_EuroInterbankOfferedRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=iff_EuroInterbankOfferedRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=iff_SecuredOvernightFinancingRateSOFRMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=iff_SecuredOvernightFinancingRateSOFRMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=iff_CitibankN.AMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=iff_CitibankN.AMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308292403008">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Additional Information - Senior Unsecured Notes (Detail)<br> &#8364; in Millions, $ in Millions</strong></div></th>
<th class="th">
<div>May 01, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 18, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 14, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 14, 2016 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Apr. 04, 2013 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 26, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 25, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 25, 2018 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,980<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember', window );">Senior Notes, Euro Notes, 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 932<span></span>
</td>
<td class="nump">&#8364; 794<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=iff_SeniorNotesDueTwoThousandTwentyEightMember', window );">Senior Notes - 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 397<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=iff_SeniorNotesDueTwoThousandFortyEightMember', window );">Senior Notes - 2048</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">787<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember', window );">Senior Notes, Euro Notes, 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.80%<span></span>
</td>
<td class="nump">1.80%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandTwentyEightMember', window );">Senior Notes - 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandFortyEightMember', window );">Senior Notes - 2048</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandTwentyThreeMember', window );">Senior Notes - 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds related to the issuance of senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 298<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandTwentyThreeMember', window );">Senior Notes - 2023 | Loans Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of debt</a></td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember', window );">Senior Notes, Euro Notes, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds related to the issuance of senior notes | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 496<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnOilAndGasHedgingActivity', window );">Gain (loss) on hedging activity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember', window );">Senior Notes, Euro Notes, 2024 | Loans Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.88%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandFortySevenMember', window );">Senior notes - 2047</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds related to the issuance of senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 494<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnOilAndGasHedgingActivity', window );">Gain (loss) on hedging activity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherDeferredCostsGross', window );">Other deferred costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnOilAndGasHedgingActivity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (loss) incurred in hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnOilAndGasHedgingActivity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherDeferredCostsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross amount of other deferred costs capitalized at the end of the reporting period. Does not include deferred finance costs or deferred acquisition costs of insurance companies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherDeferredCostsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeniorLongTermNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion. Senior note holders are paid off in full before any payments are made to junior note holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeniorLongTermNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=iff_SeniorNotesDueTwoThousandTwentyEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=iff_SeniorNotesDueTwoThousandTwentyEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=iff_SeniorNotesDueTwoThousandFortyEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=iff_SeniorNotesDueTwoThousandFortyEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandTwentyEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandTwentyEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandFortyEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandFortyEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandTwentyThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandTwentyThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandFortySevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandFortySevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308299925984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Additional Information - Commercial Paper and Redemption Provisions (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommercialPaper', window );">Proceeds from Issuance of commercial paper</a></td>
<td class="nump">$ 5,694<span></span>
</td>
<td class="nump">$ 6,040<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfCommercialPaper', window );">Repayments of commercial paper</a></td>
<td class="nump">$ 5,881<span></span>
</td>
<td class="nump">$ 6,177<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_RepurchasePriceAsPercentageOfPrincipalAmountOfSeniorNotes', window );">Repurchase price of principal amount of Senior Notes in percentage</a></td>
<td class="nump">101.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_InternationalFlavorsFragrancesIncSeniorNotesMember', window );">International Flavors &amp; Fragrances Inc Senior Notes | Loans Payable | International Flavors &amp; Fragrances Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Debt instrument, redemption price, percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember', window );">Senior Notes, Euro Notes, 2024 | Loans Payable | International Flavors &amp; Fragrances Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Margin on variable rate</a></td>
<td class="nump">0.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember', window );">Senior Notes, Euro Notes, 2026 | Loans Payable | International Flavors &amp; Fragrances Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Margin on variable rate</a></td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandTwentyEightMember', window );">Senior Notes - 2028 | Loans Payable | International Flavors &amp; Fragrances Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Margin on variable rate</a></td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandFortySevenMember', window );">Senior notes - 2047 | Loans Payable | International Flavors &amp; Fragrances Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Margin on variable rate</a></td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandFortyEightMember', window );">Senior Notes - 2048 | Loans Payable | International Flavors &amp; Fragrances Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Margin on variable rate</a></td>
<td class="nump">0.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_NutritionBiosciencesIncSeniorNotesMember', window );">Nutrition &amp; Biosciences, Inc Senior Notes | Loans Payable | Nutrition &amp; Biosciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Debt instrument, redemption price, percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandTwentyFiveMember', window );">Senior Notes, Due Two Thousand Twenty Five | Loans Payable | Nutrition &amp; Biosciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Margin on variable rate</a></td>
<td class="nump">0.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandTwentySevenMember', window );">Senior Notes, Due Two Thousand Twenty Seven | Loans Payable | Nutrition &amp; Biosciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Margin on variable rate</a></td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandThirtyMember', window );">Senior Notes, Due Two Thousand Thirty | Loans Payable | Nutrition &amp; Biosciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Margin on variable rate</a></td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandFortyMember', window );">Senior Notes, Due Two Thousand Forty | Loans Payable | Nutrition &amp; Biosciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Margin on variable rate</a></td>
<td class="nump">0.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandFiftyMember', window );">Senior Notes, Due Two Thousand Fifty | Loans Payable | Nutrition &amp; Biosciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Margin on variable rate</a></td>
<td class="nump">0.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_RepurchasePriceAsPercentageOfPrincipalAmountOfSeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Repurchase Price As Percentage Of Principal Amount Of Senior Notes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_RepurchasePriceAsPercentageOfPrincipalAmountOfSeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -SubTopic 470<br> -Topic 942<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480848/942-470-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from borrowing by issuing commercial paper.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfCommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow due to repaying amounts borrowed by issuing commercial paper.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfCommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iff_InternationalFlavorsFragrancesIncSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iff_InternationalFlavorsFragrancesIncSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=iff_InternationalFlavorsFragrancesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=iff_InternationalFlavorsFragrancesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandTwentyEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandTwentyEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandFortySevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandFortySevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandFortyEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandFortyEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iff_NutritionBiosciencesIncSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iff_NutritionBiosciencesIncSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=iff_NutritionBiosciencesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=iff_NutritionBiosciencesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandTwentyFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandTwentyFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandTwentySevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandTwentySevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandThirtyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandThirtyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandFortyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandFortyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandFiftyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iff_SeniorNotesDueTwoThousandFiftyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308296230176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Schedule of Debt Maturities (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total</a></td>
<td class="nump">$ 9,980<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">Less than 1 Year</a></td>
<td class="nump">885<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturingInYearsTwoAndThree', window );">1-3 Years</a></td>
<td class="nump">2,445<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturingInYearsFourAndFive', window );">3-5 Years</a></td>
<td class="nump">1,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">More than 5 Years</a></td>
<td class="nump">$ 5,050<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturingInYearsFourAndFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth and fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturingInYearsFourAndFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturingInYearsTwoAndThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second and third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturingInYearsTwoAndThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308305915728">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Apr. 01, 2022</div></th>
<th class="th"><div>Feb. 01, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Remaining term lease</a></td>
<td class="text">50 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Renewal term</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 689<span></span>
</td>
<td class="nump">$ 743<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating Lease, Liability</a></td>
<td class="nump">727<span></span>
</td>
<td class="nump">758<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Finance Lease, Liability</a></td>
<td class="nump">$ 25<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iff_NutritionBiosciencesIncMember', window );">Nutrition &amp; Biosciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 525<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating Lease, Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 523<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iff_HealthWrightProductsIncHealthWrightMember', window );">Health Wright Products, Inc. (&#8220;Health Wright&#8221;)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Finance Lease, Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iff_NutritionBiosciencesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iff_NutritionBiosciencesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iff_HealthWrightProductsIncHealthWrightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iff_HealthWrightProductsIncHealthWrightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308299645296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Schedule of Lease Expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 137<span></span>
</td>
<td class="nump">$ 134<span></span>
</td>
<td class="nump">$ 133<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_FinanceLeaseCost', window );">Finance lease cost</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable Lease, Cost</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Lease, Cost</a></td>
<td class="nump">$ 193<span></span>
</td>
<td class="nump">$ 187<span></span>
</td>
<td class="nump">$ 168<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_FinanceLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_FinanceLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308300624272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Cash Flow (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows for operating leases</a></td>
<td class="nump">$ 122<span></span>
</td>
<td class="nump">$ 135<span></span>
</td>
<td class="nump">$ 129<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Financing cash flows for finance leases</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">174<span></span>
</td>
<td class="nump">88<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Operating cash flows for finance leases</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308299763296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Balance Sheet (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 689<span></span>
</td>
<td class="nump">$ 743<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current operating lease obligation</a></td>
<td class="nump">85<span></span>
</td>
<td class="nump">86<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities</a></td>
<td class="nump">642<span></span>
</td>
<td class="nump">672<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating Lease, Liability</a></td>
<td class="nump">727<span></span>
</td>
<td class="nump">758<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance Lease, Right-of-Use Asset</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Current financing lease obligation</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance Lease, Liability, Noncurrent</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Finance Lease, Liability</a></td>
<td class="nump">$ 25<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Other assets<span></span>
</td>
<td class="text">Other assets<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Other current liabilities<span></span>
</td>
<td class="text">Other current liabilities<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Other liabilities<span></span>
</td>
<td class="text">Other liabilities<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308306010272">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Weighted Average (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating lease weighted average remaining lease term</a></td>
<td class="text">9 years 10 months 24 days<span></span>
</td>
<td class="text">10 years 7 months 6 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Finance lease weighted average remaining lease term</a></td>
<td class="text">3 years 6 months<span></span>
</td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating lease weighted average discount rate</a></td>
<td class="nump">4.24%<span></span>
</td>
<td class="nump">3.83%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Finance lease weighted average discount rate</a></td>
<td class="nump">4.33%<span></span>
</td>
<td class="nump">2.59%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308292529504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Schedule of Lease Maturities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">Operating lease, less than 1 year</a></td>
<td class="nump">$ 113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">Lessee, Operating Lease, Liability, to be Paid, Year Two</a></td>
<td class="nump">110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">Lessee, Operating Lease, Liability, to be Paid, Year Three</a></td>
<td class="nump">101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">Lessee, Operating Lease, Liability, to be Paid, Year Four</a></td>
<td class="nump">87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">Lessee, Operating Lease, Liability, to be Paid, Year Five</a></td>
<td class="nump">77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Operating lease, After 5 years</a></td>
<td class="nump">410<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less Imputed Interest</a></td>
<td class="num">(171)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating Lease, Liability</a></td>
<td class="nump">727<span></span>
</td>
<td class="nump">$ 758<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Lessee, Operating Lease, Liability, to be Paid, Total</a></td>
<td class="nump">898<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">Financing lease, less than 1 year</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">Finance Lease, Liability, to be Paid, Year Two</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">Finance Lease, Liability, to be Paid, Year Three</a></td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">Finance Lease, Liability, to be Paid, Year Four</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">Finance Lease, Liability, to be Paid, Year Five</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Financing lease, After 5 years</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less Imputed Interest</a></td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Finance Lease, Liability</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Finance Lease, Liability, Payment, Due, Total</a></td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearOne', window );">Lessee, Operating and Finance Lease, Liability, to be Paid, Year One</a></td>
<td class="nump">122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearTwo', window );">Lessee, Operating and Finance Lease, Liability, to be Paid, Year Two</a></td>
<td class="nump">118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearThree', window );">Lessee, Operating and Finance Lease, Liability, to be Paid, Year Three</a></td>
<td class="nump">108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFour', window );">Lessee, Operating and Finance Lease, Liability, to be Paid, Year Four</a></td>
<td class="nump">91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFive', window );">Lessee, Operating and Finance Lease, Liability, to be Paid, Year Five</a></td>
<td class="nump">77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidAfterYearFive', window );">Lessee, Operating and Finance Lease, Liability, to be Paid, after Year Five</a></td>
<td class="nump">410<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_LesseeOperatingAndFinanceLeasePaymentsDue', window );">Lessee, Operating and Finance Lease, Payments, Due</a></td>
<td class="nump">926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_LesseeOperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount', window );">Lessee, Operating and Finance Lease, Liability, Undiscounted Excess Amount</a></td>
<td class="nump">174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_OperatingAndFinanceLeaseLiability', window );">Operating and Finance Lease, Liability</a></td>
<td class="nump">$ 752<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating and Finance Lease, Liability, to be Paid, after Year Five</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating and Finance Lease, Liability, to be Paid, Year Five</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating and Finance Lease, Liability, to be Paid, Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating and Finance Lease, Liability, to be Paid, Year One</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating and Finance Lease, Liability, to be Paid, Year Three</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating and Finance Lease, Liability, to be Paid, Year Two</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_LesseeOperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating and Finance Lease, Liability, Undiscounted Excess Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_LesseeOperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_LesseeOperatingAndFinanceLeasePaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating and Finance Lease, Payments, Due</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_LesseeOperatingAndFinanceLeasePaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_OperatingAndFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating and Finance Lease, Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_OperatingAndFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308300657680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Apr. 01, 2022</div></th>
<th class="th"><div>Feb. 01, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 689<span></span>
</td>
<td class="nump">$ 743<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating Lease, Liability</a></td>
<td class="nump">727<span></span>
</td>
<td class="nump">758<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance Lease, Right-of-Use Asset</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Finance Lease, Liability</a></td>
<td class="nump">$ 25<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iff_NutritionBiosciencesIncMember', window );">Nutrition &amp; Biosciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 525<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating Lease, Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 523<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iff_HealthWrightProductsIncHealthWrightMember', window );">Health Wright Products, Inc. (&#8220;Health Wright&#8221;)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance Lease, Right-of-Use Asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Finance Lease, Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iff_NutritionBiosciencesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iff_NutritionBiosciencesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iff_HealthWrightProductsIncHealthWrightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iff_HealthWrightProductsIncHealthWrightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308294189056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Earnings before Income Taxes (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">U.S. loss before taxes</a></td>
<td class="num">$ (1,777)<span></span>
</td>
<td class="num">$ (1,918)<span></span>
</td>
<td class="num">$ (493)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign (loss) income before taxes</a></td>
<td class="num">(741)<span></span>
</td>
<td class="nump">293<span></span>
</td>
<td class="nump">847<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">(Loss) income before taxes</a></td>
<td class="num">$ (2,518)<span></span>
</td>
<td class="num">$ (1,625)<span></span>
</td>
<td class="nump">$ 354<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308302272960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Income Tax Provision (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current tax provision</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 55<span></span>
</td>
<td class="nump">$ 102<span></span>
</td>
<td class="num">$ (5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State and local</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="num">(359)<span></span>
</td>
<td class="num">(325)<span></span>
</td>
<td class="num">(303)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current income tax provision</a></td>
<td class="nump">414<span></span>
</td>
<td class="nump">476<span></span>
</td>
<td class="nump">311<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred tax provision</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="num">(113)<span></span>
</td>
<td class="num">(77)<span></span>
</td>
<td class="num">(121)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State and local</a></td>
<td class="nump">32<span></span>
</td>
<td class="num">(111)<span></span>
</td>
<td class="num">(34)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Foreign</a></td>
<td class="num">(288)<span></span>
</td>
<td class="num">(49)<span></span>
</td>
<td class="num">(81)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred income tax provision</a></td>
<td class="num">(369)<span></span>
</td>
<td class="num">(237)<span></span>
</td>
<td class="num">(236)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total provision for income taxes</a></td>
<td class="nump">$ 45<span></span>
</td>
<td class="nump">$ 239<span></span>
</td>
<td class="nump">$ 75<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308305614736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Reconciliation of Effective Income Tax Rate (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses', window );">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Amount</a></td>
<td class="num">(20.40%)<span></span>
</td>
<td class="num">(29.10%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings', window );">Difference in effective tax rate on foreign earnings and remittances(1)</a></td>
<td class="num">(0.20%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_EffectiveIncomeTaxRateReconciliationTaxBenefitFromSupplyChainOptimizationPercent', window );">Tax benefit from supply chain optimization</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">0.80%<span></span>
</td>
<td class="num">(5.80%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome', window );">Unrecognized tax benefit, net of reversals</a></td>
<td class="num">(0.80%)<span></span>
</td>
<td class="nump">0.90%<span></span>
</td>
<td class="nump">0.70%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness', window );">Tax impact on business divestitures</a></td>
<td class="num">(3.70%)<span></span>
</td>
<td class="num">(5.90%)<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_EffectiveIncomeTaxRateReconciliationDeferredTaxesonDeemedRepatriationPercent', window );">Deferred taxes on deemed repatriation(2)</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="num">(5.60%)<span></span>
</td>
<td class="nump">2.70%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiPercent', window );">Global intangible low-taxed income</a></td>
<td class="num">(0.40%)<span></span>
</td>
<td class="num">(0.80%)<span></span>
</td>
<td class="num">(4.10%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent', window );">Foreign-derived intangible income</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">1.60%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign', window );">U.S. foreign tax credit - general limitation</a></td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="num">(3.10%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch', window );">Research and development credit</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">0.80%<span></span>
</td>
<td class="num">(1.40%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_EffectiveIncomeTaxRateReconciliationAcquisitionCostsPercent', window );">Acquisition costs</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">2.40%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Establishment (release) of valuation allowance on state deferred</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(3.00%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State and local taxes including rate changes(3)</a></td>
<td class="num">(1.70%)<span></span>
</td>
<td class="nump">4.30%<span></span>
</td>
<td class="num">(4.80%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_EffectiveIncomeTaxRateReconciliationTaxImpactOnInternalAssetTransferPercent', window );">Tax impact on internal asset transfer</a></td>
<td class="nump">0.053<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other, net</a></td>
<td class="num">(2.60%)<span></span>
</td>
<td class="num">(2.30%)<span></span>
</td>
<td class="num">(2.00%)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="num">(1.80%)<span></span>
</td>
<td class="num">(14.70%)<span></span>
</td>
<td class="nump">21.20%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_EffectiveIncomeTaxRateReconciliationAcquisitionCostsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Acquisition Costs, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_EffectiveIncomeTaxRateReconciliationAcquisitionCostsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_EffectiveIncomeTaxRateReconciliationDeferredTaxesonDeemedRepatriationPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Deferred Taxes on Deemed Repatriation, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_EffectiveIncomeTaxRateReconciliationDeferredTaxesonDeemedRepatriationPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_EffectiveIncomeTaxRateReconciliationTaxBenefitFromSupplyChainOptimizationPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Tax Benefit From Supply Chain Optimization, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_EffectiveIncomeTaxRateReconciliationTaxBenefitFromSupplyChainOptimizationPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_EffectiveIncomeTaxRateReconciliationTaxImpactOnInternalAssetTransferPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Tax Impact On Internal Asset Transfer, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_EffectiveIncomeTaxRateReconciliationTaxImpactOnInternalAssetTransferPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to disposition of a business not qualifying as a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of reported income tax benefit from difference to income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to foreign-derived intangible income (FDII).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of reported income tax expense from difference to expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to global intangible low-taxed income (GILTI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationGiltiPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to impairment loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to the repatriation of foreign earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign tax credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income (loss) exempt from income taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308301776144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Reconciliation between U.S. Federal Statutory Income Tax Rate to Actual Effective Tax Rate (Detail)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Release of valuation allowance on state deferred</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(3.00%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State and local taxes</a></td>
<td class="num">(1.70%)<span></span>
</td>
<td class="nump">4.30%<span></span>
</td>
<td class="num">(4.80%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other, net</a></td>
<td class="num">(2.60%)<span></span>
</td>
<td class="num">(2.30%)<span></span>
</td>
<td class="num">(2.00%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="num">(1.80%)<span></span>
</td>
<td class="num">(14.70%)<span></span>
</td>
<td class="nump">21.20%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308294768768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Additional Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount', window );">Global intangible low-taxed income expense</a></td>
<td class="nump">$ 64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiAmount', window );">Foreign derived intangible income expense</a></td>
<td class="nump">$ 54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">U.S. federal tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="nump">$ 324<span></span>
</td>
<td class="nump">$ 262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">332<span></span>
</td>
<td class="nump">315<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsValuationAllowance', window );">Valuation allowance for net operating loss carryforwards</a></td>
<td class="nump">324<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_AccruedInterestOrPenaltiesRelatedToTaxAmounts', window );">Reduction in accrual for interest and penalties</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_UnrecognizedTaxBenefitsIncludingInterestAndPenalties', window );">Unrecognized tax benefits, including interest</a></td>
<td class="nump">170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DeferredTaxLiabilitiesDeemedRepatriation', window );">Deferred Tax Liabilities, Deemed Repatriation</a></td>
<td class="nump">155<span></span>
</td>
<td class="nump">166<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis=iff_UnrecognizedTaxBenefitsOtherLiabilitiesMember', window );">Other liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that would impact effective tax rate</a></td>
<td class="nump">123<span></span>
</td>
<td class="nump">98<span></span>
</td>
<td class="nump">130<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis=iff_UnrecognizedTaxBenefitsOtherCurrentLiabilitiesMember', window );">Other Current Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that would impact effective tax rate</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=iff_TwoThousandTwentyThreeToTwoThousandFortyTwoMember', window );">2018 to 2037 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">311<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration</a></td>
<td class="nump">106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforwards</a></td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=iff_IndefiniteMember', window );">Indefinite [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=iff_TwoThousandTwentyTwoToTwoThousandFortyOneMember', window );">Two Thousand Twenty Two To Two Thousand Forty One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">301<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember', window );">Other Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Accrued interest and penalties</a></td>
<td class="nump">47<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember', window );">Other Current Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Accrued interest and penalties</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DeferredTaxLiabilitiesDeemedRepatriation', window );">Deferred Tax Liabilities, Deemed Repatriation</a></td>
<td class="nump">155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Tax Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DeferredTaxLiabilitiesDeemedRepatriation', window );">Deferred Tax Liabilities, Deemed Repatriation</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_AccruedInterestOrPenaltiesRelatedToTaxAmounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Interest Or Penalties Related To Tax Amounts</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_AccruedInterestOrPenaltiesRelatedToTaxAmounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DeferredTaxLiabilitiesDeemedRepatriation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Deemed Repatriation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DeferredTaxLiabilitiesDeemedRepatriation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_IncomeTaxesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Taxes [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_IncomeTaxesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_UnrecognizedTaxBenefitsIncludingInterestAndPenalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unrecognized Tax Benefits, Including Interest And Penalties</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_UnrecognizedTaxBenefitsIncludingInterestAndPenalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax benefit from difference to expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to foreign-derived intangible income (FDII).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationFdiiAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax expense from difference to expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to global intangible low-taxed income (GILTI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis=iff_UnrecognizedTaxBenefitsOtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis=iff_UnrecognizedTaxBenefitsOtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis=iff_UnrecognizedTaxBenefitsOtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis=iff_UnrecognizedTaxBenefitsOtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=iff_TwoThousandTwentyThreeToTwoThousandFortyTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=iff_TwoThousandTwentyThreeToTwoThousandFortyTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=iff_IndefiniteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=iff_IndefiniteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=iff_TwoThousandTwentyTwoToTwoThousandFortyOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=iff_TwoThousandTwentyTwoToTwoThousandFortyOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308301243264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits', window );">Employee and retiree benefits</a></td>
<td class="nump">$ 118<span></span>
</td>
<td class="nump">$ 61<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Credit and net operating loss carryforwards</a></td>
<td class="nump">332<span></span>
</td>
<td class="nump">315<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment', window );">Deferred Tax Assets, in Process Research and Development</a></td>
<td class="nump">125<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DeferredTaxAssetsInterestLimitations', window );">Interest limitation</a></td>
<td class="nump">127<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInventory', window );">Inventory</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DeferredTaxAssetsLeaseObligations', window );">Deferred Tax Asset Lease Obligations</a></td>
<td class="nump">170<span></span>
</td>
<td class="nump">151<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other, net</a></td>
<td class="nump">114<span></span>
</td>
<td class="nump">131<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Gross deferred tax assets</a></td>
<td class="nump">1,021<span></span>
</td>
<td class="nump">764<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Property, plant and equipment, net</a></td>
<td class="num">(239)<span></span>
</td>
<td class="num">(229)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets', window );">Intangible assets(1)</a></td>
<td class="num">(1,792)<span></span>
</td>
<td class="num">(2,049)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DeferredTaxLiabilitiesRightOfUseAssets', window );">Deferred Tax Liabilities, Right of Use Assets</a></td>
<td class="num">(170)<span></span>
</td>
<td class="num">(151)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DeferredTaxLiabilitiesGainLossOnForeignCurrencyTranslation', window );">Loss on foreign currency translation</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(23)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DeferredTaxLiabilitiesDeemedRepatriation', window );">Deferred taxes on deemed repatriation</a></td>
<td class="num">(155)<span></span>
</td>
<td class="num">(166)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Gross deferred tax liabilities</a></td>
<td class="num">(2,356)<span></span>
</td>
<td class="num">(2,618)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(324)<span></span>
</td>
<td class="num">(262)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Total net deferred tax liabilities</a></td>
<td class="num">$ (1,659)<span></span>
</td>
<td class="num">$ (2,116)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DeferredTaxAssetsInterestLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Interest Limitations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DeferredTaxAssetsInterestLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DeferredTaxAssetsLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Lease Obligations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DeferredTaxAssetsLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DeferredTaxLiabilitiesDeemedRepatriation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Deemed Repatriation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DeferredTaxLiabilitiesDeemedRepatriation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DeferredTaxLiabilitiesGainLossOnForeignCurrencyTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Gain (Loss) On Foreign Currency Translation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DeferredTaxLiabilitiesGainLossOnForeignCurrencyTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DeferredTaxLiabilitiesRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Right-of-Use Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DeferredTaxLiabilitiesRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from postretirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308293167680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Reconciliation of Beginning and Ending Amount of Unrecognized Tax Benefits (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance of unrecognized tax benefits at beginning of year</a></td>
<td class="nump">$ 112<span></span>
</td>
<td class="nump">$ 130<span></span>
</td>
<td class="nump">$ 99<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Gross amount of increases in unrecognized tax benefits as a result of positions taken during a prior year(1)</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Gross amount of decreases in unrecognized tax benefits as a result of positions taken during a prior year</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Gross amount of increases in unrecognized tax benefits as a result of positions taken during the current year</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities', window );">The amounts of decreases in unrecognized benefits relating to settlements with taxing authorities</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(27)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Reduction in unrecognized tax benefits due to the lapse of applicable statute of limitation</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance of unrecognized tax benefits at end of year</a></td>
<td class="nump">123<span></span>
</td>
<td class="nump">112<span></span>
</td>
<td class="nump">130<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_IncomeTaxesDisclosureLineItems', window );"><strong>Income Taxes Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Gross amount of increases in unrecognized tax benefits as a result of positions taken during a prior year(1)</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember', window );">Other Current Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_IncomeTaxesDisclosureLineItems', window );"><strong>Income Taxes Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Accrued interest and penalties</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis=iff_UnrecognizedTaxBenefitsOtherCurrentLiabilitiesMember', window );">Other Current Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_IncomeTaxesDisclosureLineItems', window );"><strong>Income Taxes Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that would impact effective tax rate</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_IncomeTaxesDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Taxes Disclosure [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_IncomeTaxesDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-10B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis=iff_UnrecognizedTaxBenefitsOtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis=iff_UnrecognizedTaxBenefitsOtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308302285936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share - Reconciliation of Shares Used in Computation of Basic and Diluted Net Income Per Share (Detail) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract', window );"><strong>Net (Loss) Income</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net (loss) income available to IFF shareholders</a></td>
<td class="num">$ (2,567)<span></span>
</td>
<td class="num">$ (1,871)<span></span>
</td>
<td class="nump">$ 270<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_NetIncomeLossAvailableToCommonStockholdersAdjustment', window );">Net (loss) income available to IFF shareholders</a></td>
<td class="num">$ (2,565)<span></span>
</td>
<td class="num">$ (1,868)<span></span>
</td>
<td class="nump">$ 268<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Average number of shares outstanding - basic (in shares)</a></td>
<td class="nump">255<span></span>
</td>
<td class="nump">255<span></span>
</td>
<td class="nump">243<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Average number of shares outstanding - diluted (in shares)</a></td>
<td class="nump">255<span></span>
</td>
<td class="nump">255<span></span>
</td>
<td class="nump">243<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Net income per share - basic (in dollars per share)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income per share - basic (in dollars per share)</a></td>
<td class="num">$ (10.05)<span></span>
</td>
<td class="num">$ (7.32)<span></span>
</td>
<td class="nump">$ 1.11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income per share - diluted (in dollars per share)</a></td>
<td class="num">$ (10.05)<span></span>
</td>
<td class="num">$ (7.32)<span></span>
</td>
<td class="nump">$ 1.10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_IncreaseDecreaseInRedemptionValueRedeemableNoncontrollingInterest', window );">(Increase) Decrease In Redemption Value, Redeemable Noncontrolling Interest</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="num">$ (2)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_IncreaseDecreaseInRedemptionValueRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>(Increase) Decrease In Redemption Value, Redeemable Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_IncreaseDecreaseInRedemptionValueRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_NetIncomeLossAvailableToCommonStockholdersAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Income (Loss) Available To Common Stockholders, Adjustment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_NetIncomeLossAvailableToCommonStockholdersAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-11<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308300628288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share - Additional Information (Detail) - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 01, 2021</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 15, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.125<span></span>
</td>
<td class="nump">$ 0.125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenBasicNetIncomeLossPerShare', window );">Participating Securities, Distributed And Undistributed Earnings (Loss), Difference Between Basic Net Income (Loss) Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenDilutedNetIncomeLossPerShare', window );">Participating Securities, Distributed And Undistributed Earnings (Loss), Difference Between Diluted Net Income (Loss) Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iff_ShareEquivalentsMember', window );">Share Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iff_NutritionBiosciencesIncMember', window );">Nutrition &amp; Biosciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Business acquisition, equity interest issued or issuable, number of shares</a></td>
<td class="nump">141,740,461<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.125<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iff_NutritionBiosciencesIncMember', window );">Nutrition &amp; Biosciences, Inc | International Flavors &amp; Fragrances Inc | DuPont de Nemours, Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of voting interest acquired</a></td>
<td class="nump">55.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenBasicNetIncomeLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Participating Securities, Distributed And Undistributed Earnings (Loss), Difference Between Basic Net Income (Loss) Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenBasicNetIncomeLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenDilutedNetIncomeLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Participating Securities, Distributed And Undistributed Earnings (Loss), Difference Between Diluted Net Income (Loss) Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenDilutedNetIncomeLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iff_ShareEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iff_ShareEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iff_NutritionBiosciencesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iff_NutritionBiosciencesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=iff_InternationalFlavorsFragrancesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=iff_InternationalFlavorsFragrancesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=iff_DuPontdeNemoursIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=iff_DuPontdeNemoursIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308306563728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share - TEU (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 15, 2021</div></th>
<th class="th"><div>Sep. 17, 2018</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 14, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_TangibleEquityUnitsIssued', window );">Tangible equity units issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_TangibleEquityUnitsProceeds', window );">Tangible equity units proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_TangibleEquityUnitsPriceforSharesBasic', window );">Price for basic share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.330911<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_TangibleEquityUnitsPriceforSharesDiluted', window );">Price for diluted share (usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.330911<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock Issued During Period, Shares, Issued for Services</a></td>
<td class="nump">5,460,031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_TangibleEquityUnitsFinalSettlementRate', window );">Tangible Equity Units Final Settlement Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.330911<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_TangibleEquityUnitsFinalSettlementRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tangible Equity Units Final Settlement Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_TangibleEquityUnitsFinalSettlementRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_TangibleEquityUnitsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tangible Equity Units Issued</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_TangibleEquityUnitsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_TangibleEquityUnitsPriceforSharesBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tangible Equity Units, Price for Shares Basic</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_TangibleEquityUnitsPriceforSharesBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_TangibleEquityUnitsPriceforSharesDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tangible Equity Units, Price for Shares Diluted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_TangibleEquityUnitsPriceforSharesDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_TangibleEquityUnitsProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tangible Equity Units Proceeds</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_TangibleEquityUnitsProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308302224880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity - Additional Information (Detail) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per share (in dollars per share)</a></td>
<td class="nump">$ 3.24<span></span>
</td>
<td class="nump">$ 3.20<span></span>
</td>
<td class="nump">$ 3.12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrent', window );">Dividends payable</a></td>
<td class="nump">$ 207<span></span>
</td>
<td class="nump">$ 206<span></span>
</td>
<td class="nump">$ 201<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableAmountPerShare', window );">Dividend per share declared (in dollars per share)</a></td>
<td class="nump">$ 0.81<span></span>
</td>
<td class="nump">$ 0.81<span></span>
</td>
<td class="nump">$ 0.79<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableAmountPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The per share amount of a dividend declared, but not paid, as of the financial reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableAmountPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308292573760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Compensation Plans - Additional Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 01, 2021</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesSubjectToOutstandingAwards', window );">Shares subject to outstanding awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,817,519<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfSharesAvailableForGrant', window );">Shares remaining available for future awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">748,082<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_TargetPayoutPeriodOfCycle', window );">Target payout, cycle</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetDollarValueOfAwardIsConvertedToNumberOfNotionalSharesWhenAwardIsGranted', window );">Percentage of target dollar value of the award converted to a number of notional shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67<span></span>
</td>
<td class="nump">$ 51<span></span>
</td>
<td class="nump">$ 62<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iff_NutritionBiosciencesIncMember', window );">Nutrition &amp; Biosciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Business acquisition, equity interest issued or issuable, number of shares</a></td>
<td class="nump">141,740,461<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure', window );">Equity Issued in Business Combination, Fair Value Disclosure</a></td>
<td class="nump">$ 25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_BusinessAcquisitionPostCombinationServicePeriod', window );">Business Acquisition, Post-Combination Service Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost related to non-vested stock options and SSAR, RSU, PRS and Cash RSU awards granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=iff_LongTermIncentivePlanMember', window );">Long-Term Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_TargetPayoutCash', window );">Target payout percentage, cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_TargetPayoutStock', window );">Target payout percentage, stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=iff_TwoThousandNineteenToTwoThousandTwentyOneCycleMember', window );">2018-2020 Cycle [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock-based compensation, shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=iff_TwoThousandTwentyOnePlanMember', window );">Two Thousand Twenty-One Plan [Domain]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Shares authorized for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,290,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=iff_TwoThousandTwentyToTwoThousandTwentyTwoCycleMember', window );">Two Thousand Nineteen To Two Thousand Twenty-One Cycle</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock-based compensation, shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=iff_TwoThousandTwentyOneToTwoThousandTwentyThreeCycleMember', window );">Two Thousand Twenty-One To Two Thousand Twenty-Three Cycle | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock-based compensation, shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSU's [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost related to non-vested stock options and SSAR, RSU, PRS and Cash RSU awards granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSU's [Member] | Nutrition &amp; Biosciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Business acquisition, equity interest issued or issuable, number of shares</a></td>
<td class="nump">258,572<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember', window );">SSAR's [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTerm', window );">Contractual term, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost related to non-vested stock options and SSAR, RSU, PRS and Cash RSU awards granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember', window );">SSAR's [Member] | Nutrition &amp; Biosciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Business acquisition, equity interest issued or issuable, number of shares</a></td>
<td class="nump">5,816<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share-based Payment Arrangement, Option | Nutrition &amp; Biosciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Business acquisition, equity interest issued or issuable, number of shares</a></td>
<td class="nump">335,347<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_BusinessAcquisitionPostCombinationServicePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Post-Combination Service Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_BusinessAcquisitionPostCombinationServicePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum term of options or units granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based compensation arrangement by share-based payment award equity instruments other than options, number of shares available for grant</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetDollarValueOfAwardIsConvertedToNumberOfNotionalSharesWhenAwardIsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based compensation arrangement by share-based payment award, percentage of target dollar value of the award is converted to a number of notional shares when award is granted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetDollarValueOfAwardIsConvertedToNumberOfNotionalSharesWhenAwardIsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesSubjectToOutstandingAwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Shares Subject To Outstanding Awards</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesSubjectToOutstandingAwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_TargetPayoutCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Target payout cash</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_TargetPayoutCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_TargetPayoutPeriodOfCycle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Target Payout, Period of Cycle</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_TargetPayoutPeriodOfCycle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_TargetPayoutStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Target payout stock</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_TargetPayoutStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of equity issued in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iff_NutritionBiosciencesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iff_NutritionBiosciencesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=iff_LongTermIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=iff_LongTermIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=iff_TwoThousandNineteenToTwoThousandTwentyOneCycleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=iff_TwoThousandNineteenToTwoThousandTwentyOneCycleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=iff_TwoThousandTwentyOnePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=iff_TwoThousandTwentyOnePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=iff_TwoThousandTwentyToTwoThousandTwentyTwoCycleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=iff_TwoThousandTwentyToTwoThousandTwentyTwoCycleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=iff_TwoThousandTwentyOneToTwoThousandTwentyThreeCycleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=iff_TwoThousandTwentyOneToTwoThousandTwentyThreeCycleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308306674896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Compensation Plans - Stock-Based Compensation Expense Included in Consolidated Statement of Income and Comprehensive Income (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation</a></td>
<td class="nump">$ 67<span></span>
</td>
<td class="nump">$ 51<span></span>
</td>
<td class="nump">$ 62<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Less tax benefit</a></td>
<td class="num">(11)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Total stock-based compensation, net of tax</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=iff_EquityBasedAwardsMember', window );">Equity-based awards [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation</a></td>
<td class="nump">65<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="nump">54<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=iff_LiabilityBasedAwardsMember', window );">Liability-based awards [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of expense for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=iff_EquityBasedAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=iff_EquityBasedAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=iff_LiabilityBasedAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=iff_LiabilityBasedAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308313995040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Compensation Plans - SSAR's and Stock Option - Additional Information (Detail) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember', window );">SSAR's [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTerm', window );">Contractual term, in years</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost related to non-vested stock options and SSAR, RSU, PRS and Cash RSU awards granted</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation cost related to non-vested stock options and SSAR, RSU, PRS and Cash RSU awards granted, weighted average period, in years</a></td>
<td class="text">1 year 1 month 20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iff_StockOptionsAndStockSettledAppreciationRightsMember', window );">SSAR's and Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted average exercise price, exercisable (USD per share)</a></td>
<td class="nump">$ 109.59<span></span>
</td>
<td class="nump">$ 109.50<span></span>
</td>
<td class="nump">$ 109.77<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Intrinsic value of options/SSAR's exercised</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum term of options or units granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iff_StockOptionsAndStockSettledAppreciationRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iff_StockOptionsAndStockSettledAppreciationRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308300332256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Compensation Plans - SSAR's and Stock Option Activity (Detail) - SSAR's and Options [Member] - $ / shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares&#160;Subject&#160;to SSARs/Options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning balance (in shares)</a></td>
<td class="nump">331<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Cancelled (in shares)</a></td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending balance (in shares)</a></td>
<td class="nump">315<span></span>
</td>
<td class="nump">331<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average&#160;Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning balance (in dollars per share)</a></td>
<td class="nump">$ 115.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
<td class="nump">68.67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Cancelled (in dollars per share)</a></td>
<td class="nump">122.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending balance (in dollars per share)</a></td>
<td class="nump">$ 116.26<span></span>
</td>
<td class="nump">$ 115.35<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">SSARs/ Options Exercisable (in shares)</a></td>
<td class="nump">194<span></span>
</td>
<td class="nump">182<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Expected to Vest (in shares)</a></td>
<td class="nump">118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Expected to Vest (in dollars per share)</a></td>
<td class="nump">$ 126.99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iff_StockOptionsAndStockSettledAppreciationRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iff_StockOptionsAndStockSettledAppreciationRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308305700880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Compensation Plans - SSAR's and Stock Option Outstanding (Detail) - SSAR's and Options [Member] - Over $65<br> $ / shares in Units, shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number Outstanding (in shares) | shares</a></td>
<td class="nump">315<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted&#160;Average Remaining Contractual Life (in years)</a></td>
<td class="text">4 years 8 months 15 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted Average Exercise Price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 116.26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value | $</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number Exercisable (in shares) | shares</a></td>
<td class="nump">194<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted&#160;Average Remaining Contractual&#160;Life (in years)</a></td>
<td class="text">4 years 3 months 29 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Weighted Average Exercise&#160;Price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 109.59<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate Intrinsic Value | $</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iff_StockOptionsAndStockSettledAppreciationRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iff_StockOptionsAndStockSettledAppreciationRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=iff_Over65Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=iff_Over65Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308314006672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Compensation Plans - SSAR's and Stock Option Exercisable (Detail) - SSAR's and Options [Member] - Over $65<br> $ / shares in Units, shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number Exercisable (in shares) | shares</a></td>
<td class="nump">194<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted&#160;Average Remaining Contractual&#160;Life (in years)</a></td>
<td class="text">4 years 3 months 29 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Weighted Average Exercise&#160;Price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 109.59<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate Intrinsic Value | $</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iff_StockOptionsAndStockSettledAppreciationRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iff_StockOptionsAndStockSettledAppreciationRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=iff_Over65Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=iff_Over65Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308294328064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Compensation Plans - Restricted Stock Units Plan - Additional Information (Detail)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSU's [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentage', window );">Vesting percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period, in years</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Total fair value of vested</a></td>
<td class="nump">$ 38<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost related to non-vested stock options and SSAR, RSU, PRS and Cash RSU awards granted</a></td>
<td class="nump">$ 67<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation cost related to non-vested stock options and SSAR, RSU, PRS and Cash RSU awards granted, weighted average period, in years</a></td>
<td class="text">1 year 11 months 8 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iff_PurchasedRestrictedStockUnitMember', window );">Purchased Restricted Stock Unit</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Total fair value of vested</a></td>
<td class="nump">$ 3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost related to non-vested stock options and SSAR, RSU, PRS and Cash RSU awards granted</a></td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation cost related to non-vested stock options and SSAR, RSU, PRS and Cash RSU awards granted, weighted average period, in years</a></td>
<td class="text">1 year 21 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based compensation arrangement by share-based payment award, vesting percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iff_PurchasedRestrictedStockUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iff_PurchasedRestrictedStockUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308292277696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Compensation Plans - RSU, PRS and Cash RSU Activity (Detail) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSU's [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number&#160;of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Beginning balance (in shares)</a></td>
<td class="nump">937,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">843,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="num">(315,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="num">(78,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsChangeDueToPerformanceConditions', window );">Change due to performance conditions, net (in shares)</a></td>
<td class="num">(20,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Ending balance (in shares)</a></td>
<td class="nump">1,367,000<span></span>
</td>
<td class="nump">937,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted&#160;Average Grant Date Fair Value Per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Beginning balance (in dollars per share)</a></td>
<td class="nump">$ 120.81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
<td class="nump">87.31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share)</a></td>
<td class="nump">119.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share)</a></td>
<td class="nump">105.63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsChangeDueToPerformanceConditionsWeightedAverageGrantDateFairValue', window );">Change due to performance conditions, net (in dollars per share)</a></td>
<td class="nump">134.04<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Ending balance (in dollars per share)</a></td>
<td class="nump">$ 101.50<span></span>
</td>
<td class="nump">$ 120.81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iff_CashRestrictedStockUnitMember', window );">Cash RSU's [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number&#160;of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Beginning balance (in shares)</a></td>
<td class="nump">119,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">19,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="num">(40,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="num">(7,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Ending balance (in shares)</a></td>
<td class="nump">91,000<span></span>
</td>
<td class="nump">119,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted&#160;Average Grant Date Fair Value Per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Beginning balance (in dollars per share)</a></td>
<td class="nump">$ 104.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
<td class="nump">80.97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share)</a></td>
<td class="nump">94.72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share)</a></td>
<td class="nump">82.24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Ending balance (in dollars per share)</a></td>
<td class="nump">$ 80.97<span></span>
</td>
<td class="nump">$ 104.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iff_PurchasedRestrictedStockUnitMember', window );">Purchased Restricted Stock Unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number&#160;of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Beginning balance (in shares)</a></td>
<td class="nump">90,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="num">(26,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="num">(3,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Ending balance (in shares)</a></td>
<td class="nump">61,000<span></span>
</td>
<td class="nump">90,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted&#160;Average Grant Date Fair Value Per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Beginning balance (in dollars per share)</a></td>
<td class="nump">$ 133.36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share)</a></td>
<td class="nump">131.31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share)</a></td>
<td class="nump">138.98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Ending balance (in dollars per share)</a></td>
<td class="nump">$ 133.96<span></span>
</td>
<td class="nump">$ 133.36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedPurchasedByEmployees', window );">Issued Shares (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">43,690<span></span>
</td>
<td class="nump">61,870<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValueOfSharesPurchasedByEmployees', window );">Aggregate purchase price (in dollars per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesPurchasedByEmployees', window );">Covered shares (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">21,845<span></span>
</td>
<td class="nump">30,935<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsChangeDueToPerformanceConditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Change Due To Performance Conditions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsChangeDueToPerformanceConditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsChangeDueToPerformanceConditionsWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Change Due To Performance Conditions, Weighted Average Grant Date Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsChangeDueToPerformanceConditionsWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedPurchasedByEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Issued, Purchased By Employees</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedPurchasedByEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesPurchasedByEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of nonvested shares effectively purchased by employees for share based compensation arrangement by share based payment award equity instruments other than option grants in period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesPurchasedByEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValueOfSharesPurchasedByEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate employee purchase price for share based compensation arrangement by share based payment award equity instruments other than option grants in period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValueOfSharesPurchasedByEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iff_CashRestrictedStockUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iff_CashRestrictedStockUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iff_PurchasedRestrictedStockUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iff_PurchasedRestrictedStockUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308295550496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Compensation Plans - Purchased Restricted Stock Plan - Additional Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">PRSUs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Total fair value of vested</a></td>
<td class="nump">$ 38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost related to non-vested stock options and SSAR, RSU, PRS and Cash RSU awards granted</a></td>
<td class="nump">$ 67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation cost related to non-vested stock options and SSAR, RSU, PRS and Cash RSU awards granted, weighted average period, in years</a></td>
<td class="text">1 year 11 months 8 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iff_PurchasedRestrictedStockUnitMember', window );">Purchased Restricted Stock Unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedPurchasedByEmployees', window );">Issued Shares (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">43,690<span></span>
</td>
<td class="nump">61,870<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValueOfSharesPurchasedByEmployees', window );">Aggregate Purchases</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesPurchasedByEmployees', window );">Covered shares (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">21,845<span></span>
</td>
<td class="nump">30,935<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Total fair value of vested</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost related to non-vested stock options and SSAR, RSU, PRS and Cash RSU awards granted</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation cost related to non-vested stock options and SSAR, RSU, PRS and Cash RSU awards granted, weighted average period, in years</a></td>
<td class="text">1 year 21 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedPurchasedByEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Issued, Purchased By Employees</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedPurchasedByEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesPurchasedByEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of nonvested shares effectively purchased by employees for share based compensation arrangement by share based payment award equity instruments other than option grants in period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesPurchasedByEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValueOfSharesPurchasedByEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate employee purchase price for share based compensation arrangement by share based payment award equity instruments other than option grants in period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValueOfSharesPurchasedByEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iff_PurchasedRestrictedStockUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iff_PurchasedRestrictedStockUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308301927920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Compensation Plans - Liability Awards - Additional Information (Detail) - Cash RSU's [Member]<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentageGrantedInCashToEligibleEmployees', window );">Vesting percentage granted in cash to eligible employees</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentage', window );">Vesting percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period, in years</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Total fair value of vested</a></td>
<td class="nump">$ 4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost related to non-vested stock options and SSAR, RSU, PRS and Cash RSU awards granted</a></td>
<td class="nump">$ 2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation cost related to non-vested stock options and SSAR, RSU, PRS and Cash RSU awards granted, weighted average period, in years</a></td>
<td class="text">1 year 5 months 12 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based compensation arrangement by share-based payment award, vesting percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentageGrantedInCashToEligibleEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based compensation arrangement by share-based payment award, vesting percentage granted in cash to eligible employees</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentageGrantedInCashToEligibleEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iff_CashRestrictedStockUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iff_CashRestrictedStockUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308293440592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Additional Information (Detail)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>category </div>
<div>segment </div>
<div>customer</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>customer</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>customer</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_NumberOfFragranceCategories', window );">Number of fragrance categories | category</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment</a></td>
<td class="nump">$ 4,240<span></span>
</td>
<td class="nump">$ 4,203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of Operating Segments | segment</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_StrategicInitiativesCosts', window );">Strategic Initiative Costs</a></td>
<td class="nump">$ 31<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring and Other Charges, net</a></td>
<td class="num">(68)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="num">(41)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="num">(2,623)<span></span>
</td>
<td class="num">(2,250)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment, Long-Lived Asset, Held-for-Use</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(120)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_BusinessCombinationDivestituresAndIntegrationCosts', window );">Business Combination, Divestitures And Integration Costs</a></td>
<td class="num">(174)<span></span>
</td>
<td class="num">(201)<span></span>
</td>
<td class="num">(240)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Legal Fees</a></td>
<td class="num">(50)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_OtherCostsCredits', window );">Other (Costs) Credits</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="num">(35)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_BusinessDivestitureCosts', window );">Business Divestiture Costs</a></td>
<td class="nump">108<span></span>
</td>
<td class="nump">110<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationIntegrationRelatedCosts', window );">Business Combination, Integration Related Costs</a></td>
<td class="nump">59<span></span>
</td>
<td class="nump">94<span></span>
</td>
<td class="nump">105<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition related costs</a></td>
<td class="nump">7<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="nump">93<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iff_NutritionBiosciencesIncMember', window );">Nutrition &amp; Biosciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_BusinessCombinationInventoryStepUpCosts', window );">Business Combination, Inventory Step-Up Costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(368)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 91<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">U.S. Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment</a></td>
<td class="nump">1,742<span></span>
</td>
<td class="nump">1,771<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CN', window );">CHINA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment</a></td>
<td class="nump">$ 228<span></span>
</td>
<td class="nump">$ 258<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_EntityWideRevenueMajorCustomerNumberOfCustomers', window );">Number of customers that accounted for more than 10% of consolidated net sales | customer</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk [Member] | Revenue from Contract with Customer Benchmark</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_NumberOfCustomers', window );">Number Of Customers | customer</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk [Member] | Revenue from Contract with Customer Benchmark | Customer One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk threshold</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk [Member] | Non-US [Member] | Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk threshold</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_BusinessCombinationDivestituresAndIntegrationCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Divestitures And Integration Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_BusinessCombinationDivestituresAndIntegrationCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_BusinessCombinationInventoryStepUpCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Inventory Step-Up Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_BusinessCombinationInventoryStepUpCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_BusinessDivestitureCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Divestiture Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_BusinessDivestitureCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_EntityWideRevenueMajorCustomerNumberOfCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of customers whose net sales accounted for more than 10% of consolidated net sales.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_EntityWideRevenueMajorCustomerNumberOfCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_NumberOfCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Customers</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_NumberOfCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_NumberOfFragranceCategories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fragrance categories.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_NumberOfFragranceCategories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_OtherCostsCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other (Costs) Credits</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_OtherCostsCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_StrategicInitiativesCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Strategic Initiatives Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_StrategicInitiativesCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479405/805-10-25-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationIntegrationRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationIntegrationRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482047/420-10-45-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iff_NutritionBiosciencesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iff_NutritionBiosciencesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=iff_TopOneCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=iff_TopOneCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308292617872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Reportable Segment Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Segment assets</a></td>
<td class="nump">$ 30,978<span></span>
</td>
<td class="nump">$ 35,522<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition Related Costs</a></td>
<td class="num">(7)<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="num">$ (93)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationIntegrationRelatedCosts', window );">Integration Related Costs</a></td>
<td class="num">(59)<span></span>
</td>
<td class="num">(94)<span></span>
</td>
<td class="num">(105)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</a></td>
<td class="num">(2,518)<span></span>
</td>
<td class="num">(1,625)<span></span>
</td>
<td class="nump">354<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring and Other Charges, net</a></td>
<td class="num">(68)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="num">(41)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Gain on Sale of Assets</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(380)<span></span>
</td>
<td class="num">(336)<span></span>
</td>
<td class="num">(289)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (expense) income, net</a></td>
<td class="num">(28)<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="nump">58<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Legal Fees</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">11,479<span></span>
</td>
<td class="nump">12,440<span></span>
</td>
<td class="nump">11,656<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_SegmentAdjustedOperatingEBITDA', window );">Segment Adjusted Operating EBITDA</a></td>
<td class="nump">1,980<span></span>
</td>
<td class="nump">2,455<span></span>
</td>
<td class="nump">2,425<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_BusinessDivestitureCosts', window );">Business Divestiture Costs</a></td>
<td class="num">(108)<span></span>
</td>
<td class="num">(110)<span></span>
</td>
<td class="num">(42)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherDepreciationAndAmortization', window );">Other Depreciation and Amortization</a></td>
<td class="num">(1,142)<span></span>
</td>
<td class="num">(1,179)<span></span>
</td>
<td class="num">(1,156)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="num">(2,623)<span></span>
</td>
<td class="num">(2,250)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment, Long-Lived Asset, Held-for-Use</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(120)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iff_NourishMember', window );">Nourish</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring and Other Charges, net</a></td>
<td class="num">(37)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="num">(32)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="num">(2,623)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iff_HealthBiosciencesMember', window );">Health &amp; Biosciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring and Other Charges, net</a></td>
<td class="num">(13)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,250)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iff_ScentMember', window );">Scent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring and Other Charges, net</a></td>
<td class="num">(15)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iff_PharmaSolutionsMember', window );">Pharma Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring and Other Charges, net</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments [Member] | Nourish</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Segment assets</a></td>
<td class="nump">12,893<span></span>
</td>
<td class="nump">17,062<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">6,060<span></span>
</td>
<td class="nump">6,829<span></span>
</td>
<td class="nump">6,264<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_SegmentAdjustedOperatingEBITDA', window );">Segment Adjusted Operating EBITDA</a></td>
<td class="nump">732<span></span>
</td>
<td class="nump">1,176<span></span>
</td>
<td class="nump">1,172<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments [Member] | Health &amp; Biosciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Segment assets</a></td>
<td class="nump">10,666<span></span>
</td>
<td class="nump">10,924<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">2,081<span></span>
</td>
<td class="nump">2,339<span></span>
</td>
<td class="nump">2,329<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_SegmentAdjustedOperatingEBITDA', window );">Segment Adjusted Operating EBITDA</a></td>
<td class="nump">588<span></span>
</td>
<td class="nump">634<span></span>
</td>
<td class="nump">625<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments [Member] | Scent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Segment assets</a></td>
<td class="nump">4,274<span></span>
</td>
<td class="nump">4,309<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">2,393<span></span>
</td>
<td class="nump">2,301<span></span>
</td>
<td class="nump">2,254<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_SegmentAdjustedOperatingEBITDA', window );">Segment Adjusted Operating EBITDA</a></td>
<td class="nump">461<span></span>
</td>
<td class="nump">423<span></span>
</td>
<td class="nump">463<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments [Member] | Pharma Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Segment assets</a></td>
<td class="nump">3,145<span></span>
</td>
<td class="nump">3,227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">945<span></span>
</td>
<td class="nump">971<span></span>
</td>
<td class="nump">809<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_SegmentAdjustedOperatingEBITDA', window );">Segment Adjusted Operating EBITDA</a></td>
<td class="nump">199<span></span>
</td>
<td class="nump">222<span></span>
</td>
<td class="nump">165<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iff_NutritionBiosciencesIncMember', window );">Nutrition &amp; Biosciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition Related Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(91)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_BusinessCombinationInventoryStepUpCosts', window );">Business Combination, Inventory Step-Up Costs</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (368)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_BusinessCombinationInventoryStepUpCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Inventory Step-Up Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_BusinessCombinationInventoryStepUpCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_BusinessDivestitureCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Divestiture Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_BusinessDivestitureCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_SegmentAdjustedOperatingEBITDA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Segment Adjusted Operating EBITDA is defined as income (loss) before taxes, depreciation and amortization expense, interest expense, restructuring and other charges, net and certain non-recurring items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_SegmentAdjustedOperatingEBITDA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479405/805-10-25-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationIntegrationRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationIntegrationRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482047/420-10-45-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iff_NourishMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iff_NourishMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iff_HealthBiosciencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iff_HealthBiosciencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iff_ScentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iff_ScentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iff_PharmaSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iff_PharmaSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iff_NutritionBiosciencesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iff_NutritionBiosciencesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308292419296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Capital Expenditure and Depreciation and Amortization by Segment (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentExpenditureAdditionToLongLivedAssets', window );">Capital Expenditures</a></td>
<td class="nump">$ 503<span></span>
</td>
<td class="nump">$ 504<span></span>
</td>
<td class="nump">$ 393<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,142<span></span>
</td>
<td class="nump">1,179<span></span>
</td>
<td class="nump">1,156<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments [Member] | Nourish</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentExpenditureAdditionToLongLivedAssets', window );">Capital Expenditures</a></td>
<td class="nump">252<span></span>
</td>
<td class="nump">215<span></span>
</td>
<td class="nump">183<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">553<span></span>
</td>
<td class="nump">596<span></span>
</td>
<td class="nump">594<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments [Member] | Health &amp; Biosciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentExpenditureAdditionToLongLivedAssets', window );">Capital Expenditures</a></td>
<td class="nump">85<span></span>
</td>
<td class="nump">160<span></span>
</td>
<td class="nump">139<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">374<span></span>
</td>
<td class="nump">363<span></span>
</td>
<td class="nump">353<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments [Member] | Scent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentExpenditureAdditionToLongLivedAssets', window );">Capital Expenditures</a></td>
<td class="nump">62<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">81<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments [Member] | Pharma Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentExpenditureAdditionToLongLivedAssets', window );">Capital Expenditures</a></td>
<td class="nump">104<span></span>
</td>
<td class="nump">73<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">$ 137<span></span>
</td>
<td class="nump">$ 139<span></span>
</td>
<td class="nump">$ 125<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentExpenditureAdditionToLongLivedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenditure for addition to long-lived assets included in determination of segment assets by chief operating decision maker (CODM) or otherwise regularly provided to CODM. Excludes expenditure for addition to financial instrument, long-term customer relationship of financial institution, mortgage and other servicing rights, deferred policy acquisition cost, and deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482785/280-10-55-48<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentExpenditureAdditionToLongLivedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iff_NourishMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iff_NourishMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iff_HealthBiosciencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iff_HealthBiosciencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iff_ScentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iff_ScentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iff_PharmaSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iff_PharmaSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308292417440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Net Sales by Geographic Area (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 11,479<span></span>
</td>
<td class="nump">$ 12,440<span></span>
</td>
<td class="nump">$ 11,656<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember', window );">Europe, Africa and Middle East [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">3,834<span></span>
</td>
<td class="nump">4,219<span></span>
</td>
<td class="nump">4,093<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaMember', window );">Greater Asia [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">2,677<span></span>
</td>
<td class="nump">2,876<span></span>
</td>
<td class="nump">2,728<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_NorthAmericaMember', window );">North America [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">3,477<span></span>
</td>
<td class="nump">3,853<span></span>
</td>
<td class="nump">3,499<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_LatinAmericaMember', window );">Latin America</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,491<span></span>
</td>
<td class="nump">1,492<span></span>
</td>
<td class="nump">1,336<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionDomesticMember', window );">Geographic Distribution, Domestic [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">3,185<span></span>
</td>
<td class="nump">3,611<span></span>
</td>
<td class="nump">3,211<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionForeignMember', window );">Geographic Distribution, Foreign [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 8,294<span></span>
</td>
<td class="nump">$ 8,829<span></span>
</td>
<td class="nump">$ 8,445<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_EMEAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_NorthAmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_NorthAmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_LatinAmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_LatinAmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionDomesticMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionDomesticMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionForeignMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionForeignMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R106.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308302061520">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Segment Information Segment Information - Schedule of Long Lived Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">$ 4,240<span></span>
</td>
<td class="nump">$ 4,203<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">U.S. Pension Plans [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">1,742<span></span>
</td>
<td class="nump">1,771<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CN', window );">CHINA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">228<span></span>
</td>
<td class="nump">258<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=iff_OtherCountriesMember', window );">Other Countries [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">1,424<span></span>
</td>
<td class="nump">1,344<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_DK', window );">DENMARK</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">262<span></span>
</td>
<td class="nump">250<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_FI', window );">FINLAND</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">214<span></span>
</td>
<td class="nump">212<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_FR', window );">FRANCE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">199<span></span>
</td>
<td class="nump">187<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_DE', window );">GERMANY</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">$ 171<span></span>
</td>
<td class="nump">$ 181<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=iff_OtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=iff_OtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_DK">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_DK</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_FI">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_FI</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_FR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_FR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_DE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_DE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R107.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308294278000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 01, 2021 </div>
<div>USD ($) </div>
<div>benefit_plan</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBelowLowRange', window );">Percentage of matching contribution if compensation percentage below low range</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRange', window );">Matching participant's contribution, percentage on compensation</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBetweenHighRangeAndLowRange', window );">Percentage of matching contribution if compensation percentage between high range and low range</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRangeLow', window );">Matching participant's contribution, percentage on compensation, range low</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRangeHigh', window );">Matching participant's contribution, percentage on compensation, range high</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageReachesAverageRate', window );">Percentage of employees eligible to accrue benefits under the defined plan</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DefinedContributionPlanMatchingParticipantContributionAveragePercentageOnCompensation', window );">Matching participant's contribution, average percentage on compensation</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Retirement liabilities</a></td>
<td class="nump">$ 253,000,000<span></span>
</td>
<td class="nump">$ 231,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_AdjustmentsToAdditionalPaidInCapitalDeferredCompensation', window );">Capital in excess of par value related to deferred compensation plan</a></td>
<td class="nump">17,000,000<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashSurrenderValueOfLifeInsurance', window );">Total cash surrender value of life insurance contracts</a></td>
<td class="nump">$ 49,000,000<span></span>
</td>
<td class="nump">45,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_PercentageofActiveEmployeeswithPensionandorOtherRetirementBenefitPlansCovered', window );">Percentage of active employees with pension and or other retirement benefit plans covered</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iff_NutritionBiosciencesIncMember', window );">Nutrition &amp; Biosciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent', window );">Net defined benefit plan liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 221,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_BusinessCombinationDefinedBenefitPlanNumberOfPlansAssumed', window );">Number of defined benefit plans assumed | benefit_plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis=us-gaap_DeferredCompensationArrangementWithIndividualByTypeOfCompensationPensionAndOtherPostretirementBenefitsMember', window );">Deferred Compensation Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Retirement liabilities</a></td>
<td class="nump">$ 52,000,000<span></span>
</td>
<td class="nump">53,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan | U.S. Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Retirement liabilities</a></td>
<td class="nump">44,000,000<span></span>
</td>
<td class="nump">47,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Contribution to the plans</a></td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan | U.S. Plans | Equities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target percentage of investment in equity securities</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan | U.S. Plans | Fixed Income Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target percentage of investment in equity securities</a></td>
<td class="nump">90.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan | U.S. Plans | Qualified Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Contribution to the plans</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan | U.S. Plans | Nonqualified Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Contribution to the plans</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan | Non-U.S.&#160;Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Retirement liabilities</a></td>
<td class="nump">161,000,000<span></span>
</td>
<td class="nump">138,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Contribution to the plans</a></td>
<td class="nump">31,000,000<span></span>
</td>
<td class="nump">$ 31,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Contribution to the plans</a></td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_AdjustmentsToAdditionalPaidInCapitalDeferredCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Portion of Deferred Compensation Plan to be paid out in shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_AdjustmentsToAdditionalPaidInCapitalDeferredCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_BusinessCombinationDefinedBenefitPlanNumberOfPlansAssumed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Defined Benefit Plan, Number Of Plans Assumed</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_BusinessCombinationDefinedBenefitPlanNumberOfPlansAssumed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DefinedContributionPlanMatchingParticipantContributionAveragePercentageOnCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined contribution plan, matching participant contribution, average percentage on compensation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DefinedContributionPlanMatchingParticipantContributionAveragePercentageOnCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined contribution plan matching participant contribution percentage on compensation range</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRangeHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined contribution plan, matching participant contribution, percentage on compensation, range high</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRangeHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRangeLow">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined contribution plan, matching participant contribution, percentage on compensation, range low</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRangeLow</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBelowLowRange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined contribution plan, percentage of matching contribution if compensation percentage below low range</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBelowLowRange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBetweenHighRangeAndLowRange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined contribution plan, percentage of matching contribution if compensation percentage between high range and low range</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBetweenHighRangeAndLowRange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageReachesAverageRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined contribution plan, percentage of matching contribution if compensation percentage reaches average rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageReachesAverageRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_PercentageofActiveEmployeeswithPensionandorOtherRetirementBenefitPlansCovered">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of Active Employees with Pension and or Other Retirement Benefit Plans Covered</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_PercentageofActiveEmployeeswithPensionandorOtherRetirementBenefitPlansCovered</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashSurrenderValueOfLifeInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts which could be received based on the terms of the insurance contract upon surrendering life policies owned by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashSurrenderValueOfLifeInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of target investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iff_NutritionBiosciencesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iff_NutritionBiosciencesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis=us-gaap_DeferredCompensationArrangementWithIndividualByTypeOfCompensationPensionAndOtherPostretirementBenefitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis=us-gaap_DeferredCompensationArrangementWithIndividualByTypeOfCompensationPensionAndOtherPostretirementBenefitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_FixedIncomeSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_FixedIncomeSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTaxStatusAxis=us-gaap_QualifiedPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTaxStatusAxis=us-gaap_QualifiedPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTaxStatusAxis=us-gaap_NonqualifiedPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTaxStatusAxis=us-gaap_NonqualifiedPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R108.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308302058400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits - Plan Assets and Benefit Obligations of Defined Benefit Pension Plans (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit (income) cost</a></td>
<td class="num">$ (28)<span></span>
</td>
<td class="num">$ (19)<span></span>
</td>
<td class="num">$ (34)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">U.S. Plans | Pension Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost for benefits earned</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost on projected benefit obligation</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">71<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(31)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="num">(106)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DefinedBenefitPlanAmortizationAndDeferralsNet', window );">Net amortization and deferrals</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1', window );">Settlements and curtailments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit (income) cost</a></td>
<td class="num">(4)<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DefinedContributionAndOtherRetirementPlans', window );">Defined contribution and other retirement plans</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitExpense', window );">Total expense</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax', window );">Net actuarial loss (gain)</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax', window );">Recognized actuarial (loss) gain</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax', window );">Recognized prior service credit</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent', window );">Currency translation adjustment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax', window );">Total loss (gain) recognized in OCI (before tax effects)</a></td>
<td class="nump">26<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">U.S. Plans | Pension Plan | Restatement Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost on projected benefit obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Pension Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost for benefits earned</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost on projected benefit obligation</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(47)<span></span>
</td>
<td class="num">(42)<span></span>
</td>
<td class="num">(55)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DefinedBenefitPlanAmortizationAndDeferralsNet', window );">Net amortization and deferrals</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1', window );">Settlements and curtailments</a></td>
<td class="num">(8)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit (income) cost</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DefinedContributionAndOtherRetirementPlans', window );">Defined contribution and other retirement plans</a></td>
<td class="nump">51<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitExpense', window );">Total expense</a></td>
<td class="nump">52<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax', window );">Net actuarial loss (gain)</a></td>
<td class="nump">70<span></span>
</td>
<td class="num">(143)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax', window );">Recognized actuarial (loss) gain</a></td>
<td class="nump">9<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax', window );">Recognized prior service credit</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent', window );">Currency translation adjustment</a></td>
<td class="nump">9<span></span>
</td>
<td class="num">(27)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax', window );">Total loss (gain) recognized in OCI (before tax effects)</a></td>
<td class="nump">$ 89<span></span>
</td>
<td class="num">(181)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Pension Plan | Restatement Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost for benefits earned</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DefinedBenefitPlanAmortizationAndDeferralsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined benefit plan amortization and deferrals, net.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DefinedBenefitPlanAmortizationAndDeferralsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DefinedContributionAndOtherRetirementPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined contribution and other retirement plans expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DefinedContributionAndOtherRetirementPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, after reclassification adjustment, of increase (decrease) in accumulated other comprehensive income from gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-3A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-3A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-18<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from settlement and curtailment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-18<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (j)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, on foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost (reversal of cost) for pension and other postretirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RestatementAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RestatementAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R109.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308306677296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits - Components of Net Periodic Benefit Cost and Changes in Plan Assets and Benefit Obligations Recognized in OCI (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit (income) cost</a></td>
<td class="num">$ (28)<span></span>
</td>
<td class="num">$ (19)<span></span>
</td>
<td class="num">$ (34)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost for benefits earned</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost on projected benefit obligation</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DefinedBenefitPlanAmortizationAndDeferralsNet', window );">Net amortization and deferrals</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit (income) cost</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">$ (12)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax', window );">Net actuarial loss (gain)</a></td>
<td class="nump">3<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax', window );">Recognized actuarial (loss) gain</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax', window );">Recognized prior service credit</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax', window );">Total loss (gain) recognized in OCI (before tax effects)</a></td>
<td class="nump">$ 8<span></span>
</td>
<td class="num">$ (11)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DefinedBenefitPlanAmortizationAndDeferralsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined benefit plan amortization and deferrals, net.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DefinedBenefitPlanAmortizationAndDeferralsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, after reclassification adjustment, of increase (decrease) in accumulated other comprehensive income from gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income from prior service cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (j)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-3A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-18<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-18<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R110.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308305650368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits - Weighted-Average Actuarial Assumption Used to Determine Expense (Detail) - Pension Plan<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">U.S. Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Discount rate</a></td>
<td class="nump">5.42%<span></span>
</td>
<td class="nump">2.86%<span></span>
</td>
<td class="nump">2.51%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected return on plan assets</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="nump">3.80%<span></span>
</td>
<td class="nump">3.80%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease', window );">Rate of compensation increase</a></td>
<td class="nump">3.75%<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Discount rate</a></td>
<td class="nump">3.98%<span></span>
</td>
<td class="nump">1.43%<span></span>
</td>
<td class="nump">0.85%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected return on plan assets</a></td>
<td class="nump">4.92%<span></span>
</td>
<td class="nump">3.52%<span></span>
</td>
<td class="nump">4.21%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease', window );">Rate of compensation increase</a></td>
<td class="nump">3.01%<span></span>
</td>
<td class="nump">2.72%<span></span>
</td>
<td class="nump">2.56%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R111.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308294354400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits - Changes in Postretirement Benefit Obligation and Plan Assets (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation at beginning of year</a></td>
<td class="nump">$ 50<span></span>
</td>
<td class="nump">$ 66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost for benefits earned</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost on projected benefit obligation</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial (gain) loss</a></td>
<td class="nump">3<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DefinedBenefitPlanAdjustmentsForExpenseOrTaxContainedInServiceCost', window );">Adjustments for expense/tax contained in service cost</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant', window );">Plan participants&#8217; contributions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Benefits paid</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DefinedBenefitPlanCurtailmentsAndSettlementsBenefitObligation', window );">Curtailments/settlements</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation', window );">Translation adjustments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DefinedBenefitPlanBenefitObligationOther', window );">Other</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation at end of year</a></td>
<td class="nump">52<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="nump">66<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer contributions</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement Benefits | Restatement Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost on projected benefit obligation</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">U.S. Plans | Pension Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation at beginning of year</a></td>
<td class="nump">500<span></span>
</td>
<td class="nump">662<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost for benefits earned</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost on projected benefit obligation</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">71<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial (gain) loss</a></td>
<td class="nump">38<span></span>
</td>
<td class="num">(139)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DefinedBenefitPlanAdjustmentsForExpenseOrTaxContainedInServiceCost', window );">Adjustments for expense/tax contained in service cost</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant', window );">Plan participants&#8217; contributions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Benefits paid</a></td>
<td class="num">(39)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DefinedBenefitPlanCurtailmentsAndSettlementsBenefitObligation', window );">Curtailments/settlements</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation', window );">Translation adjustments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DefinedBenefitPlanBenefitObligationOther', window );">Other</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation at end of year</a></td>
<td class="nump">524<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="nump">662<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at beginning of year</a></td>
<td class="nump">498<span></span>
</td>
<td class="nump">649<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return on plan assets</a></td>
<td class="nump">41<span></span>
</td>
<td class="num">(118)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer contributions</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant', window );">Plan participants&#8217; contributions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid', window );">Benefits paid</a></td>
<td class="num">(39)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1', window );">Settlements</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss', window );">Translation adjustments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DefinedBenefitPlanPlanAssetsOther', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at end of year</a></td>
<td class="nump">505<span></span>
</td>
<td class="nump">498<span></span>
</td>
<td class="nump">649<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status at end of year</a></td>
<td class="num">(19)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">U.S. Plans | Pension Plan | Restatement Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost on projected benefit obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Pension Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation at beginning of year</a></td>
<td class="nump">930<span></span>
</td>
<td class="nump">1,501<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost for benefits earned</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost on projected benefit obligation</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial (gain) loss</a></td>
<td class="nump">77<span></span>
</td>
<td class="num">(468)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DefinedBenefitPlanAdjustmentsForExpenseOrTaxContainedInServiceCost', window );">Adjustments for expense/tax contained in service cost</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant', window );">Plan participants&#8217; contributions</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Benefits paid</a></td>
<td class="num">(33)<span></span>
</td>
<td class="num">(32)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DefinedBenefitPlanCurtailmentsAndSettlementsBenefitObligation', window );">Curtailments/settlements</a></td>
<td class="num">(21)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation', window );">Translation adjustments</a></td>
<td class="nump">45<span></span>
</td>
<td class="num">(104)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DefinedBenefitPlanBenefitObligationOther', window );">Other</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation at end of year</a></td>
<td class="nump">1,056<span></span>
</td>
<td class="nump">930<span></span>
</td>
<td class="nump">1,501<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at beginning of year</a></td>
<td class="nump">920<span></span>
</td>
<td class="nump">1,320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return on plan assets</a></td>
<td class="nump">50<span></span>
</td>
<td class="num">(286)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer contributions</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant', window );">Plan participants&#8217; contributions</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid', window );">Benefits paid</a></td>
<td class="num">(33)<span></span>
</td>
<td class="num">(32)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1', window );">Settlements</a></td>
<td class="num">(21)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss', window );">Translation adjustments</a></td>
<td class="nump">44<span></span>
</td>
<td class="num">(96)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DefinedBenefitPlanPlanAssetsOther', window );">Other</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at end of year</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">920<span></span>
</td>
<td class="nump">$ 1,320<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status at end of year</a></td>
<td class="num">$ (56)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Pension Plan | Restatement Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost for benefits earned</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DefinedBenefitPlanAdjustmentsForExpenseOrTaxContainedInServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined benefit plan, adjustments for expense or tax contained in service cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DefinedBenefitPlanAdjustmentsForExpenseOrTaxContainedInServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DefinedBenefitPlanBenefitObligationOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Benefit Obligation, Other</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DefinedBenefitPlanBenefitObligationOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DefinedBenefitPlanCurtailmentsAndSettlementsBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Curtailments And Settlements, Benefit Obligation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DefinedBenefitPlanCurtailmentsAndSettlementsBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DefinedBenefitPlanPlanAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Plan Assets, Other</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DefinedBenefitPlanPlanAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480266/715-60-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(6)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions received by defined benefit plan from participant which increase benefit obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(5)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedStatusOfPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-3A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 715<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480266/715-60-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(5)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions received by defined benefit plan from participant which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-3A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-18<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RestatementAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RestatementAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R112.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308306632064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Employee Benefits - Amounts Recognized in Balance Sheet (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent', window );">Other assets</a></td>
<td class="nump">$ 139<span></span>
</td>
<td class="nump">$ 180<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Retirement liabilities</a></td>
<td class="num">(253)<span></span>
</td>
<td class="num">(231)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">U.S. Plans | Pension Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent', window );">Other assets</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">51<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities', window );">Other current liabilities</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Retirement liabilities</a></td>
<td class="num">(44)<span></span>
</td>
<td class="num">(47)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet', window );">Net amount recognized</a></td>
<td class="num">(19)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Pension Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent', window );">Other assets</a></td>
<td class="nump">109<span></span>
</td>
<td class="nump">129<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities', window );">Other current liabilities</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Retirement liabilities</a></td>
<td class="num">(161)<span></span>
</td>
<td class="num">(138)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet', window );">Net amount recognized</a></td>
<td class="num">$ (56)<span></span>
</td>
<td class="num">$ (10)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset (liability), recognized in statement of financial position, for defined benefit pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(7)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R113.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308296247360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Employee Benefits - Amounts Recognized in Accumulated Other Comprehensive Income (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax', window );">Net actuarial (gain) loss</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax', window );">Prior service cost (credit)</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax', window );">Total AOCI (before tax effects)</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">U.S. Plans | Pension Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax', window );">Net actuarial (gain) loss</a></td>
<td class="nump">155<span></span>
</td>
<td class="nump">129<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax', window );">Prior service cost (credit)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax', window );">Total AOCI (before tax effects)</a></td>
<td class="nump">155<span></span>
</td>
<td class="nump">129<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Pension Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax', window );">Net actuarial (gain) loss</a></td>
<td class="nump">198<span></span>
</td>
<td class="nump">110<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax', window );">Prior service cost (credit)</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax', window );">Total AOCI (before tax effects)</a></td>
<td class="nump">$ 196<span></span>
</td>
<td class="nump">$ 107<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive (income) loss for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R114.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308305680928">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Employee Benefits - Accumulated Benefit Obligation (Detail) - Pension Plan - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">U.S. Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation', window );">Accumulated Benefit Obligation &#8212; end of year</a></td>
<td class="nump">$ 520<span></span>
</td>
<td class="nump">$ 495<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets', window );">Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation', window );">Accumulated benefit obligation</a></td>
<td class="nump">47<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation', window );">Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation</a></td>
<td class="nump">$ 47<span></span>
</td>
<td class="nump">$ 49<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate</a></td>
<td class="nump">4.47%<span></span>
</td>
<td class="nump">5.42%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease', window );">Rate of compensation increase</a></td>
<td class="nump">3.75%<span></span>
</td>
<td class="nump">3.75%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation', window );">Accumulated Benefit Obligation &#8212; end of year</a></td>
<td class="nump">$ 988<span></span>
</td>
<td class="nump">$ 870<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets', window );">Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation', window );">Accumulated benefit obligation</a></td>
<td class="nump">165<span></span>
</td>
<td class="nump">150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation', window );">Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation</a></td>
<td class="nump">$ 185<span></span>
</td>
<td class="nump">$ 169<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate</a></td>
<td class="nump">3.59%<span></span>
</td>
<td class="nump">4.02%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease', window );">Rate of compensation increase</a></td>
<td class="nump">2.83%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of plan asset for defined benefit pension plan with projected benefit obligation in excess of plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of projected benefit obligation for defined benefit pension plan with projected benefit obligation in excess of plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated benefit obligation for defined benefit plan with accumulated benefit obligation in excess of plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of plan asset for defined benefit plan with accumulated benefit obligation in excess of plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R115.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308292418624">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Employee Benefits - Estimated Future Benefit Payments (Detail)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">2024</a></td>
<td class="nump">$ 4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">2025</a></td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">2026</a></td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">2027</a></td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">2028</a></td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">2029 - 2033</a></td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear', window );">Required Company Contributions in the Following Year (2024)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">U.S. Plans | Pension Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">2024</a></td>
<td class="nump">99<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">2025</a></td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">2026</a></td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">2027</a></td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">2028</a></td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">2029 - 2033</a></td>
<td class="nump">166<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear', window );">Required Company Contributions in the Following Year (2024)</a></td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Pension Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">2024</a></td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">2025</a></td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">2026</a></td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">2027</a></td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">2028</a></td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">2029 - 2033</a></td>
<td class="nump">239<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear', window );">Required Company Contributions in the Following Year (2024)</a></td>
<td class="nump">$ 20<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-18<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R116.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308292288960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Employee Benefits - Percentage of Assets Invested (Detail) - Pension Plan<br></strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">U.S. Plans | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Percentage of assets invested</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">U.S. Plans | Equities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Percentage of assets invested</a></td>
<td class="nump">13.00%<span></span>
</td>
<td class="nump">47.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">U.S. Plans | Fixed income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Percentage of assets invested</a></td>
<td class="nump">86.00%<span></span>
</td>
<td class="nump">51.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">U.S. Plans | Property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Percentage of assets invested</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">U.S. Plans | Alternative and other investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Percentage of assets invested</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Percentage of assets invested</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Equities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Percentage of assets invested</a></td>
<td class="nump">16.00%<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Fixed income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Percentage of assets invested</a></td>
<td class="nump">42.00%<span></span>
</td>
<td class="nump">37.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Percentage of assets invested</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Alternative and other investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Percentage of assets invested</a></td>
<td class="nump">31.00%<span></span>
</td>
<td class="nump">33.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of actual investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_RealEstateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_RealEstateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherInvestmentCompaniesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherInvestmentCompaniesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R117.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308285628464">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Employee Benefits - Fair Value Hierarchy of Plan Assets (Detail) - Pension Plan - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">U.S. Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 505<span></span>
</td>
<td class="nump">$ 498<span></span>
</td>
<td class="nump">$ 649<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">U.S. Plans | Fair Value Of Plan Assets Before Receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">504<span></span>
</td>
<td class="nump">497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">U.S. Plans | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">U.S. Plans | Government&#160;&amp; Government Agency Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">U.S. Plans | Corporate Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">82<span></span>
</td>
<td class="nump">73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">U.S. Plans | Municipal Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">U.S. Plans | Pooled Funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">406<span></span>
</td>
<td class="nump">404<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">U.S. Plans | Receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">U.S. Plans | Level 1 | Fair Value Of Plan Assets Before Receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">U.S. Plans | Level 1 | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">U.S. Plans | Level 1 | Government&#160;&amp; Government Agency Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">U.S. Plans | Level 1 | Corporate Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">U.S. Plans | Level 1 | Municipal Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">U.S. Plans | Level 2 | Fair Value Of Plan Assets Before Receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">98<span></span>
</td>
<td class="nump">93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">U.S. Plans | Level 2 | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">U.S. Plans | Level 2 | Government&#160;&amp; Government Agency Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">U.S. Plans | Level 2 | Corporate Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">82<span></span>
</td>
<td class="nump">73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">U.S. Plans | Level 2 | Municipal Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">U.S. Plans | Level&#160;3 | Fair Value Of Plan Assets Before Receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">U.S. Plans | Level&#160;3 | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">U.S. Plans | Level&#160;3 | Government&#160;&amp; Government Agency Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">U.S. Plans | Level&#160;3 | Corporate Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">U.S. Plans | Level&#160;3 | Municipal Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">U.S. Plans | Fair Value Measured at Net Asset Value Per Share | Pooled Funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">65<span></span>
</td>
<td class="nump">234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">U.S. Plans | Fair Value Measured at Net Asset Value Per Share | Fixed Income Funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">341<span></span>
</td>
<td class="nump">170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">920<span></span>
</td>
<td class="nump">$ 1,320<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | U.S. Large Cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">90<span></span>
</td>
<td class="nump">73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | U.S. Mid Cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | U.S. Small Cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Non-U.S. Large Cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Non-U.S. Mid Cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Non-U.S. Small Cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Emerging Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | U.S. Corporate Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Non-U.S. Treasuries/Government Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">194<span></span>
</td>
<td class="nump">144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Non-U.S. Corporate Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">138<span></span>
</td>
<td class="nump">109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Non-U.S. Asset-Backed Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Non-U.S. Other Fixed Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Insurance Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">247<span></span>
</td>
<td class="nump">177<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Derivative Financial Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Absolute Return Funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Private Equity Funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">84<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">475<span></span>
</td>
<td class="nump">407<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level 1 | Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level 1 | U.S. Large Cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">90<span></span>
</td>
<td class="nump">73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level 1 | U.S. Mid Cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level 1 | U.S. Small Cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level 1 | Non-U.S. Large Cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level 1 | Non-U.S. Mid Cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level 1 | Non-U.S. Small Cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level 1 | Emerging Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level 1 | U.S. Corporate Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level 1 | Non-U.S. Treasuries/Government Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">194<span></span>
</td>
<td class="nump">144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level 1 | Non-U.S. Corporate Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level 1 | Non-U.S. Asset-Backed Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level 1 | Non-U.S. Other Fixed Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level 1 | Insurance Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level 1 | Derivative Financial Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level 1 | Absolute Return Funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level 1 | Private Equity Funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level 1 | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level 1 | Property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">448<span></span>
</td>
<td class="nump">429<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level 2 | Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level 2 | U.S. Large Cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level 2 | U.S. Mid Cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level 2 | U.S. Small Cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level 2 | Non-U.S. Large Cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level 2 | Non-U.S. Mid Cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level 2 | Non-U.S. Small Cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level 2 | Emerging Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level 2 | U.S. Corporate Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level 2 | Non-U.S. Treasuries/Government Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level 2 | Non-U.S. Corporate Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">88<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level 2 | Non-U.S. Asset-Backed Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level 2 | Non-U.S. Other Fixed Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level 2 | Insurance Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">247<span></span>
</td>
<td class="nump">177<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level 2 | Derivative Financial Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level 2 | Absolute Return Funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level 2 | Private Equity Funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level 2 | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level 2 | Property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level&#160;3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">77<span></span>
</td>
<td class="nump">84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level&#160;3 | Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level&#160;3 | U.S. Large Cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level&#160;3 | U.S. Mid Cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level&#160;3 | U.S. Small Cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level&#160;3 | Non-U.S. Large Cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level&#160;3 | Non-U.S. Mid Cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level&#160;3 | Non-U.S. Small Cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level&#160;3 | Emerging Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level&#160;3 | U.S. Corporate Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level&#160;3 | Non-U.S. Treasuries/Government Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level&#160;3 | Non-U.S. Corporate Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level&#160;3 | Non-U.S. Asset-Backed Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level&#160;3 | Non-U.S. Other Fixed Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level&#160;3 | Insurance Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level&#160;3 | Derivative Financial Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level&#160;3 | Absolute Return Funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level&#160;3 | Private Equity Funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level&#160;3 | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.&#160;Plans | Level&#160;3 | Property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 77<span></span>
</td>
<td class="nump">$ 81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iff_FairValueOfPlanAssetsBeforeReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iff_FairValueOfPlanAssetsBeforeReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iff_GovernmentAndGovernmentAgencyBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iff_GovernmentAndGovernmentAgencyBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CorporateBondSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CorporateBondSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_MunicipalBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_MunicipalBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iff_PooledFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iff_PooledFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iff_ReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iff_ReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_FixedIncomeFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_FixedIncomeFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CashMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CashMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesUsMidCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesUsMidCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesUsSmallCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesUsSmallCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesLargeCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesLargeCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMidCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMidCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesSmallCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesSmallCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iff_EmergingMarketsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iff_EmergingMarketsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iff_USCorporateBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iff_USCorporateBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iff_NonUSTreasuriesOrGovernmentBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iff_NonUSTreasuriesOrGovernmentBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iff_NonUSCorporateBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iff_NonUSCorporateBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iff_NonUSAssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iff_NonUSAssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iff_NonUSOtherFixedIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iff_NonUSOtherFixedIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iff_InsuranceContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iff_InsuranceContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DerivativeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DerivativeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iff_AbsoluteReturnHedgeFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iff_AbsoluteReturnHedgeFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_PrivateEquityFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_PrivateEquityFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_HedgeFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_HedgeFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_RealEstateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_RealEstateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel12And3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel12And3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R118.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308294446016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits - Reconciliation of Level 3 Non-U.S. Plan Assets Held (Detail) - Pension Plan - Non-U.S.&#160;Plans<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at beginning of year</a></td>
<td class="nump">$ 920<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at end of year</a></td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Property</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at beginning of year</a></td>
<td class="nump">85<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at end of year</a></td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at beginning of year</a></td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at beginning of year</a></td>
<td class="nump">920<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at end of year</a></td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level&#160;3</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at beginning of year</a></td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld', window );">Actual return on plan assets</a></td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements', window );">Purchases, sales and settlements</a></td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at end of year</a></td>
<td class="nump">77<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level&#160;3 | Property</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at beginning of year</a></td>
<td class="nump">81<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld', window );">Actual return on plan assets</a></td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements', window );">Purchases, sales and settlements</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at end of year</a></td>
<td class="nump">77<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level&#160;3 | Other</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at beginning of year</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld', window );">Actual return on plan assets</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements', window );">Purchases, sales and settlements</a></td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at end of year</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, measured using unobservable inputs, of increase (decrease) in plan assets of defined benefit plan from actual return (loss) on assets still held.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)(A)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, measured using unobservable input, of increase (decrease) in plan asset of defined benefit plan from purchase, sale and settlement of trade associated with underlying investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)(B)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_RealEstateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_RealEstateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_HedgeFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_HedgeFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel12And3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel12And3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R119.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308300569648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits - Weighted Average Assumptions Used to Determine Postretirement Benefit Expense and Obligation (Detail)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember', window );">Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate</a></td>
<td class="nump">5.10%<span></span>
</td>
<td class="nump">5.40%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DefinedBenefitPlanCurrentMedicalCareCostTrendRate', window );">Current medical cost trend rate</a></td>
<td class="nump">7.25%<span></span>
</td>
<td class="nump">6.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1', window );">Ultimate medical cost trend rate</a></td>
<td class="nump">4.75%<span></span>
</td>
<td class="nump">4.75%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=iff_ExpenseMember', window );">Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate</a></td>
<td class="nump">5.40%<span></span>
</td>
<td class="nump">2.90%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DefinedBenefitPlanCurrentMedicalCareCostTrendRate', window );">Current medical cost trend rate</a></td>
<td class="nump">6.50%<span></span>
</td>
<td class="nump">6.75%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1', window );">Ultimate medical cost trend rate</a></td>
<td class="nump">4.75%<span></span>
</td>
<td class="nump">4.75%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DefinedBenefitPlanCurrentMedicalCareCostTrendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current medical cost trend rate utilized to determine postretirement benefit expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DefinedBenefitPlanCurrentMedicalCareCostTrendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ultimate trend rate for health care cost for defined benefit postretirement plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=iff_ExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=iff_ExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>R120.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308294352912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments - Carrying Amount and Estimated Fair Value of Financial Instruments (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration', window );">Derivative Asset, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Prepaid expenses and other current assets<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration', window );">Derivative Liability, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Other current liabilities<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommercialPaper', window );">Commercial paper</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 187<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Carrying Amount [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">703<span></span>
</td>
<td class="nump">483<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansPayableFairValueDisclosure', window );">Credit facilities and bank overdrafts</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">106<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets(3)</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities(3)</a></td>
<td class="nump">165<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommercialPaper', window );">Commercial paper</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">187<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Fair Value [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">703<span></span>
</td>
<td class="nump">483<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansPayableFairValueDisclosure', window );">Credit facilities and bank overdrafts</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">106<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets(3)</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities(3)</a></td>
<td class="nump">165<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommercialPaper', window );">Commercial paper</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">187<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=iff_SeniorNotesDueTwoThousandTwentyThreeMember', window );">Senior Notes - 2023 | Carrying Amount [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotesCurrent', window );">Senior notes, current</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=iff_SeniorNotesDueTwoThousandTwentyThreeMember', window );">Senior Notes - 2023 | Fair Value [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotesCurrent', window );">Senior notes, current</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">298<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember', window );">Senior Notes, Euro Notes, 2024 | Carrying Amount [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">532<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotesCurrent', window );">Senior notes, current</a></td>
<td class="nump">552<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember', window );">Senior Notes, Euro Notes, 2024 | Fair Value [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">519<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotesCurrent', window );">Senior notes, current</a></td>
<td class="nump">549<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember', window );">Senior Notes, Euro Notes, 2026 | Carrying Amount [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="nump">879<span></span>
</td>
<td class="nump">845<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember', window );">Senior Notes, Euro Notes, 2026 | Fair Value [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="nump">835<span></span>
</td>
<td class="nump">774<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=iff_SeniorNotesDueTwoThousandTwentyEightMember', window );">Senior Notes - 2028 | Carrying Amount [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="nump">398<span></span>
</td>
<td class="nump">398<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=iff_SeniorNotesDueTwoThousandTwentyEightMember', window );">Senior Notes - 2028 | Fair Value [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="nump">389<span></span>
</td>
<td class="nump">380<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=iff_SeniorNotesDueTwoThousandFortySevenMember', window );">Senior notes - 2047 | Carrying Amount [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="nump">495<span></span>
</td>
<td class="nump">495<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=iff_SeniorNotesDueTwoThousandFortySevenMember', window );">Senior notes - 2047 | Fair Value [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="nump">382<span></span>
</td>
<td class="nump">390<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=iff_SeniorNotesDueTwoThousandFortyEightMember', window );">Senior Notes - 2048 | Carrying Amount [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="nump">787<span></span>
</td>
<td class="nump">787<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=iff_SeniorNotesDueTwoThousandFortyEightMember', window );">Senior Notes - 2048 | Fair Value [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="nump">678<span></span>
</td>
<td class="nump">685<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=iff_SeniorNotesDueTwoThousandTwentyFiveMember', window );">Senior Notes, Due Two Thousand Twenty Five | Carrying Amount [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=iff_SeniorNotesDueTwoThousandTwentyFiveMember', window );">Senior Notes, Due Two Thousand Twenty Five | Fair Value [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="nump">924<span></span>
</td>
<td class="nump">884<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=iff_SeniorNotesDueTwoThousandTwentySevenMember', window );">Senior Notes, Due Two Thousand Twenty Seven | Carrying Amount [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="nump">1,212<span></span>
</td>
<td class="nump">1,215<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=iff_SeniorNotesDueTwoThousandTwentySevenMember', window );">Senior Notes, Due Two Thousand Twenty Seven | Fair Value [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="nump">1,049<span></span>
</td>
<td class="nump">1,006<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=iff_SeniorNotesDueTwoThousandThirtyMember', window );">Senior Notes, Due Two Thousand Thirty | Carrying Amount [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="nump">1,508<span></span>
</td>
<td class="nump">1,510<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=iff_SeniorNotesDueTwoThousandThirtyMember', window );">Senior Notes, Due Two Thousand Thirty | Fair Value [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="nump">1,240<span></span>
</td>
<td class="nump">1,188<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=iff_SeniorNotesDueTwoThousandFortyMember', window );">Senior Notes, Due Two Thousand Forty | Carrying Amount [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="nump">773<span></span>
</td>
<td class="nump">774<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=iff_SeniorNotesDueTwoThousandFortyMember', window );">Senior Notes, Due Two Thousand Forty | Fair Value [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="nump">536<span></span>
</td>
<td class="nump">535<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=iff_SeniorNotesDueTwoThousandFiftyMember', window );">Senior Notes, Due Two Thousand Fifty | Carrying Amount [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="nump">1,569<span></span>
</td>
<td class="nump">1,571<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=iff_SeniorNotesDueTwoThousandFiftyMember', window );">Senior Notes, Due Two Thousand Fifty | Fair Value [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="nump">1,029<span></span>
</td>
<td class="nump">1,021<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=iff_A2024TermLoanMember', window );">2024 Term Loan | Carrying Amount [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">625<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotesCurrent', window );">Senior notes, current</a></td>
<td class="nump">270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=iff_A2024TermLoanMember', window );">2024 Term Loan | Fair Value [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">625<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotesCurrent', window );">Senior notes, current</a></td>
<td class="nump">270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=iff_A2026TermLoanMember', window );">2026 Term Loan | Carrying Amount [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="nump">625<span></span>
</td>
<td class="nump">625<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=iff_A2026TermLoanMember', window );">2026 Term Loan | Fair Value [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior notes</a></td>
<td class="nump">$ 625<span></span>
</td>
<td class="nump">$ 625<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of short-term borrowings using unsecured obligations issued by banks, corporations and other borrowers to investors. The maturities of these money market securities generally do not exceed 270 days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes derivative asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(3)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(3)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-10<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G)(Footnote 8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-10<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes derivative liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansPayableFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of contractual obligation to pay money on demand or on fixed or determinable dates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansPayableFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeniorLongTermNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion. Senior note holders are paid off in full before any payments are made to junior note holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeniorLongTermNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeniorNotesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term notes having the highest claim on the assets of the issuer in case of bankruptcy or liquidation, due within one year or the normal operating cycle, if longer. Senior note holders are paid off in full before any payments are made to debt holders having a lesser priority of repayment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeniorNotesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=iff_SeniorNotesDueTwoThousandTwentyThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=iff_SeniorNotesDueTwoThousandTwentyThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=iff_SeniorNotesDueTwoThousandTwentyEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=iff_SeniorNotesDueTwoThousandTwentyEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=iff_SeniorNotesDueTwoThousandFortySevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=iff_SeniorNotesDueTwoThousandFortySevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=iff_SeniorNotesDueTwoThousandFortyEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=iff_SeniorNotesDueTwoThousandFortyEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=iff_SeniorNotesDueTwoThousandTwentyFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=iff_SeniorNotesDueTwoThousandTwentyFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=iff_SeniorNotesDueTwoThousandTwentySevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=iff_SeniorNotesDueTwoThousandTwentySevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=iff_SeniorNotesDueTwoThousandThirtyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=iff_SeniorNotesDueTwoThousandThirtyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=iff_SeniorNotesDueTwoThousandFortyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=iff_SeniorNotesDueTwoThousandFortyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=iff_SeniorNotesDueTwoThousandFiftyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=iff_SeniorNotesDueTwoThousandFiftyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=iff_A2024TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=iff_A2024TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=iff_A2026TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=iff_A2026TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>R121.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308294887104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments - Derivative Instruments Notional Amount Outstanding (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember', window );">Forward Currency Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsLineItems', window );"><strong>Schedule Of Information By Major Category Of Credit Derivatives Contracts [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DerivativeNotionalAmountNet', window );">Derivative instruments outstanding, net</a></td>
<td class="num">$ (1,400)<span></span>
</td>
<td class="nump">$ 92<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember', window );">Currency Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsLineItems', window );"><strong>Schedule Of Information By Major Category Of Credit Derivatives Contracts [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative instruments outstanding</a></td>
<td class="nump">1,400<span></span>
</td>
<td class="nump">1,400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember', window );">Commodity Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsLineItems', window );"><strong>Schedule Of Information By Major Category Of Credit Derivatives Contracts [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DerivativeNotionalAmountNet', window );">Derivative instruments outstanding, net</a></td>
<td class="nump">$ 7<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DerivativeNotionalAmountNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative, Notional Amount, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DerivativeNotionalAmountNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Information By Major Category Of Credit Derivatives Contracts [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1B<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>R122.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308313659088">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments - Derivative Instruments Measured at Fair Value (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total Fair Value, Derivative Assets</a></td>
<td class="nump">$ 41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total Fair Value, Derivative Liabilities</a></td>
<td class="nump">$ 165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration', window );">Derivative Liability, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Other current liabilities<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Currency Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total Fair Value, Derivative Assets</a></td>
<td class="nump">$ 41<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total Fair Value, Derivative Liabilities</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember', window );">Currency Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total Fair Value, Derivative Liabilities</a></td>
<td class="nump">161<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Fair Value of Derivatives Designated as Hedging Instrument [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total Fair Value, Derivative Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total Fair Value, Derivative Liabilities</a></td>
<td class="nump">161<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Fair Value of Derivatives Designated as Hedging Instrument [Member] | Foreign Currency Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total Fair Value, Derivative Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total Fair Value, Derivative Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Fair Value of Derivatives Designated as Hedging Instrument [Member] | Currency Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total Fair Value, Derivative Liabilities</a></td>
<td class="nump">161<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Fair Value of Derivatives Not Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total Fair Value, Derivative Assets</a></td>
<td class="nump">41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total Fair Value, Derivative Liabilities</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Fair Value of Derivatives Not Designated as Hedging Instrument | Foreign Currency Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total Fair Value, Derivative Assets</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total Fair Value, Derivative Liabilities</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Fair Value of Derivatives Not Designated as Hedging Instrument | Currency Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total Fair Value, Derivative Liabilities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-7<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4B<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -SubTopic 20<br> -Topic 860<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481326/860-20-50-4D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-7<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4B<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -SubTopic 20<br> -Topic 860<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481326/860-20-50-4D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes derivative liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>R123.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308293985088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments - Derivative Instruments Which Were Not Designated as Hedging Instruments (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Currency Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration', window );">Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Other (expense) income, net<span></span>
</td>
<td class="text">Other (expense) income, net<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember', window );">Commodity Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration', window );">Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Cost of goods sold<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Fair Value of Derivatives Not Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Amount of gain or (loss) on derivative</a></td>
<td class="num">$ (9)<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Fair Value of Derivatives Not Designated as Hedging Instrument | Foreign Currency Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Amount of gain or (loss) on derivative</a></td>
<td class="num">(11)<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Fair Value of Derivatives Not Designated as Hedging Instrument | Commodity Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Amount of gain or (loss) on derivative</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of income or comprehensive income that includes gain (loss) from derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4E<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>139
<FILENAME>R124.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308313696160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments - Derivative Instruments Designated as Cash Flow and Net Investment Hedging Instruments (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax</a></td>
<td class="num">(109)<span></span>
</td>
<td class="nump">54<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total Fair Value, Derivative Assets</a></td>
<td class="nump">41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total Fair Value, Derivative Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Fair Value of Derivatives Not Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total Fair Value, Derivative Assets</a></td>
<td class="nump">41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=iff_SeniorNotesEuroNotesMaturing2021And2026Member', window );">Senior Notes Maturing 2021 through 2026 [Member] | Net Investment Hedging [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax</a></td>
<td class="num">(26)<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember', window );">Senior Notes, Euro Notes, 2024 | Net Investment Hedging [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax</a></td>
<td class="num">(16)<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=iff_CrossCurrencySwapsMember', window );">Cross Currency Swaps [Member] | Net Investment Hedging [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax</a></td>
<td class="num">(67)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Currency Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total Fair Value, Derivative Assets</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Currency Contracts | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total Fair Value, Derivative Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Currency Contracts | Fair Value of Derivatives Not Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total Fair Value, Derivative Assets</a></td>
<td class="nump">$ 41<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-7<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4B<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -SubTopic 20<br> -Topic 860<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481326/860-20-50-4D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4E<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 815<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4D<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and after reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iff_SeniorNotesEuroNotesMaturing2021And2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iff_SeniorNotesEuroNotesMaturing2021And2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iff_CrossCurrencySwapsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iff_CrossCurrencySwapsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>140
<FILENAME>R125.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308294458864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments - Additional Information (Detail)<br> &#8364; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>May 18, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>swap</div>
</th>
<th class="th">
<div>Mar. 31, 2016 </div>
<div>USD ($) </div>
<div>Agreement</div>
</th>
<th class="th">
<div>Mar. 31, 2016 </div>
<div>EUR (&#8364;) </div>
<div>Agreement</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>swap</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total fair value, derivative assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities', window );">Proceeds from unwinding of derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 173<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability, fair value, gross liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNetHedgeIneffectivenessGainLoss', window );">Derivative, net hedge ineffectiveness gain (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember', window );">Currency Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative instruments outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400<span></span>
</td>
<td class="nump">1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability, fair value, gross liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">161<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DeferredGainLossOnTerminatedInterestRateContracts', window );">Loss incurred on termination of interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">&#8364; 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfDerivatives', window );">Gain on deal contingent derivatives</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfInterestRateDerivativesHeld', window );">Number of interest rate derivatives held | Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=iff_A2022CrossCurrencySwapsMember', window );">2022 Cross Currency Swaps | Net Investment Hedging [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative instruments outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Fair Value of Derivatives Not Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Amount of gain or (loss) on derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total fair value, derivative assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability, fair value, gross liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Fair Value of Derivatives Not Designated as Hedging Instrument | Currency Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability, fair value, gross liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total fair value, derivative assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability, fair value, gross liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">161<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Currency Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability, fair value, gross liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 161<span></span>
</td>
<td class="nump">$ 75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | 2019 Cross Currency Swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest Income (Expense), Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfForeignCurrencyDerivativesHeld', window );">Number of Foreign Currency Derivatives Held | swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities', window );">Proceeds from unwinding of derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | 2022 Cross Currency Swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfForeignCurrencyDerivativesHeld', window );">Number of Foreign Currency Derivatives Held | swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Derivative assets (liabilities), at fair value, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 161<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DeferredGainLossOnTerminatedInterestRateContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Gain Loss On Terminated Interest Rate Contracts</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DeferredGainLossOnTerminatedInterestRateContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair values as of the balance sheet date of the net amount of all assets and liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -SubTopic 10<br> -Topic 815<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480463/815-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-7<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4B<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -SubTopic 20<br> -Topic 860<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481326/860-20-50-4D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-7<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4B<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -SubTopic 20<br> -Topic 860<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481326/860-20-50-4D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNetHedgeIneffectivenessGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from the ineffectiveness of the hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4C<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 815<br> -SubTopic 25<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480238/815-25-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNetHedgeIneffectivenessGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1B<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the book value and the sale price of options, swaps, futures, forward contracts, and other derivative instruments. This element refers to the gain (loss) included in earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(a)(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(a)(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.13(h))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfForeignCurrencyDerivativesHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of foreign currency exchange rate derivatives held by the entity at the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfForeignCurrencyDerivativesHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfInterestRateDerivativesHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of interest rate derivative instruments held by the entity at the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfInterestRateDerivativesHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow provided by derivative instruments during the period, which are classified as investing activities, excluding those designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iff_A2022CrossCurrencySwapsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iff_A2022CrossCurrencySwapsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iff_A2019And2022CrossCurrencySwapsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iff_A2019And2022CrossCurrencySwapsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>141
<FILENAME>R126.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308300675280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Loss) - Schedule of Changes in Accumulated Other Comprehensive Income (Loss) (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Accumulated other comprehensive loss, net of tax</a></td>
<td class="nump">$ 17,655<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Accumulated other comprehensive loss, net of tax</a></td>
<td class="nump">14,611<span></span>
</td>
<td class="nump">$ 17,655<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign Currency Translation Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Accumulated other comprehensive loss, net of tax</a></td>
<td class="num">(2,066)<span></span>
</td>
<td class="num">(1,133)<span></span>
</td>
<td class="num">$ (285)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">OCI before reclassifications</a></td>
<td class="nump">367<span></span>
</td>
<td class="num">(933)<span></span>
</td>
<td class="num">(848)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Amounts reclassified from AOCI</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Net current period other comprehensive income (loss)</a></td>
<td class="nump">414<span></span>
</td>
<td class="num">(933)<span></span>
</td>
<td class="num">(848)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Accumulated other comprehensive loss, net of tax</a></td>
<td class="num">(1,652)<span></span>
</td>
<td class="num">(2,066)<span></span>
</td>
<td class="num">(1,133)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIDueToBusinessDivestitures', window );">Other Comprehensive Income (Loss), Reclassification Adjustment From AOCI Due To Business Divestitures</a></td>
<td class="nump">47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember', window );">Gains&#160;(Losses)&#160;on Derivatives Qualifying as Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Accumulated other comprehensive loss, net of tax</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">OCI before reclassifications</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Amounts reclassified from AOCI</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Net current period other comprehensive income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Accumulated other comprehensive loss, net of tax</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIDueToBusinessDivestitures', window );">Other Comprehensive Income (Loss), Reclassification Adjustment From AOCI Due To Business Divestitures</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Pension and Postretirement Liability Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Accumulated other comprehensive loss, net of tax</a></td>
<td class="num">(133)<span></span>
</td>
<td class="num">(291)<span></span>
</td>
<td class="num">(406)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">OCI before reclassifications</a></td>
<td class="num">(100)<span></span>
</td>
<td class="nump">148<span></span>
</td>
<td class="nump">97<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Amounts reclassified from AOCI</a></td>
<td class="num">(11)<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Net current period other comprehensive income (loss)</a></td>
<td class="num">(112)<span></span>
</td>
<td class="nump">158<span></span>
</td>
<td class="nump">115<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Accumulated other comprehensive loss, net of tax</a></td>
<td class="num">(245)<span></span>
</td>
<td class="num">(133)<span></span>
</td>
<td class="num">(291)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIDueToBusinessDivestitures', window );">Other Comprehensive Income (Loss), Reclassification Adjustment From AOCI Due To Business Divestitures</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Accumulated other comprehensive loss, net of tax</a></td>
<td class="num">(2,198)<span></span>
</td>
<td class="num">(1,423)<span></span>
</td>
<td class="num">(698)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">OCI before reclassifications</a></td>
<td class="nump">267<span></span>
</td>
<td class="num">(785)<span></span>
</td>
<td class="num">(750)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Amounts reclassified from AOCI</a></td>
<td class="num">(11)<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Net current period other comprehensive income (loss)</a></td>
<td class="nump">302<span></span>
</td>
<td class="num">(775)<span></span>
</td>
<td class="num">(725)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Accumulated other comprehensive loss, net of tax</a></td>
<td class="num">(1,896)<span></span>
</td>
<td class="num">$ (2,198)<span></span>
</td>
<td class="num">$ (1,423)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIDueToBusinessDivestitures', window );">Other Comprehensive Income (Loss), Reclassification Adjustment From AOCI Due To Business Divestitures</a></td>
<td class="nump">$ 46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIDueToBusinessDivestitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss), Reclassification Adjustment From AOCI Due To Business Divestitures</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIDueToBusinessDivestitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments, of other comprehensive income (loss), attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482739/220-10-55-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482739/220-10-55-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>142
<FILENAME>R127.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308313582128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Loss) - Reclassifications of Accumulated Other Comprehensive Income to Consolidated Statement of Comprehensive Income (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of goods sold</a></td>
<td class="nump">$ 7,798<span></span>
</td>
<td class="nump">$ 8,289<span></span>
</td>
<td class="nump">$ 7,921<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(380)<span></span>
</td>
<td class="num">(336)<span></span>
</td>
<td class="num">(289)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Tax</a></td>
<td class="num">(45)<span></span>
</td>
<td class="num">(239)<span></span>
</td>
<td class="num">(75)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember', window );">Gains&#160;(Losses)&#160;on Derivatives Qualifying as Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember', window );">Gains&#160;(Losses)&#160;on Derivatives Qualifying as Hedges | Foreign Currency Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of goods sold</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember', window );">Gains&#160;(Losses)&#160;on Derivatives Qualifying as Hedges | Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember', window );">Gains&#160;(Losses)&#160;on Derivatives Qualifying as Hedges | Reclassification out of Accumulated Other Comprehensive Income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Total</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">(Losses) gains on pension and postretirement liability adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Tax</a></td>
<td class="nump">3<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">(Losses) gains on pension and postretirement liability adjustments | Reclassification out of Accumulated Other Comprehensive Income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Total</a></td>
<td class="nump">11<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember', window );">Prior service cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">(Losses) gains on pension and postretirement liability adjustments</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember', window );">Actuarial losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">(Losses) gains on pension and postretirement liability adjustments</a></td>
<td class="nump">8<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=iff_AccumulatedDefinedBenefitPlansAdjustmentOtherItemsAttributableToParentMember', window );">Other items</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">(Losses) gains on pension and postretirement liability adjustments</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-4<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482739/220-10-55-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=iff_AccumulatedDefinedBenefitPlansAdjustmentOtherItemsAttributableToParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=iff_AccumulatedDefinedBenefitPlansAdjustmentOtherItemsAttributableToParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>143
<FILENAME>R128.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308299590720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Concentrations Of Credit Risk - Additional Information (Detail) - Customer Concentration Risk [Member] - customer<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_EntityWideRevenueMajorCustomerNumberOfCustomers', window );">Number of customers that accounted for more than 10% of consolidated net sales</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=iff_AllForeignCountriesMember', window );">All Foreign Countries [Member] | Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk threshold</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_EntityWideRevenueMajorCustomerNumberOfCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of customers whose net sales accounted for more than 10% of consolidated net sales.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_EntityWideRevenueMajorCustomerNumberOfCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481027/954-310-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=iff_AllForeignCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=iff_AllForeignCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>144
<FILENAME>R129.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308295379104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 05, 2023</div></th>
<th class="th"><div>Mar. 11, 2020</div></th>
<th class="th"><div>Oct. 29, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jul. 28, 2021</div></th>
<th class="th"><div>Aug. 25, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_BankGuaranteesRelatedToAppealsOnIncomeTaxAndIndirectTaxCases', window );">Bank guarantees related to appeals on income tax and indirect tax cases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_AmountOfAvailableLinesOfCredit', window );">Available lines of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,848,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_BankGuaranteesAndPledgedAssetsToPursueDefensesRelatedToOtherContingencies', window );">Bank guarantees and pledged assets to pursue defenses related to other contingencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,240,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,203,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_BankGuaranteesStandbyLettersOfCreditAndCommercialGuaranteesAmountOutstanding', window );">Bank Guarantees and Standby Letters of Credit, Amount Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_BankGuaranteesCommercialGuaranteesStandbyLettersOfCreditAndSuretyBondsFacilityAmounts', window );">Bank Guarantees, Commercial Guarantees, Letters Of Credit and Surety Bonds, Facility Amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">229,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommercialPaper', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">187,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Loan Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Revolving credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Loan Facility | Citibank, N.A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Revolving credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity', window );">Line of Credit Facility, Current Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,548,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember', window );">Chief Executive Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense', window );">Deferred Compensation Arrangement with Individual, Compensation Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Estimated maximum future costs of environmental liabilities for identified sites (less than $5 million)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Estimated maximum future costs of environmental liabilities for identified sites (less than $5 million)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CN', window );">CHINA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">228,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 258,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ManufacturingFacilityMember', window );">Manufacturing Facility [Member] | CHINA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">215,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=iff_PledgedAssetsMember', window );">Pledged assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_AmountOfPledgedAssetsPrincipallyPropertyPlantAndEquipmentToCoverIncomeTaxAndIndirectTaxAssessments', window );">The amount of pledged assets, principally PP&amp;E to cover income tax and indirect tax assessments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=iff_BrazilTaxCreditsMember', window );">Brazil Tax Credits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_LossContingencyReceivableWrittenOff', window );">Loss Contingency, Receivable Written Off</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iff_PharmaSolutionsMember', window );">Pharma Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_MalpracticeLossContingencyPaymentsInceptionToDate', window );">Malpractice Loss Contingency, Payments, Inception-to-date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=country_BR', window );">BRAZIL | Foreign Tax Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIncomeTaxRefunds', window );">Proceeds from Income Tax Refunds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000,000<span></span>
</td>
<td class="nump">$ 8,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=country_BR', window );">BRAZIL | Foreign Tax Authority [Member] | BRAZIL</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIncomeTaxRefunds', window );">Proceeds from Income Tax Refunds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=iff_ZhejiangIngredientsPlantMember', window );">Zhejiang Ingredients Plant [Member] | Zhejiang, China [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_GainContingencyRelocationPaymentsReceived', window );">Gain Contingency, Relocation Payments Received</a></td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_GainContingencyExpectedRelocationPayments', window );">Gain Contingency, Expected Relocation Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_GainLossOnPlantRelocation', window );">Gain (Loss) On Plant Relocation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_EstimatedIncomeTaxExpenseBenefit', window );">Estimated Income Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_AmountOfAvailableLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount Of Available Lines Of Credit</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_AmountOfAvailableLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_AmountOfPledgedAssetsPrincipallyPropertyPlantAndEquipmentToCoverIncomeTaxAndIndirectTaxAssessments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of pledged assets, principally PP&amp;E to cover income tax and indirect tax assessments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_AmountOfPledgedAssetsPrincipallyPropertyPlantAndEquipmentToCoverIncomeTaxAndIndirectTaxAssessments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_BankGuaranteesAndPledgedAssetsToPursueDefensesRelatedToOtherContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Bank guarantees and pledged assets to pursue defenses related to other contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_BankGuaranteesAndPledgedAssetsToPursueDefensesRelatedToOtherContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_BankGuaranteesCommercialGuaranteesStandbyLettersOfCreditAndSuretyBondsFacilityAmounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Bank Guarantees, Commercial Guarantees, Standby Letters Of Credit and Surety Bonds, Facility Amounts</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_BankGuaranteesCommercialGuaranteesStandbyLettersOfCreditAndSuretyBondsFacilityAmounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_BankGuaranteesRelatedToAppealsOnIncomeTaxAndIndirectTaxCases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of bank guarantees related to appeals on income tax and indirect tax cases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_BankGuaranteesRelatedToAppealsOnIncomeTaxAndIndirectTaxCases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_BankGuaranteesStandbyLettersOfCreditAndCommercialGuaranteesAmountOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Bank Guarantees, Standby Letters Of Credit And Commercial Guarantees, Amount Outstanding</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_BankGuaranteesStandbyLettersOfCreditAndCommercialGuaranteesAmountOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_CommitmentsAndContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commitments And Contingencies [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_CommitmentsAndContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_EstimatedIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Estimated Income Tax Expense (Benefit)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_EstimatedIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_GainContingencyExpectedRelocationPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain Contingency, Expected Relocation Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_GainContingencyExpectedRelocationPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_GainContingencyRelocationPaymentsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain Contingency, Relocation Payments Received</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_GainContingencyRelocationPaymentsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_GainLossOnPlantRelocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) On Plant Relocation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_GainLossOnPlantRelocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_LossContingencyReceivableWrittenOff">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Receivable Written Off</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_LossContingencyReceivableWrittenOff</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_MalpracticeLossContingencyPaymentsInceptionToDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Malpractice Loss Contingency, Payments, Inception-to-date</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_MalpracticeLossContingencyPaymentsInceptionToDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of short-term borrowings using unsecured obligations issued by banks, corporations and other borrowers to investors. The maturities of these money market securities generally do not exceed 270 days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The compensation expense recognized during the period pertaining to the deferred compensation arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 710<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483043/710-10-30-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyEstimateOfPossibleLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyEstimateOfPossibleLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIncomeTaxRefunds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash received during the period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIncomeTaxRefunds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=iff_CitibankN.AMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=iff_CitibankN.AMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ManufacturingFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ManufacturingFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=iff_PledgedAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=iff_PledgedAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=iff_BrazilTaxCreditsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=iff_BrazilTaxCreditsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iff_PharmaSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iff_PharmaSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=country_BR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=country_BR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_BR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_BR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=iff_ZhejiangIngredientsPlantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=iff_ZhejiangIngredientsPlantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=iff_ZhejiangChinaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=iff_ZhejiangChinaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>145
<FILENAME>R130.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308293161072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Noncontrolling Interests (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInMinorityInterestRollForward', window );"><strong>Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Beginning balance</a></td>
<td class="nump">$ 30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Sale of a subsidiary with redeemable non-controlling interests</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Exercises of redeemable non-controlling interests</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Exercises of redeemable non-controlling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Ending balance</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=iff_RedeemableNoncontrollingInterestMember', window );">Redeemable Noncontrolling Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInMinorityInterestRollForward', window );"><strong>Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Beginning balance</a></td>
<td class="nump">59<span></span>
</td>
<td class="nump">105<span></span>
</td>
<td class="nump">98<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_NoncontrollingInterestImpactOfForeignExchangeTranslation', window );">Impact of foreign exchange translation</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Sale of a subsidiary with redeemable non-controlling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestChangeInRedemptionValue', window );">Redemption value adjustment for the current period</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Exercises of redeemable non-controlling interests</a></td>
<td class="num">(13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Exercises of redeemable non-controlling interests</a></td>
<td class="num">(25)<span></span>
</td>
<td class="num">(49)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_NoncontrollingInterestDecreaseFromDisposal', window );">Disposal of redeemable non-controlling interests</a></td>
<td class="num">(11)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Ending balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 59<span></span>
</td>
<td class="nump">$ 105<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=iff_RedeemableNoncontrollingInterestMember', window );">Redeemable Noncontrolling Interest | Sonarome</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInMinorityInterestRollForward', window );"><strong>Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfLongtermInvestments', window );">Proceeds from sale of long-term investments</a></td>
<td class="nump">$ 29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_NoncontrollingInterestDecreaseFromDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Decrease From Disposal</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_NoncontrollingInterestDecreaseFromDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_NoncontrollingInterestImpactOfForeignExchangeTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Impact Of Foreign Exchange Translation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_NoncontrollingInterestImpactOfForeignExchangeTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestChangeInRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in noncontrolling interest during the period as a result of a change in the redemption value of redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Subparagraph 14<br> -Paragraph 3A<br> -Section S99<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480244/480-10-S99-3A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Subparagraph 15<br> -Paragraph 3A<br> -Section S99<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480244/480-10-S99-3A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 16(c)<br> -SubTopic 10<br> -Topic 480<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480244/480-10-S99-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestChangeInRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromRedemptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-23<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromRedemptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInMinorityInterestRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInMinorityInterestRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfLongtermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, beyond the current operating cycle.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfLongtermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=iff_RedeemableNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=iff_RedeemableNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=iff_SonaromeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=iff_SonaromeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>146
<FILENAME>R131.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308313788352">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Assets and Liabilities Held For Sale (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 26<span></span>
</td>
<td class="nump">$ 52<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">689<span></span>
</td>
<td class="nump">743<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Disposal Group, Held-for-sale, Not Discontinued Operations | Savory Solutions and Fine and Specialty Ingredients</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DisposalGroupIncludingDiscontinuedOperationTradeReceivablesNet', window );">Trade receivables, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1', window );">Inventories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment', window );">Property, plant and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">348<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets', window );">Other intangible assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">428<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Total assets held-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities', window );">Deferred tax liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities', window );">Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Total liabilities held-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Disposal Group, Held-for-sale, Not Discontinued Operations | Cosmetic Ingredients</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_DisposalGroupIncludingDiscontinuedOperationTradeReceivablesNet', window );">Trade receivables, net</a></td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1', window );">Inventories</a></td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment', window );">Property, plant and equipment, net</a></td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1', window );">Goodwill</a></td>
<td class="nump">276<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets', window );">Other intangible assets, net</a></td>
<td class="nump">146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets', window );">Other assets</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Total assets held-for-sale</a></td>
<td class="nump">506<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities', window );">Deferred tax liability</a></td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities', window );">Other liabilities</a></td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Total liabilities held-for-sale</a></td>
<td class="nump">$ 46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_DisposalGroupIncludingDiscontinuedOperationTradeReceivablesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Trade Receivables, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_DisposalGroupIncludingDiscontinuedOperationTradeReceivablesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5C<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts payable attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as deferred tax liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as goodwill attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as inventory attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5C<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=iff_SavorySolutionsAndFlavorSpecialtyIngredientsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=iff_SavorySolutionsAndFlavorSpecialtyIngredientsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=iff_CosmeticIngredientsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=iff_CosmeticIngredientsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>147
<FILENAME>R132.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308305721856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other (Expense) Income, Net (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign exchange (losses) gains</a></td>
<td class="num">$ (77)<span></span>
</td>
<td class="num">$ (12)<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">(Losses) gains on business divestitures</a></td>
<td class="num">(23)<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_GainLossOnChinaFacilityRelocation', window );">Gain on China facility relocation</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Pension-related benefit</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_OtherComponentsOfOtherNonoperatingIncomeExpense', window );">Other</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (expense) income, net</a></td>
<td class="num">$ (28)<span></span>
</td>
<td class="nump">$ 37<span></span>
</td>
<td class="nump">$ 58<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_GainLossOnChinaFacilityRelocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) On China Facility Relocation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_GainLossOnChinaFacilityRelocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_OtherComponentsOfOtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Components Of Other Nonoperating Income (Expense)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_OtherComponentsOfOtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-18<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482014/830-20-35-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481956/830-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481926/830-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481839/830-10-45-17<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>148
<FILENAME>R133.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308307204768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Tangible Equity Units (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 17, 2018</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_TangibleEquityUnitsIssued', window );">Tangible equity units issued</a></td>
<td class="nump">16,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_TangibleEquityUnitsProceeds', window );">Tangible equity units proceeds</a></td>
<td class="nump">$ 800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_TangibleEquityUnitsPriceforSharesBasic', window );">Price for basic share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.330911<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_TangibleEquityUnitsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tangible Equity Units Issued</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_TangibleEquityUnitsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_TangibleEquityUnitsPriceforSharesBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tangible Equity Units, Price for Shares Basic</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_TangibleEquityUnitsPriceforSharesBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_TangibleEquityUnitsProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tangible Equity Units Proceeds</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_TangibleEquityUnitsProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>149
<FILENAME>R134.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308313316848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Tangible Equity Units (Allocation of TEU) (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Sep. 17, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_TangibleEquityUnitsLineItems', window );"><strong>Tangible Equity Units [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_TangibleEquityUnitsProceeds', window );">Tangible equity units proceeds</a></td>
<td class="nump">$ 800<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_TangibleEquityUnitsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Tangible Equity Units [Table]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_TangibleEquityUnitsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_TangibleEquityUnitsProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tangible Equity Units Proceeds</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_TangibleEquityUnitsProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>150
<FILENAME>R135.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308309860432">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Tangible Equity Units Tangible Equity - Settlement of Shares (Details) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 15, 2021</div></th>
<th class="th"><div>Sep. 14, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock Issued During Period, Shares, Issued for Services</a></td>
<td class="nump">5,460,031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iff_TangibleEquityUnitsFinalSettlementRate', window );">Tangible Equity Units Final Settlement Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.330911<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iff_TangibleEquityUnitsFinalSettlementRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tangible Equity Units Final Settlement Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iff_TangibleEquityUnitsFinalSettlementRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iff_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483014/272-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482987/272-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>151
<FILENAME>R136.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140308313881456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule II - Valuation and Qualifying Accounts and Reserves (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember', window );">Allowance for doubtful accounts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at beginning of period</a></td>
<td class="nump">$ 53<span></span>
</td>
<td class="nump">$ 46<span></span>
</td>
<td class="nump">$ 21<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Additions (deductions) charged to costs and expenses</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired', window );">Acquisitions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Accounts written off</a></td>
<td class="num">(11)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesAdjustments', window );">Translation adjustments</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at end of period</a></td>
<td class="nump">52<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember', window );">SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at beginning of period</a></td>
<td class="nump">262<span></span>
</td>
<td class="nump">232<span></span>
</td>
<td class="nump">257<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Additions (deductions) charged to costs and expenses</a></td>
<td class="nump">76<span></span>
</td>
<td class="nump">51<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired', window );">Acquisitions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Accounts written off</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesAdjustments', window );">Translation adjustments</a></td>
<td class="num">(23)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts', window );">Other</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at end of period</a></td>
<td class="nump">$ 324<span></span>
</td>
<td class="nump">$ 262<span></span>
</td>
<td class="nump">$ 232<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInValuationAllowancesAndReservesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in valuation and qualifying accounts and reserves from adjustment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to accounts other than cost and expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column D))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>153
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M88[V41WVQ;:6^,7=X[ZG@YX/0F; \\'IP?ME^W+_;Z8>1=.:RG9IQD7O,N-
M]>_+^PLMU]TKYP>IM:R[CRO.C'1K8'Y?2E,*[2[L6^S]_UJ8_P]02P,$%
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MNU^N=&]:L=*_Y;@7;2N6^N6",P!C)8"_SX5H7]ZH+]C\?NCROU!+ P04
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M&U3_?Y=EY8\W@XK_F.5?MC6N_@102P,$%     @ <41<6+$9TM=% P  %0D
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MO@H8-!HT)U"+$0V5O/^SS9NM(T^2",,J8.@<#*38)5EN4D"H>!X(2U,U().
ME#10YZS :X-[KFJR ?V&NY3>U&JJB14WXZ/CHUC:C$].)Y&P>79V]B+"T@0N
M]MP^,D)27VLRSHLMVWD(1M4VIH$_V) 5,SI1*V1?PEUT"":824Q[DU,OH1^D
M!*9VP]P&=F+ ;FS,$VK7;$)ZD6T% !BH#4AW#;Q[!1@',$F7OH>3A/<#BA Y
M&[X'Y"J1];REF 6'9!98O4^'^G=P&<A,Q1,%X(^3+X9N];UI<C!^-&MF@!%D
MGG/OYTZ#&T]W #TX,&@S(9V1W/LROALG"S3?R54!*:G7).N\N)0[0&Q;2X[>
M^N7BXM;9<K4&X@4TH:<#?@3Q"OD]7W6B':!XQ7^TV8+!(06IYG-KQ=@KAI-4
M=8#MQTT37!<A)G0CS'(I=,7ENJ6SB[3NFH4>'G)('*P-@DYO"2Z JQ<5+KXH
MJADZ'"2]FP0,6 =#QL8LN"IUI0'7U0K\3T=D?)P436VD%7*Q@IA%@','1NC0
M!G@TI@(<(#[H%N<M!1E29>#?1;6QN U]6= .A@Q!(N#<?"7) *#E-=T6:B5=
M-TJ>11_J AQ6$AIL70)TX-EF.=Q8;>W+R@3W.T:#TM(*K!='H3X_Z2I%*S%!
M,$)HK>\-F3!H(OS"V,DXBA/EN*P0#OBU!:]""W@?Q(#C!"J!/"==Y"OT^#28
M:9^9HO2WAF(6H?>3L]D7.D<HX;9.=)15>0@$TM3P -X* 0*89+'C=3,*#L.L
M3>[FNBKEMG:KD#%Y5278(Y^ ".&P ?ZM]4"?_Z61V_A1NE""B(B5Z(K#N1BR
M .]$J%>> *?;&U=5#4  DHS(9@1\#;[XO5 YP TBQRO0687"#DRT7%/,PPA1
M@N-@9;']FMU_M66)HNL52"&V7^#^,#0#U[9U@()3F<&#<+N(;UP8MX8;)DD(
MU]/@!8_@TP+M3[9A7&0'WA4)"M<'X,]0QXSD!'15#*MWGEG$6!0ZK&9= S=<
M.[3B]+<U/U4!=24(>5.P80ELJ+\!=LN%%@6-]$PQ%Z!@T"2 .+8YP5/0$B9A
MNXH,M4[0HF!HD+9@6:8MN@J!W8R[]('7:!SF42H -]89&5E$'*2D59TYY//U
M"'2T%6"H30DXEO @)SRVR VP"!NQ;[]>%\"7@'6R8(CYT4R8.>UA>.T"A!RS
M*B8X,A2M8"R#.2/A(52D&,! 3F!^ ^AK$&8=]H)CL3UKA7EHUXKZB13+ S9G
MC$%[YR!\EOEZC>\B_'"A&?$[!25YGQ8LKAK5#>!XWF@VQAQ2D>*J&<IE[<E0
M>,0*$R(+EA7SMIB#Y4.7)GN /+C1C:#.RM=AJ(#@P"<R9*(Q'3H1@+$#0X*'
M=Z,PIZQ&-X)A3!;@K;@-"&XIGAV3S-"FN+#(E OO,'T(+N)W?%>,1?:TS0HW
M+%NRB9A[16Y98Q9/R]^ R 0,F]A]0JR"_!![1J-1E&HB/))"N(LE?5P1P[48
M:L+;1M?(AP=9[TO8QH:!LXJD/VD-V$45HKON21]W';F^*.8S&!V<J[I'PD#^
MP0WQI3HCH]+BCI1VTCH5#V8T&#[)2H/D$#D5?32TL4BGF8V=9CD:PQ@]1E?"
M.2_X#,L>L:D<L<J73"%P"DP#Y<BFG8 C(I"IEWRM2J@9<[)D8?7>!]2NR$TC
M9HDT$?G- R9^&%P;,OP6Y(,[&\-[%12T 5_E_/Q%[,Y,QB_.)\/N2\3\;HOX
M<HS7)/A9)V+QX F2#1@'1%-H:-6@S<#C .<-+!EP6B6*\#EP64-19%U940J[
MHQ)HDY!I'^6:R :FCS-0(^@B@C1'%^90H\%LE53-%N U!PO(E@8Q7 (1YV#;
ML=QUD&2XAN*<0V>))&MK2\.XR_AQKUSR+DLPLW[<8#*P%^9_*$@&5UJMB?NC
M+[+@"^L+?2(;])WSA.341H2S)>[P542UWG!F;X5FDLZ"E$VCTV5)>DP^HW0*
M>$0^ 99[+;Q P5!20@PM]45;V'AX09;[,/ LJMD:('!)AEG1#2A'3P)?HG\@
MDN[1><68AOV&G T=?&,URQ($*-B\10[?H18 ,T)NB0!>80K.D5RSK+4/BM=)
M@2D-H T2$$'\CFZH ?6.M$,P!'\3*!0K VR2E$#!CQ_"BCTX;2K$L$&_+E1*
MV@H52^F</7*@R$1QVY"%DB#/H_>04'B[%#.*%XUL+E62!P!GSFJU89%%,)5P
M%:!*1"C/*S1FB.))^" ]Y*1224*#@P37;=UZ7&#4/Q*KA!@?SHN.34XGF\39
M2<Q# ;/C;O!'J+GGJN_8Q 4?W(VP>_I(AJ6SZSC9?_?QPX>+3W?)]4WRV_6'
M#YB)/QB0E_VP53][<BFFGLC!W03]+#D_.H;_GKS _YY/)H\3/UD]8L4L=<$T
M0Z;(]"PYG9*],9G^U"/>LV1RE)PD-^@4QN#UR+QGNLJ#=NGSA.%\(IG P8Y/
MX;^G !T>\LR63N#63B-^[IA.F!*O6AM#)(MN 8S,;,[Q$1 !K*LEVMR0P\8O
M).V:[#CT$;]1[ ">?G9\=.0CJ!*UK%6FHX"?%;M=2D/9/P2-E<L/)%7:!ECL
M+[WC-&:-)C_:+>AG2H0DL(J_T"'1'!7C1]4U:C/)?H<;&5T4K(/[YT*%1@H8
MF;[%(!);88"FMG3Q1A<QR4L#OF)0&.'L&&L 1_$+N#(V_^/P*4N@P.L*(6('
M;D7:R6<3'TJJ=F+P/F: A$8U!SJSZTJ8 ' :+!N[4.1A=&@$K#(@5&>"#06=
MHR!S-UX,=S<@8+JA:&]D/I7,6"I8,]C3S-"S?,I4O"F*<V",N^$PD%C^<.I%
MK<!N0F.T@X3IJ<_E/ M"WQQS]]\][;!DAIA.R"DRG&QLRAH+ENB_"T%(EWTM
MR2$:#'JV%#4AS.42ED'WDR,7,6&6F=62%"GQ3#I",3-$-B]\IAE0=GIR'N-L
M\O(\E#S?2S#.NWIZWN)'*(Q6DEQSARM>GG4.]&@")/2.^F=QS.H8?TA\]&(I
MI6Y$R^-KE4OG!\&.H9A^G!HC)7N%9L(X>4_Q,33YL$ZK23Y4&,:.I 20+I!E
M921<P<\5_!Q<PPHT%=9@+>NJ72R96.Q1?+70YXH+J59Y*:%G1#"\CF:HBS81
M#6L+4K15MTC(!G^<PN"'_VP5478.9))BM1P64+5HH ,R%X@JM).L& E<4AN:
M'G&>E(-=6Y8ZM/0&[+ E5P11$GJ&BP^FLQUHUM! [5&*#$*1)<F$JF1EZ5Q^
M21,EG-C8VJNTB'-&JH_.A=F+*--A..R)#\.R*.G6(!K@;*DO+&HH>9.U:*\P
MX?3%!Y-8)WKI/7P!.+[ F$30;5!%*HEI#I\H1C)YD*LJTX7S!CQ!#<4=-^#7
MZ,-J/@\BD**=4<5*Q4!7]5/\HM18D*>P5B\H<)(Z6O'4##H(.=CKF=^=([XL
M+X9H*=AGY FK0XV!_="-C+/+"5\ L6'2B!!M=!B!97U^G^L-U4C8T+]7[EB@
M2L?!+W_AY)GP,R<&&BU8&/9 XFB9.!QH"8!-':CY'F)')(\B@J2BDE.G,:E,
MT'LOC#4%H&[1]-KI$L72=_(WRR!=^AN,+6$@9ZU F6:M1@Q18._X[!1<WFT0
MSN842)CVD$W H:YRC&S'SB.5XF(R"6E\@V'Y74!Y9" WS%1&TL)\7QG \:L=
M/ME%Q&MO%:Z!JUO;$/BH[Y*!CW5&SR(D+FZT/SE()B]=G,N%B?8GTX.'UILF
MI\<#J\%++Y/?+8N")S&!]7N+3QY:&?U H)[_'OY_!'!O7V]7=73V9*BT:5B[
M)/10I^K!)^=(;+(&_M0:DRNZI2]?:TP:)/NBM6P$*8.7#-9%DQX\(#H4MUY2
MV238*PH_(^=3TG1_^CUG._[?GJWK9R%,[Q?;=3-*\/* KX%UND9>;,-A*AX3
M/AT!\..8C+4IE=Y9TY6.AR%Q5!EH8\@1R3)I:QVB08XQM/YUB1=0D;X+_TWA
MS<;&3?&FX#PV\P&B9)^\QPTU].CLT 96R8,\P" 8"L):@[3_BX00!>^'=68>
M;$NV M44B2QQXN95S!K#HH 8AOCQD]JXP#7%5<Y?PG\GHZ/SX^3WJOZ*^)::
M].3DZ"PY.9EB=0#K.DX&3$;3EU/X+]:0?J9:IF?)='1R?@[_>SR:@!/X :LO
M8]O0V71P+JHL#'QSU[Q@B-5=6!YH6J\EA"I?ZV^YL?YLD'&!?]SKK>DE05PN
MFQT8SMCAAZU4)+@4-1X:#(4&M/ZZ0,,(.?7/-E^[Q).R-4%X YC]Z>:%H]PR
M7VFFY[GD_,G DD.L9E6&MPJF8F#<O2*IA58$960!1P%XG%/*.YE_:PP57'L/
M.V1Z#4R5$VWQ._OY6(]'W?.QL^E.>,!_HVCII3P?0R*IP@ZDX^1W&W(8H(!.
M;":X_U'"B$21$WRH F(@S[+!U8,5@2 XX8X,24AF#%:=.F;"$<=NM*<XQNEJ
MA58B 911A79(OP63M,5BC+VHQX3]R<[&-N)G<X7]RFQY0*HRP;I<B/W=2$*3
M"M]\<2L#+W8)-K_<R_$1)_9:!'WQ-3"!V!S4#D@P2:_=,WVP@!3$.Q$)=H>Y
MIG!;GX:H.26BL2R/WTX+U9*K9BNTJ[6+GSVON'S!N3'RE:NC<M62KI"LY_?$
MR!%QX?W(<2^*JJ40'/,$L*C+6F$8D!=S81C15/U/*XX]PME8F0H8F2OB(I90
M]RHON)HEBGP:BVO26YA92G/'\+P99FNE%J-[PJ:**624+$$M 4F,P&TRS2X+
M5"Y*DN0VDH/I#I6A:^40B^+$ 44@6K_0)UG$=3/6:[>13" #SEC#/<^JNF8K
MN9:,G#N1/Z<[562"]^@:6</=@N-=6VJX<T\0#$YP9/$6O:0QFP[,R"-?)$X)
M6[X2KK/Y4)6+PP\41I64PZT3M[>%;;%Z[^3%;4?9Q-)$PK)8RI6Q0C1PK'>6
M<:4J*O"5R>; QD/B9>R=9(-C% FFRDH([ZK8>D%TM_6\+9("2XU>);,V+S!4
M8,+,J(31*?-T<L3.R4]88(G!CKHC$N6YJ7LNZ!#BO&I55 MDOCJC9B8J*:KF
M#?XA+Y_;=QV^EU3I$H 3M J&T:^'X"?KVIV[R.=>B84+BPOF*R$&Y"IMCER&
M]V&6Z [78ZZ/Q!BMJ[\)\NAH)#1URY4XWJ"P5G;7"HD)@VY]G3=H/5(!1I.+
M)BZI>8]\9JDI0-_6YE-M\08I4@G=H 43DXQ:P0&D;]D>--S.Q9YG>H':V='3
M,!5U*Z.L%+P<6G(@M#XY#T/K<7M2T"7Q%%_YL9@Q&KC@BS(#P_6!89*CY!)>
MEJ\+^CKW7PNJK9H+@H6LYK#&"GE0-4)Y%!8IU4K;V@+D 8I7?2VKS2&([*!V
M$'%# :"6ZP_8[B#ISC4;*="%\;V"Q$1\A0^(A.^1 KL.-#DBUG;LZ0XX(;:=
MG-HOH@.?T$LO0IX>QL$H.0T?[99#8G@+W4.0N'PCMML&""$HHB:=+UXTVI1D
MIQL6#M*O&<15)0JLV<H ].18KE#7Q%)L<ZW4EK3DC(4SH!'+,RY*ASXD>&!$
MT6=!^#9(ME.8F^-Q2JJ[$;I%7;5K<A&$I+B"0M6^M:D#31.&R:WU&QR?'240
M1O-0(@2*C^M<^0TL^F17UM#>4F46:$<5'S/HL^(XK<U"L^/M9'S^9QN'GE42
MX"=:L8LKOO9K4RM='/ZJ5B @?E=U1 LHF=E1J'Q#/UPPOX04%H9P,<'&L1?C
MRP/#LLK@U3!I0F'WMC&YE,+7%$-]:@2"O:E^>P*\M*Z0;2B%+&T)43<;WH-J
M&C3A9BVX))7F0G:.W8B?R+>HG$L?-(WUVIZ&BOSY&!P .;1AJJ?BF6K'!\)<
M/X+X@66><@G7I<U4#D3.9*%^N2DV#MC^+('(2E'JE]]RJM5-)*":ZY+N1>"$
M?U'K+P?G2&BLL">?U:&1>RTI<4<S!JHU6OR>$;BA?KE=P 9L_*Q@LY1B3Q=Q
M7-A';I\4E\?.<F7S%213.K4=_YI@YS\I1#<8FXM:9?JV]SMO;AG,D&687D';
M3'J]I0I5"MAI1D9-%DVFTX*$(X5SQ"2C5@",UF#]F#^JQ&J%7D"]Y&B5FY:]
M6I;RMFJ0B\RD$C.HL$SN*U2L!=4]7K4U\C2%-] <"F4UTA<EE 1"HD@?8@AK
MHEUYJKO2II(0K+;N9(E=;RQQ@=HB1A4Y# II \R-<(3KS+3CG05@/(0A4J:"
M)-_?NLQGN6V0I_8TIQU]52)Q<[=.O2WE'N@*.NV^O81]))[ZI--QN=<L%W.2
MR9)I$J,UTN.! K>%1=Z[91U."MS$6CFW)K1[&RX?)(((GEBA/[;TN%]Z7X8/
MV*N]J8#X84.C%^R&L6SR0T^D>8/JGV(D6>0"-WS5-,!EF! ?P@]1'[!2.Y_C
MI)]28H;6YNP8,1Q#H'DHH>W"K0^TMZ,66(9SNAE69;"QTK4 F2KR.C!/1,'%
M?>&2FO6XZYS26SW)T"E9H(+;ZZ@;V/C>VS-6]O3-/^NK. LT6-X!'\5Q!'X7
M)"&I81L)!T-?=+C@O'@V=Z"X_<DZ:+GYBK2 !D7I8\P>;!&17S$T&'4=\#(<
M+!WJF.=.1TN' XT6V?#-T[R!J2]!?+Q291_+40["DO?+J*7] [6T/Z&=VXHL
M<D@+J^&(%N#2$?_*EP/V?4$IB'K AQ<M0JS>9]^@1JFCME]VBLNF+[Q[''NS
M;AJ%^T>MA:@X-L=]HQ@P X'>;+0$ZKDOW742KNL\]6&^F(-LN%]UCAXU4J3"
MNJ'+%3BM'<>NH8[+A9ND$7MSRBH/-".1P=H2K12LHQ>:O,'(#=WD$9J ]59Z
MN^L$?&(T)N$*8"5 )<CE0;\PS>NT77%?8N01VIM:41(D\)HP+]4!J9MV$#F,
M6U6E%HAGFL3(T'/[M?:].7']WP$)0:).AR9FLGR!8HL\7DHW4;C/1A!C-+M$
MC1%Q$\-OR#-U#<IA6B4(=;,(&'B9HEM8#.MEG [K#5&.85HA*I_U<4$\C0V/
MB]1Q+>RPIT:9V\$W]UG4A8\,(*P>K\$\'IM(M\<8#R<H127E#;D*)O_6.Z6O
M&!1M.TI^#:>H15.;[MP4M5N>HG;GIJC)G4OBSZV%23C71TWP2=?<_G'XQ74X
M,6W_Y "; GG*6OS-Z<%.Z#CG=W;0 \W6%G5/3NI]5_1<N+$)BL-"PS2,*["Y
M(85*LZVC?G_?; Q2=F+#GFZ/! ?YAQK]#-BH!<IXV_>/>@7,'W"1#0]W@]6V
M'#%; *X6XL9P0R,L5W2/;O.9J.*E*VY 3/4]329&/PJB-HU%"H=#N/#+#ZEA
M=;DCO$/BA<19D7_5Y'X"$BAG90VS6$ZK ?%$?3WT8F21L>:A@%%X"%VXKNCM
M6AD^T0Z@*0/F*L,<U5!.%Y/^N]ZSHM8\Z80^6MFQ)H?.RQ:W(1O?HR:^)[D/
MPP"BM\<0>B'K]1 20%AS_:071GSZ&#2?9(IOX$D@BU9' 3]L006,B2U<3N'[
MV2X#]C8N&GAX48.1[3:FA[QA1,^HIL<M5X^;6L?=O'3?R^A?<.CB#%ZU^',!
M&_C$^T/FYG1\-O53M?YU!N?QV(8K>NVQWX&2G0+^AW T2,@1KJ:G1_\/N)H&
M$PC/'IQ *%M]IO$+H9:/>W/H:Z_-??6#M6.WKFG;LCQI,?QH-#R5RR5OQ;^A
M??0*YS2"2>H9T42F]\",(&94A=8'N)$E<;0)4@0=<WOD65Z7BN,U^+(;U^#&
MC=[G)BPEIXEM:L/&D.810"1))4Z%U\N/D+W,"U+CI+53X=L=+D T5T+:6JN5
M"T-)^M.5DY/K:K<U]AP8&2-'&C>:Z5+/\Z:'YB::_^*X10KM(M_8+;%#T["(
M5(&#ZXO6$:J@]MLJ/.(Q6^/51XR+P5A;%NS_7-_3B*8@I\0YT=[T#SL9P$7"
M:.%U)5Y49*WRZ K7&L$A$9R>1 ZLIZ9Q<MO6!G57XJ<JL;E,3MM QQS;+@,E
M5ZRSI1=P"*%V/ -U$0:@.X5C6B-#-7*7,M;W!!RBL 5VJVE,EF0\5)M),#%8
MBF8O%9Q%+'3&H@KK<:(%YY1G"9.L@=2X<L-=!C LX7UT_)?@5& E0HP@,6Y-
M1VD&5-LQEVF^1[/CT?!602#C0&>2/X#2TZ._$9>DFJMKD6ZD88UKVT"*Z*;A
MJ;^,F0@'#J%(:OW3@EJ@ 22 :++7YCP'3QQ+2Y',&#$3YE:8U4;&.>6K'I.3
MY>UR)8.FGAUG,]Z1A0+9Y.<0T/PL9, Y:)]*4M4,OG2"LLL6AI$Q5!_*; RF
MT]PD+*-B:U "6!(6YA0<9Y><6+"-L1'VW/2UL,G&#C;C4)!$"5EUTG3,F4X5
M32/!*(2MMU;<R\2REPI,VMD?$ONE.=A2/@&*M)%9\[B\94LUP&O@"=MX4L1V
M*(9FVB,IJ&&A@!9(XJ(;?\=66"]^'Q#-0TV,;E:H:V/\!)XKRYWDK5W(MH=+
M]8J,2B":=P]CB$W";O!M\(7,%4]M;1$5^F!DFKWG"%J:2(2BEZ?PQOMQ!(%R
M=IC^P@WC2J%.X<6]KEU3/9:XNC>E;.+(EC7X?.PUU03Q:N_\T-*XQ]@^X$;)
M\3!S13HZN*VY]%&X:C6;5I. QT(1N7.R7V01*+,%BQ"[C]7=M514 <@E%U0U
MDCQ;R1 IY?JH;9,S(!<7PT5UMFLA:7CVX_-<,80WOCKI'OPU$5[U 4!O<?IB
M[D:>,&W$DZ7$6H&M=DZ<&B5<D"2IF+Y2IC)>8*GLL>MR@WR"&0^(1&]]CY-+
M'X14P8K.10PM]9[(=3?3EN3:NZD8C"F<<8BE ?3F2GL//X"<2B)18,E%H![Q
M6](ZK.N":&D_V-!9E)3LW)$7.1UZ!4=OZARD*<7XY&+E>Q+E_0/BQ*S]@EP(
MEAQ//()/V 0G8 L7WQ"CC8< ?\^YPNI,G#'QR#1=D79R CLTX>+CY74X?IV,
MAB>.-W/E7C@<R(6U'T&:GP$0W0:APP1<>5W^ (HZJ#8<\2BQA7)(&8@KZ;H?
ML1[  7 G1: TY"SVWGPUHK$#L7(>1EE(<EW^Z _8"3/ZH6H&.?X'S^/K#/*T
M"U-=O"U,9<R+K">Y9YQ:0KEO,+%@Y?N-SL7GDDF5X  &Y@._5E*_@QD @*2L
MVY>FT>7N%S><^144:(X%8X'4=*=SQ?-D7X7]OSL'#Q$%19[[+8! DYN" %BS
MJ0ZIXMVYQ5Y3(-QV%/)L*RT%UD^21!<5)V1:KT@>[![%&=9#XPLK#JH&[5/A
M$"J7\((5#MVP2: 9K&_'QCO\F1:40FS?LQ3:M7DB@ZJLIK-_\DPYUXQ#\UEM
MFXQ,U?!#BG1F#?UV354U]@B=GTL8QAZM:']D@"9$1*?RATEL1Y"--,B83R>8
M5O",":9O/3",!5V/EJHS  )Z1QP8VPR+OT*1R2PIU3][20..Y\ %,D:2D2\S
M79<MG]&FI&G=</Z&T:F=3N6+O,-Z@%E<\VT3!*W_925,U*;<:9D7+94<6O2N
MD5OQ3/S[)&E'6+JON[E3[ZWYFW(I*Y)C&,B@-WGD(2&\J=*OT52*H"+<_M+
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M#_=;3+DK;3<P,K?7R!-IC$SM*S6BH&@!?J?C@Q^0@.K_%2[^ 5!+ P04
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M2;;67WST>/+*:*+1@,+WX;X(XE*N5(B@854?\#U=WL [C;TC2D+F>0@G1"^
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M*7S& H4+T00^?>40/UBX)<?N< QN'(8 OEPP'OMA!EY#CIW\$<P74KVZ, +
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M]\28 AYF;05#)\+<FA&V2F.ISE)4=6'&$#JBWQP$JC 5H<UEI ,X7#V4*FO
M5>W7GP%GK,DCKJ\7>;6XPTH?95Q4'(T'9R&PB:I&M8)C_B#C>PSVZ/V*MB@V
MJPY>F;.VUUWMBU*85,"27UN;P#O-<E_'7G,1P4)<K3/()%WUAH6V>[_*UQV[
M681_[T<QT0S]BH5,()A'KUJM4Z[.%? I8U809\J]+L1H! H#QRB,?&08.U(I
M.$ +GQVZ*@W6#09&2Y5(EQGHDDB82ER +PD.C=3Y3GN"$BY.#1GH]IBW'F.
MZ  U*+Z+.)<VEV9#4.5\% F5^ZMFV4O.RV#K<K-2E=1MF[_*%.GT4H:5SB@M
MLBJ:Z4&4!Q-H'-OK=55L@JS+H#W$L&4=/=*E=_TXYFU%H2$0901Q4P@%O;BW
M-UI!&+3&9%..#<FYQ.DP+"1G%DL0=KSX_NKZZ[M+U!]$)-$;GLDQYRTN  5N
M.BBWAVD_M9,?==TPFV*.AY5*S-LWS>U1X*/M/SKVT=ID"ZXX"=(XYEUIY38U
M;3/)J;V! #ZJK.:V>J%;L[B,+8"UI;#34C+\NHQ4R'VT2MR"A2*R=Y6!?BN
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MC50B@4N0]JK3ML"_!]P<3,X '[?5QX4QYC(YAQYG%C03)A>N8<+)\<7(,=]
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M[R(^^]W);G0.NV,QZO;W]6_#W _W;C 2_X'X;(B?':6C[I!&@^YXCI_WDJH
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MT7YW.NYXD.L'ITO^0 /Z.IWS;:)DI Q-P/M8:[=^H 6:+W87_P!02P,$%
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M3+ET_3C;1_AD7J>[&Y9"DBW ,<\<A:U3WEAA;U@)Q4"D#J_I4J5)'Z&Q!CW
M@7$[ 9#J9&_M> NF\I$[YW-K@8-%.N 4Q&8XW9'\ %%ODO,=/MZT/QQHSFO#
M@LR6#PB,<PXUZ>D8FC\YXRS.\M#'EIDWT9.'4( EJ=.9N$X=;CDYVXRFB0RB
M]&%P*;E@YXQA[XL[=;]SIU[%.FM8_M1./9.QVKU>[^AF&NEF?G"_O@<0$]1
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M(Y6U$S&2W.-=+DWSD(N(ZPUT,KU$:F/H- ^T B0@Q8,=LBO#E1)5FT("?E"
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M19'&_'*E)*Q/ _#Y(DT+]X8V*'_[\OI_4$L#!!0    ( '%$7%BP(UWH]!
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ME[%,U^2-K:B7F5Y ?#'Z@YS#K!,^7,;9.62>*9F+3"Z4S4Z)*HAJ#LO:;DI
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M@Y.WK[=RI:Y5^?/V*J>[DWJ5*-ZHM(BS5.3J]LW!J??R+,!X'O#/6-T7SK4
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M'1T2,HIB\)G@(']"JAQUU ^,R568K=+XW_1C$DM>#APD;+&M7*URM6+XF5Z
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MKI#M4,+J"P"(IG<R3J2Q6NPL7"-#7K3LAD;^A!G1?>I;BTTBG<21!"G/B)>
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M_/)LP9X9BGM:>XV"P32:< (U@Y^6[+&)+X6+4"\\0$PR$#Y<=8]"PPFB[K1
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M?A9Q2I)A@XOVF(7O7GZL4K:=R9Z5]-&\U5_1Z5#BW%HPME4T%SM.(#6WTW&
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MR<2:P&Q+BFQOV+#.7#UIJU%8$I+1@HK/!RY(]5)5['^\O*[8E]1>I-&(/A9
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M?."E\MM$G*D@E/NVH5\-O=>^NJJ72],2EUN;J:K(KNJJ-=5<5[G1]L>3EJ;
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M<?TM7(5G99.2,7T8:M0A'\7=,P*$S+,U4J82>7;5\29H(SWS>'^O%W2'OOB
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M /T^JRDF<G]@@G#)^JO_!U!+ P04    " !Q1%Q8^!^)=K,$  #L"P  &0
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M'$^0[70[1.+?C28-VBBUODA%[GQK"2V(LRFRIVY#+?I(9Z<TQ+D((FB &^Z
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M>^[LNPS7VMS: M'![U(J.XH*YZJC.+99@26W/5VAHI.%-B5WM#3+V%8&>1Y
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M>6R)>9(L3X\F!_DG.&#P\<,T39/+;@YL7S?VHVX^8'+YR0ESMGH Y>AHBRV
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M^HII-I4Z#)QG3MPC4O+2D1ZK0!&I(A$%R>,3NG.%*1-2DMD+L[.Z^F0X2$=
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M.:9[[44>@<'4FG_@14#2GF[O6>)VU+1-! B)B:X\@^5R-]VF3O;IEW1J'G$
M=+S2^@5V/?(NTQY(VFG$2H;)/H]$G#CU$)3 AVC,NNTK7UP2=>(+SOW4N?B
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MO*>%6"O7O7$GF(X])::1K,TH_ZT,D\PF^O^Y3$B7PRR"S+JZ*=>+$N>$6=+
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M?+1.QV(-3XP'[0LS\9U;KHEV/,E]WS:I6T+^6DZ8TTEII8^92KA('6@:,CI
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M58_;J["=ICN4@FSO$(K[6*E+O4_"RO@V*KZ&5;F4#Z)PZ0Q(V)80JO8+7)-
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M=_G:_%UE96U6-/3B_,75(ZE5<W_T[0Y30CLD/8'_N3$Y(1U>H.>D^?3N#RR
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M0F>?HJ?J/5^Y+N@2+C?UPAIZ1*6>;Z0)#.OOXKD+[=C(X;8<&C8Y--R:0ZC
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M]7-?1_Y1Q&\LK)/ .R=^TP^.X 5%[('%"SX=^XP):EA$AL@5;C@DX*_A J2
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MI6@,)&$(O60 ]\HR 0>+ CV_E\0T1F<A3-*T*BK!7'4RI+*FO(E]'/M)&)_
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M$1\:U]HLE&&^4WBY;Z?0LEKS>5U 0>G/ :&M[+3-0+.7=Z*/Q49(341-3,V
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M,#=5^#W;(Z9)HBK7N)HN<\1=V5N?[5B"2G_^% =^=$'1R:TB)WX,0_J[8:H
M&IBV'O4"<->#BQ;:VJVJQ%3*8OI$HZWA-*(IPJ/]NLWNV!</( Y;D$RY*<6)
MQ^TN691S;5W?6D!.4?O;^K5;!<,^9:W7'K;D;F2#,(!@$&Y(/HQ@Z+<4'T:V
MPOR3;A#O)7EG9Y3)42W<P&8I1;2IIYIVMYT)I_4HM+U>#Y1W3%&-4M_%C$2[
M9Q$U*E4/:?7"R-(-1G-I:,QRKTN::U'9"W2>26F:A5703LJ3?P!02P,$%
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M(!OSZA52#20K],U_SB2^(W1WA0\WRM4"_!XS)C<#I:!Y"H[_!5!+ P04
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MQ5 Y3&I;7\G6B5D1-&MI959*UYELAQ3[T$BCGAW][>ASP*BZ?Q/J5!2EY9/
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MFN> /TI<*#J,(AH!YDK CE-I+=5B'"_)K?]J QE("OUC,P]'=H[B8WA1+>
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M&[ ^4ZKN7@C!ZM>A\_\#4$L#!!0    ( '%$7%CSS:+SY X  +XT   9
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M]A&XY$F6%]&?:B+@'*0C\IS':@"+!<R:$4^FR<P9L%\4,=F#DG-8Y@6/8O4
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M:C[J##: R8!&OTY6F1Z)?G3?WE0P0'.4B'R>+]#;&AN.,'6U$U-78S"SPU)
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M\1-[ <%9$L5Q7:AX8=E.\P"+DEF&R0U<<]BT;DM4.FIG \KM=#0A$-4ZWNJ
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M2*11EU--:J>:O,>IOD#8P=F HF'39[?Y4S?Y%G\RY%"_XCAI0YA&:.[/,"%
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M#'-Z"J'Q K0_U]IM)][ [G$U^@=02P,$%     @ <41<6#<S,I\=!P  RA4
M !D   !X;"]W;W)K<VAE971S+W-H965T-3(N>&ULU5AM;]LV$/XK!Z\8;,")
M)5GR2Y<$2-*794C:(.ZV#\,PT!)M<:-$E:3B>K]^=Y0L6ZGM9MV 8?G@B-3Q
M>"_//4?Q;*7T'R;EW,*G3.;FO)-:6[P<#$R<\HR94U7P'-\LE,Z8Q:%>#DRA
M.4O<HDP. L\;#3(F\L[%F9N[UQ=GJK12Y/Q>@RFSC.GU%9=J==[Q.YN)![%,
M+4T,+LX*MN0S;G\L[C6.!HV61&0\-T+EH/GBO'/IO[P*2=X)_"3XRNP\ WDR
M5^H/&MPDYQV/#.*2QY8T,/SWR*^YE*0(S?A8Z^PT6]+"W>>-]C?.=_1ES@R_
M5O)GD=CTO#/I0,(7K)3V0:V^Y[4_$>F+E33N%U:5;!1U("Z-55F]&"W(1%[]
M9Y_J..PLF'@'%@3U@L#976WDK'S%++LXTVH%FJ11&STX5]UJ-$[DE)29U?A6
MX#I[<6D,MP98GL"M8',AA17<P/=<)H!NPXQ)#MT/;"ZYZ9T-+&Y)"P=QK?ZJ
M4A\<4.\'<*=RFQIXG2<\:2L8H*V-P<'&X*O@J,97/#Z%H=^'P N&1_0-FP ,
MG;[A(7W"Q&BAR$N>P/N":T9HJ2*"[PIEF(2W6I6%@5\NY\9J!-*O^R)1[1/N
MWX>*ZZ4I6,S/.U@]ANM'WKGX]AM_Y'UWQ(NP\2(\IOUH&A=U&O?9?%SKAY3C
M:HF%*_(E6 )!7;WB3]1NZ343&AZ9+#FH!1A""X;3B*0.)!9NS+'N$A YO<GK
M:EP)FSH%\]+@KL9 @E+&"EMJ_A*ZK][?WEX^S.#F'=S=W-[>O'\WZ\$U,RD4
M6L6<)P866F6UBC77\ (1$<%E\LCRF%?;%M8YWVQA%<PY8 9SL^!:HU%=OX=9
M1F&+QAGK1) R)'2C'MQO=F+6:C$OJP"01%D4<@ULJ3E'@K+0#7OPYDN1> '^
M-#K@V3,7[S7U;SOM5X'<G4*A;20I*.^P'S21;G+H0KXO8R[ZW@'G+LLE$AG4
M-0LU5IT-!-B8'OC'4J#_&$Q#OL('S9+:H4='/GW(T21_"#?Y(THI3?@.(TH2
M%JU=]Z&0#%-!&DE908FI%@53>*M4LA(8K#"$]^BI1CA:EB\%990Y@RK9\;!^
M7TV"[\$'99$"ZG'@1ZT*NXQC59+1!5L[>! 47O%-6-DGD+7TVL6U4BYW-'1'
MO7J+UJR/PJ_1#UR'>Y19*9E%C<JMCU6&)))2;WSDZ J..9Q@O\!=\WA=I596
MR&')[QA]!U._WHA7>@D'6J^IMAOH40QJ5[O52EXQR!=T]^KZ^Y]1QB3TX*$!
MV=/WP_$!<@B\9Y7L)!I_?;W3XKV[!\=,[@['O2^5-^)%E@GE!QL1,EM,.:8J
M["'LIE]3^Y/ /^#H'5LWW?I9E1^A<RVC(#Q$!J-IBPQ\?_0<-AB/MVPP],?'
MZ6 X&H,[J)ZHQ4EI>$,#7ILF@K!-$W[?\Z9?(HHC3#$-]E)%%.[GBJGW[Y-%
M&#Q?5U&?TK<>4.#Q[&0UMXCAJDGZO3;_A/\" =$V]>9;VPVQT63D_7TVHIG_
MEI'\?A"%\-K$= )LQ/SH\&G$Q4,X@^A8*? @T)Q,,(C#T:$CCE_W>5=E&'$K
MJT11M"EW)[%4A@*W$UG4][S32C_PI__@L..6'^<Q%*3!QL@YD^X05'W+=D,D
MLM=9(=6:$W6(;%YJ4_FW)9*O/.KX?7]TR+D?RIS#T'.,%S2,Y[#; !M;Y6BX
M92$"L3K&0A-DH;J\,VY313@D>YPWX[!-11/O*14%D_ X%6$A?DXVPV@/U8Q'
MQTO69<Z;("]3BZD*AI)TC;S!\O6WWV"G&'^' <%\*RD21RU7=>9FE#G$MR&E
M^)W'LSDUX4WWH#"YH#),@FU5=KRQB6659W4IL^UGT:X7Z>:SB+!WJ$X_-^#I
M3( '@=YSFEHPPI\H.'BHC;#9MUO9!"?'S^IF, VV2 HP/\-P<KRG^>$(R7VR
M^=C%J$G.L+7I/7UN2B?N%KRF$$1M@%$T3S":)ZZ2T5%O5./ .PZ[%]C:47QT
M[+R,C14=_!R=&*%1N >@3XT)R9; #^"W_7]55]HB%(2I.XVE+[R<R?6?KG>@
M"%DG4 J9=+=5U,_7RF!QBA@3B>R;")?[AD H=2DB6VP* ]NH%)G(F5Y#7A*L
MC(,DJ4KVQJ,/JU3$J8._*>>_$Z,C(2Y*[:)3%E1-YM2!DCS:U )I_1RZFKMK
M"$25(]$#!50H[1BY'L[8HT)[9TJ6U2U)R[\WLYN=S\Z465AQ302-0!$+@?ZP
M)[5WV@H]'2XD)T9P0=A2;F/.1CO-Y.VS)1G0_M#LT_&VX.[:3ZY/88:-X)VR
M2'=N?Y8DKFDB@$1>W6[BZ'3?9<Q@YWXMXWKI;A$1)Q2JZJJMF6TN*B^K^[FM
M>'7+><?T4F#@)%_@4N]T''6JPML,K"K<;=U<6:LR]YARI U- OA^H="%>D ;
M-->W%W\!4$L#!!0    ( '%$7%AD,GRPZ0(  $H&   9    >&PO=V]R:W-H
M965T<R]S:&5E=#4S+GAM;'U5VV[B,!#]E5&ZJD#J-B2!PE) HNU>D&B+REX>
M5OM@D@FQZMBL[13Z]SM.0I9*E!?;X\PY/N/Q3$9;I9]-AFAAEPMIQEYF[6;H
M^R;.,&?F4FU0TI=4Z9Q9,O7:-QN-+"E!N?##3N?*SQF7WF14[BWT9*0**[C$
MA093Y#G3KS<HU';L!=Y^XXFO,^LV_,EHP]:X1/MCL]!D^0U+PG.4ABL)&M.Q
M-PV&-UWG7SK\Y+@U!VMPD:R4>G;&+!E['2<(!<;6,3":7O 6A7!$).-OS>DU
M1SK@X7K/_J6,G6)9,8.W2OSBB<W&WL"#!%-6"/NDMM^PCJ?G^&(E3#G"MO*-
M^A[$A;$JK\&D(.>RFMFNOH<#P*#S#B"L 6&INSJH5'G'+)N,M-J"=M[$YA9E
MJ"6:Q''IDK*TFKYRPMG)H\U00^OSCK)LL TS&:L<+^"!WD/K.UL)-.V1;^DD
MY^_'->M-Q1J^PQJ$<*^DS0Q\E@DF;PE\DMCH#/<Z;\*3C'<87T(47$#8":,3
M?%$3=U3R12?CKJ(%)A.H;\# [^G*6$VOY<^QN"O6[G%65T%#LV$QCCTJ$8/Z
M!;W)^5EPU;D^H;G;:.Z>8I\LJ2*30B"H%([G[9CBDYS'%=?DN"?G]:.0]"AB
M105I+"9.!?E!J@15-I?K(5"2,%\1U"6J=?<XGT^?EC![@/O9?#Y[?%BVR_2Y
M(71# %195#<2<!=G3*X16D(9RD(;UM10#'R 5K_?=E,0NBFB0"V24%N+@AX$
M/1A :_X&1_6^*@S%:@PD5/;&<EL0#%IAU(8@@"""K^3I'&\S+AFD+.:"VU?J
M-$+%K&P9I/+\;! &X74S+ZI^])&\F+N$%4I,N85P ,$GB+IU8H(^=!O,J>ND
MR,)!&5F?AMX CKT3_Z"^<]3KLHL92D4A;57JS6[3**=5?_CO7G79>Z;7[H($
MI@3M7/9['NBJ<U6&59NR6ZR4I=Y3+C-J]JB= WU/E;)[PQW0_#XF_P!02P,$
M%     @ <41<6"MFY:)C%   &.,  !D   !X;"]W;W)K<VAE971S+W-H965T
M-30N>&ULQ9W_;]LXFL;_%2)WV)L!DHDEV;(]VP9(+7*GN&D;M#.W."P.!]6F
M;=W(DE>2DV8Q?_Q1\A>*%O4J:I_"\\,T3J@/)3[D*_'Q2^K54YK]D:^E+-B7
M39SDKZ_61;']^?8VGZ_E)LQ_2K<R47]9IMDF+-3';'6;;S,9+JJ#-O&M.QCX
MMYLP2J[N7E6_>\CN7J6[(HX2^9"Q?+?9A-GS&QFG3Z^OG*OC+SY&JW51_N+V
M[M4V7,E/LOA]^Y"I3[<GRB+:R"2/TH1E<OGZZM[Y63BN6QY1%?FO2#[EM9]9
M>2V?T_2/\L/;Q>NK07E*,I;SHF2$ZI]'.9-Q7*+4B?SS0+TZ55H>6/_Y2!?5
MU:NK^1SF<I;&?X\6Q?KUU>2*+>0RW,7%Q_3I%WFXHE')FZ=Q7OV?/1W*#J[8
M?)<7Z>9PL#J#393L_PV_'%JB=H W;CG /1S@GAV@6L9^@'<XP'OI </# <.7
M'C Z'#!ZZ0'^X0"_:OM]8U4M'81%>/<J2Y]85I96M/*'2J[J:-7 45)VK4]%
MIOX:J>.*N_=AL<LD2Y?LPU9F8:EVSL)DP3[M^UKYET_1*HF6T3Q,"G8_GZ>[
MI(B2%7M(XV@>R9S=L/O%(BH/#6/V-MGW][+;_!#((HSB'U_=%NI4RPIOYX?3
M>K,_+;?EM!R7O4N38ITSGBSDP@3<JFL\7:A[O- W+DD,Y/PGYCG7S!VX'OO]
M4\!^^/<?U>#8IEEY-?^[2Z+"<IZSEU/=(]6""5Z.<0@,IS'OTT>%&9C7:,&(
MEY_-P(XQ)/!.?<VKN%X+]T.V"I/H7_N^<5_K8Q^Z^]@_?E4P]K:0F_Q_;-UI
M7_/07G,9GW_.M^%<OKY2 3B7V:.\NOO+OSG^X*\VS9&P  GC2)@ P8R^,#SU
MA2%%OSMHG*L1.)?18_@YEM?LLU2Q0[(P5C>\,)E+ICZR>295<&%QFN<VX??5
MC*IJROOHXYTS'D\&U7^O;A_KLEJ*3L:.K6A GGQ?T9 P 8(9HHU.HHU(T69A
MOJYN#O/R!_G/G1(NEDI%FS![E%]K[?' L^K2+#F<6$L&HX:"8\<J("<OI&^;
M@V!&F_NG-O?)-O\H\R*+YH7<M[JMI?U&^_G6=FZ6.[3=>3,W"PZMC4R>>=]&
M!L&,1AZ?&GF,Z]CC1NNX]O9N%ARYUO9N%CQO:?+T^[8T"&:T].34TI.7=N>R
MT:_9^S29[[),-;:MK2==+3-KEAA;V[A9SAXXR-/OV](@F-'2TU-+3SO[]'75
MR(SK#GW-SA2HNOWY[S@] J;--O=&UB'0+#EJ&0,6IF,=5IR\[+X*31MW%-\_
M#XI&\SL#/;,:D (\9.E<RD7.EEFZ8;EJSG(R%38??*S3HT&SOX[M33>SE1V.
M[ \VMK*.;QTRG+Z^OBV-HIEJU.:Y#JG&;UFXD+5&5R-A+>/%C7K$O"FUN6;A
MIA3&*@:)[CN[.- ,"4;VH 6MF$-I D4S]72UGBX]NL+G31F?6)&R;:CF\/-H
M&Q:210E;AO,BS<KIHY:;;;-TE84;J[QN\XYN#V>6DHX]G%E*VJ,9?9F]10'1
M3%'T!-\AYXSJ[EX;7HDLKAEQ;S^PS!#7\BAE*SMQK-.\@#['WH,&.N5&T4Q]
M]*3;>>&L^V-MUGUO3+=G^^GVKRW3;:<YB6Z[*PV;]W[[K,Y2<M@R6*!3:13-
M%$-/IAUZ-FT10XV:#[LB+]0S61F^WCRS#X\R8YX_8D'X;!=D7\FT_HC\T\ Y
M%P,Y'PZ@- ZE"13-%%7/UAUZNFX=8;4QQ?B7K4QRR7[X*)6TZLG#[H[[C6$V
MM8\RRZ3>6C*@3[RW:-"Y/XIFBJ9G_PX]_>\7%J_9W[.HD.ER:56N.9F_L7M4
M,_JL>@]*)(U#:0)%,_75GH-#FPY]]15I)J-5PF;5P\O\F:G)0Y+'U1<75LU?
M:"[,+ 5OVAX@D48$A]($BF;*J8T-AW8V#M]4JAMD+$,52K/RV^.;='FS4Q_"
M/)=VU\)I6@S^I"6J6MR(8<O#"]*.X%":0-',+URU >+2!LBY3G$4?H[BJ(BD
M51^W:4WX0_NSI:WHV#Z.Z'/LJP^4)E T4Q]MB;BT)3+;;79E4'M4HV;Q?[N\
M*"?4:LX<[T53$^MB7?XIW5;?V*9+=O]IQMR!X]\XOE5!B[,Q;-704GCL3ZP3
M[\!2V'4<Q^Y;T9?=6Z1FU;[GGE^3*8%V,5S:Q9B%VZ@(X^A?<L&BI)#J? HV
M3W-[!',M]H.U"6:VDO;X92EIC8F<OI+>K?H]C I7&Q4N;52\W6S#**OZN^K6
M<9JL;F(U#A;$[>- K#^2-UK=XE*XYV[RH=F;11L-#G4>4#2SP;7SX-+.P_O=
MYK.:R:K&/J7<L#+E)F=_=B?AO'&;#H%_WO9(:R" TCB4)E T4TEM6[BT;6$.
MG56:+IZB.+:JUORZWO5=>PZ VTP"<(\F;&/L-,LVQ@[44T#1S!;7GH)+>PKO
MHB3:[#9,/4[-5;.'*\GFZVKFH@0HPB_LLTSD,BIOW>6M9)]?5?K@49F0I^)9
M$<M-BPE[J-JTCT;GXB G^P&4QJ$T@:*92FLCPJ6-B(<L4G/1DALI=:OG@/VW
MA]LX5))NMEGZ*/=?>X2;,F8>Q%8](TH7UV6":-E3KMFS##/[78P^ 6?0>NB,
M/K1W+X#:%5":0-',7J#M"I>V*[ZY%X1?NGH!?0(NU0N03D( I7$H3:!H9B_0
M+H=+NQSW36G+>%_-$LJX7N9MR"^'#POY*.-T6]V5JPY#B4_7.R:T1[H3 93&
MH32!HIEYTMHY\6CGY--NNXV?R[O\X3:>S-7C\35+/\?1JM6&/$"I&8K7-$[.
MGZ[H4^N=L PU3% T4Q9MF'BT8?(V>50#+,U:#"S/8E(,Q_8)NJ6LY[3D[-!G
MU5L1J#N"HIF*:/_$H_V30"YEEE7FR3S=R/)IN$4;BR$R]5JTL>2#N"T9R?3Y
M]=8&ZK&@:*8VM=4>M,?RH5BK&7^[H>(U+9"Q;TTTGEF*MECW 7U2O07!+KCX
M'AZ,IST8C_9@]H)TN/">)6VCD1%Y4,62MS%M"6%0/P5*$RB:J8KV4[S.-)"]
M#Z^B6%HII"*9JFE=KM]\E*T+7[RF"W+C3*;V_"E;8=>9VA.HZ!/N+1;4BD'1
M3+&T%>/15LS?"+O+LZVO\%L2HVV%/6_<<I.Q%/:'GO5[%4Y?0>_V_AZ&B*<-
M$8_V(X[?Q,^/W\2ORB?B'\HQ\6.587BPP*QZ(#V!F6?)ZYAZ+7I!O0TH3:!H
MIJ#:V_!H:X'_[;\??K.JA9R[SZ"T $KC4)I T4P]M4OA[6?"%UG3BYS2SZ"T
M $KC4)I T<R%O=J\&-+F!2@%<FA9J6+_[H@^G[[*0FD<2A,HFJFL]C^&M/_Q
MBPSC8LW^$FZV?V5OHC17PSB9V^<1-*KOX(72 BB-0VD"13,EUH;*T+U8/!\B
MW8T9E!9 :1Q*$RB:V26TCS/LDRM#?>%/@WH+W#1]6E,"H#5S*$V@:*9\M8TV
M:->'FK(.+0Z.9[=P9G0UO<<;U! ZT$;&=4RLUR%0-9MR:+MG2-L]'W=Y'H55
M:/W]CRPL(^8L398JA%KS,VA:[R$%708$I7$H3:!HILK:)QKZE[N-(@V>&906
M0&D<2A,HFMDEM)4U1"XRL@K?M*!:)D303!THC4-I D4S-=5NUO K%A9]Q51W
MTKA]M>Q@95EHU+*!%=2R@M($BF:*IBVK(9W@\A6YWS2Q=\AMKBYJ2Q.'5LRA
M-(&BF5N1:9MI1-M,Q(,4^Y.)*(D*>?-K)>S;I B3551N W'?JC%=75^-H;0
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M$RB:N76\]LA\VB,[:?=VK]UOX9># W;-WDOKO9<F]E71;R9QV9=M0*OE4)I
MT4P1M</ETUE7#YE\C-)='C^SC]5.&>?OPSD(!S6KH+0 2N-0FD#13'6U6>5?
M+N'*AYI;4%H I7$H3:!H9I?0!IA/&V#?M'$\S>ZMN65'H^-;7!HAW+)(S[?>
MLCGT) 6*9LJEG2J?3K#ZEIWE:71OM9KI7&[+]I+0BCF4)E T4T]M,_FTS?25
MVTO2U-Y2-ATGW[.N[0N@%7,H3:!HII2U=R?1EE//Z2=-ZRUA<]7>R+=O;PBM
MF$-I D4S)=2FDD^G3;UX^DES>HMG><N3VZ8>U/^!T@2*9JJG_1^_P__IV .
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M\:_F+Z=I,$WHI6K"+"I>:Z*X[+<N^Z#+GS>;N)I%HZ0=M^_N^0O/BW) OO]
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M-?&9)D''*#MY=LPD!8>PZNAN8'FRC!'\X!W!4')A^/;B1%AB=*3]/TT&3=1
M):V%;RQBA-N/CK+_9R\6DZY2_:7DN^79Y8YPR[$!-FK >&86$_U^?W[R#+T=
M+SM@]2S"@JRS?2J.#Y9K/VV?=_BY?LJ?]OF-\XD=GUHH98X/4?Q6]NLX+4C"
M'TO)Q<=JBLR/SR4\OA'9<_VDON^9$-FN?KGET8;GE4'Y]\<L$Z]OJ@NT3X=<
M_1]02P,$%     @ <41<6'-#UTK^!   )AX  !D   !X;"]W;W)K<VAE971S
M+W-H965T-3@N>&ULM9G;;MLX$(9?A5"+(@'<Z.!3G-@&'$O=!FA0(T&W%XN]
MH"W:)BJ)+DG'S6(??H>2(DNR3$0+]B81*<XWY#_2B&..#XS_$%M")/H51XF8
M6%LI=S>V+59;$F-QQ78D@3MKQF,LH<DWMMAQ@L/4*(YLSW$&=HQI8DW':=^"
M3\=L+R.:D 5'8A_'F+_<D8@=)I9KO78\TLU6J@Y[.M[A#7DB\MMNP:%E%Y20
MQB01E"6(D_7$FKDW@3M2!NF(/RDYB-(U4DM9,O9#->[#B>6H&9&(K*1"8/CW
M3.8DBA0)YO$SAUJ%3V58OGZE?TH7#XM98D'F+/I.0[F=6-<6"LD:[R/YR Z?
M2;Z@ON*M6"32O^B0CW4LM-H+R>+<&&80TR3[CW_E0I0,W-X9 R\W\.H&@S,&
MW=R@^U8/O=R@]U:#?FZ0+MW.UIX*YV.)IV/.#HBKT4!3%ZGZJ37H11/UH#Q)
M#G<IV,GI;/5S3P5501/H(_I,<"2WZ#M7^J(%9^%^)06Z\(G$-!*7,.3;DX\N
MWE^B]X@FZ(%&D3(=VQ(FHY#V*G<\SQQ[9QR['GI@B=P*%"0A":L &U91+,5[
M7<J=IR7.=OP*.6X'>8[G-4U(;^Z3U17J9N;=!G/_[>9-WH.WF[L:,;I%7+LI
MKWN&=[<7T",$*@48_?4%^M"])+'XNV&*=QFRUXQ4*>M&[/"*3"S(28+P9V)-
M/[QS!\YMD]HF8;Y)6& (5HE+KXA+3T>?_L%8>("7IDE^K65;^3-8/X6IK\7S
MU'4&W?[8?B[KVC"JVQUVJZ."AE&#7M<K1E64Z!=*]+5*!)@GZ.L>LLL"O^!E
M1#IHON><)+))&RVKK389;%!:3VDQF3"G0YR:*(9F5-%N4&@WT&K7G*8[Z#Z!
M+'+QX=VUYSFWE4%IGWM[V:2MUE=;;4W"?).PP!"L$K!A$;"A^70\-!D7DS#?
M)"PP!*O$Y;J(R[7V15H0OH*, UMBQ-;HF4F:;&!?(PFXDK"+A6#Q^N8D"T[&
M'95S8C5!S+6>VRIN$A88@E44'Q6*C[2*%V_"BL5+FF#U)G2@ :5'2'C:1)+C
M1*P)/R/]Z/1SU!_6Q-=.HJWX)F&!(5A%?-<Y;O<=K?QSV'/#,P[/?%7S#HHH
M7M*(RI<FR7-JY9-9?][UGMMJ;I06F*)552\56:Y6]7M(,<F&PB8'82&(;*J7
M[G)&6>-AOZZQUD]KC4W2 E.TJL;>46/O?^^L<].RM+T3:;7XUM*:I 6F:%5I
MC[6DJRV)CCE[7L[9I50RKZ3O&8?\O2$QW($]Z7RK&NK'@EG,]C 8/K3G3#OH
MBS8+&2U0<UKYH1C4JH"&(1]KSTU@:E+5V!SK25=?4+8KH_2PU@J:I/GN:9GI
M#>IB&_)8%?M8LKHF:U8]K+78_1-Y3JI6HQX#4[2JV,<:U_U=12[Z%\*B?CHE
M'#V2*$TM8DMWS9]=H^6O49IOE!:8HE7C>2R!W=]0 [M&BV"C--\H+3!%JT;G
M6 B[^DKX;5O4ZY,<-.S5]U%&ZUZCM, 4K:KQL?1U];7O5[F%C$3K2B,<,R[I
M/R1$.\(I"SOHA6#>' &]!W=TUG2N-VT=&*-%L2E:%AB[=!X&WX!->A"I?G&
M[6=VGE3T%H>=L_2(K]8_=V_\[,CRB,E.4!\PW]!$H(BL >E<#>&=X-FA9-:0
M;)>>NBV9A ]1>KDE&#:Z:@#<7S,F7QO*07$T//T/4$L#!!0    ( '%$7%B2
M26V-ZPD  (A9   9    >&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM;+6<6V_;
M.!J&_PKA+08MD,;6P8=TD@"-)<X4F'2SD^WNQ6 O:)N.M=7!(U%)"^R/7U)2
M+%-F&*OS^J:5%/(1_;W2)_(5J<NG+/]:;#@7Y%L2I\758"/$]L-P6"PW/&'%
M>;;EJ?S+.LL3)N1N_C LMCEGJZI2$@_=T6@R3%B4#JXOJV-W^?5E5HHX2OE=
M3HHR25C^_8;'V=/5P!D\'_@]>M@(=6!X?;EE#_R>BR_;NUSN#7>4593PM(BR
ME.1\?37XZ'R@_H6J4)7X5\2?BKUMHG[*(LN^JIU/JZO!2+6(QWPI%(+)_Q[Y
MG,>Q(LEV_-E ![MSJHK[V\]T6OUX^6,6K.#S+/YWM!*;J\%L0%9\S<I8_)X]
M_<J;'S16O&46%]6_Y*DI.QJ095F(+&DJRQ8D45K_S[XU@=BKX/@O5'";"FZW
MPN2%"EY3P3OV#'Y3P3^VPKBI,#ZVPJ2I,*EB7P>KBG3 !+N^S+,GDJO2DJ8V
M*KFJVC+ 4:JNK'N1R[]&LIZX_KC\LXR*2*E<D/?D<RGR:H?\Q)+MS^0FRHIE
MQ-,E+\[(IW1)W@9<L"@NWLG"7^X#\O;-._*&#$FQ83DO2)22+VDD9.$W:OLV
MBF-%OAP*V59UQN&R:=>\;I?[0KL<E]QFJ=@4)$Q7?*4#AO)'[GZI^_Q+;UPK
MD?+%.1DY9\0=N8ZI0?;J 5^>$Z^N[AFJ!\=7=PW5P^.KFQI/CZCNC%5UY\(2
M2V]WU7@5SWN!=U,6\DA1D+W+A_SQFSQ&/@F>%/\Q-/&F1OIFI,J@'XHM6_*K
M@4R1!<\?^>#ZI[\YD]'/)K&0L  )"Y$P"H)I(OL[D7T;_7J>)8F45::@Y=<S
MLF4Y>61QR<E;>6.OLCAF>4&V/*]O_7<FQ:W\OHK7L%D%4\_+Q^O1N>..+X>/
M^U(>52I$-HR"8)I&XYU&8ZM&OV39ZDDF65/TK37[1K^&C??BZHPF7C?ZAE*>
M-_4ZT3>4FOB>JY>BH.9K89WLPCJQAO6S[-+)[HD\NB(+GLHM0;8QDQVAHN#"
M]#B[L0+[1KN&3;0X7G1B;2@S&W4BC6P4!<$T0:8[0:960?:?,SF/F9#"++/"
M+(45U5>*Z4&8IQTA#DN\[U[QAT4N.D4HJ-%:=&>[Z,[LF9X5&YG@HQ41F>SK
MRU#GG"R:9[PIPK.#.W@Z'G4NOKGUG'T?T4A8B(11$$P3[F(GW(4]3V5E'A4;
MDT36BGUO B0L0,)")(R"8)J4SJ@=B8WPG>J&"=(92@N@M!!*HRB:KO7>J-OY
MX7Z;O6IO29V#9X_GS[J="4.IR6CL=QYCIE+C<8=%4>W70^NVH76MH?V5LUAL
M#OT+8ZBMJ-ZA1M("*"V$TBB*IDO<N@_.">P'!^H_0&D!E!9":11%T[5N30C'
M[D)8,R748(#2@H:VGRM]KSM@#@VE)M-)=VR :IDN0>LQ.':3X6[#\H21^RPN
MQ0MN[HT=T5L*)"V TD(HC:)HNK2MS^%,3I!)H5X'E!9 :2&41E$T7>O60G'L
M'HHUDT(]$^?0[W#<2=<L-);JVERAL=2L:Q:BVJ^'MO5/'+N!<K_DJ2!_W/)D
MP7/S/8/T'.906@"EA5 :1=%T85M_Q;DX07Z$>B]06@"EA5 :1='TU\.M_^):
MQ_S6_&BOVE?2AJ:] ?$O.OYI8"HU];L]R*:4_A[ G77R(ZK]>FA;N\.UVQV?
M4L'SE*F[A\6$QNPQRXMFB$YS]I S-4)7$PR,P8<:(E!: *6%4!I%T7316R/&
M=?&YTX4Z,E!: *6%4!I%T72M6T?&M;H U_<LYB1;D_MZLL =SU6/B#U4!__^
ME/*\V$1;PM8R#Y!_RMN]8-7,,N,E4)]*.;1[+_%]?])YOV1O4F]QH18,E$91
M-%W<UH)Q[1;,:Y/"C")"K1DH+8#20BB-HFBZU*W5XXY/D+.AW@^4%D!I(91&
M431=Z];[<>V37'9:LU;K,\+EMOA.(M5CXX4@45&4?$6RO-IBBYB?D;14XUR5
MVNMIG\:+PC _Q9?]UY$_<;J)'.H 06DAE$91-%WQU@%R[0[07Y_1UYS@E?EU
M<WL[>BN*I(50&GTU(+I4K:/DVATE4R(^(VI>FNIJF>\XJ,4$I0506MC0]+?5
M,[\[YCV%=>2VUI%KGYOSLH*RRY0E\J[[+2L*\UT&-9"@M !*"QN:]I1PNCJ>
MPA;R6EO(L]M"E$7/>5(^\)9[*?3YV2@R$I1W62KJPYLL7LGQCDE8SV#IC"_<
MCN<]M[>H]^QVZ#0<*(VB:+JVK2_EV7VI/6V9D(.<12E4#T<I*L_W/N'Y@WH<
MRO-&2T[6LA.4\VTLVY,HO[_I*K$GEJ_,<A_.ESEX5-I;V%MKJ!T%I5$43=>Z
MM:,\^[R@NV8YW+I,5U'Z0-CJOV4AE)!&Z=P#Z=X[;E<[J+T$I850&D71=.WV
MEAO9[:7=LU2FWT54&\EG<D<J*E-MM4N$<I76/,^[J\4:03U3ZO4/),4N+,*N
M+,(N+3J%J>2UII)G-Y5,H\]ZX"%3K\RV1@UKY%3K+;CGWJPK(M0N@M)"*(VB
M:+J(K5WDV6<&J=[LMLFK"Q:KMSAD%:WE72C3:L1BPI*L5/TB+D0L>TIRG+ED
MYOGJWN&J(-?M+BFP-Z>WL%!O"$JC*)HN;.L->3^X "J.V"**Y=UJ'H-ZAZZ/
MZW;]'ONY>ZL(]7N@-(JBZ2JV?H\'7#5E9_4==$)I 906>H;E6-U!)^J,NG*M
M_>/9[9\O*2M7D=)KFV>D^H $2>4]6;QD_MAYO=6#FC]06N@=FC^.ZQS,F46=
M5!>P=7\\N_OSDH!1[?UT1YMBP\D\2[8L_6Y4%VH(06D!E!8VM/UNP&0V[6I[
M"D?(;QTAW^X(]5XNZ1_:/E.ONVYF;C]K7UF@M!!*HRB:KE_K^OAVU^?5CYS\
MC]Q&:924B5%,Z&PD*"V TD(HC:)HNNBM_>.?8#:2#YV-!*4%4%H(I5$43=>Z
MM8M\NUT41&JERB,G]_57B?Y19G+ (L>AMV4LHFT<\=RH]I$3C^QG[ZTCU"."
MTBB*INNX]P&:OS;Q2"5J]NW%1 V=@@2E!5!:"*51%$T7O?64_!-,0?*A4Y"@
MM !*"Z$TBJ+I6K<VDV^WF7XT44],B7K<7:\^MY^]MXY0HPE*HRB:KF-K-/EV
MH^F(1'W\$@!9N'F=ON+D,T^R,F\HM@56]A;VS@!0^PI*"Z$TBJ+I5TYK=/FS
M$V1[J-D%I0506@BE411-U[KUQ'R[)Z:O"GB4J3Y]:">:-D:*\>5M WX]X4.=
M+2@MA-(HBE9+.=S[@&PUZ45]ZE>];2]347]A=7=T]SGAC]5'=#O'Y\Z'L/XH
M<(NIOU%\R_*'*"U(S-<2.3J?RIY'7G_VM]X1V;;Z3.TB$R)+JLT-9RN>JP+R
M[^LL$\\[Z@2[CR]?_Q]02P,$%     @ <D1<6.-!W+^(%@  &R0! !D   !X
M;"]W;W)K<VAE971S+W-H965T-C N>&ULU9U=;^-&FH7_"N$=S"2 '8L?HJ1L
MMX%ND_4QZ$X:[<SLQ6(O:*EL<T.+"DEUQ\#^^"4I6J7Z4$F</A,@-XFEKGK>
MDGU4++ZGZN6;KV7U:_TD1./]_ERLZ[<73TVS^?'ZNEX^B>>L_J'<B'7[+P]E
M]9PU[<OJ\;K>5");]9V>B^M@,HFOG[-\?7'SIG_O4W7SIMPV1;X6GRJOWCX_
M9]7+>U&47]]>^!>O;WS.'Y^:[HWKFS>;[%'<B>8?FT]5^^IZ3UGESV)=Y^7:
MJ\3#VXMW_H_<]R==C[[)/W/QM3[XV>L^RWU9_MJ]X*NW%Y-N2*(0RZ9C9.W_
MOHA;410=JAW(;P/U8A^TZWCX\RN=])^^_33W62UNR^*_\E7S]/9B?N&MQ$.V
M+9K/Y5<FAD\T[7C+LJC[_WI?A[:3"V^YK9OR>>C<CN Y7^_^G_T^_"8..OC1
MD0[!T"'0.X1'.H1#A_#<"-'0(=([Q$<Z3(<.TW,CQ$.'^-P.LZ'#[-PAS8<.
M\W,C+(8.BUX.N[]?_\=/LB:[>5.57[VJ:]W2NA]Z!?6]V[]YON[4?M=4[;_F
M;;_FYOVV;M^I:R]I-5<W>;.MA/==(IHL+^KOO2OO'W>)]]U?OO?^XN5K[V->
M%*U$ZS?731N[(UPOASCI+DYP)(X?>!_+=?-4>^EZ)586 ',#@L@!N&X_]?ZC
M!Z\?_7W@)+[;/O[@3?Q++Y@$H65 M^[N'[,7+SS>.W'W_ONVV </;+].=_=$
M+']P12?G=[=%I^=W]VU_RF\;/#_UJUNWW2>VP2LZ"/=?@;#GA4=X?+TLGX5W
MUV2-:.?QYM)[GQ79>MF^U5]OLO7*>[=:Y=WDG!7M%Z5>%F7=?D]J[_ZE>[DI
MZ_9]6I7;37WIM;ABN\K7CWW+5K+Y>BM6WL\;464=HO;^^T,[ H^WT>K_L7S\
M][OA1O;A=I>_'^M-MA1O+]KK6RVJ+^+BYJ__X<>3_[2)& E+D+ 4"2-(&$7"
M&!+&03#E>Q+MOR>1BW[SKJY%4WM/HEAY[3++:T4O;/)U4L;*%PE+D+!T!YOV
ML&Y-^>5F.HG?7'\Y5*79QF^7H6HCBAP5.V-4'!10$=%T+Z*I4T3I;]N\>?$^
MBN:I7+5S9;?HZ"9=VY+BO1,U5DE(6(*$I3M8?*@27Q.2I8DN(^20V.DA<5 \
M147Q7D6Q4T4_M9?E354NA5C5[3W74K2+UW92JLIG[_YU0;N2"UJKN)P1QHH+
M"4N0L#2V*&>J:8=8&OGQ0A-8;$YF_E1MPY!#YR"8HK#97F$SI\)NL_JI7_DM
MNQ]$.VM]:2]W1^8I)VJLE)"P! E+9X9*9I-04Y+9)IIK;:B%H\\N[(Q8'/3A
M%'W,]_J8._7QN9]TLOM"M$O^M6AO&I;;JFH%8M.'$S56'TA8@H2E<W,6F07Z
MDLC2:.[/-84@A\7.&18'152TM-AK:>'44K<*6C=EE=LO5,[.8]6#A"5(6+HP
M_DQ!-)MIZC$;A?Y4FSLH<ECLG&%Q4$1%/?Y$IO F3OU\JLJ-J)J72V]39.M=
MPJ*[8FV>C\Q';MY824%I"926#C3E>A1$^O+'VDJ_W%#HR-A9(^.HF*JR#I+#
MOE-9M"Q77_.BL(K(V76TB)"T!$I+!YJZAH[#J:XB2[,PG!DRLC2+HS#0%D#G
M!>6H3ZH*)) ""9P"^;EY$I67KYML_9BWBR$OZY-$_9+(*AHG;K1HD+0$2DL'
MVN'?;QY.]>N9I=5B,@]TR2!'QLX:&4?%5(4E<_*^,Y4Y"&NG)JN0H$ER*"V!
MTM*!IMP*Q9&N([-1/-=OX*'C8N>,BZ-"JBJ2&6O_G)2U53_0+#64ED!IZ4!3
MULR3Q6RN*\C2;#H-C*D(FJT^;VP<%515D4Q9^^Z<];OELMRNF]K[E+UT=_R7
MWNWQ>WTW:[2PH%EK*"WUS23QE1^:PK(UBXQ;?NC8V'ECXZB@JK!D%MMWI[$3
M\2!:(74^2&]!_Y+][GW(L_N\R)N\2RS]=&05!<U=0VD)E);Z9F;ZRE^$QC+*
MTBP(C,0C=&SLO+%Q5%!58S*/[;L3V;N%E*JJ<NU(5KIYH\4%36=#::EO)IFO
MIK&1'+"TBA9ZS@DZ,G;6R#@JIJHLF0'WW2EP4E8B?UP/B>_EB_>8Y6OONZ*L
MZ^_[&T"O?/":['>KR* I<2@M@=)2*(WX9C+[:A$:\QPT?PZE<11-%:U,M?ON
M7/O=4U:)I[)8B:K^6Y\E;5ZL H5FW:&T!$I+?3/#[4>QL0/!UFP63Z>Z]*#)
M]_/&QE%!U6VD,O\>N//OGT7=5/FR$3NWV"8G-V&LG*"T!$I+ S.OK5N EB;&
M;I:AS>%N RVWP$Y'XJB/I@I#IL\#=_I\V/.Y?O0*D=7"J[J=]U?EP]6V%H[<
MEILZ6BS0S#J4E@9FDMM(6Q%+HUFD7_*@XV+GC(NC0JKBDJGWP)UZ_Y@OJ_(^
MSPKOMEPW55EX_Z=M1K[TF"A65P]E==7MU?3*:FC03E3MTNS^Q;O+NFS&3V5S
M;*^R59[0'#Z4ED!I*91&H#0*I3$HC:-HZC=#>@?!GVQ#?P U*Z"T!$I+H30"
MI5$HC4%I'$53OS'2)PG</LFGU[VT_1;:PZ-@[77B]8A8ESIJOQ.U_:( ]5.@
MM&2@J=OPI]IR,H7&)% :A=(8E,91-%6ZTIP)W.;,+U6VKONIW+MKX?FRG<7?
M/59BF/E)EE?>/[-B:SVJXF:/5BW4K DL%D88ZZ)%AB10&H72&)3&4315M-+X
M"=S&3UHONSZ):%<:N34+[P:,5B;4X@DLQP6FNC"1$0F41J$T!J5Q%$T5IG2+
M K=;]*FLFZMN-=PM=[/5_VX=I[/<J-$2A1I% VVJ3)ZZ1)$1"91&H30&I7$4
M396HM)T"M^UTXH+_BZB>K6J%.DY06G+B$_L+[[DO?6"]XX+Z2U :A=(8E,91
M-%7%TH<*W#[4"17O4AB7WF>QVNZJPOQ2>K?MY%SWV;I=2J+?.-(V^2+61Y:W
M4!,+2DN@M#2P'-/0]V=;VNA.$H6.BD%I'$53BV1(ERMTNUQZ;OE46NRRRTO7
M^6IX:=.G.^)8?4)I26@:4'[@:QY "HU)H#0*I3$HC:-HJI:E,1>ZC;G^=&\_
M!0\;\)K2:YZ$]W[[(BJOG6V[%[?#,EA)'EME#/7KH+0D-)VLJ\A0,3(D@=(H
ME,:@-(ZBJ2J6#F#H=@#3YTU1O@C1+@'RY_MM5?>+!T\>3;:*%>K>06E):)Y,
MN?)UK4(].2B-0FD,2N,HFJK5@QI;[O,\>X>!Z [#S])A.+KAV0T?+5IL32SS
M'(Q9/".%QB10&H72&)3&4315MM(8"]W&V+DUK]R8T0*%VE]06@JE$2B-0FD,
M2N.A:4(&L4Q)JOJ4[E?H=K^X/'G[;CAYV]5&^D[>G+T>X?[>*ENH_P6E)5!:
M"J41*(U":0Q*XZ'I0L[CV1'92O\K/.%_C:D"YV:-%BG4"H/24BB-0&D42F-0
M&@]-0W(6'=&HM,+"<PY.'=^EZ^X^6I90^PM*2Z$T J51*(U!:3PT3W'-)T=D
M*>VO\(3]5399,<BR7Y?N]_=:10IUO:"T!$I+H30"I5$HC4%I/+241POFQV9/
MZ6^%;G]K?V9^LSLS;Q4GU)Z"TA(H+872")1&H30&I?'0M.PBWR[-2!I9D=O(
MVEW8"WDBVJ9--V.L-J&T!$I+H30"I5$HC4%I/#*/GQU4YU*U*8VIR&U,[:[N
M!]H\?8EW$T<K%>H^06DIE$:@- JE,2B-1Y8#=/$1I4KS*7*;3\=,?]H7 ?C0
M%0%X/4TP[!LH'X[N%+@7K<+%01D4J]"ASA64ED!I*91&(M-5,_:]0",R*(VC
M:*K0I7,5N9VK\?M>N@SL\<IC[G"C90SULJ"T%$HC4!J%TAB4QB.+HQA,YD=F
M[(/'M[B]+,1#$]PA1HL7ZG,--/779ASS@L8D4!J%TAB4QE$T5;S2Z(K<1M=M
M5E4OW:3[I3O+U:TEN@)#?1K,JE.HL06E)5!:"J41*(U":0Q*XP-M>MXD*YVM
MR.UL=27\Q,.#6/;5KPXJ8G6["@]F5ZMHH487E)9 :2F41B+3_EG$^@(7:E]!
M:1Q%4R4KC:[(;70E>=7)==F?+FA*KQ;V@N]NS&AY0@VOR'+>2[_)2:$A"91&
MH30&I7$43=6G=+RB$W4&B^Q+67EW&[',LZ)Y:>_ 'BNQRKO] G]4S1OW$$=K
M'^JC06DIE$:@- JE,2B-HVCJET3Z;='."OG3U+R)H.8>E)9 :2F41J T"J4Q
M*(VC:.IS2*4-.#WYU*1OK'DS-8^(!1/MU.&M>Q1CE0NEI5 :@=(HE,:@-(ZB
MJ<J5)N'4;1*^6WWI9_8^A[=I^HWI^PQ>NX"_%UXCS[99E6LY%>;KPH4Z@5!:
M"J41*(U":0Q*XRB:*ESI&4Y/>H;H(\13B[FU,.9@J-<'I:50&H'2*)3&H#2.
MHJE2EJ[@U.T* N9@B\NCZQ9J[D%I*91&H#0*I3$HC:-HJFZE"3AUFX#?=@YS
M:EILP62BJQ;JZD%I*91&H#0*I3$HC:-HJFJE^S=UNW\(ZWIJGF2RW*U!G3XH
M+872")1&H30&I7$43=6N= 2G;D?PW7.W$7YWA#A?>Z(O_6@5Z.FRBK?N6*/U
M"37UH#0"I5$HC4%I'$53]2GMOZG;_NO+X&2[(F.]!VC5INV!5+HVH8X>E)9"
M:01*HU :@](XBJ9J4UI_4[?UMU^M9DU3Y??;ICM*U'O4V\VF>/&RUXIY5LU:
MGI45Z9J%.G%06@JE$2B-0FD,2N,HFJI9Z<1-W2??^MIBC5I;[+ZK*V;5J'G
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M#(OC,)PFU.! J&Z/:60-K1.X\7JU'':*]04!-FB*Q1$LCF)Q#(OC,)PFV/!
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M=PSP79HB]N,M3NAA;D'KZ<0]V<1"G; 7LRW:X <LOFSOF%S9%<J*I#CCA&:
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M_(?4.T1'ML";-&B,7#]T.F0U5C ,'#U9OR+K&\D6@B)U0:%2?1D6.JK^$8G
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M*0-Y?4VI>%JH79]JEV_Q/U!+ P04    " !R1%Q80K# _B0#  #X"P  &0
M 'AL+W=O<FMS:&5E=',O<VAE970V-2YX;6RMEM%NVC 4AE_%RJJIE=HFA)!
M!Y& =%LONE6MNEU,NS#)@5AU8FH;Z/;TLY.0$4@#2-Q [)S_]SF?'>OT5XR_
MB!A HK>$IF)@Q%+.;TQ3A#$D6%RS.:3JS93Q!$LUY#-3S#G@*!,EU+0MRS43
M3%+#[V=S#]SOLX6D)(4'CL0B23#_,P+*5@.C9:PG'LDLEGK"]/MS/(,GD,_S
M!ZY&9ND2D01205B*.$P'QK!U$_1T?!;P@\!*;#PC7<F$L1<]N(L&AJ43 @JA
MU Y8_2UA#)1J(Y7&:^%IE$MJX>;SVOUS5KNJ98(%C!G]22(9#XRN@2*8X@65
MCVSU%8IZ.MHO9%1DOVA5Q%H&"A="LJ00JPP2DN;_^*W@L"%HN>\([$)@;PN<
M=P3M0M ^5. 4 B<CDY>2<0BPQ'Z?LQ7B.EJYZ8<,9J96Y9-4;_N3Y.HM43KI
M?V$L6A%*$4XC]%W&P-%=*G$Z(Q,*:"@$2'&)OJGS=X6&">.2_,79AMV^J9,G
M )T'(#&A%^K]\U. SL\NT!DB*;I7IBI.]$VITM2+F6&1TBA/R7XGI9:-[EDJ
M8X%NTPBBJH&IZBN+M-=%CNQ&QP#":]1N72+;LMLU"8T/E]LU\N!P>:NAFG:Y
M9>W,KWW(ENUL%@J(""D3"P[HUW B)%>?UN^Z7<A7<>I7T=?-C9CC$ :&ND\$
M\"48_L</+=?Z5$?PE&;!B<PJ=)V2KM/D[E<..9NJB^EU0031PRL.%$N(U/%>
M0Z\]WOD"G6P!?>TN?;=K]<WE)J_=&,_VJC%!34S;+F,JU77*ZCJ-U:DCZ-2E
MG*O<S92][E;*C<[';O&)S"H0W!*"NP]"IPZ"6P/!W8+0Z'PLA!.952!X)01O
M'P2W#H)7 \'9@M#H?"R$$YE5('1+"-U]$+PZ"-T="!UOZ^L<-SH?"^%$9A4(
MO1)";Q^$;AV$WL[UT^ELWPF-SL=".)%9#L'<Z(D2X+.LMQ0H9(M4YIU#.5NV
MK\.L:]N:'ZFV-N]"_]OD/?$]YC.2"D1AJBRM:T^QXGF?F0\DFV>=UX1)U<=E
MC[%JS8'K /5^RIA<#_0"9;/O_P-02P,$%     @ <D1<6*LS^\3? P  $ T
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M-3:^O7??/DBVSB^6YTQ*EN0O5X!CX-I ?;Y@3.X>]%UU^>O']%]02P,$%
M  @ <D1<6+.A+I7F%   EG(! !D   !X;"]W;W)K<VAE971S+W-H965T-C@N
M>&ULM=U=;]M6MH?QKT)X!H,.D,8B)8I2)S'0A/L5S:!(VIF+@W.AV$PL1)9\
M)-EI@'[X0\FT-S=);Y&39VX:.R%_I.NU[$W]N:A77S?;+[OKHMA'?]RLUKO7
M9]?[_>U/Y^>[R^OB9K%[N;DMUN6_?-IL;Q;[\M/MY_/=[;987!UWNEF=)Z/1
M]/QFL5R?7;PZ_MVOVXM7F[O]:KDN?MU&N[N;F\7VVYMBM?GZ^BP^>_R+]\O/
MU_O#7YQ?O+I=?"X^%/O?;W_=EI^=/RE7RYMBO5MNUM&V^/3Z[.?X)QLGQSV.
MF_QK67S=U3Z.#E_+Q\WFR^$3<_7Z;'0XI6)57.X/QJ+\X[YX6ZQ6!ZH\D?^K
MU+.G@QYVK'_\J,OC5U]^-1\7N^+M9O7OY=7^^O79["RZ*CXM[E;[]YNONJB^
MHO3@76Y6N^-_HZ\/VV:CL^CR;K??W%0[EV=PLUP__+GXH_H_4=LAGCRS0U+M
MD#1V2))G=AA7.XS[[C"I=ICT/:6TVB'M>X1IM<.T[PY9M4/6W"%^9H=9M<.L
M[Q'FU0[SOCO$H\?OW.A800_?\F.]Y(O]XN+5=O,UVAZV+[W#!\>B.^Y?ELER
M?6B0#_MM^:_+<K_]15Y\W$<_1F\W-[>;=;'>[Z+-I^CXES_DQ7ZQ7/T]^MM?
M9N/IY!_1<AV]6ZY6957O7D1_K7_ZZGQ?GLH!/+^L#OOFX;#),X>U=ZN743)[
M$26C).[8_6UX][RX?!F-X^/NX^CW#WGTPU__WL'D_9DDP(@P(XN/+Z-1_.P7
M(\.[?RANR_\7T\/N\2QP%JH/DU:,^/U]]$/UG>O"=!A[M_@6Q<=O3YP%3LF<
M4K8OHWAR9*8G3\F&L9]O2VST@#WS/3\OB_^I Y*G#DB.[CC4 6:]VV_ORA_\
M^^A_?BDWB,R^N-G];U=A/VB3;NWP^^RGW>WBLGA]5O["VA7;^^+LXF]_B:>C
M?W25.8GE)"9(3)*8(C%-8H;$+(1Y/3%^ZHEQ2+\H?QW<%-O+Y6(5W2YNBVU7
M'P2%H7WP@*5'[+"FN[\8O3J_KQ=W>XMXEOG;"/*4)(DI$M,D9DC,0IA7LY.G
MFIT$:_;P<_Q%M-JL/_^X+[8WT6)]%>VN-]O]\=,7T>7FYF.YRU57+0?EH;7\
M@$WKE3H:97&CGKNVFF>-JA?DB4D24R2F2<R0F(4PKZ+3IXI.PS^%[[;;PXJD
MO J\VR[WR^*X.'<5?E56?%<U!]6AU9RVZO3'V2QM%'/'1NF\^=.9/"U)8HK$
M-(D9$K,0YM7R]*F6I\%:_N5DU0;W'UJUTU9!SN/9M%&U[8WBT3@;-\J6/"])
M8HK$-(D9$K,0YI5M]E2V6;!LWQ?WF]7]<OTY^F6S6$=R<;E<+???HC^CM^4/
MY(^+]9<7T3]?_MQ5ST%X:#V36$YB@L0DB2D2TR1F2,Q"F-<>LZ?VF*&OG<S(
MGB"QG,0$B4D24R2F2<R0F(4PKR?F3STQ#Z]T#BU0KM,OM\75LG.E$]Q_:!?,
M3[YR0AY.D)@D,45BFL0,B5D(\TH['KFT:!0L[G?+]?+F[J9<__1<&96?B[OM
MYO)X*7OY+7J_V!>=<5'PN$.; M5R5!.H)E%-H9I&-8-JEM+\/JJEKC&Z<*HX
MJCU(+4<U@6H2U12J:50SJ&8IS6\/%\G&P73K$!Q_7JZCS3JZ7VR7BX^K(MH^
M]XOC08KC^@KHY2B.D\:+E&_#QQQ<]6C:BFH2U12J:50SJ&8IS:]Z%[K&X=3U
M/UE<O5GLBN<756A&BVHYJ@E4DZBF4$VCFD$U2VE^_[@ .)ZPBRHT]D6U'-4$
MJDE44ZBF4<V@FJ4TOSU<FAR'X^0ABZJT<U$UZEA4D0EECFH"U22J*533J&90
MS5*:7_4N=X[#P?.[Q1__I5>LT, :U7)4$Z@F44VAFD8U@VJ6TOP^<D%XG+&+
M*S3_1K4<U02J2513J*91S:":I32_/5P0'@<SQ4&+JP?I\ JT]XI5UEI;H0DW
MJ@E4DZBF4$VCFD$U2VE^T;ND.PY'W?_)VBK\@A4:C:-:CFH"U22J*533J&90
MS5*:/WCFTO1DA*ZI$C0D1[4<U02J2513J*91S:":I32_/5Q(G@13QB%KJDIJ
MKJE&K355^)"#BQZ-OE%-HII"-8UJ!M4LI?E%[Z+O)!Q]?RC6R\TV^N=F7^RB
M'X\#[IT%SXXALW/([" R.XG,CB*SL\CL,#([C?S?B,83%XTG8W:EA";?J):C
MFD UB6H*U32J&52SE.:WATN^DV!T>&'6^Z)T]\?UT>'F\^>&[,+.X+Y (V]4
M$Z@F44VAFD8U@VJVTIKK\G'RM"SW*]Z%V4DXS*Z62>O#,JFST-$A:%3+44V@
MFD0UA6H:U0RJV4JKS^&,1Z-GJMR%UTDXO.ZX&(C^/+[$NHM^77P[7!)W%C\:
M3:-:CFH"U22J*533J&90S5*:WR4NFD[8:#I!HVE4RU%-H)I$-85J&M4,JEE*
M\]O#1=-).)KN?W& CF<GW3'WN/%\C1P]JD UB6H*U32J&52SE.97O,NEDW N
M7;\X>!$]W,G77?%HWIR<GL6N-JD_<Z:^3*QJ&,V&44VAFD8U@VJ6TOP',+IL
M>!R>M*XO_5\<[TA]_+B\"IAT%7,8'%K,J):CFD UB6H*U32J&52SE.8WB$N'
MQ^P(]1@=H4:U'-4$JDE44ZBF4<V@FJ4TOSU<CCP.Y\B]5_UA9W!?H$DRJ@E4
MDZBF4$VCFJFTDS<L6^JP?LG7'EH=GI^N+_NC/Q_?MZ"SYMF'5Z/Q,*H)5).H
MIE!-HYJIM#BIU7S:O%*SU#']@G>Q[S@<^X:O$?HD!>$##&X$- ]&-8%J$M44
MJFE4,ZAF*<UO&)<:CU/VF@%-D5$M1S6!:A+5%*II5#.H9BG-;P\7-X][Q<W/
MWE01WGUP.Z"Y\KC]-.^T=IM)5>5H7(QJ"M4TJAE4LY3F5[F+B\?A9WH#JR8T
M0$:U'-4$JDE44ZBF4<V@FJ4TOV%<@#QFG_(]1G-D5,M13:":1#6%:AK5#*I9
M2O/;PZ7-XW#:W/^55C1MKK36JW*S6?.=T]#!9523J*903:.:035+:?X[K;EP
M>M(KG#Y]@T78&5KRE5:_P2)-D^8;JZ%1,ZI)5%.HIE'-H)JE-+_<7=0\"0\B
M^U<,^5T1_?9U$_UVO;G;'=YE\+>O9?5_B^3RONAS]1 ^V.">0(-H5!.H)E%-
MH9I&-8-JEM+\YG%!](1]?^4)FD>C6HYJ M4DJBE4TZAF4,U2FM\>+K2>A$/K
MWE</86=P7XR[KQZ2UG(*C:-13:*:0C6-:@;5+*7Y)5][H^9>L?6S,4-X]\&5
M/FE=-,2C9I*?5UM-@UL)],PDJBE4TZAF4,U2FE^^+D2>]!H][LX/IIT%C<;(
MJ):CFD UB6H*U32J&52SE.8WB(N1)U-VQ8_&RJB6HYI -8EJ"M4TJAE4LY3F
MMX?+GR?A_+G_BA^-F5$M1S6!:A+55*6U<Q9_;:C1HQI4LY3F5[P+D"?A">3^
M-V:'H<$ECT;'J"903:*:JC3OYN=9\V)(H\<TJ&8IS2]X%PE/>@T@/W.)T"LD
M0+-B5,M13:":1#6%:AK5#*I92O,:)G6!<LH^"3M%<V54RU%-H)I$-85J&M4,
MJEE*\]O#!=!I.(#N?<D0=@;W1?=3M>-Y\QDNZ&$%JDE44ZBF4<V@FJ4TO^1=
M;)SV>@[VLR%!>/?!E9ZT0H)9-F]6>=+*"&:3Q@RL0,]+HII"-8UJ!M4LI?G%
MZT+=M-<D\HD;ACX4]\6ZS\5 ^&B#:QT=5T8U@6H2U12J:50SJ&8IS>\>EP^G
M$_9B ,V+42U'-8%J$M44JFE4,ZAF*<UO#Y<_I^'\N?_% !H[5UKK8B"=-I=)
M:**,:A+5%*II5#.H9BG-+WF7**??-Y@<WGUPI4_;=PPE<?/&N+0]<%QNU;H<
M0!-?5%.HIE'-H)JE-+]\7>*;]I\X?GB,^ZRSBM&\%]5R5!.H)E%-H9I&-8-J
MEM+\KG"I<,J.%:=H-HQJ.:H)5).HIE!-HYI!-4MI?GNX##F%QHK#SN"^0*-B
M5!.H)M/N >I)\R5=A1Y6HYI!-4MI7LE/70H\[3]6W%7IX=V'5CJJY:@F4$U.
MVW/3D^;M/ H]I$8U@VJ6TOPJ=V'NM/\T<74UT"<$"*N#BQ\=&T8U@6H2U12J
M:50SJ&8IS>\2E_].V;'A*9H'HUJ.:@+5)*HI5-.H9E#-4IK?'BYAGD)CPV%G
M<%]TCPU/TJSQZBAZ6(%J$M44JFE4,ZAF*<TO>1<+3X.YVNFK S0&KC3O#3WG
MS4=K51M-0QL)]+PDJBE4TZAF4,U2FE^\+K2=#AD:;M\1=+W<[K_UN@Q 0UU4
MRU%-H)I$-85J&M4,JEE*\_O&);]3=I9XBB;!J):CFD UB6H*U32J&52SE.:W
MATN6I] L<=@9W!?=,[%)$C<72&ALC&H2U12J:50SJ&8IS2]Y%QM/^P\3=U8Z
M&A-7FG<O4#IJ70?,VO<"I7'SZ4'HF4E44ZBF4<V@FJ4TOWQ=K#L=,AK<NA"0
MF[[7 6CJBVHYJ@E4DZBF4$VCFD$U2VE>VV0N&L[8 >$,C8I1+4<U@6H2U12J
M:50SJ&8IS6\/EREGT(!PV!G<%]T#PN/1I+% 0@\K4$VBFD(UC6H&U2RE^27O
M N+L^P:$P[L/KO3V@'"6-<?@L_: <)8U6D&@YR513:&:1C6#:I;2_.)U\6TV
MX*V*#_< 3;+.&D;#6U3+44V@FD0UA6H:U0RJ64KSN\(EO-F$7>2CB2^JY:@F
M4$VBFD(UC6H&U2RE^>WA,N0,&OP-.X/[ LV(44V@FD0UA6JZTN*X<>?5.&N,
M*QCTN);2_)IW^6_V?9._X=T'ESJ:]Z*:0#6):@K5=-:>OTZ;XPH&/:2E-+_*
M78R;]1H0KE\.],D PNK@XD<'AE%-H)I$-85J&M4,JEE*\[O$);\9.S"<H4DP
MJN6H)E!-HII"-8UJ!M4LI?GMX9+E#!H8#CN#^^*Y,=I6!H"FPJ@F44VAFD8U
M@VJ6TKR2G[E4>/9] \/AW8=6^JQCC';>N/K*JXVFH8T$>EX2U12J:50SJ&8I
MS2]>E]G.!LX!3SJ?"A16!M<P.O>+:@+5)*HI5-.H9E#-4IK?%2[6G;%SOS,T
MYD6U'-4$JDE44ZBF4<V@FJ4TOSU<<#R#YG[#SN"^0*-C5!.H)BMM[E_--!\)
MA!Y3HYI!-4MI?KV[2'@6S-1.K_#1"!C5<E03J"8KS7O#@]8C@=!#:E0SJ&8I
MS:]RE^S.^D\'5Y<"?5[_#ZN#BQ_->5%-H)I$-85J&M4,JEE*\[O$9<$S=A9X
MAF;#J):CFD UB6H*U32J&52SE.:WAPN19] L<-@9W!?=L\!IZX'IZ&$%JDE4
M4ZBF4<V@FJ4TO^1=(CS[OEG@\.Z#*[T]"YS-F@^^FK5'@5L;"?2\)*HI5-.H
M9E#-4II?O"ZOG7W?)/#R4[])X/!A!A<Y.@F,:@+5)*HI5-.H9E#-4IK7-G.7
M^<[92> YF@&C6HYJ M4DJBE4TZAF4,U2FM\>+E6>0Y/ 86=P7SPS"=QZ(A!Z
M6(%J$M44JFE4,ZAF*<TO>1<9S[]O$CB\^^!*;T\"Q^FT^5[!\_8H<)QFC680
MZ)E)5%.HIE'-H)JE-+]\7:0[#T>ZR2B91+\5VYOC4K_/BC\,#BYH--M%-8%J
M$M44JFE4,ZAF*<UO$)<!SR?LBA_-A%$M1S6!:A+5%*II5#.H9BG-;P\7'L][
MA<?/+W_0E!C5\DJK+Y.F2?-N:?20$M44JFE4,ZAF*<VO<A?^SL.#P.%54OGY
MN^5Z>7-W4W[T9K$KHO?EY6]G-Z"A,*KEJ"903:*:0C6-:@;5+*7Y;>-"X7G&
MKIW0;!C5<E03J"913:&:1C6#:I;2_/9P ?(\'"#W?[4439)1+4<U46G>#=#^
M@DRB!U2HIE'-H)JE-+_87> \#P?.IY=0BS]Z+:'0P!G5<E03J"913:&:1C6#
M:I;2O+:)1RYQ/GQ,+J(>/:A#6"YG.<%RDN44RVF6,RQG,:[1*7&M4Z#T^00T
MO$70N6:6$X]<8ZBLD09*]JB*Y33+&9:S&-<H_:16^N$4>GB,=T(<W@/H\#++
M"9:3+*=83K.<83F+<8U>&==Z90POJ-#$F^5REA,L)UE.L9QF.<-R%N,:G3*I
M=4HP/!RRH$)3[T>N=4-?\W&S.7M@P7*2Y13+:98S+&<QKE']::WZ^T?;+Z++
MN^VV_&W17?UHR/W(U6_R2[)1J_+1&6>6DRRG6$ZSG&$YBW&-RI_6*O]DW#T=
M>C6!)MLLE[.<8#G)<HKE-,L9EK,8U^B5K-8K;,;]Z&&=@J;<+"=83K*<8CG-
M<H;E+,8U.F56ZQ0H[CX!#6^16>?51#IKOH4:>V#!<I+E%,MIEC,L9S&N4?WS
M6O7W&KA^]D;9$_L/+_IYZR*B=7-K_KA5^!98]M0DRRF6TRQG6,YBG%_'<2V.
MCL-/O0Y?&_2_%?;$<0;7.\KE+"=83K*<8CG-<H;E+,8U.J@64\<Q>\40LVDU
MRN4L)UA.LIQB.<URAN4LQC4ZI99JQ^%4N_\50Q@:WB)LF(URXI%KOAO?*&ZN
MW"1[9,5RFN4,RUF,:Y1_+:B.3\YFGUAJ];ME]L1QAG<'&V"CG& YR7**Y33+
M&9:S&-?HH%J '4_@I1:;8Z-<SG*"Y23+*9;3+&=8SF)<HU-J87<,O;WS"6AX
MBZ CW2PG'KGF4BMNW8DBV2,KEM,L9UC.8ERC_&N)=QQ.O-\7]YO5_7+]^6&I
M)1>7R]6RWQ,P3]##&X*-OE%.L)QD.<5RFN4,RUF,:S1-+?J.X>@[9J-OE,M9
M3K"<9#G%<IKE#,M9C&MT2BWZCL/1][$QRD75Y;:X6CZSK&(S[[C])/#6'80=
MV\3-M^$1[(E)EE,LIUG.L)S%N$8=UT+L.!QBOUFLOT2;^V)[M5U\VN^BPZ/"
M-_OK8MM=TFRBC7(YRPF6DRRG6$ZSG&$YBW%^FR2UC#R!1[83-@M'N9SE!,M)
MEE,LIUG.L)S%N$:GU++P)#RR/>P72A@;WB9QZQ:IUAV!'=M,FRLD]+0DRRF6
MTRQG6,YBW$-!G^^NBV*?+_:+BU>WB\_%N\7V\W*]BU;%IY(?O<S*LM@N/U\_
M?;+?W);U?Q9]W.SWFYOCA]?%XJK8'C8H__W39K-__.2\]+]NME^.Q[CX?U!+
M P04    " !R1%Q8T/D/*D<7  !4A0$ &0   'AL+W=O<FMS:&5E=',O<VAE
M970V.2YX;6R]W6UOVU::QO&O0G@'10=(8Y'48YL$:,KSM&B:;M+NOECL"UJB
M;:$RY9)RT@#]\$O)E \/)1V1SG]F7DSMA/R1=B[:MW3I4*\^KXL_RMLLVP1_
MW:WR\O7%[69S__WE93F_S>[2\N7Z/LNKO[E>%W?IIOJTN+DL[XLL7>QVNEM=
M1H/!^/(N7>87;U[M_NS7XLVK]<-FM<RS7XN@?+B[2XLO;[/5^O/KB_!B_P<?
MEC>WF^T?7+YY=9_>9!^SS>_WOQ;59Y=/RF)YE^7E<IT'17;]^N+'\'L3#@?;
M/7:;_/<R^UPV/@ZV7\O5>OW']A.S>'TQV)Y2MLKFFZV15O_YE/V4K59;JCJ1
M/VOUXNF@VQV;'^]UN?OJJZ_F*BVSG]:K_UDN-K>O+Z87P2*[3A]6FP_KSSJK
MOZ+1UINO5^7N_X//];:#BV#^4&[6=_7.U1G<+?/'_Z9_U=^)Q@[A\,0.4;U#
MU'6'N-XA[KK#L-YAV'6'4;W#J+W#Z,0.XWJ'<7N'\8D=)O4.DZZG-*UWF';=
M85;O,-O%X?'?;_>/GZ2;],VK8OTY*+9;5]KV@UV"=GM7_^;+?)OVCYNB^MME
MM=_F39)=;8+O@A\7B^4V?.DJ,/GC-;2-XG?!;UEQ%_R\3JM8YHO@8Y8OUT7P
MRWJ3E<&/976)9(O@VR3;I,O5/ZNM?_^8!-_^XY_!/X++H+Q-BVJK91[\GB\W
MY8OJ#ZN/WRU7JTHN7UUNJK/?GL/EO#Y3^7BFT8DSG07OUOGFM@Q$OL@61_97
M_OW#R -<5M^VI^]=M/_>O8V\HLRN7@:#\$40#:+AD1/ZR;_[Q^S^91#.=KO'
M1W9/NNP^VNT>'=E==#_Y\-B_AG_W))N_#.+PY,FKK]M==]_]V-=NNGSKQKO=
M!YX@Q$\74;SSAB>]W67Q>UYF\X>BNB3L52/3^7)575K5E?!W8X/=9?=W\,O#
MIMA==\$WZ=W]#\';Y;J<+[-\GE77B\GG1[ZTM]Y3V?YR_+Z\3^?9ZXOJMU^9
M%9^RBS??_$<X'OQP+*$DEI"8(#%)8HK$-(D9"'.N@>'3-3#<Z;'O%XG)RTU1
M_5+(-\'__EQM$)A-=E?^W[$8#\D8DUA"8H+$)(DI$M,D9B#,B?'H*<8C[X_R
M;8Q?!-<5'Z1WZX=\<RR[7J)O=DDL(3'QB(UVV/91TZ=JAAI5OR\_-3-)'E&1
MF"8Q V%.)L=/F1SW&R\>YV]HGO >NV^822PA,4%BDL04B6D2,Q#FA'[R%/H)
M.D],R!B36$)B@L0DB2D2TR1F(,R)\?0IQM.OGR>\1-_LDEA"8F)Z,$^,#^<)
M\HB*Q#2)F3/?"R=KLZ>LS?Y-<T*UR;MEOKQ[N#L65^]9](TKB24D)DA,DI@B
M,4UB!L*<^(<#^USV )T9:@Y*,JHEJ"903:*:0C6-:H;2W$ WRIGP[/00+)\"
M_2+89,71'\E^IW>222U!-7'F.Q8%7[*T.%XOD>>A4$VCFJ$T-[6136WT;YQ#
MTK].S2'^T^@=>E)+4$V@FD0UA6H:U0REN1>"K07#F)U'T&X/U1)4$Z@F44VA
MFD8U0VENH&W'%WJ[EQ[S"%KOH5J":N+,=RP>> 82M,]#-8UJAM+<V-I.+_27
M>MO7YS1>D_'W[C]E\&OZ);U:94?SBU9\J):@FD UB6H*U32J&4IS(VTKP7#,
MCA9HS8=J":H)5).HIE!-HYJA-#?0MNX+O37,&Y-7LT16;H(BW63!^CI85 D_
MFF2TZ4.U!-4$JLE:VSZC]=0Y#%X.XLG(;6!4UPTU>GZ&TMS\V9XN]!=U'[+[
M],OV1VGI#1]:U:%:@FH"U22JJ?"P/8M'!^E$^SI*<]-IF[VP4[67;Y](>Q',
M'XHB.UXE^YW> 47;.503J"9KK1FI:#)H_V3LL)%&S\M0FKO P39JD;?@.//(
MJ?K\X\-5F?WYL!U!Q:?=(/HNN[O*BJ-#J/]@?<.):@FJ"523J*903:.:H30W
M[K9OBT+T456$UFZHEJ":0#6):@K5-*H92G,#;:NXR%_%=9MJ:\3[>^TG_Y%Z
MIQ/MQU!-HII"-8UJAM+<=-I^+/*OFSN8+I 7M/L/VON',MJBH9I -8EJ"M4T
MJAE*<V-O6[1HR$X9:)F&:@FJ"523J*903:.:H30WT+9?BX!%<WZC=XK12@W5
M1'2X<&X<M9Z>DN@A%:II5#.4YH;3-F61?_5<__+7#_9.*MJ5H9I -8EJ"M4T
MJAE*<R-MN[*(71L7H949JB6H)E!-HII"-8UJAM+<0-OR+?*7;\UZXVB T=H-
MU1)4$Z@F44VAFHZ.+H%SIR1#'=+-I:W=(G_M=K;^J%?)[?XF7ZSS8/<RAJLT
M_R-X?WV=;9_)^+!]/<.W/YNW[S_\\VBVT<8.U1)4$Z@F44VAFD8U0VGNO:UL
M!QBSJ^IBM.5#M035!*I)5%.HIE'-4)H;:-ORQ?XU8IU?:N9W>B<9K?=03=1:
M^S5?@_9KOB1Z6(5J&M4,I;DAM<U=[&_N>HP>;],RVXT91S.,+I)#M035!*I)
M5%.HIE'-4)H;],:],]E%<C%[ TSV#ICL+3#9>V"R-\%D[X+)W@;S7U'OQ;;>
MB[UM2X_Q NWU4"U!-5%KL^9TT1XLT+(.U32J&4ISXVG+NOAK%L/9%?=?\YR&
M_Q1Z)QOM^E!-H)I$-85J&M4,I;D7@2T%8W;Y7(Q6@JB6H)I -8EJ"M4TJAE*
M<P-M*\$86C[G=WHG&>T"44W4FC-TO!Q$[;D#[?A03:.:H30WH;;CB_T=7X^Y
MP_^$!MH%HEJ":@+5)*HI5-.H9BC-#;HM#>,9.UN@!2"J):@F4$VBFD(UC6J&
MTMPW]K %X-"_"+#S;.%W^B89U1)4$[76FBW"UFR!'E.AFD8U0VEN0FVC-SQS
MU\=!-.87DO@/VCO.:/V':@+5)*HI5-.H9BC-C;WM"(<1.FD,T2X0U1)4$Z@F
M44VAFD8U0VENH&T7./0O".RTD,1O]$XQ6@"BFJ@U_T(2]) *U32J&4ISP]EX
M@SM_KW<P9)Q=2.('>R<5+?A03:":1#6%:AK5#*6YD;9=X'#$#A!HKX=J":H)
M5).HIE!-HYJA-#?0MM<;^A?[=7^J BWT4"U!-8%JLM;:+Q0=3>/6O;*Z;JC1
M\S.4YN;/UG!#?PUW;B&3?_?>L4/;-U03J"9KS3L)JRX;Z7JCL6\C0YV\FR);
ME0W/5F6>29-9=N0_A=Y)1&LT5!.H)E%-H9I&-4-I[D5@:[0A6Z,-T1H-U1)4
M$Z@F44VAFD8U0VGN&XO;&FT$U6A^IV^242U!-5%KV_>K<GJT\.!9+O2X"M4T
MJAE*<U-JJ[11SRKMF>N._(?I'6*T/$,U@6H2U12J:50SE.8&W99G([8\&Z'E
M&:HEJ"903:*:0C6-:H;2W$#;\FSD+\^ZSQ=H@89J":J)6FO/%X,C\P7:HJ&:
M1C5#:6Y*;8LV^IH6C5E^Y#^%W@%'>S=4$Z@F44VAFD8U0VGN16![MQ';NXW0
MW@W5$E03J"913:&:1C5#:6Z@;>\V@GHWO],[R6COAFJBUMJS1W3P/EH2/:Y"
M-8UJAM+<E-IV;N1OYWK,'O[G-M 6#]425!.H)E%-H9I&-4-I;M!M@3B:LO,%
M6@:B6H)J M4DJBE4TZAF*,T-M"T#1_X;<7:?+] 6$-425!.U=M"=')DOT(8/
MU32J&4IS4CJV#=_8W_#9T>*G(ELL-\&/-T66W9UXJT8_UC>JJ):@FD UB6H*
MU32J&4ISXVRKP#'[;GACM/)#M035!*I)5%.HIE'-4)H;:%OYC?WWU-P_O%LL
M/RT76;X(-K?586[7JT5PGQ7!GP]I48T91Z.-EG^U-G%^<T_#0?-_K;7$"7H&
M M4DJBE4TZAF*,T-L*WXQOZ*[TR OV3I\?2BA5^M-=,;OXR&[;RB11ZJ2513
MJ*91S5":FU=;]HW]9=_/RRRW&3T:3;2JJS7GC>$'@W8RT08.U22J*533J&8H
MS4VF;>#&_KM@NLE\L?WQ.:]FW/1F]^S"?)V7Z]5RD6ZR19!GFV"3YC?+[7/$
M:5EFFZ-+._P'[)WD1ZV]?"8>C]II1NLW5).HIE!-HYJA-#?-MGX;^^NW7YWT
MWA?K>98MRN"Z6-\%^3K_;ETLEGE:?*GC&Y3I*BN#(OOS8;E]/<5F'5QEP4-9
M?9B6U>[[-XT^&G.TP*NUYFJ<@\$7;>503:*:0C6-:H;2W(#;YF[L;^YV3T4L
MGYZ*>%']A/Z4Y>GVHZNT7%:)K@Z;+JI-YM5_R^HRR(-/:;'<]7K%B1K/?\S>
M47[4POC<:\T2]+@"U22J*533J&8HS4VTK>C&_C5^IY\K#OX.Y+*<IZO@OQZ?
MD A$7OWXO@G>Y\'[(GB;7:^++'B7%O/;( Y?!-L;:QZ--UKJH5J":@+5)*HI
M5-.H9BC-O01LJ3=F5_B-T6X/U1)4$Z@F44VAFD8U0VE.H">V_YOX^[_]TW/.
MP\=5]BDKMI-Y-88LU\=R[5?[YGIR>&O*T<N#&00]ID UB6H*U32J&4IS\VH+
MOHE_K=\S9I#_?*A^1,>#TU.'_Y"]PXR6@*@F4$VBFD(UC6J&TMS0VQ)PPJ[[
MFZ#5'ZHEJ"903:*:0C6-:H;2W$#;4G#2K13L.W6@I6"M-:>.X<OV*]$2])@"
MU22J*533J&8HS<VK+04G_E+P&5/'Q^R^^OE\5?V!=_1 NT142U!-H)I$-85J
M&M4,I;G)MZ7CA%WV-T$K151+4$V@FD0UA6H:U0REN8&VO>/$WSL^=_1 .\1:
M<T>/@\D#;1%13:*:0C6-:H;2W+C:%G'B;Q&]D\?'AZLR^_-A^TG?^F5T-.1H
MNXAJ":H)5).HIE!-HYJA-/=JL WDA%TD.$'[1%1+4$V@FD0UA6H:U0REN8&V
M?>+$OTCPN=,(6BO6FCN-'-8O:%V(:A+5%*II5#.4YN1U:NO"Z7.7"_8>1PZ>
M(#DZDOC/IV_242U!-8%J$M44JFE4,Y3F7A&VD)RR*PZG:-F(:@FJ"523J*90
M3:.:H30WT+9LG'9;<=AS)/&KO7,='8XDK7D$/:! -8EJ"M4TJAE*<\-JB\2I
MOTA\1C&39/-Z[/ \$^(_;.\TH_<;136!:A+5%*II5#.4Y@;?-I+3(3MVH$4C
MJB6H)E!-HII"-8UJAM+<0-NB<>I?W?C<L0/M&VNM.7;$AR\)08\I4$VBFD(U
MC6J&TMR\VAYQZN\1_<^$U._D_KZ*;[Z\N=T^(9*G^7P[?SS>"?KC>WG\1M#^
MP_8.-'JW4503J"913:&:1C5#:6[P;2,YG;"3!UHJHEJ":@+5)*HI5-.H9BC-
M#;0M%:?^98WOTN)FF7=:?NN7>F<9[1-13:":K+7VK2':=XQ2Z%$UJAE*<U-J
MF\*IORFLWZ;UE^W;M+X(DH<L^.WS.OCM=OU0IOFB^J3Z6?QE]V<=WN7=?ZS>
M.4:7):*:0#6):@K5-*H92G/2/K,]XVR #ADSM"9$M035!*I)5%.HIE'-4)H;
M:%L3SOSK%C_L;U!3^FX%[4=ZQQ@M!VO->Z,R@1Y2HII"-8UJAM+<=-K.;^;O
M_/H,%[\\;(KE9EF-R]^D=_<_!&^7ZW*^S/+Y=E>3S[O,'_[3Z9US=($BJ@E4
MDZBF4$VCFJ$T]X*PO>(L9N</M"]$M035!*I)5%.HIE'-4)H;:-L7SKSU3?=W
MH_ [O9.,%H6H)E!-HII"-8UJIM8.WJ%T/)L\38-N2FT)./.7@/4<DC_.(?.'
MHCAQ2T>_TSNEZ#)#5!.H)E%-H9I&-5-KIQZNN &UK=_,W_IU&Y3E\E/6:0Q&
MNSY42U!-H)I$-85J&M4,I;EQMUW?C.WZ9FC7AVH)J@E4DZBF4$VCFJ$T-]"V
MZYOYN[[N8S#:]*%:@FH"U>3L>-,71E&KZNNZH4;/SU":FS_;XLTZM7B[ ?=H
M[-!B#M425!.H)FNM.>UMWYNHG;DN6^EZJ[%W*T.=OQ.DZCA/2=I^_*\913L\
MB7LLFV=.J&\X62YA.<%RDN44RVF6,QC7NC;"QK7!+LK;>UBTT>:-Y03+2993
M+*=9SF!<*]I1(]K^JJ[S!'L&ZI]IM&5C.<%RDN44RVF6,WON<!2/CS]=%@[B
M1ES/W>FS\XLKSU#] XNV:"PG6$ZRG-ISAR_8;*V%T>R!#<:U CML!-9?E)U[
MA'9F__XI11LREA,L)UE.L9QF.;/G3C[:;$5TU(AHIY;LS"._C]FG+._20IPY
M7/]$HVT:RPF6DRRG6$ZSG,&X5O+'C>2/X<=U:,/&<@G+"9:3+*=83K.<P;A6
MM">-:/MO]-GC<1U:LK%<PG*"Y>2>.WBH,QJWGBKNO*5F3]%@7"N)TT82_1W9
M^0D8[<98+F$YP7)RSSE#812VR[%NF^G]9F-WL]9C-(-]#:U(S1J1(A:O'9U8
MGUU6H$T:RR4L)UA.LIQB.<UR!N/<BR-L%'DAN]9M[U'11KF$Y03+2993+*=9
MSF!<*]J-'B[TKWKK/M3ZH?Z99@LXE!,L)UE.L9QF.;/GVJ\^#Z=Q=.*9M;!1
MKH7G[GW9O:WP4_T3R]9K*"=83K*<VG,';47['N::/;#!N%9@&_5:Z*_7SCY6
M\^_?/Z5LIX9R@N4DRRF6TRQG]IS[B/-D6Q$V"K6P4Z%V\K'?[;*H'OMUZ2G\
M!^J?9;9Y0SG!<I+E%,MIEC,8U\I\HZ$+V7?-VWM8M-D*#N4$RTF64RRG6<Y@
M7"O:C0HN]*^ Z_&0CNW>4"YA.<%R<L^U)]HH:M\QK?.6FCU%@W&M)#8:L]#?
MF)V??=FB#.42EA,L)_><,PZ.!M.#]'793.\W<WJ*4=A>4H%]#:U(-:JOL%/U
MU6]6?6Y#X3^7_O%D:S24$RPG64ZQG&8Y@W&MRZ)1WX4S>)QERS>42UA.L)QD
M.<5RFN4,QKG1CAKE6^1?1==]G/5#O3.-<@G+"9:3+*=83K.<V7,'$_FIU111
MHT^+_'U:GW["3_7/*]NHH9Q@.<ER:L]UZ"?0 QN,:P6V4:A%G6XL>?HQFG__
M_BEE6S24$RPG64ZQG&8YL^=:CS1/]1-1HT*+.E5HIQ[SR777>L)_G/Y19JLV
ME!,L)UE.L9QF.8-QK<@W*KEHR#Z>B]CF#>42EA,L)UE.L9QF.8-QK6@WFK?(
MOS:NQ^,YMG)#N83E!,O)/=<>:./!L/T$<=<M-7N*!N-:26P495&G6T5Z1E^V
M'T.YA.4$R\D]UYP&)Y/X('P=MM+[K<;.5L-V-T%] :T\->JNJ%/=U6M.?6XU
MX3^5_M%DFS.4$RPG64ZQG&8Y@W&MJZ+1V$53>)1E6S>42UA.L)QD.<5RFN4,
MQK6BW6C=(O^BN1ZC+%NWH5S"<H+E),LIEM,L9_9<>_%$'(VG)YY(BQM56NRO
MTOJ4$WZJ=V)1+F$YP7*2Y=2>.R@G#N9D]+@&XUIY;91IL;],._L S;]__Y"R
M#1K*"9:3+*=83K.<V7/.X\S1J6HB;K1G\5>]+9M<7G>L)OS'Z9]DMF5#.<%R
MDN44RVF6,QC7BGRCC8O9-U[;>UBTV=8-Y03+2993+*=9SF!<*]J-UBWVEA\]
M'L_YH?Z99NLVE!,L)_?<0>%PN'*BZY::/46#<:TD-DJRN/O;K!T/(-N-H5S"
M<H+EY)YS7Z@RGAVDK\MF^OAFD[#=3E!?0RM2C;8K_JHW1CLZJCZWG?"?2O]T
MLL49R@F6DRRG6$ZSG,&XUE71Z.QB]OW3]AX6;;9X0SG!<I+E%,MIEC,8UXIV
MHWB+H7=2.P/USS3;N*&<8#G)<HKE-,N9/7?03@Q/MQ.--BWVMVF]V@FV3T.Y
MA.4$RTF64WNN0SO!-F44Y^9UV&C3AIW>WNWT8S3__KU#BG()RPF6DRRG6$ZS
MG-ES9U9.7):W6;9)TDWZYM5=5MQD/V6K51G,UP]YM=NV57OZTZ#(KK<)_O['
MZ.*RVM-N_N;5?7J3/?ZH+8-5=EWM.G@YJ0Y=+&]NGS[9K.^W9'"UWFS6=[L/
M;[-TD17;#:J_OUY7J:\_V1[@\[KX8W=Z;_X?4$L#!!0    ( ')$7%CC'Q0E
MB0D  .=M   9    >&PO=V]R:W-H965T<R]S:&5E=#<P+GAM;+6=76_;.!J%
M_PKA'2Q:(&/KPW:<;A(@C?C103/I).CNQ6(O%(F.A<J2*\E."^R/7^HCEFG+
M'"MSMA>-K/!]2%O'>JGW1-3E2YI]RQ=2%N3',D[RJ\&B*%8?1J,\6,BEGP_3
ME4S4;^9IMO0+]3)['N6K3/IA%;2,1XYE34=+/TH&UY?5OB_9]66Z+N(HD5\R
MDJ^72S_[^5'&Z<O5P!Z\[GB(GA=%N6-T?;GRG^6C++ZNOF3JU6A+":.E3/(H
M34@FYU>#&_N#&(_+@*K%/R/YDN]LD_*M/*7IM_+%I_!J8)4CDK$,BA+AJQ\;
M>2OCN"2I<7QOH(-MGV7@[O8KG55O7KV9)S^7MVG\KR@L%E>#V8"$<NZOX^(A
M?1&R>4.3DA>D<5[]3UZ:MM: !.N\2)=-L!K!,DKJG_Z/YH/8";#'1P*<)L Y
M-<!M MQ3 \9-P'@_8'(D8-($3/8#ID<"IDW ]-0AG3<!YZ<&S)J 675TZ\-1
M'4O/+_SKRRQ](5G96M'*C4H05;0ZA%%2:O>QR-1O(Q577'ORJ2"_DILPC$HM
M^3'YE-3?B%)9OY('N4GC390\D]M,JC:$^4$41\5/\LZ3A1_%[U6CKX\>>??+
M>_(+&9%\X6<R)U%"OB91D9^IG6K[+HIC!<PO1X4:=-GU*&@&2.L!.D<&>$'N
MTJ18Y(0FH0P[XIDYWG8,@)'ZM+8?F?/ZD7UTC,1'N1H2^^*,.);C=@SHUAS^
MVSH>$F=6A=L=X=Z?A2=#8DW+<'O6]7&:PST9#(EK'QT\^VOA_/1PIR-<F,-O
MUL_JHYM4X9;A2+I;\;L5;WR$UXK[<^HG6VEW#.RC$50FF _YR@_DU4!ED%QF
M&SFX_OO?[*GUCRZ!(&$>$D:1,(:$<21,@&":Z,9;T8TKNFLZXWY*\B);JSE
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M__TJKZ<XS95A[=_GQ=?--B[^!U!+ P04    " !R1%Q8\P:0F?<%   G+
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MC+M*!VR&[495<!=E</B-X'R,;GFF9A)]S6(:-P&ZFFE-%[_2O<!.Q"L:G:#
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MK4G>6L; O>K81@C]785P"",86",8N(W@.T*XYH Z %U2A$)KYLVZRP!VQSD
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M8N<@T+:+Z5RXZ=O66A+GV"X=W_[83@@-I#F-9&X@2?U[:C]OZMB9;BG[S=<
M OW)TIS/K+40Q85M\V0-&>8#6D N/UE2EF$A3]G*Y@4#O-"A++4]QQG9&2:Y
M%4[UM7L63NE&I"2'>X;X)LLP>[Z"E&YGEFN]7'@@J[50%^QP6N 5/(+X7MPS
M>6;7E 7)(.>$YHC!<F9]<2]B=Z@"NL4/ EN^<XS44.:4_E8GMXN9Y:@>00J)
M4 @L_SW!-:2I(LE^_%M!K?H[57#W^(5^HP<O!S/''*YI^I,LQ'IF32RT@"7>
MI.*!;K]"-:! \1*:<OT7;<NVP[&%D@T7-*O"L@<9R<O_^$\E8B<@!]H>\*J
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M!,WTX1KP IAJ(#]?4BI>3M0+T/J5>O@?4$L#!!0    ( ')$7%C>'B%0T@(
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M/E-5JP'7 #6>,":W#3U!5?V%?P%02P,$%     @ <D1<6&#I/D1D P  "0T
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MS@0  &L<   9    >&PO=V]R:W-H965T<R]S:&5E=#<Y+GAM;+69?V^C-AB
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M*"G.4<$P*0!%BYEUXU[%[D@FJ(B_,-JPG6,@IS(GY*<\>4AGEB-'A#*4<(F
MXM\;ND-9)DEB'/_64*NYITS</=[2[]7DQ63FD*$[DOW *5_-K(D%4K2 ZXP_
MD\TW5$_(E[R$9$S]!9LJ-@@LD*P9)WF=+$:0XZ+Z#W_5(G82Q$2[$[PZP3LV
M85@G#(]-&-4)HV,3_#I!3=VNYJ[$19##<$K)!E 9+6CR0-E7V<(7+N1">>%4
M?(I%'@\?D;#,P 6X25,L2P<S\%!4"U 6\C1"'.*,G8F0UY<(G'X] U\!+L!W
MG&4B@$UM+H8A8792W_*VNJ7WP2TCE S T#T'GN,-.]+OCD_W.M(C??I-20?
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MA 'H\27GZM P$S0WO.@G4$L#!!0    ( ')$7%B5E=E]F04  #86   9
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M.>!)BT-<.\3'#DF+PZAV&+W5(:D=$L=,!<7QD!)#YE=*/B-EK2&:O7!D.F^
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M?5Q!-TND <#Z0@C].3 ;5/WQ]%]02P,$%     @ <D1<6([)@E).!0  R2$
M !D   !X;"]W;W)K<VAE971S+W-H965T.#DN>&ULS9I;;Z,X%,>_BI5=C5JI
M6RZYM9TD4A- 4VDZBJ::W8?1/CAPDE@%.V.;I"/MAU\;*($L)8GDU;0/*9=S
M?AS[?[#-@=&.\6>Q!I#H)8FI&'?64F[N+$N$:TBPN&8;H.K,DO$$2[7+5Y;8
M<,!1YI3$EFO; RO!A'8FH^S8G$]&+)4QH3#G2*1)@OG/*<1L-^XXG=<#7\EJ
M+?4!:S+:X!4\@?RVF7.U9Y64B"1 !6$4<5B.._?.7> ,M4-F\2>!G:AL(]V4
M!6//>N<A&G=L'1'$$$J-P.K?%F80QYJDXOA10#OE-;5C=?N5'F2-5XU98 $S
M%O]%(KD>=VXZ*((E3F/YE>T^0=&@ON:%+!;9+]H5MG8'A:F0+"F<500)H?E_
M_%)T1,7!Z;WAX!8.[J'#X V';N'0/?4*O<*A=ZI#OW#HG^HP*!P&6=_GG97U
MM(<EGHPXVR&NK15-;V1R9=ZJ@PG5F?4DN3I+E)^<?%')^T!#E@": T=/:\P!
M_8'NHXAHY7&LSN;YJ_/@P@.)27RI+'Y'%A+:6HPLJ0+1."LL+CK++^J^<5''
M18^,RK5 /HT@J@,LU8*R&>YK,Z9N*S& Q36RG2ODVJ[3%%"[NP?A->KF[MT&
M=^]T=[?!W3_=O2GXX 1WIZ_=G=N6ONR6*='->-TW>/=4DHC$J;[ET1.$*5>I
M $JKES!.E5QHR5F"9BS9I#)/"[9$/N:4T)6H9-'WSPJ,'B0DXN^&5DWS*'K-
M4>@1]4YL< CCCAHR!? M="8??G,&]L<F?4W"/),PWR0L, 2KY46OS(M>&WVB
M%$^4V&I("I^OT 9SM,5Q"NB"4!2Q.,9<H(U2/QL5+IL4;^6?JW@.N\E@>O[<
M3NQKQ^V/K&U5RI.L?).!!89@-8WZI4;]5HT,W;M7Z#YA*95-(K8&<*Z(.6Q0
MD4<MB=3?@8K_->LVF/DF0PL,P6HR#DH9!ZTRSC&7)"0;)1%=572\0AX1DI-%
M*I66]S1"WVA4.5(J>?&9"7&IS9=+X$!#0%.0.P"*IEB0$%7F_=QV+WZ3Z*WA
MGBMZ#NM7[\D#O8]:^$<M D,AU_0;EOH-?YE^GKZ]E>V9"K8&?*Z"PZ,*'K7P
M<XMA;62VG0,1#45=$_&F%/&F5<1\%>/_2(F:YX#*IH7NM!5Q;K>:A'DF8;Y)
M6& (5A/UMA3U]ETL;F]-YH5)F&<2YIN$!89@M;QP[/V#L/VKET[M$9R;%06M
MNBKJ-2V>&NP:5T\-=H=SJJD&U"6JU"J<5HF^I))G90GT 2>;CVA*F B)GAW5
MS*KFPL8^;T6>W><F:9Y1FF^4%IBBU:5V]U*[[V*<+L(PE1XF:9Y1FF^4%IBB
MU=-C7Z)R6BL=DVDJU!$A$ [5^DQD@\(5 K4M?R)"I5HS"XF($*E*%<:S+;R(
MU>A,TV2ALD-ERYO5RVEQ\>I(Z/2<8<_N#0X6J+/V.,]6W&CER2@M,$6K*[XO
M/CG_=_7).:D6-&N/XVQ%3=)\H[3@:(?4I=K7H)SV(M2Q:1K]HW[5+4IQ\8HA
MB/&6*?UR\X#C%<?:NC#VTCFC$D6@GGG5VHH7E.^/H&_EYF'=:)7**,TS2O.-
MT@)3M'KF[,M>SN!]S/I&ZUE&:9Y1FF^4%IBBU=-C7U5SCI35@(= )5Z!UGW+
MLNI:.=MG2P%^^#JQ$#P'Z^>7REC7[_<.!W^393+/*,TW2@M,T7(IK<H;Z 3X
M*OM60*!0/PGG;W'+H^7W"/?96_B#XS/GSL^_*MAC\H\<'C%?$2I0#$N%M*^'
M:JCB^7<#^8YDF^P]]X))R9)L<PTX JX-U/DE8_)U1U^@_'IC\B]02P,$%
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ME>Y]BN%.][\@S 9]?\.Y.DR,@;JC#OX!4$L#!!0    ( ')$7%@&!0X4V (
M (0(   9    >&PO=V]R:W-H965T<R]S:&5E=#DQ+GAM;*U6WT_;,!#^5ZP,
M;2"QYF<#8VVDEC"-!R1$Q?8P[<%-KHV%8V>VV\)_/]M)0]JEJ)/H0V.?[_M\
MWYWCRVC#Q9,L !1Z+BF38Z=0JKIR79D54&(YX!4PO;+@HL1*3\72E94 G%M0
M2=W \V*WQ(0YR<C:[D4RXBM%"8-[@>2J++%XF0+EF['C.UO# UD6RAC<9%3A
M)<Q /5;W0L_<EB4G)3!).$,"%F-GXE^EL?&W#C\(;&1GC(R2.>=/9G*;CQW/
M! 04,F48L'ZLX1HH-40ZC#\-I]-N:8#=\9;]F]6NM<RQA&M.?Y)<%6/GTD$Y
M+/"*J@>^^0Z-GJ'ARSB5]A]M&E_/0=E**EXV8!U!25C]Q,]-'CH /SX "!I
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MHB=B]P?F 74,7R@29?_"+K=M.A!NE!9I#B8/TIAGO^PM%^((X+<N /P<X)\
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M>+Q10Z$TW<8)TS2C!7#!;[:H3$_9%"YL"L^3.N6)!DRFLP:,)U,[-&)J94:
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MU^1B3'%U:/1A8E7MF^M266K5?KBFMQ&U,Z#]E5+V,'$!VM<V^PE02P,$%
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MO<G3;?DPT9<TS]--^7(MPJ7(B@+J]_=IFC^]*1K8/\ V^Q]02P,$%     @
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M7J?RKGA^)S:"PIIO5J15\Q<];[#! ,W6E2RR36%5@RS)V__QETT@=@K@J*<
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MT_)RB]$:LP(@GS]1*@XWQ0N:/RSF_P!02P,$%     @ <D1<6( B"8EZ!
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M03=O3T>:=/SV=&@8C5]/DE_P_%<FZ9%N&9=QMNY,U[<O*AS<29J*?W7:E^Q
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MR2J6'[/UK[0:T%#C15DLBG_1NBH[Z*%H)6265)55#Q*6EO^3IXJ(6@6,#U3
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M3Q9]=#'0(LL[R[G0V*?FCRN@,4@#P/6%$'H[,"^H_LV8_ ]02P,$%     @
M<D1<6!!;YD^7 P  U0X  !H   !X;"]W;W)K<VAE971S+W-H965T,3$P+GAM
M;+57[V^;.A3]5RR>-&W2:P #^=$ED9+0Z4W:IJA5MP_3/KAPDZ"!S6PGZ?[[
M9QM" X6LTU@_-&#N.=QS;%]\IT?&OXL=@$2/64K%S-I)F5_;MHAVD!$Q8#E0
M]63#>$:DNN5;6^0<2&Q 66ICQQG:&4FH-9^:L36?3]E>I@F%-4=BGV6$_UQ"
MRHXSR[5. [?)=B?U@#V?YF0+=R#O\S57=W;%$B<94)$PBCAL9M;"O0Y=K $F
MXG,"1W%VC;24!\:^ZYOW\<QR=$:00B0U!5$_!UA!FFHFE<>/DM2JWJF!Y]<G
M]G=&O!+S0 2L6/HEB>5N9HTM%,.&[%-YRX[_02DHT'P12X7YCXYEK&.A:"\D
MRTJPRB!+:/%+'DLCS@#NL . 2P!N OP.@%<"O)<"_!+@&V<**<:'D$@RGW)V
M1%Q'*S9]8<PT:"4_H7K>[R173Q.%D_.;+$_93P"T! J;1 ITA;X8LR"^6AR
MJ\E'BTCN"4](BA9"+9#<S-B]@!A)AD*0P%5F@&X>U6H4@%ZK(9*D;Q35NEPA
MZY30J2U5POJU=E0FMRR2PQW)N1A]9%3N!+JA,<1U ELIK>3BD]PEOL@80C1
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M<J?Z3N Z0#W?,"9/-_H%52<[_Q]02P,$%     @ <D1<6/LG[,FV"0  =T\
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M1MI[-*0R9ERN!* ?G_5C]$E!(G_:G,W96W9V<S@OY9+$,'#TZ9,@[L&)7K[
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M.JZ7R-.&J3]Y-I]:A.I)'WOXSL6V'X)M \?/V\'Q65OXN=CV@[%MXOAI7;R
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MY[>%5A?CT/5IBVV_Q*JEY&AXFK<.(WJNR@[-G[;:_:FCMX>G1!TV9\XH]'
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MX^+T #0&83KH^SO.U4O#[([K/S=67P%02P,$%     @ <D1<6*T;;HQU!
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M4+"![F,1)4SL.*"_?U.OT8.$5/QC(B)T280C,(V(?D5$WZH%_0N@QR\@+K\
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MZ $$"BVF-VB,VM:B5$.5!A2-4&@QM4%IU$"+4IW;C](3UY:2U/ KCZCOC(,
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MIBVVO=TS3=93WU"Y8MB"<5@BI=?JX\TOLS8U&VB1VDYO(33VC?9QC:T]2!.
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M80+T^H)S]3 QS6'U9\#_ U!+ P04    " !R1%Q8D+.7_/($  #*(@  &@
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M8DJ<0I$B"$DIDI(7L=E>+3_;_N/=@S8M]PG26B&>DIFMLY9<LSM?=(P2.OA
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MO8R14?2F SV?"J$?;\P Q4'<Z!]02P,$%     @ <D1<6+Q&@,1"!0  "R
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M+G$1)6NO-)VI4U4?F15]9.%^->9([5%:*Q.:BG=V,]ZU1".MBCCN_C(,VJ@
M2N,HFBDBG65W[&GVH$AE*;U,11B329I(-7%7$_FM''NS:';SN[49PJT]<&LE
M0!/F4!J#T@(HC:-HIKQTTMZQ9^T_K!:/(MOMC;;D19Y$/"7?K'[_C3U,ZTX*
MFKIW=C/D;KV3>K,(@[8I@-(XBF:*2.?D'7M2OKSRXK9<%!I)UERIYH.0Y"Y1
M,I*%= @7TWGA$OYY+PKA-4_%H/EY*,V'TBB4QJ"T $KC*)JI4)WZ=\;'615
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MI_ \IE*FB_+EDPC5PJ4HH,[/TE2^'A0!-D^ONOH74$L#!!0    ( ')$7%@
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M,>@&\]8E' =AAO?US@5OWYR!-QG*YR ,Q6)@LP$7KF4#''BE&]>%&ZC%#8C
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M(=@G268@?E]1RI\?L@[VET7G_P%02P,$%     @ <D1<6,#:-;77!0  BBH
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M^8I/\>.\K*\XN[E>1H_RLRS_LGS(JY_.=LHT7LBTB+-4Y'+V\>16^1".A_6
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MB-'M8=@#+5U;6B32)6D[!?;C1TJ*9'V8B1-E?;$E^=Y#GD/J\I">[AE_$ &
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M&0!1KX(.4+^O&)-/-[J!_$^4^7]02P,$%     @ <D1<6(P#&&K[!0  ?"L
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M%F18 !1F?#*C\I,9G;@0C2!Y088%0&$&KW'):PRW$#FCNB(<6]>XM60!]6>
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M-4&#T1OBT.WL:@U4M7O^*X4T3-RRH'$/V@;0_EHIW!MVHO1_(.DO4$L#!!0
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MD=YB-W*JZA^7@3NLZ3" &@W-,X$J#2W38E=.E2)0[4:?S@F4SO?L_*5X6IP
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M"FLC!-3%$?"Z'1\4FHFZ4 )<N3/U*BO!2@D!=:F$UG(3K1.N E@N(:"NEW
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M;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( '%$7%B>-!OXR@D  '5(   8
M          " @0X(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M    " !Q1%Q8BF'5&#H"  # !0  &               @($.$@  >&PO=V]R
M:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ <41<6.N\8M(K!P  J1X
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M965T-RYX;6Q02P$"% ,4    " !Q1%Q8L1G2UT4#   5"0  &
M    @(%[/@  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @
M<41<6*<$S692*@  18<  !@              ("!]D$  'AL+W=O<FMS:&5E
M=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( '%$7%C]1=EF* @  &,8   9
M          " @7YL  !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#
M%     @ <41<6 H7E1L7#@  S"D  !D              ("!W70  'AL+W=O
M<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4    " !Q1%Q8-QV_[ H.  #3
M.   &0              @($K@P  >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM
M;%!+ 0(4 Q0    ( '%$7%CVKE (KP,  $\(   9              " @6R1
M  !X;"]W;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @ <41<6*@;
M;C4^"P  /R$  !D              ("!4I4  'AL+W=O<FMS:&5E=',O<VAE
M970Q-"YX;6Q02P$"% ,4    " !Q1%Q8071<CI4$  !*"@  &0
M    @(''H   >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    (
M '%$7%@@?:IF.1@  ')B   9              " @9.E  !X;"]W;W)K<VAE
M971S+W-H965T,38N>&UL4$L! A0#%     @ <41<6,4)?^M3!P  O1,  !D
M             ("! [X  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"
M% ,4    " !Q1%Q8>$F,<TT-  ##)@  &0              @(&-Q0  >&PO
M=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( '%$7%@L&$ ^H@@
M -H8   9              " @1'3  !X;"]W;W)K<VAE971S+W-H965T,3DN
M>&UL4$L! A0#%     @ <41<6#\53.WN @  H08  !D              ("!
MZML  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    " !Q1%Q8
MD,.4S&D0   ',P  &0              @($/WP  >&PO=V]R:W-H965T<R]S
M:&5E=#(Q+GAM;%!+ 0(4 Q0    ( '%$7%BP(UWH]!   "8N   9
M      " @:_O  !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%
M  @ <41<6(O-]F!M%@  _4@  !D              ("!V@ ! 'AL+W=O<FMS
M:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    " !Q1%Q8-+Y/F"X0  #0-0
M&0              @(%^%P$ >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+
M 0(4 Q0    ( '%$7%@)H$?;E@4  '<0   9              " @>,G 0!X
M;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @ <41<6,S$8YYY
M P  ?@<  !D              ("!L"T! 'AL+W=O<FMS:&5E=',O<VAE970R
M-BYX;6Q02P$"% ,4    " !Q1%Q81"XVZ'(?  !P70  &0
M@(%@,0$ >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( '%$
M7%CX'XEVLP0  .P+   9              " @0E1 0!X;"]W;W)K<VAE971S
M+W-H965T,C@N>&UL4$L! A0#%     @ <41<6$M2UN 7#@  \S@  !D
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M=#,S+GAM;%!+ 0(4 Q0    ( '%$7%@O=OB]IBH  &Z0   9
M  " @4!R 0!X;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @
M<41<6-U"3YVG!@  CQ$  !D              ("!'9T! 'AL+W=O<FMS:&5E
M=',O<VAE970S-2YX;6Q02P$"% ,4    " !Q1%Q8)>-FMP$%  "G#@  &0
M            @('[HP$ >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4
M Q0    ( '%$7%CL $B$#P8  ,\.   9              " @3.I 0!X;"]W
M;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @ <41<6)L$]/H:!P
MT14  !D              ("!>:\! 'AL+W=O<FMS:&5E=',O<VAE970S."YX
M;6Q02P$"% ,4    " !Q1%Q8"/X34.\"  "&!@  &0              @('*
MM@$ >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    ( '%$7%@2
M<(IM  8   </   9              " @?"Y 0!X;"]W;W)K<VAE971S+W-H
M965T-# N>&UL4$L! A0#%     @ <41<6-' "W&8!   -0L  !D
M     ("!)\ ! 'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( '%$7%@2M?QK> 4  *81   9              "
M@0#> 0!X;"]W;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%     @ <41<
M6 HAS..4"0  *1H  !D              ("!K^,! 'AL+W=O<FMS:&5E=',O
M<VAE970T-RYX;6Q02P$"% ,4    " !Q1%Q8\\VB\^0.  "^-   &0
M        @(%Z[0$ >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0
M   ( '%$7%@LS1/[7 @  %L;   9              " @97\ 0!X;"]W;W)K
M<VAE971S+W-H965T-#DN>&UL4$L! A0#%     @ <41<6 <O.>N8!0  3!$
M !D              ("!* 4" 'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6Q0
M2P$"% ,4    " !Q1%Q8>#]308H#  !H"0  &0              @('W"@(
M>&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    ( '%$7%@W,S*?
M'0<  ,H5   9              " @;@. @!X;"]W;W)K<VAE971S+W-H965T
M-3(N>&UL4$L! A0#%     @ <41<6&0R?+#I @  2@8  !D
M ("!#!8" 'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6Q02P$"% ,4    " !Q
M1%Q8*V;EHF,4   8XP  &0              @($L&0( >&PO=V]R:W-H965T
M<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    ( '%$7%CKEM,IV@(  (D'   9
M          " @<8M @!X;"]W;W)K<VAE971S+W-H965T-34N>&UL4$L! A0#
M%     @ <41<6#@D_!BO#@  AK8  !D              ("!US " 'AL+W=O
M<FMS:&5E=',O<VAE970U-BYX;6Q02P$"% ,4    " !Q1%Q8Z)M:=&@)   I
M4@  &0              @(&]/P( >&PO=V]R:W-H965T<R]S:&5E=#4W+GAM
M;%!+ 0(4 Q0    ( '%$7%AS0]=*_@0  "8>   9              " @5Q)
M @!X;"]W;W)K<VAE971S+W-H965T-3@N>&UL4$L! A0#%     @ <41<6)))
M;8WK"0  B%D  !D              ("!D4X" 'AL+W=O<FMS:&5E=',O<VAE
M970U.2YX;6Q02P$"% ,4    " !R1%Q8XT'<OX@6   ;) $ &0
M    @(&S6 ( >&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+ 0(4 Q0    (
M ')$7%A/":,]] 0  ,T?   9              " @7)O @!X;"]W;W)K<VAE
M971S+W-H965T-C$N>&UL4$L! A0#%     @ <D1<6!Y"^KB[!@  Y3D  !D
M             ("!G70" 'AL+W=O<FMS:&5E=',O<VAE970V,BYX;6Q02P$"
M% ,4    " !R1%Q8:)/K;68'  #_.0  &0              @(&/>P( >&PO
M=V]R:W-H965T<R]S:&5E=#8S+GAM;%!+ 0(4 Q0    ( ')$7%B0)IEF% 0
M /$3   9              " @2R# @!X;"]W;W)K<VAE971S+W-H965T-C0N
M>&UL4$L! A0#%     @ <D1<6$*PP/XD P  ^ L  !D              ("!
M=X<" 'AL+W=O<FMS:&5E=',O<VAE970V-2YX;6Q02P$"% ,4    " !R1%Q8
MJS/[Q-\#   0#0  &0              @('2B@( >&PO=V]R:W-H965T<R]S
M:&5E=#8V+GAM;%!+ 0(4 Q0    ( ')$7%@C0D,FZ00   D9   9
M      " @>B. @!X;"]W;W)K<VAE971S+W-H965T-C<N>&UL4$L! A0#%
M  @ <D1<6+.A+I7F%   EG(! !D              ("!")0" 'AL+W=O<FMS
M:&5E=',O<VAE970V."YX;6Q02P$"% ,4    " !R1%Q8T/D/*D<7  !4A0$
M&0              @($EJ0( >&PO=V]R:W-H965T<R]S:&5E=#8Y+GAM;%!+
M 0(4 Q0    ( ')$7%CC'Q0EB0D  .=M   9              " @:/  @!X
M;"]W;W)K<VAE971S+W-H965T-S N>&UL4$L! A0#%     @ <D1<6*\P91!E
M"@  :9H  !D              ("!8\H" 'AL+W=O<FMS:&5E=',O<VAE970W
M,2YX;6Q02P$"% ,4    " !R1%Q8\P:0F?<%   G+   &0
M@('_U ( >&PO=V]R:W-H965T<R]S:&5E=#<R+GAM;%!+ 0(4 Q0    ( ')$
M7%@M!0J(70(  .@%   9              " @2W; @!X;"]W;W)K<VAE971S
M+W-H965T-S,N>&UL4$L! A0#%     @ <D1<6.[J^EWA P  7A<  !D
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M=#<X+GAM;%!+ 0(4 Q0    ( ')$7%C B9.9S@0  &L<   9
M  " @83N @!X;"]W;W)K<VAE971S+W-H965T-SDN>&UL4$L! A0#%     @
M<D1<6-+$K?[I P  01<  !D              ("!B?," 'AL+W=O<FMS:&5E
M=',O<VAE970X,"YX;6Q02P$"% ,4    " !R1%Q8NA'LA=0"  !-"   &0
M            @(&I]P( >&PO=V]R:W-H965T<R]S:&5E=#@Q+GAM;%!+ 0(4
M Q0    ( ')$7%CXM_;MC ,  .T-   9              " @;3Z @!X;"]W
M;W)K<VAE971S+W-H965T.#(N>&UL4$L! A0#%     @ <D1<6)65V7V9!0
M-A8  !D              ("!=_X" 'AL+W=O<FMS:&5E=',O<VAE970X,RYX
M;6Q02P$"% ,4    " !R1%Q8]F9?QS<#  "6"@  &0              @(%'
M! , >&PO=V]R:W-H965T<R]S:&5E=#@T+GAM;%!+ 0(4 Q0    ( ')$7%AR
MJ[@78P<  "\T   9              " @;4' P!X;"]W;W)K<VAE971S+W-H
M965T.#4N>&UL4$L! A0#%     @ <D1<6$>>P)%A!   30\  !D
M     ("!3P\# 'AL+W=O<FMS:&5E=',O<VAE970X-BYX;6Q02P$"% ,4
M" !R1%Q8SHML.3$%  #I%P  &0              @('G$P, >&PO=V]R:W-H
M965T<R]S:&5E=#@W+GAM;%!+ 0(4 Q0    ( ')$7%@,1/-9Y@,  "L/   9
M              " @4\9 P!X;"]W;W)K<VAE971S+W-H965T.#@N>&UL4$L!
M A0#%     @ <D1<6([)@E).!0  R2$  !D              ("!;!T# 'AL
M+W=O<FMS:&5E=',O<VAE970X.2YX;6Q02P$"% ,4    " !R1%Q8F:!.!ID#
M  !=#P  &0              @('Q(@, >&PO=V]R:W-H965T<R]S:&5E=#DP
M+GAM;%!+ 0(4 Q0    ( ')$7%@&!0X4V (  (0(   9              "
M@<$F P!X;"]W;W)K<VAE971S+W-H965T.3$N>&UL4$L! A0#%     @ <D1<
M6"RZ69*7"@  2'D  !D              ("!T"D# 'AL+W=O<FMS:&5E=',O
M<VAE970Y,BYX;6Q02P$"% ,4    " !R1%Q8W['PTJ(#  #:#P  &0
M        @(&>- , >&PO=V]R:W-H965T<R]S:&5E=#DS+GAM;%!+ 0(4 Q0
M   ( ')$7%@4+5+T 00  %P0   9              " @7<X P!X;"]W;W)K
M<VAE971S+W-H965T.30N>&UL4$L! A0#%     @ <D1<6!!N+(#G P  NQ
M !D              ("!KSP# 'AL+W=O<FMS:&5E=',O<VAE970Y-2YX;6Q0
M2P$"% ,4    " !R1%Q8VJ'PXGP#   %"@  &0              @('-0 ,
M>&PO=V]R:W-H965T<R]S:&5E=#DV+GAM;%!+ 0(4 Q0    ( ')$7%A O.EG
M) ,  'D'   9              " @8!$ P!X;"]W;W)K<VAE971S+W-H965T
M.3<N>&UL4$L! A0#%     @ <D1<6-\"%%.. P  OPP  !D
M ("!VT<# 'AL+W=O<FMS:&5E=',O<VAE970Y."YX;6Q02P$"% ,4    " !R
M1%Q8[UOTQD$'  #,-@  &0              @(&@2P, >&PO=V]R:W-H965T
M<R]S:&5E=#DY+GAM;%!+ 0(4 Q0    ( ')$7%@2,-7;6P0  !85   :
M          " @1A3 P!X;"]W;W)K<VAE971S+W-H965T,3 P+GAM;%!+ 0(4
M Q0    ( ')$7%B00'[50P,  +X(   :              " @:M7 P!X;"]W
M;W)K<VAE971S+W-H965T,3 Q+GAM;%!+ 0(4 Q0    ( ')$7%CG6)A?,0<
M !4L   :              " @29; P!X;"]W;W)K<VAE971S+W-H965T,3 R
M+GAM;%!+ 0(4 Q0    ( ')$7%B?16/UQP@  #T]   :              "
M@8]B P!X;"]W;W)K<VAE971S+W-H965T,3 S+GAM;%!+ 0(4 Q0    ( ')$
M7%@0Z\AE= 0  +P8   :              " @8YK P!X;"]W;W)K<VAE971S
M+W-H965T,3 T+GAM;%!+ 0(4 Q0    ( ')$7%B (@F)>@0  /$:   :
M          " @3IP P!X;"]W;W)K<VAE971S+W-H965T,3 U+GAM;%!+ 0(4
M Q0    ( ')$7%B0WV"'(@0  )\8   :              " @>QT P!X;"]W
M;W)K<VAE971S+W-H965T,3 V+GAM;%!+ 0(4 Q0    ( ')$7%C3DN@MG@<
M +(X   :              " @49Y P!X;"]W;W)K<VAE971S+W-H965T,3 W
M+GAM;%!+ 0(4 Q0    ( ')$7%CD4*86_P8  .PJ   :              "
M@1R! P!X;"]W;W)K<VAE971S+W-H965T,3 X+GAM;%!+ 0(4 Q0    ( ')$
M7%C<A<Q6-00  -D0   :              " @5.( P!X;"]W;W)K<VAE971S
M+W-H965T,3 Y+GAM;%!+ 0(4 Q0    ( ')$7%@06^9/EP,  -4.   :
M          " @<", P!X;"]W;W)K<VAE971S+W-H965T,3$P+GAM;%!+ 0(4
M Q0    ( ')$7%C[)^S)M@D  '=/   :              " @8^0 P!X;"]W
M;W)K<VAE971S+W-H965T,3$Q+GAM;%!+ 0(4 Q0    ( ')$7%A_-BAR>0,
M -\.   :              " @7V: P!X;"]W;W)K<VAE971S+W-H965T,3$R
M+GAM;%!+ 0(4 Q0    ( ')$7%BY_UY F ,  (\/   :              "
M@2Z> P!X;"]W;W)K<VAE971S+W-H965T,3$S+GAM;%!+ 0(4 Q0    ( ')$
M7%C.H,S[ 00  #@2   :              " @?ZA P!X;"]W;W)K<VAE971S
M+W-H965T,3$T+GAM;%!+ 0(4 Q0    ( ')$7%A,XYR-S0,  .@0   :
M          " @3>F P!X;"]W;W)K<VAE971S+W-H965T,3$U+GAM;%!+ 0(4
M Q0    ( ')$7%BM&VZ,=00  +X>   :              " @3RJ P!X;"]W
M;W)K<VAE971S+W-H965T,3$V+GAM;%!+ 0(4 Q0    ( ')$7%A:0X#?0!P
M )6/ 0 :              " @>FN P!X;"]W;W)K<VAE971S+W-H965T,3$W
M+GAM;%!+ 0(4 Q0    ( ')$7%A0*%L$=P0  $L8   :              "
M@6'+ P!X;"]W;W)K<VAE971S+W-H965T,3$X+GAM;%!+ 0(4 Q0    ( ')$
M7%@F'CHS.0,  #@,   :              " @1#0 P!X;"]W;W)K<VAE971S
M+W-H965T,3$Y+GAM;%!+ 0(4 Q0    ( ')$7%@#R4D\1PH   AA   :
M          " @8'3 P!X;"]W;W)K<VAE971S+W-H965T,3(P+GAM;%!+ 0(4
M Q0    ( ')$7%C88I%4 @,  !@,   :              " @0#> P!X;"]W
M;W)K<VAE971S+W-H965T,3(Q+GAM;%!+ 0(4 Q0    ( ')$7%B0LY?\\@0
M ,HB   :              " @3KA P!X;"]W;W)K<VAE971S+W-H965T,3(R
M+GAM;%!+ 0(4 Q0    ( ')$7%A?:^I5\P,  )03   :              "
M@63F P!X;"]W;W)K<VAE971S+W-H965T,3(S+GAM;%!+ 0(4 Q0    ( ')$
M7%B\1H#$0@4   L@   :              " @8_J P!X;"]W;W)K<VAE971S
M+W-H965T,3(T+GAM;%!+ 0(4 Q0    ( ')$7%B)T9:W=@D  ,EJ   :
M          " @0GP P!X;"]W;W)K<VAE971S+W-H965T,3(U+GAM;%!+ 0(4
M Q0    ( ')$7%@ *0*CF08  #@J   :              " @;?Y P!X;"]W
M;W)K<VAE971S+W-H965T,3(V+GAM;%!+ 0(4 Q0    ( ')$7%C VC6UUP4
M (HJ   :              " @8@ ! !X;"]W;W)K<VAE971S+W-H965T,3(W
M+GAM;%!+ 0(4 Q0    ( ')$7%@?+R"5_P(  & *   :              "
M@9<&! !X;"]W;W)K<VAE971S+W-H965T,3(X+GAM;%!+ 0(4 Q0    ( ')$
M7%AZH.%M\P\  *+T   :              " @<X)! !X;"]W;W)K<VAE971S
M+W-H965T,3(Y+GAM;%!+ 0(4 Q0    ( ')$7%C67ZMXP 0  % 9   :
M          " @?D9! !X;"]W;W)K<VAE971S+W-H965T,3,P+GAM;%!+ 0(4
M Q0    ( ')$7%B, QAJ^P4  'PK   :              " @?$>! !X;"]W
M;W)K<VAE971S+W-H965T,3,Q+GAM;%!+ 0(4 Q0    ( ')$7%C4&7.@;@,
M #$+   :              " @20E! !X;"]W;W)K<VAE971S+W-H965T,3,R
M+GAM;%!+ 0(4 Q0    ( ')$7%BT&@_#L0(  ($'   :              "
M@<HH! !X;"]W;W)K<VAE971S+W-H965T,3,S+GAM;%!+ 0(4 Q0    ( ')$
M7%AS<1IQ#@(  #T$   :              " @;,K! !X;"]W;W)K<VAE971S
M+W-H965T,3,T+GAM;%!+ 0(4 Q0    ( ')$7%BOLC5(9P(  $P&   :
M          " @?DM! !X;"]W;W)K<VAE971S+W-H965T,3,U+GAM;%!+ 0(4
M Q0    ( ')$7%@R/S'8H@0  #L5   :              " @9@P! !X;"]W
M;W)K<VAE971S+W-H965T,3,V+GAM;%!+ 0(4 Q0    ( ')$7%B E&FK=P,
M *$7   -              "  7(U! !X;"]S='EL97,N>&UL4$L! A0#%
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K! !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@    "0 )  S"<  $M*!     $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>154
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>155
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>157
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>885</ContextCount>
  <ElementCount>767</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>238</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>15</UnitCount>
  <MyReports>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - CONSOLIDATED STATEMENT OF INCOME AND COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME</Role>
      <ShortName>CONSOLIDATED STATEMENT OF INCOME AND COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - CONSOLIDATED BALANCE SHEET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/CONSOLIDATEDBALANCESHEET</Role>
      <ShortName>CONSOLIDATED BALANCE SHEET</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - CONSOLIDATED BALANCE SHEET (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/CONSOLIDATEDBALANCESHEETParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEET (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - CONSOLIDATED STATEMENT OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENT OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - CONSOLIDATED STATEMENT OF SHAREHOLDERS EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY</Role>
      <ShortName>CONSOLIDATED STATEMENT OF SHAREHOLDERS EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Statement - CONSOLIDATED STATEMENT OF SHAREHOLDERS EQUITY (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITYParenthetical</Role>
      <ShortName>CONSOLIDATED STATEMENT OF SHAREHOLDERS EQUITY (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPolicies</Role>
      <ShortName>Nature of Operations and Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Restructuring and Other Charges</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/RestructuringandOtherCharges</Role>
      <ShortName>Restructuring and Other Charges</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Acquisitions (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.iff.com/role/AcquisitionsNotes</Role>
      <ShortName>Acquisitions (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Business Divestiture</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/BusinessDivestiture</Role>
      <ShortName>Business Divestiture</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Property, Plant and Equipment, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/PropertyPlantandEquipmentNet</Role>
      <ShortName>Property, Plant and Equipment, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Goodwill and Other Intangible Assets, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNet</Role>
      <ShortName>Goodwill and Other Intangible Assets, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Other Assets And Liabilities, Current and Noncurrent</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrent</Role>
      <ShortName>Other Assets And Liabilities, Current and Noncurrent</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/Debt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Leases (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.iff.com/role/LeasesNotes</Role>
      <ShortName>Leases (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Net Income Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/NetIncomePerShare</Role>
      <ShortName>Net Income Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/ShareholdersEquity</Role>
      <ShortName>Shareholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Stock Compensation Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/StockCompensationPlans</Role>
      <ShortName>Stock Compensation Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/SegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Employee Benefits</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/EmployeeBenefits</Role>
      <ShortName>Employee Benefits</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/FinancialInstruments</Role>
      <ShortName>Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Accumulated Other Comprehensive Income (Loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLoss</Role>
      <ShortName>Accumulated Other Comprehensive Income (Loss)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Concentrations of Credit Risk</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/ConcentrationsofCreditRisk</Role>
      <ShortName>Concentrations of Credit Risk</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Redeemable Noncontrolling Interests</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/RedeemableNoncontrollingInterests</Role>
      <ShortName>Redeemable Noncontrolling Interests</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Assets and Liabilities Held For Sale</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/AssetsandLiabilitiesHeldForSale</Role>
      <ShortName>Assets and Liabilities Held For Sale</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - Other Income and Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/OtherIncomeandExpenses</Role>
      <ShortName>Other Income and Expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Tangible Equity Units</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/TangibleEquityUnits</Role>
      <ShortName>Tangible Equity Units</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Schedule II - Valuation and Qualifying Accounts and Reserves</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/ScheduleIIValuationandQualifyingAccountsandReserves</Role>
      <ShortName>Schedule II - Valuation and Qualifying Accounts and Reserves</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9954471 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Nature of Operations and Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9954472 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Nature of Operations and Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>9954473 - Disclosure - Restructuring and Other Charges (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/RestructuringandOtherChargesTables</Role>
      <ShortName>Restructuring and Other Charges (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iff.com/role/RestructuringandOtherCharges</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9954474 - Disclosure - Acquisitions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/AcquisitionsTables</Role>
      <ShortName>Acquisitions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iff.com/role/AcquisitionsNotes</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9954475 - Disclosure - Discontinued Operations and Disposal Groups (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/DiscontinuedOperationsandDisposalGroupsTables</Role>
      <ShortName>Discontinued Operations and Disposal Groups (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9954476 - Disclosure - Property, Plant and Equipment, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/PropertyPlantandEquipmentNetTables</Role>
      <ShortName>Property, Plant and Equipment, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iff.com/role/PropertyPlantandEquipmentNet</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9954477 - Disclosure - Goodwill and Other Intangible Assets, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetTables</Role>
      <ShortName>Goodwill and Other Intangible Assets, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNet</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9954478 - Disclosure - Other Assets And Liabilities, Current and Noncurrent (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentTables</Role>
      <ShortName>Other Assets And Liabilities, Current and Noncurrent (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrent</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9954479 - Disclosure - Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/DebtTables</Role>
      <ShortName>Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iff.com/role/Debt</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9954480 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iff.com/role/LeasesNotes</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9954481 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iff.com/role/IncomeTaxes</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>9954482 - Disclosure - Net Income Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/NetIncomePerShareTables</Role>
      <ShortName>Net Income Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iff.com/role/NetIncomePerShare</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>9954484 - Disclosure - Stock Compensation Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/StockCompensationPlansTables</Role>
      <ShortName>Stock Compensation Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iff.com/role/StockCompensationPlans</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>9954485 - Disclosure - Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/SegmentInformationTables</Role>
      <ShortName>Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iff.com/role/SegmentInformation</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>9954486 - Disclosure - Employee Benefits (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/EmployeeBenefitsTables</Role>
      <ShortName>Employee Benefits (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iff.com/role/EmployeeBenefits</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>9954487 - Disclosure - Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/FinancialInstrumentsTables</Role>
      <ShortName>Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iff.com/role/FinancialInstruments</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>9954488 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossTables</Role>
      <ShortName>Accumulated Other Comprehensive Income (Loss) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLoss</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>9954489 - Disclosure - Redeemable Noncontrolling Interests (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/RedeemableNoncontrollingInterestsTables</Role>
      <ShortName>Redeemable Noncontrolling Interests (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iff.com/role/RedeemableNoncontrollingInterests</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>9954490 - Disclosure - Assets and Liabilities Held For Sale (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleTables</Role>
      <ShortName>Assets and Liabilities Held For Sale (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iff.com/role/AssetsandLiabilitiesHeldForSale</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>9954491 - Disclosure - Other (Expense) Income, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/OtherExpenseIncomeNetTables</Role>
      <ShortName>Other (Expense) Income, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrent</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>9954493 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail</Role>
      <ShortName>Nature of Operations and Summary of Significant Accounting Policies - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>9954494 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies - Schedule of Inventory (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesScheduleofInventoryDetail</Role>
      <ShortName>Nature of Operations and Summary of Significant Accounting Policies - Schedule of Inventory (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>9954495 - Disclosure - Restructuring and Other Charges - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/RestructuringandOtherChargesAdditionalInformationDetails</Role>
      <ShortName>Restructuring and Other Charges - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>9954496 - Disclosure - Restructuring and Other Charges - Movements in Restructuring and Related Accruals (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/RestructuringandOtherChargesMovementsinRestructuringandRelatedAccrualsDetail</Role>
      <ShortName>Restructuring and Other Charges - Movements in Restructuring and Related Accruals (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>9954497 - Disclosure - Acquisitions - Health Wright Products (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/AcquisitionsHealthWrightProductsDetails</Role>
      <ShortName>Acquisitions - Health Wright Products (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>9954498 - Disclosure - Acquisitions - Nutrition &amp; Biosciences, Inc (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails</Role>
      <ShortName>Acquisitions - Nutrition &amp; Biosciences, Inc (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>9954499 - Disclosure - Business Divestiture (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/BusinessDivestitureDetails</Role>
      <ShortName>Business Divestiture (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iff.com/role/BusinessDivestiture</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>9954500 - Disclosure - Property, Plant and Equipment, Net - Schedule of Property, Plant and Equipment (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetail</Role>
      <ShortName>Property, Plant and Equipment, Net - Schedule of Property, Plant and Equipment (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>9954501 - Disclosure - Goodwill and Other Intangible Assets, Net - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetNarrativeDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets, Net - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>9954502 - Disclosure - Goodwill and Other Intangible Assets, Net - Goodwill Rollforward (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetGoodwillRollforwardDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets, Net - Goodwill Rollforward (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>9954503 - Disclosure - Goodwill and Other Intangible Assets, Net - Trademark and Other Intangible Assets (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetTrademarkandOtherIntangibleAssetsDetail</Role>
      <ShortName>Goodwill and Other Intangible Assets, Net - Trademark and Other Intangible Assets (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>9954504 - Disclosure - Goodwill and Other Intangible Assets, Net - Amortization Expense (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetAmortizationExpenseDetail</Role>
      <ShortName>Goodwill and Other Intangible Assets, Net - Amortization Expense (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>9954505 - Disclosure - Other Assets And Liabilities, Current and Noncurrent - Schedule of Other Assets (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherAssetsDetail</Role>
      <ShortName>Other Assets And Liabilities, Current and Noncurrent - Schedule of Other Assets (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>9954506 - Disclosure - Other Assets And Liabilities, Current and Noncurrent - Schedule of Other Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherCurrentLiabilitiesDetails</Role>
      <ShortName>Other Assets And Liabilities, Current and Noncurrent - Schedule of Other Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>9954507 - Disclosure - Debt - Components of Debt (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/DebtComponentsofDebtDetail</Role>
      <ShortName>Debt - Components of Debt (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>9954508 - Disclosure - Debt - Additional Information - Term Loan and Senior Notes Assumed (Detail)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail</Role>
      <ShortName>Debt - Additional Information - Term Loan and Senior Notes Assumed (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>9954509 - Disclosure - Debt - Additional Information - Revolving Credit Facility (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/DebtAdditionalInformationRevolvingCreditFacilityDetail</Role>
      <ShortName>Debt - Additional Information - Revolving Credit Facility (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>9954510 - Disclosure - Debt - Additional Information - Senior Unsecured Notes (Detail)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.iff.com/role/DebtAdditionalInformationSeniorUnsecuredNotesDetail</Role>
      <ShortName>Debt - Additional Information - Senior Unsecured Notes (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>9954511 - Disclosure - Debt - Additional Information - Commercial Paper and Redemption Provisions (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/DebtAdditionalInformationCommercialPaperandRedemptionProvisionsDetail</Role>
      <ShortName>Debt - Additional Information - Commercial Paper and Redemption Provisions (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>9954512 - Disclosure - Debt - Schedule of Debt Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/DebtScheduleofDebtMaturitiesDetails</Role>
      <ShortName>Debt - Schedule of Debt Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>9954513 - Disclosure - Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/LeasesDetails</Role>
      <ShortName>Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iff.com/role/LeasesTables</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>9954514 - Disclosure - Leases - Schedule of Lease Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/LeasesScheduleofLeaseExpenseDetails</Role>
      <ShortName>Leases - Schedule of Lease Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>9954516 - Disclosure - Leases - Cash Flow (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/LeasesCashFlowDetails</Role>
      <ShortName>Leases - Cash Flow (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>9954517 - Disclosure - Leases - Balance Sheet (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/LeasesBalanceSheetDetails</Role>
      <ShortName>Leases - Balance Sheet (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>9954518 - Disclosure - Leases - Weighted Average (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/LeasesWeightedAverageDetails</Role>
      <ShortName>Leases - Weighted Average (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>9954519 - Disclosure - Leases - Schedule of Lease Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails</Role>
      <ShortName>Leases - Schedule of Lease Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>9954520 - Disclosure - Leases - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/LeasesAdditionalInformationDetails</Role>
      <ShortName>Leases - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>9954521 - Disclosure - Income Taxes - Schedule of Earnings before Income Taxes (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetail</Role>
      <ShortName>Income Taxes - Schedule of Earnings before Income Taxes (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>9954522 - Disclosure - Income Taxes - Schedule of Income Tax Provision (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/IncomeTaxesScheduleofIncomeTaxProvisionDetail</Role>
      <ShortName>Income Taxes - Schedule of Income Tax Provision (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>9954523 - Disclosure - Income Taxes - Reconciliation of Effective Income Tax Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxRateDetails</Role>
      <ShortName>Income Taxes - Reconciliation of Effective Income Tax Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>9954524 - Disclosure - Income Taxes - Schedule of Reconciliation between U.S. Federal Statutory Income Tax Rate to Actual Effective Tax Rate (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/IncomeTaxesScheduleofReconciliationbetweenUSFederalStatutoryIncomeTaxRatetoActualEffectiveTaxRateDetail</Role>
      <ShortName>Income Taxes - Schedule of Reconciliation between U.S. Federal Statutory Income Tax Rate to Actual Effective Tax Rate (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>9954525 - Disclosure - Income Taxes - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/IncomeTaxesAdditionalInformationDetail</Role>
      <ShortName>Income Taxes - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>9954526 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetail</Role>
      <ShortName>Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>9954527 - Disclosure - Income Taxes - Reconciliation of Beginning and Ending Amount of Unrecognized Tax Benefits (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofUnrecognizedTaxBenefitsDetail</Role>
      <ShortName>Income Taxes - Reconciliation of Beginning and Ending Amount of Unrecognized Tax Benefits (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>9954528 - Disclosure - Net Income Per Share - Reconciliation of Shares Used in Computation of Basic and Diluted Net Income Per Share (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/NetIncomePerShareReconciliationofSharesUsedinComputationofBasicandDilutedNetIncomePerShareDetail</Role>
      <ShortName>Net Income Per Share - Reconciliation of Shares Used in Computation of Basic and Diluted Net Income Per Share (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>9954529 - Disclosure - Net Income Per Share - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/NetIncomePerShareAdditionalInformationDetail</Role>
      <ShortName>Net Income Per Share - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>9954530 - Disclosure - Net Income Per Share - TEU (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/NetIncomePerShareTEUDetails</Role>
      <ShortName>Net Income Per Share - TEU (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>9954531 - Disclosure - Shareholders' Equity - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/ShareholdersEquityAdditionalInformationDetail</Role>
      <ShortName>Shareholders' Equity - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>9954532 - Disclosure - Stock Compensation Plans - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail</Role>
      <ShortName>Stock Compensation Plans - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>9954533 - Disclosure - Stock Compensation Plans - Stock-Based Compensation Expense Included in Consolidated Statement of Income and Comprehensive Income (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/StockCompensationPlansStockBasedCompensationExpenseIncludedinConsolidatedStatementofIncomeandComprehensiveIncomeDetail</Role>
      <ShortName>Stock Compensation Plans - Stock-Based Compensation Expense Included in Consolidated Statement of Income and Comprehensive Income (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>9954534 - Disclosure - Stock Compensation Plans - SSAR's and Stock Option - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionAdditionalInformationDetail</Role>
      <ShortName>Stock Compensation Plans - SSAR's and Stock Option - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>9954535 - Disclosure - Stock Compensation Plans - SSAR's and Stock Option Activity (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionActivityDetail</Role>
      <ShortName>Stock Compensation Plans - SSAR's and Stock Option Activity (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>95</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>9954536 - Disclosure - Stock Compensation Plans - SSAR's and Stock Option Outstanding (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionOutstandingDetail</Role>
      <ShortName>Stock Compensation Plans - SSAR's and Stock Option Outstanding (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>96</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>9954537 - Disclosure - Stock Compensation Plans - SSAR's and Stock Option Exercisable (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionExercisableDetail</Role>
      <ShortName>Stock Compensation Plans - SSAR's and Stock Option Exercisable (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>97</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>9954538 - Disclosure - Stock Compensation Plans - Restricted Stock Units Plan - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/StockCompensationPlansRestrictedStockUnitsPlanAdditionalInformationDetail</Role>
      <ShortName>Stock Compensation Plans - Restricted Stock Units Plan - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>98</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>9954539 - Disclosure - Stock Compensation Plans - RSU, PRS and Cash RSU Activity (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/StockCompensationPlansRSUPRSandCashRSUActivityDetail</Role>
      <ShortName>Stock Compensation Plans - RSU, PRS and Cash RSU Activity (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>99</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>9954540 - Disclosure - Stock Compensation Plans - Purchased Restricted Stock Plan - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/StockCompensationPlansPurchasedRestrictedStockPlanAdditionalInformationDetail</Role>
      <ShortName>Stock Compensation Plans - Purchased Restricted Stock Plan - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>100</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>9954541 - Disclosure - Stock Compensation Plans - Liability Awards - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/StockCompensationPlansLiabilityAwardsAdditionalInformationDetail</Role>
      <ShortName>Stock Compensation Plans - Liability Awards - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>101</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>9954542 - Disclosure - Segment Information - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/SegmentInformationAdditionalInformationDetail</Role>
      <ShortName>Segment Information - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>102</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>9954543 - Disclosure - Segment Information - Reportable Segment Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail</Role>
      <ShortName>Segment Information - Reportable Segment Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>103</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>9954544 - Disclosure - Segment Information - Capital Expenditure and Depreciation and Amortization by Segment (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/SegmentInformationCapitalExpenditureandDepreciationandAmortizationbySegmentDetail</Role>
      <ShortName>Segment Information - Capital Expenditure and Depreciation and Amortization by Segment (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>104</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>9954545 - Disclosure - Segment Information - Net Sales by Geographic Area (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/SegmentInformationNetSalesbyGeographicAreaDetail</Role>
      <ShortName>Segment Information - Net Sales by Geographic Area (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>105</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R106.htm</HtmlFileName>
      <LongName>9954546 - Disclosure - Segment Information Segment Information - Schedule of Long Lived Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/SegmentInformationSegmentInformationScheduleofLongLivedAssetsDetails</Role>
      <ShortName>Segment Information Segment Information - Schedule of Long Lived Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>106</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R107.htm</HtmlFileName>
      <LongName>9954547 - Disclosure - Employee Benefits - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail</Role>
      <ShortName>Employee Benefits - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>107</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R108.htm</HtmlFileName>
      <LongName>9954548 - Disclosure - Employee Benefits - Plan Assets and Benefit Obligations of Defined Benefit Pension Plans (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail</Role>
      <ShortName>Employee Benefits - Plan Assets and Benefit Obligations of Defined Benefit Pension Plans (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>108</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R109.htm</HtmlFileName>
      <LongName>9954549 - Disclosure - Employee Benefits - Components of Net Periodic Benefit Cost and Changes in Plan Assets and Benefit Obligations Recognized in OCI (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostandChangesinPlanAssetsandBenefitObligationsRecognizedinOCIDetail</Role>
      <ShortName>Employee Benefits - Components of Net Periodic Benefit Cost and Changes in Plan Assets and Benefit Obligations Recognized in OCI (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>109</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R110.htm</HtmlFileName>
      <LongName>9954550 - Disclosure - Employee Benefits - Weighted-Average Actuarial Assumption Used to Determine Expense (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/EmployeeBenefitsWeightedAverageActuarialAssumptionUsedtoDetermineExpenseDetail</Role>
      <ShortName>Employee Benefits - Weighted-Average Actuarial Assumption Used to Determine Expense (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>110</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R111.htm</HtmlFileName>
      <LongName>9954551 - Disclosure - Employee Benefits - Changes in Postretirement Benefit Obligation and Plan Assets (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail</Role>
      <ShortName>Employee Benefits - Changes in Postretirement Benefit Obligation and Plan Assets (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>111</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R112.htm</HtmlFileName>
      <LongName>9954552 - Disclosure - Employee Benefits - Amounts Recognized in Balance Sheet (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinBalanceSheetDetail</Role>
      <ShortName>Employee Benefits - Amounts Recognized in Balance Sheet (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>112</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R113.htm</HtmlFileName>
      <LongName>9954553 - Disclosure - Employee Benefits - Amounts Recognized in Accumulated Other Comprehensive Income (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetail</Role>
      <ShortName>Employee Benefits - Amounts Recognized in Accumulated Other Comprehensive Income (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>113</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R114.htm</HtmlFileName>
      <LongName>9954554 - Disclosure - Employee Benefits - Accumulated Benefit Obligation (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/EmployeeBenefitsAccumulatedBenefitObligationDetail</Role>
      <ShortName>Employee Benefits - Accumulated Benefit Obligation (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>114</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R115.htm</HtmlFileName>
      <LongName>9954555 - Disclosure - Employee Benefits - Estimated Future Benefit Payments (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/EmployeeBenefitsEstimatedFutureBenefitPaymentsDetail</Role>
      <ShortName>Employee Benefits - Estimated Future Benefit Payments (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>115</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R116.htm</HtmlFileName>
      <LongName>9954556 - Disclosure - Employee Benefits - Percentage of Assets Invested (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/EmployeeBenefitsPercentageofAssetsInvestedDetail</Role>
      <ShortName>Employee Benefits - Percentage of Assets Invested (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>116</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R117.htm</HtmlFileName>
      <LongName>9954557 - Disclosure - Employee Benefits - Fair Value Hierarchy of Plan Assets (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail</Role>
      <ShortName>Employee Benefits - Fair Value Hierarchy of Plan Assets (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>117</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R118.htm</HtmlFileName>
      <LongName>9954558 - Disclosure - Employee Benefits - Reconciliation of Level 3 Non-U.S. Plan Assets Held (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/EmployeeBenefitsReconciliationofLevel3NonUSPlanAssetsHeldDetail</Role>
      <ShortName>Employee Benefits - Reconciliation of Level 3 Non-U.S. Plan Assets Held (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>118</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R119.htm</HtmlFileName>
      <LongName>9954559 - Disclosure - Employee Benefits - Weighted Average Assumptions Used to Determine Postretirement Benefit Expense and Obligation (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/EmployeeBenefitsWeightedAverageAssumptionsUsedtoDeterminePostretirementBenefitExpenseandObligationDetail</Role>
      <ShortName>Employee Benefits - Weighted Average Assumptions Used to Determine Postretirement Benefit Expense and Obligation (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>119</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R120.htm</HtmlFileName>
      <LongName>9954561 - Disclosure - Financial Instruments - Carrying Amount and Estimated Fair Value of Financial Instruments (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/FinancialInstrumentsCarryingAmountandEstimatedFairValueofFinancialInstrumentsDetail</Role>
      <ShortName>Financial Instruments - Carrying Amount and Estimated Fair Value of Financial Instruments (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>120</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R121.htm</HtmlFileName>
      <LongName>9954562 - Disclosure - Financial Instruments - Derivative Instruments Notional Amount Outstanding (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsNotionalAmountOutstandingDetail</Role>
      <ShortName>Financial Instruments - Derivative Instruments Notional Amount Outstanding (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>121</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R122.htm</HtmlFileName>
      <LongName>9954563 - Disclosure - Financial Instruments - Derivative Instruments Measured at Fair Value (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsMeasuredatFairValueDetail</Role>
      <ShortName>Financial Instruments - Derivative Instruments Measured at Fair Value (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>122</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R123.htm</HtmlFileName>
      <LongName>9954564 - Disclosure - Financial Instruments - Derivative Instruments Which Were Not Designated as Hedging Instruments (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsWhichWereNotDesignatedasHedgingInstrumentsDetail</Role>
      <ShortName>Financial Instruments - Derivative Instruments Which Were Not Designated as Hedging Instruments (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>123</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R124.htm</HtmlFileName>
      <LongName>9954565 - Disclosure - Financial Instruments - Derivative Instruments Designated as Cash Flow and Net Investment Hedging Instruments (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowandNetInvestmentHedgingInstrumentsDetail</Role>
      <ShortName>Financial Instruments - Derivative Instruments Designated as Cash Flow and Net Investment Hedging Instruments (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>124</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R125.htm</HtmlFileName>
      <LongName>9954566 - Disclosure - Financial Instruments - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/FinancialInstrumentsAdditionalInformationDetail</Role>
      <ShortName>Financial Instruments - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>125</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R126.htm</HtmlFileName>
      <LongName>9954567 - Disclosure - Accumulated Other Comprehensive Income (Loss) - Schedule of Changes in Accumulated Other Comprehensive Income (Loss) (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossDetail</Role>
      <ShortName>Accumulated Other Comprehensive Income (Loss) - Schedule of Changes in Accumulated Other Comprehensive Income (Loss) (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossTables</ParentRole>
      <Position>126</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R127.htm</HtmlFileName>
      <LongName>9954568 - Disclosure - Accumulated Other Comprehensive Income (Loss) - Reclassifications of Accumulated Other Comprehensive Income to Consolidated Statement of Comprehensive Income (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossReclassificationsofAccumulatedOtherComprehensiveIncometoConsolidatedStatementofComprehensiveIncomeDetail</Role>
      <ShortName>Accumulated Other Comprehensive Income (Loss) - Reclassifications of Accumulated Other Comprehensive Income to Consolidated Statement of Comprehensive Income (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossTables</ParentRole>
      <Position>127</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R128.htm</HtmlFileName>
      <LongName>9954569 - Disclosure - Concentrations Of Credit Risk - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/ConcentrationsOfCreditRiskAdditionalInformationDetail</Role>
      <ShortName>Concentrations Of Credit Risk - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>128</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R129.htm</HtmlFileName>
      <LongName>9954570 - Disclosure - Commitments and Contingencies - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail</Role>
      <ShortName>Commitments and Contingencies - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>129</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R130.htm</HtmlFileName>
      <LongName>9954571 - Disclosure - Redeemable Noncontrolling Interests (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/RedeemableNoncontrollingInterestsDetails</Role>
      <ShortName>Redeemable Noncontrolling Interests (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iff.com/role/RedeemableNoncontrollingInterestsTables</ParentRole>
      <Position>130</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R131.htm</HtmlFileName>
      <LongName>9954572 - Disclosure - Assets and Liabilities Held For Sale (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleDetails</Role>
      <ShortName>Assets and Liabilities Held For Sale (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleTables</ParentRole>
      <Position>131</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R132.htm</HtmlFileName>
      <LongName>9954573 - Disclosure - Other (Expense) Income, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/OtherExpenseIncomeNetDetails</Role>
      <ShortName>Other (Expense) Income, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentTables</ParentRole>
      <Position>132</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R133.htm</HtmlFileName>
      <LongName>9954574 - Disclosure - Tangible Equity Units (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/TangibleEquityUnitsDetails</Role>
      <ShortName>Tangible Equity Units (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iff.com/role/TangibleEquityUnits</ParentRole>
      <Position>133</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R134.htm</HtmlFileName>
      <LongName>9954575 - Disclosure - Tangible Equity Units (Allocation of TEU) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/TangibleEquityUnitsAllocationofTEUDetails</Role>
      <ShortName>Tangible Equity Units (Allocation of TEU) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iff.com/role/TangibleEquityUnits</ParentRole>
      <Position>134</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R135.htm</HtmlFileName>
      <LongName>9954576 - Disclosure - Tangible Equity Units Tangible Equity - Settlement of Shares (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/TangibleEquityUnitsTangibleEquitySettlementofSharesDetails</Role>
      <ShortName>Tangible Equity Units Tangible Equity - Settlement of Shares (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>135</Position>
    </Report>
    <Report instance="iff-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R136.htm</HtmlFileName>
      <LongName>9954577 - Disclosure - Schedule II - Valuation and Qualifying Accounts and Reserves (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com/role/ScheduleIIValuationandQualifyingAccountsandReservesDetail</Role>
      <ShortName>Schedule II - Valuation and Qualifying Accounts and Reserves (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iff.com/role/ScheduleIIValuationandQualifyingAccountsandReserves</ParentRole>
      <Position>136</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" isDefinitelyFs="true" isUsgaap="true" original="iff-20231231.htm">iff-20231231.htm</File>
    <File>iff-20231231.xsd</File>
    <File>iff-20231231_cal.xml</File>
    <File>iff-20231231_def.xml</File>
    <File>iff-20231231_lab.xml</File>
    <File>iff-20231231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>iff-20231231_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1">http://fasb.org/srt/2023</BaseTaxonomy>
    <BaseTaxonomy items="2431">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="49">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
    <BaseTaxonomy items="5">http://xbrl.sec.gov/ecd/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>159
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "iff-20231231.htm": {
   "nsprefix": "iff",
   "nsuri": "http://www.iff.com/20231231",
   "dts": {
    "inline": {
     "local": [
      "iff-20231231.htm"
     ]
    },
    "schema": {
     "local": [
      "iff-20231231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "iff-20231231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "iff-20231231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "iff-20231231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "iff-20231231_pre.xml"
     ]
    }
   },
   "keyStandard": 606,
   "keyCustom": 161,
   "axisStandard": 58,
   "axisCustom": 1,
   "memberStandard": 111,
   "memberCustom": 99,
   "hidden": {
    "total": 17,
    "http://fasb.org/us-gaap/2023": 13,
    "http://xbrl.sec.gov/dei/2023": 4
   },
   "contextCount": 885,
   "entityCount": 1,
   "segmentCount": 238,
   "elementCount": 1511,
   "unitCount": 15,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2023": 2431,
    "http://xbrl.sec.gov/dei/2023": 49,
    "http://xbrl.sec.gov/ecd/2023": 5,
    "http://fasb.org/srt/2023": 1
   },
   "report": {
    "R1": {
     "role": "http://www.iff.com/role/CoverPage",
     "longName": "0000001 - Document - Cover Page",
     "shortName": "Cover Page",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.iff.com/role/AuditInformation",
     "longName": "0000002 - Document - Audit Information",
     "shortName": "Audit Information",
     "isDefault": "false",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:AuditorName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:AuditorName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME",
     "longName": "0000003 - Statement - CONSOLIDATED STATEMENT OF INCOME AND COMPREHENSIVE INCOME",
     "shortName": "CONSOLIDATED STATEMENT OF INCOME AND COMPREHENSIVE INCOME",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GrossProfit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET",
     "longName": "0000004 - Statement - CONSOLIDATED BALANCE SHEET",
     "shortName": "CONSOLIDATED BALANCE SHEET",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-11",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-11",
      "name": "us-gaap:AssetsCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.iff.com/role/CONSOLIDATEDBALANCESHEETParenthetical",
     "longName": "0000005 - Statement - CONSOLIDATED BALANCE SHEET (Parenthetical)",
     "shortName": "CONSOLIDATED BALANCE SHEET (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-11",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-11",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS",
     "longName": "0000006 - Statement - CONSOLIDATED STATEMENT OF CASH FLOWS",
     "shortName": "CONSOLIDATED STATEMENT OF CASH FLOWS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GainLossOnDispositionOfAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY",
     "longName": "0000007 - Statement - CONSOLIDATED STATEMENT OF SHAREHOLDERS EQUITY",
     "shortName": "CONSOLIDATED STATEMENT OF SHAREHOLDERS EQUITY",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-19",
      "name": "us-gaap:TreasuryStockCommonShares",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-19",
      "name": "us-gaap:TreasuryStockCommonShares",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITYParenthetical",
     "longName": "0000008 - Statement - CONSOLIDATED STATEMENT OF SHAREHOLDERS EQUITY (Parenthetical)",
     "shortName": "CONSOLIDATED STATEMENT OF SHAREHOLDERS EQUITY (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-10",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-10",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPolicies",
     "longName": "0000009 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies",
     "shortName": "Nature of Operations and Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.iff.com/role/RestructuringandOtherCharges",
     "longName": "0000010 - Disclosure - Restructuring and Other Charges",
     "shortName": "Restructuring and Other Charges",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.iff.com/role/AcquisitionsNotes",
     "longName": "0000011 - Disclosure - Acquisitions (Notes)",
     "shortName": "Acquisitions (Notes)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.iff.com/role/BusinessDivestiture",
     "longName": "0000012 - Disclosure - Business Divestiture",
     "shortName": "Business Divestiture",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R13": {
     "role": "http://www.iff.com/role/PropertyPlantandEquipmentNet",
     "longName": "0000013 - Disclosure - Property, Plant and Equipment, Net",
     "shortName": "Property, Plant and Equipment, Net",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNet",
     "longName": "0000014 - Disclosure - Goodwill and Other Intangible Assets, Net",
     "shortName": "Goodwill and Other Intangible Assets, Net",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrent",
     "longName": "0000015 - Disclosure - Other Assets And Liabilities, Current and Noncurrent",
     "shortName": "Other Assets And Liabilities, Current and Noncurrent",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "iff:OtherAssetsAndLiabilitiesDisclosureCurrentAndNoncurrentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "iff:OtherAssetsAndLiabilitiesDisclosureCurrentAndNoncurrentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.iff.com/role/Debt",
     "longName": "0000016 - Disclosure - Debt",
     "shortName": "Debt",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.iff.com/role/LeasesNotes",
     "longName": "0000017 - Disclosure - Leases (Notes)",
     "shortName": "Leases (Notes)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.iff.com/role/IncomeTaxes",
     "longName": "0000018 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.iff.com/role/NetIncomePerShare",
     "longName": "0000019 - Disclosure - Net Income Per Share",
     "shortName": "Net Income Per Share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.iff.com/role/ShareholdersEquity",
     "longName": "0000020 - Disclosure - Shareholders' Equity",
     "shortName": "Shareholders' Equity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R21": {
     "role": "http://www.iff.com/role/StockCompensationPlans",
     "longName": "0000021 - Disclosure - Stock Compensation Plans",
     "shortName": "Stock Compensation Plans",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.iff.com/role/SegmentInformation",
     "longName": "0000022 - Disclosure - Segment Information",
     "shortName": "Segment Information",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://www.iff.com/role/EmployeeBenefits",
     "longName": "0000023 - Disclosure - Employee Benefits",
     "shortName": "Employee Benefits",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.iff.com/role/FinancialInstruments",
     "longName": "0000024 - Disclosure - Financial Instruments",
     "shortName": "Financial Instruments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLoss",
     "longName": "0000025 - Disclosure - Accumulated Other Comprehensive Income (Loss)",
     "shortName": "Accumulated Other Comprehensive Income (Loss)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "iff:AccumulatedOtherComprehensiveIncomeLossTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "iff:AccumulatedOtherComprehensiveIncomeLossTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.iff.com/role/ConcentrationsofCreditRisk",
     "longName": "0000026 - Disclosure - Concentrations of Credit Risk",
     "shortName": "Concentrations of Credit Risk",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.iff.com/role/CommitmentsandContingencies",
     "longName": "0000027 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.iff.com/role/RedeemableNoncontrollingInterests",
     "longName": "0000028 - Disclosure - Redeemable Noncontrolling Interests",
     "shortName": "Redeemable Noncontrolling Interests",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.iff.com/role/AssetsandLiabilitiesHeldForSale",
     "longName": "0000029 - Disclosure - Assets and Liabilities Held For Sale",
     "shortName": "Assets and Liabilities Held For Sale",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R30": {
     "role": "http://www.iff.com/role/OtherIncomeandExpenses",
     "longName": "0000030 - Disclosure - Other Income and Expenses",
     "shortName": "Other Income and Expenses",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherNonoperatingIncomeAndExpenseTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherNonoperatingIncomeAndExpenseTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.iff.com/role/TangibleEquityUnits",
     "longName": "0000031 - Disclosure - Tangible Equity Units",
     "shortName": "Tangible Equity Units",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R32": {
     "role": "http://www.iff.com/role/ScheduleIIValuationandQualifyingAccountsandReserves",
     "longName": "0000032 - Disclosure - Schedule II - Valuation and Qualifying Accounts and Reserves",
     "shortName": "Schedule II - Valuation and Qualifying Accounts and Reserves",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ecd:MtrlTermsOfTrdArrTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ecd:MtrlTermsOfTrdArrTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies",
     "longName": "9954471 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies (Policies)",
     "shortName": "Nature of Operations and Summary of Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "iff:NatureOfOperationsPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "iff:NatureOfOperationsPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesTables",
     "longName": "9954472 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies (Tables)",
     "shortName": "Nature of Operations and Summary of Significant Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.iff.com/role/RestructuringandOtherChargesTables",
     "longName": "9954473 - Disclosure - Restructuring and Other Charges (Tables)",
     "shortName": "Restructuring and Other Charges (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.iff.com/role/AcquisitionsTables",
     "longName": "9954474 - Disclosure - Acquisitions (Tables)",
     "shortName": "Acquisitions (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://www.iff.com/role/DiscontinuedOperationsandDisposalGroupsTables",
     "longName": "9954475 - Disclosure - Discontinued Operations and Disposal Groups (Tables)",
     "shortName": "Discontinued Operations and Disposal Groups (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R39": {
     "role": "http://www.iff.com/role/PropertyPlantandEquipmentNetTables",
     "longName": "9954476 - Disclosure - Property, Plant and Equipment, Net (Tables)",
     "shortName": "Property, Plant and Equipment, Net (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetTables",
     "longName": "9954477 - Disclosure - Goodwill and Other Intangible Assets, Net (Tables)",
     "shortName": "Goodwill and Other Intangible Assets, Net (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentTables",
     "longName": "9954478 - Disclosure - Other Assets And Liabilities, Current and Noncurrent (Tables)",
     "shortName": "Other Assets And Liabilities, Current and Noncurrent (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfOtherAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfOtherAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.iff.com/role/DebtTables",
     "longName": "9954479 - Disclosure - Debt (Tables)",
     "shortName": "Debt (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.iff.com/role/LeasesTables",
     "longName": "9954480 - Disclosure - Leases (Tables)",
     "shortName": "Leases (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.iff.com/role/IncomeTaxesTables",
     "longName": "9954481 - Disclosure - Income Taxes (Tables)",
     "shortName": "Income Taxes (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.iff.com/role/NetIncomePerShareTables",
     "longName": "9954482 - Disclosure - Net Income Per Share (Tables)",
     "shortName": "Net Income Per Share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.iff.com/role/StockCompensationPlansTables",
     "longName": "9954484 - Disclosure - Stock Compensation Plans (Tables)",
     "shortName": "Stock Compensation Plans (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.iff.com/role/SegmentInformationTables",
     "longName": "9954485 - Disclosure - Segment Information (Tables)",
     "shortName": "Segment Information (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.iff.com/role/EmployeeBenefitsTables",
     "longName": "9954486 - Disclosure - Employee Benefits (Tables)",
     "shortName": "Employee Benefits (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "iff:PensionExpensesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "iff:PensionExpensesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.iff.com/role/FinancialInstrumentsTables",
     "longName": "9954487 - Disclosure - Financial Instruments (Tables)",
     "shortName": "Financial Instruments (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossTables",
     "longName": "9954488 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Tables)",
     "shortName": "Accumulated Other Comprehensive Income (Loss) (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.iff.com/role/RedeemableNoncontrollingInterestsTables",
     "longName": "9954489 - Disclosure - Redeemable Noncontrolling Interests (Tables)",
     "shortName": "Redeemable Noncontrolling Interests (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RedeemableNoncontrollingInterestTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RedeemableNoncontrollingInterestTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleTables",
     "longName": "9954490 - Disclosure - Assets and Liabilities Held For Sale (Tables)",
     "shortName": "Assets and Liabilities Held For Sale (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R53": {
     "role": "http://www.iff.com/role/OtherExpenseIncomeNetTables",
     "longName": "9954491 - Disclosure - Other (Expense) Income, Net (Tables)",
     "shortName": "Other (Expense) Income, Net (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
     "longName": "9954493 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies - Additional Information (Detail)",
     "shortName": "Nature of Operations and Summary of Significant Accounting Policies - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c-11",
      "name": "us-gaap:AccountsReceivableGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-11",
      "name": "us-gaap:AccountsReceivableGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesScheduleofInventoryDetail",
     "longName": "9954494 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies - Schedule of Inventory (Detail)",
     "shortName": "Nature of Operations and Summary of Significant Accounting Policies - Schedule of Inventory (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c-11",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-11",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://www.iff.com/role/RestructuringandOtherChargesAdditionalInformationDetails",
     "longName": "9954495 - Disclosure - Restructuring and Other Charges - Additional Information (Details)",
     "shortName": "Restructuring and Other Charges - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RestructuringCharges",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-92",
      "name": "us-gaap:RestructuringAndRelatedCostCostIncurredToDate1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "unique": true
     }
    },
    "R57": {
     "role": "http://www.iff.com/role/RestructuringandOtherChargesMovementsinRestructuringandRelatedAccrualsDetail",
     "longName": "9954496 - Disclosure - Restructuring and Other Charges - Movements in Restructuring and Related Accruals (Detail)",
     "shortName": "Restructuring and Other Charges - Movements in Restructuring and Related Accruals (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "c-12",
      "name": "us-gaap:RestructuringReserve",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R58": {
     "role": "http://www.iff.com/role/AcquisitionsHealthWrightProductsDetails",
     "longName": "9954497 - Disclosure - Acquisitions - Health Wright Products (Details)",
     "shortName": "Acquisitions - Health Wright Products (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "c-11",
      "name": "us-gaap:Goodwill",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-154",
      "name": "us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "unique": true
     }
    },
    "R59": {
     "role": "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails",
     "longName": "9954498 - Disclosure - Acquisitions - Nutrition & Biosciences, Inc (Details)",
     "shortName": "Acquisitions - Nutrition & Biosciences, Inc (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "c-11",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-166",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "unique": true
     }
    },
    "R60": {
     "role": "http://www.iff.com/role/BusinessDivestitureDetails",
     "longName": "9954499 - Disclosure - Business Divestiture (Details)",
     "shortName": "Business Divestiture (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "c-11",
      "name": "us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-181",
      "name": "iff:ProceedsFromDivestitureOfBusinessesGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "unique": true
     }
    },
    "R61": {
     "role": "http://www.iff.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetail",
     "longName": "9954500 - Disclosure - Property, Plant and Equipment, Net - Schedule of Property, Plant and Equipment (Detail)",
     "shortName": "Property, Plant and Equipment, Net - Schedule of Property, Plant and Equipment (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "c-11",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-11",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R62": {
     "role": "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetNarrativeDetails",
     "longName": "9954501 - Disclosure - Goodwill and Other Intangible Assets, Net - Narrative (Details)",
     "shortName": "Goodwill and Other Intangible Assets, Net - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "c-208",
      "name": "us-gaap:ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-208",
      "name": "us-gaap:ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R63": {
     "role": "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetGoodwillRollforwardDetails",
     "longName": "9954502 - Disclosure - Goodwill and Other Intangible Assets, Net - Goodwill Rollforward (Details)",
     "shortName": "Goodwill and Other Intangible Assets, Net - Goodwill Rollforward (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "c-12",
      "name": "us-gaap:Goodwill",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GoodwillForeignCurrencyTranslationGainLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "unique": true
     }
    },
    "R64": {
     "role": "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetTrademarkandOtherIntangibleAssetsDetail",
     "longName": "9954503 - Disclosure - Goodwill and Other Intangible Assets, Net - Trademark and Other Intangible Assets (Detail)",
     "shortName": "Goodwill and Other Intangible Assets, Net - Trademark and Other Intangible Assets (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "c-11",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-11",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R65": {
     "role": "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetAmortizationExpenseDetail",
     "longName": "9954504 - Disclosure - Goodwill and Other Intangible Assets, Net - Amortization Expense (Detail)",
     "shortName": "Goodwill and Other Intangible Assets, Net - Amortization Expense (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-11",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "unique": true
     }
    },
    "R66": {
     "role": "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherAssetsDetail",
     "longName": "9954505 - Disclosure - Other Assets And Liabilities, Current and Noncurrent - Schedule of Other Assets (Detail)",
     "shortName": "Other Assets And Liabilities, Current and Noncurrent - Schedule of Other Assets (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "c-11",
      "name": "us-gaap:ValueAddedTaxReceivableCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-11",
      "name": "us-gaap:ValueAddedTaxReceivableCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R67": {
     "role": "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherCurrentLiabilitiesDetails",
     "longName": "9954506 - Disclosure - Other Assets And Liabilities, Current and Noncurrent - Schedule of Other Current Liabilities (Details)",
     "shortName": "Other Assets And Liabilities, Current and Noncurrent - Schedule of Other Current Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "c-11",
      "name": "iff:RebatesAndIncentivesPayableCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-11",
      "name": "iff:RebatesAndIncentivesPayableCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R68": {
     "role": "http://www.iff.com/role/DebtComponentsofDebtDetail",
     "longName": "9954507 - Disclosure - Debt - Components of Debt (Detail)",
     "shortName": "Debt - Components of Debt (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "c-11",
      "name": "us-gaap:CommercialPaper",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-11",
      "name": "us-gaap:DebtLongtermAndShorttermCombinedAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "unique": true
     }
    },
    "R69": {
     "role": "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail",
     "longName": "9954508 - Disclosure - Debt - Additional Information - Term Loan and Senior Notes Assumed (Detail)",
     "shortName": "Debt - Additional Information - Term Loan and Senior Notes Assumed (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "c-254",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-254",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R70": {
     "role": "http://www.iff.com/role/DebtAdditionalInformationRevolvingCreditFacilityDetail",
     "longName": "9954509 - Disclosure - Debt - Additional Information - Revolving Credit Facility (Detail)",
     "shortName": "Debt - Additional Information - Revolving Credit Facility (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "c-295",
      "name": "iff:CommonStockDividendsPerShareMaximumDividendThresholdPerQuarter",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-295",
      "name": "iff:CommonStockDividendsPerShareMaximumDividendThresholdPerQuarter",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R71": {
     "role": "http://www.iff.com/role/DebtAdditionalInformationSeniorUnsecuredNotesDetail",
     "longName": "9954510 - Disclosure - Debt - Additional Information - Senior Unsecured Notes (Detail)",
     "shortName": "Debt - Additional Information - Senior Unsecured Notes (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "c-11",
      "name": "us-gaap:LongTermDebt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-304",
      "name": "us-gaap:LongTermDebt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "unique": true
     }
    },
    "R72": {
     "role": "http://www.iff.com/role/DebtAdditionalInformationCommercialPaperandRedemptionProvisionsDetail",
     "longName": "9954511 - Disclosure - Debt - Additional Information - Commercial Paper and Redemption Provisions (Detail)",
     "shortName": "Debt - Additional Information - Commercial Paper and Redemption Provisions (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ProceedsFromIssuanceOfCommercialPaper",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ProceedsFromIssuanceOfCommercialPaper",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R73": {
     "role": "http://www.iff.com/role/DebtScheduleofDebtMaturitiesDetails",
     "longName": "9954512 - Disclosure - Debt - Schedule of Debt Maturities (Details)",
     "shortName": "Debt - Schedule of Debt Maturities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "c-11",
      "name": "us-gaap:LongTermDebt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-11",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "unique": true
     }
    },
    "R74": {
     "role": "http://www.iff.com/role/LeasesDetails",
     "longName": "9954513 - Disclosure - Leases (Details)",
     "shortName": "Leases (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "c-11",
      "name": "us-gaap:LesseeOperatingLeaseRemainingLeaseTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-11",
      "name": "us-gaap:LesseeOperatingLeaseRemainingLeaseTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R75": {
     "role": "http://www.iff.com/role/LeasesScheduleofLeaseExpenseDetails",
     "longName": "9954514 - Disclosure - Leases - Schedule of Lease Expense (Details)",
     "shortName": "Leases - Schedule of Lease Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R76": {
     "role": "http://www.iff.com/role/LeasesCashFlowDetails",
     "longName": "9954516 - Disclosure - Leases - Cash Flow (Details)",
     "shortName": "Leases - Cash Flow (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R77": {
     "role": "http://www.iff.com/role/LeasesBalanceSheetDetails",
     "longName": "9954517 - Disclosure - Leases - Balance Sheet (Details)",
     "shortName": "Leases - Balance Sheet (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "c-11",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "iff:AssetsAndLiabilitiesLesseeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-11",
      "name": "us-gaap:FinanceLeaseLiabilityCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "iff:AssetsAndLiabilitiesLesseeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "unique": true
     }
    },
    "R78": {
     "role": "http://www.iff.com/role/LeasesWeightedAverageDetails",
     "longName": "9954518 - Disclosure - Leases - Weighted Average (Details)",
     "shortName": "Leases - Weighted Average (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "78",
     "firstAnchor": {
      "contextRef": "c-11",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-11",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R79": {
     "role": "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails",
     "longName": "9954519 - Disclosure - Leases - Schedule of Lease Maturities (Details)",
     "shortName": "Leases - Schedule of Lease Maturities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "79",
     "firstAnchor": {
      "contextRef": "c-11",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-11",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R80": {
     "role": "http://www.iff.com/role/LeasesAdditionalInformationDetails",
     "longName": "9954520 - Disclosure - Leases - Additional Information (Details)",
     "shortName": "Leases - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "80",
     "firstAnchor": {
      "contextRef": "c-11",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "iff:AssetsAndLiabilitiesLesseeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-154",
      "name": "us-gaap:FinanceLeaseRightOfUseAsset",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "unique": true
     }
    },
    "R81": {
     "role": "http://www.iff.com/role/IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetail",
     "longName": "9954521 - Disclosure - Income Taxes - Schedule of Earnings before Income Taxes (Detail)",
     "shortName": "Income Taxes - Schedule of Earnings before Income Taxes (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "81",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R82": {
     "role": "http://www.iff.com/role/IncomeTaxesScheduleofIncomeTaxProvisionDetail",
     "longName": "9954522 - Disclosure - Income Taxes - Schedule of Income Tax Provision (Detail)",
     "shortName": "Income Taxes - Schedule of Income Tax Provision (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "82",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R83": {
     "role": "http://www.iff.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxRateDetails",
     "longName": "9954523 - Disclosure - Income Taxes - Reconciliation of Effective Income Tax Rate (Details)",
     "shortName": "Income Taxes - Reconciliation of Effective Income Tax Rate (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "83",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "unique": true
     }
    },
    "R84": {
     "role": "http://www.iff.com/role/IncomeTaxesScheduleofReconciliationbetweenUSFederalStatutoryIncomeTaxRatetoActualEffectiveTaxRateDetail",
     "longName": "9954524 - Disclosure - Income Taxes - Schedule of Reconciliation between U.S. Federal Statutory Income Tax Rate to Actual Effective Tax Rate (Detail)",
     "shortName": "Income Taxes - Schedule of Reconciliation between U.S. Federal Statutory Income Tax Rate to Actual Effective Tax Rate (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "84",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R85": {
     "role": "http://www.iff.com/role/IncomeTaxesAdditionalInformationDetail",
     "longName": "9954525 - Disclosure - Income Taxes - Additional Information (Detail)",
     "shortName": "Income Taxes - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "85",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationGiltiAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationGiltiAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R86": {
     "role": "http://www.iff.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetail",
     "longName": "9954526 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Detail)",
     "shortName": "Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "86",
     "firstAnchor": {
      "contextRef": "c-11",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-11",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R87": {
     "role": "http://www.iff.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofUnrecognizedTaxBenefitsDetail",
     "longName": "9954527 - Disclosure - Income Taxes - Reconciliation of Beginning and Ending Amount of Unrecognized Tax Benefits (Detail)",
     "shortName": "Income Taxes - Reconciliation of Beginning and Ending Amount of Unrecognized Tax Benefits (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "87",
     "firstAnchor": {
      "contextRef": "c-12",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-14",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "unique": true
     }
    },
    "R88": {
     "role": "http://www.iff.com/role/NetIncomePerShareReconciliationofSharesUsedinComputationofBasicandDilutedNetIncomePerShareDetail",
     "longName": "9954528 - Disclosure - Net Income Per Share - Reconciliation of Shares Used in Computation of Basic and Diluted Net Income Per Share (Detail)",
     "shortName": "Net Income Per Share - Reconciliation of Shares Used in Computation of Basic and Diluted Net Income Per Share (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "88",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "iff:NetIncomeLossAvailableToCommonStockholdersAdjustment",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "unique": true
     }
    },
    "R89": {
     "role": "http://www.iff.com/role/NetIncomePerShareAdditionalInformationDetail",
     "longName": "9954529 - Disclosure - Net Income Per Share - Additional Information (Detail)",
     "shortName": "Net Income Per Share - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "89",
     "firstAnchor": {
      "contextRef": "c-11",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "unique": true
     }
    },
    "R90": {
     "role": "http://www.iff.com/role/NetIncomePerShareTEUDetails",
     "longName": "9954530 - Disclosure - Net Income Per Share - TEU (Details)",
     "shortName": "Net Income Per Share - TEU (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "90",
     "firstAnchor": {
      "contextRef": "c-346",
      "name": "iff:TangibleEquityUnitsIssued",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-10",
      "name": "iff:TangibleEquityUnitsPriceforSharesDiluted",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "unique": true
     }
    },
    "R91": {
     "role": "http://www.iff.com/role/ShareholdersEquityAdditionalInformationDetail",
     "longName": "9954531 - Disclosure - Shareholders' Equity - Additional Information (Detail)",
     "shortName": "Shareholders' Equity - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "91",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-13",
      "name": "us-gaap:DividendsPayableCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "unique": true
     }
    },
    "R92": {
     "role": "http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail",
     "longName": "9954532 - Disclosure - Stock Compensation Plans - Additional Information (Detail)",
     "shortName": "Stock Compensation Plans - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "92",
     "firstAnchor": {
      "contextRef": "c-11",
      "name": "iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesSubjectToOutstandingAwards",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-11",
      "name": "iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesSubjectToOutstandingAwards",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R93": {
     "role": "http://www.iff.com/role/StockCompensationPlansStockBasedCompensationExpenseIncludedinConsolidatedStatementofIncomeandComprehensiveIncomeDetail",
     "longName": "9954533 - Disclosure - Stock Compensation Plans - Stock-Based Compensation Expense Included in Consolidated Statement of Income and Comprehensive Income (Detail)",
     "shortName": "Stock Compensation Plans - Stock-Based Compensation Expense Included in Consolidated Statement of Income and Comprehensive Income (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "93",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "unique": true
     }
    },
    "R94": {
     "role": "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionAdditionalInformationDetail",
     "longName": "9954534 - Disclosure - Stock Compensation Plans - SSAR's and Stock Option - Additional Information (Detail)",
     "shortName": "Stock Compensation Plans - SSAR's and Stock Option - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "94",
     "firstAnchor": {
      "contextRef": "c-367",
      "name": "iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-367",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "unique": true
     }
    },
    "R95": {
     "role": "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionActivityDetail",
     "longName": "9954535 - Disclosure - Stock Compensation Plans - SSAR's and Stock Option Activity (Detail)",
     "shortName": "Stock Compensation Plans - SSAR's and Stock Option Activity (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "95",
     "firstAnchor": {
      "contextRef": "c-368",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-369",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "unique": true
     }
    },
    "R96": {
     "role": "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionOutstandingDetail",
     "longName": "9954536 - Disclosure - Stock Compensation Plans - SSAR's and Stock Option Outstanding (Detail)",
     "shortName": "Stock Compensation Plans - SSAR's and Stock Option Outstanding (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "96",
     "firstAnchor": {
      "contextRef": "c-372",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-372",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R97": {
     "role": "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionExercisableDetail",
     "longName": "9954537 - Disclosure - Stock Compensation Plans - SSAR's and Stock Option Exercisable (Detail)",
     "shortName": "Stock Compensation Plans - SSAR's and Stock Option Exercisable (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "97",
     "firstAnchor": {
      "contextRef": "c-372",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R98": {
     "role": "http://www.iff.com/role/StockCompensationPlansRestrictedStockUnitsPlanAdditionalInformationDetail",
     "longName": "9954538 - Disclosure - Stock Compensation Plans - Restricted Stock Units Plan - Additional Information (Detail)",
     "shortName": "Stock Compensation Plans - Restricted Stock Units Plan - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "98",
     "firstAnchor": {
      "contextRef": "c-377",
      "name": "iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentage",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-377",
      "name": "iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentage",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R99": {
     "role": "http://www.iff.com/role/StockCompensationPlansRSUPRSandCashRSUActivityDetail",
     "longName": "9954539 - Disclosure - Stock Compensation Plans - RSU, PRS and Cash RSU Activity (Detail)",
     "shortName": "Stock Compensation Plans - RSU, PRS and Cash RSU Activity (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "99",
     "firstAnchor": {
      "contextRef": "c-378",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-377",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "unique": true
     }
    },
    "R100": {
     "role": "http://www.iff.com/role/StockCompensationPlansPurchasedRestrictedStockPlanAdditionalInformationDetail",
     "longName": "9954540 - Disclosure - Stock Compensation Plans - Purchased Restricted Stock Plan - Additional Information (Detail)",
     "shortName": "Stock Compensation Plans - Purchased Restricted Stock Plan - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "100",
     "firstAnchor": {
      "contextRef": "c-377",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R101": {
     "role": "http://www.iff.com/role/StockCompensationPlansLiabilityAwardsAdditionalInformationDetail",
     "longName": "9954541 - Disclosure - Stock Compensation Plans - Liability Awards - Additional Information (Detail)",
     "shortName": "Stock Compensation Plans - Liability Awards - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "101",
     "firstAnchor": {
      "contextRef": "c-385",
      "name": "iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentageGrantedInCashToEligibleEmployees",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-385",
      "name": "iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentageGrantedInCashToEligibleEmployees",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R102": {
     "role": "http://www.iff.com/role/SegmentInformationAdditionalInformationDetail",
     "longName": "9954542 - Disclosure - Segment Information - Additional Information (Detail)",
     "shortName": "Segment Information - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "102",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "iff:NumberOfFragranceCategories",
      "unitRef": "category",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "iff:NumberOfFragranceCategories",
      "unitRef": "category",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R103": {
     "role": "http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail",
     "longName": "9954543 - Disclosure - Segment Information - Reportable Segment Information (Detail)",
     "shortName": "Segment Information - Reportable Segment Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "103",
     "firstAnchor": {
      "contextRef": "c-11",
      "name": "us-gaap:Assets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "iff:SegmentAdjustedOperatingEBITDA",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "unique": true
     }
    },
    "R104": {
     "role": "http://www.iff.com/role/SegmentInformationCapitalExpenditureandDepreciationandAmortizationbySegmentDetail",
     "longName": "9954544 - Disclosure - Segment Information - Capital Expenditure and Depreciation and Amortization by Segment (Detail)",
     "shortName": "Segment Information - Capital Expenditure and Depreciation and Amortization by Segment (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "104",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentExpenditureAdditionToLongLivedAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentExpenditureAdditionToLongLivedAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R105": {
     "role": "http://www.iff.com/role/SegmentInformationNetSalesbyGeographicAreaDetail",
     "longName": "9954545 - Disclosure - Segment Information - Net Sales by Geographic Area (Detail)",
     "shortName": "Segment Information - Net Sales by Geographic Area (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "105",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-429",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "unique": true
     }
    },
    "R106": {
     "role": "http://www.iff.com/role/SegmentInformationSegmentInformationScheduleofLongLivedAssetsDetails",
     "longName": "9954546 - Disclosure - Segment Information Segment Information - Schedule of Long Lived Assets (Details)",
     "shortName": "Segment Information Segment Information - Schedule of Long Lived Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "106",
     "firstAnchor": {
      "contextRef": "c-11",
      "name": "us-gaap:PropertyPlantAndEquipmentNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-427",
      "name": "us-gaap:PropertyPlantAndEquipmentNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "unique": true
     }
    },
    "R107": {
     "role": "http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail",
     "longName": "9954547 - Disclosure - Employee Benefits - Additional Information (Detail)",
     "shortName": "Employee Benefits - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "107",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "iff:DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBelowLowRange",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "iff:DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBelowLowRange",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R108": {
     "role": "http://www.iff.com/role/EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail",
     "longName": "9954548 - Disclosure - Employee Benefits - Plan Assets and Benefit Obligations of Defined Benefit Pension Plans (Detail)",
     "shortName": "Employee Benefits - Plan Assets and Benefit Obligations of Defined Benefit Pension Plans (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "108",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-452",
      "name": "us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "unique": true
     }
    },
    "R109": {
     "role": "http://www.iff.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostandChangesinPlanAssetsandBenefitObligationsRecognizedinOCIDetail",
     "longName": "9954549 - Disclosure - Employee Benefits - Components of Net Periodic Benefit Cost and Changes in Plan Assets and Benefit Obligations Recognized in OCI (Detail)",
     "shortName": "Employee Benefits - Components of Net Periodic Benefit Cost and Changes in Plan Assets and Benefit Obligations Recognized in OCI (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "109",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-460",
      "name": "iff:DefinedBenefitPlanAmortizationAndDeferralsNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "iff:ScheduleOfAmountsExpectedToBeRecognizedInNetPeriodicCostTableTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "unique": true
     }
    },
    "R110": {
     "role": "http://www.iff.com/role/EmployeeBenefitsWeightedAverageActuarialAssumptionUsedtoDetermineExpenseDetail",
     "longName": "9954550 - Disclosure - Employee Benefits - Weighted-Average Actuarial Assumption Used to Determine Expense (Detail)",
     "shortName": "Employee Benefits - Weighted-Average Actuarial Assumption Used to Determine Expense (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "110",
     "firstAnchor": {
      "contextRef": "c-452",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "4",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-452",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "4",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R111": {
     "role": "http://www.iff.com/role/EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail",
     "longName": "9954551 - Disclosure - Employee Benefits - Changes in Postretirement Benefit Obligation and Plan Assets (Detail)",
     "shortName": "Employee Benefits - Changes in Postretirement Benefit Obligation and Plan Assets (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "111",
     "firstAnchor": {
      "contextRef": "c-467",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfChangesInAccumulatedPostemploymentBenefitObligationsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-460",
      "name": "us-gaap:DefinedBenefitPlanActuarialGainLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfChangesInAccumulatedPostemploymentBenefitObligationsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "unique": true
     }
    },
    "R112": {
     "role": "http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinBalanceSheetDetail",
     "longName": "9954552 - Disclosure - Employee Benefits - Amounts Recognized in Balance Sheet (Detail)",
     "shortName": "Employee Benefits - Amounts Recognized in Balance Sheet (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "112",
     "firstAnchor": {
      "contextRef": "c-11",
      "name": "us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-471",
      "name": "us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "unique": true
     }
    },
    "R113": {
     "role": "http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetail",
     "longName": "9954553 - Disclosure - Employee Benefits - Amounts Recognized in Accumulated Other Comprehensive Income (Detail)",
     "shortName": "Employee Benefits - Amounts Recognized in Accumulated Other Comprehensive Income (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "113",
     "firstAnchor": {
      "contextRef": "c-473",
      "name": "us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-473",
      "name": "us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R114": {
     "role": "http://www.iff.com/role/EmployeeBenefitsAccumulatedBenefitObligationDetail",
     "longName": "9954554 - Disclosure - Employee Benefits - Accumulated Benefit Obligation (Detail)",
     "shortName": "Employee Benefits - Accumulated Benefit Obligation (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "114",
     "firstAnchor": {
      "contextRef": "c-471",
      "name": "us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedAndProjectedBenefitObligationsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-471",
      "name": "us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedAndProjectedBenefitObligationsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R115": {
     "role": "http://www.iff.com/role/EmployeeBenefitsEstimatedFutureBenefitPaymentsDetail",
     "longName": "9954555 - Disclosure - Employee Benefits - Estimated Future Benefit Payments (Detail)",
     "shortName": "Employee Benefits - Estimated Future Benefit Payments (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "115",
     "firstAnchor": {
      "contextRef": "c-473",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-473",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R116": {
     "role": "http://www.iff.com/role/EmployeeBenefitsPercentageofAssetsInvestedDetail",
     "longName": "9954556 - Disclosure - Employee Benefits - Percentage of Assets Invested (Detail)",
     "shortName": "Employee Benefits - Percentage of Assets Invested (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "116",
     "firstAnchor": {
      "contextRef": "c-474",
      "name": "us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-474",
      "name": "us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R117": {
     "role": "http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail",
     "longName": "9954557 - Disclosure - Employee Benefits - Fair Value Hierarchy of Plan Assets (Detail)",
     "shortName": "Employee Benefits - Fair Value Hierarchy of Plan Assets (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "117",
     "firstAnchor": {
      "contextRef": "c-471",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "iff:ScheduleOfFairValueOfPensionPlanAssetsByAssetCategoryTableTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-515",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "iff:ScheduleOfFairValueOfPensionPlanAssetsByAssetCategoryTableTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "unique": true
     }
    },
    "R118": {
     "role": "http://www.iff.com/role/EmployeeBenefitsReconciliationofLevel3NonUSPlanAssetsHeldDetail",
     "longName": "9954558 - Disclosure - Employee Benefits - Reconciliation of Level 3 Non-U.S. Plan Assets Held (Detail)",
     "shortName": "Employee Benefits - Reconciliation of Level 3 Non-U.S. Plan Assets Held (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "118",
     "firstAnchor": {
      "contextRef": "c-465",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfChangesInAccumulatedPostemploymentBenefitObligationsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-690",
      "name": "us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "unique": true
     }
    },
    "R119": {
     "role": "http://www.iff.com/role/EmployeeBenefitsWeightedAverageAssumptionsUsedtoDeterminePostretirementBenefitExpenseandObligationDetail",
     "longName": "9954559 - Disclosure - Employee Benefits - Weighted Average Assumptions Used to Determine Postretirement Benefit Expense and Obligation (Detail)",
     "shortName": "Employee Benefits - Weighted Average Assumptions Used to Determine Postretirement Benefit Expense and Obligation (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "119",
     "firstAnchor": {
      "contextRef": "c-694",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "4",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfHealthCareCostTrendRatesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-694",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "4",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfHealthCareCostTrendRatesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R120": {
     "role": "http://www.iff.com/role/FinancialInstrumentsCarryingAmountandEstimatedFairValueofFinancialInstrumentsDetail",
     "longName": "9954561 - Disclosure - Financial Instruments - Carrying Amount and Estimated Fair Value of Financial Instruments (Detail)",
     "shortName": "Financial Instruments - Carrying Amount and Estimated Fair Value of Financial Instruments (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "120",
     "firstAnchor": {
      "contextRef": "c-11",
      "name": "us-gaap:CommercialPaper",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-702",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "unique": true
     }
    },
    "R121": {
     "role": "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsNotionalAmountOutstandingDetail",
     "longName": "9954562 - Disclosure - Financial Instruments - Derivative Instruments Notional Amount Outstanding (Detail)",
     "shortName": "Financial Instruments - Derivative Instruments Notional Amount Outstanding (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "121",
     "firstAnchor": {
      "contextRef": "c-766",
      "name": "iff:DerivativeNotionalAmountNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-766",
      "name": "iff:DerivativeNotionalAmountNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R122": {
     "role": "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsMeasuredatFairValueDetail",
     "longName": "9954563 - Disclosure - Financial Instruments - Derivative Instruments Measured at Fair Value (Detail)",
     "shortName": "Financial Instruments - Derivative Instruments Measured at Fair Value (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "122",
     "firstAnchor": {
      "contextRef": "c-11",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-774",
      "name": "us-gaap:DerivativeFairValueOfDerivativeLiability",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "unique": true
     }
    },
    "R123": {
     "role": "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsWhichWereNotDesignatedasHedgingInstrumentsDetail",
     "longName": "9954564 - Disclosure - Financial Instruments - Derivative Instruments Which Were Not Designated as Hedging Instruments (Detail)",
     "shortName": "Financial Instruments - Derivative Instruments Which Were Not Designated as Hedging Instruments (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "123",
     "firstAnchor": {
      "contextRef": "c-791",
      "name": "us-gaap:DerivativeGainLossOnDerivativeNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-784",
      "name": "us-gaap:DerivativeGainLossOnDerivativeNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "unique": true
     }
    },
    "R124": {
     "role": "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowandNetInvestmentHedgingInstrumentsDetail",
     "longName": "9954565 - Disclosure - Financial Instruments - Derivative Instruments Designated as Cash Flow and Net Investment Hedging Instruments (Detail)",
     "shortName": "Financial Instruments - Derivative Instruments Designated as Cash Flow and Net Investment Hedging Instruments (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "124",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R125": {
     "role": "http://www.iff.com/role/FinancialInstrumentsAdditionalInformationDetail",
     "longName": "9954566 - Disclosure - Financial Instruments - Additional Information (Detail)",
     "shortName": "Financial Instruments - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "125",
     "firstAnchor": {
      "contextRef": "c-11",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DerivativeNetHedgeIneffectivenessGainLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "unique": true
     }
    },
    "R126": {
     "role": "http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossDetail",
     "longName": "9954567 - Disclosure - Accumulated Other Comprehensive Income (Loss) - Schedule of Changes in Accumulated Other Comprehensive Income (Loss) (Detail)",
     "shortName": "Accumulated Other Comprehensive Income (Loss) - Schedule of Changes in Accumulated Other Comprehensive Income (Loss) (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "126",
     "firstAnchor": {
      "contextRef": "c-12",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-814",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "unique": true
     }
    },
    "R127": {
     "role": "http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossReclassificationsofAccumulatedOtherComprehensiveIncometoConsolidatedStatementofComprehensiveIncomeDetail",
     "longName": "9954568 - Disclosure - Accumulated Other Comprehensive Income (Loss) - Reclassifications of Accumulated Other Comprehensive Income to Consolidated Statement of Comprehensive Income (Detail)",
     "shortName": "Accumulated Other Comprehensive Income (Loss) - Reclassifications of Accumulated Other Comprehensive Income to Consolidated Statement of Comprehensive Income (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "127",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-803",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "unique": true
     }
    },
    "R128": {
     "role": "http://www.iff.com/role/ConcentrationsOfCreditRiskAdditionalInformationDetail",
     "longName": "9954569 - Disclosure - Concentrations Of Credit Risk - Additional Information (Detail)",
     "shortName": "Concentrations Of Credit Risk - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "128",
     "firstAnchor": {
      "contextRef": "c-841",
      "name": "iff:EntityWideRevenueMajorCustomerNumberOfCustomers",
      "unitRef": "customer",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-844",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "unique": true
     }
    },
    "R129": {
     "role": "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail",
     "longName": "9954570 - Disclosure - Commitments and Contingencies - Additional Information (Detail)",
     "shortName": "Commitments and Contingencies - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "129",
     "firstAnchor": {
      "contextRef": "c-11",
      "name": "iff:BankGuaranteesRelatedToAppealsOnIncomeTaxAndIndirectTaxCases",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-11",
      "name": "iff:BankGuaranteesRelatedToAppealsOnIncomeTaxAndIndirectTaxCases",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R130": {
     "role": "http://www.iff.com/role/RedeemableNoncontrollingInterestsDetails",
     "longName": "9954571 - Disclosure - Redeemable Noncontrolling Interests (Details)",
     "shortName": "Redeemable Noncontrolling Interests (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "130",
     "firstAnchor": {
      "contextRef": "c-12",
      "name": "us-gaap:MinorityInterest",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-862",
      "name": "us-gaap:MinorityInterest",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:RedeemableNoncontrollingInterestTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "unique": true
     }
    },
    "R131": {
     "role": "http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleDetails",
     "longName": "9954572 - Disclosure - Assets and Liabilities Held For Sale (Details)",
     "shortName": "Assets and Liabilities Held For Sale (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "131",
     "firstAnchor": {
      "contextRef": "c-11",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-871",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "unique": true
     }
    },
    "R132": {
     "role": "http://www.iff.com/role/OtherExpenseIncomeNetDetails",
     "longName": "9954573 - Disclosure - Other (Expense) Income, Net (Details)",
     "shortName": "Other (Expense) Income, Net (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "132",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R133": {
     "role": "http://www.iff.com/role/TangibleEquityUnitsDetails",
     "longName": "9954574 - Disclosure - Tangible Equity Units (Details)",
     "shortName": "Tangible Equity Units (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "133",
     "firstAnchor": {
      "contextRef": "c-346",
      "name": "iff:TangibleEquityUnitsIssued",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R134": {
     "role": "http://www.iff.com/role/TangibleEquityUnitsAllocationofTEUDetails",
     "longName": "9954575 - Disclosure - Tangible Equity Units (Allocation of TEU) (Details)",
     "shortName": "Tangible Equity Units (Allocation of TEU) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "134",
     "firstAnchor": {
      "contextRef": "c-346",
      "name": "iff:TangibleEquityUnitsProceeds",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R135": {
     "role": "http://www.iff.com/role/TangibleEquityUnitsTangibleEquitySettlementofSharesDetails",
     "longName": "9954576 - Disclosure - Tangible Equity Units Tangible Equity - Settlement of Shares (Details)",
     "shortName": "Tangible Equity Units Tangible Equity - Settlement of Shares (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "135",
     "firstAnchor": {
      "contextRef": "c-348",
      "name": "us-gaap:StockIssuedDuringPeriodSharesIssuedForServices",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R136": {
     "role": "http://www.iff.com/role/ScheduleIIValuationandQualifyingAccountsandReservesDetail",
     "longName": "9954577 - Disclosure - Schedule II - Valuation and Qualifying Accounts and Reserves (Detail)",
     "shortName": "Schedule II - Valuation and Qualifying Accounts and Reserves (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "136",
     "firstAnchor": {
      "contextRef": "c-872",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-882",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iff-20231231.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "iff_A1.750SeniorNotesDue2024Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "A1.750SeniorNotesDue2024Member",
     "presentation": [
      "http://www.iff.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "1.750% Senior Notes Due 2024 [Member]",
        "label": "1.750% Senior Notes Due 2024 [Member]",
        "documentation": "1.750% Senior Notes Due 2024 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_A1.800SeniorNotesDue2026Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "A1.800SeniorNotesDue2026Member",
     "presentation": [
      "http://www.iff.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "1.800% Senior Notes Due 2026 [Member]",
        "label": "1.800% Senior Notes Due 2026 [Member]",
        "documentation": "1.800% Senior Notes Due 2026 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_A2015SeveranceInitiativesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "A2015SeveranceInitiativesMember",
     "presentation": [
      "http://www.iff.com/role/RestructuringandOtherChargesMovementsinRestructuringandRelatedAccrualsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2015 Severance Initiatives [Member]",
        "label": "2015 Severance Initiatives [Member]",
        "documentation": "2015 Severance Initiatives [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_A2017ProductivityProgramMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "A2017ProductivityProgramMember",
     "presentation": [
      "http://www.iff.com/role/RestructuringandOtherChargesAdditionalInformationDetails",
      "http://www.iff.com/role/RestructuringandOtherChargesMovementsinRestructuringandRelatedAccrualsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2017 Productivity Program [Member]",
        "label": "2017 Productivity Program [Member]",
        "documentation": "2017 Productivity Program [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_A2019And2022CrossCurrencySwapsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "A2019And2022CrossCurrencySwapsMember",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2019 Cross Currency Swaps",
        "label": "2019 And 2022 Cross Currency Swaps [Member]",
        "documentation": "2019 And 2022 Cross Currency Swaps"
       }
      }
     },
     "auth_ref": []
    },
    "iff_A2019SeveranceInitiativesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "A2019SeveranceInitiativesMember",
     "presentation": [
      "http://www.iff.com/role/RestructuringandOtherChargesAdditionalInformationDetails",
      "http://www.iff.com/role/RestructuringandOtherChargesMovementsinRestructuringandRelatedAccrualsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2019 Severance Initiatives [Member]",
        "label": "2019 Severance Initiatives [Member]",
        "documentation": "2019 Severance Initiatives [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_A2022CrossCurrencySwapsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "A2022CrossCurrencySwapsMember",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2022 Cross Currency Swaps",
        "label": "2022 Cross Currency Swaps [Member]",
        "documentation": "2022 Cross Currency Swaps"
       }
      }
     },
     "auth_ref": []
    },
    "iff_A2023RestructuringProgramMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "A2023RestructuringProgramMember",
     "presentation": [
      "http://www.iff.com/role/RestructuringandOtherChargesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2023 Restructuring Program",
        "label": "2023 Restructuring Program [Member]",
        "documentation": "2023 Restructuring Program"
       }
      }
     },
     "auth_ref": []
    },
    "iff_A2024TermLoanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "A2024TermLoanMember",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail",
      "http://www.iff.com/role/DebtComponentsofDebtDetail",
      "http://www.iff.com/role/FinancialInstrumentsCarryingAmountandEstimatedFairValueofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024 Term Loan",
        "label": "2024 Term Loan [Member]",
        "documentation": "2024 Term Loan"
       }
      }
     },
     "auth_ref": []
    },
    "iff_A2026TermLoanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "A2026TermLoanMember",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail",
      "http://www.iff.com/role/DebtComponentsofDebtDetail",
      "http://www.iff.com/role/FinancialInstrumentsCarryingAmountandEstimatedFairValueofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026 Term Loan",
        "label": "2026 Term Loan [Member]",
        "documentation": "2026 Term Loan"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "presentation": [
      "http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "iff_AbsoluteReturnHedgeFundsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "AbsoluteReturnHedgeFundsMember",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Absolute Return Funds",
        "label": "Absolute Return Hedge Funds [Member]",
        "documentation": "Absolute Return Hedge Funds [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingStandardsUpdate201602Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountingStandardsUpdate201602Member",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting Standards Update 2016-02 [Member]",
        "label": "Accounting Standards Update 2016-02 [Member]",
        "documentation": "Accounting Standards Update 2016-02 Leases (Topic 842)."
       }
      }
     },
     "auth_ref": [
      "r1002"
     ]
    },
    "us-gaap_AccountingStandardsUpdate201613Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountingStandardsUpdate201613Member",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting Standards Update 2016-13 [Member]",
        "label": "Accounting Standards Update 2016-13 [Member]",
        "documentation": "Accounting Standards Update 2016-13 Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments."
       }
      }
     },
     "auth_ref": [
      "r602"
     ]
    },
    "us-gaap_AccountingStandardsUpdate201712Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountingStandardsUpdate201712Member",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting Standards Update 2017-12 [Member]",
        "label": "Accounting Standards Update 2017-12 [Member]",
        "documentation": "Accounting Standards Update 2017-12 Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities."
       }
      }
     },
     "auth_ref": [
      "r943"
     ]
    },
    "us-gaap_AccountsAndOtherReceivablesNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsAndOtherReceivablesNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherAssetsDetail": {
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts and Other Receivables, Net, Current",
        "label": "Accounts and Other Receivables, Net, Current",
        "documentation": "Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Receivable Type [Axis]",
        "label": "Receivable Type [Axis]",
        "documentation": "Information by type of receivable."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.iff.com/role/BusinessDivestitureDetails": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/BusinessDivestitureDetails",
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "negatedTerseLabel": "Accounts Payable, Current",
        "label": "Accounts Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r1311"
     ]
    },
    "us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableAllowanceForCreditLossTableTextBlock",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss",
        "label": "Accounts Receivable, Allowance for Credit Loss [Table Text Block]",
        "documentation": "Tabular disclosure of allowance for credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r1490"
     ]
    },
    "iff_AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss, Foreign Currency Translation",
        "label": "Accounts Receivable, Allowance for Credit Loss, Foreign Currency Translation",
        "documentation": "Accounts Receivable, Allowance for Credit Loss, Foreign Currency Translation"
       }
      }
     },
     "auth_ref": []
    },
    "iff_AccountsReceivableFactoringReceivableProgramMaximumAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "AccountsReceivableFactoringReceivableProgramMaximumAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable, factoring receivable program, maximum amount",
        "label": "Accounts Receivable, Factoring Receivable Program, Maximum Amount",
        "documentation": "Accounts Receivable, Factoring Receivable Program, Maximum Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsReceivableGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableGross",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable, before allowance for credit loss",
        "label": "Accounts Receivable, before Allowance for Credit Loss",
        "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business."
       }
      }
     },
     "auth_ref": [
      "r430",
      "r563",
      "r1645"
     ]
    },
    "us-gaap_AccountsReceivableNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableNet",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Receivable, after Allowance for Credit Loss",
        "label": "Accounts Receivable, after Allowance for Credit Loss",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business."
       }
      }
     },
     "auth_ref": [
      "r1173",
      "r1238",
      "r1316",
      "r1645"
     ]
    },
    "iff_AccountsReceivablesOutstandingByOver365Days": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "AccountsReceivablesOutstandingByOver365Days",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Receivables, Outstanding By Over 365 Days",
        "label": "Accounts Receivables, Outstanding By Over 365 Days",
        "documentation": "Accounts Receivables, Outstanding By Over 365 Days"
       }
      }
     },
     "auth_ref": []
    },
    "iff_AccountsReceivablesOutstandingLessThan90Days": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "AccountsReceivablesOutstandingLessThan90Days",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Receivables, Outstanding Less Than 90 Days",
        "label": "Accounts Receivables, Outstanding Less Than 90 Days",
        "documentation": "Accounts Receivables, Outstanding Less Than 90 Days"
       }
      }
     },
     "auth_ref": []
    },
    "iff_AccruedCommissionsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "AccruedCommissionsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued Commissions Payable, Current",
        "label": "Accrued Commissions Payable, Current",
        "documentation": "Accrued Commissions Payable, Current"
       }
      }
     },
     "auth_ref": []
    },
    "iff_AccruedFreightCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "AccruedFreightCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued freight",
        "label": "Accrued Freight, Current",
        "documentation": "Accrued Freight, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedIncomeTaxesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued income taxes",
        "label": "Accrued Income Taxes, Current",
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations."
       }
      }
     },
     "auth_ref": [
      "r244",
      "r338"
     ]
    },
    "us-gaap_AccruedInsuranceCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedInsuranceCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued insurance (including workers\u2019 compensation)",
        "label": "Accrued Insurance, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable to insurance entities to mitigate potential loss from various risks or to satisfy a promise to provide certain coverage's to employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "iff_AccruedInterestOrPenaltiesRelatedToTaxAmounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "AccruedInterestOrPenaltiesRelatedToTaxAmounts",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reduction in accrual for interest and penalties",
        "label": "Accrued Interest Or Penalties Related To Tax Amounts",
        "documentation": "Accrued Interest Or Penalties Related To Tax Amounts"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "presentation": [
      "http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossReclassificationsofAccumulatedOtherComprehensiveIncometoConsolidatedStatementofComprehensiveIncomeDetail",
      "http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension and Postretirement Liability Adjustment",
        "verboseLabel": "(Losses) gains on pension and postretirement liability adjustments",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r41",
      "r80",
      "r1446",
      "r1447",
      "r1448"
     ]
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember",
     "presentation": [
      "http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossReclassificationsofAccumulatedOtherComprehensiveIncometoConsolidatedStatementofComprehensiveIncomeDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prior service cost",
        "label": "Accumulated Defined Benefit Plans Adjustment, Net Prior Service Attributable to Parent [Member]",
        "documentation": "Accumulated other comprehensive (income) loss related to prior service cost (credit) component of defined benefit plans attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r41",
      "r80",
      "r454",
      "r455",
      "r1446"
     ]
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember",
     "presentation": [
      "http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossReclassificationsofAccumulatedOtherComprehensiveIncometoConsolidatedStatementofComprehensiveIncomeDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Actuarial losses",
        "label": "Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member]",
        "documentation": "Accumulated other comprehensive income (loss) related to gain (loss) component of defined benefit plans attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r41",
      "r80",
      "r454",
      "r455",
      "r1446"
     ]
    },
    "iff_AccumulatedDefinedBenefitPlansAdjustmentOtherItemsAttributableToParentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentOtherItemsAttributableToParentMember",
     "presentation": [
      "http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossReclassificationsofAccumulatedOtherComprehensiveIncometoConsolidatedStatementofComprehensiveIncomeDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other items",
        "label": "Accumulated Defined Benefit Plans Adjustment, Other Items Attributable To Parent [Member]",
        "documentation": "Accumulated Defined Benefit Plans Adjustment, Other Items Attributable To Parent"
       }
      }
     },
     "auth_ref": []
    },
    "iff_AccumulatedDefinedBenefitPlansAdjustmentSettlementsCurtailmentsAttributableToParentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentSettlementsCurtailmentsAttributableToParentMember",
     "presentation": [
      "http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossReclassificationsofAccumulatedOtherComprehensiveIncometoConsolidatedStatementofComprehensiveIncomeDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Settlements / Curtailments",
        "label": "Accumulated Defined Benefit Plans Adjustment, Settlements/Curtailments Attributable To Parent [Member]",
        "documentation": "Accumulated Defined Benefit Plans Adjustment, Settlements/Curtailments Attributable To Parent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetail": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accumulated depreciation",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r119",
      "r419",
      "r1086"
     ]
    },
    "us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember",
     "presentation": [
      "http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossReclassificationsofAccumulatedOtherComprehensiveIncometoConsolidatedStatementofComprehensiveIncomeDetail",
      "http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Gains\u00a0(Losses)\u00a0on Derivatives Qualifying as Hedges",
        "label": "Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]",
        "documentation": "Accumulated other comprehensive income (loss) resulting from gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges, attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r80",
      "r936"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/BusinessDivestitureDetails",
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency gain (loss), net of tax",
        "label": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax",
        "documentation": "Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses."
       }
      }
     },
     "auth_ref": [
      "r441",
      "r443",
      "r445",
      "r446",
      "r976"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "presentation": [
      "http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r453",
      "r454",
      "r989",
      "r991",
      "r992",
      "r993",
      "r994",
      "r995"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET",
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated other comprehensive loss",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r80",
      "r260",
      "r431",
      "r1081",
      "r1117",
      "r1121"
     ]
    },
    "iff_AccumulatedOtherComprehensiveIncomeLossPensionLiabilityAndPostretirementAfterTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "AccumulatedOtherComprehensiveIncomeLossPensionLiabilityAndPostretirementAfterTax",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/BusinessDivestitureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension liability and postretirement, after tax",
        "label": "Accumulated Other Comprehensive (Income) Loss, Pension Liability And Postretirement, after Tax",
        "documentation": "Accumulated Other Comprehensive (Income) Loss, Pension Liability And Postretirement, after Tax"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "presentation": [
      "http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r453",
      "r454",
      "r989",
      "r991",
      "r992",
      "r993",
      "r994",
      "r995"
     ]
    },
    "iff_AccumulatedOtherComprehensiveIncomeLossTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "AccumulatedOtherComprehensiveIncomeLossTextBlock",
     "presentation": [
      "http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Income Loss",
        "label": "Accumulated Other Comprehensive Income (Loss) [Text Block]",
        "documentation": "Accumulated Other Comprehensive Income (Loss) [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossDetail",
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accumulated other comprehensive (loss) income",
        "terseLabel": "Total",
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r41",
      "r80",
      "r949",
      "r952",
      "r1028",
      "r1112",
      "r1113",
      "r1446",
      "r1447",
      "r1448",
      "r1468",
      "r1469",
      "r1470"
     ]
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedTranslationAdjustmentMember",
     "presentation": [
      "http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign Currency Translation Adjustments",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r41",
      "r80",
      "r454",
      "r455",
      "r991",
      "r992",
      "r993",
      "r994",
      "r995",
      "r1446"
     ]
    },
    "us-gaap_AcquisitionRelatedCostsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AcquisitionRelatedCostsMember",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquisition-related Costs [Member]",
        "label": "Acquisition-related Costs [Member]",
        "documentation": "Category of acquisition-related costs allocated to (included in) reported pro forma earnings (supplemental pro forma information)."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional 402(v) Disclosure",
        "label": "Additional 402(v) Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1369"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital in excess of par value",
        "label": "Additional Paid in Capital, Common Stock",
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital."
       }
      }
     },
     "auth_ref": [
      "r251"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital\u00a0in excess\u00a0of par\u00a0value",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r877",
      "r878",
      "r879",
      "r1134",
      "r1468",
      "r1469",
      "r1470",
      "r1620",
      "r1651"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://www.iff.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Address Type [Domain]",
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation, Amount",
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1375"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation:",
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1375"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote",
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1375"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment To PEO Compensation, Footnote",
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1375"
     ]
    },
    "us-gaap_AdjustmentForAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentForAmortization",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization",
        "label": "Amortization",
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r116"
     ]
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]",
        "label": "Accounting Standards Update [Axis]",
        "documentation": "Information by amendment to accounting standards."
       }
      }
     },
     "auth_ref": [
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r493",
      "r494",
      "r495",
      "r496",
      "r507",
      "r565",
      "r566",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r674",
      "r877",
      "r878",
      "r879",
      "r908",
      "r909",
      "r910",
      "r911",
      "r925",
      "r926",
      "r927",
      "r944",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951",
      "r952",
      "r953",
      "r954",
      "r957",
      "r958",
      "r959",
      "r960",
      "r961",
      "r962",
      "r963",
      "r964",
      "r965",
      "r966",
      "r967",
      "r968",
      "r973",
      "r974",
      "r979",
      "r980",
      "r981",
      "r982",
      "r997",
      "r998",
      "r1003",
      "r1004",
      "r1005",
      "r1006",
      "r1024",
      "r1025",
      "r1026",
      "r1027",
      "r1028",
      "r1065",
      "r1066",
      "r1067",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120",
      "r1121"
     ]
    },
    "iff_AdjustmentsToAdditionalPaidInCapitalDeferredCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "AdjustmentsToAdditionalPaidInCapitalDeferredCompensation",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital in excess of par value related to deferred compensation plan",
        "label": "Adjustments To Additional Paid In Capital Deferred Compensation",
        "documentation": "Portion of Deferred Compensation Plan to be paid out in shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r160",
      "r161",
      "r842"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile to net cash provided by operating activities:",
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Amount",
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1339",
      "r1351",
      "r1361",
      "r1387"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined",
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1342",
      "r1354",
      "r1364",
      "r1390"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Adjustments to Compensation",
        "label": "All Adjustments to Compensation [Member]"
       }
      }
     },
     "auth_ref": [
      "r1375"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Executive Categories",
        "label": "All Executive Categories [Member]"
       }
      }
     },
     "auth_ref": [
      "r1382"
     ]
    },
    "iff_AllForeignCountriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "AllForeignCountriesMember",
     "presentation": [
      "http://www.iff.com/role/ConcentrationsOfCreditRiskAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Foreign Countries [Member]",
        "label": "All Foreign Countries [Member]",
        "documentation": "All Foreign Countries [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Individuals",
        "label": "All Individuals [Member]"
       }
      }
     },
     "auth_ref": [
      "r1346",
      "r1355",
      "r1365",
      "r1382",
      "r1391",
      "r1395",
      "r1403"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Trading Arrangements",
        "label": "All Trading Arrangements [Member]"
       }
      }
     },
     "auth_ref": [
      "r1401"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/StockCompensationPlansStockBasedCompensationExpenseIncludedinConsolidatedStatementofIncomeandComprehensiveIncomeDetail": {
       "parentTag": "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansStockBasedCompensationExpenseIncludedinConsolidatedStatementofIncomeandComprehensiveIncomeDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total stock-based compensation",
        "label": "Share-Based Payment Arrangement, Expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r872",
      "r880"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllocatedShareBasedCompensationExpenseNetOfTax",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/StockCompensationPlansStockBasedCompensationExpenseIncludedinConsolidatedStatementofIncomeandComprehensiveIncomeDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansStockBasedCompensationExpenseIncludedinConsolidatedStatementofIncomeandComprehensiveIncomeDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total stock-based compensation, net of tax",
        "label": "Share-Based Payment Arrangement, Expense, after Tax",
        "documentation": "Amount, after tax, of expense for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AllowanceForCreditLossMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllowanceForCreditLossMember",
     "presentation": [
      "http://www.iff.com/role/ScheduleIIValuationandQualifyingAccountsandReservesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allowance for doubtful accounts [Member]",
        "label": "SEC Schedule, 12-09, Allowance, Credit Loss [Member]",
        "documentation": "Allowance for credit loss from right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time."
       }
      }
     },
     "auth_ref": [
      "r1461",
      "r1462",
      "r1463",
      "r1465",
      "r1466"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "documentation": "Amount of allowance for credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r432",
      "r564",
      "r616",
      "r620",
      "r623",
      "r1645"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEETParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade receivables, allowance for credit losses",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r432",
      "r564",
      "r616"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)",
        "label": "Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)",
        "documentation": "Amount of increase (decrease) in allowance for credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r1490"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Accounts Receivable, Allowance for Credit Loss, Writeoff",
        "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff",
        "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance."
       }
      }
     },
     "auth_ref": [
      "r622"
     ]
    },
    "iff_AlternativeTypeOfInvestmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "AlternativeTypeOfInvestmentsMember",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Alternative Type of Investments",
        "label": "Alternative Type Of Investments [Member]",
        "documentation": "Alternative Type Of Investments [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.iff.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AmortizationOfFinancingCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/TangibleEquityUnitsAllocationofTEUDetails",
      "http://www.iff.com/role/TangibleEquityUnitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Less: Issuance costs",
        "label": "Amortization of Debt Issuance Costs",
        "documentation": "Amount of amortization expense attributable to debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r264",
      "r732",
      "r1000",
      "r1455"
     ]
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AmortizationOfIntangibleAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME",
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetAmortizationExpenseDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of acquisition-related intangibles",
        "label": "Amortization of Intangible Assets",
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r112",
      "r116"
     ]
    },
    "iff_AmortizationOfInventoryStepUp": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "AmortizationOfInventoryStepUp",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization Of Inventory Step-Up",
        "label": "Amortization Of Inventory Step-Up",
        "documentation": "Amortization Of Inventory Step-Up"
       }
      }
     },
     "auth_ref": []
    },
    "iff_AmortizationPeriodOfInternalAndExternalDevelopmentCosts": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "AmortizationPeriodOfInternalAndExternalDevelopmentCosts",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization period of internal and external development costs, years",
        "label": "Amortization Period Of Internal And External Development Costs",
        "documentation": "Amortization period of internal and external development costs."
       }
      }
     },
     "auth_ref": []
    },
    "iff_AmortizingNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "AmortizingNoteMember",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsCarryingAmountandEstimatedFairValueofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortizing Note",
        "label": "Amortizing Note [Member]",
        "documentation": "Amortizing Note [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_AmountOfAvailableLinesOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "AmountOfAvailableLinesOfCredit",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Available lines of credit",
        "label": "Amount Of Available Lines Of Credit",
        "documentation": "Amount Of Available Lines Of Credit"
       }
      }
     },
     "auth_ref": []
    },
    "iff_AmountOfPledgedAssetsPrincipallyPropertyPlantAndEquipmentToCoverIncomeTaxAndIndirectTaxAssessments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "AmountOfPledgedAssetsPrincipallyPropertyPlantAndEquipmentToCoverIncomeTaxAndIndirectTaxAssessments",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "The amount of pledged assets, principally PP&amp;E to cover income tax and indirect tax assessments",
        "label": "Amount Of Pledged Assets Principally Property, Plant And Equipment To Cover Income Tax And Indirect Tax Assessments",
        "documentation": "The amount of pledged assets, principally PP&amp;E to cover income tax and indirect tax assessments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://www.iff.com/role/NetIncomePerShareAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r522"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://www.iff.com/role/NetIncomePerShareReconciliationofSharesUsedinComputationofBasicandDilutedNetIncomePerShareDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities [Axis]",
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://www.iff.com/role/NetIncomePerShareAdditionalInformationDetail",
      "http://www.iff.com/role/NetIncomePerShareReconciliationofSharesUsedinComputationofBasicandDilutedNetIncomePerShareDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://www.iff.com/role/NetIncomePerShareReconciliationofSharesUsedinComputationofBasicandDilutedNetIncomePerShareDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities, Name [Domain]",
        "label": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "srt_AsiaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "AsiaMember",
     "presentation": [
      "http://www.iff.com/role/RestructuringandOtherChargesAdditionalInformationDetails",
      "http://www.iff.com/role/SegmentInformationNetSalesbyGeographicAreaDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asia",
        "verboseLabel": "Greater Asia [Member]",
        "label": "Asia [Member]",
        "documentation": "Continent of Asia."
       }
      }
     },
     "auth_ref": [
      "r1654",
      "r1656",
      "r1657",
      "r1658"
     ]
    },
    "us-gaap_AssetImpairmentCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetImpairmentCharges",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetNarrativeDetails",
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.iff.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset impairment charges",
        "label": "Asset Impairment Charges",
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r117"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iff.com/role/BusinessDivestitureDetails",
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET",
      "http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Assets",
        "terseLabel": "Assets",
        "verboseLabel": "Segment assets",
        "label": "Assets",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r335",
      "r423",
      "r475",
      "r533",
      "r548",
      "r554",
      "r601",
      "r697",
      "r698",
      "r700",
      "r701",
      "r702",
      "r704",
      "r706",
      "r708",
      "r709",
      "r932",
      "r938",
      "r978",
      "r1077",
      "r1179",
      "r1311",
      "r1328",
      "r1511",
      "r1512",
      "r1632"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ASSETS",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_AssetsAndLiabilitiesLesseeTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "AssetsAndLiabilitiesLesseeTableTextBlock",
     "presentation": [
      "http://www.iff.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental Balance Sheet Information",
        "label": "Assets And Liabilities, Lessee [Table Text Block]",
        "documentation": "Assets And Liabilities, Lessee [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Current Assets",
        "label": "Assets, Current",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r414",
      "r437",
      "r475",
      "r601",
      "r697",
      "r698",
      "r700",
      "r701",
      "r702",
      "r704",
      "r706",
      "r708",
      "r709",
      "r932",
      "r938",
      "r978",
      "r1311",
      "r1511",
      "r1512",
      "r1632"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Assets:",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperation",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleDetails",
      "http://www.iff.com/role/BusinessDivestitureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total assets held-for-sale",
        "totalLabel": "Total assets held-for-sale",
        "label": "Disposal Group, Including Discontinued Operation, Assets",
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r225",
      "r234",
      "r291",
      "r412",
      "r413"
     ]
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract",
     "presentation": [
      "http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets",
        "label": "Disposal Group, Including Discontinued Operation, Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/BusinessDivestitureDetails",
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets held for sale",
        "label": "Disposal Group, Including Discontinued Operation, Assets, Current",
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r225",
      "r234",
      "r288",
      "r291",
      "r412",
      "r413"
     ]
    },
    "iff_AuditInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "AuditInformationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Audit Information [Abstract]",
        "documentation": "Audit Information"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://www.iff.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Firm ID",
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r1333",
      "r1334",
      "r1347"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorLocation",
     "presentation": [
      "http://www.iff.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Location",
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r1333",
      "r1334",
      "r1347"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorName",
     "presentation": [
      "http://www.iff.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Name",
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r1333",
      "r1334",
      "r1347"
     ]
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise Price",
        "label": "Award Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r1398"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value as of Grant Date",
        "label": "Award Grant Date Fair Value"
       }
      }
     },
     "auth_ref": [
      "r1399"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1394"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing, How MNPI Considered",
        "label": "Award Timing, How MNPI Considered [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1394"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Method",
        "label": "Award Timing Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1394"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Considered",
        "label": "Award Timing MNPI Considered [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1394"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Disclosure",
        "label": "Award Timing MNPI Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1394"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Predetermined",
        "label": "Award Timing Predetermined [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1394"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://www.iff.com/role/NetIncomePerShareAdditionalInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansLiabilityAwardsAdditionalInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansPurchasedRestrictedStockPlanAdditionalInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansRSUPRSandCashRSUActivityDetail",
      "http://www.iff.com/role/StockCompensationPlansRestrictedStockUnitsPlanAdditionalInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionActivityDetail",
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionAdditionalInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionExercisableDetail",
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionOutstandingDetail",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Axis]",
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r846",
      "r847",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Securities",
        "label": "Award Underlying Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r1397"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r1396"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures",
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r1395"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table",
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1395"
     ]
    },
    "country_BR": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "BR",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "BRAZIL",
        "label": "BRAZIL"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BalanceSheetLocationAxis",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsWeightedAverageAssumptionsUsedtoDeterminePostretirementBenefitExpenseandObligationDetail",
      "http://www.iff.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.iff.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofUnrecognizedTaxBenefitsDetail",
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Balance Sheet Location [Axis]",
        "label": "Balance Sheet Location [Axis]",
        "documentation": "Information by location on balance sheet (statement of financial position)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BalanceSheetLocationDomain",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsWeightedAverageAssumptionsUsedtoDeterminePostretirementBenefitExpenseandObligationDetail",
      "http://www.iff.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.iff.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofUnrecognizedTaxBenefitsDetail",
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Balance Sheet Location [Domain]",
        "label": "Balance Sheet Location [Domain]",
        "documentation": "Location in the balance sheet (statement of financial position)."
       }
      }
     },
     "auth_ref": [
      "r190",
      "r195"
     ]
    },
    "iff_BankBorrowingsAndOverdraftsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "BankBorrowingsAndOverdraftsMember",
     "presentation": [
      "http://www.iff.com/role/DebtComponentsofDebtDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bank overdrafts and other",
        "label": "Bank Borrowings And Overdrafts [Member]",
        "documentation": "Bank borrowings and overdrafts."
       }
      }
     },
     "auth_ref": []
    },
    "iff_BankGuaranteesAndPledgedAssetsToPursueDefensesRelatedToOtherContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "BankGuaranteesAndPledgedAssetsToPursueDefensesRelatedToOtherContingencies",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bank guarantees and pledged assets to pursue defenses related to other contingencies",
        "label": "Bank Guarantees And Pledged Assets To Pursue Defenses Related To Other Contingencies",
        "documentation": "Bank guarantees and pledged assets to pursue defenses related to other contingencies."
       }
      }
     },
     "auth_ref": []
    },
    "iff_BankGuaranteesCommercialGuaranteesStandbyLettersOfCreditAndSuretyBondsFacilityAmounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "BankGuaranteesCommercialGuaranteesStandbyLettersOfCreditAndSuretyBondsFacilityAmounts",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bank Guarantees, Commercial Guarantees, Letters Of Credit and Surety Bonds, Facility Amounts",
        "label": "Bank Guarantees, Commercial Guarantees, Standby Letters Of Credit and Surety Bonds, Facility Amounts",
        "documentation": "Bank Guarantees, Commercial Guarantees, Standby Letters Of Credit and Surety Bonds, Facility Amounts"
       }
      }
     },
     "auth_ref": []
    },
    "iff_BankGuaranteesCommercialGuaranteesStandbyLettersOfCreditAndSuretyBondsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "BankGuaranteesCommercialGuaranteesStandbyLettersOfCreditAndSuretyBondsMember",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bank Guarantees, Commercial Guarantees, Standby Letters Of Credit and Surety Bonds",
        "label": "Bank Guarantees, Commercial Guarantees, Standby Letters Of Credit and Surety Bonds [Member]",
        "documentation": "Bank Guarantees, Commercial Guarantees, Standby Letters Of Credit and Surety Bonds"
       }
      }
     },
     "auth_ref": []
    },
    "iff_BankGuaranteesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "BankGuaranteesMember",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bank guarantees [Member]",
        "label": "Bank Guarantees [Member]",
        "documentation": "Bank Guarantees [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_BankGuaranteesRelatedToAppealsOnIncomeTaxAndIndirectTaxCases": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "BankGuaranteesRelatedToAppealsOnIncomeTaxAndIndirectTaxCases",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bank guarantees related to appeals on income tax and indirect tax cases",
        "label": "Bank Guarantees Related To Appeals On Income Tax And Indirect Tax Cases",
        "documentation": "The amount of bank guarantees related to appeals on income tax and indirect tax cases."
       }
      }
     },
     "auth_ref": []
    },
    "iff_BankGuaranteesStandbyLettersOfCreditAndCommercialGuaranteesAmountOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "BankGuaranteesStandbyLettersOfCreditAndCommercialGuaranteesAmountOutstanding",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bank Guarantees and Standby Letters of Credit, Amount Outstanding",
        "label": "Bank Guarantees, Standby Letters Of Credit And Commercial Guarantees, Amount Outstanding",
        "documentation": "Bank Guarantees, Standby Letters Of Credit And Commercial Guarantees, Amount Outstanding"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BaseRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BaseRateMember",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail",
      "http://www.iff.com/role/DebtComponentsofDebtDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Base Rate",
        "label": "Base Rate [Member]",
        "documentation": "Minimum rate investor will accept."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Accounting, Policy",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "iff_BrazilTaxCreditsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "BrazilTaxCreditsMember",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Brazil Tax Credits",
        "label": "Brazil Tax Credits [Member]",
        "documentation": "Brazil Tax Credits"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BuildingAndBuildingImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BuildingAndBuildingImprovementsMember",
     "presentation": [
      "http://www.iff.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Buildings and improvements [Member]",
        "label": "Building and Building Improvements [Member]",
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing."
       }
      }
     },
     "auth_ref": []
    },
    "iff_BuildingsAndImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "BuildingsAndImprovementsMember",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Buildings And Improvements [Member]",
        "label": "Buildings And Improvements [Member]",
        "documentation": "Buildings And Improvements [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsHealthWrightProductsDetails",
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails",
      "http://www.iff.com/role/DebtTables",
      "http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail",
      "http://www.iff.com/role/LeasesAdditionalInformationDetails",
      "http://www.iff.com/role/LeasesDetails",
      "http://www.iff.com/role/NetIncomePerShareAdditionalInformationDetail",
      "http://www.iff.com/role/RestructuringandOtherChargesAdditionalInformationDetails",
      "http://www.iff.com/role/RestructuringandOtherChargesMovementsinRestructuringandRelatedAccrualsDetail",
      "http://www.iff.com/role/SegmentInformationAdditionalInformationDetail",
      "http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition, Acquiree [Domain]",
        "label": "Business Acquisition, Acquiree [Domain]",
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "auth_ref": [
      "r923",
      "r1297",
      "r1300"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsHealthWrightProductsDetails",
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails",
      "http://www.iff.com/role/DebtTables",
      "http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail",
      "http://www.iff.com/role/LeasesAdditionalInformationDetails",
      "http://www.iff.com/role/LeasesDetails",
      "http://www.iff.com/role/NetIncomePerShareAdditionalInformationDetail",
      "http://www.iff.com/role/RestructuringandOtherChargesAdditionalInformationDetails",
      "http://www.iff.com/role/RestructuringandOtherChargesMovementsinRestructuringandRelatedAccrualsDetail",
      "http://www.iff.com/role/SegmentInformationAdditionalInformationDetail",
      "http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition [Axis]",
        "label": "Business Acquisition [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r168",
      "r170",
      "r923",
      "r1297",
      "r1300"
     ]
    },
    "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails",
      "http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Transaction costs",
        "label": "Business Acquisition, Transaction Costs",
        "documentation": "Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails",
      "http://www.iff.com/role/NetIncomePerShareAdditionalInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business acquisition, equity interest issued or issuable, number of shares",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares",
        "documentation": "Number of shares of equity interests issued or issuable to acquire entity."
       }
      }
     },
     "auth_ref": [
      "r322"
     ]
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionLineItems",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsHealthWrightProductsDetails",
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition [Line Items]",
        "label": "Business Acquisition [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r923"
     ]
    },
    "iff_BusinessAcquisitionNetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "BusinessAcquisitionNetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition, Net Income (Loss)",
        "label": "Business Acquisition, Net Income (Loss)",
        "documentation": "Business Acquisition, Net Income (Loss)"
       }
      }
     },
     "auth_ref": []
    },
    "iff_BusinessAcquisitionNetSales": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "BusinessAcquisitionNetSales",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition, Net Sales",
        "label": "Business Acquisition, Net Sales",
        "documentation": "Business Acquisition, Net Sales"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsHealthWrightProductsDetails",
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails",
      "http://www.iff.com/role/NetIncomePerShareAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of voting interest acquired",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination."
       }
      }
     },
     "auth_ref": [
      "r169"
     ]
    },
    "iff_BusinessAcquisitionPostCombinationServicePeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "BusinessAcquisitionPostCombinationServicePeriod",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition, Post-Combination Service Period",
        "label": "Business Acquisition, Post-Combination Service Period",
        "documentation": "Business Acquisition, Post-Combination Service Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionProFormaInformationTextBlock",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unaudited pro forma information",
        "label": "Business Acquisition, Pro Forma Information [Table Text Block]",
        "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate."
       }
      }
     },
     "auth_ref": [
      "r1422",
      "r1423"
     ]
    },
    "us-gaap_BusinessAcquisitionSharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionSharePrice",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business acquisition share price",
        "label": "Business Acquisition, Share Price",
        "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unaudited pro forma net income attributable to the Company",
        "label": "Business Acquisition, Pro Forma Net Income (Loss)",
        "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period."
       }
      }
     },
     "auth_ref": [
      "r921",
      "r922"
     ]
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unaudited pro forma net sales",
        "label": "Business Acquisition, Pro Forma Revenue",
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period."
       }
      }
     },
     "auth_ref": [
      "r921",
      "r922"
     ]
    },
    "us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Non-controlling interest",
        "label": "Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value",
        "documentation": "This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails",
      "http://www.iff.com/role/SegmentInformationAdditionalInformationDetail",
      "http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquisition related costs",
        "negatedTerseLabel": "Acquisition Related Costs",
        "label": "Business Combination, Acquisition Related Costs",
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities."
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "iff_BusinessCombinationAdjustmentOnCashPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "BusinessCombinationAdjustmentOnCashPayment",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment on cash payment from DuPont",
        "label": "Business Combination, Adjustment On Cash Payment",
        "documentation": "Business Combination, Adjustment On Cash Payment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationConsiderationTransferred1",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iff.com/role/AcquisitionsHealthWrightProductsDetails",
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business combination, consideration transferred",
        "totalLabel": "Business combination, consideration transferred",
        "label": "Business Combination, Consideration Transferred",
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r6",
      "r37"
     ]
    },
    "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails": {
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Fair value of common stock issued to DuPont stockholders",
        "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable",
        "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r6"
     ]
    },
    "iff_BusinessCombinationConsiderationTransferredReplacementEquityAwardsIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "BusinessCombinationConsiderationTransferredReplacementEquityAwardsIssued",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails": {
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value attributable to pre-merger service for replacement equity awards",
        "label": "Business Combination, Consideration Transferred, Replacement Equity Awards Issued",
        "documentation": "Business Combination, Consideration Transferred, Replacement Equity Awards Issued"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsHealthWrightProductsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement."
       }
      }
     },
     "auth_ref": [
      "r930",
      "r1454"
     ]
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsHealthWrightProductsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent consideration, liability",
        "label": "Business Combination, Contingent Consideration, Liability",
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r176",
      "r929"
     ]
    },
    "iff_BusinessCombinationDefinedBenefitPlanNumberOfPlansAssumed": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "BusinessCombinationDefinedBenefitPlanNumberOfPlansAssumed",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of defined benefit plans assumed",
        "label": "Business Combination, Defined Benefit Plan, Number Of Plans Assumed",
        "documentation": "Business Combination, Defined Benefit Plan, Number Of Plans Assumed"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationDisclosureTextBlock",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNotes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquisitions",
        "label": "Business Combination Disclosure [Text Block]",
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable)."
       }
      }
     },
     "auth_ref": [
      "r320",
      "r924"
     ]
    },
    "iff_BusinessCombinationDivestituresAndIntegrationCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "BusinessCombinationDivestituresAndIntegrationCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Business Combination, Divestitures And Integration Costs",
        "label": "Business Combination, Divestitures And Integration Costs",
        "documentation": "Business Combination, Divestitures And Integration Costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationIntegrationRelatedCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationIntegrationRelatedCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationAdditionalInformationDetail",
      "http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Combination, Integration Related Costs",
        "negatedTerseLabel": "Integration Related Costs",
        "label": "Business Combination, Integration Related Costs",
        "documentation": "Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs."
       }
      }
     },
     "auth_ref": []
    },
    "iff_BusinessCombinationInventoryStepUpCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "BusinessCombinationInventoryStepUpCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationAdditionalInformationDetail",
      "http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Business Combination, Inventory Step-Up Costs",
        "label": "Business Combination, Inventory Step-Up Costs",
        "documentation": "Business Combination, Inventory Step-Up Costs"
       }
      }
     },
     "auth_ref": []
    },
    "iff_BusinessCombinationLeaseAdjustment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "BusinessCombinationLeaseAdjustment",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease adjustment",
        "label": "Business Combination, Lease Adjustment",
        "documentation": "Business Combination, Lease Adjustment"
       }
      }
     },
     "auth_ref": []
    },
    "iff_BusinessCombinationNetPensionBalanceDifferentialAmountSettledInCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "BusinessCombinationNetPensionBalanceDifferentialAmountSettledInCash",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net pension balance differential amount settled in cash",
        "label": "Business Combination, Net Pension Balance Differential Amount Settled In Cash",
        "documentation": "Business Combination, Net Pension Balance Differential Amount Settled In Cash"
       }
      }
     },
     "auth_ref": []
    },
    "iff_BusinessCombinationPensionFundingAdjustment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "BusinessCombinationPensionFundingAdjustment",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails": {
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Pension funding adjustment",
        "label": "Business Combination, Pension Funding Adjustment",
        "documentation": "Business Combination, Pension Funding Adjustment"
       }
      }
     },
     "auth_ref": []
    },
    "iff_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPayrollAndEmployeeBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPayrollAndEmployeeBenefits",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Accrued payroll and employee benefits",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Payroll And Employee Benefits",
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Payroll And Employee Benefits"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses and other current assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Receivables",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Accounts payable and accrued liabilities",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred income taxes",
        "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets",
        "documentation": "Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Deferred tax liabilities",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/AcquisitionsHealthWrightProductsDetails",
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventory",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "documentation": "The amount of inventory recognized as of the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r171",
      "r172"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total identifiable net assets assumed",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net",
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed."
       }
      }
     },
     "auth_ref": [
      "r171",
      "r172"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Long-term debt",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-Term Debt",
        "documentation": "Amount of long-term debt due after one year or the normal operating cycle, if longer, assumed at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other long-term liabilities",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other",
        "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, plant and equipment",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r171",
      "r172"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Purchase price",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest",
        "documentation": "Amount recognized as of the acquisition date for the assets, including goodwill, in excess of (less than) the aggregate liabilities assumed, less the noncontrolling interest in the acquiree."
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "iff_BusinessCombinationRestructuringLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "BusinessCombinationRestructuringLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/RestructuringandOtherChargesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Combination, Restructuring Liabilities",
        "label": "Business Combination, Restructuring Liabilities",
        "documentation": "Business Combination, Restructuring Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "iff_BusinessDivestitureCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "BusinessDivestitureCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationAdditionalInformationDetail",
      "http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Divestiture Costs",
        "negatedTerseLabel": "Business Divestiture Costs",
        "label": "Business Divestiture Costs",
        "documentation": "Business Divestiture Costs"
       }
      }
     },
     "auth_ref": []
    },
    "country_CN": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "CN",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail",
      "http://www.iff.com/role/SegmentInformationAdditionalInformationDetail",
      "http://www.iff.com/role/SegmentInformationSegmentInformationScheduleofLongLivedAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CHINA",
        "label": "CHINA"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued capital expenditures",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred."
       }
      }
     },
     "auth_ref": [
      "r92",
      "r93",
      "r94"
     ]
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsCarryingAmountandEstimatedFairValueofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Carrying Amount [Member]",
        "label": "Reported Value Measurement [Member]",
        "documentation": "Measured as reported on the statement of financial position (balance sheet)."
       }
      }
     },
     "auth_ref": [
      "r208",
      "r209"
     ]
    },
    "us-gaap_CashAcquiredFromAcquisition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAcquiredFromAcquisition",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash acquired from acquisition",
        "label": "Cash Acquired from Acquisition",
        "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business)."
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/BusinessDivestitureDetails",
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET",
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r89",
      "r417",
      "r1256"
     ]
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsCarryingAmountandEstimatedFairValueofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsMember",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail",
      "http://www.iff.com/role/EmployeeBenefitsPercentageofAssetsInvestedDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalents [Member]",
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash Equivalents",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r90"
     ]
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted Cash",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r333"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS",
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of year",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at end of year",
        "terseLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r89",
      "r276",
      "r472"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net change in cash, cash equivalents and restricted cash",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r276"
     ]
    },
    "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative gains included in AOCI",
        "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months",
        "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months."
       }
      }
     },
     "auth_ref": [
      "r205"
     ]
    },
    "us-gaap_CashFlowHedgingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashFlowHedgingMember",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowandNetInvestmentHedgingInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash Flow Hedging [Member]",
        "label": "Cash Flow Hedging [Member]",
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk."
       }
      }
     },
     "auth_ref": [
      "r188"
     ]
    },
    "us-gaap_CashMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashMember",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash",
        "label": "Cash [Member]",
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r417"
     ]
    },
    "iff_CashRestrictedStockUnitMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "CashRestrictedStockUnitMember",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansLiabilityAwardsAdditionalInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansRSUPRSandCashRSUActivityDetail",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash RSU's [Member]",
        "label": "Cash Restricted Stock Unit [Member]",
        "documentation": "Cash Restricted Stock Unit [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashSurrenderValueOfLifeInsurance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashSurrenderValueOfLifeInsurance",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherAssetsDetail": {
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail",
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash surrender value of life insurance contracts",
        "verboseLabel": "Total cash surrender value of life insurance contracts",
        "label": "Cash Surrender Value of Life Insurance",
        "documentation": "Carrying amount as of the balance sheet date of amounts which could be received based on the terms of the insurance contract upon surrendering life policies owned by the entity."
       }
      }
     },
     "auth_ref": [
      "r1444"
     ]
    },
    "iff_CashTransferredToTheBuyerOnTheClosingBalanceSheet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "CashTransferredToTheBuyerOnTheClosingBalanceSheet",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/BusinessDivestitureDetails": {
       "parentTag": "iff_ProceedsFromDivestitureOfBusinessNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/BusinessDivestitureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash Transferred to the Buyer on the Closing Balance Sheet",
        "label": "Cash Transferred to the Buyer on the Closing Balance Sheet",
        "documentation": "Cash Transferred to the Buyer on the Closing Balance Sheet"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CatastrophicEventDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CatastrophicEventDomain",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Catastrophic Event [Domain]",
        "label": "Catastrophic Event [Domain]",
        "documentation": "Catastrophic event, for example, but not limited to, earthquake, windstorm, fire or explosion."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changed Peer Group, Footnote",
        "label": "Changed Peer Group, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1373"
     ]
    },
    "srt_ChiefExecutiveOfficerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ChiefExecutiveOfficerMember",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Chief Executive Officer [Member]",
        "label": "Chief Executive Officer [Member]",
        "documentation": "Person with designation of chief executive officer."
       }
      }
     },
     "auth_ref": [
      "r1477"
     ]
    },
    "iff_CitibankN.AMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "CitibankN.AMember",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail",
      "http://www.iff.com/role/DebtAdditionalInformationRevolvingCreditFacilityDetail",
      "http://www.iff.com/role/DebtComponentsofDebtDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Citibank, N.A",
        "label": "Citibank, N.A [Member]",
        "documentation": "Citibank, N.A [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.iff.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.iff.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Domain]",
        "label": "Class of Stock [Domain]",
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r367",
      "r427",
      "r428",
      "r429",
      "r475",
      "r512",
      "r516",
      "r519",
      "r521",
      "r527",
      "r528",
      "r601",
      "r697",
      "r700",
      "r701",
      "r702",
      "r708",
      "r709",
      "r739",
      "r740",
      "r743",
      "r746",
      "r753",
      "r978",
      "r1126",
      "r1127",
      "r1128",
      "r1129",
      "r1134",
      "r1135",
      "r1136",
      "r1137",
      "r1138",
      "r1139",
      "r1140",
      "r1141",
      "r1142",
      "r1143",
      "r1144",
      "r1145",
      "r1165",
      "r1188",
      "r1208",
      "r1230",
      "r1231",
      "r1232",
      "r1233",
      "r1234",
      "r1410",
      "r1457",
      "r1473"
     ]
    },
    "us-gaap_ClassOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockLineItems",
     "presentation": [
      "http://www.iff.com/role/TangibleEquityUnitsTangibleEquitySettlementofSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Line Items]",
        "label": "Class of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r427",
      "r428",
      "r429",
      "r527",
      "r739",
      "r740",
      "r741",
      "r743",
      "r746",
      "r751",
      "r753",
      "r1126",
      "r1127",
      "r1128",
      "r1129",
      "r1290",
      "r1410",
      "r1457"
     ]
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Amount",
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r1374"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Name",
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r1374"
     ]
    },
    "iff_CommercialGuaranteesAmountOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "CommercialGuaranteesAmountOutstanding",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commercial Guarantees, Amount Outstanding",
        "label": "Commercial Guarantees, Amount Outstanding",
        "documentation": "Commercial Guarantees, Amount Outstanding"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommercialPaper": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommercialPaper",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail",
      "http://www.iff.com/role/DebtComponentsofDebtDetail",
      "http://www.iff.com/role/FinancialInstrumentsCarryingAmountandEstimatedFairValueofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commercial paper",
        "label": "Commercial Paper",
        "documentation": "Carrying value as of the balance sheet date of short-term borrowings using unsecured obligations issued by banks, corporations and other borrowers to investors. The maturities of these money market securities generally do not exceed 270 days."
       }
      }
     },
     "auth_ref": [
      "r241",
      "r336",
      "r1643"
     ]
    },
    "iff_CommercialPaperCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "CommercialPaperCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commercial paper",
        "label": "Commercial Paper, Current",
        "documentation": "Commercial Paper, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies (Note 19)",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r218",
      "r1079",
      "r1164"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]",
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r296",
      "r688",
      "r689",
      "r1240",
      "r1507"
     ]
    },
    "iff_CommitmentsAndContingenciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "CommitmentsAndContingenciesLineItems",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments And Contingencies [Line Items]",
        "label": "Commitments And Contingencies [Line Items]",
        "documentation": "Commitments And Contingencies [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_CommitmentsAndContingenciesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "CommitmentsAndContingenciesTable",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments And Contingencies [Table]",
        "label": "Commitments And Contingencies [Table]",
        "documentation": "Commitments And Contingencies [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommodityContractMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommodityContractMember",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsNotionalAmountOutstandingDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsWhichWereNotDesignatedasHedgingInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commodity Contracts",
        "label": "Commodity Contract [Member]",
        "documentation": "Derivative instrument whose primary underlying risk is tied to commodity prices."
       }
      }
     },
     "auth_ref": [
      "r1293",
      "r1309"
     ]
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockDividendsPerShareDeclared",
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITYParenthetical",
      "http://www.iff.com/role/ShareholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends declared per share (in dollars per share)",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding."
       }
      }
     },
     "auth_ref": [
      "r301"
     ]
    },
    "iff_CommonStockDividendsPerShareMaximumDividendThresholdPerQuarter": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "CommonStockDividendsPerShareMaximumDividendThresholdPerQuarter",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationRevolvingCreditFacilityDetail",
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum dividend threshold per quarter",
        "label": "Common Stock, Dividends Per Share, Maximum Dividend Threshold Per Quarter",
        "documentation": "Common Stock, Dividends Per Share, Maximum Dividend Threshold Per Quarter"
       }
      }
     },
     "auth_ref": []
    },
    "iff_CommonStockDividendsPerShareMaximumDividendThresholdPerYear": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "CommonStockDividendsPerShareMaximumDividendThresholdPerYear",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationRevolvingCreditFacilityDetail",
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum dividend threshold per year",
        "label": "Common Stock, Dividends Per Share, Maximum Dividend Threshold Per Year",
        "documentation": "Common Stock, Dividends Per Share, Maximum Dividend Threshold Per Year"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY",
      "http://www.iff.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r1313",
      "r1314",
      "r1315",
      "r1317",
      "r1318",
      "r1319",
      "r1322",
      "r1468",
      "r1469",
      "r1620",
      "r1648",
      "r1651"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails",
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEETParenthetical",
      "http://www.iff.com/role/NetIncomePerShareAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, par value (in dollars per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r250"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEETParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares authorized (in shares)",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r250",
      "r1165"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEETParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares issued (in shares)",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r250"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEETParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares outstanding (in shares)",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r250",
      "r1165",
      "r1185",
      "r1651",
      "r1652"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, value, issued",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r250",
      "r1080",
      "r1311"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure",
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1379"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Net Income",
        "label": "Compensation Actually Paid vs. Net Income [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1378"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Other Measure",
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1380"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return",
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1377"
     ]
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement Benefits [Abstract]",
        "label": "Retirement Benefits [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CompensationRelatedCostsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CompensationRelatedCostsPolicyTextBlock",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-Based Compensation",
        "label": "Compensation Related Costs, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense."
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Comprehensive loss attributable to IFF shareholders",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r449",
      "r451",
      "r460",
      "r1072",
      "r1095"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Comprehensive loss",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r185",
      "r324",
      "r449",
      "r451",
      "r459",
      "r1071",
      "r1094"
     ]
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskBenchmarkDomain",
     "presentation": [
      "http://www.iff.com/role/ConcentrationsOfCreditRiskAdditionalInformationDetail",
      "http://www.iff.com/role/SegmentInformationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Benchmark [Domain]",
        "label": "Concentration Risk Benchmark [Domain]",
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r101",
      "r210",
      "r211",
      "r562",
      "r1239"
     ]
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "presentation": [
      "http://www.iff.com/role/ConcentrationsOfCreditRiskAdditionalInformationDetail",
      "http://www.iff.com/role/SegmentInformationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Benchmark [Axis]",
        "label": "Concentration Risk Benchmark [Axis]",
        "documentation": "Information by benchmark of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r101",
      "r210",
      "r211",
      "r562",
      "r1122",
      "r1239"
     ]
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskByTypeAxis",
     "presentation": [
      "http://www.iff.com/role/ConcentrationsOfCreditRiskAdditionalInformationDetail",
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.iff.com/role/SegmentInformationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Type [Axis]",
        "label": "Concentration Risk Type [Axis]",
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r101",
      "r210",
      "r211",
      "r562",
      "r1239",
      "r1421"
     ]
    },
    "us-gaap_ConcentrationRiskDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskDisclosureTextBlock",
     "presentation": [
      "http://www.iff.com/role/ConcentrationsofCreditRisk"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentrations of Credit Risk",
        "label": "Concentration Risk Disclosure [Text Block]",
        "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r280"
     ]
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskLineItems",
     "presentation": [
      "http://www.iff.com/role/ConcentrationsOfCreditRiskAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk [Line Items]",
        "label": "Concentration Risk [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r1239"
     ]
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskPercentage1",
     "presentation": [
      "http://www.iff.com/role/ConcentrationsOfCreditRiskAdditionalInformationDetail",
      "http://www.iff.com/role/SegmentInformationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration risk threshold",
        "label": "Concentration Risk, Percentage",
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r101",
      "r210",
      "r211",
      "r562"
     ]
    },
    "us-gaap_ConcentrationRiskTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskTable",
     "presentation": [
      "http://www.iff.com/role/ConcentrationsOfCreditRiskAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk [Table]",
        "label": "Concentration Risk [Table]",
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark."
       }
      }
     },
     "auth_ref": [
      "r98",
      "r99",
      "r101",
      "r102",
      "r210",
      "r332",
      "r1239"
     ]
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskTypeDomain",
     "presentation": [
      "http://www.iff.com/role/ConcentrationsOfCreditRiskAdditionalInformationDetail",
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.iff.com/role/SegmentInformationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Type [Domain]",
        "label": "Concentration Risk Type [Domain]",
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r101",
      "r210",
      "r211",
      "r562",
      "r1239"
     ]
    },
    "iff_ConditionOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "ConditionOneMember",
     "presentation": [
      "http://www.iff.com/role/TangibleEquityUnitsTangibleEquitySettlementofSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Condition One [Member]",
        "label": "Condition One [Member]",
        "documentation": "Condition One [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_ConditionThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "ConditionThreeMember",
     "presentation": [
      "http://www.iff.com/role/TangibleEquityUnitsTangibleEquitySettlementofSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Condition Three [Member]",
        "label": "Condition Three [Member]",
        "documentation": "Condition Three [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_ConditionTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "ConditionTwoMember",
     "presentation": [
      "http://www.iff.com/role/TangibleEquityUnitsTangibleEquitySettlementofSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Condition Two [Member]",
        "label": "Condition Two [Member]",
        "documentation": "Condition Two [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_ConsolidatedNetSalesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "ConsolidatedNetSalesMember",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidated Net Sales",
        "label": "Consolidated Net Sales [Member]",
        "documentation": "Consolidated Net Sales"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ConsolidationItemsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ConsolidationItemsAxis",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationCapitalExpenditureandDepreciationandAmortizationbySegmentDetail",
      "http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidation Items [Axis]",
        "label": "Consolidation Items [Axis]",
        "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments."
       }
      }
     },
     "auth_ref": [
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r480",
      "r535",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r552",
      "r556",
      "r697",
      "r698",
      "r699",
      "r700",
      "r702",
      "r703",
      "r705",
      "r707",
      "r708",
      "r1440",
      "r1441",
      "r1511",
      "r1512"
     ]
    },
    "srt_ConsolidationItemsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ConsolidationItemsDomain",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationCapitalExpenditureandDepreciationandAmortizationbySegmentDetail",
      "http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidation Items [Domain]",
        "label": "Consolidation Items [Domain]",
        "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments."
       }
      }
     },
     "auth_ref": [
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r480",
      "r535",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r552",
      "r556",
      "r697",
      "r698",
      "r699",
      "r700",
      "r702",
      "r703",
      "r705",
      "r707",
      "r708",
      "r1440",
      "r1441",
      "r1511",
      "r1512"
     ]
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Principles of Consolidation",
        "label": "Consolidation, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r181",
      "r1266"
     ]
    },
    "us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Redeemable Non-controlling Interests",
        "label": "Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for subsidiaries or other investments that are consolidated, including the accounting treatment for intercompany accounts or transactions and any noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r354"
     ]
    },
    "us-gaap_ConstructionInProgressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConstructionInProgressMember",
     "presentation": [
      "http://www.iff.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Construction in process [Member]",
        "label": "Construction in Progress [Member]",
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract with Customer, Contract Asset, Contract Liability, and Receivable",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability."
       }
      }
     },
     "auth_ref": [
      "r1515"
     ]
    },
    "us-gaap_CorporateAndOtherMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CorporateAndOtherMember",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationAdditionalInformationDetail",
      "http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Corporate and Other [Member]",
        "label": "Corporate and Other [Member]",
        "documentation": "Component of an entity that provides financial and operational oversight and administrative support for other segments and other segments not separately reported due to size or nature of business activities. Excludes intersegment elimination and reconciling items."
       }
      }
     },
     "auth_ref": [
      "r1474"
     ]
    },
    "us-gaap_CorporateBondSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CorporateBondSecuritiesMember",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Corporate Bonds",
        "label": "Corporate Bond Securities [Member]",
        "documentation": "This category includes information about long-term debt securities that are issued by either a domestic or foreign corporate business entity with a date certain promise of repayment and a return to the holder for the time value of money (for example, variable or fixed interest, original issue discount)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CorporateNonSegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CorporateNonSegmentMember",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationCapitalExpenditureandDepreciationandAmortizationbySegmentDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Unallocated assets [Member]",
        "label": "Corporate, Non-Segment [Member]",
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r547",
      "r548",
      "r549",
      "r550",
      "r556",
      "r1476"
     ]
    },
    "iff_CosmeticActivesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "CosmeticActivesMember",
     "presentation": [
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cosmetic Actives",
        "label": "Cosmetic Actives [Member]",
        "documentation": "Cosmetic Actives"
       }
      }
     },
     "auth_ref": []
    },
    "iff_CosmeticIngredientsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "CosmeticIngredientsMember",
     "presentation": [
      "http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cosmetic Ingredients",
        "label": "Cosmetic Ingredients [Member]",
        "documentation": "Cosmetic Ingredients"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostOfGoodsAndServicesSold",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossReclassificationsofAccumulatedOtherComprehensiveIncometoConsolidatedStatementofComprehensiveIncomeDetail": {
       "parentTag": "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossReclassificationsofAccumulatedOtherComprehensiveIncometoConsolidatedStatementofComprehensiveIncomeDetail",
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of goods sold",
        "label": "Cost of Goods and Services Sold",
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities."
       }
      }
     },
     "auth_ref": [
      "r267",
      "r1063"
     ]
    },
    "us-gaap_CostOfSalesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostOfSalesMember",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowandNetInvestmentHedgingInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of goods sold [Member]",
        "label": "Cost of Sales [Member]",
        "documentation": "Primary financial statement caption encompassing cost of sales."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Held for Sale",
        "label": "Costs Associated with Exit or Disposal Activity or Restructuring [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for cost associated with exit or disposal activity or restructuring. Excludes entity newly acquired in business combination and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r121",
      "r294",
      "r295"
     ]
    },
    "srt_CounterpartyNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "CounterpartyNameAxis",
     "presentation": [
      "http://www.iff.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Axis]",
        "label": "Counterparty Name [Axis]",
        "documentation": "Information by name of counterparty. A counterparty is the other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution."
       }
      }
     },
     "auth_ref": [
      "r405",
      "r478",
      "r479",
      "r714",
      "r741",
      "r1029",
      "r1263",
      "r1265"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CreditFacilityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CreditFacilityAxis",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail",
      "http://www.iff.com/role/DebtAdditionalInformationRevolvingCreditFacilityDetail",
      "http://www.iff.com/role/DebtComponentsofDebtDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Facility [Axis]",
        "label": "Credit Facility [Axis]",
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CreditFacilityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CreditFacilityDomain",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail",
      "http://www.iff.com/role/DebtAdditionalInformationRevolvingCreditFacilityDetail",
      "http://www.iff.com/role/DebtComponentsofDebtDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Facility [Domain]",
        "label": "Credit Facility [Domain]",
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CreditLossFinancialInstrumentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CreditLossFinancialInstrumentPolicyTextBlock",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected Credit Loss",
        "label": "Credit Loss, Financial Instrument [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for credit loss on financial instrument measured at amortized cost basis, net investment in lease, off-balance sheet credit exposure, and available-for-sale debt security. Includes, but is not limited to, methodology used to estimate allowance for credit loss, how writeoff of uncollectible amount is recognized, and determination of past due status and nonaccrual status."
       }
      }
     },
     "auth_ref": [
      "r364",
      "r613",
      "r614",
      "r615",
      "r617",
      "r618",
      "r624",
      "r626",
      "r627",
      "r628",
      "r629",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r638"
     ]
    },
    "iff_CrossCurrencySwapsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "CrossCurrencySwapsMember",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowandNetInvestmentHedgingInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cross Currency Swaps [Member]",
        "label": "Cross Currency Swaps [Member]",
        "documentation": "Cross Currency Swaps [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "documentation": "Increase (decrease) to financial statements for cumulative-effect adjustment in period of adoption of amendment to accounting standards."
       }
      }
     },
     "auth_ref": [
      "r408",
      "r492",
      "r500",
      "r507",
      "r606",
      "r612",
      "r877",
      "r878",
      "r879",
      "r910",
      "r911",
      "r947",
      "r949",
      "r950",
      "r952",
      "r953",
      "r954",
      "r960",
      "r963",
      "r965",
      "r966",
      "r1026"
     ]
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]",
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "documentation": "Information by cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards."
       }
      }
     },
     "auth_ref": [
      "r408",
      "r492",
      "r500",
      "r507",
      "r606",
      "r612",
      "r877",
      "r878",
      "r879",
      "r910",
      "r911",
      "r947",
      "r949",
      "r950",
      "r952",
      "r953",
      "r954",
      "r960",
      "r963",
      "r965",
      "r966",
      "r1026"
     ]
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]",
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "documentation": "Cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards."
       }
      }
     },
     "auth_ref": [
      "r408",
      "r492",
      "r500",
      "r507",
      "r606",
      "r612",
      "r877",
      "r878",
      "r879",
      "r910",
      "r911",
      "r947",
      "r949",
      "r950",
      "r952",
      "r953",
      "r954",
      "r960",
      "r963",
      "r965",
      "r966",
      "r1026"
     ]
    },
    "us-gaap_CurrencySwapMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrencySwapMember",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsAdditionalInformationDetail",
      "http://www.iff.com/role/FinancialInstrumentsCarryingAmountandEstimatedFairValueofFinancialInstrumentsDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowandNetInvestmentHedgingInstrumentsDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsMeasuredatFairValueDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsNotionalAmountOutstandingDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Currency Swap",
        "label": "Currency Swap [Member]",
        "documentation": "Swap involving the exchange of principal and interest in one currency for another currency."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentFederalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/IncomeTaxesScheduleofIncomeTaxProvisionDetail": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesScheduleofIncomeTaxProvisionDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal",
        "label": "Current Federal Tax Expense (Benefit)",
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1432",
      "r1460",
      "r1614"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.iff.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentForeignTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/IncomeTaxesScheduleofIncomeTaxProvisionDetail": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesScheduleofIncomeTaxProvisionDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Foreign",
        "label": "Current Foreign Tax Expense (Benefit)",
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r1432",
      "r1460"
     ]
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/IncomeTaxesScheduleofIncomeTaxProvisionDetail": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesScheduleofIncomeTaxProvisionDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current income tax provision",
        "label": "Current Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r319",
      "r907",
      "r915",
      "r1460"
     ]
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesScheduleofIncomeTaxProvisionDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current tax provision",
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/IncomeTaxesScheduleofIncomeTaxProvisionDetail": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesScheduleofIncomeTaxProvisionDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State and local",
        "label": "Current State and Local Tax Expense (Benefit)",
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1432",
      "r1460",
      "r1614"
     ]
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CustomerConcentrationRiskMember",
     "presentation": [
      "http://www.iff.com/role/ConcentrationsOfCreditRiskAdditionalInformationDetail",
      "http://www.iff.com/role/SegmentInformationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer Concentration Risk [Member]",
        "label": "Customer Concentration Risk [Member]",
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r562"
     ]
    },
    "us-gaap_CustomerRelationshipsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CustomerRelationshipsMember",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsHealthWrightProductsDetails",
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails",
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetTrademarkandOtherIntangibleAssetsDetail",
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer Relationships",
        "label": "Customer Relationships [Member]",
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships."
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "country_DE": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "DE",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationSegmentInformationScheduleofLongLivedAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "GERMANY",
        "label": "GERMANY"
       }
      }
     },
     "auth_ref": []
    },
    "country_DK": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "DK",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationSegmentInformationScheduleofLongLivedAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "DENMARK",
        "label": "DENMARK"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DamagesFromProductDefectsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DamagesFromProductDefectsMember",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Damages from Product Defects [Member]",
        "label": "Damages from Product Defects [Member]",
        "documentation": "The risk of loss arises with respect to product defects and recalls, or improperly performed services which actually or allegedly resulted in damages suffered by the injured party, excluding major product liability matters."
       }
      }
     },
     "auth_ref": [
      "r1508"
     ]
    },
    "iff_DealContingentSwapsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DealContingentSwapsMember",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsAdditionalInformationDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsWhichWereNotDesignatedasHedgingInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deal Contingent Swaps [Member]",
        "label": "Deal Contingent Swaps [Member]",
        "documentation": "Deal Contingent Swaps [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_DebtCovenantPeriodAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DebtCovenantPeriodAxis",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationRevolvingCreditFacilityDetail",
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Covenant Period [Axis]",
        "label": "Debt Covenant Period [Axis]",
        "documentation": "Debt Covenant Period"
       }
      }
     },
     "auth_ref": []
    },
    "iff_DebtCovenantPeriodDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DebtCovenantPeriodDomain",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationRevolvingCreditFacilityDetail",
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Covenant Period [Domain]",
        "label": "Debt Covenant Period [Domain]",
        "documentation": "Debt Covenant Period [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bank borrowings, overdrafts and current portion of long-term debt",
        "label": "Debt, Current",
        "documentation": "Amount of debt and lease obligation, classified as current."
       }
      }
     },
     "auth_ref": [
      "r425"
     ]
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Disclosure [Abstract]",
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://www.iff.com/role/Debt"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt",
        "label": "Debt Disclosure [Text Block]",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r297",
      "r473",
      "r710",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r726",
      "r733",
      "r734",
      "r736"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail",
      "http://www.iff.com/role/DebtAdditionalInformationCommercialPaperandRedemptionProvisionsDetail",
      "http://www.iff.com/role/DebtAdditionalInformationRevolvingCreditFacilityDetail",
      "http://www.iff.com/role/DebtAdditionalInformationSeniorUnsecuredNotesDetail",
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail",
      "http://www.iff.com/role/DebtComponentsofDebtDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Axis]",
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r243",
      "r244",
      "r337",
      "r341",
      "r480",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r717",
      "r722",
      "r723",
      "r724",
      "r725",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r1001",
      "r1285",
      "r1286",
      "r1287",
      "r1288",
      "r1289",
      "r1458"
     ]
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationCommercialPaperandRedemptionProvisionsDetail",
      "http://www.iff.com/role/DebtAdditionalInformationRevolvingCreditFacilityDetail",
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail",
      "http://www.iff.com/role/DebtComponentsofDebtDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Margin on variable rate",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument."
       }
      }
     },
     "auth_ref": []
    },
    "iff_DebtInstrumentCovenantBasisSpreadIncreaseOnVariableRate": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DebtInstrumentCovenantBasisSpreadIncreaseOnVariableRate",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationRevolvingCreditFacilityDetail",
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument, covenant, basis spread increase on variable rate",
        "label": "Debt Instrument, Covenant, Basis Spread Increase On Variable Rate",
        "documentation": "Debt Instrument, Covenant, Basis Spread Increase On Variable Rate"
       }
      }
     },
     "auth_ref": []
    },
    "iff_DebtInstrumentCovenantLienThresholdAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DebtInstrumentCovenantLienThresholdAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationRevolvingCreditFacilityDetail",
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lien threshold",
        "label": "Debt Instrument, Covenant, Lien Threshold, Amount",
        "documentation": "Debt Instrument, Covenant, Lien Threshold, Amount"
       }
      }
     },
     "auth_ref": []
    },
    "iff_DebtInstrumentCovenantLienThresholdPercentageOfConsolidatedNetTangibleAssets": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DebtInstrumentCovenantLienThresholdPercentageOfConsolidatedNetTangibleAssets",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationRevolvingCreditFacilityDetail",
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lien threshold, percentage of consolidated net tangible assets",
        "label": "Debt Instrument, Covenant, Lien Threshold, Percentage Of Consolidated Net Tangible Assets",
        "documentation": "Debt Instrument, Covenant, Lien Threshold, Percentage Of Consolidated Net Tangible Assets"
       }
      }
     },
     "auth_ref": []
    },
    "iff_DebtInstrumentCovenantMaximumConsolidatedLeverageRatio": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DebtInstrumentCovenantMaximumConsolidatedLeverageRatio",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationRevolvingCreditFacilityDetail",
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum consolidated leverage ratio",
        "label": "Debt Instrument, Covenant, Maximum Consolidated Leverage Ratio",
        "documentation": "Debt Instrument, Covenant, Maximum Consolidated Leverage Ratio"
       }
      }
     },
     "auth_ref": []
    },
    "iff_DebtInstrumentCovenantPercentageOfProceedsFromNonOrdinaryAssetsSalesRequiredToBeUsedAsPrepayment": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DebtInstrumentCovenantPercentageOfProceedsFromNonOrdinaryAssetsSalesRequiredToBeUsedAsPrepayment",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of proceeds from non-ordinary assets sales required to be used as prepayment",
        "label": "Debt Instrument, Covenant, Percentage Of Proceeds From Non-Ordinary Assets Sales Required To Be Used As Prepayment",
        "documentation": "Debt Instrument, Covenant, Percentage Of Proceeds From Non-Ordinary Assets Sales Required To Be Used As Prepayment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt, face amount",
        "label": "Debt Instrument, Face Amount",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r214",
      "r216",
      "r711",
      "r1001",
      "r1286",
      "r1287"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationSeniorUnsecuredNotesDetail",
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail",
      "http://www.iff.com/role/DebtComponentsofDebtDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest rate of debt",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r712"
     ]
    },
    "us-gaap_DebtInstrumentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentLineItems",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationCommercialPaperandRedemptionProvisionsDetail",
      "http://www.iff.com/role/DebtAdditionalInformationRevolvingCreditFacilityDetail",
      "http://www.iff.com/role/DebtAdditionalInformationSeniorUnsecuredNotesDetail",
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail",
      "http://www.iff.com/role/DebtComponentsofDebtDetail",
      "http://www.iff.com/role/DebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Line Items]",
        "label": "Debt Instrument [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r480",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r717",
      "r722",
      "r723",
      "r724",
      "r725",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r735",
      "r1001",
      "r1285",
      "r1286",
      "r1287",
      "r1288",
      "r1289",
      "r1458"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail",
      "http://www.iff.com/role/DebtAdditionalInformationCommercialPaperandRedemptionProvisionsDetail",
      "http://www.iff.com/role/DebtAdditionalInformationRevolvingCreditFacilityDetail",
      "http://www.iff.com/role/DebtAdditionalInformationSeniorUnsecuredNotesDetail",
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail",
      "http://www.iff.com/role/DebtComponentsofDebtDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Name [Domain]",
        "label": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r480",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r717",
      "r722",
      "r723",
      "r724",
      "r725",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r1001",
      "r1285",
      "r1286",
      "r1287",
      "r1288",
      "r1289",
      "r1458"
     ]
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationCommercialPaperandRedemptionProvisionsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument, redemption price, percentage",
        "label": "Debt Instrument, Redemption Price, Percentage",
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "us-gaap_DebtInstrumentRedemptionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentRedemptionTable",
     "presentation": [
      "http://www.iff.com/role/DebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument Redemption [Table]",
        "label": "Debt Instrument Redemption [Table]",
        "documentation": "Disclosure of information about debt instruments or arrangements with redemption features. Includes, but is not limited to, description of debt redemption features, percentage price at which debt can be redeemed by the issuer, and period start and end for debt maturity or redemption."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentRedemptionTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentRedemptionTableTextBlock",
     "presentation": [
      "http://www.iff.com/role/DebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument Redemption",
        "label": "Debt Instrument Redemption [Table Text Block]",
        "documentation": "Tabular disclosure of debt instruments or arrangements with redemption features. Includes, but is not limited to, description of debt redemption features, percentage price at which debt can be redeemed by the issuer, and period start and end for debt maturity or redemption."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentTable",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationCommercialPaperandRedemptionProvisionsDetail",
      "http://www.iff.com/role/DebtAdditionalInformationRevolvingCreditFacilityDetail",
      "http://www.iff.com/role/DebtAdditionalInformationSeniorUnsecuredNotesDetail",
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail",
      "http://www.iff.com/role/DebtComponentsofDebtDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r134",
      "r137",
      "r213",
      "r214",
      "r216",
      "r219",
      "r299",
      "r300",
      "r480",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r717",
      "r722",
      "r723",
      "r724",
      "r725",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r735",
      "r1001",
      "r1285",
      "r1286",
      "r1287",
      "r1288",
      "r1289",
      "r1458"
     ]
    },
    "us-gaap_DebtInstrumentTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentTerm",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationSeniorUnsecuredNotesDetail",
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument, term",
        "label": "Debt Instrument, Term",
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtLongtermAndShorttermCombinedAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtLongtermAndShorttermCombinedAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/DebtComponentsofDebtDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt, long-term and short-term, combined",
        "label": "Debt, Long-Term and Short-Term, Combined Amount",
        "documentation": "Represents the aggregate of total long-term debt, including current maturities and short-term debt."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtPolicyTextBlock",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing Costs",
        "label": "Debt, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt."
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtRelatedCommitmentFeesAndDebtIssuanceCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationRevolvingCreditFacilityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt related commitment fees and debt issuance costs",
        "label": "Debt Related Commitment Fees and Debt Issuance Costs",
        "documentation": "Represents the charge against earnings during the period for commitment fees and debt issuance expenses."
       }
      }
     },
     "auth_ref": [
      "r271"
     ]
    },
    "us-gaap_DebtSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesMember",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsPercentageofAssetsInvestedDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fixed income",
        "label": "Debt Securities [Member]",
        "documentation": "Debt instrument issued by corporations, governments and governmental agencies, municipalities, and other institutions."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r1315",
      "r1655"
     ]
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualByTypeOfCompensationPensionAndOtherPostretirementBenefitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredCompensationArrangementWithIndividualByTypeOfCompensationPensionAndOtherPostretirementBenefitsMember",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred Compensation Plan",
        "label": "Deferred Compensation Arrangement with Individual, by Type of Compensation, Pension and Other Postretirement Benefits [Member]",
        "documentation": "Deferred compensation arrangement providing pension or other postretirement benefits, to employee or their beneficiary, that are not equivalent to defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r302",
      "r303"
     ]
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredCompensationArrangementWithIndividualCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred Compensation Arrangement with Individual, Compensation Expense",
        "label": "Deferred Compensation Arrangement with Individual, Compensation Expense",
        "documentation": "The compensation expense recognized during the period pertaining to the deferred compensation arrangement."
       }
      }
     },
     "auth_ref": [
      "r150",
      "r303"
     ]
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Postretirement Benefits, Type of Deferred Compensation [Axis]",
        "label": "Other Postretirement Benefits, Individual Contracts, Type of Deferred Compensation [Axis]",
        "documentation": "Information by type of deferred compensation related to other postretirement benefit arrangements that are not equivalent to a defined benefit other postretirement benefit plan. Includes, but is not limited to, employment contracts with one or more selected officers or key employees. Excludes equity-based compensation plans, defined benefit pension plans and defined benefit other postretirement benefit plans."
       }
      }
     },
     "auth_ref": [
      "r302",
      "r303"
     ]
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/IncomeTaxesScheduleofIncomeTaxProvisionDetail": {
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesScheduleofIncomeTaxProvisionDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1460",
      "r1613",
      "r1614"
     ]
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/IncomeTaxesScheduleofIncomeTaxProvisionDetail": {
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesScheduleofIncomeTaxProvisionDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r319",
      "r1460",
      "r1613"
     ]
    },
    "iff_DeferredGainLossOnTerminatedInterestRateContracts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DeferredGainLossOnTerminatedInterestRateContracts",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Loss incurred on termination of interest rate swaps",
        "label": "Deferred Gain Loss On Terminated Interest Rate Contracts",
        "documentation": "Deferred Gain Loss On Terminated Interest Rate Contracts"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxAssetsNet",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred Income Tax Assets, Net",
        "label": "Deferred Income Tax Assets, Net",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r887",
      "r888"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/IncomeTaxesScheduleofIncomeTaxProvisionDetail": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS",
      "http://www.iff.com/role/IncomeTaxesScheduleofIncomeTaxProvisionDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred income taxes",
        "totalLabel": "Total deferred income tax provision",
        "label": "Deferred Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r319",
      "r363",
      "r914",
      "r915",
      "r1460"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesScheduleofIncomeTaxProvisionDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax provision",
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Gross deferred tax liabilities",
        "label": "Deferred Tax Liabilities, Gross",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences."
       }
      }
     },
     "auth_ref": [
      "r247",
      "r248",
      "r339",
      "r901"
     ]
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/BusinessDivestitureDetails": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/BusinessDivestitureDetails",
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET",
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred income taxes",
        "negatedTerseLabel": "Deferred Income Tax Liabilities, Net",
        "label": "Deferred Income Tax Liabilities, Net",
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r887",
      "r888",
      "r1078"
     ]
    },
    "us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxesAndOtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherAssetsDetail": {
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred Income Taxes and Other Assets, Noncurrent",
        "label": "Deferred Income Taxes and Other Assets, Noncurrent",
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and other assets expected to be realized or consumed after one year or normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/IncomeTaxesScheduleofIncomeTaxProvisionDetail": {
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesScheduleofIncomeTaxProvisionDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State and local",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1460",
      "r1613",
      "r1614"
     ]
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Gross deferred tax assets",
        "label": "Deferred Tax Assets, Gross",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r902"
     ]
    },
    "us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsInProcessResearchAndDevelopment",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred Tax Assets, in Process Research and Development",
        "label": "Deferred Tax Assets, in Process Research and Development",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination."
       }
      }
     },
     "auth_ref": [
      "r166",
      "r1612"
     ]
    },
    "iff_DeferredTaxAssetsInterestLimitations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DeferredTaxAssetsInterestLimitations",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest limitation",
        "label": "Deferred Tax Assets, Interest Limitations",
        "documentation": "Deferred Tax Assets, Interest Limitations"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsInventory": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsInventory",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventory",
        "label": "Deferred Tax Assets, Inventory",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory."
       }
      }
     },
     "auth_ref": [
      "r166",
      "r1612"
     ]
    },
    "iff_DeferredTaxAssetsLeaseObligations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DeferredTaxAssetsLeaseObligations",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred Tax Asset Lease Obligations",
        "label": "Deferred Tax Assets, Lease Obligations",
        "documentation": "Deferred Tax Assets, Lease Obligations"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax asset",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r166",
      "r1612"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsForeign",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/ScheduleIIValuationandQualifyingAccountsandReservesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to foreign net operating loss carryforwards",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Foreign",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r166",
      "r1612"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsOther",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other, net",
        "label": "Deferred Tax Assets, Other",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other."
       }
      }
     },
     "auth_ref": [
      "r166",
      "r1612"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee and retiree benefits",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Postretirement Benefits",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from postretirement benefits."
       }
      }
     },
     "auth_ref": [
      "r1612"
     ]
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.iff.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Valuation allowance",
        "negatedLabel": "Valuation allowance",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r903"
     ]
    },
    "us-gaap_DeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Total net deferred tax liabilities",
        "label": "Deferred Tax Liabilities, Net",
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r162",
      "r1611"
     ]
    },
    "iff_DeferredTaxLiabilitiesDeemedRepatriation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DeferredTaxLiabilitiesDeemedRepatriation",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.iff.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred Tax Liabilities, Deemed Repatriation",
        "negatedTerseLabel": "Deferred taxes on deemed repatriation",
        "label": "Deferred Tax Liabilities, Deemed Repatriation",
        "documentation": "Deferred Tax Liabilities, Deemed Repatriation"
       }
      }
     },
     "auth_ref": []
    },
    "iff_DeferredTaxLiabilitiesGainLossOnForeignCurrencyTranslation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DeferredTaxLiabilitiesGainLossOnForeignCurrencyTranslation",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Loss on foreign currency translation",
        "label": "Deferred Tax Liabilities, Gain (Loss) On Foreign Currency Translation",
        "documentation": "Deferred Tax Liabilities, Gain (Loss) On Foreign Currency Translation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Intangible assets(1)",
        "label": "Deferred Tax Liabilities, Intangible Assets",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill."
       }
      }
     },
     "auth_ref": [
      "r166",
      "r1612"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilitiesInvestments",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Deferred Tax Liabilities, Investments",
        "label": "Deferred Tax Liabilities, Investments",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from investments (excludes investments in subsidiaries and equity method investments)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Property, plant and equipment, net",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment."
       }
      }
     },
     "auth_ref": [
      "r166",
      "r1612"
     ]
    },
    "iff_DeferredTaxLiabilitiesRightOfUseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DeferredTaxLiabilitiesRightOfUseAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Deferred Tax Liabilities, Right of Use Assets",
        "label": "Deferred Tax Liabilities, Right-of-Use Assets",
        "documentation": "Deferred Tax Liabilities, Right-of-Use Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanAccumulatedBenefitObligation",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsAccumulatedBenefitObligationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Benefit Obligation \u2014 end of year",
        "label": "Defined Benefit Plan, Accumulated Benefit Obligation",
        "documentation": "Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level."
       }
      }
     },
     "auth_ref": [
      "r792"
     ]
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total AOCI (before tax effects)",
        "label": "Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax",
        "documentation": "Amount, before tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit)."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r80",
      "r1560"
     ]
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetail": {
       "parentTag": "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Net actuarial (gain) loss",
        "label": "Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax",
        "documentation": "Amount, before tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r804"
     ]
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetail": {
       "parentTag": "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prior service cost (credit)",
        "label": "Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, Prior Service Cost (Credit), before Tax",
        "documentation": "Amount, before tax, of accumulated other comprehensive (income) loss for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit)."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r804"
     ]
    },
    "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanActualReturnOnPlanAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Actual return on plan assets",
        "label": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)",
        "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses."
       }
      }
     },
     "auth_ref": [
      "r774",
      "r1295"
     ]
    },
    "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsReconciliationofLevel3NonUSPlanAssetsHeldDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Actual return on plan assets",
        "label": "Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Actual Return (Loss) on Plan Assets Still Held",
        "documentation": "Amount, measured using unobservable inputs, of increase (decrease) in plan assets of defined benefit plan from actual return (loss) on assets still held."
       }
      }
     },
     "auth_ref": [
      "r788",
      "r1295"
     ]
    },
    "us-gaap_DefinedBenefitPlanActuarialGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanActuarialGainLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Actuarial (gain) loss",
        "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)",
        "documentation": "Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan."
       }
      }
     },
     "auth_ref": [
      "r767"
     ]
    },
    "iff_DefinedBenefitPlanAdjustmentsForExpenseOrTaxContainedInServiceCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DefinedBenefitPlanAdjustmentsForExpenseOrTaxContainedInServiceCost",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Adjustments for expense/tax contained in service cost",
        "label": "Defined Benefit Plan Adjustments For Expense Or Tax Contained In Service Cost",
        "documentation": "Defined benefit plan, adjustments for expense or tax contained in service cost"
       }
      }
     },
     "auth_ref": []
    },
    "iff_DefinedBenefitPlanAmortizationAndDeferralsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DefinedBenefitPlanAmortizationAndDeferralsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail": {
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostandChangesinPlanAssetsandBenefitObligationsRecognizedinOCIDetail",
      "http://www.iff.com/role/EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net amortization and deferrals",
        "label": "Defined Benefit Plan Amortization And Deferrals Net",
        "documentation": "Defined benefit plan amortization and deferrals, net."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinBalanceSheetDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinBalanceSheetDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net amount recognized",
        "label": "Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position",
        "documentation": "Amount of asset (liability), recognized in statement of financial position, for defined benefit pension and other postretirement plans."
       }
      }
     },
     "auth_ref": [
      "r143",
      "r144"
     ]
    },
    "us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostandChangesinPlanAssetsandBenefitObligationsRecognizedinOCIDetail",
      "http://www.iff.com/role/EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Net actuarial loss (gain)",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), after Reclassification Adjustment, before Tax",
        "documentation": "Amount, before tax, after reclassification adjustment, of increase (decrease) in accumulated other comprehensive income from gain (loss) of defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r260",
      "r305"
     ]
    },
    "us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostandChangesinPlanAssetsandBenefitObligationsRecognizedinOCIDetail",
      "http://www.iff.com/role/EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prior service cost",
        "verboseLabel": "Recognized prior service credit",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Reclassification Adjustment, before Tax",
        "documentation": "Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income from prior service cost (credit) of defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r260",
      "r305"
     ]
    },
    "iff_DefinedBenefitPlanAssetsCategoryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DefinedBenefitPlanAssetsCategoryMember",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail",
      "http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail",
      "http://www.iff.com/role/EmployeeBenefitsPercentageofAssetsInvestedDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Benefit Plan, Assets Category",
        "label": "Defined Benefit Plan, Assets Category [Member]",
        "documentation": "Defined Benefit Plan, Assets Category"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinBalanceSheetDetail": {
       "parentTag": "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherAssetsDetail": {
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails",
      "http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinBalanceSheetDetail",
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "netLabel": "Net defined benefit plan assets",
        "verboseLabel": "Overfunded pension plans",
        "terseLabel": "Other assets",
        "label": "Assets for Plan Benefits, Defined Benefit Plan",
        "documentation": "Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans."
       }
      }
     },
     "auth_ref": [
      "r334",
      "r758",
      "r759",
      "r782",
      "r1178",
      "r1295",
      "r1641"
     ]
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsAccumulatedBenefitObligationDetail",
      "http://www.iff.com/role/EmployeeBenefitsWeightedAverageAssumptionsUsedtoDeterminePostretirementBenefitExpenseandObligationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discount rate",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate",
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r806"
     ]
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsAccumulatedBenefitObligationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rate of compensation increase",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase",
        "documentation": "Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r807"
     ]
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsWeightedAverageActuarialAssumptionUsedtoDetermineExpenseDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discount rate",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate",
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r806"
     ]
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsWeightedAverageActuarialAssumptionUsedtoDetermineExpenseDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected return on plan assets",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate of Return on Plan Assets",
        "documentation": "Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r808",
      "r830"
     ]
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsWeightedAverageActuarialAssumptionUsedtoDetermineExpenseDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rate of compensation increase",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase",
        "documentation": "Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r807"
     ]
    },
    "us-gaap_DefinedBenefitPlanBenefitObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanBenefitObligation",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail": {
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Benefit obligation at beginning of year",
        "periodEndLabel": "Benefit obligation at end of year",
        "label": "Defined Benefit Plan, Benefit Obligation",
        "documentation": "Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r762"
     ]
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaid",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Benefits paid",
        "label": "Defined Benefit Plan, Benefit Obligation, Benefits Paid",
        "documentation": "Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services."
       }
      }
     },
     "auth_ref": [
      "r769",
      "r833"
     ]
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan participants\u2019 contributions",
        "label": "Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant",
        "documentation": "Amount of contributions received by defined benefit plan from participant which increase benefit obligation."
       }
      }
     },
     "auth_ref": [
      "r766"
     ]
    },
    "iff_DefinedBenefitPlanBenefitObligationOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DefinedBenefitPlanBenefitObligationOther",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Defined Benefit Plan, Benefit Obligation, Other",
        "documentation": "Defined Benefit Plan, Benefit Obligation, Other"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquisitions/Transferred Liabilities",
        "label": "Defined Benefit Plan, Benefit Obligation, Business Combination",
        "documentation": "Amount of increase in benefit obligation of defined benefit plan from business combination."
       }
      }
     },
     "auth_ref": [
      "r771"
     ]
    },
    "us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquisitions/Transferred Assets",
        "label": "Defined Benefit Plan, Plan Assets, Business Combination",
        "documentation": "Amount of increase in plan assets of defined benefit plan from business combination."
       }
      }
     },
     "auth_ref": [
      "r779"
     ]
    },
    "us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanByPlanAssetCategoriesAxis",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail",
      "http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail",
      "http://www.iff.com/role/EmployeeBenefitsPercentageofAssetsInvestedDetail",
      "http://www.iff.com/role/EmployeeBenefitsReconciliationofLevel3NonUSPlanAssetsHeldDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Axis]",
        "label": "Defined Benefit Plan, Plan Assets, Category [Axis]",
        "documentation": "Information by defined benefit plan asset investment."
       }
      }
     },
     "auth_ref": [
      "r783",
      "r784",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r811",
      "r1293",
      "r1294",
      "r1295"
     ]
    },
    "us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanChangeInBenefitObligationRollForward",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]",
        "label": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail",
      "http://www.iff.com/role/EmployeeBenefitsReconciliationofLevel3NonUSPlanAssetsHeldDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]",
        "label": "Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail",
      "http://www.iff.com/role/EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contribution to the plans",
        "verboseLabel": "Employer contributions",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets."
       }
      }
     },
     "auth_ref": [
      "r776",
      "r786",
      "r829",
      "r1293",
      "r1294",
      "r1295",
      "r1296"
     ]
    },
    "iff_DefinedBenefitPlanCurrentMedicalCareCostTrendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DefinedBenefitPlanCurrentMedicalCareCostTrendRate",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsWeightedAverageAssumptionsUsedtoDeterminePostretirementBenefitExpenseandObligationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current medical cost trend rate",
        "label": "Defined Benefit Plan Current Medical Care Cost Trend Rate",
        "documentation": "The current medical cost trend rate utilized to determine postretirement benefit expense."
       }
      }
     },
     "auth_ref": []
    },
    "iff_DefinedBenefitPlanCurtailmentsAndSettlementsBenefitObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DefinedBenefitPlanCurtailmentsAndSettlementsBenefitObligation",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Curtailments/settlements",
        "label": "Defined Benefit Plan Curtailments And Settlements Benefit Obligation",
        "documentation": "Defined Benefit Plan, Curtailments And Settlements, Benefit Obligation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsAccumulatedBenefitObligationDetail",
      "http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail",
      "http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetail",
      "http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinBalanceSheetDetail",
      "http://www.iff.com/role/EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail",
      "http://www.iff.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostandChangesinPlanAssetsandBenefitObligationsRecognizedinOCIDetail",
      "http://www.iff.com/role/EmployeeBenefitsEstimatedFutureBenefitPaymentsDetail",
      "http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail",
      "http://www.iff.com/role/EmployeeBenefitsPercentageofAssetsInvestedDetail",
      "http://www.iff.com/role/EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail",
      "http://www.iff.com/role/EmployeeBenefitsReconciliationofLevel3NonUSPlanAssetsHeldDetail",
      "http://www.iff.com/role/EmployeeBenefitsSensitivityofDisclosurestoChangesinSelectedAssumptionsDetail",
      "http://www.iff.com/role/EmployeeBenefitsWeightedAverageActuarialAssumptionUsedtoDetermineExpenseDetail",
      "http://www.iff.com/role/EmployeeBenefitsWeightedAverageAssumptionsUsedtoDeterminePostretirementBenefitExpenseandObligationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInAccumulatedBenefitObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInAccumulatedBenefitObligation",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsSensitivityofDisclosurestoChangesinSelectedAssumptionsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "25 BP decrease in discount rate, change in ABO",
        "label": "Defined Benefit Plan Effect Of Twenty Five Base Point Decrease In Discount Rate In Accumulated Benefit Obligation",
        "documentation": "Defined benefit plan, effect of twenty five base point decrease in discount rate in accumulated benefit obligation"
       }
      }
     },
     "auth_ref": []
    },
    "iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInPensionExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInPensionExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsSensitivityofDisclosurestoChangesinSelectedAssumptionsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "25 BP decrease in discount rate, change in pension expense",
        "label": "Defined Benefit Plan Effect Of Twenty Five Base Point Decrease In Discount Rate In Pension Expense",
        "documentation": "Defined benefit plan, effect of twenty five base point decrease in discount rate in pension expense"
       }
      }
     },
     "auth_ref": []
    },
    "iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInProjectedBenefitObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInDiscountRateInProjectedBenefitObligation",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsSensitivityofDisclosurestoChangesinSelectedAssumptionsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "25 BP decrease in discount rate, change in ABO",
        "label": "Defined Benefit Plan Effect Of Twenty Five Base Point Decrease In Discount Rate In Projected Benefit Obligation",
        "documentation": "Defined benefit plan, effect of twenty five base point decrease in discount rate in projected benefit obligation"
       }
      }
     },
     "auth_ref": []
    },
    "iff_DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInLongTermRateOfReturnInPensionExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DefinedBenefitPlanEffectOfTwentyFiveBasePointDecreaseInLongTermRateOfReturnInPensionExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsSensitivityofDisclosurestoChangesinSelectedAssumptionsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "25 BP decrease in long-term rate of return, change in pension expense",
        "label": "Defined Benefit Plan Effect Of Twenty Five Base Point Decrease In Long Term Rate Of Return In Pension Expense",
        "documentation": "Defined benefit plan, effect of twenty five base point decrease in long term rate of return in pension expense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanEquitySecuritiesLargeCapMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanEquitySecuritiesLargeCapMember",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-U.S. Large Cap",
        "label": "Defined Benefit Plan, Equity Securities, Large Cap [Member]",
        "documentation": "Security representing ownership in corporation or other legal entity, classified as having large market capitalization, for which ownership is represented by share of stock; in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant."
       }
      }
     },
     "auth_ref": [
      "r1542"
     ]
    },
    "us-gaap_DefinedBenefitPlanEquitySecuritiesMidCapMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanEquitySecuritiesMidCapMember",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-U.S. Mid Cap",
        "label": "Defined Benefit Plan, Equity Securities, Mid Cap [Member]",
        "documentation": "Security representing ownership in corporation or other legal entity, classified as having medium market capitalization, for which ownership is represented by share of stock; in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant."
       }
      }
     },
     "auth_ref": [
      "r1542"
     ]
    },
    "us-gaap_DefinedBenefitPlanEquitySecuritiesSmallCapMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanEquitySecuritiesSmallCapMember",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-U.S. Small Cap",
        "label": "Defined Benefit Plan, Equity Securities, Small Cap [Member]",
        "documentation": "Security representing ownership in corporation or other legal entity, classified as having small market capitalization, for which ownership is represented by share of stock; in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant."
       }
      }
     },
     "auth_ref": [
      "r1542"
     ]
    },
    "us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanEquitySecuritiesUsLargeCapMember",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "U.S. Large Cap",
        "label": "Defined Benefit Plan, Equity Securities, US, Large Cap [Member]",
        "documentation": "Security representing ownership in corporation or other legal entity, domiciled in United States of America (US), classified as having large market capitalization, for which ownership is represented by share of stock; in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant."
       }
      }
     },
     "auth_ref": [
      "r1295",
      "r1542"
     ]
    },
    "us-gaap_DefinedBenefitPlanEquitySecuritiesUsMidCapMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanEquitySecuritiesUsMidCapMember",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "U.S. Mid Cap",
        "label": "Defined Benefit Plan, Equity Securities, US, Mid Cap [Member]",
        "documentation": "Security representing ownership in corporation or other legal entity, domiciled in United States of America (US), classified as having medium market capitalization, for which ownership is represented by share of stock; in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant."
       }
      }
     },
     "auth_ref": [
      "r1542"
     ]
    },
    "us-gaap_DefinedBenefitPlanEquitySecuritiesUsSmallCapMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanEquitySecuritiesUsSmallCapMember",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "U.S. Small Cap",
        "label": "Defined Benefit Plan, Equity Securities, US, Small Cap [Member]",
        "documentation": "Security representing ownership in corporation or other legal entity, domiciled in United States of America (US), classified as having small market capitalization, for which ownership is represented by share of stock; in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant."
       }
      }
     },
     "auth_ref": [
      "r1542"
     ]
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsEstimatedFutureBenefitPaymentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2029 - 2033",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years",
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r793"
     ]
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsEstimatedFutureBenefitPaymentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year One",
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r793"
     ]
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsEstimatedFutureBenefitPaymentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Five",
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r793"
     ]
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsEstimatedFutureBenefitPaymentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Four",
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r793"
     ]
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsEstimatedFutureBenefitPaymentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Three",
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r793"
     ]
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsEstimatedFutureBenefitPaymentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Two",
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r793"
     ]
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsEstimatedFutureBenefitPaymentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Required Company Contributions in the Following Year (2024)",
        "label": "Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year",
        "documentation": "Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r794",
      "r1296"
     ]
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail": {
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Expected return on plan assets",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r761",
      "r798",
      "r824",
      "r1295",
      "r1296"
     ]
    },
    "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanFairValueOfPlanAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail": {
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail",
      "http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail",
      "http://www.iff.com/role/EmployeeBenefitsReconciliationofLevel3NonUSPlanAssetsHeldDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Fair value of plan assets at beginning of year",
        "periodEndLabel": "Fair value of plan assets at end of year",
        "terseLabel": "Fair value of plan assets",
        "label": "Defined Benefit Plan, Plan Assets, Amount",
        "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee."
       }
      }
     },
     "auth_ref": [
      "r773",
      "r784",
      "r786",
      "r787",
      "r1293",
      "r1294",
      "r1295"
     ]
    },
    "us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Translation adjustments",
        "label": "Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)",
        "documentation": "Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r768"
     ]
    },
    "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanFundedStatusOfPlan",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Funded status at end of year",
        "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan",
        "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status."
       }
      }
     },
     "auth_ref": [
      "r758",
      "r782",
      "r1295"
     ]
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanInterestCost",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail": {
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail",
      "http://www.iff.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostandChangesinPlanAssetsandBenefitObligationsRecognizedinOCIDetail",
      "http://www.iff.com/role/EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest cost on projected benefit obligation",
        "label": "Defined Benefit Plan, Interest Cost",
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r761",
      "r765",
      "r797",
      "r823",
      "r1295",
      "r1296"
     ]
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail": {
       "parentTag": "us-gaap_PensionAndOtherPostretirementBenefitExpense",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.iff.com/role/OtherExpenseIncomeNetDetails": {
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostandChangesinPlanAssetsandBenefitObligationsRecognizedinOCIDetail",
      "http://www.iff.com/role/EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail",
      "http://www.iff.com/role/OtherExpenseIncomeNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net periodic benefit (income) cost",
        "negatedTerseLabel": "Pension-related benefit",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r795",
      "r821",
      "r1295",
      "r1296"
     ]
    },
    "us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsAccumulatedBenefitObligationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets",
        "label": "Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets",
        "documentation": "Amount of plan asset for defined benefit pension plan with projected benefit obligation in excess of plan assets."
       }
      }
     },
     "auth_ref": [
      "r818",
      "r1295"
     ]
    },
    "us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsAccumulatedBenefitObligationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation",
        "label": "Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation",
        "documentation": "Amount of projected benefit obligation for defined benefit pension plan with projected benefit obligation in excess of plan assets."
       }
      }
     },
     "auth_ref": [
      "r818",
      "r1295"
     ]
    },
    "us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsAccumulatedBenefitObligationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated benefit obligation",
        "label": "Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Accumulated Benefit Obligation",
        "documentation": "Amount of accumulated benefit obligation for defined benefit plan with accumulated benefit obligation in excess of plan assets."
       }
      }
     },
     "auth_ref": [
      "r818",
      "r819",
      "r1295"
     ]
    },
    "us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsAccumulatedBenefitObligationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of plan assets",
        "label": "Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Plan Assets",
        "documentation": "Amount of plan asset for defined benefit plan with accumulated benefit obligation in excess of plan assets."
       }
      }
     },
     "auth_ref": [
      "r818",
      "r819",
      "r1295"
     ]
    },
    "us-gaap_DefinedBenefitPlanPlanAmendments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanPlanAmendments",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan amendments",
        "label": "Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Plan Amendment",
        "documentation": "Amount of increase (decrease) in benefit obligation of defined benefit plan from change in terms of existing plan or initiation of new plan."
       }
      }
     },
     "auth_ref": [
      "r770"
     ]
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanPlanAssetsBenefitsPaid",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Benefits paid",
        "label": "Defined Benefit Plan, Plan Assets, Benefits Paid",
        "documentation": "Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services."
       }
      }
     },
     "auth_ref": [
      "r778",
      "r1580"
     ]
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan participants\u2019 contributions",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Plan Participant",
        "documentation": "Amount of contributions received by defined benefit plan from participant which increases plan assets."
       }
      }
     },
     "auth_ref": [
      "r777"
     ]
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Translation adjustments",
        "label": "Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)",
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r775"
     ]
    },
    "iff_DefinedBenefitPlanPlanAssetsOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DefinedBenefitPlanPlanAssetsOther",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Defined Benefit Plan, Plan Assets, Other",
        "documentation": "Defined Benefit Plan, Plan Assets, Other"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanPlanAssetsTargetAllocationPercentage",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Target percentage of investment in equity securities",
        "label": "Defined Benefit Plan, Plan Assets, Target Allocation, Percentage",
        "documentation": "Percentage of target investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan."
       }
      }
     },
     "auth_ref": [
      "r783",
      "r1295"
     ]
    },
    "us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanPurchasesSalesAndSettlements",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsReconciliationofLevel3NonUSPlanAssetsHeldDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchases, sales and settlements",
        "label": "Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Purchase, Sale, and Settlement",
        "documentation": "Amount, measured using unobservable input, of increase (decrease) in plan asset of defined benefit plan from purchase, sale and settlement of trade associated with underlying investment."
       }
      }
     },
     "auth_ref": [
      "r789",
      "r1295"
     ]
    },
    "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Settlements",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement",
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement."
       }
      }
     },
     "auth_ref": [
      "r760",
      "r802",
      "r828"
     ]
    },
    "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail": {
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Settlements and curtailments",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment",
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from settlement and curtailment."
       }
      }
     },
     "auth_ref": [
      "r1518",
      "r1558",
      "r1577"
     ]
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanServiceCost",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail": {
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail",
      "http://www.iff.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostandChangesinPlanAssetsandBenefitObligationsRecognizedinOCIDetail",
      "http://www.iff.com/role/EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Service cost for benefits earned",
        "label": "Defined Benefit Plan, Service Cost",
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r763",
      "r796",
      "r822",
      "r1295",
      "r1296"
     ]
    },
    "us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanUltimateHealthCareCostTrendRate1",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsWeightedAverageAssumptionsUsedtoDeterminePostretirementBenefitExpenseandObligationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ultimate medical cost trend rate",
        "label": "Defined Benefit Plan, Ultimate Health Care Cost Trend Rate",
        "documentation": "Ultimate trend rate for health care cost for defined benefit postretirement plan."
       }
      }
     },
     "auth_ref": [
      "r810"
     ]
    },
    "us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanWeightedAverageAssetAllocations",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsPercentageofAssetsInvestedDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of assets invested",
        "label": "Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage",
        "documentation": "Percentage of actual investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan."
       }
      }
     },
     "auth_ref": [
      "r1541"
     ]
    },
    "iff_DefinedContributionAndOtherRetirementPlans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DefinedContributionAndOtherRetirementPlans",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail": {
       "parentTag": "us-gaap_PensionAndOtherPostretirementBenefitExpense",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined contribution and other retirement plans",
        "label": "Defined Contribution And Other Retirement Plans",
        "documentation": "Defined contribution and other retirement plans expense."
       }
      }
     },
     "auth_ref": []
    },
    "iff_DefinedContributionPlanMatchingParticipantContributionAveragePercentageOnCompensation": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DefinedContributionPlanMatchingParticipantContributionAveragePercentageOnCompensation",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Matching participant's contribution, average percentage on compensation",
        "label": "Defined Contribution Plan Matching Participant Contribution Average Percentage On Compensation",
        "documentation": "Defined contribution plan, matching participant contribution, average percentage on compensation"
       }
      }
     },
     "auth_ref": []
    },
    "iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRange": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRange",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Matching participant's contribution, percentage on compensation",
        "label": "Defined Contribution Plan Matching Participant Contribution Percentage On Compensation Range",
        "documentation": "Defined contribution plan matching participant contribution percentage on compensation range"
       }
      }
     },
     "auth_ref": []
    },
    "iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRangeHigh": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRangeHigh",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Matching participant's contribution, percentage on compensation, range high",
        "label": "Defined Contribution Plan Matching Participant Contribution Percentage On Compensation Range High",
        "documentation": "Defined contribution plan, matching participant contribution, percentage on compensation, range high"
       }
      }
     },
     "auth_ref": []
    },
    "iff_DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRangeLow": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRangeLow",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Matching participant's contribution, percentage on compensation, range low",
        "label": "Defined Contribution Plan Matching Participant Contribution Percentage On Compensation Range Low",
        "documentation": "Defined contribution plan, matching participant contribution, percentage on compensation, range low"
       }
      }
     },
     "auth_ref": []
    },
    "iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBelowLowRange": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBelowLowRange",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of matching contribution if compensation percentage below low range",
        "label": "Defined Contribution Plan Percentage Of Matching Contribution If Compensation Percentage Below Low Range",
        "documentation": "Defined contribution plan, percentage of matching contribution if compensation percentage below low range"
       }
      }
     },
     "auth_ref": []
    },
    "iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBetweenHighRangeAndLowRange": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBetweenHighRangeAndLowRange",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of matching contribution if compensation percentage between high range and low range",
        "label": "Defined Contribution Plan Percentage Of Matching Contribution If Compensation Percentage Between High Range And Low Range",
        "documentation": "Defined contribution plan, percentage of matching contribution if compensation percentage between high range and low range"
       }
      }
     },
     "auth_ref": []
    },
    "iff_DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageReachesAverageRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageReachesAverageRate",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of employees eligible to accrue benefits under the defined plan",
        "label": "Defined Contribution Plan Percentage Of Matching Contribution If Compensation Percentage Reaches Average Rate",
        "documentation": "Defined contribution plan, percentage of matching contribution if compensation percentage reaches average rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Depreciation",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation expense",
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r118"
     ]
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DepreciationDepletionAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS",
      "http://www.iff.com/role/SegmentInformationCapitalExpenditureandDepreciationandAmortizationbySegmentDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization",
        "label": "Depreciation, Depletion and Amortization",
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r538"
     ]
    },
    "us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsCarryingAmountandEstimatedFairValueofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Asset, Statement of Financial Position [Extensible Enumeration]",
        "label": "Derivative Asset, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes derivative asset."
       }
      }
     },
     "auth_ref": [
      "r940"
     ]
    },
    "us-gaap_DerivativeAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsCarryingAmountandEstimatedFairValueofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative assets(3)",
        "label": "Derivative Asset",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r439",
      "r440",
      "r977",
      "r1146",
      "r1147",
      "r1148",
      "r1149",
      "r1150",
      "r1152",
      "r1153",
      "r1154",
      "r1155",
      "r1156",
      "r1171",
      "r1172",
      "r1220",
      "r1223",
      "r1224",
      "r1225",
      "r1226",
      "r1227",
      "r1265",
      "r1315",
      "r1649"
     ]
    },
    "us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeAssetsLiabilitiesAtFairValueNet",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative assets (liabilities), at fair value, net",
        "label": "Derivative Assets (Liabilities), at Fair Value, Net",
        "documentation": "Fair values as of the balance sheet date of the net amount of all assets and liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments."
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeContractTypeDomain",
     "presentation": [
      "http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossReclassificationsofAccumulatedOtherComprehensiveIncometoConsolidatedStatementofComprehensiveIncomeDetail",
      "http://www.iff.com/role/FinancialInstrumentsAdditionalInformationDetail",
      "http://www.iff.com/role/FinancialInstrumentsCarryingAmountandEstimatedFairValueofFinancialInstrumentsDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowandNetInvestmentHedgingInstrumentsDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsMeasuredatFairValueDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsNotionalAmountOutstandingDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsWhichWereNotDesignatedasHedgingInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Contract Type [Domain]",
        "label": "Derivative Contract [Domain]",
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset."
       }
      }
     },
     "auth_ref": [
      "r1154",
      "r1156",
      "r1170",
      "r1171",
      "r1172",
      "r1174",
      "r1175",
      "r1176",
      "r1177",
      "r1180",
      "r1181",
      "r1182",
      "r1183",
      "r1195",
      "r1196",
      "r1197",
      "r1198",
      "r1201",
      "r1202",
      "r1203",
      "r1204",
      "r1220",
      "r1221",
      "r1224",
      "r1226",
      "r1313",
      "r1315"
     ]
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsAdditionalInformationDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowandNetInvestmentHedgingInstrumentsDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsMeasuredatFairValueDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Fair Value, Derivative Assets",
        "verboseLabel": "Total fair value, derivative assets",
        "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset",
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r193",
      "r259",
      "r438",
      "r1265"
     ]
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsAdditionalInformationDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsMeasuredatFairValueDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Fair Value, Derivative Liabilities",
        "verboseLabel": "Derivative liability, fair value, gross liability",
        "label": "Derivative Liability, Subject to Master Netting Arrangement, before Offset",
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r193",
      "r259",
      "r438",
      "r1265"
     ]
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeGainLossOnDerivativeNet",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsAdditionalInformationDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsWhichWereNotDesignatedasHedgingInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amount of gain or (loss) on derivative",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement."
       }
      }
     },
     "auth_ref": [
      "r1618"
     ]
    },
    "us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsWhichWereNotDesignatedasHedgingInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "label": "Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of income or comprehensive income that includes gain (loss) from derivative."
       }
      }
     },
     "auth_ref": [
      "r1618"
     ]
    },
    "us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowandNetInvestmentHedgingInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "label": "Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of income or comprehensive income that includes gain (loss) from effective portion of derivative instrument reclassified from accumulated other comprehensive income (AOCI) into income."
       }
      }
     },
     "auth_ref": [
      "r941"
     ]
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeInstrumentRiskAxis",
     "presentation": [
      "http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossReclassificationsofAccumulatedOtherComprehensiveIncometoConsolidatedStatementofComprehensiveIncomeDetail",
      "http://www.iff.com/role/FinancialInstrumentsAdditionalInformationDetail",
      "http://www.iff.com/role/FinancialInstrumentsCarryingAmountandEstimatedFairValueofFinancialInstrumentsDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowandNetInvestmentHedgingInstrumentsDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsMeasuredatFairValueDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsNotionalAmountOutstandingDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsWhichWereNotDesignatedasHedgingInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instrument Risk [Axis]",
        "label": "Derivative Instrument [Axis]",
        "documentation": "Information by type of derivative contract."
       }
      }
     },
     "auth_ref": [
      "r191",
      "r194",
      "r196",
      "r200",
      "r1154",
      "r1156",
      "r1170",
      "r1171",
      "r1172",
      "r1174",
      "r1175",
      "r1176",
      "r1177",
      "r1180",
      "r1181",
      "r1182",
      "r1183",
      "r1195",
      "r1196",
      "r1197",
      "r1198",
      "r1201",
      "r1202",
      "r1203",
      "r1204",
      "r1220",
      "r1221",
      "r1224",
      "r1226",
      "r1265",
      "r1313",
      "r1315"
     ]
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsAdditionalInformationDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowandNetInvestmentHedgingInstrumentsDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsNotionalAmountOutstandingDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Relationship [Axis]",
        "label": "Hedging Relationship [Axis]",
        "documentation": "Information by type of hedging relationship."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r191",
      "r196"
     ]
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowandNetInvestmentHedgingInstrumentsDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsWhichWereNotDesignatedasHedgingInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table]",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r191",
      "r196",
      "r200",
      "r202",
      "r203",
      "r942"
     ]
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowandNetInvestmentHedgingInstrumentsDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsWhichWereNotDesignatedasHedgingInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r942"
     ]
    },
    "us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowandNetInvestmentHedgingInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)",
        "label": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net",
        "documentation": "The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r198"
     ]
    },
    "us-gaap_DerivativeLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsCarryingAmountandEstimatedFairValueofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative liabilities(3)",
        "label": "Derivative Liability",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r439",
      "r440",
      "r977",
      "r1146",
      "r1147",
      "r1148",
      "r1149",
      "r1152",
      "r1153",
      "r1154",
      "r1155",
      "r1156",
      "r1180",
      "r1182",
      "r1183",
      "r1221",
      "r1222",
      "r1223",
      "r1224",
      "r1225",
      "r1226",
      "r1227",
      "r1265",
      "r1649"
     ]
    },
    "us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsCarryingAmountandEstimatedFairValueofFinancialInstrumentsDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsMeasuredatFairValueDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Liability, Statement of Financial Position [Extensible Enumeration]",
        "label": "Derivative Liability, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes derivative liability."
       }
      }
     },
     "auth_ref": [
      "r940"
     ]
    },
    "us-gaap_DerivativeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeMember",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Financial Instruments",
        "label": "Derivative [Member]",
        "documentation": "This element represents types of derivative financial instruments which are financial instruments or other contractual arrangements with all three of the following characteristics: (a) it has (1) one or more underlyings and (2) one or more notional amounts or payment provisions or both. Those terms determine the amount of the settlement or settlements, and, in some cases, whether or not a settlement is required; (b) it requires no initial net investment or an initial net investment that is smaller than would be required for other types of contracts that would be expected to have a similar response to changes in market factors; and (c) its terms require or permit net settlement, it can readily be settled net by a means outside the contract, or it provides for delivery of an asset that puts the recipient in a position not substantially different from net settlement. Notwithstanding the above characteristics, loan commitments that relate to the origination of mortgage loans that will be held for sale are accounted for as derivative instruments by the issuer of the loan commitment (that is, the potential lender)."
       }
      }
     },
     "auth_ref": [
      "r328"
     ]
    },
    "us-gaap_DerivativeNetHedgeIneffectivenessGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeNetHedgeIneffectivenessGainLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative, net hedge ineffectiveness gain (loss)",
        "label": "Derivative, Net Hedge Ineffectiveness Gain (Loss)",
        "documentation": "Amount of gain (loss) from the ineffectiveness of the hedge."
       }
      }
     },
     "auth_ref": [
      "r329",
      "r330"
     ]
    },
    "us-gaap_DerivativeNotionalAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeNotionalAmount",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsAdditionalInformationDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsNotionalAmountOutstandingDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative instruments outstanding",
        "label": "Derivative, Notional Amount",
        "documentation": "Nominal or face amount used to calculate payment on derivative."
       }
      }
     },
     "auth_ref": [
      "r1616",
      "r1617"
     ]
    },
    "iff_DerivativeNotionalAmountNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DerivativeNotionalAmountNet",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsNotionalAmountOutstandingDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative instruments outstanding, net",
        "label": "Derivative, Notional Amount, Net",
        "documentation": "Derivative, Notional Amount, Net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativesFairValueLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativesFairValueLineItems",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsAdditionalInformationDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsMeasuredatFairValueDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivatives, Fair Value [Line Items]",
        "label": "Derivatives, Fair Value [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DesignatedAsHedgingInstrumentMember",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsAdditionalInformationDetail",
      "http://www.iff.com/role/FinancialInstrumentsCarryingAmountandEstimatedFairValueofFinancialInstrumentsDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowandNetInvestmentHedgingInstrumentsDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsMeasuredatFairValueDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Designated as Hedging Instrument",
        "verboseLabel": "Fair Value of Derivatives Designated as Hedging Instrument [Member]",
        "label": "Designated as Hedging Instrument [Member]",
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "iff_DifferenceAmountBetweenBasicAndDilutedNetIncomePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DifferenceAmountBetweenBasicAndDilutedNetIncomePerShare",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.iff.com/role/NetIncomePerShareAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Difference amount between basic and diluted net income per share (in dollars per share)",
        "label": "Difference Amount Between Basic And Diluted Net Income Per Share",
        "documentation": "Difference amount between basic and diluted net income per share."
       }
      }
     },
     "auth_ref": []
    },
    "iff_DifferenceAmountBetweenBasicNetIncomeLossPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DifferenceAmountBetweenBasicNetIncomeLossPerShare",
     "presentation": [
      "http://www.iff.com/role/NetIncomePerShareAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Difference Amount Between Basic Net Income (Loss) Per Share",
        "label": "Difference Amount Between Basic Net Income (Loss) Per Share",
        "documentation": "Difference Amount Between Basic Net Income (Loss) Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "iff_DifferenceAmountBetweenDilutedNetIncomeLossPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DifferenceAmountBetweenDilutedNetIncomeLossPerShare",
     "presentation": [
      "http://www.iff.com/role/NetIncomePerShareAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Difference Amount Between Diluted Net Income (Loss) Per Share",
        "label": "Difference Amount Between Diluted Net Income (Loss) Per Share",
        "documentation": "Difference Amount Between Diluted Net Income (Loss) Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "iff_DilutiveSharesQuotientMultiplier": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DilutiveSharesQuotientMultiplier",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dilutive Shares Quotient Multiplier",
        "label": "Dilutive Shares Quotient Multiplier",
        "documentation": "Dilutive Shares Quotient Multiplier"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlans"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Compensation Plans",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r840",
      "r845",
      "r873",
      "r874",
      "r876",
      "r1304"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement [Abstract]",
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/BusinessDivestitureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax",
        "label": "Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax",
        "documentation": "Amount before tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r226",
      "r227",
      "r228"
     ]
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupClassificationAxis",
     "presentation": [
      "http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleDetails",
      "http://www.iff.com/role/BusinessDivestitureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposal Group Classification [Axis]",
        "label": "Disposal Group Classification [Axis]",
        "documentation": "Information by disposal group classification."
       }
      }
     },
     "auth_ref": [
      "r412"
     ]
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupClassificationDomain",
     "presentation": [
      "http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleDetails",
      "http://www.iff.com/role/BusinessDivestitureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposal Group Classification [Domain]",
        "label": "Disposal Group Classification [Domain]",
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember",
     "presentation": [
      "http://www.iff.com/role/BusinessDivestitureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations",
        "label": "Disposal Group, Held-for-Sale or Disposed of by Sale, Not Discontinued Operations [Member]",
        "documentation": "Disposal group that either has been sold or is classified as held-for-sale. Excludes disposals classified as discontinued operations."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r27",
      "r48"
     ]
    },
    "us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupHeldforsaleNotDiscontinuedOperationsMember",
     "presentation": [
      "http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposal Group, Held-for-sale, Not Discontinued Operations",
        "label": "Disposal Group, Held-for-Sale, Not Discontinued Operations [Member]",
        "documentation": "Disposal group that is classified as held-for-sale. Excludes disposals classified as discontinued operations."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r48",
      "r412"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsPayable",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleDetails": {
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleDetails",
      "http://www.iff.com/role/BusinessDivestitureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Disposal Group, Including Discontinued Operation, Accounts Payable",
        "documentation": "Amount classified as accounts payable attributable to disposal group held for sale or disposed of."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r225",
      "r234",
      "r291"
     ]
    },
    "iff_DisposalGroupIncludingDiscontinuedOperationAdvanceReceiptForBusinessToBeTransferred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DisposalGroupIncludingDiscontinuedOperationAdvanceReceiptForBusinessToBeTransferred",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/BusinessDivestitureDetails": {
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/BusinessDivestitureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Advance receipt for business to be transferred",
        "label": "Disposal Group, Including Discontinued Operation, Advance Receipt For Business To Be Transferred",
        "documentation": "Disposal Group, Including Discontinued Operation, Advance Receipt For Business To Be Transferred"
       }
      }
     },
     "auth_ref": []
    },
    "iff_DisposalGroupIncludingDiscontinuedOperationAmountHeldInEscrow": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DisposalGroupIncludingDiscontinuedOperationAmountHeldInEscrow",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/BusinessDivestitureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amount held in escrow",
        "label": "Disposal Group, Including Discontinued Operation, Amount Held In Escrow",
        "documentation": "Disposal Group, Including Discontinued Operation, Amount Held In Escrow"
       }
      }
     },
     "auth_ref": []
    },
    "iff_DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNetAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNetAsset",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/BusinessDivestitureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Carrying value of net asset",
        "label": "Disposal Group, Including Discontinued Operation, Carrying Value Of Net Asset",
        "documentation": "Disposal Group, Including Discontinued Operation, Carrying Value Of Net Asset"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleDetails": {
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleDetails",
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents",
        "documentation": "Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r225",
      "r234",
      "r291"
     ]
    },
    "iff_DisposalGroupIncludingDiscontinuedOperationCashTransferredToBuyer": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DisposalGroupIncludingDiscontinuedOperationCashTransferredToBuyer",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/BusinessDivestitureDetails": {
       "parentTag": "iff_ProceedsFromDivestitureOfBusinessNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/BusinessDivestitureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash transferred to buyer",
        "label": "Disposal Group, Including Discontinued Operation, Cash (Transferred To) Buyer",
        "documentation": "Disposal Group, Including Discontinued Operation, Cash (Transferred To) Buyer"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/BusinessDivestitureDetails": {
       "parentTag": "iff_ProceedsFromDivestitureOfBusinessNet",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/BusinessDivestitureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Disposal Group, Including Discontinued Operation, Consideration",
        "label": "Disposal Group, Including Discontinued Operation, Consideration",
        "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation."
       }
      }
     },
     "auth_ref": []
    },
    "iff_DisposalGroupIncludingDiscontinuedOperationConsiderationAdvanceReceiptForBusinessToBeTransferred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsiderationAdvanceReceiptForBusinessToBeTransferred",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/BusinessDivestitureDetails": {
       "parentTag": "iff_ProceedsFromDivestitureOfBusinessNet",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/BusinessDivestitureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Advance receipt for business to be transferred",
        "label": "Disposal Group, Including Discontinued Operation, Consideration, Advance Receipt For Business To Be Transferred",
        "documentation": "Disposal Group, Including Discontinued Operation, Consideration, Advance Receipt For Business To Be Transferred"
       }
      }
     },
     "auth_ref": []
    },
    "iff_DisposalGroupIncludingDiscontinuedOperationConsiderationPayableReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsiderationPayableReceivable",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/BusinessDivestitureDetails": {
       "parentTag": "iff_ProceedsFromDivestitureOfBusinessNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/BusinessDivestitureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Receivable from the buyer",
        "label": "Disposal Group, Including Discontinued Operation, Consideration Payable (Receivable)",
        "documentation": "Disposal Group, Including Discontinued Operation, Consideration Payable (Receivable)"
       }
      }
     },
     "auth_ref": []
    },
    "iff_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/BusinessDivestitureDetails": {
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/BusinessDivestitureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consideration receivable",
        "label": "Disposal Group, Including Discontinued Operation, Consideration Receivable",
        "documentation": "Disposal Group, Including Discontinued Operation, Consideration Receivable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleDetails": {
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax liability",
        "label": "Disposal Group, Including Discontinued Operation, Deferred Tax Liabilities",
        "documentation": "Amount classified as deferred tax liabilities attributable to disposal group held for sale or disposed of."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r225",
      "r234",
      "r291"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationGoodwill1",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleDetails": {
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill",
        "label": "Disposal Group, Including Discontinued Operation, Goodwill",
        "documentation": "Amount classified as goodwill attributable to disposal group held for sale or disposed of."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r225",
      "r234",
      "r291"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationIntangibleAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleDetails": {
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other intangible assets, net",
        "label": "Disposal Group, Including Discontinued Operation, Intangible Assets",
        "documentation": "Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r225",
      "r234",
      "r291"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationInventory1",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleDetails": {
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventories",
        "label": "Disposal Group, Including Discontinued Operation, Inventory",
        "documentation": "Amount classified as inventory attributable to disposal group held for sale or disposed of."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r225",
      "r234",
      "r291"
     ]
    },
    "iff_DisposalGroupIncludingDiscontinuedOperationNetAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DisposalGroupIncludingDiscontinuedOperationNetAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/BusinessDivestitureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposal Group, Including Discontinued Operation, Net Assets",
        "label": "Disposal Group, Including Discontinued Operation, Net Assets",
        "documentation": "Disposal Group, Including Discontinued Operation, Net Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleDetails": {
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleDetails",
      "http://www.iff.com/role/BusinessDivestitureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other assets",
        "label": "Disposal Group, Including Discontinued Operation, Other Assets",
        "documentation": "Amount classified as other assets attributable to disposal group held for sale or disposed of."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r225",
      "r234",
      "r291"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleDetails": {
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleDetails",
      "http://www.iff.com/role/BusinessDivestitureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other liabilities",
        "label": "Disposal Group, Including Discontinued Operation, Other Liabilities",
        "documentation": "Amount classified as other liabilities attributable to disposal group held for sale or disposed of."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r225",
      "r234",
      "r291"
     ]
    },
    "iff_DisposalGroupIncludingDiscontinuedOperationPostClosingAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DisposalGroupIncludingDiscontinuedOperationPostClosingAdjustments",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/BusinessDivestitureDetails": {
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/BusinessDivestitureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Post-closing adjustments",
        "label": "Disposal Group, Including Discontinued Operation, Post-Closing Adjustments",
        "documentation": "Disposal Group, Including Discontinued Operation, Post-Closing Adjustments"
       }
      }
     },
     "auth_ref": []
    },
    "iff_DisposalGroupIncludingDiscontinuedOperationProceedsAttributableToSupplyAgreement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DisposalGroupIncludingDiscontinuedOperationProceedsAttributableToSupplyAgreement",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/BusinessDivestitureDetails": {
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/BusinessDivestitureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Proceeds attributable to supply agreement",
        "label": "Disposal Group, Including Discontinued Operation, Proceeds Attributable To Supply Agreement",
        "documentation": "Disposal Group, Including Discontinued Operation, Proceeds Attributable To Supply Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleDetails": {
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, plant and equipment, net",
        "label": "Disposal Group, Including Discontinued Operation, Property, Plant and Equipment",
        "documentation": "Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r225",
      "r234",
      "r291"
     ]
    },
    "iff_DisposalGroupIncludingDiscontinuedOperationTradeReceivablesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DisposalGroupIncludingDiscontinuedOperationTradeReceivablesNet",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleDetails": {
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade receivables, net",
        "label": "Disposal Group, Including Discontinued Operation, Trade Receivables, Net",
        "documentation": "Disposal Group, Including Discontinued Operation, Trade Receivables, Net"
       }
      }
     },
     "auth_ref": []
    },
    "iff_DisposalGroupIncludingDiscontinuedOperationTransactionCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DisposalGroupIncludingDiscontinuedOperationTransactionCost",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/BusinessDivestitureDetails": {
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/BusinessDivestitureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Direct costs to sell",
        "label": "Disposal Group, Including Discontinued Operation, Transaction Cost",
        "documentation": "Disposal Group, Including Discontinued Operation, Transaction Cost"
       }
      }
     },
     "auth_ref": []
    },
    "iff_DisposalGroupIncludingDiscontinuedOperationTransactionCostCredits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DisposalGroupIncludingDiscontinuedOperationTransactionCostCredits",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/BusinessDivestitureDetails": {
       "parentTag": "iff_ProceedsFromDivestitureOfBusinessNet",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/BusinessDivestitureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Transaction costs",
        "label": "Disposal Group, Including Discontinued Operation, Transaction (Cost) Credits",
        "documentation": "Disposal Group, Including Discontinued Operation, Transaction (Cost) Credits"
       }
      }
     },
     "auth_ref": []
    },
    "iff_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalBeforeIncomeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DisposalGroupNotDiscontinuedOperationGainLossOnDisposalBeforeIncomeTax",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/BusinessDivestitureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gain (loss) on disposal, before income tax",
        "label": "Disposal Group, Not Discontinued Operation, Gain (Loss) On Disposal, Before Income Tax",
        "documentation": "Disposal Group, Not Discontinued Operation, Gain (Loss) On Disposal, Before Income Tax"
       }
      }
     },
     "auth_ref": []
    },
    "iff_DisposalGroupNotDiscontinuedOperationGainLossOnLiquidationBeforeIncomeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DisposalGroupNotDiscontinuedOperationGainLossOnLiquidationBeforeIncomeTax",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/BusinessDivestitureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Gain (loss) on liquidation, before taxes",
        "label": "Disposal Group, Not Discontinued Operation, Gain (Loss) On Liquidation, Before Income Tax",
        "documentation": "Disposal Group, Not Discontinued Operation, Gain (Loss) On Liquidation, Before Income Tax"
       }
      }
     },
     "auth_ref": []
    },
    "iff_DisposalGroupNotDiscontinuedOperationLiquidationTaxEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DisposalGroupNotDiscontinuedOperationLiquidationTaxEffect",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/BusinessDivestitureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liquidation tax effect",
        "label": "Disposal Group, Not Discontinued Operation, Liquidation Tax Effect",
        "documentation": "Disposal Group, Not Discontinued Operation, Liquidation Tax Effect"
       }
      }
     },
     "auth_ref": []
    },
    "iff_DisposalGroupNotDiscontinuedOperationTaxEffectOfGainLossFromDivestiture": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DisposalGroupNotDiscontinuedOperationTaxEffectOfGainLossFromDivestiture",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/BusinessDivestitureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax effect of gain (loss) on divestiture",
        "label": "Disposal Group, Not Discontinued Operation, Tax Effect Of Gain (Loss) From Divestiture",
        "documentation": "Disposal Group, Not Discontinued Operation, Tax Effect Of Gain (Loss) From Divestiture"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "presentation": [
      "http://www.iff.com/role/AssetsandLiabilitiesHeldForSale",
      "http://www.iff.com/role/BusinessDivestiture"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Divestiture",
        "verboseLabel": "Assets and Liabilities Held For Sale",
        "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]",
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component."
       }
      }
     },
     "auth_ref": [
      "r224",
      "r287"
     ]
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "presentation": [
      "http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleDetails",
      "http://www.iff.com/role/BusinessDivestitureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposal Group Name [Domain]",
        "label": "Disposal Group Name [Domain]",
        "documentation": "Name of disposal group."
       }
      }
     },
     "auth_ref": [
      "r1297",
      "r1300"
     ]
    },
    "us-gaap_DividendsCommonStockCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DividendsCommonStockCash",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cash dividends declared",
        "label": "Dividends, Common Stock, Cash",
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash."
       }
      }
     },
     "auth_ref": [
      "r301"
     ]
    },
    "us-gaap_DividendsPayableAmountPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DividendsPayableAmountPerShare",
     "presentation": [
      "http://www.iff.com/role/ShareholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividend per share declared (in dollars per share)",
        "label": "Dividends Payable, Amount Per Share",
        "documentation": "The per share amount of a dividend declared, but not paid, as of the financial reporting date."
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "us-gaap_DividendsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DividendsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET",
      "http://www.iff.com/role/ShareholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends payable",
        "label": "Dividends Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://www.iff.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Annual Report",
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r1333",
      "r1334",
      "r1347"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://www.iff.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Financial Statement Error Correction [Flag]",
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r1333",
      "r1334",
      "r1347",
      "r1383"
     ]
    },
    "dei_DocumentFinStmtRestatementRecoveryAnalysisFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFinStmtRestatementRecoveryAnalysisFlag",
     "presentation": [
      "http://www.iff.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Financial Statement Restatement Recovery Analysis [Flag]",
        "label": "Document Financial Statement Restatement Recovery Analysis [Flag]",
        "documentation": "Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to \u00a7240.10D-1(b)."
       }
      }
     },
     "auth_ref": [
      "r1333",
      "r1334",
      "r1347",
      "r1383"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.iff.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.iff.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://www.iff.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Table]",
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.iff.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.iff.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r1368"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.iff.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://www.iff.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Documents Incorporated by Reference",
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r1331"
     ]
    },
    "us-gaap_DomesticCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DomesticCountryMember",
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Domestic Tax Authority [Member]",
        "label": "Domestic Tax Authority [Member]",
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DomesticPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DomesticPlanMember",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsAccumulatedBenefitObligationDetail",
      "http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail",
      "http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetail",
      "http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinBalanceSheetDetail",
      "http://www.iff.com/role/EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail",
      "http://www.iff.com/role/EmployeeBenefitsEstimatedFutureBenefitPaymentsDetail",
      "http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail",
      "http://www.iff.com/role/EmployeeBenefitsPercentageofAssetsInvestedDetail",
      "http://www.iff.com/role/EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail",
      "http://www.iff.com/role/EmployeeBenefitsSensitivityofDisclosurestoChangesinSelectedAssumptionsDetail",
      "http://www.iff.com/role/EmployeeBenefitsWeightedAverageActuarialAssumptionUsedtoDetermineExpenseDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Domestic Plan",
        "label": "Domestic Plan [Member]",
        "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans."
       }
      }
     },
     "auth_ref": [
      "r1581",
      "r1582",
      "r1583"
     ]
    },
    "iff_DuPontdeNemoursIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "DuPontdeNemoursIncMember",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails",
      "http://www.iff.com/role/NetIncomePerShareAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "DuPont de Nemours, Inc [Member]",
        "label": "DuPont de Nemours, Inc [Member]",
        "documentation": "DuPont de Nemours, Inc [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "country_EG": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "EG",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EGYPT",
        "label": "EGYPT"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EMEAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EMEAMember",
     "presentation": [
      "http://www.iff.com/role/RestructuringandOtherChargesAdditionalInformationDetails",
      "http://www.iff.com/role/SegmentInformationNetSalesbyGeographicAreaDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EMEA",
        "verboseLabel": "Europe, Africa and Middle East [Member]",
        "label": "EMEA [Member]",
        "documentation": "Regions of Europe, Middle East and Africa."
       }
      }
     },
     "auth_ref": [
      "r1654",
      "r1656",
      "r1657",
      "r1658"
     ]
    },
    "iff_EachTwelveMonthPeriodMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "EachTwelveMonthPeriodMember",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Each twelve-month period [Member]",
        "label": "Each Twelve Month Period [Member]",
        "documentation": "Each Twelve Month Period [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_EarnOutsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "EarnOutsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/AcquisitionsHealthWrightProductsDetails",
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Earn Outs Payable, Current",
        "label": "Earn Outs Payable, Current",
        "documentation": "Earn Outs Payable, Current"
       }
      }
     },
     "auth_ref": []
    },
    "iff_EarnOutsPayableOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "EarnOutsPayableOther",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsHealthWrightProductsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Earn Outs Payable, Current",
        "label": "Earn Outs Payable, Other",
        "documentation": "Earn Outs Payable, Other"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME",
      "http://www.iff.com/role/NetIncomePerShareReconciliationofSharesUsedinComputationofBasicandDilutedNetIncomePerShareDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net income per share - basic (in dollars per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r461",
      "r497",
      "r498",
      "r500",
      "r501",
      "r503",
      "r509",
      "r512",
      "r519",
      "r520",
      "r521",
      "r525",
      "r966",
      "r967",
      "r1073",
      "r1096",
      "r1269"
     ]
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareBasicAbstract",
     "presentation": [
      "http://www.iff.com/role/NetIncomePerShareReconciliationofSharesUsedinComputationofBasicandDilutedNetIncomePerShareDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net income per share - basic (in dollars per share)",
        "label": "Earnings Per Share, Basic [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME",
      "http://www.iff.com/role/NetIncomePerShareReconciliationofSharesUsedinComputationofBasicandDilutedNetIncomePerShareDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net income per share - diluted (in dollars per share)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r461",
      "r497",
      "r498",
      "r500",
      "r501",
      "r503",
      "r512",
      "r519",
      "r520",
      "r521",
      "r525",
      "r966",
      "r967",
      "r1073",
      "r1096",
      "r1269"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Income (Loss) Per Share",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r97"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://www.iff.com/role/NetIncomePerShare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Income Per Share",
        "label": "Earnings Per Share [Text Block]",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r508",
      "r522",
      "r523",
      "r524"
     ]
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of exchange rate changes on cash, cash equivalents and restricted cash",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r988"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "calculation": {
      "http://www.iff.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxRateDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxRateDetails",
      "http://www.iff.com/role/IncomeTaxesScheduleofReconciliationbetweenUSFederalStatutoryIncomeTaxRatetoActualEffectiveTaxRateDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Effective tax rate",
        "terseLabel": "Effective tax rate",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r890"
     ]
    },
    "iff_EffectiveIncomeTaxRateReconciliationAcquisitionCostsPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "EffectiveIncomeTaxRateReconciliationAcquisitionCostsPercent",
     "calculation": {
      "http://www.iff.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquisition costs",
        "label": "Effective Income Tax Rate Reconciliation, Acquisition Costs, Percent",
        "documentation": "Effective Income Tax Rate Reconciliation, Acquisition Costs, Percent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "calculation": {
      "http://www.iff.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.iff.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxRateDetails",
      "http://www.iff.com/role/IncomeTaxesScheduleofReconciliationbetweenUSFederalStatutoryIncomeTaxRatetoActualEffectiveTaxRateDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Statutory tax rate",
        "terseLabel": "Statutory tax rate",
        "netLabel": "U.S. federal tax rate",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)."
       }
      }
     },
     "auth_ref": [
      "r477",
      "r890",
      "r917"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "calculation": {
      "http://www.iff.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxRateDetails",
      "http://www.iff.com/role/IncomeTaxesScheduleofReconciliationbetweenUSFederalStatutoryIncomeTaxRatetoActualEffectiveTaxRateDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Establishment (release) of valuation allowance on state deferred",
        "terseLabel": "Release of valuation allowance on state deferred",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r1610",
      "r1615"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsDividends": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationDeductionsDividends",
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividend deduction percentage",
        "label": "Effective Income Tax Rate Reconciliation, Deduction, Dividend, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to deduction for dividend."
       }
      }
     },
     "auth_ref": [
      "r1610",
      "r1615"
     ]
    },
    "iff_EffectiveIncomeTaxRateReconciliationDeferredTaxesonDeemedRepatriationPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "EffectiveIncomeTaxRateReconciliationDeferredTaxesonDeemedRepatriationPercent",
     "calculation": {
      "http://www.iff.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred taxes on deemed repatriation(2)",
        "label": "Effective Income Tax Rate Reconciliation, Deferred Taxes on Deemed Repatriation, Percent",
        "documentation": "Effective Income Tax Rate Reconciliation, Deferred Taxes on Deemed Repatriation, Percent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationDispositionOfBusiness",
     "calculation": {
      "http://www.iff.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax impact on business divestitures",
        "label": "Effective Income Tax Rate Reconciliation, Disposition of Business, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to disposition of a business not qualifying as a discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r1610",
      "r1615"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationFdiiAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationFdiiAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign derived intangible income expense",
        "label": "Effective Income Tax Rate Reconciliation, FDII, Amount",
        "documentation": "Amount of reported income tax benefit from difference to expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to foreign-derived intangible income (FDII)."
       }
      }
     },
     "auth_ref": [
      "r1610"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationFdiiPercent",
     "calculation": {
      "http://www.iff.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign-derived intangible income",
        "label": "Effective Income Tax Rate Reconciliation, FDII, Percent",
        "documentation": "Percentage of reported income tax benefit from difference to income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to foreign-derived intangible income (FDII)."
       }
      }
     },
     "auth_ref": [
      "r1610"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationGiltiAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Global intangible low-taxed income expense",
        "label": "Effective Income Tax Rate Reconciliation, GILTI, Amount",
        "documentation": "Amount of reported income tax expense from difference to expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to global intangible low-taxed income (GILTI)."
       }
      }
     },
     "auth_ref": [
      "r1610"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationGiltiPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationGiltiPercent",
     "calculation": {
      "http://www.iff.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Global intangible low-taxed income",
        "label": "Effective Income Tax Rate Reconciliation, GILTI, Percent",
        "documentation": "Percentage of reported income tax expense from difference to expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to global intangible low-taxed income (GILTI)."
       }
      }
     },
     "auth_ref": [
      "r1610"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses",
     "calculation": {
      "http://www.iff.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to impairment loss."
       }
      }
     },
     "auth_ref": [
      "r1610",
      "r1615"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "calculation": {
      "http://www.iff.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxRateDetails",
      "http://www.iff.com/role/IncomeTaxesScheduleofReconciliationbetweenUSFederalStatutoryIncomeTaxRatetoActualEffectiveTaxRateDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other, net",
        "terseLabel": "Other, net",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments."
       }
      }
     },
     "auth_ref": [
      "r1610",
      "r1615"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings",
     "calculation": {
      "http://www.iff.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Difference in effective tax rate on foreign earnings and remittances(1)",
        "label": "Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to the repatriation of foreign earnings."
       }
      }
     },
     "auth_ref": [
      "r1610",
      "r1615"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "calculation": {
      "http://www.iff.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxRateDetails",
      "http://www.iff.com/role/IncomeTaxesScheduleofReconciliationbetweenUSFederalStatutoryIncomeTaxRatetoActualEffectiveTaxRateDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "State and local taxes including rate changes(3)",
        "terseLabel": "State and local taxes",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r1610",
      "r1615"
     ]
    },
    "iff_EffectiveIncomeTaxRateReconciliationTaxBenefitFromSupplyChainOptimizationPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "EffectiveIncomeTaxRateReconciliationTaxBenefitFromSupplyChainOptimizationPercent",
     "calculation": {
      "http://www.iff.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax benefit from supply chain optimization",
        "label": "Effective Income Tax Rate Reconciliation, Tax Benefit From Supply Chain Optimization, Percent",
        "documentation": "Effective Income Tax Rate Reconciliation, Tax Benefit From Supply Chain Optimization, Percent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsForeign",
     "calculation": {
      "http://www.iff.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "U.S. foreign tax credit - general limitation",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign tax credit."
       }
      }
     },
     "auth_ref": [
      "r1610",
      "r1615"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsResearch",
     "calculation": {
      "http://www.iff.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Research and development credit",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit."
       }
      }
     },
     "auth_ref": [
      "r1610",
      "r1615"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationTaxExemptIncome",
     "calculation": {
      "http://www.iff.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized tax benefit, net of reversals",
        "label": "Effective Income Tax Rate Reconciliation, Tax Exempt Income, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income (loss) exempt from income taxes."
       }
      }
     },
     "auth_ref": [
      "r1610",
      "r1615"
     ]
    },
    "iff_EffectiveIncomeTaxRateReconciliationTaxImpactOnInternalAssetTransferPercent": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "EffectiveIncomeTaxRateReconciliationTaxImpactOnInternalAssetTransferPercent",
     "calculation": {
      "http://www.iff.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax impact on internal asset transfer",
        "label": "Effective Income Tax Rate Reconciliation, Tax Impact On Internal Asset Transfer, Percent",
        "documentation": "Effective Income Tax Rate Reconciliation, Tax Impact On Internal Asset Transfer, Percent"
       }
      }
     },
     "auth_ref": []
    },
    "iff_EmergingMarketsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "EmergingMarketsMember",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Emerging Markets",
        "label": "Emerging Markets [Member]",
        "documentation": "Emerging Markets [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_EmployeeReimbursementReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "EmployeeReimbursementReceivable",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/BusinessDivestitureDetails": {
       "parentTag": "iff_ProceedsFromDivestitureOfBusinessNet",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/BusinessDivestitureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Reimbursement Receivable",
        "label": "Employee Reimbursement Receivable",
        "documentation": "Employee Reimbursement Receivable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued payroll and bonus",
        "label": "Employee-related Liabilities, Current",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansLiabilityAwardsAdditionalInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansPurchasedRestrictedStockPlanAdditionalInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansRestrictedStockUnitsPlanAdditionalInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized compensation cost related to non-vested stock options and SSAR, RSU, PRS and Cash RSU awards granted",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r875"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansLiabilityAwardsAdditionalInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansPurchasedRestrictedStockPlanAdditionalInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansRestrictedStockUnitsPlanAdditionalInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized compensation cost related to non-vested stock options and SSAR, RSU, PRS and Cash RSU awards granted, weighted average period, in years",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r875"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/StockCompensationPlansStockBasedCompensationExpenseIncludedinConsolidatedStatementofIncomeandComprehensiveIncomeDetail": {
       "parentTag": "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansStockBasedCompensationExpenseIncludedinConsolidatedStatementofIncomeandComprehensiveIncomeDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less tax benefit",
        "label": "Share-Based Payment Arrangement, Expense, Tax Benefit",
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r872"
     ]
    },
    "us-gaap_EmployeeSeveranceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeSeveranceMember",
     "presentation": [
      "http://www.iff.com/role/RestructuringandOtherChargesAdditionalInformationDetails",
      "http://www.iff.com/role/RestructuringandOtherChargesMovementsinRestructuringandRelatedAccrualsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Severance",
        "label": "Employee Severance [Member]",
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan."
       }
      }
     },
     "auth_ref": []
    },
    "iff_EmployeeStockOptionAndRestrictedStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "EmployeeStockOptionAndRestrictedStockMember",
     "presentation": [
      "http://www.iff.com/role/NetIncomePerShareReconciliationofSharesUsedinComputationofBasicandDilutedNetIncomePerShareDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Stock Option And Restricted Stock [Member]",
        "label": "Employee Stock Option And Restricted Stock [Member]",
        "documentation": "Employee Stock Option And Restricted Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement, Option",
        "label": "Employee Stock Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.iff.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.iff.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.iff.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.iff.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://www.iff.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Addresses, Address Type [Axis]",
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.iff.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1330"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.iff.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.iff.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityDomain",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails",
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail",
      "http://www.iff.com/role/DebtAdditionalInformationCommercialPaperandRedemptionProvisionsDetail",
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail",
      "http://www.iff.com/role/NetIncomePerShareAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity [Domain]",
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.iff.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1330"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.iff.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.iff.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r1330"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.iff.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInformationLineItems",
     "presentation": [
      "http://www.iff.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Information [Line Items]",
        "label": "Entity Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.iff.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r1408"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Public Float",
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.iff.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1330"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.iff.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r1330"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.iff.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Small Business",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r1330"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.iff.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1330"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://www.iff.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Voluntary Filers",
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://www.iff.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Well-known Seasoned Issuer",
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r1409"
     ]
    },
    "iff_EntityWideRevenueMajorCustomerNumberOfCustomers": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "EntityWideRevenueMajorCustomerNumberOfCustomers",
     "presentation": [
      "http://www.iff.com/role/ConcentrationsOfCreditRiskAdditionalInformationDetail",
      "http://www.iff.com/role/SegmentInformationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of customers that accounted for more than 10% of consolidated net sales",
        "label": "Entity Wide Revenue Major Customer Number Of Customers",
        "documentation": "Number of customers whose net sales accounted for more than 10% of consolidated net sales."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EnvironmentalExpenseAndLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EnvironmentalExpenseAndLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Environmental expense and liabilities",
        "label": "Environmental Expense and Liabilities",
        "documentation": "The adjustment to exclude the noncash portion of, and include cash payments for environmental costs when calculating operating cash flows under the indirect method. The adjustment can include the increase (decrease) during an accounting period in total estimated obligations recorded for probable future loss attributable to environmental contamination issues."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity [Abstract]",
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_EquityBasedAwardsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "EquityBasedAwardsMember",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansStockBasedCompensationExpenseIncludedinConsolidatedStatementofIncomeandComprehensiveIncomeDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity-based awards [Member]",
        "label": "Equity Based Awards [Member]",
        "documentation": "Equity-based awards [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossReclassificationsofAccumulatedOtherComprehensiveIncometoConsolidatedStatementofComprehensiveIncomeDetail",
      "http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossDetail",
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowandNetInvestmentHedgingInstrumentsDetail",
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.iff.com/role/RedeemableNoncontrollingInterestsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component [Domain]",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r408",
      "r453",
      "r454",
      "r455",
      "r489",
      "r490",
      "r491",
      "r494",
      "r504",
      "r506",
      "r526",
      "r606",
      "r612",
      "r754",
      "r877",
      "r878",
      "r879",
      "r910",
      "r911",
      "r947",
      "r949",
      "r950",
      "r951",
      "r952",
      "r954",
      "r965",
      "r989",
      "r991",
      "r992",
      "r993",
      "r994",
      "r995",
      "r1028",
      "r1112",
      "r1113",
      "r1114",
      "r1134",
      "r1208"
     ]
    },
    "us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityIssuedInBusinessCombinationFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Issued in Business Combination, Fair Value Disclosure",
        "label": "Equity Issued in Business Combination, Fair Value Disclosure",
        "documentation": "Fair value of equity issued in a business combination."
       }
      }
     },
     "auth_ref": [
      "r206"
     ]
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "EquityMethodInvesteeNameDomain",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail",
      "http://www.iff.com/role/RedeemableNoncontrollingInterestsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment, Name [Domain]",
        "label": "Investment, Name [Domain]",
        "documentation": "Name of investment including named security. Excludes entity that is consolidated."
       }
      }
     },
     "auth_ref": [
      "r598",
      "r599",
      "r600"
     ]
    },
    "us-gaap_EquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestments",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherAssetsDetail": {
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/BusinessDivestitureDetails",
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Method Investments",
        "label": "Equity Method Investments",
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized."
       }
      }
     },
     "auth_ref": [
      "r543",
      "r597",
      "r1443",
      "r1486"
     ]
    },
    "us-gaap_EquitySecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquitySecuritiesMember",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail",
      "http://www.iff.com/role/EmployeeBenefitsPercentageofAssetsInvestedDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equities",
        "label": "Equity Securities [Member]",
        "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r1323",
      "r1324",
      "r1325",
      "r1655"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Valuation Assumption Difference, Footnote",
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1376"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneous Compensation Analysis",
        "label": "Erroneous Compensation Analysis [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1339",
      "r1351",
      "r1361",
      "r1387"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneously Awarded Compensation Recovery",
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r1336",
      "r1348",
      "r1358",
      "r1384"
     ]
    },
    "us-gaap_EscrowDeposit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EscrowDeposit",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/BusinessDivestitureDetails": {
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/BusinessDivestitureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Escrow Deposit",
        "label": "Escrow Deposit",
        "documentation": "The designation of funds furnished by a borrower to a lender to assure future payments of the borrower's real estate taxes and insurance obligations with respect to a mortgaged property. Escrow deposits may be made for a variety of other purposes such as earnest money and contingent payments. This element excludes replacement reserves which are an escrow separately provided for within the US GAAP taxonomy."
       }
      }
     },
     "auth_ref": [
      "r217",
      "r1241"
     ]
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsCarryingAmountandEstimatedFairValueofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value [Member]",
        "label": "Estimate of Fair Value Measurement [Member]",
        "documentation": "Measured as an estimate of fair value."
       }
      }
     },
     "auth_ref": [
      "r724",
      "r977",
      "r1286",
      "r1287"
     ]
    },
    "iff_EstimatedIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "EstimatedIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimated Income Tax Expense (Benefit)",
        "label": "Estimated Income Tax Expense (Benefit)",
        "documentation": "Estimated Income Tax Expense (Benefit)"
       }
      }
     },
     "auth_ref": []
    },
    "iff_EuroInterbankOfferedRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "EuroInterbankOfferedRateMember",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationRevolvingCreditFacilityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Euro Interbank Offered Rate",
        "label": "Euro Interbank Offered Rate [Member]",
        "documentation": "Euro Interbank Offered Rate"
       }
      }
     },
     "auth_ref": []
    },
    "iff_EuroSeniorNotes2016Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "EuroSeniorNotes2016Member",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowandNetInvestmentHedgingInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Euro Senior Notes 2016 [Member]",
        "label": "Euro Senior Notes 2016 [Member]",
        "documentation": "Euro Senior Notes 2016 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_EurocurrencyRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "EurocurrencyRateMember",
     "presentation": [
      "http://www.iff.com/role/DebtComponentsofDebtDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Eurocurrency Rate",
        "label": "Eurocurrency Rate [Member]",
        "documentation": "Eurocurrency Rate"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Executive Category:",
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1382"
     ]
    },
    "iff_ExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "ExpenseMember",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsWeightedAverageAssumptionsUsedtoDeterminePostretirementBenefitExpenseandObligationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expense",
        "label": "Expense [Member]",
        "documentation": "Expense [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "country_FI": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "FI",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationSegmentInformationScheduleofLongLivedAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "FINLAND",
        "label": "FINLAND"
       }
      }
     },
     "auth_ref": []
    },
    "country_FR": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "FR",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationSegmentInformationScheduleofLongLivedAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "FRANCE",
        "label": "FRANCE"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "presentation": [
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetNarrativeDetails",
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.iff.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset Class [Domain]",
        "label": "Asset Class [Domain]",
        "documentation": "Class of asset."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsCarryingAmountandEstimatedFairValueofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByAssetClassAxis",
     "presentation": [
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetNarrativeDetails",
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.iff.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset Class [Axis]",
        "label": "Asset Class [Axis]",
        "documentation": "Information by class of asset."
       }
      }
     },
     "auth_ref": [
      "r206",
      "r207"
     ]
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByBalanceSheetGroupingTable",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsCarryingAmountandEstimatedFairValueofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities."
       }
      }
     },
     "auth_ref": [
      "r206",
      "r208",
      "r209"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail",
      "http://www.iff.com/role/EmployeeBenefitsReconciliationofLevel3NonUSPlanAssetsHeldDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r724",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r971",
      "r1034",
      "r1035",
      "r1036",
      "r1286",
      "r1287",
      "r1293",
      "r1294",
      "r1295"
     ]
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByLiabilityClassAxis",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsCarryingAmountandEstimatedFairValueofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liability Class [Axis]",
        "label": "Liability Class [Axis]",
        "documentation": "Information by class of liability."
       }
      }
     },
     "auth_ref": [
      "r207",
      "r331"
     ]
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByMeasurementBasisAxis",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsCarryingAmountandEstimatedFairValueofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Basis [Axis]",
        "label": "Measurement Basis [Axis]",
        "documentation": "Information by measurement basis."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r206",
      "r724",
      "r1286",
      "r1287"
     ]
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueDisclosureItemAmountsDomain",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsCarryingAmountandEstimatedFairValueofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurement [Domain]",
        "label": "Fair Value Measurement [Domain]",
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value."
       }
      }
     },
     "auth_ref": [
      "r724",
      "r1286",
      "r1287"
     ]
    },
    "us-gaap_FairValueInputsLevel12And3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel12And3Member",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail",
      "http://www.iff.com/role/EmployeeBenefitsReconciliationofLevel3NonUSPlanAssetsHeldDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Inputs, Level 1, 2 and 3",
        "label": "Fair Value, Inputs, Level 1, Level 2, and Level 3 [Member]",
        "documentation": "Fair value measurement input including quoted price in active market for identical asset or liability reporting entity can access at measurement date (level 1), input other than quoted price included within level 1 either directly or indirectly observable for asset or liability (level 2) and unobservable input reflecting entity's own assumption (level 3)."
       }
      }
     },
     "auth_ref": [
      "r1543"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 1",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r724",
      "r786",
      "r791",
      "r971",
      "r1034",
      "r1293",
      "r1294",
      "r1295"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 2",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r724",
      "r786",
      "r791",
      "r971",
      "r1035",
      "r1286",
      "r1287",
      "r1293",
      "r1294",
      "r1295"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail",
      "http://www.iff.com/role/EmployeeBenefitsReconciliationofLevel3NonUSPlanAssetsHeldDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level\u00a03",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r724",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r971",
      "r1036",
      "r1286",
      "r1287",
      "r1293",
      "r1294",
      "r1295"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsCarryingAmountandEstimatedFairValueofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value by Liability Class [Domain]",
        "label": "Fair Value by Liability Class [Domain]",
        "documentation": "Represents classes of liabilities measured and disclosed at fair value."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasuredAtNetAssetValuePerShareMember",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measured at Net Asset Value Per Share",
        "label": "Fair Value Measured at Net Asset Value Per Share [Member]",
        "documentation": "Fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r786",
      "r969",
      "r972"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail",
      "http://www.iff.com/role/EmployeeBenefitsReconciliationofLevel3NonUSPlanAssetsHeldDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Fair Value, Measurements, Fair Value Hierarchy [Domain]",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r724",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r1034",
      "r1035",
      "r1036",
      "r1286",
      "r1287",
      "r1293",
      "r1294",
      "r1295"
     ]
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instruments",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r59"
     ]
    },
    "iff_FairValueOfPlanAssetsBeforeReceivablesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "FairValueOfPlanAssetsBeforeReceivablesMember",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Of Plan Assets Before Receivables",
        "label": "Fair Value Of Plan Assets Before Receivables [Member]",
        "documentation": "Fair Value Of Plan Assets Before Receivables [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsAdditionalInformationDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsMeasuredatFairValueDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r190",
      "r192",
      "r202"
     ]
    },
    "iff_FinanceLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "FinanceLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/LeasesScheduleofLeaseExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance lease cost",
        "label": "Finance Lease, Cost",
        "documentation": "Finance Lease, Cost"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/LeasesCashFlowDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating cash flows for finance leases",
        "label": "Finance Lease, Interest Payment on Liability",
        "documentation": "Amount of interest paid on finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r1012",
      "r1019"
     ]
    },
    "us-gaap_FinanceLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails_1": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.iff.com/role/LeasesBalanceSheetDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iff.com/role/LeasesAdditionalInformationDetails",
      "http://www.iff.com/role/LeasesBalanceSheetDetails",
      "http://www.iff.com/role/LeasesDetails",
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance Lease, Liability",
        "totalLabel": "Finance Lease, Liability",
        "label": "Finance Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease."
       }
      }
     },
     "auth_ref": [
      "r1009",
      "r1023"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/LeasesBalanceSheetDetails": {
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/LeasesBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current financing lease obligation",
        "label": "Finance Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r1009"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "presentation": [
      "http://www.iff.com/role/LeasesBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]",
        "label": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes current finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r1010"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/LeasesBalanceSheetDetails": {
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/LeasesBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance Lease, Liability, Noncurrent",
        "label": "Finance Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r1009"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "presentation": [
      "http://www.iff.com/role/LeasesBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]",
        "label": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes noncurrent finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r1010"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Finance Lease, Liability, Payment, Due, Total",
        "label": "Finance Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease."
       }
      }
     },
     "auth_ref": [
      "r1023"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing lease, After 5 years",
        "label": "Finance Lease, Liability, to be Paid, after Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r1023"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing lease, less than 1 year",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r1023"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance Lease, Liability, to be Paid, Year Five",
        "label": "Finance Lease, Liability, to be Paid, Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r1023"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance Lease, Liability, to be Paid, Year Four",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r1023"
     ]
    },
    "iff_FinanceLeaseLiabilityPaymentsDueYearFourAndFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFourAndFive",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing lease, 3-5 years",
        "label": "Finance Lease, Liability, Payments, Due Year Four And Five",
        "documentation": "Finance Lease, Liability, Payments, Due Year Four And Five"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance Lease, Liability, to be Paid, Year Three",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r1023"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance Lease, Liability, to be Paid, Year Two",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r1023"
     ]
    },
    "iff_FinanceLeaseLiabilityPaymentsDueYearTwoAndThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwoAndThree",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing lease, 1-3 years",
        "label": "Finance Lease, Liability, Payments, Due Year Two And Three",
        "documentation": "Finance Lease, Liability, Payments, Due Year Two And Three"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails_1": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Less Imputed Interest",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease."
       }
      }
     },
     "auth_ref": [
      "r1023"
     ]
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeasePrincipalPayments",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/LeasesCashFlowDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing cash flows for finance leases",
        "label": "Finance Lease, Principal Payments",
        "documentation": "Amount of cash outflow for principal payment on finance lease."
       }
      }
     },
     "auth_ref": [
      "r1011",
      "r1019"
     ]
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherAssetsDetail": {
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/LeasesAdditionalInformationDetails",
      "http://www.iff.com/role/LeasesBalanceSheetDetails",
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Finance lease right-of-use assets",
        "terseLabel": "Finance Lease, Right-of-Use Asset",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease."
       }
      }
     },
     "auth_ref": [
      "r1008"
     ]
    },
    "us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "presentation": [
      "http://www.iff.com/role/LeasesBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]",
        "label": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes finance lease right-of-use asset."
       }
      }
     },
     "auth_ref": [
      "r1010"
     ]
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://www.iff.com/role/LeasesWeightedAverageDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance lease weighted average discount rate",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for finance lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r1022",
      "r1310"
     ]
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://www.iff.com/role/LeasesWeightedAverageDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance lease weighted average remaining lease term",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1021",
      "r1310"
     ]
    },
    "us-gaap_FinancialInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinancialInstrumentAxis",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instrument [Axis]",
        "label": "Financial Instrument [Axis]",
        "documentation": "Information by type of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r618",
      "r619",
      "r624",
      "r625",
      "r630",
      "r637",
      "r638",
      "r639",
      "r735",
      "r751",
      "r955",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1093",
      "r1277",
      "r1433",
      "r1434",
      "r1435",
      "r1436",
      "r1437",
      "r1438",
      "r1439",
      "r1482",
      "r1483",
      "r1484",
      "r1485"
     ]
    },
    "us-gaap_FinancialInstrumentsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinancialInstrumentsDisclosureTextBlock",
     "presentation": [
      "http://www.iff.com/role/FinancialInstruments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instruments",
        "label": "Financial Instruments Disclosure [Text Block]",
        "documentation": "The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsHealthWrightProductsDetails",
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other intangible assets amortized period, years",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetTrademarkandOtherIntangibleAssetsDetail": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetTrademarkandOtherIntangibleAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Total accumulated amortization",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r421",
      "r664"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetAmortizationExpenseDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetAmortizationExpenseDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r285"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetAmortizationExpenseDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r285"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetAmortizationExpenseDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r285"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetAmortizationExpenseDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2026",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r285"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetAmortizationExpenseDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2025",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r285"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsHealthWrightProductsDetails",
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails",
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetTrademarkandOtherIntangibleAssetsDetail",
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "documentation": "Information by major type or class of finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r660",
      "r663",
      "r664",
      "r666",
      "r1064",
      "r1068"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetTrademarkandOtherIntangibleAssetsDetail": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetTrademarkandOtherIntangibleAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross carrying value",
        "label": "Finite-Lived Intangible Assets, Gross",
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r284",
      "r1068"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "presentation": [
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetTrademarkandOtherIntangibleAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r1064"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsHealthWrightProductsDetails",
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails",
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetTrademarkandOtherIntangibleAssetsDetail",
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r115"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsMember",
     "presentation": [
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetNarrativeDetails",
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets",
        "label": "Finite-Lived Intangible Assets [Member]",
        "documentation": "Assets, excluding financial assets, that lack physical substance, having a limited useful life."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetTrademarkandOtherIntangibleAssetsDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iff.com/role/BusinessDivestitureDetails",
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET",
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetTrademarkandOtherIntangibleAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other intangible assets, net",
        "totalLabel": "Other intangible assets, net",
        "label": "Finite-Lived Intangible Assets, Net",
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r284",
      "r1064"
     ]
    },
    "us-gaap_FinitelivedIntangibleAssetsAcquired1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinitelivedIntangibleAssetsAcquired1",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-lived intangible assets",
        "label": "Finite-Lived Intangible Assets Acquired",
        "documentation": "Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition."
       }
      }
     },
     "auth_ref": [
      "r661"
     ]
    },
    "us-gaap_FiscalPeriod": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiscalPeriod",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fiscal Year End",
        "label": "Fiscal Period, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for determining an entity's fiscal year or other fiscal period. This disclosure may include identification of the fiscal period end-date, the length of the fiscal period, any reporting period lag between the entity and its subsidiaries, or equity investees. If a reporting lag exists, the closing date of the entity having a different period end is generally noted, along with an explanation of the necessity for using different closing dates. Any intervening events that materially affect the entity's financial position or results of operations are generally also disclosed."
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "iff_FiscalQuarterEndingDecember312025Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "FiscalQuarterEndingDecember312025Member",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationRevolvingCreditFacilityDetail",
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fiscal Quarter Ending December 31, 2025",
        "label": "Fiscal Quarter Ending December 31, 2025 [Member]",
        "documentation": "Fiscal Quarter Ending December 31, 2025"
       }
      }
     },
     "auth_ref": []
    },
    "iff_FiscalQuarterEndingJune302024Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "FiscalQuarterEndingJune302024Member",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationRevolvingCreditFacilityDetail",
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fiscal Quarter Ending June 30, 2024",
        "label": "Fiscal Quarter Ending June 30, 2024 [Member]",
        "documentation": "Fiscal Quarter Ending June 30, 2024"
       }
      }
     },
     "auth_ref": []
    },
    "iff_FiscalQuarterEndingOnOrBeforeMarch312024Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "FiscalQuarterEndingOnOrBeforeMarch312024Member",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationRevolvingCreditFacilityDetail",
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fiscal Quarter Ending On Or Before March 31, 2024",
        "label": "Fiscal Quarter Ending On Or Before March 31, 2024 [Member]",
        "documentation": "Fiscal Quarter Ending On Or Before March 31, 2024"
       }
      }
     },
     "auth_ref": []
    },
    "iff_FiscalQuarterEndingSeptember302024Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "FiscalQuarterEndingSeptember302024Member",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationRevolvingCreditFacilityDetail",
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fiscal Quarter Ending September 30, 2024",
        "label": "Fiscal Quarter Ending September 30, 2024 [Member]",
        "documentation": "Fiscal Quarter Ending September 30, 2024"
       }
      }
     },
     "auth_ref": []
    },
    "iff_FixedAssetWriteDownMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "FixedAssetWriteDownMember",
     "presentation": [
      "http://www.iff.com/role/RestructuringandOtherChargesAdditionalInformationDetails",
      "http://www.iff.com/role/RestructuringandOtherChargesMovementsinRestructuringandRelatedAccrualsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fixed asset write down",
        "label": "Fixed Asset Write Down [Member]",
        "documentation": "Fixed Asset Write Down [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FixedIncomeFundsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FixedIncomeFundsMember",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fixed Income Funds",
        "label": "Fixed Income Funds [Member]",
        "documentation": "Investment that pools funds from investors to invest in a combination of underlying investments, primarily fixed income investments."
       }
      }
     },
     "auth_ref": [
      "r1542"
     ]
    },
    "us-gaap_FixedIncomeSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FixedIncomeSecuritiesMember",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fixed Income Securities",
        "label": "Fixed Income Securities [Member]",
        "documentation": "Investment that provides a return in the form of fixed periodic payments and eventual return of principal at maturity."
       }
      }
     },
     "auth_ref": [
      "r1295",
      "r1313",
      "r1314",
      "r1542"
     ]
    },
    "iff_FlavorSpecialtyIngredientsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "FlavorSpecialtyIngredientsMember",
     "presentation": [
      "http://www.iff.com/role/BusinessDivestitureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Flavor Specialty Ingredients",
        "label": "Flavor Specialty Ingredients [Member]",
        "documentation": "Flavor Specialty Ingredients"
       }
      }
     },
     "auth_ref": []
    },
    "iff_FlavorsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "FlavorsMember",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationCapitalExpenditureandDepreciationandAmortizationbySegmentDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Flavors [Member]",
        "label": "Flavors [Member]",
        "documentation": "Flavors"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ForeignCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignCountryMember",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail",
      "http://www.iff.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign Tax Authority [Member]",
        "label": "Foreign Tax Authority [Member]",
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile."
       }
      }
     },
     "auth_ref": []
    },
    "iff_ForeignCurrencyContractAndInterestRateSwapMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "ForeignCurrencyContractAndInterestRateSwapMember",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign Currency Contract And Interest Rate Swap",
        "label": "Foreign Currency Contract And Interest Rate Swap [Member]",
        "documentation": "Foreign Currency Contract And Interest Rate Swap [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_ForeignCurrencyContractsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "ForeignCurrencyContractsMember",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsAdditionalInformationDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowandNetInvestmentHedgingInstrumentsDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsWhichWereNotDesignatedasHedgingInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign Currency Contracts",
        "label": "Foreign Currency Contracts [Member]",
        "documentation": "Foreign Currency Contracts [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/OtherExpenseIncomeNetDetails": {
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/OtherExpenseIncomeNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign exchange (losses) gains",
        "label": "Gain (Loss), Foreign Currency Transaction, before Tax",
        "documentation": "Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction."
       }
      }
     },
     "auth_ref": [
      "r984",
      "r985",
      "r986",
      "r987",
      "r1205"
     ]
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign Currency Translation",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy."
       }
      }
     },
     "auth_ref": [
      "r983"
     ]
    },
    "us-gaap_ForeignExchangeContractMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignExchangeContractMember",
     "presentation": [
      "http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossReclassificationsofAccumulatedOtherComprehensiveIncometoConsolidatedStatementofComprehensiveIncomeDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowandNetInvestmentHedgingInstrumentsDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsMeasuredatFairValueDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsWhichWereNotDesignatedasHedgingInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign Currency Contracts",
        "label": "Foreign Exchange Contract [Member]",
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates."
       }
      }
     },
     "auth_ref": [
      "r1265",
      "r1293",
      "r1308"
     ]
    },
    "us-gaap_ForeignPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignPlanMember",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsAccumulatedBenefitObligationDetail",
      "http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail",
      "http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetail",
      "http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinBalanceSheetDetail",
      "http://www.iff.com/role/EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail",
      "http://www.iff.com/role/EmployeeBenefitsEstimatedFutureBenefitPaymentsDetail",
      "http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail",
      "http://www.iff.com/role/EmployeeBenefitsPercentageofAssetsInvestedDetail",
      "http://www.iff.com/role/EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail",
      "http://www.iff.com/role/EmployeeBenefitsReconciliationofLevel3NonUSPlanAssetsHeldDetail",
      "http://www.iff.com/role/EmployeeBenefitsSensitivityofDisclosurestoChangesinSelectedAssumptionsDetail",
      "http://www.iff.com/role/EmployeeBenefitsWeightedAverageActuarialAssumptionUsedtoDetermineExpenseDetail",
      "http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-U.S.\u00a0Plans",
        "label": "Foreign Plan [Member]",
        "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, not determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans."
       }
      }
     },
     "auth_ref": [
      "r1581",
      "r1582",
      "r1583"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r1343",
      "r1355",
      "r1365",
      "r1391"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount",
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r1343",
      "r1355",
      "r1365",
      "r1391"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r1343",
      "r1355",
      "r1365",
      "r1391"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery, Explanation of Impracticability",
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1343",
      "r1355",
      "r1365",
      "r1391"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r1343",
      "r1355",
      "r1365",
      "r1391"
     ]
    },
    "us-gaap_ForwardContractsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForwardContractsMember",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsAdditionalInformationDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowandNetInvestmentHedgingInstrumentsDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsNotionalAmountOutstandingDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forward Currency Contracts",
        "label": "Forward Contracts [Member]",
        "documentation": "Contracts negotiated between two parties to purchase and sell a specific quantity of a financial instrument, foreign currency, or commodity at a price specified at origination of the contract, with delivery and settlement at a specified future date."
       }
      }
     },
     "auth_ref": [
      "r1619"
     ]
    },
    "iff_FragranceCompoundsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "FragranceCompoundsMember",
     "presentation": [
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fragrance Compounds [Member]",
        "label": "Fragrance Compounds [Member]",
        "documentation": "Fragrance Compounds"
       }
      }
     },
     "auth_ref": []
    },
    "iff_FragranceIngredientsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "FragranceIngredientsMember",
     "presentation": [
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fragrance Ingredients [Member]",
        "label": "Fragrance Ingredients [Member]",
        "documentation": "Fragrance Ingredients [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_FragrancesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "FragrancesMember",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationCapitalExpenditureandDepreciationandAmortizationbySegmentDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fragrances [Member]",
        "label": "Fragrances [Member]",
        "documentation": "Fragrances."
       }
      }
     },
     "auth_ref": []
    },
    "iff_FrutaromIntegrationInitiativeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "FrutaromIntegrationInitiativeMember",
     "presentation": [
      "http://www.iff.com/role/RestructuringandOtherChargesAdditionalInformationDetails",
      "http://www.iff.com/role/RestructuringandOtherChargesMovementsinRestructuringandRelatedAccrualsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Frutarom Integration Initiative [Member]",
        "label": "Frutarom Integration Initiative [Member]",
        "documentation": "Frutarom Integration Initiative [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_FullThreeYearPeriodMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "FullThreeYearPeriodMember",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Full three-year period [Member]",
        "label": "Full Three Year Period [Member]",
        "documentation": "Full Three Year Period [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "country_GB": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "GB",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "UNITED KINGDOM",
        "label": "UNITED KINGDOM"
       }
      }
     },
     "auth_ref": []
    },
    "iff_GainContingencyExpectedRelocationPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "GainContingencyExpectedRelocationPayments",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gain Contingency, Expected Relocation Payments",
        "label": "Gain Contingency, Expected Relocation Payments",
        "documentation": "Gain Contingency, Expected Relocation Payments"
       }
      }
     },
     "auth_ref": []
    },
    "iff_GainContingencyRelocationPaymentsReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "GainContingencyRelocationPaymentsReceived",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gain Contingency, Relocation Payments Received",
        "label": "Gain Contingency, Relocation Payments Received",
        "documentation": "Gain Contingency, Relocation Payments Received"
       }
      }
     },
     "auth_ref": []
    },
    "iff_GainLossOnChinaFacilityRelocation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "GainLossOnChinaFacilityRelocation",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/OtherExpenseIncomeNetDetails": {
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/OtherExpenseIncomeNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gain on China facility relocation",
        "label": "Gain (Loss) On China Facility Relocation",
        "documentation": "Gain (Loss) On China Facility Relocation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainLossOnDispositionOfAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GainLossOnDispositionOfAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Gains on sale of assets",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property",
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property."
       }
      }
     },
     "auth_ref": [
      "r1455",
      "r1503",
      "r1504"
     ]
    },
    "us-gaap_GainLossOnOilAndGasHedgingActivity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GainLossOnOilAndGasHedgingActivity",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationSeniorUnsecuredNotesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Gain (loss) on hedging activity",
        "label": "Gain (Loss) on Hedging Activity",
        "documentation": "Gain (loss) incurred in hedging activities."
       }
      }
     },
     "auth_ref": [
      "r191"
     ]
    },
    "iff_GainLossOnPlantRelocation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "GainLossOnPlantRelocation",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gain (Loss) On Plant Relocation",
        "label": "Gain (Loss) On Plant Relocation",
        "documentation": "Gain (Loss) On Plant Relocation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainLossOnSaleOfBusiness": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GainLossOnSaleOfBusiness",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/OtherExpenseIncomeNetDetails": {
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS",
      "http://www.iff.com/role/OtherExpenseIncomeNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Losses (gains) on business divestitures",
        "terseLabel": "(Losses) gains on business divestitures",
        "label": "Gain (Loss) on Disposition of Business",
        "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant."
       }
      }
     },
     "auth_ref": [
      "r937",
      "r1455"
     ]
    },
    "us-gaap_GainLossOnSaleOfDerivatives": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GainLossOnSaleOfDerivatives",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gain on deal contingent derivatives",
        "label": "Gain (Loss) on Sale of Derivatives",
        "documentation": "The difference between the book value and the sale price of options, swaps, futures, forward contracts, and other derivative instruments. This element refers to the gain (loss) included in earnings."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r347",
      "r1195",
      "r1196",
      "r1197",
      "r1198"
     ]
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME",
      "http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Gains on sale of assets",
        "terseLabel": "Gain on Sale of Assets",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property."
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "us-gaap_GainLossRelatedToLitigationSettlement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GainLossRelatedToLitigationSettlement",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Legal Charges/Credits, net",
        "label": "Gain (Loss) Related to Litigation Settlement",
        "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process."
       }
      }
     },
     "auth_ref": [
      "r1508"
     ]
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gain (Loss) on Extinguishment of Debt",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r125",
      "r126"
     ]
    },
    "us-gaap_GeographicDistributionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GeographicDistributionAxis",
     "presentation": [
      "http://www.iff.com/role/LeasesAdditionalInformationDetails",
      "http://www.iff.com/role/SegmentInformationNetSalesbyGeographicAreaDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographic Distribution [Axis]",
        "label": "Geographic Distribution [Axis]",
        "documentation": "Information by geographic distribution of business activity identified as either domestic or foreign. Excludes names of countries, states and provinces, and cities."
       }
      }
     },
     "auth_ref": [
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r1074",
      "r1075",
      "r1274"
     ]
    },
    "us-gaap_GeographicDistributionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GeographicDistributionDomain",
     "presentation": [
      "http://www.iff.com/role/LeasesAdditionalInformationDetails",
      "http://www.iff.com/role/SegmentInformationNetSalesbyGeographicAreaDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographic Distribution [Domain]",
        "label": "Geographic Distribution [Domain]",
        "documentation": "Allocation of business activity identified as domestic or foreign. Excludes names of countries, states and provinces, and cities."
       }
      }
     },
     "auth_ref": [
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r1074",
      "r1075"
     ]
    },
    "us-gaap_GeographicDistributionDomesticMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GeographicDistributionDomesticMember",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationNetSalesbyGeographicAreaDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographic Distribution, Domestic [Member]",
        "label": "Geographic Distribution, Domestic [Member]",
        "documentation": "Allocation of business activity identified as domestic."
       }
      }
     },
     "auth_ref": [
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r1275"
     ]
    },
    "us-gaap_GeographicDistributionForeignMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GeographicDistributionForeignMember",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationNetSalesbyGeographicAreaDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographic Distribution, Foreign [Member]",
        "label": "Geographic Distribution, Foreign [Member]",
        "documentation": "Allocation of business activity identified as foreign."
       }
      }
     },
     "auth_ref": [
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r1074",
      "r1075",
      "r1276"
     ]
    },
    "iff_GlobalSharedServicesImplementationCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "GlobalSharedServicesImplementationCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Global Shared Services Implementation Costs",
        "label": "Global Shared Services Implementation Costs",
        "documentation": "Global Shared Services Implementation Costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/AcquisitionsHealthWrightProductsDetails",
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails",
      "http://www.iff.com/role/BusinessDivestitureDetails",
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET",
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetGoodwillRollforwardDetails",
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetNarrativeDetails",
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill",
        "periodStartLabel": "Goodwill",
        "periodEndLabel": "Goodwill",
        "label": "Goodwill",
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r420",
      "r647",
      "r1069",
      "r1279",
      "r1311",
      "r1493",
      "r1500"
     ]
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAcquiredDuringPeriod",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetGoodwillRollforwardDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquisitions",
        "label": "Goodwill, Acquired During Period",
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination."
       }
      }
     },
     "auth_ref": [
      "r651",
      "r1279"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "presentation": [
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill and Other Intangible Assets, Net",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "documentation": "The entire disclosure for goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r283"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill",
        "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined."
       }
      }
     },
     "auth_ref": [
      "r646",
      "r659",
      "r1279"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets",
        "label": "Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetGoodwillRollforwardDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign exchange",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r655"
     ]
    },
    "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillImpairedAccumulatedImpairmentLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill, Impaired, Accumulated Impairment Loss",
        "label": "Goodwill, Impaired, Accumulated Impairment Loss",
        "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r650",
      "r657",
      "r1279"
     ]
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillImpairmentLoss",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 5.0
      },
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS",
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME",
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetGoodwillRollforwardDetails",
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetNarrativeDetails",
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.iff.com/role/SegmentInformationAdditionalInformationDetail",
      "http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of goodwill",
        "negatedTerseLabel": "Goodwill, Impairment Loss",
        "label": "Goodwill, Impairment Loss",
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r648",
      "r654",
      "r659",
      "r1279"
     ]
    },
    "us-gaap_GoodwillLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillLineItems",
     "presentation": [
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetGoodwillRollforwardDetails",
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill [Line Items]",
        "label": "Goodwill [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r1279"
     ]
    },
    "us-gaap_GoodwillPeriodIncreaseDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillPeriodIncreaseDecrease",
     "presentation": [
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetGoodwillRollforwardDetails",
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Goodwill, period increase (decrease)",
        "terseLabel": "Reallocation",
        "label": "Goodwill, Period Increase (Decrease)",
        "documentation": "Amount of increase (decrease) of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r1492"
     ]
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetGoodwillRollforwardDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement period adjustment",
        "label": "Goodwill, Purchase Accounting Adjustments",
        "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r1499"
     ]
    },
    "us-gaap_GoodwillRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillRollForward",
     "presentation": [
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetGoodwillRollforwardDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill [Roll Forward]",
        "label": "Goodwill [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillTransfers": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillTransfers",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetGoodwillRollforwardDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Transferred to assets held for sale(3)",
        "label": "Goodwill, Transfers",
        "documentation": "Amount of transfers into (out of) an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r1499"
     ]
    },
    "us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillWrittenOffRelatedToSaleOfBusinessUnit",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetGoodwillRollforwardDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Reduction from business divestiture",
        "label": "Goodwill, Written off Related to Sale of Business Unit",
        "documentation": "Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r653",
      "r1279"
     ]
    },
    "iff_GovernmentAndGovernmentAgencyBondsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "GovernmentAndGovernmentAgencyBondsMember",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Government\u00a0&amp; Government Agency Bonds",
        "label": "Government And Government Agency Bonds [Member]",
        "documentation": "Government And Government Agency Bonds [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GrossProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GrossProfit",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Gross profit",
        "label": "Gross Profit",
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity."
       }
      }
     },
     "auth_ref": [
      "r265",
      "r475",
      "r533",
      "r547",
      "r553",
      "r556",
      "r601",
      "r697",
      "r698",
      "r700",
      "r701",
      "r702",
      "r704",
      "r706",
      "r708",
      "r709",
      "r978",
      "r1271",
      "r1511"
     ]
    },
    "iff_GuangzhouChinaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "GuangzhouChinaMember",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Guangzhou, China [Member]",
        "label": "Guangzhou, China [Member]",
        "documentation": "Guangzhou, China [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_GuangzhouFlavorsPlantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "GuangzhouFlavorsPlantMember",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Guangzhou Flavors Plant [Member]",
        "label": "Guangzhou Flavors Plant [Member]",
        "documentation": "Guangzhou Flavors Plant [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_GuangzhouFragrancePlantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "GuangzhouFragrancePlantMember",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Guangzhou Fragrance Plant [Member]",
        "label": "Guangzhou Fragrance Plant [Member]",
        "documentation": "Guangzhou Fragrance Plant [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_HangzhouChinaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "HangzhouChinaMember",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hangzhou, China [Member]",
        "label": "Hangzhou, China [Member]",
        "documentation": "Hangzhou, China [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_HealthBiosciencesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "HealthBiosciencesMember",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails",
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetGoodwillRollforwardDetails",
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetNarrativeDetails",
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.iff.com/role/RestructuringandOtherChargesMovementsinRestructuringandRelatedAccrualsDetail",
      "http://www.iff.com/role/SegmentInformationCapitalExpenditureandDepreciationandAmortizationbySegmentDetail",
      "http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Health &amp; Biosciences",
        "label": "Health &amp; Biosciences [Member]",
        "documentation": "Health &amp; Biosciences"
       }
      }
     },
     "auth_ref": []
    },
    "iff_HealthWrightProductsIncHealthWrightMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "HealthWrightProductsIncHealthWrightMember",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsHealthWrightProductsDetails",
      "http://www.iff.com/role/LeasesAdditionalInformationDetails",
      "http://www.iff.com/role/LeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Health Wright Products, Inc. (\u201cHealth Wright\u201d)",
        "label": "Health Wright Products, Inc. (\u201cHealth Wright\u201d) [Member]",
        "documentation": "Health Wright Products, Inc. (\u201cHealth Wright\u201d)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_HedgeFundsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HedgeFundsMember",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail",
      "http://www.iff.com/role/EmployeeBenefitsReconciliationofLevel3NonUSPlanAssetsHeldDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Hedge Funds [Member]",
        "documentation": "Investments in registered hedge funds."
       }
      }
     },
     "auth_ref": [
      "r1542"
     ]
    },
    "us-gaap_HedgingDesignationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HedgingDesignationAxis",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsAdditionalInformationDetail",
      "http://www.iff.com/role/FinancialInstrumentsCarryingAmountandEstimatedFairValueofFinancialInstrumentsDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowandNetInvestmentHedgingInstrumentsDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsMeasuredatFairValueDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsWhichWereNotDesignatedasHedgingInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Designation [Axis]",
        "label": "Hedging Designation [Axis]",
        "documentation": "Information by designation of purpose of derivative instrument."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r942"
     ]
    },
    "us-gaap_HedgingDesignationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HedgingDesignationDomain",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsAdditionalInformationDetail",
      "http://www.iff.com/role/FinancialInstrumentsCarryingAmountandEstimatedFairValueofFinancialInstrumentsDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowandNetInvestmentHedgingInstrumentsDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsMeasuredatFairValueDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsWhichWereNotDesignatedasHedgingInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Designation [Domain]",
        "label": "Hedging Designation [Domain]",
        "documentation": "Designation of purpose of derivative instrument."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "us-gaap_HedgingRelationshipDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HedgingRelationshipDomain",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsAdditionalInformationDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowandNetInvestmentHedgingInstrumentsDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsNotionalAmountOutstandingDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Relationship [Domain]",
        "label": "Hedging Relationship [Domain]",
        "documentation": "Nature or intent of a hedge."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://www.iff.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ICFR Auditor Attestation Flag",
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r1333",
      "r1334",
      "r1347"
     ]
    },
    "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ImpairmentOfLongLivedAssetsHeldForUse",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      },
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS",
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME",
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.iff.com/role/SegmentInformationAdditionalInformationDetail",
      "http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of long-lived assets",
        "negatedTerseLabel": "Impairment, Long-Lived Asset, Held-for-Use",
        "label": "Impairment, Long-Lived Asset, Held-for-Use",
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale)."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r117",
      "r290"
     ]
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of Long-Lived Assets",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r293"
     ]
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InProcessResearchAndDevelopmentMember",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "In Process Research and Development",
        "label": "In Process Research and Development [Member]",
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetail": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "U.S. loss before taxes",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations."
       }
      }
     },
     "auth_ref": [
      "r476",
      "r916"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.iff.com/role/IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME",
      "http://www.iff.com/role/IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetail",
      "http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "(Loss) income before taxes",
        "terseLabel": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r262",
      "r344",
      "r533",
      "r547",
      "r553",
      "r556",
      "r1075",
      "r1088",
      "r1271"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetail": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign (loss) income before taxes",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile."
       }
      }
     },
     "auth_ref": [
      "r476",
      "r916"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement [Abstract]",
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "presentation": [
      "http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleDetails",
      "http://www.iff.com/role/BusinessDivestitureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposal Group Name [Axis]",
        "label": "Disposal Group Name [Axis]",
        "documentation": "Information by name of disposal group."
       }
      }
     },
     "auth_ref": [
      "r1297",
      "r1300"
     ]
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "presentation": [
      "http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleDetails",
      "http://www.iff.com/role/BusinessDivestitureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "presentation": [
      "http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleDetails",
      "http://www.iff.com/role/BusinessDivestitureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r48",
      "r63",
      "r225",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r235",
      "r236",
      "r237",
      "r292"
     ]
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsWeightedAverageAssumptionsUsedtoDeterminePostretirementBenefitExpenseandObligationDetail",
      "http://www.iff.com/role/FinancialInstrumentsAdditionalInformationDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowandNetInvestmentHedgingInstrumentsDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsWhichWereNotDesignatedasHedgingInstrumentsDetail",
      "http://www.iff.com/role/StockCompensationPlansStockBasedCompensationExpenseIncludedinConsolidatedStatementofIncomeandComprehensiveIncomeDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs, by Report Line [Axis]",
        "terseLabel": "Income Statement Location [Axis]",
        "label": "Income Statement Location [Axis]",
        "documentation": "Information by location in the income statement."
       }
      }
     },
     "auth_ref": [
      "r667",
      "r679",
      "r1191"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsWeightedAverageAssumptionsUsedtoDeterminePostretirementBenefitExpenseandObligationDetail",
      "http://www.iff.com/role/FinancialInstrumentsAdditionalInformationDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowandNetInvestmentHedgingInstrumentsDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsWhichWereNotDesignatedasHedgingInstrumentsDetail",
      "http://www.iff.com/role/StockCompensationPlansStockBasedCompensationExpenseIncludedinConsolidatedStatementofIncomeandComprehensiveIncomeDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Employee Service Share-based Compensation, Allocation of Recognized Period Costs, Report Line [Domain]",
        "terseLabel": "Income Statement Location [Domain]",
        "label": "Income Statement Location [Domain]",
        "documentation": "Location in the income statement."
       }
      }
     },
     "auth_ref": [
      "r679",
      "r1191"
     ]
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxAuthorityAxis",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail",
      "http://www.iff.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Authority [Axis]",
        "label": "Income Tax Authority [Axis]",
        "documentation": "Information by tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxAuthorityDomain",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail",
      "http://www.iff.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Authority [Domain]",
        "label": "Income Tax Authority [Domain]",
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxAuthorityNameAxis",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Authority, Name [Axis]",
        "label": "Income Tax Authority, Name [Axis]",
        "documentation": "Information by name of taxing authority."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxAuthorityNameDomain",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Authority, Name [Domain]",
        "label": "Income Tax Authority, Name [Domain]",
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Disclosure [Abstract]",
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.iff.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information."
       }
      }
     },
     "auth_ref": [
      "r477",
      "r883",
      "r891",
      "r899",
      "r905",
      "r912",
      "r918",
      "r919",
      "r920",
      "r1131"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0,
       "order": 2.0
      },
      "http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossReclassificationsofAccumulatedOtherComprehensiveIncometoConsolidatedStatementofComprehensiveIncomeDetail": {
       "parentTag": "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossReclassificationsofAccumulatedOtherComprehensiveIncometoConsolidatedStatementofComprehensiveIncomeDetail_1": {
       "parentTag": "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.iff.com/role/IncomeTaxesScheduleofIncomeTaxProvisionDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossReclassificationsofAccumulatedOtherComprehensiveIncometoConsolidatedStatementofComprehensiveIncomeDetail",
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME",
      "http://www.iff.com/role/IncomeTaxesScheduleofIncomeTaxProvisionDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Provision for income taxes",
        "totalLabel": "Total provision for income taxes",
        "negatedTerseLabel": "Tax",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r351",
      "r365",
      "r505",
      "r506",
      "r541",
      "r889",
      "r913",
      "r1097"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r452",
      "r885",
      "r886",
      "r899",
      "r900",
      "r904",
      "r906",
      "r1125"
     ]
    },
    "iff_IncomeTaxesDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "IncomeTaxesDisclosureLineItems",
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofUnrecognizedTaxBenefitsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes Disclosure [Line Items]",
        "label": "Income Taxes Disclosure [Line Items]",
        "documentation": "Income Taxes Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_IncomeTaxesDisclosureTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "IncomeTaxesDisclosureTable",
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.iff.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofUnrecognizedTaxBenefitsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes Disclosure [Table]",
        "label": "Income Taxes Disclosure [Table]",
        "documentation": "Income Taxes Disclosure [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_IncomeTaxesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "IncomeTaxesLineItems",
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes [Line Items]",
        "label": "Income Taxes [Line Items]",
        "documentation": "Income Taxes [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxesPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxesPaid",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income taxes paid",
        "label": "Income Taxes Paid",
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income."
       }
      }
     },
     "auth_ref": [
      "r88",
      "r91"
     ]
    },
    "us-gaap_IncomeTaxesReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxesReceivable",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherAssetsDetail": {
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid income taxes",
        "label": "Income Taxes Receivable, Current",
        "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes."
       }
      }
     },
     "auth_ref": [
      "r217",
      "r1445"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Increase (Decrease) in Accounts Payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Trade receivables",
        "label": "Increase (Decrease) in Accounts Receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accruals for incentive compensation",
        "label": "Increase (Decrease) in Employee Related Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInInventories",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Inventories",
        "label": "Increase (Decrease) in Inventories",
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in assets and liabilities, net of acquisitions:",
        "label": "Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other current payables and accrued expenses",
        "label": "Increase (Decrease) in Other Accounts Payable and Accrued Liabilities",
        "documentation": "The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other assets/liabilities, net",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "iff_IncreaseDecreaseInRedemptionValueRedeemableNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "IncreaseDecreaseInRedemptionValueRedeemableNoncontrollingInterest",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/NetIncomePerShareReconciliationofSharesUsedinComputationofBasicandDilutedNetIncomePerShareDetail": {
       "parentTag": "iff_NetIncomeLossAvailableToCommonStockholdersAdjustment",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/NetIncomePerShareReconciliationofSharesUsedinComputationofBasicandDilutedNetIncomePerShareDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "(Increase) Decrease In Redemption Value, Redeemable Noncontrolling Interest",
        "label": "(Increase) Decrease In Redemption Value, Redeemable Noncontrolling Interest",
        "documentation": "(Increase) Decrease In Redemption Value, Redeemable Noncontrolling Interest"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "calculation": {
      "http://www.iff.com/role/NetIncomePerShareReconciliationofSharesUsedinComputationofBasicandDilutedNetIncomePerShareDetail": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/NetIncomePerShareReconciliationofSharesUsedinComputationofBasicandDilutedNetIncomePerShareDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment for assumed dilution (in shares)",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method."
       }
      }
     },
     "auth_ref": [
      "r513",
      "r514",
      "r515",
      "r521",
      "r844"
     ]
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]",
        "label": "Indefinite-Lived Intangible Assets [Axis]",
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit."
       }
      }
     },
     "auth_ref": [
      "r662",
      "r665"
     ]
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]",
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company."
       }
      }
     },
     "auth_ref": [
      "r114",
      "r286"
     ]
    },
    "iff_IndefiniteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "IndefiniteMember",
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Indefinite [Member]",
        "label": "Indefinite [Member]",
        "documentation": "Indefinite [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IndefinitelivedIntangibleAssetsAcquired": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IndefinitelivedIntangibleAssetsAcquired",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Indefinite-lived intangible assets",
        "label": "Indefinite-Lived Intangible Assets Acquired",
        "documentation": "Amount of increase in assets, excluding financial assets and goodwill, lacking physical substance with an indefinite life, from an acquisition."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Individual:",
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1346",
      "r1355",
      "r1365",
      "r1382",
      "r1391",
      "r1395",
      "r1403"
     ]
    },
    "iff_InformationTechnologyHardwareAndSoftwareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "InformationTechnologyHardwareAndSoftwareMember",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Information Technology Hardware And Software [Member]",
        "label": "Information Technology Hardware And Software [Member]",
        "documentation": "Information Technology Hardware And Software [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1401"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1335",
      "r1407"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Adopted",
        "label": "Insider Trading Policies and Procedures Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1335",
      "r1407"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted",
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1335",
      "r1407"
     ]
    },
    "iff_InsuranceContractsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "InsuranceContractsMember",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insurance Contracts",
        "label": "Insurance Contracts [Member]",
        "documentation": "Insurance Contracts [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IntangibleAssetsNetIncludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IntangibleAssetsNetIncludingGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/BusinessDivestitureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible Assets, Net (Including Goodwill)",
        "label": "Intangible Assets, Net (Including Goodwill)",
        "documentation": "Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IntellectualPropertyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IntellectualPropertyMember",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Technological Know-how [Member]",
        "label": "Intellectual Property [Member]",
        "documentation": "Intangible asset arising from original creative thought. Include, but is not limited to, trademarks, patents, and copyrights."
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "us-gaap_InterestCostsCapitalized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestCostsCapitalized",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capitalized interest costs",
        "label": "Interest Costs Capitalized",
        "documentation": "Amount of interest capitalized during the period."
       }
      }
     },
     "auth_ref": [
      "r212"
     ]
    },
    "us-gaap_InterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0,
       "order": 2.0
      },
      "http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossReclassificationsofAccumulatedOtherComprehensiveIncometoConsolidatedStatementofComprehensiveIncomeDetail": {
       "parentTag": "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossReclassificationsofAccumulatedOtherComprehensiveIncometoConsolidatedStatementofComprehensiveIncomeDetail",
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME",
      "http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest expense",
        "negatedLabel": "Interest expense",
        "negatedTerseLabel": "Interest expense",
        "label": "Interest Expense",
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense."
       }
      }
     },
     "auth_ref": [
      "r215",
      "r348",
      "r456",
      "r537",
      "r999",
      "r1192",
      "r1326",
      "r1650"
     ]
    },
    "us-gaap_InterestExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestExpenseMember",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsAdditionalInformationDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowandNetInvestmentHedgingInstrumentsDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsWhichWereNotDesignatedasHedgingInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest Expense [Member]",
        "label": "Interest Expense [Member]",
        "documentation": "Primary financial statement caption encompassing interest expense."
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "us-gaap_InterestIncomeExpenseNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestIncomeExpenseNet",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsAdditionalInformationDetail",
      "http://www.iff.com/role/FinancialInstrumentsCarryingAmountandEstimatedFairValueofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest Income (Expense), Net",
        "label": "Interest Income (Expense), Net",
        "documentation": "The net amount of operating interest income (expense)."
       }
      }
     },
     "auth_ref": [
      "r346"
     ]
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest paid, net of amounts capitalized",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r467",
      "r470",
      "r471"
     ]
    },
    "us-gaap_InterestPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest payable",
        "label": "Interest Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_InterestRateSwapMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestRateSwapMember",
     "presentation": [
      "http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossReclassificationsofAccumulatedOtherComprehensiveIncometoConsolidatedStatementofComprehensiveIncomeDetail",
      "http://www.iff.com/role/FinancialInstrumentsAdditionalInformationDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowandNetInvestmentHedgingInstrumentsDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsMeasuredatFairValueDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsNotionalAmountOutstandingDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsWhichWereNotDesignatedasHedgingInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest Rate Swap",
        "label": "Interest Rate Swap [Member]",
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period."
       }
      }
     },
     "auth_ref": [
      "r1254",
      "r1320",
      "r1321"
     ]
    },
    "us-gaap_InterestReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestReceivable",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsAdditionalInformationDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowandNetInvestmentHedgingInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest Receivable",
        "label": "Interest Receivable",
        "documentation": "Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable."
       }
      }
     },
     "auth_ref": [
      "r1445",
      "r1653"
     ]
    },
    "us-gaap_InternalUseSoftwarePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InternalUseSoftwarePolicy",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Software Costs",
        "label": "Internal Use Software, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for costs incurred when both (1) the software is acquired, internally developed, or modified solely to meet the entity's internal needs, and (2) during the software's development or modification, no substantive plan exists or is being developed to market the software externally."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r4"
     ]
    },
    "iff_InternationalFlavorsFragrancesIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "InternationalFlavorsFragrancesIncMember",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails",
      "http://www.iff.com/role/DebtAdditionalInformationCommercialPaperandRedemptionProvisionsDetail",
      "http://www.iff.com/role/NetIncomePerShareAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "International Flavors &amp; Fragrances Inc",
        "label": "International Flavors &amp; Fragrances Inc [Member]",
        "documentation": "International Flavors &amp; Fragrances Inc [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_InternationalFlavorsFragrancesIncSeniorNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "InternationalFlavorsFragrancesIncSeniorNotesMember",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationCommercialPaperandRedemptionProvisionsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "International Flavors &amp; Fragrances Inc Senior Notes",
        "label": "International Flavors &amp; Fragrances Inc Senior Notes [Member]",
        "documentation": "International Flavors &amp; Fragrances Inc Senior Notes"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesScheduleofInventoryDetail": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesScheduleofInventoryDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventory, Finished Goods, Net of Reserves",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale."
       }
      }
     },
     "auth_ref": [
      "r282",
      "r1260"
     ]
    },
    "us-gaap_InventoryNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryNet",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesScheduleofInventoryDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iff.com/role/BusinessDivestitureDetails",
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET",
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesScheduleofInventoryDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventories",
        "totalLabel": "Total",
        "label": "Inventory, Net",
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r434",
      "r1257",
      "r1311"
     ]
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryPolicyTextBlock",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventories",
        "label": "Inventory, Policy [Policy Text Block]",
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost."
       }
      }
     },
     "auth_ref": [
      "r353",
      "r416",
      "r433",
      "r640",
      "r641",
      "r643",
      "r1062",
      "r1267"
     ]
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryRawMaterialsNetOfReserves",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesScheduleofInventoryDetail": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesScheduleofInventoryDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventory, Raw Materials, Net of Reserves",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process."
       }
      }
     },
     "auth_ref": [
      "r282",
      "r1262"
     ]
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryWorkInProcessNetOfReserves",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesScheduleofInventoryDetail": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesScheduleofInventoryDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventory, Work in Process, Net of Reserves",
        "label": "Inventory, Work in Process, Net of Reserves",
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing."
       }
      }
     },
     "auth_ref": [
      "r282",
      "r1261"
     ]
    },
    "us-gaap_InventoryWriteDown": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryWriteDown",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventory Write-down",
        "label": "Inventory Write-down",
        "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels."
       }
      }
     },
     "auth_ref": [
      "r642"
     ]
    },
    "us-gaap_InvestmentIncomeInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentIncomeInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/OtherExpenseIncomeNetDetails": {
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/OtherExpenseIncomeNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest income",
        "label": "Investment Income, Interest",
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities."
       }
      }
     },
     "auth_ref": [
      "r270",
      "r536"
     ]
    },
    "us-gaap_LandMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LandMember",
     "presentation": [
      "http://www.iff.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Land [Member]",
        "label": "Land [Member]",
        "documentation": "Part of earth's surface not covered by water."
       }
      }
     },
     "auth_ref": [
      "r1517"
     ]
    },
    "srt_LatinAmericaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "LatinAmericaMember",
     "presentation": [
      "http://www.iff.com/role/RestructuringandOtherChargesAdditionalInformationDetails",
      "http://www.iff.com/role/SegmentInformationNetSalesbyGeographicAreaDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Latin America",
        "label": "Latin America [Member]",
        "documentation": "Region of Latin America."
       }
      }
     },
     "auth_ref": [
      "r1654",
      "r1656",
      "r1657",
      "r1658"
     ]
    },
    "us-gaap_LeaseContractualTermAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseContractualTermAxis",
     "presentation": [
      "http://www.iff.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease Contractual Term [Axis]",
        "label": "Lease Contractual Term [Axis]",
        "documentation": "Information by contractual term of lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r1425"
     ]
    },
    "us-gaap_LeaseContractualTermDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseContractualTermDomain",
     "presentation": [
      "http://www.iff.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease Contractual Term [Domain]",
        "label": "Lease Contractual Term [Domain]",
        "documentation": "Contractual term of lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r1425"
     ]
    },
    "us-gaap_LeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/LeasesScheduleofLeaseExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease, Cost",
        "label": "Lease, Cost",
        "documentation": "Amount of lease cost recognized by lessee for lease contract."
       }
      }
     },
     "auth_ref": [
      "r1016",
      "r1310"
     ]
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://www.iff.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease Costs",
        "label": "Lease, Cost [Table Text Block]",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r1627"
     ]
    },
    "us-gaap_LeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases [Abstract]",
        "label": "Leases [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails",
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail",
      "http://www.iff.com/role/DebtAdditionalInformationCommercialPaperandRedemptionProvisionsDetail",
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail",
      "http://www.iff.com/role/NetIncomePerShareAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Legal Entity [Axis]",
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LegalFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LegalFees",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationAdditionalInformationDetail",
      "http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Legal Fees",
        "terseLabel": "Legal Fees",
        "label": "Legal Fees",
        "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings."
       }
      }
     },
     "auth_ref": [
      "r268"
     ]
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeLeaseDescriptionLineItems",
     "presentation": [
      "http://www.iff.com/role/LeasesAdditionalInformationDetails",
      "http://www.iff.com/role/LeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Lease, Description [Line Items]",
        "label": "Lessee, Lease, Description [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r1015"
     ]
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeLeaseDescriptionTable",
     "presentation": [
      "http://www.iff.com/role/LeasesAdditionalInformationDetails",
      "http://www.iff.com/role/LeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Lease, Description [Table]",
        "label": "Lessee, Lease, Description [Table]",
        "documentation": "Disclosure of information about lessee's leases."
       }
      }
     },
     "auth_ref": [
      "r1015"
     ]
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Leases [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r1014"
     ]
    },
    "iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "LesseeOperatingAndFinanceLeaseLiabilityToBePaidAfterYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails": {
       "parentTag": "iff_LesseeOperatingAndFinanceLeasePaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Operating and Finance Lease, Liability, to be Paid, after Year Five",
        "label": "Lessee, Operating and Finance Lease, Liability, to be Paid, after Year Five",
        "documentation": "Lessee, Operating and Finance Lease, Liability, to be Paid, after Year Five"
       }
      }
     },
     "auth_ref": []
    },
    "iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails": {
       "parentTag": "iff_LesseeOperatingAndFinanceLeasePaymentsDue",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Operating and Finance Lease, Liability, to be Paid, Year Five",
        "label": "Lessee, Operating and Finance Lease, Liability, to be Paid, Year Five",
        "documentation": "Lessee, Operating and Finance Lease, Liability, to be Paid, Year Five"
       }
      }
     },
     "auth_ref": []
    },
    "iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails": {
       "parentTag": "iff_LesseeOperatingAndFinanceLeasePaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Operating and Finance Lease, Liability, to be Paid, Year Four",
        "label": "Lessee, Operating and Finance Lease, Liability, to be Paid, Year Four",
        "documentation": "Lessee, Operating and Finance Lease, Liability, to be Paid, Year Four"
       }
      }
     },
     "auth_ref": []
    },
    "iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearOne": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearOne",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails": {
       "parentTag": "iff_LesseeOperatingAndFinanceLeasePaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Operating and Finance Lease, Liability, to be Paid, Year One",
        "label": "Lessee, Operating and Finance Lease, Liability, to be Paid, Year One",
        "documentation": "Lessee, Operating and Finance Lease, Liability, to be Paid, Year One"
       }
      }
     },
     "auth_ref": []
    },
    "iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearThree",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails": {
       "parentTag": "iff_LesseeOperatingAndFinanceLeasePaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Operating and Finance Lease, Liability, to be Paid, Year Three",
        "label": "Lessee, Operating and Finance Lease, Liability, to be Paid, Year Three",
        "documentation": "Lessee, Operating and Finance Lease, Liability, to be Paid, Year Three"
       }
      }
     },
     "auth_ref": []
    },
    "iff_LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails": {
       "parentTag": "iff_LesseeOperatingAndFinanceLeasePaymentsDue",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Operating and Finance Lease, Liability, to be Paid, Year Two",
        "label": "Lessee, Operating and Finance Lease, Liability, to be Paid, Year Two",
        "documentation": "Lessee, Operating and Finance Lease, Liability, to be Paid, Year Two"
       }
      }
     },
     "auth_ref": []
    },
    "iff_LesseeOperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "LesseeOperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails_1": {
       "parentTag": "iff_LesseeOperatingAndFinanceLeasePaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Operating and Finance Lease, Liability, Undiscounted Excess Amount",
        "label": "Lessee, Operating and Finance Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Lessee, Operating and Finance Lease, Liability, Undiscounted Excess Amount"
       }
      }
     },
     "auth_ref": []
    },
    "iff_LesseeOperatingAndFinanceLeasePaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "LesseeOperatingAndFinanceLeasePaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Lessee, Operating and Finance Lease, Payments, Due",
        "label": "Lessee, Operating and Finance Lease, Payments, Due",
        "documentation": "Lessee, Operating and Finance Lease, Payments, Due"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://www.iff.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Operating Lease, Liability, Maturity",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r1628"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Lessee, Operating Lease, Liability, to be Paid, Total",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r1023"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease, After 5 years",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r1023"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease, less than 1 year",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r1023"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r1023"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r1023"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r1023"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r1023"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Less Imputed Interest",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r1023"
     ]
    },
    "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseRemainingLeaseTerm",
     "presentation": [
      "http://www.iff.com/role/LeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remaining term lease",
        "label": "Lessee, Operating Lease, Remaining Lease Term",
        "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1625"
     ]
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "presentation": [
      "http://www.iff.com/role/LeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Renewal term",
        "label": "Lessee, Operating Lease, Renewal Term",
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1626"
     ]
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://www.iff.com/role/LeasesNotes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Operating Leases [Text Block]",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r1007"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/BusinessDivestitureDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iff.com/role/BusinessDivestitureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Liabilities",
        "label": "Liabilities",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r475",
      "r601",
      "r697",
      "r698",
      "r700",
      "r701",
      "r702",
      "r704",
      "r706",
      "r708",
      "r709",
      "r933",
      "r938",
      "r939",
      "r978",
      "r1163",
      "r1270",
      "r1328",
      "r1511",
      "r1632",
      "r1633"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Liabilities and Shareholders\u2019 Equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r255",
      "r343",
      "r1084",
      "r1311",
      "r1459",
      "r1487",
      "r1622"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LIABILITIES AND SHAREHOLDERS\u2019 EQUITY",
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Current Liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r70",
      "r415",
      "r475",
      "r601",
      "r697",
      "r698",
      "r700",
      "r701",
      "r702",
      "r704",
      "r706",
      "r708",
      "r709",
      "r933",
      "r938",
      "r939",
      "r978",
      "r1311",
      "r1511",
      "r1632",
      "r1633"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Liabilities:",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Other Liabilities",
        "label": "Liabilities, Noncurrent",
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r238",
      "r239",
      "r240",
      "r245",
      "r475",
      "r601",
      "r697",
      "r698",
      "r700",
      "r701",
      "r702",
      "r704",
      "r706",
      "r708",
      "r709",
      "r933",
      "r938",
      "r939",
      "r978",
      "r1511",
      "r1632",
      "r1633"
     ]
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesNoncurrentAbstract",
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Liabilities:",
        "label": "Liabilities, Noncurrent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleDetails",
      "http://www.iff.com/role/BusinessDivestitureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total liabilities held-for-sale",
        "totalLabel": "Total liabilities held-for-sale",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities",
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r225",
      "r234",
      "r291",
      "r412",
      "r413"
     ]
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract",
     "presentation": [
      "http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities held for sale",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current",
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r225",
      "r234",
      "r288",
      "r291",
      "r412",
      "r413"
     ]
    },
    "iff_LiabilityBasedAwardsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "LiabilityBasedAwardsMember",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansStockBasedCompensationExpenseIncludedinConsolidatedStatementofIncomeandComprehensiveIncomeDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liability-based awards [Member]",
        "label": "Liability Based Awards [Member]",
        "documentation": "Liability-based awards [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilityForCatastropheClaimsByCatastrophicEventAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilityForCatastropheClaimsByCatastrophicEventAxis",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Catastrophic Event [Axis]",
        "label": "Catastrophic Event [Axis]",
        "documentation": "Information by type of catastrophic event, for example, but not limited to, earthquake, windstorm, fire or explosion."
       }
      }
     },
     "auth_ref": [
      "r349"
     ]
    },
    "us-gaap_LiabilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilityMember",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsWeightedAverageAssumptionsUsedtoDeterminePostretirementBenefitExpenseandObligationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liability",
        "label": "Liability [Member]",
        "documentation": "Probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCredit",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationRevolvingCreditFacilityDetail",
      "http://www.iff.com/role/DebtComponentsofDebtDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of credit",
        "label": "Long-Term Line of Credit",
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r341",
      "r1644"
     ]
    },
    "us-gaap_LineOfCreditFacilityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityAxis",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail",
      "http://www.iff.com/role/DebtAdditionalInformationRevolvingCreditFacilityDetail",
      "http://www.iff.com/role/DebtComponentsofDebtDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lender Name [Axis]",
        "label": "Lender Name [Axis]",
        "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r1458"
     ]
    },
    "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityCurrentBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of Credit Facility, Current Borrowing Capacity",
        "label": "Line of Credit Facility, Current Borrowing Capacity",
        "documentation": "Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityIncreaseDecreaseForPeriodNet",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationRevolvingCreditFacilityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of Credit Facility, Increase (Decrease), Net",
        "label": "Line of Credit Facility, Increase (Decrease), Net",
        "documentation": "Amount of increase (decrease) of the credit facility."
       }
      }
     },
     "auth_ref": [
      "r1458"
     ]
    },
    "us-gaap_LineOfCreditFacilityLenderDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityLenderDomain",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail",
      "http://www.iff.com/role/DebtAdditionalInformationRevolvingCreditFacilityDetail",
      "http://www.iff.com/role/DebtComponentsofDebtDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of Credit Facility, Lender [Domain]",
        "label": "Line of Credit Facility, Lender [Domain]",
        "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r1458"
     ]
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail",
      "http://www.iff.com/role/DebtAdditionalInformationRevolvingCreditFacilityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revolving credit facility",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "iff_LinesOfCreditFacilityTotalAmountDrawnDown": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "LinesOfCreditFacilityTotalAmountDrawnDown",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lines of Credit Facility, Current Borrowing Amount/Total Amount Drawn Down",
        "label": "Lines Of Credit Facility, Total Amount Drawn Down",
        "documentation": "Lines Of Credit Facility, Total Amount Drawn Down"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LoansPayableFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LoansPayableFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsCarryingAmountandEstimatedFairValueofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit facilities and bank overdrafts",
        "label": "Loans Payable, Fair Value Disclosure",
        "documentation": "Fair value portion of contractual obligation to pay money on demand or on fixed or determinable dates."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LoansPayableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LoansPayableMember",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationCommercialPaperandRedemptionProvisionsDetail",
      "http://www.iff.com/role/DebtAdditionalInformationSeniorUnsecuredNotesDetail",
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail",
      "http://www.iff.com/role/DebtComponentsofDebtDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loans Payable",
        "label": "Loans Payable [Member]",
        "documentation": "Borrowing supported by a written promise to pay an obligation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.iff.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "iff_LondonInterbankOfferedRateLIBOR1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "LondonInterbankOfferedRateLIBOR1Member",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "London Interbank Offered Rate (LIBOR)",
        "label": "London Interbank Offered Rate (LIBOR)1 [Member]",
        "documentation": "London Interbank Offered Rate (LIBOR)1"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongLivedAssetsByGeographicAreasTableTextBlock",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-lived Assets by Geographic Areas",
        "label": "Long-Lived Assets by Geographic Areas [Table Text Block]",
        "documentation": "Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets."
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "us-gaap_LongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/DebtScheduleofDebtMaturitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationSeniorUnsecuredNotesDetail",
      "http://www.iff.com/role/DebtScheduleofDebtMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total",
        "totalLabel": "Total",
        "label": "Long-Term Debt",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r341",
      "r723",
      "r737",
      "r1286",
      "r1287",
      "r1644"
     ]
    },
    "us-gaap_LongTermDebtCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/DebtComponentsofDebtDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Current maturities of long-term debt",
        "label": "Long-Term Debt, Current Maturities",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r424"
     ]
    },
    "us-gaap_LongTermDebtMaturingInYearsFourAndFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtMaturingInYearsFourAndFive",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/DebtScheduleofDebtMaturitiesDetails": {
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/DebtScheduleofDebtMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "3-5 Years",
        "label": "Long-Term Debt, Maturity, Year Four and Five",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth and fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r1514"
     ]
    },
    "us-gaap_LongTermDebtMaturingInYearsTwoAndThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtMaturingInYearsTwoAndThree",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/DebtScheduleofDebtMaturitiesDetails": {
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/DebtScheduleofDebtMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "1-3 Years",
        "label": "Long-Term Debt, Maturity, Year Two and Three",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second and third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r1514"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/DebtScheduleofDebtMaturitiesDetails": {
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/DebtScheduleofDebtMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "More than 5 Years",
        "label": "Long-Term Debt, Maturity, after Year Five",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r480",
      "r1514"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/DebtScheduleofDebtMaturitiesDetails": {
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/DebtScheduleofDebtMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Less than 1 Year",
        "label": "Long-Term Debt, Maturity, Year One",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r480",
      "r728"
     ]
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET",
      "http://www.iff.com/role/DebtComponentsofDebtDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term debt",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r426"
     ]
    },
    "iff_LongTermIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "LongTermIncentivePlanMember",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Term Incentive Plan [Member]",
        "label": "Long Term Incentive Plan [Member]",
        "documentation": "Long-term incentive plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongtermDebtTypeAxis",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationCommercialPaperandRedemptionProvisionsDetail",
      "http://www.iff.com/role/DebtAdditionalInformationSeniorUnsecuredNotesDetail",
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail",
      "http://www.iff.com/role/DebtComponentsofDebtDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Axis]",
        "label": "Long-Term Debt, Type [Axis]",
        "documentation": "Information by type of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongtermDebtTypeDomain",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationCommercialPaperandRedemptionProvisionsDetail",
      "http://www.iff.com/role/DebtAdditionalInformationSeniorUnsecuredNotesDetail",
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail",
      "http://www.iff.com/role/DebtComponentsofDebtDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Domain]",
        "label": "Long-Term Debt, Type [Domain]",
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r124"
     ]
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss Contingency Nature [Axis]",
        "label": "Loss Contingency Nature [Axis]",
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r690",
      "r691",
      "r692",
      "r696",
      "r1509",
      "r1510"
     ]
    },
    "us-gaap_LossContingencyEstimateOfPossibleLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LossContingencyEstimateOfPossibleLoss",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimated maximum future costs of environmental liabilities for identified sites (less than $5 million)",
        "label": "Loss Contingency, Estimate of Possible Loss",
        "documentation": "Reflects the estimated amount of loss from the specified contingency as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r691",
      "r692",
      "r695",
      "r696"
     ]
    },
    "us-gaap_LossContingencyNatureDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LossContingencyNatureDomain",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss Contingency, Nature [Domain]",
        "label": "Loss Contingency, Nature [Domain]",
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability."
       }
      }
     },
     "auth_ref": [
      "r690",
      "r691",
      "r692",
      "r696",
      "r1509",
      "r1510"
     ]
    },
    "iff_LossContingencyReceivableWrittenOff": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "LossContingencyReceivableWrittenOff",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss Contingency, Receivable Written Off",
        "label": "Loss Contingency, Receivable Written Off",
        "documentation": "Loss Contingency, Receivable Written Off"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MachineryAndEquipmentMember",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.iff.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Machinery and equipment [Member]",
        "label": "Machinery and Equipment [Member]",
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment."
       }
      }
     },
     "auth_ref": []
    },
    "srt_MajorCustomersAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MajorCustomersAxis",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer [Axis]",
        "label": "Customer [Axis]",
        "documentation": "Information by name or description of a single external customer or a group of external customers."
       }
      }
     },
     "auth_ref": [
      "r562",
      "r1292",
      "r1516",
      "r1646",
      "r1647"
     ]
    },
    "us-gaap_MalpracticeLossContingencyAccrualUndiscounted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MalpracticeLossContingencyAccrualUndiscounted",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current accrual",
        "label": "Malpractice Loss Contingency, Accrual, Undiscounted",
        "documentation": "Amount of the accrued liability on an undiscounted basis for malpractice claims (including general and professional liability) at the end of the accounting period."
       }
      }
     },
     "auth_ref": [
      "r1508"
     ]
    },
    "iff_MalpracticeLossContingencyPaymentsInceptionToDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "MalpracticeLossContingencyPaymentsInceptionToDate",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Malpractice Loss Contingency, Payments, Inception-to-date",
        "label": "Malpractice Loss Contingency, Payments, Inception-to-date",
        "documentation": "Malpractice Loss Contingency, Payments, Inception-to-date"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MalpracticeLossContingencyPeriodCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MalpracticeLossContingencyPeriodCost",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current associated costs",
        "label": "Malpractice Loss Contingency, Period Cost",
        "documentation": "Amount of costs associated with malpractice claims, including costs associated with litigating and settling claims, incurred during an accounting period."
       }
      }
     },
     "auth_ref": [
      "r220",
      "r221"
     ]
    },
    "us-gaap_MalpracticeLossContingencyPeriodIncreaseDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MalpracticeLossContingencyPeriodIncreaseDecrease",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Malpractice Loss Contingency, Period Increase (Decrease)",
        "label": "Malpractice Loss Contingency, Period Increase (Decrease)",
        "documentation": "The increase (decrease) in the accrued liability for malpractice claims during an accounting period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ManufacturingFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ManufacturingFacilityMember",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Manufacturing Facility [Member]",
        "label": "Manufacturing Facility [Member]",
        "documentation": "Structure used in the manufacturing of goods."
       }
      }
     },
     "auth_ref": [
      "r289"
     ]
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails",
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail",
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail",
      "http://www.iff.com/role/DebtComponentsofDebtDetail",
      "http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail",
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetNarrativeDetails",
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.iff.com/role/TangibleEquityUnitsTangibleEquitySettlementofSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "label": "Maximum [Member]",
        "documentation": "Upper limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r691",
      "r692",
      "r693",
      "r694",
      "r837",
      "r1061",
      "r1109",
      "r1155",
      "r1156",
      "r1213",
      "r1215",
      "r1217",
      "r1218",
      "r1228",
      "r1251",
      "r1252",
      "r1273",
      "r1290",
      "r1303",
      "r1312",
      "r1513",
      "r1634",
      "r1635",
      "r1636",
      "r1637",
      "r1638",
      "r1639"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measure:",
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1374"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Measure Name"
       }
      }
     },
     "auth_ref": [
      "r1374"
     ]
    },
    "iff_MicrobialControlMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "MicrobialControlMember",
     "presentation": [
      "http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleDetails",
      "http://www.iff.com/role/BusinessDivestitureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Microbial Control",
        "label": "Microbial Control [Member]",
        "documentation": "Microbial Control"
       }
      }
     },
     "auth_ref": []
    },
    "iff_MicrocrystallineCelluloseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "MicrocrystallineCelluloseMember",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Microcrystalline Cellulose",
        "label": "Microcrystalline Cellulose [Member]",
        "documentation": "Microcrystalline Cellulose"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails",
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail",
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail",
      "http://www.iff.com/role/DebtComponentsofDebtDetail",
      "http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail",
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetNarrativeDetails",
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.iff.com/role/TangibleEquityUnitsTangibleEquitySettlementofSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum",
        "label": "Minimum [Member]",
        "documentation": "Lower limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r691",
      "r692",
      "r693",
      "r694",
      "r837",
      "r1061",
      "r1109",
      "r1155",
      "r1156",
      "r1213",
      "r1215",
      "r1217",
      "r1218",
      "r1228",
      "r1251",
      "r1252",
      "r1273",
      "r1290",
      "r1303",
      "r1312",
      "r1513",
      "r1634",
      "r1635",
      "r1636",
      "r1637",
      "r1638",
      "r1639"
     ]
    },
    "iff_MinimumPercentageLikelihoodOfTaxBenefitToBeRealizedUponFinalSettlement": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "MinimumPercentageLikelihoodOfTaxBenefitToBeRealizedUponFinalSettlement",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum percentage chance of tax benefit realization in final settlement",
        "label": "Minimum Percentage Likelihood Of Tax Benefit To Be Realized Upon Final Settlement",
        "documentation": "Minimum percentage likelihood of tax benefit to be realized upon final settlement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MinorityInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MinorityInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET",
      "http://www.iff.com/role/RedeemableNoncontrollingInterestsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-controlling interest",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Equity, Attributable to Noncontrolling Interest",
        "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r342",
      "r475",
      "r601",
      "r697",
      "r700",
      "r701",
      "r702",
      "r708",
      "r709",
      "r978",
      "r1083",
      "r1167"
     ]
    },
    "us-gaap_MinorityInterestChangeInRedemptionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MinorityInterestChangeInRedemptionValue",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/RedeemableNoncontrollingInterestsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Redemption value adjustment for the current period",
        "label": "Noncontrolling Interest, Change in Redemption Value",
        "documentation": "Change in noncontrolling interest during the period as a result of a change in the redemption value of redeemable noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r130",
      "r131",
      "r138"
     ]
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY",
      "http://www.iff.com/role/RedeemableNoncontrollingInterestsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Dividends on non-controlling interest and other",
        "terseLabel": "Exercises of redeemable non-controlling interests",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders."
       }
      }
     },
     "auth_ref": [
      "r301"
     ]
    },
    "us-gaap_MinorityInterestDecreaseFromRedemptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MinorityInterestDecreaseFromRedemptions",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY",
      "http://www.iff.com/role/RedeemableNoncontrollingInterestsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchase of NCI",
        "terseLabel": "Exercises of redeemable non-controlling interests",
        "label": "Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests",
        "documentation": "Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests)."
       }
      }
     },
     "auth_ref": [
      "r180",
      "r301",
      "r325"
     ]
    },
    "us-gaap_MinorityInterestDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MinorityInterestDisclosureTextBlock",
     "presentation": [
      "http://www.iff.com/role/RedeemableNoncontrollingInterests"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Redeemable Noncontrolling Interests",
        "label": "Noncontrolling Interest Disclosure [Text Block]",
        "documentation": "The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock."
       }
      }
     },
     "auth_ref": [
      "r323"
     ]
    },
    "us-gaap_MinorityInterestLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MinorityInterestLineItems",
     "presentation": [
      "http://www.iff.com/role/RedeemableNoncontrollingInterestsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Noncontrolling Interest [Line Items]",
        "label": "Noncontrolling Interest [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MinorityInterestTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MinorityInterestTable",
     "presentation": [
      "http://www.iff.com/role/RedeemableNoncontrollingInterestsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Noncontrolling Interest [Table]",
        "label": "Noncontrolling Interest [Table]",
        "documentation": "Schedule of noncontrolling interest disclosure which includes the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r179",
      "r182",
      "r266"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MNPI Disclosure Timed for Compensation Value",
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1394"
     ]
    },
    "us-gaap_MovementInMinorityInterestRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MovementInMinorityInterestRollForward",
     "presentation": [
      "http://www.iff.com/role/RedeemableNoncontrollingInterestsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]",
        "label": "Equity, Attributable to Noncontrolling Interest [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MovementInValuationAllowancesAndReservesRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MovementInValuationAllowancesAndReservesRollForward",
     "presentation": [
      "http://www.iff.com/role/ScheduleIIValuationandQualifyingAccountsandReservesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]",
        "label": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Material Terms of Trading Arrangement",
        "label": "Material Terms of Trading Arrangement [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1402"
     ]
    },
    "us-gaap_MunicipalBondsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MunicipalBondsMember",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Municipal Bonds",
        "label": "Municipal Bonds [Member]",
        "documentation": "Long-term debt securities issued by state, city or local governments or the agencies operated by state, city or local governments."
       }
      }
     },
     "auth_ref": []
    },
    "country_NL": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "NL",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationAdditionalInformationDetail",
      "http://www.iff.com/role/SegmentInformationSegmentInformationScheduleofLongLivedAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NETHERLANDS",
        "label": "NETHERLANDS"
       }
      }
     },
     "auth_ref": []
    },
    "srt_NameOfMajorCustomerDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "NameOfMajorCustomerDomain",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer [Domain]",
        "label": "Customer [Domain]",
        "documentation": "Single external customer or group of external customers."
       }
      }
     },
     "auth_ref": [
      "r562",
      "r1292",
      "r1516",
      "r1646",
      "r1647"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Named Executive Officers, Footnote",
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1375"
     ]
    },
    "us-gaap_NatureOfOperations": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NatureOfOperations",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nature of Operations",
        "label": "Nature of Operations [Text Block]",
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward."
       }
      }
     },
     "auth_ref": [
      "r355",
      "r366"
     ]
    },
    "iff_NatureOfOperationsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "NatureOfOperationsPolicyTextBlock",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nature of Operations",
        "label": "Nature of Operations [Policy Text Block]",
        "documentation": "Nature of Operations"
       }
      }
     },
     "auth_ref": []
    },
    "iff_NetBorrowingsRepaymentsOfCommercialPaperMaturingInLessThanThreeMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "NetBorrowingsRepaymentsOfCommercialPaperMaturingInLessThanThreeMonths",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net (repayments) borrowings of commercial paper (maturities less than three months)",
        "label": "Net Borrowings (Repayments) Of Commercial Paper, Maturing In Less Than Three Months",
        "documentation": "Net Borrowings (Repayments) Of Commercial Paper, Maturing In Less Than Three Months"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r469"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from financing activities:",
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by (used in) investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r469"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from investing activities:",
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r276",
      "r277",
      "r278"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from operating activities:",
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/NetIncomePerShareAdditionalInformationDetail",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net income",
        "label": "Net Income (Loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r263",
      "r278",
      "r345",
      "r413",
      "r447",
      "r450",
      "r455",
      "r475",
      "r493",
      "r497",
      "r498",
      "r500",
      "r501",
      "r505",
      "r506",
      "r517",
      "r533",
      "r547",
      "r553",
      "r556",
      "r601",
      "r697",
      "r698",
      "r700",
      "r701",
      "r702",
      "r704",
      "r706",
      "r708",
      "r709",
      "r967",
      "r978",
      "r1091",
      "r1187",
      "r1206",
      "r1207",
      "r1271",
      "r1326",
      "r1511"
     ]
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME",
      "http://www.iff.com/role/RedeemableNoncontrollingInterestsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net income attributable to non-controlling interest",
        "terseLabel": "Sale of a subsidiary with redeemable non-controlling interests",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r184",
      "r326",
      "r447",
      "r450",
      "r505",
      "r506",
      "r1090",
      "r1448"
     ]
    },
    "us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLossAttributableToRedeemableNoncontrollingInterest",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Redeemable NCI",
        "label": "Net Income (Loss) Attributable to Redeemable Noncontrolling Interest",
        "documentation": "Amount of Net Income (Loss) attributable to redeemable noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r266"
     ]
    },
    "iff_NetIncomeLossAvailableToCommonStockholdersAdjustment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "NetIncomeLossAvailableToCommonStockholdersAdjustment",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/NetIncomePerShareReconciliationofSharesUsedinComputationofBasicandDilutedNetIncomePerShareDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iff.com/role/NetIncomePerShareReconciliationofSharesUsedinComputationofBasicandDilutedNetIncomePerShareDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net (loss) income available to IFF shareholders",
        "label": "Net Income (Loss) Available To Common Stockholders, Adjustment",
        "documentation": "Net Income (Loss) Available To Common Stockholders, Adjustment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.iff.com/role/NetIncomePerShareReconciliationofSharesUsedinComputationofBasicandDilutedNetIncomePerShareDetail": {
       "parentTag": "iff_NetIncomeLossAvailableToCommonStockholdersAdjustment",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME",
      "http://www.iff.com/role/NetIncomePerShareReconciliationofSharesUsedinComputationofBasicandDilutedNetIncomePerShareDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net income available to IFF common shareholders",
        "terseLabel": "Net (loss) income available to IFF shareholders",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r465",
      "r497",
      "r498",
      "r500",
      "r501",
      "r509",
      "r510",
      "r518",
      "r521",
      "r533",
      "r547",
      "r553",
      "r556",
      "r1271"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAbstract",
     "presentation": [
      "http://www.iff.com/role/NetIncomePerShareReconciliationofSharesUsedinComputationofBasicandDilutedNetIncomePerShareDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net (Loss) Income",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net (loss) income",
        "label": "Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest",
        "documentation": "Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r326",
      "r327"
     ]
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetInvestmentHedgingMember",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsAdditionalInformationDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowandNetInvestmentHedgingInstrumentsDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsNotionalAmountOutstandingDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Investment Hedging [Member]",
        "label": "Net Investment Hedging [Member]",
        "documentation": "Hedges of a net investment in a foreign operation."
       }
      }
     },
     "auth_ref": [
      "r189"
     ]
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recent Accounting Pronouncements",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-GAAP Measure Description",
        "label": "Non-GAAP Measure Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1374"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-NEOs",
        "label": "Non-NEOs [Member]"
       }
      }
     },
     "auth_ref": [
      "r1343",
      "r1355",
      "r1365",
      "r1382",
      "r1391"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1372"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount",
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1371"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO",
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r1382"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted",
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1402"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated",
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1402"
     ]
    },
    "iff_NonUSAssetBackedSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "NonUSAssetBackedSecuritiesMember",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-U.S. Asset-Backed Securities",
        "label": "Non U S Asset Backed Securities [Member]",
        "documentation": "Non U.S. Asset Backed Securities [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_NonUSCorporateBondsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "NonUSCorporateBondsMember",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-U.S. Corporate Bonds",
        "label": "Non U S Corporate Bonds [Member]",
        "documentation": "Non U.S. Corporate Bonds [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_NonUSOtherFixedIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "NonUSOtherFixedIncomeMember",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-U.S. Other Fixed Income",
        "label": "Non U S Other Fixed Income [Member]",
        "documentation": "Non U.S. Other Fixed Income [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_NonUSTreasuriesOrGovernmentBondsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "NonUSTreasuriesOrGovernmentBondsMember",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-U.S. Treasuries/Government Bonds",
        "label": "Non U S Treasuries Or Government Bonds [Member]",
        "documentation": "Non U.S. Treasuries Or Government Bonds [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NonUsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NonUsMember",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-US [Member]",
        "label": "Non-US [Member]",
        "documentation": "Countries excluding the United States of America (US)."
       }
      }
     },
     "auth_ref": [
      "r1654",
      "r1656",
      "r1657",
      "r1658"
     ]
    },
    "us-gaap_NoncontrollingInterestAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NoncontrollingInterestAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Noncontrolling Interest [Abstract]",
        "label": "Noncontrolling Interest [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_NoncontrollingInterestDecreaseFromDisposal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "NoncontrollingInterestDecreaseFromDisposal",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/RedeemableNoncontrollingInterestsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposal of redeemable non-controlling interests",
        "label": "Noncontrolling Interest, Decrease From Disposal",
        "documentation": "Noncontrolling Interest, Decrease From Disposal"
       }
      }
     },
     "auth_ref": []
    },
    "iff_NoncontrollingInterestImpactOfForeignExchangeTranslation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "NoncontrollingInterestImpactOfForeignExchangeTranslation",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/RedeemableNoncontrollingInterestsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Impact of foreign exchange translation",
        "label": "Noncontrolling Interest, Impact Of Foreign Exchange Translation",
        "documentation": "Noncontrolling Interest, Impact Of Foreign Exchange Translation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NoncontrollingInterestMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NoncontrollingInterestMember",
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-controlling interest",
        "label": "Noncontrolling Interest [Member]",
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest."
       }
      }
     },
     "auth_ref": [
      "r178",
      "r754",
      "r1468",
      "r1469",
      "r1470",
      "r1651"
     ]
    },
    "us-gaap_NondesignatedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NondesignatedMember",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsAdditionalInformationDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowandNetInvestmentHedgingInstrumentsDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsMeasuredatFairValueDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsWhichWereNotDesignatedasHedgingInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value of Derivatives Not Designated as Hedging Instrument",
        "label": "Not Designated as Hedging Instrument [Member]",
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "us-gaap_NonqualifiedPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NonqualifiedPlanMember",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nonqualified Plan",
        "label": "Nonqualified Plan [Member]",
        "documentation": "Plan without tax-exempt status in accordance with applicable tax provision of designated taxing authority. Taxing authority includes, but is not limited to, U.S. Internal Revenue Service (IRS). Includes, but is not limited to, defined benefit and defined contribution plans."
       }
      }
     },
     "auth_ref": [
      "r1417",
      "r1520",
      "r1521",
      "r1522",
      "r1523",
      "r1524",
      "r1525",
      "r1526",
      "r1527",
      "r1528",
      "r1529",
      "r1530",
      "r1531",
      "r1532",
      "r1533",
      "r1534",
      "r1535",
      "r1536",
      "r1537",
      "r1538",
      "r1539",
      "r1540",
      "r1541",
      "r1542",
      "r1543",
      "r1544",
      "r1545",
      "r1546",
      "r1547",
      "r1548",
      "r1549",
      "r1550",
      "r1551",
      "r1552",
      "r1553",
      "r1554",
      "r1555",
      "r1556",
      "r1557",
      "r1558",
      "r1559",
      "r1560",
      "r1561",
      "r1562",
      "r1563",
      "r1564",
      "r1565",
      "r1566",
      "r1567",
      "r1568",
      "r1569",
      "r1570",
      "r1571",
      "r1572",
      "r1573",
      "r1574",
      "r1575",
      "r1576",
      "r1577",
      "r1578",
      "r1579"
     ]
    },
    "us-gaap_NonrecurringAdjustmentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NonrecurringAdjustmentAxis",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nonrecurring Adjustment [Axis]",
        "label": "Nonrecurring Adjustment [Axis]",
        "documentation": "Information about material and nonrecurring adjustment directly attributable to the business combination(s) included in the reported pro forma revenue and earnings (supplemental pro forma information)."
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "us-gaap_NonrecurringAdjustmentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NonrecurringAdjustmentDomain",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nonrecurring Adjustment [Domain]",
        "label": "Nonrecurring Adjustment [Domain]",
        "documentation": "Material, nonrecurring adjustment(s) allocated (included) to (in) reported pro forma revenue and earnings (supplemental pro forma information)."
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "srt_NorthAmericaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "NorthAmericaMember",
     "presentation": [
      "http://www.iff.com/role/RestructuringandOtherChargesAdditionalInformationDetails",
      "http://www.iff.com/role/SegmentInformationNetSalesbyGeographicAreaDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "North America [Member]",
        "label": "North America [Member]",
        "documentation": "Continent of North America."
       }
      }
     },
     "auth_ref": [
      "r1654",
      "r1656",
      "r1657",
      "r1658"
     ]
    },
    "iff_NourishAndHealthBiosciencesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "NourishAndHealthBiosciencesMember",
     "presentation": [
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nourish and Health &amp; Biosciences",
        "label": "Nourish and Health &amp; Biosciences [Member]",
        "documentation": "Nourish and Health &amp; Biosciences"
       }
      }
     },
     "auth_ref": []
    },
    "iff_NourishMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "NourishMember",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails",
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetGoodwillRollforwardDetails",
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetNarrativeDetails",
      "http://www.iff.com/role/RestructuringandOtherChargesMovementsinRestructuringandRelatedAccrualsDetail",
      "http://www.iff.com/role/SegmentInformationCapitalExpenditureandDepreciationandAmortizationbySegmentDetail",
      "http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nourish",
        "label": "Nourish [Member]",
        "documentation": "Nourish [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_NumberOfCustomers": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "NumberOfCustomers",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number Of Customers",
        "label": "Number Of Customers",
        "documentation": "Number Of Customers"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfForeignCurrencyDerivativesHeld": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NumberOfForeignCurrencyDerivativesHeld",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsAdditionalInformationDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowandNetInvestmentHedgingInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of Foreign Currency Derivatives Held",
        "label": "Number of Foreign Currency Derivatives Held",
        "documentation": "Number of foreign currency exchange rate derivatives held by the entity at the reporting date."
       }
      }
     },
     "auth_ref": [
      "r186",
      "r187"
     ]
    },
    "iff_NumberOfFragranceCategories": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "NumberOfFragranceCategories",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of fragrance categories",
        "label": "Number Of Fragrance Categories",
        "documentation": "Number of fragrance categories."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfInterestRateDerivativesHeld": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NumberOfInterestRateDerivativesHeld",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of interest rate derivatives held",
        "label": "Number of Interest Rate Derivatives Held",
        "documentation": "Number of interest rate derivative instruments held by the entity at the reporting date."
       }
      }
     },
     "auth_ref": [
      "r186",
      "r187"
     ]
    },
    "us-gaap_NumberOfOperatingSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NumberOfOperatingSegments",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of Operating Segments",
        "label": "Number of Operating Segments",
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues."
       }
      }
     },
     "auth_ref": [
      "r1475"
     ]
    },
    "us-gaap_NumberOfReportingUnits": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NumberOfReportingUnits",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of reporting units",
        "label": "Number of Reporting Units",
        "documentation": "Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment."
       }
      }
     },
     "auth_ref": []
    },
    "iff_NumberOfSegments": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "NumberOfSegments",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of segments",
        "label": "Number Of Segments",
        "documentation": "Number Of Segments"
       }
      }
     },
     "auth_ref": []
    },
    "iff_NumberofFacilities": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "NumberofFacilities",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of plants",
        "label": "Number of Facilities",
        "documentation": "Number of Facilities"
       }
      }
     },
     "auth_ref": []
    },
    "iff_NutritionBiosciencesIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "NutritionBiosciencesIncMember",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails",
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail",
      "http://www.iff.com/role/DebtAdditionalInformationCommercialPaperandRedemptionProvisionsDetail",
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail",
      "http://www.iff.com/role/DebtTables",
      "http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail",
      "http://www.iff.com/role/LeasesAdditionalInformationDetails",
      "http://www.iff.com/role/LeasesDetails",
      "http://www.iff.com/role/NetIncomePerShareAdditionalInformationDetail",
      "http://www.iff.com/role/RestructuringandOtherChargesAdditionalInformationDetails",
      "http://www.iff.com/role/RestructuringandOtherChargesMovementsinRestructuringandRelatedAccrualsDetail",
      "http://www.iff.com/role/SegmentInformationAdditionalInformationDetail",
      "http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nutrition &amp; Biosciences, Inc",
        "label": "Nutrition &amp; Biosciences, Inc [Member]",
        "documentation": "Nutrition &amp; Biosciences, Inc [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_NutritionBiosciencesIncSeniorNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "NutritionBiosciencesIncSeniorNotesMember",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationCommercialPaperandRedemptionProvisionsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nutrition &amp; Biosciences, Inc Senior Notes",
        "label": "Nutrition &amp; Biosciences, Inc Senior Notes [Member]",
        "documentation": "Nutrition &amp; Biosciences, Inc Senior Notes"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OciBeforeReclassificationsNetOfTaxAttributableToParent",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "OCI before reclassifications",
        "label": "OCI, before Reclassifications, Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax, before reclassification adjustments, of other comprehensive income (loss), attributable to parent."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r80"
     ]
    },
    "iff_OperatingAndFinanceLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "OperatingAndFinanceLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails_1": {
       "parentTag": "iff_LesseeOperatingAndFinanceLeasePaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating and Finance Lease, Liability",
        "label": "Operating and Finance Lease, Liability",
        "documentation": "Operating and Finance Lease, Liability"
       }
      }
     },
     "auth_ref": []
    },
    "iff_OperatingEBITDAMargin": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "OperatingEBITDAMargin",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating EBITDA Margin",
        "label": "Operating EBITDA Margin",
        "documentation": "Operating EBITDA Margin"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Operating (loss) profit",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r533",
      "r547",
      "r553",
      "r556",
      "r1271"
     ]
    },
    "us-gaap_OperatingLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/LeasesScheduleofLeaseExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease cost",
        "label": "Operating Lease, Cost",
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
       }
      }
     },
     "auth_ref": [
      "r1017",
      "r1310"
     ]
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.iff.com/role/LeasesBalanceSheetDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iff.com/role/LeasesAdditionalInformationDetails",
      "http://www.iff.com/role/LeasesBalanceSheetDetails",
      "http://www.iff.com/role/LeasesDetails",
      "http://www.iff.com/role/LeasesScheduleofLeaseMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Lease, Liability",
        "totalLabel": "Operating Lease, Liability",
        "label": "Operating Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r1009"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/LeasesBalanceSheetDetails": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/LeasesBalanceSheetDetails",
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current operating lease obligation",
        "label": "Operating Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r1009"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "presentation": [
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]",
        "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes current operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r1010"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.iff.com/role/LeasesBalanceSheetDetails": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET",
      "http://www.iff.com/role/LeasesBalanceSheetDetails",
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r1009"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/LeasesCashFlowDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating cash flows for operating leases",
        "label": "Operating Lease, Payments",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r1013",
      "r1019"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleDetails": {
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleDetails",
      "http://www.iff.com/role/BusinessDivestitureDetails",
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET",
      "http://www.iff.com/role/LeasesAdditionalInformationDetails",
      "http://www.iff.com/role/LeasesBalanceSheetDetails",
      "http://www.iff.com/role/LeasesDetails",
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease right-of-use assets",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r1008"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://www.iff.com/role/LeasesWeightedAverageDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease weighted average discount rate",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r1022",
      "r1310"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://www.iff.com/role/LeasesWeightedAverageDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease weighted average remaining lease term",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1021",
      "r1310"
     ]
    },
    "us-gaap_OperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLossCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.iff.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Operating loss carryforwards",
        "terseLabel": "Credit and net operating loss carryforwards",
        "label": "Operating Loss Carryforwards",
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "us-gaap_OperatingLossCarryforwardsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLossCarryforwardsValuationAllowance",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Valuation allowance for net operating loss carryforwards",
        "label": "Operating Loss Carryforwards, Valuation Allowance",
        "documentation": "The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "us-gaap_OperatingSegmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingSegmentsMember",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationCapitalExpenditureandDepreciationandAmortizationbySegmentDetail",
      "http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Segments [Member]",
        "label": "Operating Segments [Member]",
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r556"
     ]
    },
    "iff_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization And Summary Of Significant Accounting Policies [Line Items]",
        "label": "Organization And Summary Of Significant Accounting Policies [Line Items]",
        "documentation": "Organization And Summary Of Significant Accounting Policies [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_OrganizationAndSummaryOfSignificantAccountingPoliciesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "OrganizationAndSummaryOfSignificantAccountingPoliciesTable",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization And Summary Of Significant Accounting Policies [Table]",
        "label": "Organization And Summary Of Significant Accounting Policies [Table]",
        "documentation": "Organization And Summary Of Significant Accounting Policies [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nature of Operations and Summary of Significant Accounting Policies",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements."
       }
      }
     },
     "auth_ref": [
      "r223",
      "r279",
      "r280",
      "r323"
     ]
    },
    "us-gaap_OtherAccountsPayableAndAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAccountsPayableAndAccruedLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses payable",
        "label": "Other Accounts Payable and Accrued Liabilities",
        "documentation": "Amount of liabilities incurred and payable to vendors for goods and services received classified as other, and expenses incurred but not yet paid, payable within one year or the operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherAddressMember",
     "presentation": [
      "http://www.iff.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Address",
        "label": "Other Address [Member]",
        "documentation": "Other address for entity"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Assets [Abstract]",
        "label": "Other Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_OtherAssetsAndLiabilitiesDisclosureCurrentAndNoncurrentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "OtherAssetsAndLiabilitiesDisclosureCurrentAndNoncurrentTextBlock",
     "presentation": [
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrent"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Current Assets and Liabilities, and Other Assets",
        "label": "Other Assets And Liabilities Disclosure, Current And Noncurrent [Text Block]",
        "documentation": "Other Assets And Liabilities Disclosure, Current And Noncurrent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherAssetsDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET",
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses and other current assets",
        "totalLabel": "Other Assets, Current",
        "label": "Other Assets, Current",
        "documentation": "Amount of current assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r436",
      "r1311"
     ]
    },
    "us-gaap_OtherAssetsMiscellaneousNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssetsMiscellaneousNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherAssetsDetail": {
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other Assets, Miscellaneous, Noncurrent",
        "documentation": "Amount of other miscellaneous assets expected to be realized or consumed after one year or normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 6.0
      },
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherAssetsDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iff.com/role/BusinessDivestitureDetails",
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET",
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other assets",
        "totalLabel": "Total",
        "label": "Other Assets, Noncurrent",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r422"
     ]
    },
    "iff_OtherComponentsOfOtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "OtherComponentsOfOtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/OtherExpenseIncomeNetDetails": {
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/OtherExpenseIncomeNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other Components Of Other Nonoperating Income (Expense)",
        "documentation": "Other Components Of Other Nonoperating Income (Expense)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recognized prior service credit",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), before Tax",
        "documentation": "Amount, before tax, of cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit)."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r260",
      "r803"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Currency translation adjustment",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent",
        "documentation": "Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, on foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r40",
      "r324"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME",
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gains on derivatives qualifying as hedges",
        "verboseLabel": "Gains (losses) on derivatives qualifying as hedges, net of tax",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness."
       }
      }
     },
     "auth_ref": [
      "r442",
      "r443"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowandNetInvestmentHedgingInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax",
        "documentation": "Amount, before tax and after reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness."
       }
      }
     },
     "auth_ref": [
      "r442",
      "r443"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITYParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification, tax",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax",
        "documentation": "Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness."
       }
      }
     },
     "auth_ref": [
      "r444"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossReclassificationsofAccumulatedOtherComprehensiveIncometoConsolidatedStatementofComprehensiveIncomeDetail_1": {
       "parentTag": "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossReclassificationsofAccumulatedOtherComprehensiveIncometoConsolidatedStatementofComprehensiveIncomeDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Settlements / Curtailments",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), before Tax",
        "documentation": "Amount, before tax, of increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r260",
      "r305"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME",
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Foreign currency translation adjustments",
        "terseLabel": "Cumulative translation adjustment",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive income (loss)",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r57",
      "r448",
      "r451",
      "r458",
      "r989",
      "r990",
      "r995",
      "r1070",
      "r1092",
      "r1446",
      "r1447"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net current period other comprehensive income (loss)",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r40",
      "r324",
      "r448",
      "r451"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract",
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive income (loss), after tax:",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostandChangesinPlanAssetsandBenefitObligationsRecognizedinOCIDetail",
      "http://www.iff.com/role/EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total loss (gain) recognized in OCI (before tax effects)",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax",
        "documentation": "Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r260",
      "r1295",
      "r1559"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME",
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Pension and postretirement liability adjustment",
        "negatedLabel": "Pension liability and postretirement adjustment; net of tax",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r260"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostandChangesinPlanAssetsandBenefitObligationsRecognizedinOCIDetail",
      "http://www.iff.com/role/EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Recognized actuarial (loss) gain",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax",
        "documentation": "Amount, before tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r260",
      "r305"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITYParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax effect of pension liability and postretirement adjustment",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax",
        "documentation": "Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r18",
      "r324"
     ]
    },
    "iff_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIDueToBusinessDivestitures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIDueToBusinessDivestitures",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Comprehensive Income (Loss), Reclassification Adjustment From AOCI Due To Business Divestitures",
        "label": "Other Comprehensive Income (Loss), Reclassification Adjustment From AOCI Due To Business Divestitures",
        "documentation": "Other Comprehensive Income (Loss), Reclassification Adjustment From AOCI Due To Business Divestitures"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowandNetInvestmentHedgingInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)",
        "label": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax",
        "documentation": "Amount before tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r204",
      "r260"
     ]
    },
    "iff_OtherCostsCredits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "OtherCostsCredits",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other (Costs) Credits",
        "label": "Other (Costs) Credits",
        "documentation": "Other (Costs) Credits"
       }
      }
     },
     "auth_ref": []
    },
    "iff_OtherCountriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "OtherCountriesMember",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationSegmentInformationScheduleofLongLivedAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Countries [Member]",
        "label": "Other Countries [Member]",
        "documentation": "Other Countries [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherCurrentLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherCurrentLiabilitiesMember",
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.iff.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofUnrecognizedTaxBenefitsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Current Liabilities [Member]",
        "label": "Other Current Liabilities [Member]",
        "documentation": "Primary financial statement caption encompassing other current liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherCurrentLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherCurrentLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Current Liabilities",
        "label": "Other Current Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of other current liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherDeferredCostsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherDeferredCostsGross",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationSeniorUnsecuredNotesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other deferred costs",
        "label": "Other Deferred Costs, Gross",
        "documentation": "Gross amount of other deferred costs capitalized at the end of the reporting period. Does not include deferred finance costs or deferred acquisition costs of insurance companies."
       }
      }
     },
     "auth_ref": [
      "r1444"
     ]
    },
    "us-gaap_OtherDepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherDepreciationAndAmortization",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other Depreciation and Amortization",
        "label": "Other Depreciation and Amortization",
        "documentation": "Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r118",
      "r268"
     ]
    },
    "us-gaap_OtherIncomeAndExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherIncomeAndExpensesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income and Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_OtherIncomeExpenseNetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "OtherIncomeExpenseNetMember",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsAdditionalInformationDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsWhichWereNotDesignatedasHedgingInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Income Expense Net [Member]",
        "label": "Other Income Expense Net [Member]",
        "documentation": "Other Income Expense, Net."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherIntangibleAssetsMember",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails",
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetTrademarkandOtherIntangibleAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other [Member]",
        "label": "Other Intangible Assets [Member]",
        "documentation": "Intangible assets classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherInvestmentCompaniesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherInvestmentCompaniesMember",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsPercentageofAssetsInvestedDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Alternative and other investments",
        "label": "Other Investment Companies [Member]",
        "documentation": "Investment in other investment companies (as defined)."
       }
      }
     },
     "auth_ref": [
      "r1313",
      "r1314"
     ]
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherCurrentLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET",
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other current liabilities",
        "totalLabel": "Total",
        "label": "Other Liabilities, Current",
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r1311"
     ]
    },
    "us-gaap_OtherLiabilitiesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Liabilities Disclosure [Abstract]",
        "label": "Other Liabilities Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesMember",
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Liabilities [Member]",
        "label": "Other Liabilities [Member]",
        "documentation": "Primary financial statement caption encompassing other liabilities."
       }
      }
     },
     "auth_ref": [
      "r190",
      "r202"
     ]
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/BusinessDivestitureDetails": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/BusinessDivestitureDetails",
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET",
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other liabilities",
        "negatedTerseLabel": "Other Liabilities, Noncurrent",
        "label": "Other Liabilities, Noncurrent",
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNonoperatingIncomeAndExpenseTextBlock",
     "presentation": [
      "http://www.iff.com/role/OtherIncomeandExpenses"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other (Expense) Income, Net",
        "label": "Other Nonoperating Income and Expense [Text Block]",
        "documentation": "The entire disclosure for the components of non-operating income or non-operating expense, including, but not limited to, amounts earned from dividends, interest on securities, gain (loss) on securities sold, equity earnings of unconsolidated affiliates, gain (loss) on sales of business, interest expense and other miscellaneous income or expense items."
       }
      }
     },
     "auth_ref": [
      "r463",
      "r464"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.iff.com/role/OtherExpenseIncomeNetDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME",
      "http://www.iff.com/role/OtherExpenseIncomeNetDetails",
      "http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other expense (income), net",
        "terseLabel": "Other (expense) income, net",
        "totalLabel": "Other (expense) income, net",
        "label": "Other Nonoperating Income (Expense)",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r272"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsWhichWereNotDesignatedasHedgingInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other (income) expense, net [Member]",
        "label": "Other Nonoperating Income (Expense) [Member]",
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense)."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Performance Measure, Amount",
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r1374"
     ]
    },
    "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail",
      "http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetail",
      "http://www.iff.com/role/EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail",
      "http://www.iff.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostandChangesinPlanAssetsandBenefitObligationsRecognizedinOCIDetail",
      "http://www.iff.com/role/EmployeeBenefitsEstimatedFutureBenefitPaymentsDetail",
      "http://www.iff.com/role/EmployeeBenefitsSensitivityofDisclosurestoChangesinSelectedAssumptionsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Postretirement Benefits",
        "label": "Other Postretirement Benefits Plan [Member]",
        "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits."
       }
      }
     },
     "auth_ref": [
      "r758",
      "r762",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r806",
      "r808",
      "r809",
      "r811",
      "r814",
      "r817",
      "r821",
      "r822",
      "r823",
      "r824",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r830",
      "r834",
      "r835",
      "r836",
      "r1295",
      "r1296",
      "r1297",
      "r1298",
      "r1299"
     ]
    },
    "us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Type of Deferred Compensation, All Types [Domain]",
        "label": "Other Postretirement Benefits, Individual Contracts, Type of Deferred Compensation [Domain]",
        "documentation": "Deferred compensation related to other postretirement benefit arrangements that are not equivalent to a defined benefit other postretirement benefit plan. Includes, but is not limited to, employment contracts with one or more selected officers or key employees. Excludes equity-based compensation plans, defined benefit pension plans and defined benefit other postretirement benefit plans."
       }
      }
     },
     "auth_ref": [
      "r302",
      "r303"
     ]
    },
    "us-gaap_OtherRestructuringCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherRestructuringCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/RestructuringandOtherChargesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Restructuring Costs",
        "label": "Other Restructuring Costs",
        "documentation": "Amount of other expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses associated with a discontinued operation or an asset retirement obligation."
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "us-gaap_OtherRestructuringMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherRestructuringMember",
     "presentation": [
      "http://www.iff.com/role/RestructuringandOtherChargesAdditionalInformationDetails",
      "http://www.iff.com/role/RestructuringandOtherChargesMovementsinRestructuringandRelatedAccrualsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other(1)",
        "label": "Other Restructuring [Member]",
        "documentation": "Restructuring and related activities classified as other."
       }
      }
     },
     "auth_ref": [
      "r1281",
      "r1282",
      "r1283",
      "r1284"
     ]
    },
    "us-gaap_OtherSundryLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherSundryLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other Sundry Liabilities, Current",
        "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r123"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount",
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1341",
      "r1353",
      "r1363",
      "r1389"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Amount",
        "label": "Outstanding Recovery Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1344",
      "r1356",
      "r1366",
      "r1392"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r1344",
      "r1356",
      "r1366",
      "r1392"
     ]
    },
    "iff_Over65Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "Over65Member",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionExercisableDetail",
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionOutstandingDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Over $65",
        "label": "Over $65 [Member]",
        "documentation": "Over $65"
       }
      }
     },
     "auth_ref": []
    },
    "srt_OwnershipAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "OwnershipAxis",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails",
      "http://www.iff.com/role/NetIncomePerShareAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ownership [Axis]",
        "label": "Ownership [Axis]",
        "documentation": "Information by name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment."
       }
      }
     },
     "auth_ref": []
    },
    "srt_OwnershipDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "OwnershipDomain",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails",
      "http://www.iff.com/role/NetIncomePerShareAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ownership [Domain]",
        "label": "Ownership [Domain]",
        "documentation": "Name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment."
       }
      }
     },
     "auth_ref": []
    },
    "iff_PandemicMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "PandemicMember",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pandemic [Member]",
        "label": "Pandemic [Member]",
        "documentation": "Pandemic [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenBasicNetIncomeLossPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenBasicNetIncomeLossPerShare",
     "presentation": [
      "http://www.iff.com/role/NetIncomePerShareAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Participating Securities, Distributed And Undistributed Earnings (Loss), Difference Between Basic Net Income (Loss) Per Share",
        "label": "Participating Securities, Distributed And Undistributed Earnings (Loss), Difference Between Basic Net Income (Loss) Per Share",
        "documentation": "Participating Securities, Distributed And Undistributed Earnings (Loss), Difference Between Basic Net Income (Loss) Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "iff_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenDilutedNetIncomeLossPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenDilutedNetIncomeLossPerShare",
     "presentation": [
      "http://www.iff.com/role/NetIncomePerShareAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Participating Securities, Distributed And Undistributed Earnings (Loss), Difference Between Diluted Net Income (Loss) Per Share",
        "label": "Participating Securities, Distributed And Undistributed Earnings (Loss), Difference Between Diluted Net Income (Loss) Per Share",
        "documentation": "Participating Securities, Distributed And Undistributed Earnings (Loss), Difference Between Diluted Net Income (Loss) Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PatentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PatentsMember",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Patents [Member]",
        "label": "Patents [Member]",
        "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law."
       }
      }
     },
     "auth_ref": [
      "r321"
     ]
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1370"
     ]
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Deferred consideration paid",
        "label": "Payment for Contingent Consideration Liability, Financing Activities",
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date."
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "us-gaap_PaymentsForProceedsFromHedgeInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsForProceedsFromHedgeInvestingActivities",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsAdditionalInformationDetail",
      "http://www.iff.com/role/FinancialInstrumentsCarryingAmountandEstimatedFairValueofFinancialInstrumentsDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowandNetInvestmentHedgingInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payments for (Proceeds from) Hedge, Investing Activities",
        "negatedTerseLabel": "Payments for (Proceeds from) Hedge, Investing Activities",
        "label": "Payments for (Proceeds from) Hedge, Investing Activities",
        "documentation": "The cash outflow or inflow for a financial contract that meets the hedge criteria as either a cash flow hedge, fair value hedge, or hedge of a net investment in a foreign operation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsForRepurchaseOfRedeemableNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchases of redeemable non-controlling interests",
        "label": "Payments for Repurchase of Redeemable Noncontrolling Interest",
        "documentation": "The cash outflow during the period for redemption of redeemable noncontrolling interests."
       }
      }
     },
     "auth_ref": [
      "r1451"
     ]
    },
    "us-gaap_PaymentsForRestructuring": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsForRestructuring",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/RestructuringandOtherChargesAdditionalInformationDetails",
      "http://www.iff.com/role/RestructuringandOtherChargesMovementsinRestructuringandRelatedAccrualsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Cash Payments",
        "label": "Payments for Restructuring",
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation."
       }
      }
     },
     "auth_ref": [
      "r678",
      "r1453"
     ]
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsOfDividendsCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cash dividends paid to shareholders",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity."
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "us-gaap_PaymentsOfDividendsMinorityInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsOfDividendsMinorityInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Payments of Ordinary Dividends, Noncontrolling Interest",
        "label": "Payments of Ordinary Dividends, Noncontrolling Interest",
        "documentation": "Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests."
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "us-gaap_PaymentsOfFinancingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsOfFinancingCosts",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Deferred financing costs",
        "label": "Payments of Financing Costs",
        "documentation": "The cash outflow for loan and debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Employee withholding taxes paid",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r466"
     ]
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireBusinessesGross",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash paid to acquire business",
        "label": "Payments to Acquire Businesses, Gross",
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r928"
     ]
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Cash paid for acquisitions, net of cash received",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase."
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireIntangibleAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Additions to intangible assets",
        "label": "Payments to Acquire Intangible Assets",
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill."
       }
      }
     },
     "auth_ref": [
      "r275"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Additions to property, plant and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r275"
     ]
    },
    "iff_PaymentsToParticipateInFactoringReceivableProgram": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "PaymentsToParticipateInFactoringReceivableProgram",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payments to participate in factoring receivable program",
        "label": "Payments To Participate In Factoring Receivable Program",
        "documentation": "Payments To Participate In Factoring Receivable Program"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Issuers, Footnote",
        "label": "Peer Group Issuers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1373"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Total Shareholder Return Amount",
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r1373"
     ]
    },
    "us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current pension and other postretirement benefit obligation",
        "label": "Liability, Pension and Other Postretirement and Postemployment Benefits, Current",
        "documentation": "Amount of liability, recognized in statement of financial position, for pension, other postretirement and postemployment benefits, classified as current."
       }
      }
     },
     "auth_ref": [
      "r143",
      "r144",
      "r244",
      "r304"
     ]
    },
    "us-gaap_PensionAndOtherPostretirementBenefitExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PensionAndOtherPostretirementBenefitExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total expense",
        "label": "Pension and Other Postretirement Benefits Cost (Reversal of Cost)",
        "documentation": "Amount of cost (reversal of cost) for pension and other postretirement benefits."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefits"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Benefits",
        "label": "Retirement Benefits [Text Block]",
        "documentation": "The entire disclosure for retirement benefits."
       }
      }
     },
     "auth_ref": [
      "r757",
      "r783",
      "r785",
      "r791",
      "r810",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r831",
      "r832",
      "r834",
      "r1295"
     ]
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinBalanceSheetDetail": {
       "parentTag": "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinBalanceSheetDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other current liabilities",
        "label": "Liability, Defined Benefit Plan, Current",
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current."
       }
      }
     },
     "auth_ref": [
      "r244",
      "r758",
      "r759",
      "r782",
      "r1295"
     ]
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails",
      "http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net defined benefit plan liabilities",
        "label": "Liability, Defined Benefit Plan",
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans."
       }
      }
     },
     "auth_ref": [
      "r340",
      "r759",
      "r782",
      "r1642"
     ]
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinBalanceSheetDetail": {
       "parentTag": "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET",
      "http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail",
      "http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinBalanceSheetDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement liabilities",
        "negatedLabel": "Retirement liabilities",
        "label": "Liability, Defined Benefit Plan, Noncurrent",
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r246",
      "r758",
      "r759",
      "r782",
      "r1295"
     ]
    },
    "us-gaap_PensionAndOtherPostretirementPlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PensionAndOtherPostretirementPlansPolicy",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement Benefits",
        "label": "Pension and Other Postretirement Plans, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for pension and other postretirement benefit plans. This accounting policy may address (1) the types of plans sponsored by the entity, and the benefits provided by each plan (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r35",
      "r36",
      "r44",
      "r149"
     ]
    },
    "us-gaap_PensionContributions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PensionContributions",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Pension contributions",
        "label": "Payment for Pension Benefits",
        "documentation": "Amount of cash outflow for pension benefit. Includes, but is not limited to, employer contribution to fund plan asset and payment to retiree. Excludes other postretirement benefit."
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "us-gaap_PensionExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PensionExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "UK Pension Settlement Charges",
        "label": "Pension Cost (Reversal of Cost)",
        "documentation": "Amount of cost (reversal of cost) for pension benefits. Excludes other postretirement benefits."
       }
      }
     },
     "auth_ref": []
    },
    "iff_PensionExpensesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "PensionExpensesTableTextBlock",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Assets and Benefit Obligations of Defined Benefit Pension Plans",
        "label": "Pension Expenses [Table Text Block]",
        "documentation": "Table for Net Periodic Benefit Cost and Changes in Plan Assets and Benefit Obligations Recognized in OCI."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PensionPlansDefinedBenefitMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PensionPlansDefinedBenefitMember",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsAccumulatedBenefitObligationDetail",
      "http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail",
      "http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetail",
      "http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinBalanceSheetDetail",
      "http://www.iff.com/role/EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail",
      "http://www.iff.com/role/EmployeeBenefitsEstimatedFutureBenefitPaymentsDetail",
      "http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail",
      "http://www.iff.com/role/EmployeeBenefitsPercentageofAssetsInvestedDetail",
      "http://www.iff.com/role/EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail",
      "http://www.iff.com/role/EmployeeBenefitsReconciliationofLevel3NonUSPlanAssetsHeldDetail",
      "http://www.iff.com/role/EmployeeBenefitsSensitivityofDisclosurestoChangesinSelectedAssumptionsDetail",
      "http://www.iff.com/role/EmployeeBenefitsWeightedAverageActuarialAssumptionUsedtoDetermineExpenseDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Plan",
        "label": "Pension Plan [Member]",
        "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits."
       }
      }
     },
     "auth_ref": [
      "r758",
      "r762",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r806",
      "r808",
      "r809",
      "r811",
      "r814",
      "r817",
      "r821",
      "r822",
      "r823",
      "r824",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r830",
      "r834",
      "r835",
      "r839",
      "r1295",
      "r1296",
      "r1300",
      "r1301",
      "r1302"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Actually Paid Compensation Amount",
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1372"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO",
        "label": "PEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r1382"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Name",
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r1375"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Total Compensation Amount",
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1371"
     ]
    },
    "iff_PercentageofActiveEmployeeswithPensionandorOtherRetirementBenefitPlansCovered": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "PercentageofActiveEmployeeswithPensionandorOtherRetirementBenefitPlansCovered",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of active employees with pension and or other retirement benefit plans covered",
        "label": "Percentage of Active Employees with Pension and or Other Retirement Benefit Plans Covered",
        "documentation": "Percentage of Active Employees with Pension and or Other Retirement Benefit Plans Covered"
       }
      }
     },
     "auth_ref": []
    },
    "iff_PharmaSolutionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "PharmaSolutionsMember",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails",
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail",
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetGoodwillRollforwardDetails",
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetNarrativeDetails",
      "http://www.iff.com/role/RestructuringandOtherChargesMovementsinRestructuringandRelatedAccrualsDetail",
      "http://www.iff.com/role/SegmentInformationCapitalExpenditureandDepreciationandAmortizationbySegmentDetail",
      "http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pharma Solutions",
        "label": "Pharma Solutions [Member]",
        "documentation": "Pharma Solutions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanAssetCategoriesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PlanAssetCategoriesDomain",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail",
      "http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail",
      "http://www.iff.com/role/EmployeeBenefitsPercentageofAssetsInvestedDetail",
      "http://www.iff.com/role/EmployeeBenefitsReconciliationofLevel3NonUSPlanAssetsHeldDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Domain]",
        "label": "Defined Benefit Plan, Plan Assets, Category [Domain]",
        "documentation": "Defined benefit plan asset investment."
       }
      }
     },
     "auth_ref": [
      "r783",
      "r784",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r811",
      "r1293",
      "r1294",
      "r1295"
     ]
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Axis]",
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1584",
      "r1585",
      "r1586",
      "r1587",
      "r1588",
      "r1589",
      "r1590",
      "r1591",
      "r1592",
      "r1593",
      "r1594",
      "r1595",
      "r1596",
      "r1597",
      "r1598",
      "r1599",
      "r1600",
      "r1601",
      "r1602",
      "r1603",
      "r1604",
      "r1605",
      "r1606",
      "r1607",
      "r1608",
      "r1609"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Domain]",
        "label": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1584",
      "r1585",
      "r1586",
      "r1587",
      "r1588",
      "r1589",
      "r1590",
      "r1591",
      "r1592",
      "r1593",
      "r1594",
      "r1595",
      "r1596",
      "r1597",
      "r1598",
      "r1599",
      "r1600",
      "r1601",
      "r1602",
      "r1603",
      "r1604",
      "r1605",
      "r1606",
      "r1607",
      "r1608",
      "r1609"
     ]
    },
    "iff_PledgedAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "PledgedAssetsMember",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pledged assets [Member]",
        "label": "Pledged Assets [Member]",
        "documentation": "Pledged Assets [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_PooledFundsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "PooledFundsMember",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pooled Funds",
        "label": "Pooled Funds [Member]",
        "documentation": "Pooled Funds [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsCarryingAmountandEstimatedFairValueofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Portion at Fair Value Measurement [Member]",
        "label": "Portion at Fair Value Measurement [Member]",
        "documentation": "Measured at fair value for financial reporting purposes."
       }
      }
     },
     "auth_ref": [
      "r975"
     ]
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidExpenseCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherAssetsDetail": {
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses",
        "label": "Prepaid Expense, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r435",
      "r644",
      "r645",
      "r1258"
     ]
    },
    "iff_PriorServiceCostsFromPlanImprovementsAmortizationPeriodMaximum": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "PriorServiceCostsFromPlanImprovementsAmortizationPeriodMaximum",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prior service costs from plan improvements amortization period, maximum, years",
        "label": "Prior Service Costs From Plan Improvements, Amortization Period, Maximum",
        "documentation": "Prior service costs from plan improvements, amortization period, maximum."
       }
      }
     },
     "auth_ref": []
    },
    "iff_PriorServiceCostsFromPlanImprovementsAmortizationPeriodMinimum": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "PriorServiceCostsFromPlanImprovementsAmortizationPeriodMinimum",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prior service costs from plan improvements amortization period, minimum, years",
        "label": "Prior Service Costs From Plan Improvements, Amortization Period, Minimum",
        "documentation": "Prior service costs from plan improvements, amortization period, minimum."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrivateEquityFundsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrivateEquityFundsMember",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Private Equity Funds",
        "label": "Private Equity Funds [Member]",
        "documentation": "Investments held in private equity funds."
       }
      }
     },
     "auth_ref": [
      "r1542"
     ]
    },
    "iff_ProceedsFromBusinessCombination": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "ProceedsFromBusinessCombination",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash acquired from acquisition",
        "label": "Proceeds From Business Combination",
        "documentation": "Proceeds From Business Combination"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromDerivativeInstrumentInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS",
      "http://www.iff.com/role/FinancialInstrumentsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from unwinding of derivative instruments",
        "label": "Proceeds from Derivative Instrument, Investing Activities",
        "documentation": "The cash inflow provided by derivative instruments during the period, which are classified as investing activities, excluding those designated as hedging instruments."
       }
      }
     },
     "auth_ref": [
      "r1413"
     ]
    },
    "iff_ProceedsFromDivestitureOfBusinessNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "ProceedsFromDivestitureOfBusinessNet",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/BusinessDivestitureDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iff.com/role/BusinessDivestitureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Proceeds From Divestiture Of Business, Net",
        "label": "Proceeds From Divestiture Of Business, Net",
        "documentation": "Proceeds From Divestiture Of Business, Net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/BusinessDivestitureDetails",
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net proceeds received from business divestitures",
        "label": "Proceeds from Divestiture of Businesses",
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period."
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "iff_ProceedsFromDivestitureOfBusinessesGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "ProceedsFromDivestitureOfBusinessesGross",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/BusinessDivestitureDetails": {
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/BusinessDivestitureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from Divestiture of Businesses, Gross",
        "label": "Proceeds from Divestiture of Businesses, Gross",
        "documentation": "Proceeds from Divestiture of Businesses, Gross"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIncomeTaxRefunds": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIncomeTaxRefunds",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from Income Tax Refunds",
        "label": "Proceeds from Income Tax Refunds",
        "documentation": "The amount of cash received during the period as refunds for the overpayment of taxes."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r277"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfCommercialPaper": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfCommercialPaper",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationCommercialPaperandRedemptionProvisionsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from Issuance of commercial paper",
        "label": "Proceeds from Issuance of Commercial Paper",
        "documentation": "The cash inflow from borrowing by issuing commercial paper."
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "iff_ProceedsFromIssuanceOfCommercialPaperMaturingInMoreThanThreeMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "ProceedsFromIssuanceOfCommercialPaperMaturingInMoreThanThreeMonths",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of commercial paper (maturities after three months)",
        "label": "Proceeds From Issuance Of Commercial Paper, Maturing In More Than Three Months",
        "documentation": "Proceeds From Issuance Of Commercial Paper, Maturing In More Than Three Months"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfDebt",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationSeniorUnsecuredNotesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds related to the issuance of senior notes",
        "label": "Proceeds from Issuance of Debt",
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt."
       }
      }
     },
     "auth_ref": [
      "r1450"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Proceeds from issuance of long-term debt",
        "label": "Proceeds from Issuance of Long-Term Debt",
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r1126"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of stock in connection with stock options",
        "label": "Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised",
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r47"
     ]
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromLinesOfCredit",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationRevolvingCreditFacilityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from Lines of Credit",
        "label": "Proceeds from Lines of Credit",
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r1458"
     ]
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other, net",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other."
       }
      }
     },
     "auth_ref": [
      "r1414",
      "r1449"
     ]
    },
    "us-gaap_ProceedsFromRepaymentsOfShortTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromRepaymentsOfShortTermDebt",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "(Decrease) increase in revolving credit facility and short term borrowings",
        "label": "Proceeds from (Repayments of) Short-Term Debt",
        "documentation": "The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "iff_ProceedsFromSaleOfAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "ProceedsFromSaleOfAccountsReceivable",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from sale of accounts receivable",
        "label": "Proceeds From Sale Of Accounts Receivable",
        "documentation": "Proceeds From Sale Of Accounts Receivable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromSaleOfLandHeldForUse": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromSaleOfLandHeldForUse",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from Sale of Land Held-for-use",
        "label": "Proceeds from Sale, Land, Held-for-Use",
        "documentation": "The cash inflow from the sale of land held for use; excludes sales of land held as inventory or investments."
       }
      }
     },
     "auth_ref": [
      "r274"
     ]
    },
    "us-gaap_ProceedsFromSaleOfLongtermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromSaleOfLongtermInvestments",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/RedeemableNoncontrollingInterestsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from sale of long-term investments",
        "label": "Proceeds from Sale of Long-Term Investments",
        "documentation": "The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, beyond the current operating cycle."
       }
      }
     },
     "auth_ref": [
      "r1413"
     ]
    },
    "us-gaap_ProceedsFromSaleOfProductiveAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromSaleOfProductiveAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from disposal of assets",
        "label": "Proceeds from Sale of Productive Assets",
        "documentation": "The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets."
       }
      }
     },
     "auth_ref": [
      "r274"
     ]
    },
    "us-gaap_ProductLiabilityAccrualPeriodExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProductLiabilityAccrualPeriodExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product liability accrual period expense",
        "label": "Product Liability Accrual, Period Expense",
        "documentation": "The amount of loss reported during the period pertaining to product liability."
       }
      }
     },
     "auth_ref": []
    },
    "iff_ProductLiabilityContingencyLossExposureinExcessofAccrualAggregateAmountPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "ProductLiabilityContingencyLossExposureinExcessofAccrualAggregateAmountPaid",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate amount paid",
        "label": "Product Liability Contingency, Loss Exposure in Excess of Accrual, Aggregate Amount Paid",
        "documentation": "Product Liability Contingency, Loss Exposure in Excess of Accrual, Aggregate Amount Paid"
       }
      }
     },
     "auth_ref": []
    },
    "iff_ProductLiabilityContingencyLossExposureinExcessofAccrualAmountPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "ProductLiabilityContingencyLossExposureinExcessofAccrualAmountPaid",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amount paid",
        "label": "Product Liability Contingency, Loss Exposure in Excess of Accrual, Amount Paid",
        "documentation": "Product Liability Contingency, Loss Exposure in Excess of Accrual, Amount Paid"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS",
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net (loss) income",
        "terseLabel": "Net (loss) income",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r413",
      "r447",
      "r450",
      "r468",
      "r475",
      "r493",
      "r505",
      "r506",
      "r533",
      "r547",
      "r553",
      "r556",
      "r601",
      "r697",
      "r698",
      "r700",
      "r701",
      "r702",
      "r704",
      "r706",
      "r708",
      "r709",
      "r931",
      "r934",
      "r935",
      "r967",
      "r978",
      "r1075",
      "r1089",
      "r1133",
      "r1187",
      "r1206",
      "r1207",
      "r1271",
      "r1306",
      "r1307",
      "r1327",
      "r1448",
      "r1511"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail",
      "http://www.iff.com/role/LeasesAdditionalInformationDetails",
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.iff.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment, Type [Axis]",
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://www.iff.com/role/PropertyPlantandEquipmentNet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment, Net",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r287",
      "r358",
      "r361",
      "r362"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetail": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, plant and equipment, gross",
        "label": "Property, Plant and Equipment, Gross",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r289",
      "r418",
      "r1087"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://www.iff.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Line Items]",
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentMember",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.iff.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment",
        "label": "Property, Plant and Equipment [Member]",
        "documentation": "Physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.iff.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iff.com/role/BusinessDivestitureDetails",
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET",
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail",
      "http://www.iff.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetail",
      "http://www.iff.com/role/SegmentInformationAdditionalInformationDetail",
      "http://www.iff.com/role/SegmentInformationSegmentInformationScheduleofLongLivedAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Property, plant and equipment, net",
        "terseLabel": "Property, plant and equipment",
        "totalLabel": "Property, plant and equipment, net",
        "label": "Property, Plant and Equipment, Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r1076",
      "r1087",
      "r1311"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentNetAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment, Net [Abstract]",
        "label": "Property, Plant and Equipment, Net [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r358",
      "r361",
      "r1085"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://www.iff.com/role/PropertyPlantandEquipmentNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Property, Plant and Equipment",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail",
      "http://www.iff.com/role/LeasesAdditionalInformationDetails",
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.iff.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment, Type [Domain]",
        "label": "Long-Lived Tangible Asset [Domain]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r289"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimated useful life of property, plant and equipment, years",
        "label": "Property, Plant and Equipment, Useful Life",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProvisionForDoubtfulAccounts",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r462",
      "r621"
     ]
    },
    "iff_PurchasedRestrictedStockUnitMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "PurchasedRestrictedStockUnitMember",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansPurchasedRestrictedStockPlanAdditionalInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansRSUPRSandCashRSUActivityDetail",
      "http://www.iff.com/role/StockCompensationPlansRestrictedStockUnitsPlanAdditionalInformationDetail",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchased Restricted Stock Unit",
        "label": "Purchased Restricted Stock Unit [Member]",
        "documentation": "Purchased Restricted Stock Unit"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure",
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r1370"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure, Table",
        "label": "Pay vs Performance [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1370"
     ]
    },
    "us-gaap_QualifiedPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "QualifiedPlanMember",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Qualified Plan",
        "label": "Qualified Plan [Member]",
        "documentation": "Plan with tax-exempt status designed and operated in accordance with applicable tax provision of designated taxing authority. Taxing authority includes, but is not limited to, U.S. Internal Revenue Service (IRS). Includes, but is not limited to, defined benefit and defined contribution plans."
       }
      }
     },
     "auth_ref": [
      "r1417",
      "r1520",
      "r1521",
      "r1522",
      "r1523",
      "r1524",
      "r1525",
      "r1526",
      "r1527",
      "r1528",
      "r1529",
      "r1530",
      "r1531",
      "r1532",
      "r1533",
      "r1534",
      "r1535",
      "r1536",
      "r1537",
      "r1538",
      "r1539",
      "r1540",
      "r1541",
      "r1542",
      "r1543",
      "r1544",
      "r1545",
      "r1546",
      "r1547",
      "r1548",
      "r1549",
      "r1550",
      "r1551",
      "r1552",
      "r1553",
      "r1554",
      "r1555",
      "r1556",
      "r1557",
      "r1558",
      "r1559",
      "r1560",
      "r1561",
      "r1562",
      "r1563",
      "r1564",
      "r1565",
      "r1566",
      "r1567",
      "r1568",
      "r1569",
      "r1570",
      "r1571",
      "r1572",
      "r1573",
      "r1574",
      "r1575",
      "r1576",
      "r1577",
      "r1578",
      "r1579"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails",
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail",
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail",
      "http://www.iff.com/role/DebtComponentsofDebtDetail",
      "http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail",
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetNarrativeDetails",
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.iff.com/role/TangibleEquityUnitsTangibleEquitySettlementofSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Axis]",
        "label": "Statistical Measurement [Axis]",
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r691",
      "r692",
      "r693",
      "r694",
      "r783",
      "r837",
      "r868",
      "r869",
      "r870",
      "r1037",
      "r1061",
      "r1109",
      "r1155",
      "r1156",
      "r1213",
      "r1215",
      "r1217",
      "r1218",
      "r1228",
      "r1251",
      "r1252",
      "r1273",
      "r1290",
      "r1303",
      "r1312",
      "r1315",
      "r1505",
      "r1513",
      "r1635",
      "r1636",
      "r1637",
      "r1638",
      "r1639"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeMember",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails",
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail",
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail",
      "http://www.iff.com/role/DebtComponentsofDebtDetail",
      "http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail",
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetNarrativeDetails",
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.iff.com/role/TangibleEquityUnitsTangibleEquitySettlementofSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Domain]",
        "label": "Statistical Measurement [Domain]",
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r691",
      "r692",
      "r693",
      "r694",
      "r783",
      "r837",
      "r868",
      "r869",
      "r870",
      "r1037",
      "r1061",
      "r1109",
      "r1155",
      "r1156",
      "r1213",
      "r1215",
      "r1217",
      "r1218",
      "r1228",
      "r1251",
      "r1252",
      "r1273",
      "r1290",
      "r1303",
      "r1312",
      "r1315",
      "r1505",
      "r1513",
      "r1635",
      "r1636",
      "r1637",
      "r1638",
      "r1639"
     ]
    },
    "us-gaap_RealEstateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RealEstateMember",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail",
      "http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail",
      "http://www.iff.com/role/EmployeeBenefitsPercentageofAssetsInvestedDetail",
      "http://www.iff.com/role/EmployeeBenefitsReconciliationofLevel3NonUSPlanAssetsHeldDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property",
        "label": "Real Estate [Member]",
        "documentation": "Property consisting of land, land improvement and buildings."
       }
      }
     },
     "auth_ref": [
      "r1517"
     ]
    },
    "us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis",
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.iff.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofUnrecognizedTaxBenefitsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nature of Uncertainty [Axis]",
        "label": "Nature of Uncertainty [Axis]",
        "documentation": "Information by nature of uncertainty related to unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r317"
     ]
    },
    "iff_RebatesAndIncentivesPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "RebatesAndIncentivesPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rebates and incentives payable",
        "label": "Rebates And Incentives Payable, Current",
        "documentation": "Rebates And Incentives Payable, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ReceivableTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReceivableTypeDomain",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Receivable [Domain]",
        "label": "Receivable [Domain]",
        "documentation": "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "iff_ReceivablesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "ReceivablesMember",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Receivables",
        "label": "Receivables [Member]",
        "documentation": "Receivables [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ReceivablesNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReceivablesNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/BusinessDivestitureDetails",
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET",
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Receivables, net, current",
        "label": "Receivables, Net, Current",
        "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value."
       }
      }
     },
     "auth_ref": [
      "r1311"
     ]
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReceivablesPolicyTextBlock",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Receivable",
        "label": "Receivable [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable."
       }
      }
     },
     "auth_ref": [
      "r1478",
      "r1479",
      "r1480",
      "r1481"
     ]
    },
    "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems",
     "presentation": [
      "http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossReclassificationsofAccumulatedOtherComprehensiveIncometoConsolidatedStatementofComprehensiveIncomeDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]",
        "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r455"
     ]
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossReclassificationsofAccumulatedOtherComprehensiveIncometoConsolidatedStatementofComprehensiveIncomeDetail_1": {
       "parentTag": "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossReclassificationsofAccumulatedOtherComprehensiveIncometoConsolidatedStatementofComprehensiveIncomeDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "(Losses) gains on pension and postretirement liability adjustments",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax",
        "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r454",
      "r989",
      "r994",
      "r995",
      "r1092",
      "r1446"
     ]
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossReclassificationsofAccumulatedOtherComprehensiveIncometoConsolidatedStatementofComprehensiveIncomeDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossReclassificationsofAccumulatedOtherComprehensiveIncometoConsolidatedStatementofComprehensiveIncomeDetail_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossReclassificationsofAccumulatedOtherComprehensiveIncometoConsolidatedStatementofComprehensiveIncomeDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r80",
      "r454",
      "r989",
      "r994",
      "r995",
      "r1446"
     ]
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Amounts reclassified from AOCI",
        "label": "Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r80"
     ]
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis",
     "presentation": [
      "http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossReclassificationsofAccumulatedOtherComprehensiveIncometoConsolidatedStatementofComprehensiveIncomeDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Axis]",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Axis]",
        "documentation": "Information by item reclassified out of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r455"
     ]
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain",
     "presentation": [
      "http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossReclassificationsofAccumulatedOtherComprehensiveIncometoConsolidatedStatementofComprehensiveIncomeDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Domain]",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Domain]",
        "documentation": "Item reclassified out of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r455"
     ]
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossReclassificationsofAccumulatedOtherComprehensiveIncometoConsolidatedStatementofComprehensiveIncomeDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Member]",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Member]",
        "documentation": "Identifies item reclassified out of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r455"
     ]
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable",
     "presentation": [
      "http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossReclassificationsofAccumulatedOtherComprehensiveIncometoConsolidatedStatementofComprehensiveIncomeDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Table]",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]",
        "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r455"
     ]
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock",
     "presentation": [
      "http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassifications of Accumulated Other Comprehensive Income to Consolidated Statement of Comprehensive Income",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]",
        "documentation": "Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofUnrecognizedTaxBenefitsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1336",
      "r1348",
      "r1358",
      "r1384"
     ]
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Redeemable non-controlling interests",
        "label": "Redeemable Noncontrolling Interest, Equity, Carrying Amount",
        "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity."
       }
      }
     },
     "auth_ref": [
      "r128",
      "r129",
      "r130",
      "r131"
     ]
    },
    "iff_RedeemableNoncontrollingInterestMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "RedeemableNoncontrollingInterestMember",
     "presentation": [
      "http://www.iff.com/role/RedeemableNoncontrollingInterestsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Redeemable Noncontrolling Interest",
        "label": "Redeemable Noncontrolling Interest [Member]",
        "documentation": "Redeemable Noncontrolling Interest [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RedeemableNoncontrollingInterestTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RedeemableNoncontrollingInterestTableTextBlock",
     "presentation": [
      "http://www.iff.com/role/RedeemableNoncontrollingInterestsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Redeemable Noncontrolling Interest",
        "label": "Redeemable Noncontrolling Interest [Table Text Block]",
        "documentation": "Tabular disclosure of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity. As of the date of the statement of financial position, such redeemable noncontrolling interest is currently redeemable, as defined, for cash or other assets of the entity at (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RepaymentsOfCommercialPaper": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RepaymentsOfCommercialPaper",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationCommercialPaperandRedemptionProvisionsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Repayments of commercial paper",
        "label": "Repayments of Commercial Paper",
        "documentation": "The cash outflow due to repaying amounts borrowed by issuing commercial paper."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "iff_RepaymentsOfCommercialPaperMaturingInMoreThanThreeMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "RepaymentsOfCommercialPaperMaturingInMoreThanThreeMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Repayments of commercial paper (maturities after three months)",
        "label": "Repayments Of Commercial Paper, Maturing In More Than Three Months",
        "documentation": "Repayments Of Commercial Paper, Maturing In More Than Three Months"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RepaymentsOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RepaymentsOfDebt",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationSeniorUnsecuredNotesDetail",
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Repayments of debt",
        "label": "Repayments of Debt",
        "documentation": "Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation."
       }
      }
     },
     "auth_ref": [
      "r1452"
     ]
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RepaymentsOfLinesOfCredit",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationRevolvingCreditFacilityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Repayments of Lines of Credit",
        "label": "Repayments of Lines of Credit",
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r1458"
     ]
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RepaymentsOfLongTermDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repayments of long-term debt",
        "label": "Repayments of Long-Term Debt",
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r1129"
     ]
    },
    "us-gaap_ReportingUnitAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReportingUnitAxis",
     "presentation": [
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetGoodwillRollforwardDetails",
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetNarrativeDetails",
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reporting Unit [Axis]",
        "label": "Reporting Unit [Axis]",
        "documentation": "Information by reporting unit."
       }
      }
     },
     "auth_ref": [
      "r658",
      "r659",
      "r1279"
     ]
    },
    "us-gaap_ReportingUnitDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReportingUnitDomain",
     "presentation": [
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetGoodwillRollforwardDetails",
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetNarrativeDetails",
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reporting Unit [Domain]",
        "label": "Reporting Unit [Domain]",
        "documentation": "Level of reporting at which goodwill is tested for impairment."
       }
      }
     },
     "auth_ref": [
      "r658",
      "r659",
      "r1279"
     ]
    },
    "us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount",
     "presentation": [
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reporting unit in excess of carrying amount",
        "label": "Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount",
        "documentation": "Percentage of fair value of reporting unit in excess of carrying amount."
       }
      }
     },
     "auth_ref": []
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "presentation": [
      "http://www.iff.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Domain]",
        "label": "Counterparty Name [Domain]",
        "documentation": "Named other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution."
       }
      }
     },
     "auth_ref": [
      "r478",
      "r479",
      "r714",
      "r741",
      "r1029",
      "r1264",
      "r1265"
     ]
    },
    "iff_RepurchasePriceAsPercentageOfPrincipalAmountOfSeniorNotes": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "RepurchasePriceAsPercentageOfPrincipalAmountOfSeniorNotes",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationCommercialPaperandRedemptionProvisionsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Repurchase price of principal amount of Senior Notes in percentage",
        "label": "Repurchase Price As Percentage Of Principal Amount Of Senior Notes",
        "documentation": "Repurchase Price As Percentage Of Principal Amount Of Senior Notes"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development expenses",
        "label": "Research and Development Expense",
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use."
       }
      }
     },
     "auth_ref": [
      "r222",
      "r882",
      "r1640"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and Development",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process."
       }
      }
     },
     "auth_ref": [
      "r881"
     ]
    },
    "iff_ReserveforTaxAssessment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "ReserveforTaxAssessment",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Tax assessment",
        "label": "Reserve for Tax Assessment",
        "documentation": "Reserve for Tax Assessment"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RestatementAdjustmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RestatementAdjustmentMember",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails",
      "http://www.iff.com/role/EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail",
      "http://www.iff.com/role/EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail",
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Adjustment",
        "label": "Revision of Prior Period, Adjustment [Member]",
        "documentation": "Cumulative increase (decrease) for adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision."
       }
      }
     },
     "auth_ref": [
      "r489",
      "r490",
      "r491",
      "r503",
      "r504",
      "r525",
      "r965",
      "r966",
      "r1415",
      "r1416",
      "r1418",
      "r1419",
      "r1424",
      "r1430",
      "r1431"
     ]
    },
    "srt_RestatementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RestatementAxis",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails",
      "http://www.iff.com/role/EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail",
      "http://www.iff.com/role/EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail",
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement [Axis]",
        "label": "Revision of Prior Period [Axis]",
        "documentation": "Information by adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision."
       }
      }
     },
     "auth_ref": [
      "r409",
      "r489",
      "r490",
      "r491",
      "r493",
      "r494",
      "r497",
      "r498",
      "r499",
      "r500",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r525",
      "r607",
      "r608",
      "r911",
      "r961",
      "r965",
      "r966",
      "r967",
      "r1006",
      "r1027",
      "r1028",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120",
      "r1121",
      "r1123"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date:",
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1337",
      "r1349",
      "r1359",
      "r1385"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date",
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r1338",
      "r1350",
      "r1360",
      "r1386"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement does not require Recovery",
        "label": "Restatement Does Not Require Recovery [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1345",
      "r1357",
      "r1367",
      "r1393"
     ]
    },
    "srt_RestatementDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RestatementDomain",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails",
      "http://www.iff.com/role/EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail",
      "http://www.iff.com/role/EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail",
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement [Domain]",
        "label": "Revision of Prior Period [Domain]",
        "documentation": "Adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision."
       }
      }
     },
     "auth_ref": [
      "r409",
      "r489",
      "r490",
      "r491",
      "r493",
      "r494",
      "r497",
      "r498",
      "r499",
      "r500",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r525",
      "r607",
      "r608",
      "r911",
      "r961",
      "r965",
      "r966",
      "r967",
      "r1006",
      "r1027",
      "r1028",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120",
      "r1121",
      "r1123"
     ]
    },
    "us-gaap_RestrictedCashCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedCashCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/BusinessDivestitureDetails",
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET",
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash",
        "label": "Restricted Cash, Current",
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r1442",
      "r1456"
     ]
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedCashNoncurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted Cash, Noncurrent",
        "label": "Restricted Cash, Noncurrent",
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r352",
      "r1444",
      "r1456"
     ]
    },
    "us-gaap_RestrictedStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedStockMember",
     "presentation": [
      "http://www.iff.com/role/NetIncomePerShareAdditionalInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansPurchasedRestrictedStockPlanAdditionalInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansRSUPRSandCashRSUActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted Stock [Member]",
        "label": "Restricted Stock [Member]",
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met."
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansPurchasedRestrictedStockPlanAdditionalInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansRSUPRSandCashRSUActivityDetail",
      "http://www.iff.com/role/StockCompensationPlansRestrictedStockUnitsPlanAdditionalInformationDetail",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RSU's [Member]",
        "verboseLabel": "PRSUs [Member]",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring and Related Activities [Abstract]",
        "label": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "presentation": [
      "http://www.iff.com/role/RestructuringandOtherCharges"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring and Other Charges",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled."
       }
      }
     },
     "auth_ref": [
      "r675",
      "r676",
      "r678",
      "r681",
      "r687"
     ]
    },
    "us-gaap_RestructuringAndRelatedCostCostIncurredToDate1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringAndRelatedCostCostIncurredToDate1",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/RestructuringandOtherChargesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring and Related Cost, Cost Incurred to Date",
        "label": "Restructuring and Related Cost, Cost Incurred to Date",
        "documentation": "Amount of costs incurred to date for the specified restructuring cost."
       }
      }
     },
     "auth_ref": [
      "r677",
      "r680",
      "r684",
      "r686"
     ]
    },
    "us-gaap_RestructuringAndRelatedCostExpectedCost1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringAndRelatedCostExpectedCost1",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/RestructuringandOtherChargesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring and Related Cost, Expected Cost",
        "label": "Restructuring and Related Cost, Expected Cost",
        "documentation": "Amount expected to be recognized in earnings for the specified restructuring cost."
       }
      }
     },
     "auth_ref": [
      "r677",
      "r680",
      "r684",
      "r686"
     ]
    },
    "us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated",
     "presentation": [
      "http://www.iff.com/role/RestructuringandOtherChargesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected Number of Positions Eliminated",
        "label": "Restructuring and Related Cost, Expected Number of Positions Eliminated",
        "documentation": "The expected number of positions to be eliminated as a result of restructuring activities."
       }
      }
     },
     "auth_ref": []
    },
    "iff_RestructuringAndRelatedCostExpectedNumberOfSitesClosed": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "RestructuringAndRelatedCostExpectedNumberOfSitesClosed",
     "presentation": [
      "http://www.iff.com/role/RestructuringandOtherChargesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected number of sites closed",
        "label": "Restructuring And Related Cost, Expected Number Of Sites Closed",
        "documentation": "Restructuring And Related Cost, Expected Number Of Sites Closed"
       }
      }
     },
     "auth_ref": []
    },
    "iff_RestructuringAndRelatedCostExpectedNumberOfSitesClosedPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "RestructuringAndRelatedCostExpectedNumberOfSitesClosedPeriod",
     "presentation": [
      "http://www.iff.com/role/RestructuringandOtherChargesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected Number Of Sites Closed, Period",
        "label": "Restructuring And Related Cost, Expected Number Of Sites Closed, Period",
        "documentation": "Restructuring And Related Cost, Expected Number Of Sites Closed, Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringAndRelatedCostNumberOfPositionsEliminated",
     "presentation": [
      "http://www.iff.com/role/RestructuringandOtherChargesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring and Related Cost, Number of Positions Eliminated",
        "label": "Restructuring and Related Cost, Number of Positions Eliminated",
        "documentation": "The number of positions eliminated during the period as a result of restructuring activities."
       }
      }
     },
     "auth_ref": []
    },
    "iff_RestructuringAndRelatedCostNumberOfSitesClosed": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "RestructuringAndRelatedCostNumberOfSitesClosed",
     "presentation": [
      "http://www.iff.com/role/RestructuringandOtherChargesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number Of Sites Closed",
        "label": "Restructuring And Related Cost, Number Of Sites Closed",
        "documentation": "Restructuring And Related Cost, Number Of Sites Closed"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestructuringCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringCharges",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/RestructuringandOtherChargesAdditionalInformationDetails",
      "http://www.iff.com/role/RestructuringandOtherChargesMovementsinRestructuringandRelatedAccrualsDetail",
      "http://www.iff.com/role/SegmentInformationAdditionalInformationDetail",
      "http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional charges, net",
        "negatedTerseLabel": "Restructuring and Other Charges, net",
        "label": "Restructuring Charges",
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r682",
      "r684",
      "r1506"
     ]
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringCostAndReserveAxis",
     "presentation": [
      "http://www.iff.com/role/RestructuringandOtherChargesAdditionalInformationDetails",
      "http://www.iff.com/role/RestructuringandOtherChargesMovementsinRestructuringandRelatedAccrualsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring Type [Axis]",
        "label": "Restructuring Type [Axis]",
        "documentation": "Information by type of restructuring cost."
       }
      }
     },
     "auth_ref": [
      "r677",
      "r678",
      "r684",
      "r685"
     ]
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringCostAndReserveLineItems",
     "presentation": [
      "http://www.iff.com/role/RestructuringandOtherChargesAdditionalInformationDetails",
      "http://www.iff.com/role/RestructuringandOtherChargesMovementsinRestructuringandRelatedAccrualsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring Cost and Reserve [Line Items]",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r677",
      "r678",
      "r679",
      "r680",
      "r684",
      "r685",
      "r686"
     ]
    },
    "us-gaap_RestructuringPlanAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringPlanAxis",
     "presentation": [
      "http://www.iff.com/role/RestructuringandOtherChargesAdditionalInformationDetails",
      "http://www.iff.com/role/RestructuringandOtherChargesMovementsinRestructuringandRelatedAccrualsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring Plan [Axis]",
        "label": "Restructuring Plan [Axis]",
        "documentation": "Information by individual restructuring plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestructuringPlanDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringPlanDomain",
     "presentation": [
      "http://www.iff.com/role/RestructuringandOtherChargesAdditionalInformationDetails",
      "http://www.iff.com/role/RestructuringandOtherChargesMovementsinRestructuringandRelatedAccrualsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring Plan [Domain]",
        "label": "Restructuring Plan [Domain]",
        "documentation": "Identification of the individual restructuring plans."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestructuringReserve": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringReserve",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherCurrentLiabilitiesDetails",
      "http://www.iff.com/role/RestructuringandOtherChargesAdditionalInformationDetails",
      "http://www.iff.com/role/RestructuringandOtherChargesMovementsinRestructuringandRelatedAccrualsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance",
        "periodEndLabel": "Balance",
        "terseLabel": "Accrued restructuring",
        "label": "Restructuring Reserve",
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan."
       }
      }
     },
     "auth_ref": [
      "r678",
      "r683"
     ]
    },
    "us-gaap_RestructuringReserveAccrualAdjustment1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringReserveAccrualAdjustment1",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/RestructuringandOtherChargesAdditionalInformationDetails",
      "http://www.iff.com/role/RestructuringandOtherChargesMovementsinRestructuringandRelatedAccrualsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Charges (Reversals), Net",
        "label": "Restructuring Reserve, Accrual Adjustment",
        "documentation": "Amount of expense (reversal of expense) which increases (decreases) the restructuring reserve from an adjustment to a previously accrued restructuring liability."
       }
      }
     },
     "auth_ref": [
      "r678",
      "r685"
     ]
    },
    "us-gaap_RestructuringReserveRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringReserveRollForward",
     "presentation": [
      "http://www.iff.com/role/RestructuringandOtherChargesAdditionalInformationDetails",
      "http://www.iff.com/role/RestructuringandOtherChargesMovementsinRestructuringandRelatedAccrualsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring Reserve [Roll Forward]",
        "label": "Restructuring Reserve [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestructuringReserveSettledWithoutCash2": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringReserveSettledWithoutCash2",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/RestructuringandOtherChargesAdditionalInformationDetails",
      "http://www.iff.com/role/RestructuringandOtherChargesMovementsinRestructuringandRelatedAccrualsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Non-Cash Charges",
        "label": "Restructuring Reserve, Settled without Cash",
        "documentation": "Amount of decrease in the reserve for full or partial settlement through consideration other than cash."
       }
      }
     },
     "auth_ref": [
      "r678",
      "r685"
     ]
    },
    "iff_RestructuringandOtherCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "RestructuringandOtherCharges",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Restructuring and other charges",
        "label": "Restructuring and Other Charges",
        "documentation": "Restructuring and Other Charges"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "(Accumulated deficit) retained earnings",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r252",
      "r301",
      "r1082",
      "r1116",
      "r1121",
      "r1130",
      "r1166",
      "r1311"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY",
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retained earnings (accumulated deficit)",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r408",
      "r489",
      "r490",
      "r491",
      "r494",
      "r504",
      "r506",
      "r606",
      "r612",
      "r877",
      "r878",
      "r879",
      "r910",
      "r911",
      "r947",
      "r950",
      "r951",
      "r954",
      "r965",
      "r1112",
      "r1114",
      "r1134",
      "r1651"
     ]
    },
    "us-gaap_RetirementPlanSponsorLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetirementPlanSponsorLocationAxis",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsAccumulatedBenefitObligationDetail",
      "http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail",
      "http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetail",
      "http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinBalanceSheetDetail",
      "http://www.iff.com/role/EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail",
      "http://www.iff.com/role/EmployeeBenefitsEstimatedFutureBenefitPaymentsDetail",
      "http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail",
      "http://www.iff.com/role/EmployeeBenefitsPercentageofAssetsInvestedDetail",
      "http://www.iff.com/role/EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail",
      "http://www.iff.com/role/EmployeeBenefitsReconciliationofLevel3NonUSPlanAssetsHeldDetail",
      "http://www.iff.com/role/EmployeeBenefitsSensitivityofDisclosurestoChangesinSelectedAssumptionsDetail",
      "http://www.iff.com/role/EmployeeBenefitsWeightedAverageActuarialAssumptionUsedtoDetermineExpenseDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement Plan Sponsor Location [Axis]",
        "label": "Retirement Plan Sponsor Location [Axis]",
        "documentation": "Information by location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans."
       }
      }
     },
     "auth_ref": [
      "r762",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r806",
      "r807",
      "r808",
      "r809",
      "r811",
      "r814",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r823",
      "r824",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r830",
      "r1581",
      "r1582",
      "r1583"
     ]
    },
    "us-gaap_RetirementPlanSponsorLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetirementPlanSponsorLocationDomain",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsAccumulatedBenefitObligationDetail",
      "http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail",
      "http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetail",
      "http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinBalanceSheetDetail",
      "http://www.iff.com/role/EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail",
      "http://www.iff.com/role/EmployeeBenefitsEstimatedFutureBenefitPaymentsDetail",
      "http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail",
      "http://www.iff.com/role/EmployeeBenefitsPercentageofAssetsInvestedDetail",
      "http://www.iff.com/role/EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail",
      "http://www.iff.com/role/EmployeeBenefitsReconciliationofLevel3NonUSPlanAssetsHeldDetail",
      "http://www.iff.com/role/EmployeeBenefitsSensitivityofDisclosurestoChangesinSelectedAssumptionsDetail",
      "http://www.iff.com/role/EmployeeBenefitsWeightedAverageActuarialAssumptionUsedtoDetermineExpenseDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement Plan Sponsor Location [Domain]",
        "label": "Retirement Plan Sponsor Location [Domain]",
        "documentation": "Location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans."
       }
      }
     },
     "auth_ref": [
      "r762",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r806",
      "r807",
      "r808",
      "r809",
      "r811",
      "r814",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r823",
      "r824",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r830",
      "r1581",
      "r1582",
      "r1583"
     ]
    },
    "us-gaap_RetirementPlanTaxStatusAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetirementPlanTaxStatusAxis",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement Plan Tax Status [Axis]",
        "label": "Retirement Plan Tax Status [Axis]",
        "documentation": "Information by tax status of plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans."
       }
      }
     },
     "auth_ref": [
      "r1417",
      "r1520",
      "r1521",
      "r1522",
      "r1523",
      "r1524",
      "r1525",
      "r1526",
      "r1527",
      "r1528",
      "r1529",
      "r1530",
      "r1531",
      "r1532",
      "r1533",
      "r1534",
      "r1535",
      "r1536",
      "r1537",
      "r1538",
      "r1539",
      "r1540",
      "r1541",
      "r1542",
      "r1543",
      "r1544",
      "r1545",
      "r1546",
      "r1547",
      "r1548",
      "r1549",
      "r1550",
      "r1551",
      "r1552",
      "r1553",
      "r1554",
      "r1555",
      "r1556",
      "r1557",
      "r1558",
      "r1559",
      "r1560",
      "r1561",
      "r1562",
      "r1563",
      "r1564",
      "r1565",
      "r1566",
      "r1567",
      "r1568",
      "r1569",
      "r1570",
      "r1571",
      "r1572",
      "r1573",
      "r1574",
      "r1575",
      "r1576",
      "r1577",
      "r1578",
      "r1579"
     ]
    },
    "us-gaap_RetirementPlanTaxStatusDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetirementPlanTaxStatusDomain",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement Plan Tax Status [Domain]",
        "label": "Retirement Plan Tax Status [Domain]",
        "documentation": "Tax status of plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans."
       }
      }
     },
     "auth_ref": [
      "r1417",
      "r1520",
      "r1521",
      "r1522",
      "r1523",
      "r1524",
      "r1525",
      "r1526",
      "r1527",
      "r1528",
      "r1529",
      "r1530",
      "r1531",
      "r1532",
      "r1533",
      "r1534",
      "r1535",
      "r1536",
      "r1537",
      "r1538",
      "r1539",
      "r1540",
      "r1541",
      "r1542",
      "r1543",
      "r1544",
      "r1545",
      "r1546",
      "r1547",
      "r1548",
      "r1549",
      "r1550",
      "r1551",
      "r1552",
      "r1553",
      "r1554",
      "r1555",
      "r1556",
      "r1557",
      "r1558",
      "r1559",
      "r1560",
      "r1561",
      "r1562",
      "r1563",
      "r1564",
      "r1565",
      "r1566",
      "r1567",
      "r1568",
      "r1569",
      "r1570",
      "r1571",
      "r1572",
      "r1573",
      "r1574",
      "r1575",
      "r1576",
      "r1577",
      "r1578",
      "r1579"
     ]
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetirementPlanTypeAxis",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsAccumulatedBenefitObligationDetail",
      "http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail",
      "http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetail",
      "http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinBalanceSheetDetail",
      "http://www.iff.com/role/EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail",
      "http://www.iff.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostandChangesinPlanAssetsandBenefitObligationsRecognizedinOCIDetail",
      "http://www.iff.com/role/EmployeeBenefitsEstimatedFutureBenefitPaymentsDetail",
      "http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail",
      "http://www.iff.com/role/EmployeeBenefitsPercentageofAssetsInvestedDetail",
      "http://www.iff.com/role/EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail",
      "http://www.iff.com/role/EmployeeBenefitsReconciliationofLevel3NonUSPlanAssetsHeldDetail",
      "http://www.iff.com/role/EmployeeBenefitsSensitivityofDisclosurestoChangesinSelectedAssumptionsDetail",
      "http://www.iff.com/role/EmployeeBenefitsWeightedAverageActuarialAssumptionUsedtoDetermineExpenseDetail",
      "http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement Plan Type [Axis]",
        "label": "Retirement Plan Type [Axis]",
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement."
       }
      }
     },
     "auth_ref": [
      "r758",
      "r762",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r806",
      "r808",
      "r809",
      "r811",
      "r814",
      "r817",
      "r821",
      "r822",
      "r823",
      "r824",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r830",
      "r834",
      "r835",
      "r836",
      "r839",
      "r1295",
      "r1296",
      "r1297",
      "r1298",
      "r1299",
      "r1300",
      "r1301",
      "r1302"
     ]
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetirementPlanTypeDomain",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsAccumulatedBenefitObligationDetail",
      "http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail",
      "http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetail",
      "http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinBalanceSheetDetail",
      "http://www.iff.com/role/EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail",
      "http://www.iff.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostandChangesinPlanAssetsandBenefitObligationsRecognizedinOCIDetail",
      "http://www.iff.com/role/EmployeeBenefitsEstimatedFutureBenefitPaymentsDetail",
      "http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail",
      "http://www.iff.com/role/EmployeeBenefitsPercentageofAssetsInvestedDetail",
      "http://www.iff.com/role/EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail",
      "http://www.iff.com/role/EmployeeBenefitsReconciliationofLevel3NonUSPlanAssetsHeldDetail",
      "http://www.iff.com/role/EmployeeBenefitsSensitivityofDisclosurestoChangesinSelectedAssumptionsDetail",
      "http://www.iff.com/role/EmployeeBenefitsWeightedAverageActuarialAssumptionUsedtoDetermineExpenseDetail",
      "http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement Plan Type [Domain]",
        "label": "Retirement Plan Type [Domain]",
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement."
       }
      }
     },
     "auth_ref": [
      "r758",
      "r762",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r806",
      "r808",
      "r809",
      "r811",
      "r814",
      "r817",
      "r821",
      "r822",
      "r823",
      "r824",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r830",
      "r834",
      "r835",
      "r836",
      "r839",
      "r1295",
      "r1296",
      "r1297",
      "r1298",
      "r1299",
      "r1300",
      "r1301",
      "r1302"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME",
      "http://www.iff.com/role/SegmentInformationNetSalesbyGeographicAreaDetail",
      "http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net sales",
        "terseLabel": "Revenue",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r534",
      "r535",
      "r546",
      "r551",
      "r552",
      "r558",
      "r560",
      "r562",
      "r755",
      "r756",
      "r1063"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerMember",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue from Contract with Customer Benchmark",
        "label": "Revenue from Contract with Customer Benchmark [Member]",
        "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation."
       }
      }
     },
     "auth_ref": [
      "r562",
      "r1420"
     ]
    },
    "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Sales by Geographic Area",
        "label": "Revenue from External Customers by Geographic Areas [Table Text Block]",
        "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueRecognitionPolicyTextBlock",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue Recognition",
        "label": "Revenue [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources."
       }
      }
     },
     "auth_ref": [
      "r1189",
      "r1253",
      "r1268"
     ]
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Revenues",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net sales",
        "label": "Revenues",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r457",
      "r475",
      "r534",
      "r535",
      "r546",
      "r551",
      "r552",
      "r558",
      "r560",
      "r562",
      "r601",
      "r697",
      "r698",
      "r700",
      "r701",
      "r702",
      "r704",
      "r706",
      "r708",
      "r709",
      "r978",
      "r1075",
      "r1511"
     ]
    },
    "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationSegmentInformationScheduleofLongLivedAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenues from External Customers and Long-Lived Assets [Line Items]",
        "label": "Revenues from External Customers and Long-Lived Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevolvingCreditFacilityMember",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail",
      "http://www.iff.com/role/DebtAdditionalInformationRevolvingCreditFacilityDetail",
      "http://www.iff.com/role/DebtComponentsofDebtDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revolving Loan Facility",
        "label": "Revolving Credit Facility [Member]",
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/LeasesCashFlowDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r1020",
      "r1310"
     ]
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/LeasesCashFlowDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r1020",
      "r1310"
     ]
    },
    "us-gaap_RisksAndUncertaintiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RisksAndUncertaintiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risks and Uncertainties [Abstract]",
        "label": "Risks and Uncertainties [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Adopted",
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1402"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Terminated",
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1402"
     ]
    },
    "iff_RussiaUkraineWarMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "RussiaUkraineWarMember",
     "presentation": [
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetNarrativeDetails",
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.iff.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Russia And Ukraine Conflict",
        "label": "Russia-Ukraine War [Member]",
        "documentation": "Russia-Ukraine War"
       }
      }
     },
     "auth_ref": []
    },
    "country_SG": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "SG",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationAdditionalInformationDetail",
      "http://www.iff.com/role/SegmentInformationSegmentInformationScheduleofLongLivedAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SINGAPORE",
        "label": "SINGAPORE"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SaleOfStockPercentageOfOwnershipAfterTransaction",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock, Percentage of Ownership after Transaction",
        "label": "Sale of Stock, Percentage of Ownership after Transaction",
        "documentation": "Percentage of subsidiary's or equity investee's stock owned by parent company after stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SalesAndExciseTaxPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SalesAndExciseTaxPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Value-added tax payable",
        "label": "Sales and Excise Tax Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "us-gaap_SalesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SalesMember",
     "presentation": [
      "http://www.iff.com/role/ConcentrationsOfCreditRiskAdditionalInformationDetail",
      "http://www.iff.com/role/SegmentInformationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sales [Member]",
        "label": "Sales [Member]",
        "documentation": "Primary financial statement caption encompassing revenue from sale of goods and services rendered in the normal course of business."
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "us-gaap_SalesRevenueNetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SalesRevenueNetMember",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue Benchmark",
        "label": "Revenue Benchmark [Member]",
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation."
       }
      }
     },
     "auth_ref": [
      "r562",
      "r1420"
     ]
    },
    "iff_SavorySolutionsAndFlavorSpecialtyIngredientsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "SavorySolutionsAndFlavorSpecialtyIngredientsMember",
     "presentation": [
      "http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Savory Solutions and Fine and Specialty Ingredients",
        "label": "Savory Solutions and Flavor Specialty Ingredients [Member]",
        "documentation": "Savory Solutions and Flavor Specialty Ingredients"
       }
      }
     },
     "auth_ref": []
    },
    "iff_SavorySolutionsBusinessMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "SavorySolutionsBusinessMember",
     "presentation": [
      "http://www.iff.com/role/BusinessDivestitureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Savory Solutions Business",
        "label": "Savory Solutions Business [Member]",
        "documentation": "Savory Solutions Business"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScenarioAdjustmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScenarioAdjustmentMember",
     "presentation": [
      "http://www.iff.com/role/ScheduleIIValuationandQualifyingAccountsandReservesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Scenario, Adjustment [Member]",
        "label": "Scenario, Adjustment [Member]",
        "documentation": "Domain member used to indicate figures that are adjustments during a period or as of a point in time. This domain member would never be expected to appear in a relationship group without the \"Scenario, Previously Reported\" Member with the same parent."
       }
      }
     },
     "auth_ref": []
    },
    "srt_ScenarioPreviouslyReportedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScenarioPreviouslyReportedMember",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Previously Reported",
        "label": "Previously Reported [Member]",
        "documentation": "Represents amount as previously reported before adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision."
       }
      }
     },
     "auth_ref": [
      "r409",
      "r489",
      "r491",
      "r493",
      "r494",
      "r497",
      "r498",
      "r506",
      "r525",
      "r911",
      "r961",
      "r965",
      "r966",
      "r1006",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120",
      "r1121",
      "r1123",
      "r1424",
      "r1428",
      "r1429",
      "r1430",
      "r1471",
      "r1488",
      "r1489",
      "r1621",
      "r1629",
      "r1630"
     ]
    },
    "srt_ScenarioUnspecifiedDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScenarioUnspecifiedDomain",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.iff.com/role/ScheduleIIValuationandQualifyingAccountsandReservesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Scenario [Domain]",
        "label": "Scenario [Domain]",
        "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts."
       }
      }
     },
     "auth_ref": [
      "r507",
      "r838",
      "r1411",
      "r1472"
     ]
    },
    "iff_ScentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "ScentMember",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails",
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail",
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetGoodwillRollforwardDetails",
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetNarrativeDetails",
      "http://www.iff.com/role/RestructuringandOtherChargesAdditionalInformationDetails",
      "http://www.iff.com/role/RestructuringandOtherChargesMovementsinRestructuringandRelatedAccrualsDetail",
      "http://www.iff.com/role/SegmentInformationCapitalExpenditureandDepreciationandAmortizationbySegmentDetail",
      "http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Scent [Member]",
        "label": "Scent [Member]",
        "documentation": "Scent [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAccumulatedAndProjectedBenefitObligationsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAccumulatedAndProjectedBenefitObligationsTableTextBlock",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Benefit Obligation",
        "label": "Schedule of Accumulated and Projected Benefit Obligations [Table Text Block]",
        "documentation": "Tabular disclosure of benefit obligations including accumulated benefit obligation and projected benefit obligation."
       }
      }
     },
     "auth_ref": [
      "r308"
     ]
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "presentation": [
      "http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Changes in Accumulated Other Comprehensive Income (Loss)",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r1623",
      "r1624"
     ]
    },
    "us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAllocationOfPlanAssetsTableTextBlock",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of Assets Invested",
        "label": "Schedule of Allocation of Plan Assets [Table Text Block]",
        "documentation": "Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans. This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall."
       }
      }
     },
     "auth_ref": [
      "r307"
     ]
    },
    "iff_ScheduleOfAmountsExpectedToBeRecognizedInNetPeriodicCostTableTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "ScheduleOfAmountsExpectedToBeRecognizedInNetPeriodicCostTableTableTextBlock",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amounts Expected to be Recognized in Net Periodic Cost",
        "label": "Schedule Of Amounts Expected To Be Recognized In Net Periodic Cost Table [Table Text Block]",
        "documentation": "Schedule Of Amounts Expected To Be Recognized In Net Periodic Cost [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amounts Recognized in Balance Sheet",
        "label": "Schedule of Amounts Recognized in Balance Sheet [Table Text Block]",
        "documentation": "Tabular disclosure of the amounts that are recognized in the balance sheet (or statement of financial position) for pension plans and/or other employee benefit plans, showing separately the assets and current and noncurrent liabilities (if applicable) recognized."
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amounts Recognized in Accumulated Other Comprehensive Income",
        "label": "Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]",
        "documentation": "Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost."
       }
      }
     },
     "auth_ref": [
      "r305"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://www.iff.com/role/NetIncomePerShareAdditionalInformationDetail",
      "http://www.iff.com/role/NetIncomePerShareReconciliationofSharesUsedinComputationofBasicandDilutedNetIncomePerShareDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities."
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "us-gaap_ScheduleOfAssumptionsUsedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAssumptionsUsedTableTextBlock",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-Average Actuarial Assumption Used to Determine Expense",
        "label": "Defined Benefit Plan, Assumptions [Table Text Block]",
        "documentation": "Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate."
       }
      }
     },
     "auth_ref": [
      "r805"
     ]
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsHealthWrightProductsDetails",
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities."
       }
      }
     },
     "auth_ref": [
      "r168",
      "r170",
      "r923"
     ]
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]",
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts."
       }
      }
     },
     "auth_ref": [
      "r168",
      "r170"
     ]
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Cash and Cash Equivalents",
        "label": "Schedule of Cash and Cash Equivalents [Table Text Block]",
        "documentation": "Tabular disclosure of the components of cash and cash equivalents."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfChangesInAccumulatedPostemploymentBenefitObligationsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfChangesInAccumulatedPostemploymentBenefitObligationsTableTextBlock",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in Postretirement Benefit Obligation and Plan Assets",
        "label": "Schedule of Changes in Accumulated Postemployment Benefit Obligations [Table Text Block]",
        "documentation": "Tabular disclosure of the change in the accumulated postemployment benefit obligation from the beginning to the end of the period, showing separately, if applicable, the effects of the following: service cost, interest cost, contributions by plan participants, actuarial gains and losses, foreign currency exchange rate changes, benefits paid, plan amendments, business combinations, divestitures, curtailments, settlements, and special and contractual termination benefits."
       }
      }
     },
     "auth_ref": [
      "r306"
     ]
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-Based Compensation Expense Included in Consolidated Statement of Income and Comprehensive Income",
        "label": "Share-Based Payment Arrangement, Cost by Plan [Table Text Block]",
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit."
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Income Tax Provision",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years."
       }
      }
     },
     "auth_ref": [
      "r315"
     ]
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDebtTableTextBlock",
     "presentation": [
      "http://www.iff.com/role/DebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Components of Debt",
        "label": "Schedule of Debt [Table Text Block]",
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r314"
     ]
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsAccumulatedBenefitObligationDetail",
      "http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail",
      "http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetail",
      "http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinBalanceSheetDetail",
      "http://www.iff.com/role/EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail",
      "http://www.iff.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostandChangesinPlanAssetsandBenefitObligationsRecognizedinOCIDetail",
      "http://www.iff.com/role/EmployeeBenefitsEstimatedFutureBenefitPaymentsDetail",
      "http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail",
      "http://www.iff.com/role/EmployeeBenefitsPercentageofAssetsInvestedDetail",
      "http://www.iff.com/role/EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail",
      "http://www.iff.com/role/EmployeeBenefitsReconciliationofLevel3NonUSPlanAssetsHeldDetail",
      "http://www.iff.com/role/EmployeeBenefitsSensitivityofDisclosurestoChangesinSelectedAssumptionsDetail",
      "http://www.iff.com/role/EmployeeBenefitsWeightedAverageActuarialAssumptionUsedtoDetermineExpenseDetail",
      "http://www.iff.com/role/EmployeeBenefitsWeightedAverageAssumptionsUsedtoDeterminePostretirementBenefitExpenseandObligationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r145",
      "r146",
      "r147",
      "r148"
     ]
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instruments Designated as Cash Flow and Net Investment Hedging Instruments",
        "label": "Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block]",
        "documentation": "Tabular disclosure of the effective portion of the gains and losses on derivative instruments designated (and non-derivative instruments) designated and qualifying in cash flow hedges and net investment hedges that was recognized in other comprehensive income (loss) during the current period."
       }
      }
     },
     "auth_ref": [
      "r197"
     ]
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instruments Measured at Fair Value",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r192"
     ]
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "presentation": [
      "http://www.iff.com/role/AssetsandLiabilitiesHeldForSaleTables",
      "http://www.iff.com/role/DiscontinuedOperationsandDisposalGroupsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets and Liabilities Held for Sale",
        "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]",
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r48",
      "r63",
      "r225",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r235",
      "r236",
      "r237",
      "r292"
     ]
    },
    "us-gaap_ScheduleOfEffectOfOnePercentagePointChangeInAssumedHealthCareCostTrendRatesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEffectOfOnePercentagePointChangeInAssumedHealthCareCostTrendRatesTableTextBlock",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sensitivity of Disclosures to Changes in Selected Assumptions",
        "label": "Schedule of Effect of One-Percentage-Point Change in Assumed Health Care Cost Trend Rates [Table Text Block]",
        "documentation": "Tabular disclosure of the effect of a one-percentage-point increase and the effect of a one-percentage-point decrease in the assumed health care cost trend rates on the aggregate of the service and interest cost components of net periodic postretirement health care benefit costs and the accumulated postretirement benefit obligation for health care benefits."
       }
      }
     },
     "auth_ref": [
      "r1519"
     ]
    },
    "us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation of Level 3 Non-U.S. Plan Assets Held",
        "label": "Schedule of Effect of Significant Unobservable Inputs, Changes in Plan Assets [Table Text Block]",
        "documentation": "Tabular disclosure of the effect of fair value measurements using significant unobservable inputs (Level 3) on changes in plan assets of pension plans and/or other employee benefit plans for the period."
       }
      }
     },
     "auth_ref": [
      "r1544"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Reconciliation between U.S. Federal Statutory Income Tax Rate to Actual Effective Tax Rate",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r313"
     ]
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail",
      "http://www.iff.com/role/RedeemableNoncontrollingInterestsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment, Name [Axis]",
        "label": "Investment, Name [Axis]",
        "documentation": "Information by name of investment including named security. Excludes entity that is consolidated."
       }
      }
     },
     "auth_ref": [
      "r598",
      "r599",
      "r600"
     ]
    },
    "us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfExpectedBenefitPaymentsTableTextBlock",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimated Future Benefit Payments",
        "label": "Schedule of Expected Benefit Payments [Table Text Block]",
        "documentation": "Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter."
       }
      }
     },
     "auth_ref": [
      "r309"
     ]
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Carrying Amount and Estimated Fair Value of Financial Instruments",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r970",
      "r971"
     ]
    },
    "iff_ScheduleOfFairValueOfPensionPlanAssetsByAssetCategoryTableTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "ScheduleOfFairValueOfPensionPlanAssetsByAssetCategoryTableTableTextBlock",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy of Plan Assets",
        "label": "Schedule Of Fair Value Of Pension Plan Assets By Asset Category Table [Table Text Block]",
        "documentation": "Schedule Of Fair Value Of Pension Plan Assets By Asset Category [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of intangible assets acquired",
        "label": "Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]",
        "documentation": "Tabular disclosure of finite-lived intangible assets acquired as part of a business combination or through an asset purchase, by major class and in total, including the value of the asset acquired, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period."
       }
      }
     },
     "auth_ref": [
      "r113"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "presentation": [
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetTrademarkandOtherIntangibleAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r115",
      "r1064"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "presentation": [
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Other Intangible Assets",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r115"
     ]
    },
    "us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
     "presentation": [
      "http://www.iff.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Future Minimum Rental Payments for Operating Leases",
        "label": "Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]",
        "documentation": "Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r350"
     ]
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfGoodwillTable",
     "presentation": [
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetGoodwillRollforwardDetails",
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Goodwill [Table]",
        "label": "Schedule of Goodwill [Table]",
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons."
       }
      }
     },
     "auth_ref": [
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r1279"
     ]
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfGoodwillTextBlock",
     "presentation": [
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Goodwill by Operating Segment",
        "label": "Schedule of Goodwill [Table Text Block]",
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule."
       }
      }
     },
     "auth_ref": [
      "r1279",
      "r1492",
      "r1493",
      "r1494",
      "r1495",
      "r1496",
      "r1497",
      "r1498",
      "r1499",
      "r1500",
      "r1501",
      "r1502"
     ]
    },
    "us-gaap_ScheduleOfHealthCareCostTrendRatesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfHealthCareCostTrendRatesTableTextBlock",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Assumptions Used to Determine Postretirement Benefit Expense and Obligation",
        "label": "Schedule of Health Care Cost Trend Rates [Table Text Block]",
        "documentation": "Tabular disclosure of the assumed health care cost trend rates for the next year used to measure the expected cost of benefits covered by the plans, including the ultimate trend rate(s) and when that rate is expected to be achieved."
       }
      }
     },
     "auth_ref": [
      "r310"
     ]
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Earnings before Income Taxes",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions."
       }
      }
     },
     "auth_ref": [
      "r1460"
     ]
    },
    "iff_ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsLineItems",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsNotionalAmountOutstandingDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule Of Information By Major Category Of Credit Derivatives Contracts [Line Items]",
        "label": "Schedule Of Information By Major Category Of Credit Derivatives Contracts [Line Items]",
        "documentation": "Schedule Of Information By Major Category Of Credit Derivatives Contracts [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "ScheduleOfInformationByMajorCategoryOfCreditDerivativesContractsTable",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsNotionalAmountOutstandingDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule Of Information By Major Category Of Credit Derivatives Contracts [Table]",
        "label": "Schedule Of Information By Major Category Of Credit Derivatives Contracts [Table]",
        "documentation": "Schedule Of Information By Major Category Of Credit Derivatives Contracts [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Inventory",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r256",
      "r257",
      "r258"
     ]
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "presentation": [
      "http://www.iff.com/role/DebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Maturities of Long-term Debt",
        "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]",
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt."
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instruments Notional Amount Outstanding",
        "label": "Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]",
        "documentation": "Tabular disclosure of the notional amounts of outstanding derivative positions."
       }
      }
     },
     "auth_ref": [
      "r186"
     ]
    },
    "us-gaap_ScheduleOfOtherAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfOtherAssetsTableTextBlock",
     "presentation": [
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Other Assets",
        "label": "Schedule of Other Assets [Table Text Block]",
        "documentation": "Tabular disclosure of the carrying amounts of other assets. This disclosure includes other current assets and other noncurrent assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfOtherCurrentAssetsTableTextBlock",
     "presentation": [
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Other Current Assets",
        "label": "Schedule of Other Current Assets [Table Text Block]",
        "documentation": "Tabular disclosure of the carrying amounts of other current assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instruments Which Were Not Designated as Hedging Instruments",
        "label": "Derivatives Not Designated as Hedging Instruments [Table Text Block]",
        "documentation": "Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument."
       }
      }
     },
     "auth_ref": [
      "r199",
      "r1426"
     ]
    },
    "us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
     "presentation": [
      "http://www.iff.com/role/OtherExpenseIncomeNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Other (Expense) Income",
        "label": "Schedule of Other Nonoperating Income (Expense) [Table Text Block]",
        "documentation": "Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://www.iff.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Property, Plant and Equipment [Table]",
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "presentation": [
      "http://www.iff.com/role/RestructuringandOtherChargesAdditionalInformationDetails",
      "http://www.iff.com/role/RestructuringandOtherChargesMovementsinRestructuringandRelatedAccrualsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring."
       }
      }
     },
     "auth_ref": [
      "r677",
      "r678",
      "r679",
      "r680",
      "r684",
      "r685",
      "r686"
     ]
    },
    "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
     "presentation": [
      "http://www.iff.com/role/RestructuringandOtherChargesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Movements in Restructuring and Related Accruals",
        "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r122"
     ]
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationSegmentInformationScheduleofLongLivedAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r261"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationAdditionalInformationDetail",
      "http://www.iff.com/role/SegmentInformationCapitalExpenditureandDepreciationandAmortizationbySegmentDetail",
      "http://www.iff.com/role/SegmentInformationNetSalesbyGeographicAreaDetail",
      "http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r107",
      "r108",
      "r111"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reportable Segment Information",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r107",
      "r108",
      "r111"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansLiabilityAwardsAdditionalInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansPurchasedRestrictedStockPlanAdditionalInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansRSUPRSandCashRSUActivityDetail",
      "http://www.iff.com/role/StockCompensationPlansRestrictedStockUnitsPlanAdditionalInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionActivityDetail",
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionAdditionalInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionExercisableDetail",
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionOutstandingDetail",
      "http://www.iff.com/role/StockCompensationPlansStockBasedCompensationExpenseIncludedinConsolidatedStatementofIncomeandComprehensiveIncomeDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r841",
      "r843",
      "r846",
      "r847",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871"
     ]
    },
    "iff_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionExercisableByExercisePriceRangeTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionExercisableByExercisePriceRangeTableTextBlock",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlans"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SSAR's and Stock Option Exercisable",
        "label": "Schedule Of Share Based Compensation, Shares Authorized Under Stock Option, Exercisable, By Exercise Price Range Table [Text Block]",
        "documentation": "Schedule Of Share-Based Compensation, Shares Authorized Under Stock Option, Exercisable, By Exercise Price Range [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SSAR's and Stock Option Outstanding",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]",
        "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms."
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SSAR's and Stock Option Activity",
        "label": "Share-Based Payment Arrangement, Option and Stock Appreciation Rights, Activity [Table Text Block]",
        "documentation": "Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock options and stock appreciation rights that were outstanding at the beginning and end of the year, exercisable at the end of the year, and the number of stock options and stock appreciation rights that were granted, exercised or converted, forfeited, and expired during the year."
       }
      }
     },
     "auth_ref": [
      "r153"
     ]
    },
    "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RSU Activity",
        "verboseLabel": "Cash RSU Activity",
        "label": "Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]",
        "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfStockByClassTable",
     "presentation": [
      "http://www.iff.com/role/TangibleEquityUnitsTangibleEquitySettlementofSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock by Class [Table]",
        "label": "Schedule of Stock by Class [Table]",
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r127",
      "r132",
      "r133",
      "r134",
      "r135",
      "r136",
      "r137",
      "r299",
      "r300",
      "r301",
      "r427",
      "r428",
      "r429",
      "r527",
      "r739",
      "r740",
      "r741",
      "r743",
      "r746",
      "r751",
      "r753",
      "r1126",
      "r1127",
      "r1128",
      "r1129",
      "r1290",
      "r1410",
      "r1457"
     ]
    },
    "us-gaap_ScheduleOfTreasuryStockByClassTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfTreasuryStockByClassTextBlock",
     "presentation": [
      "http://www.iff.com/role/ShareholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock Repurchase Activity",
        "label": "Class of Treasury Stock [Table Text Block]",
        "documentation": "Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock."
       }
      }
     },
     "auth_ref": [
      "r139",
      "r140",
      "r141",
      "r142"
     ]
    },
    "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
     "presentation": [
      "http://www.iff.com/role/ScheduleIIValuationandQualifyingAccountsandReserves"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule II - Valuation and Qualifying Accounts and Reserves",
        "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]",
        "documentation": "The entire disclosure for valuation and qualifying accounts and reserves."
       }
      }
     },
     "auth_ref": [
      "r385",
      "r488"
     ]
    },
    "us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
     "presentation": [
      "http://www.iff.com/role/NetIncomePerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation of Shares Used in Computations of Basic and Diluted Net Income Per Share",
        "label": "Schedule of Weighted Average Number of Shares [Table Text Block]",
        "documentation": "Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit)."
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "iff_ScheduleofAllocationofTangibleEquityUnitsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "ScheduleofAllocationofTangibleEquityUnitsTableTextBlock",
     "presentation": [
      "http://www.iff.com/role/TangibleEquityUnitsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Allocation of Tangible Equity Units",
        "label": "Schedule of Allocation of Tangible Equity Units [Table Text Block]",
        "documentation": "Schedule of Allocation of Tangible Equity Units [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "presentation": [
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r115"
     ]
    },
    "iff_ScheduleofStockPurchaseContractTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "ScheduleofStockPurchaseContractTableTextBlock",
     "presentation": [
      "http://www.iff.com/role/TangibleEquityUnitsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock Purchase Contract",
        "label": "Schedule of Stock Purchase Contract [Table Text Block]",
        "documentation": "Schedule of Stock Purchase Contract [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_SecuredOvernightFinancingRateSOFRMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "SecuredOvernightFinancingRateSOFRMember",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationRevolvingCreditFacilityDetail",
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Secured Overnight Financing Rate (SOFR)",
        "label": "Secured Overnight Financing Rate (SOFR) [Member]",
        "documentation": "Secured Overnight Financing Rate (SOFR)"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.iff.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1329"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.iff.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r1332"
     ]
    },
    "iff_SegmentAdjustedOperatingEBITDA": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "SegmentAdjustedOperatingEBITDA",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Adjusted Operating EBITDA",
        "label": "Segment Adjusted Operating EBITDA",
        "documentation": "Segment Adjusted Operating EBITDA is defined as income (loss) before taxes, depreciation and amortization expense, interest expense, restructuring and other charges, net and certain non-recurring items."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentDomain",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails",
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail",
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetGoodwillRollforwardDetails",
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetNarrativeDetails",
      "http://www.iff.com/role/LeasesAdditionalInformationDetails",
      "http://www.iff.com/role/RestructuringandOtherChargesAdditionalInformationDetails",
      "http://www.iff.com/role/RestructuringandOtherChargesMovementsinRestructuringandRelatedAccrualsDetail",
      "http://www.iff.com/role/SegmentInformationAdditionalInformationDetail",
      "http://www.iff.com/role/SegmentInformationCapitalExpenditureandDepreciationandAmortizationbySegmentDetail",
      "http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Domain]",
        "label": "Segments [Domain]",
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r530",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r556",
      "r562",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r680",
      "r686",
      "r1098",
      "r1099",
      "r1100",
      "r1101",
      "r1102",
      "r1103",
      "r1104",
      "r1105",
      "r1106",
      "r1107",
      "r1108",
      "r1279",
      "r1427",
      "r1646"
     ]
    },
    "us-gaap_SegmentExpenditureAdditionToLongLivedAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentExpenditureAdditionToLongLivedAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationCapitalExpenditureandDepreciationandAmortizationbySegmentDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital Expenditures",
        "label": "Segment, Expenditure, Addition to Long-Lived Assets",
        "documentation": "Amount of expenditure for addition to long-lived assets included in determination of segment assets by chief operating decision maker (CODM) or otherwise regularly provided to CODM. Excludes expenditure for addition to financial instrument, long-term customer relationship of financial institution, mortgage and other servicing rights, deferred policy acquisition cost, and deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r544",
      "r1272"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail",
      "http://www.iff.com/role/ConcentrationsOfCreditRiskAdditionalInformationDetail",
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.iff.com/role/RestructuringandOtherChargesAdditionalInformationDetails",
      "http://www.iff.com/role/SegmentInformationAdditionalInformationDetail",
      "http://www.iff.com/role/SegmentInformationNetSalesbyGeographicAreaDetail",
      "http://www.iff.com/role/SegmentInformationSegmentInformationScheduleofLongLivedAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Domain]",
        "label": "Geographical [Domain]",
        "documentation": "Geographical area."
       }
      }
     },
     "auth_ref": [
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r560",
      "r561",
      "r1148",
      "r1151",
      "r1153",
      "r1214",
      "r1216",
      "r1219",
      "r1229",
      "r1242",
      "r1243",
      "r1244",
      "r1245",
      "r1246",
      "r1247",
      "r1248",
      "r1249",
      "r1250",
      "r1255",
      "r1291",
      "r1315",
      "r1516",
      "r1646"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting [Abstract]",
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://www.iff.com/role/SegmentInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Information",
        "label": "Segment Reporting Disclosure [Text Block]",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r545",
      "r550",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r562"
     ]
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingInformationLineItems",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationAdditionalInformationDetail",
      "http://www.iff.com/role/SegmentInformationCapitalExpenditureandDepreciationandAmortizationbySegmentDetail",
      "http://www.iff.com/role/SegmentInformationNetSalesbyGeographicAreaDetail",
      "http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting Information [Line Items]",
        "label": "Segment Reporting Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SellingGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Selling and administrative expenses",
        "label": "Selling, General and Administrative Expense",
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc."
       }
      }
     },
     "auth_ref": [
      "r269"
     ]
    },
    "us-gaap_SeniorLongTermNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SeniorLongTermNotes",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationSeniorUnsecuredNotesDetail",
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail",
      "http://www.iff.com/role/DebtComponentsofDebtDetail",
      "http://www.iff.com/role/FinancialInstrumentsCarryingAmountandEstimatedFairValueofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior notes",
        "label": "Senior Notes, Noncurrent",
        "documentation": "Carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion. Senior note holders are paid off in full before any payments are made to junior note holders."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r1311"
     ]
    },
    "us-gaap_SeniorNotesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SeniorNotesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail",
      "http://www.iff.com/role/DebtComponentsofDebtDetail",
      "http://www.iff.com/role/FinancialInstrumentsCarryingAmountandEstimatedFairValueofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior notes, current",
        "label": "Senior Notes, Current",
        "documentation": "Carrying value as of the balance sheet date of the portion of long-term notes having the highest claim on the assets of the issuer in case of bankruptcy or liquidation, due within one year or the normal operating cycle, if longer. Senior note holders are paid off in full before any payments are made to debt holders having a lesser priority of repayment."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r1311"
     ]
    },
    "iff_SeniorNotesDueTwoThousandFiftyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "SeniorNotesDueTwoThousandFiftyMember",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationCommercialPaperandRedemptionProvisionsDetail",
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail",
      "http://www.iff.com/role/DebtComponentsofDebtDetail",
      "http://www.iff.com/role/FinancialInstrumentsCarryingAmountandEstimatedFairValueofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Notes, Due Two Thousand Fifty",
        "label": "Senior Notes, Due Two Thousand Fifty [Member]",
        "documentation": "Senior Notes, Due Two Thousand Fifty"
       }
      }
     },
     "auth_ref": []
    },
    "iff_SeniorNotesDueTwoThousandFortyEightMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "SeniorNotesDueTwoThousandFortyEightMember",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationCommercialPaperandRedemptionProvisionsDetail",
      "http://www.iff.com/role/DebtAdditionalInformationSeniorUnsecuredNotesDetail",
      "http://www.iff.com/role/DebtComponentsofDebtDetail",
      "http://www.iff.com/role/FinancialInstrumentsCarryingAmountandEstimatedFairValueofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Notes - 2048",
        "label": "Senior Notes, Due Two Thousand Forty Eight [Member]",
        "documentation": "Senior Notes, Due Two Thousand Forty Eight [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_SeniorNotesDueTwoThousandFortyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "SeniorNotesDueTwoThousandFortyMember",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationCommercialPaperandRedemptionProvisionsDetail",
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail",
      "http://www.iff.com/role/DebtComponentsofDebtDetail",
      "http://www.iff.com/role/FinancialInstrumentsCarryingAmountandEstimatedFairValueofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Notes, Due Two Thousand Forty",
        "label": "Senior Notes, Due Two Thousand Forty [Member]",
        "documentation": "Senior Notes, Due Two Thousand Forty"
       }
      }
     },
     "auth_ref": []
    },
    "iff_SeniorNotesDueTwoThousandFortySevenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "SeniorNotesDueTwoThousandFortySevenMember",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationCommercialPaperandRedemptionProvisionsDetail",
      "http://www.iff.com/role/DebtAdditionalInformationSeniorUnsecuredNotesDetail",
      "http://www.iff.com/role/DebtComponentsofDebtDetail",
      "http://www.iff.com/role/FinancialInstrumentsCarryingAmountandEstimatedFairValueofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior notes - 2047",
        "label": "Senior Notes, Due Two Thousand Forty Seven [Member]",
        "documentation": "Senior Notes, Due Two Thousand Forty Seven [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_SeniorNotesDueTwoThousandThirtyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "SeniorNotesDueTwoThousandThirtyMember",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationCommercialPaperandRedemptionProvisionsDetail",
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail",
      "http://www.iff.com/role/DebtComponentsofDebtDetail",
      "http://www.iff.com/role/FinancialInstrumentsCarryingAmountandEstimatedFairValueofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Notes, Due Two Thousand Thirty",
        "label": "Senior Notes, Due Two Thousand Thirty [Member]",
        "documentation": "Senior Notes, Due Two Thousand Thirty"
       }
      }
     },
     "auth_ref": []
    },
    "iff_SeniorNotesDueTwoThousandTwentyEightMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "SeniorNotesDueTwoThousandTwentyEightMember",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationCommercialPaperandRedemptionProvisionsDetail",
      "http://www.iff.com/role/DebtAdditionalInformationSeniorUnsecuredNotesDetail",
      "http://www.iff.com/role/DebtComponentsofDebtDetail",
      "http://www.iff.com/role/FinancialInstrumentsCarryingAmountandEstimatedFairValueofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Notes - 2028",
        "label": "Senior Notes, Due Two Thousand Twenty Eight [Member]",
        "documentation": "Senior Notes, Due Two Thousand Twenty Eight [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_SeniorNotesDueTwoThousandTwentyFiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "SeniorNotesDueTwoThousandTwentyFiveMember",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationCommercialPaperandRedemptionProvisionsDetail",
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail",
      "http://www.iff.com/role/DebtComponentsofDebtDetail",
      "http://www.iff.com/role/FinancialInstrumentsCarryingAmountandEstimatedFairValueofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Notes, Due Two Thousand Twenty Five",
        "label": "Senior Notes, Due Two Thousand Twenty Five [Member]",
        "documentation": "Senior Notes, Due Two Thousand Twenty Five"
       }
      }
     },
     "auth_ref": []
    },
    "iff_SeniorNotesDueTwoThousandTwentySevenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "SeniorNotesDueTwoThousandTwentySevenMember",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationCommercialPaperandRedemptionProvisionsDetail",
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail",
      "http://www.iff.com/role/DebtComponentsofDebtDetail",
      "http://www.iff.com/role/FinancialInstrumentsCarryingAmountandEstimatedFairValueofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Notes, Due Two Thousand Twenty Seven",
        "label": "Senior Notes, Due Two Thousand Twenty Seven [Member]",
        "documentation": "Senior Notes, Due Two Thousand Twenty Seven"
       }
      }
     },
     "auth_ref": []
    },
    "iff_SeniorNotesDueTwoThousandTwentyThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "SeniorNotesDueTwoThousandTwentyThreeMember",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationSeniorUnsecuredNotesDetail",
      "http://www.iff.com/role/DebtComponentsofDebtDetail",
      "http://www.iff.com/role/FinancialInstrumentsCarryingAmountandEstimatedFairValueofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Notes - 2023",
        "label": "Senior Notes, Due Two Thousand Twenty Three [Member]",
        "documentation": "Senior Notes, Due Two Thousand Twenty Three [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_SeniorNotesDueTwoThousandTwentyTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "SeniorNotesDueTwoThousandTwentyTwoMember",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail",
      "http://www.iff.com/role/FinancialInstrumentsCarryingAmountandEstimatedFairValueofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Notes, Due Two Thousand Twenty Two",
        "label": "Senior Notes, Due Two Thousand Twenty Two [Member]",
        "documentation": "Senior Notes, Due Two Thousand Twenty Two"
       }
      }
     },
     "auth_ref": []
    },
    "iff_SeniorNotesEuroNotesDueTwoThousandTwentyFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "SeniorNotesEuroNotesDueTwoThousandTwentyFourMember",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationCommercialPaperandRedemptionProvisionsDetail",
      "http://www.iff.com/role/DebtAdditionalInformationSeniorUnsecuredNotesDetail",
      "http://www.iff.com/role/DebtComponentsofDebtDetail",
      "http://www.iff.com/role/FinancialInstrumentsCarryingAmountandEstimatedFairValueofFinancialInstrumentsDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowandNetInvestmentHedgingInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Notes, Euro Notes, 2024",
        "label": "Senior Notes, Euro Notes, Due Two Thousand Twenty Four [Member]",
        "documentation": "Senior Notes, Euro Note, Due Two Thousand Twenty Four [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_SeniorNotesEuroNotesDueTwoThousandTwentySixMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "SeniorNotesEuroNotesDueTwoThousandTwentySixMember",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationCommercialPaperandRedemptionProvisionsDetail",
      "http://www.iff.com/role/DebtAdditionalInformationSeniorUnsecuredNotesDetail",
      "http://www.iff.com/role/DebtComponentsofDebtDetail",
      "http://www.iff.com/role/FinancialInstrumentsCarryingAmountandEstimatedFairValueofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Notes, Euro Notes, 2026",
        "label": "Senior Notes, Euro Notes, Due Two Thousand Twenty Six [Member]",
        "documentation": "Senior Notes, Euro Notes, Due Two Thousand Twenty Six [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_SeniorNotesEuroNotesMaturing2021And2026Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "SeniorNotesEuroNotesMaturing2021And2026Member",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowandNetInvestmentHedgingInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Notes Maturing 2021 through 2026 [Member]",
        "label": "Senior Notes, Euro Notes, Maturing 2021 and 2026 [Member]",
        "documentation": "Senior Notes Maturing 2021 through 2026 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_SeniorUnsecuredBridgeTermLoanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "SeniorUnsecuredBridgeTermLoanMember",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Unsecured Bridge Term Loan [Member]",
        "label": "Senior Unsecured Bridge Term Loan [Member]",
        "documentation": "Senior Unsecured Bridge Term Loan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_SeniorUnsecuredNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "SeniorUnsecuredNotesMember",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail",
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Unsecured Notes",
        "label": "Senior Unsecured Notes [Member]",
        "documentation": "Senior Unsecured Notes"
       }
      }
     },
     "auth_ref": []
    },
    "iff_SeniorUnsecuredTermLoanFacilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "SeniorUnsecuredTermLoanFacilitiesMember",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Unsecured Term Loan Facilities",
        "label": "Senior Unsecured Term Loan Facilities [Member]",
        "documentation": "Senior Unsecured Term Loan Facilities [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeveranceCosts1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SeveranceCosts1",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/RestructuringandOtherChargesAdditionalInformationDetails",
      "http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Severance costs",
        "verboseLabel": "Employee separation costs",
        "label": "Severance Costs",
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation."
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansLiabilityAwardsAdditionalInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansRestrictedStockUnitsPlanAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting period, in years",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r1304"
     ]
    },
    "iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTerm",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contractual term, in years",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award, Contractual Term",
        "documentation": "Maximum term of options or units granted."
       }
      }
     },
     "auth_ref": []
    },
    "iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsChangeDueToPerformanceConditions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsChangeDueToPerformanceConditions",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansRSUPRSandCashRSUActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Change due to performance conditions, net (in shares)",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Change Due To Performance Conditions",
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Change Due To Performance Conditions"
       }
      }
     },
     "auth_ref": []
    },
    "iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsChangeDueToPerformanceConditionsWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsChangeDueToPerformanceConditionsWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansRSUPRSandCashRSUActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change due to performance conditions, net (in dollars per share)",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Change Due To Performance Conditions, Weighted Average Grant Date Fair Value",
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Change Due To Performance Conditions, Weighted Average Grant Date Fair Value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansRSUPRSandCashRSUActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Forfeited (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r862"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansRSUPRSandCashRSUActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forfeited (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event."
       }
      }
     },
     "auth_ref": [
      "r862"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansRSUPRSandCashRSUActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r860"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansRSUPRSandCashRSUActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r860"
     ]
    },
    "iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedPurchasedByEmployees": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedPurchasedByEmployees",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansPurchasedRestrictedStockPlanAdditionalInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansRSUPRSandCashRSUActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issued Shares (in shares)",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Issued, Purchased By Employees",
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Issued, Purchased By Employees"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansRSUPRSandCashRSUActivityDetail",
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares granted (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "periodEndLabel": "Ending balance (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r857",
      "r858"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansRSUPRSandCashRSUActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number\u00a0of Shares",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansRSUPRSandCashRSUActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance (in dollars per share)",
        "periodEndLabel": "Ending balance (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r857",
      "r858"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansRSUPRSandCashRSUActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted\u00a0Average Grant Date Fair Value Per Share",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfSharesAvailableForGrant",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares remaining available for future awards (in shares)",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award, Equity Instruments Other Than Options, Number Of Shares Available For Grant",
        "documentation": "Share-based compensation arrangement by share-based payment award equity instruments other than options, number of shares available for grant"
       }
      }
     },
     "auth_ref": []
    },
    "iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesPurchasedByEmployees": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesPurchasedByEmployees",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansPurchasedRestrictedStockPlanAdditionalInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansRSUPRSandCashRSUActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Covered shares (in shares)",
        "verboseLabel": "Covered shares (in shares)",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Shares Purchased By Employees",
        "documentation": "Aggregate number of nonvested shares effectively purchased by employees for share based compensation arrangement by share based payment award equity instruments other than option grants in period."
       }
      }
     },
     "auth_ref": []
    },
    "iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValueOfSharesPurchasedByEmployees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValueOfSharesPurchasedByEmployees",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansPurchasedRestrictedStockPlanAdditionalInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansRSUPRSandCashRSUActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate purchase price (in dollars per share)",
        "verboseLabel": "Aggregate Purchases",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Value Of Shares Purchased By Employees",
        "documentation": "Aggregate employee purchase price for share based compensation arrangement by share based payment award equity instruments other than option grants in period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansRSUPRSandCashRSUActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Vested (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r861"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansLiabilityAwardsAdditionalInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansPurchasedRestrictedStockPlanAdditionalInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansRestrictedStockUnitsPlanAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total fair value of vested",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash."
       }
      }
     },
     "auth_ref": [
      "r864"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansRSUPRSandCashRSUActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement."
       }
      }
     },
     "auth_ref": [
      "r861"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansLiabilityAwardsAdditionalInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansPurchasedRestrictedStockPlanAdditionalInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansRSUPRSandCashRSUActivityDetail",
      "http://www.iff.com/role/StockCompensationPlansRestrictedStockUnitsPlanAdditionalInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionActivityDetail",
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionAdditionalInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionExercisableDetail",
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionOutstandingDetail",
      "http://www.iff.com/role/StockCompensationPlansStockBasedCompensationExpenseIncludedinConsolidatedStatementofIncomeandComprehensiveIncomeDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r841",
      "r843",
      "r846",
      "r847",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares authorized for issuance (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1305"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares remaining available for issuance (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable."
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumptionsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumptionsInPeriod",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assumed (in shares)",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Assumptions In Period",
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Assumptions In Period"
       }
      }
     },
     "auth_ref": []
    },
    "iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumptionsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumptionsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assumed (in dollars per share)",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Assumptions In Period, Weighted Average Exercise Price",
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Assumptions In Period, Weighted Average Exercise Price"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SSARs/ Options Exercisable (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r851"
     ]
    },
    "iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisablePeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisablePeriod",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansRestrictedStockUnitsPlanAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized compensation cost related to non-vested stock options and SSAR, RSU, PRS and Cash RSU awards granted, weighted average period, in years",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Period",
        "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average exercise price, exercisable (USD per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r851"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intrinsic value of options/SSAR's exercised",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares."
       }
      }
     },
     "auth_ref": [
      "r864"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cancelled (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period",
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired."
       }
      }
     },
     "auth_ref": [
      "r1590"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cancelled (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price of options that were either forfeited or expired."
       }
      }
     },
     "auth_ref": [
      "r1590"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "documentation": "Net number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r1591"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock options, granted",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r853"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionOutstandingDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Intrinsic Value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance (in shares)",
        "periodEndLabel": "Ending balance (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r849",
      "r850"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares\u00a0Subject\u00a0to SSARs/Options",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance (in dollars per share)",
        "periodEndLabel": "Ending balance (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r849",
      "r850"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average\u00a0Exercise Price",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected to Vest (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r865"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected to Vest (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r865"
     ]
    },
    "iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetDollarValueOfAwardIsConvertedToNumberOfNotionalSharesWhenAwardIsGranted": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetDollarValueOfAwardIsConvertedToNumberOfNotionalSharesWhenAwardIsGranted",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of target dollar value of the award converted to a number of notional shares",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award, Percentage Of Target Dollar Value Of Award Is Converted To Number Of Notional Shares When Award Is Granted",
        "documentation": "Share-based compensation arrangement by share-based payment award, percentage of target dollar value of the award is converted to a number of notional shares when award is granted"
       }
      }
     },
     "auth_ref": []
    },
    "iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesSubjectToOutstandingAwards": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesSubjectToOutstandingAwards",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares subject to outstanding awards (in shares)",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award, Shares Subject To Outstanding Awards",
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Shares Subject To Outstanding Awards"
       }
      }
     },
     "auth_ref": []
    },
    "iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentage",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansLiabilityAwardsAdditionalInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansRestrictedStockUnitsPlanAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting percentage",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Vesting Percentage",
        "documentation": "Share-based compensation arrangement by share-based payment award, vesting percentage"
       }
      }
     },
     "auth_ref": []
    },
    "iff_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentageGrantedInCashToEligibleEmployees": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentageGrantedInCashToEligibleEmployees",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansLiabilityAwardsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting percentage granted in cash to eligible employees",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Vesting Percentage, Granted In Cash To Eligible Employees",
        "documentation": "Share-based compensation arrangement by share-based payment award, vesting percentage granted in cash to eligible employees"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://www.iff.com/role/NetIncomePerShareAdditionalInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansLiabilityAwardsAdditionalInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansPurchasedRestrictedStockPlanAdditionalInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansRSUPRSandCashRSUActivityDetail",
      "http://www.iff.com/role/StockCompensationPlansRestrictedStockUnitsPlanAdditionalInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionActivityDetail",
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionAdditionalInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionExercisableDetail",
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionOutstandingDetail",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Domain]",
        "label": "Award Type [Domain]",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r846",
      "r847",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercised (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r854"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r853"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionExercisableDetail",
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionOutstandingDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise Price Range [Axis]",
        "label": "Exercise Price Range [Axis]",
        "documentation": "Information by range of option prices pertaining to options granted."
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionExercisableDetail",
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionOutstandingDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise Price Range [Domain]",
        "label": "Exercise Price Range [Domain]",
        "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices."
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionExercisableDetail",
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionOutstandingDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number Exercisable (in shares)",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable",
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied."
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionOutstandingDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number Outstanding (in shares)",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding",
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices."
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionOutstandingDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Price Range, upper limit",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit",
        "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range."
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "iff_ShareBasedPaymentArrangementPurchasedRestrictedStockUnitActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "ShareBasedPaymentArrangementPurchasedRestrictedStockUnitActivityTableTextBlock",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PRSU Activity",
        "label": "Share-Based Payment Arrangement, Purchased Restricted Stock Unit, Activity [Table Text Block]",
        "documentation": "Share-Based Payment Arrangement, Purchased Restricted Stock Unit, Activity"
       }
      }
     },
     "auth_ref": []
    },
    "iff_ShareEquivalentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "ShareEquivalentsMember",
     "presentation": [
      "http://www.iff.com/role/NetIncomePerShareAdditionalInformationDetail",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share Equivalents",
        "label": "Share Equivalents [Member]",
        "documentation": "Share Equivalents"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharePrice",
     "presentation": [
      "http://www.iff.com/role/TangibleEquityUnitsTangibleEquitySettlementofSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share Price",
        "label": "Share Price",
        "documentation": "Price of a single share of a number of saleable stocks of a company."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansRestrictedStockUnitsPlanAdditionalInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionExercisableDetail",
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionOutstandingDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Intrinsic Value",
        "verboseLabel": "Unrecognized compensation cost related to non-vested stock options and SSAR, RSU, PRS and Cash RSU awards granted",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable."
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "iff_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingPercentage",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award vesting percentage",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Percentage",
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionExercisableDetail",
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionOutstandingDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Exercise\u00a0Price (in dollars per share)",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price",
        "documentation": "Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding."
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionExercisableDetail",
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionOutstandingDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted\u00a0Average Remaining Contractual\u00a0Life (in years)",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r312"
     ]
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionOutstandingDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Exercise Price (in dollars per share)",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price",
        "documentation": "The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices."
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionOutstandingDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted\u00a0Average Remaining Contractual Life (in years)",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r311"
     ]
    },
    "iff_SharebasedCompensationSharesAuthorizedunderStockOptionPlansExercisePriceRangeExercisableOptionsUpperRangeLimit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "SharebasedCompensationSharesAuthorizedunderStockOptionPlansExercisePriceRangeExercisableOptionsUpperRangeLimit",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionExercisableDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable options, upper range limit",
        "label": "Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Upper Range Limit",
        "documentation": "Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Upper Range Limit"
       }
      }
     },
     "auth_ref": []
    },
    "iff_SharedITCorporateCostsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "SharedITCorporateCostsMember",
     "presentation": [
      "http://www.iff.com/role/RestructuringandOtherChargesAdditionalInformationDetails",
      "http://www.iff.com/role/RestructuringandOtherChargesMovementsinRestructuringandRelatedAccrualsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shared IT &amp; Corporate Costs [Member]",
        "label": "Shared IT &amp; Corporate Costs [Member]",
        "documentation": "Shared IT &amp; Corporate Costs [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_ShareholderActivismRelatedCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "ShareholderActivismRelatedCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Shareholder Activism Related Costs",
        "label": "Shareholder Activism Related Costs",
        "documentation": "Shareholder Activism Related Costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharesOutstanding",
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedPeriodStartLabel": "Beginning balance , common stock (in shares)",
        "negatedPeriodEndLabel": "Ending balance (in shares)",
        "label": "Shares, Outstanding",
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShortTermBorrowings",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/DebtComponentsofDebtDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bank overdrafts and other",
        "label": "Short-Term Debt",
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r242",
      "r337",
      "r1311",
      "r1643"
     ]
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShortTermDebtTypeAxis",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationSeniorUnsecuredNotesDetail",
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail",
      "http://www.iff.com/role/DebtComponentsofDebtDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term Debt, Type [Axis]",
        "label": "Short-Term Debt, Type [Axis]",
        "documentation": "Information by type of short-term debt arrangement."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShortTermDebtTypeDomain",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationSeniorUnsecuredNotesDetail",
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail",
      "http://www.iff.com/role/DebtComponentsofDebtDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term Debt, Type [Domain]",
        "label": "Short-Term Debt, Type [Domain]",
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain",
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.iff.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofUnrecognizedTaxBenefitsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Nature of Uncertainty [Domain]",
        "label": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Nature of Uncertainty [Domain]",
        "documentation": "The nature of the uncertainty for which it is reasonably possible that the total amount of the unrecognized tax benefit will significantly increase or decrease within twelve months of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r317"
     ]
    },
    "iff_SonaromeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "SonaromeMember",
     "presentation": [
      "http://www.iff.com/role/RedeemableNoncontrollingInterestsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sonarome",
        "label": "Sonarome [Member]",
        "documentation": "Sonarome"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StateAndLocalJurisdictionMember",
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State and Local Jurisdiction [Member]",
        "label": "State and Local Jurisdiction [Member]",
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementBusinessSegmentsAxis",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails",
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail",
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetGoodwillRollforwardDetails",
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetNarrativeDetails",
      "http://www.iff.com/role/LeasesAdditionalInformationDetails",
      "http://www.iff.com/role/RestructuringandOtherChargesAdditionalInformationDetails",
      "http://www.iff.com/role/RestructuringandOtherChargesMovementsinRestructuringandRelatedAccrualsDetail",
      "http://www.iff.com/role/SegmentInformationAdditionalInformationDetail",
      "http://www.iff.com/role/SegmentInformationCapitalExpenditureandDepreciationandAmortizationbySegmentDetail",
      "http://www.iff.com/role/SegmentInformationReportableSegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Axis]",
        "verboseLabel": "Segments [Axis]",
        "label": "Segments [Axis]",
        "documentation": "Information by business segments."
       }
      }
     },
     "auth_ref": [
      "r411",
      "r530",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r556",
      "r562",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r668",
      "r680",
      "r686",
      "r1098",
      "r1099",
      "r1100",
      "r1101",
      "r1102",
      "r1103",
      "r1104",
      "r1105",
      "r1106",
      "r1107",
      "r1108",
      "r1279",
      "r1427",
      "r1646"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.iff.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Axis]",
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r367",
      "r427",
      "r428",
      "r429",
      "r475",
      "r512",
      "r516",
      "r519",
      "r521",
      "r527",
      "r528",
      "r601",
      "r697",
      "r700",
      "r701",
      "r702",
      "r708",
      "r709",
      "r739",
      "r740",
      "r743",
      "r746",
      "r753",
      "r978",
      "r1126",
      "r1127",
      "r1128",
      "r1129",
      "r1134",
      "r1135",
      "r1136",
      "r1137",
      "r1138",
      "r1139",
      "r1140",
      "r1141",
      "r1142",
      "r1143",
      "r1144",
      "r1145",
      "r1165",
      "r1188",
      "r1208",
      "r1230",
      "r1231",
      "r1232",
      "r1233",
      "r1234",
      "r1410",
      "r1457",
      "r1473"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossReclassificationsofAccumulatedOtherComprehensiveIncometoConsolidatedStatementofComprehensiveIncomeDetail",
      "http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossDetail",
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowandNetInvestmentHedgingInstrumentsDetail",
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.iff.com/role/RedeemableNoncontrollingInterestsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Components [Axis]",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r76",
      "r408",
      "r453",
      "r454",
      "r455",
      "r489",
      "r490",
      "r491",
      "r494",
      "r504",
      "r506",
      "r526",
      "r606",
      "r612",
      "r754",
      "r877",
      "r878",
      "r879",
      "r910",
      "r911",
      "r947",
      "r949",
      "r950",
      "r951",
      "r952",
      "r954",
      "r965",
      "r989",
      "r991",
      "r992",
      "r993",
      "r994",
      "r995",
      "r1028",
      "r1112",
      "r1113",
      "r1114",
      "r1134",
      "r1208"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail",
      "http://www.iff.com/role/ConcentrationsOfCreditRiskAdditionalInformationDetail",
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.iff.com/role/RestructuringandOtherChargesAdditionalInformationDetails",
      "http://www.iff.com/role/SegmentInformationAdditionalInformationDetail",
      "http://www.iff.com/role/SegmentInformationNetSalesbyGeographicAreaDetail",
      "http://www.iff.com/role/SegmentInformationSegmentInformationScheduleofLongLivedAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Axis]",
        "label": "Geographical [Axis]",
        "documentation": "Information by geographical components."
       }
      }
     },
     "auth_ref": [
      "r386",
      "r395",
      "r560",
      "r561",
      "r1148",
      "r1151",
      "r1153",
      "r1214",
      "r1216",
      "r1219",
      "r1229",
      "r1237",
      "r1242",
      "r1243",
      "r1244",
      "r1245",
      "r1246",
      "r1247",
      "r1248",
      "r1249",
      "r1250",
      "r1255",
      "r1291",
      "r1315",
      "r1516",
      "r1646"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Line Items]",
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r489",
      "r490",
      "r491",
      "r526",
      "r1063",
      "r1124",
      "r1145",
      "r1157",
      "r1158",
      "r1159",
      "r1160",
      "r1161",
      "r1162",
      "r1165",
      "r1168",
      "r1169",
      "r1170",
      "r1171",
      "r1172",
      "r1174",
      "r1175",
      "r1176",
      "r1177",
      "r1180",
      "r1181",
      "r1182",
      "r1183",
      "r1184",
      "r1186",
      "r1189",
      "r1190",
      "r1193",
      "r1194",
      "r1195",
      "r1196",
      "r1197",
      "r1198",
      "r1199",
      "r1200",
      "r1201",
      "r1202",
      "r1203",
      "r1204",
      "r1208",
      "r1316"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Cash Flows [Abstract]",
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Financial Position [Abstract]",
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Stockholders' Equity [Abstract]",
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_StatementScenarioAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "StatementScenarioAxis",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.iff.com/role/ScheduleIIValuationandQualifyingAccountsandReservesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Scenario [Axis]",
        "label": "Scenario [Axis]",
        "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts."
       }
      }
     },
     "auth_ref": [
      "r507",
      "r838",
      "r1411",
      "r1412",
      "r1472"
     ]
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementTable",
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed."
       }
      }
     },
     "auth_ref": [
      "r489",
      "r490",
      "r491",
      "r526",
      "r1063",
      "r1124",
      "r1145",
      "r1157",
      "r1158",
      "r1159",
      "r1160",
      "r1161",
      "r1162",
      "r1165",
      "r1168",
      "r1169",
      "r1170",
      "r1171",
      "r1172",
      "r1174",
      "r1175",
      "r1176",
      "r1177",
      "r1180",
      "r1181",
      "r1182",
      "r1183",
      "r1184",
      "r1186",
      "r1189",
      "r1190",
      "r1193",
      "r1194",
      "r1195",
      "r1196",
      "r1197",
      "r1198",
      "r1199",
      "r1200",
      "r1201",
      "r1202",
      "r1203",
      "r1204",
      "r1208",
      "r1316"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Price or TSR Estimation Method",
        "label": "Stock Price or TSR Estimation Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1340",
      "r1352",
      "r1362",
      "r1388"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionAdditionalInformationDetail",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SSAR's [Member]",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impact of N&amp;B Merger (in shares)",
        "label": "Stock Issued During Period, Shares, Acquisitions",
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions."
       }
      }
     },
     "auth_ref": [
      "r249",
      "r250",
      "r301"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesConversionOfUnits",
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of tangible equity units (in shares)",
        "label": "Stock Issued During Period, Shares, Conversion of Units",
        "documentation": "The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit)."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r134",
      "r249",
      "r250",
      "r301"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesIssuedForServices",
     "presentation": [
      "http://www.iff.com/role/NetIncomePerShareTEUDetails",
      "http://www.iff.com/role/TangibleEquityUnitsTangibleEquitySettlementofSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Issued During Period, Shares, Issued for Services",
        "label": "Stock Issued During Period, Shares, Issued for Services",
        "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested restricted stock units and awards (in shares)",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r249",
      "r250",
      "r301"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansStockBasedCompensationExpenseIncludedinConsolidatedStatementofIncomeandComprehensiveIncomeDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation, shares (in shares)",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r249",
      "r250",
      "r301"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY",
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock options/SSARs (in shares)",
        "negatedLabel": "Exercised (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r249",
      "r250",
      "r301",
      "r854"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase of NCI",
        "label": "Stock Issued During Period, Value, Acquisitions",
        "documentation": "Value of stock issued pursuant to acquisitions during the period."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r76",
      "r301"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfUnits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueConversionOfUnits",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of tangible equity units",
        "label": "Stock Issued During Period, Value, Conversion of Units",
        "documentation": "Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit)."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r76",
      "r301"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested restricted stock units and awards",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures",
        "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r301"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock options/SSARs",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r76",
      "r301"
     ]
    },
    "us-gaap_StockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockOptionMember",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Options [Member]",
        "label": "Equity Option [Member]",
        "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option)."
       }
      }
     },
     "auth_ref": [
      "r1315"
     ]
    },
    "iff_StockOptionsAndSsarsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "StockOptionsAndSsarsMember",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionActivityDetail",
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionAdditionalInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionExercisableDetail",
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionOutstandingDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SSAR's and Stock Options [Member]",
        "label": "Stock Options And Ssars [Member]",
        "documentation": "Stock Options and SSARs Member."
       }
      }
     },
     "auth_ref": []
    },
    "iff_StockOptionsAndStockSettledAppreciationRightsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "StockOptionsAndStockSettledAppreciationRightsMember",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionActivityDetail",
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionAdditionalInformationDetail",
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionExercisableDetail",
      "http://www.iff.com/role/StockCompensationPlansSSARsandStockOptionOutstandingDetail",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SSAR's and Options [Member]",
        "label": "Stock Options And Stock Settled Appreciation Rights [Member]",
        "documentation": "Stock Options And Stock Settled Appreciation Rights [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_StockOptionsOrStockSettledAppreciationRightsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "StockOptionsOrStockSettledAppreciationRightsMember",
     "presentation": [
      "http://www.iff.com/role/NetIncomePerShareAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Options or Stock-Settled Appreciation Rights",
        "label": "Stock Options or Stock-Settled Appreciation Rights [Member]",
        "documentation": "Stock Options or Stock-Settled Appreciation Rights"
       }
      }
     },
     "auth_ref": []
    },
    "iff_StockPurchaseContractMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "StockPurchaseContractMember",
     "presentation": [
      "http://www.iff.com/role/NetIncomePerShareReconciliationofSharesUsedinComputationofBasicandDilutedNetIncomePerShareDetail",
      "http://www.iff.com/role/TangibleEquityUnitsAllocationofTEUDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SPC",
        "label": "Stock Purchase Contract [Member]",
        "documentation": "Stock Purchase Contract [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_StockRepurchaseProgramAdditionalAuthorizedAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "StockRepurchaseProgramAdditionalAuthorizedAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/ShareholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional authorized amount",
        "label": "Stock Repurchase Program, Additional Authorized Amount",
        "documentation": "Stock Repurchase Program, Additional Authorized Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/ShareholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares authorized under repurchase program",
        "label": "Stock Repurchase Program, Authorized Amount",
        "documentation": "Amount of stock repurchase plan authorized."
       }
      }
     },
     "auth_ref": []
    },
    "iff_StockRepurchaseProgramRemainingAuthorizedAmendedRepurchaseAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "StockRepurchaseProgramRemainingAuthorizedAmendedRepurchaseAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/ShareholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remaining authorized amended repurchase amount",
        "label": "Stock Repurchase Program, Remaining Authorized Amended Repurchase Amount",
        "documentation": "Stock Repurchase Program, Remaining Authorized Amended Repurchase Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/ShareholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remaining authorized repurchase amount",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "documentation": "Amount remaining of a stock repurchase plan authorized."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased",
     "presentation": [
      "http://www.iff.com/role/ShareholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remaining number of shares authorized to be repurchase",
        "label": "Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased",
        "documentation": "The remaining number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan."
       }
      }
     },
     "auth_ref": []
    },
    "iff_StockRepurchasedDuringPeriodAsPercentageOfSharesOutstanding": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "StockRepurchasedDuringPeriodAsPercentageOfSharesOutstanding",
     "presentation": [
      "http://www.iff.com/role/ShareholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock repurchased during period as percentage of shares outstanding",
        "label": "Stock Repurchased During Period As Percentage Of Shares Outstanding",
        "documentation": "Stock Repurchased During Period As Percentage Of Shares Outstanding"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossDetail",
      "http://www.iff.com/role/BusinessDivestitureDetails",
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Shareholders\u2019 Equity",
        "terseLabel": "Shareholders' equity",
        "periodStartLabel": "Accumulated other comprehensive loss, net of tax",
        "periodEndLabel": "Accumulated other comprehensive loss, net of tax",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r250",
      "r253",
      "r254",
      "r281",
      "r1167",
      "r1185",
      "r1209",
      "r1210",
      "r1311",
      "r1328",
      "r1459",
      "r1487",
      "r1622",
      "r1651"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shareholders\u2019 Equity:",
        "label": "Equity, Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET",
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY",
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Shareholders\u2019 Equity including non-controlling interest",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "terseLabel": "Cumulative adjustment relating to the adoption of ASC 2016-16",
        "label": "Equity, Including Portion Attributable to Noncontrolling Interest",
        "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r178",
      "r179",
      "r183",
      "r408",
      "r409",
      "r454",
      "r489",
      "r490",
      "r491",
      "r494",
      "r504",
      "r606",
      "r612",
      "r754",
      "r877",
      "r878",
      "r879",
      "r910",
      "r911",
      "r947",
      "r949",
      "r950",
      "r951",
      "r952",
      "r954",
      "r965",
      "r989",
      "r991",
      "r995",
      "r1028",
      "r1113",
      "r1114",
      "r1132",
      "r1167",
      "r1185",
      "r1209",
      "r1210",
      "r1235",
      "r1327",
      "r1459",
      "r1487",
      "r1622",
      "r1651"
     ]
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://www.iff.com/role/ShareholdersEquity",
      "http://www.iff.com/role/TangibleEquityUnits"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shareholders' Equity",
        "label": "Equity [Text Block]",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r298",
      "r474",
      "r738",
      "r740",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r752",
      "r754",
      "r956",
      "r1211",
      "r1212",
      "r1236"
     ]
    },
    "iff_StrategicInitiativesCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "StrategicInitiativesCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Strategic Initiative Costs",
        "label": "Strategic Initiatives Costs",
        "documentation": "Strategic Initiatives Costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail",
      "http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event [Member]",
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r996",
      "r1030"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail",
      "http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Axis]",
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r996",
      "r1030"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail",
      "http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Domain]",
        "label": "Subsequent Event Type [Domain]",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r996",
      "r1030"
     ]
    },
    "iff_SubsequentFiscalQuarterEndingOnOrBeforeMarch312025Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "SubsequentFiscalQuarterEndingOnOrBeforeMarch312025Member",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationRevolvingCreditFacilityDetail",
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Fiscal Quarter Ending On Or Before March 31, 2025",
        "label": "Subsequent Fiscal Quarter Ending On Or Before March 31, 2025 [Member]",
        "documentation": "Subsequent Fiscal Quarter Ending On Or Before March 31, 2025"
       }
      }
     },
     "auth_ref": []
    },
    "iff_SubsequentFiscalQuarterEndingOnOrBeforeSeptember302025Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "SubsequentFiscalQuarterEndingOnOrBeforeSeptember302025Member",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationRevolvingCreditFacilityDetail",
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Fiscal Quarter Ending On Or Before September 30, 2025",
        "label": "Subsequent Fiscal Quarter Ending On Or Before September 30, 2025 [Member]",
        "documentation": "Subsequent Fiscal Quarter Ending On Or Before September 30, 2025"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SummaryOfIncomeTaxContingenciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SummaryOfIncomeTaxContingenciesTextBlock",
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation of Beginning and Ending Amount of Unrecognized Tax Benefits",
        "label": "Summary of Income Tax Contingencies [Table Text Block]",
        "documentation": "Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months."
       }
      }
     },
     "auth_ref": [
      "r39",
      "r316",
      "r318"
     ]
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental Disclosures:",
        "label": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplierFinanceProgramObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SupplierFinanceProgramObligation",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supply chain financing, obligation",
        "label": "Supplier Finance Program, Obligation",
        "documentation": "Amount of obligation for supplier finance program."
       }
      }
     },
     "auth_ref": [
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r1280"
     ]
    },
    "iff_SupplierFinanceProgramPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "SupplierFinanceProgramPolicyPolicyTextBlock",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supply Chain Financing Program",
        "label": "Supplier Finance Program, Policy [Policy Text Block]",
        "documentation": "Supplier Finance Program, Policy"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Supplies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Supplies",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherAssetsDetail": {
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Packaging materials and supplies",
        "label": "Prepaid Supplies",
        "documentation": "Amount of consideration paid in advance for supplies that provide economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r1259",
      "r1278",
      "r1491"
     ]
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tabular List, Table",
        "label": "Tabular List [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1381"
     ]
    },
    "iff_TangibleEquityRateSettlementRate": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "TangibleEquityRateSettlementRate",
     "presentation": [
      "http://www.iff.com/role/TangibleEquityUnitsTangibleEquitySettlementofSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tangible Equity Rate, Settlement Rate",
        "label": "Tangible Equity Rate, Settlement Rate",
        "documentation": "Tangible Equity Rate, Settlement Rate"
       }
      }
     },
     "auth_ref": []
    },
    "iff_TangibleEquityUnitsAllocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "TangibleEquityUnitsAllocationAxis",
     "presentation": [
      "http://www.iff.com/role/TangibleEquityUnitsAllocationofTEUDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tangible Equity Units, Allocation [Axis]",
        "label": "Tangible Equity Units, Allocation [Axis]",
        "documentation": "Tangible Equity Units, Allocation [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_TangibleEquityUnitsAllocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "TangibleEquityUnitsAllocationDomain",
     "presentation": [
      "http://www.iff.com/role/TangibleEquityUnitsAllocationofTEUDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tangible Equity Units, Allocation [Domain]",
        "label": "Tangible Equity Units, Allocation [Domain]",
        "documentation": "[Domain] for Tangible Equity Units, Allocation [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_TangibleEquityUnitsConditionalValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "TangibleEquityUnitsConditionalValue",
     "presentation": [
      "http://www.iff.com/role/TangibleEquityUnitsTangibleEquitySettlementofSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tangible Equity Units, Conditional Value",
        "label": "Tangible Equity Units, Conditional Value",
        "documentation": "Tangible Equity Units, Conditional Value"
       }
      }
     },
     "auth_ref": []
    },
    "iff_TangibleEquityUnitsConditionsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "TangibleEquityUnitsConditionsAxis",
     "presentation": [
      "http://www.iff.com/role/TangibleEquityUnitsTangibleEquitySettlementofSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tangible Equity Units, Conditions [Axis]",
        "label": "Tangible Equity Units, Conditions [Axis]",
        "documentation": "Tangible Equity Units, Conditions [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_TangibleEquityUnitsConditionsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "TangibleEquityUnitsConditionsDomain",
     "presentation": [
      "http://www.iff.com/role/TangibleEquityUnitsTangibleEquitySettlementofSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tangible Equity Units, Conditions [Domain]",
        "label": "Tangible Equity Units, Conditions [Domain]",
        "documentation": "[Domain] for Tangible Equity Units, Conditions [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_TangibleEquityUnitsFinalSettlementRate": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "TangibleEquityUnitsFinalSettlementRate",
     "presentation": [
      "http://www.iff.com/role/NetIncomePerShareTEUDetails",
      "http://www.iff.com/role/TangibleEquityUnitsTangibleEquitySettlementofSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tangible Equity Units Final Settlement Rate",
        "label": "Tangible Equity Units Final Settlement Rate",
        "documentation": "Tangible Equity Units Final Settlement Rate"
       }
      }
     },
     "auth_ref": []
    },
    "iff_TangibleEquityUnitsInitialPrincipalAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "TangibleEquityUnitsInitialPrincipalAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/TangibleEquityUnitsAllocationofTEUDetails",
      "http://www.iff.com/role/TangibleEquityUnitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value per TEU",
        "label": "Tangible Equity Units Initial Principal Amount",
        "documentation": "Tangible Equity Units Initial Principal Amount"
       }
      }
     },
     "auth_ref": []
    },
    "iff_TangibleEquityUnitsIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "TangibleEquityUnitsIssued",
     "presentation": [
      "http://www.iff.com/role/NetIncomePerShareTEUDetails",
      "http://www.iff.com/role/TangibleEquityUnitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tangible equity units issued",
        "label": "Tangible Equity Units Issued",
        "documentation": "Tangible Equity Units Issued"
       }
      }
     },
     "auth_ref": []
    },
    "iff_TangibleEquityUnitsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "TangibleEquityUnitsLineItems",
     "presentation": [
      "http://www.iff.com/role/TangibleEquityUnitsAllocationofTEUDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tangible Equity Units [Line Items]",
        "label": "Tangible Equity Units [Line Items]",
        "documentation": "[Line Items] for Tangible Equity Units [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_TangibleEquityUnitsPricePerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "TangibleEquityUnitsPricePerUnit",
     "presentation": [
      "http://www.iff.com/role/TangibleEquityUnitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Price per unit",
        "label": "Tangible Equity Units Price Per Unit",
        "documentation": "Tangible Equity Units Price Per Unit"
       }
      }
     },
     "auth_ref": []
    },
    "iff_TangibleEquityUnitsPriceforSharesBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "TangibleEquityUnitsPriceforSharesBasic",
     "presentation": [
      "http://www.iff.com/role/NetIncomePerShareTEUDetails",
      "http://www.iff.com/role/TangibleEquityUnitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Price for basic share (in dollars per share)",
        "label": "Tangible Equity Units, Price for Shares Basic",
        "documentation": "Tangible Equity Units, Price for Shares Basic"
       }
      }
     },
     "auth_ref": []
    },
    "iff_TangibleEquityUnitsPriceforSharesDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "TangibleEquityUnitsPriceforSharesDiluted",
     "presentation": [
      "http://www.iff.com/role/NetIncomePerShareTEUDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Price for diluted share (usd per share)",
        "label": "Tangible Equity Units, Price for Shares Diluted",
        "documentation": "Tangible Equity Units, Price for Shares Diluted"
       }
      }
     },
     "auth_ref": []
    },
    "iff_TangibleEquityUnitsProceeds": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "TangibleEquityUnitsProceeds",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/NetIncomePerShareTEUDetails",
      "http://www.iff.com/role/TangibleEquityUnitsAllocationofTEUDetails",
      "http://www.iff.com/role/TangibleEquityUnitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tangible equity units proceeds",
        "label": "Tangible Equity Units Proceeds",
        "documentation": "Tangible Equity Units Proceeds"
       }
      }
     },
     "auth_ref": []
    },
    "iff_TangibleEquityUnitsStatedRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "TangibleEquityUnitsStatedRate",
     "presentation": [
      "http://www.iff.com/role/TangibleEquityUnitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stated rate",
        "label": "Tangible Equity Units Stated Rate",
        "documentation": "Tangible Equity Units Stated Rate"
       }
      }
     },
     "auth_ref": []
    },
    "iff_TangibleEquityUnitsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "TangibleEquityUnitsTable",
     "presentation": [
      "http://www.iff.com/role/TangibleEquityUnitsAllocationofTEUDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tangible Equity Units [Table]",
        "label": "Tangible Equity Units [Table]",
        "documentation": "Tangible Equity Units [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_TangibleEquityUnitsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "TangibleEquityUnitsTextBlock",
     "presentation": [
      "http://www.iff.com/role/TangibleEquityUnits"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tangible Equity Units",
        "label": "Tangible Equity Units [Text Block]",
        "documentation": "Tangible Equity Units"
       }
      }
     },
     "auth_ref": []
    },
    "iff_TargetPayoutCash": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "TargetPayoutCash",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Target payout percentage, cash",
        "label": "Target Payout Cash",
        "documentation": "Target payout cash"
       }
      }
     },
     "auth_ref": []
    },
    "iff_TargetPayoutPeriodOfCycle": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "TargetPayoutPeriodOfCycle",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Target payout, cycle",
        "label": "Target Payout, Period of Cycle",
        "documentation": "Target Payout, Period of Cycle"
       }
      }
     },
     "auth_ref": []
    },
    "iff_TargetPayoutStock": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "TargetPayoutStock",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Target payout percentage, stock",
        "label": "Target Payout Stock",
        "documentation": "Target payout stock"
       }
      }
     },
     "auth_ref": []
    },
    "iff_TasteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "TasteMember",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail",
      "http://www.iff.com/role/RestructuringandOtherChargesMovementsinRestructuringandRelatedAccrualsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Taste [Member]",
        "label": "Taste [Member]",
        "documentation": "Taste [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TaxCreditCarryforwardAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax credit carryforwards",
        "label": "Tax Credit Carryforward, Amount",
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "us-gaap_TaxCreditCarryforwardAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TaxCreditCarryforwardAxis",
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other Tax Carryforward [Axis]",
        "label": "Tax Credit Carryforward [Axis]",
        "documentation": "Information by specific tax credit related to an unused tax credit."
       }
      }
     },
     "auth_ref": [
      "r164"
     ]
    },
    "us-gaap_TaxCreditCarryforwardNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TaxCreditCarryforwardNameDomain",
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other Tax Carryforward, Name [Domain]",
        "label": "Tax Credit Carryforward, Name [Domain]",
        "documentation": "The name of the tax credit carryforward."
       }
      }
     },
     "auth_ref": [
      "r164"
     ]
    },
    "us-gaap_TaxCreditCarryforwardValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TaxCreditCarryforwardValuationAllowance",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax Credit Carryforward, Valuation Allowance",
        "label": "Tax Credit Carryforward, Valuation Allowance",
        "documentation": "Amount of valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from tax credit carryforwards for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "iff_TechnologicalKnowHowsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "TechnologicalKnowHowsMember",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Technological Know-Hows",
        "label": "Technological Know-Hows [Member]",
        "documentation": "Technological Know-Hows"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "presentation": [
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetTrademarkandOtherIntangibleAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Technological Know-how [Member]",
        "label": "Technology-Based Intangible Assets [Member]",
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights."
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "us-gaap_TechnologyEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TechnologyEquipmentMember",
     "presentation": [
      "http://www.iff.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Information technology [Member]",
        "label": "Technology Equipment [Member]",
        "documentation": "Equipment used in the creation, maintenance and utilization of information systems which include computers and peripherals."
       }
      }
     },
     "auth_ref": []
    },
    "iff_TermLoanCreditAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "TermLoanCreditAgreementMember",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail",
      "http://www.iff.com/role/FinancialInstrumentsCarryingAmountandEstimatedFairValueofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term Loan Credit Agreement",
        "label": "Term Loan Credit Agreement [Member]",
        "documentation": "Term Loan Credit Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_TerminationFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "TerminationFee",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Termination Fee",
        "label": "Termination Fee",
        "documentation": "Termination Fee"
       }
      }
     },
     "auth_ref": []
    },
    "iff_ThreeHundredSixtyFourDaySeniorUnsecuredBridgeFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "ThreeHundredSixtyFourDaySeniorUnsecuredBridgeFacilityMember",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Three Hundred Sixty Four Day Senior Unsecured Bridge Facility [Member]",
        "label": "Three Hundred Sixty Four Day Senior Unsecured Bridge Facility [Member]",
        "documentation": "Three Hundred Sixty Four Day Senior Unsecured Bridge Facility [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of Individual [Axis]",
        "label": "Title of Individual [Axis]",
        "documentation": "Information by title of individual or nature of relationship to individual or group of individuals."
       }
      }
     },
     "auth_ref": [
      "r1477",
      "r1631"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of Individual [Domain]",
        "label": "Title of Individual [Domain]",
        "documentation": "Title of individual, or nature of relationship to individual or group of individuals."
       }
      }
     },
     "auth_ref": []
    },
    "iff_TopOneCustomerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "TopOneCustomerMember",
     "presentation": [
      "http://www.iff.com/role/SegmentInformationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer One",
        "label": "Top One Customer [Member]",
        "documentation": "Top One Customer"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Amount",
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r1373"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Vs Peer Group",
        "label": "Total Shareholder Return Vs Peer Group [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1380"
     ]
    },
    "iff_TradeAccountsReceivableWithFactoringAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "TradeAccountsReceivableWithFactoringAgreementsMember",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade Accounts Receivable With Factoring Agreements [Member]",
        "label": "Trade Accounts Receivable With Factoring Agreements [Member]",
        "documentation": "Trade Accounts Receivable With Factoring Agreements [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_TradeAccountsReceivableWithTheCompanysOwnFactoringAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "TradeAccountsReceivableWithTheCompanysOwnFactoringAgreementsMember",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade Accounts Receivable With The Company's Own Factoring Agreements",
        "label": "Trade Accounts Receivable With The Company's Own Factoring Agreements [Member]",
        "documentation": "Trade Accounts Receivable With Factoring Agreements [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TradeNamesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TradeNamesMember",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails",
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade Names [Member]",
        "label": "Trade Names [Member]",
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof."
       }
      }
     },
     "auth_ref": [
      "r174"
     ]
    },
    "us-gaap_TradeReceivablesHeldForSaleAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TradeReceivablesHeldForSaleAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade receivables, held-for-sale, amount",
        "label": "Accounts Receivable, Held-for-Sale",
        "documentation": "Amount, before valuation allowance, of accounts receivable held for sale."
       }
      }
     },
     "auth_ref": [
      "r563"
     ]
    },
    "us-gaap_TrademarksAndTradeNamesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TrademarksAndTradeNamesMember",
     "presentation": [
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetTrademarkandOtherIntangibleAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade Names and Patents [Member]",
        "label": "Trademarks and Trade Names [Member]",
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof."
       }
      }
     },
     "auth_ref": [
      "r174"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangement:",
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1401"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangements, by Individual",
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r1403"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.iff.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TransactionDomain",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Transaction [Domain]",
        "label": "Transaction [Domain]",
        "documentation": "Agreement between buyer and seller for the exchange of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r1265"
     ]
    },
    "us-gaap_TransactionTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TransactionTypeAxis",
     "presentation": [
      "http://www.iff.com/role/AcquisitionsNutritionBiosciencesIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Transaction Type [Axis]",
        "label": "Transaction Type [Axis]",
        "documentation": "Information by type of agreement between buyer and seller for the exchange of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r1265"
     ]
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instruments [Domain]",
        "label": "Financial Instruments [Domain]",
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "auth_ref": [
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r735",
      "r751",
      "r955",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1093",
      "r1433",
      "r1434",
      "r1435",
      "r1436",
      "r1437",
      "r1438",
      "r1439",
      "r1482",
      "r1483",
      "r1484",
      "r1485"
     ]
    },
    "iff_TransitionServicesAgreementFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "TransitionServicesAgreementFairValue",
     "crdr": "credit",
     "calculation": {
      "http://www.iff.com/role/BusinessDivestitureDetails": {
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/BusinessDivestitureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Transition Services Agreement, Fair Value",
        "label": "Transition Services Agreement, Fair Value",
        "documentation": "Transition Services Agreement, Fair Value"
       }
      }
     },
     "auth_ref": []
    },
    "iff_TransitionServicesAgreementIncomeReductionToCostsNotIncludedInRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "TransitionServicesAgreementIncomeReductionToCostsNotIncludedInRevenue",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/BusinessDivestitureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Transition Services Agreement, Income, Reduction To Costs Not Included In Revenue",
        "label": "Transition Services Agreement, Income, Reduction To Costs Not Included In Revenue",
        "documentation": "Transition Services Agreement, Income, Reduction To Costs Not Included In Revenue"
       }
      }
     },
     "auth_ref": []
    },
    "iff_TransitionServicesAgreementTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "TransitionServicesAgreementTerm",
     "presentation": [
      "http://www.iff.com/role/BusinessDivestitureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Transition Services Agreement, Term",
        "label": "Transition Services Agreement, Term",
        "documentation": "Transition Services Agreement, Term"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adoption Date",
        "label": "Trading Arrangement Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r1404"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Arrangement Duration",
        "label": "Trading Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r1405"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r1403"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title",
        "label": "Trading Arrangement, Individual Title"
       }
      }
     },
     "auth_ref": [
      "r1403"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Available",
        "label": "Trading Arrangement, Securities Aggregate Available Amount"
       }
      }
     },
     "auth_ref": [
      "r1406"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Termination Date",
        "label": "Trading Arrangement Termination Date"
       }
      }
     },
     "auth_ref": [
      "r1404"
     ]
    },
    "us-gaap_TreasuryStockCommonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockCommonMember",
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury stock",
        "label": "Treasury Stock, Common [Member]",
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "us-gaap_TreasuryStockCommonShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockCommonShares",
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEETParenthetical",
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury stock, shares",
        "label": "Treasury Stock, Common, Shares",
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "us-gaap_TreasuryStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockValue",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDBALANCESHEET"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Treasury stock, value",
        "label": "Treasury Stock, Value",
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r139",
      "r142"
     ]
    },
    "iff_TwoThousandEightToTwoThousandTwentyCycleMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "TwoThousandEightToTwoThousandTwentyCycleMember",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2008-2020 Cycle (Cycle VIII) [Member]",
        "label": "Two Thousand Eight To Two Thousand Twenty Cycle [Member]",
        "documentation": "Two Thousand Eight To Two Thousand Twenty Cycle [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_TwoThousandEightToTwoThousandTwentyOneCycleMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "TwoThousandEightToTwoThousandTwentyOneCycleMember",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Two Thousand Eight To Two Thousand Twenty-One Cycle",
        "label": "Two Thousand Eight To Two Thousand Twenty-One Cycle [Member]",
        "documentation": "Two Thousand Eight To Two Thousand Twenty-One Cycle"
       }
      }
     },
     "auth_ref": []
    },
    "iff_TwoThousandEighteenToTwoThousandTwentyCycleMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "TwoThousandEighteenToTwoThousandTwentyCycleMember",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2017 - 2019 Cycle [Member]",
        "label": "Two Thousand Eighteen To Two Thousand Twenty Cycle [Member]",
        "documentation": "Two Thousand Eighteen To Two Thousand Twenty Cycle"
       }
      }
     },
     "auth_ref": []
    },
    "iff_TwoThousandFifteenPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "TwoThousandFifteenPlanMember",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2015 Plan [Member]",
        "label": "Two Thousand Fifteen Plan [Member]",
        "documentation": "Two Thousand Fifteen Plan"
       }
      }
     },
     "auth_ref": []
    },
    "iff_TwoThousandNineteenToTwoThousandTwentyOneCycleMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "TwoThousandNineteenToTwoThousandTwentyOneCycleMember",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2018-2020 Cycle [Member]",
        "label": "Two Thousand Nineteen To Two Thousand Twenty-One Cycle [Member]",
        "documentation": "Two Thousand Eighteen To Two Thousand Twenty Cycle [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_TwoThousandSixteenToTwoThousandEighteenCycleMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "TwoThousandSixteenToTwoThousandEighteenCycleMember",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2016-2018 Cycle [Member]",
        "label": "Two Thousand Sixteen To Two Thousand Eighteen Cycle [Member]",
        "documentation": "Two Thousand Sixteen To Two Thousand Eighteen Cycle [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_TwoThousandTenPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "TwoThousandTenPlanMember",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2010 Plan [Member]",
        "label": "Two Thousand Ten Plan [Member]",
        "documentation": "2010 Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_TwoThousandTwentyOnePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "TwoThousandTwentyOnePlanMember",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Two Thousand Twenty-One Plan [Domain]",
        "label": "Two Thousand Twenty-One Plan [Member]",
        "documentation": "Two Thousand Twenty-One Plan"
       }
      }
     },
     "auth_ref": []
    },
    "iff_TwoThousandTwentyOneToTwoThousandTwentyThreeCycleMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "TwoThousandTwentyOneToTwoThousandTwentyThreeCycleMember",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Two Thousand Twenty-One To Two Thousand Twenty-Three Cycle",
        "label": "Two Thousand Twenty-One To Two Thousand Twenty-Three Cycle [Member]",
        "documentation": "Two Thousand Twenty-One To Two Thousand Twenty-Three Cycle"
       }
      }
     },
     "auth_ref": []
    },
    "iff_TwoThousandTwentyThreeToTwoThousandFortyTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "TwoThousandTwentyThreeToTwoThousandFortyTwoMember",
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2018 to 2037 [Member]",
        "label": "Two Thousand Twenty Three To Two Thousand Forty Two [Member]",
        "documentation": "Two Thousand Twenty Three To Two Thousand Forty Two [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_TwoThousandTwentyToTwoThousandTwentyTwoCycleMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "TwoThousandTwentyToTwoThousandTwentyTwoCycleMember",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Two Thousand Nineteen To Two Thousand Twenty-One Cycle",
        "label": "Two Thousand Twenty To Two Thousand Twenty-Two Cycle [Member]",
        "documentation": "Two Thousand Twenty To Two Thousand Twenty-Two Cycle"
       }
      }
     },
     "auth_ref": []
    },
    "iff_TwoThousandTwentyTwoToTwoThousandFortyOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "TwoThousandTwentyTwoToTwoThousandFortyOneMember",
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Two Thousand Twenty Two To Two Thousand Forty One",
        "label": "Two Thousand Twenty Two To Two Thousand Forty One [Member]",
        "documentation": "Two Thousand Twenty Two To Two Thousand Forty One"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TypeOfAdoptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TypeOfAdoptionMember",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Type of Adoption [Domain]",
        "label": "Accounting Standards Update [Domain]",
        "documentation": "Amendment to accounting standards."
       }
      }
     },
     "auth_ref": [
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r493",
      "r494",
      "r495",
      "r496",
      "r507",
      "r565",
      "r566",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r674",
      "r877",
      "r878",
      "r879",
      "r908",
      "r909",
      "r910",
      "r911",
      "r925",
      "r926",
      "r927",
      "r944",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951",
      "r952",
      "r953",
      "r954",
      "r957",
      "r958",
      "r959",
      "r960",
      "r961",
      "r962",
      "r963",
      "r964",
      "r965",
      "r966",
      "r967",
      "r968",
      "r973",
      "r974",
      "r979",
      "r980",
      "r981",
      "r982",
      "r997",
      "r998",
      "r1003",
      "r1004",
      "r1005",
      "r1006",
      "r1024",
      "r1025",
      "r1026",
      "r1027",
      "r1028",
      "r1065",
      "r1066",
      "r1067",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120",
      "r1121"
     ]
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TypeOfRestructuringDomain",
     "presentation": [
      "http://www.iff.com/role/RestructuringandOtherChargesAdditionalInformationDetails",
      "http://www.iff.com/role/RestructuringandOtherChargesMovementsinRestructuringandRelatedAccrualsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Type of Restructuring [Domain]",
        "label": "Type of Restructuring [Domain]",
        "documentation": "Identification of the types of restructuring costs."
       }
      }
     },
     "auth_ref": [
      "r677",
      "r678",
      "r684",
      "r685"
     ]
    },
    "country_US": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "US",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsAccumulatedBenefitObligationDetail",
      "http://www.iff.com/role/EmployeeBenefitsAdditionalInformationDetail",
      "http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetail",
      "http://www.iff.com/role/EmployeeBenefitsAmountsRecognizedinBalanceSheetDetail",
      "http://www.iff.com/role/EmployeeBenefitsChangesinPostretirementBenefitObligationandPlanAssetsDetail",
      "http://www.iff.com/role/EmployeeBenefitsEstimatedFutureBenefitPaymentsDetail",
      "http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail",
      "http://www.iff.com/role/EmployeeBenefitsPercentageofAssetsInvestedDetail",
      "http://www.iff.com/role/EmployeeBenefitsPlanAssetsandBenefitObligationsofDefinedBenefitPensionPlansDetail",
      "http://www.iff.com/role/EmployeeBenefitsSensitivityofDisclosurestoChangesinSelectedAssumptionsDetail",
      "http://www.iff.com/role/EmployeeBenefitsWeightedAverageActuarialAssumptionUsedtoDetermineExpenseDetail",
      "http://www.iff.com/role/SegmentInformationAdditionalInformationDetail",
      "http://www.iff.com/role/SegmentInformationSegmentInformationScheduleofLongLivedAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "U.S. Plans",
        "terseLabel": "U.S. Pension Plans [Member]",
        "label": "UNITED STATES"
       }
      }
     },
     "auth_ref": []
    },
    "iff_USCorporateBondsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "USCorporateBondsMember",
     "presentation": [
      "http://www.iff.com/role/EmployeeBenefitsFairValueHierarchyofPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "U.S. Corporate Bonds",
        "label": "U S Corporate Bonds [Member]",
        "documentation": "U.S. Corporate Bonds [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnderlyingAssetClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnderlyingAssetClassAxis",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsAdditionalInformationDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsWhichWereNotDesignatedasHedgingInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Asset Class [Axis]",
        "label": "Underlying Asset Class [Axis]",
        "documentation": "Information by underlying asset class."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnderlyingAssetClassDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnderlyingAssetClassDomain",
     "presentation": [
      "http://www.iff.com/role/FinancialInstrumentsAdditionalInformationDetail",
      "http://www.iff.com/role/FinancialInstrumentsDerivativeInstrumentsWhichWereNotDesignatedasHedgingInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Asset Class [Domain]",
        "label": "Underlying Asset Class [Domain]",
        "documentation": "Major types of referenced/underlying asset classes (for example, corporate debt, sovereign debt, and structured finance)."
       }
      }
     },
     "auth_ref": [
      "r201"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Security Market Price Change",
        "label": "Underlying Security Market Price Change, Percent"
       }
      }
     },
     "auth_ref": [
      "r1400"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefits",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofUnrecognizedTaxBenefitsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance of unrecognized tax benefits at beginning of year",
        "periodEndLabel": "Balance of unrecognized tax benefits at end of year",
        "label": "Unrecognized Tax Benefits",
        "documentation": "Amount of unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r884",
      "r893"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofUnrecognizedTaxBenefitsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Gross amount of decreases in unrecognized tax benefits as a result of positions taken during a prior year",
        "terseLabel": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns."
       }
      }
     },
     "auth_ref": [
      "r894"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofUnrecognizedTaxBenefitsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "The amounts of decreases in unrecognized benefits relating to settlements with taxing authorities",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities",
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities."
       }
      }
     },
     "auth_ref": [
      "r896"
     ]
    },
    "iff_UnrecognizedTaxBenefitsIncludingInterestAndPenalties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "UnrecognizedTaxBenefitsIncludingInterestAndPenalties",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized tax benefits, including interest",
        "label": "Unrecognized Tax Benefits, Including Interest And Penalties",
        "documentation": "Unrecognized Tax Benefits, Including Interest And Penalties"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.iff.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofUnrecognizedTaxBenefitsDetail",
      "http://www.iff.com/role/IncomeTaxesScheduleofIncomeTaxProvisionDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued interest and penalties",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return."
       }
      }
     },
     "auth_ref": [
      "r892"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofUnrecognizedTaxBenefitsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross amount of increases in unrecognized tax benefits as a result of positions taken during the current year",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return."
       }
      }
     },
     "auth_ref": [
      "r895"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofUnrecognizedTaxBenefitsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross amount of increases in unrecognized tax benefits as a result of positions taken during a prior year(1)",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns."
       }
      }
     },
     "auth_ref": [
      "r894"
     ]
    },
    "iff_UnrecognizedTaxBenefitsOtherCurrentLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "UnrecognizedTaxBenefitsOtherCurrentLiabilitiesMember",
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.iff.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofUnrecognizedTaxBenefitsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Current Liabilities [Member]",
        "label": "Unrecognized Tax Benefits, Other Current Liabilities [Member]",
        "documentation": "Unrecognized tax benefits, other current liabilities [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_UnrecognizedTaxBenefitsOtherLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "UnrecognizedTaxBenefitsOtherLiabilitiesMember",
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other liabilities [Member]",
        "label": "Unrecognized Tax Benefits, Other Liabilities [Member]",
        "documentation": "Unrecognized tax benefits, other liabilities [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_UnrecognizedTaxBenefitsReductionResultingFromLapseOfApplicableStatueOfLimitationsNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "UnrecognizedTaxBenefitsReductionResultingFromLapseOfApplicableStatueOfLimitationsNextTwelveMonths",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized Tax Benefits, Reduction Resulting From Lapse Of Applicable Statue of Limitations, Next Twelve Months",
        "label": "Unrecognized Tax Benefits, Reduction Resulting From Lapse Of Applicable Statue Of Limitations, Next Twelve Months",
        "documentation": "Unrecognized Tax Benefits, Reduction Resulting From Lapse Of Applicable Statue Of Limitations, Next Twelve Months"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.iff.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofUnrecognizedTaxBenefitsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "negatedLabel": "Reduction in unrecognized tax benefits due to the lapse of applicable statute of limitation",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations."
       }
      }
     },
     "auth_ref": [
      "r897"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.iff.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofUnrecognizedTaxBenefitsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized tax benefits that would impact effective tax rate",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate."
       }
      }
     },
     "auth_ref": [
      "r898"
     ]
    },
    "us-gaap_UnsecuredDebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnsecuredDebtMember",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unsecured Debt",
        "label": "Unsecured Debt [Member]",
        "documentation": "Debt obligation not collateralized by pledge of, mortgage of or other lien on the entity's assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnusualOrInfrequentItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnusualOrInfrequentItemAxis",
     "presentation": [
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetNarrativeDetails",
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.iff.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unusual or Infrequent Item, or Both [Axis]",
        "label": "Unusual or Infrequent Item, or Both [Axis]",
        "documentation": "Information by an event or transaction that is unusual in nature or infrequent in occurrence, or both."
       }
      }
     },
     "auth_ref": [
      "r273"
     ]
    },
    "us-gaap_UnusualOrInfrequentItemDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnusualOrInfrequentItemDomain",
     "presentation": [
      "http://www.iff.com/role/GoodwillandOtherIntangibleAssetsNetNarrativeDetails",
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.iff.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unusual or Infrequent Item, or Both [Domain]",
        "label": "Unusual or Infrequent Item, or Both [Domain]",
        "documentation": "Event or transaction that is unusual in nature or infrequent in occurrence, or both."
       }
      }
     },
     "auth_ref": [
      "r273"
     ]
    },
    "iff_UnusualOrInfrequentItemsOrBothDisclosurePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "UnusualOrInfrequentItemsOrBothDisclosurePolicyTextBlock",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unusual or Infrequent Items, or Both, Disclosure",
        "label": "Unusual or Infrequent Items, or Both, Disclosure [Policy Text Block]",
        "documentation": "Unusual or Infrequent Items, or Both, Disclosure"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://www.iff.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Use of Estimates",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r103",
      "r104",
      "r105",
      "r356",
      "r357",
      "r359",
      "r360"
     ]
    },
    "us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValuationAllowanceOfDeferredTaxAssetsMember",
     "presentation": [
      "http://www.iff.com/role/ScheduleIIValuationandQualifyingAccountsandReservesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]",
        "label": "SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]",
        "documentation": "Valuation allowance of deferred tax asset attributable to deductible temporary difference and carryforward."
       }
      }
     },
     "auth_ref": [
      "r1461",
      "r1462",
      "r1463",
      "r1465",
      "r1466"
     ]
    },
    "us-gaap_ValuationAllowancesAndReservesAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValuationAllowancesAndReservesAdjustments",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/ScheduleIIValuationandQualifyingAccountsandReservesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Translation adjustments",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Increase (Decrease) Adjustment",
        "documentation": "Amount of increase (decrease) in valuation and qualifying accounts and reserves from adjustment."
       }
      }
     },
     "auth_ref": [
      "r1467"
     ]
    },
    "us-gaap_ValuationAllowancesAndReservesBalance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValuationAllowancesAndReservesBalance",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/ScheduleIIValuationandQualifyingAccountsandReservesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance at beginning of period",
        "periodEndLabel": "Balance at end of period",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount",
        "documentation": "Amount of valuation and qualifying accounts and reserves."
       }
      }
     },
     "auth_ref": [
      "r481",
      "r487"
     ]
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/ScheduleIIValuationandQualifyingAccountsandReservesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additions (deductions) charged to costs and expenses",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense",
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense."
       }
      }
     },
     "auth_ref": [
      "r484"
     ]
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValuationAllowancesAndReservesChargedToOtherAccounts",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/ScheduleIIValuationandQualifyingAccountsandReservesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account",
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to accounts other than cost and expense."
       }
      }
     },
     "auth_ref": [
      "r485"
     ]
    },
    "us-gaap_ValuationAllowancesAndReservesDeductions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValuationAllowancesAndReservesDeductions",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/ScheduleIIValuationandQualifyingAccountsandReservesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accounts written off",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction",
        "documentation": "Amount of decrease in valuation and qualifying accounts and reserves."
       }
      }
     },
     "auth_ref": [
      "r486"
     ]
    },
    "us-gaap_ValuationAllowancesAndReservesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValuationAllowancesAndReservesDomain",
     "presentation": [
      "http://www.iff.com/role/ScheduleIIValuationandQualifyingAccountsandReservesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]",
        "documentation": "Valuation and qualifying accounts and reserves."
       }
      }
     },
     "auth_ref": [
      "r481",
      "r482",
      "r483",
      "r486",
      "r487"
     ]
    },
    "us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValuationAllowancesAndReservesReservesOfBusinessesAcquired",
     "crdr": "credit",
     "presentation": [
      "http://www.iff.com/role/ScheduleIIValuationandQualifyingAccountsandReservesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquisitions",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Business Acquired",
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from business combination."
       }
      }
     },
     "auth_ref": [
      "r1464"
     ]
    },
    "us-gaap_ValuationAllowancesAndReservesTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValuationAllowancesAndReservesTypeAxis",
     "presentation": [
      "http://www.iff.com/role/ScheduleIIValuationandQualifyingAccountsandReservesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]",
        "documentation": "Information by valuation and qualifying accounts and reserves."
       }
      }
     },
     "auth_ref": [
      "r481",
      "r482",
      "r483",
      "r486",
      "r487"
     ]
    },
    "srt_ValuationAndQualifyingAccountsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ValuationAndQualifyingAccountsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ValuationAndQualifyingAccountsDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ValuationAndQualifyingAccountsDisclosureLineItems",
     "presentation": [
      "http://www.iff.com/role/ScheduleIIValuationandQualifyingAccountsandReservesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r385",
      "r481",
      "r482",
      "r483",
      "r486",
      "r487"
     ]
    },
    "srt_ValuationAndQualifyingAccountsDisclosureTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ValuationAndQualifyingAccountsDisclosureTable",
     "presentation": [
      "http://www.iff.com/role/ScheduleIIValuationandQualifyingAccountsandReservesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]",
        "documentation": "Disclosure of valuation and qualifying accounts and reserves."
       }
      }
     },
     "auth_ref": [
      "r385",
      "r481",
      "r482",
      "r483",
      "r486",
      "r487"
     ]
    },
    "us-gaap_ValueAddedTaxReceivableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValueAddedTaxReceivableCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherAssetsDetail": {
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/OtherAssetsAndLiabilitiesCurrentandNoncurrentScheduleofOtherAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Value-added tax receivable",
        "label": "Value Added Tax Receivable, Current",
        "documentation": "Carrying amount as of the balance sheet date of value added taxes due either from customers arising from sales on credit terms, or as previously overpaid to tax authorities. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r1445"
     ]
    },
    "us-gaap_VariableLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://www.iff.com/role/LeasesScheduleofLeaseExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Lease, Cost",
        "label": "Variable Lease, Cost",
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases."
       }
      }
     },
     "auth_ref": [
      "r1018",
      "r1310"
     ]
    },
    "us-gaap_VariableRateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableRateAxis",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationRevolvingCreditFacilityDetail",
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail",
      "http://www.iff.com/role/DebtComponentsofDebtDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Rate [Axis]",
        "label": "Variable Rate [Axis]",
        "documentation": "Information by type of variable rate."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VariableRateDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableRateDomain",
     "presentation": [
      "http://www.iff.com/role/DebtAdditionalInformationRevolvingCreditFacilityDetail",
      "http://www.iff.com/role/DebtAdditionalInformationTermLoanandSeniorNotesAssumedDetail",
      "http://www.iff.com/role/DebtComponentsofDebtDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Rate [Domain]",
        "label": "Variable Rate [Domain]",
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VestingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VestingAxis",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting [Axis]",
        "label": "Vesting [Axis]",
        "documentation": "Information by vesting schedule of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1584",
      "r1585",
      "r1586",
      "r1587",
      "r1588",
      "r1589",
      "r1590",
      "r1591",
      "r1592",
      "r1593",
      "r1594",
      "r1595",
      "r1596",
      "r1597",
      "r1598",
      "r1599",
      "r1600",
      "r1601",
      "r1602",
      "r1603",
      "r1604",
      "r1605",
      "r1606",
      "r1607",
      "r1608",
      "r1609"
     ]
    },
    "us-gaap_VestingDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VestingDomain",
     "presentation": [
      "http://www.iff.com/role/StockCompensationPlansAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting [Domain]",
        "label": "Vesting [Domain]",
        "documentation": "Vesting schedule of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1584",
      "r1585",
      "r1586",
      "r1587",
      "r1588",
      "r1589",
      "r1590",
      "r1591",
      "r1592",
      "r1593",
      "r1594",
      "r1595",
      "r1596",
      "r1597",
      "r1598",
      "r1599",
      "r1600",
      "r1601",
      "r1602",
      "r1603",
      "r1604",
      "r1605",
      "r1606",
      "r1607",
      "r1608",
      "r1609"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "calculation": {
      "http://www.iff.com/role/NetIncomePerShareReconciliationofSharesUsedinComputationofBasicandDilutedNetIncomePerShareDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME",
      "http://www.iff.com/role/NetIncomePerShareReconciliationofSharesUsedinComputationofBasicandDilutedNetIncomePerShareDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Average number of shares outstanding - diluted (in shares)",
        "totalLabel": "Average number of shares outstanding - diluted (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r511",
      "r521"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "presentation": [
      "http://www.iff.com/role/NetIncomePerShareReconciliationofSharesUsedinComputationofBasicandDilutedNetIncomePerShareDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares",
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "calculation": {
      "http://www.iff.com/role/NetIncomePerShareReconciliationofSharesUsedinComputationofBasicandDilutedNetIncomePerShareDetail": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iff.com/role/CONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME",
      "http://www.iff.com/role/NetIncomePerShareReconciliationofSharesUsedinComputationofBasicandDilutedNetIncomePerShareDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Average number of shares outstanding - basic (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r509",
      "r521"
     ]
    },
    "iff_ZhangjiagangChinaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "ZhangjiagangChinaMember",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Zhangjiagang, China",
        "label": "Zhangjiagang, China [Member]",
        "documentation": "Zhangjiagang, China"
       }
      }
     },
     "auth_ref": []
    },
    "iff_ZhangjiagangFlavorsPlantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "ZhangjiagangFlavorsPlantMember",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Zhangjiagang Flavors Plant",
        "label": "Zhangjiagang Flavors Plant [Member]",
        "documentation": "Zhangjiagang Flavors Plant"
       }
      }
     },
     "auth_ref": []
    },
    "iff_ZhejiangChinaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "ZhejiangChinaMember",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Zhejiang, China [Member]",
        "label": "Zhejiang, China [Member]",
        "documentation": "Zhejiang, China [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iff_ZhejiangIngredientsPlantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20231231",
     "localname": "ZhejiangIngredientsPlantMember",
     "presentation": [
      "http://www.iff.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Zhejiang Ingredients Plant [Member]",
        "label": "Zhejiang Ingredients Plant [Member]",
        "documentation": "Zhejiang Ingredients Plant [Member]"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482338/360-10-05-4"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "940",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "16",
   "SubTopic": "10",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479405/805-10-25-16"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "6",
   "SubTopic": "50",
   "Topic": "350",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482610/350-50-25-6"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "1",
   "SubTopic": "40",
   "Topic": "350",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482633/350-40-30-1"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "7",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-7"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "8",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-8"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479613/805-30-35-1"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "SubTopic": "20",
   "Topic": "205",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-10"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(a),(b),(c)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(i)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(i),(j),(k)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(i-k)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(j)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-12"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-14"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-15"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(f)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(g)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-5"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480463/815-10-45-5"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "470",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-1"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "205",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "715",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "30",
   "Topic": "350",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "30",
   "Topic": "715",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481097/715-30-50-1"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "60",
   "Topic": "715",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480266/715-60-50-1"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c),(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "80",
   "Topic": "715",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-2"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(4)",
   "SubTopic": "10",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2A"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "e",
   "SubTopic": "470",
   "Topic": "942",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "280",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-4"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "a",
   "SubTopic": "10",
   "Topic": "280",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "b",
   "SubTopic": "10",
   "Topic": "280",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(c)(2)",
   "SubTopic": "20",
   "Topic": "860",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4D"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13",
   "SubTopic": "20",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-13"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "44",
   "SubTopic": "20",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-44"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "60",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3A",
   "Subparagraph": "(3)",
   "SubTopic": "10",
   "Topic": "480",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-3A"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3A",
   "Subparagraph": "16(c)",
   "SubTopic": "10",
   "Topic": "480",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-3A"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "205",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-3"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.20)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.21)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.24)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.25)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.31)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-16"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-21"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "320",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//320/tableOfContent"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-4"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "420",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "420",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 5.P.3,4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-1"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "420",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481573/470-10-45-10"
  },
  "r124": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5"
  },
  "r125": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-2"
  },
  "r126": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-4"
  },
  "r127": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(CFRR 211.02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1"
  },
  "r128": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Section": "S99",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-3A"
  },
  "r129": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Paragraph": "3A",
   "Section": "S99",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-3A"
  },
  "r130": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Subparagraph": "14",
   "Paragraph": "3A",
   "Section": "S99",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-3A"
  },
  "r131": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Subparagraph": "15",
   "Paragraph": "3A",
   "Section": "S99",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-3A"
  },
  "r132": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481142/505-10-45-2"
  },
  "r133": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-10"
  },
  "r134": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3"
  },
  "r135": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4"
  },
  "r136": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-5"
  },
  "r137": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8"
  },
  "r138": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r139": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1"
  },
  "r140": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-2"
  },
  "r141": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-3"
  },
  "r142": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-4"
  },
  "r143": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-2"
  },
  "r144": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r145": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2"
  },
  "r146": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3"
  },
  "r147": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-4"
  },
  "r148": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17"
  },
  "r149": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "70",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480794/715-70-50-1"
  },
  "r150": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1"
  },
  "r151": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r152": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b),(f(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r153": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r154": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r155": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r156": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r157": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r158": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r159": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r160": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12"
  },
  "r161": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13"
  },
  "r162": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6"
  },
  "r163": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r164": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3"
  },
  "r165": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3"
  },
  "r166": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8"
  },
  "r167": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "25",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479405/805-10-25-23"
  },
  "r168": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r169": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r170": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3"
  },
  "r171": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "37",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479303/805-10-55-37"
  },
  "r172": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1"
  },
  "r173": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1"
  },
  "r174": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-14"
  },
  "r175": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-20"
  },
  "r176": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "25",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479668/805-30-25-6"
  },
  "r177": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-12"
  },
  "r178": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15"
  },
  "r179": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16"
  },
  "r180": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-24"
  },
  "r181": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1"
  },
  "r182": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r183": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I"
  },
  "r184": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J"
  },
  "r185": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K"
  },
  "r186": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A"
  },
  "r187": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B"
  },
  "r188": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2"
  },
  "r189": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2"
  },
  "r190": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A"
  },
  "r191": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A"
  },
  "r192": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B"
  },
  "r193": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a),(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B"
  },
  "r194": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B"
  },
  "r195": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B"
  },
  "r196": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C"
  },
  "r197": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C"
  },
  "r198": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C"
  },
  "r199": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C"
  },
  "r200": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D"
  },
  "r201": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4K",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4K"
  },
  "r202": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "182",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480401/815-10-55-182"
  },
  "r203": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "25",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480238/815-25-50-1"
  },
  "r204": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480901/815-30-45-1"
  },
  "r205": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480870/815-30-50-1"
  },
  "r206": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r207": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3"
  },
  "r208": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-11"
  },
  "r209": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-12"
  },
  "r210": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20"
  },
  "r211": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21"
  },
  "r212": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1"
  },
  "r213": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A"
  },
  "r214": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2"
  },
  "r215": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3"
  },
  "r216": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8"
  },
  "r217": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.10)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r218": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.17)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r219": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3"
  },
  "r220": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "954",
   "SubTopic": "450",
   "Section": "25",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480685/954-450-25-2"
  },
  "r221": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "954",
   "SubTopic": "450",
   "Section": "30",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480654/954-450-30-1"
  },
  "r222": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "985",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1"
  },
  "r223": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//205/tableOfContent"
  },
  "r224": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//205-20/tableOfContent"
  },
  "r225": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-11"
  },
  "r226": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-3"
  },
  "r227": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-3B"
  },
  "r228": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1"
  },
  "r229": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-3A"
  },
  "r230": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-4A"
  },
  "r231": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-4B"
  },
  "r232": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5A"
  },
  "r233": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B"
  },
  "r234": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B"
  },
  "r235": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C"
  },
  "r236": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5D"
  },
  "r237": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r238": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 201.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r239": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 201.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r240": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 201.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r241": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r242": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r243": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r244": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r245": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r246": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r247": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r248": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r249": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r250": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r251": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r252": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r253": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r254": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r255": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r256": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r257": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r258": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r259": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-7"
  },
  "r260": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11"
  },
  "r261": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r262": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r263": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r264": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r265": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r266": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.19)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r267": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r268": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r269": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r270": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r271": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.8)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r272": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r273": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483613/220-20-50-1"
  },
  "r274": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12"
  },
  "r275": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r276": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r277": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r278": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r279": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//235/tableOfContent"
  },
  "r280": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//275/tableOfContent"
  },
  "r281": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2"
  },
  "r282": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480581/330-10-S99-2"
  },
  "r283": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//350/tableOfContent"
  },
  "r284": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r285": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r286": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r287": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//360/tableOfContent"
  },
  "r288": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-9"
  },
  "r289": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r290": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-2"
  },
  "r291": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r292": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3A"
  },
  "r293": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480091/360-10-S99-2"
  },
  "r294": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-1"
  },
  "r295": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r296": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//440/tableOfContent"
  },
  "r297": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//470/tableOfContent"
  },
  "r298": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//505/tableOfContent"
  },
  "r299": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6"
  },
  "r300": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7"
  },
  "r301": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r302": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "710",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483070/710-10-25-9"
  },
  "r303": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "710",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483043/710-10-30-1"
  },
  "r304": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-3"
  },
  "r305": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r306": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "715",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r307": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "715",
   "SubTopic": "20",
   "Subparagraph": "(d)(5)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r308": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "715",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r309": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "715",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r310": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "715",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r311": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r312": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r313": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r314": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r315": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r316": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15"
  },
  "r317": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15"
  },
  "r318": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r319": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r320": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//805/tableOfContent"
  },
  "r321": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-38"
  },
  "r322": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r323": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//810/tableOfContent"
  },
  "r324": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19"
  },
  "r325": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-23"
  },
  "r326": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r327": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r328": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "15",
   "Paragraph": "83",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480647/815-10-15-83"
  },
  "r329": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C"
  },
  "r330": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "SubTopic": "25",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480238/815-25-50-1"
  },
  "r331": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r332": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21"
  },
  "r333": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r334": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r335": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r336": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r337": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r338": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r339": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r340": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r341": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r342": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r343": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r344": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r345": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r346": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04.10)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r347": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04.13(h))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r348": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04.9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r349": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-3"
  },
  "r350": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481501/840-20-50-2"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "SubTopic": "210",
   "Topic": "954",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480632/954-210-45-5"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "270",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482989/270-10-45-6"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.M.Q4)",
   "SubTopic": "20",
   "Topic": "326",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483530/326-20-S99-1"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//275/tableOfContent"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(4)",
   "Publisher": "SEC"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(5)",
   "Publisher": "SEC"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(1)(i)",
   "Publisher": "SEC"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(1)(ii)",
   "Publisher": "SEC"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Subsection": "Instruction 5",
   "Publisher": "SEC"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1406",
   "Paragraph": "(a)",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1406",
   "Paragraph": "(a)",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1406",
   "Paragraph": "(a)",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1406",
   "Paragraph": "(a)",
   "Subparagraph": "(4)",
   "Publisher": "SEC"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1406",
   "Paragraph": "(a)",
   "Subparagraph": "(5)",
   "Publisher": "SEC"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1406",
   "Paragraph": "(c)",
   "Publisher": "SEC"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "09",
   "Publisher": "SEC"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column B",
   "Publisher": "SEC"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column C",
   "Publisher": "SEC"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column D",
   "Publisher": "SEC"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column E",
   "Publisher": "SEC"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column F",
   "Publisher": "SEC"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column G",
   "Publisher": "SEC"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column H",
   "Publisher": "SEC"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column I",
   "Publisher": "SEC"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "29",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "(a)",
   "Subparagraph": "(4)(i)",
   "Publisher": "SEC"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "(a)",
   "Subparagraph": "(4)(iii)(A)",
   "Publisher": "SEC"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "(a)",
   "Subparagraph": "(4)(iii)(B)",
   "Publisher": "SEC"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "(a)",
   "Subparagraph": "(4)(iv)",
   "Publisher": "SEC"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "(a)",
   "Subparagraph": "(4)(i)",
   "Publisher": "SEC"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "(a)",
   "Subparagraph": "(4)(iii)(A)",
   "Publisher": "SEC"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "(a)",
   "Subparagraph": "(4)(iii)(B)",
   "Publisher": "SEC"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "(a)",
   "Subparagraph": "(4)(iii)(C)",
   "Publisher": "SEC"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "(a)",
   "Subparagraph": "(4)(iv)",
   "Publisher": "SEC"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "4",
   "Subsection": "08",
   "Paragraph": "(m)",
   "Subparagraph": "(1)(iii)",
   "Publisher": "SEC"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5C",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-10"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-12"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(210.5-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 6.B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column C(1)))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column C(2)))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column C)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column C)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-6"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-12"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//260/tableOfContent"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-22"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-23"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-28A"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//280/tableOfContent"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-1"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479391/326-20-30-4A"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479391/326-20-30-5A"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479366/326-20-35-8A"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-5"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-17"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-21"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-3C"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-3D"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479175/326-30-30-1B"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "13A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479148/326-30-35-13A"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479148/326-30-35-7A"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-3A"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-3C"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-3D"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//330/tableOfContent"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-1"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-2"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-4"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//350-20/tableOfContent"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-2"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1A"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479468/405-50-50-3"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479468/405-50-50-3"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479468/405-50-50-3"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479468/405-50-50-3"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479468/405-50-50-4"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147477123/405-50-65-1"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//420/tableOfContent"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-1"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-2"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-3"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//715/tableOfContent"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-2"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-3"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-3A"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-3A"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(10)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(8)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(8)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(o)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(p)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(q)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(r)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(r)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-4"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-8"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480126/715-20-S99-2"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480266/715-60-50-3"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480266/715-60-50-4"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "70",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480794/715-70-50-1"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480606/715-80-35-1"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-9"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//718/tableOfContent"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480454/718-10-45-1"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483044/730-10-05-1"
  },
  "r882": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1"
  },
  "r883": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//740/tableOfContent"
  },
  "r884": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-10B"
  },
  "r885": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25"
  },
  "r886": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28"
  },
  "r887": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4"
  },
  "r888": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6"
  },
  "r889": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10"
  },
  "r890": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r891": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14"
  },
  "r892": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15"
  },
  "r893": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r894": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r895": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r896": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r897": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r898": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r899": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17"
  },
  "r900": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19"
  },
  "r901": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r902": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r903": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r904": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20"
  },
  "r905": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21"
  },
  "r906": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r907": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r908": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r909": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r910": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r911": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r912": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r913": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r914": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r915": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r916": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r917": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r918": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2"
  },
  "r919": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1"
  },
  "r920": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2"
  },
  "r921": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r922": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r923": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5"
  },
  "r924": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5"
  },
  "r925": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3"
  },
  "r926": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3"
  },
  "r927": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3"
  },
  "r928": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r929": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r930": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-4"
  },
  "r931": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19"
  },
  "r932": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r933": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r934": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r935": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r936": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r937": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1B"
  },
  "r938": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r939": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r940": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A"
  },
  "r941": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D"
  },
  "r942": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4E"
  },
  "r943": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-3"
  },
  "r944": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r945": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r946": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r947": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r948": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r949": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r950": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r951": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r952": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r953": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r954": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r955": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5"
  },
  "r956": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6"
  },
  "r957": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r958": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r959": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r960": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r961": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r962": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r963": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r964": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r965": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r966": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r967": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r968": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-2"
  },
  "r969": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482134/820-10-35-54B"
  },
  "r970": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r971": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r972": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A"
  },
  "r973": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482477/820-10-65-13"
  },
  "r974": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482477/820-10-65-13"
  },
  "r975": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482736/825-10-45-2"
  },
  "r976": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482736/825-10-45-5A"
  },
  "r977": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10"
  },
  "r978": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r979": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6"
  },
  "r980": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6"
  },
  "r981": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6"
  },
  "r982": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6"
  },
  "r983": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//830/tableOfContent"
  },
  "r984": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481839/830-10-45-17"
  },
  "r985": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482014/830-20-35-1"
  },
  "r986": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-1"
  },
  "r987": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481926/830-20-50-1"
  },
  "r988": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r989": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17"
  },
  "r990": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r991": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r992": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r993": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r994": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r995": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1"
  },
  "r996": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2"
  },
  "r997": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "832",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483482/832-10-65-1"
  },
  "r998": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "832",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483482/832-10-65-1"
  },
  "r999": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-1"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//842-20/tableOfContent"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-2"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-1"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(4)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r1057": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r1058": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r1059": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r1060": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r1061": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6"
  },
  "r1062": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "330",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482105/912-330-50-1"
  },
  "r1063": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1"
  },
  "r1064": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5"
  },
  "r1065": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2"
  },
  "r1066": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2"
  },
  "r1067": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2"
  },
  "r1068": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "928",
   "SubTopic": "340",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1"
  },
  "r1069": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r1070": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r1071": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r1072": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r1073": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r1074": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1"
  },
  "r1075": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1"
  },
  "r1076": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1"
  },
  "r1077": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r1078": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r1079": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r1080": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r1081": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r1082": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r1083": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r1084": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r1085": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r1086": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r1087": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r1088": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r1089": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r1090": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r1091": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r1092": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r1093": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r1094": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r1095": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r1096": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r1097": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r1098": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r1099": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r1100": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r1101": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r1102": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r1103": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r1104": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r1105": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r1106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r1107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column J))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r1108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column K))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r1109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A"
  },
  "r1110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r1111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r1112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r1113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r1114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r1115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r1116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r1117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r1118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r1119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r1120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r1121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r1122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B"
  },
  "r1123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-3"
  },
  "r1124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r1125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r1126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r1127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r1128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r1129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r1130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11"
  },
  "r1131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13"
  },
  "r1132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3"
  },
  "r1133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3"
  },
  "r1134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r1135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2"
  },
  "r1136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27"
  },
  "r1137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r1138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r1139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r1140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r1141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r1142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r1143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r1144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r1145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4"
  },
  "r1146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r1147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r1148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r1149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r1150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-12"
  },
  "r1151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2"
  },
  "r1152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r1153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r1154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r1155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r1156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r1157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r1158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r1159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r1160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r1161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r1162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r1163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r1164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r1165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r1166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r1167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r1168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r1169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r1170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r1171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r1172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r1173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(5)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r1174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r1175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r1176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r1177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r1178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(7)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r1179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r1180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r1181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r1182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r1183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r1184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r1185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r1186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r1187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7"
  },
  "r1188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3"
  },
  "r1189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r1190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r1191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r1192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r1193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r1194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r1195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r1196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r1197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r1198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r1199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r1200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r1201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r1202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r1203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r1204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r1205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r1206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r1207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r1208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r1209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r1210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r1211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r1212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r1213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r1214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r1215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r1216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r1217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r1218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r1219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r1220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5"
  },
  "r1221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5"
  },
  "r1222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5"
  },
  "r1223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5A",
   "Subparagraph": "(SX 210.12-13A(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A"
  },
  "r1224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B"
  },
  "r1225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B"
  },
  "r1226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C"
  },
  "r1227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C"
  },
  "r1228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r1229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r1230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1"
  },
  "r1231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r1232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r1233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r1234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r1235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3"
  },
  "r1236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6"
  },
  "r1237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1"
  },
  "r1238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481058/954-310-45-1"
  },
  "r1239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2"
  },
  "r1240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1"
  },
  "r1241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1"
  },
  "r1242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r1243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r1244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r1245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r1246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r1247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r1248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r1249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r1250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r1251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1"
  },
  "r1252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1"
  },
  "r1253": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r1254": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)(1)",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D"
  },
  "r1255": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r1256": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r1257": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r1258": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r1259": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r1260": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r1261": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r1262": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r1263": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-16"
  },
  "r1264": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-21"
  },
  "r1265": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22"
  },
  "r1266": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r1267": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r1268": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r1269": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52"
  },
  "r1270": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r1271": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r1272": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482785/280-10-55-48"
  },
  "r1273": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A"
  },
  "r1274": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479294/326-20-55-12"
  },
  "r1275": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479294/326-20-55-12"
  },
  "r1276": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479294/326-20-55-12"
  },
  "r1277": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8"
  },
  "r1278": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5"
  },
  "r1279": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24"
  },
  "r1280": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "405",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147477128/405-50-55-5"
  },
  "r1281": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r1282": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r1283": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r1284": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r1285": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r1286": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B"
  },
  "r1287": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C"
  },
  "r1288": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E"
  },
  "r1289": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F"
  },
  "r1290": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r1291": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r1292": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r1293": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1294": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1295": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17"
  },
  "r1296": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-18"
  },
  "r1297": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11"
  },
  "r1298": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11"
  },
  "r1299": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11"
  },
  "r1300": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6"
  },
  "r1301": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6"
  },
  "r1302": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6"
  },
  "r1303": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8"
  },
  "r1304": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1305": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1306": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J"
  },
  "r1307": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K"
  },
  "r1308": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D"
  },
  "r1309": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D"
  },
  "r1310": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53"
  },
  "r1311": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10"
  },
  "r1312": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F"
  },
  "r1313": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r1314": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r1315": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1"
  },
  "r1316": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r1317": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r1318": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r1319": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r1320": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column A)(Footnote 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C"
  },
  "r1321": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column B)(Footnote 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C"
  },
  "r1322": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r1323": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7"
  },
  "r1324": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7"
  },
  "r1325": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7"
  },
  "r1326": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10"
  },
  "r1327": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11"
  },
  "r1328": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12"
  },
  "r1329": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1330": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1331": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r1332": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r1333": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r1334": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r1335": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r1336": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r1337": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r1338": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r1339": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r1340": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r1341": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r1342": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r1343": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r1344": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r1345": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r1346": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii",
   "Section": "6"
  },
  "r1347": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r1348": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r1349": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r1350": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r1351": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r1352": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r1353": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r1354": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r1355": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r1356": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r1357": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r1358": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r1359": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r1360": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r1361": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r1362": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r1363": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r1364": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r1365": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r1366": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r1367": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r1368": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r1369": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r1370": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r1371": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r1372": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r1373": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r1374": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r1375": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r1376": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r1377": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r1378": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r1379": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r1380": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r1381": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r1382": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r1383": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r1384": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r1385": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r1386": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r1387": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r1388": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r1389": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r1390": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r1391": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r1392": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r1393": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r1394": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r1395": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r1396": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r1397": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r1398": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r1399": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r1400": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r1401": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r1402": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r1403": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r1404": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r1405": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r1406": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r1407": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r1408": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r1409": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r1410": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3"
  },
  "r1411": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-10"
  },
  "r1412": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-3"
  },
  "r1413": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12"
  },
  "r1414": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r1415": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r1416": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r1417": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "SubTopic": "20",
   "Topic": "715",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1418": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r1419": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r1420": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r1421": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "SubTopic": "825",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B"
  },
  "r1422": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "SubTopic": "10",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r1423": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(3)",
   "SubTopic": "10",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r1424": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r1425": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3"
  },
  "r1426": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4CC",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4CC"
  },
  "r1427": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4H",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H"
  },
  "r1428": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r1429": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r1430": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r1431": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9"
  },
  "r1432": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r1433": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r1434": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r1435": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r1436": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r1437": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r1438": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r1439": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r1440": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "(a)",
   "Subparagraph": "(4)(ii)",
   "Publisher": "SEC"
  },
  "r1441": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "(a)",
   "Subparagraph": "(4)(iii)",
   "Publisher": "SEC"
  },
  "r1442": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r1443": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r1444": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r1445": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r1446": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r1447": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r1448": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r1449": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r1450": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r1451": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r1452": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r1453": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17"
  },
  "r1454": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r1455": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r1456": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r1457": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r1458": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r1459": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r1460": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r1461": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r1462": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column C(1)))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r1463": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column C(2)))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r1464": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column C)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r1465": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r1466": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r1467": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r1468": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r1469": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r1470": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r1471": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-12"
  },
  "r1472": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r1473": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55"
  },
  "r1474": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15"
  },
  "r1475": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18"
  },
  "r1476": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r1477": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13"
  },
  "r1478": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-2"
  },
  "r1479": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-1"
  },
  "r1480": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-2"
  },
  "r1481": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-4"
  },
  "r1482": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9"
  },
  "r1483": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r1484": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r1485": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r1486": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r1487": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r1488": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r1489": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r1490": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r1491": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1"
  },
  "r1492": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1493": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1494": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1495": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1496": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1497": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1498": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1499": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1500": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1501": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1A"
  },
  "r1502": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2"
  },
  "r1503": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-5"
  },
  "r1504": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r1505": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10"
  },
  "r1506": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482047/420-10-45-3"
  },
  "r1507": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//450/tableOfContent"
  },
  "r1508": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1"
  },
  "r1509": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4"
  },
  "r1510": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r1511": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r1512": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r1513": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r1514": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r1515": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10"
  },
  "r1516": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r1517": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r1518": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-3A"
  },
  "r1519": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1520": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1521": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1522": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(10)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1523": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1524": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1525": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1526": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1527": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1528": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1529": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(8)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1530": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1531": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1532": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1533": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1534": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1535": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1536": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1537": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1538": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1539": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(8)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1540": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1541": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1542": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1543": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1544": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1545": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1546": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1547": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1548": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1549": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1550": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1551": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1552": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1553": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1554": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1555": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1556": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1557": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1558": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1559": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1560": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1561": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1562": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1563": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1564": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1565": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1566": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(q)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1567": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2"
  },
  "r1568": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3"
  },
  "r1569": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3"
  },
  "r1570": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r1571": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r1572": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r1573": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r1574": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r1575": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r1576": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r1577": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r1578": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r1579": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-8"
  },
  "r1580": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480266/715-60-50-4"
  },
  "r1581": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480606/715-80-35-1"
  },
  "r1582": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11"
  },
  "r1583": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-9"
  },
  "r1584": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1585": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1586": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1587": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1588": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1589": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1590": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1591": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1592": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1593": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1594": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1595": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1596": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1597": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1598": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1599": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1600": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1601": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1602": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1603": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1604": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1605": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1606": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1607": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1608": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1609": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1610": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r1611": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r1612": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6"
  },
  "r1613": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r1614": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r1615": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r1616": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A"
  },
  "r1617": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B"
  },
  "r1618": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A"
  },
  "r1619": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D"
  },
  "r1620": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r1621": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r1622": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r1623": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r1624": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1"
  },
  "r1625": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3"
  },
  "r1626": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3"
  },
  "r1627": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r1628": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
  },
  "r1629": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r1630": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r1631": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2"
  },
  "r1632": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r1633": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r1634": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r1635": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r1636": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r1637": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r1638": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r1639": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r1640": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1"
  },
  "r1641": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r1642": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r1643": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r1644": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r1645": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r1646": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B"
  },
  "r1647": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r1648": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r1649": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r1650": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r1651": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r1652": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r1653": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r1654": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r1655": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r1656": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r1657": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r1658": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>160
<FILENAME>0000051253-24-000006-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000051253-24-000006-xbrl.zip
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MWUZSM;?D6V1/2<S+T=68"P"H/_C*P1!\==F=Z^&C8R'@Z;V(11S?]*I_[OH
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MJ3\'M@%(6<V9LLV6OA3<QI3W43 2+7WYOXW!R:I,A/[DXR94=Y&P$OK3E9L
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M4)ULI_$[WXE.[;(ZZ12KLJ[C@>#RQ.ZRQ#L_0.LI'AYW8/C8?>/<]9EON_X
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MSWZBM43(,C*:J4F)5$*W09:XT4E-2I4(67)G[6KREI%E0=FIQ\)"CY,>]]U
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MO,$Z[Y/EZPRB7C5#B*GN@F?$S\#O?6:(+*^WD+S>("@2J*W0_LP"@"R=5SD
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M_32(X=EN7=L'=LC2EP::5*!9U1I'EH UT*0"S:H6=+(4,B;:< >5ZP\ D2"
MD\DEMM;G5_W\XTDNLFL/"^V<XS#DD3X](#ODF%[4CELW\F">+WS'O7>=.-4,
M_.ITZ/+^V2.W8]P-<-7ONS9?\5$LS<.=9F.G=;B ;LQ>^C[=($> TI--J['3
M 'U8R&[-7/HNV>R1XP476%7^SY#_X3)_ '+R62FK&+RA$R,<% GYC4?#P,D/
M1'GZ*>>7+"7[BD.Z\ =868;\)1*3*\ZK-;NHI@NM=GAI::O='CDBSZ!FJ75@
M41\)UX'R4$..4#2H66Z%ZB[H6<.EASOM1CFH(4=L&M0LQV+M[S3V%F.QIBY]
M'VK($:P&-?2YSSURW.<KJ+$EJS(Y.KU\/YET+0*8K&@BY7OL.PB.,3YV'JGT
MC?EQG]GJB+YS9KN>!)(F;,$>62)1I?]OV>-Q#$HI8&AS6^,H-NVU"7_'4W,K
MD$+LY&:UO$0%_BA9SFX348!.XZ(V7S(@9:& )'.X@,U_010&:*4!K41S0XX&
M?6N*X$2POUP/Y*=V4:XZ2S"EZ^]:]_=)LITWV.0N9Y^_N;X[BD?:.%/[),G
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MUN\\C*R];C2T>I'@/'I*++SQH:?PSRMQ&SQD1K#9?-X*OODQ4C&NQ#687%"
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MA"\ E)C13YB)-A8Z3'\D*U03!$O86@"O.7,WA; E,?W/P(O]B E9L"C";&-
M \W'2U"V9E"EE> >AEQ6G\Q([Z=FDN\9@CE!N3D6\[Q,>$6IWO'D KCQ'$%.
MR:Y@?3+F#^2)7V-U,?B#>&*?O'0LN,TE7=IL67(716C]!/>#%=D*8WMHA<,
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M>K;;K7_/GKH++E1R+S_(?C_S\U& (QO"Y#0;A9_J;PYPY;R+0U?:6W"#!SP
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MJ^_><54JZ#$["D*^ ]/$%PY)--:*^=:^2H7(J% >9@LN M=CX(4G('7<</C
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M>;BZ!/1-,%4HEZVB=T'$5,5"_BW8;)A&/%T WS&4VTCA M!^=%;=2,2Y 0
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MPIVT.!^G\>/#K<X5P/L/\\/3F_)2VA^_[=SN"J]<P1^P,E]S_&@I79'?%(>
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MT_EM@[;#!QB)7U1XFD*2[93S]UB_Y8J.QE[\H7F8TC2Q;^6V@E6@L1<&NZ+
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M4(C;2>Y_UM*!+A>E1T9^1/([? QHMF?A--5U%0\>]*JCP;FVXG2(:UO.SJH
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M(,2?VM$%G&D#7$E3<WW&,M/@U^@GV+\H&A<Q27A6;3B/7,[(3D<2FZ8= EF
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MH#C/Q)YL2_M4ELU+MX4$-4SMQZ=3[$=CC(=:_>PW?+[@DM)WSH0$XW-[!W;
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M!\^^>_'FZ8E*$[$7$D4L1.N,KL/^I+\QK=N?UTYFZ>'7YA/!F>'#<BY^HO&
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M)B>+EN:P&#8H%I,?$;]-3NC0X\_Q -^KNM5)5Y7'DTQD+E=:^#))O=%#3"L
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MNL9"0)1D'^>3[A+"E+:S!"D2:8D&S^%(-V[5H.^/C02B'@>]ANAE,1$09-
M<1Y@!C#,5@X(#",7(81W!8='M3;6T0,>B?U@$JCA/6*I9'1J$U-9)"G:KOUD
MF:! P2U0:Q'+2EU?1:)$..=$"VW;+B& 7>V>'S92H47@65H!]E@Q0W56;894
M[> UGFC#$-[)9X;V+."$[+3E;LJ_X%7967A.^\[3B>HZ]B)5&>>79IKBTI8I
MHC/DG(EP&!5+S[Z-_>@1=2J=91 ^%H!_?"!W=^V9EQ*#'K!^DICN?H$3T=/^
MC:L,'U1"][%Z@1.PS[@4K<QS%)NS5+6'(4P.IV?'M[3B[8#P.?D?I>AH+!U^
M^H(.*OGSWHZO738#)>BYY1U@>[N55O1$&2]@IAH\EYDJKC=5Q;ZY\H0L^+6X
M3;GN6/J9.E7SMH()FE[^EJFU:$C:F$6[N90^"#C =2C7K&(R#298YS2%HD:Z
MB]BFE_$ULFPDM[-RTJR'=LV<FR;IX>;=H&%R6C5>J]&(L&W9PIN;A'FJ6JU*
MUIX^CA(MW3 HTB1MB#5/=[D, _9+0*%E'5O"N'^\W%1S]NBJ1:\CJ@0K#KB\
MMLH9NJ=!J,@TFFE4P*%2UT=:T[$FA8K9X[7X<FXNBM0,DL*Z*PV B$@6J._8
MW( ,MYR%K91%XF/%(:NWLW+9K(_JZFV8;,*FIX#ZZ.'DWO<_OCQZ>)]; C8]
MK#-]">J!G@<G,60%"J98R8C)E,68<'12]];N%CFLQOW\1+\V.#LE/0Y>L2F:
MQ4NV)<RZ)=?QBZJ@DV=]E#4N>;HW7G2%\(+5\$Y:I94M)MEO:/"D!5W6,=/I
M< HXVP/5>AP%GU,,<SJ'G[QGNDLR2V$ST#^J.GT9OXGIO= SL@:&NC9:'\<^
M=10A]7XQ)3KE*.,C;=99@, > PL1X(%QFU6(71K^<F*>5AO@D[M$EI5>S]KT
M(M/Y,"YVM'HR^)C.!9/UOK\.-DX-) <>"&];;V%[_[K7M+%_O</KNJ(-[IQ(
MLDPVN87((JE(<6;)(8,YDY@W[X?S#+C.K?,DN%V?XEMN)0RA9[OFH?ZW:K3W
M<-()34(A7=R%YJAT X0= ==LQQ6#(]1-A 4-*E6;->\F%GOF5W-=<2Z6&30P
M5EVW#6*.+4)*K!/@R*]Z;8<KAS\U D'NE0L]0/.<J$*W[UQ#(#1#;-?2I&UD
M S%=%*]7,\4 ??4N3/R;,\]LNF>C#':(K/^\:AOC4+\QQ#QG=GX;^Z_ESY*9
MVRJE!Z3;W/Z;TX7X4%=H.O?RODV)/&48SPDXXUX5D*/A5B^O_]@LQ.8DY6J1
MJI>HLUH,SAM../2.-0'.UA:^@;R;URJ2=D.G-U/M+/'\05[$J<G,&U-G=*L=
M%W?8[YLS"'*;HVRAQ#_'/AEM8'+:UIF0GK43I-612LD#EO>=WOI$ JY:!39C
M/G5A(RKW_$0,SW_-@O;C0T'[9CS+H:!MB_)GP:VQE@/LU(YO*S$W:D_1 8=)
MS;EIV:99210],&MV +5+%TJ4[#XJ1^:TK#E<OP/G^"\A]ML/WMU>$@LG-7\*
MM0Q.^K-0+R9UM0A%S* F@B<A,2M42XJE< S?;RE3"WKM@G 89R6+F^85-F-\
MTO G+\9I?/694,VLJG?'DV=1O"Z]C#NS*M#$O V7$@VN-?>0Y5UU;129WB_2
MZ$:WZPC9Z.AJ<JYC8;M% FT%> 4R&DY0+SV3$KW)N BCSD;ZGG9>*H80XX4]
MRYOA6 <FH%22&23JP4<G-W)G<E0_XZI\DJ-Q35D#5#TC"S0M &^BBEH;;K=<
M34:F)R]'PC+<EY+\$!&-#BQ^V)FFO<.I@H"VC=UU%5>(!LD:;<M"M#-]BK&(
MWV1H@D(ODKR/5LK8BP";.]S$O/X"C,$<FE7:&MZJ!RE4Z0:F P.:*L$T.,]%
M+%M'QK,%77>03AF_URLB]DCX]:P)19VQ$:_+MVI+?;8T_RE-U#Q S9MS4H[
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MI+IP;R$#H/OA0@71+F0H\7A$Z482<P$C*1Q)$9.M:9%T7]\= 6QF5L,W [!
M4BGO-L5 /.,W[<-EDEBRN\1$5#-\FT6;G0'%P2.,[TH9E*)AT1'LV)001::
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M']>I#RET%W?+\D&1-=ZRFP",)+0 96A77_7@JHWWV2WF-]/=<25!3-<D62D
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MYF10]=(^*>_E*#K@%[RPTM+0'0;A^EFY4=H]-**S1XA,_%H:*;6"@ ^^4H<
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M=7D^=X403)5:60+(E+;J_*O24#WMWN&W5)SM,YY@VS4!9W#2+:L,6ZGRW7'
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M(\:$KW(6:4_+GJDR=Q)/@+0.<"L)6 $T*2FE\FM26!WG34WE*FY&:EBIJ1O
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MRD>D/^+^1(.[2:,^R1NVMDISA]: &NH<"PSX.0Z&*#<^]1F]T]?&* YARZW
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MXMY!QR&TP2#'ER2@EF0%PHE0PQ@P!DQ!'#L@6@-M&9.?.WN@9F5#+-FQGM&
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M*W@18@HFUFFL\"YPU;"*L+)Z>9]V?T<_F4V[KZLLCOFU)63U;H(LXAH!;Q3
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MQZ@P" U!8!!'G1)_V+V7/72/NG/9PT[[Z>RAO$>]M_TW906\IX?HOD(1/GX
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M#B40V*IRA-+>/8#%-"FBV/L4W'G=ML_(3OKB=(CN#_G(1\R;*%0Y5'R'G@[
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MDG!";$YI".--6\YPA)E##\ZMF]C?^-11[ Y1RN'C/0'>NL.E=6X F[P1PKH
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M,A[I&?(*1OTDTG3>^7YY;2G6O+D\NP;'#/\P*5[P=<LJ+,L/'N$>G5#G^E"
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MN_2\<OFESYM:)//[[@-LLK;$Z4P1=FEV[NISUHQ4BIJ1S5A+43.BB/)D1>V
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M6%-TZ_.@P8B,<*9/-S1*6+'K&NQN8+\'"CF2](0/8FDKW&W\/$++ X2T\._
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M.[%'C0H>.3W[JAI YB*EMVL\+\*$&;8:.F2M\P?VV'5&+T("C+*Q2.BF(7M
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M5E;H.B1% 21#J-0X$1Z!/_!<_..N"GYD.\HZ>3[I*^]-^-_LK<KQ"_@!'+8
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M:DU.2X^^2J!1]4 AS#MIVIZ 3]4T'BB&1Z1X H^7,'*@9-UH8IZ[/O>$\G-
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MJ)NX2AM1,GWNZ]"@R /+D ^[O3UKUU'31J7,B*7,<,(0?1@5<&'T7$:$D%^
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MFC2H$4',7C=>[TF*<;(_,WVML.7@3E!]A@[[3GR36QN,4XG463#'T*\H9IW
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M>WI]>F)=_?A^WCE6H Z$3-^Y_GV9MNU*-1/'X:-@&X)9T)9HIYC)4&[<I$E
M2!4@]\X\Q*B,K/_C#$??<&;6'0TLC+ E:B.'SM 3EQ_7>3ER?1XYP1(_*\!,
MQ[3T=._MA_G0D-+&T"AL!R=@Q:E^\ZXLE(ZX4'HU"M)PC(A/ZO9=)T3,[#3(
MML9S)'#M^>.GV.ZNVGH^INI[3RTY2O?X>=3CYR8]?KU4CQ_^V<8/1AEE X++
M!AR>N]W#8L"!+@843N]>X<3&]SA&\=G$=Y<3NN=/[TF/8TZU\?.<YVD311M&
MEH=MUWI>-%+6DP29QP?R#%3"=*LT9-!H%^$D>#R8)X%:Y$!L)S)1OA="#B0(
MX']*</(IFIJ$ZES/##(;*%).I-,#$<T!X7 8FX4,.R59]C/'%+[UJN>N<1>'
M/ */1-%8S9)?QU1)'">YEP-@I [#TP>L3!@.?R&'I+FK"\2.XV,C9."!XX;>
MLTTS>L'=47.U:8(R,&=D3W@GRDV8'(*QLK",QAX+193).'907J(2TVL7<'+T
M++I@*$=IPD#FS.&LX<3R-3]\5]=XT>+;A+G@\+1=-1L]=3GJ@-3$:9QL/ONP
M]<3$0D3-%5$?*:&L;!$% B8/9NIW)W*9Y93!NOU"\S;#!)@_,!YN-%I"L-KT
M87.8_ L8F*4B3<6)S;&V2MQ-35%=X<DF<%(R6%H?@@+1\:>=CLL93D>V5==J
M\_1Z?8X\4MZENAKQA-HF4G(QFH6GOUB/D?&;_>7EY:66B"BKR4J,V'3$J3$S
M0*E,V"H]FT8B#"D);R -X>%%2(#2%=Y-*8X]"0*TQQ,10B-$R!B$)EX6O4TJ
MB(D)2:1'X*5A/STJ_4?IIF0-1!^5F#DKT7,>(ZV!C3AER)%-^$.H89:U-763
M?!\_<?K$D]Q-XTH]DC:5 QOK3YX0.>[AE25$,NNX<=I%'VY9'QF?@W5[3^,P
M]%_E)<N1E8)'7>+92=AJOA9^%8[ Z*),@6\Y$7BW>$\@&L;DT:(--\9!QSPL
M:3D;$.EL$+()K2T/O$+U$5L_L#\6Q+=AR&-"!B$LB\64^LA+#!4<TYF803.M
MH!Q0T&5"-)(F%M^/%M62'"9&&9!?C*J![6<W^AG-O,FE7[K4E<]8#U(QB_L^
MRR6D=EI7R;K!@0C&A_7>Q!,<MT^J"06'!=(P1H'LHNV+TU^0NM-C-IQA4A\@
MA\S(9RZW1U9,\C;4,#NYF@>N2E!ORO0&QJ@M:,H#$)H[ )D)!PS+=H?D! R=
MOD ;,+$G4C-F)EZ!O(%$+]TOQW2E5MG)2F9 LF&6*:3%?5;?))YX0,Y*%@N1
MHHX5P:W+670)03X*YR=9+.()-*=$@L3[YM=/G3Z/26$5S^Z@:4[-M'VT-J<;
MI&7!S[BB.1=OD#3-[N LGT&P=(-T(T"3J)A]<*^BR F?-=VY86\\Q..#/Y#]
MT!6>*QZD?#?4AIQK!&=CR/*N-K,-C_$UHF]C'(@3'&OLZE*?<Q?<[<2D^$3!
M[;;5>[&-BG,WF1XC-4"(K4-%3)EF05IPAD"/CC3$@T%VZ$!:;B".1DZHI5&F
M?J(HS)/<P&@<CD#>9]I$&>&33,E:LEYU0LS+D50\(Y"</66D3JJI77</69[L
M*6E"DQTB>.XC[!C' :&-AA^G^(QQOGT!7_1LW,08PQ >!^$Y<H:A-8],<PQ,
MP35$3B\)9"%0L@R8:4L 991I%] !?(,UXB+GW2YM)?T*<AUPY7C&D2&DD%)P
M,GN\U-6^XA)52(^,@9YP1U)3XSPK'+).EY#>*RV[*_ YI#P#G(B7L01G#%<;
MFM%=PV=WC,E-TX>)?X4#772B";_ *8&.4</H0;?C+</%BYXZN+&OUD-' :8\
MWZN-!H+-\^*BR>CH)'G+NZ?C@L/T^C)5D6A-5GA*GV5: =LO&;_+PAD9_75]
M+&^!2_4276&O( IPGA>6WLA+I+N@JTL9Q1$':7%\8/"7Z&FB0HI4I@C?7-KH
M %8:C)&.99"9V2X:=_\R//+$ I*KY2EC74&9/EAS'YP_6(BN&<(4'CG2D8Q+
M]UVY;XH^.;&TB>ZDQV8,<-:.IY9Y0<IVP1?C_F&Q**Z*HJ%TT5"EF F[&6OY
M^)FP&V,S'V.$K0="C6=(_N[$0',Y";SWU-[8<1W2WF@&YMB'WW,AI1<\LLTK
M_^R 0*78JYK: J87J0B9Z--.\'*Q%0ZY.5'ZM4$X&7A-_5F*]LF9G=K>0:N2
MJR0X.J,:&=@4T'$*]HM#D>AX^>#EPMUD%[K^0^ ]R&@DA<E<LLU A7B>\._(
M)Y<J"00W*1'2&.+)^FO<OY/Z[_;>W*+4=IGW TY' &NG@E8/+P3M,QK=^VPZ
MK,I.62+0%#L_A4]3=ZW'^\ 3,IPH5.&LC4$48W'2B<FF'B(86QIWY,A8$9NY
M8FIIF0] O]LW@S[3UQ;(T:%NK&YYN[SS;([\-0CZ-*^Y Y:I&Y(MW=8II\C:
MMR[@?MWHWK9^$W#U][*:ZKL;1&!K4#D57MS5O1,.'>L&M3Y94DF""',=.9!=
M;7*\@7RZ'*OF-O$*[?Y@:1Y.%0%H/^!.W8(J:4/9]*52+AW4&A:X[!Y%3^;F
M]97KKA^E"K;DRA9>HYU]CVQ6\Q@@P8*#5U<KU9LMM3C;^E(OU5J5Y&=\V)=*
MJ7K02'XG(_I4X54R\H_@]41LH@XI$Z#MW74N&N4*58U0Z,\Q_ 60,'%J.1B5
M-"Z%4K$)>\BUI;]O>>!K>/*.+L U8=B>,K@2 OQO+$Y!B3(,..OR]QB>A&[N
MP"(?A<2-Z0"8T43,_Y$.2N(%X,E@-A%S@[0PG+S>&4SM*DFE.F%(!90</:?A
MJP)<%W2W,'!AH<,CTA4JDHK0"<?PL'$"L-#P3IBA5CB3OCN0L]529ZE#L.2_
MZE<I79U>+T;7931:%46.0*C#K95 C/1E;FOB3[89!TA14>J%H$[DPTFNXS%@
M=:8J*[*& MSYOD5!:U8<& 8"1\]7X0P*[$1)-21FN\C1DWN1CB1R/CN(1LT2
MNI%(?.G]IL?/6[QTD!>TXI+U;_%L9!8H.1Q%X^&(B5Q&O"SR<F&#=V'PB+EA
MA^8LP4\1^GXH7>''T^^=VY-V\K-^5?I;*JE"1$*_2UUF%H]JTDK=J^3<22YA
MNA/]"<*3R685N<HB-GCNEVKIH%K3\M#L"9V!EU7+07#DEBB+XFL<_* 4A R"
MJ82!NABVXNANLM-TYJ3DE+HP!9RA_]/7^4)!G+ WV?39)AC*9S2A*85NI-:4
MO9I.JF&BTH=M@]!% ^]NDML5VZQY S(NZUCW<$-&.,;A@4QZL8;U[<;/_&PQ
MP GR*-VSKV8B!S:<+L\QC\64!(:J?UMA8$92$U](;TPZ)?@7&=."[0T$586
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M)#G84S[7#+ZH[QP=U%X=MBJ\J0VDE(79B=4HI0&44JX5E))#2ED<05^-5 Z
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MVI5ANZF&G)8?>8J2^OM@3<4%=)07(']1Q2?'O^+/(;?[6N%O8I&O![=^SNZ
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MH89F;$)*2JCA'FOSKL)E>0%S_6$[L 'K"EM*6>./9R1"_NY+:_(<D.2E3Y'
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M X\QJ>19T_UJ:55)J]:K,KQD.1UK(9;"3>^Q8 M;"CCLE5DN$%O 7'_8#FS
MNEHX#K/&'\](A/S=E];D.2#)H'\!M61ZUG\E,<YF93AH%1!:+8%W3ZTOR7I%
MZ%FUIOW1>:LD=+Y&/9H8[MS4/W"/+!TMU:_4K_;YJ[VZNB?&VT$8W ,R(.!K
MIJ&/#!.'*V'I^-QV/8=YAL.0PX34_*^:Q3P^DNF7]H^]<T>Q6V"%]*N'R#:_
M,8M-#>_!!&BD\,-V91AOM!1P0[H$Y>A7ZT_?';1W R8SZ6;3;&@@W];CADOH
M?%3K%;4?E-KW*J>S$7NW3,2^5U?OH=3"*]U]U29^JR% "%-WV$3[](]5J/3
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MLT"DY#4$C0COO +M @GF&C0.R=6J6HA)"H:#UBA^"G^-#,ZX(\_Y$VDPX(L
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M1H4YKE#(8+/22R"_YC4J^@?7IIDS PV<QY1!H&']$,BQ#W^CGS4<[P10-U
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MIOT+P2&BI?@BWS_'G7,"-^]LH%YXH<M>>&X3MSMT:X$)T8 QG&1=9IK+0)+
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M&(;D'PE<?1/8\X38X_H]Y,!D<?T\RC5 X_F(L=L@<+@AMG)C;0"B)5"[/-W
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M:G[_3@K01-H_R4H*3S!J5UNQ"W_Z#?I["1,D#FZ%#(:LX!?F][(O/[TC0!0
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M%1%J&S%A)("IFA##4$#S<(\LTD(CC*P4'L8G4$8-P,MOCN=[W247D4@ECAU
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MV.2)QT61W@24E04*Z+^Q'^+$&$O5$M2OEP7(5-EFR:^)01X_-9#S\-1[D-*
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M:[FT7O$ J6X)HG(%ZX>'./3L7!K.U%:@";MX(U,^W.+ 0.EIFH3I\O2$X5N
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MC=8>4"LEUL=5P)82$ E!)$_GFCT04<4TXX8BI)^GS<@>A/3 R*P(0AIO1C[
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MKZ$B:KZ:C:",/2 /1Y"H.VTV@OH9?06'(TC4G=8.0?G4H),H0?W**$'""JO
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MS<!Z_H1/P%/G'OJ,M@^G"".PV)T-MU$HOQ(4D0Z\EBT=1+<O?,*$] (BKBR
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M<UV)957QG8B ?(_B9W_T[&9";C@0Q3'[#G3CE>B:/BNY#G5-E^%Y/NO&3Y6
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M@WDJFXVS#A*X>9>F]L&R88T$2(>$"IU<B5LRR:NVS+H7-5P*%=U+)\9@>40
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MSKDJ'L4]=SBT<M^_I*!K!$8BY'I9+OGDYHH^+/9?!;UF]=T40&\JT!/,A,Q
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M0'Q)/@LQ@JJT"V6/*IN9$V6\3M1*=&BM B>*HI737B=E0%AI391.OQ(-MJL
MX4PSD^(_V0T]^R%V1>ELRV(FOTSMGR>)(6M_43V%74'QN@\_@LIP%/JB'Y7N
M;K^B31UKZ;G)7^&%Q\^1!R -!SN)#J$_%YL*Y#4 ^FIJ$^W[E3:'U;[7EJ_:
MFX,B(YSJ8)A7.T3<W7_B+N?SH^URWYB97[3*K$5:V"AS_F8H\^%@JD[G@[D\
M[JG#L38:#8@^UV5EI(_F\O2/86M")WY)UAQ36%P<7/_+S]INB1'],S%11;Y2
MTYQ/N]*.#1M+Z*[TF^9Z-OPW:1;90-TWBZPB:3'^)FB*T#Q>E("9+_#S6+*
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MDN;*P<B@2ABY%!](_T*C, VT#A(TD-Z1\U@5VD189)$('\A1;I?>(7FL.5,
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M2CD$!Y 1J!7!N']:VC.\XIE: <QZRT_5E"+Z\J@*=OP@ U5?00U$6\"SP>*
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M"L_TO,P(3"&)-;,^(IQ.9[7?R[3];&?WFY\F!%R,NH1$:['3]==_YYQ[M4N
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M.W$EH88ID2S]1.D%A=E/S/>O^.Q'GTX3K,<'V0_MES[WYM>62?5$R(Y]"!&
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MP@T)T!3;N8TOK=36(]; 5RT!A14G[),-$"[+A\9F5]6OSK@<#?$7&Q3ER:5
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M>=?=?!(CG E_;&"G8M& U??0FY- *=51<6..2U^"5JH9M) WA SOA"S63=4
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MTYA%S:UCC5P&="OSO0=TGPT'P"T@&J,FC8'=O<!NP&KV@CDS\2.Q7AE7?4V
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M9D<N:<8E/*I==,#FS@=O5G91RQ^UYDC)S#+A>L#F(:I#=C!@\^K'_<^[Y]B
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MM3UJ$W&/_4V>9YIYSQNB)'#N5=,-%)G?+/L/[)Q2'(2=BV&OW6^T^AEM-@4
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M]]F1IIIN"T4=N#Y 9NQQF<EQ4,P@!Q[P)W/#'@MN2!#!D_CD:TU,)(>+B$J
M''0@$N &(8+R^>Q3@Q 9GC35Z /<2B)((Y;NS_T.!G7#0P&?@3'I$SP-,K,$
M;6I^A"JQ'6UNP<U_<2F&$LUT0)1IB-GO7([1>'@.9D$ "7Z.\,-CUDV/SB[&
M&@7[:2O-'N:^+"R'2.T3Z1U +F'*R]_BM>LB8:85WJ*-P,STW/Q;4C'" W%9
MJ=]/0"CR[RQHUK8 4KL<V4S[\U*;PFH_:<:;]NZ@!1R5+2!8$D!,[C]WE]/I
MSG:Y+._B=ZTR:Y& SH'S_(>N3'O=D3J:=J?RH*WV!EJ_WV7CZ5A6^N/^5![]
M3P^D(V5Y 5EB" &EQ.^_:<.LDTP@O,]9.H/N99LS;?@)%"\W^+JS(GRRJHE$
MRH44:BA\9KTY27Q#&LNJF?7=;GJY\"4NYP2Z2@ 3/[7A]9U.LUNPE4+>HQ2X
MH5LLWVSW<^)I4<L?=529:_3 >D[\1LEMW*>![:HHR'6NN47Y.6PT.$[ZBDK=
M-U#JZ#ORG4F@#W.HU6/0ZX2C+1*.=C6_]N;?'LCD6Q,T%H_L\7NP,NSGF68*
M#W'@O,IO'-H%C6V@EC71JHX^5PI3Z^ASH=21'3487)],$^DC))E0,*%<$N&<
M= I)%[L/@L;7SXOQ58J(SVIF7#V<>BWYV#N4?$R.K<X0CX.+8;^=%Q ]YCE=
M9X9[2QE_[T",?^G,ZO6X?P\G&_::ZM;,OR04/:OQT+S%>#T;NJK\G9_/,O[>
MR^FE5,^4KAS>'1=KCZ/>9JP=TVCD0;.T5E^U[EX W<34U[/3WH^(O0='M)3#
MJQ?#7CW[^0@P[[@8?&0J]&;<G3*!.LUN58S+L]+<KV>( -+$PP3?>-Y<D,?6
MD$SFULK]9MQ_JURZE<3'C^^KQYZMA_#LKH.CRQ0$G8NADLZ\JS7]RB%AF8+@
ML'BXF63 ,6-JN]DJJQ' R3>%*\DPJ70L+QF25[>Q2T2(1V1:)2>FGO?@Y$%E
MHO7KE-U$!1S6DC?4[M;!_!*1Y$"6TL'POW)L8_T4@#)!<Z0L8:E^,3C*[( >
MS2:4LV83'A=7./ER]DA%B345M618JB**244).]:18,$-%@K!M\MZL6Y3:]K;
M4>ER0;\YE5M&\+M@(2K0[%!-^_[\2M1SJ%^VV?;(L*+I074*C_NMBV&&^N.?
M-Q64;5[.323I5V124CFOV".4QCI'P 4J7<1N00>J<DY7!E:NRKDO8Y7SX&2J
MG!\\>SSC=;0G7.],>$_8R(LF0_Q_L"WX<<[KC%$F87N(C!)H]+,*4$G<]L+'
MW7[[A@0XMTR_KM,$6<>H7!$?/\<V+Q:6=3)G;%MODC8>@U;B-J5O^!H-:(P>
MYM\#[]>#:T?OG$*3BVE$ZTHE0%<L$^/UHVYLKSC-V#]2OCSDE+P6--Q#YD7
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MC>?FWY+51/P0_%KJ#Q(0BOP[L\/BC1=V.;*9]N>E-H75?M*,-^W=07,K*J5
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M-I4"J*!$IL(KZ8?V)_!V8&2>H=G NFWVJK,W1YKJIF:.=7BI;G+(X=7P6LT
M&D&N9S,'-@U;HSUI^&XG5N8%FS/TOX1.&-G>":@UXKBI+ T@#9\9B<%;$V3"
M1,==-J1OAO9JV1P\WRP+=6$']@*_T,EJ$NR<V8X^U>%FQ*XIF"4 X+%M 21-
M#0X:P(]WH[1V+[D,<4!(P[& -)_B,_7H&Z?T1EH26DGP#=[MO(,(FO-U@ 9@
M>%1QU\ #1($/BS#>F]&E\[J\"> 60!LV2F?H^-B*2(!8*5X_@9.QWQO\3[C1
M99R2P^L]AZB=7X&+&#%??["M"2 TK"7<E6.]\STSC3].%Y1 YL<EV&J\+&^.
MM8!\(PP^$Q@%L)TWQEQF,I34_B'X6](D,@'PL)+0HGM]L+L: "VZ:;^HUS-<
M7\VAC8W>I=MOWP)"&P,XK#FN!-;MX O>(]OT=XX[QD7R=T[ ?@BO"M<,3,X*
M%A[=OK/0?;ISF.98)AY0!!.H;''.-%<<B\/UJ@8RTU=F$D<"W#"(K7!]4$":
MJC8]0'@MOJ((^@8K E[H0\U',8(2 '0$%"/]R=YCBW(U':B3ZY< LA!4 G@<
M":8@PTW&)E@2.N&EP%CJV\A>0X#/P6+Y&F;,6 @&2@>)B^38#.N&AVES"T!F
MH0$"-\ JG898-X*28P9^RY\QM4%];H"A^\)(! C"XK?[&).$/^C+N,(0W02!
M^!B/JC=8/C,N,!Q3&_^)& +\>"*]P+6X(C"/  D:T@(V8>OX7IWJ9YDVCZP@
M@3_'SU[SA&B*W_(+&](U4"4&C,0MA"HWYE]@U@/(_@Y()GX >\!!? )CR08*
MN#)1DY#N/  N,2V$Z1\VEBP_V!:\$&N# W8]TI&YS4P PLO[Y<0&NC$C?!N6
M$\=!I#J2S_X9X]/?F&&@H.:4213IH(8HN#-Q4Y2ZO*H9B.#!?R:N@JP& $+X
M5HY>4]N:2\S?,&':6("D@:O"I>MC0:L!JTUB+!J3G$DO%H8^UH1R(DY#D)R3
MN@T^NL@N' ]N(^>*OX8HLP]X/"E_9@SD"U*(FLN.,:#X.(PU?8[L) 3UBV&-
M 'P3-L<'X_(X\('F!:$"S T&.&UH(\;%ZY39N&J2*Q:_:0JKF''"@NMG#/07
M3ILVETXCF[U1[7; (I_Q7$3M.)BSH!UPX<#7C==FBPE"KL2FL/J3E@'DR-UH
M\#1C*AGZE+,RQQ75Z("<,QT8"?$[ (0^Q_>Q-&\-WL!E:Z"E<761HTX@[KCD
MH64X.<MV0\F$BW6\%\UN2#,@8E =1P*?#=">+8==3K%-0%+*Y9&EN 2.7" T
M1S*0Z/8+QRTZ/X2HS]5U@^X2!!ON51C9A@;B'0]R J?RICDSHFIQHY.@O !"
M?$5C7)$@QHAHP;I^<T9JKG@;OXTO(@I@E&-)-I/:8>S!_AGBTE<\G%PO_.E3
MQJ+BA:.%( \#+0,3WO:JVY:)N([R"BP$>/((=7ZXB>0>D"&ZXUQ BR0;S#X6
M8"Q3#\A(O-@G:(#:R)J]3VPT%,*3.0'1Q*VXI!SZ('^4P%9$Q]N8&U]"_Q;'
M4%!OS+6*T?!Z 95R7;,8.YKX)G&POFO^$)VM:Q2K%T/WS4K;Q"/;TO"L_<=]
MDKZAWA>\"-45U,\FHLO%U)L+<L/3>C%]/>K:EX'9=TX#P(:J.N)>G$8_L.9+
M$X2,I2V<C\")+(#RS#)"FO"O"#D)7TK 3.B[CT)H:1X(R#%I">%*7 L8!BEB
MGZ4/2O3(8X8?RG2=]_8 W'#>3:!D$+\Q^R*F&)/6#+@\8K[R/.%R@>MWB#:<
M-0$MH_('1 4H\6^/H9G.(@ 235<X-#/@]IFN^*!^!)@[<UK4DI536P+^T*EG
MCKDJ'K<X1Y8+T!O[;'/"#+1IWT.#P"*U -05"4SFM%@:^\M(,UV?]2$- A/]
MH?W+BNTI0C!X/IQ?^L]S(I9I"@>YW C.$CTIWE0CQXHM4)*TMC0*93TT=C<=
M.*)@(R:QIMJ(?).$3^%S"?=\JQ5#;*1V<,OU^%EETLV5XIH:&+6.&RJS4:B.
M04_VL#G/.+!SP6">""<(5QC'S*.(+*A)8WTA,)*8:T**AMA+#7RBB!JB>>*9
M,32/K NV;5L&-@=#&]N:</?-Q/9>,"X#UCA+>"?P=<P$L]&/CDY (S:L!8IA
M?/T<;&*)3:<L<QE X%R5G%@.NDPXPT:[( G=$ A<W@BORP)0:FSKBT V8S#G
M$M9QR7L<V8DW"D).Z_09KPSHHNY=M+QW$0X!K7L756$M>^U=Q.,VF>$<M6 X
MYT"82X8@MZZ16X.X=(EG<L4D="4DO!=@M%X" W)BC),B#\1,T=$%O'(,G!24
M!^21+R >N?$?UV%.R*FU05B&H=,7M#V'VX)QNX\'52)QJ2!\% 2;1?!+NO+#
MT.&;;K[</G^]\@T4D,P3-B6]4P-%^;OE@")\:X[11/_"IBBAGK5?L(X1_V/"
M0*S T0="172\XU^(CG<-'KC"%HW!-_@7CV'Y]CO'I#&(EA??.!"M(/70I>RW
M@HQD/L#[/9N>(N)QZ*M*!5D+!(;'(&4]@]U/DR'BVS  ]N5=_)@5+&YG47H[
M'2P^2NQ]3.%9+#"H+^];MDP@[[VC6;^C%NUHUL5DQ>4=O]9N'@8_=)32.IH5
M>]+Q+6IYQ[:C:K.V-/TW._$UV)/<.=+^8*G4OR+MOJIU?N6UR?MZ__W[U2,U
MR/MQ^_W[[?W=6OWQBF0Q5QPMEM8(%=SQBGYZIP6U_&9Q-=3RH2:?<)/![$W?
M,3@TS6#K-*;<KEG5*D3:J,_">2VNU/+_064P,UO3$;ESVY3AGEJM6]86C[=:
M+5V@T5]>H/'(7AD8S=]L:XZ.-GSF/W5W=BTB/#>_A _IBG),V>19^U6X]$+I
M7 R[C58WW8_F:-N-U11SNA0SJ #%=)%B^LH)->BK*>9D*6:P8KK?7BBFAQ2C
M=$^L\\AQJ)5Y.<-GUD&P&-'(%2":/ECHC5:_K)8A%6CZ4:-8!,64"J 8EETW
M5+6L1OPUBE4+Q=3#HYC:(A3;7EFN8D/)JHM^RLD^LV:2Q2ADQ;CCO5"(3!0R
M2,^N/EISLD:Q"(JM:,BS%Q13",5:6ZN2-8I5$L6Z%4 Q%5%,Z=0F_@&P)9E_
M7IOV2XAE15.LC8@E@Q[:V$B]4Q&MMS:LRL6A7<3M,G"H SC4J_T_IXE#NXAD
M9>!0%SN*GICU76EAC$6[F-6B90QR6+7/I?U:S[?E<<G0.1TN4H$PA=K#4:Z-
M=J^L<'A)IUS12'I-X36%%Z'P"N2[J#BL66FT,T:6U11>VNYJ\EX3-*=#VW(%
M4G/4 8GO;J=[6.+>Q;"!$ZBO[*G-?G=YJ5]=RICO9Q@<>7&@5-<%UG6!=5W@
M_\_>NS<GCB3MHU]%P>[^?CT1-H,N(.&>0X3;W3WK$QZ[3]NS;[Q_;0@HC+9E
MB9&$W=Y/?S)+ @2(BU!)%"(W-GJZ;23J\F157I\45Q=X#A5N,W(+9!Z/J,R-
M*LFHDJSN6?[PANVFQ#4_"W);!T:+F_Y6G9*32 KJ*P4[_.&'2H$*4F!>M#J%
MNZ)3<@O5KU0B"#N*"PX5! T$H771Z11V%E%.@I2PV5$P<"AL= Z;;O'.XW*E
M(9S&^4E% +M0OZ,(X%#4&XV><:&9LF3$4M*U6-3LR.L_%#5M1(U>/&.+5$W*
MHRX5_SN*#@[%?Z?1TR]4RIRN*6IV9-\?BAH34:-IIB2HH3S7 DD"N9* :NJA
M$[A ]3D]U)+<>Q8<'F">FE85*3"Y-D]2%SF)+XGO >);DE.R"^+;OFAKHKSS
MQQ7?[7ELJ;8(.F]Y< I);-0DX*0SZ^1()J,F =0D@)(!*1F0F@14OFKGUR1@
M9W^P*TJKE']P9Q7FI9S/,\MVV]@] 'N;)P?8[/R:'U_QZ95E1K=;C9ZIRY+A
M1GF>A/S\70#V07Y.[U(;<S\O5%-4>20)!@E&]63_90B&%@N&+#?&626J4$ZT
M.$[_ ]4EO=%K6X4CAI2E(B54-D2J#H2*T>AU=%ERGPDJ8J&R(67^0*A@,S9-
MEMRWL_*?4)K\@5SY!R*]T^@9'2(DKR=4-N3&'P@5$Z"BU:@"F:"RF[O^0*A8
M>*K( I6S,DFI=J(X!_V!H$<*MZXL%,]D7XB%BM @3P>[<15/E"2H2 F5 E&1
M#*A@X*-3,U-4ZAOTR8]LMX@%6H!;]K2A7\"SFS/JT>%1CZXEF JY!#[4BNV4
ML\5>=:'H#F^Q9;0+G\F$O9I@;Q.!=!G@,SCXBONF2P=?O?)3LT'RF4T"V"N>
M&Y]$@:]??!C??_F/SLSV_B"P9<I#-&9!>GFOO6%Z:?,+3IOG21CK1M=:T0+9
M6R>%I!VM.<0CJ1-GW*Q[>@A)IXVD78T@Q$/)Y%#*:/I0.93.P;*_Q:H>%D;*
MEY\3YH7LS,+,(N_GV5(F*YD);N1SR+#0]X<VA0IE1,:.^W8?9"!5@%[DT"-D
MR(B,7??G'M P,3)B%5&MY H:2WT?<GU&^9!LQR_*K3?P7]B%XK'#,K#.14U<
M17D(XX>_9:J+][[GSWP^\?IN0[^*Z#^^,DAV106NZ0(PT>#^E(5CC[!2A2NY
M %AXA80D8#D'*_,[:#C!=!!- ^0IL+VA$M^S-V,[>(:O^6!OIDDA)7)W+^W4
MZB9+F@E[K/8H<I62B2$C.G;V8=X3'1@-*!(*('3(B([=G7SWA =61:P719 1
M6H93]F5B.P&G^?%'RN^^/WQS7%?YT#_LECQ=-5'D+3E;QL7BWOEA?DY/T\1L
M@TY&T0>9I*>-GQWWJ"C\6(@?K5TD"$#X.4$S=1_\C)R?;'CY7Q;XF=#I(IVH
MI:G:1[)=CW09W_G>\^6=\\J&2DP*K7P8G)OM*C)F.E_<AQ$N+5_9>&'_R=SA
M5S_X$UTX^\N(U1(F(V3/G. MO2>@,H"#124:A>9/ "]"XZ_"#R!-M@/H'"SF
MZ\%?4R=T<)4OE,^PAV'D1-. <5\SQMB?8[9NY3MSL2N0<N.'>'</R:(^K'CI
MTS2$=X?AC?_2=SR^MJEE#Z^]86K5^6)G"@NV7\UH0TFFT&D#9TOED2#@8,U'
MJX@[DH C(W"VE0T)0DX;D&-(X'TY!]OY,8+=8,_. .Y@N)QA9V"_9G<O.S>[
M6=3=.U_5U*)NQCMV+94@;D-F354W;#YXF(T>I02< #J$%=]N1D<.(]<B(_<8
M653/4[!>_>!]=H6.R'P]W/=\QYYM]RO+3G>PNHT>Q>A. 1("G<<I1.Q_%G;%
M11P(,Q)B9I<'^3#0J+*!YAS,T7O.1_$)C-%7YO%[]#%BD\L_)[/[]/G<3-)<
MAV<^W\Q\D7&-_YSDUC&[T@52R$@1"2>CM84_L@P\Z82G4\-3/G6_LX7;>V]
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MQE;D%L+?O>93G9FPWX2^8PND$!8YA(E@+O$D (TW@.]1@H1R(O*5D,&0;6_
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M847V3V4RA0F$.+ ;4 )MQ]LHDO&00 Q?'1Q4_WVV'>E%X O87+^>3NW8NN8
MX5((EP.N]6><7_*S/UCPC'(%1X1R_W_LE\G'3RLB&X9P[@_Y]8]@ZCLN@H=+
MUGXG6;+H_T8Y7CO/.DLJ3RM]HGV:PFC!_H"1]),F'9_A11X;IDZL>WY,/HSX
MZ74=CW5^>K46AU>WE7EX*7;2\!'V?AB_?.7<1F$(V,!_]F#-AP!2FZ\ 2HT3
M-Q&QGT$E?>:8X1C%I?U[KJSJSHX2BJVW__J:A'>+0=Y,@P ^!(_>@^X8_R.W
M+==58?&T=5>O G!UX2\UD)+TY<Z![L/!:J?NIQDZ<.NXAW5V-2UN]G#M/.1W
M7.I2_)-?8M$83CM\]$)AHU&L4RO_KPT:%)AR_-[0]&4AA,T:C&&R1;2%E#F!
MTI7 YB8U'<3.0HUX&/V!WPH32W_F=G23NI$6G_[$7/_MSG_[;GO/+%-]Z&)/
MI]8&_2&^T@*XJ<J?XFQ:WQ9*P=)'%BO@I>>Z969ZM@F('852BL?_^9NEJ>;'
M)00!)KX%#IRE/"O&";.V/;<=N<F*/,ZV&UNV?>?R*-,)+DWY"R >%,@>G3WK
M)9WN #]!I?L;O3'F_1-.2CY5N$>V[S88Y>:ZRV_/S1X%_HN"IZGD&PY+D#U[
M,WO/I4<P[F_VC*Q&;YUV\1]-96Y<QN84ZM-PG\.5Q^!VY]HYZNQ<U5]HW=/D
M^F,KMAT^G6C__#&)[[GOS,:;^!I BO\"K2][W<!6;F<=>OQ(1VDXZ& 3?]LE
M$]F$CJS)=5NMC?<=W]M,.5^\LP;:XJTW-QQP%U?,7KC%!XD%.F:V"Y;5@#<1
M]-!\&#&P&\)I8'L#ML$>A3?&>N<[:I7+.F3<NS!ETO(S\_;K5S3' 5E<&47_
M!:J8\Q>. W_Z/$Y]<2QWW.J;P(N<Z4NX<$3,1S6QG6%32:O&0Q^&@'Z3A?\B
M^9:EJ8)"LS+3^;C0<(R'/TS-"CTY29X":M'.T+$Q52%Q$F0O$RSO"UA"ZPD.
MW*"?^R\N$W4>/4HXZPN^$0A4]$XDH WY>Y\#&];!B6>(9FT JGP-X)K>01\L
M#F[:+#O;X/1@ :Y16OIC5]('%&*M]?'SS3?^-_7C+WP79QC_P=Y3.SGSX\U^
MH@QAJP<1F%-P:<SNAGT^#AL [W7A'R@00QP?&N+,F?!-"VT7S*4+= #!ZJ(%
M-;&Y RQ^YR??#H;<+3=[W^PH&C%NNJ/8+@ZJR_AK.:I>61C%+TJ\C4ONNOCW
ML=<HK:O#0J3ZC;X"?'E=X9H8Q.%6& ',XLU+79]#%@)T9IU+N86.WX<.,ICL
M*QP%82*V'+*(4AM]G[& #NQP#,*"]CW>L:^V.^4^GI7O=U)BCJ/'B _W=,5/
MS%U%<8D0/W]P +"FK[;CVLF]SLW>]#'?5*ZC3 =H$KW+_)4V,W92$:A/L*LX
MSL<Q0_=EP$8< &FO"WJ;EQQ/N7PM1GM'"7L!7\OA'I9N2P5]89UZ;>9@X8N8
M<YX[TN:/-$\-YKE.(SN;YW*4\6*U9@1.()0S/N E3/ ^O8>#0MVP5JA670_Q
M,.?GP9-_/?<6?H.K\=:[L2=8A#<[/)<UI[Q+@QR/Z[':PR&@;LC7KG968/YK
MZP;AI@V'T]R=)I=[,@S\*_LY8&&8&)')X;:"C0FV&X_;.,^@PH_6-S1*^HSK
M,HH_C?!UH"XIX1@.W3KX]_'T3V+Y^]T!BSLH?7_QR\CQXF5-]-K90B+T)G!
M7*;TSHV:+/>!Q_LB1 CGN0\PN\?9Y/Z%<WL8W<$@;F=CR(]-=-&LI\")E[@2
MIX"MD3:+%X8IMUS+\26\+(&SEN<8\P@228P/W"2DF$0]MES;S;4,@=V)#G$(
MFU])7W[B<<,V=:_OMLSUO +X8?[N]=**\R05P<7]F$6D_#Z,V(Y]9<DYMQ:T
M6G.LO# ;4T*&65C@T6 ;=%P,)&<D]1 +S586&IU8:.082Z4L-'$.4V9JD[Z9
MG"8^H;:0TQR#BL9JZWFI:/1.4[?R4;)L>I75-%M=8:0O&HV)QB3CF-3MQ$8G
M13QSEAQ"W //G2![,)YLK4TYV26XGU4<K"_#2>&7B).(..GHJT;$2<6)DPXX
M?.NZ,"2$)(3$7E;*C-$Y[GL\%NR/>+!T B_RA\Y@J<1A'R@5(K[8A;&#.A_2
MX&AP)S^X2JE=4KZ[Y/E+_/!5YTCUX/R,>DRJQ09)+M0B%,?LP%OT>Q(ZM@[6
M\>XVH-;C +BMEWHSPT&)>2F);:7^LN*./8 CH&Z$5UE3K!%E17M'Z'0](R7!
M_0W ?CELRNL5+__+ C\S8FJAH\K25.VC),P4 LA/2##J*Q@[R-YV"$:& '0;
MO1KUD27HUQ?Z.\C8<D-?;1'T"?HG ?T=)''YH8\EW(1]POX)8'\'>UU^[&N-
MGEXC-DW"?GVQ;XK&OM[H&;*<^Y7&"Z1TUMUB4(>%45)[Z&'5X7_BPK/U)-\3
M]-QI&SQW>[&S9NQV'=E9\[NZ9JC9*.3913:',;%+T/6 T))"BR4<+6VP@@DM
M]41+;I?)3K0@HXNH+@^$%KG0DMO+L!,M)IA:HAIS$UKD0LL.EL(#T&)EECP3
M6NJ EMR6[$ZT8.!JG5/I.&BAO!,LT^6&:\"B:> I,SK,N&[UW&S7T^TL\J%D
MXW6&D^\<)@^<E.R:8R1+R#5L\+>N;JZ55IR FY9P4RB-(2=NLN-;A)M3QTUN
M@S8G;C@K\;K%0L Y=>#DMFUS @<#*^NV"^'FU'&3V\K-B1L#<+/.]$:X.77<
MY+9W<^*FW>BUU[WVE>.&8KC8;-=^0;JY_]HSRCE.3QK UI^;W7LNWJPM7(KK
MDGV=0L>U-_P\ P<@)U.T.V"[2.+7(B]H)=G[8G!C9I'S$V[J@)L-9J\8W%AP
MWA1N_4S D5,/7;-[D58<_B860IE%1/LKHP0>*4^=#;:O$,CH6'Q#B23U!,X&
MXU<,<%0 CBS7%<5]'UD4N6S1:6,PQ38@[DO,I'I>UN_I.K=*#OI^GW=,!:'^
MW7:\.S\,/T_9DY^"#\C^30H\:IXR?EVK81D_8:Y(P+A\S.F$N7IC+G>PN7S,
M&82Y4\-<V8'J T&7 :YVE@.10I'2(:KD"';YIUB'3K%3PUS9X6]QIYB9F1=^
MJI'Q&!U:4VO+P8RZ.0B^QH7ZP?$&_@O[93LIZA[^LHT<D&<@2&NV]HK_?K-$
MP9Y\2[8D^>FF4@K=RFI4GMM]O]\VG8!_ME9X*]G,SH&R;J.WWNOS,+\M04U&
MJ!7-Y2[A:#-:C5Z1-#G"F\1X*]FPSH$R50"3($&M-E#+;7+G@)J&G1<(:X2U
M0RWM'%C3LRY/V: F* ;/O]>,>ZU*:V<GN\E!$#C]:31K3.WSGLRIAMR3K0WJ
MZNFC$IW#?9-:Y6MOR/M>?Y\O,>]]ERDV!A@ZA8]H\FQ*B9K=&=R'HJ8-J"EL
M'Q-JI$3-[OSM0U'3$<&P1*B1$C4;+%8!J#%!L9.%!I904W76]J&H$5(H0JB1
M$C6[4[8/14U7(KWFK(*R3WYDNPK[.6%>R(39ZWLY54Z84C[W_.MT"NS([/X&
M2$I)_S<_C!8NA\29]"7&6]91T&[!!2**#C1/)]UCN"])P$C <L?7BPJ8*I!O
MEP1,*IR1@(G(V2\J8%HF'R4)& G8N0C8CC2*H@*&(4=1[#<D8%+AC 1,1/)(
M40%#PD%1Y?,D8%+AC 1,1,9,40'#.*XH'JY2!:Q2\HIR86%FPN)F;'O/\#IG
MJ1<!SY=9;Z\7*L&\! F?>+BYW9@^L\<BI79.A[T9^M.^R]:V+C,<432<0:.C
MT=5C="+#-;*G]G$>V4$TM0/'=A77#T/EP[/M>(58U&JJM]16-3F\VN_Z!=8I
M"A=EM+<>5U]N_)=)P,:HT[RR6UZ0B96UJ2+;3VSD!^S)_IFIS2 9;8UZ<I'P
MU%=X<M<N"I&9_6D/P/ 017L@CT =^WD2Z/H*]"[NVNIO0ZO1,V7I.4C"<V;"
M4W;GFK*$!LFAC?4,P).FAS[D^7,J5%N *&74?D"K]A<%K=HSJTP3VU5SFU3N
MX[WFN;H@OG]Z2>,:-IQ)\G7@A+"VGZ<!_!F7B6X5[DZK&/,[98/+B< =MI1,
M"%1KQUIX[.?K*0'EV!XR28+6Z%%YSJG 4:PV+Q,,=5 ):M;2\I#G=ZC[0R><
MN/8[KA';_'7T*7D^=4[1R)3]-@&)#Q1XSZLS8,H@8$.G$)OG"9[5E5AOV4P]
MN/B/\=HC3<\-7_[M1_+^$8F..#IY"7TTA,6#[;AC8+%=9RP>^WF2A9V5"Z7+
M0@;F.^)X(V5".Z'M8(.M3+29]40;Q6*VX_9F&@3,&[PK40!O<>,N]?;P/],P
M0@_ F85B*M'EOX(4PDQG*_^$"Q]_W[4W?%ILP_5\%^:2^PW=+_";*"9;L?LN
M>_*_V?">*)<Z95&/E7I#\T#57@)H=NL,S6,_3Z)1/'A3EHRLRX+9HIC-Z:"P
MFIA-A>A3,[/[*51SDK1PW;TZ8\]XX5(51NN5C\J'/H>4$MD_%9@I&T3AH4U3
MXFW.JO>B\FMA"R3WN2E?]EO&V9EY0&KB&>L$;+>DZ>(D\"3P8K(-RTRVVE?T
M]6)YA741^F,_3X<.'3H210-+.6H,.&H$<S*=[H%# D\"7XT[1@8MH]WHJ5:1
M"IJZB'WQ<.ZOW-\%_QTZK[W?^!]B_2N[0*DA*)=/[8K%@H_@W]G_6[E.9HLT
M&]V+'3P[WHR:9[;$EW@<7JG6\AF)T'9&[_&/'&\(*+^ZQ \)=VGM->$/ZB^E
MK/<^W[Z\4&:SK>$JP('A3H=8_!@J-D#[9>)[V)7/'RD/$Q;8$3PQ*X><!#X<
M&LU:;HQV2AO#6R@F[3*4#PX_\W^Y4#RVNCEX6./EXGA3[HB?:9[WTQ<8Z&#E
MXE'3O50>!V,VG+KL89146R.3X"!BPR?_$TM77J>Z=&+&SQ-WY?,_X,V?7'_P
M(W6)P(7"X&Z9P)=$P90UMN '?L>/R?D9&U\+L"6N/0G9U>PO'V?9[X['5Y8_
M]#%Y5W++H+MYU:V-P(M__?'-&4;CJVZW:;5U5,\3!WORQ?%OU2;@Y-?UG[>[
M34W3,G_5:JJ9/]_T*E5M=G0SUZLV_[RMUWQ01O:O9J_:$2G)20U9CO9H[:4\
M9EM7\SFI[7TF-8"S@P5'4HJS22^755(ET4F76\&>U"[R%UXY$7S98.>^QF,%
M-=\/^-%\!<HC"_!3<!M]?KB[N_[^J-S>*W_<WMW=/MP_KNG966IH#LU9<G!H
M+4T7->-=RGNM5DVC53M@U=0\I\Z^4789$FTW\ W/U,D0]4G0&Y5)HL+-^88'
M<#H?1"N<AQ#Z6.[[&@WNG/+#'V>EG8!-3..<@354F!UX;%@D&ZAN+M:L*<KM
M),WE(^VT\I*&I:I2\N0 F^*X,.7)02/!J*]@J(4$(T, + '%6 1]@G[YT-^1
MCY<?^EUYH'].G!ZW:"*R,#9"%-CV2>#_ASN?,]JA$,.'2"UIMO2;1,)J-7J%
M>Z1+6)I+8#E <]@)%K6>==P$E@/NVIU@T1H]6?IWG)-3A;?SB:GTDH)[;PA;
M.V)! 'M[9C7W^1*UUJ_7E40M#*1GTI?/5_O:&WZ>K37L1*9@Z(W>>F7'29>^
M$7BRKMM2P&,T>FT"3^W LZO_EACPM#$X=GSTU*/J=4\@Q$6OV>R50D)'=?1L
MU:Q-L& U9+-2GDK>2WZZ43WO9!G^AV9_2YO<31)&$G: KB9$PDR2,)*P<Y6P
MPQO*YI PJR#A/S6[IV;W)=+]U&ITYQ2PI);HM>QC69455E(_2ZM;JU@MR<XI
MR4Y1 ^M(,M/%-I%%HBWRR$NAY\\I IK9 A8O\3,+?@I-+3I:G[?]4[N[:@U3
MNVN.4;'7BD3-"+M:[?H34R_"'9\Z)Q.9^O15F,6;0SG>V+1G^VFE9Z65G*QI
M26BKR!0[$&U&5@;<Z:/MV(;9B>3"""9]7W9G$SMC!0M4I^.Q"KMW3T[&;CN+
M^?DPT_4T:!D+%':2O).\EYK[4ZGD8S]6 >Z"DY?ZXLZ&93+67Y<($I?H"=-4
ME0E39>4$A>V.FIN@L-,T.H)H][1FN]T1Q@5HU'Q0UCX$A;-?)B=40GRYE>UN
M!_Y/ZF/D[Y-I@#39(I-=ODGV8MJ=Z0XIMMTPG+Y,>.K;GR$;;F+2[9K;F'1W
M$"V7P;.\)^7WTY@I\0?8\-*&*\]^9JFHJ[V8O3*%Z2N1#\I7Q((7>-.<\MB.
ME,]LP%[Z+(B-'5U%'CMF#\;*.[,#Q0[8U9XTU<>XQ0VUG?<6U]6FT=K.>+OO
MJ^#[K>U74Y[[LEWC,75RONE<UTG&,77T0]0O5<O2OP+_;34\L%7?.5E*YC^;
MCTV%VZ%[)%G7<PGN?>]RPS+D@<SR;5(3EEQB9#YDU8B1^9!54XN>0'5=&!)"
M$L+C"&&-:-&S P.?G7" J0Q*8$>L2$92L5"2?!&3C0$3;XI&^([.V,8>*23+
M7H\;VQU,7=Y\*KNZ<[93WV&CYO&12RWE'[$:O7;36"_V+-2KLH0PR'$V]!]%
MJ/V+9E"=O73H1Y>.+ASO34MPOWB2#I(. =)A'%<Z-%@.E(ZV*.92D@Z2#G'2
MT3ZZ=*B-GM[L%LX[(^D@Z1 N'=VC2P>6<34-467W)!TD'>*DPSRZ=.B-7JMI
MB:H<JK=TU(@(*GNZLX[22L"B:>#Q1A\+0B@JOC^NBVVV.W>^]_S$@I?O?),>
M\#VP.]GBC75:S=8Z8_ 1JNEED&"1^<V$^DI<9X>@OHT&D46H)]2?JDOL$-1W
M"/6$^I-V=1V">K/1,YK=PF%%0CVA_D@NK$-0;^%9WR;4$^I/U35U".J[>-9K
M4C2 E0'UM4__0K<EUA$-_!>L,XJ[X3G>(&!V6"@=[!P$N&QW%&[.P^@FM36W
MR<YD"J^*?6J;IA0<53((;\6AEG- ?-FNJ+R(YW%YC1!/B#]5-U1>Q&N$>$+\
M2;N@\B)>1\2WI.BI3HBO)>++=C_E1;R!N;BFJ#H.0CPAOFK74U[$MWGVN11\
MMS(@?@^2-OPW[JKC3?GZ+M&])*\VM)@@?>*'#G[F*F"X::\LH65)P)-Z,"%U
M:2T>L?NA[TZCS8^L%70>B65'Z1K+]#?I/\=S!H.)_<PN^P#%'Y?V"$9[9;MO
M]GN(YT2:+\?Q+E<6<77^&V<Y&I4VRQC#(+E^P#?]"K#/ OP4C,F69BS*.,"#
MYF^.-C([?;T_ZHS4KJ&;7=NR.FPP&JB:-;!&:O_?9J/'V9[0!7F#9Y2'27!V
M+VLG5P _*^RR+.M2CT\X^!4;7D?S'QN-@RFIDH:-M][U8#!]P;..#9'!DKU,
M7/\]Q6#YL&C;F,U;!:=;9QMO58J:J;-\STA&8Y7J81F-F3)9XO/,:&/)NUNF
MDALOX+^*/9FX<.;"0ET@8Q427=F.&[-<XUM'ONOZ;W!X*_STDYG1RFR9N1FM
MVLUN-Q]OXZ976: @YN-MW,9 I-=X3):9CT/L7,<DX]Z9FKD/H]4NLI2C<E=;
M>RF V9KN?$[=$Z66$L>N=:HKL(5<ZXQ689G]6TF4ITRNL=,09O["*R>"+QOL
M%.]M>ON'SP]W=]??'Y7;>^6/V[N[VX?[QS5.\RS_1ZU8=XCAZ9!5VX?AZ2P7
MAN!$<"(X206GVJ?2?<KP@*!?Y-GQ/'1H^"-.U%U:P6_=6O3DGK_<'OY\#7CT
MO T)U]R1ZRUTM)9J-GKMXK6JI9>B;SX@\P3]2+)(LM8ERRA'LJQ&K].1GWJ1
M)(LDJRS):I<C6=U&KZO3G462=;Z2U1$@62,_>+&C_Z?A_(RNO.G+Y=#G'DE\
M:9;8::U&3[UH"\N[),&3"G\D>'L)GEG*E::I:(:18)%@G:U@6>4(EH96V"D(
M5NV)[AY9\.H,&$PNC%#WF"6(A0JS ]A:HKK;+!W+A<7[2$>RVIAZO:SIC9R?
M;'CY7Q;XF?*B8^*)I:G:1QDJ_G-<.$0SL1^2<ON1EY"4@1@#S +"2BVQDMM_
MLPLK6-5!8*DG6+JBP8+<>@:!I8Y@Z;2JTF=,TF?JC215]+%CR://U#Y#YA:S
ME!C8@]PH1.KSP/]/3(>^7CY$Y%,B#<39TF^4 ^R.)@6KB!BO(Z&EB!&X"RTZ
M!H<(+?5$2VXS<"=:D*5+BMI^0LOQ[<"=:,%N4B:AI8YHZ8A'"[)#$5CJ"!8S
MM]=@)UB06$D2L-0^ '@]B*9VX-BN\N'9=KQ?%-</0X7"?GFLNA F '_;@Y]I
MMMB_PU+?P4)GPA^;]A3N84J.L8JP\Z%D(V\_S'1 &].[:Z!9JU FO!P;+P6M
M/,%GC=GHF86U>,*.G&=-;C5^/\Q8C9[16;^@Z*R1#B\%PW^"SYJN !N0H"/E
M49,_X+<79 QT8*^[)"L_:798@3.V.A@CVXPN^I0\GZI]#/=ZB+242.(4\K1>
M]A,I?MFOD?V3RZZ-XHALCF$J 9ABN?ECN<YHE'6Z+9;_JQ]\B1?_(7BR?][,
M%O_VT.P90Q66/4,>52FAML%'< 2H:02U4X-:3AMQ0QA9%-8R,*5G>??W5^D(
M2'(":8.SH40@98:)"$C2 4E($O(1+K\V77[UAMH&I\41H-:1#6JUCWOCEBH3
M&T?CP-='(5]_\R,'2>#TI[Q7!,7!168WKQ6'WZ37^M,[?N;;8DMR21"5E-0<
M;<6I%@6BS2*TU1MMQ4G2=J$M U7=1H]**^N)I]RA> %X:K<(3S7%4_Y2W1)O
MP[:X@ 2A34JTY8[NEXDV<3&):K(#3C^8/&L#!/:R<Q@CU.EZE')ZP8O;Q+/%
M_@9KG8E_+*4IDNE+SD@YH5/<P-T)'2.SLH"@<^K0*6ZM[H0.%J6L9V\2=$X=
M.L4-TYW00<HH"M36#CH";-"=T#&S4L8).:>.G.+VY$[D6%(DA]0^C'HS#; S
M/ ^+_QJR*')YY]AS"YR*L1*S$P_22WSM#1\7B[P7V3;<\!G4:52L)1V&2LP1
MS@6A_5UQH %(YHHCE!TS/;C@205J0181,1U5IPZB7*G!14&D$8A. T0EI@67
M==]1'X::HRQ71G!9*#-D0QF5/]?L4[6/6#\%\+";='=?).Z?6>RZY-#U5S^
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MEOFK5E/-_/FF5ZEJLZ.;N5ZU^>=MG095_:",[5^^P]&Z]>SKKGTL0]D9P*'
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MTY?+H<_)XO'%6:>DU6KT.NOY7PH V<5!V]XP[TS*8._;9R9JHZ?IZRD"\ZG
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M9J>O]T>=D=HU=+-K6U:'#48#5;,&UDCM_]L$4YI?J7!-WJ#8<U9YNY>UDRN
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M,RQANW8C%GAVY+PRY>E] E_ECT#=>V5AA'F-5,M6I^?/R8ZY]<)I8'L#IMS
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M+(2.-C@.7]'66A5MD=5MK.ESB>Q]98_PGYN0MX, 7UB,EUJ(B4VR&LE2S .
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MN#&0(8>&*[P+__Y[_;&NC9PI1C'.__-//<-H?/[[XU?Z3?_\(6;2NN8;VHU
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M>W+I&8<GP42]U-52^/D%@?A+Y?_B!'Z:Y:$T<GDA#\G6_CH'K68$"HDK'-1
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M.^PQB&DR%T*XBFA%#5;&$/&X=<++?CFG\>GPZ<D&%&NF!J;D'!MUC,FMLH.
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M;O W*UV041<L'O90NN#0 ]RRBVH/?]7[U$55>!VQL,5/YELN5P4_IF;6H\_
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M-[]$&[FVZ7N;+\D]A3^AE@W/^)5Y7?P^LL<S\M_4>S8O_Q]02P,$%     @
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M,H_14,/"WJP871&6!"0NW[8<P((1N&[ACCB1]\,_5HR\AHG(%@K\S4.//\,
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MDBZ7+EO3V2281\$,]B1*!AXW1 71_(Z&@0?*H &V=X&N1?E'5!>"V MI#(/
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M( S0<G^>,I1P8:MN:>2)#P:8:P=/B\,/VS@4:!,#.#""4QKB>R<;A".X&.:
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MFN;RET%=;FREH0TW5F>VDQE12A*MYA%]#R.].*>K-HY(JXI(=2=<MNNSV[0
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M'XG\H _X%N;XHA1,M?6$AR2+97EQZ2]L85XYPPQ]9\E%\B!;.QS'7>&A_'@
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MB.PR"\%'F8/00G9UG[@-?=]"$GSG^&K%O^9I-6O"GDTN(EG\BVPPLH^L3^2
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M+C#7H2@/C*:+T10,AM1/<00<&1WS6@>&K@CEL@I"M#['QUUAJWR!@<W5\83
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MQ"L795"R=>OPEO3WSI]OC+N3\;KE3=[TJL:Q5B&(-3'2@M&0)?.D:9E6Y']
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M$K,5,+[%P&9;-C1.Q/MZ;%:M&UY2N3F/B5P0ISAJIE3)3,LD6,@F,T]&BQ3
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M2U:'HILGZVU-7)_N)4^/I9W9=50TU3O5 =%FLR!'OG!!)*94ZC2X>@\O//@
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MR#PRRT\&U0V"-TZ915-<(%IY2'7J4B2S)MG 3)9)$.6TLM976TT([WFV=9\
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MDR7%BU=S(#/7S 9-F,5%0!JI2="+:X^0HJ8JF^I[;GV/Z;@U_:@44;-KRGJ
MOP_'S61=#Q7?T;51WZ#9/T&"L^7>T$#I!")11">C*1FP^&JJ$G]1YB(S!J!Z
MWGE+:,<MP#[XJ=FY96,FS_7,G4_WI>U$+AV:1A*?2V_>D SQU*!O$IW5D6OM
MXUVE,CLG:>T&][CU=B@>:W:;:?.NO"KMW,M8RMNR+?GQ[TN+#CB7P**,1&6I
MB-21E2K0Z)98ZJ@0+(<[JSS6GNQVP7[<ZGP0AFLVTMF>&PXA".O0!U"VY'F5
M)ER>\T3 <:JYXCG?V8*EAWS\!TLP5U%# ".(7=R\DE:2D'W&!2UX%GC@FO=R
M,ETYP;S*M;\E1P.&\3B/IA2XSCBU1@G$22H(I2 H^)1\]<RYK6">_-V=.F;>
M>D&C5LFQ5Q"6-7*FUQ_9JJ;8E7_<K6C8-A25JH*5CW\[QIE[?IU?HP%=VHQO
MOEMT(M3H2P2O",X#5ECE8V"U][>W0.F<M'7M8R]]]E7Y(^E,EL*22)TH49_
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M:N2-,XV-1V-UT!R]GAZ(N W:ZY:5/1DVD\\P^3:,L(@%R_6#LHN [\>D^;8
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M<=7PU@:"SW?9<YZ%;95'=P]SUQYZV&AS;[,W-6Q6>77\W?]Y!4A0C($TBE!
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M=$'C+KJHQ4/E&/4+Q--Q,VI.AM&/_GW<?/][\WT-*P?'= 1)T/-C1.ID,4(
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M1LGJ%XH/,K ?\N]1"!ODWOEN<\U1OH+E!NX7_^?J96;2"X&Q-3&^5'OP*F'
M;8'8:#!:P1_EZFF0O0[HA[Q[('Z#K/LX!>K@NEV_IK%8K;Z<^O'?FB9]'XY&
M QNDS8QSXE2Y!%UR3ITUC$238XY4TJ#\(Y;YO0/\(?L#"&-#1G*UNS4U1KL8
MW?MF'*^Z<@.6, @/U!'/2IW:S%0Y[75$1)<Y59K[])AG^(V#^B'WG@2P0>+5
MSN\J1BE7?Q!C.4:8?O3GBURJ1(,52B82 G/+E%T+AA)JI919EIIV!TB0ZV^
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M;QQW4-P(-U&_32\7E^'\W?S-M,SQWY<$K(83E^\AF3$^>8/@5&W*+7V$P+"
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M_;NY_5 >(/S[ZAL@N89;[WTXPF(2F /(Y)=9V!E<E!Y<2D(D*U"F3@-A#JW
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MMM=.]9'N"!'9'_;JS]_J,;>BME'>6Q0&.-&X!HH3!$G89+535,SD\+8ND-\
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M\P/N@6)&^>!+!,%KZ51(#GQR ;04+G!;M&[>FGLMD-.BP'!9[RG6L;8_[=
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M)-E^_4K_^%ZT8UCB+FH$%RO9<#2TCU6&&X4F*)6E"Z[U:]T#HCSOA[L6_AF
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M.H>F3>"O+[?5B3YF9B(=-5R1L95@$$Q((&RB8R<@)T<,V<[TL&C/&L]C</<
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MBGZ<K\+%ZS!=;+@3O:*SQ#+:6F,]J!*39/YD:_V32TZH(ILWBA]'TY?%,3Y
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M'"'@![Z-&R^ QE37VEW;#??3Q".7I)&G+:<2^+M0*89I7U"5 (U,P 4[G0K
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M=>R^<QY< ))+K.6::.= 8Z]28D-&T<5'H5!;R5M;X8@%($,XLY\ 9(A?GJ<
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MMJ4U1<#V7QL_+&GDFEE7NW:(3-Z&Q><WTUS_Y]V_+B9?PWF555UALPE+%<U
M2'7S-*)&8\A V)*M8-8EW;JORF-XQF-%+__-.AF_PW91 2V_?<1T,2<CXS4J
MBIT**I\A6DNS 5."Z&L()UR1.GCG6>L.*IN1G!P9&AB\RPN"N%S#Y$+FA@D/
MF&I'(1<5.(<:,DO")^=$XNV%B>LX3HX">QN[0X[Q&X;S=XLE#?*Z$D[@MB2?
M@.4JK,V)UB5N/(B"P@FN<^E0".Q[#"?G^+V,W$%=OWI)?*F7K"<UM2QPF-Y2
M,J:B@I<4 XN8B)+%0."Y@(V9@$<A#&\MW7L<T<D1HJ$#1A&W_R=./GU>8G[S
M%>?A$Z[L\>;\_.IZ<'%F9&;>B@B2JPRJMD&*4AB(V446I#>B])>R/P'RN0K7
M]Y%^]O74@_E(+YGZ34^4_Y@0^GGZ_&UVIV=$,ZGZ5I]I*U<?/K)1)>O)><5,
M=)!]HK5,$35"):)$&9+4/G?0*#T_R7JBL:(F]OA8EUUE';CL/##C/(H<!,7H
MKY+U73BSGV1]B%^.1[(>4R+@QM*H%,6 @0+!4)0&2@=C;;K*1.E[=7RTDO5!
M?!@L61_BEP,ICK>!^"I9W\NQ.TB/=_'*@0B45+'<9 Z2!5J[G:, 4(L,*'.)
M7%/$Z?M6_#LFR7IOW@QQQCB2=2X*)0,N@1,A@$J!$'&N0!0F;4Z,1][Z8N!8
M).N#G/6T9'V(I?M(UK%(QPJS4+1!4)Q)R@5M 8R)11%J6>N3J_8]R.KKDO4A
M)AM%LJYKX,V)E,P$"ZJ@!<=R .^TE(H+:V+K9II'(EG?9[KN9^<1JWT'89PH
M"HQ7]0%&R>"U+""R8"H)]!%;K];'+%EOESWLY(%1JWUO@>LE2]8'^6WK:M\[
M&'U,R3K%K]:@L$ 0,BUBSD$P*(%[Y%B$$\+W;P[P; +^OEP88NM#2-:S%)A1
M*+"B]B.5M"!ZGFCDDG(:5DJ2L75MMB.2K _RWE#)^A#3=Q"&W5Q(_/!M_6[B
M9_R*YU=R2,&#U0)H:S0T*WP$EU@"U(JR8JV%M:W5 -LA._U8HX.'.NA';J#]
M$T,=^&79MC6\-UKII\%V"D@& 3U,E-+#XP^1JIN[>B2\@T G+#3%T$ .-M3F
M? B>-G!0'H.*P1636TL8GP&WG@AZGAVUAGBI)Z7>3_^\6"Y6%N#BS33+J^V9
M):EHZV>@E96@<FW^8I%!ELR'I#W#T/J9UE.8QH^,.KKT(?*T\$?/<.DNOBMH
MDD5)*!R@\0C*% XN,@>Z^$"!7)"ZM ZB'X%S0)8T\=TVQ-C!\".M(>(*F@\.
M<S$>C*!IH)!&&XV(-#54,E8SBZEY_\6'X;P 3NQB^ Y'<9N@R9N,+[L44X3B
M:N\?%2T$KCE(%Y13@?/B6I<6>03."^#$+H8?(47*;Y:_X'*E_%O]\0><?_P<
MYM?:<")J3DD:2)F3%52-P>J#@.25LQ*%S+[Y9<X@A"\B#FGOJU'ZS3S\L#5G
M:T01#&A]U&0+9L +7>MR2,9=R@9U_T+X1UYW8)_CG%Z^ZO \Y.''LML >ZT[
ML)<[MWY3OHLO1JT[D-#E^I05/*<]72$MCE[F^LS52YHP,=-*?-PD:5AWH ]'
MAKC@,'4'5-;,:Q<!7:F;M6=52X. TBAA2@[&WU-!GTC=@4&N&5YW8(A=&YZ7
M5(0W,=2O=YZX_(!E-L??,.'D:]U+KY^Z)6%<B$1T*SCAM+1MNZ@H@DH&4XI,
MF/NMR#;Z?\@WG^5KPD'^FHU@[ Y;Q:/U$!@YE+'Z[DT;1=B0YD,J$:1*UJ)/
MR&SKW>+Y%*/HY\4A)2F&N*#Q;O&/V5><3VM>1^CN_.833M.W'V;3?(VQ*"DL
MCQ&X21R4-!Y<O4#7(MN@>&*4D&VQ7FS[O1.C03=3=SA*>SN;_SF;TRI9,:V5
M34@V9Z&- ,R<4C&-#J*.!HI+J%14%#:U?K'X** 3(TI[)W0X6/OGQ722)G^&
M\[NL31@\H] 9@O:UKDZTX'AV(*UEQ@K%C&K]B',3CA/EP]XF;WA<40?^8486
MRC]=W(+QGO8P%2246,N*QZS 9VE !ZD$49)+OTTAL[4??&(.W=]X#0M/5##K
MPW))6XZT_WC4O((I!,9R2(XYI7F..84M/'G:\?]^9NNQ;5-H>5TA17DB7^WJ
MH!%!B: AQN A$V$%IB"C:_W"^?;K)^/E/0W;8=]='^S]XF9_+'X.\T_X-OQY
MDUHDP[3S%$M*&KC+B5(+P0$C<55(0Q]I?:DU'.7)4::SHSI</6R#^)^3?(N7
M,VT,FBK/I@F@4'F(*M#BEQ76MC+(?6N!\E",+Y)6.SMIE'I6ZW@_?@GGY[>(
MLPS9,I>!YU0O=DL-A(2"$%"'4IPSLK6(=#C*%TFL/1RU3BW3GUKWUE<=0P[5
M,D5KVK\#Q=H>380BA!+<%"W5"/WH'\7X FFUAY/6267[D^J[U34RE;EWH@:"
MB9987VI;+@,Q619<=!G5^%O@"]\ =W;0.IU<?SK=7U.-2-E39F$"+:S*Q@).
M%@Y9,2]$EBRFUH+FH1A?(*7V<-(ZJ?P^1S7OON#\TV3ZZ9]A_M]X<WND'8_*
M6$N M*711TV9 T>0)625-*MU%[8XKMGXPT_&W6W,M^'R;:\;^S\^?G?.?W,!
M)&F5*MR <(+6+58\.,TYF.@XBSPZ%[?QZ.:??E(N;6# #3[=ZT;UE]GTCX^_
MSU<R5EH]?IW?7O7=A2@T6EV(9YQ"F]K3,T)M\@G%\ER4YYD2M2U\O-W73LKG
M'0R\@0,[G\?>0-S(3)%02ATX6,R$RDH#7M:N:3[$&&RT^OX6_[#;3WYVMS'C
M!N?N?!)[@VHUSA]"^F]<OYWU41#!*#@HM('0<+F%(&2M+EU"X<I0CK.-5.*I
M[YR>JUL9=8/'][KL7(%;E8[_:?(WYO?3-/MR_1(!46=7F -.<1\H9Q(XFWQ5
M\=0'"HPA>ZI,]A.?.#T_-S#E!A?O=0OZ?DJ[29@F?#N;+N<AW82'Q3G+7-#$
M.XV@=%80/4/ZK3!&&@Q!BRW\^]#//RGG-C'B!L\V."V<3[Z&Y>3K;1\076R,
M&63VM)J83$F<1MI$@C<Y2_I_T5KT>!_#R7B^B9$W>'WGX[PZWC=Q,3N_6.)O
MN+R83_\#\R>\J[?0#$,4B>*': F:)'P>C89DO?'&L!+\-M'WXU\Y&0\W-N@&
M7^]]UO9AQ3V\/+NY"\P))J,+##!*#@HI9@R>2R@N"&6$1^M:'](^A.5D^-#4
MZ!O8L/,AV36P-7JJ(%/D-7K4.8-2;-6X.)#O2C#TBQ":=U8[V=6@B9$W"*#V
MKA6RUNU+>QE7G79R1%_+QBKP]26Z5LB<J FD:5U+YBA:JNWC];V,O,'K^U<#
MN<TC[I+1.BRI4(S)?"T9S&E#BB4HL"DP7ZPT4C<O!+(1R;&_?6MHYU%>XF]4
M\)YA$C(I$<'D54E)FR%$9B$X+3UCSK#[9S(=KM8V0GNN[='V:3/4PRNC-T7[
M#=-LFB;GDU5=\UFY+&VR.L"X'<)_X'ENUA]MZ!?;MDK;:[RC=DTS)BO.N(&D
M9>WBZ32$3*N:<=R&0@D(3ZS[9#YXUS03@Z#5ER:/9@44XYS6<<8!N8E)YER4
M;*WR/N*N:4,XLU_7M"%^>9Y=TVYK<UN]ZJ@*)GD!RJ0 07,%)0G#DW<4,#S6
MH^2E=3@8Y/DM.QP,\,"8Q>RWP?6B.QP,\=O6'0YV,/J8I)"6*Y6*!,DH]U>U
M]I<WJS76"F<LYPS[=E9\IAT.>G!AB*T/T>% ,)E"XIIFD*E/#W(&'RBT=X+S
MP'14%/>W/G<]G@X'@[PWM,/!$-,?KL-!RB:AYPD$.@9*HJ& +'$HO$03":3#
M;H6>3Z##P3ZQ1@</]2SINEWQR2W OG8X:.GQ_<K0[^"N@W<XR#XZ5F\UE:*)
MISC-ZQ@\36[E1/+,!^%;'R(^ VZUZ7 P'K6&>.D0'0XB+[5>:0*MZN6HJ[4>
M5.$0,3"FM<XZMBZ4<NP=#@:Y=&B'@R'^&*G#P34T;G.13@=@$6GPVM,FGV(!
MJXL1G/ZI;>L.D\=5N7R0[P94+A]B^.X9]J;>V('5XNF6@4557TI&"<%D!CF5
MR(I-A+/U(O(DJ-,/G-OZI4.%D&U:\VX#<92CNQ%[T0\[Q=O;L3LTH]_%*V.O
M/%=0BPC1JIR >8F@DA7@4A$TEY),+-*Z&?OV/1Z1.(-._ [!FR'.Z!'MKO7J
M-CX6IFH#UZ(L#=@5"%$+BOLY_8GBAK;EUC'+<?1$'^2J)WNB#[%SA[!U2(UU
M(ZPQV1$V6Z.IVA'&J>"A,),$16I6W'\C\]H"HV78TLM7H[; V ;8:PN,O=RY
M=7N#77PQ:@L,)YDO]6HE6!] >9<@>L4@%31!)E=\;'[[=+0M,/IP9(@+N@2R
M]W3*T45AJSI=QBH BMJ!"[1S<I-]M"8'B>VCUD.)P1N[YRD-^!#;=HA%UEXB
M%!N*%#0:57*MCQT9T)@,"!V*]H%8G5H''(=[[M'7UWO9=A3!]]O/8?H)WV^6
M&/\V.S^GV/FO,,]G-DGO$!-PK!&S=PPBDBV2%D12+[/EO'L8NBW:YRH+WT='
M.9+O1LEV-@O:8W**X#CPQ5*VSQ#!>[(3_1EG1K"D0__RE<_VF4$?;^_X]F"(
MJT99Q]ZDY44XOWQ?^^OT%NG'Y>3\O.KNS[@J,7";@?&"M0VBA:!U E3)1\V2
MUZI_?;@G8;Y@IK5U80=-S3KD#Q?S]#DL</$QG%,^4)N-+)>7ZO+%F2A)!H$2
ML/ ,JAHF9(]@HW12HBS2M2^3, 3A"^9:,\>-4JA^\QKL9!+*!$=V6)V()@61
M9PW%:(9&Z2QB_P7MD>VRU].R_\3)I\]+S&^^XCQ\0OKDQ9<_Z\]?_+' O)S]
MB$N<?R&<'V:+Y?SF:/GJ/W_W]Y\X76"8YE_C^>33Y1%SJS=HW:"U?:PVC@5'
M?=56!&54M:*VP!)K3^L$/B<-CJN8C#3%V?ZM&@[^JHU'+Y@K#*SV9 6,&8(Q
MNI9W"YI6BR":O^T[XE=M0SBSWZNV(7YY+J_:+E^K?ZP'5?7'?7<ORY0/N9Z)
M.&-$#<0"#84V3):3\(+^4C0/;1Z!<QQW4(,X,.OCBPZIV /0KA]=;0&NT[W3
MH\ .<_?4S(W;T6,/'XQ.%.5\4DID2%S4;G!(R[ W 5Q@J7"98S:M#YT/0) G
M[IT.PX\AIF_<0/<JE+RNAB)U<M%)H$W9UT*'&J+5A,L*EAW]-I1MNJI_]T/'
MSW$;&GO6PE(=#G1_".>U4.7'SXC?DQ2]"K2?<0BV7F_$4$N2U&9O#&74617=
MO&':0UA./RAHXH4.QV2;<%VQ?QMDG<*!AU$=)A9HX[TM*+&'Z3M$ 8\@E&B=
ME+2O)52T-)9H":L,8&*J[7A5MB$<.2F>V/_'YL00BW?@PL^3$"?GD^5U9;V0
MC2$T&@Q:K$^O75T'$;@7*?BBK/6M3R_N01@_6FCEG5D[TXYR WSOS/%M.$\7
MYS3ZZ:>K?^G.V2)MFK.+Z?(WBJC.*.H)W%H',2 G_CM+D4\.D+U/J02EA6DM
M1&H&_CG<M[0^!SN,9QM2='/ES[<7\SD%[__$/$GA_&V8X]O98OD[_5E>@45M
M&2^9@U"UH4+R&:*1M"JS( IMHF0UNT6J,OC#IT2A_I8?17GPQ_ER\H60_0>&
M\^7G-<#\+&7Z,=E88%+4Q]N),G<5(P1NLD/O5%+]JV<^A?*4B#62KQY,G7I=
M?'ZL8>1R\I6V]5FYDTHN9Y>WZ(O)]".>8ZHW>[>+<+/+S;T^W_8"LYTEQKVD
M5,QB+O7(IW96LTE6#8.!DK)5$I,1O'6)KV=X2<FLX8ZR%AHVHRG-!,VQ3'/,
MTO\Q:9+@L;7,[Y@O*0=P9K]+RB%^>2Z7E$\_(65>6ET8 V2*UP/7&F :"3(5
M$9EES.I1W]L>S]GD(#X,?NL_Q"\'>JJ]#<37M_Y[.7:'-]N[>.5 !*JOE+DH
M-&^TY?78CH)7KP3P&*1G.CKA6A]H'>];_]Z\&>*,'HGC[ O%IY-T]Q&ZPH*9
M4EF448!R'B%:+D'$;+U5J*5J7HE]#<7S?.T_R%GWT[[]+-WP;&EUN#7_=O;'
MQS-74BB<6<#":JTE52"@]Z"+"5%S@J ?$^LN,/W;I]G7?[_ZB9>NOOK-K9=O
MOW> ='Y/J\_V,MDHQ3ED9"H7F:%VV@3ZI2!Z1@\4&:5(OQ*RM'X"=R3%.?:9
MKOO9>90*W:O]22DM*.<B&+$>#:'*A(I[D Q9B(:C:=XQXIC+^;?+'G;R0 ==
MPX/UJ+?!]9++^0_RV[8EW'<Q^JCE_(/,(M22BJZV]E(4R49I&3!-BV%F.1K?
MNFGB,93S[\*%(;8^1#E_VL\XB[YV\#6U_;H)0 &,!..*$4EK:61K<>LQE?,?
MXKVAY?R'F+Z#\&'5K'WC*ZJ'(:-4M%&R##SHV@E44]Q;FWZSK#"*9+Q-K<_'
M=X!Y(@3J[:#&@NGUR.M=*9B6OY;?_R+HWWZ:?,4?P@(_S,C(/V*:(_WF_7="
MB_?3#_/9?ZWNQM8$&6?<6FFCH+'XNCQK7L!SPX CQ=XBLQCNUTS>4M?0%.:S
MO:S>X:[FN7FUN[1FAZ&]2>GB2Q41;1J<Y2)(SCR8I#RH1"N\CYZ#\49+S;01
M83<I3F.@KZ3MZ=EGN<Y>!B=73S?.@F$^&U=KIFA)H4BMF2(EUC%9E]%I'_-H
M:^MWT%ZIV=9[#0\?]AC.S[/II]]Q_J4.Y]=R65=E;5A&"650<T!1&Y!CC8^E
MM2 #RR[YD&F6]2/E-A!?R=G'FP]6+FDE7_MI,@W3- GG[Z<47E^L:JN\#?/Y
MM\GTTYLO=:*%:7ZWN%3DY9M"(K.RZ3_<6<76 \5^8K;N=FFD:;OM373GC<(_
MYK.+/PGH#9:;AXYOPZ7*[G:&V!"L\6B!%4YL+)+"3I$%."60F6"C-:VK!.R+
MN6'[ODT(+H_&,T].9:4!C59DEX 0>7W46Y(71A?)93^[/(QK+-W;J+QZI'M?
M&P<]%R7<G8'=//YY>QX6EU6*I?'>YL# IQQJ].(@2)U 6\D8[6-<]NP7N0[H
M4'=8[=W_,+_V=$//[FK7T":XN&HAEG^=_H;I8CZO[W3"8K+X8SJ+"YQ_K199
M]7BBOY[1S#R?K)*S^\.[/HK;8H"]&TGV&MS!FT_N2ZB'J/JLV'"4M$?DG O*
M )2E^%-%%2'2^$ **1C]SE$Z\$KW8?TPCX[M0TC0^+CJ(TXGL_DOLR4N?KS
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MF<:L"XE0D$PI$*Y,TV7: -,^\<Q#UJ;=CMQZ=>.G_U3CZ_!RGE$H\53R@O[
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M>UDB6\,;^]_RQ)+'#M)&UT24#0R1'5FN5$CIJ E 6.GC$24%:YD$%R-7W/A
M]7>94'P,"2J*NDT+Z#UYK99:Z5,@$*1VI:F+!.\=A4P<8]X+XZOWA'U."<5#
MZ%!/\"-VB"5:")&-*2E 2%9M$1;#K5U22IPJXQ=3[?3 Y]$A=@@3:@B[@?.P
MPY=:UX''J(C3!'<IC:=6B+RD/AO(5ADI@V.\^F#O/7!^>*A[/=1:BGS(L<'S
MEG= VQ04]P#7R$/="^PT+FHU-?:CQP =-"E\VP<R!F4"218D&DT@T'8&4VX.
MB>2$!&D8&EG/GR"/.*FGX<<AHF_ BS?+3VG^NIMU7U99RB57]=8\Q<U!&H0G
MQ":0HK0>M2F#+>,VC'/X UQ^"K6[F_7!-;X)4U&576,]5.[^NL)W?];F%:P4
M C4D>&"N% NGF, RQ@%7''Q(Z)VQ>_'VK=&,/:\X!TW7E&+#RNB[C+,F9!IM
M .M(J9DP'(S/'J12DD6CK;.UT[&V CD' M23=--BR(W]_69V\[/57%V!KIBG
M!*(T$D2T"I"H&F2FAGI+=6*I,A4>!75*)W:$I/4:JFAZ^;H!>*L6:OW=O)FC
M4_YEGCX5VZO(:KWE;:N*TLED10E^2C87+UVBD:5T!L*-\B9)FT2[7AP5%O"=
M<' L%3^=!M2W"[E>N<6G7RZZ/]TL;NO./VH1W"!<(Q7$U9/=N,5Q-GJ;\"0'
M;RWNK($X\(9P4$ESD9BDPM9.&SN[XKC$4TXIZ=++ []V8AD86S8?HADK'>DL
M;[>A?V?%<8?P]83%<8=0XJD4QUTO\N?_OES=+7S^TLV*B%8!(<MH8-2(DD#G
M0>1RXQQ\@J"\XIZR2&SMB[V]@+Z#$/Y!).I:*;.!ZWT/TY6+V0=4H^#]5D"G
M"=I75%S72NJC44))[:45$:SEM)3U)#!:(;BHJ4S"*&IKGZPC4N&1\/S83#A$
MV&-WSTTD*")L B850X?*"?!.<2 Y"L<(GOWZ>^B>^TP.GVJJ'+N;;A]L/S*<
M#];B0?U2CU#!V!G.Y>Y),ZIQL[5EX*XN924J0@Q22AI$-JK=;O0<,IR;L>,0
MR;?)??S3S>/]E%P\''-,08-@T9;E)G#4&Y#>>RZ]*Q?F]9,>MR!Y8CEN!VGK
M8;;C4%&/E_W,B?4Z,@E)TUBZN2;P)$50WBAGM?%&UKXJ>A;9ST,(4$'4E6L<
M?KZ<=^_3;-K-7W?+M&"$JBM0+D5JG*0@,^<(BABP5'-P,5OM \&%W\MNW)H0
ML/,%9Z#6>@*L:!2N9IG> "KX5O_QNUM>SM&21@W1%[.(OVV *NE<2((#2D B
MT$# 98T''>-*.Q4LO=^N9:NF#WKIF6B_G: KYC+W*,#Q+LG(2\$%S7@$.>'
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MZ[EZ_ATB5%I!^FM9&J7$_SG0GYO..CSMOVU>=L,G':)A*3&0VJ.:O8K@769
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M 9"'#?!GHCOLH;YX.H(-]$VMTYG'^23M_ED<6S$49_@3O!1+D'$,O$J-%!-
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M?K"&8&48\G9\6=!C8ZCB+S;00@A'[4D>W*7E/'%)8LS'ZNH=W(UO@[SQYCL
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M;V$>#>*E3*7F44F^\B;-B>5S04<ZS=43NUR1[VL3B"&/T4?90*DE&4[UHAF
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MB.6\<4_8EU%PYHQ=F'WU?S8?-?3M_V&7SQ_+__<LDQAVA:?R"$V.,85Z5@&
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M^ <[6]&0F1!K@7$C]U/B9Q)1JHCJ9O.><G!C;-XHM:-5TN-#^WP+1?+ZQ]V
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M."$AU!T63VIUT?>,BV@\TZ$'SAGW$#J.) 634H,P[WT)31.4'R/J)8('+-B
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M_+5C1%/& 48]\X2K \</H*00.(!G"@WCHYCB@9O-UCPUR:'YA%#P^#N59I+
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M(1HT96)NTPG>YFB+1RFBHN>4SH"W^I]U_?VQT9& >RS00PJ.<7 51Q9G@>+
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MF\6P64-(VDNF,A,OFGKFHS=DX?W(@8Z*!0Z3*%BQ#&@6RU9+;^38K19@9+)
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MS9 2/'X>VX-"60QC2\BPEW5\Y.EK*#;QX=>1^+JH]0BR[$^2O!T]S+%G*%2
M^HDJ]!&]!%1DW;SRN9BY4]4.J8 KM>,FOEOZ5(B-8R NO#MWPHN"C.@Y[)E^
MG3W3*<Q), [8H11[13#!M?.FZNNV]E>.2=,A3@-WRQ(8A%>Y\:8O\ T80.,
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MHCN$#T*2O3&DR9W4E1EHA-<5?(3YR>F=J4P#R)3XWN9>"!E%#09$R$=-F&V
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MN&_1]DVA&.+6=%&8[CH';49@CU-4D*L">A9D&\[Q'ZZ1_/H;J 4_(DH1X,A
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MT8^KI/SC-Q^^L?)'T:2%EZ*VYHMAQKT,,\H^L[@_ 4!Q6NT*]6IHXI>Y>%3
M:6Q2SC,M0C2JO*H!_.(Y$ \,GSC^2^*B:>[<!?*ML(XO!QQ7##5&=A-?61^E
M1%"3=Z\5TH'+H'C4"88&T5^^5FLSRT'..1G1IQ7K^YJND 21A#W=90=LP"-T
MM$- =),QL!EW1,7\M+Q7$:Y\Z6U"J^UK:9!E9.1C4KD.CHL1\D7/>FB%0-9#
MRA E94G'<>6E29]1HV8>8.TZ?=C(UL"USPLV@4A'Y8)""-[3>Z]P-FGFSIO6
MCX5JJ@#@4T@2QW5R[3Z@;&6-_O0&.R)'W&B>-VNU=@F;VM,*R4X$HK(O/T=^
M]>X\@7Q]5RFJEA^&";]$^"#&)(H?!!U#.&/S_(J-]ZP4'IY;_L &5'HU!+1Y
MK+$!5;.O^KBBLTPOU#ANX=;T\*Q3)2"%K>IHM0^1E>18ZH ULP:X[CJZ>T-U
M$DT@FR*?90=\^D:_/#]*_? 7%.G!&)Z(MEP_]5,.WS-MLRU+DN4PT"G4RQ B
MV6#)EGYRP68P3_7T#\21$S[Y21RC=*6L0W)<5F,5Q.%LSPFEPDU@&8YCE!09
MA(5^-HA2H^5;/ 3 _W@OO[AIS4S7Z2Y %V,E&'(T"#GZNJ0HS9P\>Y4\F%W-
M!ES]Y?_6^[36BI7T'=.:&>3#9F@WR3)>A!HSDS:Q08^@&S35(YE#AVPES,*^
M?*5:K([?D%QWN L^BR!:(AHY=J-*LW,*(OJ;<8Y#U6[*XHRYC@(M5&T4'4K;
MW*]TW]XL69\D,,1\R;43&U D-9.9 [M"RIR'=-:6DYFU(]=70J*S'=43(YB3
M4KYY\'0SZ\-B#=I/2>)?.NJG"<2<<\VTXN:RG#GGQWGAGUB=/'ZQV^T3UNO&
MDE)D-=8A//T(O MNW-;4/8+'IV[]>M!6Z!&8?^>;%6NMV]_)7Y:9R(T)W8U>
MUQ=:-OMP#7C8QLS,/M%H#0QN<]&.<K4=<U2\E4OO,C%=]2[-B5$TC_N?DL+D
M/]D49WUIBIK-X",,9<YY]&=84EPC/R5>:B7ON"^>O<_W9L(.[RJU5WN_P:5W
MU-90ZQZ-9E8O:+^.+MT0QDUQ;4 )=CTLI]QXI1MK]^6 I_N)I^(-DKP&)PWV
M#7 ]=93O+XPHX$$(Q!H-% -M3[4\?*R](BSPRCJ?YW5RZE:<T[NTW^F,VA[[
MMF4A^D7&/6:JWED/U $.1'SDK6G=)W/J_NMMS=?3+ZJ??Y=T,CE@&5VM=?(Y
M?FAR4[XK^;=,T> \:EY&3""Z]>&4PXOD#V<RW,?5J>Y4W5@J/S/=F0-%W5</
MLSJ!4W7(PZ.TI&73H()&9^H;T3&;SJ<_'1X=D/VA<,@WN5I+%[ADVH"BG40N
M<9,CVOMU'A*]'=MJX^XY@F,"SI\$$KR_5<?SL 'ELNF;&NMHAM@8?1^-@)\X
M7<^LTI.GP<,N='G++^D<\@P^:JB<ZA4\U'CS._+!VI3OU+&;(5Q*.SA(WF.L
M0=1..#HF]]WT"AI=EU<1XAM49;ZMV*IR5"V@N;SC29S3AQOO+%R7QM%WESLF
MD/5+[QX-+&5X#-5$DSFL*!KO^V+G& U"#,(SA?$9'H[>49%Y+>X'V\+>*,31
M255R.=A1U3@IMT*I;6J>3<H7[?ZD)Z&5*X1"#@=-_R^E4/Z7@KW=)(=<DG64
M+.22.XF.VD_#M\(E ])NBT[@R L]^4,5XX(+5A\MJTNO&X*6#^5G5MZ(E]17
MK#DZ;FE:;<WAO'>]+[%XC(,F58#M'*B\AB)N=I(I4>&C@^E3!_J]9HX8%-H:
MG6E:X^#YS>%,Y0?GRG7+[;Q<'Y6=XY[17'8E@D80D[--ZE6T%/I3^!A<,[-M
M?2Z#T(#C\00?8UCZ<3>/GP_VEKYHWO0KLA)[?S_EZ^W3T#?%/GLOD%+H*$A6
M!I;C#+EFF!\/?"0;F= &Z$)0EP7>1=_E;YY$0IR.$:+$;:_BR_'<A 'B]?/\
M=;":X1O;<I.%Y\ Y_O^ZU( 7W'.J7I4H2UO$"Y;75>Y]WGXF._R9A#[L#P7,
MXH&0K:]3KN-X<:[C^^[1&J<LI^C[&LZ%?>)]^LZGIGY&Y,Z1:^>4+1(LK"^Q
M 3S<U&UF(1O0BW#'Q?O!Y,EY;1-D8!,]:S2N![7M&E!0^=CO==,1L^=SBK\2
M[.^JFI<,:&VO,*7J-K\ZN*;HC,9-$R-C"Z49.)[-S"WKC+JT-W-L0 7W\A9=
MG=6U\YD<]+(>HEQ':D=UE)--7RB9Y!7:&8V"3ZML>H4&1ZJ-:<R"/#E&*)DU
MR+AGX\[1.4+X"O@/YD=)/BFV&IGC)Y1-7'QU)%O3ZITDA_B%<XY<HUK%('GE
MY03H%Z:]_TSJQ2<7\M +RL.GG,9F["[,S-<7!>L\XJRGB<7$XMS!O^%=B/*6
M*CP8:+JEXTRQ>Q-"09&BC6//%L<=<3X;GST N=_T$#=._,D&9 0B_.%"ZS.R
M"] EA^HO[\I8M[S1V!!#-F"L/MJ,C**"F(D(YQO5-!Q)*\F2P@?!#>A),6X.
M#*[M7NM*_42:?/&,L_3GAR\FW<.>X4PVC<;=O-//XF:^@1^GI4U)?N/=?J(9
MY7U;U+B<NKYYZ%F\\*<3UPHV<\FS# &#AFR%P0>4JN5@BG4S3F1S&/(S 7S,
M7BQ,9H3YH(]X6EWB2=%]T[PP 2*.#^K96'M64HP<'5WD7WQQX(+-L'OEJ_WG
MT#DY@"^ZSTHN#L<,IZ\/)"6MZ_+I"0-?Y+??X%%LMYV=871G((A7X014!6J5
M R91H\>&B,CH?#KK,.TN<"P+2.XL,$HU:+VR%B'E^AX=SH$+GW?3)W0BJ+84
M>1J&C+C5CS&-'NHQH(ZEYX5FQLLL[H$L'X8_2JSJDM8Y\"0:)+,Z$C/-TH(Y
MT@S)8L34 HK:%#+62]V7?[A!GSGX85TJ:O_!%("28M45T2B7+H!&MW;3.[O<
MI33SK_$\PQD]>;>4[R89GBD9"SV36HQM6T?:HOA9HK0MTE;\63U)F!JY> 93
M[&%^<&F#+E)U*7N::KDOU>64Q5Y#@ #D%FPW@=(;1*,\PW!J9)4AS#$4/Y-L
M,>M= 0*D=)V+THW: 9CRPV]U+WOGSK[F#T-R/J_E] A'-&KIR2THDI,F(4VQ
MX$BX"NYR8<["\;)#&M[U2S$;QWSN!1KRU$Q_>7U(TI*/+M<\1%5?E%7)P'WT
MZ)[N+O\)NS#UKE %NF1UP"\W9:S>J7=5KJ5&7[DXSR<?QSFK>FR 4RAXN(/J
MUX<5MK/#!Y38=XTB7Z$?=+7[.EERW<F^=>/EFXC6P.,-9_5# X1:&7;,#ZS]
ML/U]" Q6G?& 3(@DRMFH%B\>M:W_R$K_>,X=^#7<<^ =T42G+]#!M?47?JC%
MTN)SXP]3IR3O'>F"$3/(@;]0;13N$2AJ(A!%+L$W(XZH))W65A_;Y^AT+]"]
MI+(];NO>.]#LY&[^MGN[V1GAH\I>B$>K(S=IH4;59VP7K3(4(2+KOS0VYXQ4
M::V7,BB*?I*6MV#)TPM&%0))#'6&*:X!:MVJ50N^U]R;()IV?R@Q-^T+?(MU
M"U[A,#'B7IGH(1K_VXI\-7(F.WCO:;D%0YT]*YZSX 0$V8H#;&57&T 7^YHY
MJJ*74N1Q9!KA3#,*+%!].,!K&Q5S@?IFJ!<K^Y4S+U5$HQ'",[-ZLWLLB8KW
MY#44U^YU'I =E'ZV><J[YR,F=JSCR9Y92=P-V"Y'V@MO!!UB9%UK$Y6IF5J^
MJJ.:U)SQT< +-/"@\F@!A.IT'ECLO+E$%V:M1EL,A2 A#"Z/($3AA)A3QDQP
M+D7-%L_/#R9[,0>_G>T^2DMA [A/0*-;1WO(UDN>]#,>&3-YVJ=;IYI]UHU/
MS8%_>56IP05X9L%$+HZL(\$^3U''H(F+1-]H-/A/<I4[<3/>U%)U+ HG)9&[
M7S(;LY-&'IK<:O*-N"A'GFT"1X5P1YT]I^;^?O[<J)1CW<%D'[U9F=J+X+*R
MX?\>HB'\*8,#M"'04-F^4^WS5XJ_6/M4,.\&QD'R>K;?D$-9_#5D 0)2@-6/
MJDC]1O+<)G365Y"7:T<+<8^W-"6]$B-^1\9CLSR7P,]19&/0,(0:L.8#%X5W
MLB1LY\Z96PUZ)WR$%H'C76K/JSNQ 645(0#%<;F2)66CE$E,GB&D;H"YLK3]
M>Q9):],ST?KI]1OQ7XG1^!]IZ%=L@"=J=)8:27M(OTJ+:)@X0(N@2BBT+:&<
M,:SVBC07^DTGWXR;Z0GWA]=,[?S1E8KK""J5#4CZ2H'LYB6?Y_H& [V$_G3@
ME<[7T36\:I)C'>L7^"<[S:KO.E1'WP;#)^AL8J*2[K7<0P72?'U'VU@Q5:P[
M16!:"X@\0< @F4*^C _W$)08RHXB!;T9P5'=][4XVGG(#,R5&@5FP3F^>B]B
M)LR,+@4? E>H< [PJ#">=8#2W0RJ<K<F>-(MT53C7%NJC?%I1D]ST;GO^>$7
M'?/"RB"9;$"I*2,K+1*\3&<#;BHK;H3CG,GK)V);IS&R+PODVRT\UGQ,?I?V
MKNQX=)<31P<*)_,4$I_ NH/@L=6[]XZCZ_]Y3==_;WY@,3; A4/_"15IT4E-
M;( $5F N6Z[\15FEO56[@Y&+%%=.4O2KEPMFR4.IL-W<D;<Y5NHB2PB: #X.
MO4:]]\MXX_RA4V$.,XMW;_X6C[JW*ITB&/']%'09<KW';N <].* ;NY\2T>=
M(:Y^L[2&&AS>5'\!)'17<((2]T>D;BO&';[WK^H.>[_$*7QNV->;NEM1^NI_
MZE+,?]#^/JJG<'%G>Q^+E\(&R'DQ/X"74)ULP,><]\ IGMU$^815FOH8ZVXZ
MW9[CN-M8*%DT88&QAZ.GQK@_\B@,@5F/F%\+8;+>[ZTW9?'(YWEFS"X%D99!
M-X=@II_N_\9F@F(T@%P&BAYD*&SA F&,W^V455H7JY/N0I"WN1,<?Y\:L9Q"
M,<!#:/*@I1XRDII ZR-RAA)C\=A.9O'>Z<&>ZLZE.1*'8F'&.>[R.>[NKLYG
M? J^7DK/-I0,7'=YTVC%\]Z[';#-W9+-@3013^ "-(4V?<XB'>?TA <1;B<^
M7B!P/: 9*^<%D"Y0]EQ5$@U]W9+(]3JJANZX?4,HQ<EZ_P=FLOW8C4FU!#\(
MB,#9P+NXR1@0GS*F.T[O&+,(N_<W-"'4\$Q]6A-<JM=E,"#PQ,.]V\"9WS>7
MGWTQ[#BZB2YU^Q<\AYR&JS)@-%6Z'M2Y_B&ED&251.P  --D\OR%9J42RVZ<
M7]>DRQ5-#-QYL6!\@V=YP_;-W;R+=YYF&BJ-]4@$N$+1+2P!LN3SIR2<&"W3
MM&>C3IT0]'DA[97O?L6%7FV>CPN>,P)T5W@_#@-D&+$!#R$C7;9*AQ$I<#F8
M6?R2^EHTR\9F5&5UY8IXX<;^AZGU8R17/&1XBPB.\698<GR=./.+!BA>4B_F
MSJ D[\EV3U_M>0ELO-NM3T^LU1Z"J@]\ W[N^U"B ,.-.VQ@ES^R ;[JC/0_
M;("[9?-\^*<97#J]=/N2 X2ZX-DIF5^,:+SI"U?R&)+D88;#N3PA0AH'G<_]
MAN98>%_"5ZK\2JM_"U1'RS[:4P],B7>$)E&U:=$4:\,T$I A2*!^3? %7GGE
M SM$M+\\ERU:*1%H9_+SZ_B>X3K%PS_UW=Q0@F ?-B!!U!@7#78!C^ -:"J3
M<Z2C(XMLP)'BH>5VH&_Y_!W^TM(I7N4[.X-#D8C)= (?IC@0*,$:0!W5,: @
MF^]4TOY0PD;LSX_0MX\?12FH@W][+W;?TL.)BCY\V,Z<+6*Q4-0%AP_,M+,F
MU:,)^5O6=4#&@:TT9OUT_9N?T$O4;AKOY#<-+!^B41/AS#1HZQT%I^(;1V_-
MUTK45[<N9EUUYKE'#B)N/5T?Q#'4TI9'Z#<Y9 ;>AZA(A@ W#K$X!QI^3#Z&
M^(L-X!M-KDD*U'*^_'U$JR5,[8.;J'!DQ4L=,#'K6)])*0;I7)P2^17/I\@<
MN+['(G2/U6)W<IZVMN%X^<"+4R8*YZR,<G1PDYI+KAQ*T>E.1;[ \?@O*ND_
M7]\<PVC:O&AFDH;4CB?-:$M?X>V^XO!!7^K\E]1'@'UGL@>D>?6AJ-;=@+ZE
M2W2][5\P4V8>0\4[Z,#U6I>L4.8':'3/>\RQF_G,/T)KX%9?FK8*-9B\E.B.
MV@/GIJ%:JNZ/" VB=4*<R\OFK"7]BW1C3NEJ+3JX*&K_("-:B@7I#JLKUJY#
M3@SN5NW-;%ZNNV8(]Q(.I)HT_X,DP1.M208,<0/Z+5IA&PX3CUX:/Y!_%@XB
MRZ1XJU?R3)\9C>\_'9CU3.M1J2&/\@WK\XZK&1LXFC>:IB*[G$5'C:Q30Y(:
M1G6'CBQ<F!"WU8<B$9B%GV9=X)@C^;]<L+LO/^+@'"=4V;9$)$G(3@&7(TG[
M*3(?I\(F@EZ^'W#&R?OQ*/!ZOK(7/!LN;1^36W#]E.GW1KCIR_7@F1.."9+)
M_<J92?$Y0[[8MN5LH<<W0%'06J'RVPX20W\2\V]I""[(U]E7I*2\SZT*1:E9
MQDM9#_CS6PW9_\+(+ZUZE1P+O=1Q__:31H5S3O[.C59\>_8_.?AET_%FKX8]
MPA+SJT+I0FC'V-B+\*ZN0:DSY3^6A(X*/;D?>P0@GNBYC@F=KV$:ZCE8=U;9
MHO(0O $(FHHP0Q#=8.,;JR-!L8!:-^PD&_.7X-P+;.=^V6W[_/HQ5GS-P7"]
ME5C*XW0$,._PD8QD\=>1,=0\-N 09-F6;KR8+86K]I->SH]6:A8C8.F%*(T_
MNV&J4]6+$&]6 Q@0 !D)I5Z@A9$UF_?<R,^9NX)QNL%7-F$J]?OW2:DHWK-=
M[[?V:2QI[*P(1)=BW)I*-#-RES)GD]PO>23V^5Y"X6L(,=JM0(F738]W\B+Q
M!3]4_=U;SR<+9L2]R_!9OE]9!)5MZ*;) )=.T76"-<% L MSKQ'ML;G5T/N+
M6;_\&)[2?T7#EH0:O!=:O?GJV,&I_U[_+R\'&YX@&24J7O$^I^Y,VC3<$=FI
M=G:PJK)U,.M^T+MWJ(DQ'KF<2JW_5T[T'S;%+I8LO _%#Q?WB&BR^CH.C6Y.
M3*QDB9$WP.ZUKAN/ZPU6JR,2+FMTOVHAEOHS\X(_H_68:4$C2O>S;"H^MV7X
M?-^XQ?C-K"OQ+F$#/ C'C=T?)[X/E581BQ)+_<'U\,WO(U<D7I[&5K$!+WBI
MB;1-^FH,7%9O+WFZGD//-8AUKW=>S"&B0HL>:BT<>1 1O@>=S=*#-R*$(:36
M C: QY3(L8%\^ROM5;NJO'@?39PZI>??N.9\S*ET>DVK!1[0!AH-;C4_2"SM
M\S,W=?W)'/'\GN1Q<579.E39W@>V$KSYSN680I:LCW.?/6ID7,46+#6SHS@,
M)H8C/$$[TN!M>XY?F]I X/>S!L$;MQ!K=0_9@+;%-=PF8A?ZW<+1E"'3L'PJ
M',P*X[B;/8AI)_CW[$MD'-YT5!:?K4[YE$?5/=^SDCHSW=PEM:[D\LJ0YU#K
MK-V[Q]K+D#P'28IL-,,VMP4-A=A6]'OEV^&#G"^VBS%/& I1D$L?Z)(<7QE*
MV;I*\6V&1/6,S56V0ZO6.@I&NCXX562<XSE3])/W8AP@9+W5DP"[1I>='Y5!
M:\8A7'$B$U"!>V^J.GT?8%TR \.D,;YI$E^K]Y7T>FXZ'/B0[1Q\>WM.SR'P
MM\UC%%["L=/Y#+7\SP X> F+ELI/:")*AX0\U95,'/% ?V3HFCKDU#L 1Z^U
M<;3(U5B*^H'V9"< ._EJ"G3XX[A[XOHSISM\KUU_A1LN<85T1\',B>@3<Q1H
M1)/-YJ<\1ZV?UE;F12\G1LS[@R3TPZ@"YYL<SQ"YW8M)0V?3BAPJUT<VO+;F
M2.Y6@;$#/MGQ,%PN)"=&L?KW_[*GW-- FDH;XT,Y]04;\!6AR4J(P>+^/FP<
MP#JW&^3,9/T]0D0W@/X>2G)^%Q()+@4V(D1@<%I+,6L 1S;%14M*(8Y 66&>
M' AUI%Z?F"5@'69DFMC;I5[U^F=Q -^;=O$&J5/(1^'BQ\<@]F:7)?>1D#1I
M5X: :XND&(X\QFKD,,X-"L)5&C>V@8K*,,:,%P0H2(<[58T+%F9]7_Q1NO^)
M(N'S/PXZ^J^E;$'OHPW\A8JR6$*T9(8:.6 BCR+<=OC6E<GNZ$'7NW436J>M
MD%N/G_G5/?4QZ^JSO8,?:NY.3;:%0]#.,UTP$Q7^B&A==XY-P!K5K=ED;SM8
MTJ_!1PGEKDL-L:X46Y)^A4T][;C#B3[!\84@+X+?W=&SU;]O[GFK,$LKG#9-
M0&'RVP@G""@@ZQ>XXG 6V=2D#J$,C$+PBGM.7,!VWW3./GFW?3AL4.SP%3Y%
M(VHP,QOA=M > QI1HUKVL XWAMP;9YC1L!P6QE+ZQK^59Q38_7I6VVVZV;4X
M, S"'358OXU:PV^F$F@\;QHWZ_$G6,NFB>!.,W"3*$>=]_IMN 9-@48%J-,T
MXGMC$N2P6RUHB4A> A*@LZ07I>W%AD=9<D59+ZPZD<2WL[688$V\-MC%B?(3
M>YKY3N\ ;9'ZF9::N+^6%CME*$97Z'TX;#?^.1R0F_A<2G8?K^PUR WH)=:A
M3'+X*B2:HU\50W'UURBQS3T2[:%3H;W4"\N_KSS*;_^K> 'ZPT:\V$TR-?W
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M__/#5DNX26G+TF0\T9)$VWU?A[(<^G3)6T?S0Y./KXOCKV#/+356SXGE#+Q
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MB*LJ9HR"QV#F4]^4#?F>T*X1;[6_A]I(MEY:]E@ZY%/&,%-8]LYM._E=8X7
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M_&_LO7=<4]&7+QH%04! J5(D*DU$"$H1(1 ;(")&%*E"5$2:@/0H(;$!2HN
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M9F\)AG@XW;XY??Y%VY]UM_H&!F&1=Q"UA9D9%\D'E3>G?$",:%?XQ.,I-9A
MJ@X?U&3M2.A6R.0)XZ4YSRP;3\,ZSEH6CRTY(QX)-*0TA3#J3(%T['I$122,
M0@<^K>D5O5=8/CQP)+*!4UKOY'3N\S'A:SLFFY5WOC#9K[IR/;^Q,)LCE1WA
M-^S\(-WS+*W?*H0/4N/I_L/BD7TIZASO V^(U_,;]A4]_.-6RS5F^QJK;OQ6
M%KO(M%NI%VIUV^42=/YB9-*%0):M1[/Q6*5CL;CC^(^%M,85FRM6?U"CM  U
MEDCP09EP 8KK_Q^N20()Q*,$;W4,O*X)YYW\DPSB+7Y]';#C8"O_8L5IXX3
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M^)KF 7WA*WJ\K^D/U70<U"_(]^V*.CX 2^5<!P2(8(LW-Y9GS $#S]DG4<Z
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MK?6:T^2FWGB1WM/L;B@@*%F-/U6XEPS:,,8!!X9Z+-19VN/\#F _HC_"Y*J
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M(XU?68+USUJJA./5$N 7\EH<C>'&8R\D'#]%[DH\G(<4[-_1"=.^G%IWBZ!
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M_[7#_ZGM_Q@[X+*V0.%8\@HK#;C"/@6D]"P( 2DLE<-#&]C %MZ[YN(@MET
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ML8F0^_[SE)/ S.[CW^6_OV?\-5<</*^0;%OG5\RZPBVM8:9G,,4PLRL]8SC
M__P)3'K+$.-!2==$Q)Z-N3G'KXAD@Q+\Z<.$HTOWK"#W;QODH\QH!8!Z+$?Z
M\BI>KW%*8Q(6"D^]?:OB"USCV33M^#YN^3GIAFG#C"N]8NZYDO#&EI6;Z+?P
MQHBAE%^(C&((/Y@3WT!AU'?E"' (8O&10'#UVPW/\@5IN;<*#;IG0?;'3>;#
M5%48/%R%/37!_513Q^3!MA^:D_5ZSHO(A@+=P9,N[4N11_E]@3'.8&;N+8[1
M0]D:G" "TSV7$X6XO05J7LG-JQA''UR_]<_']>0+FRB$1JF/_ O_J R1]QJI
M?W,2^W,E?\$Y,J;( _SPUXCN6=5]6]WEO\2M>+@30[O?_A_GU/\1J(B-/XS=
MBU%O$,E8 0YD\6?\%@B2T;>@V#+)X6$Q;_/,HE5N?KQ8;@+L9AC1G+)_4511
M-H !U0+C,Y[(&YJ.P>WQ^NP[PYDCW#1^/B8_^O]N65_B9X'PI8*>+9 RGW/R
M$_;Z6-+" 08IJ3G>@!RJ3D+!ZL+JXK8/W[V<]!M?ZIYR'WN,"9I+:_LLV^7<
M&6>Z$ 1<[+)>WP0.0[(X!FP=U&U@NW#.8X9F_^WB]"X=%$\ (#[_)LHBM"+-
M/4O4L]>/?#?2*W_6^N/E00?%>?%?.%P,9A;"<B']QDH#.;[;J65A3=6LU1NC
M2/D,Z _:MP!N#XK,22$YOMH!I^1<>F1<9]R]7P+2O4J;:?(]MTDIOSJ[):ZF
MFXQ_OZ8>[V97XJ4I*?E:4#OMS)'J,T>3K""/(0Q7<X-,S$[,54@*7[<=#KGK
M^0VOR7V%VK\$)B?M0V2/G7F#-QJ)0-I*D3W?EKH5ZA%M O=>/FGRC>_:[HD:
M)#YJVK9 C7]R+26]YWQ:FQB$H4M8)9=/ESQ:(*)U+6VLL 7MMTA,\W=0#D9\
M\%R CA@[Q^^CL8%L2#%:D7DF)_1%:$=:TQQE]0]KQ%C^2/MAYCOEY/I:T5UV
M:BDI/CBBTRR.%<VW%)M/9U J_-2#$UWUJCJ@XG2.,986H:NWJ2YV0:.A5ZDV
M6[;$ZO(9414)$'I[1[$A)JA@9J@?SK##Y/ L -SB%@@<$A7*4P/>A#[GG&X8
MKZ-<8N"+-3_4A,>8/"#NCW<ITIVQ&W[A]R3]^&_L3/P0I 77"YXKYG.G!@J=
M2-W<A3H]%0!8O!QEI+"2&>)ZH?JOGGC[AB8OD]P:1C0,BTS/-_8/2ME=G)\P
M!S=Q]K-->1\(X"[-6D"@!P[BR%9\LU1/HS+W9%4AO2;(DQ?SQBNCV]./]9VO
MS1VV3A9K$$[F!XO=F&#X[)_%:R1YR"[+74BSWA^^/7=\86E=1T-K2IZ>>I^Y
M+#)YXT60FNJ.J[:N5I CF%Y_3"18&OUNFB)H*?.-!T7L#,4H6>I[(ET'X-+#
M@\+IT:VN&LN' EUEN]\3)8>@B;4.RR.Y@V(<,!/F!FQ74,CERTT=7E^Y I!!
M;>4'SW"=$,%R_:D6'%T6\*Q=._K(?&CJ&<8DVV=N=U9=Z6KK.XU#;U*C?,_"
M0O&'.1# @3G7ZPZ7P)MRCC#^Y$+-;U]<"+'4'G]":'K\8K@X/2;@*EBML'?5
M0PFR<8]]&/!?_$W9^$D=F\52N1F)!C_Y%$O0$S =M#BPHB&][%E[2M'0S7Z^
M1@-\%E3)UOS,&_8RZ.N$I6 ;%AJHC[ B@-0$R2X9+.(S%!48G"EY5QKJF;?\
M(_?&L?F _N>;O 8'E"\?7T<86FF6A_D^<)-P%9R!UIEN>64>/K:;8Q<*(?KI
M$<81Z9\/"SL6WT8Q?,Z(YG[12#R1[OI %_Q-N(^2BA7#"P$'QJC87GAZJ7 J
MZGA-NIP2.#T:>4V7_D=JM%%!UOF&O9; 77OH-"Q["Q0$F7TUA#;+H07GP_CL
M(=Q2(_5%1K\2+K7VNT&ESI];8QI!)_-G(K4%EK%SWBPKP)8-Q?1JP\+!(M_4
MG:>CRQ#4E5R4DQ1RR*-CNC["P"GC7#R>]-S!I+]6H_6GE.V-=UV'[TB&$]%J
M0#A+EON8#[:[D*:"?IPB>G1!KO,3"HD5^Y6C<LL\;9S6_JFD#G<-9U+GLNLG
MUBF9&MA1_-Y0V#S=S+X+_0"Y3OV3B-=&!BWU8J2ADE7(G#.= G2O\YW/!F(C
M3/>< :HOG>G]+9OV'#U*:6JM8Y0Z)=[&]3CMF@?D G>;)==#]4+^G<O>=TSH
M_="7.PI"7V\GWOXHO)*Q0:5Q!;RWJY:BYU1W,V'T0*K=[P)9E#SCL1&RLX_G
M=E^.='TF_.BH1?.!9??@ILS(B(EW!T0^+%\X<@PVZ]Z#X6OBB.V#@\K +E@N
M7KJ/(,"Q?K;NU=H&R6LNL^9)Y9V8/-_>G/UAQ$FJA5+R/&[ZQSPQ=E=GG_.G
M!U\NM/PS87:RG"?J\7N0?4,L6P:_(WAEU+DIO,H8%2."9)%Z60M!!2)Y^%$A
M?RN^L;+F;O0;9J(OY^75?('LP?3JFL!RR\7@*5@ES&(AH1%!=$AZ]@P;SXSM
M57JZ=J*[_:(HZ[.^T=.Y^8&;GYX6Q?=\?-=ZYN?P_>N[X8TK&Y-L0PY?WR=_
MXLUYR?<;))7O)EUN^HB7]_%:+1W*J(N\G.\^N;E\]XI@INO[G_O;,$:1B\,U
M:N5H3^Y+/!0EPORSH?,"^+.(X&>&180H>,YKS#FE[T1]/:G\(&&ZDAD-(2NU
MS+=)+_?:AVHZ>"SY[Q.2"^TI? II5-W'Q?)5#6SH#T$.JLZP[5."9\?H4<B6
MFI-=)N%"%3&=FW'%H@J%/Y/*WM_,?HOG;B]@)9Q'2,^'P1O'B#E9T(@865+N
M D;0XSAI)=^M]#C"/H-[:-K&4[9ZWEK[\DG01^$AB 1O'V<G4,!GX\(H:^8^
M2W%&?6=H+%L/N.G1],9;)_ZA5GF"_P7KVS6[5&V3'J"H14??)<[YK'QQ2H(H
M1A?,SO%$F6P-@$C3G&D&5*CP.?,!4[3%=:,K53T=^-8.:/$QFKEY/"D=U?:V
M0$;O3[+[QL-MYN:\Y$#(7%J43\[(Q-%5I]E^6Z#42Y/TMKTGKH5484<6OKE^
M/6PO>/W,83T("\XMA5HPV)< AR?H#[Q=#8QG>!$2RBB8JJ/=S#VM*E(^>U5R
M%,N:^BC<2V"X1B!8E]NY]PCA$#*$)5QN(,NQ9FJE0$VBF,7]<+#))EU;OSG<
M_.W3NY^9ND6O;D1CZ.)/#VYJNCW[ZZ?'M25Z$!;+X,U8^B%&/.LM<'-[ZRW3
MH)\@_ZU<E*37I?<,Z>_V43T\8>>2TYW/>>=)YR;IWP\DRTFF2LO\0&BD@?:P
MG>8(8GA1CA(@O?B0IX3:"]A3"X2 &X=4:'RW38M63CCQ3I''%M$;5]_5^?CF
M0B-:!CU,:1+N"?W]")=$:,I([%(TR)R+S0Q@U*1L-"]_ D/GE9'WQF!&"1SN
MTKH5!(MI4'W#9+/L@%FV(6^$(J??!6&.++9E&W>NPV>Q2QGI5-/;K(Q0N2S=
MU>"7WON/SEO]0Z$]RM63QP=_<'I/\9Z01!EC+!]N"5YL7:L?+K0%"H;O!!PN
MA&@DX;J,J,HZHKDN1V(=&:?K6DK<,C^(7G ZZ?OYOUTIN0)KAF=A0@D2(1W7
M^'I/BPC;@RSE>=?XNH EUQT#[A#;O@8$"D?I#5KHC#^O.^3H6GHO&^V$Z!MT
M>]'1/"_S&/'):WW3$2W\'L)H@2W68GZ%P7?S]7=G\18HLY(G5\.1+>#E.5 Q
M//D;6R"F["^N[.SO-<Q/&N2OV19((VX+-/N \.U@#07,L_J;\I]_SRSFR))8
ME7R\9GL 6N>!XTPB-;)X$2X>SBY=_M/7<>\SL5;VRYQ]%/:.P<(1JL/U\U]E
M_\WZ% ]MER$1WP*%$-)O%_<YY:"5<BZ.Q]BUCD@S&.WL>Z>Y_H5.AXEW$DZJ
ML;[^;57>G9OF]1#I:5G<\=/]GCO\4QN40SHPZ'_CW_W0JS7O2>[*,*V0FN#6
M@LT97KC.ZAB@2:*KL/U0JL"Z?.(6*!#+?U+?19[FWQ@#$;_.W<?["H"_L?.[
MWN1B1JXEY2M?5W/; I&->**:['.H ]QGQI0D&+C+*(:68-[_QVD+)(+-K,BX
M)F7512 _1+V&GKWQ=[&@Y.8=G=_^+ %N(D^1QU?BXH,9%;5>-=DM=H5=3K38
M#'#T$O:@[L]]8NBUWUK+U^X-S:_$??<4;W.XR,JQF?ST^Q(ZG]L&+V%0Q%=D
MC1+BGK.U-AWJV+:5';\OQ<9V.)7QG?<%'PW^6Z!*%P#._VN>P+'Y+VR(J_F&
M^X#N=N*AK+= ![= 7PI(L"8=S$=')SR$D_13F*/G!.A N$K%_#YR]+]N@6@Z
MXX1@)P7TK*KF=(LV+)20LB#%&,V]])SLP]O'W+W0-1GY]\&G^Q$[XL;J;H_*
MRD9=?R$L>V;WZ$TX\YY)9>*+LT\?X8Y[5WYM^MWLRG%2YK9;'N"]7Q ''&H
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M8)E:0).IB7D30Y;US9.>[2.\&)OVUONH&;G+X6M ?Z$>,>YA[4(8:[.^N*B
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M@F2@EDI0)$?B<HG-&Q 1\N4H^3"LTH>+0&UA0&+YY/B%;2_)V6^-8D-/=&9
M3N3FMR?Z>7KR!1$W.1?[>@,B!(_$CR_!QU-FHG)^F4H/,#6QTTAA=/:Q-K/P
M0WX=81K$@E&KVASQ  ?]RQJ11^;%=&7+.7I82K$H+^]7;4;"X'62/MCCO0%)
M?313.:B"?CA*&;4Z9\=KN*;CG9UAUU%ELB,V36]E)6#KOE11W26L -T-"M =
M5.P[5A88S,(X/ZU-Q[BAF)H&YU@%]2/*!>OL-WNZM-\]SE<LHQ%+%"6Z\NO-
M1 4Q<@LN# $:#BY(<WPQQCP!(:]H)D'!#CI-"[4:AA/!A3X2&5Q8!^8KPO93
M42^\_EYHN2UZ>]^>OT[DG;Z#MRSIY:7S-=%(^FPM5\& :9V&"_5%,3X+4#/6
M#)TW>@I8SK8->3'?BKWNW<.6VUL6%Q9W#4 Z2N';'?>WE^[I4P]UJVU:BQIS
M.O8)NQ]TG<%3<7B2+5C^ A3QSL9OG4 /Q&08-WJ_>6+FB,D/2TAZ.!@]:]Y7
MC_@6'[XX>S,XV+8P!T>_A:N?PUOB<X? .Q38P<)C($\!/U,KTLN,UKI-'$1I
M5LY; ;J7AKZ6NOS]>N6DZG&Q/A$(# V* SHS,BEP>BEM*U86#*'2E"^RD!3R
M==C.P@M%3'CVWMJRT>7+L$X6ZN4%Y)<IJWLZ24\F^R_)W])_<Q%I+#2C)0I>
MY?AQ!4PPV1^#YKVHQM'+X!H6M5I<%3 5D)CK=/4$W_4&Z'KI_:+<FIPW$YY,
MTJB;_'WR(/RJW.(* SD=3[Z"1O+%'5G6#"(%GP9O1.; PZ)R$C8+A4M]CQLY
M%)6!<9N9A4<,Z^5I?D :F]FI9FZKEY\UUO>Q+@X655S%<>4\V.<^PL/@X]$S
M'CVFF00EONX/K H01<6K? %+&!59-$33Y[7L@7,>.04M=9P8=V+!F ?G,"5,
M.UT(9=%VW6HO=A]8PLX0$ IZX08$RHTJ+4MKFL&G%!\<_95H6+(GWV<:C3S9
M<D\1L>OXZTZAURH#0>!Y/@W.<HT:IU*AFO!@<G8S7PS@E?=6XYQ9D>U8*]0U
M 8/#.XS,-B5WK_>P)S %UN'L?*-3>Z4&=[?M#Q(MU$"&<$_S;F)5,4Z\4KXB
M=GAYAJ 0^I#<52E]LK]S8F\R>\>/:R/K;&!RJH_54=)0E=\CMZ4]WM\L8.PO
M1 %*0/;M$.,"A<X&D%2!I7$#P!YZ-C3#J^(37P]CP8)3E(<%(7F2N 'QM5Q\
M<3)HRNQUX9N'IF;F0CW-=!F"@,$\AC>&])&3M>  (HN,^DTR&..J U$] ]K]
MW3A-<@A9-3SB&==JQ&N -!K]?.P"0N%VYZBYW57%3W5OU72DO,]XVO\@I%DN
M*O?ZJ0]S$8SJ8&G[S5Q.K<._)#V/]\8*9VCJG=387Y_?F?<X2P#FL^ L!%F,
MB_B$U?$F4P<S6@W2L$8_7'Y,6[.LLF/+-B"!4Y.YL,,'1Q1;7A8D'M<K=9)O
ME^NC7$RNNG6739 "37OXHBP8@;7<R3YN/]28M,?$QIY8+Z3D#IS0SM39KH+)
M>"%"MW^[7QJ"C1*@))B)91%-!=?EP&0MYU@B9&BU5%\OI\,A=O=T6AMO6=R?
M\K.*N5A]K^_JK6*S*_8%7&N N*A')X^YLB5XK0(X>!F?K3::@XD% CH%NI2;
M5C?CE-F8B[0?T;\],2^9+8>IS'S9;==ZW_% ?J"#@K;!-%R$3+]/W@X3\<4$
M?+)5!-:9KE\PT9_WQL(U!I/B2E\[KP&-YWPFMY3?$(J/>&FX#2*Y\E7(TU5P
MJSI8,4>..<: =X<!?@;TH1)<92#X =-4R-;C3\@$HWVX=/^%S" KX5/YKW1W
M(XO@!Z^(0 X0QI?[O-:Y"J[LA[SR1E,UC!= 3(LAW"P^A.^$B7^T59TQ6E1M
MG,OJ.[AD&9_Z=QVO)JPFV&9;YVW%K,\*]JOO G\?YXM7 JO,X!2!PU_:3#+#
MI^)D:BX14YA+A3-&N9Y%?7%8K=O\P[N6#)QAAT^^%Z\QR<%?T==7]-3PO-_S
MHBV-\]-7, R),<!-E/OP:F$JF"CP$6N54FPQO&@"T_W!WS:Z&!&SK)(=N,)\
MR%:-" JM4;)]W-*8&';>7#$VV!B]N9M\-R\7OR# !V-!7"2P*V8P;>+U" R*
M7IGLY2,R,=;/?^-WO:IOR]NE(=R8=TVLO?VEC?4>1<@35A';F-?PC95.)5RG
M:> N^SKU\-4 A9%6:E?BY@XDGQ%+G#RXK93X:"]LN,+O>,3AV?NO<AREHANS
MFX)R\6]5KD)9)Y;SR')DE G"I9U70C+[>9PIV@65&4/#S[)2"=F6[G6  D(=
M(9JKG\6XZZ=?)E3IW::SIS22<[_]&/1)C"FH7WB]$3\N,#!0MH+_<0.B'/L3
MK_3%&ZJ*7N_5VD/\U,2[-K1UTN+'7$L3^AQ5:G[D0X_<_GZSG;]7XXM(>W@W
M^*I@-GM(8!J+M%+N<0"7SD4]!AW0P=Y)6[^]59=&GEK-Z1MA&S1=:W&>^VNV
M*^=Z@&'\8YGHIUF&D/_::HOA]"=DUEF:R&:R1*XZ@Z:*[F=,ES,-V^TJ^H.D
M#@5]NFIA?&O9N/=/\@$F*;UJ4!YMU$6R3#9"JJ*=3G]FWNCOT2J_I-DM,+1[
MV\M%-7LO9:8FW-53VS];:(^:_)K@:8<A2M\?KL0_G?_HO'K4L?>-Y^2T5_5E
MOOVW=>Z) 98Y/_=.+P&T;MI<V6+J1]T@K%TN-A;<3$<MZ/'=GFN(%/38<0T$
M'&^V=@,B^Z\]?J:?6M+YR3,"51K]34CBOT0+ OXQ+P+H:KH"/[P!^1^%=B-9
MYZ- 0Y+ 8VR3 .M*0+S]AUAIR>YIK:%4TIW'TU/&J9&:V8@KDS#?P8SA<7^D
M*Y)$9CW!BFP>U27PY0O(7#OLYA'\3NA+I08Z'NJ)'<6)8:3ET*YGAQDO 3<2
MWK]"JS!.^8UB3^E%X:P+;/V%B[;H@ <*4/F,*Y[S_;KS'F[:#UM=G,[\B4%P
M_T"?@+X$=#3,M$Q*WX_UN4S5\$SLWZ/F2 EGW;_O#27R[KWZ7>0[M] +<'HW
M3[U0R9+<.);SN\IXQI274>;./.>G2[0#Q5/X]<",]I#QAD\>HLB3@KO;A_.'
MJF,G:(WO,QD<WZW!K+3TYT=Q,\Z>3-@)I0S& &DIS;/Y_N=XVX: \'W0+<GE
M&979-PTQ<>Y$[ ;$9/"'@&8J%URL][&[W%M[\<G>Q 7FYX>K?XV;3%[S(N V
M()33-"'X]W%;SPU(2B*25<+7#@8%)/WD&^8@5WU"@+BP-W'=J9M=)Y#=./",
MUP8$4/B7'L4_H__]Y%%H/T53R6MZ%8+Q^S<@.JNT?Q&;)".P^17!SZNX,,%G
M&KJ?XB?-BNK.#>FI!^-.9['#FFS&RCSO?1U3/!:S<W4@24B@6,KT$)XL3GP#
MPC@H"'P4=T(:5A,#8YU?F4);=[9:W3+^+A=F,;#?Z-JMHZ^E7$Z>3%2C2:>^
MKQC-J?17*/G\EQ[NP5SP[\%T\._6,F,1CT-N#WT:8F?UE&-QL96']Y)"-NNK
MV^$"!V_ B:8+\X))6J8BE.9A4"W]D>K!FY8\I84NW#-40;_>5/5 U?U=04>%
M<U.NOU7]2U+BMQ ];G&70!$U!,^2P!_!2>#\<> >6R_1/L16]"IEL 2CSGL:
MXPUOF'?_0QX/=HB(]7;-;W@C]$;E'M9?]Z\@PGH9;('WG!Q$%L*.^$D.V<K/
M""RTT#[[&'"X/,-BP+X[H?^"7U=2N,8F;*U?B).YT:,@,9E?3]0KXW>K:54#
M*=U(-9@M_X,6#"Q_CH&_>KC:.8'+Z;NU+0^?9&PB1*M2\R,$-TR)%3L,.7*[
M=MS*"<]Q(H2"0JL;$+Y$-',#,B'$EW!BP!6P8P06HL/R(H%M")94>(9:CRB;
M2T?W>;!9QZ$950L3^EN'/D<$C>4V>]:4YOS&.KBM=JSRQ<=KN;:\1EM?.FY"
MAJT&U@H$2F#?\Y58&DZ)]"+U!DU2 W.R,B5> !MN5P[:CE3JJ+\Y<=/GRU3N
MD,/']^ID%I(K2Z73NI&Y,%NPC"7/+@ '6>O'P4>U_37HGPQJ2KMO1,33<+6;
M5/,O)[P^+AO[^3P:#(N6Q-_5T7[Z_,E_9)'03/0N"LHBPIEZ<'5H"IR5APO?
M@/2H_WB,E^>5+'#@#&T,] MF7+IQIN7UZP.6:QY<>5>^^)S!PBZ& )SR]0!B
MKR)03C'-@<M&<5& ),6]%<%.*D+Z[HMJ\/*.OZU2S?S2%6=CH^3OL,WMVEH4
M:$"]'H.8+-],B'G3&Q,$+!0?^&RK!TU=OOSLU?"9^W_V^U2_]12SRX]UV;^T
M*I09K_.N2[N#?1T6RNN TPL)8AN0*).XX^"]*NXE\('@R:DDV:&ERUSEF:AT
MF%7K<*1%BGEI7K=BE/[9006]GKUS%V[%2;^P[R3_QU8&AW#9\+KF"L!\YAU<
MRQ;.\<>$LEQQ%ZFE\WX[6(59)B*ISX_=MLGT&UIY/_.Z!7;)]>KE#V_=SD>^
M%B%B4!PM@3+ >0]B9<:%*&29@,).KX)B-M'K;%O1@/%PTN.II,>O[D\EE? ,
M%O7>]>&F"TT+'LO<POV?K$6B>47//L0@07,41>G/4'R$3+>,FC>R-V:?;L*M
M$4N+H"M?,F%#4S(VE6O##/N%&_3!=*1R*>]QNS<@U*L% T:Y.D:,2:@B^KVW
MSM7R'\=<S">.:MYK:I3-U)?4K8\/]CQU4G,\P,X/+O!WR0'\P81E]MS-I2:R
MO$$/31YD8)!,TYMUOA-XF7 U,D%S>$"[*#I&^_:\X5)@DW=J\VTW_X^RNEET
M3=J"8SFZS9Z7@Y4-@^^0"QJMQJJ$[OB)NB)SWU3YS(U@Z>*X^!L-Q;]^ P(+
M&D>PV8*K7:PA<T($ODF#I/^#K(@51A<DXE7 %/85 %,E+.L3_(TY<Z1-*,;N
MWJ,1H<:\'W]QSF(K/=[!Y 5# R]@#H%.5UF2C/3%$J"V9UJ,E,>T6=X^_E/-
MKN\<XU&-NV1;AQ6JW_)>:73S-'K$A/IFQ]\[MJPL4\@32"2O!J:W66+%-HBC
MST4#R]VT=)QZM:TCJ@*-Z"&>];:/0*$8_9E*0BHYE<Y"I;?Z%DD6Z)E[\H;/
M6J(R:4W*BQX")U\ 9G-\,&)#\%"$*O<TBYQ*DOA.WD%219$58BLL.^R[B0EY
M3R?.O^R/,PMIN:%G\M>MURI[O&^D%)K.PUEGH<D;$"F2"G8<_C*NTS1Y]-#H
M=:X!B^8#2 6XL(+*'VQ Q*H+V9*3%QJ'!J18??7OY;0CW6Y.EDZU&:-^3JFS
MQ4!I?3Q@164VJN$I-LLY7C$)411?5!]"R&=^(N;LX7:E71&[B&G3TX9?"_V/
M:P3:UI]R<ECX*M2U5IN,;%[O(D_8=.(:1V^23,/8-*DJ[L&*+@#>K;9,S8WK
MI?9M6<1,P>:<L_C=!XQK1H*"X2'[2NM('VZ<%WJ/I6*UP"X.FM]-%A%@,Z^0
MQ7XF7AB<=!_=!93GQ*K$3K81MCN5E7WZF<08'?):LE&I+DG%OC/8]Z D,<KR
M4>E^\T3EA4U@_ BTX2B@6B.?, @3\C/6>3&#TD=U84(L,H4,?80XQ;H;I7[L
M).'R2\J.#$VZ_=VW &4IXZUNTAAY&YR>#6^06>  9Y9[R9(D(Z[G,%<FFGE-
M$,"%7*FG;16C*AZ<8 :^O'"S2/AM?89:<$I"3<"N\Y#MKHQURF 6"2I0H$;^
M)YS,+T%T\/!J9M5DLJQ[6OEIQ;L_N?OJ=!?*D\KF?/5( 9DZ1R5L"GKV4]/S
M?VE9LCQFE/NBM@JBX$LN=C/K-8+"UP2K+S&=K:E8<X"0&05O@.FJM!_>^T2I
M,JC$]\N[F#'L,/21I+%[E?]=[9)C9T?'$P:Y\HGTVBPL#.,"\F9,U=!M'BT"
M9FL*'K>-8O3W3]H-[[6XI/!1KQ&E6.^L]+FE:+O>-*:GA:BR2MN&ZU+$0M#'
M9%*8J^P<D%;]A2M%OL770H9/PUU,[J6,-ST8WA<5)2<9U? *G[#'9]'-]>!Y
M-XC6#K[L$.8JQP'7Y=9^L/K+_-G)-X_1I]R3=+Q:A^>FH#?.V6U-]-2YNSMP
MRUTSCW.ON^X]0%@_P8B"O70R:+U,1RZ:</0PSF 1BDE+ITG;ZLU4([O_1%%X
MH=Y@I5-S75/1^8_MSUJ#B%G>Y^]2-5N?4>TN=,?G$EIAT$V:BI5'R\R(]N%R
M[H#+O1.SH]3*Q%#8KA^'/D\]J&]Q2M2Y!$F]V)3E($!M1IFPBULBWEE[//H1
MS=T\VV[)%6,9+  ,O @&![YZ-C_<G,HP2K(^>8=2J(9Q9P5/])U,W97V_HOI
MTDRPFZCPZUF71T>L-B AICDD-5X++JS(=,*:7DCI2)AC%-[DJX4!$T<#F)+W
MUW@AGB.7TEU<8L/KXQ&6!7^/I,^=BPM?4/]V0P+S>P,BNLT'^8.FL 'Q]T7U
M#BF L2$<+Q"+4'&TYB;T1K?QQ)?,.W-PI5^)_3G?2/6;";2QKP47S" '0B6Y
M$A\PZL^^6SNQ'R$IA_SR.8O5338_IN>_B?V]JGNV_9G8_=79HRJ+60(^&KH\
MWD,O7XQ@!?CP"+A0',03+.J&:3?OF'_H_"-(.FW[;9TG,@H9\S6W=WF<//OV
MJ.KC[=-DFPU(&#+U#Y1"!DW2.P?385+ ^PH&3F:08X9^:EC#%<<VNVK:AA^Z
MZ& 2J:U>G5_3J7N]\@5^JE5.)4F5-<R6!*#78\1@6B@R,8XJHP3NG9 5]E,
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M9<C7XL(C?:>;K3&AV-[;B]%JSN1KQW>ZW'Q[5K23($:.&)P09<1QY:>JVYV
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M]N]_DC^M=P6\P?A^_3O>[@2FY2Z7J^,'3---6C[^SN\(S]?,\WP_B1(8>9Z
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MG7ICSNIP&L'PW-<TNWE@8/C1:,!.N&KQYO%P31/.>O%=RE+]WU<YZL66J>C
M3_(=?)?=X72[%DX0(X>$T'<B!E% .<0XX) Z8< 1BQ&*A5$H^ 1"+H[\E*1
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M@J(;_/]3?;9HV/=VJGG5<\\6,%L3KY?'LPS.96/]5&OZ,_B8%8J5J]GNIB:
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MKO#+.O*:9&*,C[RFD6+8>OD!I_E?\68GW<O[75E\Y ]\XS9YUH(FS(\)@I[
M<G$+<0P35_C*QXM\WXV$9U;!NF>LI:U$E6S -5MP^K#46QTL(30QE2LI027F
M"M2"KD #V 25'S4PL42-?2/-RF,:*C\G'9U;AC'$6YSGC^GV1EKT6:Y(J++9
M]^.]2PNZR8I=WE9GH(DO*&4.](B')6LD <2$"(B=)/&8[U$O]DU8PW#\I3%)
M*W[KN0XK*&LZ"7IT,R&TTV_G5!+7- 1^YUB).5$'V($P66(ET]%G9:J!T#QG
MKZ&/&<9HUWDF?<KR46VYE]U^M8?(=":=>B:(!ZE@#"(<NY#X(8(A90'#D>L*
M9!32>G[(I?%6-VJ]E;YN#%@^;;EL1F0:V.MQEUU$)Z:K7@ G#?G7A\D276D,
M."M#Z0/PG)0,[AS:3;&IE5''.BIO,=LJ_[#*R(O"*(H2'\' 4784=J3WY1 ,
M QRRD'M^''&C<(S>T9;&/DW \T'(<[E\ P#6W+"S!=O$%&.,V( NBAI(6&ND
MV#?6S+T4-=1^V4Y1YZ;!#8*VA9 ?H>2D.@Q 6DZ=<CN=F.FO<H3B^)_>97<X
MW:Y%X$@[AU'H^BIW)T0"D@ QR!T/2;,GP(0EAKV$K FW-%(Z%,'J)F)\JX4U
MI":KDZC'9*\U-5/O1@V;E2'MBZS#9Z_3D3W1YFZ*9!W4(_V3[(]A7I;B@K$J
M$AAOD.,]'%S:@^.C6:+B[(.6QIL'@8&4^*>'G\%!:/VZ%>?QZZ=!Z]!-S&M]
MJ$F7T::S: 3-H%H7YY\^6]T+;46[-3#T;QJXR5[%<*H0XR/<<YUM4OIX>,]1
M0$+AJ][96*@==LIA[$<$XLB/!>.1$#0TVF$W&'QIW/+^QSVG:B.X5J**TC;<
M6C>!7G-??2) )V:<#H0K<,RL M]JX:?9JAJ"FJT]=I.AY]U@'P#*B]WU(<\8
MQF-_X>RFVL??U/5F;M/[QD<A." .D51%7:SZ05$'8AK[,'1XZ+HT3%RF59;U
M[$A+8ZA&4-"5=*#3>!I=/5ZR@MG$)#0,+F.R.0N%)68Y/<ZL-')6W>><<?Z&
MF4O3/"V7<_& TXTZ-?F0Y;_)>\NURT/F"D8A"GB@P@X\2' 4P"1)&*4L2OS
MK#;81((NC9Z:\B Y5Y.K/CS<2ESU,$J+8B>7#%Y%Y%91N(7M,-RA,ZZY?[^
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M>/^#YS0M^'6>4OY9-1+_M%-AFE?B:E<6*HQ3*M:4S5ZSB(N88@*Y&PB(7)Q
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M%.9$=$QE6X3RY-GS$L,QM5Y\X$<OLAF^WHG]>O-XN*0)LJW&KU.1#PT@BNH
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M^_+/P*U' _9 G)@3#OA=[_%[?\#OMU[\C"E"#Q9+?'%FL%G)0T_QYTRB>=?
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M!UO3,;0&X=2.7$]MHD9:BUZ6%BJVO*+^P>;U8K04?^%UZ-TUM%@NO\<I:](
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MHH(IS7=5?MIC6A3J\'Z+G]6EZOM=KIJBKZ. >TF 8TAY&$.$N("QZ_L2*S?
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M4=)GQ*,$,T^:6$EHUJ1OK"A:K_^LK?HZTAGF^XU=#3WK:U*$9\KTJU4 C0Y
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M7[]5__0>%P_J7^HVL47= M:T^L=T;XSA;>1;O@<3\^-@)M%>O[8+=65H28W
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M'?<_Q4I1D+_2= 5*_-.,CNPMOAZ+O<F23NW=K%;SA5)M7^%?/M?K5>4^*-W
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MB&X<O:6Q!GHL:!W9B4GO):C?&E /)?>O-4 =$\JE#Y*]8"Z-.><.Y]*'X41
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MDI;O\DF4M-"E-!MBF<S-OG#NIJC2H_K7?_%C[Z^_*'U$]6OS6['N9_D#>[T
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MIJF/,Q;ZF!IE01@AP]RH8B\O8'V!%V#5B6S&(F/&18]B'*/MF']VM9EZXB]
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MIWJ;E#PT57]-(;JOC2W])CE))<O[*.A&C?C'0EWU+1,6!-R/..0JBQ&BTHK
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MW)07ZO2EKG:[S*)4D%C:*+Y@J@8U\B'UO0QF/H\%Y1S[PBC*8X0,<YOMG0I
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M8EPHN)71UEQSWFD,7:\R=H9ODI!QF]!;CA^W(MJ[!)/;!/589+G5/D:N#RI
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MZ%194\\&UJR&BP%*0T5<=)J9KHJ+@5(ORKB8O#?NTO&F5,O YEE=;6XNUG7
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M/E>0N?']OFS JBD5L%*91NLRJSYX%L3P&'ST^.C1]12H.V;GM_4:WM9HV!2
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M^;78B.JC;/%'<7M?;"NRYK<_9._/W\636+<W<E$J_X?%'#+B>1#Y1$":^M+
MQ)S&<>P'L1[]FW4[-U9O) >UZ L@A:]+6G;B@T9^4"N@7SO"8!2&J=H=MJX9
M6!_6T_>GY^"K7W+##<X35=*P\1D;%<4P1VN@UH5!8Y.5L#!7L%^98L3;XS8%
M7>[KRZ+:5)?D,=^05?X_JF24R"BB(H"$(1^BT.>01@F#&(L@"QDC)#9R)#W6
MT=P(O2?:ON(#*XRK QP%5L^XM@&78X[>I=VO900](>W9MJ=@L&2D'NUF4FOS
ME+*OS<:3SX_T9FDO6[ZI<I:"WQ:WY*<*M%9%\?+UW>>BK--)?B"5X)>]([2E
M%X@0\3B&F*G:H5Z&8>I%"?2C( IY$"(2Q&-\7$;*,U//ET\/CZOB68@Z:T&K
M ]B0GZ("CR37K#!V]ECIL9!3Z"=RCNGNCJ7HH"?[HDF "VO9NQMF<%&6ZF)K
M,'&DN;?,F2C:\J$9*\:TGC5G@O7&W^;<]LY(!G:U?A)-;6#5,EGGHFJW%31A
M7A2F!.(H5+'>O@\)0A%$C*2")IQ$Q,@]>+B[N=E8%RO9R[JMG]P5TY+65B>^
MH:EU FL]JK.'H&-":Y)^[24%.U$=>!+KH6(SR=?QSJ9/[W52\8.)O4Z_95[(
M8W]"J([ZFG04:_[O6VGP9<\JGS=CQ59.G'TDR?XT'Y'4R_PT@5Q(PD$<2;,L
M$P*&7A(2:9OY,4:Z93_.D&-N)+0[Y+^Z A#LU*D)::\0Z#2J__Y-5*)\TBU+
M<.[ #1/7A,/A^K#OTR7H-%D /X >7H#^'<SIP7$6064)Y3.JI9S3^V2U52Q
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M=*-@=!&.$?42R@,8I6$($0DPK)+PLB#V*2<9(XPMMYLM7KE'>#_J= C?JC$
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M1!BITY/ YP:AYCU#S8YF6RG!2HFIOE9:"6H49MV'[?"NSQYB$Y-@+:AJE7N
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M/?O'')Q#RX"@A/(@ADE,?8B$%T""4 )#CV9)@H,@BK7RBAS(.K?U,XC F\^
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MFCCQXYA)YF)5M1-?-1]/$Y@$(O1B&K(PTG(8GGSZW)BJ%A!4$NI;-2]!&[8
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MX**J^&IX9JD!N![SVH5Q8CH]"%OW<I!(-O(NC@JBVR-(?7@LL9[&@$ZI3!^
MY_QD<*=Y:/C7;[C@;W!YUGOPYNEP21,5<O4=%ZSZ:?EU1_ZER@-M;G;;<HO7
MJDE@]>MRF4:<!V'DP8P('Z+0SV#*< 8#1J,@]I$T#K4",R:5<F[45LL+REI@
M999N#B(#7,D,?I*?:UE=^+-!@_G))KJ?'V<S?1-3:B4JJ#0X[VA^\P2ZUS6J
M@DJ9!6@FOU%7I:MV%*XO,L@5GF["]0/29S'QCF+4*Y$AZ7\!2/,"--?9? &,
M@M8GGYB>./;IQG86VCXY?-UH]^D'L[I7:8XD4\:(YWL!S*IF3S@4D+"$PSCU
MTBQ,! W3S,(V99Z'R(UP?_D//_;^MM^FU/^L]RKUW^UM6(P.@JUAZ7:; @_;
ME F.5[5 F79S\AH'F%IJ:VY)+CHB9#Q?OFV6ZJOU>H=77_C#IM@N29SY08(9
M]-(@A<@C%!*4QM 3/F,!0C3D6M$MYP:8&WFT,H):2%!+J<<29T'L)P8;T$P=
MQ6&&BO;G/Z1Z3T])>6O]L<N_'+[QLP]T\ED/J=-^R8/7C<@R/VK"?;UYY&N\
MWG[,^5H5S2Q5<[6F)0^^JP(0UN5FE3-U,/2);V^/LM^7\N/&49"E,(I9(LV'
MC,$499&TFVD4TS2*DE"KJHIMP>9&%DJ+JHQPI<9"E1%N%%%.4=I1!:RY*M ]
MHKJ*]<D=]AB\UI1-36)2+7#02SE;:\U4R(&<R-O#1![4 S<J"JTSD:K]2:MB
M4P3EE2;2(#7]E2;458*Z\XDURU&? /V^3'6;P[G+5Y\ I*.L]2F>/V[K7IT:
M?"C+'6=O=T6^OJNK6=<. SGPHURYY/=R(WY;Y_(SCP7R69CX,$H1AD@$#&:9
M7)$1"D(<1CS$C)GLY<V&G]N2>Q!0+;'[%97_>Y=OG\!.B6SNHA\Y,WK[_>GP
MGMJIK@0'M>2@%KTI8]\Z2ZNLR<YT5!K8<PJ,0\Z2E\!P<*=N@W' //<CC'S*
MF+W)BP9@[%^[<MLFN;_[H1RK_*90C4XVZS9)Z"LO'G/*50.PI4<0YV'F0R_R
M) DFW(,9QBDD@A">D2 ,TE@O',^.0/.+O^MH4"77\5J'OU9=@5H=5*Q!66LA
M?VA2H]W"'.IL/)S,R^NU5@3=69(*@48C53*WZKFUGZ@/:]"H5?56=#I1)AL+
MEQ/F;#M13UP3J H>JIZ8^/3W)4D0C/O$#/<0MH#NW3E</(C#_8(M0(YW"=:>
M.K)Z,EZI@/FOWSC??E1OA#IL_)&7R\@+41*F! 8X4OV%O0"2.$4P#,,XYBA.
MLHP8%3H^,]#<[/U&3E )"EI)P>]*5LWV4X/8ZMGQ-A";>,D9!Y9Y5=X!)&P5
MT#TWC-M:MP/*OBA+.W3].&*H<@,[A6N;(V?A481$D$$>*KLX) )F-&(0Q<0+
M<()2AF,36C@]S-Q(H4[^[5:H-FM(-P"J'A]<#M7$;# ")6,JZ ?!$A&<&<0I
M#?0K^IP$!JZ^K*J%M#TZC_X@]^F-@;(,?>JAU,^@D*P $?9B2%@:RC\HC3'V
M1,3%B)3=P8%'[(9=I.GN:P^HK55'<E7'?B_[N,(2Y^= CSSL0.JXA,,H&$=7
M6AB$QG)YA//CO4I-@T'USQ4B&+[1C'[*8KO\(I\AO]HJ7D%9S)R&@@9A#"GA
M'D1>2" .O0Q&G/$X2#(:9%HUR4X\>VZV1D<\HUW'*=CZN>%","9F@2_\,6_]
M_)^+?'-H:6MI=]&C?M^7+F_K?.7R7X<O_-03G7S+/:JT7VW?)>:A>^H\L[@B
M95744"/<[.CZ&;UDE5SRC6HDL_!6G=5V5&C9\9.<Q92=5* ;3';Z O.3FFM<
M?E-O99%3::-5!T3J\*?9%^$T)3A%%/+4D^9E(&*YV<0^# )"@I12[/E:F\W!
MD>:V!BAAP9>OO_VGZ49S&-/A0Q%K2$W][58@[06M<UBK(V'KH.D?4%@#S]'9
MPR4@&ATH: '3<U;0?[^S8P M-;H>?KT;S)GSML#KL@K+;PX#RJN[@E=KN]SJ
MWB\SY+. "[D7#Q.N+&:Y-1=9!%,41@AG(DRQ=A/<@;'FQIX'<=LCS1+L!5X
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MTLSS 85GU%/_O$O9'?BGR 60X( #.H 4H,&G^X+A%O021D)WOWL)LBYHH>D
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MS"<VN KNQFK^\KE"?:\#N,E K<4SWMD5."@R,?KZX>W4HS!3S#O1:!B%P^=
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MX)VC-IY$C*K*/V' 5"$@E\ XHC%D(HH)YY'C4:.8\7@W2S,272FKZ,7,+)S
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MK,9-6_V7ADG_Q=&[^8KT3^HB'[IMO?(+6E193>O0)9PA!\,@"!E$D? @P2B
MPG-DL!XS@2,CB]+?W=+,R7-I#Q'F]U9@PU/  ;"UM_TM03C]]O]8],8< VB
M8N\XH*^SN8\%-!0_<CR@\]8XDW)@N?F0%C5KJ#1;'[)[DF[7<<2\V"$Q%+'
M$*&8P%BX5-U3=RD3/I7AM(E!Z>ML:>;D("OH"@N^U^(:&I->F/5,B2WP)C8D
MHW$S-B,Z@%@R(KU=S6I"=)1^:4"TWCF7R?)3*CT>4=4,D":JN?OT(@ KOI*\
M//!I=N*W@\O.'>[3A",HJ(L@$JYT8FB((>5!F# W"2E)QG%@6I)P:8:JRPF9
M[O4"I-ZY(4/$M3,-JYZ->]/!FM@P=L>IUJZIEG+0[_5V6P&4CNJ58_MV#?7G
M-$'@9&-AG3_4EGQOQ#QJ&=[3G*6V.SKOR*?#>?YY?[_2#;&+..&0)1Z'B*)8
M6G\60^HX''E>PGEDE!39U]G2#/ESLO%:V#-NL?;B;'8V<BYZ<QUI& ,W^OBA
M#Q'+IP9'NWJ3S?X^I4_MT?>^,]+GO".Y>$<*P:5U>A#;HN9PSW/Y353,K>^>
M#H\TF4@7/TC.ZYOXEUOI U?I%,55>2?RFSNRO7JH2B_(2/M1AM:"_U-4V?W\
MXE'DY%;\)ILN/Y!2?")IKECCQ3<9C'_*<M7JF@2!2XB+880C E&"(AB'G$$6
M,HHI9MCED9''NBS]EF8F6]EKYJ%& U"I )0.0"E1%7<0X*O(0865H?N[K!'0
M=9Z7)?6"%HA*;5CI#;K8@ XX@#Z![G,-0*!":-6F1'5  A5*H)0P@0:G%=@C
MM0(M5J#_$YUB@W6A7X(MQW]AVLT;-BQ,^5-!QT+%/(L@;,\0<X0WYD9^W,_8
MD3SF8M]# B+DJ;USYL/8BR-(<21\1_X?Q5J'<6?(L+25^Q1KU0E"JTJ=FD=I
M%).5T7#U+[$S#<+$R^!X_,^C%#,:B%&L8E,-R%L0B]F9&&-YQ<8@J4<M9M3R
M6["+C5']!,'8J*;&1</-XBD7NCW3>BG_5J2\*0JY9V*OZ]2KFO6L3!^K2W!K
M3D4<>0&!@B8N1$'H0\+="/I>$""',$J]P(#UW(I06A-T?A;T/2TTZRIB4%?$
MSHCIQ8+3#\!,-42:*"S)\D.=B1(\4^50BF(%]MJ @SKVXBHKJ%J*@LZ39=:8
MQ0IL+R,,.XV:QP,?=WE6W<&A9/OG52)M@N J+Z9Q7V+"0NP1#@7A$41"6M68
M5+QL?A!@S_5"C^FZ_?U=+<V[5]*"O;B@D;=*\-+W&@?0'?;2[6$VL67K@6N$
MMSV F[Y3;0^_F7SG,9^=D7.LATB/#SS0P&RNKIXB78]6\PUS(WHM;JL='_ZO
MG=K*:0J8;V\_OKN\^7"Q%D[,@UAZI0Y2->X\Y$$<!@BZ$4.Q[WLDT:]QU]_5
MTHQH(RUHQ05[>4$ML+Y)&,!XV)3:0V[J[?W90-.WH_; F\F.#H((T@+PA@*4
M5/6@%#WQ+YNL*/X&J) >N@"E(G1>R<<><L'2VCM7&Q?D/LO+]#_U#\1/M2$L
M5H>4^OU/U+_R'2MWN>I7O9E5ARSLCN2WJN6MJ!-/F<A+59UGFVVA[&J75R^D
MZG3Y5SMF7V\ >\S^0 .SF7T]1;IF7_.-L33';?[X?J/^*CG\<.^UKWU?>#[Q
M0N@3$4+$(PPI2I Z8,<,!R1 9MDLNATO;4FXR4JRZ9P8KCIT"=U<7%.R8\UA
MX C[!/F^#&BP!#_ &,:4RK_A@ 41$Y0Y?/TH783L+0>B*\"46T![X#>'/8=$
M#<UC/32WN2H7MO_E1&.BMP<T!<X3K^1'OFP)\/6._DNP$I09^)U(BY2#+Z*L
M5J;.@>*J78.DGUH(BQGGIC!:8Y?6['9F.FDS,%[S1QN^;[;(",;77T56F4QU
M\'QQ7^HL$4=>6]HJ\/7C%:A7@N<76*IBJ7IFYA@X_9;D3%RFWAL>!8GV_.]1
M_L@4+P3[]39[_"_Y5C.[&3],ZF-MS3)O>Y1HIV;?(Z-*W3,A>/%)BO!!D025
MJ>*%/]PHEZ9[+4*>>,3G,$)<J*W1!-)$>GK4(R&.A?0W(K$NE4##\;U.AT:3
M>=_MA%]N(S-00H..U'+QVB=ZK-0J9U3K?!CXX:#?-IQ3VX"W0M*H'+Q51.>K
M\WXNLJ:5V[5AZB_)/MS,G+76M95Z441=_[USX_#.9;NV@.Z[I[\+?BL][&]B
M4WUGQ5WZ</$S+=8>$D&($(,8>XZ,RIT08H\%, AX$H8!IC)H'Q>5FXBQ-.^L
M$1-TY03?E:2&23LC1\4T()P*ZXFM_1B8SXCWQJ!D/?HS$N*-8L$Q0)V.#$>U
M=F[Z^DD>L"K#=NWZH1,%G$$41XFJ[^U PGT"12@2ZK@X]-'(K/3^CI=FZ+I)
MS"\H_YXS_C6IR8;F3WL\] S>%"A/[]"> >H92=YZ"%G/W1[H]HU2LO7 .)UI
MK?G^Z$*1U47$$YD5_TS+N\LM3Q]3OJLC^O:AC_4QVSKPW# (0@P]S*4QBS""
M) XYC!-7Y5A'A!&MXW5; BW-R.UO>I[,%?LA50('G5;/GVS4,JX^>=ZHZOJ
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M+-%C0#E?E*59P4H;4-3J *;T >J; 0\J0>>9"_>L/ME#,ZGO:[56X$F07-.
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M)B%!+(C&D=1.+?K2_-/C!).KKK4 ] DT"( N!"OUBX;&?0\#:'&H?GNT=:#
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M41PP/W$(9$X@I/WUD P]Y-^XX\<^"KDK])B/=3M<6IB@Y 65P"M0B[P"E=#
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MWJQ(M;1%\MOKZU;&^2-VALOS_0 %JABX&[JJA#J'A+J.]'R\0' 1)4X2CB+
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M]Z<PY1_43OB'6CL?!7@VR,QT;FL' ]7/QW-Y*7C33\+S*F($!Q?R:+RO\VB
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MFZ,D(AE.&8Q2?16DRRD2E*<0B1B1/& Y2ZP*=@PKUM2(YG7X0K$<,'QA\R0
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MC%"4D33(\\3I:O9,/U.CNDI,4&HY9Z TDIKB<FKJO2N6]6\L2\9=PMB.U09
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MR#I"9[54_9FXP,.-3[WOJ;<]\YBS,)>40)HC#G&<"DC3$,$T06$6L1@EN@R
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M.(YRQF%$0PHQPP12&@N8"B1XQD0@,J?["%<!IL?S3:[UA59AIOY3EFJ/0I8
M]<A,Y3P>=K<"/E'V3OQ&=/"U@G<G_4P'?E ![DC!9^"_%-+#./E>"]E I^O.
MW8]Z.-X7G-=GV[W;Z1F-=;+24:N(U_N7_2.U&*;\T6T5<'2[W90Z:%A-]R8N
MJ0Y+^O1+K%FADP463-RO%@NY6NL7YQAE.$DB';00<(AQA&$N20YCDN*04()Y
M:'7P_78J3(UQ7T>$_>__A9+@_S32 R.^8V37^)^%'6U/>[ ]$W^[WMY!2JN6
M_H"^@)-U^:H"?#4,ZH<]$#-P%%)X^.V OVYHN5D3MADR2NW-1G*H.+?Q%1@W
M4N[-!N@HUN[M).FYAV@ND>NZZ=^>A-C\;;W:/BL1:ON8+'2"2B/^!U+)^;58
MBB_J5^4<4R1B@G.813S4B1D"F+.$PS@1>9Q&-,N#Q&E/<:5 4UOQC,M2G5J@
M5@D8G4"CU SLU ([O4"C&/A+JP:,;HXQ/U>/K>7^9,01\[U?&66PW+<S R$\
MU/;F6G'&W>X,!-[1]F>H=H?R9FUY$AG7_Q/%@-X+M6H(7:2*8<*8##-($-.%
M*A($21Y0F)"<D4!F&<_BZW*2NXCC1-JC!1K=W'[X MY1(R38D%] 2"G8ICP?
M ^-CI.Q(>#S\/5/P:3_0MO=G%;9T6)GL7:70;T"7)IN!>LR49CY=/OL@[,U_
MTTF8-W;&[ /<9<_*7JWV/(O:TE+\<ZMH_=,/]4=]Q93( (<\D# .HPCB)$>0
M8AG#4/W($469="L:>[*7J=FW>R&!D;)GQM+3B%J>M%R+D^_#$&>(W(\HNB 8
MZA3A9!_C;O2[U#S:BW<^W&_BWSZKS;A.0*G7F0]DO7ZIM^'E/,Q%D@6A@+F(
MJ)K]:C=,X@Q#7>TPB"5/ D3F:B]/5[;S_WQG+A]WNTM_W_A.UJK:*FM+Z\8$
M'1"GC%.<!Y$R6N- &:V<P%R7YL8<QY3D) \#)X(=!N Q6/;#6G!E#.FH[:6N
MNCH&VG;D.PR&GAEX_W5J*<$'*[R<2?@R% ,Q<4='H]+Q985?<[+%&_V(^<_E
M6K#5XU)7]E+V79/%H#+[U"_NQ)(L=,'MFR7_LE135I2;&U-LA<]3JBPSS!*8
MIOJN3R*FF%NQ#)<$DRRA*(^=:.4*6:;&.[58H*C%- STW,CO1C77#)$=%XT$
MO&>R:FMADMPW>LR: MSZESM=S) TVH!:G>%(;0!,!V*]:R09E18'@.PU;P[1
M9#]B_4-LJEXT8[>KO#^L[@47XKO^^0\%C*X?LEJHEAX; =2&F"BS+-(![['.
MATLIS+)40!1G+$M8EJ%<SI<FF)$_V//K%2)93?.\FN9'@OF;\GNQW9-Z7S-
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MOVL;MEAN!:_/8%?+!_+KD_%HN95_(\52V\"?E2H?%<N7FV*S78NYSC%,<YK
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M/,WE)MRH33"N;+"R4$\^K/G=:E$PU>#=>L5N^.IY(_CG!7FTX2FKAJ;&3+7
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M<0(Q"S-(J(Q@JFP5M76+ RJL3!6/,DZ-WDZ%,_<Z*?0QGI;;O;<=)<^DV6>
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M88[C6,?Z,TBEB"'+>8!CA!FBN:W-Y5/0J3'17DQ=XOE[K19@+;U (<U%Q>Y
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M^^)6;"L!+.V(4Z\O:#*V(NHXH;J^PB3&Q#DD7$VC4]W,.S'.*/OF4S_W_)
M"M7$,RN?MZKA*JU&==:@DVGHF<'4SU^?]='"C?R>E:*X4N:,X$J ;,-7$@4L
MXKX/HR!4.P]* D@HQ9"S./)1'"0Z_Z-QK,5P09:V-VD%!K7$.@:ODAG40E^
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MK]J[GWQ7!DDI[C-VG6=E1G1.\D)?$Q:K*!9I*F,,,8T4]0040QIY!'*/^#+
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M]H?:_Z8>9RF,@T! E"A;D01JC\PDPCB.8B%"9EG3WKCSI1'7)6/;9[(NJMS
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MHA C1A,,X\CC$'DIAMCW)0Q]FDI$<(*":%5N2K(VO:0][,**[G<=37B>JOL
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MF^Q8=N# F3'L],,Q,;N^&@E](O;AU4A42H!:"[!3HWKP6]](6%/K." =T>I
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MMKM-=271T0/D:E=3IUW1_]%RV[&9ZQ$UX[YW'*>)F;+5#'14N^AZ]W6U:ZW
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M5C\J521*@L2'G(<$HC1,(>9J<\V$%]) ^E2$@:E;WWQB+XW;]D)K1Z?'1DG
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M]?(]^]7$P%//$P%+.4P]7M%2H*B*,YCZ(N0D" /J&:4A&=3[TIBJ5@!4@E\
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M:UE<U#G.7\!?S7\G<<FP1,S1E:1IK[/>/5I"<7C):/NZ_9&8CIK45:LV:_7
M_76N9KDBQ+84L-[EM;5#5IQ&L>=+K)G)AX@$'*:81I *YM' 1RSF1AY?=MTN
MC:)VY7$V$FP%%^*Q"MK*-SGL:*0SE58J&9Z56P[%^;.R:0">F+A>"PU:J2]
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M 72CT#_EEEN?5ZB9G@,/PV+R@]X*AMNF&OP<_L['D'!V?-MI>N;SV;=*O3V
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MA*+ ^RUY_"8>29;K] +/Y<-FJ[/T[Y^ID_G[J]3#7A!3#E,9*D.>)\J&QT+
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MBE"*8:BC1U%(&21J5P35_T<<<91Z,;?9'PV48VE4UY$/L(WU?FCH:)CMCV;
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M#R&=!P1#C+"  148H3"E?FP406[5Z]*HJ5/.2FUVP=VG/T?5-S\!]7GS=!(
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M>M=*3#%&$?0Y22!*B"Y*XF/(XX12+L)8A$:91/N[61K3="6MHD(J6<UMC1Y
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M4M6UF.0^1AZ.< C3@.00T2" ).8!1"QCC&<D2ZE1=317@LW-1N_TZHYGA69
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M?^+GKC1OS%'N$9S!E*4$HCP(11R+,(RC)&<I8S&AVEEN)WN9VZ24@NZ9SC9
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MHR2^= I0.?HL0I:BNM>[DY 6HJ,ZF.DMY@:P<M[3N90\H#7DI6)7HQRL(&6
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M^,5C*/ 1K?'QO#!;_BLO+K_YV>;X0#E.(]KJ[GWP/%W_QM9/3G*,7B>7,3
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M7IRMWR_6_P'=;IA Y-:""40E@S*2&!;Y%",&2)1*KXWAM'9!P;ZTC?Q$^ E
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MBT=A*(>B]8& C4Q#XBJ[VGWP!F)EW'1L*SOAJ;#01)/271-PBBF8E'8F3+N
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MBLS(:,I+"[0"JH2VE+G(C &H_DYJ3]+V ^^SN,L:0EGMC/FX5DYWO7SNP8F
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MBHG@ G&@NK;K";WGC ;::.T4=X;:VF.$KE.P%Y;D\\52#WTT@*9K,KMI8=&
M)E/D$%V9 ^(R(]8P1[C.,7)#M9;U"R_OIF<OI*GGB[1JNFH =Q_A&\S/,.2-
M"XS;=C'DDU,0;23H7>927:Y(F0U-F&$J 67)\=H=@!\D:B\$ZN>+P+I::P"&
M;Q9+F'Z>;P:,(!]+/U^AD,ZK4[HO9[MC(IL]BQ@/84S$$_H*RA&7/24@T7<
M2+CO:K\F/IC8O6!KGB]LGT;+#<"YW L@ 5]*915NU=FB&VEX7EFPX6VB6 91
M'O-I:VQY..R)TQ"(#J',N(8D;'V[^B!9>T'4/E^(UM9< V!\Z5>%G?)'N8C\
MYF=%6C=WF R)"Y\"B5(X(I.S)-C(2,A:F^P#T]6G!>Y%V%Z =,\7D/6UURPD
M<>^ME]-8&@#>P_1$&Y ^&DVT9KILO]))/)4J"D>-2)Y;4SO2[D/O?BEM^M\-
MP0,HNP%@HT<.R$&8P>TM:@1*B0?"G/#HPN!F==IP8AA-B4*FB==.-=Y-S7Z@
M?(87+945U0#D-BT*2K>('2UK;O)&J>/,ND0,UP+/B>#+2VY)C#"<.\DB.M*U
M;><CZ-L/EL_XRF4P938 U+?S;\C$8GGK DEGYI@&M/%>!R)-5"0HZ0B3,GAF
M.,A<>QC"7;3L!\!G?"-314D-@&TSFVXSDNXF*\:HH%E2)'>-S%WR*!\A"/4R
MLAB=8:+^Q,,[R=D/<L_XXJ:6JAI W8=E>4^R_E'F6Y0QR<6?_;K+=*-$K-08
MH%E&(\K+*F*%DT0HG:VWQ<>H?:.S+VW[X?$97^\,HL0&P/FWQ2+].9W-D*6W
M97!]5YJ^>0E]\^OSX N="2XQYD+7UZ.#(5P9)8XV/SN9A<K1YNKO:Q]-Y'YP
M?<9W0<.JM0'<OCW]ZJ?+(K#CY<6CXN/\;C'__&[Z#=(V:]N=TCE8";@M6?F?
MIYZ$B#&=\J6RV&N59.TNVH?0N1]ZG_&5T.#*;0# ]^S0BW\ZWYD\*)-*];WB
M"G<F3:4.']UMGI7B$@#%7+LAS=[$[0?59WPU-(P:&\#GY4S>6PZ.=":B*T,X
MXQIC/E_&35A#0$3!C,K ;E9]5PC,=].R'_J>\3U0%24U +9[QP9T<P'/-U%.
M@-Y(RN7*GQ*I?1ES(C#^\RF"SYQF4[LGQ+ZT[5<8_HRO= 918@/@?(.^2'G)
M!ENBV^K_?N$_1VF$Y(F@")$IB$"L*:UQDL2/A*@8#961N1=A^\'R&5_JU%=?
M YCL&L?-_>R/%7Q:Y/6?J(L+-T-%*@$WETUEI#:S@@3/+ ')>-3"NBQJ7^;<
M2<Q^V'O&-S=UU-0 WFX.6[_E;Y37N38(PF@NU4]4$Q>3) 88A> RR[%V3Y$'
M2-H/>\_XTJ:FRAI X%T306^E ;+)3+I LE&)R,09;C')B (EP63 _]4N_=V3
MM/T0^8SO=(9080/(? 7AUBT >K%&TP2$FJPPV(\8?SEI21#:HM 82K'^.*M;
M9.R'N&=\:]-7-0V@ZYK@/IV%U31-_7(*J^/E>2>\;[#:]#F_^E%(K^?KKH'M
MN;M!A9<)N"#)48E"-,@T9Y+PC)+5FBM(]>='5B!\/P0_XXN<IU=_$YC'4^%H
MM5J@0)&9OT_77UY_GVY=!EP->#M>=C6C9W%]MNR\G0W#0H4<LXG$NU1N!*@E
MUEI*,F59<N17\?IC&'H2O1_6G_&US].J?>1>>I_.OGZ=36&Y$29\6"X^+_WI
M[F8*GO&4DE>D])1#AX@&#!9Q(X/P,7NA<[CYVG)GHY5'++D?%I_AO<Z0JFG
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MKM[#^F!KOL>']C7ACZ6[DMV^LS$8+GM52E5&-W/())C(2UTR(T%J21*@4^%
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M$ZG]'E]6P= 3=NQH2AO GEYNG+>-QI>U9F]N?H?F^\Q?78SC6<F-_70+G9O
M?291HMLB$W?$*_!E'+?ED48O<_4;OSM1V.^AWU&0>$05#0" 7^ '3*_A/<KR
M-]Q29E,_>7L]7S27^(;G6$6/F0NJ&3%6,6154Q*D,B0R)U3F4GI:^]#M '+[
M/4T["C1/I;P!)M=_0Q>MN8'U'8?]T^J//.A0+ZX+?95\N$WWOO7G%^-9&Q)O
M*5$5D$#K9(A&N)41Z.C!HT]/(@TFT,R58+67[ [D'7+H<X[ON!O'\9-5]LI+
M&<J,-V>)M!B^A! 3B5$+)KD.WG0YPWGR)?UZ8<="P>;Y2ST9]WU">.M=GETV
MUQA[%Y9*"/RM>=/>1_D^+7F%#]-/L#B'V;A)XWC7%>1!?RI.%01+B72EL;UQ
MF5CF A%HOU.4,M*'4SNV'P_6(ZE?)^P40.Q+?P-PV#98G\^OEQW3YG_.RX65
M^ZN1:PF 4M5@VARQ(XY*350RW+C(M//'BUZ?)*U?1^S8\#RFG@8%O[<7Y>A]
M_F%Z%N/UY75[LGF.:PQ:SZ<=%;WT?3Z'R?C[<I;TPYIQ[S58GXASX(@4((@-
MPA+T/C7W%H(ZXI"6P^GO-]%X>B"?6..#0OMJG]G<6S8GH3^\M:J8X4%YXF,9
MTT[+^+>8%#'H$(F< PK_>,#>B=1^\X@]&..CZ7'H<%T.T$&!S^"B^/'K6]@?
MF_E/9P/.!5:&,XFD-9&191)XS$2$(*.TPLOJ$XTJD=YOWF\0<#Z2GH<%[[L-
M".5\/FO^J_7^G]U^I(D<V0S$6R\P1"W7U1(Z6U%IR)K2&/+Q*IWV)+H3I,TK
M@O0)=#LH,*]CUQ6'ZW* G_(*V@?A.%$,>922>>)4I 3W)"6D45J$X[6)[D1B
M)Z#:UP/4^GH;%"PW+WB4@MJM QW;G@.N]/]/D @N04&\0.ZD<#)J;K(51_04
M.E#8"93N]8"RNM8&<U+[WH]G_^DGU_CEZASZCK\W-^W?;W'3^-[,;K8=\U&J
M S?4DJ08+7>.. DY2&)B0E^>:I;A0>;CF6/:P^CIEBR@+Q68O:EN4"9TV>_J
M<_XZ1N<\CZ.?+OZ<-F$.LQ^%PP_3J^O%_/94Y='EBG*V209*4BRCI+)%'\?E
M0+)1S&9N.:1C=S$[E(=N<'^QR;%!J'Y0T/\G^,GBXBUJI\V[H))2Z?7VD#]C
MN-+M="L.L1RP9.*DXH2[Q*E%'TG \<J.N]'8#;HO-IUV$M4-"IKKI?EY6EH\
MQ:+-[W#>C*>+Y7K\,&TS-I Z"B)[(X-/0'3P&7TH[LOV9'&-9OPO:0!U?/-<
MB9EN8']%R;D^P3# LJKWXZF?QK&?W U<VK^TZHF''5I>U97.:@/+9^,??MFY
M]/9]"-!_0OI>BOF6UR7&,-^"4^:H4Q9W[T1S.9>BG#A@0!@(%2@8K>JW*MF?
MW(HC'-9._[8VFG^T?7\@?9Y^@7@]FR%5;_Q\_' U.6F8RHH19ZW%/08=(91F
M),);84#'$-+QCA<J,-#W2,C3H/:)^0\GQL"@_(Q/35&TGZQR-+C'H,N_\-.$
MC-ZIYKQ9C@]^R+8&#RR4S@XRHWNEI"9>9$:RXE&Z*)/4\6C0/XCTOB=5]@WZ
MT^E]4'#?*O@/TZ^H^M:%0VNPWK37O-^:A\VILCX*EP)11E!4 0_$NH#N5#*X
MX)W05ARO[V<5%OH>EMDW_$^/@T$M@S;]?B>#.5J#=S ??Y^V"<WY2@\;HKD5
MS'Q3,C!K;[E-(Y29(P\%]G%UQO\P)"]C"$.RA&;4G50IH@*])9$#,RH&J8Y8
MM]$CXSUW_.A]R;T4S UJH6Y5V^HX8)<B&AJ#TCXE8C1#_Q1C?.(]&&(@NZRC
M32H=[PBS$A,]=Q/I?0'U@84!GOYLE-X\R_0^!T*[/?_0,Z(#N#E.#VV5 N,8
MKA+#J,9(-COB(E<D24J#-A CK7U0?*P>VKO(=J.<UB<#J@PAS:5I-#6&N-(_
MQ%J1M= F>':\D_*]2!Y4S^U=\-.IONY(JAO -O\%8NDEWF9>VV*8ZT4GSA\V
MO%$:E Z"^) 5D4%G$DK3<TN="*662T-MP-:AO-\SF(JX[4&1 ]R8OT "N"PL
M?6J0O>D"?SII77I\)\P/R-%T??*AF_%>'%3:AK>_\6Y62A+:>H2%,4*6.TF)
MV" YL2YY9CE()6M/?'B:HL.-W].R_BF" \[! 5&N]!"VRA,K7"0J266R5#JR
M7-W([4)AOYMP1?3\;-R.IJ@!&K%E#LC?RP']$R9EHNY7/]E_$%BWYQX<3>Q.
M?<51&>TLN&O<[I8CTY>=P_&#JV;N)[_/FNNKN_:!64G'/+IJ&!H[A$D()+ L
M":5@K:$RI "5U_..)%8\Q+GW?-SZ)]=MFF4K/4O/X/;L:_/>'Y)ZEM)XF;BY
M.V;8&$8CN>!.\X0>1'& F5?HQ&A%>.+:FY2!L^.=K9Z,S?X'81P+Z4\<_@P2
M0P,TX*VOO6K^LI3#I]6-V7W,]E-/.]18=Z:TDHENW[=\$:)@W1_G+@#R.48N
M%?&\W+> 5'#J)(F",<N,-IK5[L7Q-$65TUWHO33+%5)\E_+.U0L?%L<Y[21Z
M,02"-40Z:W$EA$P A (9C4KB>-?B=Z&T7S-8$4W/Y(R.H;@!&JYO?OI]C PM
MSR7:#L=[FZW'GW6HT>I(Y7'.ICE@*&'*K%!1V@$*KDB0M/ N0L;0)CI:N^ZB
MSMGTYDVC9N/Z6Y,?D^=&K0W3S&O%"34!B)2X%?N H96VP0L;M!?*/ .' UX_
MJ+/E7?2_[9+7,44_D"N(36X;I*\'#93YW$5T#U. )C)KM2>0+5MVN F*!Y(,
M#8HF4#+LT@ZNTTL'==I[.))JBWF .](GO\#0H,EW@86?IM4,^&;STMA9C*6*
M$/?G\V8R+J/@[V*,C4[8[V#AQY,]MK,C$7+P$/83R*>6[S_[[J?C_VE?@V"=
M(QEI?8'E?(/WC4J;N_*;NSH&X1,/FI+HRT4_!#2Q6J.;956*640#LO:DS2J$
M'V)8-PDXNU7OYZ?5V]J!4<Y90:2".*<QDC9E_##7@G!/6=!6^""[6-G]*>@Y
M0C@YYC8M]8GT-H T\HJ-4E '\X^-;P^C5B*=?O\"$<;M==XW-W=??\-GG_T]
MGH]4LA!$S"31Q%&\GA-O;" \9QJ2"4+YVKV6#Z&W'T2?$D]-3\H= )#O<_"N
MN?3CZ<C$Z"RZ8Z1<)2?( D7AL83?&LVX48['VE=,MM'1KRD]'0I^KFPX3"4]
MAT7?9C[!6GIWS/QKO+AXC[M+4^YSG7V?P7+3^0,N \Q&@5L65%!$8;1'),L:
M!5:Z*BI0PB9KA:4=]NU]WMTOS [7=G-"T0\76M\NH%3[^.G-_/-?T\>YM6 R
M:& DE^U IHA;A%":,&6D\#('Z\-A0.M(2;^Q^:E@=PRU#&#;O'6:EV<<A<5F
MVOK0Q?I3#3*QI$BVS",SKB0B0R+66\:TTC;HVH4S3Q+4#]1Z].#JJ6< 6'O
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MOFL'UW5QOT/S?>9+>8"?+*<C18=+PT6B2\@C10;B0"D2%9A$*?<ZU<@5/4I
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M44;G,NY*D< #)\EZD96V+(C:<S:>)>J%]86NL_'6557?QLS?M,,@OC7G?K9
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M9BX<T1F$EH)1WVW@<G7H;J?WI96YGQ+'%30\.(?REO/<S-XB,>/%QV8^1S$
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M7+T^9RLEW:#VZI(JAVME -CZ=%UZ:'W.]QIUS4>)1\IQ*1"60*-@:")6>DF
M9A6IS"J+VE9M.R7=L/5:TB 5M3( ;/W>-.FO\61RMTA*^F9D3'*LS '-#-(R
M2^Z!!^*D"K'T>:8Y5,;6=DJZ8>NU)3@J:*7G-.\?Z&Q>7E^>PRP6A7U'O_/?
M,!E?-&78SS?_]QN80AXOOC5OX LL(Z _KYHI^JA^\A46BTG;(6P4>%:&*TTH
MQD8EL:V(-]83$VE(45%JY(,\V]94;QUJNF'QM>1 >M)BW[=)9N-F]A5F/\81
MVA"]7-$J!T.X%&?-CY:?^=EEL?A+;2PK,E:"&J%4<XI00O=RR=JG,I'=">*$
M<B8']&<?GD\_<FGN$"JZ=0QY+2F3$VOMA>)S>55U)#P&\ER7BUPEO)=2D>!*
M,5SVQEMO0S+AB/A<4M$-GZ\E%W)BK?5=WO43$Y]S>^2).T(Y6O][^>4[^ &3
MICUD;^4Q J,5IUH2W!?*D/A87!N120054.H9N.\"S#U?WPV1KR7O<2H]#2"\
M^7I]=349PZQX)-.XOF7X.4S&WY?5:-YQ%R7&_B&I7"Y91V(IR[BTA'$N1PZI
M]IWDYVCJ!L;7EA>IJJF>C> [_ -*X>/J.O4;6/P%,"W#0"**]=UX<KV ] D6
M'Z:QN2Q%O5\O4#<C)U" 25#"0^EO1G4@5H(B1DH#(KI,'PZPVFH$]WQ]-]R]
MEJS(J?0T "/X85K&VS>SFU(E22D#%B4N(VTTD4+@5T)QPI22.@,+ FI7KFZ^
MOQO(7EW*8U\-].W-/7G;\"/,Y]\N_-31]KJA 2X (_TRXR&BEYJ!>.TUB<Q#
MF684;:>V"KN\LQN:7DM6XZ@:&8"=>K=Z[=+:?O-_K^L>Q^U-_E&R+AK&%)K=
M<OP9,B<8_PBB0J2@H@\ZU)[6\PQ)W?#WVC(?-?4T -A]7ES ;)E_WJBO=19R
M (QQ/"2QG")@462$:F^=M!!<K-W'<BLAW2#VVA(@A^MD ,#Z:9VL&,(E JG<
M@N*6Z&@ P^A0KN9;9,P'[UR"1%EM=#U.33>(O9:\1F7M# !G[6+9M,%W*T9Y
MQ31U@7!1KJC$E(B3(A $1Q3&2Q]C[0*\QZGIUAGZM>0E*FMG #A#"5U?7D_*
MS?:6J;?-)9)R =/Y^ <LEU%)4^,*:I.#(^&,\2Z5%A!@ROTH-->:H4=@4[0:
M.!.Y=HW[CB1V0^1KR42<0H\#@.FZ>&*46,ZQU$=HVU)K/'&460(BQ!"%5Y;7
M-G[K=W<#UFM)*!PD^0$@IN.">/Q2^UGZK^OYHF1);A>-<2I!L(:(H$H1/S<D
M:.'0P ?))8\\ZYZ,WRYL=,/Q:\M%](V':DOB__SC)[VAA/[=?M1^4O[5%\C_
MJ_S]YY</]YZ/2O@/9'7YY$]^<3V#)M^.L9C[6YTT3^OD:[R =#W!?WQ[#/H.
M%GX\N<_N?'QY-7E0#/W3 >%1R/C'G3P>2FI%S4^@/K%LX.\%3#'N^-\'!@H;
M2^HMDHE$I/7Z.M_@_'->9N'&?G([K'-^%N:+F8\8'?&8-8- LF.T).($L=[B
M0LO<,8B1IER[NVD5PJNE4;[XO_[ A\_P+4LGZ0M2,/L!\U%@,FGKT)?7.I4!
MI@P])1K+?$$4B\Y@5>T+],]3U>]TZ=-C[M'D2QV]#<!?N>7H7\WLWQ^F;3?Y
M^4.6HD=W/6@B2\X<]T*.+IA4A%D&5#G(K'H#D0YD]3,T;X!8K*2Y(8&QW"^<
MXW96HH '+'FFLI(A$AT5LL3+M2YM(^$L21:IE"K:8X'Q<;+ZF:PW0#!6TMR0
MP/BI[<^3N-"L^/R<E2$&#&F/BD01L_&62JMKYPMW+G6H7DXS0'CMJHO]<=0L
M_.0HX4\[ANHZHI^/SCMZ]\NP<'F=\"RE<7FTGWR8YF9VV;YGZ<7/]PAQ]G[5
MH6%,'1XKA2KWB&GG@+7A^%E<C'^TQ^BW$)7)6NF<(#DJ0:3SB*PD0YDX:RW5
M@II4V]'I3-S!Y:NK\+ UR-M>V1;E+B>:HX]*O8V)"%UZ@&IIB,],DDP9Y4K9
MS&CM Z<=R.LW"#D.FGXJ83V2MGK<5^>SQ>AV6_@=2DWNU<4X^LG9W^/Y"%RV
M7)9[78F5F:4NDT AD< =E)Y,UHE.S63P+1MPP^_NH/8D ?V"ZFCJ;FK+OF\
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MIK2*3,?J_3)>Z."'G52_\^"'7?30]_G=D^,)?% :0X=$4C!JN6$[5@;ZT!R
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MA6WT[!\QQ7.@0A'G/#IMP#3QI5TP-9%&Y4OY2NVY1@>0V^U*R"^;)3PU( :
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MPP#[W4:3%A!W3^!^:%KZ5<WPF_757[]=&LQCJL?9@[.1=LR+ ^>EJGD'VJK
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MF]/-AR^W-Z(S%U(;!\*8 HHQ.A8^2>"&E^18*-ZWSFA^D)AAD</G"J<V,N@
M3+51[]GV?)_?\:JV+?U DKK2M3(*R3SW$$2N?)$1HD@<"KG03CI%3DWK@KO'
MZ!GV\OM<(=5,$AV@ZF58;?<IS3]\V8? ?SP-N]W>7W$\&%ER!.X87=_("GB1
MR#]FUN98Z)#HUBKJ06*6-:>.\IK01A ](>JB,<0O&&IH);]9O\5:3TJVX@]A
MM]K]OM[$'6[W311?K?\X/Z,_WJS3ZG1U$=ZXQH7+(^MCM%IR!L[H6L<4"['
M!#I>T;"HF#6AM8Z;:R_+.IV-H/80@)>4>P?X?U!'7%X0R!)S7A1(U2-2&#/X
M@@+J@ GK(ZF*<K16AST\@?2!FZ$/;B.$V $F?U^?[\[#Z9OMJW79XK_.:2,U
M;KT_\W0G^>0-@E.UM;WT$0+# IH':9&+(%)KW_81<I;U;8]RT[<21K^XNCR
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MK7KW(*@=JWKW$+GW@/\5W23XFFZ .VD'ES>"3THK[QWPG#V9AHEN!*D8F/H
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M0_.G_D?(Z19NTV&PF4<F'<#K/::/Z\WIYL.7'\+NP2$S16D4ML9A&<K:\4Z
M+X&<ML"S95D;J5I/9AE$V+)>\C$AUUY./8#ORB'<D0F]_Z9RZVHSUJ<</7.0
MK2,[A3$-SCH/,==&,R9Q9*V=L$<)6C8^?E2P-9-+!R"[]Z7A:DRRXS9Y+>I0
M;-I*\AS(UO"0)+/6"9]C;)TB]@@YRP;*CPFP5C+I %Z/L.W:ZVE*&$.MNF8<
MB5=&@M>(X$)A,4B;M&N=]S.$KEZ*'Y=R6<<)J&_0_6.[?UN/7 NTD4ZC"*!D
MU/6YGH-3TF>?9>:\=8SK*9JZ=0]&HF XS X72=\0N]:=[\6G6L[RWWLQG@3'
M?41O(-9)' HSG=>D(AU55V+A2GMUQ!>1!ZCLUF68'88MQ#8U#C<W-'_%LQ,>
M4U1H/116R#!)Y(M[D11]BYAC,KR$(\*0*.K6<9@=<H>*8[S>VYR%TZ7BN]=/
MT\]__8'KF@\Z7T3WX>6.$,,=N-=%HK:*O!%4:(#<4[IA32%%II(%\B-$2;P8
MP>8J^#E*U/8Z[]^4V^N=6*NR5>2(2X:%C&1&KAEJ2T1GKEQDVJG6G<\?I^@Y
M16</P<Z=?OKMY-*YX7?W\/]*)_W]GWCZ&7_9K,\^DIGK60B,D[^N66W07,U<
M)CAPXJNT2A!#6V?^3J.XCTRK^5%Z1+D^.Q3_%X;M^S\W)Q$-8\(P*$KFVAO%
M@0^YCBH.)@IE8[!R4?!>$MI'J59OF!TCQ=%0_8S;N%D.K(0^/#&%D^L659UX
M1S=+<HENEL#H3%H98@[%R]:CXT:2VD<-6)> /5B2SQ2R+S?GVY-<9\M++X&Y
MVB.=<T%^YK[S4"RZF.A+;&VCCJ.TCV*S'@%[L!R?I37PDO[N2:%S2/>(!\UJ
MTKLMG,ZGY\!42"*SXD0^8MCF$4K[*'7K$JV'RO'9H?5%H96_;C5;X;2T!FQ,
MF@YFD1 Y?:6#,MSJH*5?%K(WR.VCBJXWW(Z7:(<3C_8/B9=;7>?7JQ!7IZNS
M%>XN.C(0,_*OFW6Z^.8J)+PIU_[9Z+?49DM/?5>=AP>-WEBO$W>%=9M"C:_G
MZMTS4(1S<#D6D#QD8TN1$5NG7MU#QE0]NA^0^B(3B]Z'O]YBPM7GFDUPR?03
MGS4K@D5(K/;=DPPA>%9[)9H2&%K!96MG_W&*EGTOG8J#VSJO(?<[N)-?K>DT
M(^T$=]_V<N(EJ6/F"V3M/*@:W8^2F&2319]9*H6USHN]EY!EWS!;(V<ZKSL
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MZ2'585:(M.%P![?25P_T:P[D5QWH7/!:20@V\YKR**H/JL&BRKEH3??K;$\
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M)_R,ZZM=E>"L8DA7N*!=96)BL*& E\5C3H:N]S)=*5U;<=DDV6-KI;&L[AM
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M7MEH2!>;VOBTU+PC+VI)F XY^B2T9<-@:^^<_YZ#[B-Q_@RQM0VG)".0>Z4
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M)3]]?;7!3SL+P&4=7&)0C/*U9I0L ,D=Z, -9G0LV-;^6YN53Y/_.*"!/H%
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M&( YK34YWR*%?;)&CGGV1$.XFFN\P?G>@>)[T/E^P$CUAFOCI"-/2-!VL>C
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ML&K3A?CQ&O553;2Y6S_WAIZ]>K-=0>V.L%S/=RDX0DJC BD$6<.C*G"BW(D
MK 3+Z^40:YZ T&+=T^:5GR/&AX-%OTKY%SR$9I6TXK3C(9.G033G2$H@&,BJ
M-N:J79]EZUZC+=8];;K[.6Z%X6#11>#B( 5P-3KI ;JU()^=:W+B/:^I4?6Z
ME?QNR*$PKX)SW(]DT!RX\FFS]\]Q0PP)C7,['=[A9G.QK0U<_WN^^4COKT*Z
MW'Q<KG:1**QEX;PPB#IK4#HQ<+*$VI$[Q2RB%&8DB^DX J8M1SC'[3$"4'H^
M.$[JR*$]BTFC!Z5(7RC&';@H$TCFO>:ND'Q:A\6FZKLRV+7-.>Z9T4#3\\Z9
M%:>RYFB ?*=J.S)-MB,I ROKH,.L,A.MHYRG!(4&NRPZ1P0?)+P3@T(O%Z?A
M\ =C-8--3#!;Z"0RM6\,!HB*"RA<..V-2D[NTPGH\2=T7.9_1.B[(3<[L'X;
M34%WB"(S'H!92U0+152;J$!XR8O():.4C559FY5W,87T) Q]=R,SND [@/%0
M\ZA9;;VO49*"T 64#0F<*QQ$D3)E%0)SK=VY@4B9^MYG?%0N^X-(GUT%?S E
MO5AADD$(W+':%+N -SD".F:#D+I$W">-=[ 9]X-AM@O G#SC_@#I=:#'?PH7
M-1_PW4?$S6_UW576=>=G1VR)WH!TGCR_:#4X0YPC%<"-0%$,$XT5\6-KZ6)\
M=$N3H0G3.P7/U9XSRAH;E85L;(U).]ISWFN0W IF.*O_C "?'H[B-M+> T)'
ML+X#$#VM3C&(+ *KB<G1@#(B@9=:@'!<,,XP<M^Z>+GC$[*5U.\WT&LF@HGM
MK0?U]6\WK82]+0IE\B")(Z!D=,2C**%@*MFF9"Q/>UA63S^EBTGR+4ZKQ@SM
M0-4<.83+^V)M"@JX#O7F" WXI#V$1#][&T41K4VA(0>FC0:](W'29G+:(4+K
M%YI[#5#RVI0ZSP:2K:-9"R<JHT[ LQ!%%=KQ;*1,J69CK\:SY@<%:7/Q]8O4
MP[*X"G?9!A?!H%*@O _@47DP7"5I>30XUDW<&23W38/=X03:+X@/R\HM+#+&
MM02+F@&94XK\-V:!V<RQ,&64;GT',UJR]M SX<93P ,)M,.!'K_C9L=A(NW=
M1Y+&_>*][8OK/]:8YXO:C_]R<UW5%]8U[)I_F5]<;C!_]T%'%S<.OJ132QW'
MY5FCPL>7856S,-;7C[JY7B?OKA0=$'QV&<BK(X<OD&41N"XY>I\R:]T._K&U
MG'S!>#6JY75YL=C,<V4R6??O,%WN\OEVR2F8MZFQW^3RNMQ?T,X!1J]I ]L,
M1@I9F_L5<%G4\$@=)B&STJKUU,2V%$P;>&J"N.\N"*<3<0<FR(DT__3UX0_8
M1I:-B5*E6BJ4&;'"&0'.*@U:U.PKI1WJW!CM Y(S\:WDA"A=]@F9;G?/[^$3
M7L7#4\@ELB3 ELIG7AN<9*<A5-M.9E&S"4?9 M_6-"V.NP'/7J ^4I(3WS^\
M))-X^17QW6:9_K_7GZ]F79'OL5G-$QF)V]>OKE6TU59PX2&5.J.ZA 2^, Y<
ME*A4-FB-^(%U?> C>\3?L7)>#L_TB;&T7?:;RU7Z&.KTM,76WKHB(Y1 ^ZT.
MA-$NU6%"]7(N24@LH8]"2E[\'MAYXA'3IA /AI563.WV!-Q;GW\+NTC.>&12
M )>,3/@:^G"%E'=POG#I=7#-^X.W6ONT*'T^EN%Q8.A@$]Q$76K?UQ=?PORB
MLO+]DJC]M%QL=_O'Y07!8+T-U]RXK=P5)VQF$-.V%2R9+D%%!989%!IM<;RU
M@W3D4GL\M(?&U7)\(9\?EF>:%2F,3H"Q("BM/41E$FB-.@9C$H;6:0D'+G%:
M[(X"F].@>I ,)[9']R?M1?[OR]V\BQD3COML.6UVC;NBZ\@5*0"154860W3[
M3(D\YMG3V@9C@F\4Z70P>.G?6 <)8'[Q!5?A _Y^6<WVUU<W-*\O-^M-V'6D
MO&9FUD7P)#.D6#BH:!Q$R4*=:F>TS;EXT;HY[*%K[-'/&OEX'U2L'9SK^]*W
M.Q&RL\B<"X R&% Y$"<9_4A,1"ST53=/YCIH@=.>Z<-BY4A@'BZXHU%)*XG+
M1KC<YD;4<R!<7)T26\)>;#:K>:0]OST_=K'?L,;\)GRM;WZQ6M72K-TT*RTP
MJ!(CV$*6BV+DL@;/+%B78C91.-,\,_;T54^K<D=%\,@B[E?97B5I?,?EF2+#
M2K-J_?@L:D!80,R2@8S%):6X4W(D$^&Q)4[;4+ 'A=M$>!W8K]]=J=VQ_*W!
MXHRO@V2DJ>%G"<ZG#(&)DG))06+KBKDG%S0M[KJP3-L)K /-^" Q,^^,$8RV
M:\X^UZ"S B?)_23U+F.-0O#<.A#ZX$+Z2F\Z0=#[0.@@KG<(G2N%/(O2*DLF
M ,3:@54)SL%Q9FBK*9>S%B*4UN;?(TN9UJ8;#S['<'[ZFLQM"O9U/<&KQ5O,
M^&E[3U\'$V']$3]56_3WY2+5.]GE!7W0A^LZF5EB:$51"8SAA4P*I-V".D+B
MP2KMHLYLG]ONDQ<R;2?;24_$\079>FK>@&GV+W+>%A"$BU>+LEQ]VI5E-TN9
M?^KCFZ>_[TW+X*GLB-&5DL%&1QJN9 ^^%H,@J;FL>6(IMXZ#G4DJ.S-H5:ZE
M^"F2UZ,#Z7Y3?2UT07&KO RMRX[^'JGL!R!NX%3V0T3<@7WXT^6:3I?U^D7Z
MG\OYKIAJFQ9*U@@QU7A(*!THF0V186)-:U&,A\0CMG8N'EG*LTHA/P@=]_O&
M-!!5IXBKWZ[P.D,P>L-#+ YR];.(AMKN.U@PF@<19-866V>U_7!1$S>/:2'Z
M/>!TO!RFSG"XW*RV)/PT7Z[3'!<):P'I57JHC\X9SBQ9J\F#,HPXM*UTLMEH
M)U"AW:=YS),/Z0\@)PAS.01G.] ]+VJ+Z_?TYNWN$<X5BYH#,PE)(W-:/'E8
M(!UY5B9%\JA:7R#<6<"S2H$]Y60[7BP=8.K;'5SE$B[65Q+\=A'WT]?O[^DJ
MQ=_(7N0W%V%Q*TF^9JUSRQ7(N)UX80SY^+1O;<BF"%54+*UO%(:@8^(,V.-A
M==]'F%K&'>#\X:J<Z*7 )#QY7H(VNZ)M'XK3((1RT?' .+9O9MY=@=3T^/BN
ML_FIPNJAA&I7$;9^O=K^M!L3E%]\IO6D78^'M_72^;K9H2I!)L,13%9T##':
MY9Z9 %Y+#,SJVLUFW\JJ@YX\\3G>"_9&$-O4H*QL?$EF]9=P41E[18$LK"@R
M=D#H:O^P(,%I%^H$%<8"*H5YGZ[?#W_ZM'?Y?8'K=/9/"*#U:C-[_>>"/N?C
M_/.N]+I@S7/1($6=E1PDJ6-5,DC%2M8$?Z;WFNA%GWSKW*2?OIV9WSUT8CA-
M[W.<)H9>\'.UDWAP(AA2FQJK[G3"@<_10A%!A<!)H;J]HK3[(FA*J_Y$P3TD
M_B.X./F-/'W.(NRN^7Z]"%^6J_6OJ_!A%>[&921#@5A;L6EA045?(*IZ7>M4
MS?LL*=\WRQ^Y=]_K<1T XAA1+H?EZX10R3B?_88?PL5+4K.;K[M8,2J-NF8J
M%23_%WT&%Q,#STE-:E.844\U&%MC^G\^++_\'_KHG:J@;[YIB0<>.&W*10<G
MS:E"F!@_NU5?FVP\8;(F@B;3BIA@(ZT[2F!,2R\<B]H\U?3UQ^"Y_;1IU,G)
MXEHVX-W$Q\LOEV^6BTW&W_'3\G)U2^]EED/**4))DH[:A!*"L0J"]ZA%R(J;
M?7SKQSY_.HD?+ZEE8[9U$.)KEJ>F@B733$3PJ8Y'05W;P3H/,2G&4U+1\=8]
MHD?M2S+84.\.CJU)P3"U_J,ON*IWG+NYN3_AYD_$Q2XI^/%^L3/O(K/6*!"V
MEK0(@1 "XT $*Y1!6>'W27,]\O'/I,_(03A9CBNT#I3SG38!M+.M<HQ8)'FF
MH\K7J*GA'$K&6!1SELG6[8+O+."9%+\?@[G3!=(!FAY(&*F1U<W7ZXSO]:OU
M^A+SZU7]=YL8?J=^</?;&1<,Z1R1H*VB8R5H"RY[<KIE+ED*S[1HG>K;9N7/
MI$3N%/Q. ($.@'^KJ\J;L*IW5+7D8%L$<7,R:)5<<+Q.,PB^7E#4YBI"@-!2
M64Y&?62M+[7W6-8SJ6$Y!;*MA=<!'A_8A41*JJ+]0&[ ?RXWM\IPUE=)?7FF
M5'%DPQOB'0^@<C(08ZWMUYAB+,9YVWQ(YU$KG=:?Z@*U(XBX R"?R.J=[4Y$
M!Q$-4R +K]VLE(8H,0(KO#8&8'30Q,:X;K+PO6!NGC7,QP= Q]&".\[!S=E$
M6SI6 HDN2[:2(S(]EV0P1<0DT'-7^%UT'QPG>/#!>Z'3/DMT#B^H/E%X/^QQ
MASR-AMN4$0I*!LIP5VO0$]@4/,N"B-3Z>!P^]>B]D.C^;DAL)JR)L4A&^6:>
MYI]#M6B^,?B7^7K7M0KSBT7^8Y&__7S-XDKQ-^;LL4&-9,A2!!LL&4=&2SHF
M/ =#1"NI>=@OV7.T!>^%>_]L<=\G,)[7;GE2B63M47.=02A3E0AQQ*%)(&1
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MVI1A\)E'G9/BC6VQPU8X[1U>4]B-(*+^=->O\T6XV-7AUOK,MV&#E7G%!A'
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M#OM4.Q_XV/U0]QPOKH:4S[G&1\@GW0Z)NPP7M0G<+.0ZD-,7D%;7@B8KP*G
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M"QU,.4=POC;32HEQ5"9&W;J\\%FF%A\$@B=3BP^12 =P&B3[2QLGM#0>ZK"
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MSOA"/6?%?8_\^3+SF>1!N202H&$(=% AN.@CH"O22.931MZ+"G]@_9U;*,/
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M3-:\:!;=\[2TFV#R,]W!_Z4BP9AX?M&)P(]'\P?$T<2EX,9#9D%652<$%[@
M%!J%Y<$%T8W67NO)O_B;I!<0",;$\XL.!/MK@0M"]=-6\S*6PK4#SEA];2$3
M.%MEJ+E6/'M5A'[VS@?/,O,7?W_U D+ :$B>JP3TR1<33YM1%J%B# Y$Y)54
M'LB,'BTD'E%KBJK1W&)4=G8UUF;ES_GN;/25W[F#!V'X1:<" XY5LF;92)[
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MD0D[<?_/&_R\08JA;Z@\^+S>+/-V$:0KT3I.!LBB/IQ"<"CHCQ@8ETIP&>(
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M?ZJ7.H#>HY2^>RSZ?HEA>;:[U'USL:D.HO_TPWH5+_^P$$Y'9ET"Y*8^Y*"
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M^*3]V\/J30-_ N"=YJI3%8H_C0C"2V':O$JULM\N:$ZN8/!0G""S^8(0?&'
MDA72<1[;][5^:DR]B=5/ +\3G-1?>YGOYTA;,M9>I_/7S2?\\\V:_%K_[7<_
MI!5>Z,!+LL"RH<I-9P,>#8+3H5B130GB%DWKT)XS T?2F]C[:$"<P'&=BKC?
M,6V=ZF89+G;OLE[_M5N<5/PLX_(;KLX7VD6;,GHP)J;+HR_*22)D9%+$J*R,
M$]3'CP^Z-R'V'JKGAF[N,O6\,^&K%V6_X3(M+*L=1HT %PJO8MH.@LL*F/$F
M"Q$R-ZT[F \<8F\ZZ3U@]F@73AI[[]]KWEQLZB/%W6;S:I4^YO/SL]TMU/;N
M05?43.TZ\F@>JT@H%8,!!5D9750FJ!C0'94?#!C$07CT+P"/S^NN3K."/:F9
M9DW>B7^]_3/NS%U?8.]?Y-Z=-B8?B\D."BHR=KUZ\#Q8T%FY0MF\-<VIYDT&
M?MC9.GL!T)[.WSV?#[R^V-(_V6[?K+^&Y6HWM[K$7\7_NEANEY?YT9W)*Q1:
M<Z] 8VT1(KBDR7,#T=ABH\G!M'^!U63DAZ']A5\EC>WQ[HXD[DQGQ[)<%"9=
M$6DG%\PO)9=0&DKZI?*,2RL-CT<E%O=_[S#LO83KI-&\,(]::R%<8();3]F/
M8V2SR,!EYB![@4XHEECSQT/-;M%?]@73:;XZ\1K][6JLA/7*DC_C<O-_\.PB
M_UJN]6!N6I.E8@+W"03%:U#.(Q60F=7^"UZK1&4D-F\G</1H>[M^?S[:45,_
M=ADT[YWA(N7L"ZLLYU3UU!EJ<$R;RFDQ2J,4WHT?..\=6J\4I+9(>;I2.MEM
M'5.1=I? 9U>:@S?F9]&*8&@/\LAI#PJU%:?7D7Y!%K6EW^/XYZ4/C:ZW*#D1
M,ILXK\M0>>NN8J\1MUED+;PPG$-QM>5)\O66F&LH"87@2J%-XRM /C"X7KE,
MSPS*%J[K0EKC <K"SGQ/W*4E78*MR5$2-<&62=3V*!P8XQ@#ERGYUIW1CA]M
MKU2H9\;M*,[M,KA>S_2'ZS7I,Z?_U?LT7:5>BX1@;82 Q6L1!!?86J[AT+'U
M2I>:#*)'.Z[3VZ?K_O$?\OD5'_&GB_QI?>/>C2]B$2E)6FM"UCV$!0<^L@2>
MQHE&IF*?H58Z;*R]$JN>&;(C.+93"%];\];5VJ<-KK9G.]=_9]J6Y+.,MH /
MHM!\(Z-4W4O0)B1MG++%C,^I&C+B7@E5DT7@QDZ>^77IC=I31<9$*!Y,BKDJ
MQ13:C;@$4S6-%-/:J?'?F P:<J_$JV?&]GAN[NYR]'H>E_=QWB!F-%2,*I=
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MO [0V7X67_?*_CAH]K]MENO-C4ZY;VCPR_-K0QB;DJQ$;=R]3-J)G&3#P,;
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M^4& &,Z5'^"=WN&V)RQ8E6D*5#2F>I^F2B&#!94AHBS,29ME'K=WVSRY\D.
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M0;) Z9MS%$QHD0%E+I%KBE[\N/R69UFT?A003BA:/\8J'0!M1S$N%X4B4I?
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MWV>UR#8HGABE+0?XJ4._-QW[P^@0&DWM/7BIQ?+WQ9*\>5W#(X:"9',6V@C
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M V8Z&;$VY 0<P4X]H>\@HN3LHV/UZ50I4J+BD0+6X!&R<B)YYH/PK9.?O]Z
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M1W6;T45A:Z6OC%*15K0#%\A7<T-9MS4Y2&P?;)U0*3O![)BC3/M<?>PQ>NX
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M5@55IE5P#Y(A"]%P-,TG'PS@G^^D0J-=A'R2';I$T_8A.<@L0F5.='5TEZ*
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MN68Q>J0&HX0RJ#F@P#HZK::NTEJ0@667?,BTH\<#]"$B]D:GT@&PFUNVPS+
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M$)S]%XF-C-8M%#_-EK=,NJ0OEZVT8(R.H+P-$"KI(\I2T*$-R0][&KGWL<,
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M1?YQ7H<-W1'%W_]3Q%_"#2V0*#QSHRA?C@%IG4Y2YJP=I%C0%BZ9,:[%N^T
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M;V+XD_4WL>$_S-9UYL:/\SS[,LM7-W>:@2=G:Y]U]IK5P><4]C!4D$7,7E'
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M[0+^&;ZTJ_U;=)LVQB76T5*#G& I-5\RI+!.ETK6$L8)]S'W8[&>I%8+QCZ
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M\&]\C;[]1?IBS3+\K__V_P!02P,$%     @ <T1<6)JH%J"A(   ?3,# !@
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M(ESEDX>W*)C-"K]BV7P<H#J@@+\PNVLH_7P;8'%T,,*'(GSU-K8Z-:#RB4D
MO-CR1OJZ63X)_>JH>=&TLVQR1OAPA#^]=]8IP/A&^YI=/'QFV#<4@';I.*-
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M-FKV+SOH^N;R:Z7]5?X7G5Q>-CN J,"X&*$+[!*/A0#I,)TI8C53]!@CF<,
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M?D^9RK5[>0L2""9U%UUX B:H_'J7+USEJ__&BX4GX4+C_P!02P,$%     @
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M!(.M*-AOLT5EAD7D/NDPHQS07Q68@8?@GI)/AC"\BA(84EDP%G6>PUWRN@P
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M'5@.9Z[439A:?0:F->H2N<(%HW^VY6SP#]Z>3Y?IXTW]_P]02P$"% ,4
M" !S1%Q8R?U)#/<7! "(@CD $               @ $     :69F+3(P,C,Q
M,C,Q+FAT;5!+ 0(4 Q0    ( '-$7%A,JHR7[C8  %^' @ 0
M  "  248! !I9F8M,C R,S$R,S$N>'-D4$L! A0#%     @ <T1<6%P1,&YG
M2@  .Q(# !0              ( !04\$ &EF9BTR,#(S,3(S,5]C86PN>&UL
M4$L! A0#%     @ <T1<6/5/,9KKA@$ 9 82 !0              ( !VID$
M &EF9BTR,#(S,3(S,5]D968N>&UL4$L! A0#%     @ <T1<6&E]Q*J^> $
M./D! !,              ( !]R & &EF9BTR,#(S,3(S,5]G,2YJ<&=02P$"
M% ,4    " !S1%Q8S52WJKG? @!@D1X %               @ 'FF0< :69F
M+3(P,C,Q,C,Q7VQA8BYX;6Q02P$"% ,4    " !S1%Q8'<D4#G8" @ 5(1@
M%               @ '1>0H :69F+3(P,C,Q,C,Q7W!R92YX;6Q02P$"% ,4
M    " !S1%Q8FJ@6H*$@  !],P, &               @ %Y? P :69F,3 M
M:S(P,C-E>&AI8FET,C$N:'1M4$L! A0#%     @ <T1<6"W9R*"( P  TPH
M !@              ( !4)T, &EF9C$P+6LR,#(S97AH:6)I=#(S+FAT;5!+
M 0(4 Q0    ( '-$7%A@1LJ:D@<  -<H   9              "  0ZA# !I
M9F8Q,"UK,C R,V5X:&EB:70S,3$N:'1M4$L! A0#%     @ <T1<6&8%]3^N
M!P  "2D  !D              ( !UZ@, &EF9C$P+6LR,#(S97AH:6)I=#,Q
M,BYH=&U02P$"% ,4    " !S1%Q8@GFB/]8$   B&0  &
M@ &\L P :69F,3 M:S(P,C-E>&AI8FET,S(N:'1M4$L! A0#%     @ <T1<
M6-&Y8$?[&P  L%\  !@              ( !R+4, &EF9C$P+6LR,#(S97AH
@:6)I=#DW+FAT;5!+!08     #0 - &L#  #YT0P    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>161
<FILENAME>iff-20231231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2023"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2023"
  xmlns:iff="http://www.iff.com/20231231"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2023"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="iff-20231231.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:OtherAddressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">iff:A1.750SeniorNotesDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">iff:A1.800SeniorNotesDue2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
        </entity>
        <period>
            <instant>2024-02-21</instant>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">iff:TradeAccountsReceivableWithTheCompanysOwnFactoringAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">iff:TradeAccountsReceivableWithTheCompanysOwnFactoringAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">iff:TradeAccountsReceivableWithTheCompanysOwnFactoringAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">iff:TradeAccountsReceivableWithTheCompanysOwnFactoringAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">iff:TradeAccountsReceivableWithTheCompanysOwnFactoringAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">iff:RussiaUkraineWarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:EG</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">iff:RussiaUkraineWarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iff:BuildingsAndImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iff:BuildingsAndImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iff:InformationTechnologyHardwareAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iff:InformationTechnologyHardwareAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">iff:RussiaUkraineWarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:FiniteLivedIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">iff:RussiaUkraineWarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">iff:RussiaUkraineWarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">iff:NourishMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">iff:HealthBiosciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:FrutaromIntegrationInitiativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:FrutaromIntegrationInitiativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:A2019SeveranceInitiativesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:A2019SeveranceInitiativesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:A2023RestructuringProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:FrutaromIntegrationInitiativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:FrutaromIntegrationInitiativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:FrutaromIntegrationInitiativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">iff:FixedAssetWriteDownMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:FrutaromIntegrationInitiativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">iff:FixedAssetWriteDownMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:FrutaromIntegrationInitiativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">iff:FixedAssetWriteDownMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:FrutaromIntegrationInitiativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:FrutaromIntegrationInitiativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:FrutaromIntegrationInitiativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:FrutaromIntegrationInitiativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:A2019SeveranceInitiativesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:A2019SeveranceInitiativesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:A2019SeveranceInitiativesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:FrutaromIntegrationInitiativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:FrutaromIntegrationInitiativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">iff:FixedAssetWriteDownMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:FrutaromIntegrationInitiativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">iff:FixedAssetWriteDownMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:FrutaromIntegrationInitiativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:FrutaromIntegrationInitiativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:FrutaromIntegrationInitiativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:A2019SeveranceInitiativesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:A2019SeveranceInitiativesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:FrutaromIntegrationInitiativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:FrutaromIntegrationInitiativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:A2023RestructuringProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:A2023RestructuringProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iff:A2023RestructuringProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:NourishMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:NourishMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:NourishMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:HealthBiosciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:HealthBiosciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:HealthBiosciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:ScentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:ScentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:ScentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:PharmaSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:PharmaSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:PharmaSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:HealthWrightProductsIncHealthWrightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <context id="c-155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:HealthWrightProductsIncHealthWrightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-01</endDate>
        </period>
    </context>
    <context id="c-156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:HealthWrightProductsIncHealthWrightMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <context id="c-157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:HealthWrightProductsIncHealthWrightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:HealthWrightProductsIncHealthWrightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:HealthWrightProductsIncHealthWrightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:HealthWrightProductsIncHealthWrightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-01</endDate>
        </period>
    </context>
    <context id="c-162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-15</instant>
        </period>
    </context>
    <context id="c-163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">iff:InternationalFlavorsFragrancesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">iff:DuPontdeNemoursIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-01</instant>
        </period>
    </context>
    <context id="c-164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">iff:InternationalFlavorsFragrancesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-01</endDate>
        </period>
    </context>
    <context id="c-165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-01</endDate>
        </period>
    </context>
    <context id="c-167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-01</instant>
        </period>
    </context>
    <context id="c-168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-01</instant>
        </period>
    </context>
    <context id="c-169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-01</instant>
        </period>
    </context>
    <context id="c-170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iff:FlavorSpecialtyIngredientsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-01</startDate>
            <endDate>2023-08-01</endDate>
        </period>
    </context>
    <context id="c-171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iff:FlavorSpecialtyIngredientsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-01</instant>
        </period>
    </context>
    <context id="c-172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iff:FlavorSpecialtyIngredientsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iff:FlavorSpecialtyIngredientsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iff:FlavorSpecialtyIngredientsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iff:SavorySolutionsBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-31</startDate>
            <endDate>2023-05-31</endDate>
        </period>
    </context>
    <context id="c-176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iff:SavorySolutionsBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-31</instant>
        </period>
    </context>
    <context id="c-177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iff:SavorySolutionsBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iff:SavorySolutionsBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iff:SavorySolutionsBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iff:MicrobialControlMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-07-01</endDate>
        </period>
    </context>
    <context id="c-181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iff:MicrobialControlMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-01</instant>
        </period>
    </context>
    <context id="c-182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iff:MicrobialControlMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iff:MicrobialControlMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iff:MicrobialControlMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:TechnologyEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:TechnologyEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-193">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-194">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-195">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:NourishMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-196">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:HealthBiosciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-197">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:ScentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:PharmaSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:NourishMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-200">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:HealthBiosciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:ScentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:PharmaSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:NourishMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">iff:HealthBiosciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:ScentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:PharmaSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:HealthBiosciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
        </entity>
        <period>
            <instant>2023-11-30</instant>
        </period>
    </context>
    <context id="c-209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">iff:HealthBiosciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-30</instant>
        </period>
    </context>
    <context id="c-210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">iff:FragranceIngredientsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-30</instant>
        </period>
    </context>
    <context id="c-211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">iff:PharmaSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-30</instant>
        </period>
    </context>
    <context id="c-212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandTwentyThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandTwentyThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesEuroNotesDueTwoThousandTwentyFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesEuroNotesDueTwoThousandTwentyFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandTwentyFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandTwentyFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesEuroNotesDueTwoThousandTwentySixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesEuroNotesDueTwoThousandTwentySixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandTwentySevenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandTwentySevenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandTwentyEightMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandTwentyEightMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-232">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandThirtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-233">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandThirtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-234">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandFortyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-235">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandFortyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-236">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandFortySevenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-237">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandFortySevenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-238">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandFortyEightMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-239">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandFortyEightMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-240">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandFiftyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-241">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandFiftyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-242">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:A2024TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-243">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:A2024TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-244">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:A2026TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-245">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:A2026TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-246">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-247">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-248">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:BankBorrowingsAndOverdraftsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-249">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:BankBorrowingsAndOverdraftsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-250">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">iff:CitibankN.AMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iff:EurocurrencyRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-28</startDate>
            <endDate>2021-07-28</endDate>
        </period>
    </context>
    <context id="c-251">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">iff:CitibankN.AMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iff:EurocurrencyRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-28</startDate>
            <endDate>2021-07-28</endDate>
        </period>
    </context>
    <context id="c-252">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">iff:CitibankN.AMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-28</startDate>
            <endDate>2021-07-28</endDate>
        </period>
    </context>
    <context id="c-253">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">iff:CitibankN.AMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-28</startDate>
            <endDate>2021-07-28</endDate>
        </period>
    </context>
    <context id="c-254">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorUnsecuredTermLoanFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-01</instant>
        </period>
    </context>
    <context id="c-255">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorUnsecuredNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-01</instant>
        </period>
    </context>
    <context id="c-256">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorUnsecuredNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-01</endDate>
        </period>
    </context>
    <context id="c-257">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorUnsecuredNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-01</endDate>
        </period>
    </context>
    <context id="c-258">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:A2024TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-01</instant>
        </period>
    </context>
    <context id="c-259">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:A2026TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-01</instant>
        </period>
    </context>
    <context id="c-260">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:A2024TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iff:LondonInterbankOfferedRateLIBOR1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-01</instant>
        </period>
    </context>
    <context id="c-261">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:A2024TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iff:LondonInterbankOfferedRateLIBOR1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-01</instant>
        </period>
    </context>
    <context id="c-262">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:A2026TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iff:LondonInterbankOfferedRateLIBOR1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-01</instant>
        </period>
    </context>
    <context id="c-263">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:A2026TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iff:LondonInterbankOfferedRateLIBOR1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-01</instant>
        </period>
    </context>
    <context id="c-264">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:A2024TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-01</instant>
        </period>
    </context>
    <context id="c-265">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:A2024TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-01</instant>
        </period>
    </context>
    <context id="c-266">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:A2026TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-01</instant>
        </period>
    </context>
    <context id="c-267">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:A2026TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-01</instant>
        </period>
    </context>
    <context id="c-268">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:TermLoanCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iff:SecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-23</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-269">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:TermLoanCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iff:DebtCovenantPeriodAxis">iff:FiscalQuarterEndingOnOrBeforeMarch312024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-19</instant>
        </period>
    </context>
    <context id="c-270">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:TermLoanCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iff:DebtCovenantPeriodAxis">iff:FiscalQuarterEndingJune302024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-19</instant>
        </period>
    </context>
    <context id="c-271">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:TermLoanCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iff:DebtCovenantPeriodAxis">iff:FiscalQuarterEndingSeptember302024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-19</instant>
        </period>
    </context>
    <context id="c-272">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:TermLoanCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iff:DebtCovenantPeriodAxis">iff:SubsequentFiscalQuarterEndingOnOrBeforeMarch312025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-19</instant>
        </period>
    </context>
    <context id="c-273">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:TermLoanCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iff:DebtCovenantPeriodAxis">iff:SubsequentFiscalQuarterEndingOnOrBeforeSeptember302025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-19</instant>
        </period>
    </context>
    <context id="c-274">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:TermLoanCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iff:DebtCovenantPeriodAxis">iff:FiscalQuarterEndingDecember312025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-19</instant>
        </period>
    </context>
    <context id="c-275">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:TermLoanCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-19</startDate>
            <endDate>2023-09-19</endDate>
        </period>
    </context>
    <context id="c-276">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:TermLoanCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-19</instant>
        </period>
    </context>
    <context id="c-277">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:A2024TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-278">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorUnsecuredNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-16</instant>
        </period>
    </context>
    <context id="c-279">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandTwentyTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-16</instant>
        </period>
    </context>
    <context id="c-280">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandTwentyFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-16</instant>
        </period>
    </context>
    <context id="c-281">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandTwentySevenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-16</instant>
        </period>
    </context>
    <context id="c-282">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandThirtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-16</instant>
        </period>
    </context>
    <context id="c-283">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandFortyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-16</instant>
        </period>
    </context>
    <context id="c-284">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandFiftyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-16</instant>
        </period>
    </context>
    <context id="c-285">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandTwentyTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-15</startDate>
            <endDate>2022-09-15</endDate>
        </period>
    </context>
    <context id="c-286">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">iff:CitibankN.AMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-06-06</startDate>
            <endDate>2018-06-06</endDate>
        </period>
    </context>
    <context id="c-287">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iff:EuroInterbankOfferedRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-23</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-288">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iff:SecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-23</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-289">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iff:DebtCovenantPeriodAxis">iff:FiscalQuarterEndingOnOrBeforeMarch312024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-19</instant>
        </period>
    </context>
    <context id="c-290">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iff:DebtCovenantPeriodAxis">iff:FiscalQuarterEndingJune302024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-19</instant>
        </period>
    </context>
    <context id="c-291">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iff:DebtCovenantPeriodAxis">iff:FiscalQuarterEndingSeptember302024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-19</instant>
        </period>
    </context>
    <context id="c-292">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iff:DebtCovenantPeriodAxis">iff:SubsequentFiscalQuarterEndingOnOrBeforeMarch312025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-19</instant>
        </period>
    </context>
    <context id="c-293">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iff:DebtCovenantPeriodAxis">iff:SubsequentFiscalQuarterEndingOnOrBeforeSeptember302025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-19</instant>
        </period>
    </context>
    <context id="c-294">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iff:DebtCovenantPeriodAxis">iff:FiscalQuarterEndingDecember312025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-19</instant>
        </period>
    </context>
    <context id="c-295">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-19</startDate>
            <endDate>2023-09-19</endDate>
        </period>
    </context>
    <context id="c-296">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-19</instant>
        </period>
    </context>
    <context id="c-297">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">iff:CitibankN.AMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-298">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-25</instant>
        </period>
    </context>
    <context id="c-299">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">iff:CitibankN.AMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-28</instant>
        </period>
    </context>
    <context id="c-300">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">iff:CitibankN.AMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-28</startDate>
            <endDate>2021-07-28</endDate>
        </period>
    </context>
    <context id="c-301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">iff:CitibankN.AMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-302">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">iff:CitibankN.AMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-303">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesEuroNotesDueTwoThousandTwentySixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-25</instant>
        </period>
    </context>
    <context id="c-304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">iff:SeniorNotesEuroNotesDueTwoThousandTwentySixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-25</instant>
        </period>
    </context>
    <context id="c-305">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandTwentyEightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-26</instant>
        </period>
    </context>
    <context id="c-306">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">iff:SeniorNotesDueTwoThousandTwentyEightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-26</instant>
        </period>
    </context>
    <context id="c-307">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandFortyEightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-26</instant>
        </period>
    </context>
    <context id="c-308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">iff:SeniorNotesDueTwoThousandFortyEightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-26</instant>
        </period>
    </context>
    <context id="c-309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandTwentyThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-04-04</instant>
        </period>
    </context>
    <context id="c-310">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandTwentyThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-04-04</startDate>
            <endDate>2013-04-04</endDate>
        </period>
    </context>
    <context id="c-311">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandTwentyThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-05-01</endDate>
        </period>
    </context>
    <context id="c-312">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesEuroNotesDueTwoThousandTwentyFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-03-14</instant>
        </period>
    </context>
    <context id="c-313">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesEuroNotesDueTwoThousandTwentyFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-03-14</startDate>
            <endDate>2016-03-14</endDate>
        </period>
    </context>
    <context id="c-314">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandFortySevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-05-18</instant>
        </period>
    </context>
    <context id="c-315">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandFortySevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-05-18</startDate>
            <endDate>2017-05-18</endDate>
        </period>
    </context>
    <context id="c-316">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:InternationalFlavorsFragrancesIncSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">iff:InternationalFlavorsFragrancesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-317">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesEuroNotesDueTwoThousandTwentyFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">iff:InternationalFlavorsFragrancesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-318">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesEuroNotesDueTwoThousandTwentySixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">iff:InternationalFlavorsFragrancesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-319">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandTwentyEightMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">iff:InternationalFlavorsFragrancesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-320">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandFortySevenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">iff:InternationalFlavorsFragrancesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-321">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandFortyEightMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">iff:InternationalFlavorsFragrancesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-322">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:NutritionBiosciencesIncSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-323">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandTwentyFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-324">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandTwentySevenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-325">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandThirtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandFortyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:SeniorNotesDueTwoThousandFiftyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iff:A2024TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-01</startDate>
            <endDate>2024-02-01</endDate>
        </period>
    </context>
    <context id="c-329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">iff:TwoThousandTwentyThreeToTwoThousandFortyTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">iff:TwoThousandTwentyTwoToTwoThousandFortyOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">iff:IndefiniteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-332">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis">iff:UnrecognizedTaxBenefitsOtherLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-333">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis">iff:UnrecognizedTaxBenefitsOtherLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-334">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis">iff:UnrecognizedTaxBenefitsOtherLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-335">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis">iff:UnrecognizedTaxBenefitsOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-336">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis">iff:UnrecognizedTaxBenefitsOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-337">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis">iff:UnrecognizedTaxBenefitsOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-338">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-339">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-340">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-341">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-342">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-343">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-344">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-345">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-346">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
        </entity>
        <period>
            <startDate>2018-09-17</startDate>
            <endDate>2018-09-17</endDate>
        </period>
    </context>
    <context id="c-347">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
        </entity>
        <period>
            <instant>2021-09-14</instant>
        </period>
    </context>
    <context id="c-348">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
        </entity>
        <period>
            <startDate>2021-09-15</startDate>
            <endDate>2021-09-15</endDate>
        </period>
    </context>
    <context id="c-349">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iff:ShareEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-350">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iff:ShareEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-351">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iff:ShareEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-352">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iff:EquityBasedAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-353">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iff:EquityBasedAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-354">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iff:EquityBasedAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-355">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iff:LiabilityBasedAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-356">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iff:LiabilityBasedAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-357">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iff:LiabilityBasedAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-358">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iff:TwoThousandTwentyOnePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-359">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iff:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-360">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iff:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-361">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iff:TwoThousandNineteenToTwoThousandTwentyOneCycleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c-362">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iff:TwoThousandTwentyToTwoThousandTwentyTwoCycleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-363">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iff:TwoThousandTwentyOneToTwoThousandTwentyThreeCycleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-364">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-01</endDate>
        </period>
    </context>
    <context id="c-365">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-01</endDate>
        </period>
    </context>
    <context id="c-366">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-01</endDate>
        </period>
    </context>
    <context id="c-367">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-368">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iff:StockOptionsAndStockSettledAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-369">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iff:StockOptionsAndStockSettledAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-370">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iff:StockOptionsAndStockSettledAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-371">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iff:StockOptionsAndStockSettledAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-372">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iff:StockOptionsAndStockSettledAppreciationRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iff:Over65Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-373">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iff:StockOptionsAndStockSettledAppreciationRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iff:Over65Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-374">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iff:StockOptionsAndStockSettledAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-375">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iff:StockOptionsAndStockSettledAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-376">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-377">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-378">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-379">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-380">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iff:PurchasedRestrictedStockUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-381">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iff:PurchasedRestrictedStockUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-382">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iff:PurchasedRestrictedStockUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-383">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iff:PurchasedRestrictedStockUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-384">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iff:PurchasedRestrictedStockUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-385">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iff:CashRestrictedStockUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-386">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iff:CashRestrictedStockUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-387">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iff:CashRestrictedStockUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-388">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:NourishMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-389">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:NourishMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-390">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:NourishMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-391">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:HealthBiosciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-392">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:HealthBiosciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-393">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:HealthBiosciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-394">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:ScentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-395">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:ScentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-396">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:ScentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-397">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:PharmaSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-398">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:PharmaSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-399">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:PharmaSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-400">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:NourishMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:NourishMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:HealthBiosciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:HealthBiosciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-404">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:ScentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-405">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:ScentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-406">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:PharmaSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-407">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iff:PharmaSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-408">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iff:NutritionBiosciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-409">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-410">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-411">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-412">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iff:TopOneCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-413">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iff:TopOneCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-414">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iff:TopOneCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-415">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-416">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-417">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-418">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-419">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DK</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-420">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DK</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FI</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-422">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FI</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-423">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-425">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-426">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-427">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iff:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-428">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iff:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-431">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-432">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-433">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-434">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-435">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-436">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-437">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-438">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-439">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-440">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-441">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-442">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-443">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-444">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-445">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-446">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-447">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-448">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-449">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-450">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis">us-gaap:DeferredCompensationArrangementWithIndividualByTypeOfCompensationPensionAndOtherPostretirementBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-451">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis">us-gaap:DeferredCompensationArrangementWithIndividualByTypeOfCompensationPensionAndOtherPostretirementBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-452">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-453">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-454">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-455">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-456">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-457">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-458">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-459">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-460">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-461">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-462">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-463">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-464">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-465">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-466">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-467">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-468">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-469">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-470">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-471">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-472">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-473">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-474">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-475">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-476">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-477">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-478">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-479">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-480">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-481">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-482">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-483">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-484">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-485">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-486">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-487">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-488">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-489">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-490">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentCompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-491">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentCompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-492">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentCompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-493">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentCompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-494">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-495">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-496">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-497">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-498">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-499">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:GovernmentAndGovernmentAgencyBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-500">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:GovernmentAndGovernmentAgencyBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-501">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:GovernmentAndGovernmentAgencyBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-502">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:GovernmentAndGovernmentAgencyBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-503">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-504">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-505">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-506">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-507">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-508">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-509">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-510">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-511">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:PooledFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-512">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:FairValueOfPlanAssetsBeforeReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-513">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:FairValueOfPlanAssetsBeforeReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-514">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:FairValueOfPlanAssetsBeforeReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-515">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:FairValueOfPlanAssetsBeforeReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-516">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:ReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-517">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-518">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-519">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-520">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:GovernmentAndGovernmentAgencyBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-521">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:GovernmentAndGovernmentAgencyBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-522">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:GovernmentAndGovernmentAgencyBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-523">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:GovernmentAndGovernmentAgencyBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-524">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-525">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-526">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-527">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-528">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-529">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-530">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-532">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:PooledFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-533">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:FairValueOfPlanAssetsBeforeReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-534">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:FairValueOfPlanAssetsBeforeReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-535">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:FairValueOfPlanAssetsBeforeReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-536">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:FairValueOfPlanAssetsBeforeReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-537">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:ReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-538">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:PooledFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-539">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:PooledFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-540">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-541">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-542">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-543">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-544">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-545">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-546">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-547">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-548">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-549">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-550">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMidCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-551">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMidCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-552">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMidCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-553">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMidCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-554">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsSmallCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-555">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsSmallCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-556">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsSmallCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-557">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsSmallCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-558">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesLargeCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-559">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesLargeCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-560">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesLargeCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-561">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesLargeCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-562">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMidCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-563">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMidCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-564">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMidCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-565">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMidCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-566">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesSmallCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-567">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesSmallCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-568">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesSmallCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-569">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesSmallCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-570">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:EmergingMarketsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-571">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:EmergingMarketsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-572">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:EmergingMarketsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-573">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:EmergingMarketsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-574">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:USCorporateBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-575">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:USCorporateBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-576">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:USCorporateBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-577">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:USCorporateBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-578">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSTreasuriesOrGovernmentBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-579">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSTreasuriesOrGovernmentBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-580">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSTreasuriesOrGovernmentBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-581">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSTreasuriesOrGovernmentBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-582">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSCorporateBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-583">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSCorporateBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-584">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSCorporateBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-585">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSCorporateBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-586">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSAssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-587">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSAssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-588">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSAssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-589">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSAssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-590">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSOtherFixedIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-591">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSOtherFixedIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-592">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSOtherFixedIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-593">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSOtherFixedIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-594">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:InsuranceContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-595">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:InsuranceContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-596">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:InsuranceContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-597">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:InsuranceContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-598">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DerivativeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-599">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DerivativeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-600">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DerivativeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DerivativeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-602">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:AbsoluteReturnHedgeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-603">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:AbsoluteReturnHedgeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-604">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:AbsoluteReturnHedgeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-605">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:AbsoluteReturnHedgeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-606">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-607">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-608">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-609">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-610">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-611">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-612">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-613">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-614">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-615">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-616">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-617">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-618">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-619">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-620">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-621">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-622">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-623">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-624">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-625">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMidCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMidCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMidCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMidCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-629">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesLargeCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesLargeCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-631">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesLargeCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-632">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesLargeCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-633">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMidCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-634">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMidCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-635">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMidCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-636">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMidCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-637">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesSmallCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-638">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesSmallCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-639">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesSmallCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-640">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesSmallCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-641">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:EmergingMarketsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-642">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:EmergingMarketsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-643">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:EmergingMarketsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-644">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:EmergingMarketsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-645">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:USCorporateBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-646">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:USCorporateBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-647">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:USCorporateBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-648">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:USCorporateBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-649">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSTreasuriesOrGovernmentBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-650">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSTreasuriesOrGovernmentBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-651">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSTreasuriesOrGovernmentBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-652">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSTreasuriesOrGovernmentBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-653">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSCorporateBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-654">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSCorporateBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-655">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSCorporateBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-656">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSCorporateBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-657">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSAssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-658">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSAssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-659">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSAssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-660">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSAssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-661">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSOtherFixedIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-662">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSOtherFixedIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-663">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSOtherFixedIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-664">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:NonUSOtherFixedIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-665">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:InsuranceContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-666">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:InsuranceContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-667">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:InsuranceContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-668">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:InsuranceContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-669">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DerivativeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-670">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DerivativeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-671">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DerivativeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-672">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DerivativeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-673">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:AbsoluteReturnHedgeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-674">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:AbsoluteReturnHedgeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-675">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:AbsoluteReturnHedgeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-676">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iff:AbsoluteReturnHedgeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-677">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-678">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-679">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-680">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-681">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-682">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-683">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-684">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-685">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-686">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-687">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-688">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-689">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-690">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-691">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-692">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iff:ExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-693">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iff:ExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-694">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-695">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-696">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iff:ExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-697">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iff:ExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-698">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-699">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-700">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTaxStatusAxis">us-gaap:QualifiedPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTaxStatusAxis">us-gaap:NonqualifiedPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-703">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-704">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-705">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-706">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandTwentyThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-707">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandTwentyThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-708">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandTwentyThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-709">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandTwentyThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-710">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesEuroNotesDueTwoThousandTwentyFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-711">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesEuroNotesDueTwoThousandTwentyFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-712">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesEuroNotesDueTwoThousandTwentyFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-713">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesEuroNotesDueTwoThousandTwentyFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-714">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandTwentyFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-715">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandTwentyFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-716">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandTwentyFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-717">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandTwentyFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-718">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesEuroNotesDueTwoThousandTwentySixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-719">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesEuroNotesDueTwoThousandTwentySixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-720">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesEuroNotesDueTwoThousandTwentySixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-721">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesEuroNotesDueTwoThousandTwentySixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-722">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandTwentySevenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandTwentySevenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-724">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandTwentySevenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandTwentySevenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-726">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandTwentyEightMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-727">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandTwentyEightMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-728">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandTwentyEightMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandTwentyEightMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-730">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandThirtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandThirtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-732">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandThirtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-733">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandThirtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-734">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandFortyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-735">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandFortyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-736">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandFortyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-737">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandFortyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-738">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandFortySevenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-739">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandFortySevenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-740">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandFortySevenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-741">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandFortySevenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-742">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandFortyEightMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-743">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandFortyEightMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-744">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandFortyEightMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-745">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandFortyEightMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-746">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandFiftyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-747">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandFiftyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-748">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandFiftyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-749">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:SeniorNotesDueTwoThousandFiftyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-750">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:A2024TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-751">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:A2024TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-752">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:A2024TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-753">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:A2024TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-754">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:A2026TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-755">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:A2026TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-756">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:A2026TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-757">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iff:A2026TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-758">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-03-31</instant>
        </period>
    </context>
    <context id="c-759">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-01-01</startDate>
            <endDate>2016-03-31</endDate>
        </period>
    </context>
    <context id="c-760">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-05-18</startDate>
            <endDate>2017-05-18</endDate>
        </period>
    </context>
    <context id="c-761">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iff:A2019And2022CrossCurrencySwapsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-762">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iff:A2019And2022CrossCurrencySwapsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-763">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iff:A2022CrossCurrencySwapsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-764">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iff:A2022CrossCurrencySwapsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-765">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iff:A2022CrossCurrencySwapsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-766">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-767">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-768">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-769">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-770">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-771">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-772">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-773">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-774">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-775">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-776">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-777">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-778">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-779">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-780">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-781">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-782">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-783">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-784">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-785">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-786">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-787">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-788">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-789">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-790">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-791">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-792">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-793">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iff:CrossCurrencySwapsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-794">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iff:CrossCurrencySwapsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-795">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iff:SeniorNotesEuroNotesDueTwoThousandTwentyFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-796">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iff:SeniorNotesEuroNotesDueTwoThousandTwentyFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-797">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iff:SeniorNotesEuroNotesMaturing2021And2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-798">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iff:SeniorNotesEuroNotesMaturing2021And2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-799">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-800">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-801">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-802">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-803">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-804">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-805">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-806">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-807">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-808">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-809">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-810">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-811">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-812">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-813">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-814">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-815">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-816">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-817">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-818">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-819">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-820">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-821">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-822">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-824">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-825">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-826">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-827">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-828">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-829">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-830">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-832">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-833">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-834">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-835">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iff:AccumulatedDefinedBenefitPlansAdjustmentOtherItemsAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-836">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iff:AccumulatedDefinedBenefitPlansAdjustmentOtherItemsAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-837">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iff:AccumulatedDefinedBenefitPlansAdjustmentOtherItemsAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-838">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-839">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-840">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-841">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-842">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-843">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-844">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iff:AllForeignCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-845">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iff:AllForeignCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-846">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iff:AllForeignCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-847">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">iff:PledgedAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-848">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-29</startDate>
            <endDate>2019-10-29</endDate>
        </period>
    </context>
    <context id="c-849">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-11</startDate>
            <endDate>2020-03-11</endDate>
        </period>
    </context>
    <context id="c-850">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iff:ZhejiangIngredientsPlantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iff:ZhejiangChinaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="c-851">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iff:ZhejiangIngredientsPlantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iff:ZhejiangChinaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c-852">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iff:ZhejiangIngredientsPlantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iff:ZhejiangChinaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="c-853">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iff:ZhejiangIngredientsPlantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iff:ZhejiangChinaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-05</startDate>
            <endDate>2023-06-05</endDate>
        </period>
    </context>
    <context id="c-854">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iff:ZhejiangIngredientsPlantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iff:ZhejiangChinaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-855">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ManufacturingFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-856">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">country:BR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c-857">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">country:BR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="c-858">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:BR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">country:BR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-859">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">iff:BrazilTaxCreditsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-860">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-861">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-862">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iff:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-863">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iff:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-864">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iff:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-865">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iff:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-866">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iff:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-867">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iff:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-868">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iff:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-869">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iff:SonaromeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iff:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-870">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iff:CosmeticIngredientsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-871">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iff:SavorySolutionsAndFlavorSpecialtyIngredientsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-872">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-873">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-874">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-875">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-876">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-877">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-878">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-879">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-880">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-881">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-882">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-883">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-884">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-885">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="reporting_unit">
        <measure>iff:reporting_unit</measure>
    </unit>
    <unit id="facility">
        <measure>iff:Facility</measure>
    </unit>
    <unit id="position">
        <measure>iff:Position</measure>
    </unit>
    <unit id="position2">
        <measure>iff:position</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="segment">
        <measure>iff:segment</measure>
    </unit>
    <unit id="category">
        <measure>iff:category</measure>
    </unit>
    <unit id="customer">
        <measure>iff:customer</measure>
    </unit>
    <unit id="benefit_plan">
        <measure>iff:benefit_plan</measure>
    </unit>
    <unit id="agreement">
        <measure>iff:Agreement</measure>
    </unit>
    <unit id="swap">
        <measure>iff:swap</measure>
    </unit>
    <dei:AmendmentFlag contextRef="c-1" id="f-43">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-44">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-45">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-46">0000051253</dei:EntityCentralIndexKey>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList contextRef="c-11" id="f-1085">http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList contextRef="c-12" id="f-1086">http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList contextRef="c-11" id="f-1141">http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList contextRef="c-12" id="f-1142">http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList contextRef="c-11" id="f-1145">http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent</us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList contextRef="c-12" id="f-1146">http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent</us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList contextRef="c-11" id="f-1149">http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent</us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList contextRef="c-12" id="f-1150">http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent</us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration contextRef="c-11" id="f-2472">http://fasb.org/us-gaap/2023#OtherAssetsCurrent</us-gaap:DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration>
    <us-gaap:DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration contextRef="c-11" id="f-2477">http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent</us-gaap:DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration>
    <us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration contextRef="c-786" id="f-2581">http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpense</us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration contextRef="c-787" id="f-2582">http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpense</us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration contextRef="c-790" id="f-2585">http://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSold</us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <dei:DocumentType contextRef="c-1" id="f-1">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="c-1" id="f-2">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-3">2023-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-4">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-5">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-6">1-4858</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-7">INTERNATIONAL FLAVORS&#160;&amp; FRAGRANCES INC</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-8">NY</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-9">13-1432060</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-10">521 West 57th Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-11">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-12">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-13">10019-2960</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressAddressLine1 contextRef="c-2" id="f-14">200 Powder Mill Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-2" id="f-15">Wilmington</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-2" id="f-16">DE</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-2" id="f-17">19803-2907</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-18">212</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-19">765-5500</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-3" id="f-20">Common Stock, par value 12&#160;1/2&#xa2; per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-3" id="f-21">IFF</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-3" id="f-22">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c-4" id="f-23">1.750% Senior Notes due 2024</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-4" id="f-24">IFF 24</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-4" id="f-25">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c-5" id="f-26">1.800% Senior Notes due 2026</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-5" id="f-27">IFF 26</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-5" id="f-28">NYSE</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="c-1" id="f-29">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="c-1" id="f-30">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-31">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-32">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-33">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c-1" id="f-34">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-35">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag contextRef="c-1" id="f-36">true</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="c-1" id="f-37">true</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:DocumentFinStmtRestatementRecoveryAnalysisFlag contextRef="c-1" id="f-38">true</dei:DocumentFinStmtRestatementRecoveryAnalysisFlag>
    <dei:EntityShellCompany contextRef="c-1" id="f-39">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat contextRef="c-6" decimals="0" id="f-40" unitRef="usd">20313097570</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-7" decimals="INF" id="f-41" unitRef="shares">255314909</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock contextRef="c-1" id="f-42">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Portions of the registrant&#x2019;s proxy statement for the 2024 Annual Meeting of Shareholders (the &#x201c;IFF 2024 Proxy Statement&#x201d;) are incorporated by reference in Part III of this Form 10-K.&lt;/span&gt;&lt;/div&gt;</dei:DocumentsIncorporatedByReferenceTextBlock>
    <ecd:MtrlTermsOfTrdArrTextBlock contextRef="c-1" id="f-47">&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the quarter ended December&#160;31, 2023, none of our directors or executive officers adopted or terminated any contract, instruction or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) (a &#x201c;10b5-1 trading arrangement&#x201d;) or any &#x201c;non-Rule 10b5-1 trading arrangement&#x201d; as defined in Item 408(c) of Regulation S-K.&lt;/span&gt;&lt;/div&gt;</ecd:MtrlTermsOfTrdArrTextBlock>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="c-8" id="f-48">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c-8" id="f-49">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="c-8" id="f-50">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="c-8" id="f-51">false</ecd:Rule10b51ArrTrmntdFlag>
    <dei:AuditorFirmId contextRef="c-1" id="f-52">238</dei:AuditorFirmId>
    <dei:AuditorName contextRef="c-1" id="f-53">PricewaterhouseCoopers LLP</dei:AuditorName>
    <dei:AuditorLocation contextRef="c-1" id="f-54">New York, New York</dei:AuditorLocation>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-6" id="f-55" unitRef="usd">11479000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-9" decimals="-6" id="f-56" unitRef="usd">12440000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-10" decimals="-6" id="f-57" unitRef="usd">11656000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-1" decimals="-6" id="f-58" unitRef="usd">7798000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-9" decimals="-6" id="f-59" unitRef="usd">8289000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-10" decimals="-6" id="f-60" unitRef="usd">7921000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit contextRef="c-1" decimals="-6" id="f-61" unitRef="usd">3681000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-9" decimals="-6" id="f-62" unitRef="usd">4151000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-10" decimals="-6" id="f-63" unitRef="usd">3735000000</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-1" decimals="-6" id="f-64" unitRef="usd">636000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-9" decimals="-6" id="f-65" unitRef="usd">603000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-10" decimals="-6" id="f-66" unitRef="usd">629000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-1" decimals="-6" id="f-67" unitRef="usd">1787000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-9" decimals="-6" id="f-68" unitRef="usd">1768000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-10" decimals="-6" id="f-69" unitRef="usd">1749000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <iff:RestructuringandOtherCharges contextRef="c-1" decimals="-6" id="f-70" unitRef="usd">68000000</iff:RestructuringandOtherCharges>
    <iff:RestructuringandOtherCharges contextRef="c-9" decimals="-6" id="f-71" unitRef="usd">12000000</iff:RestructuringandOtherCharges>
    <iff:RestructuringandOtherCharges contextRef="c-10" decimals="-6" id="f-72" unitRef="usd">41000000</iff:RestructuringandOtherCharges>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-1" decimals="-6" id="f-73" unitRef="usd">680000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-9" decimals="-6" id="f-74" unitRef="usd">727000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-10" decimals="-6" id="f-75" unitRef="usd">732000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-1" decimals="-6" id="f-76" unitRef="usd">2623000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-9" decimals="-6" id="f-77" unitRef="usd">2250000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-10" decimals="-6" id="f-78" unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-1" decimals="-6" id="f-79" unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-9" decimals="-6" id="f-80" unitRef="usd">120000000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-10" decimals="-6" id="f-81" unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c-1" decimals="-6" id="f-82" unitRef="usd">3000000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c-9" decimals="-6" id="f-83" unitRef="usd">3000000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c-10" decimals="-6" id="f-84" unitRef="usd">1000000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-6" id="f-85" unitRef="usd">-2110000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-9" decimals="-6" id="f-86" unitRef="usd">-1326000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-10" decimals="-6" id="f-87" unitRef="usd">585000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense contextRef="c-1" decimals="-6" id="f-88" unitRef="usd">380000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c-9" decimals="-6" id="f-89" unitRef="usd">336000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c-10" decimals="-6" id="f-90" unitRef="usd">289000000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-1" decimals="-6" id="f-91" unitRef="usd">-28000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-9" decimals="-6" id="f-92" unitRef="usd">37000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-10" decimals="-6" id="f-93" unitRef="usd">58000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-6" id="f-94" unitRef="usd">-2518000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-9" decimals="-6" id="f-95" unitRef="usd">-1625000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-10" decimals="-6" id="f-96" unitRef="usd">354000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-6" id="f-97" unitRef="usd">45000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-9" decimals="-6" id="f-98" unitRef="usd">239000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-10" decimals="-6" id="f-99" unitRef="usd">75000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="-6" id="f-100" unitRef="usd">-2563000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-9" decimals="-6" id="f-101" unitRef="usd">-1864000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-10" decimals="-6" id="f-102" unitRef="usd">279000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-1" decimals="-6" id="f-103" unitRef="usd">4000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-9" decimals="-6" id="f-104" unitRef="usd">7000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-10" decimals="-6" id="f-105" unitRef="usd">9000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-1" decimals="-6" id="f-106" unitRef="usd">-2567000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-9" decimals="-6" id="f-107" unitRef="usd">-1871000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-10" decimals="-6" id="f-108" unitRef="usd">270000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-109"
      unitRef="usdPerShare">-10.05</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-9"
      decimals="2"
      id="f-110"
      unitRef="usdPerShare">-7.32</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-10"
      decimals="2"
      id="f-111"
      unitRef="usdPerShare">1.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-112"
      unitRef="usdPerShare">-10.05</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-9"
      decimals="2"
      id="f-113"
      unitRef="usdPerShare">-7.32</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-10"
      decimals="2"
      id="f-114"
      unitRef="usdPerShare">1.10</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-6" id="f-115" unitRef="shares">255000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-9" decimals="-6" id="f-116" unitRef="shares">255000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-10" decimals="-6" id="f-117" unitRef="shares">243000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="-6" id="f-118" unitRef="shares">255000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-9" decimals="-6" id="f-119" unitRef="shares">255000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-10" decimals="-6" id="f-120" unitRef="shares">243000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="-6" id="f-121" unitRef="usd">-2563000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-9" decimals="-6" id="f-122" unitRef="usd">-1864000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-10" decimals="-6" id="f-123" unitRef="usd">279000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-1" decimals="-6" id="f-124" unitRef="usd">414000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-9" decimals="-6" id="f-125" unitRef="usd">-933000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-10" decimals="-6" id="f-126" unitRef="usd">-848000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax contextRef="c-1" decimals="-6" id="f-127" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax contextRef="c-9" decimals="-6" id="f-128" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax contextRef="c-10" decimals="-6" id="f-129" unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax contextRef="c-1" decimals="-6" id="f-130" unitRef="usd">112000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax contextRef="c-9" decimals="-6" id="f-131" unitRef="usd">-158000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax contextRef="c-10" decimals="-6" id="f-132" unitRef="usd">-115000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-1" decimals="-6" id="f-133" unitRef="usd">302000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-9" decimals="-6" id="f-134" unitRef="usd">-775000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-10" decimals="-6" id="f-135" unitRef="usd">-725000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="c-1" decimals="-6" id="f-136" unitRef="usd">-2261000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="c-9" decimals="-6" id="f-137" unitRef="usd">-2639000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="c-10" decimals="-6" id="f-138" unitRef="usd">-446000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-1" decimals="-6" id="f-139" unitRef="usd">4000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-9" decimals="-6" id="f-140" unitRef="usd">7000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-10" decimals="-6" id="f-141" unitRef="usd">9000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-1" decimals="-6" id="f-142" unitRef="usd">-2265000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-9" decimals="-6" id="f-143" unitRef="usd">-2646000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-10" decimals="-6" id="f-144" unitRef="usd">-455000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-11" decimals="-6" id="f-145" unitRef="usd">703000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-12" decimals="-6" id="f-146" unitRef="usd">483000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashCurrent contextRef="c-11" decimals="-6" id="f-147" unitRef="usd">6000000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent contextRef="c-12" decimals="-6" id="f-148" unitRef="usd">10000000</us-gaap:RestrictedCashCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="c-11" decimals="-6" id="f-149" unitRef="usd">52000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="c-12" decimals="-6" id="f-150" unitRef="usd">53000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:ReceivablesNetCurrent contextRef="c-11" decimals="-6" id="f-151" unitRef="usd">1726000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent contextRef="c-12" decimals="-6" id="f-152" unitRef="usd">1818000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:InventoryNet contextRef="c-11" decimals="-6" id="f-153" unitRef="usd">2477000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="c-12" decimals="-6" id="f-154" unitRef="usd">3151000000</us-gaap:InventoryNet>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent contextRef="c-11" decimals="-6" id="f-155" unitRef="usd">506000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent contextRef="c-12" decimals="-6" id="f-156" unitRef="usd">1200000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="c-11" decimals="-6" id="f-157" unitRef="usd">875000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="c-12" decimals="-6" id="f-158" unitRef="usd">770000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-11" decimals="-6" id="f-159" unitRef="usd">6293000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-12" decimals="-6" id="f-160" unitRef="usd">7432000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-11" decimals="-6" id="f-161" unitRef="usd">4240000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-12" decimals="-6" id="f-162" unitRef="usd">4203000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill contextRef="c-11" decimals="-6" id="f-163" unitRef="usd">10635000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-12" decimals="-6" id="f-164" unitRef="usd">13373000000</us-gaap:Goodwill>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-11" decimals="-6" id="f-165" unitRef="usd">8357000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-12" decimals="-6" id="f-166" unitRef="usd">9082000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-11" decimals="-6" id="f-167" unitRef="usd">689000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-12" decimals="-6" id="f-168" unitRef="usd">743000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-11" decimals="-6" id="f-169" unitRef="usd">764000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-12" decimals="-6" id="f-170" unitRef="usd">689000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="c-11" decimals="-6" id="f-171" unitRef="usd">30978000000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-12" decimals="-6" id="f-172" unitRef="usd">35522000000</us-gaap:Assets>
    <us-gaap:DebtCurrent contextRef="c-11" decimals="-6" id="f-173" unitRef="usd">885000000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent contextRef="c-12" decimals="-6" id="f-174" unitRef="usd">410000000</us-gaap:DebtCurrent>
    <iff:CommercialPaperCurrent contextRef="c-11" decimals="-6" id="f-175" unitRef="usd">0</iff:CommercialPaperCurrent>
    <iff:CommercialPaperCurrent contextRef="c-12" decimals="-6" id="f-176" unitRef="usd">187000000</iff:CommercialPaperCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-11" decimals="-6" id="f-177" unitRef="usd">1378000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-12" decimals="-6" id="f-178" unitRef="usd">1418000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-11" decimals="-6" id="f-179" unitRef="usd">265000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-12" decimals="-6" id="f-180" unitRef="usd">267000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:DividendsPayableCurrent contextRef="c-11" decimals="-6" id="f-181" unitRef="usd">207000000</us-gaap:DividendsPayableCurrent>
    <us-gaap:DividendsPayableCurrent contextRef="c-12" decimals="-6" id="f-182" unitRef="usd">206000000</us-gaap:DividendsPayableCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent contextRef="c-11" decimals="-6" id="f-183" unitRef="usd">46000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent contextRef="c-12" decimals="-6" id="f-184" unitRef="usd">212000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-11" decimals="-6" id="f-185" unitRef="usd">977000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-12" decimals="-6" id="f-186" unitRef="usd">1028000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-11" decimals="-6" id="f-187" unitRef="usd">3758000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-12" decimals="-6" id="f-188" unitRef="usd">3728000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-11" decimals="-6" id="f-189" unitRef="usd">9186000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-12" decimals="-6" id="f-190" unitRef="usd">10373000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent contextRef="c-11" decimals="-6" id="f-191" unitRef="usd">253000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent contextRef="c-12" decimals="-6" id="f-192" unitRef="usd">231000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-11" decimals="-6" id="f-193" unitRef="usd">1937000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-12" decimals="-6" id="f-194" unitRef="usd">2283000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-11" decimals="-6" id="f-195" unitRef="usd">642000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-12" decimals="-6" id="f-196" unitRef="usd">672000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-11" decimals="-6" id="f-197" unitRef="usd">560000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-12" decimals="-6" id="f-198" unitRef="usd">491000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="c-11" decimals="-6" id="f-199" unitRef="usd">12578000000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="c-12" decimals="-6" id="f-200" unitRef="usd">14050000000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:CommitmentsAndContingencies contextRef="c-11" id="f-201" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-12" id="f-202" unitRef="usd" xsi:nil="true"/>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount contextRef="c-11" decimals="-6" id="f-203" unitRef="usd">0</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount contextRef="c-12" decimals="-6" id="f-204" unitRef="usd">59000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-11"
      decimals="INF"
      id="f-205"
      unitRef="usdPerShare">0.125</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-12"
      decimals="INF"
      id="f-206"
      unitRef="usdPerShare">0.125</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c-12"
      decimals="INF"
      id="f-207"
      unitRef="shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c-11"
      decimals="INF"
      id="f-208"
      unitRef="shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="c-11"
      decimals="INF"
      id="f-209"
      unitRef="shares">275726629</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="c-12"
      decimals="INF"
      id="f-210"
      unitRef="shares">275726629</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-11"
      decimals="INF"
      id="f-211"
      unitRef="shares">255288535</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-12"
      decimals="INF"
      id="f-212"
      unitRef="shares">254968463</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="c-11" decimals="-6" id="f-213" unitRef="usd">35000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-12" decimals="-6" id="f-214" unitRef="usd">35000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-11" decimals="-6" id="f-215" unitRef="usd">19874000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-12" decimals="-6" id="f-216" unitRef="usd">19841000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-11" decimals="-6" id="f-217" unitRef="usd">-2439000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-12" decimals="-6" id="f-218" unitRef="usd">955000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-11" decimals="-6" id="f-219" unitRef="usd">-1896000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-12" decimals="-6" id="f-220" unitRef="usd">-2198000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockCommonShares
      contextRef="c-11"
      decimals="INF"
      id="f-221"
      unitRef="shares">20438094</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares
      contextRef="c-12"
      decimals="INF"
      id="f-222"
      unitRef="shares">20758166</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockValue contextRef="c-11" decimals="-6" id="f-223" unitRef="usd">963000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue contextRef="c-12" decimals="-6" id="f-224" unitRef="usd">978000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity contextRef="c-11" decimals="-6" id="f-225" unitRef="usd">14611000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-12" decimals="-6" id="f-226" unitRef="usd">17655000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest contextRef="c-11" decimals="-6" id="f-227" unitRef="usd">31000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest contextRef="c-12" decimals="-6" id="f-228" unitRef="usd">30000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-11" decimals="-6" id="f-229" unitRef="usd">14642000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-12" decimals="-6" id="f-230" unitRef="usd">17685000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-11" decimals="-6" id="f-231" unitRef="usd">30978000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-12" decimals="-6" id="f-232" unitRef="usd">35522000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="-6" id="f-233" unitRef="usd">-2563000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-9" decimals="-6" id="f-234" unitRef="usd">-1864000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-10" decimals="-6" id="f-235" unitRef="usd">279000000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-1" decimals="-6" id="f-236" unitRef="usd">1142000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-9" decimals="-6" id="f-237" unitRef="usd">1179000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-10" decimals="-6" id="f-238" unitRef="usd">1156000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-1" decimals="-6" id="f-239" unitRef="usd">-369000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-9" decimals="-6" id="f-240" unitRef="usd">-237000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-10" decimals="-6" id="f-241" unitRef="usd">-236000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:GainLossOnDispositionOfAssets contextRef="c-1" decimals="-6" id="f-242" unitRef="usd">3000000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets contextRef="c-9" decimals="-6" id="f-243" unitRef="usd">3000000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets contextRef="c-10" decimals="-6" id="f-244" unitRef="usd">1000000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnSaleOfBusiness contextRef="c-1" decimals="-6" id="f-245" unitRef="usd">-23000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness contextRef="c-9" decimals="-6" id="f-246" unitRef="usd">11000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness contextRef="c-10" decimals="-6" id="f-247" unitRef="usd">13000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-6" id="f-248" unitRef="usd">65000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-9" decimals="-6" id="f-249" unitRef="usd">49000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-10" decimals="-6" id="f-250" unitRef="usd">54000000</us-gaap:ShareBasedCompensation>
    <us-gaap:PensionContributions contextRef="c-1" decimals="-6" id="f-251" unitRef="usd">36000000</us-gaap:PensionContributions>
    <us-gaap:PensionContributions contextRef="c-9" decimals="-6" id="f-252" unitRef="usd">36000000</us-gaap:PensionContributions>
    <us-gaap:PensionContributions contextRef="c-10" decimals="-6" id="f-253" unitRef="usd">37000000</us-gaap:PensionContributions>
    <iff:AmortizationOfInventoryStepUp contextRef="c-1" decimals="-6" id="f-254" unitRef="usd">0</iff:AmortizationOfInventoryStepUp>
    <iff:AmortizationOfInventoryStepUp contextRef="c-9" decimals="-6" id="f-255" unitRef="usd">0</iff:AmortizationOfInventoryStepUp>
    <iff:AmortizationOfInventoryStepUp contextRef="c-10" decimals="-6" id="f-256" unitRef="usd">368000000</iff:AmortizationOfInventoryStepUp>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-1" decimals="-6" id="f-257" unitRef="usd">2623000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-9" decimals="-6" id="f-258" unitRef="usd">2250000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-10" decimals="-6" id="f-259" unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-1" decimals="-6" id="f-260" unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-9" decimals="-6" id="f-261" unitRef="usd">120000000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-10" decimals="-6" id="f-262" unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:InventoryWriteDown contextRef="c-1" decimals="-6" id="f-263" unitRef="usd">72000000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown contextRef="c-9" decimals="-6" id="f-264" unitRef="usd">0</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown contextRef="c-10" decimals="-6" id="f-265" unitRef="usd">0</us-gaap:InventoryWriteDown>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-1" decimals="-6" id="f-266" unitRef="usd">-51000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-9" decimals="-6" id="f-267" unitRef="usd">117000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-10" decimals="-6" id="f-268" unitRef="usd">169000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c-1" decimals="-6" id="f-269" unitRef="usd">-605000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c-9" decimals="-6" id="f-270" unitRef="usd">893000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c-10" decimals="-6" id="f-271" unitRef="usd">363000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-1" decimals="-6" id="f-272" unitRef="usd">-39000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-9" decimals="-6" id="f-273" unitRef="usd">-57000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-10" decimals="-6" id="f-274" unitRef="usd">419000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="c-1" decimals="-6" id="f-275" unitRef="usd">-2000000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="c-9" decimals="-6" id="f-276" unitRef="usd">-34000000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="c-10" decimals="-6" id="f-277" unitRef="usd">96000000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities contextRef="c-1" decimals="-6" id="f-278" unitRef="usd">19000000</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities contextRef="c-9" decimals="-6" id="f-279" unitRef="usd">92000000</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities contextRef="c-10" decimals="-6" id="f-280" unitRef="usd">4000000</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet contextRef="c-1" decimals="-6" id="f-281" unitRef="usd">149000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet contextRef="c-9" decimals="-6" id="f-282" unitRef="usd">41000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet contextRef="c-10" decimals="-6" id="f-283" unitRef="usd">120000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-6" id="f-284" unitRef="usd">1439000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-9" decimals="-6" id="f-285" unitRef="usd">397000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-10" decimals="-6" id="f-286" unitRef="usd">1437000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="c-1" decimals="-6" id="f-287" unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="c-9" decimals="-6" id="f-288" unitRef="usd">110000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="c-10" decimals="-6" id="f-289" unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-1" decimals="-6" id="f-290" unitRef="usd">503000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-9" decimals="-6" id="f-291" unitRef="usd">504000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-10" decimals="-6" id="f-292" unitRef="usd">393000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="c-1" decimals="-6" id="f-293" unitRef="usd">0</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="c-9" decimals="-6" id="f-294" unitRef="usd">2000000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="c-10" decimals="-6" id="f-295" unitRef="usd">4000000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:ProceedsFromSaleOfProductiveAssets contextRef="c-1" decimals="-6" id="f-296" unitRef="usd">27000000</us-gaap:ProceedsFromSaleOfProductiveAssets>
    <us-gaap:ProceedsFromSaleOfProductiveAssets contextRef="c-9" decimals="-6" id="f-297" unitRef="usd">8000000</us-gaap:ProceedsFromSaleOfProductiveAssets>
    <us-gaap:ProceedsFromSaleOfProductiveAssets contextRef="c-10" decimals="-6" id="f-298" unitRef="usd">18000000</us-gaap:ProceedsFromSaleOfProductiveAssets>
    <us-gaap:ProceedsFromDerivativeInstrumentInvestingActivities contextRef="c-1" decimals="-6" id="f-299" unitRef="usd">0</us-gaap:ProceedsFromDerivativeInstrumentInvestingActivities>
    <us-gaap:ProceedsFromDerivativeInstrumentInvestingActivities contextRef="c-9" decimals="-6" id="f-300" unitRef="usd">173000000</us-gaap:ProceedsFromDerivativeInstrumentInvestingActivities>
    <us-gaap:ProceedsFromDerivativeInstrumentInvestingActivities contextRef="c-10" decimals="-6" id="f-301" unitRef="usd">0</us-gaap:ProceedsFromDerivativeInstrumentInvestingActivities>
    <iff:ProceedsFromBusinessCombination contextRef="c-1" decimals="-6" id="f-302" unitRef="usd">0</iff:ProceedsFromBusinessCombination>
    <iff:ProceedsFromBusinessCombination contextRef="c-9" decimals="-6" id="f-303" unitRef="usd">11000000</iff:ProceedsFromBusinessCombination>
    <iff:ProceedsFromBusinessCombination contextRef="c-10" decimals="-6" id="f-304" unitRef="usd">246000000</iff:ProceedsFromBusinessCombination>
    <us-gaap:ProceedsFromDivestitureOfBusinesses contextRef="c-1" decimals="-6" id="f-305" unitRef="usd">1050000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses contextRef="c-9" decimals="-6" id="f-306" unitRef="usd">1169000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses contextRef="c-10" decimals="-6" id="f-307" unitRef="usd">115000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-1" decimals="-6" id="f-308" unitRef="usd">574000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-9" decimals="-6" id="f-309" unitRef="usd">745000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-10" decimals="-6" id="f-310" unitRef="usd">-18000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsOfDividendsCommonStock contextRef="c-1" decimals="-6" id="f-311" unitRef="usd">826000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock contextRef="c-9" decimals="-6" id="f-312" unitRef="usd">810000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock contextRef="c-10" decimals="-6" id="f-313" unitRef="usd">667000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsMinorityInterest contextRef="c-1" decimals="-6" id="f-314" unitRef="usd">13000000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:PaymentsOfDividendsMinorityInterest contextRef="c-9" decimals="-6" id="f-315" unitRef="usd">0</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:PaymentsOfDividendsMinorityInterest contextRef="c-10" decimals="-6" id="f-316" unitRef="usd">2000000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt contextRef="c-1" decimals="-6" id="f-317" unitRef="usd">-99000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt contextRef="c-9" decimals="-6" id="f-318" unitRef="usd">104000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt contextRef="c-10" decimals="-6" id="f-319" unitRef="usd">-105000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <iff:ProceedsFromIssuanceOfCommercialPaperMaturingInMoreThanThreeMonths contextRef="c-1" decimals="-6" id="f-320" unitRef="usd">0</iff:ProceedsFromIssuanceOfCommercialPaperMaturingInMoreThanThreeMonths>
    <iff:ProceedsFromIssuanceOfCommercialPaperMaturingInMoreThanThreeMonths contextRef="c-9" decimals="-6" id="f-321" unitRef="usd">225000000</iff:ProceedsFromIssuanceOfCommercialPaperMaturingInMoreThanThreeMonths>
    <iff:ProceedsFromIssuanceOfCommercialPaperMaturingInMoreThanThreeMonths contextRef="c-10" decimals="-6" id="f-322" unitRef="usd">0</iff:ProceedsFromIssuanceOfCommercialPaperMaturingInMoreThanThreeMonths>
    <iff:RepaymentsOfCommercialPaperMaturingInMoreThanThreeMonths contextRef="c-1" decimals="-6" id="f-323" unitRef="usd">0</iff:RepaymentsOfCommercialPaperMaturingInMoreThanThreeMonths>
    <iff:RepaymentsOfCommercialPaperMaturingInMoreThanThreeMonths contextRef="c-9" decimals="-6" id="f-324" unitRef="usd">421000000</iff:RepaymentsOfCommercialPaperMaturingInMoreThanThreeMonths>
    <iff:RepaymentsOfCommercialPaperMaturingInMoreThanThreeMonths contextRef="c-10" decimals="-6" id="f-325" unitRef="usd">0</iff:RepaymentsOfCommercialPaperMaturingInMoreThanThreeMonths>
    <iff:NetBorrowingsRepaymentsOfCommercialPaperMaturingInLessThanThreeMonths contextRef="c-1" decimals="-6" id="f-326" unitRef="usd">-187000000</iff:NetBorrowingsRepaymentsOfCommercialPaperMaturingInLessThanThreeMonths>
    <iff:NetBorrowingsRepaymentsOfCommercialPaperMaturingInLessThanThreeMonths contextRef="c-9" decimals="-6" id="f-327" unitRef="usd">48000000</iff:NetBorrowingsRepaymentsOfCommercialPaperMaturingInLessThanThreeMonths>
    <iff:NetBorrowingsRepaymentsOfCommercialPaperMaturingInLessThanThreeMonths contextRef="c-10" decimals="-6" id="f-328" unitRef="usd">324000000</iff:NetBorrowingsRepaymentsOfCommercialPaperMaturingInLessThanThreeMonths>
    <us-gaap:PaymentsOfFinancingCosts contextRef="c-1" decimals="-6" id="f-329" unitRef="usd">5000000</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:PaymentsOfFinancingCosts contextRef="c-9" decimals="-6" id="f-330" unitRef="usd">0</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:PaymentsOfFinancingCosts contextRef="c-10" decimals="-6" id="f-331" unitRef="usd">3000000</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:RepaymentsOfLongTermDebt contextRef="c-1" decimals="-6" id="f-332" unitRef="usd">655000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt contextRef="c-9" decimals="-6" id="f-333" unitRef="usd">300000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt contextRef="c-10" decimals="-6" id="f-334" unitRef="usd">828000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest contextRef="c-1" decimals="-6" id="f-335" unitRef="usd">39000000</us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest>
    <us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest contextRef="c-9" decimals="-6" id="f-336" unitRef="usd">47000000</us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest>
    <us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest contextRef="c-10" decimals="-6" id="f-337" unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="c-1" decimals="-6" id="f-338" unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="c-9" decimals="-6" id="f-339" unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="c-10" decimals="-6" id="f-340" unitRef="usd">3000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities contextRef="c-1" decimals="-6" id="f-341" unitRef="usd">6000000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities contextRef="c-9" decimals="-6" id="f-342" unitRef="usd">0</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities contextRef="c-10" decimals="-6" id="f-343" unitRef="usd">14000000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-1" decimals="-6" id="f-344" unitRef="usd">13000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-9" decimals="-6" id="f-345" unitRef="usd">21000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-10" decimals="-6" id="f-346" unitRef="usd">21000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities contextRef="c-1" decimals="-6" id="f-347" unitRef="usd">-8000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities contextRef="c-9" decimals="-6" id="f-348" unitRef="usd">-7000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities contextRef="c-10" decimals="-6" id="f-349" unitRef="usd">9000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="-6" id="f-350" unitRef="usd">-1851000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-9" decimals="-6" id="f-351" unitRef="usd">-1229000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-10" decimals="-6" id="f-352" unitRef="usd">-1304000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-1" decimals="-6" id="f-353" unitRef="usd">21000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-9" decimals="-6" id="f-354" unitRef="usd">-77000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-10" decimals="-6" id="f-355" unitRef="usd">-59000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-1" decimals="-6" id="f-356" unitRef="usd">183000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-9" decimals="-6" id="f-357" unitRef="usd">-164000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-10" decimals="-6" id="f-358" unitRef="usd">56000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-12" decimals="-6" id="f-359" unitRef="usd">552000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-13" decimals="-6" id="f-360" unitRef="usd">716000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-14" decimals="-6" id="f-361" unitRef="usd">660000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-11" decimals="-6" id="f-362" unitRef="usd">735000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-12" decimals="-6" id="f-363" unitRef="usd">552000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-13" decimals="-6" id="f-364" unitRef="usd">716000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet contextRef="c-1" decimals="-6" id="f-365" unitRef="usd">370000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c-9" decimals="-6" id="f-366" unitRef="usd">310000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c-10" decimals="-6" id="f-367" unitRef="usd">310000000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaid contextRef="c-1" decimals="-6" id="f-368" unitRef="usd">578000000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid contextRef="c-9" decimals="-6" id="f-369" unitRef="usd">329000000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid contextRef="c-10" decimals="-6" id="f-370" unitRef="usd">289000000</us-gaap:IncomeTaxesPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="c-1" decimals="-6" id="f-371" unitRef="usd">109000000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="c-9" decimals="-6" id="f-372" unitRef="usd">150000000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="c-10" decimals="-6" id="f-373" unitRef="usd">117000000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:SharesOutstanding
      contextRef="c-15"
      decimals="INF"
      id="f-374"
      unitRef="shares">128526137</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-15" decimals="-6" id="f-375" unitRef="usd">16000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-16" decimals="-6" id="f-376" unitRef="usd">3853000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-17" decimals="-6" id="f-377" unitRef="usd">4156000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-18" decimals="-6" id="f-378" unitRef="usd">-698000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="c-19"
      decimals="INF"
      id="f-379"
      unitRef="shares">21588147</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-19" decimals="-6" id="f-380" unitRef="usd">-1017000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-20" decimals="-6" id="f-381" unitRef="usd">12000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-14" decimals="-6" id="f-382" unitRef="usd">6322000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest contextRef="c-21" decimals="-6" id="f-383" unitRef="usd">270000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest contextRef="c-22" decimals="-6" id="f-384" unitRef="usd">3000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest contextRef="c-10" decimals="-6" id="f-385" unitRef="usd">273000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-23" decimals="-6" id="f-386" unitRef="usd">-848000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-10" decimals="-6" id="f-387" unitRef="usd">-848000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax contextRef="c-10" decimals="-6" id="f-388" unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax contextRef="c-23" decimals="-6" id="f-389" unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax contextRef="c-10" decimals="-6" id="f-390" unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax contextRef="c-10" decimals="-6" id="f-391" unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax contextRef="c-23" decimals="-6" id="f-392" unitRef="usd">-115000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax contextRef="c-10" decimals="-6" id="f-393" unitRef="usd">-115000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-10"
      decimals="INF"
      id="f-394"
      unitRef="usdPerShare">3.12</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash contextRef="c-21" decimals="-6" id="f-395" unitRef="usd">785000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash contextRef="c-10" decimals="-6" id="f-396" unitRef="usd">785000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-24" decimals="-6" id="f-397" unitRef="usd">4000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-25"
      decimals="INF"
      id="f-398"
      unitRef="shares">159222</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-25" decimals="-6" id="f-399" unitRef="usd">7000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-10" decimals="-6" id="f-400" unitRef="usd">11000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="c-26"
      decimals="INF"
      id="f-401"
      unitRef="shares">141740461</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="c-26" decimals="-6" id="f-402" unitRef="usd">18000000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="c-24" decimals="-6" id="f-403" unitRef="usd">15936000000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="c-22" decimals="-6" id="f-404" unitRef="usd">22000000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="c-10" decimals="-6" id="f-405" unitRef="usd">15976000000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits
      contextRef="c-26"
      decimals="INF"
      id="f-406"
      unitRef="shares">5460031</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits contextRef="c-26" decimals="-6" id="f-407" unitRef="usd">1000000</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits contextRef="c-24" decimals="-6" id="f-408" unitRef="usd">-1000000</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits contextRef="c-10" decimals="-6" id="f-409" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-24" decimals="-6" id="f-410" unitRef="usd">-18000000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c-25"
      decimals="INF"
      id="f-411"
      unitRef="shares">276280</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-25" decimals="-6" id="f-412" unitRef="usd">13000000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-10" decimals="-6" id="f-413" unitRef="usd">-5000000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-24" decimals="-6" id="f-414" unitRef="usd">54000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-10" decimals="-6" id="f-415" unitRef="usd">54000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest contextRef="c-24" decimals="-6" id="f-416" unitRef="usd">2000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest contextRef="c-10" decimals="-6" id="f-417" unitRef="usd">2000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="c-22" decimals="-6" id="f-418" unitRef="usd">2000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="c-10" decimals="-6" id="f-419" unitRef="usd">2000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:SharesOutstanding
      contextRef="c-27"
      decimals="INF"
      id="f-420"
      unitRef="shares">275726629</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-27" decimals="-6" id="f-421" unitRef="usd">35000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-28" decimals="-6" id="f-422" unitRef="usd">19826000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-29" decimals="-6" id="f-423" unitRef="usd">3641000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-30" decimals="-6" id="f-424" unitRef="usd">-1423000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="c-31"
      decimals="INF"
      id="f-425"
      unitRef="shares">21152645</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-31" decimals="-6" id="f-426" unitRef="usd">-997000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-32" decimals="-6" id="f-427" unitRef="usd">35000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-13" decimals="-6" id="f-428" unitRef="usd">21117000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest contextRef="c-33" decimals="-6" id="f-429" unitRef="usd">-1871000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest contextRef="c-34" decimals="-6" id="f-430" unitRef="usd">3000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest contextRef="c-9" decimals="-6" id="f-431" unitRef="usd">-1868000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-35" decimals="-6" id="f-432" unitRef="usd">-933000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-9" decimals="-6" id="f-433" unitRef="usd">-933000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax contextRef="c-9" decimals="-6" id="f-434" unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax contextRef="c-35" decimals="-6" id="f-435" unitRef="usd">-158000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax contextRef="c-9" decimals="-6" id="f-436" unitRef="usd">-158000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-9"
      decimals="INF"
      id="f-437"
      unitRef="usdPerShare">3.20</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash contextRef="c-33" decimals="-6" id="f-438" unitRef="usd">815000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash contextRef="c-9" decimals="-6" id="f-439" unitRef="usd">815000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-36" decimals="-6" id="f-440" unitRef="usd">11000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-37"
      decimals="INF"
      id="f-441"
      unitRef="shares">85728</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-37" decimals="-6" id="f-442" unitRef="usd">4000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-9" decimals="-6" id="f-443" unitRef="usd">15000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-36" decimals="-6" id="f-444" unitRef="usd">-41000000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c-37"
      decimals="INF"
      id="f-445"
      unitRef="shares">308751</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-37" decimals="-6" id="f-446" unitRef="usd">15000000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-9" decimals="-6" id="f-447" unitRef="usd">-26000000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-36" decimals="-6" id="f-448" unitRef="usd">49000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-9" decimals="-6" id="f-449" unitRef="usd">49000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:MinorityInterestDecreaseFromRedemptions contextRef="c-36" decimals="-6" id="f-450" unitRef="usd">-1000000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions contextRef="c-34" decimals="-6" id="f-451" unitRef="usd">6000000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions contextRef="c-9" decimals="-6" id="f-452" unitRef="usd">5000000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest contextRef="c-36" decimals="-6" id="f-453" unitRef="usd">5000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest contextRef="c-9" decimals="-6" id="f-454" unitRef="usd">5000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="c-34" decimals="-6" id="f-455" unitRef="usd">2000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="c-9" decimals="-6" id="f-456" unitRef="usd">2000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:SharesOutstanding
      contextRef="c-38"
      decimals="INF"
      id="f-457"
      unitRef="shares">275726629</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-38" decimals="-6" id="f-458" unitRef="usd">35000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-39" decimals="-6" id="f-459" unitRef="usd">19841000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-40" decimals="-6" id="f-460" unitRef="usd">955000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-41" decimals="-6" id="f-461" unitRef="usd">-2198000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="c-42"
      decimals="INF"
      id="f-462"
      unitRef="shares">20758166</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-42" decimals="-6" id="f-463" unitRef="usd">-978000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-43" decimals="-6" id="f-464" unitRef="usd">30000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-12" decimals="-6" id="f-465" unitRef="usd">17685000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest contextRef="c-44" decimals="-6" id="f-466" unitRef="usd">-2567000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest contextRef="c-45" decimals="-6" id="f-467" unitRef="usd">4000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest contextRef="c-1" decimals="-6" id="f-468" unitRef="usd">-2563000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-46" decimals="-6" id="f-469" unitRef="usd">414000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-1" decimals="-6" id="f-470" unitRef="usd">414000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax contextRef="c-1" decimals="-6" id="f-471" unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax contextRef="c-46" decimals="-6" id="f-472" unitRef="usd">112000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax contextRef="c-1" decimals="-6" id="f-473" unitRef="usd">112000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-1"
      decimals="INF"
      id="f-474"
      unitRef="usdPerShare">3.24</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash contextRef="c-44" decimals="-6" id="f-475" unitRef="usd">827000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash contextRef="c-1" decimals="-6" id="f-476" unitRef="usd">827000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-47" decimals="-6" id="f-477" unitRef="usd">-4000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-48"
      decimals="INF"
      id="f-478"
      unitRef="shares">89850</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-48" decimals="-6" id="f-479" unitRef="usd">4000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-1" decimals="-6" id="f-480" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-47" decimals="-6" id="f-481" unitRef="usd">-22000000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c-48"
      decimals="INF"
      id="f-482"
      unitRef="shares">230222</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-48" decimals="-6" id="f-483" unitRef="usd">11000000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-1" decimals="-6" id="f-484" unitRef="usd">-11000000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-47" decimals="-6" id="f-485" unitRef="usd">65000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-1" decimals="-6" id="f-486" unitRef="usd">65000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest contextRef="c-47" decimals="-6" id="f-487" unitRef="usd">6000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest contextRef="c-1" decimals="-6" id="f-488" unitRef="usd">6000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="c-45" decimals="-6" id="f-489" unitRef="usd">3000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="c-1" decimals="-6" id="f-490" unitRef="usd">3000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:SharesOutstanding
      contextRef="c-49"
      decimals="INF"
      id="f-491"
      unitRef="shares">275726629</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-49" decimals="-6" id="f-492" unitRef="usd">35000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-50" decimals="-6" id="f-493" unitRef="usd">19874000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-51" decimals="-6" id="f-494" unitRef="usd">-2439000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-52" decimals="-6" id="f-495" unitRef="usd">-1896000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="c-53"
      decimals="INF"
      id="f-496"
      unitRef="shares">20438094</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-53" decimals="-6" id="f-497" unitRef="usd">-963000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-54" decimals="-6" id="f-498" unitRef="usd">31000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-11" decimals="-6" id="f-499" unitRef="usd">14642000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock contextRef="c-1" id="f-500">NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Nature of Operations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;International Flavors &amp;amp; Fragrances Inc. and its subsidiaries (the &#x201c;Registrant,&#x201d; &#x201c;IFF,&#x201d; &#x201c;the Company,&#x201d; &#x201c;we,&#x201d; &#x201c;us&#x201d; and &#x201c;our&#x201d;) is a leading creator and manufacturer of food, beverage, health &amp;amp; biosciences, scent and pharma solutions and complementary adjacent products, including cosmetic active and natural health ingredients, which are used in a wide variety of consumer products. Our products are sold principally to manufacturers of perfumes and cosmetics, hair and other personal care products, soaps and detergents, cleaning products, dairy, meat and other processed foods, beverages, snacks and savory foods, sweet and baked goods, sweeteners, dietary supplements, food protection, infant and elderly nutrition, functional food, and pharmaceutical excipients and oral care products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 1, 2021 (the &#x201c;Closing Date&#x201d;), the Company completed the combination (the &#x201c;Merger&#x201d;) of IFF and DuPont de Nemours, Inc (&#x201c;DuPont&#x201d;) nutrition and biosciences business (the &#x201c;N&amp;amp;B Business&#x201d;), which had been transferred to Nutrition and Biosciences, Inc., a Delaware corporation and wholly owned subsidiary of DuPont (&#x201c;N&amp;amp;B&#x201d;) in a Reverse Morris Trust transaction. See Note 3 for additional information. As a result, the Company&#x2019;s Consolidated Financial Statements for the periods ended December&#160;31, 2023 and 2022 reflect the results of N&amp;amp;B for the full twelve months of 2023 and 2022, whereas the period ended December&#160;31, 2021 only reflect the results of N&amp;amp;B from the Closing Date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Correction of Prior Year Consolidated Financial Statements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company revised its Operating lease right-of-use assets from $636 million to $743 million and Operating lease liabilities from $565 million to $672 million on its Consolidated Balance Sheets as of December&#160;31, 2022. This reflects the correction of an error of $107 million related to a lease renewal that was not correctly reflected in the prior year period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, the Company revised its Goodwill from $13.355&#160;billion to $13.373&#160;billion and Deferred income tax liabilities from $2.265 billion to $2.283 billion on its Consolidated Balance Sheets as of December&#160;31, 2022. This reflects the correction of an error of $18 million related to deferred income tax liabilities as part of purchase accounting for the Merger with N&amp;amp;B.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also corrected an error related to the fair value of derivative assets and liabilities of cross currency swaps. As a result of this correction, the Company revised its Other assets from $699 million to $689 million, which included a $9 million impact to deferred income taxes, Other liabilities from $472 million to $491 million and Accumulated other comprehensive loss from $2.169 billion to $2.198 billion on its Consolidated Balance Sheets as of December&#160;31, 2022. The Company also revised its Cumulative translation adjustment from $(904)&#160;million to $(933)&#160;million on its Consolidated Statements of Shareholders&#x2019; Equity for the year ended December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also adjusted the disclosure of its total receivables factored for the years ended December&#160;31, 2022 and 2021 from $1.030 billion to $1.451 billion and $668 million to $1.167 billion, respectively, and the outstanding principal amounts of receivables from $212 million to $157 million as of December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The impacts of these corrections are also presented in the related footnotes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fiscal Year End&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses a calendar year of the twelve-month period from January 1 to December 31.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with U.S. generally accepted accounting principles (&#x201c;U.S. GAAP&#x201d;) requires management to make estimates and judgments that affect the amounts reported in the Consolidated Financial Statements and accompanying notes. The inputs into the Company&#x2019;s judgments and estimates take into account ongoing global current events and adverse macroeconomic impacts on the critical and significant accounting estimates, including estimates associated with future cash flows that are used in assessing the risk of impairment of certain assets. Actual results could differ from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Consolidated Financial Statements include the accounts of International Flavors&#160;&amp;amp; Fragrances Inc. and those of its subsidiaries. Significant intercompany balances and transactions have been eliminated. To the extent a subsidiary is not wholly owned, any related non-controlling interests are included as a separate component of Shareholders&#x2019; Equity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue from contracts with customers when the contract or purchase order has received approval and commitment from both parties, has the rights of the parties and payment terms (which can vary by customer) identified, has commercial substance, collectability of consideration is probable, and control has transferred. The revenue recognized reflects the consideration the Company expects to be entitled to in exchange for those goods. Sales, value added, and other taxes the Company collects are excluded from revenues. The Company receives payment in accordance with standard customer terms.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sales are reduced, at the time revenue is recognized, for applicable discounts, rebates and sales allowances based on historical experience. Related accruals are included in Other current liabilities in the accompanying Consolidated Balance Sheets. The Company considers shipping and handling activities undertaken after the customer has obtained control of the related goods as a fulfillment activity. Net sales include shipping and handling charges billed to customers. Cost of goods sold includes all costs incurred in connection with shipping and handling.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Contract Assets and Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;With respect to a small number of contracts for the sale of compounds, the Company has an &#x201c;enforceable right to payment for performance to date&#x201d; and as the products do not have an alternative use, the Company recognizes revenue for these contracts over time and records a contract asset using the output method. The output method recognizes revenue on the basis of direct measurements of the value to the customer of the goods or services transferred to date relative to the remaining goods or services promised under the contract.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023 and 2022, the Company&#x2019;s gross accounts receivable was $1.778&#160;billion and $1.871&#160;billion, respectively. The Company&#x2019;s contract assets and contract liabilities as of December&#160;31, 2023 and 2022 were not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company translates the assets and liabilities of non-U.S. subsidiaries into U.S. dollars at year-end exchange rates. Income and expense items are translated at average exchange rates during the year. Cumulative translation adjustments are shown as a separate component of Shareholders&#x2019; Equity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Research and Development&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development (&#x201c;R&amp;amp;D&#x201d;) expenses relate to the development of new and improved products, technical product support and compliance with governmental regulation. All research and development costs are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents include highly liquid investments with maturities of three months or less at date of purchase.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash is comprised of cash or cash equivalents which has been placed into an account that is restricted for a specific use and from which the Company cannot withdraw the cash on demand.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of cash, cash equivalents and restricted cash reported on the Company&#x2019;s balance sheets as of December&#160;31, 2023, 2022 and 2021 to the amounts reported on the Company&#x2019;s statement of cash flows periods ended December&#160;31, 2023, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:32.964%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.391%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.391%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents included in Assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash included in Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has various factoring agreements globally under which it can factor up to approximately $300&#160;million of its trade receivables (&#x201c;Company&#x2019;s own factoring agreements&#x201d;). In addition, the Company utilizes factoring agreements sponsored by certain customers. Under all of the arrangements, the Company sells the trade receivables on a non-recourse basis to &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;unrelated financial institutions and accounts for the transactions as sales of receivables. The applicable receivables are removed from the Company&#x2019;s Consolidated Balance Sheets when the cash proceeds are received by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company sold approximately $1.752&#160;billion, $1.451 billion and $1.167&#160;billion of receivables in 2023, 2022 and 2021, respectively, under the Company&#x2019;s own factoring agreements and customer sponsored factoring agreements. The cost of participating in these programs was approximately $25&#160;million, $12 million and $6 million, in 2023, 2022 and 2021, respectively, and is included as a component of interest expense. Under the Company&#x2019;s own factoring agreements for which the Company has continued responsibility to collect receivables and provide to its sponsor, it sold approximately $843&#160;million, $547&#160;million and $197&#160;million of receivables in 2023, 2022 and 2021, respectively. The outstanding principal amounts of receivables under the Company&#x2019;s own factoring agreements amounted to approximately $196 million and $157 million as of December&#160;31, 2023 and 2022, respectively. The proceeds from the sales of receivables are included in net cash from operating activities in the Consolidated Statements of Cash Flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Expected Credit Losses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is exposed to credit losses primarily through its sales of products. To determine the appropriate allowance for expected credit losses, the Company considers certain credit quality indicators, such as aging of customer receivable balances, loss history and creditworthiness of debtors. The Company also considers current and anticipated future conditions of the general economy in the determination of allowances, including significant aspects of a geographic location and the industries in which the Company operates. The Company&#x2019;s general allowance for credit losses is calculated using a loss rate model that is primarily based on historical write-off experiences and applied to trade receivables. As necessary, additional reserves are established based on other factors, such as aging of receivables, customer credit quality and account collectability and country risk. These allowances are reviewed and approved by the Regional and Global Credit committees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023, the Company reported $1.726 billion of trade receivables, net of allowances of $52 million. Based on the aging analysis as of December&#160;31, 2023, approximately 1% of the Company&#x2019;s accounts receivable were past due by over 365 days based on the payment terms of the invoice.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a roll forward of the Company&#x2019;s allowances for bad debts for the years ended December 31, 2022 and 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:83.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.544%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Allowance for Bad Debts&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bad debt expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bad debt expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Bad debt expense included approximately $11&#160;million related to expected credit losses on receivables from customers located in Russia and Ukraine (for export and domestic sales) due to the events in those countries.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Bad debt expense included approximately $13 million related to expected credit losses on receivables from certain customers in Egypt, offset by approximately $8 million of reversals of allowances on receivables from customers located in Russia and Ukraine. The Company will continue to evaluate its credit exposure related to Egypt, Russia and Ukraine.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories are stated at the lower of cost (on a weighted-average basis) or net realizable value. The Company&#x2019;s inventories consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.692%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines if an arrangement is a lease at contract inception. A lease exists when a contract conveys to the customer the right to control the use of identified property, plant or equipment for a period of time in exchange for consideration. The definition of a lease embodies two conditions: (1) there is an identified asset in the contract that is land or a depreciable asset (i.e., property, plant, and equipment), and (2) the customer has the right to control the use of the identified asset.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When the Company determines the arrangement is a lease, or contains a lease, at inception, it then determines whether the lease is an operating lease or a finance lease at the commencement date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases property and equipment principally under operating leases and records a right-of-use asset and related obligation at the present value of lease payments. Over the term of the lease, the Company depreciates the right-of-use asset and accretes the related obligation to future value. Some of the leases include rental escalation clauses, renewal options and/or termination options that are factored into the determination of lease payments when appropriate. The Company has elected not to separate non-lease components from lease components for all classes of leased assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When available, the Company uses the rate implicit in the lease to discount lease payments to present value, however, most of the Company&#x2019;s leases do not provide a readily determinable implicit rate and the Company calculates the applicable incremental borrowing rate to discount the lease payments based on the term of the lease at lease commencement. The incremental borrowing rate is determined based on the Company&#x2019;s credit rating, currency and lease terms.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Long-Lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Property, Plant and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment are recorded at cost. Depreciation is calculated on a straight-line basis, principally over the following estimated useful lives: buildings and improvements, 1 to 40 years; machinery and equipment, 1 to 20 years; information technology hardware and software, 1 to 7 years; and leasehold improvements which are included in buildings and improvements, the estimated life of the improvements or the remaining term of the lease, whichever is shorter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest incurred during the construction period of certain property, plant and equipment is capitalized until the underlying assets are placed in service, at which time straight-line amortization of the capitalized interest begins over the estimated useful lives of the related assets. Capitalized interest was approximately $17 million, $13 million and $9 million for the years ended December&#160;31, 2023, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Finite-Lived Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finite-lived intangible assets include customer relationships, patents, trade names, technological know-how and other intellectual property valued at acquisition and are amortized on a straight-line basis over the following estimated useful lives: customer relationships, 10 to 27 years; patents, 11 to 15 years; trade names, 4 to 28 years; and technological know-how, 5 to 28 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviews long-lived assets for impairment when events or changes in business conditions indicate that their carrying value may not be recovered. An estimate of undiscounted future cash flows produced by an asset or group of assets is compared to the carrying value to determine whether impairment exists. If assets are determined to be impaired, the loss is measured based on an estimate of fair value using various valuation techniques, including a discounted estimate of future cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;The Israel-Hamas War&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains operations in Israel and, additionally, exports products to customers in Israel from operations outside the region. The Company will continue to evaluate the current events and any potential impacts related to this matter, but does not expect there to be a material impact to its Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;The Russia-Ukraine War&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains operations in both Russia and Ukraine and, additionally, exports products to customers in Russia and Ukraine from operations outside the region. In response to the events in Ukraine, the Company has limited the production and supply of ingredients in and to Russia to only those that meet the essential needs of people, including food, hygiene and medicine.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Allowances for Bad Debts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023, the Company had a reserve of approximately $3&#160;million related to expected credit losses on receivables from customers located in Russia and Ukraine. The Company will continue to evaluate its credit exposure related to Russia and Ukraine.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the second quarter of 2022, the sales and margins declined for certain entities within Russia due to supply chain issues, reduced product demand and exchange rate volatility. Further, it was determined that such declines in operating performance were not expected to reverse in the near future. Additionally, future growth was expected to be limited given operating conditions in Russia, which inhibit the required future investment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with uncertainties related to the Company&#x2019;s operations in Russia and Ukraine, the Company updated its analysis of the undiscounted cash flows of the applicable asset groups to determine if the cash flows exceeded the carrying values of the applicable asset groups. With respect to an asset group in the Nourish segment, that manufactures and sells in Russia and related markets, it was determined that the undiscounted cash flows were insufficient to cover the carrying value and that an impairment charge was required to write-down the long-lived assets to their fair values. The fair value of such asset group was determined based on a discounted cash flow approach which involved estimating the future cash flows for the business discounted to their present values. The discount rate used in the determination of such fair value was based on consideration of the risks inherent in the cash flows and market as of the valuation date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of this assessment, the Company recognized an impairment charge of $120 million in the Consolidated Statements of (Loss) Income and Comprehensive Loss for the year ended December 31, 2022, which was allocated on a pro rata basis to intangible assets and property, plant and equipment within the asset group in the amounts of approximately $92 million and $28 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill represents the difference between the total purchase price and the fair value of identifiable assets and liabilities acquired in business acquisitions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company tests goodwill for impairment at the reporting unit level as of November 30 every year or more frequently if events or changes in circumstances indicate the asset might be impaired. A reporting unit is an operating segment or one level below an operating segment (referred to as a component) to which goodwill is assigned when initially recorded.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company identifies their reporting units by assessing whether the components of their reporting units constitute businesses for which discrete financial information is available and management of each reporting unit regularly reviews the operating results of those components. The Company determined that it has six reporting units under the Nourish, Health &amp;amp; Biosciences, Scent and Pharma Solutions segments: (1) Nourish, (2) Fragrance Compounds, (3) Fragrance Ingredients, (4) Cosmetic Ingredients, (5) Health &amp;amp; Biosciences and (6) Pharma Solutions. These reporting units were determined based on the level at which the performance is measured and reviewed by segment management. In cases where the components of an operating segment have similar economic characteristics, they are aggregated into a single reporting unit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When testing goodwill for impairment, the Company has the option of first performing a qualitative assessment to determine whether it is more likely than not that the fair value of a reporting unit is less than the carrying amount. If the Company elects to bypass the qualitative assessment for any reporting units, or if a qualitative assessment indicates it is more likely than not that the estimated carrying value of a reporting unit exceeds its fair value, the Company performs a quantitative goodwill impairment test.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the quantitative goodwill impairment test, if a reporting unit&#x2019;s carrying amount exceeds its fair value, the Company will record an impairment charge based on that difference, and the impairment charge will be limited to the amount of goodwill allocated to that reporting unit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the year ended December 31, 2023, the Company determined that the carrying value of the Nourish reporting unit exceeded its fair value and recorded an impairment charge of $2.623&#160;billion in the Consolidated Statements of (Loss) Income and Comprehensive Loss for the year ended December 31, 2023. During 2022, the Company determined that the carrying value of the Health &amp;amp; Biosciences reporting unit exceeded its fair value and recorded a goodwill impairment charge of $2.250 billion in the Consolidated Statements of (Loss) Income and Comprehensive Loss for the year ended December 31, 2022. See Note 6 for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for taxes under the asset and liability method. Under this method, deferred income taxes are recognized for temporary differences between the financial statement and tax return bases of assets and liabilities, based on enacted tax rates and other provisions of the tax law. The effect of a change in tax laws or rates on deferred tax assets and liabilities is recognized as income in the period in which such change is enacted. Future tax benefits are recognized to the extent that the realization of such benefits is more likely than not, and a valuation allowance is established for any portion of a deferred tax asset that management believes may not be realized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes uncertain tax positions that it has taken or expects to take on a tax return. Pursuant to accounting requirements, the Company first determines whether it is &#x201c;more likely than not&#x201d; its tax position will be sustained if the relevant tax authority were to audit the position with full knowledge of all the relevant facts and other information. For those tax positions that meet this threshold, the Company measures the amount of tax benefit based on the largest amount of tax benefit that it has a greater than 50% chance of realizing in a final settlement with the relevant authority. Those tax positions failing to qualify for initial recognition are recognized in the first interim period in which they meet the more likely than not standard. The Company maintains a cumulative risk portfolio relating to all of its uncertainties in income taxes in order to perform this analysis, but the evaluation of its tax positions requires significant judgment and estimation in part because, in certain cases, tax law is subject to varied interpretation, and whether a tax position will ultimately be sustained may be uncertain.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest and penalties related to unrecognized tax benefits are recognized as a component of income tax expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Retirement Benefits&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Current service costs of retirement plans and postretirement health care and life insurance benefits are accrued. Prior service costs resulting from plan improvements are amortized over periods ranging from 10 to 20 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Derivative financial instruments are used to manage interest and foreign currency exposures. The gain or loss on the hedging instrument is recorded in earnings at the same time as the transaction being hedged is recorded in earnings. The associated asset or liability related to the open hedge instrument is recorded in Prepaid expenses and Other current assets or Other current liabilities, as applicable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records all derivative financial instruments on the balance sheet at fair value. Changes in a derivative&#x2019;s fair value are recognized in earnings unless specific hedge criteria are met. If the derivative is designated as a fair value hedge, the changes in the fair value of the derivative and of the hedged item attributable to the hedged risk are recognized in Net (loss) income. If the derivative is designated as a cash flow hedge, the effective portions of changes in the fair value of the derivative are recorded in Accumulated other comprehensive income (loss) (&#x201c;AOCI&#x201d;) in the accompanying Consolidated Balance Sheets and are subsequently recognized in Net (loss) income when the hedged item affects earnings. Ineffective portions of changes in the fair value of cash flow hedges, if any, are recognized as a charge or credit to earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Software Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company capitalizes direct internal and external development costs for certain significant projects associated with internal-use software and amortizes these costs over seven years. Neither preliminary evaluation costs nor costs associated with the software after implementation are capitalized. Costs related to projects that are not significant are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net (Loss) Income Per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the two-class method, earnings are adjusted by accretion of amounts to redeemable non-controlling interests recorded at redemption value. The adjustments represent in-substance dividend distributions to the non-controlling interest holders as the holders have a contractual right to receive a specified amount upon redemption. As a result, earnings are adjusted to reflect this in-substance distribution that is different from other common shareholders.&#160;In addition, the Company has unvested share based payment awards with a right to receive nonforfeitable dividends and thus are considered participating securities which are required to be included in the computation of basic and diluted earnings per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic (loss) income per share represents the amount of earnings available to each share of common stock outstanding during the period. Basic (loss) income per share includes the effect of issuing shares of common stock, where (i) for 2021, the prepaid stock purchase contracts (&#x201c;SPCs&#x201d;) were converted using the final settlement rate on September 14, 2021 (see Note 11 for additional information), and (ii) an adjustment to (loss) income to reflect adjustments made to record the redeemable value of redeemable non-controlling interests. Diluted (loss) income per share also includes the effect of issuing shares of common stock, assuming (i) stock options and warrants are exercised, (ii) restricted stock units are fully vested under the treasury stock method, and (iii) for 2021, the incremental effect of the prepaid SPCs were converted using the final settlement rate on September 14, 2021 (see Note 11 for additional information).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Compensation cost of all stock-based awards is measured at fair value on the date of grant and recognized over the service period for which awards are expected to vest. The cost of such stock-based awards is principally recognized on a straight-line attribution basis over their respective vesting periods, net of estimated forfeitures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Financing Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Costs incurred in the issuance of debt are deferred and amortized as part of interest expense over the stated life of the applicable debt instrument. Unamortized deferred financing costs relating to debt are presented as a reduction in the amount of &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;debt outstanding on the Consolidated Balance Sheets. Unamortized deferred financing costs relating to the revolving credit facility are recorded in Other assets on the Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Redeemable Non-controlling Interests&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Non-controlling interests in subsidiaries that are redeemable for cash or other assets outside of the Company&#x2019;s control are classified as mezzanine equity, outside of equity and liabilities, at the greater of the carrying value or the redemption value. The increases or decreases in the estimated redemption amount are recorded with corresponding adjustments against Capital in excess of par value and are reflected in the computation of earnings per share using the two-class method. As of December 31, 2023, the Company has acquired or sold all of its remaining redeemable non-controlling interests. See Note 20 for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Held for Sale&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities to be disposed of by sale (&#x201c;disposal groups&#x201d;) are reclassified into assets and liabilities held for sale on the Company&#x2019;s Consolidated Balance Sheets. The reclassification occurs when an agreement to sell exists, or management has committed to a plan to sell the assets within one year. Disposal groups are measured at the lower of carrying value or fair value less costs to sell and are not depreciated or amortized. When the net realizable value of a disposal group increases during a period, a gain can be recognized to the extent that it does not increase the value of the disposal group beyond its original carrying value when the disposal group was reclassified as held for sale. The fair value of a disposal group, less any costs to sell, is assessed each reporting period it remains classified as held for sale and any remeasurement to the lower of carrying value or fair value less costs to sell is reported as an adjustment to the carrying value of the disposal group. See Note 21 for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Supply Chain Financing Program&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the fourth quarter of 2023, the Company entered into a supply chain financing (&#x201c;SCF&#x201d;) program. The program is expected to be available to U.S. based suppliers starting in the second quarter of 2024. The Company makes continuous efforts to improve working capital efficiency and has worked with suppliers to optimize payment terms and conditions. The Company&#x2019;s current payment terms with a majority of suppliers generally range from 0 to 180 days, which is deemed to be commercially reasonable. The Company&#x2019;s voluntary SCF program will allow its suppliers to elect to sell the receivables owed to them by the Company to a third-party financial institution. The suppliers, at their own discretion, will determine the invoices they want to sell and directly negotiate the arrangements with the participating third-party financial institution. Supplier participation in the program is solely the decision of the supplier and has no bearing on the Company&#x2019;s payment terms and amounts due with the supplier. The Company&#x2019;s responsibility will be limited to making payments based upon the agreed upon contractual terms and arrangements. The Company will not provide any form of guarantees under the SCF program and will have no economic interest in the suppliers&#x2019; decision to participate in the SCF program. Amounts due to suppliers that elect to participate in the SCF program will be included in Accounts payable on the Consolidated Balance Sheets. The Company, or the third-party financial institution, may choose to terminate the agreement of the program at any time upon 30 days&#x2019; prior written notice. The third-party financial institution may also terminate the agreement of the program at any time upon three business days&#x2019; prior written notice in the event there are insufficient funds available for disbursements. As of December&#160;31, 2023 and 2022, there were no amounts outstanding related to suppliers&#x2019; participation in the SCF program.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2023-09, &#x201c;Income Taxes (Topic 740): Improvements to Income Tax Disclosures.&#x201d; The ASU was issued to further enhance income tax disclosures, primarily through standardization and disaggregation of rate reconciliation categories and income taxes paid by jurisdiction. This guidance is effective for fiscal years beginning after December 15, 2024, with early adoption permitted, and may be applied either prospectively or retrospectively. The Company is currently evaluating the impact that this guidance will have on its Consolidated Financial Statements and income tax disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2023, the FASB issued ASU 2023-07, &#x201c;Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.&#x201d; The ASU intends to improve reportable segment disclosure requirements, primarily through enhanced disclosures of significant segment expenses that are regularly provided to the Chief Operating Decision Maker and included within segment profit and loss. This guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted, and applied retrospectively to all prior periods presented in the financial statements. The Company is currently evaluating the impact that this guidance will have on its Consolidated Financial Statements and reportable segment disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2022, the FASB issued ASU 2022-06, &#x201c;Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848.&#x201d; The ASU was issued to provide an update on ASU 2020-04 and ASU 2021-01 that were issued in March 2020 and January 2021, respectively, which provided optional accounting guidance for a limited period of time to ease the potential burden in accounting for reference rate reform. The guidance provides optional expedients and exceptions to existing accounting requirements for contract modifications and hedge accounting related to transitioning from discontinued reference rates, such as London Interbank Offered Rate (&#x201c;LIBOR&#x201d;), to alternative reference rates, if certain criteria are met. With the issuance of ASU 2022-06, the sunset date of Topic 848 has been deferred from December 31, 2022 to December 31, 2024, after which entities will no longer be permitted to apply the relief in Topic 848. The Company has adopted this guidance on January 1, 2023, which did not have a material impact on its Consolidated Financial Statements. On March 23, 2023, the Company amended certain existing debt agreements where the interest rate benchmark was updated from LIBOR to the Secured Overnight Financing Rate (&#x201c;Term SOFR&#x201d;). The Company applied Topic 848 to its recent amendments of its debt agreements. See Note 9 for additional information on the amendments to the debt agreements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2022, the FASB issued ASU 2022-04, &#x201c;Liabilities - Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations.&#x201d; The ASU requires that a buyer in a supplier finance program disclose sufficient information about the program to allow users of the financial statements to understand the program&#x2019;s nature, activity during the period, changes from period to period and potential magnitude. The buyer should disclose qualitative and quantitative information about its supplier finance programs. The ASU requires the buyer&#x2019;s annual disclosure to include a roll forward of the obligations under the supplier finance programs during the annual period, including the amount of obligations confirmed and subsequently paid. This guidance is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the amendment on roll forward information, which is effective for fiscal years beginning after December 15, 2023, and early adoption is permitted. The Company has adopted this guidance on January 1, 2023, which did not have a material impact on its Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
    <iff:NatureOfOperationsPolicyTextBlock contextRef="c-1" id="f-501">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Nature of Operations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;International Flavors &amp;amp; Fragrances Inc. and its subsidiaries (the &#x201c;Registrant,&#x201d; &#x201c;IFF,&#x201d; &#x201c;the Company,&#x201d; &#x201c;we,&#x201d; &#x201c;us&#x201d; and &#x201c;our&#x201d;) is a leading creator and manufacturer of food, beverage, health &amp;amp; biosciences, scent and pharma solutions and complementary adjacent products, including cosmetic active and natural health ingredients, which are used in a wide variety of consumer products. Our products are sold principally to manufacturers of perfumes and cosmetics, hair and other personal care products, soaps and detergents, cleaning products, dairy, meat and other processed foods, beverages, snacks and savory foods, sweet and baked goods, sweeteners, dietary supplements, food protection, infant and elderly nutrition, functional food, and pharmaceutical excipients and oral care products.&lt;/span&gt;&lt;/div&gt;</iff:NatureOfOperationsPolicyTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c-1" id="f-502">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 1, 2021 (the &#x201c;Closing Date&#x201d;), the Company completed the combination (the &#x201c;Merger&#x201d;) of IFF and DuPont de Nemours, Inc (&#x201c;DuPont&#x201d;) nutrition and biosciences business (the &#x201c;N&amp;amp;B Business&#x201d;), which had been transferred to Nutrition and Biosciences, Inc., a Delaware corporation and wholly owned subsidiary of DuPont (&#x201c;N&amp;amp;B&#x201d;) in a Reverse Morris Trust transaction. See Note 3 for additional information. As a result, the Company&#x2019;s Consolidated Financial Statements for the periods ended December&#160;31, 2023 and 2022 reflect the results of N&amp;amp;B for the full twelve months of 2023 and 2022, whereas the period ended December&#160;31, 2021 only reflect the results of N&amp;amp;B from the Closing Date.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-55" decimals="-6" id="f-503" unitRef="usd">636000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-12" decimals="-6" id="f-504" unitRef="usd">743000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-55" decimals="-6" id="f-505" unitRef="usd">565000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-12" decimals="-6" id="f-506" unitRef="usd">672000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-56" decimals="-6" id="f-507" unitRef="usd">107000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:Goodwill contextRef="c-55" decimals="-6" id="f-508" unitRef="usd">13355000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-12" decimals="-6" id="f-509" unitRef="usd">13373000000</us-gaap:Goodwill>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-55" decimals="-6" id="f-510" unitRef="usd">2265000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-12" decimals="-6" id="f-511" unitRef="usd">2283000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-56" decimals="-6" id="f-512" unitRef="usd">18000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-55" decimals="-6" id="f-513" unitRef="usd">699000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-12" decimals="-6" id="f-514" unitRef="usd">689000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="c-56" decimals="-6" id="f-515" unitRef="usd">9000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-55" decimals="-6" id="f-516" unitRef="usd">472000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-12" decimals="-6" id="f-517" unitRef="usd">491000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-55" decimals="-6" id="f-518" unitRef="usd">-2169000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-12" decimals="-6" id="f-519" unitRef="usd">-2198000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax contextRef="c-55" decimals="-6" id="f-520" unitRef="usd">-904000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax contextRef="c-12" decimals="-6" id="f-521" unitRef="usd">-933000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <iff:ProceedsFromSaleOfAccountsReceivable contextRef="c-57" decimals="-6" id="f-522" unitRef="usd">1030000000.00</iff:ProceedsFromSaleOfAccountsReceivable>
    <iff:ProceedsFromSaleOfAccountsReceivable contextRef="c-9" decimals="-6" id="f-523" unitRef="usd">1451000000</iff:ProceedsFromSaleOfAccountsReceivable>
    <iff:ProceedsFromSaleOfAccountsReceivable contextRef="c-58" decimals="-6" id="f-524" unitRef="usd">668000000</iff:ProceedsFromSaleOfAccountsReceivable>
    <iff:ProceedsFromSaleOfAccountsReceivable contextRef="c-10" decimals="-6" id="f-525" unitRef="usd">1167000000</iff:ProceedsFromSaleOfAccountsReceivable>
    <us-gaap:TradeReceivablesHeldForSaleAmount contextRef="c-55" decimals="-6" id="f-526" unitRef="usd">212000000</us-gaap:TradeReceivablesHeldForSaleAmount>
    <us-gaap:TradeReceivablesHeldForSaleAmount contextRef="c-12" decimals="-6" id="f-527" unitRef="usd">157000000</us-gaap:TradeReceivablesHeldForSaleAmount>
    <us-gaap:FiscalPeriod contextRef="c-1" id="f-528">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fiscal Year End&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses a calendar year of the twelve-month period from January 1 to December 31.&lt;/span&gt;&lt;/div&gt;</us-gaap:FiscalPeriod>
    <us-gaap:UseOfEstimates contextRef="c-1" id="f-529">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with U.S. generally accepted accounting principles (&#x201c;U.S. GAAP&#x201d;) requires management to make estimates and judgments that affect the amounts reported in the Consolidated Financial Statements and accompanying notes. The inputs into the Company&#x2019;s judgments and estimates take into account ongoing global current events and adverse macroeconomic impacts on the critical and significant accounting estimates, including estimates associated with future cash flows that are used in assessing the risk of impairment of certain assets. Actual results could differ from those estimates.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="c-1" id="f-530">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Consolidated Financial Statements include the accounts of International Flavors&#160;&amp;amp; Fragrances Inc. and those of its subsidiaries. Significant intercompany balances and transactions have been eliminated. To the extent a subsidiary is not wholly owned, any related non-controlling interests are included as a separate component of Shareholders&#x2019; Equity.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="c-1" id="f-531">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue from contracts with customers when the contract or purchase order has received approval and commitment from both parties, has the rights of the parties and payment terms (which can vary by customer) identified, has commercial substance, collectability of consideration is probable, and control has transferred. The revenue recognized reflects the consideration the Company expects to be entitled to in exchange for those goods. Sales, value added, and other taxes the Company collects are excluded from revenues. The Company receives payment in accordance with standard customer terms.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sales are reduced, at the time revenue is recognized, for applicable discounts, rebates and sales allowances based on historical experience. Related accruals are included in Other current liabilities in the accompanying Consolidated Balance Sheets. The Company considers shipping and handling activities undertaken after the customer has obtained control of the related goods as a fulfillment activity. Net sales include shipping and handling charges billed to customers. Cost of goods sold includes all costs incurred in connection with shipping and handling.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock contextRef="c-1" id="f-532">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Contract Assets and Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;With respect to a small number of contracts for the sale of compounds, the Company has an &#x201c;enforceable right to payment for performance to date&#x201d; and as the products do not have an alternative use, the Company recognizes revenue for these contracts over time and records a contract asset using the output method. The output method recognizes revenue on the basis of direct measurements of the value to the customer of the goods or services transferred to date relative to the remaining goods or services promised under the contract.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023 and 2022, the Company&#x2019;s gross accounts receivable was $1.778&#160;billion and $1.871&#160;billion, respectively. The Company&#x2019;s contract assets and contract liabilities as of December&#160;31, 2023 and 2022 were not material.&lt;/span&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:AccountsReceivableGross contextRef="c-11" decimals="-6" id="f-533" unitRef="usd">1778000000</us-gaap:AccountsReceivableGross>
    <us-gaap:AccountsReceivableGross contextRef="c-12" decimals="-6" id="f-534" unitRef="usd">1871000000</us-gaap:AccountsReceivableGross>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="c-1" id="f-535">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company translates the assets and liabilities of non-U.S. subsidiaries into U.S. dollars at year-end exchange rates. Income and expense items are translated at average exchange rates during the year. Cumulative translation adjustments are shown as a separate component of Shareholders&#x2019; Equity.&lt;/span&gt;&lt;/div&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="c-1" id="f-536">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Research and Development&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development (&#x201c;R&amp;amp;D&#x201d;) expenses relate to the development of new and improved products, technical product support and compliance with governmental regulation. All research and development costs are expensed as incurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="c-1" id="f-537">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents include highly liquid investments with maturities of three months or less at date of purchase.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy contextRef="c-1" id="f-538">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash is comprised of cash or cash equivalents which has been placed into an account that is restricted for a specific use and from which the Company cannot withdraw the cash on demand.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock contextRef="c-1" id="f-539">&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of cash, cash equivalents and restricted cash reported on the Company&#x2019;s balance sheets as of December&#160;31, 2023, 2022 and 2021 to the amounts reported on the Company&#x2019;s statement of cash flows periods ended December&#160;31, 2023, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:32.964%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.391%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.391%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents included in Assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash included in Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-11" decimals="-6" id="f-540" unitRef="usd">703000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-12" decimals="-6" id="f-541" unitRef="usd">483000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-13" decimals="-6" id="f-542" unitRef="usd">711000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents contextRef="c-11" decimals="-6" id="f-543" unitRef="usd">26000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents contextRef="c-12" decimals="-6" id="f-544" unitRef="usd">52000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents contextRef="c-13" decimals="-6" id="f-545" unitRef="usd">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents>
    <us-gaap:RestrictedCashCurrent contextRef="c-11" decimals="-6" id="f-546" unitRef="usd">6000000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent contextRef="c-12" decimals="-6" id="f-547" unitRef="usd">10000000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent contextRef="c-13" decimals="-6" id="f-548" unitRef="usd">4000000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-11" decimals="-6" id="f-549" unitRef="usd">0</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-12" decimals="-6" id="f-550" unitRef="usd">7000000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-13" decimals="-6" id="f-551" unitRef="usd">1000000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-11" decimals="-6" id="f-552" unitRef="usd">735000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-12" decimals="-6" id="f-553" unitRef="usd">552000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-13" decimals="-6" id="f-554" unitRef="usd">716000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:ReceivablesPolicyTextBlock contextRef="c-1" id="f-555">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has various factoring agreements globally under which it can factor up to approximately $300&#160;million of its trade receivables (&#x201c;Company&#x2019;s own factoring agreements&#x201d;). In addition, the Company utilizes factoring agreements sponsored by certain customers. Under all of the arrangements, the Company sells the trade receivables on a non-recourse basis to &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;unrelated financial institutions and accounts for the transactions as sales of receivables. The applicable receivables are removed from the Company&#x2019;s Consolidated Balance Sheets when the cash proceeds are received by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company sold approximately $1.752&#160;billion, $1.451 billion and $1.167&#160;billion of receivables in 2023, 2022 and 2021, respectively, under the Company&#x2019;s own factoring agreements and customer sponsored factoring agreements. The cost of participating in these programs was approximately $25&#160;million, $12 million and $6 million, in 2023, 2022 and 2021, respectively, and is included as a component of interest expense. Under the Company&#x2019;s own factoring agreements for which the Company has continued responsibility to collect receivables and provide to its sponsor, it sold approximately $843&#160;million, $547&#160;million and $197&#160;million of receivables in 2023, 2022 and 2021, respectively. The outstanding principal amounts of receivables under the Company&#x2019;s own factoring agreements amounted to approximately $196 million and $157 million as of December&#160;31, 2023 and 2022, respectively. The proceeds from the sales of receivables are included in net cash from operating activities in the Consolidated Statements of Cash Flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReceivablesPolicyTextBlock>
    <iff:AccountsReceivableFactoringReceivableProgramMaximumAmount contextRef="c-59" decimals="-6" id="f-556" unitRef="usd">300000000</iff:AccountsReceivableFactoringReceivableProgramMaximumAmount>
    <iff:ProceedsFromSaleOfAccountsReceivable contextRef="c-1" decimals="-6" id="f-557" unitRef="usd">1752000000</iff:ProceedsFromSaleOfAccountsReceivable>
    <iff:ProceedsFromSaleOfAccountsReceivable contextRef="c-9" decimals="-6" id="f-558" unitRef="usd">1451000000</iff:ProceedsFromSaleOfAccountsReceivable>
    <iff:ProceedsFromSaleOfAccountsReceivable contextRef="c-10" decimals="-6" id="f-559" unitRef="usd">1167000000</iff:ProceedsFromSaleOfAccountsReceivable>
    <iff:PaymentsToParticipateInFactoringReceivableProgram contextRef="c-1" decimals="-6" id="f-560" unitRef="usd">25000000</iff:PaymentsToParticipateInFactoringReceivableProgram>
    <iff:PaymentsToParticipateInFactoringReceivableProgram contextRef="c-9" decimals="-6" id="f-561" unitRef="usd">12000000</iff:PaymentsToParticipateInFactoringReceivableProgram>
    <iff:PaymentsToParticipateInFactoringReceivableProgram contextRef="c-10" decimals="-6" id="f-562" unitRef="usd">6000000</iff:PaymentsToParticipateInFactoringReceivableProgram>
    <iff:ProceedsFromSaleOfAccountsReceivable contextRef="c-60" decimals="-6" id="f-563" unitRef="usd">843000000</iff:ProceedsFromSaleOfAccountsReceivable>
    <iff:ProceedsFromSaleOfAccountsReceivable contextRef="c-61" decimals="-6" id="f-564" unitRef="usd">547000000</iff:ProceedsFromSaleOfAccountsReceivable>
    <iff:ProceedsFromSaleOfAccountsReceivable contextRef="c-62" decimals="-6" id="f-565" unitRef="usd">197000000</iff:ProceedsFromSaleOfAccountsReceivable>
    <us-gaap:TradeReceivablesHeldForSaleAmount contextRef="c-59" decimals="-6" id="f-566" unitRef="usd">196000000</us-gaap:TradeReceivablesHeldForSaleAmount>
    <us-gaap:TradeReceivablesHeldForSaleAmount contextRef="c-63" decimals="-6" id="f-567" unitRef="usd">157000000</us-gaap:TradeReceivablesHeldForSaleAmount>
    <us-gaap:CreditLossFinancialInstrumentPolicyTextBlock contextRef="c-1" id="f-568">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Expected Credit Losses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is exposed to credit losses primarily through its sales of products. To determine the appropriate allowance for expected credit losses, the Company considers certain credit quality indicators, such as aging of customer receivable balances, loss history and creditworthiness of debtors. The Company also considers current and anticipated future conditions of the general economy in the determination of allowances, including significant aspects of a geographic location and the industries in which the Company operates. The Company&#x2019;s general allowance for credit losses is calculated using a loss rate model that is primarily based on historical write-off experiences and applied to trade receivables. As necessary, additional reserves are established based on other factors, such as aging of receivables, customer credit quality and account collectability and country risk. These allowances are reviewed and approved by the Regional and Global Credit committees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023, the Company reported $1.726 billion of trade receivables, net of allowances of $52 million. Based on the aging analysis as of December&#160;31, 2023, approximately 1% of the Company&#x2019;s accounts receivable were past due by over 365 days based on the payment terms of the invoice.&lt;/span&gt;&lt;/div&gt;</us-gaap:CreditLossFinancialInstrumentPolicyTextBlock>
    <us-gaap:ReceivablesNetCurrent contextRef="c-11" decimals="-6" id="f-569" unitRef="usd">1726000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-11" decimals="-6" id="f-570" unitRef="usd">52000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <iff:AccountsReceivablesOutstandingByOver365Days contextRef="c-11" decimals="2" id="f-571" unitRef="number">0.01</iff:AccountsReceivablesOutstandingByOver365Days>
    <us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock contextRef="c-1" id="f-572">&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a roll forward of the Company&#x2019;s allowances for bad debts for the years ended December 31, 2022 and 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:83.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.544%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Allowance for Bad Debts&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bad debt expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bad debt expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Bad debt expense included approximately $11&#160;million related to expected credit losses on receivables from customers located in Russia and Ukraine (for export and domestic sales) due to the events in those countries.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Bad debt expense included approximately $13 million related to expected credit losses on receivables from certain customers in Egypt, offset by approximately $8 million of reversals of allowances on receivables from customers located in Russia and Ukraine. The Company will continue to evaluate its credit exposure related to Egypt, Russia and Ukraine.&lt;/span&gt;&lt;/div&gt;</us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-13" decimals="-6" id="f-573" unitRef="usd">46000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="c-9" decimals="-6" id="f-574" unitRef="usd">19000000</us-gaap:ProvisionForDoubtfulAccounts>
    <iff:AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation contextRef="c-9" decimals="-6" id="f-575" unitRef="usd">-12000000</iff:AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-12" decimals="-6" id="f-576" unitRef="usd">53000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="c-1" decimals="-6" id="f-577" unitRef="usd">9000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs contextRef="c-1" decimals="-6" id="f-578" unitRef="usd">11000000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <iff:AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation contextRef="c-1" decimals="-6" id="f-579" unitRef="usd">1000000</iff:AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-11" decimals="-6" id="f-580" unitRef="usd">52000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="c-64" decimals="-6" id="f-581" unitRef="usd">11000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="c-65" decimals="-6" id="f-582" unitRef="usd">13000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="c-66" decimals="-6" id="f-583" unitRef="usd">8000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:InventoryPolicyTextBlock contextRef="c-1" id="f-584">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;Inventories are stated at the lower of cost (on a weighted-average basis) or net realizable value.</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="c-1" id="f-585">The Company&#x2019;s inventories consisted of the following:&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.692%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves contextRef="c-11" decimals="-6" id="f-586" unitRef="usd">779000000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves contextRef="c-12" decimals="-6" id="f-587" unitRef="usd">1073000000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves contextRef="c-11" decimals="-6" id="f-588" unitRef="usd">406000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves contextRef="c-12" decimals="-6" id="f-589" unitRef="usd">442000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves contextRef="c-11" decimals="-6" id="f-590" unitRef="usd">1292000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves contextRef="c-12" decimals="-6" id="f-591" unitRef="usd">1636000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet contextRef="c-11" decimals="-6" id="f-592" unitRef="usd">2477000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="c-12" decimals="-6" id="f-593" unitRef="usd">3151000000</us-gaap:InventoryNet>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="c-1" id="f-594">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines if an arrangement is a lease at contract inception. A lease exists when a contract conveys to the customer the right to control the use of identified property, plant or equipment for a period of time in exchange for consideration. The definition of a lease embodies two conditions: (1) there is an identified asset in the contract that is land or a depreciable asset (i.e., property, plant, and equipment), and (2) the customer has the right to control the use of the identified asset.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When the Company determines the arrangement is a lease, or contains a lease, at inception, it then determines whether the lease is an operating lease or a finance lease at the commencement date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases property and equipment principally under operating leases and records a right-of-use asset and related obligation at the present value of lease payments. Over the term of the lease, the Company depreciates the right-of-use asset and accretes the related obligation to future value. Some of the leases include rental escalation clauses, renewal options and/or termination options that are factored into the determination of lease payments when appropriate. The Company has elected not to separate non-lease components from lease components for all classes of leased assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When available, the Company uses the rate implicit in the lease to discount lease payments to present value, however, most of the Company&#x2019;s leases do not provide a readily determinable implicit rate and the Company calculates the applicable incremental borrowing rate to discount the lease payments based on the term of the lease at lease commencement. The incremental borrowing rate is determined based on the Company&#x2019;s credit rating, currency and lease terms.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="c-1" id="f-595">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Property, Plant and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment are recorded at cost. Depreciation is calculated on a straight-line basis, principally over the following estimated useful lives: buildings and improvements, 1 to 40 years; machinery and equipment, 1 to 20 years; information technology hardware and software, 1 to 7 years; and leasehold improvements which are included in buildings and improvements, the estimated life of the improvements or the remaining term of the lease, whichever is shorter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest incurred during the construction period of certain property, plant and equipment is capitalized until the underlying assets are placed in service, at which time straight-line amortization of the capitalized interest begins over the estimated useful lives of the related assets. Capitalized interest was approximately $17 million, $13 million and $9 million for the years ended December&#160;31, 2023, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-67" id="f-596">P1Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-68" id="f-597">P40Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-69" id="f-598">P1Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-70" id="f-599">P20Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-71" id="f-600">P1Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-72" id="f-601">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:InterestCostsCapitalized contextRef="c-1" decimals="-6" id="f-602" unitRef="usd">17000000</us-gaap:InterestCostsCapitalized>
    <us-gaap:InterestCostsCapitalized contextRef="c-9" decimals="-6" id="f-603" unitRef="usd">13000000</us-gaap:InterestCostsCapitalized>
    <us-gaap:InterestCostsCapitalized contextRef="c-10" decimals="-6" id="f-604" unitRef="usd">9000000</us-gaap:InterestCostsCapitalized>
    <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy contextRef="c-1" id="f-605">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Finite-Lived Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finite-lived intangible assets include customer relationships, patents, trade names, technological know-how and other intellectual property valued at acquisition and are amortized on a straight-line basis over the following estimated useful lives: customer relationships, 10 to 27 years; patents, 11 to 15 years; trade names, 4 to 28 years; and technological know-how, 5 to 28 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviews long-lived assets for impairment when events or changes in business conditions indicate that their carrying value may not be recovered. An estimate of undiscounted future cash flows produced by an asset or group of assets is compared to the carrying value to determine whether impairment exists. If assets are determined to be impaired, the loss is measured based on an estimate of fair value using various valuation techniques, including a discounted estimate of future cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-73" id="f-606">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-74" id="f-607">P27Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-75" id="f-608">P11Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-76" id="f-609">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-77" id="f-610">P4Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-78" id="f-611">P28Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-79" id="f-612">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-80" id="f-613">P28Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <iff:UnusualOrInfrequentItemsOrBothDisclosurePolicyTextBlock contextRef="c-1" id="f-614">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;The Israel-Hamas War&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains operations in Israel and, additionally, exports products to customers in Israel from operations outside the region. The Company will continue to evaluate the current events and any potential impacts related to this matter, but does not expect there to be a material impact to its Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;The Russia-Ukraine War&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains operations in both Russia and Ukraine and, additionally, exports products to customers in Russia and Ukraine from operations outside the region. In response to the events in Ukraine, the Company has limited the production and supply of ingredients in and to Russia to only those that meet the essential needs of people, including food, hygiene and medicine.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Allowances for Bad Debts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023, the Company had a reserve of approximately $3&#160;million related to expected credit losses on receivables from customers located in Russia and Ukraine. The Company will continue to evaluate its credit exposure related to Russia and Ukraine.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the second quarter of 2022, the sales and margins declined for certain entities within Russia due to supply chain issues, reduced product demand and exchange rate volatility. Further, it was determined that such declines in operating performance were not expected to reverse in the near future. Additionally, future growth was expected to be limited given operating conditions in Russia, which inhibit the required future investment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with uncertainties related to the Company&#x2019;s operations in Russia and Ukraine, the Company updated its analysis of the undiscounted cash flows of the applicable asset groups to determine if the cash flows exceeded the carrying values of the applicable asset groups. With respect to an asset group in the Nourish segment, that manufactures and sells in Russia and related markets, it was determined that the undiscounted cash flows were insufficient to cover the carrying value and that an impairment charge was required to write-down the long-lived assets to their fair values. The fair value of such asset group was determined based on a discounted cash flow approach which involved estimating the future cash flows for the business discounted to their present values. The discount rate used in the determination of such fair value was based on consideration of the risks inherent in the cash flows and market as of the valuation date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of this assessment, the Company recognized an impairment charge of $120 million in the Consolidated Statements of (Loss) Income and Comprehensive Loss for the year ended December 31, 2022, which was allocated on a pro rata basis to intangible assets and property, plant and equipment within the asset group in the amounts of approximately $92 million and $28 million, respectively.&lt;/span&gt;&lt;/div&gt;</iff:UnusualOrInfrequentItemsOrBothDisclosurePolicyTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-81" decimals="-6" id="f-615" unitRef="usd">3000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-64" decimals="-6" id="f-616" unitRef="usd">120000000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:AssetImpairmentCharges contextRef="c-82" decimals="-6" id="f-617" unitRef="usd">92000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges contextRef="c-83" decimals="-6" id="f-618" unitRef="usd">28000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy contextRef="c-1" id="f-619">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill represents the difference between the total purchase price and the fair value of identifiable assets and liabilities acquired in business acquisitions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company tests goodwill for impairment at the reporting unit level as of November 30 every year or more frequently if events or changes in circumstances indicate the asset might be impaired. A reporting unit is an operating segment or one level below an operating segment (referred to as a component) to which goodwill is assigned when initially recorded.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company identifies their reporting units by assessing whether the components of their reporting units constitute businesses for which discrete financial information is available and management of each reporting unit regularly reviews the operating results of those components. The Company determined that it has six reporting units under the Nourish, Health &amp;amp; Biosciences, Scent and Pharma Solutions segments: (1) Nourish, (2) Fragrance Compounds, (3) Fragrance Ingredients, (4) Cosmetic Ingredients, (5) Health &amp;amp; Biosciences and (6) Pharma Solutions. These reporting units were determined based on the level at which the performance is measured and reviewed by segment management. In cases where the components of an operating segment have similar economic characteristics, they are aggregated into a single reporting unit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When testing goodwill for impairment, the Company has the option of first performing a qualitative assessment to determine whether it is more likely than not that the fair value of a reporting unit is less than the carrying amount. If the Company elects to bypass the qualitative assessment for any reporting units, or if a qualitative assessment indicates it is more likely than not that the estimated carrying value of a reporting unit exceeds its fair value, the Company performs a quantitative goodwill impairment test.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the quantitative goodwill impairment test, if a reporting unit&#x2019;s carrying amount exceeds its fair value, the Company will record an impairment charge based on that difference, and the impairment charge will be limited to the amount of goodwill allocated to that reporting unit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the year ended December 31, 2023, the Company determined that the carrying value of the Nourish reporting unit exceeded its fair value and recorded an impairment charge of $2.623&#160;billion in the Consolidated Statements of (Loss) Income and Comprehensive Loss for the year ended December 31, 2023. During 2022, the Company determined that the carrying value of the Health &amp;amp; Biosciences reporting unit exceeded its fair value and recorded a goodwill impairment charge of $2.250 billion in the Consolidated Statements of (Loss) Income and Comprehensive Loss for the year ended December 31, 2022. See Note 6 for additional information.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <us-gaap:NumberOfReportingUnits
      contextRef="c-1"
      decimals="INF"
      id="f-620"
      unitRef="reporting_unit">6</us-gaap:NumberOfReportingUnits>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-84" decimals="-6" id="f-621" unitRef="usd">2623000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-85" decimals="-6" id="f-622" unitRef="usd">2250000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="c-1" id="f-623">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for taxes under the asset and liability method. Under this method, deferred income taxes are recognized for temporary differences between the financial statement and tax return bases of assets and liabilities, based on enacted tax rates and other provisions of the tax law. The effect of a change in tax laws or rates on deferred tax assets and liabilities is recognized as income in the period in which such change is enacted. Future tax benefits are recognized to the extent that the realization of such benefits is more likely than not, and a valuation allowance is established for any portion of a deferred tax asset that management believes may not be realized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes uncertain tax positions that it has taken or expects to take on a tax return. Pursuant to accounting requirements, the Company first determines whether it is &#x201c;more likely than not&#x201d; its tax position will be sustained if the relevant tax authority were to audit the position with full knowledge of all the relevant facts and other information. For those tax positions that meet this threshold, the Company measures the amount of tax benefit based on the largest amount of tax benefit that it has a greater than 50% chance of realizing in a final settlement with the relevant authority. Those tax positions failing to qualify for initial recognition are recognized in the first interim period in which they meet the more likely than not standard. The Company maintains a cumulative risk portfolio relating to all of its uncertainties in income taxes in order to perform this analysis, but the evaluation of its tax positions requires significant judgment and estimation in part because, in certain cases, tax law is subject to varied interpretation, and whether a tax position will ultimately be sustained may be uncertain.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest and penalties related to unrecognized tax benefits are recognized as a component of income tax expense.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <iff:MinimumPercentageLikelihoodOfTaxBenefitToBeRealizedUponFinalSettlement
      contextRef="c-11"
      decimals="INF"
      id="f-624"
      unitRef="number">0.50</iff:MinimumPercentageLikelihoodOfTaxBenefitToBeRealizedUponFinalSettlement>
    <us-gaap:PensionAndOtherPostretirementPlansPolicy contextRef="c-1" id="f-625">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Retirement Benefits&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Current service costs of retirement plans and postretirement health care and life insurance benefits are accrued. Prior service costs resulting from plan improvements are amortized over periods ranging from 10 to 20 years.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementPlansPolicy>
    <iff:PriorServiceCostsFromPlanImprovementsAmortizationPeriodMinimum contextRef="c-1" id="f-626">P10Y</iff:PriorServiceCostsFromPlanImprovementsAmortizationPeriodMinimum>
    <iff:PriorServiceCostsFromPlanImprovementsAmortizationPeriodMaximum contextRef="c-1" id="f-627">P20Y</iff:PriorServiceCostsFromPlanImprovementsAmortizationPeriodMaximum>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="c-1" id="f-628">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Derivative financial instruments are used to manage interest and foreign currency exposures. The gain or loss on the hedging instrument is recorded in earnings at the same time as the transaction being hedged is recorded in earnings. The associated asset or liability related to the open hedge instrument is recorded in Prepaid expenses and Other current assets or Other current liabilities, as applicable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records all derivative financial instruments on the balance sheet at fair value. Changes in a derivative&#x2019;s fair value are recognized in earnings unless specific hedge criteria are met. If the derivative is designated as a fair value hedge, the changes in the fair value of the derivative and of the hedged item attributable to the hedged risk are recognized in Net (loss) income. If the derivative is designated as a cash flow hedge, the effective portions of changes in the fair value of the derivative are recorded in Accumulated other comprehensive income (loss) (&#x201c;AOCI&#x201d;) in the accompanying Consolidated Balance Sheets and are subsequently recognized in Net (loss) income when the hedged item affects earnings. Ineffective portions of changes in the fair value of cash flow hedges, if any, are recognized as a charge or credit to earnings.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:InternalUseSoftwarePolicy contextRef="c-1" id="f-629">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Software Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company capitalizes direct internal and external development costs for certain significant projects associated with internal-use software and amortizes these costs over seven years. Neither preliminary evaluation costs nor costs associated with the software after implementation are capitalized. Costs related to projects that are not significant are expensed as incurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:InternalUseSoftwarePolicy>
    <iff:AmortizationPeriodOfInternalAndExternalDevelopmentCosts contextRef="c-1" id="f-630">P7Y</iff:AmortizationPeriodOfInternalAndExternalDevelopmentCosts>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c-1" id="f-631">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net (Loss) Income Per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the two-class method, earnings are adjusted by accretion of amounts to redeemable non-controlling interests recorded at redemption value. The adjustments represent in-substance dividend distributions to the non-controlling interest holders as the holders have a contractual right to receive a specified amount upon redemption. As a result, earnings are adjusted to reflect this in-substance distribution that is different from other common shareholders.&#160;In addition, the Company has unvested share based payment awards with a right to receive nonforfeitable dividends and thus are considered participating securities which are required to be included in the computation of basic and diluted earnings per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic (loss) income per share represents the amount of earnings available to each share of common stock outstanding during the period. Basic (loss) income per share includes the effect of issuing shares of common stock, where (i) for 2021, the prepaid stock purchase contracts (&#x201c;SPCs&#x201d;) were converted using the final settlement rate on September 14, 2021 (see Note 11 for additional information), and (ii) an adjustment to (loss) income to reflect adjustments made to record the redeemable value of redeemable non-controlling interests. Diluted (loss) income per share also includes the effect of issuing shares of common stock, assuming (i) stock options and warrants are exercised, (ii) restricted stock units are fully vested under the treasury stock method, and (iii) for 2021, the incremental effect of the prepaid SPCs were converted using the final settlement rate on September 14, 2021 (see Note 11 for additional information).&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:CompensationRelatedCostsPolicyTextBlock contextRef="c-1" id="f-632">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Compensation cost of all stock-based awards is measured at fair value on the date of grant and recognized over the service period for which awards are expected to vest. The cost of such stock-based awards is principally recognized on a straight-line attribution basis over their respective vesting periods, net of estimated forfeitures.&lt;/span&gt;&lt;/div&gt;</us-gaap:CompensationRelatedCostsPolicyTextBlock>
    <us-gaap:DebtPolicyTextBlock contextRef="c-1" id="f-633">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Financing Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Costs incurred in the issuance of debt are deferred and amortized as part of interest expense over the stated life of the applicable debt instrument. Unamortized deferred financing costs relating to debt are presented as a reduction in the amount of &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;debt outstanding on the Consolidated Balance Sheets. Unamortized deferred financing costs relating to the revolving credit facility are recorded in Other assets on the Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtPolicyTextBlock>
    <us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy contextRef="c-1" id="f-634">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Redeemable Non-controlling Interests&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Non-controlling interests in subsidiaries that are redeemable for cash or other assets outside of the Company&#x2019;s control are classified as mezzanine equity, outside of equity and liabilities, at the greater of the carrying value or the redemption value. The increases or decreases in the estimated redemption amount are recorded with corresponding adjustments against Capital in excess of par value and are reflected in the computation of earnings per share using the two-class method. As of December 31, 2023, the Company has acquired or sold all of its remaining redeemable non-controlling interests. See Note 20 for additional information.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy>
    <us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy contextRef="c-1" id="f-635">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Held for Sale&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities to be disposed of by sale (&#x201c;disposal groups&#x201d;) are reclassified into assets and liabilities held for sale on the Company&#x2019;s Consolidated Balance Sheets. The reclassification occurs when an agreement to sell exists, or management has committed to a plan to sell the assets within one year. Disposal groups are measured at the lower of carrying value or fair value less costs to sell and are not depreciated or amortized. When the net realizable value of a disposal group increases during a period, a gain can be recognized to the extent that it does not increase the value of the disposal group beyond its original carrying value when the disposal group was reclassified as held for sale. The fair value of a disposal group, less any costs to sell, is assessed each reporting period it remains classified as held for sale and any remeasurement to the lower of carrying value or fair value less costs to sell is reported as an adjustment to the carrying value of the disposal group. See Note 21 for additional information.&lt;/span&gt;&lt;/div&gt;</us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy>
    <iff:SupplierFinanceProgramPolicyPolicyTextBlock contextRef="c-1" id="f-636">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Supply Chain Financing Program&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the fourth quarter of 2023, the Company entered into a supply chain financing (&#x201c;SCF&#x201d;) program. The program is expected to be available to U.S. based suppliers starting in the second quarter of 2024. The Company makes continuous efforts to improve working capital efficiency and has worked with suppliers to optimize payment terms and conditions. The Company&#x2019;s current payment terms with a majority of suppliers generally range from 0 to 180 days, which is deemed to be commercially reasonable. The Company&#x2019;s voluntary SCF program will allow its suppliers to elect to sell the receivables owed to them by the Company to a third-party financial institution. The suppliers, at their own discretion, will determine the invoices they want to sell and directly negotiate the arrangements with the participating third-party financial institution. Supplier participation in the program is solely the decision of the supplier and has no bearing on the Company&#x2019;s payment terms and amounts due with the supplier. The Company&#x2019;s responsibility will be limited to making payments based upon the agreed upon contractual terms and arrangements. The Company will not provide any form of guarantees under the SCF program and will have no economic interest in the suppliers&#x2019; decision to participate in the SCF program. Amounts due to suppliers that elect to participate in the SCF program will be included in Accounts payable on the Consolidated Balance Sheets. The Company, or the third-party financial institution, may choose to terminate the agreement of the program at any time upon 30 days&#x2019; prior written notice. The third-party financial institution may also terminate the agreement of the program at any time upon three business days&#x2019; prior written notice in the event there are insufficient funds available for disbursements. As of December&#160;31, 2023 and 2022, there were no amounts outstanding related to suppliers&#x2019; participation in the SCF program.&lt;/span&gt;&lt;/div&gt;</iff:SupplierFinanceProgramPolicyPolicyTextBlock>
    <us-gaap:SupplierFinanceProgramObligation contextRef="c-11" decimals="INF" id="f-637" unitRef="usd">0</us-gaap:SupplierFinanceProgramObligation>
    <us-gaap:SupplierFinanceProgramObligation contextRef="c-12" decimals="INF" id="f-638" unitRef="usd">0</us-gaap:SupplierFinanceProgramObligation>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c-1" id="f-639">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2023-09, &#x201c;Income Taxes (Topic 740): Improvements to Income Tax Disclosures.&#x201d; The ASU was issued to further enhance income tax disclosures, primarily through standardization and disaggregation of rate reconciliation categories and income taxes paid by jurisdiction. This guidance is effective for fiscal years beginning after December 15, 2024, with early adoption permitted, and may be applied either prospectively or retrospectively. The Company is currently evaluating the impact that this guidance will have on its Consolidated Financial Statements and income tax disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2023, the FASB issued ASU 2023-07, &#x201c;Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.&#x201d; The ASU intends to improve reportable segment disclosure requirements, primarily through enhanced disclosures of significant segment expenses that are regularly provided to the Chief Operating Decision Maker and included within segment profit and loss. This guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted, and applied retrospectively to all prior periods presented in the financial statements. The Company is currently evaluating the impact that this guidance will have on its Consolidated Financial Statements and reportable segment disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2022, the FASB issued ASU 2022-06, &#x201c;Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848.&#x201d; The ASU was issued to provide an update on ASU 2020-04 and ASU 2021-01 that were issued in March 2020 and January 2021, respectively, which provided optional accounting guidance for a limited period of time to ease the potential burden in accounting for reference rate reform. The guidance provides optional expedients and exceptions to existing accounting requirements for contract modifications and hedge accounting related to transitioning from discontinued reference rates, such as London Interbank Offered Rate (&#x201c;LIBOR&#x201d;), to alternative reference rates, if certain criteria are met. With the issuance of ASU 2022-06, the sunset date of Topic 848 has been deferred from December 31, 2022 to December 31, 2024, after which entities will no longer be permitted to apply the relief in Topic 848. The Company has adopted this guidance on January 1, 2023, which did not have a material impact on its Consolidated Financial Statements. On March 23, 2023, the Company amended certain existing debt agreements where the interest rate benchmark was updated from LIBOR to the Secured Overnight Financing Rate (&#x201c;Term SOFR&#x201d;). The Company applied Topic 848 to its recent amendments of its debt agreements. See Note 9 for additional information on the amendments to the debt agreements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2022, the FASB issued ASU 2022-04, &#x201c;Liabilities - Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations.&#x201d; The ASU requires that a buyer in a supplier finance program disclose sufficient information about the program to allow users of the financial statements to understand the program&#x2019;s nature, activity during the period, changes from period to period and potential magnitude. The buyer should disclose qualitative and quantitative information about its supplier finance programs. The ASU requires the buyer&#x2019;s annual disclosure to include a roll forward of the obligations under the supplier finance programs during the annual period, including the amount of obligations confirmed and subsequently paid. This guidance is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the amendment on roll forward information, which is effective for fiscal years beginning after December 15, 2023, and early adoption is permitted. The Company has adopted this guidance on January 1, 2023, which did not have a material impact on its Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock contextRef="c-1" id="f-640">RESTRUCTURING AND OTHER CHARGES&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring and other charges primarily consist of separation costs for employees including severance, outplacement and other employee benefit costs (&#x201c;Severance&#x201d;), charges related to the write-down of fixed assets of plants to be closed (&#x201c;Fixed asset write-down&#x201d;) and all other related restructuring (&#x201c;Other&#x201d;) costs. All restructuring and other charges are separately stated on the Consolidated Statements of (Loss) Income and Comprehensive Loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Frutarom Integration Initiative&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the acquisition of Frutarom, the Company executed an integration plan that, among other initiatives, sought to optimize its manufacturing network (the &#x201c;Frutarom Integration Initiative&#x201d;). Since the inception of the initiative, the Company closed 22 sites and expensed total costs of approximately $36 million. As of the first quarter of 2023, the Frutarom Integration Initiative was completed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2019 Severance Program&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2019, the Company incurred severance charges related to approximately 190 headcount reductions, excluding those previously mentioned under the Frutarom Integration Initiative. The headcount reductions were primarily related to the Scent segment associated with the establishment of a new shared service center in Europe. Since the program&#x2019;s inception, the Company expensed approximately $15 million. As of the third quarter of 2022, the program was completed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;N&amp;amp;B Merger Restructuring Liability&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For 2023, the Company incurred approximately $2 million of charges related to a lease impairment. Since the inception of the restructuring activities, there have been a total of approximately 215 headcount reductions and the Company has expensed approximately $47&#160;million. As of December 31, 2023, the restructuring activities were completed related to employee exits. The Company continues to evaluate its owned and leased properties following the Merger with N&amp;amp;B and may incur additional costs to further consolidate its footprint.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Restructuring Program&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2022, the Company announced a restructuring program mainly related to headcount reduction to improve its organizational and operating structure, drive efficiencies and achieve cost savings. For the year ended December 31, 2023, the Company incurred approximately $70 million of charges related to severance and there have been a total of approximately 680 actual and planned headcount reductions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Changes in Restructuring Liability&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in restructuring liabilities during 2021, 2022 and 2023 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:33.599%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.541%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.588%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.588%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Additional Charges (Reversals), Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-Cash Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Frutarom Integration Initiative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed asset write down&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;2019 Severance Program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Other Restructuring Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;N&amp;amp;B Merger Restructuring Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Restructuring and other charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:33.599%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.541%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.588%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.588%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Additional Charges (Reversals), Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-Cash Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Frutarom Integration Initiative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed asset write down&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;2019 Severance Program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Other Restructuring Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;N&amp;amp;B Merger Restructuring Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Restructuring and other charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:33.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.503%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Additional Charges (Reversals), Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-Cash Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Frutarom Integration Initiative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Other Restructuring Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;N&amp;amp;B Merger Restructuring Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;2023 Restructuring Program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Restructuring and other charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes supplier contract termination costs, consulting and advisory fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes charges related to legal settlement costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes lease impairment charges and losses incurred from restructuring activities related to the Merger with N&amp;amp;B.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Charges by Segment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the total amount of costs incurred in connection with these restructuring programs and activities by segment:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.047%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.694%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.694%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nourish&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health &amp;amp; Biosciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Scent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharma Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Restructuring and other charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <iff:RestructuringAndRelatedCostNumberOfSitesClosed
      contextRef="c-86"
      decimals="INF"
      id="f-641"
      unitRef="facility">22</iff:RestructuringAndRelatedCostNumberOfSitesClosed>
    <us-gaap:RestructuringAndRelatedCostCostIncurredToDate1 contextRef="c-87" decimals="-6" id="f-642" unitRef="usd">36000000</us-gaap:RestructuringAndRelatedCostCostIncurredToDate1>
    <us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated
      contextRef="c-88"
      decimals="INF"
      id="f-643"
      unitRef="position">190</us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated>
    <us-gaap:RestructuringAndRelatedCostCostIncurredToDate1 contextRef="c-89" decimals="-6" id="f-644" unitRef="usd">15000000</us-gaap:RestructuringAndRelatedCostCostIncurredToDate1>
    <us-gaap:RestructuringReserveAccrualAdjustment1 contextRef="c-90" decimals="-6" id="f-645" unitRef="usd">2000000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated
      contextRef="c-91"
      decimals="INF"
      id="f-646"
      unitRef="position">215</us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated>
    <us-gaap:RestructuringAndRelatedCostCostIncurredToDate1 contextRef="c-92" decimals="-6" id="f-647" unitRef="usd">47000000</us-gaap:RestructuringAndRelatedCostCostIncurredToDate1>
    <us-gaap:SeveranceCosts1 contextRef="c-93" decimals="-6" id="f-648" unitRef="usd">70000000</us-gaap:SeveranceCosts1>
    <us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated
      contextRef="c-93"
      decimals="INF"
      id="f-649"
      unitRef="position2">680</us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated>
    <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock contextRef="c-1" id="f-650">&lt;div style="margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in restructuring liabilities during 2021, 2022 and 2023 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:33.599%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.541%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.588%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.588%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Additional Charges (Reversals), Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-Cash Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Frutarom Integration Initiative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed asset write down&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;2019 Severance Program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Other Restructuring Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;N&amp;amp;B Merger Restructuring Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Restructuring and other charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:33.599%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.541%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.588%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.588%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Additional Charges (Reversals), Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-Cash Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Frutarom Integration Initiative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed asset write down&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;2019 Severance Program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Other Restructuring Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;N&amp;amp;B Merger Restructuring Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Restructuring and other charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:33.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.503%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Additional Charges (Reversals), Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-Cash Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Frutarom Integration Initiative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Other Restructuring Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;N&amp;amp;B Merger Restructuring Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;2023 Restructuring Program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Restructuring and other charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes supplier contract termination costs, consulting and advisory fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes charges related to legal settlement costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes lease impairment charges and losses incurred from restructuring activities related to the Merger with N&amp;amp;B.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Charges by Segment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the total amount of costs incurred in connection with these restructuring programs and activities by segment:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.047%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.694%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.694%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nourish&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health &amp;amp; Biosciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Scent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharma Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Restructuring and other charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
    <us-gaap:RestructuringReserve contextRef="c-94" decimals="-6" id="f-651" unitRef="usd">3000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserveAccrualAdjustment1 contextRef="c-95" decimals="-6" id="f-652" unitRef="usd">5000000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveSettledWithoutCash2 contextRef="c-95" decimals="-6" id="f-653" unitRef="usd">0</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:PaymentsForRestructuring contextRef="c-95" decimals="-6" id="f-654" unitRef="usd">3000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve contextRef="c-96" decimals="-6" id="f-655" unitRef="usd">5000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-97" decimals="-6" id="f-656" unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserveAccrualAdjustment1 contextRef="c-98" decimals="-6" id="f-657" unitRef="usd">5000000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveSettledWithoutCash2 contextRef="c-98" decimals="-6" id="f-658" unitRef="usd">5000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:PaymentsForRestructuring contextRef="c-98" decimals="-6" id="f-659" unitRef="usd">0</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve contextRef="c-99" decimals="-6" id="f-660" unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-100" decimals="-6" id="f-661" unitRef="usd">3000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserveAccrualAdjustment1 contextRef="c-101" decimals="-6" id="f-662" unitRef="usd">0</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveSettledWithoutCash2 contextRef="c-101" decimals="-6" id="f-663" unitRef="usd">0</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:PaymentsForRestructuring contextRef="c-101" decimals="-6" id="f-664" unitRef="usd">0</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve contextRef="c-102" decimals="-6" id="f-665" unitRef="usd">3000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-103" decimals="-6" id="f-666" unitRef="usd">6000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserveAccrualAdjustment1 contextRef="c-104" decimals="-6" id="f-667" unitRef="usd">0</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveSettledWithoutCash2 contextRef="c-104" decimals="-6" id="f-668" unitRef="usd">0</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:PaymentsForRestructuring contextRef="c-104" decimals="-6" id="f-669" unitRef="usd">1000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve contextRef="c-105" decimals="-6" id="f-670" unitRef="usd">5000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-106" decimals="-6" id="f-671" unitRef="usd">2000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserveAccrualAdjustment1 contextRef="c-107" decimals="-6" id="f-672" unitRef="usd">0</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveSettledWithoutCash2 contextRef="c-107" decimals="-6" id="f-673" unitRef="usd">0</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:PaymentsForRestructuring contextRef="c-107" decimals="-6" id="f-674" unitRef="usd">1000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve contextRef="c-108" decimals="-6" id="f-675" unitRef="usd">1000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-109" decimals="-6" id="f-676" unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserveAccrualAdjustment1 contextRef="c-110" decimals="-6" id="f-677" unitRef="usd">1000000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveSettledWithoutCash2 contextRef="c-110" decimals="-6" id="f-678" unitRef="usd">0</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:PaymentsForRestructuring contextRef="c-110" decimals="-6" id="f-679" unitRef="usd">1000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve contextRef="c-111" decimals="-6" id="f-680" unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-112" decimals="-6" id="f-681" unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserveAccrualAdjustment1 contextRef="c-113" decimals="-6" id="f-682" unitRef="usd">27000000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveSettledWithoutCash2 contextRef="c-113" decimals="-6" id="f-683" unitRef="usd">0</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:PaymentsForRestructuring contextRef="c-113" decimals="-6" id="f-684" unitRef="usd">12000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve contextRef="c-114" decimals="-6" id="f-685" unitRef="usd">15000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-115" decimals="-6" id="f-686" unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserveAccrualAdjustment1 contextRef="c-116" decimals="-6" id="f-687" unitRef="usd">3000000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveSettledWithoutCash2 contextRef="c-116" decimals="-6" id="f-688" unitRef="usd">3000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:PaymentsForRestructuring contextRef="c-116" decimals="-6" id="f-689" unitRef="usd">0</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve contextRef="c-117" decimals="-6" id="f-690" unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-14" decimals="-6" id="f-691" unitRef="usd">14000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserveAccrualAdjustment1 contextRef="c-10" decimals="-6" id="f-692" unitRef="usd">41000000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveSettledWithoutCash2 contextRef="c-10" decimals="-6" id="f-693" unitRef="usd">8000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:PaymentsForRestructuring contextRef="c-10" decimals="-6" id="f-694" unitRef="usd">18000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve contextRef="c-13" decimals="-6" id="f-695" unitRef="usd">29000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-96" decimals="-6" id="f-696" unitRef="usd">5000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserveAccrualAdjustment1 contextRef="c-118" decimals="-6" id="f-697" unitRef="usd">1000000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveSettledWithoutCash2 contextRef="c-118" decimals="-6" id="f-698" unitRef="usd">0</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:PaymentsForRestructuring contextRef="c-118" decimals="-6" id="f-699" unitRef="usd">2000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve contextRef="c-119" decimals="-6" id="f-700" unitRef="usd">4000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-99" decimals="-6" id="f-701" unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserveAccrualAdjustment1 contextRef="c-120" decimals="-6" id="f-702" unitRef="usd">3000000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveSettledWithoutCash2 contextRef="c-120" decimals="-6" id="f-703" unitRef="usd">3000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:PaymentsForRestructuring contextRef="c-120" decimals="-6" id="f-704" unitRef="usd">0</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve contextRef="c-121" decimals="-6" id="f-705" unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-102" decimals="-6" id="f-706" unitRef="usd">3000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserveAccrualAdjustment1 contextRef="c-122" decimals="-6" id="f-707" unitRef="usd">-2000000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveSettledWithoutCash2 contextRef="c-122" decimals="-6" id="f-708" unitRef="usd">0</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:PaymentsForRestructuring contextRef="c-122" decimals="-6" id="f-709" unitRef="usd">1000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve contextRef="c-123" decimals="-6" id="f-710" unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-105" decimals="-6" id="f-711" unitRef="usd">5000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserveAccrualAdjustment1 contextRef="c-124" decimals="-6" id="f-712" unitRef="usd">-5000000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveSettledWithoutCash2 contextRef="c-124" decimals="-6" id="f-713" unitRef="usd">0</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:PaymentsForRestructuring contextRef="c-124" decimals="-6" id="f-714" unitRef="usd">0</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve contextRef="c-125" decimals="-6" id="f-715" unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-108" decimals="-6" id="f-716" unitRef="usd">1000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserveAccrualAdjustment1 contextRef="c-126" decimals="-6" id="f-717" unitRef="usd">0</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveSettledWithoutCash2 contextRef="c-126" decimals="-6" id="f-718" unitRef="usd">0</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:PaymentsForRestructuring contextRef="c-126" decimals="-6" id="f-719" unitRef="usd">0</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve contextRef="c-127" decimals="-6" id="f-720" unitRef="usd">1000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-114" decimals="-6" id="f-721" unitRef="usd">15000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserveAccrualAdjustment1 contextRef="c-128" decimals="-6" id="f-722" unitRef="usd">8000000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveSettledWithoutCash2 contextRef="c-128" decimals="-6" id="f-723" unitRef="usd">0</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:PaymentsForRestructuring contextRef="c-128" decimals="-6" id="f-724" unitRef="usd">14000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve contextRef="c-129" decimals="-6" id="f-725" unitRef="usd">9000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-117" decimals="-6" id="f-726" unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserveAccrualAdjustment1 contextRef="c-130" decimals="-6" id="f-727" unitRef="usd">7000000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveSettledWithoutCash2 contextRef="c-130" decimals="-6" id="f-728" unitRef="usd">2000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:PaymentsForRestructuring contextRef="c-130" decimals="-6" id="f-729" unitRef="usd">4000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve contextRef="c-131" decimals="-6" id="f-730" unitRef="usd">1000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-13" decimals="-6" id="f-731" unitRef="usd">29000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserveAccrualAdjustment1 contextRef="c-9" decimals="-6" id="f-732" unitRef="usd">12000000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveSettledWithoutCash2 contextRef="c-9" decimals="-6" id="f-733" unitRef="usd">5000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:PaymentsForRestructuring contextRef="c-9" decimals="-6" id="f-734" unitRef="usd">21000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve contextRef="c-12" decimals="-6" id="f-735" unitRef="usd">15000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-119" decimals="-6" id="f-736" unitRef="usd">4000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserveAccrualAdjustment1 contextRef="c-132" decimals="-6" id="f-737" unitRef="usd">-3000000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveSettledWithoutCash2 contextRef="c-132" decimals="-6" id="f-738" unitRef="usd">0</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:PaymentsForRestructuring contextRef="c-132" decimals="-6" id="f-739" unitRef="usd">1000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve contextRef="c-133" decimals="-6" id="f-740" unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-127" decimals="-6" id="f-741" unitRef="usd">1000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserveAccrualAdjustment1 contextRef="c-134" decimals="-6" id="f-742" unitRef="usd">-1000000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveSettledWithoutCash2 contextRef="c-134" decimals="-6" id="f-743" unitRef="usd">0</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:PaymentsForRestructuring contextRef="c-134" decimals="-6" id="f-744" unitRef="usd">0</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve contextRef="c-135" decimals="-6" id="f-745" unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-129" decimals="-6" id="f-746" unitRef="usd">9000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserveAccrualAdjustment1 contextRef="c-91" decimals="-6" id="f-747" unitRef="usd">0</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveSettledWithoutCash2 contextRef="c-91" decimals="-6" id="f-748" unitRef="usd">0</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:PaymentsForRestructuring contextRef="c-91" decimals="-6" id="f-749" unitRef="usd">9000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve contextRef="c-136" decimals="-6" id="f-750" unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-131" decimals="-6" id="f-751" unitRef="usd">1000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserveAccrualAdjustment1 contextRef="c-137" decimals="-6" id="f-752" unitRef="usd">2000000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveSettledWithoutCash2 contextRef="c-137" decimals="-6" id="f-753" unitRef="usd">2000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:PaymentsForRestructuring contextRef="c-137" decimals="-6" id="f-754" unitRef="usd">1000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve contextRef="c-138" decimals="-6" id="f-755" unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-139" decimals="-6" id="f-756" unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserveAccrualAdjustment1 contextRef="c-140" decimals="-6" id="f-757" unitRef="usd">70000000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveSettledWithoutCash2 contextRef="c-140" decimals="-6" id="f-758" unitRef="usd">0</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:PaymentsForRestructuring contextRef="c-140" decimals="-6" id="f-759" unitRef="usd">56000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve contextRef="c-141" decimals="-6" id="f-760" unitRef="usd">14000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-12" decimals="-6" id="f-761" unitRef="usd">15000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserveAccrualAdjustment1 contextRef="c-1" decimals="-6" id="f-762" unitRef="usd">68000000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveSettledWithoutCash2 contextRef="c-1" decimals="-6" id="f-763" unitRef="usd">2000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:PaymentsForRestructuring contextRef="c-1" decimals="-6" id="f-764" unitRef="usd">67000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve contextRef="c-11" decimals="-6" id="f-765" unitRef="usd">14000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges contextRef="c-142" decimals="-6" id="f-766" unitRef="usd">37000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-143" decimals="-6" id="f-767" unitRef="usd">8000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-144" decimals="-6" id="f-768" unitRef="usd">32000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-145" decimals="-6" id="f-769" unitRef="usd">13000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-146" decimals="-6" id="f-770" unitRef="usd">2000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-147" decimals="-6" id="f-771" unitRef="usd">5000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-148" decimals="-6" id="f-772" unitRef="usd">15000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-149" decimals="-6" id="f-773" unitRef="usd">1000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-150" decimals="-6" id="f-774" unitRef="usd">3000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-151" decimals="-6" id="f-775" unitRef="usd">3000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-152" decimals="-6" id="f-776" unitRef="usd">1000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-153" decimals="-6" id="f-777" unitRef="usd">1000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-1" decimals="-6" id="f-778" unitRef="usd">68000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-9" decimals="-6" id="f-779" unitRef="usd">12000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-10" decimals="-6" id="f-780" unitRef="usd">41000000</us-gaap:RestructuringCharges>
    <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="c-1" id="f-781">ACQUISITIONS&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Acquisition of Health Wright Products, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 1, 2022 (&#x201c;Acquisition Date&#x201d;), the Company completed its acquisition of Health Wright Products, Inc. (&#x201c;Health Wright&#x201d;). IFF acquired 100% of the equity of Health Wright pursuant to a purchase agreement entered into on February 16, 2022. Health Wright is known in the consumer Health and Nutrition industries for providing high quality nutritional supplements. The acquisition was made in order to strengthen formulation and finished format capabilities to IFF&#x2019;s Health &amp;amp; Biosciences probiotics, natural extracts and botanical businesses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The acquisition was accounted for under the purchase method. The fair value of consideration transferred was approximately $157 million, including cash and estimated contingent consideration of $31 million. The purchase price allocation was performed and resulted in intangible assets of approximately $75 million, and approximately $45 million of goodwill (which is deductible for income tax purposes). The intangible assets primarily consisted of customer relationships of approximately $74 million that have been fair valued using the Multi-Period Excess Earning Method and which are being amortized over a period of approximately 19 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The purchase price allocation was finalized as of the end of 2022 when the Company finalized the valuation of the acquired goodwill, intangible assets (trade names and customer relationships) and inventory, in addition to ensuring all other assets and liabilities and contingencies have been identified and recorded. The measurement period adjustments were recorded during the year ended December 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2022, the Company remeasured the fair value of contingent consideration obligations, and, as a result, recognized a credit of approximately $5 million presented in Selling and administrative expenses on the Consolidated Statements of (Loss) Income and Comprehensive Loss. The reduction in the fair value of contingent consideration primarily resulted from changes in the probability assessment of achieving the performance targets. As of December 31, 2022, there was approximately $26&#160;million of earnout liabilities presented in Other liabilities on the Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2023, the Company remeasured the fair value of contingent consideration obligations, and, as a result, recognized an expense of approximately $6&#160;million presented in Selling and administrative expenses on the Consolidated Statements of (Loss) Income and Comprehensive Loss. As of December 31, 2023, there was approximately $32&#160;million of earnout liabilities presented in Other current liabilities on the Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No pro forma information for 2022 was presented as the acquisition was not material to the Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Transaction with Nutrition &amp;amp; Biosciences, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 1, 2021, IFF completed the Merger with N&amp;amp;B. Pursuant to the transaction related agreements, DuPont transferred its N&amp;amp;B Business to N&amp;amp;B, a wholly-owned subsidiary of DuPont, and N&amp;amp;B merged with and into a wholly owned subsidiary of IFF in exchange for 141,740,461 shares of IFF common stock, par value $0.125 per share (&#x201c;IFF Common Stock&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company completed its Merger with N&amp;amp;B in a Reverse Morris Trust transaction (the &#x201c;Transactions&#x201d;), pursuant to which the Company acquired the N&amp;amp;B Business of DuPont.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the Transactions, among other steps (i) DuPont transferred the N&amp;amp;B Business to N&amp;amp;B (the &#x201c;Separation&#x201d;); (ii) N&amp;amp;B made a cash distribution to DuPont of approximately $7.359 billion, subject to certain adjustments (the &#x201c;Special Cash Payment&#x201d;); (iii) DuPont distributed to its stockholders all of the issued and outstanding shares of N&amp;amp;B common stock by way of an exchange offer (the &#x201c;Distribution&#x201d;), and; (iv) N&amp;amp;B merged with and into a wholly owned subsidiary of IFF. As a result of the Merger, the existing shares of N&amp;amp;B common stock were automatically converted into the right to receive a number of shares of IFF Common Stock. Immediately after the Merger, holders of DuPont&#x2019;s common stock that received shares of N&amp;amp;B common stock in the Distribution owned approximately 55.4% of the outstanding shares of IFF Common Stock on a fully diluted basis and existing holders of IFF Common Stock owned approximately 44.6% of the outstanding shares of IFF on a fully diluted basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Merger was accounted for using the purchase method of accounting in accordance with ASC Topic 805, Business Combinations, with IFF identified as the acquirer. As a result of the Merger, N&amp;amp;B&#x2019;s assets, liabilities and the operating results of N&amp;amp;B were included in the Company&#x2019;s financial statements from the Closing Date. N&amp;amp;B contributed net sales of approximately $6.084 billion and net income of approximately $11 million for the year ended December&#160;31, 2021, which included the effects of purchase accounting adjustments, primarily related to changes in amortization of intangible assets, depreciation of property, plant and equipment and amortization of stepped up inventory.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to the Distribution, N&amp;amp;B incurred new indebtedness in the form of term loans and senior notes in an aggregate principal amount of $7.500 billion to pay the Special Cash Payment made to DuPont stockholders. See Note 9 for additional information regarding the term loans and senior notes incurred by N&amp;amp;B and subsequently assumed by IFF.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Purchase Price&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the aggregate purchase price consideration paid to acquire N&amp;amp;B (in millions, except share and per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:79.455%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.345%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of common stock issued to DuPont stockholders&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value attributable to pre-merger service for replacement equity awards&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension funding adjustment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total purchase consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The fair value of common stock issued to DuPont stockholders represents 141,740,461 shares of the Company's common stock determined based on the number of fully diluted shares of IFF common stock, immediately prior to the Closing Date, multiplied by the quotient of 55.4%/44.6% and IFF common stock closing share price of $112.38 on the New York Stock Exchange on the Closing Date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;At the time of the Transactions, each outstanding stock option, cash-settled stock appreciation right (&#x201c;SAR&#x201d;), restricted stock unit (&#x201c;RSU&#x201d;) award, and restricted stock award (&#x201c;RSA&#x201d;) with respect to DuPont common stock held by employees of N&amp;amp;B were canceled and converted into similar classes of equity awards of IFF&#x2019;s Class A Common Stock. Further, each outstanding Performance Share Unit (&#x201c;PSU&#x201d;) award with respect to DuPont common stock held by employees of N&amp;amp;B were canceled and converted into IFF&#x2019;s RSU awards. The conversion was based on the ratio of the volume-weighted average per share closing price of DuPont stock on the twenty trading days prior to the Closing Date and IFF&#x2019;s stock on the twenty trading days following the Closing Date. The fair value of replacement equity-based awards attributable to pre-Merger service was recorded as part of the consideration transferred in the Merger (see Note 13 for additional information).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Merger related agreements provided that if the net pension balance of N&amp;amp;B as of the Closing Date differs from $220&#160;million, such differential amount would be settled in cash. The Company estimated the amount that it would receive and, accordingly, made an adjustment of $12&#160;million to the total purchase consideration.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company incurred transaction-related costs of approximately $91&#160;million in 2021, which primarily consisted of merger and acquisition advisory, legal and professional fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pro Forma Financial Information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following unaudited pro forma financial information presents the combined results of operations of IFF and N&amp;amp;B as if the Merger had been completed as of January 1, 2020. The unaudited pro forma financial information is presented for informational purposes and is not indicative of the results of operations that would have been achieved if the Merger and related borrowings had taken place on January 1, 2020, nor are they indicative of future results. The unaudited pro forma financial information for the year ended December&#160;31, 2021 includes IFF results, including the post-Merger results of N&amp;amp;B, since February 1, 2021, and pre-Merger results of N&amp;amp;B for the period January 1, 2021 through January 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited pro forma results for the year ended December&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.022%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.778%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unaudited pro forma net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unaudited pro forma net income attributable to the Company&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited pro forma results for all periods include adjustments made to account for certain costs and transactions that would have been incurred had the Merger been completed as of January 1, 2020, including amortization charges for acquired intangibles assets, adjustments for transaction costs, adjustments for depreciation expense for property, plant and equipment, inventory step-up and adjustments to interest expense. These adjustments are net of any applicable tax impact and were included to arrive at the pro forma results above.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c-154"
      decimals="INF"
      id="f-782"
      unitRef="number">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="c-155" decimals="-6" id="f-783" unitRef="usd">157000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-154" decimals="-6" id="f-784" unitRef="usd">31000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="c-154" decimals="-6" id="f-785" unitRef="usd">75000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:Goodwill contextRef="c-154" decimals="-6" id="f-786" unitRef="usd">45000000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="c-156" decimals="-6" id="f-787" unitRef="usd">74000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-156" id="f-788">P19Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="c-157" decimals="-6" id="f-789" unitRef="usd">-5000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <iff:EarnOutsPayableOther contextRef="c-158" decimals="-6" id="f-790" unitRef="usd">26000000</iff:EarnOutsPayableOther>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="c-159" decimals="-6" id="f-791" unitRef="usd">6000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <iff:EarnOutsPayableCurrent contextRef="c-160" decimals="-6" id="f-792" unitRef="usd">32000000</iff:EarnOutsPayableCurrent>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="c-161"
      decimals="INF"
      id="f-793"
      unitRef="shares">141740461</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-162"
      decimals="3"
      id="f-794"
      unitRef="usdPerShare">0.125</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:PaymentsToAcquireBusinessesGross contextRef="c-161" decimals="-6" id="f-795" unitRef="usd">7359000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired contextRef="c-163" decimals="3" id="f-796" unitRef="number">0.554</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction contextRef="c-164" decimals="3" id="f-797" unitRef="number">0.446</us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction>
    <iff:BusinessAcquisitionNetSales contextRef="c-165" decimals="-6" id="f-798" unitRef="usd">6084000000.000</iff:BusinessAcquisitionNetSales>
    <iff:BusinessAcquisitionNetIncomeLoss contextRef="c-165" decimals="-6" id="f-799" unitRef="usd">11000000</iff:BusinessAcquisitionNetIncomeLoss>
    <us-gaap:PaymentsToAcquireBusinessesGross contextRef="c-166" decimals="-6" id="f-800" unitRef="usd">7500000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock contextRef="c-1" id="f-801">&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the aggregate purchase price consideration paid to acquire N&amp;amp;B (in millions, except share and per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:79.455%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.345%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of common stock issued to DuPont stockholders&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value attributable to pre-merger service for replacement equity awards&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension funding adjustment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total purchase consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The fair value of common stock issued to DuPont stockholders represents 141,740,461 shares of the Company's common stock determined based on the number of fully diluted shares of IFF common stock, immediately prior to the Closing Date, multiplied by the quotient of 55.4%/44.6% and IFF common stock closing share price of $112.38 on the New York Stock Exchange on the Closing Date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;At the time of the Transactions, each outstanding stock option, cash-settled stock appreciation right (&#x201c;SAR&#x201d;), restricted stock unit (&#x201c;RSU&#x201d;) award, and restricted stock award (&#x201c;RSA&#x201d;) with respect to DuPont common stock held by employees of N&amp;amp;B were canceled and converted into similar classes of equity awards of IFF&#x2019;s Class A Common Stock. Further, each outstanding Performance Share Unit (&#x201c;PSU&#x201d;) award with respect to DuPont common stock held by employees of N&amp;amp;B were canceled and converted into IFF&#x2019;s RSU awards. The conversion was based on the ratio of the volume-weighted average per share closing price of DuPont stock on the twenty trading days prior to the Closing Date and IFF&#x2019;s stock on the twenty trading days following the Closing Date. The fair value of replacement equity-based awards attributable to pre-Merger service was recorded as part of the consideration transferred in the Merger (see Note 13 for additional information).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Merger related agreements provided that if the net pension balance of N&amp;amp;B as of the Closing Date differs from $220&#160;million, such differential amount would be settled in cash. The Company estimated the amount that it would receive and, accordingly, made an adjustment of $12&#160;million to the total purchase consideration.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable contextRef="c-161" decimals="-6" id="f-802" unitRef="usd">15929000000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <iff:BusinessCombinationConsiderationTransferredReplacementEquityAwardsIssued contextRef="c-161" decimals="-6" id="f-803" unitRef="usd">25000000</iff:BusinessCombinationConsiderationTransferredReplacementEquityAwardsIssued>
    <iff:BusinessCombinationPensionFundingAdjustment contextRef="c-161" decimals="-6" id="f-804" unitRef="usd">12000000</iff:BusinessCombinationPensionFundingAdjustment>
    <us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="c-161" decimals="-6" id="f-805" unitRef="usd">15942000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="c-161"
      decimals="INF"
      id="f-806"
      unitRef="shares">141740461</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <iff:DilutiveSharesQuotientMultiplier contextRef="c-167" decimals="3" id="f-807" unitRef="number">0.554</iff:DilutiveSharesQuotientMultiplier>
    <iff:DilutiveSharesQuotientMultiplier contextRef="c-168" decimals="3" id="f-808" unitRef="number">0.446</iff:DilutiveSharesQuotientMultiplier>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="c-169"
      decimals="INF"
      id="f-809"
      unitRef="usdPerShare">112.38</us-gaap:BusinessAcquisitionSharePrice>
    <iff:BusinessCombinationNetPensionBalanceDifferentialAmountSettledInCash contextRef="c-161" decimals="-6" id="f-810" unitRef="usd">220000000</iff:BusinessCombinationNetPensionBalanceDifferentialAmountSettledInCash>
    <iff:BusinessCombinationPensionFundingAdjustment contextRef="c-161" decimals="-6" id="f-811" unitRef="usd">12000000</iff:BusinessCombinationPensionFundingAdjustment>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts contextRef="c-165" decimals="-6" id="f-812" unitRef="usd">91000000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessAcquisitionProFormaInformationTextBlock contextRef="c-1" id="f-813">&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited pro forma results for the year ended December&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.022%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.778%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unaudited pro forma net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unaudited pro forma net income attributable to the Company&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
    <us-gaap:BusinessAcquisitionsProFormaRevenue contextRef="c-165" decimals="-6" id="f-814" unitRef="usd">12163000000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss contextRef="c-165" decimals="-6" id="f-815" unitRef="usd">687000000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock contextRef="c-1" id="f-816">BUSINESS DIVESTITURES&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Divestiture of the Flavor Specialty Ingredients Business&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2022, the Company announced it had entered into an agreement to sell its Flavor Specialty Ingredients (&#x201c;FSI&#x201d;) business, which was a part of the Scent segment. The Company completed the divestiture on August 1, 2023 and received cash proceeds of approximately $205 million, which included $1 million related to the delayed transfer of the control of specific assets and liabilities of non-U.S. jurisdiction business. In addition, approximately $15 million of proceeds were held in escrow and have been released upon satisfaction of certain conditions. Concurrent with the completion of the business divestiture, the Company entered into a supply agreement arrangement with the buyer. Based on the terms of the supply agreement, an adjustment of $4 million was made against the fair value of sale consideration. The sale consideration is subject to certain post-closing adjustments, which is primarily related to cash, indebtedness and working capital balances.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the fair value of sale consideration received in connection with the business divestiture:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.592%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.208%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash proceeds from the buyer&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Advance receipt for business to be transferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Direct costs to sell&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds attributable to supply agreement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of sale consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net proceeds received from the business divestiture presented under Cash flows from investing activities represent the cash portion of the sale consideration, which was determined as the fair value of sale consideration adjusted by the direct costs to sell, advance receipt for business to be transferred and the cash transferred to the buyer as part of the transaction. The following table summarizes the different components of net proceeds received from business divestiture presented under Cash flows from investing activities:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.592%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.208%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of sale consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Direct costs to sell&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Advance receipt for business to be transferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash transferred to the buyer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net proceeds received from business divestiture&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amount of net assets associated with the business unit, adjusted for currency translation adjustment, was approximately $205 million. The major classes of assets and liabilities sold consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.592%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.208%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;August 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive income - currency translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying value of net assets (adjusted for currency translation adjustment)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of the business divestiture, the Company recognized a pre-tax loss of approximately $10 million, subject to certain post-closing adjustments, presented in Other expense (income), net on the Consolidated Statements of (Loss) Income and Comprehensive Loss for the year ended December 31, 2023. The Company has also recognized income tax effects associated with the business divestiture across multiple periods. The total income tax expense recognized was approximately $21 million, with approximately $3 million that was recognized during the year ended December 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Divestiture of a Portion of the Savory Solutions Business&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2022, the Company announced it had entered into an agreement to sell a portion of its Savory Solutions business, which was part of the Nourish segment. The Company completed the divestiture on May 31, 2023 and received cash proceeds of approximately $840 million. In addition, a receivable of approximately $37 million was recorded, which reflected the remaining sale consideration that was received in January 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the fair value of sale consideration received in connection with the business divestiture:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.592%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.208%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash proceeds from the buyer&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivable from the buyer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Direct costs to sell&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of sale consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net proceeds received from the business divestiture presented under Cash flows from investing activities represent the cash portion of the sale consideration, which was determined as the fair value of sale consideration adjusted by the amount receivable from the buyer, direct costs to sell and the cash transferred to the buyer as part of the transaction. The following table summarizes the different components of net proceeds received from business divestiture presented under Cash flows from investing activities:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.592%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.208%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of sale consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Direct costs to sell&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivable from the buyer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash transferred to the buyer (including restricted cash)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net proceeds received from business divestiture&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amount of net assets associated with the business unit, adjusted for currency translation and pension adjustments, was approximately $860 million. The major classes of assets and liabilities sold consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.592%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.208%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;May 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(92)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(190)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive income - currency translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive income - pension liability and postretirement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying value of net assets (adjusted for currency translation and pension adjustments)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of the business divestiture, the Company recognized a pre-tax loss of approximately $3 million presented in Other expense (income), net on the Consolidated Statements of (Loss) Income and Comprehensive Loss for the year ended December 31, 2023. The Company has also recognized income tax effects associated with the business divestiture across multiple periods. The total income tax expense recognized was approximately $108 million, with approximately $72 million that was recognized during the year ended December 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Liquidation of a Business in Russia&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of the liquidation of a business in Russia for the sale of the portion of the Savory Solutions business, the Company recognized a pre-tax loss of approximately $10&#160;million presented in the Other expense (income), net, and tax benefits of approximately $2&#160;million presented in Provision for income taxes on the Consolidated Statements of (Loss) Income and Comprehensive Loss for the year ended December 31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Divestiture of Microbial Control&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the third quarter of 2021, the Company announced it had entered into an agreement to sell its Microbial Control business unit, which was a part of the Health &amp;amp; Biosciences segment. The Company acquired the Microbial Control business unit as part of the Merger with N&amp;amp;B.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company completed the divestiture on July 1, 2022 and received cash proceeds of approximately $1.254 billion, of which approximately $36 million was attributable to future services to be provided under certain transition service agreements as described below. Certain transaction costs related to the divestiture of approximately $11 million, which was contingent upon the consummation of the divestiture, were determined to be direct costs to sell and, as such, were adjusted against the fair value of the sale consideration. In addition, approximately $15 million of cash proceeds held in escrow were released to the Company upon satisfaction of certain conditions. The sale consideration was further reduced by approximately $3 million for certain post-closing adjustments, which were primarily related to cash, indebtedness and working capital balances.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company entered into transition services agreements with the buyer for providing certain general accounting, information technology and other services up to 19 months following the date of the sale for minimal consideration. The fair value of these transition services agreements was determined to be approximately $36 million, which was adjusted against the sale consideration and recognized as deferred transition services income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December&#160;31, 2023 and 2022, the transition services income under the transition services agreements were approximately $25&#160;million and $11&#160;million, respectively, and was recognized as a reduction to the costs incurred to provide services under the transition services agreements, which was included in Selling and administrative expenses on the Consolidated Statements of (Loss) Income and Comprehensive Loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the fair value of the sale consideration received in connection with the business divestiture:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.592%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.208%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash proceeds from the buyer&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Escrow proceeds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds attributable to transition service agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Direct costs to sell&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net cash settlement for post-closing adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of sale consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net proceeds received from business divestiture presented under Cash flows from investing activities represent the cash portion of the sale consideration, which was determined as the fair value of sale consideration reduced by the amount held in escrow and the Cash transferred to the buyer on the closing balance sheet as part of the transaction. The following table summarizes the different components of net proceeds received from business divestiture presented under Cash flows from investing activities:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.592%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.208%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of sale consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash transferred to the buyer on the closing balance sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee reimbursement receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net proceeds received from business divestiture&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amount of net assets associated with the Microbial Control business unit was approximately $1.208 billion. The major classes of assets and liabilities sold consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.592%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.208%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill and other intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying value of net assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of the business divestiture, the Company recognized a pre-tax gain of approximately $11&#160;million presented in Other expense (income), net on the Consolidated Statements of (Loss) Income and Comprehensive Loss for the year ended December 31, 2022. The Company also recognized the income tax expense associated with the divestiture of approximately $96&#160;million during the year ended December 31, 2022.&lt;/span&gt;&lt;/div&gt;ASSETS AND LIABILITIES HELD FOR SALE&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the third quarter of 2023, the Company announced the sale process of its Cosmetic Ingredients business within the Scent segment, and in the fourth quarter of 2023, the Company entered into an agreement to sell its Cosmetic Ingredients business. The transaction is subject to customary closing conditions and is expected to close in the first quarter of 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The planned sale does not constitute a strategic shift of the Company&#x2019;s operations and does not have major effects on the Company&#x2019;s operations and financial results. Therefore, the transaction does not meet the discontinued operations criteria.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determined that the assets and liabilities of the business met the criteria to be presented as &#x201c;held for sale.&#x201d; As a result, as of December&#160;31, 2023, such assets and liabilities were classified as held for sale and are reported on the Consolidated Balance Sheets. The Company expects that the sale proceeds less costs to sell will exceed the preliminary estimate of the carrying value of the net assets for the business. The carrying value is subject to change based on developments leading up to the closing date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Included in the Company&#x2019;s Consolidated Balance Sheets as of December&#160;31, 2023 and 2022 are the following carrying amounts of the assets and liabilities held for sale:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.490%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:26.239%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:26.241%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets held-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liability&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities held-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company is currently analyzing the tax impact of the sale of the Cosmetic Ingredients business and has included preliminary numbers for the deferred tax liability, which are subject to further updates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The amounts for December&#160;31, 2022 represent the carrying amounts of the portion of the Savory Solutions business and FSI business that were classified as held for sale. The Company completed the divestitures of the businesses on May 31, 2023 and August 1, 2023, respectively. See Note 4 for additional information.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <us-gaap:ProceedsFromDivestitureOfBusinesses contextRef="c-170" decimals="-6" id="f-817" unitRef="usd">205000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <iff:DisposalGroupIncludingDiscontinuedOperationAdvanceReceiptForBusinessToBeTransferred contextRef="c-171" decimals="-6" id="f-818" unitRef="usd">1000000</iff:DisposalGroupIncludingDiscontinuedOperationAdvanceReceiptForBusinessToBeTransferred>
    <iff:DisposalGroupIncludingDiscontinuedOperationAmountHeldInEscrow contextRef="c-171" decimals="-6" id="f-819" unitRef="usd">15000000</iff:DisposalGroupIncludingDiscontinuedOperationAmountHeldInEscrow>
    <iff:DisposalGroupIncludingDiscontinuedOperationProceedsAttributableToSupplyAgreement contextRef="c-171" decimals="-6" id="f-820" unitRef="usd">4000000</iff:DisposalGroupIncludingDiscontinuedOperationProceedsAttributableToSupplyAgreement>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock contextRef="c-1" id="f-821">&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the fair value of sale consideration received in connection with the business divestiture:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.592%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.208%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash proceeds from the buyer&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Advance receipt for business to be transferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Direct costs to sell&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds attributable to supply agreement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of sale consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The following table summarizes the different components of net proceeds received from business divestiture presented under Cash flows from investing activities:&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.592%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.208%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of sale consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Direct costs to sell&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Advance receipt for business to be transferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash transferred to the buyer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net proceeds received from business divestiture&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The major classes of assets and liabilities sold consisted of the following:&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.592%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.208%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;August 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive income - currency translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying value of net assets (adjusted for currency translation adjustment)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the fair value of sale consideration received in connection with the business divestiture:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.592%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.208%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash proceeds from the buyer&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivable from the buyer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Direct costs to sell&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of sale consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The following table summarizes the different components of net proceeds received from business divestiture presented under Cash flows from investing activities:&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.592%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.208%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of sale consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Direct costs to sell&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivable from the buyer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash transferred to the buyer (including restricted cash)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net proceeds received from business divestiture&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The major classes of assets and liabilities sold consisted of the following:&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.592%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.208%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;May 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(92)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(190)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive income - currency translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive income - pension liability and postretirement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying value of net assets (adjusted for currency translation and pension adjustments)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the fair value of the sale consideration received in connection with the business divestiture:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.592%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.208%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash proceeds from the buyer&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Escrow proceeds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds attributable to transition service agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Direct costs to sell&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net cash settlement for post-closing adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of sale consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The following table summarizes the different components of net proceeds received from business divestiture presented under Cash flows from investing activities:&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.592%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.208%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of sale consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash transferred to the buyer on the closing balance sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee reimbursement receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net proceeds received from business divestiture&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.592%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.208%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill and other intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying value of net assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Included in the Company&#x2019;s Consolidated Balance Sheets as of December&#160;31, 2023 and 2022 are the following carrying amounts of the assets and liabilities held for sale:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.490%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:26.239%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:26.241%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets held-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liability&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities held-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company is currently analyzing the tax impact of the sale of the Cosmetic Ingredients business and has included preliminary numbers for the deferred tax liability, which are subject to further updates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The amounts for December&#160;31, 2022 represent the carrying amounts of the portion of the Savory Solutions business and FSI business that were classified as held for sale. The Company completed the divestitures of the businesses on May 31, 2023 and August 1, 2023, respectively. See Note 4 for additional information.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <iff:ProceedsFromDivestitureOfBusinessesGross contextRef="c-171" decimals="-6" id="f-822" unitRef="usd">205000000</iff:ProceedsFromDivestitureOfBusinessesGross>
    <iff:DisposalGroupIncludingDiscontinuedOperationAdvanceReceiptForBusinessToBeTransferred contextRef="c-171" decimals="-6" id="f-823" unitRef="usd">1000000</iff:DisposalGroupIncludingDiscontinuedOperationAdvanceReceiptForBusinessToBeTransferred>
    <iff:DisposalGroupIncludingDiscontinuedOperationTransactionCost contextRef="c-171" decimals="-6" id="f-824" unitRef="usd">5000000</iff:DisposalGroupIncludingDiscontinuedOperationTransactionCost>
    <iff:DisposalGroupIncludingDiscontinuedOperationProceedsAttributableToSupplyAgreement contextRef="c-171" decimals="-6" id="f-825" unitRef="usd">4000000</iff:DisposalGroupIncludingDiscontinuedOperationProceedsAttributableToSupplyAgreement>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration contextRef="c-171" decimals="-6" id="f-826" unitRef="usd">195000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration contextRef="c-171" decimals="-6" id="f-827" unitRef="usd">195000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <iff:DisposalGroupIncludingDiscontinuedOperationTransactionCostCredits contextRef="c-171" decimals="-6" id="f-828" unitRef="usd">5000000</iff:DisposalGroupIncludingDiscontinuedOperationTransactionCostCredits>
    <iff:DisposalGroupIncludingDiscontinuedOperationConsiderationAdvanceReceiptForBusinessToBeTransferred contextRef="c-171" decimals="-6" id="f-829" unitRef="usd">1000000</iff:DisposalGroupIncludingDiscontinuedOperationConsiderationAdvanceReceiptForBusinessToBeTransferred>
    <iff:DisposalGroupIncludingDiscontinuedOperationCashTransferredToBuyer contextRef="c-171" decimals="-6" id="f-830" unitRef="usd">-1000000</iff:DisposalGroupIncludingDiscontinuedOperationCashTransferredToBuyer>
    <iff:ProceedsFromDivestitureOfBusinessNet contextRef="c-171" decimals="-6" id="f-831" unitRef="usd">200000000</iff:ProceedsFromDivestitureOfBusinessNet>
    <iff:DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNetAsset contextRef="c-171" decimals="-6" id="f-832" unitRef="usd">205000000</iff:DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNetAsset>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-171" decimals="-6" id="f-833" unitRef="usd">1000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ReceivablesNetCurrent contextRef="c-171" decimals="-6" id="f-834" unitRef="usd">13000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:InventoryNet contextRef="c-171" decimals="-6" id="f-835" unitRef="usd">45000000</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-171" decimals="-6" id="f-836" unitRef="usd">29000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill contextRef="c-171" decimals="-6" id="f-837" unitRef="usd">44000000</us-gaap:Goodwill>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-171" decimals="-6" id="f-838" unitRef="usd">73000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-171" decimals="-6" id="f-839" unitRef="usd">10000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="c-171" decimals="-6" id="f-840" unitRef="usd">215000000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="c-171" decimals="-6" id="f-841" unitRef="usd">4000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-171" decimals="-6" id="f-842" unitRef="usd">1000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-171" decimals="-6" id="f-843" unitRef="usd">6000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="c-171" decimals="-6" id="f-844" unitRef="usd">11000000</us-gaap:Liabilities>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax contextRef="c-171" decimals="-6" id="f-845" unitRef="usd">1000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:StockholdersEquity contextRef="c-171" decimals="-6" id="f-846" unitRef="usd">1000000</us-gaap:StockholdersEquity>
    <iff:DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNetAsset contextRef="c-171" decimals="-6" id="f-847" unitRef="usd">205000000</iff:DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNetAsset>
    <iff:DisposalGroupNotDiscontinuedOperationGainLossOnDisposalBeforeIncomeTax contextRef="c-172" decimals="-6" id="f-848" unitRef="usd">-10000000</iff:DisposalGroupNotDiscontinuedOperationGainLossOnDisposalBeforeIncomeTax>
    <iff:DisposalGroupNotDiscontinuedOperationTaxEffectOfGainLossFromDivestiture contextRef="c-173" decimals="-6" id="f-849" unitRef="usd">21000000</iff:DisposalGroupNotDiscontinuedOperationTaxEffectOfGainLossFromDivestiture>
    <iff:DisposalGroupNotDiscontinuedOperationTaxEffectOfGainLossFromDivestiture contextRef="c-174" decimals="-6" id="f-850" unitRef="usd">3000000</iff:DisposalGroupNotDiscontinuedOperationTaxEffectOfGainLossFromDivestiture>
    <us-gaap:ProceedsFromDivestitureOfBusinesses contextRef="c-175" decimals="-6" id="f-851" unitRef="usd">840000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <iff:DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable contextRef="c-176" decimals="-6" id="f-852" unitRef="usd">37000000</iff:DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable>
    <iff:ProceedsFromDivestitureOfBusinessesGross contextRef="c-176" decimals="-6" id="f-853" unitRef="usd">840000000</iff:ProceedsFromDivestitureOfBusinessesGross>
    <iff:DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable contextRef="c-176" decimals="-6" id="f-854" unitRef="usd">37000000</iff:DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable>
    <iff:DisposalGroupIncludingDiscontinuedOperationTransactionCost contextRef="c-176" decimals="-6" id="f-855" unitRef="usd">20000000</iff:DisposalGroupIncludingDiscontinuedOperationTransactionCost>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration contextRef="c-176" decimals="-6" id="f-856" unitRef="usd">857000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration contextRef="c-176" decimals="-6" id="f-857" unitRef="usd">857000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <iff:DisposalGroupIncludingDiscontinuedOperationTransactionCostCredits contextRef="c-176" decimals="-6" id="f-858" unitRef="usd">20000000</iff:DisposalGroupIncludingDiscontinuedOperationTransactionCostCredits>
    <iff:DisposalGroupIncludingDiscontinuedOperationConsiderationPayableReceivable contextRef="c-176" decimals="-6" id="f-859" unitRef="usd">-37000000</iff:DisposalGroupIncludingDiscontinuedOperationConsiderationPayableReceivable>
    <iff:DisposalGroupIncludingDiscontinuedOperationCashTransferredToBuyer contextRef="c-176" decimals="-6" id="f-860" unitRef="usd">-19000000</iff:DisposalGroupIncludingDiscontinuedOperationCashTransferredToBuyer>
    <iff:ProceedsFromDivestitureOfBusinessNet contextRef="c-176" decimals="-6" id="f-861" unitRef="usd">821000000</iff:ProceedsFromDivestitureOfBusinessNet>
    <iff:DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNetAsset contextRef="c-176" decimals="-6" id="f-862" unitRef="usd">860000000</iff:DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNetAsset>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-176" decimals="-6" id="f-863" unitRef="usd">15000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashCurrent contextRef="c-176" decimals="-6" id="f-864" unitRef="usd">4000000</us-gaap:RestrictedCashCurrent>
    <us-gaap:ReceivablesNetCurrent contextRef="c-176" decimals="-6" id="f-865" unitRef="usd">69000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:InventoryNet contextRef="c-176" decimals="-6" id="f-866" unitRef="usd">116000000</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-176" decimals="-6" id="f-867" unitRef="usd">77000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill contextRef="c-176" decimals="-6" id="f-868" unitRef="usd">317000000</us-gaap:Goodwill>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-176" decimals="-6" id="f-869" unitRef="usd">367000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-176" decimals="-6" id="f-870" unitRef="usd">20000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-176" decimals="-6" id="f-871" unitRef="usd">24000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="c-176" decimals="-6" id="f-872" unitRef="usd">1009000000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="c-176" decimals="-6" id="f-873" unitRef="usd">44000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-176" decimals="-6" id="f-874" unitRef="usd">92000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-176" decimals="-6" id="f-875" unitRef="usd">54000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="c-176" decimals="-6" id="f-876" unitRef="usd">190000000</us-gaap:Liabilities>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax contextRef="c-176" decimals="-6" id="f-877" unitRef="usd">42000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <iff:AccumulatedOtherComprehensiveIncomeLossPensionLiabilityAndPostretirementAfterTax contextRef="c-176" decimals="-6" id="f-878" unitRef="usd">-1000000</iff:AccumulatedOtherComprehensiveIncomeLossPensionLiabilityAndPostretirementAfterTax>
    <us-gaap:StockholdersEquity contextRef="c-176" decimals="-6" id="f-879" unitRef="usd">41000000</us-gaap:StockholdersEquity>
    <iff:DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNetAsset contextRef="c-176" decimals="-6" id="f-880" unitRef="usd">860000000</iff:DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNetAsset>
    <iff:DisposalGroupNotDiscontinuedOperationGainLossOnDisposalBeforeIncomeTax contextRef="c-177" decimals="-6" id="f-881" unitRef="usd">-3000000</iff:DisposalGroupNotDiscontinuedOperationGainLossOnDisposalBeforeIncomeTax>
    <iff:DisposalGroupNotDiscontinuedOperationTaxEffectOfGainLossFromDivestiture contextRef="c-178" decimals="-6" id="f-882" unitRef="usd">108000000</iff:DisposalGroupNotDiscontinuedOperationTaxEffectOfGainLossFromDivestiture>
    <iff:DisposalGroupNotDiscontinuedOperationTaxEffectOfGainLossFromDivestiture contextRef="c-179" decimals="-6" id="f-883" unitRef="usd">72000000</iff:DisposalGroupNotDiscontinuedOperationTaxEffectOfGainLossFromDivestiture>
    <iff:DisposalGroupNotDiscontinuedOperationGainLossOnLiquidationBeforeIncomeTax contextRef="c-177" decimals="-6" id="f-884" unitRef="usd">-10000000</iff:DisposalGroupNotDiscontinuedOperationGainLossOnLiquidationBeforeIncomeTax>
    <iff:DisposalGroupNotDiscontinuedOperationLiquidationTaxEffect contextRef="c-177" decimals="-6" id="f-885" unitRef="usd">2000000</iff:DisposalGroupNotDiscontinuedOperationLiquidationTaxEffect>
    <us-gaap:ProceedsFromDivestitureOfBusinesses contextRef="c-180" decimals="-6" id="f-886" unitRef="usd">1254000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <iff:TransitionServicesAgreementFairValue contextRef="c-181" decimals="-6" id="f-887" unitRef="usd">36000000</iff:TransitionServicesAgreementFairValue>
    <iff:DisposalGroupIncludingDiscontinuedOperationTransactionCost contextRef="c-181" decimals="-6" id="f-888" unitRef="usd">11000000</iff:DisposalGroupIncludingDiscontinuedOperationTransactionCost>
    <us-gaap:EscrowDeposit contextRef="c-181" decimals="-6" id="f-889" unitRef="usd">15000000</us-gaap:EscrowDeposit>
    <iff:DisposalGroupIncludingDiscontinuedOperationPostClosingAdjustments contextRef="c-181" decimals="-6" id="f-890" unitRef="usd">-3000000</iff:DisposalGroupIncludingDiscontinuedOperationPostClosingAdjustments>
    <iff:TransitionServicesAgreementTerm contextRef="c-180" id="f-891">P19M</iff:TransitionServicesAgreementTerm>
    <iff:TransitionServicesAgreementFairValue contextRef="c-181" decimals="-6" id="f-892" unitRef="usd">36000000</iff:TransitionServicesAgreementFairValue>
    <iff:TransitionServicesAgreementIncomeReductionToCostsNotIncludedInRevenue contextRef="c-182" decimals="-6" id="f-893" unitRef="usd">25000000</iff:TransitionServicesAgreementIncomeReductionToCostsNotIncludedInRevenue>
    <iff:TransitionServicesAgreementIncomeReductionToCostsNotIncludedInRevenue contextRef="c-183" decimals="-6" id="f-894" unitRef="usd">11000000</iff:TransitionServicesAgreementIncomeReductionToCostsNotIncludedInRevenue>
    <iff:ProceedsFromDivestitureOfBusinessesGross contextRef="c-181" decimals="-6" id="f-895" unitRef="usd">1254000000</iff:ProceedsFromDivestitureOfBusinessesGross>
    <us-gaap:EscrowDeposit contextRef="c-181" decimals="-6" id="f-896" unitRef="usd">15000000</us-gaap:EscrowDeposit>
    <iff:TransitionServicesAgreementFairValue contextRef="c-181" decimals="-6" id="f-897" unitRef="usd">36000000</iff:TransitionServicesAgreementFairValue>
    <iff:DisposalGroupIncludingDiscontinuedOperationTransactionCost contextRef="c-181" decimals="-6" id="f-898" unitRef="usd">11000000</iff:DisposalGroupIncludingDiscontinuedOperationTransactionCost>
    <iff:DisposalGroupIncludingDiscontinuedOperationPostClosingAdjustments contextRef="c-181" decimals="-6" id="f-899" unitRef="usd">-3000000</iff:DisposalGroupIncludingDiscontinuedOperationPostClosingAdjustments>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration contextRef="c-181" decimals="-6" id="f-900" unitRef="usd">1219000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration contextRef="c-181" decimals="-6" id="f-901" unitRef="usd">1219000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <iff:CashTransferredToTheBuyerOnTheClosingBalanceSheet contextRef="c-181" decimals="-6" id="f-902" unitRef="usd">-49000000</iff:CashTransferredToTheBuyerOnTheClosingBalanceSheet>
    <iff:EmployeeReimbursementReceivable contextRef="c-181" decimals="-6" id="f-903" unitRef="usd">-1000000</iff:EmployeeReimbursementReceivable>
    <iff:ProceedsFromDivestitureOfBusinessNet contextRef="c-181" decimals="-6" id="f-904" unitRef="usd">1169000000</iff:ProceedsFromDivestitureOfBusinessNet>
    <iff:DisposalGroupIncludingDiscontinuedOperationNetAssets contextRef="c-184" decimals="-6" id="f-905" unitRef="usd">1208000000</iff:DisposalGroupIncludingDiscontinuedOperationNetAssets>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent contextRef="c-184" decimals="-6" id="f-906" unitRef="usd">263000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill contextRef="c-184" decimals="-6" id="f-907" unitRef="usd">867000000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:EquityMethodInvestments contextRef="c-184" decimals="-6" id="f-908" unitRef="usd">74000000</us-gaap:EquityMethodInvestments>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets contextRef="c-184" decimals="-6" id="f-909" unitRef="usd">80000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation contextRef="c-184" decimals="-6" id="f-910" unitRef="usd">1284000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayable contextRef="c-184" decimals="-6" id="f-911" unitRef="usd">41000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayable>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities contextRef="c-184" decimals="-6" id="f-912" unitRef="usd">35000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation contextRef="c-184" decimals="-6" id="f-913" unitRef="usd">76000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <iff:DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNetAsset contextRef="c-184" decimals="-6" id="f-914" unitRef="usd">1208000000</iff:DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNetAsset>
    <us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax contextRef="c-183" decimals="-6" id="f-915" unitRef="usd">11000000</us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax>
    <iff:DisposalGroupNotDiscontinuedOperationTaxEffectOfGainLossFromDivestiture contextRef="c-183" decimals="-6" id="f-916" unitRef="usd">96000000</iff:DisposalGroupNotDiscontinuedOperationTaxEffectOfGainLossFromDivestiture>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="c-1" id="f-917">PROPERTY, PLANT AND EQUIPMENT, NET&lt;div style="margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment, net consisted of the following amounts:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.692%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Information technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,402)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,977)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Depreciation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense was $462 million, $452 million and $424 million for the years ended December 31, 2023, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Impairment of Property, Plant and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As discussed in Note 1, for the year ended December 31, 2022, an impairment charge of approximately $28 million was recorded in connection with property, plant and equipment, primarily buildings and improvements, of an asset group that operates primarily in Russia.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="c-1" id="f-918">&lt;div style="margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment, net consisted of the following amounts:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.692%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Information technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,402)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,977)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-185" decimals="-6" id="f-919" unitRef="usd">195000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-186" decimals="-6" id="f-920" unitRef="usd">199000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-187" decimals="-6" id="f-921" unitRef="usd">1822000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-188" decimals="-6" id="f-922" unitRef="usd">1697000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-189" decimals="-6" id="f-923" unitRef="usd">3752000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-190" decimals="-6" id="f-924" unitRef="usd">3344000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-191" decimals="-6" id="f-925" unitRef="usd">473000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-192" decimals="-6" id="f-926" unitRef="usd">291000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-193" decimals="-6" id="f-927" unitRef="usd">400000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-194" decimals="-6" id="f-928" unitRef="usd">649000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-11" decimals="-6" id="f-929" unitRef="usd">6642000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-12" decimals="-6" id="f-930" unitRef="usd">6180000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-11" decimals="-6" id="f-931" unitRef="usd">2402000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-12" decimals="-6" id="f-932" unitRef="usd">1977000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-11" decimals="-6" id="f-933" unitRef="usd">4240000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-12" decimals="-6" id="f-934" unitRef="usd">4203000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation contextRef="c-1" decimals="-6" id="f-935" unitRef="usd">462000000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-9" decimals="-6" id="f-936" unitRef="usd">452000000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-10" decimals="-6" id="f-937" unitRef="usd">424000000</us-gaap:Depreciation>
    <us-gaap:AssetImpairmentCharges contextRef="c-83" decimals="-6" id="f-938" unitRef="usd">28000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock contextRef="c-1" id="f-939">GOODWILL AND OTHER INTANGIBLE ASSETS, NET&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Movements in goodwill attributable to each reportable segment during the years ended December 31, 2022 and 2023 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:32.964%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.624%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nourish&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Health &amp;amp; Biosciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Scent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pharma Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transferred to assets held for sale&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(306)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(348)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(199)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(223)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(506)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,623)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,623)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transferred to assets held for sale&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(267)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(267)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reduction from business divestiture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt"&gt;Related to the acquisition of Health Wright. See Note 3 for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt"&gt;Related to the portion of the Savory Solutions business and FSI business that were classified as held for sale as of December 31, 2022. The Company completed the divestitures of the businesses on May 31, 2023 and August 1, 2023, respectively. See Note 4 and Note 21 for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt"&gt;Related to the Cosmetic Ingredients business that was classified as held for sale as of December&#160;31, 2023. See Note 21 for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The goodwill balance at December&#160;31, 2023 included $2.623&#160;billion and $2.250 billion of accumulated impairment related to the Nourish and Health &amp;amp; Biosciences reportable segments, respectively. The goodwill balance at December&#160;31, 2022 &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;included $2.250&#160;billion of accumulated impairment related to the Health &amp;amp; Biosciences reportable segment. The accumulated impairment relates to impairment charges recorded in 2023 and 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Goodwill Impairment Test&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the annual impairment test as of November 30, 2023, the Company first utilized Step 0 of the guidance in ASC Topic 350, Intangibles &#x2013; Goodwill and Other, which allows for the assessment of qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. If, based on a review of qualitative factors, it is more likely than not that the fair value of a reporting unit is less than its carrying value, a quantitative impairment test is performed by comparing the fair value of a reporting unit with its carrying amount. Based on a review of qualitative factors, the Company determined that for one of the reporting units, Cosmetic Ingredients, a quantitative (Step 1) impairment analysis was not necessary to determine if the carrying values of the reporting unit exceeded its fair values. For the other five reporting units, the Company determined that a Step 1 test was necessary.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assessed the fair value of the reporting units using an income approach. Under the income approach, the Company determined the fair value by using a discounted cash flow method at a rate of return that reflects the relative risk of the projected future cash flows of each reporting unit, as well as a terminal value. The Company used the most current actual and forecasted operating data available. Key estimates and assumptions used in these valuations include revenue growth rates, gross margins, adjusted operating EBITDA margins, terminal growth rates and discount rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In performing the quantitative impairment test, the Company determined that the fair value of four of the five reporting units exceeded their carrying values and determined that there was no further impairment of goodwill in these reporting units as of November 30, 2023.&#160;The Company determined that the carrying value of the Nourish reporting unit exceeded its fair value and recorded an impairment charge of $2.623&#160;billion in the Consolidated Statements of (Loss) Income and Comprehensive Loss for the year ended December 31, 2023. The primary drivers of the impairment charge was a decrease in fair value due to declines in projections of the reporting unit, impacts of continued inflation and increases in interest rates. Based on the quantitative impairment test performed, the Company determined that the Health &amp;amp; Biosciences, Fragrance Ingredients and Pharma Solutions reporting units had excess fair value over carrying value of less than 25%. As of November 30, 2023, the Health &amp;amp; Biosciences, Fragrance Ingredients and Pharma Solutions reporting units had excess fair value over carrying value of approximately 8%, 18% and 8%, respectively, and goodwill of approximately $4.381&#160;billion, $295&#160;million and $1.263&#160;billion, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While management believes that the assumptions used in the impairment test were reasonable, changes in key assumptions, including lower revenue growth, operating margin, terminal growth rates or increase in discount rates could result in a future impairment. Such charge could have a material effect on the Consolidated Statements of Operations and Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2022, the Company determined that goodwill impairment triggering events occurred for its Nourish, Health &amp;amp; Biosciences and Pharma Solutions reporting units. The primary indicators that were deemed to be triggering events were declines in the Company&#x2019;s projections across various reporting units and ongoing adverse macroeconomic impacts such as inflation, increases in interest rates and unfavorable effects from exchange rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based on the quantitative impairment test, using the income approach, the Company determined that the carrying value of the Health &amp;amp; Biosciences reporting unit exceeded its fair value and recorded a goodwill impairment charge of $2.250 billion in the Consolidated Statements of (Loss) Income and Comprehensive Loss for the year ended December 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other intangible assets, net consisted of the following amounts:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.716%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.200%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset Type&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technological know-how&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names &amp;amp; patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total carrying value &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,619)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,252)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technological know-how&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(813)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(589)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names &amp;amp; patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(117)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(97)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,590)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,980)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Amortization&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense was $680 million for the year ended December&#160;31, 2023, $727 million for the year ended December 31, 2022 and $732 million for the year ended December&#160;31, 2021. Amortization expense for the next five years, based on valuations and determinations of useful lives, is expected to be as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:42.613%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.579%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated future intangible amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Impairment of Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As discussed in Note 1, for the year ended December 31, 2022, an impairment charge of approximately $92 million was recorded in connection with intangible assets, primarily customer relationships and technological know-how, of an asset group that operated primarily in Russia, which was included within accumulated amortization.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock contextRef="c-1" id="f-940">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Movements in goodwill attributable to each reportable segment during the years ended December 31, 2022 and 2023 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:32.964%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.624%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nourish&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Health &amp;amp; Biosciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Scent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pharma Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transferred to assets held for sale&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(306)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(348)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(199)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(223)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(506)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,623)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,623)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transferred to assets held for sale&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(267)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(267)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reduction from business divestiture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt"&gt;Related to the acquisition of Health Wright. See Note 3 for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt"&gt;Related to the portion of the Savory Solutions business and FSI business that were classified as held for sale as of December 31, 2022. The Company completed the divestitures of the businesses on May 31, 2023 and August 1, 2023, respectively. See Note 4 and Note 21 for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt"&gt;Related to the Cosmetic Ingredients business that was classified as held for sale as of December&#160;31, 2023. See Note 21 for additional information.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill contextRef="c-195" decimals="-6" id="f-941" unitRef="usd">6559000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-196" decimals="-6" id="f-942" unitRef="usd">6763000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-197" decimals="-6" id="f-943" unitRef="usd">1828000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-198" decimals="-6" id="f-944" unitRef="usd">1282000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-13" decimals="-6" id="f-945" unitRef="usd">16432000000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod contextRef="c-143" decimals="-6" id="f-946" unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod contextRef="c-146" decimals="-6" id="f-947" unitRef="usd">45000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod contextRef="c-149" decimals="-6" id="f-948" unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod contextRef="c-152" decimals="-6" id="f-949" unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod contextRef="c-9" decimals="-6" id="f-950" unitRef="usd">45000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-143" decimals="-6" id="f-951" unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-146" decimals="-6" id="f-952" unitRef="usd">2250000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-149" decimals="-6" id="f-953" unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-152" decimals="-6" id="f-954" unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-9" decimals="-6" id="f-955" unitRef="usd">2250000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillTransfers contextRef="c-143" decimals="-6" id="f-956" unitRef="usd">-306000000</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTransfers contextRef="c-146" decimals="-6" id="f-957" unitRef="usd">0</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTransfers contextRef="c-149" decimals="-6" id="f-958" unitRef="usd">-42000000</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTransfers contextRef="c-152" decimals="-6" id="f-959" unitRef="usd">0</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTransfers contextRef="c-9" decimals="-6" id="f-960" unitRef="usd">-348000000</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss contextRef="c-143" decimals="-6" id="f-961" unitRef="usd">-199000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss contextRef="c-146" decimals="-6" id="f-962" unitRef="usd">-223000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss contextRef="c-149" decimals="-6" id="f-963" unitRef="usd">-41000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss contextRef="c-152" decimals="-6" id="f-964" unitRef="usd">-43000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss contextRef="c-9" decimals="-6" id="f-965" unitRef="usd">-506000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill contextRef="c-199" decimals="-6" id="f-966" unitRef="usd">6054000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-200" decimals="-6" id="f-967" unitRef="usd">4335000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-201" decimals="-6" id="f-968" unitRef="usd">1745000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-202" decimals="-6" id="f-969" unitRef="usd">1239000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-12" decimals="-6" id="f-970" unitRef="usd">13373000000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-142" decimals="-6" id="f-971" unitRef="usd">2623000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-145" decimals="-6" id="f-972" unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-148" decimals="-6" id="f-973" unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-151" decimals="-6" id="f-974" unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-1" decimals="-6" id="f-975" unitRef="usd">2623000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillTransfers contextRef="c-142" decimals="-6" id="f-976" unitRef="usd">0</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTransfers contextRef="c-145" decimals="-6" id="f-977" unitRef="usd">0</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTransfers contextRef="c-148" decimals="-6" id="f-978" unitRef="usd">-267000000</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTransfers contextRef="c-151" decimals="-6" id="f-979" unitRef="usd">0</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTransfers contextRef="c-1" decimals="-6" id="f-980" unitRef="usd">-267000000</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit contextRef="c-142" decimals="-6" id="f-981" unitRef="usd">14000000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit contextRef="c-145" decimals="-6" id="f-982" unitRef="usd">0</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit contextRef="c-148" decimals="-6" id="f-983" unitRef="usd">0</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit contextRef="c-151" decimals="-6" id="f-984" unitRef="usd">0</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit contextRef="c-1" decimals="-6" id="f-985" unitRef="usd">14000000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss contextRef="c-142" decimals="-6" id="f-986" unitRef="usd">72000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss contextRef="c-145" decimals="-6" id="f-987" unitRef="usd">56000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss contextRef="c-148" decimals="-6" id="f-988" unitRef="usd">12000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss contextRef="c-151" decimals="-6" id="f-989" unitRef="usd">26000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss contextRef="c-1" decimals="-6" id="f-990" unitRef="usd">166000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill contextRef="c-203" decimals="-6" id="f-991" unitRef="usd">3489000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-204" decimals="-6" id="f-992" unitRef="usd">4391000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-205" decimals="-6" id="f-993" unitRef="usd">1490000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-206" decimals="-6" id="f-994" unitRef="usd">1265000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-11" decimals="-6" id="f-995" unitRef="usd">10635000000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss contextRef="c-203" decimals="-6" id="f-996" unitRef="usd">2623000000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss contextRef="c-207" decimals="-6" id="f-997" unitRef="usd">2250000000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss contextRef="c-200" decimals="-6" id="f-998" unitRef="usd">2250000000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-84" decimals="-6" id="f-999" unitRef="usd">2623000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount
      contextRef="c-208"
      decimals="2"
      id="f-1000"
      unitRef="number">0.25</us-gaap:ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount>
    <us-gaap:ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount
      contextRef="c-209"
      decimals="2"
      id="f-1001"
      unitRef="number">0.08</us-gaap:ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount>
    <us-gaap:ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount
      contextRef="c-210"
      decimals="2"
      id="f-1002"
      unitRef="number">0.18</us-gaap:ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount>
    <us-gaap:ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount
      contextRef="c-211"
      decimals="2"
      id="f-1003"
      unitRef="number">0.08</us-gaap:ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount>
    <us-gaap:Goodwill contextRef="c-209" decimals="-6" id="f-1004" unitRef="usd">4381000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-210" decimals="-6" id="f-1005" unitRef="usd">295000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-211" decimals="-6" id="f-1006" unitRef="usd">1263000000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-85" decimals="-6" id="f-1007" unitRef="usd">2250000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="c-1" id="f-1008">&lt;div style="margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other intangible assets, net consisted of the following amounts:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.716%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.200%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset Type&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technological know-how&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names &amp;amp; patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total carrying value &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,619)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,252)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technological know-how&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(813)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(589)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names &amp;amp; patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(117)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(97)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,590)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,980)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-212" decimals="-6" id="f-1009" unitRef="usd">8211000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-213" decimals="-6" id="f-1010" unitRef="usd">8318000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-214" decimals="-6" id="f-1011" unitRef="usd">2355000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-215" decimals="-6" id="f-1012" unitRef="usd">2339000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-216" decimals="-6" id="f-1013" unitRef="usd">337000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-217" decimals="-6" id="f-1014" unitRef="usd">358000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-218" decimals="-6" id="f-1015" unitRef="usd">44000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-219" decimals="-6" id="f-1016" unitRef="usd">47000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-11" decimals="-6" id="f-1017" unitRef="usd">10947000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-12" decimals="-6" id="f-1018" unitRef="usd">11062000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-212" decimals="-6" id="f-1019" unitRef="usd">1619000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-213" decimals="-6" id="f-1020" unitRef="usd">1252000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-214" decimals="-6" id="f-1021" unitRef="usd">813000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-215" decimals="-6" id="f-1022" unitRef="usd">589000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-216" decimals="-6" id="f-1023" unitRef="usd">117000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-217" decimals="-6" id="f-1024" unitRef="usd">97000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-218" decimals="-6" id="f-1025" unitRef="usd">41000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-219" decimals="-6" id="f-1026" unitRef="usd">42000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-11" decimals="-6" id="f-1027" unitRef="usd">2590000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-12" decimals="-6" id="f-1028" unitRef="usd">1980000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-11" decimals="-6" id="f-1029" unitRef="usd">8357000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-12" decimals="-6" id="f-1030" unitRef="usd">9082000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-1" decimals="-6" id="f-1031" unitRef="usd">680000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-9" decimals="-6" id="f-1032" unitRef="usd">727000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-10" decimals="-6" id="f-1033" unitRef="usd">732000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock contextRef="c-1" id="f-1034">Amortization expense for the next five years, based on valuations and determinations of useful lives, is expected to be as follows:&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:42.613%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.579%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated future intangible amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths contextRef="c-11" decimals="-6" id="f-1035" unitRef="usd">678000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="c-11" decimals="-6" id="f-1036" unitRef="usd">676000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="c-11" decimals="-6" id="f-1037" unitRef="usd">674000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="c-11" decimals="-6" id="f-1038" unitRef="usd">577000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive contextRef="c-11" decimals="-6" id="f-1039" unitRef="usd">558000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:AssetImpairmentCharges contextRef="c-82" decimals="-6" id="f-1040" unitRef="usd">92000000</us-gaap:AssetImpairmentCharges>
    <iff:OtherAssetsAndLiabilitiesDisclosureCurrentAndNoncurrentTextBlock contextRef="c-1" id="f-1041">OTHER CURRENT ASSETS AND LIABILITIES, AND OTHER ASSETS&lt;div style="margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid expenses and other current assets consisted of the following amounts:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.692%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Value-added tax receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Packaging materials and supplies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other assets consisted of the following amounts:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.692%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Overfunded pension plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes land usage rights in China, long-term deposits and receivables on certain derivative instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other current liabilities consisted of the following amounts:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.692%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rebates and incentives payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Value-added tax payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current pension and other postretirement benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued insurance (including workers&#x2019; compensation)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earn outs payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued restructuring&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-1085"&gt;&lt;span style="-sec-ix-hidden:f-1086"&gt;Current operating lease obligation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued freight&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued commissions payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</iff:OtherAssetsAndLiabilitiesDisclosureCurrentAndNoncurrentTextBlock>
    <us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock contextRef="c-1" id="f-1042">&lt;div style="margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid expenses and other current assets consisted of the following amounts:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.692%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Value-added tax receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Packaging materials and supplies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock>
    <us-gaap:ValueAddedTaxReceivableCurrent contextRef="c-11" decimals="-6" id="f-1043" unitRef="usd">187000000</us-gaap:ValueAddedTaxReceivableCurrent>
    <us-gaap:ValueAddedTaxReceivableCurrent contextRef="c-12" decimals="-6" id="f-1044" unitRef="usd">212000000</us-gaap:ValueAddedTaxReceivableCurrent>
    <us-gaap:IncomeTaxesReceivable contextRef="c-11" decimals="-6" id="f-1045" unitRef="usd">178000000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:IncomeTaxesReceivable contextRef="c-12" decimals="-6" id="f-1046" unitRef="usd">129000000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:Supplies contextRef="c-11" decimals="-6" id="f-1047" unitRef="usd">161000000</us-gaap:Supplies>
    <us-gaap:Supplies contextRef="c-12" decimals="-6" id="f-1048" unitRef="usd">148000000</us-gaap:Supplies>
    <us-gaap:PrepaidExpenseCurrent contextRef="c-11" decimals="-6" id="f-1049" unitRef="usd">184000000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="c-12" decimals="-6" id="f-1050" unitRef="usd">144000000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:AccountsAndOtherReceivablesNetCurrent contextRef="c-11" decimals="-6" id="f-1051" unitRef="usd">165000000</us-gaap:AccountsAndOtherReceivablesNetCurrent>
    <us-gaap:AccountsAndOtherReceivablesNetCurrent contextRef="c-12" decimals="-6" id="f-1052" unitRef="usd">137000000</us-gaap:AccountsAndOtherReceivablesNetCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="c-11" decimals="-6" id="f-1053" unitRef="usd">875000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="c-12" decimals="-6" id="f-1054" unitRef="usd">770000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:ScheduleOfOtherAssetsTableTextBlock contextRef="c-1" id="f-1055">&lt;div style="margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other assets consisted of the following amounts:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.692%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Overfunded pension plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes land usage rights in China, long-term deposits and receivables on certain derivative instruments.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherAssetsTableTextBlock>
    <us-gaap:FinanceLeaseRightOfUseAsset contextRef="c-11" decimals="-6" id="f-1056" unitRef="usd">26000000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset contextRef="c-12" decimals="-6" id="f-1057" unitRef="usd">22000000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:DeferredIncomeTaxesAndOtherAssetsNoncurrent contextRef="c-11" decimals="-6" id="f-1058" unitRef="usd">278000000</us-gaap:DeferredIncomeTaxesAndOtherAssetsNoncurrent>
    <us-gaap:DeferredIncomeTaxesAndOtherAssetsNoncurrent contextRef="c-12" decimals="-6" id="f-1059" unitRef="usd">167000000</us-gaap:DeferredIncomeTaxesAndOtherAssetsNoncurrent>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent contextRef="c-11" decimals="-6" id="f-1060" unitRef="usd">139000000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent contextRef="c-12" decimals="-6" id="f-1061" unitRef="usd">180000000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:CashSurrenderValueOfLifeInsurance contextRef="c-11" decimals="-6" id="f-1062" unitRef="usd">49000000</us-gaap:CashSurrenderValueOfLifeInsurance>
    <us-gaap:CashSurrenderValueOfLifeInsurance contextRef="c-12" decimals="-6" id="f-1063" unitRef="usd">45000000</us-gaap:CashSurrenderValueOfLifeInsurance>
    <us-gaap:EquityMethodInvestments contextRef="c-11" decimals="-6" id="f-1064" unitRef="usd">11000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments contextRef="c-12" decimals="-6" id="f-1065" unitRef="usd">10000000</us-gaap:EquityMethodInvestments>
    <us-gaap:OtherAssetsMiscellaneousNoncurrent contextRef="c-11" decimals="-6" id="f-1066" unitRef="usd">261000000</us-gaap:OtherAssetsMiscellaneousNoncurrent>
    <us-gaap:OtherAssetsMiscellaneousNoncurrent contextRef="c-12" decimals="-6" id="f-1067" unitRef="usd">265000000</us-gaap:OtherAssetsMiscellaneousNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-11" decimals="-6" id="f-1068" unitRef="usd">764000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-12" decimals="-6" id="f-1069" unitRef="usd">689000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherCurrentLiabilitiesTableTextBlock contextRef="c-1" id="f-1070">&lt;div style="margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other current liabilities consisted of the following amounts:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.692%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rebates and incentives payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Value-added tax payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current pension and other postretirement benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued insurance (including workers&#x2019; compensation)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earn outs payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued restructuring&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-1085"&gt;&lt;span style="-sec-ix-hidden:f-1086"&gt;Current operating lease obligation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued freight&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued commissions payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OtherCurrentLiabilitiesTableTextBlock>
    <iff:RebatesAndIncentivesPayableCurrent contextRef="c-11" decimals="-6" id="f-1071" unitRef="usd">105000000</iff:RebatesAndIncentivesPayableCurrent>
    <iff:RebatesAndIncentivesPayableCurrent contextRef="c-12" decimals="-6" id="f-1072" unitRef="usd">99000000</iff:RebatesAndIncentivesPayableCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrent contextRef="c-11" decimals="-6" id="f-1073" unitRef="usd">77000000</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrent contextRef="c-12" decimals="-6" id="f-1074" unitRef="usd">65000000</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:InterestPayableCurrent contextRef="c-11" decimals="-6" id="f-1075" unitRef="usd">65000000</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent contextRef="c-12" decimals="-6" id="f-1076" unitRef="usd">55000000</us-gaap:InterestPayableCurrent>
    <us-gaap:PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent contextRef="c-11" decimals="-6" id="f-1077" unitRef="usd">13000000</us-gaap:PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent>
    <us-gaap:PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent contextRef="c-12" decimals="-6" id="f-1078" unitRef="usd">10000000</us-gaap:PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent>
    <us-gaap:AccruedInsuranceCurrent contextRef="c-11" decimals="-6" id="f-1079" unitRef="usd">9000000</us-gaap:AccruedInsuranceCurrent>
    <us-gaap:AccruedInsuranceCurrent contextRef="c-12" decimals="-6" id="f-1080" unitRef="usd">9000000</us-gaap:AccruedInsuranceCurrent>
    <iff:EarnOutsPayableCurrent contextRef="c-11" decimals="-6" id="f-1081" unitRef="usd">32000000</iff:EarnOutsPayableCurrent>
    <iff:EarnOutsPayableCurrent contextRef="c-12" decimals="-6" id="f-1082" unitRef="usd">0</iff:EarnOutsPayableCurrent>
    <us-gaap:RestructuringReserve contextRef="c-11" decimals="-6" id="f-1083" unitRef="usd">14000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-12" decimals="-6" id="f-1084" unitRef="usd">15000000</us-gaap:RestructuringReserve>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-11" decimals="-6" id="f-1087" unitRef="usd">85000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-12" decimals="-6" id="f-1088" unitRef="usd">86000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <iff:AccruedFreightCurrent contextRef="c-11" decimals="-6" id="f-1089" unitRef="usd">14000000</iff:AccruedFreightCurrent>
    <iff:AccruedFreightCurrent contextRef="c-12" decimals="-6" id="f-1090" unitRef="usd">18000000</iff:AccruedFreightCurrent>
    <iff:AccruedCommissionsPayableCurrent contextRef="c-11" decimals="-6" id="f-1091" unitRef="usd">10000000</iff:AccruedCommissionsPayableCurrent>
    <iff:AccruedCommissionsPayableCurrent contextRef="c-12" decimals="-6" id="f-1092" unitRef="usd">11000000</iff:AccruedCommissionsPayableCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent contextRef="c-11" decimals="-6" id="f-1093" unitRef="usd">194000000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent contextRef="c-12" decimals="-6" id="f-1094" unitRef="usd">313000000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:OtherAccountsPayableAndAccruedLiabilities contextRef="c-11" decimals="-6" id="f-1095" unitRef="usd">262000000</us-gaap:OtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:OtherAccountsPayableAndAccruedLiabilities contextRef="c-12" decimals="-6" id="f-1096" unitRef="usd">256000000</us-gaap:OtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:OtherSundryLiabilitiesCurrent contextRef="c-11" decimals="-6" id="f-1097" unitRef="usd">97000000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent contextRef="c-12" decimals="-6" id="f-1098" unitRef="usd">91000000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-11" decimals="-6" id="f-1099" unitRef="usd">977000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-12" decimals="-6" id="f-1100" unitRef="usd">1028000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="c-1" id="f-1101">LEASES&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has leases for corporate offices, manufacturing facilities, research and development facilities and certain transportation and office equipment, the majority of which are operating leases. The Company&#x2019;s leases have remaining lease terms of up to 50 years, some of which include options to extend the leases for up to 15 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:55.204%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.978%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:55.287%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.996%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.996%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.387%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.000%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows for operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows for finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows for finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.014%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.977%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current operating lease obligations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="-sec-ix-hidden:f-1141"&gt;&lt;span style="-sec-ix-hidden:f-1142"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease right-of-use assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="-sec-ix-hidden:f-1145"&gt;&lt;span style="-sec-ix-hidden:f-1146"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current finance lease obligations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="-sec-ix-hidden:f-1149"&gt;&lt;span style="-sec-ix-hidden:f-1150"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Presented in Other assets on the Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Presented in Other current liabilities on the Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Presented in Other liabilities on the Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average remaining lease term and discount rate were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.014%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.977%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average remaining lease term in years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of lease liabilities as of December&#160;31, 2023&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.290%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.444%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.444%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.958%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total undiscounted liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(174)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Right-of-use assets and lease liabilities acquired from N&amp;amp;B were remeasured at the present value of the future minimum lease payments over the remaining lease term utilizing an updated incremental borrowing rate of the Company as if the acquired leases were new leases as of the Closing Date. Right-of-use assets were further adjusted for any off-market terms of the lease. The remaining lease term is based on the remaining term at the Closing Date plus any renewal or extension options that the Company is reasonably certain will be exercised. Additionally, the Company has elected short-term lease treatment for those acquired lease contracts which, at the Closing Date, have a remaining lease term of 12 months or less. For the leases acquired through the Transactions, the Company will retain the previous lease classification. This resulted in an increase in both operating lease right-of-use assets and operating lease liabilities of approximately $525&#160;million and $523 million, respectively, as of the Closing Date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of the Company&#x2019;s acquisition of Health Wright, there was an increase of approximately $22&#160;million in finance lease right-of-use assets and $21&#160;million in finance lease liabilities as of the Acquisition Date. In the fourth quarter of 2022, the Company exercised its option to purchase the asset and, as such, de-recognized the finance lease right-of-use assets and finance lease liabilities.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm contextRef="c-11" id="f-1102">P50Y</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:LesseeOperatingLeaseRenewalTerm contextRef="c-11" id="f-1103">P15Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:LeaseCostTableTextBlock contextRef="c-1" id="f-1104">&lt;div style="margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:55.204%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.978%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:55.287%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.996%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.996%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.387%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.000%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows for operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows for finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows for finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average remaining lease term and discount rate were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.014%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.977%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average remaining lease term in years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost contextRef="c-1" decimals="-6" id="f-1105" unitRef="usd">137000000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-9" decimals="-6" id="f-1106" unitRef="usd">134000000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-10" decimals="-6" id="f-1107" unitRef="usd">133000000</us-gaap:OperatingLeaseCost>
    <us-gaap:VariableLeaseCost contextRef="c-1" decimals="-6" id="f-1108" unitRef="usd">56000000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost contextRef="c-9" decimals="-6" id="f-1109" unitRef="usd">53000000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost contextRef="c-10" decimals="-6" id="f-1110" unitRef="usd">35000000</us-gaap:VariableLeaseCost>
    <us-gaap:LeaseCost contextRef="c-1" decimals="-6" id="f-1111" unitRef="usd">193000000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c-9" decimals="-6" id="f-1112" unitRef="usd">187000000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c-10" decimals="-6" id="f-1113" unitRef="usd">168000000</us-gaap:LeaseCost>
    <iff:FinanceLeaseCost contextRef="c-1" decimals="-6" id="f-1114" unitRef="usd">10000000</iff:FinanceLeaseCost>
    <iff:FinanceLeaseCost contextRef="c-9" decimals="-6" id="f-1115" unitRef="usd">8000000</iff:FinanceLeaseCost>
    <iff:FinanceLeaseCost contextRef="c-10" decimals="-6" id="f-1116" unitRef="usd">7000000</iff:FinanceLeaseCost>
    <us-gaap:OperatingLeasePayments contextRef="c-1" decimals="-6" id="f-1117" unitRef="usd">122000000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="c-9" decimals="-6" id="f-1118" unitRef="usd">135000000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="c-10" decimals="-6" id="f-1119" unitRef="usd">129000000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability contextRef="c-1" decimals="-6" id="f-1120" unitRef="usd">1000000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability contextRef="c-9" decimals="-6" id="f-1121" unitRef="usd">0</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability contextRef="c-10" decimals="-6" id="f-1122" unitRef="usd">0</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeasePrincipalPayments contextRef="c-1" decimals="-6" id="f-1123" unitRef="usd">8000000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments contextRef="c-9" decimals="-6" id="f-1124" unitRef="usd">7000000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments contextRef="c-10" decimals="-6" id="f-1125" unitRef="usd">6000000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-1" decimals="-6" id="f-1126" unitRef="usd">49000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-9" decimals="-6" id="f-1127" unitRef="usd">174000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-10" decimals="-6" id="f-1128" unitRef="usd">88000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability contextRef="c-1" decimals="-6" id="f-1129" unitRef="usd">22000000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability contextRef="c-9" decimals="-6" id="f-1130" unitRef="usd">7000000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability contextRef="c-10" decimals="-6" id="f-1131" unitRef="usd">15000000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <iff:AssetsAndLiabilitiesLesseeTableTextBlock contextRef="c-1" id="f-1132">&lt;div style="margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.014%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.977%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current operating lease obligations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="-sec-ix-hidden:f-1141"&gt;&lt;span style="-sec-ix-hidden:f-1142"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease right-of-use assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="-sec-ix-hidden:f-1145"&gt;&lt;span style="-sec-ix-hidden:f-1146"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current finance lease obligations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="-sec-ix-hidden:f-1149"&gt;&lt;span style="-sec-ix-hidden:f-1150"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Presented in Other assets on the Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Presented in Other current liabilities on the Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Presented in Other liabilities on the Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;</iff:AssetsAndLiabilitiesLesseeTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-11" decimals="-6" id="f-1133" unitRef="usd">689000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-12" decimals="-6" id="f-1134" unitRef="usd">743000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-11" decimals="-6" id="f-1135" unitRef="usd">85000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-12" decimals="-6" id="f-1136" unitRef="usd">86000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-11" decimals="-6" id="f-1137" unitRef="usd">642000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-12" decimals="-6" id="f-1138" unitRef="usd">672000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability contextRef="c-11" decimals="-6" id="f-1139" unitRef="usd">727000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability contextRef="c-12" decimals="-6" id="f-1140" unitRef="usd">758000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseRightOfUseAsset contextRef="c-11" decimals="-6" id="f-1143" unitRef="usd">26000000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset contextRef="c-12" decimals="-6" id="f-1144" unitRef="usd">22000000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseLiabilityCurrent contextRef="c-11" decimals="-6" id="f-1147" unitRef="usd">7000000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent contextRef="c-12" decimals="-6" id="f-1148" unitRef="usd">5000000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="c-11" decimals="-6" id="f-1151" unitRef="usd">18000000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="c-12" decimals="-6" id="f-1152" unitRef="usd">12000000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiability contextRef="c-11" decimals="-6" id="f-1153" unitRef="usd">25000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability contextRef="c-12" decimals="-6" id="f-1154" unitRef="usd">17000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-11" id="f-1155">P9Y10M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-12" id="f-1156">P10Y7M6D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-11" id="f-1157">P3Y6M</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-12" id="f-1158">P4Y</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-11" decimals="4" id="f-1159" unitRef="number">0.0424</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-12" decimals="4" id="f-1160" unitRef="number">0.0383</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent contextRef="c-11" decimals="4" id="f-1161" unitRef="number">0.0433</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent contextRef="c-12" decimals="4" id="f-1162" unitRef="number">0.0259</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="c-1" id="f-1163">&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of lease liabilities as of December&#160;31, 2023&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.290%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.444%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.444%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.958%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total undiscounted liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(174)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c-11" decimals="-6" id="f-1164" unitRef="usd">113000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c-11" decimals="-6" id="f-1165" unitRef="usd">9000000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <iff:LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearOne contextRef="c-11" decimals="-6" id="f-1166" unitRef="usd">122000000</iff:LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearOne>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="c-11" decimals="-6" id="f-1167" unitRef="usd">110000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo contextRef="c-11" decimals="-6" id="f-1168" unitRef="usd">8000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <iff:LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearTwo contextRef="c-11" decimals="-6" id="f-1169" unitRef="usd">118000000</iff:LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="c-11" decimals="-6" id="f-1170" unitRef="usd">101000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree contextRef="c-11" decimals="-6" id="f-1171" unitRef="usd">7000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <iff:LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearThree contextRef="c-11" decimals="-6" id="f-1172" unitRef="usd">108000000</iff:LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour contextRef="c-11" decimals="-6" id="f-1173" unitRef="usd">87000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour contextRef="c-11" decimals="-6" id="f-1174" unitRef="usd">4000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <iff:LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFour contextRef="c-11" decimals="-6" id="f-1175" unitRef="usd">91000000</iff:LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive contextRef="c-11" decimals="-6" id="f-1176" unitRef="usd">77000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive contextRef="c-11" decimals="-6" id="f-1177" unitRef="usd">0</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive>
    <iff:LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFive contextRef="c-11" decimals="-6" id="f-1178" unitRef="usd">77000000</iff:LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive contextRef="c-11" decimals="-6" id="f-1179" unitRef="usd">410000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive contextRef="c-11" decimals="-6" id="f-1180" unitRef="usd">0</us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive>
    <iff:LesseeOperatingAndFinanceLeaseLiabilityToBePaidAfterYearFive contextRef="c-11" decimals="-6" id="f-1181" unitRef="usd">410000000</iff:LesseeOperatingAndFinanceLeaseLiabilityToBePaidAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="c-11" decimals="-6" id="f-1182" unitRef="usd">898000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue contextRef="c-11" decimals="-6" id="f-1183" unitRef="usd">28000000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <iff:LesseeOperatingAndFinanceLeasePaymentsDue contextRef="c-11" decimals="-6" id="f-1184" unitRef="usd">926000000</iff:LesseeOperatingAndFinanceLeasePaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="c-11" decimals="-6" id="f-1185" unitRef="usd">171000000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount contextRef="c-11" decimals="-6" id="f-1186" unitRef="usd">3000000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <iff:LesseeOperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount contextRef="c-11" decimals="-6" id="f-1187" unitRef="usd">174000000</iff:LesseeOperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability contextRef="c-11" decimals="-6" id="f-1188" unitRef="usd">727000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability contextRef="c-11" decimals="-6" id="f-1189" unitRef="usd">25000000</us-gaap:FinanceLeaseLiability>
    <iff:OperatingAndFinanceLeaseLiability contextRef="c-11" decimals="-6" id="f-1190" unitRef="usd">752000000</iff:OperatingAndFinanceLeaseLiability>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-169" decimals="-6" id="f-1191" unitRef="usd">525000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability contextRef="c-169" decimals="-6" id="f-1192" unitRef="usd">523000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseRightOfUseAsset contextRef="c-154" decimals="-6" id="f-1193" unitRef="usd">22000000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseLiability contextRef="c-154" decimals="-6" id="f-1194" unitRef="usd">21000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:DebtDisclosureTextBlock contextRef="c-1" id="f-1195">DEBT&lt;div style="margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt consisted of the following at December&#160;31:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.560%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.584%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.493%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.495%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Effective Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024 Euro Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025 Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 Euro Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2030 Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2040 Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2047 Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2048 Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2050 Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024 Term Loan Facility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 Term Loan Facility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial Paper&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revolving Credit Facility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bank overdrafts and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Short term borrowings&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(885)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(597)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Amount is net of unamortized discount and debt issuance costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Amount is recorded at fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The effective interest rate of commercial paper issuances fluctuate as short-term interest rates and demand fluctuate, and deferred debt issuance costs are immaterial. Additionally, the effective interest rate of commercial paper is not meaningful as issuances do not materially differ from short-term interest rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The interest rate on the Revolving Credit Facility is, at the applicable borrower&#x2019;s option, a per annum rate equal to either (x) an eurocurrency rate plus an applicable margin varying from 1.125% to 1.750% or (y) a base rate plus an applicable margin varying from 0.125% to 0.750%, in each case depending on the public debt ratings for&#160;non-credit&#160;enhanced long-term senior unsecured debt issued by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes bank borrowings, overdrafts, current portion of long-term debt and commercial paper.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Term Loan Facility and Senior Notes assumed as part of the N&amp;amp;B Merger&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following the Merger, the Company assumed the indebtedness incurred by N&amp;amp;B in the debt financings completed prior to the Distribution. This indebtedness includes (i) a Term Loan Facility of $1.250&#160;billion pursuant to the term loan credit agreement (the &#x201c;N&amp;amp;B Term Loan Facility&#x201d;) and (ii) a series of Senior Notes in the aggregate amount of $6.250&#160;billion with maturities ranging from 2 to 30 years as further described below. N&amp;amp;B&#x2019;s indebtedness raised prior to the Merger was used to finance the Special Cash Payment to DuPont, which has been paid, and for the satisfaction of the related transaction fees and expenses. See Note 3 for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;N&amp;amp;B Term Loan Facility&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The N&amp;amp;B Term Loan Facility was funded on February 1, 2021, and provides for a senior unsecured term loan credit facility in an aggregate principal amount of $1.250&#160;billion, comprised of a $625&#160;million three-year tranche (&#x201c;2024 Term Loan Facility&#x201d;) and a $625&#160;million five-year tranche (&#x201c;2026 Term Loan Facility&#x201d;). Interest for each tranche equals, at the Company&#x2019;s option, a per annum rate equal to either (x) an adjusted LIBOR rate plus an applicable margin varying from 0.750% to 2.000% for the three-year tranche and from 1.125% to 2.375% for the five-year tranche or (y) a base rate plus an applicable margin varying from 0.000% to 1.000% for the three-year tranche and from 0.125% to 1.375% for the five-year tranche, in each case depending on the class of IFF&#x2019;s non-credit-enhanced, senior unsecured long-term debt credit rating.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2024 Term Loan Facility and 2026 Term Loan Facility are subject to customary affirmative and negative covenants and events of default after the Closing Date of the Merger. On and after the Closing Date of the N&amp;amp;B Transaction, the 2024 Term Loan Facility and 2026 Term Loan Facility are also subject to financial covenant maintenance requirements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 19, 2023, the Company entered into Amendment No. 5 (&#x201c;Term Loan Amendment No. 5&#x201d;) to amend that certain term loan credit agreement, dated January 17, 2020 (as amended by that certain Amendment No. 1 to Credit Agreement, dated as of August 25, 2020, as further supplemented by that certain Icon Debt Assumption Supplement, dated as of March 4, 2021, as further amended by that certain Amendment No. 2 to Credit Agreement, dated as of August 4, 2022, as further amended by that certain Amendment No. 3 (&#x201c;Term Loan Amendment No. 3&#x201d;) to Credit Agreement, dated as of March 23, 2023, as further amended by that certain Amendment No. 4 (&#x201c;Term Loan Amendment No. 4&#x201d;) to Credit Agreement, dated as of March 23, 2023, the &#x201c;Existing Term Loan Credit Agreement&#x201d;, and the Existing Term Loan Credit Agreement, as amended by the Term Loan Amendment, the &#x201c;Term Loan Credit Agreement&#x201d;), among the Company (as successor to Nutrition &amp;amp; Biosciences, Inc.), the lenders party thereto and Morgan Stanley Senior Funding, Inc., as administrative agent. The related deferred financing costs for the amendments in 2023 were not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Term Loan Amendment No. 3, among other things, extended the period during which certain relief was provided with respect to the financial covenant contained in the Existing Term Loan Credit Agreement which has been superseded by Term Loan Amendment No. 5.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Term Loan Amendment No. 4, among other things, replaces LIBOR with Term SOFR (as defined in the Term Loan Credit Agreement) as the reference rate for U.S. dollar-denominated loans. From March 23, 2023, loans under the Term Loan Credit Agreement now bear interest at a base rate or a rate equal to Term SOFR plus an adjustment of 0.10% per annum, plus, in each case, an applicable margin based on the Company's public debt rating. Loans may be prepaid without premium or penalty, subject to customary breakage costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Term Loan Amendment No. 5, among other things, extends the period during which certain relief is provided with respect to the financial covenant contained in the Existing Term Loan Credit Agreement through December 31, 2025, or such earlier date on which the Company elects to terminate such period (the &#x201c;Term Loan Covenant Relief Period&#x201d;), by providing that during the Term Loan Covenant Relief Period, the Company&#x2019;s Leverage Ratio (as defined in the Term Loan Credit Agreement) shall not exceed as of the end of the fiscal quarter for the period of the four fiscal quarters then ended: (i) 5.25x for any fiscal quarter ending on or before March 31, 2024, (ii) 4.75x for the fiscal quarter ending June 30, 2024, (iii) 4.50x for the fiscal quarter ending September 30, 2024, (iv) 4.25x for any subsequent fiscal quarter ending on or before March 31, 2025, (v) 4.00x for any subsequent fiscal quarter ending on or before September 30, 2025 and (vi) 3.75x for the fiscal quarter ending December 31, 2025. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the Term Loan Covenant Relief Period, the amendments prohibit the Company from (i) effecting share repurchases, (ii) declaring and paying dividends in cash on common stock in excess of $0.81 per share per fiscal quarter (for an aggregate amount of $3.24 per fiscal year) and (iii) creating liens to secure debt in excess of the greater of $300&#160;million and 3.65% of Consolidated Net Tangible Assets (as defined in the Term Loan Credit Agreement), subject to certain exceptions set forth in the Term Loan Amendment No. 5. The Company was in compliance with all covenants as of December&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Loans may be prepaid without premium or penalty, subject to customary breakage costs, and during the Term Loan Covenant Relief Period, there will be a mandatory prepayment of the loans with 100% of the net cash proceeds from non-ordinary course asset sales, subject to certain exceptions set forth in the Term Loan Amendment No. 5 and by a Term Loan Amendment No. 6, dated January 26, 2024, which provides additional exceptions to the mandatory prepayment requirements with respect to the sale of the Company&#x2019;s Cosmetic Ingredients business. The applicable margin for the loans, which is based on the Company&#x2019;s Public Debt Rating (as defined in the Term Loan Credit Agreement), will also increase by 0.125% for the duration of the Term Loan Covenant Relief Period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2023, the Company made voluntary debt repayments of $355&#160;million related to the 2024 Term Loan Facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;N&amp;amp;B Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 16, 2020, N&amp;amp;B issued $6.250&#160;billion in aggregate principal amount of senior unsecured notes consisting of: (i) $300&#160;million senior unsecured notes which matured on September 15, 2022 (the &#x201c;2022 Notes&#x201d;), bearing interest at a rate of 0.697% per year, payable semi-annually on March 15 and September 15 of each year, beginning March 15, 2021; (ii) $1.000&#160;billion senior unsecured notes maturing on October 1, 2025 (the &#x201c;2025 Notes&#x201d;), bearing interest at a rate of 1.230% per year, payable semi-annually on April 1 and October 1 of each year, beginning April 1, 2021; (iii) $1.200&#160;billion senior unsecured notes maturing on October 15, 2027 (the &#x201c;2027 Notes&#x201d;), bearing interest at a rate of 1.832% per year, payable semi-annually on April 15 and October 15 of each year, beginning April 15, 2021; (iv) $1.500&#160;billion senior unsecured notes maturing on November 1, 2030 (the &#x201c;2030 Notes&#x201d;), bearing interest at a rate of 2.300% per year, payable semi-annually on May 1 and November 1 of each year, beginning May 1, 2021; (v) $750&#160;million senior unsecured notes maturing on November 15, 2040 (the &#x201c;2040 Notes&#x201d;), bearing interest at a rate of 3.268% per year, payable semi-annually on May 15 and November 15 of each year, beginning May 15, 2021, and; (vi) $1.500&#160;billion senior unsecured notes maturing on December 1, 2050 (the &#x201c;2050 Notes&#x201d;), bearing interest at a rate of 3.468% per year, payable semi-annually on June 1 and December 1 of each year, beginning June 1, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest on each series of notes began accruing from September 16, 2020 payable semi-annually in arrears as described above. Interest is computed on the basis of a 360-day year comprised of twelve 30-day months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 15, 2022, the Company repaid the full $300&#160;million outstanding of its 2022 Notes at maturity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revolving Credit Facility&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Revolving Credit Facility is available for general corporate purposes of each borrower and its subsidiaries. The obligations under the Revolving Credit Facility are unsecured and the Company has guaranteed the obligations of each other borrower under the Revolving Credit Facility. The Company pays a commitment fee on the aggregate unused commitments; such fee is not material. The Revolving Credit Agreement contains various covenants, limitations and events of default customary for similar facilities for similarly rated borrowers, including a maximum permitted ratio of Net Debt to Consolidated EBITDA. In connection with the initial issuance of the Revolving Credit Facility, the Company incurred&#160;$1&#160;million of debt issuance costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 19, 2023, the Company and certain of its subsidiaries (collectively, the &#x201c;Loan Parties&#x201d;) entered into Amendment No. 4 (the &#x201c;Revolver Amendment No. 4&#x201d;) to amend that certain Third Amended and Restated Credit Agreement, dated July 28, 2021 (as amended by that certain Amendment No. 1 to Credit Agreement, dated August 4, 2022, as further amended by that certain Amendment No. 2 (&#x201c;Revolver Amendment No. 2&#x201d;) to Credit Agreement, dated as of March 23, 2023, as further amended by that certain Amendment No. 3 (&#x201c;Revolver Amendment No. 3&#x201d;) to Credit Agreement, dated as of March 23, 2023, the &#x201c;Existing Revolving Credit Agreement&#x201d;, and the Existing Revolving Credit Agreement, as amended by the Revolver Amendment, the &#x201c;Revolving Credit Agreement&#x201d;), among the Loan Parties, the lenders party thereto and Citibank, N.A., as administrative agent. The related deferred financing costs for the amendments in 2023 were not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revolver Amendment No. 2, among other things, extended the period during which certain relief was provided with respect to the financial covenant contained in the Existing Revolving Credit Agreement which has been superseded by Revolver Amendment No. 4.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revolver Amendment No. 3, among other things, replaces LIBOR with Term SOFR (as defined in the Revolving Credit Agreement) as the reference rate for U.S. dollar-denominated loans. From March 23, 2023, loans under the Revolving Credit Agreement now bear interest at a base rate or, in the case of U.S. dollar-denominated loans, a rate equal to Term SOFR plus an adjustment of 0.10% per annum or, in the case of Euro-denominated loans, the Euro interbank offered rate, plus, in each case, an applicable margin based on the Company&#x2019;s public debt rating. Loans may be prepaid without premium or penalty, subject to customary breakage costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revolver Amendment No. 4, among other things, extends the period during which certain relief is provided with respect to the financial covenant contained in the Existing Revolving Credit Agreement through December 31, 2025, or such earlier date on which the Company elects to terminate such period (the &#x201c;Revolver Covenant Relief Period&#x201d;), by providing that during the Revolver Covenant Relief Period, the Company&#x2019;s Leverage Ratio (as defined in the Revolving Credit Agreement) shall not exceed as of the end of the fiscal quarter for the period of the four fiscal quarters then ended: (i) 5.25x for any fiscal quarter ending on or before March 31, 2024, (ii) 4.75x for the fiscal quarter ending June 30, 2024, (iii) 4.50x for the fiscal quarter ending September 30, 2024, (iv) 4.25x for any subsequent fiscal quarter ending on or before March 31, 2025, (v) 4.00x for any subsequent fiscal quarter ending on or before September 30, 2025 and (vi) 3.75x for the fiscal quarter ending December 31, 2025. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the Revolver Covenant Relief Period, the amendments prohibit (i) the Company from effecting share repurchases, (ii) the Company from declaring and paying dividends in cash on common stock in excess of $0.81 per share per fiscal quarter (for an aggregate amount of $3.24 per fiscal year) and (iii) the Loan Parties from creating liens to secure debt in excess of the greater of $300&#160;million and 3.65% of Consolidated Net Tangible Assets (as defined in the Revolving Credit Agreement), subject to certain exceptions set forth in the Revolver Amendment No. 4. The Company was in compliance with all covenants as of December&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Loans may be prepaid without premium or penalty, subject to customary breakage costs, and during the Revolver Covenant Relief Period, the applicable margin for the loans, which is based on the Company&#x2019;s Public Debt Rating (as defined in the Revolving Credit Agreement), will increase by 0.125%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023, total capacity under the Revolving Credit Facility was&#160;$2.000 billion, with&#160;no outstanding borrowings. Under the amended terms of the Revolver Credit Agreement, the Revolving Credit Facility increased from $1.000 billion to $2.000 billion, maturing on July 28, 2026. At the option of the Company, the facility may be increased to $2.500&#160;billion subject to certain conditions. As the Revolving Credit Facility is a multi-year revolving credit agreement, the Company classifies as long-term debt the portion that it has the intent and ability to maintain outstanding longer than 12&#160;months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2023, the Company had drawdowns of $800&#160;million and repayments of $900&#160;million under the Revolving Credit Facility. During 2022, the Company had drawdowns of $550&#160;million and repayments of $450&#160;million under the Revolving Credit Facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2018 Senior Unsecured Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 25, 2018, the Company issued &#x20ac;800&#160;million aggregate principal amount of senior unsecured notes that mature on September 25, 2026 (the &#x201c;2026 Euro Notes&#x201d;). The 2026 Euro Notes bear interest at a rate of 1.8% per year, payable annually on September 25 of each year, beginning September 25, 2019. Total proceeds from the issuance of the 2026 Notes, net of underwriting discounts and offering costs, were &#x20ac;794&#160;million ($932&#160;million in USD).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 26, 2018, the Company issued $400&#160;million aggregate principal amount of senior unsecured notes that mature on September 26, 2028 (the &#x201c;2028 Notes&#x201d;). The 2028 Notes bear interest at a rate of 4.45% per year, payable semi-annually on March 26 and September 26 of each year, beginning March 26, 2019. Total proceeds from the issuance of the 2028 Notes, net of underwriting discounts and offering costs, were $397&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 26, 2018, the Company issued $800&#160;million aggregate principal amount of senior unsecured notes that mature on September 26, 2048 (the &#x201c;2048 Notes&#x201d; and collectively with the 2026 Euro Notes, 2020 Notes, 2028 Notes, the &#x201c;2018 Senior Unsecured Notes&#x201d;). The 2048 Notes bear interest at a rate of 5.0% per year, payable semi-annually on March 26 and September 26 of each year, beginning March 26, 2019. Total proceeds from the issuance of the 2048 Notes, net of underwriting discounts and offering costs, were $787&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As discussed in Note 16, the 2026 Euro Notes have been designated as a hedge of the Company&#x2019;s net investment in certain subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2023 Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April&#160;4, 2013, the Company issued $300&#160;million aggregate principal amount of senior unsecured notes that mature on May 1, 2023 (&#x201c;2023 Notes&#x201d;). The 2023 Notes bear interest at a rate of 3.20% per year, payable semi-annually on May 1 and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;November 1 of each year, beginning November 1, 2013. Total proceeds from the issuance of the 2023 Notes, net of underwriting discounts and offering costs, were $298&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 1, 2023, the Company repaid the full $300&#160;million outstanding of its 2023 Notes at maturity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2024 Euro Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 14, 2016, the Company issued &#x20ac;500 million aggregate principal amount of senior unsecured notes that mature on March 14, 2024 (&#x201c;2024 Euro Notes&#x201d;). The 2024 Euro Notes bear interest at a rate of 1.75% per year, payable annually on March 14 of each year, beginning March 14, 2017. Total proceeds from the issuance of the 2024 Euro Notes, net of underwriting discounts and offering costs, were &#x20ac;496 million. In connection with the debt issuance, the Company entered into pre-issuance hedging transactions that were settled upon issuance of the debt and resulted in a loss of approximately $3 million. The discount, deferred financing costs and pre-issuance hedge loss are being amortized as interest expense over the eight year term of the debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As discussed in Note 16, the 2024 Euro Notes have been designated as a hedge of the Company&#x2019;s net investment in certain subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2047 Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 18, 2017, the Company issued $500&#160;million aggregate principal amount of senior unsecured notes that mature on June 1, 2047 (&#x201c;2047 Notes&#x201d;). The 2047 Notes bear interest at a rate of 4.375% per year, payable semi-annually on June 1 and December 1 of each year, beginning December 1, 2017. Total proceeds from the issuance of the 2047 Notes, net of underwriting discounts and offering costs, were $494&#160;million. In addition, the Company incurred $1&#160;million in legal and professional costs associated with the issuance and such costs were recorded as deferred financing costs. In connection with the debt issuance, the Company entered into pre-issuance hedging transactions that were settled upon issuance of the debt and resulted in a loss of approximately $5&#160;million. The discount, deferred financing costs and pre-issuance hedge loss are being amortized as interest expense over the 30 year term of the debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Commercial Paper&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2023, the Company had gross issuances of $5.694 billion and repayments of $5.881 billion under the commercial paper program. The commercial paper issued had original maturities of less than 86 days. During 2022, the Company had gross issuances of $6.040&#160;billion and repayments of $6.177&#160;billion under the commercial paper program.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Commercial Paper Program is backed by the borrowing capacity available under the Revolving Credit Facility. The effective interest rate of commercial paper issuances does not materially differ from short-term interest rates, which fluctuate due to market conditions and as a result may impact our interest expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Redemption Provisions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2024 Euro Notes, 2026 Euro Notes, 2028 Notes, 2047 Notes, and 2048 Notes (collectively, the &#x201c;Notes&#x201d;) share the same redemption provisions. Upon 30 days&#x2019; notice to holders of the Notes, the Company may redeem the Notes at any time at the greater of 100% or the discounted present value of the remaining scheduled payments of principal and interest from the redemption date to the maturity date at the Treasury Rate or the Comparable Government Bond Rate (as defined in the applicable agreements) plus (i) 30 basis points in the case of the 2024 Euro Notes, (ii) 25 basis points in the case of the 2026 Euro Notes, (iii) 25 basis points in the case of the 2028 Notes, (iv) 25 basis points in the case of the 2047 Notes and (v) 30 basis points in the case of the 2048 Notes. The redemption dates of each of the Notes are provided in the below table:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:51.462%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.606%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Note&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redemption Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024 Euro Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 14, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 Euro Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 25, 2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 26, 2028&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2047 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 1, 2046&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2048 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 26, 2048&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2025 Notes, 2027 Notes, 2030 Notes, 2040 Notes and 2050 Notes (collectively, the &#x201c;N&amp;amp;B Senior Notes&#x201d;) were assumed as a result of the Merger and share the same redemption provisions. Upon 15 days&#x2019; notice to holders of the N&amp;amp;B Senior Notes, the Company may redeem the N&amp;amp;B Senior Notes at any time at the greater of 100% or the discounted present value of the remaining scheduled payments of principal and interest from the redemption date to the maturity date at the Treasury Rate (as defined in the applicable agreements) plus (i) 15 basis points in the case of the 2025 Notes, (ii) 25 basis points in the case of the 2027 Notes, (iii) 25 basis points in the case of the 2030 Notes, (iv) 30 basis points in the case of the 2040 Notes and (v) 30 basis points in the case of the 2050 Notes. The redemption dates of each of the N&amp;amp;B Senior Notes are provided in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:51.462%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.606%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Note&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redemption Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 1, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 15, 2027&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2030 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 1, 2030&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2040 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 15, 2040&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2050 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 1, 2050&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On or after the applicable redemption dates, each series of the Notes and N&amp;amp;B Senior Notes (collectively, the &#x201c;IFF Notes&#x201d;) may be redeemed by the issuer at a redemption price equal to 100% of the principal amount of the IFF Notes to be redeemed, plus accrued and unpaid interest on the notes to be redeemed to, but excluding, the redemption date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The indenture of the IFF Notes provides for customary events of default and contains certain negative covenants that limit the ability of the Company and its subsidiaries to grant liens on assets, or to enter into sale-leaseback transactions. In addition, subject to certain limitations, in the event of the occurrence of both (1) a change of control of the Company and (2) ratings of the IFF Notes is under publicly announced consideration or is downgraded below investment grade by either Moody&#x2019;s Investors Services, Inc. or Standard &amp;amp; Poor&#x2019;s Ratings Services within a specified time period, the Company will be required to make an offer to repurchase the IFF Notes at a price equal to 101% of the principal amount of the IFF Notes, plus accrued and unpaid interest to the date of repurchase.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Outstanding Borrowings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the contractual maturities of the Company&#x2019;s long-term debt as of December&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:37.225%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.647%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.647%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.647%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.647%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.651%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Payments&#160;Due&#160;by&#160;Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Less than 1 Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1-3 Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3-5 Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;More than&lt;br/&gt;5 Years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Outstanding Borrowings&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Subsequent Event&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 1, 2024, the Company repaid the remaining $270&#160;million outstanding on its 2024 Term Loan Facility.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock contextRef="c-1" id="f-1196">&lt;div style="margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt consisted of the following at December&#160;31:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.560%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.584%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.493%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.495%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Effective Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024 Euro Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025 Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 Euro Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2030 Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2040 Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2047 Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2048 Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2050 Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024 Term Loan Facility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 Term Loan Facility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial Paper&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revolving Credit Facility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bank overdrafts and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Short term borrowings&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(885)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(597)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Amount is net of unamortized discount and debt issuance costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Amount is recorded at fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The effective interest rate of commercial paper issuances fluctuate as short-term interest rates and demand fluctuate, and deferred debt issuance costs are immaterial. Additionally, the effective interest rate of commercial paper is not meaningful as issuances do not materially differ from short-term interest rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The interest rate on the Revolving Credit Facility is, at the applicable borrower&#x2019;s option, a per annum rate equal to either (x) an eurocurrency rate plus an applicable margin varying from 1.125% to 1.750% or (y) a base rate plus an applicable margin varying from 0.125% to 0.750%, in each case depending on the public debt ratings for&#160;non-credit&#160;enhanced long-term senior unsecured debt issued by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes bank borrowings, overdrafts, current portion of long-term debt and commercial paper.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-220"
      decimals="INF"
      id="f-1197"
      unitRef="number">0.0330</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:SeniorNotesCurrent contextRef="c-220" decimals="-6" id="f-1198" unitRef="usd">0</us-gaap:SeniorNotesCurrent>
    <us-gaap:SeniorNotesCurrent contextRef="c-221" decimals="-6" id="f-1199" unitRef="usd">300000000</us-gaap:SeniorNotesCurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-222"
      decimals="INF"
      id="f-1200"
      unitRef="number">0.0188</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:SeniorNotesCurrent contextRef="c-222" decimals="-6" id="f-1201" unitRef="usd">552000000</us-gaap:SeniorNotesCurrent>
    <us-gaap:SeniorLongTermNotes contextRef="c-223" decimals="-6" id="f-1202" unitRef="usd">532000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-224"
      decimals="INF"
      id="f-1203"
      unitRef="number">0.0122</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:SeniorLongTermNotes contextRef="c-224" decimals="-6" id="f-1204" unitRef="usd">1000000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes contextRef="c-225" decimals="-6" id="f-1205" unitRef="usd">1000000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-226"
      decimals="INF"
      id="f-1206"
      unitRef="number">0.0193</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:SeniorLongTermNotes contextRef="c-226" decimals="-6" id="f-1207" unitRef="usd">879000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes contextRef="c-227" decimals="-6" id="f-1208" unitRef="usd">845000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-228"
      decimals="INF"
      id="f-1209"
      unitRef="number">0.0156</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:SeniorLongTermNotes contextRef="c-228" decimals="-6" id="f-1210" unitRef="usd">1212000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes contextRef="c-229" decimals="-6" id="f-1211" unitRef="usd">1215000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-230"
      decimals="INF"
      id="f-1212"
      unitRef="number">0.0457</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:SeniorLongTermNotes contextRef="c-230" decimals="-6" id="f-1213" unitRef="usd">398000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes contextRef="c-231" decimals="-6" id="f-1214" unitRef="usd">398000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-232"
      decimals="INF"
      id="f-1215"
      unitRef="number">0.0221</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:SeniorLongTermNotes contextRef="c-232" decimals="-6" id="f-1216" unitRef="usd">1508000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes contextRef="c-233" decimals="-6" id="f-1217" unitRef="usd">1510000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-234"
      decimals="INF"
      id="f-1218"
      unitRef="number">0.0304</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:SeniorLongTermNotes contextRef="c-234" decimals="-6" id="f-1219" unitRef="usd">773000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes contextRef="c-235" decimals="-6" id="f-1220" unitRef="usd">774000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-236"
      decimals="INF"
      id="f-1221"
      unitRef="number">0.0444</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:SeniorLongTermNotes contextRef="c-236" decimals="-6" id="f-1222" unitRef="usd">495000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes contextRef="c-237" decimals="-6" id="f-1223" unitRef="usd">495000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-238"
      decimals="INF"
      id="f-1224"
      unitRef="number">0.0512</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:SeniorLongTermNotes contextRef="c-238" decimals="-6" id="f-1225" unitRef="usd">787000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes contextRef="c-239" decimals="-6" id="f-1226" unitRef="usd">787000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-240"
      decimals="INF"
      id="f-1227"
      unitRef="number">0.0321</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:SeniorLongTermNotes contextRef="c-240" decimals="-6" id="f-1228" unitRef="usd">1569000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes contextRef="c-241" decimals="-6" id="f-1229" unitRef="usd">1571000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-242"
      decimals="INF"
      id="f-1230"
      unitRef="number">0.0375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:SeniorNotesCurrent contextRef="c-242" decimals="-6" id="f-1231" unitRef="usd">270000000</us-gaap:SeniorNotesCurrent>
    <us-gaap:SeniorLongTermNotes contextRef="c-243" decimals="-6" id="f-1232" unitRef="usd">625000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-244"
      decimals="INF"
      id="f-1233"
      unitRef="number">0.0583</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:SeniorLongTermNotes contextRef="c-244" decimals="-6" id="f-1234" unitRef="usd">625000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes contextRef="c-245" decimals="-6" id="f-1235" unitRef="usd">625000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:CommercialPaper contextRef="c-11" decimals="-6" id="f-1236" unitRef="usd">0</us-gaap:CommercialPaper>
    <us-gaap:CommercialPaper contextRef="c-12" decimals="-6" id="f-1237" unitRef="usd">187000000</us-gaap:CommercialPaper>
    <us-gaap:LineOfCredit contextRef="c-246" decimals="-6" id="f-1238" unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit contextRef="c-247" decimals="-6" id="f-1239" unitRef="usd">100000000</us-gaap:LineOfCredit>
    <us-gaap:ShortTermBorrowings contextRef="c-248" decimals="-6" id="f-1240" unitRef="usd">3000000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings contextRef="c-249" decimals="-6" id="f-1241" unitRef="usd">6000000</us-gaap:ShortTermBorrowings>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount contextRef="c-11" decimals="-6" id="f-1242" unitRef="usd">10071000000</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount contextRef="c-12" decimals="-6" id="f-1243" unitRef="usd">10970000000</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:LongTermDebtCurrent contextRef="c-11" decimals="-6" id="f-1244" unitRef="usd">885000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent contextRef="c-12" decimals="-6" id="f-1245" unitRef="usd">597000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-11" decimals="-6" id="f-1246" unitRef="usd">9186000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-12" decimals="-6" id="f-1247" unitRef="usd">10373000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-250"
      decimals="5"
      id="f-1248"
      unitRef="number">0.01125</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-251"
      decimals="5"
      id="f-1249"
      unitRef="number">0.01750</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-252"
      decimals="5"
      id="f-1250"
      unitRef="number">0.00125</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-253"
      decimals="5"
      id="f-1251"
      unitRef="number">0.00750</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-254" decimals="-6" id="f-1252" unitRef="usd">1250000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-255" decimals="-6" id="f-1253" unitRef="usd">6250000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentTerm contextRef="c-256" id="f-1254">P2Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm contextRef="c-257" id="f-1255">P30Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-254" decimals="-6" id="f-1256" unitRef="usd">1250000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-258" decimals="-6" id="f-1257" unitRef="usd">625000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-259" decimals="-6" id="f-1258" unitRef="usd">625000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-260"
      decimals="5"
      id="f-1259"
      unitRef="number">0.00750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-261"
      decimals="5"
      id="f-1260"
      unitRef="number">0.02000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-262"
      decimals="5"
      id="f-1261"
      unitRef="number">0.01125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-263"
      decimals="5"
      id="f-1262"
      unitRef="number">0.02375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-264"
      decimals="5"
      id="f-1263"
      unitRef="number">0.00000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-265"
      decimals="5"
      id="f-1264"
      unitRef="number">0.01000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-266"
      decimals="5"
      id="f-1265"
      unitRef="number">0.00125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-267"
      decimals="5"
      id="f-1266"
      unitRef="number">0.01375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-268"
      decimals="4"
      id="f-1267"
      unitRef="number">0.0010</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <iff:DebtInstrumentCovenantMaximumConsolidatedLeverageRatio
      contextRef="c-269"
      decimals="2"
      id="f-1268"
      unitRef="number">5.25</iff:DebtInstrumentCovenantMaximumConsolidatedLeverageRatio>
    <iff:DebtInstrumentCovenantMaximumConsolidatedLeverageRatio
      contextRef="c-270"
      decimals="2"
      id="f-1269"
      unitRef="number">4.75</iff:DebtInstrumentCovenantMaximumConsolidatedLeverageRatio>
    <iff:DebtInstrumentCovenantMaximumConsolidatedLeverageRatio
      contextRef="c-271"
      decimals="2"
      id="f-1270"
      unitRef="number">4.50</iff:DebtInstrumentCovenantMaximumConsolidatedLeverageRatio>
    <iff:DebtInstrumentCovenantMaximumConsolidatedLeverageRatio
      contextRef="c-272"
      decimals="2"
      id="f-1271"
      unitRef="number">4.25</iff:DebtInstrumentCovenantMaximumConsolidatedLeverageRatio>
    <iff:DebtInstrumentCovenantMaximumConsolidatedLeverageRatio
      contextRef="c-273"
      decimals="2"
      id="f-1272"
      unitRef="number">4.00</iff:DebtInstrumentCovenantMaximumConsolidatedLeverageRatio>
    <iff:DebtInstrumentCovenantMaximumConsolidatedLeverageRatio
      contextRef="c-274"
      decimals="2"
      id="f-1273"
      unitRef="number">3.75</iff:DebtInstrumentCovenantMaximumConsolidatedLeverageRatio>
    <iff:CommonStockDividendsPerShareMaximumDividendThresholdPerQuarter
      contextRef="c-275"
      decimals="2"
      id="f-1274"
      unitRef="usdPerShare">0.81</iff:CommonStockDividendsPerShareMaximumDividendThresholdPerQuarter>
    <iff:CommonStockDividendsPerShareMaximumDividendThresholdPerYear
      contextRef="c-275"
      decimals="2"
      id="f-1275"
      unitRef="usdPerShare">3.24</iff:CommonStockDividendsPerShareMaximumDividendThresholdPerYear>
    <iff:DebtInstrumentCovenantLienThresholdAmount contextRef="c-276" decimals="-6" id="f-1276" unitRef="usd">300000000</iff:DebtInstrumentCovenantLienThresholdAmount>
    <iff:DebtInstrumentCovenantLienThresholdPercentageOfConsolidatedNetTangibleAssets
      contextRef="c-276"
      decimals="4"
      id="f-1277"
      unitRef="number">0.0365</iff:DebtInstrumentCovenantLienThresholdPercentageOfConsolidatedNetTangibleAssets>
    <iff:DebtInstrumentCovenantPercentageOfProceedsFromNonOrdinaryAssetsSalesRequiredToBeUsedAsPrepayment
      contextRef="c-276"
      decimals="2"
      id="f-1278"
      unitRef="number">1</iff:DebtInstrumentCovenantPercentageOfProceedsFromNonOrdinaryAssetsSalesRequiredToBeUsedAsPrepayment>
    <iff:DebtInstrumentCovenantBasisSpreadIncreaseOnVariableRate
      contextRef="c-276"
      decimals="5"
      id="f-1279"
      unitRef="number">0.00125</iff:DebtInstrumentCovenantBasisSpreadIncreaseOnVariableRate>
    <us-gaap:RepaymentsOfDebt contextRef="c-277" decimals="-6" id="f-1280" unitRef="usd">355000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-278" decimals="-6" id="f-1281" unitRef="usd">6250000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:SeniorNotesCurrent contextRef="c-279" decimals="-6" id="f-1282" unitRef="usd">300000000</us-gaap:SeniorNotesCurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-279"
      decimals="5"
      id="f-1283"
      unitRef="number">0.00697</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:SeniorLongTermNotes contextRef="c-280" decimals="-6" id="f-1284" unitRef="usd">1000000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-280"
      decimals="5"
      id="f-1285"
      unitRef="number">0.01230</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:SeniorLongTermNotes contextRef="c-281" decimals="-6" id="f-1286" unitRef="usd">1200000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-281"
      decimals="5"
      id="f-1287"
      unitRef="number">0.01832</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:SeniorLongTermNotes contextRef="c-282" decimals="-6" id="f-1288" unitRef="usd">1500000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-282"
      decimals="5"
      id="f-1289"
      unitRef="number">0.02300</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:SeniorLongTermNotes contextRef="c-283" decimals="-6" id="f-1290" unitRef="usd">750000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-283"
      decimals="5"
      id="f-1291"
      unitRef="number">0.03268</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:SeniorLongTermNotes contextRef="c-284" decimals="-6" id="f-1292" unitRef="usd">1500000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-284"
      decimals="5"
      id="f-1293"
      unitRef="number">0.03468</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfDebt contextRef="c-285" decimals="-6" id="f-1294" unitRef="usd">300000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts contextRef="c-286" decimals="-6" id="f-1295" unitRef="usd">1000000</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-287"
      decimals="4"
      id="f-1296"
      unitRef="number">0.0010</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-288"
      decimals="4"
      id="f-1297"
      unitRef="number">0.0010</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <iff:DebtInstrumentCovenantMaximumConsolidatedLeverageRatio
      contextRef="c-289"
      decimals="2"
      id="f-1298"
      unitRef="number">5.25</iff:DebtInstrumentCovenantMaximumConsolidatedLeverageRatio>
    <iff:DebtInstrumentCovenantMaximumConsolidatedLeverageRatio
      contextRef="c-290"
      decimals="2"
      id="f-1299"
      unitRef="number">4.75</iff:DebtInstrumentCovenantMaximumConsolidatedLeverageRatio>
    <iff:DebtInstrumentCovenantMaximumConsolidatedLeverageRatio
      contextRef="c-291"
      decimals="2"
      id="f-1300"
      unitRef="number">4.50</iff:DebtInstrumentCovenantMaximumConsolidatedLeverageRatio>
    <iff:DebtInstrumentCovenantMaximumConsolidatedLeverageRatio
      contextRef="c-292"
      decimals="2"
      id="f-1301"
      unitRef="number">4.25</iff:DebtInstrumentCovenantMaximumConsolidatedLeverageRatio>
    <iff:DebtInstrumentCovenantMaximumConsolidatedLeverageRatio
      contextRef="c-293"
      decimals="2"
      id="f-1302"
      unitRef="number">4.00</iff:DebtInstrumentCovenantMaximumConsolidatedLeverageRatio>
    <iff:DebtInstrumentCovenantMaximumConsolidatedLeverageRatio
      contextRef="c-294"
      decimals="2"
      id="f-1303"
      unitRef="number">3.75</iff:DebtInstrumentCovenantMaximumConsolidatedLeverageRatio>
    <iff:CommonStockDividendsPerShareMaximumDividendThresholdPerQuarter
      contextRef="c-295"
      decimals="2"
      id="f-1304"
      unitRef="usdPerShare">0.81</iff:CommonStockDividendsPerShareMaximumDividendThresholdPerQuarter>
    <iff:CommonStockDividendsPerShareMaximumDividendThresholdPerYear
      contextRef="c-295"
      decimals="2"
      id="f-1305"
      unitRef="usdPerShare">3.24</iff:CommonStockDividendsPerShareMaximumDividendThresholdPerYear>
    <iff:DebtInstrumentCovenantLienThresholdAmount contextRef="c-296" decimals="-6" id="f-1306" unitRef="usd">300000000</iff:DebtInstrumentCovenantLienThresholdAmount>
    <iff:DebtInstrumentCovenantLienThresholdPercentageOfConsolidatedNetTangibleAssets
      contextRef="c-296"
      decimals="4"
      id="f-1307"
      unitRef="number">0.0365</iff:DebtInstrumentCovenantLienThresholdPercentageOfConsolidatedNetTangibleAssets>
    <iff:DebtInstrumentCovenantBasisSpreadIncreaseOnVariableRate
      contextRef="c-296"
      decimals="5"
      id="f-1308"
      unitRef="number">0.00125</iff:DebtInstrumentCovenantBasisSpreadIncreaseOnVariableRate>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-297" decimals="-6" id="f-1309" unitRef="usd">2000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCredit contextRef="c-297" decimals="-6" id="f-1310" unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-298" decimals="-6" id="f-1311" unitRef="usd">1000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-299" decimals="-6" id="f-1312" unitRef="usd">2000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet contextRef="c-300" decimals="-6" id="f-1313" unitRef="usd">2500000000</us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet>
    <us-gaap:ProceedsFromLinesOfCredit contextRef="c-301" decimals="-6" id="f-1314" unitRef="usd">800000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit contextRef="c-301" decimals="-6" id="f-1315" unitRef="usd">900000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit contextRef="c-302" decimals="-6" id="f-1316" unitRef="usd">550000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit contextRef="c-302" decimals="-6" id="f-1317" unitRef="usd">450000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:SeniorLongTermNotes contextRef="c-303" decimals="-6" id="f-1318" unitRef="eur">800000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-303"
      decimals="INF"
      id="f-1319"
      unitRef="number">0.018</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt contextRef="c-304" decimals="-6" id="f-1320" unitRef="eur">794000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-304" decimals="-6" id="f-1321" unitRef="usd">932000000</us-gaap:LongTermDebt>
    <us-gaap:SeniorLongTermNotes contextRef="c-305" decimals="-6" id="f-1322" unitRef="usd">400000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-305"
      decimals="INF"
      id="f-1323"
      unitRef="number">0.0445</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt contextRef="c-306" decimals="-6" id="f-1324" unitRef="usd">397000000</us-gaap:LongTermDebt>
    <us-gaap:SeniorLongTermNotes contextRef="c-307" decimals="-6" id="f-1325" unitRef="usd">800000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-307"
      decimals="INF"
      id="f-1326"
      unitRef="number">0.050</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt contextRef="c-308" decimals="-6" id="f-1327" unitRef="usd">787000000</us-gaap:LongTermDebt>
    <us-gaap:SeniorLongTermNotes contextRef="c-309" decimals="-6" id="f-1328" unitRef="usd">300000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-309"
      decimals="INF"
      id="f-1329"
      unitRef="number">0.0320</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromIssuanceOfDebt contextRef="c-310" decimals="-6" id="f-1330" unitRef="usd">298000000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:RepaymentsOfDebt contextRef="c-311" decimals="-6" id="f-1331" unitRef="usd">300000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:SeniorLongTermNotes contextRef="c-312" decimals="-6" id="f-1332" unitRef="eur">500000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-312"
      decimals="INF"
      id="f-1333"
      unitRef="number">0.0175</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromIssuanceOfDebt contextRef="c-313" decimals="-6" id="f-1334" unitRef="eur">496000000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:GainLossOnOilAndGasHedgingActivity contextRef="c-313" decimals="-6" id="f-1335" unitRef="usd">-3000000</us-gaap:GainLossOnOilAndGasHedgingActivity>
    <us-gaap:DebtInstrumentTerm contextRef="c-313" id="f-1336">P8Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:SeniorLongTermNotes contextRef="c-314" decimals="-6" id="f-1337" unitRef="usd">500000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-314"
      decimals="INF"
      id="f-1338"
      unitRef="number">0.04375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromIssuanceOfDebt contextRef="c-315" decimals="-6" id="f-1339" unitRef="usd">494000000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:OtherDeferredCostsGross contextRef="c-314" decimals="-6" id="f-1340" unitRef="usd">1000000</us-gaap:OtherDeferredCostsGross>
    <us-gaap:GainLossOnOilAndGasHedgingActivity contextRef="c-315" decimals="-6" id="f-1341" unitRef="usd">-5000000</us-gaap:GainLossOnOilAndGasHedgingActivity>
    <us-gaap:ProceedsFromIssuanceOfCommercialPaper contextRef="c-1" decimals="-6" id="f-1342" unitRef="usd">5694000000</us-gaap:ProceedsFromIssuanceOfCommercialPaper>
    <us-gaap:RepaymentsOfCommercialPaper contextRef="c-1" decimals="-6" id="f-1343" unitRef="usd">5881000000</us-gaap:RepaymentsOfCommercialPaper>
    <us-gaap:ProceedsFromIssuanceOfCommercialPaper contextRef="c-9" decimals="-6" id="f-1344" unitRef="usd">6040000000.00</us-gaap:ProceedsFromIssuanceOfCommercialPaper>
    <us-gaap:RepaymentsOfCommercialPaper contextRef="c-9" decimals="-6" id="f-1345" unitRef="usd">6177000000</us-gaap:RepaymentsOfCommercialPaper>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="c-316"
      decimals="INF"
      id="f-1346"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-317"
      decimals="INF"
      id="f-1347"
      unitRef="number">0.0030</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-318"
      decimals="INF"
      id="f-1348"
      unitRef="number">0.0025</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-319"
      decimals="INF"
      id="f-1349"
      unitRef="number">0.0025</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-320"
      decimals="INF"
      id="f-1350"
      unitRef="number">0.0025</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-321"
      decimals="INF"
      id="f-1351"
      unitRef="number">0.0030</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentRedemptionTableTextBlock contextRef="c-1" id="f-1352">The redemption dates of each of the Notes are provided in the below table:&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:51.462%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.606%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Note&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redemption Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024 Euro Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 14, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 Euro Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 25, 2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 26, 2028&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2047 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 1, 2046&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2048 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 26, 2048&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtInstrumentRedemptionTableTextBlock>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="c-322"
      decimals="INF"
      id="f-1353"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-323"
      decimals="INF"
      id="f-1354"
      unitRef="number">0.0015</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-324"
      decimals="INF"
      id="f-1355"
      unitRef="number">0.0025</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-325"
      decimals="INF"
      id="f-1356"
      unitRef="number">0.0025</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-326"
      decimals="INF"
      id="f-1357"
      unitRef="number">0.0030</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-327"
      decimals="INF"
      id="f-1358"
      unitRef="number">0.0030</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentRedemptionTableTextBlock contextRef="c-90" id="f-1359">The redemption dates of each of the N&amp;amp;B Senior Notes are provided in the table below:&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:51.462%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.606%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Note&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redemption Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 1, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 15, 2027&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2030 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 1, 2030&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2040 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 15, 2040&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2050 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 1, 2050&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtInstrumentRedemptionTableTextBlock>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="c-322"
      decimals="INF"
      id="f-1360"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <iff:RepurchasePriceAsPercentageOfPrincipalAmountOfSeniorNotes
      contextRef="c-1"
      decimals="INF"
      id="f-1361"
      unitRef="number">1.01</iff:RepurchasePriceAsPercentageOfPrincipalAmountOfSeniorNotes>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock contextRef="c-1" id="f-1362">&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the contractual maturities of the Company&#x2019;s long-term debt as of December&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:37.225%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.647%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.647%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.647%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.647%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.651%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Payments&#160;Due&#160;by&#160;Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Less than 1 Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1-3 Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3-5 Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;More than&lt;br/&gt;5 Years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Outstanding Borrowings&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebt contextRef="c-11" decimals="-6" id="f-1363" unitRef="usd">9980000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths contextRef="c-11" decimals="-6" id="f-1364" unitRef="usd">885000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturingInYearsTwoAndThree contextRef="c-11" decimals="-6" id="f-1365" unitRef="usd">2445000000</us-gaap:LongTermDebtMaturingInYearsTwoAndThree>
    <us-gaap:LongTermDebtMaturingInYearsFourAndFive contextRef="c-11" decimals="-6" id="f-1366" unitRef="usd">1600000000</us-gaap:LongTermDebtMaturingInYearsFourAndFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive contextRef="c-11" decimals="-6" id="f-1367" unitRef="usd">5050000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:RepaymentsOfDebt contextRef="c-328" decimals="-6" id="f-1368" unitRef="usd">270000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c-1" id="f-1369">INCOME TAXES&lt;div style="margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Earnings before income taxes consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.222%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.640%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. loss before taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,777)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,918)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(493)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign (loss) income before taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(741)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total (loss) income before taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,518)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,625)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The income tax provision consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.222%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.640%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(111)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(288)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(369)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(237)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(236)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Effective Tax Rate Reconciliation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reconciliation between the U.S. federal statutory income tax rate to the actual effective tax rate was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.107%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.769%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.539%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.473%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.539%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.773%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Statutory tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax effect of non-deductible goodwill impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Difference in effective tax rate on foreign earnings and remittances&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax benefit from supply chain optimization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefit, net of reversals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax impact on business divestitures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred taxes on deemed repatriation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Global intangible low-taxed income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign-derived intangible income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. foreign tax credit - general limitation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Establishment (release) of valuation allowance on state deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local taxes including rate changes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax impact on internal asset transfer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________ &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;For 2021, the rate includes rate change impacts related to the Netherlands and United Kingdom.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;For 2022 and 2023, the rate includes the establishment of the held for sale deferred tax liabilities due to a change in assertion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;For 2022 and 2023, the rate includes rate change impacts related to the remeasurement of the state tax rate on deferred taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effective tax rate reflects the recording of the tax effects of the divestitures of the portion of the Savory Solutions business and Flavor Specialty Ingredients business and book to tax differences related to the impairment of goodwill in the Nourish reporting unit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has elected to treat global intangible low-taxed income (&#x201c;GILTI&#x201d;) as a current period cost if and when incurred. This tax position resulted in a net income tax expense of approximately $64 million for the year ended December&#160;31, 2023, offset in part by foreign tax credits of approximately $54 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Deferred Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The deferred tax assets and liabilities consisted of the following amounts:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.692%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee and retiree benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Credit and net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortizable research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest limitation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(239)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,792)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,049)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(151)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred taxes on deemed repatriation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(166)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,356)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,618)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(324)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(262)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,659)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes deferred taxes on intangible assets owned by a fully consolidated partnership.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net operating loss carryforwards were approximately $311 million and $301 million as of December&#160;31, 2023 and 2022, respectively. If unused, approximately $106 million will expire between 2024 and 2043. The remainder, totaling approximately $205 million, may be carried forward indefinitely. Tax credit carryforwards were approximately $21 million and $14 million as of December&#160;31, 2023 and 2022, respectively. If unused, the $21 million will expire between 2024 and 2043.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Of the deferred tax assets at December&#160;31, 2023, the Company considers it unlikely that a portion of the tax benefit will be realized. Accordingly, a valuation allowance of approximately $324 million has been established against these deferred tax assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Uncertain Tax Positions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.222%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.640%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance of unrecognized tax benefits at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross amount of increases in unrecognized tax benefits as a result of positions taken during a prior year&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross amount of decreases in unrecognized tax benefits as a result of positions taken during a prior year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross amount of increases in unrecognized tax benefits as a result of positions taken during the current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;The amounts of decreases in unrecognized benefits relating to settlements with taxing authorities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reduction in unrecognized tax benefits due to the lapse of applicable statute of limitation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance of unrecognized tax benefits at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;For 2021, the amount includes positions related to N&amp;amp;B opening balance sheet amounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023, 2022 and 2021, there were approximately $123 million, $98 million and $130 million, respectively, of unrecognized tax benefits recorded to Other liabilities. There were no amounts recorded to Other current liabilities for 2023. There were approximately $14 million and less than $1 million recorded to Other current liabilities for 2022 and 2021, respectively. If these unrecognized tax benefits were recognized, all the benefits and related interest and penalties would be recorded as a benefit to income tax expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company increased its liabilities for interest and penalties by approximately $12 million, net, for the year ended December&#160;31, 2023. The Company decreased its liabilities for interest and penalties by approximately $1 million, net, and increased its liabilities for interest and penalties by approximately $19 million, net, for the years ended December&#160;31, 2022 and 2021, respectively. As of December&#160;31, 2023, 2022 and 2021, the Company had accrued approximately $47 million, $31 million and $36 million, respectively, of interest and penalties classified as Other liabilities. As of December&#160;31, 2023, the Company had no accruals of interest and penalties classified as Other current liabilities. As of December&#160;31, 2022 and 2021, the Company had accrued approximately $4 million and less than $1 million, respectively, of interest and penalties classified as Other current liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023, the Company&#x2019;s aggregate provision for unrecognized tax benefits, including interest and penalties, was approximately $170 million associated with various tax positions principally asserted in foreign jurisdictions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023, all the unrecognized tax benefits, if recognized, would affect the effective tax rate. The total changes to uncertain tax positions over the next 12 months is impracticable to estimate and is dependent on the resolution of new or existing tax disputes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Tax benefits credited to Shareholders&#x2019; equity were not material for the years ended December 31, 2023, 2022 and 2021 associated with stock option exercises and PRSU dividends.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company regularly repatriates earnings from non-U.S. subsidiaries. As the Company repatriates these funds to the U.S.,&#160;there will be required income taxes payable in certain U.S. states and applicable foreign withholding taxes during the period when such repatriation occurs.&#160;Accordingly, as of&#160;December 31, 2023, the Company had a deferred tax liability of approximately $155 million for the effect of repatriating the funds to the U.S., attributable to various non-U.S. subsidiaries. There is no deferred tax liability associated with non-U.S. subsidiaries where the Company intends to indefinitely reinvest the earnings to fund local operations and/or capital projects.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has ongoing income tax audits and legal proceedings which are at various stages of administrative or judicial review. In addition, the Company has other ongoing tax audits and legal proceedings that relate to indirect taxes, such as value-added taxes, capital tax, sales and use and property taxes, which are discussed in Note 19.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also has several other tax audits in process and has open tax years with various taxing jurisdictions that range primarily from 2010 to 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock contextRef="c-1" id="f-1370">&lt;div style="margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Earnings before income taxes consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.222%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.640%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. loss before taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,777)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,918)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(493)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign (loss) income before taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(741)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total (loss) income before taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,518)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,625)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="c-1" decimals="-6" id="f-1371" unitRef="usd">-1777000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="c-9" decimals="-6" id="f-1372" unitRef="usd">-1918000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="c-10" decimals="-6" id="f-1373" unitRef="usd">-493000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="c-1" decimals="-6" id="f-1374" unitRef="usd">-741000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="c-9" decimals="-6" id="f-1375" unitRef="usd">293000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="c-10" decimals="-6" id="f-1376" unitRef="usd">847000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-6" id="f-1377" unitRef="usd">-2518000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-9" decimals="-6" id="f-1378" unitRef="usd">-1625000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-10" decimals="-6" id="f-1379" unitRef="usd">354000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="c-1" id="f-1380">&lt;div style="margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The income tax provision consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.222%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.640%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(111)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(288)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(369)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(237)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(236)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="c-1" decimals="-6" id="f-1381" unitRef="usd">55000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="c-9" decimals="-6" id="f-1382" unitRef="usd">102000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="c-10" decimals="-6" id="f-1383" unitRef="usd">-5000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="c-1" decimals="-6" id="f-1384" unitRef="usd">0</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="c-9" decimals="-6" id="f-1385" unitRef="usd">49000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="c-10" decimals="-6" id="f-1386" unitRef="usd">13000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit contextRef="c-1" decimals="-6" id="f-1387" unitRef="usd">359000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit contextRef="c-9" decimals="-6" id="f-1388" unitRef="usd">325000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit contextRef="c-10" decimals="-6" id="f-1389" unitRef="usd">303000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-1" decimals="-6" id="f-1390" unitRef="usd">414000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-9" decimals="-6" id="f-1391" unitRef="usd">476000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-10" decimals="-6" id="f-1392" unitRef="usd">311000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="c-1" decimals="-6" id="f-1393" unitRef="usd">-113000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="c-9" decimals="-6" id="f-1394" unitRef="usd">-77000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="c-10" decimals="-6" id="f-1395" unitRef="usd">-121000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="c-1" decimals="-6" id="f-1396" unitRef="usd">32000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="c-9" decimals="-6" id="f-1397" unitRef="usd">-111000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="c-10" decimals="-6" id="f-1398" unitRef="usd">-34000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="c-1" decimals="-6" id="f-1399" unitRef="usd">-288000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="c-9" decimals="-6" id="f-1400" unitRef="usd">-49000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="c-10" decimals="-6" id="f-1401" unitRef="usd">-81000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-1" decimals="-6" id="f-1402" unitRef="usd">-369000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-9" decimals="-6" id="f-1403" unitRef="usd">-237000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-10" decimals="-6" id="f-1404" unitRef="usd">-236000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-6" id="f-1405" unitRef="usd">45000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-9" decimals="-6" id="f-1406" unitRef="usd">239000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-10" decimals="-6" id="f-1407" unitRef="usd">75000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="c-1" id="f-1408">&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reconciliation between the U.S. federal statutory income tax rate to the actual effective tax rate was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.107%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.769%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.539%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.473%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.539%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.773%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Statutory tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax effect of non-deductible goodwill impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Difference in effective tax rate on foreign earnings and remittances&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax benefit from supply chain optimization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefit, net of reversals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax impact on business divestitures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred taxes on deemed repatriation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Global intangible low-taxed income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign-derived intangible income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. foreign tax credit - general limitation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Establishment (release) of valuation allowance on state deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local taxes including rate changes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax impact on internal asset transfer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________ &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;For 2021, the rate includes rate change impacts related to the Netherlands and United Kingdom.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;For 2022 and 2023, the rate includes the establishment of the held for sale deferred tax liabilities due to a change in assertion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;For 2022 and 2023, the rate includes rate change impacts related to the remeasurement of the state tax rate on deferred taxes.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c-1" decimals="3" id="f-1409" unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c-9" decimals="3" id="f-1410" unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c-10" decimals="3" id="f-1411" unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses contextRef="c-1" decimals="3" id="f-1412" unitRef="number">-0.204</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses contextRef="c-9" decimals="3" id="f-1413" unitRef="number">-0.291</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses contextRef="c-10" decimals="3" id="f-1414" unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses>
    <us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings contextRef="c-1" decimals="3" id="f-1415" unitRef="number">-0.002</us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings>
    <us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings contextRef="c-9" decimals="3" id="f-1416" unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings>
    <us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings contextRef="c-10" decimals="3" id="f-1417" unitRef="number">0.080</us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings>
    <iff:EffectiveIncomeTaxRateReconciliationTaxBenefitFromSupplyChainOptimizationPercent contextRef="c-1" decimals="3" id="f-1418" unitRef="number">0.005</iff:EffectiveIncomeTaxRateReconciliationTaxBenefitFromSupplyChainOptimizationPercent>
    <iff:EffectiveIncomeTaxRateReconciliationTaxBenefitFromSupplyChainOptimizationPercent contextRef="c-9" decimals="3" id="f-1419" unitRef="number">0.008</iff:EffectiveIncomeTaxRateReconciliationTaxBenefitFromSupplyChainOptimizationPercent>
    <iff:EffectiveIncomeTaxRateReconciliationTaxBenefitFromSupplyChainOptimizationPercent contextRef="c-10" decimals="3" id="f-1420" unitRef="number">-0.058</iff:EffectiveIncomeTaxRateReconciliationTaxBenefitFromSupplyChainOptimizationPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxExemptIncome contextRef="c-1" decimals="3" id="f-1421" unitRef="number">-0.008</us-gaap:EffectiveIncomeTaxRateReconciliationTaxExemptIncome>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxExemptIncome contextRef="c-9" decimals="3" id="f-1422" unitRef="number">0.009</us-gaap:EffectiveIncomeTaxRateReconciliationTaxExemptIncome>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxExemptIncome contextRef="c-10" decimals="3" id="f-1423" unitRef="number">0.007</us-gaap:EffectiveIncomeTaxRateReconciliationTaxExemptIncome>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness contextRef="c-1" decimals="3" id="f-1424" unitRef="number">-0.037</us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness contextRef="c-9" decimals="3" id="f-1425" unitRef="number">-0.059</us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness contextRef="c-10" decimals="3" id="f-1426" unitRef="number">0.040</us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness>
    <iff:EffectiveIncomeTaxRateReconciliationDeferredTaxesonDeemedRepatriationPercent contextRef="c-1" decimals="3" id="f-1427" unitRef="number">0.005</iff:EffectiveIncomeTaxRateReconciliationDeferredTaxesonDeemedRepatriationPercent>
    <iff:EffectiveIncomeTaxRateReconciliationDeferredTaxesonDeemedRepatriationPercent contextRef="c-9" decimals="3" id="f-1428" unitRef="number">-0.056</iff:EffectiveIncomeTaxRateReconciliationDeferredTaxesonDeemedRepatriationPercent>
    <iff:EffectiveIncomeTaxRateReconciliationDeferredTaxesonDeemedRepatriationPercent contextRef="c-10" decimals="3" id="f-1429" unitRef="number">0.027</iff:EffectiveIncomeTaxRateReconciliationDeferredTaxesonDeemedRepatriationPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationGiltiPercent contextRef="c-1" decimals="3" id="f-1430" unitRef="number">0.004</us-gaap:EffectiveIncomeTaxRateReconciliationGiltiPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationGiltiPercent contextRef="c-9" decimals="3" id="f-1431" unitRef="number">0.008</us-gaap:EffectiveIncomeTaxRateReconciliationGiltiPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationGiltiPercent contextRef="c-10" decimals="3" id="f-1432" unitRef="number">0.041</us-gaap:EffectiveIncomeTaxRateReconciliationGiltiPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationFdiiPercent contextRef="c-1" decimals="3" id="f-1433" unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationFdiiPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationFdiiPercent contextRef="c-9" decimals="3" id="f-1434" unitRef="number">0.011</us-gaap:EffectiveIncomeTaxRateReconciliationFdiiPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationFdiiPercent contextRef="c-10" decimals="3" id="f-1435" unitRef="number">0.016</us-gaap:EffectiveIncomeTaxRateReconciliationFdiiPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign contextRef="c-1" decimals="3" id="f-1436" unitRef="number">-0.002</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign contextRef="c-9" decimals="3" id="f-1437" unitRef="number">-0.001</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign contextRef="c-10" decimals="3" id="f-1438" unitRef="number">0.031</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch contextRef="c-1" decimals="3" id="f-1439" unitRef="number">-0.005</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch contextRef="c-9" decimals="3" id="f-1440" unitRef="number">-0.008</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch contextRef="c-10" decimals="3" id="f-1441" unitRef="number">0.014</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <iff:EffectiveIncomeTaxRateReconciliationAcquisitionCostsPercent contextRef="c-1" decimals="3" id="f-1442" unitRef="number">0</iff:EffectiveIncomeTaxRateReconciliationAcquisitionCostsPercent>
    <iff:EffectiveIncomeTaxRateReconciliationAcquisitionCostsPercent contextRef="c-9" decimals="3" id="f-1443" unitRef="number">0</iff:EffectiveIncomeTaxRateReconciliationAcquisitionCostsPercent>
    <iff:EffectiveIncomeTaxRateReconciliationAcquisitionCostsPercent contextRef="c-10" decimals="3" id="f-1444" unitRef="number">0.024</iff:EffectiveIncomeTaxRateReconciliationAcquisitionCostsPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-1" decimals="3" id="f-1445" unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-9" decimals="3" id="f-1446" unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-10" decimals="3" id="f-1447" unitRef="number">-0.030</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="c-1" decimals="3" id="f-1448" unitRef="number">-0.017</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="c-9" decimals="3" id="f-1449" unitRef="number">0.043</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="c-10" decimals="3" id="f-1450" unitRef="number">-0.048</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <iff:EffectiveIncomeTaxRateReconciliationTaxImpactOnInternalAssetTransferPercent contextRef="c-1" decimals="3" id="f-1451" unitRef="number">0.053</iff:EffectiveIncomeTaxRateReconciliationTaxImpactOnInternalAssetTransferPercent>
    <iff:EffectiveIncomeTaxRateReconciliationTaxImpactOnInternalAssetTransferPercent contextRef="c-9" decimals="3" id="f-1452" unitRef="number">0</iff:EffectiveIncomeTaxRateReconciliationTaxImpactOnInternalAssetTransferPercent>
    <iff:EffectiveIncomeTaxRateReconciliationTaxImpactOnInternalAssetTransferPercent contextRef="c-10" decimals="3" id="f-1453" unitRef="number">0</iff:EffectiveIncomeTaxRateReconciliationTaxImpactOnInternalAssetTransferPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="c-1" decimals="3" id="f-1454" unitRef="number">-0.026</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="c-9" decimals="3" id="f-1455" unitRef="number">-0.023</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="c-10" decimals="3" id="f-1456" unitRef="number">-0.020</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-1" decimals="3" id="f-1457" unitRef="number">-0.018</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-9" decimals="3" id="f-1458" unitRef="number">-0.147</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-10" decimals="3" id="f-1459" unitRef="number">0.212</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateReconciliationGiltiAmount contextRef="c-1" decimals="-6" id="f-1460" unitRef="usd">64000000</us-gaap:EffectiveIncomeTaxRateReconciliationGiltiAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationFdiiAmount contextRef="c-1" decimals="-6" id="f-1461" unitRef="usd">54000000</us-gaap:EffectiveIncomeTaxRateReconciliationFdiiAmount>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="c-1" id="f-1462">&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The deferred tax assets and liabilities consisted of the following amounts:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.692%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee and retiree benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Credit and net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortizable research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest limitation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(239)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,792)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,049)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(151)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred taxes on deemed repatriation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(166)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,356)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,618)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(324)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(262)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,659)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits contextRef="c-11" decimals="-6" id="f-1463" unitRef="usd">118000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits contextRef="c-12" decimals="-6" id="f-1464" unitRef="usd">61000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits>
    <us-gaap:OperatingLossCarryforwards contextRef="c-11" decimals="-6" id="f-1465" unitRef="usd">332000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-12" decimals="-6" id="f-1466" unitRef="usd">315000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment contextRef="c-11" decimals="-6" id="f-1467" unitRef="usd">125000000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment contextRef="c-12" decimals="-6" id="f-1468" unitRef="usd">84000000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <iff:DeferredTaxAssetsInterestLimitations contextRef="c-11" decimals="-6" id="f-1469" unitRef="usd">127000000</iff:DeferredTaxAssetsInterestLimitations>
    <iff:DeferredTaxAssetsInterestLimitations contextRef="c-12" decimals="-6" id="f-1470" unitRef="usd">3000000</iff:DeferredTaxAssetsInterestLimitations>
    <us-gaap:DeferredTaxAssetsInventory contextRef="c-11" decimals="-6" id="f-1471" unitRef="usd">35000000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsInventory contextRef="c-12" decimals="-6" id="f-1472" unitRef="usd">19000000</us-gaap:DeferredTaxAssetsInventory>
    <iff:DeferredTaxAssetsLeaseObligations contextRef="c-11" decimals="-6" id="f-1473" unitRef="usd">170000000</iff:DeferredTaxAssetsLeaseObligations>
    <iff:DeferredTaxAssetsLeaseObligations contextRef="c-12" decimals="-6" id="f-1474" unitRef="usd">151000000</iff:DeferredTaxAssetsLeaseObligations>
    <us-gaap:DeferredTaxAssetsOther contextRef="c-11" decimals="-6" id="f-1475" unitRef="usd">114000000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther contextRef="c-12" decimals="-6" id="f-1476" unitRef="usd">131000000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross contextRef="c-11" decimals="-6" id="f-1477" unitRef="usd">1021000000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="c-12" decimals="-6" id="f-1478" unitRef="usd">764000000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment contextRef="c-11" decimals="-6" id="f-1479" unitRef="usd">239000000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment contextRef="c-12" decimals="-6" id="f-1480" unitRef="usd">229000000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets contextRef="c-11" decimals="-6" id="f-1481" unitRef="usd">1792000000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets contextRef="c-12" decimals="-6" id="f-1482" unitRef="usd">2049000000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <iff:DeferredTaxLiabilitiesRightOfUseAssets contextRef="c-11" decimals="-6" id="f-1483" unitRef="usd">170000000</iff:DeferredTaxLiabilitiesRightOfUseAssets>
    <iff:DeferredTaxLiabilitiesRightOfUseAssets contextRef="c-12" decimals="-6" id="f-1484" unitRef="usd">151000000</iff:DeferredTaxLiabilitiesRightOfUseAssets>
    <iff:DeferredTaxLiabilitiesGainLossOnForeignCurrencyTranslation contextRef="c-11" decimals="-6" id="f-1485" unitRef="usd">0</iff:DeferredTaxLiabilitiesGainLossOnForeignCurrencyTranslation>
    <iff:DeferredTaxLiabilitiesGainLossOnForeignCurrencyTranslation contextRef="c-12" decimals="-6" id="f-1486" unitRef="usd">23000000</iff:DeferredTaxLiabilitiesGainLossOnForeignCurrencyTranslation>
    <iff:DeferredTaxLiabilitiesDeemedRepatriation contextRef="c-11" decimals="-6" id="f-1487" unitRef="usd">155000000</iff:DeferredTaxLiabilitiesDeemedRepatriation>
    <iff:DeferredTaxLiabilitiesDeemedRepatriation contextRef="c-12" decimals="-6" id="f-1488" unitRef="usd">166000000</iff:DeferredTaxLiabilitiesDeemedRepatriation>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="c-11" decimals="-6" id="f-1489" unitRef="usd">2356000000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="c-12" decimals="-6" id="f-1490" unitRef="usd">2618000000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-11" decimals="-6" id="f-1491" unitRef="usd">324000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-12" decimals="-6" id="f-1492" unitRef="usd">262000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxLiabilities contextRef="c-11" decimals="-6" id="f-1493" unitRef="usd">1659000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities contextRef="c-12" decimals="-6" id="f-1494" unitRef="usd">2116000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:OperatingLossCarryforwards contextRef="c-329" decimals="-6" id="f-1495" unitRef="usd">311000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-330" decimals="-6" id="f-1496" unitRef="usd">301000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration contextRef="c-329" decimals="-6" id="f-1497" unitRef="usd">106000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:OperatingLossCarryforwards contextRef="c-331" decimals="-6" id="f-1498" unitRef="usd">205000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:TaxCreditCarryforwardAmount contextRef="c-329" decimals="-6" id="f-1499" unitRef="usd">21000000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount contextRef="c-330" decimals="-6" id="f-1500" unitRef="usd">14000000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount contextRef="c-329" decimals="-6" id="f-1501" unitRef="usd">21000000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:OperatingLossCarryforwardsValuationAllowance contextRef="c-11" decimals="-6" id="f-1502" unitRef="usd">324000000</us-gaap:OperatingLossCarryforwardsValuationAllowance>
    <us-gaap:SummaryOfIncomeTaxContingenciesTextBlock contextRef="c-1" id="f-1503">&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.222%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.640%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance of unrecognized tax benefits at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross amount of increases in unrecognized tax benefits as a result of positions taken during a prior year&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross amount of decreases in unrecognized tax benefits as a result of positions taken during a prior year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross amount of increases in unrecognized tax benefits as a result of positions taken during the current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;The amounts of decreases in unrecognized benefits relating to settlements with taxing authorities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reduction in unrecognized tax benefits due to the lapse of applicable statute of limitation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance of unrecognized tax benefits at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;For 2021, the amount includes positions related to N&amp;amp;B opening balance sheet amounts.&lt;/span&gt;&lt;/div&gt;</us-gaap:SummaryOfIncomeTaxContingenciesTextBlock>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-12" decimals="-6" id="f-1504" unitRef="usd">112000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-13" decimals="-6" id="f-1505" unitRef="usd">130000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-14" decimals="-6" id="f-1506" unitRef="usd">99000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions contextRef="c-1" decimals="-6" id="f-1507" unitRef="usd">1000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions contextRef="c-9" decimals="-6" id="f-1508" unitRef="usd">1000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions contextRef="c-10" decimals="-6" id="f-1509" unitRef="usd">42000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions contextRef="c-1" decimals="-6" id="f-1510" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions contextRef="c-9" decimals="-6" id="f-1511" unitRef="usd">18000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions contextRef="c-10" decimals="-6" id="f-1512" unitRef="usd">3000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions contextRef="c-1" decimals="-6" id="f-1513" unitRef="usd">19000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions contextRef="c-9" decimals="-6" id="f-1514" unitRef="usd">31000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions contextRef="c-10" decimals="-6" id="f-1515" unitRef="usd">5000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities contextRef="c-1" decimals="-6" id="f-1516" unitRef="usd">3000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities contextRef="c-9" decimals="-6" id="f-1517" unitRef="usd">27000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities contextRef="c-10" decimals="-6" id="f-1518" unitRef="usd">1000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations contextRef="c-1" decimals="-6" id="f-1519" unitRef="usd">6000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations contextRef="c-9" decimals="-6" id="f-1520" unitRef="usd">5000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations contextRef="c-10" decimals="-6" id="f-1521" unitRef="usd">12000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-11" decimals="-6" id="f-1522" unitRef="usd">123000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-12" decimals="-6" id="f-1523" unitRef="usd">112000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-13" decimals="-6" id="f-1524" unitRef="usd">130000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate contextRef="c-332" decimals="-6" id="f-1525" unitRef="usd">123000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate contextRef="c-333" decimals="-6" id="f-1526" unitRef="usd">98000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate contextRef="c-334" decimals="-6" id="f-1527" unitRef="usd">130000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate contextRef="c-335" decimals="-6" id="f-1528" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate contextRef="c-336" decimals="-6" id="f-1529" unitRef="usd">14000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate contextRef="c-337" decimals="-6" id="f-1530" unitRef="usd">1000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <iff:AccruedInterestOrPenaltiesRelatedToTaxAmounts contextRef="c-11" decimals="-6" id="f-1531" unitRef="usd">12000000</iff:AccruedInterestOrPenaltiesRelatedToTaxAmounts>
    <iff:AccruedInterestOrPenaltiesRelatedToTaxAmounts contextRef="c-12" decimals="-6" id="f-1532" unitRef="usd">1000000</iff:AccruedInterestOrPenaltiesRelatedToTaxAmounts>
    <iff:AccruedInterestOrPenaltiesRelatedToTaxAmounts contextRef="c-13" decimals="-6" id="f-1533" unitRef="usd">19000000</iff:AccruedInterestOrPenaltiesRelatedToTaxAmounts>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued contextRef="c-338" decimals="-6" id="f-1534" unitRef="usd">47000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued contextRef="c-339" decimals="-6" id="f-1535" unitRef="usd">31000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued contextRef="c-340" decimals="-6" id="f-1536" unitRef="usd">36000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued contextRef="c-341" decimals="-6" id="f-1537" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued contextRef="c-342" decimals="-6" id="f-1538" unitRef="usd">4000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued contextRef="c-343" decimals="-6" id="f-1539" unitRef="usd">1000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <iff:UnrecognizedTaxBenefitsIncludingInterestAndPenalties contextRef="c-11" decimals="-6" id="f-1540" unitRef="usd">170000000</iff:UnrecognizedTaxBenefitsIncludingInterestAndPenalties>
    <iff:DeferredTaxLiabilitiesDeemedRepatriation contextRef="c-344" decimals="-6" id="f-1541" unitRef="usd">155000000</iff:DeferredTaxLiabilitiesDeemedRepatriation>
    <iff:DeferredTaxLiabilitiesDeemedRepatriation contextRef="c-345" decimals="-6" id="f-1542" unitRef="usd">0</iff:DeferredTaxLiabilitiesDeemedRepatriation>
    <us-gaap:EarningsPerShareTextBlock contextRef="c-1" id="f-1543">NET (LOSS) INCOME PER SHARE&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic and diluted net (loss) income per share is based on the weighted average number of shares outstanding. A reconciliation of shares used in the computation of basic and diluted net (loss) income per share is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:53.512%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.541%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.541%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.542%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(AMOUNTS IN MILLIONS EXCEPT PER SHARE AMOUNTS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net (Loss) Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (loss) income attributable to IFF shareholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,567)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,871)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustment related to decrease (increase) in redemption value of redeemable non-controlling interests in excess of earnings allocated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (loss) income available to IFF shareholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,565)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,868)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding (basic)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares assuming dilution (diluted)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net (Loss) Income per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (loss) income per share - basic&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.05)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (loss) income per share - diluted&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.05)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;On September 15, 2021, additional shares of IFF&#x2019;s common stock were issued in settlement of the SPC portion of the TEUs. See below for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;For the years ended December&#160;31, 2023, 2022 and 2021, the basic net (loss) income per share cannot be recalculated based on the information presented in the table above due to the effects of rounding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;For the years ended December&#160;31, 2023 and 2022, the diluted net loss per share cannot be recalculated based on the information presented in the table above due to the effects of rounding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of the effective time of the Merger, each issued and outstanding share of common stock of N&amp;amp;B (except for shares of common stock of N&amp;amp;B held by N&amp;amp;B as treasury stock or by DuPont, which were canceled and ceased to exist and no consideration was delivered in exchange therefor) was converted into the right to receive one share of common stock of IFF. The Merger was completed in exchange for 141,740,461 shares of IFF common stock, par value $0.125 per share (or cash payment in lieu of fractional shares), which had been approved in the special shareholder meeting that occurred on August 27, 2020 where IFF shareholders voted to approve the issuance of shares of IFF common stock in connection with the N&amp;amp;B Transaction, pursuant to the Merger Agreement. The shares issued in the Merger represented approximately 55.4% of the common stock of IFF on a fully diluted basis, after giving effect to the Merger, as of February 1, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company issued&#160;16,500,000&#160;TEUs, consisting of a prepaid SPC and a senior amortizing note, for net proceeds of&#160;approximately $800 million on September 17, 2018. On September 14, 2021, the Company notified holders of the TEUs that the final settlement rate in respect of each SPC was 0.330911 shares of IFF&#x2019;s common stock. On September 15, 2021, 5,460,031 shares of IFF's common stock were issued in settlement of the SPCs. The SPC conversion factor is based on the volume-weighted average price (&#x201c;VWAP&#x201d;) per share of the Company&#x2019;s common stock. For purposes of calculating basic net income per share, the settlement rate of 0.330911 shares per SPC, the final settlement rate, was used on December 31, 2021. For purposes of calculating diluted net income per share, the settlement rate of 0.330911 shares per SPC, the final settlement rate, was used on December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has issued shares of Purchased Restricted Stock Units (&#x201c;PRSUs&#x201d;) which contain non-forfeitable rights to dividends and thus are considered participating securities which are required to be included in the computation of basic and diluted earnings per share pursuant to the two-class method. The two-class method was not presented since there was no difference between basic net (loss) income per share for both common shareholders and PRSU holders for the years ended December 31, 2023, 2022 and 2021, and there was no difference between diluted net loss per share for both common shareholders and PRSU holders for the years ended December&#160;31, 2023 and 2022. The difference between diluted net income per share for both common shareholders and PRSU holders was less than $0.01 per share for the year ended December 31, 2021. In addition, for each year, the number of PRSUs outstanding as of December&#160;31, 2023, 2022 and 2021 was not material. Net loss allocated to such PRSUs during 2023 and 2022 was not material and net income allocated to such PRSUs during 2021 was not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were approximately 0.2&#160;million and 0.3&#160;million potentially dilutive securities excluded from the computation of diluted net loss per share for the years ended December&#160;31, 2023 and 2022, respectively, because there was a net loss attributable to IFF for the periods and, as such, the inclusion of these securities would have been anti-dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December&#160;31, 2023 and 2022, there were approximately 0.4&#160;million and 0.3&#160;million share equivalents that had an anti-dilutive effect and therefore were excluded from the computation of diluted net loss per share. There were no share equivalents excluded from the computation of diluted net income per share for the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock contextRef="c-1" id="f-1544">&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic and diluted net (loss) income per share is based on the weighted average number of shares outstanding. A reconciliation of shares used in the computation of basic and diluted net (loss) income per share is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:53.512%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.541%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.541%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.542%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(AMOUNTS IN MILLIONS EXCEPT PER SHARE AMOUNTS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net (Loss) Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (loss) income attributable to IFF shareholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,567)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,871)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustment related to decrease (increase) in redemption value of redeemable non-controlling interests in excess of earnings allocated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (loss) income available to IFF shareholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,565)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,868)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding (basic)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares assuming dilution (diluted)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net (Loss) Income per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (loss) income per share - basic&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.05)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (loss) income per share - diluted&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.05)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;On September 15, 2021, additional shares of IFF&#x2019;s common stock were issued in settlement of the SPC portion of the TEUs. See below for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;For the years ended December&#160;31, 2023, 2022 and 2021, the basic net (loss) income per share cannot be recalculated based on the information presented in the table above due to the effects of rounding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;For the years ended December&#160;31, 2023 and 2022, the diluted net loss per share cannot be recalculated based on the information presented in the table above due to the effects of rounding.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-1" decimals="-6" id="f-1545" unitRef="usd">-2567000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-9" decimals="-6" id="f-1546" unitRef="usd">-1871000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-10" decimals="-6" id="f-1547" unitRef="usd">270000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <iff:IncreaseDecreaseInRedemptionValueRedeemableNoncontrollingInterest contextRef="c-1" decimals="-6" id="f-1548" unitRef="usd">-2000000</iff:IncreaseDecreaseInRedemptionValueRedeemableNoncontrollingInterest>
    <iff:IncreaseDecreaseInRedemptionValueRedeemableNoncontrollingInterest contextRef="c-9" decimals="-6" id="f-1549" unitRef="usd">-3000000</iff:IncreaseDecreaseInRedemptionValueRedeemableNoncontrollingInterest>
    <iff:IncreaseDecreaseInRedemptionValueRedeemableNoncontrollingInterest contextRef="c-10" decimals="-6" id="f-1550" unitRef="usd">2000000</iff:IncreaseDecreaseInRedemptionValueRedeemableNoncontrollingInterest>
    <iff:NetIncomeLossAvailableToCommonStockholdersAdjustment contextRef="c-1" decimals="-6" id="f-1551" unitRef="usd">-2565000000</iff:NetIncomeLossAvailableToCommonStockholdersAdjustment>
    <iff:NetIncomeLossAvailableToCommonStockholdersAdjustment contextRef="c-9" decimals="-6" id="f-1552" unitRef="usd">-1868000000</iff:NetIncomeLossAvailableToCommonStockholdersAdjustment>
    <iff:NetIncomeLossAvailableToCommonStockholdersAdjustment contextRef="c-10" decimals="-6" id="f-1553" unitRef="usd">268000000</iff:NetIncomeLossAvailableToCommonStockholdersAdjustment>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-6" id="f-1554" unitRef="shares">255000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-9" decimals="-6" id="f-1555" unitRef="shares">255000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c-10"
      decimals="-6"
      id="f-1556"
      unitRef="shares">243000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="-6" id="f-1557" unitRef="shares">255000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-9" decimals="-6" id="f-1558" unitRef="shares">255000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c-10"
      decimals="-6"
      id="f-1559"
      unitRef="shares">243000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-1560"
      unitRef="usdPerShare">-10.05</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-9"
      decimals="2"
      id="f-1561"
      unitRef="usdPerShare">-7.32</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-10"
      decimals="2"
      id="f-1562"
      unitRef="usdPerShare">1.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-1563"
      unitRef="usdPerShare">-10.05</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-9"
      decimals="2"
      id="f-1564"
      unitRef="usdPerShare">-7.32</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-10"
      decimals="2"
      id="f-1565"
      unitRef="usdPerShare">1.10</us-gaap:EarningsPerShareDiluted>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="c-161"
      decimals="INF"
      id="f-1566"
      unitRef="shares">141740461</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-169"
      decimals="3"
      id="f-1567"
      unitRef="usdPerShare">0.125</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c-163"
      decimals="3"
      id="f-1568"
      unitRef="number">0.554</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <iff:TangibleEquityUnitsIssued
      contextRef="c-346"
      decimals="0"
      id="f-1569"
      unitRef="shares">16500000</iff:TangibleEquityUnitsIssued>
    <iff:TangibleEquityUnitsProceeds contextRef="c-346" decimals="-6" id="f-1570" unitRef="usd">800000000</iff:TangibleEquityUnitsProceeds>
    <iff:TangibleEquityUnitsFinalSettlementRate
      contextRef="c-347"
      decimals="6"
      id="f-1571"
      unitRef="usdPerShare">0.330911</iff:TangibleEquityUnitsFinalSettlementRate>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="c-348"
      decimals="INF"
      id="f-1572"
      unitRef="shares">5460031</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <iff:TangibleEquityUnitsPriceforSharesBasic
      contextRef="c-10"
      decimals="6"
      id="f-1573"
      unitRef="usdPerShare">0.330911</iff:TangibleEquityUnitsPriceforSharesBasic>
    <iff:TangibleEquityUnitsPriceforSharesDiluted
      contextRef="c-10"
      decimals="6"
      id="f-1574"
      unitRef="usdPerShare">0.330911</iff:TangibleEquityUnitsPriceforSharesDiluted>
    <iff:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenBasicNetIncomeLossPerShare
      contextRef="c-1"
      decimals="INF"
      id="f-1575"
      unitRef="usdPerShare">0</iff:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenBasicNetIncomeLossPerShare>
    <iff:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenBasicNetIncomeLossPerShare
      contextRef="c-9"
      decimals="INF"
      id="f-1576"
      unitRef="usdPerShare">0</iff:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenBasicNetIncomeLossPerShare>
    <iff:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenBasicNetIncomeLossPerShare
      contextRef="c-10"
      decimals="INF"
      id="f-1577"
      unitRef="usdPerShare">0</iff:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenBasicNetIncomeLossPerShare>
    <iff:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenDilutedNetIncomeLossPerShare
      contextRef="c-1"
      decimals="INF"
      id="f-1578"
      unitRef="usdPerShare">0</iff:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenDilutedNetIncomeLossPerShare>
    <iff:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenDilutedNetIncomeLossPerShare
      contextRef="c-9"
      decimals="INF"
      id="f-1579"
      unitRef="usdPerShare">0</iff:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenDilutedNetIncomeLossPerShare>
    <iff:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenDilutedNetIncomeLossPerShare
      contextRef="c-10"
      decimals="INF"
      id="f-1580"
      unitRef="usdPerShare">0.01</iff:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDifferenceBetweenDilutedNetIncomeLossPerShare>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-1"
      decimals="INF"
      id="f-1581"
      unitRef="shares">200000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-9"
      decimals="INF"
      id="f-1582"
      unitRef="shares">300000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-349"
      decimals="INF"
      id="f-1583"
      unitRef="shares">400000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-350"
      decimals="INF"
      id="f-1584"
      unitRef="shares">300000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-351"
      decimals="INF"
      id="f-1585"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c-1" id="f-1586">SHAREHOLDERS&#x2019; EQUITY &lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Dividends&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash dividends declared per share were $3.24, $3.20 and $3.12 for the years ended December 31, 2023, 2022 and 2021, respectively. The Consolidated Balance Sheets reflect $207 million of dividends payable at December&#160;31, 2023. This amount relates to a cash dividend of $0.81 per share declared in December 2023 and paid in January 2024. Dividends declared, but not paid as of December&#160;31, 2022 and December&#160;31, 2021 were $206 million ($0.81 per share) and $201 million ($0.79 per share), respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-1"
      decimals="INF"
      id="f-1587"
      unitRef="usdPerShare">3.24</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-9"
      decimals="INF"
      id="f-1588"
      unitRef="usdPerShare">3.20</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-10"
      decimals="INF"
      id="f-1589"
      unitRef="usdPerShare">3.12</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsPayableCurrent contextRef="c-11" decimals="-6" id="f-1590" unitRef="usd">207000000</us-gaap:DividendsPayableCurrent>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="c-11"
      decimals="INF"
      id="f-1591"
      unitRef="usdPerShare">0.81</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:DividendsPayableCurrent contextRef="c-12" decimals="-6" id="f-1592" unitRef="usd">206000000</us-gaap:DividendsPayableCurrent>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="c-12"
      decimals="INF"
      id="f-1593"
      unitRef="usdPerShare">0.81</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:DividendsPayableCurrent contextRef="c-13" decimals="-6" id="f-1594" unitRef="usd">201000000</us-gaap:DividendsPayableCurrent>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="c-13"
      decimals="INF"
      id="f-1595"
      unitRef="usdPerShare">0.79</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c-1" id="f-1596">STOCK COMPENSATION PLANS&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has various equity plans under which its officers, senior management, other key employees and Board of Directors may be granted options to purchase IFF common stock or other forms of stock-based awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The cost of all employee stock-based awards are principally recognized on a straight-line attribution basis over their respective vesting periods, net of estimated forfeitures. Total stock-based compensation expense included in the Consolidated Statements of (Loss) Income and Comprehensive Loss was as follows:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.222%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.640%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity-based awards&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability-based awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The shareholders of the Company approved the Company&#x2019;s 2021 Stock Award and Incentive Plan (the &#x201c;2021 Plan&#x201d;) on May 5, 2021.&#160;The 2021 Plan replaced the Company&#x2019;s 2015 Stock Award and Incentive Plan (the &#x201c;2015 Plan&#x201d;) and the Company&#x2019;s 2010 Stock Award and Incentive Plan (the &#x201c;2010 Plan&#x201d;), and provides the source for future deferrals of cash into deferred stock under the Company&#x2019;s Deferred Compensation Plan (with the Deferred Compensation Plan being deemed a subplan under the 2010 Plan for the sole purpose of funding deferrals under the IFF Share Fund).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the 2021 Plan, a total of 2,290,000 shares were authorized for issuance. As of December&#160;31, 2023, 1,817,519 shares were subject to outstanding awards and 748,082 shares remained available for future awards under all of the Company&#x2019;s equity award plans, including the 2015 Plan and 2010 Plan (excluding shares not yet issued under open cycles of the Company&#x2019;s Long-Term Incentive Plan).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company offers a Long-Term Incentive Plan (&#x201c;LTIP&#x201d;) for senior management. The targeted payout is principally 50% cash and 50% IFF common stock at the end of the three-year cycle. Beginning 2023, the targeted payout for all new cycles is 100% IFF common stock at the end of the three-year cycle.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the 2021-2023 cycle, the LTIP awards are earned based on the achievement of: (i) an annual Leverage Ratio for 2021, 2022 and 2023 (representing one-half of the award value) and (ii) Relative TSR targets (representing one-half of the award value). For the 2022-2024 and 2023-2025 cycles, the LTIP awards are earned based on the achievement of: (i) 3-year cumulative Return on Invested Capital (&#x201c;ROIC&#x201d;) (representing one-half of the award value) and (ii) Relative TSR targets (representing one-half of the award value).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Leverage Ratio measures Net debt as compared to a measure profitability. The ROIC measures adjusted net operating profit after tax against average invested capital. When the award is granted, 50% of the target dollar value of the award is converted to a number of &#x201c;notional&#x201d; shares based on the closing price at the beginning of the cycle. For those shares whose payout is based on Relative TSR, compensation expense is recognized using a graded-vesting attribution method, while compensation expense for the remainder of the performance shares (Leverage Ratio or ROIC targets for the applicable cycle) is recognized on a straight-line basis over the vesting period based on the probable outcome of the performance condition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2019-2021 cycle concluded at the end of 2021 and no shares of common stock were issued in March 2022. The 2020-2022 cycle concluded at the end of 2022 and no shares of common stock were issued in March 2023. The 2021-2023 cycle concluded at the end of 2023 and 5,333 shares of common stock will be issued in March 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2006, the Board of Directors approved the Equity Choice Program (the &#x201c;Program&#x201d;) for senior management. This program continued under the 2021 Plan. Eligible employees were allowed to choose from among three equity alternatives and were granted such equity awards up to certain dollar awards depending on the participant&#x2019;s employment grade level. A participant was able to choose among (1)&#160;Stock-Settled Appreciation Rights (&#x201c;SSARs&#x201d;), (2)&#160;Restricted Stock Units (&#x201c;RSUs&#x201d;) or (3)&#160;PRSUs. Beginning 2023, the Company no longer offers the choice from among three equity alternatives and all eligible employees are granted RSUs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Transaction with Nutrition and Biosciences, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the Merger, N&amp;amp;B employees&#x2019; outstanding (unvested and/or vested and unexercised) equity awards were converted into equity awards denominated in shares of the Company&#x2019;s common stock based on a defined exchange ratio. N&amp;amp;B employees&#x2019; equity awards were converted into 335,347 IFF stock options, 258,572 IFF RSU awards and 5,816 IFF SAR awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For converted RSU awards, the fair value of the equity award is based on the Closing Date market price of IFF stock. For converted stock options and SAR awards, the exercise price per share of the converted award is equal to the exercise price per share of the N&amp;amp;B award immediately prior to the Merger divided by the exchange ratio. The fair value of the IFF stock options and SAR awards that the Company issued in connection with the Merger was estimated using the Black Scholes model.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The converted awards were generally issued with the same terms and conditions as were applicable prior to the Transaction. At the Closing Date, approximately $25&#160;million of the fair value of the replacement awards granted to N&amp;amp;B employees was attributable to pre-combination service and was included in the purchase price. As of December&#160;31, 2023, there &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;was no remaining post-combination expense to be recognized related to the replacement awards over the remaining post-combination service period, which was approximately up to three years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;SSARs and Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;SSARs are a contractual right to receive the value, in shares of Company stock, of the appreciation in our stock price from the grant date to the date the SSARs are exercised by the participant. SSARs granted become exercisable on the third anniversary of the grant date and have a maximum term of seven years. SSARs do not require a financial investment by the SSARs grantee. Stock options require the participant to pay the exercise price at the time they exercise their stock options. No stock options were granted in 2023, 2022 or 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;SSARs and options activity was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.926%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.735%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.735%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.738%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(SHARE AMOUNTS IN THOUSANDS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&#160;Subject&#160;to&lt;br/&gt;SSARs/Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&#160;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;SSARs/&lt;br/&gt;Options&lt;br/&gt;Exercisable&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected to Vest at December&#160;31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average exercise price of SSARs and options exercisable at December&#160;31, 2023, 2022 and 2021 were $109.59, $109.50 and $109.77, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;SSARs and options outstanding at December&#160;31, 2023 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:30.964%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.298%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.444%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.298%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.300%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Price Range&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;Outstanding&lt;br/&gt;(in&#160;thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&#160;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual Life&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise&#160;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&#160;Value&lt;br/&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Over $65&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.71&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;SSARs and options exercisable as of December&#160;31, 2023 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:30.917%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.274%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.566%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.274%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.279%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Price Range&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;Exercisable&lt;br/&gt;(in&#160;thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&#160;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&#160;Life&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise&#160;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&#160;Value&lt;br/&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Over $65&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.33&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total intrinsic value of options/SSARs exercised during 2023 was less than $1&#160;million and approximately $2&#160;million for 2022 and $3&#160;million for 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023, the total unrecognized compensation cost related to non-vested SSARs granted was approximately $1 million; such cost is expected to be recognized over a weighted average period of approximately 1.14 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Restricted Stock Units&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has granted RSUs to eligible employees and members of the Board of Directors. The Company has granted both time-based RSUs, which contain no performance criteria provisions, and performance-based RSUs. Such RSUs are subject to forfeitures or adjustments if certain conditions are not met, including service period or pre-established cumulative performance targets. RSUs principally vest 100% at the end of three years. An RSU&#x2019;s fair value is calculated based on the market price of the Company&#x2019;s stock at date of grant, with an adjustment to reflect the fact that such awards do not participate in dividend rights. The aggregate fair value is amortized to expense ratably over the vesting period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RSU activity was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:55.644%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.160%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.163%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(SHARE AMOUNTS IN THOUSANDS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number&#160;of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&#160;Average&lt;br/&gt;Grant Date Fair&lt;br/&gt;Value Per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(315)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(78)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change due to performance conditions, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total fair value of RSUs that vested during the year ended December&#160;31, 2023 was approximately $38 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023, there was approximately $67 million of total unrecognized compensation cost related to non-vested RSUs granted under the equity incentive plans; such cost is expected to be recognized over a weighted average period of approximately 1.94 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Purchased Restricted Stock Units&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The grant of awards under the Program provided for eligible employees to purchase shares of IFF common stock and deposit them into an escrow account. For each share deposited in escrow by the eligible employee, the Company matched with the grant of a restricted stock unit. The shares of restricted stock units generally vest on the third anniversary of the grant date, are subject to continued employment and other specified conditions, and pay dividends if and when paid by the Company. Holders of restricted stock units have, in most instances, all of the rights of shareholders, except that they may not sell, assign, pledge or otherwise encumber such shares. PRSUs pay dividend equivalents and do not have voting rights.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s PRSU activity for the years ended December 31, 2023, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:35.317%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.430%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:22.541%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.844%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Issued Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate Purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Covered Shares&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;PRSU activity was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:55.938%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.014%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.015%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(SHARE AMOUNTS IN THOUSANDS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number&#160;of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&#160;Average&lt;br/&gt;Grant Date Fair&lt;br/&gt;Value Per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total fair value of PRSUs that vested during the year ended December&#160;31, 2023 was approximately $3 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023, there was approximately $1 million of total unrecognized compensation cost related to non-vested PRSUs granted under the equity incentive plans; such cost is expected to be recognized over a weighted average period of approximately 1.06 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Liability Awards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has granted cash-settled RSUs (&#x201c;Cash RSUs&#x201d;) to eligible employees that are paid out 100% in cash upon vesting. Such RSUs are subject to forfeiture if certain conditions are not met. Cash RSUs principally vest 100% at the end of three years and contain no performance criteria provisions. A Cash RSU&#x2019;s fair value is calculated based on the market price of the Company&#x2019;s stock at the date of the closing period and is accounted for as a liability award. The aggregate fair value is amortized to expense ratably over the vesting period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash RSU activity was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:57.111%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.427%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.429%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(SHARE AMOUNTS IN THOUSANDS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash&#160;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&#160;Average&#160;&lt;br/&gt;Fair&lt;br/&gt;Value&#160;Per&#160;Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total fair value of Cash RSUs that vested during the year ended December&#160;31, 2023 was approximately $4 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023, there was approximately $2 million of total unrecognized compensation cost related to non-vested Cash RSUs granted under the equity incentive plans; such cost is expected to be recognized over a weighted average period of approximately 1.45 years. The aggregate compensation cost will be adjusted based on changes in the Company&#x2019;s stock price.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock contextRef="c-1" id="f-1597">Total stock-based compensation expense included in the Consolidated Statements of (Loss) Income and Comprehensive Loss was as follows:&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.222%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.640%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity-based awards&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability-based awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-352" decimals="-6" id="f-1598" unitRef="usd">65000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-353" decimals="-6" id="f-1599" unitRef="usd">49000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-354" decimals="-6" id="f-1600" unitRef="usd">54000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-355" decimals="-6" id="f-1601" unitRef="usd">2000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-356" decimals="-6" id="f-1602" unitRef="usd">2000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-357" decimals="-6" id="f-1603" unitRef="usd">8000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-1" decimals="-6" id="f-1604" unitRef="usd">67000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-9" decimals="-6" id="f-1605" unitRef="usd">51000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-10" decimals="-6" id="f-1606" unitRef="usd">62000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense contextRef="c-1" decimals="-6" id="f-1607" unitRef="usd">11000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense contextRef="c-9" decimals="-6" id="f-1608" unitRef="usd">8000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense contextRef="c-10" decimals="-6" id="f-1609" unitRef="usd">13000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax contextRef="c-1" decimals="-6" id="f-1610" unitRef="usd">56000000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax contextRef="c-9" decimals="-6" id="f-1611" unitRef="usd">43000000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax contextRef="c-10" decimals="-6" id="f-1612" unitRef="usd">49000000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c-358"
      decimals="INF"
      id="f-1613"
      unitRef="shares">2290000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesSubjectToOutstandingAwards
      contextRef="c-11"
      decimals="INF"
      id="f-1614"
      unitRef="shares">1817519</iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesSubjectToOutstandingAwards>
    <iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfSharesAvailableForGrant
      contextRef="c-11"
      decimals="INF"
      id="f-1615"
      unitRef="shares">748082</iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfSharesAvailableForGrant>
    <iff:TargetPayoutCash
      contextRef="c-359"
      decimals="INF"
      id="f-1616"
      unitRef="number">0.50</iff:TargetPayoutCash>
    <iff:TargetPayoutStock
      contextRef="c-359"
      decimals="INF"
      id="f-1617"
      unitRef="number">0.50</iff:TargetPayoutStock>
    <iff:TargetPayoutPeriodOfCycle contextRef="c-9" id="f-1618">P3Y</iff:TargetPayoutPeriodOfCycle>
    <iff:TargetPayoutStock
      contextRef="c-360"
      decimals="INF"
      id="f-1619"
      unitRef="number">1</iff:TargetPayoutStock>
    <iff:TargetPayoutPeriodOfCycle contextRef="c-1" id="f-1620">P3Y</iff:TargetPayoutPeriodOfCycle>
    <iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetDollarValueOfAwardIsConvertedToNumberOfNotionalSharesWhenAwardIsGranted
      contextRef="c-1"
      decimals="INF"
      id="f-1621"
      unitRef="number">0.50</iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetDollarValueOfAwardIsConvertedToNumberOfNotionalSharesWhenAwardIsGranted>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="c-361"
      decimals="INF"
      id="f-1622"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="c-362"
      decimals="INF"
      id="f-1623"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="c-363"
      decimals="INF"
      id="f-1624"
      unitRef="shares">5333</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="c-364"
      decimals="INF"
      id="f-1625"
      unitRef="shares">335347</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="c-365"
      decimals="INF"
      id="f-1626"
      unitRef="shares">258572</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="c-366"
      decimals="INF"
      id="f-1627"
      unitRef="shares">5816</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:EquityIssuedInBusinessCombinationFairValueDisclosure contextRef="c-169" decimals="-6" id="f-1628" unitRef="usd">25000000</us-gaap:EquityIssuedInBusinessCombinationFairValueDisclosure>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="c-92" decimals="-6" id="f-1629" unitRef="usd">0</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <iff:BusinessAcquisitionPostCombinationServicePeriod contextRef="c-90" id="f-1630">P3Y</iff:BusinessAcquisitionPostCombinationServicePeriod>
    <iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTerm contextRef="c-367" id="f-1631">P7Y</iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTerm>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock contextRef="c-1" id="f-1632">&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;SSARs and options activity was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.926%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.735%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.735%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.738%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(SHARE AMOUNTS IN THOUSANDS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&#160;Subject&#160;to&lt;br/&gt;SSARs/Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&#160;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;SSARs/&lt;br/&gt;Options&lt;br/&gt;Exercisable&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected to Vest at December&#160;31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-368"
      decimals="-3"
      id="f-1633"
      unitRef="shares">331000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-368"
      decimals="2"
      id="f-1634"
      unitRef="usdPerShare">115.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="c-368"
      decimals="-3"
      id="f-1635"
      unitRef="shares">182000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="c-369"
      decimals="-3"
      id="f-1636"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-369"
      decimals="2"
      id="f-1637"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-369"
      decimals="-3"
      id="f-1638"
      unitRef="shares">8000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-369"
      decimals="2"
      id="f-1639"
      unitRef="usdPerShare">68.67</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="c-369"
      decimals="-3"
      id="f-1640"
      unitRef="shares">8000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="c-369"
      decimals="2"
      id="f-1641"
      unitRef="usdPerShare">122.28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-370"
      decimals="-3"
      id="f-1642"
      unitRef="shares">315000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-370"
      decimals="2"
      id="f-1643"
      unitRef="usdPerShare">116.26</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="c-370"
      decimals="-3"
      id="f-1644"
      unitRef="shares">194000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="c-370"
      decimals="-3"
      id="f-1645"
      unitRef="shares">118000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="c-370"
      decimals="2"
      id="f-1646"
      unitRef="usdPerShare">126.99</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="c-370"
      decimals="2"
      id="f-1647"
      unitRef="usdPerShare">109.59</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="c-368"
      decimals="2"
      id="f-1648"
      unitRef="usdPerShare">109.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="c-371"
      decimals="2"
      id="f-1649"
      unitRef="usdPerShare">109.77</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock contextRef="c-1" id="f-1650">&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;SSARs and options outstanding at December&#160;31, 2023 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:30.964%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.298%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.444%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.298%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.300%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Price Range&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;Outstanding&lt;br/&gt;(in&#160;thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&#160;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual Life&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise&#160;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&#160;Value&lt;br/&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Over $65&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.71&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;SSARs and options exercisable as of December&#160;31, 2023 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:30.917%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.274%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.566%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.274%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.279%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Price Range&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;Exercisable&lt;br/&gt;(in&#160;thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&#160;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&#160;Life&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise&#160;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&#160;Value&lt;br/&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Over $65&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.33&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="c-372"
      decimals="-3"
      id="f-1651"
      unitRef="shares">315000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="c-373" id="f-1652">P4Y8M15D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="c-372"
      decimals="2"
      id="f-1653"
      unitRef="usdPerShare">116.26</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-372" decimals="-6" id="f-1654" unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="c-372"
      decimals="-3"
      id="f-1655"
      unitRef="shares">194000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2 contextRef="c-373" id="f-1656">P4Y3M29D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="c-372"
      decimals="2"
      id="f-1657"
      unitRef="usdPerShare">109.59</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="c-372" decimals="-6" id="f-1658" unitRef="usd">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="c-369" decimals="-6" id="f-1659" unitRef="usd">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="c-374" decimals="-6" id="f-1660" unitRef="usd">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="c-375" decimals="-6" id="f-1661" unitRef="usd">3000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="c-376" decimals="-6" id="f-1662" unitRef="usd">1000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-367" id="f-1663">P1Y1M20D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentage
      contextRef="c-377"
      decimals="INF"
      id="f-1664"
      unitRef="number">1</iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-377" id="f-1665">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock contextRef="c-1" id="f-1666">&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RSU activity was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:55.644%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.160%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.163%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(SHARE AMOUNTS IN THOUSANDS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number&#160;of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&#160;Average&lt;br/&gt;Grant Date Fair&lt;br/&gt;Value Per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(315)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(78)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change due to performance conditions, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash RSU activity was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:57.111%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.427%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.429%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(SHARE AMOUNTS IN THOUSANDS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash&#160;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&#160;Average&#160;&lt;br/&gt;Fair&lt;br/&gt;Value&#160;Per&#160;Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-378"
      decimals="-3"
      id="f-1667"
      unitRef="shares">937000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-378"
      decimals="2"
      id="f-1668"
      unitRef="usdPerShare">120.81</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-377"
      decimals="-3"
      id="f-1669"
      unitRef="shares">843000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-377"
      decimals="2"
      id="f-1670"
      unitRef="usdPerShare">87.31</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-377"
      decimals="-3"
      id="f-1671"
      unitRef="shares">315000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-377"
      decimals="2"
      id="f-1672"
      unitRef="usdPerShare">119.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-377"
      decimals="-3"
      id="f-1673"
      unitRef="shares">78000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-377"
      decimals="2"
      id="f-1674"
      unitRef="usdPerShare">105.63</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsChangeDueToPerformanceConditions
      contextRef="c-377"
      decimals="-3"
      id="f-1675"
      unitRef="shares">20000</iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsChangeDueToPerformanceConditions>
    <iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsChangeDueToPerformanceConditionsWeightedAverageGrantDateFairValue
      contextRef="c-377"
      decimals="2"
      id="f-1676"
      unitRef="usdPerShare">134.04</iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsChangeDueToPerformanceConditionsWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-379"
      decimals="-3"
      id="f-1677"
      unitRef="shares">1367000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-379"
      decimals="2"
      id="f-1678"
      unitRef="usdPerShare">101.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="c-377" decimals="-6" id="f-1679" unitRef="usd">38000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="c-379" decimals="-6" id="f-1680" unitRef="usd">67000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-377" id="f-1681">P1Y11M8D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <iff:ShareBasedPaymentArrangementPurchasedRestrictedStockUnitActivityTableTextBlock contextRef="c-1" id="f-1682">&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s PRSU activity for the years ended December 31, 2023, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:35.317%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.430%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:22.541%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.844%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Issued Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate Purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Covered Shares&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;PRSU activity was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:55.938%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.014%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.015%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(SHARE AMOUNTS IN THOUSANDS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number&#160;of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&#160;Average&lt;br/&gt;Grant Date Fair&lt;br/&gt;Value Per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</iff:ShareBasedPaymentArrangementPurchasedRestrictedStockUnitActivityTableTextBlock>
    <iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedPurchasedByEmployees
      contextRef="c-380"
      decimals="INF"
      id="f-1683"
      unitRef="shares">0</iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedPurchasedByEmployees>
    <iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValueOfSharesPurchasedByEmployees contextRef="c-380" decimals="-6" id="f-1684" unitRef="usd">0</iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValueOfSharesPurchasedByEmployees>
    <iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesPurchasedByEmployees
      contextRef="c-380"
      decimals="INF"
      id="f-1685"
      unitRef="shares">0</iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesPurchasedByEmployees>
    <iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedPurchasedByEmployees
      contextRef="c-381"
      decimals="INF"
      id="f-1686"
      unitRef="shares">43690</iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedPurchasedByEmployees>
    <iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValueOfSharesPurchasedByEmployees contextRef="c-381" decimals="-6" id="f-1687" unitRef="usd">6000000</iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValueOfSharesPurchasedByEmployees>
    <iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesPurchasedByEmployees
      contextRef="c-381"
      decimals="INF"
      id="f-1688"
      unitRef="shares">21845</iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesPurchasedByEmployees>
    <iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedPurchasedByEmployees
      contextRef="c-382"
      decimals="INF"
      id="f-1689"
      unitRef="shares">61870</iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedPurchasedByEmployees>
    <iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValueOfSharesPurchasedByEmployees contextRef="c-382" decimals="-6" id="f-1690" unitRef="usd">9000000</iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValueOfSharesPurchasedByEmployees>
    <iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesPurchasedByEmployees
      contextRef="c-382"
      decimals="INF"
      id="f-1691"
      unitRef="shares">30935</iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesPurchasedByEmployees>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-383"
      decimals="-3"
      id="f-1692"
      unitRef="shares">90000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-383"
      decimals="2"
      id="f-1693"
      unitRef="usdPerShare">133.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-380"
      decimals="-3"
      id="f-1694"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-380"
      decimals="2"
      id="f-1695"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-380"
      decimals="-3"
      id="f-1696"
      unitRef="shares">26000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-380"
      decimals="2"
      id="f-1697"
      unitRef="usdPerShare">131.31</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-380"
      decimals="-3"
      id="f-1698"
      unitRef="shares">3000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-380"
      decimals="2"
      id="f-1699"
      unitRef="usdPerShare">138.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-384"
      decimals="-3"
      id="f-1700"
      unitRef="shares">61000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-384"
      decimals="2"
      id="f-1701"
      unitRef="usdPerShare">133.96</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="c-380" decimals="-6" id="f-1702" unitRef="usd">3000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="c-384" decimals="-6" id="f-1703" unitRef="usd">1000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-380" id="f-1704">P1Y21D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentageGrantedInCashToEligibleEmployees
      contextRef="c-385"
      decimals="INF"
      id="f-1705"
      unitRef="number">1</iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentageGrantedInCashToEligibleEmployees>
    <iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentage
      contextRef="c-385"
      decimals="INF"
      id="f-1706"
      unitRef="number">1</iff:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-385" id="f-1707">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-386"
      decimals="-3"
      id="f-1708"
      unitRef="shares">119000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-386"
      decimals="2"
      id="f-1709"
      unitRef="usdPerShare">104.84</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-385"
      decimals="-3"
      id="f-1710"
      unitRef="shares">19000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-385"
      decimals="2"
      id="f-1711"
      unitRef="usdPerShare">80.97</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-385"
      decimals="-3"
      id="f-1712"
      unitRef="shares">40000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-385"
      decimals="2"
      id="f-1713"
      unitRef="usdPerShare">94.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-385"
      decimals="-3"
      id="f-1714"
      unitRef="shares">7000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-385"
      decimals="2"
      id="f-1715"
      unitRef="usdPerShare">82.24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-387"
      decimals="-3"
      id="f-1716"
      unitRef="shares">91000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-387"
      decimals="2"
      id="f-1717"
      unitRef="usdPerShare">80.97</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="c-385" decimals="-6" id="f-1718" unitRef="usd">4000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="c-387" decimals="-6" id="f-1719" unitRef="usd">2000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-385" id="f-1720">P1Y5M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c-1" id="f-1721">SEGMENT INFORMATION&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is organized into four reportable operating segments: Nourish, Health &amp;amp; Biosciences, Scent and Pharma Solutions. These segments align with the internal structure to manage these businesses. The Company&#x2019;s Chief Operating Decision Maker regularly reviews financial information to allocate resources and assess performance utilizing these segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Nourish is comprised of Ingredients, Flavors and Food Designs, with a diversified portfolio across natural and plant-based specialty food ingredients, flavor compounds, and systems and inclusions, respectively. Ingredients provide texturizing solutions to the food industry, food protection solutions used in food and beverage products, specialty soy and pea protein with value-added formulations, emulsifiers and sweeteners. Flavors provide a range of flavor compounds and natural taste solutions that are ultimately used by IFF&#x2019;s customers in savory products, beverages, sweets and dairy products. Flavors also provide value-added spices and seasoning ingredients for meat, food service, convenience, alternative protein and culinary products. Food Designs provide blends and systems that combine key ingredients tailored to IFF customers&#x2019; specific needs. Additionally, Food Designs provide inclusion products that help with taste and texture by, among other things, combining flavorings with fruit, vegetables, and other natural ingredients for a wide range of food products, such as health snacks, baked goods, cereals, pastries, ice cream and other dairy products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Health &amp;amp; Biosciences is comprised of Health, Cultures &amp;amp; Food Enzymes, Home &amp;amp; Personal Care, Animal Nutrition and Grain Processing, with a biotechnology-driven portfolio of products that serve the health and wellness, food, consumer and industrial markets. Products within this portfolio range from enzymes, food cultures, probiotics and specialty ingredients for non-food applications. Health provides ingredients for dietary supplements, food and beverage, specialized nutrition and pharma. Cultures &amp;amp; Food Enzymes provide products that aim to serve the global demand for healthy, natural, clean label and fermented food for fresh dairy, cheese, bakery and brewing products. This is accomplished by providing IFF&#x2019;s customers with products that allow for extended shelf life and stability, which help to improve customers&#x2019; products and performance. The enzyme solution also allows IFF&#x2019;s customers to provide low sugar, high fiber and lactose-free dairy products. Home &amp;amp; Personal Care produces enzymes for detergents, cleaning and textile processing products in the laundry, dishwashing, textiles and industrials and personal care markets that help to enhance product and process performances. Animal Nutrition produces enzymes that help to improve the product and process performance of animal feed products, which aim to lessen environmental impact by reducing farm waste. Grain Processing produces enzymes for biofuel production and carbohydrate processing.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Scent is comprised of (1) Fragrance Compounds, which are ultimately used by IFF&#x2019;s customers in two broad categories: Fine Fragrances, including perfumes and colognes, and Consumer Fragrances, including fragrance compounds for personal care (e.g., soaps), household products (e.g., detergents and cleaning agents) and beauty care, including toiletries; (2) Fragrance Ingredients, consisting of synthetic and natural ingredients that can be combined with other materials to create unique fine fragrance and consumer fragrance compounds; and (3) Cosmetic Ingredients, consisting of active and functional ingredients, botanicals and delivery systems to support our customers&#x2019; cosmetic and personal care product lines. Major fragrance customers include the cosmetics industry, including perfume and toiletries manufacturers, and the household products industry, including manufacturers of soaps, detergents, fabric care, household cleaners and air fresheners.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pharma Solutions is comprised of a vast portfolio, including cellulosics and seaweed-based pharmaceutical excipients, used to improve the functionality and delivery of active pharmaceutical ingredients, including controlled or modified drug release formulations, and enabling the development of more effective pharmaceutical finished dosage formats. Pharma Solutions excipients are used in prescription and over-the-counter pharmaceuticals and dietary supplements. Pharma Solutions products &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;also serve a variety of other specialty and industrial end-uses including coatings, inks, electronics, agriculture and consumer products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s Chief Operating Decision Maker evaluates the performance of these reportable segments based on Segment Adjusted Operating EBITDA, which is defined as (Loss) Income Before Taxes before depreciation and amortization expense, interest expense, restructuring and other charges and certain items that are not related to recurring operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reportable segment information is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.979%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nourish&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health &amp;amp; Biosciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Scent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharma Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.863%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nourish&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health &amp;amp; Biosciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Scent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharma Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.979%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment Adjusted Operating EBITDA:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nourish&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health &amp;amp; Biosciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Scent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharma Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation &amp;amp; Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,156)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(380)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(336)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(289)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (Expense) Income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring and Other Charges (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment of Goodwill (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,623)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment of Long-Lived Assets (c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(120)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition, Divestiture and Integration Related Costs (d)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(174)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(201)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(240)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Strategic Initiatives Costs (e)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Regulatory Costs (f)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N&amp;amp;B Inventory Step-Up Costs (g)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(368)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (h)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Loss) Income Before Taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,518)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,625)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:2.999%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:94.801%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Represents costs primarily related to severance as part of the Company's restructuring efforts.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;For 2023, represents costs related to the impairment of goodwill in the Nourish reporting unit. For 2022, represents costs related to the impairment of goodwill in the Health &amp;amp; Biosciences reporting unit.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Represents costs related to the impairment of intangible and fixed assets of an asset group that operated primarily in Russia.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:2.999%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:94.801%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(d)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;For 2023, 2022 and 2021, primarily represents costs related to the Company's actual and planned acquisitions and divestitures and integration related activities primarily for N&amp;amp;B. These costs primarily consisted of external consulting fees, professional and legal fees and salaries of individuals who are fully dedicated to such efforts. For 2023, acquisition costs primarily relate to earn-out adjustments. For 2022, acquisition costs primarily relate to consulting fees, legal fees and earn-out adjustments. For 2021, acquisition costs primarily relate to legal and professional fees for the transaction with N&amp;amp;B. Tax expenses for business divestiture costs included establishments of deferred tax liabilities related to planned sales of businesses.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;For 2023, business divestiture, integration and acquisition related costs were approximately $108 million, $59 million and $7 million, respectively. For 2022, business divestiture, integration and acquisition related costs were approximately $110 million, $94 million and a credit of $3 million, respectively. For 2021, business divestiture, integration and acquisition related costs were approximately $42 million, $105 million and $93 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(e)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Represents costs related to the Company's strategic assessment and business portfolio optimization efforts and reorganizing the Global Shared Services Centers, primarily consulting fees.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(f)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Represents costs primarily related to legal fees incurred for the ongoing investigations of the fragrance businesses.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(g)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Represents costs related to fair value step-up of inventory for the acquired inventory through the Merger with N&amp;amp;B.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(h)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;For 2023, represents gains from sale of assets and costs related to severance, including accelerated stock compensation expense, for a certain executive who will separate from the Company in 2024. For 2022 and 2021, represents gains from sale of assets, costs related to severance, including accelerated stock compensation expense, for certain employees and executives who have been separated from the Company in 2022 and 2021, respectively, and shareholder activist related costs, primarily professional fees.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has not disclosed revenues at a lower level than provided herein, such as revenues from external customers by product, as it is impracticable for it to do so.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had no customers that accounted for greater than 10% of consolidated net sales in 2023, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-lived assets, net, by country, consisted as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.692%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denmark&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment capital expenditures and depreciation and amortization consisted as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:26.988%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.223%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.223%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.223%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.223%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.223%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.522%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Capital Expenditures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Depreciation and Amortization&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nourish&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health &amp;amp; Biosciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Scent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharma Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net sales are attributed to individual regions based upon the destination of product delivery and are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.222%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.640%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Sales by Geographic Area&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe, Africa and Middle East&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater Asia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;North America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Latin America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.047%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.694%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.694%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Sales by Geographic Area&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales related to the U.S.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales attributed to all foreign countries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No non-U.S. country had net sales greater than 7% of total consolidated net sales for 2023 and net sales greater than 6% and 7% of total consolidated net sales for 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="c-1"
      decimals="INF"
      id="f-1722"
      unitRef="segment">4</us-gaap:NumberOfOperatingSegments>
    <iff:NumberOfFragranceCategories
      contextRef="c-1"
      decimals="INF"
      id="f-1723"
      unitRef="category">2</iff:NumberOfFragranceCategories>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="c-1" id="f-1724">&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reportable segment information is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.979%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nourish&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health &amp;amp; Biosciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Scent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharma Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.863%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nourish&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health &amp;amp; Biosciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Scent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharma Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.979%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment Adjusted Operating EBITDA:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nourish&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health &amp;amp; Biosciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Scent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharma Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation &amp;amp; Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,156)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(380)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(336)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(289)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (Expense) Income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring and Other Charges (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment of Goodwill (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,623)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment of Long-Lived Assets (c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(120)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition, Divestiture and Integration Related Costs (d)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(174)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(201)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(240)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Strategic Initiatives Costs (e)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Regulatory Costs (f)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N&amp;amp;B Inventory Step-Up Costs (g)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(368)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (h)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Loss) Income Before Taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,518)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,625)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:2.999%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:94.801%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Represents costs primarily related to severance as part of the Company's restructuring efforts.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;For 2023, represents costs related to the impairment of goodwill in the Nourish reporting unit. For 2022, represents costs related to the impairment of goodwill in the Health &amp;amp; Biosciences reporting unit.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Represents costs related to the impairment of intangible and fixed assets of an asset group that operated primarily in Russia.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:2.999%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:94.801%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(d)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;For 2023, 2022 and 2021, primarily represents costs related to the Company's actual and planned acquisitions and divestitures and integration related activities primarily for N&amp;amp;B. These costs primarily consisted of external consulting fees, professional and legal fees and salaries of individuals who are fully dedicated to such efforts. For 2023, acquisition costs primarily relate to earn-out adjustments. For 2022, acquisition costs primarily relate to consulting fees, legal fees and earn-out adjustments. For 2021, acquisition costs primarily relate to legal and professional fees for the transaction with N&amp;amp;B. Tax expenses for business divestiture costs included establishments of deferred tax liabilities related to planned sales of businesses.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;For 2023, business divestiture, integration and acquisition related costs were approximately $108 million, $59 million and $7 million, respectively. For 2022, business divestiture, integration and acquisition related costs were approximately $110 million, $94 million and a credit of $3 million, respectively. For 2021, business divestiture, integration and acquisition related costs were approximately $42 million, $105 million and $93 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(e)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Represents costs related to the Company's strategic assessment and business portfolio optimization efforts and reorganizing the Global Shared Services Centers, primarily consulting fees.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(f)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Represents costs primarily related to legal fees incurred for the ongoing investigations of the fragrance businesses.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(g)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Represents costs related to fair value step-up of inventory for the acquired inventory through the Merger with N&amp;amp;B.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(h)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;For 2023, represents gains from sale of assets and costs related to severance, including accelerated stock compensation expense, for a certain executive who will separate from the Company in 2024. For 2022 and 2021, represents gains from sale of assets, costs related to severance, including accelerated stock compensation expense, for certain employees and executives who have been separated from the Company in 2022 and 2021, respectively, and shareholder activist related costs, primarily professional fees.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment capital expenditures and depreciation and amortization consisted as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:26.988%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.223%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.223%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.223%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.223%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.223%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.522%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Capital Expenditures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Depreciation and Amortization&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nourish&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health &amp;amp; Biosciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Scent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharma Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-388" decimals="-6" id="f-1725" unitRef="usd">6060000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-389" decimals="-6" id="f-1726" unitRef="usd">6829000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-390" decimals="-6" id="f-1727" unitRef="usd">6264000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-391" decimals="-6" id="f-1728" unitRef="usd">2081000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-392" decimals="-6" id="f-1729" unitRef="usd">2339000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-393" decimals="-6" id="f-1730" unitRef="usd">2329000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-394" decimals="-6" id="f-1731" unitRef="usd">2393000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-395" decimals="-6" id="f-1732" unitRef="usd">2301000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-396" decimals="-6" id="f-1733" unitRef="usd">2254000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-397" decimals="-6" id="f-1734" unitRef="usd">945000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-398" decimals="-6" id="f-1735" unitRef="usd">971000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-399" decimals="-6" id="f-1736" unitRef="usd">809000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-6" id="f-1737" unitRef="usd">11479000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-9" decimals="-6" id="f-1738" unitRef="usd">12440000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-10" decimals="-6" id="f-1739" unitRef="usd">11656000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:Assets contextRef="c-400" decimals="-6" id="f-1740" unitRef="usd">12893000000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-401" decimals="-6" id="f-1741" unitRef="usd">17062000000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-402" decimals="-6" id="f-1742" unitRef="usd">10666000000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-403" decimals="-6" id="f-1743" unitRef="usd">10924000000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-404" decimals="-6" id="f-1744" unitRef="usd">4274000000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-405" decimals="-6" id="f-1745" unitRef="usd">4309000000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-406" decimals="-6" id="f-1746" unitRef="usd">3145000000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-407" decimals="-6" id="f-1747" unitRef="usd">3227000000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-11" decimals="-6" id="f-1748" unitRef="usd">30978000000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-12" decimals="-6" id="f-1749" unitRef="usd">35522000000</us-gaap:Assets>
    <iff:SegmentAdjustedOperatingEBITDA contextRef="c-388" decimals="-6" id="f-1750" unitRef="usd">732000000</iff:SegmentAdjustedOperatingEBITDA>
    <iff:SegmentAdjustedOperatingEBITDA contextRef="c-389" decimals="-6" id="f-1751" unitRef="usd">1176000000</iff:SegmentAdjustedOperatingEBITDA>
    <iff:SegmentAdjustedOperatingEBITDA contextRef="c-390" decimals="-6" id="f-1752" unitRef="usd">1172000000</iff:SegmentAdjustedOperatingEBITDA>
    <iff:SegmentAdjustedOperatingEBITDA contextRef="c-391" decimals="-6" id="f-1753" unitRef="usd">588000000</iff:SegmentAdjustedOperatingEBITDA>
    <iff:SegmentAdjustedOperatingEBITDA contextRef="c-392" decimals="-6" id="f-1754" unitRef="usd">634000000</iff:SegmentAdjustedOperatingEBITDA>
    <iff:SegmentAdjustedOperatingEBITDA contextRef="c-393" decimals="-6" id="f-1755" unitRef="usd">625000000</iff:SegmentAdjustedOperatingEBITDA>
    <iff:SegmentAdjustedOperatingEBITDA contextRef="c-394" decimals="-6" id="f-1756" unitRef="usd">461000000</iff:SegmentAdjustedOperatingEBITDA>
    <iff:SegmentAdjustedOperatingEBITDA contextRef="c-395" decimals="-6" id="f-1757" unitRef="usd">423000000</iff:SegmentAdjustedOperatingEBITDA>
    <iff:SegmentAdjustedOperatingEBITDA contextRef="c-396" decimals="-6" id="f-1758" unitRef="usd">463000000</iff:SegmentAdjustedOperatingEBITDA>
    <iff:SegmentAdjustedOperatingEBITDA contextRef="c-397" decimals="-6" id="f-1759" unitRef="usd">199000000</iff:SegmentAdjustedOperatingEBITDA>
    <iff:SegmentAdjustedOperatingEBITDA contextRef="c-398" decimals="-6" id="f-1760" unitRef="usd">222000000</iff:SegmentAdjustedOperatingEBITDA>
    <iff:SegmentAdjustedOperatingEBITDA contextRef="c-399" decimals="-6" id="f-1761" unitRef="usd">165000000</iff:SegmentAdjustedOperatingEBITDA>
    <iff:SegmentAdjustedOperatingEBITDA contextRef="c-1" decimals="-6" id="f-1762" unitRef="usd">1980000000</iff:SegmentAdjustedOperatingEBITDA>
    <iff:SegmentAdjustedOperatingEBITDA contextRef="c-9" decimals="-6" id="f-1763" unitRef="usd">2455000000</iff:SegmentAdjustedOperatingEBITDA>
    <iff:SegmentAdjustedOperatingEBITDA contextRef="c-10" decimals="-6" id="f-1764" unitRef="usd">2425000000</iff:SegmentAdjustedOperatingEBITDA>
    <us-gaap:OtherDepreciationAndAmortization contextRef="c-1" decimals="-6" id="f-1765" unitRef="usd">1142000000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OtherDepreciationAndAmortization contextRef="c-9" decimals="-6" id="f-1766" unitRef="usd">1179000000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OtherDepreciationAndAmortization contextRef="c-10" decimals="-6" id="f-1767" unitRef="usd">1156000000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:InterestExpense contextRef="c-1" decimals="-6" id="f-1768" unitRef="usd">380000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c-9" decimals="-6" id="f-1769" unitRef="usd">336000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c-10" decimals="-6" id="f-1770" unitRef="usd">289000000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-1" decimals="-6" id="f-1771" unitRef="usd">-28000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-9" decimals="-6" id="f-1772" unitRef="usd">37000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-10" decimals="-6" id="f-1773" unitRef="usd">58000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:RestructuringCharges contextRef="c-1" decimals="-6" id="f-1774" unitRef="usd">68000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-9" decimals="-6" id="f-1775" unitRef="usd">12000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-10" decimals="-6" id="f-1776" unitRef="usd">41000000</us-gaap:RestructuringCharges>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-1" decimals="-6" id="f-1777" unitRef="usd">2623000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-9" decimals="-6" id="f-1778" unitRef="usd">2250000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-10" decimals="-6" id="f-1779" unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-1" decimals="-6" id="f-1780" unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-9" decimals="-6" id="f-1781" unitRef="usd">120000000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-10" decimals="-6" id="f-1782" unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <iff:BusinessCombinationDivestituresAndIntegrationCosts contextRef="c-1" decimals="-6" id="f-1783" unitRef="usd">174000000</iff:BusinessCombinationDivestituresAndIntegrationCosts>
    <iff:BusinessCombinationDivestituresAndIntegrationCosts contextRef="c-9" decimals="-6" id="f-1784" unitRef="usd">201000000</iff:BusinessCombinationDivestituresAndIntegrationCosts>
    <iff:BusinessCombinationDivestituresAndIntegrationCosts contextRef="c-10" decimals="-6" id="f-1785" unitRef="usd">240000000</iff:BusinessCombinationDivestituresAndIntegrationCosts>
    <iff:StrategicInitiativesCosts contextRef="c-1" decimals="-6" id="f-1786" unitRef="usd">31000000</iff:StrategicInitiativesCosts>
    <iff:StrategicInitiativesCosts contextRef="c-9" decimals="-6" id="f-1787" unitRef="usd">8000000</iff:StrategicInitiativesCosts>
    <iff:StrategicInitiativesCosts contextRef="c-10" decimals="-6" id="f-1788" unitRef="usd">0</iff:StrategicInitiativesCosts>
    <us-gaap:LegalFees contextRef="c-1" decimals="-6" id="f-1789" unitRef="usd">50000000</us-gaap:LegalFees>
    <us-gaap:LegalFees contextRef="c-9" decimals="-6" id="f-1790" unitRef="usd">0</us-gaap:LegalFees>
    <us-gaap:LegalFees contextRef="c-10" decimals="-6" id="f-1791" unitRef="usd">0</us-gaap:LegalFees>
    <iff:BusinessCombinationInventoryStepUpCosts contextRef="c-90" decimals="-6" id="f-1792" unitRef="usd">0</iff:BusinessCombinationInventoryStepUpCosts>
    <iff:BusinessCombinationInventoryStepUpCosts contextRef="c-408" decimals="-6" id="f-1793" unitRef="usd">0</iff:BusinessCombinationInventoryStepUpCosts>
    <iff:BusinessCombinationInventoryStepUpCosts contextRef="c-165" decimals="-6" id="f-1794" unitRef="usd">368000000</iff:BusinessCombinationInventoryStepUpCosts>
    <iff:OtherCostsCredits contextRef="c-1" decimals="-6" id="f-1795" unitRef="usd">2000000</iff:OtherCostsCredits>
    <iff:OtherCostsCredits contextRef="c-9" decimals="-6" id="f-1796" unitRef="usd">11000000</iff:OtherCostsCredits>
    <iff:OtherCostsCredits contextRef="c-10" decimals="-6" id="f-1797" unitRef="usd">35000000</iff:OtherCostsCredits>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-6" id="f-1798" unitRef="usd">-2518000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-9" decimals="-6" id="f-1799" unitRef="usd">-1625000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-10" decimals="-6" id="f-1800" unitRef="usd">354000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <iff:BusinessDivestitureCosts contextRef="c-1" decimals="-6" id="f-1801" unitRef="usd">108000000</iff:BusinessDivestitureCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts contextRef="c-1" decimals="-6" id="f-1802" unitRef="usd">59000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts contextRef="c-1" decimals="-6" id="f-1803" unitRef="usd">7000000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <iff:BusinessDivestitureCosts contextRef="c-9" decimals="-6" id="f-1804" unitRef="usd">110000000</iff:BusinessDivestitureCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts contextRef="c-9" decimals="-6" id="f-1805" unitRef="usd">94000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts contextRef="c-9" decimals="-6" id="f-1806" unitRef="usd">-3000000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <iff:BusinessDivestitureCosts contextRef="c-10" decimals="-6" id="f-1807" unitRef="usd">42000000</iff:BusinessDivestitureCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts contextRef="c-10" decimals="-6" id="f-1808" unitRef="usd">105000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts contextRef="c-10" decimals="-6" id="f-1809" unitRef="usd">93000000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <iff:NumberOfCustomers
      contextRef="c-409"
      decimals="INF"
      id="f-1810"
      unitRef="customer">0</iff:NumberOfCustomers>
    <iff:NumberOfCustomers
      contextRef="c-410"
      decimals="INF"
      id="f-1811"
      unitRef="customer">0</iff:NumberOfCustomers>
    <iff:NumberOfCustomers
      contextRef="c-411"
      decimals="INF"
      id="f-1812"
      unitRef="customer">0</iff:NumberOfCustomers>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-412"
      decimals="2"
      id="f-1813"
      unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-413"
      decimals="2"
      id="f-1814"
      unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-414"
      decimals="2"
      id="f-1815"
      unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock contextRef="c-1" id="f-1816">&lt;div style="margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-lived assets, net, by country, consisted as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.692%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denmark&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-415" decimals="-6" id="f-1817" unitRef="usd">1742000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-416" decimals="-6" id="f-1818" unitRef="usd">1771000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-417" decimals="-6" id="f-1819" unitRef="usd">228000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-418" decimals="-6" id="f-1820" unitRef="usd">258000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-419" decimals="-6" id="f-1821" unitRef="usd">262000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-420" decimals="-6" id="f-1822" unitRef="usd">250000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-421" decimals="-6" id="f-1823" unitRef="usd">214000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-422" decimals="-6" id="f-1824" unitRef="usd">212000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-423" decimals="-6" id="f-1825" unitRef="usd">199000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-424" decimals="-6" id="f-1826" unitRef="usd">187000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-425" decimals="-6" id="f-1827" unitRef="usd">171000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-426" decimals="-6" id="f-1828" unitRef="usd">181000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-427" decimals="-6" id="f-1829" unitRef="usd">1424000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-428" decimals="-6" id="f-1830" unitRef="usd">1344000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-11" decimals="-6" id="f-1831" unitRef="usd">4240000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-12" decimals="-6" id="f-1832" unitRef="usd">4203000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c-388" decimals="-6" id="f-1833" unitRef="usd">252000000</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c-389" decimals="-6" id="f-1834" unitRef="usd">215000000</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c-390" decimals="-6" id="f-1835" unitRef="usd">183000000</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-388" decimals="-6" id="f-1836" unitRef="usd">553000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-389" decimals="-6" id="f-1837" unitRef="usd">596000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-390" decimals="-6" id="f-1838" unitRef="usd">594000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c-391" decimals="-6" id="f-1839" unitRef="usd">85000000</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c-392" decimals="-6" id="f-1840" unitRef="usd">160000000</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c-393" decimals="-6" id="f-1841" unitRef="usd">139000000</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-391" decimals="-6" id="f-1842" unitRef="usd">374000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-392" decimals="-6" id="f-1843" unitRef="usd">363000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-393" decimals="-6" id="f-1844" unitRef="usd">353000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c-394" decimals="-6" id="f-1845" unitRef="usd">62000000</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c-395" decimals="-6" id="f-1846" unitRef="usd">56000000</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c-396" decimals="-6" id="f-1847" unitRef="usd">41000000</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-394" decimals="-6" id="f-1848" unitRef="usd">78000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-395" decimals="-6" id="f-1849" unitRef="usd">81000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-396" decimals="-6" id="f-1850" unitRef="usd">84000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c-397" decimals="-6" id="f-1851" unitRef="usd">104000000</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c-398" decimals="-6" id="f-1852" unitRef="usd">73000000</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c-399" decimals="-6" id="f-1853" unitRef="usd">30000000</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-397" decimals="-6" id="f-1854" unitRef="usd">137000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-398" decimals="-6" id="f-1855" unitRef="usd">139000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-399" decimals="-6" id="f-1856" unitRef="usd">125000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c-1" decimals="-6" id="f-1857" unitRef="usd">503000000</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c-9" decimals="-6" id="f-1858" unitRef="usd">504000000</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c-10" decimals="-6" id="f-1859" unitRef="usd">393000000</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-1" decimals="-6" id="f-1860" unitRef="usd">1142000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-9" decimals="-6" id="f-1861" unitRef="usd">1179000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-10" decimals="-6" id="f-1862" unitRef="usd">1156000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock contextRef="c-1" id="f-1863">&lt;div style="margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net sales are attributed to individual regions based upon the destination of product delivery and are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.222%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.640%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Sales by Geographic Area&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe, Africa and Middle East&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater Asia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;North America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Latin America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.047%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.694%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.694%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Sales by Geographic Area&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales related to the U.S.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales attributed to all foreign countries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-429" decimals="-6" id="f-1864" unitRef="usd">3834000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-430" decimals="-6" id="f-1865" unitRef="usd">4219000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-431" decimals="-6" id="f-1866" unitRef="usd">4093000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-432" decimals="-6" id="f-1867" unitRef="usd">2677000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-433" decimals="-6" id="f-1868" unitRef="usd">2876000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-434" decimals="-6" id="f-1869" unitRef="usd">2728000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-435" decimals="-6" id="f-1870" unitRef="usd">3477000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-436" decimals="-6" id="f-1871" unitRef="usd">3853000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-437" decimals="-6" id="f-1872" unitRef="usd">3499000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-438" decimals="-6" id="f-1873" unitRef="usd">1491000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-439" decimals="-6" id="f-1874" unitRef="usd">1492000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-440" decimals="-6" id="f-1875" unitRef="usd">1336000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-6" id="f-1876" unitRef="usd">11479000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-9" decimals="-6" id="f-1877" unitRef="usd">12440000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-10" decimals="-6" id="f-1878" unitRef="usd">11656000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-441" decimals="-6" id="f-1879" unitRef="usd">3185000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-442" decimals="-6" id="f-1880" unitRef="usd">3611000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-443" decimals="-6" id="f-1881" unitRef="usd">3211000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-444" decimals="-6" id="f-1882" unitRef="usd">8294000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-445" decimals="-6" id="f-1883" unitRef="usd">8829000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-446" decimals="-6" id="f-1884" unitRef="usd">8445000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-447"
      decimals="INF"
      id="f-1885"
      unitRef="number">0.07</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-448"
      decimals="INF"
      id="f-1886"
      unitRef="number">0.06</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-449"
      decimals="INF"
      id="f-1887"
      unitRef="number">0.07</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock contextRef="c-1" id="f-1888">EMPLOYEE BENEFITS&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has pension and/or other retirement benefit plans covering approximately 20% of active employees. In 2007, the Company amended its U.S. qualified and non-qualified pension plans under which accrual of future benefits was suspended for all participants that did not meet the rule of 70 (age plus years of service equal to at least 70 as of December&#160;31, 2007). Pension benefits are generally based on years of service and compensation during the final years of employment. Plan assets consist primarily of equity securities and corporate and government fixed income securities. Substantially all pension benefit costs are funded as accrued; such funding is limited, where applicable, to amounts deductible for income tax purposes. Certain other retirement benefits are provided by general corporate assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of the Closing Date of the Merger with N&amp;amp;B, the Company assumed responsibility for approximately 20 additional defined benefit plans and recognized liabilities in the aggregate amount of $221 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company sponsors a qualified defined contribution plan covering substantially all U.S. employees. Under this plan, effective January 1, 2023, the Company matches 100% of the first 6% of participants&#x2019; contributions. Prior to this, the Company matched 100% of participants&#x2019; contributions up to 4% of compensation and 75% of participants&#x2019; contributions from over 4% to 8%. Employees that are still eligible to accrue benefits under the pension plans are limited to a 50% match of up to 6% of the participants&#x2019; compensation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to pension benefits, certain health care and life insurance benefits are provided to qualifying U.S. employees upon retirement from IFF. Such coverage is provided through insurance plans with premiums based on benefits paid. The Company does not generally provide health care or life insurance coverage for retired employees of foreign subsidiaries; such benefits are provided in most foreign countries by government-sponsored plans, and the cost of these programs is not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company offers a non-qualified Deferred Compensation Plan (&#x201c;DCP&#x201d;) for certain key employees and non-employee directors. Eligible employees and non-employee directors may elect to defer receipt of salary, incentive payments and Board of Directors&#x2019; fees into participant-directed investments which are generally invested by the Company in individual variable life insurance contracts it owns that are designed to informally fund savings plans of this nature. The cash surrender value of life insurance is based on the net asset values of the underlying funds available to plan participants. At December&#160;31, 2023 and December&#160;31, 2022, the Consolidated Balance Sheets reflect liabilities of approximately $52 million and $53 million, respectively, related to the DCP in Other liabilities and approximately $17 million and $25 million, respectively, included in Capital in excess of par value related to the portion of the DCP that will be paid out in IFF shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total cash surrender value of life insurance contracts the Company owns in relation to the DCP and post-retirement life insurance benefits amounted to $49 million and $45 million at December&#160;31, 2023 and 2022, respectively, and are recorded in Other assets in the Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The plan assets and benefit obligations of the defined benefit pension plans are measured at December&#160;31 of each year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:36.381%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.709%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.709%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.709%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.709%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.709%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.714%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Components of net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost for benefits earned&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost on projected benefit obligation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net amortization of deferrals&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements and curtailments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit (income) cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Defined contribution and other retirement plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Changes in plan assets and benefit obligations recognized in OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net actuarial loss (gain)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized actuarial (loss) gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total loss (gain) recognized in OCI (before tax effects)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(181)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Included as a component of Operating (loss) profit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Included as a component of Other expense (income), net.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.222%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.640%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Postretirement Benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Components of net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost for benefits earned&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost on projected benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net amortization and deferrals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total credit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Changes in plan assets and benefit obligations recognized in OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net actuarial loss (gain)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total recognized in OCI (before tax effects)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:56.462%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.556%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.556%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.558%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average actuarial assumptions used to determine expense at December&#160;31 of each year are:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:31.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.488%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.488%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.635%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.488%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.488%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.638%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the postretirement benefit obligation and plan assets, as applicable, are detailed in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:35.996%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.724%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.724%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.870%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.870%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.724%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.727%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Postretirement Benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost for benefits earned&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost on projected benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial (gain) loss &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(139)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(468)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments for expense/tax contained in service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan participants&#x2019; contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Curtailments/settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(286)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employer contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Participants&#x2019; contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Funded status at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amounts recognized in the balance sheet are detailed in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.752%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.641%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Retirement liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(138)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net amount recognized&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amounts recognized in AOCI are detailed in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:36.381%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.709%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.709%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.709%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.709%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.709%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.714%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Postretirement Benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net actuarial (gain) loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service cost (credit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total AOCI (before tax effects)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.752%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.641%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated Benefit Obligation &#x2014; end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Information for Pension Plans with an Accumulated Benefit Obligation (&#x201c;ABO&#x201d;) in excess of Plan Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Information for Pension Plans with a Projected Benefit Obligation (&#x201c;PBO&#x201d;) in excess of Plan Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average assumptions used to determine obligations at December&#160;31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:56.462%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.556%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.556%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.558%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-U.S.&#160;Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Postretirement&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Estimated Future Benefit Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029 - 2033&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Required Company Contributions in the Following Year (2024)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers a number of factors in determining and selecting assumptions for the overall expected long-term rate of return on plan assets. The Company considers the historical long-term return experience of its assets, the current and expected allocation of its plan assets and expected long-term rates of return. The Company derives these expected long-term rates of return with the assistance of its investment advisors. The Company bases its expected allocation of plan assets on a diversified portfolio consisting of domestic and international equity securities, fixed income, property and alternative asset classes. The asset allocation is monitored on an ongoing basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers a variety of factors in determining and selecting its assumptions for the discount rate at December&#160;31. For the U.S. plans, the discount rate was based on the internal rate of return for a portfolio of high quality bonds rated Aa or higher by either Moody&#x2019;s or Standard &amp;amp; Poor&#x2019;s with maturities that are consistent with the projected future benefit payment obligations of the plan. For the Non-U.S. Plans, the discount rates were determined by region and are based on high quality long-term corporate bonds.&#160;Consideration has been given to the duration of the liabilities in each plan when selecting the bonds to be used in determining the discount rate. The rate of compensation increase for all plans and the medical cost trend rate for the applicable U.S. plans are based on plan experience.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The percentage of assets in the Company&#x2019;s pension plans, by type, is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.752%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.641%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-U.S.&#160;Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Alternative and other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;With respect to the U.S. plans, the expected return on plan assets was determined based on an asset allocation model using the current target allocation, real rates of return by asset class and an anticipated inflation rate. The target investment allocation is 10% equity securities and 90% fixed income securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The expected annual rate of return for the non-U.S. plans employs a similar set of criteria adapted for local investments, inflation rates and in certain cases specific government requirements. Each plan has its own target asset allocation, which is reviewed periodically and rebalanced when necessary.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the Company&#x2019;s plan assets for the U.S. and non-U.S. plans using the fair value hierarchy as of December&#160;31, 2023 and 2022. The plans&#x2019; assets were accounted for at fair value and are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company&#x2019;s assessment of the significance of a particular input to the fair value measurement requires judgment, and may affect the valuation of fair value assets and their placement within the fair value hierarchy levels. For more information on a description of the fair value hierarchy, see Note 16.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.752%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.641%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Plans for the Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Cash Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Fixed Income Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government&#160;&amp;amp; Government Agency Bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate Bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal Bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Assets measured at net asset value&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.752%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.641%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Plans for the Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Cash Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Fixed Income Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government&#160;&amp;amp; Government Agency Bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate Bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal Bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Assets measured at net asset value&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy. The fair value amounts presented in the table above are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Balance Sheets. The total amount measured at net asset value includes approximately $65 million and $234 million in pooled equity funds and $341 million and $170 million in fixed income mutual funds for the years ended December&#160;31, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.752%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.641%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-U.S. Plans for the Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Equity Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Large Cap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Mid Cap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Small Cap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. Large Cap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. Mid Cap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. Small Cap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Emerging Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Fixed Income Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Corporate Bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. Treasuries/Government Bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. Corporate Bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. Asset-Backed Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. Other Fixed Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Alternative Types of Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Insurance Contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Absolute Return Funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Private Equity Funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Property&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. Property&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.752%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.641%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-U.S. Plans for the Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Equity Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Large Cap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Mid Cap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. Large Cap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. Mid Cap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. Small Cap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Emerging Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Fixed Income Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Corporate Bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. Treasuries/Government Bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. Corporate Bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. Asset-Backed Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. Other Fixed Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Alternative Types of Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Insurance Contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Absolute Return Funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Property&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. Property&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents are primarily held in registered money market funds which are valued using a market approach based on the quoted market prices of identical instruments. Other cash and cash equivalents are valued daily by the fund using a market approach with inputs that include quoted market prices for similar instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity securities are primarily valued using a market approach based on the quoted market prices of identical instruments. Pooled funds are typically common or collective trusts valued at their net asset values (NAVs).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fixed income securities are primarily valued using a market approach with inputs that include broker quotes and benchmark yields.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Derivative instruments are valued by the custodian using closing market swap curves and market derived inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property values are primarily based on valuation of the underlying investments, which include inputs such as cost, discounted future cash flows, independent appraisals and market comparable data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Hedge funds are valued based on valuation of the underlying securities and instruments within the funds. Quoted market prices are used when available and NAVs are used for unquoted securities within the funds.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Absolute return funds are actively managed funds mainly invested in debt and equity securities and are valued at their NAVs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents a reconciliation of Level 3 non-U.S. plan assets held during the year ended December&#160;31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.222%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.640%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Property&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Hedge&lt;br/&gt;Funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases, sales and settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following weighted average assumptions were used to determine the postretirement benefit expense and obligation for the years ended December&#160;31:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:56.315%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.032%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.885%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.032%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current medical cost trend rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ultimate medical cost trend rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical cost trend rate decreases to ultimate rate in year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2034&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2030&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company contributed $31 million to its non-U.S. pension plans in 2023. No contributions were made to the Company&#x2019;s qualified U.S. pension plans in 2023. The Company contributed $5 million with respect to its non-qualified U.S. pension plan. In addition, $3 million of payments were made with respect to the Company&#x2019;s other postretirement plans.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <iff:PercentageofActiveEmployeeswithPensionandorOtherRetirementBenefitPlansCovered contextRef="c-1" decimals="2" id="f-1889" unitRef="number">0.20</iff:PercentageofActiveEmployeeswithPensionandorOtherRetirementBenefitPlansCovered>
    <iff:BusinessCombinationDefinedBenefitPlanNumberOfPlansAssumed
      contextRef="c-169"
      decimals="0"
      id="f-1890"
      unitRef="benefit_plan">20</iff:BusinessCombinationDefinedBenefitPlanNumberOfPlansAssumed>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent contextRef="c-169" decimals="-6" id="f-1891" unitRef="usd">221000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent>
    <iff:DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBelowLowRange
      contextRef="c-1"
      decimals="INF"
      id="f-1892"
      unitRef="number">1</iff:DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBelowLowRange>
    <iff:DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRange
      contextRef="c-1"
      decimals="INF"
      id="f-1893"
      unitRef="number">0.06</iff:DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRange>
    <iff:DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBelowLowRange
      contextRef="c-9"
      decimals="INF"
      id="f-1894"
      unitRef="number">1</iff:DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBelowLowRange>
    <iff:DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRange
      contextRef="c-9"
      decimals="INF"
      id="f-1895"
      unitRef="number">0.04</iff:DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRange>
    <iff:DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBetweenHighRangeAndLowRange
      contextRef="c-9"
      decimals="INF"
      id="f-1896"
      unitRef="number">0.75</iff:DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageBetweenHighRangeAndLowRange>
    <iff:DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRangeLow
      contextRef="c-9"
      decimals="INF"
      id="f-1897"
      unitRef="number">0.04</iff:DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRangeLow>
    <iff:DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRangeHigh
      contextRef="c-9"
      decimals="INF"
      id="f-1898"
      unitRef="number">0.08</iff:DefinedContributionPlanMatchingParticipantContributionPercentageOnCompensationRangeHigh>
    <iff:DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageReachesAverageRate
      contextRef="c-1"
      decimals="INF"
      id="f-1899"
      unitRef="number">0.50</iff:DefinedContributionPlanPercentageOfMatchingContributionIfCompensationPercentageReachesAverageRate>
    <iff:DefinedContributionPlanMatchingParticipantContributionAveragePercentageOnCompensation
      contextRef="c-1"
      decimals="INF"
      id="f-1900"
      unitRef="number">0.06</iff:DefinedContributionPlanMatchingParticipantContributionAveragePercentageOnCompensation>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent contextRef="c-450" decimals="-6" id="f-1901" unitRef="usd">52000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent contextRef="c-451" decimals="-6" id="f-1902" unitRef="usd">53000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <iff:AdjustmentsToAdditionalPaidInCapitalDeferredCompensation contextRef="c-11" decimals="-6" id="f-1903" unitRef="usd">17000000</iff:AdjustmentsToAdditionalPaidInCapitalDeferredCompensation>
    <iff:AdjustmentsToAdditionalPaidInCapitalDeferredCompensation contextRef="c-12" decimals="-6" id="f-1904" unitRef="usd">25000000</iff:AdjustmentsToAdditionalPaidInCapitalDeferredCompensation>
    <us-gaap:CashSurrenderValueOfLifeInsurance contextRef="c-11" decimals="-6" id="f-1905" unitRef="usd">49000000</us-gaap:CashSurrenderValueOfLifeInsurance>
    <us-gaap:CashSurrenderValueOfLifeInsurance contextRef="c-12" decimals="-6" id="f-1906" unitRef="usd">45000000</us-gaap:CashSurrenderValueOfLifeInsurance>
    <iff:PensionExpensesTableTextBlock contextRef="c-1" id="f-1907">&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The plan assets and benefit obligations of the defined benefit pension plans are measured at December&#160;31 of each year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:36.381%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.709%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.709%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.709%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.709%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.709%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.714%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Components of net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost for benefits earned&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost on projected benefit obligation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net amortization of deferrals&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements and curtailments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit (income) cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Defined contribution and other retirement plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Changes in plan assets and benefit obligations recognized in OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net actuarial loss (gain)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized actuarial (loss) gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total loss (gain) recognized in OCI (before tax effects)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(181)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Included as a component of Operating (loss) profit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Included as a component of Other expense (income), net.&lt;/span&gt;&lt;/div&gt;</iff:PensionExpensesTableTextBlock>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="c-452" decimals="-6" id="f-1908" unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="c-453" decimals="-6" id="f-1909" unitRef="usd">1000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="c-454" decimals="-6" id="f-1910" unitRef="usd">1000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="c-455" decimals="-6" id="f-1911" unitRef="usd">21000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="c-456" decimals="-6" id="f-1912" unitRef="usd">34000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="c-457" decimals="-6" id="f-1913" unitRef="usd">41000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="c-452" decimals="-6" id="f-1914" unitRef="usd">25000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="c-458" decimals="-6" id="f-1915" unitRef="usd">15000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="c-454" decimals="-6" id="f-1916" unitRef="usd">71000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="c-455" decimals="-6" id="f-1917" unitRef="usd">36000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="c-459" decimals="-6" id="f-1918" unitRef="usd">17000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="c-457" decimals="-6" id="f-1919" unitRef="usd">10000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets contextRef="c-452" decimals="-6" id="f-1920" unitRef="usd">31000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets contextRef="c-453" decimals="-6" id="f-1921" unitRef="usd">21000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets contextRef="c-454" decimals="-6" id="f-1922" unitRef="usd">106000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets contextRef="c-455" decimals="-6" id="f-1923" unitRef="usd">47000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets contextRef="c-459" decimals="-6" id="f-1924" unitRef="usd">42000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets contextRef="c-457" decimals="-6" id="f-1925" unitRef="usd">55000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <iff:DefinedBenefitPlanAmortizationAndDeferralsNet contextRef="c-452" decimals="-6" id="f-1926" unitRef="usd">2000000</iff:DefinedBenefitPlanAmortizationAndDeferralsNet>
    <iff:DefinedBenefitPlanAmortizationAndDeferralsNet contextRef="c-453" decimals="-6" id="f-1927" unitRef="usd">8000000</iff:DefinedBenefitPlanAmortizationAndDeferralsNet>
    <iff:DefinedBenefitPlanAmortizationAndDeferralsNet contextRef="c-454" decimals="-6" id="f-1928" unitRef="usd">29000000</iff:DefinedBenefitPlanAmortizationAndDeferralsNet>
    <iff:DefinedBenefitPlanAmortizationAndDeferralsNet contextRef="c-455" decimals="-6" id="f-1929" unitRef="usd">-1000000</iff:DefinedBenefitPlanAmortizationAndDeferralsNet>
    <iff:DefinedBenefitPlanAmortizationAndDeferralsNet contextRef="c-459" decimals="-6" id="f-1930" unitRef="usd">11000000</iff:DefinedBenefitPlanAmortizationAndDeferralsNet>
    <iff:DefinedBenefitPlanAmortizationAndDeferralsNet contextRef="c-457" decimals="-6" id="f-1931" unitRef="usd">19000000</iff:DefinedBenefitPlanAmortizationAndDeferralsNet>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1 contextRef="c-452" decimals="-6" id="f-1932" unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1 contextRef="c-453" decimals="-6" id="f-1933" unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1 contextRef="c-454" decimals="-6" id="f-1934" unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1 contextRef="c-455" decimals="-6" id="f-1935" unitRef="usd">8000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1 contextRef="c-459" decimals="-6" id="f-1936" unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1 contextRef="c-457" decimals="-6" id="f-1937" unitRef="usd">10000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="c-452" decimals="-6" id="f-1938" unitRef="usd">-4000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="c-453" decimals="-6" id="f-1939" unitRef="usd">3000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="c-454" decimals="-6" id="f-1940" unitRef="usd">-5000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="c-455" decimals="-6" id="f-1941" unitRef="usd">1000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="c-459" decimals="-6" id="f-1942" unitRef="usd">20000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="c-457" decimals="-6" id="f-1943" unitRef="usd">5000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <iff:DefinedContributionAndOtherRetirementPlans contextRef="c-452" decimals="-6" id="f-1944" unitRef="usd">30000000</iff:DefinedContributionAndOtherRetirementPlans>
    <iff:DefinedContributionAndOtherRetirementPlans contextRef="c-453" decimals="-6" id="f-1945" unitRef="usd">33000000</iff:DefinedContributionAndOtherRetirementPlans>
    <iff:DefinedContributionAndOtherRetirementPlans contextRef="c-454" decimals="-6" id="f-1946" unitRef="usd">36000000</iff:DefinedContributionAndOtherRetirementPlans>
    <iff:DefinedContributionAndOtherRetirementPlans contextRef="c-455" decimals="-6" id="f-1947" unitRef="usd">51000000</iff:DefinedContributionAndOtherRetirementPlans>
    <iff:DefinedContributionAndOtherRetirementPlans contextRef="c-459" decimals="-6" id="f-1948" unitRef="usd">29000000</iff:DefinedContributionAndOtherRetirementPlans>
    <iff:DefinedContributionAndOtherRetirementPlans contextRef="c-457" decimals="-6" id="f-1949" unitRef="usd">33000000</iff:DefinedContributionAndOtherRetirementPlans>
    <us-gaap:PensionAndOtherPostretirementBenefitExpense contextRef="c-452" decimals="-6" id="f-1950" unitRef="usd">26000000</us-gaap:PensionAndOtherPostretirementBenefitExpense>
    <us-gaap:PensionAndOtherPostretirementBenefitExpense contextRef="c-453" decimals="-6" id="f-1951" unitRef="usd">36000000</us-gaap:PensionAndOtherPostretirementBenefitExpense>
    <us-gaap:PensionAndOtherPostretirementBenefitExpense contextRef="c-454" decimals="-6" id="f-1952" unitRef="usd">31000000</us-gaap:PensionAndOtherPostretirementBenefitExpense>
    <us-gaap:PensionAndOtherPostretirementBenefitExpense contextRef="c-455" decimals="-6" id="f-1953" unitRef="usd">52000000</us-gaap:PensionAndOtherPostretirementBenefitExpense>
    <us-gaap:PensionAndOtherPostretirementBenefitExpense contextRef="c-459" decimals="-6" id="f-1954" unitRef="usd">49000000</us-gaap:PensionAndOtherPostretirementBenefitExpense>
    <us-gaap:PensionAndOtherPostretirementBenefitExpense contextRef="c-457" decimals="-6" id="f-1955" unitRef="usd">38000000</us-gaap:PensionAndOtherPostretirementBenefitExpense>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax contextRef="c-452" decimals="-6" id="f-1956" unitRef="usd">-27000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax contextRef="c-453" decimals="-6" id="f-1957" unitRef="usd">0</us-gaap:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax contextRef="c-455" decimals="-6" id="f-1958" unitRef="usd">-70000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax contextRef="c-459" decimals="-6" id="f-1959" unitRef="usd">143000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax contextRef="c-452" decimals="-6" id="f-1960" unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax contextRef="c-453" decimals="-6" id="f-1961" unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax contextRef="c-455" decimals="-6" id="f-1962" unitRef="usd">-9000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax contextRef="c-459" decimals="-6" id="f-1963" unitRef="usd">12000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax contextRef="c-452" decimals="-6" id="f-1964" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax contextRef="c-453" decimals="-6" id="f-1965" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax contextRef="c-455" decimals="-6" id="f-1966" unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax contextRef="c-459" decimals="-6" id="f-1967" unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent contextRef="c-452" decimals="-6" id="f-1968" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent contextRef="c-453" decimals="-6" id="f-1969" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent contextRef="c-455" decimals="-6" id="f-1970" unitRef="usd">-9000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent contextRef="c-459" decimals="-6" id="f-1971" unitRef="usd">27000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax contextRef="c-452" decimals="-6" id="f-1972" unitRef="usd">26000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax contextRef="c-453" decimals="-6" id="f-1973" unitRef="usd">-8000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax contextRef="c-455" decimals="-6" id="f-1974" unitRef="usd">89000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax contextRef="c-459" decimals="-6" id="f-1975" unitRef="usd">-181000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <iff:ScheduleOfAmountsExpectedToBeRecognizedInNetPeriodicCostTableTableTextBlock contextRef="c-1" id="f-1976">&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.222%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.640%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Postretirement Benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Components of net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost for benefits earned&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost on projected benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net amortization and deferrals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total credit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Changes in plan assets and benefit obligations recognized in OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net actuarial loss (gain)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total recognized in OCI (before tax effects)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</iff:ScheduleOfAmountsExpectedToBeRecognizedInNetPeriodicCostTableTableTextBlock>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="c-460" decimals="-6" id="f-1977" unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="c-461" decimals="-6" id="f-1978" unitRef="usd">1000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="c-462" decimals="-6" id="f-1979" unitRef="usd">1000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="c-460" decimals="-6" id="f-1980" unitRef="usd">3000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="c-461" decimals="-6" id="f-1981" unitRef="usd">1000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="c-462" decimals="-6" id="f-1982" unitRef="usd">7000000</us-gaap:DefinedBenefitPlanInterestCost>
    <iff:DefinedBenefitPlanAmortizationAndDeferralsNet contextRef="c-460" decimals="-6" id="f-1983" unitRef="usd">-6000000</iff:DefinedBenefitPlanAmortizationAndDeferralsNet>
    <iff:DefinedBenefitPlanAmortizationAndDeferralsNet contextRef="c-461" decimals="-6" id="f-1984" unitRef="usd">-5000000</iff:DefinedBenefitPlanAmortizationAndDeferralsNet>
    <iff:DefinedBenefitPlanAmortizationAndDeferralsNet contextRef="c-462" decimals="-6" id="f-1985" unitRef="usd">-20000000</iff:DefinedBenefitPlanAmortizationAndDeferralsNet>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="c-460" decimals="-6" id="f-1986" unitRef="usd">-3000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="c-461" decimals="-6" id="f-1987" unitRef="usd">-3000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="c-462" decimals="-6" id="f-1988" unitRef="usd">-12000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax contextRef="c-460" decimals="-6" id="f-1989" unitRef="usd">-3000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax contextRef="c-461" decimals="-6" id="f-1990" unitRef="usd">16000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax contextRef="c-460" decimals="-6" id="f-1991" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax contextRef="c-461" decimals="-6" id="f-1992" unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax contextRef="c-460" decimals="-6" id="f-1993" unitRef="usd">5000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax contextRef="c-461" decimals="-6" id="f-1994" unitRef="usd">6000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax contextRef="c-460" decimals="-6" id="f-1995" unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax contextRef="c-461" decimals="-6" id="f-1996" unitRef="usd">-11000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:ScheduleOfAssumptionsUsedTableTextBlock contextRef="c-1" id="f-1997">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average actuarial assumptions used to determine expense at December&#160;31 of each year are:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:31.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.488%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.488%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.635%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.488%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.488%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.638%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAssumptionsUsedTableTextBlock>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="c-452"
      decimals="4"
      id="f-1998"
      unitRef="number">0.0542</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="c-453"
      decimals="4"
      id="f-1999"
      unitRef="number">0.0286</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="c-454"
      decimals="4"
      id="f-2000"
      unitRef="number">0.0251</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="c-455"
      decimals="4"
      id="f-2001"
      unitRef="number">0.0398</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="c-459"
      decimals="4"
      id="f-2002"
      unitRef="number">0.0143</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="c-457"
      decimals="4"
      id="f-2003"
      unitRef="number">0.0085</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="c-452"
      decimals="4"
      id="f-2004"
      unitRef="number">0.0600</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="c-453"
      decimals="4"
      id="f-2005"
      unitRef="number">0.0380</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="c-454"
      decimals="4"
      id="f-2006"
      unitRef="number">0.0380</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="c-455"
      decimals="4"
      id="f-2007"
      unitRef="number">0.0492</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="c-459"
      decimals="4"
      id="f-2008"
      unitRef="number">0.0352</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="c-457"
      decimals="4"
      id="f-2009"
      unitRef="number">0.0421</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="c-452"
      decimals="4"
      id="f-2010"
      unitRef="number">0.0375</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="c-453"
      decimals="4"
      id="f-2011"
      unitRef="number">0.0325</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="c-454"
      decimals="4"
      id="f-2012"
      unitRef="number">0.0325</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="c-455"
      decimals="4"
      id="f-2013"
      unitRef="number">0.0301</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="c-459"
      decimals="4"
      id="f-2014"
      unitRef="number">0.0272</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="c-457"
      decimals="4"
      id="f-2015"
      unitRef="number">0.0256</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:ScheduleOfChangesInAccumulatedPostemploymentBenefitObligationsTableTextBlock contextRef="c-1" id="f-2016">&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the postretirement benefit obligation and plan assets, as applicable, are detailed in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:35.996%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.724%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.724%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.870%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.870%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.724%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.727%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Postretirement Benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost for benefits earned&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost on projected benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial (gain) loss &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(139)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(468)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments for expense/tax contained in service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan participants&#x2019; contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Curtailments/settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(286)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employer contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Participants&#x2019; contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Funded status at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfChangesInAccumulatedPostemploymentBenefitObligationsTableTextBlock>
    <us-gaap:DefinedBenefitPlanBenefitObligation contextRef="c-463" decimals="-6" id="f-2017" unitRef="usd">500000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation contextRef="c-464" decimals="-6" id="f-2018" unitRef="usd">662000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation contextRef="c-465" decimals="-6" id="f-2019" unitRef="usd">930000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation contextRef="c-466" decimals="-6" id="f-2020" unitRef="usd">1501000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation contextRef="c-467" decimals="-6" id="f-2021" unitRef="usd">50000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation contextRef="c-468" decimals="-6" id="f-2022" unitRef="usd">66000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="c-452" decimals="-6" id="f-2023" unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="c-453" decimals="-6" id="f-2024" unitRef="usd">1000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="c-455" decimals="-6" id="f-2025" unitRef="usd">21000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="c-459" decimals="-6" id="f-2026" unitRef="usd">34000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="c-460" decimals="-6" id="f-2027" unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="c-461" decimals="-6" id="f-2028" unitRef="usd">1000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="c-452" decimals="-6" id="f-2029" unitRef="usd">25000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="c-453" decimals="-6" id="f-2030" unitRef="usd">15000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="c-455" decimals="-6" id="f-2031" unitRef="usd">36000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="c-459" decimals="-6" id="f-2032" unitRef="usd">17000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="c-469" decimals="-6" id="f-2033" unitRef="usd">3000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="c-470" decimals="-6" id="f-2034" unitRef="usd">2000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss contextRef="c-452" decimals="-6" id="f-2035" unitRef="usd">-38000000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss contextRef="c-453" decimals="-6" id="f-2036" unitRef="usd">139000000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss contextRef="c-455" decimals="-6" id="f-2037" unitRef="usd">-77000000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss contextRef="c-459" decimals="-6" id="f-2038" unitRef="usd">468000000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss contextRef="c-460" decimals="-6" id="f-2039" unitRef="usd">-3000000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss contextRef="c-461" decimals="-6" id="f-2040" unitRef="usd">16000000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <iff:DefinedBenefitPlanAdjustmentsForExpenseOrTaxContainedInServiceCost contextRef="c-452" decimals="-6" id="f-2041" unitRef="usd">0</iff:DefinedBenefitPlanAdjustmentsForExpenseOrTaxContainedInServiceCost>
    <iff:DefinedBenefitPlanAdjustmentsForExpenseOrTaxContainedInServiceCost contextRef="c-453" decimals="-6" id="f-2042" unitRef="usd">0</iff:DefinedBenefitPlanAdjustmentsForExpenseOrTaxContainedInServiceCost>
    <iff:DefinedBenefitPlanAdjustmentsForExpenseOrTaxContainedInServiceCost contextRef="c-455" decimals="-6" id="f-2043" unitRef="usd">2000000</iff:DefinedBenefitPlanAdjustmentsForExpenseOrTaxContainedInServiceCost>
    <iff:DefinedBenefitPlanAdjustmentsForExpenseOrTaxContainedInServiceCost contextRef="c-459" decimals="-6" id="f-2044" unitRef="usd">2000000</iff:DefinedBenefitPlanAdjustmentsForExpenseOrTaxContainedInServiceCost>
    <iff:DefinedBenefitPlanAdjustmentsForExpenseOrTaxContainedInServiceCost contextRef="c-460" decimals="-6" id="f-2045" unitRef="usd">0</iff:DefinedBenefitPlanAdjustmentsForExpenseOrTaxContainedInServiceCost>
    <iff:DefinedBenefitPlanAdjustmentsForExpenseOrTaxContainedInServiceCost contextRef="c-461" decimals="-6" id="f-2046" unitRef="usd">0</iff:DefinedBenefitPlanAdjustmentsForExpenseOrTaxContainedInServiceCost>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant contextRef="c-452" decimals="-6" id="f-2047" unitRef="usd">0</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant contextRef="c-453" decimals="-6" id="f-2048" unitRef="usd">0</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant contextRef="c-455" decimals="-6" id="f-2049" unitRef="usd">4000000</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant contextRef="c-459" decimals="-6" id="f-2050" unitRef="usd">4000000</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant contextRef="c-460" decimals="-6" id="f-2051" unitRef="usd">0</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant contextRef="c-461" decimals="-6" id="f-2052" unitRef="usd">0</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid contextRef="c-452" decimals="-6" id="f-2053" unitRef="usd">39000000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid contextRef="c-453" decimals="-6" id="f-2054" unitRef="usd">38000000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid contextRef="c-455" decimals="-6" id="f-2055" unitRef="usd">33000000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid contextRef="c-459" decimals="-6" id="f-2056" unitRef="usd">32000000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid contextRef="c-460" decimals="-6" id="f-2057" unitRef="usd">3000000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid contextRef="c-461" decimals="-6" id="f-2058" unitRef="usd">2000000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <iff:DefinedBenefitPlanCurtailmentsAndSettlementsBenefitObligation contextRef="c-452" decimals="-6" id="f-2059" unitRef="usd">1000000</iff:DefinedBenefitPlanCurtailmentsAndSettlementsBenefitObligation>
    <iff:DefinedBenefitPlanCurtailmentsAndSettlementsBenefitObligation contextRef="c-453" decimals="-6" id="f-2060" unitRef="usd">0</iff:DefinedBenefitPlanCurtailmentsAndSettlementsBenefitObligation>
    <iff:DefinedBenefitPlanCurtailmentsAndSettlementsBenefitObligation contextRef="c-455" decimals="-6" id="f-2061" unitRef="usd">21000000</iff:DefinedBenefitPlanCurtailmentsAndSettlementsBenefitObligation>
    <iff:DefinedBenefitPlanCurtailmentsAndSettlementsBenefitObligation contextRef="c-459" decimals="-6" id="f-2062" unitRef="usd">21000000</iff:DefinedBenefitPlanCurtailmentsAndSettlementsBenefitObligation>
    <iff:DefinedBenefitPlanCurtailmentsAndSettlementsBenefitObligation contextRef="c-460" decimals="-6" id="f-2063" unitRef="usd">0</iff:DefinedBenefitPlanCurtailmentsAndSettlementsBenefitObligation>
    <iff:DefinedBenefitPlanCurtailmentsAndSettlementsBenefitObligation contextRef="c-461" decimals="-6" id="f-2064" unitRef="usd">0</iff:DefinedBenefitPlanCurtailmentsAndSettlementsBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation contextRef="c-452" decimals="-6" id="f-2065" unitRef="usd">0</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation contextRef="c-453" decimals="-6" id="f-2066" unitRef="usd">0</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation contextRef="c-455" decimals="-6" id="f-2067" unitRef="usd">-45000000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation contextRef="c-459" decimals="-6" id="f-2068" unitRef="usd">104000000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation contextRef="c-460" decimals="-6" id="f-2069" unitRef="usd">0</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation contextRef="c-461" decimals="-6" id="f-2070" unitRef="usd">0</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <iff:DefinedBenefitPlanBenefitObligationOther contextRef="c-452" decimals="-6" id="f-2071" unitRef="usd">1000000</iff:DefinedBenefitPlanBenefitObligationOther>
    <iff:DefinedBenefitPlanBenefitObligationOther contextRef="c-453" decimals="-6" id="f-2072" unitRef="usd">-1000000</iff:DefinedBenefitPlanBenefitObligationOther>
    <iff:DefinedBenefitPlanBenefitObligationOther contextRef="c-455" decimals="-6" id="f-2073" unitRef="usd">-1000000</iff:DefinedBenefitPlanBenefitObligationOther>
    <iff:DefinedBenefitPlanBenefitObligationOther contextRef="c-459" decimals="-6" id="f-2074" unitRef="usd">1000000</iff:DefinedBenefitPlanBenefitObligationOther>
    <iff:DefinedBenefitPlanBenefitObligationOther contextRef="c-460" decimals="-6" id="f-2075" unitRef="usd">-1000000</iff:DefinedBenefitPlanBenefitObligationOther>
    <iff:DefinedBenefitPlanBenefitObligationOther contextRef="c-461" decimals="-6" id="f-2076" unitRef="usd">-1000000</iff:DefinedBenefitPlanBenefitObligationOther>
    <us-gaap:DefinedBenefitPlanBenefitObligation contextRef="c-471" decimals="-6" id="f-2077" unitRef="usd">524000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation contextRef="c-463" decimals="-6" id="f-2078" unitRef="usd">500000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation contextRef="c-472" decimals="-6" id="f-2079" unitRef="usd">1056000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation contextRef="c-465" decimals="-6" id="f-2080" unitRef="usd">930000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation contextRef="c-473" decimals="-6" id="f-2081" unitRef="usd">52000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation contextRef="c-467" decimals="-6" id="f-2082" unitRef="usd">50000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-463" decimals="-6" id="f-2083" unitRef="usd">498000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-464" decimals="-6" id="f-2084" unitRef="usd">649000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-465" decimals="-6" id="f-2085" unitRef="usd">920000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-466" decimals="-6" id="f-2086" unitRef="usd">1320000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets contextRef="c-452" decimals="-6" id="f-2087" unitRef="usd">41000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets contextRef="c-453" decimals="-6" id="f-2088" unitRef="usd">-118000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets contextRef="c-455" decimals="-6" id="f-2089" unitRef="usd">50000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets contextRef="c-459" decimals="-6" id="f-2090" unitRef="usd">-286000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer contextRef="c-452" decimals="-6" id="f-2091" unitRef="usd">5000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer contextRef="c-453" decimals="-6" id="f-2092" unitRef="usd">5000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer contextRef="c-455" decimals="-6" id="f-2093" unitRef="usd">31000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer contextRef="c-459" decimals="-6" id="f-2094" unitRef="usd">31000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant contextRef="c-452" decimals="-6" id="f-2095" unitRef="usd">0</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant contextRef="c-453" decimals="-6" id="f-2096" unitRef="usd">0</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant contextRef="c-455" decimals="-6" id="f-2097" unitRef="usd">4000000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant contextRef="c-459" decimals="-6" id="f-2098" unitRef="usd">4000000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid contextRef="c-452" decimals="-6" id="f-2099" unitRef="usd">39000000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid contextRef="c-453" decimals="-6" id="f-2100" unitRef="usd">38000000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid contextRef="c-455" decimals="-6" id="f-2101" unitRef="usd">33000000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid contextRef="c-459" decimals="-6" id="f-2102" unitRef="usd">32000000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1 contextRef="c-452" decimals="-6" id="f-2103" unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1 contextRef="c-453" decimals="-6" id="f-2104" unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1 contextRef="c-455" decimals="-6" id="f-2105" unitRef="usd">21000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1 contextRef="c-459" decimals="-6" id="f-2106" unitRef="usd">21000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss contextRef="c-452" decimals="-6" id="f-2107" unitRef="usd">0</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss contextRef="c-453" decimals="-6" id="f-2108" unitRef="usd">0</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss contextRef="c-455" decimals="-6" id="f-2109" unitRef="usd">-44000000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss contextRef="c-459" decimals="-6" id="f-2110" unitRef="usd">96000000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <iff:DefinedBenefitPlanPlanAssetsOther contextRef="c-452" decimals="-6" id="f-2111" unitRef="usd">0</iff:DefinedBenefitPlanPlanAssetsOther>
    <iff:DefinedBenefitPlanPlanAssetsOther contextRef="c-453" decimals="-6" id="f-2112" unitRef="usd">0</iff:DefinedBenefitPlanPlanAssetsOther>
    <iff:DefinedBenefitPlanPlanAssetsOther contextRef="c-455" decimals="-6" id="f-2113" unitRef="usd">5000000</iff:DefinedBenefitPlanPlanAssetsOther>
    <iff:DefinedBenefitPlanPlanAssetsOther contextRef="c-459" decimals="-6" id="f-2114" unitRef="usd">0</iff:DefinedBenefitPlanPlanAssetsOther>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-471" decimals="-6" id="f-2115" unitRef="usd">505000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-463" decimals="-6" id="f-2116" unitRef="usd">498000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-472" decimals="-6" id="f-2117" unitRef="usd">1000000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-465" decimals="-6" id="f-2118" unitRef="usd">920000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan contextRef="c-471" decimals="-6" id="f-2119" unitRef="usd">-19000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan contextRef="c-463" decimals="-6" id="f-2120" unitRef="usd">-2000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan contextRef="c-472" decimals="-6" id="f-2121" unitRef="usd">-56000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan contextRef="c-465" decimals="-6" id="f-2122" unitRef="usd">-10000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock contextRef="c-1" id="f-2123">&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amounts recognized in the balance sheet are detailed in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.752%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.641%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Retirement liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(138)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net amount recognized&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent contextRef="c-471" decimals="-6" id="f-2124" unitRef="usd">30000000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent contextRef="c-463" decimals="-6" id="f-2125" unitRef="usd">51000000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent contextRef="c-472" decimals="-6" id="f-2126" unitRef="usd">109000000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent contextRef="c-465" decimals="-6" id="f-2127" unitRef="usd">129000000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities contextRef="c-471" decimals="-6" id="f-2128" unitRef="usd">5000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities contextRef="c-463" decimals="-6" id="f-2129" unitRef="usd">6000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities contextRef="c-472" decimals="-6" id="f-2130" unitRef="usd">4000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities contextRef="c-465" decimals="-6" id="f-2131" unitRef="usd">1000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent contextRef="c-471" decimals="-6" id="f-2132" unitRef="usd">44000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent contextRef="c-463" decimals="-6" id="f-2133" unitRef="usd">47000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent contextRef="c-472" decimals="-6" id="f-2134" unitRef="usd">161000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent contextRef="c-465" decimals="-6" id="f-2135" unitRef="usd">138000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet contextRef="c-471" decimals="-6" id="f-2136" unitRef="usd">-19000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet contextRef="c-463" decimals="-6" id="f-2137" unitRef="usd">-2000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet contextRef="c-472" decimals="-6" id="f-2138" unitRef="usd">-56000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet contextRef="c-465" decimals="-6" id="f-2139" unitRef="usd">-10000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock contextRef="c-1" id="f-2140">&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amounts recognized in AOCI are detailed in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:36.381%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.709%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.709%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.709%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.709%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.709%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.714%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Postretirement Benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net actuarial (gain) loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service cost (credit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total AOCI (before tax effects)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax contextRef="c-471" decimals="-6" id="f-2141" unitRef="usd">-155000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax contextRef="c-463" decimals="-6" id="f-2142" unitRef="usd">-129000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax contextRef="c-472" decimals="-6" id="f-2143" unitRef="usd">-198000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax contextRef="c-465" decimals="-6" id="f-2144" unitRef="usd">-110000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax contextRef="c-473" decimals="-6" id="f-2145" unitRef="usd">0</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax contextRef="c-467" decimals="-6" id="f-2146" unitRef="usd">3000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax contextRef="c-471" decimals="-6" id="f-2147" unitRef="usd">0</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax contextRef="c-463" decimals="-6" id="f-2148" unitRef="usd">0</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax contextRef="c-472" decimals="-6" id="f-2149" unitRef="usd">-2000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax contextRef="c-465" decimals="-6" id="f-2150" unitRef="usd">-3000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax contextRef="c-473" decimals="-6" id="f-2151" unitRef="usd">-4000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax contextRef="c-467" decimals="-6" id="f-2152" unitRef="usd">-9000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax contextRef="c-471" decimals="-6" id="f-2153" unitRef="usd">155000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax contextRef="c-463" decimals="-6" id="f-2154" unitRef="usd">129000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax contextRef="c-472" decimals="-6" id="f-2155" unitRef="usd">196000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax contextRef="c-465" decimals="-6" id="f-2156" unitRef="usd">107000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax contextRef="c-473" decimals="-6" id="f-2157" unitRef="usd">-4000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax contextRef="c-467" decimals="-6" id="f-2158" unitRef="usd">-12000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <us-gaap:ScheduleOfAccumulatedAndProjectedBenefitObligationsTableTextBlock contextRef="c-1" id="f-2159">&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.752%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.641%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated Benefit Obligation &#x2014; end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Information for Pension Plans with an Accumulated Benefit Obligation (&#x201c;ABO&#x201d;) in excess of Plan Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Information for Pension Plans with a Projected Benefit Obligation (&#x201c;PBO&#x201d;) in excess of Plan Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average assumptions used to determine obligations at December&#160;31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedAndProjectedBenefitObligationsTableTextBlock>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation contextRef="c-471" decimals="-6" id="f-2160" unitRef="usd">520000000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation contextRef="c-463" decimals="-6" id="f-2161" unitRef="usd">495000000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation contextRef="c-472" decimals="-6" id="f-2162" unitRef="usd">988000000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation contextRef="c-465" decimals="-6" id="f-2163" unitRef="usd">870000000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation contextRef="c-471" decimals="-6" id="f-2164" unitRef="usd">47000000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation contextRef="c-463" decimals="-6" id="f-2165" unitRef="usd">49000000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation contextRef="c-472" decimals="-6" id="f-2166" unitRef="usd">165000000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation contextRef="c-465" decimals="-6" id="f-2167" unitRef="usd">150000000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets contextRef="c-471" decimals="-6" id="f-2168" unitRef="usd">0</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets contextRef="c-463" decimals="-6" id="f-2169" unitRef="usd">0</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets contextRef="c-472" decimals="-6" id="f-2170" unitRef="usd">36000000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets contextRef="c-465" decimals="-6" id="f-2171" unitRef="usd">41000000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation contextRef="c-471" decimals="-6" id="f-2172" unitRef="usd">47000000</us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation contextRef="c-463" decimals="-6" id="f-2173" unitRef="usd">49000000</us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation contextRef="c-472" decimals="-6" id="f-2174" unitRef="usd">185000000</us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation contextRef="c-465" decimals="-6" id="f-2175" unitRef="usd">169000000</us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets contextRef="c-471" decimals="-6" id="f-2176" unitRef="usd">0</us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets>
    <us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets contextRef="c-463" decimals="-6" id="f-2177" unitRef="usd">0</us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets>
    <us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets contextRef="c-472" decimals="-6" id="f-2178" unitRef="usd">41000000</us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets>
    <us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets contextRef="c-465" decimals="-6" id="f-2179" unitRef="usd">45000000</us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="c-471"
      decimals="4"
      id="f-2180"
      unitRef="number">0.0447</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="c-463"
      decimals="4"
      id="f-2181"
      unitRef="number">0.0542</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="c-472"
      decimals="4"
      id="f-2182"
      unitRef="number">0.0359</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="c-465"
      decimals="4"
      id="f-2183"
      unitRef="number">0.0402</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="c-471"
      decimals="4"
      id="f-2184"
      unitRef="number">0.0375</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="c-463"
      decimals="4"
      id="f-2185"
      unitRef="number">0.0375</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="c-472"
      decimals="4"
      id="f-2186"
      unitRef="number">0.0283</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="c-465"
      decimals="4"
      id="f-2187"
      unitRef="number">0.0300</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock contextRef="c-1" id="f-2188">&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:56.462%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.556%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.556%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.558%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-U.S.&#160;Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Postretirement&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Estimated Future Benefit Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029 - 2033&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Required Company Contributions in the Following Year (2024)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths contextRef="c-471" decimals="-6" id="f-2189" unitRef="usd">99000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths contextRef="c-472" decimals="-6" id="f-2190" unitRef="usd">39000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths contextRef="c-473" decimals="-6" id="f-2191" unitRef="usd">4000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo contextRef="c-471" decimals="-6" id="f-2192" unitRef="usd">38000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo contextRef="c-472" decimals="-6" id="f-2193" unitRef="usd">36000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo contextRef="c-473" decimals="-6" id="f-2194" unitRef="usd">4000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree contextRef="c-471" decimals="-6" id="f-2195" unitRef="usd">38000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree contextRef="c-472" decimals="-6" id="f-2196" unitRef="usd">41000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree contextRef="c-473" decimals="-6" id="f-2197" unitRef="usd">4000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour contextRef="c-471" decimals="-6" id="f-2198" unitRef="usd">37000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour contextRef="c-472" decimals="-6" id="f-2199" unitRef="usd">40000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour contextRef="c-473" decimals="-6" id="f-2200" unitRef="usd">4000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive contextRef="c-471" decimals="-6" id="f-2201" unitRef="usd">36000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive contextRef="c-472" decimals="-6" id="f-2202" unitRef="usd">45000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive contextRef="c-473" decimals="-6" id="f-2203" unitRef="usd">4000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter contextRef="c-471" decimals="-6" id="f-2204" unitRef="usd">166000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter contextRef="c-472" decimals="-6" id="f-2205" unitRef="usd">239000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter contextRef="c-473" decimals="-6" id="f-2206" unitRef="usd">18000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear contextRef="c-471" decimals="-6" id="f-2207" unitRef="usd">5000000</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear contextRef="c-472" decimals="-6" id="f-2208" unitRef="usd">20000000</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear contextRef="c-473" decimals="-6" id="f-2209" unitRef="usd">0</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear>
    <us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock contextRef="c-1" id="f-2210">&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The percentage of assets in the Company&#x2019;s pension plans, by type, is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.752%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.641%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-U.S.&#160;Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Alternative and other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-474"
      decimals="2"
      id="f-2211"
      unitRef="number">0.01</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-475"
      decimals="2"
      id="f-2212"
      unitRef="number">0.02</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-476"
      decimals="2"
      id="f-2213"
      unitRef="number">0.03</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-477"
      decimals="2"
      id="f-2214"
      unitRef="number">0.03</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-478"
      decimals="2"
      id="f-2215"
      unitRef="number">0.13</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-479"
      decimals="2"
      id="f-2216"
      unitRef="number">0.47</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-480"
      decimals="2"
      id="f-2217"
      unitRef="number">0.16</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-481"
      decimals="2"
      id="f-2218"
      unitRef="number">0.18</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-482"
      decimals="2"
      id="f-2219"
      unitRef="number">0.86</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-483"
      decimals="2"
      id="f-2220"
      unitRef="number">0.51</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-484"
      decimals="2"
      id="f-2221"
      unitRef="number">0.42</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-485"
      decimals="2"
      id="f-2222"
      unitRef="number">0.37</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-486"
      decimals="2"
      id="f-2223"
      unitRef="number">0</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-487"
      decimals="2"
      id="f-2224"
      unitRef="number">0</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-488"
      decimals="2"
      id="f-2225"
      unitRef="number">0.08</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-489"
      decimals="2"
      id="f-2226"
      unitRef="number">0.09</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-490"
      decimals="2"
      id="f-2227"
      unitRef="number">0</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-491"
      decimals="2"
      id="f-2228"
      unitRef="number">0</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-492"
      decimals="2"
      id="f-2229"
      unitRef="number">0.31</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-493"
      decimals="2"
      id="f-2230"
      unitRef="number">0.33</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="c-494"
      decimals="INF"
      id="f-2231"
      unitRef="number">0.10</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="c-495"
      decimals="INF"
      id="f-2232"
      unitRef="number">0.90</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <iff:ScheduleOfFairValueOfPensionPlanAssetsByAssetCategoryTableTableTextBlock contextRef="c-1" id="f-2233">&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the Company&#x2019;s plan assets for the U.S. and non-U.S. plans using the fair value hierarchy as of December&#160;31, 2023 and 2022. The plans&#x2019; assets were accounted for at fair value and are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company&#x2019;s assessment of the significance of a particular input to the fair value measurement requires judgment, and may affect the valuation of fair value assets and their placement within the fair value hierarchy levels. For more information on a description of the fair value hierarchy, see Note 16.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.752%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.641%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Plans for the Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Cash Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Fixed Income Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government&#160;&amp;amp; Government Agency Bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate Bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal Bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Assets measured at net asset value&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.752%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.641%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Plans for the Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Cash Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Fixed Income Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government&#160;&amp;amp; Government Agency Bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate Bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal Bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Assets measured at net asset value&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy. The fair value amounts presented in the table above are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Balance Sheets. The total amount measured at net asset value includes approximately $65 million and $234 million in pooled equity funds and $341 million and $170 million in fixed income mutual funds for the years ended December&#160;31, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.752%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.641%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-U.S. Plans for the Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Equity Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Large Cap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Mid Cap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Small Cap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. Large Cap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. Mid Cap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. Small Cap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Emerging Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Fixed Income Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Corporate Bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. Treasuries/Government Bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. Corporate Bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. Asset-Backed Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. Other Fixed Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Alternative Types of Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Insurance Contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Absolute Return Funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Private Equity Funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Property&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. Property&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.752%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.641%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-U.S. Plans for the Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Equity Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Large Cap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Mid Cap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. Large Cap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. Mid Cap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. Small Cap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Emerging Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Fixed Income Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Corporate Bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. Treasuries/Government Bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. Corporate Bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. Asset-Backed Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. Other Fixed Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Alternative Types of Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Insurance Contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Absolute Return Funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Property&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. Property&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</iff:ScheduleOfFairValueOfPensionPlanAssetsByAssetCategoryTableTableTextBlock>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-496" decimals="-6" id="f-2234" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-497" decimals="-6" id="f-2235" unitRef="usd">6000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-498" decimals="-6" id="f-2236" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-474" decimals="-6" id="f-2237" unitRef="usd">6000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-499" decimals="-6" id="f-2238" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-500" decimals="-6" id="f-2239" unitRef="usd">5000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-501" decimals="-6" id="f-2240" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-502" decimals="-6" id="f-2241" unitRef="usd">5000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-503" decimals="-6" id="f-2242" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-504" decimals="-6" id="f-2243" unitRef="usd">82000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-505" decimals="-6" id="f-2244" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-506" decimals="-6" id="f-2245" unitRef="usd">82000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-507" decimals="-6" id="f-2246" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-508" decimals="-6" id="f-2247" unitRef="usd">5000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-509" decimals="-6" id="f-2248" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-510" decimals="-6" id="f-2249" unitRef="usd">5000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-511" decimals="-6" id="f-2250" unitRef="usd">406000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-512" decimals="-6" id="f-2251" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-513" decimals="-6" id="f-2252" unitRef="usd">98000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-514" decimals="-6" id="f-2253" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-515" decimals="-6" id="f-2254" unitRef="usd">504000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-516" decimals="-6" id="f-2255" unitRef="usd">1000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-471" decimals="-6" id="f-2256" unitRef="usd">505000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-517" decimals="-6" id="f-2257" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-518" decimals="-6" id="f-2258" unitRef="usd">9000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-519" decimals="-6" id="f-2259" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-475" decimals="-6" id="f-2260" unitRef="usd">9000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-520" decimals="-6" id="f-2261" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-521" decimals="-6" id="f-2262" unitRef="usd">6000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-522" decimals="-6" id="f-2263" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-523" decimals="-6" id="f-2264" unitRef="usd">6000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-524" decimals="-6" id="f-2265" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-525" decimals="-6" id="f-2266" unitRef="usd">73000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-526" decimals="-6" id="f-2267" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-527" decimals="-6" id="f-2268" unitRef="usd">73000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-528" decimals="-6" id="f-2269" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-529" decimals="-6" id="f-2270" unitRef="usd">5000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-530" decimals="-6" id="f-2271" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-531" decimals="-6" id="f-2272" unitRef="usd">5000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-532" decimals="-6" id="f-2273" unitRef="usd">404000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-533" decimals="-6" id="f-2274" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-534" decimals="-6" id="f-2275" unitRef="usd">93000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-535" decimals="-6" id="f-2276" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-536" decimals="-6" id="f-2277" unitRef="usd">497000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-537" decimals="-6" id="f-2278" unitRef="usd">1000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-463" decimals="-6" id="f-2279" unitRef="usd">498000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-538" decimals="-6" id="f-2280" unitRef="usd">65000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-539" decimals="-6" id="f-2281" unitRef="usd">234000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-540" decimals="-6" id="f-2282" unitRef="usd">341000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-541" decimals="-6" id="f-2283" unitRef="usd">170000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-542" decimals="-6" id="f-2284" unitRef="usd">27000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-543" decimals="-6" id="f-2285" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-544" decimals="-6" id="f-2286" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-545" decimals="-6" id="f-2287" unitRef="usd">27000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-546" decimals="-6" id="f-2288" unitRef="usd">90000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-547" decimals="-6" id="f-2289" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-548" decimals="-6" id="f-2290" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-549" decimals="-6" id="f-2291" unitRef="usd">90000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-550" decimals="-6" id="f-2292" unitRef="usd">8000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-551" decimals="-6" id="f-2293" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-552" decimals="-6" id="f-2294" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-553" decimals="-6" id="f-2295" unitRef="usd">8000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-554" decimals="-6" id="f-2296" unitRef="usd">1000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-555" decimals="-6" id="f-2297" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-556" decimals="-6" id="f-2298" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-557" decimals="-6" id="f-2299" unitRef="usd">1000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-558" decimals="-6" id="f-2300" unitRef="usd">50000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-559" decimals="-6" id="f-2301" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-560" decimals="-6" id="f-2302" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-561" decimals="-6" id="f-2303" unitRef="usd">50000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-562" decimals="-6" id="f-2304" unitRef="usd">5000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-563" decimals="-6" id="f-2305" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-564" decimals="-6" id="f-2306" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-565" decimals="-6" id="f-2307" unitRef="usd">5000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-566" decimals="-6" id="f-2308" unitRef="usd">1000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-567" decimals="-6" id="f-2309" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-568" decimals="-6" id="f-2310" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-569" decimals="-6" id="f-2311" unitRef="usd">1000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-570" decimals="-6" id="f-2312" unitRef="usd">8000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-571" decimals="-6" id="f-2313" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-572" decimals="-6" id="f-2314" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-573" decimals="-6" id="f-2315" unitRef="usd">8000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-574" decimals="-6" id="f-2316" unitRef="usd">29000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-575" decimals="-6" id="f-2317" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-576" decimals="-6" id="f-2318" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-577" decimals="-6" id="f-2319" unitRef="usd">29000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-578" decimals="-6" id="f-2320" unitRef="usd">194000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-579" decimals="-6" id="f-2321" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-580" decimals="-6" id="f-2322" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-581" decimals="-6" id="f-2323" unitRef="usd">194000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-582" decimals="-6" id="f-2324" unitRef="usd">50000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-583" decimals="-6" id="f-2325" unitRef="usd">88000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-584" decimals="-6" id="f-2326" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-585" decimals="-6" id="f-2327" unitRef="usd">138000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-586" decimals="-6" id="f-2328" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-587" decimals="-6" id="f-2329" unitRef="usd">56000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-588" decimals="-6" id="f-2330" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-589" decimals="-6" id="f-2331" unitRef="usd">56000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-590" decimals="-6" id="f-2332" unitRef="usd">2000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-591" decimals="-6" id="f-2333" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-592" decimals="-6" id="f-2334" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-593" decimals="-6" id="f-2335" unitRef="usd">2000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-594" decimals="-6" id="f-2336" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-595" decimals="-6" id="f-2337" unitRef="usd">247000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-596" decimals="-6" id="f-2338" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-597" decimals="-6" id="f-2339" unitRef="usd">247000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-598" decimals="-6" id="f-2340" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-599" decimals="-6" id="f-2341" unitRef="usd">28000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-600" decimals="-6" id="f-2342" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-601" decimals="-6" id="f-2343" unitRef="usd">28000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-602" decimals="-6" id="f-2344" unitRef="usd">3000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-603" decimals="-6" id="f-2345" unitRef="usd">2000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-604" decimals="-6" id="f-2346" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-605" decimals="-6" id="f-2347" unitRef="usd">5000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-606" decimals="-6" id="f-2348" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-607" decimals="-6" id="f-2349" unitRef="usd">27000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-608" decimals="-6" id="f-2350" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-609" decimals="-6" id="f-2351" unitRef="usd">27000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-610" decimals="-6" id="f-2352" unitRef="usd">7000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-611" decimals="-6" id="f-2353" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-612" decimals="-6" id="f-2354" unitRef="usd">77000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-488" decimals="-6" id="f-2355" unitRef="usd">84000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-613" decimals="-6" id="f-2356" unitRef="usd">475000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-614" decimals="-6" id="f-2357" unitRef="usd">448000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-615" decimals="-6" id="f-2358" unitRef="usd">77000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-616" decimals="-6" id="f-2359" unitRef="usd">1000000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-617" decimals="-6" id="f-2360" unitRef="usd">14000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-618" decimals="-6" id="f-2361" unitRef="usd">9000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-619" decimals="-6" id="f-2362" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-620" decimals="-6" id="f-2363" unitRef="usd">23000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-621" decimals="-6" id="f-2364" unitRef="usd">73000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-622" decimals="-6" id="f-2365" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-623" decimals="-6" id="f-2366" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-624" decimals="-6" id="f-2367" unitRef="usd">73000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-625" decimals="-6" id="f-2368" unitRef="usd">6000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-626" decimals="-6" id="f-2369" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-627" decimals="-6" id="f-2370" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-628" decimals="-6" id="f-2371" unitRef="usd">6000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-629" decimals="-6" id="f-2372" unitRef="usd">79000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-630" decimals="-6" id="f-2373" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-631" decimals="-6" id="f-2374" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-632" decimals="-6" id="f-2375" unitRef="usd">79000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-633" decimals="-6" id="f-2376" unitRef="usd">4000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-634" decimals="-6" id="f-2377" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-635" decimals="-6" id="f-2378" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-636" decimals="-6" id="f-2379" unitRef="usd">4000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-637" decimals="-6" id="f-2380" unitRef="usd">1000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-638" decimals="-6" id="f-2381" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-639" decimals="-6" id="f-2382" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-640" decimals="-6" id="f-2383" unitRef="usd">1000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-641" decimals="-6" id="f-2384" unitRef="usd">7000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-642" decimals="-6" id="f-2385" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-643" decimals="-6" id="f-2386" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-644" decimals="-6" id="f-2387" unitRef="usd">7000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-645" decimals="-6" id="f-2388" unitRef="usd">35000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-646" decimals="-6" id="f-2389" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-647" decimals="-6" id="f-2390" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-648" decimals="-6" id="f-2391" unitRef="usd">35000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-649" decimals="-6" id="f-2392" unitRef="usd">144000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-650" decimals="-6" id="f-2393" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-651" decimals="-6" id="f-2394" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-652" decimals="-6" id="f-2395" unitRef="usd">144000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-653" decimals="-6" id="f-2396" unitRef="usd">34000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-654" decimals="-6" id="f-2397" unitRef="usd">75000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-655" decimals="-6" id="f-2398" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-656" decimals="-6" id="f-2399" unitRef="usd">109000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-657" decimals="-6" id="f-2400" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-658" decimals="-6" id="f-2401" unitRef="usd">46000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-659" decimals="-6" id="f-2402" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-660" decimals="-6" id="f-2403" unitRef="usd">46000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-661" decimals="-6" id="f-2404" unitRef="usd">2000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-662" decimals="-6" id="f-2405" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-663" decimals="-6" id="f-2406" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-664" decimals="-6" id="f-2407" unitRef="usd">2000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-665" decimals="-6" id="f-2408" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-666" decimals="-6" id="f-2409" unitRef="usd">177000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-667" decimals="-6" id="f-2410" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-668" decimals="-6" id="f-2411" unitRef="usd">177000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-669" decimals="-6" id="f-2412" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-670" decimals="-6" id="f-2413" unitRef="usd">56000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-671" decimals="-6" id="f-2414" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-672" decimals="-6" id="f-2415" unitRef="usd">56000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-673" decimals="-6" id="f-2416" unitRef="usd">4000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-674" decimals="-6" id="f-2417" unitRef="usd">2000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-675" decimals="-6" id="f-2418" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-676" decimals="-6" id="f-2419" unitRef="usd">6000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-677" decimals="-6" id="f-2420" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-678" decimals="-6" id="f-2421" unitRef="usd">64000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-679" decimals="-6" id="f-2422" unitRef="usd">3000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-680" decimals="-6" id="f-2423" unitRef="usd">67000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-681" decimals="-6" id="f-2424" unitRef="usd">4000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-682" decimals="-6" id="f-2425" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-683" decimals="-6" id="f-2426" unitRef="usd">81000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-489" decimals="-6" id="f-2427" unitRef="usd">85000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-684" decimals="-6" id="f-2428" unitRef="usd">407000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-685" decimals="-6" id="f-2429" unitRef="usd">429000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-686" decimals="-6" id="f-2430" unitRef="usd">84000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-687" decimals="-6" id="f-2431" unitRef="usd">920000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock contextRef="c-1" id="f-2432">&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents a reconciliation of Level 3 non-U.S. plan assets held during the year ended December&#160;31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.222%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.640%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Property&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Hedge&lt;br/&gt;Funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases, sales and settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-683" decimals="-6" id="f-2433" unitRef="usd">81000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-679" decimals="-6" id="f-2434" unitRef="usd">3000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-686" decimals="-6" id="f-2435" unitRef="usd">84000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld contextRef="c-688" decimals="-6" id="f-2436" unitRef="usd">-4000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld contextRef="c-689" decimals="-6" id="f-2437" unitRef="usd">0</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld contextRef="c-690" decimals="-6" id="f-2438" unitRef="usd">-4000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld>
    <us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements contextRef="c-688" decimals="-6" id="f-2439" unitRef="usd">0</us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements>
    <us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements contextRef="c-689" decimals="-6" id="f-2440" unitRef="usd">-3000000</us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements>
    <us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements contextRef="c-690" decimals="-6" id="f-2441" unitRef="usd">-3000000</us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-612" decimals="-6" id="f-2442" unitRef="usd">77000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-691" decimals="-6" id="f-2443" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-615" decimals="-6" id="f-2444" unitRef="usd">77000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:ScheduleOfHealthCareCostTrendRatesTableTextBlock contextRef="c-1" id="f-2445">&lt;div style="margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following weighted average assumptions were used to determine the postretirement benefit expense and obligation for the years ended December&#160;31:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:56.315%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.032%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.885%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.032%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current medical cost trend rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ultimate medical cost trend rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical cost trend rate decreases to ultimate rate in year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2034&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2030&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfHealthCareCostTrendRatesTableTextBlock>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="c-692"
      decimals="4"
      id="f-2446"
      unitRef="number">0.0540</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="c-693"
      decimals="4"
      id="f-2447"
      unitRef="number">0.0290</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="c-694"
      decimals="4"
      id="f-2448"
      unitRef="number">0.0510</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="c-695"
      decimals="4"
      id="f-2449"
      unitRef="number">0.0540</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <iff:DefinedBenefitPlanCurrentMedicalCareCostTrendRate
      contextRef="c-696"
      decimals="4"
      id="f-2450"
      unitRef="number">0.0650</iff:DefinedBenefitPlanCurrentMedicalCareCostTrendRate>
    <iff:DefinedBenefitPlanCurrentMedicalCareCostTrendRate
      contextRef="c-697"
      decimals="4"
      id="f-2451"
      unitRef="number">0.0675</iff:DefinedBenefitPlanCurrentMedicalCareCostTrendRate>
    <iff:DefinedBenefitPlanCurrentMedicalCareCostTrendRate
      contextRef="c-698"
      decimals="4"
      id="f-2452"
      unitRef="number">0.0725</iff:DefinedBenefitPlanCurrentMedicalCareCostTrendRate>
    <iff:DefinedBenefitPlanCurrentMedicalCareCostTrendRate
      contextRef="c-699"
      decimals="4"
      id="f-2453"
      unitRef="number">0.0650</iff:DefinedBenefitPlanCurrentMedicalCareCostTrendRate>
    <us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate1
      contextRef="c-692"
      decimals="4"
      id="f-2454"
      unitRef="number">0.0475</us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate1>
    <us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate1
      contextRef="c-693"
      decimals="4"
      id="f-2455"
      unitRef="number">0.0475</us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate1>
    <us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate1
      contextRef="c-694"
      decimals="4"
      id="f-2456"
      unitRef="number">0.0475</us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate1>
    <us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate1
      contextRef="c-695"
      decimals="4"
      id="f-2457"
      unitRef="number">0.0475</us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate1>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer contextRef="c-455" decimals="-6" id="f-2458" unitRef="usd">31000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer contextRef="c-700" decimals="INF" id="f-2459" unitRef="usd">0</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer contextRef="c-701" decimals="-6" id="f-2460" unitRef="usd">5000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer contextRef="c-460" decimals="-6" id="f-2461" unitRef="usd">3000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:FinancialInstrumentsDisclosureTextBlock contextRef="c-1" id="f-2462">FINANCIAL INSTRUMENTS&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounting guidance on fair value measurements specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company&#x2019;s market assumptions. These two types of inputs create the following fair value hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1 &#x2014; Quoted prices for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;identical&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; instruments in active markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:45pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2 &#x2014; Quoted prices for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;similar&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:45pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3 &#x2014; Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;This hierarchy requires the Company to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value. The Company determines the fair value of structured liabilities (where performance is linked to structured interest rates, inflation or currency risks) using the Term SOFR swap curve and forward interest and exchange rates at period end. Such instruments are classified as Level 2 based on the observability of significant inputs to the model. The Company does not have any instruments classified as Level 3, other than those included in pension asset trusts included in Note 15. These valuations take into consideration the Company's credit risk and its counterparties&#x2019; credit risk.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value and the estimated fair values of financial instruments at December&#160;31 consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.752%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.641%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;LEVEL 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;LEVEL 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Credit facilities and bank overdrafts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="-sec-ix-hidden:f-2472"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="-sec-ix-hidden:f-2477"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024 Euro Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025 Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 Euro Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2030 Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2040 Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2047 Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2048 Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2050 Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024 Term Loan Facility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 Term Loan Facility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The carrying amount of cash and cash equivalents approximates fair value due to the short maturity of those instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The carrying amount approximates fair value as the interest rate is reset frequently based on current market rates as well as the short maturity of those instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The carrying amount approximates fair value as the instruments are marked-to-market and held at fair value on the Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The fair value of the Note is obtained from pricing services engaged by the Company, and the Company receives one price for each security. The fair value provided by the pricing services are estimated using pricing models, where the inputs to those models are based on observable market inputs or recent trades of similar securities. The inputs to the valuation techniques applied by the pricing services are typically benchmark yields, benchmark security prices, credit spreads, reported trades and broker-dealer quotes, all with reasonable levels of transparency.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The carrying amount approximates fair value as the Term Loans were assumed at fair value and the interest rate is reset frequently based on current market rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Derivatives&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Foreign Currency Forward Contracts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company periodically enters into foreign currency forward contracts with the objective of managing our exchange rate risk related to foreign currency denominated monetary assets and liabilities of our operations. These contracts generally involve the exchange of one currency for a second currency at a future date, have maturities not exceeding twelve months and are with counterparties which are major international financial institutions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Commodity Contracts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company utilizes options that are not designated as hedging instruments to reduce exposure to commodity price fluctuations on purchases of inventory such as soybeans, soybean oil and soybean meal.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also uses options, futures and swaps that are designated as hedging instruments to reduce exposure to commodity price fluctuations on purchases of natural gas used in our manufacturing process.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Through the third quarter of 2021, the Company maintained several forward currency contracts which qualified as cash flow hedges. The objective of these hedges is to protect against the currency risk associated with forecasted U.S. dollar (&#x201c;USD&#x201d;) denominated raw material purchases made by Euro (&#x201c;EUR&#x201d;) functional currency entities which result from changes in the EUR/USD exchange rate. The effective portions of cash flow hedges are recorded in other comprehensive income (&#x201c;OCI&#x201d;) as a component of Gains on derivatives qualifying as hedges in the accompanying Consolidated Statements of (Loss) Income and Comprehensive Loss. Realized gains/(losses) in accumulated other comprehensive income (loss) (&#x201c;AOCI&#x201d;) related to cash flow hedges of raw material purchases are recognized as a component of Cost of goods sold in the accompanying Consolidated Statements of (Loss) Income and Comprehensive Loss in the same period as the related costs are recognized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no cash flow hedges as of December&#160;31, 2023 and December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Hedges Related to Issuances of Debt&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subsequent to the issuance of the 2026 Euro Notes during the third quarter of 2018, the Company designated the debt as a hedge of a portion of its net European investments. Accordingly, the change in the value of the debt that is attributable to foreign exchange movements is recorded in OCI as a component of foreign currency translation adjustments in the accompanying Consolidated Statements of (Loss) Income and Comprehensive Loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subsequent to the issuance of the 2024 Euro Notes during the first quarter of 2016, the Company designated the debt as a hedge of a portion of its net European investments. Accordingly, the change in the value of the debt that is attributable to foreign exchange movements is recorded in OCI as a component of foreign currency translation adjustments in the accompanying Consolidated Statements of (Loss) Income and Comprehensive Loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2016, the Company entered into and terminated two Euro interest rate swap agreements to hedge the anticipated issuance of fixed-rate debt. These swaps were designated as cash flow hedges. The effective portions of cash flow hedges are recorded in OCI as a component of Losses on derivatives qualifying as hedges in the accompanying Consolidated Statements of (Loss) Income and Comprehensive Loss. The Company incurred a loss of &#x20ac;3 million ($3 million) due to the termination of these swaps. The loss is being amortized as interest expense over the life of the 2024 Euro Notes as discussed in Note 9.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2016 and the first quarter of 2017, the Company entered into interest rate swap agreements to hedge the anticipated issuance of fixed-rate debt, which are designated as cash flow hedges. The various hedge instruments were settled upon issuance of the debt on May 18, 2017 and resulted in a loss of approximately $5 million. As discussed in Note 9, the loss is being amortized as interest expense over the life of the 2047 Notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cross Currency Swaps&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the third quarter of 2022, the Company entered into a transaction to unwind the fourteen outstanding EUR/USD cross currency swaps designated as net investment hedges issued between the third quarter of 2019 and the first quarter of 2022. The Company received proceeds of approximately $183 million, including $11 million of interest income. The gain arising from the termination of the swaps has been included as a component of Accumulated other comprehensive loss. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following the unwinding of the existing swaps, during the third quarter of 2022, the Company entered into twelve new EUR/USD cross currency swaps, with a notional value of $1.400&#160;billion that mature through November 2030. The swaps all qualified as net investment hedges in order to mitigate a portion of the Company&#x2019;s net European investments from foreign currency risk. As of December&#160;31, 2023, the twelve remaining swaps were in a liability position with an aggregate fair value of $161 million which were classified as Other liabilities on the Consolidated Balance Sheets. Changes in fair value related to cross currency swaps are recorded in OCI.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the notional amount of the Company&#x2019;s derivative instruments outstanding as of December&#160;31, 2023 and December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.841%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.562%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity contracts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt"&gt;Foreign currency contracts and commodity contracts are presented net of contracts bought and sold.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables show the Company&#x2019;s derivative instruments measured at fair value (Level 2 of the fair value hierarchy) as reflected in the Consolidated Balance Sheets as of December&#160;31, 2023 and December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:42.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.640%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.055%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.057%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value of Derivatives&lt;br/&gt;Designated&#160;as Hedging&lt;br/&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value of Derivatives Not Designated as Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:42.576%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.282%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.988%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.284%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&#160;of Derivatives Designated&#160;as Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&#160;of Derivatives&#160;Not Designated as Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&#160;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Derivative assets are recorded to Prepaid expenses and other current assets on the Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Derivative liabilities are recorded to Other current liabilities and Other liabilities on the Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the effect of the Company&#x2019;s derivative instruments which were not designated as hedging instruments in the Consolidated Statements of (Loss) Income and Comprehensive Loss for the years ended December&#160;31, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:42.759%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.788%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.788%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:25.805%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:32pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount&#160;of&#160;Gain (Loss)&lt;br/&gt;For the year ended&lt;br/&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Location&#160;of&#160;Gain (Loss)&lt;br/&gt;Recognized in&lt;br/&gt;Income on Derivative&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-2581"&gt;&lt;span style="-sec-ix-hidden:f-2582"&gt;Other expense (income), net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-2585"&gt;Cost of goods sold&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt"&gt;The foreign currency contract net gains (losses) offset any recognized gains (losses) arising from the revaluation of the related intercompany loans during the same respective periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the effect of the Company&#x2019;s derivative instruments designated as net investment hedging instruments, net of tax, in the Consolidated Statements of (Loss) Income and Comprehensive Loss for the years ended December&#160;31, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:36.694%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.635%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.635%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.223%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.635%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.638%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:36pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gain (Loss)&lt;br/&gt;Recognized&#160;in OCI on Derivative and Non-Derivative&lt;br/&gt;(Effective Portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location&#160;of&#160;Gain&lt;br/&gt;(Loss) Reclassified&lt;br/&gt;from AOCI into Income&lt;br/&gt;(Effective Portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gain (Loss) Reclassified from AOCI&lt;br/&gt;into Income&lt;br/&gt;(Effective Portion)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the years ended&lt;br/&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the years ended&lt;br/&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives in Net Investment Hedging Relationships:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-Derivatives in Net Investment Hedging Relationships:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024 Euro Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 Euro Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(109)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The ineffective portion of the above noted net investment hedges was approximately $15 million and $10 million for the years ended December&#160;31, 2023 and 2022, respectively, and was recorded as a reduction to interest expense on the Consolidated Statements of (Loss) Income and Comprehensive Loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2023, based on current market rates, the Company does not expect any derivative losses (net of tax), included in AOCI, to be reclassified into earnings within the next 12 months.&lt;/span&gt;&lt;/div&gt;</us-gaap:FinancialInstrumentsDisclosureTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="c-1" id="f-2463">&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value and the estimated fair values of financial instruments at December&#160;31 consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.752%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.641%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;LEVEL 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;LEVEL 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Credit facilities and bank overdrafts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="-sec-ix-hidden:f-2472"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="-sec-ix-hidden:f-2477"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024 Euro Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025 Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 Euro Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2030 Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2040 Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2047 Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2048 Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2050 Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024 Term Loan Facility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 Term Loan Facility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The carrying amount of cash and cash equivalents approximates fair value due to the short maturity of those instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The carrying amount approximates fair value as the interest rate is reset frequently based on current market rates as well as the short maturity of those instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The carrying amount approximates fair value as the instruments are marked-to-market and held at fair value on the Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The fair value of the Note is obtained from pricing services engaged by the Company, and the Company receives one price for each security. The fair value provided by the pricing services are estimated using pricing models, where the inputs to those models are based on observable market inputs or recent trades of similar securities. The inputs to the valuation techniques applied by the pricing services are typically benchmark yields, benchmark security prices, credit spreads, reported trades and broker-dealer quotes, all with reasonable levels of transparency.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The carrying amount approximates fair value as the Term Loans were assumed at fair value and the interest rate is reset frequently based on current market rates.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-702" decimals="-6" id="f-2464" unitRef="usd">703000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-703" decimals="-6" id="f-2465" unitRef="usd">703000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-704" decimals="-6" id="f-2466" unitRef="usd">483000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-705" decimals="-6" id="f-2467" unitRef="usd">483000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:LoansPayableFairValueDisclosure contextRef="c-702" decimals="-6" id="f-2468" unitRef="usd">3000000</us-gaap:LoansPayableFairValueDisclosure>
    <us-gaap:LoansPayableFairValueDisclosure contextRef="c-703" decimals="-6" id="f-2469" unitRef="usd">3000000</us-gaap:LoansPayableFairValueDisclosure>
    <us-gaap:LoansPayableFairValueDisclosure contextRef="c-704" decimals="-6" id="f-2470" unitRef="usd">106000000</us-gaap:LoansPayableFairValueDisclosure>
    <us-gaap:LoansPayableFairValueDisclosure contextRef="c-705" decimals="-6" id="f-2471" unitRef="usd">106000000</us-gaap:LoansPayableFairValueDisclosure>
    <us-gaap:DerivativeAssets contextRef="c-702" decimals="-6" id="f-2473" unitRef="usd">41000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-703" decimals="-6" id="f-2474" unitRef="usd">41000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-704" decimals="-6" id="f-2475" unitRef="usd">1000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-705" decimals="-6" id="f-2476" unitRef="usd">1000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeLiabilities contextRef="c-702" decimals="-6" id="f-2478" unitRef="usd">165000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-703" decimals="-6" id="f-2479" unitRef="usd">165000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-704" decimals="-6" id="f-2480" unitRef="usd">75000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-705" decimals="-6" id="f-2481" unitRef="usd">75000000</us-gaap:DerivativeLiabilities>
    <us-gaap:CommercialPaper contextRef="c-702" decimals="-6" id="f-2482" unitRef="usd">0</us-gaap:CommercialPaper>
    <us-gaap:CommercialPaper contextRef="c-703" decimals="-6" id="f-2483" unitRef="usd">0</us-gaap:CommercialPaper>
    <us-gaap:CommercialPaper contextRef="c-704" decimals="-6" id="f-2484" unitRef="usd">187000000</us-gaap:CommercialPaper>
    <us-gaap:CommercialPaper contextRef="c-705" decimals="-6" id="f-2485" unitRef="usd">187000000</us-gaap:CommercialPaper>
    <us-gaap:SeniorNotesCurrent contextRef="c-706" decimals="-6" id="f-2486" unitRef="usd">0</us-gaap:SeniorNotesCurrent>
    <us-gaap:SeniorNotesCurrent contextRef="c-707" decimals="-6" id="f-2487" unitRef="usd">0</us-gaap:SeniorNotesCurrent>
    <us-gaap:SeniorNotesCurrent contextRef="c-708" decimals="-6" id="f-2488" unitRef="usd">300000000</us-gaap:SeniorNotesCurrent>
    <us-gaap:SeniorNotesCurrent contextRef="c-709" decimals="-6" id="f-2489" unitRef="usd">298000000</us-gaap:SeniorNotesCurrent>
    <us-gaap:SeniorNotesCurrent contextRef="c-710" decimals="-6" id="f-2490" unitRef="usd">552000000</us-gaap:SeniorNotesCurrent>
    <us-gaap:SeniorNotesCurrent contextRef="c-711" decimals="-6" id="f-2491" unitRef="usd">549000000</us-gaap:SeniorNotesCurrent>
    <us-gaap:SeniorLongTermNotes contextRef="c-712" decimals="-6" id="f-2492" unitRef="usd">532000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes contextRef="c-713" decimals="-6" id="f-2493" unitRef="usd">519000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes contextRef="c-714" decimals="-6" id="f-2494" unitRef="usd">1000000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes contextRef="c-715" decimals="-6" id="f-2495" unitRef="usd">924000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes contextRef="c-716" decimals="-6" id="f-2496" unitRef="usd">1000000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes contextRef="c-717" decimals="-6" id="f-2497" unitRef="usd">884000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes contextRef="c-718" decimals="-6" id="f-2498" unitRef="usd">879000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes contextRef="c-719" decimals="-6" id="f-2499" unitRef="usd">835000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes contextRef="c-720" decimals="-6" id="f-2500" unitRef="usd">845000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes contextRef="c-721" decimals="-6" id="f-2501" unitRef="usd">774000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes contextRef="c-722" decimals="-6" id="f-2502" unitRef="usd">1212000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes contextRef="c-723" decimals="-6" id="f-2503" unitRef="usd">1049000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes contextRef="c-724" decimals="-6" id="f-2504" unitRef="usd">1215000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes contextRef="c-725" decimals="-6" id="f-2505" unitRef="usd">1006000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes contextRef="c-726" decimals="-6" id="f-2506" unitRef="usd">398000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes contextRef="c-727" decimals="-6" id="f-2507" unitRef="usd">389000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes contextRef="c-728" decimals="-6" id="f-2508" unitRef="usd">398000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes contextRef="c-729" decimals="-6" id="f-2509" unitRef="usd">380000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes contextRef="c-730" decimals="-6" id="f-2510" unitRef="usd">1508000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes contextRef="c-731" decimals="-6" id="f-2511" unitRef="usd">1240000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes contextRef="c-732" decimals="-6" id="f-2512" unitRef="usd">1510000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes contextRef="c-733" decimals="-6" id="f-2513" unitRef="usd">1188000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes contextRef="c-734" decimals="-6" id="f-2514" unitRef="usd">773000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes contextRef="c-735" decimals="-6" id="f-2515" unitRef="usd">536000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes contextRef="c-736" decimals="-6" id="f-2516" unitRef="usd">774000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes contextRef="c-737" decimals="-6" id="f-2517" unitRef="usd">535000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes contextRef="c-738" decimals="-6" id="f-2518" unitRef="usd">495000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes contextRef="c-739" decimals="-6" id="f-2519" unitRef="usd">382000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes contextRef="c-740" decimals="-6" id="f-2520" unitRef="usd">495000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes contextRef="c-741" decimals="-6" id="f-2521" unitRef="usd">390000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes contextRef="c-742" decimals="-6" id="f-2522" unitRef="usd">787000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes contextRef="c-743" decimals="-6" id="f-2523" unitRef="usd">678000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes contextRef="c-744" decimals="-6" id="f-2524" unitRef="usd">787000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes contextRef="c-745" decimals="-6" id="f-2525" unitRef="usd">685000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes contextRef="c-746" decimals="-6" id="f-2526" unitRef="usd">1569000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes contextRef="c-747" decimals="-6" id="f-2527" unitRef="usd">1029000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes contextRef="c-748" decimals="-6" id="f-2528" unitRef="usd">1571000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes contextRef="c-749" decimals="-6" id="f-2529" unitRef="usd">1021000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorNotesCurrent contextRef="c-750" decimals="-6" id="f-2530" unitRef="usd">270000000</us-gaap:SeniorNotesCurrent>
    <us-gaap:SeniorNotesCurrent contextRef="c-751" decimals="-6" id="f-2531" unitRef="usd">270000000</us-gaap:SeniorNotesCurrent>
    <us-gaap:SeniorLongTermNotes contextRef="c-752" decimals="-6" id="f-2532" unitRef="usd">625000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes contextRef="c-753" decimals="-6" id="f-2533" unitRef="usd">625000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes contextRef="c-754" decimals="-6" id="f-2534" unitRef="usd">625000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes contextRef="c-755" decimals="-6" id="f-2535" unitRef="usd">625000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes contextRef="c-756" decimals="-6" id="f-2536" unitRef="usd">625000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes contextRef="c-757" decimals="-6" id="f-2537" unitRef="usd">625000000</us-gaap:SeniorLongTermNotes>
    <us-gaap:NumberOfInterestRateDerivativesHeld
      contextRef="c-758"
      decimals="INF"
      id="f-2538"
      unitRef="agreement">2</us-gaap:NumberOfInterestRateDerivativesHeld>
    <iff:DeferredGainLossOnTerminatedInterestRateContracts contextRef="c-759" decimals="-6" id="f-2539" unitRef="eur">-3000000</iff:DeferredGainLossOnTerminatedInterestRateContracts>
    <iff:DeferredGainLossOnTerminatedInterestRateContracts contextRef="c-759" decimals="-6" id="f-2540" unitRef="usd">-3000000</iff:DeferredGainLossOnTerminatedInterestRateContracts>
    <us-gaap:GainLossOnSaleOfDerivatives contextRef="c-760" decimals="-6" id="f-2541" unitRef="usd">5000000</us-gaap:GainLossOnSaleOfDerivatives>
    <us-gaap:NumberOfForeignCurrencyDerivativesHeld
      contextRef="c-761"
      decimals="INF"
      id="f-2542"
      unitRef="swap">14</us-gaap:NumberOfForeignCurrencyDerivativesHeld>
    <us-gaap:ProceedsFromDerivativeInstrumentInvestingActivities contextRef="c-762" decimals="-6" id="f-2543" unitRef="usd">183000000</us-gaap:ProceedsFromDerivativeInstrumentInvestingActivities>
    <us-gaap:InterestIncomeExpenseNet contextRef="c-762" decimals="-6" id="f-2544" unitRef="usd">11000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:NumberOfForeignCurrencyDerivativesHeld
      contextRef="c-763"
      decimals="INF"
      id="f-2545"
      unitRef="swap">12</us-gaap:NumberOfForeignCurrencyDerivativesHeld>
    <us-gaap:DerivativeNotionalAmount contextRef="c-764" decimals="-6" id="f-2546" unitRef="usd">1400000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:NumberOfForeignCurrencyDerivativesHeld
      contextRef="c-765"
      decimals="INF"
      id="f-2547"
      unitRef="swap">12</us-gaap:NumberOfForeignCurrencyDerivativesHeld>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet contextRef="c-765" decimals="-6" id="f-2548" unitRef="usd">161000000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock contextRef="c-1" id="f-2549">&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the notional amount of the Company&#x2019;s derivative instruments outstanding as of December&#160;31, 2023 and December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.841%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.562%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity contracts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt"&gt;Foreign currency contracts and commodity contracts are presented net of contracts bought and sold.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock>
    <iff:DerivativeNotionalAmountNet contextRef="c-766" decimals="-6" id="f-2550" unitRef="usd">-1400000000</iff:DerivativeNotionalAmountNet>
    <iff:DerivativeNotionalAmountNet contextRef="c-767" decimals="-6" id="f-2551" unitRef="usd">92000000</iff:DerivativeNotionalAmountNet>
    <iff:DerivativeNotionalAmountNet contextRef="c-768" decimals="-6" id="f-2552" unitRef="usd">7000000</iff:DerivativeNotionalAmountNet>
    <iff:DerivativeNotionalAmountNet contextRef="c-769" decimals="-6" id="f-2553" unitRef="usd">-1000000</iff:DerivativeNotionalAmountNet>
    <us-gaap:DerivativeNotionalAmount contextRef="c-770" decimals="-6" id="f-2554" unitRef="usd">1400000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount contextRef="c-771" decimals="-6" id="f-2555" unitRef="usd">1400000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock contextRef="c-1" id="f-2556">&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables show the Company&#x2019;s derivative instruments measured at fair value (Level 2 of the fair value hierarchy) as reflected in the Consolidated Balance Sheets as of December&#160;31, 2023 and December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:42.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.640%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.055%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.057%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value of Derivatives&lt;br/&gt;Designated&#160;as Hedging&lt;br/&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value of Derivatives Not Designated as Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:42.576%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.282%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.988%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.284%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&#160;of Derivatives Designated&#160;as Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&#160;of Derivatives&#160;Not Designated as Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&#160;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Derivative assets are recorded to Prepaid expenses and other current assets on the Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Derivative liabilities are recorded to Other current liabilities and Other liabilities on the Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-772" decimals="-6" id="f-2557" unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-773" decimals="-6" id="f-2558" unitRef="usd">41000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-774" decimals="-6" id="f-2559" unitRef="usd">41000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-775" decimals="-6" id="f-2560" unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-776" decimals="-6" id="f-2561" unitRef="usd">41000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-11" decimals="-6" id="f-2562" unitRef="usd">41000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-772" decimals="-6" id="f-2563" unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-773" decimals="-6" id="f-2564" unitRef="usd">4000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-774" decimals="-6" id="f-2565" unitRef="usd">4000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-777" decimals="-6" id="f-2566" unitRef="usd">161000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-778" decimals="-6" id="f-2567" unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-770" decimals="-6" id="f-2568" unitRef="usd">161000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-775" decimals="-6" id="f-2569" unitRef="usd">161000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-776" decimals="-6" id="f-2570" unitRef="usd">4000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-11" decimals="-6" id="f-2571" unitRef="usd">165000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-779" decimals="-6" id="f-2572" unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-780" decimals="-6" id="f-2573" unitRef="usd">1000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-781" decimals="-6" id="f-2574" unitRef="usd">1000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-782" decimals="-6" id="f-2575" unitRef="usd">75000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-783" decimals="-6" id="f-2576" unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-771" decimals="-6" id="f-2577" unitRef="usd">75000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock contextRef="c-1" id="f-2578">&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the effect of the Company&#x2019;s derivative instruments which were not designated as hedging instruments in the Consolidated Statements of (Loss) Income and Comprehensive Loss for the years ended December&#160;31, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:42.759%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.788%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.788%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:25.805%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:32pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount&#160;of&#160;Gain (Loss)&lt;br/&gt;For the year ended&lt;br/&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Location&#160;of&#160;Gain (Loss)&lt;br/&gt;Recognized in&lt;br/&gt;Income on Derivative&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-2581"&gt;&lt;span style="-sec-ix-hidden:f-2582"&gt;Other expense (income), net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-2585"&gt;Cost of goods sold&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-784" decimals="-6" id="f-2579" unitRef="usd">-11000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-785" decimals="-6" id="f-2580" unitRef="usd">7000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-788" decimals="-6" id="f-2583" unitRef="usd">2000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-789" decimals="-6" id="f-2584" unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-791" decimals="-6" id="f-2586" unitRef="usd">-9000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-792" decimals="-6" id="f-2587" unitRef="usd">7000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock contextRef="c-1" id="f-2588">&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the effect of the Company&#x2019;s derivative instruments designated as net investment hedging instruments, net of tax, in the Consolidated Statements of (Loss) Income and Comprehensive Loss for the years ended December&#160;31, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:36.694%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.635%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.635%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.223%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.635%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.638%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:36pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gain (Loss)&lt;br/&gt;Recognized&#160;in OCI on Derivative and Non-Derivative&lt;br/&gt;(Effective Portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location&#160;of&#160;Gain&lt;br/&gt;(Loss) Reclassified&lt;br/&gt;from AOCI into Income&lt;br/&gt;(Effective Portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gain (Loss) Reclassified from AOCI&lt;br/&gt;into Income&lt;br/&gt;(Effective Portion)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the years ended&lt;br/&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the years ended&lt;br/&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives in Net Investment Hedging Relationships:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-Derivatives in Net Investment Hedging Relationships:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024 Euro Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 Euro Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(109)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax contextRef="c-793" decimals="-6" id="f-2589" unitRef="usd">-67000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax contextRef="c-794" decimals="-6" id="f-2590" unitRef="usd">-16000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax contextRef="c-795" decimals="-6" id="f-2591" unitRef="usd">-16000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax contextRef="c-796" decimals="-6" id="f-2592" unitRef="usd">27000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax contextRef="c-797" decimals="-6" id="f-2593" unitRef="usd">-26000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax contextRef="c-798" decimals="-6" id="f-2594" unitRef="usd">43000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax contextRef="c-1" decimals="-6" id="f-2595" unitRef="usd">-109000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax contextRef="c-9" decimals="-6" id="f-2596" unitRef="usd">54000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet contextRef="c-1" decimals="-6" id="f-2597" unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet contextRef="c-9" decimals="-6" id="f-2598" unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeNetHedgeIneffectivenessGainLoss contextRef="c-1" decimals="-6" id="f-2599" unitRef="usd">15000000</us-gaap:DerivativeNetHedgeIneffectivenessGainLoss>
    <us-gaap:DerivativeNetHedgeIneffectivenessGainLoss contextRef="c-9" decimals="-6" id="f-2600" unitRef="usd">10000000</us-gaap:DerivativeNetHedgeIneffectivenessGainLoss>
    <iff:AccumulatedOtherComprehensiveIncomeLossTextBlock contextRef="c-1" id="f-2601">ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present changes in the accumulated balances for each component of other comprehensive income (loss), including current period other comprehensive income (loss) and reclassifications out of accumulated other comprehensive income (loss):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.752%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.576%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.988%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.576%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.403%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gains&#160;(Losses)&#160;on Derivatives&lt;br/&gt;Qualifying as&lt;br/&gt;Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pension and&lt;br/&gt;Postretirement&lt;br/&gt;Liability&lt;br/&gt;Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive (loss) income, net of tax, as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,066)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,198)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;OCI before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassifications due to business divestitures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(112)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive (loss) income, net of tax, as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,652)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(245)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,896)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.752%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.576%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.988%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.576%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.403%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gains&#160;(Losses)&#160;on Derivatives&lt;br/&gt;Qualifying as&lt;br/&gt;Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pension and&lt;br/&gt;Postretirement&lt;br/&gt;Liability&lt;br/&gt;Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive (loss) income, net of tax, as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(291)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,423)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;OCI before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(933)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(785)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(933)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(775)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive (loss) income, net of tax, as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,066)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,198)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.752%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.576%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.988%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.576%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.403%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gains&#160;(Losses)&#160;on Derivatives&lt;br/&gt;Qualifying as&lt;br/&gt;Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pension and&lt;br/&gt;Postretirement&lt;br/&gt;Liability&lt;br/&gt;Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive (loss) income, net of tax, as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(285)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(406)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(698)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;OCI before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(848)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(750)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(848)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(725)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive (loss) income, net of tax, as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(291)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,423)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides details about reclassifications out of Accumulated other comprehensive loss to the Consolidated Statements of (Loss) Income and Comprehensive Loss:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:36.381%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.525%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Affected Line Item in the Consolidated Statements of (Loss) Income and Comprehensive Loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gains (losses) on derivatives qualifying as hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of goods sold&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision&#160;for&#160;income&#160;taxes&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total, net of income taxes&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gains (losses) on pension and postretirement liability adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial gains (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total,&#160;net&#160;of&#160;income&#160;taxes&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The amortization of prior service cost and actuarial loss is included in the computation of net periodic benefit cost. See Note 15 for additional information regarding net periodic benefit cost.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Represents certain amounts of pension income that were corrected in 2021.&lt;/span&gt;&lt;/div&gt;</iff:AccumulatedOtherComprehensiveIncomeLossTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock contextRef="c-1" id="f-2602">&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present changes in the accumulated balances for each component of other comprehensive income (loss), including current period other comprehensive income (loss) and reclassifications out of accumulated other comprehensive income (loss):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.752%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.576%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.988%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.576%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.403%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gains&#160;(Losses)&#160;on Derivatives&lt;br/&gt;Qualifying as&lt;br/&gt;Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pension and&lt;br/&gt;Postretirement&lt;br/&gt;Liability&lt;br/&gt;Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive (loss) income, net of tax, as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,066)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,198)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;OCI before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassifications due to business divestitures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(112)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive (loss) income, net of tax, as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,652)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(245)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,896)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.752%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.576%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.988%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.576%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.403%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gains&#160;(Losses)&#160;on Derivatives&lt;br/&gt;Qualifying as&lt;br/&gt;Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pension and&lt;br/&gt;Postretirement&lt;br/&gt;Liability&lt;br/&gt;Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive (loss) income, net of tax, as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(291)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,423)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;OCI before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(933)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(785)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(933)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(775)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive (loss) income, net of tax, as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,066)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,198)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.752%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.576%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.988%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.576%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.403%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gains&#160;(Losses)&#160;on Derivatives&lt;br/&gt;Qualifying as&lt;br/&gt;Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pension and&lt;br/&gt;Postretirement&lt;br/&gt;Liability&lt;br/&gt;Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive (loss) income, net of tax, as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(285)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(406)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(698)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;OCI before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(848)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(750)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(848)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(725)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive (loss) income, net of tax, as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(291)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,423)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquity contextRef="c-799" decimals="-6" id="f-2603" unitRef="usd">-2066000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-800" decimals="-6" id="f-2604" unitRef="usd">1000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-801" decimals="-6" id="f-2605" unitRef="usd">-133000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-41" decimals="-6" id="f-2606" unitRef="usd">-2198000000</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent contextRef="c-802" decimals="-6" id="f-2607" unitRef="usd">367000000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent contextRef="c-803" decimals="-6" id="f-2608" unitRef="usd">0</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent contextRef="c-804" decimals="-6" id="f-2609" unitRef="usd">-100000000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent contextRef="c-46" decimals="-6" id="f-2610" unitRef="usd">267000000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <iff:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIDueToBusinessDivestitures contextRef="c-802" decimals="-6" id="f-2611" unitRef="usd">47000000</iff:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIDueToBusinessDivestitures>
    <iff:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIDueToBusinessDivestitures contextRef="c-803" decimals="-6" id="f-2612" unitRef="usd">0</iff:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIDueToBusinessDivestitures>
    <iff:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIDueToBusinessDivestitures contextRef="c-804" decimals="-6" id="f-2613" unitRef="usd">-1000000</iff:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIDueToBusinessDivestitures>
    <iff:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIDueToBusinessDivestitures contextRef="c-46" decimals="-6" id="f-2614" unitRef="usd">46000000</iff:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIDueToBusinessDivestitures>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="c-802" decimals="-6" id="f-2615" unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="c-803" decimals="-6" id="f-2616" unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="c-804" decimals="-6" id="f-2617" unitRef="usd">11000000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="c-46" decimals="-6" id="f-2618" unitRef="usd">11000000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-802" decimals="-6" id="f-2619" unitRef="usd">414000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-803" decimals="-6" id="f-2620" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-804" decimals="-6" id="f-2621" unitRef="usd">-112000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-46" decimals="-6" id="f-2622" unitRef="usd">302000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquity contextRef="c-805" decimals="-6" id="f-2623" unitRef="usd">-1652000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-806" decimals="-6" id="f-2624" unitRef="usd">1000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-807" decimals="-6" id="f-2625" unitRef="usd">-245000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-52" decimals="-6" id="f-2626" unitRef="usd">-1896000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-808" decimals="-6" id="f-2627" unitRef="usd">-1133000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-809" decimals="-6" id="f-2628" unitRef="usd">1000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-810" decimals="-6" id="f-2629" unitRef="usd">-291000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-30" decimals="-6" id="f-2630" unitRef="usd">-1423000000</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent contextRef="c-811" decimals="-6" id="f-2631" unitRef="usd">-933000000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent contextRef="c-812" decimals="-6" id="f-2632" unitRef="usd">0</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent contextRef="c-813" decimals="-6" id="f-2633" unitRef="usd">148000000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent contextRef="c-35" decimals="-6" id="f-2634" unitRef="usd">-785000000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="c-811" decimals="-6" id="f-2635" unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="c-812" decimals="-6" id="f-2636" unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="c-813" decimals="-6" id="f-2637" unitRef="usd">-10000000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="c-35" decimals="-6" id="f-2638" unitRef="usd">-10000000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-811" decimals="-6" id="f-2639" unitRef="usd">-933000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-812" decimals="-6" id="f-2640" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-813" decimals="-6" id="f-2641" unitRef="usd">158000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-35" decimals="-6" id="f-2642" unitRef="usd">-775000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquity contextRef="c-799" decimals="-6" id="f-2643" unitRef="usd">-2066000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-800" decimals="-6" id="f-2644" unitRef="usd">1000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-801" decimals="-6" id="f-2645" unitRef="usd">-133000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-41" decimals="-6" id="f-2646" unitRef="usd">-2198000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-814" decimals="-6" id="f-2647" unitRef="usd">-285000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-815" decimals="-6" id="f-2648" unitRef="usd">-7000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-816" decimals="-6" id="f-2649" unitRef="usd">-406000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-18" decimals="-6" id="f-2650" unitRef="usd">-698000000</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent contextRef="c-817" decimals="-6" id="f-2651" unitRef="usd">-848000000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent contextRef="c-818" decimals="-6" id="f-2652" unitRef="usd">1000000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent contextRef="c-819" decimals="-6" id="f-2653" unitRef="usd">97000000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent contextRef="c-23" decimals="-6" id="f-2654" unitRef="usd">-750000000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="c-817" decimals="-6" id="f-2655" unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="c-818" decimals="-6" id="f-2656" unitRef="usd">-7000000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="c-819" decimals="-6" id="f-2657" unitRef="usd">-18000000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="c-23" decimals="-6" id="f-2658" unitRef="usd">-25000000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-817" decimals="-6" id="f-2659" unitRef="usd">-848000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-818" decimals="-6" id="f-2660" unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-819" decimals="-6" id="f-2661" unitRef="usd">115000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-23" decimals="-6" id="f-2662" unitRef="usd">-725000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquity contextRef="c-808" decimals="-6" id="f-2663" unitRef="usd">-1133000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-809" decimals="-6" id="f-2664" unitRef="usd">1000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-810" decimals="-6" id="f-2665" unitRef="usd">-291000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-30" decimals="-6" id="f-2666" unitRef="usd">-1423000000</us-gaap:StockholdersEquity>
    <us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock contextRef="c-1" id="f-2667">&lt;div style="margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides details about reclassifications out of Accumulated other comprehensive loss to the Consolidated Statements of (Loss) Income and Comprehensive Loss:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:36.381%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.525%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Affected Line Item in the Consolidated Statements of (Loss) Income and Comprehensive Loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gains (losses) on derivatives qualifying as hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of goods sold&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision&#160;for&#160;income&#160;taxes&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total, net of income taxes&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gains (losses) on pension and postretirement liability adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial gains (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total,&#160;net&#160;of&#160;income&#160;taxes&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The amortization of prior service cost and actuarial loss is included in the computation of net periodic benefit cost. See Note 15 for additional information regarding net periodic benefit cost.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Represents certain amounts of pension income that were corrected in 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-820" decimals="-6" id="f-2668" unitRef="usd">0</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-821" decimals="-6" id="f-2669" unitRef="usd">0</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-822" decimals="-6" id="f-2670" unitRef="usd">-7000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:InterestExpense contextRef="c-823" decimals="-6" id="f-2671" unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c-824" decimals="-6" id="f-2672" unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c-825" decimals="-6" id="f-2673" unitRef="usd">1000000</us-gaap:InterestExpense>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-803" decimals="-6" id="f-2674" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-812" decimals="-6" id="f-2675" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-818" decimals="-6" id="f-2676" unitRef="usd">-1000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax contextRef="c-826" decimals="-6" id="f-2677" unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax contextRef="c-827" decimals="-6" id="f-2678" unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax contextRef="c-828" decimals="-6" id="f-2679" unitRef="usd">-7000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax contextRef="c-829" decimals="-6" id="f-2680" unitRef="usd">6000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax contextRef="c-830" decimals="-6" id="f-2681" unitRef="usd">7000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax contextRef="c-831" decimals="-6" id="f-2682" unitRef="usd">7000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax contextRef="c-832" decimals="-6" id="f-2683" unitRef="usd">8000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax contextRef="c-833" decimals="-6" id="f-2684" unitRef="usd">-21000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax contextRef="c-834" decimals="-6" id="f-2685" unitRef="usd">-38000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax contextRef="c-835" decimals="-6" id="f-2686" unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax contextRef="c-836" decimals="-6" id="f-2687" unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax contextRef="c-837" decimals="-6" id="f-2688" unitRef="usd">17000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-804" decimals="-6" id="f-2689" unitRef="usd">-3000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-813" decimals="-6" id="f-2690" unitRef="usd">4000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-819" decimals="-6" id="f-2691" unitRef="usd">-4000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax contextRef="c-838" decimals="-6" id="f-2692" unitRef="usd">11000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax contextRef="c-839" decimals="-6" id="f-2693" unitRef="usd">-10000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax contextRef="c-840" decimals="-6" id="f-2694" unitRef="usd">-18000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ConcentrationRiskDisclosureTextBlock contextRef="c-1" id="f-2695">CONCENTRATIONS OF CREDIT RISK&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does not have significant concentrations of risk in financial instruments. Temporary investments are made in a well-diversified portfolio of high-quality, liquid obligations of government, corporate and financial institutions. There are also limited concentrations of credit risk with respect to trade receivables because the Company has a large number of customers who are spread across many industries and geographic regions. The Company&#x2019;s larger customers are each spread across many sub-categories of its segments and geographical regions. The Company had no customer that accounted for more than 10% of its consolidated net sales for the years ended 2023, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <iff:EntityWideRevenueMajorCustomerNumberOfCustomers
      contextRef="c-841"
      decimals="0"
      id="f-2696"
      unitRef="customer">0</iff:EntityWideRevenueMajorCustomerNumberOfCustomers>
    <iff:EntityWideRevenueMajorCustomerNumberOfCustomers
      contextRef="c-842"
      decimals="0"
      id="f-2697"
      unitRef="customer">0</iff:EntityWideRevenueMajorCustomerNumberOfCustomers>
    <iff:EntityWideRevenueMajorCustomerNumberOfCustomers
      contextRef="c-843"
      decimals="0"
      id="f-2698"
      unitRef="customer">0</iff:EntityWideRevenueMajorCustomerNumberOfCustomers>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-844"
      decimals="2"
      id="f-2699"
      unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-845"
      decimals="2"
      id="f-2700"
      unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-846"
      decimals="2"
      id="f-2701"
      unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c-1" id="f-2702">COMMITMENTS AND CONTINGENCIES&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Guarantees and Letters of Credit&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has various bank guarantees, letters of credit and surety bonds which are used to support its ongoing business operations, satisfy governmental requirements associated with pending litigation in various jurisdictions and the payment of customs duties. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023, the Company had a total capacity of approximately $229 million of bank guarantees, commercial guarantees, standby letters of credit and surety bonds with various financial institutions. Included in the above aggregate amount was a total of approximately $11 million for other assessments in Brazil for various income tax and indirect &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;tax disputes related to fiscal years 1998-2011. There was a total of approximately $61&#160;million outstanding under the bank guarantees, standby letters of credit and commercial guarantees as of December&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In order to challenge the assessments in these cases in Brazil, the Company has been required to, and has separately pledged assets, principally property, plant and equipment, to cover assessments in the amount of approximately $8 million as of December&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Lines of Credit&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has various lines of credit which are available to support its ongoing business operations. As of December&#160;31, 2023, the Company had a total capacity of approximately $1.848 billion of lines of credit with various financial institutions, in addition to the $1.548&#160;billion of capacity under the Revolving Credit Facility. Pursuant to these lines of credit as of December&#160;31, 2023, the total drawdowns were not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assesses contingencies related to litigation and/or other matters to determine the degree of probability and range of possible loss. A loss contingency is accrued in the Company&#x2019;s Consolidated Financial Statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because litigation is inherently unpredictable and unfavorable resolutions could occur, assessing contingencies is highly sensitive and requires judgments about future events. On at least a quarterly basis, the Company reviews contingencies related to litigation to determine the adequacy of accruals. The amount of ultimate loss may differ from these estimates and further events may require the Company to increase or decrease the amounts it has accrued on any matter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Periodically, the Company assesses its insurance coverage for all known claims, where applicable, taking into account aggregate coverage by occurrence, limits of coverage, self-insured retentions and deductibles, historical claims experience and claims experience with its insurance carriers. The liabilities are recorded at management&#x2019;s best estimate of the probable outcome of the lawsuits and claims, taking into consideration the facts and circumstances of the individual matters as well as past experience on similar matters. At each balance sheet date, the key issues that management assesses are whether it is probable that a loss as to asserted or unasserted claims has been incurred and if so, whether the amount of loss can be reasonably estimated. The Company records the expected liability with respect to claims in Other liabilities and expected recoveries from its insurance carriers in Other assets. The Company recognizes a receivable when it believes that realization of the insurance receivable is probable under the terms of the insurance policies and its payment experience to date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Litigation Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 12, 2019, Marc Jansen filed a putative securities class action against IFF, its then Chairman and CEO, and its then-CFO, in the United States District Court for the Southern District of New York. The lawsuit was filed after IFF disclosed that preliminary results of investigations indicated that Frutarom businesses operating principally in Russia and Ukraine had made improper payments to representatives of customers. On March 16, 2020, an amended complaint was filed, which added Frutarom and certain former officers of Frutarom as defendants. The amended complaint alleges, among other things, that defendants made materially false and misleading statements or omissions concerning IFF&#x2019;s acquisition of Frutarom, the integration of the two companies, and the companies&#x2019; financial reporting and results. The amended complaint asserts claims under Section 10(b) of the Securities Exchange Act of 1934 and SEC Rule 10b-5, and under the Israeli Securities Act-1968, against all defendants, and under Section 20(a) of the Securities Exchange Act of 1934 against the individual defendants, on behalf of a putative class of persons and entities who purchased or otherwise acquired IFF securities on the New York Stock Exchange between May 7, 2018 and August 12, 2019 and persons and entities who purchased or otherwise acquired IFF securities on the Tel Aviv Stock Exchange between October 9, 2018 and August 12, 2019. The amended complaint seeks an award of unspecified compensatory damages, costs, and expenses. IFF, its officers, and Frutarom filed a motion to dismiss the case on June 26, 2020, which was granted on March 30, 2021. On April 28, 2021, lead plaintiffs filed a notice of appeal to the United States Court of Appeals for the Second Circuit. Lead plaintiffs are pursuing the appeal only against Frutarom and certain former officers of Frutarom. The parties have submitted their briefs to the Court of Appeals. The Second Circuit held oral argument on February 10, 2022. On September 30, 2022, the Second Circuit affirmed the dismissal of Plaintiffs&#x2019; claims. On October 14, 2022, Plaintiffs filed a Petition for Rehearing En Banc, which the Second Circuit denied on January 4, 2023. Plaintiffs did not seek review in the United States Supreme Court. The matter is therefore fully resolved in defendants&#x2019; favor.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Two motions to approve securities class actions were filed in the Tel Aviv District Court, Israel, in August 2019, similarly alleging, among other things, false and misleading statements largely in connection with IFF&#x2019;s acquisition of Frutarom and the above-mentioned improper payments.&#160;One motion (&#x201c;Borg&#x201d;) asserts claims under the U.S. federal securities laws against IFF, its former Chairman and CEO, and its former CFO. On November 8, 2020, IFF and its officers filed their response to the Borg motion. On April 20, 2021, Mr. Borg filed a motion to stay the proceeding pending an appellate decision in the U.S. proceeding. On June 15, 2021, August 11, 2021, November 9, 2021, January 9, 2022, April 7, 2022 and July 10, 2022, the U.S. lead plaintiffs filed update notices with the Israeli court regarding the appeal in the U.S. proceeding. On June 12, 2023, the petitioner filed a withdrawal motion, which the court then granted. The Borg case is now dismissed. The other motion (&#x201c;Oman&#x201d;) (following an initial amendment) asserted claims under the Israeli Securities Act-1968 against IFF, its former Chairman and CEO, and its former CFO, and against Frutarom and certain former Frutarom officers and directors, as well as claims under the Israeli Companies Act-1999 against certain former Frutarom officers and directors. On February 17, 2021, the court granted a motion by the Oman plaintiff to remove IFF and its officers from the motion and to add factual allegations from the US amended complaint. The amended Oman motion was filed on July 4, 2021. On August 29, 2021, the former Frutarom officers and certain former Frutarom directors filed a motion to dismiss the case. On September 30, 2021, Frutarom notified the court that it joins the legal arguments made in the motion to dismiss. On February 22, 2022, the court denied the motion to dismiss. On July 14, 2022, the court approved the parties&#x2019; motion to mediate the dispute, which postpones all case deadlines until after the mediation. In addition, a request to appeal the court&#x2019;s denial of the motion to dismiss filed by the former Frutarom officers and certain former Frutarom directors has been stayed. The parties held mediation meetings on September 13, 2022, November 22, 2022, March 1, 2023 and November 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 29, 2019, IFF and Frutarom filed a claim in the Tel Aviv District Court, Israel, against Ori Yehudai, the former President and CEO of Frutarom, and against certain former directors of Frutarom, challenging the bonus of US $20&#160;million granted to Yehudai in 2018.&#160;IFF and Frutarom allege, among other things, that Yehudai was not entitled to receive the bonus because he breached his fiduciary duty by, among other things, knowing of the above-mentioned improper payments and failing to prevent them from being made. The parties agreed, pursuant to the court&#x2019;s recommendation, to attempt to resolve the dispute through mediation, and a court decision is pending with regard to the order in which this claim and the class action described below will be heard.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 11, 2020, an IFF shareholder filed a motion to approve a class action in Israel against, among others, Frutarom, Yehudai, and Frutarom&#x2019;s former board of directors, alleging that former minority shareholders of Frutarom were harmed as a result of the US $20&#160;million bonus paid to Yehudai. The parties to this motion agreed to attempt to resolve the dispute through mediation to take place regarding the aforesaid claim against Yehudai. On July 27, 2021, counsel to the movant in the class action filed a notice with the court that the mediation process ended without an agreement. On August 26, 2021, a motion to dismiss the class action application was filed by Yehudai and certain former directors of Frutarom. On September 9, 2021, an additional motion to dismiss was filed by other former directors of Frutarom together with ICC Industries, Inc. and its affiliates. On December 9, 2021, the court denied the motions to dismiss. Responses to the class action motion were filed in May 2022, and applicant&#x2019;s response was filed in December 2022. An evidentiary hearing is set for March 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since March 2023, various putative class action lawsuits have been filed against IFF, Firmenich International SA, Givaudan SA, and Symrise AG and/or certain affiliates thereof in the Quebec Superior Court, the Federal Court of Canada, Ontario Superior Court, Supreme Court of British Columbia and, in several cases, the United States District Court for the District of New Jersey. These actions allege violations of the Canadian Competition Act and the Sherman Act, as applicable, and other related claims, and seek damages and other relief. IFF may face additional civil suits, in the United States or elsewhere, relating to such alleged conduct. At this time, IFF is unable to predict the potential outcome of these lawsuits or any potential effect they may have on the Company&#x2019;s results of operations, liquidity or financial condition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 3, 2020, the Israel Police&#x2019;s National Fraud Investigation Unit and the Israeli Securities Authority commenced an investigation into Frutarom and certain of its former executives, based on suspected bribery of foreign officials, money laundering, and violations of the Israeli Securities Act-1968. As part of the investigation, the National Fraud Investigation Unit and the Israeli Securities Authority have provided IFF and Frutarom with various orders, mainly requesting that IFF and Frutarom provide certain documents and materials. In addition, a seizure of assets was imposed on Frutarom and certain of its affiliates. IFF has been working to ensure compliance with such orders, all in accordance with, and subject to, Israeli law. On August 25, 2021, the Israeli Police informed Frutarom that they have decided to remove the temporary criminal seizure of assets order from the real estate assets of Frutarom and its related companies, which was done in parallel with the transfer of the case to the District Attorney&#x2019;s Office in Israel. On February 26, 2024, the Israeli authorities informed Frutarom that the authorities decided to close the criminal investigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 7, 2023, the European Commission (&#x201c;EC&#x201d;) and the United Kingdom Competition and Markets Authority (&#x201c;CMA&#x201d;) carried out unannounced inspections of certain of IFF&#x2019;s facilities. On the same day, IFF was served with a grand jury subpoena by the Antitrust Division of the U.S. Department of Justice (&#x201c;DOJ&#x201d;). IFF understands the EC, CMA, DOJ and the Swiss Competition Commission are investigating potential anticompetitive conduct as it relates to IFF&#x2019;s fragrance businesses. IFF has been and intends to continue cooperating with these investigations. IFF is unable, however, to predict or determine at this time the duration or outcome of the investigations, or whether the outcome of the investigations will materially impact the Company&#x2019;s results of operations, liquidity or financial condition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;China Facilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Zhejiang Ingredients Plant&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the fourth quarter of 2017, the Company concluded discussions with the government regarding the relocation of its Fragrance Ingredients plant in Zhejiang and, based on the agreements reached, expects to receive total compensation payments up to approximately $50 million. The relocation compensation will be paid to the Company over the period of the relocation. The Company received payments totaling $30 million through the end of 2019. Production at the facility ceased during 2019. In the second quarter of 2020, the Company transferred ownership of the site to the government and the remaining net book value of the plant was written off. In the third quarter of 2020, the Company received a payment of approximately $13 million. The land remediation activities were completed in November 2022 and the final land restoration activities to restore the land to its original height, per the government&#x2019;s request, were completed in April 2023. Upon completion of these activities, the land was returned to the government in April 2023 and a final payment of approximately $5&#160;million was received in June 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the second quarter of 2023, the Company recognized a pre-tax gain of approximately $22&#160;million related to this transaction presented in Other expense (income), net on the Consolidated Statements of (Loss) Income and Comprehensive Loss. The Company also recognized approximately $6 million of income taxes presented in Provision for income taxes on the Consolidated Statements of (Loss) Income and Comprehensive Loss. The calculation of the applicable income taxes related to this transaction was sent to the local tax authorities for review and final approval was received in the fourth quarter of 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Products previously manufactured at the Zhejiang Ingredients plant are now being produced at the Company&#x2019;s Ingredients plant in Jiande, China.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Total China Operations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total net book value of all plants in China was approximately $215 million as of December&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the Company is required to close a plant, or operate one at significantly reduced production levels on a permanent basis, the Company may be required to record charges that could have a material impact on its consolidated financial results of operations, financial position and cash flows in future periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Environmental Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is reporting the following environmental matter in compliance with SEC requirements to disclose environmental proceedings where a governmental authority is a party and that involve potential monetary sanctions of $300,000 or greater. On May 27, 2022, the Solae, LLC Memphis site (&#x201c;Solae&#x201d;) was served an Administrative Order and Assessment (the &#x201c;Order&#x201d;) by the City of Memphis related to alleged wastewater discharge violations. Solae submitted an appeal of the Order on June 24, 2022. Discussions with the City regarding potential resolution of the violations and penalties related to said violations are ongoing. Additionally, the Solae facility has undertaken capital project efforts, some of which began prior to the issuance of the Order, that are anticipated to address, on a schedule consistent with the Order, deadlines for attaining compliance with current wastewater permit requirements. This matter is not expected to have a material adverse effect on the Company&#x2019;s financial position, cash flows or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has contingencies involving third parties (such as labor, contract, technology or product-related claims or litigation) as well as government-related items in various jurisdictions in which it operates pertaining to such items as value-added taxes, other indirect taxes, customs and duties and sales and use taxes. It is possible that cash flows or results of operations, in any period, could be materially affected by the unfavorable resolution of one or more of these contingencies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The most significant government-related contingencies exist in Brazil. With regard to the Brazilian matters, the Company believes it has valid defenses for the underlying positions under dispute; however, in order to pursue these defenses, the Company is required to, and has provided, bank guarantees and pledged assets in the aggregate amount of approximately $19 million. The Brazilian matters take an extended period of time to proceed through the judicial process and there are a limited number of rulings to date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Brazil Tax Credits&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2017, the Brazilian Supreme Court (&#x201c;BSC&#x201d;) ruled that Brazilian tax authorities should not include a value added tax known as &#x201c;ICMS&#x201d; in the calculation of certain indirect taxes (&#x201c;PIS/COFINS&#x201d;). By removing the ICMS from the calculation of the indirect tax base, the Court effectively eliminated a &#x201c;tax on tax.&#x201d; The Brazilian tax authorities filed an appeal seeking clarification of certain matters, including the amount of ICMS to which taxpayers would be entitled in order to reduce their indirect tax base (i.e. the gross rate or the net rate). In light of the BSC&#x2019;s decision, in November 2017, the Company filed suit consistent with the BSC decision to require that ICMS be excluded from the PIS/COFINS calculation and received a favorable preliminary decision that was confirmed by the BSC in September 2018. This preliminary ruling granted the Company the right to prospectively exclude ICMS amounts from the PIS/COFINS calculation, but left open the issue of whether the Company could recover the gross or net amount of ICMS amounts paid on PIS/COFINS for the period from November 2011 to December 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2020, the Company was informed of a favorable ruling from the Brazilian tax authorities confirming that the Company was entitled to recover the overpayments of PIS/COFINS for the period from November 2011 to December 2018, plus interest on the amount of the overpayments. The overpayments arose from the inclusion of a value added tax known as ICMS in the calculation of the PIS/COFINS tax. The ruling did not, however, settle the question of whether the Company is eligible to recover overpayments based on the gross or the net amount of ICMS amounts paid on PIS/COFINS. The Company calculated the amount of overpayments using the gross method which yields a higher amount than the application of the net method. A final ruling on the gross versus net amount issue was made by the BSC who affirmed the use of the gross calculation with respect to claims submitted prior to March 2017. Although the Company had not submitted a claim until after March 2017, the Company believes that the Supreme Court, whilst confirming the use of the gross method of calculation, does not override the January 2020 ruling by the Brazilian tax authorities with respect to the timeframe for the calculation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to the $8 million recognized in the fourth quarter of 2019, during the first quarter of 2020 the Company recognized $4 million as an additional recovery on the existing claim. During 2020, the Company also recognized $3&#160;million related to a claim from another of its subsidiaries in Brazil. The income was recognized as a reduction in Selling and administrative expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2023, the BSC made an unfavorable court resolution for the Company related to the use of the gross method, which was only granted to claims submitted prior to March 2017. As a result of this unfavorable court resolution, the Company wrote off its remaining receivables of approximately $6&#160;million related to this matter during the first quarter of 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Avicel&#xae; PH NF (Pharma Solutions)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has determined that certain grades of microcrystalline cellulose (Avicel&#xae; PH 101, 102, and 200 NF and Avicel&#xae; RC-591 NF) were found to be out-of-specification (collectively, &#x201c;OOS Avicel&#xae; NF&#x201d;). The Company does not expect the OOS conductivity issue to affect the functionality of Avicel&#xae; NF grades or to pose a human health hazard. Corrective actions have been implemented to improve operational and laboratory conditions. Based on the information available, as of December&#160;31, 2023, payments associated with this matter were approximately $46 million, and the Company no longer had an accrual related to this matter. The total amount of exposure may increase if additional customers present claims or other exposures are identified.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines estimates of reasonably possible losses or ranges of reasonably possible losses in excess of related accrued liabilities, if any, when it has determined that either a loss is reasonably possible or a loss in excess of accrued amounts is reasonably possible and the amount of losses or range of losses is determinable. For all third party contingencies (including labor, contract, technology, tax, product-related claims and business litigation), the Company currently estimates that the aggregate range of reasonably possible losses in excess of any accrued liabilities is $0 to approximately $75 million. The estimates included in this amount are based on the Company&#x2019;s analysis of currently available information and, as new information is obtained, these estimates may change. Due to the inherent subjectivity of the assessments and the unpredictability of outcomes of legal proceedings, any amounts accrued or included in this aggregate amount may not represent the ultimate loss to the Company from the matters in question. Thus, the Company&#x2019;s exposure and ultimate losses may be higher or lower, and possibly significantly so, than the amounts accrued or the range disclosed above.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <iff:BankGuaranteesCommercialGuaranteesStandbyLettersOfCreditAndSuretyBondsFacilityAmounts contextRef="c-11" decimals="-6" id="f-2703" unitRef="usd">229000000</iff:BankGuaranteesCommercialGuaranteesStandbyLettersOfCreditAndSuretyBondsFacilityAmounts>
    <iff:BankGuaranteesRelatedToAppealsOnIncomeTaxAndIndirectTaxCases contextRef="c-11" decimals="-6" id="f-2704" unitRef="usd">11000000</iff:BankGuaranteesRelatedToAppealsOnIncomeTaxAndIndirectTaxCases>
    <iff:BankGuaranteesStandbyLettersOfCreditAndCommercialGuaranteesAmountOutstanding contextRef="c-11" decimals="-6" id="f-2705" unitRef="usd">61000000</iff:BankGuaranteesStandbyLettersOfCreditAndCommercialGuaranteesAmountOutstanding>
    <iff:AmountOfPledgedAssetsPrincipallyPropertyPlantAndEquipmentToCoverIncomeTaxAndIndirectTaxAssessments contextRef="c-847" decimals="-6" id="f-2706" unitRef="usd">8000000</iff:AmountOfPledgedAssetsPrincipallyPropertyPlantAndEquipmentToCoverIncomeTaxAndIndirectTaxAssessments>
    <iff:AmountOfAvailableLinesOfCredit contextRef="c-11" decimals="-6" id="f-2707" unitRef="usd">1848000000</iff:AmountOfAvailableLinesOfCredit>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity contextRef="c-297" decimals="-6" id="f-2708" unitRef="usd">1548000000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <us-gaap:DeferredCompensationArrangementWithIndividualCompensationExpense contextRef="c-848" decimals="-6" id="f-2709" unitRef="usd">20000000</us-gaap:DeferredCompensationArrangementWithIndividualCompensationExpense>
    <us-gaap:DeferredCompensationArrangementWithIndividualCompensationExpense contextRef="c-849" decimals="-6" id="f-2710" unitRef="usd">20000000</us-gaap:DeferredCompensationArrangementWithIndividualCompensationExpense>
    <iff:GainContingencyExpectedRelocationPayments contextRef="c-850" decimals="-6" id="f-2711" unitRef="usd">50000000</iff:GainContingencyExpectedRelocationPayments>
    <iff:GainContingencyRelocationPaymentsReceived contextRef="c-851" decimals="-6" id="f-2712" unitRef="usd">30000000</iff:GainContingencyRelocationPaymentsReceived>
    <iff:GainContingencyRelocationPaymentsReceived contextRef="c-852" decimals="-6" id="f-2713" unitRef="usd">13000000</iff:GainContingencyRelocationPaymentsReceived>
    <iff:GainContingencyRelocationPaymentsReceived contextRef="c-853" decimals="-6" id="f-2714" unitRef="usd">5000000</iff:GainContingencyRelocationPaymentsReceived>
    <iff:GainLossOnPlantRelocation contextRef="c-854" decimals="-6" id="f-2715" unitRef="usd">22000000</iff:GainLossOnPlantRelocation>
    <iff:EstimatedIncomeTaxExpenseBenefit contextRef="c-854" decimals="-6" id="f-2716" unitRef="usd">6000000</iff:EstimatedIncomeTaxExpenseBenefit>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-855" decimals="-6" id="f-2717" unitRef="usd">215000000</us-gaap:PropertyPlantAndEquipmentNet>
    <iff:BankGuaranteesAndPledgedAssetsToPursueDefensesRelatedToOtherContingencies contextRef="c-11" decimals="-6" id="f-2718" unitRef="usd">19000000</iff:BankGuaranteesAndPledgedAssetsToPursueDefensesRelatedToOtherContingencies>
    <us-gaap:ProceedsFromIncomeTaxRefunds contextRef="c-856" decimals="-6" id="f-2719" unitRef="usd">8000000</us-gaap:ProceedsFromIncomeTaxRefunds>
    <us-gaap:ProceedsFromIncomeTaxRefunds contextRef="c-857" decimals="-6" id="f-2720" unitRef="usd">4000000</us-gaap:ProceedsFromIncomeTaxRefunds>
    <us-gaap:ProceedsFromIncomeTaxRefunds contextRef="c-858" decimals="-6" id="f-2721" unitRef="usd">3000000</us-gaap:ProceedsFromIncomeTaxRefunds>
    <iff:LossContingencyReceivableWrittenOff contextRef="c-859" decimals="-6" id="f-2722" unitRef="usd">6000000</iff:LossContingencyReceivableWrittenOff>
    <iff:MalpracticeLossContingencyPaymentsInceptionToDate contextRef="c-206" decimals="-6" id="f-2723" unitRef="usd">46000000</iff:MalpracticeLossContingencyPaymentsInceptionToDate>
    <us-gaap:LossContingencyEstimateOfPossibleLoss contextRef="c-860" decimals="0" id="f-2724" unitRef="usd">0</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <us-gaap:LossContingencyEstimateOfPossibleLoss contextRef="c-861" decimals="-6" id="f-2725" unitRef="usd">75000000</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <us-gaap:MinorityInterestDisclosureTextBlock contextRef="c-1" id="f-2726">REDEEMABLE NON-CONTROLLING INTERESTS&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Through certain subsidiaries of the Company&#x2019;s Frutarom acquisition, there were certain non-controlling interests that carried redemption features. The non-controlling interest holders had the right, over a stipulated period of time, to sell their respective interests to Frutarom, and Frutarom had the option to purchase these interests (subject to the same timing). In most cases, these options carried similar price and conditions of exercise, and were settled on a pre-agreed formula based on a multiple of the average EBITDA of consecutive quarters to be achieved during the period ending prior to the exercise date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the details of the Company&#x2019;s&#160;redeemable&#160;non-controlling interests:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.860%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.208%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable &lt;br/&gt;Non-controlling Interests&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of foreign exchange translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share of profit or loss attributable to redeemable non-controlling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redemption value adjustment for the current period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividends paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of foreign exchange translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share of profit or loss attributable to redeemable non-controlling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redemption value adjustment for the current period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercises of redeemable non-controlling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of foreign exchange translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redemption value adjustment for the current period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividends paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercises of redeemable non-controlling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Disposal of redeemable non-controlling interests&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The disposal of redeemable non-controlling interests was related to the sale of the Company&#x2019;s investment in the Sonarome business. The total proceeds received from the sale transaction was approximately $29&#160;million.&lt;/span&gt;&lt;/div&gt;</us-gaap:MinorityInterestDisclosureTextBlock>
    <us-gaap:RedeemableNoncontrollingInterestTableTextBlock contextRef="c-1" id="f-2727">&lt;div style="margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the details of the Company&#x2019;s&#160;redeemable&#160;non-controlling interests:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.860%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.208%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable &lt;br/&gt;Non-controlling Interests&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of foreign exchange translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share of profit or loss attributable to redeemable non-controlling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redemption value adjustment for the current period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividends paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of foreign exchange translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share of profit or loss attributable to redeemable non-controlling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redemption value adjustment for the current period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercises of redeemable non-controlling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of foreign exchange translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redemption value adjustment for the current period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividends paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercises of redeemable non-controlling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Disposal of redeemable non-controlling interests&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The disposal of redeemable non-controlling interests was related to the sale of the Company&#x2019;s investment in the Sonarome business. The total proceeds received from the sale transaction was approximately $29&#160;million.&lt;/span&gt;&lt;/div&gt;</us-gaap:RedeemableNoncontrollingInterestTableTextBlock>
    <us-gaap:MinorityInterest contextRef="c-862" decimals="-6" id="f-2728" unitRef="usd">98000000</us-gaap:MinorityInterest>
    <iff:NoncontrollingInterestImpactOfForeignExchangeTranslation contextRef="c-863" decimals="-6" id="f-2729" unitRef="usd">-1000000</iff:NoncontrollingInterestImpactOfForeignExchangeTranslation>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-863" decimals="-6" id="f-2730" unitRef="usd">6000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:MinorityInterestChangeInRedemptionValue contextRef="c-863" decimals="-6" id="f-2731" unitRef="usd">2000000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="c-863" decimals="-6" id="f-2732" unitRef="usd">-2000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterest contextRef="c-864" decimals="-6" id="f-2733" unitRef="usd">105000000</us-gaap:MinorityInterest>
    <iff:NoncontrollingInterestImpactOfForeignExchangeTranslation contextRef="c-865" decimals="-6" id="f-2734" unitRef="usd">6000000</iff:NoncontrollingInterestImpactOfForeignExchangeTranslation>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-865" decimals="-6" id="f-2735" unitRef="usd">4000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:MinorityInterestChangeInRedemptionValue contextRef="c-865" decimals="-6" id="f-2736" unitRef="usd">5000000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:MinorityInterestDecreaseFromRedemptions contextRef="c-865" decimals="-6" id="f-2737" unitRef="usd">-49000000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterest contextRef="c-866" decimals="-6" id="f-2738" unitRef="usd">59000000</us-gaap:MinorityInterest>
    <iff:NoncontrollingInterestImpactOfForeignExchangeTranslation contextRef="c-867" decimals="-6" id="f-2739" unitRef="usd">8000000</iff:NoncontrollingInterestImpactOfForeignExchangeTranslation>
    <us-gaap:MinorityInterestChangeInRedemptionValue contextRef="c-867" decimals="-6" id="f-2740" unitRef="usd">-2000000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="c-867" decimals="-6" id="f-2741" unitRef="usd">-13000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromRedemptions contextRef="c-867" decimals="-6" id="f-2742" unitRef="usd">-25000000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <iff:NoncontrollingInterestDecreaseFromDisposal contextRef="c-867" decimals="-6" id="f-2743" unitRef="usd">-11000000</iff:NoncontrollingInterestDecreaseFromDisposal>
    <us-gaap:MinorityInterest contextRef="c-868" decimals="-6" id="f-2744" unitRef="usd">0</us-gaap:MinorityInterest>
    <us-gaap:ProceedsFromSaleOfLongtermInvestments contextRef="c-869" decimals="-6" id="f-2745" unitRef="usd">29000000</us-gaap:ProceedsFromSaleOfLongtermInvestments>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents contextRef="c-870" decimals="-6" id="f-2746" unitRef="usd">26000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents contextRef="c-871" decimals="-6" id="f-2747" unitRef="usd">52000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents>
    <iff:DisposalGroupIncludingDiscontinuedOperationTradeReceivablesNet contextRef="c-870" decimals="-6" id="f-2748" unitRef="usd">15000000</iff:DisposalGroupIncludingDiscontinuedOperationTradeReceivablesNet>
    <iff:DisposalGroupIncludingDiscontinuedOperationTradeReceivablesNet contextRef="c-871" decimals="-6" id="f-2749" unitRef="usd">85000000</iff:DisposalGroupIncludingDiscontinuedOperationTradeReceivablesNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1 contextRef="c-870" decimals="-6" id="f-2750" unitRef="usd">18000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1 contextRef="c-871" decimals="-6" id="f-2751" unitRef="usd">157000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment contextRef="c-870" decimals="-6" id="f-2752" unitRef="usd">7000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment contextRef="c-871" decimals="-6" id="f-2753" unitRef="usd">92000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1 contextRef="c-870" decimals="-6" id="f-2754" unitRef="usd">276000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1 contextRef="c-871" decimals="-6" id="f-2755" unitRef="usd">348000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets contextRef="c-870" decimals="-6" id="f-2756" unitRef="usd">146000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets contextRef="c-871" decimals="-6" id="f-2757" unitRef="usd">428000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-870" decimals="-6" id="f-2758" unitRef="usd">9000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-871" decimals="-6" id="f-2759" unitRef="usd">13000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets contextRef="c-870" decimals="-6" id="f-2760" unitRef="usd">9000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets contextRef="c-871" decimals="-6" id="f-2761" unitRef="usd">25000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation contextRef="c-870" decimals="-6" id="f-2762" unitRef="usd">506000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation contextRef="c-871" decimals="-6" id="f-2763" unitRef="usd">1200000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayable contextRef="c-870" decimals="-6" id="f-2764" unitRef="usd">4000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayable>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayable contextRef="c-871" decimals="-6" id="f-2765" unitRef="usd">56000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayable>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities contextRef="c-870" decimals="-6" id="f-2766" unitRef="usd">24000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities contextRef="c-871" decimals="-6" id="f-2767" unitRef="usd">92000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities contextRef="c-870" decimals="-6" id="f-2768" unitRef="usd">18000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities contextRef="c-871" decimals="-6" id="f-2769" unitRef="usd">64000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation contextRef="c-870" decimals="-6" id="f-2770" unitRef="usd">46000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation contextRef="c-871" decimals="-6" id="f-2771" unitRef="usd">212000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:OtherNonoperatingIncomeAndExpenseTextBlock contextRef="c-1" id="f-2772">OTHER (EXPENSE) INCOME, NET&lt;div style="margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other (expense) income, net consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.222%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.640%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange (losses) gains&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Losses) gains on business divestitures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on China facility relocation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension-related benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (expense) income, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OtherNonoperatingIncomeAndExpenseTextBlock>
    <us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock contextRef="c-1" id="f-2773">&lt;div style="margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other (expense) income, net consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.222%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.640%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(DOLLARS IN MILLIONS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange (losses) gains&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Losses) gains on business divestitures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on China facility relocation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension-related benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (expense) income, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c-1" decimals="-6" id="f-2774" unitRef="usd">-77000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c-9" decimals="-6" id="f-2775" unitRef="usd">-12000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c-10" decimals="-6" id="f-2776" unitRef="usd">3000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:InvestmentIncomeInterest contextRef="c-1" decimals="-6" id="f-2777" unitRef="usd">5000000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="c-9" decimals="-6" id="f-2778" unitRef="usd">15000000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="c-10" decimals="-6" id="f-2779" unitRef="usd">8000000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:GainLossOnSaleOfBusiness contextRef="c-1" decimals="-6" id="f-2780" unitRef="usd">-23000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness contextRef="c-9" decimals="-6" id="f-2781" unitRef="usd">11000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness contextRef="c-10" decimals="-6" id="f-2782" unitRef="usd">13000000</us-gaap:GainLossOnSaleOfBusiness>
    <iff:GainLossOnChinaFacilityRelocation contextRef="c-1" decimals="-6" id="f-2783" unitRef="usd">22000000</iff:GainLossOnChinaFacilityRelocation>
    <iff:GainLossOnChinaFacilityRelocation contextRef="c-9" decimals="-6" id="f-2784" unitRef="usd">0</iff:GainLossOnChinaFacilityRelocation>
    <iff:GainLossOnChinaFacilityRelocation contextRef="c-10" decimals="-6" id="f-2785" unitRef="usd">0</iff:GainLossOnChinaFacilityRelocation>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="c-1" decimals="-6" id="f-2786" unitRef="usd">-28000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="c-9" decimals="-6" id="f-2787" unitRef="usd">-19000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="c-10" decimals="-6" id="f-2788" unitRef="usd">-34000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <iff:OtherComponentsOfOtherNonoperatingIncomeExpense contextRef="c-1" decimals="-6" id="f-2789" unitRef="usd">17000000</iff:OtherComponentsOfOtherNonoperatingIncomeExpense>
    <iff:OtherComponentsOfOtherNonoperatingIncomeExpense contextRef="c-9" decimals="-6" id="f-2790" unitRef="usd">4000000</iff:OtherComponentsOfOtherNonoperatingIncomeExpense>
    <iff:OtherComponentsOfOtherNonoperatingIncomeExpense contextRef="c-10" decimals="-6" id="f-2791" unitRef="usd">0</iff:OtherComponentsOfOtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-1" decimals="-6" id="f-2792" unitRef="usd">-28000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-9" decimals="-6" id="f-2793" unitRef="usd">37000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-10" decimals="-6" id="f-2794" unitRef="usd">58000000</us-gaap:OtherNonoperatingIncomeExpense>
    <srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock contextRef="c-1" id="f-2795">&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;SCHEDULE II &#x2014; VALUATION AND QUALIFYING ACCOUNTS AND RESERVES&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(IN MILLIONS)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.999%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.280%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.280%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.280%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.280%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.280%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.280%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.287%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Year Ended December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance at&lt;br/&gt;beginning&lt;br/&gt;of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Additions (deductions) charged to costs and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accounts&lt;br/&gt;written off&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Translation&lt;br/&gt;adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance on credit and operating loss carryforwards and other net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Year Ended December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance at&lt;br/&gt;beginning&lt;br/&gt;of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Additions charged to costs and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accounts&lt;br/&gt;written off&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Translation&lt;br/&gt;adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance at&lt;br/&gt;end of&lt;br/&gt;period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance on credit and operating loss carryforwards and other net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance at&lt;br/&gt;beginning&lt;br/&gt;of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Additions charged to costs and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accounts&lt;br/&gt;written off&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Translation&lt;br/&gt;adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance at&lt;br/&gt;end of&lt;br/&gt;period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance on credit and operating loss carryforwards and other net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt"&gt;The amount relates to adjustment to allowances for bad debts as a result of purchase price allocation related to the Merger with N&amp;amp;B.&lt;/span&gt;&lt;/div&gt;</srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-872" decimals="-6" id="f-2796" unitRef="usd">53000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="c-873" decimals="-6" id="f-2797" unitRef="usd">9000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired contextRef="c-873" decimals="-6" id="f-2798" unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired>
    <us-gaap:ValuationAllowancesAndReservesDeductions contextRef="c-873" decimals="-6" id="f-2799" unitRef="usd">11000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesAdjustments contextRef="c-873" decimals="-6" id="f-2800" unitRef="usd">1000000</us-gaap:ValuationAllowancesAndReservesAdjustments>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts contextRef="c-873" decimals="-6" id="f-2801" unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-874" decimals="-6" id="f-2802" unitRef="usd">52000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-875" decimals="-6" id="f-2803" unitRef="usd">262000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="c-876" decimals="-6" id="f-2804" unitRef="usd">76000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired contextRef="c-876" decimals="-6" id="f-2805" unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired>
    <us-gaap:ValuationAllowancesAndReservesDeductions contextRef="c-876" decimals="-6" id="f-2806" unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesAdjustments contextRef="c-876" decimals="-6" id="f-2807" unitRef="usd">-23000000</us-gaap:ValuationAllowancesAndReservesAdjustments>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts contextRef="c-876" decimals="-6" id="f-2808" unitRef="usd">9000000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-877" decimals="-6" id="f-2809" unitRef="usd">324000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-878" decimals="-6" id="f-2810" unitRef="usd">46000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="c-879" decimals="-6" id="f-2811" unitRef="usd">19000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired contextRef="c-879" decimals="-6" id="f-2812" unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired>
    <us-gaap:ValuationAllowancesAndReservesDeductions contextRef="c-879" decimals="-6" id="f-2813" unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesAdjustments contextRef="c-879" decimals="-6" id="f-2814" unitRef="usd">-12000000</us-gaap:ValuationAllowancesAndReservesAdjustments>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts contextRef="c-879" decimals="-6" id="f-2815" unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-872" decimals="-6" id="f-2816" unitRef="usd">53000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-880" decimals="-6" id="f-2817" unitRef="usd">232000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="c-881" decimals="-6" id="f-2818" unitRef="usd">51000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired contextRef="c-881" decimals="-6" id="f-2819" unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired>
    <us-gaap:ValuationAllowancesAndReservesDeductions contextRef="c-881" decimals="-6" id="f-2820" unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesAdjustments contextRef="c-881" decimals="-6" id="f-2821" unitRef="usd">-21000000</us-gaap:ValuationAllowancesAndReservesAdjustments>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts contextRef="c-881" decimals="-6" id="f-2822" unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-875" decimals="-6" id="f-2823" unitRef="usd">262000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-882" decimals="-6" id="f-2824" unitRef="usd">21000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="c-883" decimals="-6" id="f-2825" unitRef="usd">6000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired contextRef="c-883" decimals="-6" id="f-2826" unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired>
    <us-gaap:ValuationAllowancesAndReservesDeductions contextRef="c-883" decimals="-6" id="f-2827" unitRef="usd">1000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesAdjustments contextRef="c-883" decimals="-6" id="f-2828" unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesAdjustments>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts contextRef="c-883" decimals="-6" id="f-2829" unitRef="usd">20000000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-878" decimals="-6" id="f-2830" unitRef="usd">46000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-884" decimals="-6" id="f-2831" unitRef="usd">257000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="c-885" decimals="-6" id="f-2832" unitRef="usd">-18000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired contextRef="c-885" decimals="-6" id="f-2833" unitRef="usd">9000000</us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired>
    <us-gaap:ValuationAllowancesAndReservesDeductions contextRef="c-885" decimals="-6" id="f-2834" unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesAdjustments contextRef="c-885" decimals="-6" id="f-2835" unitRef="usd">-16000000</us-gaap:ValuationAllowancesAndReservesAdjustments>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts contextRef="c-885" decimals="-6" id="f-2836" unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-880" decimals="-6" id="f-2837" unitRef="usd">232000000</us-gaap:ValuationAllowancesAndReservesBalance>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
